#BioGRID Chemical Interaction ID	BioGRID Gene ID	Entrez Gene ID	Systematic Name	Official Symbol	Synonyms	Organism ID	Organism	Action	Interaction Type	Author	Pubmed ID	BioGRID Publication ID	BioGRID Chemical ID	Chemical Name	Chemical Synonyms	Chemical Brands	Chemical Source	Chemical Source ID	Molecular Formula	Chemical Type	ATC Codes	CAS Number	Curated By	Method	Method Description	Related BioGRID Gene ID	Related Entrez Gene ID	Related Systematic Name	Related Official Symbol	Related Synonyms	Related Organism ID	Related Organism	Related Type	Notes	InChIKey
1	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Eriksson BI (2000)	11055889	171739	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
2	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Warkentin TE (2000)	10912644	171738	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
3	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Szaba FM (2002)	11807012	171737	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
4	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Fabrizio MC (2001)	11467439	171736	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
5	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Turpie AG (1999)	10505536	171735	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1	Lepirudin	Lepirudin recombinant|Hirudin variant-1	refludan	DRUGBANK	DB00001	C287H440N80O110S6	biologic	B01AE02	138068-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
7	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
8	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
9	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
12	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Zhang W (2007)	17704420	171743	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
14	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Snyder LC (2005)	16336752	171744	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Viloria-Petit A (2001)	11431346	171748	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Hosokawa N (1999)	10480573	171746	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Wakita H (1999)	10601294	171747	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Suwa T (2000)	10628369	171745	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Burke P (2001)	11408594	141935	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
25	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Zhang W (2007)	17704420	171743	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
29	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
30	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Negri DR (1995)	7547242	171749	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
31	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
32	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
33	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
34	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2	Cetuximab	Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer|Ctuximab|Cetuximab|Cetuximabum	erbitux	DRUGBANK	DB00002	C6484H10042N1732O2023S36	biologic	L01XC06	205923-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
35	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Duvic M (2008)	18684057	171751	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
36	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Turturro F (2007)	17187516	171750	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
37	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
38	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Foss F (2006)	16516670	171752	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
39	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Foss F (2005)	15811959	171753	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
40	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Duvic M (2008)	18684057	171751	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
41	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Turturro F (2007)	17187516	171750	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
42	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
43	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
44	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Murphy JR (1988)	3124610	171755	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
45	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Kiyokawa T (1989)	2786749	171754	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
46	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
47	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	unknown	target	Foss F (2005)	15811959	171753	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
48	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	unknown	target	Foss F (2006)	16516670	171752	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
49	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	unknown	target	Foss FM (2000)	11707860	171756	4	Denileukin diftitox	Diphtheria toxin precursor|DT|NAD(+--diphthamide ADP- ribosyltransferase)	ontak	DRUGBANK	DB00004	C2560H4042N678O799S17	biologic	L01XX29	173146-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
50	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
51	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
52	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Hughes LB (2004)	15526004	171758	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
53	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Criswell LA (2004)	15457442	171757	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
54	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
55	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
56	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
57	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
58	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
59	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
60	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
61	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
62	112987	7133	-	TNFRSF1B	CD120b|TBPII|TNF-R-II|TNF-R75|TNFBR|TNFR1B|TNFR2|TNFR80|p75|p75TNFR	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
63	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
64	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
65	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Hughes LB (2004)	15526004	171758	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
66	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Criswell LA (2004)	15457442	171757	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
67	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
68	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
69	110227	4049	DAMA-25N12.13-004	LTA	LT|TNFB|TNFSF1	9606	Homo sapiens	unknown	target	Kang CP (2005)	15695296	171759	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
70	110227	4049	DAMA-25N12.13-004	LTA	LT|TNFB|TNFSF1	9606	Homo sapiens	unknown	target	Gudbrandsdottir S (2004)	15005015	171760	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
71	110227	4049	DAMA-25N12.13-004	LTA	LT|TNFB|TNFSF1	9606	Homo sapiens	unknown	target	Buch MH (2004)	15033655	171761	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
72	110227	4049	DAMA-25N12.13-004	LTA	LT|TNFB|TNFSF1	9606	Homo sapiens	unknown	target	Pennica D (1992)	1328224	171762	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
73	110227	4049	DAMA-25N12.13-004	LTA	LT|TNFB|TNFSF1	9606	Homo sapiens	unknown	target	Johnson CJ (2001)	11302411	171763	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
74	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Hart SP (2000)	10800083	171764	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
75	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Ozgocmen S (2007)	17387033	171765	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
76	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Criswell LA (2004)	15457442	171757	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
77	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Hughes LB (2004)	15526004	171758	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
78	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
79	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Park YC (1999)	10206649	144893	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
80	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Moreland LW (1999)	10375846	171766	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
81	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Grell M (1999)	10357816	171767	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
82	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Calabrese LH (1999)	10405518	171768	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
83	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Sandborn WJ (1999)	10338381	171769	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
84	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Hart SP (2000)	10800083	171764	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
85	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Ranheim EA (1995)	7535196	171770	5	Etanercept	p75|CD120b|Tumor necrosis factor receptor 2|TNF-R2|Tumor necrosis factor receptor type II|Tumor necrosis factor receptor superfamily member 1B precursor|p80 TNF-alpha receptor	enbrel|brenzys	DRUGBANK	DB00005	C2224H3475N621O698S36	biologic	L04AB01	185243-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
86	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
87	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Gladwell TD (2002)	11833835	171773	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
88	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Scatena R (2000)	11060732	171777	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
89	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Kleiman NS (2002)	11923794	171776	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
90	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Carswell CI (2002)	11929334	171775	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
91	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Bates ER (2001)	11504570	171774	6	Bivalirudin	-	bivalirudin|bivalirudin for in	DRUGBANK	DB00006	C98H138N24O33	small molecule	B01AE06	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
92	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Imai A (1998)	9625809	171779	7	Leuprolide	Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet	eligard 45 mg|lupaneta pack|le	DRUGBANK	DB00007	C59H84N16O12	biologic	L02AE02	53714-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
93	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Borroni R (2000)	10687850	171782	7	Leuprolide	Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet	eligard 45 mg|lupaneta pack|le	DRUGBANK	DB00007	C59H84N16O12	biologic	L02AE02	53714-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
94	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Castellon E (2006)	16809153	171783	7	Leuprolide	Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet	eligard 45 mg|lupaneta pack|le	DRUGBANK	DB00007	C59H84N16O12	biologic	L02AE02	53714-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
95	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Murase M (2005)	15758569	171780	7	Leuprolide	Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet	eligard 45 mg|lupaneta pack|le	DRUGBANK	DB00007	C59H84N16O12	biologic	L02AE02	53714-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
96	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Khurana KK (1999)	10394541	171781	7	Leuprolide	Leuprorelina|L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide|Leuproreline|(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5|Leuprorelinum|Leuprorelin|PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet	eligard 45 mg|lupaneta pack|le	DRUGBANK	DB00007	C59H84N16O12	biologic	L02AE02	53714-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
97	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Dhalluin C (2005)	15898717	171786	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
98	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Yano H (2006)	16953837	171784	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
99	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
100	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
101	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Dhalluin C (2005)	15898717	171786	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
102	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Yano H (2006)	16953837	171784	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
103	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
104	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	8	Peginterferon alfa-2a	-	pegasys rbv|pegasys	DRUGBANK	DB00008	-	biologic	L03AB61|L03AB11	198153-51-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
105	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Melandri G (2009)	19436656	171787	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
106	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
107	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Longstaff C (2008)	18673235	171788	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
108	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Hilleman DE (2007)	17963464	171789	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
109	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Melandri G (2009)	19436656	171787	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
110	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Longstaff C (2008)	18673235	171788	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
111	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
112	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
113	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
114	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	9	Alteplase	t-plasminogen activator|t-PA|tPA|Tissue-type plasminogen activator precursor	activase rt-pa|lysatec rt - pa	DRUGBANK	DB00009	C2569H3928N746O781S40	biologic	B01AD02|S01XA13	105857-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
115	108959	2692	-	GHRHR	GHRFR|GRFR|IGHD1B	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	10	Sermorelin	-	-	DRUGBANK	DB00010	C149H246N44O42S	biologic	H01AC04|V04CD03	86168-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
116	108959	2692	-	GHRHR	GHRFR|GRFR|IGHD1B	9606	Homo sapiens	agonist	target	Esposito P (2003)	14499707	171790	10	Sermorelin	-	-	DRUGBANK	DB00010	C149H246N44O42S	biologic	H01AC04|V04CD03	86168-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
117	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
118	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
119	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
120	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Krown SE (1987)	10822464	171791	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
121	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
122	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
123	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
124	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
125	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Krown SE (1987)	10822464	171791	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
126	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	11	Interferon alfa-n1	Interferon alpha-n1 (Ins)|Interferon alpha-2|Interferon alpha-A|LeIF A	wellferon inj 3000000unit/ml|w	DRUGBANK	DB00011	C860H1353N227O255S9	biologic	L03AB06	74899-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
127	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	12	Darbepoetin alfa	Darbepoetin|Darbepoetin alfa,recombinant	aranesp -(hsa-free)|aranesp|ar	DRUGBANK	DB00012	C815H1317N233O241S5	biologic	B03XA02	209810-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
128	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	LaMontagne KR (2006)	16505108	171793	12	Darbepoetin alfa	Darbepoetin|Darbepoetin alfa,recombinant	aranesp -(hsa-free)|aranesp|ar	DRUGBANK	DB00012	C815H1317N233O241S5	biologic	B03XA02	209810-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
129	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Kokhaei P (2007)	17575216	171792	12	Darbepoetin alfa	Darbepoetin|Darbepoetin alfa,recombinant	aranesp -(hsa-free)|aranesp|ar	DRUGBANK	DB00012	C815H1317N233O241S5	biologic	B03XA02	209810-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
130	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Kirchhofer D (2003)	12815039	171795	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
131	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Suzuki M (2004)	14747469	171794	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
132	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Gerstein ES (2003)	12785198	171800	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
133	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Hellgren M (2003)	12709915	171797	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
134	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Chang H (2003)	12745435	171796	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
135	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Gamberi G (2003)	12579271	171799	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
136	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Shetty S (2003)	12642587	171798	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
137	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Korenberg JR (1994)	7959795	171801	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
138	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
139	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Kanalas JJ (1992)	1280065	171803	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
140	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
141	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Kanalas JJ (1993)	8241286	171802	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
142	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Lopez-Alemany R (2003)	12666133	171805	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
143	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Hashimoto M (2003)	12719778	171804	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
144	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Zhang X (2003)	12658774	171807	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
145	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Guda K (2003)	12720300	171806	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
146	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
147	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chang H (2003)	12745435	171796	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
148	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Wygrecka M (2004)	15351849	171809	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
149	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Grebenchtchikov N (2005)	15944795	171808	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
150	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Swartz JM (2004)	15277569	171810	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
151	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Iglesias D (2005)	15640330	171811	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
152	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Fernandez-Soria V (2006)	16327990	171812	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
153	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Stief TW (2003)	14507109	171813	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
154	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Chang H (2003)	12745435	171796	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
155	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Lindholt JS (2003)	12787697	171816	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
156	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Wells RG (2003)	12893898	171814	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
157	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Aleman C (2003)	12826021	171815	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
158	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Bell WR (2003)	12556741	171818	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
159	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Chang H (2003)	12745435	171796	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
160	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Gamberi G (2003)	12579271	171799	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
161	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Zhang G (2003)	12707394	171817	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
162	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Wielockx B (2003)	12824001	171819	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
163	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Fuchs T (2003)	12817472	171823	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
164	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Gutova M (2007)	17327908	171822	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
165	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Czekay RP (2003)	12615913	171821	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
166	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Kanse SM (2004)	14679304	171820	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
167	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Beaufort N (2004)	14688365	171825	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
168	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Guerrero J (2004)	14720519	171824	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
169	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Odet F (2004)	14645112	171828	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
170	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Uhrin P (2007)	17434507	171827	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
171	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Espana F (2007)	17253188	171826	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
172	110876	4811	-	NID1	NID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
173	110876	4811	-	NID1	NID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
174	110876	4811	-	NID1	NID	9606	Homo sapiens	unknown	target	Stephens RW (1992)	1499567	2893	13	Urokinase	uPA|Urokinase-type plasminogen activator precursor|U-plasminogen activator	kinlytic (urokinase for inject	DRUGBANK	DB00013	C1376H2145N383O406S18	biologic	B01AD04	9039-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
175	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Kirby RS (2009)	20053189	171829	14	Goserelin	Zoladex|ICI-118630|Goserelin|Goserelin acetate	zoladex|zoladex la inj depot 1	DRUGBANK	DB00014	C59H84N18O14	small molecule	L02AE03	65807-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLCLNMBMMGCOAS-URPVMXJPSA-N
176	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	14	Goserelin	Zoladex|ICI-118630|Goserelin|Goserelin acetate	zoladex|zoladex la inj depot 1	DRUGBANK	DB00014	C59H84N18O14	small molecule	L02AE03	65807-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLCLNMBMMGCOAS-URPVMXJPSA-N
177	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Kirby RS (2009)	20053189	171829	14	Goserelin	Zoladex|ICI-118630|Goserelin|Goserelin acetate	zoladex|zoladex la inj depot 1	DRUGBANK	DB00014	C59H84N18O14	small molecule	L02AE03	65807-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLCLNMBMMGCOAS-URPVMXJPSA-N
178	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	14	Goserelin	Zoladex|ICI-118630|Goserelin|Goserelin acetate	zoladex|zoladex la inj depot 1	DRUGBANK	DB00014	C59H84N18O14	small molecule	L02AE03	65807-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLCLNMBMMGCOAS-URPVMXJPSA-N
179	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Melandri G (2009)	19436656	171787	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
180	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
181	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Longstaff C (2008)	18673235	171788	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
182	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Hilleman DE (2007)	17963464	171789	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
183	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Melandri G (2009)	19436656	171787	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
184	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Longstaff C (2008)	18673235	171788	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
185	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
186	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
187	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
188	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	15	Reteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	retavase	DRUGBANK	DB00015	C1736H2671N499O522S22	biologic	B01AD07	133652-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
189	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	16	Erythropoietin	Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human)	eprex sterile solution 5000iu/	DRUGBANK	DB00016	C815H1317N233O241S5	biologic	B03XA01	11096-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
190	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	LaMontagne KR (2006)	16505108	171793	16	Erythropoietin	Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human)	eprex sterile solution 5000iu/	DRUGBANK	DB00016	C815H1317N233O241S5	biologic	B03XA01	11096-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
191	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Kokhaei P (2007)	17575216	171792	16	Erythropoietin	Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human)	eprex sterile solution 5000iu/	DRUGBANK	DB00016	C815H1317N233O241S5	biologic	B03XA01	11096-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
192	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	17	Salmon Calcitonin	Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon|recombinant salmon calcitonin	caltine inj 100 unit/ml (1ml a	DRUGBANK	DB00017	C145H240N44O48S2	biologic	H05BA01	47931-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
193	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Sarkar A (1997)	9231703	171830	17	Salmon Calcitonin	Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon|recombinant salmon calcitonin	caltine inj 100 unit/ml (1ml a	DRUGBANK	DB00017	C145H240N44O48S2	biologic	H05BA01	47931-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
194	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Stroop SD (1995)	7610922	171831	17	Salmon Calcitonin	Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon|recombinant salmon calcitonin	caltine inj 100 unit/ml (1ml a	DRUGBANK	DB00017	C145H240N44O48S2	biologic	H05BA01	47931-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
195	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Bouizar Z (1986)	3004987	171832	17	Salmon Calcitonin	Calcitonin, salmon|Calcitonin (Salmon Synthetic)|Fortical|Salmon calcitonin|Calcimar|Salmotonin|Cibacalcin|Miacalcin|Calcitonin salmon recombinant|Calcitonin 1 precursor|Calcitonin Salmon|Calcitonin-salmon|recombinant salmon calcitonin	caltine inj 100 unit/ml (1ml a	DRUGBANK	DB00017	C145H240N44O48S2	biologic	H05BA01	47931-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
196	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Dhalluin C (2005)	15898717	171786	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
197	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
198	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
199	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
200	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
201	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
202	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
203	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
204	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Dhalluin C (2005)	15898717	171786	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
205	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Yano H (2006)	16953837	171784	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
206	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	18	Interferon alfa-n3	-	alferon	DRUGBANK	DB00018	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
207	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Druhan LJ (2005)	15353486	171834	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
208	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Pelus LM (2004)	12958067	171835	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
209	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Jian MY (2004)	16245075	171836	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
210	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Schepers H (2007)	17475913	171837	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
211	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Carter CR (2004)	14657210	171833	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
212	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	agonist	target	Zhuang D (2005)	16033816	171838	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
213	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	agonist	target	Elsaesser A (2003)	12944913	171839	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
214	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	agonist	target	Erkeland SJ (2007)	17001306	99479	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
215	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	agonist	target	Cao YR (2005)	15949269	171841	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
216	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	agonist	target	Kotto-Kome AC (2004)	15082029	171840	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
217	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	agonist	target	Ward AC (2006)	17127322	171842	19	Pegfilgrastim	Peg-filgrastim|Granulocyte colony-stimulating factor pegfilgrastim	neulasta	DRUGBANK	DB00019	C845H1343N223O243S9	biologic	L03AA13	208265-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
218	111544	5553	-	PRG2	BMPG|MBP|MBP1	9606	Homo sapiens	unknown	target	Letuve S (2006)	16522458	171845	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
219	111544	5553	-	PRG2	BMPG|MBP|MBP1	9606	Homo sapiens	unknown	target	Kang JH (2007)	17600316	171844	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
220	111544	5553	-	PRG2	BMPG|MBP|MBP1	9606	Homo sapiens	unknown	target	Menon K (2007)	17383764	171843	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
221	109778	3563	RP11-261P4.2	IL3RA	CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra	9606	Homo sapiens	agonist	target	Sakhno LV (2007)	17500228	171847	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
222	109778	3563	RP11-261P4.2	IL3RA	CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra	9606	Homo sapiens	agonist	target	Ward KA (2006)	16698686	171846	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
223	109778	3563	RP11-261P4.2	IL3RA	CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra	9606	Homo sapiens	agonist	target	Eksioglu EA (2007)	17562355	171849	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
224	109778	3563	RP11-261P4.2	IL3RA	CD123|IL3R|IL3RAY|IL3RX|IL3RY|hIL-3Ra	9606	Homo sapiens	agonist	target	Lencz T (2007)	17522711	171848	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
225	112285	6383	-	SDC2	CD362|HSPG|HSPG1|SYND2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
226	112285	6383	-	SDC2	CD362|HSPG|HSPG1|SYND2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
227	112285	6383	-	SDC2	CD362|HSPG|HSPG1|SYND2	9606	Homo sapiens	agonist	target	Modrowski D (2000)	10734053	3718	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
228	107825	1438	-	CSF2RA	CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
229	107825	1438	-	CSF2RA	CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4	9606	Homo sapiens	agonist	target	Wang Y (2007)	17090651	171852	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
230	107825	1438	-	CSF2RA	CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4	9606	Homo sapiens	agonist	target	Lencz T (2007)	17522711	171848	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
231	107825	1438	-	CSF2RA	CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4	9606	Homo sapiens	agonist	target	Chen J (2006)	16760463	171850	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
232	107825	1438	-	CSF2RA	CD116|CDw116|CSF2R|CSF2RAX|CSF2RAY|CSF2RX|CSF2RY|GM-CSF-R-alpha|GMCSFR|GMR|SMDP4	9606	Homo sapiens	agonist	target	Xiao R (2006)	16638185	171851	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
233	107826	1439	CITF22-45C1.4	CSF2RB	CD131|CDw131|IL3RB|IL5RB|SMDP5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
234	107826	1439	CITF22-45C1.4	CSF2RB	CD131|CDw131|IL3RB|IL5RB|SMDP5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
235	107826	1439	CITF22-45C1.4	CSF2RB	CD131|CDw131|IL3RB|IL5RB|SMDP5	9606	Homo sapiens	agonist	target	Shen Y (1992)	1424804	171853	20	Sargramostim	GM-CSF	leukine	DRUGBANK	DB00020	C639H1006N168O196S8	biologic	L03AA09	123774-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
236	112248	6344	-	SCTR	SR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	21	Secretin	-	secretin inj 75unit/vial	DRUGBANK	DB00021	C130H219N43O42	biologic	V04CK01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
237	112248	6344	-	SCTR	SR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	21	Secretin	-	secretin inj 75unit/vial	DRUGBANK	DB00021	C130H219N43O42	biologic	V04CK01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
238	112248	6344	-	SCTR	SR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	21	Secretin	-	secretin inj 75unit/vial	DRUGBANK	DB00021	C130H219N43O42	biologic	V04CK01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
239	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
240	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
241	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
242	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Dhalluin C (2005)	15898717	171786	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
243	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Yano H (2006)	16953837	171784	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
244	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
245	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
246	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
247	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
248	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Dhalluin C (2005)	15898717	171786	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
249	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Yano H (2006)	16953837	171784	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
250	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Ishii K (2009)	19955815	171785	22	Peginterferon alfa-2b	-	sylatron|pegetron|pegintron|un	DRUGBANK	DB00022	-	biologic	L03AB60|L03AB10	215647-85-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
251	113104	7253	-	TSHR	CHNG1|LGR3|hTSHR-I	9606	Homo sapiens	agonist	target	Conway GS (1996)	9039330	171854	24	Thyrotropin Alfa	Thyrotropin-a|TSH|Thyrotrophin-alfa|Thyroid stimulating hormone|Thytrophin|Thyrotropin|rTSH|Thyrotropin-alpha|Thyrotrophin-alpha	thyrogen	DRUGBANK	DB00024	C975H1513N267O304S26	biologic	H01AB01|V04CJ01	194100-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
252	113104	7253	-	TSHR	CHNG1|LGR3|hTSHR-I	9606	Homo sapiens	agonist	target	Szkudlinski MW (2004)	15571461	171855	24	Thyrotropin Alfa	Thyrotropin-a|TSH|Thyrotrophin-alfa|Thyroid stimulating hormone|Thytrophin|Thyrotropin|rTSH|Thyrotropin-alpha|Thyrotrophin-alpha	thyrogen	DRUGBANK	DB00024	C975H1513N267O304S26	biologic	H01AB01|V04CJ01	194100-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
253	113104	7253	-	TSHR	CHNG1|LGR3|hTSHR-I	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	24	Thyrotropin Alfa	Thyrotropin-a|TSH|Thyrotrophin-alfa|Thyroid stimulating hormone|Thytrophin|Thyrotropin|rTSH|Thyrotropin-alpha|Thyrotrophin-alpha	thyrogen	DRUGBANK	DB00024	C975H1513N267O304S26	biologic	H01AB01|V04CJ01	194100-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
254	108456	2158	RP6-88D7.1	F9	FIX|HEMB|P19|PTC|THPH8	9606	Homo sapiens	cofactor	target	Prince AM (1984)	6422634	171856	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
255	108456	2158	RP6-88D7.1	F9	FIX|HEMB|P19|PTC|THPH8	9606	Homo sapiens	cofactor	target	Hoofnagle JH (1976)	932529	171857	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
256	108456	2158	RP6-88D7.1	F9	FIX|HEMB|P19|PTC|THPH8	9606	Homo sapiens	cofactor	target	Yoshitake S (1985)	2994716	171860	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
257	108456	2158	RP6-88D7.1	F9	FIX|HEMB|P19|PTC|THPH8	9606	Homo sapiens	cofactor	target	Hule V (1975)	1119107	171858	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
258	108456	2158	RP6-88D7.1	F9	FIX|HEMB|P19|PTC|THPH8	9606	Homo sapiens	cofactor	target	LUNDBLAD RL (1964)	14240634	171859	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
259	113289	7450	-	VWF	F8VWF|VWD	9606	Homo sapiens	binder	target	Altieri DC (1986)	2942172	171865	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
260	113289	7450	-	VWF	F8VWF|VWD	9606	Homo sapiens	binder	target	Gill JC (2003)	14750934	171864	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
261	113289	7450	-	VWF	F8VWF|VWD	9606	Homo sapiens	binder	target	Smith KJ (1990)	2128855	171863	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
262	113289	7450	-	VWF	F8VWF|VWD	9606	Homo sapiens	binder	target	Shord SS (2000)	10938981	171862	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
263	113289	7450	-	VWF	F8VWF|VWD	9606	Homo sapiens	binder	target	Lillicrap D (2002)	11858481	171861	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
264	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	BLATRIX C (1959)	13801371	171867	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
265	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Orthner CL (1984)	6436416	171866	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
266	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Radnoff OD (1975)	236567	171870	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
267	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Freedman J (2002)	11891806	171869	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
268	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	LUNDBLAD RL (1965)	14285227	171868	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
269	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
270	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	chaperone	target	Kaufman RJ (1997)	9607108	171871	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
271	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
272	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
273	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
274	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Pipe SW (1998)	9525969	1039	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
275	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Kaufman RJ (1997)	9607108	171871	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
276	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Becker S (2004)	15213841	171872	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
277	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	chaperone	target	Srour MA (2008)	17899080	171873	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
278	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
279	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Kaufman RJ (1997)	9607108	171871	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
280	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Pipe SW (1998)	9525969	1039	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
281	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
282	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	chaperone	target	Srour MA (2008)	17899080	171873	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
283	106925	433	-	ASGR2	ASGP-R2|ASGPR2|CLEC4H2|HBXBP|HL-2	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
284	106925	433	-	ASGR2	ASGP-R2|ASGPR2|CLEC4H2|HBXBP|HL-2	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
285	106925	433	-	ASGR2	ASGP-R2|ASGPR2|CLEC4H2|HBXBP|HL-2	9606	Homo sapiens	binder	target	Bovenschen N (2005)	15946216	171874	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
286	110185	3998	-	LMAN1	ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58	9606	Homo sapiens	chaperone	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
287	110185	3998	-	LMAN1	ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58	9606	Homo sapiens	chaperone	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
288	110185	3998	-	LMAN1	ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58	9606	Homo sapiens	chaperone	target	Cunningham MA (2003)	14629470	8787	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
289	110185	3998	-	LMAN1	ERGIC-53|ERGIC53|F5F8D|FMFD1|MCFD1|MR60|gp58	9606	Homo sapiens	chaperone	target	Miao HZ (2004)	14726380	171875	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
290	111282	5264	RP11-24J20.1	PHYH	LN1|LNAP1|PAHX|PHYH1|RD	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
291	111282	5264	RP11-24J20.1	PHYH	LN1|LNAP1|PAHX|PHYH1|RD	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
292	111282	5264	RP11-24J20.1	PHYH	LN1|LNAP1|PAHX|PHYH1|RD	9606	Homo sapiens	antagonist	target	Chen C (2001)	11574539	8784	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
293	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
294	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
295	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	modulator	target	Franchini M (2011)	21391865	171876	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
296	124712	90411	-	MCFD2	F5F8D|F5F8D2|LMAN1IP|SDNSF	9606	Homo sapiens	modulator	target	Imming P (2006)	17016423	171742	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
297	124712	90411	-	MCFD2	F5F8D|F5F8D2|LMAN1IP|SDNSF	9606	Homo sapiens	modulator	target	Overington JP (2006)	17139284	171741	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
298	124712	90411	-	MCFD2	F5F8D|F5F8D2|LMAN1IP|SDNSF	9606	Homo sapiens	modulator	target	Zhang B (2005)	15886209	171877	25	Antihemophilic Factor (Recombinant)	rAHF|Factor VIII (Recombinant)|Antihemophilic factor (human)|Antihemophilic factor human|Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method|moroctocog alfa|Antihemophilic Factor, Human Recombinant|Human Factor VIII (Recombinant)|octocog alfa	kogenate fs|kryobulin vh 500 u	DRUGBANK	DB00025	C11794H18314N3220O3553S83	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
299	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Do H (2006)	17083033	171889	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
300	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Vannier E (1999)	10210771	171888	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
301	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
302	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Vamvakopoulos J (2002)	12355453	171885	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
303	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Dayer JM (2003)	12817089	171884	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
304	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	So A (2007)	17352828	171887	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
305	109770	3554	-	IL1R1	CD121A|D2S1473|IL-1R-alpha|IL1R|IL1RA|P80	9606	Homo sapiens	antagonist	target	Tang YH (2007)	17498496	171886	26	Anakinra	IL1 inhibitor|ICIL-1RA|IL-1RN|IRAP|Interleukin-1 receptor antagonist protein precursor|IL-1ra	kineret	DRUGBANK	DB00026	C759H1186N208O232S10	biologic	L04AC03	143090-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
306	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
307	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
308	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
309	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
310	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
311	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
312	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
313	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
314	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
315	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
316	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
317	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
318	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
319	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
320	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
321	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	binder	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
322	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	binder	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
323	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	binder	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
324	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	binder	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
325	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	binder	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
326	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	binder	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
327	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
328	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
329	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
330	107182	721	DADB-112B14.11-001	C4B	C4B1|C4B12|C4B2|C4B3|C4B5|C4BD|C4B_2|C4F|CH|CO4|CPAMD3	9606	Homo sapiens	binder	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
331	107182	721	DADB-112B14.11-001	C4B	C4B1|C4B12|C4B2|C4B3|C4B5|C4BD|C4B_2|C4F|CH|CO4|CPAMD3	9606	Homo sapiens	binder	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
332	107182	721	DADB-112B14.11-001	C4B	C4B1|C4B12|C4B2|C4B3|C4B5|C4BD|C4B_2|C4F|CH|CO4|CPAMD3	9606	Homo sapiens	binder	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
333	108504	2210	RP11-439A17.1	FCGR1B	CD64b|IGFRB	9606	Homo sapiens	antagonist	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
334	108504	2210	RP11-439A17.1	FCGR1B	CD64b|IGFRB	9606	Homo sapiens	antagonist	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
335	108504	2210	RP11-439A17.1	FCGR1B	CD64b|IGFRB	9606	Homo sapiens	antagonist	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
336	107181	720	DAMC-258G8.6	C4A	C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG	9606	Homo sapiens	binder	target	Siberil S (2007)	17911465	171892	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
337	107181	720	DAMC-258G8.6	C4A	C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG	9606	Homo sapiens	binder	target	Baerenwaldt A (2010)	20441428	171893	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
338	107181	720	DAMC-258G8.6	C4A	C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG	9606	Homo sapiens	binder	target	Negi VS (2007)	17351760	171891	28	Immune Globulin Human	Immune Globulin Subcutaneous|Human Normal Immunoglobulin|Immune Globulin Intravenous|IVIg|Human IGG|Immunoglobulin G (human)|Human Immunoglobulin G|Immune globulin (human)|Intravenous Immunoglobulin|Immunoglobulin G, Human	gamastan s/d|octagam 10%|immun	DRUGBANK	DB00028	C6332H9826N1692O1980S42	biologic	-	9007-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
339	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Melandri G (2009)	19436656	171787	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
340	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
341	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Longstaff C (2008)	18673235	171788	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
342	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Hilleman DE (2007)	17963464	171789	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
343	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
344	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
345	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
346	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
347	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	29	Anistreplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	eminase 30 units	DRUGBANK	DB00029	C2569H3928N746O781S40	biologic	B01AD03	81669-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
348	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
349	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
350	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
351	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
352	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Bell DS (2007)	17722952	171898	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
353	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
354	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Desbuquois B (2003)	12970169	171896	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
355	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chiu SL (2010)	20230616	171897	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
356	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Tanti JF (2009)	19683471	171894	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
357	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen LM (2002)	12038982	171895	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
358	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
359	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
360	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
361	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
362	111860	5925	RP11-174I10.1	RB1	OSRC|PPP1R130|RB|p105-Rb|pRb|pp110	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
363	111860	5925	RP11-174I10.1	RB1	OSRC|PPP1R130|RB|p105-Rb|pRb|pp110	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
364	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
365	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
366	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
367	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
368	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
369	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
370	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
371	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
372	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
373	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
374	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
375	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	30	Insulin Human	Insulin human, rDNA origin|Regular Insulin, human|Insulin Human Regular|Insulin human regular (rDNA)|Human insulin|Insulin (human)|Insulin, human|Insulin human|Insulin regular|Insulin recombinant human|human insulin (rDNA)|Insulin human [rDNA origin]|Insulin recombinant purified human|High molecular weight insulin human	humulin r u-500 kwikpen|humuli	DRUGBANK	DB00030	C257H383N65O77S6	biologic	-	11061-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
376	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Lindberg P (2001)	11163592	171900	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
377	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Hattori M (2001)	14564902	171899	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
378	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
379	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Melandri G (2009)	19436656	171787	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
380	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
381	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Longstaff C (2008)	18673235	171788	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
382	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Hilleman DE (2007)	17963464	171789	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
383	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	unknown	target	Allen S (1997)	9359841	1042	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
384	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Ferrier CM (2002)	12210068	171901	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
385	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Maupas-Schwalm F (2004)	15231724	171902	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
386	111345	5329	-	PLAUR	CD87|U-PAR|UPAR|URKR	9606	Homo sapiens	unknown	target	Bankl HC (2001)	11447759	171903	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
387	107271	821	-	CANX	CNX|IP90|P90	9606	Homo sapiens	unknown	target	Allen S (1997)	9359841	1042	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
388	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Verkleij-Hagoort AC (2007)	17141398	171904	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
389	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Bremer HA (1994)	7958159	171905	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
390	111092	5055	-	SERPINB2	HsT1201|PAI|PAI-2|PAI2|PLANH2	9606	Homo sapiens	unknown	target	Stump DC (1986)	3091604	171906	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
391	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Melandri G (2009)	19436656	171787	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
392	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Longstaff C (2008)	18673235	171788	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
393	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Hilleman DE (2007)	17963464	171789	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
394	106799	302	-	ANXA2	ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV	9606	Homo sapiens	unknown	target	Kang HM (1999)	10578524	171908	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
395	106799	302	-	ANXA2	ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV	9606	Homo sapiens	unknown	target	MacLeod TJ (2003)	12730231	171909	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
396	106799	302	-	ANXA2	ANX2|ANX2L4|CAL1H|HEL-S-270|LIP2|LPC2|LPC2D|P36|PAP-IV	9606	Homo sapiens	unknown	target	Diaz VM (2004)	15194650	171907	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
397	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Moestrup SK (1993)	8344937	6349	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
398	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Nykjaer A (1992)	1378833	171911	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
399	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Hu K (2006)	16303771	171910	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
400	110054	3856	-	KRT8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	9606	Homo sapiens	unknown	target	Kralovich KR (1998)	9988531	4732	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
401	110054	3856	-	KRT8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	9606	Homo sapiens	unknown	target	Hembrough TA (1996)	8810346	171913	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
402	110054	3856	-	KRT8	CARD2|CK-8|CK8|CYK8|K2C8|K8|KO	9606	Homo sapiens	unknown	target	Hembrough TA (1996)	8760360	171912	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
403	112978	7123	-	CLEC3B	TN|TNA	9606	Homo sapiens	unknown	target	Westergaard UB (2003)	12694198	4045	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
404	112978	7123	-	CLEC3B	TN|TNA	9606	Homo sapiens	unknown	target	Vuckovic B (2007)	17853709	171915	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
405	112978	7123	-	CLEC3B	TN|TNA	9606	Homo sapiens	unknown	target	Kamper EF (1997)	9034981	171914	31	Tenecteplase	t-plasminogen activator|tPA|Tissue-type plasminogen activator precursor|t- PA	tnkase	DRUGBANK	DB00031	C2561H3919N747O781S40	biologic	B01AD11	191588-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
406	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
407	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Olive DL (1995)	7872378	171916	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
408	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
409	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	van de Weijer BH (2003)	14680547	171917	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
410	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
411	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Olive DL (1995)	7872378	171916	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
412	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
413	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
414	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	van de Weijer BH (2003)	14680547	171917	32	Menotropins	Menotropins (FSH;LH)	repronex|menopur	DRUGBANK	DB00032	C1014H1609N287O294S27	biologic	-	61489-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
415	109681	3459	RP3-503F13.3	IFNGR1	CD119|IFNGR|IMD27A|IMD27B	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	33	Interferon gamma-1b	Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b	actimmune	DRUGBANK	DB00033	C761H1206N214O225S6	biologic	-	98059-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
416	109681	3459	RP3-503F13.3	IFNGR1	CD119|IFNGR|IMD27A|IMD27B	9606	Homo sapiens	binder	target	Matsuda A (2007)	17251453	171919	33	Interferon gamma-1b	Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b	actimmune	DRUGBANK	DB00033	C761H1206N214O225S6	biologic	-	98059-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
417	109681	3459	RP3-503F13.3	IFNGR1	CD119|IFNGR|IMD27A|IMD27B	9606	Homo sapiens	binder	target	Yao X (2007)	17618444	171918	33	Interferon gamma-1b	Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b	actimmune	DRUGBANK	DB00033	C761H1206N214O225S6	biologic	-	98059-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
418	109682	3460	-	IFNGR2	AF-1|IFGR2|IFNGT1|IMD28	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	33	Interferon gamma-1b	Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b	actimmune	DRUGBANK	DB00033	C761H1206N214O225S6	biologic	-	98059-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
419	109682	3460	-	IFNGR2	AF-1|IFGR2|IFNGT1|IMD28	9606	Homo sapiens	binder	target	Park-Min KH (2007)	17239631	171920	33	Interferon gamma-1b	Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b	actimmune	DRUGBANK	DB00033	C761H1206N214O225S6	biologic	-	98059-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
420	109682	3460	-	IFNGR2	AF-1|IFGR2|IFNGT1|IMD28	9606	Homo sapiens	binder	target	Yao X (2007)	17618444	171918	33	Interferon gamma-1b	Interferon gamma-2a|Interferon gamma-1b, recombinant|IFN-gamma-1b	actimmune	DRUGBANK	DB00033	C761H1206N214O225S6	biologic	-	98059-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
421	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	unknown	target	Dhalluin C (2005)	15898717	171786	34	Interferon Alfa-2a, Recombinant	SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a	roferon-a sol inj 3million iu/	DRUGBANK	DB00034	C860H1353N227O255S9	biologic	L03AB04	76543-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
422	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	unknown	target	Cironi P (2008)	18230610	171921	34	Interferon Alfa-2a, Recombinant	SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a	roferon-a sol inj 3million iu/	DRUGBANK	DB00034	C860H1353N227O255S9	biologic	L03AB04	76543-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
423	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	unknown	target	Dhalluin C (2005)	15898717	171786	34	Interferon Alfa-2a, Recombinant	SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a	roferon-a sol inj 3million iu/	DRUGBANK	DB00034	C860H1353N227O255S9	biologic	L03AB04	76543-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
424	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	unknown	target	Cironi P (2008)	18230610	171921	34	Interferon Alfa-2a, Recombinant	SH-polypeptide-46|Recombinant human interferon alfa-2a|Interferon alfa-2a, recombinant|Interferon alpha-2a|Interferon alfa-2a,recombinant|Interferon-alfa-2a|rIFN-alpha-2a|Interferon alfa-2a (recombinant)|Interferon alfa-2a|Recombinant human interferon-alfa-2a	roferon-a sol inj 3million iu/	DRUGBANK	DB00034	C860H1353N227O255S9	biologic	L03AB04	76543-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
425	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
426	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Slusarz MJ (2006)	16333859	171922	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
427	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Del Tredici AL (2008)	18761325	171923	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
428	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Dinan TG (2004)	14971638	171926	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
429	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Craighead M (2008)	18655906	171924	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
430	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Pequeux C (2004)	15613460	171925	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
431	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Loichot C (2000)	10731046	171927	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
432	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Pequeux C (2004)	15613460	171925	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
433	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Mechaly I (1999)	10594321	171928	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
434	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Barthelmebs M (1996)	8957254	171929	35	Desmopressin	DDAVP|Desmopressine|1-deamino-8-D-arginine vasopressin|Desmopresina|1-(3-mercaptopropionic acid)-8-D-arginine-vasopressin|Minirin|1-Desamino-8-D-arginine vasopressin|Desmopressinum|Stimate|Desmopressin	ddavp rhinal tube|ddavp melt|d	DRUGBANK	DB00035	C46H64N14O12S2	small molecule	H01BA02	16679-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFLWUMRGJYTJIN-NXBWRCJVSA-N
435	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
436	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
437	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	BLATRIX C (1959)	13801371	171867	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
438	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Malinvaud G (1966)	5969560	171934	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
439	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	GAERTNER H (1964)	14227143	171931	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
440	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	HERMANSKY F (1960)	13713641	171933	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
441	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	DIDISHEIM P (1959)	13621053	171932	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
442	108451	2152	-	F3	CD142|TF|TFA	9606	Homo sapiens	unknown	target	Rogers KS (1992)	1586032	171935	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
443	108451	2152	-	F3	CD142|TF|TFA	9606	Homo sapiens	unknown	target	Christensen NJ (1983)	6658368	171936	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
444	108451	2152	-	F3	CD142|TF|TFA	9606	Homo sapiens	unknown	target	HERMANSKY F (1960)	13713641	171933	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
445	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	unknown	target	Hansen CB (2001)	11238112	171940	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
446	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	unknown	target	Lee AY (2003)	12974870	171937	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
447	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	unknown	target	Stassens P (1996)	8700900	171939	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
448	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	unknown	target	Narita M (1995)	7559599	171938	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
449	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	unknown	target	Mine S (2002)	11772005	171941	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
450	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Rizoli SB (2006)	16370916	171944	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
451	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Perera L (1999)	10388743	171945	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
452	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Siddiqui MA (2005)	15907148	171946	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
453	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Shapiro A (2001)	11735107	171942	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
454	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Shapiro A (2003)	12525826	171943	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
455	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
456	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
457	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Bouwman CA (1999)	10901669	171947	36	Coagulation factor VIIa Recombinant Human	rFVIIa|Coagulation factor VIIa|Coagulation factor VIIa (recombinant)|Eptacog alfa (activated)|Eptacog alfa	niastase rt|novoseven rt|niast	DRUGBANK	DB00036	C1972H3076N560O597S28	biologic	B02BD08	102786-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
458	109804	3590	hCG_2011440	IL11RA	CRSDA	9606	Homo sapiens	agonist	target	Romas E (1996)	8676079	171948	37	Oprelvekin	IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF	neumega	DRUGBANK	DB00038	C854H1411N253O235S2	biologic	L03AC02	145941-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
459	109804	3590	hCG_2011440	IL11RA	CRSDA	9606	Homo sapiens	agonist	target	Li R (2001)	11570967	171949	37	Oprelvekin	IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF	neumega	DRUGBANK	DB00038	C854H1411N253O235S2	biologic	L03AC02	145941-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
460	109804	3590	hCG_2011440	IL11RA	CRSDA	9606	Homo sapiens	agonist	target	Nandurkar HH (1997)	9310465	171952	37	Oprelvekin	IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF	neumega	DRUGBANK	DB00038	C854H1411N253O235S2	biologic	L03AC02	145941-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
461	109804	3590	hCG_2011440	IL11RA	CRSDA	9606	Homo sapiens	agonist	target	Nandurkar HH (2000)	11012177	171951	37	Oprelvekin	IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF	neumega	DRUGBANK	DB00038	C854H1411N253O235S2	biologic	L03AC02	145941-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
462	109804	3590	hCG_2011440	IL11RA	CRSDA	9606	Homo sapiens	agonist	target	Nandurkar HH (1996)	8637716	171950	37	Oprelvekin	IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF	neumega	DRUGBANK	DB00038	C854H1411N253O235S2	biologic	L03AC02	145941-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
463	109804	3590	hCG_2011440	IL11RA	CRSDA	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	37	Oprelvekin	IL-11|Interleukin-11 precursor|Adipogenesis inhibitory factor|AGIF	neumega	DRUGBANK	DB00038	C854H1411N253O235S2	biologic	L03AC02	145941-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
464	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	unknown	target	Mummery CL (1993)	7680555	171953	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
465	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	unknown	target	Cancilla B (2001)	11422746	171957	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
466	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	unknown	target	Beer HD (2000)	10821861	171956	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
467	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	unknown	target	Yamanaka T (2000)	11149756	171955	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
468	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	unknown	target	Launay C (1994)	7890137	171954	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
469	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Lu W (1999)	10212269	171961	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
470	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Sher I (2000)	10950949	3241	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
471	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Wang F (1999)	9890894	171958	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
472	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Matsubara A (1999)	11091737	171959	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
473	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Ostrovsky O (2002)	11714710	171960	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
474	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Beaven AW (2007)	17728847	171962	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
475	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Cardoso WV (1997)	9056643	171963	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
476	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Berman B (1999)	10593896	171966	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
477	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Radtke ML (2005)	16390600	171967	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
478	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Patrie KM (1995)	7499435	171964	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
479	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Huang YW (2006)	16854582	171965	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
480	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Zhu X (2007)	17456767	171968	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
481	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
482	114356	8829	RP11-342D11.1	NRP1	BDCA4|CD304|NP1|NRP|VEGF165R	9606	Homo sapiens	unknown	target	Friedl A (1997)	9094999	171969	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
483	114356	8829	RP11-342D11.1	NRP1	BDCA4|CD304|NP1|NRP|VEGF165R	9606	Homo sapiens	unknown	target	Wang F (1999)	9890894	171958	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
484	114356	8829	RP11-342D11.1	NRP1	BDCA4|CD304|NP1|NRP|VEGF165R	9606	Homo sapiens	unknown	target	Beer HD (2000)	10821861	171956	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
485	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	unknown	target	Imagawa W (1994)	7526860	171971	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
486	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	unknown	target	Luo Y (1998)	9843417	171970	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
487	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	unknown	target	Sher I (2000)	10950949	3241	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
488	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	unknown	target	Sannes PL (1998)	9755102	171972	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
489	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	unknown	target	Yamanaka T (2000)	11149756	171955	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
490	109571	3339	RP11-132G19.2	HSPG2	HSPG|PLC|PRCAN|SJA|SJS|SJS1	9606	Homo sapiens	unknown	target	Iwabuchi T (2006)	16989989	171975	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
491	109571	3339	RP11-132G19.2	HSPG2	HSPG|PLC|PRCAN|SJA|SJS|SJS1	9606	Homo sapiens	unknown	target	Sharma B (1998)	9788974	171973	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
492	109571	3339	RP11-132G19.2	HSPG2	HSPG|PLC|PRCAN|SJA|SJS|SJS1	9606	Homo sapiens	unknown	target	Berman B (1999)	10593896	171966	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
493	109571	3339	RP11-132G19.2	HSPG2	HSPG|PLC|PRCAN|SJA|SJS|SJS1	9606	Homo sapiens	unknown	target	Asada N (2004)	14753849	171974	38	Palifermin	FGF-7|KGF|HBGF-7|Keratinocyte growth factor precursor|Fibroblast growth factor- 7	kepivance	DRUGBANK	DB00039	C721H1142N202O204S9	biologic	V03AF08	162394-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
494	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Koerner M (2007)	17475961	171979	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
495	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Baggio LL (2007)	17498508	171978	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
496	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Brubaker PL (2003)	12529935	171977	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
497	109002	2740	-	GLP1R	-	9606	Homo sapiens	unknown	target	Fischer AJ (2007)	17534934	171976	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
498	114746	9340	-	GLP2R	-	9606	Homo sapiens	unknown	target	Boushey RP (2001)	11212269	171980	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
499	114746	9340	-	GLP2R	-	9606	Homo sapiens	unknown	target	Estall JL (2005)	15817468	171981	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
500	114746	9340	-	GLP2R	-	9606	Homo sapiens	unknown	target	Munroe DG (1999)	9990065	171982	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
501	114746	9340	-	GLP2R	-	9606	Homo sapiens	unknown	target	Brubaker PL (2003)	12529935	171977	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
502	114746	9340	-	GLP2R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
503	114746	9340	-	GLP2R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
504	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Lok S (1994)	8144028	171983	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
505	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Li XC (2007)	17623014	171984	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
506	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Katayama T (2007)	17462598	171985	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
507	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Menzel S (1994)	8020989	171986	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
508	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Fischer AJ (2007)	17534934	171976	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
509	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Winzell MS (2007)	17479245	171988	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
510	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
511	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Li P (2007)	17620721	171987	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
512	108912	2642	-	GCGR	GGR|GL-R	9606	Homo sapiens	agonist	target	Brubaker PL (2003)	12529935	171977	39	Glucagon recombinant	Glucagon, human|Glucagon|Glucagon, porcine|Glucagon (recombinant dna origin)|Glucagone|Glucagonum	glucagon|glucagen|glucagon amp	DRUGBANK	DB00040	C165H249N49O51S1	biologic	H04AA01	16941-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
513	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	modulator	target	Maclennan C (2006)	16617454	171989	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
514	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	modulator	target	Chen X (2002)	11752352	171740	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
515	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	modulator	target	Stauber DJ (2006)	16477002	171993	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
516	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	modulator	target	Cornish GH (2006)	16569767	171992	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
517	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	modulator	target	Lee KD (2006)	16596189	171991	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
518	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	modulator	target	Steppan S (2006)	16542139	171990	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
519	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Maclennan C (2006)	16617454	171989	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
520	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
521	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Stauber DJ (2006)	16477002	171993	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
522	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Cornish GH (2006)	16569767	171992	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
523	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Lee KD (2006)	16596189	171991	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
524	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	agonist	target	Steppan S (2006)	16542139	171990	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
525	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Ouyang Y (1999)	10207608	171999	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
526	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Waldmann TA (2007)	17530023	171998	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
527	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Vlad G (2007)	17584597	171997	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
528	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Waldmann TA (2007)	17216565	171996	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
529	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Liu BY (2006)	16864089	171995	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
530	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Recchia F (2003)	16767920	171994	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
531	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	modulator	target	Chen X (2002)	11752352	171740	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
532	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Ouyang Y (1999)	10207608	171999	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
533	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Waldmann TA (2007)	17530023	171998	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
534	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Vlad G (2007)	17584597	171997	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
535	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Waldmann TA (2007)	17216565	171996	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
536	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Liu BY (2006)	16864089	171995	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
537	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Recchia F (2003)	16767920	171994	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
538	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
539	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	agonist	target	Stauber DJ (2006)	16477002	171993	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
540	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	agonist	target	Blank RB (2006)	17083048	172000	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
541	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	agonist	target	Smyth CM (2007)	17363735	172001	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
542	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	agonist	target	Fonseca SG (2007)	17635814	172002	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
543	109776	3561	-	IL2RG	CD132|CIDX|IL-2RG|IMD4|P64|SCIDX|SCIDX1	9606	Homo sapiens	agonist	target	Shibata F (2007)	17598841	172003	40	Aldesleukin	Recombinant interleukin-2 human|Interleukin-2(2-133),125-ser|125-L-serine-2-133-interleukin 2 (human reduced)|Interleukin-2 aldesleukin	proleukin	DRUGBANK	DB00041	C690H1115N177O202S6	biologic	L03AC01	110942-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
544	112710	6843	-	VAMP1	SPAX1|SYB1|VAMP-1	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
545	112710	6843	-	VAMP1	SPAX1|SYB1|VAMP-1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
546	112710	6843	-	VAMP1	SPAX1|SYB1|VAMP-1	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
547	112711	6844	-	VAMP2	SYB2|VAMP-2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
548	112711	6844	-	VAMP2	SYB2|VAMP-2	9606	Homo sapiens	binder	target	Liu W (2003)	14573702	172010	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
549	126085	127833	-	SYT2	MYSPC|SytII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
550	126085	127833	-	SYT2	MYSPC|SytII	9606	Homo sapiens	unknown	target	Poulain B (2009)	19576489	172011	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
551	126085	127833	-	SYT2	MYSPC|SytII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	41	Botulinum Toxin Type B	RimabotulinumtoxinB|BTX-B|Botulinum neurotoxin type B precursor	myobloc	DRUGBANK	DB00042	-	biologic	-	93384-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
552	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	unknown	target	Mirkina I (2007)	17368811	172013	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
553	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	unknown	target	Beck LA (2004)	15356552	172012	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
554	108500	2206	-	MS4A2	APY|ATOPY|FCER1B|FCERI|IGEL|IGER|IGHER|MS4A1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
555	108500	2206	-	MS4A2	APY|ATOPY|FCER1B|FCERI|IGEL|IGER|IGHER|MS4A1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
556	108500	2206	-	MS4A2	APY|ATOPY|FCER1B|FCERI|IGEL|IGER|IGHER|MS4A1	9606	Homo sapiens	antagonist	target	DuBuske LM (2006)	17073688	172014	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
557	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	43	Lutropin alfa	Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH	pergoveris|pergonal 75 i.u.|hu	DRUGBANK	DB00044	C1014H1609N287O294S27	biologic	G03GA07	152923-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
558	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	43	Lutropin alfa	Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH	pergoveris|pergonal 75 i.u.|hu	DRUGBANK	DB00044	C1014H1609N287O294S27	biologic	G03GA07	152923-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
559	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	43	Lutropin alfa	Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH	pergoveris|pergonal 75 i.u.|hu	DRUGBANK	DB00044	C1014H1609N287O294S27	biologic	G03GA07	152923-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
560	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	agonist	target	Gibreel A (2010)	20161981	172015	43	Lutropin alfa	Lutropin alpha|Luteinizing hormone|Insterstiial cell-stimulating hormone|Lutropin beta chain precursor|LH|LH-B|LSH- beta|Lutrophin|LSH-B|Luteinizing hormone beta subunit|ICSH	pergoveris|pergonal 75 i.u.|hu	DRUGBANK	DB00044	C1014H1609N287O294S27	biologic	G03GA07	152923-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
561	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Welty DM (2003)	14617145	172016	44	OspA lipoprotein	Outer surface protein A precursor	-	DRUGBANK	DB00045	C1198H2012N322O422S2	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
562	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	45	Insulin Lispro	Insulin lispro protamine|Insulin,lispro,human/rDNA|Insulin lispro (genetical recombination)|Insulin lispro recombinant|Insulin lispro protamine recombinant|Insulin,lispro,protamine/rDNA|Insulin lispro (rDNA origin)	humalog mix75/25|humalog mix50	DRUGBANK	DB00046	C257H387N65O76S6	biologic	A10AB04|A10AC04|A10AD04	133107-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
563	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Jehle PM (1996)	8964871	172018	45	Insulin Lispro	Insulin lispro protamine|Insulin,lispro,human/rDNA|Insulin lispro (genetical recombination)|Insulin lispro recombinant|Insulin lispro protamine recombinant|Insulin,lispro,protamine/rDNA|Insulin lispro (rDNA origin)	humalog mix75/25|humalog mix50	DRUGBANK	DB00046	C257H387N65O76S6	biologic	A10AB04|A10AC04|A10AD04	133107-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
564	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Jehle PM (1996)	8937933	172017	45	Insulin Lispro	Insulin lispro protamine|Insulin,lispro,human/rDNA|Insulin lispro (genetical recombination)|Insulin lispro recombinant|Insulin lispro protamine recombinant|Insulin,lispro,protamine/rDNA|Insulin lispro (rDNA origin)	humalog mix75/25|humalog mix50	DRUGBANK	DB00046	C257H387N65O76S6	biologic	A10AB04|A10AC04|A10AD04	133107-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
565	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Sciacca L (2010)	20424816	172019	45	Insulin Lispro	Insulin lispro protamine|Insulin,lispro,human/rDNA|Insulin lispro (genetical recombination)|Insulin lispro recombinant|Insulin lispro protamine recombinant|Insulin,lispro,protamine/rDNA|Insulin lispro (rDNA origin)	humalog mix75/25|humalog mix50	DRUGBANK	DB00046	C257H387N65O76S6	biologic	A10AB04|A10AC04|A10AD04	133107-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
566	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Smith TJ (2010)	20392809	172020	45	Insulin Lispro	Insulin lispro protamine|Insulin,lispro,human/rDNA|Insulin lispro (genetical recombination)|Insulin lispro recombinant|Insulin lispro protamine recombinant|Insulin,lispro,protamine/rDNA|Insulin lispro (rDNA origin)	humalog mix75/25|humalog mix50	DRUGBANK	DB00046	C257H387N65O76S6	biologic	A10AB04|A10AC04|A10AD04	133107-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
567	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Wada T (2008)	18585815	172022	46	Insulin Glargine	Insulin Glargine (rDNA origin)|Insulin glargine recombinant	soliqua 100/33|lantus solostar	DRUGBANK	DB00047	C267H404N72O78S6	biologic	A10AE04	160337-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
568	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Sciacca L (2010)	20424816	172019	46	Insulin Glargine	Insulin Glargine (rDNA origin)|Insulin glargine recombinant	soliqua 100/33|lantus solostar	DRUGBANK	DB00047	C267H404N72O78S6	biologic	A10AE04	160337-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
569	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Le Roith D (2007)	17922476	172021	46	Insulin Glargine	Insulin Glargine (rDNA origin)|Insulin glargine recombinant	soliqua 100/33|lantus solostar	DRUGBANK	DB00047	C267H404N72O78S6	biologic	A10AE04	160337-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
570	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	46	Insulin Glargine	Insulin Glargine (rDNA origin)|Insulin glargine recombinant	soliqua 100/33|lantus solostar	DRUGBANK	DB00047	C267H404N72O78S6	biologic	A10AE04	160337-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
571	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	agonist	target	Smith TJ (2010)	20392809	172020	46	Insulin Glargine	Insulin Glargine (rDNA origin)|Insulin glargine recombinant	soliqua 100/33|lantus solostar	DRUGBANK	DB00047	C267H404N72O78S6	biologic	A10AE04	160337-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
572	107677	1280	-	COL2A1	ANFH|AOM|COL11A3|SEDC|STL1	9606	Homo sapiens	unknown	target	Imai K (2007)	17652426	172023	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
573	107677	1280	-	COL2A1	ANFH|AOM|COL11A3|SEDC|STL1	9606	Homo sapiens	unknown	target	Martin G (2004)	15299286	172026	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
574	107677	1280	-	COL2A1	ANFH|AOM|COL11A3|SEDC|STL1	9606	Homo sapiens	unknown	target	Pratta MA (2003)	12890681	172027	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
575	107677	1280	-	COL2A1	ANFH|AOM|COL11A3|SEDC|STL1	9606	Homo sapiens	unknown	target	Fraser A (2003)	14613270	172024	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
576	107677	1280	-	COL2A1	ANFH|AOM|COL11A3|SEDC|STL1	9606	Homo sapiens	unknown	target	Verstappen SM (2006)	16507130	172025	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
577	107675	1278	-	COL1A2	OI4	9606	Homo sapiens	unknown	target	Chiu CJ (2002)	12101112	172028	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
578	107678	1281	-	COL3A1	EDS4A	9606	Homo sapiens	unknown	target	Cole WG (1990)	2145268	172029	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
579	107678	1281	-	COL3A1	EDS4A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
580	107678	1281	-	COL3A1	EDS4A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
581	107674	1277	-	COL1A1	OI4	9606	Homo sapiens	unknown	target	Beare AH (2003)	12535212	172031	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
582	107674	1277	-	COL1A1	OI4	9606	Homo sapiens	unknown	target	Beare AH (2005)	15659034	172030	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
583	107674	1277	-	COL1A1	OI4	9606	Homo sapiens	unknown	target	Chiu CJ (2002)	12101112	172028	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
584	107674	1277	-	COL1A1	OI4	9606	Homo sapiens	unknown	target	Lindsey ML (2003)	12855673	172032	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
585	107674	1277	-	COL1A1	OI4	9606	Homo sapiens	unknown	target	Egeblad M (2007)	17440987	119407	47	Collagenase clostridium histolyticum	-	collagenase santyl|xiaflex	DRUGBANK	DB00048	C5028H7666N1300O1564S21	biologic	M09AB02	9001-12-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
586	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Roth C (2004)	14605254	172040	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
587	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
588	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Zapatero-Caballero H (2003)	12606421	172037	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
589	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Voelker P (2002)	11854630	172039	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
590	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Zapatero-Caballero H (2004)	14561652	172038	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
591	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Castellon E (2006)	16809153	171783	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
592	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
593	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Ascoli M (2002)	11943741	172041	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
594	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	49	Cetrorelix	Cetrorelixum	cetrotide	DRUGBANK	DB00050	C70H92ClN17O14	small molecule	H01CC02	120287-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBNPWPIBESPSIF-MHWMIDJBSA-N
595	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
596	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
597	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
598	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
599	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
600	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
601	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
602	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
603	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
604	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
605	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
606	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
607	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
608	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
609	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
610	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
611	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
612	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
613	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
614	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
615	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
616	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Flendrie M (2003)	14532145	172043	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
617	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Lorenz HM (2002)	12044041	172044	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
618	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Bang LM (2004)	15046527	172045	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
619	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Klinkhoff A (2004)	15200343	172046	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
620	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Aguillon JC (2003)	15022409	172042	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
621	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
622	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	50	Adalimumab	Ig gamma-1 chain C region	humira	DRUGBANK	DB00051	C6428H9912N1694O1987S46	biologic	L04AB04	331731-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
623	108957	2690	-	GHR	GHBP	9606	Homo sapiens	binder	target	Bernstein RM (2007)	17133434	172048	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
624	108957	2690	-	GHR	GHBP	9606	Homo sapiens	binder	target	Wu XY (2006)	16965663	172049	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
625	108957	2690	-	GHR	GHBP	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
626	108957	2690	-	GHR	GHBP	9606	Homo sapiens	binder	target	Choi JH (2006)	17128263	172047	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
627	108957	2690	-	GHR	GHBP	9606	Homo sapiens	binder	target	Adriani M (2006)	17082603	172051	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
628	108957	2690	-	GHR	GHBP	9606	Homo sapiens	binder	target	Walenkamp MJ (2006)	16917171	172050	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
629	111603	5618	-	PRLR	HPRL|MFAB|hPRLrI	9606	Homo sapiens	unknown	target	Moederscheim TA (2007)	17317019	172054	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
630	111603	5618	-	PRLR	HPRL|MFAB|hPRLrI	9606	Homo sapiens	unknown	target	Cunningham BC (1990)	2270485	172053	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
631	111603	5618	-	PRLR	HPRL|MFAB|hPRLrI	9606	Homo sapiens	unknown	target	Keeler C (2007)	17279774	172052	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
632	111603	5618	-	PRLR	HPRL|MFAB|hPRLrI	9606	Homo sapiens	unknown	target	Ahmed TA (2007)	17395896	131528	51	Somatropin recombinant	Somatropin [rDNA origin]|GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|Somatropin|GH	nutropin - kit  pws(5mg) & liq	DRUGBANK	DB00052	C990H1532N262O300S7	biologic	H01AC01	12629-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
633	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
634	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
635	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
636	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
637	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
638	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
639	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
640	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
641	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
642	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
643	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
644	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
645	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Gibbs NM (2009)	19499855	172057	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
646	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Ibbotson T (2003)	12749745	172056	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
647	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Mazzaferri EL (2008)	18510478	172055	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
648	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
649	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
650	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
651	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
652	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
653	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
654	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
655	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
656	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
657	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
658	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
659	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Hall PR (2007)	17441904	172060	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
660	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Ibbotson T (2003)	12749745	172056	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
661	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Mazzaferri EL (2008)	18510478	172055	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
662	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Amoroso G (2001)	11588534	172059	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
663	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Weber AA (2002)	12165285	172058	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
664	113287	7448	-	VTN	V75|VN|VNT	9606	Homo sapiens	unknown	target	Ibbotson T (2003)	12749745	172056	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
665	113287	7448	-	VTN	V75|VN|VNT	9606	Homo sapiens	unknown	target	Romagnoli E (2007)	17160551	172061	53	Abciximab	7E3|7E3 antibody|antiGPIIBIIIa|C7E3	reopro	DRUGBANK	DB00054	C6462H9964N1690O2049S48	biologic	B01AC13	143653-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
666	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
667	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	multitarget	target	Colin G (2008)	18954704	172062	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
668	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	multitarget	target	Geng JP (1997)	9184404	172063	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
669	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	unknown	target	Hesselvik JF (1991)	1828915	172066	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
670	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	unknown	target	Cvirn G (2002)	12062545	172064	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
671	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	unknown	target	Cosio FG (1985)	3160800	172065	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
672	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Cerchiara E (2007)	17566522	172067	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
673	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Dhainaut JF (2003)	14515185	172070	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
674	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Carr ME (2001)	11259926	172068	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
675	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	unknown	target	Idell S (2002)	12004248	172069	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
676	111287	5269	RP1-90J20.6	SERPINB6	CAP|DFNB91|MSTP057|PI-6|PI6|PTI|SPI3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
677	111287	5269	RP1-90J20.6	SERPINB6	CAP|DFNB91|MSTP057|PI-6|PI6|PTI|SPI3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
678	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Liaw PC (2004)	15118520	172074	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
679	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Cerchiara E (2007)	17566522	172067	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
680	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Castellino FJ (2002)	12353077	172071	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
681	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Ruf W (2003)	12871285	172073	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
682	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Fukudome K (1998)	9529319	172072	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
683	108452	2153	-	F5	FVL|PCCF|RPRGL1|THPH2	9606	Homo sapiens	multitarget	target	Poe K (2002)	12030642	172079	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
684	108452	2153	-	F5	FVL|PCCF|RPRGL1|THPH2	9606	Homo sapiens	multitarget	target	Bernard GR (2001)	11236773	172078	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
685	108452	2153	-	F5	FVL|PCCF|RPRGL1|THPH2	9606	Homo sapiens	multitarget	target	Joyce DE (2002)	12004250	172075	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
686	108452	2153	-	F5	FVL|PCCF|RPRGL1|THPH2	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
687	108452	2153	-	F5	FVL|PCCF|RPRGL1|THPH2	9606	Homo sapiens	multitarget	target	Kanji S (2001)	11714212	172076	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
688	108452	2153	-	F5	FVL|PCCF|RPRGL1|THPH2	9606	Homo sapiens	multitarget	target	Lyseng-Williamson KA (2002)	11893230	172077	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
689	112914	7056	-	THBD	AHUS6|BDCA3|CD141|THPH12|THRM|TM	9606	Homo sapiens	unknown	target	McCachren SS (1991)	1660324	172084	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
690	112914	7056	-	THBD	AHUS6|BDCA3|CD141|THPH12|THRM|TM	9606	Homo sapiens	unknown	target	Pineda AO (2004)	15252033	172080	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
691	112914	7056	-	THBD	AHUS6|BDCA3|CD141|THPH12|THRM|TM	9606	Homo sapiens	unknown	target	Shirai T (1988)	2836377	172081	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
692	112914	7056	-	THBD	AHUS6|BDCA3|CD141|THPH12|THRM|TM	9606	Homo sapiens	unknown	target	Gresele P (2002)	11804648	172082	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
693	112914	7056	-	THBD	AHUS6|BDCA3|CD141|THPH12|THRM|TM	9606	Homo sapiens	unknown	target	Boffa MC (1987)	3039877	172083	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
694	107748	1356	-	CP	CP-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
695	107748	1356	-	CP	CP-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
696	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
697	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
698	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Omar MN (1999)	10463819	172085	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
699	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Cvirn G (2002)	12062545	172064	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
700	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Conway EM (2002)	12208873	172087	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
701	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Gruber A (2002)	12070133	172088	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
702	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Levi M (2002)	12296618	172086	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
703	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Kobayashi H (1998)	9620917	172093	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
704	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Hayashi T (1993)	8391599	172092	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
705	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Shen L (1999)	10456457	172091	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
706	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	He X (1995)	7769227	172090	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
707	111135	5104	-	SERPINA5	PAI-3|PAI3|PCI|PCI-B|PLANH3|PROCI	9606	Homo sapiens	unknown	target	Berg DT (2003)	12671072	172089	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
708	111219	5196	-	PF4	CXCL4|PF-4|SCYB4	9606	Homo sapiens	unknown	target	Carr ME (2001)	11259926	172068	54	Drotrecogin alfa	Drotrecogin alfa activated|Blood coagulation factor XIV (human)|Drotrecogin-alfa|Recombinant human activated protein C (rH-APC)|Activated protein C|Drotrecogin alfa (activated)|Drotrecogin alfa, activated|Drotrecogin alfa (activated), lyophilized	xigris (5mg/vial)|xigris  (20m	DRUGBANK	DB00055	C1786H2779N509O519S29	biologic	B01AD10	98530-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
709	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
710	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
711	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
712	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
713	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
714	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
715	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Rogler G (1998)	9649182	172096	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
716	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Ericson SG (1994)	7509291	172095	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
717	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Caron PC (1995)	9815888	172094	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
718	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
719	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
720	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
721	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
722	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
723	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
724	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
725	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
726	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Ericson SG (1994)	7509291	172095	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
727	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
728	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
729	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Ericson SG (1994)	7509291	172095	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
730	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	McHayleh W (2010)	20564405	172101	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
731	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	van Der Velden VH (2001)	11342449	172100	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
732	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	Naito K (2000)	10942240	172102	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
733	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	Niculescu-Duvaz I (2000)	11249747	172099	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
734	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	Sievers EL (2001)	11432892	172098	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
735	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	Bross PF (2001)	11410481	172097	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
736	107383	945	-	CD33	SIGLEC-3|SIGLEC3|p67	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
737	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
738	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	55	Gemtuzumab ozogamicin	-	-	DRUGBANK	DB00056	-	biologic	-	220578-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
739	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	inhibitor	target	Topic A (2011)	20521180	172104	57	Alpha-1-proteinase inhibitor	Alpha-1-proteinase inhibitor human|Alfa1 antitrypsin|Alpha-1-antiproteinase|alpha1-proteinase inhibitor human|Alpha 1-proteinase inhibitor, human|Alpha-1-antitrypsin|Alpha1-proteinase inhibitor (human)|Alpha1-proteinase Inhibitor|Alpha 1-proteinase inhibitor (human)|API|Alpha-1 proteinase inhibitor (human)|Alpha-1 protease inhibitor|Alpha 1-antitrypsin|Alpha-1-proteinase Inhibitor, Human|Alpha-1-proteinase inhibitor,human|Alpha 1-Proteinase Inhibitor|Alpha-1-proteinase Inhibitor (human)	zemaira|prolastin-c|aralast np	DRUGBANK	DB00058	C2001H3130N514O601S10	biologic	B02AB02	9041-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
740	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	57	Alpha-1-proteinase inhibitor	Alpha-1-proteinase inhibitor human|Alfa1 antitrypsin|Alpha-1-antiproteinase|alpha1-proteinase inhibitor human|Alpha 1-proteinase inhibitor, human|Alpha-1-antitrypsin|Alpha1-proteinase inhibitor (human)|Alpha1-proteinase Inhibitor|Alpha 1-proteinase inhibitor (human)|API|Alpha-1 proteinase inhibitor (human)|Alpha-1 protease inhibitor|Alpha 1-antitrypsin|Alpha-1-proteinase Inhibitor, Human|Alpha-1-proteinase inhibitor,human|Alpha 1-Proteinase Inhibitor|Alpha-1-proteinase Inhibitor (human)	zemaira|prolastin-c|aralast np	DRUGBANK	DB00058	C2001H3130N514O601S10	biologic	B02AB02	9041-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
741	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	inhibitor	target	Karnaukhova E (2006)	16773239	172103	57	Alpha-1-proteinase inhibitor	Alpha-1-proteinase inhibitor human|Alfa1 antitrypsin|Alpha-1-antiproteinase|alpha1-proteinase inhibitor human|Alpha 1-proteinase inhibitor, human|Alpha-1-antitrypsin|Alpha1-proteinase inhibitor (human)|Alpha1-proteinase Inhibitor|Alpha 1-proteinase inhibitor (human)|API|Alpha-1 proteinase inhibitor (human)|Alpha-1 protease inhibitor|Alpha 1-antitrypsin|Alpha-1-proteinase Inhibitor, Human|Alpha-1-proteinase inhibitor,human|Alpha 1-Proteinase Inhibitor|Alpha-1-proteinase Inhibitor (human)	zemaira|prolastin-c|aralast np	DRUGBANK	DB00058	C2001H3130N514O601S10	biologic	B02AB02	9041-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
742	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Dupont SA (2002)	12034032	172105	59	Interferon beta-1a	IFN-beta|Interferon beta precursor|Fibroblast interferon	avonex pen|avonex|rebif|rebif 	DRUGBANK	DB00060	C908H1408N246O252S7	biologic	L03AB07	145258-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
743	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Russell-Harde D (1999)	10049744	172107	59	Interferon beta-1a	IFN-beta|Interferon beta precursor|Fibroblast interferon	avonex pen|avonex|rebif|rebif 	DRUGBANK	DB00060	C908H1408N246O252S7	biologic	L03AB07	145258-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
744	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Runkel L (2001)	11747625	172106	59	Interferon beta-1a	IFN-beta|Interferon beta precursor|Fibroblast interferon	avonex pen|avonex|rebif|rebif 	DRUGBANK	DB00060	C908H1408N246O252S7	biologic	L03AB07	145258-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
745	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	van Koetsveld PM (2006)	16912135	172108	59	Interferon beta-1a	IFN-beta|Interferon beta precursor|Fibroblast interferon	avonex pen|avonex|rebif|rebif 	DRUGBANK	DB00060	C908H1408N246O252S7	biologic	L03AB07	145258-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
746	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	unknown	target	Runkel L (2001)	11747625	172106	59	Interferon beta-1a	IFN-beta|Interferon beta precursor|Fibroblast interferon	avonex pen|avonex|rebif|rebif 	DRUGBANK	DB00060	C908H1408N246O252S7	biologic	L03AB07	145258-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
747	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	unknown	target	van Koetsveld PM (2006)	16912135	172108	59	Interferon beta-1a	IFN-beta|Interferon beta precursor|Fibroblast interferon	avonex pen|avonex|rebif|rebif 	DRUGBANK	DB00060	C908H1408N246O252S7	biologic	L03AB07	145258-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
748	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	binder	target	Ramos-Morales F (1997)	9299436	283	60	Pegademase bovine	Adenosine deaminase|Adenosine aminohydrolase	adagen	DRUGBANK	DB00061	C1821H2834N484O552S14	biologic	-	9026-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
749	106757	259	-	AMBP	A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI	9606	Homo sapiens	unknown	target	Sala A (2004)	15452109	172111	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
750	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Mojzisova H (2007)	17141733	172116	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
751	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Michaelis K (2006)	16554356	172114	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
752	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Yuan Z (2003)	12860569	172115	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
753	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Yuan ZY (2003)	12887764	172112	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
754	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Yamashita T (2007)	17553935	172113	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
755	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Schroer K (2003)	14618072	172126	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
756	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Schwarz M (2004)	14617694	172125	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
757	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Fischer TH (2005)	15860200	172124	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
758	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Auer J (2003)	12928738	172123	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
759	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
760	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Weber AA (2002)	12360110	172121	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
761	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Amoroso G (2001)	11588534	172059	62	Eptifibatide	Intrifiban|Integrelin	eptifibatide|eptifibatide inje	DRUGBANK	DB00063	C35H49N11O9S2	biologic	B01AC16	188627-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
762	106757	259	-	AMBP	A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
763	106757	259	-	AMBP	A1M|EDC1|HCP|HI30|IATIL|ITI|ITIL|ITILC|UTI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
764	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Wang L (2006)	17378158	172130	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
765	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
766	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
767	106845	348	-	APOE	AD2|APO-E|LDLCQ5|LPG	9606	Homo sapiens	unknown	target	Cano NJ (2006)	16441928	172131	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
768	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Mori S (2006)	16622728	172132	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
769	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Danese S (2006)	16456024	172133	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
770	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Magro F (2005)	15674127	172134	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
771	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Popa C (2005)	15804598	172135	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
772	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Shen C (2005)	15691299	172136	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
773	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Mimura T (2007)	17642244	172137	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
774	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Maini RN (2002)	12110154	172138	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
775	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Braun J (2005)	16052578	172139	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
776	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
777	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Sapienza MS (2004)	15481318	172141	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
778	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Tobin AM (2005)	15691217	172140	64	Infliximab	Ig gamma-1 chain C region	remicade|remsima|inflectra	DRUGBANK	DB00065	C6428H9912N1694O1987S46	biologic	L04AB02	170277-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
779	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Dattatreyamurty B (1993)	8319832	172143	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
780	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Lindau-Shepard B (1994)	8070368	172142	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
781	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Layman LC (2001)	11299519	172145	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
782	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Goa KL (1998)	18020563	172144	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
783	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Santa Coloma TA (1990)	2108722	172147	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
784	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Leng N (1995)	7755615	172146	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
785	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	65	Follitropin beta	FSH-b|Follitropin beta|Follitropin beta chain precursor|Follicle stimulating hormone beta|FSH-B|Follitrophin beta|FSH-beta|Follicle-stimulating hormone beta subunit	puregon 50 i.u.|puregon 100 i.	DRUGBANK	DB00066	C975H1513N267O304S26	biologic	G03GA06	9002-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
786	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Yi X (2007)	17287200	71892	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
787	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Boson WL (2006)	17020465	172148	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
788	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
789	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Slusarz MJ (2006)	16333859	171922	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
790	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Bouley R (2006)	16563128	172149	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
791	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Young WS (2006)	17027167	172152	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
792	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Slusarz MJ (2006)	16114100	172153	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
793	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Jurkevich A (2005)	15993108	172150	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
794	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Volpi S (2006)	16720725	172151	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
795	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Wersinger SR (2007)	17284170	172154	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
796	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Hammock EA (2005)	16011575	172158	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
797	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Liedman R (2006)	16532916	172159	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
798	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Aoyagi T (2007)	17303660	172156	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
799	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Adikesavan NV (2005)	16511036	172157	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
800	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	unknown	target	Hiroyama M (2007)	17275806	172155	66	Vasopressin	Antidiuretic hormone|Argipressin|AVP|8-L-arginine vasopressin|Vasopressin, unspecified|Arginine vasopressin|8-Arginine vasopressin|ADH	vasopressin injection usp|pitr	DRUGBANK	DB00067	C46H65N15O12S2	biologic	H01BA06|H01BA01	11000-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
801	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Russell-Harde D (1999)	10049744	172107	67	Interferon beta-1b	IFN-beta|Interferon beta precursor|Fibroblast interferon	betaseron|extavia	DRUGBANK	DB00068	C908H1408N246O253S6	biologic	L03AB08	145155-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
802	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	67	Interferon beta-1b	IFN-beta|Interferon beta precursor|Fibroblast interferon	betaseron|extavia	DRUGBANK	DB00068	C908H1408N246O253S6	biologic	L03AB08	145155-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
803	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Russell-Harde D (1999)	10049744	172107	67	Interferon beta-1b	IFN-beta|Interferon beta precursor|Fibroblast interferon	betaseron|extavia	DRUGBANK	DB00068	C908H1408N246O253S6	biologic	L03AB08	145155-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
804	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	67	Interferon beta-1b	IFN-beta|Interferon beta precursor|Fibroblast interferon	betaseron|extavia	DRUGBANK	DB00068	C908H1408N246O253S6	biologic	L03AB08	145155-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
805	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
806	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Yasuda S (2002)	12528473	172161	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
807	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
808	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
809	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Blatt LM (1996)	8836913	172162	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
810	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Yasuda S (2002)	12528473	172161	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
811	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	68	Interferon alfacon-1	rCon-IFN|Recombinant methionyl human consensus interferon|Recombinant Consensus Interferon|methionyl interferon consensus|consensus interferon|Interferon Consensus, Methionyl|CIFN|methionyl-interferon-consensus|IFN Alfacon-1	infergen	DRUGBANK	DB00069	C860H1353N227O255S9	biologic	L03AB09	118390-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
812	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1998)	9850732	172163	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
813	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (2001)	11327694	172166	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
814	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Locci P (1995)	7648625	172165	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
815	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1997)	9435505	172164	69	Hyaluronidase	Hyaluronidase PH-20|Hyaluronidase (sheep testis isoenzyme)|Ovine hyaluronidase|Sperm surface protein PH-20|Hyaluronidase (ovine)|HYAL-1|Hyaluronidase, ovine|Hyaluronidase (glycoprotein, sheep testis isoenzyme)|Hyaluronidase 1 precursor|Sperm adhesion molecule 1	wydase injection liq 150 units	DRUGBANK	DB00070	C2455H3775N617O704S21	biologic	B06AA03	488712-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
816	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
817	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Zhu X (2002)	12136131	172169	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
818	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
819	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Kuwahata M (2007)	17097861	172170	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
820	111151	5122	-	PCSK1	BMIQ12|NEC1|PC1|PC3|SPC3	9606	Homo sapiens	unknown	target	Marriott D (1992)	1435788	23625	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
821	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
822	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
823	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Utsunomiya N (1998)	9662053	172171	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
824	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Ohagi S (1996)	8666140	172172	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
825	111153	5126	-	PCSK2	NEC 2|NEC-2|NEC2|PC2|SPC2	9606	Homo sapiens	unknown	target	Zertal-Zidani S (2007)	17221210	172173	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
826	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
827	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	binder	target	Desbuquois B (2003)	12970169	171896	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
828	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	binder	target	Chen LM (2002)	12038982	171895	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
829	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Radulescu RT (2007)	17475416	172174	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
830	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Degeorges A (1999)	10383131	172175	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
831	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Lopez-Bermejo A (2000)	11089538	172176	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
832	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
833	109711	3490	-	IGFBP7	AGM|FSTL2|IBP-7|IGFBP-7|IGFBP-7v|IGFBPRP1|MAC25|PSF|RAMSVPS|TAF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
834	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
835	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Authier F (2002)	11779865	172178	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
836	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
837	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Nunn SE (1997)	9130467	172177	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
838	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Ogino S (1999)	10229502	172179	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
839	111860	5925	RP11-174I10.1	RB1	OSRC|PPP1R130|RB|p105-Rb|pRb|pp110	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
840	111860	5925	RP11-174I10.1	RB1	OSRC|PPP1R130|RB|p105-Rb|pRb|pp110	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
841	111860	5925	RP11-174I10.1	RB1	OSRC|PPP1R130|RB|p105-Rb|pRb|pp110	9606	Homo sapiens	unknown	target	Biener Y (1990)	1701386	172180	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
842	109363	3118	DAAP-381D23.2	HLA-DQA2	DX-ALPHA|HLA-DXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
843	109363	3118	DAAP-381D23.2	HLA-DQA2	DX-ALPHA|HLA-DXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
844	109363	3118	DAAP-381D23.2	HLA-DQA2	DX-ALPHA|HLA-DXA	9606	Homo sapiens	unknown	target	Pugliese A (1994)	8200980	172181	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
845	109363	3118	DAAP-381D23.2	HLA-DQA2	DX-ALPHA|HLA-DXA	9606	Homo sapiens	unknown	target	Donner H (1997)	9458118	172183	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
846	109363	3118	DAAP-381D23.2	HLA-DQA2	DX-ALPHA|HLA-DXA	9606	Homo sapiens	unknown	target	Hermann R (2000)	11006709	172182	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
847	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
848	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Burren CP (1999)	10084601	4485	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
849	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Lafont J (2002)	12149257	172185	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
850	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
851	110918	4856	-	NOV	CCN3|IBP-9|IGFBP-9|IGFBP9|NOVh	9606	Homo sapiens	unknown	target	Martinerie C (1996)	8622864	172184	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
852	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
853	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Fuster DG (2007)	17018843	172186	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
854	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
855	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Christensen EI (1997)	9051350	172187	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
856	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Orlando RA (1998)	9773776	6505	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
857	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Plaisance V (2006)	16831872	145324	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
858	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
859	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
860	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Torii S (2004)	15028737	172189	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
861	125120	94121	RP11-524D16__A.2	SYTL4	SLP4	9606	Homo sapiens	unknown	target	Gomi H (2005)	16216924	172188	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
862	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
863	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
864	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Polastri L (2003)	12588113	172192	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
865	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Guest PC (1989)	2481446	172190	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
866	107755	1363	-	CPE	-	9606	Homo sapiens	unknown	target	Furuta M (1998)	9452465	172191	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
867	109364	3119	DADB-249P12.2	HLA-DQB1	CELIAC1|HLA-DQB|IDDM1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
868	109364	3119	DADB-249P12.2	HLA-DQB1	CELIAC1|HLA-DQB|IDDM1	9606	Homo sapiens	unknown	target	Levy-Marchal C (1992)	1612232	172194	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
869	109364	3119	DADB-249P12.2	HLA-DQB1	CELIAC1|HLA-DQB|IDDM1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
870	109364	3119	DADB-249P12.2	HLA-DQB1	CELIAC1|HLA-DQB|IDDM1	9606	Homo sapiens	unknown	target	Mahran MZ (1992)	1728861	172193	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
871	109364	3119	DADB-249P12.2	HLA-DQB1	CELIAC1|HLA-DQB|IDDM1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
872	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Fottner C (1998)	9846170	172196	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
873	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Zhang Q (1998)	9582514	172197	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
874	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
875	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Sowers JR (1995)	7476290	172195	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
876	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
877	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
878	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
879	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Harada S (1993)	8504733	172200	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
880	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	MARIGO S (1958)	13560210	172198	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
881	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	unknown	target	Hsu MC (1998)	9643444	172199	70	Insulin Pork	Insulin (pork)|Insulin, regular, pork|Insulin purified porcine|Porcine insulin|Insulin purified pork|Insulin, porcine|Insulin porcine	-	DRUGBANK	DB00071	C257H387N65O76S6	biologic	A10AE03|A10AD03|A10AC03|A10AB03	12584-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
882	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
883	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
884	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
885	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
886	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
887	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Lin A (2007)	17660958	172202	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
888	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Treish I (2000)	11098307	172203	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
889	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Leveque D (2008)	18690878	172201	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
890	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
891	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Curnow RT (1998)	9435876	172204	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
892	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
893	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
894	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
895	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
896	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
897	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
898	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Suzuki E (2007)	17363544	172205	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
899	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
900	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
901	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Shahied LS (2004)	15471859	172206	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
902	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Kubo M (2003)	14666732	172207	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
903	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Xie Z (2005)	15680154	172210	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
904	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Bowles JA (2005)	16109421	172208	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
905	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Yamaguchi Y (2005)	15868915	172209	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
906	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
907	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Zhang W (2007)	17704420	171743	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
908	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
909	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
910	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
911	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
912	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	71	Trastuzumab	Anti HER2|Ig gamma-1 chain C region	herceptin|perjeta-herceptin	DRUGBANK	DB00072	C6470H10012N1726O2013S42	biologic	L01XC03	180288-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
913	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
914	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
915	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
916	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
917	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Hatjiharissi E (2007)	17324336	172213	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
918	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Kim DH (2006)	16609067	172212	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
919	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Treon SP (2005)	15659493	172215	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
920	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Bowles JA (2006)	16825493	172214	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
921	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Hatjiharissi E (2007)	17475906	172216	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
922	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Bowles JA (2005)	16109421	172208	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
923	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
924	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
925	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
926	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
927	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
928	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Di Gaetano N (2003)	12874252	172217	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
929	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
930	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Niwa R (2004)	15448014	172218	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
931	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Hatjiharissi E (2007)	17324336	172213	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
932	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Kim DH (2006)	16609067	172212	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
933	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
934	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
935	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
936	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
937	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	van Meerten T (2010)	20350667	172220	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
938	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
939	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Jaglowski SM (2010)	20350663	172219	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
940	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
941	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	72	Rituximab	Ig gamma-1 chain C region|AntiCD20	rituxan sc|rituxan	DRUGBANK	DB00073	C6416H9874N1688O1987S44	biologic	L01XC02	174722-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
942	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
943	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
944	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
945	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
946	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
947	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
948	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
949	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
950	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
951	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
952	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
953	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
954	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
955	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
956	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
957	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
958	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
959	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
960	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Schmitz K (2002)	11840795	172221	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
961	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Onrust SV (1999)	10188761	172222	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
962	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Emparan C (2003)	12826150	172223	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
963	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Hausen B (2000)	10708100	172224	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
964	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Warle MC (2003)	12667677	172225	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
965	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
966	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
967	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
968	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Garcia CD (2006)	16908318	172228	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
969	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Choy BY (2003)	12591363	172229	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
970	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
971	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Kovarik J (1998)	9695721	172226	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
972	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Berard JL (1999)	10512062	172227	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
973	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Mentre F (1999)	10567956	172230	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
974	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
975	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	73	Basiliximab	chimeric mouse-human antiCD25|Ig gamma-1 chain C region	simulect	DRUGBANK	DB00074	C6378H9844N1698O1997S48	biologic	L04AC02	179045-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
976	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
977	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
978	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
979	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
980	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
981	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
982	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Pellegrini P (1996)	10851527	172232	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
983	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Contasta I (1996)	10851498	172231	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
984	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
985	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
986	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
987	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
988	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
989	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
990	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
991	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
992	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
993	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
994	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
995	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
996	107353	915	-	CD3D	CD3-DELTA|IMD19|T3D	9606	Homo sapiens	unknown	target	Wilde MI (1996)	8861551	172234	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
997	107353	915	-	CD3D	CD3-DELTA|IMD19|T3D	9606	Homo sapiens	unknown	target	Todd PA (1989)	2503348	172233	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
998	107355	917	-	CD3G	CD3-GAMMA|IMD17|T3G	9606	Homo sapiens	unknown	target	Wilde MI (1996)	8861551	172234	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
999	107355	917	-	CD3G	CD3-GAMMA|IMD17|T3G	9606	Homo sapiens	unknown	target	Todd PA (1989)	2503348	172233	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1000	107357	919	RP11-104L21.1	CD247	CD3-ZETA|CD3H|CD3Q|CD3Z|IMD25|T3Z|TCRZ	9606	Homo sapiens	unknown	target	Wilde MI (1996)	8861551	172234	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1001	107357	919	RP11-104L21.1	CD247	CD3-ZETA|CD3H|CD3Q|CD3Z|IMD25|T3Z|TCRZ	9606	Homo sapiens	unknown	target	Todd PA (1989)	2503348	172233	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1002	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1003	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1004	107354	916	-	CD3E	IMD18|T3E|TCRE	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1005	107354	916	-	CD3E	IMD18|T3E|TCRE	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1006	107354	916	-	CD3E	IMD18|T3E|TCRE	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	74	Muromonab	Anti-CD3|Muromonab-CD3	okt3|orthoclone okt 3 sterile 	DRUGBANK	DB00075	C6460H9946N1720O2043S56	biologic	L04AA02	140608-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1007	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1008	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1009	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1010	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1011	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1012	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1013	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1014	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1015	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1016	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1017	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1018	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1019	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1020	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1021	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1022	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1023	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1024	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1025	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1026	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1027	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1028	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Dillman RO (2002)	11879282	172242	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1029	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Wiseman GA (1999)	10541376	172243	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1030	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Witzig TE (2002)	12011122	172240	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1031	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Goldenberg DM (2001)	11418316	172241	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1032	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Goldsmith SJ (2010)	20113680	172244	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1033	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Witzig TE (2004)	15045033	172239	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1034	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1035	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	76	Ibritumomab tiuxetan	mAb Murine (IGG1) Anti P19437 (CD20_MOUSE)|Ibritumomab	zevalin	DRUGBANK	DB00078	C6382H9830N1672O1979S54	biologic	-	206181-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1036	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1037	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1038	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1039	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1040	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1041	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1042	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1043	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1044	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1045	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1046	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1047	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1048	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1049	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1050	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1051	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1052	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1053	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1054	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1055	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Dillman RO (2002)	11879282	172242	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1056	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Goldenberg DM (2001)	11418316	172241	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1057	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Unknown (2003)	12899647	172246	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1058	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Beeson C (2003)	13129395	172247	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1059	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Silverman DH (2004)	15023434	172245	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1060	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Friedberg JW (2004)	14748653	172248	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1061	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1062	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	78	Tositumomab	Ig gamma-1 chain C region	bexxar therapy	DRUGBANK	DB00081	C6416H9874N1688O1987S44	biologic	-	208921-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1063	108957	2690	-	GHR	GHBP	9606	Homo sapiens	antagonist	target	Paisley AN (2007)	17322491	172251	79	Pegvisomant	GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH	somavert	DRUGBANK	DB00082	C990H1532N262O300S7	biologic	H01AX01	218620-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1064	108957	2690	-	GHR	GHBP	9606	Homo sapiens	antagonist	target	De Martino MC (2010)	20595800	172250	79	Pegvisomant	GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH	somavert	DRUGBANK	DB00082	C990H1532N262O300S7	biologic	H01AX01	218620-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1065	108957	2690	-	GHR	GHBP	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	79	Pegvisomant	GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH	somavert	DRUGBANK	DB00082	C990H1532N262O300S7	biologic	H01AX01	218620-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1066	108957	2690	-	GHR	GHBP	9606	Homo sapiens	antagonist	target	Moller L (2009)	19820031	172249	79	Pegvisomant	GH-N|Growth hormone|Growth hormone 1|Somatotropin precursor|Pituitary growth hormone|GH	somavert	DRUGBANK	DB00082	C990H1532N262O300S7	biologic	H01AX01	218620-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1067	106881	388	-	RHOB	ARH6|ARHB|MST081|MSTP081|RHOH6	9606	Homo sapiens	unknown	target	Ishida H (2004)	15140914	172259	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1068	112500	6616	-	SNAP25	RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1069	112500	6616	-	SNAP25	RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2	9606	Homo sapiens	inhibitor	target	Straughan D (2006)	16831062	172264	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1070	112500	6616	-	SNAP25	RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2	9606	Homo sapiens	inhibitor	target	Flynn TC (2004)	15222581	172260	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1071	112500	6616	-	SNAP25	RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2	9606	Homo sapiens	inhibitor	target	Frassoni C (2005)	15749336	172261	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1072	112500	6616	-	SNAP25	RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2	9606	Homo sapiens	inhibitor	target	Okada M (2004)	15484814	172262	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1073	112500	6616	-	SNAP25	RIC-4|RIC4|SEC9|SNAP|SNAP-25|bA416N4.2|dJ1068F16.2	9606	Homo sapiens	inhibitor	target	Zhou JY (2003)	14644446	172263	80	Botulinum Toxin Type A	IncobotulinumtoxinA|OnabotulinumtoxinA|Bontoxilysin A|BoNT/A|Botulinum neurotoxin type A precursor|BTX-A|AbobotulinumtoxinA	botox cosmetic|dysport|botox|x	DRUGBANK	DB00083	C6760H10447N1743O2010S32	biologic	-	93384-43-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1074	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1075	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Chaudhary A (1999)	10631997	172268	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1076	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Alessi MC (1999)	10581996	172269	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1077	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Caballero AR (1999)	10569766	172265	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1078	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Parry MA (2000)	10664583	172266	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1079	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	activator	target	Korol'chuk VI (2000)	10726310	172267	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1080	108448	2149	-	F2R	CF2R|HTR|PAR-1|PAR1|TR	9606	Homo sapiens	cleavage	target	McRedmond JP (2000)	10666203	172270	82	Streptokinase	Streptokinase C precursor	kabikinase - pws 250000 unit/v	DRUGBANK	DB00086	C2100H3278N566O669S4	biologic	B01AD01|B06AA55	9002-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1081	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1082	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1083	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Lin TS (2005)	15217834	172272	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1084	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Brett S (1996)	8707338	172273	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1085	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Nagler A (1997)	9337053	172275	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1086	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Osterborg A (1997)	9020367	172274	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1087	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1088	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1089	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1090	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1091	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1092	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1093	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Lin TS (2005)	15217834	172272	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1094	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1095	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1096	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1097	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1098	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1099	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Hederer RA (2000)	10744652	172279	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1100	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Rawstron AC (1999)	10520035	172278	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1101	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Rebello PR (1999)	10573085	172282	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1102	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Geissinger E (2009)	19479612	172280	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1103	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Gilliland LK (1999)	10092828	172281	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1104	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	James LC (1999)	10366506	172277	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1105	107473	1043	-	CD52	CDW52	9606	Homo sapiens	antibody	target	Quintas-Cardama A (2009)	19343298	172276	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1106	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1107	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	83	Alemtuzumab	-	mabcampath|lemtrada|campath	DRUGBANK	DB00087	C6468H10066N1732O2005S40	biologic	L04AA34	216503-57-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1108	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Smith-Jones PM (2000)	11016653	172286	85	Capromab	-	prostascint kit for the prepar	DRUGBANK	DB00089	-	biologic	-	151763-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1109	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Gregorakis AK (1998)	9508077	172284	85	Capromab	-	prostascint kit for the prepar	DRUGBANK	DB00089	-	biologic	-	151763-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1110	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Sodee DB (1998)	9792131	172285	85	Capromab	-	prostascint kit for the prepar	DRUGBANK	DB00089	-	biologic	-	151763-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1111	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	85	Capromab	-	prostascint kit for the prepar	DRUGBANK	DB00089	-	biologic	-	151763-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1112	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Sodee DB (2005)	15882479	172283	85	Capromab	-	prostascint kit for the prepar	DRUGBANK	DB00089	-	biologic	-	151763-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1113	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Keckesova Z (2006)	16641261	172295	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1114	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Stegmann CM (2010)	20368803	172294	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1115	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Schaller T (2007)	17609268	172291	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1116	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Lee J (2010)	20637127	172290	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1117	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Patwardhan AM (2006)	16849427	172293	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1118	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Redell JB (2007)	17461417	172292	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1119	115411	10105	RP11-342M3.4	PPIF	CYP3|CyP-M|Cyp-D|CypD	9606	Homo sapiens	binder	target	Handschumacher RE (1984)	6238408	172296	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1120	107269	819	-	CAMLG	CAML	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1121	107269	819	-	CAMLG	CAML	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1122	107269	819	-	CAMLG	CAML	9606	Homo sapiens	binder	target	Bernasconi R (2010)	20927389	172297	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1123	107269	819	-	CAMLG	CAML	9606	Homo sapiens	binder	target	Lee J (2010)	20637127	172290	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1124	107269	819	-	CAMLG	CAML	9606	Homo sapiens	binder	target	Yamashita H (2010)	20674565	172299	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1125	107269	819	-	CAMLG	CAML	9606	Homo sapiens	binder	target	Galat A (2010)	20602248	172298	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1126	111527	5535	RP11-102M4.2	PPP3R2	PPP3RL	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1127	111527	5535	RP11-102M4.2	PPP3R2	PPP3RL	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1128	111527	5535	RP11-102M4.2	PPP3R2	PPP3RL	9606	Homo sapiens	inhibitor	target	Yamashita H (2010)	20674565	172299	87	Cyclosporine	Ciclosporinum|Cyclosporin A|Cyclosporin|CsA|Ciclosporin|CyA|Ciclosporina|Ciclosporine	neoral 10mg|neoral oral soluti	DRUGBANK	DB00091	C62H111N11O12	small molecule	L04AD01|S01XA18	59865-13-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMATZTZNYRCHOR-CGLBZJNRSA-N
1129	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1130	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1131	107352	914	RP4-655N15.2	CD2	LFA-2|SRBC|T11	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1132	107352	914	RP4-655N15.2	CD2	LFA-2|SRBC|T11	9606	Homo sapiens	inhibitor	target	da Silva AJ (2002)	11970990	172361	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1133	107352	914	RP4-655N15.2	CD2	LFA-2|SRBC|T11	9606	Homo sapiens	inhibitor	target	Ortonne JP (2003)	12795770	172360	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1134	107352	914	RP4-655N15.2	CD2	LFA-2|SRBC|T11	9606	Homo sapiens	inhibitor	target	Larsen R (2007)	17403057	172362	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1135	107352	914	RP4-655N15.2	CD2	LFA-2|SRBC|T11	9606	Homo sapiens	inhibitor	target	Chamian F (2007)	17555598	172358	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1136	107352	914	RP4-655N15.2	CD2	LFA-2|SRBC|T11	9606	Homo sapiens	inhibitor	target	Goedkoop AY (2004)	14968366	172359	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1137	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1138	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1139	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1140	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1141	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1142	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1143	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1144	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1145	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1146	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1147	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	da Silva AJ (2002)	11970990	172361	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1148	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1149	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Vaishnaw AK (2002)	12795239	172363	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1150	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1151	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1152	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1153	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	da Silva AJ (2002)	11970990	172361	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1154	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1155	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	88	Alefacept	ASP0485	amevive	DRUGBANK	DB00092	C2306H3594N610O694S26	biologic	L04AA15	222535-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1156	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	89	Felypressin	Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine	-	DRUGBANK	DB00093	C46H65N13O11S2	small molecule	-	56-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFKQVVDKFKYTNA-YVGXZPIDNA-N
1157	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	89	Felypressin	Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine	-	DRUGBANK	DB00093	C46H65N13O11S2	small molecule	-	56-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFKQVVDKFKYTNA-YVGXZPIDNA-N
1158	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	89	Felypressin	Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine	-	DRUGBANK	DB00093	C46H65N13O11S2	small molecule	-	56-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFKQVVDKFKYTNA-YVGXZPIDNA-N
1159	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	agonist	target	Manning M (2008)	18655903	172364	89	Felypressin	Felipresina|Felypressinum|Felypressin|2-(L-phenylalanine)-8-L-lysinevasopressin|PLV-2|Felypressine	-	DRUGBANK	DB00093	C46H65N13O11S2	small molecule	-	56-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFKQVVDKFKYTNA-YVGXZPIDNA-N
1160	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Dattatreyamurty B (1993)	8319832	172143	90	Urofollitropin	FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit	humegon inj 75 i.u.|pergonal 7	DRUGBANK	DB00094	C42H65N11O12S2	biologic	G03GA04	146479-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1161	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Lindau-Shepard B (1994)	8070368	172142	90	Urofollitropin	FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit	humegon inj 75 i.u.|pergonal 7	DRUGBANK	DB00094	C42H65N11O12S2	biologic	G03GA04	146479-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1162	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Layman LC (2001)	11299519	172145	90	Urofollitropin	FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit	humegon inj 75 i.u.|pergonal 7	DRUGBANK	DB00094	C42H65N11O12S2	biologic	G03GA04	146479-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1163	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Santa Coloma TA (1990)	2108722	172147	90	Urofollitropin	FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit	humegon inj 75 i.u.|pergonal 7	DRUGBANK	DB00094	C42H65N11O12S2	biologic	G03GA04	146479-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1164	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Leng N (1995)	7755615	172146	90	Urofollitropin	FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit	humegon inj 75 i.u.|pergonal 7	DRUGBANK	DB00094	C42H65N11O12S2	biologic	G03GA04	146479-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1165	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	90	Urofollitropin	FSH-B|Follicle Stimulating Hormone|FSH|Follitropin beta chain precursor|Urofollitrophin|FSH-beta|Follicle-stimulating hormone beta subunit	humegon inj 75 i.u.|pergonal 7	DRUGBANK	DB00094	C42H65N11O12S2	biologic	G03GA04	146479-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1166	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1167	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	antibody	target	Frampton JE (2009)	19170413	172365	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1168	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	antibody	target	Descamps V (2006)	17053736	172366	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1169	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1170	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1171	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1172	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1173	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1174	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1175	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1176	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1177	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1178	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1179	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1180	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1181	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1182	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1183	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1184	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1185	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1186	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1187	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1188	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	91	Efalizumab	antiCD11 alpha|anti alphaL integrin|hu1124|Raptiva	raptiva	DRUGBANK	DB00095	-	biologic	L04AA21	214745-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1189	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Jameson JL (1996)	9027352	172369	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1190	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Tao YX (2009)	20374735	172368	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1191	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1192	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	binder	target	Lin W (2007)	17059863	172367	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1193	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Gromoll J (2003)	12606382	172370	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1194	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Bodek G (2005)	15967102	172371	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1195	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Lin W (2007)	17059863	172367	93	Chorionic Gonadotropin (Recombinant)	Chorionic gonadotrophin beta subunit|Choriogonadotropin alpha|Choriogonadotropin beta chain precursor|hCG|CG-beta|r-HCG	ovidrel	DRUGBANK	DB00097	C1105H1770N318O336S26	biologic	-	177073-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1196	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1197	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1198	107347	909	-	CD1A	CD1|FCB6|HTA1|R4|T6	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1199	107347	909	-	CD1A	CD1|FCB6|HTA1|R4|T6	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1200	107347	909	-	CD1A	CD1|FCB6|HTA1|R4|T6	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1201	107358	920	-	CD4	CD4mut	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1202	109385	3140	RP11-309G3.1	MR1	HLALS	9606	Homo sapiens	antagonist	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1203	109894	3688	RP11-479G22.2	ITGB1	CD29|FNRB|GPIIA|MDF2|MSK12|VLA-BETA|VLAB	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1204	109891	3685	-	ITGAV	CD51|MSK8|VNRA|VTNR	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1205	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1206	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Monti P (2003)	12586600	172372	94	Anti-thymocyte Globulin (Rabbit)	rabbit ATG|rATG|Thymoglobulin|Anti-thymocyte globulin (rabbit)	thymoglobulin	DRUGBANK	DB00098	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1207	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Druhan LJ (2005)	15353486	171834	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1208	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Jian MY (2004)	16245075	171836	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1209	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Schepers H (2007)	17475913	171837	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1210	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Carter CR (2004)	14657210	171833	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1211	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	El Ouriaghli F (2003)	12393522	172373	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1212	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Donini M (2007)	17311988	172374	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1213	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	stimulator	target	Ward AC (2006)	17127322	171842	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1214	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	stimulator	target	Zhuang D (2005)	16033816	171838	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1215	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	stimulator	target	Link DC (2007)	17494858	172375	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1216	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	stimulator	target	Cao YR (2005)	15949269	171841	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1217	107828	1441	-	CSF3R	CD114|GCSFR	9606	Homo sapiens	stimulator	target	Erkeland SJ (2007)	17001306	99479	95	Filgrastim	Granulocyte Colony Stimulating Factor|Tbo-filgrastim|G-CSF	grastofil|granix|neupogen	DRUGBANK	DB00099	C845H1343N223O243S9	biologic	L03AA02	121181-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1218	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	cofactor	target	Carr ME (2003)	12719776	172376	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1219	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	cofactor	target	Kalashnikova LA (2003)	14598591	172377	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1220	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	cofactor	target	Di Scipio RG (1978)	659613	172378	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1221	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	cofactor	target	Federici AB (2003)	12826528	172379	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1222	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	cofactor	target	Neels JG (2000)	11150722	172381	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1223	108455	2157	RP11-115M6.7	F8	AHF|DXS1253E|F8B|F8C|FVIII|HEMA	9606	Homo sapiens	cofactor	target	Johansen RF (2006)	16476097	172380	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1224	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Seitz R (1999)	10499905	172386	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1225	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Bauer KA (2000)	11019961	172385	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1226	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Butenas S (1999)	10498586	172384	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1227	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Koehler M (1999)	10499904	172383	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1228	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Samis JA (2000)	10648407	172382	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1229	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1230	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Jones KC (1994)	8083242	172390	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1231	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Ambrosini G (1997)	9079657	8349	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1232	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	London FS (2000)	10933803	172389	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1233	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Scandella DH (2000)	10919405	172388	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1234	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Worfolk LA (1992)	1391956	172387	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1235	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Di Scipio RG (1978)	659613	172378	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1236	108458	2160	-	F11	FXI	9606	Homo sapiens	ligand	target	Gailani D (2001)	11342438	172391	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1237	108458	2160	-	F11	FXI	9606	Homo sapiens	ligand	target	Di Scipio RG (1978)	659613	172378	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1238	108458	2160	-	F11	FXI	9606	Homo sapiens	ligand	target	Sun MF (1999)	10593931	172392	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1239	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1240	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1241	110215	4035	-	LRP1	A2MR|APOER|APR|CD91|IGFBP3R|LRP|LRP1A|TGFBR5	9606	Homo sapiens	unknown	target	Rohlena J (2003)	12522212	744	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1242	108453	2155	-	F7	SPCA	9606	Homo sapiens	ligand	target	Shord SS (2000)	10938981	171862	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1243	108453	2155	-	F7	SPCA	9606	Homo sapiens	ligand	target	Baker DC (1999)	10192655	172393	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1244	108453	2155	-	F7	SPCA	9606	Homo sapiens	ligand	target	Celie PH (2000)	10617609	172394	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1245	108453	2155	-	F7	SPCA	9606	Homo sapiens	ligand	target	Hertzberg MS (1999)	10381508	172395	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1246	108453	2155	-	F7	SPCA	9606	Homo sapiens	ligand	target	Di Scipio RG (1978)	659613	172378	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1247	108453	2155	-	F7	SPCA	9606	Homo sapiens	ligand	target	Butenas S (1999)	10498586	172384	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1248	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Rehemtulla A (1993)	8506307	172398	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1249	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Lin PJ (2004)	14660587	172399	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1250	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Wu SM (1997)	9115224	172400	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1251	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Stanley TB (1997)	9141486	172396	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1252	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Stanley TB (1998)	9748333	172397	96	Coagulation Factor IX (Recombinant)	nonacog alfa|Coagulation factor IX (recombinant)|Coagulation factor IX recombinant human|Recombinant factor IX|Factor IX (Recombinant)	benefix  - (250iu)|idelvion|ix	DRUGBANK	DB00100	C2041H3136N558O641S25	biologic	B02BD09	181054-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1253	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	Ebert M (1995)	7665222	172401	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1254	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	Heidaran MA (1991)	1702511	172402	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1255	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	Abdiu A (1998)	10070317	172403	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1256	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	Miller-Kasprzak E (2003)	12632922	172404	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1257	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	Yu J (2003)	14506245	172405	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1258	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	unknown	target	Bonner JC (1995)	7541796	172406	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1259	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	unknown	target	Lizonova A (1990)	1697862	172407	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1260	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	unknown	target	Papanas N (2008)	18686746	172408	97	Becaplermin	PDGFB|SH-POLYPEPTIDE-59|c-sis|PDGF-BB|PDGF-2|Platelet-derived growth factor beta polypeptide|PDGF B-chain|Platelet-derived growth factor B chain precursor	regranex (becaplermin) 0.01%|r	DRUGBANK	DB00102	C532H892N162O153S9	biologic	A01AD08|D03AX06	165101-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1261	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Bronstein MD (2006)	16809928	172409	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1262	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Jaquet P (2006)	16625841	172413	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1263	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Xie Y (2005)	16086874	172412	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1264	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Wang ZZ (2005)	16438887	172411	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1265	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Schmid HA (2006)	16625842	172410	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1266	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Matrone C (2004)	15103227	172415	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1267	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Ruan W (2006)	16223973	172414	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1268	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Jaquet P (2006)	16625841	172413	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1269	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Wang ZZ (2005)	16438887	172411	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1270	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Schmid HA (2006)	16625842	172410	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1271	112630	6752	-	SSTR2	-	9606	Homo sapiens	binder	target	Yim CB (2009)	19537708	172416	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1272	112630	6752	-	SSTR2	-	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	99	Octreotide	Octreotida|Octreotidum|Octrotide	sandostatin lar 20mg|sandostat	DRUGBANK	DB00104	C49H66N10O10S2	small molecule	H01CB02	83150-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEQANNDTNATYII-OULOTJBUSA-N
1273	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1274	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1275	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1276	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	binder	target	Khine AA (2000)	10567921	172419	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1277	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1278	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1279	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1280	109677	3455	-	IFNAR2	IFN-R|IFN-alpha-REC|IFNABR|IFNARB	9606	Homo sapiens	binder	target	Eid P (1995)	7584665	172420	100	Interferon Alfa-2b, Recombinant	Intron A|Intron (Interferon 2b)|Interferon -2b|rIFN-alpha-2b|Interferon alfa-2b|Intron A (Interferon 2b)	intron a inj 3000000unit/vial|	DRUGBANK	DB00105	C860H1353N229O255S9	biologic	L03AB05	98530-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1281	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Debruyne FM (2006)	16985933	172421	101	Abarelix	-	-	DRUGBANK	DB00106	C72H95ClN14O14	biologic	L02BX01	183552-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1282	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Furman DJ (2011)	21208749	172426	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1283	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Gimpl G (2008)	18655883	172424	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1284	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Frantz MC (2010)	20104850	172425	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1285	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Spyranti Z (2010)	20108008	172422	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1286	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Ahn TG (2005)	15646817	172423	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1287	111060	5020	-	OXT	OT|OT-NPI|OXT-NPI	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1288	111060	5020	-	OXT	OT|OT-NPI|OXT-NPI	9606	Homo sapiens	binder	target	Land H (1983)	6687626	172427	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1289	111060	5020	-	OXT	OT|OT-NPI|OXT-NPI	9606	Homo sapiens	binder	target	Rao VV (1992)	1486803	172428	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1290	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1291	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1292	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1293	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1294	109610	3383	-	ICAM1	BB2|CD54|P3.58	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1295	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1296	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1297	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1298	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1299	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1300	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1301	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1302	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1303	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	antibody	target	Stueve O (2007)	17461891	172435	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1304	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	antibody	target	Sheremata WA (2005)	16268663	172434	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1305	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1306	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	antibody	target	Craddock CF (1997)	9389694	172433	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1307	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	antibody	target	Niino M (2006)	16634035	172432	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1308	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1309	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1310	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1311	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1312	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1313	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1314	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1315	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	103	Natalizumab	Anti-alpha4 integrin|Anti-VLA4	tysabri	DRUGBANK	DB00108	-	biologic	L04AA23	189261-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1316	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1317	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1318	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1319	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1320	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1321	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1322	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1323	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1324	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1325	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1326	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1327	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1328	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1329	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1330	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1331	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1332	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1333	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1334	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1335	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	105	Palivizumab	anti-RSV|Synagis	synagis	DRUGBANK	DB00110	-	biologic	J06BB16	188039-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1336	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1337	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1338	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1339	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1340	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Martelletti P (1990)	2335478	172444	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1341	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Hoshino S (1991)	1835892	172445	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1342	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Galandrini R (1993)	8097750	172446	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1343	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Hayakawa K (1991)	1900882	172447	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1344	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Lanier LL (1985)	2415663	172443	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1345	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1346	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1347	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1348	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1349	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1350	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1351	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1352	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1353	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1354	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1355	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Forrest K (2005)	15814281	172448	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1356	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Light JA (2002)	12372041	172449	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1357	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1358	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Ramos EL (1989)	2571203	172450	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1359	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Burkhardt K (1989)	2647626	172451	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1360	109775	3560	RP5-1170K4.6	IL2RB	CD122|IL15RB|P70-75	9606	Homo sapiens	antibody	target	Aguillon JC (2003)	15022409	172042	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1361	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Simms HH (1991)	1828823	172452	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1362	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Garcia CD (2006)	16908318	172228	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1363	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Przepiorka D (2000)	10607689	172453	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1364	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1365	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Monti P (2009)	19788505	172457	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1366	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Patlolla V (2007)	17564638	172456	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1367	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Krouwels FH (1996)	8600944	172455	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1368	109774	3559	RP11-536K7.1	IL2RA	CD25|IDDM10|IL2R|TCGFR|p55	9606	Homo sapiens	antibody	target	Shamsi TS (2005)	16304857	172454	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1369	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1370	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	106	Daclizumab	Dacliximab|Daclizumab beta	zenapax 5mg/ml|zinbryta	DRUGBANK	DB00111	C6332H9808N1678O1989S42	biologic	L04AC01	152923-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1371	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1372	108507	2213	RP11-474I16.2	FCGR2B	CD32|CD32B|FCG2|FCGR2|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1373	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1374	108506	2212	RP11-5K23.6	FCGR2A	CD32|CD32A|CDw32|FCG2|FCGR2|FCGR2A1|FcGR|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1375	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1376	108509	2215	RP11-25K21.3	FCGR3B	CD16|CD16b|FCG3|FCGR3|FCR-10|FCRIII|FCRIIIb	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1377	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1378	107176	715	-	C1R	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1379	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1380	107174	713	RP4-815O16.3	C1QB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1381	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1382	107173	712	-	C1QA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1383	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1384	108508	2214	RP11-5K23.1	FCGR3A	CD16|CD16A|FCG3|FCGR3|FCGRIII|FCR-10|FCRIII|FCRIIIA|IGFR3|IMD20	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1385	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1386	107175	714	-	C1QC	C1Q-C|C1QG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1387	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1388	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Gerber HP (2005)	15705858	172458	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1389	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1390	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1391	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1392	114556	9103	-	FCGR2C	CD32|CD32C|CDW32|FCG2|FCRIIC|IGFR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	107	Bevacizumab	antiVEGF|Avastin	avastin	DRUGBANK	DB00112	C6538H10034N1716O2033S44	biologic	L01XC07	216974-75-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1393	107103	634	-	CEACAM1	BGP|BGP1|BGPI	9606	Homo sapiens	unknown	target	Hughes K (1997)	9389396	172459	108	Arcitumomab	IMMU-4|anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment	-	DRUGBANK	DB00113	C6398H9900N1714O1995S54	biologic	-	154361-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1394	107103	634	-	CEACAM1	BGP|BGP1|BGPI	9606	Homo sapiens	unknown	target	Fuster D (2003)	12865871	172460	108	Arcitumomab	IMMU-4|anti-Carcinoembryonic Antigen Monoclonal Antibody Fab' Fragment	-	DRUGBANK	DB00113	C6398H9900N1714O1995S54	biologic	-	154361-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1395	107873	1491	-	CTH	-	9606	Homo sapiens	cofactor	target	Lowicka E (2007)	17377202	172462	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1396	107873	1491	-	CTH	-	9606	Homo sapiens	cofactor	target	Yamagata S (2004)	15184188	172463	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1397	107873	1491	-	CTH	-	9606	Homo sapiens	cofactor	target	Okuno T (2001)	11578145	172461	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1398	107873	1491	-	CTH	-	9606	Homo sapiens	cofactor	target	Lima CP (2006)	16857832	172464	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1399	107873	1491	-	CTH	-	9606	Homo sapiens	cofactor	target	Bertoldi M (2005)	15823094	172465	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1400	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1401	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1402	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	cofactor	target	Lee IS (1995)	7592550	172466	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1403	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	cofactor	target	Takada Y (1984)	6703688	172467	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1404	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Gospe SM (2006)	16538088	172471	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1405	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Hwang IK (2007)	17531224	172470	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1406	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Burd L (2000)	11108513	172468	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1407	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Tong JC (2002)	12021103	172469	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1408	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Myers MA (2000)	11034389	172472	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1409	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Hwang IK (2007)	17531224	172470	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1410	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Liu W (2005)	15723541	172473	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1411	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Markova M (2005)	16096275	172475	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1412	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Sulaiman SA (2003)	14567543	172474	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1413	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Storici P (2004)	14534310	172476	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1414	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1415	112761	6898	-	TAT	-	9606	Homo sapiens	cofactor	target	Biagini MR (2006)	16570355	172479	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1416	112761	6898	-	TAT	-	9606	Homo sapiens	cofactor	target	Kim SY (2006)	16466641	172478	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1417	112761	6898	-	TAT	-	9606	Homo sapiens	cofactor	target	Shaffer WA (2002)	12441383	172480	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1418	112761	6898	-	TAT	-	9606	Homo sapiens	cofactor	target	Venhorst J (2003)	12798391	172477	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1419	112761	6898	-	TAT	-	9606	Homo sapiens	cofactor	target	Clayton TA (2007)	16902803	172481	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1420	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1421	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	cofactor	target	Mavrides C (1975)	236311	172482	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1422	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1423	117027	23464	-	GCAT	KBL	9606	Homo sapiens	cofactor	target	Schmidt A (2001)	11318637	172483	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1424	130074	285313	-	IGSF10	CMF608	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1425	130074	285313	-	IGSF10	CMF608	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1426	130074	285313	-	IGSF10	CMF608	9606	Homo sapiens	cofactor	target	Berman HM (2000)	10592235	172122	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1427	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	cofactor	target	Gospe SM (2006)	16538088	172471	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1428	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	cofactor	target	Hwang IK (2005)	16207494	172484	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1429	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	cofactor	target	Mills PB (2005)	15772097	172485	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1430	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	cofactor	target	Hoffmann GF (2007)	17216302	172486	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1431	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	cofactor	target	Pearl PL (2006)	17032564	172487	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1432	111792	5834	RP5-965G21.1	PYGB	GPBB	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1433	111792	5834	RP5-965G21.1	PYGB	GPBB	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1434	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Rahman MK (1982)	6983619	172488	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1435	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Allen GF (2010)	20403077	172489	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1436	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1437	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Rorsman F (1995)	7567987	172491	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1438	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Bertoldi M (2000)	11085948	172490	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1439	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1440	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1441	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1442	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1443	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Bennett CL (2005)	16075246	172494	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1444	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1445	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Cormier-Daire V (2000)	10978228	172493	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1446	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Vassort C (1993)	8499653	172492	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1447	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1448	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Mehta R (2008)	17918169	172495	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1449	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1450	119599	51540	-	SCLY	SCL|hSCL	9606	Homo sapiens	cofactor	target	Heidenreich T (2005)	15561708	87295	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1451	122980	79896	-	THNSL1	TSH1	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1452	122980	79896	-	THNSL1	TSH1	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1453	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1454	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1455	114894	9517	-	SPTLC2	HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a	9606	Homo sapiens	cofactor	target	Ikushiro H (2001)	11279212	172497	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1456	114894	9517	-	SPTLC2	HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a	9606	Homo sapiens	cofactor	target	Hanada K (2003)	12782147	172496	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1457	114894	9517	-	SPTLC2	HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a	9606	Homo sapiens	cofactor	target	Gable K (2002)	11781309	17464	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1458	114894	9517	-	SPTLC2	HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a	9606	Homo sapiens	cofactor	target	Tamura K (2001)	11726713	56201	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1459	114894	9517	-	SPTLC2	HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a	9606	Homo sapiens	cofactor	target	Tamura K (2000)	11171191	53696	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1460	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1461	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Bennett CL (2005)	16075246	172494	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1462	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1463	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Cormier-Daire V (2000)	10978228	172493	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1464	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	cofactor	target	Vassort C (1993)	8499653	172492	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1465	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1466	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1467	119280	51091	-	SEPSECS	LP|PCH2D|SLA|SLA/LP	9606	Homo sapiens	cofactor	target	Kernebeck T (2001)	11481605	172499	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1468	119280	51091	-	SEPSECS	LP|PCH2D|SLA|SLA/LP	9606	Homo sapiens	cofactor	target	Xu XM (2007)	17194211	172498	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1469	111795	5837	-	PYGM	-	9606	Homo sapiens	cofactor	target	Kurganov BI (2000)	11052666	172501	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1470	111795	5837	-	PYGM	-	9606	Homo sapiens	cofactor	target	Okada M (2001)	11508701	172500	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1471	111795	5837	-	PYGM	-	9606	Homo sapiens	cofactor	target	Livanova NB (2002)	12460107	172503	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1472	111795	5837	-	PYGM	-	9606	Homo sapiens	cofactor	target	Geremia S (2002)	12217700	172502	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1473	111795	5837	-	PYGM	-	9606	Homo sapiens	cofactor	target	Okada M (1999)	11228757	172504	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1474	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	cofactor	target	Battchikova N (1996)	8695645	172505	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1475	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	cofactor	target	Kapetaniou EG (2006)	16532449	172507	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1476	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	cofactor	target	Hester G (1999)	10024454	172506	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1477	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1478	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1479	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	cofactor	target	Berman HM (2000)	10592235	172122	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1480	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Nishijima S (2006)	16847354	172509	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1481	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Danpure CJ (2003)	12686111	172508	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1482	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Nishijima S (2002)	12383475	172510	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1483	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Gable K (2002)	11781309	17464	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1484	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Nishijima S (2003)	12544342	172511	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1485	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	cofactor	target	Beranek M (2001)	11330835	172512	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1486	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	cofactor	target	Baines CJ (2004)	15347780	172513	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1487	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	cofactor	target	Cheung PY (2003)	14688239	172516	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1488	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	cofactor	target	Halfon P (2002)	12537583	172514	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1489	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	cofactor	target	Inubushi T (2005)	16179747	172515	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1490	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1491	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1492	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	activator	target	Eliot AC (2002)	11888303	172518	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1493	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	activator	target	Waldmann A (2006)	16925884	172519	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1494	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1495	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	activator	target	Cooper AJ (2002)	12167474	172517	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1496	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	activator	target	Hansen CM (2001)	11340119	172520	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1497	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Perry C (2007)	17482557	172523	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1498	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Mukherjee M (2006)	16980404	172522	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1499	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Trivedi V (2002)	11877399	172521	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1500	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Bhavani S (2005)	15865438	172525	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1501	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Rajaram V (2007)	17651438	172524	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1502	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1503	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1504	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	cofactor	target	Skoeldberg F (2004)	15070923	172526	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1505	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1506	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Shoolingin-Jordan PM (2003)	12686158	172529	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1507	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1508	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Harigae H (1999)	10577279	172527	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1509	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Nakamura I (1981)	7275938	172528	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1510	119346	51166	-	AADAT	KAT2|KATII	9606	Homo sapiens	cofactor	target	Cooper AJ (2004)	15016471	172530	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1511	119346	51166	-	AADAT	KAT2|KATII	9606	Homo sapiens	cofactor	target	Goh DL (2002)	12126930	172531	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1512	111007	4953	-	ODC1	ODC	9606	Homo sapiens	cofactor	target	Myers DP (2001)	11683631	172534	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1513	111007	4953	-	ODC1	ODC	9606	Homo sapiens	cofactor	target	Khomutov AR (2002)	12460114	172535	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1514	111007	4953	-	ODC1	ODC	9606	Homo sapiens	cofactor	target	Jackson LK (2004)	15476392	172536	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1515	111007	4953	-	ODC1	ODC	9606	Homo sapiens	cofactor	target	Jackson LK (2003)	12672797	172532	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1516	111007	4953	-	ODC1	ODC	9606	Homo sapiens	cofactor	target	Jackson LK (2003)	12627959	172533	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1517	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	cofactor	target	Strisovsky K (2005)	16185077	172541	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1518	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	cofactor	target	Schell MJ (2004)	15306409	172537	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1519	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	cofactor	target	Strisovsky K (2003)	12560076	172538	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1520	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	cofactor	target	Hashimoto A (2005)	16289454	172539	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1521	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	cofactor	target	Uo T (2002)	12596860	172540	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1522	116381	11212	-	PROSC	-	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1523	116381	11212	-	PROSC	-	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1524	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1525	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1526	115809	10558	RP11-118F2.1	SPTLC1	HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI	9606	Homo sapiens	cofactor	target	Ikushiro H (2001)	11279212	172497	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1527	115809	10558	RP11-118F2.1	SPTLC1	HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI	9606	Homo sapiens	cofactor	target	Hanada K (2003)	12782147	172496	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1528	115809	10558	RP11-118F2.1	SPTLC1	HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI	9606	Homo sapiens	cofactor	target	Gable K (2002)	11781309	17464	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1529	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	cofactor	target	Berman HM (2000)	10592235	172122	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1530	119599	51540	-	SCLY	SCL|hSCL	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1531	119599	51540	-	SCLY	SCL|hSCL	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1532	119599	51540	-	SCLY	SCL|hSCL	9606	Homo sapiens	cofactor	target	Berman HM (2000)	10592235	172122	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1533	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	cofactor	target	Graham DE (2002)	11980912	172545	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1534	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	cofactor	target	Kidron H (2007)	16997906	172544	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1535	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	cofactor	target	Patel CN (2004)	15583399	172546	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1536	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	cofactor	target	Shah R (2007)	17305368	172543	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1537	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	cofactor	target	Arena ME (2001)	11168717	172542	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1538	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Hwang IK (2004)	15381280	172547	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1539	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Chen CH (2003)	12535612	172549	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1540	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Rust E (2001)	11488610	172548	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1541	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Jin H (2005)	15686475	172550	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1542	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	cofactor	target	Tong JC (2002)	12067524	172551	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1543	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1544	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1545	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	cofactor	target	Rooseboom M (2002)	12204580	172554	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1546	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	cofactor	target	Lima S (2007)	17300176	172555	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1547	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	cofactor	target	Walsh HA (2002)	11985583	172552	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1548	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	cofactor	target	Momany C (2004)	14756555	172553	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1549	116681	23042	-	PDXDC1	LP8165	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1550	116681	23042	-	PDXDC1	LP8165	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1551	125255	113675	-	SDSL	SDH 2|SDS-RS1|TDH|cSDH	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1552	125255	113675	-	SDSL	SDH 2|SDS-RS1|TDH|cSDH	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1553	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	cofactor	target	Coulter-Mackie MB (2006)	16971151	172556	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1554	108993	2731	RP11-472F14.1	GLDC	GCE|GCSP|HYGN1	9606	Homo sapiens	cofactor	target	Igamberdiev AU (2005)	16228305	172557	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1555	108993	2731	RP11-472F14.1	GLDC	GCE|GCSP|HYGN1	9606	Homo sapiens	cofactor	target	Nakai T (2005)	15791207	172558	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1556	114398	8879	-	SGPL1	S1PL|SPL	9606	Homo sapiens	cofactor	target	Ikeda M (2004)	15522238	172560	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1557	114398	8879	-	SGPL1	S1PL|SPL	9606	Homo sapiens	cofactor	target	Bobbin RP (2001)	11377878	172559	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1558	120590	55304	RP5-1077I2.1	SPTLC3	C20orf38|LCB2B|LCB3|SPT3|SPTLC2L|dJ718P11|dJ718P11.1|hLCB2b	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1559	120590	55304	RP5-1077I2.1	SPTLC3	C20orf38|LCB2B|LCB3|SPT3|SPTLC2L|dJ718P11|dJ718P11.1|hLCB2b	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1560	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1561	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1562	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Skoeldberg F (2004)	15070923	172526	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1563	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Skoeldberg F (2003)	12679420	172563	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1564	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Yee RE (2001)	11709201	172562	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1565	108011	1644	-	DDC	AADC	9606	Homo sapiens	cofactor	target	Tan EK (2005)	15965967	172561	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1566	130959	339896	-	GADL1	ADC|CSADC|HuADC|HuCSADC	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1567	130959	339896	-	GADL1	ADC|CSADC|HuADC|HuCSADC	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1568	121128	56267	RP11-82K18.3	CCBL2	KAT3|KATIII	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1569	121128	56267	RP11-82K18.3	CCBL2	KAT3|KATIII	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1570	124425	85007	PP9286	PHYKPL	AGXT2L2|PHLU	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1571	124425	85007	PP9286	PHYKPL	AGXT2L2|PHLU	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1572	120363	55034	-	MOCOS	HMCS|MCS|MOS	9606	Homo sapiens	cofactor	target	Mendel RR (2006)	16784786	172565	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1573	120363	55034	-	MOCOS	HMCS|MCS|MOS	9606	Homo sapiens	cofactor	target	Anantharaman V (2002)	11886751	172564	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1574	120363	55034	-	MOCOS	HMCS|MCS|MOS	9606	Homo sapiens	cofactor	target	Heidenreich T (2005)	15561708	87295	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1575	120363	55034	-	MOCOS	HMCS|MCS|MOS	9606	Homo sapiens	cofactor	target	Bittner F (2001)	11553608	87807	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1576	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1577	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	cofactor	target	Welch S (1975)	241701	172566	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1578	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1579	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Zhang J (2002)	12191993	172567	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1580	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Choi HP (2004)	15251194	172570	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1581	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Ferreira GC (2002)	12699240	172571	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1582	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Turbeville TD (2007)	17469798	172569	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1583	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	cofactor	target	Zhang J (2005)	15840827	172568	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1584	121330	57026	RP1-37E16.5	PDXP	CIN|PLP|dJ37E16.5	9606	Homo sapiens	cofactor	target	Hwang IK (2007)	17531224	172470	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1585	121330	57026	RP1-37E16.5	PDXP	CIN|PLP|dJ37E16.5	9606	Homo sapiens	cofactor	target	Kim DW (2005)	16336786	172572	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1586	121330	57026	RP1-37E16.5	PDXP	CIN|PLP|dJ37E16.5	9606	Homo sapiens	cofactor	target	Jang YM (2003)	14522954	172573	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1587	121330	57026	RP1-37E16.5	PDXP	CIN|PLP|dJ37E16.5	9606	Homo sapiens	cofactor	target	Tirrell IM (2006)	16336194	172574	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1588	121330	57026	RP1-37E16.5	PDXP	CIN|PLP|dJ37E16.5	9606	Homo sapiens	cofactor	target	McCarty MF (2000)	11000053	172575	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1589	116189	10993	-	SDS	SDH	9606	Homo sapiens	cofactor	target	Yamada T (2003)	14596599	172578	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1590	116189	10993	-	SDS	SDH	9606	Homo sapiens	cofactor	target	Sun L (2005)	15689518	172579	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1591	116189	10993	-	SDS	SDH	9606	Homo sapiens	cofactor	target	Cicchillo RM (2004)	15155761	172580	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1592	116189	10993	-	SDS	SDH	9606	Homo sapiens	cofactor	target	Ogawa H (2006)	16580895	172576	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1593	116189	10993	-	SDS	SDH	9606	Homo sapiens	cofactor	target	Sun L (2003)	14646100	172577	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1594	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	cofactor	target	Mosca M (2003)	12850267	172581	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1595	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	cofactor	target	Cooper AJ (2006)	16463021	172583	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1596	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	cofactor	target	Zhang L (2006)	16846239	172582	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1597	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	cofactor	target	Cooper AJ (2002)	12167474	172517	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1598	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	cofactor	target	Venhorst J (2003)	12798391	172477	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1599	109317	3067	-	HDC	-	9606	Homo sapiens	cofactor	target	Graham DE (2002)	11980912	172545	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1600	109317	3067	-	HDC	-	9606	Homo sapiens	cofactor	target	Landete JM (2006)	16790022	172585	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1601	109317	3067	-	HDC	-	9606	Homo sapiens	cofactor	target	Skoeldberg F (2003)	12679420	172563	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1602	109317	3067	-	HDC	-	9606	Homo sapiens	cofactor	target	Moya-Garcia AA (2006)	16547811	172584	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1603	109317	3067	-	HDC	-	9606	Homo sapiens	cofactor	target	Skoeldberg F (2004)	15070923	172526	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1604	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	cofactor	target	Frazzon J (2002)	12196163	172589	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1605	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	cofactor	target	Ollagnier-De-Choudens S (2002)	12119030	172588	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1606	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	cofactor	target	Cupp-Vickery JR (2003)	12860127	172590	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1607	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	cofactor	target	You D (2007)	17469805	172587	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1608	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	cofactor	target	Forlani F (2005)	16310786	172586	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1609	107321	875	-	CBS	HIP4	9606	Homo sapiens	cofactor	target	Taoka S (2002)	11948191	172592	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1610	107321	875	-	CBS	HIP4	9606	Homo sapiens	cofactor	target	Evande R (2004)	15196993	172593	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1611	107321	875	-	CBS	HIP4	9606	Homo sapiens	cofactor	target	Mino K (2003)	12644499	172591	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1612	107321	875	-	CBS	HIP4	9606	Homo sapiens	cofactor	target	Linnebank M (2004)	15365998	172594	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1613	107321	875	-	CBS	HIP4	9606	Homo sapiens	cofactor	target	Taoka S (2002)	12173932	172595	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1614	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1615	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1616	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	cofactor	target	Beauchamp NJ (2007)	17705025	172596	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
1617	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Moras E (2007)	17011224	141921	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1618	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Brooks AJ (2005)	16305240	141598	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1619	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Kozlowski PM (2006)	16813422	172598	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1620	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Stover PJ (2010)	19904199	172599	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1621	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Worgan LC (2006)	16281286	172597	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1622	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Erdogan MO (2010)	20589617	172600	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1623	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Nakamura T (2002)	11979347	172601	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1624	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	cofactor	target	van der Linden IJ (2006)	17024475	172602	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1625	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	cofactor	target	Berkun Y (2007)	17611986	172603	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1626	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	cofactor	target	Gueant-Rodriguez RM (2005)	16268464	172606	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1627	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	cofactor	target	O'Leary VB (2005)	15979034	172604	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1628	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	cofactor	target	Miriuka SG (2005)	15612980	172605	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1629	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	cofactor	target	Morel CF (2006)	16714133	137281	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1630	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	cofactor	target	Chandler RJ (2006)	16843692	172608	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1631	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	cofactor	target	Ben-Omran TI (2007)	17431913	172609	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1632	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	cofactor	target	Lerner-Ellis JP (2006)	16311595	172607	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1633	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Allen LH (2008)	18709879	172610	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1634	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Stover PJ (2010)	19904199	172599	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1635	127933	166785	-	MMAA	cblA	9606	Homo sapiens	cofactor	target	Dobson CM (2006)	16697227	172611	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1636	127933	166785	-	MMAA	cblA	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1637	127933	166785	-	MMAA	cblA	9606	Homo sapiens	cofactor	target	Lerner-Ellis JP (2004)	15523652	172612	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1638	127933	166785	-	MMAA	cblA	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	110	Cyanocobalamin	Vitamin B12|Vitamin B12 complex|Cyanocob(III)alamin	vitamin b complex 100 tab|mult	DRUGBANK	DB00115	C63H89CoN14O14P	small molecule	B03BA01|B03AE01|B03BA51	68-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEKGMJVHSBBHRD-WZHZPDAFSA-M
1639	116052	10840	-	ALDH1L1	10-FTHFDH|10-fTHF|FDH|FTHFD	9606	Homo sapiens	cofactor	target	Oleinik NV (2006)	16712799	172624	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1640	116052	10840	-	ALDH1L1	10-FTHFDH|10-fTHF|FDH|FTHFD	9606	Homo sapiens	cofactor	target	Anguera MC (2006)	16627483	172625	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1641	116052	10840	-	ALDH1L1	10-FTHFDH|10-fTHF|FDH|FTHFD	9606	Homo sapiens	cofactor	target	Krupenko SA (2001)	11320079	172626	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1642	116052	10840	-	ALDH1L1	10-FTHFDH|10-fTHF|FDH|FTHFD	9606	Homo sapiens	cofactor	target	Krupenko SA (1999)	10585460	172622	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1643	116052	10840	-	ALDH1L1	10-FTHFDH|10-fTHF|FDH|FTHFD	9606	Homo sapiens	cofactor	target	Fu TF (1999)	10395731	172623	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1644	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1645	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Chang WN (2007)	17664250	172627	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1646	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1647	106772	275	-	AMT	GCE|GCST|GCVT|NKH	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1648	106772	275	-	AMT	GCE|GCST|GCVT|NKH	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1649	106772	275	-	AMT	GCE|GCST|GCVT|NKH	9606	Homo sapiens	cofactor	target	Masai E (2004)	15090517	172628	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1650	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	cofactor	target	Kohls D (1999)	10329787	172632	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1651	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	cofactor	target	Bashour AM (1998)	9677387	172631	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1652	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	cofactor	target	Cook RJ (2001)	11488596	172630	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1653	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	cofactor	target	Kohls D (2000)	10673422	172629	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1654	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	cofactor	target	Akar N (2001)	11323021	172633	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1655	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	cofactor	target	Prasannan P (2003)	12937168	172637	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1656	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	cofactor	target	Salmassi TM (2003)	12949177	172636	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1657	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	cofactor	target	Walkup AS (2005)	16171773	172635	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1658	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	cofactor	target	Matakidou A (2007)	17533396	172634	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1661	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Siva A (2007)	17636160	172638	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1662	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Leopardi P (2006)	16950805	172639	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1663	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Ott K (2006)	16929515	172640	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1664	125820	123263	-	MTFMT	COXPD15|FMT1	9606	Homo sapiens	cofactor	target	Li Y (2000)	10781559	51297	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1665	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	cofactor	target	Wolan DW (2003)	12974624	172642	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1666	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	cofactor	target	Bulock KG (2002)	11948179	172641	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1667	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Prabhu V (1998)	9449840	172646	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1668	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Contestabile R (2001)	11737206	172644	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1669	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Vatsyayan R (2007)	17142057	172645	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1670	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Heil SG (2001)	11386852	172643	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1671	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Rajaram V (2007)	17651438	172524	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1672	116011	10797	-	MTHFD2	NMDMC	9606	Homo sapiens	cofactor	target	Salmassi TM (2003)	12949177	172636	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1673	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Hall DA (2000)	10978155	172647	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1674	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Jarrett JT (1998)	9730838	172651	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1675	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Fowler B (2001)	11169015	172650	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1676	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Fu TF (2001)	11237340	172648	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1677	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Jarrett JT (1997)	9398303	172649	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
1680	109317	3067	-	HDC	-	9606	Homo sapiens	unknown	target	Castellani ML (2006)	17191019	172655	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1681	109317	3067	-	HDC	-	9606	Homo sapiens	unknown	target	Kitamura Y (2006)	17075268	172654	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1682	109317	3067	-	HDC	-	9606	Homo sapiens	unknown	target	Nitta Y (2007)	17227057	172656	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1683	109317	3067	-	HDC	-	9606	Homo sapiens	unknown	target	Landete JM (2006)	16790022	172585	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1684	109317	3067	-	HDC	-	9606	Homo sapiens	unknown	target	Fernandez M (2006)	16960050	172653	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1685	109285	3035	-	HARS	HRS|USH3B	9606	Homo sapiens	unknown	target	Nagatoyo Y (2006)	17150756	172657	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1686	109285	3035	-	HARS	HRS|USH3B	9606	Homo sapiens	unknown	target	Rosen AE (2006)	16741232	172658	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1687	109284	3034	-	HAL	HIS|HSTD	9606	Homo sapiens	unknown	target	Katona A (2006)	17193285	172660	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1688	109284	3034	-	HAL	HIS|HSTD	9606	Homo sapiens	unknown	target	Viergutz S (2004)	17191848	172661	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1689	109284	3034	-	HAL	HIS|HSTD	9606	Homo sapiens	unknown	target	Lambrecht NW (2007)	17536021	172662	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1690	109284	3034	-	HAL	HIS|HSTD	9606	Homo sapiens	unknown	target	Watts KT (2006)	17185227	172659	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1691	116187	10991	-	SLC38A3	G17|NAT1|SN1|SNAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1692	116187	10991	-	SLC38A3	G17|NAT1|SN1|SNAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1693	116187	10991	-	SLC38A3	G17|NAT1|SN1|SNAT3	9606	Homo sapiens	unknown	target	Eppig JJ (2005)	15843493	172663	112	L-Histidine	His|(S)-alpha-Amino-1H-imidazole-4-propionic acid|H|L-Histidin|L-()-histidine|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-Histidine|(S)--amino-1H-Imidazole-4-propanoic acid|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|L-(-)-Histidine|Histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00117	C6H9N3O2	small molecule	-	71-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNDVDQJCIGZPNO-YFKPBYRVSA-N
1694	118081	27232	-	GNMT	-	9606	Homo sapiens	cofactor	target	Rowling MJ (2001)	11435507	172668	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1695	118081	27232	-	GNMT	-	9606	Homo sapiens	cofactor	target	Luka Z (2002)	11810299	172669	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1696	118081	27232	-	GNMT	-	9606	Homo sapiens	cofactor	target	Moller MT (2003)	12697024	12306	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1697	118081	27232	-	GNMT	-	9606	Homo sapiens	cofactor	target	Uthus EO (2003)	12742526	172666	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1698	118081	27232	-	GNMT	-	9606	Homo sapiens	cofactor	target	Rowling MJ (2002)	12221207	172667	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1699	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	cofactor	target	Notari S (2004)	15051528	172673	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1700	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	cofactor	target	Ndjonka D (2003)	12974388	172672	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1701	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	cofactor	target	Dudkowska M (2003)	12545203	172671	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1702	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	cofactor	target	Yerlikaya A (2006)	16515461	172670	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1703	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	cofactor	target	Lee BW (2010)	20196537	172675	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1704	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	cofactor	target	Rutherford K (2008)	18486144	172674	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1705	110314	4144	-	MAT2A	MATA2|MATII|SAMS2	9606	Homo sapiens	cofactor	target	Farrar C (2002)	12023972	172677	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1706	110314	4144	-	MAT2A	MATA2|MATII|SAMS2	9606	Homo sapiens	cofactor	target	Mudd SH (2001)	11596649	172676	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1707	110314	4144	-	MAT2A	MATA2|MATII|SAMS2	9606	Homo sapiens	cofactor	target	Martinez-Chantar ML (2003)	12671891	10442	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1708	110314	4144	-	MAT2A	MATA2|MATII|SAMS2	9606	Homo sapiens	cofactor	target	Martinez-Chantar ML (2003)	12660248	172678	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1709	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	cofactor	target	Santamaria E (2003)	12631701	172680	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1710	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	cofactor	target	Carretero MV (2001)	11301045	172681	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1711	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	cofactor	target	Martinez-Chantar ML (2003)	12671891	10442	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1712	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	cofactor	target	Martinez-Chantar ML (2002)	12060674	172679	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1713	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	cofactor	target	Martinez-Chantar ML (2003)	12660248	172678	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1714	107321	875	-	CBS	HIP4	9606	Homo sapiens	activator	target	Janosik M (2001)	11524006	172682	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1715	107321	875	-	CBS	HIP4	9606	Homo sapiens	activator	target	Evande R (2002)	12269827	172683	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1716	107321	875	-	CBS	HIP4	9606	Homo sapiens	activator	target	Choumenkovitch SF (2002)	12163655	172684	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1717	107321	875	-	CBS	HIP4	9606	Homo sapiens	activator	target	Jacobs RL (2001)	11559709	172685	113	S-Adenosylmethionine	SAM|S-adenosyl-L-methionine|[1-(Adenin-9-yl)-1,5-dideoxy-beta-D-ribofuranos-5-yl][(3S)-3-amino-3-carboxypropyl](methyl)sulfonium|S-Adenosylmethionine|SAMe|AdoMet|(3S)-5'-[(3-amino-3-Carboxypropyl)methylsulfonio]-5'-deoxyadenosine, inner salt|S-(5'-Deoxyadenosin-5'-yl)-L-methionine|Acylcarnitine	-	DRUGBANK	DB00118	C15H23N6O5S	small molecule	-	29908-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFKEPWMEQBLKI-AIRLBKTGSA-O
1718	114629	9194	-	SLC16A7	MCT2	9606	Homo sapiens	unknown	target	Bonen A (2006)	16604139	172691	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1719	114629	9194	-	SLC16A7	MCT2	9606	Homo sapiens	unknown	target	Yoshida Y (2007)	17556391	172693	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1720	114629	9194	-	SLC16A7	MCT2	9606	Homo sapiens	unknown	target	Pierre K (2005)	15953344	172692	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1721	114629	9194	-	SLC16A7	MCT2	9606	Homo sapiens	unknown	target	Hinoi E (2006)	16766717	172695	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1722	114629	9194	-	SLC16A7	MCT2	9606	Homo sapiens	unknown	target	de Laplanche E (2006)	16597615	172694	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1723	117083	23539	RP5-1039K5.14-003	SLC16A8	MCT3|REMP	9606	Homo sapiens	unknown	target	Jansen S (2006)	16514190	172696	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1724	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1725	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1726	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Tamaki N (1989)	2632679	172697	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1727	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Schmidt C (2006)	16435204	172698	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1728	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1729	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Andersen G (2007)	17355287	72343	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1730	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	unknown	target	Duerr JM (2007)	17583564	172699	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1731	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	unknown	target	Han M (2006)	16110503	172702	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1732	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	unknown	target	Philp A (2005)	16326938	172701	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1733	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	unknown	target	Shimada A (2006)	16213084	172700	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1734	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	unknown	target	Shimoyama Y (2007)	17606506	172703	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1735	114571	9123	-	SLC16A3	MCT 3|MCT 4|MCT-3|MCT-4|MCT3|MCT4	9606	Homo sapiens	unknown	target	Shimada A (2006)	16213084	172700	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1736	114569	9121	-	SLC16A5	MCT5|MCT6	9606	Homo sapiens	unknown	target	Bonen A (2006)	16604139	172691	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1737	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Ikeda K (2007)	16765071	172708	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1738	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Liu L (2007)	17008113	172707	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1739	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Jitrapakdee S (2006)	16505973	172706	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1740	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Simpson NE (2006)	16575559	172705	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1741	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Jensen MV (2006)	16740637	172704	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1742	114568	9120	-	SLC16A6	MCT6|MCT7	9606	Homo sapiens	unknown	target	Bonen A (2006)	16604139	172691	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1743	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16365052	172709	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1744	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Percy MJ (2007)	17574881	172710	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1745	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Rajaseger G (2006)	16720364	172711	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1746	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Xu J (2006)	16644726	172712	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1747	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Meza NW (2007)	17547515	172713	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1748	111188	5162	-	PDHB	PDHBD|PDHE1-B|PHE1B	9606	Homo sapiens	unknown	target	Kumar V (2006)	16855207	172714	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1749	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Li Y (2005)	16132722	172715	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1750	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Staib P (2005)	16375581	172716	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1751	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Stetak A (2007)	17308100	172717	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1752	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Weinberger R (2007)	17587357	172718	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1753	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Vlaeminck-Guillem V (2006)	16741870	172719	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1754	112455	6567	RP11-449M9.1	SLC16A2	AHDS|DXS128|DXS128E|MCT 7|MCT 8|MCT7|MCT8|MRX22|XPCT	9606	Homo sapiens	unknown	target	Bonen A (2006)	16604139	172691	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1755	114570	9122	RP5-1074L1.3	SLC16A4	MCT4|MCT5	9606	Homo sapiens	unknown	target	Bonen A (2006)	16604139	172691	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1756	114570	9122	RP5-1074L1.3	SLC16A4	MCT4|MCT5	9606	Homo sapiens	unknown	target	Kay HH (2007)	17275903	172720	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1757	114570	9122	RP5-1074L1.3	SLC16A4	MCT4|MCT5	9606	Homo sapiens	unknown	target	Shimada A (2006)	16213084	172700	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1758	114570	9122	RP5-1074L1.3	SLC16A4	MCT4|MCT5	9606	Homo sapiens	unknown	target	Pierre K (2005)	15953344	172692	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1759	114570	9122	RP5-1074L1.3	SLC16A4	MCT4|MCT5	9606	Homo sapiens	unknown	target	Han M (2006)	16110503	172702	114	Pyruvic acid	CH3COCOOH|2-ketopropionic acid|Pyroracemic acid|BTS|Acide pyruvique|2-Oxopropanoic acid|-ketopropionic acid|alpha-Ketopropionic acid|2-Oxopropansaeure|alpha-Oxopropionsaeure|2-Oxopropionsaeure|a-Ketopropionic acid|Acetylformic acid|Brenztraubensaeure|Pyruvic acid	-	DRUGBANK	DB00119	C3H4O3	small molecule	-	127-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTONWCANYUPML-UHFFFAOYSA-N
1760	116996	23428	-	SLC7A8	LAT2|LPI-PC1	9606	Homo sapiens	unknown	target	Shennan DB (2002)	12101005	172729	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1761	116996	23428	-	SLC7A8	LAT2|LPI-PC1	9606	Homo sapiens	unknown	target	Nemoto T (2003)	12498902	172728	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1762	116996	23428	-	SLC7A8	LAT2|LPI-PC1	9606	Homo sapiens	unknown	target	Rossier G (1999)	10574970	447	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1763	116996	23428	-	SLC7A8	LAT2|LPI-PC1	9606	Homo sapiens	unknown	target	Babu E (2003)	12930836	172727	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1764	116996	23428	-	SLC7A8	LAT2|LPI-PC1	9606	Homo sapiens	unknown	target	Satoh S (1997)	9349567	172726	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1765	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Pueschel SM (1988)	2975336	172732	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1766	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Thorolfsson M (2002)	12056888	172733	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1767	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Nagasaki Y (1999)	10203136	172730	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1768	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Fusetti F (1998)	9642259	12571	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1769	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Stokka AJ (2003)	12379147	172731	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1770	108487	2193	-	FARSA	CML33|FARSL|FARSLA|FRSA|PheHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1771	108487	2193	-	FARSA	CML33|FARSL|FARSLA|FRSA|PheHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1772	108487	2193	-	FARSA	CML33|FARSL|FARSLA|FRSA|PheHA	9606	Homo sapiens	unknown	target	Kodama K (2006)	16969782	172734	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1773	108487	2193	-	FARSA	CML33|FARSL|FARSLA|FRSA|PheHA	9606	Homo sapiens	unknown	target	Kotik-Kogan O (2005)	16338408	172735	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1774	115909	10667	RP1-236A3.1	FARS2	COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1775	115909	10667	RP1-236A3.1	FARS2	COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1776	115909	10667	RP1-236A3.1	FARS2	COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2	9606	Homo sapiens	unknown	target	Kodama K (2006)	16969782	172734	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1777	115909	10667	RP1-236A3.1	FARS2	COXPD14|FARS1|HSPC320|PheRS|dJ520B18.2	9606	Homo sapiens	unknown	target	Kotik-Kogan O (2005)	16338408	172735	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1778	112761	6898	-	TAT	-	9606	Homo sapiens	unknown	target	Rege AA (1987)	2890101	172738	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1779	112761	6898	-	TAT	-	9606	Homo sapiens	unknown	target	De-Eknamkul W (1989)	16666560	172739	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1780	112761	6898	-	TAT	-	9606	Homo sapiens	unknown	target	Luong TN (1997)	9356140	172736	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1781	112761	6898	-	TAT	-	9606	Homo sapiens	unknown	target	Patrizio M (2001)	11299302	172737	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1782	115367	10056	HSPC173	FARSB	FARSLB|FRSB|PheHB|PheRS	9606	Homo sapiens	unknown	target	Kotik-Kogan O (2005)	16338408	172735	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1783	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1784	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Fusetti F (1998)	9642259	12571	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1785	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	McQuade PS (1983)	6621777	172743	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1786	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Schallreuter KU (2003)	12565907	172742	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1787	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Ogawa S (2006)	16581181	172741	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1788	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Fukami MH (1990)	1973034	172740	115	L-Phenylalanine	-phenyl-L-alanine|F|(S)-2-Amino-3-phenylpropionic acid|Phe|(S)-alpha-Amino-beta-phenylpropionic acid|beta-Phenyl-L-alanine|Phenylalanine|3-phenyl-L-alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00120	C9H11NO2	small molecule	-	63-91-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-QMMMGPOBSA-N
1789	111128	5095	RP11-151A6.1	PCCA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1790	111128	5095	RP11-151A6.1	PCCA	-	9606	Homo sapiens	unknown	target	Vlasova TI (2005)	15623830	172746	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1791	111128	5095	RP11-151A6.1	PCCA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1792	111128	5095	RP11-151A6.1	PCCA	-	9606	Homo sapiens	unknown	target	Clavero S (2002)	12385775	172744	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1793	111128	5095	RP11-151A6.1	PCCA	-	9606	Homo sapiens	unknown	target	Cherbonnel-Lasserre CL (1997)	9311592	172745	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1794	106549	31	-	ACACA	ACAC|ACACAD|ACC|ACC1|ACCA	9606	Homo sapiens	unknown	target	Brownsey RW (2006)	16545081	172747	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1795	106549	31	-	ACACA	ACAC|ACACAD|ACC|ACC1|ACCA	9606	Homo sapiens	unknown	target	Aoki H (2006)	16636450	172750	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1796	106549	31	-	ACACA	ACAC|ACACAD|ACC|ACC1|ACCA	9606	Homo sapiens	unknown	target	Leonard E (2007)	17468269	172751	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1797	106549	31	-	ACACA	ACAC|ACACAD|ACC|ACC1|ACCA	9606	Homo sapiens	unknown	target	Bilder P (2006)	16460018	172749	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1798	106549	31	-	ACACA	ACAC|ACACAD|ACC|ACC1|ACCA	9606	Homo sapiens	unknown	target	Santoro N (2006)	16707089	172748	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1799	121249	56922	-	MCCC1	MCC-B|MCCA	9606	Homo sapiens	unknown	target	Friebel D (2006)	16773504	172752	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1800	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1801	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Ishii M (2004)	14997352	172753	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1802	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Cherbonnel-Lasserre CL (1997)	9311592	172745	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1803	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1804	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Vlasova TI (2005)	15623830	172746	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1805	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Ferreira G (2007)	17297119	172754	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1806	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Liu L (2007)	17008113	172707	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1807	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Jitrapakdee S (2007)	17478118	72451	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1808	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Jitrapakdee S (2007)	17659996	73562	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1809	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Ozimek PZ (2007)	17316367	72375	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1810	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Liu Y (2007)	17477831	172755	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1811	109386	3141	-	HLCS	HCS	9606	Homo sapiens	unknown	target	Hassan YI (2006)	16772434	172758	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1812	109386	3141	-	HLCS	HCS	9606	Homo sapiens	unknown	target	Velazquez-Arellano A (2006)	16359899	172756	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1813	109386	3141	-	HLCS	HCS	9606	Homo sapiens	unknown	target	Camporeale G (2006)	17056793	172757	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1814	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Janoria KG (2006)	17038304	172759	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1815	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Camporeale G (2007)	17374649	172761	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1816	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Luo S (2006)	16749865	172760	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1817	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Reidling JC (2007)	17135299	172762	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1818	122050	64087	-	MCCC2	MCCB	9606	Homo sapiens	unknown	target	Luedke A (2007)	17254330	172764	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1819	122050	64087	-	MCCC2	MCCB	9606	Homo sapiens	unknown	target	de Queiroz MS (2007)	17266990	172763	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1820	122050	64087	-	MCCC2	MCCB	9606	Homo sapiens	unknown	target	Jitrapakdee S (2007)	17659996	73562	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1821	122050	64087	-	MCCC2	MCCB	9606	Homo sapiens	unknown	target	Santoro N (2006)	16707089	172748	116	Biotin	Biotinum|Vitamin H|(3AS,4S,6ar)-hexahydro-2-oxo-1H-thieno[3,4-D]imidazole-4-valeric acid|cis-Hexahydro-2-oxo-1H-thieno(3,4)imidazole-4-valeric acid|cis-Tetrahydro-2-oxothieno(3,4-D)imidazoline-4-valeric acid|(+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid|Vitamin B7|Coenzyme R|D(+)-Biotin|Biotin|D-(+)-Biotin|5-(2-Oxohexahydro-1H-thieno[3,4-D]imidazol-4-yl)pentanoic acid|D-Biotin|Biotine|cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid|Biotina	balanced b 125 srt|nata komple	DRUGBANK	DB00121	C10H16N2O3S	small molecule	A11HA05	58-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJHBAHKTGYVGT-ZKWXMUAHSA-N
1822	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	product of	target	Anzai J (2006)	17139155	172765	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1823	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	product of	target	Longobardi F (2005)	16302752	172767	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1824	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	product of	target	Amenta F (2006)	16297435	172766	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1825	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	product of	target	Durcan N (2006)	16456188	172769	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1826	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	product of	target	Alkondon M (2006)	16565162	172768	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1827	111353	5337	-	PLD1	-	9606	Homo sapiens	product of	target	Lee JS (2005)	16179605	172770	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1828	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Calaf GM (2007)	17390078	172774	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1829	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Amenta F (2006)	16297435	172766	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1830	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Hsieh BC (2007)	17329059	172772	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1831	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Stoytcheva M (2006)	16376069	172773	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1832	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	product of	target	Lurie S (2007)	17636231	172771	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1833	127819	162466	-	PHOSPHO1	-	9606	Homo sapiens	product of	target	Imming P (2006)	17016423	171742	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1834	127819	162466	-	PHOSPHO1	-	9606	Homo sapiens	product of	target	Overington JP (2006)	17139284	171741	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1835	114854	9468	-	PCYT1B	CCTB|CTB	9606	Homo sapiens	product of	target	Imming P (2006)	17016423	171742	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1836	114854	9468	-	PCYT1B	CCTB|CTB	9606	Homo sapiens	product of	target	Overington JP (2006)	17139284	171741	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1837	114854	9468	-	PCYT1B	CCTB|CTB	9606	Homo sapiens	product of	target	Wang L (2005)	15798219	172775	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1838	111157	5130	-	PCYT1A	CCTA|CT|CTA|CTPCT|PCYT1|SMDCRD	9606	Homo sapiens	product of	target	Enaw JO (2006)	17184542	172776	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1839	111157	5130	-	PCYT1A	CCTA|CT|CTA|CTPCT|PCYT1|SMDCRD	9606	Homo sapiens	product of	target	Li L (2007)	17218027	172777	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1840	111354	5338	-	PLD2	-	9606	Homo sapiens	product of	target	Szumilo M (2006)	16921342	71101	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1841	111354	5338	-	PLD2	-	9606	Homo sapiens	product of	target	Singh AT (2005)	16459925	172780	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1842	111354	5338	-	PLD2	-	9606	Homo sapiens	product of	target	Lee JS (2005)	16179605	172770	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1843	111354	5338	-	PLD2	-	9606	Homo sapiens	product of	target	Paruch S (2007)	17627030	172778	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1844	111354	5338	-	PLD2	-	9606	Homo sapiens	product of	target	Fensome-Green A (2006)	16878701	172779	117	Choline	Choline ion|Choline|Bilineurine|trimethylethanolamine|N,N,N-trimethylethanol-ammonium|N-trimethylethanolamine	nata komplete|dayclear sinus p	DRUGBANK	DB00122	C5H14NO	small molecule	N02BA03	62-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEYIOHPDSNJKLS-UHFFFAOYSA-N
1845	112435	6545	-	SLC7A4	CAT-4|CAT4|HCAT3|VH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1846	112435	6545	-	SLC7A4	CAT-4|CAT4|HCAT3|VH	9606	Homo sapiens	unknown	target	Rotoli BM (2005)	15746185	172830	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1847	112435	6545	-	SLC7A4	CAT-4|CAT4|HCAT3|VH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1848	109938	3735	-	KARS	CMTRIB|DFNB89|KARS1|KARS2|KRS	9606	Homo sapiens	unknown	target	Wu XR (2007)	17425721	172831	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1849	109938	3735	-	KARS	CMTRIB|DFNB89|KARS1|KARS2|KRS	9606	Homo sapiens	unknown	target	Kamenski P (2007)	17560369	72256	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1850	109938	3735	-	KARS	CMTRIB|DFNB89|KARS1|KARS2|KRS	9606	Homo sapiens	unknown	target	Kwon I (2006)	16953616	172833	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1851	109938	3735	-	KARS	CMTRIB|DFNB89|KARS1|KARS2|KRS	9606	Homo sapiens	unknown	target	Chou TF (2007)	17158446	172832	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1852	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1853	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1854	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Nicholson B (1998)	9614060	172835	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1855	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Fernandez J (2003)	14523001	172834	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1856	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Lopez AB (2007)	17042743	117779	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1857	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1858	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Rotoli BM (2005)	15746185	172830	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1859	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1860	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Schwartz D (2003)	12475743	172837	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1861	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Low BC (1995)	7499219	172836	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1862	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1863	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Hosokawa H (1997)	9079705	172838	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1864	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1865	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Humphrey BD (2006)	16406639	172839	118	L-Lysine	Lysine|L-lys|Lysina|LYS|Lysinum|L-2,6-Diaminocaproic acid|(S)-lysine|(S)-,-diaminocaproic acid|6-ammonio-L-norleucine|L-Lysin|Lysine acid|(S)-2,6-diaminohexanoic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00123	C6H14N2O2	small molecule	B05XB03	56-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-MLHKIVSYNA-N
1866	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	unknown	target	Yang HQ (2007)	17287563	172840	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1867	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	unknown	target	Regunathan S (2006)	17025265	172841	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1868	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	unknown	target	Wu N (2008)	17653850	172842	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1869	125246	113451	-	AZIN2	ADC|AZI2|AZIB1|ODC-p|ODC1L|ODCp	9606	Homo sapiens	unknown	target	Kotil K (2006)	16703907	172843	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1870	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Rotoli BM (2007)	17363779	172848	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1871	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Rotmann A (2007)	17329401	172844	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1872	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Vasquez R (2007)	17427197	172845	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1873	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Yang Z (2007)	17325243	172846	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1874	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Cerec V (2007)	17065601	172847	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1875	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Topal G (2006)	16801455	172849	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1876	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Hood HM (2007)	16979358	71274	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1877	112435	6545	-	SLC7A4	CAT-4|CAT4|HCAT3|VH	9606	Homo sapiens	unknown	target	Rotmann A (2007)	17329401	172844	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1878	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Cheng PN (2007)	17210712	172853	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1879	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Moradi H (2006)	16809898	172852	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1880	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Feun L (2006)	16787144	172851	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1881	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Szlosarek PW (2007)	17354225	172850	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1882	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Bizzoco E (2007)	17198704	172857	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1883	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Mages W (2007)	17611150	172856	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1884	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Tischner R (2007)	17651442	172855	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1885	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Mori M (2007)	17513437	172854	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1886	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Moradi H (2006)	16809898	172852	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1887	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Rotoli BM (2007)	17363779	172848	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1888	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Devan BD (2007)	17362916	172861	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1889	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Cui YY (2006)	16778961	172860	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1890	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Kagemann G (2007)	17340133	172859	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1891	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Popovic PJ (2007)	17513447	172858	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1892	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Huang Y (2007)	17234578	172862	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1893	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Rotmann A (2007)	17329401	172844	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1894	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Haruna Y (2006)	16729278	172866	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1895	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Ishikawa T (2006)	16720041	172867	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1896	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Yang J (2006)	16717106	172864	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1897	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Gautier C (2006)	16690332	172865	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1898	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Akamine EH (2006)	16682803	172863	119	L-Arginine	(2S)-2-amino-5-(Carbamimidamido)pentanoic acid|L-Arginine|Arginine|(2S)-2-amino-5-Guanidinopentanoic acid|(S)-2-Amino-5-guanidinovaleric acid|L-Arginin|L-Arg|Arg|R|L-(+)-Arginine|(S)-2-amino-5-guanidinopentanoic acid	2.5% travasol amino acid injec	DRUGBANK	DB00125	C6H14N4O2	small molecule	B05XB01	74-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-N
1899	114467	8985	-	PLOD3	LH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1900	114467	8985	-	PLOD3	LH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1901	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1902	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1903	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Vaz FM (2000)	10709635	172871	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1904	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Dunn WA (1984)	6432788	172870	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1905	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Rebouche CJ (1991)	1962562	172869	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1906	111366	5351	RP5-1077B9.2	PLOD1	EDS6|LH|LH1|LLH|PLOD	9606	Homo sapiens	activator	target	Salavoura K (2006)	17100196	172875	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1907	111366	5351	RP5-1077B9.2	PLOD1	EDS6|LH|LH1|LLH|PLOD	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1908	111282	5264	RP11-24J20.1	PHYH	LN1|LNAP1|PAHX|PHYH1|RD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1909	111282	5264	RP11-24J20.1	PHYH	LN1|LNAP1|PAHX|PHYH1|RD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1910	111367	5352	-	PLOD2	LH2|TLH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1911	111367	5352	-	PLOD2	LH2|TLH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1912	125185	112399	-	EGLN3	HIFP4H3|HIFPH3|PHD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1913	125185	112399	-	EGLN3	HIFP4H3|HIFPH3|PHD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1914	120060	54583	PNAS-118	EGLN1	C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1915	120060	54583	PNAS-118	EGLN1	C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1916	113891	8284	-	KDM5D	HY|HYA|JARID1D|SMCY	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1917	113891	8284	-	KDM5D	HY|HYA|JARID1D|SMCY	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1918	128686	221120	-	ALKBH3	ABH3|DEPC-1|DEPC1|PCA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1919	128686	221120	-	ALKBH3	ABH3|DEPC-1|DEPC1|PCA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1920	125184	112398	-	EGLN2	EIT6|HIF-PH1|HIFPH1|HPH-1|HPH-3|PHD1	9606	Homo sapiens	unknown	target	Bruegge K (2007)	17627521	172876	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1921	125184	112398	-	EGLN2	EIT6|HIF-PH1|HIFPH1|HPH-1|HPH-3|PHD1	9606	Homo sapiens	unknown	target	Nytko KJ (2007)	17627474	127532	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1922	120532	55239	-	OGFOD1	TPA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1923	120532	55239	-	OGFOD1	TPA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1924	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1925	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	unknown	target	Feng J (2000)	10947967	172877	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1926	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1927	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	unknown	target	Pettingill TM (1991)	1894598	172879	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1928	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	unknown	target	Suzuki E (1997)	9505234	172878	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1929	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1930	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Floryszak-Wieczorek J (2006)	16773376	172880	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1931	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Crespo A (2006)	17002377	172881	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1932	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Romero I (2007)	17570561	172882	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1933	122098	64175	PSEC0109	P3H1	GROS1|LEPRE1|OI8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1934	122098	64175	PSEC0109	P3H1	GROS1|LEPRE1|OI8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1935	122801	79676	-	OGFOD2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1936	122801	79676	-	OGFOD2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1937	125741	121642	-	ALKBH2	ABH2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1938	125741	121642	-	ALKBH2	ABH2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1939	120510	55214	-	P3H2	LEPREL1|MCVD|MLAT4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1940	120510	55214	-	P3H2	LEPREL1|MCVD|MLAT4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1941	115790	10536	-	LEPREL2	GRCB|HSU47926|P3H3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1942	115790	10536	-	LEPREL2	GRCB|HSU47926|P3H3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1943	120100	54681	-	P4HTM	EGLN4|HIFPH4|P4H-TM|PH-4|PH4|PHD4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1944	120100	54681	-	P4HTM	EGLN4|HIFPH4|P4H-TM|PH-4|PH4|PHD4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1945	120513	55217	-	TMLHE	AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1946	120513	55217	-	TMLHE	AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1947	115288	9963	-	SLC23A1	SLC23A2|SVCT1|YSPL3	9606	Homo sapiens	unknown	target	Kang JS (2007)	17008880	172884	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1948	115288	9963	-	SLC23A1	SLC23A2|SVCT1|YSPL3	9606	Homo sapiens	unknown	target	Perez MJ (2007)	17645691	172885	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1949	115288	9963	-	SLC23A1	SLC23A2|SVCT1|YSPL3	9606	Homo sapiens	unknown	target	Johnston L (2007)	17258485	172886	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1950	115288	9963	-	SLC23A1	SLC23A2|SVCT1|YSPL3	9606	Homo sapiens	unknown	target	Savini I (2008)	17541511	172887	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1951	115288	9963	-	SLC23A1	SLC23A2|SVCT1|YSPL3	9606	Homo sapiens	unknown	target	Steiling H (2007)	17664139	172883	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1952	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1953	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
1954	111007	4953	-	ODC1	ODC	9606	Homo sapiens	product of	target	Roehn G (2001)	11408092	172889	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1955	111007	4953	-	ODC1	ODC	9606	Homo sapiens	product of	target	Ernestus RI (2001)	11413269	172893	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1956	111007	4953	-	ODC1	ODC	9606	Homo sapiens	product of	target	Nilsson J (2000)	10698696	172892	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1957	111007	4953	-	ODC1	ODC	9606	Homo sapiens	product of	target	Ray RM (2000)	10712236	172891	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1958	111007	4953	-	ODC1	ODC	9606	Homo sapiens	product of	target	Korhonen VP (2001)	11160858	172890	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1960	119994	54498	RP4-779E11.4	SMOX	C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO	9606	Homo sapiens	ligand	target	Wang Y (2003)	12727196	172899	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1961	119994	54498	RP4-779E11.4	SMOX	C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO	9606	Homo sapiens	ligand	target	Binda C (2001)	11258887	172898	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1962	119994	54498	RP4-779E11.4	SMOX	C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO	9606	Homo sapiens	ligand	target	Vujcic S (2002)	12141946	172897	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1963	119994	54498	RP4-779E11.4	SMOX	C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO	9606	Homo sapiens	ligand	target	Bacchi CJ (2004)	15133083	172896	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1964	119994	54498	RP4-779E11.4	SMOX	C20orf16|PAO|PAO-1|PAO1|PAOH|PAOH1|SMO	9606	Homo sapiens	ligand	target	Vujcic S (2003)	12477380	172895	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1965	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Korhonen VP (2001)	11160858	172890	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1966	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Theiss C (2002)	11950995	172905	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1967	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Lopatin AN (2000)	11040105	172904	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1968	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Cason AL (2003)	14508504	172907	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1969	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Wang X (2011)	21318872	172906	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1970	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Wang X (2004)	15459188	172901	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1971	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Kobayashi M (2006)	16651710	172900	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1972	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Schwartz CE (2011)	21318891	172903	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1973	112495	6611	-	SMS	MRSR|SPMSY|SRS|SpS	9606	Homo sapiens	ligand	target	Krauss M (2006)	16515550	172902	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
1974	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1975	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1976	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1977	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1978	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1979	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Grell EH (1976)	823072	172918	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1980	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Recasens M (1979)	261660	172919	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1981	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Collier RH (1972)	4404056	172917	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1982	114164	8604	-	SLC25A12	AGC1|ARALAR	9606	Homo sapiens	unknown	target	Satrustegui J (2007)	17237342	172923	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1983	114164	8604	-	SLC25A12	AGC1|ARALAR	9606	Homo sapiens	unknown	target	Contreras L (2007)	17213189	172922	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1984	114164	8604	-	SLC25A12	AGC1|ARALAR	9606	Homo sapiens	unknown	target	Correia C (2006)	17151801	172921	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1985	114164	8604	-	SLC25A12	AGC1|ARALAR	9606	Homo sapiens	unknown	target	Satrustegui J (2007)	17497669	172920	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1986	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1987	106935	443	-	ASPA	ACY2|ASP	9606	Homo sapiens	unknown	target	Moffett JR (2007)	17275978	172927	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1988	106935	443	-	ASPA	ACY2|ASP	9606	Homo sapiens	unknown	target	Srikanth SG (2007)	17219235	172926	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1989	106935	443	-	ASPA	ACY2|ASP	9606	Homo sapiens	unknown	target	Wang J (2007)	17254025	172925	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1990	106935	443	-	ASPA	ACY2|ASP	9606	Homo sapiens	unknown	target	Bitto E (2007)	17194761	172924	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1991	106935	443	-	ASPA	ACY2|ASP	9606	Homo sapiens	unknown	target	Janson CG (2006)	17177147	172928	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1992	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1993	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1994	106610	95	-	ACY1	ACY-1|ACY1D|HEL-S-5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1995	106610	95	-	ACY1	ACY-1|ACY1D|HEL-S-5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1996	106610	95	-	ACY1	ACY-1|ACY1D|HEL-S-5	9606	Homo sapiens	unknown	target	Mitta M (1992)	1284246	172929	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1997	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1998	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
1999	123142	80150	-	ASRGL1	ALP|ALP1|CRASH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2000	123142	80150	-	ASRGL1	ALP|ALP1|CRASH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2001	124869	91703	-	ACY3	ACY-3|HCBP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2002	124869	91703	-	ACY3	ACY-3|HCBP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2003	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Ozawa S (2007)	17663137	172930	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2004	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Tai YH (2007)	17346885	172931	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2005	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Tao Z (2007)	17389249	172932	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2006	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Teichman S (2007)	17535962	172933	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2007	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Tordjman J (2007)	17545671	172938	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2008	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Zappacosta B (2007)	17328883	172934	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2009	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Girgin S (2006)	17168267	172935	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2010	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Guidetti P (2007)	17442055	172936	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2011	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Wu ZM (2007)	17244260	172937	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2012	106936	444	-	ASPH	AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2013	106936	444	-	ASPH	AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin	9606	Homo sapiens	unknown	target	Iijima T (1977)	403177	172939	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2014	106936	444	-	ASPH	AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2015	106936	444	-	ASPH	AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin	9606	Homo sapiens	unknown	target	Whiteman P (1980)	6785382	172940	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2016	107984	1615	PIG40	DARS	HBSL|aspRS	9606	Homo sapiens	unknown	target	Eiler S (1999)	10562565	172941	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2017	107984	1615	PIG40	DARS	HBSL|aspRS	9606	Homo sapiens	unknown	target	Cavarelli J (1994)	8313877	37601	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2018	107984	1615	PIG40	DARS	HBSL|aspRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2019	107984	1615	PIG40	DARS	HBSL|aspRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2020	107984	1615	PIG40	DARS	HBSL|aspRS	9606	Homo sapiens	unknown	target	Fender A (2006)	16597625	172942	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2021	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2022	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Ben-Yoseph Y (1989)	2791302	172943	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2023	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2024	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Shen LJ (2005)	15588718	172945	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2025	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Flam BR (2007)	17869551	172944	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2026	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2027	106668	159	RP11-518L10.4	ADSS	ADEH|ADSS 2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2028	106668	159	RP11-518L10.4	ADSS	ADEH|ADSS 2	9606	Homo sapiens	unknown	target	Raman J (2004)	15500910	172948	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2029	106668	159	RP11-518L10.4	ADSS	ADEH|ADSS 2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2030	106668	159	RP11-518L10.4	ADSS	ADEH|ADSS 2	9606	Homo sapiens	unknown	target	Mehrotra S (2007)	17929831	172947	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2031	106668	159	RP11-518L10.4	ADSS	ADEH|ADSS 2	9606	Homo sapiens	unknown	target	Datta SK (1994)	7825060	172946	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2032	120459	55157	RP3-383J4.2	DARS2	ASPRS|LBSL|MT-ASPRS	9606	Homo sapiens	unknown	target	Eiler S (1999)	10562565	172941	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2033	120459	55157	RP3-383J4.2	DARS2	ASPRS|LBSL|MT-ASPRS	9606	Homo sapiens	unknown	target	Cavarelli J (1994)	8313877	37601	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2034	120459	55157	RP3-383J4.2	DARS2	ASPRS|LBSL|MT-ASPRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2035	120459	55157	RP3-383J4.2	DARS2	ASPRS|LBSL|MT-ASPRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2036	120459	55157	RP3-383J4.2	DARS2	ASPRS|LBSL|MT-ASPRS	9606	Homo sapiens	unknown	target	Fender A (2006)	16597625	172942	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2037	107243	790	-	CAD	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2038	107243	790	-	CAD	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2039	115852	10606	-	PAICS	ADE2|ADE2H1|AIRC|PAIS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2040	115852	10606	-	PAICS	ADE2|ADE2H1|AIRC|PAIS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
2046	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Mitruka BM (1967)	5335895	172952	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2047	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Natesan S (2001)	11691635	172953	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2048	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2049	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Thomasset N (1982)	7173402	172954	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2050	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2051	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	unknown	target	Inubushi T (2005)	16179747	172515	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2052	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	unknown	target	Kaneko S (2007)	17197567	172956	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2053	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	unknown	target	Levillain O (2005)	15616821	172955	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2054	111000	4946	-	OAZ1	AZI|OAZ	9606	Homo sapiens	unknown	target	Lopez-Contreras AJ (2006)	16916800	119168	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2055	111000	4946	-	OAZ1	AZI|OAZ	9606	Homo sapiens	unknown	target	Yamaguchi Y (2006)	16354653	172958	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2056	111000	4946	-	OAZ1	AZI|OAZ	9606	Homo sapiens	unknown	target	Jaenne J (2004)	15009201	172957	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2057	115468	10166	RP11-346L13.4	SLC25A15	D13S327|HHH|ORC1|ORNT1	9606	Homo sapiens	unknown	target	Korman SH (2004)	14759633	172959	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2058	115468	10166	RP11-346L13.4	SLC25A15	D13S327|HHH|ORC1|ORNT1	9606	Homo sapiens	unknown	target	Camacho JA (2006)	16940241	172960	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2059	111001	4947	-	OAZ2	AZ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2060	111001	4947	-	OAZ2	AZ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2061	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Rotmann A (2004)	15491978	172962	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2062	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Yeramian A (2006)	16703566	172961	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2063	112432	6541	RP11-274A8.1	SLC7A1	ATRC1|CAT-1|ERR|HCAT1|REC1L	9606	Homo sapiens	unknown	target	Cerec V (2007)	17065601	172847	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2064	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Bussiere FI (2005)	15548540	172963	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2065	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Levillain O (2005)	15539552	172967	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2066	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Nissim I (2005)	15753084	172966	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2067	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Rodriguez PC (2003)	12874210	172965	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2068	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Levillain O (2004)	14871882	172964	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2069	123796	83884	-	SLC25A2	ORC2|ORNT2	9606	Homo sapiens	unknown	target	Begum L (2002)	11997094	172949	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2070	123796	83884	-	SLC25A2	ORC2|ORNT2	9606	Homo sapiens	unknown	target	Camacho JA (2003)	12948741	172968	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2071	123796	83884	-	SLC25A2	ORC2|ORNT2	9606	Homo sapiens	unknown	target	Camacho JA (2006)	16940241	172960	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2072	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Yeramian A (2006)	16703566	172961	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2073	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Endo M (2003)	12679322	172969	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2074	112433	6542	-	SLC7A2	ATRC2|CAT2|HCAT2	9606	Homo sapiens	unknown	target	Cerec V (2007)	17065601	172847	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2075	112435	6545	-	SLC7A4	CAT-4|CAT4|HCAT3|VH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2076	112435	6545	-	SLC7A4	CAT-4|CAT4|HCAT3|VH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2077	119677	51686	RP11-98D18.13-004	OAZ3	AZ3|OAZ-t|TISP15	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2078	119677	51686	RP11-98D18.13-004	OAZ3	AZ3|OAZ-t|TISP15	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2079	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	El Alami M (2003)	12679340	96036	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2080	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Gobert AP (2002)	11971019	172970	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2081	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Bansal V (2003)	12589193	172971	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2082	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Stickings P (2002)	12446178	172972	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2083	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Iwata S (2002)	12135320	172973	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2084	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Templeton MD (2005)	15766270	172974	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2085	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	El Alami M (2003)	12679340	96036	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2086	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Morizono H (2006)	16585758	172976	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2087	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Barcelona-Andres B (2002)	12399499	172975	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2088	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2089	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Hosokawa H (1997)	9079705	172838	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2090	124329	84889	-	SLC7A3	ATRC3|CAT-3|CAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	123	L-Ornithine	(S)-,-diaminovaleric acid|(S)-alpha,delta-Diaminovaleric acid|(S)-2,5-diaminovaleric acid|(S)-ornithine|L-Ornithine|(S)-2,5-Diaminopentanoate|(S)-2,5-Diaminopentanoic acid	primene 10%|primene 10%-liq iv	DRUGBANK	DB00129	C5H12N2O2	small molecule	-	70-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLPHDHHMVZTML-BYPYZUCNSA-N
2091	107883	1503	-	CTPS1	CTPS|IMD24	9606	Homo sapiens	antagonist	target	Taylor SD (2006)	17137369	172977	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2092	107883	1503	-	CTPS1	CTPS|IMD24	9606	Homo sapiens	antagonist	target	MacLeod TJ (2006)	16427816	172978	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2093	107883	1503	-	CTPS1	CTPS|IMD24	9606	Homo sapiens	antagonist	target	Fijolek A (2007)	17331943	172979	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2094	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Tan S (2006)	16547651	172984	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2095	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Mong JA (2005)	16326016	172981	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2096	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Rose C (2005)	16382338	172980	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2097	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Miguel-Hidalgo JJ (2006)	16484281	172983	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2098	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	product of	target	Chatauret N (2006)	16530878	172982	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2099	111467	5471	-	PPAT	ATASE|GPAT|PRAT	9606	Homo sapiens	product of	target	Jiang P (2007)	17355124	172985	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2100	111467	5471	-	PPAT	ATASE|GPAT|PRAT	9606	Homo sapiens	product of	target	Jiang P (2007)	17355125	172986	124	L-Glutamine	L-(+)-glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-glutamic acid -amide|L-Glutamin|Levoglutamide|(S)-2,5-diamino-5-oxopentanoic acid|L-Glutamic acid gamma-amide|L-Glutamine|L-Glutaminsure-5-amid|Glutamic acid 5-amide|Q|L-2-aminoglutaramic acid|GLUTAMINE|Glutamic acid amide|(2S)-2,5-Diamino-5-oxopentanoic acid|L-Glutaminsaeure-5-amid	nutrestore	DRUGBANK	DB00130	C5H10N2O3	small molecule	A16AA03	56-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXPYRJPNDTMRX-VKHMYHEASA-N
2101	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Whitehead JP (2006)	16634986	173038	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2102	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Ruderman NB (2006)	16642960	173039	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2103	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	McGee SL (2006)	16620308	173036	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2104	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Neurath KM (2006)	16518831	173037	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2105	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Richter EA (2006)	16513051	173035	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2106	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	product of	target	Terrin A (2006)	17088426	173040	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2107	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	product of	target	Porteous DJ (2006)	16843095	173042	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2108	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	product of	target	Siuciak JA (2007)	17333137	173041	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2109	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	product of	target	Terrin A (2006)	17088426	173040	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2110	124122	84532	RP4-568C11.1	ACSS1	ACAS2L|ACECS1|AceCS2L	9606	Homo sapiens	product of	target	Imming P (2006)	17016423	171742	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2111	124122	84532	RP4-568C11.1	ACSS1	ACAS2L|ACECS1|AceCS2L	9606	Homo sapiens	product of	target	Overington JP (2006)	17139284	171741	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2112	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	antagonist	target	Xue Y (1994)	7809062	173044	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2113	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	antagonist	target	Hebeisen P (2008)	18650089	173043	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2114	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	inhibitory allosteric modulator	target	Xue Y (1994)	7809062	173044	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2115	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	inhibitory allosteric modulator	target	Hebeisen P (2008)	18650089	173043	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2116	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	product of	target	Chou TF (2007)	17217311	173046	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2117	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	product of	target	Chou TF (2007)	17337452	173045	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2118	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	product of	target	Chou TF (2007)	17158446	172832	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2119	111552	5565	-	PRKAB2	-	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2120	111552	5565	-	PRKAB2	-	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2121	107775	1385	-	CREB1	CREB	9606	Homo sapiens	activator	target	Brenhouse HC (2007)	17324065	173047	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2122	107775	1385	-	CREB1	CREB	9606	Homo sapiens	activator	target	Ulfhammer E (2006)	16879221	173050	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2123	107775	1385	-	CREB1	CREB	9606	Homo sapiens	activator	target	Saha B (2006)	17083486	173051	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2124	107775	1385	-	CREB1	CREB	9606	Homo sapiens	activator	target	Kozinn J (2006)	17122581	173049	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2125	107775	1385	-	CREB1	CREB	9606	Homo sapiens	activator	target	Perlis RH (2007)	17300755	173048	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2126	111310	5292	-	PIM1	PIM	9606	Homo sapiens	product of	target	Imming P (2006)	17016423	171742	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2127	111310	5292	-	PIM1	PIM	9606	Homo sapiens	product of	target	Overington JP (2006)	17139284	171741	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2128	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Mayes MA (2007)	17167165	173052	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2129	106644	132	-	ADK	AK	9606	Homo sapiens	product of	target	Park J (2008)	18560757	173053	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2130	106644	132	-	ADK	AK	9606	Homo sapiens	product of	target	Leoncini R (2006)	17065073	173054	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2131	106621	107	-	ADCY1	AC1|DFNB44	9606	Homo sapiens	product of	target	Chen X (2002)	11752352	171740	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2132	106621	107	-	ADCY1	AC1|DFNB44	9606	Homo sapiens	product of	target	Nicol X (2006)	17229090	173055	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2133	106621	107	-	ADCY1	AC1|DFNB44	9606	Homo sapiens	product of	target	Yang ZF (2006)	16895552	173056	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2134	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	product of	target	Reger AS (2007)	17497934	173058	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2135	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	product of	target	Linne U (2007)	17303131	173059	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2136	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	product of	target	Ingram-Smith C (2006)	16981708	69339	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2137	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	product of	target	Ingram-Smith C (2007)	17350930	173057	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2138	108476	2180	-	ACSL1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	9606	Homo sapiens	product of	target	Ingram-Smith C (2006)	16981708	69339	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2139	108476	2180	-	ACSL1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	9606	Homo sapiens	product of	target	Ingram-Smith C (2007)	17350930	173057	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2140	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2141	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	125	Adenosine monophosphate	Adenosine 5'-(dihydrogen phosphate)|5'-Adenosine monophosphate|Adenosine 5'-monophosphate|Adenosine-5'-monophosphoric acid|PAdo|Adenylate|Phosphate d'adenosine|Adenosine-5'-Monophosphate|5'-O-Phosphonoadenosine|Adenosine phosphate|Ado5'p|Adenosine-5'p|AMP|Fosfato de adenosina|5'-Adenylic acid|ADENOSINE monophosphate|Phosaden|Adenylic acid|Phosphaden|5'-AMP|Adenosini phosphas|Adenosine 5'-phosphate	-	DRUGBANK	DB00131	C10H14N5O7P	small molecule	-	61-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDMBCSSLTHHNCD-KQYNXXCUSA-N
2142	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Mohan IK (2000)	10765977	173065	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2143	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Maniongui C (1993)	8487621	173064	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2144	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Xiang M (2006)	16988497	173067	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2145	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Descomps B (1995)	8673626	173066	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2146	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Hoffman DR (2001)	11518758	173063	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2147	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Xiang M (2006)	16988497	173067	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2148	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Baylin A (2007)	17284757	158289	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2149	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Li MC (2004)	15481543	173069	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2150	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Portolesi R (2007)	17409318	173068	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2151	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Ge L (2003)	12713571	158520	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2152	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Tan L (2011)	21210105	110703	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2153	112661	6785	-	ELOVL4	ADMD|CT118|ISQMR|SCA34|STGD2|STGD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2154	112661	6785	-	ELOVL4	ADMD|CT118|ISQMR|SCA34|STGD2|STGD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2155	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2156	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2157	112436	6546	-	SLC8A1	NCX1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2158	112436	6546	-	SLC8A1	NCX1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2159	112436	6546	-	SLC8A1	NCX1	9606	Homo sapiens	unknown	target	Ander BP (2007)	17059813	173070	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2160	115809	10558	RP11-118F2.1	SPTLC1	HSAN1|HSN1|LBC1|LCB1|SPT1|SPTI	9606	Homo sapiens	unknown	target	Yard BA (2007)	17559874	72070	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2161	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	unknown	target	Fujitani Y (2007)	17499824	77309	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2162	121963	63826	-	SRR	ILV1|ISO1	9606	Homo sapiens	unknown	target	Ying-Luan Z (2007)	17663143	173072	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2163	114894	9517	-	SPTLC2	HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a	9606	Homo sapiens	unknown	target	Yard BA (2007)	17559874	72070	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2164	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Ikushiro H (2007)	17557831	173074	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2165	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Cowart LA (2007)	17322298	72498	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2166	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Son JH (2007)	17654249	173073	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2167	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Yard BA (2007)	17559874	72070	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2168	116189	10993	-	SDS	SDH	9606	Homo sapiens	unknown	target	Velayudhan J (2004)	14688104	173076	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2169	116189	10993	-	SDS	SDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2170	116189	10993	-	SDS	SDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2171	116189	10993	-	SDS	SDH	9606	Homo sapiens	unknown	target	Wong HC (1979)	500557	173075	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2172	116189	10993	-	SDS	SDH	9606	Homo sapiens	unknown	target	Snell K (1974)	4377655	173077	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2173	112208	6301	RP11-352P4.2	SARS	SERRS|SERS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2174	112208	6301	RP11-352P4.2	SARS	SERRS|SERS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2175	112208	6301	RP11-352P4.2	SARS	SERRS|SERS	9606	Homo sapiens	unknown	target	Zhang Y (2007)	16950556	173080	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2176	112208	6301	RP11-352P4.2	SARS	SERRS|SERS	9606	Homo sapiens	unknown	target	McClendon CL (2006)	16517553	173078	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2177	112208	6301	RP11-352P4.2	SARS	SERRS|SERS	9606	Homo sapiens	unknown	target	Follis KE (2005)	16081124	173079	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2178	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Qu K (2008)	17629356	173082	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2179	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Sen S (2007)	17352495	173081	127	L-Serine	L-Ser|(S)-2-Amino-3-hydroxypropanoic acid|beta-Hydroxyalanine|beta-Hydroxy-L-alanine|L-()-serine|(2S)-2-amino-3-Hydroxypropanoic acid|Ser|(S)-alpha-Amino-beta-hydroxypropionic acid|(S)-Serine|L-3-Hydroxy-alanine|L-(-)-Serine|L-2-Amino-3-hydroxypropionic acid|L-Serin|L-Serine|L-3-Hydroxy-2-aminopropionic acid|(S)-(-)-Serine|S|Serine|(S)-()-serine	freamine iii|primene 10%|2.75%	DRUGBANK	DB00133	C3H7NO3	small molecule	-	56-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-REOHCLBHSA-N
2180	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	product of	target	Liu J (2007)	17350061	173083	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2181	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	product of	target	Slow S (2006)	16920841	172788	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2182	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	product of	target	Hazra A (2007)	17389618	173086	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2183	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	product of	target	Uthus EO (2007)	17513393	173085	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2184	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	product of	target	Sparks JD (2006)	16396637	173084	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2185	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	product of	target	Addlagatta A (2006)	16823043	173090	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2186	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	product of	target	Hu X (2006)	17114291	173089	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2187	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	product of	target	Nonato MC (2006)	16540317	173088	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2188	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	product of	target	Sheppard GS (2006)	16789740	173087	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2189	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	product of	target	Upadhya R (2006)	16917013	68115	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2190	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	product of	target	Taurog RE (2006)	16618098	173094	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2191	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	product of	target	Banks EC (2007)	17222188	173095	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2192	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	product of	target	Reynolds E (2006)	17052662	173091	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2193	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	product of	target	Yamada K (2007)	17615995	173092	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2194	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	product of	target	Hughes JA (2006)	16788729	173093	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2195	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	product of	target	Kim DJ (2006)	17079868	173096	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2196	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	product of	target	Elmore CL (2007)	17369066	173097	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2197	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	product of	target	Tvedegaard KC (2006)	17101561	173098	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2198	117245	23743	-	BHMT2	-	9606	Homo sapiens	product of	target	Imming P (2006)	17016423	171742	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2199	117245	23743	-	BHMT2	-	9606	Homo sapiens	product of	target	Overington JP (2006)	17139284	171741	128	L-Methionine	L-alpha-amino-gamma-Methylmercaptobutyric acid|(S)-2-amino-4-(methylthio)butanoic acid|(S)-methionine|(S)-2-amino-4-(methylthio)butyric acid|M|L-a-Amino-g-methylthiobutyric acid|Met|L--amino--methylmercaptobutyric acid|Methionine|(2S)-2-amino-4-(Methylsulfanyl)butanoic acid|L-Methionine|L-(-)-Methionine|L-Methionin	2.5% travasol amino acid injec	DRUGBANK	DB00134	C5H11NO2S	small molecule	V03AB26	63-68-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-BYPYZUCNSA-N
2200	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Rostrup M (2008)	17520326	173119	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2201	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2202	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Olsovska J (2007)	17604359	173120	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2203	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Bodnar I (2007)	17451064	173121	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2204	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Ugriumov MV (2007)	17578016	173122	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2205	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Richards AB (2007)	17561836	173123	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2206	119258	51067	CGI-04	YARS2	MLASA2|MT-TYRRS|TYRRS	9606	Homo sapiens	unknown	target	Zhang Y (2005)	15840835	173124	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2207	119258	51067	CGI-04	YARS2	MLASA2|MT-TYRRS|TYRRS	9606	Homo sapiens	unknown	target	Kobayashi T (2003)	12754495	173125	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2208	119258	51067	CGI-04	YARS2	MLASA2|MT-TYRRS|TYRRS	9606	Homo sapiens	unknown	target	Kiga D (2002)	12097643	173126	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2209	119258	51067	CGI-04	YARS2	MLASA2|MT-TYRRS|TYRRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2210	119258	51067	CGI-04	YARS2	MLASA2|MT-TYRRS|TYRRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2211	112761	6898	-	TAT	-	9606	Homo sapiens	unknown	target	Dong S (2007)	17389761	173127	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2212	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Bonnefond L (2007)	17401211	173128	129	L-Tyrosine	(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|()--amino-p-hydroxyhydrocinnamic acid|L-Tyrosine|(S)-Tyrosine|4-hydroxy-L-phenylalanine|(S)-(-)-Tyrosine|(S)-3-(p-Hydroxyphenyl)alanine|L-Tyrosin|(S)--amino-4-hydroxybenzenepropanoic acid|(-)-alpha-amino-P-Hydroxyhydrocinnamic acid|Y|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|TYROSINE|Tyr|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid	primene 10%|2.5% travasol amin	DRUGBANK	DB00135	C9H11NO3	small molecule	-	60-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUYCCCASQSFEME-QMMMGPOBSA-N
2213	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	130	Calcitriol	1alpha,25-Dihydroxyvitamin D3|(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1-alpha-25-Dihydroxyvitamin D3|1alpha,25(OH)2D3|1,25-dihydroxycholecalciferol|Calcitriolum|1,25-dihydroxycholecalciferol|1,25-DHCC|1,25-dihydroxyvitamin D3|Decostriol|Calcitriol|Rocaltrol|5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol|(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1,25(OH)2D3|1alpha,25-Dihydroxycholecalciferol|(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol|Calcijex	rocaltrol oral solution 1mcg/m	DRUGBANK	DB00136	C27H44O3	small molecule	A11CC04|D05AX03	32222-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMRQFYUYWCNGIN-NKMMMXOESA-N
2214	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	antagonist	target	Reinhart GA (2004)	15503649	173130	130	Calcitriol	1alpha,25-Dihydroxyvitamin D3|(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1-alpha-25-Dihydroxyvitamin D3|1alpha,25(OH)2D3|1,25-dihydroxycholecalciferol|Calcitriolum|1,25-dihydroxycholecalciferol|1,25-DHCC|1,25-dihydroxyvitamin D3|Decostriol|Calcitriol|Rocaltrol|5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol|(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol|1,25(OH)2D3|1alpha,25-Dihydroxycholecalciferol|(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol|Calcijex	rocaltrol oral solution 1mcg/m	DRUGBANK	DB00136	C27H44O3	small molecule	A11CC04|D05AX03	32222-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMRQFYUYWCNGIN-NKMMMXOESA-N
2215	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	unknown	target	Tomi M (2003)	12898700	173139	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2216	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	unknown	target	Bridges CC (2005)	16014042	173138	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2217	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	unknown	target	Hosoya K (2002)	12065721	173137	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2218	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	unknown	target	Ruiz E (2003)	12498985	173136	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2219	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	unknown	target	Tomi M (2002)	11867597	173135	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2220	116309	11136	-	SLC7A9	BAT1|CSNU3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2221	116309	11136	-	SLC7A9	BAT1|CSNU3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2222	112410	6519	-	SLC3A1	ATR1|CSNU1|D2H|NBAT|RBAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2223	112410	6519	-	SLC3A1	ATR1|CSNU1|D2H|NBAT|RBAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2224	107878	1497	-	CTNS	CTNS-LSB|PQLC4	9606	Homo sapiens	unknown	target	Kalatzis V (2001)	11689434	55988	132	L-Cystine	,'-dithiodialanine|L-alpha-Diamino-beta-dithiolactic acid|(R,R)-3,3'-dithiobis(2-aminopropanoic acid)|L-Dicysteine	-	DRUGBANK	DB00138	C6H12N2O4S2	small molecule	-	56-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEVWYRKDKASIDU-SEFKMRKONA-N
2225	112450	6561	-	SLC13A1	NAS1|NaSi-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2226	112450	6561	-	SLC13A1	NAS1|NaSi-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2227	112450	6561	-	SLC13A1	NAS1|NaSi-1	9606	Homo sapiens	unknown	target	Lee A (2000)	11161786	173140	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2228	114467	8985	-	PLOD3	LH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2229	114467	8985	-	PLOD3	LH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2230	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2231	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2232	114008	8424	-	BBOX1	BBH|BBOX|G-BBH|gamma-BBH	9606	Homo sapiens	unknown	target	Yoshisue K (2000)	10820142	173141	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2233	122037	64064	FKSG25	OXCT2	SCOTT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2234	122037	64064	FKSG25	OXCT2	SCOTT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2235	121179	56670	-	SUCNR1	GPR91	9606	Homo sapiens	unknown	target	Macaulay IC (2007)	17192395	173142	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2236	111366	5351	RP5-1077B9.2	PLOD1	EDS6|LH|LH1|LLH|PLOD	9606	Homo sapiens	unknown	target	Cudic M (2007)	17610258	173143	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2237	114464	8974	UNQ290/PRO330	P4HA2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2238	114464	8974	UNQ290/PRO330	P4HA2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2239	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Sun F (2005)	15989954	173146	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2240	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Brink I (2006)	16374125	173147	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2241	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Lehtonen HJ (2007)	17520677	173144	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2242	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Bayley JP (2006)	16405730	173145	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2243	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Bayley JP (2005)	16288654	173148	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2244	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Szeto SS (2007)	17636259	73680	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2245	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Kubo Y (2005)	16232921	68096	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2246	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Bayley JP (2006)	16405730	173145	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2247	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Bayley JP (2005)	16288654	173148	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2248	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Leibowitz G (2005)	15986240	173149	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2249	111059	5019	-	OXCT1	OXCT|SCOT	9606	Homo sapiens	unknown	target	Coros AM (2004)	15388917	173150	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2250	114330	8802	-	SUCLG1	GALPHA|MTDPS9|SUCLA1	9606	Homo sapiens	unknown	target	Ostergaard E (2007)	17668387	173151	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2251	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Arikawa Y (2005)	16232421	68288	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2252	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Lehtonen HJ (2007)	17520677	173144	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2253	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Bayley JP (2006)	16405730	173145	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2254	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Bayley JP (2005)	16288654	173148	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2255	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Szeto SS (2007)	17636259	73680	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2256	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2257	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Ackrell BA (2002)	12231007	173154	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2258	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2259	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Takeo S (2000)	10779596	173153	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2260	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Maklashina E (2006)	16484232	173152	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2261	106936	444	-	ASPH	AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2262	106936	444	-	ASPH	AAH|BAH|CASQ2BP1|FDLAB|HAAH|JCTN|junctin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2263	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Yogeeswari P (2005)	15853764	173155	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2264	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Ahn SJ (2007)	17584458	173157	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2265	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Popov VN (2007)	17619587	173156	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2266	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2267	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Wang C (2006)	16942602	173159	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2268	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Chiribau CB (2006)	16689938	173158	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2269	114329	8801	-	SUCLG2	GBETA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2270	114329	8801	-	SUCLG2	GBETA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2271	114520	9058	-	SLC13A2	NADC1|NaCT|NaDC-1|SDCT1	9606	Homo sapiens	unknown	target	Hagos Y (2006)	16735460	173160	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2272	114520	9058	-	SLC13A2	NADC1|NaCT|NaDC-1|SDCT1	9606	Homo sapiens	unknown	target	Takahashi R (2006)	16188913	173161	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2273	114520	9058	-	SLC13A2	NADC1|NaCT|NaDC-1|SDCT1	9606	Homo sapiens	unknown	target	Hall JA (2005)	16030212	173162	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2274	114520	9058	-	SLC13A2	NADC1|NaCT|NaDC-1|SDCT1	9606	Homo sapiens	unknown	target	Burckhardt BC (2005)	15561973	173163	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2275	114183	8630	-	HSD17B6	HSE|RODH|SDR9C6	9606	Homo sapiens	unknown	target	Bayley JP (2006)	16405730	173145	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2276	114183	8630	-	HSD17B6	HSE|RODH|SDR9C6	9606	Homo sapiens	unknown	target	Gupta D (2004)	15646028	173164	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2277	114183	8630	-	HSD17B6	HSE|RODH|SDR9C6	9606	Homo sapiens	unknown	target	Goel HC (2005)	15639001	173165	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2278	114183	8630	-	HSD17B6	HSE|RODH|SDR9C6	9606	Homo sapiens	unknown	target	Huang LS (2006)	16371358	173166	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2279	114183	8630	-	HSD17B6	HSE|RODH|SDR9C6	9606	Homo sapiens	unknown	target	Dudkina NV (2005)	15713802	88002	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2280	122098	64175	PSEC0109	P3H1	GROS1|LEPRE1|OI8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2281	122098	64175	PSEC0109	P3H1	GROS1|LEPRE1|OI8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2282	120510	55214	-	P3H2	LEPREL1|MCVD|MLAT4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2283	120510	55214	-	P3H2	LEPREL1|MCVD|MLAT4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2284	114331	8803	RP11-528D24.2	SUCLA2	A-BETA|MTDPS5|SCS-betaA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2285	114331	8803	RP11-528D24.2	SUCLA2	A-BETA|MTDPS5|SCS-betaA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2286	114331	8803	RP11-528D24.2	SUCLA2	A-BETA|MTDPS5|SCS-betaA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2287	107850	1468	-	SLC25A10	DIC	9606	Homo sapiens	unknown	target	Mizuarai S (2005)	16027120	173168	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2288	107850	1468	-	SLC25A10	DIC	9606	Homo sapiens	unknown	target	Ventura FV (2005)	16176879	173167	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2289	115790	10536	-	LEPREL2	GRCB|HSU47926|P3H3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2290	115790	10536	-	LEPREL2	GRCB|HSU47926|P3H3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2291	120513	55217	-	TMLHE	AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2292	120513	55217	-	TMLHE	AUTSX6|BBOX2|TMLD|TMLH|TMLHED|XAP130	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2293	122322	64849	RP1-257E24.1	SLC13A3	NADC3|SDCT2	9606	Homo sapiens	unknown	target	Hagos Y (2006)	16735460	173160	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2294	122322	64849	RP1-257E24.1	SLC13A3	NADC3|SDCT2	9606	Homo sapiens	unknown	target	Oshiro N (2005)	15944208	173169	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2295	122322	64849	RP1-257E24.1	SLC13A3	NADC3|SDCT2	9606	Homo sapiens	unknown	target	Burckhardt BC (2005)	15561973	173163	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2296	122322	64849	RP1-257E24.1	SLC13A3	NADC3|SDCT2	9606	Homo sapiens	unknown	target	Yodoya E (2006)	16524379	173171	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2297	122322	64849	RP1-257E24.1	SLC13A3	NADC3|SDCT2	9606	Homo sapiens	unknown	target	Wolff NA (2007)	17526543	173170	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2298	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2299	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	133	Succinic acid	HOOC-CH2-CH2-COOH|Bernsteinsaeure|Bernsteinsaure|1,2-Ethanedicarboxylic acid|Succinic acid|Acide succinique|Dihydrofumaric acid|Spirit of amber|e363|Acidum succinicum|Acide butanedioique|Butandisaeure|Butanedioic acid|Ethylenesuccinic acid|Amber acid|Butanedionic acid|Succinate|Asuccin	-	DRUGBANK	DB00139	C4H6O4	small molecule	-	110-15-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDYFGRWQOYBRFD-UHFFFAOYSA-N
2300	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	ligand	target	Bertollo CM (2006)	16962092	173177	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2301	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	ligand	target	Werner R (2005)	16081269	173176	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2302	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	ligand	target	Hirano G (2011)	21308351	173175	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2303	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	ligand	target	Solovieva IM (2005)	15668000	173174	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2304	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	ligand	target	Sandoval FJ (2005)	16183635	173173	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2305	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	ligand	target	Ishchuk OP (2007)	17290783	72680	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2306	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	product of	target	Russell TR (2004)	14769034	173179	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2307	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	product of	target	van Pee KH (2006)	16544142	173178	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2308	850215	945848	b1662	ribC	ECK1658|JW1654|ribE	511145	Escherichia coli	unknown	target	Long Q (2010)	20148904	173180	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2309	850215	945848	b1662	ribC	ECK1658|JW1654|ribE	511145	Escherichia coli	unknown	target	Kim RR (2010)	20143812	173181	134	Riboflavin	Riboflavina|Riboflavinum|Riboflavine|7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine|E101|6,7-Dimethyl-9-D-ribitylisoalloxazine|Vitamin B2|7,8-Dimethyl-10-ribitylisoalloxazine|Vitamin G|1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol|Lactoflavin|Lactoflavine	vitamin b complex 100 tab|phot	DRUGBANK	DB00140	C17H20N4O6	small molecule	A11HA04	83-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUNGANRZJHBGPY-SCRDCRAPSA-N
2310	119351	51172	-	NAGPA	APAA|UCE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2311	119351	51172	-	NAGPA	APAA|UCE	9606	Homo sapiens	unknown	target	Chavez CA (2007)	17927214	173188	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2312	119351	51172	-	NAGPA	APAA|UCE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2313	119351	51172	-	NAGPA	APAA|UCE	9606	Homo sapiens	unknown	target	Mullis KG (1994)	8294420	173186	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2314	119351	51172	-	NAGPA	APAA|UCE	9606	Homo sapiens	unknown	target	Kornfeld R (1998)	9722550	173187	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2315	114247	8704	-	B4GALT2	B4Gal-T2|B4Gal-T3|beta4Gal-T2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2316	114247	8704	-	B4GALT2	B4Gal-T2|B4Gal-T3|beta4Gal-T2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2317	120728	55577	-	NAGK	GNK|HSA242910	9606	Homo sapiens	unknown	target	Yang C (2006)	16857666	173191	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2318	120728	55577	-	NAGK	GNK|HSA242910	9606	Homo sapiens	unknown	target	Weihofen WA (2006)	17010375	173190	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2319	120728	55577	-	NAGK	GNK|HSA242910	9606	Homo sapiens	unknown	target	An HJ (2006)	16674097	173192	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2320	120728	55577	-	NAGK	GNK|HSA242910	9606	Homo sapiens	unknown	target	Uehara T (2004)	15489439	173189	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2321	120728	55577	-	NAGK	GNK|HSA242910	9606	Homo sapiens	unknown	target	Nishimasu H (2007)	17229727	173193	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2322	114246	8703	-	B4GALT3	beta4Gal-T3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2323	114246	8703	-	B4GALT3	beta4Gal-T3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2324	114245	8702	UNQ552/PRO1109	B4GALT4	B4Gal-T4|beta4Gal-T4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2325	114245	8702	UNQ552/PRO1109	B4GALT4	B4Gal-T4|beta4Gal-T4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2326	114245	8702	UNQ552/PRO1109	B4GALT4	B4Gal-T4|beta4Gal-T4	9606	Homo sapiens	unknown	target	Buelter T (2001)	11948877	173194	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2327	111905	5973	-	RENBP	RBP|RNBP	9606	Homo sapiens	unknown	target	Lee YC (2007)	17349707	173198	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2328	111905	5973	-	RENBP	RBP|RNBP	9606	Homo sapiens	unknown	target	Takahashi S (2005)	16011304	173195	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2329	111905	5973	-	RENBP	RBP|RNBP	9606	Homo sapiens	unknown	target	Ferrero MA (2007)	17565386	173197	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2330	111905	5973	-	RENBP	RBP|RNBP	9606	Homo sapiens	unknown	target	Lee YC (2007)	17292397	173196	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2331	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Hidalgo A (2006)	17203585	173199	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2332	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Ramakrishnan B (2005)	15736931	173200	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2333	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Ramakrishnan B (2004)	15449940	173201	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2334	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Ramasamy V (2005)	16157350	173202	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2335	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Boeggeman E (2007)	17370997	173203	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2336	110750	4669	-	NAGLU	MPS-IIIB|MPS3B|NAG|UFHSD	9606	Homo sapiens	activator	target	Vishu Kumar AB (2005)	15932346	173205	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2337	110750	4669	-	NAGLU	MPS-IIIB|MPS3B|NAG|UFHSD	9606	Homo sapiens	activator	target	Zou L (2007)	17414423	173204	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2338	110750	4669	-	NAGLU	MPS-IIIB|MPS3B|NAG|UFHSD	9606	Homo sapiens	activator	target	Spiro RG (2004)	15112051	173207	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2339	110750	4669	-	NAGLU	MPS-IIIB|MPS3B|NAG|UFHSD	9606	Homo sapiens	activator	target	Nogawa M (1998)	16349528	173206	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2340	110750	4669	-	NAGLU	MPS-IIIB|MPS3B|NAG|UFHSD	9606	Homo sapiens	activator	target	Shirazi F (2007)	17576230	173208	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2341	110750	4669	-	NAGLU	MPS-IIIB|MPS3B|NAG|UFHSD	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	135	N-Acetyl-D-glucosamine	aldehydo-N-acetyl-D-glucosamine|N-Acetyl-D-glucosamine|N-Acetylchitosamine|2-Acetamido-2-deoxy-D-glucose|D-GlcNAc	-	DRUGBANK	DB00141	C8H15NO6	small molecule	-	7512-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBLBDJOUHNCFQT-LXGUWJNJSA-N
2342	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2343	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2344	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Smirnov SV (2007)	17559390	173209	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2345	109156	2899	-	GRIK3	EAA5|GLR7|GLUR7|GluK3|GluR7a	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2346	109156	2899	-	GRIK3	EAA5|GLR7|GLUR7|GluK3|GluR7a	9606	Homo sapiens	unknown	target	Bettler B (1992)	1371217	173212	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2347	109156	2899	-	GRIK3	EAA5|GLR7|GLUR7|GluK3|GluR7a	9606	Homo sapiens	unknown	target	Stuehmer T (1996)	8622118	173210	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2348	109156	2899	-	GRIK3	EAA5|GLR7|GLUR7|GluK3|GluR7a	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2349	109156	2899	-	GRIK3	EAA5|GLR7|GLUR7|GluK3|GluR7a	9606	Homo sapiens	unknown	target	Takeda M (2000)	11058796	173211	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2350	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Miglio G (2007)	17662248	173213	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2351	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2352	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2353	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Far SR (1996)	8979623	173216	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2354	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Haeppoelae O (1987)	3299141	173214	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2355	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Imai H (1991)	1983997	173215	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2356	112761	6898	-	TAT	-	9606	Homo sapiens	unknown	target	Ozturk M (2006)	16840830	173217	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2357	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2358	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2359	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2360	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Recasens M (1979)	261660	172919	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2361	109175	2918	-	GRM8	GLUR8|GPRC1H|MGLUR8|mGlu8	9606	Homo sapiens	unknown	target	Suzuki G (2007)	17360958	173218	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2362	109175	2918	-	GRM8	GLUR8|GPRC1H|MGLUR8|mGlu8	9606	Homo sapiens	unknown	target	Morimoto R (2006)	16957773	173219	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2363	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Olmos G (1999)	10455281	173220	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2364	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Kuner T (1993)	7905294	173222	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2365	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Sundstroem E (1997)	9417820	173221	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2366	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2367	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2368	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Rutter AR (2000)	11080203	173223	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2369	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2370	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2371	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Rutter AR (2002)	12068077	173225	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2372	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Bresink I (1996)	8886398	173224	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2373	112398	6507	-	SLC1A3	EA6|EAAT1|GLAST|GLAST1	9606	Homo sapiens	unknown	target	Glowatzki E (2006)	16855093	173228	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2374	112398	6507	-	SLC1A3	EA6|EAAT1|GLAST|GLAST1	9606	Homo sapiens	unknown	target	Nickell J (2007)	16959378	173227	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2375	112398	6507	-	SLC1A3	EA6|EAAT1|GLAST|GLAST1	9606	Homo sapiens	unknown	target	Beart PM (2007)	17088867	173226	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2376	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2377	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Ting SM (1994)	8132637	173229	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2378	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2379	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Cerini C (1997)	9063462	173230	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2380	111790	5832	-	ALDH18A1	ARCL3A|GSAS|P5CS|PYCS	9606	Homo sapiens	unknown	target	Morita Y (2003)	12513997	59313	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2381	111790	5832	-	ALDH18A1	ARCL3A|GSAS|P5CS|PYCS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2382	111790	5832	-	ALDH18A1	ARCL3A|GSAS|P5CS|PYCS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2383	111790	5832	-	ALDH18A1	ARCL3A|GSAS|P5CS|PYCS	9606	Homo sapiens	unknown	target	Krishna RV (1979)	114173	173231	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2384	111790	5832	-	ALDH18A1	ARCL3A|GSAS|P5CS|PYCS	9606	Homo sapiens	unknown	target	Kamoun P (1998)	9622938	173232	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2385	117922	26873	-	OPLAH	5-Opase|OPLA|OPLAHD	9606	Homo sapiens	unknown	target	Nishimura A (2001)	11302195	173234	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2386	117922	26873	-	OPLAH	5-Opase|OPLA|OPLAHD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2387	117922	26873	-	OPLAH	5-Opase|OPLA|OPLAHD	9606	Homo sapiens	unknown	target	Seddon AP (1984)	6145710	173235	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2388	117922	26873	-	OPLAH	5-Opase|OPLA|OPLAHD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2389	117922	26873	-	OPLAH	5-Opase|OPLA|OPLAHD	9606	Homo sapiens	unknown	target	Van der Werf P (1973)	4514988	173233	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2390	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2391	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Anagnou NP (1993)	8288265	173236	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2392	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2393	109152	2895	-	GRID2	GluD2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2394	109152	2895	-	GRID2	GluD2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2395	123744	83733	-	SLC25A18	GC2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2396	123744	83733	-	SLC25A18	GC2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2397	127816	162417	-	NAGS	AGAS|ARGA	9606	Homo sapiens	unknown	target	Xu Y (2007)	17347518	173237	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2398	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2399	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2400	122862	79751	-	SLC25A22	EIEE3|GC1|NET44	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2401	122862	79751	-	SLC25A22	EIEE3|GC1|NET44	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2402	108342	2028	-	ENPEP	APA|CD249|gp160	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2403	108342	2028	-	ENPEP	APA|CD249|gp160	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2404	108342	2028	-	ENPEP	APA|CD249|gp160	9606	Homo sapiens	unknown	target	Acartuerk F (2001)	11732752	173238	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2405	108342	2028	-	ENPEP	APA|CD249|gp160	9606	Homo sapiens	unknown	target	Sasaki M (1995)	8568030	173239	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2406	108342	2028	-	ENPEP	APA|CD249|gp160	9606	Homo sapiens	unknown	target	Tobe H (1980)	7448199	173240	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2407	112402	6511	-	SLC1A6	EAAT4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2408	112402	6511	-	SLC1A6	EAAT4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2409	112402	6511	-	SLC1A6	EAAT4	9606	Homo sapiens	unknown	target	Lin CL (1998)	9838098	173241	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2410	112402	6511	-	SLC1A6	EAAT4	9606	Homo sapiens	unknown	target	Gegelashvili G (1997)	9224806	173242	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2411	119608	51557	-	LGSN	GLULD1|LGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2412	119608	51557	-	LGSN	GLULD1|LGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2413	125866	124454	-	EARS2	COXPD12|MSE1	9606	Homo sapiens	unknown	target	Sekine S (2006)	17161369	173243	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2414	108992	2730	RP4-561L24.2	GCLM	GLCLR	9606	Homo sapiens	unknown	target	Giordano G (2006)	17000861	173244	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2415	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Linden AM (2001)	11406192	173245	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2416	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2417	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Henley JM (1993)	7679210	173247	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2418	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2419	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Cristovao AJ (2002)	12008069	173246	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2420	109171	2914	-	GRM4	GPRC1D|MGLUR4|mGlu4	9606	Homo sapiens	unknown	target	Suzuki G (2007)	17360958	173218	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2421	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2422	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2423	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Maung J (2004)	15336276	173249	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2424	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Rodriguez CE (2001)	11916141	173248	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2425	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Davis MI (2005)	15837926	173250	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2426	111221	5198	-	PFAS	FGAMS|FGAR-AT|FGARAT|PURL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2427	111221	5198	-	PFAS	FGAMS|FGAR-AT|FGARAT|PURL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2428	111221	5198	-	PFAS	FGAMS|FGAR-AT|FGARAT|PURL	9606	Homo sapiens	unknown	target	Jayaram HN (1990)	2347042	172999	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2429	109174	2917	-	GRM7	GLUR7|GPRC1G|MGLU7|MGLUR7|PPP1R87	9606	Homo sapiens	unknown	target	Suzuki G (2007)	17360958	173218	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2430	111211	5188	HSPC199	GATB	PET112|PET112L	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2431	111211	5188	HSPC199	GATB	PET112|PET112L	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2432	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	unknown	target	Ohgami N (2007)	16854580	173251	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2433	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2434	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2435	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Menaker D (2006)	16831195	173252	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2436	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Tao Z (2007)	17389249	172932	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2437	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Nickell J (2007)	16959378	173227	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2438	112396	6505	RP11-6J24.1	SLC1A1	DCBXA|EAAC1|EAAT3|SCZD18	9606	Homo sapiens	unknown	target	Yun JY (2007)	17382927	173253	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2439	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Yudkoff M (2007)	17444813	173254	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2440	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2441	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2442	119346	51166	-	AADAT	KAT2|KATII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2443	119346	51166	-	AADAT	KAT2|KATII	9606	Homo sapiens	unknown	target	Kocki T (2003)	12850557	173255	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2444	119346	51166	-	AADAT	KAT2|KATII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2445	108639	2356	RP11-228B15.1	FPGS	-	9606	Homo sapiens	unknown	target	DeMartino JK (2006)	16686541	173256	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2446	108639	2356	RP11-228B15.1	FPGS	-	9606	Homo sapiens	unknown	target	Gangjee A (2006)	16990006	173257	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2447	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	unknown	target	Tronci E (2007)	17445798	173260	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2448	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	unknown	target	Manto MU (2007)	17600364	173262	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2449	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	unknown	target	Tueting P (2006)	16769115	173261	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2450	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	unknown	target	Akama K (2007)	17562689	173258	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2451	108845	2571	-	GAD1	CPSQ1|GAD|SCP	9606	Homo sapiens	unknown	target	Wang FY (2006)	16643338	173259	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2452	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Goncalves-Butruille M (1996)	12226216	173264	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2453	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2454	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Gaziola SA (1997)	9249048	173265	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2455	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2456	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Noda C (1978)	687635	173263	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2457	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Lal S (2006)	17112295	173267	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2458	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	unknown	target	Zhu A (2007)	17327402	173266	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2459	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	unknown	target	Natale NR (2006)	16719820	173268	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2460	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2461	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2462	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2463	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2464	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	unknown	target	Katsura Y (2004)	15103612	173269	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2465	119001	29968	-	PSAT1	EPIP|NLS2|PSA|PSAT|PSATD	9606	Homo sapiens	unknown	target	Hester G (1999)	10024454	172506	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2466	109009	2747	-	GLUD2	GDH2|GLUDP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2467	109009	2747	-	GLUD2	GDH2|GLUDP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2468	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	unknown	target	Valgeirsson J (2003)	13129570	173270	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2469	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	unknown	target	Sahara Y (1997)	9254673	173271	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2470	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	unknown	target	Stensbol TB (1999)	10513575	173272	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2471	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2472	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2473	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2474	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	unknown	target	Sundstroem E (1997)	9417820	173221	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2475	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2476	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	unknown	target	Pliss L (2002)	11755246	173273	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2477	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	unknown	target	Bresink I (1996)	8886398	173224	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2478	112397	6506	-	SLC1A2	EAAT2|GLT-1	9606	Homo sapiens	unknown	target	Nickell J (2007)	16959378	173227	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2479	112397	6506	-	SLC1A2	EAAT2|GLT-1	9606	Homo sapiens	unknown	target	Glowatzki E (2006)	16855093	173228	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2480	112397	6506	-	SLC1A2	EAAT2|GLT-1	9606	Homo sapiens	unknown	target	King N (2006)	16718509	173274	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2481	112397	6506	-	SLC1A2	EAAT2|GLT-1	9606	Homo sapiens	unknown	target	Beart PM (2007)	17088867	173226	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2482	117093	23549	-	DNPEP	ASPEP|DAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2483	117093	23549	-	DNPEP	ASPEP|DAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2484	117093	23549	-	DNPEP	ASPEP|DAP	9606	Homo sapiens	unknown	target	Watanabe J (2007)	17928682	173275	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2485	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2486	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Henley JM (1993)	7679210	173247	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2487	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2488	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Stein E (1992)	1279377	173276	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2489	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Li F (1995)	7838123	173277	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2490	120488	55191	-	NADSYN1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2491	120488	55191	-	NADSYN1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2492	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Yamamoto S (2007)	17284842	173278	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2493	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Scaraffia PY (2006)	16876704	173279	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2494	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Singh U (2006)	16973920	173281	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2495	109014	2752	-	GLUL	GLNS|GS|PIG43|PIG59	9606	Homo sapiens	unknown	target	Re DB (2006)	16673373	173280	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2496	112403	6512	RP11-334A14.7	SLC1A7	AAAT|EAAT5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2497	112403	6512	RP11-334A14.7	SLC1A7	AAAT|EAAT5	9606	Homo sapiens	unknown	target	Takarada T (2004)	15128272	173283	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2498	112403	6512	RP11-334A14.7	SLC1A7	AAAT|EAAT5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2499	112403	6512	RP11-334A14.7	SLC1A7	AAAT|EAAT5	9606	Homo sapiens	unknown	target	Arriza JL (1997)	9108121	173282	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2500	109158	2901	-	GRIK5	EAA2|GRIK2|GluK5|KA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2501	109158	2901	-	GRIK5	EAA2|GRIK2|GluK5|KA2	9606	Homo sapiens	unknown	target	Takeda M (2000)	11058796	173211	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2502	109158	2901	-	GRIK5	EAA2|GRIK2|GluK5|KA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2503	109158	2901	-	GRIK5	EAA2|GRIK2|GluK5|KA2	9606	Homo sapiens	unknown	target	Murphy DE (1988)	2850065	173284	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2504	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2505	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Henley JM (1993)	7679210	173247	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2506	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2507	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Stein E (1992)	1279377	173276	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2508	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Li F (1995)	7838123	173277	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2509	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2510	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2511	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	unknown	target	Gao YS (1998)	9837973	173285	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2512	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Miglio G (2007)	17662248	173213	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2513	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Verkhratsky A (2007)	17229973	173286	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2514	121128	56267	RP11-82K18.3	CCBL2	KAT3|KATIII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2515	121128	56267	RP11-82K18.3	CCBL2	KAT3|KATIII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2516	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Wong AY (2007)	17581967	173287	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2517	109157	2900	-	GRIK4	EAA1|GRIK|GluK4|KA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2518	109157	2900	-	GRIK4	EAA1|GRIK|GluK4|KA1	9606	Homo sapiens	unknown	target	Korczak B (1995)	8589992	173288	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2519	109157	2900	-	GRIK4	EAA1|GRIK|GluK4|KA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2520	109168	2911	-	GRM1	GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13	9606	Homo sapiens	unknown	target	San Gabriel AM (2007)	17331504	173289	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2521	109168	2911	-	GRM1	GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13	9606	Homo sapiens	unknown	target	Suzuki G (2007)	17360958	173218	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2522	109168	2911	-	GRM1	GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13	9606	Homo sapiens	unknown	target	Chiocchetti A (2006)	16751798	173290	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2523	109006	2744	-	GLS	AAD20|GAC|GAM|GLS1|KGA	9606	Homo sapiens	unknown	target	Ashiuchi M (2006)	16952838	173292	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2524	109006	2744	-	GLS	AAD20|GAC|GAM|GLS1|KGA	9606	Homo sapiens	unknown	target	Ashiuchi M (2006)	16861819	173293	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2525	109006	2744	-	GLS	AAD20|GAC|GAM|GLS1|KGA	9606	Homo sapiens	unknown	target	Karmaker S (2006)	16824605	173291	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2526	109006	2744	-	GLS	AAD20|GAC|GAM|GLS1|KGA	9606	Homo sapiens	unknown	target	Yang XX (2006)	16815871	173294	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2527	109006	2744	-	GLS	AAD20|GAC|GAM|GLS1|KGA	9606	Homo sapiens	unknown	target	Shi F (2006)	16720907	173295	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2528	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2529	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Henley JM (1993)	7679210	173247	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2530	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2531	115676	10404	-	CPQ	LDP|PGCP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2532	115676	10404	-	CPQ	LDP|PGCP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2533	115676	10404	-	CPQ	LDP|PGCP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2534	108991	2729	-	GCLC	GCL|GCS|GLCL|GLCLC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2535	108991	2729	-	GCLC	GCL|GCS|GLCL|GLCLC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2536	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	unknown	target	Castelli MP (2007)	17507169	173298	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2537	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	unknown	target	Manto MU (2007)	17600364	173262	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2538	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	unknown	target	Pop SM (2007)	17317763	173296	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2539	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	unknown	target	Wei J (2006)	16879709	173297	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2540	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	unknown	target	Wang FY (2006)	16643338	173259	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2541	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2542	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2543	118044	27165	-	GLS2	GA|GLS|LGA|hLGA	9606	Homo sapiens	unknown	target	Dossena L (2007)	17373776	173300	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2544	118044	27165	-	GLS2	GA|GLS|LGA|hLGA	9606	Homo sapiens	unknown	target	Yoshimune K (2006)	16793004	173301	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2545	118044	27165	-	GLS2	GA|GLS|LGA|hLGA	9606	Homo sapiens	unknown	target	Kita K (2007)	17321558	173299	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2546	114360	8833	-	GMPS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2547	114360	8833	-	GMPS	-	9606	Homo sapiens	unknown	target	Myers RS (2005)	16142895	68640	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2548	114360	8833	-	GMPS	-	9606	Homo sapiens	unknown	target	Boehlein SK (1994)	7907328	173302	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2549	114360	8833	-	GMPS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2550	114360	8833	-	GMPS	-	9606	Homo sapiens	unknown	target	Ravasio S (2002)	12069605	173303	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2551	109151	2894	RP11-93H12.1	GRID1	GluD1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2552	109151	2894	RP11-93H12.1	GRID1	GluD1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2553	109139	2882	UNQ469/PRO828	GPX7	CL683|GPX6|GPx-7|GSHPx-7|NPGPx	9606	Homo sapiens	cofactor	target	Giovannini C (2008)	17588737	173305	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2554	128713	221357	-	GSTA5	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2555	128713	221357	-	GSTA5	-	9606	Homo sapiens	unknown	target	McDonagh PD (1999)	10085232	173308	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2556	128713	221357	-	GSTA5	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2557	128713	221357	-	GSTA5	-	9606	Homo sapiens	unknown	target	McLeod R (1997)	9331086	173306	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2558	128713	221357	-	GSTA5	-	9606	Homo sapiens	unknown	target	Kazi S (2002)	12076520	173307	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2559	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2560	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Baek IJ (2007)	17503194	173309	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2561	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2562	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Nam SY (2003)	14967915	173311	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2563	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Moreno SG (2003)	12751792	173310	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2564	110234	4056	-	LTC4S	-	9606	Homo sapiens	unknown	target	Ago H (2007)	17632548	160488	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2565	110234	4056	-	LTC4S	-	9606	Homo sapiens	unknown	target	Martinez Molina D (2007)	17632546	160398	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2566	119228	51022	RP11-101E13.4	GLRX2	CGI-133|GRX2	9606	Homo sapiens	unknown	target	Hashemy SI (2007)	17355958	173314	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2567	119228	51022	RP11-101E13.4	GLRX2	CGI-133|GRX2	9606	Homo sapiens	unknown	target	Sagemark J (2007)	17546662	173313	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2568	119228	51022	RP11-101E13.4	GLRX2	CGI-133|GRX2	9606	Homo sapiens	unknown	target	Sheng J (2007)	17401194	173312	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2569	125638	119391	RP11-127L20.2	GSTO2	GSTO 2-2|bA127L20.1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2570	125638	119391	RP11-127L20.2	GSTO2	GSTO 2-2|bA127L20.1	9606	Homo sapiens	unknown	target	Board PG (2007)	17226937	173316	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2571	125638	119391	RP11-127L20.2	GSTO2	GSTO 2-2|bA127L20.1	9606	Homo sapiens	unknown	target	Whitbread AK (2003)	12618591	173315	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2572	125638	119391	RP11-127L20.2	GSTO2	GSTO 2-2|bA127L20.1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2573	125638	119391	RP11-127L20.2	GSTO2	GSTO 2-2|bA127L20.1	9606	Homo sapiens	unknown	target	Whitbread AK (2006)	16399380	173317	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2574	110414	4258	-	MGST2	GST2|MGST-II	9606	Homo sapiens	unknown	target	Ago H (2007)	17632548	160488	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2575	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Mohanpuria P (2007)	17607728	173321	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2576	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Janaky R (2007)	17401648	173322	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2577	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Herrera K (2007)	17452339	173320	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2578	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Bridges CC (2007)	17467761	173319	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2579	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Forcella M (2007)	17630655	173318	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2580	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2581	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Fernandez-Canon JM (2002)	12052898	173324	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2582	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2583	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Hagedorn SR (1985)	4019417	173325	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2584	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Lim CE (2004)	15277241	173323	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2585	109207	2952	-	GSTT1	-	9606	Homo sapiens	unknown	target	Ouerhani S (2007)	17381051	173326	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2586	109207	2952	-	GSTT1	-	9606	Homo sapiens	unknown	target	Moore LE (2007)	17617661	173327	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2587	109207	2952	-	GSTT1	-	9606	Homo sapiens	unknown	target	Schwartzbaum JA (2007)	17372252	173330	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2588	109207	2952	-	GSTT1	-	9606	Homo sapiens	unknown	target	Joensson LS (2007)	17333241	173328	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2589	109207	2952	-	GSTT1	-	9606	Homo sapiens	unknown	target	Gawecki W (2007)	17653748	173329	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2590	109135	2877	-	GPX2	GI-GPx|GPRP|GPRP-2|GPx-2|GPx-GI|GSHPX-GI|GSHPx-2	9606	Homo sapiens	cofactor	target	Walshe J (2007)	17510403	173331	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2591	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2592	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Liddell JR (2006)	16721761	173334	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2593	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2594	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Destro-Bisol G (1989)	2742004	173333	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2595	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Ursini F (2005)	15679624	173332	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2596	114836	9446	RP11-99N20.1	GSTO1	GSTO 1-1|GSTTLp28|HEL-S-21|P28|SPG-R	9606	Homo sapiens	unknown	target	Tulayakul P (2007)	17537474	173335	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2597	114836	9446	RP11-99N20.1	GSTO1	GSTO 1-1|GSTTLp28|HEL-S-21|P28|SPG-R	9606	Homo sapiens	unknown	target	Harju TH (2007)	17617905	173336	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2598	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Kadokawa Y (2007)	17517071	173337	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2599	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Ramachandran K (2007)	17465221	173338	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2600	110415	4259	RP11-466F5.1	MGST3	GST-III	9606	Homo sapiens	unknown	target	Ago H (2007)	17632548	160488	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2601	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2602	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2603	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Cantlay AM (1994)	7974294	173340	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2604	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Beuckmann CT (2000)	10905636	3668	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2605	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2606	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Efferth T (2005)	15796179	173339	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2607	109196	2941	RP1-214M20.1	GSTA4	GSTA4-4|GTA4	9606	Homo sapiens	unknown	target	Gallagher EP (2007)	17553661	173341	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2608	109202	2947	RP4-735C1.2	GSTM3	GST5|GSTB|GSTM3-3|GTM3	9606	Homo sapiens	unknown	target	Moore LE (2007)	17617661	173327	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2609	109202	2947	RP4-735C1.2	GSTM3	GST5|GSTB|GSTM3-3|GTM3	9606	Homo sapiens	unknown	target	Schwartzbaum JA (2007)	17372252	173330	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2610	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Kurtovic S (2007)	17490601	173344	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2611	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Yalcinkaya S (2007)	17498936	173345	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2612	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Gallagher EP (2007)	17553661	173341	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2613	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Roh JY (2007)	17604895	173342	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2614	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Vararattanavech A (2007)	17523921	173343	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2615	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Maity S (2008)	17512104	173346	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2616	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Markaryan AA (2006)	17369902	173347	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2617	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Guruvayoorappan C (2007)	17338281	173348	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2618	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Brocardo PS (2007)	17327255	173349	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2619	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Messarah M (2007)	17303537	173350	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2620	110413	4257	-	MGST1	GST12|MGST|MGST-I	9606	Homo sapiens	unknown	target	Busenlehner LS (2007)	17297922	173352	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2621	110413	4257	-	MGST1	GST12|MGST|MGST-I	9606	Homo sapiens	unknown	target	Siritantikorn A (2007)	17306223	173351	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2622	138926	493869	UNQ847/PRO1785	GPX8	EPLA847|GPx-8|GSHPx-8|UNQ847	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2623	138926	493869	UNQ847/PRO1785	GPX8	EPLA847|GPx-8|GSHPx-8|UNQ847	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2624	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Ohkama-Ohtsu N (2007)	17316176	173353	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2625	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Adamis PD (2007)	17644279	73689	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2626	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Anilakumar KR (2007)	17569287	173356	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2627	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Zhu Y (2007)	17291629	173355	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2628	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Martin MN (2007)	17545509	173354	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2629	119252	51060	UNQ713/PRO1376	TXNDC12	AG1|AGR1|ERP16|ERP18|ERP19|PDIA16|TLP19|hAG-1|hTLP19	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2630	119252	51060	UNQ713/PRO1376	TXNDC12	AG1|AGR1|ERP16|ERP18|ERP19|PDIA16|TLP19|hAG-1|hTLP19	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2631	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Kim I (2007)	17425746	173358	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2632	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Soederdahl T (2007)	17346923	173357	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2633	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2634	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Joensson LS (2007)	17333241	173328	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2635	109194	2939	-	GSTA2	GST2|GSTA2-2|GTA2|GTH2	9606	Homo sapiens	unknown	target	Sharma P (2007)	17317527	173362	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2636	109194	2939	-	GSTA2	GST2|GSTA2-2|GTA2|GTH2	9606	Homo sapiens	unknown	target	Gupta S (2007)	17401685	173359	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2637	109194	2939	-	GSTA2	GST2|GSTA2-2|GTA2|GTH2	9606	Homo sapiens	unknown	target	Ozkilic AC (2007)	17338280	173361	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2638	109194	2939	-	GSTA2	GST2|GSTA2-2|GTA2|GTH2	9606	Homo sapiens	unknown	target	Guruvayoorappan C (2007)	17338281	173348	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2639	109194	2939	-	GSTA2	GST2|GSTA2-2|GTA2|GTH2	9606	Homo sapiens	unknown	target	Skamarauskas J (2007)	17321661	173360	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2640	108402	2098	RP11-147L20.1	ESD	FGH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2641	108402	2098	RP11-147L20.1	ESD	FGH	9606	Homo sapiens	unknown	target	Sabatier L (1989)	2554783	173363	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2642	108402	2098	RP11-147L20.1	ESD	FGH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2643	108402	2098	RP11-147L20.1	ESD	FGH	9606	Homo sapiens	unknown	target	Neben I (1980)	7397203	173364	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2644	108402	2098	RP11-147L20.1	ESD	FGH	9606	Homo sapiens	unknown	target	Yurimoto H (2003)	12904537	173365	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2645	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Hakansson KO (2007)	17327665	173370	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2646	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Rouhier N (2007)	17460036	173368	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2647	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Diwakar L (2007)	17512091	173369	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2648	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Wang J (2007)	17431186	173366	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2649	109007	2745	-	GLRX	GRX|GRX1	9606	Homo sapiens	unknown	target	Lu J (2007)	17640917	173367	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2650	109204	2949	RP4-735C1.1	GSTM5	GSTM5-5|GTM5	9606	Homo sapiens	unknown	target	Schnakenberg E (2001)	11173863	173371	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2651	109204	2949	RP4-735C1.1	GSTM5	GSTM5-5|GTM5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2652	109204	2949	RP4-735C1.1	GSTM5	GSTM5-5|GTM5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2653	109204	2949	RP4-735C1.1	GSTM5	GSTM5-5|GTM5	9606	Homo sapiens	unknown	target	Rao AV (2001)	11684093	173372	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2654	129206	257202	-	GPX6	GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2655	129206	257202	-	GPX6	GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1	9606	Homo sapiens	cofactor	target	Myllylae V (1986)	3532684	173373	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2656	129206	257202	-	GPX6	GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2657	129206	257202	-	GPX6	GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1	9606	Homo sapiens	cofactor	target	Giovannini C (2008)	17588737	173305	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2658	129206	257202	-	GPX6	GPX5p|GPXP3|GPx-6|GSHPx-6|dJ1186N24|dJ1186N24.1	9606	Homo sapiens	cofactor	target	Brigelius-Flohe R (2006)	17081103	173374	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2659	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Walshe J (2007)	17510403	173331	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2660	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Chattopadhyay S (2007)	17561443	173375	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2661	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Du X (2007)	17387467	71461	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2662	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Sordillo LM (2007)	17297093	173377	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2663	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Sheridan PA (2007)	17513408	173376	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2664	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2665	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Urade Y (1993)	8415655	173378	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2666	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Aritake K (2006)	16547010	152941	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2667	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2668	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2669	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Inoue T (2004)	15113825	152402	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2670	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Deponte M (2007)	17664277	173379	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2671	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Barati MT (2007)	17609286	173380	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2672	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Ouerhani S (2007)	17381051	173326	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2673	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Contreras-Vergara CA (2007)	17427177	173381	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2674	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Sakoda LC (2008)	17624589	173382	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2675	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Moore LE (2007)	17311259	173383	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2676	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Schwartzbaum JA (2007)	17372252	173330	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2677	131875	373156	HDCMD47P	GSTK1	GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2678	131875	373156	HDCMD47P	GSTK1	GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2679	131875	373156	HDCMD47P	GSTK1	GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1	9606	Homo sapiens	unknown	target	Robinson A (2004)	14709161	173384	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2680	131875	373156	HDCMD47P	GSTK1	GST|GST 13-13|GST13|GST13-13|GSTK1-1|hGSTK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2681	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Board PG (1998)	9480897	173385	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2682	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	McHugh TE (1996)	8910329	173386	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2683	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2684	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2685	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2686	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	McDonagh PD (1999)	10085232	173308	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2687	109138	2880	-	GPX5	HEL-S-75p	9606	Homo sapiens	cofactor	target	Koh CS (2007)	17531267	173387	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2688	109136	2878	-	GPX3	GPx-P|GSHPx-3|GSHPx-P	9606	Homo sapiens	cofactor	target	Carmeli E (2007)	17578749	173388	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2689	109136	2878	-	GPX3	GPx-P|GSHPx-3|GSHPx-P	9606	Homo sapiens	cofactor	target	Jacobson GA (2007)	17558897	173389	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2690	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2691	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2692	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Al-Timari A (1986)	3955057	173392	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2693	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Ridderstroem M (2000)	11018726	173391	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2694	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Chyan MK (1994)	8589803	173390	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2695	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Osada Y (2006)	16530182	173407	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2696	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Zhang J (2006)	16371234	173406	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2697	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Yancey PG (2004)	14594995	173405	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2698	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Nakagawa A (2005)	15791597	173404	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2699	107387	949	-	SCARB1	CD36L1|CLA-1|CLA1|HDLQTL6|SR-BI|SRB1	9606	Homo sapiens	unknown	target	Yan X (2004)	15541376	173408	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2700	115135	9791	-	PTDSS1	LMHD|PSS1|PSSA	9606	Homo sapiens	unknown	target	Kuge O (2003)	12761285	173410	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2701	115135	9791	-	PTDSS1	LMHD|PSS1|PSSA	9606	Homo sapiens	unknown	target	Ohsawa T (2004)	15130088	173411	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2702	115135	9791	-	PTDSS1	LMHD|PSS1|PSSA	9606	Homo sapiens	unknown	target	Steenbergen R (2006)	16627002	173412	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2703	115135	9791	-	PTDSS1	LMHD|PSS1|PSSA	9606	Homo sapiens	unknown	target	Kuge O (2003)	12912985	173409	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2704	120692	55512	-	SMPD3	NSMASE2	9606	Homo sapiens	unknown	target	Krut O (2006)	16517606	173413	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2705	120692	55512	-	SMPD3	NSMASE2	9606	Homo sapiens	unknown	target	Marchesini N (2003)	12566438	59548	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2706	120766	55627	-	SMPD4	NET13|NSMASE-3|NSMASE3	9606	Homo sapiens	unknown	target	Krut O (2006)	16517606	173413	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2707	114097	8527	-	DGKD	DGKdelta|dgkd-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2708	114097	8527	-	DGKD	DGKdelta|dgkd-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2709	114097	8527	-	DGKD	DGKdelta|dgkd-2	9606	Homo sapiens	unknown	target	Bregoli L (2001)	11309392	173414	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2710	114097	8527	-	DGKD	DGKdelta|dgkd-2	9606	Homo sapiens	unknown	target	Sakane F (1996)	8626538	84998	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2711	107978	1608	-	DGKG	DAGK3|DGK-GAMMA	9606	Homo sapiens	unknown	target	Yamaguchi Y (2006)	16905533	173415	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2712	117262	23761	RP5-858B16.2	PISD	DJ858B16|PSD|PSDC|PSSC|dJ858B16.2	9606	Homo sapiens	unknown	target	Roggero R (2004)	15273086	63769	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2713	117262	23761	RP5-858B16.2	PISD	DJ858B16|PSD|PSDC|PSSC|dJ858B16.2	9606	Homo sapiens	unknown	target	Buergermeister M (2004)	15522832	173417	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2714	117262	23761	RP5-858B16.2	PISD	DJ858B16|PSD|PSDC|PSSC|dJ858B16.2	9606	Homo sapiens	unknown	target	Buergermeister M (2004)	15522831	64580	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2715	117262	23761	RP5-858B16.2	PISD	DJ858B16|PSD|PSDC|PSSC|dJ858B16.2	9606	Homo sapiens	unknown	target	Wu WI (2004)	14660568	173416	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2716	117262	23761	RP5-858B16.2	PISD	DJ858B16|PSD|PSDC|PSSC|dJ858B16.2	9606	Homo sapiens	unknown	target	Voelker DR (2005)	16246067	69182	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2717	123499	81490	-	PTDSS2	PSS2	9606	Homo sapiens	unknown	target	Dygas A (2003)	12833164	173418	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2718	123499	81490	-	PTDSS2	PSS2	9606	Homo sapiens	unknown	target	Grandmaison PA (2004)	14984733	173419	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2719	123499	81490	-	PTDSS2	PSS2	9606	Homo sapiens	unknown	target	Bergo MO (2002)	12361952	173421	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2720	123499	81490	-	PTDSS2	PSS2	9606	Homo sapiens	unknown	target	Wen Z (2007)	17387686	173420	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2721	123499	81490	-	PTDSS2	PSS2	9606	Homo sapiens	unknown	target	Vance JE (2004)	15052332	173422	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2722	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Yu D (2002)	12269833	173425	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2723	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Lopez-Andreo MJ (2005)	16114872	173424	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2724	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Rodriguez-Alfaro JA (2004)	14698304	173426	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2725	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Corbin JA (2007)	17367165	173423	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2726	115668	10396	-	ATP8A1	ATPASEII|ATPIA|ATPP2	9606	Homo sapiens	unknown	target	Paterson JK (2006)	16618126	69306	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2727	115668	10396	-	ATP8A1	ATPASEII|ATPIA|ATPP2	9606	Homo sapiens	unknown	target	Wolfs JL (2005)	15971000	173427	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2728	115668	10396	-	ATP8A1	ATPASEII|ATPIA|ATPP2	9606	Homo sapiens	unknown	target	Bettache N (2003)	12697835	173429	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2729	115668	10396	-	ATP8A1	ATPASEII|ATPIA|ATPP2	9606	Homo sapiens	unknown	target	Mandal D (2005)	16179347	173428	138	Phosphatidyl serine	PS|Phosphatidyl-L-serine|Ptd-L-Ser|Phosphatidylserine	-	DRUGBANK	DB00144	C13H24NO10P	small molecule	-	1446756-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJJBGNPUUVVFQ-ZJUUUORDSA-N
2730	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Dutta U (2007)	16970975	173430	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2731	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Wang L (2007)	17486546	173431	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2732	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2733	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2734	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Baker PR (2004)	15240345	173432	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2735	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Takada Y (1984)	6703688	172467	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2736	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	unknown	target	Eulenburg V (2006)	16884688	173434	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2737	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	unknown	target	Heinze L (2007)	17154252	173433	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2738	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Widdowson PS (1996)	8955518	173436	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2739	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2740	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2741	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Malayev A (2002)	11861317	173435	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2742	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Al-Ghoul WM (1997)	9073168	173437	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2743	117027	23464	-	GCAT	KBL	9606	Homo sapiens	unknown	target	Bashir Q (2006)	17146529	173438	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2744	108887	2617	-	GARS	CMT2D|DSMAV|GlyRS|HMN5|SMAD1	9606	Homo sapiens	unknown	target	Cader MZ (2007)	17544401	173443	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2745	108887	2617	-	GARS	CMT2D|DSMAV|GlyRS|HMN5|SMAD1	9606	Homo sapiens	unknown	target	Okamoto K (2006)	17150752	173442	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2746	108887	2617	-	GARS	CMT2D|DSMAV|GlyRS|HMN5|SMAD1	9606	Homo sapiens	unknown	target	Antonellis A (2006)	17035524	173441	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2747	108887	2617	-	GARS	CMT2D|DSMAV|GlyRS|HMN5|SMAD1	9606	Homo sapiens	unknown	target	Scherer SS (2006)	16982409	173440	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2748	108887	2617	-	GARS	CMT2D|DSMAV|GlyRS|HMN5|SMAD1	9606	Homo sapiens	unknown	target	Tsang SW (2008)	17433503	173439	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2749	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Pai CH (2006)	17124497	173446	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2750	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Janaky R (2007)	17401648	173322	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2751	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Herrera K (2007)	17452339	173320	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2752	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Ristoff E (2007)	17397529	173445	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2753	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Ducruix C (2006)	16996193	173444	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2754	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2755	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	unknown	target	Shoolingin-Jordan PM (2003)	12686158	172529	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2756	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2757	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	unknown	target	Munakata H (1993)	8407861	173447	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2758	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	unknown	target	Hungerer C (1995)	7883699	173448	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2759	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Chang WN (2007)	17664250	172627	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2760	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2761	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Bouwman RA (2007)	17905752	173449	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2762	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2763	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Kon K (2007)	17567465	173450	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2764	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	unknown	target	Qi Z (2006)	17012403	173451	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2765	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	unknown	target	Majumdar S (2007)	17550639	173452	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2766	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	unknown	target	Young-Pearse TL (2006)	16847326	173453	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2767	114599	9152	-	SLC6A5	GLYT-2|GLYT2|HKPX3|NET1	9606	Homo sapiens	unknown	target	Eulenburg V (2006)	16884688	173434	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2768	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2769	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Milutinovic PS (2007)	17646495	173458	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2770	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Gabra BH (2007)	17405869	173454	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2771	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Brosnan RJ (2007)	17513636	173455	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2772	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Liu Y (2007)	17360906	173456	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2773	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Domingues A (2007)	17403555	173457	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2774	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Ricoult C (2006)	16899523	173461	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2775	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Han Q (2006)	16990263	173460	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2776	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Lu TC (2007)	17616291	173459	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2777	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	unknown	target	He XM (2007)	17578005	173462	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2778	106713	211	OK/SW-cl.121	ALAS1	ALAS|ALAS3|ALASH|MIG4	9606	Homo sapiens	unknown	target	Turbeville TD (2007)	17469798	172569	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2779	109005	2743	-	GLRB	HKPX2	9606	Homo sapiens	unknown	target	Eulenburg V (2006)	16884688	173434	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2780	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Gagnon D (2006)	16876889	173463	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2781	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Chang WN (2007)	17664250	172627	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2782	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Rajinikanth M (2007)	17355947	173465	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2783	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Nijhout HF (2006)	17150100	173464	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2784	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Vatsyayan R (2007)	17142057	172645	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2785	118081	27232	-	GNMT	-	9606	Homo sapiens	unknown	target	Luka Z (2007)	17158459	173468	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2786	118081	27232	-	GNMT	-	9606	Homo sapiens	unknown	target	Velichkova P (2005)	16851960	173467	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2787	118081	27232	-	GNMT	-	9606	Homo sapiens	unknown	target	Soriano A (2006)	17154529	173466	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2788	112427	6536	-	SLC6A9	GLYT1	9606	Homo sapiens	unknown	target	Igartua I (2007)	17462677	173469	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2789	112427	6536	-	SLC6A9	GLYT1	9606	Homo sapiens	unknown	target	Wiles AL (2006)	16899062	173472	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2790	112427	6536	-	SLC6A9	GLYT1	9606	Homo sapiens	unknown	target	Sur C (2007)	17504107	173470	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2791	112427	6536	-	SLC6A9	GLYT1	9606	Homo sapiens	unknown	target	Raiteri L (2008)	17597258	173471	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2792	112427	6536	-	SLC6A9	GLYT1	9606	Homo sapiens	unknown	target	Lindsley CW (2006)	17017963	173473	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2793	119422	51268	-	PIPOX	LPIPOX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2794	119422	51268	-	PIPOX	LPIPOX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2795	126644	140679	-	SLC32A1	VGAT|VIAAT	9606	Homo sapiens	unknown	target	Fujii M (2007)	17418495	173476	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2796	126644	140679	-	SLC32A1	VGAT|VIAAT	9606	Homo sapiens	unknown	target	Uchigashima M (2007)	17652600	173474	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2797	126644	140679	-	SLC32A1	VGAT|VIAAT	9606	Homo sapiens	unknown	target	Aubrey KR (2007)	17554001	173475	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2798	108993	2731	RP11-472F14.1	GLDC	GCE|GCSP|HYGN1	9606	Homo sapiens	unknown	target	Mukherjee M (2006)	17158739	173478	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2799	108993	2731	RP11-472F14.1	GLDC	GCE|GCSP|HYGN1	9606	Homo sapiens	unknown	target	Engel N (2007)	17496108	173479	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2800	108993	2731	RP11-472F14.1	GLDC	GCE|GCSP|HYGN1	9606	Homo sapiens	unknown	target	Kanno J (2007)	17361008	173477	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2801	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Pellicoro A (2007)	17256745	158237	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2802	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Styles NA (2007)	17379925	173482	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2803	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Nakamura K (2007)	16931649	173481	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2804	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Visser WF (2007)	17416343	173480	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2805	108923	2653	-	GCSH	GCE|NKH	9606	Homo sapiens	unknown	target	Kanno J (2007)	17361008	173477	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2806	115543	10249	-	GLYAT	ACGNAT|CAT|GAT	9606	Homo sapiens	unknown	target	Narasipura SD (2006)	17146584	71952	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2807	115543	10249	-	GLYAT	ACGNAT|CAT|GAT	9606	Homo sapiens	unknown	target	Zhou CX (2007)	17143481	173483	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2808	109100	2841	RP11-461N23.8	GPR18	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2809	109100	2841	RP11-461N23.8	GPR18	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2810	124929	92292	-	GLYATL1	GATF-C|GNAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2811	124929	92292	-	GLYATL1	GATF-C|GNAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2812	128607	219970	-	GLYATL2	BXMAS2-10|GATF-B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2813	128607	219970	-	GLYATL2	BXMAS2-10|GATF-B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2814	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Gagnon D (2006)	16876889	173463	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2815	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Vatsyayan R (2007)	17142057	172645	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2816	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Rajinikanth M (2007)	17355947	173465	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2817	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	unknown	target	Smothers CT (2007)	17502428	173484	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2818	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Broeer A (2006)	16052352	173487	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2819	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Bermingham JR (2004)	15058382	173486	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2820	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Metzner L (2004)	14718599	173485	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2821	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2822	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2823	113705	8001	-	GLRA3	-	9606	Homo sapiens	unknown	target	Heinze L (2007)	17154252	173433	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2824	113705	8001	-	GLRA3	-	9606	Homo sapiens	unknown	target	Majumdar S (2007)	17550639	173452	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2825	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	140	Calcidiol	Calcidiol|25-Hydroxyvitamin D3|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|Calcifediolum|Calcifediol Anhydrous|Calcifediol|25(OH)D3|3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol|(3S,5Z,7e)-9,10-Secocholesta-5,7,10-triene-3,25-diol|(3,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol|(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|25-hydroxycholecalciferol	rayaldee	DRUGBANK	DB00146	C27H44O2	small molecule	A11CC06	19356-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWUBBDSIWDLEOM-DTOXIADCSA-N
2826	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Reinhart GA (2004)	15503649	173130	140	Calcidiol	Calcidiol|25-Hydroxyvitamin D3|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|Calcifediolum|Calcifediol Anhydrous|Calcifediol|25(OH)D3|3-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexanol|(3S,5Z,7e)-9,10-Secocholesta-5,7,10-triene-3,25-diol|(3,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-3,25-diol|(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol|25-hydroxycholecalciferol	rayaldee	DRUGBANK	DB00146	C27H44O2	small molecule	A11CC06	19356-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWUBBDSIWDLEOM-DTOXIADCSA-N
2827	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Newman JA (2006)	16978644	173493	141	Pyridoxal	3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde|Pyridoxaldehyde|2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine|Piridoxal|3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde	-	DRUGBANK	DB00147	C8H9NO3	small molecule	-	66-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RADKZDMFGJYCBB-UHFFFAOYSA-N
2828	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Adams JB (2006)	16494569	173494	141	Pyridoxal	3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde|Pyridoxaldehyde|2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine|Piridoxal|3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde	-	DRUGBANK	DB00147	C8H9NO3	small molecule	-	66-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RADKZDMFGJYCBB-UHFFFAOYSA-N
2829	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Tang L (2005)	15985434	173495	141	Pyridoxal	3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde|Pyridoxaldehyde|2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine|Piridoxal|3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde	-	DRUGBANK	DB00147	C8H9NO3	small molecule	-	66-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RADKZDMFGJYCBB-UHFFFAOYSA-N
2830	112426	6535	-	SLC6A8	CCDS1|CRT|CRTR|CT1|CTR5	9606	Homo sapiens	unknown	target	Lunardi G (2006)	16949212	173498	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2831	112426	6535	-	SLC6A8	CCDS1|CRT|CRTR|CT1|CTR5	9606	Homo sapiens	unknown	target	Campistol J (2007)	17385170	173499	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2832	112426	6535	-	SLC6A8	CCDS1|CRT|CRTR|CT1|CTR5	9606	Homo sapiens	unknown	target	Wang L (2007)	17486546	173431	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2833	112426	6535	-	SLC6A8	CCDS1|CRT|CRTR|CT1|CTR5	9606	Homo sapiens	unknown	target	Derave W (2006)	16849631	173496	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2834	112426	6535	-	SLC6A8	CCDS1|CRT|CRTR|CT1|CTR5	9606	Homo sapiens	unknown	target	Rosenberg EH (2006)	16763899	173497	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2835	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	product of	target	Kan HE (2007)	17347380	173501	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2836	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	product of	target	Almeida LS (2007)	17336114	173500	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2837	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	product of	target	Wang L (2007)	17486546	173431	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2838	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	ligand	target	Wallimann T (1992)	1731757	173504	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2839	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	ligand	target	Zhou DQ (2006)	17000714	173502	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2840	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	ligand	target	Zeng L (2007)	17389266	173503	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2841	107572	1152	-	CKB	B-CK|BCK|CKBB|HEL-211|HEL-S-29	9606	Homo sapiens	ligand	target	Buerklen TS (2007)	17036164	173506	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2842	107572	1152	-	CKB	B-CK|BCK|CKBB|HEL-211|HEL-S-29	9606	Homo sapiens	ligand	target	Debrincat MA (2007)	17148442	140592	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2843	107572	1152	-	CKB	B-CK|BCK|CKBB|HEL-211|HEL-S-29	9606	Homo sapiens	ligand	target	Wallimann T (1992)	1731757	173504	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2844	107572	1152	-	CKB	B-CK|BCK|CKBB|HEL-211|HEL-S-29	9606	Homo sapiens	ligand	target	Tian XF (2006)	16875703	173505	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2845	139227	548596	-	CKMT1A	CKMT1	9606	Homo sapiens	ligand	target	Wyss M (1990)	2394753	173508	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2846	139227	548596	-	CKMT1A	CKMT1	9606	Homo sapiens	ligand	target	Muehlebach SM (1996)	8662608	173509	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2847	139227	548596	-	CKMT1A	CKMT1	9606	Homo sapiens	ligand	target	Imming P (2006)	17016423	171742	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2848	139227	548596	-	CKMT1A	CKMT1	9606	Homo sapiens	ligand	target	Slenzka K (1996)	11538605	173507	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2849	139227	548596	-	CKMT1A	CKMT1	9606	Homo sapiens	ligand	target	Wallimann T (1992)	1731757	173504	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2850	139227	548596	-	CKMT1A	CKMT1	9606	Homo sapiens	ligand	target	Overington JP (2006)	17139284	171741	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2851	107580	1160	-	CKMT2	SMTCK	9606	Homo sapiens	ligand	target	Imming P (2006)	17016423	171742	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2852	107580	1160	-	CKMT2	SMTCK	9606	Homo sapiens	ligand	target	Wallimann T (1992)	1731757	173504	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2853	107580	1160	-	CKMT2	SMTCK	9606	Homo sapiens	ligand	target	Overington JP (2006)	17139284	171741	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2854	107580	1160	-	CKMT2	SMTCK	9606	Homo sapiens	ligand	target	Koufen P (1999)	10567223	173511	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2855	107580	1160	-	CKMT2	SMTCK	9606	Homo sapiens	ligand	target	Stachowiak O (1998)	9642223	173510	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2856	107580	1160	-	CKMT2	SMTCK	9606	Homo sapiens	ligand	target	Wyss M (1993)	8399219	173512	142	Creatine	((amino(Imino)methyl)(methyl)amino)acetic acid|N-(aminoiminomethyl)-N-methylglycine|N-[(e)-AMINO(imino)methyl]-N-methylglycine|N-Methyl-N-guanylglycine|Creatine|Creatin|N-Amidinosarcosine|Methylglycocyamine|(alpha-Methylguanido)acetic acid|Kreatin|N-Carbamimidoyl-N-methylglycine|(-methylguanido)acetic acid|(N-methylcarbamimidamido)acetic acid|alpha-Methylguanidino acetic acid	-	DRUGBANK	DB00148	C4H9N3O2	small molecule	-	57-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVSVTCORWBXHQV-UHFFFAOYSA-N
2857	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Saito M (2007)	17077963	173514	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2858	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Chen CD (2007)	17554170	173513	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2859	119584	51520	-	LARS	HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl	9606	Homo sapiens	unknown	target	Ma JJ (2006)	17144674	173515	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2860	119584	51520	-	LARS	HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl	9606	Homo sapiens	unknown	target	Vu MT (2007)	17407263	173517	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2861	119584	51520	-	LARS	HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl	9606	Homo sapiens	unknown	target	Dohm JC (2006)	16955236	173516	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2862	119584	51520	-	LARS	HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl	9606	Homo sapiens	unknown	target	Hsu JL (2006)	16774921	70697	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2863	119584	51520	-	LARS	HSPC192|ILFS1|LARS1|LEURS|LEUS|LFIS|LRS|PIG44|RNTLS|hr025Cl	9606	Homo sapiens	unknown	target	Karkhanis VA (2006)	16956879	173518	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2864	115173	9836	-	LCMT2	PPM2|TYW4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2865	115173	9836	-	LCMT2	PPM2|TYW4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2866	119549	51451	CGI-68	LCMT1	LCMT|PPMT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2867	119549	51451	CGI-68	LCMT1	LCMT|PPMT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2868	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2869	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2870	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Berger BJ (2003)	12670965	173519	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2871	116968	23395	-	LARS2	LEURS|PRLTS4	9606	Homo sapiens	unknown	target	Ma JJ (2006)	17144674	173515	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2872	116968	23395	-	LARS2	LEURS|PRLTS4	9606	Homo sapiens	unknown	target	Lue SW (2007)	17378584	173520	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2873	116968	23395	-	LARS2	LEURS|PRLTS4	9606	Homo sapiens	unknown	target	Vu MT (2007)	17407263	173517	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2874	116968	23395	-	LARS2	LEURS|PRLTS4	9606	Homo sapiens	unknown	target	Hsu JL (2006)	16774921	70697	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2875	116968	23395	-	LARS2	LEURS|PRLTS4	9606	Homo sapiens	unknown	target	Zhu B (2007)	17095543	173521	143	L-Leucine	(2S)-alpha-Leucine|(S)-(+)-Leucine|L-Leucin|(2S)-2-Amino-4-methylpentanoic acid|L|2-Amino-4-methylvaleric acid|(S)-Leucine|Leucine|L-Leuzin|Leu|(2S)-alpha-2-Amino-4-methylvaleric acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00149	C6H13NO2	small molecule	-	61-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROHFNLRQFUQHCH-YFKPBYRVSA-N
2876	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	inhibitor	target	Zhu L (2006)	17114500	173528	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2877	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	inhibitor	target	Tsuchiya W (2006)	17150540	173524	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2878	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	inhibitor	target	Retailleau P (2007)	17428498	173525	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2879	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	inhibitor	target	Yadav MC (2007)	17661345	173526	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2880	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	inhibitor	target	Yang XL (2006)	16724112	173527	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2881	115633	10352	-	WARS2	TrpRS	9606	Homo sapiens	inhibitor	target	Paley EL (2006)	17114825	173529	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2882	115633	10352	-	WARS2	TrpRS	9606	Homo sapiens	inhibitor	target	Yang XL (2006)	16724112	173527	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2883	115633	10352	-	WARS2	TrpRS	9606	Homo sapiens	inhibitor	target	Retailleau P (2007)	17428498	173525	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2884	115633	10352	-	WARS2	TrpRS	9606	Homo sapiens	inhibitor	target	Banin E (2006)	16639024	173531	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2885	115633	10352	-	WARS2	TrpRS	9606	Homo sapiens	inhibitor	target	Charriere F (2006)	16636268	173530	144	L-Tryptophan	(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|(S)-alpha-amino-1H-indole-3-propanoic acid|(-)-Tryptophan|L--3-indolylalanine|L-()-tryptophan|L-(-)-Tryptophan|L-beta-3-Indolylalanine|(S)--amino-1H-indole-3-propanoic acid|W|(S)-Tryptophan|L-Tryptophan|Tryptophan|(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid|Trp	2.5% travasol amino acid injec	DRUGBANK	DB00150	C11H12N2O2	small molecule	N06AX02	73-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVBCDIJIAJPQS-VIFPVBQESA-N
2886	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Zhang H (2006)	16428267	173548	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2887	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Wallace JL (2007)	17634391	173549	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2888	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Fiorucci S (2005)	16108046	173547	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2889	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	Jin HF (2007)	17657274	173551	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2890	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	McCoy JG (2006)	16492780	173550	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2891	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	Ye S (2007)	17135237	173553	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2892	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	Roopnarinesingh ES (2005)	16355974	173552	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2893	108992	2730	RP4-561L24.2	GCLM	GLCLR	9606	Homo sapiens	unknown	target	Ashida H (2005)	15695431	173554	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2894	122730	79587	OK/SW-cl.10	CARS2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2895	122730	79587	OK/SW-cl.10	CARS2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2896	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2897	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2898	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2899	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2900	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	unknown	target	Daniels KM (1982)	7131091	173555	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2901	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	unknown	target	Chan-Palay V (1982)	6953423	173557	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2902	119512	51380	-	CSAD	CSD|PCAP	9606	Homo sapiens	unknown	target	Guion-Rain M-C (1975)	236774	173556	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2903	108991	2729	-	GCLC	GCL|GCS|GLCL|GLCLC	9606	Homo sapiens	unknown	target	Srivastava S (2008)	17615559	173558	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2904	108991	2729	-	GCLC	GCL|GCS|GLCL|GLCLC	9606	Homo sapiens	unknown	target	Ashida H (2005)	15695431	173554	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2905	107283	833	-	CARS	CARS1|CYSRS|MGC:11246	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2906	107283	833	-	CARS	CARS1|CYSRS|MGC:11246	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2907	123266	80704	-	SLC19A3	BBGD|THMD2|THTR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2908	123266	80704	-	SLC19A3	BBGD|THMD2|THTR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2909	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	Ding B (2005)	15828873	173559	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2910	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	Ding H (2005)	15985427	173562	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2911	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	Yang J (2006)	16877383	173560	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2912	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	Layer G (2006)	16603772	173561	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2913	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	You D (2007)	17469805	172587	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2914	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Tanaka T (2006)	16940754	173563	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2915	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	Pierce BS (2007)	17602574	173564	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2916	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Lowicka E (2007)	17377202	172462	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2917	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Oh GS (2006)	16781459	173565	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2918	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Zhang H (2006)	16428267	173548	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2919	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Bhatia M (2005)	15671155	173567	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2920	107321	875	-	CBS	HIP4	9606	Homo sapiens	unknown	target	Tamizhselvi R (2007)	17488480	173566	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2921	110411	4255	RP11-109A6.1	MGMT	-	9606	Homo sapiens	unknown	target	Niture SK (2007)	16950796	173568	145	L-Cysteine	(2R)-2-amino-3-mercaptopropanoic acid|Cys|L-Cys|L-Cystein|(R)-2-Amino-3-mercaptopropanoic acid|L-Zystein|Cysteine|L-2-Amino-3-mercaptopropionic acid|Free Cysteine|(2R)-2-amino-3-sulfanylpropanoic acid	vamin n|primene 10%|primene 10	DRUGBANK	DB00151	C3H7NO2S	small molecule	-	52-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-RUOZJJLTNA-N
2922	117952	27010	-	TPK1	HTPK1|PP20|THMD5	9606	Homo sapiens	ligand	target	de Jong L (2004)	15514058	173572	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2923	117952	27010	-	TPK1	HTPK1|PP20|THMD5	9606	Homo sapiens	ligand	target	Melnick J (2004)	15150256	173571	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2924	117952	27010	-	TPK1	HTPK1|PP20|THMD5	9606	Homo sapiens	ligand	target	Pylypchuk SIu (2001)	11642045	173570	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2925	117952	27010	-	TPK1	HTPK1|PP20|THMD5	9606	Homo sapiens	ligand	target	Bellyei S (2005)	15664409	173569	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2926	115811	10560	RP1-206D15.4	SLC19A2	TC1|THMD1|THT1|THTR1|TRMA	9606	Homo sapiens	binder	target	Labay V (1999)	10391221	173573	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2927	115811	10560	RP1-206D15.4	SLC19A2	TC1|THMD1|THT1|THTR1|TRMA	9606	Homo sapiens	binder	target	Diaz GA (1999)	10391223	173574	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2928	115811	10560	RP1-206D15.4	SLC19A2	TC1|THMD1|THT1|THTR1|TRMA	9606	Homo sapiens	binder	target	Liberman MC (2006)	16642288	173575	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2929	115811	10560	RP1-206D15.4	SLC19A2	TC1|THMD1|THT1|THTR1|TRMA	9606	Homo sapiens	binder	target	Fleming JC (1999)	10391222	48745	146	Thiamine	Vitamin B1|thiamine(1+) ion|thiamine(1+)|Thiamin|Aneurin|Antiberiberi factor|Thiamine|3-(4-AMINO-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazol-3-ium|thiaminium	vitamin b complex 100 tab|mult	DRUGBANK	DB00152	C12H17N4OS	small molecule	A11DA01	59-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRWCGZRTZMZEH-UHFFFAOYSA-N
2930	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Jurutka PW (2007)	18290715	112374	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2931	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2932	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Ewing AK (2007)	17519354	115875	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2933	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Gallagher JC (2010)	20525913	173579	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2934	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Marks HD (2007)	17207992	173578	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2935	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Straube S (2010)	20091647	173580	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2936	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Mikhak B (2007)	17440943	173581	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2937	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Carvallo L (2007)	17218095	104088	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2938	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Liu W (2006)	16949927	173577	147	Ergocalciferol	Vitamina D2|(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Vitamin D2|Calciferol|Viosterol|(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol|Ergocalciferolum|(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol|Oleovitamin D2|Ercalciol|Ergocalciferol|Activated ergosterol	vitamines pour bebes et enfant	DRUGBANK	DB00153	C28H44O	small molecule	A11CC01	50-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MECHNRXZTMCUDQ-RKHKHRCZSA-N
2939	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2940	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	15990700	173594	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2941	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2942	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Thuresson ED (2001)	11121413	173590	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2943	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Malkowski MG (2001)	11477109	173593	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2944	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Levin G (2002)	11939906	173592	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2945	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	15990700	173594	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2946	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	16190133	173591	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2947	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Thuresson ED (2001)	11121413	173590	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2948	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Levin G (2002)	11939906	173592	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2949	117107	23564	DADB-110M10.5	DDAH2	DDAH|DDAHII|G6a|HEL-S-277|NG30	9606	Homo sapiens	unknown	target	Tran CT (2000)	10950934	173595	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2950	117107	23564	DADB-110M10.5	DDAH2	DDAH|DDAHII|G6a|HEL-S-277|NG30	9606	Homo sapiens	unknown	target	Tain YL (2007)	17653133	173596	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2951	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Van Geldre LA (2002)	12445581	173601	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2952	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Hammermann R (1998)	9879717	173597	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2953	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Husson A (2003)	12709047	173599	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2954	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Zandvliet MM (2007)	17427379	173598	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2955	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Takahashi H (2006)	16449956	173600	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2956	131667	353238	-	PADI6	hPADVI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2957	131667	353238	-	PADI6	hPADVI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2958	117114	23576	RP4-621F18.1	DDAH1	DDAH|HEL-S-16	9606	Homo sapiens	unknown	target	Tran CT (2000)	10950934	173595	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2959	117114	23576	RP4-621F18.1	DDAH1	DDAH|HEL-S-16	9606	Homo sapiens	unknown	target	Arrigoni FI (2003)	12615801	173603	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2960	117114	23576	RP4-621F18.1	DDAH1	DDAH|HEL-S-16	9606	Homo sapiens	unknown	target	Mishima T (2004)	14766200	173602	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2961	116404	11240	RP1-37C10.6	PADI2	PAD-H19|PAD2|PDI2	9606	Homo sapiens	unknown	target	Dong S (2005)	15854045	173604	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2962	118980	29943	-	PADI1	HPAD10|PAD1|PDI|PDI1	9606	Homo sapiens	unknown	target	Iida A (2004)	15150696	173605	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2963	119686	51702	hCG_25124	PADI3	PAD3|PDI3	9606	Homo sapiens	unknown	target	Iida A (2004)	15150696	173605	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2964	119686	51702	hCG_25124	PADI3	PAD3|PDI3	9606	Homo sapiens	unknown	target	Kanno T (2000)	11069618	173606	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2965	119686	51702	hCG_25124	PADI3	PAD3|PDI3	9606	Homo sapiens	unknown	target	Dong S (2006)	16671893	108543	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2966	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Morizono H (2006)	16585758	172976	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2967	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Quintero MJ (2000)	10648527	173607	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2968	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Braissant O (1999)	10407171	173612	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2969	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Zhang WY (2000)	11072090	173609	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2970	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Braissant O (1999)	10353334	173608	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2971	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Keilhoff G (2000)	10944418	173610	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2972	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Zhang B (2000)	11067741	173611	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2973	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Giraldi-Guimaraes A (1999)	10681601	173616	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2974	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Perry JM (2000)	10799481	173617	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2975	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Yu W (2000)	10962148	173614	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2976	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Adak S (2000)	10945985	173615	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2977	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Kominami S (1999)	10502685	173613	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2978	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Wang Y (2004)	15345777	113170	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2979	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Chang X (2006)	16355400	173620	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2980	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Yamamoto K (2005)	16271291	173621	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2981	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Wysocka J (2005)	16146736	173618	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2982	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Okazaki Y (2006)	16412378	173619	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2983	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Yi GB (2003)	12745988	173625	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2984	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Cunningham JM (2000)	10906995	173624	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2985	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Conrad KP (2002)	11742852	173623	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2986	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Knowles RG (2000)	10906994	173622	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2987	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Keilhoff G (2000)	10944418	173610	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2988	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Trovati M (1999)	10440125	173627	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2989	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Hayakawa H (1999)	10403604	173626	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2990	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Tan E (1999)	10690351	173630	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2991	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Abu-Soud HM (2000)	10749853	173629	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2992	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	McDuffie JE (1999)	10460702	173628	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2993	112760	6897	-	TARS	ThrRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
2994	112760	6897	-	TARS	ThrRS	9606	Homo sapiens	unknown	target	Ruan B (2005)	15507440	173631	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
2995	112760	6897	-	TARS	ThrRS	9606	Homo sapiens	unknown	target	Cusack S (1998)	9493271	173632	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
2996	112760	6897	-	TARS	ThrRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
2997	112760	6897	-	TARS	ThrRS	9606	Homo sapiens	unknown	target	Torres-Larios A (2003)	12875846	173633	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
2998	123188	80222	RP11-54A4.9	TARS2	COXPD21|TARSL1|thrRS	9606	Homo sapiens	unknown	target	Caillet J (2007)	17644600	173634	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
2999	122980	79896	-	THNSL1	TSH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
3000	122980	79896	-	THNSL1	TSH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	150	L-Threonine	L-2-Amino-3-hydroxybutyric acid|L-(-)-Threonine|Thr|2-Amino-3-hydroxybutyric acid|L-alpha-amino-beta-hydroxybutyric acid|L-Threonin|(2S,3R)-(-)-Threonine|L--amino--hydroxybutyric acid|Threonine|(2S)-threonine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00156	C4H9NO3	small molecule	-	72-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFVYJQAPQTCCC-FGNFWGHYNA-N
3001	111892	5959	-	RDH5	9cRDH|HSD17B9|RDH1|SDR9C5	9606	Homo sapiens	unknown	target	Dalfo D (2007)	17608724	173635	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3002	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3003	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3004	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Thielen J (1991)	1938903	25707	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3005	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Widenius TV (1987)	3593480	173636	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3006	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Plapp BV (2001)	11306066	173637	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3007	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Li S (2003)	14511985	173638	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3008	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Hedl M (2004)	15152097	173639	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3009	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3010	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3011	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Huber R (2005)	15755483	173640	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3012	110782	4702	-	NDUFA8	CI-19KD|CI-PGIV|PGIV	9606	Homo sapiens	unknown	target	Triepels R (1998)	9860297	173641	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3013	110782	4702	-	NDUFA8	CI-19KD|CI-PGIV|PGIV	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3014	110782	4702	-	NDUFA8	CI-19KD|CI-PGIV|PGIV	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3015	111186	5160	RP11-723P2.1	PDHA1	PDHA|PDHAD|PDHCE1A|PHE1A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3016	111186	5160	RP11-723P2.1	PDHA1	PDHA|PDHAD|PDHCE1A|PHE1A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3017	113653	7923	DADB-100D22.4	HSD17B8	D6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3018	113653	7923	DADB-100D22.4	HSD17B8	D6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3019	110778	4698	-	NDUFA5	B13|CI-13KD-B|CI-13kB|NUFM|UQOR13	9606	Homo sapiens	unknown	target	Chen CL (2007)	17444656	173643	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3020	110778	4698	-	NDUFA5	B13|CI-13KD-B|CI-13kB|NUFM|UQOR13	9606	Homo sapiens	unknown	target	Belevich G (2007)	17209562	173642	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3021	110785	4705	-	NDUFA10	CI-42KD|CI-42k	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3022	110785	4705	-	NDUFA10	CI-42KD|CI-42k	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3023	110804	4725	RP11-781D11.3	NDUFS5	CI-15k|CI15K	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3024	110804	4725	RP11-781D11.3	NDUFS5	CI-15k|CI15K	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3025	110804	4725	RP11-781D11.3	NDUFS5	CI-15k|CI15K	9606	Homo sapiens	unknown	target	Loeffen J (1999)	10070614	173644	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3026	110802	4723	-	NDUFV1	CI-51K|CI51KD|UQOR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3027	110802	4723	-	NDUFV1	CI-51K|CI51KD|UQOR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3028	110802	4723	-	NDUFV1	CI-51K|CI51KD|UQOR1	9606	Homo sapiens	unknown	target	Grad LI (2004)	14662656	173645	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3029	110802	4723	-	NDUFV1	CI-51K|CI51KD|UQOR1	9606	Homo sapiens	unknown	target	Ali ST (1993)	8288251	173647	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3030	110802	4723	-	NDUFV1	CI-51K|CI51KD|UQOR1	9606	Homo sapiens	unknown	target	Schuelke M (1998)	9571201	173646	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3031	106721	219	-	ALDH1B1	ALDH5|ALDHX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3032	106721	219	-	ALDH1B1	ALDH5|ALDHX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3033	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3034	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	unknown	target	Bowne SJ (2006)	16384941	173648	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3035	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3036	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3037	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3038	109278	3028	RP3-339A18.2	HSD17B10	17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3039	109278	3028	RP3-339A18.2	HSD17B10	17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3040	109528	3295	-	HSD17B4	DBP|MFE-2|MPF-2|PRLTS1|SDR8C1	9606	Homo sapiens	unknown	target	Haapalainen AM (2003)	12517343	173649	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3041	109528	3295	-	HSD17B4	DBP|MFE-2|MPF-2|PRLTS1|SDR8C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3042	109528	3295	-	HSD17B4	DBP|MFE-2|MPF-2|PRLTS1|SDR8C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3043	113205	7358	-	UGDH	GDH|UDP-GlcDH|UDPGDH|UGD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3044	113205	7358	-	UGDH	GDH|UDP-GlcDH|UDPGDH|UGD	9606	Homo sapiens	unknown	target	Castellani AA (1986)	3804697	173650	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3045	113205	7358	-	UGDH	GDH|UDP-GlcDH|UDPGDH|UGD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3046	113205	7358	-	UGDH	GDH|UDP-GlcDH|UDPGDH|UGD	9606	Homo sapiens	unknown	target	Alary J (1992)	1472079	173651	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3047	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Cheng Z (2007)	17550271	173652	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3048	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Gazaryan IG (2007)	17565998	173653	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3049	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Aon MA (2007)	17540766	173656	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3050	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Wan C (2007)	17053903	173654	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3051	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Knapp KG (2007)	17502280	173655	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3052	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Manriquez D (2006)	16897483	71149	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3053	110781	4701	-	NDUFA7	B14.5a	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3054	110781	4701	-	NDUFA7	B14.5a	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3055	110792	4712	RP11-205M20.6	NDUFB6	B17|CI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3056	110792	4712	RP11-205M20.6	NDUFB6	B17|CI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3057	109283	3033	-	HADH	HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD	9606	Homo sapiens	unknown	target	Norman JP (2007)	17202348	173657	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3058	110631	4535	-	ND1	MTND1	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3059	110631	4535	-	ND1	MTND1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3060	110631	4535	-	ND1	MTND1	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3061	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3062	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Plapp BV (2003)	12604203	173658	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3063	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3064	109524	3291	-	HSD11B2	AME|AME1|HSD11K|HSD2|SDR9C3	9606	Homo sapiens	unknown	target	Hermans JJ (1995)	8585102	173660	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3065	109524	3291	-	HSD11B2	AME|AME1|HSD11K|HSD2|SDR9C3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3066	109524	3291	-	HSD11B2	AME|AME1|HSD11K|HSD2|SDR9C3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3067	109524	3291	-	HSD11B2	AME|AME1|HSD11K|HSD2|SDR9C3	9606	Homo sapiens	unknown	target	Mercer WR (1992)	1727721	173659	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3068	109647	3421	hCG_2004980	IDH3G	H-IDHG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3069	109647	3421	hCG_2004980	IDH3G	H-IDHG	9606	Homo sapiens	unknown	target	SANWAL BD (1964)	14189899	173662	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3070	109647	3421	hCG_2004980	IDH3G	H-IDHG	9606	Homo sapiens	unknown	target	Stein AM (1967)	4292141	173661	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3071	109647	3421	hCG_2004980	IDH3G	H-IDHG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3072	109647	3421	hCG_2004980	IDH3G	H-IDHG	9606	Homo sapiens	unknown	target	Rose ZB (1966)	4380379	173663	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3073	117076	23530	hCG_17428	NNT	GCCD4	9606	Homo sapiens	unknown	target	Kabus A (2007)	17216441	173664	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3074	111017	4967	-	OGDH	AKGDH|E1k|OGDC	9606	Homo sapiens	unknown	target	Mailloux RJ (2007)	17668068	173665	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3075	117618	26227	RP4-683H9.1	PHGDH	3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3076	117618	26227	RP4-683H9.1	PHGDH	3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3077	117618	26227	RP4-683H9.1	PHGDH	3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA	9606	Homo sapiens	unknown	target	Grant GA (1989)	2692566	173667	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3078	117618	26227	RP4-683H9.1	PHGDH	3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA	9606	Homo sapiens	unknown	target	Goldsmith LA (1976)	945314	173666	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3079	117618	26227	RP4-683H9.1	PHGDH	3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA	9606	Homo sapiens	unknown	target	Grant GA (2002)	12183470	173668	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3080	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Ikegami T (2007)	17341833	173669	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3081	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Roma GW (2006)	16814740	173670	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3082	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Nussenzveig RH (2006)	17082011	173671	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3083	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Kim S (2007)	17401193	173672	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3084	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Kurian JR (2006)	17040106	173673	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3085	110635	4539	-	ND4L	MTND4L	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3086	110635	4539	-	ND4L	MTND4L	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3087	110777	4697	-	NDUFA4	CI-9k|CI-MLRQ|MLRQ	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3088	110777	4697	-	NDUFA4	CI-9k|CI-MLRQ|MLRQ	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3089	109527	3294	-	HSD17B2	EDH17B2|HSD17|SDR9C2	9606	Homo sapiens	unknown	target	Fukuda T (1986)	3463506	173674	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3090	109527	3294	-	HSD17B2	EDH17B2|HSD17|SDR9C2	9606	Homo sapiens	unknown	target	Pineda JA (1989)	2615366	173675	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3091	109527	3294	-	HSD17B2	EDH17B2|HSD17|SDR9C2	9606	Homo sapiens	unknown	target	Wintergalen N (1995)	8529651	173676	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3092	109527	3294	-	HSD17B2	EDH17B2|HSD17|SDR9C2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3093	109527	3294	-	HSD17B2	EDH17B2|HSD17|SDR9C2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3094	124950	92483	-	LDHAL6B	LDH6B|LDHAL6|LDHL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3095	124950	92483	-	LDHAL6B	LDH6B|LDHAL6|LDHL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3096	107958	1586	RP11-753C18.1	CYP17A1	CPT7|CYP17|P450C17|S17AH	9606	Homo sapiens	unknown	target	Pandey AV (2007)	17595315	173677	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3097	110793	4713	-	NDUFB7	B18|CI-B18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3098	110793	4713	-	NDUFB7	B18|CI-B18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3099	110793	4713	-	NDUFB7	B18|CI-B18	9606	Homo sapiens	unknown	target	Raha S (2002)	11864782	173678	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3100	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3101	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3102	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Russo J (2002)	11872149	173679	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3103	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Lamb AL (1999)	10320326	173680	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3104	110780	4700	-	NDUFA6	B14|CI-B14|LYRM6|NADHB14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3105	110780	4700	-	NDUFA6	B14|CI-B14|LYRM6|NADHB14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3106	110776	4696	-	NDUFA3	B9|CI-B9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3107	110776	4696	-	NDUFA3	B9|CI-B9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3108	110637	4541	-	ND6	MTND6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3109	110637	4541	-	ND6	MTND6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3110	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3111	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3112	110794	4714	RP11-411B6.5	NDUFB8	ASHI|CI-ASHI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3113	110794	4714	RP11-411B6.5	NDUFB8	ASHI|CI-ASHI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3114	119563	51478	RP11-331H2.1	HSD17B7	PRAP|SDR37C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3115	119563	51478	RP11-331H2.1	HSD17B7	PRAP|SDR37C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3116	110791	4711	-	NDUFB5	CISGDH|SGDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3117	110791	4711	-	NDUFB5	CISGDH|SGDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3118	107113	644	-	BLVRA	BLVR|BVR|BVRA	9606	Homo sapiens	unknown	target	Franklin E (2007)	17402939	173681	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3119	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Linster CL (2007)	17222174	173683	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3120	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Ido Y (2007)	17508915	173682	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3121	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3122	107468	1036	-	CDO1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3123	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Baeumchen C (2007)	17619232	173685	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3124	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Baron R (2006)	16821840	173684	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3125	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Schirwitz K (2007)	17525463	173687	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3126	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Okochi M (2007)	17092593	173686	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3127	113115	7264	-	TSTA3	FX|P35B|SDR4E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3128	113115	7264	-	TSTA3	FX|P35B|SDR4E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3129	108282	1962	-	EHHADH	ECHD|FRTS3|L-PBE|LBFP|LBP|PBFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3130	108282	1962	-	EHHADH	ECHD|FRTS3|L-PBE|LBFP|LBP|PBFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3131	110636	4540	-	ND5	MTND5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3132	110636	4540	-	ND5	MTND5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3133	110636	4540	-	ND5	MTND5	9606	Homo sapiens	unknown	target	Johnson WE (1997)	9071018	173689	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3134	110636	4540	-	ND5	MTND5	9606	Homo sapiens	unknown	target	Bao HG (2007)	17614984	173688	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3135	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3136	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3137	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Graham CE (2006)	16241904	155769	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3138	107091	622	-	BDH1	BDH|SDR9C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3139	107091	622	-	BDH1	BDH|SDR9C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3140	107091	622	-	BDH1	BDH|SDR9C1	9606	Homo sapiens	unknown	target	Rudy B (1989)	2550053	173692	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3141	107091	622	-	BDH1	BDH|SDR9C1	9606	Homo sapiens	unknown	target	Tabata M (1995)	8533882	173690	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3142	107091	622	-	BDH1	BDH|SDR9C1	9606	Homo sapiens	unknown	target	Smith CM (1979)	38961	173691	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3143	116011	10797	-	MTHFD2	NMDMC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3144	116011	10797	-	MTHFD2	NMDMC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3145	110798	4718	HLC1	NDUFC2	B14.5b|CI-B14.5b|HLC-1|NADHDH2	9606	Homo sapiens	unknown	target	Quiles MJ (2006)	16898010	173696	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3146	110798	4718	HLC1	NDUFC2	B14.5b|CI-B14.5b|HLC-1|NADHDH2	9606	Homo sapiens	unknown	target	Brooijmans RJ (2007)	17496098	173694	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3147	110798	4718	HLC1	NDUFC2	B14.5b|CI-B14.5b|HLC-1|NADHDH2	9606	Homo sapiens	unknown	target	Zhu X (2007)	17513495	173695	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3148	110798	4718	HLC1	NDUFC2	B14.5b|CI-B14.5b|HLC-1|NADHDH2	9606	Homo sapiens	unknown	target	Gyan S (2006)	17015645	173693	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3149	110798	4718	HLC1	NDUFC2	B14.5b|CI-B14.5b|HLC-1|NADHDH2	9606	Homo sapiens	unknown	target	Bao HG (2007)	17614984	173688	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3150	109280	3030	-	HADHA	ECHA|GBP|HADH|LCEH|LCHAD|MTPA|TP-ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3151	109280	3030	-	HADHA	ECHA|GBP|HADH|LCEH|LCHAD|MTPA|TP-ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3152	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Xu H (2007)	17542618	173697	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3153	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Xu H (2006)	17002315	173698	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3154	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Xu H (2007)	17223709	173699	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3155	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Gutierrez-Correa J (2006)	17017892	173700	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3156	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Yan LJ (2007)	17315258	173701	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3157	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Islam MM (2007)	17314104	173702	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3158	109080	2819	-	GPD1	GPD-C|GPDH-C|HTGTI	9606	Homo sapiens	unknown	target	Fonvielle M (2007)	17088060	173703	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3159	106723	221	-	ALDH3B1	ALDH4|ALDH7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3160	106723	221	-	ALDH3B1	ALDH4|ALDH7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3161	106724	222	-	ALDH3B2	ALDH8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3162	106724	222	-	ALDH3B2	ALDH8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3163	110801	4722	-	NDUFS3	CI-30	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3164	110801	4722	-	NDUFS3	CI-30	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3165	110633	4537	-	ND3	MTND3	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3166	110633	4537	-	ND3	MTND3	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3167	110633	4537	-	ND3	MTND3	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3168	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Rimsay RL (1988)	3164265	173704	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3169	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Fukuda T (1986)	3463506	173674	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3170	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3171	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3172	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Pineda JA (1989)	2615366	173675	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3173	121013	55967	-	NDUFA12	B17.2|DAP13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3174	121013	55967	-	NDUFA12	B17.2|DAP13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3175	109009	2747	-	GLUD2	GDH2|GLUDP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3176	109009	2747	-	GLUD2	GDH2|GLUDP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3177	110795	4715	-	NDUFB9	B22|CI-B22|LYRM3|UQOR22	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3178	110795	4715	-	NDUFB9	B22|CI-B22|LYRM3|UQOR22	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3179	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3180	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3181	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Deng D (2007)	17559398	173705	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3182	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3183	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Pineda JA (1989)	2615366	173675	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3184	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Pineda JA (1990)	2146972	173706	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3185	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3186	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Nicolas JC (1983)	6584048	173707	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3187	110790	4710	-	NDUFB4	B15|CI-B15	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3188	110790	4710	-	NDUFB4	B15|CI-B15	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3189	127750	160287	-	LDHAL6A	LDH6A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3190	127750	160287	-	LDHAL6A	LDH6A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3191	112535	6652	-	SORD	HEL-S-95n|SORD1	9606	Homo sapiens	unknown	target	Klimacek M (2007)	17343568	173708	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3192	112535	6652	-	SORD	HEL-S-95n|SORD1	9606	Homo sapiens	unknown	target	Ido Y (2007)	17508915	173682	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3193	108081	1737	-	DLAT	DLTA|PDC-E2|PDCE2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3194	108081	1737	-	DLAT	DLTA|PDC-E2|PDCE2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3195	108081	1737	-	DLAT	DLTA|PDC-E2|PDCE2	9606	Homo sapiens	unknown	target	Shi S (2006)	16368957	173709	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3196	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Burczynski ME (2001)	11060293	173710	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3197	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Fukuda T (1986)	3463506	173674	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3198	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3199	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3200	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Pineda JA (1989)	2615366	173675	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3201	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Tanaka M (2006)	16986858	173712	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3202	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Goldstone AB (2006)	17157188	173711	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3203	107534	1109	-	AKR1C4	3-alpha-HSD|C11|CDR|CHDR|DD-4|DD4|HAKRA	9606	Homo sapiens	unknown	target	Atalla A (2000)	11037109	173713	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3204	107534	1109	-	AKR1C4	3-alpha-HSD|C11|CDR|CHDR|DD-4|DD4|HAKRA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3205	107534	1109	-	AKR1C4	3-alpha-HSD|C11|CDR|CHDR|DD-4|DD4|HAKRA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3206	110472	4329	-	ALDH6A1	MMSADHA|MMSDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3207	110472	4329	-	ALDH6A1	MMSADHA|MMSDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3208	110472	4329	-	ALDH6A1	MMSADHA|MMSDH	9606	Homo sapiens	unknown	target	Kedishvili NY (1991)	1898092	173714	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3209	116289	11112	-	HIBADH	NS5ATP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3210	116289	11112	-	HIBADH	NS5ATP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3211	112214	6307	-	MSMO1	DESP4|ERG25|SC4MOL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3212	112214	6307	-	MSMO1	DESP4|ERG25|SC4MOL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3213	111187	5161	hCG_1643458	PDHA2	PDHAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3214	111187	5161	hCG_1643458	PDHA2	PDHAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3215	110363	4199	-	ME1	HUMNDME|MES	9606	Homo sapiens	unknown	target	McKinlay JB (2007)	17197218	173715	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3216	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	unknown	target	Zafar KS (2006)	16790533	173717	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3217	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	unknown	target	Jadhav JP (2007)	17292452	173716	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3218	106726	224	-	ALDH3A2	ALDH10|FALDH|SLS	9606	Homo sapiens	unknown	target	Bognar A (1983)	6603890	173718	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3219	106726	224	-	ALDH3A2	ALDH10|FALDH|SLS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3220	106726	224	-	ALDH3A2	ALDH10|FALDH|SLS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3221	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3222	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Ismail SA (2005)	16239728	173719	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3223	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3224	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Graciet E (2003)	12492483	173720	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3225	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Maeda K (2004)	15488735	173721	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3226	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	unknown	target	Ishii-Ohba H (1987)	2961942	173722	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3227	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	unknown	target	Widenius TV (1987)	3476810	173723	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3228	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3229	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3230	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	unknown	target	Thomas JL (1990)	2362440	173724	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3231	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Wang J (2007)	17496727	173725	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3232	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3233	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3234	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Prieto MI (1987)	3129020	173726	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3235	106725	223	-	ALDH9A1	ALDH4|ALDH7|ALDH9|E3|TMABADH	9606	Homo sapiens	unknown	target	Testore G (1995)	7584606	173727	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3236	110789	4709	-	NDUFB3	B12|CI-B12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3237	110789	4709	-	NDUFB3	B12|CI-B12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3238	110800	4720	-	NDUFS2	CI-49	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3239	110800	4720	-	NDUFS2	CI-49	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3240	106643	131	-	ADH7	ADH4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3241	106643	131	-	ADH7	ADH4	9606	Homo sapiens	unknown	target	Suzuki Y (1993)	8490052	173728	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3242	106643	131	-	ADH7	ADH4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3243	106643	131	-	ADH7	ADH4	9606	Homo sapiens	unknown	target	Dalfo D (2007)	17608724	173635	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3244	106643	131	-	ADH7	ADH4	9606	Homo sapiens	unknown	target	Kim DS (2001)	11410692	173729	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3245	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3246	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	unknown	target	Thomas JL (1991)	1911436	173730	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3247	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	unknown	target	Fan DF (1975)	239964	173731	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3248	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3249	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	unknown	target	Widenius TV (1987)	3476810	173723	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3250	119270	51079	CGI-39	NDUFA13	B16.6|CDA016|GRIM-19|GRIM19	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3251	119270	51079	CGI-39	NDUFA13	B16.6|CDA016|GRIM-19|GRIM19	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3252	114933	9563	RP3-510D11.3	H6PD	CORTRD1|G6PDH|GDH	9606	Homo sapiens	unknown	target	Takenaka M (2007)	17531229	173733	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3253	114933	9563	RP3-510D11.3	H6PD	CORTRD1|G6PDH|GDH	9606	Homo sapiens	unknown	target	Siu E (2007)	17269701	173732	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3254	114933	9563	RP3-510D11.3	H6PD	CORTRD1|G6PDH|GDH	9606	Homo sapiens	unknown	target	Markova EV (2006)	16898590	173735	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3255	114933	9563	RP3-510D11.3	H6PD	CORTRD1|G6PDH|GDH	9606	Homo sapiens	unknown	target	Lu Y (2007)	17171348	173734	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3256	114933	9563	RP3-510D11.3	H6PD	CORTRD1|G6PDH|GDH	9606	Homo sapiens	unknown	target	Zhang M (2007)	17298031	173736	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3257	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Iskander K (2006)	16905546	173738	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3258	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Jamieson D (2006)	17031400	173737	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3259	110799	4719	-	NDUFS1	CI-75Kd|CI-75k|PRO1304	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3260	110799	4719	-	NDUFS1	CI-75Kd|CI-75k|PRO1304	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3261	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	O'Brien J (2006)	17006762	173739	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3262	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Draghia AC (2007)	17308685	173740	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3263	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Semenza GL (2007)	17555402	73182	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3264	110774	4694	-	NDUFA1	CI-MWFE|MWFE|ZNF183	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3265	110774	4694	-	NDUFA1	CI-MWFE|MWFE|ZNF183	9606	Homo sapiens	unknown	target	Au HC (1999)	10200266	173741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3266	110774	4694	-	NDUFA1	CI-MWFE|MWFE|ZNF183	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3267	110774	4694	-	NDUFA1	CI-MWFE|MWFE|ZNF183	9606	Homo sapiens	unknown	target	Raha S (2002)	11864782	173678	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3268	111789	5831	-	PYCR1	ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR	9606	Homo sapiens	unknown	target	Wang ZQ (2007)	16777263	173742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3269	111789	5831	-	PYCR1	ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR	9606	Homo sapiens	unknown	target	Forlani G (2007)	17474756	173743	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3270	110806	4728	-	NDUFS8	CI-23k|CI23KD|TYKY	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3271	110806	4728	-	NDUFS8	CI-23k|CI23KD|TYKY	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3272	110806	4728	-	NDUFS8	CI-23k|CI23KD|TYKY	9606	Homo sapiens	unknown	target	Jose Quiles M (1998)	9576793	173744	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3273	110806	4728	-	NDUFS8	CI-23k|CI23KD|TYKY	9606	Homo sapiens	unknown	target	Loeffen J (1998)	9837812	173745	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3274	110806	4728	-	NDUFS8	CI-23k|CI23KD|TYKY	9606	Homo sapiens	unknown	target	Albracht SP (2000)	11086155	173746	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3275	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Bieganowski P (2006)	16760478	70877	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3276	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Manriquez D (2006)	16897483	71149	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3277	125981	126328	-	NDUFA11	B14.7|CI-B14.7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3278	125981	126328	-	NDUFA11	B14.7|CI-B14.7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3279	111798	5860	-	QDPR	DHPR|PKU2|SDR33C1	9606	Homo sapiens	unknown	target	Lee PL (2000)	10814540	173748	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3280	111798	5860	-	QDPR	DHPR|PKU2|SDR33C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3281	111798	5860	-	QDPR	DHPR|PKU2|SDR33C1	9606	Homo sapiens	unknown	target	Nakanishi N (1986)	3086306	173749	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3282	111798	5860	-	QDPR	DHPR|PKU2|SDR33C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3283	111798	5860	-	QDPR	DHPR|PKU2|SDR33C1	9606	Homo sapiens	unknown	target	van der Heiden C (1982)	6820434	173747	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3284	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Trost P (2006)	17031544	173750	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3285	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Markova EV (2006)	16898590	173735	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3286	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Swearengin TA (2006)	17194030	173751	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3287	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Ido Y (2007)	17508915	173682	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3288	110786	4706	-	NDUFAB1	ACP|FASN2A|SDAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3289	110786	4706	-	NDUFAB1	ACP|FASN2A|SDAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3290	110356	4191	-	MDH2	M-MDH|MDH|MGC:3559|MOR1	9606	Homo sapiens	unknown	target	Baeumchen C (2007)	17619232	173685	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3291	110356	4191	-	MDH2	M-MDH|MDH|MGC:3559|MOR1	9606	Homo sapiens	unknown	target	Markova EV (2006)	16898590	173735	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3292	110356	4191	-	MDH2	M-MDH|MDH|MGC:3559|MOR1	9606	Homo sapiens	unknown	target	Gallarta F (2007)	17203264	173754	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3293	110356	4191	-	MDH2	M-MDH|MDH|MGC:3559|MOR1	9606	Homo sapiens	unknown	target	Yennaco LJ (2007)	17487443	173753	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3294	110356	4191	-	MDH2	M-MDH|MDH|MGC:3559|MOR1	9606	Homo sapiens	unknown	target	Rzem R (2007)	17603759	173752	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3295	118962	29920	RP4-559A3.4	PYCR2	P5CR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3296	118962	29920	RP4-559A3.4	PYCR2	P5CR2	9606	Homo sapiens	unknown	target	Murahama M (2001)	11479381	173755	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3297	118962	29920	RP4-559A3.4	PYCR2	P5CR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3298	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3299	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3300	121231	56901	-	NDUFA4L2	NUOMS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3301	121231	56901	-	NDUFA4L2	NUOMS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3302	119131	50814	-	NSDHL	H105E3|SDR31E1|XAP104	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3303	119131	50814	-	NSDHL	H105E3|SDR31E1|XAP104	9606	Homo sapiens	unknown	target	Cunningham D (2005)	15805545	173756	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3304	119131	50814	-	NSDHL	H105E3|SDR31E1|XAP104	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3305	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Hermans JJ (1995)	8585102	173660	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3306	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Diederich S (1997)	9141556	173757	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3307	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3308	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3309	116081	10873	-	ME3	NADP-ME	9606	Homo sapiens	unknown	target	Rzem R (2007)	17603759	173752	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3310	116081	10873	-	ME3	NADP-ME	9606	Homo sapiens	unknown	target	Luo C (2006)	16740313	173759	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3311	116081	10873	-	ME3	NADP-ME	9606	Homo sapiens	unknown	target	Wei H (2006)	17080607	173758	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3312	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3313	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Auclair K (2003)	12699699	60080	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3314	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3315	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Calo LA (2003)	12897089	173760	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3316	110797	4717	-	NDUFC1	KFYI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3317	110797	4717	-	NDUFC1	KFYI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3318	108063	1717	-	DHCR7	SLOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3319	108063	1717	-	DHCR7	SLOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3320	109646	3420	RP4-686C3.2	IDH3B	H-IDHB|RP46	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3321	109646	3420	RP4-686C3.2	IDH3B	H-IDHB|RP46	9606	Homo sapiens	unknown	target	SANWAL BD (1964)	14189899	173662	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3322	109646	3420	RP4-686C3.2	IDH3B	H-IDHB|RP46	9606	Homo sapiens	unknown	target	Stein AM (1967)	4292141	173661	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3323	109646	3420	RP4-686C3.2	IDH3B	H-IDHB|RP46	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3324	109646	3420	RP4-686C3.2	IDH3B	H-IDHB|RP46	9606	Homo sapiens	unknown	target	Rose ZB (1966)	4380379	173663	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3325	110809	4731	-	NDUFV3	CI-10k|CI-9KD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3326	110809	4731	-	NDUFV3	CI-10k|CI-9KD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3327	110788	4708	-	NDUFB2	AGGG|CI-AGGG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3328	110788	4708	-	NDUFB2	AGGG|CI-AGGG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3329	109485	3248	-	HPGD	15-PGDH|PGDH|PGDH1|PHOAR1|SDR36C1	9606	Homo sapiens	unknown	target	Gao L (2007)	17463062	173761	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3330	110775	4695	-	NDUFA2	B8|CD14|CIB8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3331	110775	4695	-	NDUFA2	B8|CD14|CIB8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3332	110634	4538	-	ND4	MTND4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3333	110634	4538	-	ND4	MTND4	9606	Homo sapiens	unknown	target	Carper DA (1999)	9950599	173764	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3334	110634	4538	-	ND4	MTND4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3335	110634	4538	-	ND4	MTND4	9606	Homo sapiens	unknown	target	Dzelzkalns VA (1994)	7846157	173762	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3336	110634	4538	-	ND4	MTND4	9606	Homo sapiens	unknown	target	Shen XY (2004)	15560738	173763	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3337	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3338	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Wroczynski P (2006)	16583981	173765	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3339	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3340	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Russo J (2002)	11872149	173679	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3341	110803	4724	-	NDUFS4	AQDQ|CI-18	9606	Homo sapiens	unknown	target	Papa S (2002)	11860175	173766	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3342	110803	4724	-	NDUFS4	AQDQ|CI-18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3343	110803	4724	-	NDUFS4	AQDQ|CI-18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3344	110803	4724	-	NDUFS4	AQDQ|CI-18	9606	Homo sapiens	unknown	target	Raha S (2002)	11864782	173678	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3345	110803	4724	-	NDUFS4	AQDQ|CI-18	9606	Homo sapiens	unknown	target	Petruzzella V (2001)	11181577	173767	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3346	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3347	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3348	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Rizner TL (2003)	12810547	173768	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3349	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Trauger JW (2002)	12416991	173769	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3350	107951	1579	-	CYP4A11	CP4Y|CYP4A2|CYP4AII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3351	107951	1579	-	CYP4A11	CP4Y|CYP4A2|CYP4AII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3352	107951	1579	-	CYP4A11	CP4Y|CYP4A2|CYP4AII	9606	Homo sapiens	unknown	target	Ngo S (2000)	11246504	173770	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3353	110787	4707	-	NDUFB1	CI-MNLL|CI-SGDH|MNLL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3354	110787	4707	-	NDUFB1	CI-MNLL|CI-SGDH|MNLL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3355	109526	3293	RP11-240L7.3	HSD17B3	EDH17B3|SDR12C2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3356	109526	3293	RP11-240L7.3	HSD17B3	EDH17B3|SDR12C2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3357	109526	3293	RP11-240L7.3	HSD17B3	EDH17B3|SDR12C2	9606	Homo sapiens	unknown	target	Inano H (1975)	237755	173771	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3358	131889	374291	-	NDUFS7	CI-20|CI-20KD|MY017|PSST	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3359	131889	374291	-	NDUFS7	CI-20|CI-20KD|MY017|PSST	9606	Homo sapiens	unknown	target	Albracht SP (1993)	8369340	173774	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3360	131889	374291	-	NDUFS7	CI-20|CI-20KD|MY017|PSST	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3361	131889	374291	-	NDUFS7	CI-20|CI-20KD|MY017|PSST	9606	Homo sapiens	unknown	target	Hyslop SJ (1996)	8938450	173773	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3362	131889	374291	-	NDUFS7	CI-20|CI-20KD|MY017|PSST	9606	Homo sapiens	unknown	target	Schuler F (1999)	10097178	173772	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3363	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Quintanilla ME (2007)	17488809	173775	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3364	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Quintanilla ME (2006)	16961761	173776	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3365	106990	501	-	ALDH7A1	ATQ1|EPD|PDE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3366	106990	501	-	ALDH7A1	ATQ1|EPD|PDE	9606	Homo sapiens	unknown	target	de La Fuente JL (1997)	9355735	173777	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3367	106990	501	-	ALDH7A1	ATQ1|EPD|PDE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3368	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Vickers TJ (2006)	17032644	173779	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3369	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Argyrou A (2006)	17115689	173778	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3370	110807	4729	-	NDUFV2	CI-24k	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3371	110807	4729	-	NDUFV2	CI-24k	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3372	110807	4729	-	NDUFV2	CI-24k	9606	Homo sapiens	unknown	target	Paunesku T (2000)	10716640	50870	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3373	114208	8659	RP11-128M10.1	ALDH4A1	ALDH4|P5CD|P5CDh	9606	Homo sapiens	unknown	target	Inagaki E (2006)	16934832	173780	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3374	110796	4716	-	NDUFB10	PDSW	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3375	110796	4716	-	NDUFB10	PDSW	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3376	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3377	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3378	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Razeto A (2002)	12054772	173781	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3379	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Mdluli K (2005)	16198644	173782	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3380	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Clausen J (1969)	4303363	173783	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3381	109645	3419	-	IDH3A	-	9606	Homo sapiens	unknown	target	PLAUT GW (1954)	13152105	173784	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3382	109645	3419	-	IDH3A	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3383	109645	3419	-	IDH3A	-	9606	Homo sapiens	unknown	target	Stein AM (1967)	4292141	173661	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3384	109645	3419	-	IDH3A	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3385	109645	3419	-	IDH3A	-	9606	Homo sapiens	unknown	target	Rose ZB (1966)	4380379	173663	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3386	106772	275	-	AMT	GCE|GCST|GCVT|NKH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3387	106772	275	-	AMT	GCE|GCST|GCVT|NKH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3388	111188	5162	-	PDHB	PDHBD|PDHE1-B|PHE1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3389	111188	5162	-	PDHB	PDHBD|PDHE1-B|PHE1B	9606	Homo sapiens	unknown	target	Taylor SI (1975)	1116996	173785	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3390	111188	5162	-	PDHB	PDHBD|PDHE1-B|PHE1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3391	110355	4190	-	MDH1	HEL-S-32|MDH-s|MDHA|MGC:1375|MOR2	9606	Homo sapiens	unknown	target	Drew DP (2007)	16983536	173786	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3392	110805	4726	-	NDUFS6	CI-13kA|CI-13kD-A|CI13KDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3393	110805	4726	-	NDUFS6	CI-13kA|CI-13kD-A|CI13KDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3394	106720	218	-	ALDH3A1	ALDH3|ALDHIII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3395	106720	218	-	ALDH3A1	ALDH3|ALDHIII	9606	Homo sapiens	unknown	target	Wroczynski P (2006)	16583981	173765	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3396	106720	218	-	ALDH3A1	ALDH3|ALDHIII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3397	110632	4536	-	ND2	MTND2	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3398	110632	4536	-	ND2	MTND2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3399	110632	4536	-	ND2	MTND2	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3400	110632	4536	-	ND2	MTND2	9606	Homo sapiens	binder	target	Nikonova EV (2005)	15700717	173788	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3401	110632	4536	-	ND2	MTND2	9606	Homo sapiens	binder	target	Zhang HB (2003)	12882707	173787	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3402	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3403	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3404	110784	4704	-	NDUFA9	CC6|CI-39k|CI39k|NDUFS2L|SDR22E1	9606	Homo sapiens	unknown	target	Matsuzaki S (2007)	17260964	173793	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3405	110784	4704	-	NDUFA9	CC6|CI-39k|CI39k|NDUFS2L|SDR22E1	9606	Homo sapiens	unknown	target	Balaban RS (2006)	17132781	173792	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3406	110784	4704	-	NDUFA9	CC6|CI-39k|CI39k|NDUFS2L|SDR22E1	9606	Homo sapiens	unknown	target	Barker CD (2007)	17323923	173791	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3407	110784	4704	-	NDUFA9	CC6|CI-39k|CI39k|NDUFS2L|SDR22E1	9606	Homo sapiens	unknown	target	Fisher N (2007)	17499024	173790	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3408	110784	4704	-	NDUFA9	CC6|CI-39k|CI39k|NDUFS2L|SDR22E1	9606	Homo sapiens	unknown	target	Liu Y (2008)	17530440	173789	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3409	110140	3948	-	LDHC	CT32|LDH3|LDHX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3410	110140	3948	-	LDHC	CT32|LDH3|LDHX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3411	110140	3948	-	LDHC	CT32|LDH3|LDHX	9606	Homo sapiens	unknown	target	Spielmann H (1976)	182529	173796	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3412	110140	3948	-	LDHC	CT32|LDH3|LDHX	9606	Homo sapiens	unknown	target	Morris ID (1986)	3735252	173795	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3413	110140	3948	-	LDHC	CT32|LDH3|LDHX	9606	Homo sapiens	unknown	target	Gu Y (1989)	2751392	173794	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3414	108633	2350	-	FOLR2	BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3	9606	Homo sapiens	binder	target	Wlodarczyk BJ (2006)	16620997	173803	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3415	108633	2350	-	FOLR2	BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3	9606	Homo sapiens	binder	target	Boyles AL (2006)	17035141	173802	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3416	108633	2350	-	FOLR2	BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3417	108633	2350	-	FOLR2	BETA-HFR|FBP|FBP/PL-1|FR-BETA|FR-P3	9606	Homo sapiens	binder	target	Dixit V (2006)	16704197	173804	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3418	108635	2352	-	FOLR3	FR-G|FR-gamma|gamma-hFR	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3419	108635	2352	-	FOLR3	FR-G|FR-gamma|gamma-hFR	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3420	108635	2352	-	FOLR3	FR-G|FR-gamma|gamma-hFR	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3421	108635	2352	-	FOLR3	FR-G|FR-gamma|gamma-hFR	9606	Homo sapiens	binder	target	Shen F (1995)	7727426	173807	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3422	108635	2352	-	FOLR3	FR-G|FR-gamma|gamma-hFR	9606	Homo sapiens	binder	target	Shen F (1994)	8110752	173806	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3423	108635	2352	-	FOLR3	FR-G|FR-gamma|gamma-hFR	9606	Homo sapiens	binder	target	Prasad PD (1994)	8061055	173805	152	Folic Acid	Pteroyl-L-glutamate|PteGlu|PGA|Pteroyl-L-monoglutamic acid|Vitamin Bc|Pteroyl-L-glutamic acid|Folate|N-Pteroyl-L-glutamic acid|Pteroylglutamic acid|Vitamin B9|Folacin|N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid|Folsaeure|Folic acid|Vitamin M	vitamin b complex 100 tab|foli	DRUGBANK	DB00158	C19H19N7O6	small molecule	B03BB51|B03AE01|B03AE02|B03BB01	59-30-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVBPIULPVIDEAO-LBPRGKRZSA-N
3424	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Yang P (2004)	14993240	173821	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3425	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Machida T (2005)	16141635	173820	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3426	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lee JY (2003)	12562875	173822	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3427	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Vecchio AJ (2010)	20463020	173819	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3428	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	15990700	173594	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3429	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3430	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Malkowski MG (2001)	11477109	173593	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3431	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Engler MM (2000)	11026622	173823	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3432	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Watts JL (1999)	9917342	173825	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3433	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Navarro E (2000)	10685788	173824	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3434	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Barham JB (2000)	10917903	173827	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3435	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Chavali SR (1998)	9610840	173826	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3436	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Horia E (2007)	17052999	173829	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3437	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Ramakers JD (2007)	17610002	173828	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3438	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Selvaraj RK (2006)	16702329	173830	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3439	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chambrier C (2002)	12055328	173831	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3440	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Iwata Y (2001)	11552681	173832	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3441	109122	2864	-	FFAR1	FFA1R|GPCR40|GPR40	9606	Homo sapiens	agonist	target	Itoh Y (2005)	16214394	173833	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3442	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inducer	target	Heimli H (2003)	12784866	173834	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3443	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inducer	target	Covault J (2004)	15108178	173835	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3444	112436	6546	-	SLC8A1	NCX1	9606	Homo sapiens	inhibitor	target	Xiao YF (2004)	15358223	173836	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3445	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Iwata Y (2001)	11552681	173832	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3446	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Inoue I (1998)	9610365	173838	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3447	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Caldari-Torres C (2006)	16507691	173839	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3448	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Xu HE (1999)	10198642	173837	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3449	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Kondo H (2007)	17632107	173840	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3450	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	inducer	target	Matta JA (2007)	17038422	173841	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3451	108477	2181	-	ACSL3	ACS3|FACL3|PRO2194	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3452	108477	2181	-	ACSL3	ACS3|FACL3|PRO2194	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Machida T (2005)	16141635	173820	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee JY (2003)	12562875	173822	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3455	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chene G (2007)	17459764	173843	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3456	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vecchio AJ (2010)	20463020	173819	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3457	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3458	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ait-Said F (2003)	12573452	173842	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3459	121569	57505	RP11-444E17.1	AARS2	AARSL|COXPD8|LKENP|MT-ALARS|MTALARS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3460	121569	57505	RP11-444E17.1	AARS2	AARSL|COXPD8|LKENP|MT-ALARS|MTALARS	9606	Homo sapiens	unknown	target	McClain WH (1996)	8601277	173846	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3461	121569	57505	RP11-444E17.1	AARS2	AARSL|COXPD8|LKENP|MT-ALARS|MTALARS	9606	Homo sapiens	unknown	target	Buechter DD (1995)	7742303	173845	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3462	121569	57505	RP11-444E17.1	AARS2	AARSL|COXPD8|LKENP|MT-ALARS|MTALARS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3463	121569	57505	RP11-444E17.1	AARS2	AARSL|COXPD8|LKENP|MT-ALARS|MTALARS	9606	Homo sapiens	unknown	target	Nagan MC (2000)	10871402	173847	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3464	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3465	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3466	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Takada Y (1984)	6703688	172467	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3467	122342	64902	-	AGXT2	AGT2|DAIBAT	9606	Homo sapiens	unknown	target	Okuno E (1988)	2907870	173848	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3468	112400	6509	-	SLC1A4	ASCT1|SATT	9606	Homo sapiens	unknown	target	Wu Y (2007)	17195090	173850	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3469	112400	6509	-	SLC1A4	ASCT1|SATT	9606	Homo sapiens	unknown	target	Zhang Z (2007)	17237199	173851	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3470	112400	6509	-	SLC1A4	ASCT1|SATT	9606	Homo sapiens	unknown	target	Pinho MJ (2007)	17475673	173852	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3471	112400	6509	-	SLC1A4	ASCT1|SATT	9606	Homo sapiens	unknown	target	Zhang Z (2007)	17311416	173853	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3472	112400	6509	-	SLC1A4	ASCT1|SATT	9606	Homo sapiens	unknown	target	Takasaki C (2007)	17510490	173849	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3473	116996	23428	-	SLC7A8	LAT2|LPI-PC1	9606	Homo sapiens	unknown	target	Broeer S (2007)	17504263	173029	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3474	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3475	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Amadasi A (2007)	17504214	173854	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3476	124425	85007	PP9286	PHYKPL	AGXT2L2|PHLU	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3477	124425	85007	PP9286	PHYKPL	AGXT2L2|PHLU	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3478	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	unknown	target	Lima S (2007)	17300176	172555	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3479	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	unknown	target	Christensen M (2007)	17334708	173855	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3480	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Jadhao SB (2004)	15122758	173858	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3481	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3482	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3483	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Yang RZ (2002)	11863375	173856	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3484	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	unknown	target	Rajamohan F (2006)	16495081	173857	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3485	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3486	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Amoroso A (2001)	11562405	173859	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3487	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3488	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Pirulli D (1999)	10453743	173861	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3489	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Salido EC (2006)	17110443	173860	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3490	106534	16	-	AARS	CMT2N	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3491	106534	16	-	AARS	CMT2N	9606	Homo sapiens	unknown	target	McClain WH (1996)	8601277	173846	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3492	106534	16	-	AARS	CMT2N	9606	Homo sapiens	unknown	target	Buechter DD (1995)	7742303	173845	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3493	106534	16	-	AARS	CMT2N	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3494	106534	16	-	AARS	CMT2N	9606	Homo sapiens	unknown	target	Nagan MC (2000)	10871402	173847	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3495	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3496	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3497	128503	206358	-	SLC36A1	Dct1|LYAAT1|PAT1|TRAMD3	9606	Homo sapiens	unknown	target	Miyauchi S (2005)	16373326	173862	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3498	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	unknown	target	Miyashita Y (2007)	17319845	173865	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3499	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	unknown	target	Chen CH (2007)	17353078	173864	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3500	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	unknown	target	Gray S (2007)	17403374	173866	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3501	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	unknown	target	Taracha E (2006)	17163821	173863	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3502	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	Zeng J (2007)	17660944	173867	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3503	114516	9054	HUSSY-08	NFS1	IscS|NIFS	9606	Homo sapiens	unknown	target	You D (2007)	17469805	172587	154	L-Alanine	(S)-Alanine|Alanine|(S)-2-Aminopropanoic acid|L--alanine|(2S)-2-Aminopropanoic acid|ALA|L-2-Aminopropionic acid|L-alpha-Alanine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00160	C3H7NO2	small molecule	-	56-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAYBMKLOCPYGJ-RUOZJJLTNA-N
3504	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Saito M (2007)	17077963	173514	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3505	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Beck HC (2005)	15667998	173868	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3506	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Chen CD (2007)	17554170	173513	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3507	113250	7407	DAAP-21F2.2	VARS	G7A|VARS1|VARS2	9606	Homo sapiens	unknown	target	Zhu B (2007)	17095543	173521	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3508	113250	7407	DAAP-21F2.2	VARS	G7A|VARS1|VARS2	9606	Homo sapiens	unknown	target	Laforest MJ (2005)	15710393	173869	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3509	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3510	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3511	111129	5096	-	PCCB	-	9606	Homo sapiens	unknown	target	Kim SN (2002)	12409268	173870	155	L-Valine	(S)-Valine|Val|(2S)-2-Amino-3-methylbutanoic acid|L-(+)-alpha-Aminoisovaleric acid|L-alpha-Amino-beta-methylbutyric acid|2-Amino-3-methylbutyric acid|Valine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00161	C5H11NO2	small molecule	-	72-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KZSNJWFQEVHDMF-SGAVLPGINA-N
3512	111892	5959	-	RDH5	9cRDH|HSD17B9|RDH1|SDR9C5	9606	Homo sapiens	unknown	target	Gidlof AC (2006)	16837774	173874	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3513	111892	5959	-	RDH5	9cRDH|HSD17B9|RDH1|SDR9C5	9606	Homo sapiens	unknown	target	Dalfo D (2007)	17608724	173635	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3514	111892	5959	-	RDH5	9cRDH|HSD17B9|RDH1|SDR9C5	9606	Homo sapiens	unknown	target	Belyaeva OV (2006)	16860536	173872	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3515	111892	5959	-	RDH5	9cRDH|HSD17B9|RDH1|SDR9C5	9606	Homo sapiens	unknown	target	Zhang M (2007)	17435174	173873	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3516	111892	5959	-	RDH5	9cRDH|HSD17B9|RDH1|SDR9C5	9606	Homo sapiens	unknown	target	Maeda A (2006)	16566595	173871	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3517	111883	5949	-	RBP3	D10S64|D10S65|D10S66|IRBP|RBPI|RP66	9606	Homo sapiens	unknown	target	Qtaishat NM (2005)	15935345	173876	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3518	111883	5949	-	RBP3	D10S64|D10S65|D10S66|IRBP|RBPI|RP66	9606	Homo sapiens	unknown	target	Salvador-Silva M (2005)	15928609	173877	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3519	111883	5949	-	RBP3	D10S64|D10S65|D10S66|IRBP|RBPI|RP66	9606	Homo sapiens	unknown	target	Wu Q (2007)	17602665	173875	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3520	111883	5949	-	RBP3	D10S64|D10S65|D10S66|IRBP|RBPI|RP66	9606	Homo sapiens	unknown	target	Duncan T (2007)	17200663	173878	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3521	111883	5949	-	RBP3	D10S64|D10S65|D10S66|IRBP|RBPI|RP66	9606	Homo sapiens	unknown	target	Kolesnikov AV (2007)	17049961	173879	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3522	116107	10901	UNQ851/PRO1800	DHRS4	CR|NRDR|PHCR|PSCD|SCAD-SRL|SDR-SRL|SDR25C1|SDR25C2	9606	Homo sapiens	unknown	target	Du K (2007)	17534402	173880	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3523	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Szatmari I (2006)	16982809	173883	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3524	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Nakazawa N (2007)	17270546	173882	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3525	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Isken A (2007)	17098734	173881	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3526	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Halilagic A (2007)	17184764	119197	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3527	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Asson-Batres MA (2006)	16538685	173884	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3528	114658	9227	-	LRAT	LCA14	9606	Homo sapiens	unknown	target	Liu L (2005)	16174770	173886	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3529	114658	9227	-	LRAT	LCA14	9606	Homo sapiens	unknown	target	Kaschula CH (2006)	16054134	173885	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3530	119119	50700	-	RDH8	PRRDH|SDR28C2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3531	119119	50700	-	RDH8	PRRDH|SDR28C2	9606	Homo sapiens	unknown	target	Han W (2006)	17081426	173889	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3532	119119	50700	-	RDH8	PRRDH|SDR28C2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3533	119119	50700	-	RDH8	PRRDH|SDR28C2	9606	Homo sapiens	unknown	target	Han W (2003)	14661078	173887	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3534	119119	50700	-	RDH8	PRRDH|SDR28C2	9606	Homo sapiens	unknown	target	Fishman GA (2004)	14718298	173888	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3535	121698	57665	UNQ529/PRO1072	RDH14	PAN2|SDR7C4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3536	121698	57665	UNQ529/PRO1072	RDH14	PAN2|SDR7C4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3537	119298	51109	CGI-82	RDH11	ARSDR1|CGI82|HCBP12|MDT1|PSDR1|RALR1|RDJCSS|SCALD|SDR7C1	9606	Homo sapiens	unknown	target	Gallego O (2006)	16787387	173890	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3538	120232	54884	UNQ439/PRO872	RETSAT	-	9606	Homo sapiens	unknown	target	Moise AR (2007)	17253779	173891	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3539	111881	5947	-	RBP1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	9606	Homo sapiens	unknown	target	Quadro L (2005)	15994349	173894	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3540	111881	5947	-	RBP1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	9606	Homo sapiens	unknown	target	Yapi HF (2005)	15951260	173895	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3541	111881	5947	-	RBP1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	9606	Homo sapiens	unknown	target	Harrison EH (2005)	16011460	173896	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3542	111881	5947	-	RBP1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	9606	Homo sapiens	unknown	target	Paci E (2005)	16156801	173892	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3543	111881	5947	-	RBP1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	9606	Homo sapiens	unknown	target	Folli C (2005)	16157297	173893	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3544	114675	9249	RP11-514N2.1	DHRS3	DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3545	114675	9249	RP11-514N2.1	DHRS3	DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1	9606	Homo sapiens	unknown	target	Chai Z (2003)	12697717	173898	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3546	114675	9249	RP11-514N2.1	DHRS3	DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3547	114675	9249	RP11-514N2.1	DHRS3	DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1	9606	Homo sapiens	unknown	target	Haeseleer F (1998)	9705317	173897	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3548	114675	9249	RP11-514N2.1	DHRS3	DD83.1|RDH17|Rsdr1|SDR1|SDR16C1|retSDR1	9606	Homo sapiens	unknown	target	Cerignoli F (2002)	11861404	173899	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3549	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Nakazawa N (2007)	17270546	173882	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3550	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Maden M (2007)	17486539	173900	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3551	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Everts HB (2005)	15950969	173901	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3552	106722	220	RP11-66B24.1	ALDH1A3	ALDH1A6|ALDH6|MCOP8|RALDH3	9606	Homo sapiens	unknown	target	Halilagic A (2007)	17184764	119197	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3553	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Gyamfi MA (2006)	16829625	173902	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3554	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Huq MD (2006)	16763553	173903	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3555	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Maden M (2007)	17486539	173900	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3556	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Chambers D (2007)	17329364	173904	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3557	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Asson-Batres MA (2006)	16538685	173884	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3558	126895	145226	-	RDH12	LCA13|LCA3|RP53|SDR7C2	9606	Homo sapiens	unknown	target	Thompson DA (2005)	16269441	173906	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3559	126895	145226	-	RDH12	LCA13|LCA3|RP53|SDR7C2	9606	Homo sapiens	unknown	target	Maeda A (2006)	17032653	173907	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3560	126895	145226	-	RDH12	LCA13|LCA3|RP53|SDR7C2	9606	Homo sapiens	unknown	target	Keller B (2007)	17512723	173905	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3561	125200	112724	PSEC0082	RDH13	SDR7C3	9606	Homo sapiens	unknown	target	Keller B (2007)	17512723	173905	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3562	111949	6017	-	RLBP1	CRALBP	9606	Homo sapiens	unknown	target	Salvador-Silva M (2005)	15928609	173877	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3563	111949	6017	-	RLBP1	CRALBP	9606	Homo sapiens	unknown	target	Wenzel A (2007)	17251447	173908	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3564	111949	6017	-	RLBP1	CRALBP	9606	Homo sapiens	unknown	target	Muniz A (2006)	17014079	173909	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3565	111949	6017	-	RLBP1	CRALBP	9606	Homo sapiens	unknown	target	Vogel JS (2007)	17652763	173910	156	Vitamin A	Retinol|all-trans-retinol|(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol|Vitamin A1|all-trans-retinyl alcohol|all-trans-vitamin A alcohol	infant's multiple vitamin drop	DRUGBANK	DB00162	C20H30O	small molecule	A11CA01|R01AX02|S01XA02|D10AD02	68-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPIPGXGPPPQFEQ-OVSJKPMPSA-N
3566	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Rabovsky A (2006)	16603143	173919	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3567	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Meijerman I (2006)	16880233	173920	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3568	117085	23541	-	SEC14L2	C22orf6|SPF|TAP|TAP1	9606	Homo sapiens	unknown	target	Ni J (2007)	17252538	173921	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3569	117085	23541	-	SEC14L2	C22orf6|SPF|TAP|TAP1	9606	Homo sapiens	unknown	target	Neuzil J (2006)	16579965	173922	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3570	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Ganz MB (2000)	10644549	173924	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3571	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3572	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3573	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Wigg SJ (2004)	15184978	173925	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3574	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Huang Y (2002)	11850093	173923	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3575	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3576	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Sylvester PW (2001)	11736999	173926	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3577	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3578	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Azzi A (1997)	9430404	173927	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3579	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	Huang Y (2002)	11850093	173923	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3580	111508	5516	-	PPP2CB	PP2Abeta|PP2CB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3581	111508	5516	-	PPP2CB	PP2Abeta|PP2CB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3582	107976	1606	-	DGKA	DAGK|DAGK1|DGK-alpha	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3583	107976	1606	-	DGKA	DAGK|DAGK1|DGK-alpha	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3584	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Taccone-Gallucci M (2006)	16531984	173928	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3585	129297	266629	-	SEC14L3	TAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3586	129297	266629	-	SEC14L3	TAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3587	129297	266629	-	SEC14L3	TAP2	9606	Homo sapiens	unknown	target	Ye X (2004)	15040456	173929	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3588	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3589	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3590	129974	284904	-	SEC14L4	TAP3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3591	129974	284904	-	SEC14L4	TAP3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3592	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	ligand	target	Kim SY (2006)	16466641	172478	158	Pyridoxine	2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol	pyridoxine-s tab 50mg|vitamin 	DRUGBANK	DB00165	C8H11NO3	small molecule	A11HA02	65-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXNHXLLTXMVWPM-UHFFFAOYSA-N
3593	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	ligand	target	Newman JA (2006)	16978644	173493	158	Pyridoxine	2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol	pyridoxine-s tab 50mg|vitamin 	DRUGBANK	DB00165	C8H11NO3	small molecule	A11HA02	65-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXNHXLLTXMVWPM-UHFFFAOYSA-N
3594	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	ligand	target	Adams JB (2006)	16494569	173494	158	Pyridoxine	2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol	pyridoxine-s tab 50mg|vitamin 	DRUGBANK	DB00165	C8H11NO3	small molecule	A11HA02	65-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXNHXLLTXMVWPM-UHFFFAOYSA-N
3595	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	ligand	target	Nagahashi Y (2008)	18256491	173934	158	Pyridoxine	2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine|Pyridoxol|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Vitamin B6|Pyridoxine|3-Hydroxy-4,5-dimethylol-alpha-picoline|5-Hydroxy-6-methyl-3,4-pyridinedimethanol	pyridoxine-s tab 50mg|vitamin 	DRUGBANK	DB00165	C8H11NO3	small molecule	A11HA02	65-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXNHXLLTXMVWPM-UHFFFAOYSA-N
3596	116209	11019	HUSSY-01	LIAS	LAS|LIP1|LS|PDHLD	9606	Homo sapiens	unknown	target	Yasuno R (1998)	9808738	46858	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3597	116209	11019	HUSSY-01	LIAS	LAS|LIP1|LS|PDHLD	9606	Homo sapiens	unknown	target	Morikawa T (2001)	11389890	119780	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3598	116209	11019	HUSSY-01	LIAS	LAS|LIP1|LS|PDHLD	9606	Homo sapiens	unknown	target	Wrenger C (2004)	15225307	173938	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3599	116209	11019	HUSSY-01	LIAS	LAS|LIP1|LS|PDHLD	9606	Homo sapiens	unknown	target	Ollagnier-de Choudens S (1999)	10403368	173937	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3600	116209	11019	HUSSY-01	LIAS	LAS|LIP1|LS|PDHLD	9606	Homo sapiens	unknown	target	Guenther S (2005)	16246025	173936	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3601	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Griffin JB (2002)	12214555	173939	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3602	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Dey S (2002)	11955628	173940	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3603	114403	8884	-	SLC5A6	SMVT	9606	Homo sapiens	unknown	target	Prasad PD (1999)	10334869	173941	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3604	119630	51601	-	LIPT1	-	9606	Homo sapiens	unknown	target	Gueguen V (1999)	10473591	173944	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3605	119630	51601	-	LIPT1	-	9606	Homo sapiens	unknown	target	Macherel D (1996)	8617275	173945	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3606	119630	51601	-	LIPT1	-	9606	Homo sapiens	unknown	target	Fujiwara K (2007)	17570395	173942	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3607	119630	51601	-	LIPT1	-	9606	Homo sapiens	unknown	target	Guenther S (2005)	16246025	173936	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3608	119630	51601	-	LIPT1	-	9606	Homo sapiens	unknown	target	Fujiwara K (2005)	16043486	173943	159	Lipoic Acid	Biletan|Acetate-replacing factor|6-thioctic acid|5-[3-(1,2-dithiolanyl)]pentanoic acid|Thioctansure|6,8-thiotic acid|5-(dithiolan-3-yl)valeric acid|liponic acid|6,8-thioctic acid|1,2-dithiolane-3-valeric acid|alpha-Liponsure|Thioctsure|5-(1,2-dithiolan-3-yl)valeric acid|-lipoic acid|Thioktsure|Thioctic acid|alpha-Lipoic acid|6-thiotic acid|1,2-dithiolane-3-pentanoic acid	strovite one caplets	DRUGBANK	DB00166	C8H14O2S2	small molecule	A16AX01	62-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGBQKNBQESQNJD-UHFFFAOYSA-N
3609	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Berger BJ (2003)	12670965	173519	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3610	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Beck HC (2005)	15667998	173868	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3611	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Goto M (2003)	12667063	173951	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3612	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Madsen SM (2002)	12147502	173950	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3613	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Chen CD (2007)	17554170	173513	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3614	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Thage BV (2004)	14962140	173949	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3615	109605	3376	RP11-62C3.1	IARS	IARS1|ILERS|ILRS|IRS|PRO0785	9606	Homo sapiens	unknown	target	Wang P (2003)	12783542	173955	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3616	109605	3376	RP11-62C3.1	IARS	IARS1|ILERS|ILRS|IRS|PRO0785	9606	Homo sapiens	unknown	target	Fukunaga R (2004)	14672940	173954	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3617	109605	3376	RP11-62C3.1	IARS	IARS1|ILERS|ILRS|IRS|PRO0785	9606	Homo sapiens	unknown	target	Mock ML (2006)	16397872	173956	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3618	109605	3376	RP11-62C3.1	IARS	IARS1|ILERS|ILRS|IRS|PRO0785	9606	Homo sapiens	unknown	target	Pezo V (2004)	15163798	173953	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3619	109605	3376	RP11-62C3.1	IARS	IARS1|ILERS|ILRS|IRS|PRO0785	9606	Homo sapiens	unknown	target	Crasto CF (2003)	12788342	173952	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3620	106554	36	RP11-162A23.1	ACADSB	2-MEBCAD|ACAD7|SBCAD	9606	Homo sapiens	unknown	target	Korman SH (2006)	16950638	173957	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3621	106554	36	RP11-162A23.1	ACADSB	2-MEBCAD|ACAD7|SBCAD	9606	Homo sapiens	unknown	target	Madsen PP (2006)	16317551	173959	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3622	106554	36	RP11-162A23.1	ACADSB	2-MEBCAD|ACAD7|SBCAD	9606	Homo sapiens	unknown	target	Korman SH (2005)	15615815	173958	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3623	120824	55699	-	IARS2	ILERS	9606	Homo sapiens	unknown	target	Fukunaga R (2006)	16697013	173960	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3624	120824	55699	-	IARS2	ILERS	9606	Homo sapiens	unknown	target	Zhu B (2007)	17095543	173521	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3625	120824	55699	-	IARS2	ILERS	9606	Homo sapiens	unknown	target	Fukunaga R (2005)	15663927	173961	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3626	120824	55699	-	IARS2	ILERS	9606	Homo sapiens	unknown	target	Wang P (2003)	12783542	173955	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3627	120824	55699	-	IARS2	ILERS	9606	Homo sapiens	unknown	target	Fukunaga R (2004)	14672940	173954	160	L-Isoleucine	Ile|alpha-amino-beta-methylvaleric acid|I|-amino--methylvaleric acid|L-Isoleucine|2-Amino-3-methylvaleric acid|(2S,3S)-2-Amino-3-methylpentanoic acid|Isoleucine	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00167	C6H13NO2	small molecule	-	73-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGPKZVBTJJNPAG-WHFBIAKZSA-N
3628	123327	80834	-	TAS1R2	GPR71|T1R2|TR2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	161	Aspartame	Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame	-	DRUGBANK	DB00168	C14H18N2O5	small molecule	-	22839-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAOZJIPTCAWIRG-QWRGUYRKSA-N
3629	123327	80834	-	TAS1R2	GPR71|T1R2|TR2	9606	Homo sapiens	agonist	target	Cui M (2006)	17168764	173962	161	Aspartame	Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame	-	DRUGBANK	DB00168	C14H18N2O5	small molecule	-	22839-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAOZJIPTCAWIRG-QWRGUYRKSA-N
3630	123327	80834	-	TAS1R2	GPR71|T1R2|TR2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	161	Aspartame	Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame	-	DRUGBANK	DB00168	C14H18N2O5	small molecule	-	22839-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAOZJIPTCAWIRG-QWRGUYRKSA-N
3631	123327	80834	-	TAS1R2	GPR71|T1R2|TR2	9606	Homo sapiens	agonist	target	Xu H (2004)	15353592	173963	161	Aspartame	Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame	-	DRUGBANK	DB00168	C14H18N2O5	small molecule	-	22839-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAOZJIPTCAWIRG-QWRGUYRKSA-N
3632	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	inducer	target	Riera CE (2007)	17567713	173964	161	Aspartame	Asp-phe-ome|Aspartamum|3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester|3-Amino-N-(-carboxyphenethyl)succinamic acid N-methyl ester|1-methyl N-L--aspartyl-L-phenylalanate|Aspartamo|1-Methyl N-L-alpha-aspartyl-L-phenylalanine|Aspartylphenylalanine methyl ester|Aspartam|L-Aspartyl-L-phenylalanine methyl ester|3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid|1-Methyl N-L-alpha-aspartyl-L-phenylalanate|3-Amino-N-(-methoxycarbonylphenethyl) succinamic acid|Aspartame	-	DRUGBANK	DB00168	C14H18N2O5	small molecule	-	22839-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAOZJIPTCAWIRG-QWRGUYRKSA-N
3633	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Fujishima T (2010)	20435140	173968	162	Cholecalciferol	(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Activated 7-dehydrocholesterol|Vitamin D3|Oleovitamin D3|(+)-vitamin D3|CC|Cholecalciferol|delta-D|(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol|calciol|Colecalciferol|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol	port a mins super calcium 750 	DRUGBANK	DB00169	C27H44O	small molecule	M05BX53|A11CC05|M05BB03|M05BB07|M05BB05|M05BB04|M05BB08	67-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSXJUFSXHHAJI-YRZJJWOYSA-N
3634	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	162	Cholecalciferol	(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Activated 7-dehydrocholesterol|Vitamin D3|Oleovitamin D3|(+)-vitamin D3|CC|Cholecalciferol|delta-D|(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol|calciol|Colecalciferol|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol	port a mins super calcium 750 	DRUGBANK	DB00169	C27H44O	small molecule	M05BX53|A11CC05|M05BB03|M05BB07|M05BB05|M05BB04|M05BB08	67-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSXJUFSXHHAJI-YRZJJWOYSA-N
3635	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Reinhart GA (2004)	15503649	173130	162	Cholecalciferol	(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol|Activated 7-dehydrocholesterol|Vitamin D3|Oleovitamin D3|(+)-vitamin D3|CC|Cholecalciferol|delta-D|(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol|calciol|Colecalciferol|(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol	port a mins super calcium 750 	DRUGBANK	DB00169	C27H44O	small molecule	M05BX53|A11CC05|M05BB03|M05BB07|M05BB05|M05BB04|M05BB08	67-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSXJUFSXHHAJI-YRZJJWOYSA-N
3636	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Foster CE (1999)	10433694	173988	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3637	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Boutin JA (2005)	15733542	173989	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3638	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Celli CM (2006)	16765324	173986	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3639	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Long DJ (2002)	12351651	173987	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3640	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Kwiek JJ (2004)	15078100	173985	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3641	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3642	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	activator	target	Milgrom E (2007)	17215245	72606	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3643	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3644	108456	2158	RP6-88D7.1	F9	FIX|HEMB|P19|PTC|THPH8	9606	Homo sapiens	activator	target	Berkessel A (2007)	17348045	173990	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3645	127558	154807	-	VKORC1L1	-	9606	Homo sapiens	cofactor	target	Stafford DW (2005)	16102054	173991	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3646	127558	154807	-	VKORC1L1	-	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3647	127558	154807	-	VKORC1L1	-	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3648	127558	154807	-	VKORC1L1	-	9606	Homo sapiens	cofactor	target	Oldenburg J (2006)	16677080	173992	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3649	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	cofactor	target	Stafford DW (2005)	16102054	173991	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3650	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3651	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3652	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	cofactor	target	Oldenburg J (2006)	16677080	173992	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3653	114382	8858	-	PROZ	PZ	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3654	114382	8858	-	PROZ	PZ	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3655	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3656	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3657	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	agonist	target	Price PA (1988)	3060178	173993	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3658	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	activator	target	Chai YC (1994)	8161215	173995	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3659	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	activator	target	Mallis RJ (2002)	12033454	173994	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3660	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Kishi T (2002)	12069105	173999	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3661	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Ip SP (2000)	10939639	173998	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3662	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Munday R (1999)	10654840	174000	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3663	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Munday R (1999)	10190578	173997	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3664	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Chiou TJ (1999)	10614691	173996	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3665	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Wang Z (1995)	7657295	174004	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3666	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	McCarthy DJ (1989)	2922761	174005	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3667	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Szejtli J (1983)	6867080	174002	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3668	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Lee SK (1999)	10469489	174003	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3669	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	activator	target	Casper HH (1989)	2484931	174001	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3670	108453	2155	-	F7	SPCA	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3671	108453	2155	-	F7	SPCA	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3672	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	cofactor	target	Presnell SR (2002)	12083499	174006	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3673	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	cofactor	target	Stafford DW (2005)	16102054	173991	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3674	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	cofactor	target	Wang Z (1995)	7657295	174004	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
3675	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3676	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3677	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3678	106864	369	RP1-230G1.1	ARAF	A-RAF|ARAF1|PKS2|RAFA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3679	106864	369	RP1-230G1.1	ARAF	A-RAF|ARAF1|PKS2|RAFA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3680	122381	65061	-	CDK15	ALS2CR7|PFTAIRE2|PFTK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3681	122381	65061	-	CDK15	ALS2CR7|PFTAIRE2|PFTK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3682	106665	156	-	ADRBK1	BARK1|BETA-ARK1|GRK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3683	106665	156	-	ADRBK1	BARK1|BETA-ARK1|GRK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3684	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3685	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3686	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3687	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3688	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3689	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Blume H (2006)	16944963	174014	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3690	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Fukui N (2007)	17417072	174011	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3691	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Gardner ER (2006)	16890580	174010	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3692	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Lage H (2006)	16842213	174013	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3693	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Gervasini G (2006)	17120199	174012	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3694	106609	94	-	ACVRL1	ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3695	106609	94	-	ACVRL1	ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3696	116139	10939	-	AFG3L2	SCA28|SPAX5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3697	116139	10939	-	AFG3L2	SCA28|SPAX5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3698	106606	91	-	ACVR1B	ACTRIB|ACVRLK4|ALK4|SKR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3699	106606	91	-	ACVR1B	ACTRIB|ACVRLK4|ALK4|SKR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3700	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3701	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3702	106814	317	-	APAF1	APAF-1|CED4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3703	106814	317	-	APAF1	APAF-1|CED4	9606	Homo sapiens	unknown	target	Chinnaiyan AM (1999)	10935465	174015	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3704	106814	317	-	APAF1	APAF-1|CED4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3705	106621	107	-	ADCY1	AC1|DFNB44	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3706	106621	107	-	ADCY1	AC1|DFNB44	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3707	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	unknown	target	Starai VJ (2002)	12493915	174016	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3708	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3709	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	unknown	target	Schuler AJ (2004)	14704009	174017	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3710	120989	55902	RP5-1161H23.2	ACSS2	ACAS2|ACECS|ACS|ACSA|dJ1161H23.1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3711	114199	8647	-	ABCB11	ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP	9606	Homo sapiens	unknown	target	Snow KL (2007)	17126857	174019	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3712	114199	8647	-	ABCB11	ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP	9606	Homo sapiens	unknown	target	Suchy FJ (2006)	16819395	174018	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3713	116627	22978	RP11-30H12.3	NT5C2	GMP|NT5B|PNT5|SPG45|SPG65|cN-II	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3714	116627	22978	RP11-30H12.3	NT5C2	GMP|NT5B|PNT5|SPG45|SPG65|cN-II	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3715	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	unknown	target	Zhao JL (2006)	16845255	174020	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3716	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	unknown	target	Yang YJ (2007)	16829188	174021	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3717	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	unknown	target	Bryan J (2007)	16897043	174022	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3718	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3719	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3720	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	unknown	target	Zarubica A (2007)	16858612	174023	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3721	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	unknown	target	Porchay I (2006)	17135600	174024	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3722	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	unknown	target	Badeau R (2007)	17224860	174025	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3723	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	unknown	target	Nakamura A (2007)	17325510	174028	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3724	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	unknown	target	Bryan J (2007)	16897043	174022	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3725	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	unknown	target	Tanaka K (2007)	17457130	174026	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3726	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	unknown	target	Bienengraeber M (2006)	16931986	174027	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3727	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Van Meter TE (2006)	17041888	174029	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3728	106666	157	-	ADRBK2	BARK2|GRK3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3729	106666	157	-	ADRBK2	BARK2|GRK3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3730	106605	90	-	ACVR1	ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3731	106605	90	-	ACVR1	ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3732	114980	9619	-	ABCG1	ABC8|WHITE1	9606	Homo sapiens	unknown	target	Lage H (2006)	16842213	174013	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3733	114980	9619	-	ABCG1	ABC8|WHITE1	9606	Homo sapiens	unknown	target	Materna V (2006)	16876126	174033	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3734	114980	9619	-	ABCG1	ABC8|WHITE1	9606	Homo sapiens	unknown	target	Pinkett HW (2007)	17158291	174032	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3735	114980	9619	-	ABCG1	ABC8|WHITE1	9606	Homo sapiens	unknown	target	Girardin F (2006)	17117613	174031	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3736	114980	9619	-	ABCG1	ABC8|WHITE1	9606	Homo sapiens	unknown	target	Thomas AC (2006)	16902423	174030	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3737	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	unknown	target	Li GX (2007)	17467962	174035	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3738	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	unknown	target	Rau T (2006)	17112803	174034	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3739	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	unknown	target	Materna V (2006)	16876126	174033	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3740	124122	84532	RP4-568C11.1	ACSS1	ACAS2L|ACECS1|AceCS2L	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3741	124122	84532	RP4-568C11.1	ACSS1	ACAS2L|ACECS1|AceCS2L	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3742	106931	439	-	ASNA1	ARSA-I|ARSA1|ASNA-I|GET3|TRC40|hASNA-I	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3743	106931	439	-	ASNA1	ARSA-I|ARSA1|ASNA-I|GET3|TRC40|hASNA-I	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3744	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Walther T (2007)	17210842	174036	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3745	108476	2180	-	ACSL1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3746	108476	2180	-	ACSL1	ACS1|FACL1|FACL2|LACS|LACS1|LACS2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3747	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3748	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3749	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3750	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3751	106766	269	-	AMHR2	AMHR|MISR2|MISRII|MRII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3752	106766	269	-	AMHR2	AMHR|MISR2|MISRII|MRII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3753	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3754	106937	445	RP11-618A20.2	ASS1	ASS|CTLN1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3755	122418	65263	-	PYCRL	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3756	122418	65263	-	PYCRL	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3757	122418	65263	-	PYCRL	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3758	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3759	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3760	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3761	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3762	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3763	114464	8974	UNQ290/PRO330	P4HA2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3764	114464	8974	UNQ290/PRO330	P4HA2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3765	111789	5831	-	PYCR1	ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR	9606	Homo sapiens	unknown	target	Hu CA (2007)	16874462	174037	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3766	111789	5831	-	PYCR1	ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR	9606	Homo sapiens	unknown	target	Huang TC (2007)	17536821	174039	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3767	111789	5831	-	PYCR1	ARCL2B|ARCL3B|P5C|P5CR|PIG45|PP222|PRO3|PYCR	9606	Homo sapiens	unknown	target	Meng Z (2006)	16600630	174038	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3768	111609	5625	-	PRODH	HSPOX2|PIG6|POX|PRODH1|PRODH2|TP53I6	9606	Homo sapiens	unknown	target	White TA (2005)	16511143	174040	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3769	111609	5625	-	PRODH	HSPOX2|PIG6|POX|PRODH1|PRODH2|TP53I6	9606	Homo sapiens	unknown	target	White TA (2007)	17344208	174041	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3770	111609	5625	-	PRODH	HSPOX2|PIG6|POX|PRODH1|PRODH2|TP53I6	9606	Homo sapiens	unknown	target	Huang TC (2007)	17536821	174039	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3771	115728	10465	-	PPIH	CYP-20|CYPH|SnuCyp-20|USA-CYP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3772	115728	10465	-	PPIH	CYP-20|CYPH|SnuCyp-20|USA-CYP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3773	111475	5479	-	PPIB	CYP-S1|CYPB|HEL-S-39|OI9|SCYLP	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3774	111475	5479	-	PPIB	CYP-S1|CYPB|HEL-S-39|OI9|SCYLP	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3775	111475	5479	-	PPIB	CYP-S1|CYPB|HEL-S-39|OI9|SCYLP	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3776	111476	5480	-	PPIC	CYPC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3777	111476	5480	-	PPIC	CYPC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3778	114761	9360	-	PPIG	CARS-Cyp|CYP|SCAF10|SRCyp	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3779	114761	9360	-	PPIG	CARS-Cyp|CYP|SCAF10|SRCyp	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3780	118962	29920	RP4-559A3.4	PYCR2	P5CR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3781	118962	29920	RP4-559A3.4	PYCR2	P5CR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3782	117457	25973	-	PARS2	MT-PRORS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3783	117457	25973	-	PARS2	MT-PRORS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3784	125210	112849	-	L3HYPDH	C14orf149	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3785	125210	112849	-	L3HYPDH	C14orf149	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3786	112425	6534	-	SLC6A7	PROT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3787	112425	6534	-	SLC6A7	PROT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3788	118962	29920	RP4-559A3.4	PYCR2	P5CR2	9606	Homo sapiens	unknown	target	Murahama M (2001)	11479381	173755	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3789	116415	11254	RP3-452H17.1	SLC6A14	BMIQ11	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3790	116415	11254	RP3-452H17.1	SLC6A14	BMIQ11	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3791	115411	10105	RP11-342M3.4	PPIF	CYP3|CyP-M|Cyp-D|CypD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3792	115411	10105	RP11-342M3.4	PPIF	CYP3|CyP-M|Cyp-D|CypD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3793	122098	64175	PSEC0109	P3H1	GROS1|LEPRE1|OI8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3794	122098	64175	PSEC0109	P3H1	GROS1|LEPRE1|OI8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3795	120510	55214	-	P3H2	LEPREL1|MCVD|MLAT4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3796	120510	55214	-	P3H2	LEPREL1|MCVD|MLAT4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3797	116381	11212	-	PROSC	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3798	116381	11212	-	PROSC	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3799	115790	10536	-	LEPREL2	GRCB|HSU47926|P3H3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3800	115790	10536	-	LEPREL2	GRCB|HSU47926|P3H3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3801	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3802	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	165	L-Proline	(2S)-Pyrrolidine-2-carboxylic acid|(-)-(S)-Proline|2-Pyrrolidinecarboxylic acid|L-pyrrolidine-2-carboxylic acid|P|L--pyrrolidinecarboxylic acid|(-)-2-Pyrrolidinecarboxylic acid|(S)-2-Pyrrolidinecarboxylic acid|L-Prolin|L-(-)-Proline|Prolina|()-(S)-proline|L-alpha-pyrrolidinecarboxylic acid|(-)-Proline|Prolinum|(S)-Pyrrolidine-2-carboxylic acid|()-proline|L-Proline|(S)-2-Carboxypyrrolidine|PROLINE|()-2-pyrrolidinecarboxylic acid	freamine iii|primene 10%|2.5% 	DRUGBANK	DB00172	C5H9NO2	small molecule	-	147-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIBWKKTOPOVIA-BYPYZUCNSA-N
3803	112611	6733	-	SRPK2	SFRSK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3804	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Boitz JM (2006)	16597468	174046	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3805	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Di Pietro V (2007)	17126311	174047	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3806	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Katahira R (2006)	17064924	174044	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3807	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Katahira R (2006)	16845529	174045	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3808	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Barrett C (2006)	17199504	173062	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3809	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3810	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Witters LA (1987)	2880560	174050	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3811	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3812	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3813	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Rasmussen JT (1993)	8318018	174048	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3814	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Itani SI (2003)	12829626	174049	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3815	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3816	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3817	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3818	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3819	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Wang S (2000)	10684601	50701	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3820	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Magherini F (2004)	15358193	20131	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3821	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Ostanin K (1995)	7629177	33867	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3822	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Singh V (2006)	17090056	174051	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3823	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Chow WA (2006)	16631464	174053	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3824	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Chattopadhyay S (2006)	17041099	174052	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3825	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3826	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Singh V (2005)	16128565	174058	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3827	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3828	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Walker RD (1975)	1125818	174059	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3829	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Singh V (2007)	17298059	174057	166	Adenine	A|6-Aminopurine|ADENINE|Adenin|Ade|Vitamin B4	nutricel additive system - as3	DRUGBANK	DB00173	C5H5N5	small molecule	-	73-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFFGJBXGBJISGV-UHFFFAOYSA-N
3830	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Al Sarraj J (2005)	16164412	172990	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3831	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Chaffei C (2004)	15574844	174064	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3832	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Iwamoto S (2007)	17380207	174061	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3833	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Fresquet V (2004)	14990305	174062	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3834	106932	440	-	ASNS	ASNSD|TS11	9606	Homo sapiens	unknown	target	Tesson AR (2003)	12706338	174063	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3835	122846	79731	-	NARS2	SLM5|asnRS	9606	Homo sapiens	unknown	target	Iwasaki W (2006)	16753178	174065	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3836	122846	79731	-	NARS2	SLM5|asnRS	9606	Homo sapiens	unknown	target	Roy H (2003)	12874385	174066	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3837	112401	6510	-	SLC1A5	AAAT|ASCT2|ATBO|M7V1|M7VS1|R16|RDRC	9606	Homo sapiens	unknown	target	Oppedisano F (2004)	15581847	174067	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3838	112401	6510	-	SLC1A5	AAAT|ASCT2|ATBO|M7V1|M7VS1|R16|RDRC	9606	Homo sapiens	unknown	target	Dun Y (2007)	17094966	173025	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3839	116187	10991	-	SLC38A3	G17|NAT1|SN1|SNAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3840	116187	10991	-	SLC38A3	G17|NAT1|SN1|SNAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3841	123142	80150	-	ASRGL1	ALP|ALP1|CRASH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3842	123142	80150	-	ASRGL1	ALP|ALP1|CRASH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3843	110758	4677	-	NARS	ASNRS|NARS1	9606	Homo sapiens	unknown	target	Iwasaki W (2006)	16753178	174065	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3844	110758	4677	-	NARS	ASNRS|NARS1	9606	Homo sapiens	unknown	target	Iwamoto S (2007)	17380207	174061	167	L-Asparagine	(S)-Asparagine|alpha-aminosuccinamic acid|-aminosuccinamic acid|Asparagine|(2S)-2,4-diamino-4-oxobutanoic acid|(2S)-2-amino-3-carbamoylpropanoic acid|(S)-2-amino-3-carbamoylpropanoic acid|L-aspartic acid -amide|N|L-Asparagin|L-aspartic acid beta-amide|Aspartamic acid|L-Asparagine|2-Aminosuccinamic acid|L-2-aminosuccinamic acid|Asn	-	DRUGBANK	DB00174	C4H8N2O3	small molecule	-	70-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCXYFEDJOCDNAF-REOHCLBHSA-N
3845	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	168	Pravastatin	Pravastatina|Pravastatinum|Pravastatin acid|(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid|Pravastatine	pravachol - tab 20mg|ach-prava	DRUGBANK	DB00175	C23H36O7	small molecule	C10BA03|C10BX02|C10AA03	81093-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUZYXOIXSAXUGO-PZAWKZKUSA-N
3846	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Miolo G (2002)	12208313	174086	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3847	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	McMahon LR (2001)	11166521	174087	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3848	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Yoshida K (2002)	11817517	174084	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3849	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Millan MJ (2003)	12721776	174085	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3850	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Williams K (2010)	20687077	174091	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3851	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Dell'Osso B (2005)	16316311	174090	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3852	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Kakiuchi T (2001)	11304754	174093	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3853	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Suhara T (2003)	12695316	174092	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3854	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Irons J (2005)	18568110	174088	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3855	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Inoue K (2004)	15170064	174089	169	Fluvoxamine	Fluvoxamine|Fluvoxamina|Fluvoxaminum	fluvoxamine-50|fluvoxamine mal	DRUGBANK	DB00176	C15H21F3N2O2	small molecule	N06AB08	54739-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJOFXWAVKWHTFT-XSFVSMFZSA-N
3856	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Criscione L (1993)	8242249	174107	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3857	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	de Gasparo M (1995)	8577935	174106	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3858	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Azizi M (2004)	15579516	174105	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3859	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Shargorodsky M (2002)	12460705	174104	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3860	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3861	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Siragy HM (2002)	12023686	174108	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3862	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3863	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Levitt DG (2006)	16398929	174113	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3864	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3865	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3866	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3867	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Lambert JD (2001)	11318430	174118	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3868	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	West M (2004)	15379894	174119	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3869	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Jeon SB (2005)	15694390	174121	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3870	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Azadzoi KM (2004)	15098224	174120	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3871	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Audouin C (2001)	11277534	174117	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3872	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3873	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hochhaus G (1990)	2386110	174125	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3874	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hoegger P (1998)	9523318	174124	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3875	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Philibert D (1993)	8466638	174127	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3876	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Valotis A (2004)	15285788	174126	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3877	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Johnson M (1998)	9563368	174123	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3878	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Badia L (2001)	11368283	174122	173	Flunisolide	Flunisolide|Flunisolida|Flunisolide anhydrous|Flunisolidum	flunisolide|pms-flunisolide|no	DRUGBANK	DB00180	C24H31FO6	small molecule	R03BA03|R01AD04	3385-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSFJVAJPIHIPKU-XWCQMRHXSA-N
3879	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3880	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Belley M (1999)	10658574	174128	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3881	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3882	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Martin SC (1999)	10328880	174135	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3883	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Jones KA (2000)	11008066	174132	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3884	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3885	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Filippov AK (2000)	10751439	174130	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3886	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Braun M (2004)	15235087	174131	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3887	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3888	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Stringer JL (1999)	10094428	174140	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3889	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3890	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Motalli R (1999)	10444662	174138	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3891	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Ogasawara T (1999)	10494996	174139	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3892	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Mott DD (1999)	10482760	174136	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3893	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Garcia-Gil L (1999)	10386831	174137	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3894	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3895	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	174	Baclofen	beta-(4-Chlorophenyl)gaba|DL-Baclofen|DL-4-Amino-3-P-chlorophenylbutanoic acid|beta-(P-Chlorophenyl)-gamma-aminobutyric acid|gamma-Amino-beta-(P-chlorophenyl)butyric acid|4-Amino-3-(4-chlorophenyl)butyric acid|Baclofene|Baclofeno|beta-(Aminomethyl)-4-chlorobenzenepropanoic acid|Baclofenum|beta-(Aminomethyl)-P-chlorohydrocinnamic acid|(+-)-Baclofen	lioresal intrathecal 2mg/ml|ri	DRUGBANK	DB00181	C10H12ClNO2	small molecule	M03BX01	1134-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPYSYYIEGFHWSV-UHFFFAOYSA-N
3896	114970	9607	-	CARTPT	CART	9606	Homo sapiens	agonist	target	Vicentic A (2006)	16713658	174148	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3897	114970	9607	-	CARTPT	CART	9606	Homo sapiens	agonist	target	Loos RJ (2005)	15597110	174143	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3898	114970	9607	-	CARTPT	CART	9606	Homo sapiens	agonist	target	Muehlhaeusler BS (2005)	15661821	174147	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3899	114970	9607	-	CARTPT	CART	9606	Homo sapiens	agonist	target	Scruggs P (2005)	15680473	174146	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3900	114970	9607	-	CARTPT	CART	9606	Homo sapiens	agonist	target	McAlister ED (2004)	15644956	174145	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3901	114970	9607	-	CARTPT	CART	9606	Homo sapiens	agonist	target	Oliveira VX (2005)	15680478	174144	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3902	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	stimulator	target	Rothman RB (2003)	12954796	174149	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3903	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	stimulator	target	Wall SC (1995)	7700252	174150	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3904	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Teng L (1998)	9648873	174154	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3905	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (1995)	7751968	174151	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3906	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3907	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Eiden LE (2011)	21272013	174153	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3908	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Innis RB (1992)	1532675	174155	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3909	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Clarke DE (1982)	7059347	174156	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3910	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Miller GM (2005)	15764732	174161	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3911	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234900	174160	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3912	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Wolinsky TD (2007)	17212650	174157	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3913	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Reese EA (2007)	17218486	174158	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3914	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234899	174159	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3915	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Miller GM (2005)	15764732	174161	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3916	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Garcia BG (2005)	15795321	174163	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3917	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Lott DC (2005)	15602501	174162	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3918	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Kahlig KM (2005)	15728379	174165	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3919	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fone KC (2005)	15661631	174164	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3920	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Madras BK (2005)	15950014	174166	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3921	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3922	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3923	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3924	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3925	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3926	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3927	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3928	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3929	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3930	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3931	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3932	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3933	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3934	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3935	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3936	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3937	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Leibowitz SF (1970)	4399738	174168	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3938	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Reisine TD (1980)	6245760	174167	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3939	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	binder	target	Fleckenstein AE (2007)	17209801	174169	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
3940	107329	887	-	CCKBR	CCK-B|CCK2R|GASR	9606	Homo sapiens	agonist	target	Radu D (2002)	12073167	174176	176	Pentagastrin	-	pentagastrin|peptavlon liq inj	DRUGBANK	DB00183	C37H49N7O9S	small molecule	V04CG04	5534-95-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEYNJQRKHLUJRU-DZUOILHNSA-N
3941	107329	887	-	CCKBR	CCK-B|CCK2R|GASR	9606	Homo sapiens	agonist	target	Singh P (1986)	3004700	174177	176	Pentagastrin	-	pentagastrin|peptavlon liq inj	DRUGBANK	DB00183	C37H49N7O9S	small molecule	V04CG04	5534-95-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEYNJQRKHLUJRU-DZUOILHNSA-N
3942	107329	887	-	CCKBR	CCK-B|CCK2R|GASR	9606	Homo sapiens	agonist	target	Makovec F (1992)	1732532	174174	176	Pentagastrin	-	pentagastrin|peptavlon liq inj	DRUGBANK	DB00183	C37H49N7O9S	small molecule	V04CG04	5534-95-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEYNJQRKHLUJRU-DZUOILHNSA-N
3943	107329	887	-	CCKBR	CCK-B|CCK2R|GASR	9606	Homo sapiens	agonist	target	Nishida A (1995)	7491961	174175	176	Pentagastrin	-	pentagastrin|peptavlon liq inj	DRUGBANK	DB00183	C37H49N7O9S	small molecule	V04CG04	5534-95-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEYNJQRKHLUJRU-DZUOILHNSA-N
3944	107329	887	-	CCKBR	CCK-B|CCK2R|GASR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	176	Pentagastrin	-	pentagastrin|peptavlon liq inj	DRUGBANK	DB00183	C37H49N7O9S	small molecule	V04CG04	5534-95-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEYNJQRKHLUJRU-DZUOILHNSA-N
3945	107329	887	-	CCKBR	CCK-B|CCK2R|GASR	9606	Homo sapiens	agonist	target	Khan S (2004)	15157745	174178	176	Pentagastrin	-	pentagastrin|peptavlon liq inj	DRUGBANK	DB00183	C37H49N7O9S	small molecule	V04CG04	5534-95-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEYNJQRKHLUJRU-DZUOILHNSA-N
3946	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3947	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3948	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3949	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3950	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Olincy A (2006)	16754836	174185	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3951	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Mexal S (2007)	17360707	174184	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3952	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3953	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3954	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3955	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3956	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3957	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3958	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3959	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3960	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	unknown	target	Barbieri RL (1986)	3711333	174186	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3961	107528	1103	-	CHAT	CHOACTASE|CMS1A|CMS1A2	9606	Homo sapiens	unknown	target	FAHMY AR (1954)	13192619	174187	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3962	121345	57053	-	CHRNA10	-	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3963	121345	57053	-	CHRNA10	-	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3964	121345	57053	-	CHRNA10	-	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3965	121345	57053	-	CHRNA10	-	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3966	107564	1142	-	CHRNB3	-	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3967	107564	1142	-	CHRNB3	-	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3968	107564	1142	-	CHRNB3	-	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3969	107564	1142	-	CHRNB3	-	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3970	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Espeseth T (2007)	17590520	174190	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3971	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	De Luca V (2006)	16636791	174191	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3972	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Ehringer MA (2007)	17226798	174192	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3973	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Klaassen A (2006)	17146052	174189	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3974	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Winterer G (2007)	17613539	174188	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3975	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3976	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3977	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3978	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3979	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3980	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3981	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3982	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3983	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3984	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3985	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3986	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3987	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Sullivan PF (2004)	15048644	174193	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3988	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3989	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3990	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3991	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3992	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	agonist	target	De Luca V (2006)	16636791	174191	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3993	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	agonist	target	Ehringer MA (2007)	17226798	174192	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3994	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3995	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3996	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3997	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3998	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Zaniewska M (2010)	20081230	174183	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
3999	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Jackson KJ (2010)	20400469	174182	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4000	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Narahashi T (2000)	11006350	174181	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4001	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	agonist	target	Mansvelder HD (2009)	19560048	174180	177	Nicotine	(S)-3-(N-methylpyrrolidin-2-yl)pyridine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|L()-nicotine|()-nicotine|(S)-Nicotine|3-(2-(N-methylpyrrolidinyl))pyridine|(S)-()-nicotine|3-(N-methylpyrollidino)pyridine	good neighbor pharmacy nicotin	DRUGBANK	DB00184	C10H14N2	small molecule	N07BA01	54-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNICXCGAKADSCV-JTQLQIEISA-N
4002	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Li X (2008)	18450949	174198	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4003	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4004	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4005	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4006	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4007	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Fisher A (1996)	8624083	174199	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4008	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	178	Cevimeline	Cevimelina|2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine|Sni 2011|Cevimelinum	cevimeline hydrochloride|evoxa	DRUGBANK	DB00185	C10H17NOS	small molecule	N07AX03	107233-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUTYZMFRCNBCHQ-LHIURRSHSA-N
4009	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4010	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4011	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4012	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4013	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4014	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4015	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4016	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4017	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4018	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4019	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4020	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4021	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4022	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4023	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4024	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4025	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Uusi-Oukari M (1991)	1647706	174204	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4026	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Park CH (1996)	8787774	174205	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4027	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Venneti S (2006)	17156911	174206	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4028	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Miller EI (2006)	16959136	174203	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4029	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Kirshenbaum JM (1989)	2568748	174208	180	Esmolol	methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester	brevibloc liq iv 10mg/ml|brevi	DRUGBANK	DB00187	C16H25NO4	small molecule	C07AB09	81147-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQNDDEOPVVGCPG-UHFFFAOYSA-N
4030	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Jahn P (1995)	7612051	174209	180	Esmolol	methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester	brevibloc liq iv 10mg/ml|brevi	DRUGBANK	DB00187	C16H25NO4	small molecule	C07AB09	81147-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQNDDEOPVVGCPG-UHFFFAOYSA-N
4031	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Jacobs JR (1988)	2894187	174212	180	Esmolol	methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester	brevibloc liq iv 10mg/ml|brevi	DRUGBANK	DB00187	C16H25NO4	small molecule	C07AB09	81147-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQNDDEOPVVGCPG-UHFFFAOYSA-N
4032	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	180	Esmolol	methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester	brevibloc liq iv 10mg/ml|brevi	DRUGBANK	DB00187	C16H25NO4	small molecule	C07AB09	81147-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQNDDEOPVVGCPG-UHFFFAOYSA-N
4033	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Volz-Zang C (1994)	7957532	174210	180	Esmolol	methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester	brevibloc liq iv 10mg/ml|brevi	DRUGBANK	DB00187	C16H25NO4	small molecule	C07AB09	81147-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQNDDEOPVVGCPG-UHFFFAOYSA-N
4034	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Howie MB (1990)	1975995	174211	180	Esmolol	methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|()-esmolol|Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate|()-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate|3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester	brevibloc liq iv 10mg/ml|brevi	DRUGBANK	DB00187	C16H25NO4	small molecule	C07AB09	81147-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQNDDEOPVVGCPG-UHFFFAOYSA-N
4051	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4052	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4053	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4054	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4055	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4056	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4057	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4058	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4059	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4060	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4061	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4062	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4063	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4064	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4065	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4066	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4067	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Kaufmann H (2003)	12885750	174222	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4068	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Durso R (2000)	10934669	174219	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4069	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Orlefors H (2006)	16184369	174221	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4070	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Yee RE (2001)	11709201	172562	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4071	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4072	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Gilbert JA (2000)	11106255	174220	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4073	108011	1644	-	DDC	AADC	9606	Homo sapiens	inhibitor	target	Calabrese V (2007)	17241115	174218	183	Carbidopa	L--methyldopahydrazine|(S)-carbidopa|Carbidopum|(S)-()-carbidopa|L-3-(3,4-dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid|(-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate|(S)--hydrazino-3,4-dihydroxy--methylbenzenepropanoic acid	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB00190	C10H14N2O4	small molecule	-	28860-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFNLOMSOLWIDK-JTQLQIEISA-N
4074	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4075	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Proietto J (2000)	11060745	174223	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4076	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4077	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Samanin R (1993)	7902561	174224	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4078	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Stephens LC (2005)	16119498	174225	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4079	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Ulus IH (2000)	10799660	174228	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4080	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Kilpatrick IC (2001)	11673765	174229	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4081	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Rothman RB (1999)	10231134	174226	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4082	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Nandigama RK (2002)	11911838	174227	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4083	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Mekontso-Dessap A (2006)	16380550	174231	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4084	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Zolkowska D (2006)	16644904	174230	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4085	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	John CE (2007)	17459426	174233	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4086	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rothman RB (1999)	10458725	174232	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4087	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Johnson GJ (2003)	14675103	174234	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4088	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Rothman RB (1999)	10218558	174235	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4089	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Ulus IH (2000)	10799660	174228	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4090	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Kilpatrick IC (2001)	11673765	174229	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4091	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Rothman RB (1999)	10231134	174226	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4092	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Nandigama RK (2002)	11911838	174227	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4093	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	John CE (2007)	17459426	174233	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4094	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Gruner JA (2009)	19928382	174236	184	Phentermine	Phenterminum|Fentermina|alpha,alpha-Dimethylphenethylamine	phentermine resin er|lomaira|f	DRUGBANK	DB00191	C10H15N	small molecule	A08AA01	122-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHHVAGZRUROJKS-UHFFFAOYSA-N
4095	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Jaillon P (1989)	2688391	174237	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4096	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4097	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Steinberg MI (1984)	6206315	174238	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4098	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4099	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4100	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Holland DR (1989)	2476626	174239	185	Indecainide	Indecainide|Indecainidum|Indecainida	-	DRUGBANK	DB00192	C20H24N2O	small molecule	-	74517-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCEWGESNIULAGX-UHFFFAOYSA-N
4101	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Sun HL (2003)	12570923	174240	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4102	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Sagata K (2002)	11916794	174241	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4103	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Berrocoso E (2009)	19341511	174242	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4104	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Frink MC (1996)	8955860	174243	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4105	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4106	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Wentland MP (2009)	19027293	174244	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4107	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Frink MC (1996)	8955860	174243	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4108	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Driessen B (1992)	1596676	174245	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4109	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Barann M (2006)	16427041	174246	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4111	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Potschka H (2000)	10991912	174253	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4112	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Grond S (2004)	15509185	174252	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4113	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Gillen C (2000)	10961373	174251	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4114	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Raffa RB (1992)	1309873	174250	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4115	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4116	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Minami K (2007)	17380034	174248	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4117	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Ide S (2006)	16793069	174249	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4118	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Frink MC (1996)	8955860	174243	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4119	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Shiga Y (2002)	12401609	174255	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4120	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Shiraishi M (2001)	11561087	174254	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4121	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Hara K (2005)	15845694	174256	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4122	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Horishita T (2006)	16679816	174257	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4123	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Ogata J (2004)	15105221	174258	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
4124	971723	3783681	-	BALF5	-	10376	Human Herpesvirus 4	inhibitor	target	Imming P (2006)	17016423	171742	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
4125	971723	3783681	-	BALF5	-	10376	Human Herpesvirus 4	inhibitor	target	Overington JP (2006)	17139284	171741	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
4126	971723	3783681	-	BALF5	-	10376	Human Herpesvirus 4	inhibitor	target	Suzuki M (2006)	16797734	174260	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
4127	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rait JL (1999)	10080340	174264	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4128	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Rudoy CA (2007)	17513029	174266	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4129	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	McLean AJ (2002)	12181453	174267	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4130	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4131	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Lesar TS (1987)	2891463	174265	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4132	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Satoh N (1990)	2077180	174268	188	Betaxolol	1-(Isopropylamino)-3-[P-(cyclopropylmethoxyethyl)phenoxy]-2-propanol|1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol|Betaxololum	betaxolol|novo-betaxolol|betop	DRUGBANK	DB00195	C18H29NO3	small molecule	S01ED02|S01ED52|C07AB05	63659-18-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIUTZDMDHAVTP-UHFFFAOYSA-N
4133	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Chau AS (2006)	16966400	70318	189	Fluconazole	Triflucan|Fluconazolum|2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol|Diflucan|Elazor|Biozole|Fluconazol|2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol	diflucan tab 100mg|monicure co	DRUGBANK	DB00196	C13H12F2N6O	small molecule	J01RA07|D01AC15|J02AC01	86386-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFHAOTPXVQNOHP-UHFFFAOYSA-N
4134	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Guinea J (2006)	16966178	68500	189	Fluconazole	Triflucan|Fluconazolum|2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol|Diflucan|Elazor|Biozole|Fluconazol|2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol	diflucan tab 100mg|monicure co	DRUGBANK	DB00196	C13H12F2N6O	small molecule	J01RA07|D01AC15|J02AC01	86386-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFHAOTPXVQNOHP-UHFFFAOYSA-N
4135	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Bellamine A (2004)	15314102	174269	189	Fluconazole	Triflucan|Fluconazolum|2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol|Diflucan|Elazor|Biozole|Fluconazol|2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol	diflucan tab 100mg|monicure co	DRUGBANK	DB00196	C13H12F2N6O	small molecule	J01RA07|D01AC15|J02AC01	86386-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFHAOTPXVQNOHP-UHFFFAOYSA-N
4136	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	inverse agonist	target	Wang Y (2010)	20298676	174274	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4137	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	antagonist	target	Kruszynska YT (2000)	10871202	174275	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4138	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	antagonist	target	Nordt TK (2000)	10770198	174277	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4139	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	antagonist	target	Kato K (2000)	10831180	174276	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4140	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	antagonist	target	Gottschling-Zeller H (2000)	10768100	174279	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4141	111091	5054	-	SERPINE1	PAI|PAI-1|PAI1|PLANH1	9606	Homo sapiens	antagonist	target	Sobel BE (1999)	10418858	174278	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4142	108344	2030	-	SLC29A1	ENT1	9606	Homo sapiens	inhibitor	target	Leung GP (2005)	15963471	174280	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4143	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4144	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Demetri GD (1999)	10097144	174284	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4145	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Petrova TV (1999)	10200320	174285	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4146	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Kitamura S (1999)	10076568	174286	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4147	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Baek SJ (2003)	12475986	174281	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4148	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Camp HS (1999)	10214942	174282	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4149	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Satoh T (1999)	10222233	174283	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4150	108405	2101	-	ESRRA	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	9606	Homo sapiens	inverse agonist	target	Wang Y (2010)	20298676	174274	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4151	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Lewin TM (2002)	12147264	174287	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4152	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Kim JH (2001)	11319222	174288	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4153	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Lewin TM (2001)	11319232	174289	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4154	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Zhu HJ (2009)	19022936	174299	191	Oseltamivir	Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir	nat-oseltamivir|tamiflu oral s	DRUGBANK	DB00198	C16H28N2O4	small molecule	J05AH02	196618-13-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSZGPKBBMSAYNT-RRFJBIMHSA-N
4155	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Wattanagoon Y (2009)	19104028	174298	191	Oseltamivir	Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir	nat-oseltamivir|tamiflu oral s	DRUGBANK	DB00198	C16H28N2O4	small molecule	J05AH02	196618-13-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSZGPKBBMSAYNT-RRFJBIMHSA-N
4156	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Shi D (2006)	16966469	174297	191	Oseltamivir	Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir	nat-oseltamivir|tamiflu oral s	DRUGBANK	DB00198	C16H28N2O4	small molecule	J05AH02	196618-13-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSZGPKBBMSAYNT-RRFJBIMHSA-N
4157	110832	4759	-	NEU2	SIAL2	9606	Homo sapiens	inhibitor	target	Chavas LM (2010)	20222714	174303	191	Oseltamivir	Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir	nat-oseltamivir|tamiflu oral s	DRUGBANK	DB00198	C16H28N2O4	small molecule	J05AH02	196618-13-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSZGPKBBMSAYNT-RRFJBIMHSA-N
4158	110831	4758	DAAP-222I20.1	NEU1	NANH|NEU|SIAL1	9606	Homo sapiens	inhibitor	target	Chavas LM (2010)	20222714	174303	191	Oseltamivir	Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|osltamivir|Oseltamivirum|()-oseltamivir|Oseltamivir	nat-oseltamivir|tamiflu oral s	DRUGBANK	DB00198	C16H28N2O4	small molecule	J05AH02	196618-13-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSZGPKBBMSAYNT-RRFJBIMHSA-N
4159	113724	8029	RP11-416D8.1	CUBN	IFCR|MGA1|gp280	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4160	113724	8029	RP11-416D8.1	CUBN	IFCR|MGA1|gp280	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4161	113724	8029	RP11-416D8.1	CUBN	IFCR|MGA1|gp280	9606	Homo sapiens	unknown	target	Seetharam B (2003)	14585166	174321	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4162	112807	6947	-	TCN1	HC|TC-1|TC1|TCI	9606	Homo sapiens	unknown	target	MacDonald CM (1977)	844253	174323	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4163	112807	6947	-	TCN1	HC|TC-1|TC1|TCI	9606	Homo sapiens	unknown	target	Rothenberg SP (1984)	6726060	174322	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4164	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Quadros EV (1995)	7599160	135811	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4165	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Chen X (2002)	11752352	171740	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4166	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Tkachuck RD (1977)	18565	174327	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4167	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Mayatepek E (1996)	8741039	174326	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4168	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Dayem LC (2002)	11955068	174325	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4169	110680	4594	-	MUT	MCM	9606	Homo sapiens	cofactor	target	Willard HF (1979)	36882	174324	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4170	123571	81693	UNQ513/PRO1028	AMN	PRO1028|amnionless	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4171	123571	81693	UNQ513/PRO1028	AMN	PRO1028|amnionless	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4172	123571	81693	UNQ513/PRO1028	AMN	PRO1028|amnionless	9606	Homo sapiens	unknown	target	Seetharam B (2003)	14585166	174321	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4173	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4174	110645	4552	-	MTRR	MSR|cblE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4175	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4176	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4177	117458	25974	RP11-291L19.3	MMACHC	cblC	9606	Homo sapiens	unknown	target	Lerner-Ellis JP (2006)	16311595	172607	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4178	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Tkachuck RD (1977)	18565	174327	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4179	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Quadros EV (1995)	7599160	135811	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4180	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Kolhouse JF (1991)	1744096	144013	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4181	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Rosenblatt DS (1987)	3812589	174329	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4182	110642	4548	-	MTR	HMAG|MS|cblG	9606	Homo sapiens	cofactor	target	Ogier de Baulny H (1998)	9587031	174328	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4183	130605	326625	-	MMAB	ATR|CFAP23|cblB|cob	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4184	130605	326625	-	MMAB	ATR|CFAP23|cblB|cob	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4185	127933	166785	-	MMAA	cblA	9606	Homo sapiens	unknown	target	Rosenblatt DS (1987)	20301409	174330	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4186	127933	166785	-	MMAA	cblA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4187	127933	166785	-	MMAA	cblA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	193	Hydroxocobalamin	Hydroxocobalaminum anhydrous|OH-Cbl|Hydroxycobalamin|Vitamin B-12b|Hydroxocobalamin anhydrous|Hydroxocobalamine	hydro cobex inj 1000mcg/ml|hyd	DRUGBANK	DB00200	C62H89CoN13O15P	small molecule	V03AB33|B03BA03|B03BA53	13422-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZNUFWCRFCGIH-WZHZPDAFSA-K
4188	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4189	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4190	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Daly JW (2007)	17514358	174335	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4191	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4192	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Gaytan SP (2006)	16702031	174337	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4193	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Listos J (2006)	17085856	174336	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4194	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Wang SJ (2007)	17372967	174340	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4195	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Mustafa S (2006)	17162470	174338	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4196	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Rieg T (2007)	17126319	174339	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4197	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4198	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	multitarget	target	Gaytan SP (2006)	16702031	174337	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4199	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	multitarget	target	Listos J (2006)	17085856	174336	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4200	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	multitarget	target	Wang SJ (2007)	17372967	174340	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4201	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	multitarget	target	Mustafa S (2006)	17162470	174338	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4202	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	multitarget	target	Rieg T (2007)	17126319	174339	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4203	111163	5137	-	PDE1C	Hcam3|cam-PDE 1C|hCam-3	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4204	111163	5137	-	PDE1C	Hcam3|cam-PDE 1C|hCam-3	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4205	111177	5151	-	PDE8A	HsT19550	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4206	111177	5151	-	PDE8A	HsT19550	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4207	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4208	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4209	111162	5136	-	PDE1A	CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4210	111162	5136	-	PDE1A	CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4211	111171	5145	-	PDE6A	CGPR-A|PDEA|RP43	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4212	111171	5145	-	PDE6A	CGPR-A|PDEA|RP43	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4213	111178	5152	-	PDE9A	HSPDE9A2	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4214	111178	5152	-	PDE9A	HSPDE9A2	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4215	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4216	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4217	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4218	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4219	111179	5153	-	PDE1B	PDE1B1|PDES1B	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4220	111179	5153	-	PDE1B	PDE1B1|PDES1B	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4221	119167	50940	-	PDE11A	PPNAD2	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4222	119167	50940	-	PDE11A	PPNAD2	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4223	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4224	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4225	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4226	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4227	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4228	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4229	118010	27115	RP11-472E5.2	PDE7B	bA472E5.1	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4230	118010	27115	RP11-472E5.2	PDE7B	bA472E5.1	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4231	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4232	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4233	114177	8622	PIG22	PDE8B	ADSD|PPNAD3	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4234	114177	8622	PIG22	PDE8B	ADSD|PPNAD3	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4235	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4236	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4237	111172	5146	-	PDE6C	ACHM5|COD4|PDEA2	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4238	111172	5146	-	PDE6C	ACHM5|COD4|PDEA2	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4239	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4240	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4241	111184	5158	-	PDE6B	CSNB3|CSNBAD2|PDEB|RP40|rd1	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4242	111184	5158	-	PDE6B	CSNB3|CSNBAD2|PDEB|RP40|rd1	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4243	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor, competitive	target	Ribeiro JA (2010)	20164566	174341	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4244	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor, competitive	target	Essayan DM (2001)	11692087	174342	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4245	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4246	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Cornelis MC (2007)	17616786	174343	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4247	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Riksen NP (2007)	17558310	174345	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4248	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Zhao G (2007)	17577101	174344	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4249	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4250	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Cornelis MC (2007)	17616786	174343	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4251	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Riksen NP (2007)	17558310	174345	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4252	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	multitarget	target	Zhao G (2007)	17577101	174344	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4253	111311	5293	RP11-558F24.3	PIK3CD	APDS|IMD14|P110DELTA|PI3K|p110D	9606	Homo sapiens	unknown	target	Foukas LC (2002)	12145276	174346	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4254	111309	5291	-	PIK3CB	P110BETA|PI3K|PI3KBETA|PIK3C1	9606	Homo sapiens	unknown	target	Foukas LC (2002)	12145276	174346	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4255	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Parker I (1991)	1844813	174347	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4256	109914	3709	-	ITPR2	CFAP48|IP3R2	9606	Homo sapiens	unknown	target	Parker I (1991)	1844813	174347	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4257	109915	3710	-	ITPR3	IP3R|IP3R3	9606	Homo sapiens	unknown	target	Parker I (1991)	1844813	174347	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4258	111577	5591	-	PRKDC	DNA-PKcs|DNAPK|DNPK1|HYRC|HYRC1|IMD26|XRCC7|p350	9606	Homo sapiens	unknown	target	Foukas LC (2002)	12145276	174346	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4259	111308	5290	-	PIK3CA	CLOVE|CWS5|MCAP|MCM|MCMTC|PI3K|p110-alpha	9606	Homo sapiens	unknown	target	Foukas LC (2002)	12145276	174346	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4260	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	unknown	target	Daly JW (2007)	17514358	174335	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4261	106962	472	-	ATM	AT1|ATA|ATC|ATD|ATDC|ATE|TEL1|TELO1	9606	Homo sapiens	unknown	target	Blasina A (1999)	10531013	174349	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4262	106962	472	-	ATM	AT1|ATA|ATC|ATD|ATDC|ATE|TEL1|TELO1	9606	Homo sapiens	unknown	target	Sarkaria JN (1999)	10485486	174348	194	Caffeine	Cafine|1,3,7-trimethylpurine-2,6-dione|Theine|7-methyltheophylline|Coffein|Methyltheobromine|Koffein|Guaranine|1-methyltheobromine|Thein|tena|1,3,7-trimethyl-2,6-dioxopurine|Coffeinum|Anhydrous caffeine|Matena|1,3,7-trimethylxanthine|Caffeinum|Cafena|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion	stay awake maximum strength|fi	DRUGBANK	DB00201	C8H10N4O2	small molecule	N06BC01|V04CG30	58-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYYVLZVUVIJVGH-UHFFFAOYSA-N
4263	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Hou VY (1998)	9523819	174352	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4264	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4265	121345	57053	-	CHRNA10	-	9606	Homo sapiens	agonist	target	Jonsson M (2006)	16571968	174353	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4269	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4270	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4271	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Fisher DM (1999)	10437710	174357	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4272	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Hou VY (1998)	9523819	174352	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
4273	111175	5149	-	PDE6H	ACHM6|RCD3	9606	Homo sapiens	inhibitor	target	Uckert S (2006)	16815627	174359	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4274	111174	5148	-	PDE6G	PDEG|RP57	9606	Homo sapiens	inhibitor	target	Uckert S (2006)	16815627	174359	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4275	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Wang H (2008)	17959709	174363	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4276	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Carson CC (2003)	12614192	174362	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4277	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Corbin JD (2002)	12414329	174361	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4278	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Rybalkin SD (2003)	12554648	174360	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4279	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Kruuse C (2003)	12477710	174367	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4280	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Wang J (1999)	12567500	174366	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4281	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Zoraghi R (2007)	17979301	174365	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4282	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Wang H (2006)	16735511	174364	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4283	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	196	Sildenafil	1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine	revatio|pb-sildenafil|auro-sil	DRUGBANK	DB00203	C22H30N6O4S	small molecule	G04BE03	139755-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNRNXUUZRGQAQC-UHFFFAOYSA-N
4284	109977	3776	-	KCNK2	K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4285	109977	3776	-	KCNK2	K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4286	109977	3776	-	KCNK2	K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e	9606	Homo sapiens	inhibitor	target	Roukoz H (2007)	17187453	174371	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4287	109970	3768	-	KCNJ12	IRK-2|IRK2|KCNJN1|Kir2.2|Kir2.2v|hIRK|hIRK1|hkir2.2x|kcnj12x	9606	Homo sapiens	inhibitor	target	Kiehn J (1996)	8700146	174372	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4288	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Finlayson K (2001)	11698075	174374	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4289	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Ficker E (2001)	11723241	174375	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4290	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Kang J (2005)	15548764	174376	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4291	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Ficker E (1998)	9486667	174377	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4292	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Overholt JL (2000)	10712445	174373	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4293	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4294	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Finlayson K (2001)	11166283	174378	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4295	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Lees-Miller JP (2000)	10648647	174379	197	Dofetilide	Tikosyn|beta-((P-Methanesulfonamidophenethyl)methylamino)methanesulfono-P-phenetidide|Dofetilide|Dofetilidum|Dofetilida	dofetilide|tikosyn	DRUGBANK	DB00204	C19H27N3O5S2	small molecule	C01BD04	115256-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXTMWRCNAAVVAI-UHFFFAOYSA-N
4296	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Rastelli G (2003)	12951104	174385	198	Pyrimethamine	2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn	pyrimethamine leucovorin|darap	DRUGBANK	DB00205	C12H13ClN4	small molecule	P01BD01|P01BD51|P01BF04	58-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKSAUQYGYAYLPV-UHFFFAOYSA-N
4297	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Fidock DA (1997)	9380737	174384	198	Pyrimethamine	2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn	pyrimethamine leucovorin|darap	DRUGBANK	DB00205	C12H13ClN4	small molecule	P01BD01|P01BD51|P01BF04	58-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKSAUQYGYAYLPV-UHFFFAOYSA-N
4298	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	198	Pyrimethamine	2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn	pyrimethamine leucovorin|darap	DRUGBANK	DB00205	C12H13ClN4	small molecule	P01BD01|P01BD51|P01BF04	58-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKSAUQYGYAYLPV-UHFFFAOYSA-N
4299	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Wooden JM (1997)	9108546	42426	198	Pyrimethamine	2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|Pirimetamina|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|Ethylpyrimidine|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|Pyrimethaminum|CD|2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine|Primethamine|Chloridine|Diaminopyritamin|Chloridyn	pyrimethamine leucovorin|darap	DRUGBANK	DB00205	C12H13ClN4	small molecule	P01BD01|P01BD51|P01BF04	58-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKSAUQYGYAYLPV-UHFFFAOYSA-N
4300	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Mandela P (2010)	20176067	174386	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4301	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Erickson JD (1992)	1438304	174389	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4302	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sievert MK (2007)	17559790	174388	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4303	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4304	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Naudon L (1995)	8525459	174387	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4305	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4306	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4307	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	unknown	target	Ashe KM (2011)	21712771	174390	199	Reserpine	Reserpin|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Apoplon|Serpalan|Reserpine|()-reserpine|(-)-Reserpine|3,4,5-trimethoxybenzoyl methyl reserpate	hydropres 25 tab|serpasil 0.25	DRUGBANK	DB00206	C33H40N2O9	small molecule	C02AA02|C02LA01|C02LA71|C02LA51|C02AA52	50-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEVHRUUCFGRFIF-MDEJGZGSSA-N
4308	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Boeynaems JM (2005)	15816504	174397	201	Ticlopidine	Ticlopidinum|Ticlopidina	dom-ticlopidine|ticlopidine|my	DRUGBANK	DB00208	C14H14ClNS	small molecule	B01AC05	55142-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWBOXQYWZNQIN-UHFFFAOYSA-N
4309	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Zhan C (2007)	17110146	174400	201	Ticlopidine	Ticlopidinum|Ticlopidina	dom-ticlopidine|ticlopidine|my	DRUGBANK	DB00208	C14H14ClNS	small molecule	B01AC05	55142-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWBOXQYWZNQIN-UHFFFAOYSA-N
4310	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	201	Ticlopidine	Ticlopidinum|Ticlopidina	dom-ticlopidine|ticlopidine|my	DRUGBANK	DB00208	C14H14ClNS	small molecule	B01AC05	55142-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWBOXQYWZNQIN-UHFFFAOYSA-N
4311	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Gachet C (2005)	15955565	174398	201	Ticlopidine	Ticlopidinum|Ticlopidina	dom-ticlopidine|ticlopidine|my	DRUGBANK	DB00208	C14H14ClNS	small molecule	B01AC05	55142-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWBOXQYWZNQIN-UHFFFAOYSA-N
4312	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Storey RF (2001)	11454254	174399	201	Ticlopidine	Ticlopidinum|Ticlopidina	dom-ticlopidine|ticlopidine|my	DRUGBANK	DB00208	C14H14ClNS	small molecule	B01AC05	55142-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWBOXQYWZNQIN-UHFFFAOYSA-N
4313	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	202	Trospium	-	trospium chloride|trospium chl	DRUGBANK	DB00209	C25H30NO3	small molecule	G04BD09|A03DA06	47608-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYYDSUSKLWTMMQ-JKHIJQBDSA-N
4314	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	202	Trospium	-	trospium chloride|trospium chl	DRUGBANK	DB00209	C25H30NO3	small molecule	G04BD09|A03DA06	47608-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYYDSUSKLWTMMQ-JKHIJQBDSA-N
4315	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Shroot B (1998)	9557255	174402	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4316	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Griffiths CE (1998)	9990415	174403	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4317	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Kim MJ (2000)	10651997	174406	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4318	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Michel S (1998)	9990413	174404	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4319	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Shroot B (1997)	9204085	174405	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4320	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Shroot B (1998)	9557255	174402	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4321	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4322	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Michel S (1998)	9990413	174404	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4323	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Shroot B (1997)	9204085	174405	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4324	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4325	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4326	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Kim MJ (2000)	10651997	174406	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4327	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4328	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4329	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Kim MJ (2000)	10651997	174406	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4330	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Kim MJ (2000)	10651997	174406	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4331	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Bernard BA (1993)	8142113	174407	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4332	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4333	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4334	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	203	Adapalene	Adapaleno|Differine|Adapalenum|Adaferin|6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid	tactupump forte|differin - gel	DRUGBANK	DB00210	C28H28O3	small molecule	D10AD53|D10AD03	106685-40-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZCDAPDGXCYOEH-UHFFFAOYSA-N
4335	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Buckner SA (2002)	12163120	174410	204	Midodrine	1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid	midodrine hydrochloride|midodr	DRUGBANK	DB00211	C12H18N2O4	small molecule	C01CA17	42794-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTKSEFOSCHHMPD-UHFFFAOYSA-N
4336	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Altenbach RJ (2004)	15163201	174408	204	Midodrine	1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid	midodrine hydrochloride|midodr	DRUGBANK	DB00211	C12H18N2O4	small molecule	C01CA17	42794-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTKSEFOSCHHMPD-UHFFFAOYSA-N
4337	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Taniguchi N (1996)	9007522	174409	204	Midodrine	1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid	midodrine hydrochloride|midodr	DRUGBANK	DB00211	C12H18N2O4	small molecule	C01CA17	42794-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTKSEFOSCHHMPD-UHFFFAOYSA-N
4338	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Altenbach RJ (2004)	15163201	174408	204	Midodrine	1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid	midodrine hydrochloride|midodr	DRUGBANK	DB00211	C12H18N2O4	small molecule	C01CA17	42794-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTKSEFOSCHHMPD-UHFFFAOYSA-N
4339	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Altenbach RJ (2002)	12238918	174411	204	Midodrine	1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol|(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide|Midodrinum|Midodrina|2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide|Midodrin|DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid	midodrine hydrochloride|midodr	DRUGBANK	DB00211	C12H18N2O4	small molecule	C01CA17	42794-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTKSEFOSCHHMPD-UHFFFAOYSA-N
4340	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4341	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	van Paassen P (1999)	10583449	174413	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4342	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Hilgers KF (1994)	8206619	174415	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4343	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Kiowski W (1994)	7994817	174414	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4344	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Clozel JP (1993)	8319997	174417	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4345	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	MacFadyen RJ (1995)	7769797	174416	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4346	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Moreira Dias L (2009)	19938880	174419	206	Pantoprazole	Pantoprazolum|Pantoprazol	pantoprazole sodium delayed-re	DRUGBANK	DB00213	C16H15F2N3O4S	small molecule	A02BD11|A02BD04|A02BC02	102625-70-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQPSEEYGBUAQFF-UHFFFAOYSA-N
4347	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Cheer SM (2002)	12487624	174418	206	Pantoprazole	Pantoprazolum|Pantoprazol	pantoprazole sodium delayed-re	DRUGBANK	DB00213	C16H15F2N3O4S	small molecule	A02BD11|A02BD04|A02BC02	102625-70-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQPSEEYGBUAQFF-UHFFFAOYSA-N
4348	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	206	Pantoprazole	Pantoprazolum|Pantoprazol	pantoprazole sodium delayed-re	DRUGBANK	DB00213	C16H15F2N3O4S	small molecule	A02BD11|A02BD04|A02BC02	102625-70-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQPSEEYGBUAQFF-UHFFFAOYSA-N
4349	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Vormfelde SV (2007)	17460608	174425	207	Torasemide	1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea|Torasemida|Luprac|N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide|Demadex|Torsemide|Torasemidum	demadex tablets - 20mg|demadex	DRUGBANK	DB00214	C16H20N4O3S	small molecule	C03CA04	56211-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGBFQHCMQULJNZ-UHFFFAOYSA-N
4350	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	207	Torasemide	1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea|Torasemida|Luprac|N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide|Demadex|Torsemide|Torasemidum	demadex tablets - 20mg|demadex	DRUGBANK	DB00214	C16H20N4O3S	small molecule	C03CA04	56211-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGBFQHCMQULJNZ-UHFFFAOYSA-N
4351	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Fortuno A (1999)	10406837	174426	207	Torasemide	1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea|Torasemida|Luprac|N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide|Demadex|Torsemide|Torasemidum	demadex tablets - 20mg|demadex	DRUGBANK	DB00214	C16H20N4O3S	small molecule	C03CA04	56211-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGBFQHCMQULJNZ-UHFFFAOYSA-N
4352	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Dutta AK (2001)	11300876	174433	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4353	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Plenge P (2005)	15955412	174432	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4354	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Vicentic A (1999)	10546982	174431	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4355	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4356	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Dugar A (2001)	11180498	174437	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4357	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rasmussen TN (2009)	19500602	174436	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4358	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Maines LW (1999)	10188639	174435	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4359	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Bareggi SR (2007)	17916059	174434	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4360	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Eriksson E (1999)	10063489	174428	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4361	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Schloss P (1995)	7548008	174429	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4362	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Zhong H (2009)	19616061	174427	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4363	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	binder	target	Bareggi SR (2007)	17916059	174434	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4364	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	binder	target	Bareggi SR (2007)	17916059	174434	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4365	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Bareggi SR (2007)	17916059	174434	208	Citalopram	Citadur|Nitalapram	citalopram tablets usp|q-cital	DRUGBANK	DB00215	C20H21FN2O	small molecule	N06AB04	59729-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-UHFFFAOYSA-N
4366	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4367	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4368	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lambert GA (2002)	12384251	174445	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4369	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4370	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Knyihar-Csillik E (2000)	11069595	174443	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4371	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	van den Broek RW (2000)	11050304	174441	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4372	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Bhalla P (2002)	11834243	174446	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4373	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Jaehnichen S (2004)	15185063	174447	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4374	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4375	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4376	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4377	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4378	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4379	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4380	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4381	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4382	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4383	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Strijbos PJ (2002)	12498013	174450	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4384	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4385	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Wackenfors A (2005)	15821444	174449	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4386	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4387	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	209	Eletriptan	Eletriptanum	gd-eletriptan|relpax|apo-eletr	DRUGBANK	DB00216	C22H26N2O2S	small molecule	N02CC06	143322-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWVXXGRKLHYWKM-LJQANCHMSA-N
4388	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4389	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Hart GR (1981)	6114720	174453	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4390	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bacaner MB (1982)	6812406	174452	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4391	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4392	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Hart GR (1981)	6114720	174453	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4393	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Bacaner MB (1982)	6812406	174452	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4394	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4395	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Hart GR (1981)	6114720	174453	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4396	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Bacaner MB (1982)	6812406	174452	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4397	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Bkaily G (1988)	3167688	174455	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4398	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Bkaily G (1990)	2157221	174454	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4399	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Noshiro T (1989)	2545383	174457	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4400	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Noshiro T (1990)	1962798	174456	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4401	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Noshiro T (1989)	2545383	174457	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4402	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Noshiro T (1990)	1962798	174456	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4403	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Noshiro T (1989)	2545383	174457	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4404	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Noshiro T (1990)	1962798	174456	210	Bethanidine	Betanidina|Betanidinum|Betanidine|N,N'-dimethyl-N''-(phenylmethyl)-guanidine	-	DRUGBANK	DB00217	C10H15N3	small molecule	C02CC01	55-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIVZHWNOUVJHKV-UHFFFAOYSA-N
4405	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	211	Moxifloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid	mylan-moxifloxacin|priva-moxif	DRUGBANK	DB00218	C21H24FN3O4	small molecule	S01AE07|J01MA14	151096-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FABPRXSRWADJSP-MEDUHNTESA-N
4406	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Wohlkonig A (2010)	20802486	174459	211	Moxifloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid	mylan-moxifloxacin|priva-moxif	DRUGBANK	DB00218	C21H24FN3O4	small molecule	S01AE07|J01MA14	151096-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FABPRXSRWADJSP-MEDUHNTESA-N
4407	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Reuveni D (2010)	20596674	174458	211	Moxifloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4as,7as)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid	mylan-moxifloxacin|priva-moxif	DRUGBANK	DB00218	C21H24FN3O4	small molecule	S01AE07|J01MA14	151096-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FABPRXSRWADJSP-MEDUHNTESA-N
4408	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4409	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4410	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4411	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eglen RM (1987)	3580704	174466	212	Oxyphenonium	Oxyphenonium cation|Oxyphenonium ion	-	DRUGBANK	DB00219	C21H34NO3	small molecule	A03AB03|A03AB53	14214-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFRUPHOKLBPHTQ-UHFFFAOYSA-N
4412	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gaulton A (2012)	21948594	174478	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4413	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Horinouchi T (2007)	17628611	174482	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4414	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Muszkat M (2007)	17329986	174483	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4415	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Terra SG (2005)	15917856	174480	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4416	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Burniston JG (2006)	16973691	174481	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4417	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Rodrigues LL (2006)	17157779	174479	214	Isoetarine	Isoetharine|Isoetarinum|Isoetarina	-	DRUGBANK	DB00221	C13H21NO3	small molecule	R03CC06|R03AC07	79490-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYWAWARQUIQLE-UHFFFAOYSA-N
4418	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Kramer W (1996)	8911984	174486	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4419	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Kramer W (1995)	8529521	174484	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4420	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Mueller G (1994)	8172912	174485	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4421	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4422	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Bataille D (2002)	12703060	174488	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4423	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4424	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Proks P (2002)	12475777	174487	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4425	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Lawrence CL (2002)	12086984	174490	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4426	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Bataille D (2002)	12703060	174488	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4427	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Song DK (2001)	11325810	174489	215	Glimepiride	Glimepirida|Glimpiride|Amaryl|Glimepiridum	ratio-glimepiride|avandaryl|du	DRUGBANK	DB00222	C24H34N4O5S	small molecule	A10BB12|A10BD06|A10BD04	93479-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIGIZIANZCJQQY-UHFFFAOYSA-N
4428	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Pearce DJ (2004)	15764038	174491	216	Diflorasone	(6,11,16)-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Diflorasonum|(6alpha,11beta,16beta)-6,9-Difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Diflorasona	diflorasone diacetate|apexicon	DRUGBANK	DB00223	C22H28F2O5	small molecule	D07AC10	2557-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-XHIJKXOTSA-N
4429	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wittayanarakul K (2008)	17849388	174468	217	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous	crixivan	DRUGBANK	DB00224	C36H47N5O4	small molecule	J05AE02	150378-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBVCZFGXHXORBI-PXQQMZJSSA-N
4430	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Hoetelmans RM (1997)	9297727	174493	217	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous	crixivan	DRUGBANK	DB00224	C36H47N5O4	small molecule	J05AE02	150378-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBVCZFGXHXORBI-PXQQMZJSSA-N
4431	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Stein DS (1996)	8724039	174492	217	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous	crixivan	DRUGBANK	DB00224	C36H47N5O4	small molecule	J05AE02	150378-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBVCZFGXHXORBI-PXQQMZJSSA-N
4432	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dandache S (2007)	17638694	174467	217	Indinavir	(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide|Indinavir anhydrous	crixivan	DRUGBANK	DB00224	C36H47N5O4	small molecule	J05AE02	150378-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBVCZFGXHXORBI-PXQQMZJSSA-N
4433	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	219	Guanadrel	Guanadrel|Guanadrelum	-	DRUGBANK	DB00226	C10H19N3O2	small molecule	-	40580-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPBNRIOWIXYZFK-UHFFFAOYSA-N
4434	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	partial agonist	target	Finnerty FA (1985)	3896742	174498	219	Guanadrel	Guanadrel|Guanadrelum	-	DRUGBANK	DB00226	C10H19N3O2	small molecule	-	40580-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPBNRIOWIXYZFK-UHFFFAOYSA-N
4435	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	partial agonist	target	Malinow SH (1983)	6850722	174499	219	Guanadrel	Guanadrel|Guanadrelum	-	DRUGBANK	DB00226	C10H19N3O2	small molecule	-	40580-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPBNRIOWIXYZFK-UHFFFAOYSA-N
4436	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	219	Guanadrel	Guanadrel|Guanadrelum	-	DRUGBANK	DB00226	C10H19N3O2	small molecule	-	40580-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPBNRIOWIXYZFK-UHFFFAOYSA-N
4437	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	partial agonist	target	Palmer JD (1983)	6351026	174497	219	Guanadrel	Guanadrel|Guanadrelum	-	DRUGBANK	DB00226	C10H19N3O2	small molecule	-	40580-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPBNRIOWIXYZFK-UHFFFAOYSA-N
4438	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Kallen J (1999)	10493852	4708	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4439	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Farina HG (2002)	12405293	174503	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4440	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Buxbaum JD (2001)	12214063	174502	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4441	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Abe Y (2002)	12172803	174501	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4442	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Podar K (2009)	19249983	174500	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4443	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Baranova NA (2002)	12369143	174506	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4444	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Miyazaki A (2002)	12204108	174505	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4445	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Dimitroulakos J (2002)	12082550	174504	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4446	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4447	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	unknown	target	Lin YC (2008)	18381445	112336	220	Lovastatin	Mevinolin|Lovastatina|Mevacor|Lovastatinum|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|6-alpha-methylcompactin|LOVASTATIN|(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|MK-803|ML-530b|6-methylcompactin|6alpha-Methylcompactin|Lovastatine	dom-lovastatin|phl-lovastatin|	DRUGBANK	DB00227	C24H36O5	small molecule	C10BA01|C10AA02	75330-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCZOHLXUXFIOCF-BXMDZJJMSA-N
4448	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Kosk-Kosicka D (1993)	8214757	174516	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4449	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Kosk-Kosicka D (1993)	8214757	174516	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4450	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Kosk-Kosicka D (1994)	7873420	174517	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4451	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Matchett GA (2009)	19298752	174518	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4452	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Dildy-Mayfield JE (1996)	8786535	174519	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4453	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4454	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4455	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4456	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4457	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4458	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4459	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4460	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4461	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4462	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4463	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4464	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4465	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4466	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4467	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4468	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4469	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4470	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4471	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4472	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4473	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4474	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4475	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4476	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4477	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4478	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4479	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4480	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4481	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4482	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4483	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4484	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4485	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4486	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4487	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4488	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4489	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4490	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4491	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4492	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4493	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4494	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4495	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4496	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4497	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4498	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4499	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4500	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4501	109005	2743	-	GLRB	HKPX2	9606	Homo sapiens	agonist	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4502	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4503	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Namba T (2000)	10794813	174523	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4504	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Gazulla J (2006)	16899342	174529	223	Pregabalin	S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008	pregabalin-150|ran-pregabalin|	DRUGBANK	DB00230	C8H17NO2	small molecule	N03AX16	148553-50-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYXYPKUFHZROOJ-ZETCQYMHSA-N
4505	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Jacquy J (2006)	17144644	174528	223	Pregabalin	S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008	pregabalin-150|ran-pregabalin|	DRUGBANK	DB00230	C8H17NO2	small molecule	N03AX16	148553-50-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYXYPKUFHZROOJ-ZETCQYMHSA-N
4506	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Taylor CP (2007)	17126531	174530	223	Pregabalin	S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008	pregabalin-150|ran-pregabalin|	DRUGBANK	DB00230	C8H17NO2	small molecule	N03AX16	148553-50-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYXYPKUFHZROOJ-ZETCQYMHSA-N
4507	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Gazulla J (2007)	17489948	174531	223	Pregabalin	S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008	pregabalin-150|ran-pregabalin|	DRUGBANK	DB00230	C8H17NO2	small molecule	N03AX16	148553-50-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYXYPKUFHZROOJ-ZETCQYMHSA-N
4508	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Field MJ (2006)	17088553	174532	223	Pregabalin	S-(+)-3-isobutylgaba|Lyrica|3-Isobutyl gaba|(S)-3-Isobutyl gaba|CI-1008	pregabalin-150|ran-pregabalin|	DRUGBANK	DB00230	C8H17NO2	small molecule	N03AX16	148553-50-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYXYPKUFHZROOJ-ZETCQYMHSA-N
4509	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4510	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4511	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4512	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4513	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4514	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4515	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4516	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4517	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4518	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4519	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4520	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4521	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4522	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4523	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4524	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4525	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4526	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4527	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4528	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4529	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4530	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4531	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4532	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4533	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Dobbin M (2003)	12850901	174535	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4534	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Mant A (1993)	7911332	174536	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4535	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Miller EI (2006)	16959136	174203	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4536	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4537	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4538	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4539	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4540	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4541	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4542	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4543	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4544	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4545	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4546	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4547	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4548	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4549	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4550	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4551	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4552	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4553	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Couloigner V (1998)	9546276	174541	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4554	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4555	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4556	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Meyerson LR (1991)	1901209	174543	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4557	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Schaeffer P (1990)	2226620	174542	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4558	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4559	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4560	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	225	Methyclothiazide	Enduron	methyclothiazide|duretic 5mg	DRUGBANK	DB00232	C9H11Cl2N3O4S2	small molecule	C03AA08|C03AB08	135-07-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CESYKOGBSMNBPD-UHFFFAOYSA-N
4561	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Weber CK (2000)	11054378	174546	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4562	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Bantel H (2000)	11151876	174545	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4563	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4564	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4565	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4566	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4567	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4571	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4572	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4573	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mitchell HA (2006)	16893531	174557	227	Reboxetine	-	-	DRUGBANK	DB00234	C19H23NO3	small molecule	N06AX18	71620-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBQGYUDMJHNJBX-RTBURBONSA-N
4574	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Lin KS (2005)	15878511	174561	227	Reboxetine	-	-	DRUGBANK	DB00234	C19H23NO3	small molecule	N06AX18	71620-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBQGYUDMJHNJBX-RTBURBONSA-N
4575	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Rauhut AS (2002)	12388649	174560	227	Reboxetine	-	-	DRUGBANK	DB00234	C19H23NO3	small molecule	N06AX18	71620-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBQGYUDMJHNJBX-RTBURBONSA-N
4576	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Wilson AA (2003)	12623106	174562	227	Reboxetine	-	-	DRUGBANK	DB00234	C19H23NO3	small molecule	N06AX18	71620-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBQGYUDMJHNJBX-RTBURBONSA-N
4577	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Kasper S (2000)	11249515	174558	227	Reboxetine	-	-	DRUGBANK	DB00234	C19H23NO3	small molecule	N06AX18	71620-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBQGYUDMJHNJBX-RTBURBONSA-N
4578	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Spivak B (2006)	16633143	174559	227	Reboxetine	-	-	DRUGBANK	DB00234	C19H23NO3	small molecule	N06AX18	71620-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBQGYUDMJHNJBX-RTBURBONSA-N
4579	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	228	Milrinone	1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone	milrinone lactate|milrinone la	DRUGBANK	DB00235	C12H9N3O	small molecule	C01CE02	78415-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZRHRDRVRGEVNW-UHFFFAOYSA-N
4580	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Zhang W (2002)	12181427	174565	228	Milrinone	1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone	milrinone lactate|milrinone la	DRUGBANK	DB00235	C12H9N3O	small molecule	C01CE02	78415-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZRHRDRVRGEVNW-UHFFFAOYSA-N
4581	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Kuethe A (2000)	10859452	174564	228	Milrinone	1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone	milrinone lactate|milrinone la	DRUGBANK	DB00235	C12H9N3O	small molecule	C01CE02	78415-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZRHRDRVRGEVNW-UHFFFAOYSA-N
4582	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Shakur Y (2002)	12652111	174566	228	Milrinone	1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone	milrinone lactate|milrinone la	DRUGBANK	DB00235	C12H9N3O	small molecule	C01CE02	78415-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZRHRDRVRGEVNW-UHFFFAOYSA-N
4583	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Cone J (1999)	10511123	174563	228	Milrinone	1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone	milrinone lactate|milrinone la	DRUGBANK	DB00235	C12H9N3O	small molecule	C01CE02	78415-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZRHRDRVRGEVNW-UHFFFAOYSA-N
4584	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Lefievre L (2002)	12135876	1411	228	Milrinone	1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|Milrinonum|Milrinona|Milrinone	milrinone lactate|milrinone la	DRUGBANK	DB00235	C12H9N3O	small molecule	C01CE02	78415-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZRHRDRVRGEVNW-UHFFFAOYSA-N
4585	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4586	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4587	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4588	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4589	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4590	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4591	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4592	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4593	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4594	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4595	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4596	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4597	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4598	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4599	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4600	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4601	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4602	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4603	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4604	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4605	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4606	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4607	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4608	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4609	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4610	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4611	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4612	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4613	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4614	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4615	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4616	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4617	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4618	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4619	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4620	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4621	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4622	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4623	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4624	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4625	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4626	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4627	1218855	3635917	C2_02460W_A	ERG7	CaO19.1570|CA3994|CAWG_04014|CaO19.9143|C2_02460W|orf6.6427|orf6.480|IPF19258.2|CaO6.6427|Contig4-2925_0007|CaO6.480|orf19.1570|IPF8270.1|C2_02460W_B|orf19.9143	237561	Candida albicans	inhibitor	target	Gebre-Hiwot A (1993)	8144423	174574	232	Oxiconazole	Oxiconazol|Oxiconazole|Oxiconazolum	oxiconazole nitrate cream 1%|o	DRUGBANK	DB00239	C18H13Cl4N3O	small molecule	D01AC11|G01AF17	64211-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRJJEGAJXVEBNE-HKOYGPOVSA-N
4628	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Carrillo-Munoz AJ (2006)	16964330	174576	232	Oxiconazole	Oxiconazol|Oxiconazole|Oxiconazolum	oxiconazole nitrate cream 1%|o	DRUGBANK	DB00239	C18H13Cl4N3O	small molecule	D01AC11|G01AF17	64211-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRJJEGAJXVEBNE-HKOYGPOVSA-N
4629	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Rossello A (2002)	12383016	174575	232	Oxiconazole	Oxiconazol|Oxiconazole|Oxiconazolum	oxiconazole nitrate cream 1%|o	DRUGBANK	DB00239	C18H13Cl4N3O	small molecule	D01AC11|G01AF17	64211-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRJJEGAJXVEBNE-HKOYGPOVSA-N
4630	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Labeur M (2010)	20920967	174580	233	Alclometasone	7-Chloro-16-methylprednisolone|(7alpha,11beta,16alpha)-7-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione	aclovate|alclometasone dipropi	DRUGBANK	DB00240	C22H29ClO5	small molecule	D07AB10|S01BA10	67452-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJXOGVLKCZQRDN-PHCHRAKRSA-N
4631	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hofmann TG (1998)	9891987	174579	233	Alclometasone	7-Chloro-16-methylprednisolone|(7alpha,11beta,16alpha)-7-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione	aclovate|alclometasone dipropi	DRUGBANK	DB00240	C22H29ClO5	small molecule	D07AB10|S01BA10	67452-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJXOGVLKCZQRDN-PHCHRAKRSA-N
4632	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4633	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4634	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4635	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4636	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4637	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4638	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4639	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4640	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4641	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4642	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Cutrer FM (2001)	11279945	174583	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4643	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4644	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4645	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4646	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4647	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4648	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4649	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4650	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4651	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4652	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4653	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4654	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4655	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4656	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4657	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4658	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4659	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	inducer	target	Takimoto T (1988)	3260648	174589	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4660	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	inducer	target	Dumontet C (1999)	10500836	174588	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4661	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	inducer	target	Bzowska A (1995)	8521855	174587	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4662	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	inducer	target	Dumontet C (1999)	10444166	174586	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4663	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	inducer	target	Carson DA (1982)	6808516	174585	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4664	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Kline JP (2005)	16316309	174590	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4665	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Hartman WR (2004)	14722255	174591	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4666	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4667	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Takahashi T (1999)	9923554	174593	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4668	119071	50484	-	RRM2B	MTDPS8A|MTDPS8B|P53R2	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17852710	174594	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4669	119071	50484	-	RRM2B	MTDPS8A|MTDPS8B|P53R2	9606	Homo sapiens	inhibitor	target	Sampat K (2009)	19715446	174595	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4670	119071	50484	-	RRM2B	MTDPS8A|MTDPS8B|P53R2	9606	Homo sapiens	inhibitor	target	Kline JP (2005)	16316309	174590	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4671	119071	50484	-	RRM2B	MTDPS8A|MTDPS8B|P53R2	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4672	119071	50484	-	RRM2B	MTDPS8A|MTDPS8B|P53R2	9606	Homo sapiens	inhibitor	target	Takahashi T (1999)	9923554	174593	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4673	111422	5426	-	POLE	CRCS12|FILS|POLE1	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4674	111423	5427	-	POLE2	DPE2	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4675	121168	56655	-	POLE4	YHHQ1|p12	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4676	119903	54107	-	POLE3	CHARAC17|CHRAC17|YBL1|p17	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4677	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17852710	174594	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4678	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Sampat K (2009)	19715446	174595	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4679	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Kline JP (2005)	16316309	174590	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4680	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4681	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Takahashi T (1999)	9923554	174593	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4682	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17852710	174594	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4683	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Sampat K (2009)	19715446	174595	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4684	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Kline JP (2005)	16316309	174590	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4685	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4686	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Takahashi T (1999)	9923554	174593	235	Cladribine	2-Chlorodeoxyadenosine|(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|CldAdo|2-Chloro-2'-deoxy-beta-adenosine|Cladribinum|2-chloro-Deoxyadenosine|2ClAdo|2-CdA|2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine|Cladribina|2-Chloro-2'-deoxyadenosine|Cladribine	leustatin 1mg/ml|cladribine in	DRUGBANK	DB00242	C10H12ClN5O3	small molecule	L01BB04	4291-63-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOAARAWEBMLNO-KVQBGUIXSA-N
4687	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Rajamani S (2008)	19077543	174602	236	Ranolazine	-	ranexa	DRUGBANK	DB00243	C24H33N3O4	small molecule	C01EB18	95635-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
4688	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	236	Ranolazine	-	ranexa	DRUGBANK	DB00243	C24H33N3O4	small molecule	C01EB18	95635-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
4689	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Rajamani S (2008)	19077543	174602	236	Ranolazine	-	ranexa	DRUGBANK	DB00243	C24H33N3O4	small molecule	C01EB18	95635-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
4690	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hale SL (2006)	17220471	174603	236	Ranolazine	-	ranexa	DRUGBANK	DB00243	C24H33N3O4	small molecule	C01EB18	95635-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKLMZUWKNUAPSZ-UHFFFAOYSA-N
4691	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4692	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4693	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4694	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Schwab M (2008)	18544567	174605	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4695	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4696	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rousseaux C (2005)	15824083	174607	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4697	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4698	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4699	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4700	110493	4353	-	MPO	-	9606	Homo sapiens	unknown	target	Nandi J (2008)	17503181	174609	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4701	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Weber CK (2000)	11054378	174546	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4702	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Bantel H (2000)	11151876	174545	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4703	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4704	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Weber CK (2000)	11054378	174546	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4705	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Bantel H (2000)	11151876	174545	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4706	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4709	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4710	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4711	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4712	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kulkarni SS (2006)	16460947	174610	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4713	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4714	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4715	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4716	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Reith ME (2001)	11395483	174615	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4717	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Simoni D (2001)	11277529	174614	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4718	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Zou MF (2001)	11728190	174613	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4719	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Todd CL (1999)	10230713	174612	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4720	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Katz JL (2001)	11349389	174611	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4721	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Kulkarni SS (2006)	16460947	174610	238	Benzatropine	Benztropine|Tropine Benzohydryl Ether|3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropinum|3alpha-(Diphenylmethoxy)tropane|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3-(diphenylmethoxy)-1H,5H-tropane|3alpha-(Diphenylmethoxy)-1alphah,5alphah-tropane|3endo-benzhydryloxytropane|Benzatropina|3-alpha-(diphenylmethoxy)tropane|3alpha-Benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|3-(diphenylmethoxy)tropane	cogentin inj 1mg/ml|bensylate 	DRUGBANK	DB00245	C21H25NO	small molecule	N04AC01	86-13-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIJXKZJWITVLHI-PMOLBWCYSA-N
4722	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4723	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4724	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4725	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4726	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4727	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Mamo D (2004)	15121646	174622	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4728	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Stahl SM (2004)	14728084	174620	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4729	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Mansbach RS (2001)	11509214	174621	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4730	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Ichikawa J (2002)	12445705	174617	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4731	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4732	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Lu BY (2002)	12530423	174619	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4733	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kast RE (2007)	17450180	174618	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4734	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4735	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4736	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4737	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4738	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4739	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4740	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4741	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4742	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4743	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4744	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Arnt J (1995)	7498321	174624	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4745	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4746	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4747	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Andersohn F (2010)	20075651	174625	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4748	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4749	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4750	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4751	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4752	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kopecek M (2005)	15726024	174628	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4753	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4754	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeger TF (1995)	7562537	174627	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4755	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4756	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Stahl SM (2004)	14728084	174620	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4757	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4764	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Meltzer HY (1999)	10432496	174635	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4765	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Stark AD (2007)	17242925	174634	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4766	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Meltzer HY (1995)	7583621	174633	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4767	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Seeger TF (1995)	7562537	174627	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4768	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Sprouse JS (1999)	10516958	174631	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4769	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4770	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Stahl SM (2004)	14728084	174620	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4771	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Wilner KD (2002)	11910268	174629	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4772	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Seeger TF (1995)	7562537	174627	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4773	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Sanchez C (2000)	11103883	174637	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4774	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Wood MD (2006)	16918396	174636	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4775	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4776	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Stahl SM (2004)	14728084	174620	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4777	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	binder	target	Matsumoto I (1992)	1738111	174640	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4778	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	binder	target	Adham N (1993)	8380639	174641	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4779	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Shaw AM (2000)	11061982	174644	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4780	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Prins NH (2001)	11704657	174645	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4781	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Connor JD (2001)	11720080	174646	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4782	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Geerts IS (1999)	10455282	174642	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4783	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Castilho VM (1999)	10080233	174643	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4784	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Schmuck K (1996)	8743744	174647	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4785	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Skyba DA (2003)	14581123	174652	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4786	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Scrogin KE (2000)	11049861	174651	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4787	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Sugimoto Y (2003)	14501155	174650	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4788	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Sugimoto Y (2003)	14517765	174648	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4789	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Pranzatelli MR (1991)	1838579	174649	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4790	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Sugimoto Y (2003)	14501155	174650	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4791	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	binder	target	Adham N (1993)	8380639	174641	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4792	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Johnson MP (2003)	12555241	174653	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4793	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	240	Methysergide	1-Methyllysergic acid butanolamide|(+)-N-(1-(Hydroxymethyl)propyl)-1-methyl-D-lysergamide|9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8-carboxamide|1-Methylmethylergonovine|Methysergidum|1-Methyl-D-lysergic acid butanolamide|(+)-9,10-Didehydro-N-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide|Metisergido|Metisergida|1-Methyl-dextro-lysergic acid (+)-1-hydroxy-2-butylamide|Methysergide|N-(1-(Hydroxymethyl)propyl)-1-methyl-dextro-(+)-lysergamide	sansert	DRUGBANK	DB00247	C21H27N3O2	small molecule	N02CA04	361-37-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPJZHOPZRAFDTN-NQUBZZJWSA-N
4794	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4795	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kageyama K (2002)	12008749	174661	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4796	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4797	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Ichikawa K (2001)	11436517	174659	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4798	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Pastor P (2003)	12721865	174660	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4799	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Linazasoro G (2008)	18303487	174658	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4800	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Curran MP (2004)	15341508	174657	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4801	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Miyagi M (1996)	8951172	174656	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4802	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lombardi G (2002)	12464354	174655	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4803	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	binder	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4804	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4805	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (2002)	12388667	174663	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4806	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4807	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4808	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4809	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	binder	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4810	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4811	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4812	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4813	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4814	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (2002)	12388667	174663	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4815	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4816	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4817	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4818	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Sharif NA (2010)	20426763	174666	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4819	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4820	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4821	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4822	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Sharif NA (2010)	20426763	174666	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4823	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Huang XP (2009)	19570945	174667	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4824	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4825	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4826	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4827	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4828	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4829	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4830	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2006)	16982285	174668	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4831	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Ichikawa K (2001)	11436517	174659	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4832	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4833	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4834	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2006)	16982285	174668	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4835	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Ichikawa K (2001)	11436517	174659	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4836	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4837	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	binder	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4838	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4839	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4840	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	binder	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4841	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4842	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (2002)	12388667	174663	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4843	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4844	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4845	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Millan MJ (2002)	12388666	174654	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4846	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4847	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Newman-Tancredi A (2002)	12388667	174663	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4848	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4849	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Sharif NA (2010)	20426763	174666	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4850	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4851	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4852	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Berman HM (2000)	10592235	172122	244	Terconazole	Terazol 3	terconazole|terazol 3 vaginal 	DRUGBANK	DB00251	C26H31Cl2N5O3	small molecule	G01AG02	67915-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLSQLHNBWJLIBQ-OZXSUGGESA-N
4853	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Cauwenbergh G (1989)	2677363	174677	244	Terconazole	Terazol 3	terconazole|terazol 3 vaginal 	DRUGBANK	DB00251	C26H31Cl2N5O3	small molecule	G01AG02	67915-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLSQLHNBWJLIBQ-OZXSUGGESA-N
4854	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Vanden Bossche H (1991)	1951574	174676	244	Terconazole	Terazol 3	terconazole|terazol 3 vaginal 	DRUGBANK	DB00251	C26H31Cl2N5O3	small molecule	G01AG02	67915-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLSQLHNBWJLIBQ-OZXSUGGESA-N
4855	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Tate SK (2005)	15805193	174679	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4856	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Tate SK (2006)	17001291	174678	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4857	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Mantegazza M (2010)	20298965	174680	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4858	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Mitiushin VM (1978)	150666	174681	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4859	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Swadron SP (2004)	15001403	174682	245	Phenytoin	Phentytoin|Phenytoinum|5,5-diphenylimidazolidine-2,4-dione|Fenitoina|Phenytoine|Diphenylhydantoin|5,5-Diphenyl-imidazolidine-2,4-dione|5,5-Diphenyltetrahydro-1H-2,4-imidazoledione|5,5-diphenyltetrahydro-1H-2,4-imidazoledione	phenytoin sodium injection usp	DRUGBANK	DB00252	C15H12N2O2	small molecule	N03AB52|N03AB02	57-41-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOFVDLJLONNDW-UHFFFAOYSA-N
4860	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	246	Medrysone	HMS|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione	hms	DRUGBANK	DB00253	C22H32O3	small molecule	S01BA08	2668-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZENKSODFLBBHQ-ILSZZQPISA-N
4861	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Southren AL (1983)	6336597	174690	246	Medrysone	HMS|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione	hms	DRUGBANK	DB00253	C22H32O3	small molecule	S01BA08	2668-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZENKSODFLBBHQ-ILSZZQPISA-N
4864	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Griffin MO (2010)	20592239	174691	247	Doxycycline	Doxycyclin|6-deoxy-5-oxytetracycline|Doxycycline (anhydrous)|5-hydroxy--6-deoxytetracycline|Doxiciclina|Doxycyclinum|Anhydrous doxycycline|6alpha-deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline	acticlate|doxycycline tablets|	DRUGBANK	DB00254	C22H24N2O8	small molecule	J01AA02|A01AB22	564-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIWCJUYHHGXTC-AKNGSSGZSA-N
4867	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Griffin MO (2010)	20592239	174691	247	Doxycycline	Doxycyclin|6-deoxy-5-oxytetracycline|Doxycycline (anhydrous)|5-hydroxy--6-deoxytetracycline|Doxiciclina|Doxycyclinum|Anhydrous doxycycline|6alpha-deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline	acticlate|doxycycline tablets|	DRUGBANK	DB00254	C22H24N2O8	small molecule	J01AA02|A01AB22	564-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIWCJUYHHGXTC-AKNGSSGZSA-N
4868	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	agonist	target	Greschik H (2004)	15161930	174694	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4869	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4870	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4871	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Baron S (2007)	17317669	116189	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4872	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Hart SA (2007)	17314305	174699	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4873	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kwok KC (2010)	20387803	174698	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4874	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Dixon A (2007)	17308373	174697	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4875	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bains M (2007)	17320868	174696	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4876	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Munoz G (2007)	17306201	174695	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4877	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Unknown Authors (2009)	19101832	174701	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4878	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Geistlinger TR (2004)	15123288	174700	248	Diethylstilbestrol	trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|,'-diethyl-(E)-4,4'-stilbenediol|trans-Diethylstilbesterol|Diethylstilbestrol|Stilboestrol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|4,4'-dihydroxy-,-diethylstilbene|DES|(e)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol|Dietilestilbestrol|trans-Diethylstilboesterol|Diethylstilbestrolum|Distilbene|trans-Diethylstilbestrol|alpha,Alpha'-diethyl-(e)-4,4'-stilbenediol	stilbestrol 1.0mg tablet|stilb	DRUGBANK	DB00255	C18H20O2	small molecule	G03CB02|L02AA04|G03CC05|L02AA01	56-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGLYKWWBQGJZGM-ISLYRVAYSA-N
4879	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	249	Lymecycline	Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline	-	DRUGBANK	DB00256	C29H38N4O10	small molecule	J01AA04	992-21-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHEVKYYGXVEWNO-UEPZRUIBSA-N
4880	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	249	Lymecycline	Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline	-	DRUGBANK	DB00256	C29H38N4O10	small molecule	J01AA04	992-21-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHEVKYYGXVEWNO-UEPZRUIBSA-N
4881	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Smythies JR (1972)	5087060	174706	249	Lymecycline	Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline	-	DRUGBANK	DB00256	C29H38N4O10	small molecule	J01AA04	992-21-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHEVKYYGXVEWNO-UEPZRUIBSA-N
4882	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	249	Lymecycline	Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline	-	DRUGBANK	DB00256	C29H38N4O10	small molecule	J01AA04	992-21-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHEVKYYGXVEWNO-UEPZRUIBSA-N
4883	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	249	Lymecycline	Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline	-	DRUGBANK	DB00256	C29H38N4O10	small molecule	J01AA04	992-21-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHEVKYYGXVEWNO-UEPZRUIBSA-N
4884	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Smythies JR (1972)	5087060	174706	249	Lymecycline	Tetracycline-L-methylene lysine|Limeciclina|Lymecyclinum|(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide|Tetracycline-L-methylenelysine|N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine|N-Lysinomethyltetracycline|N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline	-	DRUGBANK	DB00256	C29H38N4O10	small molecule	J01AA04	992-21-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHEVKYYGXVEWNO-UEPZRUIBSA-N
4885	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Gachotte D (1997)	9326581	19002	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4886	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Henry KW (2000)	10991846	52547	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4887	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Lorenz RT (1991)	1929324	25650	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4888	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Warrilow AG (2010)	20625155	174707	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4889	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Berman HM (2000)	10592235	172122	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4890	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Gachotte D (1997)	9326581	19002	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4891	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Henry KW (2000)	10991846	52547	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4892	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Lorenz RT (1991)	1929324	25650	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4893	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Warrilow AG (2010)	20625155	174707	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4894	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Berman HM (2000)	10592235	172122	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4895	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Brugnara C (1996)	8636434	174708	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4896	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
4897	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Prabhu V (1997)	9127492	174718	252	Sulfanilamide	P-Aminobenzenesulfonamide|Streptocide|Sulfamine|Para-aminobenzenesulfonamide|4-Azanylbenzenesulfonamide|4-Aminobenzene sulfonic acid amide|SA|Sulfanilamide|Prontosil album|Sulphanilamide|P-Aminobenzenesulfamide	avc vaginal|avc cream - 15%|av	DRUGBANK	DB00259	C6H8N2O2S	small molecule	D06BA05|J01EB06	63-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDDDEECHVMSUSB-UHFFFAOYSA-N
4898	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Djapa LY (2006)	16487326	71891	252	Sulfanilamide	P-Aminobenzenesulfonamide|Streptocide|Sulfamine|Para-aminobenzenesulfonamide|4-Azanylbenzenesulfonamide|4-Aminobenzene sulfonic acid amide|SA|Sulfanilamide|Prontosil album|Sulphanilamide|P-Aminobenzenesulfamide	avc vaginal|avc cream - 15%|av	DRUGBANK	DB00259	C6H8N2O2S	small molecule	D06BA05|J01EB06	63-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDDDEECHVMSUSB-UHFFFAOYSA-N
4899	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Nzila A (2006)	16997145	174717	252	Sulfanilamide	P-Aminobenzenesulfonamide|Streptocide|Sulfamine|Para-aminobenzenesulfonamide|4-Azanylbenzenesulfonamide|4-Aminobenzene sulfonic acid amide|SA|Sulfanilamide|Prontosil album|Sulphanilamide|P-Aminobenzenesulfamide	avc vaginal|avc cream - 15%|av	DRUGBANK	DB00259	C6H8N2O2S	small molecule	D06BA05|J01EB06	63-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDDDEECHVMSUSB-UHFFFAOYSA-N
4900	849690	945313	b0381	ddlA	ECK0376|JW0372	511145	Escherichia coli	inhibitor	target	Noda M (2004)	15302885	174720	253	Cycloserine	D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS	seromycin cap 250mg|cycloserin	DRUGBANK	DB00260	C3H6N2O2	small molecule	J04AB01	68-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYDCUQKUCUHJBH-UWTATZPHSA-N
4901	849690	945313	b0381	ddlA	ECK0376|JW0372	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	253	Cycloserine	D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS	seromycin cap 250mg|cycloserin	DRUGBANK	DB00260	C3H6N2O2	small molecule	J04AB01	68-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYDCUQKUCUHJBH-UWTATZPHSA-N
4902	849690	945313	b0381	ddlA	ECK0376|JW0372	511145	Escherichia coli	inhibitor	target	Chen X (2002)	11752352	171740	253	Cycloserine	D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS	seromycin cap 250mg|cycloserin	DRUGBANK	DB00260	C3H6N2O2	small molecule	J04AB01	68-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYDCUQKUCUHJBH-UWTATZPHSA-N
4903	849690	945313	b0381	ddlA	ECK0376|JW0372	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	253	Cycloserine	D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS	seromycin cap 250mg|cycloserin	DRUGBANK	DB00260	C3H6N2O2	small molecule	J04AB01	68-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYDCUQKUCUHJBH-UWTATZPHSA-N
4904	849690	945313	b0381	ddlA	ECK0376|JW0372	511145	Escherichia coli	inhibitor	target	Belanger AE (2000)	11073937	174721	253	Cycloserine	D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS	seromycin cap 250mg|cycloserin	DRUGBANK	DB00260	C3H6N2O2	small molecule	J04AB01	68-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYDCUQKUCUHJBH-UWTATZPHSA-N
4905	849690	945313	b0381	ddlA	ECK0376|JW0372	511145	Escherichia coli	inhibitor	target	McCoy AJ (2005)	15948948	174719	253	Cycloserine	D-(+)-Cycloserine|D-Cycloserine|Cycloserine|(+)-Cycloserine|Seromycin|Orientomycin|-Cycloserine|(R)-4-AMINO-isoxazolidin-3-one|Cycloserinum|cyclo-D-Serine|D-4-amino-3-Isoxazolidinone|Ro-1-9213|PA 94|D-4-amino-3-Isoxazolidone|(+)-4-Amino-3-isoxazolidinone|alpha-Cycloserine|Cicloserina|PA-94|DCS	seromycin cap 250mg|cycloserin	DRUGBANK	DB00260	C3H6N2O2	small molecule	J04AB01	68-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYDCUQKUCUHJBH-UWTATZPHSA-N
4906	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	254	Anagrelide	Anagrelida|Anagrelidum	pms-anagrelide|dom-anagrelide|	DRUGBANK	DB00261	C10H7Cl2N3O	small molecule	L01XX35	68475-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTBXOEAOVRKTNQ-UHFFFAOYSA-N
4907	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	254	Anagrelide	Anagrelida|Anagrelidum	pms-anagrelide|dom-anagrelide|	DRUGBANK	DB00261	C10H7Cl2N3O	small molecule	L01XX35	68475-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTBXOEAOVRKTNQ-UHFFFAOYSA-N
4908	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	254	Anagrelide	Anagrelida|Anagrelidum	pms-anagrelide|dom-anagrelide|	DRUGBANK	DB00261	C10H7Cl2N3O	small molecule	L01XX35	68475-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTBXOEAOVRKTNQ-UHFFFAOYSA-N
4909	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Venuti MC (1988)	2846839	174727	254	Anagrelide	Anagrelida|Anagrelidum	pms-anagrelide|dom-anagrelide|	DRUGBANK	DB00261	C10H7Cl2N3O	small molecule	L01XX35	68475-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTBXOEAOVRKTNQ-UHFFFAOYSA-N
4910	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Jopperi-Davis KS (2004)	15104113	174729	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4911	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Akella SS (1999)	10378469	174728	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4912	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Vallyathan V (1992)	1312851	174734	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4913	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Kirsch JD (2002)	12477282	174735	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4914	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Brodie AE (1992)	1394620	174730	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4915	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Powell SR (1987)	3806383	174731	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4916	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Doroshenko N (2004)	15321730	174732	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4917	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	inhibitor	target	Puglia CD (1984)	6094175	174733	255	Carmustine	Bischloroethyl nitrosourea|N,N'-Bis(2-chloroethyl)-N-nitrosourea|Gliadel|Bicnu (tn)|Carmustina|Carmustine|BCNU|Carmustinum|bis-chloroethylnitrosourea	gliadel wafer|gliadel|bicnu	DRUGBANK	DB00262	C5H9Cl2N3O2	small molecule	L01AD01	154-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLGOEMSEDOSKAD-UHFFFAOYSA-N
4918	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	256	Sulfisoxazole	3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide	sulfizole tab 500mg|sulfisoxaz	DRUGBANK	DB00263	C11H13N3O3S	small molecule	S01AB02|J01EB05	127-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHUHCSRWZMLRLA-UHFFFAOYSA-N
4919	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Jorgensen JH (2005)	16000430	174736	256	Sulfisoxazole	3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide	sulfizole tab 500mg|sulfisoxaz	DRUGBANK	DB00263	C11H13N3O3S	small molecule	S01AB02|J01EB05	127-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHUHCSRWZMLRLA-UHFFFAOYSA-N
4920	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Fiebelkorn KR (2005)	15673729	174737	256	Sulfisoxazole	3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide	sulfizole tab 500mg|sulfisoxaz	DRUGBANK	DB00263	C11H13N3O3S	small molecule	S01AB02|J01EB05	127-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHUHCSRWZMLRLA-UHFFFAOYSA-N
4921	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hong YL (1995)	7486915	174738	256	Sulfisoxazole	3,4-Dimethyl-5-sulphonamidoisoxazole|Sulfofurazole|Sulfisonazole|Sulfisoxazol|3,4-Dimethyl-5-sulfanilamidoisoxazole|Sulfadimethylisoxazole|Sulphafurazol|3,4-Dimethylisoxazole-5-sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide|Sulfafurazolum|N'-(3,4)dimethylisoxazol-5-yl-sulphanilamide|Sulphaisoxazole|Sulfisoxasole|3,4-Dimethyl-5-sulphanilamidoisoxazole|3,4-Dimethylisoxazole-5-sulfanilamide|5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole|Sulphafurazole|5-Sulfanilamido-3,4-dimethylisoxazole|3,4-Dimethyl-5-sulfonamidoisoxazole|Sulphisoxazol|Sulfasoxazole|Sulfaisoxazole|Sulfafurazole|Sulphofurazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide|4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide|Sulphadimethylisoxazole|5-(P-Aminobenzenesulphonamido)-3,4-dimethylisoxazole|Sulfafurazol|5-(P-Aminobenzenesulfonamido)-3,4-dimethylisoxazole|5-Sulphanilamido-3,4-dimethyl-isoxazole|N(1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide	sulfizole tab 500mg|sulfisoxaz	DRUGBANK	DB00263	C11H13N3O3S	small molecule	S01AB02|J01EB05	127-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHUHCSRWZMLRLA-UHFFFAOYSA-N
4922	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Zebrack JS (2009)	19637941	174739	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4923	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Staudt Y (2003)	12679135	174744	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4924	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4925	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Staudt A (2001)	11448474	174741	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4926	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Johnson JA (2003)	12844134	174740	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4927	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Liu J (2003)	14534524	174743	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4928	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Schaefer M (2000)	10913016	174742	257	Metoprolol	DL-metoprolol|Metoprolol slow release|(RS)-Metoprolol|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol	metoprolol succinate and hydro	DRUGBANK	DB00264	C15H25NO3	small molecule	C07AB02|C07BB02|C07BB52|C07FB02|C07AB52|C07CB02	51384-51-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUBSYMUCCVWXPE-UHFFFAOYSA-N
4929	107816	1429	-	CRYZ	-	9606	Homo sapiens	inhibitor	target	Maser E (1991)	1722672	174754	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4930	107816	1429	-	CRYZ	-	9606	Homo sapiens	inhibitor	target	Hao H (2007)	17305492	174752	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4931	107816	1429	-	CRYZ	-	9606	Homo sapiens	inhibitor	target	Audi SH (2003)	12882764	174753	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4932	107816	1429	-	CRYZ	-	9606	Homo sapiens	inhibitor	target	Asher G (2006)	16700548	174750	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4933	107816	1429	-	CRYZ	-	9606	Homo sapiens	inhibitor	target	Evans PJ (1999)	10561120	174751	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4934	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	inhibitor	target	Joseph P (2000)	10755406	174758	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4935	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	inhibitor	target	Floreani M (2000)	10874136	174759	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4936	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	inhibitor	target	Chen S (1999)	10419545	174756	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4937	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	inhibitor	target	Preusch PC (1990)	2113031	174757	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4938	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	inhibitor	target	Jaiswal AK (2000)	10683249	174755	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4939	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	inhibitor	target	Arriagada C (2000)	10949919	174760	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4940	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4941	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4942	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4943	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Wallin R (1986)	2424118	174761	259	Dicoumarol	bis-3,3'-(4-hydroxycoumarinyl)methane|Dicumarol|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxycoumarin)|Dicoumarol|3,3'-Methylen-bis(4-hydroxy-cumarin)|bis-hydroxycoumarin|di-(4-hydroxy-3-coumarinyl)methane|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|Bis(4-hydroxycoumarin-3-yl)methane|Dicoumarolum|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)	-	DRUGBANK	DB00266	C19H12O6	small molecule	B01AA01	66-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOBMPNYZJYQDGZ-UHFFFAOYSA-N
4944	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Tsuchiya K (1981)	6941742	174762	260	Cefmenoxime	(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-((1-methyl-1H-5-tetraazolylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure|Cefmenoxima|(6R,7R)-7-[[(2e)-2-(2-amino-1,3-Thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (iupac)|Cefmenoximum	-	DRUGBANK	DB00267	C16H17N9O5S3	small molecule	J01DD05	65085-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJJDBAOLQAWBMH-YCRCPZNHSA-N
4945	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4946	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4947	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Iida M (1999)	10446316	174765	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4948	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Matsukawa N (2007)	17573046	174764	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4949	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	de Mey C (1991)	1683559	174763	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4950	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4951	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4952	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4953	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4954	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4955	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4956	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4957	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4958	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4959	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4960	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4961	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4962	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4963	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4964	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4965	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4966	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4967	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Jordan VC (1983)	6872937	174767	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4968	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Wang JY (2006)	17236558	174766	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4969	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4970	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kupfer D (1990)	2307235	174768	262	Chlorotrianisene	Chlortrianizen|Chlortrianisestrol|Chloortrianisestrol|Chlorotrianizen|Chlortrianisoestrolum|Clorotrianiseno|Chlorotrianisenum|Chlorestrolo|Chlorotrianisine|Chlortrianisen	-	DRUGBANK	DB00269	C23H21ClO3	small molecule	G03CA06	569-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPSDSIWYFKGBC-UHFFFAOYSA-N
4971	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4972	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2009)	18974361	174771	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4973	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4974	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4975	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4976	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4977	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Zuehlke RD (1998)	9607315	174773	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4978	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Berjukow S (2000)	10766758	174774	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4979	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Hitzl M (2002)	12135765	174775	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4980	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4981	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Koschak A (2001)	11285265	174776	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4982	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4983	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4984	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2009)	18974361	174771	263	Isradipine	Isradipino|Dynacirc|Isradipinum	isradipine	DRUGBANK	DB00270	C19H21N3O5	small molecule	C08CA03	75695-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMJIYCCIJYRONP-UHFFFAOYSA-N
4985	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Ribeiro TC (1980)	7213132	174778	265	Betazole	Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine	-	DRUGBANK	DB00272	C5H9N3	small molecule	V04CG02	105-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXDFEQONERDKSS-UHFFFAOYSA-N
4986	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Leth R (1987)	3661710	174779	265	Betazole	Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine	-	DRUGBANK	DB00272	C5H9N3	small molecule	V04CG02	105-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXDFEQONERDKSS-UHFFFAOYSA-N
4987	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	265	Betazole	Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine	-	DRUGBANK	DB00272	C5H9N3	small molecule	V04CG02	105-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXDFEQONERDKSS-UHFFFAOYSA-N
4988	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Katz LB (1987)	2886642	174781	265	Betazole	Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine	-	DRUGBANK	DB00272	C5H9N3	small molecule	V04CG02	105-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXDFEQONERDKSS-UHFFFAOYSA-N
4989	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Katz LB (1986)	2874214	174780	265	Betazole	Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine	-	DRUGBANK	DB00272	C5H9N3	small molecule	V04CG02	105-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXDFEQONERDKSS-UHFFFAOYSA-N
4990	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Hammond JB (1988)	2892392	174782	265	Betazole	Ametazole|3-(beta-aminoethyl)pyrazole|3-(2-Aminoethyl)pyrazole|2-(1H-Pyrazol-5-yl)ethanamine|Betazolum|1H-pyrazole-3-ethanamine|3-(-aminoethyl)pyrazole|Betazol|2-(3-Pyrazolyl)ethylamine	-	DRUGBANK	DB00272	C5H9N3	small molecule	V04CG02	105-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXDFEQONERDKSS-UHFFFAOYSA-N
4991	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4992	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	antagonist	target	Braga MF (2009)	19417176	174783	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4993	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	antagonist	target	Gryder DS (2003)	12904467	174785	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4994	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	12724156	174784	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4995	109154	2897	-	GRIK1	EAA3|EEA3|GLR5|GLUR5|GluK1	9606	Homo sapiens	antagonist	target	Kaminski RM (2004)	15111016	174786	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4996	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4997	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Braga MF (2009)	19417176	174783	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4998	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4999	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Nowakowska E (2009)	19998575	174787	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5000	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Abbate F (2004)	14684331	174789	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5001	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Dodgson SJ (2000)	10768298	174788	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5002	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Masereel B (2002)	11784136	174790	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5003	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Vullo D (2004)	14971907	174791	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5004	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Ceulemans B (2004)	15508261	174792	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5005	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Ceulemans B (2004)	15526956	174793	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5006	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Coppola G (2002)	11948006	174796	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5007	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Korff C (2007)	17621480	174794	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5008	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Nieto Barrera M (2003)	12861512	174795	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5009	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Di Fiore A (2007)	17251017	174798	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5010	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Maryanoff BE (2005)	15771438	174799	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5011	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Ma L (2007)	17521680	174797	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5012	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Casini A (2003)	12617904	174800	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5013	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Winum JY (2005)	15478125	174801	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5014	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	de la Rosa EJ (1985)	3898066	174802	267	Cefmetazole	Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum	-	DRUGBANK	DB00274	C15H17N7O5S3	small molecule	J01DC09	56796-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNBUBQHDYVFSQF-HIFRSBDPSA-N
5015	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	de la Rosa EJ (1985)	3898066	174802	267	Cefmetazole	Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum	-	DRUGBANK	DB00274	C15H17N7O5S3	small molecule	J01DC09	56796-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNBUBQHDYVFSQF-HIFRSBDPSA-N
5016	849607	945222	b0632	dacA	ECK0625|JW0627|pfv	511145	Escherichia coli	inhibitor	target	de la Rosa EJ (1985)	3898066	174802	267	Cefmetazole	Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum	-	DRUGBANK	DB00274	C15H17N7O5S3	small molecule	J01DC09	56796-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNBUBQHDYVFSQF-HIFRSBDPSA-N
5017	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	de la Rosa EJ (1985)	3898066	174802	267	Cefmetazole	Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum	-	DRUGBANK	DB00274	C15H17N7O5S3	small molecule	J01DC09	56796-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNBUBQHDYVFSQF-HIFRSBDPSA-N
5018	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	de la Rosa EJ (1985)	3898066	174802	267	Cefmetazole	Cefmetazolo|(6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefmetazolum	-	DRUGBANK	DB00274	C15H17N7O5S3	small molecule	J01DC09	56796-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNBUBQHDYVFSQF-HIFRSBDPSA-N
5019	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5020	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Kreutz R (2006)	17163232	174806	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5021	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Koike H (2001)	11451212	174807	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5022	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Warner GT (2002)	12076183	174810	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5023	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Mire DE (2005)	16220064	174808	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5024	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Ochiai K (2006)	16775509	174809	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5025	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5026	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Finlay GJ (2000)	10691026	174815	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5027	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Matsumoto Y (2001)	11473732	174814	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5028	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Ferlin MG (2000)	11006484	174816	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5029	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Lee MS (1992)	1311390	174813	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5030	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Arimondo P (2000)	11716434	174812	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5031	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Nitiss JL (1992)	1322791	23092	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5032	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15148258	174817	269	Amsacrine	4'-(9-Acridinylamino)methanesulphon-m-anisidide|Acridinyl anisidide|4'-(9-Acridinylamino)methanesulfon-meta-anisidide|4'-(9-Acridinylamino)methanesulfon-m-anisidide|m-AMSA|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide|mAMSA|Amsacrine	amsa pd inj 50mg/ml	DRUGBANK	DB00276	C21H19N3O3S	small molecule	L01XX01	51264-14-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCPGHVQEEXUHNC-UHFFFAOYSA-N
5033	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Lipworth BJ (2005)	15639300	174818	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5034	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Nantwi KD (2004)	14992338	174820	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5035	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5036	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5037	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Philipp S (2006)	16545350	174821	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5038	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Holgate ST (2005)	15980878	174822	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5039	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Phelps PT (2006)	16581066	174823	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5040	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Fozard JR (2003)	12954362	174824	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5041	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5042	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Wang K (2002)	12421478	174828	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5043	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Rickards KJ (2003)	12887610	174829	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5044	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Haider S (2003)	12547256	174825	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5045	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Usta C (2004)	15253881	174826	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5046	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Lee JM (2004)	15351234	174827	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5047	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5048	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Pechlivanova DM (2005)	16357952	174830	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5049	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Rickards KJ (2003)	12887610	174829	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5050	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Kajikawa S (2006)	16651698	174832	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5051	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Wu BN (2004)	15237094	174831	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5052	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5053	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	activator	target	Cosio BG (2004)	15337792	174834	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5054	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	activator	target	Ito K (2002)	12070353	174833	270	Theophylline	1,3-dimethyl-7H-purine-2,6-dione|Theophylline, anhydrous|Theophylline anhydrous|1,3-dimethylxanthine|Theophyllin	theo-24|idm tab|theolair|theop	DRUGBANK	DB00277	C7H8N4O2	small molecule	R03DA54|R03DA74|R03DB04|R03DA04	58-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFXYFBGIUFBOJW-UHFFFAOYSA-N
5055	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5056	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Kawada T (1999)	10226408	174842	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5057	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Matsuo T (1995)	10608016	174843	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5058	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Sakai M (1999)	10353669	174840	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5059	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Serebruany VL (1999)	10608050	174841	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5060	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Jang IK (1999)	10362188	174844	271	Argatroban	-	argatroban	DRUGBANK	DB00278	C23H36N6O5S	small molecule	B01AE03	74863-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXNPVXPOPUZYGB-XYVMCAHJSA-N
5061	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5062	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Kariv R (2003)	12955882	174848	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5063	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Jiang W (2004)	15283690	174849	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5064	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Timmer DC (2003)	14596673	174846	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5065	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Mai W (2004)	15240882	174847	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5066	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Sciaudone MP (2004)	15235154	174845	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5067	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5068	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5069	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5070	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Kullak-Ublick GA (2001)	11159893	174851	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5071	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Wu SY (2005)	16099238	174850	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5072	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Yen PM (2003)	12776178	174853	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5073	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Gonzalez-Sancho JM (2003)	12668276	174852	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5074	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Bernal J (2007)	17315033	174854	272	Liothyronine	Liothyroninum|L-3,5,3'-Triiodothyronine|T3|Triiodothyronine|3,5,3'-Triiodo-L-thyronine|3,5,3'-Triiodothyronine|Liotironina|3,5,3'TRIIODOTHYRONINE|Tresitope|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|L-T3|Liothyronine|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|Tertroxin|3,3',5-triiodo-L-thyronine	triostat|liothyronine sodium|n	DRUGBANK	DB00279	C15H12I3NO4	small molecule	H03AA02|H03AA03	6893-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUYYCJSJGJYCDS-LBPRGKRZSA-N
5075	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Yamamoto N (1999)	10413067	174865	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5076	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ishida Y (1990)	1690310	174866	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5077	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Yamamoto N (1999)	10413067	174865	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5078	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Ishida Y (1990)	1690310	174866	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5079	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Yamamoto N (1999)	10413067	174865	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5080	109954	3752	RP4-773A18.7	KCND3	KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22	9606	Homo sapiens	inhibitor	target	Casis O (1998)	9781919	174867	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5081	109953	3751	-	KCND2	KV4.2|RK5	9606	Homo sapiens	inhibitor	target	Casis O (1998)	9781919	174867	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5082	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5083	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	11196553	174870	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5084	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sugao M (2005)	15897781	174868	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5085	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Fujiki A (2004)	15028073	174869	273	Disopyramide	Disopyramidum|Disopiramida	rythmodan cap 150mg|norpace ca	DRUGBANK	DB00280	C21H29N3O	small molecule	C01BA03	3737-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTNFZQICZKOEM-UHFFFAOYNA-N
5086	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Muroi Y (2009)	19088384	174879	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5087	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Karoly R (2010)	20585544	174878	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5088	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Sheets PL (2007)	17430993	174880	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5089	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Sakaguchi M (2006)	16551906	174881	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5090	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Muroi Y (2009)	19088384	174879	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5091	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Karoly R (2010)	20585544	174878	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5092	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Ekberg J (2006)	17077153	174882	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5093	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Karoly R (2010)	20585544	174878	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5094	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Cerne A (2006)	16840798	174886	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5095	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Itoh H (2007)	17445919	174884	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5096	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Wallace CH (2006)	17016511	174885	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5097	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Fedida D (2006)	16686685	174883	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5098	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Muroi Y (2009)	19088384	174879	274	Lidocaine	2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|alpha-diethylamino-2,6-dimethylacetanilide|Lignocaine|2-(Diethylamino)-2',6'-acetoxylidide|-diethylamino-2,6-dimethylacetanilide	scar zone burn gel|sting relie	DRUGBANK	DB00281	C14H22N2O	small molecule	C05AD01|N01BB52|D04AB01|C01BB01|N01BB02|R02AD02|S01HA07|S02DA01	137-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNJVILVZKWQKPM-UHFFFAOYSA-N
5099	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Zhang PL (2004)	15487700	174888	275	Pamidronate	Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat	aredia liq inj 3mg/ml|val-pami	DRUGBANK	DB00282	C3H11NO7P2	small molecule	M05BA03	40391-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRUUGTRCQOWXEG-UHFFFAOYSA-N
5100	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Notarnicola M (2005)	15713990	174889	275	Pamidronate	Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat	aredia liq inj 3mg/ml|val-pami	DRUGBANK	DB00282	C3H11NO7P2	small molecule	M05BA03	40391-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRUUGTRCQOWXEG-UHFFFAOYSA-N
5101	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	275	Pamidronate	Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat	aredia liq inj 3mg/ml|val-pami	DRUGBANK	DB00282	C3H11NO7P2	small molecule	M05BA03	40391-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRUUGTRCQOWXEG-UHFFFAOYSA-N
5102	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Bergstrom JD (2000)	10620343	174891	275	Pamidronate	Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat	aredia liq inj 3mg/ml|val-pami	DRUGBANK	DB00282	C3H11NO7P2	small molecule	M05BA03	40391-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRUUGTRCQOWXEG-UHFFFAOYSA-N
5103	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Riebeling C (2002)	12177810	174890	275	Pamidronate	Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat	aredia liq inj 3mg/ml|val-pami	DRUGBANK	DB00282	C3H11NO7P2	small molecule	M05BA03	40391-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRUUGTRCQOWXEG-UHFFFAOYSA-N
5104	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Dunford JE (2001)	11160603	174892	275	Pamidronate	Acide pamidronique|Acidum pamidronicum|Pamidronic acid|Acido pamidronico|Ribodroat	aredia liq inj 3mg/ml|val-pami	DRUGBANK	DB00282	C3H11NO7P2	small molecule	M05BA03	40391-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRUUGTRCQOWXEG-UHFFFAOYSA-N
5105	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hallberg T (1984)	6701456	174899	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5106	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Dorsch W (1984)	6387510	174898	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5107	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Taniguchi K (1987)	2890562	174895	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5108	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hayashi H (1976)	1266718	174894	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5109	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Taniguchi K (1991)	1678430	174897	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5110	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Oishi R (1994)	7513381	174896	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5111	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5112	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Thomson NC (1980)	6449094	174902	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5113	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Thomas RH (1985)	4074605	174901	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5114	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Schran HF (1996)	8930778	174900	276	Clemastine	(+)-(2R)-2-(2-(((R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine|Meclastin|(+)-(2R)-2-[2-[[(R)-P-chloro-alpha-Methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine|Clemastina|Clemastine|Clemastinum	dayhist allergy 12 hour relief	DRUGBANK	DB00283	C21H26ClNO	small molecule	R06AA54|R06AA04|D04AA14	15686-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNNUSGIPVFPVBX-NHCUHLMSSA-N
5115	112371	6476	-	SI	-	9606	Homo sapiens	inhibitor	target	Newbrun E (1983)	6226260	174907	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5116	112371	6476	-	SI	-	9606	Homo sapiens	inhibitor	target	Samulitis BK (1987)	2962844	174906	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5117	112371	6476	-	SI	-	9606	Homo sapiens	inhibitor	target	Juretic D (2003)	12864906	174905	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5118	112371	6476	-	SI	-	9606	Homo sapiens	inhibitor	target	Karley AJ (2005)	16169004	174904	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5119	112371	6476	-	SI	-	9606	Homo sapiens	inhibitor	target	Meyer H (2004)	15322845	174903	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5120	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5121	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Bourbon JR (1987)	3539207	174910	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5122	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Li Y (2004)	15292070	174911	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5123	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Lundquist I (1992)	1594557	174912	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5124	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Gelb MH (2006)	16763908	174913	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5125	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Zhang H (2006)	16702880	174914	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5126	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Salehi A (2001)	11404235	174909	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5127	108823	2548	-	GAA	LYAG	9606	Homo sapiens	inhibitor	target	Luellmann-Rauch R (1987)	3467980	174908	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5128	106776	279	-	AMY2A	AMY2|AMY2B|PA	9606	Homo sapiens	inhibitor	target	Jonas L (2003)	12890998	174915	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5129	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5130	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Gelb MH (2006)	16763908	174913	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5131	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Zhang H (2006)	16702880	174914	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5132	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Yamagishi S (2009)	19275550	174916	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5133	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Okumiya T (2006)	16359900	174917	277	Acarbose	Acarbose|Acarbosum|Precose|Acarbosa|Glucobay	acarbose|glucobay|precose	DRUGBANK	DB00284	C25H43NO18	small molecule	A10BF01|A10BD17	56180-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFXOAAUWZOOIT-JMPDRRIHSA-N
5134	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5135	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Westenberg HG (2009)	19238127	174925	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5136	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Sindrup SH (2005)	15910402	174924	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5137	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Shang Y (2007)	17224717	174921	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5138	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Chen F (2005)	15695064	174920	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5139	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Gould GG (2006)	16140280	174923	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5140	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Van Ameringen M (2009)	19728573	174922	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5141	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Beique J (2000)	10884561	174918	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5142	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Malizia AL (1997)	9305421	174919	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5143	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mitchell HA (2006)	16893531	174557	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5144	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Westenberg HG (2009)	19238127	174925	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5145	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Sindrup SH (2005)	15910402	174924	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5146	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5147	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Beique JC (1998)	9669506	174926	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5148	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Van Ameringen M (2009)	19728573	174922	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5149	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Beique J (2000)	10884561	174918	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5150	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Bourin M (1999)	10434156	174929	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5151	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Barkin RL (2000)	11319571	174928	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5152	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Dawson LA (1999)	10462128	174930	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5153	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Lemke MR (2007)	17187269	174931	278	Venlafaxine	Venlafaxine|Venlafaxinum|Venlafaxina|Elafax	gd-venlafaxine xr|ran-venlafax	DRUGBANK	DB00285	C17H27NO2	small molecule	N06AX16	93413-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNVNVHUZROJLTJ-UHFFFAOYSA-N
5154	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Stroud FC (2006)	16884174	174936	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5155	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Smith MR (2006)	16985877	174937	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5156	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Hou NN (2006)	16955786	174940	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5157	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Gouva L (2006)	16982590	174938	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5158	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ropero AB (2006)	16876190	174939	279	Conjugated Equine Estrogens	Estrogens, Conjugated|conjugated estrogens	apo-conest tab 0.3mg|premphase	DRUGBANK	DB00286	C18H21NaO5S	small molecule	G03CA57|G03CC07	438-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCAHVBMSFIGAI-ZFINNJDLSA-M
5159	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Thieme H (2006)	16505027	161229	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5160	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5161	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Toris CB (2008)	19038618	174972	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5162	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Costagliola C (2009)	19929706	174973	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5163	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ota T (2005)	16249494	174971	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5164	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Lim KS (2008)	18452763	174976	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5165	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Arranz-Marquez E (2008)	18983226	174977	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5166	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Neacsu AM (2009)	19697832	174974	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5167	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ferrari G (1996)	9038626	174975	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5168	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5169	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Serres M (1994)	7981624	174978	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5170	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5171	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5172	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5173	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5174	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5175	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5176	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5177	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5178	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Tatsumi M (1997)	9537821	174430	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5179	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Michelson D (2003)	12547466	174990	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5180	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Gaillez C (2007)	18033153	174991	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5181	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Purper-Ouakil D (2005)	16142049	174992	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5182	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Wernicke JF (2003)	12862507	174987	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5183	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Garnock-Jones KP (2009)	19445548	174986	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5184	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Biederman J (2002)	12456942	174985	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5185	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Kaplan S (2004)	15801334	174984	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5186	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Wernicke JF (2004)	14709944	174989	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5187	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Spencer T (2002)	12523874	174988	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5188	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5189	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5190	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5191	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5192	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5193	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5194	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5195	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Tatsumi M (1997)	9537821	174430	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5196	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	binder	target	Bymaster FP (2002)	12431845	174994	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5197	110166	3978	-	LIG1	-	9606	Homo sapiens	inhibitor	target	Rose JL (2007)	17202402	174995	283	Bleomycin	Bleomicina|Bleomycinum|Bleomycin A2|BLM|Bleomycine|Bleomicin|Bleocin	bleomycin for injection usp|bl	DRUGBANK	DB00290	C55H84N17O21S3	small molecule	L01DC01	11056-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYVAGSVQBOHSSS-WXFSZRTFSA-O
5198	110168	3980	-	LIG3	LIG2	9606	Homo sapiens	inhibitor	target	Rose JL (2007)	17202402	174995	283	Bleomycin	Bleomicina|Bleomycinum|Bleomycin A2|BLM|Bleomycine|Bleomicin|Bleocin	bleomycin for injection usp|bl	DRUGBANK	DB00290	C55H84N17O21S3	small molecule	L01DC01	11056-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYVAGSVQBOHSSS-WXFSZRTFSA-O
5199	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Paris A (2003)	14508322	175001	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5200	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Creagh O (2010)	20496522	175002	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5201	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5202	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Desai R (2009)	19741491	175004	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5203	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5204	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5205	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Martin LJ (2009)	19809285	175003	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5206	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5207	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5208	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Cao S (1999)	10430100	175007	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5209	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Yin MB (1999)	10047461	175006	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5210	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Chen VJ (1999)	10598555	175012	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5211	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Orlandi L (1999)	10496350	175010	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5212	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Yang Z (2008)	18773878	175011	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5213	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Ferguson PJ (1999)	10482907	175009	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5214	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Grem JL (1999)	10499608	175008	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5215	108639	2356	RP11-228B15.1	FPGS	-	9606	Homo sapiens	antagonist	target	Innocenti F (2002)	11916544	175013	286	Raltitrexed	ZD1694|Raltitrexed|Tomudex	tomudex	DRUGBANK	DB00293	C21H22N4O6S	small molecule	L01BA03	112887-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVTVGDXNLFLDRM-HNNXBMFYSA-N
5216	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5217	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5218	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Sitruk-Ware R (2004)	15063480	175016	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5219	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Macpherson AM (1999)	10601100	175014	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5220	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Charnock-Jones DS (2000)	11041225	175015	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5221	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	287	Etonogestrel	Etonogestrelum|3-Ketodesogestrel|Implanon|3-Oxodesogestrel	nexplanon|implanon|nuvaring	DRUGBANK	DB00294	C22H28O2	small molecule	G03AC08	54048-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKFUYQCUCGESZ-BPIQYHPVSA-N
5222	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5223	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Kozak CA (1994)	7959748	175017	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5224	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5225	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Teodorov E (2006)	16753266	175018	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5226	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Leventhal L (1998)	9808678	175019	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5227	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5228	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Koch T (2006)	16539674	175025	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5229	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Dortch-Carnes J (2006)	16534251	175024	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5230	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Galeotti N (2006)	16650582	175023	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5231	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Kieffer BL (2002)	12015197	175022	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5232	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Yamada H (2006)	16530171	175021	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5233	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Asensio VJ (2006)	16678156	175020	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5234	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Castro RR (2006)	16580848	175027	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5235	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Choi HS (2006)	16580639	175026	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5236	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5237	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Yamada H (2006)	16530171	175021	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5238	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Johnson EA (2006)	16682505	175028	288	Morphine	Morfina|Morphin|()-morphine|(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|Morphia|Morphium|(-)-Morphine|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol|Morphinum|Morphine|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol	ms contin srt 15mg|doloral 1|s	DRUGBANK	DB00295	C17H19NO3	small molecule	N02AA01|A07DA52|N02AA51|N02AG01	57-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQJCRHHNABKAKU-KBQPJGBKSA-N
5239	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	289	Ropivacaine	Ropivacainum|(S)-()-1-propyl-2',6'-pipecoloxylidide|L-N-n-propylpipecolic acid-2,6-xylidide|Ropivacaine|Ropivacaina|(S)-ropivacaine	ropivacaine hydrochloride|ropi	DRUGBANK	DB00296	C17H26N2O	small molecule	N01BB09	84057-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKMNUMMKYBVTFN-GGYSOQFKNA-N
5240	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	289	Ropivacaine	Ropivacainum|(S)-()-1-propyl-2',6'-pipecoloxylidide|L-N-n-propylpipecolic acid-2,6-xylidide|Ropivacaine|Ropivacaina|(S)-ropivacaine	ropivacaine hydrochloride|ropi	DRUGBANK	DB00296	C17H26N2O	small molecule	N01BB09	84057-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKMNUMMKYBVTFN-GGYSOQFKNA-N
5241	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Liu BG (2000)	10781449	175035	289	Ropivacaine	Ropivacainum|(S)-()-1-propyl-2',6'-pipecoloxylidide|L-N-n-propylpipecolic acid-2,6-xylidide|Ropivacaine|Ropivacaina|(S)-ropivacaine	ropivacaine hydrochloride|ropi	DRUGBANK	DB00296	C17H26N2O	small molecule	N01BB09	84057-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKMNUMMKYBVTFN-GGYSOQFKNA-N
5242	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5243	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5244	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	unknown	target	Beloeil H (2009)	19690271	175037	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5245	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Sheets MF (2010)	20685573	175038	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5246	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5247	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5248	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5249	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Eltze M (1997)	9401944	175040	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5250	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5251	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5252	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5253	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5254	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	291	Dapiprazole	Dapiprazolum|5,6,7,8-Tetrahydro-3-(2-(4-(O-tolyl)-1-piperazinyl)ethyl)-S-triazolo(4,3-a)pyridine|Dapiprazol	-	DRUGBANK	DB00298	C19H27N5	small molecule	S01EX02	72822-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFWZESUMWJKKRN-UHFFFAOYSA-N
5255	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Imming P (2006)	17016423	171742	292	Penciclovir	9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine	denavir|penciclovir	DRUGBANK	DB00299	C10H15N5O3	small molecule	J05AB13|D06BB06	39809-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNTOCHDNEULJHD-UHFFFAOYSA-N
5256	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Chen X (2002)	11752352	171740	292	Penciclovir	9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine	denavir|penciclovir	DRUGBANK	DB00299	C10H15N5O3	small molecule	J05AB13|D06BB06	39809-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNTOCHDNEULJHD-UHFFFAOYSA-N
5257	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Agut H (2009)	19895215	175045	292	Penciclovir	9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine	denavir|penciclovir	DRUGBANK	DB00299	C10H15N5O3	small molecule	J05AB13|D06BB06	39809-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNTOCHDNEULJHD-UHFFFAOYSA-N
5258	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Scott GM (2005)	16033961	175044	292	Penciclovir	9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine	denavir|penciclovir	DRUGBANK	DB00299	C10H15N5O3	small molecule	J05AB13|D06BB06	39809-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNTOCHDNEULJHD-UHFFFAOYSA-N
5259	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Deval J (2009)	19228073	175046	292	Penciclovir	9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine|9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine|PCV|Penciclovirum|PE2|9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine|9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine	denavir|penciclovir	DRUGBANK	DB00299	C10H15N5O3	small molecule	J05AB13|D06BB06	39809-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNTOCHDNEULJHD-UHFFFAOYSA-N
5260	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Hanson AJ (2002)	12115473	175061	295	Tranexamic Acid	trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid	tranexamic acid|cyklokapron 50	DRUGBANK	DB00302	C8H15NO2	small molecule	B02AA02	1197-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYDJEQRTZSCIOI-LJGSYFOKSA-N
5261	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Dunn CJ (1999)	10400410	175060	295	Tranexamic Acid	trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid	tranexamic acid|cyklokapron 50	DRUGBANK	DB00302	C8H15NO2	small molecule	B02AA02	1197-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYDJEQRTZSCIOI-LJGSYFOKSA-N
5262	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	295	Tranexamic Acid	trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid	tranexamic acid|cyklokapron 50	DRUGBANK	DB00302	C8H15NO2	small molecule	B02AA02	1197-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYDJEQRTZSCIOI-LJGSYFOKSA-N
5263	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Bangert K (2000)	10959704	175058	295	Tranexamic Acid	trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid	tranexamic acid|cyklokapron 50	DRUGBANK	DB00302	C8H15NO2	small molecule	B02AA02	1197-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYDJEQRTZSCIOI-LJGSYFOKSA-N
5264	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Marti DN (1999)	10625440	175059	295	Tranexamic Acid	trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid	tranexamic acid|cyklokapron 50	DRUGBANK	DB00302	C8H15NO2	small molecule	B02AA02	1197-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYDJEQRTZSCIOI-LJGSYFOKSA-N
5265	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Jansen AJ (1999)	10673876	175057	295	Tranexamic Acid	trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Acide tranexamique|Trans AMCHA|Tranhexamic acid|trans-Amcha|Tranexamsaeure|Acido tranexamico|trans-4-aminomethylcyclohexane-1-carboxylic acid|trans-Tranexamic acid|Cyklokapron|Acidum tranexamicum|Tranexmic acid	tranexamic acid|cyklokapron 50	DRUGBANK	DB00302	C8H15NO2	small molecule	B02AA02	1197-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYDJEQRTZSCIOI-LJGSYFOKSA-N
5266	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Kohler J (1999)	10223931	175063	296	Ertapenem	(1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM	invanz	DRUGBANK	DB00303	C22H25N3O7S	small molecule	J01DH03	153832-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZNIMUFDBIJCM-ANEDZVCMSA-N
5267	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Kohler J (1999)	10223931	175063	296	Ertapenem	(1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM	invanz	DRUGBANK	DB00303	C22H25N3O7S	small molecule	J01DH03	153832-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZNIMUFDBIJCM-ANEDZVCMSA-N
5268	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Kohler J (1999)	10223931	175063	296	Ertapenem	(1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM	invanz	DRUGBANK	DB00303	C22H25N3O7S	small molecule	J01DH03	153832-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZNIMUFDBIJCM-ANEDZVCMSA-N
5269	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	Kohler J (1999)	10223931	175063	296	Ertapenem	(1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM	invanz	DRUGBANK	DB00303	C22H25N3O7S	small molecule	J01DH03	153832-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZNIMUFDBIJCM-ANEDZVCMSA-N
5270	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Kohler J (1999)	10223931	175063	296	Ertapenem	(1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM	invanz	DRUGBANK	DB00303	C22H25N3O7S	small molecule	J01DH03	153832-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZNIMUFDBIJCM-ANEDZVCMSA-N
5271	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Kohler J (1999)	10223931	175063	296	Ertapenem	(1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid|(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|ERTAPENEM	invanz	DRUGBANK	DB00303	C22H25N3O7S	small molecule	J01DH03	153832-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZNIMUFDBIJCM-ANEDZVCMSA-N
5272	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Juchem M (1990)	2175153	175067	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5273	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fuhrmann U (1995)	7750284	175066	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5274	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Rabe T (2000)	10836199	175065	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5275	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Fuhrmann U (1995)	7750284	175066	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5276	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5277	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Bergink EW (1983)	6645495	175068	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5278	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Macpherson AM (1999)	10601100	175014	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5279	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Charnock-Jones DS (2000)	11041225	175015	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5280	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Kloosterboer HJ (1988)	3139361	175069	297	Desogestrel	Cerazette|Desogestrelum|13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol	freya 21|linessa 28|apri|lines	DRUGBANK	DB00304	C22H30O	small molecule	G03AA09|G03FB10|G03AC09|G03AB05	54024-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPLCPCMSCLEKRS-BPIQYHPVSA-N
5281	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5282	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5283	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5284	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5285	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5286	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5287	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5288	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5289	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5290	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5291	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5292	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5293	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5294	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5295	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5296	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5297	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5298	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5299	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5300	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5301	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5302	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5303	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5304	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5305	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5306	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5307	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Rizvi N (2001)	14700480	175074	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5308	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Tsai DE (2008)	18765556	175075	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5309	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Yen WC (2006)	16495926	175076	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5310	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Yen WC (2005)	15897247	175077	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5311	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Rigas JR (2005)	15632250	175072	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5312	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Lowe MN (2001)	11702369	175073	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5313	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Tooker P (2007)	17483357	175078	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5314	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Lalloyer F (2006)	17008586	175079	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5315	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Farol LT (2004)	15056048	175080	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5316	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Rizvi N (2001)	14700480	175074	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5317	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Tsai DE (2008)	18765556	175075	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5318	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Yen WC (2006)	16495926	175076	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5319	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Yen WC (2005)	15897247	175077	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5320	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Rigas JR (2005)	15632250	175072	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5321	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Lowe MN (2001)	11702369	175073	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5322	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Tooker P (2007)	17483357	175078	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5323	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Lalloyer F (2006)	17008586	175079	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5324	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Farol LT (2004)	15056048	175080	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5325	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Rizvi N (2001)	14700480	175074	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5326	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Tsai DE (2008)	18765556	175075	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5327	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Yen WC (2006)	16495926	175076	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5328	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Yen WC (2005)	15897247	175077	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5329	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Rigas JR (2005)	15632250	175072	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5330	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Lowe MN (2001)	11702369	175073	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5331	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5332	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5333	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Tooker P (2007)	17483357	175078	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5334	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Lalloyer F (2006)	17008586	175079	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5335	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Farol LT (2004)	15056048	175080	300	Bexarotene	p-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl]benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|Bexarotene|Targrexin|Bexarotenum|Bexaroteno|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|Bexaroten|P-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|Bexarotne|Targretyn	targretin|bexarotene	DRUGBANK	DB00307	C24H28O2	small molecule	L01XX25	153559-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAVMQTYZDKMPEU-UHFFFAOYSA-N
5336	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	activator	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5337	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	activator	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5338	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5339	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	activator	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5340	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	activator	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5341	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5342	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5343	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5344	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5345	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5346	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5347	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	activator	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5348	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	activator	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5349	109976	3775	RP4-550F15.1	KCNK1	DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5350	109976	3775	RP4-550F15.1	KCNK1	DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5351	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5352	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5353	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	activator	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5354	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	activator	target	Foster RH (1997)	9257085	175082	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5355	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Yang T (2001)	11602820	175085	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5356	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Perry M (2004)	15266014	175084	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5357	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Perry M (2006)	16291873	175087	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5358	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Wolpert C (2007)	17497253	175086	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5359	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Doggrell SA (2005)	15926871	175081	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5360	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Wolpert C (2005)	16076272	175083	301	Ibutilide	Ibutilida|N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide|Ibutilidum|Ibutilide|Ibutilid	ibutilide fumarate|corvert	DRUGBANK	DB00308	C20H36N2O3S	small molecule	C01BD05	122647-31-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBUEHUHMBRLE-UHFFFAOYSA-N
5361	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	302	Vindesine	3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide	eldisine inj 5mg/2ml	DRUGBANK	DB00309	C43H55N5O7	small molecule	L01CA03	53643-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHJUWIANJFBDHT-KOTLKJBCSA-N
5362	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	302	Vindesine	3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide	eldisine inj 5mg/2ml	DRUGBANK	DB00309	C43H55N5O7	small molecule	L01CA03	53643-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHJUWIANJFBDHT-KOTLKJBCSA-N
5363	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Fiebig HH (2007)	17878523	175089	302	Vindesine	3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide	eldisine inj 5mg/2ml	DRUGBANK	DB00309	C43H55N5O7	small molecule	L01CA03	53643-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHJUWIANJFBDHT-KOTLKJBCSA-N
5364	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Natsume T (2000)	10920282	175088	302	Vindesine	3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide	eldisine inj 5mg/2ml	DRUGBANK	DB00309	C43H55N5O7	small molecule	L01CA03	53643-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHJUWIANJFBDHT-KOTLKJBCSA-N
5365	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Yoshida M (2007)	17465195	175090	302	Vindesine	3-Carbamoyl-4-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|3-(Aminocarbonyl)-O(4)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine|Desacetylvinblastine amide	eldisine inj 5mg/2ml	DRUGBANK	DB00309	C43H55N5O7	small molecule	L01CA03	53643-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHJUWIANJFBDHT-KOTLKJBCSA-N
5366	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	303	Chlorthalidone	Phthalamodine|2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide|Chlorphthalidolone|3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine|1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline|Chlortalidone|Phthalamudine|2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide|Chlorthalidone|3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine|1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline	tenoretic|apo chlorthalidone t	DRUGBANK	DB00310	C14H11ClN2O4S	small molecule	C03EA06|C03BA04|C03BB04	77-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVPVXMEBJLZRO-UHFFFAOYSA-N
5367	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	303	Chlorthalidone	Phthalamodine|2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide|Chlorphthalidolone|3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine|1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline|Chlortalidone|Phthalamudine|2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide|Chlorthalidone|3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine|1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline	tenoretic|apo chlorthalidone t	DRUGBANK	DB00310	C14H11ClN2O4S	small molecule	C03EA06|C03BA04|C03BB04	77-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVPVXMEBJLZRO-UHFFFAOYSA-N
5368	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	303	Chlorthalidone	Phthalamodine|2-chloro-5-(1-Hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide|Chlorphthalidolone|3-(4'-chloro-3'-Sulfamoylphenyl)-3-hydroxyphthalimidine|1-oxo-3-(3-Sulfamyl-4-chlorophenyl)-3-hydroxyisoindoline|Chlortalidone|Phthalamudine|2-chloro-5-(2,3-dihydro-1-Hydroxy-3-oxo-1H-isoindol-1-yl)benzenesulfonamide|Chlorthalidone|3-Hydroxy-3-(4-chloro-3-sulfamylphenyl)phthalimidine|1-keto-3-(3'-Sulfamyl-4'-chlorophenyl)-3-hydroxyisoindoline	tenoretic|apo chlorthalidone t	DRUGBANK	DB00310	C14H11ClN2O4S	small molecule	C03EA06|C03BA04|C03BB04	77-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVPVXMEBJLZRO-UHFFFAOYSA-N
5369	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5370	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5371	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Koehling R (2000)	10995826	175096	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5372	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Heck RW (1994)	7929150	175097	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5373	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Scozzafava A (2000)	10649985	175094	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5374	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Bertucci A (2009)	19520577	175095	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5375	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Perez Velazquez JL (2003)	12956733	175092	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5376	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Siffert W (1982)	6816217	175093	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5377	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	304	Ethoxzolamide	Ethoxazolamide|Ethoxyzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide	-	DRUGBANK	DB00311	C9H10N2O3S2	small molecule	-	452-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUZWUKMCLIBBOG-UHFFFAOYSA-N
5378	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5379	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5380	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5381	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5382	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5383	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5384	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Steinbach JH (2001)	11744750	175099	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5385	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5386	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5387	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5388	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Rahman M (2006)	16866778	175100	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5389	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Feigenspan A (2004)	15240758	175101	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5390	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Davies DL (2001)	11605100	175102	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5391	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5392	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5393	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5394	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5395	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5396	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5397	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5398	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5399	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5400	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5401	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5402	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5403	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5404	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5405	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5406	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5407	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5408	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5409	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5410	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5411	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5412	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5413	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5414	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5415	106554	36	RP11-162A23.1	ACADSB	2-MEBCAD|ACAD7|SBCAD	9606	Homo sapiens	inhibitor	target	Bazinet RP (2006)	16344985	175104	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5416	106554	36	RP11-162A23.1	ACADSB	2-MEBCAD|ACAD7|SBCAD	9606	Homo sapiens	inhibitor	target	Ito M (1990)	2112956	175105	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5417	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Semba J (1989)	2559361	175107	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5418	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Bruni J (1979)	110294	175108	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5419	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Rosenberg G (2007)	17514356	175109	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5420	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5421	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Loescher W (1982)	6805473	175106	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5422	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5423	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Ha JH (2000)	11025174	175110	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5424	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Rosenberg G (2007)	17514356	175109	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5425	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Kanai H (2004)	15289798	175113	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5426	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Beutler AS (2005)	15850602	175112	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5427	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Michaelis M (2004)	15242819	175111	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5428	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Ylisastigui L (2004)	15166525	175115	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5429	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Stockhausen MT (2005)	15685243	175114	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5430	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Kawano T (2010)	20811699	123468	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5431	111017	4967	-	OGDH	AKGDH|E1k|OGDC	9606	Homo sapiens	inhibitor	target	Johannessen CU (2003)	12847559	175116	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5432	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5433	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5434	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5435	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5436	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5437	112238	6334	-	SCN8A	CERIII|CIAT|EIEE13|MED|NaCh6|Nav1.6|PN4	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5438	112237	6332	-	SCN7A	NaG|Nav2.1|Nav2.2|SCN6A	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5439	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5440	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5441	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5442	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5443	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5444	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5445	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5446	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Johannessen CU (2003)	12847559	175116	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5447	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	unknown	target	Kraemer OH (2003)	12840003	110006	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5448	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	unknown	target	Goettlicher M (2004)	15124690	175118	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5449	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Martin GR (1997)	9399012	175123	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5450	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Reuter U (2004)	15096229	175126	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5451	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Le Grand B (2000)	10844127	175127	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5452	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Whale R (1999)	10463324	175124	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5453	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Hargreaves RJ (1999)	10563228	175125	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5454	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5455	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Pascual J (1998)	9859690	175129	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5456	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	de Almeida RM (2001)	11594437	175130	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5457	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5458	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Gowin JL (2010)	20407761	175128	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5459	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5460	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Wainscott DB (1998)	9718276	175131	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5461	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Villalon CM (2002)	12434581	175133	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5462	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Villalon CM (2003)	15320857	175132	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5463	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Reuter U (2004)	15096229	175126	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5464	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5465	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Bhalla P (2002)	11834243	174446	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5466	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	de Almeida RM (2001)	11594437	175130	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5467	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pascual J (1998)	9859690	175129	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5468	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Reuter U (2004)	15096229	175126	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5469	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Le Grand B (2000)	10844127	175127	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5470	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Whale R (1999)	10463324	175124	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5471	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Martin GR (1997)	9399012	175123	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5472	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Gowin JL (2010)	20407761	175128	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5473	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Hargreaves RJ (1999)	10563228	175125	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5474	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5475	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	308	Zolmitriptan	Zolmitriptanum|4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one|Zomig|Zolmitriptan|(S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one|311C90	sandoz zolmitriptan odt|mar-zo	DRUGBANK	DB00315	C16H21N3O2	small molecule	N02CC03	139264-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULSDMUVEXKOYBU-ZDUSSCGKSA-N
5476	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5477	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee YS (2007)	17175104	175138	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5478	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5479	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Weinheimer EM (2007)	17322116	175137	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5480	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2008)	17884974	175136	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5481	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Nicholson RI (2001)	11566608	175152	310	Gefitinib	N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa	iressa	DRUGBANK	DB00317	C22H24ClFN4O3	small molecule	L01XE02	184475-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGALLCVXEZPNRQ-UHFFFAOYSA-N
5482	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Albanell J (2001)	11522647	175151	310	Gefitinib	N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa	iressa	DRUGBANK	DB00317	C22H24ClFN4O3	small molecule	L01XE02	184475-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGALLCVXEZPNRQ-UHFFFAOYSA-N
5483	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Arteaga CL (2001)	11673690	175150	310	Gefitinib	N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa	iressa	DRUGBANK	DB00317	C22H24ClFN4O3	small molecule	L01XE02	184475-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGALLCVXEZPNRQ-UHFFFAOYSA-N
5484	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	310	Gefitinib	N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa	iressa	DRUGBANK	DB00317	C22H24ClFN4O3	small molecule	L01XE02	184475-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGALLCVXEZPNRQ-UHFFFAOYSA-N
5485	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Ciardiello F (2000)	10815932	175148	310	Gefitinib	N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa	iressa	DRUGBANK	DB00317	C22H24ClFN4O3	small molecule	L01XE02	184475-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGALLCVXEZPNRQ-UHFFFAOYSA-N
5486	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Moasser MM (2001)	11585753	175149	310	Gefitinib	N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|Gefitinib|ZD 1839|4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|Iressa	iressa	DRUGBANK	DB00317	C22H24ClFN4O3	small molecule	L01XE02	184475-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGALLCVXEZPNRQ-UHFFFAOYSA-N
5487	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5488	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5489	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	partial agonist	target	Mignat C (1995)	7885194	175160	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5490	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	partial agonist	target	Takahama K (2007)	17620111	175159	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5491	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5492	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Loghin F (2002)	12067475	175164	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5493	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Ortiz MI (2005)	16386786	175162	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5494	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Karlsson JA (1990)	2156065	175163	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5495	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Mignat C (1995)	7885194	175160	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5496	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Advenier C (1993)	8119316	175161	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5497	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5498	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Freissmuth M (1993)	8306082	175165	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5499	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Grond S (2004)	15509185	174252	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5500	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Takahama K (2007)	17620111	175159	311	Codeine	Codine|L-Codeine|3-Methylmorphin|7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|morphine-3-methyl ether|Codein|(5,6)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol|3-methylmorphine|O(3)-methylmorphine|Methylmorphine|Codena|Morphine monomethyl ether|morphine 3-methyl ether|()-Codeine|Codeinum|Codeine anhydrous|7,8-didehydro-4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6alpha-ol|morphine monomethyl ether	acetaminophen 500 mg with 15 m	DRUGBANK	DB00318	C18H21NO3	small molecule	N02AA79|N02AA59|R05DA04	76-57-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROGSEYTTFOCAN-DNJOTXNNSA-N
5501	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5502	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Buzzi MG (1992)	1379707	175175	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5503	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Villalon CM (2004)	14744615	175174	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5504	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Silberstein SD (2003)	12558771	175176	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5505	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Buzzi MG (1992)	1324091	175171	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5506	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Lesage AS (1998)	9605573	175173	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5507	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Hoyer D (1992)	1407010	175172	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5508	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Villalon CM (2004)	14744615	175174	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5509	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Schaerlinger B (2003)	12970106	157246	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5510	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5511	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Buzzi MG (1991)	1660351	175180	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5512	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Villalon CM (2004)	14744615	175174	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5513	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Yu XJ (1996)	8622623	175177	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5514	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Willems EW (1999)	10455274	175179	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5515	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pauwels PJ (1998)	9650800	175178	313	Dihydroergotamine	Dihydroergotamine|Diidroergotamina|Dihydroergotamin|9,10-dihydro-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide|Dihidroergotamina|Dihydroergotaminum|9,10-dihydroergotamine|5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman	migranal nasal spray 4mg/ml|di	DRUGBANK	DB00320	C33H37N5O5	small molecule	N02CA01|N02CA51	511-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUZRJRNZXALNLM-JGRZULCMSA-N
5516	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5517	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5518	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5519	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	inhibitor	target	Punke MA (2007)	17456683	175184	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5520	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	agonist	target	Jang SW (2009)	19549602	175185	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5521	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Punke MA (2007)	17456683	175184	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5522	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5523	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5524	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Lucchelli A (2000)	10997731	175186	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5525	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5526	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5527	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5528	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Kalia M (2005)	15877309	175187	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5529	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Gould GG (2006)	16140280	174923	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5530	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Troelsen KB (2005)	16032412	175188	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5531	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Ushijima K (2005)	16079297	175189	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5532	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Villard V (2011)	21427517	175190	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5533	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5534	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5535	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Ozdogan UK (2004)	14757140	175191	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5536	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5537	109510	3274	-	HRH2	H2R	9606	Homo sapiens	blocker	target	Angus JA (1980)	6103762	175192	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5538	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5539	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5540	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5541	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5542	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Onali P (2010)	19828880	175193	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5543	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inhibitor	target	Punke MA (2007)	17456683	175184	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5544	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5545	110970	4915	RP11-263K15.1	NTRK2	GP145-TrkB|TRKB|trk-B	9606	Homo sapiens	agonist	target	Jang SW (2009)	19549602	175185	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5546	109954	3752	RP4-773A18.7	KCND3	KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22	9606	Homo sapiens	inhibitor	target	Casis O (1998)	9781919	174867	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5547	109953	3751	-	KCND2	KV4.2|RK5	9606	Homo sapiens	inhibitor	target	Casis O (1998)	9781919	174867	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5548	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5549	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Sebben M (1994)	7696602	175195	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5550	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Kohen R (1996)	8522988	175194	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5551	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Onali P (2010)	19828880	175193	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5552	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5553	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5554	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5555	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5556	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	binder	target	Hamon M (1987)	3037421	175197	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5557	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	binder	target	Wahlstroem A (1994)	7971731	175196	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5558	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	inhibitor	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5559	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5560	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	binder	target	Werling LL (2007)	17689532	175182	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5561	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	binder	target	Nguyen T (2001)	11179435	175198	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5562	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	binder	target	Di Matteo V (2001)	11339973	175199	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5563	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Kuwa K (2000)	10697523	175207	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
5564	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Murakami Y (2000)	10891536	175210	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
5565	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Ferguson PJ (1999)	10482907	175009	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
5566	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Kuwa K (2000)	10697524	175209	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
5567	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Kubota T (1999)	10553409	175208	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
5568	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Ries V (2010)	20502133	175221	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5569	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5570	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Stocchi F (2007)	18046910	175222	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5571	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Kaakkola S (2000)	10882160	175220	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5572	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Guay DR (1999)	9917075	175218	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5573	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Truong DD (2009)	19503773	175219	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5574	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Apud JA (2007)	17063156	175213	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5575	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Tai CH (2002)	11873938	175214	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5576	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Ruottinen HM (1998)	9808337	175215	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5577	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Keating GM (2005)	15697329	175216	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5578	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Forsberg M (2003)	12538800	175217	316	Tolcapone	Tolcapon|Tolcaponum|4'-Methyl-3,4-dihydroxy-5-nitrobenzophenone|3,4-Dihydroxy-5-nitro-4'-methylbenzophenone|Tolcapona|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|Tolcapone|(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone	tasmar|tolcapone	DRUGBANK	DB00323	C14H11NO5	small molecule	N04BX01	134308-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIQPIUSUKVNLNT-UHFFFAOYSA-N
5579	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5580	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5581	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5582	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5583	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5584	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Samudre SS (2004)	15684812	175223	317	Fluorometholone	9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione|Fluorometholonum|Oxylone|Fluorometolona|Fluor-OP|NSC 33001|Fluorometholon|Fluoromtholone|Fluorometholone|(1R,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-1-fluoro-14,17-dihydroxy-2,8,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one	fml forte sus 0.25%|fml forte|	DRUGBANK	DB00324	C22H29FO4	small molecule	S01BB03|D10AA01|S01CA07|D07AB06|C05AA06|D07CB03|D07XB04|S01BA07|S01CB05	426-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAOZLTXFLGPHNG-KNAQIMQKSA-N
5585	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Madhani M (2006)	17016498	175225	318	Nitroprusside	[Fe(CN)5(NO)](2-)|Nitroferricyanide	sodium nitroprusside for injec	DRUGBANK	DB00325	C5FeN6O	small molecule	C02DD01	15078-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASPOIVQEUUCDQT-UHFFFAOYSA-N
5586	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Steinmetz M (2004)	15093694	175224	318	Nitroprusside	[Fe(CN)5(NO)](2-)|Nitroferricyanide	sodium nitroprusside for injec	DRUGBANK	DB00325	C5FeN6O	small molecule	C02DD01	15078-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASPOIVQEUUCDQT-UHFFFAOYSA-N
5587	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Fortin Y (2006)	16902599	175226	318	Nitroprusside	[Fe(CN)5(NO)](2-)|Nitroferricyanide	sodium nitroprusside for injec	DRUGBANK	DB00325	C5FeN6O	small molecule	C02DD01	15078-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASPOIVQEUUCDQT-UHFFFAOYSA-N
5588	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5589	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Gharagozlou P (2006)	16433932	175227	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5590	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5591	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5592	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	partial agonist	target	Guay DR (2007)	17658959	175229	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5593	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	partial agonist	target	Hartvig P (1989)	2478994	175228	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5594	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	partial agonist	target	Fang X (1997)	9301669	175232	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5595	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	partial agonist	target	Jiang Q (1994)	7511163	175230	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5596	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	partial agonist	target	Hennies HH (1988)	2849950	175231	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5597	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Kumar P (2008)	18789923	175236	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5598	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Sarhill N (2001)	11305075	175234	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5599	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Quigley C (2002)	11869661	175235	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5600	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Inturrisi CE (2002)	12479250	175233	320	Hydromorphone	Idromorfone|Hydromorfona|(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one|Hydromorphone|7,8-Dihydromorphinone|6-Deoxy-7,8-dihydro-6-oxomorphine|Hydromorphonum|Dihydromorfinon|Hidromorfona|4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone|Dimorphone|Dihydromorphinone|4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one	hydromorphone hydrochloride su	DRUGBANK	DB00327	C17H19NO3	small molecule	N02AA03|N02AG04	466-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLOADHCBXTIJK-YNHQPCIGSA-N
5601	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Fornai M (2005)	15831902	175237	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5602	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bobadilla L RA (2005)	15743404	175241	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5603	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Higuchi K (2005)	15700751	175240	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5604	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kundu N (2005)	15891886	175238	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5605	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Moth CW (2005)	15887968	175239	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5606	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Cho MC (2003)	12689521	175243	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5607	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Lehmann JM (1997)	9013583	175242	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5608	126915	145482	-	PTGR2	HEL-S-298|PGR2|ZADH1	9606	Homo sapiens	inhibitor	target	Wu YH (2008)	19000823	175244	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5609	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Hata AN (2005)	16030019	168216	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5610	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Hata AN (2005)	15563582	161179	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5611	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Mathiesen JM (2005)	15870392	175245	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5612	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	inhibitor	target	Sato S (2007)	17243824	175246	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5613	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Lehmann JM (1997)	9013583	175242	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pilane CM (2005)	15668944	175250	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jerde TJ (2005)	15667901	175249	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yokota A (2005)	15831440	175248	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Armstrong PJ (2005)	15770365	175247	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhang GS (2004)	15730717	175251	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5619	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Ruderman NB (2003)	14500570	175273	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5620	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Kovacic S (2003)	12890675	175276	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5621	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Vucicevic L (2009)	19428322	175277	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5622	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Leverve XM (2003)	14502105	175274	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5623	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Leclerc I (2004)	14871885	175275	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5624	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Hardie DG (2003)	12960015	175278	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5625	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Towler MC (2007)	17307971	175279	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5626	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	inducer	target	Musi N (2002)	12086935	175280	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWYZXLIPXDOLR-UHFFFAOYSA-N
5627	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Wellington K (2005)	15987237	175290	324	Ipratropium bromide	Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide	atroventhfa|combivent udv|atro	DRUGBANK	DB00332	C20H30BrNO3	small molecule	R01AX03|R03AL02|R03AL01|R03BB01	22254-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHLMOSXCXGLMMN-VVQPYUEFSA-M
5628	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Wellington K (2005)	15987237	175290	324	Ipratropium bromide	Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide	atroventhfa|combivent udv|atro	DRUGBANK	DB00332	C20H30BrNO3	small molecule	R01AX03|R03AL02|R03AL01|R03BB01	22254-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHLMOSXCXGLMMN-VVQPYUEFSA-M
5629	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Wellington K (2005)	15987237	175290	324	Ipratropium bromide	Ipratropium bromide (anhydrous)|Ipratropiumbromid|8-Isopropylnoratropine methobromide|Bromuro de ipratropio|3-hydroxy-8-isopropyl-1H,5H-tropanium bromide ()-tropate|Ipratropii bromidum|N-Isopropylnoratropinium bromomethylate|Ipratropium bromide anhydrous|Bromure d'ipratropium|(endo,syn)-()-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide	atroventhfa|combivent udv|atro	DRUGBANK	DB00332	C20H30BrNO3	small molecule	R01AX03|R03AL02|R03AL01|R03BB01	22254-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHLMOSXCXGLMMN-VVQPYUEFSA-M
5630	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5631	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5632	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5633	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Sotgiu ML (2009)	19717013	175293	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5634	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5635	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Gross ER (2009)	19843777	175294	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5636	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5637	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5638	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Kvam TM (2004)	14991152	175295	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5639	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Kakko J (2008)	17850768	175296	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5640	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Shi J (2002)	11933204	175297	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5641	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Deeb TZ (2009)	19131665	175298	325	Methadone	()-methadone|Methadonum|6-Dimethylamino-4,4-diphenyl-3-heptanone|(+/-)-Methadone|dl-Methadone|(+-)-Methadone	diskets|methadose dispersible|	DRUGBANK	DB00333	C21H27NO	small molecule	N07BC02|N02AC52	76-99-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSIQXCVUWKGNF-UHFFFAOYSA-N
5642	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5643	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Hutchison KE (2006)	16237394	175302	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5644	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5645	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5646	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5647	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5648	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5649	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5650	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5651	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5652	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yatham LN (2005)	16038601	175308	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5653	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	McDonald LM (2003)	14530903	175309	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5654	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Padin JF (2006)	16905159	175306	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5655	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Moresco RM (2004)	15358979	175307	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5656	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5657	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Sharpley AL (2005)	15816787	175305	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5658	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5659	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5660	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5661	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Fernandez J (2005)	15771415	175310	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5662	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5663	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Fernandez J (2005)	15771415	175310	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5664	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5665	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5666	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5667	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5668	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5669	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5670	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5671	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5672	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5673	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5674	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5675	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5676	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5677	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5678	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5679	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5680	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Poyurovsky M (2005)	15729086	175314	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5681	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5682	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5683	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Altschuler EL (2005)	15893120	175313	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5684	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Rasmussen K (2005)	16141369	175312	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5685	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5686	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5687	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5688	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5689	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5690	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5691	109593	3361	-	HTR5A	5-HT5A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5692	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5693	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5694	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5695	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5696	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5697	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5698	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5699	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lencz T (2006)	16513877	175319	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5700	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Jordan S (2007)	17092971	175318	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5701	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Weizman T (2003)	14575800	175315	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5702	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Thacker SK (2006)	17067304	175317	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5703	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Naiker DV (2006)	16730699	175316	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5704	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5705	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5706	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5707	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lencz T (2006)	16513877	175319	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5708	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Jordan S (2007)	17092971	175318	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5709	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Weizman T (2003)	14575800	175315	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5710	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Thacker SK (2006)	17067304	175317	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5711	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Naiker DV (2006)	16730699	175316	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5712	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5713	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5714	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5715	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5716	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5717	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5718	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5719	108833	2559	-	GABRA6	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5720	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5721	108834	2560	-	GABRB1	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5722	108842	2568	-	GABRP	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5723	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5724	108831	2557	-	GABRA4	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5725	108835	2561	-	GABRB2	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5726	108839	2565	-	GABRG1	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5727	108832	2558	-	GABRA5	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5728	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5729	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5730	108829	2555	-	GABRA2	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5731	108830	2556	-	GABRA3	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5732	108841	2567	-	GABRG3	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5733	108838	2564	-	GABRE	-	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5734	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5735	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5736	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5737	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Wood MD (2006)	16918396	174636	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5738	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Hertel P (2006)	16952163	175321	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5739	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Overstreet DH (2007)	17624999	175322	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5740	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Theisen FM (2007)	16983399	175323	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5741	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Zhang JY (2006)	16336943	175324	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5742	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Bymaster FP (1999)	10227113	175304	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5743	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Nuttall SL (2003)	12795776	175328	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5744	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5745	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Alberti C (1997)	9300315	175329	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5746	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5747	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Brown RA (2002)	12065078	175330	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5748	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Schaefer M (2000)	10913016	174742	327	Atenolol	1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|Atenololum	tenoretic|ftp-atenolol|dom-ate	DRUGBANK	DB00335	C14H22N2O3	small molecule	C07AB03|C07BB03|C07FB03|C07CB53|C07DB01|C07CB03	29122-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-UHFFFAOYSA-N
5749	852322	948014	b3500	gor	ECK3485|JW3467|gorA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5750	852322	948014	b3500	gor	ECK3485|JW3467|gorA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5751	852322	948014	b3500	gor	ECK3485|JW3467|gorA	511145	Escherichia coli	inhibitor	target	Vega-Teijido M (2006)	16275032	175331	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5752	849616	945231	b0618	citC	ECK0611|JW0610|ybeO	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5753	849616	945231	b0618	citC	ECK0611|JW0610|ybeO	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5754	850492	946132	b0871	poxB	ECK0862|JW0855	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5755	850492	946132	b0871	poxB	ECK0862|JW0855	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5756	852165	947854	b3236	mdh	ECK3225|JW3205	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5757	852165	947854	b3236	mdh	ECK3225|JW3205	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	328	Nitrofural	Nitrofurazone|Nitrofural|5-Nitro-2-furaldehyde semicarbazone|Furacilin|Furacin	-	DRUGBANK	DB00336	C6H6N4O4	small molecule	S02AA02|P01CC02|B05CA03|S01AX04|D08AF01|D09AA03	59-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAIWVQXQOWNYOU-FPYGCLRLSA-N
5758	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	potentiator	target	Reitamo S (2002)	12113647	175334	329	Pimecrolimus	Pimecrolimusum|Pimecrolimus|33-Epi-chloro-33-desoxyascomycin	elidel	DRUGBANK	DB00337	C43H68ClNO11	small molecule	D11AH02	137071-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KASDHRXLYQOAKZ-XDSKOBMDSA-N
5759	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	potentiator	target	Reitamo S (2002)	12113647	175334	329	Pimecrolimus	Pimecrolimusum|Pimecrolimus|33-Epi-chloro-33-desoxyascomycin	elidel	DRUGBANK	DB00337	C43H68ClNO11	small molecule	D11AH02	137071-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KASDHRXLYQOAKZ-XDSKOBMDSA-N
5760	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2009)	18925391	175337	330	Omeprazole	OMZ|OMEP|Prilosec|OMP	dg health omeprazole|genozol|q	DRUGBANK	DB00338	C17H19N3O3S	small molecule	A02BD01|A02BC01|A02BD05	73590-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-UHFFFAOYSA-N
5761	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Tajima A (2008)	19120905	175336	330	Omeprazole	OMZ|OMEP|Prilosec|OMP	dg health omeprazole|genozol|q	DRUGBANK	DB00338	C17H19N3O3S	small molecule	A02BD01|A02BC01|A02BD05	73590-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-UHFFFAOYSA-N
5762	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	330	Omeprazole	OMZ|OMEP|Prilosec|OMP	dg health omeprazole|genozol|q	DRUGBANK	DB00338	C17H19N3O3S	small molecule	A02BD01|A02BC01|A02BD05	73590-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-UHFFFAOYSA-N
5763	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Shi S (2008)	18679668	175338	330	Omeprazole	OMZ|OMEP|Prilosec|OMP	dg health omeprazole|genozol|q	DRUGBANK	DB00338	C17H19N3O3S	small molecule	A02BD01|A02BC01|A02BD05	73590-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-UHFFFAOYSA-N
5764	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5765	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5766	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5767	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5768	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5769	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5770	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5771	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5772	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5773	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5774	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	332	Metixene	Methixene|Metisene|Metixenum|Methixen|Metixeno	-	DRUGBANK	DB00340	C20H23NS	small molecule	N04AA03	4969-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJFJKKXQDNNUJF-UHFFFAOYSA-N
5775	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cavero I (1999)	10597865	175351	333	Cetirizine	Cetirizin|Cetirizina|Cetirizinum	target childrens all day aller	DRUGBANK	DB00341	C21H25ClN2O3	small molecule	R06AE07	83881-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-UHFFFAOYSA-N
5776	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tashiro M (2004)	15286093	175350	333	Cetirizine	Cetirizin|Cetirizina|Cetirizinum	target childrens all day aller	DRUGBANK	DB00341	C21H25ClN2O3	small molecule	R06AE07	83881-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-UHFFFAOYSA-N
5777	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tamura T (2005)	15942272	175347	333	Cetirizine	Cetirizin|Cetirizina|Cetirizinum	target childrens all day aller	DRUGBANK	DB00341	C21H25ClN2O3	small molecule	R06AE07	83881-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-UHFFFAOYSA-N
5778	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Christophe B (2003)	12787835	175348	333	Cetirizine	Cetirizin|Cetirizina|Cetirizinum	target childrens all day aller	DRUGBANK	DB00341	C21H25ClN2O3	small molecule	R06AE07	83881-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-UHFFFAOYSA-N
5779	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tillement JP (2003)	14505791	175349	333	Cetirizine	Cetirizin|Cetirizina|Cetirizinum	target childrens all day aller	DRUGBANK	DB00341	C21H25ClN2O3	small molecule	R06AE07	83881-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-UHFFFAOYSA-N
5780	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	333	Cetirizine	Cetirizin|Cetirizina|Cetirizinum	target childrens all day aller	DRUGBANK	DB00341	C21H25ClN2O3	small molecule	R06AE07	83881-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-UHFFFAOYSA-N
5781	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	binder	target	Yasuda SU (1999)	10212017	175352	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5782	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Salata JJ (1995)	8001268	175353	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5783	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wood-Baker R (1995)	7654486	175355	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5784	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Phillips GD (1989)	2569356	175354	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5785	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kishimoto W (1997)	9485522	175357	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5786	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Rafferty P (1987)	2879489	175356	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5787	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5788	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	binder	target	Yasuda SU (1999)	10212017	175352	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5789	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5790	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	binder	target	Yasuda SU (1999)	10212017	175352	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5791	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Yasuda SU (1999)	10212017	175352	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5792	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Gessner G (2004)	15102940	175359	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5793	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Testai L (2010)	20636881	175358	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5794	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	334	Terfenadine	Terfnadine|Terfenadin|Terfenadina|Terfenadine|Terfenadinum|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol	seldane 120mg once-a-day caple	DRUGBANK	DB00342	C32H41NO2	small molecule	R06AX12	50679-08-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUGOEEXESWIERI-UHFFFAOYSA-N
5795	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	335	Diltiazem	Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one	cardizem injectable liq 5mg/ml	DRUGBANK	DB00343	C22H26N2O4S	small molecule	C05AE03|C08DB01	42399-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSUGRBWQSSZJOP-RTWAWAEBSA-N
5796	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Romero M (2003)	15320693	175364	335	Diltiazem	Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one	cardizem injectable liq 5mg/ml	DRUGBANK	DB00343	C22H26N2O4S	small molecule	C05AE03|C08DB01	42399-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSUGRBWQSSZJOP-RTWAWAEBSA-N
5797	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	335	Diltiazem	Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one	cardizem injectable liq 5mg/ml	DRUGBANK	DB00343	C22H26N2O4S	small molecule	C05AE03|C08DB01	42399-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSUGRBWQSSZJOP-RTWAWAEBSA-N
5798	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Budriesi R (2009)	19929811	175363	335	Diltiazem	Diltiazemum|(2S,3S)-5-(2-(dimethylamino)Ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Diltiazem|(+)-cis-5-[2-(dimethylamino)Ethyl]-2,3-dihydro-3-hydroxy-2-(P-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(2S-cis)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one	cardizem injectable liq 5mg/ml	DRUGBANK	DB00343	C22H26N2O4S	small molecule	C05AE03|C08DB01	42399-41-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSUGRBWQSSZJOP-RTWAWAEBSA-N
5799	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5800	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Cheetham SC (1996)	8684598	175370	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5801	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5802	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5803	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5804	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Kovachich GB (1992)	1476595	175373	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5805	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Daws LC (1998)	9694957	175372	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5806	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Frazer A (1998)	9928259	175371	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5807	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rouillon F (1996)	8767026	175375	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5808	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	McDougle CJ (1998)	9672904	175374	336	Protriptyline	Protriptilina|Protriptyline|Protriptylin|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|Amimetilina|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene|N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine|3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine	triptil tab 10mg|protriptyline	DRUGBANK	DB00344	C19H21N	small molecule	N06AA11	438-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWPIARFWQZKAIA-UHFFFAOYSA-N
5809	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	McVary KT (2006)	16613526	175397	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5810	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Roehrborn CG (2001)	11750253	175396	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5811	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5812	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Kenny BA (1996)	8799556	175399	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5813	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Andersson KE (1997)	9122046	175398	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5814	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Elhilali MM (2006)	16553574	175401	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5815	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Faure C (1994)	8196478	175400	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5816	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Martin DJ (1997)	9223558	175403	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5817	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Lee M (2003)	12892027	175402	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5818	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Lowe FC (2004)	15639685	175405	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5819	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Beique L (1998)	9870119	175404	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5820	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	McVary KT (2006)	16613526	175397	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5821	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Roehrborn CG (2001)	11750253	175396	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5822	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5823	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Kenny BA (1996)	8799556	175399	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5824	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Andersson KE (1997)	9122046	175398	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5825	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Elhilali MM (2006)	16553574	175401	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5826	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Faure C (1994)	8196478	175400	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5827	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Lowe FC (2004)	15639685	175405	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5828	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Beique L (1998)	9870119	175404	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5829	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	McVary KT (2006)	16613526	175397	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5830	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Roehrborn CG (2001)	11750253	175396	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5831	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5832	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Kenny BA (1996)	8799556	175399	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5833	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Andersson KE (1997)	9122046	175398	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5834	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Elhilali MM (2006)	16553574	175401	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5835	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Faure C (1994)	8196478	175400	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5836	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Lowe FC (2004)	15639685	175405	338	Alfuzosin	Alfuzosinum|Alfuzosin|()-N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furamide|Alfuzosine|N-[3-[(4-amino-6,7-dimethoxy-quinazolin-2-yl)- methyl-amino]propyl] tetrahydrofuran- 2-carboxamide|Alfuzosina	alfuzosin hydrochloride extend	DRUGBANK	DB00346	C19H27N5O4	small molecule	G04CA01|G04CA51	81403-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNMJYKCGWZFFKR-UHFFFAOYSA-N
5837	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	339	Trimethadione	Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone	tridione	DRUGBANK	DB00347	C6H9NO3	small molecule	N03AC02	127-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRYJRGCIQBGHIV-UHFFFAOYSA-N
5838	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Shen H (2007)	17291698	175408	339	Trimethadione	Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone	tridione	DRUGBANK	DB00347	C6H9NO3	small molecule	N03AC02	127-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRYJRGCIQBGHIV-UHFFFAOYSA-N
5839	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	339	Trimethadione	Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone	tridione	DRUGBANK	DB00347	C6H9NO3	small molecule	N03AC02	127-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRYJRGCIQBGHIV-UHFFFAOYSA-N
5840	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	339	Trimethadione	Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone	tridione	DRUGBANK	DB00347	C6H9NO3	small molecule	N03AC02	127-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRYJRGCIQBGHIV-UHFFFAOYSA-N
5841	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Barton ME (2005)	16171802	175407	339	Trimethadione	Trimethadionum|Trimethinum|Trimthadione|Tridione|Trimethadion|Troxidone	tridione	DRUGBANK	DB00347	C6H9NO3	small molecule	N03AC02	127-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRYJRGCIQBGHIV-UHFFFAOYSA-N
5842	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	inhibitor	target	Hanauske-Abel HM (2002)	12142814	175412	340	Nitisinone	Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin	mdk-nitisinone|nitisinone tabl	DRUGBANK	DB00348	C14H10F3NO5	small molecule	A16AX04	104206-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBCNLGXQFSTLU-UHFFFAOYSA-N
5843	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	inhibitor	target	Fisher AA (2004)	15931360	175413	340	Nitisinone	Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin	mdk-nitisinone|nitisinone tabl	DRUGBANK	DB00348	C14H10F3NO5	small molecule	A16AX04	104206-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBCNLGXQFSTLU-UHFFFAOYSA-N
5844	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	340	Nitisinone	Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin	mdk-nitisinone|nitisinone tabl	DRUGBANK	DB00348	C14H10F3NO5	small molecule	A16AX04	104206-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBCNLGXQFSTLU-UHFFFAOYSA-N
5845	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	inhibitor	target	Yang DY (2003)	14668946	175411	340	Nitisinone	Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin	mdk-nitisinone|nitisinone tabl	DRUGBANK	DB00348	C14H10F3NO5	small molecule	A16AX04	104206-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBCNLGXQFSTLU-UHFFFAOYSA-N
5846	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	inhibitor	target	Suwannarat P (2005)	15931605	175414	340	Nitisinone	Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin	mdk-nitisinone|nitisinone tabl	DRUGBANK	DB00348	C14H10F3NO5	small molecule	A16AX04	104206-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBCNLGXQFSTLU-UHFFFAOYSA-N
5847	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5848	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5849	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5850	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5851	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5852	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5853	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5854	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5855	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5856	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5857	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5858	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5859	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5860	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5861	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5862	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5863	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5864	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5865	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5866	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5867	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5868	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5869	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5870	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5871	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5872	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5873	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5874	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5875	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5876	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5877	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5878	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5879	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inducer	target	Gaffar A (1995)	7560228	175418	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5880	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inducer	target	Kurbel S (1999)	10616041	175416	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5881	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inducer	target	Michelet JF (1997)	9008235	175417	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5882	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Evans JM (2005)	16169954	175419	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5883	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5884	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5885	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Black KL (2008)	18602898	175423	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5886	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Kirsten R (1998)	9646008	175422	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5887	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Bray KM (1992)	1601843	175421	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5888	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inducer	target	Loeffler-Walz C (1998)	9579735	175420	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5889	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Gonzalez Villarroel P (2008)	18411198	175429	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5890	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lamberts SW (1985)	2982481	175428	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5891	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Wiedemann K (1998)	9744490	175427	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5892	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chao Y (1997)	9195366	175426	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5893	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Kontula K (1983)	6222739	175425	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5894	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Wermers RA (2004)	15595341	175424	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5895	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Schindler AE (2009)	19434889	175430	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5896	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5897	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Lamberts SW (1985)	2982481	175428	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5898	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Vadivelu S (2010)	19731987	175434	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5899	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Gruber T (2004)	15086241	175433	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5900	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Wiedemann K (1998)	9744490	175427	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5901	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Mokbel K (2003)	14687437	175431	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5902	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Wentling GK (2005)	16343217	175432	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5903	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Wermers RA (2004)	15595341	175424	343	Megestrol acetate	6-Methyl-17-acetoxypregna-4,6-diene-3,20-dione|6-Dehydro-6-methyl-17alpha-acetoxyprogesterone|6-Methyl-6-dehydro-17-acetoxyprogesterone|17alpha-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate|6-Methyl-17-hydroxy-delta(sup 6)-progesterone acetate|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate|6-Dehydro-6-methyl-17-acetoxyprogesterone|6-Methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17-ol-3,20-dione acetate|MGA|17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione|6-Methyl-delta(sup 6)-dehydro-17-acetoxyprogesterone|17alpha-Acetoxy-6-dehydro-6-methylprogesterone|17-Acetoxy-6-dehydro-6-methylprogesterone|6-Methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione|6-Methyl-17alpha-hydroxy-delta(sup 6)-progesterone acetate|6-Methyl-6-dehydro-17alpha-acetoxyprogesterone|6-Methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione acetate	apo-megestrol|megace os|megace	DRUGBANK	DB00351	C23H30O4	small molecule	G03FA08|G03AB01|G03DB02|G03AA04|G03FB04|L02AB01|G03AC05	595-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URXWVWVPMJSAJD-KOORYGTMSA-N
5904	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5905	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5906	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5907	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Reyes FD (2005)	15930499	175441	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5908	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nargeot R (1999)	10200235	175442	345	Methylergometrine	9,10-Didehydro-N-[1-(hydroxymethyl)-propyl]-D-lysergamide|D-lysergic acid 1-butanolamide|Mthylergomtrine|Metilergometrina|Methylergometrine|Methylergometrinum|Ergotyl|Methergine|Methylergometrin|Methylergobasin|Methylergonovine	methylergonovine maleate|methe	DRUGBANK	DB00353	C20H25N3O2	small molecule	G02AB01|G02AC01	113-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBRKDKAWYKMIV-QWQRMKEZSA-N
5909	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5910	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5911	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5912	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5913	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	346	Buclizine	1-(P-Tert-butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine|Buclizine|Buclizinum|Buclizina	-	DRUGBANK	DB00354	C28H33ClN2	small molecule	R06AE01|R06AE51	82-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYGZHXDRJNJEP-UHFFFAOYSA-N
5914	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Mock CN (1995)	7487468	175445	347	Aztreonam	Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid	cayston|azactam|aztreonam	DRUGBANK	DB00355	C13H17N5O8S2	small molecule	J01DF01	78110-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZPBZJONDBGPKJ-VEHQQRBSSA-N
5915	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Fung-Tomc J (1997)	9145861	175444	347	Aztreonam	Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid	cayston|azactam|aztreonam	DRUGBANK	DB00355	C13H17N5O8S2	small molecule	J01DF01	78110-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZPBZJONDBGPKJ-VEHQQRBSSA-N
5916	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Overington JP (2006)	17139284	171741	347	Aztreonam	Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid	cayston|azactam|aztreonam	DRUGBANK	DB00355	C13H17N5O8S2	small molecule	J01DF01	78110-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZPBZJONDBGPKJ-VEHQQRBSSA-N
5917	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Rittenbury MS (1990)	2244291	175446	347	Aztreonam	Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid	cayston|azactam|aztreonam	DRUGBANK	DB00355	C13H17N5O8S2	small molecule	J01DF01	78110-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZPBZJONDBGPKJ-VEHQQRBSSA-N
5918	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Imming P (2006)	17016423	171742	347	Aztreonam	Aztreonam|Primbactam|Aztreonamum|Azactam|2-({[(1Z)-1-(2-amino-1,3-thiazol-4-yl) -2- {[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino} -2- oxoethylidene]amino}oxy)-2-methylpropanoic acid|Aztronam|(Z,)-2-((((2-Amino-4-thiazolyl)(((2S,3S,)-2-methyl-4-oxo-1-sulfo-3-azetidinyl)carbamoyl)methylene)amino)oxy)-2-methylpropionic acid	cayston|azactam|aztreonam	DRUGBANK	DB00355	C13H17N5O8S2	small molecule	J01DF01	78110-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZPBZJONDBGPKJ-VEHQQRBSSA-N
5919	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Dong DL (2006)	16859676	175452	348	Chlorzoxazone	5-chloro-2-Benzoxazolone|Chlorzoxazone|2-hydroxy-5-chlorobenzoxazole|5-chloro-2-Benzoxazolol|Clorzoxazona|Chlorzoxane|Chlorzoxazonum|5-chlorobenzoxazolin-2-one|5-chloro-2-Benzoxazolinone|Chlorzoxazona|5-chloro-3H-benzooxazol-2-one|5-Chlorobenzoxazolidone|Clorzoxazone|Chlorzoxazon|5-chloro-2-Hydroxybenzoxazole|5-chloro-2(3H)-benzoxazolone	parafon forte dsc|acetazone fo	DRUGBANK	DB00356	C7H4ClNO2	small molecule	M03BB53|M03BB03|M03BB73	95-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFWDZFKRBELIQ-UHFFFAOYSA-N
5920	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Alvina K (2010)	20505091	175450	348	Chlorzoxazone	5-chloro-2-Benzoxazolone|Chlorzoxazone|2-hydroxy-5-chlorobenzoxazole|5-chloro-2-Benzoxazolol|Clorzoxazona|Chlorzoxane|Chlorzoxazonum|5-chlorobenzoxazolin-2-one|5-chloro-2-Benzoxazolinone|Chlorzoxazona|5-chloro-3H-benzooxazol-2-one|5-Chlorobenzoxazolidone|Clorzoxazone|Chlorzoxazon|5-chloro-2-Hydroxybenzoxazole|5-chloro-2(3H)-benzoxazolone	parafon forte dsc|acetazone fo	DRUGBANK	DB00356	C7H4ClNO2	small molecule	M03BB53|M03BB03|M03BB73	95-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFWDZFKRBELIQ-UHFFFAOYSA-N
5921	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Syme CA (2000)	10712246	175451	348	Chlorzoxazone	5-chloro-2-Benzoxazolone|Chlorzoxazone|2-hydroxy-5-chlorobenzoxazole|5-chloro-2-Benzoxazolol|Clorzoxazona|Chlorzoxane|Chlorzoxazonum|5-chlorobenzoxazolin-2-one|5-chloro-2-Benzoxazolinone|Chlorzoxazona|5-chloro-3H-benzooxazol-2-one|5-Chlorobenzoxazolidone|Clorzoxazone|Chlorzoxazon|5-chloro-2-Hydroxybenzoxazole|5-chloro-2(3H)-benzoxazolone	parafon forte dsc|acetazone fo	DRUGBANK	DB00356	C7H4ClNO2	small molecule	M03BB53|M03BB03|M03BB73	95-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZFWDZFKRBELIQ-UHFFFAOYSA-N
5922	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Siraki AG (2007)	17602675	175459	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5923	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5924	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5925	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5926	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Greco F (2005)	16332571	175462	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5927	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Shirakawa H (2006)	16474421	175461	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5928	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Martinez-Campa C (2005)	16244789	175460	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5929	107955	1583	-	CYP11A1	CYP11A|CYPXIA1|P450SCC	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5930	107955	1583	-	CYP11A1	CYP11A|CYPXIA1|P450SCC	9606	Homo sapiens	inhibitor	target	Oka H (2000)	11161433	175464	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5931	107955	1583	-	CYP11A1	CYP11A|CYPXIA1|P450SCC	9606	Homo sapiens	inhibitor	target	Slominski A (2006)	16817851	175463	349	Aminoglutethimide	alpha-(P-Aminophenyl)-alpha-ethylglutarimide|Aminoglutthimide|Dl-Aminoglutethimide|P-Aminoglutethimide|Aminoglutethimid|2-(p-Aminophenyl)-2-ethylglutarimide|Aminoglutethimidum|Elipten|3-Ethyl-3-(P-aminophenyl)-2,6-dioxopiperidine|Aminoglutetimide|Aminoglutethimide|Aminoglutetimida	cytadren tab 250mg	DRUGBANK	DB00357	C13H16N2O2	small molecule	L02BG01	125-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBVIMPUHSLWNV-UHFFFAOYSA-N
5932	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	350	Mefloquine	[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina	mefloquine|lariam tab 250mg|me	DRUGBANK	DB00358	C17H16F6N2O	small molecule	P01BF02|P01BC02	53230-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEEQGYMUWCZPDN-UHFFFAOYSA-N
5933	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	350	Mefloquine	[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina	mefloquine|lariam tab 250mg|me	DRUGBANK	DB00358	C17H16F6N2O	small molecule	P01BF02|P01BC02	53230-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEEQGYMUWCZPDN-UHFFFAOYSA-N
5934	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Gillespie RJ (2008)	18406614	175466	350	Mefloquine	[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|Mefloquinum|Mfloquine|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|Mefloquin|Mefloquine|Mefloquina	mefloquine|lariam tab 250mg|me	DRUGBANK	DB00358	C17H16F6N2O	small molecule	P01BF02|P01BC02	53230-10-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEEQGYMUWCZPDN-UHFFFAOYSA-N
5935	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	cofactor	target	Chen X (2002)	11752352	171740	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5936	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	cofactor	target	Schwarz EJ (1999)	10543618	175473	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5937	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	cofactor	target	Koshimura K (1999)	10197775	175474	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5938	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	cofactor	target	Ichinose H (1999)	10464780	175475	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5939	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	cofactor	target	Schallreuter KU (1999)	10643998	175476	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5940	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	cofactor	target	Flatmark T (1999)	10411647	175477	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5941	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	cofactor	target	Fitzpatrick PF (2000)	10872454	175478	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5942	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	cofactor	target	Werner ER (2000)	10839989	175479	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5943	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	cofactor	target	Zekanowski C (1998)	10089284	175481	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5944	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	cofactor	target	Jennings IG (2001)	11163771	175482	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5945	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	cofactor	target	Ayling JE (2000)	10924272	175480	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5946	113019	7166	-	TPH1	TPRH|TRPH	9606	Homo sapiens	cofactor	target	Chamas F (1999)	10381000	175483	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5947	113019	7166	-	TPH1	TPRH|TRPH	9606	Homo sapiens	cofactor	target	Serova LI (2004)	15223360	175485	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5948	113019	7166	-	TPH1	TPRH|TRPH	9606	Homo sapiens	cofactor	target	Haavik J (1989)	2665179	175484	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5949	113019	7166	-	TPH1	TPRH|TRPH	9606	Homo sapiens	cofactor	target	Martinez A (2001)	11472242	175487	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5950	113019	7166	-	TPH1	TPRH|TRPH	9606	Homo sapiens	cofactor	target	Ikemoto K (2002)	12414107	175486	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5951	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Huang A (2000)	10749876	175489	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5952	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Gorren AC (2002)	12003347	175488	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5953	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Gorren AC (2000)	10995244	175492	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5954	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Heller R (1999)	10075731	175493	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5955	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Shinozaki K (2000)	11009561	175490	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5956	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	cofactor	target	Berka V (2000)	10924132	175491	352	Sapropterin	5,6,7,8-tetrahydrobiopterin|6R-5,6,7,8-tetrahydrobiopterin|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone|R-THBP|Tetrahydrobiopterin|6R-BH4|6R-L-5,6,7,8-tetrahydrobiopterin|L-erythro-tetrahydrobiopterin|5,6,7,8 tetrahydrobiopterin	kuvan	DRUGBANK	DB00360	C9H15N5O3	small molecule	A16AX07	62989-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-UHFFFAOYSA-N
5957	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	353	Vinorelbine	Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine	vinorelbine tartrate injection	DRUGBANK	DB00361	C45H54N4O8	small molecule	L01CA04	71486-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBABOYUKABKIAF-GHYRFKGUSA-N
5958	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	353	Vinorelbine	Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine	vinorelbine tartrate injection	DRUGBANK	DB00361	C45H54N4O8	small molecule	L01CA04	71486-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBABOYUKABKIAF-GHYRFKGUSA-N
5959	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Chang AY (1995)	7740336	175496	353	Vinorelbine	Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine	vinorelbine tartrate injection	DRUGBANK	DB00361	C45H54N4O8	small molecule	L01CA04	71486-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBABOYUKABKIAF-GHYRFKGUSA-N
5960	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Kruczynski A (1998)	9515574	175497	353	Vinorelbine	Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine	vinorelbine tartrate injection	DRUGBANK	DB00361	C45H54N4O8	small molecule	L01CA04	71486-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBABOYUKABKIAF-GHYRFKGUSA-N
5961	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Seve P (2010)	20403547	175495	353	Vinorelbine	Vinorelbin|Vinorelbinum|Vinorelbine|Vinorelbina|Nor-5'-anhydrovinblastine|5'-Noranhydrovinblastine	vinorelbine tartrate injection	DRUGBANK	DB00361	C45H54N4O8	small molecule	L01CA04	71486-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBABOYUKABKIAF-GHYRFKGUSA-N
5962	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5963	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Glatt SJ (2003)	13129658	175503	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5964	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Patel S (2003)	12763097	175504	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5965	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Zhao AL (2005)	16223700	175505	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5966	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Kuballa G (2005)	15886414	175506	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5967	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Nakane M (2005)	15992586	175502	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5968	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5969	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5970	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5971	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Heiser P (2004)	14751426	175508	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5972	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Broderick PA (2004)	14687870	175509	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5973	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	McDonald LM (2003)	14530903	175309	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5974	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Goldstein JM (1999)	12973385	175507	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5975	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Reist C (2004)	15037867	175511	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5976	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5977	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5978	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5979	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5980	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5981	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5982	119105	50632	RP11-122K13.5	CALY	DRD1IP|NSG3	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5983	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5984	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5985	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5986	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5987	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5988	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Roegge CS (2007)	17382376	175512	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5989	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5990	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5991	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5992	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5993	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5994	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5995	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Stonehouse AH (2005)	15781964	175516	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5996	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Green AI (2002)	12769622	175515	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5997	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Young RM (2004)	15286066	175514	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5998	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Takano A (2006)	16040180	175513	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5999	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Weizman T (2003)	14575800	175315	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6000	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Tomic M (2004)	15261283	175517	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6001	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Zahorodna A (2004)	15213359	175520	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6002	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (2003)	12923612	174630	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6003	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Chou YH (2003)	12589516	175519	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6004	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Hagino Y (2002)	12564641	175518	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6005	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6006	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6007	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	antagonist	target	Smits RA (2006)	16854056	175522	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6008	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6009	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	antagonist	target	Sugata Y (2007)	17346280	94071	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6010	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	antagonist	target	Adachi N (2006)	16860312	175521	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6011	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Navailles S (2006)	16182256	175524	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6012	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Sodhi MS (2005)	15917433	175523	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6013	108535	2244	-	FGB	HEL-S-78p	9606	Homo sapiens	antagonist	target	Terao N (1980)	6892775	175526	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6014	108557	2266	PRO2061	FGG	-	9606	Homo sapiens	antagonist	target	Terao N (1980)	6892775	175526	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6015	108534	2243	-	FGA	Fib2	9606	Homo sapiens	antagonist	target	Terao N (1980)	6892775	175526	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6016	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Szabo S (1995)	8578198	175527	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6017	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Konturek SJ (1990)	1970337	175531	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6018	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Tarnawski A (1995)	8578218	175530	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6019	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Szabo S (1991)	1957124	175528	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6020	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	agonist	target	Korman MG (1994)	7948825	175529	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6021	108270	1950	-	EGF	HOMG4|URG	9606	Homo sapiens	inducer	target	Konturek SJ (1990)	1970337	175531	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6022	108270	1950	-	EGF	HOMG4|URG	9606	Homo sapiens	inducer	target	Tarnawski A (1995)	8578218	175530	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6023	108270	1950	-	EGF	HOMG4|URG	9606	Homo sapiens	inducer	target	Szabo S (1991)	1957124	175528	356	Sucralfate	Sucralfate|Sucralfatum|Sucralfato|Hexadeca--hydroxytetracosahydroxy[8-[1,3,4,6-tetra-O-sulfo--Dfructofuranosyl--D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminum|Sucralfat	sulcrate suspension plus|caraf	DRUGBANK	DB00364	C11H28Al8O51S8	small molecule	A02BX02	54182-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNQYNQBOVCBZIQ-JQOFMKNESA-A
6024	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6025	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6026	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6027	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6028	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	358	Doxylamine	Doxylaminum|2-Dimethylaminoethoxyphenylmethyl-2-picoline|Doxilminio|Dossilamina|Doxilamina|N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine|2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine|Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether	tylenol cold and flu nighttime	DRUGBANK	DB00366	C17H22N2O	small molecule	R06AA09|R06AA59	469-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCFDWZZGGLSKEP-UHFFFAOYSA-N
6029	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Kloosterboer HJ (1988)	3139361	175069	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6030	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Freyberger A (2010)	19833195	175550	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6031	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Freyberger A (2010)	19836445	175548	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6032	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Shields-Botella J (2003)	14672731	175549	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6033	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Vereide AB (2006)	16325240	175553	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6034	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Mirkin S (2005)	16084894	175552	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6035	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Vijayanathan V (2006)	16609013	175551	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6036	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Sun D (2007)	17634204	175555	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6037	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Abdel-Aleem H (2005)	16307966	175554	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6038	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6039	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Hompes PG (2007)	17484506	175559	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6040	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Bray JD (2005)	16157482	175558	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6041	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Mirkin S (2005)	16084894	175552	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6042	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Maruo T (2007)	17531625	175557	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6043	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Creinin MD (2006)	17077229	175556	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6044	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Rabe T (2000)	11075290	175560	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6045	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Hammond GL (2001)	11521119	175561	359	Levonorgestrel	13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one|Lvonorgestrel|17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol|Postinor|Levonorgestrelum|13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one|13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one|(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one|18-Methyl-17-alpha-ethynyl-19-nortestosterone|Levonova|(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one|NorLevo|Jadelle|17alpha-Ethynyl-18-homo-19-nortestosterone|17-alpha-Ethynyl-13-ethyl-19-nortestosterone|d(-)-Norgestrel|17-Ethynyl-18-methyl-19-nortestosterone|Microval|Levonorgestrel|Mirena|17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one|Levonelle|18-Methylnorethisterone|Microlut|17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one|Plan b|Microluton	option 2|levonest|sronyx|lillo	DRUGBANK	DB00367	C21H28O2	small molecule	G03AB03|G03FA11|G03AA07|G03AD01|G03AC03|G03FB09	797-63-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-XUDSTZEESA-N
6046	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6047	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6048	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6049	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6050	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Weinshenker D (2001)	11504801	175566	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6051	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6052	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tarizzo VI (1994)	7969507	175564	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6053	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Sanders VM (1998)	9666280	175565	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6054	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Nash DT (1990)	1980236	175570	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6055	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6056	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6057	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Rudling JE (2000)	11053214	175571	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6058	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6059	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Vizi ES (2001)	11728431	175568	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6060	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Gobbi M (1990)	1979424	175569	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6061	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6062	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6063	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Burt RP (1996)	8825367	175572	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6064	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Bishop MJ (2007)	17266602	175573	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6065	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Lachnit WG (1997)	9138687	175574	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6066	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Nash DT (1990)	1980236	175570	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6067	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6068	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6069	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6070	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Rump LC (1995)	8590979	175575	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6071	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Shreve PE (1991)	1654268	175577	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6072	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Bruck H (2007)	17410123	175576	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6073	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Martinez A (1991)	1646718	175579	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6074	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Molinoff PB (1974)	4156788	175578	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6075	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6076	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6077	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Martinez A (1990)	2226440	175580	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6078	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	binder	target	Erickson JD (1996)	8643547	175581	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6079	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6080	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6081	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Bishop MJ (2007)	17266602	175573	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6082	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6083	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Kenny BA (1995)	7582530	175582	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6084	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Cleary L (2004)	15451776	175583	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6085	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Testa R (1995)	7674815	175584	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6086	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6087	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6088	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Tamaoki J (1993)	8105356	175585	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6089	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Galitzky J (1993)	8106131	175586	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6090	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Carpene C (1993)	8097243	175587	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6091	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6092	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6093	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6094	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6095	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6096	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	binder	target	Erickson JD (1996)	8643547	175581	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6097	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6098	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6099	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6100	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Nash DT (1990)	1980236	175570	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6101	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Hieble JP (1998)	9836297	175588	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6102	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	MacLennan SJ (2000)	10742288	175589	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6103	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Nyroenen T (2001)	11306720	175591	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6104	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Giovannoni MP (2009)	18680204	175590	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6105	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6106	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6107	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6108	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Bishop MJ (2007)	17266602	175573	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6109	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Izzo NJ (1994)	8294418	175594	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6110	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Izzo NJ (1994)	8166240	175593	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6111	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Testa R (1995)	7773533	175592	360	Norepinephrine	4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol|L-Norepinephrine|Norepinefrina|Norepinephrinum|(R)-Norepinephrine|(-)-Noradrenaline|(R)-(-)-Norepinephrine|Arterenol|L-noradrenaline|Norepinephrine|(-)-Norepinephrine|Noradrenaline|Nor-adrenaline|(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol|(-)-Arterenol	norepinephrine bitartrate|levo	DRUGBANK	DB00368	C8H11NO3	small molecule	C01CA03	51-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFLSHLFXELFNJZ-QMMMGPOBSA-N
6112	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Schreiber S (2002)	12372565	175609	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6113	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6114	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	binder	target	Tatsumi M (1997)	9537821	174430	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6115	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6116	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	binder	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6117	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6118	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6119	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6120	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	binder	target	Tatsumi M (1997)	9537821	174430	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6121	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6122	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6123	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6124	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6125	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6126	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6127	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6128	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Laakmann G (1999)	10451911	175614	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6129	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nutt DJ (1999)	10446738	175615	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6130	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Gorman JM (1999)	10446735	175616	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6131	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Westenberg HG (1999)	10446734	175617	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6132	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Waldinger MD (2000)	11063897	175613	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6133	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Anttila SA (2001)	11607047	175618	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6134	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	binder	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6135	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6136	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	binder	target	de Boer T (1996)	8636062	175619	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6137	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6138	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	binder	target	de Boer T (1995)	8930006	175620	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6139	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6140	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6141	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	de Boer T (1995)	8930006	175620	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6142	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6143	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6144	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	binding	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6145	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	binding	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6146	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	Pytliak M (2010)	20945968	175621	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6147	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6148	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6149	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6150	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gorman JM (1999)	10446735	175616	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6151	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Westenberg HG (1999)	10446734	175617	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6152	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6153	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Anttila SA (2001)	11607047	175618	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6154	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	de Boer T (1995)	8930006	175620	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6155	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Kast RE (2007)	17587360	175622	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6156	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	binder	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6157	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6158	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	binder	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6159	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6160	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6161	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	binder	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6162	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6163	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6164	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	binder	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6165	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6166	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Anttila SA (2001)	11607047	175618	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6167	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Garcia-Sevilla JA (2004)	14628003	175623	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6168	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Rogoz Z (2003)	12523492	175625	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6169	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Schreiber S (2002)	11931344	175624	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6170	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Rogoz Z (2002)	11939713	175627	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6171	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Besson A (2000)	10793320	175626	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6172	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	binder	target	Tatsumi M (1997)	9537821	174430	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6173	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6174	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10762339	175610	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6175	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6176	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Dekeyne A (2001)	11271412	175629	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6177	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Millan MJ (2006)	16433010	175628	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6178	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Benelli A (2004)	14615872	175630	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6179	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Meert TF (1997)	9832994	175631	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6180	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6181	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6182	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6183	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6184	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6185	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6186	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6187	108833	2559	-	GABRA6	-	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6188	108833	2559	-	GABRA6	-	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6189	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6190	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6191	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6192	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6193	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6194	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6195	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Briani C (2004)	15469457	175635	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6196	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6197	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6198	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6199	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6200	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6201	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6202	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Fuchsjager-Mayrl G (2005)	16205624	175638	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6203	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rotmensch HH (1993)	8103526	175639	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6204	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Van der Graaf PH (1995)	8719802	175636	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6205	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Borger P (1998)	9730867	175637	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6206	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Ferro A (1997)	9088585	175640	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6207	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6208	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Varma DR (1999)	10433496	175645	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6209	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Bhattacharyya BJ (2002)	12221524	175644	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6210	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Hirooka K (2000)	10870519	175643	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6211	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Wang T (1996)	8864321	175642	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6212	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Nieminen T (2005)	16315032	175641	365	Timolol	Timololo|Timolol anhydrous|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timolol|Timololum	teva-latanoprost/timolol|sando	DRUGBANK	DB00373	C13H24N4O3S	small molecule	C07DA06|S01ED51|C07BA06|S01ED01|C07AA06	26839-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLJRIMJGRPQVNF-UHFFFAOYSA-N
6213	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Ali FY (2006)	16239641	175647	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6214	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6215	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6216	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Falcetti E (2010)	20622039	152865	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6217	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6218	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Sprague RS (2008)	18574748	175649	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6219	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Olschewski H (2004)	15163595	175648	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6220	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Freedman SB (1988)	3208836	175651	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6221	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Doerje F (1991)	1994002	175652	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6222	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Bognar IT (1992)	1635586	175653	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6223	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Doerje F (1991)	1994002	175652	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6224	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Bognar IT (1992)	1635586	175653	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6225	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6226	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6227	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6228	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Freedman SB (1988)	3208836	175651	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6229	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Doerje F (1991)	1994002	175652	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6230	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Prus AJ (2009)	18685832	175654	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6231	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tanda G (2007)	17631384	175655	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6232	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Giachetti A (1986)	2432979	175656	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6233	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Doerje F (1991)	1994002	175652	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6234	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Bognar IT (1992)	1635586	175653	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6235	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Freedman SB (1988)	3208836	175651	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6236	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Doerje F (1991)	1994002	175652	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6237	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Bognar IT (1992)	1635586	175653	368	Trihexyphenidyl	Trihexyphnidyle|Trihexyphenidyl|Benzhexol Hydrochloride|(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol|Trihexifenidilo|Trihexyphenidylum|Apo-trihex	trihexyphen tab 2mg|nu-trihexy	DRUGBANK	DB00376	C20H31NO	small molecule	N04AA01	144-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWHLPVGTWGOCJO-UHFFFAOYSA-N
6238	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6239	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Yang LP (2009)	19852528	175657	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6240	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gralla R (2003)	14504060	175665	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6241	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Rubenstein EB (2004)	16163194	175664	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6242	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	De Leon A (2006)	17106506	175667	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6243	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Eisenberg P (2004)	14760130	175666	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6244	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Navari RM (2006)	17026451	175661	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6245	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Hesketh PJ (2004)	15232725	175660	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6246	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Grunberg SM (2003)	14640928	175663	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6247	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Stoltz R (2004)	15102873	175662	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6248	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Eisenberg P (2003)	14635083	175658	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6249	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Stoltz R (2004)	15378559	175659	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
6250	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	370	Dydrogesterone	Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone	-	DRUGBANK	DB00378	C21H28O2	small molecule	G03FB08|G03DB01|G03FA14	152-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMOKGBVKVMRFX-HQZYFCCVSA-N
6251	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Tamaya T (1979)	436795	175672	370	Dydrogesterone	Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone	-	DRUGBANK	DB00378	C21H28O2	small molecule	G03FB08|G03DB01|G03FA14	152-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMOKGBVKVMRFX-HQZYFCCVSA-N
6252	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Blois SM (2004)	15128769	175673	370	Dydrogesterone	Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone	-	DRUGBANK	DB00378	C21H28O2	small molecule	G03FB08|G03DB01|G03FA14	152-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMOKGBVKVMRFX-HQZYFCCVSA-N
6253	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Tamaya T (1983)	6827166	175670	370	Dydrogesterone	Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone	-	DRUGBANK	DB00378	C21H28O2	small molecule	G03FB08|G03DB01|G03FA14	152-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMOKGBVKVMRFX-HQZYFCCVSA-N
6254	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Raghupathy R (2005)	16045524	175671	370	Dydrogesterone	Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone	-	DRUGBANK	DB00378	C21H28O2	small molecule	G03FB08|G03DB01|G03FA14	152-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMOKGBVKVMRFX-HQZYFCCVSA-N
6255	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Okada H (1993)	8486204	175669	370	Dydrogesterone	Didrogesterone|Hydrogestrone|Retro-6-dehydroprogesterone|Didrogesterona|10alpha-Isopregnenone|Dydrogestrone|Isopregnenone|delta(6)-Retroprogesterone|Dydrogesterone|Dydrogesteronum|Dydrogesterona|9,10-pregna-4,6-diene-3,20-dione|(9,10)-pregna-4,6-diene-3,20-dione|Gestatron|delta(Sup 6)-retroprogesterone|Hydrogesterone|6-Dehydro-retro-progesterone	-	DRUGBANK	DB00378	C21H28O2	small molecule	G03FB08|G03DB01|G03FA14	152-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMOKGBVKVMRFX-HQZYFCCVSA-N
6256	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	11196553	174870	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6257	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6258	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Fabritz L (2003)	12650887	175676	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6259	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Napolitano C (2006)	16168489	175677	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6260	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Valdivia CR (2002)	12123767	175674	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6261	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Wang HW (2003)	12676070	175675	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6262	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chinushi M (2003)	12604879	175678	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6263	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Hu W (2007)	17327465	175679	371	Mexiletine	1-Methyl-2-(2,6-xylyloxy)ethanamine|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|Mexiltine|Mexiletinum|1-(2',6'-Dimethylphenoxy)-2-aminopropane|(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine	teva-mexiletine|mexitil cap 20	DRUGBANK	DB00379	C11H17NO	small molecule	C01BB02	31828-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-UHFFFAOYSA-N
6264	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6265	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hasinoff BB (2001)	11179439	175688	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6266	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hasinoff BB (2007)	17652819	175683	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6267	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hasinoff BB (2000)	11046078	175682	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6268	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hasinoff BB (1999)	10194547	175681	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6269	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Langer SW (2001)	11332155	175687	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6270	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Renodon-Corniere A (2003)	12911317	175686	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6271	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hasinoff BB (2002)	11984069	175685	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6272	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Kik K (2006)	17115008	175684	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6273	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6274	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6275	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	372	Dexrazoxane	4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione|Dexrazoxan|(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione|Dextrorazoxane|Dexrazoxano|(+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane|Dexrazoxane|Dexrazoxanum	dexrazoxane hydrochloride|dexr	DRUGBANK	DB00380	C11H16N4O4	small molecule	V03AF02	24584-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMKDZUISNHGIBY-ZETCQYMHSA-N
6276	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6277	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6278	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6279	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6280	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Miyashita Y (2010)	20097194	175689	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6281	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Ogihara T (2009)	19634509	175694	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6282	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Murakami M (2001)	11426839	175690	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6283	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Qu YL (1998)	10374627	175691	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6284	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6285	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Furukawa T (1997)	9249249	175693	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6286	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6287	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Miyashita Y (2010)	20097194	175689	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6288	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Ogihara T (2009)	19634509	175694	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6289	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Murakami M (2001)	11426839	175690	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6290	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Qu YL (1998)	10374627	175691	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6291	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6292	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Furukawa T (1997)	9249249	175693	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6293	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Miyashita Y (2010)	20097194	175689	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6294	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Ogihara T (2009)	19634509	175694	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6295	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Murakami M (2001)	11426839	175690	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6296	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Qu YL (1998)	10374627	175691	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6297	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6298	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Furukawa T (1997)	9249249	175693	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6299	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas L (2000)	11101200	175695	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6300	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2001)	11392054	175696	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6301	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	11061585	175697	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6302	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	unknown	target	Kornhuber J (2011)	21909365	175698	373	Amlodipine	3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipine|Amlodipine free base|3-Ethyl 5-methylester, ()-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate|Amlodipinum|Amlodipino|(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate	amlodipine and benazepril hydr	DRUGBANK	DB00381	C20H25ClN2O5	small molecule	C08CA01|C09BX01|C08GA02|C10BX07|C09XA53|C09BB03|C10BX03|C09BB07|C09XA54|C09DB02|C09DB01|C09DB07|C09DB06|C09DB05|C09DB04|C09DX01|C09BB04|C09DX03|C10BX09|C10BX11	88150-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIQEAQVCYTUBX-UHFFFAOYSA-N
6303	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6304	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Traykov L (1999)	10210906	175711	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6305	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Wang H (1999)	10208549	175708	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6306	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Villarroya M (2004)	15544507	175709	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6307	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Du DM (2004)	15544504	175710	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6308	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Marco JL (2003)	12871155	175702	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6309	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Wang H (1998)	10375753	175703	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6310	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Krustev AD (2006)	17218977	175701	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6311	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Takatori Y (2006)	16880719	175706	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6312	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Ahmed M (2006)	16860785	175707	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6313	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Kosasa T (1999)	10513568	175704	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6314	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Davis KL (1999)	10024872	175705	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6315	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Marco JL (2003)	12871155	175702	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6316	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Wang H (1998)	10375753	175703	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6317	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Krustev AD (2006)	17218977	175701	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6318	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Ahmed M (2006)	16860785	175707	374	Tacrine	Tacrin|Tacrinum|1,2,3,4-tetrahydroacridin-9-amine|THA|Tetrahydroaminacrine|Tacrine|Tetrahydroaminoacridine	-	DRUGBANK	DB00382	C13H14N2	small molecule	N06DA01	321-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJREFDVOIBQDA-UHFFFAOYSA-N
6319	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6320	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Schjelderup L (1988)	3247303	175713	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6321	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6322	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6323	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6324	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Schjelderup L (1988)	3247303	175713	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6325	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6326	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6327	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6328	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Schjelderup L (1988)	3247303	175713	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6329	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6330	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	375	Oxyphencyclimine	Oxyphencycliminum|Oxifencicliminum|Oxyphencyclimine	-	DRUGBANK	DB00383	C20H28N2O3	small molecule	A03CA03|A03AA01	125-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUDKAZCAISNGQN-UHFFFAOYSA-N
6331	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6332	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6333	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6334	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Busch AE (1996)	8772124	175715	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6335	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Wagner CA (2001)	11509829	175716	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6336	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6337	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6338	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Busch AE (1996)	8772124	175715	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6339	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Hiraoka Y (2003)	12827214	175717	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6340	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Wagner CA (2001)	11509829	175716	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6341	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6342	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6343	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Wagner CA (2001)	11509829	175716	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6344	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6345	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6346	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Busch AE (1996)	8772124	175715	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6347	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Wagner CA (2001)	11509829	175716	376	Triamterene	6-phenylpteridine-2,4,7-triamine|Teridin|Triamterenum|Triamtrne|Dyrenium|Triamterene|Triamteren|Triamtereno	triamterene and hydrochlorothi	DRUGBANK	DB00384	C12H11N7	small molecule	C03DB02	396-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNYLWPVRPXGIIP-UHFFFAOYSA-N
6348	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Perabo FG (2005)	16019763	175718	377	Valrubicin	Valrubicin|(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)--L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8-valerate|Valrubicinum|2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate|Valrubicina|Valrubicine|Valstar	valtaxin|valstar	DRUGBANK	DB00385	C34H36F3NO13	small molecule	L01DB09	56124-62-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOCKGBMQLCSHFP-KQRAQHLDSA-N
6349	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	377	Valrubicin	Valrubicin|(8S, 10S)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)--L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione 8-valerate|Valrubicinum|2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate|Valrubicina|Valrubicine|Valstar	valtaxin|valstar	DRUGBANK	DB00385	C34H36F3NO13	small molecule	L01DB09	56124-62-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOCKGBMQLCSHFP-KQRAQHLDSA-N
6350	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	FORD RV (1958)	13505370	175719	378	Alseroxylon	Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab	-	DRUGBANK	DB00386	-	small molecule	-	8063-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6351	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	378	Alseroxylon	Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab	-	DRUGBANK	DB00386	-	small molecule	-	8063-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6352	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	378	Alseroxylon	Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab	-	DRUGBANK	DB00386	-	small molecule	-	8063-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6353	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	378	Alseroxylon	Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab	-	DRUGBANK	DB00386	-	small molecule	-	8063-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6354	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	SCHLAGEL CA (1957)	13438725	175720	378	Alseroxylon	Rautensin|Rauwiloid|Egalin|Alseroxylon|Rau-Tab	-	DRUGBANK	DB00386	-	small molecule	-	8063-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6355	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Myhrer T (2010)	20624420	175721	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6356	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Alberts P (1995)	7616431	175722	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6357	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1990)	2253700	175723	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6358	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6359	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6360	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6361	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Larson EW (1991)	2027917	175724	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6362	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Myhrer T (2010)	20624420	175721	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6363	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1990)	2253700	175723	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6364	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6365	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6366	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6367	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Myhrer T (2010)	20624420	175721	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6368	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6369	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Larson EW (1991)	2027917	175724	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6370	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Myhrer T (2010)	20624420	175721	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6371	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Waelbroeck M (1990)	2253700	175723	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6372	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6373	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6374	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Waelbroeck M (1992)	1426023	175714	379	Procyclidine	1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol|Tricyclamol|Prociclidina|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-yl-propan-1-ol hydrochloride|Procyclidinum|Procyclidine|Procyclidin	phl-procyclidine tablets|pendo	DRUGBANK	DB00387	C19H29NO	small molecule	N04AA04	77-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYDUSKDSKCASEF-UHFFFAOYSA-N
6375	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Tomiyama Y (2007)	17658513	175725	380	Phenylephrine	R(-)-Phenylephrine|Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)-|(-)-m-Hydroxy--(methylaminomethyl)benzyl alcohol|Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-|Phenylephrine|Fenilefrina|(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol|l-(3-Hydroxyphenyl)-N-methylethanolamine|Phenylephrinum|Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)-	tylenol cold and flu nighttime	DRUGBANK	DB00388	C9H13NO2	small molecule	R01AA04|R01BA03|R01BA53|R01AB01|S01GA55|C01CA06|S01GA05|S01FB01	59-42-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SONNWYBIRXJNDC-VIFPVBQESA-N
6376	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Martinez-Salas SG (2007)	17584443	175726	380	Phenylephrine	R(-)-Phenylephrine|Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)-|(-)-m-Hydroxy--(methylaminomethyl)benzyl alcohol|Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-|Phenylephrine|Fenilefrina|(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol|l-(3-Hydroxyphenyl)-N-methylethanolamine|Phenylephrinum|Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)-	tylenol cold and flu nighttime	DRUGBANK	DB00388	C9H13NO2	small molecule	R01AA04|R01BA03|R01BA53|R01AB01|S01GA55|C01CA06|S01GA05|S01FB01	59-42-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SONNWYBIRXJNDC-VIFPVBQESA-N
6377	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	380	Phenylephrine	R(-)-Phenylephrine|Benzenemethanol, 3-hydroxy-.alpha.-[(methylamino)methyl]-, (R)-|(-)-m-Hydroxy--(methylaminomethyl)benzyl alcohol|Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)-|Phenylephrine|Fenilefrina|(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol|l-(3-Hydroxyphenyl)-N-methylethanolamine|Phenylephrinum|Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, (-)-	tylenol cold and flu nighttime	DRUGBANK	DB00388	C9H13NO2	small molecule	R01AA04|R01BA03|R01BA53|R01AB01|S01GA55|C01CA06|S01GA05|S01FB01	59-42-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SONNWYBIRXJNDC-VIFPVBQESA-N
6378	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Taurog A (1976)	1278093	175733	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6379	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Guilhem I (2006)	17042691	175732	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6380	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Humar M (2008)	18055877	175731	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6381	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Perrild H (1994)	7952157	175730	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6382	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Magnusson RP (1984)	6706930	175735	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6383	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Nakashima T (1979)	476986	175734	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6384	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6385	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Orgiazzi J (1994)	7528484	175729	381	Carbimazole	Athyromazole|Carbinazole|Carbimazolum|Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Carbimazolo|Carbethoxymethimazole|1H-Imidazole-1-carboxylic acid, 2,3-dihydro-3-methyl-2-thioxo-, ethyl ester  Ethyl 3-methyl-2-thioimidazoline-1-carboxylate|Thyrostat|Carbimazol	-	DRUGBANK	DB00389	C7H10N2O2S	small molecule	H03BB01	22232-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFOYWRHIYXMDOT-UHFFFAOYSA-N
6386	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Ravikumar A (2000)	11272406	175739	382	Digoxin	4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum	novo-digoxin tab 0.25mg|apo-di	DRUGBANK	DB00390	C41H64O14	small molecule	C01AA05	20830-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTMHDMANZUZIPE-PUGKRICDSA-N
6387	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Chen JJ (2001)	11309248	175738	382	Digoxin	4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum	novo-digoxin tab 0.25mg|apo-di	DRUGBANK	DB00390	C41H64O14	small molecule	C01AA05	20830-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTMHDMANZUZIPE-PUGKRICDSA-N
6388	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Aizman O (2001)	11687608	175737	382	Digoxin	4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum	novo-digoxin tab 0.25mg|apo-di	DRUGBANK	DB00390	C41H64O14	small molecule	C01AA05	20830-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTMHDMANZUZIPE-PUGKRICDSA-N
6389	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Kumar AR (2001)	11515751	175740	382	Digoxin	4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum	novo-digoxin tab 0.25mg|apo-di	DRUGBANK	DB00390	C41H64O14	small molecule	C01AA05	20830-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTMHDMANZUZIPE-PUGKRICDSA-N
6390	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Ke YS (2000)	11324464	175741	382	Digoxin	4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5H-furan-2-one|Digossina|12beta-Hydroxydigitoxin|12-hydroxydigitoxin|Digoxine|Digoxin|Lanadicor|Digoxina|Digazolan|Digoxinum	novo-digoxin tab 0.25mg|apo-di	DRUGBANK	DB00390	C41H64O14	small molecule	C01AA05	20830-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTMHDMANZUZIPE-PUGKRICDSA-N
6391	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Jaber M (1994)	7518029	175760	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6392	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6393	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cavallotti C (2002)	12010185	175759	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6394	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Collo G (2008)	18973551	175761	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6395	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Lipina TV (2009)	19795811	175762	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6396	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6397	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6398	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Reynolds IJ (1988)	2849655	175765	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6399	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Jevtovic-Todorovic V (2003)	12681372	175766	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6400	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Katayama S (1990)	2236897	175768	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6401	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6402	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6403	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Burke RE (1986)	2904117	175767	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6404	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Katayama S (1990)	2236897	175768	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6405	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Burke RE (1986)	2904117	175767	384	Ethopropazine	Profenamine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|Profenamina|10-(2-Diethylaminopropyl)phenothiazine|2-Diethylamino-1-propyl-N-dibenzoparathiazine|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|10-[2-(Diethylamino)propyl]phenothiazine|Profenaminum|Ethopropazine|10-[2-(Diethylamino)-1-propyl]phenothiazine|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine	parsitan 50mg	DRUGBANK	DB00392	C19H24N2S	small molecule	N04AA05	522-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOZDBSBBXSXLB-UHFFFAOYSA-N
6406	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6407	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6408	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6409	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6410	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6411	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6412	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6413	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6414	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6415	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6416	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6417	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6418	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6419	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6420	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6421	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6422	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6423	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6424	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6425	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6426	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6427	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Marchetti C (1996)	8731425	175776	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6428	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6429	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6430	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6431	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6432	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6433	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Dietz JD (2008)	18250364	175777	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6434	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Hu W (2007)	17327465	175679	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6435	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6436	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6437	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6438	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6439	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6440	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6441	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6442	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6443	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6444	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6445	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6446	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Kim JH (2009)	19844625	175775	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6447	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Dong CJ (2010)	20335610	175774	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6448	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Kumar R (2010)	20661350	175773	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6449	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Weant KA (2010)	20334460	175772	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6450	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Keyrouz SG (2007)	17705883	175771	385	Nimodipine	Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate|BAY e 9736|2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester|Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|Nimodipino|Periplum|Nimodipinum|Nimodipine|Nimotop	nymalize|nimotop iv 0.2mg/ml|n	DRUGBANK	DB00393	C21H26N2O7	small molecule	C08CA06	66085-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIAGMCDKSXEBJQ-UHFFFAOYSA-N
6451	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Usmani OS (2005)	15860753	175780	386	Beclomethasone dipropionate	9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate	beclovent rotacaps  -  inh 200	DRUGBANK	DB00394	C28H37ClO7	small molecule	D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01	5534-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUVIULQEHSCUHY-XYWKZLDCSA-N
6452	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Saklatvala J (2002)	12010562	175779	386	Beclomethasone dipropionate	9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate	beclovent rotacaps  -  inh 200	DRUGBANK	DB00394	C28H37ClO7	small molecule	D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01	5534-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUVIULQEHSCUHY-XYWKZLDCSA-N
6453	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	386	Beclomethasone dipropionate	9-chloro-11beta-Hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate|Beclometasone|Beclometasone dipropionate|Beclometasone 17,21-dipropionate|9-chloro-16-methylprednisolone|Beclomethasone dipropionate|9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(11beta,16beta)-9-chloro-11-Hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione|9-chloro-16beta-Methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate	beclovent rotacaps  -  inh 200	DRUGBANK	DB00394	C28H37ClO7	small molecule	D07CC04|A07EA07|D07AC15|R03BA01|R03AK08|R01AD01	5534-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUVIULQEHSCUHY-XYWKZLDCSA-N
6454	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Rupprecht R (1993)	8282004	175782	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6455	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	activator	target	Dawson-Basoa ME (1996)	8867260	175783	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6456	107958	1586	RP11-753C18.1	CYP17A1	CPT7|CYP17|P450C17|S17AH	9606	Homo sapiens	inhibitor	target	Haidar S (2003)	12596217	175784	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6457	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ghebeh H (2007)	17415709	175788	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6458	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lessey BA (2006)	17118173	175789	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6459	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yuri T (2007)	17203775	175786	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6460	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Montero Girard G (2007)	17341305	175787	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6461	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kumar AS (2007)	17103262	175785	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6462	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Tranguch S (2006)	17169175	175791	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6463	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Boonyaratanakornkit V (2007)	17138644	175790	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6464	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Wu HB (2006)	17109827	175793	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6465	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Madauss KP (2007)	17013809	175792	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6466	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Luconi M (1998)	9506743	175795	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6467	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Gizard F (2006)	17015480	175794	388	Progesterone	Akrolutin|Lutogynon|(S)-Pregn-4-en-3,20-dione|Luteohormone|17alpha-Progesterone|Progesteron|delta(4)-Pregnene-3,20-dione|Crinone|(S)-Progesterone|Progesterona|Pregn-4-ene-3,20-dione|Progesterone|17-progesterone|Progestrone|Agolutin|(S)-4-Pregnene-3,20-dione|Corpus Luteum Hormone|Gelbkoerperhormon|Progesteronum|4-Pregnene-3,20-dione	gesterol in oil-liq im 50mg/ml	DRUGBANK	DB00396	C21H30O2	small molecule	G03DA04|G03FA04	57-83-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKFOVLPORLFTN-LEKSSAKUSA-N
6468	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Moya-Huff FA (1987)	2881994	175801	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6469	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	partial agonist	target	Cheng JT (2003)	12873745	175802	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6470	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6471	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6472	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Flavahan NA (2005)	15608085	175803	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6473	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6474	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Buckner SA (2002)	12163120	174410	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6475	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Altenbach RJ (2004)	15163201	174408	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6476	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Moya-Huff FA (1987)	2881994	175801	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6477	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Wellman PJ (1997)	9164583	175804	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6478	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Thomas SH (1991)	1722692	175805	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6479	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Moya-Huff FA (1987)	2881994	175801	389	Phenylpropanolamine	PPA|Fenilpropanolamina|Phnylpropanolamine|Phenylpropanolamin|Phenylpropanolaminum|Norephedrine|-hydroxyamphetamine|2-amino-1-phenylpropan-1-ol|Norephedrin	trisulfaminic tab|tantacol dm 	DRUGBANK	DB00397	C9H13NO	small molecule	R01BA51|R01BA01	14838-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLNKOYKMWOXYQA-VXNVDRBHSA-N
6480	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	antagonist	target	Adnane L (2006)	16757355	175807	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6481	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	antagonist	target	Reddy GK (2006)	16729906	175809	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6482	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	antagonist	target	Strumberg D (2005)	16474853	175808	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6483	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	antagonist	target	Lathia C (2006)	16133532	175810	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6484	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	antagonist	target	Gridelli C (2007)	17296815	175811	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6485	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Carlomagno F (2006)	16507829	175814	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6486	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Wilhelm S (2006)	17016424	175812	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6487	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Wilhelm SM (2004)	15466206	175813	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6488	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Cascone T (2007)	17272980	175818	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6489	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Huether A (2007)	17266941	175819	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6490	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Smalley KS (2009)	18794803	175816	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6491	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Lu X (2010)	20812347	175817	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6492	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Adnane L (2006)	16757355	175807	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6493	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Wilhelm SM (2008)	18852116	175815	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6494	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Gridelli C (2007)	17296815	175811	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6495	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	inhibitor	target	Gollob JA (2006)	16890795	175820	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6496	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Adnane L (2006)	16757355	175807	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6497	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Rini BI (2006)	16503817	175824	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6498	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Veronese ML (2006)	16446323	175823	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6499	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Lacouture ME (2006)	16824050	175822	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6500	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Schoeffski P (2006)	16418310	175821	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6501	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Lu X (2010)	20812347	175817	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6502	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6503	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Kim S (2007)	17575107	175827	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6504	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Eisen T (2006)	16880785	175826	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6505	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Haluska FG (2006)	16901402	175825	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6506	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Flaherty KT (2006)	16609060	175828	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6507	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Liu L (2006)	17178882	175830	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6508	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Guida T (2007)	17545544	175831	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6509	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Lierman E (2007)	17229632	175832	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6510	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Cascone T (2007)	17272980	175818	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6511	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Koch CA (2006)	17102120	175829	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6512	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Guida T (2007)	17545544	175831	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6513	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Gollob JA (2005)	16425993	175833	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6514	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Unnithan J (2007)	17619763	175834	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6515	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Carlomagno F (2006)	16507829	175814	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6516	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Wilhelm S (2006)	17016424	175812	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6517	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Wilhelm SM (2004)	15466206	175813	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6518	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	inhibitor	target	Carlomagno F (2006)	16507829	175814	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6519	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	inhibitor	target	Wilhelm S (2006)	17016424	175812	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6520	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	inhibitor	target	Wilhelm SM (2004)	15466206	175813	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6521	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	antagonist	target	Lierman E (2007)	17229632	175832	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6522	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	antagonist	target	Auclair D (2007)	17205056	175835	390	Sorafenib	N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|Sorafenibum|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide	nexavar	DRUGBANK	DB00398	C21H16ClF3N4O3	small molecule	L01XE05	284461-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLDQJTXFUGDVEO-UHFFFAOYSA-N
6523	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Guo RT (2007)	17535895	175844	391	Zoledronic acid	Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid	reclast|act zoledronic acid co	DRUGBANK	DB00399	C5H10N2O7P2	small molecule	M05BA08|M05BB08	118072-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRASPMIURGNCCH-UHFFFAOYSA-N
6524	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Glickman JF (2007)	17477829	175843	391	Zoledronic acid	Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid	reclast|act zoledronic acid co	DRUGBANK	DB00399	C5H10N2O7P2	small molecule	M05BA08|M05BB08	118072-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRASPMIURGNCCH-UHFFFAOYSA-N
6525	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	391	Zoledronic acid	Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid	reclast|act zoledronic acid co	DRUGBANK	DB00399	C5H10N2O7P2	small molecule	M05BA08|M05BB08	118072-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRASPMIURGNCCH-UHFFFAOYSA-N
6526	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Dunford JE (2001)	11160603	174892	391	Zoledronic acid	Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid	reclast|act zoledronic acid co	DRUGBANK	DB00399	C5H10N2O7P2	small molecule	M05BA08|M05BB08	118072-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRASPMIURGNCCH-UHFFFAOYSA-N
6527	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	inhibitor	target	Guo RT (2007)	17535895	175844	391	Zoledronic acid	Anhydrous Zoledronic Acid|Zoledronic Acid, Anhydrous|Zol|Zoledronate|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Zoledronic Acid Anhydrous|(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid	reclast|act zoledronic acid co	DRUGBANK	DB00399	C5H10N2O7P2	small molecule	M05BA08|M05BB08	118072-93-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRASPMIURGNCCH-UHFFFAOYSA-N
6528	110057	3859	-	KRT12	K12	9606	Homo sapiens	unknown	target	Sobue S (2004)	14693542	175850	392	Griseofulvin	Fulvicin|Grifulvin|(+)-griseofulvin|Griseofulvin|Griseofulvine|Griseofulvin, ultramicrosize|Griseofulvina|Likuden|Griseofulvinum|Grysio|Lamoryl|Spirofulvin|Grisactin|Amudane|Poncyl|Sporostatin|Curling factor|Fulcin|Griseofulvin, microcrystalline|Grisovin	grisovin-fp 250mg tab|griseofu	DRUGBANK	DB00400	C17H17ClO6	small molecule	D01BA01|D01AA08	126-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDUHZTYCFQRHIY-RBHXEPJQSA-N
6529	110057	3859	-	KRT12	K12	9606	Homo sapiens	unknown	target	Nakamichi I (2002)	12388748	175851	392	Griseofulvin	Fulvicin|Grifulvin|(+)-griseofulvin|Griseofulvin|Griseofulvine|Griseofulvin, ultramicrosize|Griseofulvina|Likuden|Griseofulvinum|Grysio|Lamoryl|Spirofulvin|Grisactin|Amudane|Poncyl|Sporostatin|Curling factor|Fulcin|Griseofulvin, microcrystalline|Grisovin	grisovin-fp 250mg tab|griseofu	DRUGBANK	DB00400	C17H17ClO6	small molecule	D01BA01|D01AA08	126-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDUHZTYCFQRHIY-RBHXEPJQSA-N
6530	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6531	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6532	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6533	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6534	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Hu H (1998)	9584217	175856	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6535	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Morel N (1998)	9846638	175854	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6536	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Wei X (1995)	7592963	175855	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6537	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	393	Nisoldipine	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine|Nisoldipin|Nisoldipinum|Nisoldipino|Sular	nisoldipine|sular	DRUGBANK	DB00401	C20H24N2O6	small molecule	C08CA07	63675-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQFCGNPDRICFG-UHFFFAOYSA-N
6538	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6539	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6540	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Hanson SM (2008)	18973287	175858	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6541	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Nutt DJ (2010)	19942638	175857	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6542	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Hanson SM (2008)	18973287	175858	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6543	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Nutt DJ (2010)	19942638	175857	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6544	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6545	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6546	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Becker PM (2009)	19744401	175860	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6547	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Jufe GS (2008)	18265473	175859	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6548	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Hanson SM (2008)	18973287	175858	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6549	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Nutt DJ (2010)	19942638	175857	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6550	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	inducer	target	Shinohara S (1992)	1356589	175863	395	Ceruletide	Ceruletidum|Cerulein|Ceruletida|Caerulein	-	DRUGBANK	DB00403	C58H73N13O21S2	small molecule	V04CC04	17650-98-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRALAIOMGQZKOW-HYAOXDFASA-N
6551	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	inducer	target	Katsuura G (1992)	1620654	175862	395	Ceruletide	Ceruletidum|Cerulein|Ceruletida|Caerulein	-	DRUGBANK	DB00403	C58H73N13O21S2	small molecule	V04CC04	17650-98-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRALAIOMGQZKOW-HYAOXDFASA-N
6552	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	inducer	target	Makovec F (1987)	3440035	175861	395	Ceruletide	Ceruletidum|Cerulein|Ceruletida|Caerulein	-	DRUGBANK	DB00403	C58H73N13O21S2	small molecule	V04CC04	17650-98-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRALAIOMGQZKOW-HYAOXDFASA-N
6553	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	inducer	target	Maurice T (1994)	8182534	175866	395	Ceruletide	Ceruletidum|Cerulein|Ceruletida|Caerulein	-	DRUGBANK	DB00403	C58H73N13O21S2	small molecule	V04CC04	17650-98-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRALAIOMGQZKOW-HYAOXDFASA-N
6554	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	inducer	target	Ibii N (1989)	2587420	175865	395	Ceruletide	Ceruletidum|Cerulein|Ceruletida|Caerulein	-	DRUGBANK	DB00403	C58H73N13O21S2	small molecule	V04CC04	17650-98-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRALAIOMGQZKOW-HYAOXDFASA-N
6555	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	inducer	target	Ishikawa Y (1990)	2087492	175864	395	Ceruletide	Ceruletidum|Cerulein|Ceruletida|Caerulein	-	DRUGBANK	DB00403	C58H73N13O21S2	small molecule	V04CC04	17650-98-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRALAIOMGQZKOW-HYAOXDFASA-N
6556	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6557	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6558	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6559	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6560	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6561	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6562	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6563	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6564	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6565	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6566	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6567	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6568	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6569	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6570	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6571	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6572	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6573	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6574	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6575	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6576	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6577	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6578	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6579	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6580	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6581	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6582	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6583	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6584	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6585	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6586	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6587	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6588	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	McLeod RL (1998)	9691225	175869	397	Dexbrompheniramine	(+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine	m-end max d|bionatuss dxp|pana	DRUGBANK	DB00405	C16H19BrN2	small molecule	R06AB06|R06AB56	132-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-HNNXBMFYSA-N
6589	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yanni JM (1994)	7714410	175868	397	Dexbrompheniramine	(+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine	m-end max d|bionatuss dxp|pana	DRUGBANK	DB00405	C16H19BrN2	small molecule	R06AB06|R06AB56	132-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-HNNXBMFYSA-N
6590	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Boekesoy TA (1991)	1680053	175870	397	Dexbrompheniramine	(+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine	m-end max d|bionatuss dxp|pana	DRUGBANK	DB00405	C16H19BrN2	small molecule	R06AB06|R06AB56	132-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-HNNXBMFYSA-N
6591	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	397	Dexbrompheniramine	(+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine	m-end max d|bionatuss dxp|pana	DRUGBANK	DB00405	C16H19BrN2	small molecule	R06AB06|R06AB56	132-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-HNNXBMFYSA-N
6592	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Onaran HO (1990)	1970615	175871	397	Dexbrompheniramine	(+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine	m-end max d|bionatuss dxp|pana	DRUGBANK	DB00405	C16H19BrN2	small molecule	R06AB06|R06AB56	132-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-HNNXBMFYSA-N
6593	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Mousa SA (2002)	12397367	175874	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6594	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Shaughnessy SG (1995)	7632944	175872	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6595	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Lin P (2001)	11287128	175873	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6596	109303	3053	-	SERPIND1	D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10	9606	Homo sapiens	agonist	target	Mousa SA (2002)	12397367	175874	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6597	109303	3053	-	SERPIND1	D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6598	109303	3053	-	SERPIND1	D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6599	109303	3053	-	SERPIND1	D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	399	Ardeparin	Ardeparin sodium	-	DRUGBANK	DB00407	-	small molecule	-	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
6600	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6601	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Li Z (2003)	12664192	175875	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6602	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6603	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lang AE (1995)	8665533	175881	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6604	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hjerde E (2005)	15694653	175879	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6605	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1997)	9342550	175878	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6606	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lee T (1984)	6239298	175876	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6607	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1993)	8101879	175877	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6608	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kalkman HO (1998)	9570468	175880	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6609	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Herrick-Davis K (2000)	10991983	175882	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6610	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Lang A (1994)	7800667	175884	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6611	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Okuyama S (1999)	10562961	175883	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6612	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6613	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6614	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lang AE (1995)	8665533	175881	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6615	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Christian AJ (2001)	11325388	175885	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6616	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Seeman P (1997)	9015795	175886	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6617	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Seeman P (1997)	9015795	175886	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6618	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6619	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6620	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6621	107557	1135	-	CHRNA2	-	9606	Homo sapiens	agonist	target	An MC (2010)	20498043	175895	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6622	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Weiner DM (2004)	15059034	175896	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6623	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Zuchner T (2005)	16181410	175897	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6624	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	May LT (2005)	15333678	175900	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6625	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Sterin-Borda L (2002)	12505062	175901	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6626	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Peter JC (2004)	15485827	175898	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6627	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Sawatzky DA (2003)	12948933	175899	403	Carbachol	Carbacholum|Carbachol chloride|Carbamylcholine|Karbamoylcholin chlorid|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Karbachol|Choline chlorine carbamate|Choline chloride, carbamate|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbacol|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline carbamate chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride	isopto carbachol 1.5%|carbacho	DRUGBANK	DB00411	C6H15ClN2O2	small molecule	N07AB01|S01EB02	51-83-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXAANGOTKPUOY-UHFFFAOYSA-N
6628	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Askari B (2007)	17259370	160377	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6629	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Johnson BA (2000)	10764590	175913	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6630	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Camp HS (2000)	10871190	175912	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6631	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rieusset J (1999)	10548525	175911	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6632	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Kameda N (2000)	10707565	175910	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6633	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6634	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Su JL (1999)	10475242	175909	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6635	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6636	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6637	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6638	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6639	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6640	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6641	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6642	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6643	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6644	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6645	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6646	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6647	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6648	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6649	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6650	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6651	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6652	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6653	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6654	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6655	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6656	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6657	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6658	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	partial agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6659	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	partial agonist	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6660	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6661	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6662	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	unknown	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6663	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	406	Acetohexamide	1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea|Acetohexamidum|1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide|Actohexamide|Acetohexamid|Acetohexamida|Acetohexamide|N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea	dimelor tablet 1843 500mg	DRUGBANK	DB00414	C15H20N2O4S	small molecule	A10BB31	968-81-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGZSUPCWNCWDAN-UHFFFAOYSA-N
6664	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	406	Acetohexamide	1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea|Acetohexamidum|1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide|Actohexamide|Acetohexamid|Acetohexamida|Acetohexamide|N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea	dimelor tablet 1843 500mg	DRUGBANK	DB00414	C15H20N2O4S	small molecule	A10BB31	968-81-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGZSUPCWNCWDAN-UHFFFAOYSA-N
6665	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	408	Metocurine Iodide	(+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi	metubine iodide inj 2mg/ml	DRUGBANK	DB00416	C40H48I2N2O6	small molecule	-	7601-55-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIGFQJFCDPKEPF-OIUSMDOTSA-L
6666	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	408	Metocurine Iodide	(+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi	metubine iodide inj 2mg/ml	DRUGBANK	DB00416	C40H48I2N2O6	small molecule	-	7601-55-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIGFQJFCDPKEPF-OIUSMDOTSA-L
6667	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	408	Metocurine Iodide	(+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi	metubine iodide inj 2mg/ml	DRUGBANK	DB00416	C40H48I2N2O6	small molecule	-	7601-55-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIGFQJFCDPKEPF-OIUSMDOTSA-L
6668	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2008)	18633030	175926	408	Metocurine Iodide	(+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi	metubine iodide inj 2mg/ml	DRUGBANK	DB00416	C40H48I2N2O6	small molecule	-	7601-55-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIGFQJFCDPKEPF-OIUSMDOTSA-L
6669	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Iwatsuki N (1980)	6107062	175925	408	Metocurine Iodide	(+)-O,O'-Dimethylchondrocurarine Di-iodide|Dimetiltubocurarinio, ioduro de|Metubine iodide|Trimethyltubocurarine Iodide|Metocurini Iodidum|Metocurine iodide|Dimethyl Tubocurarine Iodide|Dimethyltubocurarine Iodide|Metokurinjodid|Metokuriinijodidi	metubine iodide inj 2mg/ml	DRUGBANK	DB00416	C40H48I2N2O6	small molecule	-	7601-55-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIGFQJFCDPKEPF-OIUSMDOTSA-L
6670	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	409	Phenoxymethylpenicillin	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID|Phnoxymthylpnicilline|Fenoximetilpenicilina|Phenoxymethylenepenicillinic acid|(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|6-phenoxyacetamidopenicillanic acid|Penicillin Phenoxymethyl|Phenoxymethylpenicillinum|Penicillin V|Oracillin|PV|Phenoxomethylpenicillin|Phenoxymethyl Penicillin	nadopen v tab 500000iu|pen-vee	DRUGBANK	DB00417	C16H18N2O5S	small molecule	J01CE02|J01CE10	87-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPLBGHOLXOTWMN-MBNYWOFBSA-N
6671	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6672	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6673	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6674	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6675	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6676	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6677	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6678	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6679	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6680	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Peters JA (1988)	2850060	175928	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6681	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6682	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6683	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Miller LG (1988)	2906155	175929	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6684	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6685	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Kirkness EF (1986)	3006661	175927	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6686	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6687	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6688	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6689	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6690	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6691	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6692	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6693	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6694	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6695	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6696	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6697	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6698	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6699	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6700	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6701	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6702	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6703	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6704	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6705	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6706	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6707	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Moyses C (2003)	12803929	175940	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6708	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6709	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Treiber A (2007)	17624027	175939	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6710	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Pastores GM (2006)	18221193	175938	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6711	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Ficicioglu C (2008)	18728838	175933	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6712	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Weinreb NJ (2005)	16247743	175932	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6713	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Chien YH (2007)	17603755	175935	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6714	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Wraith JE (2009)	19956552	175934	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6715	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	McCormack PL (2003)	14609352	175937	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6716	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	inhibitor	target	Giraldo P (2006)	16627252	175936	411	Miglustat	N-Butyl-1-deoxynojirimycin|SC-48334|Miglustatum|Butyldeoxynojirimycin|Zavesca|NB-dnj|N-Butyl deoxynojirimycin|BuDNJ|N-(N-Butyl)deoxynojirimycin|N-Butylmoranoline	miglustat|zavesca|sandoz miglu	DRUGBANK	DB00419	C10H21NO4	small molecule	A16AX06	72599-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQRORFVVSGFNRO-UTINFBMNSA-N
6717	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6718	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6719	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6720	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6721	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6722	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6723	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6724	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6725	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6726	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6727	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6728	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6729	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6730	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6731	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6732	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Govitrapong P (2002)	12106771	175942	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6733	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6734	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Govitrapong P (2000)	10980325	175943	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6735	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6736	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6737	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6738	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6739	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6740	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6741	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6742	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6743	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6744	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6745	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6746	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6747	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6748	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6749	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6750	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Rogerson FM (2003)	14664717	175944	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6751	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Rogerson FM (2004)	15554912	175945	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6752	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Rossi G (2005)	15808807	175946	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6753	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Sitruk-Ware R (2002)	11791081	175947	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6754	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Gertner RA (2004)	14978157	175948	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6755	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Frishman WH (2004)	15128471	175949	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6756	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Sica DA (2005)	15947888	175950	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6757	112359	6462	-	SHBG	ABP|SBP|TEBG	9606	Homo sapiens	binder	target	Braunstein GD (2007)	17881754	175951	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6758	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Fagart J (2010)	20650892	175952	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6759	107957	1585	-	CYP11B2	ALDOS|CPN2|CYP11B|CYP11BL|CYPXIB2|P-450C18|P450C18|P450aldo	9606	Homo sapiens	antagonist	target	Cheng SC (1976)	976190	175953	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6760	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Fagart J (2010)	20650892	175952	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6761	112594	6716	-	SRD5A2	-	9606	Homo sapiens	antagonist	target	Corvol P (1975)	166833	175954	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6762	122772	79644	-	SRD5A3	CDG1P|CDG1Q|KRIZI|SRD5A2L|SRD5A2L1	9606	Homo sapiens	antagonist	target	Corvol P (1975)	166833	175954	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6763	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	antagonist	target	Corvol P (1975)	166833	175954	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6764	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6765	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6766	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6767	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6768	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6769	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6770	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6771	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6772	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6773	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6774	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6775	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6776	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6777	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6778	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6779	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6780	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6781	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6782	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6783	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6784	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6785	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6786	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6787	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6788	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6789	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6790	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6791	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6792	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6793	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6794	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6795	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6796	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	unknown	target	Melander A (1977)	872489	175956	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6797	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	unknown	target	Sorrentino R (2000)	10942165	175955	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6798	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Ye P (2009)	18819053	175957	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6799	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6800	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Yang L (2004)	15322419	175959	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6801	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Gray JD (2007)	17611273	175958	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6802	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Williard RL (2007)	17218796	175962	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6803	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tilley MR (2008)	18698001	175963	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6804	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Sandoval V (2001)	11160413	175960	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6805	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chuhan YS (2006)	16246598	175961	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6806	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6807	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6808	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Volkow ND (1999)	10025684	175966	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6809	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Izenwasser S (1999)	10414438	175967	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6810	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wayment HK (1999)	10037500	175964	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6811	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Dresel SH (1999)	10199939	175965	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6812	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tilley MR (2008)	18698001	175963	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6813	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Viggiano D (2004)	15303308	175968	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6814	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Volkow ND (1999)	10403500	175969	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6815	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Izenwasser S (1999)	10414438	175967	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6816	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Dresel SH (1999)	10199939	175965	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6817	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Stehouwer JS (2006)	17154506	175970	414	Methylphenidate	alpha-Phenyl-2-piperidineacetic acid methyl ester|Methylphenidatum|Methyl phenidylacetate|Methylphenidate|Metilfenidato|MPH|Methylphenidan|Daytrana|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate	methylphenidate hydrochloride 	DRUGBANK	DB00422	C14H19NO2	small molecule	N06BA04	113-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-UHFFFAOYSA-N
6818	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Parr JS (1992)	1460006	175971	415	Methocarbamol	Robaxin|(RS)-2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate|Methocarbamol|Metocarbamol|Mthocarbamol|Delaxin|Metocarbamolo|Methocarbamolum	aspirin backache|aspirin night	DRUGBANK	DB00423	C11H15NO5	small molecule	M03BA73|M03BA03|M03BA53	532-03-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNXFOGHNGIVQEH-UHFFFAOYSA-N
6819	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Lysikova M (2001)	11495349	175972	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6820	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Lysikova M (2001)	11495349	175972	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6821	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6822	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6823	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Huang XP (1998)	9732369	175973	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6824	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6825	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6826	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Lysikova M (2001)	11495349	175972	416	Hyoscyamine	(S)-(-)-Hyoscyamine|(S)-()-hyoscyamine|Hyoscyamine|(-)-Hyoscyamine|()-atropine|Tropine, (-)-tropate|Daturin|Hyoscyaminum|(-)-Atropine|[3(S)-Endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Tropine-L-tropate|Hyoscyamin|Duboisine|L-Hyoscyamine|L-Tropine Tropate|(S)-atropine|()-hyoscyamine|Daturine	uro-mp|symax sr|hyophen|bellad	DRUGBANK	DB00424	C17H23NO3	small molecule	A03BA03|A03CB31	101-31-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-FXUDXRNXSA-N
6827	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Pritchett DB (1990)	2157817	175975	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6828	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Smith AJ (2001)	11306694	175974	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6829	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Pritchett DB (1990)	2157817	175975	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6830	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Smith AJ (2001)	11306694	175974	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6831	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Pritchett DB (1990)	2157817	175975	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6832	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Smith AJ (2001)	11306694	175974	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6833	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6834	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Vlainic J (2009)	19345234	175976	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6835	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6836	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Imming P (2006)	17016423	171742	418	Famciclovir	FCV|BRL-42810|9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine|Famvir|Famciclovir|2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate|Famciclovirum|Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester	ava-famciclovir|pms-famciclovi	DRUGBANK	DB00426	C14H19N5O4	small molecule	J05AB09|S01AD07	104227-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXKWVWZWMLJEH-UHFFFAOYSA-N
6837	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Schmid-Wendtner MH (2004)	15452407	175977	418	Famciclovir	FCV|BRL-42810|9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine|Famvir|Famciclovir|2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate|Famciclovirum|Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester	ava-famciclovir|pms-famciclovi	DRUGBANK	DB00426	C14H19N5O4	small molecule	J05AB09|S01AD07	104227-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXKWVWZWMLJEH-UHFFFAOYSA-N
6838	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6839	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Peroutka SJ (1981)	7214150	175988	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6840	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Paton DM (1985)	2866055	175984	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6841	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Simons FE (1994)	7913608	175985	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6842	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hiroi T (1995)	7853212	175986	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6843	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Estelle F (1999)	10582735	175987	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6844	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Claro E (1986)	3011460	175980	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6845	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kuzmin AI (1999)	10493107	175981	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6846	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Mann KV (1989)	2568212	175982	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6847	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ziganshina LE (1996)	8907591	175983	419	Triprolidine	Myidyl|Actidil|Corphed|Triphed|Allerfed|Trilitron|Histafed|Actahist|Myfed|Actifed|Triprolidin|Triprolidinum|Tripolidina|Triprolidine	actifed plus caplets|histex-pe	DRUGBANK	DB00427	C19H22N2	small molecule	R06AX07	486-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBEQULMOCCWAQT-WOJGMQOQSA-N
6848	112405	6514	-	SLC2A2	GLUT2	9606	Homo sapiens	ligand	target	Schnedl WJ (1994)	7926307	175991	420	Streptozocin	2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|Estreptozocina|Streptozocinium|Streptozocine|Streptozocinum|Streptozocin|Zanosar|N-D-Glucosyl-(2)-n&#39;-nitrosomethylharnstoff|2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose|N-D-Glucosyl-(2)-n'-nitrosomethylurea|Streptozotocin	zanosar|zanosar sterile powder	DRUGBANK	DB00428	C8H15N3O7	small molecule	L01AD04	18883-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSJLQEPLLKMAKR-GKHCUFPYSA-N
6849	112405	6514	-	SLC2A2	GLUT2	9606	Homo sapiens	ligand	target	Wang Z (1998)	9421374	175990	420	Streptozocin	2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|Estreptozocina|Streptozocinium|Streptozocine|Streptozocinum|Streptozocin|Zanosar|N-D-Glucosyl-(2)-n&#39;-nitrosomethylharnstoff|2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose|N-D-Glucosyl-(2)-n'-nitrosomethylurea|Streptozotocin	zanosar|zanosar sterile powder	DRUGBANK	DB00428	C8H15N3O7	small molecule	L01AD04	18883-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSJLQEPLLKMAKR-GKHCUFPYSA-N
6850	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6851	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Carrasco MP (1997)	9462300	175997	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6852	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Hay A (2010)	20519365	175996	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6853	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Tsuboi K (2001)	11338376	175995	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6854	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	Pfaller MA (1984)	6426381	176000	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6855	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6856	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	Fass RJ (1986)	3943292	175998	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6857	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Pfaller MA (1984)	6426381	176000	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6858	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6859	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Fass RJ (1986)	3943292	175998	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6860	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6861	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Fass RJ (1986)	3943292	175998	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6862	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6863	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Fass RJ (1986)	3943292	175998	422	Cefpiramide	Cefpiramidum|Cefpiramide|Cefpiramido	-	DRUGBANK	DB00430	C25H24N8O7S2	small molecule	J01DD11	70797-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAUCHMQEXVFJR-PMAPCBKXSA-N
6864	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Joy RM (1995)	7566682	176008	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6865	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Heusinkveld HJ (2010)	20600211	176009	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6866	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Cole LM (1995)	7885191	176003	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6867	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6868	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6869	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Sauviat MP (2003)	12645305	176004	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6870	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6871	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Narahashi T (1996)	8841090	176006	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6872	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Vale C (2003)	12614680	176005	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6873	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Bloomquist JR (2003)	14635176	176010	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6874	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Anand M (1998)	9530529	176007	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6875	109005	2743	-	GLRB	HKPX2	9606	Homo sapiens	antagonist	target	Heusinkveld HJ (2010)	20600211	176009	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6876	109005	2743	-	GLRB	HKPX2	9606	Homo sapiens	antagonist	target	Vale C (2003)	12614680	176005	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6877	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	antagonist	target	Heusinkveld HJ (2010)	20600211	176009	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6878	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	antagonist	target	Vale C (2003)	12614680	176005	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6879	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	antagonist	target	Heusinkveld HJ (2010)	20600211	176009	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6880	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	antagonist	target	Vale C (2003)	12614680	176005	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6881	113705	8001	-	GLRA3	-	9606	Homo sapiens	antagonist	target	Heusinkveld HJ (2010)	20600211	176009	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6882	113705	8001	-	GLRA3	-	9606	Homo sapiens	antagonist	target	Vale C (2003)	12614680	176005	423	Lindane	gamma-Hexachlorocyclohexane|Kwell|gamma-HCH|(1R,2c,3t,4c,5c,6t)-1,2,3,4,5,6-Hexachlorocyclohexane|-lindane|gamma-Hexachlorzyklohexan|gamma-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Lindane|1,2,3,4,5,6-Hexachlorocyclohexane|Benzene hexachloride|Gammallin|Gammaxene|-Hexachlorzyklohexan|gamma-BHC|-hexachlorocyclohexane|Lindan|(1alpha,2alpha,3beta,4alpha,5alpha,6beta)-1,2,3,4,5,6-Hexachlorocyclohexane|gamma-Benzene hexachloride	kwellada lotion 1%|lindane lot	DRUGBANK	DB00431	C6H6Cl6	small molecule	P03AB02	58-89-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLYXXMFPNIAWKQ-GNIYUCBRSA-N
6883	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6884	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Baessler R (1966)	6010427	176022	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6885	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Bijnsdorp IV (2008)	18600528	176023	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6886	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Madeira VM (1973)	4719131	176020	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6887	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Overman MJ (2008)	18798063	176021	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6888	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Temmink OH (2004)	15571283	176017	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6889	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Emura T (2004)	14719072	176016	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6890	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Hong DS (2006)	16902987	176015	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6891	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Temmink OH (2006)	16010590	176014	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6892	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Shintani M (2010)	20372850	176013	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6893	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Temmink OH (2007)	17179993	176012	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6894	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	De Clercq E (2004)	15125867	176011	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6895	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Oberg B (1984)	6436227	176024	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6896	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Bijnsdorp IV (2010)	19816940	176019	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6897	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Bijnsdorp IV (2010)	19886911	176018	424	Trifluridine	FT|Viroptic|5-(Trifluoromethyl)deoxyuridine|Trifluridin|Trifluridina|Trifluorothymidine|5-Trifluoromethyl-2-deoxyuridine|Trifluorothymine deoxyriboside|Trifluridinum|TFT|Trifluridine|Trifluoromethyldeoxyuridine	apo-trifluridine ophthalmic so	DRUGBANK	DB00432	C10H11F3N2O5	small molecule	S01AD02|L01BC59	70-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSQQQLOSPVPRAZ-RRKCRQDMSA-N
6898	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hamik A (1989)	2527092	176028	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6899	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Callan JE (2008)	18534808	176029	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6900	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Roberge RJ (2006)	16677982	176027	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6901	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6902	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Narita M (2008)	18955042	176031	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6903	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Golembiewski J (2006)	17169748	176030	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6904	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Vinson DR (2006)	17044574	176032	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6905	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6906	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Calka O (2006)	16418149	176035	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6907	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Honda M (2003)	12498911	176034	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6908	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Rashid M (2002)	12233819	176037	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6909	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Hoenicke EM (1992)	1403790	176036	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6910	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Callaway CW (1992)	1358088	176033	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6911	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Eltze M (1989)	2625138	176038	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6912	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Eltze M (1989)	2625138	176038	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6913	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eltze M (1989)	2625138	176038	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6914	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Honda M (2003)	12498911	176034	426	Cyproheptadine	1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5H-Dibenzo(a,D)cyclohepten-5-ylidene)-1-methylpiperidine|Dihexazin|Axoprol|4-Dibenzo[a,D]cyclohepten-5-ylidene-1-methyl-piperidine|4-(5-Dibenzo(a,D)cyclohepten-5-ylidine)-1-methylpiperidine|Cyproheptadine|Cyproheptadin|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|Ciproheptadina|5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|Cyproheptadinum|Glutodina	pms-cyproheptadine hcl tab 4mg	DRUGBANK	DB00434	C21H21N	small molecule	R06AX02	129-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJCFRYNCJDLXIK-UHFFFAOYSA-N
6915	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	inducer	target	Moncada S (1991)	1852778	176040	427	Nitric Oxide	Mononitrogen monoxide|Nitrogen monoxide|Oxyde azotique|Nitrosyl|Stickstoffmonoxid|(.)NO|endothelium-derived relaxing factor|NO|nitrogen monooxide|Monoxyde d'azote|[NO]|Monoxido de nitrogeno|Oxyde nitrique|(NO)(.)|Stickstoff(ii)-oxid|Oxido nitrico|Nitric oxide|EDRF|NO(.)|Oxido de nitrogeno(ii)	noxivent|kinox|inomax|nitric o	DRUGBANK	DB00435	NO	small molecule	R07AX01	10102-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWUXSHHQAYIFBG-UHFFFAOYSA-N
6916	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	inducer	target	Mancuso C (2010)	20089135	176039	427	Nitric Oxide	Mononitrogen monoxide|Nitrogen monoxide|Oxyde azotique|Nitrosyl|Stickstoffmonoxid|(.)NO|endothelium-derived relaxing factor|NO|nitrogen monooxide|Monoxyde d'azote|[NO]|Monoxido de nitrogeno|Oxyde nitrique|(NO)(.)|Stickstoff(ii)-oxid|Oxido nitrico|Nitric oxide|EDRF|NO(.)|Oxido de nitrogeno(ii)	noxivent|kinox|inomax|nitric o	DRUGBANK	DB00435	NO	small molecule	R07AX01	10102-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWUXSHHQAYIFBG-UHFFFAOYSA-N
6917	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6918	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6919	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inducer	target	Tricarico D (2004)	14766795	176046	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6920	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6921	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Vallon V (2008)	18216144	176047	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6922	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Monroy A (2000)	10894798	176048	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6923	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6924	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6925	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6926	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	428	Bendroflumethiazide	Bendroflumetiazida|+--3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Bendroflumethiazidum|Benzhydroflumethiazide|Bendroflumthiazide|Bendrofluazide|6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Bendroflumethiazid	corzide|naturetin 5mg|nadolol 	DRUGBANK	DB00436	C15H14F3N3O4S2	small molecule	C03AA01|C03EA13|C03AB01	73-48-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDWIHXWEUNVBIY-UHFFFAOYSA-N
6927	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6928	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Higgins P (2009)	20029618	176059	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6929	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Pacher P (2006)	16507884	176058	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6930	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	George J (2009)	19436671	176053	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6931	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Taha MO (2009)	19376361	176052	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6932	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Okamoto K (2008)	18409526	176051	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6933	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Dincer HE (2002)	12184468	176050	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6934	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Suzuki I (2009)	19584965	176057	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6935	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Carro MD (2010)	19654053	176056	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6936	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Terkeltaub R (2010)	20046204	176055	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6937	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Kelley WN (1970)	5415686	176054	429	Allopurinol	4'-Hydroxypyrazolol(3,4-D)pyrimidine|Zyloprim (tn)|1H-Pyrazolo(3,4-D)pyrimidin-4-ol|4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine|4-Hydroxypyrazolo(3,4-D)pyrimidine|4H-Pyrazolo(3,4-D)pyrimidin-4-one|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one|4-Hydroxypyrazolopyrimidine|Allopurinol|Alopurinol|4-HPP|4-Hydroxy-3,4-pyrazolopyrimidine|1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one|Allopurinolum|4-Hydroxypyrazolyl(3,4-D)pyrimidine|AL-100	riva-purinol 300mg tablets|all	DRUGBANK	DB00437	C5H4N4O	small molecule	M04AA01|M04AA51	315-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFCNXPDARWKPPY-UHFFFAOYSA-N
6938	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Hayes MV (1983)	6413485	176060	430	Ceftazidime	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum	ceptaz injection -  pws iv  2g	DRUGBANK	DB00438	C22H22N6O7S2	small molecule	J01DD52|J01DD02	78439-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORFOPKXBNMVMKC-DWVKKRMSSA-N
6939	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Hayes MV (1983)	6413485	176060	430	Ceftazidime	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum	ceptaz injection -  pws iv  2g	DRUGBANK	DB00438	C22H22N6O7S2	small molecule	J01DD52|J01DD02	78439-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORFOPKXBNMVMKC-DWVKKRMSSA-N
6940	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Hayes MV (1983)	6413485	176060	430	Ceftazidime	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum	ceptaz injection -  pws iv  2g	DRUGBANK	DB00438	C22H22N6O7S2	small molecule	J01DD52|J01DD02	78439-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORFOPKXBNMVMKC-DWVKKRMSSA-N
6941	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Hayes MV (1983)	6413485	176060	430	Ceftazidime	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum	ceptaz injection -  pws iv  2g	DRUGBANK	DB00438	C22H22N6O7S2	small molecule	J01DD52|J01DD02	78439-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORFOPKXBNMVMKC-DWVKKRMSSA-N
6942	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	431	Cerivastatin	-	baycol (0.2mg)|baycol (0.3mg)|	DRUGBANK	DB00439	C26H34FNO5	small molecule	C10AA06	145599-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEERZIQQUAZTOL-ANMDKAQQSA-N
6943	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Shiomi M (1999)	10193776	176062	431	Cerivastatin	-	baycol (0.2mg)|baycol (0.3mg)|	DRUGBANK	DB00439	C26H34FNO5	small molecule	C10AA06	145599-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEERZIQQUAZTOL-ANMDKAQQSA-N
6944	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Wong WW (2001)	11448925	176063	431	Cerivastatin	-	baycol (0.2mg)|baycol (0.3mg)|	DRUGBANK	DB00439	C26H34FNO5	small molecule	C10AA06	145599-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEERZIQQUAZTOL-ANMDKAQQSA-N
6945	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Denoyelle C (2001)	11470741	176061	431	Cerivastatin	-	baycol (0.2mg)|baycol (0.3mg)|	DRUGBANK	DB00439	C26H34FNO5	small molecule	C10AA06	145599-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEERZIQQUAZTOL-ANMDKAQQSA-N
6946	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Ganne F (2000)	11057870	176064	431	Cerivastatin	-	baycol (0.2mg)|baycol (0.3mg)|	DRUGBANK	DB00439	C26H34FNO5	small molecule	C10AA06	145599-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEERZIQQUAZTOL-ANMDKAQQSA-N
6947	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Blumenthal RS (2000)	10740137	176065	431	Cerivastatin	-	baycol (0.2mg)|baycol (0.3mg)|	DRUGBANK	DB00439	C26H34FNO5	small molecule	C10AA06	145599-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEERZIQQUAZTOL-ANMDKAQQSA-N
6948	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6949	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6950	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6951	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Rosowsky A (1999)	10090784	176071	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6952	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Oefner C (2009)	19622858	176070	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6953	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Gamarro F (1995)	8538681	176068	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6954	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Reche P (1996)	8920005	176069	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6955	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6956	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Laskowska E (2003)	14629008	176073	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6957	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Rosowsky A (2004)	15115391	176072	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6958	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Nahimana A (2004)	15504856	176075	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6959	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Floris-Moore MA (2003)	14632594	176074	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6960	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Barrow EW (2004)	15561838	176076	432	Trimethoprim	Trimpex|Proloprim|Trimethoprimum|Trimethoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|Trimthoprime|Trimetoprima	polytrim|septra injection|poly	DRUGBANK	DB00440	C14H18N4O3	small molecule	J01EE07|J01EE04|J01EE05|J01EE02|J01EE03|J01EE01|J01EA01	738-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-N
6961	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Nakahira S (2007)	17131328	176080	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6962	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Smid K (2006)	17065054	176081	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6963	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Bepler G (2006)	16966686	176082	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6964	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Kwon WS (2006)	16708051	176077	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6965	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Rosell R (2006)	16807441	176079	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6966	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Cerqueira NM (2007)	17636467	176078	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6967	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6968	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Giovannetti E (2005)	15795320	176083	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6969	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Rosell R (2004)	15655942	176084	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6970	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Zhao XD (2006)	17166391	176085	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6971	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Giovannetti E (2006)	16818496	176086	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6972	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Huang CL (2006)	16563096	176087	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6973	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Marce S (2006)	16818276	176088	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6974	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	inhibitor	target	Maring JG (2005)	16041392	176089	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6975	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	inhibitor	target	Lam W (2007)	17565005	176092	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6976	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	inhibitor	target	Vernejoul F (2006)	17000136	176091	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6977	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	inhibitor	target	Hsu CH (2005)	15550676	176090	433	Gemcitabine	Gemcitabina|Gemcitabine|2'-Deoxy-2',2'-difluorocytidine|4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Gemcitabinum|Gemcitabin|2',2'-Difluorodeoxycytidine	gemcitabine hydrochloride|gemc	DRUGBANK	DB00441	C9H11F2N3O4	small molecule	L01BC05	95058-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDUQYLNIPVEERB-QPPQHZFASA-N
6978	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6979	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Johnstone JF (2005)	15866114	176102	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6980	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Aida K (2004)	15336699	176103	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6981	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Tanigawa K (2002)	12188035	176104	435	Betamethasone	Betamethasonum|16-Methyl-1,4-pregnadiene-9-fluoro-11,17,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betadexamethasone|9alpha-Fluoro-16beta-methylprednisolone|Rinderon|Betametasona|16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione|9-Fluoro-16-methylprednisolone|Betamethasone|9-Fluoro-16beta-methylprednisolone|beta-Methasone alcohol|Betamethasonvalerat Mikron	betnesol retention enema 5mg/1	DRUGBANK	DB00443	C22H29FO5	small molecule	S03CA06|D07CC01|S01CA05|S01BB04|R03BA04|A07EA04|H02AB01|C05AA05|S03BA03|D07BC01|D07AC01|D07XC01|S02BA07|S01BA06|R01AD06|S01CB04	378-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-DVTGEIKXSA-N
6982	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	436	Teniposide	Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid	teniposide|vumon	DRUGBANK	DB00444	C32H32O13S	small molecule	L01CB02	29767-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRUKOCRGYNPUPR-QBPJDGROSA-N
6983	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Umanskaya ON (2006)	16480143	176110	436	Teniposide	Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid	teniposide|vumon	DRUGBANK	DB00444	C32H32O13S	small molecule	L01CB02	29767-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRUKOCRGYNPUPR-QBPJDGROSA-N
6984	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Winnicka K (2007)	17514873	176107	436	Teniposide	Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid	teniposide|vumon	DRUGBANK	DB00444	C32H32O13S	small molecule	L01CB02	29767-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRUKOCRGYNPUPR-QBPJDGROSA-N
6985	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	de Lucio B (2005)	16271071	176106	436	Teniposide	Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid	teniposide|vumon	DRUGBANK	DB00444	C32H32O13S	small molecule	L01CB02	29767-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRUKOCRGYNPUPR-QBPJDGROSA-N
6986	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Uesaka T (2007)	17361331	176109	436	Teniposide	Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid	teniposide|vumon	DRUGBANK	DB00444	C32H32O13S	small molecule	L01CB02	29767-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRUKOCRGYNPUPR-QBPJDGROSA-N
6987	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Faure P (1996)	8702194	176108	436	Teniposide	Teniposido|4'-demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)|Epidophyllotoxin|Tniposide|Teniposidum|Teniposid	teniposide|vumon	DRUGBANK	DB00444	C32H32O13S	small molecule	L01CB02	29767-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRUKOCRGYNPUPR-QBPJDGROSA-N
6988	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Petit T (2004)	14728934	176113	437	Epirubicin	Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine	epirubicin hydrochloride for i	DRUGBANK	DB00445	C27H29NO11	small molecule	L01DB03	56420-45-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-VTZDEGQISA-N
6989	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Knoop AS (2005)	16234514	176114	437	Epirubicin	Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine	epirubicin hydrochloride for i	DRUGBANK	DB00445	C27H29NO11	small molecule	L01DB03	56420-45-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-VTZDEGQISA-N
6990	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Liang CH (2007)	17639997	176115	437	Epirubicin	Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine	epirubicin hydrochloride for i	DRUGBANK	DB00445	C27H29NO11	small molecule	L01DB03	56420-45-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-VTZDEGQISA-N
6991	107530	1105	-	CHD1	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	437	Epirubicin	Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine	epirubicin hydrochloride for i	DRUGBANK	DB00445	C27H29NO11	small molecule	L01DB03	56420-45-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-VTZDEGQISA-N
6992	107530	1105	-	CHD1	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	437	Epirubicin	Pidorubicinum|Epirubicinum|Epiadriamycin|Epirubicine|4'-Epiadriamycin|Epirubicin|Pidorubicina|Epirubicina|Pidorubicine	epirubicin hydrochloride for i	DRUGBANK	DB00445	C27H29NO11	small molecule	L01DB03	56420-45-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-VTZDEGQISA-N
6993	852118	947806	b3313	rplP	ECK3300|JW3275	511145	Escherichia coli	inhibitor	target	Nierhaus D (1973)	4365366	176123	438	Chloramphenicol	Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide	ophtho-chloram liq 0.5%|pms-ch	DRUGBANK	DB00446	C11H12Cl2N2O5	small molecule	S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01	56-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIIZWVCIJKGZOK-RKDXNWHRSA-N
6994	852118	947806	b3313	rplP	ECK3300|JW3275	511145	Escherichia coli	inhibitor	target	Baxter RM (1987)	3549294	176125	438	Chloramphenicol	Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide	ophtho-chloram liq 0.5%|pms-ch	DRUGBANK	DB00446	C11H12Cl2N2O5	small molecule	S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01	56-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIIZWVCIJKGZOK-RKDXNWHRSA-N
6995	852118	947806	b3313	rplP	ECK3300|JW3275	511145	Escherichia coli	inhibitor	target	Murray IA (1995)	7500366	176124	438	Chloramphenicol	Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide	ophtho-chloram liq 0.5%|pms-ch	DRUGBANK	DB00446	C11H12Cl2N2O5	small molecule	S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01	56-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIIZWVCIJKGZOK-RKDXNWHRSA-N
6996	107974	1604	RP11-357P18.1	CD55	CR|CROM|DAF|TC	9606	Homo sapiens	unknown	target	Korotkova N (2007)	17376081	176127	438	Chloramphenicol	Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide	ophtho-chloram liq 0.5%|pms-ch	DRUGBANK	DB00446	C11H12Cl2N2O5	small molecule	S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01	56-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIIZWVCIJKGZOK-RKDXNWHRSA-N
6997	107974	1604	RP11-357P18.1	CD55	CR|CROM|DAF|TC	9606	Homo sapiens	unknown	target	Pettigrew D (2004)	15331605	176126	438	Chloramphenicol	Cloramfenicol|Chloramphenicolum|Chlorocol|Chloromycetin|Levomicetina|Oleomycetin|Levomycetin|Chloramphenicol|D-(-)-threo-1-P-Nitrophenyl-2-dichloroacetylamino-1,3-propanediol|Chloramex|Fenicol|Globenicol|Laevomycetinum|Sificetina|Chlorocid|Chlornitromycin|Halomycetin|D-(-)-2,2-Dichloro-N-(beta-hydroxy-alpha-(hydroxymethyl)-P-nitrophenylethyl)acetamide	ophtho-chloram liq 0.5%|pms-ch	DRUGBANK	DB00446	C11H12Cl2N2O5	small molecule	S02AA01|D10AF03|D06AX02|G01AA05|S03AA08|S01AA01|J01BA01	56-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIIZWVCIJKGZOK-RKDXNWHRSA-N
6998	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	440	Lansoprazole	Ogastro|Lansoprazole|Lanzol|Prevacid|Lansoprazol|Lansoprazolum|Lanzul|Limpidex|Monolitum|AG 1749|Lanzopral|Bamalite|Opiren	health mart lansoprazole|dg he	DRUGBANK	DB00448	C16H14F3N3O2S	small molecule	A02BD07|A02BD02|A02BD03|A02BC53|A02BD09|A02BC03|A02BD10	103577-45-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJIHNNLFOKEZEW-UHFFFAOYSA-N
6999	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Langtry HD (1997)	9279507	176141	440	Lansoprazole	Ogastro|Lansoprazole|Lanzol|Prevacid|Lansoprazol|Lansoprazolum|Lanzul|Limpidex|Monolitum|AG 1749|Lanzopral|Bamalite|Opiren	health mart lansoprazole|dg he	DRUGBANK	DB00448	C16H14F3N3O2S	small molecule	A02BD07|A02BD02|A02BD03|A02BC53|A02BD09|A02BC03|A02BD10	103577-45-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJIHNNLFOKEZEW-UHFFFAOYSA-N
7000	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Matheson AJ (2001)	11693467	176140	440	Lansoprazole	Ogastro|Lansoprazole|Lanzol|Prevacid|Lansoprazol|Lansoprazolum|Lanzul|Limpidex|Monolitum|AG 1749|Lanzopral|Bamalite|Opiren	health mart lansoprazole|dg he	DRUGBANK	DB00448	C16H14F3N3O2S	small molecule	A02BD07|A02BD02|A02BD03|A02BC53|A02BD09|A02BC03|A02BD10	103577-45-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJIHNNLFOKEZEW-UHFFFAOYSA-N
7001	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Nakamura M (1993)	8446367	176143	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7002	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ozakca I (2007)	17622774	176145	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7003	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lucin KM (2007)	17597612	176144	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7004	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7005	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Prenner L (2007)	17417877	176146	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7006	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	potentiator	target	Nakamura M (1993)	8446367	176143	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7007	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7008	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7009	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Tomiyama Y (2007)	17658513	175725	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7010	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Sanbe A (2007)	17603545	176147	441	Dipivefrin	Dipivefrin|Dipivalyl Epinephrine|(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate|Pro-Epinephrine|Dipivefrinum|1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol|Dipivefrina|Dipivfrine	pms-dipivefrin|probeta - liq o	DRUGBANK	DB00449	C19H29NO5	small molecule	S01EA02	52365-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCUJLLGVOUDECM-UHFFFAOYSA-N
7011	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Grip G (1992)	1549935	176149	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7012	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Larson MD (2003)	14633536	176148	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7013	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hamik A (1989)	2527092	176028	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7014	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Gao HR (2010)	20358234	176150	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7015	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Zupko I (2003)	12505540	176151	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7016	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7017	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7018	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7019	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Nakajima Y (2010)	20615127	176152	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7020	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Bernal J (2007)	17315033	174854	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7021	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7022	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Marazuela M (2008)	18816177	176154	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7023	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Grasberger H (2005)	16053391	176155	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7024	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Sivakumar T (2010)	20151830	176153	443	Levothyroxine	O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|3,5,3',5'-TETRAIODO-L-thyronine|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|3,3',5,5'-Tetraiodo-L-thyronine|T4|LT4|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|Levothyroxin|L-Thyroxine|L-T4	pms-levothyroxine sodium tab 3	DRUGBANK	DB00451	C15H11I4NO4	small molecule	H03AA01	51-48-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-LBPRGKRZSA-N
7025	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7026	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Famulok M (1996)	8605174	176157	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7027	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7028	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Litovchick A (2001)	11747436	176158	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7029	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Borkow G (2003)	14638394	176159	444	Framycetin	Framycetin|Fradiomycin B|Neomycin B|Framycetinum|Framicetina|Framyctine	proctosedyl sup|sandoz opticor	DRUGBANK	DB00452	C23H46N6O13	small molecule	S01AA07|D09AA01|R01AX08	119-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
7030	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	445	Clomocycline	Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina	-	DRUGBANK	DB00453	C23H25ClN2O9	small molecule	J01AA11	1181-54-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJGDLRSSCNAKGL-KMVLDZISSA-N
7031	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	445	Clomocycline	Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina	-	DRUGBANK	DB00453	C23H25ClN2O9	small molecule	J01AA11	1181-54-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJGDLRSSCNAKGL-KMVLDZISSA-N
7032	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	445	Clomocycline	Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina	-	DRUGBANK	DB00453	C23H25ClN2O9	small molecule	J01AA11	1181-54-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJGDLRSSCNAKGL-KMVLDZISSA-N
7033	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	445	Clomocycline	Clomociclina|Chlormethylenecycline|Clomocyclinum|Clomocyclina	-	DRUGBANK	DB00453	C23H25ClN2O9	small molecule	J01AA11	1181-54-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJGDLRSSCNAKGL-KMVLDZISSA-N
7034	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7035	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7036	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Gu X (2010)	20980153	176161	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7037	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Lomenzo SA (2005)	15743177	176160	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7038	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7039	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7040	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7041	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7042	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Poulain R (2001)	11585443	176163	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7043	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	binder	target	Hustveit O (1994)	8164394	176164	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7044	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	binder	target	Hustveit O (1994)	8164394	176164	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7045	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	binder	target	Hustveit O (1994)	8164394	176164	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7046	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Hustveit O (1994)	8164394	176164	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7047	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	binder	target	Hustveit O (1994)	8164394	176164	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7048	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	unknown	target	Lomenzo SA (1999)	10612583	176165	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7049	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	unknown	target	Gu X (2010)	20980153	176161	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7050	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	unknown	target	Lomenzo SA (2005)	15743177	176160	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7051	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7052	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	binding	target	Gu X (2010)	20980153	176161	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7053	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	binding	target	Lomenzo SA (2005)	15743177	176160	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7054	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cavero I (1999)	10597865	175351	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7055	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tamura T (2005)	15942272	175347	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7056	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Menardo JL (1998)	9444440	176170	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7057	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Baroody FM (2001)	11291777	176171	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7058	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cieslewicz G (1992)	1303772	176172	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7059	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Grzelewska-Rzymowska I (1992)	1303773	176173	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7060	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Howarth PH (1990)	1977506	176174	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7061	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7062	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Letari O (1994)	8174605	176169	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7063	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cieslewicz G (1995)	7581058	176168	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCNYMKQOSZNPW-UHFFFAOYSA-N
7064	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	potentiator	target	Imming P (2006)	17016423	171742	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
7065	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	potentiator	target	Oelschlaeger P (2005)	15722450	176183	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
7066	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	potentiator	target	Overington JP (2006)	17139284	171741	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
7067	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	potentiator	target	Bethel CR (2006)	16982784	176185	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
7068	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	potentiator	target	Diaz N (2005)	15689162	176184	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
7069	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Uhlen S (1991)	1666366	176190	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7070	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Tomiyama Y (2007)	17658513	175725	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7071	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7072	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Suzuki Y (2000)	10771044	176192	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7073	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Zacharia J (2004)	14980979	176193	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7074	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7075	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chang HK (2003)	12841945	176196	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7076	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Eltze M (1996)	8925876	176194	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7077	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Morris DP (2004)	15258254	176195	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7078	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7079	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Sharpe IA (2003)	12824165	176198	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7080	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Al-Damluji S (2001)	11156594	176199	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7081	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7082	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7083	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Ishiguro M (2002)	12270758	176197	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7084	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Eltze M (1996)	8925876	176194	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7085	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7086	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7087	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Yamamoto Y (2001)	11682453	176202	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7088	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Nagaoka Y (2008)	18187928	176201	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7089	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7090	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	binder	target	Uhlen S (1991)	1666366	176190	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7091	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	449	Prazosin	Prazosine|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|Prazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine	prazosin hydrochloride|alti-pr	DRUGBANK	DB00457	C19H21N5O4	small molecule	C02LE01|C02CA01	19216-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IENZQIKPVFGBNW-UHFFFAOYSA-N
7092	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7093	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Zanoveli JM (2005)	16170231	176205	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7094	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7095	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	binder	target	Toll L (1998)	9686407	176206	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7096	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Toll L (1998)	9686407	176206	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7097	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Dziedzicka-Wasylewska M (2006)	16554743	176210	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7098	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Anton M (2004)	14716684	176208	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7099	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1999)	10193665	176209	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7100	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Kantor L (2001)	11356924	176207	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7101	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mitchell HA (2006)	16893531	174557	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7102	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Roth BL (1994)	7804391	176211	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7103	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Lucchelli A (2000)	10997731	175186	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7104	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7105	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Schloss P (1995)	7548008	174429	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7106	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Quintin P (2001)	11513817	176213	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7107	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Barkan T (2004)	15056483	176212	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7108	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Goulet M (2001)	11746710	176215	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7109	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Leboyer M (1999)	10624553	176214	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7110	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Scholze P (2000)	10869387	176216	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7111	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	unknown	target	Melikian HE (1999)	10479674	176217	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7112	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7113	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7114	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7115	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7116	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7117	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7118	109954	3752	RP4-773A18.7	KCND3	KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22	9606	Homo sapiens	inhibitor	target	Casis O (1998)	9781919	174867	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7119	109953	3751	-	KCND2	KV4.2|RK5	9606	Homo sapiens	inhibitor	target	Casis O (1998)	9781919	174867	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7120	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7121	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Teschemacher AG (1999)	10510461	176218	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7122	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	binder	target	Grimaldi B (1998)	9606024	176219	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7123	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	binder	target	Roth BL (1994)	7804391	176211	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7124	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Peddi S (2004)	15081025	176220	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7125	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7126	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	activator	target	Haddjeri N (1998)	9822768	176221	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7127	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7128	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Roth BL (1994)	7804391	176211	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7129	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Paelvimaeki EP (1996)	8876023	176222	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7130	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	binder	target	Roth BL (1994)	7804391	176211	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7131	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	binder	target	Paelvimaeki EP (1996)	8876023	176222	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7132	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Tippmann F (2009)	19144697	176230	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7133	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Orfanos CE (1997)	9074840	176227	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7134	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Tian K (1997)	9153406	176228	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7135	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Saurat JH (1999)	10459139	176229	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7136	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Zouboulis CC (2001)	11586072	176232	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7137	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Berggren Soederlund M (1995)	7755585	176231	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7138	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Tippmann F (2009)	19144697	176230	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7139	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7140	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7141	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Orfanos CE (1997)	9074840	176227	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7142	111881	5947	-	RBP1	CRABP-I|CRBP|CRBP1|CRBPI|RBPC	9606	Homo sapiens	agonist	target	Berni R (1993)	8375617	176233	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7143	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7144	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7145	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7146	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7147	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7148	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Orfanos CE (1997)	9074840	176227	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7149	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Tian K (1997)	9153406	176228	451	Acitretin	Acitretina|Etretin|Acitretine|Acetretin|Acitretin|(all-e)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid|all-trans-3,7-Dimethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-2,4,6,8-nonatetraenoic acid|Soriatane|Neotigason|Acitretinum	acitretin|soriatane	DRUGBANK	DB00459	C21H26O3	small molecule	D05BB02	55079-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHUNBGSDBOWDMA-AQFIFDHZSA-N
7150	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bensen W (1998)	9481468	176239	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7151	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Takeuchi K (2006)	16469680	176238	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7152	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cipollone F (1995)	7554708	176237	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7153	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Giuliano F (2001)	11525777	176240	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7154	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7155	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elliott SN (1995)	7615202	176244	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7156	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Roy HK (2001)	11304699	176245	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7157	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hedner T (2004)	15456329	176242	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7158	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Kraaij DJ (2002)	12047490	176243	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7159	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7160	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Saito M (2010)	20687226	176250	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7161	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Sykes DA (2009)	19498041	176248	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7162	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Voigtlaender U (2003)	12815157	176249	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7163	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7164	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7165	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Figueroa KW (2010)	20590642	176251	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7166	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7167	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Soukup O (2009)	19565307	176252	454	Methylscopolamine bromide	Scopolamine Methobromide|Hyoscine Methobromide|Pamine|Methscopolamine bromide|N-methylscopolammonium bromide|N-methylhyoscine bromide|Scopolamine methyl bromide|Hyoscine methyl bromide|()-scopolamine methyl bromide|()-scopolamine methobromide	pamine forte|methscopolamine|p	DRUGBANK	DB00462	C18H24BrNO4	small molecule	-	155-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXYRUNPLKGGUJF-JIRGPDKYSA-M
7168	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7169	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7170	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7171	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7172	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7173	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7174	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7175	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7176	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7177	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7178	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7179	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7180	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7181	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7182	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7183	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7184	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7185	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7186	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7187	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7188	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7189	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7190	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7191	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7192	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7193	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7194	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	456	Sodium Tetradecyl Sulfate	Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt	tromboject 3% inj 30mg/ml|trom	DRUGBANK	DB00464	C14H29NaO4S	small molecule	C05BB04	139-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVEFRICMTUKAML-UHFFFAOYSA-M
7195	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	inhibitor	target	Parsi K (2009)	19442540	176254	456	Sodium Tetradecyl Sulfate	Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt	tromboject 3% inj 30mg/ml|trom	DRUGBANK	DB00464	C14H29NaO4S	small molecule	C05BB04	139-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVEFRICMTUKAML-UHFFFAOYSA-M
7196	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	456	Sodium Tetradecyl Sulfate	Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt	tromboject 3% inj 30mg/ml|trom	DRUGBANK	DB00464	C14H29NaO4S	small molecule	C05BB04	139-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVEFRICMTUKAML-UHFFFAOYSA-M
7197	111608	5624	-	PROC	APC|PC|PROC1|THPH3|THPH4	9606	Homo sapiens	inhibitor	target	Jacobson BF (1992)	1344580	176253	456	Sodium Tetradecyl Sulfate	Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt	tromboject 3% inj 30mg/ml|trom	DRUGBANK	DB00464	C14H29NaO4S	small molecule	C05BB04	139-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVEFRICMTUKAML-UHFFFAOYSA-M
7198	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	inhibitor	target	Parsi K (2009)	19442540	176254	456	Sodium Tetradecyl Sulfate	Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt	tromboject 3% inj 30mg/ml|trom	DRUGBANK	DB00464	C14H29NaO4S	small molecule	C05BB04	139-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVEFRICMTUKAML-UHFFFAOYSA-M
7199	111611	5627	-	PROS1	PROS|PS21|PS22|PS23|PS24|PS25|PSA|THPH5|THPH6	9606	Homo sapiens	inhibitor	target	Jacobson BF (1992)	1344580	176253	456	Sodium Tetradecyl Sulfate	Sodium tetradecyl sulphate|Sodium 2-methyl-7-ethylundecanol-4-sulfate|Tetradecyl sulfate de sodium|Tetradecyl sodium sulfate|Sodium 7-ethyl-2-methyl-4-undecanol sulfate|Tetradecilsulfato sodico|7-ethyl-2-methyl-4-undecanolsulfate, sodium salt|Natrii tetradecylis sulfa|STS|Sodium tetradecylsulfate|7-Ethyl-2-methyl-4-undecanol sulfate sodium salt	tromboject 3% inj 30mg/ml|trom	DRUGBANK	DB00464	C14H29NaO4S	small molecule	C05BB04	139-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVEFRICMTUKAML-UHFFFAOYSA-M
7200	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Dionne RA (2001)	11695255	176255	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7201	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Uzan A (2005)	16262557	176257	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7202	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blais V (2005)	16277613	176256	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7203	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bosch-Marce M (1999)	10220509	176259	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7204	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lashbrook JM (1999)	10422661	176258	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7205	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blais V (2002)	12446609	176260	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7206	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568028	176261	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7207	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Padi SS (2004)	15102535	176262	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7208	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hoecherl K (2002)	12110513	176263	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7209	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568029	176264	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7210	113705	8001	-	GLRA3	-	9606	Homo sapiens	antagonist	target	Yang Z (2007)	17714449	176265	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7211	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7212	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7213	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7214	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Richter D (2010)	20491873	176266	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7215	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Law RJ (2008)	18446586	176267	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7216	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7217	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7218	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	antagonist	target	Richter D (2010)	20491873	176266	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7219	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	antagonist	target	Law RJ (2008)	18446586	176267	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7220	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	antagonist	target	Wang DS (2007)	17405877	176268	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7221	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	antagonist	target	Yang Z (2007)	17714449	176265	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7222	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	459	Enoxacin	Enoxacina|Enoxacin|Enoxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid|1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid|noxacine|Enoxacinum	-	DRUGBANK	DB00467	C15H17FN4O3	small molecule	J01MA04	74011-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDYZIJYBMGIQMJ-UHFFFAOYSA-N
7223	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Snyder RD (1999)	10089819	176273	459	Enoxacin	Enoxacina|Enoxacin|Enoxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid|1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid|noxacine|Enoxacinum	-	DRUGBANK	DB00467	C15H17FN4O3	small molecule	J01MA04	74011-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDYZIJYBMGIQMJ-UHFFFAOYSA-N
7224	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Maki T (2008)	18471102	176272	459	Enoxacin	Enoxacina|Enoxacin|Enoxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid|1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid|noxacine|Enoxacinum	-	DRUGBANK	DB00467	C15H17FN4O3	small molecule	J01MA04	74011-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDYZIJYBMGIQMJ-UHFFFAOYSA-N
7225	109077	2815	-	GP9	CD42a|GPIX	9606	Homo sapiens	unknown	target	Asvadi P (2003)	12738668	176280	460	Quinine	(-)-Quinine|(8S,9R)-Quinine|Chinin|Chininum|(R)-(-)-Quinine|Chinine|Quinina|6'-Methoxycinchonidine|Quinine|(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol	quinine sulfate|quinine - odan	DRUGBANK	DB00468	C20H24N2O2	small molecule	M09AA72|P01BC01	130-95-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-WZBLMQSHSA-N
7226	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	460	Quinine	(-)-Quinine|(8S,9R)-Quinine|Chinin|Chininum|(R)-(-)-Quinine|Chinine|Quinina|6'-Methoxycinchonidine|Quinine|(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol	quinine sulfate|quinine - odan	DRUGBANK	DB00468	C20H24N2O2	small molecule	M09AA72|P01BC01	130-95-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-WZBLMQSHSA-N
7227	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Yamada M (1997)	9152412	176290	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7228	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kothekar V (2001)	11563332	176288	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7229	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Ozgocmen S (2005)	15943176	176289	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7230	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lucio M (2006)	17017983	176286	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7231	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lora M (1997)	9175172	176287	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7232	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7233	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Galvao RI (2005)	15756931	176291	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7234	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamada M (1997)	9152412	176290	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7235	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yilmaz H (2005)	16245223	176292	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7236	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kothekar V (2001)	11563332	176288	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7237	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ozgocmen S (2005)	15943176	176289	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7238	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	agonist	target	Pertwee RG (2009)	19226257	176293	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7239	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	agonist	target	Davis M (2007)	17139494	176294	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7240	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7241	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7242	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7243	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	agonist	target	Pryce G (2003)	12686391	176295	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7244	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	agonist	target	Tsai SJ (2000)	11204352	176296	462	Dronabinol	6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol|delta(1)-Tetrahydrocannabinol|(-)-delta9-trans-Tetrahydrocannabinol|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol|Dronabinol|delta-9-THC|Dronabinolum|Tetrahydrocannabinol|delta9-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|delta(9)-THC	dronabinol|marinol|sativex|mar	DRUGBANK	DB00470	C21H30O2	small molecule	A04AD10	1972-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYQFCXCEBYINGO-IAGOWNOFSA-N
7245	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Nayak A (2004)	15013935	176301	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7246	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Zhang YJ (2004)	15456537	176300	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7247	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7248	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Langlois A (2006)	16815146	176297	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7249	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Hamacher J (2006)	16815057	176299	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7250	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Alfieri AB (2007)	17199874	176298	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7251	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Ramires R (2004)	15474500	176302	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7252	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Iceta R (2007)	17289086	176303	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7253	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7254	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Richman A (2007)	17215106	176307	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7255	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Mirza NR (2007)	17335951	176306	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7256	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Goeren MZ (2007)	17486443	176305	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7257	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Sanders AC (2007)	17356573	176304	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7258	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	464	Fluoxetine	(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Fluoxetinum|Prozac|Fluoxetin|Fluoxetina|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine|Fluoxtine	pro-fluoxetine|olanzapine and 	DRUGBANK	DB00472	C17H18F3NO	small molecule	N06CA03|N06AB03	54910-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHCYVBBDHJXIQ-UHFFFAOYSA-N
7259	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7260	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7261	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7262	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7263	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	465	Hexylcaine	Cyclaine|Hexylcaine|Hexilcaina|Hexylcainum	-	DRUGBANK	DB00473	C16H23NO2	small molecule	-	532-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKLKMKYDWHYZTD-UHFFFAOYSA-N
7264	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7265	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7266	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7267	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Koltchine VV (1996)	9014160	176312	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7268	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7269	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7270	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7271	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7272	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7273	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7274	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7275	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7276	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7277	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7278	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7279	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7280	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7281	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7282	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7283	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7284	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Jost W (2004)	15316838	176314	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7285	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Carter NJ (2009)	19480470	176315	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7286	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	van Groeningen CJ (1989)	2784100	176316	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7287	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Karpa KD (2002)	12481192	176317	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7288	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Mirza NR (2007)	17335951	176306	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7289	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Bymaster FP (2005)	15892657	176318	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7290	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Khullar V (2010)	20432324	176319	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7291	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7292	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Beique JC (1998)	9669506	174926	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7293	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Chen F (2005)	15695064	174920	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7294	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Gould GG (2007)	16650830	176321	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7295	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Hunziker ME (2005)	16199241	176320	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7296	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Trivedi MH (2008)	18408530	176322	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7297	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Troelsen KB (2005)	16032412	175188	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7298	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Jost W (2004)	15316838	176314	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7299	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Carter NJ (2009)	19480470	176315	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7300	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	van Groeningen CJ (1989)	2784100	176316	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7301	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Karpa KD (2002)	12481192	176317	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7302	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mirza NR (2007)	17335951	176306	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7303	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7304	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Bymaster FP (2005)	15892657	176318	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7305	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Khullar V (2010)	20432324	176319	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7306	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7307	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Beique JC (1998)	9669506	174926	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7308	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Gould GG (2007)	16650830	176321	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7309	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Hunziker ME (2005)	16199241	176320	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7310	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Schou M (2005)	16139169	176323	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7311	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Trivedi MH (2008)	18408530	176322	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7312	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Vincent S (2004)	15184278	176324	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7313	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7314	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Hunziker ME (2005)	16199241	176320	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7315	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7316	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Pereira P (2009)	18973814	176325	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7317	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Carter NJ (2009)	19480470	176315	468	Duloxetine	(S)-duloxetine|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine	ipg-duloxetine|cymbalta|mylan-	DRUGBANK	DB00476	C18H19NOS	small molecule	N06AX21	116539-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEUITGRIYCTCEM-KRWDZBQOSA-N
7318	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7319	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7320	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	binder	target	Roth BL (1995)	8524985	176332	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7321	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yamada J (1995)	8593484	176333	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7322	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kusumi I (2000)	10821438	176334	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7323	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	binder	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7324	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	binder	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7325	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	binder	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7326	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	unknown	target	Seeman P (1993)	8104554	176336	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7327	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	unknown	target	Seeman P (1993)	8104554	176336	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7328	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	unknown	target	Yoshida Y (1985)	2419314	176337	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7329	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cosi C (2001)	11755134	176338	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7330	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (1998)	9760039	176339	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7331	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	binder	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7332	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	Freedman SB (1994)	8301582	176340	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7333	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Huerta-Bahena J (1983)	6135146	176341	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7334	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	unknown	target	Huerta-Bahena J (1983)	6135146	176341	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7335	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Huerta-Bahena J (1983)	6135146	176341	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7336	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	unknown	target	Bylund DB (1988)	2835476	176342	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7337	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Bylund DB (1988)	2835476	176342	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7338	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	unknown	target	Bylund DB (1988)	2835476	176342	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7339	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ruffolo RR (1978)	25190	176346	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7340	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Johnson HG (1979)	91313	176345	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7341	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Church MK (1983)	6189542	176344	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7342	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Palmer GC (1978)	687395	176343	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7343	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7344	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7345	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Davies MA (2005)	15765260	176347	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7346	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Thomas D (2003)	12788816	176348	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7347	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	binder	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7348	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7349	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7350	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7351	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7352	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7353	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7354	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Roth BL (1995)	8524985	176332	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7355	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7356	111046	5004	RP11-82I1.3	ORM1	AGP-A|AGP1|HEL-S-153w|ORM	9606	Homo sapiens	binder	target	Herve F (1996)	8946472	176353	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7357	111047	5005	RP11-82I1.2	ORM2	AGP-B|AGP-B|AGP2	9606	Homo sapiens	binder	target	Herve F (1996)	8946472	176353	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7358	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	unknown	target	Davies MA (2005)	15765260	176347	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7359	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Marshak DR (1985)	2986673	176354	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7360	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	binder	target	Nguyen T (2001)	11179435	175198	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7361	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	471	Amikacin	Amikacine|Amiglyde-v|Amikacin|Briclin|1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a|Amikacinum|O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine|Amikavet|Amicacin|Amikacina	amikacin sulfate|amikacin sulf	DRUGBANK	DB00479	C22H43N5O13	small molecule	J01RA06|J01GB06|S01AA21|D06AX12	37517-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKCWBDHBTVXHDL-RMDFUYIESA-N
7362	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	471	Amikacin	Amikacine|Amiglyde-v|Amikacin|Briclin|1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a|Amikacinum|O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine|Amikavet|Amicacin|Amikacina	amikacin sulfate|amikacin sulf	DRUGBANK	DB00479	C22H43N5O13	small molecule	J01RA06|J01GB06|S01AA21|D06AX12	37517-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKCWBDHBTVXHDL-RMDFUYIESA-N
7363	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Tolmasky ME (2000)	10702385	176368	471	Amikacin	Amikacine|Amiglyde-v|Amikacin|Briclin|1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a|Amikacinum|O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine|Amikavet|Amicacin|Amikacina	amikacin sulfate|amikacin sulf	DRUGBANK	DB00479	C22H43N5O13	small molecule	J01RA06|J01GB06|S01AA21|D06AX12	37517-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKCWBDHBTVXHDL-RMDFUYIESA-N
7364	114160	8600	RP11-86N24.2	TNFSF11	CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf	9606	Homo sapiens	inhibitor	target	Melchert M (2007)	17369076	176369	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7365	114160	8600	RP11-86N24.2	TNFSF11	CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf	9606	Homo sapiens	inhibitor	target	Akobeng AK (2009)	19370685	176370	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7366	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Zhu YX (2013)	22966948	176371	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7367	107438	1003	-	CDH5	7B4|CD144	9606	Homo sapiens	antagonist	target	Lu L (2009)	18805433	176372	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7368	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Payvandi F (2004)	15598423	176374	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7369	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Zeldis JB (2003)	12720152	176373	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7370	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sun J (2002)	11861516	176376	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7371	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7372	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Iannone MA (2001)	11500849	112774	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7373	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Zhou W (2002)	11810032	176377	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7374	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Kim IY (2002)	12097269	176375	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7375	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Bryant HU (1999)	10418979	176378	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7376	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Moen MD (2008)	18778124	176379	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7377	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7378	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Matsumoto T (2006)	16951478	176385	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7379	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Khovidhunkit W (1999)	10068418	176383	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7380	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Figtree GA (1999)	10477535	176382	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7381	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Cummings SR (1999)	10376571	176381	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7382	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Scott JA (1999)	10507743	176380	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7383	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bryant HU (1999)	10418979	176378	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7384	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Schafer JI (1999)	10485477	176384	473	Raloxifene	(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Keoxifene|RAL|Raloxifene|LY 139481|Raloxifeno|Raloxifenum	pms-raloxifene|evista|act ralo	DRUGBANK	DB00481	C28H27NO4S	small molecule	G03XC01	84449-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZUITABIAKMVPG-UHFFFAOYSA-N
7385	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	inhibitor	target	Kulp SK (2004)	14973075	176389	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7386	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	inhibitor	target	Tong Z (2005)	16060857	176390	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7387	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	inhibitor	target	Li J (2006)	16455452	176391	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7388	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	inhibitor	target	Zhu J (2004)	15205346	176392	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7389	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	inhibitor	target	Tseng PH (2006)	16887935	176393	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7390	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7391	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ahmad SR (2002)	12093311	176398	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7392	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Scheiman JM (2002)	12086292	176394	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7393	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Reddy BS (2002)	12086402	176395	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7394	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lu S (2002)	12104042	176396	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7395	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sigthorsson G (2002)	12055598	176397	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7396	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Robaire B (1975)	1207670	176408	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7397	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Seto Y (1988)	3190453	176404	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7398	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Radic Z (1999)	10421444	176405	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7399	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Radic Z (2001)	11920914	176406	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7400	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Bourgeois JP (1978)	417864	176407	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7401	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Elsinghorst PW (2007)	17944454	176403	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7402	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7403	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7404	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Aoshima H (1992)	1337082	176409	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7405	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Redka DS (2008)	18552124	176413	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7406	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Ten Berge RE (1996)	9007524	176412	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7407	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Ehlert FJ (2008)	18305010	176411	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7408	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cembala TM (2007)	17588565	176410	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7409	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Huang XP (2005)	15937215	176417	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7410	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Spina D (1994)	7522861	176416	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7411	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Maier-Peuschel M (2010)	20083608	176415	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7412	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	De Vries B (2001)	11426849	176414	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7413	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Elsinghorst PW (2007)	17944454	176403	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7414	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	475	Gallamine Triethiodide	Gallamin triethiodid|Trithiodure de Gallamine|Gallamini Triethiodidum|Trietioduro de galamina|Flaxedil	flaxedil inj 20mg/ml	DRUGBANK	DB00483	C30H60I3N3O3	small molecule	-	65-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REEUVFCVXKWOFE-UHFFFAOYSA-K
7415	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Bohmann C (1993)	8097565	176419	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7416	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Trendelenburg AU (2003)	14610637	176418	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7417	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Meana JJ (1992)	1373179	176422	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7418	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Wikberg-Matsson A (2001)	11481271	176420	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7419	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Rauly I (2000)	10799649	176421	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7420	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7421	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Orito K (2001)	11606316	176423	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7422	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Trendelenburg AU (2003)	14610637	176418	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7423	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Zhang W (2003)	12670699	176424	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7424	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Prinster SC (2006)	16757535	176425	476	Brimonidine	Brimonidinum|Bromoxidine|Brimonidine|5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline|Brimonidina	pms-brimonidine|brimonidine|sa	DRUGBANK	DB00484	C11H10BrN5	small molecule	S01EA05|D11AX21	59803-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYLJNLCSTIOKRM-UHFFFAOYSA-N
7425	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	partial agonist	target	Kraft B (2004)	15221424	176431	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7426	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	partial agonist	target	Conti S (2002)	11786493	176430	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7427	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	partial agonist	target	Darmani NA (2001)	11698062	176428	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7428	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	partial agonist	target	Mendizabal VE (2007)	17450170	176429	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7429	107669	1269	RP11-4M23.1	CNR2	CB-2|CB2|CX5	9606	Homo sapiens	partial agonist	target	Davis M (2007)	17139494	176294	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7430	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	partial agonist	target	Hirst RA (1996)	8981483	176433	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7431	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	partial agonist	target	Pertwee RG (1999)	10575283	176432	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7432	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	partial agonist	target	Pertwee RG (1996)	8864542	176434	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7433	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7434	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	partial agonist	target	Davis M (2007)	17139494	176294	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7435	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	partial agonist	target	Darmani NA (2001)	11698062	176428	478	Nabilone	Nabilon|Cesamet|Nabilone|Nabilona|Nabilonum	act nabilone|cesamet|pms-nabil	DRUGBANK	DB00486	C24H36O3	small molecule	A04AD11	51022-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GECBBEABIDMGGL-RTBURBONSA-N
7436	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	479	Pefloxacin	Pefloxacin|Pefloxacino|Labocton|Pefloxacine|PFLX|Pefloxacinum	-	DRUGBANK	DB00487	C17H20FN3O3	small molecule	J01MA03	70458-92-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHFYDNQZQSQIAI-UHFFFAOYSA-N
7437	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Doggrell SA (1993)	8095397	176448	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7438	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Lowe MD (2002)	11815381	176449	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7439	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Yalcin I (2009)	19259968	176450	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7440	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Joseph SS (2004)	15060759	176446	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7441	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Juberg EN (1985)	2865685	176447	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7442	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Yalcin I (2009)	19259968	176450	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7443	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7444	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Doggrell SA (1993)	8095397	176448	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7445	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Lowe MD (2002)	11815381	176449	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7446	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Joseph SS (2004)	15060759	176446	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7447	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Juberg EN (1985)	2865685	176447	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7448	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Fedida D (2006)	16686685	174883	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7449	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Wolpert C (2005)	15673388	176453	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7450	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Wolpert C (2005)	16076272	175083	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7451	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	10931813	176451	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7452	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Numaguchi H (2000)	11090546	176452	481	Sotalol	Sotalolo|beta-Cardone|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Sotalol|Sotalolum	pro-sotalol|sotalol hydrochlor	DRUGBANK	DB00489	C12H20N2O3S	small molecule	C07BA07|C07AA57|C07AA07	3930-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBMZVLHSJCTVON-UHFFFAOYSA-N
7453	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Osei-Owusu P (2004)	14769835	176457	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7454	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Rehman J (1999)	10064829	176456	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7455	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	de Boer SF (1999)	10027850	176455	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7456	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Becker C (1999)	10221756	176454	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7457	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7458	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Liang KC (1999)	10215901	176459	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7459	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Dupuis DS (1999)	10428422	176458	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7460	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Malt EA (2003)	12781354	176464	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7461	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nader MA (1993)	11224194	176462	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7462	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Fernandez-Perez S (2005)	16214127	176463	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7463	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Pache DM (2003)	14522358	176460	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7464	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Boido A (2001)	11421254	176461	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7465	108866	2595	-	GANC	-	9606	Homo sapiens	antagonist	target	Fukaya N (2009)	19818342	176466	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7466	108866	2595	-	GANC	-	9606	Homo sapiens	antagonist	target	Hirata A (2009)	19085811	176467	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7467	116802	23193	-	GANAB	G2AN|GLUII	9606	Homo sapiens	antagonist	target	Fukaya N (2009)	19818342	176466	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7468	116802	23193	-	GANAB	G2AN|GLUII	9606	Homo sapiens	antagonist	target	Hirata A (2009)	19085811	176467	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7469	108823	2548	-	GAA	LYAG	9606	Homo sapiens	antagonist	target	Fukaya N (2009)	19818342	176466	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7470	108823	2548	-	GAA	LYAG	9606	Homo sapiens	antagonist	target	Hirata A (2009)	19085811	176467	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7471	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Fukaya N (2009)	19818342	176466	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7472	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7473	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Rossi EJ (2006)	16817895	176468	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7474	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Mooradian AD (1999)	9951949	176469	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7475	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	antagonist	target	Fukaya N (2009)	19818342	176466	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7476	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7477	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	antagonist	target	Rossi EJ (2006)	16817895	176468	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7478	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	antagonist	target	Mooradian AD (1999)	9951949	176469	483	Miglitol	Miglitolum|Glyset|Miglitol	glyset|miglitol	DRUGBANK	DB00491	C8H17NO5	small molecule	A10BF02	72432-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBAQFPQHRJAVAV-ULAWRXDQSA-N
7479	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Ondetti MA (1988)	2836111	176471	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7480	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7481	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7482	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Sharma S (1999)	11329095	176470	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7483	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Imming P (2006)	17016423	171742	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
7484	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Georgopapadakou NH (1983)	6338822	176474	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
7485	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Overington JP (2006)	17139284	171741	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
7486	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Selakovitch-Chenu L (1993)	8510666	176473	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
7487	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Krauss J (1997)	9145848	176472	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
7488	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7489	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Kaakkola S (2000)	10882160	175220	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7490	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Holm KJ (1999)	10439935	176479	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7491	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Chong BS (2000)	10981253	176478	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7492	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Najib J (2001)	11440283	176475	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7493	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Poewe WH (2002)	11939936	176477	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7494	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Brooks DJ (2003)	12876237	176476	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7495	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Tai CH (2002)	11873938	175214	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7496	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Ruottinen HM (1998)	9808337	175215	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7497	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	inhibitor	target	Forsberg M (2003)	12538800	175217	486	Entacapone	Comtan|Entacapone|Entacapona|Comtess|Entacaponum|(e)-alpha-Cyano-N,N-diethyl-3,4-dihydroxy-5-nitrocinnamamide|N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide	comtan|teva-entacapone|apo-ent	DRUGBANK	DB00494	C14H15N3O5	small molecule	N04BX02	130929-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRURYQJSLYLRLN-BJMVGYQFSA-N
7498	112874	7015	-	TERT	CMM9|DKCA2|DKCB4|EST2|PFBMFT1|TCS1|TP2|TRT|hEST2|hTRT	9606	Homo sapiens	inhibitor	target	Leeansyah E (2013)	23303810	176483	487	Zidovudine	AZT|ZDV|Azidothymidine|Zidovudin|Zidovudinum	trizivir|retrovir (azt)|apo-la	DRUGBANK	DB00495	C10H13N5O4	small molecule	J05AR01|J05AF01|J05AR05|J05AR04	30516-87-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBOMLICNUCNMMY-XLPZGREQSA-N
7499	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Bozkurt TE (2009)	19416629	176499	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7500	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Bharucha AE (2010)	20395537	176498	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7501	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Jha S (2007)	18046909	176497	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7502	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7503	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Jha S (2007)	18046909	176497	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7504	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Moriya H (1999)	10374898	176500	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7505	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Jha S (2007)	18046909	176497	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7506	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Moriya H (1999)	10374898	176500	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7507	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Jha S (2007)	18046909	176497	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7508	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Moriya H (1999)	10374898	176500	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7509	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Jha S (2007)	18046909	176497	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7510	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Moriya H (1999)	10374898	176500	488	Darifenacin	Darifenacin|Darifenacinum|Darifenacina|(S)-1-(2-(2,3-dihydro-5-Benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|Darifnacine	darifenacin hydrobromide exten	DRUGBANK	DB00496	C28H30N2O2	small molecule	G04BD10	133099-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXGBXQDTNZMWGS-RUZDIDTESA-N
7511	111046	5004	RP11-82I1.3	ORM1	AGP-A|AGP1|HEL-S-153w|ORM	9606	Homo sapiens	binder	target	Leow KP (1993)	8249052	176502	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7512	111047	5005	RP11-82I1.2	ORM2	AGP-B|AGP-B|AGP2	9606	Homo sapiens	binder	target	Leow KP (1993)	8249052	176502	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7513	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Ordonez Gallego A (2007)	17525040	176505	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7514	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Nielsen CK (2007)	17467904	176504	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7515	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Riley J (2008)	18039433	176503	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7516	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Ordonez Gallego A (2007)	17525040	176505	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7517	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7518	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Ordonez Gallego A (2007)	17525040	176505	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7519	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dietis N (2009)	19474215	176506	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7520	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Riley J (2008)	18039433	176503	489	Oxycodone	Oxicodona|Oxycodonum|Dihydro-14-hydroxycodeinone|Dihydrohydroxycodeinone|Dihydroxycodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|(-)-14-Hydroxydihydrocodeinone|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one	sandoz oxycodone cr|oxy.ir|rox	DRUGBANK	DB00497	C18H21NO4	small molecule	N02AA05|N02AA55	76-42-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRUQQQPBMZOVGD-XFKAJCMBSA-N
7521	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	490	Phenindione	Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion	-	DRUGBANK	DB00498	C15H10O2	small molecule	B01AA02	83-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFBAXHOPROOJAW-UHFFFAOYSA-N
7522	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Mentre F (1998)	9465843	176507	490	Phenindione	Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion	-	DRUGBANK	DB00498	C15H10O2	small molecule	B01AA02	83-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFBAXHOPROOJAW-UHFFFAOYSA-N
7523	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	490	Phenindione	Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion	-	DRUGBANK	DB00498	C15H10O2	small molecule	B01AA02	83-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFBAXHOPROOJAW-UHFFFAOYSA-N
7524	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	490	Phenindione	Phnindione|Phenindionum|2-Phenyl-1,3(2H)-indenedione|2-Phenyl-1,3-indandione|PID|2-Phenyl-1,3-diketohydrindene|Fenindione|Fenindiona|Phenindion	-	DRUGBANK	DB00498	C15H10O2	small molecule	B01AA02	83-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFBAXHOPROOJAW-UHFFFAOYSA-N
7525	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7526	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Shilling AD (2000)	11162924	176512	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7527	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Martelli A (2000)	10752671	176513	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7528	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Montalvo L (2000)	10822172	176510	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7529	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Pazos F (2000)	10879806	176511	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7530	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Balk SP (2002)	12231070	176509	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7531	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Chang HC (1999)	10500149	176508	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7532	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Hu W (2007)	17327465	175679	491	Flutamide	FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Eulexin|Flutamidum|Niftolid|Flutamide|Niftolide|Flutamida|NFBA|Flutamid|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide	flutamide-250|penta-flutamide|	DRUGBANK	DB00499	C11H11F3N2O3	small molecule	L02BB01	13311-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXKFYHWDHIYRV-UHFFFAOYSA-N
7533	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kennedy JH (2003)	14613550	176516	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7534	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Burdan F (2005)	16182428	176517	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7535	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Capasso A (1997)	9253954	176515	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7536	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Capasso A (1999)	10465690	176518	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7537	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7538	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kennedy JH (2003)	14613550	176516	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7539	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1997)	9253954	176515	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7540	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Burdan F (2004)	15458776	176519	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7541	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1999)	10465690	176518	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7542	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirkova M (2007)	17391279	176520	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7543	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	493	Cimetidine	Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200	cimetidine tab 300mg|gaviscon 	DRUGBANK	DB00501	C10H16N6S	small molecule	A02BA51|A02BA01	51481-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQIXAKUUQRKLND-UHFFFAOYSA-N
7544	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Kuint J (1996)	8863950	176524	493	Cimetidine	Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200	cimetidine tab 300mg|gaviscon 	DRUGBANK	DB00501	C10H16N6S	small molecule	A02BA51|A02BA01	51481-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQIXAKUUQRKLND-UHFFFAOYSA-N
7545	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Hernandez-Munoz R (2000)	10950107	176523	493	Cimetidine	Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200	cimetidine tab 300mg|gaviscon 	DRUGBANK	DB00501	C10H16N6S	small molecule	A02BA51|A02BA01	51481-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQIXAKUUQRKLND-UHFFFAOYSA-N
7546	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Takahashi HK (2006)	16723495	176525	493	Cimetidine	Cimetidin|N-Cyano-n'-methyl-n''-(2-([(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl)ethyl)guanidine|Cimetag|Cimtidine|Ulcerfen|Cimetidinum|N''-cyano-N-methyl-n'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine|Cimetidina|2-Cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine|1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine|Tagamet hb 200	cimetidine tab 300mg|gaviscon 	DRUGBANK	DB00501	C10H16N6S	small molecule	A02BA51|A02BA01	51481-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQIXAKUUQRKLND-UHFFFAOYSA-N
7547	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Tadori Y (2008)	18831971	176538	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7548	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Leysen JE (1994)	7520908	175510	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7549	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Malmberg (1998)	9536001	176535	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7550	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Tuppurainen H (2009)	19496999	176536	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7551	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Kessler RM (2005)	16123775	176537	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7552	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7553	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7554	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7555	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Bustillo J (2006)	16132064	176540	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7556	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Osinski MA (2005)	15894081	176541	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7557	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Ishiwata K (2006)	17134027	176539	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7558	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Naiker DV (2006)	16730699	175316	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7559	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7560	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7561	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Gallagher MJ (1998)	9572299	176543	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7562	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Hattori K (2006)	16407246	176542	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7563	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Zhuravliova E (2007)	17092607	176545	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7564	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Gu WH (2007)	17588330	176544	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7565	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Sinor JD (2000)	11102491	176547	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7566	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Steinmetz RD (2002)	11741727	176546	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7567	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7568	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7569	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Leysen JE (1994)	7520908	175510	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7570	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wittayanarakul K (2008)	17849388	174468	495	Ritonavir	Norvir|Ritonavir|Ritonavirum	technivie|norvir sec|kaletra|v	DRUGBANK	DB00503	C37H48N6O5S2	small molecule	J05AX66|J05AX67|J05AR10|J05AE03	155213-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCDNCNXCDXHOMX-XGKFQTDJSA-N
7571	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Garriga C (2007)	17854027	174469	495	Ritonavir	Norvir|Ritonavir|Ritonavirum	technivie|norvir sec|kaletra|v	DRUGBANK	DB00503	C37H48N6O5S2	small molecule	J05AX66|J05AX67|J05AR10|J05AE03	155213-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCDNCNXCDXHOMX-XGKFQTDJSA-N
7572	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Hoetelmans RM (1997)	9297727	174493	495	Ritonavir	Norvir|Ritonavir|Ritonavirum	technivie|norvir sec|kaletra|v	DRUGBANK	DB00503	C37H48N6O5S2	small molecule	J05AX66|J05AX67|J05AR10|J05AE03	155213-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCDNCNXCDXHOMX-XGKFQTDJSA-N
7573	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Das A (2007)	17627597	176551	495	Ritonavir	Norvir|Ritonavir|Ritonavirum	technivie|norvir sec|kaletra|v	DRUGBANK	DB00503	C37H48N6O5S2	small molecule	J05AX66|J05AX67|J05AR10|J05AE03	155213-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCDNCNXCDXHOMX-XGKFQTDJSA-N
7574	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Markowitz M (1995)	7477168	176552	495	Ritonavir	Norvir|Ritonavir|Ritonavirum	technivie|norvir sec|kaletra|v	DRUGBANK	DB00503	C37H48N6O5S2	small molecule	J05AX66|J05AX67|J05AR10|J05AE03	155213-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCDNCNXCDXHOMX-XGKFQTDJSA-N
7575	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Traynor JR (1995)	7723747	176560	496	Levallorphan	Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan	-	DRUGBANK	DB00504	C19H25NO	small molecule	-	152-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYUPQUCAUTOBP-QXAKKESOSA-N
7576	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Emmerson PJ (1996)	8819494	176558	496	Levallorphan	Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan	-	DRUGBANK	DB00504	C19H25NO	small molecule	-	152-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYUPQUCAUTOBP-QXAKKESOSA-N
7577	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Selley DE (1997)	9016350	176559	496	Levallorphan	Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan	-	DRUGBANK	DB00504	C19H25NO	small molecule	-	152-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYUPQUCAUTOBP-QXAKKESOSA-N
7578	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Picker MJ (1996)	8968334	176556	496	Levallorphan	Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan	-	DRUGBANK	DB00504	C19H25NO	small molecule	-	152-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYUPQUCAUTOBP-QXAKKESOSA-N
7579	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Morgan D (1998)	9862398	176557	496	Levallorphan	Levallorphan|Levallofano|Lvallorphane|Naloxiphan|Levallorphanum|Levalorfano|Lorfan	-	DRUGBANK	DB00504	C19H25NO	small molecule	-	152-02-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYUPQUCAUTOBP-QXAKKESOSA-N
7580	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7581	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7582	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7583	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7584	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7585	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	497	Tridihexethyl	-	-	DRUGBANK	DB00505	C21H36NO	small molecule	A03AB08	60-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPRHVSBSZMAEIN-UHFFFAOYSA-N
7586	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7587	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7588	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Snyder S (1974)	4152054	176563	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7589	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7590	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7591	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7592	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7593	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Snyder S (1974)	4152054	176563	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7594	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7595	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7596	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7597	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7598	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7599	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Cooper M (1979)	497523	176564	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7600	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Bernal J (2007)	17315033	174854	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7601	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Kariv R (2003)	12955882	174848	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7602	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Jiang W (2004)	15283690	174849	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7603	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Timmer DC (2003)	14596673	174846	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7604	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Mai W (2004)	15240882	174847	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7605	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Sciaudone MP (2004)	15235154	174845	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7606	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	unknown	target	Visser TJ (2006)	16617153	176565	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7607	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7608	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7609	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7610	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Wu SY (2005)	16099238	174850	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7611	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Yen PM (2003)	12776178	174853	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7612	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Gonzalez-Sancho JM (2003)	12668276	174852	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7613	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Bernal J (2007)	17315033	174854	500	Dextrothyroxine	O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine|D-thyroxine|DT4|D-T4|Dextrothyroxine	choloxin tablet 4mg|choloxin t	DRUGBANK	DB00509	C15H11I4NO4	small molecule	C10AX01	51-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUIIKFGFIJCVMT-GFCCVEGCSA-N
7614	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Gonzalez-Garcia C (1987)	2826993	176566	501	Acetyldigitoxin	Acetyl-digitoxin-alpha|alpha-Monoacetyldigitoxin|Acetildigitoxina|Desglucolanatoside A|Acetyldigitoxinum|Acetylgitaloxin|Acetylgitoxin|Digitoxin 3'''-acetate|Acetyldiginatin|alpha-Acetylgitaloxin|alpha-Acetyldigitoxin	-	DRUGBANK	DB00511	C43H66O14	small molecule	C01AA01	1111-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPMZBILYSWLILX-UMDUKNJSSA-N
7615	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Kanalas JJ (1992)	1280065	171803	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7616	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Mochalkin I (1999)	10026282	176570	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7617	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Prandota J (2001)	11304653	176571	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7618	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7619	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Sun Z (2002)	12007600	176568	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7620	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	inhibitor	target	Lee KN (2002)	11927133	176569	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7621	110202	4018	-	LPA	AK38|APOA|LP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7622	110202	4018	-	LPA	AK38|APOA|LP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7623	110202	4018	-	LPA	AK38|APOA|LP	9606	Homo sapiens	unknown	target	Becker L (2004)	15287725	176572	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7624	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	antagonist	target	Tran-Thang C (1994)	7962113	176574	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7625	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	antagonist	target	Urano T (1988)	3146348	176575	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7626	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	antagonist	target	Husain SS (1989)	2502209	176576	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7627	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	antagonist	target	Krishnamurti C (1994)	8073394	176573	503	Aminocaproic Acid	Aminocapronsure|Acidum Aminocaproicum|6-aminohexanoic acid|Z|Epsicaprom|Epsilon-Aminocaproic Acid|Aminocaproic acid|epsilon-Aminohexanoic acid|epsilon-Ahx|Epsilcapramine|Aminohexanoic acid|EACA|Caproamin|AMICAR|6-Aminocaproic acid|Acide aminocaproque|Ahx|cido aminocaprico|Acide aminocaproque|Eaca|AMINOCAPROIC	exoden white tooth|amicar|amin	DRUGBANK	DB00513	C6H13NO2	small molecule	B02AA01	60-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXKOJJOQWFEFD-UHFFFAOYSA-N
7628	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Codd EE (1995)	7562497	176578	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7629	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Codd EE (1995)	7562497	176578	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7630	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7631	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Codd EE (1995)	7562497	176578	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7632	107915	1535	-	CYBA	p22-PHOX	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7633	107916	1536	-	CYBB	AMCBX2|CGD|GP91-1|GP91-PHOX|GP91PHOX|IMD34|NOX2|p91-PHOX	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7634	575724	653361	-	NCF1	NCF1A|NOXO2|SH3PXD1A|p47phox	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7635	110768	4688	RP1-127C7.5	NCF2	NCF-2|NOXA2|P67-PHOX|P67PHOX	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7636	111817	5879	MIG5	RAC1	Rac-1|TC-25|p21-Rac1	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7637	111818	5880	-	RAC2	EN-7|Gx|HSPC022|p21-Rac2	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7638	110769	4689	CTA-833B7.1	NCF4	NCF|P40PHOX|SH3PXD4	9606	Homo sapiens	inhibitor	target	Zhang W (2004)	14734632	176580	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7639	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7640	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Codd EE (1995)	7562497	176578	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7641	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7642	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Henderson MG (1992)	1280529	176581	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7643	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Codd EE (1995)	7562497	176578	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7644	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7645	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7646	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chou YC (1999)	10064839	176582	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7647	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7648	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7649	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Wong BY (1988)	2897648	176584	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7650	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7651	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Kamel IR (2008)	18812887	176583	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7652	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Chou YC (1999)	10064839	176582	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7653	116068	10857	-	PGRMC1	HPR6.6|MPR	9606	Homo sapiens	binder	target	Chou YC (1999)	10064839	176582	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7654	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Shin EJ (2005)	15723099	176586	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7655	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Shin EJ (2007)	17386960	176587	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7656	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Church AJ (2005)	15716633	176585	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7657	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7658	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7659	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7660	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7661	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Lee JH (2006)	16563374	176588	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7662	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7663	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7664	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Damaj MI (2005)	15356218	176579	504	Dextromethorphan	Dex|DM|Dextromthorphane|Dextromethorfan|Dextromethorphan|DXM|Dextrometorfano|D-methorphan|(+)-dextromethorphan|delta-Methorphan|Dextromethorphanum	tylenol cold and flu nighttime	DRUGBANK	DB00514	C18H25NO	small molecule	N07XX59|R05DA09	125-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKXZASYAUGDDCJ-NJAFHUGGSA-N
7665	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Bachrach WH (1972)	4555460	176615	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7666	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7667	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7668	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Bachrach WH (1972)	4555460	176615	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7669	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7670	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Pace F (2010)	20391952	176617	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7671	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7672	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tittor W (1982)	6897316	176616	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7673	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Bachrach WH (1972)	4555460	176615	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7674	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7675	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	507	Anisotropine Methylbromide	Methylbromure d'octatropine|Octatropini methylbromidum|Methyloctatropine bromide|Endo-8,8-dimethyl-3-((1-oxo-2-propylpentyl)oxy)-8-azoniabicyclo(3.2.1)octane bromide|8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide|Anisotropine methobromide|Anisotropine methylbromide|8-Methyltropinium bromide 2-propylpentanoate|Metilbromuro de octatropina|Octatropine methylbromide|8-Methyltropinium bromide 2-propylvalerate	-	DRUGBANK	DB00517	C17H32BrNO2	small molecule	-	80-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSFKGMJOKUZAJM-UHFFFAOYSA-M
7676	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Ramirez T (2001)	11343808	176619	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7677	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7678	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Chu SW (2009)	19846910	176618	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7679	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Solana HD (2002)	11980387	176620	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7680	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Chu SW (2009)	19846910	176618	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7681	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	508	Albendazole	Zentel|Eskazole|Proftril|Ricobendazole|Albendazolum|Albenza|Valbazen|Rycobendazole|Albendazol|(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester|Albendazole|5-(Propylthio)-2-carbomethoxyaminobenzimidazole|O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate	albenza	DRUGBANK	DB00518	C12H15N3O2S	small molecule	P02CA03	54965-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXHWSAZORRCQMX-UHFFFAOYSA-N
7682	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7683	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7684	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7685	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7686	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1992)	1349493	176626	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7687	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bruck H (2004)	15526107	176627	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7688	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Chidlow G (2000)	10864881	176628	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7689	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Floreani M (2005)	16160085	176629	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7690	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7691	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Bruck H (2004)	15526107	176627	511	Carteolol	Carteolol|Carteololum	carteolol hydrochloride	DRUGBANK	DB00521	C16H24N2O3	small molecule	C07AA15|S01ED55|S01ED05	51781-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAFSWPYPHEXKX-UHFFFAOYSA-N
7692	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	ligand	target	Toskes PP (1984)	6371722	176633	512	Bentiromide	Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide	-	DRUGBANK	DB00522	C23H20N2O5	small molecule	V04CK03	37106-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPPTWHFVYKCNNK-FQEVSTJZSA-N
7693	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	ligand	target	Chowdhury RS (2003)	12641496	176632	512	Bentiromide	Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide	-	DRUGBANK	DB00522	C23H20N2O5	small molecule	V04CK03	37106-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPPTWHFVYKCNNK-FQEVSTJZSA-N
7694	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	ligand	target	Bujanover Y (1988)	3258344	176631	512	Bentiromide	Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide	-	DRUGBANK	DB00522	C23H20N2O5	small molecule	V04CK03	37106-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPPTWHFVYKCNNK-FQEVSTJZSA-N
7695	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	ligand	target	Berman HM (2000)	10592235	172122	512	Bentiromide	Bentiromidum|PFT|Bentiromido|BTPABA|Bentiromide	-	DRUGBANK	DB00522	C23H20N2O5	small molecule	V04CK03	37106-97-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPPTWHFVYKCNNK-FQEVSTJZSA-N
7696	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Rasooly R (2005)	16339527	176637	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7697	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Schrage K (2006)	16420438	176636	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7698	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Cheng C (2008)	18321241	176635	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7699	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Milliano MT (2005)	16253547	176634	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7700	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Ritter M (2006)	16424870	109390	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7701	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7702	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Baumann L (2005)	16144296	176638	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7703	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Mizuiri H (2005)	16128742	176642	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7704	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Nalbandian A (2005)	16316409	176643	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7705	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Garnock-Jones KP (2009)	19678713	176640	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7706	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Milliano MT (2005)	16253547	176634	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7707	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Husson M (2006)	16531051	176639	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7708	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Liu Z (2005)	16297713	176641	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7709	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Garnock-Jones KP (2009)	19678713	176640	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7710	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	He JC (2007)	17182884	176646	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7711	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Brtko J (2007)	17491551	176647	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7712	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Germain P (2006)	17132853	176644	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7713	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Day RM (2006)	16456186	176645	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7714	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Adamczewski Z (2006)	17006844	176648	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7715	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Hoegberg P (2005)	16109390	176650	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7716	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Garnock-Jones KP (2009)	19678713	176640	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7717	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Brtko J (2007)	17491551	176647	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7718	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Germain P (2006)	17132853	176644	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7719	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Schrage K (2006)	16420438	176636	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7720	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Bergheim I (2005)	16277658	176649	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7721	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Cheng C (2008)	18321241	176635	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7722	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Parrella E (2006)	16788091	176651	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7723	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Li M (2006)	16880407	176653	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7724	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Garnock-Jones KP (2009)	19678713	176640	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7725	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Dzhagalov I (2007)	17277115	176652	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7726	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7727	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Garnock-Jones KP (2009)	19678713	176640	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7728	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Mizuguchi Y (2006)	16946489	176655	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7729	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Calleja C (2006)	16751185	176654	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7730	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Fukasawa H (2006)	16819260	176657	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7731	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Zhelyaznik N (2006)	16782282	176656	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7732	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Bartholin L (2006)	16428452	120010	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7733	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Cheng C (2008)	18321241	176635	513	Alitretinoin	Alitrtinone|9(Z)-Retinoic acid|Alitretinoinum|(2e,4e,6Z,8e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|Panretyn|Alitretinona|Panretin|Alitretinoin|9-cis-Retinoic acid|(7e,9Z,11e,13e)-Retinoic acid|9-cis-Tretinoin	toctino|panretin	DRUGBANK	DB00523	C20H28O2	small molecule	D11AH04|L01XX22	5300-03-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-ZVCIMWCZSA-N
7734	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	514	Metolazone	Metolazona|Mtolazone|7-Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6-quinazolinesulfonamide|2-Methyl-3-O-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone|7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-O-tolyl-6-quinazolinesulfonamide|Metolazon|Zaroxolyn|Metolazonum	zaroxolyn tab 10mg|metolazone|	DRUGBANK	DB00524	C16H16ClN3O3S	small molecule	C03BA08|C03EA12	17560-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQCHWTWZEMGIFD-UHFFFAOYSA-N
7735	1229551	3646458	C1_08590C_A	ERG1	Contig4-2020_0009|CaO19.406|CAWG_00567|IPF19729.1|CaO19.8036|CA1353|CaO6.2816|C1_08590C_B|orf19.8036|orf6.2816|IPF26914.1|C1_08590C|orf19.406|Contig4-2020_0010	237561	Candida albicans	inhibitor	target	Barrett-Bee K (1995)	8852337	40923	515	Tolnaftate	Tolnaftatum|m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester|N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide|Separin|Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester|Tolnaphthate|2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate|O-2-Naphthyl m,N-dimethylthiocarbanilate|Tolnaftato|Tinactin	fungicure gel|healthy accents 	DRUGBANK	DB00525	C19H17NOS	small molecule	D01AE18	2398-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSNMLFNXJSCDI-UHFFFAOYSA-N
7736	1229551	3646458	C1_08590C_A	ERG1	Contig4-2020_0009|CaO19.406|CAWG_00567|IPF19729.1|CaO19.8036|CA1353|CaO6.2816|C1_08590C_B|orf19.8036|orf6.2816|IPF26914.1|C1_08590C|orf19.406|Contig4-2020_0010	237561	Candida albicans	inhibitor	target	Georgopapadakou NH (1992)	1416865	176666	515	Tolnaftate	Tolnaftatum|m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester|N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide|Separin|Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester|Tolnaphthate|2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate|O-2-Naphthyl m,N-dimethylthiocarbanilate|Tolnaftato|Tinactin	fungicure gel|healthy accents 	DRUGBANK	DB00525	C19H17NOS	small molecule	D01AE18	2398-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSNMLFNXJSCDI-UHFFFAOYSA-N
7737	1229551	3646458	C1_08590C_A	ERG1	Contig4-2020_0009|CaO19.406|CAWG_00567|IPF19729.1|CaO19.8036|CA1353|CaO6.2816|C1_08590C_B|orf19.8036|orf6.2816|IPF26914.1|C1_08590C|orf19.406|Contig4-2020_0010	237561	Candida albicans	inhibitor	target	Ryder NS (1986)	3524433	176667	515	Tolnaftate	Tolnaftatum|m,N-Dimethylthiocarbanilic acid O-2-naphthyl ester|N-Methyl-N-(3-methylphenyl)-1-(naphthalen-2-yloxy)methanethioamide|Separin|Methyl (3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester|Tolnaphthate|2-Naphthyl N-methyl-N-(3-tolyl)thionocarbamate|O-2-Naphthyl m,N-dimethylthiocarbanilate|Tolnaftato|Tinactin	fungicure gel|healthy accents 	DRUGBANK	DB00525	C19H17NOS	small molecule	D01AE18	2398-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSNMLFNXJSCDI-UHFFFAOYSA-N
7738	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Louro SR (1998)	9742684	176670	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7739	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7740	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Ryan SE (1996)	8798723	176671	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7741	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7742	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Louro SR (1998)	9742684	176670	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7743	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7744	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Oka M (2002)	12354567	176672	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7745	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ryan SE (1996)	8798723	176671	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7746	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7747	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7748	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Volpi M (1981)	6262771	176673	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7749	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Sambandam T (1993)	8382768	176676	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7750	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Liu SH (1993)	7680317	176675	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7751	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Muto Y (1983)	6140014	176674	517	Cinchocaine	alpha-Butyloxycinchoninic acid diethylethylenediamide|Cincocainio|N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide|2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide|Dibucaine|CINCHOCAINE|2-Butoxy-N-(alpha-diethylaminoethyl)cinchoninamide|2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide|2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide|2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide|Cinchocainum|2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide|Dibucaine base|2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide|alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine	proctol ointment|proctosone su	DRUGBANK	DB00527	C20H29N3O2	small molecule	S01HA06|D04AB02|C05AD04|N01BB06|S02DA04	85-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUFQVTATUTYEAL-UHFFFAOYSA-N
7752	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Burnier M (2009)	19619074	176678	518	Lercanidipine	Lercanidipine|Lercanil	-	DRUGBANK	DB00528	C36H41N3O6	small molecule	C08CA13|C09BB02|C09DB08	100427-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXUKAKRHYTAKV-UHFFFAOYSA-N
7753	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	518	Lercanidipine	Lercanidipine|Lercanil	-	DRUGBANK	DB00528	C36H41N3O6	small molecule	C08CA13|C09BB02|C09DB08	100427-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXUKAKRHYTAKV-UHFFFAOYSA-N
7754	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	518	Lercanidipine	Lercanidipine|Lercanil	-	DRUGBANK	DB00528	C36H41N3O6	small molecule	C08CA13|C09BB02|C09DB08	100427-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDXUKAKRHYTAKV-UHFFFAOYSA-N
7755	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Imming P (2006)	17016423	171742	519	Foscarnet	Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid	foscarnet sodium|foscavir	DRUGBANK	DB00529	CH3O5P	small molecule	J05AD01	4428-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJAOAACCNHFJAH-UHFFFAOYSA-N
7756	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Bonnafous P (2007)	17926642	176679	519	Foscarnet	Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid	foscarnet sodium|foscavir	DRUGBANK	DB00529	CH3O5P	small molecule	J05AD01	4428-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJAOAACCNHFJAH-UHFFFAOYSA-N
7757	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Overington JP (2006)	17139284	171741	519	Foscarnet	Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid	foscarnet sodium|foscavir	DRUGBANK	DB00529	CH3O5P	small molecule	J05AD01	4428-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJAOAACCNHFJAH-UHFFFAOYSA-N
7758	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Tchesnokov EP (2006)	16415021	176680	519	Foscarnet	Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid	foscarnet sodium|foscavir	DRUGBANK	DB00529	CH3O5P	small molecule	J05AD01	4428-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJAOAACCNHFJAH-UHFFFAOYSA-N
7759	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Ducancelle A (2007)	17197042	176681	519	Foscarnet	Carboxyphosphonic acid|Phosphonoformate|Foscarmet|Phosphonomethanoic acid|Phosphonoformic acid	foscarnet sodium|foscavir	DRUGBANK	DB00529	CH3O5P	small molecule	J05AD01	4428-95-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJAOAACCNHFJAH-UHFFFAOYSA-N
7760	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	van Erp NP (2009)	19733976	175838	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7761	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Harmsen S (2009)	18839173	176682	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7762	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Bulgaru AM (2003)	12820772	176686	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7763	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Kim TE (2002)	12498017	176687	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7764	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Akita RW (2003)	12840797	176684	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7765	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Laird AD (2003)	12517254	176685	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7766	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Delbaldo C (2003)	12814826	176683	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7767	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	520	Erlotinib	OSI-774|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|Erlotinib	pms-erlotinib|tarceva|teva-erl	DRUGBANK	DB00530	C22H23N3O4	small molecule	L01XE03	183321-74-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAKJLRGGTJKAMG-UHFFFAOYSA-N
7768	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lenkowski PW (2004)	15066664	176695	522	Mephenytoin	-	-	DRUGBANK	DB00532	C12H14N2O2	small molecule	N03AB04|N03AB54	50-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMHKMTDVRCWUDX-UHFFFAOYSA-N
7769	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	522	Mephenytoin	-	-	DRUGBANK	DB00532	C12H14N2O2	small molecule	N03AB04|N03AB54	50-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMHKMTDVRCWUDX-UHFFFAOYSA-N
7770	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Swadron SP (2004)	15001403	174682	522	Mephenytoin	-	-	DRUGBANK	DB00532	C12H14N2O2	small molecule	N03AB04|N03AB54	50-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMHKMTDVRCWUDX-UHFFFAOYSA-N
7771	108321	2006	-	ELN	SVAS|WBS|WS	9606	Homo sapiens	unknown	target	Oitate M (2007)	17164475	176699	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7772	108321	2006	-	ELN	SVAS|WBS|WS	9606	Homo sapiens	unknown	target	Oitate M (2007)	17620346	176701	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7773	108321	2006	-	ELN	SVAS|WBS|WS	9606	Homo sapiens	unknown	target	Oitate M (2006)	16679386	176700	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7774	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Malmstrom K (1999)	10566562	176707	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Matheson AJ (2001)	11398914	176706	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Langman MJ (1999)	10580458	176705	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chakraborti AK (2010)	20166930	176704	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ashok V (2011)	20724158	176703	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Baron JA (2008)	18922570	176702	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7781	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pascucci RA (1999)	10643177	176709	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7782	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hawkey C (2000)	10693877	176708	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7783	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ehrich EW (1999)	10555907	176710	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7784	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7785	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Oda Y (1968)	5692397	176711	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7786	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7787	113645	7915	-	ALDH5A1	SSADH|SSDH	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7788	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7789	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inducer	target	Mannuzzu LM (1993)	8391582	176712	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7790	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7791	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inducer	target	Tabern DL (1970)	5455277	176713	524	Chlormerodrin	Chlormerodrine|Chlormerodrinum|1-[3-(Chloromercuri)-2-methoxypropyl]urea|{3-[(aminocarbonyl)amino]-2-methoxypropyl}chloromercury|Chlormerodrina	-	DRUGBANK	DB00534	C5H11ClHgN2O2	small molecule	-	62-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJFGVYCULWBXKF-UHFFFAOYSA-M
7792	110493	4353	-	MPO	-	9606	Homo sapiens	inhibitor	target	Labro MT (1994)	8133056	176716	525	Cefdinir	(6R,7R)-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino}-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|(6R,7R,Z)-7-(2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefdinir|Cefdinirum|CFDN	cefdinir	DRUGBANK	DB00535	C14H13N5O5S2	small molecule	J01DD15	91832-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTXOFQZKPXMALH-GHXIOONMSA-N
7793	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7794	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7795	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7796	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Komoto J (2004)	15533043	176719	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7797	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7798	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7799	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Karelin AA (1976)	179611	176720	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7800	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7801	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7802	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7803	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Dodge RW (1994)	7986344	176721	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7804	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Loh SN (1996)	8700871	176723	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7805	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Nasiri H (2005)	16302208	176722	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7806	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7807	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7808	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7809	851906	947590	b3172	argG	Arg6|ECK3161|JW3140|argE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7810	851906	947590	b3172	argG	Arg6|ECK3161|JW3140|argE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7811	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Robinson MJ (1992)	1323952	176727	527	Ciprofloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum	riva-ciprofloxacin|cipro tab 2	DRUGBANK	DB00537	C17H18FN3O3	small molecule	S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03	85721-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
7812	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	527	Ciprofloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum	riva-ciprofloxacin|cipro tab 2	DRUGBANK	DB00537	C17H18FN3O3	small molecule	S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03	85721-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
7813	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hussy P (1986)	3015015	176728	527	Ciprofloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum	riva-ciprofloxacin|cipro tab 2	DRUGBANK	DB00537	C17H18FN3O3	small molecule	S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03	85721-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
7814	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Lewis-Wambi JS (2006)	16917142	176743	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7815	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Liu X (2003)	12870885	176742	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7816	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Locci P (2001)	11747628	176741	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7817	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Gennari L (2007)	17503894	176740	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7818	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Shelly W (2008)	18279543	176738	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7819	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Jones KL (2004)	15369444	176739	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7820	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Ariazi EA (2006)	16515478	176736	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7821	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Goldstein LJ (2006)	16595024	176737	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7822	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Smith MR (2006)	17062721	176734	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7823	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Taneja SS (2006)	16503765	176735	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7824	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Chen X (2002)	11752352	171740	529	Toremifene	Toremifenum|Toremifeno	fareston	DRUGBANK	DB00539	C26H28ClNO	small molecule	L02BA02	89778-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFCLJVABOIYOMF-QPLCGJKRSA-N
7825	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	binder	target	Monsma FJ (1993)	7680751	176745	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7826	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7827	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sadava D (1984)	6096660	176746	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7828	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7829	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7830	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7831	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7832	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Wisner KL (2006)	16855451	176749	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7833	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Joyce PR (2003)	14604448	176748	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7834	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Pollock BG (2000)	11027924	176750	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7835	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rausch JL (2003)	12640215	176747	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7836	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7837	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7838	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7839	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Barker EL (1996)	8863842	176754	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7840	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Kim H (2006)	17018806	176751	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7841	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Roubert C (2001)	11092898	176752	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7842	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Roubert C (2001)	11502876	176753	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7843	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Vaishnavi SN (2004)	14744476	174927	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7844	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7845	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Nojimoto FD (2010)	20363235	175181	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7846	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7847	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7848	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Peroutka SJ (1982)	6121969	176755	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7849	247238	25187	-	Htr2c	5-HT2C|5-HTR2C|5HT-1C	10116	Rattus norvegicus	antagonist	target	Jenck F (1993)	8453978	176756	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7850	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7851	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7852	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7853	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Paelvimaeki EP (1996)	8876023	176222	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7854	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Yasui M (2010)	20691709	176761	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7855	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Gan PP (2010)	20442307	176760	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7856	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Vilpo JA (2000)	11168494	176759	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7857	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7858	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Gan PP (2010)	20442307	176760	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7859	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7860	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Kurtzberg LS (2009)	19277662	176762	531	Vincristine	22-Oxovincaleukoblastin|Vincristinum|Vincristina|Vincristin|22-Oxovincaleukoblastine|Leurocristine	oncovin solution 1mg/ml|vincri	DRUGBANK	DB00541	C46H56N4O10	small molecule	L01CA02	57-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWKCGZFUXNPDA-XQKSVPLYSA-N
7861	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	532	Benazepril	Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))-	amlodipine and benazepril hydr	DRUGBANK	DB00542	C24H28N2O5	small molecule	C09AA07|C09BA07	86541-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPCFTKFZXHTYIP-PMACEKPBSA-N
7862	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	532	Benazepril	Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))-	amlodipine and benazepril hydr	DRUGBANK	DB00542	C24H28N2O5	small molecule	C09AA07|C09BA07	86541-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPCFTKFZXHTYIP-PMACEKPBSA-N
7863	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Burstein ES (2005)	16135699	176776	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7864	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7865	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Gozlan H (1991)	1666997	176778	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7866	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasu R (2000)	11180191	176779	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7867	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Paelvimaeki EP (1996)	8876023	176222	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7868	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7869	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7870	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7871	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7872	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Spurlock G (1994)	7984281	176780	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7873	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Burstein ES (2005)	16135699	176776	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7874	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gozlan H (1991)	1666997	176778	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7875	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7876	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7877	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7878	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7879	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7880	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7881	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7882	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7883	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7884	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7885	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Glusa E (2000)	10821800	176783	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7886	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7887	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7888	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7889	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7890	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7891	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Richelson E (1983)	6130192	176784	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7892	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7893	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Roth BL (1994)	7908055	176335	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7894	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasu R (2000)	11180191	176779	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7895	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7896	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Gozlan H (1991)	1666997	176778	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7897	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Roth BL (1994)	7908055	176335	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7898	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7899	108833	2559	-	GABRA6	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7900	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7901	108834	2560	-	GABRB1	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7902	108842	2568	-	GABRP	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7903	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7904	108831	2557	-	GABRA4	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7905	108835	2561	-	GABRB2	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7906	108839	2565	-	GABRG1	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7907	108832	2558	-	GABRA5	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7908	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7909	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7910	108829	2555	-	GABRA2	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7911	108830	2556	-	GABRA3	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7912	108841	2567	-	GABRG3	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7913	108838	2564	-	GABRE	-	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7914	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	binder	target	Lim HD (2005)	15947036	176785	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7915	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Glusa E (2000)	10821800	176783	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7916	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Fernandez-Contreras ME (2006)	16596248	176790	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7917	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Rustum YM (2004)	15353299	176791	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7918	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Ploylearmsaeng SA (2006)	16719540	176789	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7919	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Formentini A (2007)	16538493	176788	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7920	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Garcia V (2006)	16609021	176787	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7921	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7922	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Huang CL (2006)	16563096	176087	534	Fluorouracil	5-FU|5-Fluoracil|5-Fluracil|Fluorouracil|Fluouracil|Fluorouracilum|5-Fluoropyrimidine-2,4-dione|5-Fluorouracil|Fluoro Uracil|Fluorouracilo|FU	efudex crm 5%|carac|fluorourac	DRUGBANK	DB00544	C4H3FN2O2	small molecule	L01BC02|L01BC52	51-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHASVSINZRGABV-UHFFFAOYSA-N
7923	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Sinton CM (2000)	10814558	176801	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7924	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Servatius RJ (2000)	10869589	176802	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7925	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Prasad V (2000)	10685600	176803	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7926	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Drake-Baumann R (1999)	10366222	176804	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7927	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Ricordel I (2000)	10669805	176805	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7928	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7929	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Sinton CM (2000)	10814558	176801	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7930	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Servatius RJ (2000)	10869589	176802	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7931	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Prasad V (2000)	10685600	176803	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7932	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Drake-Baumann R (1999)	10366222	176804	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7933	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Ricordel I (2000)	10669805	176805	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7934	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7935	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	antagonist	target	Servatius RJ (2000)	10869589	176802	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7936	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	antagonist	target	Abou-Donia MB (1996)	8954750	176806	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7937	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	antagonist	target	Somani SM (2000)	10942908	176807	535	Pyridostigmine	Mestinon|Bromure de Pyridostigmine|Regonol|Pyridostigmine|Pyridostigmini Bromidum|Pyridostigmin bromid|Bromuro de piridostigmina	mestinon|mestinon tab 60mg usp	DRUGBANK	DB00545	C9H13N2O2	small molecule	N07AA02	155-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVOLLAQWKVFTGE-UHFFFAOYSA-N
7938	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7939	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7940	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7941	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7942	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7943	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7944	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7945	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7946	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7947	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7948	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7949	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7950	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7951	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7952	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7953	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7954	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7955	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7956	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7957	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7958	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7959	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7960	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7961	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7962	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7963	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7964	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7965	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7966	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7967	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7968	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7969	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7970	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lange K (2000)	10754457	176811	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7971	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7972	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7973	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7974	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7975	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	537	Desoximetasone	Desoximetasonum|Dsoximtasone|9alpha-Fluoro-16alpha-methyl-delta(1)-corticosterone|Desoxymethasone|(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione|Desoximetasona|Desoximetason	topicort gel 0.05%|topicort mi	DRUGBANK	DB00547	C22H29FO4	small molecule	D07XC02|D07AC03	382-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWVSBHGCDBMOOT-IIEHVVJPSA-N
7976	112596	6718	-	AKR1D1	3o5bred|CBAS2|SRD5B1	9606	Homo sapiens	inhibitor	target	Stamatiadis D (1988)	3207614	176812	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7977	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7978	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7979	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Stamatiadis D (1988)	3207614	176812	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7980	852653	948356	b3863	polA	ECK3855|JW3835|resA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7981	852653	948356	b3863	polA	ECK3855|JW3835|resA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7982	852653	948356	b3863	polA	ECK3855|JW3835|resA	511145	Escherichia coli	inhibitor	target	Galhaup I (1989)	2475996	176813	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7983	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Nazzaro-Porro M (1987)	2963038	176817	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7984	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Schallreuter KU (1990)	2114832	176814	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7985	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Nazzaro-Porro M (1979)	448162	176819	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7986	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Picardo M (1985)	4004885	176818	538	Azelaic Acid	Acidum azelaicum|N-Nonanedioic acid|Anchoic acid|Finacea|Nonandisaeure|1,7-Heptanedicarboxylic acid|Azelaic acid|Azelainsaeure|Acidum acelaicum|Acide azlaque|1,9-Nonanedioic acid|Nonanedioic acid|Nonandisure|Azelainsure|Skinoren|Lepargylic acid|Azelex|1,7-Dicarboxyheptane|cido azelaico	azelex|finacea|vp-zel|azelaic 	DRUGBANK	DB00548	C9H16O4	small molecule	D10AX03	123-99-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDJRBEYXGGNYIS-UHFFFAOYSA-N
7987	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Wang S (2000)	11006272	176822	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7988	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Cazzola M (2000)	11061985	176823	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7989	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	O'Byrne PM (1997)	9042024	176820	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7990	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Murata Y (2002)	11979731	176821	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7991	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7992	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Heise CE (2000)	10851239	12727	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7993	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Sugawara M (1999)	10365684	176826	540	Propylthiouracil	Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone	propyl-thyracil|apo-propylthio	DRUGBANK	DB00550	C7H10N2OS	small molecule	H03BA02	51-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNAHARQHSZJURB-UHFFFAOYSA-N
7994	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Manzon RG (2001)	11241400	176827	540	Propylthiouracil	Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone	propyl-thyracil|apo-propylthio	DRUGBANK	DB00550	C7H10N2OS	small molecule	H03BA02	51-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNAHARQHSZJURB-UHFFFAOYSA-N
7995	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Schmutzler C (2007)	17379648	176825	540	Propylthiouracil	Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone	propyl-thyracil|apo-propylthio	DRUGBANK	DB00550	C7H10N2OS	small molecule	H03BA02	51-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNAHARQHSZJURB-UHFFFAOYSA-N
7996	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	540	Propylthiouracil	Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone	propyl-thyracil|apo-propylthio	DRUGBANK	DB00550	C7H10N2OS	small molecule	H03BA02	51-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNAHARQHSZJURB-UHFFFAOYSA-N
7997	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Taurog A (1989)	2656250	176828	540	Propylthiouracil	Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone	propyl-thyracil|apo-propylthio	DRUGBANK	DB00550	C7H10N2OS	small molecule	H03BA02	51-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNAHARQHSZJURB-UHFFFAOYSA-N
7998	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Ferreira AC (2003)	12755690	176829	540	Propylthiouracil	Propylthiouracilum|Propylthiouracile|6-Thio-4-propyluracil|2,3-dihydro-6-Propyl-2-thioxo-4(1H)-pyrimidinone|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|2-Mercapto-6-propylpyrimid-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|4-Propyl-2-thiouracil|2-Thio-6-propyl-1,3-pyrimidin-4-one|Propiltiouracilo|Propylthiouracil|6-Propylthiouracil|6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|2-Mercapto-6-propyl-4-pyrimidone	propyl-thyracil|apo-propylthio	DRUGBANK	DB00550	C7H10N2OS	small molecule	H03BA02	51-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNAHARQHSZJURB-UHFFFAOYSA-N
7999	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	inhibitor	target	Fukuda M (2006)	16959356	176837	541	Acetohydroxamic Acid	Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide	lithostat	DRUGBANK	DB00551	C2H5NO2	small molecule	G04BX03	546-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRUDCFGSUDOHDG-UHFFFAOYSA-N
8000	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	inhibitor	target	Bertini I (2007)	17269766	176836	541	Acetohydroxamic Acid	Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide	lithostat	DRUGBANK	DB00551	C2H5NO2	small molecule	G04BX03	546-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRUDCFGSUDOHDG-UHFFFAOYSA-N
8001	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	inhibitor	target	Mannino C (2006)	16899369	176839	541	Acetohydroxamic Acid	Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide	lithostat	DRUGBANK	DB00551	C2H5NO2	small molecule	G04BX03	546-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRUDCFGSUDOHDG-UHFFFAOYSA-N
8002	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	inhibitor	target	Bertini I (2005)	15809432	176838	541	Acetohydroxamic Acid	Acethydroxamsaeure|Acetohydroxamic acid|Acethydroxamsaure|AHA|Acetyl hydroxyamino|Acidum acetohydroxamicum|Acetic acid, oxime|Acetohydroximic acid|N-Acetyl hydroxyacetamide|N-Acetylhydroxylamine|Acetylhydroxamic acid|Acetohydroxamate|Acido acetohidroxamico|Cetohyroxamic acid|Acide acetohydroxamique|Methylhydroxamic acid|Lithostat|N-Hydroxyacetamide	lithostat	DRUGBANK	DB00551	C2H5NO2	small molecule	G04BX03	546-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRUDCFGSUDOHDG-UHFFFAOYSA-N
8003	106614	100	-	ADA	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	542	Pentostatin	Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent	nipent pws 10mg/vial|nipent	DRUGBANK	DB00552	C11H16N4O4	small molecule	L01XX08	53910-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPVKHBSQESCIEP-JQCXWYLXSA-N
8004	106614	100	-	ADA	-	9606	Homo sapiens	inhibitor	target	Newman DJ (2007)	17309302	176840	542	Pentostatin	Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent	nipent pws 10mg/vial|nipent	DRUGBANK	DB00552	C11H16N4O4	small molecule	L01XX08	53910-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPVKHBSQESCIEP-JQCXWYLXSA-N
8005	106614	100	-	ADA	-	9606	Homo sapiens	inhibitor	target	Cabanillas F (2000)	10887639	176841	542	Pentostatin	Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent	nipent pws 10mg/vial|nipent	DRUGBANK	DB00552	C11H16N4O4	small molecule	L01XX08	53910-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPVKHBSQESCIEP-JQCXWYLXSA-N
8006	106614	100	-	ADA	-	9606	Homo sapiens	inhibitor	target	Jackson RC (1986)	2433905	176842	542	Pentostatin	Pentostatin|Co-vidarabine|Pentostatinum|Pentostatine|Pentostatina|Nipent	nipent pws 10mg/vial|nipent	DRUGBANK	DB00552	C11H16N4O4	small molecule	L01XX08	53910-25-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPVKHBSQESCIEP-JQCXWYLXSA-N
8007	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8008	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bugajski J (2001)	11785774	176845	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8009	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Raju J (2002)	11952155	176846	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8010	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Veiga AP (2004)	15464832	176843	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8011	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8012	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8013	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8014	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8015	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bugajski J (2001)	11785774	176845	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8016	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Raju J (2002)	11952155	176846	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8017	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Veiga AP (2004)	15464832	176843	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8018	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	545	Lamotrigine	Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal	ratio-lamotrigine|dom-lamotrig	DRUGBANK	DB00555	C9H7Cl2N5	small molecule	N03AX09	84057-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYZRQGJRPPTADH-UHFFFAOYSA-N
8019	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	545	Lamotrigine	Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal	ratio-lamotrigine|dom-lamotrig	DRUGBANK	DB00555	C9H7Cl2N5	small molecule	N03AX09	84057-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYZRQGJRPPTADH-UHFFFAOYSA-N
8020	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Lipkind GM (2005)	16174788	176847	545	Lamotrigine	Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal	ratio-lamotrigine|dom-lamotrig	DRUGBANK	DB00555	C9H7Cl2N5	small molecule	N03AX09	84057-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYZRQGJRPPTADH-UHFFFAOYSA-N
8021	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sakaguchi T (2008)	19057127	176853	547	Hydroxyzine	Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine	atarax cap 25mg|hydroxyzine hy	DRUGBANK	DB00557	C21H27ClN2O2	small molecule	N05BB51|N05BB01	68-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQDWXGKKHFNSQK-UHFFFAOYSA-N
8022	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Snowman AM (1990)	1979798	176852	547	Hydroxyzine	Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine	atarax cap 25mg|hydroxyzine hy	DRUGBANK	DB00557	C21H27ClN2O2	small molecule	N05BB51|N05BB01	68-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQDWXGKKHFNSQK-UHFFFAOYSA-N
8023	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen C (2008)	18781943	176851	547	Hydroxyzine	Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine	atarax cap 25mg|hydroxyzine hy	DRUGBANK	DB00557	C21H27ClN2O2	small molecule	N05BB51|N05BB01	68-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQDWXGKKHFNSQK-UHFFFAOYSA-N
8024	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	547	Hydroxyzine	Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine	atarax cap 25mg|hydroxyzine hy	DRUGBANK	DB00557	C21H27ClN2O2	small molecule	N05BB51|N05BB01	68-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQDWXGKKHFNSQK-UHFFFAOYSA-N
8025	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Spahr L (2007)	17222324	176854	547	Hydroxyzine	Hydroxine|Hydroxyzine|Hydroxyzinum|Hidroxizina|Hydroxyzin|Hychotine|Hydroxizinum|Hydroxycine|Hydroksyzyny|Hydroxizine	atarax cap 25mg|hydroxyzine hy	DRUGBANK	DB00557	C21H27ClN2O2	small molecule	N05BB51|N05BB01	68-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQDWXGKKHFNSQK-UHFFFAOYSA-N
8026	110832	4759	-	NEU2	SIAL2	9606	Homo sapiens	inhibitor	target	Chavas LM (2010)	20222714	174303	548	Zanamivir	ZMR|4-Guanidino-neu5ac2en|ZANAMIVIR|Relenza|GNA|(2R,3R,4S)-3-(acetylamino)-4-Carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid|GANA|4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid|5-(acetylamino)-2,6-Anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid|5-acetamido-2,6-Anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid|Zanamavir|Modified sialic acid	relenza	DRUGBANK	DB00558	C12H20N4O7	small molecule	J05AH01	139110-80-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARAIBEBZBOPLMB-UFGQHTETSA-N
8027	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kramp R (2001)	11704565	176862	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8028	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kiowski W (2001)	11447307	176863	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8029	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8030	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Sihvola RK (2002)	11849873	176861	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8031	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Martin C (2000)	10961375	176864	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8032	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Albertini M (2001)	11728166	176865	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8033	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Richard V (1994)	7858879	176868	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8034	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Marano G (1998)	9806221	176869	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8035	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gardiner SM (1994)	7921608	176870	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8036	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8037	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Said SA (2005)	15629255	176866	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8038	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gupta SK (2005)	16335785	176867	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8039	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	adduct	target	da Silva LM (2010)	20431506	176875	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8040	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	adduct	target	Olson MW (2006)	16723578	176874	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8041	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	da Silva LM (2010)	20431506	176875	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8042	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Olson MW (2006)	16723578	176874	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8043	852123	947811	b3316	rpsS	ECK3303|JW3278	511145	Escherichia coli	adduct	target	da Silva LM (2010)	20431506	176875	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8044	852123	947811	b3316	rpsS	ECK3303|JW3278	511145	Escherichia coli	adduct	target	Olson MW (2006)	16723578	176874	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8045	852113	947801	b3307	rpsN	ECK3294|JW3269	511145	Escherichia coli	adduct	target	da Silva LM (2010)	20431506	176875	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8046	852113	947801	b3307	rpsN	ECK3294|JW3269	511145	Escherichia coli	adduct	target	Olson MW (2006)	16723578	176874	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8047	852103	947791	b3298	rpsM	ECK3285|JW3260	511145	Escherichia coli	adduct	target	da Silva LM (2010)	20431506	176875	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8048	852103	947791	b3298	rpsM	ECK3285|JW3260	511145	Escherichia coli	adduct	target	Olson MW (2006)	16723578	176874	550	Tigecycline	Tigecycline|Tigecyclinum|Tigeciclina|(4S,4AS,5ar,12as)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide	tygacil|tigecycline	DRUGBANK	DB00560	C29H39N5O8	small molecule	J01AA12	220620-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPZLLRFZJZRHSY-HJYUBDRYSA-N
8049	109978	3777	-	KCNK3	K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1	9606	Homo sapiens	inhibitor	target	Anderson-Beck R (1995)	7617294	176878	551	Doxapram	Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram	dopram|dopram inj 20mg/ml|dopr	DRUGBANK	DB00561	C24H30N2O2	small molecule	R07AB01	309-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDJYSQDBULQSI-UHFFFAOYSA-N
8050	109978	3777	-	KCNK3	K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1	9606	Homo sapiens	inhibitor	target	Yost CS (2007)	17227289	176877	551	Doxapram	Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram	dopram|dopram inj 20mg/ml|dopr	DRUGBANK	DB00561	C24H30N2O2	small molecule	R07AB01	309-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDJYSQDBULQSI-UHFFFAOYSA-N
8051	109978	3777	-	KCNK3	K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1	9606	Homo sapiens	inhibitor	target	Peers C (1991)	1667613	176876	551	Doxapram	Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram	dopram|dopram inj 20mg/ml|dopr	DRUGBANK	DB00561	C24H30N2O2	small molecule	R07AB01	309-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDJYSQDBULQSI-UHFFFAOYSA-N
8052	119456	51305	-	KCNK9	K2p9.1|KT3.2|TASK-3|TASK3	9606	Homo sapiens	inhibitor	target	Anderson-Beck R (1995)	7617294	176878	551	Doxapram	Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram	dopram|dopram inj 20mg/ml|dopr	DRUGBANK	DB00561	C24H30N2O2	small molecule	R07AB01	309-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDJYSQDBULQSI-UHFFFAOYSA-N
8053	119456	51305	-	KCNK9	K2p9.1|KT3.2|TASK-3|TASK3	9606	Homo sapiens	inhibitor	target	Yost CS (2007)	17227289	176877	551	Doxapram	Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram	dopram|dopram inj 20mg/ml|dopr	DRUGBANK	DB00561	C24H30N2O2	small molecule	R07AB01	309-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDJYSQDBULQSI-UHFFFAOYSA-N
8054	119456	51305	-	KCNK9	K2p9.1|KT3.2|TASK-3|TASK3	9606	Homo sapiens	inhibitor	target	Peers C (1991)	1667613	176876	551	Doxapram	Doxapramum|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-Doxapram|Doxapram	dopram|dopram inj 20mg/ml|dopr	DRUGBANK	DB00561	C24H30N2O2	small molecule	R07AB01	309-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDJYSQDBULQSI-UHFFFAOYSA-N
8055	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8056	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8057	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8058	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8059	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8060	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8061	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8062	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8063	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8064	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8065	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	552	Benzthiazide	Benzothiazide|3-((Benzylthio)methyl)-6-chloro-7-sulfamoyl-2H-benzo-1,2,4-thiadiazine 1,1-dioxide|Benzthiazid|Benzotiazida|Benzthiazide|3-Benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|3-Benzylthiomethyl-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-1,1-dioxo-3-(Phenylmethylsulfanylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide|Benztiazide|Benzthiazidum|6-chloro-7-Sulfamoyl-3-benzylthiomethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00562	C15H14ClN3O4S3	small molecule	-	91-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDTSRXAMMQDVSW-UHFFFAOYSA-N
8066	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Bennett B (2006)	17130456	176879	553	Methotrexate	Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid	rheumatrex dose pack|apo-metho	DRUGBANK	DB00563	C20H22N8O5	small molecule	L01BA01|L04AX03	59-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOZXECLQNJBKD-ZDUSSCGKSA-N
8067	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	553	Methotrexate	Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid	rheumatrex dose pack|apo-metho	DRUGBANK	DB00563	C20H22N8O5	small molecule	L01BA01|L04AX03	59-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOZXECLQNJBKD-ZDUSSCGKSA-N
8068	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Assaraf YG (2007)	17333344	176880	553	Methotrexate	Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid	rheumatrex dose pack|apo-metho	DRUGBANK	DB00563	C20H22N8O5	small molecule	L01BA01|L04AX03	59-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOZXECLQNJBKD-ZDUSSCGKSA-N
8069	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Totani K (2006)	16647263	176881	553	Methotrexate	Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid	rheumatrex dose pack|apo-metho	DRUGBANK	DB00563	C20H22N8O5	small molecule	L01BA01|L04AX03	59-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOZXECLQNJBKD-ZDUSSCGKSA-N
8070	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Al-Rashood ST (2006)	16971132	176882	553	Methotrexate	Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid	rheumatrex dose pack|apo-metho	DRUGBANK	DB00563	C20H22N8O5	small molecule	L01BA01|L04AX03	59-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOZXECLQNJBKD-ZDUSSCGKSA-N
8071	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Uga H (2006)	16936229	176883	553	Methotrexate	Metotrexato|MTX|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Methotrexatum|Mthotrexate|Ledertrexate|Methotrexat|Rheumatrex|Trexall|4-amino-10-methylfolic acid|Emtexate|Amethopterin|4-amino-N(10)-Methylpteroylglutamic acid	rheumatrex dose pack|apo-metho	DRUGBANK	DB00563	C20H22N8O5	small molecule	L01BA01|L04AX03	59-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOZXECLQNJBKD-ZDUSSCGKSA-N
8072	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8073	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Yang YC (2010)	20526191	176913	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8074	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8075	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Yang YC (2002)	12391287	176914	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8076	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lipkind GM (2010)	20643904	176915	554	Carbamazepine	Carbamazepin|Carbamazepen|5-Carbamoyl-5H-dibenz(b,f)azepine|Carbamazepina|5-Carbamoyl-5H-dibenzo(b,F)azepine|5H-Dibenz(b,F)azepine-5-carboxamide|Carbamazpine|Carbamazepinum|5-Carbamoyl-5H-dibenz[b,F]azepine|CBZ|5-Carbamyl-5H-dibenzo(b,F)azepine	tegretol cr tab 200mg|carbamaz	DRUGBANK	DB00564	C15H12N2O	small molecule	N03AF01	298-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFGPTBGBLSHEPO-UHFFFAOYSA-N
8077	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	555	Cisatracurium besylate	(1R,1'R,2R,2'r)-atracurium besylate|(1R-cis,1'R-cis)-atracurium besylate|Besilate de cisatracurium|(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate|Cisatracurium-Kation|Cisatracurium dibenzenesulfonate|Cisatracurii besilas|Besilato de cisatracurio|Cisatracurium besilate	aj-cisatracurium|cisatracurium	DRUGBANK	DB00565	C65H82N2O18S2	small molecule	-	96946-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXZSQOVSEBAPGS-DONVQRBFSA-L
8078	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Tuba Z (2002)	12171561	176921	555	Cisatracurium besylate	(1R,1'R,2R,2'r)-atracurium besylate|(1R-cis,1'R-cis)-atracurium besylate|Besilate de cisatracurium|(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate|Cisatracurium-Kation|Cisatracurium dibenzenesulfonate|Cisatracurii besilas|Besilato de cisatracurio|Cisatracurium besilate	aj-cisatracurium|cisatracurium	DRUGBANK	DB00565	C65H82N2O18S2	small molecule	-	96946-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXZSQOVSEBAPGS-DONVQRBFSA-L
8079	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	555	Cisatracurium besylate	(1R,1'R,2R,2'r)-atracurium besylate|(1R-cis,1'R-cis)-atracurium besylate|Besilate de cisatracurium|(1R-cis,1'R-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate|Cisatracurium-Kation|Cisatracurium dibenzenesulfonate|Cisatracurii besilas|Besilato de cisatracurio|Cisatracurium besilate	aj-cisatracurium|cisatracurium	DRUGBANK	DB00565	C65H82N2O18S2	small molecule	-	96946-42-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXZSQOVSEBAPGS-DONVQRBFSA-L
8080	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8081	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8082	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Paton DM (1985)	2866055	175984	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8083	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8084	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8085	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8086	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8087	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8088	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8089	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8090	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8091	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8092	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8093	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8094	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8095	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8096	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8097	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8098	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8099	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Kuzuhara S (1997)	9014432	176935	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8100	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Bruecke T (1995)	7714010	176936	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8101	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8102	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Nasu R (2000)	11180191	176779	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8103	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Singh BN (1986)	3530295	176934	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8104	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8105	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Donat F (2002)	12383039	176937	559	Fondaparinux sodium	Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt	fondaparinux sodium injection|	DRUGBANK	DB00569	C31H45N3Na10O49S8	small molecule	-	114870-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEKSTYNIJLDDAZ-JASSWCPGSA-F
8106	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Cheng JW (2002)	12501872	176938	559	Fondaparinux sodium	Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt	fondaparinux sodium injection|	DRUGBANK	DB00569	C31H45N3Na10O49S8	small molecule	-	114870-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEKSTYNIJLDDAZ-JASSWCPGSA-F
8107	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Dager WE (2004)	15317404	176939	559	Fondaparinux sodium	Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt	fondaparinux sodium injection|	DRUGBANK	DB00569	C31H45N3Na10O49S8	small molecule	-	114870-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEKSTYNIJLDDAZ-JASSWCPGSA-F
8108	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Paolucci F (2002)	12383040	176940	559	Fondaparinux sodium	Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt	fondaparinux sodium injection|	DRUGBANK	DB00569	C31H45N3Na10O49S8	small molecule	-	114870-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEKSTYNIJLDDAZ-JASSWCPGSA-F
8109	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Grouzi E (2010)	19825921	176941	559	Fondaparinux sodium	Arixtra|Methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranuronosyl-(1-4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1-4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranoside, decasodium salt	fondaparinux sodium injection|	DRUGBANK	DB00569	C31H45N3Na10O49S8	small molecule	-	114870-03-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEKSTYNIJLDDAZ-JASSWCPGSA-F
8110	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	adduct	target	Correia JJ (1991)	1818332	176945	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8111	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	adduct	target	Islam MN (2004)	15579115	176944	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8112	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	adduct	target	Gupta S (2003)	14619954	176946	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8113	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	adduct	target	Jordan A (1998)	9664292	176943	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8114	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	adduct	target	Jordan MA (2007)	18220533	176942	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8115	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Martinez-Campa C (2006)	16555127	176947	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8116	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Duan L (2007)	17126817	176949	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8117	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Obey TB (2005)	16111654	176948	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8118	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Brantley-Finley C (2003)	12907245	176950	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8119	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Bene A (2004)	15498923	176951	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8120	119352	51174	-	TUBD1	TUBD	9606	Homo sapiens	adduct	target	Correia JJ (1991)	1818332	176945	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8121	119352	51174	-	TUBD1	TUBD	9606	Homo sapiens	adduct	target	Islam MN (2004)	15579115	176944	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8122	119352	51174	-	TUBD1	TUBD	9606	Homo sapiens	adduct	target	Gupta S (2003)	14619954	176946	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8123	119352	51174	-	TUBD1	TUBD	9606	Homo sapiens	adduct	target	Jordan A (1998)	9664292	176943	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8124	119352	51174	-	TUBD1	TUBD	9606	Homo sapiens	adduct	target	Jordan MA (2007)	18220533	176942	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8125	113134	7283	-	TUBG1	CDCBM4|GCP-1|TUBG|TUBGCP1	9606	Homo sapiens	adduct	target	Correia JJ (1991)	1818332	176945	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8126	113134	7283	-	TUBG1	CDCBM4|GCP-1|TUBG|TUBGCP1	9606	Homo sapiens	adduct	target	Islam MN (2004)	15579115	176944	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8127	113134	7283	-	TUBG1	CDCBM4|GCP-1|TUBG|TUBGCP1	9606	Homo sapiens	adduct	target	Gupta S (2003)	14619954	176946	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8128	113134	7283	-	TUBG1	CDCBM4|GCP-1|TUBG|TUBGCP1	9606	Homo sapiens	adduct	target	Jordan A (1998)	9664292	176943	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8129	113134	7283	-	TUBG1	CDCBM4|GCP-1|TUBG|TUBGCP1	9606	Homo sapiens	adduct	target	Jordan MA (2007)	18220533	176942	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8130	119353	51175	RP1-142L7.1	TUBE1	TUBE|dJ142L7.2	9606	Homo sapiens	adduct	target	Correia JJ (1991)	1818332	176945	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8131	119353	51175	RP1-142L7.1	TUBE1	TUBE|dJ142L7.2	9606	Homo sapiens	adduct	target	Islam MN (2004)	15579115	176944	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8132	119353	51175	RP1-142L7.1	TUBE1	TUBE|dJ142L7.2	9606	Homo sapiens	adduct	target	Gupta S (2003)	14619954	176946	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8133	119353	51175	RP1-142L7.1	TUBE1	TUBE|dJ142L7.2	9606	Homo sapiens	adduct	target	Jordan A (1998)	9664292	176943	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8134	119353	51175	RP1-142L7.1	TUBE1	TUBE|dJ142L7.2	9606	Homo sapiens	adduct	target	Jordan MA (2007)	18220533	176942	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8135	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	adduct	target	Correia JJ (1991)	1818332	176945	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8136	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	adduct	target	Islam MN (2004)	15579115	176944	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8137	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	adduct	target	Gupta S (2003)	14619954	176946	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8138	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	adduct	target	Jordan A (1998)	9664292	176943	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8139	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	adduct	target	Jordan MA (2007)	18220533	176942	560	Vinblastine	Vinblastinum|(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine|Vinblastina|VLB|Vinblastine|Vinblastin|Vincaleukoblastine	vinblastine sulphate injection	DRUGBANK	DB00570	C46H58N4O9	small molecule	L01CA01	865-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXLYSJRDGCGARV-XQKSVPLYSA-N
8140	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Smejkal-Jagar L (1995)	7759768	176961	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8141	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8142	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8143	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rouget C (2006)	16177222	176964	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8144	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Isaza C (2005)	16082424	176963	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8145	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Illingworth CJ (2006)	16706406	176962	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8146	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Berg T (2010)	20231523	176965	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8147	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8148	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Rezmann-Vitti LA (2004)	15236843	176968	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8149	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Lewis CJ (2004)	14757703	176967	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8150	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Yazawa K (2007)	17572694	176966	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8151	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8152	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Rouget C (2006)	16177222	176964	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8153	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8154	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Bailey SR (1998)	9760032	176970	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8155	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Choppin A (1995)	7881730	176969	561	Propranolol	Propranololo|-Propranolol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|Propranololum|Propanolol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|beta-Propranolol|Propranolol|Propanalol	nu-propranolol tab 120mg|heman	DRUGBANK	DB00571	C16H21NO2	small molecule	C07BA05|C07AA05|C07FA05	525-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQHHHDLHHXJYJD-UHFFFAOYSA-N
8156	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8157	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8158	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8159	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8160	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8161	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8162	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8163	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8164	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8165	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8166	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8167	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8168	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8169	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Roman S (2005)	16248990	176973	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8170	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nelson CP (2006)	16188951	176974	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8171	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Minaba M (2006)	17087737	176975	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8172	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cembala TM (2007)	17588565	176410	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8173	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8174	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	May LT (2005)	15333678	175900	562	Atropine	Atropin|(+,-)-Tropyl tropate|Tropine tropate|Mydriasine|Atropinum|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-hyoscyamine|[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|(3-Endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|()-atropine|dl-Hyoscyamine|dl-tropyltropate|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|Atropine|(+-)-Atropine|Atropina|(+-)-Hyoscyamine	belladonna alkaloids with phen	DRUGBANK	DB00572	C17H23NO3	small molecule	A03CB03|A03BA01|S01FA01	51-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUNBYITZUJHSG-SPUOUPEWSA-N
8175	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Poggi JC (2006)	17050798	176976	563	Fenoprofen	2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid	nalfon tab 600mg|fenoprofen|na	DRUGBANK	DB00573	C15H14O3	small molecule	M01AE04	29679-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDJGLLICXDHJDY-UHFFFAOYSA-N
8176	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poggi JC (2006)	17050798	176976	563	Fenoprofen	2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid	nalfon tab 600mg|fenoprofen|na	DRUGBANK	DB00573	C15H14O3	small molecule	M01AE04	29679-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDJGLLICXDHJDY-UHFFFAOYSA-N
8177	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rothman RB (2003)	14515341	176978	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8178	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rothman RB (2008)	18991872	176979	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8179	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Cosgrove KP (2010)	20610163	176980	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8180	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Johnson GJ (2003)	14675103	174234	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8181	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Xie T (2006)	16452989	176977	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8182	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Nonogaki K (2006)	16973729	176981	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8183	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Miller KJ (2005)	16249524	176983	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8184	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	McCreary AC (2003)	12708517	176982	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8185	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Fitzgerald LW (2000)	10617681	176985	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8186	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Schuhler S (2005)	15869562	176984	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8187	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Rothman RB (2000)	11104741	176990	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8188	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Fitzgerald LW (2000)	10617681	176985	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8189	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Blanpain C (2003)	14659797	176987	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8190	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Setola V (2003)	12761331	176986	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8191	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Roth BL (2007)	17202450	176989	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8192	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Kaumann AJ (2006)	16960982	176988	564	Fenfluramine	Fenfluramina|Fenfluraminum	pondimin tab 20mg	DRUGBANK	DB00574	C12H16F3N	small molecule	A08AA02	458-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-UHFFFAOYSA-N
8193	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Lavand'homme PM (2002)	12357167	176992	565	Clonidine	2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline	clonidine|teva-clonidine|catap	DRUGBANK	DB00575	C9H9Cl2N3	small molecule	N02CX02|C02LC01|S01EA04|C02LC51|C02AC01	4205-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSURZIOUXUGAL-UHFFFAOYSA-N
8194	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Fairbanks CA (2002)	11752127	176993	565	Clonidine	2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline	clonidine|teva-clonidine|catap	DRUGBANK	DB00575	C9H9Cl2N3	small molecule	N02CX02|C02LC01|S01EA04|C02LC51|C02AC01	4205-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSURZIOUXUGAL-UHFFFAOYSA-N
8195	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Ozdogan UK (2004)	14757140	175191	565	Clonidine	2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline	clonidine|teva-clonidine|catap	DRUGBANK	DB00575	C9H9Cl2N3	small molecule	N02CX02|C02LC01|S01EA04|C02LC51|C02AC01	4205-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSURZIOUXUGAL-UHFFFAOYSA-N
8196	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Wang XM (2002)	12098614	176994	565	Clonidine	2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline	clonidine|teva-clonidine|catap	DRUGBANK	DB00575	C9H9Cl2N3	small molecule	N02CX02|C02LC01|S01EA04|C02LC51|C02AC01	4205-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSURZIOUXUGAL-UHFFFAOYSA-N
8197	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Ozdogan UK (2004)	15306201	176995	565	Clonidine	2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|Clonidina|Clonidin|Clonidinum|2-[(2,6-Dichlorophenyl)imino]imidazoline|Chlofazoline	clonidine|teva-clonidine|catap	DRUGBANK	DB00575	C9H9Cl2N3	small molecule	N02CX02|C02LC01|S01EA04|C02LC51|C02AC01	4205-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSURZIOUXUGAL-UHFFFAOYSA-N
8198	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	566	Sulfamethizole	Sulfamethizolum|Sulfamethylthiadiazole|Sulfamthizol|Sulfamethizol|Rufol|Sulfamethizole|Sulfametizol	-	DRUGBANK	DB00576	C9H10N4O2S2	small molecule	B05CA04|S01AB01|J01EB02|D06BA04	144-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VACCAVUAMIDAGB-UHFFFAOYSA-N
8199	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Watanabe H (1990)	2372557	176998	566	Sulfamethizole	Sulfamethizolum|Sulfamethylthiadiazole|Sulfamthizol|Sulfamethizol|Rufol|Sulfamethizole|Sulfametizol	-	DRUGBANK	DB00576	C9H10N4O2S2	small molecule	B05CA04|S01AB01|J01EB02|D06BA04	144-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VACCAVUAMIDAGB-UHFFFAOYSA-N
8200	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	566	Sulfamethizole	Sulfamethizolum|Sulfamethylthiadiazole|Sulfamthizol|Sulfamethizol|Rufol|Sulfamethizole|Sulfametizol	-	DRUGBANK	DB00576	C9H10N4O2S2	small molecule	B05CA04|S01AB01|J01EB02|D06BA04	144-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VACCAVUAMIDAGB-UHFFFAOYSA-N
8201	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Imming P (2006)	17016423	171742	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
8202	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Overington JP (2006)	17139284	171741	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
8203	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Scott GM (2005)	16033961	175044	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
8204	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8205	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Raffel DM (2006)	16954558	177014	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8206	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Zhao L (2000)	10966747	177015	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8207	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Sharpe IA (2003)	12885787	177016	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8208	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Raffel DM (2004)	15300361	177017	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8209	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Ritz MC (1990)	2120386	177018	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8210	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Goettl VM (2000)	10980236	177025	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8211	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Purkerson-Parker S (2001)	11719704	177024	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8212	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8213	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Saunders C (2000)	10823899	177021	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8214	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tidjane Corera A (2001)	11248372	177020	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8215	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Kulkarni SS (2002)	12213055	177023	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8216	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Houlihan WJ (2002)	12213053	177022	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8217	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Itzhak Y (1999)	10082805	177019	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8218	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	569	Mazindol	Sanorex|Mazindolum|Mazindolo|Mazindol	sanorex	DRUGBANK	DB00579	C16H13ClN2O	small molecule	A08AA05	22232-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPXSCAKFGYXMGA-UHFFFAOYSA-N
8219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10715145	177027	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hood WF (2003)	12644588	177026	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jain KK (2000)	11060833	177030	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8222	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (2005)	15494548	177031	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8223	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8224	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2003)	12564662	177029	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8225	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan JJ (2002)	12167567	177028	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8226	851899	947583	b3076	ebgA	ECK3066|JW5511	511145	Escherichia coli	unknown	target	Cook GC (1978)	97820	177034	571	Lactulose	Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose	lactulose solution usp - liq 6	DRUGBANK	DB00581	C12H22O11	small molecule	A06AD61|A06AD11	4618-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCQLYHFGKNRPGE-FCVZTGTOSA-N
8227	851899	947583	b3076	ebgA	ECK3066|JW5511	511145	Escherichia coli	unknown	target	Hall BG (1998)	9718732	177035	571	Lactulose	Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose	lactulose solution usp - liq 6	DRUGBANK	DB00581	C12H22O11	small molecule	A06AD61|A06AD11	4618-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCQLYHFGKNRPGE-FCVZTGTOSA-N
8228	851899	947583	b3076	ebgA	ECK3066|JW5511	511145	Escherichia coli	unknown	target	Noone C (1986)	3089818	177032	571	Lactulose	Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose	lactulose solution usp - liq 6	DRUGBANK	DB00581	C12H22O11	small molecule	A06AD61|A06AD11	4618-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCQLYHFGKNRPGE-FCVZTGTOSA-N
8229	851899	947583	b3076	ebgA	ECK3066|JW5511	511145	Escherichia coli	unknown	target	Bjarnason I (1996)	8949640	177033	571	Lactulose	Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose	lactulose solution usp - liq 6	DRUGBANK	DB00581	C12H22O11	small molecule	A06AD61|A06AD11	4618-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCQLYHFGKNRPGE-FCVZTGTOSA-N
8230	851899	947583	b3076	ebgA	ECK3066|JW5511	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	571	Lactulose	Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose	lactulose solution usp - liq 6	DRUGBANK	DB00581	C12H22O11	small molecule	A06AD61|A06AD11	4618-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCQLYHFGKNRPGE-FCVZTGTOSA-N
8231	851899	947583	b3076	ebgA	ECK3066|JW5511	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	571	Lactulose	Lactulosa|Lactulosum|4-O-beta-D-Galactopyranosyl-D-fructofuranose|4-O-beta-D-Galactopyranosyl-D-fructose|Lactulose	lactulose solution usp - liq 6	DRUGBANK	DB00581	C12H22O11	small molecule	A06AD61|A06AD11	4618-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCQLYHFGKNRPGE-FCVZTGTOSA-N
8232	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Thompson GR (2010)	19947892	177036	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8233	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Xu Y (2010)	20362444	177037	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8234	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Overington JP (2006)	17139284	171741	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8235	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Imming P (2006)	17016423	171742	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8236	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Morales IJ (2003)	12606318	59714	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8237	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Berman HM (2000)	10592235	172122	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8238	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Xu J (2011)	21420761	177038	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8239	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Li X (2004)	14657086	61965	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8240	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Sanguinetti M (2005)	15673750	65194	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8241	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Thompson GR (2010)	19947892	177036	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8242	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Xu Y (2010)	20362444	177037	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8243	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Overington JP (2006)	17139284	171741	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8244	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Imming P (2006)	17016423	171742	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8245	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Morales IJ (2003)	12606318	59714	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8246	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Berman HM (2000)	10592235	172122	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8247	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Xu J (2011)	21420761	177038	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8248	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Li X (2004)	14657086	61965	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8249	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Sanguinetti M (2005)	15673750	65194	572	Voriconazole	(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|Voriconazol|Voriconazolum|VCZ|Vfend	apo-voriconazole|teva-voricona	DRUGBANK	DB00582	C16H14F3N5O	small molecule	J02AC03	137234-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCEHBSKCWLPMDN-MGPLVRAMSA-N
8250	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Cordente AG (2004)	15155769	177040	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8251	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Cordente AG (2006)	16681386	177039	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8252	112470	6583	-	SLC22A4	OCTN1	9606	Homo sapiens	unknown	target	Amat di San Filippo C (2003)	14506273	177043	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8253	112470	6583	-	SLC22A4	OCTN1	9606	Homo sapiens	unknown	target	Lamhonwah AM (2005)	16246312	177042	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8254	112470	6583	-	SLC22A4	OCTN1	9606	Homo sapiens	unknown	target	Lash LH (2006)	16997449	177041	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8255	112470	6583	-	SLC22A4	OCTN1	9606	Homo sapiens	unknown	target	Kristufek D (2002)	12181285	177044	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8256	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Di Giacomo C (1993)	8255367	177045	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8257	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Vikramadithyan RK (2003)	12582227	177049	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8258	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Cordente AG (2004)	15155769	177040	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8259	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Jogl G (2003)	12526798	177047	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8260	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Wu D (2003)	12562770	177046	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8261	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Govindasamy L (2004)	15099582	177048	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8262	112471	6584	-	SLC22A5	CDSP|OCTN2|OCTN2VT	9606	Homo sapiens	unknown	target	Hou JW (2002)	12635840	177053	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8263	112471	6584	-	SLC22A5	CDSP|OCTN2|OCTN2VT	9606	Homo sapiens	unknown	target	Lahjouji K (2002)	12175785	177050	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8264	112471	6584	-	SLC22A5	CDSP|OCTN2|OCTN2VT	9606	Homo sapiens	unknown	target	Ohashi R (2002)	12183691	177051	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8265	112471	6584	-	SLC22A5	CDSP|OCTN2|OCTN2VT	9606	Homo sapiens	unknown	target	Friedrich A (2003)	12644265	177052	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8266	112471	6584	-	SLC22A5	CDSP|OCTN2|OCTN2VT	9606	Homo sapiens	unknown	target	Kristufek D (2002)	12181285	177044	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8267	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Bell FP (1984)	6509906	177054	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8268	107241	788	-	SLC25A20	CAC|CACT	9606	Homo sapiens	unknown	target	Sekoguchi E (2003)	12882971	177055	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8269	107241	788	-	SLC25A20	CAC|CACT	9606	Homo sapiens	unknown	target	Tonazzi A (2005)	15757911	177056	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8270	107241	788	-	SLC25A20	CAC|CACT	9606	Homo sapiens	unknown	target	Peluso G (2005)	15515015	177057	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8271	110493	4353	-	MPO	-	9606	Homo sapiens	unknown	target	Derin N (2005)	16130180	177058	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8272	125814	123096	-	SLC25A29	C14orf69|CACL|ORNT3	9606	Homo sapiens	unknown	target	Sekoguchi E (2003)	12882971	177055	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8273	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	activator	target	Waldner R (2006)	16283381	177061	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8274	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	activator	target	Tripodi G (2005)	15647998	177060	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8275	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	activator	target	Xu ZR (2003)	12705401	177063	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8276	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	activator	target	Morillas M (2004)	14711372	177062	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8277	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	activator	target	Shin ES (2006)	16362726	177059	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8278	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8279	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	unknown	target	Lehtihet M (2003)	12684219	177068	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8280	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	unknown	target	Barrero MJ (2003)	12408750	177065	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8281	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	unknown	target	Rasmussen BB (2002)	12464674	177064	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8282	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	unknown	target	Kong JY (2002)	12445488	177067	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8283	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	unknown	target	Price NT (2003)	12662154	177066	573	L-Carnitine	3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt|(R)-Carnitine|(-)-Carnitine|Levocarnitina|Levocarnitin|Lvocarnitine|Levocarnitine|Vitamin BT|Levocarnitinum|(-)-L-Carnitine|Carnitine	carnitor - liq iv 200mg/ml|car	DRUGBANK	DB00583	C7H15NO3	small molecule	A16AA01	541-15-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-N
8284	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Natesh R (2004)	15236580	177072	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8285	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8286	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8287	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Liu YH (2006)	16424790	177074	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8288	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Lin TM (1986)	2877081	177078	575	Nizatidine	Nizatidina|Nizatidinum|Nizatidine	apo-nizatidine|novo-nizatidine	DRUGBANK	DB00585	C12H21N5O2S2	small molecule	A02BA04	76963-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGXXNSQHWDMGGP-UHFFFAOYSA-N
8289	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Meredith CG (1985)	2858133	177079	575	Nizatidine	Nizatidina|Nizatidinum|Nizatidine	apo-nizatidine|novo-nizatidine	DRUGBANK	DB00585	C12H21N5O2S2	small molecule	A02BA04	76963-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGXXNSQHWDMGGP-UHFFFAOYSA-N
8290	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Enriz RD (1991)	1843561	177081	575	Nizatidine	Nizatidina|Nizatidinum|Nizatidine	apo-nizatidine|novo-nizatidine	DRUGBANK	DB00585	C12H21N5O2S2	small molecule	A02BA04	76963-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGXXNSQHWDMGGP-UHFFFAOYSA-N
8291	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Kounenis G (1987)	2895808	177080	575	Nizatidine	Nizatidina|Nizatidinum|Nizatidine	apo-nizatidine|novo-nizatidine	DRUGBANK	DB00585	C12H21N5O2S2	small molecule	A02BA04	76963-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGXXNSQHWDMGGP-UHFFFAOYSA-N
8292	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	575	Nizatidine	Nizatidina|Nizatidinum|Nizatidine	apo-nizatidine|novo-nizatidine	DRUGBANK	DB00585	C12H21N5O2S2	small molecule	A02BA04	76963-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGXXNSQHWDMGGP-UHFFFAOYSA-N
8293	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Okabe S (1989)	2567267	177077	575	Nizatidine	Nizatidina|Nizatidinum|Nizatidine	apo-nizatidine|novo-nizatidine	DRUGBANK	DB00585	C12H21N5O2S2	small molecule	A02BA04	76963-41-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGXXNSQHWDMGGP-UHFFFAOYSA-N
8294	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Calkin AC (2002)	12414874	177087	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8295	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kaempfer H (2003)	12713596	177086	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8296	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8297	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hinz B (2003)	12966366	177084	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8298	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2003)	12534640	177083	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8299	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8300	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Singh N (2006)	16552142	177090	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8301	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Maekelae A (1997)	9279965	177089	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8302	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Madanick RD (2005)	15906762	177088	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8303	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Jones NG (2004)	15574747	177091	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8304	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Voilley N (2004)	15032643	177092	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8305	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Yang YC (2005)	15824190	177093	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8306	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Whittle BJ (2004)	15525540	177094	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8307	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Charlier C (2003)	12932896	177095	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8308	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Kudo C (2003)	12826271	177096	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8309	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Xiong Q (2008)	18206251	177098	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8310	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Peretz A (2005)	15598972	177097	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8311	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Xiong Q (2008)	18206251	177098	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8312	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Peretz A (2005)	15598972	177097	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8313	106559	41	-	ASIC1	ACCN2|ASIC|BNaC2	9606	Homo sapiens	inhibitor	target	Voilley N (2001)	11588175	177099	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2003)	12534640	177083	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8315	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8316	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rowlinson SW (2003)	12925531	177102	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8317	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beubler E (2003)	12705061	177100	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8318	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blomme EA (2003)	12588370	177101	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8319	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Foller M (2009)	19826192	177107	577	Cinalukast	3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast	-	DRUGBANK	DB00587	C23H28N2O3S	small molecule	-	128312-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZMKNPGKXJAIDV-VAWYXSNFSA-N
8320	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	577	Cinalukast	3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast	-	DRUGBANK	DB00587	C23H28N2O3S	small molecule	-	128312-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZMKNPGKXJAIDV-VAWYXSNFSA-N
8321	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Adelroth E (1997)	9042047	177108	577	Cinalukast	3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast	-	DRUGBANK	DB00587	C23H28N2O3S	small molecule	-	128312-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZMKNPGKXJAIDV-VAWYXSNFSA-N
8322	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Austin RJ (2002)	12503693	177109	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8323	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Issar M (2006)	16507850	175778	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8324	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hoegger P (1994)	7878687	177114	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8325	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lumry WR (1999)	10518812	177111	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8326	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Johnson M (1996)	8646863	177110	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8327	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Andersson O (1999)	10200007	177113	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8328	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Zhang X (2001)	11730731	177112	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8329	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8330	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Austin RJ (2002)	12503693	177109	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8331	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8332	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Sano A (1999)	10351938	177115	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8333	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Myo S (2004)	15083746	177116	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8334	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8335	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8336	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8337	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8338	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8339	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8340	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8341	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Egan CT (1998)	9600588	177119	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8342	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8343	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Miyazawa T (1991)	1783326	177120	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8344	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Akai T (1991)	1678728	177121	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8345	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Cunningham KA (1987)	2887435	177122	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8346	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Marona-Lewicka D (2002)	12373423	177123	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8347	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kimura K (1991)	11224054	177124	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8348	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8349	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8350	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8351	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8352	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8353	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8354	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8355	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8356	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8357	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Egan CT (1998)	9600588	177119	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8358	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Martin DJ (1999)	10393471	177125	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8359	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Yono M (2004)	15573147	177126	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8360	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Michel MC (1996)	8736427	177127	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8361	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Ishizuka O (1997)	9205965	177128	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8362	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Greco KA (2008)	19002123	177129	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8363	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8364	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Roehrborn CG (2004)	14767264	177132	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8365	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Shannon R (2006)	17070143	177131	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8366	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Bae JH (2005)	16225542	177130	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8367	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Greco KA (2008)	19002123	177129	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8368	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Lepor H (2008)	18231614	177133	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8369	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Martin DJ (1999)	10393471	177125	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8370	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Shannon R (2006)	17070143	177131	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8371	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8372	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8373	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Greco KA (2008)	19002123	177129	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8374	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Lepor H (2008)	18231614	177133	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8375	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Martin DJ (1999)	10393471	177125	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8376	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Shannon R (2006)	17070143	177131	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8377	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	580	Doxazosin	1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|Doxazosina|Doxazosinum|Doxazosine|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin	cardura-1 tab 1mg|doxazosin-2|	DRUGBANK	DB00590	C23H25N5O5	small molecule	C02CA04	74191-85-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUZYUOTYCVRMRZ-UHFFFAOYSA-N
8378	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Nehme A (2009)	19744340	105018	581	Fluocinolone Acetonide	6alpha-fluorotriamcinolone acetonide|fluocinolon acetonid|actonide de fluocinolone|fluocinoloni acetonidum|6,9-difluoro-16-hydroxyprednisolone 16,17-acetonide|6alpha,9alpha-difluoro-16alpha-hydroxyprednisolone 16,17-acetonide|6-fluorotriamcinolone acetonide|fluocinolone 16,17-acetonide|acetnido de fluocinolona	fluocinolone acetonide oil|syn	DRUGBANK	DB00591	C24H30F2O6	small molecule	D07CC02|S01CA10|D07AC04|S02CA05|C05AA10|S02BA08|D07BC02|S01BA15	67-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEBLZLNTKCEFIT-VSXGLTOVSA-N
8379	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	582	Piperazine	Diethylenediamine|Piperazidine|Piperazin	veriga 125|formule c34|vermire	DRUGBANK	DB00592	C4H10N2	small molecule	P02CB01	110-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLUUGHFHXGJENI-UHFFFAOYSA-N
8380	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Maskell PD (2001)	11156579	177135	582	Piperazine	Diethylenediamine|Piperazidine|Piperazin	veriga 125|formule c34|vermire	DRUGBANK	DB00592	C4H10N2	small molecule	P02CB01	110-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLUUGHFHXGJENI-UHFFFAOYSA-N
8381	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	582	Piperazine	Diethylenediamine|Piperazidine|Piperazin	veriga 125|formule c34|vermire	DRUGBANK	DB00592	C4H10N2	small molecule	P02CB01	110-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLUUGHFHXGJENI-UHFFFAOYSA-N
8382	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	582	Piperazine	Diethylenediamine|Piperazidine|Piperazin	veriga 125|formule c34|vermire	DRUGBANK	DB00592	C4H10N2	small molecule	P02CB01	110-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLUUGHFHXGJENI-UHFFFAOYSA-N
8383	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Gomora JC (2001)	11641441	177137	583	Ethosuximide	(+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide	zarontin|zarontin cap 250mg|et	DRUGBANK	DB00593	C7H11NO2	small molecule	N03AD01|N03AD51	77-67-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAPOVYFOVVWLRS-UHFFFAOYSA-N
8384	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Wang G (2008)	19005061	177136	583	Ethosuximide	(+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide	zarontin|zarontin cap 250mg|et	DRUGBANK	DB00593	C7H11NO2	small molecule	N03AD01|N03AD51	77-67-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAPOVYFOVVWLRS-UHFFFAOYSA-N
8385	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	583	Ethosuximide	(+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide	zarontin|zarontin cap 250mg|et	DRUGBANK	DB00593	C7H11NO2	small molecule	N03AD01|N03AD51	77-67-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAPOVYFOVVWLRS-UHFFFAOYSA-N
8386	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Matthews EA (2001)	11274992	177138	583	Ethosuximide	(+-)-2-Ethyl-2-methylsuccinimide|Ethosuximide|Etosuximida|alpha-Methyl-alpha-ethylsuccinimide|3-Methyl-3-ethylsuccinimide|gamma-Ethyl-gamma-methyl-succinimide|2-ethyl-2-methylsuccinimide|Ethosuximidum|Atysmal|Thilopemal|alpha-Ethyl-alpha-methylsuccinimide|()-2-ethyl-2-methylsuccinimide|3-ethyl-3-methyl-2,5-pyrrolidinedione|Ethosuximid|3-Methyl-3-ethylpyrrolidine-2,5-dione|-ethyl--methyl-succinimide|2-Methyl-2-ethylsuccinimide|gamma-Methyl-gamma-ethyl-succinimide|3-Ethyl-3-methylsuccinimide|Aethosuximide	zarontin|zarontin cap 250mg|et	DRUGBANK	DB00593	C7H11NO2	small molecule	N03AD01|N03AD51	77-67-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAPOVYFOVVWLRS-UHFFFAOYSA-N
8387	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Viemann M (2001)	11344206	177142	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8388	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Yamagata T (2002)	12396248	177143	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8389	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Iwai N (2001)	11463765	177140	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8390	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Akcay A (2002)	12503866	177141	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8391	112244	6340	-	SCNN1G	BESC3|ENaCg|ENaCgamma|PHA1|SCNEG	9606	Homo sapiens	inhibitor	target	Ludwig M (2004)	15547682	177139	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8392	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Yamagata T (2002)	12396248	177143	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8393	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Brooks HL (2002)	11882592	177146	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8394	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Planes C (2005)	15681398	177147	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8395	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Lebowitz J (2003)	12746257	177144	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8396	112242	6338	hCG_23853	SCNN1B	BESC1|ENaCb|ENaCbeta|SCNEB	9606	Homo sapiens	inhibitor	target	Kamide K (2004)	15198480	177145	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8397	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Ji HL (2004)	14660613	177151	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8398	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Ji HL (2006)	16423824	177150	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8399	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Yamamura H (2004)	14726523	177148	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8400	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Yamamura H (2005)	16107516	177149	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8401	112243	6339	RP5-902P8.9	SCNN1D	ENaCd|ENaCdelta|SCNED|dNaCh	9606	Homo sapiens	inhibitor	target	Yamamura H (2005)	16033954	177152	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8402	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	inhibitor	target	Konstantinou-Tegou A (2001)	11604219	177153	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8403	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	inhibitor	target	Cuthbert AW (2003)	12872009	177155	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8404	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	inhibitor	target	Serrani RE (2001)	11688549	177154	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8405	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	inhibitor	target	Lee MG (2000)	10841524	177157	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8406	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	inhibitor	target	Furukawa O (2004)	12881227	177156	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8407	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Cejkova J (2005)	15866288	177159	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8408	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Jankun J (2001)	11562773	177158	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8409	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8410	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Luikart S (2002)	12183060	177160	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8411	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Chen YX (2003)	12897821	177161	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8412	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	inhibitor	target	Vakili J (2001)	11544332	177162	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8413	106544	26	-	AOC1	ABP|ABP1|DAO|DAO1|KAO	9606	Homo sapiens	inhibitor	target	Padiglia A (2000)	10850957	177164	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8414	106544	26	-	AOC1	ABP|ABP1|DAO|DAO1|KAO	9606	Homo sapiens	inhibitor	target	Padiglia A (1999)	10938536	177163	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8415	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Otulakowski G (2007)	17556672	177165	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8416	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Ji HL (2004)	15084585	177166	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8417	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Kelly O (2003)	12928313	177167	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8418	112241	6337	-	SCNN1A	BESC2|ENaCa|ENaCalpha|SCNEA|SCNN1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8419	106559	41	-	ASIC1	ACCN2|ASIC|BNaC2	9606	Homo sapiens	inhibitor	target	Jones NG (2004)	15574747	177091	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8420	106559	41	-	ASIC1	ACCN2|ASIC|BNaC2	9606	Homo sapiens	inhibitor	target	Petruska JC (2002)	12401318	177171	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8421	106559	41	-	ASIC1	ACCN2|ASIC|BNaC2	9606	Homo sapiens	inhibitor	target	Wang W (2006)	16319075	177170	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8422	106559	41	-	ASIC1	ACCN2|ASIC|BNaC2	9606	Homo sapiens	inhibitor	target	Sugiura T (2005)	15758172	177168	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8423	106559	41	-	ASIC1	ACCN2|ASIC|BNaC2	9606	Homo sapiens	inhibitor	target	Xiong ZG (2006)	16685601	177169	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8424	106558	40	-	ASIC2	ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1	9606	Homo sapiens	inhibitor	target	Peng BG (2004)	15537887	177173	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8425	106558	40	-	ASIC2	ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1	9606	Homo sapiens	inhibitor	target	Berdiev BK (2003)	12584187	177172	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8426	106558	40	-	ASIC2	ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1	9606	Homo sapiens	inhibitor	target	Ugawa S (2003)	14686475	177176	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8427	106558	40	-	ASIC2	ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1	9606	Homo sapiens	inhibitor	target	Ugawa S (2003)	12736332	177175	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8428	106558	40	-	ASIC2	ACCN|ACCN1|ASIC2a|BNC1|BNaC1|MDEG|hBNaC1	9606	Homo sapiens	inhibitor	target	Vila-Carriles WH (2006)	16704974	177174	584	Amiloride	Amilorida|Amiloridum|Amilorid|Amyloride|N-amidino-3,5-diamino-6-chloropyrazinecarboxamide|Amipramidine|Amipramidin|3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide	amiloride hydrocloride|amilori	DRUGBANK	DB00594	C6H8ClN7O	small molecule	C03DB01	2609-46-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSDQTOBWRPYKKA-UHFFFAOYSA-N
8429	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8430	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8431	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Aminov RI (2004)	15156014	177177	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8432	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Skoeld SE (1981)	6163479	177178	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8433	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8434	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8435	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Aminov RI (2004)	15156014	177177	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8436	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Skoeld SE (1981)	6163479	177178	585	Oxytetracycline	Oxytetracycline (anhydrous)|Oxytetracyclinum|Oxitetraciclina|Oxyterracin|Hydroxytetracyclinum|Oxytetracyclin|Oxyterracine|Oxyttracycline|Embryostat|Oxytetracycline amphoteric|Mepatar|5-Hydroxytetracycline	-	DRUGBANK	DB00595	C22H24N2O9	small molecule	J01AA06|D06AA03|J01AA56|G01AA07|S01AA04	79-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVCMVBTMGNXQD-PXOLEDIWSA-N
8437	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Mohandas S (2009)	19293512	177179	586	Ulobetasol	Ulobtasol|Halobetasol|21-chloro diflorasone|Ulobetasolum|Ulobetasol	ultravate cream|ultravate oint	DRUGBANK	DB00596	C22H27ClF2O4	small molecule	D07AC21	98651-66-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEHFPXVYPMWYQD-XHIJKXOTSA-N
8438	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hofmann TG (1998)	9891987	174579	586	Ulobetasol	Ulobtasol|Halobetasol|21-chloro diflorasone|Ulobetasolum|Ulobetasol	ultravate cream|ultravate oint	DRUGBANK	DB00596	C22H27ClF2O4	small molecule	D07AC21	98651-66-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEHFPXVYPMWYQD-XHIJKXOTSA-N
8439	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8440	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	van Zwieten PA (1993)	7684671	177184	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8441	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Rosendorff C (1993)	8104240	177185	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8442	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Pujos E (2009)	19879818	177182	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8443	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sassard J (1983)	6355664	177183	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8444	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Doggrell SA (1992)	1361547	177180	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8445	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Doggrell SA (1988)	2907566	177181	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8446	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8447	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Nakagawa Y (1981)	7286847	177188	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8448	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Monopoli A (1984)	6151824	177186	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8449	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Riva E (1991)	1687367	177187	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8450	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	van Zwieten PA (1993)	7684671	177184	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8451	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Rosendorff C (1993)	8104240	177185	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8452	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Pujos E (2009)	19879818	177182	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8453	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Sassard J (1983)	6355664	177183	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8454	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Sassard J (1983)	6355664	177183	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8455	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Shiraishi K (1992)	1358746	177189	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8456	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	van Zwieten PA (1993)	7684671	177184	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8457	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Rosendorff C (1993)	8104240	177185	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8458	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Pedersen ME (2007)	17686376	177191	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8459	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nakamura T (1999)	10529655	177190	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8460	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Bernstein JS (1989)	2696507	177192	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8461	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Sassard J (1983)	6355664	177183	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8462	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Shiraishi K (1992)	1358746	177189	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8463	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	van Zwieten PA (1993)	7684671	177184	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8464	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Rosendorff C (1993)	8104240	177185	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8465	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Pedersen ME (2007)	17686376	177191	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8466	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Nakamura T (1999)	10529655	177190	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8467	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Bernstein JS (1989)	2696507	177192	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8468	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Sassard J (1983)	6355664	177183	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8469	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Shiraishi K (1992)	1358746	177189	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8470	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	van Zwieten PA (1993)	7684671	177184	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8471	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Rosendorff C (1993)	8104240	177185	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8472	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Pedersen ME (2007)	17686376	177191	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8473	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nakamura T (1999)	10529655	177190	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8474	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Bernstein JS (1989)	2696507	177192	588	Labetalol	Labetalol|Labetolol|Labetalolum|3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol|5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide	labetalol hcl|labetalol hydroc	DRUGBANK	DB00598	C19H24N2O3	small molecule	C07BG01|C07CG01|C07AG01	36894-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUAFYQXFOLMHL-UHFFFAOYSA-N
8475	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8476	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	inhibitor	target	Patel S (2003)	12839875	177193	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8477	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8478	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8479	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8480	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8481	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8482	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8483	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Grasshoff C (2008)	18619475	177194	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8484	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8485	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8486	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8487	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8488	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8489	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8490	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8491	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8492	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8493	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8494	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8495	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8496	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8497	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8498	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8499	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8500	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8501	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Chen YR (2009)	19159217	177195	590	Monobenzone	Benzyl p-hydroxyphenyl ether|MONOBENZYL ether OF hydroquinone|4-Benzyloxy-phenol|Hydroquinone monobenzyl ether|Monobenzonum|Hydrochinon monobenzylether|Monobenzyl hydroquinone|4-Benzyloxyphenol|4-(Benzyloxyl)phenol|4-(Benzyloxy)phenol|p-(Benzyloxy)phenol|Monobenzone|p-Hydroxyphenyl benzyl ether|4-(Phenylmethoxy)phenol|Hydroquinone benzyl ether|Monobenzona	benoquin crm 20%	DRUGBANK	DB00600	C13H12O2	small molecule	D11AX13	103-16-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYQNWZOUAUKGHI-UHFFFAOYSA-N
8502	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8503	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Feng XP (2002)	12421359	177198	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8504	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8505	113705	8001	-	GLRA3	-	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8506	113705	8001	-	GLRA3	-	9606	Homo sapiens	agonist	target	McCavera S (2009)	19336526	177199	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8507	113705	8001	-	GLRA3	-	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8508	113705	8001	-	GLRA3	-	9606	Homo sapiens	agonist	target	Yates DM (2004)	15313134	177200	592	Ivermectin	Ivermectin|Ivermectine|Ivermectinum|Ivermectina	ivermectin|sklice|rosiver|stro	DRUGBANK	DB00602	C95H146O28	small molecule	D11AX22|P02CF01	70288-86-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPBDXSGPUHCETR-CVSKBELMSA-N
8509	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Jain JK (2007)	17094978	177204	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8510	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ghebeh H (2007)	17415709	175788	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8511	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lessey BA (2006)	17118173	175789	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8512	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yuri T (2007)	17203775	175786	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8513	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kumar AS (2007)	17103262	175785	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8514	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8515	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Boonyaratanakornkit V (2007)	17138644	175790	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8516	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Wu HB (2006)	17109827	175793	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8517	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Madauss KP (2007)	17013809	175792	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8518	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Gizard F (2006)	17015480	175794	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8519	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Risch HA (2006)	16985038	177205	593	Medroxyprogesterone acetate	6-Methyl-17-hydroxyprogesterone acetate|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|Medroxyprogesterone acetate|17alpha-Hydroxy-6alpha-methylprogesterone acetate|Medroxyprogesterone 17-acetate|Metigestrona|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|MPA|6-Methyl-17-acetoxy progesterone|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|17-Acetoxy-6alpha-methylprogesterone|6-alpha-Methyl-17-alpha-acetoxyprogesterone|17-hydroxy-6-methylprogesterone acetate|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|17-Acetoxy-6-methylprogesterone|Methylacetoxyprogesterone|6alpha-Methyl-17-acetoxy progesterone|Medroxyacetate progesterone	provera 2.5mg tablets|medroxy-	DRUGBANK	DB00603	C24H34O4	small molecule	G03AA08|G03FA12|G03FB06|G03DA02|G03AC06|L02AB02	71-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSGAAPLEWMOORI-PEINSRQWSA-N
8520	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8521	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Bach T (2001)	11218067	177209	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8522	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Crema F (1999)	10027842	177208	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8523	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Nagakura Y (1999)	10328995	177212	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8524	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Rahme MM (1999)	10556228	177210	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8525	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Bharucha AE (2000)	11034583	177211	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8526	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	agonist	target	Haga N (1998)	9697104	177214	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8527	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	agonist	target	de Ridder WJ (1993)	8093733	177215	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8528	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	agonist	target	Nagakura Y (1999)	10328995	177212	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8529	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	agonist	target	Talley NJ (1992)	1600046	177213	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8530	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Cushing DJ (1993)	8423526	177216	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8531	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Beubler E (1990)	1969947	177217	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8532	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Nieto JE (2000)	11131599	177218	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8533	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Lin J (2005)	15967876	177220	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8534	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Walker BD (1999)	10510456	177223	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8535	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chen J (2002)	12209010	177222	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8536	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Mohammad S (1997)	9374794	177221	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8537	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Perrio M (2007)	17408310	177219	594	Cisapride	4-amino-5-chloro-N-(1-(3-(4-Fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(P-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-O-anisamide|cis-4-amino-5-chloro-N-(1-(3-(P-Fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-O-anisamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|Cisapridum|(+-)-Cisapride|Cisaprid|Cisaprida|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapride	prepulsid sus 1mg/ml|prepulsid	DRUGBANK	DB00604	C23H29ClFN3O4	small molecule	A03FA02	81098-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCSUBABJRXZOMT-IRLDBZIGSA-N
8538	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cheng ZJ (2003)	12586211	177227	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8539	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lim JT (1999)	10484067	177226	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8540	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cheng ZJ (2002)	12512695	177225	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8541	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Giuliano F (1999)	10372826	177229	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8542	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Soriano AF (1999)	10626810	177228	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8543	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8544	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Jacobson M (1983)	6413448	177230	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8545	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Sharma YR (1989)	2632448	177231	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8546	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chaudhry PS (1983)	6409111	177232	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8547	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Crabbe MJ (1985)	3920599	177233	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8548	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	van der Sloot P (1995)	8529171	177234	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8549	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	antagonist	target	Hata AN (2005)	15563582	161179	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8550	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2001)	11245463	177238	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8551	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2004)	15548677	177239	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8552	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2003)	12566304	177235	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8553	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Pangburn HA (2005)	16138927	177236	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8554	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Rice PL (2006)	16546990	177237	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8555	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	negative modulator	target	Liou JY (2007)	17409426	177241	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8556	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	negative modulator	target	Kim DJ (2006)	16418176	177240	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8557	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	negative modulator	target	Jarvis MC (2005)	16091736	177243	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8558	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	negative modulator	target	He TC (1999)	10555149	177242	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8559	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	negative modulator	target	Babbar N (2003)	14506281	170907	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8560	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Giuliano F (1999)	10372826	177229	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8561	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yip-Schneider MT (2000)	10657949	177245	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8562	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fosslien E (2000)	11078056	177244	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8563	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Molina MA (1999)	10485483	177247	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Taylor MT (2000)	11118042	177246	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8565	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8566	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8567	106976	486	-	FXYD2	ATP1G1|HOMG2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8568	106976	486	-	FXYD2	ATP1G1|HOMG2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8569	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Pirotte B (1998)	9685234	177252	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8570	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Rammes G (1996)	8882618	177253	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8571	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Fleck MW (1996)	8793745	177251	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8572	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Rammes G (1999)	9929558	177254	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8573	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Larson J (1994)	8003661	177255	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8574	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8575	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Liljequist S (1995)	8615854	177256	596	Cyclothiazide	Ciclotiazida|6-chloro-3,4-dihydro-3-(5-Norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Cyclothiazide|Cyclothiazidum|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-chloro-3,4-dihydro-3-(2-Norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide|Ciclotiazide|6-chloro-3-(2-Norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide	-	DRUGBANK	DB00606	C14H16ClN3O4S2	small molecule	C03AA09|C03AB09	2259-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOCUKUHCLICSIY-UHFFFAOYSA-N
8576	109194	2939	-	GSTA2	GST2|GSTA2-2|GTA2|GTH2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8577	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Jang CH (2006)	16418198	177263	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8578	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Dias-Melicio LA (2007)	17456179	177260	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8579	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Lim EJ (2006)	16870179	177261	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8580	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Rachmilewitz D (2006)	16670522	177259	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8581	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Wozniacka A (2006)	16761500	177262	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8582	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Huang LY (2005)	16148144	177269	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8583	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Rutz M (2004)	15307186	177268	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8584	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Lenert P (2005)	15762869	177267	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8585	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Trevani AS (2003)	14579285	177266	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8586	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	unknown	target	Merrell MA (2006)	16849519	177265	598	Chloroquine	Chloraquine|Chloroquine|Chloroquina|Chloroquinum|Chloroquinium|Chlorochine|Chlorochin|N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|Cloroquina	aralen|chloroquine|teva-chloro	DRUGBANK	DB00608	C18H26ClN3	small molecule	P01BA01	54-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTVZRBIWZFKQO-UHFFFAOYSA-N
8587	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	600	Metaraminol	Hydroxynorephedrine|1-Metaraminol|(-)-Erythro-metaraminol|2-Amino-1-(m-hydroxyphenyl)-1-propanol|Mtaraminol|m-Hydroxypropadrine|Metaraminolum|alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol|1-(m-Hydroxyphenyl)-2-amino-1-propanol|3-Hydroxyphenylisopropanolamine|alpha-(m-Hydroxyphenyl)-beta-aminopropanol|m-Hydroxy norephedrine|m-Hydroxyphenylpropanolamine|Metaraminol|L-Metaraminol	-	DRUGBANK	DB00610	C9H13NO2	small molecule	C01CA09	54-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXFIGDLSSYIKKV-RCOVLWMOSA-N
8588	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	600	Metaraminol	Hydroxynorephedrine|1-Metaraminol|(-)-Erythro-metaraminol|2-Amino-1-(m-hydroxyphenyl)-1-propanol|Mtaraminol|m-Hydroxypropadrine|Metaraminolum|alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol|1-(m-Hydroxyphenyl)-2-amino-1-propanol|3-Hydroxyphenylisopropanolamine|alpha-(m-Hydroxyphenyl)-beta-aminopropanol|m-Hydroxy norephedrine|m-Hydroxyphenylpropanolamine|Metaraminol|L-Metaraminol	-	DRUGBANK	DB00610	C9H13NO2	small molecule	C01CA09	54-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXFIGDLSSYIKKV-RCOVLWMOSA-N
8589	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Tatsuta M (1998)	9663612	177277	600	Metaraminol	Hydroxynorephedrine|1-Metaraminol|(-)-Erythro-metaraminol|2-Amino-1-(m-hydroxyphenyl)-1-propanol|Mtaraminol|m-Hydroxypropadrine|Metaraminolum|alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol|1-(m-Hydroxyphenyl)-2-amino-1-propanol|3-Hydroxyphenylisopropanolamine|alpha-(m-Hydroxyphenyl)-beta-aminopropanol|m-Hydroxy norephedrine|m-Hydroxyphenylpropanolamine|Metaraminol|L-Metaraminol	-	DRUGBANK	DB00610	C9H13NO2	small molecule	C01CA09	54-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXFIGDLSSYIKKV-RCOVLWMOSA-N
8590	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Wakabayashi H (1995)	8746803	177285	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8591	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Narita M (1994)	7705457	177284	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8592	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Ohta S (1989)	2555580	177286	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8593	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Park Y (2000)	10779697	177281	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8594	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Fan LW (2002)	12470863	177279	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8595	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Fan LW (2002)	12127012	177283	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8596	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Vivian JA (1999)	10381785	177282	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8597	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Commiskey S (2005)	15942128	177278	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8598	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Picker MJ (1996)	8968334	176556	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8599	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Walsh SL (2008)	17909753	177280	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8600	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Wakabayashi H (1995)	8746803	177285	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8601	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Narita M (1994)	7705457	177284	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8602	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Picker MJ (1997)	9399970	177287	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8603	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Commiskey S (2005)	15942128	177278	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8604	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Fan LW (2002)	12470863	177279	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8605	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Fan LW (2002)	12127012	177283	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8606	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Vivian JA (1999)	10381785	177282	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8607	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Picker MJ (1996)	8968334	176556	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8608	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial antagonist	target	Walsh SL (2008)	17909753	177280	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8609	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Wakabayashi H (1995)	8746803	177285	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8610	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Narita M (1994)	7705457	177284	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8611	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Commiskey S (2005)	15942128	177278	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8612	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Fan LW (2002)	12470863	177279	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8613	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Fan LW (2002)	12127012	177283	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8614	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8615	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Picker MJ (1996)	8968334	176556	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8616	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Walsh SL (2008)	17909753	177280	601	Butorphanol	(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|(-)-Butorphanol|Butorphanolum|Butorfanol|(-)-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|Butorphanol	stadol ns - 10mg/ml aem-liq|pm	DRUGBANK	DB00611	C21H29NO2	small molecule	N02AF01	42408-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKLAQQSCNILHL-QHAWAJNXSA-N
8617	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bruck H (2004)	15526107	176627	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8618	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Motomura S (1990)	1968697	177289	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8619	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brodde OE (1986)	2439795	177288	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8620	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brouri F (2004)	14757145	177290	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8621	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Daul A (1986)	2886573	177291	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8622	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Bruck H (2005)	16325050	177294	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8623	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Breed JG (1992)	1280737	177295	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8624	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Mauz AB (1990)	1691366	177292	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8625	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Lipworth BJ (1991)	1676675	177293	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8626	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Brouri F (2004)	14757145	177290	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8627	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHYCDWMUTMEGQY-UHFFFAOYSA-N
8628	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8629	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Nowak JZ (1980)	6789797	177300	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8630	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Barth H (1975)	1203620	177301	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8631	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	inhibitor	target	Yokoyama A (2007)	17222819	177299	603	Amodiaquine	Amodiaquina|Amodiaquinum|Amodiaquine	-	DRUGBANK	DB00613	C20H22ClN3O	small molecule	P01BF03|P01BA06	86-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCDSSHSILBFBN-UHFFFAOYSA-N
8632	852781	948487	b3988	rpoC	ECK3979|JW3951|tabB	511145	Escherichia coli	inhibitor	target	Maddix DS (1994)	7849340	177307	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8633	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Maddix DS (1994)	7849340	177307	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8634	852106	947794	b3295	rpoA	ECK3282|JW3257|pez|phs|sez	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8635	852106	947794	b3295	rpoA	ECK3282|JW3257|pez|phs|sez	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8636	852106	947794	b3295	rpoA	ECK3282|JW3257|pez|phs|sez	511145	Escherichia coli	inhibitor	target	Maddix DS (1994)	7849340	177307	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8637	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Srethapakdi M (2000)	10919672	177312	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8638	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Yang J (2001)	11358819	177311	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8639	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Neckers L (2000)	10759403	177310	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8640	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Schnaider T (2000)	10701840	177308	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8641	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Muenster PN (2001)	11306472	177309	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8642	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Barzilay E (2004)	14660597	177313	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8643	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Chavany C (1996)	8617772	5846	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8644	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Lawson B (1998)	9428803	177314	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8645	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Dumoulin MJ (2001)	11300648	177316	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8646	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Kostova E (2006)	16642666	177315	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8647	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Elsner D (1992)	1386491	177320	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8648	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Hirata Y (1994)	7511759	177321	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8649	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Plamboeck A (2005)	16025254	177317	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8650	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	O'Connell JE (1992)	1315825	177319	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8651	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Sansoe G (2006)	16449355	177318	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8652	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8653	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	suppressor	target	Imming P (2006)	17016423	171742	607	Paramethadione	Parametadiona|Paramethadionum|Paradione|Parametadione|Paramethadione	-	DRUGBANK	DB00617	C7H11NO3	small molecule	N03AC01	115-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQASKUSHBVDKGU-UHFFFAOYSA-N
8654	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	suppressor	target	Overington JP (2006)	17139284	171741	607	Paramethadione	Parametadiona|Paramethadionum|Paradione|Parametadione|Paramethadione	-	DRUGBANK	DB00617	C7H11NO3	small molecule	N03AC01	115-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQASKUSHBVDKGU-UHFFFAOYSA-N
8655	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	608	Demeclocycline	7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin	declomycin - tab 300mg|declomy	DRUGBANK	DB00618	C21H21ClN2O8	small molecule	D06AA01|J01AA01	127-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMTDIUIBLCQGJB-SEYHBJAFSA-N
8656	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	608	Demeclocycline	7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin	declomycin - tab 300mg|declomy	DRUGBANK	DB00618	C21H21ClN2O8	small molecule	D06AA01|J01AA01	127-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMTDIUIBLCQGJB-SEYHBJAFSA-N
8657	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	608	Demeclocycline	7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin	declomycin - tab 300mg|declomy	DRUGBANK	DB00618	C21H21ClN2O8	small molecule	D06AA01|J01AA01	127-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMTDIUIBLCQGJB-SEYHBJAFSA-N
8658	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	608	Demeclocycline	7-Chloro-6-demethyltetracycline|Demeclocycline|6-Demethyl-7-chlorotetracycline|Demeclocyclinum|Demeclociclina|DMCT|[4S-(4alpha,4Aalpha,5aalpha,6beta,12aalpha)]-7-chloro-4-(dimethylamino)1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide|Demethylchlortetracycline|DMCTC|Demethylchlortetracyclin	declomycin - tab 300mg|declomy	DRUGBANK	DB00618	C21H21ClN2O8	small molecule	D06AA01|J01AA01	127-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMTDIUIBLCQGJB-SEYHBJAFSA-N
8659	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Dewar AL (2005)	15917650	177323	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8660	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Haberler C (2006)	16205964	177326	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8661	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Agirre X (2005)	15949566	177327	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8662	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Brueggemeier SB (2005)	16153117	177324	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8663	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Hoerth E (2004)	15799618	177325	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8664	107234	780	DAAP-278B20.1	DDR1	CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE	9606	Homo sapiens	antagonist	target	Gotlib J (2005)	15972446	177331	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8665	107234	780	DAAP-278B20.1	DDR1	CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE	9606	Homo sapiens	antagonist	target	Neef M (2006)	16168515	177330	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8666	107234	780	DAAP-278B20.1	DDR1	CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE	9606	Homo sapiens	antagonist	target	Jubert C (2006)	16298518	177328	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8667	107234	780	DAAP-278B20.1	DDR1	CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE	9606	Homo sapiens	antagonist	target	Benjamin RS (2006)	16401709	177329	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8668	107234	780	DAAP-278B20.1	DDR1	CAK|CD167|DDR|EDDR1|HGK2|MCK10|NEP|NTRK4|PTK3|PTK3A|RTK6|TRKE	9606	Homo sapiens	antagonist	target	Xu L (2005)	15994946	177332	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8669	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Posadas EM (2007)	17559139	177333	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8670	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Lee JL (2006)	16865565	177335	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8671	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Rutkowski P (2007)	17458563	177334	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8672	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	De Giorgi U (2007)	17369583	177337	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8673	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Dy GK (2005)	16087693	177336	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8674	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	multitarget	target	Posadas EM (2007)	17559139	177333	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8675	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	multitarget	target	Lee JL (2006)	16865565	177335	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8676	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	multitarget	target	Rutkowski P (2007)	17458563	177334	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8677	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	multitarget	target	De Giorgi U (2007)	17369583	177337	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8678	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	multitarget	target	Dy GK (2005)	16087693	177336	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8679	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Modi S (2005)	15803362	177339	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8680	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Jones RL (2005)	15794712	177338	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8681	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Chen J (2006)	15893416	177342	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8682	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Basciani S (2005)	15753388	177340	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8683	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Johnson FM (2005)	15887238	177341	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8684	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	inhibitor	target	de Groot JW (2006)	16782438	177343	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8685	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	antagonist	target	de Groot JW (2006)	16782438	177343	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8686	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	antagonist	target	Kovacs M (2005)	16052979	177344	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8687	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	antagonist	target	Delbaldo C (2007)	17582306	177345	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8688	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	antagonist	target	de Groot JW (2007)	17579194	177346	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8689	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	antagonist	target	Catani M (2005)	15832750	177347	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8690	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	antagonist	target	Dewar AL (2006)	16449525	177348	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8691	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	antagonist	target	Ando W (2006)	16816921	177349	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8692	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	antagonist	target	El Hajj Dib I (2006)	17049513	177351	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8693	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	antagonist	target	Dewar AL (2005)	15917650	177323	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8694	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	antagonist	target	Taylor JR (2006)	16170366	177350	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8695	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	antagonist	target	Borbenyi Z (2005)	15921304	177356	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8696	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	antagonist	target	Tefferi A (2005)	15995325	177355	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8697	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	antagonist	target	Yi ES (2005)	15894928	177354	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8698	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	antagonist	target	Chen LL (2005)	15946589	177353	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8699	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	antagonist	target	Corless CL (2005)	15928335	177352	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTUFNOKKBVMGRW-UHFFFAOYSA-N
8700	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shahin V (2005)	15976447	177375	610	Triamcinolone	9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona	triamcinolone acetonide inject	DRUGBANK	DB00620	C21H27FO6	small molecule	D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|S01BA05|D07XB02|D07BB03	124-94-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFNANZIMVAIWHM-OBYCQNJPSA-N
8701	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Nehme A (2009)	19744340	105018	610	Triamcinolone	9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona	triamcinolone acetonide inject	DRUGBANK	DB00620	C21H27FO6	small molecule	D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|S01BA05|D07XB02|D07BB03	124-94-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFNANZIMVAIWHM-OBYCQNJPSA-N
8702	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	610	Triamcinolone	9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|Fluoxyprednisolone|Triamcinolonum|9-fluoro-16-hydroxyprednisolone|9-fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione|11,16,17,21-tetrahydroxy-9-fluoro-1,4-pregnadiene-3,20-dione|Tiamcinolonum|Triamcinolona	triamcinolone acetonide inject	DRUGBANK	DB00620	C21H27FO6	small molecule	D07AB09|A01AC01|S02CA04|R03BA06|C05AA12|H02AB08|R01AD11|D07CB01|S01BA05|D07XB02|D07BB03	124-94-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFNANZIMVAIWHM-OBYCQNJPSA-N
8703	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Bi LX (2007)	17364004	177384	611	Oxandrolone	Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar	oxandrolone	DRUGBANK	DB00621	C19H30O3	small molecule	A14AA08	53-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLJIVKCVHQPLV-PEMPUTJUSA-N
8704	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Cadwallader AB (2010)	20230007	177385	611	Oxandrolone	Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar	oxandrolone	DRUGBANK	DB00621	C19H30O3	small molecule	A14AA08	53-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLJIVKCVHQPLV-PEMPUTJUSA-N
8705	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Juul A (2001)	11392377	177386	611	Oxandrolone	Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar	oxandrolone	DRUGBANK	DB00621	C19H30O3	small molecule	A14AA08	53-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLJIVKCVHQPLV-PEMPUTJUSA-N
8706	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	611	Oxandrolone	Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar	oxandrolone	DRUGBANK	DB00621	C19H30O3	small molecule	A14AA08	53-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLJIVKCVHQPLV-PEMPUTJUSA-N
8707	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Zhao J (2004)	15219414	177383	611	Oxandrolone	Oxandrolon|Oxandrolonum|Ossandrolone|Oxandrolona|Oxandrolone|Protivar	oxandrolone	DRUGBANK	DB00621	C19H30O3	small molecule	A14AA08	53-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLJIVKCVHQPLV-PEMPUTJUSA-N
8708	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8709	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8710	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8711	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8712	111179	5153	-	PDE1B	PDE1B1|PDES1B	9606	Homo sapiens	inhibitor	target	Sharma RK (1997)	9231746	177388	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8713	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8714	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Bell DC (2001)	11160515	177389	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8715	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8716	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Thayer SA (1983)	6865927	177390	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8717	111162	5136	-	PDE1A	CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A	9606	Homo sapiens	inhibitor	target	Sharma RK (1997)	9231746	177388	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8718	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8719	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8720	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8721	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8722	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Thayer SA (1985)	2981533	177387	612	Nicardipine	Nicardipino|Nicardipinum|Cardene	nicardipine hydrochloride|card	DRUGBANK	DB00622	C26H29N3O6	small molecule	C08CA04	55985-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBBHBTPTTSWHBA-UHFFFAOYSA-N
8723	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8724	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hoyberg OJ (1993)	7508675	177392	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8725	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8726	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Qin ZH (1994)	7828655	177391	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8727	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Edlind T (2002)	12366848	58606	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8728	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kauss H (1981)	16661928	177393	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8729	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kawai M (2001)	11409178	54890	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8730	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mongin AA (1999)	10516112	177395	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8731	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Nakabayashi H (1992)	1515867	177394	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8732	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8733	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8734	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8735	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Van Kampen JM (2000)	11113312	177396	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8736	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Small EJ (2006)	17084172	177399	614	Testosterone	Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F	taro-testosterone|testosterone	DRUGBANK	DB00624	C19H28O2	small molecule	G03BA03|G03EA02	58-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-DYKIIFRCSA-N
8737	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Omwancha J (2006)	17086931	177398	614	Testosterone	Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F	taro-testosterone|testosterone	DRUGBANK	DB00624	C19H28O2	small molecule	G03BA03|G03EA02	58-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-DYKIIFRCSA-N
8738	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	614	Testosterone	Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F	taro-testosterone|testosterone	DRUGBANK	DB00624	C19H28O2	small molecule	G03BA03|G03EA02	58-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-DYKIIFRCSA-N
8739	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Maudsley S (2007)	17202804	177400	614	Testosterone	Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F	taro-testosterone|testosterone	DRUGBANK	DB00624	C19H28O2	small molecule	G03BA03|G03EA02	58-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-DYKIIFRCSA-N
8740	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Lapauw B (2007)	17322500	177397	614	Testosterone	Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F	taro-testosterone|testosterone	DRUGBANK	DB00624	C19H28O2	small molecule	G03BA03|G03EA02	58-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-DYKIIFRCSA-N
8741	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Petraki CD (2007)	17128417	177401	614	Testosterone	Testosterona|Mertestate|17beta-Hydroxy-4-androsten-3-one|4-Androsten-17beta-ol-3-one|Virosterone|Androderm|Testryl|Testosteronum|Testoxyl|Testosteron|Testostrone|Depo-Testadiol|4-androsten-17-ol-3-one|17beta-hydroxy-4-androsten-3-one|Synandrol F	taro-testosterone|testosterone	DRUGBANK	DB00624	C19H28O2	small molecule	G03BA03|G03EA02	58-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-DYKIIFRCSA-N
8742	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Maxfield FR (1979)	42903	177414	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8743	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Gliemann J (1983)	6187372	177415	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8744	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Dickson RB (1981)	6165617	177416	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8745	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Dickson RB (1981)	6162847	177412	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8746	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	inhibitor	target	Hanover JA (1983)	6184373	177413	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8747	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8748	109642	3416	RP11-366I13.1	IDE	INSULYSIN	9606	Homo sapiens	inhibitor	target	Medina V (1993)	8484964	177417	616	Bacitracin	Bacitracin F, 1-(N-((2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl)carbonyl)-L-leucine)-|Bacitracin a2a	bacitin|walgreenstriple antibi	DRUGBANK	DB00626	C66H103N17O16S	small molecule	R02AB04|J01XX10|D06AX05	1405-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKOFPXJLQSYAH-ABRJDSQDSA-N
8749	110900	4837	-	NNMT	-	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8750	110900	4837	-	NNMT	-	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8751	110900	4837	-	NNMT	-	9606	Homo sapiens	binder	target	Riederer M (2009)	18996527	177419	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8752	117035	23475	-	QPRT	HEL-S-90n|QPRTase	9606	Homo sapiens	binder	target	Zheng XQ (2005)	15837705	177421	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8753	117035	23475	-	QPRT	HEL-S-90n|QPRTase	9606	Homo sapiens	binder	target	Shin DH (2005)	15753098	177420	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8754	117035	23475	-	QPRT	HEL-S-90n|QPRTase	9606	Homo sapiens	binder	target	Fukuwatari T (2001)	11758903	177422	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8755	130748	338442	-	HCAR2	GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Zellner C (2005)	15580557	177423	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8756	130748	338442	-	HCAR2	GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Tunaru S (2005)	16099840	177425	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8757	130748	338442	-	HCAR2	GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Zhang Y (2005)	16018973	177424	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8758	130748	338442	-	HCAR2	GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Wise A (2003)	12522134	177427	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8759	130748	338442	-	HCAR2	GPR109A|HCA2|HM74a|HM74b|NIACR1|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Soga T (2003)	12646212	177426	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8760	114370	8843	-	HCAR3	GPR109B|HCA3|HM74|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Tunaru S (2003)	12563315	177430	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8761	114370	8843	-	HCAR3	GPR109B|HCA3|HM74|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Tunaru S (2005)	16099840	177425	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8762	114370	8843	-	HCAR3	GPR109B|HCA3|HM74|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Zhang Y (2005)	16018973	177424	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8763	114370	8843	-	HCAR3	GPR109B|HCA3|HM74|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Wise A (2003)	12522134	177427	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8764	114370	8843	-	HCAR3	GPR109B|HCA3|HM74|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Taggart AK (2005)	15929991	177429	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8765	114370	8843	-	HCAR3	GPR109B|HCA3|HM74|PUMAG|Puma-g	9606	Homo sapiens	agonist	target	Benyo Z (2005)	16322797	177428	617	Niacin	Niacin|Nicotinic Acid|pyridine--carboxylic acid|-pyridinecarboxylic acid|beta-Pyridinecarboxylic acid|Pyridine-beta-carboxylic acid|3-Pyridylcarboxylic acid|Acido nicotinico|M-Pyridinecarboxylic Acid|Pellagra preventive factor|Vitamin B3|Acide Nicotinique|3-carboxypyridine|3-Pyridinecarboxylic acid|Nikotinsaeure|Acidum Nicotinicum|PP Factor|Anti-pellagra vitamin|P.P. factor	b-3 500mg continuous released|	DRUGBANK	DB00627	C6H5NO2	small molecule	C10BA01|C10AD02|C10AD52|C04AC01	59-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVNIIMVLHYAWGP-UHFFFAOYSA-N
8766	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8767	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8768	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8769	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8770	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8771	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8772	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8773	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8774	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8775	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8776	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8777	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8778	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8779	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8780	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8781	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8782	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8783	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8784	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8785	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8786	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8787	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8788	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8789	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8790	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8791	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8792	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8793	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8794	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8795	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8796	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8797	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8798	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Park CH (1996)	8787774	174205	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8799	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Uhlen S (1991)	1666366	176190	619	Guanabenz	Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo	-	DRUGBANK	DB00629	C8H8Cl2N4	small molecule	-	5051-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDZVGELJXXEGPV-YIXHJXPBSA-N
8800	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Bockman CS (1993)	7903385	177438	619	Guanabenz	Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo	-	DRUGBANK	DB00629	C8H8Cl2N4	small molecule	-	5051-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDZVGELJXXEGPV-YIXHJXPBSA-N
8801	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	van Zwieten PA (1997)	9050980	177436	619	Guanabenz	Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo	-	DRUGBANK	DB00629	C8H8Cl2N4	small molecule	-	5051-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDZVGELJXXEGPV-YIXHJXPBSA-N
8802	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Bockman CS (1996)	8819507	177437	619	Guanabenz	Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo	-	DRUGBANK	DB00629	C8H8Cl2N4	small molecule	-	5051-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDZVGELJXXEGPV-YIXHJXPBSA-N
8803	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Piletz JE (1993)	8263811	177434	619	Guanabenz	Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo	-	DRUGBANK	DB00629	C8H8Cl2N4	small molecule	-	5051-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDZVGELJXXEGPV-YIXHJXPBSA-N
8804	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Galeotti N (2004)	15265636	177435	619	Guanabenz	Guanabenz|WY-8678|Guanabenzum|Wytensin|Guanabenzo	-	DRUGBANK	DB00629	C8H8Cl2N4	small molecule	-	5051-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDZVGELJXXEGPV-YIXHJXPBSA-N
8805	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8806	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Bergstrom JD (2000)	10620343	174891	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8807	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Guo RT (2007)	17535895	175844	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8808	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Dunford JE (2001)	11160603	174892	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8809	111741	5775	-	PTPN4	MEG|PTPMEG|PTPMEG1	9606	Homo sapiens	inhibitor	target	Opas EE (1997)	9310349	177440	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8810	111766	5802	-	PTPRS	PTPSIGMA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8811	111766	5802	-	PTPRS	PTPSIGMA	9606	Homo sapiens	inhibitor	target	Schmidt A (1996)	8610169	177441	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8812	111766	5802	-	PTPRS	PTPSIGMA	9606	Homo sapiens	inhibitor	target	Opas EE (1997)	9310349	177440	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8813	111755	5791	RP11-380J17.1	PTPRE	HPTPE|PTPE|R-PTP-EPSILON	9606	Homo sapiens	inhibitor	target	Schmidt A (1996)	8610169	177441	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8814	107007	523	-	ATP6V1A	ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1	9606	Homo sapiens	inhibitor	target	David P (1996)	8889850	177442	620	Alendronic acid	ABDP|(4-amino-1-hydroxybutylidene)bisphosphonic acid|4-amino-1-hydroxybutane-1,1-diphosphonic acid|Acido Alendronico|Alendronate|Acidum Alendronicum|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|Acide Alendronique	pms-alendronate|jamp-alendrona	DRUGBANK	DB00630	C4H13NO7P2	small molecule	M05BB03|M05BA04|M05BB06|M05BB05	66376-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSPWJRAVKPPFI-UHFFFAOYSA-N
8815	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Lech-Maranda E (2009)	19519505	177447	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8816	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Pession A (2010)	20631817	177446	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8817	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Harned TM (2008)	18728851	177445	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8818	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Musto P (2008)	18780321	177444	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8819	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Unknown Authors (2004)	15230627	177443	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8820	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8821	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8822	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17852710	174594	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8823	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8824	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Lech-Maranda E (2009)	19519505	177447	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8825	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Pession A (2010)	20631817	177446	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8826	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Harned TM (2008)	18728851	177445	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8827	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Musto P (2008)	18780321	177444	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8828	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Unknown Authors (2004)	15230627	177443	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8829	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8830	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8831	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17852710	174594	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8832	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Zhenchuk A (2009)	19576186	174592	621	Clofarabine	CL-F-Ara-a|Clofarabina|Clofarabine|Clofarabin|2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine|Clofarabinum|Clolar|Clofarex|(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol|CAFdA|2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine	clolar	DRUGBANK	DB00631	C10H11ClFN5O3	small molecule	L01BB06	123318-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDDPHFBMKLOVOX-AYQXTPAHSA-N
8833	971755	3783713	HHV4_BLLF1	BLLF1	-	10376	Human Herpesvirus 4	intercalation	target	Imming P (2006)	17016423	171742	622	Docosanol	Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol	abreva	DRUGBANK	DB00632	C22H46O	small molecule	D06BB11	661-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOPFSRXAKWQILS-UHFFFAOYSA-N
8834	971755	3783713	HHV4_BLLF1	BLLF1	-	10376	Human Herpesvirus 4	intercalation	target	Treister NS (2010)	20210688	177450	622	Docosanol	Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol	abreva	DRUGBANK	DB00632	C22H46O	small molecule	D06BB11	661-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOPFSRXAKWQILS-UHFFFAOYSA-N
8835	971755	3783713	HHV4_BLLF1	BLLF1	-	10376	Human Herpesvirus 4	intercalation	target	Overington JP (2006)	17139284	171741	622	Docosanol	Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol	abreva	DRUGBANK	DB00632	C22H46O	small molecule	D06BB11	661-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOPFSRXAKWQILS-UHFFFAOYSA-N
8836	971755	3783713	HHV4_BLLF1	BLLF1	-	10376	Human Herpesvirus 4	intercalation	target	Leung DT (2004)	15571473	177449	622	Docosanol	Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol	abreva	DRUGBANK	DB00632	C22H46O	small molecule	D06BB11	661-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOPFSRXAKWQILS-UHFFFAOYSA-N
8837	971755	3783713	HHV4_BLLF1	BLLF1	-	10376	Human Herpesvirus 4	intercalation	target	Pope LE (1998)	9864049	177448	622	Docosanol	Docosyl alcohol|Behenic alcohol|Docosan-1-ol|Behenyl alcohol|1-Docosanol|N-Docosanol|Docosanol	abreva	DRUGBANK	DB00632	C22H46O	small molecule	D06BB11	661-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOPFSRXAKWQILS-UHFFFAOYSA-N
8838	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Fairbanks CA (2002)	11752127	176993	623	Dexmedetomidine	Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole	dexmedetomidine|dexmedetomidin	DRUGBANK	DB00633	C13H16N2	small molecule	N05CM18	113775-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUHVIMMYOGQXCV-NSHDSACASA-N
8839	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Ozdogan UK (2004)	15306201	176995	623	Dexmedetomidine	Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole	dexmedetomidine|dexmedetomidin	DRUGBANK	DB00633	C13H16N2	small molecule	N05CM18	113775-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUHVIMMYOGQXCV-NSHDSACASA-N
8840	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Davies MF (2004)	14583739	177451	623	Dexmedetomidine	Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole	dexmedetomidine|dexmedetomidin	DRUGBANK	DB00633	C13H16N2	small molecule	N05CM18	113775-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUHVIMMYOGQXCV-NSHDSACASA-N
8841	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Dawson C (2004)	15087625	177452	623	Dexmedetomidine	Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole	dexmedetomidine|dexmedetomidin	DRUGBANK	DB00633	C13H16N2	small molecule	N05CM18	113775-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUHVIMMYOGQXCV-NSHDSACASA-N
8842	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Menon DV (2007)	17692748	177453	623	Dexmedetomidine	Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole	dexmedetomidine|dexmedetomidin	DRUGBANK	DB00633	C13H16N2	small molecule	N05CM18	113775-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUHVIMMYOGQXCV-NSHDSACASA-N
8843	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Scheibner J (2002)	11834617	177454	623	Dexmedetomidine	Dexmdtomidine|(S)-medetomidine|(+)-medetomidine|Dexmedetomidin|Dexmedetomidinum|Dexmedetomidina|(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole	dexmedetomidine|dexmedetomidin	DRUGBANK	DB00633	C13H16N2	small molecule	N05CM18	113775-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUHVIMMYOGQXCV-NSHDSACASA-N
8844	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Patel OG (2004)	14700578	177461	624	Sulfacetamide	N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide	sodium sulamyd 10%|balsulph op	DRUGBANK	DB00634	C8H10N2O3S	small molecule	D10AF06|S01AB04	144-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKIVFJLNDNKQPD-UHFFFAOYSA-N
8845	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	BROWN GM (1962)	13873645	177463	624	Sulfacetamide	N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide	sodium sulamyd 10%|balsulph op	DRUGBANK	DB00634	C8H10N2O3S	small molecule	D10AF06|S01AB04	144-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKIVFJLNDNKQPD-UHFFFAOYSA-N
8847	35583	855465	YNL256W	FOL1	trifunctional dihydropteroate synthetase/dihydrohydroxymethylpterin pyrophosphokinase/dihydroneopterin aldolase FOL1|L000000620	559292	Saccharomyces cerevisiae	inhibitor	target	Patel OG (2004)	14700578	177461	624	Sulfacetamide	N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide	sodium sulamyd 10%|balsulph op	DRUGBANK	DB00634	C8H10N2O3S	small molecule	D10AF06|S01AB04	144-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKIVFJLNDNKQPD-UHFFFAOYSA-N
8848	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	ligand	target	Raza K (2010)	20634231	177464	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8849	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8850	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Friel PN (2006)	16597193	177469	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8851	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Diez JJ (2007)	17504182	177468	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8852	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Yano A (2006)	17062674	177465	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8853	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Liu BG (2006)	17121036	177467	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8854	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Yano A (2006)	16707595	177466	625	Prednisone	17,21-Dihydroxypregna-1,4-diene-3,11,20-trione|Dehydrocortisone|Prednisona|1,2-Dehydrocortisone|Prednisonum|1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione	rayos|contrast allergy premed 	DRUGBANK	DB00635	C21H26O5	small molecule	A07EA03|H02AB07	53-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFYZVNMUHMLCC-ZPOLXVRWSA-N
8855	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Palkar PS (2010)	20637823	177478	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8856	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Hunt MC (2000)	10787442	177476	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8857	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Koemueves LG (2000)	10951268	177477	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8858	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Barclay TB (1999)	10454501	177474	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8859	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Casas F (2000)	10922459	177475	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8860	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Murata M (2000)	10753628	177472	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8861	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Gelosa P (2010)	20671072	177473	626	Clofibrate	Ethyl chlorophenoxyisobutyrate|ELPI|alpha-(p-Chlorophenoxy)isobutyric acid, ethyl ester|Atromid-S|Liprin|2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester|alpha-p-Chlorophenoxyisobutyryl ethyl ester|Clofibrate|Lipofacton|2-(p-Chlorophenoxy)-2-methylpropionic acid ethyl ester|Clofibrato|EPIB|Ethyl 2-(P-chlorophenoxy)isobutyrate|Clofibratum|Ethyl clofibrate	novo-fibrate cap 500mg|atromid	DRUGBANK	DB00636	C12H15ClO3	small molecule	C10AB01	637-07-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHUKKLJHYUCFP-UHFFFAOYSA-N
8862	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cavero I (1999)	10597865	175351	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8863	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Salata JJ (1995)	8001268	175353	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8864	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8865	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Krstenansky PM (1987)	2892659	177483	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8866	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Howarth PH (1984)	6146346	177482	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8867	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kaliner MA (1988)	3147222	177481	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8868	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Llenas J (1999)	10597866	177485	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8869	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richards DM (1984)	6204835	177484	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8870	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Taglialatela M (1999)	10444235	177490	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8871	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chiu PJ (2004)	15272206	177489	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8872	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Grzelewska-Rzymowska I (2001)	11575008	177488	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8873	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chachin M (1999)	10422790	177487	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8874	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Zhou Z (1999)	10376921	177486	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
8875	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Trincavelli ML (2010)	20370662	177502	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8876	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Ezeamuzie CI (2007)	17321471	177503	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8877	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Buenestado A (2010)	20136829	177500	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8878	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Schenone S (2010)	20370661	177501	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8879	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Funakoshi H (2007)	17438146	177498	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8880	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Haschemi A (2007)	17442976	177499	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8881	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Trincavelli ML (2010)	20370662	177502	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8882	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Ezeamuzie CI (2007)	17321471	177503	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8883	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Buenestado A (2010)	20136829	177500	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8884	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Schenone S (2010)	20370661	177501	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8885	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Kreckler LM (2009)	19749080	177504	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8886	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Kreckler LM (2006)	16339914	177505	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8887	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Funakoshi H (2007)	17438146	177498	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8888	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Haschemi A (2007)	17442976	177499	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8889	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Trincavelli ML (2010)	20370662	177502	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8890	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Ezeamuzie CI (2007)	17321471	177503	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8891	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Buenestado A (2010)	20136829	177500	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8892	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Schenone S (2010)	20370661	177501	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8893	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Kreckler LM (2006)	16339914	177505	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8894	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8895	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Funakoshi H (2007)	17438146	177498	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8896	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	agonist	target	Haschemi A (2007)	17442976	177499	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8897	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Trincavelli ML (2010)	20370662	177502	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8898	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Ezeamuzie CI (2007)	17321471	177503	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8899	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Buenestado A (2010)	20136829	177500	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8900	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Schenone S (2010)	20370661	177501	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8901	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Kreckler LM (2006)	16339914	177505	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8902	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Funakoshi H (2007)	17438146	177498	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8903	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	agonist	target	Haschemi A (2007)	17442976	177499	630	Adenosine	Adenosin|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Adenoscan|Deoxyadenosine|Adenocard|Adenocor|Adenosinum|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adnosine|Adenosina|Adenin riboside|Ade-rib|beta-D-Adenosine|Ado|Adenine deoxyribonucleoside|Adenyldeoxyriboside|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Desoxyadenosine	the prestige bb spf25 pa 2plus	DRUGBANK	DB00640	C10H13N5O4	small molecule	C01EB10	58-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-KQYNXXCUSA-N
8904	109895	3689	-	ITGB2	CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7	9606	Homo sapiens	unknown	target	Fujii T (2007)	17289088	177511	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8905	109895	3689	-	ITGB2	CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7	9606	Homo sapiens	unknown	target	Fujii T (2006)	16828882	177510	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8906	109895	3689	-	ITGB2	CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7	9606	Homo sapiens	unknown	target	Takahashi HK (2005)	15936988	177508	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8907	109895	3689	-	ITGB2	CD18|LAD|LCAMB|LFA-1|MAC-1|MF17|MFI7	9606	Homo sapiens	unknown	target	Katano H (2004)	15041742	177509	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8908	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Kocarek TA (2002)	12433810	177513	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8909	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Liu L (2003)	12852453	177512	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8910	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Pappu AS (2003)	12677170	177515	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8911	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Stoebner PE (2003)	12671581	177514	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8912	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Cenedella RJ (2003)	12518039	177516	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8913	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	631	Simvastatin	2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK-733|Zocor|Simvastatinum|Simvastatin|Simvastatine|Simvastatina|Synvinolin	septa-simvastatin|riva-simvast	DRUGBANK	DB00641	C25H38O5	small molecule	A10BH51|C10AA01|C10BX01|C10BA02|C10BA04|C10BX04	79902-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYMZZMVNJRMUDD-HGQWONQESA-N
8914	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Hanauske AR (2001)	11524555	177528	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8915	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Adjei AA (2001)	11742712	177529	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8916	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Schultz RM (2002)	11848474	177524	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8917	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Molina JR (2003)	14596699	177525	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8918	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Norman P (2001)	11763166	177526	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8919	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Adjei AA (2002)	12023793	177527	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8920	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Pivot X (2001)	11531245	177521	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8921	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Kindler HL (2002)	12571811	177522	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8922	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Adjei AA (2001)	11252887	177523	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8923	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Giovannetti E (2005)	15795320	176083	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8924	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8925	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Hanauske AR (2001)	11524555	177528	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8926	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Adjei AA (2001)	11742712	177529	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8927	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Schultz RM (2002)	11848474	177524	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8928	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Molina JR (2003)	14596699	177525	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8929	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Adjei AA (2002)	12023793	177527	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8930	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8931	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Kindler HL (2002)	12571811	177522	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8932	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Adjei AA (2001)	11252887	177523	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8933	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Giovannetti E (2005)	15795320	176083	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8934	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	inhibitor	target	Pivot X (2001)	11531245	177521	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8935	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Adjei AA (2002)	12023793	177527	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8936	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Hanauske AR (2001)	11524555	177528	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8937	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Adjei AA (2001)	11742712	177529	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8938	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Schultz RM (2002)	11848474	177524	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8939	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Molina JR (2003)	14596699	177525	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8940	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8941	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Mauritz R (2002)	11841783	177530	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8942	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Pivot X (2001)	11531245	177521	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8943	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Kindler HL (2002)	12571811	177522	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8944	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Adjei AA (2001)	11252887	177523	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8945	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Giovannetti E (2005)	15795320	176083	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8946	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Norman P (2001)	11763166	177526	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8947	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	inhibitor	target	Racanelli AC (2009)	19549896	177531	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8948	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	inhibitor	target	Hanauske AR (2001)	11524555	177528	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8949	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	inhibitor	target	Kindler HL (2002)	12571811	177522	632	Pemetrexed	-	alimta|pemetrexed|pemetrexed d	DRUGBANK	DB00642	C20H21N5O6	small molecule	L01BA04	137281-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
8950	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Lubega GW (1993)	8139621	177533	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8951	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Wampande EM (2007)	17662615	177537	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8952	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Oxberry ME (2001)	11444621	177536	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8953	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Ochola DO (2002)	12099434	177535	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8954	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8955	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	inhibitor	target	MacDonald LM (2004)	15500920	177534	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8956	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Lubega GW (1993)	8139621	177533	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8957	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Wampande EM (2007)	17662615	177537	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8958	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Oxberry ME (2001)	11444621	177536	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8959	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Ochola DO (2002)	12099434	177535	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8960	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8961	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	inhibitor	target	MacDonald LM (2004)	15500920	177534	633	Mebendazole	Vermox|(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester|Mebendazol|Mbendazole|Mebendazolum|MBDZ	vermox|vermox tablets 100 mg|m	DRUGBANK	DB00643	C16H13N3O3	small molecule	P02CA01|P02CA51	31431-39-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPXLLQIJSORQAM-UHFFFAOYSA-N
8962	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Moles G (2007)	16962597	177539	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8963	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Lee PA (2006)	17002488	177538	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8964	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8965	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Bliss SP (2007)	17068198	177542	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8966	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Mamputha S (2007)	16973761	177540	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8967	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Lu ZL (2005)	15967801	177541	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8968	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Li JH (2005)	15635044	177546	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8969	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Morgan K (2006)	16916952	177544	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8970	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Silver MR (2006)	16720727	177545	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8971	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Montagnani Marelli M (2006)	16712461	177543	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8972	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Mamputha S (2007)	16973761	177540	634	Gonadorelin	GnRH-I|Gonadoliberin I|Gonadorline|Gonadotropin-releasing hormone|Gonadorelin decapeptide|Gonadorelinum|Gonadorelin|Fertagyl|Gonadorelina|GnRH	factrel pws 500mcg/vial|reliso	DRUGBANK	DB00644	C55H75N17O13	small molecule	V04CM01|H01CA01	33515-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLXSAKCOAKORKW-UHFFFAOYSA-N
8973	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	635	Dyclonine	Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone	sucrets extra strength mint fl	DRUGBANK	DB00645	C18H27NO2	small molecule	N01BX02|R02AD04	586-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZEWSEKUUPWQDQ-UHFFFAOYSA-N
8974	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Roghani S (1999)	10355012	177547	635	Dyclonine	Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone	sucrets extra strength mint fl	DRUGBANK	DB00645	C18H27NO2	small molecule	N01BX02|R02AD04	586-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZEWSEKUUPWQDQ-UHFFFAOYSA-N
8975	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	635	Dyclonine	Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone	sucrets extra strength mint fl	DRUGBANK	DB00645	C18H27NO2	small molecule	N01BX02|R02AD04	586-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZEWSEKUUPWQDQ-UHFFFAOYSA-N
8976	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Tella SR (1998)	9476974	177548	635	Dyclonine	Dyclocaine|4'-Butoxy-3-piperidinopropiophenone|4-Butoxy-beta-piperidinopropiophenone|Dyclonin|Dycloninum|1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone|Dyclonine|4-N-Butoxy-beta-(1-piperidyl)propiophenone|3-Piperidino-4'-butoxypropiophenone|Diclonina|2-(1-Piperidyl)ethyl P-butoxyphenyl ketone	sucrets extra strength mint fl	DRUGBANK	DB00645	C18H27NO2	small molecule	N01BX02|R02AD04	586-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZEWSEKUUPWQDQ-UHFFFAOYSA-N
8977	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8978	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Neil A (1984)	6151117	177549	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8979	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Neil A (1984)	6151117	177549	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8980	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Picker MJ (1997)	9399970	177287	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8981	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8982	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Codd EE (1995)	7562497	176578	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8983	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Bannwarth B (2009)	19604717	177551	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8984	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Tyers MB (1980)	6249436	177550	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8985	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Ulens C (1999)	10690289	177553	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8986	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Walker EA (1999)	10379623	177552	637	Dextropropoxyphene	Dextropropoxyphne|Dextropropoxifeno|Dextropropoxyphenum|Destropropossifene|Dextropropoxyphen|d-Propoxyphene	692 tab|642 tab|692 tablet|pro	DRUGBANK	DB00647	C22H29NO2	small molecule	N02AC54|N02AC74|N02AC04	469-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLMALTXPSGQGBX-PEODTPIXNA-N
8987	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inducer	target	Lindhe O (2002)	11889204	177554	638	Mitotane	Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum	lysodren	DRUGBANK	DB00648	C14H10Cl4	small molecule	L01XX23	53-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWBOIMRXGHLCPP-UHFFFAOYSA-N
8988	108521	2230	-	FDX1	ADX|FDX|LOH11CR1D	9606	Homo sapiens	unknown	target	Cai W (1997)	9118466	177555	638	Mitotane	Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum	lysodren	DRUGBANK	DB00648	C14H10Cl4	small molecule	L01XX23	53-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWBOIMRXGHLCPP-UHFFFAOYSA-N
8989	108521	2230	-	FDX1	ADX|FDX|LOH11CR1D	9606	Homo sapiens	unknown	target	Cabrini DA (2001)	11159707	177557	638	Mitotane	Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum	lysodren	DRUGBANK	DB00648	C14H10Cl4	small molecule	L01XX23	53-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWBOIMRXGHLCPP-UHFFFAOYSA-N
8990	108521	2230	-	FDX1	ADX|FDX|LOH11CR1D	9606	Homo sapiens	unknown	target	Kandul SV (1986)	3770229	177556	638	Mitotane	Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum	lysodren	DRUGBANK	DB00648	C14H10Cl4	small molecule	L01XX23	53-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWBOIMRXGHLCPP-UHFFFAOYSA-N
8995	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
8996	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
8997	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Hariton C (1994)	7925603	177565	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
8998	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
8999	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9000	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Hariton C (1994)	7925603	177565	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9001	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Iancu L (1979)	225216	177566	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9002	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Schwabe U (1985)	2997628	177567	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9003	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9004	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9005	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Hariton C (1994)	7925603	177565	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9006	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Iancu L (1979)	225216	177566	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9007	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9008	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9009	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9010	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Hariton C (1994)	7925603	177565	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9011	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Iancu L (1979)	225216	177566	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9012	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Schwabe U (1985)	2997628	177567	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9013	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9014	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9015	118010	27115	RP11-472E5.2	PDE7B	bA472E5.1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9016	118010	27115	RP11-472E5.2	PDE7B	bA472E5.1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	641	Dyphylline	Diprophylline|7-(beta,gamma-Dihydroxypropyl)theophylline|(1,2-Dihydroxy-3-propyl)thiophyllin|1,3-Dimethyl-7-(2,3-dihydroxypropyl)xanthine|(+-)-Dyphylline|(+-)-Diprophylline|Diprophyllinum|Dyphylline|()-dyphylline|Diprofilina|()-diprophylline|(+-)-7-(2,3-Dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione|7-(,-dihydroxypropyl)theophylline|7-(2,3-Dihydroxypropyl)theophylline|Dihydroxypropyl theopylin|7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine	protophylline sup 500mg adulte	DRUGBANK	DB00651	C10H14N4O4	small molecule	R03DB01|R03DA01|R03DA51	479-18-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSCFJBIXMNOVSH-UHFFFAOYSA-N
9017	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Pal A (2007)	17622576	177568	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9018	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Mamolo MG (2008)	18069094	177569	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9019	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Chien CC (1995)	8788445	177572	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9020	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Colabufo NA (2009)	20021350	177571	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9021	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Dun Y (2007)	17898305	177570	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9022	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Chien CC (1995)	8788445	177572	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9023	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Picker MJ (1996)	8968334	176556	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9024	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Saha N (1990)	2286420	177575	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9025	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Martin BR (1984)	6094791	177574	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9026	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Levine JD (1988)	3419842	177573	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9027	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Kamei J (1994)	8042002	177576	642	Pentazocine	Pentazocin|Pentazocinum|Fortral|Pentazocine|Pentazocina	pentazocine hcl and acetaminop	DRUGBANK	DB00652	C19H27NO	small molecule	N02AD01	359-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKSWYLNZZRQPF-GDIGMMSISA-N
9028	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9029	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9030	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9031	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9032	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9033	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9034	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9035	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9036	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9037	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9038	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9039	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	643	Magnesium Sulfate	Magnesium sulfate (1:1)|Magnesiumsulfat|MgSO4|Magnesium sulfate anhydrous|Magnesium sulphate|Magnesium(ii) sulfate	eucalyptus scented natural eps	DRUGBANK	DB00653	MgO4S	small molecule	D11AX05|V04CC02|A06AD04|B05XA05|A12CC02	7487-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNNHWWHGAXBCP-UHFFFAOYSA-L
9040	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Takagi Y (2004)	15037111	177577	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9041	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9042	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Nakajima T (2003)	14646172	177579	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9043	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ocklind A (1998)	9733584	177578	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9044	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ota T (2005)	16249494	174971	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9045	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Maxey KM (2002)	12204699	177580	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9046	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	645	Estrone	Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone	oestrilin creme vaginale 1mg|e	DRUGBANK	DB00655	C18H22O2	small molecule	G03CA07|G03CC04	53-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNXHEGUUPJUMQT-CBZIJGRNSA-N
9047	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	645	Estrone	Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone	oestrilin creme vaginale 1mg|e	DRUGBANK	DB00655	C18H22O2	small molecule	G03CA07|G03CC04	53-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNXHEGUUPJUMQT-CBZIJGRNSA-N
9048	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Margeat E (2003)	12547192	177584	645	Estrone	Folliculin|Estrona|Estronum|Estrone|follicular hormone|3-Hydroxy-1,3,5(10)-estratrien-17-one|Oestrone	oestrilin creme vaginale 1mg|e	DRUGBANK	DB00655	C18H22O2	small molecule	G03CA07|G03CC04	53-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNXHEGUUPJUMQT-CBZIJGRNSA-N
9049	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9050	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Noguchi S (1992)	1353628	177589	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9051	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9052	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9053	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9054	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Pazzagli M (1999)	10594316	177591	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9055	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Marcoli M (2001)	11714900	177590	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9056	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Conn PJ (1987)	3039120	177593	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9057	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Marek GJ (1992)	1365657	177592	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9058	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Luparini MR (2004)	15610924	177594	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9059	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9060	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Odagaki Y (2005)	15888508	177596	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9061	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Subhash MN (2002)	12127910	177595	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9062	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Cusack B (1994)	7855217	175183	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9063	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9064	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9065	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9066	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Conn PJ (1987)	3039120	177593	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9067	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Fiorella D (1995)	7659770	177597	646	Trazodone	Trazodone|2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one|Trazodonum|Trazodona	penta-trazodone tablets|ratio-	DRUGBANK	DB00656	C19H22ClN5O	small molecule	N06AX05	19794-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLBKPHSAVXXEF-UHFFFAOYSA-N
9068	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	647	Mecamylamine	Versamine	mecamylamine hydrochloride|vec	DRUGBANK	DB00657	C11H21N	small molecule	C02BB01	60-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMYZQPCYWPFTAG-UHFFFAOYSA-N
9069	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Struthers AM (2009)	19778551	177602	647	Mecamylamine	Versamine	mecamylamine hydrochloride|vec	DRUGBANK	DB00657	C11H21N	small molecule	C02BB01	60-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMYZQPCYWPFTAG-UHFFFAOYSA-N
9070	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	647	Mecamylamine	Versamine	mecamylamine hydrochloride|vec	DRUGBANK	DB00657	C11H21N	small molecule	C02BB01	60-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMYZQPCYWPFTAG-UHFFFAOYSA-N
9071	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Shytle RD (2002)	12080428	177603	647	Mecamylamine	Versamine	mecamylamine hydrochloride|vec	DRUGBANK	DB00657	C11H21N	small molecule	C02BB01	60-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMYZQPCYWPFTAG-UHFFFAOYSA-N
9072	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	647	Mecamylamine	Versamine	mecamylamine hydrochloride|vec	DRUGBANK	DB00657	C11H21N	small molecule	C02BB01	60-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMYZQPCYWPFTAG-UHFFFAOYSA-N
9073	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9074	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9075	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9076	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9077	108842	2568	-	GABRP	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9078	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9079	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9080	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9081	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9082	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9083	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9084	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9085	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9086	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9087	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9088	108838	2564	-	GABRE	-	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9089	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9090	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9091	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9092	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9093	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9094	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9095	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9096	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9097	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9098	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9099	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9100	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9101	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9102	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9103	109172	2915	-	GRM5	GPRC1E|MGLUR5|PPP1R86|mGlu5	9606	Homo sapiens	antagonist	target	De Witte P (2005)	15963001	177611	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9104	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9105	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9106	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9107	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9108	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9109	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Morel N (1998)	9846638	175854	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9110	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Patel MK (2005)	15880143	177614	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9111	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Dilmac N (2004)	15286207	177615	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9112	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9113	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9114	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Freeze BS (2006)	16699084	177616	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9115	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Tatsumi M (1997)	9537821	174430	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9116	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Brown NL (1986)	2940099	177617	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9117	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9118	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9119	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9120	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9121	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Shigeto M (2007)	17409272	177618	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9122	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Yamada S (2006)	17038430	177619	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9123	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9124	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Duan JJ (2007)	17588331	177623	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9125	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Cheng HC (2006)	16507347	177622	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9126	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Shimizu W (2005)	15892662	177621	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9127	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Schneider J (2005)	15814090	177620	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9128	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Ridley JM (2004)	15135665	177624	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9129	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9130	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	unknown	target	Milberg P (2005)	15944809	177625	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9131	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Tfelt-Hansen P (2009)	19125880	177613	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9132	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9133	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	651	Verapamil	D-365|Verapamil|Vrapamil|Verapamilo|Iproveratril|Tarka|CP-16533-1|Isoptin sr|Calan sr|CP-165331|Isoptin|Verelan|Covera-hs|Calan|Verapamilum	verapamil hydrochloride inject	DRUGBANK	DB00661	C27H38N2O4	small molecule	C08DA01|C08DA51|C09BB10	52-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGTNSNPWRIOYBX-UHFFFAOYSA-N
9134	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9135	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Labeur M (2010)	20920967	174580	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9136	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9137	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Maier C (2005)	16079279	177640	653	Flumethasone	Flumtasone|Flumetasone|Flumetasona|Flumetason|Flumetasonum	locacorten vioform|locasalen|l	DRUGBANK	DB00663	C22H28F2O5	small molecule	D07CB05|S02CA02|D07BB01|D07AB03|D07XB01	2135-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXURHACBFYSXBI-GQKYHHCASA-N
9138	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9139	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Brawer MK (2006)	16986000	177645	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9140	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Schasfoort EM (2002)	12497048	177644	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9141	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Moguilewsky M (1987)	3320565	177647	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9142	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Kaisary AV (2002)	12497018	177646	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9143	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Raynaud JP (1984)	6374639	177643	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9144	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Raynaud JP (1988)	3071951	177642	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9145	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Labrie F (2010)	20541672	177649	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9146	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Kolvenbag GJ (1998)	12496872	177648	655	Nilutamide	Nilandron|Nilutamide|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|Nilutamidum|Nilutamida	anandron tab 50mg|nilutamide|a	DRUGBANK	DB00665	C12H10F3N3O4	small molecule	L02BB02	63612-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWXYUMMDTVBTOU-UHFFFAOYSA-N
9147	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9148	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Valle RF (2003)	14644830	177656	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9149	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Hugues JN (1998)	9622415	177657	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9150	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Suh J (2004)	14687742	177654	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9151	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Batzer FR (2006)	17097577	177655	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9152	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Saltiel E (1991)	1830521	177652	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9153	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Barbieri RL (1990)	2137975	177653	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9154	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Garner C (1994)	7996307	177651	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9155	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Chrisp P (1990)	2140979	177658	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9156	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	agonist	target	Letassy NA (1990)	2151003	177659	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9157	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9158	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9159	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Valle RF (2003)	14644830	177656	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9160	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Hugues JN (1998)	9622415	177657	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9161	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Suh J (2004)	14687742	177654	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9162	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Batzer FR (2006)	17097577	177655	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9163	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Saltiel E (1991)	1830521	177652	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9164	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Barbieri RL (1990)	2137975	177653	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9165	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Garner C (1994)	7996307	177651	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9166	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Chrisp P (1990)	2140979	177658	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9167	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	agonist	target	Letassy NA (1990)	2151003	177659	656	Nafarelin	Nafarelin|Nafarelina|Nafarline|Nafarelinum	synarel nas sol 2mg/ml|synarel	DRUGBANK	DB00666	C66H83N17O13	small molecule	H01CA02	76932-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHUEXWOYVBUCI-ITQXDASVSA-N
9168	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Francis H (2007)	17334413	117236	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9169	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9170	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Soga F (2007)	17359382	177660	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9171	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Miyoshi K (2006)	16648669	177664	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9172	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Tanimoto A (2007)	17478759	177663	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9173	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Han SK (2006)	17114052	177662	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9174	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Suzuki K (2007)	17336292	177661	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9175	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Spahr L (2007)	17222324	176854	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9176	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	agonist	target	Minick DJ (2007)	17575572	177667	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9177	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	agonist	target	Arrang JM (2007)	17652997	177666	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9178	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	agonist	target	Petroianu G (2006)	16599255	177665	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9179	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	agonist	target	Garduno-Torres B (2006)	16715497	177668	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9180	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	agonist	target	Yu B (2010)	20618322	177670	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9181	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	agonist	target	Cowden JM (2010)	20573261	177671	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9182	121882	59340	-	HRH4	AXOR35|BG26|GPCR105|GPRv53|H4|H4R|HH4R	9606	Homo sapiens	agonist	target	Blaya B (2010)	20632959	177669	657	Histamine Phosphate	4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)|Histamine diphosphate|Histamine phosphate (1:2)|Histaminum|Histamine acid phosphate|Histamine dihydrogen phosphate|4-(2-Aminoethyl)imidazole di-acid phosphate|Histamine biphosphate	histamine positive skin test c	DRUGBANK	DB00667	C5H15N3O8P2	small molecule	V04CG03	51-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHIBQGJKHVBLJJ-UHFFFAOYSA-N
9183	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ozakca I (2007)	17622774	176145	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9184	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lucin KM (2007)	17597612	176144	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9185	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9186	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Prenner L (2007)	17417877	176146	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9187	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Rudling JE (2000)	11053214	175571	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9188	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9189	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Vizi ES (2001)	11728431	175568	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9190	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Gobbi M (1990)	1979424	175569	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9191	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Nash DT (1990)	1980236	175570	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9192	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Tomiyama Y (2007)	17658513	175725	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9193	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Sanbe A (2007)	17603545	176147	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9194	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Du L (2010)	20412040	177674	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9195	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Jensen BC (2010)	20857090	177675	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9196	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Du L (2010)	20412040	177674	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9197	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Jensen BC (2010)	20857090	177675	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9198	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Cotecchia S (2010)	20954794	177676	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9199	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Shieh JP (2009)	19730427	177677	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9200	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	antagonist	target	Erlandsen H (1998)	9843368	177678	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9201	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Du L (2010)	20412040	177674	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9202	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Jensen BC (2010)	20857090	177675	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9203	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Cotecchia S (2010)	20954794	177676	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9204	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Shieh JP (2009)	19730427	177677	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9205	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antagonist	target	van der Poll T (1996)	8609227	177679	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9206	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Ozakca I (2007)	17622774	176145	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9207	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Leineweber K (2007)	17541557	177680	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9208	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9209	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9210	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Nash DT (1990)	1980236	175570	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9211	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Hieble JP (1998)	9836297	175588	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9212	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	MacLennan SJ (2000)	10742288	175589	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9213	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Nyroenen T (2001)	11306720	175591	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9214	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Giovannoni MP (2009)	18680204	175590	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9215	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Bylund DB (1992)	1346768	177681	658	Epinephrine	(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol|Epinefrin|Epinephrinum|(-)-(R)-Epinephrine|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol|L-Adrenaline|(R)-()-adrenaline|Epinephrine|Epinefrina|Primatene|()-adrenaline|(R)-(-)-Adrenaline|Adrenaline|(-)-Adrenaline|(R)-(-)-Epirenamine|levoepinephrine|(R)-(-)-Adnephrine|Epinephrin|Adrenalin|(R)-(-)-Epinephrine	dentsply 2% lidocaine with epi	DRUGBANK	DB00668	C9H13NO3	small molecule	A01AD01|B02BC09|C01CA24|S01EA01|R03AA01|R03AK01|S01EA51|R01AA14	51-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCTWMZQNUQWSLP-VIFPVBQESA-N
9216	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Mitsikostas DD (2002)	12110114	177691	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9217	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9218	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Zohar J (2004)	15554784	177690	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9219	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Nikai T (2008)	18723285	177683	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9220	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Cohen ML (1999)	10454495	177682	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9221	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Roy A (2000)	10772044	177685	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9222	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Baxter LR (2001)	11641558	177684	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9223	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Razzaque Z (2002)	11874390	177687	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9224	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Akin D (2002)	12010765	177686	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9225	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Koran LM (2001)	11313163	177689	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9226	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Mitsikostas DD (1999)	10225363	177688	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9227	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Johnson DE (2001)	11513839	174444	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9228	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9229	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Janssen P (2004)	15178373	177692	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9230	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Pauwels PJ (1999)	10367177	177693	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9231	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Nikai T (2008)	18723285	177683	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9232	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Mitsikostas DD (2002)	12110114	177691	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9233	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Razzaque Z (1999)	10073743	177694	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9234	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Cohen ML (2000)	11015308	177695	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9235	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Mitsikostas DD (1999)	10225363	177688	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9236	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Mitsikostas DD (2002)	12110114	177691	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9237	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9238	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Nikai T (2008)	18723285	177683	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9239	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Cohen ML (1999)	10454495	177682	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9240	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Granaes C (1999)	10513577	177696	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9241	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Cohen Z (1999)	10458598	177697	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9242	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Razzaque Z (2002)	11874390	177687	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9243	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Akin D (2002)	12010765	177686	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9244	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Roy A (2000)	10772044	177685	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9245	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Mitsikostas DD (1999)	10225363	177688	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9246	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Dupuis DS (1999)	10101238	177698	659	Sumatriptan	Sumatriptan|3-[2-(dimethylamino)Ethyl]-N-methylindole-5-methanesulfonamide|(3-[2-(dimethylamino)Ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|Sumatriptanum|3-(2-(dimethylamino)Ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Sumatriptn|Imigran|Sumax|Sumatriptan Succinate|NP101|Sumatran|Imitrex|1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|triptan	phl-sumatriptan|sumavel dosepr	DRUGBANK	DB00669	C14H21N3O2S	small molecule	N02CC01	103628-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQKPFRSPSRPDEB-UHFFFAOYSA-N
9247	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Pedretti RF (2003)	12717096	177702	660	Pirenzepine	Pirenzpine|Pirenzepinum|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|Pirenzepina|Pirenzepin	gastrozepin tab 50mg	DRUGBANK	DB00670	C19H21N5O2	small molecule	A02BX03	28797-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMHMFHUVIITRHF-UHFFFAOYSA-N
9248	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	660	Pirenzepine	Pirenzpine|Pirenzepinum|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|Pirenzepina|Pirenzepin	gastrozepin tab 50mg	DRUGBANK	DB00670	C19H21N5O2	small molecule	A02BX03	28797-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMHMFHUVIITRHF-UHFFFAOYSA-N
9249	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Mizuno CS (2008)	18220763	177706	662	Chlorpropamide	N-Propyl-n'-(P-chlorobenzenesulfonyl)urea|N-(P-Chlorobenzenesulfonyl)-n'-propylurea|Chlorpropamide|4-chloro-N-((Propylamino)carbonyl)benzenesulfonamide|N-Propyl-n'-P-chlorophenylsulfonylcarbamide|1-(P-Chlorobenzenesulfonyl)-3-propylurea|1-(P-Chlorophenylsulfonyl)-3-propylurea|Chlorpropamidum|Clorpropamida|N-(4-Chlorophenylsulfonyl)-n'-propylurea|Chlorpropamid|1-Propyl-3-(P-chlorobenzenesulfonyl)urea|4-chloro-N-[(Propylamino)carbonyl]benzenesulfonamide	chlorpropamide|apo chlorpropam	DRUGBANK	DB00672	C10H13ClN2O3S	small molecule	A10BB02	94-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKWGIWYCVPQPMF-UHFFFAOYSA-N
9250	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	663	Aprepitant	3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum	emend|aprepitant|emend tri-pac	DRUGBANK	DB00673	C23H21F7N4O3	small molecule	A04AD12	170729-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATALOFNDEOCMKK-OITMNORJSA-N
9251	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Bergstroem M (2004)	15121485	177709	663	Aprepitant	3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum	emend|aprepitant|emend tri-pac	DRUGBANK	DB00673	C23H21F7N4O3	small molecule	A04AD12	170729-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATALOFNDEOCMKK-OITMNORJSA-N
9252	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Brands KM (2003)	12590540	177713	663	Aprepitant	3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum	emend|aprepitant|emend tri-pac	DRUGBANK	DB00673	C23H21F7N4O3	small molecule	A04AD12	170729-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATALOFNDEOCMKK-OITMNORJSA-N
9253	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Rodgers J (2007)	17643344	177712	663	Aprepitant	3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum	emend|aprepitant|emend tri-pac	DRUGBANK	DB00673	C23H21F7N4O3	small molecule	A04AD12	170729-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATALOFNDEOCMKK-OITMNORJSA-N
9254	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Poli-Bigelli S (2003)	12784346	177711	663	Aprepitant	3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum	emend|aprepitant|emend tri-pac	DRUGBANK	DB00673	C23H21F7N4O3	small molecule	A04AD12	170729-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATALOFNDEOCMKK-OITMNORJSA-N
9255	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Zhao MM (2002)	12227806	177710	663	Aprepitant	3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one|Aprpitant|Aprepitant|Aprepitantum	emend|aprepitant|emend tri-pac	DRUGBANK	DB00673	C23H21F7N4O3	small molecule	A04AD12	170729-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATALOFNDEOCMKK-OITMNORJSA-N
9256	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Blesa R (2000)	10971049	177720	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9257	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9258	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Greenblatt HM (1999)	10606746	177721	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9259	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9260	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9261	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Tonkopii VD (1976)	1026294	177722	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9262	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Guillou C (2000)	10762042	177723	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9263	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9264	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9265	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Stahl SM (2000)	11078030	177717	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9266	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9267	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9268	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9269	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9270	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9271	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9272	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9273	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9274	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9275	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9276	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9277	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9278	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9279	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9280	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9281	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9282	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9283	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9284	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9285	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9286	107568	1146	-	CHRNG	ACHRG	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9287	107568	1146	-	CHRNG	ACHRG	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9288	107568	1146	-	CHRNG	ACHRG	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9289	107568	1146	-	CHRNG	ACHRG	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9290	107568	1146	-	CHRNG	ACHRG	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9291	107568	1146	-	CHRNG	ACHRG	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9292	107567	1145	-	CHRNE	ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9293	107567	1145	-	CHRNE	ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9294	107567	1145	-	CHRNE	ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9295	107567	1145	-	CHRNE	ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9296	107567	1145	-	CHRNE	ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9297	107567	1145	-	CHRNE	ACHRE|CMS1D|CMS1E|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9298	121345	57053	-	CHRNA10	-	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9299	121345	57053	-	CHRNA10	-	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9300	121345	57053	-	CHRNA10	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9301	121345	57053	-	CHRNA10	-	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9302	121345	57053	-	CHRNA10	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9303	121345	57053	-	CHRNA10	-	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9304	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Giacobini E (2002)	11888344	177726	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9305	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Svoboda Z (2006)	17159811	177727	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9306	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Wilkinson DG (2001)	19811027	177728	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9307	107564	1142	-	CHRNB3	-	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9308	107564	1142	-	CHRNB3	-	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9309	107564	1142	-	CHRNB3	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9310	107564	1142	-	CHRNB3	-	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9311	107564	1142	-	CHRNB3	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9312	107564	1142	-	CHRNB3	-	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9313	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9314	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9315	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9316	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9317	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9318	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9319	107562	1140	-	CHRNB1	ACHRB|CHRNB|CMS1D|CMS2A|SCCMS	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9320	107562	1140	-	CHRNB1	ACHRB|CHRNB|CMS1D|CMS2A|SCCMS	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9321	107562	1140	-	CHRNB1	ACHRB|CHRNB|CMS1D|CMS2A|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9322	107562	1140	-	CHRNB1	ACHRB|CHRNB|CMS1D|CMS2A|SCCMS	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9323	107562	1140	-	CHRNB1	ACHRB|CHRNB|CMS1D|CMS2A|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9324	107562	1140	-	CHRNB1	ACHRB|CHRNB|CMS1D|CMS2A|SCCMS	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9325	107566	1144	-	CHRND	ACHRD|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9326	107566	1144	-	CHRND	ACHRD|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9327	107566	1144	-	CHRND	ACHRD|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9328	107566	1144	-	CHRND	ACHRD|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9329	107566	1144	-	CHRND	ACHRD|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9330	107566	1144	-	CHRND	ACHRD|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9331	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9332	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9333	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9334	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9335	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9336	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9337	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9338	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9339	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9340	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9341	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9342	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9343	107557	1135	-	CHRNA2	-	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9344	107557	1135	-	CHRNA2	-	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9345	107557	1135	-	CHRNA2	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9346	107557	1135	-	CHRNA2	-	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9347	107557	1135	-	CHRNA2	-	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9348	107557	1135	-	CHRNA2	-	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9349	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9350	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9351	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9352	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9353	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9354	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9355	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9356	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9357	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9358	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9359	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9360	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9361	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	allosteric modulator	target	Guillou C (2000)	20480924	177724	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9362	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	allosteric modulator	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9363	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2000)	10971048	177719	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9364	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	allosteric modulator	target	Woodruff-Pak DS (2002)	12481195	177718	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9365	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	allosteric modulator	target	Lilienfeld S (2002)	12177686	177716	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9366	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	allosteric modulator	target	Olin J (2002)	12137632	177715	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
9367	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Mc Ilroy M (2006)	17158759	131588	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9368	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9369	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9370	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Hayes DF (2010)	20827267	177731	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9371	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Gruvberger-Saal SK (2007)	17404078	177730	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9372	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Girault I (2006)	16822624	177733	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9373	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Horner-Glister E (2005)	16326830	177732	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9374	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Chen B (2005)	16010412	177729	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9375	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Mc Ilroy M (2006)	17158759	131588	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9376	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9377	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9378	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Hayes DF (2010)	20827267	177731	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9379	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Gruvberger-Saal SK (2007)	17404078	177730	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9380	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Girault I (2006)	16822624	177733	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9381	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Horner-Glister E (2005)	16326830	177732	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9382	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	antagonist	target	Chen B (2005)	16010412	177729	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9383	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fabian CJ (2002)	11906441	177735	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9384	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9385	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9386	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Cyrus K (2010)	20512796	177734	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9387	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Fabian CJ (2002)	11906441	177735	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9388	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Sasson S (1991)	2011412	177583	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9389	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9390	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Cyrus K (2010)	20512796	177734	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9391	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9392	111576	5590	RP11-181G12.1	PRKCZ	PKC-ZETA|PKC2	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9393	111570	5584	-	PRKCI	DXS1179E|PKCI|nPKC-iota	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9394	111566	5580	-	PRKCD	ALPS3|CVID9|MAY1|PKCD|nPKC-delta	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9395	111568	5582	-	PRKCG	PKC-gamma|PKCC|PKCG|SCA14	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9396	111567	5581	-	PRKCE	PKCE|nPKC-epsilon	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9397	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9398	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	O'Brian CA (1985)	3157445	177736	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9399	115921	10682	-	EBP	CDPX2|CHO2|CPX|CPXD	9606	Homo sapiens	unknown	target	Paul R (1998)	9618436	177737	665	Tamoxifen	1-P-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Citofen|Valodex|Tamoxifene|Tamoxifeno|Nourytam|(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine|Crisafeno|Tamone|1-Para-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene|Retaxim|Tamoxifenum|Apo-tamox|Tamoxifne|Zemide|Istubol|Noltam|Diemon|Tamofen|trans-Tamoxifen|Tamoxasta|Oncomox|Tamoxifen|Gen-tamoxifen|(Z)-2-(Para-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine	pms-tamoxifen|tamone  -  (20 m	DRUGBANK	DB00675	C26H29NO	small molecule	L02BA01	10540-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKANXQFJJICGDU-QPLCGJKRSA-N
9400	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	da Costa VL (2001)	11350858	177753	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9401	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Quistad GB (2000)	10898598	177752	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9402	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Pang YP (2003)	12837382	177751	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9403	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Ashani Y (1990)	1692236	177750	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9404	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9405	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Malatova Z (1999)	10378121	177749	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9406	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Kelly SS (1990)	2361169	177758	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9407	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Acey RA (2002)	12459190	177757	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9408	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Pittel Z (1992)	1511344	177756	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9409	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Kamata R (2001)	11405252	177755	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9410	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Miller RB (1991)	1776688	177754	667	Isoflurophate	Isopropyl fluophosphate|Diisopropyl Fluorophosphonate|Diisopropoxyphosphoryl Fluoride|Diisopropyl Phosphofluoridate|Diisopropylfluorophosphoric acid ester|Diisopropyl fluorophosphate|Diisopropylfluorophosphate|Isoflurophosphate|DFP|Diisopropyl Phosphorofluoridate|Diisopropylphosphorofluoridate|Fluorodiisopropyl Phosphate|Isopropyl Phosphorofluoridate|Isoflurophate|Neoglaucit|Fluorostigmine|Diisopropylphosphofluoridate|O,O'-diisopropyl phosphoryl fluoride|Isofluorphate	-	DRUGBANK	DB00677	C6H14FO3P	small molecule	-	55-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCZHBLJLSDCSD-UHFFFAOYSA-N
9411	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9412	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Sardo MA (2004)	15026875	177762	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9413	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Anand-Srivastava MB (2003)	12710529	177763	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9414	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Rocha I (2003)	12719755	177760	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9415	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Dickstein K (1998)	15991937	177761	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9416	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Guan J (2004)	15573751	177764	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9417	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (1990)	1978482	177771	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9418	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Barth VN (2006)	16434058	177773	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9419	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Assie MB (1993)	7689973	177772	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9420	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Carey GJ (1997)	9292626	177775	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9421	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dimpfel W (1992)	1352051	177774	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9422	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9423	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9424	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9425	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Hammock RG (1995)	8720030	177776	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9426	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Morisset S (1999)	9918563	177779	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9427	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Andree TH (1986)	2866233	177778	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9428	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Burki HR (1986)	2423886	177780	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9429	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Canton H (1994)	7898773	177777	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9430	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Costall B (1995)	8680734	177781	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9431	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Milnes JT (2006)	17056009	177782	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9432	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9433	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9434	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9435	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ahmmed GU (2002)	12402511	177783	670	Moricizine	Moracizina|EN-313|Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate|Moracizin|Ethmozin|Moricizine|Moracizinum|Etmozin|[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester|Ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate|Moracizine	-	DRUGBANK	DB00680	C22H25N3O4S	small molecule	C01BG01	31883-05-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUBVWMNBEHXPSU-UHFFFAOYSA-N
9436	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Zhu Y (2007)	17510308	177788	672	Warfarin	Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin	coumadin tab 3mg|taro-warfarin	DRUGBANK	DB00682	C19H16O4	small molecule	B01AA03	81-81-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-UHFFFAOYNA-N
9437	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	672	Warfarin	Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin	coumadin tab 3mg|taro-warfarin	DRUGBANK	DB00682	C19H16O4	small molecule	B01AA03	81-81-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-UHFFFAOYNA-N
9438	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Yin T (2006)	17161452	177784	672	Warfarin	Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin	coumadin tab 3mg|taro-warfarin	DRUGBANK	DB00682	C19H16O4	small molecule	B01AA03	81-81-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-UHFFFAOYNA-N
9439	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Gebauer M (2007)	17275317	177785	672	Warfarin	Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin	coumadin tab 3mg|taro-warfarin	DRUGBANK	DB00682	C19H16O4	small molecule	B01AA03	81-81-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-UHFFFAOYNA-N
9440	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Limdi NA (2008)	17653141	177786	672	Warfarin	Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin	coumadin tab 3mg|taro-warfarin	DRUGBANK	DB00682	C19H16O4	small molecule	B01AA03	81-81-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-UHFFFAOYNA-N
9441	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Osman A (2007)	17413769	177787	672	Warfarin	Coumafene|4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin|Zoocoumarin	coumadin tab 3mg|taro-warfarin	DRUGBANK	DB00682	C19H16O4	small molecule	B01AA03	81-81-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-UHFFFAOYNA-N
9442	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9443	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9444	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9445	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9446	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9447	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9448	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9449	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9450	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9451	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9452	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9453	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9454	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9455	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9456	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9457	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9458	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9459	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9460	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9461	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9462	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9463	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9464	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9465	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9466	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9467	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9468	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9469	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9470	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9471	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9472	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9473	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9474	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9475	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9476	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9477	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9478	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9479	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9480	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	674	Tobramycin	Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum	tobrex ophthalmic ont 3mg/gm|t	DRUGBANK	DB00684	C18H37N5O9	small molecule	S01AA12|J01GB01	32986-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLVFBUXFDBBNBW-PBSUHMDJSA-N
9481	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	674	Tobramycin	Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum	tobrex ophthalmic ont 3mg/gm|t	DRUGBANK	DB00684	C18H37N5O9	small molecule	S01AA12|J01GB01	32986-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLVFBUXFDBBNBW-PBSUHMDJSA-N
9482	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Yang G (2006)	16942021	177803	674	Tobramycin	Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum	tobrex ophthalmic ont 3mg/gm|t	DRUGBANK	DB00684	C18H37N5O9	small molecule	S01AA12|J01GB01	32986-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLVFBUXFDBBNBW-PBSUHMDJSA-N
9483	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Gill AE (2004)	15332709	177802	674	Tobramycin	Tobrex (tn)|Nebramycin 6|Tobracin (tn)|Tobramycin|Tobramycine|Nebramycin-Faktor 6|O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine|Nebramycin factir 6|Tobramicina|3'-Deoxykanamycin b|Tobramycinum	tobrex ophthalmic ont 3mg/gm|t	DRUGBANK	DB00684	C18H37N5O9	small molecule	S01AA12|J01GB01	32986-56-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLVFBUXFDBBNBW-PBSUHMDJSA-N
9484	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	675	Trovafloxacin	-	trovan tablets 200mg|trovan ta	DRUGBANK	DB00685	C20H15F3N4O3	small molecule	J01MA13	147059-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVPSKSLAZQPAKQ-CDMJZVDBSA-N
9485	108540	2249	-	FGF4	HBGF-4|HST|HST-1|HSTF1|K-FGF|KFGF	9606	Homo sapiens	inhibitor	target	Zugmaier G (1992)	1279186	177810	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9486	108540	2249	-	FGF4	HBGF-4|HST|HST-1|HSTF1|K-FGF|KFGF	9606	Homo sapiens	inhibitor	target	Wellstein A (1991)	1708834	177809	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9487	108540	2249	-	FGF4	HBGF-4|HST|HST-1|HSTF1|K-FGF|KFGF	9606	Homo sapiens	inhibitor	target	McLeskey SW (1996)	8738610	177808	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9488	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Zugmaier G (2000)	10667230	177811	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9489	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Pluda JM (1993)	7692072	177812	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9490	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Mucha S (2002)	12375053	177813	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9491	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	Jerebtsova M (2007)	17071728	177814	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9492	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	antagonist	target	McLeskey SW (1996)	8738610	177808	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9493	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	antagonist	target	Jerebtsova M (2007)	17071728	177814	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9494	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	antagonist	target	Pascu C (1996)	8867461	177815	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9495	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	antagonist	target	Zenjari C (1996)	8946244	177816	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
9496	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Oelkers W (1994)	8157723	177818	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9497	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Young MJ (1996)	8733007	177819	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9498	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9499	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Otte C (2003)	12888122	177821	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9500	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Buckley TM (2007)	17666187	177820	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9501	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Kingsley-Kallesen M (2002)	12198239	177817	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9502	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Matias PM (2002)	11906285	177823	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9503	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Krishnan AV (2002)	11956172	177822	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9504	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Trune DR (2010)	20800906	177824	677	Fludrocortisone	9alpha-FLUOROCORTISOL|Fludrocortisone|Fludrocortisona|Fludrocortisonum|Fluohydrocortisone|Fludrocortison	florinef acetate 0.1mg|fludroc	DRUGBANK	DB00687	C21H29FO5	small molecule	H02AA02|S02CA07|S03CA05|S01CA06	127-31-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAXVEMMRQDVLJB-BULBTXNYSA-N
9505	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Bremer S (2007)	17463174	177825	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9506	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9507	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Vannozzi F (2004)	15621150	177826	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9508	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Wang J (2008)	17851563	177828	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9509	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Bremer S (2007)	17463174	177825	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9510	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Sanquer S (2008)	17713475	177827	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9511	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9512	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9513	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	678	Mycophenolate mofetil	Mycophenolic acid morpholinoethyl ester|2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate|MMF|Cellcept|RS 61443	accel-mycophenolate mofetil ta	DRUGBANK	DB00688	C23H31NO7	small molecule	-	128794-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTGDFNSFWBGLEC-SYZQJQIISA-N
9514	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9515	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9516	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9517	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9518	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9519	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9520	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9521	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9522	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9523	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9524	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9525	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9526	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9527	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9528	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9529	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9530	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9531	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9532	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9533	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9534	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9535	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9536	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9537	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9538	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9539	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9540	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9541	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9542	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9543	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9544	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9545	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9546	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9547	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9548	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9549	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9550	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9551	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9552	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chrysant SG (2004)	15286086	177842	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9553	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Edling O (1995)	7473177	177841	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9554	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9555	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9556	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Chrysant SG (2004)	15286086	177842	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9557	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Edling O (1995)	7473177	177841	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9558	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9559	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9560	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Bylund DB (1992)	1346768	177681	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9561	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Giussani DA (1995)	7562640	177849	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9562	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Vonend O (2007)	17115069	177848	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9563	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Polak J (2005)	16273345	177843	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9564	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Blandizzi C (2003)	12770936	177847	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9565	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Molderings GJ (2000)	10988273	177846	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9566	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Trendelenburg AU (2003)	12721093	177845	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9567	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Saeed M (1982)	6176798	177844	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9568	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Bylund DB (1992)	1346768	177681	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9569	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Giussani DA (1995)	7562640	177849	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9570	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Saeed M (1982)	6176798	177844	682	Phentolamine	Phentolamine mesylate|Regitina|Phentolamine|Regitine|Phentolaminum|Vesomax|Fentolamina|Phentolamin|Rogitine|2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline	rogitine 5mg/vial|phentolamine	DRUGBANK	DB00692	C17H19N3O	small molecule	V03AB36|C04AB01	50-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRBDMNSDAVCSSF-UHFFFAOYSA-N
9571	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Aubel-Sadron G (1984)	6380596	177851	684	Daunorubicin	Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine	daunoxome|cerubidine 20mg/vial	DRUGBANK	DB00694	C27H29NO10	small molecule	L01DB02	20830-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STQGQHZAVUOBTE-VGBVRHCVSA-N
9572	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Zunino F (1990)	1963303	177852	684	Daunorubicin	Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine	daunoxome|cerubidine 20mg/vial	DRUGBANK	DB00694	C27H29NO10	small molecule	L01DB02	20830-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STQGQHZAVUOBTE-VGBVRHCVSA-N
9573	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	inhibitor	target	Aubel-Sadron G (1984)	6380596	177851	684	Daunorubicin	Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine	daunoxome|cerubidine 20mg/vial	DRUGBANK	DB00694	C27H29NO10	small molecule	L01DB02	20830-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STQGQHZAVUOBTE-VGBVRHCVSA-N
9574	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	inhibitor	target	Zunino F (1990)	1963303	177852	684	Daunorubicin	Daunorubicinum|(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione|(+)-Daunomycin|Daunorubicin|Daunomycin|Acetyladriamycin|Leukaemomycin C|Rubidomycin|Daunorubicina|Daunorubicine	daunoxome|cerubidine 20mg/vial	DRUGBANK	DB00694	C27H29NO10	small molecule	L01DB02	20830-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STQGQHZAVUOBTE-VGBVRHCVSA-N
9575	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	685	Furosemide	Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid	lasix injection 10mg/ml|apo fu	DRUGBANK	DB00695	C12H11ClN2O5S	small molecule	C03EB01|C03CB01|C03CA01	54-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZUFCTLCJUWOSV-UHFFFAOYSA-N
9576	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Vormfelde SV (2007)	17460608	174425	685	Furosemide	Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid	lasix injection 10mg/ml|apo fu	DRUGBANK	DB00695	C12H11ClN2O5S	small molecule	C03EB01|C03CB01|C03CA01	54-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZUFCTLCJUWOSV-UHFFFAOYSA-N
9577	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	685	Furosemide	Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid	lasix injection 10mg/ml|apo fu	DRUGBANK	DB00695	C12H11ClN2O5S	small molecule	C03EB01|C03CB01|C03CA01	54-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZUFCTLCJUWOSV-UHFFFAOYSA-N
9578	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Brater DC (2000)	10653443	177874	685	Furosemide	Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid	lasix injection 10mg/ml|apo fu	DRUGBANK	DB00695	C12H11ClN2O5S	small molecule	C03EB01|C03CB01|C03CA01	54-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZUFCTLCJUWOSV-UHFFFAOYSA-N
9579	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Davies DL (1975)	1092541	177873	685	Furosemide	Furosemide|Furosemid|4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid|4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid|Frusemide|Lasix (tn)|2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid|Furosemidum|Furosemidu|Furosemida|4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid	lasix injection 10mg/ml|apo fu	DRUGBANK	DB00695	C12H11ClN2O5S	small molecule	C03EB01|C03CB01|C03CA01	54-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZUFCTLCJUWOSV-UHFFFAOYSA-N
9580	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Larson BT (1995)	7665369	177878	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9581	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Verhoeff NP (1993)	8242725	177879	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9582	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9583	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9584	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9585	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9586	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	partial agonist	target	Goernemann T (2008)	18066532	177880	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9587	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	partial agonist	target	Goernemann T (2008)	18066532	177880	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9588	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Willems EW (1999)	10455274	175179	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9589	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Villalon CM (1999)	10188968	177882	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9590	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Valdivia LF (2004)	15224175	177881	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9591	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Cohen ML (2000)	11015308	177695	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9592	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9593	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	partial agonist	target	Goernemann T (2008)	18066532	177880	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9594	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Bom AH (1989)	2758221	177885	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9595	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Panconesi A (1994)	8014033	177884	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9596	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9597	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9598	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9599	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9600	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9601	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9602	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Sanchez-Lopez A (2003)	14504136	177887	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9603	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Lovenberg TW (1993)	8384716	177886	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9604	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Silberstein SD (2003)	12558771	175176	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9605	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Deliganis AV (1991)	1646776	177888	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9606	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Hoyer D (1992)	1407010	175172	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9607	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9608	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9609	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	partial agonist	target	Goernemann T (2008)	18066532	177880	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9610	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9611	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9612	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Bigal ME (2003)	12525272	177883	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9613	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Piletz JE (1996)	8930173	177889	687	Tizanidine	Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin	tizanidine hydrochloride|zanaf	DRUGBANK	DB00697	C9H8ClN5S	small molecule	M03BX02	51322-75-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFYDIVBRZNQMJC-UHFFFAOYSA-N
9614	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Piletz JE (1996)	8930173	177889	687	Tizanidine	Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin	tizanidine hydrochloride|zanaf	DRUGBANK	DB00697	C9H8ClN5S	small molecule	M03BX02	51322-75-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFYDIVBRZNQMJC-UHFFFAOYSA-N
9615	116358	11188	-	NISCH	I-1|IR1|IRAS|hIRAS	9606	Homo sapiens	agonist	target	Rolon PA (1977)	893017	177890	687	Tizanidine	Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin	tizanidine hydrochloride|zanaf	DRUGBANK	DB00697	C9H8ClN5S	small molecule	M03BX02	51322-75-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFYDIVBRZNQMJC-UHFFFAOYSA-N
9616	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Piletz JE (1996)	8930173	177889	687	Tizanidine	Tizanidina|Tizanidinum|5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole|Tizanidine|Tizanidin	tizanidine hydrochloride|zanaf	DRUGBANK	DB00697	C9H8ClN5S	small molecule	M03BX02	51322-75-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFYDIVBRZNQMJC-UHFFFAOYSA-N
9617	850934	946587	b1378	pfo	ECK1374|JW1372|nifJ|soi-9|ydbK	511145	Escherichia coli	potentiator	target	Imming P (2006)	17016423	171742	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9618	850934	946587	b1378	pfo	ECK1374|JW1372|nifJ|soi-9|ydbK	511145	Escherichia coli	potentiator	target	Sisson G (2002)	12069963	177893	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9619	850934	946587	b1378	pfo	ECK1374|JW1372|nifJ|soi-9|ydbK	511145	Escherichia coli	potentiator	target	Breeze AS (1983)	6363380	177892	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9620	850934	946587	b1378	pfo	ECK1374|JW1372|nifJ|soi-9|ydbK	511145	Escherichia coli	potentiator	target	Overington JP (2006)	17139284	171741	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9621	849857	945483	b0851	nfsA	ECK0842|JW0835|mda18|mdaA|snrA|ybjB	511145	Escherichia coli	potentiator	target	Imming P (2006)	17016423	171742	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9622	849857	945483	b0851	nfsA	ECK0842|JW0835|mda18|mdaA|snrA|ybjB	511145	Escherichia coli	potentiator	target	Overington JP (2006)	17139284	171741	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9623	849857	945483	b0851	nfsA	ECK0842|JW0835|mda18|mdaA|snrA|ybjB	511145	Escherichia coli	potentiator	target	Lightfoot RT (2000)	10832075	177894	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9624	849857	945483	b0851	nfsA	ECK0842|JW0835|mda18|mdaA|snrA|ybjB	511145	Escherichia coli	potentiator	target	Kutty R (2005)	16187099	177895	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9625	852128	947816	b3321	rpsJ	ECK3308|JW3283|nusE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9626	852128	947816	b3321	rpsJ	ECK3308|JW3283|nusE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	688	Nitrofurantoin	Nitrofurantoin, macrocrystalline|Nitrofurantoinum anhydrous|nitrofurantoine|1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione|nitrofurantoina|1-((5-nitrofurfurylidene)amino)hydantoin|nitrofurantoinum|Nitrofurantoin anhydrous|N-(5-Nitrofurfurylidene)-1-aminohydantoin|Nitrofurantoin macrocrystal|Nitrofurantoin macrocrystalline|Nitrofurantoin, macrocrystals|5-Nitrofurantoin	pms-nitrofurantoin|nitrofurant	DRUGBANK	DB00698	C8H6N4O5	small molecule	J01XE01|J01XE51	67-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXFQHRVNIOXGAQ-YCRREMRBSA-N
9628	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Fraccarollo D (2003)	14607457	177899	690	Eplerenone	Epoxymexrenone|Inspra	eplerenone|inspra	DRUGBANK	DB00700	C24H30O6	small molecule	C03DA04	107724-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUKPWJGBANNWMW-VWBFHTRKSA-N
9629	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	690	Eplerenone	Epoxymexrenone|Inspra	eplerenone|inspra	DRUGBANK	DB00700	C24H30O6	small molecule	C03DA04	107724-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUKPWJGBANNWMW-VWBFHTRKSA-N
9630	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Rogerson FM (2004)	15554912	175945	690	Eplerenone	Epoxymexrenone|Inspra	eplerenone|inspra	DRUGBANK	DB00700	C24H30O6	small molecule	C03DA04	107724-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUKPWJGBANNWMW-VWBFHTRKSA-N
9631	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Moore TD (2003)	14503934	177900	690	Eplerenone	Epoxymexrenone|Inspra	eplerenone|inspra	DRUGBANK	DB00700	C24H30O6	small molecule	C03DA04	107724-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUKPWJGBANNWMW-VWBFHTRKSA-N
9632	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wittayanarakul K (2008)	17849388	174468	691	Amprenavir	Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir	agenerase	DRUGBANK	DB00701	C25H35N3O6S	small molecule	J05AE05	161814-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMARZQAQMVYCKC-OEMFJLHTSA-N
9633	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dandache S (2007)	17638694	174467	691	Amprenavir	Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir	agenerase	DRUGBANK	DB00701	C25H35N3O6S	small molecule	J05AE05	161814-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMARZQAQMVYCKC-OEMFJLHTSA-N
9634	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Unknown Authors (1999)	10436772	177902	691	Amprenavir	Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir	agenerase	DRUGBANK	DB00701	C25H35N3O6S	small molecule	J05AE05	161814-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMARZQAQMVYCKC-OEMFJLHTSA-N
9635	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Sadler BM (1999)	10390223	177901	691	Amprenavir	Agenerase|Amprenavirum|Amprnavir|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|Amprenavir	agenerase	DRUGBANK	DB00701	C25H35N3O6S	small molecule	J05AE05	161814-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMARZQAQMVYCKC-OEMFJLHTSA-N
9636	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9637	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9638	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Winum JY (2004)	14684332	177906	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9639	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Ilies MA (2004)	15110853	177907	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9640	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Scozzafava A (2000)	10649985	175094	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9641	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Iyer GR (1999)	10533697	177905	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9642	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Lindskog S (1997)	9336012	177908	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9643	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	693	Methazolamide	Neptazaneat|Methenamide|Methazolamidum|Metazolamida|Mthazolamide|Methazolamid|Neptazane	neptazane tablets 25mg|methazo	DRUGBANK	DB00703	C5H8N4O3S2	small molecule	S01EC05	554-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLOSMHQXBMRNHR-UHFFFAOYSA-N
9644	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9645	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9646	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Herz A (1997)	9040115	177911	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9647	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Wee S (2009)	19484223	177910	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9648	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Barrios de Tomasi E (2007)	17661275	177909	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9649	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Barrios de Tomasi E (2007)	17661275	177909	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9650	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Kato H (2008)	19068776	177915	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9651	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Goodman AJ (2007)	17918759	177914	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9652	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9653	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Herz A (1998)	9673788	177916	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9654	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Weerts EM (2008)	17487229	177913	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9655	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9656	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Barrios de Tomasi E (2007)	17661275	177909	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9657	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Roy S (2005)	15788780	177917	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9658	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Herz A (1998)	9673788	177916	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9659	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Herz A (1997)	9040115	177911	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9660	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Weerts EM (2008)	17487229	177913	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9661	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9662	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Herz A (1997)	9040115	177911	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9663	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Wee S (2009)	19484223	177910	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9664	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	694	Naltrexone	N-Cyclopropylmethylnoroxymorphone|Naltrexone|Naltrexona|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|Naltrexon|Naltrexonum|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one	revia - tab 50mg|revia|naltrex	DRUGBANK	DB00704	C20H23NO4	small molecule	N07BB04|A08AA62	16590-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQCKKXVULJGBQN-XFWGSAIBSA-N
9665	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chen Y (2009)	19427736	177928	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9666	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Lee E (1997)	9352700	177929	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9667	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9668	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Michel MC (2004)	14680444	177923	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9669	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chapple CR (1996)	8647141	177924	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9670	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Schulman CC (1996)	8647140	177925	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9671	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Abrams P (1997)	9352698	177926	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9672	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Na YJ (1999)	10503165	177927	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9673	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9674	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Michel MC (2004)	14680444	177923	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9675	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Taguchi K (1997)	8996174	177933	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9676	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Tomiyama Y (2006)	16518087	177932	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9677	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Lowe FC (2006)	16986050	177931	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9678	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Noble AJ (1997)	9117115	177930	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9679	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Ishiguro M (2002)	12270758	176197	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9680	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9681	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Michel MC (2004)	14680444	177923	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9682	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Michel MC (1994)	7911719	177935	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9683	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richardson CD (1997)	9294627	177934	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9684	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Taguchi K (1997)	8996174	177933	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9685	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Ishiguro M (2002)	12270758	176197	696	Tamsulosin	(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|Tamsulosin	jamp-tamsulosin|tamsulosin cr|	DRUGBANK	DB00706	C20H28N2O5S	small molecule	G04CA02|G04CA53|G04CA52	106133-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHKJLXJIQTDTD-OAHLLOKOSA-N
9686	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	antagonist	target	Krutmann J (1989)	2544592	177939	697	Porfimer	Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium	photofrin	DRUGBANK	DB00707	C68H74N8O11	small molecule	L01XD01	87806-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYJWFGRGMQINH-STKOUIOXSA-N
9687	110141	3949	-	LDLR	FH|FHC|LDLCQ2	9606	Homo sapiens	unknown	target	Korbelik M (1992)	1531856	177942	697	Porfimer	Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium	photofrin	DRUGBANK	DB00707	C68H74N8O11	small molecule	L01XD01	87806-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYJWFGRGMQINH-STKOUIOXSA-N
9688	110141	3949	-	LDLR	FH|FHC|LDLCQ2	9606	Homo sapiens	unknown	target	Maziere JC (1992)	1450993	177943	697	Porfimer	Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium	photofrin	DRUGBANK	DB00707	C68H74N8O11	small molecule	L01XD01	87806-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYJWFGRGMQINH-STKOUIOXSA-N
9689	110141	3949	-	LDLR	FH|FHC|LDLCQ2	9606	Homo sapiens	unknown	target	Candide C (1986)	2945739	177940	697	Porfimer	Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium	photofrin	DRUGBANK	DB00707	C68H74N8O11	small molecule	L01XD01	87806-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYJWFGRGMQINH-STKOUIOXSA-N
9690	110141	3949	-	LDLR	FH|FHC|LDLCQ2	9606	Homo sapiens	unknown	target	Maziere JC (1994)	7994588	177941	697	Porfimer	Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium	photofrin	DRUGBANK	DB00707	C68H74N8O11	small molecule	L01XD01	87806-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYJWFGRGMQINH-STKOUIOXSA-N
9691	110141	3949	-	LDLR	FH|FHC|LDLCQ2	9606	Homo sapiens	unknown	target	Tsukagoshi S (1995)	7661580	177944	697	Porfimer	Dihaematoporphyrin Ether|Porfimer sodico|Porfimre sodique|Porfimerum natricum|Dihematoporphyrin ether|Photofrin II|Porfimer natrium	photofrin	DRUGBANK	DB00707	C68H74N8O11	small molecule	L01XD01	87806-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYJWFGRGMQINH-STKOUIOXSA-N
9692	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	unknown	target	Zhu J (1996)	8612823	177946	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9693	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	unknown	target	Chang HM (1989)	2467589	177945	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9694	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Zhu J (1996)	8612823	177946	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9695	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Freye E (1992)	1330549	177947	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9696	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9697	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Ilien B (1988)	2847746	177951	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9698	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Leysen JE (1982)	6131653	177950	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9699	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Hurle MA (2001)	11299311	177952	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9700	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Levron JC (1991)	1688220	177948	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9701	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Colpaert FC (1986)	3014923	177949	698	Sufentanil	Sufentanyl|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide|Sufentanil|Sufentanilum|Sufentanilo|N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide	sufentanil citrate injection, 	DRUGBANK	DB00708	C22H30N2O2S	small molecule	N01AH03	56030-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCSSNBKKAUURC-UHFFFAOYSA-N
9702	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	700	Ibandronate	Bondronat|Ibandronic Acid	bondronat|boniva|ibandronate s	DRUGBANK	DB00710	C9H23NO7P2	small molecule	M05BA06	114084-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPBVHIBUJCELCL-UHFFFAOYSA-N
9703	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Chapurlat RD (2006)	16932286	177963	700	Ibandronate	Bondronat|Ibandronic Acid	bondronat|boniva|ibandronate s	DRUGBANK	DB00710	C9H23NO7P2	small molecule	M05BA06	114084-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPBVHIBUJCELCL-UHFFFAOYSA-N
9704	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Rondeau JM (2006)	16892359	177962	700	Ibandronate	Bondronat|Ibandronic Acid	bondronat|boniva|ibandronate s	DRUGBANK	DB00710	C9H23NO7P2	small molecule	M05BA06	114084-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPBVHIBUJCELCL-UHFFFAOYSA-N
9705	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Dunford JE (2001)	11160603	174892	700	Ibandronate	Bondronat|Ibandronic Acid	bondronat|boniva|ibandronate s	DRUGBANK	DB00710	C9H23NO7P2	small molecule	M05BA06	114084-78-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPBVHIBUJCELCL-UHFFFAOYSA-N
9706	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	McGarry HF (2005)	15932636	177964	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9707	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9708	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Cernak I (1996)	8606397	177968	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9709	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Bach MK (1986)	3004501	177969	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9710	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Davidson D (1992)	1400062	177965	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9711	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Gross NJ (1991)	1886988	177966	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9712	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zunic G (1999)	10518442	177967	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9713	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Nivsarkar M (2008)	19066416	177973	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9714	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kurahashi K (2001)	11811354	177972	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9715	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hewett SJ (2000)	10773011	177971	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9716	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Basselin M (2007)	17562170	177977	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9717	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Rieke CJ (1999)	10358065	177976	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9718	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Droege MJ (2003)	12711844	177975	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9719	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Klegeris A (2002)	12392782	177974	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9720	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bayly CI (1999)	10091674	177979	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9721	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2001)	11405284	177978	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9722	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Haeringen NJ (2000)	10977131	177980	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9723	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nivsarkar M (2008)	19066416	177973	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9724	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith T (2000)	11006278	160486	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9725	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hewett SJ (2000)	10773011	177971	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9726	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Basselin M (2007)	17562170	177977	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9727	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Melis MR (2006)	17067298	177986	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9728	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9729	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9730	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Mansbach RS (1998)	9497025	177984	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9731	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Boeckler F (2004)	15007532	177985	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9732	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Succu S (2007)	17164075	177983	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9733	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9734	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9735	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9736	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9737	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9738	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Berlin I (2000)	11343576	177987	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9739	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Yamada S (2000)	11215397	177991	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9740	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lucht MJ (2001)	11692072	177990	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9741	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9742	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Yamada S (1999)	10494453	177988	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9743	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kim HJ (2001)	11212866	177989	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9744	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9745	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9746	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9747	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9748	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9749	119105	50632	RP11-122K13.5	CALY	DRD1IP|NSG3	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9750	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9751	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9752	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9753	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9754	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9755	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9756	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Guo H (2002)	12453049	177992	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9757	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9758	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9759	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Rubin RT (2000)	11203183	177995	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9760	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Nemeroff CB (2003)	14566196	177994	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9761	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9762	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Gilmor ML (2002)	12359676	177993	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9763	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9764	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Pollock BG (2000)	11027924	176750	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9765	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Wihlbaeck AC (2001)	11530128	177997	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9766	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Preuss UW (2000)	10980326	177996	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9767	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Haughey HM (2000)	10987842	177998	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9768	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Scholze P (2000)	10869387	176216	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9769	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Bixo M (2001)	11403977	178000	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9770	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Meyer JH (2001)	11136637	177999	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9771	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9772	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9773	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9774	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	705	Paroxetine	(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Paroxetinum|Paroxetina|(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|Paroxetine	paroxetine|paroxetine-10|brisd	DRUGBANK	DB00715	C19H20FNO3	small molecule	N06AB05	61869-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHOUBRCZNHFOSL-YOEHRIQHSA-N
9775	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Yazid S (2010)	20558817	178002	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9776	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Radeau T (1993)	8386571	178003	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9777	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Overington JP (2006)	17139284	171741	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9778	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Monteseirin J (2005)	16164449	178004	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9779	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Imming P (2006)	17016423	171742	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9780	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9781	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9782	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Lane SJ (1996)	8939179	178006	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9783	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Ahluwalia P (2001)	11544467	178005	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9784	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Okada M (2003)	12803546	178008	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9785	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Nishikawa M (2008)	17980980	178007	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9786	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Yazid S (2010)	20558817	178002	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9787	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9788	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9789	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Monteseirin J (2005)	16164449	178004	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9790	108640	2357	-	FPR1	FMLP|FPR	9606	Homo sapiens	antagonist	target	Carolan EJ (1992)	1329582	178011	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9791	108640	2357	-	FPR1	FMLP|FPR	9606	Homo sapiens	antagonist	target	Warringa RA (1993)	8384226	178010	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9792	108640	2357	-	FPR1	FMLP|FPR	9606	Homo sapiens	antagonist	target	Peroni DG (1992)	1326878	178009	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9793	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Madauss KP (2004)	15189034	178013	707	Norethisterone	17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one	microgestin|norethindrone and 	DRUGBANK	DB00717	C20H26O2	small molecule	G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01	68-22-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIKNJXKGJWUCNN-XGXHKTLJSA-N
9794	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Mendoza-Rodriguez CA (1999)	10494488	178012	707	Norethisterone	17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one	microgestin|norethindrone and 	DRUGBANK	DB00717	C20H26O2	small molecule	G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01	68-22-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIKNJXKGJWUCNN-XGXHKTLJSA-N
9795	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Pasapera AM (1995)	7711211	178015	707	Norethisterone	17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one	microgestin|norethindrone and 	DRUGBANK	DB00717	C20H26O2	small molecule	G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01	68-22-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIKNJXKGJWUCNN-XGXHKTLJSA-N
9796	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Garcia-Becerra R (2004)	15261304	178014	707	Norethisterone	17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one	microgestin|norethindrone and 	DRUGBANK	DB00717	C20H26O2	small molecule	G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01	68-22-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIKNJXKGJWUCNN-XGXHKTLJSA-N
9797	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Mirkin S (2005)	16084894	175552	707	Norethisterone	17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one	microgestin|norethindrone and 	DRUGBANK	DB00717	C20H26O2	small molecule	G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01	68-22-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIKNJXKGJWUCNN-XGXHKTLJSA-N
9798	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	707	Norethisterone	17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one|17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one|19-Norethisterone|19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one|19-Nor-17-alpha-ethynyltestosterone|17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one|17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one|4-Estren-17alpha-ethynyl-17beta-ol-3-one|17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one|Norethisteronum|17alpha-Ethynyl-19-nortestosterone|(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one|17-ethinyl-19-nortestosterone|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one|19-nor-17-ethynyltestosterone|17alpha-Ethynyl-4-estren-17-ol-3-one|Noretisterona|Norethindrone|17alpha-Ethinyl-19-nortestosterone|19-Nor-ethindrone|19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one|17-alpha-Ethynyl-4-estren-17-ol-3-one|Norethisteron|17-alpha-Ethynyl-17-hydroxy-4-estren-3-one|19-Nor-17alpha-ethynyltestosterone|17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17alpha-Ethynyl-17-hydroxy-4-estren-3-one|17alpha-Ethinylestra-4-en-17beta-ol-3-one|17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one|17-alpha-Ethynyl-19-nortestosterone|17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one|19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one	microgestin|norethindrone and 	DRUGBANK	DB00717	C20H26O2	small molecule	G03AB04|G03FA01|G03AA05|G03DC02|G03FB05|G03AC01	68-22-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIKNJXKGJWUCNN-XGXHKTLJSA-N
9799	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Singh N (1998)	9638277	178022	709	Azatadine	Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin	trinalin repetabs|optimine tab	DRUGBANK	DB00719	C20H22N2	small molecule	R06AX09	3964-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEBMTIQKRHYNIT-UHFFFAOYSA-N
9800	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	709	Azatadine	Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin	trinalin repetabs|optimine tab	DRUGBANK	DB00719	C20H22N2	small molecule	R06AX09	3964-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEBMTIQKRHYNIT-UHFFFAOYSA-N
9801	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Clissold SP (1989)	2523301	178020	709	Azatadine	Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin	trinalin repetabs|optimine tab	DRUGBANK	DB00719	C20H22N2	small molecule	R06AX09	3964-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEBMTIQKRHYNIT-UHFFFAOYSA-N
9802	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Haria M (1994)	7528133	178021	709	Azatadine	Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin	trinalin repetabs|optimine tab	DRUGBANK	DB00719	C20H22N2	small molecule	R06AX09	3964-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEBMTIQKRHYNIT-UHFFFAOYSA-N
9803	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Mann KV (1989)	2568212	175982	709	Azatadine	Azatadinum|Azatadina|11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|Azatadine|Azatadin	trinalin repetabs|optimine tab	DRUGBANK	DB00719	C20H22N2	small molecule	R06AX09	3964-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEBMTIQKRHYNIT-UHFFFAOYSA-N
9804	106790	293	RP11-261P4.6	SLC25A6	2|3|AAC3|ANT|ANT 2|ANT 3|ANT3|ANT3Y	9606	Homo sapiens	inhibitor	target	Lehenkari PP (2002)	11961144	178023	710	Clodronate	Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid	bonefos|clasteon|ostac cap 400	DRUGBANK	DB00720	CH4Cl2O6P2	small molecule	-	10596-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACSIXWWBWUQEHA-UHFFFAOYSA-N
9805	106789	292	-	SLC25A5	2F1|AAC2|ANT2|T2|T3	9606	Homo sapiens	inhibitor	target	Lehenkari PP (2002)	11961144	178023	710	Clodronate	Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid	bonefos|clasteon|ostac cap 400	DRUGBANK	DB00720	CH4Cl2O6P2	small molecule	-	10596-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACSIXWWBWUQEHA-UHFFFAOYSA-N
9806	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	710	Clodronate	Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid	bonefos|clasteon|ostac cap 400	DRUGBANK	DB00720	CH4Cl2O6P2	small molecule	-	10596-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACSIXWWBWUQEHA-UHFFFAOYSA-N
9807	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	inhibitor	target	Lehenkari PP (2002)	11961144	178023	710	Clodronate	Dichloromethanediphosphonic acid|Clodronsure|Dichloromethylene-1,1-diphosphonic acid|(Dichloro-phosphono-methyl)-phosphonic acid|Clodronate|Acido Clodronico|Dichloromethylidene diphosphonate|(Dichloromethylene)diphosphonic acid|Acide Clodronique|(Dichloromethylene)bisphosphonic acid|Acidum Clodronicum|Clodronsaeure|Dichloromethylene-1,1-bisphosphonic acid	bonefos|clasteon|ostac cap 400	DRUGBANK	DB00720	CH4Cl2O6P2	small molecule	-	10596-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACSIXWWBWUQEHA-UHFFFAOYSA-N
9808	109983	3782	RP11-274N19.1	KCNN3	KCa2.3|SK3|SKCA3|hSK3	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9809	115536	10242	hCG_1646471	KCNMB2	-	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9810	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9811	109980	3779	-	KCNMB1	BKbeta1|K(VCA)beta|SLO-BETA|hbeta1|hslo-beta|k(VCA)beta-1|slo-beta-1	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9812	109981	3780	-	KCNN1	KCa2.1|SK1|SKCA1|hSK1	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9813	117996	27094	-	KCNMB3	BKBETA3|HBETA3|K(VCA)BETA-3|KCNMB2|KCNMBL|SLO-BETA-3|SLOBETA3	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9814	118157	27345	-	KCNMB4	-	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9815	109982	3781	-	KCNN2	KCa2.2|SK2|SKCA2|SKCa 2|hSK2	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9816	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	binder	target	Benham CD (1985)	2580269	178026	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9817	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9818	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9819	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Nishizawa N (2002)	11812692	178028	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9820	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Hahnenkamp K (2006)	16299047	178027	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9821	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9822	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Katalymov LL (1995)	8581044	178030	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9823	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Creveling CR (1990)	2167458	178031	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9824	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9825	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Braeu ME (1998)	9768788	178029	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9826	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Wang H (2010)	20045405	178032	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9827	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	MacFarlane MD (1975)	1109354	178033	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9828	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	MacFarlane MD (1975)	1109354	178033	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9829	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Sato T (2000)	10685879	178036	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9830	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wilcox KM (2005)	16206183	178035	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9831	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Kiyatkin EA (2006)	16956595	178034	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9832	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9833	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Fan P (1994)	7539114	178037	711	Procaine	Procaina|4-aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl 4-aminobenzoate|2-Diethylaminoethyl p-aminobenzoate|Vitamin H3|Procainum|Novocaine|p-Aminobenzoic acid 2-diethylaminoethyl ester|-(diethylamino)ethyl p-aminobenzoate	novocain 20 mg/ml|novocain liq	DRUGBANK	DB00721	C13H20N2O2	small molecule	S01HA05|C05AD05|N01BA52|N01BA02	59-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDFERRIHVXMIY-UHFFFAOYSA-N
9834	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9835	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9836	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9837	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9838	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tellez-Sanz R (1998)	9506845	178040	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9839	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9840	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9841	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9842	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor	target	Parish RC (1992)	1536695	178041	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9843	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Sattar MA (1994)	7511752	178046	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9844	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Hoang TV (1996)	8986981	178044	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9845	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Suzuki E (1990)	1978244	178045	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9846	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Satoh M (1994)	7875228	178042	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9847	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Piascik MT (1991)	1680715	178043	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9848	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Waugh DJ (2001)	11331292	178047	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9849	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9850	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Simpson P (1985)	2988814	178050	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9851	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Tsujimoto G (1989)	2546049	178048	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9852	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Oleksa LM (1996)	8635240	178049	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9853	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	binder	target	Zeng A (2009)	19493707	178051	713	Methoxamine	Mthoxamdrine|Methoxamin|Pseudomethoxamine|Vasoxyl|Metossamina|Mthoxamine|Methoxaminum|Metoxamina	vasoxyl inj 20mg/ml	DRUGBANK	DB00723	C11H17NO3	small molecule	C01CA10	390-28-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJAJPNHVVFWKKL-UHFFFAOYSA-N
9854	119462	51311	UNQ249/PRO286	TLR8	CD288	9606	Homo sapiens	agonist	target	Gorden KB (2005)	15661881	178054	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9855	119462	51311	UNQ249/PRO286	TLR8	CD288	9606	Homo sapiens	agonist	target	Zhu J (2008)	18439678	178053	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9856	119462	51311	UNQ249/PRO286	TLR8	CD288	9606	Homo sapiens	agonist	target	Dummer R (2003)	14616353	178052	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9857	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	agonist	target	Gibson SJ (2002)	12470615	178055	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9858	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	agonist	target	Akira S (2003)	12527213	178057	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9859	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	agonist	target	Ambach A (2004)	15072849	178056	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9860	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	agonist	target	Dummer R (2003)	14616353	178052	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9861	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9862	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	agonist	target	Otero M (2004)	15068862	178058	714	Imiquimod	R 837|Imiquimodum|4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline|Imiquimod|Zartra|1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine	aldara p|apo-imiquimod|vyloma|	DRUGBANK	DB00724	C14H16N4	small molecule	D06BB10	99011-02-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOUYETYNHWVLEO-UHFFFAOYSA-N
9863	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9864	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9865	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Li CK (1980)	6893558	178059	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9866	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9867	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9868	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9869	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Gil L (2000)	11124384	178060	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9870	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9871	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9872	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	George N (2010)	20085574	178061	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9873	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Gil L (2000)	11124384	178060	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9874	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9875	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9876	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Li CK (1980)	6893558	178059	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9877	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Gil L (2000)	11124384	178060	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9878	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9879	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Manjeet S (1989)	2612581	178062	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9880	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9881	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	George N (2010)	20085574	178061	715	Homatropine Methylbromide	3-alpha-Hydroxy-8-methyl-1-alpha-H,5-alpha-H-tropanium bromide mandelate|8-Methylhomatropinium bromide|Methylhomatropine|Homatropine methylbromide|Tropinium methobromide mandelate|Metilbromuro de homatropina|Omatropina metilbromuro|Methylhomatropinum bromatum|Methylbromure d'homatropine|Methylhomatropine bromide|Homatropini methylbromidum	hydromet|tussigon|hydrocodone 	DRUGBANK	DB00725	C17H24BrNO3	small molecule	A03CB04	80-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUFVKLQESJNNAN-UHFFFAOYSA-M
9882	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9883	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9884	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9885	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9886	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9887	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9888	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9889	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9890	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9891	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Diamond M (2006)	16388933	178064	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9892	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9893	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9894	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9895	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9896	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9897	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	unknown	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9898	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	binder	target	Eikmeier G (1990)	1979173	178065	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9899	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	binder	target	Eikmeier G (1990)	1979173	178065	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9900	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	binder	target	Eikmeier G (1990)	1979173	178065	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9901	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Eikmeier G (1990)	1979173	178065	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9902	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	binder	target	Eikmeier G (1990)	1979173	178065	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9903	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9904	247238	25187	-	Htr2c	5-HT2C|5-HTR2C|5HT-1C	10116	Rattus norvegicus	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9905	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9906	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	desensitize the target	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9907	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	binder	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9908	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9909	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Bauersachs J (2009)	19732062	178066	717	Nitroglycerin	Nitrolingual|Glyceroltrinitrat|Nitro-dur|Glyceryl trinitrate|Glycerol trinitrate|NG|Glycerin trinitrate|Trinitroglycerol|Nitromist|Propane-1,2,3-triyl trinitrate|Glycerol, nitric acid triester|1,2,3-Propanetrioltrinitrate|Nitroglycerine|Trinitrine|Transderm nitro|Nitroglicerina|Glyceroli trinitratis|Rectogesic|Natispray|Trinitroglycerin|Nitromed|Nitrostat|Nitroglycerol|Nitroglycerin|1,2,3-Propanetriyl nitrate|Minitran	nitrolingual pumpspray|transde	DRUGBANK	DB00727	C3H5N3O9	small molecule	C01DA02|C05AE01|C01DA52	55-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNIOPGDIGTZGOP-UHFFFAOYSA-N
9910	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Madhani M (2003)	12890708	178067	717	Nitroglycerin	Nitrolingual|Glyceroltrinitrat|Nitro-dur|Glyceryl trinitrate|Glycerol trinitrate|NG|Glycerin trinitrate|Trinitroglycerol|Nitromist|Propane-1,2,3-triyl trinitrate|Glycerol, nitric acid triester|1,2,3-Propanetrioltrinitrate|Nitroglycerine|Trinitrine|Transderm nitro|Nitroglicerina|Glyceroli trinitratis|Rectogesic|Natispray|Trinitroglycerin|Nitromed|Nitrostat|Nitroglycerol|Nitroglycerin|1,2,3-Propanetriyl nitrate|Minitran	nitrolingual pumpspray|transde	DRUGBANK	DB00727	C3H5N3O9	small molecule	C01DA02|C05AE01|C01DA52	55-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNIOPGDIGTZGOP-UHFFFAOYSA-N
9911	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9912	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson M (2006)	16931985	178069	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9913	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9914	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9915	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson Fagerlund M (2009)	19417616	178070	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9916	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2008)	18633030	175926	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9917	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Min KT (2000)	10648343	178071	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9918	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9919	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9920	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Milchert M (2009)	20400785	178072	718	Rocuronium	Rocuronium	rocuronium bromide injection|r	DRUGBANK	DB00728	C32H53N2O4	small molecule	M03AC09	143558-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXRDKMPIGHSVRX-OOJCLDBCSA-N
9921	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	719	Diphemanil Methylsulfate	Diphemanil methylsulfat|Mtilsulfate de Diphmanil|P-(alpha-Phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate|Diphemanili metilsulfas|Diphemanil metilsulfate|4-(Diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate|Metilsulfato de difemanilo|Diphemanil methosulfate|Vagophemanil|N,N-Dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate	-	DRUGBANK	DB00729	C21H27NO4S	small molecule	-	62-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BREMLQBSKCSNNH-UHFFFAOYSA-M
9922	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	719	Diphemanil Methylsulfate	Diphemanil methylsulfat|Mtilsulfate de Diphmanil|P-(alpha-Phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate|Diphemanili metilsulfas|Diphemanil metilsulfate|4-(Diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate|Metilsulfato de difemanilo|Diphemanil methosulfate|Vagophemanil|N,N-Dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate	-	DRUGBANK	DB00729	C21H27NO4S	small molecule	-	62-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BREMLQBSKCSNNH-UHFFFAOYSA-M
9923	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	719	Diphemanil Methylsulfate	Diphemanil methylsulfat|Mtilsulfate de Diphmanil|P-(alpha-Phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate|Diphemanili metilsulfas|Diphemanil metilsulfate|4-(Diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate|Metilsulfato de difemanilo|Diphemanil methosulfate|Vagophemanil|N,N-Dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate	-	DRUGBANK	DB00729	C21H27NO4S	small molecule	-	62-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BREMLQBSKCSNNH-UHFFFAOYSA-M
9924	852959	948667	b4154	frdA	ECK4150|JW4115	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	720	Thiabendazole	Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole	mintezol chewable tab 500mg	DRUGBANK	DB00730	C10H7N3S	small molecule	D01AC06|P02CA02	148-79-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJCNZQLZVWNLKY-UHFFFAOYSA-N
9925	852959	948667	b4154	frdA	ECK4150|JW4115	511145	Escherichia coli	inhibitor	target	Chen X (2002)	11752352	171740	720	Thiabendazole	Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole	mintezol chewable tab 500mg	DRUGBANK	DB00730	C10H7N3S	small molecule	D01AC06|P02CA02	148-79-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJCNZQLZVWNLKY-UHFFFAOYSA-N
9926	852959	948667	b4154	frdA	ECK4150|JW4115	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	720	Thiabendazole	Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole	mintezol chewable tab 500mg	DRUGBANK	DB00730	C10H7N3S	small molecule	D01AC06|P02CA02	148-79-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJCNZQLZVWNLKY-UHFFFAOYSA-N
9927	852959	948667	b4154	frdA	ECK4150|JW4115	511145	Escherichia coli	inhibitor	target	Ge Z (2000)	11031122	178075	720	Thiabendazole	Tiabendazole|Thiabendazole|2-(1,3-THIAZOL-4-yl)-1H-benzimidazole|TBZ|TBDZ|Equizole|Mintezol|4-(2-Benzimidazolyl)thiazole|MK 360|Thibenzole	mintezol chewable tab 500mg	DRUGBANK	DB00730	C10H7N3S	small molecule	D01AC06|P02CA02	148-79-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJCNZQLZVWNLKY-UHFFFAOYSA-N
9928	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9929	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Hu S (2000)	10773014	51241	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9930	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Norman P (2001)	12764427	178080	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9931	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Sunaga Y (2001)	11716850	178081	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9932	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Dornhorst A (2001)	11728565	178079	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9933	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Hansen AM (2002)	12196472	178078	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9934	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Chachin M (2003)	12604678	178077	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9935	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	722	Atracurium besylate	Atracurium dibesylate|Atracurium besilate|1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium	atracurium   -  (for single do	DRUGBANK	DB00732	C65H82N2O18S2	small molecule	-	64228-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXZSQOVSEBAPGS-UHFFFAOYSA-L
9936	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	722	Atracurium besylate	Atracurium dibesylate|Atracurium besilate|1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium	atracurium   -  (for single do	DRUGBANK	DB00732	C65H82N2O18S2	small molecule	-	64228-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXZSQOVSEBAPGS-UHFFFAOYSA-L
9937	107557	1135	-	CHRNA2	-	9606	Homo sapiens	inhibitor	target	Jonsson Fagerlund M (2009)	19417616	178070	722	Atracurium besylate	Atracurium dibesylate|Atracurium besilate|1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium	atracurium   -  (for single do	DRUGBANK	DB00732	C65H82N2O18S2	small molecule	-	64228-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXZSQOVSEBAPGS-UHFFFAOYSA-L
9938	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	activator	target	Wong L (2000)	10801325	178083	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9939	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	activator	target	Kovacic P (2003)	14529460	178086	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9940	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	activator	target	Jokanovic M (2009)	19519385	178084	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9941	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	activator	target	Jokanovic M (2009)	19651196	178085	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9942	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	activator	target	Pohanka M (2009)	18825528	178088	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9943	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	activator	target	Khan S (2001)	11393267	178087	723	Pralidoxime	Pralidoxime|Pralidoximum|Pralidoxima|2-PAM|Pralidoxim	duodote|protopam chloride  -  	DRUGBANK	DB00733	C7H9N2O	small molecule	V03AB04	6735-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBKPUQTUERUYQE-UHFFFAOYSA-O
9944	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Remington G (2006)	16513859	178091	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9945	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lane HY (2004)	15140279	178090	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9946	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9947	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9948	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Catafau AM (2006)	17059881	178089	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9949	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9950	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Naiker DV (2006)	16730699	175316	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9951	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9952	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Canton H (1994)	7898773	177777	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9953	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nourian Z (2008)	18542932	178093	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9954	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9955	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9956	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9957	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9958	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Eltze M (1996)	8925876	176194	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9959	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9960	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9961	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9962	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9963	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9964	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Eltze M (1996)	8925876	176194	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9965	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Schreiber S (1997)	9197279	178095	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9966	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9967	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9968	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9969	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9970	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9971	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9972	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9973	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9974	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9975	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9976	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9977	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9978	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9979	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9980	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9981	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9982	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9983	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9984	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9985	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9986	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9987	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9988	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	725	Naftifine	Naftifinum|Naftifine|Naftifin|Naftin|Naftifina	naftin crm 1%|naftin gel 1%|na	DRUGBANK	DB00735	C21H21N	small molecule	D01AE22	65472-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZGNYLLQHRPOBR-DHZHZOJOSA-N
9989	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Ryder NS (1992)	1287164	178103	725	Naftifine	Naftifinum|Naftifine|Naftifin|Naftin|Naftifina	naftin crm 1%|naftin gel 1%|na	DRUGBANK	DB00735	C21H21N	small molecule	D01AE22	65472-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZGNYLLQHRPOBR-DHZHZOJOSA-N
9990	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Ryder NS (1985)	3877503	178102	725	Naftifine	Naftifinum|Naftifine|Naftifin|Naftin|Naftifina	naftin crm 1%|naftin gel 1%|na	DRUGBANK	DB00735	C21H21N	small molecule	D01AE22	65472-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZGNYLLQHRPOBR-DHZHZOJOSA-N
9991	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Mukherjee PK (2003)	12499173	178101	725	Naftifine	Naftifinum|Naftifine|Naftifin|Naftin|Naftifina	naftin crm 1%|naftin gel 1%|na	DRUGBANK	DB00735	C21H21N	small molecule	D01AE22	65472-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZGNYLLQHRPOBR-DHZHZOJOSA-N
9992	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Favre B (1996)	8834895	40846	725	Naftifine	Naftifinum|Naftifine|Naftifin|Naftin|Naftifina	naftin crm 1%|naftin gel 1%|na	DRUGBANK	DB00735	C21H21N	small molecule	D01AE22	65472-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZGNYLLQHRPOBR-DHZHZOJOSA-N
9993	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Vanden Bossche H (1991)	1951574	174676	725	Naftifine	Naftifinum|Naftifine|Naftifin|Naftin|Naftifina	naftin crm 1%|naftin gel 1%|na	DRUGBANK	DB00735	C21H21N	small molecule	D01AE22	65472-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZGNYLLQHRPOBR-DHZHZOJOSA-N
9994	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	726	Esomeprazole	(S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole	esomeprazole magnesium|pms-eso	DRUGBANK	DB00736	C17H19N3O3S	small molecule	A02BC05|A02BD06|M01AE52	119141-88-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-DEOSSOPVSA-N
9995	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Vachhani R (2009)	19210109	178106	726	Esomeprazole	(S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole	esomeprazole magnesium|pms-eso	DRUGBANK	DB00736	C17H19N3O3S	small molecule	A02BC05|A02BD06|M01AE52	119141-88-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-DEOSSOPVSA-N
9996	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Saccar CL (2009)	19606942	178105	726	Esomeprazole	(S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole	esomeprazole magnesium|pms-eso	DRUGBANK	DB00736	C17H19N3O3S	small molecule	A02BC05|A02BD06|M01AE52	119141-88-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-DEOSSOPVSA-N
9997	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	McKeage K (2008)	18627213	178104	726	Esomeprazole	(S)-omeprazole|Perprazole|Omeprazole S-form|somprazole|Esomeprazolum|Esomeprazol|()-omeprazole|(S)-()-omeprazole	esomeprazole magnesium|pms-eso	DRUGBANK	DB00736	C17H19N3O3S	small molecule	A02BC05|A02BD06|M01AE52	119141-88-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUBDBMMJDZJVOS-DEOSSOPVSA-N
9998	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Oishi R (1994)	7513381	174896	727	Meclizine	Meclozine|Meclizine|Nevidoxine	rugbymeclizine hcl, 12.5 mg ea	DRUGBANK	DB00737	C25H27ClN2	small molecule	R06AE05|R06AE55	569-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCJYIGYOJCODJL-UHFFFAOYSA-N
9999	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Taniguchi K (1991)	1678430	174897	727	Meclizine	Meclozine|Meclizine|Nevidoxine	rugbymeclizine hcl, 12.5 mg ea	DRUGBANK	DB00737	C25H27ClN2	small molecule	R06AE05|R06AE55	569-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCJYIGYOJCODJL-UHFFFAOYSA-N
10000	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Pasquale CP (1992)	1362160	178108	727	Meclizine	Meclozine|Meclizine|Nevidoxine	rugbymeclizine hcl, 12.5 mg ea	DRUGBANK	DB00737	C25H27ClN2	small molecule	R06AE05|R06AE55	569-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCJYIGYOJCODJL-UHFFFAOYSA-N
10001	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Martins MA (1992)	1350745	178109	727	Meclizine	Meclozine|Meclizine|Nevidoxine	rugbymeclizine hcl, 12.5 mg ea	DRUGBANK	DB00737	C25H27ClN2	small molecule	R06AE05|R06AE55	569-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCJYIGYOJCODJL-UHFFFAOYSA-N
10002	108124	1787	RP11-406H21.1	TRDMT1	DMNT2|DNMT2|MHSAIIP|PUMET|RNMT1	9606	Homo sapiens	unknown	target	Sun T (2008)	18263620	178110	728	Pentamidine	Pentamidin|Pentamidindiisetionat|Pentamidina|4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide|4,4'-Diamidinodiphenoxypentane|P,P'-(pentamethylenedioxy)dibenzamidine|4,4'-(Pentamethylenedioxy)dibenzamidine|Pentamidine|Pentamidinum|1,5-Bis(4-amidinophenoxy)pentane	pentam 300|pentamidine isethio	DRUGBANK	DB00738	C19H24N4O2	small molecule	P01CX01	100-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDRYMKDFEDOLFX-UHFFFAOYSA-N
10003	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inducer	target	Dunlop J (2003)	12629173	178114	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10004	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inducer	target	Azbill RD (2000)	10899284	178115	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10005	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inducer	target	Hayashida K (2010)	20059984	178116	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10006	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inducer	target	Gosselin RD (2010)	20226190	178117	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10007	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inducer	target	Wokke J (1996)	8813989	178118	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10008	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Song JH (1997)	9262334	178121	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10009	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Weiss S (2010)	20590601	178120	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10010	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10011	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Schwartz G (2002)	12440368	178119	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10012	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	730	Riluzole	Riluzolum|Riluzole|Riluzol	mylan-riluzole|rilutek|apo-ril	DRUGBANK	DB00740	C8H5F3N2OS	small molecule	N07XX02	1744-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTALBRSUTCGOEG-UHFFFAOYSA-N
10013	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10014	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Sato-Matsumura KC (2000)	11142771	178123	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10015	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10016	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Serres M (1994)	8060156	178125	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10017	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	White MV (1991)	1712816	178124	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10018	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10019	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10020	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10021	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10022	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10023	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Berger W (2007)	17394438	178138	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10024	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Hardy DB (1999)	10377029	178139	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10025	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Qian C (2001)	11529688	178143	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10026	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10027	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zouboulis CC (2009)	20436887	178144	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10028	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zouboulis CC (2010)	19645854	178136	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10029	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Coffey MJ (2001)	11561080	178137	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10030	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wenzel SE (1999)	10322101	178141	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10031	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Yamashita M (2000)	10694244	178140	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10032	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wenzel SE (1996)	8826571	178142	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10033	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Guidot DM (1994)	8058773	178145	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10034	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Swanson JM (2003)	14658934	178147	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10035	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Madras BK (2006)	16885432	178150	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10036	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Dopheide MM (2007)	17477916	178151	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10037	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wisor JP (2001)	11222668	178149	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10038	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Zhou J (2004)	15537337	178148	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10039	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10040	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	partial agonist	target	Chen CR (2007)	17681557	178152	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10041	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	735	Modafinil	Modafinilo|Provigil|Moderateafinil|Modafinilum|Modafinil	auro-modafinil|ipg-modafinil|p	DRUGBANK	DB00745	C15H15NO2S	small molecule	N06BA07	68693-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-UHFFFAOYSA-N
10042	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Reitz AB (2007)	18045203	178159	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10043	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10044	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Johnson DE (2005)	15627430	178160	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10045	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Reitz AB (2007)	18045203	178159	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10046	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Reitz AB (2007)	18045203	178159	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10047	112371	6476	-	SI	-	9606	Homo sapiens	inhibitor	target	Minai-Tehrani D (2010)	20230815	178161	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10048	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Klinkenberg I (2010)	20398692	178163	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10049	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Murasaki O (2003)	14534362	178162	737	Scopolamine	6,7-Epoxytropine tropate|6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate|scopine ()-tropate|(-)-scopolamine|Hyoscine|(1S,3S,5R,6R,7S)-6,7-Epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate|scopine (-)-tropate|alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester|Scopolamine hydrobromide|(-)-hyoscine	se-donna pb hyos|donnatal tab|	DRUGBANK	DB00747	C17H21NO4	small molecule	A04AD01|N05CM05|A04AD51|S01FA02	51-34-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STECJAGHUSJQJN-FWXGHANASA-N
10050	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yang J (2009)	19761204	178165	738	Carbinoxamine	{2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina	karbinal er|carbinoxamine male	DRUGBANK	DB00748	C16H19ClN2O	small molecule	R06AA08	486-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFSXZCBGQGRNV-UHFFFAOYSA-N
10051	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Darby WJ (1975)	1143714	178164	738	Carbinoxamine	{2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina	karbinal er|carbinoxamine male	DRUGBANK	DB00748	C16H19ClN2O	small molecule	R06AA08	486-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFSXZCBGQGRNV-UHFFFAOYSA-N
10052	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Oishi R (1994)	7513381	174896	738	Carbinoxamine	{2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina	karbinal er|carbinoxamine male	DRUGBANK	DB00748	C16H19ClN2O	small molecule	R06AA08	486-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFSXZCBGQGRNV-UHFFFAOYSA-N
10053	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ramadan AA (2006)	16574052	178166	738	Carbinoxamine	{2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina	karbinal er|carbinoxamine male	DRUGBANK	DB00748	C16H19ClN2O	small molecule	R06AA08	486-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFSXZCBGQGRNV-UHFFFAOYSA-N
10054	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	738	Carbinoxamine	{2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine|Paracarbinoxamine|2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine|Carbinoxamine base|Carbinoxaminum|(+-)-Carbinoxamine|Carbinoxamin|Carbinoxamine|Carbinoxamina	karbinal er|carbinoxamine male	DRUGBANK	DB00748	C16H19ClN2O	small molecule	R06AA08	486-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFSXZCBGQGRNV-UHFFFAOYSA-N
10055	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Glaser K (1995)	8566109	178167	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10056	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Riendeau D (1997)	9146894	178169	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10057	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hirate K (2006)	16473424	178168	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10058	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Campbell NB (2002)	12358053	178170	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10059	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10060	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Kolluri SK (2005)	15699354	178172	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10061	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2001)	11275997	178176	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10062	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Svendsen KB (2000)	11009046	178174	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10063	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kusuhara H (1999)	10594327	178175	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10064	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2003)	12824918	178173	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10065	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10066	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10067	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	740	Prilocaine	O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum	prikaan|relador pak plus|derma	DRUGBANK	DB00750	C13H20N2O	small molecule	N01BB54|N01BB04	721-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVFGUOIZUNYYSO-UHFFFAOYSA-N
10068	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	740	Prilocaine	O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum	prikaan|relador pak plus|derma	DRUGBANK	DB00750	C13H20N2O	small molecule	N01BB54|N01BB04	721-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVFGUOIZUNYYSO-UHFFFAOYSA-N
10069	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	740	Prilocaine	O-Methyl-2-propylaminopropionanilide|Prilocaina|2-Methyl-alpha-propylaminopropionanilide|Prilocane|Propitocaine|Prilocain|alpha-N-Propylamino-2-methylpropionanilide|2-(Propylamino)-O-propionotoluidide|N-(2-Methylphenyl)-2-(propylamino)propanamide|Prilocaine base|O-Methyl-alpha-propylaminopropionanilide|Prilocainum	prikaan|relador pak plus|derma	DRUGBANK	DB00750	C13H20N2O	small molecule	N01BB54|N01BB04	721-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVFGUOIZUNYYSO-UHFFFAOYSA-N
10070	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Bielory L (2005)	16131920	178180	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10071	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tsujii T (2007)	17534605	178182	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10072	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Walther G (1990)	1972625	178181	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10073	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10074	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Dupont LJ (1996)	8836655	178183	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10075	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Dupont LJ (1996)	8836655	178183	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10076	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Dupont LJ (1999)	10596692	178184	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10077	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Dupont LJ (1999)	10596692	178184	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10078	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Dupont LJ (1996)	8836655	178183	741	Epinastine	Epinastine|Epinastin|Epinastina|Epinastinum|(+-)-Epinastine|3-amino-9,13b-dihydro-1H-Dibenz(c,F)imidazo(1,5-a)azepine	epinastine hydrochloride|elest	DRUGBANK	DB00751	C16H15N3	small molecule	R06AX24|S01GX10	80012-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHWZLSFABNNENI-UHFFFAOYSA-N
10079	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Shioda K (2010)	20655983	178189	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10080	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Wiest SA (1999)	10494892	178188	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10081	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Salsali M (2004)	15049511	178194	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10082	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Todd KG (1995)	8749840	178187	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10083	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Finberg JP (2002)	12504917	178196	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10084	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Gatch MB (2006)	16495723	178197	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10085	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Nolen WA (2003)	14574774	178190	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10086	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Volz HP (1998)	9829163	178186	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10087	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Lang W (2004)	15351283	178192	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10088	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Shioda K (2004)	15276688	178191	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10089	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Cohen C (1999)	10548268	178195	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10090	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Loescher W (1999)	10027835	178193	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10091	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10092	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Shioda K (2010)	20655983	178189	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10093	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Wiest SA (1999)	10494892	178188	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10094	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Salsali M (2004)	15049511	178194	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10095	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Todd KG (1995)	8749840	178187	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10096	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Finberg JP (2002)	12504917	178196	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10097	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Gatch MB (2006)	16495723	178197	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10098	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Nolen WA (2003)	14574774	178190	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10099	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Volz HP (1998)	9829163	178186	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10100	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Lang W (2004)	15351283	178192	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10101	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Shioda K (2004)	15276688	178191	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10102	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Cohen C (1999)	10548268	178195	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10103	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Loescher W (1999)	10027835	178193	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10104	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	742	Tranylcypromine	Tranylcypromin|Tranilcipromina|Transamine|Tranylcypromine|Parnate|Tranylcyprominum	parnate|tranylcypromine sulfat	DRUGBANK	DB00752	C9H11N	small molecule	N06AF04	155-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-YGPZHTELSA-N
10105	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10106	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10107	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10108	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Kosk-Kosicka D (1993)	8214757	174516	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10109	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10110	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	McCracken ML (2010)	20826568	178200	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10111	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10112	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10113	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Seo K (2010)	20097266	178199	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10114	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Grasshoff C (2006)	16973644	174521	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10115	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10116	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10117	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10118	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10119	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Matchett GA (2009)	19298752	174518	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10120	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Dildy-Mayfield JE (1996)	8786535	174519	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10121	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Guo L (2007)	17207582	139486	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10122	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Fan RS (2005)	15845548	178201	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10123	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Bickler PE (2005)	16129978	178202	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10124	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Sazonova OV (2007)	17229152	178203	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10125	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lenkowski PW (2004)	15066664	176695	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10126	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10127	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10128	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	744	Ethotoin	3-Ethyl-5-phenyl-imidazolidine-2,4-dione|(+-)-3-Ethyl-5-phenylhydantoin|Ethotone|Etotoina|3-Ethyl-5-phenylhydantoin|Ethotoin|Ethotoinum|3-Ethyl-5-phenylimidazolidin-2,4-dione|1-Ethyl-2,5-dioxo-4-phenylimidazolidine|3-Ethyl-5-phenyl-2,4-imidazolidinedione	peganone	DRUGBANK	DB00754	C11H12N2O2	small molecule	N03AB01	86-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZQIFWWUIBRPBZ-UHFFFAOYSA-N
10129	114514	9052	-	GPRC5A	GPCR5A|PEIG-1|RAI3|RAIG1|TIG1	9606	Homo sapiens	unknown	target	Xu J (2005)	15677768	178205	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10130	114514	9052	-	GPRC5A	GPCR5A|PEIG-1|RAI3|RAIG1|TIG1	9606	Homo sapiens	unknown	target	Inoue S (2004)	15086536	178206	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10131	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Mic FA (2004)	15069081	178208	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10132	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Mic FA (2004)	15366004	178209	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10133	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Everts HB (2005)	15950969	173901	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10134	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Bordelon T (2004)	15299009	178210	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10135	114379	8854	-	ALDH1A2	RALDH(II)|RALDH2|RALDH2-T	9606	Homo sapiens	unknown	target	Doxakis E (2005)	15950488	178207	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10136	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Mic FA (2004)	15366004	178209	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10137	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Gidlof AC (2006)	16837774	173874	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10138	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Matt N (2005)	16207763	119194	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10139	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Kim H (2005)	16166285	178211	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10140	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Everts HB (2004)	15245423	178212	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10141	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Koda T (2007)	17161848	178213	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10142	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Wang J (2004)	14993281	178214	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10143	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	He JC (2007)	17182884	176646	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10144	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Day RM (2006)	16456186	176645	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10145	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Schrage K (2006)	16420438	176636	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10146	111853	5918	-	RARRES1	LXNL|TIG1	9606	Homo sapiens	agonist	target	Zirn B (2005)	15897880	178216	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10147	111853	5918	-	RARRES1	LXNL|TIG1	9606	Homo sapiens	agonist	target	Youssef EM (2004)	15059893	178215	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10148	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Nagasawa H (2005)	16392701	178217	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10149	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Schrage K (2006)	16420438	176636	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10150	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Hoegberg P (2005)	16109390	176650	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10151	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Stafslien DK (2007)	17184907	178219	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10152	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Redfern CP (2004)	15379735	178218	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10153	106695	190	-	NR0B1	AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10154	106695	190	-	NR0B1	AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10155	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10156	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10157	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10158	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10159	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Kamei Y (1993)	8394693	178222	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10160	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Reddy AP (1992)	1332684	178220	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10161	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Borger DR (2000)	10792999	178221	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-YCNIQYBTSA-N
10162	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	inhibitor	target	Lokanatha V (1999)	10487417	178226	746	Hexachlorophene	Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm	sapoderm|phisohex	DRUGBANK	DB00756	C13H6Cl6O2	small molecule	D08AE01	70-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGUYXCXAPNIKK-UHFFFAOYSA-N
10163	850996	946653	b2133	dld	ECK2126|JW2121	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	746	Hexachlorophene	Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm	sapoderm|phisohex	DRUGBANK	DB00756	C13H6Cl6O2	small molecule	D08AE01	70-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGUYXCXAPNIKK-UHFFFAOYSA-N
10164	850996	946653	b2133	dld	ECK2126|JW2121	511145	Escherichia coli	inhibitor	target	Wang JL (1978)	570044	178227	746	Hexachlorophene	Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm	sapoderm|phisohex	DRUGBANK	DB00756	C13H6Cl6O2	small molecule	D08AE01	70-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGUYXCXAPNIKK-UHFFFAOYSA-N
10165	850996	946653	b2133	dld	ECK2126|JW2121	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	746	Hexachlorophene	Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm	sapoderm|phisohex	DRUGBANK	DB00756	C13H6Cl6O2	small molecule	D08AE01	70-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGUYXCXAPNIKK-UHFFFAOYSA-N
10166	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	inhibitor	target	Wang JL (1978)	570044	178227	746	Hexachlorophene	Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm	sapoderm|phisohex	DRUGBANK	DB00756	C13H6Cl6O2	small molecule	D08AE01	70-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGUYXCXAPNIKK-UHFFFAOYSA-N
10167	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	inhibitor	target	Li M (2009)	19531491	178228	746	Hexachlorophene	Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Soy-dome|Nabac|Septi-soft|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|Germa-medica|Steral|Distodin|Septofen|Gamophene|Phisodan|Septisol|Hexabalm|Gamophen|Hexafen|Esaclorofene|Hexaclorofeno|Surofene|Surgi-cen|Hexide|Phiso-scrub|Armohex|Hexachlorophenum|Ster-zac|Hexa-germ|Staphene O|Turgex|Acigena|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|Steraskin|Hexascrub|Surgi-cin|Tersaseptic|Exofene|2,2'-Methanediylbis(3,4,6-trichlorophenol)|Solu-heks|Almederm	sapoderm|phisohex	DRUGBANK	DB00756	C13H6Cl6O2	small molecule	D08AE01	70-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGUYXCXAPNIKK-UHFFFAOYSA-N
10168	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10169	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gan TJ (2005)	15740177	178235	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10170	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Balfour JA (1997)	9257083	178229	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10171	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Eisenberg P (2003)	14635083	175658	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10172	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Conroy T (1994)	8141114	178234	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10173	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Boeijinga PH (1992)	1397053	178236	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10174	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gregory RE (1998)	9506240	178231	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10175	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Monaca-Charley C (2003)	14586600	178230	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10176	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Reith MK (1995)	7493546	178233	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10177	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Hui YF (1997)	9341357	178232	747	Dolasetron	Dolasetron|Dolastron|Dolasetronum	anzemet injection 20 mg/ml|anz	DRUGBANK	DB00757	C19H20N2O3	small molecule	A04AA04	115956-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKTAZPQNNNJVKR-KJGYPYNMSA-N
10178	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Wihlborg AK (2004)	15308557	178244	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10179	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Dorsam RT (2003)	14668029	178245	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10180	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10181	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Savi P (2006)	16835302	178240	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10182	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	van Gestel MA (2003)	12615691	178241	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10183	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Herbert JM (2003)	15199474	178242	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10184	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Gladding P (2008)	19463375	178243	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10185	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Wang L (2004)	15291969	178239	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10186	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Taubert D (2004)	15269827	178238	748	Clopidogrel	(+)-Clopidogrel|Clopidogrelum	ipg-clopidogrel|mar-clopidogre	DRUGBANK	DB00758	C16H16ClNO2S	small molecule	B01AC04	113665-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKTWGGQPFAXNFI-HNNXBMFYSA-N
10187	852157	947846	b3341	rpsG	ECK3328|JW3303	511145	Escherichia coli	inhibitor	target	Buck MA (1990)	2200507	178254	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10188	111606	5621	RP5-1068H6.2	PRNP	ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10189	111606	5621	RP5-1068H6.2	PRNP	ASCR|AltPrP|CD230|CJD|GSS|KURU|PRIP|PrP|PrP27-30|PrP33-35C|PrPc|p27-30	9606	Homo sapiens	inhibitor	target	De Luigi A (2008)	18365024	178255	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10190	852123	947811	b3316	rpsS	ECK3303|JW3278	511145	Escherichia coli	inhibitor	target	Buck MA (1990)	2200507	178254	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10191	852126	947814	b3314	rpsC	ECK3301|JW3276	511145	Escherichia coli	inhibitor	target	Buck MA (1990)	2200507	178254	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10192	852113	947801	b3307	rpsN	ECK3294|JW3269	511145	Escherichia coli	inhibitor	target	Buck MA (1990)	2200507	178254	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10193	852114	947802	b3306	rpsH	ECK3293|JW3268	511145	Escherichia coli	inhibitor	target	Buck MA (1990)	2200507	178254	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
10194	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	750	Meropenem	(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate	meropenem for injection|merrem	DRUGBANK	DB00760	C17H25N3O5S	small molecule	J01DH02	119478-56-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMJNNHOOLUXYBV-PQTSNVLCSA-N
10195	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	750	Meropenem	(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate	meropenem for injection|merrem	DRUGBANK	DB00760	C17H25N3O5S	small molecule	J01DH02	119478-56-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMJNNHOOLUXYBV-PQTSNVLCSA-N
10196	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Ubukata K (2001)	11353613	178257	750	Meropenem	(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate	meropenem for injection|merrem	DRUGBANK	DB00760	C17H25N3O5S	small molecule	J01DH02	119478-56-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMJNNHOOLUXYBV-PQTSNVLCSA-N
10197	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Kanazawa K (1997)	9099227	178256	750	Meropenem	(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid|Meropenem anhydrous|Antibiotic sm 7338|Meropenem|Meropenem trihydrate|Meropenemum|Meropenemum trihydricum|(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Meropenem Hydrate	meropenem for injection|merrem	DRUGBANK	DB00760	C17H25N3O5S	small molecule	J01DH02	119478-56-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMJNNHOOLUXYBV-PQTSNVLCSA-N
10198	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	binder	target	Fujiwara TM (2005)	16093448	178262	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10199	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	binder	target	Pressler CA (2006)	16807401	178260	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10200	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	binder	target	Bichet DG (2006)	16713495	178261	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10201	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10202	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10203	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	binder	target	Overington JP (2006)	17139284	171741	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10204	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10205	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	unknown	target	Hebert SC (2003)	12920401	178263	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10206	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10207	112449	6560	-	SLC12A4	KCC1	9606	Homo sapiens	unknown	target	Capo-Aponte JE (2007)	17418819	178266	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10208	112449	6560	-	SLC12A4	KCC1	9606	Homo sapiens	unknown	target	Misri S (2006)	16949074	178264	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10209	112449	6560	-	SLC12A4	KCC1	9606	Homo sapiens	unknown	target	Klein T (2006)	16943364	178265	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10210	121538	57468	RP11-465L10.5	SLC12A5	KCC2	9606	Homo sapiens	unknown	target	Tornberg J (2007)	16936706	178268	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10211	121538	57468	RP11-465L10.5	SLC12A5	KCC2	9606	Homo sapiens	unknown	target	Takayama C (2007)	17134779	178269	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10212	121538	57468	RP11-465L10.5	SLC12A5	KCC2	9606	Homo sapiens	unknown	target	Capo-Aponte JE (2007)	17418819	178266	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10213	121538	57468	RP11-465L10.5	SLC12A5	KCC2	9606	Homo sapiens	unknown	target	Takayama C (2006)	17008020	178267	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10214	121538	57468	RP11-465L10.5	SLC12A5	KCC2	9606	Homo sapiens	unknown	target	Misri S (2006)	16949074	178264	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10215	115311	9990	-	SLC12A6	ACCPN|KCC3|KCC3A|KCC3B	9606	Homo sapiens	unknown	target	Capo-Aponte JE (2007)	17418819	178266	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10216	115311	9990	-	SLC12A6	ACCPN|KCC3|KCC3A|KCC3B	9606	Homo sapiens	unknown	target	Misri S (2006)	16949074	178264	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10217	115311	9990	-	SLC12A6	ACCPN|KCC3|KCC3A|KCC3B	9606	Homo sapiens	unknown	target	Klein T (2006)	16943364	178265	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10218	115947	10723	-	SLC12A7	KCC4	9606	Homo sapiens	unknown	target	Capo-Aponte JE (2007)	17418819	178266	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10219	115947	10723	-	SLC12A7	KCC4	9606	Homo sapiens	unknown	target	Misri S (2006)	16949074	178264	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10220	115947	10723	-	SLC12A7	KCC4	9606	Homo sapiens	unknown	target	Klein T (2006)	16943364	178265	751	Potassium Chloride	Klor-CON|Monopotassium chloride|Chloride of potash|KCl|Kaliumchlorid|Chlorid draselny|Muriate of potash|Kaon-CL 10|Sylvite|[KCl]|Klotrix	isolyte r in 5% dextrose|acid 	DRUGBANK	DB00761	ClK	small molecule	B05XA01|A12BA51|A12BA01	7447-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUXLLCKKVVCTQ-UHFFFAOYSA-M
10221	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Nakagawa H (2006)	16309825	178271	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10222	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Ishikawa T (2006)	16454746	178270	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10223	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Yoshikawa M (2004)	15255290	178273	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10224	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Ramesh M (2010)	19852077	178272	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10225	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Yang X (2005)	15975002	178275	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10226	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Yoshikawa M (2004)	15170677	178274	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10227	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Chabot GG (1997)	9342501	178276	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10228	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10229	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Nakagawa H (2006)	16309825	178271	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10230	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Ishikawa T (2006)	16454746	178270	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10231	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Yoshikawa M (2004)	15255290	178273	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10232	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Ramesh M (2010)	19852077	178272	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10233	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Yang X (2005)	15975002	178275	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10234	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Yoshikawa M (2004)	15170677	178274	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10235	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Chabot GG (1997)	9342501	178276	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10236	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10237	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10238	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	752	Irinotecan	Biotecan|Camptothecin-11	irinotecan hydrochloride injec	DRUGBANK	DB00762	C33H38N4O6	small molecule	L01XX19	97682-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWKQSNNFCGGAFS-XIFFEERXSA-N
10239	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Sugawara M (1999)	10365684	176826	753	Methimazole	1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole	phl-methimazole|tapazole 5mg t	DRUGBANK	DB00763	C4H6N2S	small molecule	H03BB52|H03BB02	60-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMRYVIKBURPHAH-UHFFFAOYSA-N
10240	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Manzon RG (2001)	11241400	176827	753	Methimazole	1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole	phl-methimazole|tapazole 5mg t	DRUGBANK	DB00763	C4H6N2S	small molecule	H03BB52|H03BB02	60-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMRYVIKBURPHAH-UHFFFAOYSA-N
10241	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Magnusson RP (1992)	1320313	178284	753	Methimazole	1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole	phl-methimazole|tapazole 5mg t	DRUGBANK	DB00763	C4H6N2S	small molecule	H03BB52|H03BB02	60-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMRYVIKBURPHAH-UHFFFAOYSA-N
10242	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Chiovato L (1991)	1663395	178285	753	Methimazole	1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole	phl-methimazole|tapazole 5mg t	DRUGBANK	DB00763	C4H6N2S	small molecule	H03BB52|H03BB02	60-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMRYVIKBURPHAH-UHFFFAOYSA-N
10243	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	753	Methimazole	1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole	phl-methimazole|tapazole 5mg t	DRUGBANK	DB00763	C4H6N2S	small molecule	H03BB52|H03BB02	60-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMRYVIKBURPHAH-UHFFFAOYSA-N
10244	113026	7173	-	TPO	MSA|TDH2A|TPX	9606	Homo sapiens	inhibitor	target	Ferreira AC (2003)	12755690	176829	753	Methimazole	1-METHYL-1,3-dihydro-2H-imidazole-2-thione|Thiamazol|Thacapzol|USAF el-30|Danantizol|Favistan|Strumazol|Methimazole|Tiamazol|1-Methylimidazole-2(3H)-thione|Thiamazole|Mercazolyl|Thiamazolum|Tapazole	phl-methimazole|tapazole 5mg t	DRUGBANK	DB00763	C4H6N2S	small molecule	H03BB52|H03BB02	60-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMRYVIKBURPHAH-UHFFFAOYSA-N
10245	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Zhang X (2002)	12127907	178288	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10246	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10247	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Lumry WR (1999)	10518812	177111	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10248	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Isogai M (1993)	8439518	178286	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10249	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Smith CL (1998)	9793625	178287	754	Mometasone	Mometasonfuroat|Momtasone|(+)-Mometasone|Mometasone Furoate|Mometasoni furoas|Mometason furoat-1-Wasser|Mometasona|Mometasonum|Momtasone (furoate de)|Mometason|Mometasone Furoate Hydrate	nasal allergy and congestion r	DRUGBANK	DB00764	C22H28Cl2O4	small molecule	D07AC13|R03BA07|R03AK09|D07XC03|R01AD09	105102-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLIIKPVHVRXHRI-CXSFZGCWSA-N
10250	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Shore PA (1975)	1168577	178289	755	Metyrosine	Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine	demser	DRUGBANK	DB00765	C10H13NO3	small molecule	C02KB01	672-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHTGHBARYWONDQ-JTQLQIEISA-N
10251	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	755	Metyrosine	Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine	demser	DRUGBANK	DB00765	C10H13NO3	small molecule	C02KB01	672-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHTGHBARYWONDQ-JTQLQIEISA-N
10252	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Nasrallah HA (1977)	17374	178292	755	Metyrosine	Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine	demser	DRUGBANK	DB00765	C10H13NO3	small molecule	C02KB01	672-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHTGHBARYWONDQ-JTQLQIEISA-N
10253	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Yoshimoto Y (2005)	15710413	178291	755	Metyrosine	Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine	demser	DRUGBANK	DB00765	C10H13NO3	small molecule	C02KB01	672-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHTGHBARYWONDQ-JTQLQIEISA-N
10254	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	binder	target	Moore KE (1980)	7409209	178290	755	Metyrosine	Metyrosine|Metirosin|Metirosine|alpha-Methyl-P-tyrosine|Metirosina|Methyltyrosine|Metirosinum|Mtirosine|(-)-alpha-Methyl-L-tyrosine|alpha-Methyl-L-P-tyrosine|L-alpha-Methyltyrosine|alpha-Methyl-para-tyrosine|(S)-alpha-Methyltyrosine|alpha-Methyltyrosine	demser	DRUGBANK	DB00765	C10H13NO3	small molecule	C02KB01	672-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHTGHBARYWONDQ-JTQLQIEISA-N
10255	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10256	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10257	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10258	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10259	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Niemegeers CJ (1982)	6130555	178299	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10260	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Maurer H (1988)	2905706	178298	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10261	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10262	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10263	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10264	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10265	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10266	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10267	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10268	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	757	Benzquinamide	BZQ	-	DRUGBANK	DB00767	C22H32N2O5	small molecule	-	63-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSZILQVIPPROJI-UHFFFAOYSA-N
10269	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Roland PS (2010)	20402382	178301	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10270	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ohmori K (2002)	12046981	178300	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10271	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yanni JM (1996)	8951675	178303	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10272	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ohmori K (2001)	11496828	178302	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10273	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kaliner MA (2010)	20406593	178305	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10274	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tamura T (2005)	15942272	175347	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10275	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ohmori K (2005)	15646365	178306	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10276	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10277	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Roland PS (2010)	20482305	178304	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10278	112191	6283	-	S100A12	CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6	9606	Homo sapiens	antagonist	target	Kishimoto K (2006)	16864903	178308	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10279	112191	6283	-	S100A12	CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6	9606	Homo sapiens	antagonist	target	Okada M (2002)	11944917	178307	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10280	112192	6284	-	S100A13	-	9606	Homo sapiens	unknown	target	Okada M (2002)	11944917	178307	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10281	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Okada M (2002)	11944917	178307	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10282	112179	6271	RP1-178F15.1	S100A1	S100|S100-alpha|S100A	9606	Homo sapiens	antagonist	target	Okada M (2002)	11944917	178307	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10283	112181	6273	RP11-49N14.8	S100A2	CAN19|S100L	9606	Homo sapiens	antagonist	target	Okada M (2002)	11944917	178307	758	Olopatadine	Opatanol|Olopatadina|Olopatadinum|Olopatadin|Olopatadine	patanol|act olopatadine 0.1%|o	DRUGBANK	DB00768	C21H23NO3	small molecule	R01AC08|S01GX09	113806-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIMVDZLSHOPLA-LSCVHKIXSA-N
10284	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	759	Hydrocortamate	17-Hydroxycorticosterone, 21-(diethylamino)acetate|Hydrocortamatum|Hidrocortamato	-	DRUGBANK	DB00769	C27H41NO6	small molecule	-	76-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWFVLWGEFDIZMJ-FOMYWIRZSA-N
10285	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	759	Hydrocortamate	17-Hydroxycorticosterone, 21-(diethylamino)acetate|Hydrocortamatum|Hidrocortamato	-	DRUGBANK	DB00769	C27H41NO6	small molecule	-	76-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWFVLWGEFDIZMJ-FOMYWIRZSA-N
10286	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Dijkstra BG (1999)	10509658	178309	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10287	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10288	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Takahashi HK (2005)	15840408	178310	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10289	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Ito Y (2000)	10670413	178312	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10290	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Norel X (2004)	15560119	178313	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10291	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Takahashi HK (2003)	14561849	178311	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10292	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Matlhagela K (2006)	16516814	178314	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10293	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Tokuda H (2001)	11524243	178315	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10294	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	761	Clidinium	3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|Clidinii Bromidum|3-hydroxy-1-methylquinuclidinium benzilate ester|N-methyl quinuclidinyl benzilate|Clidinium bromid|Bromure de Clidinium	corium cap|chlordiazepoxide hy	DRUGBANK	DB00771	C22H26NO3	small molecule	A03CA02	7020-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOSGZJRQIVJSZ-NNBUQUNQSA-N
10295	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	761	Clidinium	3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|Clidinii Bromidum|3-hydroxy-1-methylquinuclidinium benzilate ester|N-methyl quinuclidinyl benzilate|Clidinium bromid|Bromure de Clidinium	corium cap|chlordiazepoxide hy	DRUGBANK	DB00771	C22H26NO3	small molecule	A03CA02	7020-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOSGZJRQIVJSZ-NNBUQUNQSA-N
10296	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	761	Clidinium	3-(2-Hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane|Bromuro de clidinio|Clidinii Bromidum|3-hydroxy-1-methylquinuclidinium benzilate ester|N-methyl quinuclidinyl benzilate|Clidinium bromid|Bromure de Clidinium	corium cap|chlordiazepoxide hy	DRUGBANK	DB00771	C22H26NO3	small molecule	A03CA02	7020-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOSGZJRQIVJSZ-NNBUQUNQSA-N
10297	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Ramos ZR (2006)	16782587	178319	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10298	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Ahmed M (2007)	17364237	178317	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10299	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10300	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	da Silva AP (2006)	16716398	178318	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10301	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10302	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	762	Malathion	O,O-Dimethyl S-(1,2-bis(ethoxycarbonyl)ethyl)|O,O-Dimethyl S-1,2-di(ethoxycarbamyl)ethyl|Mercaptothion|O,O-Dimethyldithiophosphate diethylmercaptosuccinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl) dithiophosphate|Karbofos|Carbophos|Maldison|Malathion|Diethyl (dimethoxyphosphinothioylthio)succinate|O,O-Dimethyl S-(1,2-dicarbethoxyethyl)phosphorodithioate|[(Dimethoxyphosphinothioyl)thio]butanedioic acid diethyl ester	ovide|malathion lotion, 0.5%|m	DRUGBANK	DB00772	C10H19O6PS2	small molecule	P03AX03	121-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXSJBGJIGXNWCI-UHFFFAOYSA-N
10303	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Moneypenny CG (2006)	16377807	178321	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10304	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Lopez-Lazaro M (2005)	16309315	178320	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10305	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Winnicka K (2007)	17514873	176107	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10306	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	de Lucio B (2005)	16271071	176106	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10307	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Uesaka T (2007)	17361331	176109	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10308	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10309	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	inhibitor	target	Azarova AM (2007)	17578914	178322	763	Etoposide	Toposar|Etoposido|Etoposide|Vepesid|EPEG|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|trans-Etoposide|VP-16|Etopophos|Etoposid|(-)-Etoposide|Eposin|EPE|Lastet|Epipodophyllotoxin|Etoposidum	etoposide - liq iv 20mg/ml|eto	DRUGBANK	DB00773	C29H32O13	small molecule	L01CB01	33419-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJJPUSNTGOMMGY-MRVIYFEKSA-N
10310	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10311	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10312	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10313	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10314	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10315	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10316	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10317	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10318	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10319	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10320	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10321	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10322	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10323	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10324	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10325	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10326	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Schaeffer P (1990)	2226620	174542	764	Hydroflumethiazide	Hidroflumetiazida|Hydroflumthiazide|Dihydroflumethazide|Hydroflumethiazide|Hidroflumetiazid|Metforylthiadiazin|Saluron|Idroflumetiazide|Hydroflumethiazidum	-	DRUGBANK	DB00774	C8H8F3N3O4S2	small molecule	C03AB02|C03AH02|C03AA02	135-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDGGSIALPNSEE-UHFFFAOYSA-N
10327	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Juwana YB (2010)	20210689	178329	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10328	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10329	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10330	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Juwana YB (2010)	20210689	178329	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10331	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	von Segesser LK (2001)	11565896	178334	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10332	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Kondo K (2002)	11929319	178330	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10333	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Dickfeld T (2001)	11342206	178331	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10334	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Roffi M (2002)	12057986	178332	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10335	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	antagonist	target	Theroux P (2000)	11076818	178333	765	Tirofiban	Tirofibanum|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|Tirofiban|(2S)-2-(Butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid	aggrastat	DRUGBANK	DB00775	C22H36N2O5S	small molecule	B01AC17	144494-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COKMIXFXJJXBQG-NRFANRHFSA-N
10336	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	766	Oxcarbazepine	OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide	jamp-oxcarbazepine|trileptal 3	DRUGBANK	DB00776	C15H12N2O2	small molecule	N03AF02	28721-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTRLABGOLIVAIY-UHFFFAOYSA-N
10337	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Vohora D (2010)	20502724	178335	766	Oxcarbazepine	OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide	jamp-oxcarbazepine|trileptal 3	DRUGBANK	DB00776	C15H12N2O2	small molecule	N03AF02	28721-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTRLABGOLIVAIY-UHFFFAOYSA-N
10338	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	766	Oxcarbazepine	OCBZ|Oxcarbazepina|Oxcarbazepine|Oxcarbamazepine|Oxcarbazepinum|10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide	jamp-oxcarbazepine|trileptal 3	DRUGBANK	DB00776	C15H12N2O2	small molecule	N03AF02	28721-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTRLABGOLIVAIY-UHFFFAOYSA-N
10339	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10340	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10341	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10342	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10343	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10344	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10345	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10346	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10347	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10348	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10349	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10350	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	KRAKOWSKI AJ (1962)	14035428	178336	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10351	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10352	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10353	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10354	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10355	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10356	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10357	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10358	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10359	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10360	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10361	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10362	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10363	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10364	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10365	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10366	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10367	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10368	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10369	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Beltinger J (2006)	16595573	178341	768	Roxithromycin	Roxitromicina|Roxithromycin|(9e)-Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime)|Roxithromycinum|Roxithromycine	-	DRUGBANK	DB00778	C41H76N2O15	small molecule	J01FA06	80214-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXZBMPWDPOLZGW-XMRMVWPWSA-N
10370	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Kaufmann P (2006)	17164692	178340	768	Roxithromycin	Roxitromicina|Roxithromycin|(9e)-Erythromycin 9-(O-((2-methoxyethoxy)methyl)oxime)|Roxithromycinum|Roxithromycine	-	DRUGBANK	DB00778	C41H76N2O15	small molecule	J01FA06	80214-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXZBMPWDPOLZGW-XMRMVWPWSA-N
10371	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10372	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Nolen WA (2003)	14574774	178190	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10373	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Volz HP (1998)	9829163	178186	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10374	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	McIntyre RS (2006)	16370964	178345	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10375	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Wooters TE (2007)	17912044	178344	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10376	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Pickar D (1982)	7092487	178347	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10377	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Chiche F (2009)	19201819	178346	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10378	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	antagonist	target	Chenu F (2009)	18700056	178343	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10379	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Todd KG (1995)	8749840	178187	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10380	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Todd KG (2009)	19203467	178349	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10381	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	McKenna KF (1991)	1881457	178348	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10382	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	McManus DJ (1992)	1610412	178352	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10383	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	MacKenzie EM (2008)	17768678	178353	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10384	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Tanay VA (2001)	11775064	178350	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10385	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	McKenna KF (1994)	7931216	178351	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10386	108846	2572	RP11-420F12.2	GAD2	GAD65	9606	Homo sapiens	inhibitor	target	McKenna KF (1994)	7931216	178351	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10387	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10388	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Nolen WA (2003)	14574774	178190	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10389	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Volz HP (1998)	9829163	178186	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10390	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	McIntyre RS (2006)	16370964	178345	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10391	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Wooters TE (2007)	17912044	178344	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10392	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Pickar D (1982)	7092487	178347	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10393	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Chiche F (2009)	19201819	178346	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10394	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	MacKenzie EM (2008)	17768678	178353	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10395	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	antagonist	target	Chenu F (2009)	18700056	178343	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10396	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	inhibitor	target	Todd KG (2009)	19203467	178349	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10397	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	inhibitor	target	McKenna KF (1991)	1881457	178348	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10398	124217	84706	-	GPT2	ALT2	9606	Homo sapiens	inhibitor	target	Tanay VA (2001)	11775064	178350	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10399	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	inhibitor	target	Todd KG (2009)	19203467	178349	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10400	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	inhibitor	target	McKenna KF (1991)	1881457	178348	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10401	109133	2875	-	GPT	AAT1|ALT1|GPT1	9606	Homo sapiens	inhibitor	target	Tanay VA (2001)	11775064	178350	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10402	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Chiche F (2009)	19201819	178346	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10403	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Biasi D (1995)	8539478	178356	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10404	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Lizcano JM (1996)	8694842	178357	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10405	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Kumar D (1998)	9570326	178354	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10406	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Tipnis UR (1992)	1483111	178355	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10407	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	MacKenzie EM (2008)	17768678	178353	770	Phenelzine	Phenelzinum|Phenelzin|Alazine|Phnelzine|Nardil|-Phenylethylhydrazine|Fenelzina|Monofen	nardil|phenelzine sulfate	DRUGBANK	DB00780	C8H12N2	small molecule	N06AF03	51-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMUCZJUITONUFY-UHFFFAOYSA-N
10408	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Mokry J (2005)	16080359	178362	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10409	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Saitoh H (1986)	3572714	178361	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10410	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Lukacs VA (1989)	2656175	178360	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10411	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10412	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10413	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Trkulja V (2004)	15337834	178359	772	Propantheline	Propanthelini Bromidum|Propantheline|Propanthelin bromid|Propantelina bromuro|Propanthline, bromure de|Propantelina, bromuro de	propantheline bromide|propanth	DRUGBANK	DB00782	C23H30NO3	small molecule	A03CA34|A03AB05	298-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVWYOYDLCMFIEM-UHFFFAOYSA-N
10414	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Xue Y (2007)	17327420	178363	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10415	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10416	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Vijayanathan V (2007)	17464340	178364	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10417	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10418	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lehnes K (2007)	17138652	178365	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10419	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10420	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brama M (2007)	17125913	178366	773	Estradiol	Estradiol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|beta-Estradiol|Dihydrotheelin|Dihydrofolliculin|17beta-Oestradiol|17beta Oestradiol|Femestral|Estradiolum|Benzhormovarine|Lio-Oid|17beta-Estra-1,3,5(10)-triene-3,17-diol|Dihydroxyestrin|Estradiol-17beta|cis-Estradiol|Dihydrofollicular hormone	climara 100|sandoz estradiol d	DRUGBANK	DB00783	C18H24O2	small molecule	G03CA03|G03FA13|G03FA12|G03FA11|G03FA10|G03FA17|G03FA16|G03FA15|G03FA14|G03CA53|G03AB08|G03FB10|G03FB11|G03FB12|G03FA08|G03FA09|G03EA01|G03EA03|G03EA02|G03FA01|G03FA02|G03FA03|G03FA04|G03FA05|G03FA06|G03FA07|G03AA14|G03HB01|G02BB01|G03FB03|G03FB02|G03FB01|G03FB07|G03FB06|G03FB05|G03FB04|G03FB09|G03FB08	50-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXZDWNPVJITMN-ZBRFXRBCSA-N
10421	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cryer B (1998)	9626023	178378	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10422	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Joo Y (2006)	16223958	178379	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10423	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Gierse JK (1995)	7832763	178380	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10424	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Sinniah R (2001)	11316248	178376	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10425	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Laudanno OM (1998)	9773153	178377	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10426	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2005)	15792781	65577	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10427	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Walton LJ (1999)	10393680	178381	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10428	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (1995)	7832763	178380	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10429	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10430	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2007)	17150210	178382	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10431	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cryer B (1998)	9626023	178378	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10432	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10433	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10434	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10435	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10436	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10437	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10438	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10439	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10440	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10441	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Jandhyala BS (1966)	5918523	178383	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10442	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10443	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Jandhyala ML (1968)	5674398	178384	775	Cryptenamine	-	-	DRUGBANK	DB00785	-	small molecule	-	1356-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
10444	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10445	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Shinoda K (2003)	12527923	178389	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10446	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Bernardo MM (2002)	11790786	178388	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10447	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10448	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Bourd-Boittin K (2005)	15748894	178385	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10449	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Fanchon S (2004)	15056115	178387	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10450	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Treharne GD (1999)	10460642	178386	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10451	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Nenan S (2007)	17234180	178390	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10452	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Underwood CK (2003)	12763661	178391	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10453	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10454	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10455	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10456	110462	4319	-	MMP10	SL-2|STMY2	9606	Homo sapiens	antagonist	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10457	110462	4319	-	MMP10	SL-2|STMY2	9606	Homo sapiens	antagonist	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10458	122039	64066	UNQ2503/PRO5992	MMP27	MMP-27	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10459	122039	64066	UNQ2503/PRO5992	MMP27	MMP-27	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10460	122566	79148	UNQ1893/PRO4339	MMP28	EPILYSIN|MM28|MMP-25|MMP-28|MMP25	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10461	122566	79148	UNQ1893/PRO4339	MMP28	EPILYSIN|MM28|MMP-25|MMP-28|MMP25	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10462	122149	64386	-	MMP25	MMP-25|MMP20|MMP20A|MMPL1|MT-MMP 6|MT-MMP6|MT6-MMP|MT6MMP|MTMMP6	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10463	122149	64386	-	MMP25	MMP-25|MMP20|MMP20A|MMPL1|MT-MMP 6|MT-MMP6|MT6-MMP|MT6MMP|MTMMP6	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10464	121151	56547	-	MMP26	-	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10465	121151	56547	-	MMP26	-	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10466	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10467	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10468	110468	4325	-	MMP16	C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10469	110468	4325	-	MMP16	C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10470	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10471	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10472	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10473	114082	8510	RP11-345P4.2	MMP23B	MIFR|MIFR-1|MMP22|MMP23A	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10474	114082	8510	RP11-345P4.2	MMP23B	MIFR|MIFR-1|MMP22|MMP23A	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10475	116099	10893	RP4-614O4.10-001	MMP24	MMP-24|MMP25|MT-MMP 5|MT-MMP5|MT5-MMP|MT5MMP|MTMMP5	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10476	116099	10893	RP4-614O4.10-001	MMP24	MMP-24|MMP25|MT-MMP 5|MT-MMP5|MT5-MMP|MT5MMP|MTMMP5	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10477	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10478	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10479	110459	4316	-	MMP7	MMP-7|MPSL1|PUMP-1	9606	Homo sapiens	antagonist	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10480	110459	4316	-	MMP7	MMP-7|MPSL1|PUMP-1	9606	Homo sapiens	antagonist	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10481	110463	4320	-	MMP11	SL-3|ST3|STMY3	9606	Homo sapiens	antagonist	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10482	110463	4320	-	MMP11	SL-3|ST3|STMY3	9606	Homo sapiens	antagonist	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10483	110466	4323	-	MMP14	MMP-14|MMP-X1|MT-MMP|MT-MMP 1|MT1-MMP|MT1MMP|MTMMP1|WNCHRS	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10484	110466	4323	-	MMP14	MMP-14|MMP-X1|MT-MMP|MT-MMP 1|MT1-MMP|MT1MMP|MTMMP1|WNCHRS	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10485	110467	4324	-	MMP15	MT2-MMP|MTMMP2|SMCP-2	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10486	110467	4324	-	MMP15	MT2-MMP|MTMMP2|SMCP-2	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10487	110469	4326	-	MMP17	MT4-MMP	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10488	110469	4326	-	MMP17	MT4-MMP	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10489	110470	4327	-	MMP19	MMP18|RASI-1	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10490	110470	4327	-	MMP19	MMP18|RASI-1	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10491	114725	9313	-	MMP20	AI2A2|MMP-20	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10492	114725	9313	-	MMP20	AI2A2|MMP-20	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10493	125624	118856	-	MMP21	MMP-21	9606	Homo sapiens	inhibitor	target	Heath EI (2000)	10852638	178392	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10494	125624	118856	-	MMP21	MMP-21	9606	Homo sapiens	inhibitor	target	Belotti D (2000)	10669951	178393	776	Marimastat	BB-2516|Marimastat	-	DRUGBANK	DB00786	C15H29N3O5	small molecule	-	154039-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCSMOTCMPXTDND-OUAUKWLOSA-N
10495	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Imming P (2006)	17016423	171742	777	Aciclovir	Aciclovirum|Acycloguanosine|Acyclovir	apo-acyclovir - tab 800mg|zovi	DRUGBANK	DB00787	C8H11N5O3	small molecule	J05AB01|D06BB53|D06BB03|S01AD03	59277-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKUXAQIIEYXACX-UHFFFAOYSA-N
10496	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Liu S (2006)	16638752	178395	777	Aciclovir	Aciclovirum|Acycloguanosine|Acyclovir	apo-acyclovir - tab 800mg|zovi	DRUGBANK	DB00787	C8H11N5O3	small molecule	J05AB01|D06BB53|D06BB03|S01AD03	59277-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKUXAQIIEYXACX-UHFFFAOYSA-N
10497	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Overington JP (2006)	17139284	171741	777	Aciclovir	Aciclovirum|Acycloguanosine|Acyclovir	apo-acyclovir - tab 800mg|zovi	DRUGBANK	DB00787	C8H11N5O3	small molecule	J05AB01|D06BB53|D06BB03|S01AD03	59277-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKUXAQIIEYXACX-UHFFFAOYSA-N
10498	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Suzuki M (2006)	16797734	174260	777	Aciclovir	Aciclovirum|Acycloguanosine|Acyclovir	apo-acyclovir - tab 800mg|zovi	DRUGBANK	DB00787	C8H11N5O3	small molecule	J05AB01|D06BB53|D06BB03|S01AD03	59277-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKUXAQIIEYXACX-UHFFFAOYSA-N
10499	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Sergerie Y (2008)	17913252	175604	777	Aciclovir	Aciclovirum|Acycloguanosine|Acyclovir	apo-acyclovir - tab 800mg|zovi	DRUGBANK	DB00787	C8H11N5O3	small molecule	J05AB01|D06BB53|D06BB03|S01AD03	59277-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKUXAQIIEYXACX-UHFFFAOYSA-N
10500	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	James MJ (2007)	17541796	178397	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10501	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10502	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10503	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10504	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10505	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10506	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10507	111247	5226	-	PGD	6PGD	9606	Homo sapiens	inhibitor	target	Akkemik E (2010)	20235752	176889	779	Gadopentetate dimeglumine	Meglumine gadopentetate|Gd-DTPA|Diethylenetriaminepentaacetic acid dimeglumine salt gadolinium chelate|Gadopentetic acid dimeglumine salt|Magnevist|Dimeglumine-gadolinium-dtpa	magnevist|gadopentetate dimegl	DRUGBANK	DB00789	C28H54GdN5O20	small molecule	-	86050-77-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LGMLJQFQKXPRGA-VPVMAENOSA-K
10508	111247	5226	-	PGD	6PGD	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	779	Gadopentetate dimeglumine	Meglumine gadopentetate|Gd-DTPA|Diethylenetriaminepentaacetic acid dimeglumine salt gadolinium chelate|Gadopentetic acid dimeglumine salt|Magnevist|Dimeglumine-gadolinium-dtpa	magnevist|gadopentetate dimegl	DRUGBANK	DB00789	C28H54GdN5O20	small molecule	-	86050-77-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LGMLJQFQKXPRGA-VPVMAENOSA-K
10509	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Alfakih K (2006)	16370923	178404	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10510	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10511	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10512	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Brugts JJ (2009)	19379059	178403	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10513	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ohta Y (1999)	10208755	178408	782	Tripelennamine	Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine	vagin-x|vaginex w tripelennami	DRUGBANK	DB00792	C16H21N3	small molecule	D04AA04|R06AC04	91-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFLGIAIHIAPJJC-UHFFFAOYSA-N
10514	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sansone M (1988)	3253717	178409	782	Tripelennamine	Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine	vagin-x|vaginex w tripelennami	DRUGBANK	DB00792	C16H21N3	small molecule	D04AA04|R06AC04	91-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFLGIAIHIAPJJC-UHFFFAOYSA-N
10515	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chiba S (1976)	996853	178406	782	Tripelennamine	Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine	vagin-x|vaginex w tripelennami	DRUGBANK	DB00792	C16H21N3	small molecule	D04AA04|R06AC04	91-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFLGIAIHIAPJJC-UHFFFAOYSA-N
10516	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Shimizu K (1982)	6759742	178407	782	Tripelennamine	Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine	vagin-x|vaginex w tripelennami	DRUGBANK	DB00792	C16H21N3	small molecule	D04AA04|R06AC04	91-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFLGIAIHIAPJJC-UHFFFAOYSA-N
10517	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	782	Tripelennamine	Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine	vagin-x|vaginex w tripelennami	DRUGBANK	DB00792	C16H21N3	small molecule	D04AA04|R06AC04	91-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFLGIAIHIAPJJC-UHFFFAOYSA-N
10518	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Suzuki T (1997)	9226736	178410	782	Tripelennamine	Tripelennamina|PBZ-sr|PBZ|Tripelennaminum|Tripelennamin|Triplennamine	vagin-x|vaginex w tripelennami	DRUGBANK	DB00792	C16H21N3	small molecule	D04AA04|R06AC04	91-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFLGIAIHIAPJJC-UHFFFAOYSA-N
10519	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10520	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10521	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10522	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10523	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10524	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10525	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10526	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10527	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10528	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10529	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10530	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10531	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10532	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10533	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10534	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10535	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10536	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10537	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10538	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10539	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10540	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10541	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10542	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10543	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10544	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10545	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10546	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10547	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	inhibitor	target	Gout PW (2001)	11587223	178411	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10548	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	antagonist	target	Stenson WF (1983)	6135423	178412	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10549	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10550	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Schwab M (2008)	18544567	174605	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10551	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10552	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rousseaux C (2005)	15824083	174607	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10553	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10554	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10555	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10556	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	antagonist	target	Pruzanski W (1997)	9256165	174553	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10557	106556	38	-	ACAT1	ACAT|MAT|T2|THIL	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10558	106556	38	-	ACAT1	ACAT|MAT|T2|THIL	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10559	106556	38	-	ACAT1	ACAT|MAT|T2|THIL	9606	Homo sapiens	inhibitor	target	Faison LD (1992)	1357724	178413	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10560	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Weber CK (2000)	11054378	174546	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10561	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10562	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Weber CK (2000)	11054378	174546	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10563	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10569	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Caballero-George C (2003)	12504781	178423	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10570	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Engelhorn T (2006)	16901636	178419	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10571	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Wada T (1996)	10968199	178418	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10572	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Vauquelin G (2006)	16601569	178415	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10573	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Meredith PA (2007)	17588300	178421	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10574	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Malmqvist K (2000)	10826401	178417	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10575	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Mendis B (2009)	19563275	178416	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10576	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Cervenka L (1999)	9892163	178424	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10577	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	McInnes GT (2000)	10805052	178420	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10578	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10579	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Baguet JP (2009)	19436650	178422	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10580	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Gaulton A (2012)	21948594	174478	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10581	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Ward RM (1984)	6386273	178426	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10582	109510	3274	-	HRH2	H2R	9606	Homo sapiens	agonist	target	Roll C (1993)	8487790	178427	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10583	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Roll C (1993)	8487790	178427	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10584	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Song W (2002)	11938943	178428	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10585	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Teskin O (2006)	16368348	178429	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10586	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10587	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10588	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	binder	target	Trendelenburg AU (1997)	9089664	178430	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10589	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Trendelenburg AU (1997)	9089664	178430	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10590	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Song W (2002)	11938943	178428	787	Tolazoline	2-Benzyl-2-imidazoline|Tolazolina|Tolazolinum|2-Benzyl-4,5-imidazoline|Benzazolin|Tolazolin|2-Benzylimidazoline|Tolazoline|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole	-	DRUGBANK	DB00797	C10H12N2	small molecule	M02AX02|C04AB02	59-98-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVZKJJQOZQXQB-UHFFFAOYSA-N
10593	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Tamehiro N (2003)	14602594	178433	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10594	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Hu H (2001)	11282646	178432	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10595	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Schroeder R (2000)	10619838	178431	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10596	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Gill AE (2004)	15332709	177802	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10597	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Nagai J (2006)	16488503	178436	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10598	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Watanabe A (2004)	15023454	178435	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10599	110216	4036	-	LRP2	DBS|GP330	9606	Homo sapiens	unknown	target	Takamoto K (2005)	15777622	178434	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
10600	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Arechalde A (2000)	18034539	178437	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10601	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10602	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10603	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10604	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10605	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Baumann L (2005)	16144296	176638	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10606	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Nagpal S (2000)	10828316	178442	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10607	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Chandraratna RA (1996)	9035701	178440	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10608	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Yen A (2004)	15383624	178441	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10609	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Meder W (2003)	14675762	178439	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10610	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Wang Q (2001)	11519864	178438	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10611	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Arechalde A (2000)	18034539	178437	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10612	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Jones PH (2003)	12942109	178443	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10613	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Chandraratna RA (1996)	9035701	178440	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10614	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Orlandi A (2004)	15102095	178444	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10615	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Nagpal S (2000)	10828316	178442	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10616	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10617	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	789	Tazarotene	Tazarotene|Tazaroteno|Tazarotenum|Zorac|Avage|Tazorac	tazorac|fabior|avage	DRUGBANK	DB00799	C21H21NO2S	small molecule	D05AX05	118292-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGQICQVSFDPSEI-UHFFFAOYSA-N
10618	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10619	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Dhasmana KM (1993)	8103596	178446	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10620	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Zeng C (2009)	19293728	178445	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10621	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Martin SW (1995)	7670737	178447	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10622	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Martin SW (1995)	7670737	178447	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10623	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10624	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10625	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Martin SW (1995)	7670737	178447	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10626	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	unknown	target	Martin SW (1995)	7670737	178447	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10627	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10628	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10629	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Dhasmana KM (1993)	8103596	178446	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10630	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Zeng C (2009)	19293728	178445	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10631	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10632	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10633	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Martin SW (1995)	7670737	178447	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10634	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10635	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10636	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Martin SW (1995)	7670737	178447	790	Fenoldopam	Fenoldopam|Fenoldopamum|Fnoldopam	corlopam	DRUGBANK	DB00800	C16H16ClNO3	small molecule	C01CA19	67227-56-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVURRHSHRRELCG-UHFFFAOYSA-N
10637	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10638	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10639	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10640	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10641	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10642	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10643	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10644	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10645	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10646	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10647	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10648	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10649	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10650	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10651	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10652	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10653	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10654	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10655	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10656	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10657	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10658	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10659	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10660	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10661	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10662	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10663	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10664	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10665	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10666	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10667	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10668	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10669	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10670	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10671	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10672	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Oertel BG (2006)	16906017	178451	792	Alfentanil	Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl	alfenta inj 500mcg/ml|alfentan	DRUGBANK	DB00802	C21H32N6O3	small molecule	N01AH02	71195-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDBPHNDTYPBSNI-UHFFFAOYSA-N
10673	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Leung A (2001)	11240090	178450	792	Alfentanil	Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl	alfenta inj 500mcg/ml|alfentan	DRUGBANK	DB00802	C21H32N6O3	small molecule	N01AH02	71195-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDBPHNDTYPBSNI-UHFFFAOYSA-N
10674	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	792	Alfentanil	Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl	alfenta inj 500mcg/ml|alfentan	DRUGBANK	DB00802	C21H32N6O3	small molecule	N01AH02	71195-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDBPHNDTYPBSNI-UHFFFAOYSA-N
10675	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Garrido M (2000)	10955836	178452	792	Alfentanil	Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl	alfenta inj 500mcg/ml|alfentan	DRUGBANK	DB00802	C21H32N6O3	small molecule	N01AH02	71195-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDBPHNDTYPBSNI-UHFFFAOYSA-N
10676	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Loetsch J (2005)	15694871	178453	792	Alfentanil	Alfentanilum|N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide|Alfentanyl	alfenta inj 500mcg/ml|alfentan	DRUGBANK	DB00802	C21H32N6O3	small molecule	N01AH02	71195-58-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDBPHNDTYPBSNI-UHFFFAOYSA-N
10677	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10678	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10679	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10680	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Jin CH (2009)	19533734	178460	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10681	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Pavia J (1997)	9059856	178461	794	Dicyclomine	DICYCLOMINE|Dicycloverine|Bicyclohexyl-1-carboxylic acid 2-diethylamino-ethyl ester|2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate|Dicycloverinum|Dicicloverina|Dicycloverin	bentylol tablet 10mg|dicyclomi	DRUGBANK	DB00804	C19H35NO2	small molecule	A03AA07	77-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CURUTKGFNZGFSE-UHFFFAOYSA-N
10682	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Duarte CD (2007)	18045214	178462	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10683	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Contreras JM (1999)	10052979	178463	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10684	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10685	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10686	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10687	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10688	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Kan JP (1986)	3954800	178464	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10689	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10690	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10691	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Biziere K (1985)	3836113	178465	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10692	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Muramatsu M (1988)	2975224	178466	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10693	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kodama K (1992)	1361012	178467	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10694	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nabeshima T (1989)	2530096	178468	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10695	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10696	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Kodama K (1992)	1361012	178467	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10697	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Muramatsu M (1988)	2975224	178466	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10698	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10699	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10700	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Worms P (1989)	2586634	178469	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10701	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Duarte CD (2007)	18045214	178462	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10702	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10703	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Kodama K (1992)	1361012	178467	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10704	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Muramatsu M (1988)	2975224	178466	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10705	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10706	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10707	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10708	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10709	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10710	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Kreth S (2010)	19997047	178470	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10711	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10712	110962	4907	RP11-321N4.1	NT5E	CALJA|CD73|E5NT|NT|NT5|NTE|eN|eNT	9606	Homo sapiens	inhibitor	target	Ustunsoy H (2006)	16426349	178471	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10713	110962	4907	RP11-321N4.1	NT5E	CALJA|CD73|E5NT|NT|NT5|NTE|eN|eNT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	796	Pentoxifylline	Pentoxil|Trental|Pentoxifilina|Pentoxifyllinum|Pentoxifylline|Oxpentifylline|Pentoxifyllin	trental tab 400mg|gapeam budib	DRUGBANK	DB00806	C13H18N4O3	small molecule	C04AD03	6493-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYPFEZZEUUWMEJ-UHFFFAOYSA-N
10714	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	797	Proparacaine	Proxymetacaine|Proximetacaina|Proxymetacainum	alcaine|proparacaine hydrochlo	DRUGBANK	DB00807	C16H26N2O3	small molecule	S01HA04	499-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCLANYCVBBTKTO-UHFFFAOYSA-N
10715	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	797	Proparacaine	Proxymetacaine|Proximetacaina|Proxymetacainum	alcaine|proparacaine hydrochlo	DRUGBANK	DB00807	C16H26N2O3	small molecule	S01HA04	499-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCLANYCVBBTKTO-UHFFFAOYSA-N
10716	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Tella SR (1998)	9476974	177548	797	Proparacaine	Proxymetacaine|Proximetacaina|Proxymetacainum	alcaine|proparacaine hydrochlo	DRUGBANK	DB00807	C16H26N2O3	small molecule	S01HA04	499-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCLANYCVBBTKTO-UHFFFAOYSA-N
10717	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	inhibitor	target	Li RA (2001)	11351021	178473	798	Indapamide	Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide	dom-indapamide tablets 1.25mg|	DRUGBANK	DB00808	C16H16ClN3O3S	small molecule	C03BA11|C09BX01	26807-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDAHWYSQHTHNT-UHFFFAOYSA-N
10718	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	inhibitor	target	Ohya S (2002)	11804849	178472	798	Indapamide	Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide	dom-indapamide tablets 1.25mg|	DRUGBANK	DB00808	C16H16ClN3O3S	small molecule	C03BA11|C09BX01	26807-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDAHWYSQHTHNT-UHFFFAOYSA-N
10719	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	798	Indapamide	Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide	dom-indapamide tablets 1.25mg|	DRUGBANK	DB00808	C16H16ClN3O3S	small molecule	C03BA11|C09BX01	26807-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDAHWYSQHTHNT-UHFFFAOYSA-N
10720	109955	3753	-	KCNE1	ISK|JLNS|JLNS2|LQT2/5|LQT5|MinK	9606	Homo sapiens	inhibitor	target	Ohya S (2002)	11804849	178472	798	Indapamide	Indapamide|Indapamida|Indapamidum|Indapamid|Metindamide	dom-indapamide tablets 1.25mg|	DRUGBANK	DB00808	C16H16ClN3O3S	small molecule	C03BA11|C09BX01	26807-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDAHWYSQHTHNT-UHFFFAOYSA-N
10721	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10722	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10723	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10724	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Betz AJ (2007)	17594079	178475	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10725	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Betz AJ (2007)	17594079	178475	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10726	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Betz AJ (2007)	17594079	178475	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10727	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Betz AJ (2007)	17594079	178475	799	Tropicamide	Tropicamid|Tropicamide|Tropicamidum|Tropicamida|Mydriacyl	diotrope 1% solution|minims tr	DRUGBANK	DB00809	C17H20N2O2	small molecule	S01FA06|S01FA56	1508-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDKAVGWHJFAGW-UHFFFAOYSA-N
10728	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10729	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10730	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10731	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10732	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10733	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eltze M (1994)	8081071	178479	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10734	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Eltze M (1999)	10370904	178478	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10735	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Pehl C (1998)	9798802	178477	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10736	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Hosoi R (2000)	10907719	178476	800	Biperiden	Biperideno|Biperidene|alpha-Bicyclo[2.2.1]hept-5-en-2-yl-alpha-phenyl-1-piperidinepropanol|alpha-5-Norbornen-2-yl-alpha-phenyl-1-piperidinepropanol|Beperiden|1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol|Biperidenum	akineton tab 2mg	DRUGBANK	DB00810	C21H29NO	small molecule	N04AA02	514-65-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSXKPIUOCJLQIE-UHFFFAOYSA-N
10737	106644	132	-	ADK	AK	9606	Homo sapiens	activator	target	Wu JZ (2005)	15917509	178480	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10738	106644	132	-	ADK	AK	9606	Homo sapiens	activator	target	Kumarapperuma SC (2007)	17379518	178481	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10739	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10740	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Leyssen P (2006)	16421290	178482	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10741	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	McHutchison JG (2005)	16152757	178483	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10742	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Gish RG (2006)	16293677	178484	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10743	111193	5167	-	ENPP1	ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10744	111193	5167	-	ENPP1	ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10745	116627	22978	RP11-30H12.3	NT5C2	GMP|NT5B|PNT5|SPG45|SPG65|cN-II	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10746	116627	22978	RP11-30H12.3	NT5C2	GMP|NT5B|PNT5|SPG45|SPG65|cN-II	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
10747	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Morton AJ (2005)	15563928	178490	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10748	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Zitova A (2010)	19849999	178488	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10749	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10750	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10751	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10752	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Marnett LJ (1984)	6434940	178491	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10753	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Reed GA (1985)	3917545	178493	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10754	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Tobin T (1986)	3517382	178492	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10755	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Takada Y (2004)	15489888	178495	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10756	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Arifah AK (2002)	12213119	178494	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10757	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10758	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10759	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Pascoe JE (2008)	18325678	178496	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10760	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Poonawala T (2005)	15828941	178497	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10761	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Rodrigues AR (2005)	15665994	178502	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10762	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Darwish M (2006)	16861092	178501	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10763	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Sahin AS (2005)	15868528	178500	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10764	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Hajiha M (2009)	19403616	178499	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10765	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Darwish M (2005)	16372825	178498	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10766	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10767	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Scott LJ (2005)	16332149	178507	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10768	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dardonville C (2006)	16797997	178506	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10769	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dosen-Micovic L (2006)	16376082	178505	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10770	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Scott LJ (2005)	16114980	178504	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10771	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	You HJ (2005)	15589524	178503	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10772	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Hajiha M (2009)	19403616	178499	803	Fentanyl	N-phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Fentanyl CII|N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide|N-(1-phenethyl-4-piperidyl)propionanilide|Fentanyl|N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|1-phenethyl-4-N-propionylanilinopiperidine|Phentanyl|Fentanila|Fentanylum|Fentanil|N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|Fentanilo	ran-fentanyl transdermal syste	DRUGBANK	DB00813	C22H28N2O	small molecule	N02AB03|N01AH01|N01AH51	437-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJMPHNIQZUBGLI-UHFFFAOYSA-N
10773	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10774	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Panara MR (1999)	10381787	178508	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tegeder I (1999)	10340919	178510	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poulsen Nautrup B (1999)	10220944	178511	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gross JM (1999)	10567199	178509	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Panara MR (1999)	10381787	178508	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10781	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kimura M (1999)	10490901	178519	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10782	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10783	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Fitch KD (1986)	2870555	178521	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10784	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hu DN (2000)	10973730	178520	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10785	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Singh H (1996)	8760245	178523	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10786	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gelmont DM (1988)	3168573	178522	806	Orciprenaline	Orciprenaline|Metaproterenol|Orciprenalinum|Orciprenalina	metaproterenol sulfate|tanta o	DRUGBANK	DB00816	C11H17NO3	small molecule	R03AB03|R03CB53|R03CB03	586-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMOINURANNBYCM-UHFFFAOYSA-N
10787	851816	947499	b3019	parC	ECK3010|JW2987	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10788	851816	947499	b3019	parC	ECK3010|JW2987	511145	Escherichia coli	inhibitor	target	Zweerink MM (1986)	3010848	178524	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10789	851816	947499	b3019	parC	ECK3010|JW2987	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10790	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	inhibitor	target	Hirai K (1986)	3532944	178525	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10791	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10792	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	inhibitor	target	Chen X (2002)	11752352	171740	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10793	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10794	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	inhibitor	target	Zweerink MM (1986)	3010848	178524	807	Rosoxacin	Rosoxacino|Rosoxacin|Acrosoxacin|Rosoxacine|Rosoxacinum|ROS|Roxadyl	-	DRUGBANK	DB00817	C17H14N2O3	small molecule	J01MB01	40034-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBPZXDSZHPDXQU-UHFFFAOYSA-N
10795	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Franks NP (2006)	16402123	174522	808	Propofol	Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan	pms-propofol|propofol-ii injec	DRUGBANK	DB00818	C12H18O	small molecule	N01AX10	2078-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLBCVFGFOZPWHH-UHFFFAOYSA-N
10796	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Haeseler G (2008)	18574460	178526	808	Propofol	Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan	pms-propofol|propofol-ii injec	DRUGBANK	DB00818	C12H18O	small molecule	N01AX10	2078-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLBCVFGFOZPWHH-UHFFFAOYSA-N
10797	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Franks NP (2006)	16402123	174522	808	Propofol	Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan	pms-propofol|propofol-ii injec	DRUGBANK	DB00818	C12H18O	small molecule	N01AX10	2078-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLBCVFGFOZPWHH-UHFFFAOYSA-N
10798	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Haeseler G (2008)	18574460	178526	808	Propofol	Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan	pms-propofol|propofol-ii injec	DRUGBANK	DB00818	C12H18O	small molecule	N01AX10	2078-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLBCVFGFOZPWHH-UHFFFAOYSA-N
10799	106854	358	-	AQP1	AQP-CHIP|CHIP28|CO	9606	Homo sapiens	inhibitor	target	Mu SM (2003)	12830709	178536	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10800	106854	358	-	AQP1	AQP-CHIP|CHIP28|CO	9606	Homo sapiens	inhibitor	target	Xiang Y (2002)	12147198	178537	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10801	106854	358	-	AQP1	AQP-CHIP|CHIP28|CO	9606	Homo sapiens	inhibitor	target	Xiang Y (2004)	15169637	178534	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10802	106854	358	-	AQP1	AQP-CHIP|CHIP28|CO	9606	Homo sapiens	inhibitor	target	Ma B (2004)	14704128	178535	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10803	106854	358	-	AQP1	AQP-CHIP|CHIP28|CO	9606	Homo sapiens	inhibitor	target	Oshio K (2004)	14753499	178538	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10804	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10805	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Avvaru BS (2010)	20605094	178539	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10806	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10807	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Perez Velazquez JL (2003)	12956733	175092	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10808	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10809	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2001)	11430635	178542	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10810	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (1996)	8667211	178541	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10811	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Meierkord H (2000)	10651143	178540	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10812	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10813	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Avvaru BS (2010)	20605094	178539	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10814	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10815	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Avvaru BS (2010)	20605094	178539	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10816	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	809	Acetazolamide	Diamox|Diluran|N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide|Acetazolamid|N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide|Diacarb|Defiltran|Glaupax|Acetazolamidum|Actazolamide	diamox pws 500mg/vial|diamox i	DRUGBANK	DB00819	C4H6N4O3S2	small molecule	S01EC01	59-66-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZKPWHYZMXOIDC-UHFFFAOYSA-N
10817	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Zoraghi R (2007)	17979301	174365	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10818	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10819	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Curran M (2003)	14498756	178543	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10820	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Rotella DP (2003)	12625031	178547	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10821	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Montorsi F (2003)	12603396	178546	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10822	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Roumeguere T (2003)	12891884	178545	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10823	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Eardley I (2002)	12074215	178544	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10824	119167	50940	-	PDE11A	PPNAD2	9606	Homo sapiens	inhibitor	target	Weeks JL (2007)	17696499	178549	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10825	119167	50940	-	PDE11A	PPNAD2	9606	Homo sapiens	inhibitor	target	Weeks JL (2009)	19641165	178548	810	Tadalafil	(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadanafil|Adcirca|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|ICOS 351|Cialis	act tadalafil|mylan-tadalafil|	DRUGBANK	DB00820	C22H19N3O4	small molecule	G04BE08	171596-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOXKDUGGOYFFRN-IIBYNOLFSA-N
10826	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10827	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10828	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10829	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brideau C (2001)	11703020	178550	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10830	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narlawar R (2006)	17181139	178551	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10831	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10832	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10833	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	inhibitor	target	Gaval-Cruz M (2009)	19720750	178553	812	Disulfiram	Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide	antabuse tab 0.25gm|antabuse t	DRUGBANK	DB00822	C10H20N2S4	small molecule	P03AA54|P03AA04|N07BB01	97-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUZONCFQVSMFAP-UHFFFAOYSA-N
10834	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	inhibitor	target	Mackenzie IS (2005)	16051882	178554	812	Disulfiram	Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide	antabuse tab 0.25gm|antabuse t	DRUGBANK	DB00822	C10H20N2S4	small molecule	P03AA54|P03AA04|N07BB01	97-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUZONCFQVSMFAP-UHFFFAOYSA-N
10835	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	inhibitor	target	Ho MP (2007)	17220694	178555	812	Disulfiram	Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide	antabuse tab 0.25gm|antabuse t	DRUGBANK	DB00822	C10H20N2S4	small molecule	P03AA54|P03AA04|N07BB01	97-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUZONCFQVSMFAP-UHFFFAOYSA-N
10836	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10837	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kappus H (1973)	4123746	178556	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10838	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10839	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10840	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Tamaya T (1977)	858280	178557	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10841	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Briggs MH (1975)	166800	178558	813	Ethynodiol diacetate	Etynodiolum|17-Ethynyl-4-estrene-3,17-diol diacetate|3,17-Diacetoxy-19-nor-17-pregn-4-en-20-yne|Etynodiol|Etynodiol acetate|tynodiol|Etinodiol|17-Ethynyl-19-norandrost-4-ene-3,17-beta-diol diacetate|19-Nor-17-pregn-4-en-20-yne-3,17-diol diacetate|3, 17-Diacetoxy-17-ethynyl-4-oestrene|17-Ethynylestr-4-ene-3,17-diol acetate|17-Ethynyl-3,17-dihydroxy-4-estrene diacetate|Ethynodiol	kelnor 1/35|demulen 30 (28 day	DRUGBANK	DB00823	C24H32O4	small molecule	G03AA01|G03DC06|G03FA06	297-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONKUMRGIYFNPJW-KIEAKMPYSA-N
10842	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10843	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10844	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	unknown	target	Linden J (1999)	10496952	178559	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10845	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Holgate ST (2005)	15980878	174822	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10846	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10847	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10848	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Ukena D (1985)	3002801	178561	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10849	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Dar MS (1990)	2262902	178560	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10850	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Dulloo AG (1991)	1885257	178563	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10851	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Featherstone RL (2004)	17670210	178562	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10852	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Berg G (1987)	3446047	178564	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10853	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Linden J (1999)	10496952	178559	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10854	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	unknown	target	Linden J (1999)	10496952	178559	814	Enprofylline	3-Propylxanthine|3,7-dihydro-3-Propyl-1H-purine-2,6-dione|Enprofilina|3-Propyl-3,7-dihydro-purine-2,6-dione|3-n-Propylxanthine|Enprofylline|Enprofyllinum	-	DRUGBANK	DB00824	C8H10N4O2	small molecule	-	41078-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIQPXVQCUCHWDI-UHFFFAOYSA-N
10855	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10856	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Eccles R (1994)	7529306	178570	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10857	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Story GM (2003)	12654248	178565	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10858	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Behrendt HJ (2004)	14757700	178567	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10859	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Bandell M (2004)	15046718	178566	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10860	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Andersson DA (2004)	15190109	178569	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10861	122512	79054	-	TRPM8	LTRPC6|TRPP8	9606	Homo sapiens	inducer	target	Stein RJ (2004)	15311065	178568	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10862	127821	162514	-	TRPV3	OLMS|VRL3	9606	Homo sapiens	inducer	target	Macpherson LJ (2006)	16829128	178571	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10863	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Namer B (2005)	15931068	178572	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10864	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10865	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Macpherson LJ (2006)	16829128	178571	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10866	114471	8989	-	TRPA1	ANKTM1|FEPS	9606	Homo sapiens	inducer	target	Story GM (2003)	12654248	178565	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10867	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Taniguchi Y (1994)	7851817	178573	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10868	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Galeotti N (2002)	11897159	178574	815	Menthol	(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol|Levomentholum|(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol|L-menthol|L-(-)-menthol|(r)-(-)-menthol|Levomenthol|(-)-(1R,3R,4S)-Menthol|(1R,3R,4S)-(-)-Menthol|Levomentol|(-)-menthol	prozero|western family pain re	DRUGBANK	DB00825	C10H20O	small molecule	-	2216-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOLISFMXDJSKH-KXUCPTDWSA-N
10869	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10870	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10871	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	Samland AK (1999)	10529188	178577	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10872	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	Kim DH (1996)	8664284	178578	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10873	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	McCoy AJ (2003)	12562791	178579	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10874	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	Eschenburg S (2005)	15531591	178581	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10875	852016	947703	b3189	murA	ECK3178|JW3156|mrbA|murZ	511145	Escherichia coli	inhibitor	target	Brown ED (1995)	7608103	178580	818	Fosfomycin	FOSFOMYCIN|Phosphomycin|(1R,2S)-Epoxypropylphosphonic acid|Fosfocina|Fosfomycinum|Phosphonemycin|cis-(1R,2S)-Epoxypropylphosphonic acid|L-cis-1,2-Epoxypropylphosphonic acid|1R-cis-(1,2-Epoxypropyl)phosphonic acid|(-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid|Phosphonomycin|(2R-cis)-(3-Methyloxiranyl)phosphonic acid|Fosfomycine|Fosfomicina|FCM	monurol	DRUGBANK	DB00828	C3H7O4P	small molecule	J01XX01	23155-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMDXZJFXQJVXBF-STHAYSLISA-N
10876	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10877	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10878	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10879	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10880	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10881	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10882	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10883	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10884	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10885	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10886	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10887	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10888	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10889	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10890	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10891	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10892	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10893	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10894	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10895	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10896	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10897	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10898	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10899	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10900	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	potentiator	target	Falchi AM (2007)	17631921	178583	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10901	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10902	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10903	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10904	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10905	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10906	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10907	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10908	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10909	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10910	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10911	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10912	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10913	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10914	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10915	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10916	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10917	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Rothman RB (2002)	12106802	178586	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10918	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Rothman RB (2006)	17017961	178585	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10919	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10920	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10921	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Rothman RB (2002)	12106802	178586	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10922	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Rothman RB (2006)	17017961	178585	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10923	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	820	Phenmetrazine	Fenmetrazina|Phenmetrazinum|2-Phenyl-3-methylmorpholine|Fenmetrazin|Phenmetrazin	-	DRUGBANK	DB00830	C11H15NO	small molecule	-	134-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOBHFESNSZDWIU-UHFFFAOYSA-N
10924	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10925	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10926	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Schmidt MH (1991)	1676523	178589	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10927	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (1976)	945467	178588	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10928	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lahti RA (1993)	8102973	178587	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10929	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10930	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Fujinaga M (1994)	8150214	178590	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10931	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10932	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10933	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Huerta-Bahena J (1983)	6135146	176341	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10934	119105	50632	RP11-122K13.5	CALY	DRD1IP|NSG3	9606	Homo sapiens	antagonist	target	Madrid PB (2007)	17407813	178591	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10935	119105	50632	RP11-122K13.5	CALY	DRD1IP|NSG3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10936	119105	50632	RP11-122K13.5	CALY	DRD1IP|NSG3	9606	Homo sapiens	antagonist	target	Seeman P (1976)	945467	178588	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10937	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Torres-Piedra M (2011)	21129983	178592	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10938	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10939	112183	6275	-	S100A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	9606	Homo sapiens	inhibitor	target	Malashkevich VN (2010)	20421509	178593	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10940	112183	6275	-	S100A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10941	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Kleerekoper Q (1998)	9525919	178594	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10942	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10943	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Gu G (2005)	15909120	178604	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10944	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Aida K (2004)	15336699	176103	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10945	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	LeVan TD (1999)	10796070	178601	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10946	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	de Pablos RM (2006)	16723527	178602	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10947	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Attardi BJ (2004)	15120421	178603	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10948	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10949	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	antagonist	target	Greb RR (1999)	10374120	178608	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10950	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	antagonist	target	Gao Y (1998)	10806733	178609	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10951	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	antagonist	target	Sun M (1998)	10682471	178605	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10952	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	antagonist	target	Hazra BG (2000)	10699595	178606	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10953	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	antagonist	target	Jiang J (2001)	11783365	178607	824	Mifepristone	RU-486|11-(4-DIMETHYLAMINO-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodec ahydro-cyclopenta[a]phenanthren-3-one|Mifpristone|RU486|Corlux|Mifepristonum|Mifepriston|Mifepristona|Mifeprex|Mifegyne	korlym|mifegymiso	DRUGBANK	DB00834	C29H35NO2	small molecule	G03XB01|G03XB51	84371-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKHAHZOOUSRJNA-GCNJZUOMSA-N
10954	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10955	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10956	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10957	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yanni JM (1994)	7714410	175868	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10958	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10959	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Boekesoy TA (1991)	1680053	175870	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10960	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Onaran HO (1990)	1970615	175871	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10961	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10962	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10963	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10964	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Yasuda SU (1999)	10212017	175352	825	Brompheniramine	2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine|Brompheniramin|3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine|Bromfeniramina|[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine|3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|Bromphniramine|BPN|1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Brompheniraminum	lohist peb dm|brompheniramine 	DRUGBANK	DB00835	C16H19BrN2	small molecule	R06AB51|R06AB01	86-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-UHFFFAOYSA-N
10965	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	DeHaven-Hudkins DL (1999)	10087042	178611	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10966	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	modulator	target	Nomura A (2001)	11474216	178613	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10967	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	modulator	target	Auernhammer CJ (1992)	1322429	178612	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10968	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	modulator	target	Ambrosi B (1989)	2545766	178616	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10969	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	modulator	target	Ambrosi B (1987)	2832297	178615	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10970	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	modulator	target	Bochicchio D (1988)	2855105	178614	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10971	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10972	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Giagnoni G (1983)	6319884	178618	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10973	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	di Bosco AM (2008)	18284554	178617	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10974	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10975	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Tan-No K (2003)	14592702	178620	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10976	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Roge J (1993)	8488368	178619	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10977	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Giagnoni G (1983)	6319884	178618	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10978	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	DeHaven-Hudkins DL (1999)	10087042	178611	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10979	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	di Bosco AM (2008)	18284554	178617	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10980	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Diener M (1988)	2851449	178622	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10981	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Suzuki T (2000)	10991984	178623	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10982	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mellstrand T (1987)	2820051	178621	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10983	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Daly JW (2000)	10949586	178624	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10984	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Stoll R (1988)	2836258	178625	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10985	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10986	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10987	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Church J (1994)	8183255	178626	826	Loperamide	Lopramide|Loperamida|Loperamid|Loperamidum	dg health loperamide hydrochlo	DRUGBANK	DB00836	C29H33ClN2O2	small molecule	A07DA53|A07DA05|A07DA03	53179-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDOIQAHITMMDAJ-UHFFFAOYSA-N
10988	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Grech DM (1993)	7831422	178631	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10989	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Fadda F (1985)	2985405	178630	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10990	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Agmo A (1998)	9443561	178632	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10991	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10992	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10993	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Fadda F (1985)	2985405	178630	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10994	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10995	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Agmo A (1998)	9443561	178632	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10996	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Buchwald P (2008)	18022656	178633	828	Clocortolone	9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona	cloderm|clocortolone pivalate	DRUGBANK	DB00838	C22H28ClFO4	small molecule	D07AB21	4828-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTMADLUXIRMGX-RFPWEZLHSA-N
10997	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Tanigawa K (2002)	12188035	176104	828	Clocortolone	9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona	cloderm|clocortolone pivalate	DRUGBANK	DB00838	C22H28ClFO4	small molecule	D07AB21	4828-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTMADLUXIRMGX-RFPWEZLHSA-N
10998	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Ali A (2008)	18691892	178634	828	Clocortolone	9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione|9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione|Clocortolonum|Clocortolone|Clocortolon|Clocortolona	cloderm|clocortolone pivalate	DRUGBANK	DB00838	C22H28ClFO4	small molecule	D07AB21	4828-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTMADLUXIRMGX-RFPWEZLHSA-N
10999	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	829	Tolazamide	1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea	tolazamide	DRUGBANK	DB00839	C14H21N3O3S	small molecule	A10BB05	1156-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUDSBRTVNLOZBN-UHFFFAOYSA-N
11000	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	829	Tolazamide	1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea	tolazamide	DRUGBANK	DB00839	C14H21N3O3S	small molecule	A10BB05	1156-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUDSBRTVNLOZBN-UHFFFAOYSA-N
11001	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Szabo C (1996)	8799949	178635	829	Tolazamide	1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea	tolazamide	DRUGBANK	DB00839	C14H21N3O3S	small molecule	A10BB05	1156-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUDSBRTVNLOZBN-UHFFFAOYSA-N
11002	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Asano K (1999)	10354277	178636	829	Tolazamide	1-(hexahydro-1H-Azepin-1-yl)-3-(P-tolylsulfonyl)urea|U 17835|N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide|Tolazamid|4-(P-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide|Tolazamide|Norglycin|Tolazamida|EINECS 214-588-3|BRN 1323565|Tolazamidum|1-(hexahydro-1-Azepinyl)-3-P-tolylsulfonylurea|U-17835|CCRIS 591|Tolinase|Diabewas|N-(P-Toluenesulfonyl)-n'-hexamethyleniminourea	tolazamide	DRUGBANK	DB00839	C14H21N3O3S	small molecule	A10BB05	1156-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUDSBRTVNLOZBN-UHFFFAOYSA-N
11003	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tibayan FA (1997)	9279221	178637	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11004	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Raddatz A (2006)	16627864	178639	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11005	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	La Rosee K (2004)	15564877	178638	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11006	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11007	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Junker V (2002)	12098582	178640	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11008	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Bruck H (2005)	16325050	177294	831	Dobutamine	rac-Dobutamine|3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine|Dobutamin|4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol|(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol|Dobutamine|DL-Dobutamine|Dobutamina|Racemic-dobutamine|Dobutaminum	dobutamine hydrochloride injec	DRUGBANK	DB00841	C18H23NO3	small molecule	C01CA07	34368-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRWZLRBJNMZMFE-UHFFFAOYSA-N
11009	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11010	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11011	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11012	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11013	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11014	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11015	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11016	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11017	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11018	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11019	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11020	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11021	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11022	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11023	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11024	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11025	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11026	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11027	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11028	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11029	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11030	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11031	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11032	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11033	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11034	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11035	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11036	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11037	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11038	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11039	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11040	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11041	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11042	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11043	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11044	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11045	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11046	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11047	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Sugimoto H (2002)	11893059	178648	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11048	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Jann MW (2000)	10641971	178649	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11049	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11050	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Ki YS (2010)	20522977	178644	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11051	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Kryger G (1999)	10368299	178645	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11052	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Shepherd G (1999)	10466911	178646	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11053	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Repantis D (2010)	20193764	178647	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11054	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Kosasa T (1999)	10513568	175704	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11055	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Davis KL (1999)	10024872	175705	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11056	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Hayslett RL (2003)	14643839	178651	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11057	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Hayslett RL (2005)	16045972	178650	833	Donepezil	Donepezilo|Domepezil|Donepezilum|Donepezil	donepezil hydrochloride 10mg|b	DRUGBANK	DB00843	C24H29NO3	small molecule	N06DA02|N06DA53|N06DA52	120014-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-UHFFFAOYSA-N
11058	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11059	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11060	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Hoehe M (1993)	8388112	178657	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11061	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Mello NK (2005)	15602503	178656	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11062	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Gear RW (1999)	10534607	178655	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11063	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Peng X (2007)	17407276	178654	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11064	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Chen SL (2005)	15655510	178653	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11065	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Tao PL (2006)	16517095	178652	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11066	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Smith MA (2009)	19403853	178658	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11067	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11068	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Chen JC (1993)	8093631	178660	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11069	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	De Souza EB (1988)	2826773	178659	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11070	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Picker MJ (1997)	9399970	177287	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11071	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Zernig G (1997)	9084061	178664	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11072	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Meerpohl JJ (2008)	18810678	178662	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11073	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	McNicol ED (2008)	18425947	178663	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11074	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Kishioka S (2000)	10844102	178661	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11075	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Hoehe M (1993)	8388112	178657	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11076	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Mello NK (2005)	15602503	178656	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11077	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Peng X (2007)	17407276	178654	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11078	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Tao PL (2006)	16517095	178652	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11079	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Smith MA (2009)	19403853	178658	834	Nalbuphine	Nalbuphin|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|Nalbuphinum|Nalbuphine|Nalbufina	nubain injection 10mg/ml|nubai	DRUGBANK	DB00844	C21H27NO4	small molecule	N02AF02	20594-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETZHAKZCGBWSS-CEDHKZHLSA-N
11080	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Baschant U (2010)	20346397	178666	836	Flurandrenolide	Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide	cordran|flurandrenolide cream|	DRUGBANK	DB00846	C24H33FO6	small molecule	D07CC03|D07AC07	1524-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POPFMWWJOGLOIF-XWCQMRHXSA-N
11081	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Fitzgerald P (2006)	16255837	178667	836	Flurandrenolide	Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide	cordran|flurandrenolide cream|	DRUGBANK	DB00846	C24H33FO6	small molecule	D07CC03|D07AC07	1524-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POPFMWWJOGLOIF-XWCQMRHXSA-N
11082	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Issar M (2006)	16507850	175778	836	Flurandrenolide	Fludroxicortide|Fludroxycortid|Fludroxicortida|Fludrossicortide|Fludroxycortidum|Flurandrenolone|Fludroxycortide|Cordran|Flurandrenolide	cordran|flurandrenolide cream|	DRUGBANK	DB00846	C24H33FO6	small molecule	D07CC03|D07AC07	1524-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POPFMWWJOGLOIF-XWCQMRHXSA-N
11083	110947	4887	-	NPY2R	NPY2-R	9606	Homo sapiens	unknown	target	Li W (1992)	1314592	178671	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11084	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	McIntosh C (1984)	6142843	178675	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11085	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	McIntosh CH (1988)	2901134	178674	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11086	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11087	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	Ahren B (1989)	2653642	178673	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11088	112628	6750	-	SST	SMST	9606	Homo sapiens	binder	target	Terry LC (1985)	4080089	178672	837	Cysteamine	Mercaptamina|-aminoethylthiol|MEA|beta-MEA|beta-Mercaptoethylamine|Mercaptaminum|-MEA|2-Amino-1-ethanethiol|beta-Aminoethylthiol|2-Aminoethanethiol|Thioethanolamine|2-AMINO-ethanethiol|Mercaptamine|Cysteamine|beta-Aminoethanethiol	cystaran|cystagon|procysbi del	DRUGBANK	DB00847	C2H7NS	small molecule	A16AA04|S01XA21	60-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFULAYFCSOUIOV-UHFFFAOYSA-N
11089	38136	172703	T08G11.5	unc-29	CELE_T08G11.5|unc-21|tmr-4|unc-56	6239	Caenorhabditis elegans	activator	target	Culetto E (2004)	15280391	178680	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11090	38136	172703	T08G11.5	unc-29	CELE_T08G11.5|unc-21|tmr-4|unc-56	6239	Caenorhabditis elegans	activator	target	Rayes D (2007)	17314321	178679	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11091	43360	178269	CELE_F09E8.7	lev-1	-	6239	Caenorhabditis elegans	activator	target	Culetto E (2004)	15280391	178680	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11092	43360	178269	CELE_F09E8.7	lev-1	-	6239	Caenorhabditis elegans	activator	target	Rayes D (2007)	17314321	178679	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11093	37611	172150	Y110A7A.3	unc-63	CELE_Y110A7A.3|tmr-3|lev-7	6239	Caenorhabditis elegans	activator	target	Culetto E (2004)	15280391	178680	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11094	37611	172150	Y110A7A.3	unc-63	CELE_Y110A7A.3|tmr-3|lev-7	6239	Caenorhabditis elegans	activator	target	Rayes D (2007)	17314321	178679	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11095	37567	172105	F21F3.5	unc-38	CELE_F21F3.5|tmr-2	6239	Caenorhabditis elegans	activator	target	Culetto E (2004)	15280391	178680	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11096	37567	172105	F21F3.5	unc-38	CELE_F21F3.5|tmr-2	6239	Caenorhabditis elegans	activator	target	Rayes D (2007)	17314321	178679	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11097	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inhibitor	target	Mota A (2008)	18719742	178684	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11098	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inhibitor	target	Chang YL (2000)	10951365	178685	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11099	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inhibitor	target	Funk CJ (2001)	11304750	178686	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11100	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inhibitor	target	de Aguiar Matos JA (2001)	11403767	178681	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11101	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inhibitor	target	Soory M (2003)	12615144	178682	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11102	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inhibitor	target	McDougall K (2002)	11850443	178683	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11103	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Parker S (2007)	17629760	108198	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11104	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Rayes D (2007)	17314321	178679	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11105	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11106	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11107	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11108	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Hu Y (2009)	19668355	178687	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11109	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Culetto E (2004)	15280391	178680	838	Levamisole	Levamisol|Levamisolum	ergamisol tab 50mg|novo-levami	DRUGBANK	DB00848	C11H12N2S	small molecule	P02CE01	14769-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLFSDGLLUJUHTE-SNVBAGLBSA-N
11110	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11111	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11112	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11113	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11114	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11115	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11116	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11117	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11118	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11119	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11120	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11121	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Roden WH (2010)	20692323	178689	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11122	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11123	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11124	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11125	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11126	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11127	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11128	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11129	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11130	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11131	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11132	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11133	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11134	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11135	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11136	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11137	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11138	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11139	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11140	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11141	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11142	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11143	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Talvik M (2004)	15007534	178691	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11144	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Farde L (1989)	2573104	178690	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11145	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11146	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hoyberg OJ (1993)	7508675	177392	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11147	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Qin ZH (1994)	7828655	177391	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11148	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11149	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Edlind T (2002)	12366848	58606	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11150	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Natochin YuV (1987)	2885243	178692	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11151	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kawai M (2001)	11409178	54890	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11152	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mongin AA (1999)	10516112	177395	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11153	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Dolzan V (2007)	17455212	178693	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11154	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Farde L (1989)	2573104	178690	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11155	111247	5226	-	PGD	6PGD	9606	Homo sapiens	inhibitor	target	Akkemik E (2010)	20235752	176889	841	Dacarbazine	DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide	dacarbazine|dacarbazine for in	DRUGBANK	DB00851	C6H10N6O	small molecule	L01AX04	4342-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDKXTQMXEQVLRF-UHFFFAOYSA-N
11156	111247	5226	-	PGD	6PGD	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	841	Dacarbazine	DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide	dacarbazine|dacarbazine for in	DRUGBANK	DB00851	C6H10N6O	small molecule	L01AX04	4342-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDKXTQMXEQVLRF-UHFFFAOYSA-N
11157	117176	23649	-	POLA2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	841	Dacarbazine	DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide	dacarbazine|dacarbazine for in	DRUGBANK	DB00851	C6H10N6O	small molecule	L01AX04	4342-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDKXTQMXEQVLRF-UHFFFAOYSA-N
11158	117176	23649	-	POLA2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	841	Dacarbazine	DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide	dacarbazine|dacarbazine for in	DRUGBANK	DB00851	C6H10N6O	small molecule	L01AX04	4342-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDKXTQMXEQVLRF-UHFFFAOYSA-N
11159	117176	23649	-	POLA2	-	9606	Homo sapiens	unknown	target	Loenn U (1987)	3098406	178695	841	Dacarbazine	DTIE|4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide|NSC 45388|DIC|HSDB 3219|Dacarbazinum|Dtic-dome (tn)|Biocarbazine|5-(Dimethyltriazeno)imidazole-4-carboxamide|DTCI|Imidazole Carboxamide|4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide|4-(Dimethyltriazeno)imidazole-5-carboxamide|Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)-|Dacarbazin|Dacarbazine|Dacarbazina|NSC-45388|5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide|NCI-C04717|ICDMT|5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide	dacarbazine|dacarbazine for in	DRUGBANK	DB00851	C6H10N6O	small molecule	L01AX04	4342-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDKXTQMXEQVLRF-UHFFFAOYSA-N
11160	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11161	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11162	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Vansal SS (1999)	10449190	178696	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11163	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Foley KF (2002)	12373557	178698	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11164	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Wee S (2004)	15189772	178697	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11165	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11166	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Wellington K (2002)	11772135	178699	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11167	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11168	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Wee S (2004)	15189772	178697	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11169	116487	22809	-	ATF5	ATFX|HMFN0395	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11170	106957	467	RP11-338C15.1	ATF3	-	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11171	107776	1386	-	ATF2	CRE-BP1|CREB-2|CREB2|HB16|TREB7	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11172	106958	468	-	ATF4	CREB-2|CREB2|TAXREB67|TXREB	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11173	108636	2353	-	FOS	AP-1|C-FOS|p55	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11174	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11175	125807	122953	-	JDP2	JUNDM2	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11176	116586	22926	-	ATF6	ATF6A	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11177	106956	466	-	ATF1	EWS-ATF1|FUS/ATF-1|TREB36	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11178	116206	11016	-	ATF7	ATFA	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11179	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11180	110845	4772	-	NFATC1	NF-ATC|NFAT2|NFATc	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11181	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Wu Z (2014)	24365491	178701	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11182	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Fiebich BL (2012)	21631396	178700	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11183	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Foley KF (2002)	12373557	178698	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11184	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wee S (2004)	15189772	178697	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11185	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Vansal SS (1999)	10449190	178696	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11186	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Vansal SS (1999)	10449190	178696	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11187	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11188	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	842	Pseudoephedrine	L-(+)-Pseudoephedrine|Isoephedrine|Psi-ephedrine|d-Pseudoephedrine|Pseudoephedrinum|d-Isoephedrine|d-psi-Ephedrine|Pseudoefedrina|(+)-(1S,2S)-Pseudoephedrine|(+)-Pseudoephedrine|d-psi-2-Methylamino-1-phenyl-1-propanol|pseudophdrine|L(+)-psi-Ephedrine|(+)-threo-Ephedrine|(+) threo-2-(methylamino)-1-phenyl-1-propanol|Pseudoephedrine D-form|-ephedrine|(+)-psi-Ephedrine|Psi-ephedrin|trans-Ephedrine	children's tylenol cold liquid	DRUGBANK	DB00852	C10H15NO	small molecule	R01BA52|R01BA02	90-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WCBMZHEXSA-N
11189	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Prommer E (2007)	17039381	178702	844	Levorphanol	Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum	levorphanol tartrate	DRUGBANK	DB00854	C17H23NO	small molecule	-	77-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAQUASYNZVUNQP-USXIJHARSA-N
11190	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Prommer E (2007)	17039381	178702	844	Levorphanol	Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum	levorphanol tartrate	DRUGBANK	DB00854	C17H23NO	small molecule	-	77-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAQUASYNZVUNQP-USXIJHARSA-N
11191	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Allen RM (2003)	12975489	178703	844	Levorphanol	Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum	levorphanol tartrate	DRUGBANK	DB00854	C17H23NO	small molecule	-	77-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAQUASYNZVUNQP-USXIJHARSA-N
11192	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Prommer E (2007)	17039381	178702	844	Levorphanol	Levorfanolo|Lvorphanol|Levorphanol|Levorfanol|Levorphanolum	levorphanol tartrate	DRUGBANK	DB00854	C17H23NO	small molecule	-	77-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAQUASYNZVUNQP-USXIJHARSA-N
11193	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Sakai T (2000)	10812836	178705	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11194	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Flora SJ (2002)	12107644	178704	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11195	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Frere F (2002)	12079382	178707	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11196	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Akagi R (1999)	10519994	178706	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11197	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11198	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Tomas-Zapico C (2002)	11906825	178709	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11199	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	inducer	target	Vajpayee P (2000)	10879826	178708	845	Aminolevulinic acid	5-Aminolevulinic acid|DALA|delta-ALA|Aminolevulinic acid|Aminolevulinate|ALA|5-Amino-4-oxopentanoate|delta-Aminolevulinic acid|5-Aminolevulinate|ALA-PDT|5-Amino-4-oxovaleric acid|5-ALA	ameluz|levulan kerastick	DRUGBANK	DB00855	C5H9NO3	small molecule	L01XD04	106-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGXJTSGNIOSYLO-UHFFFAOYSA-N
11200	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Klobucnikova V (2003)	12963042	61237	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11201	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Wentzinger LF (2002)	12226513	178725	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11202	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Darkes MJ (2002)	12477372	178724	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11203	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Krishnan-Natesan S (2009)	19874252	178723	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11204	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Ryder NS (1992)	1543672	178722	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11205	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Sander CS (2002)	12100530	178721	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11206	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Leber R (2003)	14638499	61876	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11207	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	847	Terbinafine	Terbinafinum|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafina|(e)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine	kroger antifungal|goodsense te	DRUGBANK	DB00857	C21H25N	small molecule	D01BA02|D01AE15	91161-71-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMXUEMWDBAQBQ-WEVVVXLNSA-N
11208	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Takahashi M (2004)	15351799	178730	848	Drostanolone	Drostanolonum|Medrotestron|Metholone|2alpha-Methyldihydrotestosterone|Dihydro-2alpha-methyltestosterone|Medrosteron|Drostanolona|Dromostanolone|Drostanolone|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one	-	DRUGBANK	DB00858	C20H32O2	small molecule	-	58-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKXILDNPCZPPRV-RFMGOVQKSA-N
11209	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Zakar T (1986)	3758193	178731	848	Drostanolone	Drostanolonum|Medrotestron|Metholone|2alpha-Methyldihydrotestosterone|Dihydro-2alpha-methyltestosterone|Medrosteron|Drostanolona|Dromostanolone|Drostanolone|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one	-	DRUGBANK	DB00858	C20H32O2	small molecule	-	58-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKXILDNPCZPPRV-RFMGOVQKSA-N
11210	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	848	Drostanolone	Drostanolonum|Medrotestron|Metholone|2alpha-Methyldihydrotestosterone|Dihydro-2alpha-methyltestosterone|Medrosteron|Drostanolona|Dromostanolone|Drostanolone|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one	-	DRUGBANK	DB00858	C20H32O2	small molecule	-	58-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKXILDNPCZPPRV-RFMGOVQKSA-N
11211	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Ikonomidis I (2009)	19482847	178735	850	Prednisolone	Prednisolona|delta-dehydrocortisol|delta-hydrocortisone|Prednisolonum|PRDL|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Metacortandralone|Hydroretrocortine|3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene|delta(1)-Hydrocortisone|delta(1)-Dehydrohydrocortisone|delta(1)-Dehydrocortisol|delta-dehydrohydrocortisone|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione	pms-prednisolone sod phos oph 	DRUGBANK	DB00860	C21H28O5	small molecule	S01BB02|S03BA02|S01CA02|H02AB06|D07AA03|D07BA01|D07XA02|V03AB05|S01BA04|D07CA03|A01AC54|C05AA04|R01AD52|S02CA01|S01CB02|R01AD02|A07EA01|S02BA03|S03CA02	50-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIGNJSKKLXVSLS-VWUMJDOOSA-N
11212	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Boudinot FD (1986)	2879901	178736	850	Prednisolone	Prednisolona|delta-dehydrocortisol|delta-hydrocortisone|Prednisolonum|PRDL|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Metacortandralone|Hydroretrocortine|3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene|delta(1)-Hydrocortisone|delta(1)-Dehydrohydrocortisone|delta(1)-Dehydrocortisol|delta-dehydrohydrocortisone|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione	pms-prednisolone sod phos oph 	DRUGBANK	DB00860	C21H28O5	small molecule	S01BB02|S03BA02|S01CA02|H02AB06|D07AA03|D07BA01|D07XA02|V03AB05|S01BA04|D07CA03|A01AC54|C05AA04|R01AD52|S02CA01|S01CB02|R01AD02|A07EA01|S02BA03|S03CA02	50-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIGNJSKKLXVSLS-VWUMJDOOSA-N
11213	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cappon GD (2003)	12852483	178741	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11214	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen QH (2005)	15755648	178740	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11215	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Young JM (1996)	8737748	178742	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11216	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cappon GD (2003)	12852483	178741	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11217	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11218	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Young JM (1996)	8737748	178742	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jeske AH (1999)	10825891	178745	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mao H (2001)	11673972	178744	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Moore PA (2001)	11315375	178743	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11222	111175	5149	-	PDE6H	ACHM6|RCD3	9606	Homo sapiens	allosteric modulator	target	Zhang XJ (2008)	18779324	178753	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11223	111174	5148	-	PDE6G	PDEG|RP57	9606	Homo sapiens	allosteric modulator	target	Zhang XJ (2008)	18779324	178753	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11224	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Wang H (2008)	17959709	174363	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11225	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Sung BJ (2003)	12955149	178758	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11226	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Saenz de Tejada I (2001)	11890515	178759	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11227	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Zoraghi R (2007)	17979301	174365	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11228	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11229	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Scheen AJ (2003)	14626653	178756	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11230	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Blount MA (2006)	16926278	178757	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11231	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Kim NN (2001)	11669467	178754	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11232	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Carrier S (2003)	12625845	178755	852	Vardenafil	Vardnafil|Vardenafilum|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-F][1,2,4]triazin-4(1H)-one|Vardenafil|Levitra	staxyn|levitra	DRUGBANK	DB00862	C23H32N6O4S	small molecule	G04BE09	224785-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECKRCOLJRRGGV-UHFFFAOYSA-N
11233	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	853	Ranitidine	RAN|Ranitidina|Ranitidinum	mylan-ranitidine|zantac maximu	DRUGBANK	DB00863	C13H22N4O3S	small molecule	A02BA07|A02BA02	66357-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMXUWOKSQNHOCA-UKTHLTGXSA-N
11234	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Pattichis K (1995)	7554999	178760	853	Ranitidine	RAN|Ranitidina|Ranitidinum	mylan-ranitidine|zantac maximu	DRUGBANK	DB00863	C13H22N4O3S	small molecule	A02BA07|A02BA02	66357-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMXUWOKSQNHOCA-UKTHLTGXSA-N
11235	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	inhibitor	target	Masri M (2007)	17524933	178762	854	Tacrolimus	Tacrolimus anhydrous|Anhydrous tacrolimus|Tacrolimus, anhydrous	envarsus xr|advagraf|sandoz ta	DRUGBANK	DB00864	C44H69NO12	small molecule	L04AD02|D11AH01	104987-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJJXYPPXXYFBGM-LFZNUXCKSA-N
11236	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	inhibitor	target	Labrande C (2005)	16289353	178761	854	Tacrolimus	Tacrolimus anhydrous|Anhydrous tacrolimus|Tacrolimus, anhydrous	envarsus xr|advagraf|sandoz ta	DRUGBANK	DB00864	C44H69NO12	small molecule	L04AD02|D11AH01	104987-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJJXYPPXXYFBGM-LFZNUXCKSA-N
11237	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inducer	target	Sulzer D (1995)	7751968	174151	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11238	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11239	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11240	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11241	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11242	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Kahlig KM (2005)	15728379	174165	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11243	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	855	Benzphetamine	Benzfetamina|(+)-benzphetamine|Benzfetamine|(S)-(+)-benzphetamine|N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine|Benzfetaminum|(S)-(+)-N-benzyl-N,-dimethylphenethylamine|(S)-benzphetamine|(+)-N-Benzyl-N,alpha-dimethylphenethylamine|D-N-Methyl-N-benzyl-beta-phenylisopropylamine|(AlphaS)-N,alpha-dimethylphenethylamine|Benzphetamine|Benzaphetamine|(+)-N,-dimethyl-N-(phenylmethyl)-benzeneethanamine|Benzylamphetamine|(+)-N,alpha-Dimethyl-N-(phenylmethyl)-benzeneethanamine|d-N-methyl-N-benzyl--phenylisopropylamine|(S)-(+)-N-Benzyl-N,alpha-dimethylphenethylamine|(+)-N-benzyl-N,-dimethylphenethylamine	benzphetamine|didrex|regimex|b	DRUGBANK	DB00865	C17H21N	small molecule	-	156-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXKTVDFXDRQTKV-HNNXBMFYSA-N
11244	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Kuipers W (1997)	9145928	178774	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11245	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Darmani NA (1993)	8392199	178775	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11246	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Millan MJ (1992)	1323650	178776	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11247	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Misane I (1998)	9806333	178777	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11248	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brodde OE (1985)	2859531	178778	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11249	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brodde OE (1986)	2439825	178779	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11250	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Abrahamsson T (1986)	2871880	178780	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11251	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11252	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Surman AJ (1993)	7678677	178784	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11253	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Varma DR (1999)	10433496	175645	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11254	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	De Ponti F (1995)	7606348	178781	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11255	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Brahmadevara N (2003)	12522078	178783	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11256	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Im MJ (1988)	2828119	178782	856	Alprenolol	(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|Alprnolol|Alprenolol|Alfeprol|1-(O-Allylphenoxy)-3-(isopropylamino)-2-propanol|Alprenololum|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|Aprenololo	-	DRUGBANK	DB00866	C15H23NO2	small molecule	C07AA01	13655-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZJSJFMUHDSTF-UHFFFAOYSA-N
11257	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11258	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lenselink DR (1994)	8059831	178789	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11259	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bianchetti A (1990)	1976401	178788	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11260	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tanaka N (2001)	11311067	178785	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11261	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Schwarz MK (2003)	12871140	178787	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11262	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Lye SJ (1992)	1332478	178786	857	Ritodrine	Ritodrina|Yutopar|DU-21220|Ritodrine|Ritodrinium	yutopar inj 50mg/5ml|yutopar t	DRUGBANK	DB00867	C17H21NO3	small molecule	G02CA01	26652-09-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOVGROKTTNBUGK-SJCJKPOMSA-N
11263	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	antagonist	target	Thimann DA (2012)	23258970	178790	858	Benzonatate	Benzononatine|3,6,9,12,15,18,21,24,27-Nonaoxaoctacosyl 4-butylaminobenzoate|Benzonatat|Benzonatate|P-Butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester|2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate|Nonaethyleneglycol monomethyl ether P-N-butylaminobenzoate|Benzonatato|4-(Butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester|2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl P-(butylamino)benzoate|Benzonatatum	zonatuss|benzonatate|tessalon	DRUGBANK	DB00868	C30H53NO11	small molecule	R05DB01	104-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAFMQEKGGFWBAB-UHFFFAOYSA-N
11264	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Sugrue MF (1996)	8875343	178791	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11265	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Hasegawa T (1994)	8070313	178792	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11266	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Maren TH (1997)	9029437	178793	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11267	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Sugrue MF (1996)	8875343	178791	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11268	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11269	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Lachmann C (1998)	10048009	178798	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11270	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Wong BK (1996)	8781782	178796	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11271	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Srinivas SP (2002)	12356834	178797	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11272	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Berg JT (2004)	15258186	178794	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11273	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Sugrue MF (2000)	10614682	178795	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11274	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Hasegawa T (1994)	8070313	178792	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11275	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Maren TH (1997)	9029437	178793	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11276	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Sugrue MF (1996)	8875343	178791	859	Dorzolamide	Dorzolamide|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamidum|Dorzolamid|(4S,trans)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|(4S-trans)-4-(ETHYLAMINO)-5,6-dihydro-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|Dorzolamida|4S,6S-Dorzolamide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide	med-dorzolamide|jamp-dorzolami	DRUGBANK	DB00869	C10H16N2O4S3	small molecule	S01EC03	120279-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAVUPMFITXYVAF-XPUUQOCRSA-N
11277	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11278	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Loll PJ (1996)	8652509	178801	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11279	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Llorens O (2002)	11885959	178800	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11280	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bender A (2007)	17477341	178799	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11281	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11282	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Llorens O (2002)	11885959	178800	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11283	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11284	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chong LK (2003)	12569076	178802	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11285	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Riether C (2011)	20674738	178803	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11286	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ramer-Quinn DS (2000)	11120594	178806	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11287	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Schaefers RF (1999)	10226872	178807	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11288	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Haahtela T (1991)	2062329	178804	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11289	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hochhaus G (1992)	1358833	178805	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11290	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cooperberg BA (2008)	18782903	178808	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11291	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Zetterlund A (2001)	11256987	178809	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11292	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Nakamura A (2001)	11675405	178810	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11293	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	861	Terbutaline	Terbutaline (sulfate de)|Terbutalina|Terbutalinsulfat|Terbutalinum|Terbutalini sulfas|Terbutalin	terbutaline sulfate|bricanyl t	DRUGBANK	DB00871	C12H19NO3	small molecule	R03CC53|R03AC03|R03CC03	23031-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTYSIMOBUGWOL-UHFFFAOYSA-N
11294	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Wada K (2005)	15659304	178813	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11295	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ali F (2007)	17428103	178812	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11296	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Hoque MZ (2009)	19663609	178815	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11297	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Palm C (2006)	16843091	178814	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11298	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ali F (2007)	17919259	178817	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11299	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ghali JK (2006)	16522696	178816	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11300	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Mao ZL (2009)	19695403	178819	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11301	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Annane D (2009)	19057376	178818	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11302	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11303	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Wada K (2007)	17202666	178820	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11304	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Walter KA (2007)	17592003	178821	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11305	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Ghali JK (2010)	20054444	178822	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11306	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Ali F (2007)	17428103	178812	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11307	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Hoque MZ (2009)	19663609	178815	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11308	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Ali F (2007)	17919259	178817	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11309	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Ghali JK (2006)	16522696	178816	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11310	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Mao ZL (2009)	19695403	178819	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11311	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Annane D (2009)	19057376	178818	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11312	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11313	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Wada K (2007)	17202666	178820	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11314	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Walter KA (2007)	17592003	178821	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11315	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Ghali JK (2010)	20054444	178822	862	Conivaptan	4'-((4,5-dihydro-2-Methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide|Conivaptan	vaprisol dextrose in plastic c	DRUGBANK	DB00872	C32H26N4O2	small molecule	C03XA02	210101-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKENVDNFQMCRTR-UHFFFAOYSA-N
11316	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Druzgala P (1991)	2004037	178824	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11317	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Bodor N (2006)	17020532	178825	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11318	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11319	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Samudre SS (2004)	15684812	175223	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11320	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Szelenyi I (2000)	12861354	178823	863	Loteprednol	Loteprednol|Loteprednolum	zylet|lotemax ointment|lotemax	DRUGBANK	DB00873	C21H27ClO5	small molecule	S01BA14	129260-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZVAYHNBBHPTO-MXRBDKCISA-N
11321	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Huettl P (1991)	1674528	178828	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11322	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nilsson CL (1996)	8797192	178829	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11323	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11324	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11325	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Reimold M (2007)	17111172	178827	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11326	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Arnt J (1995)	7498321	174624	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11327	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Ogren SO (1984)	6149133	178826	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11328	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11329	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11330	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11331	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Cai G (1999)	10531405	176548	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11332	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11333	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Reimold M (2007)	17111172	178827	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11334	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Reimold M (2007)	17111172	178827	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11335	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11336	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	de la Sierra A (2007)	18093407	178839	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11337	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Ilson BE (1998)	9602957	178838	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11338	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11339	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Hedner T (2002)	12184062	178837	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11340	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Gremmler B (2000)	10856732	178846	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11341	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Heusser K (2003)	12927226	178844	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11342	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Puig JG (2002)	12766389	178845	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11343	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Murdoch DR (2001)	11320369	178842	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11344	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Nap A (2003)	12782193	178843	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11345	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Suzuki G (2003)	12540520	178840	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11346	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Ruilope L (2003)	12517247	178841	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11347	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Sehgal SN (2003)	12742462	178847	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11348	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11349	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Sehgal SN (2003)	12742462	178847	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11350	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Sehgal SN (2003)	12742462	178847	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11351	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11352	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Dowling RJ (2010)	20005306	178848	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11353	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Shuuin T (2009)	19620795	178849	867	Sirolimus	(-)-Rapamycin|Rapamycin	rapamune oral solution|sirolim	DRUGBANK	DB00877	C51H79NO13	small molecule	L04AA10|S01XA23	53123-88-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFJCIRLUMZQUOT-KLHQEZAJSA-N
11354	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10954127	178858	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11355	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11356	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Thakker RV (2000)	11014932	178860	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11357	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Schmidt H (2001)	11456284	178861	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11358	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Reinalter SC (2004)	15283765	178862	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11359	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Maki N (2004)	15069170	178859	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11360	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Wilson FH (2003)	12515852	9939	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11361	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10954127	178858	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11362	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11363	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11364	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Weiner ID (2003)	14656370	178863	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11365	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Verlander JW (2003)	12388412	178864	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11366	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10954127	178858	870	Chlorothiazide	Clorotiazida|Chlorthiazide|Mechlozid|Chlorothiazidum|Chlorothiazide|Chlorothiazid|6-Chloro-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide|6-chloro-7-Sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|Uroflux	chlorothiazide sodium|sodium d	DRUGBANK	DB00880	C7H6ClN3O4S2	small molecule	C03AA04|C03AB04|C03AH01	58-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBMKAUGHUNFTOL-UHFFFAOYSA-N
11367	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11368	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11369	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Klutchko S (1986)	3020249	178865	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11370	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Culy CR (2002)	11817979	178866	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11371	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Homburg R (2005)	15878925	178873	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11372	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overbeek A (2009)	19761360	178872	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11373	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kurosawa T (2010)	20379036	178871	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11374	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brown J (2009)	19821295	178870	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11375	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11376	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11377	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Hughes E (2010)	20091498	178868	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11378	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Unknown Authors (2006)	17055820	178869	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11379	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Homburg R (2008)	18320435	178867	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11380	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Homburg R (2005)	15878925	178873	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11381	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Overbeek A (2009)	19761360	178872	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11382	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Kurosawa T (2010)	20379036	178871	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11383	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Brown J (2009)	19821295	178870	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11384	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Sasson S (1991)	2011412	177583	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11385	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11386	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Hughes E (2010)	20091498	178868	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11387	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Unknown Authors (2006)	17055820	178869	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11388	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Homburg R (2008)	18320435	178867	872	Clomifene	Clomifeno|Clomifene|Clomiphene|Clomifenum	clomid|serophene tab 50mg|clom	DRUGBANK	DB00882	C26H28ClNO	small molecule	G03GB02	911-45-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKIRPKYJQBWNGO-OCEACIFDSA-N
11389	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	873	Isosorbide Dinitrate	Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida	isosorbide tab 30mg|isordil su	DRUGBANK	DB00883	C6H8N2O8	small molecule	C01DA08|C05AE02|C01DA58	87-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYKHGMNXAOIAT-JGWLITMVSA-N
11390	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Villarroya M (2005)	16007231	178876	873	Isosorbide Dinitrate	Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida	isosorbide tab 30mg|isordil su	DRUGBANK	DB00883	C6H8N2O8	small molecule	C01DA08|C05AE02|C01DA58	87-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYKHGMNXAOIAT-JGWLITMVSA-N
11391	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	873	Isosorbide Dinitrate	Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida	isosorbide tab 30mg|isordil su	DRUGBANK	DB00883	C6H8N2O8	small molecule	C01DA08|C05AE02|C01DA58	87-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYKHGMNXAOIAT-JGWLITMVSA-N
11392	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Beauregard C (2002)	12419094	178874	873	Isosorbide Dinitrate	Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida	isosorbide tab 30mg|isordil su	DRUGBANK	DB00883	C6H8N2O8	small molecule	C01DA08|C05AE02|C01DA58	87-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYKHGMNXAOIAT-JGWLITMVSA-N
11393	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Takabuchi S (2004)	15465035	178875	873	Isosorbide Dinitrate	Dianhydrosorbitol 2,5-dinitrate|Nitrosorbide|Isosorbide 2,5-dinitrate|Cedocard retard|Carvasin|Dinitroisosorbide|1,4:3,6-Dianhydrosorbitol 2,5-dinitrate|Flindix|Dinitrate d'isosorbide|Sorbidnitrate|Isosorbide dinitrate|Isosorbidi dinitras|Sorbidilat|Isordil|Isorbid|Sorbide nitrate|Isoket|D-Isosorbide dinitrate|Dinitrosorbide|ISDN|Dinitrato de isosorbida	isosorbide tab 30mg|isordil su	DRUGBANK	DB00883	C6H8N2O8	small molecule	C01DA08|C05AE02|C01DA58	87-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOYKHGMNXAOIAT-JGWLITMVSA-N
11394	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Coxon FP (2005)	16006204	178877	874	Risedronate	Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate	pms-risedronate plus calcium|p	DRUGBANK	DB00884	C7H11NO7P2	small molecule	M05BB02|M05BB04|M05BB07|M05BA07	105462-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIDJRNMFWXDHID-UHFFFAOYSA-N
11395	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	874	Risedronate	Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate	pms-risedronate plus calcium|p	DRUGBANK	DB00884	C7H11NO7P2	small molecule	M05BB02|M05BB04|M05BB07|M05BA07	105462-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIDJRNMFWXDHID-UHFFFAOYSA-N
11396	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Bergstrom JD (2000)	10620343	174891	874	Risedronate	Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate	pms-risedronate plus calcium|p	DRUGBANK	DB00884	C7H11NO7P2	small molecule	M05BB02|M05BB04|M05BB07|M05BA07	105462-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIDJRNMFWXDHID-UHFFFAOYSA-N
11397	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Russell RG (2007)	18056045	178879	874	Risedronate	Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate	pms-risedronate plus calcium|p	DRUGBANK	DB00884	C7H11NO7P2	small molecule	M05BB02|M05BB04|M05BB07|M05BA07	105462-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIDJRNMFWXDHID-UHFFFAOYSA-N
11398	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Dunford JE (2001)	11160603	174892	874	Risedronate	Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate	pms-risedronate plus calcium|p	DRUGBANK	DB00884	C7H11NO7P2	small molecule	M05BB02|M05BB04|M05BB07|M05BA07	105462-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIDJRNMFWXDHID-UHFFFAOYSA-N
11399	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	inhibitor	target	Ortiz-Gomez A (2006)	16835450	178878	874	Risedronate	Acidum risedronicum|Risedronic acid|Ridron|Acido risedronico|Risedronsure|Acide risdroniqe|Risedronate	pms-risedronate plus calcium|p	DRUGBANK	DB00884	C7H11NO7P2	small molecule	M05BB02|M05BB04|M05BB07|M05BA07	105462-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIDJRNMFWXDHID-UHFFFAOYSA-N
11400	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Neal B (2002)	12584671	178882	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11401	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Trippodo NC (1999)	10598120	178883	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11402	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Ferdinand KC (2001)	11588409	178881	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11403	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Azizi M (2000)	10856268	178884	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11404	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Heudi O (2002)	12487427	178885	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11405	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Intengan HD (2000)	10856267	178888	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11406	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Troughton RW (2000)	11040230	178889	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11407	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Burrell LM (2000)	11041166	178886	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11408	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	McClean DR (2000)	10933361	178887	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11409	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Azizi M (2000)	10856268	178884	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11410	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Reddy MM (1999)	9886939	178890	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11411	112449	6560	-	SLC12A4	KCC1	9606	Homo sapiens	inhibitor	target	Reid KH (2000)	10793196	178891	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11412	112449	6560	-	SLC12A4	KCC1	9606	Homo sapiens	inhibitor	target	Jean-Xavier C (2006)	16807348	178892	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11413	121538	57468	RP11-465L10.5	SLC12A5	KCC2	9606	Homo sapiens	inhibitor	target	Reid KH (2000)	10793196	178891	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11414	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Akar F (2001)	11443057	178893	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11415	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Wall SM (2001)	11292635	178895	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11416	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Jiang G (2001)	11698253	178894	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11417	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Evans RL (2000)	10831596	178897	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11418	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Panet R (2000)	10567922	178896	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11419	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Thakker RV (1998)	9690036	178899	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11420	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Thakker RV (1999)	10561751	178898	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11421	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Long P (2009)	19141616	178901	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11422	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Karolyi L (1998)	9587066	178900	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11423	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	877	Bumetanide	3-Butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid|3-Butylamino-4-phenoxy-5-sulfamoyl-benzoic acid|Bumetanidum|3-Butylamino-4-phenoxy-5-sulfamoylbenzoic acid|Bumetanida|3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid	burinex tab 5mg|bumetanide|bur	DRUGBANK	DB00887	C17H20N2O5S	small molecule	C03EB02|C03CA02|C03CB02	28395-03-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAEIEVLCKWDQJH-UHFFFAOYSA-N
11424	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Turvill JL (2000)	10882387	178909	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11425	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Hillsley K (1999)	10412832	178908	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11426	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Ho KY (2006)	17093363	178907	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11427	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11428	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Tan M (2003)	12943486	178910	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11429	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Feyer P (2005)	16044252	178906	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11430	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Cappelli A (2002)	11814868	178912	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11431	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Abdelsayed GG (2007)	17379085	178911	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11432	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gan TJ (2005)	15740177	178235	879	Granisetron	granisetronum|granistron|granisetrn	granisetron hydrochloride inje	DRUGBANK	DB00889	C18H24N4O	small molecule	A04AA02	109889-09-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFWNKCLOYSRHCJ-BTTYYORXSA-N
11433	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Grove RI (1987)	3622377	178918	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11434	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Juriansz RL (1988)	3334987	178919	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11435	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bovee TF (2004)	15276617	178914	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11436	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Maru BS (2009)	18976723	178915	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11437	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chae K (1998)	9558716	178916	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11438	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kuiper GG (1997)	9048584	178917	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11439	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	880	Dienestrol	Cycladiene|alpha-dienestrol diacetate|Dinestrol|Dehydrostilbestrol|Dienestrolum|DV|Dienestrol	ortho dienestrol crm	DRUGBANK	DB00890	C18H18O2	small molecule	G03CB01|G03CC02	13029-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFDFQCUYFHCNBW-SCGPFSFSSA-N
11440	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	882	Oxybuprocaine	Oxyriprocaine|BNX|4-Amino-3-N-butoxy-benzoesaeure-diaethylaminoaethylester|4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester|Oxibuprocaina|Benoxil|4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid|Butoxyaminobenzoyldiethylaminoethanol|Oxybuprocainum|Oxybucaine|Benoxinate	fluress|fluorox|minims benoxin	DRUGBANK	DB00892	C17H28N2O3	small molecule	D04AB03|S01HA02	99-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMHHMUWAYWTMGS-UHFFFAOYSA-N
11441	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Hung CH (2009)	19429093	178921	882	Oxybuprocaine	Oxyriprocaine|BNX|4-Amino-3-N-butoxy-benzoesaeure-diaethylaminoaethylester|4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester|Oxibuprocaina|Benoxil|4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid|Butoxyaminobenzoyldiethylaminoethanol|Oxybuprocainum|Oxybucaine|Benoxinate	fluress|fluorox|minims benoxin	DRUGBANK	DB00892	C17H28N2O3	small molecule	D04AB03|S01HA02	99-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMHHMUWAYWTMGS-UHFFFAOYSA-N
11442	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	882	Oxybuprocaine	Oxyriprocaine|BNX|4-Amino-3-N-butoxy-benzoesaeure-diaethylaminoaethylester|4-Amino-3-butoxy-benzoic acid 2-diethylamino-ethyl ester|Oxibuprocaina|Benoxil|4-Amino-3-butoxy-2-(diethylamino)ethyl ester benzoic acid|Butoxyaminobenzoyldiethylaminoethanol|Oxybuprocainum|Oxybucaine|Benoxinate	fluress|fluorox|minims benoxin	DRUGBANK	DB00892	C17H28N2O3	small molecule	D04AB03|S01HA02	99-43-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMHHMUWAYWTMGS-UHFFFAOYSA-N
11443	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	activator	target	Imming P (2006)	17016423	171742	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11444	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11445	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	activator	target	Overington JP (2006)	17139284	171741	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11446	108789	2512	-	FTL	LFTD|NBIA3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11447	108789	2512	-	FTL	LFTD|NBIA3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11448	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	activator	target	Chen X (2002)	11752352	171740	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11449	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	activator	target	Zaric J (1998)	9629498	178924	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11450	108773	2495	OK/SW-cl.84	FTH1	FHC|FTH|FTHL6|HFE5|PIG15|PLIF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11451	108773	2495	OK/SW-cl.84	FTH1	FHC|FTH|FTHL6|HFE5|PIG15|PLIF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	883	Iron Dextran	Dextran iron|Iron dextran complex|Dexferrum	se-tan plus|preferaob plus dha	DRUGBANK	DB00893	-	small molecule	-	9004-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
11452	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Raman JD (2002)	11792932	178932	884	Testolactone	(4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone	-	DRUGBANK	DB00894	C19H24O3	small molecule	-	968-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPEWUONYVDABNZ-DZBHQSCQSA-N
11453	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Dunkel L (2006)	16766117	178933	884	Testolactone	(4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone	-	DRUGBANK	DB00894	C19H24O3	small molecule	-	968-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPEWUONYVDABNZ-DZBHQSCQSA-N
11454	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Herzog AG (1998)	9521275	178930	884	Testolactone	(4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone	-	DRUGBANK	DB00894	C19H24O3	small molecule	-	968-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPEWUONYVDABNZ-DZBHQSCQSA-N
11455	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Cepa MM (2005)	16190763	178931	884	Testolactone	(4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone	-	DRUGBANK	DB00894	C19H24O3	small molecule	-	968-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPEWUONYVDABNZ-DZBHQSCQSA-N
11456	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	884	Testolactone	(4AS,4br,10ar,10bs,12as)-10a,12a-dimethyl-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2H-naphtho[2,1-F]chromene-2,8(4bh)-dione|D-Homo-17a-oxaandrosta-1,4-diene-3,17-dione|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone|Teslac|Testolactonum|Testolattone|Testolactone|1,2-Didehydrotestololactone|1-Dehydrotestololactone|Testolactona|delta(1)-Testololactone	-	DRUGBANK	DB00894	C19H24O3	small molecule	-	968-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPEWUONYVDABNZ-DZBHQSCQSA-N
11457	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11458	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11459	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11460	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Chandra RK (1980)	7436456	178934	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11461	108501	2207	-	FCER1G	FCRG	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11462	108501	2207	-	FCER1G	FCRG	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11463	108501	2207	-	FCER1G	FCRG	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11464	108501	2207	-	FCER1G	FCRG	9606	Homo sapiens	agonist	target	Chandra RK (1980)	7436456	178934	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11465	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hochhaus G (1990)	2386110	174125	886	Rimexolone	Rimexolon	vexol|vexol ophthalmic suspens	DRUGBANK	DB00896	C24H34O3	small molecule	H02AB12|S01BA13	49697-38-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTTRZHGPGKRAFB-OOKHYKNYSA-N
11466	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11467	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11468	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11469	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11470	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11471	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11472	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11473	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11474	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11475	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11476	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11477	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11478	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11479	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11480	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11481	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11482	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11483	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11484	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11485	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11486	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11487	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11488	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11489	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11490	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Park CH (1996)	8787774	174205	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11491	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11492	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11493	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11494	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11495	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11496	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11497	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11498	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11499	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11500	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11501	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11502	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11503	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11504	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11505	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11506	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11507	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11508	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Earl DE (2011)	21262851	178936	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11509	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11510	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11511	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Ye Q (1998)	9452448	178938	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11512	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11513	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Fuentealba J (2010)	21044637	178939	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11514	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Baenziger JE (2011)	20713066	178937	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11523	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Xu M (2011)	21163614	178947	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11524	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Wang J (2011)	21289476	178946	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11525	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Nishimura FT (2009)	21204417	178945	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11526	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Nishimura FT (2009)	21204407	178944	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11527	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11528	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11533	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11534	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	agonist	target	Ye Q (1998)	9452448	178938	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11535	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11536	109004	2742	-	GLRA2	GLR	9606	Homo sapiens	agonist	target	Baenziger JE (2011)	20713066	178937	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11537	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Pascoe JE (2008)	18325678	178496	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11538	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Wong GT (2010)	19878098	178948	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11539	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Stucke AG (2008)	18815346	178949	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11540	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Poonawala T (2005)	15828941	178497	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11541	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Rodrigues AR (2005)	15665994	178502	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11542	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Darwish M (2006)	16861092	178501	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11543	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Sahin AS (2005)	15868528	178500	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11544	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Darwish M (2005)	16372825	178498	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11545	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11546	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Scott LJ (2005)	16332149	178507	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11547	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Scott LJ (2005)	16114980	178504	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11548	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Warner DS (1996)	8694317	178950	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11549	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Guy J (1997)	9066316	178951	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11550	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Patel SS (1996)	8875131	178952	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11551	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Hoke JF (1997)	9103501	178953	889	Remifentanil	REMIFENTANIL|Remifentanyl	remifentanil hydrochloride for	DRUGBANK	DB00899	C20H28N2O5	small molecule	N01AH06	132875-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVQQQVZCWLTDF-UHFFFAOYSA-N
11552	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	890	Didanosine	Didanosina|9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one|Didanosine|9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one|9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one|9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol|DDI|Dideoxyinosine|2,3-Dideoxyinosine|Didanosinum|DdIno	videx|didanosine|videx chewabl	DRUGBANK	DB00900	C10H12N4O3	small molecule	J05AF02	69655-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXZVVICBKDXVGW-NKWVEPMBSA-N
11553	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	890	Didanosine	Didanosina|9-((2R,5S)-5-(Hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purin-6(9H)-one|Didanosine|9-((2R,5S)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydro-purin-6-one|9-[(2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one|9-((2S,5R)-5-Hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-ol|DDI|Dideoxyinosine|2,3-Dideoxyinosine|Didanosinum|DdIno	videx|didanosine|videx chewabl	DRUGBANK	DB00900	C10H12N4O3	small molecule	J05AF02	69655-05-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXZVVICBKDXVGW-NKWVEPMBSA-N
11554	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11555	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11556	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Friedel HA (1988)	3278878	178955	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11557	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Wilson AJ (2000)	10796631	178956	891	Bitolterol	Bitolterol Mesylate|Bitolterolum	-	DRUGBANK	DB00901	C28H31NO5	small molecule	R03AC17	30392-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZGVEKPRDOIXJY-UHFFFAOYSA-N
11558	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	892	Methdilazine	Tacaryl|Metodilazina|Methdilazinum	-	DRUGBANK	DB00902	C18H20N2S	small molecule	R06AD04	1982-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTMIBDQKFHUPSX-UHFFFAOYSA-N
11559	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chattopadhyay D (1998)	9700532	178958	892	Methdilazine	Tacaryl|Metodilazina|Methdilazinum	-	DRUGBANK	DB00902	C18H20N2S	small molecule	R06AD04	1982-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTMIBDQKFHUPSX-UHFFFAOYSA-N
11560	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	892	Methdilazine	Tacaryl|Metodilazina|Methdilazinum	-	DRUGBANK	DB00902	C18H20N2S	small molecule	R06AD04	1982-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTMIBDQKFHUPSX-UHFFFAOYSA-N
11561	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	892	Methdilazine	Tacaryl|Metodilazina|Methdilazinum	-	DRUGBANK	DB00902	C18H20N2S	small molecule	R06AD04	1982-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTMIBDQKFHUPSX-UHFFFAOYSA-N
11562	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Dasgupta A (2010)	20012879	178957	892	Methdilazine	Tacaryl|Metodilazina|Methdilazinum	-	DRUGBANK	DB00902	C18H20N2S	small molecule	R06AD04	1982-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTMIBDQKFHUPSX-UHFFFAOYSA-N
11563	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Valdes RM (2003)	12680902	178959	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11564	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Ronquist G (1975)	124205	178961	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11565	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Schurek HJ (1975)	127690	178960	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11566	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Kiil F (2003)	12713517	178963	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11567	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Proverbio F (1975)	124600	178962	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11568	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Bowes TJ (2005)	15389563	178964	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11569	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	893	Etacrynic acid	Methylenebutyrylphenoxyacetic acid|acide tacrynique|acidum etacrynicum|Ethacrynic acid|Ethacrynate|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|Etakrinic acid|Ethacryinic Acid|cido etacrnico|Etacrinic acid	sodium edecrin|edecrin tab 50m	DRUGBANK	DB00903	C13H12Cl2O4	small molecule	C03CC01	58-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVOLMBLBETYQHX-UHFFFAOYSA-N
11570	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	van Wijngaarden I (1990)	2164935	178972	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11571	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	van Wijngaarden I (1990)	2164935	178972	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11572	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Mohan KC (1995)	8588861	178982	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11573	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11574	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gan TJ (2005)	15740177	178235	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11575	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Llacer JM (2001)	11763467	178981	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11576	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Arcioni R (2002)	12032025	178980	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11577	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Artaiz I (1998)	10065930	178978	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11578	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Fortuno A (1999)	10517265	178979	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11579	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gallardo Lara V (2009)	19320280	178976	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11580	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Carvalho F (2002)	11972287	178977	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11581	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Szajewska H (2007)	17269994	178974	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11582	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Dimitrov DH (2010)	20098535	178975	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11583	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gregory RE (1998)	9506240	178231	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11584	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Ramsook C (2002)	11919526	178973	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11585	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	unknown	target	van Wijngaarden I (1990)	2164935	178972	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11586	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	van Wijngaarden I (1990)	2164935	178972	894	Ondansetron	Zofran odt	riva-ondansetron|septa-ondanse	DRUGBANK	DB00904	C18H19N3O	small molecule	A04AA01	99614-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FELGMEQIXOGIFQ-UHFFFAOYSA-N
11587	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Gabelt BT (2009)	19232013	178983	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11588	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Ota T (2006)	16877408	178985	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11589	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Sharif NA (2003)	14733708	178984	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11590	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Ota T (2006)	16877408	178985	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11591	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Sharif NA (2003)	14733708	178984	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11592	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11593	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11594	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sharif NA (2002)	12222762	178987	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11595	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Mintz EE (1978)	689791	178986	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11596	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sharif NA (2003)	14733708	178984	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11597	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Wan Z (2007)	17724194	178989	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11598	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sharif NA (2001)	11740958	178988	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11599	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Lim KS (2008)	18452763	174976	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11600	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Neacsu AM (2009)	19697832	174974	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11601	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11602	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Sunol C (2010)	20512624	178994	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11603	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Henjum S (2007)	17069932	178990	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11604	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Pollack MH (2005)	16420077	178991	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11605	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Sheehan DV (2007)	18007567	178992	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11606	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Foster AC (2006)	16377242	178993	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11607	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Carrera MR (2004)	15351386	178995	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11608	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Zhao Y (2004)	15113605	178996	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11609	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Galli A (1995)	7500004	178997	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11610	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Burchett SA (1997)	9387868	178998	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11611	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Corey JL (1994)	8302852	179001	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11612	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Barker EL (1999)	10366604	179000	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11613	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11614	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Patkar AA (2002)	12057823	178999	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11615	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Carrera MR (2004)	15351386	178995	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11616	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Carrera MR (2004)	15351386	178995	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11617	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11618	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11619	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Carrera MR (2004)	15351386	178995	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11620	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Rothman RB (1999)	10420171	179003	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11621	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wilson JM (1996)	8797532	179002	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11622	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11623	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Kim DI (2003)	12672245	179004	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11624	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11625	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11626	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Carrera MR (2004)	15351386	178995	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11627	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Sharkey J (1988)	3047364	179005	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11628	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Satish OS (2005)	15880981	179008	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11629	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Antzelevitch C (2006)	17038146	179007	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11630	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Wright SN (1999)	9876137	179006	897	Cocaine	Methyl benzoylecgonine|Cocainum|Cocaine|Kokain|L-Cocain|2-Methyl-3beta-hydroxy-1alphah,5alphah-tropane-2beta-carboxylate benzoate (ester)|Benzoylmethylecgonine|Methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Cocain|beta-Cocain|L-Cocaine|(-)-Cocaine|()-cocaine|Neurocaine|[1R-(Exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|Cocaina	cocaine hydrochloride top sol 	DRUGBANK	DB00907	C17H21NO4	small molecule	N01BC01|S02DA02|R02AD03|S01HA01	50-36-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPUCINDJVBIVPJ-LJISPDSOSA-N
11631	109976	3775	RP4-550F15.1	KCNK1	DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1	9606	Homo sapiens	inhibitor	target	Lesage F (1996)	8605869	179010	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11632	109976	3775	RP4-550F15.1	KCNK1	DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1	9606	Homo sapiens	inhibitor	target	Fink M (1996)	9003761	179011	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11633	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Itoh H (2005)	15877619	179012	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11634	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Stokoe KS (2007)	17023504	179013	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11635	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Grant AO (2005)	16138883	179016	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11636	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ohgo T (2007)	17556186	179014	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11637	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Napolitano C (2006)	16972995	179015	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11638	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11639	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Tella SR (1998)	9476974	177548	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11640	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sheets MF (2010)	20685573	175038	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11641	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Patel AJ (2000)	10887187	179018	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11642	114817	9424	-	KCNK6	K2p6.1|KCNK8|TOSS|TWIK-2|TWIK2	9606	Homo sapiens	inhibitor	target	Guerard NC (2008)	18582585	179017	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11643	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Po SS (1999)	10028924	179020	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11644	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Wolpert C (2005)	15673388	176453	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11645	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Guerard NC (2008)	18582585	179017	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11646	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Dong DL (2004)	15125690	179022	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11647	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Lin C (2005)	15821840	179021	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11648	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Lin C (2005)	16041196	179019	898	Quinidine	CIN-QUIN|Pitayine|beta-Quinine|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|(+)-quinidine|Chinidin|Quinidine|(S)-(6-Methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidina|Conchinin|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|-quinine|(R)-(6-Methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|Kinidin|Conquinine|Chinidinum|(8R,9S)-Quinidine	cardioquin tablets|quinidex ex	DRUGBANK	DB00908	C20H24N2O2	small molecule	C01BA51|C01BA01|C01BA71	56-54-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOUPRKONTZGTKE-LHHVKLHASA-N
11649	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11650	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11651	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murata M (2001)	11755227	179027	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11652	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murata M (2004)	14965331	179030	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11653	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11654	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Okada M (1995)	8991786	179032	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11655	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Okada M (1994)	7856330	179033	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11656	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11657	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Okada M (1995)	8991786	179032	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11658	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11659	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11660	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11661	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11662	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11663	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11664	112235	6330	-	SCN4B	ATFB17|LQT10|Navbeta4	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11665	107224	770	UNQ211/PRO237	CA11	CARPX1	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11666	107224	770	UNQ211/PRO237	CA11	CARPX1	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11667	107224	770	UNQ211/PRO237	CA11	CARPX1	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11668	107224	770	UNQ211/PRO237	CA11	CARPX1	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11669	107224	770	UNQ211/PRO237	CA11	CARPX1	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11670	132020	377677	-	CA13	CAXIII	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11671	132020	377677	-	CA13	CAXIII	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11672	132020	377677	-	CA13	CAXIII	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11673	132020	377677	-	CA13	CAXIII	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11674	132020	377677	-	CA13	CAXIII	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11675	107222	767	-	CA8	CA-VIII|CALS|CAMRQ3|CARP	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11676	107222	767	-	CA8	CA-VIII|CALS|CAMRQ3|CARP	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11677	107222	767	-	CA8	CA-VIII|CALS|CAMRQ3|CARP	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11678	107222	767	-	CA8	CA-VIII|CALS|CAMRQ3|CARP	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11679	107222	767	-	CA8	CA-VIII|CALS|CAMRQ3|CARP	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11680	121259	56934	hucep-15	CA10	CA-RPX|CARPX	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11681	121259	56934	hucep-15	CA10	CA-RPX|CARPX	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11682	121259	56934	hucep-15	CA10	CA-RPX|CARPX	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11683	121259	56934	hucep-15	CA10	CA-RPX|CARPX	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11684	121259	56934	hucep-15	CA10	CA-RPX|CARPX	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11685	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11686	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11687	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11688	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11689	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11690	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11691	112232	6327	UNQ326/PRO386	SCN2B	ATFB14	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11692	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11693	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11694	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11695	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11696	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11697	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11698	120912	55800	-	SCN3B	ATFB16|BRGDA7|HSA243396|SCNB3	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11699	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11700	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11701	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11702	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11703	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11704	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11705	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11706	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11707	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11708	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11709	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11710	112229	6324	-	SCN1B	ATFB13|BRGDA5|GEFSP1	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11711	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11712	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11713	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11714	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11715	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11716	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11717	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11718	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Murata M (2004)	14965331	179030	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11719	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11720	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11721	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11722	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11723	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11724	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Masuda Y (1993)	8494570	179045	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11725	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	De Simone G (2005)	15837316	179044	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11726	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18162396	179047	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11727	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Shank RP (2008)	18343915	179046	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11728	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11729	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11730	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11731	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11732	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11733	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11734	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11735	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11736	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11737	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11738	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Murata M (2004)	14965331	179030	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11739	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11740	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11741	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11742	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11743	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11744	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11745	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11746	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11747	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11748	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11749	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11750	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11751	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11752	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11753	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11754	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11755	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11756	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11757	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11758	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11759	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11760	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11761	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11762	116436	11280	-	SCN11A	FEPS3|HSAN7|NAV1.9|NaN|PN5|SCN12A|SNS-2	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11763	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11764	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11765	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11766	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11767	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11768	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11769	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11770	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11771	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18162396	179047	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11772	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11773	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11774	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11775	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11776	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11777	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11778	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11779	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11780	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11781	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11782	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11783	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11784	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	De Simone G (2005)	15837316	179044	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11785	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11786	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11787	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11788	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11789	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11790	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	De Simone G (2005)	15837316	179044	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11791	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11792	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11793	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11794	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11795	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Murata M (2010)	20502722	179028	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11796	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11797	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11798	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11799	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11800	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11801	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11802	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Murata M (2004)	14965331	179030	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11803	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11804	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11805	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11806	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11807	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11808	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11809	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11810	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11811	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11812	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11813	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11814	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11815	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11816	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11817	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11818	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11819	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11820	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11821	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11822	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11823	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11824	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11825	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11826	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11827	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11828	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11829	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11830	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11831	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11832	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11833	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11834	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11835	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11836	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11837	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11838	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11839	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11840	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11841	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11842	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11843	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11844	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Farooq MU (2008)	18782051	179029	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11845	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Masuda Y (1993)	8494570	179045	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11846	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	De Simone G (2005)	15837316	179044	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11847	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18162396	179047	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11848	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Shank RP (2008)	18343915	179046	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11849	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Unknown Authors (2007)	17582922	179041	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11850	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Biton V (2007)	17762320	179040	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11851	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	De Simone G (2009)	19703035	179043	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11852	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18537527	179042	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11853	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	900	Paricalcitol	19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar	paricalcitol|zemplar	DRUGBANK	DB00910	C27H44O3	small molecule	H05BX02	131918-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKAHTKRCLCHEA-UBFJEZKGSA-N
11854	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	900	Paricalcitol	19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar	paricalcitol|zemplar	DRUGBANK	DB00910	C27H44O3	small molecule	H05BX02	131918-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKAHTKRCLCHEA-UBFJEZKGSA-N
11855	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	900	Paricalcitol	19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar	paricalcitol|zemplar	DRUGBANK	DB00910	C27H44O3	small molecule	H05BX02	131918-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKAHTKRCLCHEA-UBFJEZKGSA-N
11856	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Brancaccio D (2009)	19494617	179054	900	Paricalcitol	19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar	paricalcitol|zemplar	DRUGBANK	DB00910	C27H44O3	small molecule	H05BX02	131918-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKAHTKRCLCHEA-UBFJEZKGSA-N
11857	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Andress DL (2005)	16076355	179052	900	Paricalcitol	19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar	paricalcitol|zemplar	DRUGBANK	DB00910	C27H44O3	small molecule	H05BX02	131918-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKAHTKRCLCHEA-UBFJEZKGSA-N
11858	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Wu-Wong JR (2010)	20204178	179053	900	Paricalcitol	19-Nor-1alpha,25-dihydroxyvitamin D2|Paricalcitol|Zemplar	paricalcitol|zemplar	DRUGBANK	DB00910	C27H44O3	small molecule	H05BX02	131918-61-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKAHTKRCLCHEA-UBFJEZKGSA-N
11859	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11860	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Hu S (2000)	10773014	51241	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11861	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Sunaga Y (2001)	11716850	178081	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11862	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Dornhorst A (2001)	11728565	178079	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11863	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Hansen AM (2002)	12196472	178078	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11864	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Waengler B (2004)	15219283	179056	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11865	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Waengler B (2004)	15380228	179057	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11866	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	903	Anileridine	N--(p-aminophenyl)ethylnormeperidine|1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester|ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate|N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine|N-beta-(P-Aminophenyl)ethylnormeperidine|Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate|Anileridina|Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate|Anileridinum	leritine tablets 25mg|leritine	DRUGBANK	DB00913	C22H28N2O2	small molecule	N01AH05	144-14-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYQLAWMNBFNJT-UHFFFAOYSA-N
11867	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	903	Anileridine	N--(p-aminophenyl)ethylnormeperidine|1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester|ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate|N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine|N-beta-(P-Aminophenyl)ethylnormeperidine|Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate|Anileridina|Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate|Anileridinum	leritine tablets 25mg|leritine	DRUGBANK	DB00913	C22H28N2O2	small molecule	N01AH05	144-14-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYQLAWMNBFNJT-UHFFFAOYSA-N
11868	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	903	Anileridine	N--(p-aminophenyl)ethylnormeperidine|1-[2-(4-Aminophenyl)ethyl]-4-phenyl-4-piperidinecarboxlic acid ethyl ester|ethyl 1-(4-aminophenethyl)-4-phenylisonipecotate|N-(beta-(P-Aminophenyl)ethyl)-4-phenyl-4-carbethoxypiperidine|N-beta-(P-Aminophenyl)ethylnormeperidine|Ethyl 1-(2-(4-aminophenyl)ethyl)-4-phenyl-4-piperidinecarboxylate|Anileridina|Ethyl 1-(P-aminophenethyl)-4-phenylisonipecotate|Anileridinum	leritine tablets 25mg|leritine	DRUGBANK	DB00913	C22H28N2O2	small molecule	N01AH05	144-14-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYQLAWMNBFNJT-UHFFFAOYSA-N
11869	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Zhang L (2007)	17369473	179062	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11870	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Chen S (2008)	17995453	179061	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11871	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Woollhead AM (2007)	17603555	179060	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11872	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Aziz Q (2010)	20188727	179063	904	Phenformin	DBI|Fenformin|Phenformine|-Phenethybiguanide|Fenformina|Phenforminum	-	DRUGBANK	DB00914	C10H15N5	small molecule	A10BD01|A10BA01	114-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICFJFFQQTFMIBG-UHFFFAOYSA-N
11873	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Blanpied TA (2005)	15800186	179065	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11874	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Hesselink MB (1999)	10443547	179064	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11875	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Tomitaka S (1995)	8566141	179067	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11876	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Cousins MS (1997)	9098680	179066	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11877	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Hesselink MB (1999)	10443547	179064	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11878	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Ameri A (1998)	9806328	179068	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11879	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11880	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11881	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11882	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11883	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11884	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11885	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11886	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11887	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11888	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11889	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11890	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11891	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11892	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Wise H (2006)	16545798	179086	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11893	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11894	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11895	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11896	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11897	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Gras J (2001)	11642004	179088	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11898	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11899	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11900	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Bou J (2000)	11134654	179087	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11901	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Fleishaker JC (2000)	10824628	179089	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11902	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11903	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Bou J (2000)	11134654	179087	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11904	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Napier C (1999)	10193663	174442	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11905	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Knyihar-Csillik E (2000)	11069595	174443	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11906	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	van den Broek RW (2000)	11050304	174441	908	Almotriptan	1-(((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)sulfonyl)pyrrolidine	axert 12.5mg|sandoz almotripta	DRUGBANK	DB00918	C17H25N3O2S	small molecule	N02CC05	154323-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKEMJKQOLOHJLZ-UHFFFAOYSA-N
11907	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	909	Spectinomycin	SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum	trobicin inj 400mg/ml	DRUGBANK	DB00919	C14H24N2O7	small molecule	J01XX04	1695-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNFWWIHTNXNPBV-WXKVUWSESA-N
11908	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Carter AP (2000)	11014183	179093	909	Spectinomycin	SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum	trobicin inj 400mg/ml	DRUGBANK	DB00919	C14H24N2O7	small molecule	J01XX04	1695-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNFWWIHTNXNPBV-WXKVUWSESA-N
11909	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	909	Spectinomycin	SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum	trobicin inj 400mg/ml	DRUGBANK	DB00919	C14H24N2O7	small molecule	J01XX04	1695-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNFWWIHTNXNPBV-WXKVUWSESA-N
11910	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Gordeev VK (1983)	6339322	179096	909	Spectinomycin	SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum	trobicin inj 400mg/ml	DRUGBANK	DB00919	C14H24N2O7	small molecule	J01XX04	1695-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNFWWIHTNXNPBV-WXKVUWSESA-N
11911	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Eisenstein BI (1980)	6103875	179094	909	Spectinomycin	SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum	trobicin inj 400mg/ml	DRUGBANK	DB00919	C14H24N2O7	small molecule	J01XX04	1695-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNFWWIHTNXNPBV-WXKVUWSESA-N
11912	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Yamagata H (1980)	6451613	179095	909	Spectinomycin	SCM|Spectinomycine|Actinospectacina|Spectinomicina|Espectinomicina|Spectinomycinum	trobicin inj 400mg/ml	DRUGBANK	DB00919	C14H24N2O7	small molecule	J01XX04	1695-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNFWWIHTNXNPBV-WXKVUWSESA-N
11913	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Okabe S (1992)	1434122	179098	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11914	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Mita H (1995)	7893266	179099	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11915	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11916	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ito K (1996)	8836617	179097	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11917	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Werner-Klein M (2008)	18490184	179100	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11918	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hashimoto T (2006)	16404130	179101	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11919	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yokoyama H (1993)	8101246	179102	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11920	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11921	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11922	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11923	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11924	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11925	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11926	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11927	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11928	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11929	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11930	111177	5151	-	PDE8A	HsT19550	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11931	118010	27115	RP11-472E5.2	PDE7B	bA472E5.1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11932	118010	27115	RP11-472E5.2	PDE7B	bA472E5.1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11933	114177	8622	PIG22	PDE8B	ADSD|PPNAD3	9606	Homo sapiens	inhibitor	target	Castillo JG (1990)	1702263	179104	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11934	111247	5226	-	PGD	6PGD	9606	Homo sapiens	inhibitor	target	Akkemik E (2010)	20235752	176889	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11935	111247	5226	-	PGD	6PGD	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	910	Ketotifen	Ketotifenum|Ketotifene|Ketotifeno	nu-ketotifen syrup - 1mg/5ml|z	DRUGBANK	DB00920	C19H19NOS	small molecule	R06AX17|S01GX08	34580-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCVMWBYGMWKGHF-UHFFFAOYSA-N
11936	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Boothby LA (2007)	17244875	179105	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11937	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Robinson SE (2006)	16953647	179106	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11938	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Lester PA (2006)	16443205	179108	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11939	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Induru RR (2009)	19666890	179109	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11940	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Megarbane B (2006)	16169027	179107	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11941	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Ide S (2004)	15100703	179114	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11942	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Mizoguchi H (2002)	12435410	179113	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11943	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Kishioka S (2000)	10729371	179112	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11944	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Zubieta J (2000)	10942856	179111	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11945	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Sanchez-Blazquez P (2001)	11275413	179110	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11946	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	911	Buprenorphine	2-[3-Cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|Buprenorfina|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|()-buprenorphine|(-)-Buprenorphine|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|Buprenophine|Buprenorphinum|21-Cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine	act buprenorphine/naloxone|bup	DRUGBANK	DB00921	C29H41NO4	small molecule	N07BC51|N02AE01|N07BC01	52485-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMRJXGBAOAMLHD-IHFGGWKQSA-N
11947	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Szilagyi S (2005)	16116344	179116	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11948	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inducer	target	Yildiz O (2007)	17452812	179117	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11949	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11950	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	potentiator	target	Lehmann A (2003)	12975736	179119	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11951	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	potentiator	target	Levijoki J (2000)	10731446	179118	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11952	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	potentiator	target	Kleerekoper Q (1999)	10446160	179122	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11953	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	potentiator	target	Sorsa T (2001)	11113122	179120	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11954	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	potentiator	target	Sorsa T (2003)	12967628	179121	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11955	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inducer	target	Yildiz O (2007)	17452812	179117	912	Levosimendan	Levosimedan|Levosimendanum|Simdax	-	DRUGBANK	DB00922	C14H12N6O	small molecule	C01CX08	141505-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHXMKTBCFHIYNQ-SECBINFHSA-N
11956	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Honda M (2003)	12498911	176034	914	Cyclobenzaprine	Cyclobenzaprinum|N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-5,-propylamine|(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine|Cyclobenzaprine|Ciclobenzaprina|N,N-Dimethyl-5H-dibenzo(a,D)cycloheptene-delta(5,gamma)-propylamine	flexeril   -(10mg)|jamp-cyclob	DRUGBANK	DB00924	C20H21N	small molecule	M03BX08	303-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JURKNVYFZMSNLP-UHFFFAOYSA-N
11957	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kobayashi H (1996)	8884233	179125	914	Cyclobenzaprine	Cyclobenzaprinum|N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-5,-propylamine|(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine|Cyclobenzaprine|Ciclobenzaprina|N,N-Dimethyl-5H-dibenzo(a,D)cycloheptene-delta(5,gamma)-propylamine	flexeril   -(10mg)|jamp-cyclob	DRUGBANK	DB00924	C20H21N	small molecule	M03BX08	303-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JURKNVYFZMSNLP-UHFFFAOYSA-N
11958	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Frang H (2001)	11395517	179127	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11959	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Frang H (2001)	11395517	179127	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11960	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Michel MC (1994)	7911719	177935	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11961	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Suzuki E (1990)	1978244	178045	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11962	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Stam WB (1999)	10401556	136712	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11963	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Salles J (1996)	8935707	179128	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11964	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Yu Y (2003)	12818701	179129	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11965	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Frang H (2001)	11395517	179127	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11966	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Minneman KP (1994)	7969082	179130	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11967	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Kuromi H (1997)	9100252	179135	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11968	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Lukas TJ (1985)	3994963	179134	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11969	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Suko J (1986)	3758070	179131	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11970	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Earl CQ (1984)	6146911	179133	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11971	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Cimino M (1988)	3134891	179132	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11972	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Frang H (2001)	11395517	179127	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11973	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Minneman KP (1994)	7969082	179130	915	Phenoxybenzamine	Phenoxybenzamine|Fenossibenzamina|Dibenzyline|Fenoxibenzamina|Phenoxybenzaminum|POB	phenoxybenzamine hydrochloride	DRUGBANK	DB00925	C18H22ClNO	small molecule	C04AX02	59-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZVCTJOXCFMACW-UHFFFAOYSA-N
11974	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Orfanos CE (1997)	9074840	176227	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11975	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Harnish DC (1990)	1965892	179137	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11976	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Billoni N (1997)	9298126	179136	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11977	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Saurat JH (1999)	10459139	176229	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11978	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Zitnik RJ (1994)	8301142	179138	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11979	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Billoni N (1997)	9298126	179136	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11980	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Zitnik RJ (1994)	8301142	179138	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11981	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11982	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11983	112170	6258	-	RXRG	NR2B3|RXRC	9606	Homo sapiens	agonist	target	Billoni N (1997)	9298126	179136	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11984	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11985	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11986	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11987	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11988	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11989	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Billoni N (1997)	9298126	179136	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11990	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Zitnik RJ (1994)	8301142	179138	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11991	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	agonist	target	Orfanos CE (1997)	9074840	176227	916	Etretinate	-	-	DRUGBANK	DB00926	C23H30O3	small molecule	D05BB01	54350-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMNCQVAMBCHCO-DJRRULDNSA-N
11992	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Leurs R (1991)	1646056	179148	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11993	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Amagase K (2003)	12832840	179144	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11994	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Kesiova M (2006)	16702624	179145	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11995	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Ojiako K (2008)	18310651	179146	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11996	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Lesclous P (2006)	16513821	179147	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11997	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Weydert JA (2003)	12509588	179140	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11998	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Inan A (2009)	19578661	179141	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
11999	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Fukuda M (2007)	17273750	179142	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
12000	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Miyata K (1991)	2067140	179143	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
12001	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Takahashi HK (2006)	16723495	176525	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
12002	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	917	Famotidine	Famotidinum|Pepcid|3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine|3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide|(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide|N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide|Famotidina	equate acid controller origina	DRUGBANK	DB00927	C8H15N7O2S3	small molecule	A02BA53|A02BA03	76824-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFQPHANEAPEMJ-UHFFFAOYSA-N
12003	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Cataldo VD (2009)	19589026	179158	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12004	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Fenaux P (2005)	16341239	179149	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12005	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Kaminskas E (2005)	15793220	179153	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12006	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	O'Dwyer K (2008)	18627335	179152	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12007	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Ghoshal K (2007)	17612710	179151	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12008	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Hollenbach PW (2010)	20126405	179150	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12009	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Leone G (2003)	14585280	179157	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12010	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Silverman LR (2002)	12011120	179156	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12011	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Glover AB (1987)	2443243	179155	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12012	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Silverman LR (2001)	11700387	179154	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12013	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMUSYJAQQFHJEW-KVTDHHQDSA-N
12014	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12015	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12016	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12017	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12018	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12019	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12020	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12021	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12022	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12023	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Crider JY (2002)	11993717	160612	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12024	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12025	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12026	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12027	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12028	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12029	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12030	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Muzammil S (2007)	17360759	179171	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12031	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Koh Y (2007)	17635930	179170	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12032	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Temesgen Z (2007)	17712762	179166	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12033	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Tenore SB (2009)	20428639	179167	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12034	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Luna B (2007)	18158073	179165	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12035	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Croom KF (2005)	16060700	179168	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12036	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Hsieh SM (2009)	19751502	179169	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12037	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Chen X (2002)	11752352	171740	922	Tipranavir	-	aptivus	DRUGBANK	DB00932	C31H33F3N2O5S	small molecule	J05AE09	174484-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUJUHGSWHZTSEU-FYBSXPHGSA-N
12038	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12039	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Burstein ES (2005)	16135699	176776	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12040	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Choi S (2004)	15357957	179174	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12041	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Rauser L (2001)	11561066	179175	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12042	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Choi S (2004)	15357957	179174	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12043	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Herrick-Davis K (2000)	10991983	175882	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12044	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12045	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	El-Fakahany E (1983)	6297650	179177	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12046	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Doggrell SA (1981)	6118411	179176	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12047	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Cloonan SM (2010)	20141432	179179	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12048	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Saba W (2007)	17068778	179178	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12049	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Dronjak S (2007)	17984940	179182	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12050	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Arai S (2003)	12573515	179180	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12051	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mochizucki D (2004)	15378668	179181	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12052	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12053	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Lucchelli A (2000)	10997731	175186	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12054	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cavero I (1981)	6115693	179183	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12055	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kanba S (1984)	6146381	179184	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12056	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Noguchi S (1992)	1353628	177589	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12057	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	binder	target	Peroutka SJ (1981)	7221567	179185	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12058	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12059	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	El-Fakahany E (1983)	6297650	179177	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12060	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Doggrell SA (1981)	6118411	179176	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12061	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12062	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	El-Fakahany E (1983)	6297650	179177	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12063	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Doggrell SA (1981)	6118411	179176	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12064	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12065	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12066	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12067	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12068	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12069	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12070	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12071	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	El-Fakahany E (1983)	6297650	179177	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12072	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Doggrell SA (1981)	6118411	179176	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12073	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Golds PR (1980)	7052344	178830	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12074	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	El-Fakahany E (1983)	6297650	179177	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12075	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Doggrell SA (1981)	6118411	179176	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12076	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12077	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12078	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12079	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	binder	target	Peroutka SJ (1981)	7221567	179185	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12080	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Uhlen S (1991)	1666366	176190	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12081	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Gaulton A (2012)	21948594	174478	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12082	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Shibata K (2001)	11774707	179189	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12083	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Yang HT (1996)	8894610	179193	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12084	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Furukawa K (1995)	8564226	179192	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12085	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Deplanne V (1996)	8768700	179191	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12086	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Gonzalez-Espinosa C (2001)	11527538	179190	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12087	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12088	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Akinaga J (2013)	23364786	179195	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12089	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12090	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Gaulton A (2012)	21948594	174478	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12091	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Mitrani P (2007)	17164433	179197	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12092	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	MacKinnon AC (1992)	1327384	179196	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12093	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Lepretre N (1994)	7892112	179198	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12094	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Akinaga J (2013)	23364786	179195	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12095	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12096	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Gaulton A (2012)	21948594	174478	925	Oxymetazoline	6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|Oxymetazolinum|Oxymethazoline|Oxymetozoline|Oxymetazolina|Oximetazolinum|2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol	sunmark nasal|shopko extra moi	DRUGBANK	DB00935	C16H24N2O	small molecule	S01GA04|R01AB07|R01AA05	1491-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYWIFABBXFUGLM-UHFFFAOYSA-N
12097	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Celik G (2005)	15871445	179199	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12098	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12099	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Sun R (2005)	15840771	179203	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12100	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Liu X (2006)	16368818	179202	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12101	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12102	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Moon C (2004)	14746879	179200	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12103	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Vane JR (1971)	5284360	179204	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12104	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	inhibitor	target	Dhagat U (2007)	18045204	179205	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12105	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12106	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12107	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12108	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vane JR (1971)	5284360	179204	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12109	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12110	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12111	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	927	Diethylpropion	Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone	tenuate dospan|diethylpropion 	DRUGBANK	DB00937	C13H19NO	small molecule	A08AA03	90-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXEPPPIWZFICOJ-UHFFFAOYSA-N
12112	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	927	Diethylpropion	Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone	tenuate dospan|diethylpropion 	DRUGBANK	DB00937	C13H19NO	small molecule	A08AA03	90-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXEPPPIWZFICOJ-UHFFFAOYSA-N
12113	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Arias HR (2009)	19897080	179213	927	Diethylpropion	Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone	tenuate dospan|diethylpropion 	DRUGBANK	DB00937	C13H19NO	small molecule	A08AA03	90-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXEPPPIWZFICOJ-UHFFFAOYSA-N
12114	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Yu H (2000)	11131159	179214	927	Diethylpropion	Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone	tenuate dospan|diethylpropion 	DRUGBANK	DB00937	C13H19NO	small molecule	A08AA03	90-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXEPPPIWZFICOJ-UHFFFAOYSA-N
12115	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Arias HR (2009)	19897080	179213	927	Diethylpropion	Diethylpropion|2-(Diethylamino)propiophenone|2-(Diethylamino)-1-phenyl-1-propanone|Diethylcathinone|Amfepramone|alpha-Benzoyltriethylamine|(+-)-Diethylpropion|()-diethylpropion|alpha-Diethylaminopropiophenone|Anfepramona|Amfepramonum|1-phenyl-2-diethylamino-1-propanone	tenuate dospan|diethylpropion 	DRUGBANK	DB00937	C13H19NO	small molecule	A08AA03	90-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXEPPPIWZFICOJ-UHFFFAOYSA-N
12116	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12117	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Rong Y (1999)	10471277	179215	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12118	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Green SA (2001)	11516429	179216	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12119	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Finney PA (2001)	11250877	179217	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12120	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brogden RN (1992)	1359777	179218	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12121	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Meliton AY (2003)	12897749	179219	928	Salmeterol	GR-33343-X|GR-33343X|Salmeterolum|Salmaterol|Serevent diskus|Serevent|Salmeterol	advair diskus|advair 100 disku	DRUGBANK	DB00938	C25H37NO4	small molecule	R03AC12|R03AK06|R03AK12	89365-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIIZNNXWQWCKIB-UHFFFAOYSA-N
12122	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Shiels IA (2000)	11094641	179221	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12123	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Meade EA (1993)	8454631	179220	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12124	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kalgutkar AS (2000)	10639181	179223	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12125	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Perez-Vizcaino F (2002)	12225961	179222	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12126	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12127	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Peretz A (2005)	15598972	177097	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12128	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Peretz A (2005)	15598972	177097	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12129	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Boctor AM (1986)	3020588	179225	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12130	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Yu XY (1992)	1539679	179224	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12131	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narsinghani T (2006)	16290292	179228	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12132	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalgutkar AS (2000)	10639181	179223	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12133	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12134	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Traupe T (2002)	12409963	179227	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12135	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith WL (1994)	7825862	179226	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12136	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Hough LB (1981)	6116801	179229	930	Methantheline	Methanthelinium|Methanthelinum|Methantheline	-	DRUGBANK	DB00940	C21H26NO3	small molecule	A03AB07	5818-17-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZHFODJQISUKAY-UHFFFAOYSA-N
12137	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	930	Methantheline	Methanthelinium|Methanthelinum|Methantheline	-	DRUGBANK	DB00940	C21H26NO3	small molecule	A03AB07	5818-17-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZHFODJQISUKAY-UHFFFAOYSA-N
12138	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	930	Methantheline	Methanthelinium|Methanthelinum|Methantheline	-	DRUGBANK	DB00940	C21H26NO3	small molecule	A03AB07	5818-17-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZHFODJQISUKAY-UHFFFAOYSA-N
12139	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Schuh FR (1976)	948350	179230	931	Hexafluronium	Hexafluorenium|Hexafluorenium ion|Hexamethylenebis(fluoren-9-yldimethylammonium)|Hexafluorenium cation	-	DRUGBANK	DB00941	C36H42N2	small molecule	M03AC05	4844-10-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDZAQYPYABGTCL-UHFFFAOYSA-N
12140	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	931	Hexafluronium	Hexafluorenium|Hexafluorenium ion|Hexamethylenebis(fluoren-9-yldimethylammonium)|Hexafluorenium cation	-	DRUGBANK	DB00941	C36H42N2	small molecule	M03AC05	4844-10-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDZAQYPYABGTCL-UHFFFAOYSA-N
12141	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Vedasiromoni JR (1976)	1267542	179231	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12142	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12143	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12144	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	932	Cycrimine	(+-)-Cycrimine|alpha-Cyclopentyl-alpha-phenyl-1-piperidinepropanol|Cicrimina|Cycriminum	-	DRUGBANK	DB00942	C19H29NO	small molecule	-	77-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRUZBWLEWHWRI-UHFFFAOYSA-N
12145	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	934	Demecarium	Demecarium	-	DRUGBANK	DB00944	C32H52N4O4	small molecule	S01EB04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZVPVOZTJJMNU-UHFFFAOYSA-N
12146	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Ward DA (2003)	12641839	179236	934	Demecarium	Demecarium	-	DRUGBANK	DB00944	C32H52N4O4	small molecule	S01EB04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZVPVOZTJJMNU-UHFFFAOYSA-N
12147	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Gum GG (1993)	8430939	179238	934	Demecarium	Demecarium	-	DRUGBANK	DB00944	C32H52N4O4	small molecule	S01EB04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZVPVOZTJJMNU-UHFFFAOYSA-N
12148	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Meiniel R (1981)	7196602	179237	934	Demecarium	Demecarium	-	DRUGBANK	DB00944	C32H52N4O4	small molecule	S01EB04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZVPVOZTJJMNU-UHFFFAOYSA-N
12149	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Birnbaum Y (2007)	17259075	179239	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12150	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12151	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Flipo RM (2006)	17078596	179243	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12152	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Guthikonda S (2007)	17319904	179242	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12153	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Stevenson DD (2006)	17030227	179241	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12154	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Schwartz KA (2006)	17131625	179240	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12155	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	inhibitor	target	Dhagat U (2007)	18045204	179205	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12156	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	acetylation	target	Alfonso LF (2009)	21475861	179244	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12157	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	binding	target	Deng WG (2001)	11689471	179245	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12158	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12159	111551	5564	-	PRKAB1	AMPK|HAMPKb	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12160	111552	5565	-	PRKAB2	-	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12161	111552	5565	-	PRKAB2	-	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12162	119791	53632	-	PRKAG3	AMPKG3	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12163	119791	53632	-	PRKAG3	AMPKG3	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12164	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12165	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12166	111558	5571	-	PRKAG1	AMPKG	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12167	111558	5571	-	PRKAG1	AMPKG	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12168	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12169	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12170	119531	51422	-	PRKAG2	AAKG|AAKG2|CMH6|H91620p|WPWS	9606	Homo sapiens	activator	target	Din FV (2012)	22406476	179247	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12171	119531	51422	-	PRKAG2	AAKG|AAKG2|CMH6|H91620p|WPWS	9606	Homo sapiens	activator	target	Hawley SA (2012)	22517326	179246	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12172	110859	4792	-	NFKBIA	IKBA|MAD-3|NFKBI	9606	Homo sapiens	unknown	target	Stevenson MA (1999)	10553090	179248	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12173	110858	4791	-	NFKB2	CVID10|H2TF1|LYT-10|LYT10|NF-kB2|p100|p52	9606	Homo sapiens	antagonist	target	Kopp E (1994)	8052854	179249	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12174	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Kopp E (1994)	8052854	179249	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12175	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Talbodec A (2000)	10727528	179250	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12176	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	unknown	target	Yin MJ (1998)	9817203	179251	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12177	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12178	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12179	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12180	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hall MN (2007)	17301265	179255	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12181	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12182	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12183	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	unknown	target	Stevenson MA (1999)	10553090	179248	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12184	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Reitsma PH (2005)	16201835	179259	936	Phenprocoumon	Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin	-	DRUGBANK	DB00946	C18H16O3	small molecule	B01AA04	435-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQDAYGNAKTZFIW-UHFFFAOYSA-N
12185	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	936	Phenprocoumon	Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin	-	DRUGBANK	DB00946	C18H16O3	small molecule	B01AA04	435-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQDAYGNAKTZFIW-UHFFFAOYSA-N
12186	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Schalekamp T (2007)	17192772	179261	936	Phenprocoumon	Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin	-	DRUGBANK	DB00946	C18H16O3	small molecule	B01AA04	435-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQDAYGNAKTZFIW-UHFFFAOYSA-N
12187	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Thijssen HH (1988)	3207986	179260	936	Phenprocoumon	Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin	-	DRUGBANK	DB00946	C18H16O3	small molecule	B01AA04	435-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQDAYGNAKTZFIW-UHFFFAOYSA-N
12188	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Thijssen HH (1989)	2706010	179262	936	Phenprocoumon	Phenprocumone|Fenprocumone|4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one|Phenprocoumarole|Phenprocoumonum|Phenprocoumarol|3-(alpha-Ethylbenzyl)-4-hydroxycoumarin|Phenprocoumone|3-(1'-Phenyl-propyl)-4-oxycoumarin|4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one|Fenprocumon|3-(1-Phenylpropyl)-4-hydroxycoumarin|3-(alpha-Phenylpropyl)-4-hydroxycoumarin	-	DRUGBANK	DB00946	C18H16O3	small molecule	B01AA04	435-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQDAYGNAKTZFIW-UHFFFAOYSA-N
12189	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Curran M (2001)	11398912	179274	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12190	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Elkak AE (2002)	11922402	179275	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12191	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Morris C (2002)	12542403	179272	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12192	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Dow KH (2002)	12080538	179273	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12193	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Bundred N (2002)	12113237	179270	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12194	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Kabos P (2010)	20151846	179271	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12195	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12196	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	McKeage K (2004)	15018596	179269	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12197	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Jones SE (2005)	15865850	179268	937	Fulvestrant	ICI 182,780	faslodex	DRUGBANK	DB00947	C32H47F5O3S	small molecule	L02BA03	129453-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWUXBMIQPBEWFH-LQKBAPIOSA-N
12198	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Lei Y (1989)	2683579	179276	938	Mezlocillin	(2S,5R,6R)-3,3-Dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Mezlin|6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid|Mezlocilina|Mezlocilline|Mezlocillin|Mezlocillinum	-	DRUGBANK	DB00948	C21H25N5O8S2	small molecule	J01CA10	51481-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPBATNHYBCGSSN-VWPFQQQWSA-N
12199	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12200	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12201	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Harty TP (2000)	10690753	179282	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12202	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Luszczki JJ (2008)	18253065	179281	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12203	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chang HR (2008)	18311896	179280	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12204	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12205	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Kleckner NW (1999)	10215667	179279	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12206	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12207	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cavero I (1999)	10597865	175351	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12208	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tashiro M (2004)	15286093	175350	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12209	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Amon U (2000)	10864400	179289	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12210	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Devillier P (2008)	18336052	179288	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12211	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Smith SM (2009)	19545214	179283	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12212	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12213	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Abbas MN (2004)	15352500	179287	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12214	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Markham A (1998)	9506246	179286	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12215	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Dhanya NB (2008)	18797058	179285	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12216	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Grzelewska-Rzymowska I (2003)	12712828	179284	940	Fexofenadine	Fexofenadine|Terfenadine-COOH|Terfenadine acid metabolite|Carboxyterfenadine|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|Terfenadine carboxylate	allegra|dg health aller ease|f	DRUGBANK	DB00950	C32H39NO4	small molecule	R06AX26	83799-24-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWTNPBWLLIMQHL-UHFFFAOYSA-N
12217	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Pauwels PJ (1996)	8741180	179298	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12218	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Hoskin KL (2004)	14725972	179299	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12219	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Hargreaves RJ (1999)	10563228	175125	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12220	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Akin D (2002)	12010764	179302	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12221	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Donaldson C (2002)	11897116	179303	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12222	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Dulli DA (1999)	10410185	179300	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12223	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Johnston MM (2010)	20687618	179301	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12224	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Lambert GA (2006)	16389295	179306	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12225	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Boers PM (2004)	14728705	179304	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12226	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Massiou H (2002)	12463278	179305	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12227	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12228	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12229	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Boers PM (2004)	14728705	179304	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12230	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12231	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Villalon CM (2002)	12434581	175133	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12232	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Villalon CM (2003)	15320857	175132	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12233	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Hoskin KL (2004)	14725972	179299	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12234	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12235	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Goadsby PJ (2003)	14614913	179307	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12236	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Massiou H (2002)	12463278	179305	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12237	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12238	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Hoskin KL (2004)	14725972	179299	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12239	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Akin D (2002)	12010764	179302	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12240	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Dulli DA (1999)	10410185	179300	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12241	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Johnston MM (2010)	20687618	179301	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12242	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lambert GA (2006)	16389295	179306	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12243	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Boers PM (2004)	14728705	179304	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12244	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Massiou H (2002)	12463278	179305	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12245	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pauwels PJ (1998)	9650800	175178	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12246	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12247	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	942	Naratriptan	N-Methyl-2-(3-(1-methylpiperiden-4-yl)indole-5-yl)ethanesulfonamide|N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]-ethanesulfonamide|Naratriptanum	teva-naratriptan|naratriptan|s	DRUGBANK	DB00952	C17H25N3O2S	small molecule	N02CC02	121679-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMKVXSZCKVJAGH-UHFFFAOYSA-N
12248	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Longmore J (1996)	8904614	179309	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12249	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Wellington K (2002)	12269863	179311	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12250	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Ikemoto F (2004)	15056946	179310	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12251	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Sciberras DG (1997)	9056052	179313	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12252	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Longmore J (1997)	9127118	179312	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12253	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Williamson DJ (2001)	11487512	179315	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12254	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Wellington K (2002)	12093318	179314	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12255	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12256	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Wackenfors A (2005)	15821444	174449	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12257	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Wainscott DB (1998)	9718276	175131	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12258	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Villalon CM (2002)	12434581	175133	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12259	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Villalon CM (2003)	15320857	175132	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12260	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12261	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	agonist	target	Goadsby PJ (2003)	14614913	179307	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12262	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Wellington K (2002)	12269863	179311	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12263	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Ikemoto F (2004)	15056946	179310	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12264	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12265	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Williamson DJ (2001)	11487512	179315	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12266	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Wellington K (2002)	12093318	179314	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12267	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Pauwels PJ (1998)	9650800	175178	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12268	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Wackenfors A (2005)	15821444	174449	943	Rizatriptan	Rizatriptan|Risatriptan|N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine|N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-ethanamine|Rizatriptanum|Rizatriptn	maxalt|ipg-rizatriptan|jamp-ri	DRUGBANK	DB00953	C15H19N5	small molecule	N02CC04	144034-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULFRLSNUDGIQQP-UHFFFAOYSA-N
12269	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	945	Netilmicin	Netilmycin|Netilmicin|O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine|1-N-Ethylsisomicin	netromycin inj 100mg/ml|netrom	DRUGBANK	DB00955	C21H41N5O7	small molecule	J01GB07|S01AA23	56391-56-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBGPYVZLYBDXKO-HILBYHGXSA-N
12270	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	945	Netilmicin	Netilmycin|Netilmicin|O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4))-2-deoxy-N(1)-ethyl-D-streptamine|1-N-Ethylsisomicin	netromycin inj 100mg/ml|netrom	DRUGBANK	DB00955	C21H41N5O7	small molecule	J01GB07|S01AA23	56391-56-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBGPYVZLYBDXKO-HILBYHGXSA-N
12271	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Peckham EM (2006)	16291875	179319	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12272	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12273	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Thompson CM (2004)	14600248	179320	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12274	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Peckham EM (2006)	16291875	179319	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12275	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12276	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Thompson CM (2004)	14600248	179320	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12277	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Walsh SL (2008)	18606504	179321	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12278	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Kotzer CJ (2000)	10640321	179322	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12279	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Stoops WW (2010)	20665209	179323	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12280	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Hennies HH (1988)	2849950	175231	946	Hydrocodone	4,5-alpha-Epoxy-3-methoxy-17-methylmorphinan-6-one|Hydroconum|(-)-Dihydrocodeinone|Hidrocodona|Hydrocone|Hydrocodone|Hydrocodon|Hydrocodonum|Idrocodone|Dihydrocodeinone	vasofrinic dh|hyrdrocodone apa	DRUGBANK	DB00956	C18H21NO3	small molecule	R05DA03	125-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLPOLZWFYMWNKH-CMKMFDCUSA-N
12281	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Pasqualini JR (2003)	14670645	179325	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12282	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Juchem M (1990)	2175153	175067	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12283	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Shields-Botella J (2003)	14672731	175549	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12284	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12285	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Kuhnz W (1995)	7750291	179326	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12286	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Juchem M (1993)	8384965	179327	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12287	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Graziottin A (2006)	17107221	179328	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12288	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	London RS (1992)	1324557	179329	947	Norgestimate	(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|Dexnorgestrel Acetime|Norgestimato|D-13beta-Ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime|Norgestimatum|(17alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime	tri-cyclen tablets - 21-day|fe	DRUGBANK	DB00957	C23H31NO3	small molecule	G03FA13|G03AA11	35189-28-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIQQMECNKUGGKA-NMYWJIRASA-N
12289	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Juruena MF (2006)	17016711	179339	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12290	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12291	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Quesnell RR (2007)	17251323	179338	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12292	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Owen HC (2007)	17182172	179337	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12293	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Boivin MA (2007)	17068119	179336	949	Methylprednisolone	Metilprednisolona|6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione|(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Methylprednisolon|Medrone|Medrate|Methylprednisolone|1-dehydro-6-methylhydrocortisone|delta(1)-6alpha-Methylhydrocortisone|Medrol|(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione|Solomet|Urbason|1-dehydro-6alpha-Methylhydrocortisone|Methylprednisolonum	methylprednisolone acetate inj	DRUGBANK	DB00959	C22H30O5	small molecule	D10AA02|D07AA01|S01CA08|H02BX01|D07CA02|H02AB04	83-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRSUDSXCMQTMA-PJHHCJLFSA-N
12294	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Haddjeri N (1999)	10331108	179344	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12295	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Andree B (1999)	10435400	179345	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12296	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Fornal CA (1999)	10490909	179342	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12297	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Smeraldi E (1999)	10088139	179343	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12298	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Gobert A (1999)	10432475	179341	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12299	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12300	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Wheeldon NM (1991)	1678274	179346	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12301	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1991)	1687398	179347	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12302	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Dejgaard A (1991)	1666931	179350	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12303	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12304	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Rubenstein LA (2006)	16574446	179348	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12305	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1990)	1979630	179349	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12306	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Watkins DJ (1996)	8884690	179354	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12307	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Joseph SS (2003)	14608456	179351	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12308	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Brodde OE (1988)	2907348	179353	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12309	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1991)	1687398	179347	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12310	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12311	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Berendsen HH (1990)	2148726	179352	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12312	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Dawson LA (2000)	10727715	179355	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12313	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Herrick-Davis K (1988)	3141589	179357	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12314	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Leonhardt S (1989)	2664084	179356	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12315	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Ariani K (1989)	2512511	179359	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12316	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Terron JA (1994)	7944828	179358	950	Pindolol	Pindololum|Carvisken|Prinodolol|Decreten|Durapindol|Pynastin|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|Pectobloc|Cardilate|Betapindol|Pinbetol|1-(1H-indol-4-Yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Blocklin L|Blockin L|Pindolol|Blocklin-L|1-(1H-indol-4-Yloxy)-3-(isopropylamino)propan-2-ol|Glauco-visken|Visken|Calvisken|1-(1H-indol-4-Yloxy)-3-(propan-2-ylamino)-propan-2-ol	apo-pindol tab 5mg|teva-pindol	DRUGBANK	DB00960	C14H20N2O2	small molecule	C07CA03|C07AA03	13523-86-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZQKKSLKJUAGIC-UHFFFAOYSA-N
12317	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	951	Mepivacaine	1-methyl-2',6'-pipecoloxylidide|Carbocaine|Mepivacainum|Mepivacaina|N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide|DL-Mepivacaine|(+-)-1-Methyl-2',6'-pipecoloxylidide|N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide	mepivacaine hydrochloride and 	DRUGBANK	DB00961	C15H22N2O	small molecule	N01BB03|N01BB53	96-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INWLQCZOYSRPNW-UHFFFAOYSA-N
12318	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Leffler A (2010)	20044988	179360	951	Mepivacaine	1-methyl-2',6'-pipecoloxylidide|Carbocaine|Mepivacainum|Mepivacaina|N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide|DL-Mepivacaine|(+-)-1-Methyl-2',6'-pipecoloxylidide|N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide	mepivacaine hydrochloride and 	DRUGBANK	DB00961	C15H22N2O	small molecule	N01BB03|N01BB53	96-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INWLQCZOYSRPNW-UHFFFAOYSA-N
12319	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	951	Mepivacaine	1-methyl-2',6'-pipecoloxylidide|Carbocaine|Mepivacainum|Mepivacaina|N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide|DL-Mepivacaine|(+-)-1-Methyl-2',6'-pipecoloxylidide|N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide	mepivacaine hydrochloride and 	DRUGBANK	DB00961	C15H22N2O	small molecule	N01BB03|N01BB53	96-88-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INWLQCZOYSRPNW-UHFFFAOYSA-N
12320	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12321	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12322	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Patat A (2001)	12404558	179361	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12323	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Sanger DJ (1999)	10515302	179362	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12324	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Barbera J (2005)	15783240	179363	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12325	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Terzano MG (2003)	12608888	179364	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12326	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12327	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12328	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12329	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Waterbury LD (2006)	16846546	179366	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12330	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Matienzo D (2006)	16982289	179368	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12331	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Waterbury LD (2006)	16846546	179366	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12332	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chitturi S (2002)	12016548	179367	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12333	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Liu JH (1991)	1676991	179370	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12334	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Wikberg-Matsson A (2001)	11481271	176420	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12335	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12336	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Chen PL (2006)	16935593	179378	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12337	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12338	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Sueke H (2010)	20399934	179376	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12339	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Mirzai H (2006)	16921219	179375	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12340	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Moodley AA (2007)	17824139	179374	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12341	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Costa VP (2003)	14575724	179373	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12342	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Unknown Authors (2003)	12630335	179372	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12343	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Scheinfeld N (2005)	15748550	179371	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12344	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Watts P (2007)	17572343	179377	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12345	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Freedman KA (2005)	15937427	179380	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12346	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Kawasaki A (2008)	18454417	179379	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12347	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Chen PL (2006)	16935593	179378	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12348	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Watts P (2007)	17572343	179377	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12349	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Sueke H (2010)	20399934	179376	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12350	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Mirzai H (2006)	16921219	179375	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12351	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Moodley AA (2007)	17824139	179374	954	Apraclonidine	Apraclonidina|Apraclonidinum|4-Aminoclonidine	apraclonidine ophthalmic|iopid	DRUGBANK	DB00964	C9H10Cl2N4	small molecule	S01EA03	66711-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEJXVRYNEISIKR-UHFFFAOYSA-N
12352	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2004)	15617852	179382	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12353	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2007)	17691961	179383	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12354	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Kurtz TW (2008)	18580862	179381	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12355	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Kurtz TW (2005)	15868121	179386	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12356	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Imayama I (2006)	16938288	179384	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12357	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2005)	16154710	179385	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12358	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Tagami T (2009)	19147680	171006	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12359	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Yamagishi S (2004)	15617852	179382	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12360	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Strohmenger HU (1997)	9259062	179390	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12361	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Fujimoto M (2004)	15498586	179393	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12362	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Kurtz TW (2008)	18580862	179381	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12363	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Balt JC (2001)	11444497	179387	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12364	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Imayama I (2006)	16938288	179384	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12365	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Yamagishi S (2007)	17691961	179383	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12366	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Gohlke P (2001)	11408526	179388	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12367	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	McClellan KJ (1998)	9878991	179389	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12368	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Karlberg BE (1999)	10067800	179391	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12369	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Sharpe M (2001)	11558835	179392	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12370	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12371	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Galzerano D (2010)	20448797	179394	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12372	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Devillier P (2008)	18336052	179288	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12373	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	DuBuske L (2007)	17902729	179395	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12374	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wu RL (2004)	15564772	179397	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12375	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Simons FE (2003)	12642846	179396	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12376	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12377	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Dhanya NB (2008)	18797058	179285	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12378	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Letari O (1994)	8174605	176169	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12379	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cieslewicz G (1995)	7581058	176168	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAUOIFJMECXRGI-UHFFFAOYSA-N
12380	108011	1644	-	DDC	AADC	9606	Homo sapiens	unknown	target	SOURKES TL (1954)	13189588	179398	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12381	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Head GA (1999)	10415926	179404	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12382	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	van Zwieten PA (1996)	8743022	179401	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12383	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Sica DA (2007)	17485976	179400	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12384	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Velliquette RA (2003)	14557373	179403	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12385	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Kawasaki H (1997)	9284427	179402	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12386	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	van Zwieten PA (1992)	1363322	179399	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12387	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12388	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	958	Methyldopa	-methyl-L-dopa|alpha-methyl-L-dopa|Methyldopa anhydrous|AMD|Methyl dopa|L-alpha-Methyldopa|(S)-(-)-alpha-Methyldopa|Anhydrous methyldopa|Alphamethyldopa|-Methyl dopa|alpha-Methyl dopa|Alpha medopa|L-Methyl Dopa|3-Hydroxy-alpha-methyl-L-tyrosine	methyldopa 125 tab 125mg|novo-	DRUGBANK	DB00968	C10H13NO4	small molecule	-	555-30-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJCSPKMFHVPWAR-UEQNJFAPNA-N
12389	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Camilleri M (2000)	11060667	179416	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12390	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Houghton LA (2000)	10848662	179414	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12391	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Rahimi R (2008)	18555935	179407	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12392	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Gunput MD (1999)	10429744	179415	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12393	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Lewis JH (2010)	20136586	179412	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12394	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Coldwell JR (2007)	17138606	179413	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12395	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Andresen V (2004)	15061683	179410	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12396	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Clayton NM (1999)	10354345	179411	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12397	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12398	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Balfour JA (2000)	10776833	179409	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12399	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Mayer EA (2003)	14596662	179408	959	Alosetron	2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one	lotronex|alosetron hydrochlori	DRUGBANK	DB00969	C17H18N4O	small molecule	A03AE01	122852-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSWZEAMFRNKZNL-UHFFFAOYSA-N
12400	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	unknown	target	Felix CA (1995)	7756657	179417	960	Dactinomycin	Actinomycin D|Dactinomycine|ActD|Dactinomycin|Actinomycin C1|Actinomycin iv|2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide|Dactinomycinum|Dactinomicina|Meractinomycin	cosmegen	DRUGBANK	DB00970	C62H86N12O16	small molecule	L01DA01	50-76-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJURFGZVJUQBHK-IIXSONLDSA-N
12401	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Felix CA (1995)	7756657	179417	960	Dactinomycin	Actinomycin D|Dactinomycine|ActD|Dactinomycin|Actinomycin C1|Actinomycin iv|2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide|Dactinomycinum|Dactinomicina|Meractinomycin	cosmegen	DRUGBANK	DB00970	C62H86N12O16	small molecule	L01DA01	50-76-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJURFGZVJUQBHK-IIXSONLDSA-N
12402	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Conde Hernandez DJ (1995)	8829888	179425	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12403	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Bernstein JA (2007)	17723160	179424	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12404	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Horak F (2008)	19209282	179423	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12405	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Golden SJ (1999)	10478514	179422	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12406	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Casale TB (1989)	2540229	179421	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12407	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Antepara I (1998)	9585822	179420	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12408	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBUVEWMHONZEQD-UHFFFAOYSA-N
12409	118936	29881	-	NPC1L1	NPC11L1	9606	Homo sapiens	inhibitor	target	von Bergmann K (2005)	15992510	179430	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12410	118936	29881	-	NPC1L1	NPC11L1	9606	Homo sapiens	inhibitor	target	Garcia-Calvo M (2005)	15928087	179431	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12411	118936	29881	-	NPC1L1	NPC11L1	9606	Homo sapiens	inhibitor	target	Altmann SW (2004)	14976318	179429	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12412	118936	29881	-	NPC1L1	NPC11L1	9606	Homo sapiens	inhibitor	target	Sudhop T (2005)	15737409	179428	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12413	118936	29881	-	NPC1L1	NPC11L1	9606	Homo sapiens	inhibitor	target	Wang J (2005)	15679830	179427	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12414	118936	29881	-	NPC1L1	NPC11L1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12415	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Wang HH (2008)	18442485	179432	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12416	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Costet P (2010)	20227438	179433	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12417	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Singh A (2009)	19669185	179434	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12418	106787	290	-	ANPEP	APN|CD13|GP150|LAP1|P150|PEPN	9606	Homo sapiens	unknown	target	Kramer W (2005)	15494415	179435	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12419	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12420	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12421	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor	target	Fujishige K (1999)	10373451	179448	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12422	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12423	106614	100	-	ADA	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12424	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Kruuse C (2006)	16886928	179449	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12425	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Santini F (2005)	16080974	179452	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12426	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Jackson EK (2007)	17308037	179450	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12427	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Kulkarni SK (2004)	15672122	179451	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12428	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	965	Dipyridamole	Dipyridamolum|Dipyudamine|Dypyridamol|Cardoxin|Dipyridamine|Dipiridamol|Cleridium 150|Curantyl|Persantin	dipyridamole for injection|nov	DRUGBANK	DB00975	C24H40N8O4	small molecule	B01AC07	58-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZEKFCXSFNUWAM-UHFFFAOYSA-N
12429	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Xue Y (2007)	17327420	178363	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12430	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brama M (2007)	17125913	178366	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12431	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Micevych PE (2007)	17095591	179458	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12432	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Notch EG (2009)	19237207	179459	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12433	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12434	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lehnes K (2007)	17138652	178365	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12435	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Bennink HJ (2009)	19434891	179462	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12436	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Mukai H (2006)	17142999	179461	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12437	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Garcia-Segura LM (2006)	17124377	179460	967	Ethinyl Estradiol	17-ethinylestradiol|17-ethinyl-3,17-estradiol|17 alpha-Ethinylestradiol|Ethinyloestradiol|Ethinyl-Oestranol|Ethinylestradiolum|Etinilestradiol|17 alpha-Ethynyloestradiol|Ethinylestriol|17alpha-Ethinyl estradiol|Ethynylestradiol|17-ethynylestradiol|17-ethinyl-3,17-oestradiol|17 alpha-Ethynylestradiol|Ethynyloestradiol|Ethinylestradiol|Ethynyl estradiol	sronyx|linessa 21|levonorgestr	DRUGBANK	DB00977	C20H24O2	small molecule	G03AA09|G03AA08|G03AB01|L02AA03|G03AB07|G03AB04|G03AB05|G03AA01|G03AA03|G03AA02|G03AA05|G03AA04|G03AA07|G03AA06|G03AB02|G03CA01|G03AB03|G03AA16|G03AA15|G03AA12|G03AA13|G03AA10|G03AA11|G03AB06	57-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPYWIDHMRZLRN-RHKZOZTBNA-N
12438	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	968	Lomefloxacin	LFLX|Lomefloxacino|Lomefloxacine|1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Lomefloxacinum	-	DRUGBANK	DB00978	C17H19F2N3O3	small molecule	S01AE04|J01MA07	98079-51-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKZLJVOYLTDKK-UHFFFAOYSA-N
12439	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	969	Cyclopentolate	2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate|Ciclopentolato|beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate|(+-)-Cyclopentolate|alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|()-cyclopentolate|Cyclopentolatum|-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate|Cyclopentolate|2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester|1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester	cyclomydril|cyclogyl oph dps 1	DRUGBANK	DB00979	C17H25NO3	small molecule	S01FA54|S01FA04	512-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKYSRIRYMSLOIN-UHFFFAOYSA-N
12440	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	969	Cyclopentolate	2-(dimethylamino)Ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate|Ciclopentolato|beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|-dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate|beta-(dimethylamino)Ethyl (1-hydroxycyclopentyl)phenylacetate|(+-)-Cyclopentolate|alpha-(1-Hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|()-cyclopentolate|Cyclopentolatum|-(1-hydroxycyclopentyl)benzeneacetic acid 2-(dimethylamino)ethyl ester|2-(dimethylamino)Ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate|Cyclopentolate|2-Phenyl-2-(1-hydroxycyclopentyl)ethanoic acid beta-(dimethylamino)ethyl ester|1-Hydroxy-alpha-phenylcyclopentaneacetic acid 2-(dimethylamino)ethyl ester	cyclomydril|cyclogyl oph dps 1	DRUGBANK	DB00979	C17H25NO3	small molecule	S01FA54|S01FA04	512-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKYSRIRYMSLOIN-UHFFFAOYSA-N
12441	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Miyamoto M (2009)	19768947	179481	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12442	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12443	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Miyamoto M (2006)	16730121	179480	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12444	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Greenblatt DJ (2007)	17389558	179474	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12445	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Johnson MW (2006)	17015817	179475	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12446	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Karim A (2006)	16432265	179476	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12447	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Pandi-Perumal SR (2009)	19568703	179477	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12448	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Kato K (2005)	15695169	179473	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12449	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Unknown Authors (2005)	15869323	179484	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12450	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Miyamoto M (2009)	19228178	179478	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12451	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Zammit G (2007)	17803013	179479	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12452	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Borja NL (2006)	17157111	179483	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12453	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	multitarget	target	Roth T (2005)	16173650	179482	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12454	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Miyamoto M (2009)	19768947	179481	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12455	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12456	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Miyamoto M (2006)	16730121	179480	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12457	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Greenblatt DJ (2007)	17389558	179474	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12458	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Johnson MW (2006)	17015817	179475	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12459	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Karim A (2006)	16432265	179476	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12460	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Pandi-Perumal SR (2009)	19568703	179477	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12461	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Kato K (2005)	15695169	179473	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12462	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Unknown Authors (2005)	15869323	179484	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12463	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Miyamoto M (2009)	19228178	179478	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12464	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Zammit G (2007)	17803013	179479	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12465	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Borja NL (2006)	17157111	179483	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12466	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	multitarget	target	Roth T (2005)	16173650	179482	970	Ramelteon	Rozerem	rozerem	DRUGBANK	DB00980	C16H21NO2	small molecule	N05CH02	196597-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLXDSYKOBKBWJQ-LBPRGKRZSA-N
12467	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	971	Physostigmine	Physostol|Antilirium|Eserine|Physostigmine	physostigmine salicylate|antil	DRUGBANK	DB00981	C15H21N3O2	small molecule	S01EB05|V03AB19	57-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIJVFDBKTWXHHD-HIFRSBDPSA-N
12468	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Blasina MF (2000)	10741458	179489	971	Physostigmine	Physostol|Antilirium|Eserine|Physostigmine	physostigmine salicylate|antil	DRUGBANK	DB00981	C15H21N3O2	small molecule	S01EB05|V03AB19	57-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIJVFDBKTWXHHD-HIFRSBDPSA-N
12469	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Nguyen PV (1999)	10368402	179488	971	Physostigmine	Physostol|Antilirium|Eserine|Physostigmine	physostigmine salicylate|antil	DRUGBANK	DB00981	C15H21N3O2	small molecule	S01EB05|V03AB19	57-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIJVFDBKTWXHHD-HIFRSBDPSA-N
12470	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Bolognesi ML (2001)	11141093	179487	971	Physostigmine	Physostol|Antilirium|Eserine|Physostigmine	physostigmine salicylate|antil	DRUGBANK	DB00981	C15H21N3O2	small molecule	S01EB05|V03AB19	57-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIJVFDBKTWXHHD-HIFRSBDPSA-N
12471	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Tuovinen K (1999)	10403635	179486	971	Physostigmine	Physostol|Antilirium|Eserine|Physostigmine	physostigmine salicylate|antil	DRUGBANK	DB00981	C15H21N3O2	small molecule	S01EB05|V03AB19	57-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIJVFDBKTWXHHD-HIFRSBDPSA-N
12472	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Monnet-Tschudi F (2000)	10873710	179490	971	Physostigmine	Physostol|Antilirium|Eserine|Physostigmine	physostigmine salicylate|antil	DRUGBANK	DB00981	C15H21N3O2	small molecule	S01EB05|V03AB19	57-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIJVFDBKTWXHHD-HIFRSBDPSA-N
12473	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	unknown	target	Dahl AR (2000)	10955779	179494	972	Isotretinoin	13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA	clarus|absorica|ran-isotretino	DRUGBANK	DB00982	C20H28O2	small molecule	D10BA01|D10AD04|D10AD54	4759-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-XFYACQKRSA-N
12474	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	unknown	target	Shroot B (1997)	9204085	174405	972	Isotretinoin	13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA	clarus|absorica|ran-isotretino	DRUGBANK	DB00982	C20H28O2	small molecule	D10BA01|D10AD04|D10AD54	4759-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-XFYACQKRSA-N
12475	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	unknown	target	Vu-Dac N (1998)	9691099	179492	972	Isotretinoin	13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA	clarus|absorica|ran-isotretino	DRUGBANK	DB00982	C20H28O2	small molecule	D10BA01|D10AD04|D10AD54	4759-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-XFYACQKRSA-N
12476	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	unknown	target	Taylor LE (1995)	7601910	179493	972	Isotretinoin	13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA	clarus|absorica|ran-isotretino	DRUGBANK	DB00982	C20H28O2	small molecule	D10BA01|D10AD04|D10AD54	4759-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-XFYACQKRSA-N
12477	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	unknown	target	Zouboulis CC (2006)	16983322	179491	972	Isotretinoin	13-cis-Retinoic acid|Isotretinoino|Neovitamin a acid|Isotretinoine|Accutane|Isotretinoinum|cis-RA|Claravis|Isotretinoina|Amnesteem|(7e,9e,11e,13Z)-Retinoic acid|13-cis-Vitamin a acid|13-RA	clarus|absorica|ran-isotretino	DRUGBANK	DB00982	C20H28O2	small molecule	D10BA01|D10AD04|D10AD54	4759-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHGAZHPCJJPHSC-XFYACQKRSA-N
12478	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12479	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Op't Holt TB (2007)	17594727	179504	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12480	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kompa AR (1995)	7675115	179498	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12481	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Faulds D (1991)	1718682	179499	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12482	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cheer SM (2004)	14720051	179496	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12483	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Scola AM (2004)	14662724	179497	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12484	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bartow RA (1998)	9506248	179495	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12485	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ryall JG (2006)	16432501	179500	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12486	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Steiropoulos P (2008)	18686730	179501	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12487	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Handley DA (2002)	12090787	179502	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12488	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Loefdahl CG (1989)	2544117	179503	973	Formoterol	2'-Hydroxy-5'-{1-hydroxy-2-[(P-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|Formoterolum|2'-Hydroxy-5'-(1-hydroxy-2-((P-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|N-[2-Hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide	dulera|foradil|duaklir genuair	DRUGBANK	DB00983	C19H24N2O4	small molecule	R03AC13|R03AK11|R03AK07|R03AL05|R03AK08|R03AK09	73573-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-UHFFFAOYSA-N
12489	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Cen Y (2003)	14663936	179507	974	Nandrolone phenpropionate	Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate	-	DRUGBANK	DB00984	C27H34O3	small molecule	-	434-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBWXUGDQUBIEIZ-QNTYDACNSA-N
12490	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	974	Nandrolone phenpropionate	Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate	-	DRUGBANK	DB00984	C27H34O3	small molecule	-	434-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBWXUGDQUBIEIZ-QNTYDACNSA-N
12491	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Burger LL (2007)	17405825	179508	974	Nandrolone phenpropionate	Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate	-	DRUGBANK	DB00984	C27H34O3	small molecule	-	434-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBWXUGDQUBIEIZ-QNTYDACNSA-N
12492	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Yan W (2003)	12760377	179509	974	Nandrolone phenpropionate	Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate	-	DRUGBANK	DB00984	C27H34O3	small molecule	-	434-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBWXUGDQUBIEIZ-QNTYDACNSA-N
12493	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Li K (2003)	14619588	179511	974	Nandrolone phenpropionate	Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate	-	DRUGBANK	DB00984	C27H34O3	small molecule	-	434-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBWXUGDQUBIEIZ-QNTYDACNSA-N
12494	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Fujii Y (2004)	14761877	179510	974	Nandrolone phenpropionate	Norandrolone phenyl propionate|19NTPP|Nandrolon phenylpropionate|Norandrostenolone phenylpropionate|NTPP|Nandrolone phenpropionate|Nandrolone phenylpionate|Nadrolone phenylpropionate|Nandrolone phenylpropionate|NPP|Durabolin|Nortestosterone phenylpropionate	-	DRUGBANK	DB00984	C27H34O3	small molecule	-	434-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBWXUGDQUBIEIZ-QNTYDACNSA-N
12495	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Halpert AG (2002)	11835984	179512	975	Dimenhydrinate	Diphenhydrinate|Dimenhidrinato|Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline|Diphenhydramine theoclate|(O-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophylline|8-chloro-1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)|O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophyllinate|N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate|Dimenhydrinatum|beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine	travamine tab 50mg|travamine s	DRUGBANK	DB00985	C24H28ClN5O3	small molecule	-	523-87-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKHVTDUUNTVKOW-UHFFFAOYSA-N
12496	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	975	Dimenhydrinate	Diphenhydrinate|Dimenhidrinato|Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline|Diphenhydramine theoclate|(O-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophylline|8-chloro-1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)|O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate|Diphenhydramine 8-chlorotheophyllinate|N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate|Dimenhydrinatum|beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine	travamine tab 50mg|travamine s	DRUGBANK	DB00985	C24H28ClN5O3	small molecule	-	523-87-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKHVTDUUNTVKOW-UHFFFAOYSA-N
12497	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Haddad EB (1999)	10385241	179513	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12498	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12499	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12500	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12501	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ali-Melkkilae T (1993)	8249551	179514	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12502	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	binder	target	Haddad EB (1999)	10385241	179513	976	Glycopyrronium	Glycopyrrolate ion|Glycopyrrolate cation|Glycopyrronium cation|Glycopyrronium ion	robinul forte tab 2mg|ultibro 	DRUGBANK	DB00986	C19H28NO3	small molecule	R03BB06|R03AL04|A03AB02|A03CA05	740028-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANGKOCUUWGHLCE-HKUYNNGSSA-N
12503	111419	5423	-	POLB	-	9606	Homo sapiens	inhibitor	target	Krynetskaia NF (2009)	19372559	179517	977	Cytarabine	1-beta-D-Arabinofuranosylcytosine|Cytarabine|Arabinofuranosyl Cytidine|Cytosine arabinoside|4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone|Cytarabinum|Ara-C|Cytosine-1-beta-D-arabinofuranoside|Citarabina|cytosine--D-arabinofuranoside|Cytosine-beta-D-arabinofuranoside	aj-cytarabine|cytarabine injec	DRUGBANK	DB00987	C9H13N3O5	small molecule	L01BC01	147-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHDGCWIWMRVCDJ-CCXZUQQUSA-N
12504	111419	5423	-	POLB	-	9606	Homo sapiens	inhibitor	target	Angeli JP (2006)	16866189	179516	977	Cytarabine	1-beta-D-Arabinofuranosylcytosine|Cytarabine|Arabinofuranosyl Cytidine|Cytosine arabinoside|4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone|Cytarabinum|Ara-C|Cytosine-1-beta-D-arabinofuranoside|Citarabina|cytosine--D-arabinofuranoside|Cytosine-beta-D-arabinofuranoside	aj-cytarabine|cytarabine injec	DRUGBANK	DB00987	C9H13N3O5	small molecule	L01BC01	147-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHDGCWIWMRVCDJ-CCXZUQQUSA-N
12505	111419	5423	-	POLB	-	9606	Homo sapiens	inhibitor	target	Miura S (2004)	15011952	179515	977	Cytarabine	1-beta-D-Arabinofuranosylcytosine|Cytarabine|Arabinofuranosyl Cytidine|Cytosine arabinoside|4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone|Cytarabinum|Ara-C|Cytosine-1-beta-D-arabinofuranoside|Citarabina|cytosine--D-arabinofuranoside|Cytosine-beta-D-arabinofuranoside	aj-cytarabine|cytarabine injec	DRUGBANK	DB00987	C9H13N3O5	small molecule	L01BC01	147-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHDGCWIWMRVCDJ-CCXZUQQUSA-N
12506	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	binder	target	Weber JT (1997)	9185324	179520	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12507	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	binder	target	Toll L (1998)	9686407	176206	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12508	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12509	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12510	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Rothman RB (2001)	11071707	179522	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12511	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Rothman RB (2001)	11071707	179522	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12512	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12513	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Dolzan V (2007)	17455212	178693	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12514	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Fu W (2007)	17468175	179523	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12515	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12516	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Hoenicka J (2007)	17449449	179524	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12517	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	da Silva Lobo DS (2007)	17394052	179525	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12518	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	ligand	target	Goldman JM (2007)	17258889	179530	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12519	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	ligand	target	Arboleda G (2007)	17561816	179528	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12520	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	ligand	target	Garland EM (2007)	17625104	179529	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12521	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	ligand	target	Pyatskowit JW (2007)	17287146	179526	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12522	107989	1621	RP11-317B10.1	DBH	DBM	9606	Homo sapiens	ligand	target	LeBlanc J (2007)	17433386	179527	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12523	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	binder	target	Shen Y (1993)	8394362	179531	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12524	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	binder	target	Lovenberg TW (1993)	8398139	179532	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12525	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inducer	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12526	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12527	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Huebner H (2000)	10691700	179533	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12528	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Huebner H (2000)	10691700	179533	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12529	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12530	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Greig NH (2003)	12636181	179548	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12531	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Goldblum D (2000)	10673128	179540	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12532	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Birks J (2009)	19370562	179541	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12533	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Lalli S (2008)	18671661	179542	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12534	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Grossberg GT (2000)	10713582	179543	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12535	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Gottwald MD (1999)	11139819	179544	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12536	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Onor ML (2007)	18044073	179545	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12537	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Kennedy JS (1999)	10587286	179546	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12538	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Farlow MR (2003)	14587496	179547	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12539	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Stahl SM (2000)	11078030	177717	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12540	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12541	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Greig NH (2003)	12636181	179548	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12542	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Bassil N (2009)	19374459	179549	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12543	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Birks J (2009)	19370562	179541	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12544	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Lalli S (2008)	18671661	179542	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12545	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Gottwald MD (1999)	11139819	179544	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12546	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Onor ML (2007)	18044073	179545	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12547	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Farlow MR (2003)	14587496	179547	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12548	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Smith DA (2009)	19420308	179550	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12549	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Stahl SM (2000)	11078030	177717	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12550	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
12551	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12552	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Untch M (2008)	19337436	179557	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12553	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Koutras A (2009)	19930708	179556	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12554	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Abrial C (2009)	20360896	179555	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12555	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Nabholtz JM (2008)	18728707	179554	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12556	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Barnadas A (2009)	19156139	179553	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12557	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Brueggemeier RW (2006)	17020418	179552	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12558	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Robinson A (2009)	19436613	179551	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12559	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Brueggemeier RW (2005)	15814851	179558	980	Exemestane	Exemestanum|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestane|Exemestano	apo-exemestane|teva-exemestane	DRUGBANK	DB00990	C20H24O2	small molecule	L02BG06	107868-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFYIZQONLCFLEV-DAELLWKTSA-N
12560	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Ottonello L (2009)	19338579	179563	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12561	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9831331	179562	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12562	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Yood MU (2006)	17024689	179560	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12563	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kean WF (2004)	15324530	179559	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12564	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Zhou XP (2009)	19952416	179561	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9650852	159681	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamazaki R (2002)	12065695	179564	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9831331	179562	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ottonello L (2009)	19338579	179563	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yood MU (2006)	17024689	179560	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhou XP (2009)	19952416	179561	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12571	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	antibody	target	Imming P (2006)	17016423	171742	982	Methyl aminolevulinate	Methyl aminolevulinate|Aminolevulinic acid methyl ester|Methyl delta-aminolevulinate|5-Aminolevulinic acid methyl ester	metvix	DRUGBANK	DB00992	C6H11NO3	small molecule	L01XD03	33320-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUUAYBAIHCDHHD-UHFFFAOYSA-N
12572	108503	2209	RP11-196G18.2	FCGR1A	CD64|CD64A|FCRI|IGFR1	9606	Homo sapiens	antibody	target	Overington JP (2006)	17139284	171741	982	Methyl aminolevulinate	Methyl aminolevulinate|Aminolevulinic acid methyl ester|Methyl delta-aminolevulinate|5-Aminolevulinic acid methyl ester	metvix	DRUGBANK	DB00992	C6H11NO3	small molecule	L01XD03	33320-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUUAYBAIHCDHHD-UHFFFAOYSA-N
12573	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	inhibitor	target	Anstey A (1998)	18020555	179566	983	Azathioprine	Imuran (tn)|6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine|6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine	azathioprine sodium for inject	DRUGBANK	DB00993	C9H7N7O2S	small molecule	L04AX01	446-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMEKQMALGUDUQG-UHFFFAOYSA-N
12574	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	inhibitor	target	Dubinsky MC (2004)	15354273	179565	983	Azathioprine	Imuran (tn)|6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine|6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine	azathioprine sodium for inject	DRUGBANK	DB00993	C9H7N7O2S	small molecule	L04AX01	446-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMEKQMALGUDUQG-UHFFFAOYSA-N
12575	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	984	Neomycin	-	walgreenstriple antibiotic|gfa	DRUGBANK	DB00994	C23H46N6O13	small molecule	J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08	1404-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
12576	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	984	Neomycin	-	walgreenstriple antibiotic|gfa	DRUGBANK	DB00994	C23H46N6O13	small molecule	J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08	1404-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
12577	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Gill AE (2004)	15332709	177802	984	Neomycin	-	walgreenstriple antibiotic|gfa	DRUGBANK	DB00994	C23H46N6O13	small molecule	J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08	1404-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
12578	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Eisenstein BI (1980)	6103875	179094	984	Neomycin	-	walgreenstriple antibiotic|gfa	DRUGBANK	DB00994	C23H46N6O13	small molecule	J01GB05|B05CA09|A07AA01|S02AA07|A07AA51|R02AB01|D06AX04|S01AA03|S03AA01|A01AB08	1404-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGBHMTALBVVCIT-VCIWKGPPSA-N
12579	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Jeon KI (2003)	12754408	179568	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12580	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Youn HS (2006)	17034761	179569	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12581	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12582	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	inhibitor	target	Venardos K (2004)	15191400	179571	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12583	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	inhibitor	target	Gundimeda U (2009)	19578042	179570	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12584	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	inhibitor	target	Rigobello MP (2002)	12163349	179573	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12585	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	inhibitor	target	Rigobello MP (2005)	16036347	179572	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
12586	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	De Vry J (2004)	15140630	179580	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12587	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Kralic JE (2005)	15765150	179579	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12588	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	agonist	target	Zuchora B (2005)	15572277	179578	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12589	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Gazulla J (2006)	16899342	174529	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12590	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Hota D (2007)	17982508	179581	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12591	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Hoffmann U (2010)	20588320	179582	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12592	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Hendrich J (2008)	18299583	179583	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12593	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Cheng JK (2006)	16368827	179584	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12594	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Hoffmann U (2010)	20588320	179582	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12595	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Hendrich J (2008)	18299583	179583	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12596	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Gazulla J (2006)	16899342	174529	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12597	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Maneuf YP (2006)	17067834	179585	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12598	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Hota D (2007)	17982508	179581	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12599	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Hoffmann U (2010)	20588320	179582	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12600	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Hendrich J (2008)	18299583	179583	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12601	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12602	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12603	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12604	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12605	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12606	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12607	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12608	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Koehn H (2007)	17351394	179591	987	Doxorubicin	14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside	adriamycin rdf inj 50mg/vial|a	DRUGBANK	DB00997	C27H29NO11	small molecule	L01DB01	23214-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-TZSSRYMLSA-N
12609	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hayashi S (2006)	17016621	179590	987	Doxorubicin	14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside	adriamycin rdf inj 50mg/vial|a	DRUGBANK	DB00997	C27H29NO11	small molecule	L01DB01	23214-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-TZSSRYMLSA-N
12610	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Azarova AM (2007)	17578914	178322	987	Doxorubicin	14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside	adriamycin rdf inj 50mg/vial|a	DRUGBANK	DB00997	C27H29NO11	small molecule	L01DB01	23214-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-TZSSRYMLSA-N
12611	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	987	Doxorubicin	14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside	adriamycin rdf inj 50mg/vial|a	DRUGBANK	DB00997	C27H29NO11	small molecule	L01DB01	23214-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-TZSSRYMLSA-N
12612	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Rody A (2007)	17010609	179588	987	Doxorubicin	14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside	adriamycin rdf inj 50mg/vial|a	DRUGBANK	DB00997	C27H29NO11	small molecule	L01DB01	23214-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-TZSSRYMLSA-N
12613	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Menendez JA (2006)	17089011	179589	987	Doxorubicin	14-hydroxydaunorubicine|Doxorubicinum|Doxorubicine|Adriamycin|14-hydroxydaunomycin|Doxorubicin|(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|Hydroxydaunorubicin|(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside	adriamycin rdf inj 50mg/vial|a	DRUGBANK	DB00997	C27H29NO11	small molecule	L01DB01	23214-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOJJSUZBOXZQNB-TZSSRYMLSA-N
12614	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Easthope SE (2001)	11735616	179593	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12615	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Deleu D (2000)	10883409	179597	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12616	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Parsons AA (1998)	9700983	179596	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12617	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Elkind AH (2004)	15342617	179595	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12618	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Balbisi EA (2004)	15311727	179594	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12619	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Comer MB (2002)	12028320	179599	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12620	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Buchan P (2002)	12028322	179598	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12621	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Jaehnichen S (2004)	15185063	174447	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12622	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Balbisi EA (2006)	18360605	179600	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12623	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12624	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12625	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Easthope SE (2001)	11735616	179593	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12626	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Deleu D (2000)	10883409	179597	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12627	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Parsons AA (1998)	9700983	179596	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12628	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Elkind AH (2004)	15342617	179595	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12629	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Balbisi EA (2004)	15311727	179594	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12630	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12631	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Buchan P (2002)	12028322	179598	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12632	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Dodick DW (2006)	17190530	179602	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12633	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Markus F (2007)	18001261	179601	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12634	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Balbisi EA (2006)	18360605	179600	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12635	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Comer MB (2002)	12028320	179599	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12636	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Tfelt-Hansen P (2000)	11152011	174448	988	Frovatriptan	-	teva-frovatriptan|apo-frovatri	DRUGBANK	DB00998	C14H17N3O	small molecule	N02CC07	158747-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPSQPHWEGNHMSK-SECBINFHSA-N
12637	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12638	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Tricarico D (2004)	14766795	176046	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12639	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12640	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12641	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Barry EL (1997)	9038817	179607	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12642	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Ran XW (2005)	16078592	179606	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12643	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Kurschat C (2003)	12772080	179605	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12644	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Abuladze N (1998)	9596079	179604	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12645	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Monroy A (2000)	10894798	176048	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12646	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Turner ST (2005)	16172412	179603	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12647	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12648	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12649	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12650	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Couloigner V (1998)	9546276	174541	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12651	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Puscas I (2000)	10713865	174540	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12652	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12653	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12654	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12655	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Meyerson LR (1991)	1901209	174543	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12656	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Schaeffer P (1990)	2226620	174542	989	Hydrochlorothiazide	HCTZ|Microzide|Esidrix	amlodipine, valsartan, hydroch	DRUGBANK	DB00999	C7H8ClN3O4S2	small molecule	C03AB03|C09XA52|C03AA03|C09XA54|C03EA01|C09DX01|C09DX03|C03AX01	58-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZUFKLXOESDKRF-UHFFFAOYSA-N
12657	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chong LK (2003)	12569076	178802	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12658	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brouri F (2004)	14757145	177290	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12659	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Choudhry S (2005)	15557128	179610	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12660	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12661	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Yamanishi T (2003)	12808710	179609	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12662	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brichetto L (2003)	12388338	179608	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12663	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Baker JG (2005)	15655528	179611	991	Salbutamol	Albuterol	ventolin nebules p.f. sol 2.5m	DRUGBANK	DB01001	C13H21NO3	small molecule	R03AC02|R03CC02|R03AK04|R03AL02	18559-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDAUXUAQIAJITI-UHFFFAOYSA-N
12664	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	992	Levobupivacaine	Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine	-	DRUGBANK	DB01002	C18H28N2O	small molecule	N01BB10	27262-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-INIZCTEOSA-N
12665	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Vladimirov M (2000)	10969308	179612	992	Levobupivacaine	Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine	-	DRUGBANK	DB01002	C18H28N2O	small molecule	N01BB10	27262-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-INIZCTEOSA-N
12666	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	992	Levobupivacaine	Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine	-	DRUGBANK	DB01002	C18H28N2O	small molecule	N01BB10	27262-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-INIZCTEOSA-N
12667	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Braeu ME (2000)	11094008	179614	992	Levobupivacaine	Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine	-	DRUGBANK	DB01002	C18H28N2O	small molecule	N01BB10	27262-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-INIZCTEOSA-N
12668	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Ueta K (2006)	16418020	179613	992	Levobupivacaine	Levobupivacaine|(-)-Bupivacaine|(S)-1-Butyl-2',6'-pipecoloxylidide|(S)-Bupivacaine|L-(-)-1-Butyl-2',6'-pipecoloxylidide|L-(-)-Bupivacaine	-	DRUGBANK	DB01002	C18H28N2O	small molecule	N01BB10	27262-47-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-INIZCTEOSA-N
12669	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	993	Cromoglicic acid	Acide Cromoglicique|Cromoglicate|Acido Cromoglicico|5-[3-(2-Carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid|Cromolyn|Acidum Cromoglicicum|Cromoglycate|Cromoglicic Acid	anti-allergy eye drops|vistacr	DRUGBANK	DB01003	C23H16O11	small molecule	A07EB01|R03BC01|S01GX01|S01GX51|R01AC01|R03AK04|R03AK05|R01AC51|D11AH03	16110-51-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMZMKUWMOSJXDT-UHFFFAOYSA-N
12670	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	993	Cromoglicic acid	Acide Cromoglicique|Cromoglicate|Acido Cromoglicico|5-[3-(2-Carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid|Cromolyn|Acidum Cromoglicicum|Cromoglycate|Cromoglicic Acid	anti-allergy eye drops|vistacr	DRUGBANK	DB01003	C23H16O11	small molecule	A07EB01|R03BC01|S01GX01|S01GX51|R01AC01|R03AK04|R03AK05|R01AC51|D11AH03	16110-51-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMZMKUWMOSJXDT-UHFFFAOYSA-N
12671	112194	6286	-	S100P	MIG9	9606	Homo sapiens	antagonist	target	Arumugam T (2006)	17179482	179615	993	Cromoglicic acid	Acide Cromoglicique|Cromoglicate|Acido Cromoglicico|5-[3-(2-Carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid|Cromolyn|Acidum Cromoglicicum|Cromoglycate|Cromoglicic Acid	anti-allergy eye drops|vistacr	DRUGBANK	DB01003	C23H16O11	small molecule	A07EB01|R03BC01|S01GX01|S01GX51|R01AC01|R03AK04|R03AK05|R01AC51|D11AH03	16110-51-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMZMKUWMOSJXDT-UHFFFAOYSA-N
12672	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Imming P (2006)	17016423	171742	994	Ganciclovir	2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one	cytovene - pws 500mg/10m/-vial	DRUGBANK	DB01004	C9H13N5O4	small molecule	S01AD09|J05AB06	82410-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSCQMHQWWYFCW-UHFFFAOYSA-N
12673	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Boivin G (2005)	16173018	179618	994	Ganciclovir	2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one	cytovene - pws 500mg/10m/-vial	DRUGBANK	DB01004	C9H13N5O4	small molecule	S01AD09|J05AB06	82410-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSCQMHQWWYFCW-UHFFFAOYSA-N
12674	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Overington JP (2006)	17139284	171741	994	Ganciclovir	2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one	cytovene - pws 500mg/10m/-vial	DRUGBANK	DB01004	C9H13N5O4	small molecule	S01AD09|J05AB06	82410-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSCQMHQWWYFCW-UHFFFAOYSA-N
12675	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Wang JT (2005)	16298966	179616	994	Ganciclovir	2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one	cytovene - pws 500mg/10m/-vial	DRUGBANK	DB01004	C9H13N5O4	small molecule	S01AD09|J05AB06	82410-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSCQMHQWWYFCW-UHFFFAOYSA-N
12676	971473	2703462	HHV1gp046	UL30	-	10298	Human Herpesvirus 1	inhibitor	target	Shi R (2006)	16705640	179617	994	Ganciclovir	2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one	cytovene - pws 500mg/10m/-vial	DRUGBANK	DB01004	C9H13N5O4	small molecule	S01AD09|J05AB06	82410-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSCQMHQWWYFCW-UHFFFAOYSA-N
12677	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Culligan K (2004)	15075397	179619	995	Hydroxyurea	Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid	hydrea cap 500mg|mylan-hydroxy	DRUGBANK	DB01005	CH4N2O2	small molecule	L01XX05	127-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSNHCAURESNICA-UHFFFAOYSA-N
12678	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Jiang W (2010)	20462199	179621	995	Hydroxyurea	Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid	hydrea cap 500mg|mylan-hydroxy	DRUGBANK	DB01005	CH4N2O2	small molecule	L01XX05	127-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSNHCAURESNICA-UHFFFAOYSA-N
12679	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Davies BW (2009)	20005847	179620	995	Hydroxyurea	Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid	hydrea cap 500mg|mylan-hydroxy	DRUGBANK	DB01005	CH4N2O2	small molecule	L01XX05	127-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSNHCAURESNICA-UHFFFAOYSA-N
12680	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Zhou B (2003)	14583450	7216	995	Hydroxyurea	Oxyurea|N-Hydroxyurea|Carbamyl Hydroxamate|Hydroxycarbamide|Hidroxicarbamida|Carbamoyl Oxime|Hydroxyurea|N-Carbamoylhydroxylamine|Carbamohydroximic Acid|Hydrea|Hydroxyharnstoff|Hydroxycarbamidum|Carbamohydroxamic Acid|Hydroxycarbamid	hydrea cap 500mg|mylan-hydroxy	DRUGBANK	DB01005	CH4N2O2	small molecule	L01XX05	127-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSNHCAURESNICA-UHFFFAOYSA-N
12681	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	antagonist	target	Ebert AD (2003)	14505258	179624	996	Letrozole	Letrozole|Femara|Letrozol	letrozole|riva-letrozole|nat-l	DRUGBANK	DB01006	C17H11N5	small molecule	L02BG04	112809-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPJKCIUCZWXJDR-UHFFFAOYSA-N
12682	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	996	Letrozole	Letrozole|Femara|Letrozol	letrozole|riva-letrozole|nat-l	DRUGBANK	DB01006	C17H11N5	small molecule	L02BG04	112809-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPJKCIUCZWXJDR-UHFFFAOYSA-N
12683	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	antagonist	target	Murphy MJ (1999)	10388095	179623	996	Letrozole	Letrozole|Femara|Letrozol	letrozole|riva-letrozole|nat-l	DRUGBANK	DB01006	C17H11N5	small molecule	L02BG04	112809-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPJKCIUCZWXJDR-UHFFFAOYSA-N
12684	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	antagonist	target	Long BJ (2004)	15026471	179622	996	Letrozole	Letrozole|Femara|Letrozol	letrozole|riva-letrozole|nat-l	DRUGBANK	DB01006	C17H11N5	small molecule	L02BG04	112809-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPJKCIUCZWXJDR-UHFFFAOYSA-N
12685	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12686	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Fliri AF (2005)	15625110	179625	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12687	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12688	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12689	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Chau AS (2006)	16966400	70318	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12690	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Fliri AF (2005)	15625110	179625	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12691	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Ballard SA (1988)	3202901	179626	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12692	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Preissner S (2010)	19934256	172211	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12693	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Guinea J (2006)	16966178	68500	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12694	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Bellamine A (2004)	15314102	174269	997	Tioconazole	Vagistat-1|Tioconazolum|Tioconazol	leader tioconastat 1 1 dose tr	DRUGBANK	DB01007	C16H13Cl3N2OS	small molecule	G01AF08|D01AC07	65899-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXHHHPZILQDDPS-UHFFFAOYSA-N
12695	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kurahashi K (2001)	11811354	177972	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12696	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Zuniga J (2003)	14513718	179627	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12697	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Parsadaniantz SM (2000)	10929089	179629	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12698	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Levoin N (2004)	15476667	179628	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12699	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Martic M (2004)	14987823	179630	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12700	109791	3577	-	CXCR1	C-C|C-C-CKR-1|CD128|CD181|CDw128a|CKR-1|CMKAR1|IL8R1|IL8RA|IL8RBA	9606	Homo sapiens	unknown	target	Wang LM (1997)	9093816	179632	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12701	109791	3577	-	CXCR1	C-C|C-C-CKR-1|CD128|CD181|CDw128a|CKR-1|CMKAR1|IL8R1|IL8RA|IL8RBA	9606	Homo sapiens	unknown	target	Bizzarri C (2001)	11331079	179633	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12702	109791	3577	-	CXCR1	C-C|C-C-CKR-1|CD128|CD181|CDw128a|CKR-1|CMKAR1|IL8R1|IL8RA|IL8RBA	9606	Homo sapiens	unknown	target	Allegretti M (2005)	15974585	179631	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12703	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12704	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zuniga J (2003)	14513718	179627	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12705	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sommerauer M (2001)	11729362	179635	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12706	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Levoin N (2002)	11814865	179634	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12709	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Ravelli RB (1998)	10089512	179638	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12710	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Keymer JE (1999)	10103097	179639	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12711	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Luo C (1999)	10421446	179636	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12712	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Huby F (1999)	10363282	179637	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12713	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12714	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Martin-Biosca Y (2009)	19472276	179641	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12715	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Luo C (1999)	10433700	179640	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12716	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Harel M (1992)	1438284	179643	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12717	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Saxena A (1997)	9398183	179642	1000	Edrophonium	N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium|Edrophonium|EDR|Edrophonium Ion|(3-Hydroxyphenyl)dimethylethylammonium|N-ethyl-3-hydroxy-N,N-dimethylanilinium|Ethyl-(3-hydroxy-phenyl)-dimethyl-ammonium|3-hydroxy-N,N-dimethyl-N-ethylanilinium	tensilon|enlon liq iv 10mg/ml|	DRUGBANK	DB01010	C10H16NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWLHWLSRQJQWRG-UHFFFAOYSA-O
12718	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12719	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Young EA (2007)	17462829	179646	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12720	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Johansson MK (2002)	11869873	179645	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12721	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Hermansson V (2007)	17487473	179644	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12722	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Drueeke TB (2009)	19056615	179647	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12723	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12724	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Eriguchi R (2008)	19461861	179649	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12725	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Belozeroff V (2009)	19261825	179648	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12726	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	de Francisco AL (2005)	15794735	179654	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12727	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Rothe HM (2005)	15864123	179655	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12728	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Cunningham J (2005)	16109140	179650	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12729	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Tasic V (2005)	15884662	179651	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12730	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Moe SM (2005)	16030053	179652	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12731	107296	846	-	CASR	CAR|EIG8|FHH|FIH|GPRC2A|HHC|HHC1|HYPOC1|NSHPT|PCAR1	9606	Homo sapiens	agonist	target	Meola M (2009)	19181759	179653	1002	Cinacalcet	N-((1R)-1-(Naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine|(R)-alpha-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine|CNC|Mimpara	teva-cinacalcet|sandoz cinacal	DRUGBANK	DB01012	C22H22F3N	small molecule	H05BX01	226256-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDHAWDNDOKGFTD-MRXNPFEDSA-N
12732	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Fitzgerald P (2006)	16255837	178667	1003	Clobetasol propionate	clobetasol 17-propionate|21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-propionate|clobetasol 17-propanoate|Clobetasol propionate E	taro-clobetasol topical soluti	DRUGBANK	DB01013	C25H32ClFO5	small molecule	-	25122-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBGUOGMQLZIXBE-KBUOYLHWNA-N
12733	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hofmann TG (1998)	9891987	174579	1003	Clobetasol propionate	clobetasol 17-propionate|21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-propionate|clobetasol 17-propanoate|Clobetasol propionate E	taro-clobetasol topical soluti	DRUGBANK	DB01013	C25H32ClFO5	small molecule	-	25122-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBGUOGMQLZIXBE-KBUOYLHWNA-N
12734	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12735	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12736	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12737	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12738	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12739	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12740	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Iacucci M (2010)	20151072	179657	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12741	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Tursi A (2009)	19708827	179658	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12742	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12743	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12744	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Rask-Madsen J (1992)	1359745	179659	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12746	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stolfi C (2008)	17981262	179660	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12747	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12748	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12749	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12750	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	inhibitor	target	Winstanley PA (1995)	7786001	179661	1005	Sulfamethoxazole	3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole	septra injection|roubac tab 16	DRUGBANK	DB01015	C10H11N3O3S	small molecule	J01EC01|J01EE01	723-46-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLKIGFTWXXRPMT-UHFFFAOYSA-N
12751	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	1005	Sulfamethoxazole	3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole	septra injection|roubac tab 16	DRUGBANK	DB01015	C10H11N3O3S	small molecule	J01EC01|J01EE01	723-46-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLKIGFTWXXRPMT-UHFFFAOYSA-N
12752	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	1005	Sulfamethoxazole	3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole	septra injection|roubac tab 16	DRUGBANK	DB01015	C10H11N3O3S	small molecule	J01EC01|J01EE01	723-46-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLKIGFTWXXRPMT-UHFFFAOYSA-N
12753	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hong YL (1995)	7486915	174738	1005	Sulfamethoxazole	3-(p-Aminophenylsulfonamido)-5-methylisoxazole|SMX|Gantanol (tn)|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|3-Sulfanilamido-5-methylisoxazole|Sulfamethoxazole	septra injection|roubac tab 16	DRUGBANK	DB01015	C10H11N3O3S	small molecule	J01EC01|J01EE01	723-46-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLKIGFTWXXRPMT-UHFFFAOYSA-N
12754	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	modulator	target	Zhao JL (2006)	16845255	174020	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12755	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	modulator	target	Rainbow RD (2004)	14672537	179663	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12756	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	modulator	target	Felsch H (2004)	15023854	179662	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12757	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	modulator	target	Hambrock A (2002)	12145099	179665	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12758	115371	10060	-	ABCC9	ABC37|ATFB12|CANTU|CMD1O|SUR2	9606	Homo sapiens	modulator	target	Wang YH (2007)	17294036	179664	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12759	109964	3762	-	KCNJ5	CIR|GIRK4|KATP1|KIR3.4|LQT13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12760	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	unknown	target	Jaburek M (1998)	9593694	179666	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12761	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	unknown	target	Jaburek M (1998)	9593694	179666	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12762	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Nieland TJ (2004)	15102890	179672	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12763	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Agassandian M (2004)	15039140	179670	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12764	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Muehl H (2003)	14660039	179671	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12765	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Reddy ST (2002)	12426219	179667	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12766	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Lamkanfi M (2009)	19805629	179669	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12767	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Alder-Baerens N (2005)	15905177	179668	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12768	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Hambrock A (2002)	12107069	179673	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12769	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Serrano-Martin X (2006)	17015627	179676	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12770	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Ueda K (1999)	9990013	179677	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12771	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Babenko AP (2002)	12213829	179674	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12772	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Dabrowski M (2002)	12031979	179675	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12773	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Hambrock A (2002)	12145099	179665	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12774	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	modulator	target	Nielsen FE (2002)	12213059	179678	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12775	114199	8647	-	ABCB11	ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP	9606	Homo sapiens	inhibitor	target	Byrne JA (2002)	12404239	172310	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12776	114199	8647	-	ABCB11	ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP	9606	Homo sapiens	inhibitor	target	Horikawa M (2004)	15618715	179679	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12777	114199	8647	-	ABCB11	ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP	9606	Homo sapiens	inhibitor	target	Kemp DC (2004)	15465654	179680	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12778	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Lu M (2006)	16470247	179682	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12779	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Pondugula SR (2006)	16263802	179681	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12780	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Lee SY (2005)	15365090	179687	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12781	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Zhou Z (2002)	12407077	179686	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12782	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Reddy MM (2002)	12202948	179685	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12783	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Jiang J (2003)	12391048	179684	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12784	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Larsen EH (2003)	14729151	179683	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12785	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	unknown	target	Patel TB (1986)	3090894	179689	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12786	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	unknown	target	Cook GA (1987)	3104327	179688	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12787	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	modulator	target	Lim JG (2004)	15294453	179690	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12788	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	modulator	target	Ball AJ (2004)	15082027	179691	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12789	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	modulator	target	Nielsen FE (2002)	12213059	179678	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12790	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	modulator	target	Hambrock A (2002)	12145099	179665	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12791	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	modulator	target	Gojkovic-Bukarica L (2002)	12359624	179692	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
12792	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Zhanel GG (2004)	14723559	179693	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12793	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Sanchez Mejia RO (2001)	11383749	179694	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12794	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Vincent JA (2007)	17192486	179695	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12795	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Chen M (2000)	10888929	179696	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12796	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	negative modulator	target	Kim HS (2009)	18977395	179697	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12797	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Steinmeyer J (1998)	9413935	179698	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12798	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Sadowski T (2001)	11246672	179699	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12799	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Amin AR (1996)	8943052	179700	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12800	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Oringer RJ (2002)	12211491	179701	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12801	852105	947793	b3296	rpsD	ECK3283|JW3258|ramA|sud	511145	Escherichia coli	inhibitor	target	Zhanel GG (2004)	14723559	179693	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12802	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	inhibitor	target	Yao JS (2004)	15256478	179704	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12803	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	inhibitor	target	Sasamura H (2002)	11875741	179702	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12804	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	inhibitor	target	Rocchetti R (2005)	16224178	179703	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12805	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Baptiste DC (2004)	15304547	179708	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12806	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Lee SM (2003)	14588118	179706	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12807	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Arvin KL (2002)	12112047	179707	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12808	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Dommergues MA (2003)	14568022	179705	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12809	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Chen M (2000)	10888929	179696	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12810	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	negative modulator	target	Kim HS (2009)	18977395	179697	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12811	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Song Y (2004)	15371729	179711	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12812	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Song Y (2006)	16574083	179710	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12813	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chu LS (2007)	17506934	179709	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12814	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	negative modulator	target	Heo K (2006)	16469440	179715	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12815	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	negative modulator	target	Zhu S (2002)	11986668	179714	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12816	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	negative modulator	target	Chu HC (2005)	15665864	179716	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12817	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	negative modulator	target	Matsuki S (2003)	14680842	179713	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12818	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	negative modulator	target	Mansson R (2007)	17067803	179712	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12819	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	negative modulator	target	Kim HS (2009)	18977395	179697	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12820	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Koistinaho M (2005)	15674236	179720	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12821	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Sutton TA (2005)	15353401	179721	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12822	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Brundula V (2002)	12023318	179717	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12823	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Lee CZ (2006)	16395286	179719	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12824	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Machado LS (2006)	16846501	179718	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12825	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Uhlen S (1991)	1666366	176190	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12826	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Millan MJ (1992)	1356794	179722	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12827	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Avery RA (2000)	10942848	179723	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12828	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Yuan R (2005)	15928018	179724	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12829	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Stahl SM (2010)	20331927	179725	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12830	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Sagvolden T (2006)	17173664	179726	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12831	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Birnbaum SG (2000)	11164065	179727	1008	Guanfacine	Estulic|Guanfacinum|Guanfacina	guanfacine|intuniv xr|intuniv|	DRUGBANK	DB01018	C9H9Cl2N3O	small molecule	C02AC02	29110-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INJOMKTZOLKMBF-UHFFFAOYSA-N
12832	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Buranakarl C (2001)	11798291	179728	1009	Bethanechol	(2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine	myotonachol tablets 25mg|myoto	DRUGBANK	DB01019	C7H17N2O2	small molecule	N07AB02	674-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZUPCNDJBJXXRF-UHFFFAOYSA-O
12833	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Agrawal A (2007)	17413603	179729	1009	Bethanechol	(2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine	myotonachol tablets 25mg|myoto	DRUGBANK	DB01019	C7H17N2O2	small molecule	N07AB02	674-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZUPCNDJBJXXRF-UHFFFAOYSA-O
12834	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1009	Bethanechol	(2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine	myotonachol tablets 25mg|myoto	DRUGBANK	DB01019	C7H17N2O2	small molecule	N07AB02	674-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZUPCNDJBJXXRF-UHFFFAOYSA-O
12835	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1009	Bethanechol	(2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine	myotonachol tablets 25mg|myoto	DRUGBANK	DB01019	C7H17N2O2	small molecule	N07AB02	674-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZUPCNDJBJXXRF-UHFFFAOYSA-O
12836	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Cruzblanca H (2006)	16953191	179730	1009	Bethanechol	(2-Hydroxypropyl)trimethylammonium carbamate|Carbamoyl-beta-methylcholine|2-Carbamoyloxypropyl-trimethylazanium|Bethanechol|carbamyl--methylcholine|Amidopropyldimethylbetaine|carbamoyl--methylcholine|2-(Carbamoyloxy)-N,N,N-trimethylpropan-1-aminium|Carbamyl-beta-methylcholine	myotonachol tablets 25mg|myoto	DRUGBANK	DB01019	C7H17N2O2	small molecule	N07AB02	674-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZUPCNDJBJXXRF-UHFFFAOYSA-O
12837	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	inducer	target	Moncada S (1991)	1852778	176040	1010	Isosorbide Mononitrate	IS 5-MN|mononitrato de isosorbida|Isosorbide 5-mononitrate|Isosorbide-5-mononitrate|IS-5MN|Monosorbitrate|IS-5-MN|isosorbidi mononitras|Isosorbide 5-nitrate|mononitrate d'isosorbide|ISMN|Iso-5-mononitrate	isosorbide mononitrate|imdur|p	DRUGBANK	DB01020	C6H9NO6	small molecule	C01DA14	16051-77-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWXYYJSYQOXTPL-SLPGGIOYSA-N
12838	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	inducer	target	Mancuso C (2010)	20089135	176039	1010	Isosorbide Mononitrate	IS 5-MN|mononitrato de isosorbida|Isosorbide 5-mononitrate|Isosorbide-5-mononitrate|IS-5MN|Monosorbitrate|IS-5-MN|isosorbidi mononitras|Isosorbide 5-nitrate|mononitrate d'isosorbide|ISMN|Iso-5-mononitrate	isosorbide mononitrate|imdur|p	DRUGBANK	DB01020	C6H9NO6	small molecule	C01DA14	16051-77-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWXYYJSYQOXTPL-SLPGGIOYSA-N
12839	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Takahashi N (1995)	7752578	179731	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12840	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12841	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12842	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12843	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12844	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12845	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12846	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12847	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12848	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2009)	19119014	174539	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12849	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12850	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Hasannejad H (2004)	14610216	179734	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12851	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Smith SM (2010)	20187262	179733	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12852	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Li J (2007)	17414671	179732	1011	Trichlormethiazide	Naqua	-	DRUGBANK	DB01021	C8H8Cl3N3O4S2	small molecule	C03AB06|C03AA06|C03EA02	133-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-UHFFFAOYSA-N
12853	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	agonist	target	Sato Y (1999)	10418836	179737	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12854	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	agonist	target	Kawana K (2001)	11678581	179736	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12855	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	agonist	target	Schurgers LJ (2001)	11374034	179735	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12856	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	agonist	target	Vermeer C (1998)	11541904	179739	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12857	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	agonist	target	Askim M (2001)	11668761	179738	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12858	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12859	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inducer	target	Tasatargil A (2006)	16929463	179742	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12860	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inducer	target	Morris DP (1993)	8473318	179743	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12861	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inducer	target	Tuan RS (1979)	105006	179740	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12862	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inducer	target	Reedstrom CK (1995)	7638250	179741	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12863	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inducer	target	Olson RE (1984)	6380538	179744	1012	Phylloquinone	Phytonadione|Phyllochinonum|-phylloquinone|Phylloquinone|Phytomenadione|Phyllochinon|alpha-Phylloquinone|3-Phytylmenadione|Phythyl-menadion|trans-Phylloquinone|2-Methyl-3-phytyl-1,4-naphthochinon|Phytylmenadione|Fitomenadiona|Phytonadionum|2-Methyl-3-[(2e)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone|Vitamin K1|Phytomenadionum|2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione|2-Methyl-3-phytyl-1,4-naphthoquinone	vitamin k1 inj 10mg/ml usp|mep	DRUGBANK	DB01022	C31H46O2	small molecule	B02BA01	84-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBWXNTAXLNYFJB-NKFFZRIASA-N
12864	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Dietz JD (2008)	18250364	175777	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12865	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12866	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2009)	18974361	174771	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12867	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12868	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12869	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12870	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Zahradnikova A (2007)	17475903	179745	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12871	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12872	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12873	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Zahradnikova A (2007)	17475903	179745	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12874	111179	5153	-	PDE1B	PDE1B1|PDES1B	9606	Homo sapiens	inhibitor	target	Sharma RK (1997)	9231746	177388	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12875	111179	5153	-	PDE1B	PDE1B1|PDES1B	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12876	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12877	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12878	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Zahradnikova A (2007)	17475903	179745	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12879	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12880	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Johnson JD (1987)	2442519	182258	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12881	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Mills JS (1985)	4074665	182259	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12882	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lamers JM (1987)	2964559	182257	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12883	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Walsh MP (1988)	2833901	182260	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12884	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lamers JM (1985)	2933041	179746	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12885	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Bostroem SL (1988)	3178884	179747	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12886	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12887	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2009)	18974361	174771	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12888	111162	5136	-	PDE1A	CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A	9606	Homo sapiens	inhibitor	target	Sharma RK (1997)	9231746	177388	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12889	111162	5136	-	PDE1A	CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12890	112980	7125	-	TNNC2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12891	112980	7125	-	TNNC2	-	9606	Homo sapiens	unknown	target	Bostroem SL (1988)	3178884	179747	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12892	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Bostroem SL (1988)	3178884	179747	1013	Felodipine	(+-)-Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester|Felodipinum|Felodipina|Felodipine|3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate	sandoz felodipine|renedil|rene	DRUGBANK	DB01023	C18H19Cl2NO4	small molecule	C08CA02|C09BB05	72509-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZTAMFZIAATZDJ-UHFFFAOYSA-N
12893	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12894	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Vannozzi F (2004)	15621150	177826	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12895	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12896	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Dzidic A (2006)	16629948	179750	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12897	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Wang J (2007)	17496727	173725	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12898	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Yam P (2006)	16647299	179748	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12899	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Penuelas S (2005)	15614187	179749	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12900	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Dzidic A (2006)	16629948	179750	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPNSFSBZBAHARI-RUDMXATFSA-N
12901	109777	3562	-	IL3	IL-3|MCGF|MULTI-CSF	9606	Homo sapiens	antagonist	target	Urisu A (1990)	1701989	179751	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12902	109777	3562	-	IL3	IL-3|MCGF|MULTI-CSF	9606	Homo sapiens	antagonist	target	Nagai H (1992)	1378042	179752	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12903	112191	6283	-	S100A12	CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6	9606	Homo sapiens	antagonist	target	Kishimoto K (2006)	16864903	178308	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12904	112191	6283	-	S100A12	CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6	9606	Homo sapiens	antagonist	target	Shishibori T (1999)	10051426	179753	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12905	112191	6283	-	S100A12	CAAF1|CAGC|CGRP|ENRAGE|MRP-6|MRP6|p6	9606	Homo sapiens	antagonist	target	Okada M (2002)	11944917	178307	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12906	112192	6284	-	S100A13	-	9606	Homo sapiens	antagonist	target	Shishibori T (1999)	10051426	179753	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12907	112192	6284	-	S100A13	-	9606	Homo sapiens	antagonist	target	Matsunaga H (2006)	16519964	179755	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12908	112192	6284	-	S100A13	-	9606	Homo sapiens	antagonist	target	Mouta Carreira C (1998)	9712836	2875	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12909	112192	6284	-	S100A13	-	9606	Homo sapiens	antagonist	target	Okada M (2002)	11944917	178307	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12910	112192	6284	-	S100A13	-	9606	Homo sapiens	antagonist	target	Landriscina M (2000)	10921913	179754	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12911	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	inhibitor	target	Rajalingam D (2005)	16300395	179756	1015	Amlexanox	Amlexanox|2-Amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid|Amoxanox|Amlexanoxum|Amlexanoxo	apthera	DRUGBANK	DB01025	C16H14N2O4	small molecule	R03DX01|A01AD07	68302-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGRYPYWGNKJSDL-UHFFFAOYSA-N
12912	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	unknown	target	Weber MM (1991)	2004042	179757	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12913	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	binder	target	Eil C (1992)	1526623	179758	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12914	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Imming P (2006)	17016423	171742	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12915	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Overington JP (2006)	17139284	171741	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12916	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Berman HM (2000)	10592235	172122	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12917	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Croxtall JD (2009)	19275277	90682	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12918	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Warrilow AG (2010)	20625155	174707	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12919	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Agut J (1992)	1627191	179759	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12920	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Agut J (1992)	1627190	179760	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12921	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Borgers M (2005)	16375669	179761	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12922	107961	1589	DADB-112B14.10-001	CYP21A2	CA21H|CAH1|CPS1|CYP21|CYP21B|P450c21B	9606	Homo sapiens	unknown	target	Trachtenberg J (1988)	2966691	179762	1016	Ketoconazole	Nizoral a-D|Extina|Xolegel|Ketozole|Ketoconazol|Ketoconazole|Nizoral|Ketoconazolum	nizoral shp 2%|nizoral a-d|tev	DRUGBANK	DB01026	C26H28Cl2N4O4	small molecule	G01AF11|J02AB02|D01AC08	65277-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMAYWYJOQHXEEK-UHFFFAOYSA-N
12923	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12924	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12925	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12926	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12927	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Lopez MM (1995)	7499320	179763	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12928	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12929	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12930	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12931	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Moody EJ (1988)	2459308	179764	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12932	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Krasowski MD (2000)	10683198	179765	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12933	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Moody EJ (1988)	2845216	179766	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12934	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12935	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Krasowski MD (2000)	10683198	179765	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12936	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12937	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12938	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12939	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Elliott JR (1992)	1336744	179767	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12940	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12941	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12942	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Martin DC (1995)	7702639	179768	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12943	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12944	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12945	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Zhu ZS (2004)	15133856	179770	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12946	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	unknown	target	Cheng SM (2004)	15210574	179769	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12947	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12948	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Waeber B (2003)	15030294	179779	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12949	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Croom KF (2004)	15101793	179778	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12950	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Adams MA (2000)	10822210	179782	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12951	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Voigt JP (2007)	17408613	179780	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12952	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Dol F (2001)	11486244	179781	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12953	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	van den Meiracker AH (1995)	7843749	179773	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12954	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Mazzolai L (1999)	10082498	179772	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12955	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Carraway JW (1999)	10069682	179771	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12956	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Martin G (2004)	14716205	179777	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12957	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Croom KF (2008)	18627212	179776	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12958	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Morsing P (1999)	10373224	179775	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12959	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Hope S (1999)	10075381	179774	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12960	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Zhang J (2002)	12520736	179790	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12961	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12962	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Streltsov SA (2002)	12437383	179786	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12963	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Aisner J (2003)	12855624	179787	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12964	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Herben VM (1996)	8853931	179784	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12965	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Schmidt F (2001)	11166732	179785	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12966	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Dennis MJ (1997)	9122737	179783	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12967	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	strel'tsov SA (2001)	11443926	179788	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12968	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Kollmannsberger C (1999)	9885371	179789	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12969	125510	116447	-	TOP1MT	-	9606	Homo sapiens	inhibitor	target	Kosovsky MJ (1993)	8390858	179791	1019	Topotecan	9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin|Topotecane|Topotecanum	topotecan|topotecan injection|	DRUGBANK	DB01030	C23H23N3O5	small molecule	L01XX17	123948-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFGDBYHRUNTLO-QHCPKHFHSA-N
12970	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Parr JS (1992)	1460006	175971	1020	Ethinamate	Ethinamate|Ethinamatum|1-Ethynylcyclohexanol carbamate|Etinamato|Aethinyl-cyclohexyl-carbamat	-	DRUGBANK	DB01031	C9H13NO2	small molecule	-	126-52-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXRZIMHKGDIBEW-UHFFFAOYSA-N
12971	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1020	Ethinamate	Ethinamate|Ethinamatum|1-Ethynylcyclohexanol carbamate|Etinamato|Aethinyl-cyclohexyl-carbamat	-	DRUGBANK	DB01031	C9H13NO2	small molecule	-	126-52-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXRZIMHKGDIBEW-UHFFFAOYSA-N
12972	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Parr JS (1992)	1460006	175971	1020	Ethinamate	Ethinamate|Ethinamatum|1-Ethynylcyclohexanol carbamate|Etinamato|Aethinyl-cyclohexyl-carbamat	-	DRUGBANK	DB01031	C9H13NO2	small molecule	-	126-52-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXRZIMHKGDIBEW-UHFFFAOYSA-N
12973	117295	24145	UNQ2529/PRO6028	PANX1	MRS1|PX1|UNQ2529	9606	Homo sapiens	antagonist	target	Silverman W (2008)	18596212	179795	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12974	117295	24145	UNQ2529/PRO6028	PANX1	MRS1|PX1|UNQ2529	9606	Homo sapiens	antagonist	target	Ransford GA (2009)	19213873	179794	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12975	117295	24145	UNQ2529/PRO6028	PANX1	MRS1|PX1|UNQ2529	9606	Homo sapiens	antagonist	target	Bunse S (2009)	19780818	179796	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12976	117295	24145	UNQ2529/PRO6028	PANX1	MRS1|PX1|UNQ2529	9606	Homo sapiens	antagonist	target	Ma W (2009)	19023039	179793	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12977	117295	24145	UNQ2529/PRO6028	PANX1	MRS1|PX1|UNQ2529	9606	Homo sapiens	antagonist	target	Silverman WR (2009)	19416975	179792	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12978	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	inhibitor	target	Takeda M (2002)	12130730	175259	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12979	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	inhibitor	target	Takeda M (2001)	11426832	179797	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12980	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12981	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	inhibitor	target	Jung KY (2001)	11669456	173965	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12982	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	inhibitor	target	Hashimoto T (2004)	15377641	179798	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12983	120967	55867	-	SLC22A11	OAT4|hOAT4	9606	Homo sapiens	inhibitor	target	Takeda M (2002)	12130730	175259	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12984	120967	55867	-	SLC22A11	OAT4|hOAT4	9606	Homo sapiens	inhibitor	target	Enomoto A (2002)	12023506	179799	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12985	120967	55867	-	SLC22A11	OAT4|hOAT4	9606	Homo sapiens	inhibitor	target	Hashimoto T (2004)	15377641	179798	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12986	120967	55867	-	SLC22A11	OAT4|hOAT4	9606	Homo sapiens	inhibitor	target	Babu E (2002)	12063169	173967	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12987	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	inhibitor	target	Takeda M (2002)	12130730	175259	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12988	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12989	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	inhibitor	target	Jung KY (2001)	11669456	173965	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12990	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	inhibitor	target	Takeda M (2001)	11426832	179797	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12991	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	inhibitor	target	Sweet DH (2003)	12488248	179800	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12992	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	inhibitor	target	Kusuhara H (1999)	10224140	174964	1021	Probenecid	Probenecidum|Probenecide|Probenecid acid|4-(Di-N-propylsulfamoyl)benzoesaeure|4-(N,N-Dipropylsulfamoyl)benzoesaeure|P-(Dipropylsulfamoyl)benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|Probenecida	probenecid|probenecid and colc	DRUGBANK	DB01032	C13H19NO4S	small molecule	M04AB01	57-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBABZHXKTCFAPX-UHFFFAOYSA-N
12993	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Sahasranaman S (2008)	18506437	179567	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
12994	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
12995	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Sahasranaman S (2008)	18506437	179567	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
12996	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
12997	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	inhibitor	target	Dubinsky MC (2004)	15354273	179565	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
12998	111467	5471	-	PPAT	ATASE|GPAT|PRAT	9606	Homo sapiens	unknown	target	Sahasranaman S (2008)	18506437	179567	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
12999	111467	5471	-	PPAT	ATASE|GPAT|PRAT	9606	Homo sapiens	unknown	target	Gaulton A (2012)	21948594	174478	1022	Mercaptopurine	Mercapurin|Mercaptopurina|6-Thiohypoxanthine|6-Thioxopurine|6-MP|6 MP|mercaptopurinum|6-Mercaptopurine	mercaptopurine|purixan|purinet	DRUGBANK	DB01033	C5H4N4S	small molecule	L01BB02	50-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLVAUDGFNGKCSF-UHFFFAOYSA-N
13000	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Schujman GE (2001)	11325930	179801	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13001	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Price AC (2001)	11050088	179803	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13002	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Heath RJ (2001)	11591436	179802	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13003	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Heath RJ (2004)	15043388	179805	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13004	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Khandekar SS (2003)	12570782	179804	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13005	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Omura S (1976)	791237	179807	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13006	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	inhibitor	target	Heath RJ (2002)	12021787	179806	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13007	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Kauppinen S (1988)	3076376	29664	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13008	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Slabaugh MB (1998)	9681003	179808	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13009	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Price AC (2001)	11050088	179803	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13010	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Heath RJ (2001)	11591436	179802	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13011	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Heath RJ (2004)	15043388	179805	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13012	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Khandekar SS (2003)	12570782	179804	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13013	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	inhibitor	target	Omura S (1976)	791237	179807	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13014	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Young K (2006)	16436705	179809	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13015	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Price AC (2001)	11050088	179803	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13016	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Heath RJ (2001)	11591436	179802	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13017	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Heath RJ (2004)	15043388	179805	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13018	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Khandekar SS (2003)	12570782	179804	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13019	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Omura S (1976)	791237	179807	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13020	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	inhibitor	target	Heath RJ (2002)	12021787	179806	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13021	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13022	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Oskouian B (1999)	10102370	47998	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13023	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Heiligtag SJ (2002)	12181752	179812	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13024	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Lupu R (2006)	17168665	179813	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13025	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Flavin R (2010)	20373869	179810	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13026	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Ronnett GV (2005)	15878185	179811	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13027	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Li JN (2001)	11245456	179814	1023	Cerulenin	Cerulenin|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)-oxirane-2-carboxylic acid amide|(2R,3S)-3-((4e,7e)-Nona-4,7-dienoyl)oxirane-2-carboxamide	-	DRUGBANK	DB01034	C12H17NO3	small molecule	-	17397-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEZIHKRYBHEFX-NQQPLRFYSA-N
13028	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13029	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Brugada J (1999)	11225790	179818	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13030	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Weiss R (2002)	11839626	179819	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13031	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Brugada R (2000)	10662748	179816	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13032	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen SM (2000)	11155778	179817	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13033	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Brugada J (1999)	10443304	179815	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13034	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Lee BH (2005)	16230360	179823	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13035	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Oelke K (2004)	15188362	179822	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13036	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Januchowski R (2005)	15795105	179821	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13037	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Scheinbart LS (1991)	2066944	179820	1024	Procainamide	Procainamida|Procainamide|Biocoryl|p-Aminobenzoic diethylaminoethylamide|Procainamidum|p-Amino-N-(2-diethylaminoethyl)benzamide	apo-procainamide cap 375mg|pro	DRUGBANK	DB01035	C13H21N3O	small molecule	C01BA02	51-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REQCZEXYDRLIBE-UHFFFAOYSA-N
13038	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13039	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Schneider T (2004)	14769832	179826	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13040	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Sellers DJ (2000)	11193006	179825	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13041	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	McNamara A (2009)	19168050	179824	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13042	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Maruyama S (2006)	16406943	179827	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13043	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Maruyama S (2006)	16406943	179827	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13044	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13045	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13046	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Schneider T (2004)	14769832	179826	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13047	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nelson CP (2006)	16188951	176974	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13048	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Schneider T (2004)	14769832	179826	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13049	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Sellers DJ (2000)	11193006	179825	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13050	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	McNamara A (2009)	19168050	179824	1025	Tolterodine	Tolterodina|Tolterodinum|(+)-Tolterodine|Tolterodine|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol	mylan-tolterodine er|teva-tolt	DRUGBANK	DB01036	C22H31NO	small molecule	G04BD07	124937-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOGJQPCLVADCPB-HXUWFJFHSA-N
13051	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chrisp P (1991)	1794016	179834	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13052	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1994)	7995016	179835	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13053	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13054	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Deleu D (2002)	11978145	179837	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13055	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Macleod AD (2005)	16034956	179830	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13056	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13057	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Unknown Authors (2002)	12199263	179832	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13058	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1998)	9673855	179833	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13059	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13060	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13061	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13062	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13063	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13064	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13065	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
13066	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Bora G (1968)	4887393	179838	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13067	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Platz AR (1967)	4861216	179839	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13068	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Vinar O (1967)	4889058	179840	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13069	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13070	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Bora G (1968)	4887393	179838	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13071	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Platz AR (1967)	4861216	179839	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13072	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Vinar O (1967)	4889058	179840	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13073	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bora G (1968)	4887393	179838	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13074	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Platz AR (1967)	4861216	179839	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13075	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Vinar O (1967)	4889058	179840	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13078	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13079	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Clavey V (1999)	10494028	179845	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13080	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Casas F (2000)	11018525	179844	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13081	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Bouly M (2001)	11342537	179847	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13082	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Chaput E (2000)	10799317	179846	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13083	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Guerre-Millo M (2000)	10828060	179843	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13084	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Dana SL (2001)	11474486	179848	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
13085	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13086	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Yasui K (2005)	15723633	179849	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13087	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	antagonist	target	Eichholz A (2010)	20616958	179850	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13088	111046	5004	RP11-82I1.3	ORM1	AGP-A|AGP1|HEL-S-153w|ORM	9606	Homo sapiens	binder	target	Turk BE (1996)	8755512	179851	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13089	111047	5005	RP11-82I1.2	ORM2	AGP-B|AGP-B|AGP2	9606	Homo sapiens	binder	target	Turk BE (1996)	8755512	179851	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13090	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13091	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Richardson P (2002)	12046682	179856	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13092	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Fu LM (2002)	12102294	179854	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13093	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Vescovo G (2002)	12167383	179855	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13094	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Enomoto N (2002)	12105857	179852	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13095	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Rajkumar SV (2001)	12113124	179853	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13096	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Turk BE (1996)	8755512	179851	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13097	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Zhu YX (2013)	22966948	176371	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13098	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Kim JH (2011)	21507989	179857	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13099	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Payvandi F (2004)	15598423	176374	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13100	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Hada M (2004)	15446566	179858	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13101	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Horrobin DF (2003)	12710892	179859	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13102	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Wiedmann MW (2005)	15892618	179861	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13103	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Du GJ (2005)	15982930	179860	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13104	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Seeman P (2008)	18000814	179862	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13105	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	binder	target	Kotermanski SE (2009)	19687120	179863	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13107	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Blanpied TA (1997)	9120573	179867	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13108	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Chen HS (2005)	15901795	179866	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13109	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Maler JM (2005)	16009352	179865	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13110	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	14530799	179868	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13111	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Bresink I (1996)	8886398	173224	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13112	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Schrattenholz A (2006)	16719808	179870	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13113	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Smothers CT (2007)	17502428	173484	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13114	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Foster AC (2006)	16377242	178993	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13115	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Chatterton JE (2002)	11823786	179869	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13116	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	14530799	179868	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13117	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Rammes G (2001)	11403963	179871	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13118	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Blanpied TA (1997)	9120573	179867	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13119	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Maler JM (2005)	16009352	179865	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13120	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Nakazato E (2005)	15452358	179873	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13121	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Kashiwagi K (2002)	11854433	179872	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13122	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	14530799	179868	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13123	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Cheng J (2009)	19460945	179874	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13124	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Chen J (2006)	16480505	179875	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13125	852781	948487	b3988	rpoC	ECK3979|JW3951|tabB	511145	Escherichia coli	inhibitor	target	Campbell EA (2001)	11290327	179878	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13126	852781	948487	b3988	rpoC	ECK3979|JW3951|tabB	511145	Escherichia coli	inhibitor	target	Villain-Guillot P (2007)	17331884	179879	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13127	852781	948487	b3988	rpoC	ECK3979|JW3951|tabB	511145	Escherichia coli	inhibitor	target	Tupin A (2010)	20185278	179880	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13128	852781	948487	b3988	rpoC	ECK3979|JW3951|tabB	511145	Escherichia coli	inhibitor	target	Wehrli W (1983)	6356275	179876	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13129	852781	948487	b3988	rpoC	ECK3979|JW3951|tabB	511145	Escherichia coli	inhibitor	target	White RJ (1971)	4942761	179877	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13130	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Campbell EA (2001)	11290327	179878	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13131	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Villain-Guillot P (2007)	17331884	179879	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13132	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Tupin A (2010)	20185278	179880	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13133	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Wehrli W (1983)	6356275	179876	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13134	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	White RJ (1971)	4942761	179877	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
13135	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13136	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Lacy BE (2008)	18686757	179881	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13137	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Ambizas EM (2007)	17519292	179883	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13138	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Moeser AJ (2007)	17053162	179882	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13139	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Crowell MD (2007)	17263187	179885	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13140	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Lacy BE (2009)	19236188	179884	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13141	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Lacy BE (2007)	17413599	179887	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13142	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Johanson JF (2007)	17509103	179886	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13143	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Unknown Authors (2005)	15991886	179889	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13144	107595	1181	-	CLCN2	CIC-2|CLC2|ECA2|ECA3|EGI11|EGI3|EGMA|EJM6|EJM8|LKPAT|clC-2	9606	Homo sapiens	inducer	target	Kapoor S (2010)	20345211	179888	1035	Lubiprostone	-	amitiza	DRUGBANK	DB01046	C20H32F2O5	small molecule	A06AX03	136790-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGFOBBZOWHGYQH-MXHNKVEKSA-N
13145	112492	6608	-	SMO	FZD11|Gx|SMOH	9606	Homo sapiens	agonist	target	Wang J (2010)	20439738	179890	1036	Fluocinonide	Lidex|Fluocinonide|Fluocinonido|Vanos|Fluocinonidum	fluocinonide|lidex ont 0.05%|l	DRUGBANK	DB01047	C26H32F2O7	small molecule	D07AC08|C05AA11|D07CC05	356-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJOHZNCJWYWUJD-IUGZLZTKSA-N
13146	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Jessop S (2001)	11279785	179891	1036	Fluocinonide	Lidex|Fluocinonide|Fluocinonido|Vanos|Fluocinonidum	fluocinonide|lidex ont 0.05%|l	DRUGBANK	DB01047	C26H32F2O7	small molecule	D07AC08|C05AA11|D07CC05	356-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJOHZNCJWYWUJD-IUGZLZTKSA-N
13147	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13148	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13149	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13150	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13151	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13152	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13153	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13154	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13155	116442	11309	-	SLCO2B1	OATP-B|OATP2B1|OATPB|SLC21A9	9606	Homo sapiens	inhibitor	target	Lu WJ (2006)	16707409	179896	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13156	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13157	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13158	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13159	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13160	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13161	108833	2559	-	GABRA6	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13162	108833	2559	-	GABRA6	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13163	108833	2559	-	GABRA6	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13164	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13165	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13166	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13167	108834	2560	-	GABRB1	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13168	108834	2560	-	GABRB1	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13169	108834	2560	-	GABRB1	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13170	108842	2568	-	GABRP	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13171	108842	2568	-	GABRP	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13172	108842	2568	-	GABRP	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13173	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13174	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13175	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13176	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13177	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13178	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13179	108835	2561	-	GABRB2	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13180	108835	2561	-	GABRB2	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13181	108835	2561	-	GABRB2	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13182	108839	2565	-	GABRG1	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13183	108839	2565	-	GABRG1	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13184	108839	2565	-	GABRG1	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13185	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13186	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13187	108832	2558	-	GABRA5	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13188	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13189	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13190	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13191	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13192	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13193	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13194	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13195	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13196	108829	2555	-	GABRA2	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13197	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13198	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13199	108830	2556	-	GABRA3	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13200	108841	2567	-	GABRG3	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13201	108841	2567	-	GABRG3	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13202	108841	2567	-	GABRG3	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13203	108838	2564	-	GABRE	-	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13204	108838	2564	-	GABRE	-	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13205	108838	2564	-	GABRE	-	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13206	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13207	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13208	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13209	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13210	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13211	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13212	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13213	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13214	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13215	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13216	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13217	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13218	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13219	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13220	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13221	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13222	130056	285242	-	HTR3E	5-HT3-E|5-HT3E|5-HT3c1	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13223	130056	285242	-	HTR3E	5-HT3-E|5-HT3E|5-HT3c1	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13224	130056	285242	-	HTR3E	5-HT3-E|5-HT3E|5-HT3c1	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13225	130056	285242	-	HTR3E	5-HT3-E|5-HT3E|5-HT3c1	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13226	128355	200909	-	HTR3D	5HT3D	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13227	128355	200909	-	HTR3D	5HT3D	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13228	128355	200909	-	HTR3D	5HT3D	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13229	128355	200909	-	HTR3D	5HT3D	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13230	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13231	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13232	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13233	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13234	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13235	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13236	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13237	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13238	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13239	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13240	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13241	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13242	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13243	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13244	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13245	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13246	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13247	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13248	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13249	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13250	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13251	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13252	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13253	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13254	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13255	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13256	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13257	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13258	128062	170572	-	HTR3C	-	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13259	128062	170572	-	HTR3C	-	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13260	128062	170572	-	HTR3C	-	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13261	128062	170572	-	HTR3C	-	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13262	114615	9177	-	HTR3B	5-HT3B	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13263	114615	9177	-	HTR3B	5-HT3B	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13264	114615	9177	-	HTR3B	5-HT3B	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13265	114615	9177	-	HTR3B	5-HT3B	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13266	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13267	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13268	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Flynn BL (1999)	10084415	179894	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13269	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Wadworth AN (1992)	1606351	179895	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13270	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13271	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13272	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13273	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13274	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13275	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13276	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chavez ML (2003)	12852704	177085	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13277	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13278	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Martic M (2004)	14987823	179630	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13279	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Gupta K (2004)	14741265	179900	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13280	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Yu L (2013)	23536207	179901	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13281	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Patrignani P (2003)	14592549	179902	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13282	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Hillarp A (2004)	15575422	179899	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13283	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	modulator	target	Palayoor ST (2012)	22668799	179903	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13284	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Dill J (2010)	20089905	179904	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13285	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	negative modulator	target	Palayoor ST (2012)	22668799	179903	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13286	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	inhibitor	target	Devor DC (1998)	9710435	179905	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13287	112914	7056	-	THBD	AHUS6|BDCA3|CD141|THPH12|THRM|TM	9606	Homo sapiens	modulator	target	Palayoor ST (2012)	22668799	179903	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13288	108467	2169	-	FABP2	FABPI|I-FABP	9606	Homo sapiens	binder	target	Velkov T (2005)	15722357	179906	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13289	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13290	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13291	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gallego-Sandin S (2004)	15481334	179907	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13292	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Murphey LJ (2004)	15494133	179908	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13293	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ouellet M (2004)	14510637	179909	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13294	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Fidalgo S (2004)	15556152	179910	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13295	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13296	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13297	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13298	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13299	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2009)	18974361	174771	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13300	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13301	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2009)	18974361	174771	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13302	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13303	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1042	Nitrendipine	Deiten|Nidrel|Nitrendipino|Baypress|Bylotensin|Bayotensin|1,4-dihydro-2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ethyl methyl ester|Nitrendipinum|BAY e 5009	-	DRUGBANK	DB01054	C18H20N2O6	small molecule	C08CA08|C09BB06	39562-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVHUJELLJLJGLN-UHFFFAOYSA-N
13304	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Sugumaran M (1986)	3094574	179914	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13305	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Khan KM (2006)	16750372	179913	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13306	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Woolery GL (1984)	6234942	179912	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13307	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Ahmad VU (2004)	15577244	179911	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13308	112251	6347	-	CCL2	GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF	9606	Homo sapiens	inhibitor	target	Frydas S (2005)	15698514	179916	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13309	112251	6347	-	CCL2	GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF	9606	Homo sapiens	inhibitor	target	Conti P (2002)	11936838	179915	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13310	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	inhibitor	target	Perry C (2005)	15531579	179917	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13311	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	inhibitor	target	Conti P (2002)	11936838	179915	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13312	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	inhibitor	target	Oppenheim EW (2000)	10766749	179919	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13313	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	inhibitor	target	Lin HB (1996)	8576220	179918	1043	Mimosine	Leucaenine|Leucenine|Leucaenol|Mimosin|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate|Leucenol|L-Mimosine	-	DRUGBANK	DB01055	C8H10N2O4	small molecule	-	500-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZNJWVWKTVETCG-YFKPBYRVSA-N
13314	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1044	Tocainide	2-amino-N-(2,6-Dimethylphenyl)propanamide|Tocainidum|2-Amino-N-(2,6-dimethylphenyl)propionamid|Tocainida|Alanyl-2,6-xylidide|2-Amino-2',6'-propionoxylidide	tonocard tab 400 mg	DRUGBANK	DB01056	C11H16N2O	small molecule	C01BB03	41708-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUJAGSGYPOAWEI-UHFFFAOYSA-N
13315	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Georgijevic Milic L (2000)	10953551	179920	1044	Tocainide	2-amino-N-(2,6-Dimethylphenyl)propanamide|Tocainidum|2-Amino-N-(2,6-dimethylphenyl)propionamid|Tocainida|Alanyl-2,6-xylidide|2-Amino-2',6'-propionoxylidide	tonocard tab 400 mg	DRUGBANK	DB01056	C11H16N2O	small molecule	C01BB03	41708-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUJAGSGYPOAWEI-UHFFFAOYSA-N
13316	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1045	Echothiophate	Ecothiopatum|Phospholine|Echothiophate|2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide	phospholine iodide - pws 12.5m	DRUGBANK	DB01057	C9H23NO3PS	small molecule	-	6736-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJOLKYGKSZKIGU-UHFFFAOYSA-N
13317	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Henderson EG (1989)	2481033	179921	1045	Echothiophate	Ecothiopatum|Phospholine|Echothiophate|2-(Diethoxyphosphorylsulfanyl)ethyl-N,N,N-trimethylazanium iodide	phospholine iodide - pws 12.5m	DRUGBANK	DB01057	C9H23NO3PS	small molecule	-	6736-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJOLKYGKSZKIGU-UHFFFAOYSA-N
13318	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1047	Norfloxacin	Norfloxacine|NFLX|1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure|Norfloxacino|1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|Norfloxacinum|1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid	riva-norfloxacin|ntp-norfloxac	DRUGBANK	DB01059	C16H18FN3O3	small molecule	J01MA06|S01AE02|J01RA13	70458-96-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGJPXUAPXNRGGI-UHFFFAOYSA-N
13319	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Maruyama S (2006)	16406943	179827	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13320	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13321	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13322	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13323	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13324	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Oki T (2007)	17222678	179925	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13325	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Ito Y (2009)	19446545	179922	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13326	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Baldwin CM (2009)	19275276	179923	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13327	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Oki T (2007)	17222678	179925	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13328	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13329	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13330	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13331	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Maruyama S (2006)	16406943	179827	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13332	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Dmochowski R (2005)	15963006	179926	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13333	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nelson CP (2006)	16188951	176974	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13334	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13335	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Oki T (2007)	17222678	179925	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13336	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Ito Y (2009)	19446545	179922	1050	Oxybutynin	4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|Oxybutynine|Oxybutynin|Oxibutinina|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|Oxybutyninum|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat	ditropan syrup 1mg/ml|oxybutyn	DRUGBANK	DB01062	C22H31NO3	small molecule	G04BD04	5633-20-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIQVNETUBQGFHX-UHFFFAOYSA-N
13337	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13338	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13339	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13340	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13341	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Tam SW (1984)	6147851	179927	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13342	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13343	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13344	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13345	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13346	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Jones SM (2003)	14656380	179930	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13347	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Abraham G (2003)	12963495	179933	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13348	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Teixeira CE (2004)	14752060	179932	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13349	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Odley A (2004)	15105445	179928	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13350	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Uezono Y (2004)	15151902	179929	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13351	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15381832	179935	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13352	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	agonist	target	Slomiany BL (2005)	15985706	179934	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13353	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15527548	179937	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13354	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	agonist	target	Machida K (2005)	15618457	179936	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13355	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15110780	179938	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13356	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Dubey RK (2004)	15292328	179944	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13357	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Oudit GY (2003)	12963636	179940	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13358	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Vaniotis G (2011)	20732414	179941	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13359	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Azzi M (2003)	13679574	179942	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13360	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Yeh CK (2005)	15689414	179943	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13361	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Adissu HA (2004)	15138589	179939	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13362	111314	5296	-	PIK3R2	MPPH|MPPH1|P85B|p85|p85-BETA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15381832	179935	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13363	111314	5296	-	PIK3R2	MPPH|MPPH1|P85B|p85|p85-BETA	9606	Homo sapiens	agonist	target	Slomiany BL (2005)	15985706	179934	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13364	111314	5296	-	PIK3R2	MPPH|MPPH1|P85B|p85|p85-BETA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15527548	179937	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13365	111314	5296	-	PIK3R2	MPPH|MPPH1|P85B|p85|p85-BETA	9606	Homo sapiens	agonist	target	Machida K (2005)	15618457	179936	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13366	111314	5296	-	PIK3R2	MPPH|MPPH1|P85B|p85|p85-BETA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15110780	179938	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13367	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Schiffelers SL (2000)	10824635	179945	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13368	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13369	114075	8503	RP4-533D7.2	PIK3R3	p55|p55-GAMMA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15381832	179935	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13370	114075	8503	RP4-533D7.2	PIK3R3	p55|p55-GAMMA	9606	Homo sapiens	agonist	target	Slomiany BL (2005)	15985706	179934	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13371	114075	8503	RP4-533D7.2	PIK3R3	p55|p55-GAMMA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15527548	179937	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13372	114075	8503	RP4-533D7.2	PIK3R3	p55|p55-GAMMA	9606	Homo sapiens	agonist	target	Machida K (2005)	15618457	179936	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13373	114075	8503	RP4-533D7.2	PIK3R3	p55|p55-GAMMA	9606	Homo sapiens	agonist	target	Slomiany BL (2004)	15110780	179938	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13374	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Kobayashi H (2005)	16038799	179948	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13375	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Sato M (2004)	14734046	179946	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13376	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Jurgens CW (2005)	15908512	179947	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13377	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13378	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1052	Isoprenaline	(+-)-Isoprenaline|Isoproterenol|Isoprenalina|N-isopropyl--dihydroxyphenyl--hydroxyethylamine|(+-)-Isoproterenol|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|Isoprenaline|Isopropyl noradrenaline|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|()-isoprenaline|Isoprenalinum|N-Isopropylnorepinephrine|()-isoproterenol|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|-(isopropylaminomethyl)protocatechuyl alcohol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|N-Isopropylnoradrenaline	isuprel mistometer aem 0.25%|i	DRUGBANK	DB01064	C11H17NO3	small molecule	R03AK02|R03AB02|C01CA02|R03CB01|R03CB51	7683-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZZKOKVBUJMES-UHFFFAOYSA-N
13379	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Radogna F (2009)	19463840	179949	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13380	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Hardeland R (2009)	19449447	179953	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13381	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Srinivasan V (2010)	20827520	179952	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13382	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Carocci A (2010)	20674373	179951	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13383	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Prendergast BJ (2010)	19966183	179950	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13384	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Boutin JA (2005)	15992934	179954	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13385	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13386	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Radogna F (2009)	19463840	179949	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13387	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	del Rio B (2004)	15229223	179956	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13388	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Yoo YM (2009)	19796047	179955	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13389	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	unknown	target	Hardeland R (2009)	19449447	179953	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13390	107262	811	-	CALR	CRT|HEL-S-99n|RO|SSA|cC1qR	9606	Homo sapiens	unknown	target	Macias M (2003)	12603316	179957	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13391	113893	8288	-	EPX	EPO|EPP|EPX-PEN	9606	Homo sapiens	inhibitor	target	Lu T (2008)	18516076	179958	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13392	112023	6096	-	RORB	NR1F2|ROR-BETA|RZR-BETA|RZRB|bA133M9.1	9606	Homo sapiens	agonist	target	Becker-Andre M (1994)	7961794	179959	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13393	110493	4353	-	MPO	-	9606	Homo sapiens	inhibitor	target	Galijasevic S (2008)	18237195	179960	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13394	106930	438	RP13-297E16.2	ASMT	ASMTY|HIOMT|HIOMTY	9606	Homo sapiens	unknown	target	Minneman KP (1976)	180879	179961	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13395	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Hardeland R (2009)	19449447	179953	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13396	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Srinivasan V (2010)	20827520	179952	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13397	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Carocci A (2010)	20674373	179951	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13398	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Prendergast BJ (2010)	19966183	179950	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13399	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Boutin JA (2005)	15992934	179954	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13400	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Radogna F (2009)	19463840	179949	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13401	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Radogna F (2009)	19463840	179949	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13402	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	del Rio B (2004)	15229223	179956	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13403	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13404	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Reimann F (2001)	11574406	179962	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13405	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Lawrence CL (2001)	11484080	179963	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13406	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Proks P (2002)	12475777	174487	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13407	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Harrower A (2000)	11078469	179964	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13408	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Gribble FM (2000)	11078468	179965	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13409	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13410	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13411	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13412	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13413	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13414	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13415	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13416	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13417	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13418	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13419	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13420	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13421	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13422	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13423	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13424	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13425	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13426	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13427	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13428	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13429	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13430	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13431	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13432	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13433	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13434	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13435	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13436	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13437	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13438	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13439	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13440	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13441	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13442	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Awad M (1989)	2723642	179968	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13443	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Bono F (1999)	10558889	179969	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13444	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Carmel I (1999)	10423168	179970	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13445	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Marano G (1990)	2364987	179966	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13446	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	unknown	target	Bolger GT (1990)	1691678	179967	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13447	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13448	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Suzuki A (2003)	12657913	179975	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13449	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13450	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Paton DM (1985)	2866055	175984	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13451	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ikeda H (1997)	9442829	179973	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13452	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Miller RA (1989)	2576052	179972	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13453	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Claro E (1986)	3011460	175980	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13454	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Smith BN (1993)	8098142	179974	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13455	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13456	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13457	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13458	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kelley BM (1997)	9258998	179979	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13459	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Fiorella D (1995)	8584617	179978	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13460	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Hoenicke EM (1992)	1403790	176036	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13461	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Martinez F (1990)	2329012	179977	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13462	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Bileviciute I (1998)	9863661	179976	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13463	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13464	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13465	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Cohen ME (1986)	3022601	182263	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13466	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	DiPaola M (1984)	6319437	182262	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13467	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Lohr KM (1984)	6092486	182261	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13468	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Luchowski EM (1984)	6433001	182265	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13469	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Scott JA (1986)	3820316	182264	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13470	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13471	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13472	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Qaw F (1993)	8380156	179980	1058	Dihydrotachysterol	Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10	hytakerol	DRUGBANK	DB01070	C28H46O	small molecule	A11CC02	67-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILYCWAKSDCYMBB-OPCMSESCSA-N
13473	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Qaw FS (1992)	1336906	179981	1058	Dihydrotachysterol	Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10	hytakerol	DRUGBANK	DB01070	C28H46O	small molecule	A11CC02	67-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILYCWAKSDCYMBB-OPCMSESCSA-N
13474	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1058	Dihydrotachysterol	Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10	hytakerol	DRUGBANK	DB01070	C28H46O	small molecule	A11CC02	67-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILYCWAKSDCYMBB-OPCMSESCSA-N
13475	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1058	Dihydrotachysterol	Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10	hytakerol	DRUGBANK	DB01070	C28H46O	small molecule	A11CC02	67-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILYCWAKSDCYMBB-OPCMSESCSA-N
13476	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1058	Dihydrotachysterol	Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10	hytakerol	DRUGBANK	DB01070	C28H46O	small molecule	A11CC02	67-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILYCWAKSDCYMBB-OPCMSESCSA-N
13477	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Gallagher JC (2010)	20525913	173579	1058	Dihydrotachysterol	Dihydrotachysterolum|Vitamin D4|Dihydrotachysterol|AT 10|Dihidrotaquisterol|Anti-tetany substance 10	hytakerol	DRUGBANK	DB01070	C28H46O	small molecule	A11CC02	67-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILYCWAKSDCYMBB-OPCMSESCSA-N
13478	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wiseman LR (1996)	8808167	179982	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13479	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yakuo I (1994)	7511558	179983	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13480	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wang YJ (2002)	12244568	179984	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13481	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	ter Laak AM (1995)	7650688	179985	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13482	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nicholson AN (1983)	6418550	179986	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13483	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nakamura K (1998)	9454781	179987	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13484	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1059	Mequitazine	Mequitazinum|Mequitazina|Kitazemin	-	DRUGBANK	DB01071	C20H22N2S	small molecule	R06AD07	29216-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKDBMAJZXIPGC-UHFFFAOYSA-N
13485	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dierynck I (2007)	17928344	179988	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13486	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Lopez-Cortes LF (2008)	20116610	179989	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13487	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Chen X (2002)	11752352	171740	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13488	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dandache S (2007)	17638694	174467	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13489	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Le Tiec C (2005)	16176117	179994	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13490	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wood R (2008)	19053892	179993	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13491	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Menendez-Arias L (2008)	18054799	179992	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13492	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Busti AJ (2004)	15585441	179991	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13493	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Pyrko P (2007)	18006837	179990	1060	Atazanavir	ATV|Atazanavirum|Zrivada|ATZ|Latazanavir	reyataz|evotaz	DRUGBANK	DB01072	C38H52N6O7	small molecule	J05AR15|J05AE08	198904-31-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXRYRYVKAWYZBR-GASGPIRDSA-N
13494	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Lech-Maranda E (2009)	19519505	177447	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13495	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13496	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Robak T (2009)	19325518	179995	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13497	112154	6240	-	RRM1	R1|RIR1|RR1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13498	108001	1633	-	DCK	-	9606	Homo sapiens	agonist	target	Jordheim LP (2005)	15820918	179997	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13499	108001	1633	-	DCK	-	9606	Homo sapiens	agonist	target	Yao L (2010)	20137114	179996	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13500	108001	1633	-	DCK	-	9606	Homo sapiens	agonist	target	Zhang Y (2006)	16421443	179998	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13501	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Lech-Maranda E (2009)	19519505	177447	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13502	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13503	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Robak T (2009)	19325518	179995	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13504	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13505	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Robak T (2006)	17168705	179999	1061	Fludarabine	2-fluoro ARA-A|2-F-ARAA	fludarabine phosphate for inje	DRUGBANK	DB01073	C10H12FN5O4	small molecule	L01BB05	21679-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-FJFJXFQQSA-N
13506	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13507	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13508	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13509	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Ashrafian H (2007)	17445089	180001	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13510	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Unger SA (2005)	16306812	180000	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13511	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Kennedy JA (1996)	8694852	180003	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13512	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor	target	Kennedy JA (2000)	11117381	180002	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13513	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	inhibitor	target	Unger SA (2005)	16306812	180000	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13514	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	inhibitor	target	Kennedy JA (1996)	8694852	180003	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13515	107767	1376	-	CPT2	CPT1|CPTASE|IIAE4	9606	Homo sapiens	inhibitor	target	Kennedy JA (2000)	11117381	180002	1062	Perhexiline	Perhexilinum|Perhexilline|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilene|(-)-2-(2,2-Dicyclohexylethyl)piperidine|2-(2,2-Dicyclohexylethyl)piperidine|Perhexiline|Perhexilina	-	DRUGBANK	DB01074	C19H35N	small molecule	C08EX02	6621-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYXKNKQEMFBLER-UHFFFAOYSA-N
13516	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kesiova M (2006)	16702624	179145	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13517	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13518	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wang Z (2007)	17196194	180008	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13519	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hasala H (2007)	17390763	180005	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13520	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Havas TE (1986)	2878016	180004	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13521	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Piao H (2007)	17169617	180007	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13522	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ishikawa T (2007)	17329841	180006	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
13523	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13524	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Davidson MH (2002)	12769127	180009	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13525	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Boesel J (2005)	15748157	180012	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13526	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Jafari M (2003)	12808485	180013	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13527	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Baxter JD (2004)	15109613	180010	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13528	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Maejima T (2004)	15474503	180011	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13529	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Chauvin B (2013)	23703578	180014	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13530	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Hu W (2007)	17327465	175679	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13531	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Taldone T (2008)	18068977	180015	1064	Atorvastatin	Lipovastatinklonal	caduet|ran-atorvastatin|mar-at	DRUGBANK	DB01076	C33H34FN2O5	small molecule	C10AA05|C10BX03|C10BA05|C10BX06|C10BX08|C10BX11	134523-00-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKUURHRXDUEBC-UHFFFAOYNA-M
13532	107007	523	-	ATP6V1A	ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1	9606	Homo sapiens	inhibitor	target	David P (1996)	8889850	177442	1065	Etidronic acid	Acetodiphosphonic acid|1,1,1-Ethanetriol diphosphonate|acidum etidronicum|acide tidronique|Etidronsure|cido etidrnico|(1-hydroxy-ethylidene)diphosphonic acid|Etidronate|1-Hydroxyethane-1,1-diphosphonic acid|1-Hydroxyethylidene-1,1-diphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonic acid|(1-Hydroxyethylidene)bis(phosphonic acid)|1-Hydroxyethane-1,1-bisphosphonic acid|Hydroxyethanediphosphonic acid|1-Hydroxyethylidene-1,1-bisphosphonate|1-hydroxyethane 1,1-diphosphonic acid|1-Hydroxyethanediphosphonic acid|Oxyethylidenediphosphonic acid|1-Hydroxyethane-1,1-diphosphonate|Ethane-1-hydroxy-1,1-bisphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonate|1-Hydroxy-1,1-diphosphonoethane|(1-Hydroxyethylidene)diphosphonic acid|EHDP|HEDP|(Hydroxyethylidene)diphosphonic acid|(1-Hydroxyethylidene)bisphosphonic acid|(1-Hydroxyethylene)diphosphonic acid	act etidronate|didrocal|mylan-	DRUGBANK	DB01077	C2H8O7P2	small molecule	M05BA01|M05BB01	2809-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBVJJBKOTRCVKF-UHFFFAOYSA-N
13533	111766	5802	-	PTPRS	PTPSIGMA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1065	Etidronic acid	Acetodiphosphonic acid|1,1,1-Ethanetriol diphosphonate|acidum etidronicum|acide tidronique|Etidronsure|cido etidrnico|(1-hydroxy-ethylidene)diphosphonic acid|Etidronate|1-Hydroxyethane-1,1-diphosphonic acid|1-Hydroxyethylidene-1,1-diphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonic acid|(1-Hydroxyethylidene)bis(phosphonic acid)|1-Hydroxyethane-1,1-bisphosphonic acid|Hydroxyethanediphosphonic acid|1-Hydroxyethylidene-1,1-bisphosphonate|1-hydroxyethane 1,1-diphosphonic acid|1-Hydroxyethanediphosphonic acid|Oxyethylidenediphosphonic acid|1-Hydroxyethane-1,1-diphosphonate|Ethane-1-hydroxy-1,1-bisphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonate|1-Hydroxy-1,1-diphosphonoethane|(1-Hydroxyethylidene)diphosphonic acid|EHDP|HEDP|(Hydroxyethylidene)diphosphonic acid|(1-Hydroxyethylidene)bisphosphonic acid|(1-Hydroxyethylene)diphosphonic acid	act etidronate|didrocal|mylan-	DRUGBANK	DB01077	C2H8O7P2	small molecule	M05BA01|M05BB01	2809-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBVJJBKOTRCVKF-UHFFFAOYSA-N
13534	111766	5802	-	PTPRS	PTPSIGMA	9606	Homo sapiens	inhibitor	target	Schmidt A (1996)	8610169	177441	1065	Etidronic acid	Acetodiphosphonic acid|1,1,1-Ethanetriol diphosphonate|acidum etidronicum|acide tidronique|Etidronsure|cido etidrnico|(1-hydroxy-ethylidene)diphosphonic acid|Etidronate|1-Hydroxyethane-1,1-diphosphonic acid|1-Hydroxyethylidene-1,1-diphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonic acid|(1-Hydroxyethylidene)bis(phosphonic acid)|1-Hydroxyethane-1,1-bisphosphonic acid|Hydroxyethanediphosphonic acid|1-Hydroxyethylidene-1,1-bisphosphonate|1-hydroxyethane 1,1-diphosphonic acid|1-Hydroxyethanediphosphonic acid|Oxyethylidenediphosphonic acid|1-Hydroxyethane-1,1-diphosphonate|Ethane-1-hydroxy-1,1-bisphosphonic acid|Ethane-1-hydroxy-1,1-diphosphonate|1-Hydroxy-1,1-diphosphonoethane|(1-Hydroxyethylidene)diphosphonic acid|EHDP|HEDP|(Hydroxyethylidene)diphosphonic acid|(1-Hydroxyethylidene)bisphosphonic acid|(1-Hydroxyethylene)diphosphonic acid	act etidronate|didrocal|mylan-	DRUGBANK	DB01077	C2H8O7P2	small molecule	M05BA01|M05BB01	2809-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBVJJBKOTRCVKF-UHFFFAOYSA-N
13535	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Zhao YN (2005)	16319518	180016	1066	Deslanoside	(3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide|Desacetyllanatoside C|Deslanosido|Deacetyllanatoside C|Deslanosidum|3-[(O-beta-D-Glucopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3beta,5beta,12beta-card-20(22)-enolide|Glucodigoxin	-	DRUGBANK	DB01078	C47H74O19	small molecule	C01AA07	17598-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBATZBGFDSVCJD-LALPQLPRSA-N
13536	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1066	Deslanoside	(3beta,5beta,12beta)-3-{[beta-D-glucopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide|Desacetyllanatoside C|Deslanosido|Deacetyllanatoside C|Deslanosidum|3-[(O-beta-D-Glucopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-3beta,5beta,12beta-card-20(22)-enolide|Glucodigoxin	-	DRUGBANK	DB01078	C47H74O19	small molecule	C01AA07	17598-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBATZBGFDSVCJD-LALPQLPRSA-N
13537	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13538	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Kamm MA (2002)	11876686	180021	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13539	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Corsetti M (2002)	12150698	180020	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13540	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13541	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Camilleri M (2001)	11207504	180018	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13542	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Cole P (2004)	15645012	180019	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13543	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	partial agonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13544	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Kamm MA (2002)	11876686	180021	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13545	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Corsetti M (2002)	12150698	180020	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13546	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13547	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Camilleri M (2001)	11207504	180018	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13548	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Cole P (2004)	15645012	180019	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13549	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	antagonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13550	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13551	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Beattie DT (2004)	15466450	180017	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13552	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Greenwood-Van Meerveld B (2006)	16629860	180023	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13553	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	McCullough JL (2006)	16495076	180022	1067	Tegaserod	tgasrod|1-(((5-Methoxyindol-3-yl)methylene)amino)-3-pentylguanidine|tegaserodum	-	DRUGBANK	DB01079	C16H23N5O	small molecule	A06AX06	145158-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKBKZGMPCYNSLU-RGVLZGJSSA-N
13554	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Valdizan EM (1999)	10206175	180027	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13555	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	French JA (1999)	10530689	180026	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13556	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Molina PE (1999)	10503933	180025	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13557	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Arndt CF (1999)	10214744	180024	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13558	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13559	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	inhibitor	target	Weber OM (1999)	10195585	180028	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13560	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Tyacke RJ (2010)	20655489	180029	1068	Vigabatrin	gamma-Vinyl GABA|Vinyl gamma-aminobutyric acid|Vigabatrine|GVG|Vigabatrina|Vigabatrinum|gamma-Vinyl-gamma-aminobutyric acid|4-Amino-5-hexenoic acid|Vigabatrin|Gamma vinyl GABA	sabril pwr 1g/sachet|sabril pw	DRUGBANK	DB01080	C6H11NO2	small molecule	N03AG04	68506-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJDFLNIOAUIZSL-UHFFFAOYSA-N
13561	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Coupar IM (1995)	8583364	180030	1069	Diphenoxylate	Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate	diphenoxylate hcl and atropine	DRUGBANK	DB01081	C30H32N2O2	small molecule	A07DA01	915-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYPPXZBJBPSRLK-UHFFFAOYSA-N
13562	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Coupar IM (1995)	8583364	180030	1069	Diphenoxylate	Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate	diphenoxylate hcl and atropine	DRUGBANK	DB01081	C30H32N2O2	small molecule	A07DA01	915-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYPPXZBJBPSRLK-UHFFFAOYSA-N
13563	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	De Luca A (1993)	8386327	180031	1069	Diphenoxylate	Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate	diphenoxylate hcl and atropine	DRUGBANK	DB01081	C30H32N2O2	small molecule	A07DA01	915-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYPPXZBJBPSRLK-UHFFFAOYSA-N
13564	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Baker DE (2008)	18192961	178628	1069	Diphenoxylate	Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate	diphenoxylate hcl and atropine	DRUGBANK	DB01081	C30H32N2O2	small molecule	A07DA01	915-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYPPXZBJBPSRLK-UHFFFAOYSA-N
13565	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1069	Diphenoxylate	Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate	diphenoxylate hcl and atropine	DRUGBANK	DB01081	C30H32N2O2	small molecule	A07DA01	915-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYPPXZBJBPSRLK-UHFFFAOYSA-N
13566	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Corazziari E (1999)	10202212	180032	1069	Diphenoxylate	Difenossilato|Diphenoxylatum|2,2-Diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile|Difenoxilato|4-Ethoxycarbonyl-alpha,alpha,4-triphenyl-1-piperidinebutyronitrile|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotate|1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester|Ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylate	diphenoxylate hcl and atropine	DRUGBANK	DB01081	C30H32N2O2	small molecule	A07DA01	915-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYPPXZBJBPSRLK-UHFFFAOYSA-N
13569	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Mieskes KT (2001)	11357996	180034	1070	Streptomycin	Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM	streptomycin sulfate injection	DRUGBANK	DB01082	C21H39N7O12	small molecule	J04AM01|A07AA04|A07AA54|J01GA01	57-92-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCSJYZPVAKXKNQ-HZYVHMACSA-N
13570	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Kenney TJ (1994)	7928982	180033	1070	Streptomycin	Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM	streptomycin sulfate injection	DRUGBANK	DB01082	C21H39N7O12	small molecule	J04AM01|A07AA04|A07AA54|J01GA01	57-92-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCSJYZPVAKXKNQ-HZYVHMACSA-N
13571	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Fukuda M (1997)	9364810	180035	1070	Streptomycin	Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM	streptomycin sulfate injection	DRUGBANK	DB01082	C21H39N7O12	small molecule	J04AM01|A07AA04|A07AA54|J01GA01	57-92-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCSJYZPVAKXKNQ-HZYVHMACSA-N
13572	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Bray GA (2008)	18987274	180041	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13573	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Henness S (2006)	16956313	180040	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13574	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Curran MP (2004)	15563254	180043	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13575	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Nelson RH (2005)	16259579	180042	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13576	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Heck AM (2000)	10730683	180038	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13577	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Ballinger A (2002)	12007529	180039	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13578	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Wong NN (2001)	11728255	180036	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13579	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	inhibitor	target	Drew BS (2008)	18200802	180037	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13580	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Henness S (2006)	16956313	180040	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13581	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Nelson RH (2005)	16259579	180042	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13582	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Uusitupa M (1999)	10095983	180045	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13583	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Leonhardt M (1999)	10338682	180044	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13584	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	McNeely W (1998)	9711448	180047	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13585	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Bray GA (2000)	11054601	180046	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13586	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Gomis Barbara R (2004)	15382615	180049	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13587	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Bray GA (1999)	10932681	180048	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13588	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13589	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Heck AM (2000)	10730683	180038	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13590	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Ballinger A (2002)	12007529	180039	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13591	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Wong NN (2001)	11728255	180036	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13592	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	inhibitor	target	Drew BS (2008)	18200802	180037	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13593	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Purohit VC (2006)	16749788	180052	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13594	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Kremer L (2005)	16091048	180053	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13595	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Kridel SJ (2004)	15026345	180050	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13596	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Knowles LM (2004)	15138278	180051	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13597	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Menendez JA (2005)	15870086	180054	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13598	108488	2194	-	FASN	FAS|OA-519|SDR27X1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1071	Orlistat	(-)-Tetrahydrolipstatin|Xenical|Orlipastat|Orlipastatum|Tetrahydrolipstatin	xenical|xenical 120mg capsule|	DRUGBANK	DB01083	C29H53NO5	small molecule	A08AB01	96829-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHLBNYSZXLDEJQ-FWEHEUNISA-N
13599	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Murota H (2009)	19558341	180056	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13600	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Corrado ME (2004)	15553105	180057	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13601	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sharif NA (1994)	7714409	180055	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13602	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Inagaki N (1998)	9747899	180058	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13603	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Murota H (2008)	18714531	180059	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13604	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yanni JM (1994)	7714410	175868	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13605	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1072	Emedastine	Emedastinum|Emedastine difumarate|1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole|1-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole|1-[2-(Ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazole|EMEDASTINE|Emedastina	emadine	DRUGBANK	DB01084	C17H26N4O	small molecule	S01GX06	87233-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBUZBQVCBVDWKX-UHFFFAOYSA-N
13606	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Figueroa KW (2009)	18824613	180060	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13607	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Sykes DA (2009)	19498041	176248	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13608	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13609	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13610	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Figueroa KW (2009)	18824613	180060	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13611	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Moreno-Vinasco L (2009)	19465517	180061	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13612	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Figueroa KW (2009)	18824613	180060	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13613	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1073	Pilocarpine	(3S,4R)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone|(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone|Pilocarpine	pms-pilocarpine 4%|pilocarpine	DRUGBANK	DB01085	C11H16N2O2	small molecule	N07AX01|S01EB51|S01EB01	92-13-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCHFTSOMWOSFHM-WPRPVWTQSA-N
13614	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1074	Benzocaine	p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina	insect bite relief|benzodent|v	DRUGBANK	DB01086	C9H11NO2	small molecule	R02AD01|D04AB04|N01BA05|C05AD03	94-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFLLBZGZJTVJG-UHFFFAOYSA-N
13615	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Hanck DA (2009)	19661462	180062	1074	Benzocaine	p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina	insect bite relief|benzodent|v	DRUGBANK	DB01086	C9H11NO2	small molecule	R02AD01|D04AB04|N01BA05|C05AD03	94-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFLLBZGZJTVJG-UHFFFAOYSA-N
13616	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1074	Benzocaine	p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina	insect bite relief|benzodent|v	DRUGBANK	DB01086	C9H11NO2	small molecule	R02AD01|D04AB04|N01BA05|C05AD03	94-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFLLBZGZJTVJG-UHFFFAOYSA-N
13617	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Lipkind GM (2005)	16174788	176847	1074	Benzocaine	p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina	insect bite relief|benzodent|v	DRUGBANK	DB01086	C9H11NO2	small molecule	R02AD01|D04AB04|N01BA05|C05AD03	94-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFLLBZGZJTVJG-UHFFFAOYSA-N
13618	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Ahern CA (2008)	17967784	180063	1074	Benzocaine	p-Ethoxycarboxylic Aniline|Benzocainum|Amben ethyl ester|4-aminobenzoic acid ethyl ester|p-Carbethoxyaniline|Ethyl Aminobenzoate|Ethyl p-Aminobenzoate|Ethyl p-Aminophenylcarboxylate|p-(Ethoxycarbonyl)aniline|Benzocaine|Benzocaina	insect bite relief|benzodent|v	DRUGBANK	DB01086	C9H11NO2	small molecule	R02AD01|D04AB04|N01BA05|C05AD03	94-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFLLBZGZJTVJG-UHFFFAOYSA-N
13619	110053	3855	-	KRT7	CK7|K2C7|K7|SCL	9606	Homo sapiens	unknown	target	Heard CM (2003)	12711178	180065	1075	Primaquine	Primachinum|8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline|Neo-quipenyl|Primaquin|8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline|Primachin|6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline|Primaquina|Primaquinum	primaquine|primaquine phosphat	DRUGBANK	DB01087	C15H21N3O	small molecule	P01BA03	90-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INDBQLZJXZLFIT-UHFFFAOYSA-N
13620	110053	3855	-	KRT7	CK7|K2C7|K7|SCL	9606	Homo sapiens	unknown	target	Basso LG (2011)	20713019	180064	1075	Primaquine	Primachinum|8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline|Neo-quipenyl|Primaquin|8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline|Primachin|6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline|Primaquina|Primaquinum	primaquine|primaquine phosphat	DRUGBANK	DB01087	C15H21N3O	small molecule	P01BA03	90-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INDBQLZJXZLFIT-UHFFFAOYSA-N
13621	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	inhibitor	target	Graves PR (2002)	12435804	180066	1075	Primaquine	Primachinum|8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline|Neo-quipenyl|Primaquin|8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline|Primachin|6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline|Primaquina|Primaquinum	primaquine|primaquine phosphat	DRUGBANK	DB01087	C15H21N3O	small molecule	P01BA03	90-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INDBQLZJXZLFIT-UHFFFAOYSA-N
13622	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inducer	target	Schermuly RT (2003)	12952271	180070	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13623	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inducer	target	Wilkens H (2001)	11551870	180069	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13624	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inducer	target	Ghofrani HA (2002)	12441759	180068	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13625	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inducer	target	Grant PG (1988)	2461561	180067	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13626	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Schermuly RT (2003)	12952271	180070	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13627	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Wilkens H (2001)	11551870	180069	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13628	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Ghofrani HA (2002)	12441759	180068	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13629	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inducer	target	Grant PG (1988)	2461561	180067	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13630	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inducer	target	Schermuly RT (2003)	12952271	180070	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13631	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inducer	target	Wilkens H (2001)	11551870	180069	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13632	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inducer	target	Ghofrani HA (2002)	12441759	180068	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13633	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inducer	target	Grant PG (1988)	2461561	180067	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13634	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inducer	target	Schermuly RT (2003)	12952271	180070	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13635	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inducer	target	Wilkens H (2001)	11551870	180069	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13636	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inducer	target	Ghofrani HA (2002)	12441759	180068	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13637	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inducer	target	Grant PG (1988)	2461561	180067	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13638	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Anderson JR (2010)	20395700	180078	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13639	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Krug S (2009)	19475782	180074	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13640	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Schermuly RT (2007)	17257398	180075	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13641	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Tsai AL (1988)	2456096	180076	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13642	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Idzko M (2007)	17273558	180077	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13643	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Takamatsu H (2002)	11792366	180071	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13644	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Mubarak KK (2010)	19683911	180072	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13645	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Crutchley DJ (1992)	1375507	180073	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13646	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Olschewski H (2004)	15163595	175648	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13647	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Nichols WW (1991)	1717784	180082	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13648	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Kerins DM (1992)	1370924	180081	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13649	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Herczenik E (2007)	17510465	180079	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13650	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Nicolini FA (1990)	1689620	180083	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13651	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Nizankowski R (1991)	1726988	180080	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13652	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Walch L (2001)	11739243	180085	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13653	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Sharif NA (2002)	11999132	180084	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13654	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Fulton SC (1976)	11134	180087	1077	Deserpidine	11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum	-	DRUGBANK	DB01089	C32H38N2O8	small molecule	C02LA03|C02AA05	131-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVBMAZKKCSYWQR-WCGOZPBSSA-N
13655	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Loeffler LJ (1979)	574544	180086	1077	Deserpidine	11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum	-	DRUGBANK	DB01089	C32H38N2O8	small molecule	C02LA03|C02AA05	131-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVBMAZKKCSYWQR-WCGOZPBSSA-N
13656	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Erickson JD (1992)	1438304	174389	1077	Deserpidine	11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum	-	DRUGBANK	DB01089	C32H38N2O8	small molecule	C02LA03|C02AA05	131-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVBMAZKKCSYWQR-WCGOZPBSSA-N
13657	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sievert MK (2007)	17559790	174388	1077	Deserpidine	11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum	-	DRUGBANK	DB01089	C32H38N2O8	small molecule	C02LA03|C02AA05	131-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVBMAZKKCSYWQR-WCGOZPBSSA-N
13658	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Naudon L (1995)	8525459	174387	1077	Deserpidine	11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum	-	DRUGBANK	DB01089	C32H38N2O8	small molecule	C02LA03|C02AA05	131-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVBMAZKKCSYWQR-WCGOZPBSSA-N
13659	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Mandela P (2010)	20176067	174386	1077	Deserpidine	11-demethoxyreserpine|Deserpidine|(3beta,16beta,17alpha,18beta,20alpha)-17-Methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|Canescine|Deserpidina|11-desmethoxyreserpine|Harmonyl|Recanescine|Raunormine|Deserpidinum	-	DRUGBANK	DB01089	C32H38N2O8	small molecule	C02LA03|C02AA05	131-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVBMAZKKCSYWQR-WCGOZPBSSA-N
13660	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	antagonist	target	Cachelin AB (1995)	7761270	180088	1078	Pentolinium	Pentolonum|Pentolonium|Pentolineum	-	DRUGBANK	DB01090	C15H32N2	small molecule	-	144-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBSKEQEUFOSDD-UHFFFAOYSA-N
13661	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	antagonist	target	Cachelin AB (1995)	7761270	180088	1078	Pentolinium	Pentolonum|Pentolonium|Pentolineum	-	DRUGBANK	DB01090	C15H32N2	small molecule	-	144-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBSKEQEUFOSDD-UHFFFAOYSA-N
13662	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1078	Pentolinium	Pentolonum|Pentolonium|Pentolineum	-	DRUGBANK	DB01090	C15H32N2	small molecule	-	144-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBSKEQEUFOSDD-UHFFFAOYSA-N
13663	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1078	Pentolinium	Pentolonum|Pentolonium|Pentolineum	-	DRUGBANK	DB01090	C15H32N2	small molecule	-	144-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBSKEQEUFOSDD-UHFFFAOYSA-N
13664	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	McKay DB (1993)	8516349	180089	1078	Pentolinium	Pentolonum|Pentolonium|Pentolineum	-	DRUGBANK	DB01090	C15H32N2	small molecule	-	144-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBSKEQEUFOSDD-UHFFFAOYSA-N
13665	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Cachelin AB (1995)	7761270	180088	1078	Pentolinium	Pentolonum|Pentolonium|Pentolineum	-	DRUGBANK	DB01090	C15H32N2	small molecule	-	144-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBSKEQEUFOSDD-UHFFFAOYSA-N
13666	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Gao PH (2005)	16079485	180092	1079	Butenafine	N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine	dr. scholl's athlete's foot cr	DRUGBANK	DB01091	C23H27N	small molecule	D01AE23	101828-21-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABJKWBDEJIDSJZ-UHFFFAOYSA-N
13667	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Singal A (2008)	18624686	180093	1079	Butenafine	N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine	dr. scholl's athlete's foot cr	DRUGBANK	DB01091	C23H27N	small molecule	D01AE23	101828-21-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABJKWBDEJIDSJZ-UHFFFAOYSA-N
13668	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Iwatani W (1993)	8494375	180090	1079	Butenafine	N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine	dr. scholl's athlete's foot cr	DRUGBANK	DB01091	C23H27N	small molecule	D01AE23	101828-21-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABJKWBDEJIDSJZ-UHFFFAOYSA-N
13669	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Ramam M (2007)	17642865	180091	1079	Butenafine	N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine	dr. scholl's athlete's foot cr	DRUGBANK	DB01091	C23H27N	small molecule	D01AE23	101828-21-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABJKWBDEJIDSJZ-UHFFFAOYSA-N
13670	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1079	Butenafine	N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine	dr. scholl's athlete's foot cr	DRUGBANK	DB01091	C23H27N	small molecule	D01AE23	101828-21-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABJKWBDEJIDSJZ-UHFFFAOYSA-N
13671	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Mukherjee PK (2003)	12499173	178101	1079	Butenafine	N-(P-Tert-butylbenzyl)-N-methyl-1-naphthalenemethylamine|4-Tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine|Butenafina|(4-Tert-butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine|Butenafinum|(4-Tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine|Butenafine	dr. scholl's athlete's foot cr	DRUGBANK	DB01091	C23H27N	small molecule	D01AE23	101828-21-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABJKWBDEJIDSJZ-UHFFFAOYSA-N
13672	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Almotrefi AA (1999)	10593659	180096	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPMXVESGRSUGHW-HBYQJFLCSA-N
13673	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Mentre P (1999)	10541475	180097	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPMXVESGRSUGHW-HBYQJFLCSA-N
13674	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Tao QF (1999)	10567200	180094	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPMXVESGRSUGHW-HBYQJFLCSA-N
13675	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Qazzaz HM (1999)	10564763	180095	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPMXVESGRSUGHW-HBYQJFLCSA-N
13676	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPMXVESGRSUGHW-HBYQJFLCSA-N
13677	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Hawke TJ (1999)	10593655	180098	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPMXVESGRSUGHW-HBYQJFLCSA-N
13678	114015	8435	-	SOAT2	ACACT2|ACAT2|ARGP2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13679	114015	8435	-	SOAT2	ACACT2|ACAT2|ARGP2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13680	114015	8435	-	SOAT2	ACACT2|ACAT2|ARGP2	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13681	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Chung MY (2004)	15114505	180100	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13682	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Wilcox LJ (2001)	11352979	180099	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13683	110641	4547	-	MTTP	ABL|MTP	9606	Homo sapiens	antagonist	target	Wilcox LJ (2001)	11352979	180099	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13684	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1083	Fluvastatin	-	fluvastatin|fluvastatin sodium	DRUGBANK	DB01095	C24H26FNO4	small molecule	C10AA04	93957-54-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLGEFLZQAZZCD-NDDZYTDBNA-N
13685	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Podar K (2009)	19249983	174500	1083	Fluvastatin	-	fluvastatin|fluvastatin sodium	DRUGBANK	DB01095	C24H26FNO4	small molecule	C10AA04	93957-54-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLGEFLZQAZZCD-NDDZYTDBNA-N
13686	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Fukushima R (2007)	17604599	180110	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13687	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13688	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Herrmann ML (2000)	10878294	180111	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13689	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Reitzik M (1975)	1060033	180104	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13690	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Goldenberg MM (1999)	10890256	180105	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13691	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Li EK (2004)	15189743	180106	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13692	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Breedveld FC (2000)	11053058	180107	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13693	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Wozel G (2002)	12063741	180101	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13694	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Fox RI (1998)	9666414	180102	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13695	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Schattenkirchner M (2000)	10878295	180103	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13696	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Prakash A (1999)	10651393	180108	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13697	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Sanders S (2002)	12003373	180109	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13698	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	antagonist	target	Steeghs N (2007)	17103252	180113	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13699	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	antagonist	target	Pytel D (2009)	19149483	180112	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13700	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	antagonist	target	Fukushima R (2007)	17604599	180110	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13701	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Hu W (2007)	17327465	175679	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13702	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	O'Donnell EF (2010)	20957046	180114	1085	Leflunomide	Arava|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|Leflunomide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|Leflunomida|Lefunomide|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide|Leflunomidum	arava 20 mg|arava 10mg|teva-le	DRUGBANK	DB01097	C12H9F3N2O2	small molecule	L04AA13	75706-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHOGYURTWQBHIL-UHFFFAOYSA-N
13703	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	McTaggart F (2001)	11256847	180120	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13704	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Hanefeld M (2001)	11501230	180121	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13705	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Olsson AG (2002)	12481202	180117	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13706	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Carbonell T (2005)	16128575	180116	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13707	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Davidson MH (2002)	11772327	180115	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13708	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Holdgate GA (2003)	12773150	180119	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13709	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chapman MJ (2003)	12539816	180118	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13710	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1086	Rosuvastatin	(3R,5S,6e)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6e)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid	priva-rosuvastatin|crestor - 2	DRUGBANK	DB01098	C22H28FN3O6S	small molecule	C10BA06|C10AA07|C10BX05|C10BX07|C10BX09|C10BX10	287714-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPRHUIZQVSMCRT-VEUZHWNKSA-N
13711	1226461	3643463	C2_05190W_A	CDC21	orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102	237561	Candida albicans	inhibitor	target	Imming P (2006)	17016423	171742	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13712	1226461	3643463	C2_05190W_A	CDC21	orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102	237561	Candida albicans	inhibitor	target	Rehemtulla A (2004)	15274300	182268	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13713	1226461	3643463	C2_05190W_A	CDC21	orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102	237561	Candida albicans	inhibitor	target	Overington JP (2006)	17139284	171741	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13714	1226461	3643463	C2_05190W_A	CDC21	orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102	237561	Candida albicans	inhibitor	target	Wang ZH (1998)	9524100	182267	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13715	1226461	3643463	C2_05190W_A	CDC21	orf6.4652|CaO19.3549|IPF19442.2|Contig4-1753_0001|orf6.102|CaO19.11033|C2_05190W_B|C2_05190W|IPF13364.2|CAWG_04271|CaO6.4652|orf19.3549|orf19.11033|CA2665|TMP1|CaO6.102	237561	Candida albicans	inhibitor	target	Fox BA (1999)	10029312	182266	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13716	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Wyszynski MW (1993)	8441637	180122	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13717	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13718	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13719	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	unknown	target	Shieh FK (2007)	17897676	180123	1087	Flucytosine	5-Fluorocystosine|5-Fluorocytosin|Flucytosine|5-Fluorocytosine|5-Flurocytosine|Fluorcytosine|5-FC|Fluocytosine|Flucytosin|Ancobon (tn)	ancobon|flucytosine	DRUGBANK	DB01099	C4H4FN3O	small molecule	D01AE21|J02AX01	2022-85-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRECTZIEBJDKEO-UHFFFAOYSA-N
13720	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13721	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13722	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Silva MR (2003)	12828573	180126	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13723	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Murphy LL (1999)	10503726	180127	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13724	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Muscat R (1990)	2378927	180124	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13725	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Zarrindast MR (1994)	8082693	180125	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13726	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13727	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Freedman SB (1994)	8301582	176340	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13728	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Wang XB (1990)	2120879	182269	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13729	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Mody I (1984)	6146939	182270	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13730	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Papadopoulos V (1990)	1965307	182271	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13731	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Strobl JS (1990)	2386945	182272	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13732	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Cimino M (1988)	3134891	179132	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13733	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Freedman SB (1994)	8301582	176340	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13734	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Kang J (2001)	11511086	180131	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13735	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Osypenko VM (2001)	11296551	180130	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13736	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Kang J (2000)	10762666	180128	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13737	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Shuba YM (2001)	11377395	180129	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13738	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1089	Capecitabine	Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate	capecitabine|teva-capecitabine	DRUGBANK	DB01101	C15H22FN3O6	small molecule	L01BC06	154361-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAGWJHPBXLXJQN-UORFTKCHSA-N
13739	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Fischel JL (2006)	16926630	180132	1089	Capecitabine	Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate	capecitabine|teva-capecitabine	DRUGBANK	DB01101	C15H22FN3O6	small molecule	L01BC06	154361-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAGWJHPBXLXJQN-UORFTKCHSA-N
13740	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Carlini LE (2005)	15709193	180135	1089	Capecitabine	Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate	capecitabine|teva-capecitabine	DRUGBANK	DB01101	C15H22FN3O6	small molecule	L01BC06	154361-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAGWJHPBXLXJQN-UORFTKCHSA-N
13741	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Eliason JF (2004)	15134221	180134	1089	Capecitabine	Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate	capecitabine|teva-capecitabine	DRUGBANK	DB01101	C15H22FN3O6	small molecule	L01BC06	154361-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAGWJHPBXLXJQN-UORFTKCHSA-N
13742	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Li KM (2005)	15866500	180136	1089	Capecitabine	Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate	capecitabine|teva-capecitabine	DRUGBANK	DB01101	C15H22FN3O6	small molecule	L01BC06	154361-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAGWJHPBXLXJQN-UORFTKCHSA-N
13743	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Patel A (2004)	15132128	180133	1089	Capecitabine	Capecitabina|Capecitabin|Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate|Xeloda|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester|Capecitabinum|Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate	capecitabine|teva-capecitabine	DRUGBANK	DB01101	C15H22FN3O6	small molecule	L01BC06	154361-50-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAGWJHPBXLXJQN-UORFTKCHSA-N
13744	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Abou-Mohamed G (1996)	8723169	180137	1090	Arbutamine	Arbutamina|Arbutaminum	-	DRUGBANK	DB01102	C18H23NO4	small molecule	C01CA22	128470-16-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIRWWTKISYTTBL-SFHVURJKSA-N
13745	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Abou-Mohamed G (1996)	8723169	180137	1090	Arbutamine	Arbutamina|Arbutaminum	-	DRUGBANK	DB01102	C18H23NO4	small molecule	C01CA22	128470-16-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIRWWTKISYTTBL-SFHVURJKSA-N
13746	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1090	Arbutamine	Arbutamina|Arbutaminum	-	DRUGBANK	DB01102	C18H23NO4	small molecule	C01CA22	128470-16-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIRWWTKISYTTBL-SFHVURJKSA-N
13747	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1090	Arbutamine	Arbutamina|Arbutaminum	-	DRUGBANK	DB01102	C18H23NO4	small molecule	C01CA22	128470-16-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIRWWTKISYTTBL-SFHVURJKSA-N
13748	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Abou-Mohamed G (1996)	8723169	180137	1090	Arbutamine	Arbutamina|Arbutaminum	-	DRUGBANK	DB01102	C18H23NO4	small molecule	C01CA22	128470-16-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIRWWTKISYTTBL-SFHVURJKSA-N
13749	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Sastry BV (1999)	10229494	180139	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13750	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Nuttle LC (1999)	10199854	180138	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13751	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Lohmann CH (1999)	10449625	180140	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13752	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Schwartz Z (2000)	10653606	180142	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13753	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Sylvia VL (2001)	11455568	180141	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13754	111350	5334	-	PLCL1	PLCE|PLCL|PLDL1|PPP1R127|PRIP	9606	Homo sapiens	inhibitor	target	Bjoro T (1993)	8469910	180143	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13755	111350	5334	-	PLCL1	PLCE|PLCL|PLDL1|PPP1R127|PRIP	9606	Homo sapiens	inhibitor	target	Biondi C (2001)	11207202	180144	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13756	111350	5334	-	PLCL1	PLCE|PLCL|PLDL1|PPP1R127|PRIP	9606	Homo sapiens	inhibitor	target	Otamiri T (1989)	2551803	180145	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13757	111350	5334	-	PLCL1	PLCE|PLCL|PLDL1|PPP1R127|PRIP	9606	Homo sapiens	inhibitor	target	Noveral JP (1995)	7573467	180146	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13758	111350	5334	-	PLCL1	PLCE|PLCL|PLDL1|PPP1R127|PRIP	9606	Homo sapiens	inhibitor	target	Takuwa N (1991)	1860838	180147	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13759	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Ong WY (2003)	12582837	180148	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13760	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Hellstrand M (2002)	12110374	180149	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13761	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Kim BC (1998)	9480923	180150	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13762	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13763	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Durham LK (2004)	12955294	180159	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13764	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Borkowska A (2003)	12647451	180158	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13765	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rogoz Z (2006)	16963794	180157	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13766	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Benmansour S (2002)	12151556	180156	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13767	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Benmansour S (1999)	10575045	180155	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13768	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Chen F (2005)	15606893	180154	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13769	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Iehle C (1993)	8664165	180153	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13770	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	David DJ (2001)	11243491	180152	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13771	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Muneoka K (2009)	18751896	180151	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13772	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Lemke MR (2007)	17187269	174931	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13773	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13774	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Nemeroff CB (2004)	15181382	180162	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13775	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Goodnick PJ (1998)	9808077	180160	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13776	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Ghanizadeh A (2008)	18664165	180161	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGKDLMBJGBXTGI-SJCJKPOMSA-N
13777	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Heusser K (2006)	16678551	180166	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13778	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Heusser K (2007)	17284621	180167	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13779	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Sharma B (2008)	18671470	180164	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13780	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Birkenfeld AL (2005)	15944869	180165	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13781	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Berke EM (2000)	10929704	180171	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13782	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Birkenfeld AL (2002)	12417543	180163	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13783	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Gomis Barbara R (2004)	15382615	180049	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13784	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13785	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Jordan J (2005)	15685250	180168	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13786	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Krahn LE (2001)	11152984	180169	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13787	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tziomalos K (2009)	19475780	180170	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13788	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Heusser K (2006)	16678551	180166	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13789	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Heusser K (2007)	17284621	180167	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13790	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Sharma B (2008)	18671470	180164	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13791	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Birkenfeld AL (2005)	15944869	180165	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13792	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Berke EM (2000)	10929704	180171	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13793	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Birkenfeld AL (2002)	12417543	180163	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13794	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Vazquez Roque MI (2007)	17544870	180172	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13795	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Gomis Barbara R (2004)	15382615	180049	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13796	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Jordan J (2005)	15685250	180168	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13797	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Krahn LE (2001)	11152984	180169	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13798	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tziomalos K (2009)	19475780	180170	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13799	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Balcioglu A (2000)	10974319	180174	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13800	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Berke EM (2000)	10929704	180171	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13801	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tziomalos K (2009)	19475780	180170	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13802	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Nakagawa T (2001)	15111248	180173	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13803	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Gomis Barbara R (2004)	15382615	180049	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13804	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Krahn LE (2001)	11152984	180169	1093	Sibutramine	Sibutraminum|Butramin|Sibutramina	apo-sibutramine|meridia	DRUGBANK	DB01105	C17H26ClN	small molecule	A08AA10	106650-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNAANXDKBXWMLN-UHFFFAOYSA-N
13805	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sugimoto Y (1999)	10631382	180175	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13806	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chalon P (1996)	8647296	180177	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13807	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yamada M (1998)	9627096	180176	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13808	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13809	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Betancur C (1998)	9551716	180179	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13810	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Akiyoshi M (2002)	11915520	180178	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13811	117153	23620	-	NTSR2	NTR2	9606	Homo sapiens	partial antagonist	target	Chalon P (1996)	8647296	180177	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13812	117153	23620	-	NTSR2	NTR2	9606	Homo sapiens	partial antagonist	target	Richard F (2001)	11723247	180180	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13813	117153	23620	-	NTSR2	NTR2	9606	Homo sapiens	partial antagonist	target	Botto JM (1997)	9080465	180181	1094	Levocabastine	Levocabastina|Levocabastin|Levocabastinum	livostin sus nas 0.5mg/ml|livo	DRUGBANK	DB01106	C26H29FN2O2	small molecule	S01GX02|R01AC02	79516-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCGOMHNNNFPNMX-KYTRFIICSA-N
13814	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13815	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13816	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13817	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	de Fiebre CM (1992)	1352660	180182	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13818	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Naville D (1991)	1944305	180188	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13819	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Suzuki S (1984)	6362415	180189	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13820	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Duffy DM (1994)	7989460	180184	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13821	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Igaz P (2008)	18991633	180185	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13822	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Takahashi M (1990)	2268554	180186	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13823	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Cooke GM (1996)	8809191	180187	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13824	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	inhibitor	target	Mensah-Nyagan AG (1994)	7996177	180183	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13825	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	allosteric modulator	target	Barker S (2006)	16806905	180192	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13826	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2002)	12209583	180191	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13827	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2006)	17109615	180190	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13828	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Naville D (1991)	1944305	180188	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13829	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Suzuki S (1984)	6362415	180189	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13830	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Duffy DM (1994)	7989460	180184	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13831	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Igaz P (2008)	18991633	180185	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13832	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Takahashi M (1990)	2268554	180186	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13833	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Cooke GM (1996)	8809191	180187	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13834	109517	3284	RP5-871G17.2	HSD3B2	HSD3B|HSDB|SDR11E2	9606	Homo sapiens	inhibitor	target	Mensah-Nyagan AG (1994)	7996177	180183	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13835	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	allosteric modulator	target	Barker S (2006)	16806905	180192	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13836	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2002)	12209583	180191	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13837	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	allosteric modulator	target	Puddefoot JR (2006)	17109615	180190	1096	Trilostane	Trilostano|Trilostanum	-	DRUGBANK	DB01108	C20H27NO3	small molecule	H02CA01	13647-35-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVJXBPDAXMEYOA-CXANFOAXSA-N
13838	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Asberg AE (2007)	17651117	180199	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13839	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Maugeri N (2007)	17549299	180198	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13840	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Simonis D (2007)	17458940	180193	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13841	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Gao Y (2005)	15995351	180197	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13842	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Koenig A (1998)	9466983	180196	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13843	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Nelson RM (1993)	7694675	180195	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13844	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Simonis D (2007)	17629851	180194	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13845	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Sun W (2007)	17600786	180206	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13846	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Pappalardo F (2006)	17201083	180205	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13847	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Petitou M (1999)	10201371	180204	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13848	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Schedin-Weiss S (2010)	20816747	180203	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13849	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Chuang YJ (2001)	11278930	180202	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13850	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Gettins PG (2009)	19818773	180201	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13851	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Mirow N (2007)	17537059	180200	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13852	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13853	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Patey SJ (2006)	17004727	180207	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13854	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Rezaie AR (2000)	11369259	180210	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13855	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Ignjatovic V (2006)	17118432	180209	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13856	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Rosenberg RD (1985)	3155697	180208	1097	Heparin	Liquaemin|Unfractionated heparin|Panheprin|Calciparine|Heparinate|Eparina|Heparinic acid|Hep-lock	calcilean inj 20000unit/0.8ml|	DRUGBANK	DB01109	-	small molecule	S01XA14|B01AB01|C05BA03|C05BA53|B01AB51	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
13857	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13858	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Kikuchi K (2005)	15778703	180212	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13859	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13860	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Kikuchi K (2005)	15778703	180212	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13861	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13862	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13863	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Edlind T (2002)	12366848	58606	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13864	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Georgopapadakou NH (1996)	8834867	180214	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13865	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	White TC (1998)	9564569	180215	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13866	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Ghannoum MA (1999)	10515900	180216	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13867	109983	3782	RP11-274N19.1	KCNN3	KCa2.3|SK3|SKCA3|hSK3	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13868	109983	3782	RP11-274N19.1	KCNN3	KCa2.3|SK3|SKCA3|hSK3	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13869	115536	10242	hCG_1646471	KCNMB2	-	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13870	115536	10242	hCG_1646471	KCNMB2	-	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13871	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13872	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Kikuchi K (2005)	15778703	180212	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13873	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13874	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13875	109980	3779	-	KCNMB1	BKbeta1|K(VCA)beta|SLO-BETA|hbeta1|hslo-beta|k(VCA)beta-1|slo-beta-1	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13876	109980	3779	-	KCNMB1	BKbeta1|K(VCA)beta|SLO-BETA|hbeta1|hslo-beta|k(VCA)beta-1|slo-beta-1	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13877	117996	27094	-	KCNMB3	BKBETA3|HBETA3|K(VCA)BETA-3|KCNMB2|KCNMBL|SLO-BETA-3|SLOBETA3	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13878	117996	27094	-	KCNMB3	BKBETA3|HBETA3|K(VCA)BETA-3|KCNMB2|KCNMBL|SLO-BETA-3|SLOBETA3	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13879	109981	3780	-	KCNN1	KCa2.1|SK1|SKCA1|hSK1	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13880	109981	3780	-	KCNN1	KCa2.1|SK1|SKCA1|hSK1	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13881	109982	3781	-	KCNN2	KCa2.2|SK2|SKCA2|SKCa 2|hSK2	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13882	109982	3781	-	KCNN2	KCa2.2|SK2|SKCA2|SKCa 2|hSK2	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13883	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Bogle RG (1994)	7518297	180218	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13884	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Sennequier N (1999)	9873034	180219	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13885	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Dudek RR (1995)	7536941	180220	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13886	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Wolff DJ (1993)	7683652	180217	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13887	118157	27345	-	KCNMB4	-	9606	Homo sapiens	inhibitor	target	Hatton CJ (1996)	8760033	180211	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13888	118157	27345	-	KCNMB4	-	9606	Homo sapiens	inhibitor	target	Alvarez J (1992)	1376313	180213	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13889	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Bogle RG (1994)	7518297	180218	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13890	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Sennequier N (1999)	9873034	180219	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13891	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Dudek RR (1995)	7536941	180220	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13892	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	inhibitor	target	Wolff DJ (1993)	7683652	180217	1098	Miconazole	1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|Monistat iv (tn)|Daktarin iv|Miconazole	aloe vesta antifungal|triple p	DRUGBANK	DB01110	C18H14Cl4N2O	small molecule	S02AA13|J02AB01|G01AF04|A07AC01|D01AC02|D01AC52|A01AB09	22916-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBLEWFAAKGYCD-UHFFFAOYSA-N
13893	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor	target	Weber M (2009)	19066855	136813	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13894	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13895	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13896	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Xin ZC (2003)	12646997	180221	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13897	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Zhu S (2009)	19231363	180222	1101	Papaverine	Mesotina	papaverine hydrochloride injec	DRUGBANK	DB01113	C20H21NO4	small molecule	G04BE02|G04BE52|A03AD01	58-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQYZDYMELSJDRZ-UHFFFAOYSA-N
13898	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hasenoehrl RU (2001)	11640974	180225	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13899	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nicholson AN (1991)	1686208	180224	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13900	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Salata JJ (1995)	8001268	175353	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13901	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yasuda SU (1995)	7648771	180226	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13902	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tagawa M (2001)	11736858	180223	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13903	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13904	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13905	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13906	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1102	Chlorphenamine	Chlorophenylpyridamine|Chlorphenaminum|-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|3-(p-chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|Chlorpheniramine polistirex|Chlorpheniraminum|-(4-chlorophenyl)--(2-pyridyl)propyldimethylamine|Clorfeniramina|Chlorpheniramine|Clorfenamina|2-[p-chloro--[2-(dimethylamino)ethyl]benzyl]pyridine|1-(p-chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|Chlorphenamin	allergy mutli-symptom|children	DRUGBANK	DB01114	C16H19ClN2	small molecule	R06AB54|R06AB04	132-22-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOYKEARSMXGVTM-UHFFFAOYSA-N
13907	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13908	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13909	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13910	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Li GR (2006)	16484345	180227	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13911	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13912	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Morel N (1998)	9846638	175854	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13913	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13914	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inhibitor	target	Bett GC (2008)	18096604	180229	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13915	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Bell DC (2001)	11160515	177389	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13916	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13917	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1103	Nifedipine	Adalat|Nifedipine|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Nifedipres|Nifecard|Nifedipino|Coracten|Nifecor|Procardia|Nifedipinum|Adapine	nifedipine|adalat xl plus|adal	DRUGBANK	DB01115	C17H18N2O6	small molecule	C08CA55|C08CA05|C08GA01	21829-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYIMSNHJOBLJNT-UHFFFAOYSA-N
13918	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1104	Trimethaphan	Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum	-	DRUGBANK	DB01116	C22H25N2OS	small molecule	C02BA01	7187-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHQOEHPMXSHGCL-UHFFFAOYSA-N
13919	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1104	Trimethaphan	Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum	-	DRUGBANK	DB01116	C22H25N2OS	small molecule	C02BA01	7187-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHQOEHPMXSHGCL-UHFFFAOYSA-N
13920	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Loiacono R (1993)	8232788	180230	1104	Trimethaphan	Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum	-	DRUGBANK	DB01116	C22H25N2OS	small molecule	C02BA01	7187-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHQOEHPMXSHGCL-UHFFFAOYSA-N
13921	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Kurenny DE (1994)	7963258	180231	1104	Trimethaphan	Trimetaphan|Trimethaphan|Thimethaphan|Trimetaphanum	-	DRUGBANK	DB01116	C22H25N2OS	small molecule	C02BA01	7187-66-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHQOEHPMXSHGCL-UHFFFAOYSA-N
13922	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Hansen M (2004)	15044733	180236	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13923	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Seymour KK (1994)	7909690	180234	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13924	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Ittarat I (1995)	7726490	180235	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13925	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Seymour KK (1997)	9425362	180232	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13926	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Knecht W (2000)	10658902	180233	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13927	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13928	1210638	3885966	PFF0160c	PFF0160c	-	36329	Plasmodium falciparum	inhibitor	target	Cushion MT (2000)	10681344	180237	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13929	1210638	3885966	PFF0160c	PFF0160c	-	36329	Plasmodium falciparum	inhibitor	target	Chen X (2002)	11752352	171740	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13930	1210638	3885966	PFF0160c	PFF0160c	-	36329	Plasmodium falciparum	inhibitor	target	Ittarat I (1995)	7726490	180235	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13931	1210638	3885966	PFF0160c	PFF0160c	-	36329	Plasmodium falciparum	inhibitor	target	Seymour KK (1994)	7909690	180234	1105	Atovaquone	Acuvel|2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|Mepron|Wellvone	malarone pediatric|mylan-atova	DRUGBANK	DB01117	C22H19ClO3	small molecule	P01AX06	95233-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUCQYCKVKVOKAY-CTYIDZIISA-N
13932	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13933	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Lewalter T (2010)	20221978	180238	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13934	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13935	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Lewalter T (2010)	20221978	180238	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13936	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Doggrell SA (2002)	12083991	180239	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13937	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Wang SP (2008)	18505444	180242	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13938	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Varro A (2004)	14754422	180241	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13939	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Waldhauser KM (2008)	18604229	180240	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13940	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1106	Amiodarone	2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|Amiodarone|Amiodarona|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|Amiodaronum	cordarone intravenous - liq iv	DRUGBANK	DB01118	C25H29I2NO3	small molecule	C01BD01	1951-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYIKLHRQXLHMJQ-UHFFFAOYSA-N
13941	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inducer	target	D'hahan N (1999)	10518593	180243	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13942	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inducer	target	de Lonlay P (2002)	11808879	180247	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13943	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inducer	target	Russ U (2003)	12770942	180246	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13944	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inducer	target	Sakura H (1999)	10581306	180245	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13945	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inducer	target	Shindo T (2000)	10604939	180244	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13946	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Kloeckner U (1989)	2541731	180249	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13947	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	O'Malley D (2003)	12726817	180248	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13948	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	unknown	target	Zhang L (2006)	16446048	180250	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13949	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Lawrence CL (2002)	12086984	174490	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13950	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Comelli M (2007)	17287451	180251	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13951	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Guo W (2007)	17281115	180252	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13952	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13953	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13954	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Scuvee-Moreau J (1997)	9439778	180254	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13955	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Erdemli G (1995)	7585327	180255	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13956	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Erdemli G (1993)	8298083	180256	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13957	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Crepel V (1993)	7681475	180257	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13958	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Domoki F (2004)	15306243	180253	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13959	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Munoz A (2003)	12511769	180258	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13960	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Sekine N (1996)	8612523	180259	1107	Diazoxide	Diazoxidum|Diazossido|Diazoxido|Eudemine|Diazoxide	proglycem|proglycem susp 50mg/	DRUGBANK	DB01119	C8H7ClN2O2S	small molecule	C02DA01|V03AH01	364-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLBFKVLRPITMI-UHFFFAOYSA-N
13961	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Mamputu JC (2004)	14746574	180261	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13962	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Kimura T (2007)	17602961	180260	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13963	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Mamputu JC (2002)	12126787	180263	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13964	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Li L (2006)	17046555	180262	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13965	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	binder	target	Reimann F (2001)	11574406	179962	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13966	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	binder	target	Lawrence CL (2001)	11484080	179963	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13967	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	binder	target	Proks P (2002)	12475777	174487	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13968	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	binder	target	Harrower A (2000)	11078469	179964	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13969	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	binder	target	Gribble FM (2000)	11078468	179965	1108	Gliclazide	1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea|Gliclazida|1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea|Gliclazidum|N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea	sandoz gliclazide|glic|nu-glic	DRUGBANK	DB01120	C15H21N3O3S	small molecule	A10BB09	21187-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOVGTQGAOIONJV-BETUJISGNA-N
13970	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1109	Phenacemide	Phenurone	-	DRUGBANK	DB01121	C9H10N2O2	small molecule	N03AX07	63-98-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPFRXWCVYUEORT-UHFFFAOYSA-N
13971	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1109	Phenacemide	Phenurone	-	DRUGBANK	DB01121	C9H10N2O2	small molecule	N03AX07	63-98-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPFRXWCVYUEORT-UHFFFAOYSA-N
13972	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1109	Phenacemide	Phenurone	-	DRUGBANK	DB01121	C9H10N2O2	small molecule	N03AX07	63-98-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPFRXWCVYUEORT-UHFFFAOYSA-N
13973	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Wong MG (1986)	3959032	180264	1109	Phenacemide	Phenurone	-	DRUGBANK	DB01121	C9H10N2O2	small molecule	N03AX07	63-98-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPFRXWCVYUEORT-UHFFFAOYSA-N
13974	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Papp MI (2006)	15982786	180269	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13975	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Kenakin TP (1985)	2857786	180268	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13976	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13977	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Lockhart B (2001)	11330337	180265	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13978	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Bolognesi ML (2003)	13679187	180267	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13979	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Hodge AS (1992)	1588924	180266	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13980	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Webb GD (1965)	5833399	180270	1110	Ambenonium	Ambenonium base|Ambenonum|Ambenonium	-	DRUGBANK	DB01122	C28H42Cl2N4O2	small molecule	N07AA30	7648-98-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMHBPUNFVFNHJK-UHFFFAOYSA-P
13981	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Valeri AM (1980)	7407200	180272	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13982	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Koehler KA (1974)	4857231	180273	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13983	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	De Cristofaro R (1995)	7837275	180271	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13984	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13985	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Sie P (1991)	1711542	180274	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13986	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Sonder SA (1984)	6722124	180275	1111	Proflavine	3,6-acridinediamine|Proflavina|Diaminoacridine|2,8-Diaminoacridine|Proflavine|Proflavin|Proflavinum|3,6-diaminoacridine	triple dye|perineze triple dye	DRUGBANK	DB01123	C13H11N3	small molecule	-	92-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDVSHHCDHLJJJR-UHFFFAOYSA-N
13987	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Mizuno CS (2008)	18220763	177706	1112	Tolbutamide	3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea	orinase 1gm|novo-butamide 500m	DRUGBANK	DB01124	C12H18N2O3S	small molecule	V04CA01|A10BB03	64-77-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRGJRBPOGGCBT-UHFFFAOYSA-N
13988	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Liu X (1999)	10455193	180278	1112	Tolbutamide	3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea	orinase 1gm|novo-butamide 500m	DRUGBANK	DB01124	C12H18N2O3S	small molecule	V04CA01|A10BB03	64-77-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRGJRBPOGGCBT-UHFFFAOYSA-N
13989	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Proks P (2001)	11226127	180276	1112	Tolbutamide	3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea	orinase 1gm|novo-butamide 500m	DRUGBANK	DB01124	C12H18N2O3S	small molecule	V04CA01|A10BB03	64-77-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRGJRBPOGGCBT-UHFFFAOYSA-N
13990	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	inhibitor	target	Smith PA (1998)	9647478	180277	1112	Tolbutamide	3-(P-Tolyl-4-sulfonyl)-1-butylurea|N-(4-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-tosylurea|N-(4-Methylphenylsulfonyl)-n'-butylurea|N-Butyl-n'-P-toluenesulfonylurea|Tolbutamide|N-(Sulfonyl-P-methylbenzene)-n'-N-butylurea|N-N-Butyl-n'-tosylurea|N-(P-Methylbenzenesulfonyl)-n'-butylurea|1-Butyl-3-(P-methylphenylsulfonyl)urea|1-P-Toluenesulfonyl-3-butylurea|N-Butyl-n'-(4-methylphenylsulfonyl)urea|1-Butyl-3-(P-tolylsulfonyl)urea|Orinase (tn)|N-Butyl-N'-(p-tolylsulfonyl)urea|Tolbutamida|Tolbutamidum|Tolylsulfonylbutylurea	orinase 1gm|novo-butamide 500m	DRUGBANK	DB01124	C12H18N2O3S	small molecule	V04CA01|A10BB03	64-77-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRGJRBPOGGCBT-UHFFFAOYSA-N
13991	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1113	Anisindione	2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione|2-P-Anisyl-1,3-indandione|Anisin indandione|2-(4-Methoxyphenyl)indan-1,3-dione|Anisindionum|Anisindiona|2-(P-Methoxyphenyl)-1,3-indandione|2-(P-Methoxyphenyl)indane-1,3-dione|2-Para-anisyl-1,3-indandione	-	DRUGBANK	DB01125	C16H12O3	small molecule	-	117-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRCFXMGQEVUZFC-UHFFFAOYSA-N
13992	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1113	Anisindione	2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione|2-P-Anisyl-1,3-indandione|Anisin indandione|2-(4-Methoxyphenyl)indan-1,3-dione|Anisindionum|Anisindiona|2-(P-Methoxyphenyl)-1,3-indandione|2-(P-Methoxyphenyl)indane-1,3-dione|2-Para-anisyl-1,3-indandione	-	DRUGBANK	DB01125	C16H12O3	small molecule	-	117-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRCFXMGQEVUZFC-UHFFFAOYSA-N
13993	108945	2677	-	GGCX	VKCFD1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1113	Anisindione	2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione|2-P-Anisyl-1,3-indandione|Anisin indandione|2-(4-Methoxyphenyl)indan-1,3-dione|Anisindionum|Anisindiona|2-(P-Methoxyphenyl)-1,3-indandione|2-(P-Methoxyphenyl)indane-1,3-dione|2-Para-anisyl-1,3-indandione	-	DRUGBANK	DB01125	C16H12O3	small molecule	-	117-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRCFXMGQEVUZFC-UHFFFAOYSA-N
13994	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Rittmaster RS (2009)	19200641	180286	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
13995	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Keam SJ (2008)	18318566	180285	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
13996	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Shah SK (2009)	19091347	180279	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
13997	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Xu Y (2006)	16818707	180283	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
13998	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Goldenberg L (2009)	19543428	180282	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
13999	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Aggarwal S (2010)	19879888	180281	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14000	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Smith AB (2009)	19707263	180280	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14001	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14002	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Rathnayake D (2010)	20426708	180284	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14003	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Rittmaster RS (2009)	19200641	180286	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14004	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Keam SJ (2008)	18318566	180285	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14005	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Shah SK (2009)	19091347	180279	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14006	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Xu Y (2006)	16818707	180283	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14007	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Goldenberg L (2009)	19543428	180282	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14008	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Aggarwal S (2010)	19879888	180281	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14009	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Smith AB (2009)	19707263	180280	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14010	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14011	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Rathnayake D (2010)	20426708	180284	1114	Dutasteride	(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide	teva-dutasteride|med-dutasteri	DRUGBANK	DB01126	C27H30F6N2O2	small molecule	G04CB02|G04CA52	164656-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWJOTENAMICLJG-QWBYCMEYSA-N
14012	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Pietila MP (2006)	16543605	180287	1115	Econazole	(+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate	econazole nitrate topical foam	DRUGBANK	DB01127	C18H15Cl3N2O	small molecule	G01AF05|D01AC03	27220-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-UHFFFAOYSA-N
14013	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Imming P (2006)	17016423	171742	1115	Econazole	(+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate	econazole nitrate topical foam	DRUGBANK	DB01127	C18H15Cl3N2O	small molecule	G01AF05|D01AC03	27220-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-UHFFFAOYSA-N
14014	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Berman HM (2000)	10592235	172122	1115	Econazole	(+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate	econazole nitrate topical foam	DRUGBANK	DB01127	C18H15Cl3N2O	small molecule	G01AF05|D01AC03	27220-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-UHFFFAOYSA-N
14015	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Strushkevich N (2010)	20149798	180289	1115	Econazole	(+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate	econazole nitrate topical foam	DRUGBANK	DB01127	C18H15Cl3N2O	small molecule	G01AF05|D01AC03	27220-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-UHFFFAOYSA-N
14016	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Jackson CJ (2000)	11064188	180288	1115	Econazole	(+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate	econazole nitrate topical foam	DRUGBANK	DB01127	C18H15Cl3N2O	small molecule	G01AF05|D01AC03	27220-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-UHFFFAOYSA-N
14017	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Warrilow AG (2010)	20625155	174707	1115	Econazole	(+-)-Econazole|1-(2,4-Dichloro-beta-((P-chlorobenzyl)oxy)phenethyl)imidazole|Econazole|Econazole Nitrate	econazole nitrate topical foam	DRUGBANK	DB01127	C18H15Cl3N2O	small molecule	G01AF05|D01AC03	27220-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-UHFFFAOYSA-N
14018	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1116	Bicalutamide	Casodex	ag-bicalutamide|ratio-bicaluta	DRUGBANK	DB01128	C18H14F4N2O4S	small molecule	L02BB03	90357-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-UHFFFAOYSA-N
14019	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Wang LG (1998)	10076535	180290	1116	Bicalutamide	Casodex	ag-bicalutamide|ratio-bicaluta	DRUGBANK	DB01128	C18H14F4N2O4S	small molecule	L02BB03	90357-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-UHFFFAOYSA-N
14020	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Bouchal J (2002)	11931851	180291	1116	Bicalutamide	Casodex	ag-bicalutamide|ratio-bicaluta	DRUGBANK	DB01128	C18H14F4N2O4S	small molecule	L02BB03	90357-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-UHFFFAOYSA-N
14021	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Hara T (2003)	12517791	180292	1116	Bicalutamide	Casodex	ag-bicalutamide|ratio-bicaluta	DRUGBANK	DB01128	C18H14F4N2O4S	small molecule	L02BB03	90357-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-UHFFFAOYSA-N
14022	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Laufer M (1999)	10754148	180293	1116	Bicalutamide	Casodex	ag-bicalutamide|ratio-bicaluta	DRUGBANK	DB01128	C18H14F4N2O4S	small molecule	L02BB03	90357-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-UHFFFAOYSA-N
14023	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Chang HC (1999)	10500149	176508	1116	Bicalutamide	Casodex	ag-bicalutamide|ratio-bicaluta	DRUGBANK	DB01128	C18H14F4N2O4S	small molecule	L02BB03	90357-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-UHFFFAOYSA-N
14024	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1117	Rabeprazole	Rabeprazole|Clofezone	rabeprazole|apo-rabeprazole|sa	DRUGBANK	DB01129	C18H21N3O3S	small molecule	A02BC04|A02BC54|M01AA05|M02AA03	117976-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YREYEVIYCVEVJK-UHFFFAOYSA-N
14025	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Carswell CI (2002)	11772142	180294	1117	Rabeprazole	Rabeprazole|Clofezone	rabeprazole|apo-rabeprazole|sa	DRUGBANK	DB01129	C18H21N3O3S	small molecule	A02BC04|A02BC54|M01AA05|M02AA03	117976-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YREYEVIYCVEVJK-UHFFFAOYSA-N
14026	106985	495	-	ATP4A	ATP6A	9606	Homo sapiens	inhibitor	target	Langtry HD (1999)	10551440	180295	1117	Rabeprazole	Rabeprazole|Clofezone	rabeprazole|apo-rabeprazole|sa	DRUGBANK	DB01129	C18H21N3O3S	small molecule	A02BC04|A02BC54|M01AA05|M02AA03	117976-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YREYEVIYCVEVJK-UHFFFAOYSA-N
14027	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Ikonomidis I (2009)	19482847	178735	1118	Prednicarbate	-	dermatop|dermatop emollient cr	DRUGBANK	DB01130	C27H36O8	small molecule	D07AC18	73771-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNPXMHRZILFCKX-KAJVQRHHSA-N
14028	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Boudinot FD (1986)	2879901	178736	1118	Prednicarbate	-	dermatop|dermatop emollient cr	DRUGBANK	DB01130	C27H36O8	small molecule	D07AC18	73771-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNPXMHRZILFCKX-KAJVQRHHSA-N
14029	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1119	Proguanil	N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide	malarone pediatric|mylan-atova	DRUGBANK	DB01131	C11H16ClN5	small molecule	P01BB51|P01BB01	500-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSOLNOMRVKKSON-UHFFFAOYSA-N
14030	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Le Bras J (2003)	12667224	182274	1119	Proguanil	N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide	malarone pediatric|mylan-atova	DRUGBANK	DB01131	C11H16ClN5	small molecule	P01BB51|P01BB01	500-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSOLNOMRVKKSON-UHFFFAOYSA-N
14031	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Tahar R (2001)	11295178	182275	1119	Proguanil	N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide	malarone pediatric|mylan-atova	DRUGBANK	DB01131	C11H16ClN5	small molecule	P01BB51|P01BB01	500-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSOLNOMRVKKSON-UHFFFAOYSA-N
14032	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Kaneko A (1999)	10068594	182276	1119	Proguanil	N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide	malarone pediatric|mylan-atova	DRUGBANK	DB01131	C11H16ClN5	small molecule	P01BB51|P01BB01	500-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSOLNOMRVKKSON-UHFFFAOYSA-N
14033	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Vasconcelos KF (2000)	10998224	182277	1119	Proguanil	N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide	malarone pediatric|mylan-atova	DRUGBANK	DB01131	C11H16ClN5	small molecule	P01BB51|P01BB01	500-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSOLNOMRVKKSON-UHFFFAOYSA-N
14034	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Durand R (2001)	11740746	182273	1119	Proguanil	N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide|1-(P-Chlorophenyl)-5-isopropylbiguanide|Chloroguanide|Proguanilum|Chlorguanide	malarone pediatric|mylan-atova	DRUGBANK	DB01131	C11H16ClN5	small molecule	P01BB51|P01BB01	500-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSOLNOMRVKKSON-UHFFFAOYSA-N
14035	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Miyazaki Y (2004)	15356026	180300	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14036	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14037	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Lehmann JM (1995)	7768881	180298	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14038	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Willson TM (1996)	8576907	180299	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14039	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Sugii S (2009)	20018750	180296	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14040	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Spiegelman BM (1998)	9568680	180297	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14041	107007	523	-	ATP6V1A	ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1	9606	Homo sapiens	inhibitor	target	David P (1996)	8889850	177442	1121	Tiludronate	Tiludronic acid|Acide tiludronique|Tiludronate|Acido tiludronico|Acidum tiludronicum	-	DRUGBANK	DB01133	C7H9ClO6P2S	small molecule	M05BA05	89987-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKJJVAGXPKPDRL-UHFFFAOYSA-N
14042	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	inhibitor	target	Murakami H (1997)	9145236	180301	1121	Tiludronate	Tiludronic acid|Acide tiludronique|Tiludronate|Acido tiludronico|Acidum tiludronicum	-	DRUGBANK	DB01133	C7H9ClO6P2S	small molecule	M05BA05	89987-06-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKJJVAGXPKPDRL-UHFFFAOYSA-N
14043	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1122	Desoxycorticosterone Pivalate	DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate	-	DRUGBANK	DB01134	C26H38O4	small molecule	-	808-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVOIQBFMTVCINR-WWMZEODYSA-N
14044	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1122	Desoxycorticosterone Pivalate	DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate	-	DRUGBANK	DB01134	C26H38O4	small molecule	-	808-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVOIQBFMTVCINR-WWMZEODYSA-N
14045	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1122	Desoxycorticosterone Pivalate	DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate	-	DRUGBANK	DB01134	C26H38O4	small molecule	-	808-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVOIQBFMTVCINR-WWMZEODYSA-N
14046	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Sekihara H (1978)	744157	180302	1122	Desoxycorticosterone Pivalate	DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate	-	DRUGBANK	DB01134	C26H38O4	small molecule	-	808-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVOIQBFMTVCINR-WWMZEODYSA-N
14047	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	agonist	target	Beaumont K (1983)	6227474	180303	1122	Desoxycorticosterone Pivalate	DOCP|DTMA|Desoxycortone Pivalate|Deoxycortone Trimethylacetate|11-deoxycorticosterone pivalate|Desoxycorticosterone Trimethylacetate|Deoxycortone Pivalate|Deoxycorticosterone Pivalate|Deoxycortolone Pivalate|Deoxycorticosterone Trimethylacetate	-	DRUGBANK	DB01134	C26H38O4	small molecule	-	808-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVOIQBFMTVCINR-WWMZEODYSA-N
14048	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14049	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14050	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14051	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2008)	18633030	175926	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14052	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Hou VY (1998)	9523819	174352	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14053	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14054	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1123	Doxacurium chloride	-	nuromax	DRUGBANK	DB01135	C56H78Cl2N2O16	small molecule	M03AC07	106819-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APADFLLAXHIMFU-LGIHQUBZSA-L
14055	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Koshimizu TA (2004)	15306222	180304	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14056	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Okajima K (2004)	14764656	180306	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14057	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Nichols AJ (1991)	1712335	180307	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14058	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Irodova NL (2002)	12360591	180305	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14059	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Maebara C (2002)	12398570	180308	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14060	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Koshimizu TA (2004)	15306222	180304	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14061	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14062	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14063	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Koshimizu TA (2004)	15306222	180304	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14064	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Koshimizu TA (2004)	15306222	180304	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14065	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Van Tassell BW (2008)	18657662	180309	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14066	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	de Boer RA (2001)	11378004	180311	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14067	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Shyu KG (2005)	15732037	180310	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14068	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Shyu KG (2005)	15942707	180313	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14069	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Saijonmaa O (2004)	15071347	180312	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14070	113255	7412	-	VCAM1	CD106|INCAM-100	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14071	113255	7412	-	VCAM1	CD106|INCAM-100	9606	Homo sapiens	inhibitor	target	Chen JW (2004)	15374848	180314	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14072	113255	7412	-	VCAM1	CD106|INCAM-100	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14073	112301	6401	RP1-117P20.2	SELE	CD62E|ELAM|ELAM1|ESEL|LECAM2	9606	Homo sapiens	inhibitor	target	Chen JW (2004)	15374848	180314	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14074	110939	4879	-	NPPB	BNP	9606	Homo sapiens	unknown	target	Richards AM (2001)	11401111	180315	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14075	110939	4879	-	NPPB	BNP	9606	Homo sapiens	unknown	target	Takeda Y (2004)	15325927	180317	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14076	110939	4879	-	NPPB	BNP	9606	Homo sapiens	unknown	target	Ohta Y (2001)	11206715	180316	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14077	110939	4879	-	NPPB	BNP	9606	Homo sapiens	unknown	target	Frantz RP (2005)	15864245	180319	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14078	110939	4879	-	NPPB	BNP	9606	Homo sapiens	unknown	target	Konishi H (2003)	14692707	180318	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14079	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Nichols AJ (1989)	2577144	180320	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14080	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	de Mey C (1994)	7908256	180321	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14081	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Nichols AJ (1989)	2575762	180322	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14082	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Nichols AJ (1991)	1712335	180307	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14083	110798	4718	HLC1	NDUFC2	B14.5b|CI-B14.5b|HLC-1|NADHDH2	9606	Homo sapiens	inhibitor	target	Oliveira PJ (2000)	10666308	180323	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14084	109338	3091	-	HIF1A	HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78	9606	Homo sapiens	modulator	target	Shyu KG (2005)	15732037	180310	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14085	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Koshimizu TA (2004)	15306222	180304	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14086	108964	2697	-	GJA1	AVSD3|CMDR|CX43|GJAL|HLHS1|HSS|ODDD	9606	Homo sapiens	unknown	target	Fan SY (2005)	16563290	180324	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14087	108964	2697	-	GJA1	AVSD3|CMDR|CX43|GJAL|HLHS1|HSS|ODDD	9606	Homo sapiens	unknown	target	Yeh HI (2006)	16448880	180325	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14088	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Kawakami K (2006)	16314852	180326	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14089	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Karle CA (2001)	11164846	180327	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHNVEJMJSYVRP-UHFFFAOYSA-N
14090	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1125	Levofloxacin	(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid|(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid|(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid|L-ofloxacin|Levofloxacine|(S)-Ofloxacin|Ofloxacin S-(-)-form|(-)-Ofloxacin|Levofloxacinum|Levofloxacino	ava-levofloxacin|pms-levofloxa	DRUGBANK	DB01137	C18H20FN3O4	small molecule	J01RA05|J01MA12|A02BD10|S01AE05	100986-85-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSDSWSVVBLHKDQ-JTQLQIEISA-N
14091	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Evers R (2000)	10917554	173398	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14092	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Raggers RJ (1999)	9885294	180328	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14093	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Depeille P (2004)	15044619	180329	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14094	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14095	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Bakos E (2000)	10727523	176911	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14096	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Morrow CS (1998)	9685354	180330	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14097	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Flanagan SD (2002)	11834888	176952	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14098	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Evers R (2000)	10917554	173398	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14099	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Bakos E (2000)	10727523	176911	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14100	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Ito K (2001)	11500505	180333	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14101	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Morrow CS (2000)	11108662	180332	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14102	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Hagos Y (2007)	17229912	180331	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14103	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14104	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14105	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14106	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14107	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Maj J (1977)	309138	180335	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14108	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14109	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14110	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14111	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14112	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14113	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14114	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14115	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Ehlert FJ (1990)	2329499	180337	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14116	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14117	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14118	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14119	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14120	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Beil W (1988)	2897127	180338	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14121	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Ehlert FJ (1990)	2329499	180337	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14122	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14123	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14124	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tashiro M (2004)	15286093	175350	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14125	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Singh H (2007)	17685877	180341	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14126	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tran VT (1981)	7238574	180339	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14127	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14128	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kano M (2004)	15255990	180340	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14129	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14130	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14131	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14132	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Claro E (1986)	3011460	175980	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14133	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14134	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14135	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14136	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14137	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Maj J (1977)	309138	180335	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14138	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14139	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Ehlert FJ (1990)	2329499	180337	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14140	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14141	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14142	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ehlert FJ (1990)	2329499	180337	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14143	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14144	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14145	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14146	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Duncan RS (2007)	17560554	180342	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14147	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14148	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14149	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Stahl SM (2008)	19179941	180334	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14150	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14151	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14152	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Maj J (1977)	309138	180335	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14153	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14154	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Ehlert FJ (1990)	2329499	180337	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14155	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Figueiredo A (1990)	2141000	180336	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14156	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14157	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Maj J (1977)	309138	180335	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14158	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14159	111193	5167	-	ENPP1	ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14160	111193	5167	-	ENPP1	ARHR2|COLED|M6S1|NPP1|NPPS|PC-1|PCA1|PDNP1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14161	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inducer	target	Plasswilm L (2000)	10628381	180343	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14162	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inducer	target	Buschini A (2000)	10995012	137566	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14163	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inducer	target	Santini V (1999)	10553165	180346	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14164	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inducer	target	Capizzi RL (1999)	10348255	180344	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14165	106752	251	-	ALPPL2	ALPG|ALPPL|GCAP	9606	Homo sapiens	inducer	target	Orditura M (1999)	10523712	180345	1131	Amifostine	Ethyol|Amifostinum|Aminopropylaminoethyl Thiophosphate|Amifostina|Amifostine|Apaetp|Gammaphos|Amifostine Ethiofos|SAPEP|Ethiofos|WR-1065	ethyol|amifostine|ethyol - pws	DRUGBANK	DB01143	C5H15N2O3PS	small molecule	V03AF05	20537-88-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKOQGQFVAUAYPM-UHFFFAOYSA-N
14166	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14167	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14168	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Winum JY (2004)	14684332	177906	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14169	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Cleland JC (2008)	19019313	180348	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14170	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Nishimori I (2007)	17228881	180349	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14171	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Giacomotto J (2009)	19648295	180347	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14172	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Lindskog S (1997)	9336012	177908	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14173	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Mincione F (2008)	18336310	175091	1132	Diclofenamide	1,3-disulfamoyl-4,5-dichlorobenzene|1,3-Disulfamyl-4,5-dichlorobenzene|Dichlofenamide|4,5-DICHLOROBENZENE-1,3-disulfonamide|Diclofenamida|Dichlorphenamide|Dichlorophenamide|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|Diclofenamidum|4,5-dichloro-1,3-disulfamoylbenzene|4,5-dichloro-m-benzenedisulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Diclofenamide	daranide|keveyis	DRUGBANK	DB01144	C6H6Cl2N2O4S2	small molecule	S01EC02	120-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJQPMPFPNINLKP-UHFFFAOYSA-N
14174	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Lapa GB (2005)	15627433	180352	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14175	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14176	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nakai T (1991)	1912125	180350	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14177	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Taniguchi K (1991)	1678430	174897	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14178	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14179	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Weis R (2008)	18977145	180351	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14180	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14181	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Lapa GB (2005)	15627433	180352	1134	Diphenylpyraline	1-Methyl-4-hydroxypiperidine benzhydryl ether|4-(Benzhydryloxy)-N-methylpiperidine|Difenilpiralina|Diphenylpyralamine|Diphenylpyralinum|1-Methyl-4-piperidyl benzhydryl ether|4-(Benzhydryloxy)-1-methylpiperidine	biohisdine dm decongestant|ora	DRUGBANK	DB01146	C19H23NO	small molecule	R06AA57|R06AA07	147-20-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWQUZNMMYNAXSL-UHFFFAOYSA-N
14182	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	inducer	target	Imming P (2006)	17016423	171742	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
14183	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	inducer	target	Ruppe E (2006)	16971653	180353	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
14184	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	inducer	target	Overington JP (2006)	17139284	171741	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
14185	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	inducer	target	Guan XZ (2004)	15631796	180354	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
14186	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	inducer	target	Mirelis B (2006)	16792938	175447	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
14187	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14188	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14189	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Abbiati GA (1988)	3247311	180355	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14190	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14191	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Greco KA (2008)	19002123	177129	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14192	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14193	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Abbiati GA (1988)	3247311	180355	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14194	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Uckert S (2000)	10858873	180356	1136	Flavoxate	Flavoxatum|beta-Piperidinoethyl 3-methylflavone-8-carboxylate|2-Piperidinoethyl 3-methylflavone-8-carboxylate|2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate|2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate|Flavoxato|Flavoxate HCI|Flavoxate	pms-flavoxate|flavoxate|urispa	DRUGBANK	DB01148	C24H25NO4	small molecule	G04BD02	15301-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPIUTQOUKAMGCX-UHFFFAOYSA-N
14195	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Owens MJ (1995)	7475971	180359	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14196	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Owen D (1999)	10512149	180358	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14197	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14198	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Taylor DP (1995)	7649970	180360	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14199	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Davis R (1997)	9098663	180357	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14200	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Taylor DP (1995)	7649970	180360	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14201	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14202	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14203	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14204	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14205	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Owens MJ (1995)	7475971	180359	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14206	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14207	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Taylor DP (1995)	7649970	180360	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14208	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Narayan M (1998)	9472845	180361	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14209	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Davis R (1997)	9098663	180357	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14210	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14211	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Davis R (1997)	9098663	180357	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14212	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Meyer JH (1999)	10435395	180364	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14213	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Avila A (2003)	14520130	180365	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14214	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Eckler JR (2003)	12873632	180366	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14215	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Taylor DP (1995)	7649970	180360	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14216	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Hidalgo R (1999)	10220119	180362	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14217	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Horton JC (1999)	10577608	180363	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14218	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14219	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14220	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14221	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Millan MJ (2006)	16433010	175628	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14222	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1137	Nefazodone	Nefazodonum|Nefazodona|1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta2-1,2,4-triazolin-5-one|Nefazodone	serzone-5ht2|nefazodone hydroc	DRUGBANK	DB01149	C25H32ClN5O2	small molecule	N06AX06	83366-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRBKIVRKKCLPHA-UHFFFAOYSA-N
14223	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Abadie C (1996)	8988485	180370	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14224	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Osadchii OE (2007)	17558518	180367	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14225	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Matsumoto K (1994)	7816863	180368	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14226	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sapena R (1996)	8741184	180369	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14227	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Prenner L (2007)	17417877	176146	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14228	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14229	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14230	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Bryan-Lluka LJ (2003)	12837768	180373	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14231	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Zavosh A (1999)	10424850	180372	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14232	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Ordway GA (2005)	15814154	180371	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14233	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Weinshenker D (2002)	12137927	180375	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14234	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Zhu MY (2004)	15002740	180374	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14235	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14236	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14237	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Holmes A (2002)	12464448	180378	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14238	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14239	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Hoffman AF (1998)	9422361	180377	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14240	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Zhou L (2006)	16300628	180376	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14241	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Gould GG (2006)	16140280	174923	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14242	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sawynok J (1999)	10467920	180379	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14243	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14244	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14245	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14246	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14247	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14248	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	binder	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14249	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14250	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Samnick S (2004)	15093822	180382	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14251	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Matsumoto K (1994)	7816863	180368	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14252	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Sapena R (1996)	8741184	180369	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14253	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Mudunkotuwa NT (1996)	8730743	180380	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14254	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Buergi S (2003)	12393876	180381	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14255	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14256	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14257	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14258	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14259	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	binder	target	Paelvimaeki EP (1996)	8876023	176222	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14260	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14261	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14262	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14263	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	binder	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14264	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	binder	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14265	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	binder	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14266	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	inhibitor	target	Zeidan YH (2006)	16803890	180388	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14267	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	inhibitor	target	Hurwitz R (1994)	7945993	180386	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14268	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	inhibitor	target	Kornhuber J (2010)	20502000	180387	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14269	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	inhibitor	target	Koelzer M (2004)	14960314	180384	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14270	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	inhibitor	target	Testai FD (2004)	14689449	180385	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14271	112493	6609	-	SMPD1	ASM|ASMASE|NPD	9606	Homo sapiens	inhibitor	target	Erdreich-Epstein A (2005)	15705795	180383	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14272	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Imming P (2006)	17016423	171742	1141	Sertaconazole	Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo	ertaczo	DRUGBANK	DB01153	C20H15Cl3N2OS	small molecule	G01AF19|D01AC14	99592-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLGKQTAYUIMGRK-UHFFFAOYSA-N
14273	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Overington JP (2006)	17139284	171741	1141	Sertaconazole	Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo	ertaczo	DRUGBANK	DB01153	C20H15Cl3N2OS	small molecule	G01AF19|D01AC14	99592-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLGKQTAYUIMGRK-UHFFFAOYSA-N
14274	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Berman HM (2000)	10592235	172122	1141	Sertaconazole	Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo	ertaczo	DRUGBANK	DB01153	C20H15Cl3N2OS	small molecule	G01AF19|D01AC14	99592-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLGKQTAYUIMGRK-UHFFFAOYSA-N
14275	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Croxtall JD (2009)	19275277	90682	1141	Sertaconazole	Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo	ertaczo	DRUGBANK	DB01153	C20H15Cl3N2OS	small molecule	G01AF19|D01AC14	99592-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLGKQTAYUIMGRK-UHFFFAOYSA-N
14276	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Agut J (1992)	1627191	179759	1141	Sertaconazole	Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo	ertaczo	DRUGBANK	DB01153	C20H15Cl3N2OS	small molecule	G01AF19|D01AC14	99592-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLGKQTAYUIMGRK-UHFFFAOYSA-N
14277	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Agut J (1992)	1627190	179760	1141	Sertaconazole	Sertaconazolum|Demofix|Sertaconazole|Sertaconazol|Ertaczo	ertaczo	DRUGBANK	DB01153	C20H15Cl3N2OS	small molecule	G01AF19|D01AC14	99592-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLGKQTAYUIMGRK-UHFFFAOYSA-N
14278	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Eguchi S (2005)	15852621	180391	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14279	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Kawano T (2004)	14739809	180390	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14280	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Tsutsumi Y (2000)	10754636	180389	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14281	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14282	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14283	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Krasowski MD (1999)	10487207	174567	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14284	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Grasshoff C (2008)	18619475	177194	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14285	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Sugimura M (2002)	11900777	180392	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14286	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Mehta AK (1999)	10209232	174569	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14287	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Yamakura T (2001)	11264449	174568	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14288	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Whiting PJ (2003)	14579514	174584	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14289	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Eguchi S (2005)	15852621	180391	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14290	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Kawano T (2004)	14739809	180390	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14291	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	inhibitor	target	Tsutsumi Y (2000)	10754636	180389	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14292	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	antagonist	target	Slemmer JE (2000)	10991997	180394	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14293	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	antagonist	target	Fryer JD (1999)	9862757	180393	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14294	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Stahl SM (2004)	15361919	180395	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14295	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14296	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Bondarev ML (2003)	12909199	180396	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14297	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mitchell HA (2006)	16893531	174557	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14298	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14299	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14300	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Meyer JH (2002)	12185406	180401	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14301	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Kugaya A (2003)	12589396	180399	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14302	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Szabo Z (2004)	15787205	180398	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14303	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Stahl SM (2004)	15361919	180395	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14304	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Miller DK (2002)	12183670	180400	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14305	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Learned-Coughlin SM (2003)	14550679	180397	1144	Bupropion	Amfebutamone	bupropion hydrochloride (sr)|b	DRUGBANK	DB01156	C13H18ClNO	small molecule	A08AA62|N06AX12	34911-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNPPWIUOZRMYNY-UHFFFAOYSA-N
14306	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Warlick CA (2002)	11752096	182278	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14307	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14308	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Graffner-Nordberg M (2001)	11448221	182280	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14309	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Bertino JR (1999)	10386066	182281	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14310	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Polshakov VI (1999)	10091649	182279	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14311	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Zhu WY (2002)	12416030	182283	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14312	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Sweeney CL (2003)	12649191	182282	1145	Trimetrexate	Trimetrexatum|TMQ|TMX|CI-898|Trimetrexato|Trimetrexate|Neutrexin	neutrexin pws iv 25mg/vial	DRUGBANK	DB01157	C19H23N5O3	small molecule	P01AX07	52128-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOYPYLRCIDNJJB-UHFFFAOYSA-N
14313	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Helms JB (2004)	15121098	180403	1146	Bretylium	2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium	bretylium tosylate 0.2% and de	DRUGBANK	DB01158	C11H17BrN	small molecule	-	59-41-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAQOQKQBGPPFNS-UHFFFAOYSA-N
14314	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Dzimiri N (1992)	1334399	180402	1146	Bretylium	2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium	bretylium tosylate 0.2% and de	DRUGBANK	DB01158	C11H17BrN	small molecule	-	59-41-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAQOQKQBGPPFNS-UHFFFAOYSA-N
14315	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Dzimiri N (1991)	1662173	180405	1146	Bretylium	2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium	bretylium tosylate 0.2% and de	DRUGBANK	DB01158	C11H17BrN	small molecule	-	59-41-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAQOQKQBGPPFNS-UHFFFAOYSA-N
14316	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Tiku PE (1991)	1667290	180404	1146	Bretylium	2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium|N-Ethyl-N,N-dimethyl-2-bromobenzenemethanaminium|(2-Bromobenzyl)ethyldimethylaminium	bretylium tosylate 0.2% and de	DRUGBANK	DB01158	C11H17BrN	small molecule	-	59-41-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAQOQKQBGPPFNS-UHFFFAOYSA-N
14317	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14318	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14319	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14320	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14321	110631	4535	-	ND1	MTND1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14322	110631	4535	-	ND1	MTND1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14323	110631	4535	-	ND1	MTND1	9606	Homo sapiens	inhibitor	target	Hanley PJ (2002)	12411515	178204	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14324	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	allosteric modulator	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14325	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	allosteric modulator	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14326	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	allosteric modulator	target	Schofield CM (2004)	15287733	180406	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14327	119933	54331	-	GNG2	-	9606	Homo sapiens	unknown	target	Milovic S (2004)	15175324	180409	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14328	119933	54331	-	GNG2	-	9606	Homo sapiens	unknown	target	Streiff J (2003)	12826849	180408	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14329	119933	54331	-	GNG2	-	9606	Homo sapiens	unknown	target	Ishizawa Y (2000)	10913255	180410	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14330	119933	54331	-	GNG2	-	9606	Homo sapiens	unknown	target	Yoshimura H (2003)	12657848	180411	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14331	119933	54331	-	GNG2	-	9606	Homo sapiens	unknown	target	Zang WJ (2000)	11961592	180407	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14332	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inhibitor	target	Namba T (2000)	10794813	174523	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14333	109979	3778	RP11-443A13.1	KCNMA1	BKTM|KCa1.1|MaxiK|SAKCA|SLO|SLO-ALPHA|SLO1|bA205K10.1|mSLO1	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14334	132263	387129	-	NPSR1	ASRT2|GPR154|GPRA|NPSR|PGR14|VRR1	9606	Homo sapiens	unknown	target	Ishizawa Y (2002)	11961111	180412	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14335	132263	387129	-	NPSR1	ASRT2|GPR154|GPRA|NPSR|PGR14|VRR1	9606	Homo sapiens	unknown	target	Streiff J (2003)	12826849	180408	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14336	132263	387129	-	NPSR1	ASRT2|GPR154|GPRA|NPSR|PGR14|VRR1	9606	Homo sapiens	unknown	target	Ishizawa Y (2000)	10913255	180410	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14337	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Perouansky M (1996)	8968191	180413	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14338	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Ishizawa Y (2000)	10913255	180410	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14339	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Keller C (2001)	11157886	180414	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14340	109962	3760	-	KCNJ3	GIRK1|KGA|KIR3.1	9606	Homo sapiens	inhibitor	target	Milovic S (2004)	15175324	180409	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14341	109962	3760	-	KCNJ3	GIRK1|KGA|KIR3.1	9606	Homo sapiens	inhibitor	target	Yamakura T (2001)	11465552	180416	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14342	109962	3760	-	KCNJ3	GIRK1|KGA|KIR3.1	9606	Homo sapiens	inhibitor	target	Weigl LG (2001)	11455015	180415	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14343	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Perouansky M (1996)	8968191	180413	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14344	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14345	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Namba T (2000)	10794813	174523	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14346	109984	3783	-	KCNN4	IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14347	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14348	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14349	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Perouansky M (1996)	8968191	180413	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14350	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	inhibitor	target	Milovic S (2004)	15175324	180409	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14351	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	inhibitor	target	Hara K (2005)	16243998	180417	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14352	109978	3777	-	KCNK3	K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1	9606	Homo sapiens	binder	target	Lazarenko RM (2010)	20519544	180418	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14353	109978	3777	-	KCNK3	K2p3.1|OAT1|PPH4|TASK|TASK-1|TBAK1	9606	Homo sapiens	binder	target	Pandit JJ (2010)	20217349	180419	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14354	119456	51305	-	KCNK9	K2p9.1|KT3.2|TASK-3|TASK3	9606	Homo sapiens	binder	target	Lazarenko RM (2010)	20519544	180418	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14355	119456	51305	-	KCNK9	K2p9.1|KT3.2|TASK-3|TASK3	9606	Homo sapiens	binder	target	Pandit JJ (2010)	20217349	180419	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14356	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14357	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14358	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14359	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sakamoto K (1995)	8777582	180420	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14360	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14361	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14362	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14363	121345	57053	-	CHRNA10	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14364	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14365	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Wong K (1993)	8418714	180421	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14366	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14367	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14368	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14369	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Mansbach RS (1995)	7768269	180423	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14370	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wilcox KM (1999)	10078990	180422	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14371	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wilcox KM (2000)	11255924	180425	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14372	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wilcox KM (2001)	11605081	180424	1149	Chloroprocaine	Chloroprocaine|Chlorprocaine|2-Chloroprocaine|Chloroprocain|Cloroprocaina|4-amino-2-Chlorobenzoic acid 2-(diethylamino)ethyl ester|Chloroprocainum	chloroprocaine hydrochloride|n	DRUGBANK	DB01161	C13H19ClN2O2	small molecule	N01BA04	133-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDANGULDQQJODZ-UHFFFAOYSA-N
14373	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Lee E (1997)	9352700	177929	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14374	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chapple CR (1998)	9732824	180426	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14375	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Michel MC (1996)	8736427	177127	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14376	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14377	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Roehrborn CG (2004)	14767264	177132	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14378	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Na YJ (1999)	10503165	177927	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14379	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14380	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Boyle P (2001)	11711348	180428	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14381	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Vincent J (1992)	1358918	180427	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14382	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Simpson P (1985)	2988814	178050	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14383	123351	81033	-	KCNH6	ERG-2|ERG2|HERG2|Kv11.2|hERG-2	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14384	124667	90134	-	KCNH7	ERG3|HERG3|Kv11.3	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14385	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14386	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Thomas D (2004)	15098086	176200	1150	Terazosin	Terazosine|Terazosin|Terazosinum|Terazosina|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine	hytrin-7 tabs 1mg-7 tabs 2mg-1	DRUGBANK	DB01162	C19H25N5O4	small molecule	G04CA03	63590-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCKUSRYTPJJLNI-UHFFFAOYSA-N
14387	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Licht J (1993)	8190989	180429	1151	Amdinocillin	Penicillin HX|Mecillinam	-	DRUGBANK	DB01163	C15H23N3O3S	small molecule	J01CA11	32887-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWWVAEOLVKTZFQ-ISVUSNJMSA-N
14388	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Neu HC (1983)	6311012	180430	1151	Amdinocillin	Penicillin HX|Mecillinam	-	DRUGBANK	DB01163	C15H23N3O3S	small molecule	J01CA11	32887-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWWVAEOLVKTZFQ-ISVUSNJMSA-N
14389	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Divo AA (1988)	2847647	180431	1153	Ofloxacin	Ofloxacine|8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid|Ofloxacino|OFLX|Ofloxacinum	floxin otic|floxin tablets 400	DRUGBANK	DB01165	C18H20FN3O4	small molecule	J01MA01|S02AA16|J01RA09|S01AE01	82419-36-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSDSWSVVBLHKDQ-UHFFFAOYSA-N
14390	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Hong KW (2006)	16472148	180434	1154	Cilostazol	Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole	cilostazol|pletal	DRUGBANK	DB01166	C20H27N5O2	small molecule	B01AC23	73963-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRGUKTPIGVIEKM-UHFFFAOYSA-N
14391	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Schroer K (2002)	12180353	180435	1154	Cilostazol	Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole	cilostazol|pletal	DRUGBANK	DB01166	C20H27N5O2	small molecule	B01AC23	73963-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRGUKTPIGVIEKM-UHFFFAOYSA-N
14392	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1154	Cilostazol	Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole	cilostazol|pletal	DRUGBANK	DB01166	C20H27N5O2	small molecule	B01AC23	73963-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRGUKTPIGVIEKM-UHFFFAOYSA-N
14393	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Mokry J (2008)	19218671	180432	1154	Cilostazol	Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole	cilostazol|pletal	DRUGBANK	DB01166	C20H27N5O2	small molecule	B01AC23	73963-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRGUKTPIGVIEKM-UHFFFAOYSA-N
14394	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Parkkonen J (2008)	18282775	180433	1154	Cilostazol	Cilostazolum|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazole	cilostazol|pletal	DRUGBANK	DB01166	C20H27N5O2	small molecule	B01AC23	73963-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRGUKTPIGVIEKM-UHFFFAOYSA-N
14395	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Carrillo-Munoz AJ (2006)	16964330	174576	1155	Itraconazole	Itrizole (tn)|Itraconazolum|Sporanox (tn)|Oriconazole|Itraconazole|Itraconazol	sporanox oral solution 10mg/ml	DRUGBANK	DB01167	C35H38Cl2N8O4	small molecule	J02AC02	84625-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHVPQPYKVGDNFY-ZPGVKDDISA-N
14396	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Cotrim PC (1999)	10608831	180436	1155	Itraconazole	Itrizole (tn)|Itraconazolum|Sporanox (tn)|Oriconazole|Itraconazole|Itraconazol	sporanox oral solution 10mg/ml	DRUGBANK	DB01167	C35H38Cl2N8O4	small molecule	J02AC02	84625-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHVPQPYKVGDNFY-ZPGVKDDISA-N
14397	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1155	Itraconazole	Itrizole (tn)|Itraconazolum|Sporanox (tn)|Oriconazole|Itraconazole|Itraconazol	sporanox oral solution 10mg/ml	DRUGBANK	DB01167	C35H38Cl2N8O4	small molecule	J02AC02	84625-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHVPQPYKVGDNFY-ZPGVKDDISA-N
14398	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Kietzmann T (2003)	12637567	180441	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14399	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Li J (2003)	12547826	180437	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14400	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Dong Z (2002)	12426127	180438	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14401	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Drobna Z (2003)	12475910	180439	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14402	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	inducer	target	Muscarella DE (2002)	12075113	180440	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14403	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	Dong Z (2002)	12426127	180438	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14404	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inducer	target	He Z (2003)	12529330	180442	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14405	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Tsou TC (2005)	16239170	180445	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14406	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Fauconneau B (2002)	12472888	180444	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14407	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Ivanov VN (2005)	15580309	180446	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14408	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	Wang ZX (2005)	15916724	180443	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14409	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inducer	target	He Z (2003)	12529330	180442	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14410	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	inhibitor	target	Lu J (2007)	17640917	173367	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14411	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Fauconneau B (2002)	12472888	180444	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14412	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Tanaka-Kagawa T (2003)	14674888	180447	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14413	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Jung DK (2003)	14516795	180449	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14414	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Mousa SA (2007)	17158527	180448	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14415	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inducer	target	Felix K (2005)	15849723	180450	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14416	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inducer	target	Chen X (2002)	11752352	171740	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14417	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inducer	target	Ouyang W (2007)	17450217	180452	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14418	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inducer	target	Ouyang W (2005)	16230390	180453	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14419	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inducer	target	Ouyang W (2006)	16387740	180451	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14420	107067	595	-	CCND1	BCL1|D11S287E|PRAD1|U21B31	9606	Homo sapiens	antagonist	target	Hwang BJ (2006)	17005224	180456	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14421	107067	595	-	CCND1	BCL1|D11S287E|PRAD1|U21B31	9606	Homo sapiens	antagonist	target	Ouyang W (2007)	17370311	180454	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14422	107067	595	-	CCND1	BCL1|D11S287E|PRAD1|U21B31	9606	Homo sapiens	antagonist	target	Hyun Park W (2003)	12480548	180455	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14423	107067	595	-	CCND1	BCL1|D11S287E|PRAD1|U21B31	9606	Homo sapiens	antagonist	target	Ouyang W (2005)	16230390	180453	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14424	107067	595	-	CCND1	BCL1|D11S287E|PRAD1|U21B31	9606	Homo sapiens	antagonist	target	Ouyang W (2006)	16387740	180451	1157	Arsenic trioxide	Arsenicum album|Arsenious Acid|White arsenic|Arsenigen Saure|Arseni Trioxydum|Arsenious Acid Anhydride|Arsentrioxide|Arseneous anhydride|Anhydride Arsenieux|Arsenic(III) oxide|Arseneous oxide|Oxyde Arsenieux|Acide Arsenieux|Tetraarsenic hexaoxide|Arsenic Oxidearsenous Trioxide|Arsenic oxide|Arsenolite|Arsenic sesquioxide|Diarsenic trioxide|Arsenic Blanc|Arsenious Trioxide	trisenox	DRUGBANK	DB01169	As2O3	small molecule	L01XX27	1327-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOQADKPFYVWPSE-UHFFFAOYSA-N
14425	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Galli A (1996)	8710929	180457	1158	Guanethidine	N-(2-Perhydroazocin-1-ylethyl)guanidine|Azocine, 1-(2-guanidinoethyl)octahydro-|Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-|guanthidine|guanetidina|2-(1-N,N-Heptamethyleneimino)ethylguanidine|2-(1'-Azacyclooctyl)ethylguanidine|(2-(Octahydro-1-azocinyl)ethyl)guanidine|guanethidinum|Heptamethylenimine, 1-(2-guanidinoethyl)-|(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine	apo guanethidine sulfate tab 1	DRUGBANK	DB01170	C10H22N4	small molecule	C02LF01|C02CC02|S01EX01	55-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGDKVXYNVEAGU-UHFFFAOYSA-N
14426	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Yi E (2005)	16126010	180458	1158	Guanethidine	N-(2-Perhydroazocin-1-ylethyl)guanidine|Azocine, 1-(2-guanidinoethyl)octahydro-|Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-|guanthidine|guanetidina|2-(1-N,N-Heptamethyleneimino)ethylguanidine|2-(1'-Azacyclooctyl)ethylguanidine|(2-(Octahydro-1-azocinyl)ethyl)guanidine|guanethidinum|Heptamethylenimine, 1-(2-guanidinoethyl)-|(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine	apo guanethidine sulfate tab 1	DRUGBANK	DB01170	C10H22N4	small molecule	C02LF01|C02CC02|S01EX01	55-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGDKVXYNVEAGU-UHFFFAOYSA-N
14427	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Joyce PI (2001)	11403930	180459	1158	Guanethidine	N-(2-Perhydroazocin-1-ylethyl)guanidine|Azocine, 1-(2-guanidinoethyl)octahydro-|Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-|guanthidine|guanetidina|2-(1-N,N-Heptamethyleneimino)ethylguanidine|2-(1'-Azacyclooctyl)ethylguanidine|(2-(Octahydro-1-azocinyl)ethyl)guanidine|guanethidinum|Heptamethylenimine, 1-(2-guanidinoethyl)-|(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine	apo guanethidine sulfate tab 1	DRUGBANK	DB01170	C10H22N4	small molecule	C02LF01|C02CC02|S01EX01	55-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGDKVXYNVEAGU-UHFFFAOYSA-N
14428	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1159	Moclobemide	p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid	manerix|nu-moclobemide|manerix	DRUGBANK	DB01171	C13H17ClN2O2	small molecule	N06AG02	71320-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXISWVBGDMDLQ-UHFFFAOYSA-N
14429	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Berlin I (1990)	1705137	180461	1159	Moclobemide	p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid	manerix|nu-moclobemide|manerix	DRUGBANK	DB01171	C13H17ClN2O2	small molecule	N06AG02	71320-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXISWVBGDMDLQ-UHFFFAOYSA-N
14430	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Fulton B (1996)	8875133	180460	1159	Moclobemide	p-Chloro-N-(2-morpholinoethyl)benzamide|Moclobemida|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|Moclobemidum|Moclaime|Moclamine|4-Chlor-N-(2-morpholinoethyl)benzamid|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Aurorix|Moclamide|Moclobemide|Moclobemid	manerix|nu-moclobemide|manerix	DRUGBANK	DB01171	C13H17ClN2O2	small molecule	N06AG02	71320-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXISWVBGDMDLQ-UHFFFAOYSA-N
14431	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	1160	Kanamycin	Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside	-	DRUGBANK	DB01172	C18H36N4O11	small molecule	S01AA24|J01GB04|A07AA08	59-01-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBUJHOSQTJFQJX-LCMAVPODNA-N
14432	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	1160	Kanamycin	Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside	-	DRUGBANK	DB01172	C18H36N4O11	small molecule	S01AA24|J01GB04|A07AA08	59-01-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBUJHOSQTJFQJX-LCMAVPODNA-N
14433	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Amanuma K (2000)	10625393	180463	1160	Kanamycin	Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside	-	DRUGBANK	DB01172	C18H36N4O11	small molecule	S01AA24|J01GB04|A07AA08	59-01-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBUJHOSQTJFQJX-LCMAVPODNA-N
14434	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Stavropoulos TA (2001)	11247671	180462	1160	Kanamycin	Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside	-	DRUGBANK	DB01172	C18H36N4O11	small molecule	S01AA24|J01GB04|A07AA08	59-01-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBUJHOSQTJFQJX-LCMAVPODNA-N
14435	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Gondo Y (1996)	8657204	180464	1160	Kanamycin	Kanamycin A|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|4,6-diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi--D-glucoside	-	DRUGBANK	DB01172	C18H36N4O11	small molecule	S01AA24|J01GB04|A07AA08	59-01-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBUJHOSQTJFQJX-LCMAVPODNA-N
14436	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14437	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Rumore MM (1985)	2578597	180465	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14438	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14439	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14440	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Kornhuber J (1995)	8788072	180466	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14441	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14442	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14443	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Kornhuber J (1995)	8788072	180466	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14444	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14445	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Pubill D (1999)	10344632	180467	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14446	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14447	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Kornhuber J (1995)	8788072	180466	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14448	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14449	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	inhibitor	target	Pubill D (1999)	10344632	180467	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14450	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14451	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Kornhuber J (1995)	8788072	180466	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14452	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1161	Orphenadrine	o-methyldiphenhydramine|o-monomethyldiphenhydramine|Orfenadrina|2-methyldiphenhydramine|ORPHENADRINE|Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine|N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine|Orphenadrinum|beta-Dimethylaminoethyl 2-methylbenzhydryl ether|2-(phenyl-o-tolylmethoxy)ethyldimethylamine|N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine|-dimethylaminoethyl 2-methylbenzhydryl ether|Phenyl-O-tolylmethyl dimethyaminoethyl ether|N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine	norgesic forte|orphenadrine ci	DRUGBANK	DB01173	C18H23NO	small molecule	M03BC51|N04AB02|M03BC01	83-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVYRGXJJSLMXQH-UHFFFAOYSA-N
14453	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14454	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14455	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Jin LJ (2010)	20051697	180468	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14456	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14457	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14458	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14459	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14460	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14461	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14462	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Macdonald RL (1986)	2871724	180469	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14463	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14464	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14465	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14466	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14467	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14468	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14469	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14470	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14471	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14472	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14473	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14474	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14475	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14476	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14477	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14478	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Fabre V (2003)	12876551	180470	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14479	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14480	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Fabre V (2003)	12876551	180470	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14481	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14482	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Zhong H (2009)	19616061	174427	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14483	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14484	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Fabre V (2003)	12876551	180470	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14485	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Burke WJ (2002)	12387707	180471	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14486	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Owens MJ (2001)	11543737	180472	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14487	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Owens JM (2002)	12232544	180473	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14488	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Waugh J (2003)	12665392	180474	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14489	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Sanchez C (2003)	12719960	180475	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14490	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14491	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14492	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Bareggi SR (2007)	17916059	174434	1163	Escitalopram	Escitalopram Oxalate|Esertia|(+)-Citalopram|(S)-Citalopram|S-(+)-Citalopram|S(+)-Citalopram|Escitalopramum	escitalopram oxalate|escitalop	DRUGBANK	DB01175	C20H21FN2O	small molecule	N06AB10	128196-01-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSEQXVZVJXJVFP-FQEVSTJZSA-N
14493	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1164	Cyclizine	1-(Diphenylmethyl)-4-methylpiperazine|Cyclizine|()-1-diphenylmethyl-4-methylpiperazine|(N-Benzhydryl)(n'-methyl)diethylenediamine|Cyclizinum|1-Benzhydryl-4-methylpiperazin|N-methyl-N'-benzhydrylpiperazine|(+-)-1-Diphenylmethyl-4-methylpiperazine|N-Benzhydryl-N'-methylpiperazine|Ciclizina	megral tabs|marzine inj 50mg/m	DRUGBANK	DB01176	C18H22N2	small molecule	R06AE53|R06AE03	82-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVKZSORBKUEBAZ-UHFFFAOYSA-N
14494	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Leza JC (1990)	1983158	180476	1164	Cyclizine	1-(Diphenylmethyl)-4-methylpiperazine|Cyclizine|()-1-diphenylmethyl-4-methylpiperazine|(N-Benzhydryl)(n'-methyl)diethylenediamine|Cyclizinum|1-Benzhydryl-4-methylpiperazin|N-methyl-N'-benzhydrylpiperazine|(+-)-1-Diphenylmethyl-4-methylpiperazine|N-Benzhydryl-N'-methylpiperazine|Ciclizina	megral tabs|marzine inj 50mg/m	DRUGBANK	DB01176	C18H22N2	small molecule	R06AE53|R06AE03	82-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVKZSORBKUEBAZ-UHFFFAOYSA-N
14495	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	inhibitor	target	Bamforth KJ (1992)	1397064	180477	1164	Cyclizine	1-(Diphenylmethyl)-4-methylpiperazine|Cyclizine|()-1-diphenylmethyl-4-methylpiperazine|(N-Benzhydryl)(n'-methyl)diethylenediamine|Cyclizinum|1-Benzhydryl-4-methylpiperazin|N-methyl-N'-benzhydrylpiperazine|(+-)-1-Diphenylmethyl-4-methylpiperazine|N-Benzhydryl-N'-methylpiperazine|Ciclizina	megral tabs|marzine inj 50mg/m	DRUGBANK	DB01176	C18H22N2	small molecule	R06AE53|R06AE03	82-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVKZSORBKUEBAZ-UHFFFAOYSA-N
14496	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1165	Idarubicin	Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin	idarubicin hydrochloride|idamy	DRUGBANK	DB01177	C26H27NO9	small molecule	L01DB06	58957-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXDZDZNSLXDNA-TZNDIEGXSA-N
14497	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Bigioni M (1994)	8036155	180481	1165	Idarubicin	Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin	idarubicin hydrochloride|idamy	DRUGBANK	DB01177	C26H27NO9	small molecule	L01DB06	58957-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXDZDZNSLXDNA-TZNDIEGXSA-N
14498	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Zhou R (1999)	10523799	180480	1165	Idarubicin	Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin	idarubicin hydrochloride|idamy	DRUGBANK	DB01177	C26H27NO9	small molecule	L01DB06	58957-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXDZDZNSLXDNA-TZNDIEGXSA-N
14499	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Gonzalez-Cid M (2002)	11836027	180482	1165	Idarubicin	Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin	idarubicin hydrochloride|idamy	DRUGBANK	DB01177	C26H27NO9	small molecule	L01DB06	58957-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXDZDZNSLXDNA-TZNDIEGXSA-N
14500	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	De Renzo A (1999)	10203104	180478	1165	Idarubicin	Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin	idarubicin hydrochloride|idamy	DRUGBANK	DB01177	C26H27NO9	small molecule	L01DB06	58957-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXDZDZNSLXDNA-TZNDIEGXSA-N
14501	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Willmore E (2002)	12034365	180479	1165	Idarubicin	Idarubicine|4-Demethoxydaunorubicin|(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Idarubicinum|5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-|Idarubicina|4-Demethoxydaunomycin	idarubicin hydrochloride|idamy	DRUGBANK	DB01177	C26H27NO9	small molecule	L01DB06	58957-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXDZDZNSLXDNA-TZNDIEGXSA-N
14502	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1166	Chlormezanone	2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide|Chlormezanonum|2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide|Chlormezanone|(+-)-Chlormezanone|Chlormezanona|Chlormethazanone|()-chlormezanone|Clormezanona	-	DRUGBANK	DB01178	C11H12ClNO3S	small molecule	M03BB52|M03BB72|M03BB02	80-77-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEQAYVWKMWHEJO-UHFFFAOYSA-N
14503	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1166	Chlormezanone	2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide|Chlormezanonum|2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide|Chlormezanone|(+-)-Chlormezanone|Chlormezanona|Chlormethazanone|()-chlormezanone|Clormezanona	-	DRUGBANK	DB01178	C11H12ClNO3S	small molecule	M03BB52|M03BB72|M03BB02	80-77-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEQAYVWKMWHEJO-UHFFFAOYSA-N
14504	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1166	Chlormezanone	2-(P-Chlorphenyl)-3-methyl-1,3-perhydrothiazin-4-on-1,1-dioxide|Chlormezanonum|2-(P-Chlorophenyl)tetrahydro-3-methyl-4H-1,3-thiazin-4-one 1,1-dioxide|Chlormezanone|(+-)-Chlormezanone|Chlormezanona|Chlormethazanone|()-chlormezanone|Clormezanona	-	DRUGBANK	DB01178	C11H12ClNO3S	small molecule	M03BB52|M03BB72|M03BB02	80-77-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEQAYVWKMWHEJO-UHFFFAOYSA-N
14505	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14506	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Zhang YL (1992)	1331331	180483	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14507	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Kamal A (2005)	16061385	180485	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14508	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Ruckdeschel JC (1991)	1845848	180484	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14509	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Terada T (1992)	1334447	180487	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14510	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Iida A (2000)	10783066	180486	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14511	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Kim ND (2010)	20810285	180492	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14512	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Li CM (2010)	20814887	180493	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14513	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Screpanti E (2010)	20657644	180490	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14514	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Alam MA (2009)	19286405	180491	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14515	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Labruere R (2010)	20979080	180489	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14516	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	inhibitor	target	Clark PI (1992)	1411635	180488	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14517	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Wolff J (1991)	2011590	180494	1167	Podofilox	Podophyllinic acid lactone|Podophyllotoxin|9-HYDROXY-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-D][1,3]dioxol-6(5ah)-one|Podofilox|Condylox|(-)-Podophyllotoxin|Podophyllotoxin 7|PPT	wartec|condyline|podofilox|con	DRUGBANK	DB01179	C22H22O8	small molecule	D06BB04	518-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJGVMLPVUAXIQN-KJYZGMDISA-N
14518	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14519	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14520	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14521	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Azhar I (2005)	16431399	180495	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14522	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14523	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14524	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14525	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Mergenthaler J (2001)	11330342	180496	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14526	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Arias C (2003)	12618228	180497	1170	Propafenone	1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|Propafenonum|Propafenona|2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone	mylan-propafenone|propafenone|	DRUGBANK	DB01182	C21H27NO3	small molecule	C01BC03	54063-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWHAUXFOSRPERK-UHFFFAOYSA-N
14527	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Peng X (2007)	17305578	180498	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14528	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	van Dorp E (2007)	17367258	180499	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14529	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14530	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Farooqui M (2006)	16546975	180500	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14531	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14532	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Kakinohana M (2003)	12657847	180501	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14533	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Chudapongse N (2003)	14646257	180502	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14534	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Moncada A (2003)	12650833	180503	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14535	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Breljak D (2003)	12749773	180504	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14536	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Osman AM (2003)	14708857	180505	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14537	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	van Dorp E (2007)	17367258	180499	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14538	107775	1385	-	CREB1	CREB	9606	Homo sapiens	unknown	target	Chartoff EH (2003)	12969258	180508	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14539	107775	1385	-	CREB1	CREB	9606	Homo sapiens	unknown	target	Li J (2003)	12956944	180509	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14540	107775	1385	-	CREB1	CREB	9606	Homo sapiens	unknown	target	Walters CL (2005)	15953421	180510	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14541	107775	1385	-	CREB1	CREB	9606	Homo sapiens	unknown	target	Gao C (2003)	14653953	180506	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14542	107775	1385	-	CREB1	CREB	9606	Homo sapiens	unknown	target	Hawes JJ (2006)	16417577	180507	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14543	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	van Dorp E (2007)	17367258	180499	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14544	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Goodman AJ (2007)	17918759	177914	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14545	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14546	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Helm S (2008)	18354714	177912	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14547	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Spetea M (2003)	12887410	180515	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14548	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Neal CR (2003)	12842269	180514	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14549	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Freye E (1998)	12799988	180513	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14550	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Narita M (2003)	12566163	180512	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14551	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Marek GJ (2003)	12909198	180511	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14552	112954	7099	-	TLR4	ARMD10|CD284|TLR-4|TOLL	9606	Homo sapiens	inhibitor	target	Lewis SS (2012)	22520687	180516	1171	Naloxone	Naloxona|N-Allylnoroxymorphone|Nalossone|Naloxone|L-Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|EN 1530 Base|17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Naloxonum	naloxone hydrochloride|naloxon	DRUGBANK	DB01183	C19H21NO4	small molecule	V03AB15	465-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZHSEJADLWPNLE-GRGSLBFTSA-N
14553	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Ali I (2006)	18970411	180517	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14554	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Osinski MA (2005)	15894081	176541	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14555	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14556	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cavallotti C (2002)	12010185	175759	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14557	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	de Mey C (1991)	1683559	174763	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14558	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Freedman SB (1994)	8301582	176340	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14559	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Mayer M (1975)	173192	180518	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14560	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Smallridge RC (1984)	6439037	180519	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14561	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14562	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Fernandez L (1994)	8119180	180522	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14563	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Kasperk CH (1989)	2521824	180523	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14564	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Kemppainen JA (1999)	10077001	180520	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14565	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Miner JN (2007)	17023534	180521	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14566	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Sledge GW (2000)	10637238	180526	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14567	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Perloff M (1996)	8622076	180527	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14568	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Swain SM (1988)	3058238	180524	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14569	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Pearson OH (1982)	7044524	180525	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14570	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Ingle JN (2006)	16538529	180528	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14571	111603	5618	-	PRLR	HPRL|MFAB|hPRLrI	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14572	111603	5618	-	PRLR	HPRL|MFAB|hPRLrI	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1173	Fluoxymesterone	9-Fluoro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one|Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-|17-Methyl-9-fluoro-11-hydroxytesterone|Fluoxymesteronum|Fluoximesterona|11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-4-androster-3-one|17alpha-Methyl-9alpha-fluoro-11beta-hydroxytesterone|9alpha-Fluoro-11beta-hydroxy-17-methyltestosterone	androxy|halotestin	DRUGBANK	DB01185	C20H29FO3	small molecule	G03BA01	76-43-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLRFCQOZQXIBAB-RBZZARIASA-N
14573	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Huettl P (1991)	1674528	178828	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14574	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14575	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14576	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Mehta MA (2006)	16842172	180531	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14577	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Fuller RW (1985)	2860228	180530	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14578	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14579	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Linazasoro G (1999)	10516878	180532	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14580	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Paturle L (1987)	3828803	180529	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14581	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14582	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14583	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14584	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14585	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14586	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14587	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14588	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14589	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Wachtel H (1991)	1683537	180533	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14590	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14591	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14592	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Cussac D (2008)	18703043	159118	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14593	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14594	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14595	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Cussac D (2008)	18703043	159118	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14596	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14597	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14598	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14599	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14600	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14601	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14602	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14603	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14604	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14605	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14606	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14607	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14608	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14609	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14610	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14611	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Cussac D (2008)	18703043	159118	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14612	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14613	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Niewerth M (2003)	12760852	60390	1176	Ciclopirox	Ciclopiroxum|6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone	ciclodan|taro-ciclopirox|lopro	DRUGBANK	DB01188	C12H17NO2	small molecule	G01AX12|D01AE14	29342-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SCKYRAXSEDYPSA-UHFFFAOYSA-N
14614	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14615	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Kosk-Kosicka D (1993)	8214757	174516	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14616	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14617	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14618	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14619	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14620	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14621	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Grasshoff C (2006)	16973644	174521	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14622	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14623	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14624	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14625	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14626	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Matchett GA (2009)	19298752	174518	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14627	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14628	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14629	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Dildy-Mayfield JE (1996)	8786535	174519	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14630	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14631	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14632	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14633	108833	2559	-	GABRA6	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14634	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14635	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14636	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14637	108834	2560	-	GABRB1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14638	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14639	108842	2568	-	GABRP	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14640	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14641	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14642	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14643	108831	2557	-	GABRA4	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14644	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14645	108835	2561	-	GABRB2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14646	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14647	108839	2565	-	GABRG1	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14648	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14649	108832	2558	-	GABRA5	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14650	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14651	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14652	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14653	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14654	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14655	108829	2555	-	GABRA2	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14656	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14657	108830	2556	-	GABRA3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14658	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14659	108841	2567	-	GABRG3	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14660	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14661	108838	2564	-	GABRE	-	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14662	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Rothman RB (2003)	14515341	176978	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14663	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Wang X (2004)	15266556	180534	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14664	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Eddahibi S (2001)	11259539	180536	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14665	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Russell BR (2001)	11325413	180535	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14666	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Johnson GJ (2003)	14675103	174234	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14667	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Wilson AW (2001)	11198050	180540	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14668	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Vickers SP (2001)	11489456	180537	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14669	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Vickers SP (1999)	10353435	180539	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14670	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Bickerdike MJ (2003)	12678838	180538	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14671	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Tomkins DM (2002)	11888565	180541	1179	Dexfenfluramine	(+)-fenfluramine|(S)-N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine|(S)-fenfluramine|Dextrofenfluramine|Dexfenfluraminum|Dexfenfluramina|D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine|Dexfenfluramine	-	DRUGBANK	DB01191	C12H16F3N	small molecule	A08AA04	3239-44-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBGIVFWFUFKIQN-VIFPVBQESA-N
14672	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Ananthan S (2004)	14998329	180542	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14673	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Chamberlin KW (2007)	17595308	180543	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14674	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Gardell LR (2006)	16343768	180544	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14675	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Lemberg KK (2006)	17006080	180545	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14676	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Spetea M (1998)	9712193	180546	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14677	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Halimi G (2000)	10854833	180547	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14678	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chamberlin KW (2007)	17595308	180543	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14679	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1180	Oxymorphone	Opana|Oxymorphone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorphonum|Numorphan|EN3202|14-Hydroxydihydromorphinone|Oxymorphine	opana|opana er|numorphan injec	DRUGBANK	DB01192	C17H19NO4	small molecule	-	76-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQCNKQCJZOAFTQ-ISWURRPUSA-N
14680	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Varma DR (1999)	10433496	175645	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14681	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Fraysse B (2005)	16268148	180548	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14682	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Lima JJ (1996)	8968966	180549	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14683	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14684	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Abrahamsson T (1989)	2568935	180550	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14685	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Fraysse B (2005)	16268148	180548	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14686	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	van den Meiracker AH (1988)	2453744	180551	1181	Acebutolol	Acebutololum|5'-butyramido-2'-(2-hydroxy-3-isopropylaminopropoxy)acetophenone|3'-acetyl-4'-(2-hydroxy-3-(isopropylamino)propoxy)butyranilide|(+-)-Acebutolol|N-(3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl)butanamide|()-acebutolol|Acebutolol|N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide|Acetobutolol	apo-acebutolol|monitan 400|ace	DRUGBANK	DB01193	C18H28N2O4	small molecule	C07BB04|C07AB04	37517-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOEMGAFJFRBGGG-UHFFFAOYSA-N
14687	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Vullo D (2004)	14971907	174791	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14688	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	Vullo D (2004)	14971907	174791	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14689	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Winum JY (2004)	14684332	177906	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14690	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Herkel U (2001)	11224713	180552	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14691	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Boriack-Sjodin PA (1998)	9865942	180553	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14692	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Ilies M (2000)	11003159	180557	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14693	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Iester M (2008)	19668749	180556	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14694	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Stams T (1998)	9541386	180555	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14695	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	DeSantis L (2000)	10665514	180554	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14696	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Winum JY (2004)	14684332	177906	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14697	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Vullo D (2004)	14971907	174791	1182	Brinzolamide	Azopt|Brinzolamide	sandoz brinzolamide|simbrinza|	DRUGBANK	DB01194	C12H21N3O5S3	small molecule	S01EC04|S01EC54	138890-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCRKCZRJWPKOAR-JTQLQIEISA-N
14698	112234	6329	-	SCN4A	HOKPP2|HYKPP|HYPP|NAC1A|Na(V)1.4|Nav1.4|SkM1	9606	Homo sapiens	inhibitor	target	Desaphy JF (2004)	14608015	180558	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14699	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Shimizu W (2000)	11196553	174870	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14700	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Liu H (2003)	12601084	180559	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14701	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Priori SG (2000)	10961955	180562	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14702	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Benhorin J (2000)	10758053	180563	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14703	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Cerrone M (2001)	11307783	180560	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14704	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Nagatomo T (2000)	10617684	180561	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14705	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14706	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Viswanathan PC (2001)	11535580	180564	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14707	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ramos E (2004)	15272045	180565	1183	Flecainide	(+-)-Flecainide|Flecainida|CCRIS 313|N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide|Flecainidum|Flecaine	flecainide|tambocor|auro-fleca	DRUGBANK	DB01195	C17H20F6N2O3	small molecule	C01BC04	54143-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJBNUMBKLMJRSA-UHFFFAOYSA-N
14708	110303	4130	-	MAP1A	MAP1L|MTAP1A	9606	Homo sapiens	antagonist	target	Stearns ME (1991)	1647395	180566	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14709	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Ho SM (2004)	14755680	180567	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14710	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Tew KD (1983)	6364362	180571	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14711	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	von Schoultz E (1994)	7703721	180570	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14712	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yoshizumi N (1985)	3989343	180568	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14713	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fernoe M (1987)	3314674	180569	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14714	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Friden B (1991)	1908244	180575	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14715	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Tew KD (1983)	6364362	180571	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14716	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Falconer MM (1989)	2679799	180573	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14717	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Moraga D (1992)	1599956	180572	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14718	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Stearns ME (1991)	1647395	180566	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14719	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	antagonist	target	Burns RG (1990)	2125244	180574	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14720	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Williams RN (2005)	15993560	180580	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14721	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Brower GL (2007)	17308006	180581	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14722	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Reinhardt D (2002)	12381651	180579	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14723	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Okada M (2008)	19057128	180578	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14724	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Prontera C (1999)	10328230	180577	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14725	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	inhibitor	target	Yamamoto D (2010)	20184869	180576	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14726	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Natesh R (2004)	15236580	177072	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14727	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14728	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Dalkas GA (2010)	20014331	180582	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14729	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tzakos AG (2006)	16889963	180583	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14730	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14731	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14732	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14733	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Williams RN (2005)	15993560	180580	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14734	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Okada M (2008)	19057128	180578	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14735	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Yamamoto D (2008)	18501888	180584	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14736	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	inhibitor	target	Reinhardt D (2002)	12381651	180579	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14737	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Thunnissen MM (2002)	12207002	152292	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14738	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14739	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Ramerstorfer J (2010)	20303942	180585	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14740	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14741	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14742	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Skerritt JH (1983)	6135616	176313	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14743	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Ramerstorfer J (2010)	20303942	180585	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14744	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14745	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14746	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Ramerstorfer J (2010)	20303942	180585	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14747	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14748	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14749	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14750	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14751	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Skerritt JH (1983)	6135616	176313	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14752	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Ramerstorfer J (2010)	20303942	180585	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14753	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Sanger DJ (2004)	15291009	180586	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14754	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14755	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Gupta RC (1992)	1475066	180588	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14756	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Radic Z (1999)	10421444	176405	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14757	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Radic Z (2001)	11920914	176406	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14758	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Bianchi DA (2005)	15878275	180589	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14759	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Golicnik M (2002)	11823003	180587	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14760	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14761	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14762	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14763	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson Fagerlund M (2009)	19417616	178070	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14764	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Nishimura K (2010)	20338223	180591	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14765	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Wenningmann I (2001)	11562442	180590	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14766	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2008)	18633030	175926	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14767	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Yan D (2006)	16723497	180596	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14768	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Yan D (2002)	12243766	180595	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14769	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Peters JA (1990)	1691468	180594	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14770	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Emerit MB (1993)	7684066	180593	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14771	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Hefft S (1999)	10066903	180592	1187	Tubocurarine	7',12'-Dihydroxy-6,6'-dimethoxy-2,2',2'-trimethyltubocuraranium|d-tubocurarine|(+)-tubocurarine|Tubocurarin	tubocurarine chloride inj 3mg/	DRUGBANK	DB01199	C37H41N2O6	small molecule	M03AA02	57-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFJZZMVDLULRGK-URLMMPGGSA-O
14772	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lahlou S (2000)	10626749	180597	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14773	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14774	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lahlou S (2000)	10721819	180600	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14775	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14776	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14777	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Cavallotti C (2002)	12010185	175759	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14778	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lahlou S (2003)	12753422	180599	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14779	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Stefaneanu L (2001)	11444429	180598	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14780	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14781	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14782	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	de Leeuw van Weenen JE (2010)	20138024	180601	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14783	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14784	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14785	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14786	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14787	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14788	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14789	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14790	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	de Leeuw van Weenen JE (2010)	20138024	180601	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14791	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14792	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14793	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Cussac D (2008)	18703043	159118	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14794	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14795	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14796	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Cussac D (2008)	18703043	159118	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14797	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14798	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14799	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14800	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14801	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Knight JA (2009)	18996971	180602	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14802	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14803	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14804	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14805	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14806	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14807	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	de Leeuw van Weenen JE (2010)	20138024	180601	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14808	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14809	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14810	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14811	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Cussac D (2008)	18703043	159118	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14812	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14813	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	Johannessen Landmark C (2007)	18072813	180609	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14814	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	Gillard M (2006)	16556440	180608	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14815	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	Lambeng N (2006)	16434140	180603	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14816	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	Stahl SM (2004)	15367040	180607	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14817	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	Newton HB (2007)	17431542	180606	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14818	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	Lynch BA (2004)	15210974	180605	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14819	115229	9900	PSEC0174	SV2A	SV2	9606	Homo sapiens	agonist	target	De Smedt T (2007)	17461889	180604	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14820	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	Lukyanetz EA (2002)	11879381	180610	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14821	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	inhibitor	target	De Smedt T (2007)	17461889	180604	1190	Levetiracetam	Levitiracetam|Levetiracetamum|Levetiracetame|Levetiracetam	levetiracetam extended-release	DRUGBANK	DB01202	C8H14N2O2	small molecule	N03AX14	102767-28-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPHUVLMMVZITSG-LURJTMIESA-N
14822	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Ozakca I (2007)	17622774	176145	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14823	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14824	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Liu YL (1995)	8574280	180611	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14825	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1994)	7981009	180612	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14826	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Varma DR (1999)	10433496	175645	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14827	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1992)	1349493	176626	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14828	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Koshiji M (1992)	1354084	180614	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14829	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Varma DR (1999)	10606440	180615	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14830	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14831	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1994)	7981009	180612	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14832	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Wheeldon NM (1994)	7912539	180613	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14833	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Varma DR (1999)	10433496	175645	1191	Nadolol	Corgard	teva-nadolol|nadolol-160 tab 1	DRUGBANK	DB01203	C17H27NO4	small molecule	C07AA12|C07BA12	42200-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWPOSFSPZNDTMJ-UCWKZMIHSA-N
14834	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Wang H (2001)	11278845	180621	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14835	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Takeda K (1998)	9631585	180620	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14836	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	McPherson JP (1998)	9494516	180618	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14837	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Ko MW (2008)	18687447	180619	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14838	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Satherley K (2000)	11004693	180616	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14839	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Mao Y (1999)	10451375	180617	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14840	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
14841	108832	2558	-	GABRA5	-	9606	Homo sapiens	antagonist	target	Clement Y (2009)	19907641	180622	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14842	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	antagonist	target	Whitwam JG (1995)	8693922	180623	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14843	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	antagonist	target	Wingrove PB (2002)	11864636	180625	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14844	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	antagonist	target	Padgett CL (2008)	17974564	180624	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14845	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14846	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Whitwam JG (1995)	8693922	180623	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14847	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Wingrove PB (2002)	11864636	180625	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14848	123515	81551	-	STMN4	RB3	9606	Homo sapiens	antagonist	target	Wu WW (2008)	18162179	180627	1194	Lomustine	Chloroethylcyclohexylnitrosourea|CCNU|Lomustina|Belustine|Cecenu|Cyclohexyl chloroethyl nitrosourea|1-(2-Chloroethyl)-3-cyclohexylnitrosourea|Lomustinum|CeeNU|CINU|1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea|N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea	gleostine|lomustine|ceenu	DRUGBANK	DB01206	C9H16ClN3O2	small molecule	L01AD02	13010-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GQYIWUVLTXOXAJ-UHFFFAOYSA-N
14849	123515	81551	-	STMN4	RB3	9606	Homo sapiens	antagonist	target	Liang XJ (2008)	18593927	180626	1194	Lomustine	Chloroethylcyclohexylnitrosourea|CCNU|Lomustina|Belustine|Cecenu|Cyclohexyl chloroethyl nitrosourea|1-(2-Chloroethyl)-3-cyclohexylnitrosourea|Lomustinum|CeeNU|CINU|1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea|N-(2-Chloroethyl)-n'-cyclohexyl-N-nitrosourea	gleostine|lomustine|ceenu	DRUGBANK	DB01206	C9H16ClN3O2	small molecule	L01AD02	13010-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GQYIWUVLTXOXAJ-UHFFFAOYSA-N
14850	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	De Cree J (1993)	8376914	180632	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14851	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Tytgat GN (2002)	11856082	180630	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14852	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Carty E (2000)	10848666	180631	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14853	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Park SJ (1999)	11270983	180629	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14854	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Unknown Authors (1994)	8313547	180628	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14855	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14856	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Ragni M (1996)	8697470	180633	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14857	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Hempelmann RG (1999)	10522750	180636	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14858	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Soyka R (1994)	8289199	180637	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14859	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Carvalho MH (1997)	9272380	180634	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14860	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Heinisch G (1996)	8831771	180635	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14861	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14862	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1196	Sparfloxacin	Sparfloxacin|cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid	-	DRUGBANK	DB01208	C19H22F2N4O3	small molecule	J01MA09	110871-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZZWHBIBMUVIIW-DTORHVGOSA-N
14863	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14864	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14865	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14866	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Gharagozlou P (2006)	16433932	175227	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14867	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Picker MJ (1997)	9399970	177287	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14868	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Morgan D (1999)	9972766	180642	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14869	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Gharagozlou P (2003)	12513698	180641	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14870	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Jacobs AM (1992)	1361946	180640	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14871	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Barrett AC (2001)	11702089	180638	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14872	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Cook CD (2000)	10958085	180639	1197	Dezocine	Dezocina|Dezocinum|(-)-13beta-amino-5,6,7,8,9,10,11alpha,12-Octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-ol	-	DRUGBANK	DB01209	C16H23NO	small molecule	N02AX03	53648-55-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTMVHDZWSFQSQP-VBNZEHGJSA-N
14873	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sharif NA (2001)	11572462	180647	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14874	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Quast U (1984)	6147147	180646	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14875	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Brooks AM (1992)	1351412	180645	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14876	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Gonzalez JP (1987)	2892662	180644	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14877	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Harris A (1994)	7928182	180643	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14878	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14879	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Lesar TS (1987)	2891463	174265	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14880	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Sharif NA (2001)	11572462	180647	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14881	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Brooks AM (1992)	1351412	180645	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14882	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Gonzalez JP (1987)	2892662	180644	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14883	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Harris A (1994)	7928182	180643	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14884	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chidlow G (2000)	10864881	176628	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14885	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Lesar TS (1987)	2891463	174265	1198	Levobunolol	Levobunololum|Levobunolol|(-)-Bunolol|(S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone	betagan oph soln 0.25%|probeta	DRUGBANK	DB01210	C17H25NO3	small molecule	S01ED03	47141-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXHBTMCLRNMKHZ-LBPRGKRZSA-N
14886	107297	847	-	CAT	-	9606	Homo sapiens	inhibitor	target	Bradford BU (1993)	8423764	38291	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14887	107297	847	-	CAT	-	9606	Homo sapiens	inhibitor	target	Thurman RG (1975)	240743	180649	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14888	107297	847	-	CAT	-	9606	Homo sapiens	inhibitor	target	Handler JA (1988)	3416882	180648	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14889	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	inhibitor	target	Eriksson CJ (2001)	11391066	180650	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14890	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	inhibitor	target	Brent J (2009)	19458366	180651	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14891	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	inhibitor	target	Calello DP (2006)	16871118	180652	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14892	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	inhibitor	target	Betten DP (2006)	16946442	172237	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14893	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	inhibitor	target	Betten DP (2006)	16946442	172237	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14894	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	inhibitor	target	Eriksson CJ (2001)	11391066	180650	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14895	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	inhibitor	target	Brent J (2009)	19458366	180651	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14896	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	inhibitor	target	Calello DP (2006)	16871118	180652	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14897	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	inhibitor	target	Kassam JP (1989)	2573502	180653	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14898	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	inhibitor	target	Yin SJ (1992)	1590750	180654	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14899	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	inhibitor	target	Mukherjee PK (2006)	16790752	71152	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14900	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	inhibitor	target	Betten DP (2006)	16946442	172237	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14901	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	inhibitor	target	Brent J (2009)	19458366	180651	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14902	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	inhibitor	target	Calello DP (2006)	16871118	180652	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14903	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	inhibitor	target	Nussrallah BA (1989)	2789998	180655	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14904	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	inhibitor	target	Nagata H (1996)	8997246	180656	1201	Fomepizole	Fomepizole|Fomepizolum|4-Methylpyrazol|Antizol|Fomepizol|4-methylpyrazole	antizol|fomepizole|fomepizole 	DRUGBANK	DB01213	C4H6N2	small molecule	V03AB34	7554-65-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKMMFOAQPJVMX-UHFFFAOYSA-N
14905	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14906	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14907	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Bilcikova L (1987)	2885244	180658	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14908	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Drimal J (1987)	2895037	180659	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14909	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Arai K (2003)	12967722	180660	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14910	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Noack E (1986)	2876128	180657	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14911	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Bilcikova L (1987)	2885244	180658	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14912	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Drimal J (1987)	2895037	180659	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14913	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14914	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Arai K (2003)	12967722	180660	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14915	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1202	Metipranolol	Metipranolol|Metipranololum|Acetic acid 4-(2-hydroxy-3-isopropylamino-propoxy)-2,3,6-trimethyl-phenyl ester|(+-)-Metipranolol	metipranolol	DRUGBANK	DB01214	C17H27NO4	small molecule	C07BA68|S01ED54|S01ED04	22664-55-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQIPXWYNLPYNHW-UHFFFAOYSA-N
14916	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14917	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14918	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14919	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14920	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14921	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14922	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14923	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14924	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14925	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14926	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14927	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14928	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14929	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14930	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14931	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14932	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14933	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14934	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14935	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14936	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14937	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14938	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14939	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14940	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14941	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14942	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14943	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14944	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14945	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14946	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14947	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14948	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Xu Y (2006)	16818707	180283	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14949	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Goldenberg L (2009)	19543428	180282	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14950	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Smith AB (2009)	19707263	180280	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14951	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Joseph MA (2005)	16019620	180665	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14952	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Ha SJ (2003)	12670724	180664	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14953	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Suzuki R (2010)	20460827	180666	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14954	112594	6716	-	SRD5A2	-	9606	Homo sapiens	inhibitor	target	Bowman CJ (2003)	12773767	180663	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14955	112596	6718	-	AKR1D1	3o5bred|CBAS2|SRD5B1	9606	Homo sapiens	inhibitor	target	Drury JE (2009)	19515843	180667	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14956	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Suzuki R (2010)	20460827	180666	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14957	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Thigpen AE (1992)	1314830	180669	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14958	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Levy MA (1995)	7734398	180668	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14959	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Tian G (1994)	8117686	180670	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14960	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Smith AB (2009)	19707263	180280	1204	Finasteride	Finasteridum|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|Finasterida	auro-finasteride 1mg|act finas	DRUGBANK	DB01216	C23H36N2O2	small molecule	D11AX10|G04CB01|G04CA51	98319-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBEPLOCGEIEOCV-WSBQPABSSA-N
14961	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14962	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Mauras N (2009)	19470631	180678	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14963	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Nabholtz JM (2006)	16439860	180676	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14964	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Gangadhara S (2009)	19753124	180677	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14965	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Santen RJ (2009)	19389994	180674	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14966	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Milani M (2009)	19794821	180675	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14967	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Rugo HS (2008)	17693420	180672	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14968	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Cuzick J (2005)	16034487	180673	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14969	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	inhibitor	target	Jakesz R (2007)	18073378	180671	1205	Anastrozole	alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Anastrozol	sandoz anastrozole|taro-anastr	DRUGBANK	DB01217	C17H19N5	small molecule	L02BG03	120511-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBBLVLTVTVSKRW-UHFFFAOYSA-N
14970	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Mbai M (2002)	12176129	180680	1206	Halofantrine	Halfan|Halofantrine|Halofantrinum|Halofantrina	halfan - tab 250mg	DRUGBANK	DB01218	C26H30Cl2F3NO	small molecule	P01BX01	69756-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOHHNHSLJDZUGQ-UHFFFAOYSA-N
14971	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Tie H (2000)	10952689	180679	1206	Halofantrine	Halfan|Halofantrine|Halofantrinum|Halofantrina	halfan - tab 250mg	DRUGBANK	DB01218	C26H30Cl2F3NO	small molecule	P01BX01	69756-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOHHNHSLJDZUGQ-UHFFFAOYSA-N
14972	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14973	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Paul-Pletzer K (2002)	12167662	180683	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14974	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Gerbershagen MU (2003)	12666006	180682	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14975	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Flewellen EH (1980)	7362049	180681	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14976	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Tonner PH (1995)	7488490	180687	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14977	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Britt BA (1984)	6704779	180686	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14978	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Harrison GG (1998)	9924249	180685	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14979	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Zhao X (2006)	16945924	180684	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14980	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	antagonist	target	Krause T (2004)	15023108	180688	1207	Dantrolene	Dantrolene|Dantamacrin|Dantroleno|F-368|Dantrolenum|Dantrium	dantrium cap 100mg|ryanodex da	DRUGBANK	DB01219	C14H10N4O5	small molecule	M03CA01	7261-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZOMQRBLCMDCEG-VIZOYTHASA-N
14981	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Cheng J (2010)	20627999	180689	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14982	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Ma X (2007)	17442842	180690	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14983	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14984	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Chen X (2002)	11752352	171740	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14985	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14986	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Scarpignato C (2006)	16498249	180694	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14987	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Koo HL (2009)	19898648	180695	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14988	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Vitali B (2007)	17408927	180691	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14989	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Pimentel M (2009)	19243285	180692	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14990	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	inhibitor	target	Ojetti V (2009)	19442033	180693	1208	Rifaximin	Rifaxidin|Rifamycin L 105SV|Rifamycin L 105|Rifaximine|Xifaxsan|Rifaximina|Rifaximinun|Rifaximinum|Rifaximin	xifaxan|zaxine	DRUGBANK	DB01220	C43H51N3O11	small molecule	D06AX11|A07AA11	80621-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZCRJKRKKOLAOJ-XRCRFVBUSA-N
14991	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Smith DJ (1980)	6246318	180696	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14992	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14993	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Seeman P (2009)	19391150	180698	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14994	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Seeman P (2009)	19391150	180698	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14995	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	binder	target	Smith DJ (1980)	6246318	180696	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14996	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14997	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Salt PJ (1979)	508488	180699	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14998	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	binder	target	Smith DJ (1980)	6246318	180696	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14999	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15000	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Okamoto T (2003)	12818951	180700	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15001	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15002	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15003	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15004	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15005	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	binder	target	Hustveit O (1995)	8835358	180697	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15006	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Harrison NL (1985)	2858237	180702	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15007	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Radovanovic D (2004)	14740534	180703	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15008	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Sinner B (2008)	18175098	180701	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15009	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Smothers CT (2007)	17502428	173484	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15010	109587	3355	-	HTR1F	5-HT-1F|5-HT1F|5HT6|HTR1EL|MR77	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15011	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15012	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15013	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15014	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15015	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15016	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15017	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Martin LL (1982)	6460944	180704	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15018	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Kunz S (2003)	12920235	180706	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15019	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Henriksson G (2001)	11258648	180707	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15020	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Zhang X (2000)	11040338	180705	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15021	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15022	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Zhang X (2001)	11730731	177112	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15023	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Kompella UB (2003)	12601049	180708	1210	Budesonide	(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione	pulmicort nebuamp 0.25 mg/ml|u	DRUGBANK	DB01222	C25H34O6	small molecule	R03AK12|A07EA06|R03AK07|R03BA02|D07AC09|R01AD05	51333-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOVIALXJUBGFJZ-KWVAZRHASA-N
15024	106650	140	RP11-552M11.7	ADORA3	A3AR	9606	Homo sapiens	antagonist	target	Stella L (1998)	9806324	180709	1211	Aminophylline	Somophyllin|Theophylline ethylenediamine|Aminophyllin	aminophylline tab 100mg|aminop	DRUGBANK	DB01223	C16H24N10O4	small molecule	R03DA55|R03DB05|R03DA05	317-34-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPFAHBPWDRTLU-UHFFFAOYSA-N
15025	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Hirota K (2002)	11939921	180710	1211	Aminophylline	Somophyllin|Theophylline ethylenediamine|Aminophyllin	aminophylline tab 100mg|aminop	DRUGBANK	DB01223	C16H24N10O4	small molecule	R03DA55|R03DB05|R03DA05	317-34-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPFAHBPWDRTLU-UHFFFAOYSA-N
15026	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1211	Aminophylline	Somophyllin|Theophylline ethylenediamine|Aminophyllin	aminophylline tab 100mg|aminop	DRUGBANK	DB01223	C16H24N10O4	small molecule	R03DA55|R03DB05|R03DA05	317-34-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPFAHBPWDRTLU-UHFFFAOYSA-N
15027	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Yamamoto S (2003)	12735630	180711	1211	Aminophylline	Somophyllin|Theophylline ethylenediamine|Aminophyllin	aminophylline tab 100mg|aminop	DRUGBANK	DB01223	C16H24N10O4	small molecule	R03DA55|R03DB05|R03DA05	317-34-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPFAHBPWDRTLU-UHFFFAOYSA-N
15028	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Lerman BB (1993)	8425287	180712	1211	Aminophylline	Somophyllin|Theophylline ethylenediamine|Aminophyllin	aminophylline tab 100mg|aminop	DRUGBANK	DB01223	C16H24N10O4	small molecule	R03DA55|R03DB05|R03DA05	317-34-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPFAHBPWDRTLU-UHFFFAOYSA-N
15029	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	activator	target	Ito K (2002)	12070353	174833	1211	Aminophylline	Somophyllin|Theophylline ethylenediamine|Aminophyllin	aminophylline tab 100mg|aminop	DRUGBANK	DB01223	C16H24N10O4	small molecule	R03DA55|R03DB05|R03DA05	317-34-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPFAHBPWDRTLU-UHFFFAOYSA-N
15030	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15031	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15032	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15033	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15034	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15035	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15036	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15037	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	McIntyre RS (2007)	17563257	180713	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15038	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15039	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yatham LN (2005)	16038601	175308	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15040	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Goldstein JM (1999)	12973385	175507	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15041	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	unknown	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15042	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15043	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15044	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15045	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15046	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15047	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15048	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	unknown	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15049	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15050	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15051	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15052	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15053	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15054	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15055	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15056	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15057	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15058	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15059	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15060	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15061	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	unknown	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15062	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	unknown	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15063	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15064	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15065	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	unknown	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15066	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15067	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15068	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15069	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kapur S (2000)	10839333	180714	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15070	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15071	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15072	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Ichikawa J (2002)	12445705	174617	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15073	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15074	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	McIntyre RS (2007)	17563257	180713	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15075	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Wood MD (2006)	16918396	174636	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15076	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15077	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15078	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15079	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15080	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15081	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Peng K (2005)	16207425	180715	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15082	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Lee S (2007)	17489664	180717	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15083	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Bisio A (2009)	19888521	180716	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15084	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Sanchez-Pena P (2005)	16187968	180719	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15085	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Graff J (2007)	17474542	180718	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15086	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Berges A (2007)	17509040	180720	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15087	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Paige JT (2007)	17567541	180721	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15088	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Dalmora SL (2005)	15675440	180722	1213	Enoxaparin	Enoxaparin sodium	lovenox|enoxaparin sodium|love	DRUGBANK	DB01225	C26H42N2O37S5	small molecule	B01AB05	9005-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTTJABKRGRZYRN-UHFFFAOYSA-N
15089	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Habre W (2008)	19020136	180723	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15090	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15091	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson M (2006)	16931985	178069	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15092	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15093	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15094	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson Fagerlund M (2009)	19417616	178070	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15095	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Ihmsen H (2009)	19352159	180724	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15096	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Kao YJ (1996)	8922768	180725	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15097	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15098	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15099	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15100	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1214	Mivacurium	Mivacurium	mivacron	DRUGBANK	DB01226	C58H80N2O14	small molecule	M03AC10	133814-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILVYCEVXHALBSC-OTBYEXOQSA-N
15101	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	unknown	target	Xiao Y (2001)	11561100	180726	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15102	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	antagonist	target	Xiao Y (2001)	11561100	180726	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15103	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15104	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Skoulis NP (1989)	2471291	180727	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15105	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Yu Y (1997)	9360954	180728	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15106	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Xiao Y (2001)	11561100	180726	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15107	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Kreek MJ (2000)	10911931	180729	1215	Levomethadyl Acetate	Levacetylmethadol|Levomethadyl|LAAM|1-alpha-Acetylmethadol|(1S,4S)-4-(dimethylamino)-1-Ethyl-2,2-diphenylpentyl acetate|Levo-methadyl acetate|Levomethadyl acetate|Levacetylmethadolum|Orlaam|Levo--acetylmethadol|Levacetilmetadol|(-)-alpha-Acetylmethadol|Levo-alpha-acetylmethadol	-	DRUGBANK	DB01227	C23H31NO2	small molecule	N07BC03	1477-40-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-AVRDEDQJSA-N
15108	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15109	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Guo J (2006)	16751287	180732	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15110	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Starmer CF (1991)	1653123	180731	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15111	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Krishnan SC (1998)	9835260	180730	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15112	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1216	Encainide	(+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide|Encainide|Encainida|(+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide|4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide|Encainidum|4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide	-	DRUGBANK	DB01228	C22H28N2O2	small molecule	C01BC08	66778-36-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWPNDMDCLXCOM-UHFFFAOYSA-N
15113	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Matsuyoshi S (2006)	17119350	180733	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15114	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Thomadaki H (2006)	16895478	180737	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15115	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Yoshino T (2006)	17062688	180736	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15116	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Zhang X (2007)	17230521	180735	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15117	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Gan Y (2006)	16741658	180734	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15118	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	inducer	target	Harmsen S (2009)	18839173	176682	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15119	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15120	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Kovacs P (2007)	17314054	180739	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15121	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15122	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Cheung CH (2009)	19575780	180738	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15123	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Horwitz SB (1992)	1350385	180740	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15124	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15125	110306	4134	-	MAP4	-	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15126	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1217	Paclitaxel	5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|Taxol|Taxol A|Paclitaxel	abraxane|paclitaxel injection,	DRUGBANK	DB01229	C47H51NO14	small molecule	L01CD01	33069-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCINICONZNJXQF-MZXODVADSA-N
15127	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15128	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Waelbroeck M (1991)	1863523	180744	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15129	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15130	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Varoli L (1999)	10530931	180742	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15131	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Braverman AS (2002)	12185001	180743	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15132	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15133	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Waelbroeck M (1991)	1863523	180744	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15134	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15135	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Pavia J (1997)	9059856	178461	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15136	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Jovanovic A (1994)	8050463	180748	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15137	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Lazartigues E (1998)	9851542	180746	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15138	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Kovacs I (1998)	9454790	180747	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15139	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Waelbroeck M (1991)	1863523	180744	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15140	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Pelat M (1999)	10497897	180745	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15141	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Varoli L (1999)	10530931	180742	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15142	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Braverman AS (2002)	12185001	180743	1219	Diphenidol	Diphenyl(3-(1-piperidyl)propyl)carbinol|Difenidolum|alpha,alpha-Diphenyl-1-piperidinebutanol|Difenidolo|Diphenidol|Difenidol	-	DRUGBANK	DB01231	C21H27NO	small molecule	-	972-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGAKLTJNUQRZJU-UHFFFAOYSA-N
15143	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dandache S (2007)	17638694	174467	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15144	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Hoetelmans RM (1997)	9297727	174493	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15145	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Vella S (1996)	11322246	180749	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15146	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wittayanarakul K (2008)	17849388	174468	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15147	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Rhee SY (2010)	20660676	180751	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15148	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Alcaro S (2009)	19537723	180750	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15149	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dandache S (2008)	19040279	180752	1220	Saquinavir	Saquinavir Mesylate|SQV	invirase|fortovase roche|invir	DRUGBANK	DB01232	C38H50N6O5	small molecule	J05AE01	127779-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWAXKHKRTORLEM-UGJKXSETSA-N
15150	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15151	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kishibayashi N (1995)	7745844	180758	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15152	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hammer D (2005)	15835479	180755	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15153	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dahloef CG (1998)	9876882	180754	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15154	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chemnitius JM (1996)	8981558	180757	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15155	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	See RE (1996)	8730709	180756	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15156	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Harrold MW (1993)	8230103	180753	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15157	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Guillemot J (2009)	18948374	180759	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15158	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Burger DM (2006)	16466463	180760	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15159	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Hammer D (2005)	15835479	180755	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15160	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15161	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15162	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	agonist	target	Costall B (1987)	2955843	180761	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15163	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Morand EF (2006)	16883066	180762	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15164	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Davies E (2007)	17158208	180763	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15165	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	John CD (2006)	17076770	180764	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15166	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Wang C (2007)	17644190	180765	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15167	106695	190	-	NR0B1	AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2	9606	Homo sapiens	stimulator	target	Gummow BM (2006)	16857744	180766	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15168	106695	190	-	NR0B1	AHC|AHCH|AHX|DAX-1|DAX1|DSS|GTD|HHG|NROB1|SRXY2	9606	Homo sapiens	stimulator	target	Yu CC (2006)	17526944	180767	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15169	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Vaitkuviene A (2006)	16963802	180771	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15170	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Wang D (2007)	16971495	180770	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15171	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15172	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Warne JP (2006)	16835395	180768	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15173	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Funato H (2006)	16956592	180769	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15174	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15175	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	negative modulator	target	Nandi J (2008)	17503181	174609	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15176	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	negative modulator	target	Chen X (2002)	11752352	171740	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15177	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	negative modulator	target	Huang H (2007)	17494951	180773	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15178	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	negative modulator	target	Soederberg M (2007)	17379310	180772	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15179	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15180	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15181	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15182	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15183	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15184	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15185	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15186	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15187	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15188	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Zappia M (2005)	15824260	180777	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15189	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kovoor A (2005)	15728856	180776	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15190	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15191	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15192	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Dupre KB (2007)	17553470	180779	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15193	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Mori A (2005)	15710490	180778	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15194	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15195	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15196	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15197	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15198	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15199	106998	513	-	ATP5D	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15200	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15201	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15202	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15203	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15204	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15205	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15206	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15207	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15208	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15209	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15210	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15211	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15212	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1225	Bromodiphenhydramine	Bromazine|2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine|Bromazina|Bromazinum|beta-(P-Bromobenzhydryloxy)ethyldimethylamine|Bromodiphenhydramine|beta-Dimethylaminoethyl P-bromobenzhydryl ether	-	DRUGBANK	DB01237	C17H20BrNO	small molecule	R06AA01	118-23-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUNIWXHYABYXKF-UHFFFAOYSA-N
15213	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1225	Bromodiphenhydramine	Bromazine|2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine|Bromazina|Bromazinum|beta-(P-Bromobenzhydryloxy)ethyldimethylamine|Bromodiphenhydramine|beta-Dimethylaminoethyl P-bromobenzhydryl ether	-	DRUGBANK	DB01237	C17H20BrNO	small molecule	R06AA01	118-23-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUNIWXHYABYXKF-UHFFFAOYSA-N
15214	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1225	Bromodiphenhydramine	Bromazine|2-(P-Bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine|Bromazina|Bromazinum|beta-(P-Bromobenzhydryloxy)ethyldimethylamine|Bromodiphenhydramine|beta-Dimethylaminoethyl P-bromobenzhydryl ether	-	DRUGBANK	DB01237	C17H20BrNO	small molecule	R06AA01	118-23-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUNIWXHYABYXKF-UHFFFAOYSA-N
15215	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15216	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15217	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15218	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15219	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15220	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Stark AD (2007)	17242925	174634	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15221	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Meltzer HY (2003)	14642974	180780	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15222	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Bortolozzi A (2007)	17265076	180781	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15223	109586	3354	-	HTR1E	5-HT1E	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15224	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15225	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15226	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15227	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15228	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15229	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15230	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15231	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15232	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15233	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15234	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15235	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15236	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15237	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15238	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15239	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15240	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Kim E (2006)	16981227	180782	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15241	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Hirose T (2005)	16366516	180783	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15242	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15243	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Wood M (2007)	17501690	180786	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15244	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Inoue A (1997)	9083792	180784	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15245	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Wood MD (2006)	16925992	180785	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15246	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kim E (2006)	16981227	180782	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15247	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hirose T (2005)	16366516	180783	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15248	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15249	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wood M (2007)	17501690	180786	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15250	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Inoue A (1997)	9083792	180784	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15251	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wood MD (2006)	16925992	180785	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15252	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Jordan S (2002)	12063084	180791	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15253	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Cosi C (2005)	15862515	180790	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15254	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Jordan S (2004)	14709325	180788	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15255	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Marona-Lewicka D (2004)	14647959	180789	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15256	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Swainston Harrison T (2004)	15257633	180787	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15257	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Jordan S (2002)	12063084	180791	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15258	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cosi C (2005)	15862515	180790	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15259	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Jordan S (2004)	14709325	180788	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15260	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Marona-Lewicka D (2004)	14647959	180789	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15261	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Swainston Harrison T (2004)	15257633	180787	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15262	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15263	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15264	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15265	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15266	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15267	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	von Coburg Y (2009)	19091563	180793	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15268	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15269	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15270	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1993)	8101879	175877	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15271	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15272	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15273	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15274	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15275	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15276	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15277	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15278	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15279	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Antkiewicz-Michaluk L (1986)	3774629	180795	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15280	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Wander TJ (1987)	2891550	180794	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15281	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15282	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15283	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15284	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15285	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15286	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15287	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15288	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15289	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	agonist	target	Yang J (2002)	12297509	180798	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15290	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	agonist	target	Kobsar AL (2010)	20085435	180797	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15291	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	agonist	target	Cattaneo M (2007)	17155953	180796	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15292	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Kasza Z (2009)	19302827	180799	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15293	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Yang J (2002)	12297509	180798	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15294	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Ibrahim S (2010)	20522800	160395	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15295	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15296	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inducer	target	Ruan KH (2008)	18081314	180801	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15297	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inducer	target	Nakayama T (2010)	20357747	180800	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15298	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Clavey V (1999)	10494028	179845	1229	Gemfibrozil	Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil	scheinpharm gemfibrozil|penta-	DRUGBANK	DB01241	C15H22O3	small molecule	C10AB04	25812-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEMJJKBWTPKOJG-UHFFFAOYSA-N
15299	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Bosse Y (2002)	12172398	180804	1229	Gemfibrozil	Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil	scheinpharm gemfibrozil|penta-	DRUGBANK	DB01241	C15H22O3	small molecule	C10AB04	25812-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEMJJKBWTPKOJG-UHFFFAOYSA-N
15300	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Pahan K (2002)	12244038	180805	1229	Gemfibrozil	Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil	scheinpharm gemfibrozil|penta-	DRUGBANK	DB01241	C15H22O3	small molecule	C10AB04	25812-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEMJJKBWTPKOJG-UHFFFAOYSA-N
15301	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Rizvi F (2003)	12935323	180803	1229	Gemfibrozil	Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil	scheinpharm gemfibrozil|penta-	DRUGBANK	DB01241	C15H22O3	small molecule	C10AB04	25812-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEMJJKBWTPKOJG-UHFFFAOYSA-N
15302	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Shoji Y (2003)	12834305	180802	1229	Gemfibrozil	Gemfibrozilo|Gemfibrozilum|2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure|Lopid|2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure|2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid|Gemfibrozil	scheinpharm gemfibrozil|penta-	DRUGBANK	DB01241	C15H22O3	small molecule	C10AB04	25812-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEMJJKBWTPKOJG-UHFFFAOYSA-N
15303	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Jungkun G (2001)	11341486	180806	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15304	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15305	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Alvarez JC (1999)	10613618	180807	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15306	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15307	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Suhara T (2003)	12695316	174092	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15308	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Borkowska A (2003)	12647451	180158	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15309	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Larsen AK (2004)	14993096	180809	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15310	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Gillman PK (2007)	17471183	180808	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15311	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Malizia AL (1997)	9305421	174919	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15312	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15313	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	inhibitor	target	Baranczyk-Kuzma A (2001)	11899840	180810	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15314	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	inhibitor	target	Baranczyk-Kuzma A (2004)	15094841	180811	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15315	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Hentall ID (2000)	10682715	180815	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15316	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Sargent PA (1998)	9862411	180814	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15317	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Sugimoto Y (2003)	14501155	174650	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15318	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Contreras CM (1992)	1296670	180812	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15319	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Trifunovic RD (1996)	8558452	180813	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15320	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Sargent PA (1998)	9862411	180814	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15321	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Sugimoto Y (2003)	14501155	174650	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15322	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Contreras CM (1992)	1296670	180812	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15323	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Sargent PA (1998)	9862411	180814	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15324	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Sugimoto Y (2003)	14501155	174650	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15325	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Contreras CM (1992)	1296670	180812	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
15326	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15327	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Bezprozvanny I (1995)	7565636	180816	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15328	111179	5153	-	PDE1B	PDE1B1|PDES1B	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15329	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Smith SJ (1990)	2207500	180817	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15330	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Kovacic H (1992)	1329768	180820	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15331	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15332	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Raess BU (1990)	2148481	180818	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15333	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Fuchs J (1986)	2938592	180819	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15334	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	binder	target	Lamers JM (1985)	2933041	179746	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15335	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	binder	target	Lamers JM (1987)	2964559	182257	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15336	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Cohen CJ (1992)	1281221	174770	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15337	114678	9254	-	CACNA2D2	CACNA2D	9606	Homo sapiens	inhibitor	target	Bezprozvanny I (1995)	7565636	180816	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15338	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	inhibitor	target	Chouabe C (2000)	10860024	180823	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15339	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	inhibitor	target	Chouabe C (1998)	9765513	180822	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15340	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	inhibitor	target	Yumoto Y (2004)	14716203	180821	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15341	111162	5136	-	PDE1A	CAM-PDE-1A|HCAM-1|HCAM1|HSPDE1A	9606	Homo sapiens	inhibitor	target	Lamers JM (1985)	2933041	179746	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15342	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	MacLachlan LK (1990)	2351672	180825	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15343	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Abusamhadneh E (2001)	11591369	180824	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15344	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Kleerekoper Q (1998)	9525919	178594	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15345	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Wang X (2002)	12060657	12566	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15346	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15347	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Bezprozvanny I (1995)	7565636	180816	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15348	107227	773	-	CACNA1A	APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIEATEWHFDRYRU-UHFFFAOYSA-N
15349	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Seto Y (1988)	3190453	176404	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15350	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Sinha BK (1975)	239236	180826	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15351	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Robaire B (1975)	1207670	176408	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15352	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Wu CS (1989)	2913485	180827	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15353	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Hallek M (1988)	3345199	180828	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15354	107557	1135	-	CHRNA2	-	9606	Homo sapiens	partial agonist	target	Imming P (2006)	17016423	171742	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15355	107557	1135	-	CHRNA2	-	9606	Homo sapiens	partial agonist	target	Maneckjee R (1994)	7848904	180830	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15356	107557	1135	-	CHRNA2	-	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15357	107557	1135	-	CHRNA2	-	9606	Homo sapiens	partial agonist	target	Overington JP (2006)	17139284	171741	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15358	107557	1135	-	CHRNA2	-	9606	Homo sapiens	partial agonist	target	Lee C (2002)	12067008	180829	1233	Decamethonium	Decamethylenebis(trimethylammonium)|Decamethonum|DECAMETHONIUM ion|N,N,N,N',n',n'-hexamethyl-1,10-decanediaminium|Decamethonium	-	DRUGBANK	DB01245	C16H38N2	small molecule	-	156-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCUAOILFDZKCO-UHFFFAOYSA-N
15359	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Santos DE (1995)	7713167	180831	1234	Alimemazine	Trimeprazine|Alimemazine|Methylpromazine|Repeltin	panectyl tab 2.5mg|panectyl ta	DRUGBANK	DB01246	C18H22N2S	small molecule	R06AD01	84-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZHLYYDVIOPZBE-UHFFFAOYSA-N
15360	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1234	Alimemazine	Trimeprazine|Alimemazine|Methylpromazine|Repeltin	panectyl tab 2.5mg|panectyl ta	DRUGBANK	DB01246	C18H22N2S	small molecule	R06AD01	84-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZHLYYDVIOPZBE-UHFFFAOYSA-N
15361	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Kettler R (1990)	2248058	180832	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15362	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Mason ST (1985)	4070383	180833	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15363	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Kettler R (1990)	2248058	180832	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15364	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Thase ME (1995)	7612154	180834	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15365	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1235	Isocarboxazid	Isocarboxazide|Isocarboxazidum|Marplan|Isocarboxazida	marplan	DRUGBANK	DB01247	C12H13N3O2	small molecule	N06AF01	59-63-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPYPQQHFEXRZ-UHFFFAOYSA-N
15366	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Inoue Y (2005)	15643508	180835	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15367	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Magi-Galluzzi C (2007)	17674353	180836	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15368	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Marshall J (2004)	15277270	180837	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15369	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Gligorov J (2004)	15161985	180838	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15370	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Petrylak DP (2005)	15685445	180839	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15371	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Miyoshi Y (2005)	15714982	180840	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15372	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	binder	target	Ikezoe T (2004)	15492266	180841	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15373	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Gligorov J (2004)	15161985	180838	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15374	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Matesanz R (2008)	18559268	180843	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15375	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Snyder JP (2001)	11309480	180842	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15376	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Belani CP (2004)	15698529	180844	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15377	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15378	110306	4134	-	MAP4	-	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15379	110305	4133	-	MAP2	MAP2A|MAP2B|MAP2C	9606	Homo sapiens	unknown	target	McGrogan BT (2008)	18068131	180741	1236	Docetaxel	N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel|TXL|N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol|Docetaxel anhydrous	taxotere|docetaxel for injecti	DRUGBANK	DB01248	C43H53NO14	small molecule	L01CD02	114977-28-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZOTLJHXYCWBA-VCVYQWHSSA-N
15380	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Ito R (2006)	17034586	180845	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15381	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Egan LJ (1998)	9797390	180846	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15382	113025	7172	-	TPMT	-	9606	Homo sapiens	inhibitor	target	Lennard L (1998)	9780130	180849	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15383	113025	7172	-	TPMT	-	9606	Homo sapiens	inhibitor	target	Lennard L (2002)	12117866	180848	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15384	113025	7172	-	TPMT	-	9606	Homo sapiens	inhibitor	target	Lewis LD (1997)	9357398	180850	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15385	113025	7172	-	TPMT	-	9606	Homo sapiens	inhibitor	target	Shipkova M (2004)	14752016	180847	1238	Olsalazine	Dipentum	dipentum	DRUGBANK	DB01250	C14H10N2O6	small molecule	A07EC03	15722-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBDLJCYGRGAKP-FOCLMDBBSA-N
15386	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Szewczyk A (1997)	9015372	180852	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15387	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Hill RA (2003)	12670661	180853	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15388	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Sato T (2006)	16174795	180851	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15389	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Reimann F (2001)	11574406	179962	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15390	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Lawrence CL (2001)	11484080	179963	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15391	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Proks P (2002)	12475777	174487	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15392	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Harrower A (2000)	11078469	179964	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15393	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Gribble FM (2000)	11078468	179965	1239	Gliquidone	Glurenorm	-	DRUGBANK	DB01251	C27H33N3O6S	small molecule	A10BB08	33342-05-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLJFMFZYVVLQKT-UHFFFAOYSA-N
15394	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	1240	Mitiglinide	-	-	DRUGBANK	DB01252	C19H25NO3	small molecule	A10BX08	145375-43-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPGGHFDDFPHPOB-BBWFWOEESA-N
15395	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Sunaga Y (2001)	11716850	178081	1240	Mitiglinide	-	-	DRUGBANK	DB01252	C19H25NO3	small molecule	A10BX08	145375-43-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPGGHFDDFPHPOB-BBWFWOEESA-N
15396	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Nagamatsu S (2006)	17003348	180854	1240	Mitiglinide	-	-	DRUGBANK	DB01252	C19H25NO3	small molecule	A10BX08	145375-43-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPGGHFDDFPHPOB-BBWFWOEESA-N
15397	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inhibitor	target	Ogawa K (2007)	17592198	180855	1240	Mitiglinide	-	-	DRUGBANK	DB01252	C19H25NO3	small molecule	A10BX08	145375-43-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPGGHFDDFPHPOB-BBWFWOEESA-N
15398	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Zhu F (2010)	19933260	178527	1241	Ergonovine	Ergobasine|N-(alpha-(Hydroxymethyl)ethyl)-D-lysergamide|9,10-Didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-methylergoline-8-beta-carboxamide|Ergonovine|9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8beta(S)-carboxamide|Ergometrinum|[8beta(S)]-9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide|Ergometrina|D-Lysergic acid 1-hydroxymethylethylamide|Ergometrine|(6AR,9R)-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((S)-2-hydroxy-1-methyl-ethyl)-amide|N-(2-Hydroxy-1-methylethyl)-D(+)-lysergamide|Ergotrate maleate|D-Lysergic acid-L-propanolamide	ergotrate maleate tablet 1572 	DRUGBANK	DB01253	C19H23N3O2	small molecule	G02AB03	60-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVVSZNPYNCNODU-XTQGRXLLSA-N
15399	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Gibson A (1988)	2897449	180856	1241	Ergonovine	Ergobasine|N-(alpha-(Hydroxymethyl)ethyl)-D-lysergamide|9,10-Didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-methylergoline-8-beta-carboxamide|Ergonovine|9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8beta(S)-carboxamide|Ergometrinum|[8beta(S)]-9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide|Ergometrina|D-Lysergic acid 1-hydroxymethylethylamide|Ergometrine|(6AR,9R)-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((S)-2-hydroxy-1-methyl-ethyl)-amide|N-(2-Hydroxy-1-methylethyl)-D(+)-lysergamide|Ergotrate maleate|D-Lysergic acid-L-propanolamide	ergotrate maleate tablet 1572 	DRUGBANK	DB01253	C19H23N3O2	small molecule	G02AB03	60-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVVSZNPYNCNODU-XTQGRXLLSA-N
15400	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	multitarget	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15401	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15402	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15403	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Schittenhelm MM (2006)	16397263	180858	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15404	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Quintas-Cardama A (2006)	17155893	180859	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15405	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15406	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Kamath AV (2008)	17429625	180862	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15407	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Nam S (2005)	16230377	180861	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15408	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	multitarget	target	Serrels A (2006)	17148760	180860	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15409	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	multitarget	target	Piccaluga PP (2007)	17701954	180863	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15410	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	multitarget	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15411	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15412	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Schittenhelm MM (2006)	16397263	180858	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15413	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Dizdar O (2008)	17351742	180865	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15414	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Shah NP (2006)	16434489	180864	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15415	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Zhang Z (2006)	16497876	180867	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15416	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Chen Z (2006)	16436588	180866	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15417	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	antagonist	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15418	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15419	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15420	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Overington JP (2006)	17139284	171741	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15421	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15422	112654	6777	-	STAT5B	STAT5	9606	Homo sapiens	inhibitor	target	Nam S (2007)	17431118	180869	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15423	112654	6777	-	STAT5B	STAT5	9606	Homo sapiens	inhibitor	target	Fiskus W (2006)	17020995	180868	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15424	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	inhibitor	target	Trevino JG (2006)	16507911	180870	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15425	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	inhibitor	target	Margutti S (2007)	17541990	180871	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15426	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	inhibitor	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15427	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15428	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15429	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	antagonist	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15430	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Chen X (2002)	11752352	171740	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15431	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Lindauer M (2010)	20072833	180857	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15432	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	multitarget	target	Das J (2006)	17154512	180872	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
15433	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Hamidovic A (2010)	20091113	180873	1243	Lisdexamfetamine	Lisdexamfetamine|NRP104|lisdexamfetamine dimesylate	vyvanse	DRUGBANK	DB01255	C15H25N3O	small molecule	N06BA12	608137-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOBHXZCDAVEXEY-JSGCOSHPSA-N
15434	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1243	Lisdexamfetamine	Lisdexamfetamine|NRP104|lisdexamfetamine dimesylate	vyvanse	DRUGBANK	DB01255	C15H25N3O	small molecule	N06BA12	608137-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOBHXZCDAVEXEY-JSGCOSHPSA-N
15435	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1243	Lisdexamfetamine	Lisdexamfetamine|NRP104|lisdexamfetamine dimesylate	vyvanse	DRUGBANK	DB01255	C15H25N3O	small molecule	N06BA12	608137-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOBHXZCDAVEXEY-JSGCOSHPSA-N
15436	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Imming P (2006)	17016423	171742	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15437	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15438	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Overington JP (2006)	17139284	171741	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15439	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Rother RP (2007)	17989688	180880	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15440	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Hillmen P (2006)	16990386	180874	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15441	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Dmytrijuk A (2008)	18784156	180875	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15442	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Kelly R (2009)	20011245	180876	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15443	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Luzzatto L (2010)	20378572	180877	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15444	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Singer AL (2009)	19399743	180878	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15445	107188	727	-	C5	C5D|C5a|C5b|CPAMD4|ECLZB	9606	Homo sapiens	antibody	target	Hillmen P (2007)	17702897	180879	1245	Eculizumab	5G1.1	soliris	DRUGBANK	DB01257	-	biologic	L04AA25	219685-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15446	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Zhou H (2004)	14751502	180891	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15447	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Burris HA (2004)	15163842	180890	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15448	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Xia W (2004)	14737100	180889	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15449	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Vazquez-Martin A (2011)	20658522	180888	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15450	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Grana TM (2003)	14633707	180885	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15451	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Wood ER (2004)	15374980	180884	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15452	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Johnston SR (2006)	16894399	180887	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15453	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Xia W (2002)	12214266	180886	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15454	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Langer CJ (2004)	14967461	180881	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15455	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15456	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Tevaarwerk AJ (2010)	20110044	180883	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15457	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Medina PJ (2008)	18803986	180882	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15458	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Zhou H (2004)	14751502	180891	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15459	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Burris HA (2004)	15163842	180890	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15460	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Xia W (2004)	14737100	180889	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15461	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Vazquez-Martin A (2011)	20658522	180888	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15462	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Grana TM (2003)	14633707	180885	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15463	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Wood ER (2004)	15374980	180884	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15464	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Johnston SR (2006)	16894399	180887	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15465	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Xia W (2002)	12214266	180886	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15466	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Langer CJ (2004)	14967461	180881	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15467	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15468	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Tevaarwerk AJ (2010)	20110044	180883	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15469	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antagonist	target	Medina PJ (2008)	18803986	180882	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCFGMOOMADDAQU-UHFFFAOYSA-N
15470	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	1247	Desonide	11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide	tridesilon crm 0.05%|verdeso|t	DRUGBANK	DB01260	C24H32O6	small molecule	S01BA11|D07AB08|D07BB02	638-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBGKWQHBNHJJPZ-LECWWXJVSA-N
15471	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Otte C (2010)	20371666	180892	1247	Desonide	11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide	tridesilon crm 0.05%|verdeso|t	DRUGBANK	DB01260	C24H32O6	small molecule	S01BA11|D07AB08|D07BB02	638-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBGKWQHBNHJJPZ-LECWWXJVSA-N
15472	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Russell GM (2010)	20427668	180893	1247	Desonide	11beta,21-Dihydroxy-16alpha,17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione|16alpha,17alpha-Isopropylidenedioxyprednisolone|11beta,21-Dihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione|Desonidum|Desonida|16alpha-Hydroxyprednisole-16,17-acetonide|16alpha-Hydroxyprednisolone-16alpha,17-acetonide|11beta,21-Dihydroxy-16alpha,17-isopropylidenedioxypregna-1,4-diene-3,20-dione|Desfluorotriamcinolone acetonide	tridesilon crm 0.05%|verdeso|t	DRUGBANK	DB01260	C24H32O6	small molecule	S01BA11|D07AB08|D07BB02	638-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBGKWQHBNHJJPZ-LECWWXJVSA-N
15473	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15474	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Lyseng-Williamson KA (2007)	17352516	180904	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15475	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Pratley RE (2007)	17407649	180898	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15476	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Gallwitz B (2006)	16682937	180899	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15477	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Gallwitz B (2007)	17315049	180896	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15478	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Karasik A (2008)	18182122	180897	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15479	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Herman GA (2006)	16855072	180894	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15480	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Bergman AJ (2006)	16490580	180895	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15481	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Hermansen K (2007)	17593236	180900	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15482	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Herman GA (2005)	16338283	180901	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15483	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Miller S (2006)	16868220	180902	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15484	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Richter B (2008)	19065993	180903	1248	Sitagliptin	Sitagliptine|Sitagliptina|Sitagliptin phosphate|MK-0431|Sitagliptan|(2R)-4-OXO-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|Sitagliptinum	janumet|janumet xr|januvia	DRUGBANK	DB01261	C16H15F6N5O	small molecule	A10BH51|A10BD12|A10BD07|A10BH01	486460-32-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFFMDFFZMYYVKS-SECBINFHSA-N
15485	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Csankovszki G (2001)	11352938	131895	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15486	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15487	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Daskalakis M (2010)	20072836	180910	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15488	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Oki Y (2007)	17023173	180908	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15489	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Takebayashi S (2001)	11688997	91253	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15490	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Saba HI (2005)	16015501	180912	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15491	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Stresemann C (2008)	18425818	180905	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15492	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Jabbour E (2008)	18398832	180906	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15493	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Karpf AR (2001)	11259619	180907	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15494	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Saunthararajah Y (2003)	12907443	180911	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15495	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor	target	Ando T (2000)	11069027	180909	1249	Decitabine	Azadc|5-Azadeoxycytidine|Decitabine|5-aza-2'-deoxycytidine|4-amino-1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one|Dezocitidine	decitabine|dacogen	DRUGBANK	DB01262	C8H12N4O4	small molecule	L01BC08	2353-33-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAUDJQYHKZQPEU-KVQBGUIXSA-N
15496	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Chau AS (2004)	15155210	63282	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15497	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Imming P (2006)	17016423	171742	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15498	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Overington JP (2006)	17139284	171741	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15499	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Berman HM (2000)	10592235	172122	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15500	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Li X (2004)	14657086	61965	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15501	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Kwon DS (2007)	17516880	180913	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15502	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Groll AH (2005)	16107193	180917	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15503	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Warrilow AG (2010)	20660663	180916	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15504	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Schiller DS (2007)	18035188	180915	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15505	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	antagonist	target	Bhattacharya M (2010)	20622401	180914	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAGOYPUPXAKGKH-XAKZXMRKSA-N
15506	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Dierynck I (2007)	17928344	179988	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15507	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Ghosh AK (2007)	17900913	180921	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15508	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Chen X (2002)	11752352	171740	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15509	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	De Meyer S (2005)	15917527	180920	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15510	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Kovalevsky AY (2006)	16480273	180922	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15511	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Tremblay CL (2008)	19209258	180923	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15512	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	McKeage K (2009)	19323590	180919	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15513	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wang YF (2007)	17696515	180918	1251	Darunavir	N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|TMC114|{(1S,2R)-3-[(4-amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavir|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3AS,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate|(3R,3AS,6ar)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3as,6ar)-(hexahydro-furo[2,3-b]furan-3-yl) ester|Darunavirum|TMC-114	pat-darunavir|prezista|prezcob	DRUGBANK	DB01264	C27H37N3O7S	small molecule	J05AE10|J05AR14	206361-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJBJHOAVZSMMDJ-HEXNFIEUSA-N
15514	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15515	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15516	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15517	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Nourian Z (2008)	18542932	178093	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15518	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15519	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15520	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15521	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15522	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cohen LJ (1994)	7524043	180924	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15523	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15524	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Eltze M (1996)	8925876	176194	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15525	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Nourian Z (2008)	18542932	178093	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15526	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15527	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Keks NA (1999)	15992090	178094	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15528	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15529	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15530	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cohen LJ (1994)	7524043	180924	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15531	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Sleight AJ (1993)	7691623	176191	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15532	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Eltze M (1996)	8925876	176194	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15533	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15534	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Cohen LJ (1994)	7524043	180924	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15535	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15536	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15537	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15538	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Remington G (2006)	16513859	178091	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15539	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15540	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15541	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15542	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Yamada Y (2002)	12211096	180926	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15543	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cohen LJ (1994)	7524043	180924	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15544	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Regenthal R (2005)	16119512	180925	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15545	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15546	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15547	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yamada Y (2002)	12211096	180926	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15548	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	He H (1995)	7542676	180927	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15549	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Cohen LJ (1994)	7524043	180924	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15550	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15551	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15552	107940	1565	RP4-669P10.2	CYP2D6	CPD6|CYP2D|CYP2D7AP|CYP2D7BP|CYP2D7P2|CYP2D8P2|CYP2DL1|CYPIID6|P450-DB1|P450C2D|P450DB1	9606	Homo sapiens	unknown	target	Boerth JM (2005)	15767244	180928	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15553	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15554	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Gunes A (2008)	18708991	180929	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15555	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15556	107949	1577	-	CYP3A5	CP35|CYPIIIA5|P450PCN3|PCN3	9606	Homo sapiens	unknown	target	Yasui-Furukori N (2001)	11560868	178097	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15557	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15558	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15559	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15560	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15594	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Heymach JV (2006)	16857825	180948	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15595	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Cohen RB (2003)	12620146	180949	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15596	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Chen X (2002)	11752352	171740	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15597	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Foon KA (2004)	14967460	180947	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15598	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Keating GM (2010)	20481659	180957	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15599	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Yang XD (2001)	11255078	180956	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15600	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Segaert S (2005)	16012181	180955	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15601	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Lynch DH (2002)	11894013	180954	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15602	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Saadeh CE (2007)	17355997	180953	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15603	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Wu M (2008)	18343240	180952	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15604	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Jean GW (2008)	18503402	180951	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15605	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	suppressor	target	Keating GM (2010)	20623992	180950	1256	Panitumumab	ABX-EGF	vectibix	DRUGBANK	DB01269	-	biologic	L01XC08	339177-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15606	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Ferrara N (2006)	17031284	180966	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15607	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Gaudreault J (2007)	18046235	180967	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15608	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Kourlas H (2007)	18035187	180964	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15609	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Spitzer MS (2008)	19668384	180965	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15610	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Pieramici DJ (2006)	17049020	180962	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15611	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Nguyen QD (2006)	17046701	180963	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15612	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Michels S (2005)	15973626	180960	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15613	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Rosenfeld PJ (2006)	16935211	180961	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15614	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Gaudreault J (2005)	15671306	180959	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15615	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Bakri SJ (2007)	18054637	180958	1257	Ranibizumab	rhuFab V2	lucentis	DRUGBANK	DB01270	C2158H3282N562O681S12	biologic	S01LA04	347396-82-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15616	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1258	Idursulfase	Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase	elaprase	DRUGBANK	DB01271	C2654H4000N688O774S14	biologic	A16AB09	50936-59-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15617	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1258	Idursulfase	Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase	elaprase	DRUGBANK	DB01271	C2654H4000N688O774S14	biologic	A16AB09	50936-59-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15618	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	Burrow TA (2008)	19707363	180970	1258	Idursulfase	Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase	elaprase	DRUGBANK	DB01271	C2654H4000N688O774S14	biologic	A16AB09	50936-59-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15619	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	Wraith JE (2008)	18038146	180968	1258	Idursulfase	Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase	elaprase	DRUGBANK	DB01271	C2654H4000N688O774S14	biologic	A16AB09	50936-59-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15620	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	Clarke LA (2008)	18201153	180969	1258	Idursulfase	Alpha-L-iduronate sulfate sulfatase|Iduronate 2-sulfatase	elaprase	DRUGBANK	DB01271	C2654H4000N688O774S14	biologic	A16AB09	50936-59-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15621	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	binder	target	Chavez CA (2007)	17927214	173188	1259	Alglucosidase alfa	Aglucosidase alfa|Aglucosidase alpha|Acid-alpha glucosidase|alpha-1,4-glucosidase|Acid maltase|Lysosomal Alpha-Glucosidase|Alpha-glucosidase	lumizyme|myozyme	DRUGBANK	DB01272	C4435H6739N1175O1279S32	biologic	A16AB07	420784-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15622	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	partial agonist	target	Mihalak KB (2006)	16766716	180971	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15623	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	partial agonist	target	Mihalak KB (2006)	16766716	180971	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15624	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Mihalak KB (2006)	16766716	180971	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15625	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	partial agonist	target	Steensland P (2007)	17626178	180975	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15626	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	partial agonist	target	Rollema H (2007)	17573127	180974	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15627	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15628	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	partial agonist	target	Nakamura M (2007)	17692720	180973	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15629	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	partial agonist	target	McColl SL (2008)	18288085	180972	1260	Varenicline	CP-526,555	chantix|champix|gd-varenicline	DRUGBANK	DB01273	C13H13N3	small molecule	N07BA03	249296-44-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQSHBVHOMNKWFT-DTORHVGOSA-N
15630	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cazzola M (2005)	16022567	180980	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15631	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cazzola M (2010)	20406080	180978	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15632	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Matera MG (2007)	17352511	180977	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15633	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Unknown Authors (2004)	14725487	180976	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15634	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Op't Holt TB (2007)	17594727	179504	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15635	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kharidia J (2008)	18501650	180979	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15636	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15637	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Baumgartner RA (2007)	17472819	180981	1261	Arformoterol	(R,R)-formoterol|(-)-Formoterol	brovana	DRUGBANK	DB01274	C19H24N2O4	small molecule	-	67346-49-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPZSYCZIITTYBL-YJYMSZOUSA-N
15638	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Claud P (2001)	11302941	180984	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15639	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Barrand MA (1985)	4091799	180985	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15640	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Vidrio H (2005)	16116337	180986	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15641	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Groenvall JL (2000)	11061213	180987	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15642	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Vidrio H (2003)	12970383	180982	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15643	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Barrand MA (1984)	6150080	180983	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15644	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Vidrio H (2004)	15255812	180988	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15645	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Lyles GA (1989)	2568436	180989	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15646	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Vidrio H (2007)	17385063	180991	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15647	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Groenvall JL (1998)	9740313	180990	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15648	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	inhibitor	target	Lizcano JM (1996)	8694842	178357	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15649	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	inhibitor	target	Chen KH (1977)	856725	180993	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15650	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	inhibitor	target	Murad S (1985)	2994564	180992	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15651	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15652	111072	5033	RP11-344N10.1	P4HA1	P4HA	9606	Homo sapiens	inhibitor	target	Knowles HJ (2004)	15192023	180994	1262	Hydralazine	Hydrazone 1(2H)-phthalazinone|Hypophthalin|1-Phthalazinylhydrazine|Idralazina|6-Hydralazine|Hydrazinophthalazine|Hydrallazine|Hydralazin|Hidralazina|1-Hydrazinophthalazine|(1Z)-1(2H)-Phthalazinone hydrazone|Phthalazin-1-ylhydrazine|Hydralazinum|(2H)-Phthalazinone hydrazone	hydralazine-10 tab 10mg|hydral	DRUGBANK	DB01275	C8H8N4	small molecule	C02DB02|C02LG02	86-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPTUSVTUFVMDQK-UHFFFAOYSA-N
15653	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Lebovitz HE (2006)	16627399	181004	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15654	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Kolterman OG (2005)	15700891	181005	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15655	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Degn KB (2004)	15331551	180997	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15656	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Briones M (2006)	16722815	180996	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15657	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Barnett AH (2005)	16341288	180995	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15658	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Diamant M (2004)	15495988	181001	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15659	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Wajchenberg BL (2007)	17353295	180999	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15660	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Mack CM (2006)	16534527	180998	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15661	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Hargrove DM (2007)	17292977	181000	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15662	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Mann RJ (2010)	20649595	181002	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15663	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15664	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Geelhoed-Duijvestijn PH (2007)	17379930	181003	1263	Exenatide	Byetta|AC002993|AC 2993|AC2993|AC2993a|Bydureon|AC-2993|Synthetic exendin-4|Exenatide|Exenatide synthetic	bydureon|byetta	DRUGBANK	DB01276	C184H282N50O60S	biologic	A10BX04	141758-74-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15665	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	unknown	target	Rosenbloom AL (2009)	19198769	181006	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15666	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	agonist	target	Rosenbloom AL (2009)	19198769	181006	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15667	109707	3486	tcag7.703	IGFBP3	BP-53|IBP3	9606	Homo sapiens	unknown	target	Unknown Authors (2005)	15777106	181007	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15668	109707	3486	tcag7.703	IGFBP3	BP-53|IBP3	9606	Homo sapiens	unknown	target	Williams RM (2008)	18363546	181008	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15669	109707	3486	tcag7.703	IGFBP3	BP-53|IBP3	9606	Homo sapiens	unknown	target	Kemp SF (2009)	19627167	181009	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15670	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	unknown	target	Rosenbloom AL (2009)	19198769	181006	1264	Mecasermin	IGF1|IGF-1|Mecasermin rinfabate recombinant|Mecasermin rinfabate|Mechano growth factor|Somatomedin-C|Insulin-like growth factor 1|Mecasermin recombinant	increlex	DRUGBANK	DB01277	C331H518N94O101S7	biologic	H01AC03|H01AC05	68562-41-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15671	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Roth JD (2009)	19273748	181015	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15672	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Qi T (2008)	18593822	181014	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15673	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Lutz TA (2010)	20357016	181011	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15674	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Qi T (2010)	20015292	181010	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15675	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Nyholm B (2001)	11772274	181013	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15676	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Hay DL (2004)	15494035	181012	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15677	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15678	115558	10267	-	RAMP1	-	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15679	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Roth JD (2009)	19273748	181015	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15680	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Qi T (2008)	18593822	181014	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15681	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Lutz TA (2010)	20357016	181011	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15682	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Qi T (2010)	20015292	181010	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15683	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Nyholm B (2001)	11772274	181013	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15684	107250	799	-	CALCR	CRT|CT-R|CTR|CTR1	9606	Homo sapiens	agonist	target	Hay DL (2004)	15494035	181012	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15685	115557	10266	-	RAMP2	-	9606	Homo sapiens	agonist	target	Roth JD (2009)	19273748	181015	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15686	115557	10266	-	RAMP2	-	9606	Homo sapiens	agonist	target	Qi T (2008)	18593822	181014	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15687	115557	10266	-	RAMP2	-	9606	Homo sapiens	agonist	target	Qi T (2010)	20015292	181010	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15688	115557	10266	-	RAMP2	-	9606	Homo sapiens	agonist	target	Hay DL (2004)	15494035	181012	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15689	115557	10266	-	RAMP2	-	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15690	115557	10266	-	RAMP2	-	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15691	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Roth JD (2009)	19273748	181015	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15692	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Qi T (2008)	18593822	181014	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15693	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Lutz TA (2010)	20357016	181011	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15694	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Qi T (2010)	20015292	181010	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15695	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Nyholm B (2001)	11772274	181013	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15696	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Hay DL (2004)	15494035	181012	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15697	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15698	115559	10268	-	RAMP3	-	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1265	Pramlintide	-	symlinpen	DRUGBANK	DB01278	C171H267N51O53S2	biologic	A10BX05	151126-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15699	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1266	Galsulfase	Arylsufatase B|ARSB	naglazyme	DRUGBANK	DB01279	C2534H3851N691O719S16	biologic	A16AB08	552858-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15700	115520	10226	-	PLIN3	M6PRBP1|PP17|TIP47	9606	Homo sapiens	unknown	target	White JT (2008)	18709516	181016	1266	Galsulfase	Arylsufatase B|ARSB	naglazyme	DRUGBANK	DB01279	C2534H3851N691O719S16	biologic	A16AB08	552858-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15701	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Buie LW (2007)	18035189	181020	1267	Nelarabine	2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine	arranon|atriance	DRUGBANK	DB01280	C11H15N5O5	small molecule	L01BB07	121032-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXOXBSCIXZEQEQ-UHTZMRCNSA-N
15702	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Rodriguez CO (2003)	12750168	181017	1267	Nelarabine	2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine	arranon|atriance	DRUGBANK	DB01280	C11H15N5O5	small molecule	L01BB07	121032-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXOXBSCIXZEQEQ-UHTZMRCNSA-N
15703	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Ono K (1979)	91427	181019	1267	Nelarabine	2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine	arranon|atriance	DRUGBANK	DB01280	C11H15N5O5	small molecule	L01BB07	121032-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXOXBSCIXZEQEQ-UHTZMRCNSA-N
15704	111418	5422	-	POLA1	NSX|POLA|p180	9606	Homo sapiens	inhibitor	target	Curbo S (2006)	18473971	181018	1267	Nelarabine	2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine|GW-506U78|Arranon|Nelzarabine	arranon|atriance	DRUGBANK	DB01280	C11H15N5O5	small molecule	L01BB07	121032-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXOXBSCIXZEQEQ-UHTZMRCNSA-N
15705	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Kremer JM (2005)	16357751	181021	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15706	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Weyand CM (2006)	16932686	181022	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15707	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Maxwell LJ (2010)	20080922	181023	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15708	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Hervey PS (2006)	16573350	181024	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15709	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Vincenti F (2006)	17020493	181025	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15710	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Nogid A (2006)	17212998	181026	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15711	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Reynolds J (2007)	18041889	181027	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15712	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Scheinfeld N (2006)	16971318	181028	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15713	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15714	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Kremer JM (2005)	16357751	181021	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15715	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Weyand CM (2006)	16932686	181022	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15716	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Maxwell LJ (2010)	20080922	181023	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15717	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Hervey PS (2006)	16573350	181024	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15718	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Vincenti F (2006)	17020493	181025	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15719	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Nogid A (2006)	17212998	181026	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15720	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Reynolds J (2007)	18041889	181027	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15721	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Scheinfeld N (2006)	16971318	181028	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15722	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1268	Abatacept	CTLA4-Ig|CTLA4IgG4m|CTLA4-IgG4m|CTLA4Ig	orencia	DRUGBANK	DB01281	C3498H5458N922O1090S32	biologic	L04AA24	332348-12-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15723	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Engstrom T (1998)	9760035	181029	1269	Carbetocin	Carbetocino|Carbetocinum|Deamino-2-O-methyltyrosine-1-carbaoxytocin|1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin|1-Butyric acid-2-(3-(P-methoxyphenyl)-L-alanine)oxytocin	duratocin injection	DRUGBANK	DB01282	C45H69N11O12S	small molecule	H01BB03	37025-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSTRIRCPWQHTIA-DTRKZRJBSA-N
15724	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1269	Carbetocin	Carbetocino|Carbetocinum|Deamino-2-O-methyltyrosine-1-carbaoxytocin|1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin|1-Butyric acid-2-(3-(P-methoxyphenyl)-L-alanine)oxytocin	duratocin injection	DRUGBANK	DB01282	C45H69N11O12S	small molecule	H01BB03	37025-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSTRIRCPWQHTIA-DTRKZRJBSA-N
15725	111061	5021	-	OXTR	OT-R	9606	Homo sapiens	agonist	target	Gimpl G (2005)	15740719	181030	1269	Carbetocin	Carbetocino|Carbetocinum|Deamino-2-O-methyltyrosine-1-carbaoxytocin|1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin|1-Butyric acid-2-(3-(P-methoxyphenyl)-L-alanine)oxytocin	duratocin injection	DRUGBANK	DB01282	C45H69N11O12S	small molecule	H01BB03	37025-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSTRIRCPWQHTIA-DTRKZRJBSA-N
15726	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Esser R (2005)	15655513	181035	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15727	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Warner TD (2006)	16403783	181034	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15728	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Capone ML (2003)	14552704	181033	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15729	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blobaum AL (2007)	17434872	181032	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15730	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Jermany J (2005)	16172182	181031	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15731	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalbag J (2004)	15177307	181038	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15732	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2004)	14965322	181037	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15733	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Atherton C (2004)	15017615	181036	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15734	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Esser R (2005)	15655513	181035	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15735	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2003)	14552704	181033	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15736	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15737	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1271	Tetracosactide	adrenocorticotropic hormone 1-24|1-24-corticotrophin|1-24-corticotrophin|Tetracosactrin|Adrenocorticotropic hormone fragment 1-24 human, rat|corticotropin-(1-24)|alpha(1-24)-corticotrophin|Tetracosactide|beta(1-24)-corticotrophin|Corticotropin tetracosapeptide|Cosyntropin|ATCH (1-24)|corticotropin-(1-24) tetracosapeptide	cortrosyn|cosyntropin|cortrosy	DRUGBANK	DB01284	C136H210N40O31S	small molecule	H01AA02	16960-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOEFCCMDUURGSE-XWTFHMIISA-N
15738	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	antagonist	target	Moraes RB (2010)	20562554	181041	1271	Tetracosactide	adrenocorticotropic hormone 1-24|1-24-corticotrophin|1-24-corticotrophin|Tetracosactrin|Adrenocorticotropic hormone fragment 1-24 human, rat|corticotropin-(1-24)|alpha(1-24)-corticotrophin|Tetracosactide|beta(1-24)-corticotrophin|Corticotropin tetracosapeptide|Cosyntropin|ATCH (1-24)|corticotropin-(1-24) tetracosapeptide	cortrosyn|cosyntropin|cortrosy	DRUGBANK	DB01284	C136H210N40O31S	small molecule	H01AA02	16960-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOEFCCMDUURGSE-XWTFHMIISA-N
15739	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	antagonist	target	Mehrabani PA (1990)	2156274	181040	1271	Tetracosactide	adrenocorticotropic hormone 1-24|1-24-corticotrophin|1-24-corticotrophin|Tetracosactrin|Adrenocorticotropic hormone fragment 1-24 human, rat|corticotropin-(1-24)|alpha(1-24)-corticotrophin|Tetracosactide|beta(1-24)-corticotrophin|Corticotropin tetracosapeptide|Cosyntropin|ATCH (1-24)|corticotropin-(1-24) tetracosapeptide	cortrosyn|cosyntropin|cortrosy	DRUGBANK	DB01284	C136H210N40O31S	small molecule	H01AA02	16960-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOEFCCMDUURGSE-XWTFHMIISA-N
15740	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	antagonist	target	Schwerin M (2005)	15710205	181039	1271	Tetracosactide	adrenocorticotropic hormone 1-24|1-24-corticotrophin|1-24-corticotrophin|Tetracosactrin|Adrenocorticotropic hormone fragment 1-24 human, rat|corticotropin-(1-24)|alpha(1-24)-corticotrophin|Tetracosactide|beta(1-24)-corticotrophin|Corticotropin tetracosapeptide|Cosyntropin|ATCH (1-24)|corticotropin-(1-24) tetracosapeptide	cortrosyn|cosyntropin|cortrosy	DRUGBANK	DB01284	C136H210N40O31S	small molecule	H01AA02	16960-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOEFCCMDUURGSE-XWTFHMIISA-N
15741	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	agonist	target	Carey LC (2006)	16478774	181042	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15742	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	agonist	target	Johnston H (2007)	17636172	181043	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15743	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	agonist	target	Suri D (2006)	17185906	181046	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15744	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	agonist	target	Lin L (2007)	17223989	181044	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15745	110328	4158	-	MC2R	ACTHR	9606	Homo sapiens	agonist	target	Hruby VJ (2007)	17584128	181045	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15746	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Hellman P (2006)	16467980	181051	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15747	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Zhao LF (2006)	16503922	181050	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15748	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Wagner U (2006)	16523405	181048	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15749	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Matejec R (2006)	16534240	181049	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15750	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	agonist	target	Dinan TG (2006)	16472586	181047	1272	Corticotropin	Acthar|H.P. acthar gel|ACTH|Cortigel|Adrenocorticotrophin|Corticotrophin|Adrenocorticotropic hormone	acthar gel hp inj 40unit/ml|ac	DRUGBANK	DB01285	C207H308N56O58S	biologic	H01AA01	12427-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15751	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15752	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Boterman M (2006)	16324695	181052	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15753	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Marone G (1984)	6203844	181055	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15754	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Coqueret O (1996)	8777955	181054	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15755	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bouillon T (1996)	8911881	181056	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15756	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	de Vries B (2001)	11730729	181053	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15757	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Hoffmann C (2004)	14730417	181057	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15758	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Hoffmann C (2004)	14730417	181057	1273	Fenoterol	3,5-Dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol|Phenoterol|Fenoterolum|5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol|1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane|1-(P-Hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane	berotec forte metered aer|bero	DRUGBANK	DB01288	C17H21NO4	small molecule	R03CC04|G02CA03|R03AL01|R03AC04	13392-18-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSLYOANBFKQKPT-UHFFFAOYSA-N
15759	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Szewczyk A (1997)	9015372	180852	1274	Glisoxepide	RP-22410|BAY-b-4231|FBB-4231|Glisoxepide	-	DRUGBANK	DB01289	C20H27N5O5S	small molecule	A10BB11	25046-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKUDBRCEOBOWLF-UHFFFAOYSA-N
15760	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	inhibitor	target	Sato T (2006)	16174795	180851	1274	Glisoxepide	RP-22410|BAY-b-4231|FBB-4231|Glisoxepide	-	DRUGBANK	DB01289	C20H27N5O5S	small molecule	A10BB11	25046-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKUDBRCEOBOWLF-UHFFFAOYSA-N
15761	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Leier CV (1982)	7053311	181059	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15762	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hamdad N (1996)	8945911	181058	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15763	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15764	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Carie AE (2007)	17260025	181060	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15765	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	van Zwieten PA (1988)	2901958	181061	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15766	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Kenakin TP (1984)	6143816	181062	1275	Pirbuterol	Pirbuterolum|(+/-)-pirbuterol	maxair aem 240mcg/aem	DRUGBANK	DB01291	C12H20N2O3	small molecule	R03AC08|R03CC07	38677-81-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQDBNKDJNJQRDG-UHFFFAOYSA-N
15767	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15768	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Shiraishi K (1992)	1358746	177189	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15769	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Loefdahl CG (1984)	6148733	181064	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15770	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Horinouchi T (2007)	17628611	174482	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15771	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Dukes ID (1985)	2858236	181066	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15772	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Hino T (1989)	2568629	181065	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15773	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Vaughan Williams EM (1987)	2888789	181063	1277	Bevantolol	Bevantololum|1-((2-(3,4-Dimethoxyphenyl)ethyl)amino)-3-(3-methylphenoxy)-2-propanol|1-(3,4-Dimethoxyphenethylamino)-3-m-tolyloxy-propan-2-ol|1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-m-tolyloxy-propan-2-ol|(+-)-Bevantolol|1-(3,4-Dimethoxyphenethylamino)-3-(m-tolyloxy)-2-propanol	-	DRUGBANK	DB01295	C20H27NO4	small molecule	C07BB06|C07AB06	59170-23-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXLAFSUPPDYFEO-UHFFFAOYSA-N
15774	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Chen JT (2006)	16431966	181067	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15775	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Sarrazin S (2005)	16155294	181068	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15776	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Lortat-Jacob H (2006)	16709188	181069	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15777	109680	3458	-	IFNG	IFG|IFI	9606	Homo sapiens	unknown	target	Chen JT (2006)	17238806	181070	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15778	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Fenton JI (2002)	12405690	181073	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15779	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Dodge GR (2003)	12801482	181072	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15780	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Chu SC (2006)	16756968	181071	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15781	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Mendis E (2006)	16616490	181075	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15782	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	antagonist	target	Rajapakse N (2007)	17498959	181074	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15783	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Lapaque N (2006)	16469053	181079	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15784	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Chen JT (2006)	16431966	181067	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15785	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Yi HA (2005)	16445576	181077	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15786	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Bitler CM (2005)	15930455	181076	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15787	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Delcommenne M (2002)	12244074	181078	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15788	110858	4791	-	NFKB2	CVID10|H2TF1|LYT-10|LYT10|NF-kB2|p100|p52	9606	Homo sapiens	antagonist	target	Largo R (2003)	12681956	181080	1278	Glucosamine	2-Amino-2-deoxy-D-glucose|Chitosamine|D-Glucosamine	remaxazon external patch	DRUGBANK	DB01296	C6H13NO5	small molecule	M01AX05	3416-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-IVMDWMLBSA-N
15789	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Keyrilaeinen O (1978)	30388	181083	1279	Practolol	N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum	-	DRUGBANK	DB01297	C14H22N2O3	small molecule	C07AB01	6673-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DURULFYMVIFBIR-UHFFFAOYSA-N
15790	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1279	Practolol	N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum	-	DRUGBANK	DB01297	C14H22N2O3	small molecule	C07AB01	6673-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DURULFYMVIFBIR-UHFFFAOYSA-N
15791	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Saarnivaara L (1984)	6524278	181082	1279	Practolol	N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum	-	DRUGBANK	DB01297	C14H22N2O3	small molecule	C07AB01	6673-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DURULFYMVIFBIR-UHFFFAOYSA-N
15792	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Abrahamsson T (1986)	2871880	178780	1279	Practolol	N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum	-	DRUGBANK	DB01297	C14H22N2O3	small molecule	C07AB01	6673-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DURULFYMVIFBIR-UHFFFAOYSA-N
15793	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Buxton IL (1985)	2857116	181081	1279	Practolol	N-(4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)acetamide|1-(4-Acetamidophenoxy)-3-isopropylamino-2-propanol|4'-(2-Hydroxy-3-(isopropylamino)propoxy)acetanilide|Tocris-0831|(+-)-Practolol|Practololum	-	DRUGBANK	DB01297	C14H22N2O3	small molecule	C07AB01	6673-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DURULFYMVIFBIR-UHFFFAOYSA-N
15794	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	1280	Sulfacytine	1-ethyl-N-sulfanilylcytosine|N-sulfanilyl-l-ethylcytosine|Sulfacitina|Renoquid|Sulfacitinum|1-ethyl N4-sulfanilylcytosin	-	DRUGBANK	DB01298	C12H14N4O3S	small molecule	-	17784-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIBQAECNSSQUOD-UHFFFAOYSA-N
15795	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hughes J (1975)	1195474	181084	1280	Sulfacytine	1-ethyl-N-sulfanilylcytosine|N-sulfanilyl-l-ethylcytosine|Sulfacitina|Renoquid|Sulfacitinum|1-ethyl N4-sulfanilylcytosin	-	DRUGBANK	DB01298	C12H14N4O3S	small molecule	-	17784-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIBQAECNSSQUOD-UHFFFAOYSA-N
15796	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	1280	Sulfacytine	1-ethyl-N-sulfanilylcytosine|N-sulfanilyl-l-ethylcytosine|Sulfacitina|Renoquid|Sulfacitinum|1-ethyl N4-sulfanilylcytosin	-	DRUGBANK	DB01298	C12H14N4O3S	small molecule	-	17784-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIBQAECNSSQUOD-UHFFFAOYSA-N
15797	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Carrasco-Pancorbo A (2008)	18501371	181085	1282	Rolitetracycline	Pyrrolidino-methyl-tetracycline|Rolitetracyclinum|Reverin|Synterin|N-(Pyrrolidinomethyl)tetracycline|N-(1-Pyrrolidinylmethyl)-tetracycline|Rolitetraciclina	reverin 275mg	DRUGBANK	DB01301	C27H33N3O8	small molecule	J01AA09	751-97-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMEYVGGHISAPJR-IAHYZSEUSA-N
15798	853248	949000	b3230	rpsI	ECK3219|JW3199	511145	Escherichia coli	inhibitor	target	Griffin MO (2010)	20592239	174691	1282	Rolitetracycline	Pyrrolidino-methyl-tetracycline|Rolitetracyclinum|Reverin|Synterin|N-(Pyrrolidinomethyl)tetracycline|N-(1-Pyrrolidinylmethyl)-tetracycline|Rolitetraciclina	reverin 275mg	DRUGBANK	DB01301	C27H33N3O8	small molecule	J01AA09	751-97-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMEYVGGHISAPJR-IAHYZSEUSA-N
15799	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Wang K (2002)	12421478	174828	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15800	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Rickards KJ (2003)	12887610	174829	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15801	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Haider S (2003)	12547256	174825	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15802	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Usta C (2004)	15253881	174826	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15803	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Lee JM (2004)	15351234	174827	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15804	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Rickards KJ (2003)	12887610	174829	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15805	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Kajikawa S (2006)	16651698	174832	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15806	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Wu BN (2004)	15237094	174831	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15807	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Nantwi KD (2004)	14992338	174820	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15808	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15809	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	activator	target	Cosio BG (2004)	15337792	174834	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15810	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	activator	target	Ito K (2002)	12070353	174833	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15811	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15812	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Pechlivanova DM (2005)	16357952	174830	1283	Oxtriphylline	Oxtriphylline|Theophyline - choline mixt|Theocolin|Choline theophylline|Choline theophyllinate	apo oxtriphylline tab 100mg|no	DRUGBANK	DB01303	C12H21N5O3	small molecule	R03DA02|R03DB02	4499-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLANKEDHRWMNRO-UHFFFAOYSA-M
15813	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Zib I (2006)	17026485	181086	1284	Insulin Aspart	Aspart|Insulin X14|Insulin, Asp(B28)|INA-X14|Insulin aspart recombinant|B28-Aspart-Insulin|Aspart Insulin|Insulin aspart protamine recombinant	novorapid|novolog mix 70/30|no	DRUGBANK	DB01306	C256H381N65O79S6	biologic	A10AB05|A10AD06|A10AD05	116094-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15814	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1284	Insulin Aspart	Aspart|Insulin X14|Insulin, Asp(B28)|INA-X14|Insulin aspart recombinant|B28-Aspart-Insulin|Aspart Insulin|Insulin aspart protamine recombinant	novorapid|novolog mix 70/30|no	DRUGBANK	DB01306	C256H381N65O79S6	biologic	A10AB05|A10AD06|A10AD05	116094-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15815	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Wada T (2008)	18585815	172022	1285	Insulin Detemir	Insulin,detemir,human|Insulin detemir recombinant|Detemir	levemir flextouch|levemir|leve	DRUGBANK	DB01307	C267H402N64O76S6	biologic	A10AE05	169148-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15816	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Hennige AM (2006)	16570163	181087	1285	Insulin Detemir	Insulin,detemir,human|Insulin detemir recombinant|Detemir	levemir flextouch|levemir|leve	DRUGBANK	DB01307	C267H402N64O76S6	biologic	A10AE05	169148-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15817	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1285	Insulin Detemir	Insulin,detemir,human|Insulin detemir recombinant|Detemir	levemir flextouch|levemir|leve	DRUGBANK	DB01307	C267H402N64O76S6	biologic	A10AE05	169148-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15818	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Sorensen AR (2010)	20590743	181088	1285	Insulin Detemir	Insulin,detemir,human|Insulin detemir recombinant|Detemir	levemir flextouch|levemir|leve	DRUGBANK	DB01307	C267H402N64O76S6	biologic	A10AE05	169148-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15819	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Kurtzhals P (2000)	10866053	181089	1285	Insulin Detemir	Insulin,detemir,human|Insulin detemir recombinant|Detemir	levemir flextouch|levemir|leve	DRUGBANK	DB01307	C267H402N64O76S6	biologic	A10AE05	169148-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15820	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Sciacca L (2010)	20424816	172019	1286	Insulin Glulisine	Insulin Glulisine (recombinant DNA origin)|Insulin glulisine recombinant	apidra solostar|apidra	DRUGBANK	DB01309	C258H384N64O78S6	biologic	A10AB06	207748-29-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15821	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1286	Insulin Glulisine	Insulin Glulisine (recombinant DNA origin)|Insulin glulisine recombinant	apidra solostar|apidra	DRUGBANK	DB01309	C258H384N64O78S6	biologic	A10AB06	207748-29-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15822	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Chen X (2002)	11752352	171740	1287	Fosamprenavir	Fosamprenavir	telzir|lexiva	DRUGBANK	DB01319	C25H36N3O9PS	small molecule	J05AE07	226700-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLBVMOWEQCZNCC-OEMFJLHTSA-N
15823	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Furfine ES (2004)	14982766	181094	1287	Fosamprenavir	Fosamprenavir	telzir|lexiva	DRUGBANK	DB01319	C25H36N3O9PS	small molecule	J05AE07	226700-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLBVMOWEQCZNCC-OEMFJLHTSA-N
15824	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wire MB (2006)	16485915	181091	1287	Fosamprenavir	Fosamprenavir	telzir|lexiva	DRUGBANK	DB01319	C25H36N3O9PS	small molecule	J05AE07	226700-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLBVMOWEQCZNCC-OEMFJLHTSA-N
15825	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wood R (2004)	14693528	181090	1287	Fosamprenavir	Fosamprenavir	telzir|lexiva	DRUGBANK	DB01319	C25H36N3O9PS	small molecule	J05AE07	226700-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLBVMOWEQCZNCC-OEMFJLHTSA-N
15826	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Hoffman RM (2007)	18042502	181093	1287	Fosamprenavir	Fosamprenavir	telzir|lexiva	DRUGBANK	DB01319	C25H36N3O9PS	small molecule	J05AE07	226700-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLBVMOWEQCZNCC-OEMFJLHTSA-N
15827	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Sension M (2004)	15116286	181092	1287	Fosamprenavir	Fosamprenavir	telzir|lexiva	DRUGBANK	DB01319	C25H36N3O9PS	small molecule	J05AE07	226700-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLBVMOWEQCZNCC-OEMFJLHTSA-N
15828	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Lenkowski PW (2004)	15066664	176695	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15829	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Mantegazza M (2010)	20298965	174680	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15830	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15831	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Swadron SP (2004)	15001403	174682	1288	Fosphenytoin	Fosphenytoin|Cerebyx|Fosphenytoine|Fosphenytoinum|Fosfenitoina|(3-Phosphoryloxymethyl)phenytoin	fosphenytoin|cerebyx|fosphenyt	DRUGBANK	DB01320	C16H15N2O6P	small molecule	N03AB05	93390-81-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWLUWCNOOVRFPX-UHFFFAOYSA-N
15832	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Frindt G (2002)	12217863	181095	1292	Polythiazide	Renese	-	DRUGBANK	DB01324	C11H13ClF3N3O4S3	small molecule	C03AA05|C03AB05	346-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYLWJCABXYDINA-UHFFFAOYSA-N
15833	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1292	Polythiazide	Renese	-	DRUGBANK	DB01324	C11H13ClF3N3O4S3	small molecule	C03AA05|C03AB05	346-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYLWJCABXYDINA-UHFFFAOYSA-N
15834	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Monroy A (2000)	10894798	176048	1292	Polythiazide	Renese	-	DRUGBANK	DB01324	C11H13ClF3N3O4S3	small molecule	C03AA05|C03AB05	346-18-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYLWJCABXYDINA-UHFFFAOYSA-N
15835	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Ellison DH (2003)	12538756	181097	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15836	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Ko B (2009)	19636250	181096	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15837	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Duarte JD (2010)	20528637	181099	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15838	112447	6558	-	SLC12A2	BSC|BSC2|NKCC1|PPP1R141	9606	Homo sapiens	inhibitor	target	Gamba G (2009)	19474192	181098	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15839	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Ellison DH (2003)	12538756	181097	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15840	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Ko B (2009)	19636250	181096	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15841	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Duarte JD (2010)	20528637	181099	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15842	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Gamba G (2009)	19474192	181098	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15843	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18374572	181102	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15844	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18600270	181101	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15845	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18336309	181100	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15846	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Ellison DH (2003)	12538756	181097	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15847	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Ko B (2009)	19636250	181096	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15848	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Duarte JD (2010)	20528637	181099	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15849	112448	6559	-	SLC12A3	NCC|NCCT|TSC	9606	Homo sapiens	inhibitor	target	Gamba G (2009)	19474192	181098	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15850	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18374572	181102	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15851	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Temperini C (2008)	18600270	181101	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15852	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Supuran CT (2008)	18336309	181100	1293	Quinethazone	Quinetazona|Hydromox|Quinethazon|Chinetazone|Chinethazonum|Quinethazonum	-	DRUGBANK	DB01325	C10H12ClN3O3S	small molecule	C03BB02|C03BA02	73-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMMTXLNIQSRCG-UHFFFAOYSA-N
15853	111440	5444	-	PON1	ESA|MVCD5|PON	9606	Homo sapiens	inhibitor	target	Sinan S (2006)	16600468	181103	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15854	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15855	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15856	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15857	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15858	851484	947152	b2519	pbpC	ECK2515|JW2503|yfgN	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15859	851484	947152	b2519	pbpC	ECK2515|JW2503|yfgN	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15860	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15861	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15862	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15863	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1295	Cefazolin	CEZ|Cefazolina|Cefazoline|Cephazoline|(6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefazolinum|Cephazolin|Cephamezine|Cefamezin|Cephazolidin	kefzol add-vantage inj 500mg/v	DRUGBANK	DB01327	C14H14N8O4S3	small molecule	J01DB04	25953-19-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLYYVTUWGNIJIB-BXKDBHETSA-N
15864	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Rake JB (1984)	6376452	181105	1296	Cefonicid	Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum	-	DRUGBANK	DB01328	C18H18N6O8S3	small molecule	J01DC06	61270-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYAIAHUQIPBDIP-AXAPSJFSSA-N
15865	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Rake JB (1984)	6376452	181105	1296	Cefonicid	Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum	-	DRUGBANK	DB01328	C18H18N6O8S3	small molecule	J01DC06	61270-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYAIAHUQIPBDIP-AXAPSJFSSA-N
15866	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Rake JB (1984)	6376452	181105	1296	Cefonicid	Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum	-	DRUGBANK	DB01328	C18H18N6O8S3	small molecule	J01DC06	61270-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYAIAHUQIPBDIP-AXAPSJFSSA-N
15867	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Rake JB (1984)	6376452	181105	1296	Cefonicid	Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum	-	DRUGBANK	DB01328	C18H18N6O8S3	small molecule	J01DC06	61270-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYAIAHUQIPBDIP-AXAPSJFSSA-N
15868	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Rake JB (1984)	6376452	181105	1296	Cefonicid	Cefonicido|(6R,7R)-7-{[(2R)-2-hydroxy-2-phenylacetyl]amino}-8-oxo-3-({[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefonicid|Cefonicidum	-	DRUGBANK	DB01328	C18H18N6O8S3	small molecule	J01DC06	61270-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYAIAHUQIPBDIP-AXAPSJFSSA-N
15869	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15870	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15871	849607	945222	b0632	dacA	ECK0625|JW0627|pfv	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15872	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15873	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15874	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15875	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Matsubara N (1980)	6448021	175999	1297	Cefoperazone	Cefoperazonum|(6R,7R)-7-[[2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefoperazono|Cefoperazone|(6R,7R)-7-((R)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarboxamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazol-5-yl)thiomethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carbonsaeure	-	DRUGBANK	DB01329	C25H27N9O8S2	small molecule	J01DD62|J01DD12	62893-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCFBRXLSHGKWDP-WTKTZPJXSA-N
15876	849829	945455	b0839	dacC	ECK0829|JW0823	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15877	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15878	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15879	849607	945222	b0632	dacA	ECK0625|JW0627|pfv	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15880	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15881	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15882	851004	946662	b2134	pbpG	ECK2127|JW5355|psv|yohB	511145	Escherichia coli	inhibitor	target	Matsuhashi M (1978)	368000	181106	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
15883	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Shigi Y (1981)	7018389	181107	1300	Ceftizoxime	CEFIZOX|Syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid|Ceftizoxime|Ceftizoxima|Ceftizoximum|7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	cefizox	DRUGBANK	DB01332	C13H13N5O5S2	small molecule	J01DD07	68401-81-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNULBSISHYWZJU-LLKWHZGFSA-N
15884	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Shigi Y (1981)	7018389	181107	1300	Ceftizoxime	CEFIZOX|Syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid|Ceftizoxime|Ceftizoxima|Ceftizoximum|7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	cefizox	DRUGBANK	DB01332	C13H13N5O5S2	small molecule	J01DD07	68401-81-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNULBSISHYWZJU-LLKWHZGFSA-N
15885	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Shigi Y (1981)	7018389	181107	1300	Ceftizoxime	CEFIZOX|Syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)-3-cephem-4-carboxylic acid|Ceftizoxime|Ceftizoxima|Ceftizoximum|7-[2-(2-Amino-thiazol-4-yl)-2-methoxyimino-acetylamino]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	cefizox	DRUGBANK	DB01332	C13H13N5O5S2	small molecule	J01DD07	68401-81-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNULBSISHYWZJU-LLKWHZGFSA-N
15886	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Sharma UK (1995)	7592463	181108	1301	Cefradine	Eskacef|CED|(6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Sefril|7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid|Velosef|Cefradinum|(6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefradina|Anspor|Cefradine|Cephradine|Cephradin	-	DRUGBANK	DB01333	C16H19N3O4S	small molecule	J01DB09	38821-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDLPVSKMFDYCOR-UEKVPHQBSA-N
15887	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Groebe DR (1994)	8132625	181110	1302	Metocurine	Dimethyltubocurarine	-	DRUGBANK	DB01336	C40H48N2O6	small molecule	M03AA04	5152-30-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFXBEKISTKFVAB-AJQTZOPKSA-N
15888	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2009)	18842832	181111	1302	Metocurine	Dimethyltubocurarine	-	DRUGBANK	DB01336	C40H48N2O6	small molecule	M03AA04	5152-30-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFXBEKISTKFVAB-AJQTZOPKSA-N
15889	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1302	Metocurine	Dimethyltubocurarine	-	DRUGBANK	DB01336	C40H48N2O6	small molecule	M03AA04	5152-30-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFXBEKISTKFVAB-AJQTZOPKSA-N
15890	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2008)	18633030	175926	1302	Metocurine	Dimethyltubocurarine	-	DRUGBANK	DB01336	C40H48N2O6	small molecule	M03AA04	5152-30-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFXBEKISTKFVAB-AJQTZOPKSA-N
15891	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Wang HL (2003)	12799358	181109	1302	Metocurine	Dimethyltubocurarine	-	DRUGBANK	DB01336	C40H48N2O6	small molecule	M03AA04	5152-30-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFXBEKISTKFVAB-AJQTZOPKSA-N
15892	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Son SL (1980)	7437219	181112	1302	Metocurine	Dimethyltubocurarine	-	DRUGBANK	DB01336	C40H48N2O6	small molecule	M03AA04	5152-30-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFXBEKISTKFVAB-AJQTZOPKSA-N
15893	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Okanlami OA (1996)	8572329	181113	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15894	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Milchert M (2009)	20400785	178072	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15895	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15896	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Dilger JP (2007)	17525594	181114	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15897	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson Fagerlund M (2009)	19417616	178070	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15898	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Cembala TM (2007)	17588565	176410	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15899	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Okanlami OA (1996)	8572329	181113	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15900	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Milchert M (2009)	20400785	178072	1303	Pancuronium	Bromuro de pancuronio|Bromure de pancuronium|Pancuronium	pancuronium bromide|pancuroniu	DRUGBANK	DB01337	C35H60N2O4	small molecule	M03AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVEAYVLWDAFXET-XGHATYIMSA-N
15901	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Karpati E (2002)	12426786	181115	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15902	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15903	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15904	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Karpati E (2002)	12426786	181115	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15905	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Kiss JP (1997)	9227834	181116	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15906	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Toeroecsik A (1991)	1748153	181117	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15907	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Zappi L (1999)	10598601	181118	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15908	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Karpati E (2002)	12426786	181115	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15909	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	1304	Pipecuronium	Pipecuronium|Pipecurium	-	DRUGBANK	DB01338	C35H62N4O4	small molecule	M03AC06	68399-58-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWLUIWOFHMHOQ-XGHATYIMSA-N
15910	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Paul M (2002)	12145052	181119	1305	Vecuronium	Vecuronium	vecuronium bromide for injecti	DRUGBANK	DB01339	C34H57N2O4	small molecule	M03AC03	86029-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGSZAXLLHYERSY-XQIGCQGXSA-N
15911	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Liu M (2008)	18633030	175926	1305	Vecuronium	Vecuronium	vecuronium bromide for injecti	DRUGBANK	DB01339	C34H57N2O4	small molecule	M03AC03	86029-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGSZAXLLHYERSY-XQIGCQGXSA-N
15912	107557	1135	-	CHRNA2	-	9606	Homo sapiens	antagonist	target	Jonsson Fagerlund M (2009)	19417616	178070	1305	Vecuronium	Vecuronium	vecuronium bromide for injecti	DRUGBANK	DB01339	C34H57N2O4	small molecule	M03AC03	86029-43-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGSZAXLLHYERSY-XQIGCQGXSA-N
15913	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Hannedouche T (1992)	1382161	181125	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15914	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Yoshiyama M (1999)	10205231	181124	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15915	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Kihara M (1999)	10398211	181121	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15916	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Mervaala E (1999)	10446934	181120	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15917	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tylicki L (2008)	18423812	181123	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15918	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Rosendorff C (1992)	1382157	181122	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15919	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15920	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1307	Dihydroquinidine barbiturate	-	-	DRUGBANK	DB01341	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15921	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1307	Dihydroquinidine barbiturate	-	-	DRUGBANK	DB01341	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15922	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Hagmann M (1997)	9156352	181127	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15923	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Usune S (1996)	8981065	181126	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15924	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15925	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Tokunaga R (2001)	11569611	181128	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15926	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Simon WA (2007)	17369284	181132	1310	Potassium	K|UN2257|UN1420|Kalium|Potassium alloy	complexed potassium tablets - 	DRUGBANK	DB01345	-	small molecule	C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04	7440-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15927	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Li C (2007)	17347782	181129	1310	Potassium	K|UN2257|UN1420|Kalium|Potassium alloy	complexed potassium tablets - 	DRUGBANK	DB01345	-	small molecule	C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04	7440-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15928	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Silva E (2007)	17334838	181133	1310	Potassium	K|UN2257|UN1420|Kalium|Potassium alloy	complexed potassium tablets - 	DRUGBANK	DB01345	-	small molecule	C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04	7440-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15929	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Iannello S (2007)	17444965	181130	1310	Potassium	K|UN2257|UN1420|Kalium|Potassium alloy	complexed potassium tablets - 	DRUGBANK	DB01345	-	small molecule	C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04	7440-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15930	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Stanely Mainzen Prince P (2007)	17366541	181131	1310	Potassium	K|UN2257|UN1420|Kalium|Potassium alloy	complexed potassium tablets - 	DRUGBANK	DB01345	-	small molecule	C03AB06|C03AB07|C03AB04|C03AB05|C03AB02|C03AB03|C03AB01|B05XA17|C03AB08|C03AB09|C03BB05|C03BB03|C03BB02|C03BB07|C03CB01|C03CB02|C03BB04	7440-09-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15931	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15932	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Stobbs SH (2004)	15169831	181134	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15933	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15934	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Stobbs SH (2004)	15169831	181134	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15935	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15936	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15937	109976	3775	RP4-550F15.1	KCNK1	DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1	9606	Homo sapiens	inhibitor	target	Lesage F (1996)	8605869	179010	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15938	109976	3775	RP4-550F15.1	KCNK1	DPK|HOHO|K2P1|K2p1.1|KCNO1|TWIK-1|TWIK1	9606	Homo sapiens	inhibitor	target	Fink M (1996)	9003761	179011	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15939	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Stobbs SH (2004)	15169831	181134	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15940	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15941	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15942	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15943	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15944	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15945	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Itoh H (2005)	15877619	179012	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15946	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Stokoe KS (2007)	17023504	179013	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15947	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Grant AO (2005)	16138883	179016	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15948	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Ohgo T (2007)	17556186	179014	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15949	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Napolitano C (2006)	16972995	179015	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15950	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15951	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Tella SR (1998)	9476974	177548	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15952	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sheets MF (2010)	20685573	175038	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15953	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1312	Saprisartan	-	-	DRUGBANK	DB01347	C25H22BrF3N4O4S	small molecule	-	146623-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUEWVPTZCSAMNB-UHFFFAOYSA-N
15954	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Timmermans PB (1999)	10579749	181135	1312	Saprisartan	-	-	DRUGBANK	DB01347	C25H22BrF3N4O4S	small molecule	-	146623-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUEWVPTZCSAMNB-UHFFFAOYSA-N
15955	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Hermida RC (2010)	20524801	181136	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15956	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Maul B (2005)	16126915	181137	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15957	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15958	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15959	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Arend U (2002)	12613273	181138	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15960	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15961	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Elokdah HM (2002)	12113820	181140	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15962	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Unger T (2001)	11683476	181141	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15963	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Maillard MP (2000)	11046101	181139	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15964	106692	186	-	AGTR2	AT2|ATGR2|MRX88	9606	Homo sapiens	antagonist	target	Unger T (2001)	11683476	181141	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15965	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15966	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15967	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15968	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15969	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15970	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15971	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15972	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15973	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15974	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15975	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15976	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15977	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15978	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15979	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15980	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15981	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15982	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15983	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15984	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15985	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15986	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15987	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15988	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15989	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15990	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15991	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15992	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15993	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15994	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15995	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15996	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15997	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15998	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15999	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16000	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16001	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16002	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16003	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16004	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16005	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16006	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16007	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16008	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16009	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16010	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16011	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16012	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16013	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16014	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16015	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16016	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16017	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16018	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16019	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16020	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16021	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16022	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16023	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16024	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16025	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16026	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16027	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16028	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16029	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16030	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16031	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16032	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16033	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16034	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16035	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16036	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16037	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16038	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16039	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16040	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16041	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16042	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16043	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16044	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16045	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16046	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16047	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16048	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16049	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16050	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16051	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16052	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16053	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16054	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16055	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16056	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16057	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16058	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16059	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16060	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16061	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16062	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16063	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16064	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16065	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16066	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16067	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16068	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16069	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16070	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Tomlin SL (1999)	10360871	181142	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16071	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16072	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16073	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16074	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16075	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16076	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16077	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16078	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16079	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16080	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16081	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16082	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16083	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16084	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16085	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16086	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16087	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16088	109187	2932	-	GSK3B	-	9606	Homo sapiens	inhibitor	target	Borsotto M (2007)	16733521	181143	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16089	109187	2932	-	GSK3B	-	9606	Homo sapiens	inhibitor	target	Adli M (2007)	17628506	181145	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16090	109187	2932	-	GSK3B	-	9606	Homo sapiens	inhibitor	target	O'Brien WT (2009)	19754466	181144	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16091	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	potentiator	target	Karkanias NB (1999)	10626836	181146	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16092	109826	3613	-	IMPA2	-	9606	Homo sapiens	inhibitor	target	Ohnishi T (2007)	17068342	181149	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16093	109826	3613	-	IMPA2	-	9606	Homo sapiens	inhibitor	target	Cryns K (2007)	16841073	181148	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16094	109826	3613	-	IMPA2	-	9606	Homo sapiens	inhibitor	target	Ohnishi T (2007)	17251911	181147	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16095	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	inhibitor	target	Ohnishi T (2007)	17251911	181147	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16096	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	inhibitor	target	Trinquet E (2006)	16965760	181151	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16097	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	inhibitor	target	Sarkar S (2006)	16874097	181152	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16098	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	inhibitor	target	Li Z (2010)	20027624	181153	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16099	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	inhibitor	target	Tanizawa Y (2006)	17158747	181150	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16100	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	inhibitor	target	Ohnishi T (2007)	17068342	181149	1320	Lithium	Lithium, ion|Lithium cation|Lithium ion|Li(+)|Lithium, ion (li1+)	lithium carbonate|carbolith ca	DRUGBANK	DB01356	Li	small molecule	N05AN01	7439-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBGRARXTFLTSG-UHFFFAOYSA-N
16101	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Cleuren AC (2010)	20524981	181154	1321	Mestranol	-	ortho-novum 1/50 tablets (28 d	DRUGBANK	DB01357	C21H26O2	small molecule	-	72-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMSSROKUHAOUJS-ZTUUXWJNNA-N
16102	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Dulos J (2010)	20497523	181155	1321	Mestranol	-	ortho-novum 1/50 tablets (28 d	DRUGBANK	DB01357	C21H26O2	small molecule	-	72-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMSSROKUHAOUJS-ZTUUXWJNNA-N
16103	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1321	Mestranol	-	ortho-novum 1/50 tablets (28 d	DRUGBANK	DB01357	C21H26O2	small molecule	-	72-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMSSROKUHAOUJS-ZTUUXWJNNA-N
16104	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Rabiner EA (2000)	10942852	181156	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16105	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Hjorth S (1992)	1468487	181157	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16106	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Kulkarni RD (1977)	16716	181161	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16107	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Hjorth S (1996)	8982649	181160	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16108	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Sanchez C (1993)	11224195	181163	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16109	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Frishman WH (1990)	2189902	181162	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16110	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Ijzerman AP (1987)	2446632	181158	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16111	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Hjorth S (1993)	8098761	181159	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16112	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Kulkarni RD (1977)	16716	181161	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16113	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Hjorth S (1996)	8982649	181160	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16114	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sanchez C (1993)	11224195	181163	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16115	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Frishman WH (1990)	2189902	181162	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16116	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Ijzerman AP (1987)	2446632	181158	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16117	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Hjorth S (1993)	8098761	181159	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16118	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Sanchez C (1993)	11224195	181163	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16119	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Frishman WH (1990)	2189902	181162	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16120	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Venter CP (1982)	6755764	181165	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16121	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Doze P (2002)	11738481	181164	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16122	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Sanchez C (1993)	11224195	181163	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16123	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Frishman WH (1990)	2189902	181162	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16124	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Venter CP (1982)	6755764	181165	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16125	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Doze P (2002)	11738481	181164	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16126	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Hjorth S (1993)	8098761	181159	1322	Penbutolol	Levatol|HOE 893|Penbutololum|HOE 893D|1-(tert-Butylamino)-3-(o-cyclopentylphenoxy)propan-2-ol|2-Propanol, 1-(2-cyclopentylphenoxy)-3-((1,1-dimethylethyl)amino)-, (S)-|(2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol|Penbutolol	-	DRUGBANK	DB01359	C18H29NO2	small molecule	C07AA23|C07CA23	38363-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXKVJAGOJTNJS-HNNXBMFYSA-N
16127	852130	947818	b3319	rplD	ECK3306|JW3281|eryA	511145	Escherichia coli	inhibitor	target	Scharre KA (1981)	6972981	181166	1323	Troleandomycin	Troleandomycin|Triacetyloleandomycin|TAO	-	DRUGBANK	DB01361	C41H67NO15	small molecule	J01FA08	2751-09-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQCLVBQBTUVCEQ-QTFUVMRISA-N
16128	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Vansal SS (1999)	10449190	178696	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16129	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16130	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Rothman RB (2003)	12954796	174149	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16131	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Wee S (2004)	15189772	178697	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16132	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Haughey HM (2000)	10773193	181167	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16133	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16134	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Kobayashi S (2003)	14570629	181168	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16135	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Rothman RB (2003)	12954796	174149	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16136	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16137	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16138	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Wee S (2004)	15189772	178697	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16139	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16140	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16141	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Kobayashi S (2003)	14570629	181168	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16142	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Rothman RB (2003)	12954796	174149	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16143	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16144	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16145	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16146	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Vansal SS (1999)	10449190	178696	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16147	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16148	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Rothman RB (2003)	12954796	174149	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16149	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Wee S (2004)	15189772	178697	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16150	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Haughey HM (2000)	10773193	181167	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16151	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16152	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Vansal SS (1999)	10449190	178696	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16153	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16154	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Henry JP (1998)	9587917	181169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16155	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16156	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Kobayashi S (2003)	14570629	181168	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16157	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Rothman RB (2003)	12954796	174149	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16158	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16159	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16160	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Henry JP (1998)	9587917	181169	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16161	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1325	Ephedra	Chinese jointfir|Ma huang|Indian jointfir	stacker 2 nasal decongestant|e	DRUGBANK	DB01363	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16162	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Singh AK (1998)	9568379	181170	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16163	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inverse agonist	target	Fleckenstein AE (2007)	17209801	174169	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16164	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inverse agonist	target	Kobayashi S (2003)	14570629	181168	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16165	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inverse agonist	target	McMahon LR (2003)	12757963	181171	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16166	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inverse agonist	target	Sulzer D (2005)	15955613	174152	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16167	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Wellman PJ (2003)	12557268	181172	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16168	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Ma G (2007)	17405867	181173	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16169	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16170	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16171	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Yasumoto S (2009)	19429089	181176	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16172	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (1995)	7751968	174151	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16173	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16174	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Horton DB (2011)	21177475	181175	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
16176	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16177	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16178	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16179	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16180	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16181	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16182	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16183	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16184	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16185	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16186	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16187	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16188	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16189	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Ahlquist RP (1976)	10722	179931	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16190	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Mohta M (2010)	21182601	181177	1327	Mephentermine	Mephentermine	wyamine sulfate injection liq 	DRUGBANK	DB01365	C11H17N	small molecule	C01CA11	100-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQCGGRTAILOIN-UHFFFAOYSA-N
16191	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Kobayashi M (2002)	12428391	181178	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16192	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Aizawa H (1991)	1684063	181179	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16193	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Brodde OE (1990)	1968366	181182	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16194	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Noguchi K (1991)	1682484	181181	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16195	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Yamasaki Y (2004)	15069780	181180	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16196	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1328	Procaterol	-	pro-air aerosol 10mcg/aem	DRUGBANK	DB01366	C16H22N2O3	small molecule	R03AC16|R03CC08	72332-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKNXQNWAXFXVNW-BLLLJJGKSA-N
16197	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	activator	target	Bar-Am O (2005)	16148027	181187	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16198	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	activator	target	Youdim MB (2001)	12043833	181186	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16199	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	activator	target	Maruyama W (2002)	12200198	181185	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16200	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	activator	target	Youdim MB (2003)	14555244	181184	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16201	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	activator	target	Akao Y (2002)	12057839	181183	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16202	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Youdim MB (2001)	12043833	181186	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16203	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16204	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chen JJ (2007)	18035186	181189	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16205	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Naoi M (2009)	19673610	181188	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16206	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Youdim MB (2004)	15573406	181190	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16207	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Weinreb O (2010)	20600573	181191	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16208	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chau KY (2010)	20624440	181192	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16209	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Leegwater-Kim J (2010)	20517484	181193	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16210	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Uzun M (2009)	19499843	181194	1329	Rasagiline	(R)-Indan-1-yl-prop-2-ynyl-amine|(1R)-N-Propargylindan-1-amine|RAS|(R)-N-2-Propynyl-1-indanamine	apo-rasagiline|teva-rasagiline	DRUGBANK	DB01367	C12H13N	small molecule	N04BD02	136236-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-GFCCVEGCSA-N
16211	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16212	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Kohila T (2004)	15254985	181198	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16213	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Kohila T (2004)	15651920	181199	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16214	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Amador FC (2001)	15111247	181195	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16215	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Silva VS (2003)	14507470	181196	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16216	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Menz RI (2001)	11509182	181197	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16217	112876	7018	PRO1400	TF	PRO1557|PRO2086|TFQTL1	9606	Homo sapiens	unknown	target	Nagaoka MH (2005)	16139893	181200	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16218	112876	7018	PRO1400	TF	PRO1557|PRO2086|TFQTL1	9606	Homo sapiens	unknown	target	Nolte E (2001)	11327511	181201	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16219	112876	7018	PRO1400	TF	PRO1557|PRO2086|TFQTL1	9606	Homo sapiens	unknown	target	Mizutani K (2005)	16301797	181202	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16220	112876	7018	PRO1400	TF	PRO1557|PRO2086|TFQTL1	9606	Homo sapiens	unknown	target	Beardmore J (2007)	17629565	181203	1331	Aluminium	Aluminio|Aluminium|13Al|Al|Aluminum	humco aluminum acetate (burrow	DRUGBANK	DB01370	Al	small molecule	-	7429-90-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAGFODPZIPBFFR-UHFFFAOYSA-N
16221	112589	6711	-	SPTBN1	ELF|HEL102|SPTB2|betaSpII	9606	Homo sapiens	agonist	target	Wallis CJ (1992)	1537825	181204	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16222	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	ligand	target	Boda D (2011)	21303162	181205	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16223	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	agonist	target	Bonza MC (2010)	20573858	181206	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16224	117963	27032	HUSSY-28	ATP2C1	ATP2C1A|BCPM|HHD|PMR1|SPCA1|hSPCA1	9606	Homo sapiens	agonist	target	Shi X (1998)	9787799	181207	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16225	107281	831	-	CAST	BS-17	9606	Homo sapiens	unknown	target	Hanna RA (2007)	17543955	181208	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16226	107281	831	-	CAST	BS-17	9606	Homo sapiens	unknown	target	De Tullio R (2007)	17570336	181209	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16227	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Sosa V (2007)	17537429	182285	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16228	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lo LW (2007)	17612522	182284	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16229	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Schallreuter KU (2007)	17592724	182287	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16230	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Caride AJ (2007)	17595168	182286	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16231	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Zhou Z (2007)	17550897	182288	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16232	112980	7125	-	TNNC2	-	9606	Homo sapiens	agonist	target	Kreutziger KL (2011)	21035455	181213	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16233	112980	7125	-	TNNC2	-	9606	Homo sapiens	agonist	target	Dweck D (2010)	20371872	181212	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16234	112980	7125	-	TNNC2	-	9606	Homo sapiens	agonist	target	Robertson IM (2010)	20801130	181211	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16235	112980	7125	-	TNNC2	-	9606	Homo sapiens	agonist	target	Martin SR (2011)	21250664	181210	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16236	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Lee TS (2007)	17515952	181217	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16237	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Liang J (2007)	17612632	181216	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16238	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Friel LA (2007)	17624933	181215	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16239	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Marlatt NM (2007)	17536784	181214	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16240	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	agonist	target	Dweck D (2010)	20371872	181212	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16241	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	agonist	target	Parvatiyar MS (2010)	20566645	181219	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16242	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	agonist	target	Swindle N (2010)	20459070	181218	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16243	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	agonist	target	Baylor SM (2011)	20599552	181220	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16244	107706	1311	-	COMP	EDM1|EPD1|MED|PSACH|THBS5	9606	Homo sapiens	unknown	target	Chen FH (2007)	17588949	181221	1332	Calcium	-	super cal mag plus|g.a.s. comp	DRUGBANK	DB01373	Ca	small molecule	A11AA02|M05BB02|M05BB01|M05BB05|M05BB04|M05BB08	7440-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPRJOBELJOOCE-UHFFFAOYSA-N
16245	113259	7416	-	VDAC1	PORIN|VDAC-1	9606	Homo sapiens	inhibitor	target	Zhang DW (1989)	2469483	181222	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16246	113259	7416	-	VDAC1	PORIN|VDAC-1	9606	Homo sapiens	inhibitor	target	Zhang DW (1990)	1694685	181223	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16247	113260	7417	RP11-375G3.1	VDAC2	POR	9606	Homo sapiens	inhibitor	target	Zhang DW (1989)	2469483	181222	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16248	113260	7417	RP11-375G3.1	VDAC2	POR	9606	Homo sapiens	inhibitor	target	Zhang DW (1990)	1694685	181223	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16249	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	stimulator	target	Chen X (2002)	11752352	171740	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16250	113262	7419	-	VDAC3	HD-VDAC3|VDAC-3	9606	Homo sapiens	inhibitor	target	Zhang DW (1989)	2469483	181222	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16251	113262	7419	-	VDAC3	HD-VDAC3|VDAC-3	9606	Homo sapiens	inhibitor	target	Zhang DW (1990)	1694685	181223	1333	Aluminium monostearate	Aluminum stearate|Dihydroxy(stearato)aluminum|Aluminum stearate 300|Aluminium, dihydroxide stearate|Aluminum monostearate|dihydroxyaluminum stearate|dibasic aluminum stearate|Dibasic aluminium stearate|Dihydroxy(stearato)aluminium	-	DRUGBANK	DB01375	C18H37AlO4	small molecule	-	7047-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGMCXQCYOVCMTB-UHFFFAOYSA-K
16252	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Sirijovski N (2006)	16928192	181226	1335	Magnesium	-	mnps formula supplement|calciu	DRUGBANK	DB01378	Mg	small molecule	-	7439-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLVVSXFLKOJNIY-UHFFFAOYSA-N
16253	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Nogovitsina OR (2007)	17294093	181227	1335	Magnesium	-	mnps formula supplement|calciu	DRUGBANK	DB01378	Mg	small molecule	-	7439-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLVVSXFLKOJNIY-UHFFFAOYSA-N
16254	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Balasubramaniyan V (2006)	16990961	181224	1335	Magnesium	-	mnps formula supplement|calciu	DRUGBANK	DB01378	Mg	small molecule	-	7439-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLVVSXFLKOJNIY-UHFFFAOYSA-N
16255	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	unknown	target	Buchachenko AL (2006)	16808357	181225	1335	Magnesium	-	mnps formula supplement|calciu	DRUGBANK	DB01378	Mg	small molecule	-	7439-95-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLVVSXFLKOJNIY-UHFFFAOYSA-N
16256	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Schlechte JA (1982)	7062741	181228	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16257	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Schlechte JA (1982)	7054210	181229	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16258	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16259	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16260	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16261	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16262	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	1336	Cortisone acetate	Cortisyl|Cortone acetate	cortisone acetate|cortisone ac	DRUGBANK	DB01380	C23H30O6	small molecule	S01BA03|H02AB10	50-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITRJWOMZKQRYTA-RFZYENFJSA-N
16263	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Fehske CJ (2009)	19427589	181230	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16264	108835	2561	-	GABRB2	-	9606	Homo sapiens	negative modulator	target	Hanrahan JR (2003)	12824018	181231	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16265	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Lim H (2006)	16651744	181233	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16266	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Kim HK (1999)	10418340	181232	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16267	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Weichel O (1999)	10619176	181234	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16268	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	antagonist	target	Heads JA (2008)	18221374	181235	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16269	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	negative modulator	target	Hanrahan JR (2003)	12824018	181231	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16270	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	negative modulator	target	Hanrahan JR (2003)	12824018	181231	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16271	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Hambrock A (2002)	12107069	179673	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16272	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Hambrock A (2002)	12145099	179665	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16273	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Ueda K (1999)	9990013	179677	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16274	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Babenko AP (2002)	12213829	179674	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16275	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Dabrowski M (2002)	12031979	179675	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16276	112700	6833	-	ABCC8	ABC36|HHF1|HI|HRINS|MRP8|PHHI|SUR|SUR1|SUR1delta2|TNDM2	9606	Homo sapiens	inducer	target	Nielsen FE (2002)	12213059	179678	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16277	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16278	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16279	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Greeley SA (2010)	20434356	181237	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16280	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Guirgis FK (1976)	134717	181236	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16281	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Serrano-Martin X (2006)	17015627	179676	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16282	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Lu M (2006)	16470247	179682	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16283	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Pondugula SR (2006)	16263802	179681	1338	Glycodiazine	Glidiazine|Glymidine	-	DRUGBANK	DB01382	C13H15N3O4S	small molecule	A10BC01	339-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWPJPIVLCBXFJ-UHFFFAOYSA-N
16284	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Fitzgerald P (2006)	16255837	178667	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16285	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Rautanen A (2006)	16895953	174979	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16286	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Shaw JR (2007)	17038445	174983	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16287	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Hammer F (2006)	16980198	174982	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16288	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Grossman R (2006)	16891588	174981	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16289	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Sher L (2006)	17086345	174980	1339	Paramethasone	Dillar	-	DRUGBANK	DB01384	C22H29FO5	small molecule	H02AB05	53-33-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPDWECBUAZOHP-AFYJWTTESA-N
16290	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16291	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16292	107239	785	-	CACNB4	CAB4|CACNLB4|EA5|EIG9|EJM|EJM4|EJM6	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16293	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16294	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16295	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16296	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Coste B (2007)	17190903	181240	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16297	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Perez-Reyes E (2004)	14993472	181241	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16298	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Brueggemann LI (2005)	15498818	181242	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16299	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Clozel JP (1997)	9481612	181243	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16300	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	McNulty MM (2004)	15562257	181244	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16301	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Massie BM (1997)	9375939	181245	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16302	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Cribbs LL (1998)	9670923	181246	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16303	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16304	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16305	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16306	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16307	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Clozel JP (1997)	9481612	181243	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16308	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	McNulty MM (2004)	15562257	181244	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16309	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16310	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Massie BM (1997)	9375939	181245	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16311	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Clozel JP (1997)	9481612	181243	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16312	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	McNulty MM (2004)	15562257	181244	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16313	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Massie BM (1997)	9375939	181245	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16314	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Monteil A (2000)	10692398	181247	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16315	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16316	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16317	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16318	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16319	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16320	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16321	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16322	107238	784	-	CACNB3	CAB3|CACNLB3	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16323	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16324	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16325	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16326	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16327	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16328	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16329	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Moosmang S (2006)	16306443	181248	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16330	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Jimenez C (2000)	10665814	181238	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16331	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Lee TS (2006)	16899990	180228	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16332	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Mocanu MM (1999)	10372226	181239	1340	Mibefradil	-	-	DRUGBANK	DB01388	C29H38FN3O3	small molecule	C08CX01	116644-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBNPJJILLOYFJU-VMPREFPWSA-N
16333	109972	3770	-	KCNJ14	IRK4|KIR2.4	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16334	109966	3764	-	KCNJ8	KIR6.1|uKATP-1	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16335	109968	3766	-	KCNJ10	BIRK-10|KCNJ13-PEN|KIR1.2|KIR4.1|SESAME	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16336	109969	3767	-	KCNJ11	BIR|HHF2|IKATP|KIR6.2|PHHI|TNDM3	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16337	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16338	109974	3772	-	KCNJ15	IRKK|KIR1.3|KIR4.2	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16339	109970	3768	-	KCNJ12	IRK-2|IRK2|KCNJN1|Kir2.2|Kir2.2v|hIRK|hIRK1|hkir2.2x|kcnj12x	9606	Homo sapiens	unknown	target	Plant TD (1990)	2282453	181249	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16340	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Freitag A (1996)	8872361	181255	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16341	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Alonso E (2007)	17123717	181254	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16342	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Cleary L (2002)	12110610	181253	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16343	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Takada K (2002)	12170055	181252	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16344	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16345	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Gyires K (2000)	10822066	181250	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16346	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Cleary L (2005)	16176444	181259	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16347	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Lalchandani SG (2002)	12438517	181258	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16348	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Rizzo CA (2001)	11226402	181257	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16349	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Kalkman HO (2003)	12591093	181256	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16350	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Cleary L (2002)	12110610	181253	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16351	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16352	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16353	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Kaumann AJ (1983)	6136920	181260	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16354	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16355	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16356	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kaumann AJ (1983)	6136920	181260	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16357	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Baxter GS (1994)	8032658	181261	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16358	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Bonhaus DW (1997)	9225287	181262	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16359	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Baxter GS (1994)	8032658	181261	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16360	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16361	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Kaumann AJ (1983)	6136920	181260	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16362	109584	3352	-	HTR1D	5-HT1D|HT1DA|HTR1DA|HTRL|RDC4	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16363	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Ozdogan UK (2006)	16325800	181266	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16364	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Laurila JM (2007)	17558432	181264	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16365	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Paul BZ (1999)	10506165	181265	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16366	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Zadori ZS (2007)	17664022	181263	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16367	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Kalkman HO (2003)	12591093	181256	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16368	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16369	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Kaumann AJ (1983)	6136920	181260	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16370	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Baxter GS (1994)	8032658	181261	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16371	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	agonist	target	Tenenbaum A (2005)	16168052	181267	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16372	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Tenenbaum A (2005)	16168052	181267	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16373	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Goldenberg I (2008)	18629356	181274	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16374	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Cabrero A (2000)	10933891	181271	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16375	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Guan Y (2001)	11422732	181270	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16376	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Pedraza N (2000)	10909982	181273	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16377	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Fruchart JC (2006)	16511610	181272	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16378	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16379	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Bonilla S (2001)	11519881	181268	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16380	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Inoue I (2001)	11172467	181269	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16381	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Acharya BR (2009)	19527023	181275	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16382	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Cerquaglia C (2005)	15720245	181277	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16383	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Finkelstein Y (2010)	20586571	181276	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16384	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16385	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16386	123347	81027	-	TUBB1	-	9606	Homo sapiens	inhibitor	target	Li CM (2010)	20814887	180493	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16387	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Acharya BR (2009)	19527023	181275	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16388	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Li CM (2010)	20814887	180493	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16389	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Cerquaglia C (2005)	15720245	181277	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16390	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	inhibitor	target	Yee KW (2005)	16166440	181278	1344	Colchicine	Colchicina|Colchicinum|Colchicin	colcrys|euro-colchicine|colchi	DRUGBANK	DB01394	C22H25NO6	small molecule	M04AC01	64-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAKHMKGGTNLKSZ-UHFFFAOYSA-N
16391	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Fuhrmann U (1996)	8922878	181280	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16392	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16393	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Oelkers WK (1996)	8732994	181279	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16394	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Krattenmacher R (2000)	11024226	181281	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16395	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	antagonist	target	Muhn P (1995)	7625729	181282	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16396	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Krattenmacher R (2000)	11024226	181281	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16397	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Sitruk-Ware R (2004)	15493951	181284	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16398	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Sitruk-Ware R (2005)	16291771	181285	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16399	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Fuhrmann U (1996)	8922878	181280	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16400	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Krattenmacher R (2000)	11024226	181281	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16401	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Arias-Loza PA (2006)	17000933	181283	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16402	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Bray JD (2005)	16157482	175558	1345	Drospirenone	6beta,7Beta;15beta,16beta-dimethylene-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Drospirenona|DRSP|6,7,15,16-dimethylene-3-oxo-17-pregn-4-ene-21,17 carbolactone|1,2-Dihydrospirorenone|Drospirenonum|Dehydrospirorenone	drospirenone and ethinyl estra	DRUGBANK	DB01395	C24H30O3	small molecule	G03AC10|G03AA12|G03FA17	67392-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METQSPRSQINEEU-HXCATZOESA-N
16403	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Chen JJ (2001)	11309248	175738	1346	Digitoxin	Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin	digitaline welcker tab 0.1mg	DRUGBANK	DB01396	C41H64O13	small molecule	C01AA04	71-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJUZGPOPHTGOT-XUDUSOBPSA-N
16404	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Prignitz R (1976)	131389	181288	1346	Digitoxin	Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin	digitaline welcker tab 0.1mg	DRUGBANK	DB01396	C41H64O13	small molecule	C01AA04	71-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJUZGPOPHTGOT-XUDUSOBPSA-N
16405	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Hauck C (2009)	19751721	181289	1346	Digitoxin	Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin	digitaline welcker tab 0.1mg	DRUGBANK	DB01396	C41H64O13	small molecule	C01AA04	71-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJUZGPOPHTGOT-XUDUSOBPSA-N
16406	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Marcus FI (1975)	123547	181286	1346	Digitoxin	Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin	digitaline welcker tab 0.1mg	DRUGBANK	DB01396	C41H64O13	small molecule	C01AA04	71-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJUZGPOPHTGOT-XUDUSOBPSA-N
16407	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Bluschke V (1976)	132355	181290	1346	Digitoxin	Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin	digitaline welcker tab 0.1mg	DRUGBANK	DB01396	C41H64O13	small molecule	C01AA04	71-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJUZGPOPHTGOT-XUDUSOBPSA-N
16408	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor	target	Fricke U (1976)	136410	181287	1346	Digitoxin	Digitoxoside|Digitoksin|Crystodigin (tn)|Digitoxinum|Digitoxin	digitaline welcker tab 0.1mg	DRUGBANK	DB01396	C41H64O13	small molecule	C01AA04	71-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJUZGPOPHTGOT-XUDUSOBPSA-N
16409	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Sun R (2005)	15840771	179203	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16410	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Liu X (2006)	16368818	179202	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16411	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16412	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Moon C (2004)	14746879	179200	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16413	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Celik G (2005)	15871445	179199	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16414	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16415	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16416	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16417	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16418	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16431	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Stevenson DD (2004)	15242723	181293	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16432	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Schmidt A (1991)	1680855	181292	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16433	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16434	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Josephs MD (1999)	10452868	181294	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16435	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Schaefer MG (2003)	12901032	181297	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16436	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Motsko SP (2006)	16808554	181296	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16437	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stichtenoth DO (1998)	9711054	181295	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16438	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Josephs MD (1999)	10452868	181294	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16439	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Naves LA (2001)	11313435	181299	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16440	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Zhang B (2009)	19257799	181298	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16441	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16442	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Takeuchi K (2000)	11819669	181301	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16443	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Trevisani GT (2000)	10826417	181300	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16444	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Minic J (2003)	12522088	181303	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16445	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Beck KD (2003)	12726885	181302	1350	Neostigmine	Eustigmine|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|Eustigmin|m-Trimethylammoniumphenyldimethylcarbamate	pms-neostigmine methylsulfate 	DRUGBANK	DB01400	C12H19N2O2	small molecule	N07AA01|S01EB06|N07AA51	59-99-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALWKGYPQUAPLQC-UHFFFAOYSA-N
16446	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Simon RA (2004)	14680616	181305	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16447	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Nizankowska E (1990)	2083404	181304	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16448	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Schwartz KA (2006)	17131625	179240	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Simon RA (2004)	14680616	181305	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16454	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16455	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16456	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Tsukamoto T (1984)	6149771	181308	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16457	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16458	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16459	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16460	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16461	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16462	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16463	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16464	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Tsukamoto T (1984)	6149771	181308	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16465	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16466	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16467	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16468	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16469	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16470	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16471	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16472	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16473	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16474	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16475	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16476	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16477	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16478	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16479	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Tsukamoto T (1984)	6149771	181308	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16480	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16481	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16482	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16483	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16484	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16485	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Hals PA (1988)	2899826	175941	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16486	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16487	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16488	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16489	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antagonist	target	Kim SJ (2007)	17436372	181309	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16490	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antagonist	target	Kim DH (2003)	14642426	181310	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16491	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	agonist	target	Wang Y (2008)	19022240	181311	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16492	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kim SJ (2007)	17436372	181309	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16493	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yim HW (2005)	15753395	181312	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16494	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Seo JY (2005)	15778128	181313	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16495	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Fujimoto J (1995)	7540578	181316	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16496	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Snyder BW (1990)	2326286	181314	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16497	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sanfilippo JS (1985)	4039467	181315	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16498	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16499	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	negative modulator	target	Roth C (2004)	14605254	172040	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16500	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	negative modulator	target	Menon M (1986)	3004220	181317	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16501	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	negative modulator	target	Dmowski WP (1990)	2404115	181318	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16502	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	negative modulator	target	Tian ZZ (2003)	14571621	181319	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16503	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	negative modulator	target	Imming P (2006)	17016423	171742	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16504	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	negative modulator	target	Menon M (1986)	3004220	181317	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16505	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	negative modulator	target	Overington JP (2006)	17139284	171741	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16506	125366	114814	-	GNRHR2	GnRH-II-R	9606	Homo sapiens	negative modulator	target	Dmowski WP (1990)	2404115	181318	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16507	112251	6347	-	CCL2	GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF	9606	Homo sapiens	inhibitor	target	Boucher A (2000)	11056242	181321	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16508	112251	6347	-	CCL2	GDCF-2|HC11|HSMCR30|MCAF|MCP-1|MCP1|SCYA2|SMC-CF	9606	Homo sapiens	inhibitor	target	Jolicoeur C (2001)	11216879	181320	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16509	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Huang HF (1994)	8000225	181324	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16510	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Sasagawa S (2008)	18061638	181323	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16511	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Beaumont H (2007)	17636649	181322	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16512	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Dmowski WP (1990)	2404115	181318	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16513	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Gomez F (2000)	10882672	181327	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16514	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Roselli CE (1998)	9593936	181326	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16515	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Donaldson VH (1989)	2486535	181325	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16516	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Sasagawa S (2008)	18061638	181323	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16517	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Dmowski WP (1990)	2404115	181318	1355	Danazol	Cyclomen|Danazolum|Danocrine	cyclomen|danazol	DRUGBANK	DB01406	C22H27NO2	small molecule	G03XA01	17230-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POZRVZJJTULAOH-LHZXLZLDSA-N
16518	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16519	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Sillence MN (1991)	1685013	181329	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16520	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mazzanti G (2007)	17449161	181328	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16521	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Zhu Y (2001)	11720783	181330	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16522	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Choo JJ (1992)	1322047	181331	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16523	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Ryall JG (2002)	12388476	181332	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16524	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Baker JG (2010)	20590599	181333	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16525	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Izeboud CA (1999)	10071758	181338	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16526	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Laan TT (2005)	16261833	181334	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16527	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Izeboud CA (2004)	15021963	181335	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16528	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	van den Hoven R (2006)	17139543	181336	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16529	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Yoshimura T (2000)	11193379	181337	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16530	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Riaz SS (1999)	11221812	181341	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16531	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Samina Riaz S (2000)	11146120	181339	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16532	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Puls I (1999)	10637819	181343	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16533	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Semkova I (1999)	10525174	181342	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16534	110869	4803	-	NGF	Beta-NGF|HSAN5|NGFB	9606	Homo sapiens	stimulator	target	Culmsee C (1999)	10403429	181340	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16535	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Baker JG (2010)	20590599	181333	1356	Clenbuterol	4-amino-alpha-((Tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|()-clenbuterol|(+-)-Clenbuterol|1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol|4-amino-3,5-Dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol|CLENBUTEROL|4-amino--((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol|Clenbuterolum	-	DRUGBANK	DB01407	C12H18Cl2N2O	small molecule	R03AC14|R03CC13	37148-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STJMRWALKKWQGH-UHFFFAOYSA-N
16536	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Waldeck B (2002)	12065188	181345	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16537	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Coleman RA (1996)	8885698	181344	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16538	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chou YL (2010)	20012638	181347	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16539	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Rosberg B (1993)	8223836	181346	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16540	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Zhang D (2007)	18065099	181349	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16541	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Svensson LA (1988)	3262993	181348	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16542	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1357	Bambuterol	Bambuterolum|Bambuterol|bambutrol|()-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)	-	DRUGBANK	DB01408	C18H29N3O5	small molecule	R03CC12	81732-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANZXOIAKUNOVQU-UHFFFAOYSA-N
16543	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Barnes PJ (2001)	11281822	181352	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16544	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Barnes PJ (1995)	10188785	181350	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16545	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Hansel TT (2002)	12582447	181351	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16546	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16547	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Barnes PJ (2001)	11281822	181352	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16548	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Barnes PJ (1995)	10188785	181350	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16549	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Hansel TT (2002)	12582447	181351	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16550	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Barnes PJ (1995)	10188785	181350	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16551	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Hansel TT (2002)	12582447	181351	1358	Tiotropium	-	inspiolto respimat|spiriva res	DRUGBANK	DB01409	C19H22NO4S2	small molecule	R03BB54|R03BB04|R03AL06	186691-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LERNTVKEWCAPOY-DZZGSBJMSA-N
16552	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Barnes NC (2007)	17530144	181353	1359	Ciclesonide	-	apo-ciclesonide|alvesco|omnari	DRUGBANK	DB01410	C32H44O7	small molecule	R01AD13|R03BA08	126544-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKZNWIVRBCLON-GXOBDPJESA-N
16553	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Horiguchi T (1999)	10028377	181356	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16554	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Ishioka S (1999)	10804983	181357	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16555	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Obase Y (2001)	11476469	181354	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16556	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Kanazawa H (2004)	15136379	181355	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16557	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Hojo M (2000)	10773010	181362	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16558	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Fukushima C (2005)	15650315	181358	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16559	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Matsuse H (2006)	16892782	181359	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16560	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Nogimura M (2002)	12692940	181360	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16561	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Nabe T (2002)	11972613	181361	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16562	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	unknown	target	Ichiyama T (2003)	12801316	181363	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16563	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	unknown	target	Tomari S (2003)	12801315	181364	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16564	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Shirasaki H (2006)	16864492	181369	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16565	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Yoo SH (2001)	11264758	181368	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16566	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16567	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Ding Q (2006)	17112405	181367	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16568	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Ogasawara H (2002)	11854273	181366	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16569	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Ishinaga H (2005)	15475658	181365	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16570	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Ichiyama T (2003)	12801316	181363	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16571	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Ichiyama T (2007)	17430359	181370	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16572	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Tomari S (2003)	12801315	181364	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16573	110670	4583	-	MUC2	MLP|MUC-2|SMUC	9606	Homo sapiens	unknown	target	Bai CH (2007)	17223000	181371	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16574	110670	4583	-	MUC2	MLP|MUC-2|SMUC	9606	Homo sapiens	unknown	target	Ishinaga H (2005)	15475658	181365	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16575	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Essayan DM (2001)	11692087	174342	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16576	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Daly JW (2007)	17514358	174335	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16577	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Fisone G (2004)	15095008	181372	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16578	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Deree J (2008)	18568240	181373	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16579	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Chou CC (2003)	12602592	181374	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16580	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16581	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Fisone G (2004)	15095008	181372	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16582	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Cornelis MC (2007)	17616786	174343	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16583	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Riksen NP (2007)	17558310	174345	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16584	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	antagonist	target	Zhao G (2007)	17577101	174344	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16585	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Wang SJ (2007)	17372967	174340	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16586	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Chou CC (2003)	12602592	181374	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16587	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Fisone G (2004)	15095008	181372	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16588	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Listos J (2006)	17085856	174336	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16589	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Gaytan SP (2006)	16702031	174337	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16590	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Mustafa S (2006)	17162470	174338	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16591	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Rieg T (2007)	17126319	174339	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16592	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	antagonist	target	Daly JW (1987)	3588607	174819	1361	Theobromine	Theobromine|Theobromin|3,7-dihydro-3,7-Dimethyl-1H-purine-2,6-dione|3,7-Dimethylxanthine|3,7-Dimethylpurine-2,6-dione	-	DRUGBANK	DB01412	C7H8N4O2	small molecule	C03BD01|R03DA57|R03DA07	83-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAPQBXQYLJRXSA-UHFFFAOYSA-N
16593	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Grassi GG (1993)	8150771	181375	1362	Cefepime	Cefepima|(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|Cefepime|Cefepimum	cefepime hydrochloride and dex	DRUGBANK	DB01413	C19H24N6O5S2	small molecule	J01RA06|J01DE01	88040-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVFLCNVBZFFHBT-ZKDACBOMSA-N
16594	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Grassi GG (1993)	8150771	181375	1362	Cefepime	Cefepima|(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|Cefepime|Cefepimum	cefepime hydrochloride and dex	DRUGBANK	DB01413	C19H24N6O5S2	small molecule	J01RA06|J01DE01	88040-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVFLCNVBZFFHBT-ZKDACBOMSA-N
16595	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1363	Cefacetrile	Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary]	-	DRUGBANK	DB01414	C13H13N3O6S	small molecule	J01DB10	10206-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRYMAQUWDLIUPV-BXKDBHETSA-N
16596	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1363	Cefacetrile	Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary]	-	DRUGBANK	DB01414	C13H13N3O6S	small molecule	J01DB10	10206-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRYMAQUWDLIUPV-BXKDBHETSA-N
16597	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Truesdell SE (1989)	2722720	181104	1363	Cefacetrile	Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary]	-	DRUGBANK	DB01414	C13H13N3O6S	small molecule	J01DB10	10206-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRYMAQUWDLIUPV-BXKDBHETSA-N
16598	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Yotsuji A (1988)	3266730	179123	1363	Cefacetrile	Cefacetrilum|Cephacetrile|Cefacetrilo|Vetrimast [veterinary]	-	DRUGBANK	DB01414	C13H13N3O6S	small molecule	J01DB10	10206-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRYMAQUWDLIUPV-BXKDBHETSA-N
16599	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Wise R (1990)	2120175	181376	1364	Ceftibuten	cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum	cedax|ceftibuten	DRUGBANK	DB01415	C15H14N4O6S2	small molecule	J01DD14	97519-39-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJFKXSSGBWRBZ-BJCIPQKHSA-N
16600	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Wise R (1990)	2120175	181376	1364	Ceftibuten	cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum	cedax|ceftibuten	DRUGBANK	DB01415	C15H14N4O6S2	small molecule	J01DD14	97519-39-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJFKXSSGBWRBZ-BJCIPQKHSA-N
16601	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Wise R (1990)	2120175	181376	1364	Ceftibuten	cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum	cedax|ceftibuten	DRUGBANK	DB01415	C15H14N4O6S2	small molecule	J01DD14	97519-39-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJFKXSSGBWRBZ-BJCIPQKHSA-N
16602	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Wise R (1990)	2120175	181376	1364	Ceftibuten	cis-Ceftibuten|Ceftibutene|Ceftibuteno|(+)-(6R,7R)-7-((Z)-2-(2-amino-4-Thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid|Ceftibutenum	cedax|ceftibuten	DRUGBANK	DB01415	C15H14N4O6S2	small molecule	J01DD14	97519-39-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJFKXSSGBWRBZ-BJCIPQKHSA-N
16603	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	inhibitor	target	Boaretti M (1991)	12041787	181377	1365	Cefpodoxime	Cefpodoxima|Cefpodoximum	cefpodoxime proxetil|orelox	DRUGBANK	DB01416	C15H17N5O6S2	small molecule	J01DD13	80210-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYUSVOMTXWRGEK-HBWVYFAYSA-N
16604	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Rettie AE (2006)	16869821	181381	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16605	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Montes R (2006)	16611310	181379	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16606	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Zhou SF (2009)	19515014	174101	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16607	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Gonzalez-Conejero R (2007)	17596133	181382	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16608	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16609	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Schalekamp T (2006)	16815313	181378	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16610	122472	79001	MSTP134	VKORC1	EDTP308|IMAGE3455200|MST134|MST576|VKCFD2|VKOR	9606	Homo sapiens	inhibitor	target	Bodin L (2005)	15790782	181380	1366	Acenocoumarol	Acenocumarolo|3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin|Acenokumarin|Nitrovarfarian|Acenocoumarin|3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin|3-(alpha-(P-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin|Acenocumarol|3-(alpha-Acetonyl-P-nitrobenzyl)-4-hydroxycoumarin|Nitrophenylacetylethyl-4-hydroxycoumarine|4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one|4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one|Nicumalon|Nitrowarfarin|3-(alpha-P-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin|Acenocoumarolum|Nicoumalone	sintrom	DRUGBANK	DB01418	C19H15NO6	small molecule	B01AA07	152-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABCILAOYCMVPS-UHFFFAOYSA-N
16611	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Berry H (1983)	6342700	181384	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16612	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	James MJ (2007)	17541796	178397	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16613	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hassan SM (1982)	7088753	181383	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16619	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16620	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Yin D (2003)	12604714	181385	1368	Testosterone Propionate	Testex	malogen in oil liq 100mg/ml|te	DRUGBANK	DB01420	C22H32O3	small molecule	-	57-85-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMMFKSKQVNJMI-BLQWBTBKSA-N
16621	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Small EJ (2006)	17084172	177399	1368	Testosterone Propionate	Testex	malogen in oil liq 100mg/ml|te	DRUGBANK	DB01420	C22H32O3	small molecule	-	57-85-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMMFKSKQVNJMI-BLQWBTBKSA-N
16622	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Omwancha J (2006)	17086931	177398	1368	Testosterone Propionate	Testex	malogen in oil liq 100mg/ml|te	DRUGBANK	DB01420	C22H32O3	small molecule	-	57-85-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMMFKSKQVNJMI-BLQWBTBKSA-N
16623	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Petraki CD (2007)	17128417	177401	1368	Testosterone Propionate	Testex	malogen in oil liq 100mg/ml|te	DRUGBANK	DB01420	C22H32O3	small molecule	-	57-85-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMMFKSKQVNJMI-BLQWBTBKSA-N
16624	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Maudsley S (2007)	17202804	177400	1368	Testosterone Propionate	Testex	malogen in oil liq 100mg/ml|te	DRUGBANK	DB01420	C22H32O3	small molecule	-	57-85-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMMFKSKQVNJMI-BLQWBTBKSA-N
16625	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Lapauw B (2007)	17322500	177397	1368	Testosterone Propionate	Testex	malogen in oil liq 100mg/ml|te	DRUGBANK	DB01420	C22H32O3	small molecule	-	57-85-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMMFKSKQVNJMI-BLQWBTBKSA-N
16626	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	inhibitor	target	Shim JS (2010)	21088277	181386	1370	Nitroxoline	5-Nitro-8-hydroxyquinoline|5NOK|8-Hydroxy-5-nitroquinoline|Nitroxolinum|5-Nitrox|5-Nitro-8-quinolinol|Nitroxolina|5-NOK|5-Nitro-8-oxyquinoline	-	DRUGBANK	DB01422	C9H6N2O3	small molecule	J01XX07	4008-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJIWZDNTCBHXAL-UHFFFAOYSA-N
16627	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kilpatrick GJ (1986)	2943980	181389	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16628	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Gomez F (1999)	10075867	181387	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16629	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dhasmana KM (1993)	8103596	178446	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16630	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Szelenyi I (1994)	7865862	181388	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16631	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hoogendijk MG (2009)	20022821	181394	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16632	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Khodorov BI (1983)	6088360	181395	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16633	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Barajas-Martinez HM (2008)	18599870	181392	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16634	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hermida JS (2010)	21126620	181393	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16635	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Leoni AL (2010)	20174578	181390	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16636	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Hoogendijk MG (2011)	20870038	181391	1374	Ajmaline	(5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol|Ajmalin|(+)-Ajmaline	-	DRUGBANK	DB01426	C20H26N2O2	small molecule	C01BA05	4360-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJDRUOGAGYHKKD-HEFSZTOGSA-N
16637	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16638	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16639	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Kobayashi T (2002)	12076859	181396	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16640	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Kucuk C (2009)	18468627	181397	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16641	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16642	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Ko Y (2009)	19901885	181398	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16643	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Kumar A (1999)	10075051	181402	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16644	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Haddad JJ (2002)	11805217	181403	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16645	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Bergman MR (1999)	10444479	181400	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16646	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Marx D (2002)	11969359	181401	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16647	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Giroir BP (1992)	1611705	181399	1375	Amrinone	Inamrinone|Amrinonum|Amcoral|Amrinona	inocor  liq 5mg/ml	DRUGBANK	DB01427	C10H9N3O	small molecule	C01CE01	60719-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNLQIBCLLYYYFJ-UHFFFAOYSA-N
16648	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	inhibitor	target	Levine SN (1983)	6186851	182289	1377	Aprindine	Aprindine|Compound 99170|Aprindina|Aprindinum	-	DRUGBANK	DB01429	C22H30N2	small molecule	C01BB04	37640-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZLBHDRPUJLHCE-UHFFFAOYSA-N
16649	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Sato R (1991)	1660104	181404	1377	Aprindine	Aprindine|Compound 99170|Aprindina|Aprindinum	-	DRUGBANK	DB01429	C22H30N2	small molecule	C01BB04	37640-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZLBHDRPUJLHCE-UHFFFAOYSA-N
16650	112236	6331	-	SCN5A	CDCD2|CMD1E|CMPD2|HB1|HB2|HBBD|HH1|ICCD|IVF|LQT3|Nav1.5|PFHB1|SSS1|VF1	9606	Homo sapiens	inhibitor	target	Kamiya K (1991)	1653644	181405	1377	Aprindine	Aprindine|Compound 99170|Aprindina|Aprindinum	-	DRUGBANK	DB01429	C22H30N2	small molecule	C01BB04	37640-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZLBHDRPUJLHCE-UHFFFAOYSA-N
16651	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	1378	Almitrine	2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina	-	DRUGBANK	DB01430	C26H29F2N7	small molecule	R07AB07	27469-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBDOVFRMEYHSQB-UHFFFAOYSA-N
16652	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Rigoulet M (1990)	2144185	181409	1378	Almitrine	2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina	-	DRUGBANK	DB01430	C26H29F2N7	small molecule	R07AB07	27469-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBDOVFRMEYHSQB-UHFFFAOYSA-N
16653	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Rigoulet M (1990)	2165421	181406	1378	Almitrine	2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina	-	DRUGBANK	DB01430	C26H29F2N7	small molecule	R07AB07	27469-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBDOVFRMEYHSQB-UHFFFAOYSA-N
16654	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Benzi G (1993)	8099718	181407	1378	Almitrine	2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina	-	DRUGBANK	DB01430	C26H29F2N7	small molecule	R07AB07	27469-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBDOVFRMEYHSQB-UHFFFAOYSA-N
16655	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	binder	target	Rigoulet M (1989)	2527061	181408	1378	Almitrine	2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine|Almitrinum|Almitrina	-	DRUGBANK	DB01430	C26H29F2N7	small molecule	R07AB07	27469-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBDOVFRMEYHSQB-UHFFFAOYSA-N
16656	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Csaba G (1996)	8820988	181410	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16657	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Yuri T (2007)	17203775	175786	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16658	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Montero Girard G (2007)	17341305	175787	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16659	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Kumar AS (2007)	17103262	175785	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16660	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Ghebeh H (2007)	17415709	175788	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16661	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lessey BA (2006)	17118173	175789	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16662	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Bergink EW (1985)	3928974	181411	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16663	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Tranguch S (2006)	17169175	175791	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16664	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Boonyaratanakornkit V (2007)	17138644	175790	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16665	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Wu HB (2006)	17109827	175793	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16666	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Madauss KP (2007)	17013809	175792	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16667	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Gizard F (2006)	17015480	175794	1379	Allylestrenol	Perselin|Allyloestrenol|Allyl estrenol	-	DRUGBANK	DB01431	C21H32O	small molecule	G03DC01	432-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATXHVCQZZJYMCF-XUDSTZEESA-N
16668	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Walczak SA (1981)	6268422	181413	1381	Methadyl Acetate	Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol	-	DRUGBANK	DB01433	C23H31NO2	small molecule	-	509-74-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-UHFFFAOYSA-N
16669	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Mancino MJ (2010)	20163389	181412	1381	Methadyl Acetate	Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol	-	DRUGBANK	DB01433	C23H31NO2	small molecule	-	509-74-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-UHFFFAOYSA-N
16670	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1381	Methadyl Acetate	Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol	-	DRUGBANK	DB01433	C23H31NO2	small molecule	-	509-74-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-UHFFFAOYSA-N
16671	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Wolstein J (2009)	19153939	181414	1381	Methadyl Acetate	Acetilmetadol|Acetylmethadolum|Betamethadol|Acetylmethadol	-	DRUGBANK	DB01433	C23H31NO2	small molecule	-	509-74-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMIVRRWGCYBTQ-UHFFFAOYSA-N
16672	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Brune K (2001)	11695253	181415	1383	Antipyrine	1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon	auralgan eardrops|antipyrine a	DRUGBANK	DB01435	C11H12N2O	small molecule	S02DA03|N02BB51|N02BB71|N02BB01	60-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEQOALNAAJBPNY-UHFFFAOYSA-N
16673	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brune K (2001)	11695253	181415	1383	Antipyrine	1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon	auralgan eardrops|antipyrine a	DRUGBANK	DB01435	C11H12N2O	small molecule	S02DA03|N02BB51|N02BB71|N02BB01	60-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEQOALNAAJBPNY-UHFFFAOYSA-N
16674	107966	1594	-	CYP27B1	CP2B|CYP1|CYP1alpha|CYP27B|P450c1|PDDR|VDD1|VDDR|VDDRI|VDR	9606	Homo sapiens	unknown	target	Uchida E (2004)	15369780	173973	1384	Alfacalcidol	1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol	one alpha caps 1mcg|one alpha 	DRUGBANK	DB01436	C27H44O2	small molecule	A11CC03|M05BB06	41294-56-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHCOWSQAMBJIW-AVJTYSNKSA-N
16675	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Fujishima T (2010)	20435140	173968	1384	Alfacalcidol	1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol	one alpha caps 1mcg|one alpha 	DRUGBANK	DB01436	C27H44O2	small molecule	A11CC03|M05BB06	41294-56-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHCOWSQAMBJIW-AVJTYSNKSA-N
16676	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1384	Alfacalcidol	1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol	one alpha caps 1mcg|one alpha 	DRUGBANK	DB01436	C27H44O2	small molecule	A11CC03|M05BB06	41294-56-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHCOWSQAMBJIW-AVJTYSNKSA-N
16677	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	agonist	target	Reinhart GA (2004)	15503649	173130	1384	Alfacalcidol	1-hydroxycholecalciferol|1alpha-hydroxycholecalciferol|(5Z,7e)-9,10-Seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol|1alpha-Hydroxy-vitamin D3|1alpha-hydroxyvitamin D3|Alsiodol|Alfacalcidolum|9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta-diol	one alpha caps 1mcg|one alpha 	DRUGBANK	DB01436	C27H44O2	small molecule	A11CC03|M05BB06	41294-56-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHCOWSQAMBJIW-AVJTYSNKSA-N
16678	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Skerritt JH (1983)	6318143	181416	1385	Glutethimide	Doriden|2-Ethyl-2-phenylglutarimide	-	DRUGBANK	DB01437	C13H15NO2	small molecule	N05CE01	77-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMBQKKAJIKAWKF-UHFFFAOYSA-N
16679	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Aizawa N (2010)	20976818	181418	1386	Phenazopyridine	3-(Phenylazo)-2,6-pyridinediamine|Fenazopiridina	pyronium tab 200mg|cvs health 	DRUGBANK	DB01438	C11H11N5	small molecule	G04BX06	94-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPFYXYFORQJZEC-FOCLMDBBSA-N
16680	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Ragsdale DS (1996)	8799190	181417	1386	Phenazopyridine	3-(Phenylazo)-2,6-pyridinediamine|Fenazopiridina	pyronium tab 200mg|cvs health 	DRUGBANK	DB01438	C11H11N5	small molecule	G04BX06	94-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPFYXYFORQJZEC-FOCLMDBBSA-N
16681	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Pascoe JE (2008)	18325678	178496	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16682	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Poonawala T (2005)	15828941	178497	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16683	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Rodrigues AR (2005)	15665994	178502	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16684	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Darwish M (2006)	16861092	178501	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16685	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Sahin AS (2005)	15868528	178500	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16686	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Hajiha M (2009)	19403616	178499	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16687	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Darwish M (2005)	16372825	178498	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16688	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16689	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Scott LJ (2005)	16332149	178507	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16690	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dardonville C (2006)	16797997	178506	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16691	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dosen-Micovic L (2006)	16376082	178505	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16692	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Scott LJ (2005)	16114980	178504	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16693	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	You HJ (2005)	15589524	178503	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16694	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Hajiha M (2009)	19403616	178499	1387	3-Methylthiofentanyl	3-Methyl-thiofentanyl	-	DRUGBANK	DB01439	C21H28N2OS	small molecule	-	86052-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRARDYUHGVMEQI-UHFFFAOYSA-N
16695	122725	79581	-	SLC52A2	BVVLS2|D15Ertd747e|GPCR41|GPR172A|PAR1|RFT3|RFVT2|hRFT3	9606	Homo sapiens	agonist	target	Castelli MP (2002)	12098579	181419	1388	Gamma Hydroxybutyric Acid	3-carboxypropoxy acid|4-hydroxy-butyric acid|gamma-Hydroxybutyrate|4-hydroxybutanoic acid|-Hydroxybutyric acid|GHB|4-hydroxybutanoate|oxy-n-butyric acid|4-Hydroxybutyric acid|gamma-Hydroxybutyric acid	-	DRUGBANK	DB01440	C4H7O3	small molecule	-	591-81-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJZRECIVHVDYJC-UHFFFAOYSA-M
16696	122725	79581	-	SLC52A2	BVVLS2|D15Ertd747e|GPCR41|GPR172A|PAR1|RFT3|RFVT2|hRFT3	9606	Homo sapiens	agonist	target	Castelli MP (2003)	14535954	181420	1388	Gamma Hydroxybutyric Acid	3-carboxypropoxy acid|4-hydroxy-butyric acid|gamma-Hydroxybutyrate|4-hydroxybutanoic acid|-Hydroxybutyric acid|GHB|4-hydroxybutanoate|oxy-n-butyric acid|4-Hydroxybutyric acid|gamma-Hydroxybutyric acid	-	DRUGBANK	DB01440	C4H7O3	small molecule	-	591-81-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJZRECIVHVDYJC-UHFFFAOYSA-M
16697	108834	2560	-	GABRB1	-	9606	Homo sapiens	agonist	target	Maitre M (2005)	15745703	181421	1388	Gamma Hydroxybutyric Acid	3-carboxypropoxy acid|4-hydroxy-butyric acid|gamma-Hydroxybutyrate|4-hydroxybutanoic acid|-Hydroxybutyric acid|GHB|4-hydroxybutanoate|oxy-n-butyric acid|4-Hydroxybutyric acid|gamma-Hydroxybutyric acid	-	DRUGBANK	DB01440	C4H7O3	small molecule	-	591-81-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJZRECIVHVDYJC-UHFFFAOYSA-M
16698	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16699	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16700	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Henry JP (1998)	9587917	181169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16701	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16702	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16703	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16704	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Fleckenstein AE (2007)	17209801	174169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16705	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16706	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16707	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Haughey HM (2000)	10987842	177998	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16708	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Kokoshka JM (1998)	9666084	181422	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16709	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16710	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Haughey HM (2000)	10773193	181167	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16711	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16712	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16713	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Henry JP (1998)	9587917	181169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16714	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16715	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16716	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Imming P (2006)	17016423	171742	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16717	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Overington JP (2006)	17139284	171741	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16718	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Haughey HM (2000)	10773193	181167	1390	MMDA	3-Methoxy-4,5-methylenedioxyphenylisopropylamine|5-Methoxy-3,4-methylenedioxyamphetamine|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine|Amphetamine, 3,4-methylenedioxy-5-methoxy|(+-)-mmda|3-METHOXY-METHYLENEDIOXYAMPHETAMINE	-	DRUGBANK	DB01442	C11H15NO3	small molecule	-	13674-05-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQYUWUKDEVZFDB-UHFFFAOYSA-N
16719	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1392	Dimethylthiambutene	Ohton|Dimethibutin	-	DRUGBANK	DB01444	C14H17NS2	small molecule	-	524-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CANBGVXYBPOLRR-UHFFFAOYSA-N
16720	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1392	Dimethylthiambutene	Ohton|Dimethibutin	-	DRUGBANK	DB01444	C14H17NS2	small molecule	-	524-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CANBGVXYBPOLRR-UHFFFAOYSA-N
16721	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1392	Dimethylthiambutene	Ohton|Dimethibutin	-	DRUGBANK	DB01444	C14H17NS2	small molecule	-	524-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CANBGVXYBPOLRR-UHFFFAOYSA-N
16722	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1392	Dimethylthiambutene	Ohton|Dimethibutin	-	DRUGBANK	DB01444	C14H17NS2	small molecule	-	524-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CANBGVXYBPOLRR-UHFFFAOYSA-N
16723	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	GREEN AF (1959)	13651575	181423	1392	Dimethylthiambutene	Ohton|Dimethibutin	-	DRUGBANK	DB01444	C14H17NS2	small molecule	-	524-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CANBGVXYBPOLRR-UHFFFAOYSA-N
16724	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Wee S (2010)	20352414	181424	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16725	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Klein G (2008)	18343363	181425	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16726	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Klein G (2008)	18343363	181425	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16727	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16728	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Kieffer BL (2002)	12015197	175022	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16729	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Choi HS (2006)	16580639	175026	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16730	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Becker J (2004)	15013161	181426	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16731	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Greenwald MK (2003)	12902992	181427	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16732	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Yao L (2005)	15937104	181428	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16733	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Antonilli L (2005)	15986196	181429	1399	Heroin	O,O'-Diacetylmorphine|(5,6)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester)|Diamorphine|Diacetylmorphine|7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate|3,6-Diacetylmorphine	-	DRUGBANK	DB01452	C21H23NO5	small molecule	N07BC06	561-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGLGOZIDCSQPN-PVHGPHFFSA-N
16734	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16735	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Haughey HM (2000)	10773193	181167	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16736	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Sulzer D (2005)	15955613	174152	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16737	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Whitworth TL (2002)	11756522	181433	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16738	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Szabo Z (2002)	11994534	181432	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16739	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Saldana SN (2004)	14700733	181431	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16740	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Bogen IL (2003)	12742084	181430	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16741	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Boot BP (2002)	12398910	181435	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16742	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Shankaran M (1999)	10607865	181434	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16743	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Nash JF (1994)	7824160	181437	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16744	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	agonist	target	Lyon RA (1986)	2871581	181436	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16745	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	agonist	target	Lyon RA (1986)	2871581	181436	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16746	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16747	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Hansen JP (2002)	11861820	181439	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16748	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fitzgerald JL (1990)	1982265	181438	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16749	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Hansen JP (2002)	11861820	181439	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16750	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Biezonski DK (2010)	20002520	181440	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16751	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Nash JF (1994)	7824160	181437	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16752	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	agonist	target	Lyon RA (1986)	2871581	181436	1401	3,4-Methylenedioxymethamphetamine	Ecstasy|MDMA	-	DRUGBANK	DB01454	C11H15NO2	small molecule	-	42542-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHXWCVYOXRDMCX-UHFFFAOYSA-N
16753	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Li SM (2006)	16478825	181442	1409	Fencamfamine	Fencamfamin|Fencamfamine|Fencamfaminum|Fencanfamina	-	DRUGBANK	DB01463	C15H21N	small molecule	N06BA06	1209-98-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKFBPFGUINLYQI-UHFFFAOYSA-N
16754	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Seyfried CA (1983)	6136281	181441	1409	Fencamfamine	Fencamfamin|Fencamfamine|Fencamfaminum|Fencanfamina	-	DRUGBANK	DB01463	C15H21N	small molecule	N06BA06	1209-98-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKFBPFGUINLYQI-UHFFFAOYSA-N
16755	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Castro RR (2006)	16580848	175027	1412	Ethylmorphine	Ethyl morphine|Ethylmorphine|Dionine	-	DRUGBANK	DB01466	C19H23NO3	small molecule	S01XA06|R05DA01	76-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDVEMNWJVYAJL-LEPYJNQMSA-N
16756	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Choi HS (2006)	16580639	175026	1412	Ethylmorphine	Ethyl morphine|Ethylmorphine|Dionine	-	DRUGBANK	DB01466	C19H23NO3	small molecule	S01XA06|R05DA01	76-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDVEMNWJVYAJL-LEPYJNQMSA-N
16757	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1412	Ethylmorphine	Ethyl morphine|Ethylmorphine|Dionine	-	DRUGBANK	DB01466	C19H23NO3	small molecule	S01XA06|R05DA01	76-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDVEMNWJVYAJL-LEPYJNQMSA-N
16758	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Yamada H (2006)	16530171	175021	1412	Ethylmorphine	Ethyl morphine|Ethylmorphine|Dionine	-	DRUGBANK	DB01466	C19H23NO3	small molecule	S01XA06|R05DA01	76-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDVEMNWJVYAJL-LEPYJNQMSA-N
16759	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Johnson EA (2006)	16682505	175028	1412	Ethylmorphine	Ethyl morphine|Ethylmorphine|Dionine	-	DRUGBANK	DB01466	C19H23NO3	small molecule	S01XA06|R05DA01	76-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDVEMNWJVYAJL-LEPYJNQMSA-N
16760	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Green AL (1980)	6103055	181444	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16761	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Ask AL (1983)	6646243	181443	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16762	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16763	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16764	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Hansen JP (2002)	11861820	181439	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16765	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Biezonski DK (2010)	20002520	181440	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16766	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Green AL (1980)	6103055	181444	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16767	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Ask AL (1983)	6646243	181443	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16768	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16769	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Hansen JP (2002)	11861820	181439	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16770	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Fitzgerald JL (1990)	1982265	181438	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16771	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Daws LC (2000)	11041537	181445	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16772	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16773	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16774	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Whitworth TL (2002)	11756522	181433	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16775	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Szabo Z (2002)	11994534	181432	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16776	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Saldana SN (2004)	14700733	181431	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16777	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Bogen IL (2003)	12742084	181430	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16778	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Boot BP (2002)	12398910	181435	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16779	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Shankaran M (1999)	10607865	181434	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16780	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Daws LC (2000)	11041537	181445	1418	4-Methoxyamphetamine	Paramethoxyamphetamine|(2RS)-1-(4-methoxyphenyl)propan-2-amine|P-methoxyamfetamine|P-methoxyamphetamine|4-methoxyamfetamine|Formoterol fumarate related compound G|D,L-p-methoxyamphetamine	-	DRUGBANK	DB01472	C10H15NO	small molecule	-	64-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEGYEDYHPHMHGK-UHFFFAOYSA-N
16781	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Friedel A (2006)	16621347	181446	1427	Delta1-dihydrotestosterone	1-testosterone|1-Testo|1-T|17beta-hydroxy-5alpha-androst-1-en-3-one	-	DRUGBANK	DB01481	C19H28O2	small molecule	-	65-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKJCFMUGMSVJBG-ABEVXSGRSA-N
16782	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1427	Delta1-dihydrotestosterone	1-testosterone|1-Testo|1-T|17beta-hydroxy-5alpha-androst-1-en-3-one	-	DRUGBANK	DB01481	C19H28O2	small molecule	-	65-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKJCFMUGMSVJBG-ABEVXSGRSA-N
16783	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1427	Delta1-dihydrotestosterone	1-testosterone|1-Testo|1-T|17beta-hydroxy-5alpha-androst-1-en-3-one	-	DRUGBANK	DB01481	C19H28O2	small molecule	-	65-06-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKJCFMUGMSVJBG-ABEVXSGRSA-N
16784	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16785	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16786	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16787	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16788	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16789	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16790	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16791	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16792	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16793	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16794	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16795	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16796	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16797	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16798	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16799	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16800	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16801	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16802	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16803	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16804	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16805	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16806	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16807	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	unknown	target	Glennon RA (1978)	278843	181447	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16808	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	unknown	target	Glennon RA (2000)	10715164	181450	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16809	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	unknown	target	Glennon RA (1977)	270770	181448	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16810	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	unknown	target	Nyandege A (2007)	17239595	181449	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16811	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Su TP (2009)	19278957	181451	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16812	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Su TP (2009)	19278957	181451	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16813	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Pierce PA (1989)	2540505	181452	1434	Dimethyltryptamine	-	-	DRUGBANK	DB01488	C12H16N2	small molecule	-	61-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMULVCHRPCFFGV-UHFFFAOYSA-N
16814	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16815	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16816	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16817	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16818	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16819	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16820	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16821	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16822	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16823	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16824	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16825	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16826	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16827	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16828	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16829	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16830	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16831	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16832	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16833	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16834	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	antagonist	target	Arias HR (2005)	16248797	174570	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16835	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16836	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16837	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Wannemacher KM (2007)	17720886	181454	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16838	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Gharagozlou P (2006)	16433932	175227	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16839	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Niwa M (1995)	7739347	181453	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16840	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	unknown	target	Dum J (1983)	6132412	181455	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16841	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	unknown	target	Nicolas P (1985)	2987913	181457	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16842	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	unknown	target	Xu JY (1992)	1328609	181456	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16843	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	unknown	target	Lemaire S (1981)	6259293	181459	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16844	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	unknown	target	Sanchez-Blazquez P (1992)	1318989	181458	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16845	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16846	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Li JG (2000)	10999950	181460	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16847	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Tao PL (1991)	1665782	181461	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16848	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Marie N (2003)	12672796	181462	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16849	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Li JG (2003)	12606694	181463	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16850	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Sumner BE (1992)	1316589	181464	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16851	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Niwa M (1995)	7739347	181453	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16852	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16853	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Gomes BA (2002)	11900797	181468	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16854	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Melone M (2000)	11098106	181469	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16855	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Duttaroy A (2000)	10881033	181465	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16856	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Stafford K (2001)	11420091	181466	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16857	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Patel MB (2002)	12435815	181467	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16858	111032	4987	-	OPRL1	KOR-3|NOCIR|OOR|ORL1	9606	Homo sapiens	agonist	target	Hawkinson JE (2000)	10688973	181470	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16859	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Maneckjee R (1988)	2828423	181475	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16860	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Audigier Y (1980)	6247160	181474	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16861	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Pfeiffer A (1982)	6124875	181473	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16862	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Stojilkovic SS (1987)	3036471	181472	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16863	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Pesce G (1987)	3037028	181471	1442	Etorphine	Etorphinum	-	DRUGBANK	DB01497	C25H33NO4	small molecule	-	14521-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHCBJPUTCKATP-HBDRVVKHSA-N
16864	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16865	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16867	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16868	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Geldenhuys WJ (2007)	17157509	181478	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16869	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16870	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Geldenhuys WJ (2007)	17157509	181478	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16871	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16872	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Geldenhuys WJ (2007)	17157509	181478	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16873	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16874	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Mayberg HS (1991)	1656846	181480	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16875	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Barry U (2005)	15853689	181479	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16876	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Mayberg HS (1991)	1656846	181480	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16877	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Barry U (2005)	15853689	181479	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16878	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Jewett DM (2004)	15028244	181482	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16879	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Bencherif B (2004)	14744466	181483	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16880	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Mayberg HS (1991)	1656846	181480	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16881	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Bartenstein PA (1994)	7957034	181481	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16882	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Bencherif B (2004)	15001679	181484	1475	Carfentanil	Carfentanyl	-	DRUGBANK	DB01535	C24H30N2O3	small molecule	-	59708-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSDEBIZUNNPOB-UHFFFAOYSA-N
16883	109516	3283	RP5-920G3.4	HSD3B1	3BETAHSD|HSD3B|HSDB3|HSDB3A|I|SDR11E1	9606	Homo sapiens	positive allosteric modulator	target	Ishii-Ohba H (1986)	2945972	181485	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16884	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16885	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16886	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16887	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16888	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1481	Boldenone	1,4-androstadiene-3-one-17beta-ol|delta1-Testosterone|1-Dehydrotestosterone|17beta-Hydroxyandrosta-1,4-dien-3-one|dehydrotestosterone|17beta-Hydroxyandrosta-1,4-diene-3-one|1,2-Dehydrotestosterone|1,4-Androstadien-17beta-ol-3-one|Boldenona|1,2-Didehydrotestosterone|17beta-Boldenone|17-beta-Hydroxy-17-alpha-1,4-androstadien-3-one|Boldenonum|17-beta-Hydroxyandrosta-1,4-dien-3-one	-	DRUGBANK	DB01541	C19H26O2	small molecule	-	846-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSIHSRDYCUFFLA-DYKIIFRCSA-N
16889	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1481	Boldenone	1,4-androstadiene-3-one-17beta-ol|delta1-Testosterone|1-Dehydrotestosterone|17beta-Hydroxyandrosta-1,4-dien-3-one|dehydrotestosterone|17beta-Hydroxyandrosta-1,4-diene-3-one|1,2-Dehydrotestosterone|1,4-Androstadien-17beta-ol-3-one|Boldenona|1,2-Didehydrotestosterone|17beta-Boldenone|17-beta-Hydroxy-17-alpha-1,4-androstadien-3-one|Boldenonum|17-beta-Hydroxyandrosta-1,4-dien-3-one	-	DRUGBANK	DB01541	C19H26O2	small molecule	-	846-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSIHSRDYCUFFLA-DYKIIFRCSA-N
16890	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Merlanti R (2007)	17386710	181486	1481	Boldenone	1,4-androstadiene-3-one-17beta-ol|delta1-Testosterone|1-Dehydrotestosterone|17beta-Hydroxyandrosta-1,4-dien-3-one|dehydrotestosterone|17beta-Hydroxyandrosta-1,4-diene-3-one|1,2-Dehydrotestosterone|1,4-Androstadien-17beta-ol-3-one|Boldenona|1,2-Didehydrotestosterone|17beta-Boldenone|17-beta-Hydroxy-17-alpha-1,4-androstadien-3-one|Boldenonum|17-beta-Hydroxyandrosta-1,4-dien-3-one	-	DRUGBANK	DB01541	C19H26O2	small molecule	-	846-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSIHSRDYCUFFLA-DYKIIFRCSA-N
16891	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16892	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	You H (2010)	20638393	181489	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16893	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Oblak AL (2011)	20858465	181488	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16894	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16895	108831	2557	-	GABRA4	-	9606	Homo sapiens	agonist	target	Skilbeck KJ (2008)	17976880	181487	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16896	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16897	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	You H (2010)	20638393	181489	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16898	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Oblak AL (2011)	20858465	181488	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16899	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16900	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Santhakumar V (2006)	16554486	181490	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16901	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	You H (2010)	20638393	181489	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16902	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Skilbeck KJ (2008)	17976880	181487	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16903	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Oblak AL (2011)	20858465	181488	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16904	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	You H (2010)	20638393	181489	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16905	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16906	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16907	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Skilbeck KJ (2008)	17976880	181487	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16908	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Oelschlaeger H (1989)	2570451	181491	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16909	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Gandolfo P (1997)	9098698	181493	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16910	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Katz Y (1992)	1320691	181492	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16911	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Papadopoulos V (1991)	1847384	181495	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16912	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Poisnel G (2009)	19443999	181494	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16913	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Papadopoulos V (1991)	1651852	181496	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16914	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Awad M (1989)	2723642	179968	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16915	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16916	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	You H (2010)	20638393	181489	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16917	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1484	Flunitrazepam	Flunitrazepamum|Rohypnol	-	DRUGBANK	DB01544	C16H12FN3O3	small molecule	N05CD03	1622-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTYJKAXVCCBDU-UHFFFAOYSA-N
16918	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	unknown	target	Law PY (1985)	2982865	181499	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16919	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	unknown	target	Pfeiffer A (1982)	6287305	181498	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16920	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	unknown	target	Cvejic S (1996)	8626742	181500	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16921	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	unknown	target	Pfeiffer A (1982)	6124875	181473	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16922	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	unknown	target	Chang KJ (1981)	6270660	181497	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16923	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Cvejic S (1996)	20641600	181501	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16924	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Webster JM (2003)	12909189	181503	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16925	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Jones AK (1999)	10413036	181502	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16926	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Cvejic S (1996)	20641600	181501	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16927	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Willoch F (1999)	10319982	181505	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16928	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Kampa M (2001)	11526449	181504	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16929	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Marie N (2003)	12672796	181462	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16930	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Cvejic S (1996)	20641600	181501	1488	Diprenorphine	Diprenorfin	-	DRUGBANK	DB01548	C26H35NO4	small molecule	-	14357-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIJXLIIMXHRJJH-KNLIIKEYSA-N
16931	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Seeman P (2009)	19391150	180698	1489	Rolicyclidine	Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine	-	DRUGBANK	DB01549	C16H23N	small molecule	-	2201-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYOWWXMGDATDQY-UHFFFAOYSA-N
16932	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	unknown	target	Yuede CM (2010)	20613880	181507	1489	Rolicyclidine	Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine	-	DRUGBANK	DB01549	C16H23N	small molecule	-	2201-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYOWWXMGDATDQY-UHFFFAOYSA-N
16933	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	unknown	target	Willoch F (1999)	20641908	181506	1489	Rolicyclidine	Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine	-	DRUGBANK	DB01549	C16H23N	small molecule	-	2201-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYOWWXMGDATDQY-UHFFFAOYSA-N
16934	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16935	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16936	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16937	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16938	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16939	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16940	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16941	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16942	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16943	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16944	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16945	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16946	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16947	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16948	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16949	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16950	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16951	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16952	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16953	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16954	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16955	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16956	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Baburin I (2008)	18604239	181509	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16957	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Baburin I (2008)	18604239	181509	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16958	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16959	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16960	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16961	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16962	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Baburin I (2008)	18604239	181509	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16963	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16964	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16965	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16966	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16967	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16968	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Baburin I (2008)	18604239	181509	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16969	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16970	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Berman HM (2000)	10592235	172122	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16971	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16972	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16973	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16974	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1501	Androstanedione	5alpha-Androstan-3,17-dione	-	DRUGBANK	DB01561	C19H28O2	small molecule	-	846-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJWOBJTTGJROA-WZNAKSSCSA-N
16975	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1501	Androstanedione	5alpha-Androstan-3,17-dione	-	DRUGBANK	DB01561	C19H28O2	small molecule	-	846-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJWOBJTTGJROA-WZNAKSSCSA-N
16976	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1501	Androstanedione	5alpha-Androstan-3,17-dione	-	DRUGBANK	DB01561	C19H28O2	small molecule	-	846-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJWOBJTTGJROA-WZNAKSSCSA-N
16977	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Small EJ (2006)	17084172	177399	1504	Calusterone	Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS	-	DRUGBANK	DB01564	C21H32O2	small molecule	-	17021-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVFYLRMMHVYGJH-PVPPCFLZSA-N
16978	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Omwancha J (2006)	17086931	177398	1504	Calusterone	Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS	-	DRUGBANK	DB01564	C21H32O2	small molecule	-	17021-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVFYLRMMHVYGJH-PVPPCFLZSA-N
16979	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1504	Calusterone	Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS	-	DRUGBANK	DB01564	C21H32O2	small molecule	-	17021-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVFYLRMMHVYGJH-PVPPCFLZSA-N
16980	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Lapauw B (2007)	17322500	177397	1504	Calusterone	Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS	-	DRUGBANK	DB01564	C21H32O2	small molecule	-	17021-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVFYLRMMHVYGJH-PVPPCFLZSA-N
16981	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	McPhaul MJ (2001)	11511858	181510	1504	Calusterone	Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS	-	DRUGBANK	DB01564	C21H32O2	small molecule	-	17021-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVFYLRMMHVYGJH-PVPPCFLZSA-N
16982	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Brodkin RA (1978)	152592	181511	1504	Calusterone	Calusteronum|Calusterona|7-beta,17-alpha-Dimethyl testosterone|7-beta,17-Dimethyltestosterone|17beta-Hydroxy-7beta,17-dimethylandrost-4-en-3-one|Calusteron|17beta-Hydroxy-7beta,17alpha-dimethylandrost-4-ene-3-one|17-beta-Hydroxy-7-beta,17-alpha-dimethylandrost-4-ene-3-one|7beta,17-Dimethyltestosterone|7beta,17alpha-Dimethyltestosterone|CLS	-	DRUGBANK	DB01564	C21H32O2	small molecule	-	17021-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVFYLRMMHVYGJH-PVPPCFLZSA-N
16983	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Koman A (1987)	2855368	181514	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16984	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Ho CL (1985)	2985086	181515	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16985	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Maneckjee R (1988)	2828423	181475	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16986	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Ishizuka Y (1987)	2835832	181512	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16987	115501	10206	-	TRIM13	CAR|DLEU5|LEU5|RFP2|RNF77	9606	Homo sapiens	agonist	target	Liebmann C (1991)	1654566	181513	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16988	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Crooks PA (2006)	16777416	181516	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16989	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Dietis N (2009)	19474215	176506	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16990	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Gilbert AK (2004)	15178355	181517	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16991	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	agonist	target	Johnson N (1982)	6292632	181518	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16992	111439	5443	-	POMC	ACTH|CLIP|LPH|MSH|NPP|POC	9606	Homo sapiens	agonist	target	Somoza E (1978)	29252	181519	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16993	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Crooks PA (2006)	16777416	181516	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16994	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Dietis N (2009)	19474215	176506	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16995	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Gilbert AK (2004)	15178355	181517	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16996	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Crooks PA (2006)	16777416	181516	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16997	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dietis N (2009)	19474215	176506	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16998	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Gilbert AK (2004)	15178355	181517	1505	Dihydromorphine	-	-	DRUGBANK	DB01565	C17H21NO3	small molecule	-	509-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJVCSMSMFSCRME-KBQPJGBKSA-N
16999	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17000	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17001	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17002	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17003	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17004	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17005	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17006	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17007	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17008	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17009	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17010	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17011	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17012	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17013	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17014	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17015	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Wang ZX (1993)	8030414	181521	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17016	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Jin WQ (1981)	6264594	181523	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17017	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Zhu J (1996)	8576134	181522	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17018	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Wang ZX (1993)	8030414	181521	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17019	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Jin WQ (1981)	6264594	181523	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17020	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Zhu J (1996)	8576134	181522	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17021	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Wang ZX (1993)	8030414	181521	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17022	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Jin WQ (1981)	6264594	181523	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17023	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Zhu J (1996)	8576134	181522	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17024	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Subramanian G (2000)	10669565	181524	1511	3-Methylfentanyl	3-MF|mefentanyl	-	DRUGBANK	DB01571	C23H30N2O	small molecule	-	42045-86-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLQRZXNZHAOCHQ-UHFFFAOYSA-N
17025	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Dlugos AM (2009)	19727679	181525	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17026	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Burnette WB (1996)	8794928	181527	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17027	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Dlugos A (2007)	17239355	181526	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17028	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17029	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17030	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17031	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17032	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17033	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inducer	target	Sulzer D (1995)	7751968	174151	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17034	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inducer	target	Sulzer D (2005)	15955613	174152	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17035	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Miller GM (2005)	15764732	174161	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17036	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234900	174160	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17037	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Wolinsky TD (2007)	17212650	174157	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17038	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Reese EA (2007)	17218486	174158	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17039	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234899	174159	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17040	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Rothman RB (2009)	19244097	181529	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17041	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Zhen J (2005)	16122767	181528	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17042	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Kuczenski R (1995)	7869099	181530	1516	Dextroamphetamine	(+)-alpha-Methylphenethylamine|(S)-(+)-Amphetamine|(S)-1-Phenyl-2-aminopropane|dexamphetamine|(S)-(+)-beta-Phenylisopropylamine|Dextroamphetamine|(+)-alpha-Methylphenylethylamine|(+)-(S)-amphetamine|(+)-Amphetamine|d-amphetamine|Dexamfetamine|(S)-amphetamine|(S)-alpha-Methylbenzeneethanamine|(AlphaS)-alpha-methylbenzeneethanamine|(S)-1-Phenyl-2-propylamine	act amphetamine xr|dextroamphe	DRUGBANK	DB01576	C9H13N	small molecule	N06BA02	51-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-QMMMGPOBSA-N
17043	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17044	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17045	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Jeng CH (1998)	9551769	181531	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17046	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17047	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17048	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Yasumoto S (2009)	19429089	181176	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17049	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (1995)	7751968	174151	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17050	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17051	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Horton DB (2011)	21177475	181175	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17052	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17053	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17054	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Jeng CH (1998)	9551769	181531	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17055	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17056	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Ulus IH (2000)	10799660	174228	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17057	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17058	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Grandy DK (2007)	17888514	181532	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17059	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Borowsky B (2001)	11459929	181533	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17060	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Reese EA (2007)	17218486	174158	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17061	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234899	174159	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17062	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234900	174160	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17063	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Wolinsky TD (2007)	17212650	174157	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17064	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Miller GM (2005)	15764732	174161	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17065	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Miller GM (2005)	15764732	174161	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17066	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Garcia BG (2005)	15795321	174163	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17067	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Lott DC (2005)	15602501	174162	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17068	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Kahlig KM (2005)	15728379	174165	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17069	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fone KC (2005)	15661631	174164	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17070	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Escubedo E (2009)	19897077	181534	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17071	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Madras BK (2005)	15950014	174166	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17072	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	negative modulator	target	Fleckenstein AE (2007)	17209801	174169	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17073	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Fleckenstein AE (2007)	17209801	174169	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17074	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Henry JP (1998)	9587917	181169	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17075	112458	6570	-	SLC18A1	CGAT|VAT1|VMAT1	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17076	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Jeng CH (1998)	9551769	181531	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17077	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Sulzer D (2005)	15955613	174152	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17078	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Nishio M (2002)	12453616	181535	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17079	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Numachi Y (2007)	17673199	181538	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17080	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Sora I (2009)	19607959	181536	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17081	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	negative modulator	target	Tellez R (2010)	20226815	181537	1517	Methamphetamine	d-deoxyephedrine|Mtamftamine|(S)-N,-dimethylbenzeneethanamine|(S)-N,alpha-Dimethylbenzeneethanamine|(S)-N,-dimethylbenzeneethanamine|Methamphetamine|(+)-(S)-N--dimethylphenethylamine|d-phenylisopropylmethylamine|Methamphetaminum|d-N-methylamphetamine|Metamfetamine|(+)-(S)-N-alpha-Dimethylphenethylamine|Metamfetaminum|d-1-phenyl-2-methylaminopropane|Dextromethamphetamine|Metanfetamina|methyl--phenylisopropylamine|Methyl-beta-phenylisopropylamine|d-desoxyephedrine|(AlphaS)-N,alpha-dimethylbenzeneethanamine	desoxyn|methamphetamine hydroc	DRUGBANK	DB01577	C10H15N	small molecule	N06BA03	537-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYWUZJCMWCOHBA-VIFPVBQESA-N
17082	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	negative modulator	target	Rothman RB (2006)	17017961	178585	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17083	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17084	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Rothman RB (2006)	17017961	178585	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17085	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17086	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Bray GA (2005)	16265126	181539	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17087	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Bray GA (2000)	11054601	180046	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17088	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Bray GA (2005)	16265126	181539	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17089	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Bray GA (2000)	11054601	180046	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17090	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17091	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17092	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17093	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Rothman RB (2006)	17017961	178585	1519	Phendimetrazine	(2S,3S)-3,4-dimethyl-2-phenylmorpholine	bontril|phendimetrazine tartra	DRUGBANK	DB01579	C12H17NO	small molecule	-	634-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFOCDFTXLCYLKU-CMPLNLGQSA-N
17094	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17095	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17096	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Fujita H (1998)	9509999	181542	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17097	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Prinz M (2001)	11311890	181541	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17098	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Sekut L (1995)	7882570	181540	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17099	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Lemmer B (1982)	6124492	181544	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17100	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Campbell CA (1984)	6202960	181543	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17101	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17102	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17103	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17104	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Abrahamsson T (1986)	2871880	178780	1520	Oxprenolol	Oxprenololum|Oxprenolol	trasicor tab 80mg|slow trasico	DRUGBANK	DB01580	C15H23NO3	small molecule	C07CA02|C07AA02|C07BA02	6452-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEMAWMOMDPGJMB-UHFFFAOYSA-N
17105	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Thijssen HH (1973)	4577373	181546	1521	Sulfamerazine	Sulfamethyldiazine|2-(Sulfanilamido)-4-methylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin|4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide|N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide|Sulphamerazine|Sulfamerazina|2-Sulfa-4-methylpyrimidine|2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine|N-(4-Methyl-2-pyrimidyl)sulfanilamide|Sulfamerazinum|2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine	trisulfaminic sus|trisulfamini	DRUGBANK	DB01581	C11H12N4O2S	small molecule	J01ED07|J01EE07|D06BA06	127-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPBRPIAZZHUNT-UHFFFAOYSA-N
17106	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Friaza V (2010)	21084778	181545	1521	Sulfamerazine	Sulfamethyldiazine|2-(Sulfanilamido)-4-methylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin|4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide|N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide|Sulphamerazine|Sulfamerazina|2-Sulfa-4-methylpyrimidine|2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine|N-(4-Methyl-2-pyrimidyl)sulfanilamide|Sulfamerazinum|2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine	trisulfaminic sus|trisulfamini	DRUGBANK	DB01581	C11H12N4O2S	small molecule	J01ED07|J01EE07|D06BA06	127-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPBRPIAZZHUNT-UHFFFAOYSA-N
17107	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hong YL (1995)	7486915	174738	1521	Sulfamerazine	Sulfamethyldiazine|2-(Sulfanilamido)-4-methylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin|4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide|N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide|Sulphamerazine|Sulfamerazina|2-Sulfa-4-methylpyrimidine|2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine|N-(4-Methyl-2-pyrimidyl)sulfanilamide|Sulfamerazinum|2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine	trisulfaminic sus|trisulfamini	DRUGBANK	DB01581	C11H12N4O2S	small molecule	J01ED07|J01EE07|D06BA06	127-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPBRPIAZZHUNT-UHFFFAOYSA-N
17108	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Thijssen HH (1973)	4577373	181546	1522	Sulfamethazine	N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|SMZ|Sulphadimethylpyrimidine|Sulfametazina|Sulfamezathine|N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide|2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|Sulfadimidinum|2-Sulfanilamido-4,6-dimethylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin|Sulfadimethylpyrimidine|Sulphamethazine|Sulfadimidina|Sulfadimidine|Sulfadimethyldiazine|6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin|4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide|Sulfametazyny|4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide|N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide|2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|4,6-Dimethyl-2-sulfanilamidopyrimidine	trisulfaminic sus|trisulfamini	DRUGBANK	DB01582	C12H14N4O2S	small molecule	J01EB03|J01EE05	57-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASWVTGNCAZCNNR-UHFFFAOYSA-N
17109	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Friaza V (2010)	21084778	181545	1522	Sulfamethazine	N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|SMZ|Sulphadimethylpyrimidine|Sulfametazina|Sulfamezathine|N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide|2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|Sulfadimidinum|2-Sulfanilamido-4,6-dimethylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin|Sulfadimethylpyrimidine|Sulphamethazine|Sulfadimidina|Sulfadimidine|Sulfadimethyldiazine|6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin|4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide|Sulfametazyny|4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide|N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide|2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|4,6-Dimethyl-2-sulfanilamidopyrimidine	trisulfaminic sus|trisulfamini	DRUGBANK	DB01582	C12H14N4O2S	small molecule	J01EB03|J01EE05	57-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASWVTGNCAZCNNR-UHFFFAOYSA-N
17110	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hong YL (1995)	7486915	174738	1522	Sulfamethazine	N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|SMZ|Sulphadimethylpyrimidine|Sulfametazina|Sulfamezathine|N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide|2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|Sulfadimidinum|2-Sulfanilamido-4,6-dimethylpyrimidine|(P-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin|Sulfadimethylpyrimidine|Sulphamethazine|Sulfadimidina|Sulfadimidine|Sulfadimethyldiazine|6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin|4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide|Sulfametazyny|4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide|N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide|4-amino-N-(4,6-Dimethylpyrimidin-2-yl)benzenesulfonamide|2-(P-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine|4,6-Dimethyl-2-sulfanilamidopyrimidine	trisulfaminic sus|trisulfamini	DRUGBANK	DB01582	C12H14N4O2S	small molecule	J01EB03|J01EE05	57-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASWVTGNCAZCNNR-UHFFFAOYSA-N
17111	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17112	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17113	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17114	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Nakajima Y (2010)	20615127	176152	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17115	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Mai W (2004)	15240882	174847	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17116	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Kariv R (2003)	12955882	174848	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17117	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Jiang W (2004)	15283690	174849	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17118	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Timmer DC (2003)	14596673	174846	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17119	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Bernal J (2007)	17315033	174854	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17120	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	agonist	target	Sciaudone MP (2004)	15235154	174845	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17121	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Grasberger H (2005)	16053391	176155	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17122	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17123	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Marazuela M (2008)	18816177	176154	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17124	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17125	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17126	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Sivakumar T (2010)	20151830	176153	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17127	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Wu SY (2005)	16099238	174850	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17128	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Yen PM (2003)	12776178	174853	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17129	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Gonzalez-Sancho JM (2003)	12668276	174852	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17130	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	agonist	target	Bernal J (2007)	17315033	174854	1523	Liotrix	Liotrix (T4;T3)|Levothyroxine sodium - liothyronine sodium mixt|Thyrolar	-	DRUGBANK	DB01583	C30H21I7N2Na2O8	small molecule	-	8065-29-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWLLWWYBVUPP-XOCLESOZSA-L
17131	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	inducer	target	Amaral JD (2009)	19747134	181547	1525	Ursodeoxycholic acid	Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid	actigall|urso 250|phl-ursodiol	DRUGBANK	DB01586	C24H40O4	small molecule	A05AA02	128-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-UZVSRGJWSA-N
17132	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1525	Ursodeoxycholic acid	Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid	actigall|urso 250|phl-ursodiol	DRUGBANK	DB01586	C24H40O4	small molecule	A05AA02	128-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-UZVSRGJWSA-N
17133	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1525	Ursodeoxycholic acid	Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid	actigall|urso 250|phl-ursodiol	DRUGBANK	DB01586	C24H40O4	small molecule	A05AA02	128-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-UZVSRGJWSA-N
17134	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17135	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17136	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17137	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Blaschke G (1986)	2874815	181548	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17138	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17139	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17140	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17141	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Blaschke G (1986)	2874815	181548	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17142	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17143	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17144	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17145	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Falchi AM (2007)	17631921	178583	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17146	107168	706	RP3-526I14.4	TSPO	BPBS|BZRP|DBI|IBP|MBR|PBR|PBS|PKBS|PTBR|mDRC|pk18	9606	Homo sapiens	agonist	target	Vega D (2001)	11443263	181549	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17147	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17148	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17149	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17150	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17151	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17152	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17153	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17154	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17155	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Amin J (1997)	9145922	181551	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17156	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17157	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17158	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17159	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17160	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17161	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17162	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17163	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17164	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17165	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17166	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17167	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17168	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17169	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Schove LT (1994)	7773620	181550	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17170	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17171	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17172	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17173	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17174	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17175	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17176	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17177	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17178	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17179	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17180	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17181	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17182	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17183	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17184	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17185	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17186	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17187	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17188	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17189	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17190	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17191	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17192	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17193	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17194	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17195	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17196	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17197	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17198	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17199	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17200	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17201	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17202	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17203	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17204	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Rostaing L (2010)	20155724	181558	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17205	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	George S (2009)	19774211	181559	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17206	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Ettenger R (2008)	18466433	181554	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17207	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Coppin C (2010)	20531964	181555	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17208	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Albert S (2010)	20569080	181556	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17209	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Teachey DT (2009)	19344392	181557	1529	Everolimus	40-O-(2-hydroxyethyl)-rapamycin	afinitor|afinitor disperz|zort	DRUGBANK	DB01590	C53H83NO14	small molecule	L04AA18|L01XE10	159351-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKVAMNSJSFKALM-GKUWKFKPSA-N
17210	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17211	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17212	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17213	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17214	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Ito Y (2009)	19446545	179922	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17215	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17216	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17217	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17218	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17219	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17220	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17221	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17222	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Sinha S (2010)	20590605	179924	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17223	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	1530	Solifenacin	-	act solifenacin|mint-solifenac	DRUGBANK	DB01591	C23H26N2O2	small molecule	G04BD08|G04CA53	242478-37-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBOUYBDGKBSUES-VXKWHMMOSA-N
17224	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17225	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17226	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17227	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Amin J (1997)	9145922	181551	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17228	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17229	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17230	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17231	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17232	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17233	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17234	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17235	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17236	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17237	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17238	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17239	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Walash MI (1994)	7849137	181561	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17240	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17241	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17242	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17243	108831	2557	-	GABRA4	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17244	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17245	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17246	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17247	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17248	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17249	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Tanaka M (2008)	18603831	181563	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17250	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Podhorna J (2000)	10877119	181562	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17251	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17252	108834	2560	-	GABRB1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17253	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17254	108832	2558	-	GABRA5	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17255	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17256	108833	2559	-	GABRA6	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17257	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17258	108829	2555	-	GABRA2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17259	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	unknown	target	McLean MJ (1988)	2450203	181564	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17260	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17261	108843	2569	RP11-63L7.1	GABRR1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17262	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17263	108839	2565	-	GABRG1	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17264	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17265	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17266	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17267	108844	2570	RP1-131H7.1	GABRR2	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17268	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17269	128361	200959	-	GABRR3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17270	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17271	108830	2556	-	GABRA3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17272	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17273	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17274	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17275	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17276	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17277	108842	2568	-	GABRP	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17278	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17279	108838	2564	-	GABRE	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17280	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17281	108841	2567	-	GABRG3	-	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17282	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17283	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17284	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17285	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Farrell CA (1987)	3038022	181569	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17286	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Keynan S (1995)	7492120	181568	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17287	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Hirota T (1986)	3780719	181565	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17288	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Kumon H (1987)	3480361	181567	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17289	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Lin JH (1989)	2571484	181566	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17290	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Richerson MA (1998)	9573653	181570	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17291	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Hirota T (1987)	3474745	181571	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17292	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Luchi M (2000)	11061029	181574	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17293	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Neu HC (1985)	3873871	181575	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17294	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Nicolau DP (2008)	18076336	181572	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17295	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Zhanel GG (2007)	17488146	181573	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17296	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Nicolau DP (2008)	18076336	181572	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17297	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Zhanel GG (2007)	17488146	181573	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17298	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Nicolau DP (2008)	18076336	181572	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17299	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Nicolau DP (2008)	18076336	181572	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
17300	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Jeon SM (2005)	16292755	181576	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17301	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Shichiri M (2010)	19427182	181582	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17302	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	de la Llera-Moya M (2010)	20075420	181581	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17303	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Sirtori CR (1991)	1868500	181580	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17304	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Arakawa R (2009)	19458386	181578	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17305	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Yamamoto A (2008)	19075491	181579	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17306	106537	19	-	ABCA1	ABC-1|ABC1|CERP|HDLDT1|TGD	9606	Homo sapiens	inhibitor	target	Favari E (2004)	15514211	181577	1537	Probucol	Bisbid|Biphenabid|Superlipid|Lorelco|4,4'- (Isopropylidenedithio)bis(2,6-di-tert-butylphenol)|Lurselle|Acetone bis(3,5-di-tert-butyl-4-hydroxyphenyl) mercaptole|Probucolum|Bisphenabid|Lesterol|DH-581|Serterol	lorelco	DRUGBANK	DB01599	C31H48O2S2	small molecule	C10AX02	23288-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYPMFJGVHOHGLL-UHFFFAOYSA-N
17307	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Gupta K (2004)	14741265	179900	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17308	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Patrignani P (2003)	14592549	179902	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17309	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hillarp A (2004)	15575422	179899	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17310	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Martic M (2004)	14987823	179630	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17311	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brandt KD (1990)	2277128	181583	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17312	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17313	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17315	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Wittayanarakul K (2008)	17849388	174468	1539	Lopinavir	LPV	lopinavir-ritonavir|kaletra	DRUGBANK	DB01601	C37H48N4O5	small molecule	J05AR10	192725-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJHKTHWMRKYKJE-SUGCFTRWSA-N
17316	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Garriga C (2007)	17854027	174469	1539	Lopinavir	LPV	lopinavir-ritonavir|kaletra	DRUGBANK	DB01601	C37H48N4O5	small molecule	J05AR10	192725-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJHKTHWMRKYKJE-SUGCFTRWSA-N
17317	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Chen X (2002)	11752352	171740	1539	Lopinavir	LPV	lopinavir-ritonavir|kaletra	DRUGBANK	DB01601	C37H48N4O5	small molecule	J05AR10	192725-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJHKTHWMRKYKJE-SUGCFTRWSA-N
17318	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Reddy GS (2007)	17696512	181585	1539	Lopinavir	LPV	lopinavir-ritonavir|kaletra	DRUGBANK	DB01601	C37H48N4O5	small molecule	J05AR10	192725-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJHKTHWMRKYKJE-SUGCFTRWSA-N
17319	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	inhibitor	target	Unknown Authors (2001)	11151088	181584	1539	Lopinavir	LPV	lopinavir-ritonavir|kaletra	DRUGBANK	DB01601	C37H48N4O5	small molecule	J05AR10	192725-17-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJHKTHWMRKYKJE-SUGCFTRWSA-N
17320	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17321	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Tsukamoto T (1984)	6149771	181308	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17322	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17323	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17324	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1546	Propericiazine	10-(3-(4-Hydroxypiperidino)propyl)phenothiazine-2-carbonitrile|Cyano-3 ((hydroxy-4 piperidyl-1)-3 propyl)-10 phenothiazine|Periciazinum|Piperocyanomazine|Pericyazine|2-Cyano-10-(3-(4-hydroxypiperidino)propyl)phenothiazine|Propericiazine|Periciazine|2-Cyano-10-(3-(4-hydroxy-1-piperidyl)propyl)phenothiazine|Periciazina	neuleptil 5mg capsules|neulept	DRUGBANK	DB01608	C21H23N3OS	small molecule	N05AC01	2622-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUALIOATIOESLM-UHFFFAOYSA-N
17325	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17326	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	antagonist	target	Trevani AS (2003)	14579285	177266	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17327	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	antagonist	target	Sun S (2007)	18220957	181586	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17328	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	antagonist	target	Trevani AS (2003)	14579285	177266	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17329	119902	54106	UNQ5798/PRO19605	TLR9	CD289	9606	Homo sapiens	antagonist	target	Sun S (2007)	18220957	181586	1549	Hydroxychloroquine	7-chloro-4-[4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-(4-(N-Ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Hydroxychloroquinum|Hidroxicloroquina|Oxichloroquine|Oxichlorochine|2-((4-((7-chloro-4-Quinolyl)amino)pentyl)ethylamino)ethanol|(+-)-Hydroxychloroquine|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-chloro-4-(4-(Ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|NSC4375|7-chloro-4-[5-(N-Ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|()-hydroxychloroquine|Polirreumin	pms-hydroxychloroquine|apo-hyd	DRUGBANK	DB01611	C18H26ClN3O	small molecule	P01BA02	118-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSMGPRMXLTPCZ-UHFFFAOYSA-N
17330	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Bauersachs J (2009)	19732062	178066	1550	Amyl Nitrite	n-pentyl nitrite|Nitramyl|1-nitropentane|pentyl nitrite|n-Amyl nitrite	amylnitrite glass cap 5min|amy	DRUGBANK	DB01612	C5H11NO2	small molecule	V03AB22	8017-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSDTZUBPSYWZDX-UHFFFAOYSA-N
17331	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Madhani M (2003)	12890708	178067	1550	Amyl Nitrite	n-pentyl nitrite|Nitramyl|1-nitropentane|pentyl nitrite|n-Amyl nitrite	amylnitrite glass cap 5min|amy	DRUGBANK	DB01612	C5H11NO2	small molecule	V03AB22	8017-89-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSDTZUBPSYWZDX-UHFFFAOYSA-N
17332	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1551	Erythrityl Tetranitrate	Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate	-	DRUGBANK	DB01613	C4H6N4O12	small molecule	C01DA13|C01DA63	7297-25-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNFOERUNNSHUGP-ZXZARUISSA-N
17333	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1551	Erythrityl Tetranitrate	Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate	-	DRUGBANK	DB01613	C4H6N4O12	small molecule	C01DA13|C01DA63	7297-25-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNFOERUNNSHUGP-ZXZARUISSA-N
17334	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	agonist	target	Schroeder H (1987)	2895614	181587	1551	Erythrityl Tetranitrate	Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate	-	DRUGBANK	DB01613	C4H6N4O12	small molecule	C01DA13|C01DA63	7297-25-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNFOERUNNSHUGP-ZXZARUISSA-N
17335	110942	4882	-	NPR2	AMDM|ANPRB|ANPb|ECDM|GUC2B|GUCY2B|NPRB|NPRBi	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1551	Erythrityl Tetranitrate	Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate	-	DRUGBANK	DB01613	C4H6N4O12	small molecule	C01DA13|C01DA63	7297-25-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNFOERUNNSHUGP-ZXZARUISSA-N
17336	110942	4882	-	NPR2	AMDM|ANPRB|ANPb|ECDM|GUC2B|GUCY2B|NPRB|NPRBi	9606	Homo sapiens	agonist	target	Lange K (2009)	19406636	181588	1551	Erythrityl Tetranitrate	Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate	-	DRUGBANK	DB01613	C4H6N4O12	small molecule	C01DA13|C01DA63	7297-25-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNFOERUNNSHUGP-ZXZARUISSA-N
17337	110942	4882	-	NPR2	AMDM|ANPRB|ANPb|ECDM|GUC2B|GUCY2B|NPRB|NPRBi	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1551	Erythrityl Tetranitrate	Eritrityli tetranitras|Tetranitrato de eritritilo|1,2,3,4-Butanetetralyl tetranitrate|Erythritol tetranitrate|ETN|Eritrityl tetranitrate|Tetranitrate d'eritrityle|Tetranitrol|Erythrol tetranitrate|Meso-erythritol tetranitrate|Tetranitrin|(2R*,3S)-rel-1,2,3,4-butanetetroltetranitrate	-	DRUGBANK	DB01613	C4H6N4O12	small molecule	C01DA13|C01DA63	7297-25-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNFOERUNNSHUGP-ZXZARUISSA-N
17338	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17339	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17340	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17341	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17342	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17343	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17344	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17345	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17346	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17347	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yamada J (1995)	8593484	176333	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17348	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kusumi I (2000)	10821438	176334	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17349	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cosi C (2001)	11755134	176338	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17350	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (1998)	9760039	176339	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17351	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1553	Aceprometazine	Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone	-	DRUGBANK	DB01615	C19H22N2OS	small molecule	-	13461-01-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOQNFNTQIRSOX-UHFFFAOYSA-N
17352	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1553	Aceprometazine	Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone	-	DRUGBANK	DB01615	C19H22N2OS	small molecule	-	13461-01-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOQNFNTQIRSOX-UHFFFAOYSA-N
17353	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1553	Aceprometazine	Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone	-	DRUGBANK	DB01615	C19H22N2OS	small molecule	-	13461-01-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOQNFNTQIRSOX-UHFFFAOYSA-N
17354	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Mercier J (1974)	4406367	181589	1553	Aceprometazine	Acepromethazine|Aceprometazina|Aceprometazinum|10-(2-(Dimethylamino)propyl)phenothiazin-2-yl methyl ketone	-	DRUGBANK	DB01615	C19H22N2OS	small molecule	-	13461-01-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOQNFNTQIRSOX-UHFFFAOYSA-N
17355	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Coelho AM (2001)	11697552	181590	1554	Alverine	N-Ethyl-N-(3-phenylpropyl)benzenepropanamine|N-Ethyl-3,3'-diphenyldipropylamine|N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine|Bis(gamma-phenylpropyl)ethylamine|N,N-Bis(3-phenylpropyl)ethylamine|Di(phenylpropyl)ethylamine|Alverinum|Phenopropamine|Alverina|Phenpropamine	-	DRUGBANK	DB01616	C20H27N	small molecule	A03AX58|A03AX08	150-59-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPFXAOWNKLFJDN-UHFFFAOYSA-N
17356	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Nguyen TV (1989)	2586632	181591	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17357	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17358	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17359	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1997)	9342550	175878	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17360	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (1998)	9577836	181592	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17361	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lidow MS (1997)	9353417	181593	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17362	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Neeper R (1991)	1678146	181594	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17363	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nguyen TV (1989)	2586632	181591	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17364	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1556	Phenindamine	Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin	-	DRUGBANK	DB01619	C19H19N	small molecule	R06AX04	82-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISFHAYSTHMVOJR-UHFFFAOYSA-N
17365	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Witek TJ (1992)	1360991	181595	1556	Phenindamine	Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin	-	DRUGBANK	DB01619	C19H19N	small molecule	R06AX04	82-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISFHAYSTHMVOJR-UHFFFAOYSA-N
17366	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1556	Phenindamine	Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin	-	DRUGBANK	DB01619	C19H19N	small molecule	R06AX04	82-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISFHAYSTHMVOJR-UHFFFAOYSA-N
17367	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	van Drooge MJ (1991)	1686618	181596	1556	Phenindamine	Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin	-	DRUGBANK	DB01619	C19H19N	small molecule	R06AX04	82-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISFHAYSTHMVOJR-UHFFFAOYSA-N
17368	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	ter Laak AM (1995)	7650688	179985	1556	Phenindamine	Phenindamine|Phenindaminum|Nolahist|Phenindiamine|Fenindamina|Thephorin	-	DRUGBANK	DB01619	C19H19N	small molecule	R06AX04	82-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISFHAYSTHMVOJR-UHFFFAOYSA-N
17369	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17370	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17371	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Yanni JM (1994)	7714410	175868	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17372	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Leurs R (1989)	2567596	181600	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17373	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nosal R (2009)	20027159	181601	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17374	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Gepdiremen A (2003)	14506317	181597	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17375	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Karadag CH (1996)	8835636	181598	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17376	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nath C (2001)	11526976	181599	1557	Pheniramine	Feniramina|Pheniraminum|Pheniramine	extra strength pharmacitron|ca	DRUGBANK	DB01620	C16H20N2	small molecule	D04AA16|R06AB05	86-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJHNSHDBIRRJRN-UHFFFAOYSA-N
17377	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cosi C (2001)	11755134	176338	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17378	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (1998)	9760039	176339	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17379	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17380	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17381	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17382	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17383	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17384	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Boireau A (1986)	2875894	181602	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17385	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17386	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17387	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yamada J (1995)	8593484	176333	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17388	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kusumi I (2000)	10821438	176334	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17389	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17390	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17391	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17392	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17393	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17394	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17395	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17396	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17397	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17398	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yamada J (1995)	8593484	176333	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17399	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kusumi I (2000)	10821438	176334	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17400	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Cosi C (2001)	11755134	176338	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17401	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Newman-Tancredi A (1998)	9760039	176339	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17402	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17403	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17404	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17405	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17406	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17407	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Shultz PJ (1987)	3039860	181603	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17408	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17409	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Kanba S (1994)	7918347	176330	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17410	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shultz PJ (1987)	3039860	181603	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17411	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Yamada J (1995)	8593484	176333	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17412	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kusumi I (2000)	10821438	176334	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17413	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Manzaneque JM (1999)	10222441	181604	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17414	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Lublin H (1991)	1822319	181605	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17415	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Khalifa AE (2003)	12957216	181606	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17416	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nyberg S (1995)	8748043	181608	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17417	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17418	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lublin H (1991)	1822319	181605	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17419	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Gareri P (2007)	17535043	181607	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17420	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Nyberg S (1995)	8748043	181608	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17421	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Gjerden P (2009)	19644682	181609	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17422	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Khalifa AE (2003)	12957216	181606	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17423	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Manzaneque JM (1999)	10222441	181604	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17424	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	antagonist	target	Lublin H (1991)	1822319	181605	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17425	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Khalifa AE (2003)	12957216	181606	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17426	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Eglen RM (1987)	3580704	174466	1562	Isopropamide	Isopropamide	stelabid no 1|stelabid forte|s	DRUGBANK	DB01625	C23H33N2O	small molecule	A03CA01|A03AB09	7492-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPUMZTWMWIVPA-UHFFFAOYSA-O
17427	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Lane MA (1978)	29133	181610	1562	Isopropamide	Isopropamide	stelabid no 1|stelabid forte|s	DRUGBANK	DB01625	C23H33N2O	small molecule	A03CA01|A03AB09	7492-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPUMZTWMWIVPA-UHFFFAOYSA-O
17428	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Eglen RM (1987)	3580704	174466	1562	Isopropamide	Isopropamide	stelabid no 1|stelabid forte|s	DRUGBANK	DB01625	C23H33N2O	small molecule	A03CA01|A03AB09	7492-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPUMZTWMWIVPA-UHFFFAOYSA-O
17429	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Lane MA (1978)	29133	181610	1562	Isopropamide	Isopropamide	stelabid no 1|stelabid forte|s	DRUGBANK	DB01625	C23H33N2O	small molecule	A03CA01|A03AB09	7492-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPUMZTWMWIVPA-UHFFFAOYSA-O
17430	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Chrisp P (1991)	1794016	179834	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17431	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1994)	7995016	179835	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17432	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17433	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Deleu D (2002)	11978145	179837	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17434	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Macleod AD (2005)	16034956	179830	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17435	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17436	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Unknown Authors (2002)	12199263	179832	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17437	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heinonen EH (1998)	9673855	179833	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17438	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17439	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17440	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Murphy DL (1998)	9564606	181613	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17441	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Fuentes JA (1979)	477738	181612	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17442	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Villeneuve C (2009)	19542488	181611	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17443	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Patkar AA (2006)	16641841	179836	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17444	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Baker GB (2007)	17823646	179831	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17445	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Lee KC (2007)	19300583	179829	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17446	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Azzaro AJ (2007)	17715422	179828	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17447	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Murphy DL (1998)	9564606	181613	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17448	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Fuentes JA (1979)	477738	181612	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
17449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan Y (2007)	17691997	181616	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2007)	17164136	181615	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	FitzGerald GA (2007)	17573128	181614	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17455	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1566	5-Fluorouridine	5-Fur|5-Fluorouracil 1beta-D-ribofuranoside|FUrd|5-Fluoro-uridine	-	DRUGBANK	DB01629	C9H11FN2O6	small molecule	-	316-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHIDNBAQOFJWCA-UAKXSSHOSA-N
17456	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1566	5-Fluorouridine	5-Fur|5-Fluorouracil 1beta-D-ribofuranoside|FUrd|5-Fluoro-uridine	-	DRUGBANK	DB01629	C9H11FN2O6	small molecule	-	316-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHIDNBAQOFJWCA-UAKXSSHOSA-N
17457	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1567	SC-74020	-	-	DRUGBANK	DB01630	C29H42N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJNCFXPJICILOK-HHHXNRCGSA-N
17458	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1567	SC-74020	-	-	DRUGBANK	DB01630	C29H42N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJNCFXPJICILOK-HHHXNRCGSA-N
17459	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1568	Methyl Nonanoate (Ester)	-	-	DRUGBANK	DB01631	C10H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJXHLVMUNBOGRR-UHFFFAOYSA-N
17460	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1568	Methyl Nonanoate (Ester)	-	-	DRUGBANK	DB01631	C10H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJXHLVMUNBOGRR-UHFFFAOYSA-N
17461	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1568	Methyl Nonanoate (Ester)	-	-	DRUGBANK	DB01631	C10H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJXHLVMUNBOGRR-UHFFFAOYSA-N
17462	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1568	Methyl Nonanoate (Ester)	-	-	DRUGBANK	DB01631	C10H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJXHLVMUNBOGRR-UHFFFAOYSA-N
17463	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17464	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17465	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17466	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17467	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17468	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17469	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1569	Alpha-Phosphoribosylpyrophosphoric Acid	5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phospho-alpha-D-ribose 1-diphosphate|Phosphoribosylpyrophosphate	-	DRUGBANK	DB01632	C5H13O14P3	small molecule	-	13270-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQGCEDQWHSBAJP-TXICZTDVSA-N
17470	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1571	2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine	-	-	DRUGBANK	DB01634	C14H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZUQIXJQZOMXAS-IUCAKERBSA-N
17471	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1571	2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine	-	-	DRUGBANK	DB01634	C14H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZUQIXJQZOMXAS-IUCAKERBSA-N
17472	853137	948857	b2976	glcB	ECK2970|JW2943|glc	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1575	Sorbitol	L-Gulitol|D-()-sorbitol|D-Sorbit|D-Sorbitol|D-glucitol|()-sorbitol|G-ol	sorbitol-mannitol|cystosol w 3	DRUGBANK	DB01638	C6H14O6	small molecule	V04CC01|A06AG07|A06AD18|B05CX02	50-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBPFZTCFMRRESA-JGWLITMVSA-N
17473	853137	948857	b2976	glcB	ECK2970|JW2943|glc	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1575	Sorbitol	L-Gulitol|D-()-sorbitol|D-Sorbit|D-Sorbitol|D-glucitol|()-sorbitol|G-ol	sorbitol-mannitol|cystosol w 3	DRUGBANK	DB01638	C6H14O6	small molecule	V04CC01|A06AG07|A06AD18|B05CX02	50-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBPFZTCFMRRESA-JGWLITMVSA-N
17474	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1576	N-Methyl-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB01639	C9H13NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBNMAKRKGWDQHB-UHFFFAOYSA-O
17475	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1576	N-Methyl-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB01639	C9H13NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBNMAKRKGWDQHB-UHFFFAOYSA-O
17476	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1577	(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One	-	-	DRUGBANK	DB01640	C24H24IN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNURTFDBHAQRSI-HNNXBMFYSA-N
17477	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1577	(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One	-	-	DRUGBANK	DB01640	C24H24IN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNURTFDBHAQRSI-HNNXBMFYSA-N
17478	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17479	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17480	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17481	850229	945862	b1274	topA	ECK1268|JW1266|asuA?|supX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17482	850229	945862	b1274	topA	ECK1268|JW1266|asuA?|supX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17483	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17484	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
17485	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1581	3,6-Dihydroxy-Xanthene-9-Propionic Acid	-	-	DRUGBANK	DB01644	C16H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFQGLFBMMPZYEU-UHFFFAOYSA-N
17486	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1581	3,6-Dihydroxy-Xanthene-9-Propionic Acid	-	-	DRUGBANK	DB01644	C16H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFQGLFBMMPZYEU-UHFFFAOYSA-N
17487	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1581	3,6-Dihydroxy-Xanthene-9-Propionic Acid	-	-	DRUGBANK	DB01644	C16H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFQGLFBMMPZYEU-UHFFFAOYSA-N
17488	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17489	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17490	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17491	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17492	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17493	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17494	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17495	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17496	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17497	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
17498	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1583	N-Acetylmethionine	Methionamine|Methionin|DL-n-acetylmethionine|N-acetyl-d-methionine|Acetylmethionin|Thiomedon|DL-acetylmethionine|N-acetyl-DL-methionine|N-acetyl(methyl)homocysteine|L-(n-acetyl)methionine|Acetylmethionine|N-acetyl-S-methylhomocysteine|Acetyl-DL-methionine|Acetyl-l-methionine|N-acetyl-l-methionine	-	DRUGBANK	DB01646	C7H13NO3S	small molecule	-	65-82-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUYPXLNMDZIRQH-LURJTMIESA-N
17499	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1584	(R)-Mesopram	-	-	DRUGBANK	DB01647	C14H19NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCPERGCFKIYIS-AWEZNQCLSA-N
17500	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1584	(R)-Mesopram	-	-	DRUGBANK	DB01647	C14H19NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCPERGCFKIYIS-AWEZNQCLSA-N
17501	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1584	(R)-Mesopram	-	-	DRUGBANK	DB01647	C14H19NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCPERGCFKIYIS-AWEZNQCLSA-N
17502	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1586	7-Methyl-Gpppa	P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE	-	DRUGBANK	DB01649	C21H30N10O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQOHNVHGNZYSBP-XPWFQUROSA-O
17503	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1586	7-Methyl-Gpppa	P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE	-	DRUGBANK	DB01649	C21H30N10O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQOHNVHGNZYSBP-XPWFQUROSA-O
17504	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1586	7-Methyl-Gpppa	P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE	-	DRUGBANK	DB01649	C21H30N10O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQOHNVHGNZYSBP-XPWFQUROSA-O
17505	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1586	7-Methyl-Gpppa	P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE	-	DRUGBANK	DB01649	C21H30N10O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQOHNVHGNZYSBP-XPWFQUROSA-O
17506	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1588	Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside	-	-	DRUGBANK	DB01651	C10H16O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZVLEQWFATHTF-IJWOWSJNSA-N
17507	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1588	Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside	-	-	DRUGBANK	DB01651	C10H16O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDZVLEQWFATHTF-IJWOWSJNSA-N
17508	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1591	L-Guluronic Acid 6-Phosphate	-	-	DRUGBANK	DB01655	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-QTBDOELSSA-N
17509	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1591	L-Guluronic Acid 6-Phosphate	-	-	DRUGBANK	DB01655	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-QTBDOELSSA-N
17510	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Barone FC (2007)	17726343	181617	1592	Roflumilast	ROF|Daliresp|Roflumilastum	daxas|daliresp	DRUGBANK	DB01656	C17H14Cl2F2N2O3	small molecule	R03DX07	162401-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNDBXUUTURYVHR-UHFFFAOYSA-N
17511	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Barone FC (2007)	17726343	181617	1592	Roflumilast	ROF|Daliresp|Roflumilastum	daxas|daliresp	DRUGBANK	DB01656	C17H14Cl2F2N2O3	small molecule	R03DX07	162401-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNDBXUUTURYVHR-UHFFFAOYSA-N
17512	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1592	Roflumilast	ROF|Daliresp|Roflumilastum	daxas|daliresp	DRUGBANK	DB01656	C17H14Cl2F2N2O3	small molecule	R03DX07	162401-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNDBXUUTURYVHR-UHFFFAOYSA-N
17513	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Barone FC (2007)	17726343	181617	1592	Roflumilast	ROF|Daliresp|Roflumilastum	daxas|daliresp	DRUGBANK	DB01656	C17H14Cl2F2N2O3	small molecule	R03DX07	162401-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNDBXUUTURYVHR-UHFFFAOYSA-N
17514	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Barone FC (2007)	17726343	181617	1592	Roflumilast	ROF|Daliresp|Roflumilastum	daxas|daliresp	DRUGBANK	DB01656	C17H14Cl2F2N2O3	small molecule	R03DX07	162401-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNDBXUUTURYVHR-UHFFFAOYSA-N
17515	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1593	2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid	-	-	DRUGBANK	DB01657	C18H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDTWKLJWNHRCPJ-WGCYKYFSSA-N
17516	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1593	2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid	-	-	DRUGBANK	DB01657	C18H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDTWKLJWNHRCPJ-WGCYKYFSSA-N
17517	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17518	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17519	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17520	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17521	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17522	112719	6853	RP1-230G1.2	SYN1	SYN1a|SYN1b|SYNI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17523	112719	6853	RP1-230G1.2	SYN1	SYN1a|SYN1b|SYNI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17524	112719	6853	RP1-230G1.2	SYN1	SYN1a|SYN1b|SYNI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1596	Adenosine-5'-Diphosphate Monothiophosphate	-	-	DRUGBANK	DB01660	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
17525	850896	946549	b2019	hisG	ECK2014|JW2001	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1597	Phosphoribosyl Atp	-	-	DRUGBANK	DB01661	C15H19N5O20P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKNHJBVBFHDXGR-QBPNNELESA-H
17526	850896	946549	b2019	hisG	ECK2014|JW2001	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1597	Phosphoribosyl Atp	-	-	DRUGBANK	DB01661	C15H19N5O20P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKNHJBVBFHDXGR-QBPNNELESA-H
17527	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1598	Trans-O-Hydroxy-Alpha-Methyl Cinnamate	-	-	DRUGBANK	DB01662	C10H12O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGNFDPZASRDVLL-SSDOTTSWSA-N
17528	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1600	(S)-Des-Me-Ampa	(S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID	-	DRUGBANK	DB01664	C6H8N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLGQYGPVBFAQQ-BYPYZUCNSA-N
17529	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1600	(S)-Des-Me-Ampa	(S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID	-	DRUGBANK	DB01664	C6H8N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLGQYGPVBFAQQ-BYPYZUCNSA-N
17530	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1600	(S)-Des-Me-Ampa	(S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID	-	DRUGBANK	DB01664	C6H8N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLGQYGPVBFAQQ-BYPYZUCNSA-N
17531	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1601	ZK-800270	2H-BENZOIMIDAZOL-2-YLAMINE	-	DRUGBANK	DB01665	C7H7N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERVZEOWPBCBHO-UHFFFAOYSA-N
17532	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1601	ZK-800270	2H-BENZOIMIDAZOL-2-YLAMINE	-	DRUGBANK	DB01665	C7H7N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERVZEOWPBCBHO-UHFFFAOYSA-N
17533	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1601	ZK-800270	2H-BENZOIMIDAZOL-2-YLAMINE	-	DRUGBANK	DB01665	C7H7N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERVZEOWPBCBHO-UHFFFAOYSA-N
17534	115731	10468	-	FST	FS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1602	D-Myo-Inositol-Hexasulphate	-	-	DRUGBANK	DB01666	C6H12O24S6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBTMNFYXJYCQHQ-OQYPVSDDSA-N
17535	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1603	8-azaguanine	Azaguanine-8|Azaguanine|Pathocidin|Pathocidine|Guanazol	-	DRUGBANK	DB01667	C4H4N6O	small molecule	-	134-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPXQRXLUHJKZIE-UHFFFAOYSA-N
17536	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1603	8-azaguanine	Azaguanine-8|Azaguanine|Pathocidin|Pathocidine|Guanazol	-	DRUGBANK	DB01667	C4H4N6O	small molecule	-	134-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPXQRXLUHJKZIE-UHFFFAOYSA-N
17537	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1607	4-(Hydroxymercury)Benzoic Acid	-	-	DRUGBANK	DB01671	C7H6HgO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMHRYLDWLOGHSG-UHFFFAOYSA-M
17538	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1607	4-(Hydroxymercury)Benzoic Acid	-	-	DRUGBANK	DB01671	C7H6HgO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMHRYLDWLOGHSG-UHFFFAOYSA-M
17539	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1608	2,3-Dihydroxy-Benzoic Acid	-	-	DRUGBANK	DB01672	C7H6O4	small molecule	-	303-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLDQAMYCGOIJDV-UHFFFAOYSA-N
17540	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1608	2,3-Dihydroxy-Benzoic Acid	-	-	DRUGBANK	DB01672	C7H6O4	small molecule	-	303-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLDQAMYCGOIJDV-UHFFFAOYSA-N
17541	854192	936509	BSU31980	dhbE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1608	2,3-Dihydroxy-Benzoic Acid	-	-	DRUGBANK	DB01672	C7H6O4	small molecule	-	303-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLDQAMYCGOIJDV-UHFFFAOYSA-N
17542	854192	936509	BSU31980	dhbE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1608	2,3-Dihydroxy-Benzoic Acid	-	-	DRUGBANK	DB01672	C7H6O4	small molecule	-	303-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLDQAMYCGOIJDV-UHFFFAOYSA-N
17543	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1609	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine	-	-	DRUGBANK	DB01673	C23H36N4O20P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTMMCWJNQNKACG-RXHIUOCHSA-N
17544	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1609	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine	-	-	DRUGBANK	DB01673	C23H36N4O20P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTMMCWJNQNKACG-RXHIUOCHSA-N
17545	117965	27034	-	ACAD8	ACAD-8|ARC42	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1611	Methacrylyl-Coenzyme A	-	-	DRUGBANK	DB01675	C25H40N7O17P3S	small molecule	-	6008-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPALUEYCDZWBOV-BPJJUHQGSA-N
17546	117965	27034	-	ACAD8	ACAD-8|ARC42	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1611	Methacrylyl-Coenzyme A	-	-	DRUGBANK	DB01675	C25H40N7O17P3S	small molecule	-	6008-91-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPALUEYCDZWBOV-BPJJUHQGSA-N
17547	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1613	Fumarate	-	-	DRUGBANK	DB01677	C4H2O4	small molecule	-	110-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-OWOJBTEDSA-L
17548	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1613	Fumarate	-	-	DRUGBANK	DB01677	C4H2O4	small molecule	-	110-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-OWOJBTEDSA-L
17549	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1613	Fumarate	-	-	DRUGBANK	DB01677	C4H2O4	small molecule	-	110-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-OWOJBTEDSA-L
17550	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1613	Fumarate	-	-	DRUGBANK	DB01677	C4H2O4	small molecule	-	110-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-OWOJBTEDSA-L
17551	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1613	Fumarate	-	-	DRUGBANK	DB01677	C4H2O4	small molecule	-	110-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-OWOJBTEDSA-L
17552	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1614	RU84687	N-acetyl-N-[1-(1,1'-biphenyl-4-ylmethyl)-2-oxoazepan-3-yl]-3-formyl-O-phosphonotyrosinamide	-	DRUGBANK	DB01678	C31H34N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAFPHFWYRLLBFO-IZLXSDGUSA-N
17553	111245	5224	-	PGAM2	GSD10|PGAM-M|PGAMM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1616	Benzene Hexacarboxylic Acid	-	-	DRUGBANK	DB01681	C12H6O12	small molecule	-	517-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSWCNNOKPMOTP-UHFFFAOYSA-N
17554	111245	5224	-	PGAM2	GSD10|PGAM-M|PGAMM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1616	Benzene Hexacarboxylic Acid	-	-	DRUGBANK	DB01681	C12H6O12	small molecule	-	517-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSWCNNOKPMOTP-UHFFFAOYSA-N
17555	111245	5224	-	PGAM2	GSD10|PGAM-M|PGAMM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1616	Benzene Hexacarboxylic Acid	-	-	DRUGBANK	DB01681	C12H6O12	small molecule	-	517-60-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDSWCNNOKPMOTP-UHFFFAOYSA-N
17556	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1619	1-Hydroxy-1-Thio-Glycerol	-	-	DRUGBANK	DB01684	C3H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLQCXFUWHQZWJQ-GSVOUGTGSA-N
17557	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1619	1-Hydroxy-1-Thio-Glycerol	-	-	DRUGBANK	DB01684	C3H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLQCXFUWHQZWJQ-GSVOUGTGSA-N
17558	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1619	1-Hydroxy-1-Thio-Glycerol	-	-	DRUGBANK	DB01684	C3H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLQCXFUWHQZWJQ-GSVOUGTGSA-N
17559	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1620	4-[5-Pyridin-4-Yl-1h-[1,2,4]Triazol-3-Yl]-Pyridine-2-Carbonitrile	-	-	DRUGBANK	DB01685	C13H8N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBVZQGOVTLIHLH-UHFFFAOYSA-N
17560	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	van Guldener C (2007)	17937610	181618	1621	N,N-dimethylarginine	dimethyl-L-arginine|L-NG,NG-dimethylarginine|N(g)-dimethylarginine|N(omega),N(omega)-dimethyl-l-arginine|Guanidino-n,n-dimethylarginine|ADMA|NG,NG-dimethyl-l-arginine|N(5)-[(dimethylamino)(imino)methyl]-L-ornithine|N(G1),N(G1)-Dimethylarginine|Asymmetric dimethylarginine|N(g),N(g)-dimethylarginine|N(g),N(g)-dimethyl-l-arginine|N(5)-((Dimethylamino)iminomethyl)-L-ornithine	-	DRUGBANK	DB01686	C8H18N4O2	small molecule	-	30315-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDGMGEXADBMOMJ-LURJTMIESA-N
17561	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1621	N,N-dimethylarginine	dimethyl-L-arginine|L-NG,NG-dimethylarginine|N(g)-dimethylarginine|N(omega),N(omega)-dimethyl-l-arginine|Guanidino-n,n-dimethylarginine|ADMA|NG,NG-dimethyl-l-arginine|N(5)-[(dimethylamino)(imino)methyl]-L-ornithine|N(G1),N(G1)-Dimethylarginine|Asymmetric dimethylarginine|N(g),N(g)-dimethylarginine|N(g),N(g)-dimethyl-l-arginine|N(5)-((Dimethylamino)iminomethyl)-L-ornithine	-	DRUGBANK	DB01686	C8H18N4O2	small molecule	-	30315-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDGMGEXADBMOMJ-LURJTMIESA-N
17562	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1624	Inhibitor Idd 384	-	-	DRUGBANK	DB01689	C19H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJKKMQCZOLCXAM-UHFFFAOYSA-N
17563	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1624	Inhibitor Idd 384	-	-	DRUGBANK	DB01689	C19H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJKKMQCZOLCXAM-UHFFFAOYSA-N
17564	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1624	Inhibitor Idd 384	-	-	DRUGBANK	DB01689	C19H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJKKMQCZOLCXAM-UHFFFAOYSA-N
17565	853303	949060	b0103	coaE	ECK0103|JW0100|yacE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1625	Bis(Adenosine)-5'-Triphosphate	-	-	DRUGBANK	DB01690	C20H27N10O16P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCICUPZZLIQAPA-APSSSFQSSA-N
17566	853303	949060	b0103	coaE	ECK0103|JW0100|yacE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1625	Bis(Adenosine)-5'-Triphosphate	-	-	DRUGBANK	DB01690	C20H27N10O16P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCICUPZZLIQAPA-APSSSFQSSA-N
17567	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1626	Indole Naphthyridinone	-	-	DRUGBANK	DB01691	C22H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAZMNDXVXVUKFY-JXMROGBWSA-N
17568	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1626	Indole Naphthyridinone	-	-	DRUGBANK	DB01691	C22H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAZMNDXVXVUKFY-JXMROGBWSA-N
17569	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	1626	Indole Naphthyridinone	-	-	DRUGBANK	DB01691	C22H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAZMNDXVXVUKFY-JXMROGBWSA-N
17570	112938	7083	-	TK1	TK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1627	Dithioerythritol	(2R,3S)-1,4-dimercaptobutane-2,3-diol|erythro-1,4-Dimercapto-2,3-butanediol|(2R*,3S*)-1,4-dimercapto-2,3-butanediol|DTE|1,4-dithioerythritol	-	DRUGBANK	DB01692	C4H10O2S2	small molecule	-	6892-68-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-ZXZARUISSA-N
17571	112938	7083	-	TK1	TK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1627	Dithioerythritol	(2R,3S)-1,4-dimercaptobutane-2,3-diol|erythro-1,4-Dimercapto-2,3-butanediol|(2R*,3S*)-1,4-dimercapto-2,3-butanediol|DTE|1,4-dithioerythritol	-	DRUGBANK	DB01692	C4H10O2S2	small molecule	-	6892-68-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-ZXZARUISSA-N
17574	852403	948096	b3575	yiaK	ECK3564|JW3547	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17575	852403	948096	b3575	yiaK	ECK3564|JW3547	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17576	119926	54210	-	TREM1	CD354|TREM-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17577	119926	54210	-	TREM1	CD354|TREM-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17578	107011	528	-	ATP6V1C1	ATP6C|ATP6D|VATC|Vma5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17579	117990	27087	-	B3GAT1	CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17580	117990	27087	-	B3GAT1	CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1629	D-tartaric acid	D-Tartrate|(S,S)-Tartaric acid|(2S,3S)-Tartaric acid|(S,S)-Tartrate|D-threaric acid|(-)-Tartaric acid|Levotartaric Acid	-	DRUGBANK	DB01694	C4H6O6	small molecule	-	147-71-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWJPZIEWOKRBE-XIXRPRMCSA-N
17581	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1630	N-Hydroxy-4-Phosphono-Butanamide	-	-	DRUGBANK	DB01695	C4H8NO5P	small molecule	-	146086-80-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKXSFRVADDCWTF-UHFFFAOYSA-L
17582	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1630	N-Hydroxy-4-Phosphono-Butanamide	-	-	DRUGBANK	DB01695	C4H8NO5P	small molecule	-	146086-80-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKXSFRVADDCWTF-UHFFFAOYSA-L
17583	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1630	N-Hydroxy-4-Phosphono-Butanamide	-	-	DRUGBANK	DB01695	C4H8NO5P	small molecule	-	146086-80-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKXSFRVADDCWTF-UHFFFAOYSA-L
17586	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1633	Rutin	rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside	-	DRUGBANK	DB01698	C27H30O16	small molecule	C05CA01|C05CA51	153-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKGXIBQEEMLURG-BKUODXTLSA-N
17587	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1633	Rutin	rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside	-	DRUGBANK	DB01698	C27H30O16	small molecule	C05CA01|C05CA51	153-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKGXIBQEEMLURG-BKUODXTLSA-N
17588	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1634	(4e)-4-Aminohex-4-Enoic Acid	-	-	DRUGBANK	DB01699	C6H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQFBUAIXCIGKAP-DJWKRKHSSA-N
17589	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1634	(4e)-4-Aminohex-4-Enoic Acid	-	-	DRUGBANK	DB01699	C6H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQFBUAIXCIGKAP-DJWKRKHSSA-N
17590	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1634	(4e)-4-Aminohex-4-Enoic Acid	-	-	DRUGBANK	DB01699	C6H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQFBUAIXCIGKAP-DJWKRKHSSA-N
17591	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1635	Aicar	-	-	DRUGBANK	DB01700	C9H15N4O8P	small molecule	-	3031-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOTGFIUVDGNKRI-BZKDHIKHSA-N
17592	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1635	Aicar	-	-	DRUGBANK	DB01700	C9H15N4O8P	small molecule	-	3031-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOTGFIUVDGNKRI-BZKDHIKHSA-N
17593	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1635	Aicar	-	-	DRUGBANK	DB01700	C9H15N4O8P	small molecule	-	3031-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOTGFIUVDGNKRI-BZKDHIKHSA-N
17594	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1639	2,4-Dihydroxy-Trans Cinnamic Acid	-	-	DRUGBANK	DB01704	C9H8O4	small molecule	-	614-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGEFWFBFQKWVMY-DUXPYHPUSA-N
17595	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1640	Bis(5-Amidino-Benzimidazolyl)Methane	-	-	DRUGBANK	DB01705	C17H16N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17596	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1640	Bis(5-Amidino-Benzimidazolyl)Methane	-	-	DRUGBANK	DB01705	C17H16N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17597	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1640	Bis(5-Amidino-Benzimidazolyl)Methane	-	-	DRUGBANK	DB01705	C17H16N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17598	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	activator	target	Kohalmy K (2007)	17591676	181619	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17599	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17600	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17601	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17602	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17603	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17604	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17605	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17606	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	activator	target	Chen F (2005)	15994348	181621	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17607	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17608	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17609	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17610	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17611	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17612	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17613	115295	9970	-	NR1I3	CAR|CAR1|MB67	9606	Homo sapiens	activator	target	Kohalmy K (2007)	17591676	181619	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17614	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17615	108833	2559	-	GABRA6	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17616	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17617	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17618	108842	2568	-	GABRP	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17619	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17620	108831	2557	-	GABRA4	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17621	108835	2561	-	GABRB2	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17622	108839	2565	-	GABRG1	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17623	108832	2558	-	GABRA5	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17624	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17625	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17626	108829	2555	-	GABRA2	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17627	108830	2556	-	GABRA3	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17628	108841	2567	-	GABRG3	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17629	108838	2564	-	GABRE	-	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17630	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Waterhouse RN (2007)	17447254	181623	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17631	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	binder	target	Chen F (2005)	15994348	181621	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17632	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	activator	target	Tamasi V (2008)	18079279	181624	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17633	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	activator	target	Kohalmy K (2007)	17591676	181619	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17634	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17635	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17636	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17637	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1645	Porphyrin Fe(Iii)	-	-	DRUGBANK	DB01710	C20H12FeN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTECGTLHXLUHQQ-QDJBTJTOSA-N
17638	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1645	Porphyrin Fe(Iii)	-	-	DRUGBANK	DB01710	C20H12FeN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTECGTLHXLUHQQ-QDJBTJTOSA-N
17639	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1645	Porphyrin Fe(Iii)	-	-	DRUGBANK	DB01710	C20H12FeN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTECGTLHXLUHQQ-QDJBTJTOSA-N
17640	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1646	2,3,4,5,6-Pentafluorobenzyl Alcohol	-	-	DRUGBANK	DB01711	C7H3F5O	small molecule	-	440-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGJYYCIOYBZTPU-UHFFFAOYSA-N
17641	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1646	2,3,4,5,6-Pentafluorobenzyl Alcohol	-	-	DRUGBANK	DB01711	C7H3F5O	small molecule	-	440-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGJYYCIOYBZTPU-UHFFFAOYSA-N
17642	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1646	2,3,4,5,6-Pentafluorobenzyl Alcohol	-	-	DRUGBANK	DB01711	C7H3F5O	small molecule	-	440-60-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGJYYCIOYBZTPU-UHFFFAOYSA-N
17643	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1647	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester	-	-	DRUGBANK	DB01712	C23H28N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDSSAGSYFVBTG-SFTDATJTSA-N
17644	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1650	7,8-Diamino-Nonanoic Acid	-	-	DRUGBANK	DB01715	C9H20N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCEGBPIYGIWCDH-JGVFFNPUSA-N
17645	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1650	7,8-Diamino-Nonanoic Acid	-	-	DRUGBANK	DB01715	C9H20N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCEGBPIYGIWCDH-JGVFFNPUSA-N
17646	856126	938508	BSU01370	adk	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17647	856126	938508	BSU01370	adk	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17648	106707	204	-	AK2	ADK2|AK 2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17649	106707	204	-	AK2	ADK2|AK 2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17650	106707	204	-	AK2	ADK2|AK 2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17651	849486	945097	b0474	adk	ECK0468|JW0463|dnaW|plsA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17652	849486	945097	b0474	adk	ECK0468|JW0463|dnaW|plsA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17653	127645	158067	RP11-143F18.1	AK8	AK 8|C9orf98|DDX31	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17654	127645	158067	RP11-143F18.1	AK8	AK 8|C9orf98|DDX31	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17655	127645	158067	RP11-143F18.1	AK8	AK 8|C9orf98|DDX31	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17656	106706	203	RP11-203J24.1	AK1	HTL-S-58j	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17657	106706	203	RP11-203J24.1	AK1	HTL-S-58j	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1652	Bis(Adenosine)-5'-Pentaphosphate	-	-	DRUGBANK	DB01717	C20H29N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIMACDRJUANHTJ-APSSSFQSSA-N
17658	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1658	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	-	-	DRUGBANK	DB01723	C38H47NO11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCRAOPQCACRFC-JBOQNHBVSA-N
17659	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1658	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	-	-	DRUGBANK	DB01723	C38H47NO11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCRAOPQCACRFC-JBOQNHBVSA-N
17660	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1658	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	-	-	DRUGBANK	DB01723	C38H47NO11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCRAOPQCACRFC-JBOQNHBVSA-N
17661	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1660	CRA_7806	-	-	DRUGBANK	DB01725	C20H15N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17662	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1660	CRA_7806	-	-	DRUGBANK	DB01725	C20H15N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17663	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1660	CRA_7806	-	-	DRUGBANK	DB01725	C20H15N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17664	109644	3418	-	IDH2	D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17665	109644	3418	-	IDH2	D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17666	109644	3418	-	IDH2	D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17667	109643	3417	-	IDH1	HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17668	109643	3417	-	IDH1	HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17669	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17670	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17671	849387	944990	b0331	prpB	ECK0329|JW0323|yahQ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17672	849387	944990	b0331	prpB	ECK0329|JW0323|yahQ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17673	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17674	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17675	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1662	Isocitric Acid	-	-	DRUGBANK	DB01727	C6H8O7	small molecule	-	320-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODBLHEXUDAPZAU-OKKQSCSOSA-N
17676	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1663	3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol	-	-	DRUGBANK	DB01728	C37H74NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLKDGVPOSSLUAI-DHUJRADRSA-N
17677	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1663	3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol	-	-	DRUGBANK	DB01728	C37H74NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLKDGVPOSSLUAI-DHUJRADRSA-N
17678	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1663	3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol	-	-	DRUGBANK	DB01728	C37H74NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLKDGVPOSSLUAI-DHUJRADRSA-N
17679	113293	7454	-	WAS	IMD2|SCNX|THC|THC1|WASP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1665	(S)-Wiskostatin	-	-	DRUGBANK	DB01731	C17H18Br2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBJEDZHBUPBKL-ZDUSSCGKSA-N
17680	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1667	L-Phospholactate	-	-	DRUGBANK	DB01733	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSZRNWHGZPKNKY-UWTATZPHSA-N
17681	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1667	L-Phospholactate	-	-	DRUGBANK	DB01733	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSZRNWHGZPKNKY-UWTATZPHSA-N
17682	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1667	L-Phospholactate	-	-	DRUGBANK	DB01733	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSZRNWHGZPKNKY-UWTATZPHSA-N
17683	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1668	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	-	-	DRUGBANK	DB01734	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQBLKSRRWDWNKQ-UHFFFAOYSA-N
17684	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1668	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	-	-	DRUGBANK	DB01734	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQBLKSRRWDWNKQ-UHFFFAOYSA-N
17685	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1668	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	-	-	DRUGBANK	DB01734	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQBLKSRRWDWNKQ-UHFFFAOYSA-N
17686	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1670	[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium	-	-	DRUGBANK	DB01736	C17H36N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNGWKQJZIUZUPR-UHFFFAOYSA-N
17687	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1671	Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester	-	-	DRUGBANK	DB01737	C20H24N4O5S	small molecule	-	133397-81-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEIKQDHLCFGAA-KRWDZBQOSA-N
17688	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1672	O-Phosphoethanolamine	Colamine phosphoric acid|Phosphorylethanolamine	-	DRUGBANK	DB01738	C3H10NO4P	small molecule	-	1071-23-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUQZVISZELWDNZ-UHFFFAOYSA-N
17689	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1672	O-Phosphoethanolamine	Colamine phosphoric acid|Phosphorylethanolamine	-	DRUGBANK	DB01738	C3H10NO4P	small molecule	-	1071-23-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUQZVISZELWDNZ-UHFFFAOYSA-N
17690	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1672	O-Phosphoethanolamine	Colamine phosphoric acid|Phosphorylethanolamine	-	DRUGBANK	DB01738	C3H10NO4P	small molecule	-	1071-23-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUQZVISZELWDNZ-UHFFFAOYSA-N
17691	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1675	CRA_17693	-	-	DRUGBANK	DB01741	C24H17FN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCOFROALSAFROV-CQSZACIVSA-L
17692	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1675	CRA_17693	-	-	DRUGBANK	DB01741	C24H17FN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCOFROALSAFROV-CQSZACIVSA-L
17693	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1675	CRA_17693	-	-	DRUGBANK	DB01741	C24H17FN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCOFROALSAFROV-CQSZACIVSA-L
17694	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1676	(3r)-1-Acetyl-3-Methylpiperidine	-	-	DRUGBANK	DB01742	C8H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPNHDGLSYZRC-SSDOTTSWSA-N
17695	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1676	(3r)-1-Acetyl-3-Methylpiperidine	-	-	DRUGBANK	DB01742	C8H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPNHDGLSYZRC-SSDOTTSWSA-N
17696	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1676	(3r)-1-Acetyl-3-Methylpiperidine	-	-	DRUGBANK	DB01742	C8H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKFPNHDGLSYZRC-SSDOTTSWSA-N
17697	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1679	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester	-	-	DRUGBANK	DB01745	C27H30N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJLGQWCKMHPBEB-DEOSSOPVSA-N
17698	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1679	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester	-	-	DRUGBANK	DB01745	C27H30N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJLGQWCKMHPBEB-DEOSSOPVSA-N
17699	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1679	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester	-	-	DRUGBANK	DB01745	C27H30N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJLGQWCKMHPBEB-DEOSSOPVSA-N
17700	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1681	Coprogen	-	-	DRUGBANK	DB01747	C35H53FeN6O13	small molecule	-	31418-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQIVLXIUJLOKPL-DWZMLRRXSA-N
17701	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1681	Coprogen	-	-	DRUGBANK	DB01747	C35H53FeN6O13	small molecule	-	31418-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQIVLXIUJLOKPL-DWZMLRRXSA-N
17702	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1682	N-Benzyl-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB01748	C14H14N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZKNSZUJCJHTTM-UHFFFAOYSA-N
17703	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1682	N-Benzyl-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB01748	C14H14N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZKNSZUJCJHTTM-UHFFFAOYSA-N
17704	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1682	N-Benzyl-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB01748	C14H14N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZKNSZUJCJHTTM-UHFFFAOYSA-N
17705	112391	6500	-	SKP1	EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1684	Naphthalen-1-Yl-Acetic Acid	-	-	DRUGBANK	DB01750	C12H10O2	small molecule	-	86-87-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRPINYUDVPFIRX-UHFFFAOYSA-N
17706	109512	3276	-	PRMT1	ANM1|HCP1|HRMT1L2|IR1B4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17707	850146	945779	b1212	prmC	ECK1200|JW1203|hemK	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17708	850146	945779	b1212	prmC	ECK1200|JW1203|hemK	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17709	118081	27232	-	GNMT	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17710	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17711	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17712	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17713	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17714	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17715	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17716	115491	10196	-	PRMT3	HRMT1L3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17717	119637	51611	AD-018	DPH5	CGI-30|HSPC143|NPD015	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17718	111141	5110	-	PCMT1	PIMT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17719	111141	5110	-	PCMT1	PIMT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17720	111141	5110	-	PCMT1	PIMT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17721	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17722	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
17723	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1688	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	-	-	DRUGBANK	DB01754	C10H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJEQMXDNMETQ-UHFFFAOYSA-N
17724	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1688	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	-	-	DRUGBANK	DB01754	C10H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJEQMXDNMETQ-UHFFFAOYSA-N
17725	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1688	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	-	-	DRUGBANK	DB01754	C10H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJEQMXDNMETQ-UHFFFAOYSA-N
17726	116594	22934	-	RPIA	RPI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1690	D-4-Phosphoerythronic Acid	-	-	DRUGBANK	DB01756	C4H9O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCZXOHUILRHRQJ-STHAYSLISA-N
17727	116594	22934	-	RPIA	RPI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1690	D-4-Phosphoerythronic Acid	-	-	DRUGBANK	DB01756	C4H9O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCZXOHUILRHRQJ-STHAYSLISA-N
17728	116594	22934	-	RPIA	RPI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1690	D-4-Phosphoerythronic Acid	-	-	DRUGBANK	DB01756	C4H9O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCZXOHUILRHRQJ-STHAYSLISA-N
17729	853135	948855	b1637	tyrS	ECK1633|JW1629	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1691	3-Iodo-Tyrosine	-	-	DRUGBANK	DB01758	C9H10INO3	small molecule	-	70-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQTZMGFTRHFAAM-ZETCQYMHSA-N
17730	853135	948855	b1637	tyrS	ECK1633|JW1629	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1691	3-Iodo-Tyrosine	-	-	DRUGBANK	DB01758	C9H10INO3	small molecule	-	70-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQTZMGFTRHFAAM-ZETCQYMHSA-N
17731	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1693	2-Methoxy-3-Isopropylpyrazine	-	-	DRUGBANK	DB01760	C8H12N2O	small molecule	-	25773-40-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTOPKICPEQUPPH-UHFFFAOYSA-N
17732	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1693	2-Methoxy-3-Isopropylpyrazine	-	-	DRUGBANK	DB01760	C8H12N2O	small molecule	-	25773-40-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTOPKICPEQUPPH-UHFFFAOYSA-N
17733	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1693	2-Methoxy-3-Isopropylpyrazine	-	-	DRUGBANK	DB01760	C8H12N2O	small molecule	-	25773-40-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTOPKICPEQUPPH-UHFFFAOYSA-N
17734	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1694	4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine	-	-	DRUGBANK	DB01761	C28H29F3N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QICPQLFMWYQJGX-SFHVURJKSA-N
17735	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1694	4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine	-	-	DRUGBANK	DB01761	C28H29F3N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QICPQLFMWYQJGX-SFHVURJKSA-N
17736	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1695	Acetoacetic Acid	-	-	DRUGBANK	DB01762	C4H6O3	small molecule	-	541-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJHALXBUFZDSR-UHFFFAOYSA-N
17737	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1695	Acetoacetic Acid	-	-	DRUGBANK	DB01762	C4H6O3	small molecule	-	541-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJHALXBUFZDSR-UHFFFAOYSA-N
17738	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1695	Acetoacetic Acid	-	-	DRUGBANK	DB01762	C4H6O3	small molecule	-	541-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDJHALXBUFZDSR-UHFFFAOYSA-N
17739	117076	23530	hCG_17428	NNT	GCCD4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1696	7-thionicotinamide-adenine-dinucleotide phosphate	TATP	-	DRUGBANK	DB01763	C21H28N7O16P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJNFDOAQUXJWED-NNYOXOHSSA-N
17740	117076	23530	hCG_17428	NNT	GCCD4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1696	7-thionicotinamide-adenine-dinucleotide phosphate	TATP	-	DRUGBANK	DB01763	C21H28N7O16P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJNFDOAQUXJWED-NNYOXOHSSA-N
17741	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1698	(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid	-	-	DRUGBANK	DB01765	C17H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INSBKYCYLCEBOD-UHFFFAOYSA-N
17742	111317	5300	-	PIN1	DOD|UBL5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1699	Beta-(2-Naphthyl)-Alanine	-	-	DRUGBANK	DB01766	C13H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPZXHKDZASGCLU-LBPRGKRZSA-N
17743	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1699	Beta-(2-Naphthyl)-Alanine	-	-	DRUGBANK	DB01766	C13H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPZXHKDZASGCLU-LBPRGKRZSA-N
17744	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1699	Beta-(2-Naphthyl)-Alanine	-	-	DRUGBANK	DB01766	C13H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPZXHKDZASGCLU-LBPRGKRZSA-N
17745	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1700	Hemi-Babim	-	-	DRUGBANK	DB01767	C16H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKJYVDXDZURHMA-UHFFFAOYSA-N
17746	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1700	Hemi-Babim	-	-	DRUGBANK	DB01767	C16H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKJYVDXDZURHMA-UHFFFAOYSA-N
17747	107429	994	RP5-1009E24.3	CDC25B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17748	107429	994	RP5-1009E24.3	CDC25B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17749	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17750	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17751	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17752	856137	938519	BSU38300	thiM	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17753	856137	938519	BSU38300	thiM	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17754	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17755	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17756	116446	11315	CTA-215D11.1	PARK7	DJ-1|DJ1|HEL-S-67p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17757	116446	11315	CTA-215D11.1	PARK7	DJ-1|DJ1|HEL-S-67p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17758	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17759	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1702	Double Oxidized Cysteine	-	-	DRUGBANK	DB01769	C3H6NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GEAMCHVNTOUKJC-REOHCLBHSA-N
17760	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1704	CRA_10991	-	-	DRUGBANK	DB01771	C20H20ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXAURVOBXQBPAP-UHFFFAOYSA-N
17761	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1705	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01772	C22H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPGZQOOZHIEPJW-HNNXBMFYSA-N
17762	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1705	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01772	C22H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPGZQOOZHIEPJW-HNNXBMFYSA-N
17763	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1705	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01772	C22H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPGZQOOZHIEPJW-HNNXBMFYSA-N
17764	852441	948134	b3619	hldD	ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1707	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	-	-	DRUGBANK	DB01774	C16H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPZSXYXPSUOPY-ZPOXOAFESA-N
17765	852441	948134	b3619	hldD	ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1707	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	-	-	DRUGBANK	DB01774	C16H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPZSXYXPSUOPY-ZPOXOAFESA-N
17766	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1709	M-Cresol	-	-	DRUGBANK	DB01776	C7H8O	small molecule	-	108-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLSSMJSEOOYNOY-UHFFFAOYSA-N
17767	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1709	M-Cresol	-	-	DRUGBANK	DB01776	C7H8O	small molecule	-	108-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLSSMJSEOOYNOY-UHFFFAOYSA-N
17768	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1709	M-Cresol	-	-	DRUGBANK	DB01776	C7H8O	small molecule	-	108-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLSSMJSEOOYNOY-UHFFFAOYSA-N
17769	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1710	Coa-S-Trimethylene-Acetyl-Tryptamine	-	-	DRUGBANK	DB01777	C36H53N9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTVMELLORVUIRF-JNIGBQAFSA-N
17770	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1710	Coa-S-Trimethylene-Acetyl-Tryptamine	-	-	DRUGBANK	DB01777	C36H53N9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTVMELLORVUIRF-JNIGBQAFSA-N
17771	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1710	Coa-S-Trimethylene-Acetyl-Tryptamine	-	-	DRUGBANK	DB01777	C36H53N9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTVMELLORVUIRF-JNIGBQAFSA-N
17772	113363	7531	-	YWHAE	14-3-3E|HEL2|KCIP-1|MDCR|MDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1713	Fusicoccin	-	-	DRUGBANK	DB01780	C36H56O12	small molecule	-	20108-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXTYBXCEQOANSX-MQYZIMMHSA-N
17773	113363	7531	-	YWHAE	14-3-3E|HEL2|KCIP-1|MDCR|MDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1713	Fusicoccin	-	-	DRUGBANK	DB01780	C36H56O12	small molecule	-	20108-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXTYBXCEQOANSX-MQYZIMMHSA-N
17774	113363	7531	-	YWHAE	14-3-3E|HEL2|KCIP-1|MDCR|MDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1713	Fusicoccin	-	-	DRUGBANK	DB01780	C36H56O12	small molecule	-	20108-30-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXTYBXCEQOANSX-MQYZIMMHSA-N
17775	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17776	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17777	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17778	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17779	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17780	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1714	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	-	-	DRUGBANK	DB01782	C14H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACPOUJIDANTYHO-UHFFFAOYSA-N
17781	852773	948479	b3974	coaA	ECK3966|JW3942|panK|rts|ts-9	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1715	Pantothenic acid	D-pantothenic acid|(+)-Pantothenic acid|Vitamin B5|Pantothenate	vitamin b complex 100 tab|arma	DRUGBANK	DB01783	C9H17NO5	small molecule	A11HA31|D03AX04	79-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHOKWGTUZJEAQD-UHFFFAOYSA-N
17782	852773	948479	b3974	coaA	ECK3966|JW3942|panK|rts|ts-9	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1715	Pantothenic acid	D-pantothenic acid|(+)-Pantothenic acid|Vitamin B5|Pantothenate	vitamin b complex 100 tab|arma	DRUGBANK	DB01783	C9H17NO5	small molecule	A11HA31|D03AX04	79-83-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHOKWGTUZJEAQD-UHFFFAOYSA-N
17783	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1716	4-Flourobenzenesulfonamide	-	-	DRUGBANK	DB01784	C6H6FNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFLSATHZMYYIAQ-UHFFFAOYSA-N
17784	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1716	4-Flourobenzenesulfonamide	-	-	DRUGBANK	DB01784	C6H6FNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFLSATHZMYYIAQ-UHFFFAOYSA-N
17785	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1717	Dimethylallyl Diphosphate	-	-	DRUGBANK	DB01785	C5H12O7P2	small molecule	-	358-72-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBIDRCWHNCKSTO-UHFFFAOYSA-N
17786	109648	3422	-	IDI1	IPP1|IPPI1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1717	Dimethylallyl Diphosphate	-	-	DRUGBANK	DB01785	C5H12O7P2	small molecule	-	358-72-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBIDRCWHNCKSTO-UHFFFAOYSA-N
17787	849179	944777	b0029	ispH	ECK0030|JW0027|lytB|yaaE	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	1717	Dimethylallyl Diphosphate	-	-	DRUGBANK	DB01785	C5H12O7P2	small molecule	-	358-72-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBIDRCWHNCKSTO-UHFFFAOYSA-N
17788	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1719	4-Imino-5-Methidyl-2-Methylpyrimidine	-	-	DRUGBANK	DB01788	C6H7N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXFPKNUSOMMYRV-UHFFFAOYSA-N
17789	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1719	4-Imino-5-Methidyl-2-Methylpyrimidine	-	-	DRUGBANK	DB01788	C6H7N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXFPKNUSOMMYRV-UHFFFAOYSA-N
17790	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1721	Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate	-	-	DRUGBANK	DB01790	C10H12N5O5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMPNJFHAPJOHPP-BTQOAJACSA-N
17791	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1721	Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate	-	-	DRUGBANK	DB01790	C10H12N5O5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMPNJFHAPJOHPP-BTQOAJACSA-N
17792	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1721	Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate	-	-	DRUGBANK	DB01790	C10H12N5O5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMPNJFHAPJOHPP-BTQOAJACSA-N
17793	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	unknown	target	Beeh KM (2005)	15765929	181625	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17794	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Beeh KM (2005)	15765929	181625	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17795	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17796	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Beeh KM (2005)	15765929	181625	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17797	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17798	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	unknown	target	Beeh KM (2005)	15765929	181625	1722	Piclamilast	RP 73-401	-	DRUGBANK	DB01791	C18H18Cl2N2O3	small molecule	-	144035-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRRUXBQSQLKHEL-UHFFFAOYSA-N
17799	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1724	I-5	-	-	DRUGBANK	DB01793	C17H10Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONVZFCHLOZUXRP-UHFFFAOYSA-N
17800	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1724	I-5	-	-	DRUGBANK	DB01793	C17H10Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONVZFCHLOZUXRP-UHFFFAOYSA-N
17801	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1724	I-5	-	-	DRUGBANK	DB01793	C17H10Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONVZFCHLOZUXRP-UHFFFAOYSA-N
17802	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1730	4-Hydroxy-3-Methyl Butyl Diphosphate	-	-	DRUGBANK	DB01799	C5H14O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URURINNTPGGDIV-YFKPBYRVSA-N
17803	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1730	4-Hydroxy-3-Methyl Butyl Diphosphate	-	-	DRUGBANK	DB01799	C5H14O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URURINNTPGGDIV-YFKPBYRVSA-N
17804	106903	410	-	ARSA	MLD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1731	N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium	-	-	DRUGBANK	DB01800	C6H5NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMCCOOONGGUOLA-UHFFFAOYSA-N
17805	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17806	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17807	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17808	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17809	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17810	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17811	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17812	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17813	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1735	Monoisopropylphosphorylserine	-	-	DRUGBANK	DB01805	C6H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALHHSOTZKMXMV-RXMQYKEDSA-N
17814	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1737	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB01807	C20H21ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGHHVFLTANTIZ-PTGBLXJZSA-N
17815	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1737	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB01807	C20H21ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGHHVFLTANTIZ-PTGBLXJZSA-N
17816	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1737	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB01807	C20H21ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGHHVFLTANTIZ-PTGBLXJZSA-N
17817	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1739	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB01809	C16H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVPDNRVYHLRXLX-UHFFFAOYSA-N
17818	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1739	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB01809	C16H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVPDNRVYHLRXLX-UHFFFAOYSA-N
17819	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1739	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB01809	C16H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVPDNRVYHLRXLX-UHFFFAOYSA-N
17820	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1739	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB01809	C16H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVPDNRVYHLRXLX-UHFFFAOYSA-N
17821	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1740	[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester	-	-	DRUGBANK	DB01810	C23H24N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOXVWFAAXREWMI-GURWAVDKSA-N
17822	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1741	3h-Indole-5,6-Diol	-	-	DRUGBANK	DB01811	C8H6NO2	small molecule	-	3131-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17823	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1741	3h-Indole-5,6-Diol	-	-	DRUGBANK	DB01811	C8H6NO2	small molecule	-	3131-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17824	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1741	3h-Indole-5,6-Diol	-	-	DRUGBANK	DB01811	C8H6NO2	small molecule	-	3131-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
17825	111965	6036	-	RNASE2	EDN|RAF3|RNS2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17826	111965	6036	-	RNASE2	EDN|RAF3|RNS2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17827	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17828	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17829	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17830	112686	6817	OK/SW-cl.88	SULT1A1	HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17831	112686	6817	OK/SW-cl.88	SULT1A1	HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17832	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17833	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17834	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17835	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17836	850229	945862	b1274	topA	ECK1268|JW1266|asuA?|supX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17837	850229	945862	b1274	topA	ECK1268|JW1266|asuA?|supX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17838	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17839	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17840	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17841	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17842	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17843	115282	9957	-	HS3ST1	3OST|3OST1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17844	115282	9957	-	HS3ST1	3OST|3OST1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17845	115282	9957	-	HS3ST1	3OST|3OST1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1742	Adenosine-3'-5'-Diphosphate	-	-	DRUGBANK	DB01812	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHTCPDAXWFLDIH-PERBPWGJSA-N
17846	850898	946551	b2021	hisC	ECK2016|JW2003	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1743	Pyridoxyl-Glutamic Acid-5'-Monophosphate	-	-	DRUGBANK	DB01813	C13H20N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMRKOGDJNHPMHS-SNVBAGLBSA-O
17847	850898	946551	b2021	hisC	ECK2016|JW2003	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1743	Pyridoxyl-Glutamic Acid-5'-Monophosphate	-	-	DRUGBANK	DB01813	C13H20N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMRKOGDJNHPMHS-SNVBAGLBSA-O
17848	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1743	Pyridoxyl-Glutamic Acid-5'-Monophosphate	-	-	DRUGBANK	DB01813	C13H20N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMRKOGDJNHPMHS-SNVBAGLBSA-O
17849	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1743	Pyridoxyl-Glutamic Acid-5'-Monophosphate	-	-	DRUGBANK	DB01813	C13H20N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMRKOGDJNHPMHS-SNVBAGLBSA-O
17850	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1744	2-Tridecanoyloxy-Pentadecanoic Acid	-	-	DRUGBANK	DB01814	C28H54O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLKQLKMXKFGMQI-AREMUKBSSA-N
17851	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1744	2-Tridecanoyloxy-Pentadecanoic Acid	-	-	DRUGBANK	DB01814	C28H54O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLKQLKMXKFGMQI-AREMUKBSSA-N
17852	1219931	3636837	C1_02990C_A	XOG1	C1_02990C|orf6.1982|orf19.2990|CaO19.10507|EXG|Contig4-2184_0004|CA0822|orf19.10507|EXG1|IPF14073.2|IPF24307.1|CaO19.2990|C1_02990C_B|CaO6.1982|CAWG_01085	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	1746	Castanospermine	(1S,6S,7R,8R,8aR)-1,6,7,8-tetrahydroxyindolizidine|1,6,7,8-tetrahydroxyoctahydroindolizine|(1S-(1,6,7,8,8))-octahydro-1,6,7,8-indolizinetetrol	-	DRUGBANK	DB01816	C8H15NO4	small molecule	-	79831-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDVVGAQPNNXQDW-TVNFTVLESA-N
17853	1219931	3636837	C1_02990C_A	XOG1	C1_02990C|orf6.1982|orf19.2990|CaO19.10507|EXG|Contig4-2184_0004|CA0822|orf19.10507|EXG1|IPF14073.2|IPF24307.1|CaO19.2990|C1_02990C_B|CaO6.1982|CAWG_01085	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	1746	Castanospermine	(1S,6S,7R,8R,8aR)-1,6,7,8-tetrahydroxyindolizidine|1,6,7,8-tetrahydroxyoctahydroindolizine|(1S-(1,6,7,8,8))-octahydro-1,6,7,8-indolizinetetrol	-	DRUGBANK	DB01816	C8H15NO4	small molecule	-	79831-76-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDVVGAQPNNXQDW-TVNFTVLESA-N
17854	851774	947454	b2957	ansB	ECK2952|JW2924	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1747	Threonine-Aspartic Ester	-	-	DRUGBANK	DB01817	C8H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCAYFLVMRCFGDV-OMMKOOBNSA-N
17855	851774	947454	b2957	ansB	ECK2952|JW2924	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1747	Threonine-Aspartic Ester	-	-	DRUGBANK	DB01817	C8H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCAYFLVMRCFGDV-OMMKOOBNSA-N
17856	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1748	O3-Sulfonylgalactose	-	-	DRUGBANK	DB01818	C6H12O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHRMGTRTCHNCRO-XKTQNOIPSA-N
17857	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1748	O3-Sulfonylgalactose	-	-	DRUGBANK	DB01818	C6H12O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHRMGTRTCHNCRO-XKTQNOIPSA-N
17858	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1748	O3-Sulfonylgalactose	-	-	DRUGBANK	DB01818	C6H12O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHRMGTRTCHNCRO-XKTQNOIPSA-N
17859	849979	945605	b0754	aroG	ECK0743|JW0737	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17860	849979	945605	b0754	aroG	ECK0743|JW0737	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17861	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17862	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17863	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17864	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17865	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1749	Phosphoenolpyruvate	-	-	DRUGBANK	DB01819	C3H5O6P	small molecule	-	138-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTBNBXWJWCWCIK-UHFFFAOYSA-N
17866	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1750	Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide	-	-	DRUGBANK	DB01820	C29H31N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UESXELNYBIOROE-HSZRJFAPSA-N
17867	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1750	Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide	-	-	DRUGBANK	DB01820	C29H31N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UESXELNYBIOROE-HSZRJFAPSA-N
17868	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17869	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17870	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17871	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17872	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17873	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17874	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1753	Beta-D-Glucopyranose Spirohydantoin	-	-	DRUGBANK	DB01823	C8H12N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXBDPYWCAAAAI-UXDJRKLDSA-N
17875	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1753	Beta-D-Glucopyranose Spirohydantoin	-	-	DRUGBANK	DB01823	C8H12N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXBDPYWCAAAAI-UXDJRKLDSA-N
17876	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1753	Beta-D-Glucopyranose Spirohydantoin	-	-	DRUGBANK	DB01823	C8H12N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXBDPYWCAAAAI-UXDJRKLDSA-N
17877	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1756	N-Butyl Isocyanide	-	-	DRUGBANK	DB01826	C5H9N	small molecule	-	2769-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBLVBBRXSCOKU-UHFFFAOYSA-N
17878	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1756	N-Butyl Isocyanide	-	-	DRUGBANK	DB01826	C5H9N	small molecule	-	2769-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBLVBBRXSCOKU-UHFFFAOYSA-N
17879	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1756	N-Butyl Isocyanide	-	-	DRUGBANK	DB01826	C5H9N	small molecule	-	2769-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBLVBBRXSCOKU-UHFFFAOYSA-N
17880	110149	3958	-	LGALS3	CBP35|GAL3|GALBP|GALIG|L31|LGALS2|MAC2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1757	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	-	-	DRUGBANK	DB01827	C8H5F4NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTXPTSGPUNTKSM-UHFFFAOYSA-N
17881	110149	3958	-	LGALS3	CBP35|GAL3|GALBP|GALIG|L31|LGALS2|MAC2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1757	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	-	-	DRUGBANK	DB01827	C8H5F4NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTXPTSGPUNTKSM-UHFFFAOYSA-N
17882	110149	3958	-	LGALS3	CBP35|GAL3|GALBP|GALIG|L31|LGALS2|MAC2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1757	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	-	-	DRUGBANK	DB01827	C8H5F4NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTXPTSGPUNTKSM-UHFFFAOYSA-N
17883	849473	945084	b0451	amtB	ECK0445|JW0441|ybaG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1758	Methylamine	-	-	DRUGBANK	DB01828	CH5N	small molecule	-	74-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAVYZALUXZFZLV-UHFFFAOYSA-N
17884	849473	945084	b0451	amtB	ECK0445|JW0441|ybaG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1758	Methylamine	-	-	DRUGBANK	DB01828	CH5N	small molecule	-	74-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAVYZALUXZFZLV-UHFFFAOYSA-N
17885	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1760	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	-	-	DRUGBANK	DB01830	C30H41N3O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPSGYTWOIGAABK-RPBOFIJWSA-N
17886	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1760	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	-	-	DRUGBANK	DB01830	C30H41N3O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPSGYTWOIGAABK-RPBOFIJWSA-N
17887	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1761	Tryptophanyl-5'amp	-	-	DRUGBANK	DB01831	C21H24N7O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFQVDHDRFCKAAW-SQIXAUHQSA-N
17888	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1761	Tryptophanyl-5'amp	-	-	DRUGBANK	DB01831	C21H24N7O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFQVDHDRFCKAAW-SQIXAUHQSA-N
17889	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1762	4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid	-	-	DRUGBANK	DB01832	C5H9O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZTALSPOBPYJPG-UHFFFAOYSA-N
17890	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1762	4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid	-	-	DRUGBANK	DB01832	C5H9O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZTALSPOBPYJPG-UHFFFAOYSA-N
17891	108479	2184	-	FAH	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1762	4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid	-	-	DRUGBANK	DB01832	C5H9O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZTALSPOBPYJPG-UHFFFAOYSA-N
17892	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1763	L-2-Amino-4-(Guanidinooxy)Butyric Acid	-	-	DRUGBANK	DB01833	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBIGDSBMBYOPN-VKHMYHEASA-N
17893	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1763	L-2-Amino-4-(Guanidinooxy)Butyric Acid	-	-	DRUGBANK	DB01833	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBIGDSBMBYOPN-VKHMYHEASA-N
17894	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1763	L-2-Amino-4-(Guanidinooxy)Butyric Acid	-	-	DRUGBANK	DB01833	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSBIGDSBMBYOPN-VKHMYHEASA-N
17895	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17896	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17897	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17898	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17899	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1764	(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB01834	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
17900	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1765	4r-Fluoro-N6-Ethanimidoyl-L-Lysine	-	-	DRUGBANK	DB01835	C8H16FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTCJJIZTKXNFGK-RQJHMYQMSA-N
17901	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1765	4r-Fluoro-N6-Ethanimidoyl-L-Lysine	-	-	DRUGBANK	DB01835	C8H16FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTCJJIZTKXNFGK-RQJHMYQMSA-N
17902	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1765	4r-Fluoro-N6-Ethanimidoyl-L-Lysine	-	-	DRUGBANK	DB01835	C8H16FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTCJJIZTKXNFGK-RQJHMYQMSA-N
17903	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1766	[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone	-	-	DRUGBANK	DB01836	C25H27ClN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLAKCKVFSRSENR-UHFFFAOYSA-N
17904	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1766	[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone	-	-	DRUGBANK	DB01836	C25H27ClN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLAKCKVFSRSENR-UHFFFAOYSA-N
17905	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1766	[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone	-	-	DRUGBANK	DB01836	C25H27ClN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLAKCKVFSRSENR-UHFFFAOYSA-N
17906	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1767	O-acetyl-L-serine	L-Serine, acetate (ester)|O3-acetyl-L-serine	-	DRUGBANK	DB01837	C5H9NO4	small molecule	-	5147-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZXPDPZARILFQX-BYPYZUCNSA-N
17907	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1767	O-acetyl-L-serine	L-Serine, acetate (ester)|O3-acetyl-L-serine	-	DRUGBANK	DB01837	C5H9NO4	small molecule	-	5147-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZXPDPZARILFQX-BYPYZUCNSA-N
17908	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1767	O-acetyl-L-serine	L-Serine, acetate (ester)|O3-acetyl-L-serine	-	DRUGBANK	DB01837	C5H9NO4	small molecule	-	5147-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZXPDPZARILFQX-BYPYZUCNSA-N
17909	851603	947273	b2799	fucO	ECK2794|JW2770	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1769	1,2-Propanediol	-	-	DRUGBANK	DB01839	C3H8O2	small molecule	-	57-55-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-UHFFFAOYSA-N
17910	851603	947273	b2799	fucO	ECK2794|JW2770	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1769	1,2-Propanediol	-	-	DRUGBANK	DB01839	C3H8O2	small molecule	-	57-55-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-UHFFFAOYSA-N
17911	108460	2162	RP11-232H4.1	F13A1	F13A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1769	1,2-Propanediol	-	-	DRUGBANK	DB01839	C3H8O2	small molecule	-	57-55-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-UHFFFAOYSA-N
17912	108460	2162	RP11-232H4.1	F13A1	F13A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1769	1,2-Propanediol	-	-	DRUGBANK	DB01839	C3H8O2	small molecule	-	57-55-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-UHFFFAOYSA-N
17913	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1770	2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate	-	-	DRUGBANK	DB01840	C7H15O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQSGBWQBMZTMQ-AEVYZNAZSA-N
17914	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1770	2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate	-	-	DRUGBANK	DB01840	C7H15O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQSGBWQBMZTMQ-AEVYZNAZSA-N
17915	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1770	2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate	-	-	DRUGBANK	DB01840	C7H15O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQSGBWQBMZTMQ-AEVYZNAZSA-N
17916	855974	938356	BSU03040	amyE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1771	4,6-Dideoxyglucose	-	-	DRUGBANK	DB01841	C6H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJBURJZEESAQPG-JGWLITMVSA-N
17917	855974	938356	BSU03040	amyE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1771	4,6-Dideoxyglucose	-	-	DRUGBANK	DB01841	C6H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJBURJZEESAQPG-JGWLITMVSA-N
17918	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1772	3'-Phosphate-Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01842	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBWIZKLHXYJOA-PERBPWGJSA-N
17919	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1772	3'-Phosphate-Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01842	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBWIZKLHXYJOA-PERBPWGJSA-N
17920	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1772	3'-Phosphate-Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01842	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBWIZKLHXYJOA-PERBPWGJSA-N
17921	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1773	3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB01843	C8H13N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLJXQBRQPPSXPZ-UXDJRKLDSA-N
17922	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1773	3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB01843	C8H13N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLJXQBRQPPSXPZ-UXDJRKLDSA-N
17923	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1773	3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB01843	C8H13N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLJXQBRQPPSXPZ-UXDJRKLDSA-N
17924	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17925	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17926	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17927	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17928	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17929	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17930	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1778	Isocitrate Calcium Complex	-	-	DRUGBANK	DB01848	C6H7CaO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJKBMQLDNVJREQ-LEJBHHMKSA-N
17931	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1778	Isocitrate Calcium Complex	-	-	DRUGBANK	DB01848	C6H7CaO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJKBMQLDNVJREQ-LEJBHHMKSA-N
17932	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1781	Tetrabutylammonium Ion	-	-	DRUGBANK	DB01851	C16H36N	small molecule	-	2052-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLFLBLQUQXARW-UHFFFAOYSA-N
17933	126370	133688	-	UGT3A1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1782	Kaempherol	-	-	DRUGBANK	DB01852	C15H10O6	small molecule	-	520-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYRMWMYZSQPJKC-UHFFFAOYSA-N
17934	106910	417	-	ART1	ART2|ARTC1|CD296|RT6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1784	5-Bromonicotinamide	-	-	DRUGBANK	DB01854	C6H5BrN2O	small molecule	-	28733-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOQRXZIMSKLRCY-UHFFFAOYSA-N
17935	106910	417	-	ART1	ART2|ARTC1|CD296|RT6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1784	5-Bromonicotinamide	-	-	DRUGBANK	DB01854	C6H5BrN2O	small molecule	-	28733-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOQRXZIMSKLRCY-UHFFFAOYSA-N
17936	106910	417	-	ART1	ART2|ARTC1|CD296|RT6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1784	5-Bromonicotinamide	-	-	DRUGBANK	DB01854	C6H5BrN2O	small molecule	-	28733-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOQRXZIMSKLRCY-UHFFFAOYSA-N
17937	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1788	[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate	-	-	DRUGBANK	DB01858	C23H29FN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTPYRNAKLBXKNP-SFHVURJKSA-N
17938	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1790	Cordycepin Triphosphate	-	-	DRUGBANK	DB01860	C10H16N5O12P3	small molecule	-	73-04-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLIHPCYXRYQPSD-VGIXGZPDSA-N
17939	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1790	Cordycepin Triphosphate	-	-	DRUGBANK	DB01860	C10H16N5O12P3	small molecule	-	73-04-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLIHPCYXRYQPSD-VGIXGZPDSA-N
17940	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1790	Cordycepin Triphosphate	-	-	DRUGBANK	DB01860	C10H16N5O12P3	small molecule	-	73-04-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLIHPCYXRYQPSD-VGIXGZPDSA-N
17941	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
17942	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
17943	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
17944	849733	945357	b0758	galT	ECK0747|JW0741|galB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
17945	849733	945357	b0758	galT	ECK0747|JW0741|galB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
17946	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1792	Isopropyl beta-D-thiogalactopyranoside	isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG	-	DRUGBANK	DB01862	C9H18O5S	small molecule	-	367-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPHPUYQFMNQIOC-NXRLNHOXSA-N
17947	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1792	Isopropyl beta-D-thiogalactopyranoside	isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG	-	DRUGBANK	DB01862	C9H18O5S	small molecule	-	367-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPHPUYQFMNQIOC-NXRLNHOXSA-N
17948	850046	945674	b0342	lacA	ECK0339|JW0333	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1792	Isopropyl beta-D-thiogalactopyranoside	isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG	-	DRUGBANK	DB01862	C9H18O5S	small molecule	-	367-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPHPUYQFMNQIOC-NXRLNHOXSA-N
17949	850046	945674	b0342	lacA	ECK0339|JW0333	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1792	Isopropyl beta-D-thiogalactopyranoside	isopropyl--D-thiogalactoside|isopropyl -D-thiogalactoside|isopropyl -D-1-thiogalactopyranoside|isopropyl--D-thiogalactopyranoside|isopropyl -D-thiogalactopyranoside|isopropyl thiogalactoside|IPTG	-	DRUGBANK	DB01862	C9H18O5S	small molecule	-	367-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPHPUYQFMNQIOC-NXRLNHOXSA-N
17950	121697	57664	-	PLEKHA4	PEPP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17951	121697	57664	-	PLEKHA4	PEPP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17952	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17953	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17954	117981	27071	HSPC066	DAPP1	BAM32	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17955	117981	27071	HSPC066	DAPP1	BAM32	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17956	109911	3706	-	ITPKA	IP3-3KA|IP3KA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17957	109911	3706	-	ITPKA	IP3-3KA|IP3KA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17958	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17959	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17960	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17961	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17962	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17963	114686	9265	tcag7.847	CYTH3	ARNO3|GRP1|PSCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17964	114686	9265	tcag7.847	CYTH3	ARNO3|GRP1|PSCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17965	114686	9265	tcag7.847	CYTH3	ARNO3|GRP1|PSCD3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17966	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17967	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1793	Inositol 1,3,4,5-Tetrakisphosphate	-	-	DRUGBANK	DB01863	C6H16O18P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIPFCGZLFXVXBG-ZIQZFLOESA-N
17968	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17969	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17970	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17971	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17972	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17973	114299	8766	-	RAB11A	YL8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17974	114299	8766	-	RAB11A	YL8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17975	114299	8766	-	RAB11A	YL8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1794	5'-Guanosine-Diphosphate-Monothiophosphate	-	-	DRUGBANK	DB01864	C10H16N5O13P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOFLBQFBSOEHOG-BZKDHIKHSA-N
17976	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1795	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	-	-	DRUGBANK	DB01865	C19H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKFPMLBVLWZSQX-CSKARUKUSA-N
17977	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1795	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	-	-	DRUGBANK	DB01865	C19H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKFPMLBVLWZSQX-CSKARUKUSA-N
17978	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	1795	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	-	-	DRUGBANK	DB01865	C19H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKFPMLBVLWZSQX-CSKARUKUSA-N
17979	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1796	RU79256	-	-	DRUGBANK	DB01866	C8H8O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USNMCXDGQQVYSW-SSDOTTSWSA-N
17980	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1798	1,4-Dithio-Alpha-D-Mannose	-	-	DRUGBANK	DB01870	C6H12O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUOMBPNNVXJUGT-UKFBFLRUSA-N
17981	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1798	1,4-Dithio-Alpha-D-Mannose	-	-	DRUGBANK	DB01870	C6H12O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUOMBPNNVXJUGT-UKFBFLRUSA-N
17982	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1798	1,4-Dithio-Alpha-D-Mannose	-	-	DRUGBANK	DB01870	C6H12O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUOMBPNNVXJUGT-UKFBFLRUSA-N
17983	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1799	[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester	-	-	DRUGBANK	DB01871	C27H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OACUXIVGLLCILS-ZEQRLZLVSA-N
17984	113129	7278	-	TUBA3C	TUBA2|bA408E5.3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17985	113129	7278	-	TUBA3C	TUBA2|bA408E5.3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17986	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17987	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17988	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17989	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17990	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17991	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17992	119733	51807	-	TUBA8	TUBAL2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17993	119733	51807	-	TUBA8	TUBAL2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17994	115655	10382	-	TUBB4A	DYT4|TUBB4|beta-5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17995	115655	10382	-	TUBB4A	DYT4|TUBB4|beta-5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17996	124259	84790	-	TUBA1C	TUBA6|bcm948	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17997	124259	84790	-	TUBA1C	TUBA6|bcm948	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17998	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
17999	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18000	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18001	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18002	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18003	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18004	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18005	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1801	Epothilone D	Desoxyepothilone B|12,13-desoxyepothilone B|(-)-desoxyepothilone B	-	DRUGBANK	DB01873	C27H41NO5S	small molecule	-	189453-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOZIUKBZLSUILX-GIQCAXHBSA-N
18006	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1804	Bis(5-Amidino-2-Benzimidazolyl)Methanone	-	-	DRUGBANK	DB01876	C17H12N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18007	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1804	Bis(5-Amidino-2-Benzimidazolyl)Methanone	-	-	DRUGBANK	DB01876	C17H12N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18008	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1804	Bis(5-Amidino-2-Benzimidazolyl)Methanone	-	-	DRUGBANK	DB01876	C17H12N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18009	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1805	N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide	-	-	DRUGBANK	DB01877	C13H19N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLWCTMBGWSVFC-JOYOIKCWSA-N
18010	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1805	N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide	-	-	DRUGBANK	DB01877	C13H19N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLWCTMBGWSVFC-JOYOIKCWSA-N
18011	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1808	3,4-Dihydroxycinnamic Acid	-	-	DRUGBANK	DB01880	C9H8O4	small molecule	-	331-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QAIPRVGONGVQAS-DUXPYHPUSA-N
18012	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1812	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	-	-	DRUGBANK	DB01884	C9H18N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHBAVXVTGLANPI-QMMMGPOBSA-N
18013	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1812	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	-	-	DRUGBANK	DB01884	C9H18N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHBAVXVTGLANPI-QMMMGPOBSA-N
18014	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1812	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	-	-	DRUGBANK	DB01884	C9H18N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHBAVXVTGLANPI-QMMMGPOBSA-N
18015	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1813	D-Galctopyranosyl-1-On	-	-	DRUGBANK	DB01885	C6H10O6	small molecule	-	15892-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHOQVHQSTUBQQK-MBMOQRBOSA-N
18016	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1813	D-Galctopyranosyl-1-On	-	-	DRUGBANK	DB01885	C6H10O6	small molecule	-	15892-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHOQVHQSTUBQQK-MBMOQRBOSA-N
18017	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1815	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	-	-	DRUGBANK	DB01888	C23H33N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDIWBYRNTPTYQI-QAQDUYKDSA-N
18018	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1815	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	-	-	DRUGBANK	DB01888	C23H33N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDIWBYRNTPTYQI-QAQDUYKDSA-N
18019	115295	9970	-	NR1I3	CAR|CAR1|MB67	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1816	16,17-Androstene-3-Ol	-	-	DRUGBANK	DB01889	C19H30O	small molecule	-	7148-51-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRVXMNNRSSQZJP-PHFHYRSDSA-N
18020	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18021	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18022	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18023	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18024	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1817	N,N-bis(3-(D-gluconamido)propyl)deoxycholamide	Deoxy-bigchap	-	DRUGBANK	DB01890	C42H75N3O15	small molecule	-	86303-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJSUWTDDXLCUFR-HGZMBBKESA-N
18025	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18026	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18027	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18028	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18029	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1820	N6-Benzyl Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01893	C17H21N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRHGMAGSDAQUFH-HVOFVXBASA-N
18030	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1820	N6-Benzyl Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB01893	C17H21N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRHGMAGSDAQUFH-HVOFVXBASA-N
18031	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1823	M-Aminophenylboronic Acid	-	-	DRUGBANK	DB01896	C6H8BNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMZFEHDNIAQMNB-UHFFFAOYSA-N
18032	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1823	M-Aminophenylboronic Acid	-	-	DRUGBANK	DB01896	C6H8BNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMZFEHDNIAQMNB-UHFFFAOYSA-N
18033	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1824	2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride	-	-	DRUGBANK	DB01897	C24H16N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEIGFKLRGRRJJA-JLHYYAGUSA-O
18034	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1824	2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride	-	-	DRUGBANK	DB01897	C24H16N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEIGFKLRGRRJJA-JLHYYAGUSA-O
18035	856852	939259	BSU13900	ptsH	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1826	Nd1-Phosphonohistidine	-	-	DRUGBANK	DB01899	C6H11N3O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOHVXLVXSYAFOA-YFKPBYRVSA-O
18036	856852	939259	BSU13900	ptsH	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1826	Nd1-Phosphonohistidine	-	-	DRUGBANK	DB01899	C6H11N3O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOHVXLVXSYAFOA-YFKPBYRVSA-O
18037	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1828	Sucrosofate	Sucrose octasulfate	-	DRUGBANK	DB01901	C12H22O35S8	small molecule	-	57680-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEPNHBQBLCNOBB-UGDNZRGBSA-N
18038	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1828	Sucrosofate	Sucrose octasulfate	-	DRUGBANK	DB01901	C12H22O35S8	small molecule	-	57680-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEPNHBQBLCNOBB-UGDNZRGBSA-N
18039	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1828	Sucrosofate	Sucrose octasulfate	-	DRUGBANK	DB01901	C12H22O35S8	small molecule	-	57680-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEPNHBQBLCNOBB-UGDNZRGBSA-N
18040	121155	56605	RP5-985L19.2	ERO1LB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1829	1-Ethyl-Pyrrolidine-2,5-Dione	-	-	DRUGBANK	DB01902	C6H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHAZCVNUKKZTLG-UHFFFAOYSA-N
18041	121155	56605	RP5-985L19.2	ERO1LB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1829	1-Ethyl-Pyrrolidine-2,5-Dione	-	-	DRUGBANK	DB01902	C6H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHAZCVNUKKZTLG-UHFFFAOYSA-N
18042	121155	56605	RP5-985L19.2	ERO1LB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1829	1-Ethyl-Pyrrolidine-2,5-Dione	-	-	DRUGBANK	DB01902	C6H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHAZCVNUKKZTLG-UHFFFAOYSA-N
18043	110960	4905	-	NSF	SKD2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1829	1-Ethyl-Pyrrolidine-2,5-Dione	-	-	DRUGBANK	DB01902	C6H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHAZCVNUKKZTLG-UHFFFAOYSA-N
18044	110960	4905	-	NSF	SKD2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1829	1-Ethyl-Pyrrolidine-2,5-Dione	-	-	DRUGBANK	DB01902	C6H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHAZCVNUKKZTLG-UHFFFAOYSA-N
18045	110960	4905	-	NSF	SKD2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1829	1-Ethyl-Pyrrolidine-2,5-Dione	-	-	DRUGBANK	DB01902	C6H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHAZCVNUKKZTLG-UHFFFAOYSA-N
18046	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1832	2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB01905	C15H15N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFCKHJJALHETHG-UHFFFAOYSA-O
18047	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1832	2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB01905	C15H15N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFCKHJJALHETHG-UHFFFAOYSA-O
18048	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1834	RU85493	-	-	DRUGBANK	DB01908	C32H36N3O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWEWSHNGVWABKG-SXOMAYOGSA-N
18049	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1834	RU85493	-	-	DRUGBANK	DB01908	C32H36N3O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWEWSHNGVWABKG-SXOMAYOGSA-N
18050	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1834	RU85493	-	-	DRUGBANK	DB01908	C32H36N3O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWEWSHNGVWABKG-SXOMAYOGSA-N
18051	857353	939772	BSU10130	hemH	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1837	N-Methylmesoporphyrin	-	-	DRUGBANK	DB01911	C35H40N4O4	small molecule	-	142234-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNWHQWMCLCANDI-YIYRCNGCSA-N
18052	857353	939772	BSU10130	hemH	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1837	N-Methylmesoporphyrin	-	-	DRUGBANK	DB01911	C35H40N4O4	small molecule	-	142234-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNWHQWMCLCANDI-YIYRCNGCSA-N
18053	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1840	D-Glucose in Linear Form	-	-	DRUGBANK	DB01914	C6H12O6	small molecule	-	815-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZCGUPFRVQAUEE-FSIIMWSLSA-N
18054	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1840	D-Glucose in Linear Form	-	-	DRUGBANK	DB01914	C6H12O6	small molecule	-	815-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZCGUPFRVQAUEE-FSIIMWSLSA-N
18055	106557	39	-	ACAT2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18056	106557	39	-	ACAT2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18057	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18058	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18059	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18060	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18061	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18062	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18063	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18064	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18065	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18066	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18067	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1841	S-Hydroxycysteine	-	-	DRUGBANK	DB01915	C3H7NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXIRVRPOOYSARH-REOHCLBHSA-N
18068	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18069	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18070	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18071	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18072	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18073	849854	945480	b0854	potF	ECK0845|JW0838	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18074	849854	945480	b0854	potF	ECK0845|JW0838	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1842	Putrescine	-	-	DRUGBANK	DB01917	C4H12N2	small molecule	-	110-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIDHWZJUCRJVML-UHFFFAOYSA-N
18075	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1844	Pentanal	-	-	DRUGBANK	DB01919	C5H10O	small molecule	-	110-62-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBOYTHUEUWSSQ-UHFFFAOYSA-N
18076	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1844	Pentanal	-	-	DRUGBANK	DB01919	C5H10O	small molecule	-	110-62-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBOYTHUEUWSSQ-UHFFFAOYSA-N
18077	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1844	Pentanal	-	-	DRUGBANK	DB01919	C5H10O	small molecule	-	110-62-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBOYTHUEUWSSQ-UHFFFAOYSA-N
18078	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1845	1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose	-	-	DRUGBANK	DB01920	C12H15NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUWPCJHYPSUOFW-SVNGYHJRSA-N
18079	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1845	1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose	-	-	DRUGBANK	DB01920	C12H15NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUWPCJHYPSUOFW-SVNGYHJRSA-N
18080	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1848	L-Xylulose 5-Phosphate	-	-	DRUGBANK	DB01923	C5H13O7P	small molecule	-	60802-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPXGTKHZRCDZTL-UOWFLXDJSA-N
18081	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1848	L-Xylulose 5-Phosphate	-	-	DRUGBANK	DB01923	C5H13O7P	small molecule	-	60802-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPXGTKHZRCDZTL-UOWFLXDJSA-N
18082	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1851	Carboxymycobactin S	-	-	DRUGBANK	DB01926	C36H51FeN5O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHVPNAZTTVYYAS-JSXYRWHJSA-M
18083	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1851	Carboxymycobactin S	-	-	DRUGBANK	DB01926	C36H51FeN5O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHVPNAZTTVYYAS-JSXYRWHJSA-M
18084	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1852	Duroquinone	-	-	DRUGBANK	DB01927	C10H12O2	small molecule	-	527-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAMKWBHYPYBEJY-UHFFFAOYSA-N
18085	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1852	Duroquinone	-	-	DRUGBANK	DB01927	C10H12O2	small molecule	-	527-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAMKWBHYPYBEJY-UHFFFAOYSA-N
18086	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1852	Duroquinone	-	-	DRUGBANK	DB01927	C10H12O2	small molecule	-	527-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAMKWBHYPYBEJY-UHFFFAOYSA-N
18088	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1854	5-Chloryl-2,4,6-Quinazolinetriamine	-	-	DRUGBANK	DB01929	C8H8ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOIWFGJNGXKHGL-UHFFFAOYSA-N
18089	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1856	Dcka, 5,7-Dichlorokynurenic Acid	-	-	DRUGBANK	DB01931	C10H5Cl2NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGKFPRIGXAVYNX-UHFFFAOYSA-N
18090	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1858	7-Hydroxystaurosporine	-	-	DRUGBANK	DB01933	C28H26N4O4	small molecule	-	112953-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBCZSGKMGDDXIJ-HQCWYSJUSA-N
18091	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1858	7-Hydroxystaurosporine	-	-	DRUGBANK	DB01933	C28H26N4O4	small molecule	-	112953-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBCZSGKMGDDXIJ-HQCWYSJUSA-N
18092	851379	947040	b2568	lepB	ECK2566|JW2552|lep	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1859	N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide	-	-	DRUGBANK	DB01934	C42H60N6O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFSXYWAZCKMYJN-IRWFPOEQSA-N
18093	851379	947040	b2568	lepB	ECK2566|JW2552|lep	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1859	N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide	-	-	DRUGBANK	DB01934	C42H60N6O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFSXYWAZCKMYJN-IRWFPOEQSA-N
18094	852562	948260	b3752	rbsK	ECK3746|JW3731	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1861	Ribose	-	-	DRUGBANK	DB01936	C5H10O5	small molecule	-	50-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-MBMOQRBOSA-N
18095	852562	948260	b3752	rbsK	ECK3746|JW3731	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1861	Ribose	-	-	DRUGBANK	DB01936	C5H10O5	small molecule	-	50-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-MBMOQRBOSA-N
18096	855182	937529	BSU39340	hutP	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1863	L-Histidine Beta Naphthylamide	-	-	DRUGBANK	DB01938	C16H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKDILZBBFKZMRO-OAHLLOKOSA-N
18097	855182	937529	BSU39340	hutP	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1863	L-Histidine Beta Naphthylamide	-	-	DRUGBANK	DB01938	C16H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKDILZBBFKZMRO-OAHLLOKOSA-N
18098	855182	937529	BSU39340	hutP	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	1863	L-Histidine Beta Naphthylamide	-	-	DRUGBANK	DB01938	C16H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKDILZBBFKZMRO-OAHLLOKOSA-N
18099	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1864	5-Amidino-Benzimidazole	-	-	DRUGBANK	DB01939	C8H9N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHGFPMUGEQINGV-UHFFFAOYSA-O
18100	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1865	Balanol Analog 2	-	-	DRUGBANK	DB01940	C27H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQLYTJZXRRDERK-LADGPHEKSA-N
18101	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1865	Balanol Analog 2	-	-	DRUGBANK	DB01940	C27H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQLYTJZXRRDERK-LADGPHEKSA-N
18102	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1865	Balanol Analog 2	-	-	DRUGBANK	DB01940	C27H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQLYTJZXRRDERK-LADGPHEKSA-N
18103	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1866	6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid	-	-	DRUGBANK	DB01941	C24H29NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXTWXQUEZSSTJ-UHFFFAOYSA-N
18104	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1866	6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid	-	-	DRUGBANK	DB01941	C24H29NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLXTWXQUEZSSTJ-UHFFFAOYSA-N
18105	849930	945556	b0945	pyrD	ECK0936|JW0928	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18106	849930	945556	b0945	pyrD	ECK0936|JW0928	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18107	111774	5816	CITF22-126G10.2	PVALB	D22S749	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18108	851539	947207	b2739	ygbM	ECK2734|JW2709	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18109	851539	947207	b2739	ygbM	ECK2734|JW2709	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18110	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18111	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18112	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18113	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18114	124581	87769	RP11-151A6.2	GGACT	A2LD1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18115	106613	98	-	ACYP2	ACYM|ACYP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18116	107869	1487	-	CTBP1	BARS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18117	107869	1487	-	CTBP1	BARS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18118	107869	1487	-	CTBP1	BARS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18119	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18120	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18121	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18122	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18123	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18124	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18125	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18126	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18127	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18128	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18129	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18130	850694	946337	b1812	pabB	ECK1810|JW1801	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18131	850694	946337	b1812	pabB	ECK1810|JW1801	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18132	115537	10243	-	GPHN	GEPH|GPH|GPHRYN|HKPX1|MOCODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18133	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1868	(S)-blebbistatin	-	-	DRUGBANK	DB01944	C18H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZAXPYOBKSJSEX-GOSISDBHSA-N
18134	108100	1760	-	DMPK	DM|DM1|DM1PK|DMK|MDPK|MT-PK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1870	3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01946	C24H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHKJRCFSLMWIA-UHFFFAOYSA-N
18135	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1870	3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01946	C24H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHKJRCFSLMWIA-UHFFFAOYSA-N
18136	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1870	3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01946	C24H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHKJRCFSLMWIA-UHFFFAOYSA-N
18137	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1870	3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01946	C24H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHKJRCFSLMWIA-UHFFFAOYSA-N
18138	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1871	RU78262	-	-	DRUGBANK	DB01947	C7H7O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYNSFVCWJXZPOW-UHFFFAOYSA-N
18139	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1872	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	-	-	DRUGBANK	DB01948	C26H22Cl2F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXIYTVJEIXMAQF-UHFFFAOYSA-N
18140	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1872	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	-	-	DRUGBANK	DB01948	C26H22Cl2F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXIYTVJEIXMAQF-UHFFFAOYSA-N
18141	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1873	2-Amino-N,3,3-Trimethylbutanamide	-	-	DRUGBANK	DB01949	C7H16N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKJNEIOHOEWLO-RXMQYKEDSA-N
18142	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1873	2-Amino-N,3,3-Trimethylbutanamide	-	-	DRUGBANK	DB01949	C7H16N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPKJNEIOHOEWLO-RXMQYKEDSA-N
18143	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1874	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	-	-	DRUGBANK	DB01950	C12H12N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEMHJKFIIIULI-UHFFFAOYSA-N
18144	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1874	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	-	-	DRUGBANK	DB01950	C12H12N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEMHJKFIIIULI-UHFFFAOYSA-N
18145	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1874	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	-	-	DRUGBANK	DB01950	C12H12N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAEMHJKFIIIULI-UHFFFAOYSA-N
18146	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1875	Gpi-1046	-	-	DRUGBANK	DB01951	C20H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQAHHWOPVDDWHD-INIZCTEOSA-N
18147	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1877	Inhibitor of P38 Kinase	-	-	DRUGBANK	DB01953	C15H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUEYCHLWAOBOHG-UHFFFAOYSA-N
18148	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1877	Inhibitor of P38 Kinase	-	-	DRUGBANK	DB01953	C15H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUEYCHLWAOBOHG-UHFFFAOYSA-N
18149	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1877	Inhibitor of P38 Kinase	-	-	DRUGBANK	DB01953	C15H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUEYCHLWAOBOHG-UHFFFAOYSA-N
18150	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18151	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18152	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18153	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18154	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18155	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1878	Rolipram	4-[3-(cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|(R,S)-rolipram|(+/-)-rolipram	-	DRUGBANK	DB01954	C16H21NO3	small molecule	-	61413-54-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-UHFFFAOYSA-N
18156	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18157	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18158	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18159	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18160	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18161	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18162	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18163	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18164	851153	946812	b2328	mepA	ECK2322|JW2325	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18165	851153	946812	b2328	mepA	ECK2322|JW2325	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18166	849412	945021	b0368	tauD	ECK0365|JW0360|ssiD|yaiG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1880	2-Aminoethanesulfonic Acid	-	-	DRUGBANK	DB01956	C2H7NO3S	small molecule	-	107-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOAAWQZATWQOTB-UHFFFAOYSA-N
18167	849412	945021	b0368	tauD	ECK0365|JW0360|ssiD|yaiG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1880	2-Aminoethanesulfonic Acid	-	-	DRUGBANK	DB01956	C2H7NO3S	small molecule	-	107-35-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XOAAWQZATWQOTB-UHFFFAOYSA-N
18168	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1882	5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine	-	-	DRUGBANK	DB01958	C18H20N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNYDVPDMLAJJPB-UHFFFAOYSA-N
18169	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18170	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18171	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18172	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1883	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB01959	C14H15N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSYGAHOHLUJIKV-UHFFFAOYSA-N
18173	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18174	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18175	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18176	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18177	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18178	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1885	Cytidine-3'-Monophosphate	-	-	DRUGBANK	DB01961	C9H14N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOOOPKANIPLQPU-VXUIKNBNSA-N
18179	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1885	Cytidine-3'-Monophosphate	-	-	DRUGBANK	DB01961	C9H14N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOOOPKANIPLQPU-VXUIKNBNSA-N
18180	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1885	Cytidine-3'-Monophosphate	-	-	DRUGBANK	DB01961	C9H14N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOOOPKANIPLQPU-VXUIKNBNSA-N
18181	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18182	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18183	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18184	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18185	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18186	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1886	Phosphonotyrosine	-	-	DRUGBANK	DB01962	C9H12NO6P	small molecule	-	21820-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCWXELXMIBXGTH-QMMMGPOBSA-N
18187	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1887	Phenylethane Boronic Acid	-	-	DRUGBANK	DB01963	C8H11BO2	small molecule	-	34420-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPRUMANMDWQMNF-UHFFFAOYSA-N
18188	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1887	Phenylethane Boronic Acid	-	-	DRUGBANK	DB01963	C8H11BO2	small molecule	-	34420-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPRUMANMDWQMNF-UHFFFAOYSA-N
18189	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1887	Phenylethane Boronic Acid	-	-	DRUGBANK	DB01963	C8H11BO2	small molecule	-	34420-17-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPRUMANMDWQMNF-UHFFFAOYSA-N
18190	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1888	AL5424	-	-	DRUGBANK	DB01964	C13H14N2O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWTSOJQGEWPWGO-NSHDSACASA-N
18191	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1888	AL5424	-	-	DRUGBANK	DB01964	C13H14N2O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWTSOJQGEWPWGO-NSHDSACASA-N
18192	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1888	AL5424	-	-	DRUGBANK	DB01964	C13H14N2O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWTSOJQGEWPWGO-NSHDSACASA-N
18193	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1889	2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate	-	-	DRUGBANK	DB01965	C9H16N3O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZLLMTSKYYYJLH-GKROBHDKSA-N
18194	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1889	2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate	-	-	DRUGBANK	DB01965	C9H16N3O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZLLMTSKYYYJLH-GKROBHDKSA-N
18195	111639	5660	-	PSAP	GLBA|SAP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1890	Di-Stearoyl-3-Sn-Phosphatidylethanolamine	-	-	DRUGBANK	DB01966	C41H82NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNGJLRDBYCPGB-KDXMTYKHSA-N
18196	111639	5660	-	PSAP	GLBA|SAP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1890	Di-Stearoyl-3-Sn-Phosphatidylethanolamine	-	-	DRUGBANK	DB01966	C41H82NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNGJLRDBYCPGB-KDXMTYKHSA-N
18197	851209	946869	b2412	zipA	ECK2407|JW2404	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	1891	N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide	-	-	DRUGBANK	DB01967	C21H29N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LICJTIDRHJECTD-SFHVURJKSA-N
18198	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1893	Trifluoroacetonyl Coenzyme A	-	-	DRUGBANK	DB01969	C24H37F3N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDIQTPZOIIYCTR-DBXDFDKESA-N
18199	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1893	Trifluoroacetonyl Coenzyme A	-	-	DRUGBANK	DB01969	C24H37F3N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDIQTPZOIIYCTR-DBXDFDKESA-N
18200	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1893	Trifluoroacetonyl Coenzyme A	-	-	DRUGBANK	DB01969	C24H37F3N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDIQTPZOIIYCTR-DBXDFDKESA-N
18201	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1894	Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide	-	-	DRUGBANK	DB01970	C17H35NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REPLXGVUTGZQCG-JHNDHUHGSA-N
18202	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1894	Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide	-	-	DRUGBANK	DB01970	C17H35NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REPLXGVUTGZQCG-JHNDHUHGSA-N
18203	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18204	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18205	109242	2987	RP11-520H14.2	GUK1	GMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18206	109242	2987	RP11-520H14.2	GUK1	GMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18207	109242	2987	RP11-520H14.2	GUK1	GMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18208	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18209	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18210	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18211	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18212	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18213	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18214	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18215	851135	946794	b2312	purF	ECK2306|JW2309|ade|purC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18216	851135	946794	b2312	purF	ECK2306|JW2309|ade|purC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18217	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18218	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18219	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18220	853738	936046	BSU06490	purF	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18221	853738	936046	BSU06490	purF	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18222	109028	2766	RP3-467D16.2	GMPR	GMPR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18223	109028	2766	RP3-467D16.2	GMPR	GMPR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18224	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18225	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18226	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18227	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1897	O-Benzylsulfonyl-Serine	-	-	DRUGBANK	DB01973	C10H13NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCZVEKLTOLTWLM-VIFPVBQESA-N
18228	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1897	O-Benzylsulfonyl-Serine	-	-	DRUGBANK	DB01973	C10H13NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCZVEKLTOLTWLM-VIFPVBQESA-N
18229	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1897	O-Benzylsulfonyl-Serine	-	-	DRUGBANK	DB01973	C10H13NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCZVEKLTOLTWLM-VIFPVBQESA-N
18230	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1901	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB01977	C18H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPTICWHONWNW-UHFFFAOYSA-N
18231	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1901	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB01977	C18H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPTICWHONWNW-UHFFFAOYSA-N
18232	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1901	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB01977	C18H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPTICWHONWNW-UHFFFAOYSA-N
18233	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1903	Methyl alpha-D-mannoside	-	-	DRUGBANK	DB01979	C7H14O6	small molecule	-	25281-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOVAGTYPODGVJG-VEIUFWFVSA-N
18234	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1903	Methyl alpha-D-mannoside	-	-	DRUGBANK	DB01979	C7H14O6	small molecule	-	25281-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOVAGTYPODGVJG-VEIUFWFVSA-N
18235	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1903	Methyl alpha-D-mannoside	-	-	DRUGBANK	DB01979	C7H14O6	small molecule	-	25281-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOVAGTYPODGVJG-VEIUFWFVSA-N
18236	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1907	2(S)-Amino-6-Boronohexanoic Acid	-	-	DRUGBANK	DB01983	C6H15BNO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLVGFZFOWWBCCZ-YFKPBYRVSA-N
18237	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1907	2(S)-Amino-6-Boronohexanoic Acid	-	-	DRUGBANK	DB01983	C6H15BNO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLVGFZFOWWBCCZ-YFKPBYRVSA-N
18238	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1907	2(S)-Amino-6-Boronohexanoic Acid	-	-	DRUGBANK	DB01983	C6H15BNO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLVGFZFOWWBCCZ-YFKPBYRVSA-N
18239	849234	944834	b0114	aceE	ECK0113|JW0110	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1911	Thiamin Diphosphate	-	-	DRUGBANK	DB01987	C12H18N4O7P2S	small molecule	-	154-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYEKOFBPNLCAJY-UHFFFAOYSA-N
18240	849234	944834	b0114	aceE	ECK0113|JW0110	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1911	Thiamin Diphosphate	-	-	DRUGBANK	DB01987	C12H18N4O7P2S	small molecule	-	154-87-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYEKOFBPNLCAJY-UHFFFAOYSA-N
18241	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1912	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	-	-	DRUGBANK	DB01988	C30H27N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFSFNKVFXLIZIY-MHZLTWQESA-N
18242	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1912	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	-	-	DRUGBANK	DB01988	C30H27N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFSFNKVFXLIZIY-MHZLTWQESA-N
18243	112948	7093	-	TLL2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1913	Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome	-	-	DRUGBANK	DB01989	C36H52N6O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVJRALIDWYDPLY-RJHOZCNWSA-O
18244	112948	7093	-	TLL2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1913	Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome	-	-	DRUGBANK	DB01989	C36H52N6O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVJRALIDWYDPLY-RJHOZCNWSA-O
18245	112948	7093	-	TLL2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1913	Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome	-	-	DRUGBANK	DB01989	C36H52N6O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVJRALIDWYDPLY-RJHOZCNWSA-O
18246	112022	6095	-	RORA	NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1914	Cholesterol-Sulfate	-	-	DRUGBANK	DB01990	C27H46O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHYOQNUELFTYRT-MFYRMPRMSA-N
18247	112022	6095	-	RORA	NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1914	Cholesterol-Sulfate	-	-	DRUGBANK	DB01990	C27H46O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHYOQNUELFTYRT-MFYRMPRMSA-N
18248	112022	6095	-	RORA	NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1914	Cholesterol-Sulfate	-	-	DRUGBANK	DB01990	C27H46O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHYOQNUELFTYRT-MFYRMPRMSA-N
18249	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18250	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18251	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18252	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18253	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18254	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18255	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18256	107990	1622	-	DBI	ACBD1|ACBP|CCK-RP|EP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18257	107990	1622	-	DBI	ACBD1|ACBP|CCK-RP|EP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18258	107990	1622	-	DBI	ACBD1|ACBP|CCK-RP|EP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18259	115779	10524	-	KAT5	ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18260	115779	10524	-	KAT5	ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18261	115779	10524	-	KAT5	ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18262	853245	948997	b0038	caiB	ECK0039|JW0037|yaaN	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18263	853245	948997	b0038	caiB	ECK0039|JW0037|yaaN	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18264	849888	945514	b0903	pflB	ECK0894|JW0886|pfl	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18265	849888	945514	b0903	pflB	ECK0894|JW0886|pfl	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18266	850046	945674	b0342	lacA	ECK0339|JW0333	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18267	850046	945674	b0342	lacA	ECK0339|JW0333	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18268	108918	2648	-	KAT2A	GCN5|GCN5L2|PCAF-b|hGCN5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18269	106557	39	-	ACAT2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18270	106557	39	-	ACAT2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18271	852548	948246	b3730	glmU	ECK3723|JW3708|tms|yieA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18272	852548	948246	b3730	glmU	ECK3723|JW3708|tms|yieA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18273	852773	948479	b3974	coaA	ECK3966|JW3942|panK|rts|ts-9	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18274	852773	948479	b3974	coaA	ECK3966|JW3942|panK|rts|ts-9	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18275	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18276	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18277	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18278	854858	937204	BSU32150	paiA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18279	854858	937204	BSU32150	paiA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18280	855814	938194	BSU04620	acpS	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18281	855814	938194	BSU04620	acpS	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1916	Coenzyme A	CoA|CoA-SH|CoASH|3'-phosphoadenosine-(5')diphospho(4')pantatheine|HSCoA	-	DRUGBANK	DB01992	C21H36N7O16P3S	small molecule	-	85-61-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGJOEKWQDUBAIZ-VPHNIEJBSA-N
18282	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1920	3-Methylpyridine	-	-	DRUGBANK	DB01996	C6H7N	small molecule	-	108-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITQTTZVARXURQS-UHFFFAOYSA-N
18283	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1920	3-Methylpyridine	-	-	DRUGBANK	DB01996	C6H7N	small molecule	-	108-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITQTTZVARXURQS-UHFFFAOYSA-N
18284	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1920	3-Methylpyridine	-	-	DRUGBANK	DB01996	C6H7N	small molecule	-	108-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITQTTZVARXURQS-UHFFFAOYSA-N
18285	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1920	3-Methylpyridine	-	-	DRUGBANK	DB01996	C6H7N	small molecule	-	108-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITQTTZVARXURQS-UHFFFAOYSA-N
18286	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18287	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18288	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18289	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18290	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18291	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18292	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18293	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18294	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18295	111283	5265	PRO0684	SERPINA1	A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1922	2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB01998	C20H38O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMFJFQAURAFEAH-WXZRAZJNSA-N
18296	111283	5265	PRO0684	SERPINA1	A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1922	2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB01998	C20H38O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMFJFQAURAFEAH-WXZRAZJNSA-N
18297	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1925	5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine	-	-	DRUGBANK	DB02001	C18H19N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZLWCJRHDBTCGQ-UHFFFAOYSA-N
18298	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1928	5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine	-	-	DRUGBANK	DB02004	C19H18Cl2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCJFINNFYUNFGH-UHFFFAOYSA-N
18299	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1928	5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine	-	-	DRUGBANK	DB02004	C19H18Cl2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCJFINNFYUNFGH-UHFFFAOYSA-N
18300	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1928	5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine	-	-	DRUGBANK	DB02004	C19H18Cl2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCJFINNFYUNFGH-UHFFFAOYSA-N
18301	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18302	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18303	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18304	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18305	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18306	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18307	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18308	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18309	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18310	853852	936161	BSU08180	malA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18311	853852	936161	BSU08180	malA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18312	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18313	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18314	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18315	109345	3098	-	HK1	HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18316	109345	3098	-	HK1	HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18317	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1932	1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	-	-	DRUGBANK	DB02008	C25H26FN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHSHXKJSPVHPCJ-UHFFFAOYSA-N
18318	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1932	1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	-	-	DRUGBANK	DB02008	C25H26FN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHSHXKJSPVHPCJ-UHFFFAOYSA-N
18319	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1932	1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	-	-	DRUGBANK	DB02008	C25H26FN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHSHXKJSPVHPCJ-UHFFFAOYSA-N
18320	113367	7535	-	ZAP70	SRK|STCD|STD|TZK|ZAP-70	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18321	113367	7535	-	ZAP70	SRK|STCD|STD|TZK|ZAP-70	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18322	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18323	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18324	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18325	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18326	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18327	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18328	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18329	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18330	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18331	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18332	107832	1445	-	CSK	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18333	107832	1445	-	CSK	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18334	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18335	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18336	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18337	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18338	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18339	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18340	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18341	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18342	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18343	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18344	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1935	N-(Phosphonoacetyl)-L-Ornithine	-	-	DRUGBANK	DB02011	C7H15N2O6P	small molecule	-	63446-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCIHAQFHXJOLIF-YFKPBYRVSA-N
18345	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1935	N-(Phosphonoacetyl)-L-Ornithine	-	-	DRUGBANK	DB02011	C7H15N2O6P	small molecule	-	63446-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCIHAQFHXJOLIF-YFKPBYRVSA-N
18346	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1937	Compound 9	5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid	-	DRUGBANK	DB02014	C21H16FNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKHWJUMLYAYZFS-ONEGZZNKSA-N
18347	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1937	Compound 9	5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid	-	DRUGBANK	DB02014	C21H16FNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKHWJUMLYAYZFS-ONEGZZNKSA-N
18348	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1937	Compound 9	5-{2-fluoro-5-[3-(3-hydroxy-2-methoxycarbonyl-phenoxy)-propenyl]-phenyl}-isoxazole-3-carboxylic acid	-	DRUGBANK	DB02014	C21H16FNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKHWJUMLYAYZFS-ONEGZZNKSA-N
18349	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1938	Dihydrofolic Acid	-	-	DRUGBANK	DB02015	C19H21N7O6	small molecule	-	4033-27-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZRNSSUDZOLUSN-GFCCVEGCSA-N
18350	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1938	Dihydrofolic Acid	-	-	DRUGBANK	DB02015	C19H21N7O6	small molecule	-	4033-27-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZRNSSUDZOLUSN-GFCCVEGCSA-N
18351	110225	4047	-	LSS	OSC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1939	R048-8071	-	-	DRUGBANK	DB02016	C23H27BrFNO2	small molecule	-	161582-11-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMYCCJYVZIMDFU-UHFFFAOYSA-N
18352	110225	4047	-	LSS	OSC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1939	R048-8071	-	-	DRUGBANK	DB02016	C23H27BrFNO2	small molecule	-	161582-11-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMYCCJYVZIMDFU-UHFFFAOYSA-N
18353	122201	64499	-	TPSB2	TPS2|tryptaseB|tryptaseC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1941	Amido Phenyl Pyruvic Acid	-	-	DRUGBANK	DB02018	C10H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXBYWYQEQQBMBT-UHFFFAOYSA-N
18354	122201	64499	-	TPSB2	TPS2|tryptaseB|tryptaseC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1941	Amido Phenyl Pyruvic Acid	-	-	DRUGBANK	DB02018	C10H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXBYWYQEQQBMBT-UHFFFAOYSA-N
18355	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1943	Alrestatin	-	-	DRUGBANK	DB02020	C14H9NO4	small molecule	-	51411-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCUCIFQCGJIRNT-UHFFFAOYSA-N
18356	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1943	Alrestatin	-	-	DRUGBANK	DB02020	C14H9NO4	small molecule	-	51411-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCUCIFQCGJIRNT-UHFFFAOYSA-N
18357	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1943	Alrestatin	-	-	DRUGBANK	DB02020	C14H9NO4	small molecule	-	51411-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCUCIFQCGJIRNT-UHFFFAOYSA-N
18358	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1944	Fidarestat	Aldos|(S,S)-fidarestat	-	DRUGBANK	DB02021	C12H10FN3O4	small molecule	-	136087-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAAPEIZFCHNLKK-UFBFGSQYSA-N
18359	857387	939807	BSU11650	tenA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1945	4-Amino-5-Hydroxymethyl-2-Methylpyrimidine	-	-	DRUGBANK	DB02022	C6H9N3O	small molecule	-	73-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUTBELPREDJDDH-UHFFFAOYSA-N
18360	857387	939807	BSU11650	tenA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1945	4-Amino-5-Hydroxymethyl-2-Methylpyrimidine	-	-	DRUGBANK	DB02022	C6H9N3O	small molecule	-	73-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUTBELPREDJDDH-UHFFFAOYSA-N
18361	849225	944824	b0099	mutT	ECK0100|JW0097|nudA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1946	8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB02023	C10H14N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQIVLFLYHYFRKU-MROZADKFSA-N
18362	849225	944824	b0099	mutT	ECK0100|JW0097|nudA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1946	8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB02023	C10H14N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQIVLFLYHYFRKU-MROZADKFSA-N
18363	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1947	3-phenylpropionic acid	3PP|3-Phenyl-propionic acid|3-Phenylpropanoic acid|Hydrocinnamic acid|Phenylpropanoate|beta-Phenylpropionic acid	-	DRUGBANK	DB02024	C9H10O2	small molecule	-	501-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMIIGOLPHOKFCH-UHFFFAOYSA-N
18364	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1947	3-phenylpropionic acid	3PP|3-Phenyl-propionic acid|3-Phenylpropanoic acid|Hydrocinnamic acid|Phenylpropanoate|beta-Phenylpropionic acid	-	DRUGBANK	DB02024	C9H10O2	small molecule	-	501-52-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMIIGOLPHOKFCH-UHFFFAOYSA-N
18365	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18366	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18367	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18368	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18369	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18370	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18371	113126	7275	-	TUB	rd5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1951	L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate	-	-	DRUGBANK	DB02028	C9H19O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBQPYAMQMBKZDT-CMLZIERQSA-N
18372	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1952	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	-	-	DRUGBANK	DB02029	C13H17IN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQTBUVAFYDVTFD-UHFFFAOYSA-N
18373	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1952	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	-	-	DRUGBANK	DB02029	C13H17IN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQTBUVAFYDVTFD-UHFFFAOYSA-N
18374	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1952	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	-	-	DRUGBANK	DB02029	C13H17IN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQTBUVAFYDVTFD-UHFFFAOYSA-N
18375	856417	938802	BSU07630	nosA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	1954	(6s)-5,6,7,8-Tetrahydrofolate	-	-	DRUGBANK	DB02031	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-VXGBXAGGSA-N
18376	856417	938802	BSU07630	nosA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	1954	(6s)-5,6,7,8-Tetrahydrofolate	-	-	DRUGBANK	DB02031	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-VXGBXAGGSA-N
18377	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1954	(6s)-5,6,7,8-Tetrahydrofolate	-	-	DRUGBANK	DB02031	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-VXGBXAGGSA-N
18378	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1954	(6s)-5,6,7,8-Tetrahydrofolate	-	-	DRUGBANK	DB02031	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-VXGBXAGGSA-N
18379	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18380	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18381	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18382	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1957	Swainsonine	(1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol|Tridolgosir	-	DRUGBANK	DB02034	C8H15NO3	small molecule	-	72741-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUAIOOAOAVCGD-WCTZXXKLSA-N
18383	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1957	Swainsonine	(1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol|Tridolgosir	-	DRUGBANK	DB02034	C8H15NO3	small molecule	-	72741-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUAIOOAOAVCGD-WCTZXXKLSA-N
18384	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1957	Swainsonine	(1S,2R,8R,8AR)-octahydro-1,2,8-indolizinetriol|Tridolgosir	-	DRUGBANK	DB02034	C8H15NO3	small molecule	-	72741-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUAIOOAOAVCGD-WCTZXXKLSA-N
18385	111530	5538	RP11-115D7.2	PPT1	CLN1|INCL|PPT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1958	1-Hexadecylsulfonyl Fluoride	-	-	DRUGBANK	DB02035	C16H33FO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVFMUVBIHIZAM-UHFFFAOYSA-N
18386	111530	5538	RP11-115D7.2	PPT1	CLN1|INCL|PPT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1958	1-Hexadecylsulfonyl Fluoride	-	-	DRUGBANK	DB02035	C16H33FO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVFMUVBIHIZAM-UHFFFAOYSA-N
18387	111530	5538	RP11-115D7.2	PPT1	CLN1|INCL|PPT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1958	1-Hexadecylsulfonyl Fluoride	-	-	DRUGBANK	DB02035	C16H33FO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIVFMUVBIHIZAM-UHFFFAOYSA-N
18388	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1962	S-Acetyl-Cysteine	-	-	DRUGBANK	DB02039	C5H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCIRMLHOFVDUDP-SCSAIBSYSA-N
18389	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1962	S-Acetyl-Cysteine	-	-	DRUGBANK	DB02039	C5H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCIRMLHOFVDUDP-SCSAIBSYSA-N
18390	115779	10524	-	KAT5	ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1962	S-Acetyl-Cysteine	-	-	DRUGBANK	DB02039	C5H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCIRMLHOFVDUDP-SCSAIBSYSA-N
18391	115779	10524	-	KAT5	ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1962	S-Acetyl-Cysteine	-	-	DRUGBANK	DB02039	C5H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCIRMLHOFVDUDP-SCSAIBSYSA-N
18392	115779	10524	-	KAT5	ESA1|HTATIP|HTATIP1|PLIP|TIP|TIP60|ZC2HC5|cPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1962	S-Acetyl-Cysteine	-	-	DRUGBANK	DB02039	C5H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCIRMLHOFVDUDP-SCSAIBSYSA-N
18393	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1966	N-(3-(Aminomethyl)Benzyl)Acetamidine	-	-	DRUGBANK	DB02044	C10H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RODUKNYOEVZQPR-UHFFFAOYSA-N
18394	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1966	N-(3-(Aminomethyl)Benzyl)Acetamidine	-	-	DRUGBANK	DB02044	C10H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RODUKNYOEVZQPR-UHFFFAOYSA-N
18395	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1966	N-(3-(Aminomethyl)Benzyl)Acetamidine	-	-	DRUGBANK	DB02044	C10H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RODUKNYOEVZQPR-UHFFFAOYSA-N
18396	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1967	Amylamine	-	-	DRUGBANK	DB02045	C5H13N	small molecule	-	110-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPBLXKKOBLCELK-UHFFFAOYSA-N
18397	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1967	Amylamine	-	-	DRUGBANK	DB02045	C5H13N	small molecule	-	110-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPBLXKKOBLCELK-UHFFFAOYSA-N
18398	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1967	Amylamine	-	-	DRUGBANK	DB02045	C5H13N	small molecule	-	110-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPBLXKKOBLCELK-UHFFFAOYSA-N
18399	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1968	N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid	-	-	DRUGBANK	DB02046	C21H26N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHPKSASOSKNDPY-PKOBYXMFSA-N
18400	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1969	2-(1,1'-Biphenyl-4-Yl)Propanoic Acid	-	-	DRUGBANK	DB02047	C15H14O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JALUUBQFLPUJMY-NSHDSACASA-N
18401	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1970	1,2,4-Triazole-Carboxamidine	-	-	DRUGBANK	DB02048	C3H6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDIOIIJXUJXYPB-UHFFFAOYSA-O
18402	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1970	1,2,4-Triazole-Carboxamidine	-	-	DRUGBANK	DB02048	C3H6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDIOIIJXUJXYPB-UHFFFAOYSA-O
18403	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1970	1,2,4-Triazole-Carboxamidine	-	-	DRUGBANK	DB02048	C3H6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDIOIIJXUJXYPB-UHFFFAOYSA-O
18404	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1971	2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide	-	-	DRUGBANK	DB02049	C19H20ClNO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOPFTBAEAJQKSY-UHFFFAOYSA-N
18405	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18406	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18407	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18408	114376	8851	-	CDK5R1	CDK5P35|CDK5R|NCK5A|p23|p25|p35|p35nck5a	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18409	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18410	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18411	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18412	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18413	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1973	Indirubin-3'-Monoxime	-	-	DRUGBANK	DB02052	C16H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBDSHCUSXQATPO-BGBJRWHRSA-N
18414	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1975	Gabaculine	-	-	DRUGBANK	DB02054	C7H7NO2	small molecule	-	87980-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDUHJPVQKIXHO-UHFFFAOYSA-N
18415	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1975	Gabaculine	-	-	DRUGBANK	DB02054	C7H7NO2	small molecule	-	87980-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDUHJPVQKIXHO-UHFFFAOYSA-N
18416	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1977	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid	-	-	DRUGBANK	DB02056	C20H32O5	small molecule	-	41598-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHMBVRSPMRCCGG-OUTUXVNYSA-N
18417	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1977	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid	-	-	DRUGBANK	DB02056	C20H32O5	small molecule	-	41598-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHMBVRSPMRCCGG-OUTUXVNYSA-N
18418	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1977	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid	-	-	DRUGBANK	DB02056	C20H32O5	small molecule	-	41598-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHMBVRSPMRCCGG-OUTUXVNYSA-N
18419	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1978	(S)-AMPA	(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	-	DRUGBANK	DB02057	C7H10N2O4	small molecule	-	83643-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUDAMDVQRQNNHZ-YFKPBYRVSA-N
18420	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1978	(S)-AMPA	(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	-	DRUGBANK	DB02057	C7H10N2O4	small molecule	-	83643-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUDAMDVQRQNNHZ-YFKPBYRVSA-N
18421	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1978	(S)-AMPA	(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	-	DRUGBANK	DB02057	C7H10N2O4	small molecule	-	83643-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUDAMDVQRQNNHZ-YFKPBYRVSA-N
18422	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	1979	SU4984	-	-	DRUGBANK	DB02058	C20H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZGZGRJOCKSSHA-GOSISDBHSA-N
18423	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1979	SU4984	-	-	DRUGBANK	DB02058	C20H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZGZGRJOCKSSHA-GOSISDBHSA-N
18424	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18425	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18426	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18427	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18428	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18429	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18430	116982	23410	-	SIRT3	SIR2L3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18431	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18432	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18433	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18434	851603	947273	b2799	fucO	ECK2794|JW2770	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18435	851603	947273	b2799	fucO	ECK2794|JW2770	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1980	Adenosine-5-Diphosphoribose	ADPR	-	DRUGBANK	DB02059	C15H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRNWOUGRCWSEMX-ZQSHOCFMSA-N
18436	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18437	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18438	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18439	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18440	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1984	CRA_16847	2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE	-	DRUGBANK	DB02063	C18H12BrN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18441	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1984	CRA_16847	2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE	-	DRUGBANK	DB02063	C18H12BrN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18442	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1984	CRA_16847	2-(3-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL-2-YL}-5-BROMO-4-OXIDOPHENYL)SUCCINATE	-	DRUGBANK	DB02063	C18H12BrN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18443	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1986	N7-Methyl-Formycin A	-	-	DRUGBANK	DB02066	C11H14N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWIUYFGURMAWQD-CPXCQARFSA-N
18444	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1986	N7-Methyl-Formycin A	-	-	DRUGBANK	DB02066	C11H14N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWIUYFGURMAWQD-CPXCQARFSA-N
18445	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1987	Triglu-5-Formyl-Tetrahydrofolate	-	-	DRUGBANK	DB02067	C30H37N9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLOMJLIQXBKNHU-FCGDIQPGSA-N
18446	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1987	Triglu-5-Formyl-Tetrahydrofolate	-	-	DRUGBANK	DB02067	C30H37N9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLOMJLIQXBKNHU-FCGDIQPGSA-N
18447	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1987	Triglu-5-Formyl-Tetrahydrofolate	-	-	DRUGBANK	DB02067	C30H37N9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLOMJLIQXBKNHU-FCGDIQPGSA-N
18448	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1988	Delta-Amino Valeric Acid	-	-	DRUGBANK	DB02068	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJMDCOVWQOJGCB-UHFFFAOYSA-O
18449	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1988	Delta-Amino Valeric Acid	-	-	DRUGBANK	DB02068	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJMDCOVWQOJGCB-UHFFFAOYSA-O
18450	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1988	Delta-Amino Valeric Acid	-	-	DRUGBANK	DB02068	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJMDCOVWQOJGCB-UHFFFAOYSA-O
18451	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1988	Delta-Amino Valeric Acid	-	-	DRUGBANK	DB02068	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJMDCOVWQOJGCB-UHFFFAOYSA-O
18452	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1988	Delta-Amino Valeric Acid	-	-	DRUGBANK	DB02068	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJMDCOVWQOJGCB-UHFFFAOYSA-O
18453	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1989	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02069	C14H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULYMHSXFSKOHGH-UHFFFAOYSA-N
18454	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1989	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02069	C14H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULYMHSXFSKOHGH-UHFFFAOYSA-N
18455	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1989	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02069	C14H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULYMHSXFSKOHGH-UHFFFAOYSA-N
18456	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1991	WAY-151693	n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide	-	DRUGBANK	DB02071	C21H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AINJYWXKBKRQSX-UHFFFAOYSA-N
18457	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1991	WAY-151693	n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide	-	DRUGBANK	DB02071	C21H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AINJYWXKBKRQSX-UHFFFAOYSA-N
18458	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1991	WAY-151693	n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide	-	DRUGBANK	DB02071	C21H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AINJYWXKBKRQSX-UHFFFAOYSA-N
18459	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1992	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02072	C10H9NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPDVRWNOCOREGF-UHFFFAOYSA-N
18460	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1992	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02072	C10H9NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPDVRWNOCOREGF-UHFFFAOYSA-N
18461	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1992	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02072	C10H9NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPDVRWNOCOREGF-UHFFFAOYSA-N
18462	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18463	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18464	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18465	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18466	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18467	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18468	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18469	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1993	Biliverdine Ix Alpha	-	-	DRUGBANK	DB02073	C33H33N4O6	small molecule	-	114-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18470	852246	947937	b3437	gntK	ECK3422|JW3400	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18471	852246	947937	b3437	gntK	ECK3422|JW3400	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18472	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18473	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18474	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18475	111247	5226	-	PGD	6PGD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18476	111247	5226	-	PGD	6PGD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18477	111247	5226	-	PGD	6PGD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1996	6-Phosphogluconic Acid	-	-	DRUGBANK	DB02076	C6H13O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIRSGZKFKXLSJQ-MGCNEYSASA-N
18478	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18479	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18480	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18481	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18482	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18483	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18484	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1998	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	-	-	DRUGBANK	DB02078	C8H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFNKIDBQEZZDLK-UHFFFAOYSA-N
18485	111238	5217	-	PFN2	D3S1319E|PFL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1998	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	-	-	DRUGBANK	DB02078	C8H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFNKIDBQEZZDLK-UHFFFAOYSA-N
18486	850142	945775	b1209	lolB	ECK1197|JW1200|hemM|ychC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	1998	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	-	-	DRUGBANK	DB02078	C8H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFNKIDBQEZZDLK-UHFFFAOYSA-N
18487	115411	10105	RP11-342M3.4	PPIF	CYP3|CyP-M|Cyp-D|CypD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1998	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	-	-	DRUGBANK	DB02078	C8H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFNKIDBQEZZDLK-UHFFFAOYSA-N
18488	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1999	Aminooxyacetic acid	(aminooxy)acetic acid|AOAA|Carboxymethoxylamine|aminoxyacetic acid|carboxymethoxyamine	-	DRUGBANK	DB02079	C2H5NO3	small molecule	-	645-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRKYASMKDDGHT-UHFFFAOYSA-N
18489	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1999	Aminooxyacetic acid	(aminooxy)acetic acid|AOAA|Carboxymethoxylamine|aminoxyacetic acid|carboxymethoxyamine	-	DRUGBANK	DB02079	C2H5NO3	small molecule	-	645-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRKYASMKDDGHT-UHFFFAOYSA-N
18490	851379	947040	b2568	lepB	ECK2566|JW2552|lep	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2000	1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene	-	-	DRUGBANK	DB02080	C21H36O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEUDUECKTWTQQR-UHFFFAOYSA-N
18491	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2000	1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene	-	-	DRUGBANK	DB02080	C21H36O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEUDUECKTWTQQR-UHFFFAOYSA-N
18492	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2001	Bis-Benzamidine	-	-	DRUGBANK	DB02081	C23H28N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXYGSMRTHHSAHZ-WOJBJXKFSA-N
18493	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2001	Bis-Benzamidine	-	-	DRUGBANK	DB02081	C23H28N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXYGSMRTHHSAHZ-WOJBJXKFSA-N
18494	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2001	Bis-Benzamidine	-	-	DRUGBANK	DB02081	C23H28N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXYGSMRTHHSAHZ-WOJBJXKFSA-N
18495	119719	51762	-	RAB8B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2002	Phosphoaminophosphonic Acid Guanylate Ester	-	-	DRUGBANK	DB02082	C10H17N6O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQABYHGXWYXDTK-BZKDHIKHSA-N
18496	119719	51762	-	RAB8B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2002	Phosphoaminophosphonic Acid Guanylate Ester	-	-	DRUGBANK	DB02082	C10H17N6O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQABYHGXWYXDTK-BZKDHIKHSA-N
18497	119719	51762	-	RAB8B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2002	Phosphoaminophosphonic Acid Guanylate Ester	-	-	DRUGBANK	DB02082	C10H17N6O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQABYHGXWYXDTK-BZKDHIKHSA-N
18498	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2004	CRA_17312	-	-	DRUGBANK	DB02084	C25H19N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18499	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2004	CRA_17312	-	-	DRUGBANK	DB02084	C25H19N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18500	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2004	CRA_17312	-	-	DRUGBANK	DB02084	C25H19N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18501	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2007	3,5-Difluorobenzenesulfonamide	-	-	DRUGBANK	DB02087	C6H5F2NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKQPOVUFDWKPNO-UHFFFAOYSA-N
18502	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2007	3,5-Difluorobenzenesulfonamide	-	-	DRUGBANK	DB02087	C6H5F2NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKQPOVUFDWKPNO-UHFFFAOYSA-N
18503	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2008	Norleucine Phosphonate	-	-	DRUGBANK	DB02088	C5H14NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXTPDFMZKSLVRK-RXMQYKEDSA-N
18504	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2008	Norleucine Phosphonate	-	-	DRUGBANK	DB02088	C5H14NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXTPDFMZKSLVRK-RXMQYKEDSA-N
18505	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2009	CP-526423	bis[5-chloro-1h-indol-2-yl-carbonyl-aminoethyl]-ethylene glycol|1,2-bis(2-(5-chloroindole-2-carbonylamino)ethoxy)ethane	-	DRUGBANK	DB02089	C24H24Cl2N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWWXABBBAPKJDX-UHFFFAOYSA-N
18506	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2009	CP-526423	bis[5-chloro-1h-indol-2-yl-carbonyl-aminoethyl]-ethylene glycol|1,2-bis(2-(5-chloroindole-2-carbonylamino)ethoxy)ethane	-	DRUGBANK	DB02089	C24H24Cl2N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWWXABBBAPKJDX-UHFFFAOYSA-N
18507	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2010	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	-	-	DRUGBANK	DB02090	C20H37N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLEGVELHGVWFGG-BBWFWOEESA-N
18508	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2010	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	-	-	DRUGBANK	DB02090	C20H37N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLEGVELHGVWFGG-BBWFWOEESA-N
18509	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2010	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	-	-	DRUGBANK	DB02090	C20H37N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLEGVELHGVWFGG-BBWFWOEESA-N
18510	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18511	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18512	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18513	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2011	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB02091	C9H10N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTFDMGIBHFQWKB-UHFFFAOYSA-N
18514	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2013	5-Phospho-D-Arabinohydroxamic Acid	-	-	DRUGBANK	DB02093	C5H12NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHQFMJPEBPCIEQ-PZGQECOJSA-N
18515	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2013	5-Phospho-D-Arabinohydroxamic Acid	-	-	DRUGBANK	DB02093	C5H12NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHQFMJPEBPCIEQ-PZGQECOJSA-N
18516	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2013	5-Phospho-D-Arabinohydroxamic Acid	-	-	DRUGBANK	DB02093	C5H12NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHQFMJPEBPCIEQ-PZGQECOJSA-N
18517	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2014	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	-	-	DRUGBANK	DB02094	C7H10BNO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXAPSUDMBNWYNC-UHFFFAOYSA-N
18518	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2014	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	-	-	DRUGBANK	DB02094	C7H10BNO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXAPSUDMBNWYNC-UHFFFAOYSA-N
18519	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2014	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	-	-	DRUGBANK	DB02094	C7H10BNO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXAPSUDMBNWYNC-UHFFFAOYSA-N
18520	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2016	FR221647	1-[(2R)-1-hydroxy-4-phenylbutan-2-yl]-1H-imidazole-4-carboxamide	-	DRUGBANK	DB02096	C14H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUYUIKKHHBEVHL-GFCCVEGCSA-N
18521	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2017	Cytidine	-	-	DRUGBANK	DB02097	C9H13N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHDGCWIWMRVCDJ-ZAKLUEHWSA-N
18522	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2017	Cytidine	-	-	DRUGBANK	DB02097	C9H13N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHDGCWIWMRVCDJ-ZAKLUEHWSA-N
18523	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18524	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18525	111965	6036	-	RNASE2	EDN|RAF3|RNS2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18526	111965	6036	-	RNASE2	EDN|RAF3|RNS2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18527	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18528	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18529	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2018	Adenosine-2'-5'-Diphosphate	-	-	DRUGBANK	DB02098	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEOBEOJCBAYXBA-FCIPNVEPSA-N
18530	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2021	(S,R)-fidarestat	(2S,4R)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione|Fidarestat(stereoisomer)	-	DRUGBANK	DB02101	C12H10FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAAPEIZFCHNLKK-QPUJVOFHSA-N
18531	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2021	(S,R)-fidarestat	(2S,4R)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione|Fidarestat(stereoisomer)	-	DRUGBANK	DB02101	C12H10FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAAPEIZFCHNLKK-QPUJVOFHSA-N
18532	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2023	2-Chlorodideoxyadenosine	-	-	DRUGBANK	DB02103	C10H12ClN5O2	small molecule	-	114849-58-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNLILOONPKMGST-NTSWFWBYSA-N
18533	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2024	2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB02104	C19H24N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGMMEYCSOZKIT-UHFFFAOYSA-N
18534	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2024	2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB02104	C19H24N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGMMEYCSOZKIT-UHFFFAOYSA-N
18535	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2024	2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB02104	C19H24N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGMMEYCSOZKIT-UHFFFAOYSA-N
18536	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2025	3,5-Dinitrocatechol	-	-	DRUGBANK	DB02105	C6H4N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDCDWNDTNSWDFJ-UHFFFAOYSA-N
18537	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2025	3,5-Dinitrocatechol	-	-	DRUGBANK	DB02105	C6H4N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDCDWNDTNSWDFJ-UHFFFAOYSA-N
18538	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2025	3,5-Dinitrocatechol	-	-	DRUGBANK	DB02105	C6H4N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDCDWNDTNSWDFJ-UHFFFAOYSA-N
18539	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2026	[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid	-	-	DRUGBANK	DB02106	C23H23Br2NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIRQJXNQGZAKGR-HSZRJFAPSA-N
18540	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2026	[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid	-	-	DRUGBANK	DB02106	C23H23Br2NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIRQJXNQGZAKGR-HSZRJFAPSA-N
18541	135647	404203	UNQ844/PRO1782	SPINK6	BUSI2|UNQ844	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2027	Leucine - Reduced Carbonyl	-	-	DRUGBANK	DB02107	C6H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBMPKNTYKDYCG-ZCFIWIBFSA-N
18542	135647	404203	UNQ844/PRO1782	SPINK6	BUSI2|UNQ844	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2027	Leucine - Reduced Carbonyl	-	-	DRUGBANK	DB02107	C6H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBMPKNTYKDYCG-ZCFIWIBFSA-N
18543	135647	404203	UNQ844/PRO1782	SPINK6	BUSI2|UNQ844	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2027	Leucine - Reduced Carbonyl	-	-	DRUGBANK	DB02107	C6H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNBMPKNTYKDYCG-ZCFIWIBFSA-N
18544	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2028	2-Aminoethanimidic Acid	-	-	DRUGBANK	DB02108	C2H6N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXQVKDQRBAXYBP-UHFFFAOYSA-N
18545	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2028	2-Aminoethanimidic Acid	-	-	DRUGBANK	DB02108	C2H6N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXQVKDQRBAXYBP-UHFFFAOYSA-N
18546	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2029	Hadacidin	-	-	DRUGBANK	DB02109	C3H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJHVPKUWOUENU-UHFFFAOYSA-N
18547	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2029	Hadacidin	-	-	DRUGBANK	DB02109	C3H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJHVPKUWOUENU-UHFFFAOYSA-N
18548	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2029	Hadacidin	-	-	DRUGBANK	DB02109	C3H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJHVPKUWOUENU-UHFFFAOYSA-N
18549	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2029	Hadacidin	-	-	DRUGBANK	DB02109	C3H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJHVPKUWOUENU-UHFFFAOYSA-N
18550	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2029	Hadacidin	-	-	DRUGBANK	DB02109	C3H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJHVPKUWOUENU-UHFFFAOYSA-N
18551	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18552	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18553	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18554	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18555	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18556	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18557	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2032	Zk-806450	-	-	DRUGBANK	DB02112	C31H31N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLGSWPXZYDHBD-UHFFFAOYSA-N
18558	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2032	Zk-806450	-	-	DRUGBANK	DB02112	C31H31N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLGSWPXZYDHBD-UHFFFAOYSA-N
18559	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2032	Zk-806450	-	-	DRUGBANK	DB02112	C31H31N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLGSWPXZYDHBD-UHFFFAOYSA-N
18560	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2033	6-Methylpurine	-	-	DRUGBANK	DB02113	C6H6N4	small molecule	-	2004-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYMHUEFSSMBHJA-UHFFFAOYSA-N
18561	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2033	6-Methylpurine	-	-	DRUGBANK	DB02113	C6H6N4	small molecule	-	2004-03-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYMHUEFSSMBHJA-UHFFFAOYSA-N
18562	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2034	Para-Isopropylaniline	-	-	DRUGBANK	DB02114	C9H13N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRTFPLFDLJYEKT-UHFFFAOYSA-N
18563	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2034	Para-Isopropylaniline	-	-	DRUGBANK	DB02114	C9H13N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRTFPLFDLJYEKT-UHFFFAOYSA-N
18564	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2034	Para-Isopropylaniline	-	-	DRUGBANK	DB02114	C9H13N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRTFPLFDLJYEKT-UHFFFAOYSA-N
18565	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2035	Daidzin	Daidzoside|7-O-B-D-GLUCOPYRANOSIDE|Daidzein-7-glucoside|Daidzein 7-glucoside|Daidzein 7-O-glucoside|7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-chromen-4-one|4',7-Dihydroxyisoflavone	-	DRUGBANK	DB02115	C21H20O9	small molecule	-	552-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYQZWONCHDNPDP-QNDFHXLGSA-N
18566	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2035	Daidzin	Daidzoside|7-O-B-D-GLUCOPYRANOSIDE|Daidzein-7-glucoside|Daidzein 7-glucoside|Daidzein 7-O-glucoside|7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-chromen-4-one|4',7-Dihydroxyisoflavone	-	DRUGBANK	DB02115	C21H20O9	small molecule	-	552-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYQZWONCHDNPDP-QNDFHXLGSA-N
18567	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2035	Daidzin	Daidzoside|7-O-B-D-GLUCOPYRANOSIDE|Daidzein-7-glucoside|Daidzein 7-glucoside|Daidzein 7-O-glucoside|7-(beta-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-(beta-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-chromen-4-one|4',7-Dihydroxyisoflavone	-	DRUGBANK	DB02115	C21H20O9	small molecule	-	552-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYQZWONCHDNPDP-QNDFHXLGSA-N
18568	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18569	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18570	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18571	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18572	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18573	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18574	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2036	Olomoucine	-	-	DRUGBANK	DB02116	C15H18N6O	small molecule	-	101622-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTVPOLSIJWJJNY-UHFFFAOYSA-N
18575	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2037	CP-271485	2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) ethyl-4-(4'-ethoxy [1,1'-biphenyl]-4-yl)-4-oxobutanoic acid|(6R)-4-BENZYL-6-(1-METHYL-2,2-DIOXIDO-1,3-DIHYDRO-2,1-BENZISOTHIAZOL-5-YL)MORPHOLIN-3-ONE	-	DRUGBANK	DB02118	C19H20N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIUMOGWIMXNXSQ-GOSISDBHSA-N
18576	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2037	CP-271485	2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) ethyl-4-(4'-ethoxy [1,1'-biphenyl]-4-yl)-4-oxobutanoic acid|(6R)-4-BENZYL-6-(1-METHYL-2,2-DIOXIDO-1,3-DIHYDRO-2,1-BENZISOTHIAZOL-5-YL)MORPHOLIN-3-ONE	-	DRUGBANK	DB02118	C19H20N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIUMOGWIMXNXSQ-GOSISDBHSA-N
18577	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2037	CP-271485	2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl) ethyl-4-(4'-ethoxy [1,1'-biphenyl]-4-yl)-4-oxobutanoic acid|(6R)-4-BENZYL-6-(1-METHYL-2,2-DIOXIDO-1,3-DIHYDRO-2,1-BENZISOTHIAZOL-5-YL)MORPHOLIN-3-ONE	-	DRUGBANK	DB02118	C19H20N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIUMOGWIMXNXSQ-GOSISDBHSA-N
18578	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2038	6-Hydroxymethyl-7,8-Dihydropterin	-	-	DRUGBANK	DB02119	C7H9N5O2	small molecule	-	3672-03-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQQNNQTXUGLUEV-UHFFFAOYSA-N
18579	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2038	6-Hydroxymethyl-7,8-Dihydropterin	-	-	DRUGBANK	DB02119	C7H9N5O2	small molecule	-	3672-03-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQQNNQTXUGLUEV-UHFFFAOYSA-N
18580	855974	938356	BSU03040	amyE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2039	6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol	-	-	DRUGBANK	DB02120	C7H13NO4	small molecule	-	38231-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPHOBMULWMGEBA-WNJXEPBRSA-N
18581	855974	938356	BSU03040	amyE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2039	6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol	-	-	DRUGBANK	DB02120	C7H13NO4	small molecule	-	38231-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPHOBMULWMGEBA-WNJXEPBRSA-N
18582	850511	946151	b1619	hdhA	ECK1614|JW1611|hsd|hsdH	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2042	Glycochenodeoxycholic Acid	-	-	DRUGBANK	DB02123	C26H43NO5	small molecule	-	640-79-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHCZAUBVMUEKKP-GYPHWSFCSA-N
18583	850511	946151	b1619	hdhA	ECK1614|JW1611|hsd|hsdH	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2042	Glycochenodeoxycholic Acid	-	-	DRUGBANK	DB02123	C26H43NO5	small molecule	-	640-79-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHCZAUBVMUEKKP-GYPHWSFCSA-N
18584	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2045	4-Carboxycinnamic Acid	-	-	DRUGBANK	DB02126	C10H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAEJSGLKJYIYTB-ZZXKWVIFSA-N
18585	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2045	4-Carboxycinnamic Acid	-	-	DRUGBANK	DB02126	C10H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAEJSGLKJYIYTB-ZZXKWVIFSA-N
18586	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2048	Dihydroorotic Acid	-	-	DRUGBANK	DB02129	C5H6N2O4	small molecule	-	155-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFIVEPVSAGBUSI-REOHCLBHSA-N
18587	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2048	Dihydroorotic Acid	-	-	DRUGBANK	DB02129	C5H6N2O4	small molecule	-	155-54-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFIVEPVSAGBUSI-REOHCLBHSA-N
18588	852839	948545	b4039	ubiC	ECK4031|JW5713|sdgG?	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2049	4-Hydroxy-3-Methoxybenzoate	-	-	DRUGBANK	DB02130	C8H7O4	small molecule	-	121-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKOLLVMJNQIZCI-UHFFFAOYSA-M
18589	852839	948545	b4039	ubiC	ECK4031|JW5713|sdgG?	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2049	4-Hydroxy-3-Methoxybenzoate	-	-	DRUGBANK	DB02130	C8H7O4	small molecule	-	121-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKOLLVMJNQIZCI-UHFFFAOYSA-M
18590	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2050	N-1-Methylheptylformamide	-	-	DRUGBANK	DB02131	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWFHDUFNGSJLTL-VIFPVBQESA-N
18591	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2050	N-1-Methylheptylformamide	-	-	DRUGBANK	DB02131	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWFHDUFNGSJLTL-VIFPVBQESA-N
18592	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2051	[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid	-	-	DRUGBANK	DB02132	C17H11BrClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXONDGSPUVNZLO-UHFFFAOYSA-N
18593	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2051	[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid	-	-	DRUGBANK	DB02132	C17H11BrClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXONDGSPUVNZLO-UHFFFAOYSA-N
18594	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2051	[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid	-	-	DRUGBANK	DB02132	C17H11BrClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXONDGSPUVNZLO-UHFFFAOYSA-N
18595	851218	946878	b2407	xapA	ECK2401|JW2398|pndA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2053	Xanthine	-	-	DRUGBANK	DB02134	C5H4N4O2	small molecule	-	69-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRFVTYWOQMYALW-UHFFFAOYSA-N
18596	851218	946878	b2407	xapA	ECK2401|JW2398|pndA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2053	Xanthine	-	-	DRUGBANK	DB02134	C5H4N4O2	small molecule	-	69-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRFVTYWOQMYALW-UHFFFAOYSA-N
18597	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2053	Xanthine	-	-	DRUGBANK	DB02134	C5H4N4O2	small molecule	-	69-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRFVTYWOQMYALW-UHFFFAOYSA-N
18598	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2053	Xanthine	-	-	DRUGBANK	DB02134	C5H4N4O2	small molecule	-	69-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRFVTYWOQMYALW-UHFFFAOYSA-N
18599	107892	1512	-	CTSH	ACC-4|ACC-5|CPSB|minichain	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2059	N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide	-	-	DRUGBANK	DB02140	C22H26N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPFPZRVOBBMZMP-SFHVURJKSA-N
18600	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2060	S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	-	-	DRUGBANK	DB02141	C12H18N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZWGDUUJDZCYJR-UHFFFAOYSA-N
18601	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18602	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18603	852375	948067	b2662	gabT	ECK2656|JW2637	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18604	852375	948067	b2662	gabT	ECK2656|JW2637	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18605	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18606	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18607	850898	946551	b2021	hisC	ECK2016|JW2003	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18608	850898	946551	b2021	hisC	ECK2016|JW2003	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
18609	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18610	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18611	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18612	111323	5306	-	PITPNA	HEL-S-36|PI-TPalpha|PITPN|VIB1A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2063	1,2-Diacyl-Sn-Glycero-3-Phosphoinositol	-	-	DRUGBANK	DB02144	C43H80O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDLAMJKMOKWLAJ-KGUAWZMVSA-M
18613	111323	5306	-	PITPNA	HEL-S-36|PI-TPalpha|PITPN|VIB1A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2063	1,2-Diacyl-Sn-Glycero-3-Phosphoinositol	-	-	DRUGBANK	DB02144	C43H80O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDLAMJKMOKWLAJ-KGUAWZMVSA-M
18614	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18615	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18616	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2067	3-Amino-4-Oxybenzyl-2-Butanone	-	-	DRUGBANK	DB02148	C11H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISLRAQPEXPIKDJ-NSHDSACASA-N
18617	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2068	Methionine Phosphonate	-	-	DRUGBANK	DB02151	C4H12NO3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKCSXHUCPYVQIW-SCSAIBSYSA-N
18618	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2068	Methionine Phosphonate	-	-	DRUGBANK	DB02151	C4H12NO3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKCSXHUCPYVQIW-SCSAIBSYSA-N
18619	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2068	Methionine Phosphonate	-	-	DRUGBANK	DB02151	C4H12NO3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKCSXHUCPYVQIW-SCSAIBSYSA-N
18620	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2068	Methionine Phosphonate	-	-	DRUGBANK	DB02151	C4H12NO3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKCSXHUCPYVQIW-SCSAIBSYSA-N
18621	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2069	K-252a	-	-	DRUGBANK	DB02152	C27H21N3O5	small molecule	-	97161-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOZFSFOOLUUIGY-SOLYNIJKSA-N
18622	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2069	K-252a	-	-	DRUGBANK	DB02152	C27H21N3O5	small molecule	-	97161-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOZFSFOOLUUIGY-SOLYNIJKSA-N
18623	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2069	K-252a	-	-	DRUGBANK	DB02152	C27H21N3O5	small molecule	-	97161-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOZFSFOOLUUIGY-SOLYNIJKSA-N
18624	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2069	K-252a	-	-	DRUGBANK	DB02152	C27H21N3O5	small molecule	-	97161-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOZFSFOOLUUIGY-SOLYNIJKSA-N
18625	856605	939005	BSU22690	aroH	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18626	856605	939005	BSU22690	aroH	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18627	850522	946162	b1636	pdxY	ECK1632|JW1628|ydgS	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18628	850522	946162	b1636	pdxY	ECK1632|JW1628|ydgS	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18629	112860	7001	-	PRDX2	HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18630	112860	7001	-	PRDX2	HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18631	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18632	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18633	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18634	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18635	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2070	3-Sulfinoalanine	S-Cysteinesulfinic acid|S-Sulfinocysteine	-	DRUGBANK	DB02153	C3H7NO4S	small molecule	-	1115-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADVPTQAUNPRNPO-REOHCLBHSA-N
18636	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2072	Balanol Analog 8	-	-	DRUGBANK	DB02155	C32H36N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLMXAUKCDSMMW-WBZRNCBQSA-N
18637	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2072	Balanol Analog 8	-	-	DRUGBANK	DB02155	C32H36N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLMXAUKCDSMMW-WBZRNCBQSA-N
18638	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2072	Balanol Analog 8	-	-	DRUGBANK	DB02155	C32H36N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLMXAUKCDSMMW-WBZRNCBQSA-N
18639	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2074	(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol	-	-	DRUGBANK	DB02158	C12H19N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLCQGEBEQIBOOJ-XKBJCNPTSA-N
18640	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2074	(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol	-	-	DRUGBANK	DB02158	C12H19N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLCQGEBEQIBOOJ-XKBJCNPTSA-N
18641	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2074	(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol	-	-	DRUGBANK	DB02158	C12H19N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLCQGEBEQIBOOJ-XKBJCNPTSA-N
18642	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2074	(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol	-	-	DRUGBANK	DB02158	C12H19N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLCQGEBEQIBOOJ-XKBJCNPTSA-N
18643	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2075	(R)-Propylene glycol	R-1,2-propanediol	-	DRUGBANK	DB02159	C3H8O2	small molecule	-	4254-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-GSVOUGTGSA-N
18644	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2075	(R)-Propylene glycol	R-1,2-propanediol	-	DRUGBANK	DB02159	C3H8O2	small molecule	-	4254-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-GSVOUGTGSA-N
18645	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2077	Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester	-	-	DRUGBANK	DB02161	C16H21NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTVIKZXZYLEVOL-CBBWQLFWSA-N
18646	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2078	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02162	C12H18N6O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONCSLXAPOGUODU-FNQQPIMXSA-N
18647	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2078	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02162	C12H18N6O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONCSLXAPOGUODU-FNQQPIMXSA-N
18648	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2078	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02162	C12H18N6O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONCSLXAPOGUODU-FNQQPIMXSA-N
18649	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2080	N-Sulfo-Flavin Mononucleotide	-	-	DRUGBANK	DB02164	C17H21N4O12PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLPUGFBBLGQWBS-YRGRVCCFSA-N
18650	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2080	N-Sulfo-Flavin Mononucleotide	-	-	DRUGBANK	DB02164	C17H21N4O12PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLPUGFBBLGQWBS-YRGRVCCFSA-N
18651	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2080	N-Sulfo-Flavin Mononucleotide	-	-	DRUGBANK	DB02164	C17H21N4O12PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLPUGFBBLGQWBS-YRGRVCCFSA-N
18652	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2081	Zinc Trihydroxide	-	-	DRUGBANK	DB02165	H3O3Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTXMHASAYZWVCS-UHFFFAOYSA-K
18653	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2081	Zinc Trihydroxide	-	-	DRUGBANK	DB02165	H3O3Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTXMHASAYZWVCS-UHFFFAOYSA-K
18654	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2082	Propidium	-	-	DRUGBANK	DB02166	C27H34N4	small molecule	-	36015-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDWVWKDAWBGPDN-UHFFFAOYSA-O
18655	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2082	Propidium	-	-	DRUGBANK	DB02166	C27H34N4	small molecule	-	36015-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDWVWKDAWBGPDN-UHFFFAOYSA-O
18656	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2082	Propidium	-	-	DRUGBANK	DB02166	C27H34N4	small molecule	-	36015-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDWVWKDAWBGPDN-UHFFFAOYSA-O
18657	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2085	9,10-Deepithio-9,10-Didehydroacanthifolicin	-	-	DRUGBANK	DB02169	C44H68O13	small molecule	-	78111-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNDVLZJODHBUFM-NHKYITFXSA-N
18658	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2085	9,10-Deepithio-9,10-Didehydroacanthifolicin	-	-	DRUGBANK	DB02169	C44H68O13	small molecule	-	78111-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNDVLZJODHBUFM-NHKYITFXSA-N
18659	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2085	9,10-Deepithio-9,10-Didehydroacanthifolicin	-	-	DRUGBANK	DB02169	C44H68O13	small molecule	-	78111-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNDVLZJODHBUFM-NHKYITFXSA-N
18660	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2086	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	-	-	DRUGBANK	DB02170	C13H7NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOHCDJRFYXKEQW-UHFFFAOYSA-N
18661	849667	945290	b0678	nagB	ECK0666|JW0664|glmD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2087	D-Fructose-6-Phosphate (Open Form)	-	-	DRUGBANK	DB02171	C6H15O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GACTWZZMVMUKNG-ZXXMMSQZSA-N
18662	849667	945290	b0678	nagB	ECK0666|JW0664|glmD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2087	D-Fructose-6-Phosphate (Open Form)	-	-	DRUGBANK	DB02171	C6H15O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=GACTWZZMVMUKNG-ZXXMMSQZSA-N
18663	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18664	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18665	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18666	853625	935930	BSU34100	rsbQ	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18667	853625	935930	BSU34100	rsbQ	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2091	Malonic acid	Propanedioic acid|Malonate	-	DRUGBANK	DB02175	C3H4O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-N
18668	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2093	1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine	-	-	DRUGBANK	DB02177	C25H27N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMYWMMGDMOATRV-UHFFFAOYSA-N
18669	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2093	1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine	-	-	DRUGBANK	DB02177	C25H27N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMYWMMGDMOATRV-UHFFFAOYSA-N
18670	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2094	Phenylacetaldehyde	-	-	DRUGBANK	DB02178	C8H8O	small molecule	-	122-78-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTUQWGWMVIHBKE-UHFFFAOYSA-N
18671	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2094	Phenylacetaldehyde	-	-	DRUGBANK	DB02178	C8H8O	small molecule	-	122-78-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTUQWGWMVIHBKE-UHFFFAOYSA-N
18672	1218551	3635457	C4_01440W_A	NMT1	NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	2096	Myristoyl-Coa	-	-	DRUGBANK	DB02180	C35H62N7O17P3S	small molecule	-	3130-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAFKXOFBZQTQE-IXZVNPRYSA-N
18673	1218551	3635457	C4_01440W_A	NMT1	NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	2096	Myristoyl-Coa	-	-	DRUGBANK	DB02180	C35H62N7O17P3S	small molecule	-	3130-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAFKXOFBZQTQE-IXZVNPRYSA-N
18674	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2096	Myristoyl-Coa	-	-	DRUGBANK	DB02180	C35H62N7O17P3S	small molecule	-	3130-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAFKXOFBZQTQE-IXZVNPRYSA-N
18675	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2096	Myristoyl-Coa	-	-	DRUGBANK	DB02180	C35H62N7O17P3S	small molecule	-	3130-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAFKXOFBZQTQE-IXZVNPRYSA-N
18676	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2096	Myristoyl-Coa	-	-	DRUGBANK	DB02180	C35H62N7O17P3S	small molecule	-	3130-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAFKXOFBZQTQE-IXZVNPRYSA-N
18677	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2097	2'-Deoxyguanosine-5'-Triphosphate	-	-	DRUGBANK	DB02181	C10H16N5O13P3	small molecule	-	2564-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAAZLUGHYHWQIW-NGJCXOISSA-N
18678	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2097	2'-Deoxyguanosine-5'-Triphosphate	-	-	DRUGBANK	DB02181	C10H16N5O13P3	small molecule	-	2564-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAAZLUGHYHWQIW-NGJCXOISSA-N
18679	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2097	2'-Deoxyguanosine-5'-Triphosphate	-	-	DRUGBANK	DB02181	C10H16N5O13P3	small molecule	-	2564-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAAZLUGHYHWQIW-NGJCXOISSA-N
18680	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2099	Adenosine-5'-Ditungstate	-	-	DRUGBANK	DB02183	C10H15N5O10W2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIACDJFRUAAXOT-WKUNHNPKSA-K
18681	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2099	Adenosine-5'-Ditungstate	-	-	DRUGBANK	DB02183	C10H15N5O10W2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIACDJFRUAAXOT-WKUNHNPKSA-K
18682	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2101	2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One	-	-	DRUGBANK	DB02185	C9H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GDNZNIJPBQATCZ-SECBINFHSA-N
18683	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2103	Equilin	7-Dehydroestrone|Equilin|Dihydroequilenin|1,3,5,7-Estratetraen-3-ol-17-one	-	DRUGBANK	DB02187	C18H20O2	small molecule	-	474-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKRLQDKEXYKHJB-HFTRVMKXSA-N
18684	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2103	Equilin	7-Dehydroestrone|Equilin|Dihydroequilenin|1,3,5,7-Estratetraen-3-ol-17-one	-	DRUGBANK	DB02187	C18H20O2	small molecule	-	474-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKRLQDKEXYKHJB-HFTRVMKXSA-N
18685	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2103	Equilin	7-Dehydroestrone|Equilin|Dihydroequilenin|1,3,5,7-Estratetraen-3-ol-17-one	-	DRUGBANK	DB02187	C18H20O2	small molecule	-	474-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKRLQDKEXYKHJB-HFTRVMKXSA-N
18686	857353	939772	BSU10130	hemH	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2104	N-Methylmesoporphyrin Containing Copper	-	-	DRUGBANK	DB02188	C35H39CuN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDSHXUIGVQAIDP-ZHZUXMKXSA-M
18687	857353	939772	BSU10130	hemH	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2104	N-Methylmesoporphyrin Containing Copper	-	-	DRUGBANK	DB02188	C35H39CuN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDSHXUIGVQAIDP-ZHZUXMKXSA-M
18688	108127	1791	-	DNTT	TDT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2105	2',3'-Dideoxyadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02189	C10H16N5O11P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAKPWEUQDVLTCN-NKWVEPMBSA-N
18689	108127	1791	-	DNTT	TDT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2105	2',3'-Dideoxyadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02189	C10H16N5O11P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAKPWEUQDVLTCN-NKWVEPMBSA-N
18690	108127	1791	-	DNTT	TDT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2105	2',3'-Dideoxyadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02189	C10H16N5O11P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAKPWEUQDVLTCN-NKWVEPMBSA-N
18691	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2106	2-Oxalosuccinic Acid	-	-	DRUGBANK	DB02190	C6H6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFSCUAXLTRFIDC-UWTATZPHSA-N
18692	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2106	2-Oxalosuccinic Acid	-	-	DRUGBANK	DB02190	C6H6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFSCUAXLTRFIDC-UWTATZPHSA-N
18693	851209	946869	b2412	zipA	ECK2407|JW2404	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2107	(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One	-	-	DRUGBANK	DB02191	C15H16N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGKUSHWBQJPFOP-LBPRGKRZSA-N
18694	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2109	2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB02193	C14H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDVCRKGBQLPJRQ-ZROIWOOFSA-O
18695	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2109	2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB02193	C14H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDVCRKGBQLPJRQ-ZROIWOOFSA-O
18696	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2109	2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB02193	C14H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDVCRKGBQLPJRQ-ZROIWOOFSA-O
18697	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2111	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	-	-	DRUGBANK	DB02195	C18H12FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSMYZLKEZDYVPI-UHFFFAOYSA-N
18698	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2111	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	-	-	DRUGBANK	DB02195	C18H12FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSMYZLKEZDYVPI-UHFFFAOYSA-N
18699	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2111	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	-	-	DRUGBANK	DB02195	C18H12FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSMYZLKEZDYVPI-UHFFFAOYSA-N
18700	850678	946321	b0090	murG	ECK0091|JW0088	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18701	850678	946321	b0090	murG	ECK0091|JW0088	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18702	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18703	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18704	112557	6675	-	UAP1	AGX|AGX1|AGX2|SPAG2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18705	112557	6675	-	UAP1	AGX|AGX1|AGX2|SPAG2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18706	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18707	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18708	849190	944789	b3786	wecB	ECK3778|JW5600|nfrC|rffE|yifF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18709	849190	944789	b3786	wecB	ECK3778|JW5600|nfrC|rffE|yifF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18710	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18711	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18712	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2112	Uridine-Diphosphate-N-Acetylgalactosamine	-	-	DRUGBANK	DB02196	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-NESSUJCYSA-N
18713	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2113	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB02197	C17H14N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKORVPQBJCGYEC-UHFFFAOYSA-N
18714	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2113	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB02197	C17H14N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKORVPQBJCGYEC-UHFFFAOYSA-N
18715	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2113	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB02197	C17H14N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKORVPQBJCGYEC-UHFFFAOYSA-N
18716	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2114	2-Bromoacetyl Group	-	-	DRUGBANK	DB02198	C2H3BrO2	small molecule	-	79-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDPAWGWELVVRCH-UHFFFAOYSA-N
18717	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2114	2-Bromoacetyl Group	-	-	DRUGBANK	DB02198	C2H3BrO2	small molecule	-	79-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDPAWGWELVVRCH-UHFFFAOYSA-N
18718	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2114	2-Bromoacetyl Group	-	-	DRUGBANK	DB02198	C2H3BrO2	small molecule	-	79-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDPAWGWELVVRCH-UHFFFAOYSA-N
18719	112289	6388	-	SDF2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2117	Malonate Ion	-	-	DRUGBANK	DB02201	C3H2O4	small molecule	-	141-82-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFOBLEOULBTSOW-UHFFFAOYSA-L
18720	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2120	6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One	-	-	DRUGBANK	DB02205	C19H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCDLLLXYAICSQV-INIZCTEOSA-N
18721	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18722	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18723	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18724	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18725	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18726	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2121	7-Nitroindazole	-	-	DRUGBANK	DB02207	C7H4N3O2	small molecule	-	2942-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18727	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2122	Pyridoxine-5'-Phosphate	-	-	DRUGBANK	DB02209	C8H12NO6P	small molecule	-	447-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHOMFKWHIQZTHY-UHFFFAOYSA-N
18728	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2122	Pyridoxine-5'-Phosphate	-	-	DRUGBANK	DB02209	C8H12NO6P	small molecule	-	447-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHOMFKWHIQZTHY-UHFFFAOYSA-N
18729	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2122	Pyridoxine-5'-Phosphate	-	-	DRUGBANK	DB02209	C8H12NO6P	small molecule	-	447-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHOMFKWHIQZTHY-UHFFFAOYSA-N
18730	851378	947039	b2564	pdxJ	ECK2562|JW2548	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2122	Pyridoxine-5'-Phosphate	-	-	DRUGBANK	DB02209	C8H12NO6P	small molecule	-	447-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHOMFKWHIQZTHY-UHFFFAOYSA-N
18731	851378	947039	b2564	pdxJ	ECK2562|JW2548	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2122	Pyridoxine-5'-Phosphate	-	-	DRUGBANK	DB02209	C8H12NO6P	small molecule	-	447-05-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHOMFKWHIQZTHY-UHFFFAOYSA-N
18732	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18733	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18734	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18735	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18736	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18737	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18738	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18739	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18740	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2124	N-Methyl-N-Propargyl-1(R)-Aminoindan	-	-	DRUGBANK	DB02211	C13H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSVGVHNFFZWQJU-CYBMUJFWSA-N
18741	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2127	Furoyl-Leucine	-	-	DRUGBANK	DB02215	C11H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXBURZIESWDWIV-QMMMGPOBSA-N
18742	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18743	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18744	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18745	110411	4255	RP11-109A6.1	MGMT	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18746	110411	4255	RP11-109A6.1	MGMT	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2128	S-Methylcysteine	-	-	DRUGBANK	DB02216	C4H9NO2S	small molecule	-	1187-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDIDJDIHTAOVLG-VKHMYHEASA-N
18747	121277	56953	-	NT5M	dNT-2|dNT2|mdN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2129	Dpb-T	-	-	DRUGBANK	DB02217	C17H19N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTZFKHNHHRPQOU-WSMBLCCSSA-N
18748	121277	56953	-	NT5M	dNT-2|dNT2|mdN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2129	Dpb-T	-	-	DRUGBANK	DB02217	C17H19N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTZFKHNHHRPQOU-WSMBLCCSSA-N
18749	121277	56953	-	NT5M	dNT-2|dNT2|mdN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2129	Dpb-T	-	-	DRUGBANK	DB02217	C17H19N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTZFKHNHHRPQOU-WSMBLCCSSA-N
18750	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2130	N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside	-	-	DRUGBANK	DB02218	C13H23NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RBZIIHWPZWOIDU-IJZUXERNSA-N
18751	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2130	N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside	-	-	DRUGBANK	DB02218	C13H23NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RBZIIHWPZWOIDU-IJZUXERNSA-N
18752	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2130	N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside	-	-	DRUGBANK	DB02218	C13H23NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RBZIIHWPZWOIDU-IJZUXERNSA-N
18753	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2132	Al7089a	-	-	DRUGBANK	DB02220	C14H17N3O5S3	small molecule	-	220402-83-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOXCYSVWCHXII-LBPRGKRZSA-N
18754	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2132	Al7089a	-	-	DRUGBANK	DB02220	C14H17N3O5S3	small molecule	-	220402-83-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOXCYSVWCHXII-LBPRGKRZSA-N
18755	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2132	Al7089a	-	-	DRUGBANK	DB02220	C14H17N3O5S3	small molecule	-	220402-83-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOXCYSVWCHXII-LBPRGKRZSA-N
18756	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2133	4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02221	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVTYOTODFLDHRL-UHFFFAOYSA-N
18757	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2133	4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02221	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVTYOTODFLDHRL-UHFFFAOYSA-N
18758	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2133	4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02221	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVTYOTODFLDHRL-UHFFFAOYSA-N
18759	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2134	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	-	-	DRUGBANK	DB02222	C9H13N6O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWEKFDHXJHJYGB-YFKPBYRVSA-L
18760	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2134	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	-	-	DRUGBANK	DB02222	C9H13N6O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWEKFDHXJHJYGB-YFKPBYRVSA-L
18761	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2134	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	-	-	DRUGBANK	DB02222	C9H13N6O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWEKFDHXJHJYGB-YFKPBYRVSA-L
18762	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2135	Ly231514 Tetra Glu	-	-	DRUGBANK	DB02223	C35H41N8O15	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQPYXDMJABUDJG-CLAROIROSA-N
18763	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2135	Ly231514 Tetra Glu	-	-	DRUGBANK	DB02223	C35H41N8O15	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQPYXDMJABUDJG-CLAROIROSA-N
18764	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2138	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	-	-	DRUGBANK	DB02226	C42H45N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAARZDJZGYBXKL-UHFFFAOYSA-O
18765	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2138	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	-	-	DRUGBANK	DB02226	C42H45N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAARZDJZGYBXKL-UHFFFAOYSA-O
18766	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2138	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	-	-	DRUGBANK	DB02226	C42H45N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAARZDJZGYBXKL-UHFFFAOYSA-O
18769	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2141	5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine	-	-	DRUGBANK	DB02229	C15H25N7O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQDXXTAOGLOMRP-JJWYTCDVSA-N
18770	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2141	5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine	-	-	DRUGBANK	DB02229	C15H25N7O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQDXXTAOGLOMRP-JJWYTCDVSA-N
18771	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2142	Immucillin-G	-	-	DRUGBANK	DB02230	C11H14N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIPPVMAGWLJAHY-VQVVZVRGSA-N
18772	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2142	Immucillin-G	-	-	DRUGBANK	DB02230	C11H14N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIPPVMAGWLJAHY-VQVVZVRGSA-N
18773	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18774	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18775	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18776	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18777	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18778	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2145	Ethylisothiourea	-	-	DRUGBANK	DB02234	C3H8N2S	small molecule	-	1071-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
18779	106848	351	-	APP	AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2146	L-methionine (R)-S-oxide	Methionine Sulfoxide	-	DRUGBANK	DB02235	C5H11NO3S	small molecule	-	62697-73-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFRNWWLZKMPFJ-ZXPFJRLXSA-N
18780	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2147	Glycinamide Ribonucleotide	-	-	DRUGBANK	DB02236	C7H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQMLSFOUZUIOB-DOAVWBMOSA-L
18781	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2147	Glycinamide Ribonucleotide	-	-	DRUGBANK	DB02236	C7H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQMLSFOUZUIOB-DOAVWBMOSA-L
18782	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2147	Glycinamide Ribonucleotide	-	-	DRUGBANK	DB02236	C7H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQMLSFOUZUIOB-DOAVWBMOSA-L
18783	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2147	Glycinamide Ribonucleotide	-	-	DRUGBANK	DB02236	C7H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQMLSFOUZUIOB-DOAVWBMOSA-L
18784	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2147	Glycinamide Ribonucleotide	-	-	DRUGBANK	DB02236	C7H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQMLSFOUZUIOB-DOAVWBMOSA-L
18785	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2147	Glycinamide Ribonucleotide	-	-	DRUGBANK	DB02236	C7H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQMLSFOUZUIOB-DOAVWBMOSA-L
18786	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2150	Laevulinic Acid	-	-	DRUGBANK	DB02239	C5H8O3	small molecule	-	123-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOOXCMJARBKPKM-UHFFFAOYSA-N
18787	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2150	Laevulinic Acid	-	-	DRUGBANK	DB02239	C5H8O3	small molecule	-	123-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOOXCMJARBKPKM-UHFFFAOYSA-N
18788	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2150	Laevulinic Acid	-	-	DRUGBANK	DB02239	C5H8O3	small molecule	-	123-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOOXCMJARBKPKM-UHFFFAOYSA-N
18789	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2154	4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide	-	-	DRUGBANK	DB02243	C31H42N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBHNKJTHNHXQT-OIWPGSPOSA-N
18790	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2154	4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide	-	-	DRUGBANK	DB02243	C31H42N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBHNKJTHNHXQT-OIWPGSPOSA-N
18791	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2156	Hydrolyzed Cephalothin	-	-	DRUGBANK	DB02247	C14H16N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRYZEMHNDUZNMI-RYUDHWBXSA-N
18792	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2156	Hydrolyzed Cephalothin	-	-	DRUGBANK	DB02247	C14H16N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRYZEMHNDUZNMI-RYUDHWBXSA-N
18793	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2156	Hydrolyzed Cephalothin	-	-	DRUGBANK	DB02247	C14H16N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRYZEMHNDUZNMI-RYUDHWBXSA-N
18794	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2158	2-Ethoxyethanol	-	-	DRUGBANK	DB02249	C4H10O2	small molecule	-	110-80-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNQVEEAIQZEUHB-UHFFFAOYSA-N
18795	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2158	2-Ethoxyethanol	-	-	DRUGBANK	DB02249	C4H10O2	small molecule	-	110-80-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNQVEEAIQZEUHB-UHFFFAOYSA-N
18796	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2158	2-Ethoxyethanol	-	-	DRUGBANK	DB02249	C4H10O2	small molecule	-	110-80-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNQVEEAIQZEUHB-UHFFFAOYSA-N
18797	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2159	Cu-Bicyclam	-	-	DRUGBANK	DB02250	C28H48Cu2N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXKCQEUBRKEWMQ-UHFFFAOYSA-N
18798	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2159	Cu-Bicyclam	-	-	DRUGBANK	DB02250	C28H48Cu2N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXKCQEUBRKEWMQ-UHFFFAOYSA-N
18799	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2159	Cu-Bicyclam	-	-	DRUGBANK	DB02250	C28H48Cu2N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXKCQEUBRKEWMQ-UHFFFAOYSA-N
18800	851075	946734	b2261	menC	ECK2255|JW2256	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2160	O-Succinylbenzoate	-	-	DRUGBANK	DB02251	C11H10O5	small molecule	-	27415-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YIVWQNVQRXFZJB-UHFFFAOYSA-N
18801	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2163	Trifluoro-thiamin phosphate	FTP	-	DRUGBANK	DB02254	C12H13F3N4O4PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIBIECXVPMYJCV-UHFFFAOYSA-M
18802	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2163	Trifluoro-thiamin phosphate	FTP	-	DRUGBANK	DB02254	C12H13F3N4O4PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIBIECXVPMYJCV-UHFFFAOYSA-M
18803	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2164	Ilomastat	GM6001|Galardin	-	DRUGBANK	DB02255	C20H28N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NITYDPDXAAFEIT-DYVFJYSZSA-N
18804	106684	176	-	ACAN	AGC1|AGCAN|CSPG1|CSPGCP|MSK16|SEDK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2164	Ilomastat	GM6001|Galardin	-	DRUGBANK	DB02255	C20H28N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NITYDPDXAAFEIT-DYVFJYSZSA-N
18805	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2165	2'-Deoxyuridine	-	-	DRUGBANK	DB02256	C9H12N2O5	small molecule	-	951-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXHRCPNRJAMMIM-BBVRLYRLSA-N
18806	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2165	2'-Deoxyuridine	-	-	DRUGBANK	DB02256	C9H12N2O5	small molecule	-	951-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXHRCPNRJAMMIM-BBVRLYRLSA-N
18807	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2165	2'-Deoxyuridine	-	-	DRUGBANK	DB02256	C9H12N2O5	small molecule	-	951-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXHRCPNRJAMMIM-BBVRLYRLSA-N
18808	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2165	2'-Deoxyuridine	-	-	DRUGBANK	DB02256	C9H12N2O5	small molecule	-	951-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXHRCPNRJAMMIM-BBVRLYRLSA-N
18809	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2167	SR11254	-	-	DRUGBANK	DB02258	C26H27NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNZIUDLOJHVHLZ-VYIQYICTSA-N
18810	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2167	SR11254	-	-	DRUGBANK	DB02258	C26H27NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNZIUDLOJHVHLZ-VYIQYICTSA-N
18811	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2167	SR11254	-	-	DRUGBANK	DB02258	C26H27NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNZIUDLOJHVHLZ-VYIQYICTSA-N
18812	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2168	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide	-	-	DRUGBANK	DB02259	C23H18Br2N2O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSYGXLAJQDAWCZ-UHFFFAOYSA-N
18813	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2168	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide	-	-	DRUGBANK	DB02259	C23H18Br2N2O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSYGXLAJQDAWCZ-UHFFFAOYSA-N
18814	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2169	4-Oxosebacic Acid	-	-	DRUGBANK	DB02260	C10H16O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTQIBFVBYWIHIP-UHFFFAOYSA-N
18815	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2169	4-Oxosebacic Acid	-	-	DRUGBANK	DB02260	C10H16O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTQIBFVBYWIHIP-UHFFFAOYSA-N
18816	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2169	4-Oxosebacic Acid	-	-	DRUGBANK	DB02260	C10H16O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTQIBFVBYWIHIP-UHFFFAOYSA-N
18817	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2169	4-Oxosebacic Acid	-	-	DRUGBANK	DB02260	C10H16O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTQIBFVBYWIHIP-UHFFFAOYSA-N
18818	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2170	Platelet Activating Factor	-	-	DRUGBANK	DB02261	C26H54NO7P	small molecule	-	74389-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVAUUPRFYPCOCA-AREMUKBSSA-N
18819	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2170	Platelet Activating Factor	-	-	DRUGBANK	DB02261	C26H54NO7P	small molecule	-	74389-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVAUUPRFYPCOCA-AREMUKBSSA-N
18820	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18821	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18822	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18823	849930	945556	b0945	pyrD	ECK0936|JW0928	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18824	849930	945556	b0945	pyrD	ECK0936|JW0928	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18825	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18826	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	inhibitor	target	Chen X (2002)	11752352	171740	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18827	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	2171	Orotic Acid	-	-	DRUGBANK	DB02262	C5H4N2O4	small molecule	-	65-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXQPEWDEAKTCGB-UHFFFAOYSA-N
18828	851992	947679	b1779	gapA	ECK1777|JW1768	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2172	Glyceraldehyde-3-Phosphate	-	-	DRUGBANK	DB02263	C3H7O6P	small molecule	-	142-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXJXRIRHZLFYRP-VKHMYHEASA-N
18829	851992	947679	b1779	gapA	ECK1777|JW1768	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2172	Glyceraldehyde-3-Phosphate	-	-	DRUGBANK	DB02263	C3H7O6P	small molecule	-	142-10-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXJXRIRHZLFYRP-VKHMYHEASA-N
18830	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
18831	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
18832	109330	3082	-	HGF	DFNB39|F-TCF|HGFB|HPTA|SF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
18833	109330	3082	-	HGF	DFNB39|F-TCF|HGFB|HPTA|SF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
18834	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
18835	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
18836	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Ouellet M (1995)	7864817	181626	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18837	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18838	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18839	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18840	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18841	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Lovering AL (2004)	14996743	159435	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18842	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Ouellet M (1995)	7864817	181626	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18843	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2176	Argininosuccinate	-	-	DRUGBANK	DB02267	C10H18N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDZOASGQNOPSCU-NTSWFWBYSA-N
18844	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2176	Argininosuccinate	-	-	DRUGBANK	DB02267	C10H18N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDZOASGQNOPSCU-NTSWFWBYSA-N
18845	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2176	Argininosuccinate	-	-	DRUGBANK	DB02267	C10H18N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDZOASGQNOPSCU-NTSWFWBYSA-N
18846	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2178	[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium	-	-	DRUGBANK	DB02269	C34H36N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFKJQTGPBFWMGT-UHFFFAOYSA-O
18847	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2178	[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium	-	-	DRUGBANK	DB02269	C34H36N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFKJQTGPBFWMGT-UHFFFAOYSA-O
18848	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2178	[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium	-	-	DRUGBANK	DB02269	C34H36N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFKJQTGPBFWMGT-UHFFFAOYSA-O
18849	852982	948690	b4171	miaA	ECK4167|JW4129|trpX	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2179	Dimethylallyl S-Thiolodiphosphate	-	-	DRUGBANK	DB02270	C5H14O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWSFTDFHOGCIEL-UHFFFAOYSA-N
18850	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2179	Dimethylallyl S-Thiolodiphosphate	-	-	DRUGBANK	DB02270	C5H14O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWSFTDFHOGCIEL-UHFFFAOYSA-N
18851	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2179	Dimethylallyl S-Thiolodiphosphate	-	-	DRUGBANK	DB02270	C5H14O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWSFTDFHOGCIEL-UHFFFAOYSA-N
18852	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2179	Dimethylallyl S-Thiolodiphosphate	-	-	DRUGBANK	DB02270	C5H14O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWSFTDFHOGCIEL-UHFFFAOYSA-N
18853	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2180	S-(2-Oxo)Pentadecylcoa	-	-	DRUGBANK	DB02271	C36H64N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKWHUJMJVNMKEF-QNHLWXDRSA-N
18854	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2180	S-(2-Oxo)Pentadecylcoa	-	-	DRUGBANK	DB02271	C36H64N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKWHUJMJVNMKEF-QNHLWXDRSA-N
18855	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2180	S-(2-Oxo)Pentadecylcoa	-	-	DRUGBANK	DB02271	C36H64N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKWHUJMJVNMKEF-QNHLWXDRSA-N
18856	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2181	Porphobilinogen	2-aminomethylpyrrol-3-acetic acid 4-propionic acid|5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid|PBG	-	DRUGBANK	DB02272	C10H13N2O4	small molecule	-	487-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPHQRHBJEUDWJW-UHFFFAOYSA-N
18857	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2181	Porphobilinogen	2-aminomethylpyrrol-3-acetic acid 4-propionic acid|5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid|PBG	-	DRUGBANK	DB02272	C10H13N2O4	small molecule	-	487-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPHQRHBJEUDWJW-UHFFFAOYSA-N
18858	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2181	Porphobilinogen	2-aminomethylpyrrol-3-acetic acid 4-propionic acid|5-(Aminomethyl)-4-(carboxymethyl)-1H-pyrrole-3-propionic acid|PBG	-	DRUGBANK	DB02272	C10H13N2O4	small molecule	-	487-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPHQRHBJEUDWJW-UHFFFAOYSA-N
18859	849752	945376	b0774	bioA	ECK0763|JW0757	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2183	7-Keto-8-Aminopelargonic Acid	-	-	DRUGBANK	DB02274	C9H17NO3	small molecule	-	4707-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUAHPAJOXVYFON-SSDOTTSWSA-N
18860	849752	945376	b0774	bioA	ECK0763|JW0757	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2183	7-Keto-8-Aminopelargonic Acid	-	-	DRUGBANK	DB02274	C9H17NO3	small molecule	-	4707-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUAHPAJOXVYFON-SSDOTTSWSA-N
18861	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2185	(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide	-	-	DRUGBANK	DB02276	C18H28N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HARXAJAHMRMERT-HOTGVXAUSA-N
18862	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2185	(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide	-	-	DRUGBANK	DB02276	C18H28N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HARXAJAHMRMERT-HOTGVXAUSA-N
18863	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2185	(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide	-	-	DRUGBANK	DB02276	C18H28N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HARXAJAHMRMERT-HOTGVXAUSA-N
18864	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2186	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	-	-	DRUGBANK	DB02277	C15H19ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWIJKWMXNHRSRO-UHFFFAOYSA-N
18865	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2186	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	-	-	DRUGBANK	DB02277	C15H19ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWIJKWMXNHRSRO-UHFFFAOYSA-N
18866	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2186	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	-	-	DRUGBANK	DB02277	C15H19ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWIJKWMXNHRSRO-UHFFFAOYSA-N
18867	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2188	Benzoylformic Acid	-	-	DRUGBANK	DB02279	C8H6O3	small molecule	-	611-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAQJJMHZNSSFSM-UHFFFAOYSA-N
18868	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2188	Benzoylformic Acid	-	-	DRUGBANK	DB02279	C8H6O3	small molecule	-	611-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAQJJMHZNSSFSM-UHFFFAOYSA-N
18869	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2188	Benzoylformic Acid	-	-	DRUGBANK	DB02279	C8H6O3	small molecule	-	611-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAQJJMHZNSSFSM-UHFFFAOYSA-N
18870	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2190	Formycin	-	-	DRUGBANK	DB02281	C10H12N5O4	small molecule	-	6742-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLDFCABASJKCEZ-IGPDFVGCSA-N
18871	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2190	Formycin	-	-	DRUGBANK	DB02281	C10H12N5O4	small molecule	-	6742-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLDFCABASJKCEZ-IGPDFVGCSA-N
18872	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2190	Formycin	-	-	DRUGBANK	DB02281	C10H12N5O4	small molecule	-	6742-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLDFCABASJKCEZ-IGPDFVGCSA-N
18873	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2190	Formycin	-	-	DRUGBANK	DB02281	C10H12N5O4	small molecule	-	6742-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLDFCABASJKCEZ-IGPDFVGCSA-N
18874	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2191	5'-Deoxy-5'-Methylthioadenosine	-	-	DRUGBANK	DB02282	C11H15N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUUGFSXJNOTRMR-WOIOKPISSA-N
18875	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2191	5'-Deoxy-5'-Methylthioadenosine	-	-	DRUGBANK	DB02282	C11H15N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUUGFSXJNOTRMR-WOIOKPISSA-N
18876	108789	2512	-	FTL	LFTD|NBIA3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2193	Protoporphyrin Ix	protoporphyrin IX|protoporphyrin|553-12-8|Ooporphyrin|Protoporpyrin IX|ppIX|Porphyrinogen IX|Protoporphyrin IX disodium|Kammerers prophyrin	-	DRUGBANK	DB02285	C34H33N4O4	small molecule	-	553-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18877	108789	2512	-	FTL	LFTD|NBIA3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2193	Protoporphyrin Ix	protoporphyrin IX|protoporphyrin|553-12-8|Ooporphyrin|Protoporpyrin IX|ppIX|Porphyrinogen IX|Protoporphyrin IX disodium|Kammerers prophyrin	-	DRUGBANK	DB02285	C34H33N4O4	small molecule	-	553-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18878	108789	2512	-	FTL	LFTD|NBIA3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2193	Protoporphyrin Ix	protoporphyrin IX|protoporphyrin|553-12-8|Ooporphyrin|Protoporpyrin IX|ppIX|Porphyrinogen IX|Protoporphyrin IX disodium|Kammerers prophyrin	-	DRUGBANK	DB02285	C34H33N4O4	small molecule	-	553-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
18879	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2195	2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB02287	C14H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJKRCBBKTXOHS-UHFFFAOYSA-O
18880	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2196	CRA_9334	-	-	DRUGBANK	DB02288	C15H13BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKCHOMIJYLHXLI-UHFFFAOYSA-N
18881	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2199	6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate	-	-	DRUGBANK	DB02292	C14H15NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSLPMJSGSBLWRE-UHFFFAOYSA-N
18882	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2199	6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate	-	-	DRUGBANK	DB02292	C14H15NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSLPMJSGSBLWRE-UHFFFAOYSA-N
18883	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2199	6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate	-	-	DRUGBANK	DB02292	C14H15NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSLPMJSGSBLWRE-UHFFFAOYSA-N
18884	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2201	(5r,6s,7s,8s)-5-Hydroxymethyl-6,7,8-Trihydroxy-Tetrazolo[1,5-a]Piperidine	-	-	DRUGBANK	DB02294	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
18885	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2201	(5r,6s,7s,8s)-5-Hydroxymethyl-6,7,8-Trihydroxy-Tetrazolo[1,5-a]Piperidine	-	-	DRUGBANK	DB02294	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
18886	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2203	1-Hydroxy-3-Methylbutane	-	-	DRUGBANK	DB02296	C5H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTQWCKDNZKARW-UHFFFAOYSA-N
18887	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2203	1-Hydroxy-3-Methylbutane	-	-	DRUGBANK	DB02296	C5H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTQWCKDNZKARW-UHFFFAOYSA-N
18888	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2203	1-Hydroxy-3-Methylbutane	-	-	DRUGBANK	DB02296	C5H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTQWCKDNZKARW-UHFFFAOYSA-N
18889	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2204	2-Amino-6-Chloropyrazine	-	-	DRUGBANK	DB02297	C4H4ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPXVCKCLBROOJ-UHFFFAOYSA-N
18890	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2204	2-Amino-6-Chloropyrazine	-	-	DRUGBANK	DB02297	C4H4ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTPXVCKCLBROOJ-UHFFFAOYSA-N
18891	109942	3739	-	KCNA4	HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2206	Arginineamide	-	-	DRUGBANK	DB02299	C6H16N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULEBESPCVWBNIF-BYPYZUCNSA-O
18892	109942	3739	-	KCNA4	HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2206	Arginineamide	-	-	DRUGBANK	DB02299	C6H16N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULEBESPCVWBNIF-BYPYZUCNSA-O
18893	109942	3739	-	KCNA4	HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2206	Arginineamide	-	-	DRUGBANK	DB02299	C6H16N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULEBESPCVWBNIF-BYPYZUCNSA-O
18894	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	2207	Calcipotriol	Daivonex|Calcipotriene|Dovonex|Calcipotriol	calcipotriene|enstilar|dovonex	DRUGBANK	DB02300	C27H40O3	small molecule	D05AX52|D05AX02	112965-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWQQLNNNIPYSNX-UROSTWAQSA-N
18895	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	2207	Calcipotriol	Daivonex|Calcipotriene|Dovonex|Calcipotriol	calcipotriene|enstilar|dovonex	DRUGBANK	DB02300	C27H40O3	small molecule	D05AX52|D05AX02	112965-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWQQLNNNIPYSNX-UROSTWAQSA-N
18896	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	2207	Calcipotriol	Daivonex|Calcipotriene|Dovonex|Calcipotriol	calcipotriene|enstilar|dovonex	DRUGBANK	DB02300	C27H40O3	small molecule	D05AX52|D05AX02	112965-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWQQLNNNIPYSNX-UROSTWAQSA-N
18897	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2208	5,10-Methylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02301	C20H21N7O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHJAPJNOACHPNI-CHWSQXEVSA-N
18898	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2208	5,10-Methylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02301	C20H21N7O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHJAPJNOACHPNI-CHWSQXEVSA-N
18899	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2210	(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione	-	-	DRUGBANK	DB02303	C4H5IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGKCTZPSAOUUMT-UWTATZPHSA-N
18900	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2210	(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione	-	-	DRUGBANK	DB02303	C4H5IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGKCTZPSAOUUMT-UWTATZPHSA-N
18901	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2210	(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione	-	-	DRUGBANK	DB02303	C4H5IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGKCTZPSAOUUMT-UWTATZPHSA-N
18902	121818	58488	-	PCTP	PC-TP|STARD2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2213	Palmitoyl-Linoleoyl Phosphatidylcholine	-	-	DRUGBANK	DB02306	C42H80NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLPULHDHAOZNQI-GSZNELEDSA-N
18903	121818	58488	-	PCTP	PC-TP|STARD2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2213	Palmitoyl-Linoleoyl Phosphatidylcholine	-	-	DRUGBANK	DB02306	C42H80NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLPULHDHAOZNQI-GSZNELEDSA-N
18904	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2215	4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium	-	-	DRUGBANK	DB02308	C6H15BNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTZDASPSWBAPAR-UHFFFAOYSA-O
18905	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2215	4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium	-	-	DRUGBANK	DB02308	C6H15BNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTZDASPSWBAPAR-UHFFFAOYSA-O
18906	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2215	4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium	-	-	DRUGBANK	DB02308	C6H15BNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTZDASPSWBAPAR-UHFFFAOYSA-O
18907	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2216	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	-	-	DRUGBANK	DB02309	C10H14N4O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCTLYFZHFGENCW-BZKDHIKHSA-O
18908	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2216	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	-	-	DRUGBANK	DB02309	C10H14N4O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCTLYFZHFGENCW-BZKDHIKHSA-O
18909	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2216	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	-	-	DRUGBANK	DB02309	C10H14N4O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCTLYFZHFGENCW-BZKDHIKHSA-O
18910	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2216	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	-	-	DRUGBANK	DB02309	C10H14N4O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCTLYFZHFGENCW-BZKDHIKHSA-O
18911	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2216	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	-	-	DRUGBANK	DB02309	C10H14N4O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCTLYFZHFGENCW-BZKDHIKHSA-O
18912	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2216	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	-	-	DRUGBANK	DB02309	C10H14N4O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCTLYFZHFGENCW-BZKDHIKHSA-O
18913	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2217	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	-	-	DRUGBANK	DB02310	C17H19N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQTUZNACZKILMC-UHFFFAOYSA-N
18914	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2217	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	-	-	DRUGBANK	DB02310	C17H19N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQTUZNACZKILMC-UHFFFAOYSA-N
18915	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2218	Methyl Methylsulfinylmethyl Sulfide	-	-	DRUGBANK	DB02311	C3H8OS2	small molecule	-	33577-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTKFCIVOVKCFHR-ZCFIWIBFSA-N
18916	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2218	Methyl Methylsulfinylmethyl Sulfide	-	-	DRUGBANK	DB02311	C3H8OS2	small molecule	-	33577-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTKFCIVOVKCFHR-ZCFIWIBFSA-N
18917	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2218	Methyl Methylsulfinylmethyl Sulfide	-	-	DRUGBANK	DB02311	C3H8OS2	small molecule	-	33577-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTKFCIVOVKCFHR-ZCFIWIBFSA-N
18918	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2221	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	-	-	DRUGBANK	DB02314	C28H43N5O23P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJZCATPXPWFLHF-OVXNVHGFSA-N
18919	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2221	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	-	-	DRUGBANK	DB02314	C28H43N5O23P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJZCATPXPWFLHF-OVXNVHGFSA-N
18920	849192	944791	b0085	murE	ECK0086|JW0083	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2221	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	-	-	DRUGBANK	DB02314	C28H43N5O23P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJZCATPXPWFLHF-OVXNVHGFSA-N
18921	849192	944791	b0085	murE	ECK0086|JW0083	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2221	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	-	-	DRUGBANK	DB02314	C28H43N5O23P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJZCATPXPWFLHF-OVXNVHGFSA-N
18922	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18923	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18924	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18925	107081	610	-	HCN2	BCNG-2|BCNG2|HAC-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18926	107081	610	-	HCN2	BCNG-2|BCNG2|HAC-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18927	107081	610	-	HCN2	BCNG-2|BCNG2|HAC-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18928	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18929	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18930	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2222	Cyclic Guanosine Monophosphate	Guanosine-3',5'-monophosphate	-	DRUGBANK	DB02315	C10H12N5O7P	small molecule	-	7665-99-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOOGRGPOEVQQDX-KHLHZJAASA-N
18931	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2223	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	-	-	DRUGBANK	DB02316	C22H21Cl2NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTGPYFFQVOIJKR-UHFFFAOYSA-N
18932	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2223	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	-	-	DRUGBANK	DB02316	C22H21Cl2NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTGPYFFQVOIJKR-UHFFFAOYSA-N
18933	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2223	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	-	-	DRUGBANK	DB02316	C22H21Cl2NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTGPYFFQVOIJKR-UHFFFAOYSA-N
18934	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2225	2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride	-	-	DRUGBANK	DB02318	C6H10F2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZRDPODBASCWCK-QZABAPFNSA-N
18935	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2225	2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride	-	-	DRUGBANK	DB02318	C6H10F2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZRDPODBASCWCK-QZABAPFNSA-N
18936	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2225	2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride	-	-	DRUGBANK	DB02318	C6H10F2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZRDPODBASCWCK-QZABAPFNSA-N
18937	851810	947493	b3011	yqhD	ECK3003|JW2978	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2226	5,6-Dihydroxy-Nadp	-	-	DRUGBANK	DB02319	C21H32N7O19P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRAVAOPKUBJONV-MFVBCOROSA-N
18938	851810	947493	b3011	yqhD	ECK3003|JW2978	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2226	5,6-Dihydroxy-Nadp	-	-	DRUGBANK	DB02319	C21H32N7O19P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRAVAOPKUBJONV-MFVBCOROSA-N
18939	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2227	1-N-Acetyl-Beta-D-Glucosamine	-	-	DRUGBANK	DB02320	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBONACLSSOLHFU-RLMOJYMMSA-N
18940	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2227	1-N-Acetyl-Beta-D-Glucosamine	-	-	DRUGBANK	DB02320	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBONACLSSOLHFU-RLMOJYMMSA-N
18941	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2227	1-N-Acetyl-Beta-D-Glucosamine	-	-	DRUGBANK	DB02320	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBONACLSSOLHFU-RLMOJYMMSA-N
18942	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2227	1-N-Acetyl-Beta-D-Glucosamine	-	-	DRUGBANK	DB02320	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBONACLSSOLHFU-RLMOJYMMSA-N
18943	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2227	1-N-Acetyl-Beta-D-Glucosamine	-	-	DRUGBANK	DB02320	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBONACLSSOLHFU-RLMOJYMMSA-N
18944	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2228	5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol	-	-	DRUGBANK	DB02321	C9H17NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFWYNFDWRYSRA-FIJBBSBCSA-N
18945	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2228	5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol	-	-	DRUGBANK	DB02321	C9H17NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFWYNFDWRYSRA-FIJBBSBCSA-N
18946	112255	6352	-	CCL5	D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2229	Heparin Disaccharide I-S	-	-	DRUGBANK	DB02322	C12H15NO19S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRPGJWKAYQRIAQ-XKUCOZAXSA-J
18947	112255	6352	-	CCL5	D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2229	Heparin Disaccharide I-S	-	-	DRUGBANK	DB02322	C12H15NO19S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRPGJWKAYQRIAQ-XKUCOZAXSA-J
18948	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2230	EM-1745	-	-	DRUGBANK	DB02323	C37H51N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKSDYJASHNGOOS-YNUFDGECSA-N
18949	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2230	EM-1745	-	-	DRUGBANK	DB02323	C37H51N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKSDYJASHNGOOS-YNUFDGECSA-N
18950	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2232	1-Hydroxyamine-2-Isobutylmalonic Acid	-	-	DRUGBANK	DB02326	C7H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CINIOMOBGSHXRK-RXMQYKEDSA-N
18951	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2232	1-Hydroxyamine-2-Isobutylmalonic Acid	-	-	DRUGBANK	DB02326	C7H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CINIOMOBGSHXRK-RXMQYKEDSA-N
18952	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2232	1-Hydroxyamine-2-Isobutylmalonic Acid	-	-	DRUGBANK	DB02326	C7H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CINIOMOBGSHXRK-RXMQYKEDSA-N
18953	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2234	2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid	-	-	DRUGBANK	DB02328	C13H18N2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKWJKURKEYQKKW-QDWZKYKZSA-N
18954	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2235	Carbenoxolone	-	-	DRUGBANK	DB02329	C34H50O7	small molecule	A02BX71|A02BX51|A02BX01	5697-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBZHEBDUNPOCJG-WBXJDKIVSA-N
18955	850940	946593	b2065	dcd	ECK2059|JW2050|dus|paxA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2238	Deoxyuridine-5'-Triphosphate	-	-	DRUGBANK	DB02333	C9H15N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCYMLUZIRLXAA-GKROBHDKSA-N
18956	850940	946593	b2065	dcd	ECK2059|JW2050|dus|paxA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2238	Deoxyuridine-5'-Triphosphate	-	-	DRUGBANK	DB02333	C9H15N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCYMLUZIRLXAA-GKROBHDKSA-N
18957	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2238	Deoxyuridine-5'-Triphosphate	-	-	DRUGBANK	DB02333	C9H15N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCYMLUZIRLXAA-GKROBHDKSA-N
18958	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2238	Deoxyuridine-5'-Triphosphate	-	-	DRUGBANK	DB02333	C9H15N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCYMLUZIRLXAA-GKROBHDKSA-N
18959	854285	936605	BSU28050	maf	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2238	Deoxyuridine-5'-Triphosphate	-	-	DRUGBANK	DB02333	C9H15N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCYMLUZIRLXAA-GKROBHDKSA-N
18960	854285	936605	BSU28050	maf	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2238	Deoxyuridine-5'-Triphosphate	-	-	DRUGBANK	DB02333	C9H15N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCYMLUZIRLXAA-GKROBHDKSA-N
18961	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2240	2-Aminothiazoline	-	-	DRUGBANK	DB02335	C3H6N2S	small molecule	-	1779-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REGFWZVTTFGQOJ-UHFFFAOYSA-N
18962	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2240	2-Aminothiazoline	-	-	DRUGBANK	DB02335	C3H6N2S	small molecule	-	1779-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REGFWZVTTFGQOJ-UHFFFAOYSA-N
18963	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2240	2-Aminothiazoline	-	-	DRUGBANK	DB02335	C3H6N2S	small molecule	-	1779-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REGFWZVTTFGQOJ-UHFFFAOYSA-N
18964	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2241	RU83876	-	-	DRUGBANK	DB02336	C30H35N3O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCMLXBUNHNAMNH-FTJBHMTQSA-N
18965	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2241	RU83876	-	-	DRUGBANK	DB02336	C30H35N3O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCMLXBUNHNAMNH-FTJBHMTQSA-N
18966	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2241	RU83876	-	-	DRUGBANK	DB02336	C30H35N3O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCMLXBUNHNAMNH-FTJBHMTQSA-N
18967	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2242	S-(D-Carboxybutyl)-L-Homocysteine	-	-	DRUGBANK	DB02337	C9H17NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMONDXDFXRPNKQ-ZETCQYMHSA-N
18968	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2242	S-(D-Carboxybutyl)-L-Homocysteine	-	-	DRUGBANK	DB02337	C9H17NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMONDXDFXRPNKQ-ZETCQYMHSA-N
18969	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18970	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18971	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18972	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18973	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18974	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18975	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18976	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18977	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
18978	108460	2162	RP11-232H4.1	F13A1	F13A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2245	N-Acetyl-Serine	-	-	DRUGBANK	DB02340	C5H9NO4	small molecule	-	16354-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJIHLJJYMXLCOY-BYPYZUCNSA-N
18979	108460	2162	RP11-232H4.1	F13A1	F13A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2245	N-Acetyl-Serine	-	-	DRUGBANK	DB02340	C5H9NO4	small molecule	-	16354-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJIHLJJYMXLCOY-BYPYZUCNSA-N
18980	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2246	Mdl 101,146	-	-	DRUGBANK	DB02341	C29H37F5N4O6	small molecule	-	149859-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQAMVCHQGHAELT-YPAWHYETSA-N
18981	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2246	Mdl 101,146	-	-	DRUGBANK	DB02341	C29H37F5N4O6	small molecule	-	149859-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQAMVCHQGHAELT-YPAWHYETSA-N
18982	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2246	Mdl 101,146	-	-	DRUGBANK	DB02341	C29H37F5N4O6	small molecule	-	149859-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQAMVCHQGHAELT-YPAWHYETSA-N
18983	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2246	Mdl 101,146	-	-	DRUGBANK	DB02341	C29H37F5N4O6	small molecule	-	149859-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQAMVCHQGHAELT-YPAWHYETSA-N
18984	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2246	Mdl 101,146	-	-	DRUGBANK	DB02341	C29H37F5N4O6	small molecule	-	149859-17-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQAMVCHQGHAELT-YPAWHYETSA-N
18985	109338	3091	-	HIF1A	HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78	9606	Homo sapiens	unknown	target	Dai Y (2007)	17498737	181627	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18986	109338	3091	-	HIF1A	HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78	9606	Homo sapiens	unknown	target	Zhou D (2008)	17716391	181628	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18987	107925	1545	-	CYP1B1	CP1B|CYPIB1|GLC3A|P4501B1	9606	Homo sapiens	unknown	target	Dawling S (2003)	12810639	181629	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18988	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Parvez S (1975)	1170911	181630	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18989	107923	1543	-	CYP1A1	AHH|AHRR|CP11|CYP1|P1-450|P450-C|P450DX	9606	Homo sapiens	unknown	target	Dawling S (2003)	12810639	181629	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18990	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	unknown	target	Purohit A (1999)	10405348	181631	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18991	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2248	3,6,9,12,15-Pentaoxaheptadecane	-	-	DRUGBANK	DB02343	C12H26O5	small molecule	-	4353-28-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYDWALOBQJFOMS-UHFFFAOYSA-N
18992	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18993	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18994	852878	948584	b4079	fdhF	ECK4072|JW4040	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18995	852878	948584	b4079	fdhF	ECK4072|JW4040	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18996	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18997	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18998	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
18999	107270	820	HSD26	CAMP	CAP-18|CAP18|CRAMP|FALL-39|FALL39|LL37	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
19000	107270	820	HSD26	CAMP	CAP-18|CAP18|CRAMP|FALL-39|FALL39|LL37	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
19001	107270	820	HSD26	CAMP	CAP-18|CAP18|CRAMP|FALL-39|FALL39|LL37	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2250	Selenocysteine	Selenium cysteine|3-selenyl-L-alanine|L-selenocysteine	-	DRUGBANK	DB02345	C3H7NO2Se	small molecule	-	10236-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZBPNGNEQAJSX-REOHCLBHSA-N
19002	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2252	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB02347	C11H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGSOOCUNMTYPSE-ZETCQYMHSA-N
19003	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2252	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB02347	C11H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGSOOCUNMTYPSE-ZETCQYMHSA-N
19004	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2252	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB02347	C11H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGSOOCUNMTYPSE-ZETCQYMHSA-N
19005	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2253	Fluoro-Phosphite Ion	-	-	DRUGBANK	DB02348	FO3P	small molecule	-	10163-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWYMPOCYEZONEA-UHFFFAOYSA-L
19006	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2253	Fluoro-Phosphite Ion	-	-	DRUGBANK	DB02348	FO3P	small molecule	-	10163-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWYMPOCYEZONEA-UHFFFAOYSA-L
19007	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2253	Fluoro-Phosphite Ion	-	-	DRUGBANK	DB02348	FO3P	small molecule	-	10163-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWYMPOCYEZONEA-UHFFFAOYSA-L
19008	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2255	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	-	-	DRUGBANK	DB02350	C15H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYYCSKFJEOSZTF-CYBMUJFWSA-N
19009	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2255	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	-	-	DRUGBANK	DB02350	C15H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYYCSKFJEOSZTF-CYBMUJFWSA-N
19010	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2255	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	-	-	DRUGBANK	DB02350	C15H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYYCSKFJEOSZTF-CYBMUJFWSA-N
19011	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2256	Hirulog	-	-	DRUGBANK	DB02351	C98H138N24O33	small molecule	-	128270-60-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRCOABEOLEUMC-GEJPAHFPSA-N
19012	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19013	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19014	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19015	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19016	112255	6352	-	CCL5	D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2258	Heparin Disaccharide Iii-S	-	-	DRUGBANK	DB02353	C12H16NO16S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSYQGRODWXMUOO-XKUCOZAXSA-K
19017	112255	6352	-	CCL5	D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2258	Heparin Disaccharide Iii-S	-	-	DRUGBANK	DB02353	C12H16NO16S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSYQGRODWXMUOO-XKUCOZAXSA-K
19018	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2259	4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine	-	-	DRUGBANK	DB02354	C25H25N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRKPNOLLMNHSOU-UHFFFAOYSA-N
19019	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2259	4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine	-	-	DRUGBANK	DB02354	C25H25N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRKPNOLLMNHSOU-UHFFFAOYSA-N
19020	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2259	4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine	-	-	DRUGBANK	DB02354	C25H25N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRKPNOLLMNHSOU-UHFFFAOYSA-N
19021	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2263	LY374571	-	-	DRUGBANK	DB02358	C17H19N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHRIPFGZWWRKW-SECBINFHSA-N
19022	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2263	LY374571	-	-	DRUGBANK	DB02358	C17H19N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHRIPFGZWWRKW-SECBINFHSA-N
19023	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2264	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB02359	C18H23N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPFZLLAIQRZNJE-UHFFFAOYSA-N
19024	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2265	Bis-Napthyl Beta-Ketophosphonic Acid	-	-	DRUGBANK	DB02360	C22H17O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHMUASCSJJNNA-JOCHJYFZSA-N
19025	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2265	Bis-Napthyl Beta-Ketophosphonic Acid	-	-	DRUGBANK	DB02360	C22H17O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHMUASCSJJNNA-JOCHJYFZSA-N
19026	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2265	Bis-Napthyl Beta-Ketophosphonic Acid	-	-	DRUGBANK	DB02360	C22H17O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFHMUASCSJJNNA-JOCHJYFZSA-N
19027	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2268	2'-Monophosphoadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02363	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPTPYQSAVGGMFN-FCIPNVEPSA-N
19028	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2268	2'-Monophosphoadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02363	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPTPYQSAVGGMFN-FCIPNVEPSA-N
19029	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2268	2'-Monophosphoadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02363	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPTPYQSAVGGMFN-FCIPNVEPSA-N
19030	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2268	2'-Monophosphoadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02363	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPTPYQSAVGGMFN-FCIPNVEPSA-N
19031	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2268	2'-Monophosphoadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02363	C10H16N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPTPYQSAVGGMFN-FCIPNVEPSA-N
19032	849516	945127	b0494	tesA	ECK0488|JW0483|apeA|pldC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2269	2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid	-	-	DRUGBANK	DB02364	C7H16NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOFCKRBDMJNCOC-ZCFIWIBFSA-N
19033	849516	945127	b0494	tesA	ECK0488|JW0483|apeA|pldC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2269	2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid	-	-	DRUGBANK	DB02364	C7H16NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOFCKRBDMJNCOC-ZCFIWIBFSA-N
19034	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2271	CRA_10762	-	-	DRUGBANK	DB02366	C20H14ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19035	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2271	CRA_10762	-	-	DRUGBANK	DB02366	C20H14ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19036	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2271	CRA_10762	-	-	DRUGBANK	DB02366	C20H14ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19037	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2272	(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine	-	-	DRUGBANK	DB02367	C16H25N3O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDXUWXTVRRUND-SWLSCSKDSA-N
19038	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2272	(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine	-	-	DRUGBANK	DB02367	C16H25N3O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDXUWXTVRRUND-SWLSCSKDSA-N
19039	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2276	2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB02371	C6H15NO6S	small molecule	-	7365-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOCBASBOOFNAJA-UHFFFAOYSA-N
19040	107177	716	-	C1S	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2276	2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB02371	C6H15NO6S	small molecule	-	7365-44-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOCBASBOOFNAJA-UHFFFAOYSA-N
19041	108563	2272	-	FHIT	AP3Aase|FRA3B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2278	Adenosine Monotungstate	-	-	DRUGBANK	DB02373	C10H14N5O7W	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJSJQPRHXPUMLC-LRDMJOKZSA-L
19042	108563	2272	-	FHIT	AP3Aase|FRA3B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2278	Adenosine Monotungstate	-	-	DRUGBANK	DB02373	C10H14N5O7W	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJSJQPRHXPUMLC-LRDMJOKZSA-L
19043	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2280	Myricetin	3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|Cannabiscetin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|Myricetol|3,5,7,3',4',5'-Hexahydroxyflavone|MYC|Myricitin|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one	-	DRUGBANK	DB02375	C15H10O8	small molecule	-	529-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMDFBPHZNJCSN-UHFFFAOYSA-N
19044	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2280	Myricetin	3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|Cannabiscetin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|Myricetol|3,5,7,3',4',5'-Hexahydroxyflavone|MYC|Myricitin|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one	-	DRUGBANK	DB02375	C15H10O8	small molecule	-	529-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMDFBPHZNJCSN-UHFFFAOYSA-N
19045	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2280	Myricetin	3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|Cannabiscetin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|Myricetol|3,5,7,3',4',5'-Hexahydroxyflavone|MYC|Myricitin|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one	-	DRUGBANK	DB02375	C15H10O8	small molecule	-	529-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMDFBPHZNJCSN-UHFFFAOYSA-N
19046	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2281	D-Gluconhydroximo-1,5-Lactam	-	-	DRUGBANK	DB02376	C6H12N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBXHGXTYZGYTQG-MBMOQRBOSA-N
19047	108913	2643	-	GCH1	DYT14|DYT5|DYT5a|GCH|GTP-CH-1|GTPCH1|HPABH4B	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19048	851218	946878	b2407	xapA	ECK2401|JW2398|pndA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19049	851218	946878	b2407	xapA	ECK2401|JW2398|pndA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19050	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19051	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19052	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19053	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2282	Guanine	-	-	DRUGBANK	DB02377	C5H4N5O	small molecule	-	73-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOJBSLDWMHFRAL-UHFFFAOYSA-N
19054	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2283	MMI-175	-	-	DRUGBANK	DB02378	C38H62N6O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJAPFAZHNSZLJE-KXZVVICLSA-N
19055	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2283	MMI-175	-	-	DRUGBANK	DB02378	C38H62N6O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJAPFAZHNSZLJE-KXZVVICLSA-N
19056	852950	948658	b4139	aspA	ECK4133|JW4099	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19057	852950	948658	b4139	aspA	ECK4133|JW4099	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19058	855974	938356	BSU03040	amyE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19059	855974	938356	BSU03040	amyE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19060	110148	3957	-	LGALS2	HL14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19061	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19062	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19063	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19064	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19065	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19066	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19067	115325	10007	-	GNPDA1	GNP1|GNPDA|GNPI|GPI|HLN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19068	115325	10007	-	GNPDA1	GNP1|GNPDA|GNPI|GPI|HLN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19069	136219	440021	-	KRTAP5-2	KRTAP5-8|KRTAP5.2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19070	108915	2645	-	GCK	FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19071	108915	2645	-	GCK	FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19072	112339	6441	-	SFTPD	COLEC7|PSP-D|SFTP4|SP-D	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19073	112339	6441	-	SFTPD	COLEC7|PSP-D|SFTP4|SP-D	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19074	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19075	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19076	852231	947922	b3417	malP	ECK3404|JW5689|blu|malA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19077	852231	947922	b3417	malP	ECK3404|JW5689|blu|malA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19078	109345	3098	-	HK1	HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19079	109345	3098	-	HK1	HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19080	132267	387266	-	KRTAP5-3	KRTAP5-9|KRTAP5.3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19081	119744	53343	PSEC0099	NUDT9	NUDT10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19082	119744	53343	PSEC0099	NUDT9	NUDT10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19083	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19084	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19085	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19086	114045	8467	-	SMARCA5	ISWI|SNF2H|WCRF135|hISWI|hSNF2H	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19087	114045	8467	-	SMARCA5	ISWI|SNF2H|WCRF135|hISWI|hSNF2H	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19088	114045	8467	-	SMARCA5	ISWI|SNF2H|WCRF135|hISWI|hSNF2H	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19089	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19090	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19091	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19092	110154	3963	-	LGALS7	GAL7|LGALS7A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19093	110154	3963	-	LGALS7	GAL7|LGALS7A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19094	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19095	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19096	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19097	109678	3456	RP11-113D19.1	IFNB1	IFB|IFF|IFNB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19098	109678	3456	RP11-113D19.1	IFNB1	IFB|IFF|IFNB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19099	112498	6614	-	SIGLEC1	CD169|SIGLEC-1|SN|dJ1009E24.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19100	853285	949041	b2150	mglB	ECK2143|JW2137	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19101	853285	949041	b2150	mglB	ECK2143|JW2137	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19102	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19103	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19104	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19105	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19106	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19107	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19108	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19109	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19110	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19111	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19112	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19113	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19114	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19115	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19116	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2286	Nor-N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB02381	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOBHCUDVWOTEKO-VKHMYHEASA-N
19117	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2286	Nor-N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB02381	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOBHCUDVWOTEKO-VKHMYHEASA-N
19118	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2286	Nor-N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB02381	C5H12N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOBHCUDVWOTEKO-VKHMYHEASA-N
19119	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19120	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19121	115610	10327	RP4-697E16.2	AKR1A1	ALDR1|ALR|ARM|DD3|HEL-S-6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19122	121325	57016	-	AKR1B10	AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19123	850101	945731	b1461	pptA	ECK1455|JW1456|ydcE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2289	(E)-2-Fluoro-P-Hydroxycinnamate	-	-	DRUGBANK	DB02384	C9H6FO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBIZDOWXYPNTOJ-YVMONPNESA-M
19124	850101	945731	b1461	pptA	ECK1455|JW1456|ydcE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2289	(E)-2-Fluoro-P-Hydroxycinnamate	-	-	DRUGBANK	DB02384	C9H6FO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBIZDOWXYPNTOJ-YVMONPNESA-M
19125	119248	51056	-	LAP3	HEL-S-106|LAP|LAPEP|PEPS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2291	Leucine Phosphonic Acid	-	-	DRUGBANK	DB02386	C5H14NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGCAUCAWEADMPM-RXMQYKEDSA-N
19126	119248	51056	-	LAP3	HEL-S-106|LAP|LAPEP|PEPS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2291	Leucine Phosphonic Acid	-	-	DRUGBANK	DB02386	C5H14NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGCAUCAWEADMPM-RXMQYKEDSA-N
19127	119248	51056	-	LAP3	HEL-S-106|LAP|LAPEP|PEPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2291	Leucine Phosphonic Acid	-	-	DRUGBANK	DB02386	C5H14NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGCAUCAWEADMPM-RXMQYKEDSA-N
19128	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2293	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB02388	C27H34Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQFRSHRWRKYNDE-UHFFFAOYSA-N
19129	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2293	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB02388	C27H34Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQFRSHRWRKYNDE-UHFFFAOYSA-N
19130	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2295	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	-	-	DRUGBANK	DB02391	C10H16N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYCDSKWPYZSIDU-UHFFFAOYSA-N
19131	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2295	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	-	-	DRUGBANK	DB02391	C10H16N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYCDSKWPYZSIDU-UHFFFAOYSA-N
19132	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2295	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	-	-	DRUGBANK	DB02391	C10H16N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYCDSKWPYZSIDU-UHFFFAOYSA-N
19133	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2296	D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate	-	-	DRUGBANK	DB02393	C6H14O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBOWGOLYQKBCFB-BXKVDMCESA-N
19134	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2296	D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate	-	-	DRUGBANK	DB02393	C6H14O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBOWGOLYQKBCFB-BXKVDMCESA-N
19135	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2296	D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate	-	-	DRUGBANK	DB02393	C6H14O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBOWGOLYQKBCFB-BXKVDMCESA-N
19136	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2298	3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol	-	-	DRUGBANK	DB02395	C15H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCDRCRHGKFTQS-UHFFFAOYSA-N
19137	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2298	3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol	-	-	DRUGBANK	DB02395	C15H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCCDRCRHGKFTQS-UHFFFAOYSA-N
19138	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2299	Methylethylamine	-	-	DRUGBANK	DB02396	C3H9N	small molecule	-	624-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIWAQLJGPBVORC-UHFFFAOYSA-N
19139	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2299	Methylethylamine	-	-	DRUGBANK	DB02396	C3H9N	small molecule	-	624-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIWAQLJGPBVORC-UHFFFAOYSA-N
19140	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2299	Methylethylamine	-	-	DRUGBANK	DB02396	C3H9N	small molecule	-	624-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIWAQLJGPBVORC-UHFFFAOYSA-N
19141	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2301	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02398	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBDETRVUYOIHQ-UHFFFAOYSA-N
19142	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2301	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02398	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBDETRVUYOIHQ-UHFFFAOYSA-N
19143	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2301	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02398	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBDETRVUYOIHQ-UHFFFAOYSA-N
19144	852697	948400	b3903	rhaA	ECK3896|JW5561	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2302	L-Rhamnitol	-	-	DRUGBANK	DB02399	C6H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKCKOFZKJLZSFA-FSIIMWSLSA-N
19145	852697	948400	b3903	rhaA	ECK3896|JW5561	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2302	L-Rhamnitol	-	-	DRUGBANK	DB02399	C6H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKCKOFZKJLZSFA-FSIIMWSLSA-N
19146	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2303	5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione	-	-	DRUGBANK	DB02400	C18H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBLWSLZYYZHSRG-UHFFFAOYSA-N
19147	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2303	5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione	-	-	DRUGBANK	DB02400	C18H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBLWSLZYYZHSRG-UHFFFAOYSA-N
19148	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2303	5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione	-	-	DRUGBANK	DB02400	C18H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBLWSLZYYZHSRG-UHFFFAOYSA-N
19149	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2304	4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02401	C3H2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBRWUZLLHSXPKL-UHFFFAOYSA-N
19150	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2304	4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02401	C3H2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBRWUZLLHSXPKL-UHFFFAOYSA-N
19151	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2305	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	-	-	DRUGBANK	DB02402	C15H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZJZAIZIMCJRC-UHFFFAOYSA-N
19152	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2307	1-Deoxy-1-Thio-Heptaethylene Glycol	-	-	DRUGBANK	DB02404	C14H30O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACMBXVJDKVNCGH-UHFFFAOYSA-N
19153	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2308	12-Bromododecanoic Acid	-	-	DRUGBANK	DB02405	C12H23BrO2	small molecule	-	73367-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYKBWYBUCFHYPR-UHFFFAOYSA-N
19154	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19155	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19156	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19157	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2310	6-O-Cyclohexylmethyl Guanine	-	-	DRUGBANK	DB02407	C12H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGXGTJJAOZBNW-UHFFFAOYSA-N
19158	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2318	N-Octyl-2-Hydroxyethyl Sulfoxide	-	-	DRUGBANK	DB02415	C10H22O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRJUEMKMQDEOTQ-CYBMUJFWSA-N
19159	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2318	N-Octyl-2-Hydroxyethyl Sulfoxide	-	-	DRUGBANK	DB02415	C10H22O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRJUEMKMQDEOTQ-CYBMUJFWSA-N
19160	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2318	N-Octyl-2-Hydroxyethyl Sulfoxide	-	-	DRUGBANK	DB02415	C10H22O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRJUEMKMQDEOTQ-CYBMUJFWSA-N
19161	853286	949042	b2155	cirA	ECK2148|JW2142|cir|feuA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2318	N-Octyl-2-Hydroxyethyl Sulfoxide	-	-	DRUGBANK	DB02415	C10H22O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRJUEMKMQDEOTQ-CYBMUJFWSA-N
19162	113170	7322	-	UBE2D2	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2321	(R,R)-2,3-Butanediol	-	-	DRUGBANK	DB02418	C4H10O2	small molecule	-	24347-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWBTYPJTUOEWEK-ZXZARUISSA-N
19163	113170	7322	-	UBE2D2	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2321	(R,R)-2,3-Butanediol	-	-	DRUGBANK	DB02418	C4H10O2	small molecule	-	24347-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWBTYPJTUOEWEK-ZXZARUISSA-N
19164	113170	7322	-	UBE2D2	E2(17)KB2|PUBC1|UBC4|UBC4/5|UBCH4|UBCH5B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2321	(R,R)-2,3-Butanediol	-	-	DRUGBANK	DB02418	C4H10O2	small molecule	-	24347-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWBTYPJTUOEWEK-ZXZARUISSA-N
19165	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2322	Ethyl Oxo(Piperidin-1-Yl)Acetate	-	-	DRUGBANK	DB02419	C9H15NO3	small molecule	-	53074-96-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASBDXHCMVYVJQQ-UHFFFAOYSA-N
19166	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2323	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	-	-	DRUGBANK	DB02420	C9H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKILOCCSAVHHJT-UHFFFAOYSA-N
19167	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2323	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	-	-	DRUGBANK	DB02420	C9H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKILOCCSAVHHJT-UHFFFAOYSA-N
19168	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2324	Uridine-5'-Diphosphate-Mannose	-	-	DRUGBANK	DB02421	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-NYYOCOOHSA-N
19169	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2324	Uridine-5'-Diphosphate-Mannose	-	-	DRUGBANK	DB02421	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-NYYOCOOHSA-N
19170	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2325	Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside	-	-	DRUGBANK	DB02422	C13H24O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAYOKHSZGNFKSX-JGVJERAOSA-N
19171	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2325	Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside	-	-	DRUGBANK	DB02422	C13H24O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAYOKHSZGNFKSX-JGVJERAOSA-N
19172	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19173	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19174	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19175	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19176	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19177	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2329	Carboxyatractyloside	-	-	DRUGBANK	DB02426	C31H46O19S2	small molecule	-	33286-30-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYBVQIBJEFQVPD-GWDNDVLHSA-N
19178	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2329	Carboxyatractyloside	-	-	DRUGBANK	DB02426	C31H46O19S2	small molecule	-	33286-30-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYBVQIBJEFQVPD-GWDNDVLHSA-N
19179	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2329	Carboxyatractyloside	-	-	DRUGBANK	DB02426	C31H46O19S2	small molecule	-	33286-30-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYBVQIBJEFQVPD-GWDNDVLHSA-N
19180	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2330	2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline	-	-	DRUGBANK	DB02427	C18H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBJANOUTWRTBDK-UHFFFAOYSA-N
19181	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2332	4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02429	C14H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXDVPACDZDRCTN-UHFFFAOYSA-N
19182	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2332	4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02429	C14H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXDVPACDZDRCTN-UHFFFAOYSA-N
19183	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2332	4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02429	C14H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXDVPACDZDRCTN-UHFFFAOYSA-N
19184	853049	948760	b4241	treR	ECK4236|JW4200	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2333	Trehalose-6-Phosphate	-	-	DRUGBANK	DB02430	C12H23O14P	small molecule	-	4484-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LABSPYBHMPDTEL-JGZVXCDNSA-N
19185	853049	948760	b4241	treR	ECK4236|JW4200	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2333	Trehalose-6-Phosphate	-	-	DRUGBANK	DB02430	C12H23O14P	small molecule	-	4484-88-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LABSPYBHMPDTEL-JGZVXCDNSA-N
19186	854488	936809	BSU35740	tagD	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19187	854488	936809	BSU35740	tagD	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19188	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19189	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19190	853291	949047	b3639	dfp	ECK3629|JW5642|coaBC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19191	853291	949047	b3639	dfp	ECK3629|JW5642|coaBC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19192	852571	948269	b2747	ispD	ECK2742|JW2717|ygbP	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19193	852571	948269	b2747	ispD	ECK2742|JW2717|ygbP	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2334	Cytidine-5'-Triphosphate	-	-	DRUGBANK	DB02431	C9H16N3O14P3	small molecule	-	65-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCDQPRRSZKQHHS-ZAKLUEHWSA-N
19194	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2335	RU90395	-	-	DRUGBANK	DB02432	C35H36FN3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLAUERCSKPFGD-FQLXRVMXSA-N
19195	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2335	RU90395	-	-	DRUGBANK	DB02432	C35H36FN3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLAUERCSKPFGD-FQLXRVMXSA-N
19196	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2335	RU90395	-	-	DRUGBANK	DB02432	C35H36FN3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLAUERCSKPFGD-FQLXRVMXSA-N
19197	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2338	Aminomethylcyclohexane	-	-	DRUGBANK	DB02435	C7H16N	small molecule	-	3218-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKNGPAMCBSNSO-UHFFFAOYSA-O
19198	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2338	Aminomethylcyclohexane	-	-	DRUGBANK	DB02435	C7H16N	small molecule	-	3218-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKNGPAMCBSNSO-UHFFFAOYSA-O
19199	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2338	Aminomethylcyclohexane	-	-	DRUGBANK	DB02435	C7H16N	small molecule	-	3218-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKNGPAMCBSNSO-UHFFFAOYSA-O
19200	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2339	2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid	-	-	DRUGBANK	DB02436	C27H33N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKONADSQADEJJP-NHCUHLMSSA-N
19201	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2339	2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid	-	-	DRUGBANK	DB02436	C27H33N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKONADSQADEJJP-NHCUHLMSSA-N
19202	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2340	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	-	-	DRUGBANK	DB02437	C7H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHKWPAAHPLALGC-LURJTMIESA-N
19203	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2340	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	-	-	DRUGBANK	DB02437	C7H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHKWPAAHPLALGC-LURJTMIESA-N
19204	853133	948853	b4328	iadA	ECK4319|JW4291|yjiF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2340	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	-	-	DRUGBANK	DB02437	C7H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHKWPAAHPLALGC-LURJTMIESA-N
19205	853133	948853	b4328	iadA	ECK4319|JW4291|yjiF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2340	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	-	-	DRUGBANK	DB02437	C7H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHKWPAAHPLALGC-LURJTMIESA-N
19211	849667	945290	b0678	nagB	ECK0666|JW0664|glmD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2346	2-Deoxy-2-Amino Glucitol-6-Phosphate	-	-	DRUGBANK	DB02445	C6H16NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBNVXZROMBUNNQ-ZXXMMSQZSA-N
19212	849667	945290	b0678	nagB	ECK0666|JW0664|glmD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2346	2-Deoxy-2-Amino Glucitol-6-Phosphate	-	-	DRUGBANK	DB02445	C6H16NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBNVXZROMBUNNQ-ZXXMMSQZSA-N
19213	115325	10007	-	GNPDA1	GNP1|GNPDA|GNPI|GPI|HLN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2346	2-Deoxy-2-Amino Glucitol-6-Phosphate	-	-	DRUGBANK	DB02445	C6H16NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBNVXZROMBUNNQ-ZXXMMSQZSA-N
19214	115325	10007	-	GNPDA1	GNP1|GNPDA|GNPI|GPI|HLN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2346	2-Deoxy-2-Amino Glucitol-6-Phosphate	-	-	DRUGBANK	DB02445	C6H16NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBNVXZROMBUNNQ-ZXXMMSQZSA-N
19215	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2346	2-Deoxy-2-Amino Glucitol-6-Phosphate	-	-	DRUGBANK	DB02445	C6H16NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBNVXZROMBUNNQ-ZXXMMSQZSA-N
19216	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2346	2-Deoxy-2-Amino Glucitol-6-Phosphate	-	-	DRUGBANK	DB02445	C6H16NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBNVXZROMBUNNQ-ZXXMMSQZSA-N
19217	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2347	Glutamine Hydroxamate	HGA	-	DRUGBANK	DB02446	C5H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVGZXTQJQNXIAU-VKHMYHEASA-N
19218	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2347	Glutamine Hydroxamate	HGA	-	DRUGBANK	DB02446	C5H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVGZXTQJQNXIAU-VKHMYHEASA-N
19219	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2348	3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB02447	C8H12N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHDZZZHACPJCFJ-UXDJRKLDSA-N
19220	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2348	3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB02447	C8H12N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHDZZZHACPJCFJ-UXDJRKLDSA-N
19221	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2348	3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB02447	C8H12N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHDZZZHACPJCFJ-UXDJRKLDSA-N
19222	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2349	N-Tridecanoic Acid	-	-	DRUGBANK	DB02448	C13H26O2	small molecule	-	638-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHOJFHSIKHZHA-UHFFFAOYSA-N
19223	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2349	N-Tridecanoic Acid	-	-	DRUGBANK	DB02448	C13H26O2	small molecule	-	638-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHOJFHSIKHZHA-UHFFFAOYSA-N
19224	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2349	N-Tridecanoic Acid	-	-	DRUGBANK	DB02448	C13H26O2	small molecule	-	638-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHOJFHSIKHZHA-UHFFFAOYSA-N
19225	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2350	3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid	-	-	DRUGBANK	DB02449	C28H28N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUWISPSREJFEEW-HHHXNRCGSA-N
19226	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2350	3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid	-	-	DRUGBANK	DB02449	C28H28N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUWISPSREJFEEW-HHHXNRCGSA-N
19227	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2352	Thymidine-5'-Triphosphate	-	-	DRUGBANK	DB02452	C10H17N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVNXKFIZYSCEB-GJMOJQLCSA-N
19228	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2352	Thymidine-5'-Triphosphate	-	-	DRUGBANK	DB02452	C10H17N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVNXKFIZYSCEB-GJMOJQLCSA-N
19229	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2352	Thymidine-5'-Triphosphate	-	-	DRUGBANK	DB02452	C10H17N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVNXKFIZYSCEB-GJMOJQLCSA-N
19230	112938	7083	-	TK1	TK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2352	Thymidine-5'-Triphosphate	-	-	DRUGBANK	DB02452	C10H17N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVNXKFIZYSCEB-GJMOJQLCSA-N
19231	112938	7083	-	TK1	TK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2352	Thymidine-5'-Triphosphate	-	-	DRUGBANK	DB02452	C10H17N2O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVNXKFIZYSCEB-GJMOJQLCSA-N
19232	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2356	Cytosine Arabinose-5'-Phosphate	-	-	DRUGBANK	DB02456	C9H14N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
19233	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2356	Cytosine Arabinose-5'-Phosphate	-	-	DRUGBANK	DB02456	C9H14N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
19234	114085	8513	RP11-186O14.1	LIPF	GL|HGL|HLAL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2357	Undecyl-Phosphinic Acid Butyl Ester	-	-	DRUGBANK	DB02457	C15H33O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCBLJDSWVGAXQB-UHFFFAOYSA-N
19235	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2358	Glutathione S-(2,4 Dinitrobenzene)	-	-	DRUGBANK	DB02458	C16H19N5O10S	small molecule	-	26289-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXEUKVKGTKDDIQ-VHSXEESVSA-N
19236	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2358	Glutathione S-(2,4 Dinitrobenzene)	-	-	DRUGBANK	DB02458	C16H19N5O10S	small molecule	-	26289-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXEUKVKGTKDDIQ-VHSXEESVSA-N
19237	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2358	Glutathione S-(2,4 Dinitrobenzene)	-	-	DRUGBANK	DB02458	C16H19N5O10S	small molecule	-	26289-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXEUKVKGTKDDIQ-VHSXEESVSA-N
19238	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2358	Glutathione S-(2,4 Dinitrobenzene)	-	-	DRUGBANK	DB02458	C16H19N5O10S	small molecule	-	26289-39-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXEUKVKGTKDDIQ-VHSXEESVSA-N
19239	107098	629	DADB-122G4.5	CFB	AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2359	4-Guanidinobenzoic Acid	-	-	DRUGBANK	DB02459	C8H9N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXTSBZBQQRIYCU-UHFFFAOYSA-N
19240	107098	629	DADB-122G4.5	CFB	AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2359	4-Guanidinobenzoic Acid	-	-	DRUGBANK	DB02459	C8H9N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXTSBZBQQRIYCU-UHFFFAOYSA-N
19241	850750	946393	b1882	cheY	ECK1883|JW1871	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2361	S-Methyl Phosphocysteine	-	-	DRUGBANK	DB02461	C4H10NO5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIALWEPLPCANHU-VKHMYHEASA-N
19242	850750	946393	b1882	cheY	ECK1883|JW1871	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2361	S-Methyl Phosphocysteine	-	-	DRUGBANK	DB02461	C4H10NO5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIALWEPLPCANHU-VKHMYHEASA-N
19243	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2362	Thiocoumarin	-	-	DRUGBANK	DB02462	C14H17NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIOZFKOOIBATNZ-UHFFFAOYSA-N
19244	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2363	2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB02463	C15H14N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGNPKIYCTXJPG-UHFFFAOYSA-O
19245	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2364	Benzylamine	-	-	DRUGBANK	DB02464	C7H9N	small molecule	-	100-46-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGQKYBSKWIADBV-UHFFFAOYSA-N
19246	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2364	Benzylamine	-	-	DRUGBANK	DB02464	C7H9N	small molecule	-	100-46-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGQKYBSKWIADBV-UHFFFAOYSA-N
19247	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2364	Benzylamine	-	-	DRUGBANK	DB02464	C7H9N	small molecule	-	100-46-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGQKYBSKWIADBV-UHFFFAOYSA-N
19248	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2364	Benzylamine	-	-	DRUGBANK	DB02464	C7H9N	small molecule	-	100-46-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGQKYBSKWIADBV-UHFFFAOYSA-N
19249	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2364	Benzylamine	-	-	DRUGBANK	DB02464	C7H9N	small molecule	-	100-46-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGQKYBSKWIADBV-UHFFFAOYSA-N
19250	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2364	Benzylamine	-	-	DRUGBANK	DB02464	C7H9N	small molecule	-	100-46-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGQKYBSKWIADBV-UHFFFAOYSA-N
19251	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2365	Methoxy arachidonyl fluorophosphonate	MAFP	-	DRUGBANK	DB02465	C21H36FO2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWKZCGMJGHHOKJ-PDXKBQATSA-N
19252	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2365	Methoxy arachidonyl fluorophosphonate	MAFP	-	DRUGBANK	DB02465	C21H36FO2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWKZCGMJGHHOKJ-PDXKBQATSA-N
19253	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2365	Methoxy arachidonyl fluorophosphonate	MAFP	-	DRUGBANK	DB02465	C21H36FO2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWKZCGMJGHHOKJ-PDXKBQATSA-N
19254	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2366	4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid	-	-	DRUGBANK	DB02466	C24H26O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXQHMEUGMCXKLO-KPKJPENVSA-N
19255	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2366	4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid	-	-	DRUGBANK	DB02466	C24H26O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXQHMEUGMCXKLO-KPKJPENVSA-N
19256	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2366	4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid	-	-	DRUGBANK	DB02466	C24H26O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXQHMEUGMCXKLO-KPKJPENVSA-N
19257	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2367	L-methionine (S)-S-oxide	-	-	DRUGBANK	DB02467	C5H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFRNWWLZKMPFJ-MFXDVPHUSA-N
19258	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2367	L-methionine (S)-S-oxide	-	-	DRUGBANK	DB02467	C5H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFRNWWLZKMPFJ-MFXDVPHUSA-N
19259	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2367	L-methionine (S)-S-oxide	-	-	DRUGBANK	DB02467	C5H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFRNWWLZKMPFJ-MFXDVPHUSA-N
19260	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2368	12-Phenylheme	-	-	DRUGBANK	DB02468	C40H38FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYZKGXFDXHPSJI-YLQNXEDKSA-L
19261	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2368	12-Phenylheme	-	-	DRUGBANK	DB02468	C40H38FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYZKGXFDXHPSJI-YLQNXEDKSA-L
19262	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19263	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19264	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19265	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19266	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19267	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19268	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2371	Nojirimycine Tetrazole	-	-	DRUGBANK	DB02471	C6H10N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJXQRFJERKPOZ-KLVWXMOXSA-N
19269	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2372	6-Hydroxy-7,8-Dihydro Purine Nucleoside	-	-	DRUGBANK	DB02472	C10H14N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWTNXGIZBOQCAJ-FCIPNVEPSA-N
19270	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2372	6-Hydroxy-7,8-Dihydro Purine Nucleoside	-	-	DRUGBANK	DB02472	C10H14N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWTNXGIZBOQCAJ-FCIPNVEPSA-N
19271	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2372	6-Hydroxy-7,8-Dihydro Purine Nucleoside	-	-	DRUGBANK	DB02472	C10H14N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWTNXGIZBOQCAJ-FCIPNVEPSA-N
19272	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2373	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02473	C24H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRHANBWAKSYPEN-UHFFFAOYSA-N
19273	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2373	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02473	C24H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRHANBWAKSYPEN-UHFFFAOYSA-N
19274	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2373	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02473	C24H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRHANBWAKSYPEN-UHFFFAOYSA-N
19275	1218551	3635457	C4_01440W_A	NMT1	NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	2376	[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine	-	-	DRUGBANK	DB02477	C33H52N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHLPIOSHBKQGHA-LOYHVIPDSA-N
19276	1218551	3635457	C4_01440W_A	NMT1	NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	2376	[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine	-	-	DRUGBANK	DB02477	C33H52N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHLPIOSHBKQGHA-LOYHVIPDSA-N
19277	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2377	(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02479	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFWHOUCRVSOZJE-CQSZACIVSA-N
19278	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2377	(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02479	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFWHOUCRVSOZJE-CQSZACIVSA-N
19279	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2377	(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02479	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFWHOUCRVSOZJE-CQSZACIVSA-N
19280	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2378	(S)-4-Bromo-3-Hydroxy-3-Methylbutyl Diphosphate	-	-	DRUGBANK	DB02480	C5H13BrO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKAYCWPQDPILSA-RXMQYKEDSA-N
19281	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2378	(S)-4-Bromo-3-Hydroxy-3-Methylbutyl Diphosphate	-	-	DRUGBANK	DB02480	C5H13BrO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKAYCWPQDPILSA-RXMQYKEDSA-N
19282	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2379	N-Benzylformamide	-	-	DRUGBANK	DB02481	C8H9NO	small molecule	-	6343-54-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBOGKHTXBPGEI-UHFFFAOYSA-N
19283	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2379	N-Benzylformamide	-	-	DRUGBANK	DB02481	C8H9NO	small molecule	-	6343-54-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBOGKHTXBPGEI-UHFFFAOYSA-N
19284	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19285	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19286	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19287	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19288	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19289	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19290	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19291	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19292	111554	5567	RP11-82H13.1	PRKACB	PKA C-beta|PKACB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19293	111554	5567	RP11-82H13.1	PRKACB	PKA C-beta|PKACB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19294	111554	5567	RP11-82H13.1	PRKACB	PKA C-beta|PKACB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19295	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19296	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19297	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19298	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19299	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19300	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19301	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2380	Phosphonothreonine	-	-	DRUGBANK	DB02482	C4H10NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRGIUJOYOXOQJ-STHAYSLISA-N
19302	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2381	Etheno-Nad	-	-	DRUGBANK	DB02483	C17H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAISUABIKYXTN-BVNNLCGGSA-N
19303	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2381	Etheno-Nad	-	-	DRUGBANK	DB02483	C17H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAISUABIKYXTN-BVNNLCGGSA-N
19304	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2381	Etheno-Nad	-	-	DRUGBANK	DB02483	C17H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAISUABIKYXTN-BVNNLCGGSA-N
19305	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2381	Etheno-Nad	-	-	DRUGBANK	DB02483	C17H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAISUABIKYXTN-BVNNLCGGSA-N
19306	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2381	Etheno-Nad	-	-	DRUGBANK	DB02483	C17H23N5O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWAISUABIKYXTN-BVNNLCGGSA-N
19307	854488	936809	BSU35740	tagD	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2382	Cytidine 5'-Diphosphoglycerol	-	-	DRUGBANK	DB02484	C12H21N3O13P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHPOUCCVONEPRK-DLGSQSEFSA-N
19308	854488	936809	BSU35740	tagD	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2382	Cytidine 5'-Diphosphoglycerol	-	-	DRUGBANK	DB02484	C12H21N3O13P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHPOUCCVONEPRK-DLGSQSEFSA-N
19309	120993	55907	-	CMAS	CSS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2383	Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid	-	-	DRUGBANK	DB02485	C20H31N4O16P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXCIAUNLDRJGJZ-XPVTVWDUSA-N
19310	120993	55907	-	CMAS	CSS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2383	Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid	-	-	DRUGBANK	DB02485	C20H31N4O16P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXCIAUNLDRJGJZ-XPVTVWDUSA-N
19311	120993	55907	-	CMAS	CSS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2383	Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid	-	-	DRUGBANK	DB02485	C20H31N4O16P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXCIAUNLDRJGJZ-XPVTVWDUSA-N
19312	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2387	(Diaminomethyl-Methyl-Amino)-Acetic Acid	-	-	DRUGBANK	DB02490	C4H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNHURFGTTODJOO-UHFFFAOYSA-N
19313	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2387	(Diaminomethyl-Methyl-Amino)-Acetic Acid	-	-	DRUGBANK	DB02490	C4H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNHURFGTTODJOO-UHFFFAOYSA-N
19314	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2387	(Diaminomethyl-Methyl-Amino)-Acetic Acid	-	-	DRUGBANK	DB02490	C4H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNHURFGTTODJOO-UHFFFAOYSA-N
19315	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2388	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	-	-	DRUGBANK	DB02491	C25H30ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJSSYVIHFXDFFC-UHFFFAOYSA-N
19316	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2388	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	-	-	DRUGBANK	DB02491	C25H30ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJSSYVIHFXDFFC-UHFFFAOYSA-N
19317	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2389	Ghavamiol	-	-	DRUGBANK	DB02492	C9H18NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWOSRVQDYDWMAB-QKCLAQEOSA-K
19318	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2389	Ghavamiol	-	-	DRUGBANK	DB02492	C9H18NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWOSRVQDYDWMAB-QKCLAQEOSA-K
19319	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2389	Ghavamiol	-	-	DRUGBANK	DB02492	C9H18NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWOSRVQDYDWMAB-QKCLAQEOSA-K
19320	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2390	Hydantocidin-5'-Phosphate	-	-	DRUGBANK	DB02493	C7H11N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVXIMXHBUJADCC-MDASVERJSA-N
19321	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2390	Hydantocidin-5'-Phosphate	-	-	DRUGBANK	DB02493	C7H11N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVXIMXHBUJADCC-MDASVERJSA-N
19322	112063	6143	-	RPL19	L19	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19323	112058	6138	TCBAP0781	RPL15	DBA12|EC45|L15|RPL10|RPLY10|RPYL10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19324	114752	9349	-	RPL23	L23|rpL17	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19325	117068	23521	-	RPL13A	L13A|TSTA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19326	126711	140801	-	RPL10L	RPL10_5_1358	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19327	112055	6135	RP11-223J15.3	RPL11	DBA7|GIG34|L11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19328	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19329	119362	51187	My024	RSL24D1	C15orf15|HRP-L30-iso|L30|RLP24|RPL24|RPL24L|TVAS3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19330	112067	6147	-	RPL23A	L23A|MDA20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19331	119308	51121	-	RPL26L1	RPL26P1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19332	112052	6132	-	RPL8	L8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19333	112086	6167	-	RPL37	L37	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19334	112042	6122	OK/SW-cl.32	RPL3	ASC-1|L3|TARBP-B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19335	110874	4809	CTA-216E10.8	NHP2L1	15.5K|FA-1|FA1|NHPX|OTK27|SNRNP15-5|SNU13|SPAG12|SSFA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2391	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	-	-	DRUGBANK	DB02494	C9H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOXXWSYKYCBWHO-QMMMGPOBSA-N
19336	851378	947039	b2564	pdxJ	ECK2562|JW2548	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2393	1-Deoxy-D-xylulose 5-phosphate	-	-	DRUGBANK	DB02496	C5H11O7P	small molecule	-	190079-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJPADPZSRRUGHI-RFZPGFLSSA-N
19337	851378	947039	b2564	pdxJ	ECK2562|JW2548	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2393	1-Deoxy-D-xylulose 5-phosphate	-	-	DRUGBANK	DB02496	C5H11O7P	small molecule	-	190079-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJPADPZSRRUGHI-RFZPGFLSSA-N
19338	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2393	1-Deoxy-D-xylulose 5-phosphate	-	-	DRUGBANK	DB02496	C5H11O7P	small molecule	-	190079-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJPADPZSRRUGHI-RFZPGFLSSA-N
19339	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2393	1-Deoxy-D-xylulose 5-phosphate	-	-	DRUGBANK	DB02496	C5H11O7P	small molecule	-	190079-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJPADPZSRRUGHI-RFZPGFLSSA-N
19340	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2394	L-Alpha-Glycerophosphorylserine	-	-	DRUGBANK	DB02497	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWZWYGMENQVNFU-WHFBIAKZSA-N
19341	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2394	L-Alpha-Glycerophosphorylserine	-	-	DRUGBANK	DB02497	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWZWYGMENQVNFU-WHFBIAKZSA-N
19342	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2394	L-Alpha-Glycerophosphorylserine	-	-	DRUGBANK	DB02497	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWZWYGMENQVNFU-WHFBIAKZSA-N
19343	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2395	Carba-Nicotinamide-Adenine-Dinucleotide	-	-	DRUGBANK	DB02498	C22H29N7O13P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGPLSUKWXXSBCU-QQWIQQAJSA-N
19344	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2395	Carba-Nicotinamide-Adenine-Dinucleotide	-	-	DRUGBANK	DB02498	C22H29N7O13P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGPLSUKWXXSBCU-QQWIQQAJSA-N
19345	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2395	Carba-Nicotinamide-Adenine-Dinucleotide	-	-	DRUGBANK	DB02498	C22H29N7O13P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGPLSUKWXXSBCU-QQWIQQAJSA-N
19346	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2396	Dinor-N(Omega)-Hydroxy-L-Arginine	-	-	DRUGBANK	DB02499	C4H10N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPHCSGPGZUWMRV-REOHCLBHSA-N
19347	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2396	Dinor-N(Omega)-Hydroxy-L-Arginine	-	-	DRUGBANK	DB02499	C4H10N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPHCSGPGZUWMRV-REOHCLBHSA-N
19348	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2396	Dinor-N(Omega)-Hydroxy-L-Arginine	-	-	DRUGBANK	DB02499	C4H10N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPHCSGPGZUWMRV-REOHCLBHSA-N
19349	850618	946259	b1745	astB	ECK1743|JW1734|ydjT	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2398	N~2~-Succinylarginine	-	-	DRUGBANK	DB02501	C10H18N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMOXFSXIFQOWTD-ZCFIWIBFSA-N
19350	850618	946259	b1745	astB	ECK1743|JW1734|ydjT	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2398	N~2~-Succinylarginine	-	-	DRUGBANK	DB02501	C10H18N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMOXFSXIFQOWTD-ZCFIWIBFSA-N
19351	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2400	4-(Carboxyvin-2-Yl)Phenylboronic Acid	-	-	DRUGBANK	DB02503	C9H9BO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEMLKNHGGSYOMP-ZZXKWVIFSA-N
19352	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2400	4-(Carboxyvin-2-Yl)Phenylboronic Acid	-	-	DRUGBANK	DB02503	C9H9BO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEMLKNHGGSYOMP-ZZXKWVIFSA-N
19353	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2400	4-(Carboxyvin-2-Yl)Phenylboronic Acid	-	-	DRUGBANK	DB02503	C9H9BO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEMLKNHGGSYOMP-ZZXKWVIFSA-N
19354	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2401	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	-	-	DRUGBANK	DB02504	C21H25N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQEYCNKFBRLUOT-UHFFFAOYSA-N
19355	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2401	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	-	-	DRUGBANK	DB02504	C21H25N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQEYCNKFBRLUOT-UHFFFAOYSA-N
19356	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2401	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	-	-	DRUGBANK	DB02504	C21H25N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQEYCNKFBRLUOT-UHFFFAOYSA-N
19357	111512	5520	-	PPP2R2A	B55A|B55ALPHA|PR52A|PR55A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19358	111510	5518	-	PPP2R1A	PP2A-Aalpha|PP2AAALPHA|PR65A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19359	111493	5499	-	PPP1CA	PP-1A|PP1A|PP1alpha|PPP1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19360	111519	5527	-	PPP2R5C	B56G|PR61G	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19361	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2403	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	-	-	DRUGBANK	DB02506	C20H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWTFXINHZPXNOX-DZBHQSCQSA-N
19362	107937	1559	RP11-208C17.6	CYP2C9	CPC9|CYP2C|CYP2C10|CYPIIC9|P450IIC9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2404	4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One	-	-	DRUGBANK	DB02507	C19H16O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-HNNXBMFYSA-N
19363	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2405	Isopentyl Pyrophosphate	-	-	DRUGBANK	DB02508	C5H14O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPFXNYPSBSIFOB-UHFFFAOYSA-N
19364	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2405	Isopentyl Pyrophosphate	-	-	DRUGBANK	DB02508	C5H14O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPFXNYPSBSIFOB-UHFFFAOYSA-N
19365	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2405	Isopentyl Pyrophosphate	-	-	DRUGBANK	DB02508	C5H14O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPFXNYPSBSIFOB-UHFFFAOYSA-N
19366	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2405	Isopentyl Pyrophosphate	-	-	DRUGBANK	DB02508	C5H14O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPFXNYPSBSIFOB-UHFFFAOYSA-N
19367	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2406	Farnesol	-	-	DRUGBANK	DB02509	C15H26O	small molecule	-	4602-84-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CRDAMVZIKSXKFV-FBXUGWQNSA-N
19368	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2407	'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02510	C15H21N7O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKVJEMXWEODCAY-WTOVGXSXSA-N
19369	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2407	'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02510	C15H21N7O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKVJEMXWEODCAY-WTOVGXSXSA-N
19370	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2407	'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02510	C15H21N7O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKVJEMXWEODCAY-WTOVGXSXSA-N
19371	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2409	1,6-Fructose Diphosphate (Linear Form)	-	-	DRUGBANK	DB02512	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPYBSIWDXQFNMH-PQLUHFTBSA-N
19372	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2409	1,6-Fructose Diphosphate (Linear Form)	-	-	DRUGBANK	DB02512	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPYBSIWDXQFNMH-PQLUHFTBSA-N
19373	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2409	1,6-Fructose Diphosphate (Linear Form)	-	-	DRUGBANK	DB02512	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPYBSIWDXQFNMH-PQLUHFTBSA-N
19374	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2409	1,6-Fructose Diphosphate (Linear Form)	-	-	DRUGBANK	DB02512	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPYBSIWDXQFNMH-PQLUHFTBSA-N
19375	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2409	1,6-Fructose Diphosphate (Linear Form)	-	-	DRUGBANK	DB02512	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPYBSIWDXQFNMH-PQLUHFTBSA-N
19376	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2409	1,6-Fructose Diphosphate (Linear Form)	-	-	DRUGBANK	DB02512	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPYBSIWDXQFNMH-PQLUHFTBSA-N
19377	851378	947039	b2564	pdxJ	ECK2562|JW2548	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19378	851378	947039	b2564	pdxJ	ECK2562|JW2548	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19379	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19380	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19381	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19382	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19383	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19384	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2412	3-Phosphoglycerol	-	-	DRUGBANK	DB02515	C3H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWUCVROLDVIAJX-GSVOUGTGSA-N
19385	853245	948997	b0038	caiB	ECK0039|JW0037|yaaN	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2413	O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine	-	-	DRUGBANK	DB02516	C28H49N8O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBRISSLDTUHWKG-NBWGOZPRSA-N
19386	853245	948997	b0038	caiB	ECK0039|JW0037|yaaN	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2413	O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine	-	-	DRUGBANK	DB02516	C28H49N8O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBRISSLDTUHWKG-NBWGOZPRSA-N
19387	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2415	N-Acetylalanine	L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine	-	DRUGBANK	DB02518	C5H9NO3	small molecule	-	97-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTHDTJVBEPMMGL-VKHMYHEASA-N
19388	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2415	N-Acetylalanine	L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine	-	DRUGBANK	DB02518	C5H9NO3	small molecule	-	97-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTHDTJVBEPMMGL-VKHMYHEASA-N
19389	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2415	N-Acetylalanine	L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine	-	DRUGBANK	DB02518	C5H9NO3	small molecule	-	97-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTHDTJVBEPMMGL-VKHMYHEASA-N
19390	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2416	Indirubin-5-Sulphonate	-	-	DRUGBANK	DB02519	C16H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHBOEHLUIBMBMY-YPKPFQOOSA-N
19391	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2416	Indirubin-5-Sulphonate	-	-	DRUGBANK	DB02519	C16H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHBOEHLUIBMBMY-YPKPFQOOSA-N
19392	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2416	Indirubin-5-Sulphonate	-	-	DRUGBANK	DB02519	C16H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHBOEHLUIBMBMY-YPKPFQOOSA-N
19393	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2423	CRA_10655	-	-	DRUGBANK	DB02526	C19H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCFWDBPDMBXMTQ-UHFFFAOYSA-N
19394	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2423	CRA_10655	-	-	DRUGBANK	DB02526	C19H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCFWDBPDMBXMTQ-UHFFFAOYSA-N
19395	111563	5577	-	PRKAR2B	PRKAR2|RII-BETA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19396	111563	5577	-	PRKAR2B	PRKAR2|RII-BETA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19397	111563	5577	-	PRKAR2B	PRKAR2|RII-BETA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19398	107081	610	-	HCN2	BCNG-2|BCNG2|HAC-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19399	107081	610	-	HCN2	BCNG-2|BCNG2|HAC-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19400	107081	610	-	HCN2	BCNG-2|BCNG2|HAC-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19401	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19402	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19403	111559	5573	-	PRKAR1A	ACRDYS1|ADOHR|CAR|CNC|CNC1|PKR1|PPNAD1|PRKAR1|TSE1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19404	852178	947867	b3357	crp	ECK3345|JW5702|cap|csm	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19405	852178	947867	b3357	crp	ECK3345|JW5702|cap|csm	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2424	Cyclic Adenosine Monophosphate	cAMP|3',5'-Cyclic AMP|Cyclic adenylic acid|3'-5'-cyclic adenosine monophosphate|Cyclic AMP	-	DRUGBANK	DB02527	C10H12N5O6P	small molecule	-	60-92-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVOMOUWHDPKRLL-ASCDQALMSA-N
19406	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2425	Tetrazolyl Histidine	-	-	DRUGBANK	DB02528	C7H8N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19407	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2425	Tetrazolyl Histidine	-	-	DRUGBANK	DB02528	C7H8N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19408	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2425	Tetrazolyl Histidine	-	-	DRUGBANK	DB02528	C7H8N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19409	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2427	Gamma(Amino)-Butyric Acid	-	-	DRUGBANK	DB02530	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTCSSZJGUNDROE-UHFFFAOYSA-N
19410	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2427	Gamma(Amino)-Butyric Acid	-	-	DRUGBANK	DB02530	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTCSSZJGUNDROE-UHFFFAOYSA-N
19411	609057	728635	-	DHRS4L1	SDR25C4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2429	2,4,6-Triaminoquinazoline	-	-	DRUGBANK	DB02532	C8H9N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJBWEZVYRBKOCI-UHFFFAOYSA-N
19412	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2430	Aminoguanidine	-	-	DRUGBANK	DB02533	CH6N4	small molecule	-	79-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAMNKKUPIHEESI-UHFFFAOYSA-N
19413	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2430	Aminoguanidine	-	-	DRUGBANK	DB02533	CH6N4	small molecule	-	79-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAMNKKUPIHEESI-UHFFFAOYSA-N
19414	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2430	Aminoguanidine	-	-	DRUGBANK	DB02533	CH6N4	small molecule	-	79-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAMNKKUPIHEESI-UHFFFAOYSA-N
19415	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2430	Aminoguanidine	-	-	DRUGBANK	DB02533	CH6N4	small molecule	-	79-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAMNKKUPIHEESI-UHFFFAOYSA-N
19416	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2432	Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide	-	-	DRUGBANK	DB02535	C13H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGGYVKRXFQLYQD-UHFFFAOYSA-N
19417	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2432	Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide	-	-	DRUGBANK	DB02535	C13H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGGYVKRXFQLYQD-UHFFFAOYSA-N
19418	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2435	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	-	-	DRUGBANK	DB02538	C14H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCRPPLDDHBLUES-UHFFFAOYSA-N
19419	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2435	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	-	-	DRUGBANK	DB02538	C14H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCRPPLDDHBLUES-UHFFFAOYSA-N
19420	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2435	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	-	-	DRUGBANK	DB02538	C14H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCRPPLDDHBLUES-UHFFFAOYSA-N
19421	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2436	S-Ethylisothiourea	-	-	DRUGBANK	DB02539	C3H8N2S	small molecule	-	2986-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
19422	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2436	S-Ethylisothiourea	-	-	DRUGBANK	DB02539	C3H8N2S	small molecule	-	2986-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZBHJTOHUOEK-UHFFFAOYSA-N
19423	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2437	(10S)-10-Formyl-5,8,10-Trideazafolic Acid	-	-	DRUGBANK	DB02540	C23H22N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAOQLLQRJAXMGY-RHSMWYFYSA-N
19424	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2437	(10S)-10-Formyl-5,8,10-Trideazafolic Acid	-	-	DRUGBANK	DB02540	C23H22N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAOQLLQRJAXMGY-RHSMWYFYSA-N
19425	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2438	4-Hydroxybutan-1-Aminium	-	-	DRUGBANK	DB02541	C4H12NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFRQYKZFKYQLO-UHFFFAOYSA-O
19426	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2438	4-Hydroxybutan-1-Aminium	-	-	DRUGBANK	DB02541	C4H12NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFRQYKZFKYQLO-UHFFFAOYSA-O
19427	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2438	4-Hydroxybutan-1-Aminium	-	-	DRUGBANK	DB02541	C4H12NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLFRQYKZFKYQLO-UHFFFAOYSA-O
19428	113162	7314	-	UBB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2439	(4s)-5-Fluoro-L-Leucine	-	-	DRUGBANK	DB02542	C6H12FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHOARJRQRXAPOF-WHFBIAKZSA-N
19429	113162	7314	-	UBB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2439	(4s)-5-Fluoro-L-Leucine	-	-	DRUGBANK	DB02542	C6H12FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHOARJRQRXAPOF-WHFBIAKZSA-N
19430	113162	7314	-	UBB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2439	(4s)-5-Fluoro-L-Leucine	-	-	DRUGBANK	DB02542	C6H12FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHOARJRQRXAPOF-WHFBIAKZSA-N
19431	115296	9971	-	NR1H4	BAR|FXR|HRR-1|HRR1|RIP14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2442	Fexaramine	-	-	DRUGBANK	DB02545	C32H36N2O3	small molecule	-	574013-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLQTUNDJHLEFEQ-KGENOOAVSA-N
19432	115296	9971	-	NR1H4	BAR|FXR|HRR-1|HRR1|RIP14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2442	Fexaramine	-	-	DRUGBANK	DB02545	C32H36N2O3	small molecule	-	574013-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLQTUNDJHLEFEQ-KGENOOAVSA-N
19433	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Xu WS (2007)	17694093	181632	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
19434	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	inhibitor	target	Xu WS (2007)	17694093	181632	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
19435	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	inhibitor	target	Xu WS (2007)	17694093	181632	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
19436	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
19437	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	inhibitor	target	Xu WS (2007)	17694093	181632	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
19438	109024	2762	RP1-118B18.1	GMDS	GMD|SDR3E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2444	Guanosine-5'-Diphosphate-Rhamnose	-	-	DRUGBANK	DB02547	C16H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQEBEXMHBLQMDB-DNTSILOFSA-N
19439	109024	2762	RP1-118B18.1	GMDS	GMD|SDR3E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2444	Guanosine-5'-Diphosphate-Rhamnose	-	-	DRUGBANK	DB02547	C16H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQEBEXMHBLQMDB-DNTSILOFSA-N
19440	109024	2762	RP1-118B18.1	GMDS	GMD|SDR3E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2444	Guanosine-5'-Diphosphate-Rhamnose	-	-	DRUGBANK	DB02547	C16H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQEBEXMHBLQMDB-DNTSILOFSA-N
19441	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2445	D-glucitol 6-phosphate	Sorbitol-6-phosphate|Sorbitol 6-phosphate|D-sorbitol-6-phosphate|D-Sorbitol 6-phosphate|D-Glucitol, 6-(dihydrogen phosphate)	-	DRUGBANK	DB02548	C6H15O9P	small molecule	-	20479-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GACTWZZMVMUKNG-SLPGGIOYSA-N
19442	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2445	D-glucitol 6-phosphate	Sorbitol-6-phosphate|Sorbitol 6-phosphate|D-sorbitol-6-phosphate|D-Sorbitol 6-phosphate|D-Glucitol, 6-(dihydrogen phosphate)	-	DRUGBANK	DB02548	C6H15O9P	small molecule	-	20479-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GACTWZZMVMUKNG-SLPGGIOYSA-N
19443	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2445	D-glucitol 6-phosphate	Sorbitol-6-phosphate|Sorbitol 6-phosphate|D-sorbitol-6-phosphate|D-Sorbitol 6-phosphate|D-Glucitol, 6-(dihydrogen phosphate)	-	DRUGBANK	DB02548	C6H15O9P	small molecule	-	20479-58-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GACTWZZMVMUKNG-SLPGGIOYSA-N
19444	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2447	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB02550	C20H21ClFN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCIOVTSUEXGUFJ-UHFFFAOYSA-N
19445	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2448	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02551	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNMYQLXKMSQTG-AWEZNQCLSA-N
19446	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2448	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02551	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNMYQLXKMSQTG-AWEZNQCLSA-N
19447	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2448	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02551	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNMYQLXKMSQTG-AWEZNQCLSA-N
19448	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2449	Geranyl Diphosphate	-	-	DRUGBANK	DB02552	C10H20O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVVPGTZRZFNKDS-JXMROGBWSA-N
19449	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2449	Geranyl Diphosphate	-	-	DRUGBANK	DB02552	C10H20O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVVPGTZRZFNKDS-JXMROGBWSA-N
19450	849446	945057	b2746	ispF	ECK2741|JW2716|ygbB	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2449	Geranyl Diphosphate	-	-	DRUGBANK	DB02552	C10H20O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVVPGTZRZFNKDS-JXMROGBWSA-N
19451	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2450	Glutathionylspermidine Disulfide	-	-	DRUGBANK	DB02553	C34H66N12O10S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCMZDPYSWPSKSP-XDZVQPMWSA-N
19452	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2450	Glutathionylspermidine Disulfide	-	-	DRUGBANK	DB02553	C34H66N12O10S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCMZDPYSWPSKSP-XDZVQPMWSA-N
19453	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2452	SP4160	-	-	DRUGBANK	DB02555	C33H42Cl2N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCXMTWSYQSVWRK-AREMUKBSSA-N
19454	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2452	SP4160	-	-	DRUGBANK	DB02555	C33H42Cl2N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCXMTWSYQSVWRK-AREMUKBSSA-N
19455	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2452	SP4160	-	-	DRUGBANK	DB02555	C33H42Cl2N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCXMTWSYQSVWRK-AREMUKBSSA-N
19456	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2453	D-Phenylalanine	-	-	DRUGBANK	DB02556	C9H11NO2	small molecule	-	673-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-MRVPVSSYSA-N
19457	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2453	D-Phenylalanine	-	-	DRUGBANK	DB02556	C9H11NO2	small molecule	-	673-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-MRVPVSSYSA-N
19458	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2453	D-Phenylalanine	-	-	DRUGBANK	DB02556	C9H11NO2	small molecule	-	673-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COLNVLDHVKWLRT-MRVPVSSYSA-N
19459	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2454	Phosphoramidon	-	-	DRUGBANK	DB02557	C23H34N3O10P	small molecule	-	36357-77-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPHBZEQOLSRPAK-XLCYBJAPSA-N
19460	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2455	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	-	-	DRUGBANK	DB02558	C21H24N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNILVMARPONFBX-JCGIZDLHSA-N
19461	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2455	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	-	-	DRUGBANK	DB02558	C21H24N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNILVMARPONFBX-JCGIZDLHSA-N
19462	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2455	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	-	-	DRUGBANK	DB02558	C21H24N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNILVMARPONFBX-JCGIZDLHSA-N
19463	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2456	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	-	-	DRUGBANK	DB02559	C17H33N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQIGGQUKAQTGU-SZTTVXCBSA-N
19464	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2456	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	-	-	DRUGBANK	DB02559	C17H33N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQIGGQUKAQTGU-SZTTVXCBSA-N
19465	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2456	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	-	-	DRUGBANK	DB02559	C17H33N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQIGGQUKAQTGU-SZTTVXCBSA-N
19466	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2459	Quinonoid 7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB02562	C9H13N5O3	small molecule	-	79647-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHQJVZLJDXWFFX-KODRXGBYSA-N
19467	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2459	Quinonoid 7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB02562	C9H13N5O3	small molecule	-	79647-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHQJVZLJDXWFFX-KODRXGBYSA-N
19468	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2460	Hexanoyl-Coenzyme A	-	-	DRUGBANK	DB02563	C27H46N7O17P3S	small molecule	-	5060-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEXFMSFODMQEPE-CGSNXLPNSA-N
19469	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2460	Hexanoyl-Coenzyme A	-	-	DRUGBANK	DB02563	C27H46N7O17P3S	small molecule	-	5060-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEXFMSFODMQEPE-CGSNXLPNSA-N
19470	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2460	Hexanoyl-Coenzyme A	-	-	DRUGBANK	DB02563	C27H46N7O17P3S	small molecule	-	5060-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEXFMSFODMQEPE-CGSNXLPNSA-N
19471	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2461	4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide	-	-	DRUGBANK	DB02565	C16H25N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXWDXXXCTLNLQS-OAHLLOKOSA-N
19472	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2461	4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide	-	-	DRUGBANK	DB02565	C16H25N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXWDXXXCTLNLQS-OAHLLOKOSA-N
19473	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2461	4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide	-	-	DRUGBANK	DB02565	C16H25N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXWDXXXCTLNLQS-OAHLLOKOSA-N
19474	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2464	Peldesine	Peldesine|2-Amino-3,5-dihydro-7-(3-pyridylmethyl)-4H-pyrrolo(3,2-d)pyrimidin-4-one|4H-Pyrrolo(3,2-d)pyrimidin-4-one, 2-amino-3,5-dihydro-7-(3-pyridinylmethyl)-	-	DRUGBANK	DB02568	C12H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOHVAKFYAHLCJP-UHFFFAOYSA-N
19475	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2464	Peldesine	Peldesine|2-Amino-3,5-dihydro-7-(3-pyridylmethyl)-4H-pyrrolo(3,2-d)pyrimidin-4-one|4H-Pyrrolo(3,2-d)pyrimidin-4-one, 2-amino-3,5-dihydro-7-(3-pyridinylmethyl)-	-	DRUGBANK	DB02568	C12H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOHVAKFYAHLCJP-UHFFFAOYSA-N
19476	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2465	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate	-	-	DRUGBANK	DB02569	C10H14N2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXCAIISEDMYORY-JGVFFNPUSA-N
19477	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2465	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate	-	-	DRUGBANK	DB02569	C10H14N2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXCAIISEDMYORY-JGVFFNPUSA-N
19478	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2465	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate	-	-	DRUGBANK	DB02569	C10H14N2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXCAIISEDMYORY-JGVFFNPUSA-N
19479	107276	826	-	CAPNS1	CALPAIN4|CANP|CANPS|CAPN4|CDPS|CSS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2466	PD150606	-	-	DRUGBANK	DB02570	C9H9IO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXQYDIIKDPMYMF-QMMMGPOBSA-N
19480	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2469	2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate	-	-	DRUGBANK	DB02573	C19H25N8O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYWWDKIADIGKTH-NJTCAMEISA-N
19481	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2469	2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate	-	-	DRUGBANK	DB02573	C19H25N8O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYWWDKIADIGKTH-NJTCAMEISA-N
19482	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2469	2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate	-	-	DRUGBANK	DB02573	C19H25N8O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYWWDKIADIGKTH-NJTCAMEISA-N
19483	111238	5217	-	PFN2	D3S1319E|PFL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2475	1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane	-	-	DRUGBANK	DB02580	C12H26O6	small molecule	-	1191-87-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMDPGPKXQDIQQG-UHFFFAOYSA-N
19484	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2476	5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid	-	-	DRUGBANK	DB02581	C30H37Cl2N7O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNZHOIDQBPFEJU-OAQYLSRUSA-N
19485	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2476	5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid	-	-	DRUGBANK	DB02581	C30H37Cl2N7O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNZHOIDQBPFEJU-OAQYLSRUSA-N
19486	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2476	5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid	-	-	DRUGBANK	DB02581	C30H37Cl2N7O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNZHOIDQBPFEJU-OAQYLSRUSA-N
19487	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2478	N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine	-	-	DRUGBANK	DB02583	C17H20N6O2	small molecule	-	175354-76-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZTFNSCZLJLPEO-UHFFFAOYSA-N
19488	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2478	N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine	-	-	DRUGBANK	DB02583	C17H20N6O2	small molecule	-	175354-76-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZTFNSCZLJLPEO-UHFFFAOYSA-N
19489	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2478	N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine	-	-	DRUGBANK	DB02583	C17H20N6O2	small molecule	-	175354-76-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZTFNSCZLJLPEO-UHFFFAOYSA-N
19490	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2479	4-(Hydroxymethyl)Benzamidine	-	-	DRUGBANK	DB02585	C8H10N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMKAFNJMLEDSN-UHFFFAOYSA-N
19491	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2479	4-(Hydroxymethyl)Benzamidine	-	-	DRUGBANK	DB02585	C8H10N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMKAFNJMLEDSN-UHFFFAOYSA-N
19492	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2479	4-(Hydroxymethyl)Benzamidine	-	-	DRUGBANK	DB02585	C8H10N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMKAFNJMLEDSN-UHFFFAOYSA-N
19493	106624	111	-	ADCY5	AC5|FDFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2481	Colforsin	Forskolin	-	DRUGBANK	DB02587	C22H34O7	small molecule	-	66575-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHCQJHSOBUTRHG-KGGHGJDLSA-N
19494	106622	108	-	ADCY2	AC2|HBAC2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2481	Colforsin	Forskolin	-	DRUGBANK	DB02587	C22H34O7	small molecule	-	66575-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHCQJHSOBUTRHG-KGGHGJDLSA-N
19495	109040	2778	RP4-543J19.4	GNAS	AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PHP1A|PHP1B|PHP1C|POH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2481	Colforsin	Forskolin	-	DRUGBANK	DB02587	C22H34O7	small molecule	-	66575-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHCQJHSOBUTRHG-KGGHGJDLSA-N
19496	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2482	Moxalactam Derivative	-	-	DRUGBANK	DB02588	C18H18N2O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYYVEEGHXUADBF-PDSMFRHLSA-N
19497	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2482	Moxalactam Derivative	-	-	DRUGBANK	DB02588	C18H18N2O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYYVEEGHXUADBF-PDSMFRHLSA-N
19498	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2482	Moxalactam Derivative	-	-	DRUGBANK	DB02588	C18H18N2O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYYVEEGHXUADBF-PDSMFRHLSA-N
19499	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2483	Se-Ethyl-Isoselenourea	-	-	DRUGBANK	DB02589	C3H8N2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFKYNFXDBBLWGF-UHFFFAOYSA-N
19500	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2483	Se-Ethyl-Isoselenourea	-	-	DRUGBANK	DB02589	C3H8N2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFKYNFXDBBLWGF-UHFFFAOYSA-N
19501	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2483	Se-Ethyl-Isoselenourea	-	-	DRUGBANK	DB02589	C3H8N2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFKYNFXDBBLWGF-UHFFFAOYSA-N
19502	852856	948562	b4055	aphA	ECK4047|JW4015|hobH|napA|yjbP	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2488	2'-Deoxycytidine	dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC	-	DRUGBANK	DB02594	C9H13N3O4	small molecule	-	951-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKTSBUTUHBMZGZ-SHYZEUOFSA-N
19503	852856	948562	b4055	aphA	ECK4047|JW4015|hobH|napA|yjbP	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2488	2'-Deoxycytidine	dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC	-	DRUGBANK	DB02594	C9H13N3O4	small molecule	-	951-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKTSBUTUHBMZGZ-SHYZEUOFSA-N
19504	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2488	2'-Deoxycytidine	dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC	-	DRUGBANK	DB02594	C9H13N3O4	small molecule	-	951-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKTSBUTUHBMZGZ-SHYZEUOFSA-N
19505	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2488	2'-Deoxycytidine	dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC	-	DRUGBANK	DB02594	C9H13N3O4	small molecule	-	951-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKTSBUTUHBMZGZ-SHYZEUOFSA-N
19506	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2488	2'-Deoxycytidine	dCYD|Deoxyribose cytidine|1-(2-deoxy-.beta.-d-ribofuranosyl)cytosine|4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinone|dC	-	DRUGBANK	DB02594	C9H13N3O4	small molecule	-	951-77-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKTSBUTUHBMZGZ-SHYZEUOFSA-N
19507	853185	948908	b4392	slt	ECK4384|JW4355|sltY	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2489	Bulgecin A	-	-	DRUGBANK	DB02595	C16H30N3O14S2	small molecule	-	92953-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPNZWZDLNYCCIG-RWQOYFMZSA-O
19508	853185	948908	b4392	slt	ECK4384|JW4355|sltY	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2489	Bulgecin A	-	-	DRUGBANK	DB02595	C16H30N3O14S2	small molecule	-	92953-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPNZWZDLNYCCIG-RWQOYFMZSA-O
19509	851516	947184	b2701	mltB	ECK2696|JW2671	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2489	Bulgecin A	-	-	DRUGBANK	DB02595	C16H30N3O14S2	small molecule	-	92953-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPNZWZDLNYCCIG-RWQOYFMZSA-O
19510	851516	947184	b2701	mltB	ECK2696|JW2671	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2489	Bulgecin A	-	-	DRUGBANK	DB02595	C16H30N3O14S2	small molecule	-	92953-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPNZWZDLNYCCIG-RWQOYFMZSA-O
19511	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2490	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02596	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWZRIXWFRFUQB-WOIOKPISSA-N
19512	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2490	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02596	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWZRIXWFRFUQB-WOIOKPISSA-N
19513	855957	938339	BSU03130	nadE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2490	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02596	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWZRIXWFRFUQB-WOIOKPISSA-N
19514	855957	938339	BSU03130	nadE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2490	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02596	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWZRIXWFRFUQB-WOIOKPISSA-N
19515	131564	349565	FKSG76	NMNAT3	PNAT-3|PNAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2490	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02596	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWZRIXWFRFUQB-WOIOKPISSA-N
19516	131564	349565	FKSG76	NMNAT3	PNAT-3|PNAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2490	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	-	-	DRUGBANK	DB02596	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWZRIXWFRFUQB-WOIOKPISSA-N
19517	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2491	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	-	-	DRUGBANK	DB02597	C19H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOIYKVXXGCPHQU-BPUTZDHNSA-N
19518	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2491	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	-	-	DRUGBANK	DB02597	C19H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOIYKVXXGCPHQU-BPUTZDHNSA-N
19519	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2491	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	-	-	DRUGBANK	DB02597	C19H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOIYKVXXGCPHQU-BPUTZDHNSA-N
19520	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2492	N-Alpha-Acetyl-3,5-Diiodotyrosylglycine	-	-	DRUGBANK	DB02598	C13H14I2N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXRYVFRVDCDPKH-JTQLQIEISA-N
19521	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2492	N-Alpha-Acetyl-3,5-Diiodotyrosylglycine	-	-	DRUGBANK	DB02598	C13H14I2N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXRYVFRVDCDPKH-JTQLQIEISA-N
19522	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2492	N-Alpha-Acetyl-3,5-Diiodotyrosylglycine	-	-	DRUGBANK	DB02598	C13H14I2N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXRYVFRVDCDPKH-JTQLQIEISA-N
19523	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2496	AL7182	-	-	DRUGBANK	DB02602	C13H14N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICIXQGGQPKFQRL-UHFFFAOYSA-N
19524	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2496	AL7182	-	-	DRUGBANK	DB02602	C13H14N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICIXQGGQPKFQRL-UHFFFAOYSA-N
19525	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2496	AL7182	-	-	DRUGBANK	DB02602	C13H14N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICIXQGGQPKFQRL-UHFFFAOYSA-N
19526	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2497	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	-	-	DRUGBANK	DB02603	C13H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPUIDVRYMVIXGO-UHFFFAOYSA-N
19527	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2497	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	-	-	DRUGBANK	DB02603	C13H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPUIDVRYMVIXGO-UHFFFAOYSA-N
19528	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2497	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	-	-	DRUGBANK	DB02603	C13H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPUIDVRYMVIXGO-UHFFFAOYSA-N
19529	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2498	2-Deoxy-Glucose-6-Phosphate	-	-	DRUGBANK	DB02604	C6H13O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQJFZAAGZAYVKZ-KAZBKCHUSA-N
19530	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2498	2-Deoxy-Glucose-6-Phosphate	-	-	DRUGBANK	DB02604	C6H13O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQJFZAAGZAYVKZ-KAZBKCHUSA-N
19531	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2498	2-Deoxy-Glucose-6-Phosphate	-	-	DRUGBANK	DB02604	C6H13O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQJFZAAGZAYVKZ-KAZBKCHUSA-N
19532	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2500	Adenosine Phosphonoacetic Acid	-	-	DRUGBANK	DB02607	C12H16N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJNLSEOJEFDELT-REFFQAGNSA-N
19533	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2500	Adenosine Phosphonoacetic Acid	-	-	DRUGBANK	DB02607	C12H16N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJNLSEOJEFDELT-REFFQAGNSA-N
19534	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2500	Adenosine Phosphonoacetic Acid	-	-	DRUGBANK	DB02607	C12H16N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJNLSEOJEFDELT-REFFQAGNSA-N
19535	849317	944919	b0052	pdxA	ECK0053|JW0051	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2502	4-Hydroxy-L-Threonine-5-Monophosphate	-	-	DRUGBANK	DB02609	C4H10NO7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKHAKIJOKDGEII-HRFVKAFMSA-N
19536	849317	944919	b0052	pdxA	ECK0053|JW0051	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2502	4-Hydroxy-L-Threonine-5-Monophosphate	-	-	DRUGBANK	DB02609	C4H10NO7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKHAKIJOKDGEII-HRFVKAFMSA-N
19537	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2503	N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02610	C14H9F5N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRKSHOLYETXPGY-UHFFFAOYSA-N
19538	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2503	N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02610	C14H9F5N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRKSHOLYETXPGY-UHFFFAOYSA-N
19539	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2503	N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB02610	C14H9F5N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRKSHOLYETXPGY-UHFFFAOYSA-N
19540	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2504	Balanol Analog 1	-	-	DRUGBANK	DB02611	C20H22N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZJQHARRQUNVGZ-QZTJIDSGSA-N
19541	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19542	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19543	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19544	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19545	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19546	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19547	111409	5408	-	PNLIPRP2	PLRP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
19548	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19549	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19550	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19551	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2507	Compound 19	-	-	DRUGBANK	DB02615	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19552	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2508	FR117016	-	-	DRUGBANK	DB02616	C16H15N7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKJGKHXCUDWFDC-UHFFFAOYSA-N
19553	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2512	Sp7343-Sp7964	-	-	DRUGBANK	DB02620	C19H27N5O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMSKFAYIWROESZ-HDJSIYSDSA-N
19554	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2512	Sp7343-Sp7964	-	-	DRUGBANK	DB02620	C19H27N5O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMSKFAYIWROESZ-HDJSIYSDSA-N
19555	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2513	Latrunculin A	LAT-A|LatA|(+)-latrunculin A|(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one	-	DRUGBANK	DB02621	C22H31NO5S	small molecule	-	76343-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDVBPZROPPMBLW-IZGXTMSKSA-N
19556	109189	2934	RP11-477J21.1	GSN	ADF|AGEL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2513	Latrunculin A	LAT-A|LatA|(+)-latrunculin A|(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one	-	DRUGBANK	DB02621	C22H31NO5S	small molecule	-	76343-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDVBPZROPPMBLW-IZGXTMSKSA-N
19557	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2514	2-(Oxalyl-Amino)-Benzoic Acid	-	-	DRUGBANK	DB02622	C9H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBYNNSFEMMNINN-UHFFFAOYSA-N
19558	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2514	2-(Oxalyl-Amino)-Benzoic Acid	-	-	DRUGBANK	DB02622	C9H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBYNNSFEMMNINN-UHFFFAOYSA-N
19559	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2514	2-(Oxalyl-Amino)-Benzoic Acid	-	-	DRUGBANK	DB02622	C9H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBYNNSFEMMNINN-UHFFFAOYSA-N
19560	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2515	Aminophosphonic Acid-Guanylate Ester	-	-	DRUGBANK	DB02623	C10H16N6O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGPDMUBRWRJAQQ-BZKDHIKHSA-N
19561	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2515	Aminophosphonic Acid-Guanylate Ester	-	-	DRUGBANK	DB02623	C10H16N6O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGPDMUBRWRJAQQ-BZKDHIKHSA-N
19562	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2515	Aminophosphonic Acid-Guanylate Ester	-	-	DRUGBANK	DB02623	C10H16N6O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGPDMUBRWRJAQQ-BZKDHIKHSA-N
19563	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2516	Homoserine Lactone	-	-	DRUGBANK	DB02624	C4H7NO2	small molecule	-	1192-20-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJPWUUJVYOJNMH-GSVOUGTGSA-N
19564	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2516	Homoserine Lactone	-	-	DRUGBANK	DB02624	C4H7NO2	small molecule	-	1192-20-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJPWUUJVYOJNMH-GSVOUGTGSA-N
19565	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2518	Phenylferricrocin-Iron	-	-	DRUGBANK	DB02626	C34H51FeN9O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJKVBDKBQHKHPK-OVSNALSBSA-N
19566	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2518	Phenylferricrocin-Iron	-	-	DRUGBANK	DB02626	C34H51FeN9O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJKVBDKBQHKHPK-OVSNALSBSA-N
19567	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2519	4,4'-Biphenyldiboronic Acid	-	-	DRUGBANK	DB02627	C12H12B2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLHKDOGTVUCXKX-UHFFFAOYSA-N
19568	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2519	4,4'-Biphenyldiboronic Acid	-	-	DRUGBANK	DB02627	C12H12B2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLHKDOGTVUCXKX-UHFFFAOYSA-N
19569	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2519	4,4'-Biphenyldiboronic Acid	-	-	DRUGBANK	DB02627	C12H12B2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLHKDOGTVUCXKX-UHFFFAOYSA-N
19570	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2520	1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide	-	-	DRUGBANK	DB02628	C25H38N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUJIMRZGUBTJRV-NASSWSRMSA-N
19571	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2520	1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide	-	-	DRUGBANK	DB02628	C25H38N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUJIMRZGUBTJRV-NASSWSRMSA-N
19572	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2520	1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide	-	-	DRUGBANK	DB02628	C25H38N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUJIMRZGUBTJRV-NASSWSRMSA-N
19573	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2522	L-xylitol 5-phosphate	Xylitol 5-P|Xylitol 5-phosphate	-	DRUGBANK	DB02630	C5H13O8P	small molecule	-	64913-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJDOAZKNBQCAGE-WISUUJSJSA-N
19574	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2522	L-xylitol 5-phosphate	Xylitol 5-P|Xylitol 5-phosphate	-	DRUGBANK	DB02630	C5H13O8P	small molecule	-	64913-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJDOAZKNBQCAGE-WISUUJSJSA-N
19575	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2524	4-nitrophenyl-beta-D-galactoside	p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose	-	DRUGBANK	DB02632	C12H15NO8	small molecule	-	3150-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFBHRQDFSNCLOZ-YBXAARCKSA-N
19576	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2524	4-nitrophenyl-beta-D-galactoside	p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose	-	DRUGBANK	DB02632	C12H15NO8	small molecule	-	3150-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFBHRQDFSNCLOZ-YBXAARCKSA-N
19577	850046	945674	b0342	lacA	ECK0339|JW0333	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2524	4-nitrophenyl-beta-D-galactoside	p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose	-	DRUGBANK	DB02632	C12H15NO8	small molecule	-	3150-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFBHRQDFSNCLOZ-YBXAARCKSA-N
19578	850046	945674	b0342	lacA	ECK0339|JW0333	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2524	4-nitrophenyl-beta-D-galactoside	p-Nitrophenyl-beta-D-galactoside|4-Nitrophenylgalactoside|4-Nitrophenyl-beta-D-galactopyranoside|1-O-[p-nitrophenyl]-beta-D-galactopyranose|1-O-(4-nitrophenyl)--D-galactopyranose|p-Nitrophenyl beta-D-galactopyranoside|4-nitrophenyl--D-galactopyranoside|1-O-(4-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactose|1-O-(p-nitrophenyl)--D-galactopyranose	-	DRUGBANK	DB02632	C12H15NO8	small molecule	-	3150-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFBHRQDFSNCLOZ-YBXAARCKSA-N
19579	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19580	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19581	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19582	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19583	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2525	Cibacron Blue	-	-	DRUGBANK	DB02633	C29H20ClN7O11S3	small molecule	-	84166-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKCWQPZFAFZLBI-UHFFFAOYSA-N
19584	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2526	N-[O-Phosphono-Pyridoxyl]-Isoleucine	-	-	DRUGBANK	DB02635	C14H23N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZZDWFDWHXPWJK-PELKAZGASA-N
19585	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2526	N-[O-Phosphono-Pyridoxyl]-Isoleucine	-	-	DRUGBANK	DB02635	C14H23N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZZDWFDWHXPWJK-PELKAZGASA-N
19586	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2527	9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid	-	-	DRUGBANK	DB02636	C17H11NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCLGCTLOEZZSLA-UHFFFAOYSA-N
19587	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2528	Oxaloacetate Ion	-	-	DRUGBANK	DB02637	C4H3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPXUQMNIQBQEV-UHFFFAOYSA-M
19588	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2528	Oxaloacetate Ion	-	-	DRUGBANK	DB02637	C4H3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPXUQMNIQBQEV-UHFFFAOYSA-M
19589	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2528	Oxaloacetate Ion	-	-	DRUGBANK	DB02637	C4H3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPXUQMNIQBQEV-UHFFFAOYSA-M
19590	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2528	Oxaloacetate Ion	-	-	DRUGBANK	DB02637	C4H3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPXUQMNIQBQEV-UHFFFAOYSA-M
19591	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2528	Oxaloacetate Ion	-	-	DRUGBANK	DB02637	C4H3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPXUQMNIQBQEV-UHFFFAOYSA-M
19592	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2528	Oxaloacetate Ion	-	-	DRUGBANK	DB02637	C4H3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPXUQMNIQBQEV-UHFFFAOYSA-M
19593	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Yi X (2007)	17287200	71892	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19594	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Boson WL (2006)	17020465	172148	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19595	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Slusarz MJ (2006)	16333859	171922	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19596	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	agonist	target	Bouley R (2006)	16563128	172149	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19597	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Young WS (2006)	17027167	172152	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19598	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Slusarz MJ (2006)	16114100	172153	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19599	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Jurkevich A (2005)	15993108	172150	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19600	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Volpi S (2006)	16720725	172151	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19601	107034	553	-	AVPR1B	AVPR3	9606	Homo sapiens	unknown	target	Wersinger SR (2007)	17284170	172154	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19602	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	stimulator	target	Hammock EA (2005)	16011575	172158	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19603	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	stimulator	target	Liedman R (2006)	16532916	172159	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19604	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	stimulator	target	Chen X (2002)	11752352	171740	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19605	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	stimulator	target	Aoyagi T (2007)	17303660	172156	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19606	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	stimulator	target	Adikesavan NV (2005)	16511036	172157	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19607	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	stimulator	target	Hiroyama M (2007)	17275806	172155	2529	Terlipressin	Terlipressine|Terlipressina|Terlipressinum|Terlipressin	-	DRUGBANK	DB02638	C52H74N16O15S2	small molecule	H01BA04	14636-12-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BENFXAYNYRLAIU-QSVFAHTRSA-N
19608	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	ligand	target	Chen X (2002)	11752352	171740	2531	Fumagillin	-	-	DRUGBANK	DB02640	C26H36O7	small molecule	P01AX10	23110-15-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXVWUXWNPOXVQB-GJNCDYHDSA-N
19609	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2534	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	-	-	DRUGBANK	DB02643	C17H38NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZWSFJTYBVKZNK-UHFFFAOYSA-O
19610	109700	3479	-	IGF1	IGF-I|IGF1A|IGFI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2534	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	-	-	DRUGBANK	DB02643	C17H38NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZWSFJTYBVKZNK-UHFFFAOYSA-O
19611	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19612	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19613	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19614	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19615	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19616	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19617	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2537	Nitrosoethane	-	-	DRUGBANK	DB02646	C2H5NO	small molecule	-	925-91-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFYCAQIXDKZDTB-UHFFFAOYSA-N
19618	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2537	Nitrosoethane	-	-	DRUGBANK	DB02646	C2H5NO	small molecule	-	925-91-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFYCAQIXDKZDTB-UHFFFAOYSA-N
19619	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2537	Nitrosoethane	-	-	DRUGBANK	DB02646	C2H5NO	small molecule	-	925-91-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFYCAQIXDKZDTB-UHFFFAOYSA-N
19620	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2538	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	-	-	DRUGBANK	DB02647	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUCORKWTQSQFFU-UHFFFAOYSA-N
19621	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2538	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	-	-	DRUGBANK	DB02647	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUCORKWTQSQFFU-UHFFFAOYSA-N
19622	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2538	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	-	-	DRUGBANK	DB02647	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUCORKWTQSQFFU-UHFFFAOYSA-N
19623	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2539	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	-	-	DRUGBANK	DB02648	C7H16NO3	small molecule	-	461-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-O
19624	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2539	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	-	-	DRUGBANK	DB02648	C7H16NO3	small molecule	-	461-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-O
19625	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2539	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	-	-	DRUGBANK	DB02648	C7H16NO3	small molecule	-	461-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-O
19626	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2539	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	-	-	DRUGBANK	DB02648	C7H16NO3	small molecule	-	461-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-O
19627	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2539	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	-	-	DRUGBANK	DB02648	C7H16NO3	small molecule	-	461-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-O
19628	107774	1384	RP11-247A12.5	CRAT	CAT1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2539	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	-	-	DRUGBANK	DB02648	C7H16NO3	small molecule	-	461-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHIQHXFUZVPYII-ZCFIWIBFSA-O
19629	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2542	{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)	-	-	DRUGBANK	DB02651	C29H23F6N3O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTAGTGWPDROBMG-UHFFFAOYSA-N
19630	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2542	{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)	-	-	DRUGBANK	DB02651	C29H23F6N3O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTAGTGWPDROBMG-UHFFFAOYSA-N
19631	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2543	L-[(N-Hydroxyamino)Carbonyl]Phenylalanine	-	-	DRUGBANK	DB02652	C10H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOFPEOPOAMOMBE-QMMMGPOBSA-N
19632	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19633	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19634	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19635	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2547	2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One	-	-	DRUGBANK	DB02656	C19H17NO3	small molecule	-	154447-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZQHHVNHHHRRDU-UHFFFAOYSA-N
19636	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2548	Glucosamine 6-Phosphate	-	-	DRUGBANK	DB02657	C6H14NO8P	small molecule	-	3616-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHMJOUIAFHJHBW-VFUOTHLCSA-N
19637	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2548	Glucosamine 6-Phosphate	-	-	DRUGBANK	DB02657	C6H14NO8P	small molecule	-	3616-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHMJOUIAFHJHBW-VFUOTHLCSA-N
19638	854301	936621	BSU35010	nagA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2548	Glucosamine 6-Phosphate	-	-	DRUGBANK	DB02657	C6H14NO8P	small molecule	-	3616-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHMJOUIAFHJHBW-VFUOTHLCSA-N
19639	854301	936621	BSU35010	nagA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2548	Glucosamine 6-Phosphate	-	-	DRUGBANK	DB02657	C6H14NO8P	small molecule	-	3616-42-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHMJOUIAFHJHBW-VFUOTHLCSA-N
19640	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19641	107732	1339	-	COX6A2	COX6AH|COXVIAH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19642	108526	2235	-	FECH	EPP|FCE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19643	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19644	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19645	107739	1346	-	COX7A1	COX7A|COX7AH|COX7AM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19646	110616	4513	-	COX2	COII|MTCO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19647	108470	2172	-	FABP6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19648	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19649	107742	1349	-	COX7B	APLCC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19650	107720	1327	-	COX4I1	COX4|COX4-1|COXIV	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19651	110617	4514	-	COX3	COIII|MTCO3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19652	114778	9377	-	COX5A	COX|COX-VA|VA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19653	108526	2235	-	FECH	EPP|FCE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19654	108526	2235	-	FECH	EPP|FCE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19655	107733	1340	-	COX6B1	COX6B|COXG|COXVIb1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19656	110615	4512	-	COX1	COI|MTCO1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19657	107744	1351	-	COX8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19658	107743	1350	-	COX7C	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19659	107722	1329	-	COX5B	COXVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19660	107738	1345	-	COX6C	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19661	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2551	Filaminast	-	-	DRUGBANK	DB02660	C15H20N2O4	small molecule	-	141184-34-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STTRYQAGHGJXJJ-LICLKQGHSA-N
19662	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2551	Filaminast	-	-	DRUGBANK	DB02660	C15H20N2O4	small molecule	-	141184-34-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STTRYQAGHGJXJJ-LICLKQGHSA-N
19663	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2551	Filaminast	-	-	DRUGBANK	DB02660	C15H20N2O4	small molecule	-	141184-34-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STTRYQAGHGJXJJ-LICLKQGHSA-N
19664	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2552	Adenosine-5'-Diphosphate-2',3'-Vanadate	-	-	DRUGBANK	DB02661	C10H13N5O12P2V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUULDHXBMSNFAO-YVAIFPRKSA-N
19665	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2552	Adenosine-5'-Diphosphate-2',3'-Vanadate	-	-	DRUGBANK	DB02661	C10H13N5O12P2V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUULDHXBMSNFAO-YVAIFPRKSA-N
19666	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2552	Adenosine-5'-Diphosphate-2',3'-Vanadate	-	-	DRUGBANK	DB02661	C10H13N5O12P2V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUULDHXBMSNFAO-YVAIFPRKSA-N
19667	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2553	Novo Nordisk a/S Compound	-	-	DRUGBANK	DB02662	C9H6INO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSWHSQPJKMCPN-UHFFFAOYSA-N
19668	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2553	Novo Nordisk a/S Compound	-	-	DRUGBANK	DB02662	C9H6INO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSWHSQPJKMCPN-UHFFFAOYSA-N
19669	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2553	Novo Nordisk a/S Compound	-	-	DRUGBANK	DB02662	C9H6INO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSWHSQPJKMCPN-UHFFFAOYSA-N
19670	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2556	Trans-2-Phenylcyclopropylamine	-	-	DRUGBANK	DB02665	C9H12N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-DTWKUNHWSA-O
19671	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2556	Trans-2-Phenylcyclopropylamine	-	-	DRUGBANK	DB02665	C9H12N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-DTWKUNHWSA-O
19672	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2556	Trans-2-Phenylcyclopropylamine	-	-	DRUGBANK	DB02665	C9H12N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AELCINSCMGFISI-DTWKUNHWSA-O
19673	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2557	(C8-R)-Hydantocidin 5'-Phosphate	[8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE	-	DRUGBANK	DB02666	C13H22N3O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAXSFYCTFIBEAR-MHHWUYOGSA-N
19674	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2557	(C8-R)-Hydantocidin 5'-Phosphate	[8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE	-	DRUGBANK	DB02666	C13H22N3O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAXSFYCTFIBEAR-MHHWUYOGSA-N
19675	114045	8467	-	SMARCA5	ISWI|SNF2H|WCRF135|hISWI|hSNF2H	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2561	4-Deoxy-Alpha-D-Glucose	-	-	DRUGBANK	DB02670	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDEMQQHXNOJATE-UNTFVMJOSA-N
19676	114045	8467	-	SMARCA5	ISWI|SNF2H|WCRF135|hISWI|hSNF2H	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2561	4-Deoxy-Alpha-D-Glucose	-	-	DRUGBANK	DB02670	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDEMQQHXNOJATE-UNTFVMJOSA-N
19677	114045	8467	-	SMARCA5	ISWI|SNF2H|WCRF135|hISWI|hSNF2H	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2561	4-Deoxy-Alpha-D-Glucose	-	-	DRUGBANK	DB02670	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDEMQQHXNOJATE-UNTFVMJOSA-N
19678	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2562	1-Methylimidazole	-	-	DRUGBANK	DB02671	C4H7N2	small molecule	-	616-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCTWTZJPVLRJOU-UHFFFAOYSA-O
19679	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2562	1-Methylimidazole	-	-	DRUGBANK	DB02671	C4H7N2	small molecule	-	616-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCTWTZJPVLRJOU-UHFFFAOYSA-O
19680	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2562	1-Methylimidazole	-	-	DRUGBANK	DB02671	C4H7N2	small molecule	-	616-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCTWTZJPVLRJOU-UHFFFAOYSA-O
19681	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2563	(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium	-	-	DRUGBANK	DB02673	C32H37N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLGAHTYYCHWLNI-YYKZIPJASA-N
19682	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2563	(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium	-	-	DRUGBANK	DB02673	C32H37N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLGAHTYYCHWLNI-YYKZIPJASA-N
19683	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2563	(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium	-	-	DRUGBANK	DB02673	C32H37N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLGAHTYYCHWLNI-YYKZIPJASA-N
19684	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2566	2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol	-	-	DRUGBANK	DB02676	C11H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHKZCCWKTZRCCL-UHFFFAOYSA-N
19685	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2566	2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol	-	-	DRUGBANK	DB02676	C11H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHKZCCWKTZRCCL-UHFFFAOYSA-N
19686	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2566	2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol	-	-	DRUGBANK	DB02676	C11H26N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHKZCCWKTZRCCL-UHFFFAOYSA-N
19687	110154	3963	-	LGALS7	GAL7|LGALS7A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2568	2-Deoxy-2-Aminogalactose	-	-	DRUGBANK	DB02678	C6H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-VFUOTHLCSA-N
19688	110154	3963	-	LGALS7	GAL7|LGALS7A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2568	2-Deoxy-2-Aminogalactose	-	-	DRUGBANK	DB02678	C6H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSWZFWKMSRAUBD-VFUOTHLCSA-N
19689	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2569	Cyanamide	-	-	DRUGBANK	DB02679	CH2N2	small molecule	-	420-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZMCDFZZKTWFGF-UHFFFAOYSA-N
19690	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2569	Cyanamide	-	-	DRUGBANK	DB02679	CH2N2	small molecule	-	420-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZMCDFZZKTWFGF-UHFFFAOYSA-N
19691	107582	1163	RP11-307C12.6	CKS1B	CKS1|PNAS-16|PNAS-18|ckshs1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2571	Meta Vanadate	-	-	DRUGBANK	DB02681	O19V7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZDNYIINYVFKD-UHFFFAOYSA-N
19692	107582	1163	RP11-307C12.6	CKS1B	CKS1|PNAS-16|PNAS-18|ckshs1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2571	Meta Vanadate	-	-	DRUGBANK	DB02681	O19V7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZDNYIINYVFKD-UHFFFAOYSA-N
19693	107582	1163	RP11-307C12.6	CKS1B	CKS1|PNAS-16|PNAS-18|ckshs1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2571	Meta Vanadate	-	-	DRUGBANK	DB02681	O19V7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZDNYIINYVFKD-UHFFFAOYSA-N
19694	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2571	Meta Vanadate	-	-	DRUGBANK	DB02681	O19V7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZDNYIINYVFKD-UHFFFAOYSA-N
19695	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2571	Meta Vanadate	-	-	DRUGBANK	DB02681	O19V7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZDNYIINYVFKD-UHFFFAOYSA-N
19696	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2572	2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine	-	-	DRUGBANK	DB02682	C10H15N4O10P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYBPOGVUIOPXHI-KMPDEGCQSA-O
19697	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2572	2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine	-	-	DRUGBANK	DB02682	C10H15N4O10P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYBPOGVUIOPXHI-KMPDEGCQSA-O
19698	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2574	5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02684	C13H19N7O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTSDEWPMACCNGN-FLNYCXGNSA-N
19699	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2574	5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02684	C13H19N7O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTSDEWPMACCNGN-FLNYCXGNSA-N
19700	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2574	5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB02684	C13H19N7O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTSDEWPMACCNGN-FLNYCXGNSA-N
19701	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2575	3-Methylphenylalanine	-	-	DRUGBANK	DB02685	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRBSTONIYRNRI-VIFPVBQESA-N
19702	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2575	3-Methylphenylalanine	-	-	DRUGBANK	DB02685	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZRBSTONIYRNRI-VIFPVBQESA-N
19703	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2578	S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine	-	-	DRUGBANK	DB02689	C5H14N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTCWCYHVPRUAOX-BYPYZUCNSA-N
19704	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2578	S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine	-	-	DRUGBANK	DB02689	C5H14N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTCWCYHVPRUAOX-BYPYZUCNSA-N
19705	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2578	S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine	-	-	DRUGBANK	DB02689	C5H14N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTCWCYHVPRUAOX-BYPYZUCNSA-N
19706	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2579	NU1025	-	-	DRUGBANK	DB02690	C9H8N2O2	small molecule	-	90417-38-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJDAOHJWLUNFLX-UHFFFAOYSA-N
19707	108470	2172	-	FABP6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2580	N-Cholylglycine	-	-	DRUGBANK	DB02691	C26H43NO6	small molecule	-	475-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFDAIACWWDREDC-YUHACDEOSA-N
19708	108470	2172	-	FABP6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2580	N-Cholylglycine	-	-	DRUGBANK	DB02691	C26H43NO6	small molecule	-	475-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFDAIACWWDREDC-YUHACDEOSA-N
19709	108470	2172	-	FABP6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2580	N-Cholylglycine	-	-	DRUGBANK	DB02691	C26H43NO6	small molecule	-	475-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFDAIACWWDREDC-YUHACDEOSA-N
19710	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19711	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19712	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19713	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19714	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19715	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19716	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19717	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19718	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19719	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19720	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2585	6-Aminohexyl-Uridine-C1,5'-Diphosphate	-	-	DRUGBANK	DB02696	C15H27N3O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLWJBKPFDKRHBM-SCUASFONSA-N
19721	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2585	6-Aminohexyl-Uridine-C1,5'-Diphosphate	-	-	DRUGBANK	DB02696	C15H27N3O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLWJBKPFDKRHBM-SCUASFONSA-N
19722	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2585	6-Aminohexyl-Uridine-C1,5'-Diphosphate	-	-	DRUGBANK	DB02696	C15H27N3O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLWJBKPFDKRHBM-SCUASFONSA-N
19723	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2586	Hydroxyaminovaline	-	-	DRUGBANK	DB02697	C5H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSBBYRBOWZYSB-SCSAIBSYSA-N
19724	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2586	Hydroxyaminovaline	-	-	DRUGBANK	DB02697	C5H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSBBYRBOWZYSB-SCSAIBSYSA-N
19725	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2586	Hydroxyaminovaline	-	-	DRUGBANK	DB02697	C5H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSBBYRBOWZYSB-SCSAIBSYSA-N
19726	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2586	Hydroxyaminovaline	-	-	DRUGBANK	DB02697	C5H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USSBBYRBOWZYSB-SCSAIBSYSA-N
19727	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2589	3-Deoxy-D-Glucosamine	-	-	DRUGBANK	DB02700	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDZDGQLFKEBLF-FSIIMWSLSA-N
19728	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2589	3-Deoxy-D-Glucosamine	-	-	DRUGBANK	DB02700	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDZDGQLFKEBLF-FSIIMWSLSA-N
19729	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19730	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19731	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19732	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19733	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19734	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19735	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19736	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19737	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2590	Nicotinamide	Nicotinic amide|Niacinamide	neogen dermalogy real fresh fo	DRUGBANK	DB02701	C6H6N2O	small molecule	A11HA01	98-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPAKSUCGFBDDF-UHFFFAOYSA-N
19738	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2594	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02705	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DARQQJKHXPXSRO-QFIPXVFZSA-N
19739	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2594	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02705	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DARQQJKHXPXSRO-QFIPXVFZSA-N
19740	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2594	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	-	-	DRUGBANK	DB02705	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DARQQJKHXPXSRO-QFIPXVFZSA-N
19741	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Wang Z (2004)	15381063	181864	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19742	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Buryanovskyy L (2004)	15350128	181862	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19743	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19744	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19746	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2598	2,3,-Dihydroxybenzoylserine	-	-	DRUGBANK	DB02710	C10H11NO6	small molecule	-	127658-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDTYHTVHFIIEIL-LURJTMIESA-N
19747	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2598	2,3,-Dihydroxybenzoylserine	-	-	DRUGBANK	DB02710	C10H11NO6	small molecule	-	127658-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDTYHTVHFIIEIL-LURJTMIESA-N
19748	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2598	2,3,-Dihydroxybenzoylserine	-	-	DRUGBANK	DB02710	C10H11NO6	small molecule	-	127658-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDTYHTVHFIIEIL-LURJTMIESA-N
19749	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2600	Sorbinil	-	-	DRUGBANK	DB02712	C11H9FN2O3	small molecule	-	68367-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXANPKRCLVQAOG-NSHDSACASA-N
19750	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2600	Sorbinil	-	-	DRUGBANK	DB02712	C11H9FN2O3	small molecule	-	68367-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXANPKRCLVQAOG-NSHDSACASA-N
19751	856969	939377	BSU11670	thiO	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2601	Acetylamino-Acetic Acid	-	-	DRUGBANK	DB02713	C4H7NO3	small molecule	-	543-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKJIRPAQVSHGFK-UHFFFAOYSA-N
19752	856969	939377	BSU11670	thiO	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2601	Acetylamino-Acetic Acid	-	-	DRUGBANK	DB02713	C4H7NO3	small molecule	-	543-24-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKJIRPAQVSHGFK-UHFFFAOYSA-N
19753	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2602	3'-Uridinemonophosphate	3'-UMP|Uridine 3'-phosphate|Uridine 3'-monophosphate|3'-Uridylic acid	-	DRUGBANK	DB02714	C9H13N2O9P	small molecule	-	84-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOGRQMPFHUHIGU-XVFCMESISA-N
19754	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2602	3'-Uridinemonophosphate	3'-UMP|Uridine 3'-phosphate|Uridine 3'-monophosphate|3'-Uridylic acid	-	DRUGBANK	DB02714	C9H13N2O9P	small molecule	-	84-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOGRQMPFHUHIGU-XVFCMESISA-N
19755	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2602	3'-Uridinemonophosphate	3'-UMP|Uridine 3'-phosphate|Uridine 3'-monophosphate|3'-Uridylic acid	-	DRUGBANK	DB02714	C9H13N2O9P	small molecule	-	84-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOGRQMPFHUHIGU-XVFCMESISA-N
19756	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2603	Compound 18	-	-	DRUGBANK	DB02715	C27H29NO4S	small molecule	-	31112-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19757	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2603	Compound 18	-	-	DRUGBANK	DB02715	C27H29NO4S	small molecule	-	31112-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZOOIPXOYYJULJ-OALGXETFSA-N
19758	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2604	7-Methyl-Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB02716	C11H19N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKVRNHPCAOHRSI-FCIPNVEPSA-O
19759	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2604	7-Methyl-Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB02716	C11H19N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKVRNHPCAOHRSI-FCIPNVEPSA-O
19760	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2604	7-Methyl-Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB02716	C11H19N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKVRNHPCAOHRSI-FCIPNVEPSA-O
19761	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2606	5-Formyl-6-Hydrofolic Acid	-	-	DRUGBANK	DB02718	C20H21N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJLRPFSRJZBYFE-CHWSQXEVSA-N
19762	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2606	5-Formyl-6-Hydrofolic Acid	-	-	DRUGBANK	DB02718	C20H21N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJLRPFSRJZBYFE-CHWSQXEVSA-N
19763	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2607	C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide	-	-	DRUGBANK	DB02719	C7H13NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTZYCNDAJQDPQC-QVVHOTIMSA-N
19764	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2607	C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide	-	-	DRUGBANK	DB02719	C7H13NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTZYCNDAJQDPQC-QVVHOTIMSA-N
19765	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2607	C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide	-	-	DRUGBANK	DB02719	C7H13NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTZYCNDAJQDPQC-QVVHOTIMSA-N
19766	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2608	Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide	-	-	DRUGBANK	DB02720	C7H13NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKWLGCFJAVEFPE-QYESYBIKSA-N
19767	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2608	Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide	-	-	DRUGBANK	DB02720	C7H13NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKWLGCFJAVEFPE-QYESYBIKSA-N
19768	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2608	Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide	-	-	DRUGBANK	DB02720	C7H13NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKWLGCFJAVEFPE-QYESYBIKSA-N
19769	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19770	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19771	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19772	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19773	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19774	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19775	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2609	4-Iodopyrazole	-	-	DRUGBANK	DB02721	C3H2IN2	small molecule	-	3469-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
19776	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2611	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide	-	-	DRUGBANK	DB02723	C22H32N6O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHTSUHWLPAEEQB-OALUTQOASA-N
19777	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2611	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide	-	-	DRUGBANK	DB02723	C22H32N6O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHTSUHWLPAEEQB-OALUTQOASA-N
19778	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2612	Delta-2-Albomycin A1	-	-	DRUGBANK	DB02724	C37H57FeN12O18S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQZRKFJHRUDTLB-VPDFUAHVSA-N
19779	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2612	Delta-2-Albomycin A1	-	-	DRUGBANK	DB02724	C37H57FeN12O18S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQZRKFJHRUDTLB-VPDFUAHVSA-N
19780	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2612	Delta-2-Albomycin A1	-	-	DRUGBANK	DB02724	C37H57FeN12O18S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQZRKFJHRUDTLB-VPDFUAHVSA-N
19781	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2612	Delta-2-Albomycin A1	-	-	DRUGBANK	DB02724	C37H57FeN12O18S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQZRKFJHRUDTLB-VPDFUAHVSA-N
19782	849752	945376	b0774	bioA	ECK0763|JW0757	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2613	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	-	-	DRUGBANK	DB02725	C10H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAJWZJCOWPUSOA-YIZRAAEISA-N
19783	849752	945376	b0774	bioA	ECK0763|JW0757	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2613	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	-	-	DRUGBANK	DB02725	C10H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAJWZJCOWPUSOA-YIZRAAEISA-N
19784	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19785	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19786	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19787	849979	945605	b0754	aroG	ECK0743|JW0737	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19788	849979	945605	b0754	aroG	ECK0743|JW0737	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19789	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19790	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19791	108340	2026	-	ENO2	HEL-S-279|NSE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19792	108340	2026	-	ENO2	HEL-S-279|NSE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19793	108340	2026	-	ENO2	HEL-S-279|NSE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19794	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19795	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19796	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19797	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19798	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19799	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19800	854299	936619	BSU35020	nagBA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19801	854299	936619	BSU35020	nagBA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2614	2-Phosphoglycolic Acid	-	-	DRUGBANK	DB02726	C2H5O6P	small molecule	-	13147-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASCFNMCAHFUBCO-UHFFFAOYSA-N
19802	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19803	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19804	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19805	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2616	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB02728	C12H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IETDBZQIWIJQJG-UHFFFAOYSA-N
19806	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2616	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB02728	C12H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IETDBZQIWIJQJG-UHFFFAOYSA-N
19807	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2616	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB02728	C12H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IETDBZQIWIJQJG-UHFFFAOYSA-N
19808	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2618	4-Methylthio-Alpha-D-Mannose	-	-	DRUGBANK	DB02730	C7H14O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYUQSQYXZFSOEM-IBISWUOJSA-N
19809	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2618	4-Methylthio-Alpha-D-Mannose	-	-	DRUGBANK	DB02730	C7H14O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYUQSQYXZFSOEM-IBISWUOJSA-N
19810	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2618	4-Methylthio-Alpha-D-Mannose	-	-	DRUGBANK	DB02730	C7H14O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYUQSQYXZFSOEM-IBISWUOJSA-N
19811	111059	5019	-	OXCT1	OXCT|SCOT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2619	Ethylmercurithiosalicylic acid	2-(ethylmercuri-thio)-benzoic acid|2-(ethylmercuriothio)benzoic acid|[(o-carboxyphenyl)thio]ethylmercury	-	DRUGBANK	DB02731	C9H10HgO2S	small molecule	-	148-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQVQGWHFRNKMS-UHFFFAOYSA-M
19812	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19813	112611	6733	-	SRPK2	SFRSK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19814	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19815	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19816	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19817	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19818	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2621	Purvalanol	-	-	DRUGBANK	DB02733	C20H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKDXRFMOHZVXSG-HNNXBMFYSA-N
19819	106905	412	-	STS	ARSC|ARSC1|ASC|ES|SSDD|XLI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2623	2-Amino-3-Oxo-4-Sulfo-Butyric Acid	-	-	DRUGBANK	DB02735	C3H5NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZIKAUMRZOEFET-SFOWXEAESA-N
19820	106905	412	-	STS	ARSC|ARSC1|ASC|ES|SSDD|XLI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2623	2-Amino-3-Oxo-4-Sulfo-Butyric Acid	-	-	DRUGBANK	DB02735	C3H5NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZIKAUMRZOEFET-SFOWXEAESA-N
19821	107044	567	CDABP0092	B2M	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2626	3-Indolebutyric Acid	-	-	DRUGBANK	DB02740	C12H13NO2	small molecule	-	133-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTEDVYBZBROSJT-UHFFFAOYSA-N
19822	109350	3105	DAQB-90C11.16-002	HLA-A	HLAA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2626	3-Indolebutyric Acid	-	-	DRUGBANK	DB02740	C12H13NO2	small molecule	-	133-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTEDVYBZBROSJT-UHFFFAOYSA-N
19823	118489	28639	-	TRBC1	BV05S1J2.2|TCRB|TCRBC1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2626	3-Indolebutyric Acid	-	-	DRUGBANK	DB02740	C12H13NO2	small molecule	-	133-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTEDVYBZBROSJT-UHFFFAOYSA-N
19825	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2627	CD564	-	-	DRUGBANK	DB02741	C26H26O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWYREGSYPCNZTL-UHFFFAOYSA-N
19826	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2627	CD564	-	-	DRUGBANK	DB02741	C26H26O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWYREGSYPCNZTL-UHFFFAOYSA-N
19827	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2627	CD564	-	-	DRUGBANK	DB02741	C26H26O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWYREGSYPCNZTL-UHFFFAOYSA-N
19828	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2628	Kifunensine	-	-	DRUGBANK	DB02742	C8H12N2O6	small molecule	-	109944-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIURYJWYVIAOCW-PQMKYFCFSA-N
19829	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2628	Kifunensine	-	-	DRUGBANK	DB02742	C8H12N2O6	small molecule	-	109944-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIURYJWYVIAOCW-PQMKYFCFSA-N
19830	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2628	Kifunensine	-	-	DRUGBANK	DB02742	C8H12N2O6	small molecule	-	109944-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIURYJWYVIAOCW-PQMKYFCFSA-N
19831	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2628	Kifunensine	-	-	DRUGBANK	DB02742	C8H12N2O6	small molecule	-	109944-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIURYJWYVIAOCW-PQMKYFCFSA-N
19832	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2628	Kifunensine	-	-	DRUGBANK	DB02742	C8H12N2O6	small molecule	-	109944-15-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIURYJWYVIAOCW-PQMKYFCFSA-N
19833	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2630	RPR131247	-	-	DRUGBANK	DB02744	C19H19N5O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQJGWYQPOHCEDO-ZDUSSCGKSA-N
19834	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2630	RPR131247	-	-	DRUGBANK	DB02744	C19H19N5O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQJGWYQPOHCEDO-ZDUSSCGKSA-N
19835	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2630	RPR131247	-	-	DRUGBANK	DB02744	C19H19N5O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQJGWYQPOHCEDO-ZDUSSCGKSA-N
19836	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2631	Uridine	-	-	DRUGBANK	DB02745	C9H12N2O6	small molecule	-	58-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRTQHJPVMGBUCF-ZAKLUEHWSA-N
19837	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2631	Uridine	-	-	DRUGBANK	DB02745	C9H12N2O6	small molecule	-	58-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRTQHJPVMGBUCF-ZAKLUEHWSA-N
19838	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2631	Uridine	-	-	DRUGBANK	DB02745	C9H12N2O6	small molecule	-	58-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRTQHJPVMGBUCF-ZAKLUEHWSA-N
19839	850602	946242	b0411	tsx	ECK0405|JW0401|T6rec|nupA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2631	Uridine	-	-	DRUGBANK	DB02745	C9H12N2O6	small molecule	-	58-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRTQHJPVMGBUCF-ZAKLUEHWSA-N
19840	850602	946242	b0411	tsx	ECK0405|JW0401|T6rec|nupA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2631	Uridine	-	-	DRUGBANK	DB02745	C9H12N2O6	small molecule	-	58-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRTQHJPVMGBUCF-ZAKLUEHWSA-N
19841	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2634	Pyromellitic Acid	-	-	DRUGBANK	DB02749	C10H6O8	small molecule	-	89-05-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYIDZMCFTVVTJO-UHFFFAOYSA-N
19842	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2634	Pyromellitic Acid	-	-	DRUGBANK	DB02749	C10H6O8	small molecule	-	89-05-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYIDZMCFTVVTJO-UHFFFAOYSA-N
19843	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2634	Pyromellitic Acid	-	-	DRUGBANK	DB02749	C10H6O8	small molecule	-	89-05-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYIDZMCFTVVTJO-UHFFFAOYSA-N
19844	122761	79631	-	EFTUD1	FAM42A|HsT19294|RIA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2635	S-(Methylmercury)-L-Cysteine	-	-	DRUGBANK	DB02750	C4H9HgNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMYFBIZVJYGJJA-YBBRRFGFSA-M
19845	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2636	N-[Amino(Imino)Methyl]Glycine	-	-	DRUGBANK	DB02751	C3H7N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPMFZUMJYQTVII-UHFFFAOYSA-N
19846	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2636	N-[Amino(Imino)Methyl]Glycine	-	-	DRUGBANK	DB02751	C3H7N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPMFZUMJYQTVII-UHFFFAOYSA-N
19847	108865	2593	-	GAMT	CCDS2|HEL-S-20|PIG2|TP53I2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2636	N-[Amino(Imino)Methyl]Glycine	-	-	DRUGBANK	DB02751	C3H7N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPMFZUMJYQTVII-UHFFFAOYSA-N
19848	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2637	Tosyl-D-Proline	-	-	DRUGBANK	DB02752	C12H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGPHGPCHVUSFFA-LLVKDONJSA-N
19849	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2637	Tosyl-D-Proline	-	-	DRUGBANK	DB02752	C12H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGPHGPCHVUSFFA-LLVKDONJSA-N
19850	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2637	Tosyl-D-Proline	-	-	DRUGBANK	DB02752	C12H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGPHGPCHVUSFFA-LLVKDONJSA-N
19851	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19852	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19853	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19854	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19855	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19856	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19857	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2640	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	-	-	DRUGBANK	DB02755	C18H33O19P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDQMHAJOIVYOIP-QPBMUXFQSA-N
19858	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2642	Pyrazole	1,2-Diazole	-	DRUGBANK	DB02757	C3H4N2	small molecule	-	288-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTKZEGDFNFYCGP-UHFFFAOYSA-N
19859	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2642	Pyrazole	1,2-Diazole	-	DRUGBANK	DB02757	C3H4N2	small molecule	-	288-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTKZEGDFNFYCGP-UHFFFAOYSA-N
19860	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2642	Pyrazole	1,2-Diazole	-	DRUGBANK	DB02757	C3H4N2	small molecule	-	288-13-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTKZEGDFNFYCGP-UHFFFAOYSA-N
19861	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2643	Indolylpropionic Acid	-	-	DRUGBANK	DB02758	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOLXRNDWAUTYKT-UHFFFAOYSA-N
19862	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2643	Indolylpropionic Acid	-	-	DRUGBANK	DB02758	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOLXRNDWAUTYKT-UHFFFAOYSA-N
19863	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2643	Indolylpropionic Acid	-	-	DRUGBANK	DB02758	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOLXRNDWAUTYKT-UHFFFAOYSA-N
19864	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2643	Indolylpropionic Acid	-	-	DRUGBANK	DB02758	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOLXRNDWAUTYKT-UHFFFAOYSA-N
19865	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2644	4-Methylumbelliferyl Chitobiose	-	-	DRUGBANK	DB02759	C26H34N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSFMJHZUCSEHU-IWMPZAEYSA-N
19866	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2644	4-Methylumbelliferyl Chitobiose	-	-	DRUGBANK	DB02759	C26H34N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSFMJHZUCSEHU-IWMPZAEYSA-N
19867	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2644	4-Methylumbelliferyl Chitobiose	-	-	DRUGBANK	DB02759	C26H34N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSFMJHZUCSEHU-IWMPZAEYSA-N
19868	113114	7263	LL22NC01-146D10.3	TST	RDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2646	S-Mercaptocysteine	-	-	DRUGBANK	DB02761	C3H7NO2S2	small molecule	-	5652-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBKONSCREBSMCS-REOHCLBHSA-N
19869	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2646	S-Mercaptocysteine	-	-	DRUGBANK	DB02761	C3H7NO2S2	small molecule	-	5652-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBKONSCREBSMCS-REOHCLBHSA-N
19870	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2646	S-Mercaptocysteine	-	-	DRUGBANK	DB02761	C3H7NO2S2	small molecule	-	5652-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBKONSCREBSMCS-REOHCLBHSA-N
19871	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2647	RU79072	-	-	DRUGBANK	DB02762	C10H7N2O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQLPTOOPFMPCHQ-UHFFFAOYSA-N
19872	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2648	5-Mercapto-2-Nitro-Benzoic Acid	-	-	DRUGBANK	DB02763	C7H5NO4S	small molecule	-	15139-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GANZODCWZFAEGN-UHFFFAOYSA-N
19873	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2648	5-Mercapto-2-Nitro-Benzoic Acid	-	-	DRUGBANK	DB02763	C7H5NO4S	small molecule	-	15139-21-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GANZODCWZFAEGN-UHFFFAOYSA-N
19879	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2652	3-Hydroxy-Myristic Acid	-	-	DRUGBANK	DB02767	C14H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATRNZOYKSNPPBF-CYBMUJFWSA-N
19880	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2652	3-Hydroxy-Myristic Acid	-	-	DRUGBANK	DB02767	C14H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATRNZOYKSNPPBF-CYBMUJFWSA-N
19881	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2652	3-Hydroxy-Myristic Acid	-	-	DRUGBANK	DB02767	C14H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATRNZOYKSNPPBF-CYBMUJFWSA-N
19882	112954	7099	-	TLR4	ARMD10|CD284|TLR-4|TOLL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2652	3-Hydroxy-Myristic Acid	-	-	DRUGBANK	DB02767	C14H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATRNZOYKSNPPBF-CYBMUJFWSA-N
19883	117170	23643	-	LY96	ESOP-1|MD-2|MD2|ly-96	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2652	3-Hydroxy-Myristic Acid	-	-	DRUGBANK	DB02767	C14H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATRNZOYKSNPPBF-CYBMUJFWSA-N
19884	850210	945843	b1252	tonB	ECK1246|JW5195|T1rec|exbA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2652	3-Hydroxy-Myristic Acid	-	-	DRUGBANK	DB02767	C14H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATRNZOYKSNPPBF-CYBMUJFWSA-N
19885	854285	936605	BSU28050	maf	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19886	854285	936605	BSU28050	maf	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19887	119569	51493	HSPC117	RTCB	C22orf28|DJ149A16.6|FAAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19888	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19889	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19890	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19891	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19892	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19893	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19894	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19895	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2656	Sucrose	-	childrens emetrol dye free gra	DRUGBANK	DB02772	C12H22O11	small molecule	-	57-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZMRCDWAGMRECN-MTNNYNCSSA-N
19896	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2657	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	-	-	DRUGBANK	DB02773	C11H13ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEJHPAGTOOIBFT-UHFFFAOYSA-N
19897	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2658	1,3-Propandiol	-	-	DRUGBANK	DB02774	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPFDHNVEDLHUCE-UHFFFAOYSA-N
19898	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2658	1,3-Propandiol	-	-	DRUGBANK	DB02774	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPFDHNVEDLHUCE-UHFFFAOYSA-N
19899	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2658	1,3-Propandiol	-	-	DRUGBANK	DB02774	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPFDHNVEDLHUCE-UHFFFAOYSA-N
19900	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2661	2,5-Anhydroglucitol-1,6-Biphosphate	-	-	DRUGBANK	DB02778	C6H14O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSMBXSQDFPTODV-BXKVDMCESA-N
19901	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2661	2,5-Anhydroglucitol-1,6-Biphosphate	-	-	DRUGBANK	DB02778	C6H14O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSMBXSQDFPTODV-BXKVDMCESA-N
19902	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2661	2,5-Anhydroglucitol-1,6-Biphosphate	-	-	DRUGBANK	DB02778	C6H14O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSMBXSQDFPTODV-BXKVDMCESA-N
19903	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2662	Dodecane-Trimethylamine	-	-	DRUGBANK	DB02779	C15H34N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VICYBMUVWHJEFT-UHFFFAOYSA-N
19904	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2662	Dodecane-Trimethylamine	-	-	DRUGBANK	DB02779	C15H34N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VICYBMUVWHJEFT-UHFFFAOYSA-N
19905	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2662	Dodecane-Trimethylamine	-	-	DRUGBANK	DB02779	C15H34N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VICYBMUVWHJEFT-UHFFFAOYSA-N
19906	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2665	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB02783	C10H15N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYKRUCBLHROXCK-UHFFFAOYSA-N
19907	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2665	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB02783	C10H15N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYKRUCBLHROXCK-UHFFFAOYSA-N
19908	109068	2806	-	GOT2	KAT4|KATIV|mitAAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2665	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB02783	C10H15N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYKRUCBLHROXCK-UHFFFAOYSA-N
19909	852375	948067	b2662	gabT	ECK2656|JW2637	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2665	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB02783	C10H15N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYKRUCBLHROXCK-UHFFFAOYSA-N
19910	852375	948067	b2662	gabT	ECK2656|JW2637	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2665	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	-	-	DRUGBANK	DB02783	C10H15N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYKRUCBLHROXCK-UHFFFAOYSA-N
19911	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2666	N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid	-	-	DRUGBANK	DB02784	C18H23BrN4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYAWTDCWUJJPHZ-CYBMUJFWSA-N
19912	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2666	N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid	-	-	DRUGBANK	DB02784	C18H23BrN4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYAWTDCWUJJPHZ-CYBMUJFWSA-N
19913	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2671	Pregnenolone	-	-	DRUGBANK	DB02789	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORNBQBCIOKFOEO-QGVNFLHTSA-N
19914	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2671	Pregnenolone	-	-	DRUGBANK	DB02789	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORNBQBCIOKFOEO-QGVNFLHTSA-N
19915	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2671	Pregnenolone	-	-	DRUGBANK	DB02789	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORNBQBCIOKFOEO-QGVNFLHTSA-N
19916	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2672	Phenyl-Uridine-5'-Diphosphate	-	-	DRUGBANK	DB02790	C15H18N2O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHUWBKDWWGKIEN-SCUASFONSA-N
19917	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2672	Phenyl-Uridine-5'-Diphosphate	-	-	DRUGBANK	DB02790	C15H18N2O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHUWBKDWWGKIEN-SCUASFONSA-N
19920	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2676	N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide	-	-	DRUGBANK	DB02794	C30H37N6O15P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUCAWXKEZPFBV-RCQHZQLASA-N
19921	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2676	N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide	-	-	DRUGBANK	DB02794	C30H37N6O15P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUCAWXKEZPFBV-RCQHZQLASA-N
19922	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19923	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19924	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19925	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19926	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19927	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19928	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2678	9-Deazainosine	-	-	DRUGBANK	DB02796	C11H12N3O5	small molecule	-	89458-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPJICFPVOAERJL-RAWIJENESA-N
19929	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2678	9-Deazainosine	-	-	DRUGBANK	DB02796	C11H12N3O5	small molecule	-	89458-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPJICFPVOAERJL-RAWIJENESA-N
19930	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2678	9-Deazainosine	-	-	DRUGBANK	DB02796	C11H12N3O5	small molecule	-	89458-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPJICFPVOAERJL-RAWIJENESA-N
19931	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2679	3-Nitrophenylboronic Acid	-	-	DRUGBANK	DB02797	C6H6BNO4	small molecule	-	13331-27-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNRGSYUVFVNSAW-UHFFFAOYSA-N
19932	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2679	3-Nitrophenylboronic Acid	-	-	DRUGBANK	DB02797	C6H6BNO4	small molecule	-	13331-27-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNRGSYUVFVNSAW-UHFFFAOYSA-N
19933	854661	936985	BSU00510	prs	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2680	Alpha-Methylene Adenosine Monophosphate	-	-	DRUGBANK	DB02798	C11H16N5O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXSSQXBLDTZHLF-WOIOKPISSA-N
19934	854661	936985	BSU00510	prs	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2680	Alpha-Methylene Adenosine Monophosphate	-	-	DRUGBANK	DB02798	C11H16N5O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXSSQXBLDTZHLF-WOIOKPISSA-N
19935	852539	948237	b3728	pstS	ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2681	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	-	-	DRUGBANK	DB02799	C20H21N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJBZDUMTXGGVSP-KTKRTIGZSA-N
19936	852539	948237	b3728	pstS	ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2681	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	-	-	DRUGBANK	DB02799	C20H21N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJBZDUMTXGGVSP-KTKRTIGZSA-N
19937	852539	948237	b3728	pstS	ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2681	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	-	-	DRUGBANK	DB02799	C20H21N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJBZDUMTXGGVSP-KTKRTIGZSA-N
19938	1239943	876747	MPN348	MPN348	H91_orf164	272634	Mycoplasma pneumoniae	unknown	target	Imming P (2006)	17016423	171742	2682	5-Hydroxymethylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02800	C20H23N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIEPLRAFVCMHQF-CHWSQXEVSA-N
19939	1239943	876747	MPN348	MPN348	H91_orf164	272634	Mycoplasma pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	2682	5-Hydroxymethylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02800	C20H23N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIEPLRAFVCMHQF-CHWSQXEVSA-N
19940	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2682	5-Hydroxymethylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02800	C20H23N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIEPLRAFVCMHQF-CHWSQXEVSA-N
19941	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2682	5-Hydroxymethylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02800	C20H23N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIEPLRAFVCMHQF-CHWSQXEVSA-N
19942	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2682	5-Hydroxymethylene-6-Hydrofolic Acid	-	-	DRUGBANK	DB02800	C20H23N7O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIEPLRAFVCMHQF-CHWSQXEVSA-N
19943	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2685	3-Phenyl-1,2-Propandiol	-	-	DRUGBANK	DB02803	C9H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHWQMXKQJVAWKI-VIFPVBQESA-N
19944	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2685	3-Phenyl-1,2-Propandiol	-	-	DRUGBANK	DB02803	C9H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHWQMXKQJVAWKI-VIFPVBQESA-N
19945	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2685	3-Phenyl-1,2-Propandiol	-	-	DRUGBANK	DB02803	C9H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHWQMXKQJVAWKI-VIFPVBQESA-N
19946	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2687	Uracil arabinose-3'-phosphate	Arabinouridine 3'-Phosphate|1-(3-O-phosphono-beta-L-arabinofuranosyl)Pyrimidine-2,4(1H,3H)-Dione	-	DRUGBANK	DB02805	C9H13N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOGRQMPFHUHIGU-PXBUCIJWSA-N
19947	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2687	Uracil arabinose-3'-phosphate	Arabinouridine 3'-Phosphate|1-(3-O-phosphono-beta-L-arabinofuranosyl)Pyrimidine-2,4(1H,3H)-Dione	-	DRUGBANK	DB02805	C9H13N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOGRQMPFHUHIGU-PXBUCIJWSA-N
19948	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2687	Uracil arabinose-3'-phosphate	Arabinouridine 3'-Phosphate|1-(3-O-phosphono-beta-L-arabinofuranosyl)Pyrimidine-2,4(1H,3H)-Dione	-	DRUGBANK	DB02805	C9H13N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOGRQMPFHUHIGU-PXBUCIJWSA-N
19949	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2694	(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide	-	-	DRUGBANK	DB02812	C20H26N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXDAVYUFYPFGDX-CFVMTHIKSA-N
19950	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2694	(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide	-	-	DRUGBANK	DB02812	C20H26N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXDAVYUFYPFGDX-CFVMTHIKSA-N
19951	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2694	(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide	-	-	DRUGBANK	DB02812	C20H26N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXDAVYUFYPFGDX-CFVMTHIKSA-N
19952	109323	3074	HCC7	HEXB	ENC-1AS|HEL-248	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2695	2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone	-	-	DRUGBANK	DB02813	C8H13NO6	small molecule	-	19026-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NELQYZRSPDCGRQ-DBRKOABJSA-N
19953	109323	3074	HCC7	HEXB	ENC-1AS|HEL-248	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2695	2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone	-	-	DRUGBANK	DB02813	C8H13NO6	small molecule	-	19026-22-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NELQYZRSPDCGRQ-DBRKOABJSA-N
19954	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2700	Iodo-Willardiine	-	-	DRUGBANK	DB02818	C7H8IN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXXYLTBQIQBTES-BYPYZUCNSA-N
19955	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2700	Iodo-Willardiine	-	-	DRUGBANK	DB02818	C7H8IN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXXYLTBQIQBTES-BYPYZUCNSA-N
19956	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2700	Iodo-Willardiine	-	-	DRUGBANK	DB02818	C7H8IN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXXYLTBQIQBTES-BYPYZUCNSA-N
19957	109278	3028	RP3-339A18.2	HSD17B10	17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2702	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	-	-	DRUGBANK	DB02820	C40H44N12O15P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHBACRZQFHLVAV-LYPPOYJRSA-L
19958	109278	3028	RP3-339A18.2	HSD17B10	17b-HSD10|ABAD|CAMR|DUPXp11.22|ERAB|HADH2|HCD2|MHBD|MRPP2|MRX17|MRX31|MRXS10|SCHAD|SDR5C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2702	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	-	-	DRUGBANK	DB02820	C40H44N12O15P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHBACRZQFHLVAV-LYPPOYJRSA-L
19959	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2703	Canaline	-	-	DRUGBANK	DB02821	C4H10N2O3	small molecule	-	496-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPGMQABJNQLLF-GSVOUGTGSA-N
19960	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2703	Canaline	-	-	DRUGBANK	DB02821	C4H10N2O3	small molecule	-	496-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPGMQABJNQLLF-GSVOUGTGSA-N
19961	110996	4942	-	OAT	GACR|HOGA|OATASE|OKT	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2703	Canaline	-	-	DRUGBANK	DB02821	C4H10N2O3	small molecule	-	496-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQPGMQABJNQLLF-GSVOUGTGSA-N
19962	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2704	Para-Bromobenzyl Alcohol	-	-	DRUGBANK	DB02822	C7H7BrO	small molecule	-	873-75-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEDDBHYQWFOITD-UHFFFAOYSA-N
19963	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2704	Para-Bromobenzyl Alcohol	-	-	DRUGBANK	DB02822	C7H7BrO	small molecule	-	873-75-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEDDBHYQWFOITD-UHFFFAOYSA-N
19964	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2704	Para-Bromobenzyl Alcohol	-	-	DRUGBANK	DB02822	C7H7BrO	small molecule	-	873-75-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEDDBHYQWFOITD-UHFFFAOYSA-N
19965	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2705	Phosphonoacetic Acid	-	-	DRUGBANK	DB02823	C2H5O5P	small molecule	-	4408-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUYJLQHKOGNDPB-UHFFFAOYSA-N
19966	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2705	Phosphonoacetic Acid	-	-	DRUGBANK	DB02823	C2H5O5P	small molecule	-	4408-78-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUYJLQHKOGNDPB-UHFFFAOYSA-N
19967	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2706	N-Pyridoxyl-Glycine-5-Monophosphate	-	-	DRUGBANK	DB02824	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEVQWBMNLWUBTF-UHFFFAOYSA-N
19968	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2706	N-Pyridoxyl-Glycine-5-Monophosphate	-	-	DRUGBANK	DB02824	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEVQWBMNLWUBTF-UHFFFAOYSA-N
19969	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2706	N-Pyridoxyl-Glycine-5-Monophosphate	-	-	DRUGBANK	DB02824	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEVQWBMNLWUBTF-UHFFFAOYSA-N
19970	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2706	N-Pyridoxyl-Glycine-5-Monophosphate	-	-	DRUGBANK	DB02824	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEVQWBMNLWUBTF-UHFFFAOYSA-N
19971	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2706	N-Pyridoxyl-Glycine-5-Monophosphate	-	-	DRUGBANK	DB02824	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEVQWBMNLWUBTF-UHFFFAOYSA-N
19972	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2706	N-Pyridoxyl-Glycine-5-Monophosphate	-	-	DRUGBANK	DB02824	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEVQWBMNLWUBTF-UHFFFAOYSA-N
19973	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2707	Methylphosphonic Acid Ester Group	-	-	DRUGBANK	DB02825	CH4O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCDIWLCKOCHCIH-UHFFFAOYSA-M
19974	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2707	Methylphosphonic Acid Ester Group	-	-	DRUGBANK	DB02825	CH4O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCDIWLCKOCHCIH-UHFFFAOYSA-M
19975	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2707	Methylphosphonic Acid Ester Group	-	-	DRUGBANK	DB02825	CH4O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCDIWLCKOCHCIH-UHFFFAOYSA-M
19976	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2709	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02827	C18H14N2O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDYIGSPVMWSFEZ-JTQLQIEISA-N
19977	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2709	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02827	C18H14N2O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDYIGSPVMWSFEZ-JTQLQIEISA-N
19978	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2709	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB02827	C18H14N2O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDYIGSPVMWSFEZ-JTQLQIEISA-N
19979	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2712	FR236913	-	-	DRUGBANK	DB02830	C24H26N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCCUBLLGAMGDJL-HXUWFJFHSA-N
19980	852539	948237	b3728	pstS	ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2713	Dihydrogenphosphate Ion	-	-	DRUGBANK	DB02831	H2O4P	small molecule	-	29505-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBIIXXVUZAFLBC-UHFFFAOYSA-M
19981	852539	948237	b3728	pstS	ECK3721|JW3706|R2pho|nmpA|phoR2a|phoS	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2713	Dihydrogenphosphate Ion	-	-	DRUGBANK	DB02831	H2O4P	small molecule	-	29505-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBIIXXVUZAFLBC-UHFFFAOYSA-M
19982	119357	51181	-	DCXR	DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2713	Dihydrogenphosphate Ion	-	-	DRUGBANK	DB02831	H2O4P	small molecule	-	29505-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBIIXXVUZAFLBC-UHFFFAOYSA-M
19983	119357	51181	-	DCXR	DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2713	Dihydrogenphosphate Ion	-	-	DRUGBANK	DB02831	H2O4P	small molecule	-	29505-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBIIXXVUZAFLBC-UHFFFAOYSA-M
19984	851563	947231	b2763	cysI	ECK2758|JW2733	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2714	Siroheme	-	-	DRUGBANK	DB02832	C42H42FeN4O16	small molecule	-	52553-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGYXHNRRBJLFEV-NBUGCWMUSA-N
19985	851563	947231	b2763	cysI	ECK2758|JW2733	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2714	Siroheme	-	-	DRUGBANK	DB02832	C42H42FeN4O16	small molecule	-	52553-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGYXHNRRBJLFEV-NBUGCWMUSA-N
19986	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
19987	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
19988	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
19989	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2715	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	-	-	DRUGBANK	DB02833	C14H12N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYTKVFHLKPDNRW-UHFFFAOYSA-N
19990	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2716	IDD552	-	-	DRUGBANK	DB02834	C17H10F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCAGEXZTORJQDZ-UHFFFAOYSA-N
19991	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2716	IDD552	-	-	DRUGBANK	DB02834	C17H10F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCAGEXZTORJQDZ-UHFFFAOYSA-N
19992	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2716	IDD552	-	-	DRUGBANK	DB02834	C17H10F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCAGEXZTORJQDZ-UHFFFAOYSA-N
19993	111256	5236	-	PGM1	CDG1T|GSD14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2717	Alpha-D-Glucose 1,6-Bisphosphate	-	-	DRUGBANK	DB02835	C6H13O12P2	small molecule	-	10139-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHOZGRAXYWRNX-MDMQIMBFSA-M
19994	111256	5236	-	PGM1	CDG1T|GSD14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2717	Alpha-D-Glucose 1,6-Bisphosphate	-	-	DRUGBANK	DB02835	C6H13O12P2	small molecule	-	10139-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHOZGRAXYWRNX-MDMQIMBFSA-M
19995	111256	5236	-	PGM1	CDG1T|GSD14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2717	Alpha-D-Glucose 1,6-Bisphosphate	-	-	DRUGBANK	DB02835	C6H13O12P2	small molecule	-	10139-18-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWHOZGRAXYWRNX-MDMQIMBFSA-M
19996	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2718	Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate	-	-	DRUGBANK	DB02836	C10H14N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGYWTCOGOZELRS-KHLHZJAASA-N
19997	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2718	Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate	-	-	DRUGBANK	DB02836	C10H14N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGYWTCOGOZELRS-KHLHZJAASA-N
19998	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2719	O4-Sulfonylgalactose	-	-	DRUGBANK	DB02837	C6H12O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOTQRUGOUKUSEY-RUTHBDMASA-N
19999	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2719	O4-Sulfonylgalactose	-	-	DRUGBANK	DB02837	C6H12O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOTQRUGOUKUSEY-RUTHBDMASA-N
20000	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2719	O4-Sulfonylgalactose	-	-	DRUGBANK	DB02837	C6H12O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOTQRUGOUKUSEY-RUTHBDMASA-N
20001	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2720	3,4-Dihydro-2h-Pyrrolium-5-Carboxylate	-	-	DRUGBANK	DB02838	C5H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHTAIKJZSXNELN-UHFFFAOYSA-N
20002	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2720	3,4-Dihydro-2h-Pyrrolium-5-Carboxylate	-	-	DRUGBANK	DB02838	C5H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHTAIKJZSXNELN-UHFFFAOYSA-N
20003	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2720	3,4-Dihydro-2h-Pyrrolium-5-Carboxylate	-	-	DRUGBANK	DB02838	C5H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHTAIKJZSXNELN-UHFFFAOYSA-N
20004	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20005	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20006	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20007	850140	945773	b1002	agp	ECK0993|JW0987	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20008	850140	945773	b1002	agp	ECK0993|JW0987	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20009	852231	947922	b3417	malP	ECK3404|JW5689|blu|malA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20010	852231	947922	b3417	malP	ECK3404|JW5689|blu|malA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20011	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20012	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20013	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2725	Alpha-D-Glucose-1-Phosphate	-	-	DRUGBANK	DB02843	C6H13O9P	small molecule	-	59-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXXFSFRBOHSIMQ-VFUOTHLCSA-N
20014	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2727	Methylphosphinic Acid	-	-	DRUGBANK	DB02845	CH5O2P	small molecule	-	4206-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCDIWLCKOCHCIH-UHFFFAOYSA-N
20015	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2727	Methylphosphinic Acid	-	-	DRUGBANK	DB02845	CH5O2P	small molecule	-	4206-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCDIWLCKOCHCIH-UHFFFAOYSA-N
20016	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2727	Methylphosphinic Acid	-	-	DRUGBANK	DB02845	CH5O2P	small molecule	-	4206-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCDIWLCKOCHCIH-UHFFFAOYSA-N
20017	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2728	L-thioproline	(4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid	-	DRUGBANK	DB02846	C4H7NO2S	small molecule	-	2756-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLNHFMRPBPULJ-VKHMYHEASA-N
20018	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2728	L-thioproline	(4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid	-	DRUGBANK	DB02846	C4H7NO2S	small molecule	-	2756-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLNHFMRPBPULJ-VKHMYHEASA-N
20019	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2728	L-thioproline	(4R)-4-Thiazolidinecarboxylic acid|Thiazolidinecarboxylic acid|L-thiaproline|L-Thiazolidine-4-carboxylic acid|(R)-(-)-4-Thiazolidinecarboxylic acid|4-thiaproline|-thioproline|(R)-4-Thiazolidinecarboxylic acid	-	DRUGBANK	DB02846	C4H7NO2S	small molecule	-	2756-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZLNHFMRPBPULJ-VKHMYHEASA-N
20020	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2730	{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol	-	-	DRUGBANK	DB02848	C22H22N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJESXGUODSBHSK-UHFFFAOYSA-N
20021	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2732	(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone	-	-	DRUGBANK	DB02850	C23H28N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXVKJVRSQXCDKX-UHFFFAOYSA-N
20022	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2732	(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone	-	-	DRUGBANK	DB02850	C23H28N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXVKJVRSQXCDKX-UHFFFAOYSA-N
20023	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2732	(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone	-	-	DRUGBANK	DB02850	C23H28N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXVKJVRSQXCDKX-UHFFFAOYSA-N
20024	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2734	Domoic Acid	L-domoic acid|(-)-domoic acid	-	DRUGBANK	DB02852	C15H21NO6	small molecule	-	14277-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZFRNCSOCOPNDB-AOKDLOFSSA-N
20025	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2734	Domoic Acid	L-domoic acid|(-)-domoic acid	-	DRUGBANK	DB02852	C15H21NO6	small molecule	-	14277-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZFRNCSOCOPNDB-AOKDLOFSSA-N
20026	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2734	Domoic Acid	L-domoic acid|(-)-domoic acid	-	DRUGBANK	DB02852	C15H21NO6	small molecule	-	14277-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZFRNCSOCOPNDB-AOKDLOFSSA-N
20027	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2736	Aetiocholanolone	-	-	DRUGBANK	DB02854	C19H30O2	small molecule	-	53-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGXBDMJGAMFCBF-BNSUEQOYSA-N
20028	119349	51170	PSEC0029	HSD17B11	17-BETA-HSD11|17-BETA-HSDXI|17BHSD11|DHRS8|PAN1B|RETSDR2|SDR16C2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2736	Aetiocholanolone	-	-	DRUGBANK	DB02854	C19H30O2	small molecule	-	53-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGXBDMJGAMFCBF-BNSUEQOYSA-N
20029	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2736	Aetiocholanolone	-	-	DRUGBANK	DB02854	C19H30O2	small molecule	-	53-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGXBDMJGAMFCBF-BNSUEQOYSA-N
20030	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2736	Aetiocholanolone	-	-	DRUGBANK	DB02854	C19H30O2	small molecule	-	53-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGXBDMJGAMFCBF-BNSUEQOYSA-N
20031	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2736	Aetiocholanolone	-	-	DRUGBANK	DB02854	C19H30O2	small molecule	-	53-42-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGXBDMJGAMFCBF-BNSUEQOYSA-N
20032	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2737	N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline	N-(3-Propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline	-	DRUGBANK	DB02855	C18H31N3O6	small molecule	-	134448-10-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDNIFTKCMDIXFC-ABHRYQDASA-N
20033	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2739	Guanosine	Guanine riboside|G|9--D-ribofuranosyl-guanine|Guo|2-amino-1,9-dihydro-9--D-ribofuranosyl-6H-purin-6-one|Guanine-9--D-ribofuranoside|2(3H)-imino-9--D-ribofuranosyl-9H-purin-6(1H)-one|Guanosin	-	DRUGBANK	DB02857	C10H13N5O5	small molecule	-	118-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYHBQMYGNKIUIF-UUOKFMHZSA-N
20034	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2739	Guanosine	Guanine riboside|G|9--D-ribofuranosyl-guanine|Guo|2-amino-1,9-dihydro-9--D-ribofuranosyl-6H-purin-6-one|Guanine-9--D-ribofuranoside|2(3H)-imino-9--D-ribofuranosyl-9H-purin-6(1H)-one|Guanosin	-	DRUGBANK	DB02857	C10H13N5O5	small molecule	-	118-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYHBQMYGNKIUIF-UUOKFMHZSA-N
20035	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2740	3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid	-	-	DRUGBANK	DB02858	C16H14BNO6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZOKHYPIQNIFRQ-UHFFFAOYSA-N
20036	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2740	3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid	-	-	DRUGBANK	DB02858	C16H14BNO6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZOKHYPIQNIFRQ-UHFFFAOYSA-N
20037	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2740	3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid	-	-	DRUGBANK	DB02858	C16H14BNO6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZOKHYPIQNIFRQ-UHFFFAOYSA-N
20038	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2741	Soraphen A	-	-	DRUGBANK	DB02859	C29H44O8	small molecule	-	122547-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPMGNXPRKGXGBO-AKNGRICVSA-N
20039	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2741	Soraphen A	-	-	DRUGBANK	DB02859	C29H44O8	small molecule	-	122547-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPMGNXPRKGXGBO-AKNGRICVSA-N
20040	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2741	Soraphen A	-	-	DRUGBANK	DB02859	C29H44O8	small molecule	-	122547-72-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPMGNXPRKGXGBO-AKNGRICVSA-N
20041	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2742	Calyculin A	(-)-calyculin A	-	DRUGBANK	DB02860	C50H81N4O15P	small molecule	-	101932-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKAWLXNLHHIHLA-YCBIHMBMSA-N
20042	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2742	Calyculin A	(-)-calyculin A	-	DRUGBANK	DB02860	C50H81N4O15P	small molecule	-	101932-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKAWLXNLHHIHLA-YCBIHMBMSA-N
20043	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2743	4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02861	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEHMSTGBNAXEGX-UHFFFAOYSA-N
20044	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2743	4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02861	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEHMSTGBNAXEGX-UHFFFAOYSA-N
20045	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2743	4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB02861	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEHMSTGBNAXEGX-UHFFFAOYSA-N
20046	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2747	Glucosamine 4-Phosphate	-	-	DRUGBANK	DB02865	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDBGVNDGYUIAC-QZABAPFNSA-N
20047	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2747	Glucosamine 4-Phosphate	-	-	DRUGBANK	DB02865	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDBGVNDGYUIAC-QZABAPFNSA-N
20048	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2748	Dansylamide	-	-	DRUGBANK	DB02866	C12H14N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYNBFJJKZPTRKS-UHFFFAOYSA-N
20049	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2748	Dansylamide	-	-	DRUGBANK	DB02866	C12H14N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYNBFJJKZPTRKS-UHFFFAOYSA-N
20050	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2748	Dansylamide	-	-	DRUGBANK	DB02866	C12H14N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYNBFJJKZPTRKS-UHFFFAOYSA-N
20051	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2750	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	-	-	DRUGBANK	DB02868	C46H55ClN5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20052	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2750	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	-	-	DRUGBANK	DB02868	C46H55ClN5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20053	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2750	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	-	-	DRUGBANK	DB02868	C46H55ClN5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20054	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2751	3-amino-5-phenylpentane	-	-	DRUGBANK	DB02869	C17H21NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQRZZKAHRWPIFX-INIZCTEOSA-N
20055	107895	1515	UNQ268/PRO305	CTSV	CATL2|CTSL2|CTSU	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2751	3-amino-5-phenylpentane	-	-	DRUGBANK	DB02869	C17H21NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQRZZKAHRWPIFX-INIZCTEOSA-N
20056	107895	1515	UNQ268/PRO305	CTSV	CATL2|CTSL2|CTSU	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2751	3-amino-5-phenylpentane	-	-	DRUGBANK	DB02869	C17H21NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQRZZKAHRWPIFX-INIZCTEOSA-N
20057	107895	1515	UNQ268/PRO305	CTSV	CATL2|CTSL2|CTSU	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2751	3-amino-5-phenylpentane	-	-	DRUGBANK	DB02869	C17H21NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQRZZKAHRWPIFX-INIZCTEOSA-N
20058	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2753	3-Butylthiolane 1-Oxide	-	-	DRUGBANK	DB02871	C8H16OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVVQIIIFHZDBDL-WCBMZHEXSA-N
20059	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2754	Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone	-	-	DRUGBANK	DB02872	C31H34Br2N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVRYEWOXWGDQHA-FQLXRVMXSA-N
20060	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2754	Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone	-	-	DRUGBANK	DB02872	C31H34Br2N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVRYEWOXWGDQHA-FQLXRVMXSA-N
20061	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2755	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	-	-	DRUGBANK	DB02873	C24H20Cl2F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAWZIQKDHQIHOS-UHFFFAOYSA-N
20062	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2755	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	-	-	DRUGBANK	DB02873	C24H20Cl2F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAWZIQKDHQIHOS-UHFFFAOYSA-N
20063	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2755	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	-	-	DRUGBANK	DB02873	C24H20Cl2F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAWZIQKDHQIHOS-UHFFFAOYSA-N
20064	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2756	CRA_1802	-	-	DRUGBANK	DB02875	C14H11FN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOGOACSSLJEREC-UHFFFAOYSA-N
20065	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	unknown	target	Alvarez R (2004)	15546741	181870	2758	TTNPB	Arotinoic acid|CCRIS 3297|Arotinoid acid|Tocris-0761|(E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1 -propenyl] benzoic acid	-	DRUGBANK	DB02877	C24H28O2	small molecule	-	71441-28-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOIVPCKZDPCJJY-JQIJEIRASA-N
20066	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2758	TTNPB	Arotinoic acid|CCRIS 3297|Arotinoid acid|Tocris-0761|(E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1 -propenyl] benzoic acid	-	DRUGBANK	DB02877	C24H28O2	small molecule	-	71441-28-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOIVPCKZDPCJJY-JQIJEIRASA-N
20067	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2759	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	-	-	DRUGBANK	DB02878	C10H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMRGRIXXWLVLTR-JGVFFNPUSA-N
20068	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2759	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	-	-	DRUGBANK	DB02878	C10H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMRGRIXXWLVLTR-JGVFFNPUSA-N
20069	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2764	2',3'-Dideoxycytidine-5'-Monophosphate	-	-	DRUGBANK	DB02883	C9H14N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJMXAZJKUGYGW-POYBYMJQSA-N
20070	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2764	2',3'-Dideoxycytidine-5'-Monophosphate	-	-	DRUGBANK	DB02883	C9H14N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJMXAZJKUGYGW-POYBYMJQSA-N
20071	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2766	4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine	-	-	DRUGBANK	DB02885	C6H4F3N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKFRUALXTUDSBW-UHFFFAOYSA-N
20072	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2766	4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine	-	-	DRUGBANK	DB02885	C6H4F3N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKFRUALXTUDSBW-UHFFFAOYSA-N
20073	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2767	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate	-	-	DRUGBANK	DB02887	C10H15N2O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODSQODTUNULBHF-JGVFFNPUSA-N
20074	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2767	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate	-	-	DRUGBANK	DB02887	C10H15N2O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODSQODTUNULBHF-JGVFFNPUSA-N
20075	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2767	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate	-	-	DRUGBANK	DB02887	C10H15N2O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODSQODTUNULBHF-JGVFFNPUSA-N
20076	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2768	FKB-001	-	-	DRUGBANK	DB02888	C35H42F2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBYCDVVSYOMFMS-VMPREFPWSA-N
20077	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2768	FKB-001	-	-	DRUGBANK	DB02888	C35H42F2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBYCDVVSYOMFMS-VMPREFPWSA-N
20078	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2768	FKB-001	-	-	DRUGBANK	DB02888	C35H42F2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBYCDVVSYOMFMS-VMPREFPWSA-N
20079	851455	947121	b1281	pyrF	ECK1276|JW1273	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2770	6-Hydroxyuridine-5'-Phosphate	-	-	DRUGBANK	DB02890	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDOBICLZEKUKCV-YHSFNTFWSA-N
20080	851455	947121	b1281	pyrF	ECK1276|JW1273	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2770	6-Hydroxyuridine-5'-Phosphate	-	-	DRUGBANK	DB02890	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDOBICLZEKUKCV-YHSFNTFWSA-N
20081	113218	7372	OK/SW-cl.21	UMPS	OPRT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2770	6-Hydroxyuridine-5'-Phosphate	-	-	DRUGBANK	DB02890	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDOBICLZEKUKCV-YHSFNTFWSA-N
20082	113218	7372	OK/SW-cl.21	UMPS	OPRT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2770	6-Hydroxyuridine-5'-Phosphate	-	-	DRUGBANK	DB02890	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDOBICLZEKUKCV-YHSFNTFWSA-N
20083	113218	7372	OK/SW-cl.21	UMPS	OPRT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2770	6-Hydroxyuridine-5'-Phosphate	-	-	DRUGBANK	DB02890	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDOBICLZEKUKCV-YHSFNTFWSA-N
20084	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2773	D-Methionine	-	-	DRUGBANK	DB02893	C5H11NO2S	small molecule	-	348-67-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-SCSAIBSYSA-N
20085	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2773	D-Methionine	-	-	DRUGBANK	DB02893	C5H11NO2S	small molecule	-	348-67-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFEARJCKVFRZRR-SCSAIBSYSA-N
20086	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2774	Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester	-	-	DRUGBANK	DB02894	C9H15NO10S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGOAQSGCBDRTHT-AZRUVXNYSA-N
20087	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2774	Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester	-	-	DRUGBANK	DB02894	C9H15NO10S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGOAQSGCBDRTHT-AZRUVXNYSA-N
20088	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2775	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	-	-	DRUGBANK	DB02895	C6H10OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSVQDVSVQIMRSS-CDAZIORVSA-N
20089	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2775	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	-	-	DRUGBANK	DB02895	C6H10OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSVQDVSVQIMRSS-CDAZIORVSA-N
20090	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Bennett EM (2003)	12937174	181829	2776	Methylthioinosine	Me6MPR|6-methyl-9-ribofuranosylpurine-6-thiol|6-(Methylthio)purine ribonucleoside|6-methylmercaptopurine riboside|6-S-methyl-6-thioinosine|6-methylmercaptopurine ribonucleoside|6-methyl MP-riboside|6-MMPR|6-methyl MP riboside|6-methylthiopurine riboside|6-methylthioinosine|methylmercaptopurine riboside|MMPR	-	DRUGBANK	DB02896	C11H14N4O4S	small molecule	-	342-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDRFDHHANOYUTE-IOSLPCCCSA-N
20091	850910	946563	b2052	wcaG	ECK2046|JW2037|fcl|yefB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2777	Acetylphosphate	-	-	DRUGBANK	DB02897	C2H5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIPOUNRJVLNBCD-UHFFFAOYSA-N
20092	850910	946563	b2052	wcaG	ECK2046|JW2037|fcl|yefB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2777	Acetylphosphate	-	-	DRUGBANK	DB02897	C2H5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIPOUNRJVLNBCD-UHFFFAOYSA-N
20093	854261	936581	BSU37660	eutD	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2777	Acetylphosphate	-	-	DRUGBANK	DB02897	C2H5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIPOUNRJVLNBCD-UHFFFAOYSA-N
20094	854261	936581	BSU37660	eutD	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2777	Acetylphosphate	-	-	DRUGBANK	DB02897	C2H5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIPOUNRJVLNBCD-UHFFFAOYSA-N
20095	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2778	5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone	-	-	DRUGBANK	DB02898	C10H11N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKHIYHEECHGIB-RXMQYKEDSA-N
20096	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2778	5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone	-	-	DRUGBANK	DB02898	C10H11N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKHIYHEECHGIB-RXMQYKEDSA-N
20097	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2779	N-Carboxymethionine	-	-	DRUGBANK	DB02899	C6H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWQBAQJPCYBWJQ-BYPYZUCNSA-N
20098	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2779	N-Carboxymethionine	-	-	DRUGBANK	DB02899	C6H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWQBAQJPCYBWJQ-BYPYZUCNSA-N
20099	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2779	N-Carboxymethionine	-	-	DRUGBANK	DB02899	C6H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWQBAQJPCYBWJQ-BYPYZUCNSA-N
20100	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20101	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20102	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20103	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20104	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20105	110251	4074	-	M6PR	CD-MPR|MPR 46|MPR-46|MPR46|SMPR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2780	alpha-D-mannose 6-phosphate	Man6P|6-H2PO3Man|(6P)Man|(6P)Mana|6-O-phosphono--D-mannopyranose	-	DRUGBANK	DB02900	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-PQMKYFCFSA-N
20106	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2781	Dihydrotestosterone	17beta-Hydroxy-5alpha-androstane-3-one|Dihydrotestosteron|Dihydrotestostrone|Stanolone|17beta-Hydroxy-5alpha-androstan-3-one|4-Dihydrotestosterone|17-hydroxy-3-oxo-5-androstanone|5-DHT|17-hydroxy-5-androstan-3-one|17beta-Hydroxyandrostan-3-one|DHT|Androstanolone|5alpha-Dihydrotestosterone	-	DRUGBANK	DB02901	C19H30O2	small molecule	A14AA01|G03BB02	521-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVKAWKQGWWIWPM-ABEVXSGRSA-N
20107	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Askew EB (2007)	17591767	182022	2781	Dihydrotestosterone	17beta-Hydroxy-5alpha-androstane-3-one|Dihydrotestosteron|Dihydrotestostrone|Stanolone|17beta-Hydroxy-5alpha-androstan-3-one|4-Dihydrotestosterone|17-hydroxy-3-oxo-5-androstanone|5-DHT|17-hydroxy-5-androstan-3-one|17beta-Hydroxyandrostan-3-one|DHT|Androstanolone|5alpha-Dihydrotestosterone	-	DRUGBANK	DB02901	C19H30O2	small molecule	A14AA01|G03BB02	521-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVKAWKQGWWIWPM-ABEVXSGRSA-N
20108	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2782	3'-Phosphate-Adenosine-5'-Phosphate Sulfate	-	-	DRUGBANK	DB02902	C10H15N5O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GACDQMDRPRGCTN-PERBPWGJSA-N
20109	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2782	3'-Phosphate-Adenosine-5'-Phosphate Sulfate	-	-	DRUGBANK	DB02902	C10H15N5O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GACDQMDRPRGCTN-PERBPWGJSA-N
20110	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2787	2-Amino-Vinyl-Phosphate	-	-	DRUGBANK	DB02907	C2H6NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYMLMTPYCDIFEC-OWOJBTEDSA-N
20111	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2787	2-Amino-Vinyl-Phosphate	-	-	DRUGBANK	DB02907	C2H6NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYMLMTPYCDIFEC-OWOJBTEDSA-N
20112	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2788	RU78783	-	-	DRUGBANK	DB02908	C7H10O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRLTXWJJMCIUNT-UHFFFAOYSA-N
20113	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2788	RU78783	-	-	DRUGBANK	DB02908	C7H10O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRLTXWJJMCIUNT-UHFFFAOYSA-N
20114	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2788	RU78783	-	-	DRUGBANK	DB02908	C7H10O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRLTXWJJMCIUNT-UHFFFAOYSA-N
20115	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2789	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	-	-	DRUGBANK	DB02909	C11H7ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJGGWIHXGHQXMM-UHFFFAOYSA-N
20116	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2789	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	-	-	DRUGBANK	DB02909	C11H7ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJGGWIHXGHQXMM-UHFFFAOYSA-N
20117	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2789	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	-	-	DRUGBANK	DB02909	C11H7ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJGGWIHXGHQXMM-UHFFFAOYSA-N
20118	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20119	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20120	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20121	108000	1632	-	ECI1	DCI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20122	108000	1632	-	ECI1	DCI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20123	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20124	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20125	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2790	Octanoyl-Coenzyme A	-	-	DRUGBANK	DB02910	C29H50N7O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQMZYOXOBSXMII-OSFHJVGRSA-N
20126	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2791	2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine	-	-	DRUGBANK	DB02911	C12H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEKRIXRQADJFAG-QMMMGPOBSA-N
20127	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20128	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20129	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20130	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2794	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine	-	-	DRUGBANK	DB02915	C16H13F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZFDQUDLQCVNX-UHFFFAOYSA-N
20131	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2796	N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide	-	-	DRUGBANK	DB02917	C17H15N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFGYSFPVLMPUPE-UHFFFAOYSA-N
20132	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2796	N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide	-	-	DRUGBANK	DB02917	C17H15N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFGYSFPVLMPUPE-UHFFFAOYSA-N
20133	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2796	N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide	-	-	DRUGBANK	DB02917	C17H15N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFGYSFPVLMPUPE-UHFFFAOYSA-N
20134	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2797	6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One	-	-	DRUGBANK	DB02918	C12H10F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJMQDJPMQIHLPB-UHFFFAOYSA-N
20135	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2798	2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB02919	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUOZHLHNKHRTOW-UHFFFAOYSA-N
20136	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2798	2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB02919	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUOZHLHNKHRTOW-UHFFFAOYSA-N
20137	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2798	2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB02919	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUOZHLHNKHRTOW-UHFFFAOYSA-N
20138	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2803	D-Limonene 1,2-Epoxide	-	-	DRUGBANK	DB02924	C10H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCEFMUBVSUDRLG-KXUCPTDWSA-N
20139	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2803	D-Limonene 1,2-Epoxide	-	-	DRUGBANK	DB02924	C10H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCEFMUBVSUDRLG-KXUCPTDWSA-N
20140	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2803	D-Limonene 1,2-Epoxide	-	-	DRUGBANK	DB02924	C10H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCEFMUBVSUDRLG-KXUCPTDWSA-N
20141	112446	6557	-	SLC12A1	BSC1|NKCC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2804	Piretanide	-	-	DRUGBANK	DB02925	C17H18N2O5S	small molecule	C03CA03	55837-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJEWTUDSLQGTOA-UHFFFAOYSA-N
20142	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2805	Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid	-	-	DRUGBANK	DB02927	C10H21N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJJZZEABROBUCE-JGVFFNPUSA-N
20143	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2805	Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid	-	-	DRUGBANK	DB02927	C10H21N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJJZZEABROBUCE-JGVFFNPUSA-N
20144	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2806	3-Amino-6-Hydroxy-Tyrosine	-	-	DRUGBANK	DB02928	C9H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIXIYIGKZVEKPI-LURJTMIESA-N
20145	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2806	3-Amino-6-Hydroxy-Tyrosine	-	-	DRUGBANK	DB02928	C9H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIXIYIGKZVEKPI-LURJTMIESA-N
20146	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2807	K201	-	-	DRUGBANK	DB02929	C25H32N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCWGETCFOVJEPI-UHFFFAOYSA-N
20147	852615	948318	b3822	recQ	ECK3816|JW5855	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2808	Phosphothiophosphoric Acid-Adenylate Ester	-	-	DRUGBANK	DB02930	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
20148	852615	948318	b3822	recQ	ECK3816|JW5855	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2808	Phosphothiophosphoric Acid-Adenylate Ester	-	-	DRUGBANK	DB02930	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
20149	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2808	Phosphothiophosphoric Acid-Adenylate Ester	-	-	DRUGBANK	DB02930	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
20150	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2808	Phosphothiophosphoric Acid-Adenylate Ester	-	-	DRUGBANK	DB02930	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
20151	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2808	Phosphothiophosphoric Acid-Adenylate Ester	-	-	DRUGBANK	DB02930	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
20152	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2808	Phosphothiophosphoric Acid-Adenylate Ester	-	-	DRUGBANK	DB02930	C10H16N5O12P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLTUCYMLOPLUHL-FCIPNVEPSA-N
20153	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2809	Coa-S-Acetyl Tryptamine	-	-	DRUGBANK	DB02931	C33H47N9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEDBOMCWRKFRNZ-KOGRCXSVSA-N
20154	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2809	Coa-S-Acetyl Tryptamine	-	-	DRUGBANK	DB02931	C33H47N9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEDBOMCWRKFRNZ-KOGRCXSVSA-N
20155	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2809	Coa-S-Acetyl Tryptamine	-	-	DRUGBANK	DB02931	C33H47N9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEDBOMCWRKFRNZ-KOGRCXSVSA-N
20156	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2810	(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide	-	-	DRUGBANK	DB02932	C18H14F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKJPYSCBVHEWIU-KRWDZBQOSA-N
20157	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2811	5'-Deoxy-5'-(Methylthio)-Tubercidin	-	-	DRUGBANK	DB02933	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBPLMFVTQMIPLW-MFYTUXHUSA-N
20158	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2811	5'-Deoxy-5'-(Methylthio)-Tubercidin	-	-	DRUGBANK	DB02933	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBPLMFVTQMIPLW-MFYTUXHUSA-N
20159	110611	4507	-	MTAP	BDMF|DMSFH|DMSMFH|HEL-249|LGMBF|MSAP|c86fus	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2811	5'-Deoxy-5'-(Methylthio)-Tubercidin	-	-	DRUGBANK	DB02933	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBPLMFVTQMIPLW-MFYTUXHUSA-N
20160	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2811	5'-Deoxy-5'-(Methylthio)-Tubercidin	-	-	DRUGBANK	DB02933	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBPLMFVTQMIPLW-MFYTUXHUSA-N
20161	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2811	5'-Deoxy-5'-(Methylthio)-Tubercidin	-	-	DRUGBANK	DB02933	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBPLMFVTQMIPLW-MFYTUXHUSA-N
20162	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2811	5'-Deoxy-5'-(Methylthio)-Tubercidin	-	-	DRUGBANK	DB02933	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBPLMFVTQMIPLW-MFYTUXHUSA-N
20163	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2812	9-(6-Deoxy-Alpha-L-Talofuranosyl)-6-Methylpurine	-	-	DRUGBANK	DB02934	C12H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJZDIUOABWMPLZ-DLOONRPBSA-N
20164	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2812	9-(6-Deoxy-Alpha-L-Talofuranosyl)-6-Methylpurine	-	-	DRUGBANK	DB02934	C12H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJZDIUOABWMPLZ-DLOONRPBSA-N
20165	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2813	1-Methoxy-2-(2-Methoxyethoxy)Ethane	-	-	DRUGBANK	DB02935	C6H14O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBZXBUIDTXKZTM-UHFFFAOYSA-N
20166	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2813	1-Methoxy-2-(2-Methoxyethoxy)Ethane	-	-	DRUGBANK	DB02935	C6H14O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBZXBUIDTXKZTM-UHFFFAOYSA-N
20167	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2813	1-Methoxy-2-(2-Methoxyethoxy)Ethane	-	-	DRUGBANK	DB02935	C6H14O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBZXBUIDTXKZTM-UHFFFAOYSA-N
20168	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2814	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	-	-	DRUGBANK	DB02936	C22H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STENXUCYNKOBHJ-UHFFFAOYSA-N
20169	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2814	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	-	-	DRUGBANK	DB02936	C22H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STENXUCYNKOBHJ-UHFFFAOYSA-N
20170	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2814	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	-	-	DRUGBANK	DB02936	C22H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STENXUCYNKOBHJ-UHFFFAOYSA-N
20171	852720	948423	b3926	glpK	ECK3918|JW3897	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2815	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02937	C11H19AsN5O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACTCPZXBRDYEOC-WOIOKPISSA-N
20172	852720	948423	b3926	glpK	ECK3918|JW3897	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2815	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02937	C11H19AsN5O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACTCPZXBRDYEOC-WOIOKPISSA-N
20173	851285	946946	b1740	nadE	ECK1738|JW1729|efg|ntrL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2815	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02937	C11H19AsN5O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACTCPZXBRDYEOC-WOIOKPISSA-N
20174	851285	946946	b1740	nadE	ECK1738|JW1729|efg|ntrL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2815	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	-	-	DRUGBANK	DB02937	C11H19AsN5O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACTCPZXBRDYEOC-WOIOKPISSA-N
20175	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2816	Heptanoic Acid	-	-	DRUGBANK	DB02938	C7H14O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNWFXJYAOYHMED-UHFFFAOYSA-N
20177	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2819	3-(1-Aminoethyl)Nonanedioic Acid	-	-	DRUGBANK	DB02941	C11H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHQUUILSXUJSSP-RKDXNWHRSA-N
20178	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2819	3-(1-Aminoethyl)Nonanedioic Acid	-	-	DRUGBANK	DB02941	C11H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHQUUILSXUJSSP-RKDXNWHRSA-N
20179	113999	8411	-	EEA1	MST105|MSTP105|ZFYVE2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2820	Inositol 1,3-Bisphosphate	-	-	DRUGBANK	DB02942	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUVHMWJJTITUGO-KNBDEEDGSA-N
20180	113999	8411	-	EEA1	MST105|MSTP105|ZFYVE2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2820	Inositol 1,3-Bisphosphate	-	-	DRUGBANK	DB02942	C6H14O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUVHMWJJTITUGO-KNBDEEDGSA-N
20181	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2824	2-Fluoro-2'-Deoxyadenosine	-	-	DRUGBANK	DB02947	C10H12FN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWPYUXAXLRFWQC-NGJCXOISSA-N
20182	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2824	2-Fluoro-2'-Deoxyadenosine	-	-	DRUGBANK	DB02947	C10H12FN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWPYUXAXLRFWQC-NGJCXOISSA-N
20183	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2825	Fosmidomycin	-	-	DRUGBANK	DB02948	C4H10NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJXWDTUCERCKIX-UHFFFAOYSA-N
20184	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2825	Fosmidomycin	-	-	DRUGBANK	DB02948	C4H10NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJXWDTUCERCKIX-UHFFFAOYSA-N
20185	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20186	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20187	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20188	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20189	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20190	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2827	Hymenialdisine	-	-	DRUGBANK	DB02950	C11H10BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPCBNXNDVYOBIP-WHFBIAKZSA-N
20191	110914	4852	-	NPY	PYY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2829	Alpha-Aminoisobutyric Acid	-	-	DRUGBANK	DB02952	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUOOLUPWFVMBKG-UHFFFAOYSA-N
20192	107782	1392	-	CRH	CRF|CRH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2829	Alpha-Aminoisobutyric Acid	-	-	DRUGBANK	DB02952	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUOOLUPWFVMBKG-UHFFFAOYSA-N
20193	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2830	2-Thiomethyl-3-Phenylpropanoic Acid	-	-	DRUGBANK	DB02953	C10H12O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUEBVBPVXLQMQR-SECBINFHSA-N
20194	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2830	2-Thiomethyl-3-Phenylpropanoic Acid	-	-	DRUGBANK	DB02953	C10H12O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUEBVBPVXLQMQR-SECBINFHSA-N
20195	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2830	2-Thiomethyl-3-Phenylpropanoic Acid	-	-	DRUGBANK	DB02953	C10H12O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUEBVBPVXLQMQR-SECBINFHSA-N
20196	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2831	(Carboxyhydroxyamino)Ethanoic Acid	-	-	DRUGBANK	DB02954	C3H5NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJSQPIOQKDFEKE-UHFFFAOYSA-N
20197	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2831	(Carboxyhydroxyamino)Ethanoic Acid	-	-	DRUGBANK	DB02954	C3H5NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJSQPIOQKDFEKE-UHFFFAOYSA-N
20198	852697	948400	b3903	rhaA	ECK3896|JW5561	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2838	L-Rhamnose	-	-	DRUGBANK	DB02961	C6H12O5	small molecule	-	3615-41-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNNNRSAQSRJVSB-JGWLITMVSA-N
20199	852697	948400	b3903	rhaA	ECK3896|JW5561	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2838	L-Rhamnose	-	-	DRUGBANK	DB02961	C6H12O5	small molecule	-	3615-41-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNNNRSAQSRJVSB-JGWLITMVSA-N
20200	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2840	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	-	-	DRUGBANK	DB02963	C13H11ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNXHNRYPADEAD-UHFFFAOYSA-N
20201	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2840	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	-	-	DRUGBANK	DB02963	C13H11ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNXHNRYPADEAD-UHFFFAOYSA-N
20202	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2840	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	-	-	DRUGBANK	DB02963	C13H11ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNXHNRYPADEAD-UHFFFAOYSA-N
20203	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2841	8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One	-	-	DRUGBANK	DB02964	C8H12N2O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEWLGQKSTDZKFN-UXDJRKLDSA-N
20204	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2841	8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One	-	-	DRUGBANK	DB02964	C8H12N2O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEWLGQKSTDZKFN-UXDJRKLDSA-N
20205	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2841	8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One	-	-	DRUGBANK	DB02964	C8H12N2O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEWLGQKSTDZKFN-UXDJRKLDSA-N
20206	853061	948774	b4254	argI	ECK4247|JW4211	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2842	Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine	-	-	DRUGBANK	DB02965	C5H15N4O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDGVOXPIIICZEK-LQMFNZFOSA-N
20207	853061	948774	b4254	argI	ECK4247|JW4211	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2842	Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine	-	-	DRUGBANK	DB02965	C5H15N4O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDGVOXPIIICZEK-LQMFNZFOSA-N
20208	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2843	Fluoro-Willardiine	-	-	DRUGBANK	DB02966	C7H8FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBWPFHJYSTVBCZ-BYPYZUCNSA-N
20209	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2843	Fluoro-Willardiine	-	-	DRUGBANK	DB02966	C7H8FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBWPFHJYSTVBCZ-BYPYZUCNSA-N
20210	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2843	Fluoro-Willardiine	-	-	DRUGBANK	DB02966	C7H8FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBWPFHJYSTVBCZ-BYPYZUCNSA-N
20211	107592	1178	-	CLC	GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2844	N-Ethylmaleimide	-	-	DRUGBANK	DB02967	C6H7NO2	small molecule	-	128-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDFGOPSGAURCEO-UHFFFAOYSA-N
20212	107592	1178	-	CLC	GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2844	N-Ethylmaleimide	-	-	DRUGBANK	DB02967	C6H7NO2	small molecule	-	128-53-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDFGOPSGAURCEO-UHFFFAOYSA-N
20213	856137	938519	BSU38300	thiM	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2846	4-Methyl-5-Hydroxyethylthiazole	-	-	DRUGBANK	DB02969	C6H9NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKAWJIRCKVUVED-UHFFFAOYSA-N
20214	856137	938519	BSU38300	thiM	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2846	4-Methyl-5-Hydroxyethylthiazole	-	-	DRUGBANK	DB02969	C6H9NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKAWJIRCKVUVED-UHFFFAOYSA-N
20215	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2850	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	-	-	DRUGBANK	DB02973	C14H9BrN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWTHJLODYBOEIY-VHEBQXMUSA-N
20216	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2850	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	-	-	DRUGBANK	DB02973	C14H9BrN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWTHJLODYBOEIY-VHEBQXMUSA-N
20217	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2850	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	-	-	DRUGBANK	DB02973	C14H9BrN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWTHJLODYBOEIY-VHEBQXMUSA-N
20218	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2851	4-(4-Chlorophenyl)Imidazole	-	-	DRUGBANK	DB02974	C9H6ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20219	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2851	4-(4-Chlorophenyl)Imidazole	-	-	DRUGBANK	DB02974	C9H6ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20220	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2851	4-(4-Chlorophenyl)Imidazole	-	-	DRUGBANK	DB02974	C9H6ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20221	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2854	PNU177836	-	-	DRUGBANK	DB02977	C31H47N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVFJFYADATXBBE-ZKBMQHRLSA-N
20222	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2854	PNU177836	-	-	DRUGBANK	DB02977	C31H47N3O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVFJFYADATXBBE-ZKBMQHRLSA-N
20223	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2856	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	-	-	DRUGBANK	DB02979	C18H38N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOKDMHHZKWLWKO-UHFFFAOYSA-N
20224	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2856	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	-	-	DRUGBANK	DB02979	C18H38N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOKDMHHZKWLWKO-UHFFFAOYSA-N
20225	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2856	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	-	-	DRUGBANK	DB02979	C18H38N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOKDMHHZKWLWKO-UHFFFAOYSA-N
20226	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2858	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	-	-	DRUGBANK	DB02981	C14H23N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVFCSUYJRWFNW-GFCCVEGCSA-N
20227	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2858	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	-	-	DRUGBANK	DB02981	C14H23N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHVFCSUYJRWFNW-GFCCVEGCSA-N
20228	107592	1178	-	CLC	GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20229	107592	1178	-	CLC	GAL10|Gal-10|LGALS10|LGALS10A|LPPL_HUMAN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20230	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20231	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20232	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2860	Para-Mercury-Benzenesulfonic Acid	-	-	DRUGBANK	DB02983	C6H5HgO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAOIKIZSJJTII-UHFFFAOYSA-N
20233	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2861	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB02984	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSDVOSGGMBSMK-UHFFFAOYSA-N
20234	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2861	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB02984	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSDVOSGGMBSMK-UHFFFAOYSA-N
20235	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2861	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB02984	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUSDVOSGGMBSMK-UHFFFAOYSA-N
20236	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2863	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	-	-	DRUGBANK	DB02986	C9H10N2O4S4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STOTVDLYLKWVJB-UHFFFAOYSA-N
20237	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2863	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	-	-	DRUGBANK	DB02986	C9H10N2O4S4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STOTVDLYLKWVJB-UHFFFAOYSA-N
20238	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2863	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	-	-	DRUGBANK	DB02986	C9H10N2O4S4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STOTVDLYLKWVJB-UHFFFAOYSA-N
20239	110992	4938	-	OAS1	IFI-4|OIAS|OIASI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2864	Cysteine-S-Acetamide	-	-	DRUGBANK	DB02987	C5H10N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFKYKPOTSJWPIU-VKHMYHEASA-N
20240	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2864	Cysteine-S-Acetamide	-	-	DRUGBANK	DB02987	C5H10N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFKYKPOTSJWPIU-VKHMYHEASA-N
20241	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2864	Cysteine-S-Acetamide	-	-	DRUGBANK	DB02987	C5H10N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFKYKPOTSJWPIU-VKHMYHEASA-N
20242	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2864	Cysteine-S-Acetamide	-	-	DRUGBANK	DB02987	C5H10N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFKYKPOTSJWPIU-VKHMYHEASA-N
20243	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2865	Imino-Tryptophan	-	-	DRUGBANK	DB02988	C11H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKYWXXAVLLVJAS-UHFFFAOYSA-N
20244	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2866	CRA_10972	-	-	DRUGBANK	DB02989	C18H18ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20245	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2866	CRA_10972	-	-	DRUGBANK	DB02989	C18H18ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20246	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2866	CRA_10972	-	-	DRUGBANK	DB02989	C18H18ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20247	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2868	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	-	-	DRUGBANK	DB02991	C10H11F3N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCMOXIFARISMOH-UHFFFAOYSA-N
20248	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20249	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20250	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20251	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20252	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20253	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20254	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20255	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20256	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2873	2-(Thiomethylene)-4-Methylpentanoic Acid	-	-	DRUGBANK	DB02996	C7H14O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCTDRFXPPSVRRP-ZCFIWIBFSA-N
20257	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2874	Methyltrienolone	Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one	-	DRUGBANK	DB02998	C19H24O2	small molecule	-	965-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCCIJQPRIXGQOE-XWSJACJDSA-N
20258	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2874	Methyltrienolone	Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one	-	DRUGBANK	DB02998	C19H24O2	small molecule	-	965-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCCIJQPRIXGQOE-XWSJACJDSA-N
20259	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2874	Methyltrienolone	Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one	-	DRUGBANK	DB02998	C19H24O2	small molecule	-	965-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCCIJQPRIXGQOE-XWSJACJDSA-N
20260	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2874	Methyltrienolone	Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one	-	DRUGBANK	DB02998	C19H24O2	small molecule	-	965-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCCIJQPRIXGQOE-XWSJACJDSA-N
20261	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2874	Methyltrienolone	Metribolone|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one	-	DRUGBANK	DB02998	C19H24O2	small molecule	-	965-93-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCCIJQPRIXGQOE-XWSJACJDSA-N
20262	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20263	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20264	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20265	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20266	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20267	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20268	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20269	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20270	109193	2938	RP11-392A23.1	GSTA1	GST2|GSTA1-1|GTH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20271	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20272	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20273	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20274	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20275	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20276	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20277	850125	945758	b1635	gstA	ECK1631|JW1627|gst	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20278	850125	945758	b1635	gstA	ECK1631|JW1627|gst	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2879	Glutathione Sulfonic Acid	-	-	DRUGBANK	DB03003	C10H17N3O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWRMTHFAZVWAM-NTSWFWBYSA-N
20279	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2881	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	-	-	DRUGBANK	DB03005	C42H45N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISUOMOOYAOQQPZ-UHFFFAOYSA-O
20280	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2881	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	-	-	DRUGBANK	DB03005	C42H45N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISUOMOOYAOQQPZ-UHFFFAOYSA-O
20281	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2881	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	-	-	DRUGBANK	DB03005	C42H45N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISUOMOOYAOQQPZ-UHFFFAOYSA-O
20282	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2882	Arsanilic acid	4-Aminophenylarsonsure|4-arsanilic acid|p-arsanilic acid|4-aminobenzenearsonic acid|4-Aminophenylarsonic acid|(p-aminophenyl)arsonic acid|atoxylic acid|Arsanilsure	-	DRUGBANK	DB03006	C6H8AsNO3	small molecule	-	98-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKNKHVGWJDPIRJ-UHFFFAOYSA-N
20283	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2882	Arsanilic acid	4-Aminophenylarsonsure|4-arsanilic acid|p-arsanilic acid|4-aminobenzenearsonic acid|4-Aminophenylarsonic acid|(p-aminophenyl)arsonic acid|atoxylic acid|Arsanilsure	-	DRUGBANK	DB03006	C6H8AsNO3	small molecule	-	98-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKNKHVGWJDPIRJ-UHFFFAOYSA-N
20284	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2882	Arsanilic acid	4-Aminophenylarsonsure|4-arsanilic acid|p-arsanilic acid|4-aminobenzenearsonic acid|4-Aminophenylarsonic acid|(p-aminophenyl)arsonic acid|atoxylic acid|Arsanilsure	-	DRUGBANK	DB03006	C6H8AsNO3	small molecule	-	98-50-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKNKHVGWJDPIRJ-UHFFFAOYSA-N
20285	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2884	5-Fluoro-Beta-L-Gulosyl Fluoride	-	-	DRUGBANK	DB03008	C6H10F2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGHYRMVVRYCAON-MDMQIMBFSA-N
20286	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2884	5-Fluoro-Beta-L-Gulosyl Fluoride	-	-	DRUGBANK	DB03008	C6H10F2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGHYRMVVRYCAON-MDMQIMBFSA-N
20287	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2884	5-Fluoro-Beta-L-Gulosyl Fluoride	-	-	DRUGBANK	DB03008	C6H10F2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGHYRMVVRYCAON-MDMQIMBFSA-N
20288	113129	7278	-	TUBA3C	TUBA2|bA408E5.3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20289	113129	7278	-	TUBA3C	TUBA2|bA408E5.3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20290	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20291	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20292	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20293	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20294	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20295	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20296	119733	51807	-	TUBA8	TUBAL2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20297	119733	51807	-	TUBA8	TUBAL2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20298	115655	10382	-	TUBB4A	DYT4|TUBB4|beta-5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20299	115655	10382	-	TUBB4A	DYT4|TUBB4|beta-5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20300	124259	84790	-	TUBA1C	TUBA6|bcm948	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20301	124259	84790	-	TUBA1C	TUBA6|bcm948	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20302	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20303	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20304	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20305	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20306	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20307	113128	7277	-	TUBA4A	H2-ALPHA|TUBA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20308	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20309	128444	203068	DAAP-285E11.4	TUBB	CDCBM6|M40|OK/SW-cl.56|TUBB1|TUBB5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2886	Epothilone B	Patupilone|()-epothilone B|Epo B	-	DRUGBANK	DB03010	C27H41NO6S	small molecule	-	152044-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXRSDHAAWVKZLJ-PVYNADRNSA-N
20310	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2888	Phenylalanine-N-Sulfonamide	-	-	DRUGBANK	DB03012	C9H12N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHGMHLLGXKQIDY-QMMMGPOBSA-N
20311	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2889	Di(N-Acetyl-D-Glucosamine)	-	-	DRUGBANK	DB03013	C16H28N2O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOJPCSDOXYJJF-OSJSAICRSA-N
20312	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2889	Di(N-Acetyl-D-Glucosamine)	-	-	DRUGBANK	DB03013	C16H28N2O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOJPCSDOXYJJF-OSJSAICRSA-N
20313	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2889	Di(N-Acetyl-D-Glucosamine)	-	-	DRUGBANK	DB03013	C16H28N2O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOJPCSDOXYJJF-OSJSAICRSA-N
20314	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2889	Di(N-Acetyl-D-Glucosamine)	-	-	DRUGBANK	DB03013	C16H28N2O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOJPCSDOXYJJF-OSJSAICRSA-N
20315	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2889	Di(N-Acetyl-D-Glucosamine)	-	-	DRUGBANK	DB03013	C16H28N2O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOJPCSDOXYJJF-OSJSAICRSA-N
20316	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2889	Di(N-Acetyl-D-Glucosamine)	-	-	DRUGBANK	DB03013	C16H28N2O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDOJPCSDOXYJJF-OSJSAICRSA-N
20317	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2890	6-Hydroxy-1,6-Dihydro Purine Nucleoside	-	-	DRUGBANK	DB03015	C10H15N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGRXVKRHIMUTPD-DGCCPWOOSA-O
20318	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2890	6-Hydroxy-1,6-Dihydro Purine Nucleoside	-	-	DRUGBANK	DB03015	C10H15N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGRXVKRHIMUTPD-DGCCPWOOSA-O
20319	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2890	6-Hydroxy-1,6-Dihydro Purine Nucleoside	-	-	DRUGBANK	DB03015	C10H15N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGRXVKRHIMUTPD-DGCCPWOOSA-O
20320	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2891	CRA_1801	-	-	DRUGBANK	DB03016	C13H10N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20321	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2891	CRA_1801	-	-	DRUGBANK	DB03016	C13H10N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20322	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2891	CRA_1801	-	-	DRUGBANK	DB03016	C13H10N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20323	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2893	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB03019	C8H5Cl2N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAPYICJQRHSQGK-UHFFFAOYSA-N
20324	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2893	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	-	-	DRUGBANK	DB03019	C8H5Cl2N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAPYICJQRHSQGK-UHFFFAOYSA-N
20325	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2894	5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide	-	-	DRUGBANK	DB03020	C21H27N7O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UINNILASBHZOTM-NYTQINMXSA-N
20326	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2894	5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide	-	-	DRUGBANK	DB03020	C21H27N7O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UINNILASBHZOTM-NYTQINMXSA-N
20327	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2894	5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide	-	-	DRUGBANK	DB03020	C21H27N7O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UINNILASBHZOTM-NYTQINMXSA-N
20328	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2895	Ulapualide A	-	-	DRUGBANK	DB03021	C46H66N4O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIOFXPZEAVIPDB-OYYPEJFMSA-N
20329	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2895	Ulapualide A	-	-	DRUGBANK	DB03021	C46H66N4O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIOFXPZEAVIPDB-OYYPEJFMSA-N
20330	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2895	Ulapualide A	-	-	DRUGBANK	DB03021	C46H66N4O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIOFXPZEAVIPDB-OYYPEJFMSA-N
20331	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20332	110245	4067	-	LYN	JTK8|p53Lyn|p56Lyn	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20333	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20334	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20335	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2897	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	-	-	DRUGBANK	DB03023	C15H17ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBRWFOVCUAONR-UHFFFAOYSA-O
20336	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2898	2-Methyl-3-(2-Aminothiazolo)Propanal	-	-	DRUGBANK	DB03024	C7H10N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFMAJVLZSDMFBV-YFKPBYRVSA-N
20337	852698	948401	b3902	rhaD	ECK3895|JW3873	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20338	852698	948401	b3902	rhaD	ECK3895|JW3873	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20339	851736	947415	b2925	fbaA	ECK2921|JW2892|ald|fba|fda	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20340	851736	947415	b2925	fbaA	ECK2921|JW2892|ald|fba|fda	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20341	851610	947282	b2800	fucA	ECK2795|JW2771|fucC|prd	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20342	851610	947282	b2800	fucA	ECK2795|JW2771|fucC|prd	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20343	851957	947644	b3137	kbaY	ECK3125|JW3106|agaY|kba|yraC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20344	851957	947644	b3137	kbaY	ECK3125|JW3106|agaY|kba|yraC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20345	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20346	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20347	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2900	Phosphoglycolohydroxamic Acid	-	-	DRUGBANK	DB03026	C2H6NO6P	small molecule	-	51528-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BAXHHWZKQZIJID-UHFFFAOYSA-N
20348	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2901	1h-Benoximidazole-2-Carboxylic Acid	-	-	DRUGBANK	DB03028	C8H5N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20349	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2901	1h-Benoximidazole-2-Carboxylic Acid	-	-	DRUGBANK	DB03028	C8H5N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20350	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2901	1h-Benoximidazole-2-Carboxylic Acid	-	-	DRUGBANK	DB03028	C8H5N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20351	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2903	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	-	-	DRUGBANK	DB03030	C15H14N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMOFOLLUKPBVQG-UHFFFAOYSA-N
20352	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2903	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	-	-	DRUGBANK	DB03030	C15H14N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMOFOLLUKPBVQG-UHFFFAOYSA-N
20353	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	2903	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	-	-	DRUGBANK	DB03030	C15H14N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMOFOLLUKPBVQG-UHFFFAOYSA-N
20354	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2905	S-Octylglutathione	-	-	DRUGBANK	DB03032	C18H33N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJWCZWAVSJZQNL-UONOGXRCSA-N
20355	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2905	S-Octylglutathione	-	-	DRUGBANK	DB03032	C18H33N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJWCZWAVSJZQNL-UONOGXRCSA-N
20356	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2905	S-Octylglutathione	-	-	DRUGBANK	DB03032	C18H33N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJWCZWAVSJZQNL-UONOGXRCSA-N
20357	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2906	1-Methyloxy-4-Sulfone-Benzene	-	-	DRUGBANK	DB03033	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUNSZADDFLWFOL-UHFFFAOYSA-N
20358	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2906	1-Methyloxy-4-Sulfone-Benzene	-	-	DRUGBANK	DB03033	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUNSZADDFLWFOL-UHFFFAOYSA-N
20359	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2906	1-Methyloxy-4-Sulfone-Benzene	-	-	DRUGBANK	DB03033	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUNSZADDFLWFOL-UHFFFAOYSA-N
20360	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2906	1-Methyloxy-4-Sulfone-Benzene	-	-	DRUGBANK	DB03033	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUNSZADDFLWFOL-UHFFFAOYSA-N
20361	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2908	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	-	-	DRUGBANK	DB03035	C14H7NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIYCICFDXLNQPV-UHFFFAOYSA-N
20362	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2910	LY341770	-	-	DRUGBANK	DB03038	C20H19N9O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20363	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2910	LY341770	-	-	DRUGBANK	DB03038	C20H19N9O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20364	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2911	4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB03039	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGUALXMKQVDIO-UHFFFAOYSA-N
20365	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2911	4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB03039	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGUALXMKQVDIO-UHFFFAOYSA-N
20366	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2911	4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB03039	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGUALXMKQVDIO-UHFFFAOYSA-N
20367	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2912	Nitrilotriacetic Acid	-	-	DRUGBANK	DB03040	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGFYIUFZLHCRTH-UHFFFAOYSA-N
20368	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2912	Nitrilotriacetic Acid	-	-	DRUGBANK	DB03040	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGFYIUFZLHCRTH-UHFFFAOYSA-N
20369	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2912	Nitrilotriacetic Acid	-	-	DRUGBANK	DB03040	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGFYIUFZLHCRTH-UHFFFAOYSA-N
20370	117620	26229	-	B3GAT3	GLCATI|glcUAT-I	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2913	UDP-alpha-D-glucuronic acid	UDPglucuronate|UDP-alpha-D-glucuronate|Uridine-5'-diphosphate-glucuronic acid|UDP-glucuronate|uridine diphosphate glucuronic acid|UDP-Glucuronic Acid|UDP-D-glucuronate	-	DRUGBANK	DB03041	C15H22N2O18P2	small molecule	-	2616-64-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDYANYHVCAPMJV-LXQIFKJMSA-N
20371	117620	26229	-	B3GAT3	GLCATI|glcUAT-I	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2913	UDP-alpha-D-glucuronic acid	UDPglucuronate|UDP-alpha-D-glucuronate|Uridine-5'-diphosphate-glucuronic acid|UDP-glucuronate|uridine diphosphate glucuronic acid|UDP-Glucuronic Acid|UDP-D-glucuronate	-	DRUGBANK	DB03041	C15H22N2O18P2	small molecule	-	2616-64-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDYANYHVCAPMJV-LXQIFKJMSA-N
20372	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2914	5-Phosphoarabinonic Acid	-	-	DRUGBANK	DB03042	C5H11O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNECGPFIYSOYHF-UZBSEBFBSA-N
20373	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2914	5-Phosphoarabinonic Acid	-	-	DRUGBANK	DB03042	C5H11O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNECGPFIYSOYHF-UZBSEBFBSA-N
20374	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2914	5-Phosphoarabinonic Acid	-	-	DRUGBANK	DB03042	C5H11O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNECGPFIYSOYHF-UZBSEBFBSA-N
20375	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2916	Doramapimod	DSSTOX_RID_83151|KINOME_2137|CCG-264915|1-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|ZINC24044436|DORAMAPIMOD1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|NSC785337|AKOS005256489|S1574|ALBB-035131|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|MLS006010153|NCGC00241104-07|BIRB 0796|NSC-785337|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|1-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-3-(4-(2-(MORPHOLIN-4-YL)ETHOXY)NAPHTHALEN-1-YL)UREA|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA.|CS-0219|BIRB796|1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|BIRB 796BS|MFCD09752957|BIRB 796 (DORAMAPIMOD)|UNII-HO1A8B3YVV|SR-00000002531|Q-101419|B96|EX-A4530|DB03044|D03736|TOX21_113386_1|AS-19375|BIRB 796 BS|SW219700-1|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-PYRAZOLYL]-3-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|285983-48-4|UREA, N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-(2-(4-MORPHOLINYL)ETHOXY)-1-NAPHTHALENYL)-|UREA, N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-|BIRB-796 BS|DORAMAPIMOD (BIRB-796)|BIRB-796, 3|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3(4-(2-MORPHOLIN-4-YL-ETHOXY)NAPHTHALEN-1-YL)UREA|BIRB-796|FT-0667779|DSSTOX_GSID_48957|NCGC00241104-01|BIRB 796|BCPP000333|DORAMAPIMOD|BCP01896|1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|CID_156422|BRD-K74065929-001-01-5|N-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA|TOX21_113386|GTPL5668|SMR004458704|1KV2|P38 MAP KINASE INHIBITOR X, BIRB 796 - CAS 285983-48-4|1-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]- N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-UREA|NCGC00241104-02|DSSTOX_CID_28883|DORAMAPIMOD [INN]|BIRB 796,DORAMAPIMOD|DORAMAPIMOD [USAN]|HMS3295M15|DORAMAPIMOD (USAN/INN)|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|DTXSID2048957|DIARYL UREA COMPOUND 10|HMS3747G11|HO1A8B3YVV|DORAMAPIMOD (BIRB 796)|SR-00000002531-1|DORAMAPIMOD [WHO-DD]|BCP9000416|US8933228, BIRB 796|HY-10320|BIBR-796|AC-24379|HMS3655C07|DORAMAPIMOD [USAN:INN]|A819503|SB16634|Q27077098|BIRB-0796|3-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-1-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|3-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-1-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA	-	DRUGBANK	DB03044	C31H37N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVCOAUNKQVWQHZ-UHFFFAOYSA-N
20376	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2916	Doramapimod	DSSTOX_RID_83151|KINOME_2137|CCG-264915|1-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|ZINC24044436|DORAMAPIMOD1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|NSC785337|AKOS005256489|S1574|ALBB-035131|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|MLS006010153|NCGC00241104-07|BIRB 0796|NSC-785337|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|1-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-3-(4-(2-(MORPHOLIN-4-YL)ETHOXY)NAPHTHALEN-1-YL)UREA|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA.|CS-0219|BIRB796|1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|BIRB 796BS|MFCD09752957|BIRB 796 (DORAMAPIMOD)|UNII-HO1A8B3YVV|SR-00000002531|Q-101419|B96|EX-A4530|DB03044|D03736|TOX21_113386_1|AS-19375|BIRB 796 BS|SW219700-1|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-PYRAZOLYL]-3-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|285983-48-4|UREA, N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-(2-(4-MORPHOLINYL)ETHOXY)-1-NAPHTHALENYL)-|UREA, N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-|BIRB-796 BS|DORAMAPIMOD (BIRB-796)|BIRB-796, 3|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3(4-(2-MORPHOLIN-4-YL-ETHOXY)NAPHTHALEN-1-YL)UREA|BIRB-796|FT-0667779|DSSTOX_GSID_48957|NCGC00241104-01|BIRB 796|BCPP000333|DORAMAPIMOD|BCP01896|1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|CID_156422|BRD-K74065929-001-01-5|N-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA|TOX21_113386|GTPL5668|SMR004458704|1KV2|P38 MAP KINASE INHIBITOR X, BIRB 796 - CAS 285983-48-4|1-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]- N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-UREA|NCGC00241104-02|DSSTOX_CID_28883|DORAMAPIMOD [INN]|BIRB 796,DORAMAPIMOD|DORAMAPIMOD [USAN]|HMS3295M15|DORAMAPIMOD (USAN/INN)|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|DTXSID2048957|DIARYL UREA COMPOUND 10|HMS3747G11|HO1A8B3YVV|DORAMAPIMOD (BIRB 796)|SR-00000002531-1|DORAMAPIMOD [WHO-DD]|BCP9000416|US8933228, BIRB 796|HY-10320|BIBR-796|AC-24379|HMS3655C07|DORAMAPIMOD [USAN:INN]|A819503|SB16634|Q27077098|BIRB-0796|3-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-1-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|3-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-1-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA	-	DRUGBANK	DB03044	C31H37N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVCOAUNKQVWQHZ-UHFFFAOYSA-N
20377	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2918	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB03046	C16H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQUXAFOLFXHVQN-UHFFFAOYSA-N
20378	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2918	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB03046	C16H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQUXAFOLFXHVQN-UHFFFAOYSA-N
20379	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2918	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB03046	C16H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQUXAFOLFXHVQN-UHFFFAOYSA-N
20380	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2920	6-Carboxymethyluracil	-	-	DRUGBANK	DB03048	C6H6N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQAUNZZEYKWTHM-UHFFFAOYSA-N
20381	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2920	6-Carboxymethyluracil	-	-	DRUGBANK	DB03048	C6H6N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQAUNZZEYKWTHM-UHFFFAOYSA-N
20382	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2920	6-Carboxymethyluracil	-	-	DRUGBANK	DB03048	C6H6N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQAUNZZEYKWTHM-UHFFFAOYSA-N
20383	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2921	S-Selanyl Cysteine	-	-	DRUGBANK	DB03049	C3H7NO2SSe	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRUPEGHZMWTFPP-REOHCLBHSA-N
20384	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2921	S-Selanyl Cysteine	-	-	DRUGBANK	DB03049	C3H7NO2SSe	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRUPEGHZMWTFPP-REOHCLBHSA-N
20388	849974	945600	b1014	putA	ECK1005|JW0999|poaA|putC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2923	Tetrahydrofuran-2-Carboxylic Acid	-	-	DRUGBANK	DB03051	C5H8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJJLJRQIPMGXEZ-SCSAIBSYSA-N
20389	849974	945600	b1014	putA	ECK1005|JW0999|poaA|putC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2923	Tetrahydrofuran-2-Carboxylic Acid	-	-	DRUGBANK	DB03051	C5H8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJJLJRQIPMGXEZ-SCSAIBSYSA-N
20390	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20391	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20392	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20393	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20394	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2927	4-Piperidino-Piperidine	-	-	DRUGBANK	DB03056	C10H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDVBKXJMLILLLB-UHFFFAOYSA-N
20395	108039	1675	-	CFD	ADIPSIN|ADN|DF|PFD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2929	2-Aminobenzyl alcohol	o-(Hydroxymethyl)aniline|2-Aminobenzenemethanol|o-Aminobenzylic alcohol|2-Aminobenzyl alcohol|o-Aminobenzyl alcohol	-	DRUGBANK	DB03058	C7H9NO	small molecule	-	5344-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFOAVADNIHPTR-UHFFFAOYSA-N
20396	108039	1675	-	CFD	ADIPSIN|ADN|DF|PFD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2929	2-Aminobenzyl alcohol	o-(Hydroxymethyl)aniline|2-Aminobenzenemethanol|o-Aminobenzylic alcohol|2-Aminobenzyl alcohol|o-Aminobenzyl alcohol	-	DRUGBANK	DB03058	C7H9NO	small molecule	-	5344-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFOAVADNIHPTR-UHFFFAOYSA-N
20397	109283	3033	-	HADH	HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20398	109283	3033	-	HADH	HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20399	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20400	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20401	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20402	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20403	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20404	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2930	Acetoacetyl-Coenzyme A	-	-	DRUGBANK	DB03059	C25H40N7O18P3S	small molecule	-	1420-36-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFDKHTZOUZBOS-YTJNUSSGSA-N
20405	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2931	Sri-9662	-	-	DRUGBANK	DB03060	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNDJHUNKXPAREB-PLNGDYQASA-N
20406	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2931	Sri-9662	-	-	DRUGBANK	DB03060	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNDJHUNKXPAREB-PLNGDYQASA-N
20407	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2931	Sri-9662	-	-	DRUGBANK	DB03060	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNDJHUNKXPAREB-PLNGDYQASA-N
20408	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2932	(R)-N-(1-Methyl-Hexyl)-Formamide	-	-	DRUGBANK	DB03061	C8H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFVRKPKAQHTAQK-QMMMGPOBSA-N
20409	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2932	(R)-N-(1-Methyl-Hexyl)-Formamide	-	-	DRUGBANK	DB03061	C8H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFVRKPKAQHTAQK-QMMMGPOBSA-N
20410	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2932	(R)-N-(1-Methyl-Hexyl)-Formamide	-	-	DRUGBANK	DB03061	C8H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFVRKPKAQHTAQK-QMMMGPOBSA-N
20411	1218551	3635457	C4_01440W_A	NMT1	NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	2933	(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone	-	-	DRUGBANK	DB03062	C23H24N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZBQJKIOAOUYJL-UHFFFAOYSA-N
20412	1218551	3635457	C4_01440W_A	NMT1	NMT|orf19.12111|IPF15592.2|CaO19.12111|CaO6.2367|C4_01440W_B|C4_01440W|CA1063|IPF22592.1|orf6.2367|orf19.4641|Contig4-2596_0003|CaO19.4641|CAWG_03640	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	2933	(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone	-	-	DRUGBANK	DB03062	C23H24N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZBQJKIOAOUYJL-UHFFFAOYSA-N
20413	110899	4836	-	NMT1	NMT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2933	(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone	-	-	DRUGBANK	DB03062	C23H24N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZBQJKIOAOUYJL-UHFFFAOYSA-N
20414	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2935	3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline	-	-	DRUGBANK	DB03064	C14H23NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXIDJQZEXUQBGG-UHFFFAOYSA-N
20415	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2936	7-Nitroindazole-2-Carboxamidine	-	-	DRUGBANK	DB03065	C8H7N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFYAZUABYOOPCN-UHFFFAOYSA-N
20416	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2938	4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	-	-	DRUGBANK	DB03067	C28H18N4O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFYAZSTYKPFSFL-UHFFFAOYSA-N
20417	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2938	4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	-	-	DRUGBANK	DB03067	C28H18N4O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFYAZSTYKPFSFL-UHFFFAOYSA-N
20418	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2938	4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	-	-	DRUGBANK	DB03067	C28H18N4O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFYAZSTYKPFSFL-UHFFFAOYSA-N
20419	851005	946663	b2143	cdd	ECK2136|JW2131	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2939	Zebularine	pyrimidin-2-one beta-ribofuranoside|Pyrimidin-2-one beta-D-ribofuranoside|1-beta-D-ribofuranosyl-2(1H)-pyrimidinone|1-beta-D-ribofuranosylpyrimidin-2(1H)-one|Pyrimidin-2-one ribonucleoside|DHZ	-	DRUGBANK	DB03068	C9H12N2O5	small molecule	-	3690-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPQZTTQVRYEKCR-WCTZXXKLSA-N
20420	851005	946663	b2143	cdd	ECK2136|JW2131	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2939	Zebularine	pyrimidin-2-one beta-ribofuranoside|Pyrimidin-2-one beta-D-ribofuranoside|1-beta-D-ribofuranosyl-2(1H)-pyrimidinone|1-beta-D-ribofuranosylpyrimidin-2(1H)-one|Pyrimidin-2-one ribonucleoside|DHZ	-	DRUGBANK	DB03068	C9H12N2O5	small molecule	-	3690-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPQZTTQVRYEKCR-WCTZXXKLSA-N
20421	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2941	Selenazole-4-Carboxyamide-Adenine Dinucleotide	-	-	DRUGBANK	DB03070	C19H25N7O14P2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKNBJMQZTZPCPF-FXXOXGJPSA-N
20422	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2941	Selenazole-4-Carboxyamide-Adenine Dinucleotide	-	-	DRUGBANK	DB03070	C19H25N7O14P2Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKNBJMQZTZPCPF-FXXOXGJPSA-N
20423	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2943	2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone	-	-	DRUGBANK	DB03072	C23H24FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOFDUAJQRUYHBR-UHFFFAOYSA-N
20424	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2943	2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone	-	-	DRUGBANK	DB03072	C23H24FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOFDUAJQRUYHBR-UHFFFAOYSA-N
20425	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2943	2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone	-	-	DRUGBANK	DB03072	C23H24FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOFDUAJQRUYHBR-UHFFFAOYSA-N
20426	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2944	3-Methoxybenzamide	-	-	DRUGBANK	DB03073	C8H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKPLPDIMEREJJF-UHFFFAOYSA-N
20427	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2944	3-Methoxybenzamide	-	-	DRUGBANK	DB03073	C8H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKPLPDIMEREJJF-UHFFFAOYSA-N
20428	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2944	3-Methoxybenzamide	-	-	DRUGBANK	DB03073	C8H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKPLPDIMEREJJF-UHFFFAOYSA-N
20429	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2949	PASBN	-	-	DRUGBANK	DB03078	C14H13O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWDTUFYQEUEVQD-UHFFFAOYSA-N
20430	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20431	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20432	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20433	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2952	Crc200 (Chiron-Behring)	-	-	DRUGBANK	DB03081	C29H39N5O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOXOKTJHZSUHRJ-PKTZIBPZSA-N
20434	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2952	Crc200 (Chiron-Behring)	-	-	DRUGBANK	DB03081	C29H39N5O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOXOKTJHZSUHRJ-PKTZIBPZSA-N
20435	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2952	Crc200 (Chiron-Behring)	-	-	DRUGBANK	DB03081	C29H39N5O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOXOKTJHZSUHRJ-PKTZIBPZSA-N
20436	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2953	6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide	-	-	DRUGBANK	DB03082	C23H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSWQJKHBMACTGB-UHFFFAOYSA-N
20437	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2953	6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide	-	-	DRUGBANK	DB03082	C23H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSWQJKHBMACTGB-UHFFFAOYSA-N
20438	107839	1455	-	CSNK1G2	CK1g2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2954	IC261	-	-	DRUGBANK	DB03083	C18H17NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBJYTZXCZDNOJW-JLHYYAGUSA-N
20439	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2955	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB03084	C25H30Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTKFTOEAKJMII-UHFFFAOYSA-N
20440	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2955	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	-	-	DRUGBANK	DB03084	C25H30Cl2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTKFTOEAKJMII-UHFFFAOYSA-N
20441	856969	939377	BSU11670	thiO	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	2956	Hydroxyacetic Acid	Hydroxyethanoic Acid	-	DRUGBANK	DB03085	C2H4O3	small molecule	-	79-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMRFAOFKBGASW-UHFFFAOYSA-N
20442	856969	939377	BSU11670	thiO	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	2956	Hydroxyacetic Acid	Hydroxyethanoic Acid	-	DRUGBANK	DB03085	C2H4O3	small molecule	-	79-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMRFAOFKBGASW-UHFFFAOYSA-N
20443	108814	2539	-	G6PD	G6PD1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2956	Hydroxyacetic Acid	Hydroxyethanoic Acid	-	DRUGBANK	DB03085	C2H4O3	small molecule	-	79-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMRFAOFKBGASW-UHFFFAOYSA-N
20444	108814	2539	-	G6PD	G6PD1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2956	Hydroxyacetic Acid	Hydroxyethanoic Acid	-	DRUGBANK	DB03085	C2H4O3	small molecule	-	79-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMRFAOFKBGASW-UHFFFAOYSA-N
20445	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2957	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	-	-	DRUGBANK	DB03086	C17H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQMLIGOOOFEBAH-CVEARBPZSA-N
20446	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2957	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	-	-	DRUGBANK	DB03086	C17H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQMLIGOOOFEBAH-CVEARBPZSA-N
20447	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2957	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	-	-	DRUGBANK	DB03086	C17H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQMLIGOOOFEBAH-CVEARBPZSA-N
20448	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2958	2-(Sec-Butyl)Thiazole	-	-	DRUGBANK	DB03087	C7H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MHJSWOZJMPIGJQ-ZCFIWIBFSA-N
20449	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2958	2-(Sec-Butyl)Thiazole	-	-	DRUGBANK	DB03087	C7H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MHJSWOZJMPIGJQ-ZCFIWIBFSA-N
20450	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2958	2-(Sec-Butyl)Thiazole	-	-	DRUGBANK	DB03087	C7H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MHJSWOZJMPIGJQ-ZCFIWIBFSA-N
20451	109310	3060	-	HCRT	NRCLP1|OX|PPOX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20452	136219	440021	-	KRTAP5-2	KRTAP5-8|KRTAP5.2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20453	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20454	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20455	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20456	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20457	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20458	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20459	112890	7032	-	TFF2	SML1|SP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20460	109753	3537	-	IGLC1	IGLC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20461	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20462	106780	283	-	ANG	ALS9|HEL168|RAA1|RNASE4|RNASE5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20463	106780	283	-	ANG	ALS9|HEL168|RAA1|RNASE4|RNASE5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20464	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20465	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2959	Pyroglutamic Acid	-	-	DRUGBANK	DB03088	C5H7NO3	small molecule	-	98-79-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODHCTXKNWHHXJC-GSVOUGTGSA-N
20466	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	2961	Ethylaminobenzylmethylcarbonyl Group	-	-	DRUGBANK	DB03090	C11H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZZLSNMWFMAXGJ-LLVKDONJSA-N
20467	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	2961	Ethylaminobenzylmethylcarbonyl Group	-	-	DRUGBANK	DB03090	C11H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZZLSNMWFMAXGJ-LLVKDONJSA-N
20468	852549	948247	b3736	atpF	ECK3729|JW3714|papF|uncF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2962	4-Amido-4-Carbamoyl-Butyric Acid	-	-	DRUGBANK	DB03091	C5H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEFLONBTGZFSGQ-VKHMYHEASA-N
20469	852549	948247	b3736	atpF	ECK3729|JW3714|papF|uncF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2962	4-Amido-4-Carbamoyl-Butyric Acid	-	-	DRUGBANK	DB03091	C5H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEFLONBTGZFSGQ-VKHMYHEASA-N
20470	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2963	5-Hydroxymethyl-Chonduritol	-	-	DRUGBANK	DB03092	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJPGMULJEYSZBS-VWDOSNQTSA-N
20471	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2963	5-Hydroxymethyl-Chonduritol	-	-	DRUGBANK	DB03092	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJPGMULJEYSZBS-VWDOSNQTSA-N
20472	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2963	5-Hydroxymethyl-Chonduritol	-	-	DRUGBANK	DB03092	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJPGMULJEYSZBS-VWDOSNQTSA-N
20473	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2963	5-Hydroxymethyl-Chonduritol	-	-	DRUGBANK	DB03092	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJPGMULJEYSZBS-VWDOSNQTSA-N
20474	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2963	5-Hydroxymethyl-Chonduritol	-	-	DRUGBANK	DB03092	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJPGMULJEYSZBS-VWDOSNQTSA-N
20475	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2964	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03093	C14H14FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWHAHELTVGJGFJ-UHFFFAOYSA-N
20476	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2966	Tetramethylammonium Ion	-	-	DRUGBANK	DB03095	C4H12N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEMXHQIAXOOASZ-UHFFFAOYSA-N
20477	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2966	Tetramethylammonium Ion	-	-	DRUGBANK	DB03095	C4H12N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEMXHQIAXOOASZ-UHFFFAOYSA-N
20478	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2967	N-Aminoethylmorpholine	-	-	DRUGBANK	DB03096	C6H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWIVICVCHVMHMU-UHFFFAOYSA-N
20479	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2967	N-Aminoethylmorpholine	-	-	DRUGBANK	DB03096	C6H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWIVICVCHVMHMU-UHFFFAOYSA-N
20480	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2967	N-Aminoethylmorpholine	-	-	DRUGBANK	DB03096	C6H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWIVICVCHVMHMU-UHFFFAOYSA-N
20481	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20482	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20483	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20484	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20485	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2971	6-Nitroindazole	-	-	DRUGBANK	DB03100	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20486	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2972	Ribose-1-Phosphate	-	-	DRUGBANK	DB03101	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXJDFQJKERBOBM-TXICZTDVSA-N
20487	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2972	Ribose-1-Phosphate	-	-	DRUGBANK	DB03101	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXJDFQJKERBOBM-TXICZTDVSA-N
20488	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2972	Ribose-1-Phosphate	-	-	DRUGBANK	DB03101	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXJDFQJKERBOBM-TXICZTDVSA-N
20489	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2972	Ribose-1-Phosphate	-	-	DRUGBANK	DB03101	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXJDFQJKERBOBM-TXICZTDVSA-N
20490	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2972	Ribose-1-Phosphate	-	-	DRUGBANK	DB03101	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXJDFQJKERBOBM-TXICZTDVSA-N
20491	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2973	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB03102	C10H9NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNOZMNTPOIDSI-UHFFFAOYSA-N
20492	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2973	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB03102	C10H9NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNOZMNTPOIDSI-UHFFFAOYSA-N
20493	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2973	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	-	-	DRUGBANK	DB03102	C10H9NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNOZMNTPOIDSI-UHFFFAOYSA-N
20494	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2974	Thymidine-5'- Diphosphate	-	-	DRUGBANK	DB03103	C10H16N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLXYODCHAELLY-GJMOJQLCSA-N
20495	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2974	Thymidine-5'- Diphosphate	-	-	DRUGBANK	DB03103	C10H16N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLXYODCHAELLY-GJMOJQLCSA-N
20496	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2974	Thymidine-5'- Diphosphate	-	-	DRUGBANK	DB03103	C10H16N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLXYODCHAELLY-GJMOJQLCSA-N
20497	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2975	RU82129	-	-	DRUGBANK	DB03104	C33H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKMPOVPTYDXGEC-HMIUAYQISA-N
20498	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2975	RU82129	-	-	DRUGBANK	DB03104	C33H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKMPOVPTYDXGEC-HMIUAYQISA-N
20499	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2975	RU82129	-	-	DRUGBANK	DB03104	C33H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKMPOVPTYDXGEC-HMIUAYQISA-N
20500	108899	2629	-	GBA	GBA1|GCB|GLUC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2977	Myo-Inositol	-	-	DRUGBANK	DB03106	C6H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDAISMWEOUEBRE-CDRYSYESSA-N
20501	108899	2629	-	GBA	GBA1|GCB|GLUC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2977	Myo-Inositol	-	-	DRUGBANK	DB03106	C6H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDAISMWEOUEBRE-CDRYSYESSA-N
20502	115692	10423	-	CDIPT	PIS|PIS1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2977	Myo-Inositol	-	-	DRUGBANK	DB03106	C6H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDAISMWEOUEBRE-CDRYSYESSA-N
20503	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2980	N-Acetyl-D-Allosamine	-	-	DRUGBANK	DB03109	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-UIAUGNHASA-N
20504	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2980	N-Acetyl-D-Allosamine	-	-	DRUGBANK	DB03109	C8H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-UIAUGNHASA-N
20505	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2981	2-Chlorophenol	-	-	DRUGBANK	DB03110	C6H5ClO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISPYQTSUDJAMAB-UHFFFAOYSA-N
20506	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2981	2-Chlorophenol	-	-	DRUGBANK	DB03110	C6H5ClO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISPYQTSUDJAMAB-UHFFFAOYSA-N
20507	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2982	Glucosamine 1-Phosphate	-	-	DRUGBANK	DB03111	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMJBYRVFGYXULK-GKFJPSPNSA-N
20508	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2982	Glucosamine 1-Phosphate	-	-	DRUGBANK	DB03111	C6H14NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMJBYRVFGYXULK-GKFJPSPNSA-N
20509	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2985	PAS219	-	-	DRUGBANK	DB03114	C14H19O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBEVTZVQKMYQPM-UHFFFAOYSA-N
20510	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2986	5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide	-	-	DRUGBANK	DB03115	C16H13BrF3IN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSSGBYXSKOLAM-MRVPVSSYSA-N
20511	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2986	5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide	-	-	DRUGBANK	DB03115	C16H13BrF3IN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXSSGBYXSKOLAM-MRVPVSSYSA-N
20512	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2987	5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate	-	-	DRUGBANK	DB03116	C10H16O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUQKBSPZUVNKIF-CLIVKXMMSA-N
20513	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2987	5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate	-	-	DRUGBANK	DB03116	C10H16O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUQKBSPZUVNKIF-CLIVKXMMSA-N
20514	851729	947408	b2919	scpB	ECK2915|JW2886|mmcD|ygfG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	2988	2-Carboxypropyl-Coenzyme A	-	-	DRUGBANK	DB03117	C25H42N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLEVKEKTOJAHCY-KDBHINKISA-N
20515	851729	947408	b2919	scpB	ECK2915|JW2886|mmcD|ygfG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	2988	2-Carboxypropyl-Coenzyme A	-	-	DRUGBANK	DB03117	C25H42N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLEVKEKTOJAHCY-KDBHINKISA-N
20516	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2991	Para-Toluene Sulfonate	-	-	DRUGBANK	DB03120	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOXIMZWYDAKGHI-UHFFFAOYSA-N
20517	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2991	Para-Toluene Sulfonate	-	-	DRUGBANK	DB03120	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOXIMZWYDAKGHI-UHFFFAOYSA-N
20518	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2991	Para-Toluene Sulfonate	-	-	DRUGBANK	DB03120	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOXIMZWYDAKGHI-UHFFFAOYSA-N
20519	107892	1512	-	CTSH	ACC-4|ACC-5|CPSB|minichain	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2991	Para-Toluene Sulfonate	-	-	DRUGBANK	DB03120	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOXIMZWYDAKGHI-UHFFFAOYSA-N
20520	107892	1512	-	CTSH	ACC-4|ACC-5|CPSB|minichain	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2991	Para-Toluene Sulfonate	-	-	DRUGBANK	DB03120	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOXIMZWYDAKGHI-UHFFFAOYSA-N
20521	107892	1512	-	CTSH	ACC-4|ACC-5|CPSB|minichain	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2991	Para-Toluene Sulfonate	-	-	DRUGBANK	DB03120	C7H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOXIMZWYDAKGHI-UHFFFAOYSA-N
20522	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2992	1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid	-	-	DRUGBANK	DB03121	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKCBTQHDTUHRJ-UHFFFAOYSA-N
20523	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2992	1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid	-	-	DRUGBANK	DB03121	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKCBTQHDTUHRJ-UHFFFAOYSA-N
20524	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2992	1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid	-	-	DRUGBANK	DB03121	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKCBTQHDTUHRJ-UHFFFAOYSA-N
20525	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2993	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	-	-	DRUGBANK	DB03124	C20H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBAHOXPDTNUYCX-INIZCTEOSA-N
20526	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2993	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	-	-	DRUGBANK	DB03124	C20H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBAHOXPDTNUYCX-INIZCTEOSA-N
20527	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2993	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	-	-	DRUGBANK	DB03124	C20H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBAHOXPDTNUYCX-INIZCTEOSA-N
20528	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2994	2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium	-	-	DRUGBANK	DB03125	C14H19N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEDVJHCEMCRBQM-UHFFFAOYSA-O
20529	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2995	Mant-Adp	-	-	DRUGBANK	DB03126	C18H22N6O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPKUEBLEGWBRHC-HZSPNIEDSA-N
20530	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2995	Mant-Adp	-	-	DRUGBANK	DB03126	C18H22N6O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPKUEBLEGWBRHC-HZSPNIEDSA-N
20531	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2995	Mant-Adp	-	-	DRUGBANK	DB03126	C18H22N6O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPKUEBLEGWBRHC-HZSPNIEDSA-N
20532	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20533	112645	6768	-	ST14	ARCI11|HAI|MT-SP1|MTSP1|PRSS14|SNC19|TADG15|TMPRSS14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20534	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20535	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20536	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20537	108000	1632	-	ECI1	DCI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20538	108000	1632	-	ECI1	DCI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20539	108000	1632	-	ECI1	DCI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20540	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20541	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20542	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20543	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20544	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20545	106965	475	-	ATOX1	ATX1|HAH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20546	106965	475	-	ATOX1	ATX1|HAH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20547	106965	475	-	ATOX1	ATX1|HAH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20548	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20549	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20550	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20551	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20552	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20553	111634	5653	-	KLK6	Bssp|Klk7|PRSS18|PRSS9|SP59|hK6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20554	111634	5653	-	KLK6	Bssp|Klk7|PRSS18|PRSS9|SP59|hK6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20555	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2997	Acetylcholine	Acetylcholine Chloride	miochol e|miogan pws 20mg/vial	DRUGBANK	DB03128	C7H16NO2	small molecule	S01EB09	51-84-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIPILFWXSMYKGL-UHFFFAOYSA-N
20556	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2997	Acetylcholine	Acetylcholine Chloride	miochol e|miogan pws 20mg/vial	DRUGBANK	DB03128	C7H16NO2	small molecule	S01EB09	51-84-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIPILFWXSMYKGL-UHFFFAOYSA-N
20557	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2997	Acetylcholine	Acetylcholine Chloride	miochol e|miogan pws 20mg/vial	DRUGBANK	DB03128	C7H16NO2	small molecule	S01EB09	51-84-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIPILFWXSMYKGL-UHFFFAOYSA-N
20558	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2998	[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine	-	-	DRUGBANK	DB03129	C6H15BN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHANCKHXGBJANE-UHFFFAOYSA-O
20559	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2999	S-P-Nitrobenzyloxycarbonylglutathione	-	-	DRUGBANK	DB03130	C18H24N4O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYFGPQQSJQOGEO-VEVIJQCQSA-N
20560	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2999	S-P-Nitrobenzyloxycarbonylglutathione	-	-	DRUGBANK	DB03130	C18H24N4O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYFGPQQSJQOGEO-VEVIJQCQSA-N
20561	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3000	3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid	-	-	DRUGBANK	DB03132	C10H11NO3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBNHRNFODJOFRU-UHFFFAOYSA-N
20562	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3001	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole	-	-	DRUGBANK	DB03133	C14H17N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20563	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3001	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole	-	-	DRUGBANK	DB03133	C14H17N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20564	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3001	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole	-	-	DRUGBANK	DB03133	C14H17N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20565	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3003	[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid	-	-	DRUGBANK	DB03135	C3H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBAIGNUEKZLOMI-UHFFFAOYSA-N
20566	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3003	[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid	-	-	DRUGBANK	DB03135	C3H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBAIGNUEKZLOMI-UHFFFAOYSA-N
20567	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3003	[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid	-	-	DRUGBANK	DB03135	C3H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBAIGNUEKZLOMI-UHFFFAOYSA-N
20568	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3004	4-Iodobenzo[B]Thiophene-2-Carboxamidine	-	-	DRUGBANK	DB03136	C9H8IN2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YERQOXAYAFWFEJ-UHFFFAOYSA-O
20569	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3004	4-Iodobenzo[B]Thiophene-2-Carboxamidine	-	-	DRUGBANK	DB03136	C9H8IN2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YERQOXAYAFWFEJ-UHFFFAOYSA-O
20570	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3004	4-Iodobenzo[B]Thiophene-2-Carboxamidine	-	-	DRUGBANK	DB03136	C9H8IN2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YERQOXAYAFWFEJ-UHFFFAOYSA-O
20571	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3005	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03137	C19H20FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOYVWKKOKERSW-UHFFFAOYSA-N
20572	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3008	4-Carboxyphenylboronic Acid	-	-	DRUGBANK	DB03140	C7H7BO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIAVMDKGVRXFAX-UHFFFAOYSA-N
20573	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3008	4-Carboxyphenylboronic Acid	-	-	DRUGBANK	DB03140	C7H7BO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIAVMDKGVRXFAX-UHFFFAOYSA-N
20574	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3010	Alpha-L-Arabinose	-	-	DRUGBANK	DB03142	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-QMKXCQHVSA-N
20575	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3010	Alpha-L-Arabinose	-	-	DRUGBANK	DB03142	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-QMKXCQHVSA-N
20576	849182	944780	b0064	araC	ECK0065|JW0063	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3010	Alpha-L-Arabinose	-	-	DRUGBANK	DB03142	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-QMKXCQHVSA-N
20577	849182	944780	b0064	araC	ECK0065|JW0063	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3010	Alpha-L-Arabinose	-	-	DRUGBANK	DB03142	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-QMKXCQHVSA-N
20578	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20579	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20580	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20581	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20582	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20583	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20584	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20585	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20586	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20587	856417	938802	BSU07630	nosA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20588	856417	938802	BSU07630	nosA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20589	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20590	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20591	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20592	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3013	4-Methyl-5-Hydroxyethylthiazole Phosphate	-	-	DRUGBANK	DB03145	C6H10NO4PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCYMERZCMYJQQO-UHFFFAOYSA-N
20593	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3013	4-Methyl-5-Hydroxyethylthiazole Phosphate	-	-	DRUGBANK	DB03145	C6H10NO4PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCYMERZCMYJQQO-UHFFFAOYSA-N
20594	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3014	2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB03146	C10H15N4O10P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYBPOGVUIOPXHI-KMPDEGCQSA-O
20595	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3014	2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB03146	C10H15N4O10P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYBPOGVUIOPXHI-KMPDEGCQSA-O
20596	852729	948432	b3941	metF	ECK3933|JW3913	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20597	852729	948432	b3941	metF	ECK3933|JW3913	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20598	121155	56605	RP5-985L19.2	ERO1LB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20599	121155	56605	RP5-985L19.2	ERO1LB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20600	121155	56605	RP5-985L19.2	ERO1LB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20601	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20602	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20603	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20604	849974	945600	b1014	putA	ECK1005|JW0999|poaA|putC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20605	849974	945600	b1014	putA	ECK1005|JW0999|poaA|putC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20606	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20607	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20608	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20609	108082	1738	tcag7.39	DLD	DLDD|DLDH|E3|GCSL|LAD|PHE3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20610	849618	945235	b2036	glf	ECK2030|JW2021|yefE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20611	849618	945235	b2036	glf	ECK2030|JW2021|yefE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20612	117965	27034	-	ACAD8	ACAD-8|ARC42	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20613	117965	27034	-	ACAD8	ACAD-8|ARC42	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20614	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20615	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20616	106553	35	-	ACADS	ACAD3|SCAD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20617	119690	51706	UNQ3049/PRO9865	CYB5R1	B5R.1|B5R1|B5R2|NQO3A2|humb5R2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20618	108523	2232	-	FDXR	ADXR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20619	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20620	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20621	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20622	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20623	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20624	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20625	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20626	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20627	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20628	108939	2671	-	GFER	ALR|ERV1|HERV1|HPO|HPO1|HPO2|HSS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20629	853298	949054	b0888	trxB	ECK0879|JW0871	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20630	853298	949054	b0888	trxB	ECK0879|JW0871	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20631	850996	946653	b2133	dld	ECK2126|JW2121	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20632	850996	946653	b2133	dld	ECK2126|JW2121	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20633	109916	3712	-	IVD	ACAD2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20634	109916	3712	-	IVD	ACAD2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20635	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20636	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20637	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20638	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20639	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20640	852322	948014	b3500	gor	ECK3485|JW3467|gorA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20641	852322	948014	b3500	gor	ECK3485|JW3467|gorA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20642	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20643	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20644	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20645	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20646	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20647	114579	9131	RP3-438D16.2	AIFM1	AIF|CMT2D|CMTX4|COWCK|COXPD6|NADMR|NAMSD|PDCD8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20648	114579	9131	RP3-438D16.2	AIFM1	AIF|CMT2D|CMTX4|COWCK|COXPD6|NADMR|NAMSD|PDCD8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20649	114579	9131	RP3-438D16.2	AIFM1	AIF|CMT2D|CMTX4|COWCK|COXPD6|NADMR|NAMSD|PDCD8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20650	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20651	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20652	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20653	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20654	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20655	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20656	108909	2639	-	GCDH	ACAD5|GCD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20657	108909	2639	-	GCDH	ACAD5|GCD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20658	856969	939377	BSU11670	thiO	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20659	856969	939377	BSU11670	thiO	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20660	106567	51	-	ACOX1	ACOX|PALMCOX|SCOX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20661	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20662	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20663	108071	1727	-	CYB5R3	B5R|DIA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20664	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20665	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20666	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20667	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20668	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20669	854661	936985	BSU00510	prs	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3016	Phosphomethylphosphonic Acid Adenosyl Ester	-	-	DRUGBANK	DB03148	C11H17N5O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLCWZBFDIYXLAA-WOIOKPISSA-N
20670	854661	936985	BSU00510	prs	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3016	Phosphomethylphosphonic Acid Adenosyl Ester	-	-	DRUGBANK	DB03148	C11H17N5O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLCWZBFDIYXLAA-WOIOKPISSA-N
20671	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3017	Phenylalanylmethane	-	-	DRUGBANK	DB03149	C10H13NO	small molecule	-	5440-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTUDQBPZFFIRAD-UHFFFAOYSA-N
20672	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3018	2',3'-Dideoxythymidine-5'-Monophosphate	-	-	DRUGBANK	DB03150	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVNRRNJFRREKAR-JGVFFNPUSA-N
20673	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3018	2',3'-Dideoxythymidine-5'-Monophosphate	-	-	DRUGBANK	DB03150	C10H15N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVNRRNJFRREKAR-JGVFFNPUSA-N
20674	849871	945497	b0875	aqpZ	ECK0866|JW0859|bniP	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3020	B-2-Octylglucoside	-	-	DRUGBANK	DB03152	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVHPDIWLWHHJPD-RKQHYHRCSA-N
20675	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3020	B-2-Octylglucoside	-	-	DRUGBANK	DB03152	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVHPDIWLWHHJPD-RKQHYHRCSA-N
20676	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3020	B-2-Octylglucoside	-	-	DRUGBANK	DB03152	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVHPDIWLWHHJPD-RKQHYHRCSA-N
20677	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3020	B-2-Octylglucoside	-	-	DRUGBANK	DB03152	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVHPDIWLWHHJPD-RKQHYHRCSA-N
20678	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3020	B-2-Octylglucoside	-	-	DRUGBANK	DB03152	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVHPDIWLWHHJPD-RKQHYHRCSA-N
20679	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3021	3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol	-	-	DRUGBANK	DB03153	C5H4N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGCXIHWGXUQTCQ-UHFFFAOYSA-N
20680	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3021	3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol	-	-	DRUGBANK	DB03153	C5H4N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGCXIHWGXUQTCQ-UHFFFAOYSA-N
20681	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3021	3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol	-	-	DRUGBANK	DB03153	C5H4N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGCXIHWGXUQTCQ-UHFFFAOYSA-N
20682	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3022	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	-	-	DRUGBANK	DB03154	C12H10F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHKBLEYUHBIBNR-UHFFFAOYSA-N
20683	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3022	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	-	-	DRUGBANK	DB03154	C12H10F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHKBLEYUHBIBNR-UHFFFAOYSA-N
20684	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3022	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	-	-	DRUGBANK	DB03154	C12H10F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHKBLEYUHBIBNR-UHFFFAOYSA-N
20685	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3023	1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione	-	-	DRUGBANK	DB03155	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFIXUMAFUNKIAA-MLQRGLMKSA-N
20686	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3023	1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione	-	-	DRUGBANK	DB03155	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFIXUMAFUNKIAA-MLQRGLMKSA-N
20687	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3023	1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione	-	-	DRUGBANK	DB03155	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFIXUMAFUNKIAA-MLQRGLMKSA-N
20688	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3025	N,O-Didansyl-L-Tyrosine	-	-	DRUGBANK	DB03157	C33H33N3O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBOPDUYHWABFG-MUUNZHRXSA-N
20689	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3025	N,O-Didansyl-L-Tyrosine	-	-	DRUGBANK	DB03157	C33H33N3O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBOPDUYHWABFG-MUUNZHRXSA-N
20690	109845	3633	RP11-109P14.7	INPP5B	5PTase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3026	D-Myo-Inositol-1,4-Bisphosphate	-	-	DRUGBANK	DB03158	C6H14O12P2	small molecule	-	47055-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PELZSPZCXGTUMR-HYDKFDCNSA-N
20691	109845	3633	RP11-109P14.7	INPP5B	5PTase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3026	D-Myo-Inositol-1,4-Bisphosphate	-	-	DRUGBANK	DB03158	C6H14O12P2	small molecule	-	47055-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PELZSPZCXGTUMR-HYDKFDCNSA-N
20692	109845	3633	RP11-109P14.7	INPP5B	5PTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3026	D-Myo-Inositol-1,4-Bisphosphate	-	-	DRUGBANK	DB03158	C6H14O12P2	small molecule	-	47055-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PELZSPZCXGTUMR-HYDKFDCNSA-N
20693	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3027	CRA_8696	-	-	DRUGBANK	DB03159	C21H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAVRMVQHHVMXFD-UHFFFAOYSA-N
20694	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3027	CRA_8696	-	-	DRUGBANK	DB03159	C21H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAVRMVQHHVMXFD-UHFFFAOYSA-N
20695	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3027	CRA_8696	-	-	DRUGBANK	DB03159	C21H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAVRMVQHHVMXFD-UHFFFAOYSA-N
20696	849760	945384	b0776	bioF	ECK0765|JW0759	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3028	N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate	-	-	DRUGBANK	DB03160	C17H27N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXEXNGWPUWJMIT-LLVKDONJSA-N
20697	849760	945384	b0776	bioF	ECK0765|JW0759	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3028	N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate	-	-	DRUGBANK	DB03160	C17H27N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXEXNGWPUWJMIT-LLVKDONJSA-N
20698	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3033	2-Dimethylamino-Ethyl-Diphosphate	-	-	DRUGBANK	DB03165	C4H13NO7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGKJQRINUQGSJM-UHFFFAOYSA-N
20699	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3033	2-Dimethylamino-Ethyl-Diphosphate	-	-	DRUGBANK	DB03165	C4H13NO7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGKJQRINUQGSJM-UHFFFAOYSA-N
20700	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3037	(S)-Hmg-Coa	-	-	DRUGBANK	DB03169	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20701	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3037	(S)-Hmg-Coa	-	-	DRUGBANK	DB03169	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20702	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3040	Tubercidin	Sparsomycin A|Tubercidine|TBN|Toyocamycin|7-Deazadenosine|7-deazaadenosine	-	DRUGBANK	DB03172	C11H14N4O4	small molecule	-	69-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDZZVAMISRMYHH-LITAXDCLSA-N
20703	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3040	Tubercidin	Sparsomycin A|Tubercidine|TBN|Toyocamycin|7-Deazadenosine|7-deazaadenosine	-	DRUGBANK	DB03172	C11H14N4O4	small molecule	-	69-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDZZVAMISRMYHH-LITAXDCLSA-N
20704	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3041	CRA_10433	-	-	DRUGBANK	DB03173	C20H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFSQPEBVGUSQII-UHFFFAOYSA-N
20705	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3043	1-Proponol	-	-	DRUGBANK	DB03175	C3H8O	small molecule	-	71-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDERNNFJNOPAEC-UHFFFAOYSA-N
20706	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3043	1-Proponol	-	-	DRUGBANK	DB03175	C3H8O	small molecule	-	71-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDERNNFJNOPAEC-UHFFFAOYSA-N
20707	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3043	1-Proponol	-	-	DRUGBANK	DB03175	C3H8O	small molecule	-	71-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDERNNFJNOPAEC-UHFFFAOYSA-N
20708	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3044	3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid	-	-	DRUGBANK	DB03176	C17H16Cl2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYQIQVPUZANTM-UHFFFAOYSA-N
20709	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3044	3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid	-	-	DRUGBANK	DB03176	C17H16Cl2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYQIQVPUZANTM-UHFFFAOYSA-N
20710	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3044	3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid	-	-	DRUGBANK	DB03176	C17H16Cl2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYQIQVPUZANTM-UHFFFAOYSA-N
20711	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3044	3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid	-	-	DRUGBANK	DB03176	C17H16Cl2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZYQIQVPUZANTM-UHFFFAOYSA-N
20712	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3047	Sinapoyl Coenzyme A	-	-	DRUGBANK	DB03179	C32H44N7O20P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJGDVDUGXUSOGA-YMVOPXNESA-N
20713	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3047	Sinapoyl Coenzyme A	-	-	DRUGBANK	DB03179	C32H44N7O20P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJGDVDUGXUSOGA-YMVOPXNESA-N
20714	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3047	Sinapoyl Coenzyme A	-	-	DRUGBANK	DB03179	C32H44N7O20P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJGDVDUGXUSOGA-YMVOPXNESA-N
20715	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3049	2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione	-	-	DRUGBANK	DB03181	C20H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQAVKWRCZYGMV-UHFFFAOYSA-N
20716	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3049	2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione	-	-	DRUGBANK	DB03181	C20H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQAVKWRCZYGMV-UHFFFAOYSA-N
20717	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3049	2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione	-	-	DRUGBANK	DB03181	C20H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXQAVKWRCZYGMV-UHFFFAOYSA-N
20718	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3050	Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex	-	-	DRUGBANK	DB03182	C23H37FN7O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYRBBNPCUSRRNJ-MJOCJWJMSA-N
20719	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3050	Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex	-	-	DRUGBANK	DB03182	C23H37FN7O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYRBBNPCUSRRNJ-MJOCJWJMSA-N
20720	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3050	Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex	-	-	DRUGBANK	DB03182	C23H37FN7O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYRBBNPCUSRRNJ-MJOCJWJMSA-N
20721	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3051	1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03183	C14H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIEYZIRYXYDMSK-UHFFFAOYSA-N
20722	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3054	U-Pi-a-Pi	-	-	DRUGBANK	DB03186	C19H27N7O20P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIAJERGOUFOENU-WEVDFKDHSA-N
20723	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3054	U-Pi-a-Pi	-	-	DRUGBANK	DB03186	C19H27N7O20P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIAJERGOUFOENU-WEVDFKDHSA-N
20724	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3054	U-Pi-a-Pi	-	-	DRUGBANK	DB03186	C19H27N7O20P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIAJERGOUFOENU-WEVDFKDHSA-N
20725	108923	2653	-	GCSH	GCE|NKH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3055	6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid	-	-	DRUGBANK	DB03187	C11H23NO3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFRWEULQQALYNZ-SNVBAGLBSA-N
20726	108923	2653	-	GCSH	GCE|NKH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3055	6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid	-	-	DRUGBANK	DB03187	C11H23NO3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFRWEULQQALYNZ-SNVBAGLBSA-N
20727	108923	2653	-	GCSH	GCE|NKH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3055	6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid	-	-	DRUGBANK	DB03187	C11H23NO3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFRWEULQQALYNZ-SNVBAGLBSA-N
20728	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3057	Cu-Cyclam	-	-	DRUGBANK	DB03189	C10H20CuN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPVUWNNWLZFNKK-UHFFFAOYSA-N
20729	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3057	Cu-Cyclam	-	-	DRUGBANK	DB03189	C10H20CuN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPVUWNNWLZFNKK-UHFFFAOYSA-N
20730	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3057	Cu-Cyclam	-	-	DRUGBANK	DB03189	C10H20CuN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPVUWNNWLZFNKK-UHFFFAOYSA-N
20731	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3059	3-Oxiran-2ylalanine	-	-	DRUGBANK	DB03191	C5H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKPCHCJYQVJLIZ-DMTCNVIQSA-N
20732	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3059	3-Oxiran-2ylalanine	-	-	DRUGBANK	DB03191	C5H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKPCHCJYQVJLIZ-DMTCNVIQSA-N
20733	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3059	3-Oxiran-2ylalanine	-	-	DRUGBANK	DB03191	C5H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKPCHCJYQVJLIZ-DMTCNVIQSA-N
20734	109528	3295	-	HSD17B4	DBP|MFE-2|MPF-2|PRLTS1|SDR8C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3060	3r-Hydroxydecanoyl-Coa	-	-	DRUGBANK	DB03192	C31H54N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIVSMYZAMUNFKZ-XFYLRIHESA-N
20735	109528	3295	-	HSD17B4	DBP|MFE-2|MPF-2|PRLTS1|SDR8C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3060	3r-Hydroxydecanoyl-Coa	-	-	DRUGBANK	DB03192	C31H54N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIVSMYZAMUNFKZ-XFYLRIHESA-N
20736	109528	3295	-	HSD17B4	DBP|MFE-2|MPF-2|PRLTS1|SDR8C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3060	3r-Hydroxydecanoyl-Coa	-	-	DRUGBANK	DB03192	C31H54N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIVSMYZAMUNFKZ-XFYLRIHESA-N
20737	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3061	Stearic acid	Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure	for sope|obeo baby bubble|dr.g	DRUGBANK	DB03193	C18H36O2	small molecule	-	57-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQXTHQIDYTFRH-UHFFFAOYSA-N
20738	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3061	Stearic acid	Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure	for sope|obeo baby bubble|dr.g	DRUGBANK	DB03193	C18H36O2	small molecule	-	57-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQXTHQIDYTFRH-UHFFFAOYSA-N
20739	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3061	Stearic acid	Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure	for sope|obeo baby bubble|dr.g	DRUGBANK	DB03193	C18H36O2	small molecule	-	57-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQXTHQIDYTFRH-UHFFFAOYSA-N
20740	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3062	beta-L-methyl-fucose	-	-	DRUGBANK	DB03194	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHWCAVRRXKJCRB-XUVCUMPTSA-N
20741	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3062	beta-L-methyl-fucose	-	-	DRUGBANK	DB03194	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHWCAVRRXKJCRB-XUVCUMPTSA-N
20742	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3062	beta-L-methyl-fucose	-	-	DRUGBANK	DB03194	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHWCAVRRXKJCRB-XUVCUMPTSA-N
20743	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3063	Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester	-	-	DRUGBANK	DB03195	C10H14FN2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCAVPJXJISBOA-XLPZGREQSA-N
20744	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3063	Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester	-	-	DRUGBANK	DB03195	C10H14FN2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCAVPJXJISBOA-XLPZGREQSA-N
20745	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3063	Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester	-	-	DRUGBANK	DB03195	C10H14FN2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGCAVPJXJISBOA-XLPZGREQSA-N
20746	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3065	6-Hydroxymethylpterin	-	-	DRUGBANK	DB03197	C7H7N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWIBNWDLMIPNF-UHFFFAOYSA-N
20747	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3065	6-Hydroxymethylpterin	-	-	DRUGBANK	DB03197	C7H7N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWIBNWDLMIPNF-UHFFFAOYSA-N
20748	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3069	D-Cysteine	D-Amino-3-mercaptopropionic acid|D-Cystein|(2S)-2-amino-3-mercaptopropanoic acid|(2S)-2-amino-3-sulfanylpropanoic acid|D-Zystein|(S)-2-amino-3-mercaptopropanoic acid	-	DRUGBANK	DB03201	C3H7NO2S	small molecule	-	921-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-UWTATZPHSA-N
20749	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3069	D-Cysteine	D-Amino-3-mercaptopropionic acid|D-Cystein|(2S)-2-amino-3-mercaptopropanoic acid|(2S)-2-amino-3-sulfanylpropanoic acid|D-Zystein|(S)-2-amino-3-mercaptopropanoic acid	-	DRUGBANK	DB03201	C3H7NO2S	small molecule	-	921-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-UWTATZPHSA-N
20750	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3069	D-Cysteine	D-Amino-3-mercaptopropionic acid|D-Cystein|(2S)-2-amino-3-mercaptopropanoic acid|(2S)-2-amino-3-sulfanylpropanoic acid|D-Zystein|(S)-2-amino-3-mercaptopropanoic acid	-	DRUGBANK	DB03201	C3H7NO2S	small molecule	-	921-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJNEKJLAYXESH-UWTATZPHSA-N
20751	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3070	2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide	-	-	DRUGBANK	DB03202	C19H22F3N5O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWSWTHSJMGVOKE-HNNXBMFYSA-N
20752	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3071	Sphingosine	-	-	DRUGBANK	DB03203	C18H37NO2	small molecule	-	123-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUZIQQURGPMPG-BXDGKWANSA-N
20753	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3071	Sphingosine	-	-	DRUGBANK	DB03203	C18H37NO2	small molecule	-	123-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUZIQQURGPMPG-BXDGKWANSA-N
20754	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3071	Sphingosine	-	-	DRUGBANK	DB03203	C18H37NO2	small molecule	-	123-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUZIQQURGPMPG-BXDGKWANSA-N
20755	111775	5817	-	PVR	CD155|HVED|NECL5|Necl-5|PVS|TAGE4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3071	Sphingosine	-	-	DRUGBANK	DB03203	C18H37NO2	small molecule	-	123-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUZIQQURGPMPG-BXDGKWANSA-N
20756	116414	11253	RP11-350O14.2	MAN1B1	ERMAN1|MANA-ER|MRT15	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3074	Duvoglustat	1 deoxynojirimycin|1-deoxynojirimycin|1,5-dideoxy-1,5-imino-D-glucitol|D-1-deoxynojirimycin|Deoxynojirimycin|5-amino-1,5-dideoxy-D-glucopyranose|DNJ|1-deoxy-nojirimycin|1,5-deoxy-1,5-imino-D-mannitol	-	DRUGBANK	DB03206	C6H13NO4	small molecule	-	19130-96-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXBIFEVIBLOUGU-JGWLITMVSA-N
20757	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3075	2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid	-	-	DRUGBANK	DB03207	C22H19NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNVMUDXGABBWGP-OAQYLSRUSA-N
20758	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3075	2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid	-	-	DRUGBANK	DB03207	C22H19NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNVMUDXGABBWGP-OAQYLSRUSA-N
20759	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3075	2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid	-	-	DRUGBANK	DB03207	C22H19NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNVMUDXGABBWGP-OAQYLSRUSA-N
20760	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3080	4-Deoxyglucarate	-	-	DRUGBANK	DB03212	C6H8O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZLURCXZSPTANB-BXXZVTAOSA-L
20761	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3080	4-Deoxyglucarate	-	-	DRUGBANK	DB03212	C6H8O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZLURCXZSPTANB-BXXZVTAOSA-L
20762	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3081	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone	-	-	DRUGBANK	DB03213	C17H14N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20763	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3081	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone	-	-	DRUGBANK	DB03213	C17H14N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20764	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3081	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone	-	-	DRUGBANK	DB03213	C17H14N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20765	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3082	Vinylglycine	L-vinylglycine|(2s)-2-Aminobut-3-Enoicacid|(2s)-2-Amino-3-Butenoic Acid	-	DRUGBANK	DB03214	C4H7NO2	small molecule	-	52773-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQVLGLPAZTUBKX-VKHMYHEASA-N
20766	124199	84680	-	ACCS	ACS|PHACS	9606	Homo sapiens	unknown	target	Satoh S (1989)	16667107	181938	3082	Vinylglycine	L-vinylglycine|(2s)-2-Aminobut-3-Enoicacid|(2s)-2-Amino-3-Butenoic Acid	-	DRUGBANK	DB03214	C4H7NO2	small molecule	-	52773-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQVLGLPAZTUBKX-VKHMYHEASA-N
20767	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3084	(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine	-	-	DRUGBANK	DB03216	C10H11N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQPALADHFYHEHK-CHKWXVPMSA-N
20768	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3084	(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine	-	-	DRUGBANK	DB03216	C10H11N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQPALADHFYHEHK-CHKWXVPMSA-N
20769	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3085	DPI59	-	-	DRUGBANK	DB03217	C11H11O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXIBZLYWMBUYRV-NSHDSACASA-N
20770	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3086	N-Acetyl-N'-Beta-D-Glucopyranosyl Urea	-	-	DRUGBANK	DB03218	C9H16N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQKBNLXZEGBQAF-RLMOJYMMSA-N
20771	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3086	N-Acetyl-N'-Beta-D-Glucopyranosyl Urea	-	-	DRUGBANK	DB03218	C9H16N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQKBNLXZEGBQAF-RLMOJYMMSA-N
20772	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3086	N-Acetyl-N'-Beta-D-Glucopyranosyl Urea	-	-	DRUGBANK	DB03218	C9H16N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQKBNLXZEGBQAF-RLMOJYMMSA-N
20773	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3088	FR233623	-	-	DRUGBANK	DB03220	C19H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OODDZQQDDOVCFD-SCLBCKFNSA-N
20774	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3089	AL7099A	-	-	DRUGBANK	DB03221	C14H17N3O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOXCYSVWCHXII-GFCCVEGCSA-N
20775	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3089	AL7099A	-	-	DRUGBANK	DB03221	C14H17N3O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOXCYSVWCHXII-GFCCVEGCSA-N
20776	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3089	AL7099A	-	-	DRUGBANK	DB03221	C14H17N3O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOXCYSVWCHXII-GFCCVEGCSA-N
20777	111419	5423	-	POLB	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3090	2'-Deoxyadenosine 5'-Triphosphate	-	-	DRUGBANK	DB03222	C10H16N5O12P3	small molecule	-	1927-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUYVUBYJARFZHO-DSYKOEDSSA-N
20778	111419	5423	-	POLB	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3090	2'-Deoxyadenosine 5'-Triphosphate	-	-	DRUGBANK	DB03222	C10H16N5O12P3	small molecule	-	1927-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUYVUBYJARFZHO-DSYKOEDSSA-N
20779	111419	5423	-	POLB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3090	2'-Deoxyadenosine 5'-Triphosphate	-	-	DRUGBANK	DB03222	C10H16N5O12P3	small molecule	-	1927-31-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUYVUBYJARFZHO-DSYKOEDSSA-N
20780	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3091	Diphthamide	2-(3-Carboxyamido-3-(Trimethylammonio)Propyl)Histidine	-	DRUGBANK	DB03223	C13H23N5O3	small molecule	-	75645-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTHSRDDMOFBHA-UWVGGRQHSA-O
20781	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3091	Diphthamide	2-(3-Carboxyamido-3-(Trimethylammonio)Propyl)Histidine	-	DRUGBANK	DB03223	C13H23N5O3	small molecule	-	75645-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTHSRDDMOFBHA-UWVGGRQHSA-O
20782	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3091	Diphthamide	2-(3-Carboxyamido-3-(Trimethylammonio)Propyl)Histidine	-	DRUGBANK	DB03223	C13H23N5O3	small molecule	-	75645-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTHSRDDMOFBHA-UWVGGRQHSA-O
20783	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3093	D-Tryptophan	-	-	DRUGBANK	DB03225	C11H11N2O2	small molecule	-	153-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMQXPTSGLUXAQK-VIFPVBQESA-N
20784	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3093	D-Tryptophan	-	-	DRUGBANK	DB03225	C11H11N2O2	small molecule	-	153-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMQXPTSGLUXAQK-VIFPVBQESA-N
20785	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3093	D-Tryptophan	-	-	DRUGBANK	DB03225	C11H11N2O2	small molecule	-	153-94-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMQXPTSGLUXAQK-VIFPVBQESA-N
20786	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3094	Trifluoroethanol	-	-	DRUGBANK	DB03226	C2H3F3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQDFWAXVIIEBN-UHFFFAOYSA-N
20787	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3094	Trifluoroethanol	-	-	DRUGBANK	DB03226	C2H3F3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQDFWAXVIIEBN-UHFFFAOYSA-N
20788	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3094	Trifluoroethanol	-	-	DRUGBANK	DB03226	C2H3F3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQDFWAXVIIEBN-UHFFFAOYSA-N
20789	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3094	Trifluoroethanol	-	-	DRUGBANK	DB03226	C2H3F3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQDFWAXVIIEBN-UHFFFAOYSA-N
20790	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3094	Trifluoroethanol	-	-	DRUGBANK	DB03226	C2H3F3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQDFWAXVIIEBN-UHFFFAOYSA-N
20791	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3094	Trifluoroethanol	-	-	DRUGBANK	DB03226	C2H3F3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQDFWAXVIIEBN-UHFFFAOYSA-N
20792	131564	349565	FKSG76	NMNAT3	PNAT-3|PNAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20793	131564	349565	FKSG76	NMNAT3	PNAT-3|PNAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20794	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20795	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20796	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20797	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3095	Nicotinamide Mononucleotide	-	-	DRUGBANK	DB03227	C11H16N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYLJWODMCOQEW-WYOJIJJFSA-O
20798	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3096	5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide	-	-	DRUGBANK	DB03228	C11H12Cl2N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMALWRRERBILB-UHFFFAOYSA-N
20799	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3096	5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide	-	-	DRUGBANK	DB03228	C11H12Cl2N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMALWRRERBILB-UHFFFAOYSA-N
20800	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3096	5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide	-	-	DRUGBANK	DB03228	C11H12Cl2N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMALWRRERBILB-UHFFFAOYSA-N
20801	850505	946145	b1056	yceI	ECK1041|JW1043	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3100	2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol	-	-	DRUGBANK	DB03232	C46H70O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUNQJPPPTJIREN-CMAXTTDKSA-N
20802	850505	946145	b1056	yceI	ECK1041|JW1043	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3100	2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol	-	-	DRUGBANK	DB03232	C46H70O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUNQJPPPTJIREN-CMAXTTDKSA-N
20803	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3101	Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester	-	-	DRUGBANK	DB03233	C10H16N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQZMHQZNZNBJNF-GJMOJQLCSA-N
20804	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3101	Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester	-	-	DRUGBANK	DB03233	C10H16N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQZMHQZNZNBJNF-GJMOJQLCSA-N
20805	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3105	2,3-Dihydroxy-5-Oxo-Hexanedioate	-	-	DRUGBANK	DB03237	C6H6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUURPCHWPQNNGL-ZAFYKAAXSA-L
20806	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3105	2,3-Dihydroxy-5-Oxo-Hexanedioate	-	-	DRUGBANK	DB03237	C6H6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUURPCHWPQNNGL-ZAFYKAAXSA-L
20807	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3108	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	-	-	DRUGBANK	DB03240	C10H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSGUEKZRMJVQOH-LURJTMIESA-N
20808	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3108	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	-	-	DRUGBANK	DB03240	C10H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSGUEKZRMJVQOH-LURJTMIESA-N
20809	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3108	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	-	-	DRUGBANK	DB03240	C10H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSGUEKZRMJVQOH-LURJTMIESA-N
20810	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	3109	1-Amino-1-Carbonyl Pentane	-	-	DRUGBANK	DB03241	C6H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZJGKUCHNFFHGN-ZCFIWIBFSA-N
20811	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	3109	1-Amino-1-Carbonyl Pentane	-	-	DRUGBANK	DB03241	C6H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZJGKUCHNFFHGN-ZCFIWIBFSA-N
20812	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3111	4-Fluorobenzylamine	-	-	DRUGBANK	DB03243	C7H9FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIFVWLUQBAIPMJ-UHFFFAOYSA-O
20813	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3111	4-Fluorobenzylamine	-	-	DRUGBANK	DB03243	C7H9FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIFVWLUQBAIPMJ-UHFFFAOYSA-O
20814	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3111	4-Fluorobenzylamine	-	-	DRUGBANK	DB03243	C7H9FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIFVWLUQBAIPMJ-UHFFFAOYSA-O
20815	108909	2639	-	GCDH	ACAD5|GCD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3113	S-4-Nitrobutyryl-Coa	-	-	DRUGBANK	DB03245	C25H42N8O19P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXDJZADOCCLHJS-NEQUNHHKSA-N
20816	108909	2639	-	GCDH	ACAD5|GCD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3113	S-4-Nitrobutyryl-Coa	-	-	DRUGBANK	DB03245	C25H42N8O19P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXDJZADOCCLHJS-NEQUNHHKSA-N
20817	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3114	Beta-L-Arabinose	-	-	DRUGBANK	DB03246	C5H10O5	small molecule	-	5328-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-KLVWXMOXSA-N
20818	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3114	Beta-L-Arabinose	-	-	DRUGBANK	DB03246	C5H10O5	small molecule	-	5328-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMFHBZSHGGEWLO-KLVWXMOXSA-N
20819	114468	8986	-	RPS6KA4	MSK2|RSK-B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20820	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20821	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20822	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20823	119356	51179	RP5-871G17.1	HAO2	GIG16|HAOX2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20824	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20825	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20826	120594	55312	RP11-422N19.2	RFK	RIFK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20827	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20828	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20829	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20830	121921	60490	MDS018	PPCDC	PPC-DC|coaC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20831	112344	6446	RP1-188K17.1	SGK1	SGK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20832	851147	946806	b1638	pdxH	ECK1634|JW1630	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20833	851147	946806	b1638	pdxH	ECK1634|JW1630	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20834	849930	945556	b0945	pyrD	ECK0936|JW0928	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20835	849930	945556	b0945	pyrD	ECK0936|JW0928	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20836	849857	945483	b0851	nfsA	ECK0842|JW0835|mda18|mdaA|snrA|ybjB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20837	849857	945483	b0851	nfsA	ECK0842|JW0835|mda18|mdaA|snrA|ybjB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20838	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20839	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20840	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20841	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20842	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20843	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20844	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20845	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20846	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20847	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20848	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20849	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20850	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20851	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20852	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20853	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20854	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3118	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole	-	-	DRUGBANK	DB03250	C14H17NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WGJFWQVWYRZPEP-KABOQKQYSA-N
20855	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3119	RWJ-51084	-	-	DRUGBANK	DB03251	C19H25N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQABUEUFRXDDFI-AWEZNQCLSA-N
20856	851640	947313	b2838	lysA	ECK2836|JW2806	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3120	D-Lysine	(R)-2,6-diaminohexanoic acid|D-2,6-Diaminohexanoic acid|D-Lysin	-	DRUGBANK	DB03252	C6H14N2O2	small molecule	-	923-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-RXMQYKEDSA-N
20857	851640	947313	b2838	lysA	ECK2836|JW2806	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3120	D-Lysine	(R)-2,6-diaminohexanoic acid|D-2,6-Diaminohexanoic acid|D-Lysin	-	DRUGBANK	DB03252	C6H14N2O2	small molecule	-	923-27-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDXKERNSBIXSRK-RXMQYKEDSA-N
20858	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3121	(2s)-Pyrrolidin-2-Ylmethylamine	-	-	DRUGBANK	DB03253	C5H12N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUKXFNABVHIUAC-YFKPBYRVSA-N
20859	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3121	(2s)-Pyrrolidin-2-Ylmethylamine	-	-	DRUGBANK	DB03253	C5H12N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUKXFNABVHIUAC-YFKPBYRVSA-N
20860	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3121	(2s)-Pyrrolidin-2-Ylmethylamine	-	-	DRUGBANK	DB03253	C5H12N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUKXFNABVHIUAC-YFKPBYRVSA-N
20861	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3124	(6R)-Folinic acid	(6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate	-	DRUGBANK	DB03256	C20H23N7O7	small molecule	-	73951-54-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVIAGPKUTFNRDU-OLZOCXBDSA-N
20862	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3124	(6R)-Folinic acid	(6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate	-	DRUGBANK	DB03256	C20H23N7O7	small molecule	-	73951-54-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVIAGPKUTFNRDU-OLZOCXBDSA-N
20863	116053	10841	-	FTCD	LCHC1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3124	(6R)-Folinic acid	(6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate	-	DRUGBANK	DB03256	C20H23N7O7	small molecule	-	73951-54-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVIAGPKUTFNRDU-OLZOCXBDSA-N
20864	851996	947683	b2255	arnA	ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3124	(6R)-Folinic acid	(6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate	-	DRUGBANK	DB03256	C20H23N7O7	small molecule	-	73951-54-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVIAGPKUTFNRDU-OLZOCXBDSA-N
20865	851996	947683	b2255	arnA	ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3124	(6R)-Folinic acid	(6R)-Leucovorin|(6R,2'S)-Folinic acid|L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-|N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid|[6R]-5-formyl-5,6,7,8-tetrahydrofolate	-	DRUGBANK	DB03256	C20H23N7O7	small molecule	-	73951-54-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVIAGPKUTFNRDU-OLZOCXBDSA-N
20866	850940	946593	b2065	dcd	ECK2059|JW2050|dus|paxA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3126	2'-Deoxycytidine-5'-Triphosphate	-	-	DRUGBANK	DB03258	C9H16N3O13P3	small molecule	-	2056-98-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGWHQCVHVJXOKC-GKROBHDKSA-N
20867	850940	946593	b2065	dcd	ECK2059|JW2050|dus|paxA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3126	2'-Deoxycytidine-5'-Triphosphate	-	-	DRUGBANK	DB03258	C9H16N3O13P3	small molecule	-	2056-98-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGWHQCVHVJXOKC-GKROBHDKSA-N
20868	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3129	Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	-	-	DRUGBANK	DB03262	C17H19N3O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZLYYZPXSSNGJS-UHFFFAOYSA-N
20869	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3129	Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	-	-	DRUGBANK	DB03262	C17H19N3O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZLYYZPXSSNGJS-UHFFFAOYSA-N
20870	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3129	Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	-	-	DRUGBANK	DB03262	C17H19N3O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZLYYZPXSSNGJS-UHFFFAOYSA-N
20871	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3133	1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	-	-	DRUGBANK	DB03267	C21H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFOWZKUTPKXWIE-UHFFFAOYSA-N
20872	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3133	1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	-	-	DRUGBANK	DB03267	C21H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFOWZKUTPKXWIE-UHFFFAOYSA-N
20873	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3133	1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	-	-	DRUGBANK	DB03267	C21H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFOWZKUTPKXWIE-UHFFFAOYSA-N
20874	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3134	RU82197	-	-	DRUGBANK	DB03268	C32H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKTQBTSOHBKBRW-WDYNHAJCSA-N
20875	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3134	RU82197	-	-	DRUGBANK	DB03268	C32H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKTQBTSOHBKBRW-WDYNHAJCSA-N
20876	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3134	RU82197	-	-	DRUGBANK	DB03268	C32H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKTQBTSOHBKBRW-WDYNHAJCSA-N
20877	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3136	2,6-Difluorobenzenesulfonamide	-	-	DRUGBANK	DB03270	C6H5F2NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVVVGGCOFWWDEL-UHFFFAOYSA-N
20878	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3136	2,6-Difluorobenzenesulfonamide	-	-	DRUGBANK	DB03270	C6H5F2NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVVVGGCOFWWDEL-UHFFFAOYSA-N
20884	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3139	3'-Oxo-Adenosine	-	-	DRUGBANK	DB03273	C10H11N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIAZJCOESMXYNJ-AYPRXHQESA-N
20885	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3139	3'-Oxo-Adenosine	-	-	DRUGBANK	DB03273	C10H11N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIAZJCOESMXYNJ-AYPRXHQESA-N
20886	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3139	3'-Oxo-Adenosine	-	-	DRUGBANK	DB03273	C10H11N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIAZJCOESMXYNJ-AYPRXHQESA-N
20887	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3140	2'-5'dideoxyuridine	-	-	DRUGBANK	DB03274	C9H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDCFKLBIAIKUKB-CHKWXVPMSA-N
20888	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3140	2'-5'dideoxyuridine	-	-	DRUGBANK	DB03274	C9H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDCFKLBIAIKUKB-CHKWXVPMSA-N
20889	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3142	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	-	-	DRUGBANK	DB03276	C37H45N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHYFMOCFCFUTNH-GZNVFMSSSA-N
20890	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3142	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	-	-	DRUGBANK	DB03276	C37H45N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHYFMOCFCFUTNH-GZNVFMSSSA-N
20891	109142	2885	-	GRB2	ASH|EGFRBP-GRB2|Grb3-3|MST084|MSTP084|NCKAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3142	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	-	-	DRUGBANK	DB03276	C37H45N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHYFMOCFCFUTNH-GZNVFMSSSA-N
20892	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3143	alpha-maltotriose	-maltotriose	-	DRUGBANK	DB03277	C18H32O16	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYGDTMLNYKFZSV-PXXRMHSHSA-N
20893	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3143	alpha-maltotriose	-maltotriose	-	DRUGBANK	DB03277	C18H32O16	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYGDTMLNYKFZSV-PXXRMHSHSA-N
20894	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3143	alpha-maltotriose	-maltotriose	-	DRUGBANK	DB03277	C18H32O16	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYGDTMLNYKFZSV-PXXRMHSHSA-N
20895	849888	945514	b0903	pflB	ECK0894|JW0886|pfl	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3144	D-Treitol	-	-	DRUGBANK	DB03278	C4H10O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNXHWFMMPAWVPI-IMJSIDKUSA-N
20896	849888	945514	b0903	pflB	ECK0894|JW0886|pfl	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3144	D-Treitol	-	-	DRUGBANK	DB03278	C4H10O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNXHWFMMPAWVPI-IMJSIDKUSA-N
20897	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3145	Dodecyl-Alpha-D-Maltoside	-	-	DRUGBANK	DB03279	C24H46O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLEBIOOXCVAHBD-DAMKUWBJSA-N
20898	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3145	Dodecyl-Alpha-D-Maltoside	-	-	DRUGBANK	DB03279	C24H46O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLEBIOOXCVAHBD-DAMKUWBJSA-N
20899	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3145	Dodecyl-Alpha-D-Maltoside	-	-	DRUGBANK	DB03279	C24H46O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLEBIOOXCVAHBD-DAMKUWBJSA-N
20900	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3146	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	-	-	DRUGBANK	DB03280	C20H30N7O23P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCFDSPQTEMXXLO-MZWJRZEOSA-N
20901	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3146	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	-	-	DRUGBANK	DB03280	C20H30N7O23P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCFDSPQTEMXXLO-MZWJRZEOSA-N
20902	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3146	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	-	-	DRUGBANK	DB03280	C20H30N7O23P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCFDSPQTEMXXLO-MZWJRZEOSA-N
20903	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3148	beta-L-fucose	6-Deoxy-Beta-L-Galactose	-	DRUGBANK	DB03283	C6H12O5	small molecule	-	2438-80-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-KGJVWPDLSA-N
20904	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3148	beta-L-fucose	6-Deoxy-Beta-L-Galactose	-	DRUGBANK	DB03283	C6H12O5	small molecule	-	2438-80-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-KGJVWPDLSA-N
20905	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3148	beta-L-fucose	6-Deoxy-Beta-L-Galactose	-	DRUGBANK	DB03283	C6H12O5	small molecule	-	2438-80-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-KGJVWPDLSA-N
20906	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3151	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	-	-	DRUGBANK	DB03286	C7H14N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAKOUYZWWLMCSL-IEMWZLDZSA-N
20907	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3151	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	-	-	DRUGBANK	DB03286	C7H14N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAKOUYZWWLMCSL-IEMWZLDZSA-N
20908	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3151	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	-	-	DRUGBANK	DB03286	C7H14N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAKOUYZWWLMCSL-IEMWZLDZSA-N
20909	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3153	5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide	-	-	DRUGBANK	DB03288	C18H24ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXABTOCIIZSEPD-QGZVFWFLSA-N
20910	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3153	5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide	-	-	DRUGBANK	DB03288	C18H24ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXABTOCIIZSEPD-QGZVFWFLSA-N
20911	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3153	5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide	-	-	DRUGBANK	DB03288	C18H24ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXABTOCIIZSEPD-QGZVFWFLSA-N
20912	111695	5723	-	PSPH	PSP|PSPHD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3157	D-2-Amino-3-Phosphono-Propionic Acid	-	-	DRUGBANK	DB03292	C3H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBTABPSJONFLPO-REOHCLBHSA-N
20913	111695	5723	-	PSPH	PSP|PSPHD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3157	D-2-Amino-3-Phosphono-Propionic Acid	-	-	DRUGBANK	DB03292	C3H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBTABPSJONFLPO-REOHCLBHSA-N
20914	111695	5723	-	PSPH	PSP|PSPHD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3157	D-2-Amino-3-Phosphono-Propionic Acid	-	-	DRUGBANK	DB03292	C3H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBTABPSJONFLPO-REOHCLBHSA-N
20915	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3159	1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide	-	-	DRUGBANK	DB03294	C8H8N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPYCCVFXMWMJM-UHFFFAOYSA-N
20916	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3159	1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide	-	-	DRUGBANK	DB03294	C8H8N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPYCCVFXMWMJM-UHFFFAOYSA-N
20917	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3159	1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide	-	-	DRUGBANK	DB03294	C8H8N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFPYCCVFXMWMJM-UHFFFAOYSA-N
20918	112531	6648	RP1-56L9.2	SOD2	IPOB|MNSOD|MVCD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20919	112531	6648	RP1-56L9.2	SOD2	IPOB|MNSOD|MVCD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20920	112531	6648	RP1-56L9.2	SOD2	IPOB|MNSOD|MVCD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20921	853625	935930	BSU34100	rsbQ	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20922	853625	935930	BSU34100	rsbQ	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20923	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20924	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20925	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3162	Benzylsulfinic Acid	-	-	DRUGBANK	DB03297	C7H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVSONFIVLCXXDH-UHFFFAOYSA-N
20926	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3163	Phenylphosphate	-	-	DRUGBANK	DB03298	C6H7O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMPQUABWPXYYSH-UHFFFAOYSA-N
20927	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3163	Phenylphosphate	-	-	DRUGBANK	DB03298	C6H7O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMPQUABWPXYYSH-UHFFFAOYSA-N
20928	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3163	Phenylphosphate	-	-	DRUGBANK	DB03298	C6H7O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMPQUABWPXYYSH-UHFFFAOYSA-N
20929	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3170	N5-Iminoethyl-L-Ornithine	-	-	DRUGBANK	DB03305	C7H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYZFAUAYFLEHRC-ZCFIWIBFSA-N
20930	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3170	N5-Iminoethyl-L-Ornithine	-	-	DRUGBANK	DB03305	C7H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYZFAUAYFLEHRC-ZCFIWIBFSA-N
20931	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3170	N5-Iminoethyl-L-Ornithine	-	-	DRUGBANK	DB03305	C7H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYZFAUAYFLEHRC-ZCFIWIBFSA-N
20932	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3171	RU78300	-	-	DRUGBANK	DB03306	C8H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGEZBCISRKFHLZ-UHFFFAOYSA-N
20933	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3172	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB03307	C10H11N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFVVRPJERUECT-UHFFFAOYSA-N
20934	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3172	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB03307	C10H11N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFVVRPJERUECT-UHFFFAOYSA-N
20935	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3172	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	-	-	DRUGBANK	DB03307	C10H11N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFVVRPJERUECT-UHFFFAOYSA-N
20936	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3174	N-Cyclohexyltaurine	CHES	-	DRUGBANK	DB03309	C8H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKWKNSIESPFAQN-UHFFFAOYSA-N
20937	112689	6820	-	SULT2B1	HSST2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3174	N-Cyclohexyltaurine	CHES	-	DRUGBANK	DB03309	C8H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKWKNSIESPFAQN-UHFFFAOYSA-N
20938	108335	2020	tcag7.568	EN2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3174	N-Cyclohexyltaurine	CHES	-	DRUGBANK	DB03309	C8H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKWKNSIESPFAQN-UHFFFAOYSA-N
20939	108335	2020	tcag7.568	EN2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3174	N-Cyclohexyltaurine	CHES	-	DRUGBANK	DB03309	C8H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKWKNSIESPFAQN-UHFFFAOYSA-N
20940	108335	2020	tcag7.568	EN2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3174	N-Cyclohexyltaurine	CHES	-	DRUGBANK	DB03309	C8H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKWKNSIESPFAQN-UHFFFAOYSA-N
20941	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3175	Oxidized Glutathione Disulfide	-	-	DRUGBANK	DB03310	C20H32N6O12S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZRWBKMTBYPTK-DDHJBXDOSA-N
20942	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3175	Oxidized Glutathione Disulfide	-	-	DRUGBANK	DB03310	C20H32N6O12S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZRWBKMTBYPTK-DDHJBXDOSA-N
20943	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3175	Oxidized Glutathione Disulfide	-	-	DRUGBANK	DB03310	C20H32N6O12S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZRWBKMTBYPTK-DDHJBXDOSA-N
20944	109201	2946	-	GSTM2	GST4|GSTM|GSTM2-2|GTHMUS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3175	Oxidized Glutathione Disulfide	-	-	DRUGBANK	DB03310	C20H32N6O12S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPZRWBKMTBYPTK-DDHJBXDOSA-N
20945	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3176	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide	-	-	DRUGBANK	DB03311	C26H19Br2N3O7S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXKBTDJJEQQEGE-UHFFFAOYSA-N
20946	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3176	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide	-	-	DRUGBANK	DB03311	C26H19Br2N3O7S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXKBTDJJEQQEGE-UHFFFAOYSA-N
20947	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3179	Fluorotryptophane	5-Fluoro-L-tryptophan	-	DRUGBANK	DB03314	C11H11FN2O2	small molecule	-	16626-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INPQIVHQSQUEAJ-VIFPVBQESA-N
20948	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3179	Fluorotryptophane	5-Fluoro-L-tryptophan	-	DRUGBANK	DB03314	C11H11FN2O2	small molecule	-	16626-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INPQIVHQSQUEAJ-VIFPVBQESA-N
20949	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3179	Fluorotryptophane	5-Fluoro-L-tryptophan	-	DRUGBANK	DB03314	C11H11FN2O2	small molecule	-	16626-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INPQIVHQSQUEAJ-VIFPVBQESA-N
20950	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3179	Fluorotryptophane	5-Fluoro-L-tryptophan	-	DRUGBANK	DB03314	C11H11FN2O2	small molecule	-	16626-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INPQIVHQSQUEAJ-VIFPVBQESA-N
20951	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3179	Fluorotryptophane	5-Fluoro-L-tryptophan	-	DRUGBANK	DB03314	C11H11FN2O2	small molecule	-	16626-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INPQIVHQSQUEAJ-VIFPVBQESA-N
20952	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3179	Fluorotryptophane	5-Fluoro-L-tryptophan	-	DRUGBANK	DB03314	C11H11FN2O2	small molecule	-	16626-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INPQIVHQSQUEAJ-VIFPVBQESA-N
20953	118965	29924	-	EPN1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20954	118965	29924	-	EPN1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20955	118965	29924	-	EPN1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20956	112901	7043	-	TGFB3	ARVD|ARVD1|RNHF|TGF-beta3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20957	112901	7043	-	TGFB3	ARVD|ARVD1|RNHF|TGF-beta3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20958	112901	7043	-	TGFB3	ARVD|ARVD1|RNHF|TGF-beta3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20959	115915	10673	RP11-153I24.1	TNFSF13B	BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20960	115915	10673	RP11-153I24.1	TNFSF13B	BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3181	1,4-Diethylene Dioxide	-	-	DRUGBANK	DB03316	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYHBNJHYFVUHQT-UHFFFAOYSA-N
20961	852865	948571	b4070	nrfA	ECK4063|JW4031	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3182	Heme C	-	-	DRUGBANK	DB03317	C34H34FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQIYSLZKNYNMH-STIJKOADSA-N
20962	852865	948571	b4070	nrfA	ECK4063|JW4031	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3182	Heme C	-	-	DRUGBANK	DB03317	C34H34FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQIYSLZKNYNMH-STIJKOADSA-N
20963	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3182	Heme C	-	-	DRUGBANK	DB03317	C34H34FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQIYSLZKNYNMH-STIJKOADSA-N
20964	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3182	Heme C	-	-	DRUGBANK	DB03317	C34H34FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQIYSLZKNYNMH-STIJKOADSA-N
20965	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3182	Heme C	-	-	DRUGBANK	DB03317	C34H34FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQIYSLZKNYNMH-STIJKOADSA-N
20966	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3184	(S)-ATPA	(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid	-	DRUGBANK	DB03319	C10H15N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIXJURSCCVBKRF-ZCFIWIBFSA-M
20967	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3184	(S)-ATPA	(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid	-	DRUGBANK	DB03319	C10H15N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIXJURSCCVBKRF-ZCFIWIBFSA-M
20968	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3184	(S)-ATPA	(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid	-	DRUGBANK	DB03319	C10H15N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIXJURSCCVBKRF-ZCFIWIBFSA-M
20969	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20970	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20971	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20972	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20973	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20974	852231	947922	b3417	malP	ECK3404|JW5689|blu|malA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20975	852231	947922	b3417	malP	ECK3404|JW5689|blu|malA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3188	Maltose	Maltose anhydrous|D-(+)-maltose	-	DRUGBANK	DB03323	C12H22O11	small molecule	-	69-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKXNBNKWCZZMJT-WUJBLJFYSA-N
20976	853135	948855	b1637	tyrS	ECK1633|JW1629	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3189	Tyrosyladenylate	-	-	DRUGBANK	DB03325	C19H23N7O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZAZMKENKZBAJ-NEYKFGMSSA-N
20977	853135	948855	b1637	tyrS	ECK1633|JW1629	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3189	Tyrosyladenylate	-	-	DRUGBANK	DB03325	C19H23N7O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZAZMKENKZBAJ-NEYKFGMSSA-N
20978	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Listgarten JN (1995)	15299807	181858	3190	deoxycytidylyl-3',5'-guanosine	-	-	DRUGBANK	DB03326	C19H25N8O10P	small molecule	-	52474-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBCJQWSXSLYWHI-BSTSDWCZSA-N
20979	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3190	deoxycytidylyl-3',5'-guanosine	-	-	DRUGBANK	DB03326	C19H25N8O10P	small molecule	-	52474-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBCJQWSXSLYWHI-BSTSDWCZSA-N
20980	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3192	dioxothiomolybdenum(VI) ion	-	-	DRUGBANK	DB03328	HMoO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDSRWPHSAKXXRG-UHFFFAOYSA-M
20981	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3192	dioxothiomolybdenum(VI) ion	-	-	DRUGBANK	DB03328	HMoO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDSRWPHSAKXXRG-UHFFFAOYSA-M
20982	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3192	dioxothiomolybdenum(VI) ion	-	-	DRUGBANK	DB03328	HMoO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDSRWPHSAKXXRG-UHFFFAOYSA-M
20983	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20984	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20985	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3193	2-Pyridinethiol	-	-	DRUGBANK	DB03329	C5H5NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMDPDGBKYUEMW-UHFFFAOYSA-N
20986	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3194	S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione	-	-	DRUGBANK	DB03330	C17H23IN4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SCHAHXXLASZJCD-JKDFXYPNSA-N
20987	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3194	S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione	-	-	DRUGBANK	DB03330	C17H23IN4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SCHAHXXLASZJCD-JKDFXYPNSA-N
20988	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3195	N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	-	-	DRUGBANK	DB03331	C30H30N6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OARVXDFNTLYMCJ-OYILCWTOSA-N
20989	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3195	N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	-	-	DRUGBANK	DB03331	C30H30N6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OARVXDFNTLYMCJ-OYILCWTOSA-N
20990	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3195	N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	-	-	DRUGBANK	DB03331	C30H30N6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OARVXDFNTLYMCJ-OYILCWTOSA-N
20991	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3196	5,6-Cyclic-Tetrahydropteridine	-	-	DRUGBANK	DB03332	C8H9N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAZOBOCYEGBXHD-GSVOUGTGSA-N
20992	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3196	5,6-Cyclic-Tetrahydropteridine	-	-	DRUGBANK	DB03332	C8H9N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAZOBOCYEGBXHD-GSVOUGTGSA-N
20993	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3196	5,6-Cyclic-Tetrahydropteridine	-	-	DRUGBANK	DB03332	C8H9N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAZOBOCYEGBXHD-GSVOUGTGSA-N
20994	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3197	(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester	-	-	DRUGBANK	DB03333	C13H14N2O3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXMUSVRWCFYOTJ-UHFFFAOYSA-N
20995	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3197	(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester	-	-	DRUGBANK	DB03333	C13H14N2O3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXMUSVRWCFYOTJ-UHFFFAOYSA-N
20996	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3197	(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester	-	-	DRUGBANK	DB03333	C13H14N2O3S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXMUSVRWCFYOTJ-UHFFFAOYSA-N
20997	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3199	BIA	-	-	DRUGBANK	DB03336	C20H20F3N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVIVJQWOYSWCCZ-UHFFFAOYSA-N
20998	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3200	1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea	-	-	DRUGBANK	DB03337	C20H18N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHCAYBOLUMAUQX-UHFFFAOYSA-N
20999	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3201	Heptyl-Beta-D-Glucopyranoside	-	-	DRUGBANK	DB03338	C13H26O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIDYWHLDTIVRJT-UJPOAAIJSA-N
21000	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3201	Heptyl-Beta-D-Glucopyranoside	-	-	DRUGBANK	DB03338	C13H26O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIDYWHLDTIVRJT-UJPOAAIJSA-N
21001	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3201	Heptyl-Beta-D-Glucopyranoside	-	-	DRUGBANK	DB03338	C13H26O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIDYWHLDTIVRJT-UJPOAAIJSA-N
21002	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3201	Heptyl-Beta-D-Glucopyranoside	-	-	DRUGBANK	DB03338	C13H26O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIDYWHLDTIVRJT-UJPOAAIJSA-N
21003	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3204	Coa-S-Acetyl 5-Bromotryptamine	-	-	DRUGBANK	DB03341	C33H47BrN9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBDVCGJBELWXIQ-KOGRCXSVSA-N
21004	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3204	Coa-S-Acetyl 5-Bromotryptamine	-	-	DRUGBANK	DB03341	C33H47BrN9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBDVCGJBELWXIQ-KOGRCXSVSA-N
21005	106533	15	-	AANAT	DSPS|SNAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3204	Coa-S-Acetyl 5-Bromotryptamine	-	-	DRUGBANK	DB03341	C33H47BrN9O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBDVCGJBELWXIQ-KOGRCXSVSA-N
21006	114686	9265	tcag7.847	CYTH3	ARNO3|GRP1|PSCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3207	Inositol-(1,3,4,5,6)-Pentakisphosphate	-	-	DRUGBANK	DB03344	C6H17O21P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTPQAXVNYGZUAJ-WPRNADSXSA-N
21007	114686	9265	tcag7.847	CYTH3	ARNO3|GRP1|PSCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3207	Inositol-(1,3,4,5,6)-Pentakisphosphate	-	-	DRUGBANK	DB03344	C6H17O21P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTPQAXVNYGZUAJ-WPRNADSXSA-N
21008	114686	9265	tcag7.847	CYTH3	ARNO3|GRP1|PSCD3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3207	Inositol-(1,3,4,5,6)-Pentakisphosphate	-	-	DRUGBANK	DB03344	C6H17O21P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTPQAXVNYGZUAJ-WPRNADSXSA-N
21009	116609	22955	-	SCMH1	Scml3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21010	851147	946806	b1638	pdxH	ECK1634|JW1630	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21011	851147	946806	b1638	pdxH	ECK1634|JW1630	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21012	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21013	111283	5265	PRO0684	SERPINA1	A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21014	111283	5265	PRO0684	SERPINA1	A1A|A1AT|AAT|PI|PI1|PRO2275|alpha1AT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21015	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21016	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21017	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21018	120463	55163	-	PNPO	HEL-S-302|PDXPO	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3208	Beta-Mercaptoethanol	2-Sulfhydryl-Ethanol	-	DRUGBANK	DB03345	C2H6OS	small molecule	-	60-24-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGVVWUTYPXICAM-UHFFFAOYSA-N
21019	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3209	3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol	-	-	DRUGBANK	DB03346	C12H6Cl4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCYDXOVJXVALHY-UHFFFAOYSA-N
21020	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3209	3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol	-	-	DRUGBANK	DB03346	C12H6Cl4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCYDXOVJXVALHY-UHFFFAOYSA-N
21021	112660	6783	-	SULT1E1	EST|EST-1|ST1E1|STE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3209	3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol	-	-	DRUGBANK	DB03346	C12H6Cl4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCYDXOVJXVALHY-UHFFFAOYSA-N
21022	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	He XC (2007)	17126020	181976	3211	Huperzine B	HupB|HUB	-	DRUGBANK	DB03348	C16H20N2O	small molecule	-	103548-82-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYWGABLTRMRUIT-UHFFFAOYSA-N
21023	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3211	Huperzine B	HupB|HUB	-	DRUGBANK	DB03348	C16H20N2O	small molecule	-	103548-82-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYWGABLTRMRUIT-UHFFFAOYSA-N
21024	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21025	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21026	109341	3094	-	HINT1	HINT|NMAN|PKCI-1|PRKCNH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21027	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21028	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3212	8-Bromo-Adenosine-5'-Monophosphate	-	-	DRUGBANK	DB03349	C10H13BrN5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNPIJKNXFSPNNY-BZKDHIKHSA-N
21029	851838	947521	b3035	tolC	ECK3026|JW5503|colE1-i|mtcB|mukA|refI|toc|weeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3213	Cobalt Hexammine Ion	-	-	DRUGBANK	DB03350	CoH12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRZXATGLRMBRQI-UHFFFAOYSA-N
21030	851838	947521	b3035	tolC	ECK3026|JW5503|colE1-i|mtcB|mukA|refI|toc|weeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3213	Cobalt Hexammine Ion	-	-	DRUGBANK	DB03350	CoH12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRZXATGLRMBRQI-UHFFFAOYSA-N
21031	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3214	Sri-9439	-	-	DRUGBANK	DB03351	C18H17N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMSATRJZEXNGDP-UHFFFAOYSA-N
21032	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3214	Sri-9439	-	-	DRUGBANK	DB03351	C18H17N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMSATRJZEXNGDP-UHFFFAOYSA-N
21033	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3214	Sri-9439	-	-	DRUGBANK	DB03351	C18H17N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMSATRJZEXNGDP-UHFFFAOYSA-N
21034	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3217	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole	-	-	DRUGBANK	DB03354	C9H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCSFWJQLIPWUFZ-RLMOJYMMSA-N
21035	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3217	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole	-	-	DRUGBANK	DB03354	C9H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCSFWJQLIPWUFZ-RLMOJYMMSA-N
21036	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3217	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole	-	-	DRUGBANK	DB03354	C9H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCSFWJQLIPWUFZ-RLMOJYMMSA-N
21037	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3221	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	-	-	DRUGBANK	DB03359	C11H15F3NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGVDBJQLTHWAJF-UHFFFAOYSA-N
21038	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3221	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	-	-	DRUGBANK	DB03359	C11H15F3NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGVDBJQLTHWAJF-UHFFFAOYSA-N
21039	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3221	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	-	-	DRUGBANK	DB03359	C11H15F3NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGVDBJQLTHWAJF-UHFFFAOYSA-N
21040	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3227	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB03365	C16H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNDYIYYKEIXHNK-UHFFFAOYSA-N
21041	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3227	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB03365	C16H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNDYIYYKEIXHNK-UHFFFAOYSA-N
21042	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3227	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	-	-	DRUGBANK	DB03365	C16H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNDYIYYKEIXHNK-UHFFFAOYSA-N
21043	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3228	PF-00356231	3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid	-	DRUGBANK	DB03367	C25H20N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMTJQZUZINLEKC-JOCHJYFZSA-N
21044	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3228	PF-00356231	3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid	-	DRUGBANK	DB03367	C25H20N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMTJQZUZINLEKC-JOCHJYFZSA-N
21045	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3228	PF-00356231	3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid	-	DRUGBANK	DB03367	C25H20N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMTJQZUZINLEKC-JOCHJYFZSA-N
21046	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3229	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	-	-	DRUGBANK	DB03368	C17H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTBMLCLTYAPKIF-UHFFFAOYSA-N
21047	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3229	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	-	-	DRUGBANK	DB03368	C17H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTBMLCLTYAPKIF-UHFFFAOYSA-N
21048	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3229	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	-	-	DRUGBANK	DB03368	C17H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTBMLCLTYAPKIF-UHFFFAOYSA-N
21049	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3231	FR239087	-	-	DRUGBANK	DB03370	C15H17Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCJYSIGJDKNVRU-TVQRCGJNSA-N
21050	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3233	3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One	-	-	DRUGBANK	DB03372	C14H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGWLHSPOMCORRH-UHFFFAOYSA-N
21051	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3234	ZK-806711	-	-	DRUGBANK	DB03373	C27H30N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21052	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3234	ZK-806711	-	-	DRUGBANK	DB03373	C27H30N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21053	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3234	ZK-806711	-	-	DRUGBANK	DB03373	C27H30N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21054	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3235	3,5-Diiodotyrosine	-	-	DRUGBANK	DB03374	C9H9I2NO3	small molecule	-	300-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYPYHUZRZVSYKL-ZETCQYMHSA-N
21055	852290	947981	b3476	nikA	ECK3460|JW3441|hydC|hydD	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3235	3,5-Diiodotyrosine	-	-	DRUGBANK	DB03374	C9H9I2NO3	small molecule	-	300-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYPYHUZRZVSYKL-ZETCQYMHSA-N
21056	133150	389434	-	IYD	C6orf71|DEHAL1|TDH4|dJ422F24.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3235	3,5-Diiodotyrosine	-	-	DRUGBANK	DB03374	C9H9I2NO3	small molecule	-	300-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYPYHUZRZVSYKL-ZETCQYMHSA-N
21057	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3235	3,5-Diiodotyrosine	-	-	DRUGBANK	DB03374	C9H9I2NO3	small molecule	-	300-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYPYHUZRZVSYKL-ZETCQYMHSA-N
21058	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3235	3,5-Diiodotyrosine	-	-	DRUGBANK	DB03374	C9H9I2NO3	small molecule	-	300-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYPYHUZRZVSYKL-ZETCQYMHSA-N
21059	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3236	'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB03376	C13H19N7O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWWYMWDIYBJVLP-KOMLLWLHSA-N
21060	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3236	'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB03376	C13H19N7O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWWYMWDIYBJVLP-KOMLLWLHSA-N
21061	108372	2058	PIG32	EPRS	EARS|GLUPRORS|PARS|QARS|QPRS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3236	'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine	-	-	DRUGBANK	DB03376	C13H19N7O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWWYMWDIYBJVLP-KOMLLWLHSA-N
21062	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3238	2-Carboxyethylphosphonic Acid	-	-	DRUGBANK	DB03379	C3H7O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBSQHGCGGFVJW-UHFFFAOYSA-N
21063	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3238	2-Carboxyethylphosphonic Acid	-	-	DRUGBANK	DB03379	C3H7O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBSQHGCGGFVJW-UHFFFAOYSA-N
21064	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3238	2-Carboxyethylphosphonic Acid	-	-	DRUGBANK	DB03379	C3H7O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLBSQHGCGGFVJW-UHFFFAOYSA-N
21065	107138	670	-	BPHL	BPH-RP|MCNAA|VACVASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3239	L-Tyrosinamide	L-Tyrosine amide|Tyrosinamide	-	DRUGBANK	DB03380	C9H12N2O2	small molecule	-	4985-46-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQFMNVGMJJMLAE-QMMMGPOBSA-N
21066	110914	4852	-	NPY	PYY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3239	L-Tyrosinamide	L-Tyrosine amide|Tyrosinamide	-	DRUGBANK	DB03380	C9H12N2O2	small molecule	-	4985-46-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQFMNVGMJJMLAE-QMMMGPOBSA-N
21067	107990	1622	-	DBI	ACBD1|ACBP|CCK-RP|EP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3240	Hexadecanal	Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde	-	DRUGBANK	DB03381	C16H32O	small molecule	-	629-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIOYUNMRJMEDGI-UHFFFAOYSA-N
21068	107990	1622	-	DBI	ACBD1|ACBP|CCK-RP|EP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3240	Hexadecanal	Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde	-	DRUGBANK	DB03381	C16H32O	small molecule	-	629-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIOYUNMRJMEDGI-UHFFFAOYSA-N
21069	107990	1622	-	DBI	ACBD1|ACBP|CCK-RP|EP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3240	Hexadecanal	Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde	-	DRUGBANK	DB03381	C16H32O	small molecule	-	629-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIOYUNMRJMEDGI-UHFFFAOYSA-N
21070	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3240	Hexadecanal	Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde	-	DRUGBANK	DB03381	C16H32O	small molecule	-	629-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIOYUNMRJMEDGI-UHFFFAOYSA-N
21071	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3240	Hexadecanal	Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde	-	DRUGBANK	DB03381	C16H32O	small molecule	-	629-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIOYUNMRJMEDGI-UHFFFAOYSA-N
21072	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3240	Hexadecanal	Palmitoyl|N-hexadecanal|Palmitaldehyde|PLY|16-Hexadecanal|PLM|Palmitoyl aldehyde	-	DRUGBANK	DB03381	C16H32O	small molecule	-	629-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIOYUNMRJMEDGI-UHFFFAOYSA-N
21073	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3241	S-Oxy Cysteine	-	-	DRUGBANK	DB03382	C3H6NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLKIIDDWGJYRSN-REOHCLBHSA-N
21074	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3241	S-Oxy Cysteine	-	-	DRUGBANK	DB03382	C3H6NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLKIIDDWGJYRSN-REOHCLBHSA-N
21075	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3241	S-Oxy Cysteine	-	-	DRUGBANK	DB03382	C3H6NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLKIIDDWGJYRSN-REOHCLBHSA-N
21076	112530	6647	-	SOD1	ALS|ALS1|HEL-S-44|IPOA|SOD|hSod1|homodimer	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3241	S-Oxy Cysteine	-	-	DRUGBANK	DB03382	C3H6NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLKIIDDWGJYRSN-REOHCLBHSA-N
21077	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3242	5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide	-	-	DRUGBANK	DB03383	C23H23ClFN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDCGVASFVACWKF-NRFANRHFSA-N
21078	107290	840	RP11-211N11.6	CASP7	CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3243	Fica	-	-	DRUGBANK	DB03384	C11H11FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFUIHGAGFMFNRD-UHFFFAOYSA-N
21079	107290	840	RP11-211N11.6	CASP7	CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3243	Fica	-	-	DRUGBANK	DB03384	C11H11FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFUIHGAGFMFNRD-UHFFFAOYSA-N
21080	107290	840	RP11-211N11.6	CASP7	CASP-7|CMH-1|ICE-LAP3|LICE2|MCH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3243	Fica	-	-	DRUGBANK	DB03384	C11H11FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFUIHGAGFMFNRD-UHFFFAOYSA-N
21081	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21082	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21083	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21084	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21085	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21086	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21087	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21088	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3244	4-Methylimidazole	-	-	DRUGBANK	DB03385	C4H5N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21089	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3248	alpha-D-Xylopyranose	-	-	DRUGBANK	DB03389	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRBFZHDQGSBBOR-LECHCGJUSA-N
21090	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3249	N-Propyl-Tartramic Acid	-	-	DRUGBANK	DB03390	C7H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEZKQHJUNIZIS-CRCLSJGQSA-N
21091	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3249	N-Propyl-Tartramic Acid	-	-	DRUGBANK	DB03390	C7H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEZKQHJUNIZIS-CRCLSJGQSA-N
21092	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3251	(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester	-	-	DRUGBANK	DB03392	C8H18NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJBUJRWZZYUNKX-RLMOJYMMSA-N
21093	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3251	(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester	-	-	DRUGBANK	DB03392	C8H18NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJBUJRWZZYUNKX-RLMOJYMMSA-N
21094	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3251	(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester	-	-	DRUGBANK	DB03392	C8H18NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJBUJRWZZYUNKX-RLMOJYMMSA-N
21095	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3252	(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-	-	-	DRUGBANK	DB03393	C60H91N5O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONJZYZYZIKTIEG-PMMGGZNHSA-N
21096	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3252	(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-	-	-	DRUGBANK	DB03393	C60H91N5O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONJZYZYZIKTIEG-PMMGGZNHSA-N
21097	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3252	(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-	-	-	DRUGBANK	DB03393	C60H91N5O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONJZYZYZIKTIEG-PMMGGZNHSA-N
21098	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3253	Enalkiren	-	-	DRUGBANK	DB03395	C35H56N6O6	small molecule	-	113082-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXVERRYBYGQJZ-WRPDIKACSA-N
21099	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3254	(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide	-	-	DRUGBANK	DB03396	C18H32N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVBBTOIQETYGOA-JTPZDHBBSA-N
21100	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3254	(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide	-	-	DRUGBANK	DB03396	C18H32N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVBBTOIQETYGOA-JTPZDHBBSA-N
21101	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21102	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21103	112557	6675	-	UAP1	AGX|AGX1|AGX2|SPAG2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21104	112557	6675	-	UAP1	AGX|AGX1|AGX2|SPAG2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21105	852548	948246	b3730	glmU	ECK3723|JW3708|tms|yieA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21106	852548	948246	b3730	glmU	ECK3723|JW3708|tms|yieA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21107	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21108	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21109	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21110	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21111	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21112	110401	4245	-	MGAT1	GLCNAC-TI|GLCT1|GLYT1|GNT-1|GNT-I|MGAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21113	110401	4245	-	MGAT1	GLCNAC-TI|GLCT1|GLYT1|GNT-1|GNT-I|MGAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21114	110401	4245	-	MGAT1	GLCNAC-TI|GLCT1|GLYT1|GNT-1|GNT-I|MGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3255	Uridine-Diphosphate-N-Acetylglucosamine	-	-	DRUGBANK	DB03397	C17H27N3O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFTYTUAZOPRMMI-LSIJYXAZSA-N
21115	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3256	Ethyl Isocyanide	-	-	DRUGBANK	DB03399	C3H6N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEGVKBYNUPNGJU-UHFFFAOYSA-N
21116	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3256	Ethyl Isocyanide	-	-	DRUGBANK	DB03399	C3H6N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEGVKBYNUPNGJU-UHFFFAOYSA-N
21117	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3256	Ethyl Isocyanide	-	-	DRUGBANK	DB03399	C3H6N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEGVKBYNUPNGJU-UHFFFAOYSA-N
21118	112589	6711	-	SPTBN1	ELF|HEL102|SPTB2|betaSpII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21119	112589	6711	-	SPTBN1	ELF|HEL102|SPTB2|betaSpII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21120	112589	6711	-	SPTBN1	ELF|HEL102|SPTB2|betaSpII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21121	111349	5333	-	PLCD1	NDNC3|PLC-III	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21122	111349	5333	-	PLCD1	NDNC3|PLC-III	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21123	111349	5333	-	PLCD1	NDNC3|PLC-III	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21124	109911	3706	-	ITPKA	IP3-3KA|IP3KA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21125	109911	3706	-	ITPKA	IP3-3KA|IP3KA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21126	118965	29924	-	EPN1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21127	118965	29924	-	EPN1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21128	118965	29924	-	EPN1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21129	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21130	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21131	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21132	111894	5962	-	RDX	DFNB24	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21133	111894	5962	-	RDX	DFNB24	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21134	111894	5962	-	RDX	DFNB24	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21135	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21136	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21137	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3258	D-Myo-Inositol-1,4,5-Triphosphate	-	-	DRUGBANK	DB03401	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
21138	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21139	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21140	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21141	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21142	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21143	853291	949047	b3639	dfp	ECK3629|JW5642|coaBC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21144	853291	949047	b3639	dfp	ECK3629|JW5642|coaBC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21145	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21146	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3260	Cytidine-5'-Monophosphate	-	-	DRUGBANK	DB03403	C9H14N3O8P	small molecule	-	84-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IERHLVCPSMICTF-ZAKLUEHWSA-N
21150	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3262	1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N	-	-	DRUGBANK	DB03405	C32H42N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXENQLUSOCKXDN-ZONZVBGPSA-N
21151	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3262	1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N	-	-	DRUGBANK	DB03405	C32H42N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXENQLUSOCKXDN-ZONZVBGPSA-N
21152	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3262	1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N	-	-	DRUGBANK	DB03405	C32H42N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXENQLUSOCKXDN-ZONZVBGPSA-N
21153	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3265	gamma-Glutamylcysteine	gamma-L-Glutamyl-L-cysteine|5-L-Glutamyl-L-cysteine|L-gamma-Glutamylcysteine|GluCys|L-gamma-glutamyl-L-cysteine|Glu(-Cys)|gamma-Glu-Cys	-	DRUGBANK	DB03408	C8H14N2O5S	small molecule	-	636-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RITKHVBHSGLULN-WHFBIAKZSA-N
21154	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3265	gamma-Glutamylcysteine	gamma-L-Glutamyl-L-cysteine|5-L-Glutamyl-L-cysteine|L-gamma-Glutamylcysteine|GluCys|L-gamma-glutamyl-L-cysteine|Glu(-Cys)|gamma-Glu-Cys	-	DRUGBANK	DB03408	C8H14N2O5S	small molecule	-	636-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RITKHVBHSGLULN-WHFBIAKZSA-N
21155	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3265	gamma-Glutamylcysteine	gamma-L-Glutamyl-L-cysteine|5-L-Glutamyl-L-cysteine|L-gamma-Glutamylcysteine|GluCys|L-gamma-glutamyl-L-cysteine|Glu(-Cys)|gamma-Glu-Cys	-	DRUGBANK	DB03408	C8H14N2O5S	small molecule	-	636-58-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RITKHVBHSGLULN-WHFBIAKZSA-N
21156	108187	1854	-	DUT	dUTPase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3270	Deoxyuridine-5'-Diphosphate	-	-	DRUGBANK	DB03413	C9H14N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHWZTVCCBMIIKE-GKROBHDKSA-N
21157	108187	1854	-	DUT	dUTPase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3270	Deoxyuridine-5'-Diphosphate	-	-	DRUGBANK	DB03413	C9H14N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHWZTVCCBMIIKE-GKROBHDKSA-N
21158	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3270	Deoxyuridine-5'-Diphosphate	-	-	DRUGBANK	DB03413	C9H14N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHWZTVCCBMIIKE-GKROBHDKSA-N
21159	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3270	Deoxyuridine-5'-Diphosphate	-	-	DRUGBANK	DB03413	C9H14N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHWZTVCCBMIIKE-GKROBHDKSA-N
21160	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3271	5-Thio-a/B-D-Mannopyranosylamine	-	-	DRUGBANK	DB03414	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGVRMLQUWLZGLJ-VFUOTHLCSA-N
21161	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3271	5-Thio-a/B-D-Mannopyranosylamine	-	-	DRUGBANK	DB03414	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGVRMLQUWLZGLJ-VFUOTHLCSA-N
21162	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3271	5-Thio-a/B-D-Mannopyranosylamine	-	-	DRUGBANK	DB03414	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGVRMLQUWLZGLJ-VFUOTHLCSA-N
21163	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3272	3-Thiaoctanoyl-Coenzyme A	-	-	DRUGBANK	DB03415	C28H48N7O17P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMFXDZKFFYUOAN-AJHJKSEASA-N
21164	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3272	3-Thiaoctanoyl-Coenzyme A	-	-	DRUGBANK	DB03415	C28H48N7O17P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMFXDZKFFYUOAN-AJHJKSEASA-N
21165	106552	34	RP4-682C21.1	ACADM	ACAD1|MCAD|MCADH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3272	3-Thiaoctanoyl-Coenzyme A	-	-	DRUGBANK	DB03415	C28H48N7O17P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMFXDZKFFYUOAN-AJHJKSEASA-N
21166	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3273	Thiamin Phosphate	-	-	DRUGBANK	DB03416	C12H17N4O4PS	small molecule	-	532-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZSAJDVWZRBGIF-UHFFFAOYSA-N
21167	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3273	Thiamin Phosphate	-	-	DRUGBANK	DB03416	C12H17N4O4PS	small molecule	-	532-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZSAJDVWZRBGIF-UHFFFAOYSA-N
21168	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3274	1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid	-	-	DRUGBANK	DB03417	C18H33N7O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVNQCAHTTOIOEK-QWHCGFSZSA-N
21169	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3274	1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid	-	-	DRUGBANK	DB03417	C18H33N7O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVNQCAHTTOIOEK-QWHCGFSZSA-N
21170	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3274	1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid	-	-	DRUGBANK	DB03417	C18H33N7O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVNQCAHTTOIOEK-QWHCGFSZSA-N
21171	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21172	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21173	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21174	971411	2703370	HHV1gp004	UL2	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21175	971411	2703370	HHV1gp004	UL2	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21176	849754	945378	b2183	rsuA	ECK2177|JW2171|yejD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21177	849754	945378	b2183	rsuA	ECK2177|JW2171|yejD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21178	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21179	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21180	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3276	Uracil	-	-	DRUGBANK	DB03419	C4H4N2O2	small molecule	-	66-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISAKRJDGNUQOIC-UHFFFAOYSA-N
21181	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3281	Ubenimex	Bestatin	-	DRUGBANK	DB03424	C16H24N2O4	small molecule	-	58970-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGGGPCQERPFHOB-RDBSUJKOSA-N
21182	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3281	Ubenimex	Bestatin	-	DRUGBANK	DB03424	C16H24N2O4	small molecule	-	58970-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGGGPCQERPFHOB-RDBSUJKOSA-N
21183	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3282	2s,4r-4-Methylglutamate	-	-	DRUGBANK	DB03425	C6H12NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKRAOXTGDJWNI-IMJSIDKUSA-O
21184	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3282	2s,4r-4-Methylglutamate	-	-	DRUGBANK	DB03425	C6H12NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKRAOXTGDJWNI-IMJSIDKUSA-O
21185	109155	2898	-	GRIK2	EAA4|GLR6|GLUK6|GLUR6|GluK2|MRT6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3282	2s,4r-4-Methylglutamate	-	-	DRUGBANK	DB03425	C6H12NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKRAOXTGDJWNI-IMJSIDKUSA-O
21186	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21187	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21188	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21189	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21190	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21191	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3285	SU9516	-	-	DRUGBANK	DB03428	C13H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNUKRWAIZMBVCU-WCIBSUBMSA-N
21192	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3286	Cardiolipin	CDL|Diphosphatidyl Glycerol|Diphosphatidylglycerol	-	DRUGBANK	DB03429	C81H158O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVTUQDWPJJBEHJ-KZCWQMDCSA-N
21193	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3286	Cardiolipin	CDL|Diphosphatidyl Glycerol|Diphosphatidylglycerol	-	DRUGBANK	DB03429	C81H158O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVTUQDWPJJBEHJ-KZCWQMDCSA-N
21194	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3286	Cardiolipin	CDL|Diphosphatidyl Glycerol|Diphosphatidylglycerol	-	DRUGBANK	DB03429	C81H158O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVTUQDWPJJBEHJ-KZCWQMDCSA-N
21195	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3287	(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile	-	-	DRUGBANK	DB03430	C8H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOOPXDSCKBLFG-MRVPVSSYSA-N
21196	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3287	(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile	-	-	DRUGBANK	DB03430	C8H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOOPXDSCKBLFG-MRVPVSSYSA-N
21197	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3287	(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile	-	-	DRUGBANK	DB03430	C8H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOOOPXDSCKBLFG-MRVPVSSYSA-N
21198	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3290	3[N-Morpholino]Propane Sulfonic Acid	-	-	DRUGBANK	DB03434	C7H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVLFYONBTKHTER-UHFFFAOYSA-N
21199	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3290	3[N-Morpholino]Propane Sulfonic Acid	-	-	DRUGBANK	DB03434	C7H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVLFYONBTKHTER-UHFFFAOYSA-N
21200	115829	10578	-	GNLY	519|D2S69E|LAG-2|LAG2|NKG5|TLA519	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3290	3[N-Morpholino]Propane Sulfonic Acid	-	-	DRUGBANK	DB03434	C7H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVLFYONBTKHTER-UHFFFAOYSA-N
21201	115829	10578	-	GNLY	519|D2S69E|LAG-2|LAG2|NKG5|TLA519	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3290	3[N-Morpholino]Propane Sulfonic Acid	-	-	DRUGBANK	DB03434	C7H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVLFYONBTKHTER-UHFFFAOYSA-N
21202	852476	948169	b3656	yicI	ECK3646|JW3631	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3290	3[N-Morpholino]Propane Sulfonic Acid	-	-	DRUGBANK	DB03434	C7H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVLFYONBTKHTER-UHFFFAOYSA-N
21203	852476	948169	b3656	yicI	ECK3646|JW3631	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3290	3[N-Morpholino]Propane Sulfonic Acid	-	-	DRUGBANK	DB03434	C7H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DVLFYONBTKHTER-UHFFFAOYSA-N
21204	854907	937253	BSU37910	spsA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21205	854907	937253	BSU37910	spsA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21206	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21207	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21208	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21209	109247	2992	-	GYG1	GSD15|GYG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21210	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21211	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21212	117620	26229	-	B3GAT3	GLCATI|glcUAT-I	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21213	117620	26229	-	B3GAT3	GLCATI|glcUAT-I	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21214	849190	944789	b3786	wecB	ECK3778|JW5600|nfrC|rffE|yifF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21215	849190	944789	b3786	wecB	ECK3778|JW5600|nfrC|rffE|yifF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21216	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21217	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21218	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21219	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21220	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21221	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21222	108436	2135	-	EXTL2	EXTR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21223	117990	27087	-	B3GAT1	CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21224	117990	27087	-	B3GAT1	CD57|GLCATP|GLCUATP|HNK1|LEU7|NK-1|NK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21225	849733	945357	b0758	galT	ECK0747|JW0741|galB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21226	849733	945357	b0758	galT	ECK0747|JW0741|galB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21227	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21228	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21229	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3291	Uridine-5'-Diphosphate	-	-	DRUGBANK	DB03435	C9H14N2O12P2	small molecule	-	58-98-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCTYIAWTASOJW-ZAKLUEHWSA-N
21230	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	antagonist	target	Imming P (2006)	17016423	171742	3292	Gallichrome	-	-	DRUGBANK	DB03436	C28H44GaN9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEDMDXBTNSVNGS-NIAPTITASA-N
21231	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	antagonist	target	Clarke TE (2000)	10742172	181747	3292	Gallichrome	-	-	DRUGBANK	DB03436	C28H44GaN9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEDMDXBTNSVNGS-NIAPTITASA-N
21232	851827	947510	b0152	fhuD	ECK0151|JW0148	511145	Escherichia coli	antagonist	target	Overington JP (2006)	17139284	171741	3292	Gallichrome	-	-	DRUGBANK	DB03436	C28H44GaN9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEDMDXBTNSVNGS-NIAPTITASA-N
21233	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3293	2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid	-	-	DRUGBANK	DB03437	C14H19N5O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVNKGXXVZIQNIV-YWDVHJRKSA-N
21234	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3293	2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid	-	-	DRUGBANK	DB03437	C14H19N5O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVNKGXXVZIQNIV-YWDVHJRKSA-N
21235	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3295	4,6-Dideoxy-4-Amino-Alpha-D-Glucose	-	-	DRUGBANK	DB03439	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKBJEZZABBYBA-QYESYBIKSA-N
21236	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3295	4,6-Dideoxy-4-Amino-Alpha-D-Glucose	-	-	DRUGBANK	DB03439	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJKBJEZZABBYBA-QYESYBIKSA-N
21237	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3297	2-Benzyl-3-Iodopropanoic Acid	-	-	DRUGBANK	DB03441	C10H11IO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CRYXPGIJLMKFPX-VIFPVBQESA-N
21238	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3298	2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid	-	-	DRUGBANK	DB03442	C18H16N4O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQURKNIKJDEPW-FMQUCBEESA-N
21239	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3298	2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid	-	-	DRUGBANK	DB03442	C18H16N4O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQURKNIKJDEPW-FMQUCBEESA-N
21240	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3298	2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid	-	-	DRUGBANK	DB03442	C18H16N4O9S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQURKNIKJDEPW-FMQUCBEESA-N
21241	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3299	Bis(5-Amidino-Benzimidazolyl)Methanone Zinc	-	-	DRUGBANK	DB03443	C17H16N8OZn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21242	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3299	Bis(5-Amidino-Benzimidazolyl)Methanone Zinc	-	-	DRUGBANK	DB03443	C17H16N8OZn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21243	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3299	Bis(5-Amidino-Benzimidazolyl)Methanone Zinc	-	-	DRUGBANK	DB03443	C17H16N8OZn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21244	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3300	(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime	-	-	DRUGBANK	DB03444	C16H10BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLZLOKCJHBUHD-WAVHTBQISA-N
21245	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3303	Uridylyl-2'-5'-Phospho-Adenosine	-	-	DRUGBANK	DB03447	C19H24N7O12P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QARCCHXXGAIRFS-YZCDDZTHSA-N
21246	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3303	Uridylyl-2'-5'-Phospho-Adenosine	-	-	DRUGBANK	DB03447	C19H24N7O12P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QARCCHXXGAIRFS-YZCDDZTHSA-N
21247	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3303	Uridylyl-2'-5'-Phospho-Adenosine	-	-	DRUGBANK	DB03447	C19H24N7O12P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QARCCHXXGAIRFS-YZCDDZTHSA-N
21248	111967	6038	-	RNASE4	RAB1|RNS4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21249	111967	6038	-	RNASE4	RAB1|RNS4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21250	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21251	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21252	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3304	2'-Deoxyuridine 3'-Monophosphate	-	-	DRUGBANK	DB03448	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXKGKXYIAAKOCT-SHYZEUOFSA-N
21253	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3305	N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine	-	-	DRUGBANK	DB03449	C20H20ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVGLDBDDYESAB-UHFFFAOYSA-N
21254	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3305	N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine	-	-	DRUGBANK	DB03449	C20H20ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVGLDBDDYESAB-UHFFFAOYSA-N
21255	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3307	1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3	-	-	DRUGBANK	DB03451	C29H48O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLZOTDOJMRMLDX-UWVZFVHNSA-N
21256	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3307	1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3	-	-	DRUGBANK	DB03451	C29H48O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLZOTDOJMRMLDX-UWVZFVHNSA-N
21257	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3308	3-Trimethylsilylsuccinic Acid	-	-	DRUGBANK	DB03452	C7H14O4Si	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTXZCZFAAYFFKF-YFKPBYRVSA-N
21258	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3308	3-Trimethylsilylsuccinic Acid	-	-	DRUGBANK	DB03452	C7H14O4Si	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTXZCZFAAYFFKF-YFKPBYRVSA-N
21259	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3309	(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester	-	-	DRUGBANK	DB03453	C26H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRNGXYMKYHNMLV-XZOQPEGZSA-N
21260	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3309	(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester	-	-	DRUGBANK	DB03453	C26H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRNGXYMKYHNMLV-XZOQPEGZSA-N
21261	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3309	(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester	-	-	DRUGBANK	DB03453	C26H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRNGXYMKYHNMLV-XZOQPEGZSA-N
21262	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3311	(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid	-	-	DRUGBANK	DB03455	C12H14N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJAWIBGKKKXXAL-LLVKDONJSA-N
21263	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3312	N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide	-	-	DRUGBANK	DB03456	C19H26N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMTUSTXBVIALBC-SJORKVTESA-N
21264	107243	790	-	CAD	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3314	Sparfosic acid	PALA|N-(phosphonacetyl)-L-aspartic acid|phosphonoacetyl-L-aspartic acid|N-phosphonacetyl-L-aspartic acid|N-(phosphonoacetyl)-L-aspartic acid	-	DRUGBANK	DB03459	C6H10NO8P	small molecule	-	51321-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZKNRXZVGOYGJT-VKHMYHEASA-N
21265	107243	790	-	CAD	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3314	Sparfosic acid	PALA|N-(phosphonacetyl)-L-aspartic acid|phosphonoacetyl-L-aspartic acid|N-phosphonacetyl-L-aspartic acid|N-(phosphonoacetyl)-L-aspartic acid	-	DRUGBANK	DB03459	C6H10NO8P	small molecule	-	51321-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZKNRXZVGOYGJT-VKHMYHEASA-N
21266	107243	790	-	CAD	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3314	Sparfosic acid	PALA|N-(phosphonacetyl)-L-aspartic acid|phosphonoacetyl-L-aspartic acid|N-phosphonacetyl-L-aspartic acid|N-(phosphonoacetyl)-L-aspartic acid	-	DRUGBANK	DB03459	C6H10NO8P	small molecule	-	51321-79-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZKNRXZVGOYGJT-VKHMYHEASA-N
21267	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21268	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21269	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21270	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21271	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21272	113653	7923	DADB-100D22.4	HSD17B8	D6S2245E|FABG|FABGL|H2-KE6|HKE6|KE6|RING2|SDR30C1|dJ1033B10.9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21273	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21274	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21275	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21276	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21277	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21278	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21279	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21280	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21281	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21282	110363	4199	-	ME1	HUMNDME|MES	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21283	110363	4199	-	ME1	HUMNDME|MES	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21284	110363	4199	-	ME1	HUMNDME|MES	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21285	108523	2232	-	FDXR	ADXR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21286	107816	1429	-	CRYZ	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21287	107816	1429	-	CRYZ	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21288	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21289	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21290	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21291	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21292	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21293	121325	57016	-	AKR1B10	AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21294	852441	948134	b3619	hldD	ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21295	852441	948134	b3619	hldD	ECK3609|JW3594|gmhD|htrM|nbsB|rfaD|waaD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21296	850017	945645	b1093	fabG	ECK1079|JW1079	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21297	850017	945645	b1093	fabG	ECK1079|JW1079	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21298	108814	2539	-	G6PD	G6PD1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21299	108814	2539	-	G6PD	G6PD1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21300	116604	22949	RP11-16L21.1	PTGR1	LTB4DH|PGR1|ZADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21301	109643	3417	-	IDH1	HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21302	109643	3417	-	IDH1	HEL-216|HEL-S-26|IDCD|IDH|IDP|IDPC|PICD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21303	110355	4190	-	MDH1	HEL-S-32|MDH-s|MDHA|MGC:1375|MOR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21304	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21305	109525	3292	-	HSD17B1	EDH17B2|EDHB17|HSD17|SDR28C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21306	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21307	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21308	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21309	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21310	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21311	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21312	852088	947776	b3281	aroE	ECK3268|JW3242	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21313	852088	947776	b3281	aroE	ECK3268|JW3242	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21314	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21315	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21316	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21317	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21318	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21319	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21320	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21321	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21322	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21323	850910	946563	b2052	wcaG	ECK2046|JW2037|fcl|yefB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21324	850910	946563	b2052	wcaG	ECK2046|JW2037|fcl|yefB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21325	119357	51181	-	DCXR	DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21326	119357	51181	-	DCXR	DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21327	119357	51181	-	DCXR	DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21328	117076	23530	hCG_17428	NNT	GCCD4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21329	117076	23530	hCG_17428	NNT	GCCD4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21330	117076	23530	hCG_17428	NNT	GCCD4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21331	609057	728635	-	DHRS4L1	SDR25C4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21332	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21333	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21334	115610	10327	RP4-697E16.2	AKR1A1	ALDR1|ALR|ARM|DD3|HEL-S-6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21335	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21336	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21337	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21338	853178	948901	b4382	deoA	ECK4374|JW4345|TP|tpp|ttg	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3317	Thymine	-	-	DRUGBANK	DB03462	C5H6N2O2	small molecule	-	65-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWQNBRDOKXIBIV-UHFFFAOYSA-N
21339	853178	948901	b4382	deoA	ECK4374|JW4345|TP|tpp|ttg	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3317	Thymine	-	-	DRUGBANK	DB03462	C5H6N2O2	small molecule	-	65-71-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWQNBRDOKXIBIV-UHFFFAOYSA-N
21340	850857	946508	b1982	amn	ECK1977|JW1963	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3319	Formycin-5'-Monophosphate	-	-	DRUGBANK	DB03464	C10H13N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAUAPMASXALRIE-IGPDFVGCSA-N
21341	850857	946508	b1982	amn	ECK1977|JW1963	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3319	Formycin-5'-Monophosphate	-	-	DRUGBANK	DB03464	C10H13N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAUAPMASXALRIE-IGPDFVGCSA-N
21342	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3320	2-Phospho-D-Glyceric Acid	-	-	DRUGBANK	DB03465	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXIURPTVHJPJLF-UWTATZPHSA-N
21343	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3320	2-Phospho-D-Glyceric Acid	-	-	DRUGBANK	DB03465	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXIURPTVHJPJLF-UWTATZPHSA-N
21344	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3320	2-Phospho-D-Glyceric Acid	-	-	DRUGBANK	DB03465	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXIURPTVHJPJLF-UWTATZPHSA-N
21345	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3321	BMS184394	-	-	DRUGBANK	DB03466	C26H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYAJZQYENGWICE-QHCPKHFHSA-N
21346	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3321	BMS184394	-	-	DRUGBANK	DB03466	C26H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYAJZQYENGWICE-QHCPKHFHSA-N
21347	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3321	BMS184394	-	-	DRUGBANK	DB03466	C26H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYAJZQYENGWICE-QHCPKHFHSA-N
21348	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3323	1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide	-	-	DRUGBANK	DB03468	C9H12N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGLLZXSYRBMNOS-UHFFFAOYSA-N
21349	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3323	1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide	-	-	DRUGBANK	DB03468	C9H12N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGLLZXSYRBMNOS-UHFFFAOYSA-N
21350	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3323	1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide	-	-	DRUGBANK	DB03468	C9H12N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGLLZXSYRBMNOS-UHFFFAOYSA-N
21351	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3326	6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid	-	-	DRUGBANK	DB03471	C25H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMNHQYPORNSAQH-QHCPKHFHSA-N
21352	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3326	6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid	-	-	DRUGBANK	DB03471	C25H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMNHQYPORNSAQH-QHCPKHFHSA-N
21353	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3331	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	-	-	DRUGBANK	DB03476	C20H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRIWXVAIWPBEM-OALUTQOASA-N
21354	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3331	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	-	-	DRUGBANK	DB03476	C20H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRIWXVAIWPBEM-OALUTQOASA-N
21355	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3331	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	-	-	DRUGBANK	DB03476	C20H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQRIWXVAIWPBEM-OALUTQOASA-N
21356	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3332	1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole	-	-	DRUGBANK	DB03477	C16H11BrF3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYZKFVIVPRQRQQ-UHFFFAOYSA-N
21357	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3333	2'-O-Acetyl Adenosine-5-Diphosphoribose	-	-	DRUGBANK	DB03478	C17H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFNOPXRXIQJDHO-BVNNLCGGSA-N
21358	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3333	2'-O-Acetyl Adenosine-5-Diphosphoribose	-	-	DRUGBANK	DB03478	C17H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFNOPXRXIQJDHO-BVNNLCGGSA-N
21359	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3333	2'-O-Acetyl Adenosine-5-Diphosphoribose	-	-	DRUGBANK	DB03478	C17H25N5O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFNOPXRXIQJDHO-BVNNLCGGSA-N
21360	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3334	8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB03479	C9H14N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIUIMUSXAGXXON-QMGFNSACSA-N
21361	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3334	8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB03479	C9H14N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIUIMUSXAGXXON-QMGFNSACSA-N
21362	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3334	8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	-	-	DRUGBANK	DB03479	C9H14N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIUIMUSXAGXXON-QMGFNSACSA-N
21363	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3335	Brequinar Analog	-	-	DRUGBANK	DB03480	C23H16FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYKKHJQZENLZID-UHFFFAOYSA-N
21364	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3335	Brequinar Analog	-	-	DRUGBANK	DB03480	C23H16FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYKKHJQZENLZID-UHFFFAOYSA-N
21365	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3338	4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid	-	-	DRUGBANK	DB03483	C32H34F4N4O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJIWNECQGQOIKP-UBFVSLLYSA-N
21366	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3338	4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid	-	-	DRUGBANK	DB03483	C32H34F4N4O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJIWNECQGQOIKP-UBFVSLLYSA-N
21367	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3339	L-Alpha-Glycerophosphorylethanolamine	-	-	DRUGBANK	DB03484	C5H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZNWSCPGTDBMEW-YFKPBYRVSA-N
21368	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3339	L-Alpha-Glycerophosphorylethanolamine	-	-	DRUGBANK	DB03484	C5H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZNWSCPGTDBMEW-YFKPBYRVSA-N
21369	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3339	L-Alpha-Glycerophosphorylethanolamine	-	-	DRUGBANK	DB03484	C5H14NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZNWSCPGTDBMEW-YFKPBYRVSA-N
21370	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3340	Alpha-D-Fucose	-	-	DRUGBANK	DB03485	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-PHYPRBDBSA-N
21371	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3340	Alpha-D-Fucose	-	-	DRUGBANK	DB03485	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-PHYPRBDBSA-N
21372	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3340	Alpha-D-Fucose	-	-	DRUGBANK	DB03485	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-PHYPRBDBSA-N
21373	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3340	Alpha-D-Fucose	-	-	DRUGBANK	DB03485	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-PHYPRBDBSA-N
21374	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3340	Alpha-D-Fucose	-	-	DRUGBANK	DB03485	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-PHYPRBDBSA-N
21375	125875	124583	-	CANT1	DBQD|SCAN-1|SCAN1|SHAPY	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3341	Phosphomethylphosphonic Acid Guanosyl Ester	-	-	DRUGBANK	DB03486	C11H17N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCJWYBKRHNXUME-FCIPNVEPSA-N
21376	125875	124583	-	CANT1	DBQD|SCAN-1|SCAN1|SHAPY	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3341	Phosphomethylphosphonic Acid Guanosyl Ester	-	-	DRUGBANK	DB03486	C11H17N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCJWYBKRHNXUME-FCIPNVEPSA-N
21377	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3342	3-Aminosuccinimide	-	-	DRUGBANK	DB03487	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDNMHDRXNOHCJH-UWTATZPHSA-N
21378	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3342	3-Aminosuccinimide	-	-	DRUGBANK	DB03487	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDNMHDRXNOHCJH-UWTATZPHSA-N
21379	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3342	3-Aminosuccinimide	-	-	DRUGBANK	DB03487	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDNMHDRXNOHCJH-UWTATZPHSA-N
21380	850750	946393	b1882	cheY	ECK1883|JW1871	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3342	3-Aminosuccinimide	-	-	DRUGBANK	DB03487	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDNMHDRXNOHCJH-UWTATZPHSA-N
21381	850750	946393	b1882	cheY	ECK1883|JW1871	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3342	3-Aminosuccinimide	-	-	DRUGBANK	DB03487	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDNMHDRXNOHCJH-UWTATZPHSA-N
21382	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3343	Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-Alpha-D-Galactose	-	-	DRUGBANK	DB03488	C15H23FN2O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGTCPFGWXMBZEP-IRCXUGDUSA-N
21383	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3343	Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-Alpha-D-Galactose	-	-	DRUGBANK	DB03488	C15H23FN2O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGTCPFGWXMBZEP-IRCXUGDUSA-N
21384	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3345	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	-	-	DRUGBANK	DB03490	C15H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHOACLCXCKJMAK-UHFFFAOYSA-N
21385	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3345	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	-	-	DRUGBANK	DB03490	C15H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHOACLCXCKJMAK-UHFFFAOYSA-N
21386	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3345	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	-	-	DRUGBANK	DB03490	C15H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHOACLCXCKJMAK-UHFFFAOYSA-N
21387	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3346	2'-Deoxyguanosine-5'-Diphosphate	-	-	DRUGBANK	DB03491	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIKGWCTVFSRMJU-NGJCXOISSA-N
21388	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3346	2'-Deoxyguanosine-5'-Diphosphate	-	-	DRUGBANK	DB03491	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIKGWCTVFSRMJU-NGJCXOISSA-N
21389	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3346	2'-Deoxyguanosine-5'-Diphosphate	-	-	DRUGBANK	DB03491	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIKGWCTVFSRMJU-NGJCXOISSA-N
21390	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3349	CRA_10950	-	-	DRUGBANK	DB03494	C18H19FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSUDDASMRZSVON-UHFFFAOYSA-N
21391	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21392	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21393	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21394	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21395	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21396	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21397	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21398	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21399	107458	1024	-	CDK8	K35	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21400	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21401	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Zvelebil MJ (1998)	18465538	182075	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21402	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21403	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3351	Flavopiridol	Alvocidib freebase|Alvocidib	-	DRUGBANK	DB03496	C21H20ClNO5	small molecule	-	146426-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIIVYFLTOXDAOV-YVEFUNNKSA-N
21404	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3353	Mercaptomethyl Phosphonate	-	-	DRUGBANK	DB03498	CH3O3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZCELCYTRONIX-UHFFFAOYSA-L
21405	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3353	Mercaptomethyl Phosphonate	-	-	DRUGBANK	DB03498	CH3O3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZCELCYTRONIX-UHFFFAOYSA-L
21406	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21407	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21408	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21409	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21410	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21411	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21412	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3354	Malate Ion	-	-	DRUGBANK	DB03499	C4H5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJEPYKJPYRNKOW-UWTATZPHSA-M
21413	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Thoden JB (2001)	11279193	54231	3356	Galactose-uridine-5'-diphosphate	UDP-D-galactopyranose|UDP-galactose|UDP--D-galactose|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-D-galactose|Uridine pyrophosphogalactose|UDP--D-galactopyranose|Uridine diphosphategalactose|Uridine diphosphate galactose|UDP galactose	-	DRUGBANK	DB03501	C15H24N2O17P2	small molecule	-	2956-16-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-ABVWGUQPSA-N
21414	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3356	Galactose-uridine-5'-diphosphate	UDP-D-galactopyranose|UDP-galactose|UDP--D-galactose|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-D-galactose|Uridine pyrophosphogalactose|UDP--D-galactopyranose|Uridine diphosphategalactose|Uridine diphosphate galactose|UDP galactose	-	DRUGBANK	DB03501	C15H24N2O17P2	small molecule	-	2956-16-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-ABVWGUQPSA-N
21415	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Ramakrishnan B (2002)	12051854	181794	3356	Galactose-uridine-5'-diphosphate	UDP-D-galactopyranose|UDP-galactose|UDP--D-galactose|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-D-galactose|Uridine pyrophosphogalactose|UDP--D-galactopyranose|Uridine diphosphategalactose|Uridine diphosphate galactose|UDP galactose	-	DRUGBANK	DB03501	C15H24N2O17P2	small molecule	-	2956-16-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-ABVWGUQPSA-N
21416	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Nguyen HP (2003)	12972418	181831	3356	Galactose-uridine-5'-diphosphate	UDP-D-galactopyranose|UDP-galactose|UDP--D-galactose|Uridinediphosphogalactose|UDPgal|Uridine diphosphogalactose|UDP-alpha-D-galactose|Uridine pyrophosphogalactose|UDP--D-galactopyranose|Uridine diphosphategalactose|Uridine diphosphate galactose|UDP galactose	-	DRUGBANK	DB03501	C15H24N2O17P2	small molecule	-	2956-16-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-ABVWGUQPSA-N
21417	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3359	9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03504	C19H24ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVPCTHKPOPQMSX-UHFFFAOYSA-N
21418	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3361	9-Deazaadenine	-	-	DRUGBANK	DB03506	C6H5N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSTZHXCJJATBAC-UHFFFAOYSA-N
21419	112986	7132	-	TNFRSF1A	CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3362	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	-	-	DRUGBANK	DB03507	C21H20N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXGUZFZBZPPZGL-UHFFFAOYSA-N
21420	112986	7132	-	TNFRSF1A	CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3362	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	-	-	DRUGBANK	DB03507	C21H20N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXGUZFZBZPPZGL-UHFFFAOYSA-N
21421	112986	7132	-	TNFRSF1A	CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3362	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	-	-	DRUGBANK	DB03507	C21H20N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXGUZFZBZPPZGL-UHFFFAOYSA-N
21422	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3364	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	-	-	DRUGBANK	DB03509	C15H10ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLYGLPYJEQPCFY-UHFFFAOYSA-N
21423	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3364	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	-	-	DRUGBANK	DB03509	C15H10ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLYGLPYJEQPCFY-UHFFFAOYSA-N
21424	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3364	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	-	-	DRUGBANK	DB03509	C15H10ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLYGLPYJEQPCFY-UHFFFAOYSA-N
21425	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3365	6-O-Phosphoryl Inosine Monophosphate	-	-	DRUGBANK	DB03510	C10H14N4O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXRZOKQPANIEDW-FCIPNVEPSA-N
21426	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3365	6-O-Phosphoryl Inosine Monophosphate	-	-	DRUGBANK	DB03510	C10H14N4O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXRZOKQPANIEDW-FCIPNVEPSA-N
21427	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3365	6-O-Phosphoryl Inosine Monophosphate	-	-	DRUGBANK	DB03510	C10H14N4O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXRZOKQPANIEDW-FCIPNVEPSA-N
21428	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3367	Uridine-2',3'-Vanadate	-	-	DRUGBANK	DB03512	C9H12N2O9V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSPAHXDHRUTBDP-VKTKOMAXSA-L
21429	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3367	Uridine-2',3'-Vanadate	-	-	DRUGBANK	DB03512	C9H12N2O9V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSPAHXDHRUTBDP-VKTKOMAXSA-L
21430	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3367	Uridine-2',3'-Vanadate	-	-	DRUGBANK	DB03512	C9H12N2O9V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSPAHXDHRUTBDP-VKTKOMAXSA-L
21431	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Porter DJ (1994)	7961725	181691	3371	Eniluracil	5-Ethynyluracil|5-ethynyl-2,4(1H,3H)-Pyrimidinedione|Compound 776C	-	DRUGBANK	DB03516	C6H4N2O2	small molecule	-	59989-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOZGNYDSEBIJDH-UHFFFAOYSA-N
21432	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Czito BG (2006)	16466986	181929	3371	Eniluracil	5-Ethynyluracil|5-ethynyl-2,4(1H,3H)-Pyrimidinedione|Compound 776C	-	DRUGBANK	DB03516	C6H4N2O2	small molecule	-	59989-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOZGNYDSEBIJDH-UHFFFAOYSA-N
21433	106813	316	-	AOX1	AO|AOH1	9606	Homo sapiens	unknown	target	Porter DJ (1994)	8161345	181694	3371	Eniluracil	5-Ethynyluracil|5-ethynyl-2,4(1H,3H)-Pyrimidinedione|Compound 776C	-	DRUGBANK	DB03516	C6H4N2O2	small molecule	-	59989-18-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOZGNYDSEBIJDH-UHFFFAOYSA-N
21434	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3374	2-Amino-Pentanoic Acid	-	-	DRUGBANK	DB03519	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
21435	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3374	2-Amino-Pentanoic Acid	-	-	DRUGBANK	DB03519	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
21436	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3377	Brequinar	6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid	-	DRUGBANK	DB03523	C23H15F2NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHEZJEYUWHETKO-UHFFFAOYSA-N
21437	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3377	Brequinar	6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid	-	DRUGBANK	DB03523	C23H15F2NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHEZJEYUWHETKO-UHFFFAOYSA-N
21438	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3377	Brequinar	6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid	-	DRUGBANK	DB03523	C23H15F2NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHEZJEYUWHETKO-UHFFFAOYSA-N
21439	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3379	RU79073	-	-	DRUGBANK	DB03525	C9H12NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSJSAHCLJYVEDM-UHFFFAOYSA-N
21440	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3380	AL5927	-	-	DRUGBANK	DB03526	C12H14N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRRAIRJIZOLGPR-UHFFFAOYSA-N
21441	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3380	AL5927	-	-	DRUGBANK	DB03526	C12H14N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRRAIRJIZOLGPR-UHFFFAOYSA-N
21442	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3380	AL5927	-	-	DRUGBANK	DB03526	C12H14N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRRAIRJIZOLGPR-UHFFFAOYSA-N
21443	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3381	9-Beta-D-Xylofuranosyl-Adenine	-	-	DRUGBANK	DB03528	C10H13N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-FCIPNVEPSA-N
21444	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3381	9-Beta-D-Xylofuranosyl-Adenine	-	-	DRUGBANK	DB03528	C10H13N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-FCIPNVEPSA-N
21445	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3382	Acylated Ceftazidime	-	-	DRUGBANK	DB03530	C17H19N5O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEHPZKIFULQYFS-BQFDAFGASA-N
21446	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3382	Acylated Ceftazidime	-	-	DRUGBANK	DB03530	C17H19N5O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEHPZKIFULQYFS-BQFDAFGASA-N
21447	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3383	Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone	-	-	DRUGBANK	DB03531	C31H39N9O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVZGWZAMSAFRNS-UUVTYHGUSA-N
21448	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3383	Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone	-	-	DRUGBANK	DB03531	C31H39N9O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVZGWZAMSAFRNS-UUVTYHGUSA-N
21449	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3383	Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone	-	-	DRUGBANK	DB03531	C31H39N9O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVZGWZAMSAFRNS-UUVTYHGUSA-N
21450	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3386	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	-	-	DRUGBANK	DB03534	C22H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWTBJNJPBKTHEV-UHFFFAOYSA-N
21451	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3386	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	-	-	DRUGBANK	DB03534	C22H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWTBJNJPBKTHEV-UHFFFAOYSA-N
21452	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3386	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	-	-	DRUGBANK	DB03534	C22H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWTBJNJPBKTHEV-UHFFFAOYSA-N
21453	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3387	Z-Pro-Prolinal	-	-	DRUGBANK	DB03535	C18H22N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORZXYSPOAVJYRU-HOTGVXAUSA-N
21454	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3388	Benzoyl-Arginine-Alanine-Methyl Ketone	-	-	DRUGBANK	DB03536	C18H29N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLLMMFWUJVANSC-WFASDCNBSA-N
21455	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3390	2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose	-	-	DRUGBANK	DB03539	C8H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJMIXNAZGREWGZ-REQIZBSHSA-N
21456	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3390	2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose	-	-	DRUGBANK	DB03539	C8H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJMIXNAZGREWGZ-REQIZBSHSA-N
21457	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3392	10-Propargyl-5,8-Dideazafolic Acid	-	-	DRUGBANK	DB03541	C24H23N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTKHPMDRMUCUEB-IBGZPJMESA-N
21458	609057	728635	-	DHRS4L1	SDR25C4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3392	10-Propargyl-5,8-Dideazafolic Acid	-	-	DRUGBANK	DB03541	C24H23N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTKHPMDRMUCUEB-IBGZPJMESA-N
21459	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3392	10-Propargyl-5,8-Dideazafolic Acid	-	-	DRUGBANK	DB03541	C24H23N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTKHPMDRMUCUEB-IBGZPJMESA-N
21460	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3392	10-Propargyl-5,8-Dideazafolic Acid	-	-	DRUGBANK	DB03541	C24H23N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTKHPMDRMUCUEB-IBGZPJMESA-N
21461	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3392	10-Propargyl-5,8-Dideazafolic Acid	-	-	DRUGBANK	DB03541	C24H23N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTKHPMDRMUCUEB-IBGZPJMESA-N
21462	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3392	10-Propargyl-5,8-Dideazafolic Acid	-	-	DRUGBANK	DB03541	C24H23N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTKHPMDRMUCUEB-IBGZPJMESA-N
21463	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3393	L-Myo-Inositol-1-Phosphate	-	-	DRUGBANK	DB03542	C6H11O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INAPMGSXUVUWAF-CDRYSYESSA-L
21464	109825	3612	-	IMPA1	IMP|IMPA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3393	L-Myo-Inositol-1-Phosphate	-	-	DRUGBANK	DB03542	C6H11O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INAPMGSXUVUWAF-CDRYSYESSA-L
21465	849893	945519	b1262	trpC	ECK1256|JW1254|trpF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3394	1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate	-	-	DRUGBANK	DB03543	C12H18NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AULMJMUNCOBRHC-HBNTYKKESA-N
21466	849893	945519	b1262	trpC	ECK1256|JW1254|trpF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3394	1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate	-	-	DRUGBANK	DB03543	C12H18NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AULMJMUNCOBRHC-HBNTYKKESA-N
21467	849715	945339	b1738	chbB	ECK1736|JW1727|celA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3395	S-Phosphocysteine	-	-	DRUGBANK	DB03544	C3H8NO5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNEMQJJMDDZXRO-REOHCLBHSA-N
21468	849715	945339	b1738	chbB	ECK1736|JW1727|celA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3395	S-Phosphocysteine	-	-	DRUGBANK	DB03544	C3H8NO5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNEMQJJMDDZXRO-REOHCLBHSA-N
21469	853058	948771	b4243	ridA	ECK4238|JW5755|yjgF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3395	S-Phosphocysteine	-	-	DRUGBANK	DB03544	C3H8NO5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNEMQJJMDDZXRO-REOHCLBHSA-N
21470	853058	948771	b4243	ridA	ECK4238|JW5755|yjgF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3395	S-Phosphocysteine	-	-	DRUGBANK	DB03544	C3H8NO5PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNEMQJJMDDZXRO-REOHCLBHSA-N
21471	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3396	10-CF3C(OH)2-DDACTHF	Hydrolyzed Form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB03546	C22H30F3N5O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOLDLUFBEMUZIM-WUAYEBGVSA-N
21472	108888	2618	-	GART	AIRS|GARS|GARTF|PAIS|PGFT|PRGS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3396	10-CF3C(OH)2-DDACTHF	Hydrolyzed Form of 10-trifluoroacetyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB03546	C22H30F3N5O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOLDLUFBEMUZIM-WUAYEBGVSA-N
21473	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3397	3-Deoxy-D-Manno-Oct-2-Ulosonic Acid	-	-	DRUGBANK	DB03548	C8H14O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNLZBVFSCVTSLA-JDSYOCTRSA-N
21474	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3397	3-Deoxy-D-Manno-Oct-2-Ulosonic Acid	-	-	DRUGBANK	DB03548	C8H14O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNLZBVFSCVTSLA-JDSYOCTRSA-N
21475	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3400	4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol	-	-	DRUGBANK	DB03551	C12H18N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFVGWLHAOKEIOJ-VPOLOUISSA-N
21476	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3400	4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol	-	-	DRUGBANK	DB03551	C12H18N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFVGWLHAOKEIOJ-VPOLOUISSA-N
21477	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3401	Meta-Tyrosine	-	-	DRUGBANK	DB03552	C9H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZKXXXDKRQWDET-QMMMGPOBSA-N
21478	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3401	Meta-Tyrosine	-	-	DRUGBANK	DB03552	C9H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZKXXXDKRQWDET-QMMMGPOBSA-N
21479	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3401	Meta-Tyrosine	-	-	DRUGBANK	DB03552	C9H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZKXXXDKRQWDET-QMMMGPOBSA-N
21480	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3402	Glutaric Acid	-	-	DRUGBANK	DB03553	C5H8O4	small molecule	-	110-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFCQEDHGNNZCLN-UHFFFAOYSA-N
21481	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3402	Glutaric Acid	-	-	DRUGBANK	DB03553	C5H8O4	small molecule	-	110-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFCQEDHGNNZCLN-UHFFFAOYSA-N
21482	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3402	Glutaric Acid	-	-	DRUGBANK	DB03553	C5H8O4	small molecule	-	110-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFCQEDHGNNZCLN-UHFFFAOYSA-N
21483	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3402	Glutaric Acid	-	-	DRUGBANK	DB03553	C5H8O4	small molecule	-	110-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFCQEDHGNNZCLN-UHFFFAOYSA-N
21484	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3403	5-Iodouracil	-	-	DRUGBANK	DB03554	C4H3IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSNXJLQDQOIRIP-UHFFFAOYSA-N
21485	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3403	5-Iodouracil	-	-	DRUGBANK	DB03554	C4H3IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSNXJLQDQOIRIP-UHFFFAOYSA-N
21486	108140	1806	-	DPYD	DHP|DHPDHASE|DPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3403	5-Iodouracil	-	-	DRUGBANK	DB03554	C4H3IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSNXJLQDQOIRIP-UHFFFAOYSA-N
21487	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3404	CRA_11092	-	-	DRUGBANK	DB03555	C21H22FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21488	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3404	CRA_11092	-	-	DRUGBANK	DB03555	C21H22FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21489	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3404	CRA_11092	-	-	DRUGBANK	DB03555	C21H22FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21490	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3406	N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid	-	-	DRUGBANK	DB03557	C32H41F4N5O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKZDIBIDJQPGC-WXFUMESZSA-N
21491	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3406	N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid	-	-	DRUGBANK	DB03557	C32H41F4N5O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKZDIBIDJQPGC-WXFUMESZSA-N
21492	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3407	Sp-876	-	-	DRUGBANK	DB03558	C20H25N3O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRAHBOKVSSZEHQ-CABCVRRESA-N
21493	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3407	Sp-876	-	-	DRUGBANK	DB03558	C20H25N3O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRAHBOKVSSZEHQ-CABCVRRESA-N
21494	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3408	Cyclohexylformamide	-	-	DRUGBANK	DB03559	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGXDLRCJNEEGZ-UHFFFAOYSA-N
21495	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3408	Cyclohexylformamide	-	-	DRUGBANK	DB03559	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGXDLRCJNEEGZ-UHFFFAOYSA-N
21496	106639	127	-	ADH4	ADH-2|HEL-S-4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3408	Cyclohexylformamide	-	-	DRUGBANK	DB03559	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGXDLRCJNEEGZ-UHFFFAOYSA-N
21497	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3408	Cyclohexylformamide	-	-	DRUGBANK	DB03559	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGXDLRCJNEEGZ-UHFFFAOYSA-N
21498	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3408	Cyclohexylformamide	-	-	DRUGBANK	DB03559	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGXDLRCJNEEGZ-UHFFFAOYSA-N
21499	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3408	Cyclohexylformamide	-	-	DRUGBANK	DB03559	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGXDLRCJNEEGZ-UHFFFAOYSA-N
21503	855531	937885	BSU25300	cdd	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3411	Tetrahydrodeoxyuridine	-	-	DRUGBANK	DB03562	C9H14N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMJRLEURHMTTRX-BBVRLYRLSA-N
21504	855531	937885	BSU25300	cdd	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3411	Tetrahydrodeoxyuridine	-	-	DRUGBANK	DB03562	C9H14N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMJRLEURHMTTRX-BBVRLYRLSA-N
21507	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3414	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	-	-	DRUGBANK	DB03565	C20H45NO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCCNUBYROFOKAU-FQEVSTJZSA-N
21508	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3414	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	-	-	DRUGBANK	DB03565	C20H45NO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCCNUBYROFOKAU-FQEVSTJZSA-N
21509	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3414	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	-	-	DRUGBANK	DB03565	C20H45NO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCCNUBYROFOKAU-FQEVSTJZSA-N
21510	850054	945682	b1123	potD	ECK1109|JW1109	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21511	850054	945682	b1123	potD	ECK1109|JW1109	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21512	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21513	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21514	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3415	Spermidine	1,5,10-Triazadecane|4-Azaoctane-1,8-diamine|N-(3-Aminopropyl)-1,4-butanediamine|N-(3-Aminopropyl)-1,4-diaminobutane|Spermidin|N-(3-aminopropyl)butane-1,4-diamine|N-(3-Aminopropyl)-1,4-butane-diamine|1,8-Diamino-4-azaoctane	-	DRUGBANK	DB03566	C7H19N3	small molecule	-	124-20-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATHGHQPFGPMSJY-UHFFFAOYSA-N
21515	854094	936411	BSU11660	tenI	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3419	Tris-Hydroxymethyl-Methyl-Ammonium	-	-	DRUGBANK	DB03570	C4H12NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRDCQJADRSJFFD-UHFFFAOYSA-N
21516	854094	936411	BSU11660	tenI	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3419	Tris-Hydroxymethyl-Methyl-Ammonium	-	-	DRUGBANK	DB03570	C4H12NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRDCQJADRSJFFD-UHFFFAOYSA-N
21517	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3421	FR230513	-	-	DRUGBANK	DB03572	C18H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URGFTPMACWKJKU-OAHLLOKOSA-N
21518	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3422	WRR-99	-	-	DRUGBANK	DB03573	C19H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVZMXOVSHIMGNA-CVEARBPZSA-N
21519	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3423	Ferricrocin-Iron	-	-	DRUGBANK	DB03574	C28H44FeN9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNBCUYMSQPYITB-WESVPMFNSA-N
21520	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3423	Ferricrocin-Iron	-	-	DRUGBANK	DB03574	C28H44FeN9O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNBCUYMSQPYITB-WESVPMFNSA-N
21521	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21522	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21523	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21524	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	3424	Phencyclidine	1-(1-Phenylcyclohexyl)piperidine|PCP	-	DRUGBANK	DB03575	C17H25N	small molecule	-	77-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJMJGYZQZDUJJ-UHFFFAOYSA-N
21525	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3426	Alpha-Benzyl-Aminobenzyl-Phosphonic Acid	-	-	DRUGBANK	DB03577	C14H16NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLMGIUOAZCYKPE-CQSZACIVSA-N
21526	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3426	Alpha-Benzyl-Aminobenzyl-Phosphonic Acid	-	-	DRUGBANK	DB03577	C14H16NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLMGIUOAZCYKPE-CQSZACIVSA-N
21527	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3426	Alpha-Benzyl-Aminobenzyl-Phosphonic Acid	-	-	DRUGBANK	DB03577	C14H16NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLMGIUOAZCYKPE-CQSZACIVSA-N
21528	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3429	Glucose-6-Phosphate	-	-	DRUGBANK	DB03581	C6H13O9P	small molecule	-	56-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFRROHXSMXFLSN-KCDKBNATSA-N
21529	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3429	Glucose-6-Phosphate	-	-	DRUGBANK	DB03581	C6H13O9P	small molecule	-	56-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFRROHXSMXFLSN-KCDKBNATSA-N
21530	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3429	Glucose-6-Phosphate	-	-	DRUGBANK	DB03581	C6H13O9P	small molecule	-	56-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFRROHXSMXFLSN-KCDKBNATSA-N
21531	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3429	Glucose-6-Phosphate	-	-	DRUGBANK	DB03581	C6H13O9P	small molecule	-	56-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFRROHXSMXFLSN-KCDKBNATSA-N
21532	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3429	Glucose-6-Phosphate	-	-	DRUGBANK	DB03581	C6H13O9P	small molecule	-	56-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFRROHXSMXFLSN-KCDKBNATSA-N
21533	850618	946259	b1745	astB	ECK1743|JW1734|ydjT	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3430	N~2~-Succinylornithine	-	-	DRUGBANK	DB03582	C9H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWXQFHJBQHTHMK-ZCFIWIBFSA-N
21534	850618	946259	b1745	astB	ECK1743|JW1734|ydjT	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3430	N~2~-Succinylornithine	-	-	DRUGBANK	DB03582	C9H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWXQFHJBQHTHMK-ZCFIWIBFSA-N
21535	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3431	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	-	-	DRUGBANK	DB03583	C22H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYOAIABDFUJDKQ-SQJPUDIVSA-N
21536	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3431	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	-	-	DRUGBANK	DB03583	C22H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYOAIABDFUJDKQ-SQJPUDIVSA-N
21537	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3431	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	-	-	DRUGBANK	DB03583	C22H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYOAIABDFUJDKQ-SQJPUDIVSA-N
21538	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3433	Oxyphenbutazone	Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona	oxybutazone tab 100mg|oxyphenb	DRUGBANK	DB03585	C19H20N2O3	small molecule	S01BC02|M01AA03|M02AA04	129-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFHZKZSRXITVMK-UHFFFAOYSA-N
21539	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3433	Oxyphenbutazone	Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona	oxybutazone tab 100mg|oxyphenb	DRUGBANK	DB03585	C19H20N2O3	small molecule	S01BC02|M01AA03|M02AA04	129-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFHZKZSRXITVMK-UHFFFAOYSA-N
21540	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3433	Oxyphenbutazone	Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona	oxybutazone tab 100mg|oxyphenb	DRUGBANK	DB03585	C19H20N2O3	small molecule	S01BC02|M01AA03|M02AA04	129-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFHZKZSRXITVMK-UHFFFAOYSA-N
21541	852476	948169	b3656	yicI	ECK3646|JW3631	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3434	5(R)-5-Fluoro-Beta-D-Xylopyranosyl-Enzyme Intermediate	-	-	DRUGBANK	DB03586	C5H8FO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSWSGZBYLQUXQI-VQOCEVNASA-N
21542	852476	948169	b3656	yicI	ECK3646|JW3631	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3434	5(R)-5-Fluoro-Beta-D-Xylopyranosyl-Enzyme Intermediate	-	-	DRUGBANK	DB03586	C5H8FO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSWSGZBYLQUXQI-VQOCEVNASA-N
21543	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3435	Pyruvoyl Group	-	-	DRUGBANK	DB03587	C3H4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIJULSRZWUXGPQ-UHFFFAOYSA-N
21544	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3435	Pyruvoyl Group	-	-	DRUGBANK	DB03587	C3H4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIJULSRZWUXGPQ-UHFFFAOYSA-N
21545	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3435	Pyruvoyl Group	-	-	DRUGBANK	DB03587	C3H4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIJULSRZWUXGPQ-UHFFFAOYSA-N
21546	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21547	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21548	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3436	Diphenylacetic Acid	-	-	DRUGBANK	DB03588	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYHXGXCGESYPCW-UHFFFAOYSA-N
21549	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3437	Alpha-Ketomalonic Acid	-	-	DRUGBANK	DB03589	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEEVLJKYYUVTRC-UHFFFAOYSA-N
21550	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3437	Alpha-Ketomalonic Acid	-	-	DRUGBANK	DB03589	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEEVLJKYYUVTRC-UHFFFAOYSA-N
21551	849192	944791	b0085	murE	ECK0086|JW0083	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3438	2,6-Diaminopimelic Acid	-	-	DRUGBANK	DB03590	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMKMEZVLHJARHF-WHFBIAKZSA-N
21552	849192	944791	b0085	murE	ECK0086|JW0083	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3438	2,6-Diaminopimelic Acid	-	-	DRUGBANK	DB03590	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMKMEZVLHJARHF-WHFBIAKZSA-N
21553	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3439	RU82209	-	-	DRUGBANK	DB03591	C31H34F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVZDQVATAQEMCX-IZLXSDGUSA-N
21554	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3439	RU82209	-	-	DRUGBANK	DB03591	C31H34F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVZDQVATAQEMCX-IZLXSDGUSA-N
21555	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3439	RU82209	-	-	DRUGBANK	DB03591	C31H34F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVZDQVATAQEMCX-IZLXSDGUSA-N
21556	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3441	N7-Methyl-Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB03593	C11H17N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOKQNZVJJXPUQA-FCIPNVEPSA-O
21557	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3441	N7-Methyl-Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB03593	C11H17N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOKQNZVJJXPUQA-FCIPNVEPSA-O
21558	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3442	1,2,4-Triazole	-	-	DRUGBANK	DB03594	C2H2N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21559	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3442	1,2,4-Triazole	-	-	DRUGBANK	DB03594	C2H2N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21560	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3443	CRA_9785	-	-	DRUGBANK	DB03595	C15H11F3N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJUALJXOBAXGBO-UHFFFAOYSA-N
21561	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3444	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03596	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSRPBGBMEKDSIJ-CYBMUJFWSA-N
21562	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3444	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03596	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSRPBGBMEKDSIJ-CYBMUJFWSA-N
21563	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3444	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03596	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSRPBGBMEKDSIJ-CYBMUJFWSA-N
21564	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3445	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	-	-	DRUGBANK	DB03597	C17H22IN3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFYJAEOZTBVJQM-QWHCGFSZSA-N
21565	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3445	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	-	-	DRUGBANK	DB03597	C17H22IN3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFYJAEOZTBVJQM-QWHCGFSZSA-N
21566	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3445	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	-	-	DRUGBANK	DB03597	C17H22IN3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFYJAEOZTBVJQM-QWHCGFSZSA-N
21567	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3445	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	-	-	DRUGBANK	DB03597	C17H22IN3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFYJAEOZTBVJQM-QWHCGFSZSA-N
21568	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3445	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	-	-	DRUGBANK	DB03597	C17H22IN3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFYJAEOZTBVJQM-QWHCGFSZSA-N
21569	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3446	Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	-	-	DRUGBANK	DB03598	C18H21N3O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSUAVPPTKHUTDX-UHFFFAOYSA-N
21570	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3446	Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	-	-	DRUGBANK	DB03598	C18H21N3O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSUAVPPTKHUTDX-UHFFFAOYSA-N
21571	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3446	Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	-	-	DRUGBANK	DB03598	C18H21N3O6S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSUAVPPTKHUTDX-UHFFFAOYSA-N
21572	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3448	Decanoic Acid	Capric acid	-	DRUGBANK	DB03600	C10H20O2	small molecule	-	334-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHVNFZFCNZKVNT-UHFFFAOYSA-N
21573	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3448	Decanoic Acid	Capric acid	-	DRUGBANK	DB03600	C10H20O2	small molecule	-	334-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHVNFZFCNZKVNT-UHFFFAOYSA-N
21574	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3448	Decanoic Acid	Capric acid	-	DRUGBANK	DB03600	C10H20O2	small molecule	-	334-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHVNFZFCNZKVNT-UHFFFAOYSA-N
21575	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3448	Decanoic Acid	Capric acid	-	DRUGBANK	DB03600	C10H20O2	small molecule	-	334-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHVNFZFCNZKVNT-UHFFFAOYSA-N
21576	111082	5045	-	FURIN	FUR|PACE|PCSK3|SPC1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3448	Decanoic Acid	Capric acid	-	DRUGBANK	DB03600	C10H20O2	small molecule	-	334-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHVNFZFCNZKVNT-UHFFFAOYSA-N
21577	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3450	S-Benzyl-Glutathione	-	-	DRUGBANK	DB03602	C17H23N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYJWEQWNNKNSFU-QWHCGFSZSA-N
21578	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3450	S-Benzyl-Glutathione	-	-	DRUGBANK	DB03602	C17H23N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYJWEQWNNKNSFU-QWHCGFSZSA-N
21579	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3451	Glucarate	-	-	DRUGBANK	DB03603	C6H8O8	small molecule	-	87-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSLZVSRJTYRBFB-ZNIBRBMXSA-L
21580	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3451	Glucarate	-	-	DRUGBANK	DB03603	C6H8O8	small molecule	-	87-73-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSLZVSRJTYRBFB-ZNIBRBMXSA-L
21581	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3452	[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid	-	-	DRUGBANK	DB03604	C14H9I3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOWZUVNAGUAEQC-UHFFFAOYSA-N
21582	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3452	[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid	-	-	DRUGBANK	DB03604	C14H9I3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOWZUVNAGUAEQC-UHFFFAOYSA-N
21583	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21584	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21585	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21586	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3454	(S)-Rolipram	(S)-(+)-rolipram|S-rolipram|(+)-rolipram	-	DRUGBANK	DB03606	C16H21NO3	small molecule	-	85416-73-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-GFCCVEGCSA-N
21587	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3456	Diminazene	Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate	-	DRUGBANK	DB03608	C14H15N7	small molecule	-	536-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNYZHCFCZNMTFY-UHFFFAOYSA-N
21588	106544	26	-	AOC1	ABP|ABP1|DAO|DAO1|KAO	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3456	Diminazene	Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate	-	DRUGBANK	DB03608	C14H15N7	small molecule	-	536-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNYZHCFCZNMTFY-UHFFFAOYSA-N
21589	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3456	Diminazene	Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate	-	DRUGBANK	DB03608	C14H15N7	small molecule	-	536-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNYZHCFCZNMTFY-UHFFFAOYSA-N
21590	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3456	Diminazene	Diminazine|4,4'-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide|Diminazene aceturate|4,4'-(Diazoamino)benzamidine|1,3-TRIS-(4'AMIDINOPHENYL)TRIAZINE|Diminazine aceturate	-	DRUGBANK	DB03608	C14H15N7	small molecule	-	536-71-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNYZHCFCZNMTFY-UHFFFAOYSA-N
21591	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3457	3-Deoxyguanosine	-	-	DRUGBANK	DB03609	C10H13N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROIAVZITJBGSM-PJPYAQQDSA-N
21592	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3457	3-Deoxyguanosine	-	-	DRUGBANK	DB03609	C10H13N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROIAVZITJBGSM-PJPYAQQDSA-N
21593	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3459	L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid	-	-	DRUGBANK	DB03611	C5H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLOPMQJRUIOMJO-FSSWKIGTSA-N
21594	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3459	L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid	-	-	DRUGBANK	DB03611	C5H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLOPMQJRUIOMJO-FSSWKIGTSA-N
21595	110313	4143	RP11-36D19.2	MAT1A	MAT|MATA1|SAMS|SAMS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3459	L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid	-	-	DRUGBANK	DB03611	C5H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLOPMQJRUIOMJO-FSSWKIGTSA-N
21596	109283	3033	-	HADH	HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3460	3-Hydroxybutyryl-Coenzyme A	-	-	DRUGBANK	DB03612	C25H42N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHHKKMYHDBRONY-XQUJUNONSA-N
21597	109283	3033	-	HADH	HAD|HADH1|HADHSC|HCDH|HHF4|MSCHAD|SCHAD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3460	3-Hydroxybutyryl-Coenzyme A	-	-	DRUGBANK	DB03612	C25H42N7O18P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHHKKMYHDBRONY-XQUJUNONSA-N
21598	852816	948522	b4019	metH	ECK4011|JW3979	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3462	Methylcobalamin	methyl(III)cobalamin|Methylcobalamin|Co-methylcobalamin|mecobalamin|MeCbl	maxaron forte|b-combo|methaver	DRUGBANK	DB03614	C63H91CoN13O14P	small molecule	B03BA05	13422-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEWJRMKHSMTXPP-WZHZPDAFSA-L
21599	852816	948522	b4019	metH	ECK4011|JW3979	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3462	Methylcobalamin	methyl(III)cobalamin|Methylcobalamin|Co-methylcobalamin|mecobalamin|MeCbl	maxaron forte|b-combo|methaver	DRUGBANK	DB03614	C63H91CoN13O14P	small molecule	B03BA05	13422-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEWJRMKHSMTXPP-WZHZPDAFSA-L
21600	111073	5034	-	P4HB	DSI|ERBA2L|GIT|P4Hbeta|PDI|PDIA1|PHDB|PO4DB|PO4HB|PROHB	9606	Homo sapiens	unknown	target	Horibe T (2001)	11741285	181782	3463	Ribostamycin	Xylostasin|Vistamycin|RIO|Xylostacin|5-Amino-2-Aminomethyl-6-[4,6-Diamino-2-(3,4-Dihydroxy-5-Hydroxymethyl-Tetrahydro-Furan-2-Yloxy)-3-Hydroxy-Cyclohexyloxy]-Tetrahydro-Pyran-3,4-Diol|Ribastamin	-	DRUGBANK	DB03615	C17H34N4O10	small molecule	J01GB10	25546-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSKGQURZWSPSBC-NLZFXWNVSA-N
21601	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3464	Kabiramide C	-	-	DRUGBANK	DB03616	C48H75N5O14	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYKNXOJYKRVXBX-LBCSWZFUSA-N
21602	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3464	Kabiramide C	-	-	DRUGBANK	DB03616	C48H75N5O14	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYKNXOJYKRVXBX-LBCSWZFUSA-N
21603	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3464	Kabiramide C	-	-	DRUGBANK	DB03616	C48H75N5O14	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYKNXOJYKRVXBX-LBCSWZFUSA-N
21604	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3468	L-709,587	-	-	DRUGBANK	DB03621	C52H76N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APSPCHLQXFEUHG-ZOQAXNDZSA-N
21605	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3468	L-709,587	-	-	DRUGBANK	DB03621	C52H76N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APSPCHLQXFEUHG-ZOQAXNDZSA-N
21606	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3468	L-709,587	-	-	DRUGBANK	DB03621	C52H76N2O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APSPCHLQXFEUHG-ZOQAXNDZSA-N
21607	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3469	2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione	-	-	DRUGBANK	DB03622	C17H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPBPOBHSNJFRFT-UHFFFAOYSA-N
21608	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3469	2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione	-	-	DRUGBANK	DB03622	C17H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPBPOBHSNJFRFT-UHFFFAOYSA-N
21609	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3469	2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione	-	-	DRUGBANK	DB03622	C17H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPBPOBHSNJFRFT-UHFFFAOYSA-N
21610	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3470	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	-	-	DRUGBANK	DB03623	C18H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUSSGTWHFMSCOY-UHFFFAOYSA-N
21611	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3470	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	-	-	DRUGBANK	DB03623	C18H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUSSGTWHFMSCOY-UHFFFAOYSA-N
21612	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3470	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	-	-	DRUGBANK	DB03623	C18H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUSSGTWHFMSCOY-UHFFFAOYSA-N
21613	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3471	7-(Carboxyamino)-8-Amino-Nonanoic Acid	-	-	DRUGBANK	DB03624	C10H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQNJZSIPDMTUAJ-JGVFFNPUSA-N
21614	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3471	7-(Carboxyamino)-8-Amino-Nonanoic Acid	-	-	DRUGBANK	DB03624	C10H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQNJZSIPDMTUAJ-JGVFFNPUSA-N
21615	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3472	5,10-Dideazatetrahydrofolic Acid	-	-	DRUGBANK	DB03625	C21H25N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUQBAQVRAURMCL-SWLSCSKDSA-N
21616	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3472	5,10-Dideazatetrahydrofolic Acid	-	-	DRUGBANK	DB03625	C21H25N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUQBAQVRAURMCL-SWLSCSKDSA-N
21617	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3473	5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione	-	-	DRUGBANK	DB03626	C18H17NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRPJCFILHCLEJI-UHFFFAOYSA-N
21618	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3473	5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione	-	-	DRUGBANK	DB03626	C18H17NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRPJCFILHCLEJI-UHFFFAOYSA-N
21619	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3473	5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione	-	-	DRUGBANK	DB03626	C18H17NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRPJCFILHCLEJI-UHFFFAOYSA-N
21620	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3475	ISO24	-	-	DRUGBANK	DB03628	C9H12NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGNSYMGWPCEFDZ-UHFFFAOYSA-N
21621	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3476	Pyridoxal-5'-Phosphate-N-Oxide	-	-	DRUGBANK	DB03629	C8H10NO7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBWRYPTUKZTWFD-UHFFFAOYSA-N
21622	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3476	Pyridoxal-5'-Phosphate-N-Oxide	-	-	DRUGBANK	DB03629	C8H10NO7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBWRYPTUKZTWFD-UHFFFAOYSA-N
21623	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3478	3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine	-	-	DRUGBANK	DB03631	C9H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKLZKBKFGLLJJV-LURJTMIESA-N
21624	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3478	3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine	-	-	DRUGBANK	DB03631	C9H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKLZKBKFGLLJJV-LURJTMIESA-N
21625	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3479	Argifin	-	-	DRUGBANK	DB03632	C29H41N9O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBHXSDKGLPPGO-YHUYVZNPSA-N
21626	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3479	Argifin	-	-	DRUGBANK	DB03632	C29H41N9O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBHXSDKGLPPGO-YHUYVZNPSA-N
21627	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21628	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21629	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21630	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21631	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21632	111469	5473	-	PPBP	B-TG1|Beta-TG|CTAP-III|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|PBP|SCYB7|TC1|TC2|TGB|TGB1|THBGB|THBGB1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3482	Ethanesulfonic Acid	-	-	DRUGBANK	DB03635	C2H6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCIVGXIOQKPBKL-UHFFFAOYSA-N
21633	111469	5473	-	PPBP	B-TG1|Beta-TG|CTAP-III|CTAP3|CTAPIII|CXCL7|LA-PF4|LDGF|MDGF|NAP-2|PBP|SCYB7|TC1|TC2|TGB|TGB1|THBGB|THBGB1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3482	Ethanesulfonic Acid	-	-	DRUGBANK	DB03635	C2H6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCIVGXIOQKPBKL-UHFFFAOYSA-N
21634	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3483	Glycinamid	-	-	DRUGBANK	DB03636	C2H6N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEBCJVAWIBVWNZ-UHFFFAOYSA-N
21635	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3483	Glycinamid	-	-	DRUGBANK	DB03636	C2H6N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEBCJVAWIBVWNZ-UHFFFAOYSA-N
21636	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3484	Guanidine-3-Propanol	-	-	DRUGBANK	DB03637	C4H12N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDXXTKLHHZMVIO-UHFFFAOYSA-O
21637	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3484	Guanidine-3-Propanol	-	-	DRUGBANK	DB03637	C4H12N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDXXTKLHHZMVIO-UHFFFAOYSA-O
21638	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3484	Guanidine-3-Propanol	-	-	DRUGBANK	DB03637	C4H12N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDXXTKLHHZMVIO-UHFFFAOYSA-O
21639	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21640	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21641	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21642	108070	1725	-	DHPS	DHS|DS|MIG13	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3486	1-Guanidinium-7-Aminoheptane	-	-	DRUGBANK	DB03639	C8H22N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKGAVCHIFDRDTK-UHFFFAOYSA-N
21643	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3489	Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide	-	-	DRUGBANK	DB03642	C26H30N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBPPNJCVXGAZDD-WOJBJXKFSA-N
21644	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3489	Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide	-	-	DRUGBANK	DB03642	C26H30N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBPPNJCVXGAZDD-WOJBJXKFSA-N
21645	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3489	Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide	-	-	DRUGBANK	DB03642	C26H30N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBPPNJCVXGAZDD-WOJBJXKFSA-N
21646	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3490	CRA_1144	-	-	DRUGBANK	DB03643	C14H12N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJKRCBBKTXOHS-UHFFFAOYSA-N
21647	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3490	CRA_1144	-	-	DRUGBANK	DB03643	C14H12N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URJKRCBBKTXOHS-UHFFFAOYSA-N
21648	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3492	Phosphonoacetohydroxamic Acid	-	-	DRUGBANK	DB03645	C2H6NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDKRAXXVBWHMRH-UHFFFAOYSA-N
21649	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3492	Phosphonoacetohydroxamic Acid	-	-	DRUGBANK	DB03645	C2H6NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDKRAXXVBWHMRH-UHFFFAOYSA-N
21650	108341	2027	-	ENO3	GSD13|MSE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3492	Phosphonoacetohydroxamic Acid	-	-	DRUGBANK	DB03645	C2H6NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDKRAXXVBWHMRH-UHFFFAOYSA-N
21651	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3496	[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate	-	-	DRUGBANK	DB03649	C6H9ClN2O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNMYZGAZFGNKTH-UHFFFAOYSA-N
21652	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3496	[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate	-	-	DRUGBANK	DB03649	C6H9ClN2O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNMYZGAZFGNKTH-UHFFFAOYSA-N
21653	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3497	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	-	-	DRUGBANK	DB03650	C14H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJASRZFZRYISET-UHFFFAOYSA-N
21654	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3497	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	-	-	DRUGBANK	DB03650	C14H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJASRZFZRYISET-UHFFFAOYSA-N
21655	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3497	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	-	-	DRUGBANK	DB03650	C14H10N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJASRZFZRYISET-UHFFFAOYSA-N
21656	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3504	1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose	-	-	DRUGBANK	DB03657	C8H15NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZZJOGWXTFEDLL-ZYNSJIGGSA-N
21657	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3504	1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose	-	-	DRUGBANK	DB03657	C8H15NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZZJOGWXTFEDLL-ZYNSJIGGSA-N
21658	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3504	1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose	-	-	DRUGBANK	DB03657	C8H15NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZZJOGWXTFEDLL-ZYNSJIGGSA-N
21659	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3505	2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid	-	-	DRUGBANK	DB03658	C16H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMLJDSWXGVMNTH-MNXVOIDGSA-N
21660	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3505	2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid	-	-	DRUGBANK	DB03658	C16H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMLJDSWXGVMNTH-MNXVOIDGSA-N
21661	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	3506	Butylamine	1-aminobutane|1-butanamine|n-butylamine	-	DRUGBANK	DB03659	C4H11N	small molecule	-	109-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQABUPZFAYXKJW-UHFFFAOYSA-N
21662	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	3506	Butylamine	1-aminobutane|1-butanamine|n-butylamine	-	DRUGBANK	DB03659	C4H11N	small molecule	-	109-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQABUPZFAYXKJW-UHFFFAOYSA-N
21663	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3507	4-Iodo-L-phenylalanine	p-iodophenylalanine|p-Iodo-L-phenylalanine|4-iodophenylalanine	-	DRUGBANK	DB03660	C9H10INO2	small molecule	-	24250-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZNQZSRPDOEBMS-QMMMGPOBSA-N
21664	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21665	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21666	107429	994	RP5-1009E24.3	CDC25B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21667	107429	994	RP5-1009E24.3	CDC25B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21668	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21669	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21670	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21671	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3508	Cysteinesulfonic Acid	-	-	DRUGBANK	DB03661	C3H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVOYSCVBGLVSOL-REOHCLBHSA-N
21672	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3509	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	-	-	DRUGBANK	DB03662	C13H21N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYAMSLLSQINIQO-NSHDSACASA-N
21673	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3509	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	-	-	DRUGBANK	DB03662	C13H21N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYAMSLLSQINIQO-NSHDSACASA-N
21674	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3510	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	-	-	DRUGBANK	DB03663	C10H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEXUQVHWMLPYKY-UHFFFAOYSA-N
21675	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3510	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	-	-	DRUGBANK	DB03663	C10H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEXUQVHWMLPYKY-UHFFFAOYSA-N
21676	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3510	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	-	-	DRUGBANK	DB03663	C10H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEXUQVHWMLPYKY-UHFFFAOYSA-N
21677	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3511	P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate	-	-	DRUGBANK	DB03664	C19H28N7O24P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTLFMDLEWCNMJ-YZCDDZTHSA-N
21678	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3511	P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate	-	-	DRUGBANK	DB03664	C19H28N7O24P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTLFMDLEWCNMJ-YZCDDZTHSA-N
21679	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3511	P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate	-	-	DRUGBANK	DB03664	C19H28N7O24P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTLFMDLEWCNMJ-YZCDDZTHSA-N
21680	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3512	3'-Azido-3'-Deoxythymidine-5'-Monophosphate	-	-	DRUGBANK	DB03666	C10H14N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIFWQOKDSPDILA-GJMOJQLCSA-N
21681	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3512	3'-Azido-3'-Deoxythymidine-5'-Monophosphate	-	-	DRUGBANK	DB03666	C10H14N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIFWQOKDSPDILA-GJMOJQLCSA-N
21682	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3512	3'-Azido-3'-Deoxythymidine-5'-Monophosphate	-	-	DRUGBANK	DB03666	C10H14N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIFWQOKDSPDILA-GJMOJQLCSA-N
21683	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3513	Acetic Acid Salicyloyl-Amino-Ester	-	-	DRUGBANK	DB03667	C9H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCFWLDHLJWUGSU-UHFFFAOYSA-N
21684	851455	947121	b1281	pyrF	ECK1276|JW1273	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3514	1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid	-	-	DRUGBANK	DB03668	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AODYJUNLDJOADV-YHSFNTFWSA-N
21685	851455	947121	b1281	pyrF	ECK1276|JW1273	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3514	1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid	-	-	DRUGBANK	DB03668	C9H13N2O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AODYJUNLDJOADV-YHSFNTFWSA-N
21686	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3516	2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid	-	-	DRUGBANK	DB03670	C10H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIBMATWHOAGNTR-UHFFFAOYSA-N
21687	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3516	2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid	-	-	DRUGBANK	DB03670	C10H10N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIBMATWHOAGNTR-UHFFFAOYSA-N
21688	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3518	9-N-Phenylmethylamino-Tacrine	-	-	DRUGBANK	DB03672	C20H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYJAEHAURXXPSD-UHFFFAOYSA-N
21689	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3518	9-N-Phenylmethylamino-Tacrine	-	-	DRUGBANK	DB03672	C20H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYJAEHAURXXPSD-UHFFFAOYSA-N
21690	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3518	9-N-Phenylmethylamino-Tacrine	-	-	DRUGBANK	DB03672	C20H20N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYJAEHAURXXPSD-UHFFFAOYSA-N
21691	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3519	Beta(2-Thienyl)Alanine	-	-	DRUGBANK	DB03673	C7H9NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTOFYLAWDLQMBZ-LURJTMIESA-N
21692	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3519	Beta(2-Thienyl)Alanine	-	-	DRUGBANK	DB03673	C7H9NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTOFYLAWDLQMBZ-LURJTMIESA-N
21700	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3523	N-Cyclohexyl-N'-Decylurea	-	-	DRUGBANK	DB03677	C17H34N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPXYBLIRYGCMPQ-UHFFFAOYSA-N
21701	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3526	Tartronate	-	-	DRUGBANK	DB03680	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBFUDYVXSDBQM-UHFFFAOYSA-L
21702	110364	4200	-	ME2	ODS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3526	Tartronate	-	-	DRUGBANK	DB03680	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBFUDYVXSDBQM-UHFFFAOYSA-L
21703	116081	10873	-	ME3	NADP-ME	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3526	Tartronate	-	-	DRUGBANK	DB03680	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBFUDYVXSDBQM-UHFFFAOYSA-L
21704	116081	10873	-	ME3	NADP-ME	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3526	Tartronate	-	-	DRUGBANK	DB03680	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBFUDYVXSDBQM-UHFFFAOYSA-L
21705	116081	10873	-	ME3	NADP-ME	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3526	Tartronate	-	-	DRUGBANK	DB03680	C3H2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROBFUDYVXSDBQM-UHFFFAOYSA-L
21706	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3529	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	-	-	DRUGBANK	DB03683	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFMOJNDZFCHHPV-SSDOTTSWSA-N
21707	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3529	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	-	-	DRUGBANK	DB03683	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFMOJNDZFCHHPV-SSDOTTSWSA-N
21708	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3529	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	-	-	DRUGBANK	DB03683	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFMOJNDZFCHHPV-SSDOTTSWSA-N
21709	851996	947683	b2255	arnA	ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21710	851996	947683	b2255	arnA	ECK2248|JW2249|SAF|pbgP3|pmrI|yfbG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21711	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21712	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21713	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21714	849754	945378	b2183	rsuA	ECK2177|JW2171|yejD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21715	849754	945378	b2183	rsuA	ECK2177|JW2171|yejD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21716	109876	3669	-	ISG20	CD25|HEM45	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21717	109876	3669	-	ISG20	CD25|HEM45	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21718	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21719	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21720	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21721	849733	945357	b0758	galT	ECK0747|JW0741|galB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21722	849733	945357	b0758	galT	ECK0747|JW0741|galB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21723	853655	935960	BSU15550	pyrF	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21724	853655	935960	BSU15550	pyrF	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21725	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21726	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21727	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21728	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21729	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21730	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3530	Uridine-5'-Monophosphate	-	-	DRUGBANK	DB03685	C9H13N2O9P	small molecule	-	58-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJJCXFVJDGTHFX-ZAKLUEHWSA-N
21731	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3531	S-(P-Nitrobenzyl)Glutathione	-	-	DRUGBANK	DB03686	C17H22N4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWORKDPTSAMBZ-QWHCGFSZSA-N
21732	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3531	S-(P-Nitrobenzyl)Glutathione	-	-	DRUGBANK	DB03686	C17H22N4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWORKDPTSAMBZ-QWHCGFSZSA-N
21733	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3531	S-(P-Nitrobenzyl)Glutathione	-	-	DRUGBANK	DB03686	C17H22N4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWORKDPTSAMBZ-QWHCGFSZSA-N
21734	852571	948269	b2747	ispD	ECK2742|JW2717|ygbP	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3532	4-Diphosphocytidyl-2-C-Methyl-D-Erythritol	-	-	DRUGBANK	DB03687	C14H25N3O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFAUKWZNPVBCFF-GSNOWDBKSA-N
21735	852571	948269	b2747	ispD	ECK2742|JW2717|ygbP	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3532	4-Diphosphocytidyl-2-C-Methyl-D-Erythritol	-	-	DRUGBANK	DB03687	C14H25N3O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFAUKWZNPVBCFF-GSNOWDBKSA-N
21736	852225	947916	b3412	bioH	ECK3399|JW3375|bioB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3533	3-Hydroxy-Propanoic Acid	-	-	DRUGBANK	DB03688	C3H6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALRHLSYJTWAHJZ-UHFFFAOYSA-N
21737	852225	947916	b3412	bioH	ECK3399|JW3375|bioB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3533	3-Hydroxy-Propanoic Acid	-	-	DRUGBANK	DB03688	C3H6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALRHLSYJTWAHJZ-UHFFFAOYSA-N
21738	111323	5306	-	PITPNA	HEL-S-36|PI-TPalpha|PITPN|VIB1A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3534	(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide	-	-	DRUGBANK	DB03690	C44H85NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNKAWJBJQDLSFF-OOMOHMHFSA-O
21739	111323	5306	-	PITPNA	HEL-S-36|PI-TPalpha|PITPN|VIB1A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3534	(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide	-	-	DRUGBANK	DB03690	C44H85NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNKAWJBJQDLSFF-OOMOHMHFSA-O
21740	111323	5306	-	PITPNA	HEL-S-36|PI-TPalpha|PITPN|VIB1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3534	(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide	-	-	DRUGBANK	DB03690	C44H85NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNKAWJBJQDLSFF-OOMOHMHFSA-O
21741	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3535	WRR-112	-	-	DRUGBANK	DB03691	C19H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVZMXOVSHIMGNA-HOTGVXAUSA-N
21742	852605	948307	b3821	pldA	ECK3815|JW3794	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3536	1-Hexadecanosulfonyl-O-L-Serine	-	-	DRUGBANK	DB03692	C19H39NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKAIXQDVYXAWPS-SFHVURJKSA-N
21743	852605	948307	b3821	pldA	ECK3815|JW3794	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3536	1-Hexadecanosulfonyl-O-L-Serine	-	-	DRUGBANK	DB03692	C19H39NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKAIXQDVYXAWPS-SFHVURJKSA-N
21744	852605	948307	b3821	pldA	ECK3815|JW3794	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3536	1-Hexadecanosulfonyl-O-L-Serine	-	-	DRUGBANK	DB03692	C19H39NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKAIXQDVYXAWPS-SFHVURJKSA-N
21745	107839	1455	-	CSNK1G2	CK1g2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3537	N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide	-	-	DRUGBANK	DB03693	C11H12ClN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGKYMFFYOWUTKV-UHFFFAOYSA-N
21746	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3539	6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine	-	-	DRUGBANK	DB03695	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJXSSYDSOJBUAV-UHFFFAOYSA-N
21747	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3539	6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine	-	-	DRUGBANK	DB03695	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJXSSYDSOJBUAV-UHFFFAOYSA-N
21748	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3539	6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine	-	-	DRUGBANK	DB03695	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJXSSYDSOJBUAV-UHFFFAOYSA-N
21749	110225	4047	-	LSS	OSC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3540	Lanosterol	-	-	DRUGBANK	DB03696	C30H50O	small molecule	-	79-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHGCLMLTWQZNJ-RGEKOYMOSA-N
21750	110225	4047	-	LSS	OSC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3540	Lanosterol	-	-	DRUGBANK	DB03696	C30H50O	small molecule	-	79-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAHGCLMLTWQZNJ-RGEKOYMOSA-N
21751	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3541	4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	-	-	DRUGBANK	DB03697	C11H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDYFRIZTYRFPJC-UHFFFAOYSA-N
21752	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3541	4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	-	-	DRUGBANK	DB03697	C11H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDYFRIZTYRFPJC-UHFFFAOYSA-N
21753	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3542	5-Mercaptoethanol-2-Decenoyl-Coenzyme A	-	-	DRUGBANK	DB03698	C33H54N7O18P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21754	851910	947594	b3081	fadH	ECK3071|JW3052|ygjL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3542	5-Mercaptoethanol-2-Decenoyl-Coenzyme A	-	-	DRUGBANK	DB03698	C33H54N7O18P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21755	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3546	2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid	-	-	DRUGBANK	DB03702	C26H33F3N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRTSIBBMOWLRPY-MISYRCLQSA-N
21756	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3546	2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid	-	-	DRUGBANK	DB03702	C26H33F3N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRTSIBBMOWLRPY-MISYRCLQSA-N
21757	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3546	2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid	-	-	DRUGBANK	DB03702	C26H33F3N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRTSIBBMOWLRPY-MISYRCLQSA-N
21758	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3547	Cyclohexanol	-	-	DRUGBANK	DB03703	C6H12O	small molecule	-	108-93-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPXRVTGHNJAIIH-UHFFFAOYSA-N
21759	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3547	Cyclohexanol	-	-	DRUGBANK	DB03703	C6H12O	small molecule	-	108-93-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPXRVTGHNJAIIH-UHFFFAOYSA-N
21760	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3548	12-Hydroxydodecanoic Acid	-	-	DRUGBANK	DB03704	C12H24O3	small molecule	-	505-95-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDHCZVWCTKTBRY-UHFFFAOYSA-N
21761	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3548	12-Hydroxydodecanoic Acid	-	-	DRUGBANK	DB03704	C12H24O3	small molecule	-	505-95-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDHCZVWCTKTBRY-UHFFFAOYSA-N
21762	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3548	12-Hydroxydodecanoic Acid	-	-	DRUGBANK	DB03704	C12H24O3	small molecule	-	505-95-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDHCZVWCTKTBRY-UHFFFAOYSA-N
21763	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3550	1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane	-	-	DRUGBANK	DB03706	C19H26N4O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWXHXYSGHBAIBL-QLFBSQMISA-N
21764	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3550	1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane	-	-	DRUGBANK	DB03706	C19H26N4O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWXHXYSGHBAIBL-QLFBSQMISA-N
21765	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3550	1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane	-	-	DRUGBANK	DB03706	C19H26N4O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWXHXYSGHBAIBL-QLFBSQMISA-N
21766	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3551	S-Ethyl-N-Phenyl-Isothiourea	-	-	DRUGBANK	DB03707	C9H12N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAXNJIWNBHHMDO-UHFFFAOYSA-N
21767	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3551	S-Ethyl-N-Phenyl-Isothiourea	-	-	DRUGBANK	DB03707	C9H12N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAXNJIWNBHHMDO-UHFFFAOYSA-N
21768	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3552	Adenosine-5'-Phosphosulfate	-	-	DRUGBANK	DB03708	C10H14N5O10PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRLPACMLTUPBCL-FCIPNVEPSA-N
21769	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3552	Adenosine-5'-Phosphosulfate	-	-	DRUGBANK	DB03708	C10H14N5O10PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRLPACMLTUPBCL-FCIPNVEPSA-N
21770	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3552	Adenosine-5'-Phosphosulfate	-	-	DRUGBANK	DB03708	C10H14N5O10PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRLPACMLTUPBCL-FCIPNVEPSA-N
21771	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3553	Bicine	-	-	DRUGBANK	DB03709	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSVCELGFZIQNCK-UHFFFAOYSA-N
21772	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3553	Bicine	-	-	DRUGBANK	DB03709	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSVCELGFZIQNCK-UHFFFAOYSA-N
21773	851516	947184	b2701	mltB	ECK2696|JW2671	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3553	Bicine	-	-	DRUGBANK	DB03709	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSVCELGFZIQNCK-UHFFFAOYSA-N
21774	851516	947184	b2701	mltB	ECK2696|JW2671	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3553	Bicine	-	-	DRUGBANK	DB03709	C6H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSVCELGFZIQNCK-UHFFFAOYSA-N
21775	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21776	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21777	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21778	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3555	6-Hydroxy-6-Methyl-Heptan-3-One	-	-	DRUGBANK	DB03711	C8H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGPMBONEKHYAHO-UHFFFAOYSA-N
21779	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3555	6-Hydroxy-6-Methyl-Heptan-3-One	-	-	DRUGBANK	DB03711	C8H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGPMBONEKHYAHO-UHFFFAOYSA-N
21780	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3555	6-Hydroxy-6-Methyl-Heptan-3-One	-	-	DRUGBANK	DB03711	C8H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGPMBONEKHYAHO-UHFFFAOYSA-N
21781	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3556	RU85053	-	-	DRUGBANK	DB03712	C33H35N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEKLBQMULVLLTD-WDYNHAJCSA-N
21782	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3556	RU85053	-	-	DRUGBANK	DB03712	C33H35N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEKLBQMULVLLTD-WDYNHAJCSA-N
21783	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3556	RU85053	-	-	DRUGBANK	DB03712	C33H35N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEKLBQMULVLLTD-WDYNHAJCSA-N
21784	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3557	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	-	-	DRUGBANK	DB03714	C17H17F2N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWCIKSGGKYNHT-ZDUSSCGKSA-N
21785	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3557	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	-	-	DRUGBANK	DB03714	C17H17F2N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWCIKSGGKYNHT-ZDUSSCGKSA-N
21786	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3557	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	-	-	DRUGBANK	DB03714	C17H17F2N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWWCIKSGGKYNHT-ZDUSSCGKSA-N
21787	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3562	N-Ethyl-5'-Carboxamido Adenosine	-	-	DRUGBANK	DB03719	C12H16N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JADDQZYHOWSFJD-BMYQGPEFSA-N
21788	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3562	N-Ethyl-5'-Carboxamido Adenosine	-	-	DRUGBANK	DB03719	C12H16N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JADDQZYHOWSFJD-BMYQGPEFSA-N
21789	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3562	N-Ethyl-5'-Carboxamido Adenosine	-	-	DRUGBANK	DB03719	C12H16N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JADDQZYHOWSFJD-BMYQGPEFSA-N
21790	112498	6614	-	SIGLEC1	CD169|SIGLEC-1|SN|dJ1009E24.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21791	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21792	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21793	111899	5967	-	REG1A	ICRF|P19|PSP|PSPS|PSPS1|PTP|REG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21794	111899	5967	-	REG1A	ICRF|P19|PSP|PSPS|PSPS1|PTP|REG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21795	112301	6401	RP1-117P20.2	SELE	CD62E|ELAM|ELAM1|ESEL|LECAM2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21796	112301	6401	RP1-117P20.2	SELE	CD62E|ELAM|ELAM1|ESEL|LECAM2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21797	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21798	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21799	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3564	N-acetyl-alpha-neuraminic acid	O-sialic acid|-Neu5Ac|alpha-sialoside	-	DRUGBANK	DB03721	C11H19NO9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVRNKJHWKZAKO-YRMXFSIDSA-N
21800	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3565	3,4-Dihydro-5-Methyl-Isoquinolinone	-	-	DRUGBANK	DB03722	C10H11NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLZPXDJYADIEU-UHFFFAOYSA-N
21801	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3565	3,4-Dihydro-5-Methyl-Isoquinolinone	-	-	DRUGBANK	DB03722	C10H11NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLZPXDJYADIEU-UHFFFAOYSA-N
21802	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3565	3,4-Dihydro-5-Methyl-Isoquinolinone	-	-	DRUGBANK	DB03722	C10H11NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLZPXDJYADIEU-UHFFFAOYSA-N
21803	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3568	Phosphomethylphosphonic Acid-Guanylate Ester	-	-	DRUGBANK	DB03725	C11H18N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHBDHXOBFUBCJD-FCIPNVEPSA-N
21804	111136	5105	-	PCK1	PEPCK-C|PEPCK1|PEPCKC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3568	Phosphomethylphosphonic Acid-Guanylate Ester	-	-	DRUGBANK	DB03725	C11H18N5O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHBDHXOBFUBCJD-FCIPNVEPSA-N
21805	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3569	Purine Riboside-5'-Monophosphate	-	-	DRUGBANK	DB03726	C10H13N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCWDCZIDTUQRHK-QHOPCYEYSA-N
21806	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3569	Purine Riboside-5'-Monophosphate	-	-	DRUGBANK	DB03726	C10H13N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCWDCZIDTUQRHK-QHOPCYEYSA-N
21807	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3569	Purine Riboside-5'-Monophosphate	-	-	DRUGBANK	DB03726	C10H13N4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCWDCZIDTUQRHK-QHOPCYEYSA-N
21808	113235	7389	RP11-69J16.2	UROD	PCT|UPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3570	Coproporphyrin I	-	-	DRUGBANK	DB03727	C36H40N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21809	113235	7389	RP11-69J16.2	UROD	PCT|UPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3570	Coproporphyrin I	-	-	DRUGBANK	DB03727	C36H40N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21810	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3572	2-Amino-5-Hydroxy-Benzimidazole	-	-	DRUGBANK	DB03729	C7H6N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21811	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3572	2-Amino-5-Hydroxy-Benzimidazole	-	-	DRUGBANK	DB03729	C7H6N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21812	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3574	S-2-(Boronoethyl)-L-Cysteine	-	-	DRUGBANK	DB03731	C5H13BNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTAXROQIMJHCAK-BYPYZUCNSA-N
21813	106879	384	-	ARG2	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3574	S-2-(Boronoethyl)-L-Cysteine	-	-	DRUGBANK	DB03731	C5H13BNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTAXROQIMJHCAK-BYPYZUCNSA-N
21814	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3574	S-2-(Boronoethyl)-L-Cysteine	-	-	DRUGBANK	DB03731	C5H13BNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTAXROQIMJHCAK-BYPYZUCNSA-N
21815	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3574	S-2-(Boronoethyl)-L-Cysteine	-	-	DRUGBANK	DB03731	C5H13BNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTAXROQIMJHCAK-BYPYZUCNSA-N
21816	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3574	S-2-(Boronoethyl)-L-Cysteine	-	-	DRUGBANK	DB03731	C5H13BNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTAXROQIMJHCAK-BYPYZUCNSA-N
21817	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3575	Etheno-Nadp	-	-	DRUGBANK	DB03732	C17H24N5O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWEQFQACRLGUSH-MMKYUKOKSA-N
21818	107148	683	-	BST1	CD157	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3575	Etheno-Nadp	-	-	DRUGBANK	DB03732	C17H24N5O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWEQFQACRLGUSH-MMKYUKOKSA-N
21819	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3577	Xylarohydroxamate	-	-	DRUGBANK	DB03734	C5H8NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMGBHBFPSRKPBV-ADNNCPOWSA-M
21820	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3577	Xylarohydroxamate	-	-	DRUGBANK	DB03734	C5H8NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMGBHBFPSRKPBV-ADNNCPOWSA-M
21821	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3578	9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine	-	-	DRUGBANK	DB03735	C11H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJXRKKYXNZWKDB-HRDYMLBCSA-N
21822	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3578	9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine	-	-	DRUGBANK	DB03735	C11H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJXRKKYXNZWKDB-HRDYMLBCSA-N
21823	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3579	2-Cyclopropylmethylenepropanal	-	-	DRUGBANK	DB03736	C7H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQCSSAEKDLHCI-ZCFIWIBFSA-N
21824	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3579	2-Cyclopropylmethylenepropanal	-	-	DRUGBANK	DB03736	C7H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQCSSAEKDLHCI-ZCFIWIBFSA-N
21825	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3579	2-Cyclopropylmethylenepropanal	-	-	DRUGBANK	DB03736	C7H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQCSSAEKDLHCI-ZCFIWIBFSA-N
21826	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3580	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	-	-	DRUGBANK	DB03737	C20H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAKYKJWUUUKCCW-MPLBGYFPSA-N
21827	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3580	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	-	-	DRUGBANK	DB03737	C20H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAKYKJWUUUKCCW-MPLBGYFPSA-N
21828	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3580	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	-	-	DRUGBANK	DB03737	C20H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAKYKJWUUUKCCW-MPLBGYFPSA-N
21829	121921	60490	MDS018	PPCDC	PPC-DC|coaC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3581	Pantothenoylaminoethenethiol	-	-	DRUGBANK	DB03738	C11H20N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVPONLWGQFZYSV-CYNONHLPSA-N
21830	121921	60490	MDS018	PPCDC	PPC-DC|coaC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3581	Pantothenoylaminoethenethiol	-	-	DRUGBANK	DB03738	C11H20N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVPONLWGQFZYSV-CYNONHLPSA-N
21831	121921	60490	MDS018	PPCDC	PPC-DC|coaC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3581	Pantothenoylaminoethenethiol	-	-	DRUGBANK	DB03738	C11H20N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVPONLWGQFZYSV-CYNONHLPSA-N
21832	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21833	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21834	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21835	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21836	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21837	117967	27036	-	SIGLEC7	AIRM1|CD328|CDw328|D-siglec|QA79|SIGLEC-7|SIGLEC19P|SIGLECP2|p75|p75/AIRM1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21838	117967	27036	-	SIGLEC7	AIRM1|CD328|CDw328|D-siglec|QA79|SIGLEC-7|SIGLEC19P|SIGLECP2|p75|p75/AIRM1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21839	108899	2629	-	GBA	GBA1|GCB|GLUC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21840	108899	2629	-	GBA	GBA1|GCB|GLUC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21841	853827	936136	BSU07980	pdaA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21842	853827	936136	BSU07980	pdaA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21843	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3585	Compound 4-D	-	-	DRUGBANK	DB03742	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWZNCTCQAGRUGQ-KAYWLYCHSA-N
21844	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3585	Compound 4-D	-	-	DRUGBANK	DB03742	C27H29NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWZNCTCQAGRUGQ-KAYWLYCHSA-N
21845	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3586	Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate	-	-	DRUGBANK	DB03744	C22H20ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONLONYAIBUEKT-IBGZPJMESA-N
21846	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3586	Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate	-	-	DRUGBANK	DB03744	C22H20ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONLONYAIBUEKT-IBGZPJMESA-N
21847	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3586	Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate	-	-	DRUGBANK	DB03744	C22H20ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONLONYAIBUEKT-IBGZPJMESA-N
21848	109323	3074	HCC7	HEXB	ENC-1AS|HEL-248	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3589	3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol	-	-	DRUGBANK	DB03747	C8H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHXTSWSUAJOJZ-GWVFRZDISA-N
21849	109323	3074	HCC7	HEXB	ENC-1AS|HEL-248	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3589	3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol	-	-	DRUGBANK	DB03747	C8H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRHXTSWSUAJOJZ-GWVFRZDISA-N
21850	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21851	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21852	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21853	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3592	Isovaleric Acid	-	-	DRUGBANK	DB03750	C5H10O2	small molecule	-	503-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GWYFCOCPABKNJV-UHFFFAOYSA-N
21854	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3592	Isovaleric Acid	-	-	DRUGBANK	DB03750	C5H10O2	small molecule	-	503-74-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GWYFCOCPABKNJV-UHFFFAOYSA-N
21855	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3594	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	-	-	DRUGBANK	DB03752	C14H11IO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIZPHGUBGPJBAR-QMMMGPOBSA-N
21856	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3595	Flurbiprofen Methyl Ester	-	-	DRUGBANK	DB03753	C16H15FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJBKHZROFMSQM-NSHDSACASA-N
21857	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3595	Flurbiprofen Methyl Ester	-	-	DRUGBANK	DB03753	C16H15FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJBKHZROFMSQM-NSHDSACASA-N
21858	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3595	Flurbiprofen Methyl Ester	-	-	DRUGBANK	DB03753	C16H15FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJBKHZROFMSQM-NSHDSACASA-N
21859	849746	945370	b0775	bioB	ECK0764|JW0758	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21860	849746	945370	b0775	bioB	ECK0764|JW0758	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21861	851986	947673	b3163	nlpI	ECK3151|JW3132|yhbM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21862	851986	947673	b3163	nlpI	ECK3151|JW3132|yhbM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21863	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21864	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21865	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21866	125875	124583	-	CANT1	DBQD|SCAN-1|SCAN1|SHAPY	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21867	125875	124583	-	CANT1	DBQD|SCAN-1|SCAN1|SHAPY	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21868	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21869	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21870	108002	1634	-	DCN	CSCD|DSPG2|PG40|PGII|PGS2|SLRR1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21871	108002	1634	-	DCN	CSCD|DSPG2|PG40|PGII|PGS2|SLRR1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21872	108002	1634	-	DCN	CSCD|DSPG2|PG40|PGII|PGS2|SLRR1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
21873	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3599	(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine	-	-	DRUGBANK	DB03757	C11H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAXZAMSRJZWMEV-NKWVEPMBSA-N
21874	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3599	(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine	-	-	DRUGBANK	DB03757	C11H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAXZAMSRJZWMEV-NKWVEPMBSA-N
21875	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3599	(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine	-	-	DRUGBANK	DB03757	C11H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAXZAMSRJZWMEV-NKWVEPMBSA-N
21876	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3600	Radicicol	-	-	DRUGBANK	DB03758	C18H23ClO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPBJMOGBFQDN-YMYQVXQQSA-N
21877	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3600	Radicicol	-	-	DRUGBANK	DB03758	C18H23ClO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPBJMOGBFQDN-YMYQVXQQSA-N
21878	108081	1737	-	DLAT	DLTA|PDC-E2|PDCE2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3600	Radicicol	-	-	DRUGBANK	DB03758	C18H23ClO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPBJMOGBFQDN-YMYQVXQQSA-N
21879	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3600	Radicicol	-	-	DRUGBANK	DB03758	C18H23ClO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AECPBJMOGBFQDN-YMYQVXQQSA-N
21880	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3601	FG-9041	6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX	-	DRUGBANK	DB03759	C8H4N4O6	small molecule	-	2379-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVIMCIPOAXUDG-UHFFFAOYSA-N
21881	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3601	FG-9041	6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX	-	DRUGBANK	DB03759	C8H4N4O6	small molecule	-	2379-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVIMCIPOAXUDG-UHFFFAOYSA-N
21882	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3601	FG-9041	6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX	-	DRUGBANK	DB03759	C8H4N4O6	small molecule	-	2379-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVIMCIPOAXUDG-UHFFFAOYSA-N
21883	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3602	Dihydrolipoic Acid	-	-	DRUGBANK	DB03760	C8H16O2S2	small molecule	-	462-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZFHEQBZOYJLPK-SSDOTTSWSA-N
21884	108923	2653	-	GCSH	GCE|NKH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3602	Dihydrolipoic Acid	-	-	DRUGBANK	DB03760	C8H16O2S2	small molecule	-	462-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZFHEQBZOYJLPK-SSDOTTSWSA-N
21885	108081	1737	-	DLAT	DLTA|PDC-E2|PDCE2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3602	Dihydrolipoic Acid	-	-	DRUGBANK	DB03760	C8H16O2S2	small molecule	-	462-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZFHEQBZOYJLPK-SSDOTTSWSA-N
21886	857144	939555	BSU17680	thyA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3603	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	-	-	DRUGBANK	DB03761	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFEKDTCAMMOLQP-DSYKOEDSSA-N
21887	857144	939555	BSU17680	thyA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3603	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	-	-	DRUGBANK	DB03761	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFEKDTCAMMOLQP-DSYKOEDSSA-N
21888	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3603	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	-	-	DRUGBANK	DB03761	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFEKDTCAMMOLQP-DSYKOEDSSA-N
21889	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3603	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	-	-	DRUGBANK	DB03761	C9H12FN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFEKDTCAMMOLQP-DSYKOEDSSA-N
21890	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3606	2'-cytidylic acid	cytidine 2'-phosphate|2'-CMP|2'-cytidinephosphoric acid|Cytidine-2'-monophosphate|Cytidine, 2'-phosphate	-	DRUGBANK	DB03765	C9H14N3O8P	small molecule	-	85-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQUAKORMLHPSLZ-XVFCMESISA-N
21891	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3606	2'-cytidylic acid	cytidine 2'-phosphate|2'-CMP|2'-cytidinephosphoric acid|Cytidine-2'-monophosphate|Cytidine, 2'-phosphate	-	DRUGBANK	DB03765	C9H14N3O8P	small molecule	-	85-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQUAKORMLHPSLZ-XVFCMESISA-N
21892	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3606	2'-cytidylic acid	cytidine 2'-phosphate|2'-CMP|2'-cytidinephosphoric acid|Cytidine-2'-monophosphate|Cytidine, 2'-phosphate	-	DRUGBANK	DB03765	C9H14N3O8P	small molecule	-	85-94-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQUAKORMLHPSLZ-XVFCMESISA-N
21893	115537	10243	-	GPHN	GEPH|GPH|GPHRYN|HKPX1|MOCODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3607	Propanoic Acid	-	-	DRUGBANK	DB03766	C3H6O2	small molecule	-	79-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBDQKXXYIPTUBI-UHFFFAOYSA-N
21894	115537	10243	-	GPHN	GEPH|GPH|GPHRYN|HKPX1|MOCODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3607	Propanoic Acid	-	-	DRUGBANK	DB03766	C3H6O2	small molecule	-	79-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBDQKXXYIPTUBI-UHFFFAOYSA-N
21895	115537	10243	-	GPHN	GEPH|GPH|GPHRYN|HKPX1|MOCODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3607	Propanoic Acid	-	-	DRUGBANK	DB03766	C3H6O2	small molecule	-	79-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBDQKXXYIPTUBI-UHFFFAOYSA-N
21896	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3608	Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide	-	-	DRUGBANK	DB03767	C21H30N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXEDKIMJQBOMSU-MOPGFXCFSA-N
21897	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3608	Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide	-	-	DRUGBANK	DB03767	C21H30N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXEDKIMJQBOMSU-MOPGFXCFSA-N
21898	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3608	Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide	-	-	DRUGBANK	DB03767	C21H30N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXEDKIMJQBOMSU-MOPGFXCFSA-N
21899	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3610	D-Eritadenine	Eritadenine|Lentysine|Lentinacin	-	DRUGBANK	DB03769	C9H11N5O4	small molecule	-	23918-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIEMBEWXEZJEEZ-INEUFUBQSA-N
21900	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3610	D-Eritadenine	Eritadenine|Lentysine|Lentinacin	-	DRUGBANK	DB03769	C9H11N5O4	small molecule	-	23918-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIEMBEWXEZJEEZ-INEUFUBQSA-N
21901	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3610	D-Eritadenine	Eritadenine|Lentysine|Lentinacin	-	DRUGBANK	DB03769	C9H11N5O4	small molecule	-	23918-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIEMBEWXEZJEEZ-INEUFUBQSA-N
21902	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3613	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol	-	-	DRUGBANK	DB03772	C12H24O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXGXIVBQPNUSRY-DDHJBXDOSA-N
21903	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3613	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol	-	-	DRUGBANK	DB03772	C12H24O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXGXIVBQPNUSRY-DDHJBXDOSA-N
21904	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3613	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol	-	-	DRUGBANK	DB03772	C12H24O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXGXIVBQPNUSRY-DDHJBXDOSA-N
21905	849746	945370	b0775	bioB	ECK0764|JW0758	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3616	D-Dethiobiotin	-	-	DRUGBANK	DB03775	C10H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUTOLBMXDDTRRT-JGVFFNPUSA-N
21906	849746	945370	b0775	bioB	ECK0764|JW0758	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3616	D-Dethiobiotin	-	-	DRUGBANK	DB03775	C10H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUTOLBMXDDTRRT-JGVFFNPUSA-N
21907	849746	945370	b0775	bioB	ECK0764|JW0758	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3616	D-Dethiobiotin	-	-	DRUGBANK	DB03775	C10H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUTOLBMXDDTRRT-JGVFFNPUSA-N
21908	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3616	D-Dethiobiotin	-	-	DRUGBANK	DB03775	C10H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUTOLBMXDDTRRT-JGVFFNPUSA-N
21909	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3616	D-Dethiobiotin	-	-	DRUGBANK	DB03775	C10H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUTOLBMXDDTRRT-JGVFFNPUSA-N
21910	849762	945387	b0778	bioD	ECK0767|JW0761	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3616	D-Dethiobiotin	-	-	DRUGBANK	DB03775	C10H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUTOLBMXDDTRRT-JGVFFNPUSA-N
21911	111570	5584	-	PRKCI	DXS1179E|PKCI|nPKC-iota	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21912	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21913	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21914	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21915	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3618	Rbt205 Inhibitor	-	-	DRUGBANK	DB03777	C25H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMGUOJYZJKLOLH-UHFFFAOYSA-N
21916	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3621	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	-	-	DRUGBANK	DB03781	C15H12Cl2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOLBCHYXZDXLDS-SECBINFHSA-N
21917	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3622	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	-	-	DRUGBANK	DB03782	C19H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQPLKJCBEOVDBS-CSVIQDERSA-N
21918	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3622	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	-	-	DRUGBANK	DB03782	C19H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQPLKJCBEOVDBS-CSVIQDERSA-N
21919	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3622	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	-	-	DRUGBANK	DB03782	C19H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQPLKJCBEOVDBS-CSVIQDERSA-N
21920	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3623	Phenacetin	Acetophenetin|Acetphenetidin|Acetophenetidine|Acetophenetidin	-	DRUGBANK	DB03783	C10H13NO2	small molecule	N02BE73|N02BE03|N02BE53	62-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJSUEIXXCENMM-UHFFFAOYSA-N
21921	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3624	Elaidoylamide	-	-	DRUGBANK	DB03784	C18H35NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FATBGEAMYMYZAF-MDZDMXLPSA-N
21922	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3624	Elaidoylamide	-	-	DRUGBANK	DB03784	C18H35NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FATBGEAMYMYZAF-MDZDMXLPSA-N
21923	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3624	Elaidoylamide	-	-	DRUGBANK	DB03784	C18H35NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FATBGEAMYMYZAF-MDZDMXLPSA-N
21924	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3627	GC-24	-	-	DRUGBANK	DB03788	C24H24O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYHIGYLGYNCMGI-UHFFFAOYSA-N
21925	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3627	GC-24	-	-	DRUGBANK	DB03788	C24H24O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYHIGYLGYNCMGI-UHFFFAOYSA-N
21926	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3630	(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid	-	-	DRUGBANK	DB03791	C33H37ClF3NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVXMWVZLCQSTKR-GDLZYMKVSA-N
21927	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3630	(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid	-	-	DRUGBANK	DB03791	C33H37ClF3NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVXMWVZLCQSTKR-GDLZYMKVSA-N
21928	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3631	5-Amino-1h-Pyrimidine-2,4-Dione	-	-	DRUGBANK	DB03792	C4H5N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BISHACNKZIBDFM-UHFFFAOYSA-N
21929	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3631	5-Amino-1h-Pyrimidine-2,4-Dione	-	-	DRUGBANK	DB03792	C4H5N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BISHACNKZIBDFM-UHFFFAOYSA-N
21930	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3631	5-Amino-1h-Pyrimidine-2,4-Dione	-	-	DRUGBANK	DB03792	C4H5N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BISHACNKZIBDFM-UHFFFAOYSA-N
21931	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21932	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21933	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21934	850101	945731	b1461	pptA	ECK1455|JW1456|ydcE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21935	850101	945731	b1461	pptA	ECK1455|JW1456|ydcE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21936	852758	948462	b3961	oxyR	ECK3953|JW3933|momR|mor	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21937	852758	948462	b3961	oxyR	ECK3953|JW3933|momR|mor	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21938	115541	10247	-	HRSP12	P14.5|PSP|UK114	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21939	115541	10247	-	HRSP12	P14.5|PSP|UK114	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21940	114768	9367	-	RAB9A	RAB9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21941	114768	9367	-	RAB9A	RAB9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21942	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21943	117352	25824	SBBI10	PRDX5	ACR1|AOEB166|B166|HEL-S-55|PLP|PMP20|PRDX6|PRXV|prx-V	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21944	852230	947921	b3418	malT	ECK3405|JW3381|malA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21945	852230	947921	b3418	malT	ECK3405|JW3381|malA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3632	Benzoic Acid	-	larynsol loz|hyophen|mrx liq|c	DRUGBANK	DB03793	C7H6O2	small molecule	A16AX11|V04CG30	65-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPYMKLBDIGXBTP-UHFFFAOYSA-N
21946	849239	944839	b0134	panB	ECK0133|JW0130|panA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3634	2-Dehydropantoate	-	-	DRUGBANK	DB03795	C6H10O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PKVVTUWHANFMQC-UHFFFAOYSA-N
21947	849239	944839	b0134	panB	ECK0133|JW0130|panA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3634	2-Dehydropantoate	-	-	DRUGBANK	DB03795	C6H10O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PKVVTUWHANFMQC-UHFFFAOYSA-N
21948	117085	23541	-	SEC14L2	C22orf6|SPF|TAP|TAP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21949	117085	23541	-	SEC14L2	C22orf6|SPF|TAP|TAP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21950	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21951	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21952	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21953	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21954	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21955	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21956	107936	1558	-	CYP2C8	CPC8|CYPIIC8|MP-12/MP-20	9606	Homo sapiens	unknown	target	Schoch GA (2004)	14676196	181840	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21957	111530	5538	RP11-115D7.2	PPT1	CLN1|INCL|PPT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21958	111530	5538	RP11-115D7.2	PPT1	CLN1|INCL|PPT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21959	111530	5538	RP11-115D7.2	PPT1	CLN1|INCL|PPT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21960	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21961	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21962	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21963	110101	3906	-	LALBA	-	9606	Homo sapiens	unknown	target	Barbana C (2008)	18620538	182082	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21964	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3638	Trifluoromethionine	-	-	DRUGBANK	DB03799	C5H8F3NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJLTSVBCXYTQK-VKHMYHEASA-N
21965	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3638	Trifluoromethionine	-	-	DRUGBANK	DB03799	C5H8F3NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJLTSVBCXYTQK-VKHMYHEASA-N
21966	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3638	Trifluoromethionine	-	-	DRUGBANK	DB03799	C5H8F3NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJLTSVBCXYTQK-VKHMYHEASA-N
21967	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3638	Trifluoromethionine	-	-	DRUGBANK	DB03799	C5H8F3NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLJLTSVBCXYTQK-VKHMYHEASA-N
21968	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21969	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21970	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21971	852900	948607	b3640	dut	ECK3630|JW3615|dnaS|sof	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21972	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21973	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21974	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3639	2'-deoxyuridylic acid	dUMP	-	DRUGBANK	DB03800	C9H13N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSRLJPSBLDHEIO-SHYZEUOFSA-N
21975	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21976	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21977	853133	948853	b4328	iadA	ECK4319|JW4291|yjiF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21978	853133	948853	b4328	iadA	ECK4319|JW4291|yjiF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21979	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21980	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21981	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21982	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21983	849192	944791	b0085	murE	ECK0086|JW0083	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21984	849192	944791	b0085	murE	ECK0086|JW0083	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3640	Lysine Nz-Carboxylic Acid	-	-	DRUGBANK	DB03801	C7H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWIKLEYMFKCERQ-YFKPBYRVSA-N
21985	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3641	1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB03802	C29H33N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGHFWBDHZZKWSI-GGXMVOPNSA-N
21986	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3641	1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB03802	C29H33N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGHFWBDHZZKWSI-GGXMVOPNSA-N
21987	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3644	Antiproliferative Agent A771726	-	-	DRUGBANK	DB03805	C12H11F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YODXEQNROKSLLQ-GMSGAONNSA-N
21988	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3644	Antiproliferative Agent A771726	-	-	DRUGBANK	DB03805	C12H11F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YODXEQNROKSLLQ-GMSGAONNSA-N
21989	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3644	Antiproliferative Agent A771726	-	-	DRUGBANK	DB03805	C12H11F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YODXEQNROKSLLQ-GMSGAONNSA-N
21990	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3645	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03807	C14H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQCKNCFQOJFQFK-UHFFFAOYSA-N
21991	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3645	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03807	C14H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQCKNCFQOJFQFK-UHFFFAOYSA-N
21992	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3645	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB03807	C14H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQCKNCFQOJFQFK-UHFFFAOYSA-N
21993	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3647	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB03809	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWLWUGBHOXIUBP-UHFFFAOYSA-N
21994	850878	946531	b2020	hisD	ECK2015|JW2002	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3649	Histidinol	-	-	DRUGBANK	DB03811	C6H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21995	850878	946531	b2020	hisD	ECK2015|JW2002	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3649	Histidinol	-	-	DRUGBANK	DB03811	C6H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21996	851328	946989	b2514	hisS	ECK2510|JW2498	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3649	Histidinol	-	-	DRUGBANK	DB03811	C6H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21997	851328	946989	b2514	hisS	ECK2510|JW2498	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3649	Histidinol	-	-	DRUGBANK	DB03811	C6H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
21998	849942	945568	b0954	fabA	ECK0945|JW0937	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3651	2-Decenoyl N-Acetyl Cysteamine	-	-	DRUGBANK	DB03813	C14H25NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYDKTIAWESXLEF-KTKRTIGZSA-N
21999	121129	56269	-	IRGC	CINEMA|IFGGE|IRGC1|Iigp5|R30953_1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22000	851992	947679	b1779	gapA	ECK1777|JW1768	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22001	851992	947679	b1779	gapA	ECK1777|JW1768	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22002	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22003	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22004	108950	2683	-	B4GALT1	B4GAL-T1|CDG2D|GGTB2|GT1|GTB|beta4Gal-T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22005	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22006	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22007	851686	947363	b2893	dsbC	ECK2888|JW2861|xprA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22008	851686	947363	b2893	dsbC	ECK2888|JW2861|xprA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22009	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22010	852543	948241	b3729	glmS	ECK3722|JW3707	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22011	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22012	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22013	575839	653509	RP11-589B3.2	SFTPA1	COLEC4|PSAP|PSP-A|PSPA|SFTP1|SFTPA1B|SP-A|SP-A1|SPA|SPA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22014	106927	435	-	ASL	ASAL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22015	114956	9588	-	PRDX6	1-Cys|AOP2|HEL-S-128m|NSGPx|PRX|aiPLA2|p29	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22016	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22017	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22018	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22019	111798	5860	-	QDPR	DHPR|PKU2|SDR33C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22020	852548	948246	b3730	glmU	ECK3723|JW3708|tms|yieA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22021	852548	948246	b3730	glmU	ECK3723|JW3708|tms|yieA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22022	106896	403	RP11-47A8.3	ARL3	ARFL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22023	852476	948169	b3656	yicI	ECK3646|JW3631	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22024	852476	948169	b3656	yicI	ECK3646|JW3631	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22025	851640	947313	b2838	lysA	ECK2836|JW2806	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22026	851640	947313	b2838	lysA	ECK2836|JW2806	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22027	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22028	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3652	2-(N-Morpholino)-Ethanesulfonic Acid	-	-	DRUGBANK	DB03814	C6H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXGZJKUKBWWHRA-UHFFFAOYSA-N
22029	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3654	Difluoromethionine	-	-	DRUGBANK	DB03816	C5H9F2NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHBNXKYHZMAFED-VKHMYHEASA-N
22030	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3654	Difluoromethionine	-	-	DRUGBANK	DB03816	C5H9F2NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHBNXKYHZMAFED-VKHMYHEASA-N
22031	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3656	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	-	-	DRUGBANK	DB03818	C14H20N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWUYDTGYTUQMDG-CYBMUJFWSA-N
22032	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3656	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	-	-	DRUGBANK	DB03818	C14H20N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWUYDTGYTUQMDG-CYBMUJFWSA-N
22033	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3656	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	-	-	DRUGBANK	DB03818	C14H20N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWUYDTGYTUQMDG-CYBMUJFWSA-N
22034	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3662	7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline	-	-	DRUGBANK	DB03824	C9H10IN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFCFXJXBXUOFIU-UHFFFAOYSA-N
22035	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3662	7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline	-	-	DRUGBANK	DB03824	C9H10IN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFCFXJXBXUOFIU-UHFFFAOYSA-N
22036	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3662	7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline	-	-	DRUGBANK	DB03824	C9H10IN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFCFXJXBXUOFIU-UHFFFAOYSA-N
22037	849497	945108	b0462	acrB	ECK0456|JW0451|acrE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3663	Rhodamine 6G	Basic red 1|R6G|CI basic red 1|Calcozine rhodamine 6GX	-	DRUGBANK	DB03825	C28H31ClN2O3	small molecule	-	989-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFKVYXCRNATCOO-UHFFFAOYSA-M
22038	849497	945108	b0462	acrB	ECK0456|JW0451|acrE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3663	Rhodamine 6G	Basic red 1|R6G|CI basic red 1|Calcozine rhodamine 6GX	-	DRUGBANK	DB03825	C28H31ClN2O3	small molecule	-	989-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFKVYXCRNATCOO-UHFFFAOYSA-M
22039	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3666	RU78299	-	-	DRUGBANK	DB03828	C9H9O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAYNUXXSJZLKPW-UHFFFAOYSA-N
22040	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3668	Phosphorylated Dihydropteroate	-	-	DRUGBANK	DB03830	C14H13N6O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNKVHXNVVYQUDC-UHFFFAOYSA-N
22041	849825	945451	b2315	folC	ECK2309|JW2312|dedC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3668	Phosphorylated Dihydropteroate	-	-	DRUGBANK	DB03830	C14H13N6O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNKVHXNVVYQUDC-UHFFFAOYSA-N
22042	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3670	3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium	-	-	DRUGBANK	DB03832	C15H30NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXTATJFJDMJMIY-ZDUSSCGKSA-O
22043	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3670	3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium	-	-	DRUGBANK	DB03832	C15H30NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXTATJFJDMJMIY-ZDUSSCGKSA-O
22044	120098	54677	-	CROT	COT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3670	3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium	-	-	DRUGBANK	DB03832	C15H30NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXTATJFJDMJMIY-ZDUSSCGKSA-O
22045	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3673	N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide	-	-	DRUGBANK	DB03835	C10H15N3O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAHIOGAAEAWGLR-WIWHXQPGSA-N
22046	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3673	N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide	-	-	DRUGBANK	DB03835	C10H15N3O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAHIOGAAEAWGLR-WIWHXQPGSA-N
22047	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3673	N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide	-	-	DRUGBANK	DB03835	C10H15N3O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAHIOGAAEAWGLR-WIWHXQPGSA-N
22048	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3675	Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide	-	-	DRUGBANK	DB03837	C28H37N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUMYYTORLYHUFW-ZUDLOMHPSA-N
22049	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3675	Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide	-	-	DRUGBANK	DB03837	C28H37N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUMYYTORLYHUFW-ZUDLOMHPSA-N
22050	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3678	Y-700	-	-	DRUGBANK	DB03841	C16H17N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AETHRPHBGJAIBT-UHFFFAOYSA-N
22051	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3681	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03844	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFNCKGXGCCDDFN-UHFFFAOYSA-N
22052	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3681	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03844	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFNCKGXGCCDDFN-UHFFFAOYSA-N
22053	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3681	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03844	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFNCKGXGCCDDFN-UHFFFAOYSA-N
22054	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3682	P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate	-	-	DRUGBANK	DB03845	C20H24N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNIWSXQXLJIUJW-HCYMPCJFSA-I
22055	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3682	P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate	-	-	DRUGBANK	DB03845	C20H24N10O22P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNIWSXQXLJIUJW-HCYMPCJFSA-I
22056	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22057	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22058	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22059	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22060	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3684	Gamma-Carboxy-Glutamic Acid	-	-	DRUGBANK	DB03847	C6H9NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBYWPGGCSDKFX-VKHMYHEASA-N
22061	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3685	Benzenesulfonyl	-	-	DRUGBANK	DB03848	C6H6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEHKKBHWRAXMCH-UHFFFAOYSA-N
22062	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3685	Benzenesulfonyl	-	-	DRUGBANK	DB03848	C6H6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEHKKBHWRAXMCH-UHFFFAOYSA-N
22068	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3687	Jaspisamide A	-	-	DRUGBANK	DB03850	C44H64N4O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMTDLKOWOZYTPX-CQJHWTDNSA-N
22069	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3687	Jaspisamide A	-	-	DRUGBANK	DB03850	C44H64N4O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMTDLKOWOZYTPX-CQJHWTDNSA-N
22070	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3687	Jaspisamide A	-	-	DRUGBANK	DB03850	C44H64N4O13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMTDLKOWOZYTPX-CQJHWTDNSA-N
22071	852571	948269	b2747	ispD	ECK2742|JW2717|ygbP	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3691	Pentane-1,5-Diamine	-	-	DRUGBANK	DB03854	C5H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRGRCVQAFMJIZ-UHFFFAOYSA-N
22072	852571	948269	b2747	ispD	ECK2742|JW2717|ygbP	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3691	Pentane-1,5-Diamine	-	-	DRUGBANK	DB03854	C5H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRGRCVQAFMJIZ-UHFFFAOYSA-N
22073	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3692	L-Threonohydroxamate 4-Phosphate	-	-	DRUGBANK	DB03855	C4H12NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSVKNYIFCYRDJM-FLRLBIABSA-N
22074	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3692	L-Threonohydroxamate 4-Phosphate	-	-	DRUGBANK	DB03855	C4H12NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSVKNYIFCYRDJM-FLRLBIABSA-N
22075	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3693	Alpha-Difluoromethylornithine	-	-	DRUGBANK	DB03856	C6H12F2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLCYCQAOQCDTCN-ZCFIWIBFSA-N
22076	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3693	Alpha-Difluoromethylornithine	-	-	DRUGBANK	DB03856	C6H12F2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLCYCQAOQCDTCN-ZCFIWIBFSA-N
22077	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3693	Alpha-Difluoromethylornithine	-	-	DRUGBANK	DB03856	C6H12F2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLCYCQAOQCDTCN-ZCFIWIBFSA-N
22078	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3697	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	-	-	DRUGBANK	DB03860	C34H55NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVVFOLSZMQVDKV-ILEXQBCSSA-N
22079	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3697	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	-	-	DRUGBANK	DB03860	C34H55NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVVFOLSZMQVDKV-ILEXQBCSSA-N
22080	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3697	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	-	-	DRUGBANK	DB03860	C34H55NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVVFOLSZMQVDKV-ILEXQBCSSA-N
22081	109323	3074	HCC7	HEXB	ENC-1AS|HEL-248	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3698	(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium	-	-	DRUGBANK	DB03861	C8H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVRQJNSUOIUFV-HSNKUXOKSA-N
22082	109323	3074	HCC7	HEXB	ENC-1AS|HEL-248	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3698	(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium	-	-	DRUGBANK	DB03861	C8H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWVRQJNSUOIUFV-HSNKUXOKSA-N
22083	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3701	Monothioglycerol	-	-	DRUGBANK	DB03864	C3H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJUIMOJAAPLTRJ-GSVOUGTGSA-N
22084	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3701	Monothioglycerol	-	-	DRUGBANK	DB03864	C3H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJUIMOJAAPLTRJ-GSVOUGTGSA-N
22085	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3701	Monothioglycerol	-	-	DRUGBANK	DB03864	C3H8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJUIMOJAAPLTRJ-GSVOUGTGSA-N
22086	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3702	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB03865	C21H17ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEKRWNWZMOSVBX-UHFFFAOYSA-O
22087	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3702	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB03865	C21H17ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEKRWNWZMOSVBX-UHFFFAOYSA-O
22088	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3702	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB03865	C21H17ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEKRWNWZMOSVBX-UHFFFAOYSA-O
22089	109486	3249	-	HPN	TMPRSS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3702	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	-	-	DRUGBANK	DB03865	C21H17ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEKRWNWZMOSVBX-UHFFFAOYSA-O
22090	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3703	Prostaglandin G2	-	-	DRUGBANK	DB03866	C20H32O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUKUZOVHSFKPH-YNNPMVKQSA-N
22091	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3704	Meta-Nitro-Tyrosine	-	-	DRUGBANK	DB03867	C9H10N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBTSQILOGYXGMD-LURJTMIESA-N
22092	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3704	Meta-Nitro-Tyrosine	-	-	DRUGBANK	DB03867	C9H10N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBTSQILOGYXGMD-LURJTMIESA-N
22093	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3713	Thieno[2,3-B]Pyridine-2-Carboxamidine	-	-	DRUGBANK	DB03876	C8H8N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZEJMYFXZMUAEC-UHFFFAOYSA-O
22094	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3713	Thieno[2,3-B]Pyridine-2-Carboxamidine	-	-	DRUGBANK	DB03876	C8H8N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZEJMYFXZMUAEC-UHFFFAOYSA-O
22095	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3714	AL4623	-	-	DRUGBANK	DB03877	C11H19N3O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XACIEZJJSXJZMD-SECBINFHSA-N
22096	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3714	AL4623	-	-	DRUGBANK	DB03877	C11H19N3O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XACIEZJJSXJZMD-SECBINFHSA-N
22097	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3715	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	-	-	DRUGBANK	DB03878	C22H18N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWQVBESSYLICRX-UHFFFAOYSA-N
22098	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3716	alpha-L-methyl-fucose	-	-	DRUGBANK	DB03879	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHWCAVRRXKJCRB-CXNFULCWSA-N
22099	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3716	alpha-L-methyl-fucose	-	-	DRUGBANK	DB03879	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHWCAVRRXKJCRB-CXNFULCWSA-N
22100	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3716	alpha-L-methyl-fucose	-	-	DRUGBANK	DB03879	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHWCAVRRXKJCRB-CXNFULCWSA-N
22101	116277	11096	-	ADAMTS5	ADAM-TS 11|ADAM-TS 5|ADAM-TS5|ADAMTS-11|ADAMTS-5|ADAMTS11|ADMP-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22102	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22103	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22104	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22105	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22106	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22107	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22108	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22109	110468	4325	-	MMP16	C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22110	110468	4325	-	MMP16	C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22111	110468	4325	-	MMP16	C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3717	Batimastat	-	-	DRUGBANK	DB03880	C23H31N3O4S2	small molecule	-	130370-60-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFILPEOLDIKJHX-QYZOEREBSA-N
22112	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Shi W (2004)	14982926	181843	3718	MT-Immucillin-H	(1s)-1-(0-Deazahypoxanthin-9-Yl)-1,4-Dideoxy-1,4-Imino-5-Methylthio-D-Ribitol|MT-ImmH|5'-Methylthio-Immucillin-H	-	DRUGBANK	DB03881	C12H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFMVQWXGRIIFDH-SEZOGAINSA-O
22113	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Norata GD (2010)	20557886	182158	3719	5-Alpha-Androstane-3-Beta,17beta-Diol	-	-	DRUGBANK	DB03882	C19H32O2	small molecule	-	571-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBMYJHIOYJEBSB-YSZCXEEOSA-N
22114	854757	937084	BSU37730	bacB	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	3721	3-Phenylpyruvic Acid	-	-	DRUGBANK	DB03884	C9H8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTNMPGBKDVTSJY-UHFFFAOYSA-N
22115	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3721	3-Phenylpyruvic Acid	-	-	DRUGBANK	DB03884	C9H8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTNMPGBKDVTSJY-UHFFFAOYSA-N
22116	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3723	Biopterin	-	-	DRUGBANK	DB03886	C9H11N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHQIJBMDNUYRAM-AWFVSMACSA-N
22117	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3723	Biopterin	-	-	DRUGBANK	DB03886	C9H11N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHQIJBMDNUYRAM-AWFVSMACSA-N
22118	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3723	Biopterin	-	-	DRUGBANK	DB03886	C9H11N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHQIJBMDNUYRAM-AWFVSMACSA-N
22119	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3723	Biopterin	-	-	DRUGBANK	DB03886	C9H11N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHQIJBMDNUYRAM-AWFVSMACSA-N
22120	111769	5805	-	PTS	PTPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3723	Biopterin	-	-	DRUGBANK	DB03886	C9H11N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHQIJBMDNUYRAM-AWFVSMACSA-N
22121	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3726	S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione	-	-	DRUGBANK	DB03889	C17H23BrN4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGZMPQOWGQBWAV-JKDFXYPNSA-N
22122	109279	3029	-	HAGH	GLO2|GLX2|GLXII|HAGH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3726	S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione	-	-	DRUGBANK	DB03889	C17H23BrN4O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGZMPQOWGQBWAV-JKDFXYPNSA-N
22123	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3727	N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide	-	-	DRUGBANK	DB03890	C19H33N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSBJWRKWANAVRQ-POTLKAILSA-N
22124	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3728	1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide	-	-	DRUGBANK	DB03891	C29H40N6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGDUWJVGIGLVOH-DNQXCXABSA-N
22125	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3728	1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide	-	-	DRUGBANK	DB03891	C29H40N6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGDUWJVGIGLVOH-DNQXCXABSA-N
22126	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3728	1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide	-	-	DRUGBANK	DB03891	C29H40N6O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGDUWJVGIGLVOH-DNQXCXABSA-N
22127	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22128	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22129	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22130	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3730	Thionicotinamide-Adenine-Dinucleotide	-	-	DRUGBANK	DB03893	C21H27N7O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQYPZLRUJKCREN-XCSFTKGKSA-N
22131	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3730	Thionicotinamide-Adenine-Dinucleotide	-	-	DRUGBANK	DB03893	C21H27N7O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQYPZLRUJKCREN-XCSFTKGKSA-N
22132	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3730	Thionicotinamide-Adenine-Dinucleotide	-	-	DRUGBANK	DB03893	C21H27N7O13P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQYPZLRUJKCREN-XCSFTKGKSA-N
22133	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3731	N-Propargyl-1(S)-Aminoindan	-	-	DRUGBANK	DB03894	C12H13N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUOKEQAAGRXIBM-LBPRGKRZSA-N
22134	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3733	Triphospate	-	-	DRUGBANK	DB03896	H5O10P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNXRWKVEANCORM-UHFFFAOYSA-N
22135	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3733	Triphospate	-	-	DRUGBANK	DB03896	H5O10P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNXRWKVEANCORM-UHFFFAOYSA-N
22136	116119	10914	-	PAPOLA	PAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3733	Triphospate	-	-	DRUGBANK	DB03896	H5O10P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNXRWKVEANCORM-UHFFFAOYSA-N
22137	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3736	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB03899	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVYATAJRTRFKSW-UHFFFAOYSA-N
22138	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22139	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22140	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22141	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22142	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22143	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22144	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22145	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22146	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22147	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3737	2-Methyl-2-Propanol	-	-	DRUGBANK	DB03900	C4H10O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKGAVHZHDRPRBM-UHFFFAOYSA-N
22148	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3739	Oxalic Acid	-	-	DRUGBANK	DB03902	C2H2O4	small molecule	-	144-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUBZPKHOEPUJKR-UHFFFAOYSA-N
22149	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3739	Oxalic Acid	-	-	DRUGBANK	DB03902	C2H2O4	small molecule	-	144-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUBZPKHOEPUJKR-UHFFFAOYSA-N
22150	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3739	Oxalic Acid	-	-	DRUGBANK	DB03902	C2H2O4	small molecule	-	144-62-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUBZPKHOEPUJKR-UHFFFAOYSA-N
22151	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3740	Tmr	-	-	DRUGBANK	DB03903	C28H25N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFLZYXDJDOIEE-UHFFFAOYSA-N
22152	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3740	Tmr	-	-	DRUGBANK	DB03903	C28H25N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFLZYXDJDOIEE-UHFFFAOYSA-N
22153	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3740	Tmr	-	-	DRUGBANK	DB03903	C28H25N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFLZYXDJDOIEE-UHFFFAOYSA-N
22154	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22155	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22156	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22157	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22158	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22159	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22160	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22161	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22162	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22163	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22164	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3743	2-Phenylheme	-	-	DRUGBANK	DB03906	C40H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHCCVTLDOSIQDM-NULOGZTHSA-L
22165	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3743	2-Phenylheme	-	-	DRUGBANK	DB03906	C40H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHCCVTLDOSIQDM-NULOGZTHSA-L
22166	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3744	N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide	-	-	DRUGBANK	DB03907	C19H20N7O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMADSMUMXWKIMS-PINBASSTSA-N
22167	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3744	N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide	-	-	DRUGBANK	DB03907	C19H20N7O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMADSMUMXWKIMS-PINBASSTSA-N
22168	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3744	N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide	-	-	DRUGBANK	DB03907	C19H20N7O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMADSMUMXWKIMS-PINBASSTSA-N
22169	852246	947937	b3437	gntK	ECK3422|JW3400	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22170	852246	947937	b3437	gntK	ECK3422|JW3400	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22171	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22172	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22173	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22174	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22175	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22176	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22177	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22178	852562	948260	b3752	rbsK	ECK3746|JW3731	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22179	852562	948260	b3752	rbsK	ECK3746|JW3731	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22180	111251	5230	RP4-570L12.1	PGK1	HEL-S-68p|MIG10|PGKA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22181	111251	5230	RP4-570L12.1	PGK1	HEL-S-68p|MIG10|PGKA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22182	111251	5230	RP4-570L12.1	PGK1	HEL-S-68p|MIG10|PGKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22183	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22184	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22185	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3746	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	-	-	DRUGBANK	DB03909	C11H18N5O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFZTZBNSLXELAL-WOIOKPISSA-N
22186	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3747	S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	-	-	DRUGBANK	DB03910	C12H18N4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEUSLPIIQGZHQB-UHFFFAOYSA-N
22187	852445	948138	b3617	kbl	ECK3607|JW3592	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3752	2-Amino-3-Ketobutyric Acid	-	-	DRUGBANK	DB03915	C4H7NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAUCHDKDCUROAO-VKHMYHEASA-N
22188	852445	948138	b3617	kbl	ECK3607|JW3592	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3752	2-Amino-3-Ketobutyric Acid	-	-	DRUGBANK	DB03915	C4H7NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAUCHDKDCUROAO-VKHMYHEASA-N
22189	851209	946869	b2412	zipA	ECK2407|JW2404	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3753	4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine	-	-	DRUGBANK	DB03916	C22H26ClN7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHOOHUMOHVIXEF-UHFFFAOYSA-N
22190	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3755	6S-5,6,7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB03918	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-ZMIZWQJLSA-N
22191	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3755	6S-5,6,7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB03918	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-ZMIZWQJLSA-N
22192	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3755	6S-5,6,7,8-Tetrahydrobiopterin	-	-	DRUGBANK	DB03918	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNKQXYHWGSIFBK-ZMIZWQJLSA-N
22193	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3758	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline	-	-	DRUGBANK	DB03921	C17H12N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBCXZJCWDGCXQT-UHFFFAOYSA-N
22194	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3759	Feruloyl Coenzyme A	-	-	DRUGBANK	DB03923	C31H44N7O20P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILSPFIPSQSFPCN-VYBUCKLUSA-N
22195	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3759	Feruloyl Coenzyme A	-	-	DRUGBANK	DB03923	C31H44N7O20P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILSPFIPSQSFPCN-VYBUCKLUSA-N
22196	125625	118881	UNQ766/PRO1558	COMTD1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3759	Feruloyl Coenzyme A	-	-	DRUGBANK	DB03923	C31H44N7O20P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILSPFIPSQSFPCN-VYBUCKLUSA-N
22197	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3760	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	-	-	DRUGBANK	DB03924	C14H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVEMRPAUHFWHRV-UHFFFAOYSA-N
22198	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	inhibitor	target	Yoshimura Y (2003)	14530017	181836	3761	ONO-6818	CP-955	-	DRUGBANK	DB03925	C23H30N6O4	small molecule	-	208848-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMPQTEPEMQZWQH-QZTJIDSGSA-N
22199	108306	1991	-	ELANE	ELA2|GE|HLE|HNE|NE|PMN-E|SCN1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3761	ONO-6818	CP-955	-	DRUGBANK	DB03925	C23H30N6O4	small molecule	-	208848-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMPQTEPEMQZWQH-QZTJIDSGSA-N
22200	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3761	ONO-6818	CP-955	-	DRUGBANK	DB03925	C23H30N6O4	small molecule	-	208848-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMPQTEPEMQZWQH-QZTJIDSGSA-N
22201	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3761	ONO-6818	CP-955	-	DRUGBANK	DB03925	C23H30N6O4	small molecule	-	208848-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMPQTEPEMQZWQH-QZTJIDSGSA-N
22202	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3761	ONO-6818	CP-955	-	DRUGBANK	DB03925	C23H30N6O4	small molecule	-	208848-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMPQTEPEMQZWQH-QZTJIDSGSA-N
22203	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3764	Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol	-	-	DRUGBANK	DB03928	C10H7ClN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGDMJXZYDKFEGJ-UHFFFAOYSA-N
22204	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3765	D-Serine	-	-	DRUGBANK	DB03929	C3H7NO3	small molecule	-	312-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-UWTATZPHSA-N
22205	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3765	D-Serine	-	-	DRUGBANK	DB03929	C3H7NO3	small molecule	-	312-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-UWTATZPHSA-N
22206	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3765	D-Serine	-	-	DRUGBANK	DB03929	C3H7NO3	small molecule	-	312-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-UWTATZPHSA-N
22207	112223	6317	-	SERPINB3	HsT1196|SCC|SCCA-1|SCCA-PD|SCCA1|T4-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3765	D-Serine	-	-	DRUGBANK	DB03929	C3H7NO3	small molecule	-	312-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-UWTATZPHSA-N
22208	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3765	D-Serine	-	-	DRUGBANK	DB03929	C3H7NO3	small molecule	-	312-84-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MTCFGRXMJLQNBG-UWTATZPHSA-N
22209	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3768	LFA703	-	-	DRUGBANK	DB03932	C37H49NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPVRNXUYVXQXPY-UVJQNAMXSA-N
22210	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3768	LFA703	-	-	DRUGBANK	DB03932	C37H49NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPVRNXUYVXQXPY-UVJQNAMXSA-N
22211	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3770	Protoporphyrin Ix Containing Zn	-	-	DRUGBANK	DB03934	C34H32N4O4Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIKDOVQLXOIXCZ-RGGAHWMASA-L
22212	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3770	Protoporphyrin Ix Containing Zn	-	-	DRUGBANK	DB03934	C34H32N4O4Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIKDOVQLXOIXCZ-RGGAHWMASA-L
22213	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3770	Protoporphyrin Ix Containing Zn	-	-	DRUGBANK	DB03934	C34H32N4O4Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIKDOVQLXOIXCZ-RGGAHWMASA-L
22214	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22215	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22216	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22217	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22218	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3771	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03935	C6H10O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRTONBQROPNEJZ-UOWFLXDJSA-N
22219	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3773	Erythose-4-Phosphate	-	-	DRUGBANK	DB03937	C4H9O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGHMDNPXVRFFGS-IMJSIDKUSA-N
22220	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3773	Erythose-4-Phosphate	-	-	DRUGBANK	DB03937	C4H9O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGHMDNPXVRFFGS-IMJSIDKUSA-N
22221	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3773	Erythose-4-Phosphate	-	-	DRUGBANK	DB03937	C4H9O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGHMDNPXVRFFGS-IMJSIDKUSA-N
22222	849391	944996	b0337	codA	ECK0334|JW0328	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3775	4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One	-	-	DRUGBANK	DB03939	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEAAWXYGBWCVJW-GSVOUGTGSA-N
22223	849391	944996	b0337	codA	ECK0334|JW0328	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3775	4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One	-	-	DRUGBANK	DB03939	C4H6N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEAAWXYGBWCVJW-GSVOUGTGSA-N
22224	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22225	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22226	110131	3939	PIG19	LDHA	GSD11|HEL-S-133P|LDH1|LDHM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22227	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22228	110137	3945	-	LDHB	HEL-S-281|LDH-B|LDH-H|LDHBD|TRG-5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22229	849888	945514	b0903	pflB	ECK0894|JW0886|pfl	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22230	849888	945514	b0903	pflB	ECK0894|JW0886|pfl	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3776	Oxamic Acid	-	-	DRUGBANK	DB03940	C2H3NO3	small molecule	-	471-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOWBFZRMHSNYGE-UHFFFAOYSA-N
22231	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3778	Carboxylic PRPP	CPRPP	-	DRUGBANK	DB03942	C6H15O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OICBXEWBKALHHB-FSIIMWSLSA-N
22232	849218	944817	b0238	gpt	ECK0239|JW0228|gpp|gxu	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3778	Carboxylic PRPP	CPRPP	-	DRUGBANK	DB03942	C6H15O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OICBXEWBKALHHB-FSIIMWSLSA-N
22233	851135	946794	b2312	purF	ECK2306|JW2309|ade|purC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3778	Carboxylic PRPP	CPRPP	-	DRUGBANK	DB03942	C6H15O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OICBXEWBKALHHB-FSIIMWSLSA-N
22234	851135	946794	b2312	purF	ECK2306|JW2309|ade|purC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3778	Carboxylic PRPP	CPRPP	-	DRUGBANK	DB03942	C6H15O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OICBXEWBKALHHB-FSIIMWSLSA-N
22235	854676	937000	BSU00470	purR	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3778	Carboxylic PRPP	CPRPP	-	DRUGBANK	DB03942	C6H15O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OICBXEWBKALHHB-FSIIMWSLSA-N
22236	854676	937000	BSU00470	purR	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3778	Carboxylic PRPP	CPRPP	-	DRUGBANK	DB03942	C6H15O13P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OICBXEWBKALHHB-FSIIMWSLSA-N
22237	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3780	5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One	-	-	DRUGBANK	DB03944	C22H23N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLRMTJLQCLMKF-CYBMUJFWSA-N
22238	107791	1401	RP11-419N10.4	CRP	PTX1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22239	107791	1401	RP11-419N10.4	CRP	PTX1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22240	122060	64100	-	ELSPBP1	E12|EDDM12|EL149|HE12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22241	122060	64100	-	ELSPBP1	E12|EDDM12|EL149|HE12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22242	122060	64100	-	ELSPBP1	E12|EDDM12|EL149|HE12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3781	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	Ethanaminium, N,N,N-trimethyl-2-(phosphonooxy)-|Choline, dihydrogen phosphate (ester) (8CI)|Phosphocholine cation	-	DRUGBANK	DB03945	C5H15NO4P	small molecule	-	3616-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHHSONZFOIEMCP-UHFFFAOYSA-O
22243	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3784	6-Chloropurine Riboside, 5'-Monophosphate	-	-	DRUGBANK	DB03948	C10H13ClN4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBOMYIOYNCBS-FCIPNVEPSA-O
22244	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3784	6-Chloropurine Riboside, 5'-Monophosphate	-	-	DRUGBANK	DB03948	C10H13ClN4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBOMYIOYNCBS-FCIPNVEPSA-O
22245	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3784	6-Chloropurine Riboside, 5'-Monophosphate	-	-	DRUGBANK	DB03948	C10H13ClN4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBOMYIOYNCBS-FCIPNVEPSA-O
22246	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3784	6-Chloropurine Riboside, 5'-Monophosphate	-	-	DRUGBANK	DB03948	C10H13ClN4O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALOBOMYIOYNCBS-FCIPNVEPSA-O
22247	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3786	(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03950	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFWHOUCRVSOZJE-AWEZNQCLSA-N
22248	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3786	(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03950	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFWHOUCRVSOZJE-AWEZNQCLSA-N
22249	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3786	(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	-	-	DRUGBANK	DB03950	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFWHOUCRVSOZJE-AWEZNQCLSA-N
22250	849667	945290	b0678	nagB	ECK0666|JW0664|glmD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3787	16g	-	-	DRUGBANK	DB03951	C8H16NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRGMHAYQAZFZDJ-JAJWTYFOSA-N
22251	849667	945290	b0678	nagB	ECK0666|JW0664|glmD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3787	16g	-	-	DRUGBANK	DB03951	C8H16NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRGMHAYQAZFZDJ-JAJWTYFOSA-N
22252	115325	10007	-	GNPDA1	GNP1|GNPDA|GNPI|GPI|HLN	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3787	16g	-	-	DRUGBANK	DB03951	C8H16NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRGMHAYQAZFZDJ-JAJWTYFOSA-N
22253	115325	10007	-	GNPDA1	GNP1|GNPDA|GNPI|GPI|HLN	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3787	16g	-	-	DRUGBANK	DB03951	C8H16NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRGMHAYQAZFZDJ-JAJWTYFOSA-N
22254	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3788	9-(6-Deoxy-Beta-D-Allofuranosyl)-6-Methylpurine	-	-	DRUGBANK	DB03952	C12H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJZDIUOABWMPLZ-DLOONRPBSA-N
22255	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3788	9-(6-Deoxy-Beta-D-Allofuranosyl)-6-Methylpurine	-	-	DRUGBANK	DB03952	C12H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJZDIUOABWMPLZ-DLOONRPBSA-N
22256	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3789	L-Thiocitrulline	-	-	DRUGBANK	DB03953	C6H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKGWACHYAMTLAF-BYPYZUCNSA-N
22257	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3789	L-Thiocitrulline	-	-	DRUGBANK	DB03953	C6H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKGWACHYAMTLAF-BYPYZUCNSA-N
22258	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3789	L-Thiocitrulline	-	-	DRUGBANK	DB03953	C6H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKGWACHYAMTLAF-BYPYZUCNSA-N
22259	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3790	1-deoxymannojirimycin	D-manno-Deoxynojirimycin	-	DRUGBANK	DB03955	C6H13NO4	small molecule	-	84444-90-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXBIFEVIBLOUGU-KVTDHHQDSA-N
22260	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3790	1-deoxymannojirimycin	D-manno-Deoxynojirimycin	-	DRUGBANK	DB03955	C6H13NO4	small molecule	-	84444-90-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXBIFEVIBLOUGU-KVTDHHQDSA-N
22261	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3790	1-deoxymannojirimycin	D-manno-Deoxynojirimycin	-	DRUGBANK	DB03955	C6H13NO4	small molecule	-	84444-90-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXBIFEVIBLOUGU-KVTDHHQDSA-N
22262	111349	5333	-	PLCD1	NDNC3|PLC-III	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3791	D-Myo-Inositol-2,4,5-Trisphosphate	-	-	DRUGBANK	DB03956	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
22263	111349	5333	-	PLCD1	NDNC3|PLC-III	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3791	D-Myo-Inositol-2,4,5-Trisphosphate	-	-	DRUGBANK	DB03956	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
22264	111349	5333	-	PLCD1	NDNC3|PLC-III	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3791	D-Myo-Inositol-2,4,5-Trisphosphate	-	-	DRUGBANK	DB03956	C6H15O15P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWCIQZXVOZEGG-WZWPATEWSA-N
22265	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3792	SP2456	-	-	DRUGBANK	DB03957	C25H32Cl2N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQEJVHAIGZKLBA-HSZRJFAPSA-N
22266	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3792	SP2456	-	-	DRUGBANK	DB03957	C25H32Cl2N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQEJVHAIGZKLBA-HSZRJFAPSA-N
22267	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3792	SP2456	-	-	DRUGBANK	DB03957	C25H32Cl2N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQEJVHAIGZKLBA-HSZRJFAPSA-N
22268	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3793	7-methyl-guanosine-5'-triphosphate-5'-guanosine	mRNA cap analog N7-Methyl GpppG	-	DRUGBANK	DB03958	C21H30N10O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHHZHGZBHYYWTG-RPKOMYRRSA-O
22269	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3793	7-methyl-guanosine-5'-triphosphate-5'-guanosine	mRNA cap analog N7-Methyl GpppG	-	DRUGBANK	DB03958	C21H30N10O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHHZHGZBHYYWTG-RPKOMYRRSA-O
22270	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22271	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22272	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22273	109330	3082	-	HGF	DFNB39|F-TCF|HGFB|HPTA|SF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22274	109330	3082	-	HGF	DFNB39|F-TCF|HGFB|HPTA|SF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22275	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22276	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22277	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22278	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22279	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22280	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
22281	111247	5226	-	PGD	6PGD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3797	Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate	-	-	DRUGBANK	DB03962	C21H27BrN7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKMTCCUJSRQGW-ZDYBBARQSA-N
22282	111247	5226	-	PGD	6PGD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3797	Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate	-	-	DRUGBANK	DB03962	C21H27BrN7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKMTCCUJSRQGW-ZDYBBARQSA-N
22283	111247	5226	-	PGD	6PGD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3797	Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate	-	-	DRUGBANK	DB03962	C21H27BrN7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKMTCCUJSRQGW-ZDYBBARQSA-N
22284	116496	22820	-	COPG1	COPG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22285	116496	22820	-	COPG1	COPG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22286	113352	7518	-	XRCC4	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22287	113352	7518	-	XRCC4	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22288	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22289	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22290	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22291	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22292	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22293	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3799	4-Hydroxy-Aconitate Ion	-	-	DRUGBANK	DB03964	C6H3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUUVSJBKHXDKBS-XDSMRRFISA-K
22294	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3799	4-Hydroxy-Aconitate Ion	-	-	DRUGBANK	DB03964	C6H3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUUVSJBKHXDKBS-XDSMRRFISA-K
22295	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3799	4-Hydroxy-Aconitate Ion	-	-	DRUGBANK	DB03964	C6H3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUUVSJBKHXDKBS-XDSMRRFISA-K
22296	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	unknown	target	Tsai FT (1997)	9144789	181718	3800	Clorobiocin	Chlorobiocin	-	DRUGBANK	DB03966	C35H36ClN2O11	small molecule	-	39868-96-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22297	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	unknown	target	Hooper DC (1982)	6295263	181676	3800	Clorobiocin	Chlorobiocin	-	DRUGBANK	DB03966	C35H36ClN2O11	small molecule	-	39868-96-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22298	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3801	Dodecyl Sulfate	-	-	DRUGBANK	DB03967	C12H26O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOTZDAYCYVMXPC-UHFFFAOYSA-N
22299	850717	946360	b0622	pagP	ECK0615|JW0617|crcA|ybeG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3801	Dodecyl Sulfate	-	-	DRUGBANK	DB03967	C12H26O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOTZDAYCYVMXPC-UHFFFAOYSA-N
22300	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3802	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	-	-	DRUGBANK	DB03968	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YARDEGUIPATLSG-UHFFFAOYSA-N
22301	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3802	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	-	-	DRUGBANK	DB03968	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YARDEGUIPATLSG-UHFFFAOYSA-N
22302	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3802	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	-	-	DRUGBANK	DB03968	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YARDEGUIPATLSG-UHFFFAOYSA-N
22303	849164	944762	b0031	dapB	ECK0032|JW0029	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3803	3-Acetyl Pyridine Adenine Dinucleotide	-	-	DRUGBANK	DB03969	C22H28N6O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPVQNXLUPNWQHM-IYAKUPGSSA-N
22304	849164	944762	b0031	dapB	ECK0032|JW0029	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3803	3-Acetyl Pyridine Adenine Dinucleotide	-	-	DRUGBANK	DB03969	C22H28N6O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPVQNXLUPNWQHM-IYAKUPGSSA-N
22305	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3808	L-Homoarginine	-	-	DRUGBANK	DB03974	C7H17N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUOGESRFPZDMMT-YFKPBYRVSA-O
22306	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3808	L-Homoarginine	-	-	DRUGBANK	DB03974	C7H17N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUOGESRFPZDMMT-YFKPBYRVSA-O
22307	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3808	L-Homoarginine	-	-	DRUGBANK	DB03974	C7H17N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUOGESRFPZDMMT-YFKPBYRVSA-O
22308	852952	948660	b4137	cutA	ECK4131|JW4097|cutA1|cycY	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3809	Mercuribenzoic Acid	-	-	DRUGBANK	DB03975	C7H5HgO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFZSVRSDNUCGG-UHFFFAOYSA-N
22309	852952	948660	b4137	cutA	ECK4131|JW4097|cutA1|cycY	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3809	Mercuribenzoic Acid	-	-	DRUGBANK	DB03975	C7H5HgO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFZSVRSDNUCGG-UHFFFAOYSA-N
22310	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3809	Mercuribenzoic Acid	-	-	DRUGBANK	DB03975	C7H5HgO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFZSVRSDNUCGG-UHFFFAOYSA-N
22311	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3809	Mercuribenzoic Acid	-	-	DRUGBANK	DB03975	C7H5HgO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVFZSVRSDNUCGG-UHFFFAOYSA-N
22312	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22313	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22314	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22315	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22316	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22317	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22318	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22319	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3810	Phosphorylisopropane	-	-	DRUGBANK	DB03976	C3H9O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPPQHRDVPBTVEV-UHFFFAOYSA-N
22320	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22321	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22322	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22323	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22324	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22325	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3811	N-Trimethyllysine	-	-	DRUGBANK	DB03977	C9H21N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MXNRLFUSFKVQSK-MRVPVSSYSA-O
22326	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3812	Tyrosinal	-	-	DRUGBANK	DB03978	C9H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXGAIOIQACHYRK-QMMMGPOBSA-N
22327	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3812	Tyrosinal	-	-	DRUGBANK	DB03978	C9H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXGAIOIQACHYRK-QMMMGPOBSA-N
22328	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3812	Tyrosinal	-	-	DRUGBANK	DB03978	C9H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXGAIOIQACHYRK-QMMMGPOBSA-N
22329	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3814	4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole	-	-	DRUGBANK	DB03980	C17H16FN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYXQGDDCDXJK-UHFFFAOYSA-N
22330	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22331	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22332	106805	308	-	ANXA5	ANX5|ENX2|HEL-S-7|PP4|RPRGL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22333	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22334	108538	2247	-	FGF2	BFGF|FGF-2|FGFB|HBGF-2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22335	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22336	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3815	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB03981	C6H8O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBOXLMLDIGNGG-NQXXGFSBSA-N
22337	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3816	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	-	-	DRUGBANK	DB03982	C19H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQWCUHJIERBOSM-UHFFFAOYSA-N
22338	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3816	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	-	-	DRUGBANK	DB03982	C19H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQWCUHJIERBOSM-UHFFFAOYSA-N
22339	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3816	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	-	-	DRUGBANK	DB03982	C19H13NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQWCUHJIERBOSM-UHFFFAOYSA-N
22340	112690	6821	-	SUOX	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3817	(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)	-	-	DRUGBANK	DB03983	C10H13MoN5O8PS3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVSRPVEMXBYTQ-ZLGQENBPSA-K
22341	112690	6821	-	SUOX	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3817	(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)	-	-	DRUGBANK	DB03983	C10H13MoN5O8PS3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVSRPVEMXBYTQ-ZLGQENBPSA-K
22342	112690	6821	-	SUOX	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3817	(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)	-	-	DRUGBANK	DB03983	C10H13MoN5O8PS3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQVSRPVEMXBYTQ-ZLGQENBPSA-K
22343	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3818	Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide	-	-	DRUGBANK	DB03984	C24H29N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWTQNXVXPLTHJB-YADHBBJMSA-N
22344	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3818	Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide	-	-	DRUGBANK	DB03984	C24H29N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWTQNXVXPLTHJB-YADHBBJMSA-N
22345	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3818	Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide	-	-	DRUGBANK	DB03984	C24H29N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWTQNXVXPLTHJB-YADHBBJMSA-N
22346	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3820	6-Methyl-Formycin A	-	-	DRUGBANK	DB03986	C11H15N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZVZLZFBHQNYSK-CPXCQARFSA-N
22347	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3820	6-Methyl-Formycin A	-	-	DRUGBANK	DB03986	C11H15N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZVZLZFBHQNYSK-CPXCQARFSA-N
22348	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3821	2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	-	-	DRUGBANK	DB03987	C17H20N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWCCXDBXMCTZPW-UHFFFAOYSA-N
22349	852897	948604	b4088	alsB	ECK4081|JW4049|yjcX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3823	D-Allopyranose	D-Allose	-	DRUGBANK	DB03989	C6H12O6	small molecule	-	2595-97-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-IVMDWMLBSA-N
22350	852897	948604	b4088	alsB	ECK4081|JW4049|yjcX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3823	D-Allopyranose	D-Allose	-	DRUGBANK	DB03989	C6H12O6	small molecule	-	2595-97-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-IVMDWMLBSA-N
22351	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3827	4-Methyl Valeric Acid	-	-	DRUGBANK	DB03993	C6H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGKJLKRYENPLQH-UHFFFAOYSA-N
22352	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3827	4-Methyl Valeric Acid	-	-	DRUGBANK	DB03993	C6H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGKJLKRYENPLQH-UHFFFAOYSA-N
22353	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3829	Cyclo-Hepta-Amylose	-	-	DRUGBANK	DB03995	C42H70O35	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHGYBXFWUBPSRW-RUPPEMBSSA-N
22354	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3829	Cyclo-Hepta-Amylose	-	-	DRUGBANK	DB03995	C42H70O35	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHGYBXFWUBPSRW-RUPPEMBSSA-N
22355	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3830	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	-	-	DRUGBANK	DB03996	C17H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBZAPFWYAPXRGQ-KRWDZBQOSA-N
22356	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3830	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	-	-	DRUGBANK	DB03996	C17H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBZAPFWYAPXRGQ-KRWDZBQOSA-N
22357	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3830	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	-	-	DRUGBANK	DB03996	C17H15ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBZAPFWYAPXRGQ-KRWDZBQOSA-N
22358	850898	946551	b2021	hisC	ECK2016|JW2003	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3831	Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester	-	-	DRUGBANK	DB03997	C6H11N3O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22359	850898	946551	b2021	hisC	ECK2016|JW2003	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3831	Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester	-	-	DRUGBANK	DB03997	C6H11N3O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22360	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3834	Bromo-Willardiine	-	-	DRUGBANK	DB04000	C7H8BrN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKIJKSVXKWGRJ-BYPYZUCNSA-N
22361	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3834	Bromo-Willardiine	-	-	DRUGBANK	DB04000	C7H8BrN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKIJKSVXKWGRJ-BYPYZUCNSA-N
22362	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3834	Bromo-Willardiine	-	-	DRUGBANK	DB04000	C7H8BrN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKIJKSVXKWGRJ-BYPYZUCNSA-N
22363	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3835	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	-	-	DRUGBANK	DB04001	C11H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHWMERGBWWROMM-UHFFFAOYSA-N
22364	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3835	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	-	-	DRUGBANK	DB04001	C11H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHWMERGBWWROMM-UHFFFAOYSA-N
22365	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3835	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	-	-	DRUGBANK	DB04001	C11H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHWMERGBWWROMM-UHFFFAOYSA-N
22366	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3836	4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide	-	-	DRUGBANK	DB04002	C12H19N3O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLYYIFIRODREFK-UHFFFAOYSA-N
22367	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3836	4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide	-	-	DRUGBANK	DB04002	C12H19N3O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLYYIFIRODREFK-UHFFFAOYSA-N
22368	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3836	4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide	-	-	DRUGBANK	DB04002	C12H19N3O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLYYIFIRODREFK-UHFFFAOYSA-N
22369	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3837	(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid	-	-	DRUGBANK	DB04003	C29H38N3O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUGQWABROMTDA-GAJHUEQPSA-N
22370	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3837	(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid	-	-	DRUGBANK	DB04003	C29H38N3O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXUGQWABROMTDA-GAJHUEQPSA-N
22371	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3839	Uridine 5'-Triphosphate	-	-	DRUGBANK	DB04005	C9H15N2O15P3	small molecule	-	63-39-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGAVKCOVUIYSFO-ZAKLUEHWSA-N
22372	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3839	Uridine 5'-Triphosphate	-	-	DRUGBANK	DB04005	C9H15N2O15P3	small molecule	-	63-39-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGAVKCOVUIYSFO-ZAKLUEHWSA-N
22373	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3840	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	-	-	DRUGBANK	DB04006	C21H13F2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUGJIPFLBOATGL-UHFFFAOYSA-N
22374	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3840	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	-	-	DRUGBANK	DB04006	C21H13F2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUGJIPFLBOATGL-UHFFFAOYSA-N
22375	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3840	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	-	-	DRUGBANK	DB04006	C21H13F2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUGJIPFLBOATGL-UHFFFAOYSA-N
22376	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3842	Bis(5-Amidino-Benzimidazolyl)Methane Zinc	-	-	DRUGBANK	DB04008	C17H14N8Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22377	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3842	Bis(5-Amidino-Benzimidazolyl)Methane Zinc	-	-	DRUGBANK	DB04008	C17H14N8Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22378	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3842	Bis(5-Amidino-Benzimidazolyl)Methane Zinc	-	-	DRUGBANK	DB04008	C17H14N8Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22379	107908	1528	-	CYB5A	CYB5|MCB5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3843	Dimethyl Propionate Ester Heme	-	-	DRUGBANK	DB04009	C36H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKKVXUGDBLTOLY-YPFLCKFZSA-N
22380	107908	1528	-	CYB5A	CYB5|MCB5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3843	Dimethyl Propionate Ester Heme	-	-	DRUGBANK	DB04009	C36H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKKVXUGDBLTOLY-YPFLCKFZSA-N
22381	107908	1528	-	CYB5A	CYB5|MCB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3843	Dimethyl Propionate Ester Heme	-	-	DRUGBANK	DB04009	C36H36FeN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKKVXUGDBLTOLY-YPFLCKFZSA-N
22382	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3844	2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide	-	-	DRUGBANK	DB04010	C15H13N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVVWVYYHTKCIAE-UHFFFAOYSA-N
22383	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3846	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine	-	-	DRUGBANK	DB04012	C18H26N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFEHACHKMVZGNQ-HOTGVXAUSA-N
22384	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3847	1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide	-	-	DRUGBANK	DB04013	C9H16N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTAMPRAONLFQI-HYMLEYLXSA-N
22385	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3847	1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide	-	-	DRUGBANK	DB04013	C9H16N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTAMPRAONLFQI-HYMLEYLXSA-N
22386	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3847	1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide	-	-	DRUGBANK	DB04013	C9H16N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTAMPRAONLFQI-HYMLEYLXSA-N
22387	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22388	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22389	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22390	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22391	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3848	Alsterpaullone	-	-	DRUGBANK	DB04014	C16H11N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUKILHGKRVDCT-UHFFFAOYSA-N
22392	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3849	Methionine Phosphinate	-	-	DRUGBANK	DB04015	C4H12NO2PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZRBNMUARBZMHQ-SCSAIBSYSA-N
22393	850988	946643	b2114	metG	ECK2107|JW2101	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3849	Methionine Phosphinate	-	-	DRUGBANK	DB04015	C4H12NO2PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZRBNMUARBZMHQ-SCSAIBSYSA-N
22394	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3849	Methionine Phosphinate	-	-	DRUGBANK	DB04015	C4H12NO2PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZRBNMUARBZMHQ-SCSAIBSYSA-N
22395	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3849	Methionine Phosphinate	-	-	DRUGBANK	DB04015	C4H12NO2PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZRBNMUARBZMHQ-SCSAIBSYSA-N
22396	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3850	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	-	-	DRUGBANK	DB04016	C40H35N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJQPDQURBZEGJ-KXQOOQHDSA-N
22397	107891	1511	-	CTSG	CATG|CG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3850	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	-	-	DRUGBANK	DB04016	C40H35N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJQPDQURBZEGJ-KXQOOQHDSA-N
22398	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3850	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	-	-	DRUGBANK	DB04016	C40H35N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJQPDQURBZEGJ-KXQOOQHDSA-N
22399	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3850	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	-	-	DRUGBANK	DB04016	C40H35N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUJQPDQURBZEGJ-KXQOOQHDSA-N
22400	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3851	N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine	-	-	DRUGBANK	DB04017	C13H15Cl2NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTFHLQRNAMSNLC-UHFFFAOYSA-N
22401	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3852	S-Isopropyl-Isothiourea	-	-	DRUGBANK	DB04018	C4H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSSNABKEYXKKMK-UHFFFAOYSA-N
22402	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3852	S-Isopropyl-Isothiourea	-	-	DRUGBANK	DB04018	C4H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSSNABKEYXKKMK-UHFFFAOYSA-N
22403	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3852	S-Isopropyl-Isothiourea	-	-	DRUGBANK	DB04018	C4H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSSNABKEYXKKMK-UHFFFAOYSA-N
22404	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3853	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol	-	-	DRUGBANK	DB04020	C24H29ClN6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIBKIFHSQQYXLG-UHFFFAOYSA-N
22405	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3853	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol	-	-	DRUGBANK	DB04020	C24H29ClN6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIBKIFHSQQYXLG-UHFFFAOYSA-N
22406	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3854	MF268	-	-	DRUGBANK	DB04021	C15H30N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXVBAZRPAJEAHR-GASCZTMLSA-N
22407	856663	939064	BSU22070	xpt	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3855	Guanosine-5',3'-Tetraphosphate	-	-	DRUGBANK	DB04022	C10H17N5O17P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUFLLCUFNHESEH-FULWYAMNSA-N
22408	856663	939064	BSU22070	xpt	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3855	Guanosine-5',3'-Tetraphosphate	-	-	DRUGBANK	DB04022	C10H17N5O17P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUFLLCUFNHESEH-FULWYAMNSA-N
22409	855155	937502	BSU27920	obgE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3855	Guanosine-5',3'-Tetraphosphate	-	-	DRUGBANK	DB04022	C10H17N5O17P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUFLLCUFNHESEH-FULWYAMNSA-N
22410	855155	937502	BSU27920	obgE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3855	Guanosine-5',3'-Tetraphosphate	-	-	DRUGBANK	DB04022	C10H17N5O17P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUFLLCUFNHESEH-FULWYAMNSA-N
22411	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3859	D-Arginine	-	-	DRUGBANK	DB04027	C6H15N4O2	small molecule	-	157-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-O
22412	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3859	D-Arginine	-	-	DRUGBANK	DB04027	C6H15N4O2	small molecule	-	157-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-O
22413	107578	1158	-	CKM	CKMM|M-CK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3859	D-Arginine	-	-	DRUGBANK	DB04027	C6H15N4O2	small molecule	-	157-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODKSFYDXXFIFQN-BYPYZUCNSA-O
22414	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3862	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	-	-	DRUGBANK	DB04030	C25H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXYEWMDAGIULV-UHFFFAOYSA-N
22415	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3862	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	-	-	DRUGBANK	DB04030	C25H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXYEWMDAGIULV-UHFFFAOYSA-N
22416	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3862	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	-	-	DRUGBANK	DB04030	C25H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXYEWMDAGIULV-UHFFFAOYSA-N
22417	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3863	Serine Vanadate	SVA	-	DRUGBANK	DB04031	C3H7NO7V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYEBJDHHGBFL-PUAMRSTPSA-M
22418	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3863	Serine Vanadate	SVA	-	DRUGBANK	DB04031	C3H7NO7V	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYEBJDHHGBFL-PUAMRSTPSA-M
22419	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3866	Ribulose-5-Phosphate	-	-	DRUGBANK	DB04034	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNZLKVNUWIIPSJ-RFZPGFLSSA-N
22420	853006	948714	b4196	ulaD	ECK4192|JW4154|sgaH|yjfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3866	Ribulose-5-Phosphate	-	-	DRUGBANK	DB04034	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNZLKVNUWIIPSJ-RFZPGFLSSA-N
22421	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3867	Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate	-	-	DRUGBANK	DB04035	C10H15BN4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZECCQELUYUPTSB-UUASQNMZSA-N
22422	109916	3712	-	IVD	ACAD2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3868	Coenzyme a Persulfide	-	-	DRUGBANK	DB04036	C21H36N7O16P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REVPHPVBPSIEKM-VPHNIEJBSA-N
22423	109916	3712	-	IVD	ACAD2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3868	Coenzyme a Persulfide	-	-	DRUGBANK	DB04036	C21H36N7O16P3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REVPHPVBPSIEKM-VPHNIEJBSA-N
22424	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3871	3-Oxo-Pentadecanoic Acid	-	-	DRUGBANK	DB04039	C15H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJTNJZWHYGHVCD-UHFFFAOYSA-N
22425	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3871	3-Oxo-Pentadecanoic Acid	-	-	DRUGBANK	DB04039	C15H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJTNJZWHYGHVCD-UHFFFAOYSA-N
22426	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3871	3-Oxo-Pentadecanoic Acid	-	-	DRUGBANK	DB04039	C15H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJTNJZWHYGHVCD-UHFFFAOYSA-N
22427	852764	948468	b3966	btuB	ECK3958|JW3938|bfe|cer|dcrC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3871	3-Oxo-Pentadecanoic Acid	-	-	DRUGBANK	DB04039	C15H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJTNJZWHYGHVCD-UHFFFAOYSA-N
22428	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3875	Carboxymycobactin T	-	-	DRUGBANK	DB04043	C35H49FeN5O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJULHJRORAZCG-QMDLAEJKSA-M
22429	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3875	Carboxymycobactin T	-	-	DRUGBANK	DB04043	C35H49FeN5O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJULHJRORAZCG-QMDLAEJKSA-M
22430	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3876	4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	-	-	DRUGBANK	DB04044	C21H14N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAQUAVBNIYTIIS-UHFFFAOYSA-N
22431	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3879	[Pterin-6-Yl Methanyl]-Phosphonophosphate	-	-	DRUGBANK	DB04047	C7H9N5O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMDUVUKDRBIVAH-UHFFFAOYSA-N
22432	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3879	[Pterin-6-Yl Methanyl]-Phosphonophosphate	-	-	DRUGBANK	DB04047	C7H9N5O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMDUVUKDRBIVAH-UHFFFAOYSA-N
22433	112860	7001	-	PRDX2	HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3880	N-Carbamoyl-Alanine	-	-	DRUGBANK	DB04048	C4H8N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUSWEUMSEVLFEQ-UWTATZPHSA-N
22434	112860	7001	-	PRDX2	HEL-S-2a|NKEF-B|NKEFB|PRP|PRX2|PRXII|PTX1|TDPX1|TPX1|TSA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3880	N-Carbamoyl-Alanine	-	-	DRUGBANK	DB04048	C4H8N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUSWEUMSEVLFEQ-UWTATZPHSA-N
22435	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3882	N-Propyl Isocyanide	-	-	DRUGBANK	DB04050	C4H7N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFDKYFGBIQQMSR-UHFFFAOYSA-N
22436	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3882	N-Propyl Isocyanide	-	-	DRUGBANK	DB04050	C4H7N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFDKYFGBIQQMSR-UHFFFAOYSA-N
22437	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3882	N-Propyl Isocyanide	-	-	DRUGBANK	DB04050	C4H7N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFDKYFGBIQQMSR-UHFFFAOYSA-N
22438	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3886	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04054	C18H22FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PASRTKOWXJDFFV-UHFFFAOYSA-N
22439	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3887	2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium	-	-	DRUGBANK	DB04055	C20H21ClNO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMSIYRVIPQHZBI-UHFFFAOYSA-O
22440	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3887	2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium	-	-	DRUGBANK	DB04055	C20H21ClNO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMSIYRVIPQHZBI-UHFFFAOYSA-O
22441	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3887	2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium	-	-	DRUGBANK	DB04055	C20H21ClNO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMSIYRVIPQHZBI-UHFFFAOYSA-O
22442	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3889	Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor	-	-	DRUGBANK	DB04057	C32H34N9O15P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRZABKCMPVBQFX-PXOKFWMZSA-N
22443	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3889	Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor	-	-	DRUGBANK	DB04057	C32H34N9O15P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRZABKCMPVBQFX-PXOKFWMZSA-N
22444	106961	471	OK/SW-cl.86	ATIC	AICAR|AICARFT|HEL-S-70p|IMPCHASE|PURH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3889	Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor	-	-	DRUGBANK	DB04057	C32H34N9O15P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRZABKCMPVBQFX-PXOKFWMZSA-N
22445	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3890	D-[(Amino)Carbonyl]Phenylalanine	-	-	DRUGBANK	DB04058	C10H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPWQOZCSQLTKOI-QMMMGPOBSA-N
22446	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3891	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB04059	C15H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRQLDCHTDNYVQI-UHFFFAOYSA-N
22447	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3891	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB04059	C15H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRQLDCHTDNYVQI-UHFFFAOYSA-N
22448	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3891	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	-	-	DRUGBANK	DB04059	C15H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRQLDCHTDNYVQI-UHFFFAOYSA-N
22449	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3894	Beta-D-Fucose	-	-	DRUGBANK	DB04062	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-FPRJBGLDSA-N
22450	850766	946409	b1901	araF	ECK1899|JW1889	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3894	Beta-D-Fucose	-	-	DRUGBANK	DB04062	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-FPRJBGLDSA-N
22451	849182	944780	b0064	araC	ECK0065|JW0063	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3894	Beta-D-Fucose	-	-	DRUGBANK	DB04062	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-FPRJBGLDSA-N
22452	849182	944780	b0064	araC	ECK0065|JW0063	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3894	Beta-D-Fucose	-	-	DRUGBANK	DB04062	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHZGCJCMOBCMKK-FPRJBGLDSA-N
22453	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3895	2-Methylleucine	-	-	DRUGBANK	DB04063	C7H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARSWQPLPYROOBG-ZETCQYMHSA-N
22454	852580	948278	b3770	ilvE	ECK3762|JW5606	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3895	2-Methylleucine	-	-	DRUGBANK	DB04063	C7H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARSWQPLPYROOBG-ZETCQYMHSA-N
22455	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3897	N-Cyclopentyl-N-Cyclobutylformamide	-	-	DRUGBANK	DB04065	C10H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWGVYBRKKSJLNS-UHFFFAOYSA-N
22456	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3897	N-Cyclopentyl-N-Cyclobutylformamide	-	-	DRUGBANK	DB04065	C10H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWGVYBRKKSJLNS-UHFFFAOYSA-N
22457	106636	124	-	ADH1A	ADH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3897	N-Cyclopentyl-N-Cyclobutylformamide	-	-	DRUGBANK	DB04065	C10H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWGVYBRKKSJLNS-UHFFFAOYSA-N
22458	116604	22949	RP11-16L21.1	PTGR1	LTB4DH|PGR1|ZADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3898	Para-Coumaric Acid	-	-	DRUGBANK	DB04066	C9H8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGSWKAQJJWESNS-ZZXKWVIFSA-N
22459	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3900	Fudp	-	-	DRUGBANK	DB04068	C9H13FN2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLQBZMZTRNPUDL-BBVRLYRLSA-N
22460	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3900	Fudp	-	-	DRUGBANK	DB04068	C9H13FN2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLQBZMZTRNPUDL-BBVRLYRLSA-N
22461	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3900	Fudp	-	-	DRUGBANK	DB04068	C9H13FN2O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLQBZMZTRNPUDL-BBVRLYRLSA-N
22462	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3901	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	-	-	DRUGBANK	DB04069	C12H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKVREUJWFZJEJK-UHFFFAOYSA-N
22463	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3901	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	-	-	DRUGBANK	DB04069	C12H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKVREUJWFZJEJK-UHFFFAOYSA-N
22464	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3901	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	-	-	DRUGBANK	DB04069	C12H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKVREUJWFZJEJK-UHFFFAOYSA-N
22465	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3903	Cpad	-	-	DRUGBANK	DB04071	C21H27N7O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFERELMXERXKKQ-NYTQINMXSA-N
22466	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3903	Cpad	-	-	DRUGBANK	DB04071	C21H27N7O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFERELMXERXKKQ-NYTQINMXSA-N
22467	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3903	Cpad	-	-	DRUGBANK	DB04071	C21H27N7O14P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFERELMXERXKKQ-NYTQINMXSA-N
22468	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3904	Alpha-Methylisocitric Acid	-	-	DRUGBANK	DB04072	C7H10O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHKPKXCSHMJWCF-NOWQDGDBSA-N
22469	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3904	Alpha-Methylisocitric Acid	-	-	DRUGBANK	DB04072	C7H10O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHKPKXCSHMJWCF-NOWQDGDBSA-N
22470	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3904	Alpha-Methylisocitric Acid	-	-	DRUGBANK	DB04072	C7H10O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHKPKXCSHMJWCF-NOWQDGDBSA-N
22471	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3906	Alpha-ketoisovalerate	2-Oxoisovalerate|3-Methyl-2-oxobutanoic acid|2-Oxoisopentanoate|2-Ketovaline|3-Methyl-2-oxobutanoate|3-Methyl-2-oxobutyric acid|2-Oxo-3-methylbutanoate|2-Keto-3-methylbutyric acid|alpha-Ketovaline	-	DRUGBANK	DB04074	C5H8O3	small molecule	-	759-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHKABHOOEWYVLI-UHFFFAOYSA-N
22472	107062	587	-	BCAT2	BCAM|BCATM|BCT2|PP18	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3906	Alpha-ketoisovalerate	2-Oxoisovalerate|3-Methyl-2-oxobutanoic acid|2-Oxoisopentanoate|2-Ketovaline|3-Methyl-2-oxobutanoate|3-Methyl-2-oxobutyric acid|2-Oxo-3-methylbutanoate|2-Keto-3-methylbutyric acid|alpha-Ketovaline	-	DRUGBANK	DB04074	C5H8O3	small molecule	-	759-05-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHKABHOOEWYVLI-UHFFFAOYSA-N
22473	852760	948464	b3959	argB	ECK3950|JW5553	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3907	N-Acetyl-L-Glutamate	-	-	DRUGBANK	DB04075	C7H11NO5	small molecule	-	1188-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFMMMVDNIPUKGG-YFKPBYRVSA-N
22474	852760	948464	b3959	argB	ECK3950|JW5553	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3907	N-Acetyl-L-Glutamate	-	-	DRUGBANK	DB04075	C7H11NO5	small molecule	-	1188-37-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFMMMVDNIPUKGG-YFKPBYRVSA-N
22475	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3908	Hypoxanthine	-	-	DRUGBANK	DB04076	C5H3N4O	small molecule	-	68-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWQZZPRFMBHEEG-UHFFFAOYSA-N
22476	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3908	Hypoxanthine	-	-	DRUGBANK	DB04076	C5H3N4O	small molecule	-	68-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWQZZPRFMBHEEG-UHFFFAOYSA-N
22477	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3908	Hypoxanthine	-	-	DRUGBANK	DB04076	C5H3N4O	small molecule	-	68-94-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWQZZPRFMBHEEG-UHFFFAOYSA-N
22478	852983	948691	b4170	mutL	ECK4166|JW4128	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22479	852983	948691	b4170	mutL	ECK4166|JW4128	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22480	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22481	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22482	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22483	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22484	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22485	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22486	110749	4668	-	NAGA	D22S674|GALB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22487	110749	4668	-	NAGA	D22S674|GALB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22488	110749	4668	-	NAGA	D22S674|GALB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22489	112906	7048	-	TGFBR2	AAT3|FAA3|LDS1B|LDS2|LDS2B|MFS2|RIIC|TAAD2|TGFR-2|TGFbeta-RII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22490	112906	7048	-	TGFBR2	AAT3|FAA3|LDS1B|LDS2|LDS2B|MFS2|RIIC|TAAD2|TGFR-2|TGFbeta-RII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22491	852719	948422	b3927	glpF	ECK3919|JW3898	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22492	852719	948422	b3927	glpF	ECK3919|JW3898	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22493	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22494	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22495	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22496	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22497	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22498	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22499	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22500	114522	9061	-	PAPSS1	ATPSK1|PAPSS|SK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22501	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22502	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22503	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22504	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22505	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22506	850878	946531	b2020	hisD	ECK2015|JW2002	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22507	850878	946531	b2020	hisD	ECK2015|JW2002	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22508	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22509	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22510	109913	3708	-	ITPR1	ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22511	851906	947590	b3172	argG	Arg6|ECK3161|JW3140|argE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22512	851906	947590	b3172	argG	Arg6|ECK3161|JW3140|argE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22513	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22514	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22515	111084	5047	RP11-98L5.3	PAEP	GD|GdA|GdF|GdS|PAEG|PEP|PP14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22516	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3911	Heptane-1,2,3-Triol	-	-	DRUGBANK	DB04079	C7H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXYCHJFUBNTKQR-BQBZGAKWSA-N
22517	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3911	Heptane-1,2,3-Triol	-	-	DRUGBANK	DB04079	C7H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXYCHJFUBNTKQR-BQBZGAKWSA-N
22518	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3911	Heptane-1,2,3-Triol	-	-	DRUGBANK	DB04079	C7H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXYCHJFUBNTKQR-BQBZGAKWSA-N
22519	850784	946427	b4291	fecA	ECK4281|JW4251	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3911	Heptane-1,2,3-Triol	-	-	DRUGBANK	DB04079	C7H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXYCHJFUBNTKQR-BQBZGAKWSA-N
22520	850784	946427	b4291	fecA	ECK4281|JW4251	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3911	Heptane-1,2,3-Triol	-	-	DRUGBANK	DB04079	C7H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXYCHJFUBNTKQR-BQBZGAKWSA-N
22521	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3912	RU78191	-	-	DRUGBANK	DB04080	C9H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYDYZMNFQIYPT-UHFFFAOYSA-N
22522	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3913	(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide	-	-	DRUGBANK	DB04081	C9H14N2O4S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYXFWOIZPYXNRU-CAHLUQPWSA-N
22523	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3913	(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide	-	-	DRUGBANK	DB04081	C9H14N2O4S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYXFWOIZPYXNRU-CAHLUQPWSA-N
22524	850482	946122	b0172	frr	ECK0171|JW0167|rrf	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3914	Decyloxy-Methanol	-	-	DRUGBANK	DB04082	C11H24O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDMVCFBAVCCGIE-UHFFFAOYSA-N
22525	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22526	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22527	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22528	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22529	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22530	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22531	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22532	849752	945376	b0774	bioA	ECK0763|JW0757	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22533	849752	945376	b0774	bioA	ECK0763|JW0757	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22534	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22535	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22536	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22537	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3915	N'-Pyridoxyl-Lysine-5'-Monophosphate	-	-	DRUGBANK	DB04083	C14H24N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIXMYVJXXYQYGI-GFCCVEGCSA-N
22538	853179	948902	b4381	deoC	ECK4373|JW4344|dra|thyR|tlr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3919	Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate	-	-	DRUGBANK	DB04087	C5H13O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCHBTVQJICBXEI-RFZPGFLSSA-N
22539	853179	948902	b4381	deoC	ECK4373|JW4344|dra|thyR|tlr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3919	Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate	-	-	DRUGBANK	DB04087	C5H13O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCHBTVQJICBXEI-RFZPGFLSSA-N
22540	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3920	N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)	Compound 6	-	DRUGBANK	DB04088	C34H35N3O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJBRKLISQICDU-XMMPIXPASA-N
22541	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3920	N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)	Compound 6	-	DRUGBANK	DB04088	C34H35N3O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTJBRKLISQICDU-XMMPIXPASA-N
22542	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3921	AL5300	-	-	DRUGBANK	DB04089	C11H12N2O5S4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHPUQNGRNUOYCD-VIFPVBQESA-N
22543	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3921	AL5300	-	-	DRUGBANK	DB04089	C11H12N2O5S4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHPUQNGRNUOYCD-VIFPVBQESA-N
22544	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3921	AL5300	-	-	DRUGBANK	DB04089	C11H12N2O5S4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHPUQNGRNUOYCD-VIFPVBQESA-N
22545	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3922	2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione	-	-	DRUGBANK	DB04090	C12H14N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKDLOGLNPDVUCX-UHFFFAOYSA-N
22546	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3922	2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione	-	-	DRUGBANK	DB04090	C12H14N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKDLOGLNPDVUCX-UHFFFAOYSA-N
22547	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3923	Alpha-L-1-Methyl-Fucose	-	-	DRUGBANK	DB04091	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=OHWCAVRRXKJCRB-ZYNSJIGGSA-N
22548	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3923	Alpha-L-1-Methyl-Fucose	-	-	DRUGBANK	DB04091	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=OHWCAVRRXKJCRB-ZYNSJIGGSA-N
22549	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3923	Alpha-L-1-Methyl-Fucose	-	-	DRUGBANK	DB04091	C7H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=OHWCAVRRXKJCRB-ZYNSJIGGSA-N
22550	851707	947385	b2908	pepP	ECK2903|JW2876	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3924	Apstatin	-	-	DRUGBANK	DB04092	C23H33N5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUUZAPYLPWFHE-HXFGRODQSA-N
22551	851707	947385	b2908	pepP	ECK2903|JW2876	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3924	Apstatin	-	-	DRUGBANK	DB04092	C23H33N5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUUZAPYLPWFHE-HXFGRODQSA-N
22552	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3926	4-Hydroxy-2-Butanone	-	-	DRUGBANK	DB04094	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVSQXDHWDCMMRJ-UHFFFAOYSA-N
22553	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3926	4-Hydroxy-2-Butanone	-	-	DRUGBANK	DB04094	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVSQXDHWDCMMRJ-UHFFFAOYSA-N
22554	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3926	4-Hydroxy-2-Butanone	-	-	DRUGBANK	DB04094	C4H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVSQXDHWDCMMRJ-UHFFFAOYSA-N
22555	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3929	Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose	-	-	DRUGBANK	DB04097	C15H23FN2O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAPPZHVTNHJVAL-LJMZODOWSA-N
22556	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3929	Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose	-	-	DRUGBANK	DB04097	C15H23FN2O16P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAPPZHVTNHJVAL-LJMZODOWSA-N
22557	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3930	Balanol	-	-	DRUGBANK	DB04098	C28H26N2O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYUFCXJZFZPEJD-PGRDOPGGSA-N
22558	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3930	Balanol	-	-	DRUGBANK	DB04098	C28H26N2O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYUFCXJZFZPEJD-PGRDOPGGSA-N
22559	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3930	Balanol	-	-	DRUGBANK	DB04098	C28H26N2O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYUFCXJZFZPEJD-PGRDOPGGSA-N
22560	855957	938339	BSU03130	nadE	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22561	855957	938339	BSU03130	nadE	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22562	851285	946946	b1740	nadE	ECK1738|JW1729|efg|ntrL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22563	851285	946946	b1740	nadE	ECK1738|JW1729|efg|ntrL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22564	131564	349565	FKSG76	NMNAT3	PNAT-3|PNAT3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22565	131564	349565	FKSG76	NMNAT3	PNAT-3|PNAT3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22566	855465	937818	BSU25640	nadD	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22567	855465	937818	BSU25640	nadD	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22568	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22569	122308	64802	RP11-807G9.1	NMNAT1	LCA9|NMNAT|PNAT1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3931	Deamido-Nad+	-	-	DRUGBANK	DB04099	C21H27N6O15P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SENPVEZBRZQVST-AAIUHBJKSA-O
22570	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3933	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	-	-	DRUGBANK	DB04101	C10H11N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVKZTPFHUYGZBI-UHFFFAOYSA-N
22571	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3933	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	-	-	DRUGBANK	DB04101	C10H11N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVKZTPFHUYGZBI-UHFFFAOYSA-N
22572	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3933	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	-	-	DRUGBANK	DB04101	C10H11N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVKZTPFHUYGZBI-UHFFFAOYSA-N
22573	851471	947137	b3549	tag	ECK3536|JW3518|tagA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3936	3-Methyladenine	-	-	DRUGBANK	DB04104	C6H7N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSASIHFSFGAIJM-UHFFFAOYSA-N
22574	851471	947137	b3549	tag	ECK3536|JW3518|tagA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3936	3-Methyladenine	-	-	DRUGBANK	DB04104	C6H7N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSASIHFSFGAIJM-UHFFFAOYSA-N
22575	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3937	N-Heptylformamide	-	-	DRUGBANK	DB04105	C8H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAUHDTOEJHVKJO-UHFFFAOYSA-N
22576	106637	125	-	ADH1B	ADH2|HEL-S-117	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3937	N-Heptylformamide	-	-	DRUGBANK	DB04105	C8H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAUHDTOEJHVKJO-UHFFFAOYSA-N
22577	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3938	Fotemustine	Fotemustinum|(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate|Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate|Fotemustina	-	DRUGBANK	DB04106	C9H19ClN3O5P	small molecule	L01AD05	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAKWPXVTIGTRJH-QMMMGPOBSA-N
22578	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3938	Fotemustine	Fotemustinum|(+-)-Diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate|Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate|Fotemustina	-	DRUGBANK	DB04106	C9H19ClN3O5P	small molecule	L01AD05	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAKWPXVTIGTRJH-QMMMGPOBSA-N
22579	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3939	[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester	-	-	DRUGBANK	DB04107	C29H31N7O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNOYCNIZOAIUSV-LSWMGQQCSA-N
22580	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3939	[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester	-	-	DRUGBANK	DB04107	C29H31N7O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNOYCNIZOAIUSV-LSWMGQQCSA-N
22581	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3939	[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester	-	-	DRUGBANK	DB04107	C29H31N7O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNOYCNIZOAIUSV-LSWMGQQCSA-N
22582	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3940	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	-	-	DRUGBANK	DB04108	C19H26N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIIOXZPEXXZCML-KKXDTOCCSA-N
22583	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3940	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	-	-	DRUGBANK	DB04108	C19H26N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIIOXZPEXXZCML-KKXDTOCCSA-N
22584	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3940	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	-	-	DRUGBANK	DB04108	C19H26N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIIOXZPEXXZCML-KKXDTOCCSA-N
22585	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3941	[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine	-	-	DRUGBANK	DB04109	C10H14BN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCLFQXCQQHVLJQ-UHFFFAOYSA-O
22586	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3944	1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide	-	-	DRUGBANK	DB04112	C26H54NO6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZULTVWFLRZJENJ-SANMLTNESA-N
22587	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3944	1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide	-	-	DRUGBANK	DB04112	C26H54NO6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZULTVWFLRZJENJ-SANMLTNESA-N
22588	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3945	N-Formylpiperidine	-	-	DRUGBANK	DB04113	C6H11NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWLNYSYJNLUOO-UHFFFAOYSA-N
22589	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3945	N-Formylpiperidine	-	-	DRUGBANK	DB04113	C6H11NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWLNYSYJNLUOO-UHFFFAOYSA-N
22590	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3945	N-Formylpiperidine	-	-	DRUGBANK	DB04113	C6H11NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEWLNYSYJNLUOO-UHFFFAOYSA-N
22591	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3946	3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine	-	-	DRUGBANK	DB04114	C18H19ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTPHSDHUHXUYFE-NWDGAFQWSA-N
22592	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3948	Allolactose	-	-	DRUGBANK	DB04116	C12H22O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLRVVLDZNNYCBX-CAPXFGMSSA-N
22593	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3948	Allolactose	-	-	DRUGBANK	DB04116	C12H22O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLRVVLDZNNYCBX-CAPXFGMSSA-N
22594	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3949	4-(N,N-Dimethylamino)Cinnamoyl-Coa	-	-	DRUGBANK	DB04117	C32H47N8O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUPGKDRUIPTRA-OBPDMEEPSA-N
22595	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3949	4-(N,N-Dimethylamino)Cinnamoyl-Coa	-	-	DRUGBANK	DB04117	C32H47N8O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUPGKDRUIPTRA-OBPDMEEPSA-N
22596	108221	1892	-	ECHS1	SCEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3949	4-(N,N-Dimethylamino)Cinnamoyl-Coa	-	-	DRUGBANK	DB04117	C32H47N8O17P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWUPGKDRUIPTRA-OBPDMEEPSA-N
22597	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22598	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22599	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22600	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22601	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22602	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3951	Hexatantalum Dodecabromide	-	-	DRUGBANK	DB04119	Br12Ta6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJVLLWDZYINSDB-UHFFFAOYSA-N
22603	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3953	Guanosine-3'-Monophosphate-5'-Diphosphate	-	-	DRUGBANK	DB04121	C10H16N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEYSFDAMRDTCJM-FULWYAMNSA-N
22604	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3953	Guanosine-3'-Monophosphate-5'-Diphosphate	-	-	DRUGBANK	DB04121	C10H16N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEYSFDAMRDTCJM-FULWYAMNSA-N
22605	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3953	Guanosine-3'-Monophosphate-5'-Diphosphate	-	-	DRUGBANK	DB04121	C10H16N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEYSFDAMRDTCJM-FULWYAMNSA-N
22606	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3957	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine	-	-	DRUGBANK	DB04125	C26H29N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUWBXGHMVKDMQO-DEOSSOPVSA-N
22607	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3957	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine	-	-	DRUGBANK	DB04125	C26H29N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUWBXGHMVKDMQO-DEOSSOPVSA-N
22608	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3957	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine	-	-	DRUGBANK	DB04125	C26H29N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUWBXGHMVKDMQO-DEOSSOPVSA-N
22609	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3958	N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane	-	-	DRUGBANK	DB04126	C15H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBIWEWPGBHKYML-RYUDHWBXSA-N
22610	107892	1512	-	CTSH	ACC-4|ACC-5|CPSB|minichain	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3958	N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane	-	-	DRUGBANK	DB04126	C15H28N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBIWEWPGBHKYML-RYUDHWBXSA-N
22611	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3961	Willardiine	-	-	DRUGBANK	DB04129	C7H9N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FACUYWPMDKTVFU-BYPYZUCNSA-N
22612	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3961	Willardiine	-	-	DRUGBANK	DB04129	C7H9N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FACUYWPMDKTVFU-BYPYZUCNSA-N
22613	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3961	Willardiine	-	-	DRUGBANK	DB04129	C7H9N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FACUYWPMDKTVFU-BYPYZUCNSA-N
22614	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22615	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22616	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22617	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22618	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22619	109203	2948	-	GSTM4	GSTM4-4|GTM4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22620	109208	2953	hCG_41095	GSTT2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22621	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22622	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3964	S-Hexylglutathione	-	-	DRUGBANK	DB04132	C16H30N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXJDWCWJDCOHDG-NWDGAFQWSA-O
22623	849391	944996	b0337	codA	ECK0334|JW0328	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3966	5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine	-	-	DRUGBANK	DB04135	C4H5FN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRVUBDAKZJCBTI-GSVOUGTGSA-N
22624	849391	944996	b0337	codA	ECK0334|JW0328	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3966	5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine	-	-	DRUGBANK	DB04135	C4H5FN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRVUBDAKZJCBTI-GSVOUGTGSA-N
22625	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3967	Lysophosphotidylserine	-	-	DRUGBANK	DB04136	C21H44NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPZLJDFLPRHXGM-SLFFLAALSA-N
22626	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3967	Lysophosphotidylserine	-	-	DRUGBANK	DB04136	C21H44NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPZLJDFLPRHXGM-SLFFLAALSA-N
22627	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3967	Lysophosphotidylserine	-	-	DRUGBANK	DB04136	C21H44NO9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPZLJDFLPRHXGM-SLFFLAALSA-N
22628	106883	390	-	RND3	ARHE|Rho8|RhoE|memB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22629	106883	390	-	RND3	ARHE|Rho8|RhoE|memB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22630	106883	390	-	RND3	ARHE|Rho8|RhoE|memB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22631	111846	5911	RP11-128N14.2	RAP2A	K-REV|KREV|RAP2|RbBP-30	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22632	111846	5911	RP11-128N14.2	RAP2A	K-REV|KREV|RAP2|RbBP-30	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22633	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22634	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22635	120301	54963	RP4-591C20.1	UCKL1	UCK1L|URKL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22636	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22637	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22638	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22639	852646	948349	b3857	mobA	ECK3849|JW3829|chlB|mob|narB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22640	852646	948349	b3857	mobA	ECK3849|JW3829|chlB|mob|narB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22641	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22642	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22643	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22644	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22645	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22646	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22647	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22648	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22649	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22650	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22651	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22652	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22653	855637	938009	BSU28190	engB	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22654	855637	938009	BSU28190	engB	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22655	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22656	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22657	109008	2746	-	GLUD1	GDH|GDH1|GLUD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22658	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22659	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22660	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3968	Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB04137	C10H16N5O14P3	small molecule	-	86-01-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKMLYUALXHKNFT-BZKDHIKHSA-N
22661	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3969	2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide	-	-	DRUGBANK	DB04138	C14H16Br2N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDKRZLSOYPYTKG-UHFFFAOYSA-N
22662	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3969	2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide	-	-	DRUGBANK	DB04138	C14H16Br2N4O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDKRZLSOYPYTKG-UHFFFAOYSA-N
22663	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3971	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	-	-	DRUGBANK	DB04140	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUSMVCKSLVPRCL-QGZVFWFLSA-N
22664	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3971	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	-	-	DRUGBANK	DB04140	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUSMVCKSLVPRCL-QGZVFWFLSA-N
22665	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3971	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	-	-	DRUGBANK	DB04140	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUSMVCKSLVPRCL-QGZVFWFLSA-N
22666	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22667	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22668	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22669	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22670	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22671	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22672	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22673	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22674	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22675	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22676	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22677	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22678	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22679	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22680	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22681	108411	2110	-	ETFDH	ETFQO|MADD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22682	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3972	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	-	-	DRUGBANK	DB04141	C12H24O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVAZJLFFSJARQM-YBXAARCKSA-N
22683	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3973	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide	-	-	DRUGBANK	DB04142	C19H17Br2NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEYGJZKVMASWJB-UHFFFAOYSA-N
22684	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3973	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide	-	-	DRUGBANK	DB04142	C19H17Br2NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEYGJZKVMASWJB-UHFFFAOYSA-N
22685	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3975	Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone	-	-	DRUGBANK	DB04144	C30H32Cl2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIPEZDMQNYFOO-VSGBNLITSA-N
22686	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3975	Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone	-	-	DRUGBANK	DB04144	C30H32Cl2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIPEZDMQNYFOO-VSGBNLITSA-N
22687	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3975	Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone	-	-	DRUGBANK	DB04144	C30H32Cl2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIPEZDMQNYFOO-VSGBNLITSA-N
22688	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22689	850256	945889	b1319	ompG	ECK1315|JW1312	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22690	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22691	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22692	849463	945074	b0452	tesB	ECK0446|JW0442	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22693	849463	945074	b0452	tesB	ECK0446|JW0442	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22694	849463	945074	b0452	tesB	ECK0446|JW0442	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22695	852245	947936	b3424	glpG	ECK3410|JW5687	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22696	850210	945843	b1252	tonB	ECK1246|JW5195|T1rec|exbA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22697	116223	11034	-	DSTN	ACTDP|ADF|HEL32|bA462D18.2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22698	118320	28442	-	IGHV3-23	DP47|IGHV323|V3-23|VH26	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22699	107499	1072	-	CFL1	CFL|HEL-S-15	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22700	110851	4779	-	NFE2L1	LCR-F1|NRF1|TCF11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22701	849473	945084	b0451	amtB	ECK0445|JW0441|ybaG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22702	849517	945128	b1256	ompW	ECK1250|JW1248|yciD	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22703	851161	946820	b2344	fadL	ECK2338|JW2341|ttr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22704	851161	946820	b2344	fadL	ECK2338|JW2341|ttr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22705	851161	946820	b2344	fadL	ECK2338|JW2341|ttr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22706	850717	946360	b0622	pagP	ECK0615|JW0617|crcA|ybeG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22707	850717	946360	b0622	pagP	ECK0615|JW0617|crcA|ybeG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22708	850717	946360	b0622	pagP	ECK0615|JW0617|crcA|ybeG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22709	850784	946427	b4291	fecA	ECK4281|JW4251	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22710	850784	946427	b4291	fecA	ECK4281|JW4251	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22711	850784	946427	b4291	fecA	ECK4281|JW4251	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22712	851184	946843	b4311	nanC	ECK4302|JW5778|yjhA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22713	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22714	853286	949042	b2155	cirA	ECK2148|JW2142|cir|feuA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22715	852764	948468	b3966	btuB	ECK3958|JW3938|bfe|cer|dcrC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3978	Lauryl Dimethylamine-N-Oxide	-	-	DRUGBANK	DB04147	C14H31NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYELZBGXAIXKHU-UHFFFAOYSA-N
22716	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	3979	(R)-Rolipram	R-rolipram|(-)-rolipram|(R)-(-)-rolipram	-	DRUGBANK	DB04149	C16H21NO3	small molecule	-	85416-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-LBPRGKRZSA-N
22717	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3979	(R)-Rolipram	R-rolipram|(-)-rolipram|(R)-(-)-rolipram	-	DRUGBANK	DB04149	C16H21NO3	small molecule	-	85416-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-LBPRGKRZSA-N
22718	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	3979	(R)-Rolipram	R-rolipram|(-)-rolipram|(R)-(-)-rolipram	-	DRUGBANK	DB04149	C16H21NO3	small molecule	-	85416-75-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJORMJIFDVBMOB-LBPRGKRZSA-N
22719	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3980	Threonine Derivative	-	-	DRUGBANK	DB04150	C15H18I2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWMKRGDZEJLDDH-JPWUCKPDSA-N
22720	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3980	Threonine Derivative	-	-	DRUGBANK	DB04150	C15H18I2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWMKRGDZEJLDDH-JPWUCKPDSA-N
22721	111101	5066	-	PAM	PAL|PHM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3980	Threonine Derivative	-	-	DRUGBANK	DB04150	C15H18I2N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWMKRGDZEJLDDH-JPWUCKPDSA-N
22722	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3981	4-Methyl-Histidine	-	-	DRUGBANK	DB04151	C7H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRMWTNUJHUMWMS-LURJTMIESA-N
22723	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3981	4-Methyl-Histidine	-	-	DRUGBANK	DB04151	C7H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRMWTNUJHUMWMS-LURJTMIESA-N
22724	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3981	4-Methyl-Histidine	-	-	DRUGBANK	DB04151	C7H11N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRMWTNUJHUMWMS-LURJTMIESA-N
22725	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3982	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB04152	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJEPOXZLPHUVFE-ZETCQYMHSA-N
22726	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3982	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB04152	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJEPOXZLPHUVFE-ZETCQYMHSA-N
22727	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3982	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB04152	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJEPOXZLPHUVFE-ZETCQYMHSA-N
22728	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3983	S-Hydroxymethyl Glutathione	-	-	DRUGBANK	DB04153	C11H19N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIUSLWSYOYFRFR-NKWVEPMBSA-N
22729	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3983	S-Hydroxymethyl Glutathione	-	-	DRUGBANK	DB04153	C11H19N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIUSLWSYOYFRFR-NKWVEPMBSA-N
22730	851209	946869	b2412	zipA	ECK2407|JW2404	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3984	N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide	-	-	DRUGBANK	DB04154	C20H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALBWBHNFOJJMCV-UHFFFAOYSA-N
22731	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3985	2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose	-	-	DRUGBANK	DB04155	C12H21FO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWMZPXRIEZDXAQ-DHRRBEGDSA-N
22732	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3985	2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose	-	-	DRUGBANK	DB04155	C12H21FO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWMZPXRIEZDXAQ-DHRRBEGDSA-N
22733	849806	945432	b0822	ybiV	ECK0812|JW0806|supH	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22734	849806	945432	b0822	ybiV	ECK0812|JW0806|supH	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22735	850750	946393	b1882	cheY	ECK1883|JW1871	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22736	850750	946393	b1882	cheY	ECK1883|JW1871	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22737	121804	58190	-	CTDSP1	NIF3|NLI-IF|NLIIF|SCP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22738	121804	58190	-	CTDSP1	NIF3|NLI-IF|NLIIF|SCP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22739	121804	58190	-	CTDSP1	NIF3|NLI-IF|NLIIF|SCP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3986	Aspartate Beryllium Trifluoride	-	-	DRUGBANK	DB04156	C4H8BeF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSAVTCVIBRBWGG-VKZMHLLXSA-K
22740	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3988	6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin	-	-	DRUGBANK	DB04158	C17H24N10O17P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKRKFZJAQKKHKL-MSLFWYFASA-N
22741	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3988	6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin	-	-	DRUGBANK	DB04158	C17H24N10O17P4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKRKFZJAQKKHKL-MSLFWYFASA-N
22742	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22743	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22744	851285	946946	b1740	nadE	ECK1738|JW1729|efg|ntrL	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22745	851285	946946	b1740	nadE	ECK1738|JW1729|efg|ntrL	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22746	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22747	849453	945064	b0421	ispA	ECK0415|JW0411	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22748	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22749	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	3990	Diphosphate	-	-	DRUGBANK	DB04160	O7P2	small molecule	-	2466-09-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPPKVPWEQAFLFU-UHFFFAOYSA-J
22750	856549	938949	BSU23250	ribH	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	3992	5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione	-	-	DRUGBANK	DB04162	C9H14N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSKGHNZSCSCHEQ-MRKVFDINSA-N
22751	856549	938949	BSU23250	ribH	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	3992	5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione	-	-	DRUGBANK	DB04162	C9H14N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSKGHNZSCSCHEQ-MRKVFDINSA-N
22752	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3993	5-Phenylsulfanyl-2,4-Quinazolinediamine	-	-	DRUGBANK	DB04163	C14H12N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUFDQCGCADQQQY-UHFFFAOYSA-N
22753	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3996	2-Aminobenzoic Acid	-	-	DRUGBANK	DB04166	C7H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZYAGGXGHYGMB-UHFFFAOYSA-N
22754	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3996	2-Aminobenzoic Acid	-	-	DRUGBANK	DB04166	C7H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZYAGGXGHYGMB-UHFFFAOYSA-N
22755	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3996	2-Aminobenzoic Acid	-	-	DRUGBANK	DB04166	C7H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZYAGGXGHYGMB-UHFFFAOYSA-N
22756	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3996	2-Aminobenzoic Acid	-	-	DRUGBANK	DB04166	C7H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZYAGGXGHYGMB-UHFFFAOYSA-N
22757	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3996	2-Aminobenzoic Acid	-	-	DRUGBANK	DB04166	C7H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZYAGGXGHYGMB-UHFFFAOYSA-N
22758	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3996	2-Aminobenzoic Acid	-	-	DRUGBANK	DB04166	C7H7NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWZYAGGXGHYGMB-UHFFFAOYSA-N
22759	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4000	4-Bromo-3-Hydroxy-3-Methyl Butyl Diphosphate	-	-	DRUGBANK	DB04170	C5H13BrO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKAYCWPQDPILSA-RXMQYKEDSA-N
22760	853265	949020	b2889	idi	ECK2884|JW2857|ygfV	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4000	4-Bromo-3-Hydroxy-3-Methyl Butyl Diphosphate	-	-	DRUGBANK	DB04170	C5H13BrO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKAYCWPQDPILSA-RXMQYKEDSA-N
22761	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4002	[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine	-	-	DRUGBANK	DB04172	C32H48N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WATXEHGLYJKXOF-MUUNZHRXSA-N
22762	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4002	[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine	-	-	DRUGBANK	DB04172	C32H48N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WATXEHGLYJKXOF-MUUNZHRXSA-N
22763	108563	2272	-	FHIT	AP3Aase|FRA3B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4003	Fructose	-	good neighbor pharmacy anti na	DRUGBANK	DB04173	C6H12O6	small molecule	V06DC02	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFSUNEUAIZKAJO-AZGQCCRYSA-N
22764	108563	2272	-	FHIT	AP3Aase|FRA3B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4003	Fructose	-	good neighbor pharmacy anti na	DRUGBANK	DB04173	C6H12O6	small molecule	V06DC02	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFSUNEUAIZKAJO-AZGQCCRYSA-N
22765	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4005	Mdl-29951	-	-	DRUGBANK	DB04175	C12H9Cl2NO4	small molecule	-	101861-63-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNBSYZNKEAWABY-UHFFFAOYSA-N
22766	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4008	Di-Stearoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04178	C44H89NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRJAVPSFFCBXDT-WBCKFURZSA-O
22767	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4008	Di-Stearoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04178	C44H89NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRJAVPSFFCBXDT-WBCKFURZSA-O
22768	106788	291	-	SLC25A4	1|AAC1|ANT|ANT 1|ANT1|MTDPS12|PEO2|PEO3|T1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4008	Di-Stearoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04178	C44H89NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRJAVPSFFCBXDT-WBCKFURZSA-O
22769	107139	671	RP13-218F6_A.1	BPI	BPIFD1|rBPI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4008	Di-Stearoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04178	C44H89NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRJAVPSFFCBXDT-WBCKFURZSA-O
22770	107139	671	RP13-218F6_A.1	BPI	BPIFD1|rBPI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4008	Di-Stearoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04178	C44H89NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRJAVPSFFCBXDT-WBCKFURZSA-O
22771	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4010	4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB04180	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTDFJEKGSGSXME-UHFFFAOYSA-N
22772	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4010	4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB04180	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTDFJEKGSGSXME-UHFFFAOYSA-N
22773	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4010	4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB04180	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTDFJEKGSGSXME-UHFFFAOYSA-N
22774	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4012	(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid	-	-	DRUGBANK	DB04182	C9H17NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFXXRJSDEMCBPH-APQOSEDMSA-N
22775	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4012	(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid	-	-	DRUGBANK	DB04182	C9H17NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFXXRJSDEMCBPH-APQOSEDMSA-N
22776	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4014	Norvaline	-	-	DRUGBANK	DB04185	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
22777	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4014	Norvaline	-	-	DRUGBANK	DB04185	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
22778	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4014	Norvaline	-	-	DRUGBANK	DB04185	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
22779	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4014	Norvaline	-	-	DRUGBANK	DB04185	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
22780	111050	5009	-	OTC	OCTD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4014	Norvaline	-	-	DRUGBANK	DB04185	C5H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNDPXSYFESPGGJ-BYPYZUCNSA-N
22781	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4015	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	-	-	DRUGBANK	DB04186	C17H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLVYMYQTRZCMLE-CYBMUJFWSA-N
22782	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4015	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	-	-	DRUGBANK	DB04186	C17H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLVYMYQTRZCMLE-CYBMUJFWSA-N
22783	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4015	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	-	-	DRUGBANK	DB04186	C17H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLVYMYQTRZCMLE-CYBMUJFWSA-N
22784	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4016	(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB04187	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
22785	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4016	(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB04187	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
22786	109199	2944	-	GSTM1	GST1|GSTM1-1|GSTM1a-1a|GSTM1b-1b|GTH4|GTM1|H-B|MU|MU-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4016	(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene	-	-	DRUGBANK	DB04187	C24H27N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNNIZILNBMPOAC-XHIHJMKYSA-N
22787	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4022	Chitotriose	-	-	DRUGBANK	DB04194	C24H41N3O16	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZZVUHWLNMNWLW-WNRCWLGZSA-N
22788	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4022	Chitotriose	-	-	DRUGBANK	DB04194	C24H41N3O16	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZZVUHWLNMNWLW-WNRCWLGZSA-N
22789	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4022	Chitotriose	-	-	DRUGBANK	DB04194	C24H41N3O16	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZZVUHWLNMNWLW-WNRCWLGZSA-N
22790	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4023	Heptulose-2-Phosphate	-	-	DRUGBANK	DB04195	C7H15O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZBAZODTRUGOQS-XUUWZHRGSA-N
22791	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4023	Heptulose-2-Phosphate	-	-	DRUGBANK	DB04195	C7H15O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZBAZODTRUGOQS-XUUWZHRGSA-N
22792	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4023	Heptulose-2-Phosphate	-	-	DRUGBANK	DB04195	C7H15O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZBAZODTRUGOQS-XUUWZHRGSA-N
22793	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4025	Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine	-	-	DRUGBANK	DB04197	C4H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYBLXYGPQAIGPY-UHFFFAOYSA-O
22794	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4025	Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine	-	-	DRUGBANK	DB04197	C4H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYBLXYGPQAIGPY-UHFFFAOYSA-O
22795	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4025	Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine	-	-	DRUGBANK	DB04197	C4H13N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYBLXYGPQAIGPY-UHFFFAOYSA-O
22796	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4026	Formycin B	-	-	DRUGBANK	DB04198	C10H11N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22797	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4026	Formycin B	-	-	DRUGBANK	DB04198	C10H11N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22798	130457	317749	-	DHRS4L2	SDR25C3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4028	Matairesinol	3R,4R-Bis((4-hydroxy-3-methoxyphenyl)methyl)dihydro-2(3H)-furanone|Artigenin congener|(-)-Matairesinol|Dibenzylbutyrolactone lignanolide|(alphaR,betaR)-alpha,beta-Bis(4-hydroxy-3-methoxybenzyl)butyrolactone	-	DRUGBANK	DB04200	C20H22O6	small molecule	-	580-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MATGKVZWFZHCLI-LSDHHAIUSA-N
22799	851328	946989	b2514	hisS	ECK2510|JW2498	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4029	Histidyl-Adenosine Monophosphate	-	-	DRUGBANK	DB04201	C16H20N8O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22800	851328	946989	b2514	hisS	ECK2510|JW2498	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4029	Histidyl-Adenosine Monophosphate	-	-	DRUGBANK	DB04201	C16H20N8O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22801	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4031	3-Mercuri-4-Aminobenzenesulfonamide	-	-	DRUGBANK	DB04203	C6H7HgN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGGLGSZFQPTPPT-UHFFFAOYSA-N
22802	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4031	3-Mercuri-4-Aminobenzenesulfonamide	-	-	DRUGBANK	DB04203	C6H7HgN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGGLGSZFQPTPPT-UHFFFAOYSA-N
22803	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4032	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	-	-	DRUGBANK	DB04204	C18H20F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRHSAABKYJDBDV-UHFFFAOYSA-N
22804	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4032	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	-	-	DRUGBANK	DB04204	C18H20F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRHSAABKYJDBDV-UHFFFAOYSA-N
22805	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4032	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	-	-	DRUGBANK	DB04204	C18H20F4O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRHSAABKYJDBDV-UHFFFAOYSA-N
22806	850229	945862	b1274	topA	ECK1268|JW1266|asuA?|supX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4033	Thymidine-3',5'-Diphosphate	-	-	DRUGBANK	DB04205	C10H16N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNCBOPUCJOHLS-GJMOJQLCSA-N
22807	850229	945862	b1274	topA	ECK1268|JW1266|asuA?|supX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4033	Thymidine-3',5'-Diphosphate	-	-	DRUGBANK	DB04205	C10H16N2O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSNCBOPUCJOHLS-GJMOJQLCSA-N
22808	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4035	N-(5-Amino-5-Carboxypentyl)Glutamic Acid	-	-	DRUGBANK	DB04207	C11H20N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDGJAHTZVHVLOT-YUMQZZPRSA-N
22809	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4035	N-(5-Amino-5-Carboxypentyl)Glutamic Acid	-	-	DRUGBANK	DB04207	C11H20N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDGJAHTZVHVLOT-YUMQZZPRSA-N
22810	115459	10157	-	AASS	LKR/SDH|LKRSDH|LORSDH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4035	N-(5-Amino-5-Carboxypentyl)Glutamic Acid	-	-	DRUGBANK	DB04207	C11H20N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDGJAHTZVHVLOT-YUMQZZPRSA-N
22811	849497	945108	b0462	acrB	ECK0456|JW0451|acrE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4037	Dequadin	-	-	DRUGBANK	DB04209	C30H40N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCSWXVJAIHCTMO-UHFFFAOYSA-P
22812	849497	945108	b0462	acrB	ECK0456|JW0451|acrE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4037	Dequadin	-	-	DRUGBANK	DB04209	C30H40N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCSWXVJAIHCTMO-UHFFFAOYSA-P
22813	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4041	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	-	-	DRUGBANK	DB04213	C16H24N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBTZVNKXMFGOOJ-UHFFFAOYSA-N
22814	106568	52	-	ACP1	HAAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4042	4-Nitrophenyl Phosphate	-	-	DRUGBANK	DB04214	C6H6NO6P	small molecule	-	330-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZKIHKMTEMTJQX-UHFFFAOYSA-N
22815	120275	54935	RP11-190A12.1	DUSP23	DUSP25|LDP-3|MOSP|VHZ	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4042	4-Nitrophenyl Phosphate	-	-	DRUGBANK	DB04214	C6H6NO6P	small molecule	-	330-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZKIHKMTEMTJQX-UHFFFAOYSA-N
22816	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4043	CRA_9076	-	-	DRUGBANK	DB04215	C16H14BrN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVTBOJXEAPSOEB-UHFFFAOYSA-N
22817	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22818	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22819	109305	3055	RP5-836N17.3	HCK	JTK9|p59Hck|p61Hck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22820	126370	133688	-	UGT3A1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22821	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22822	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22823	117658	26275	-	HIBCH	HIBYLCOAH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22824	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22825	106994	506	-	ATP5B	ATPMB|ATPSB|HEL-S-271	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22826	106987	498	-	ATP5A1	ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22827	106997	509	RP11-401E9.1	ATP5C1	ATP5C|ATP5CL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
22828	850545	946185	b1680	sufS	ECK1676|JW1670|csdB|ynhB	511145	Escherichia coli	unknown	target	Mihara H (2002)	11983074	181792	4045	L-2-amino-3-butynoic acid	(S)-2-Amino-4-pentynoic acid|L-C-Propargylglycine|(S)-2-Amino-3-butynoic acid	-	DRUGBANK	DB04217	C4H5NO2	small molecule	-	73537-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSUAJFIEKRKPEE-VKHMYHEASA-N
22829	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4045	L-2-amino-3-butynoic acid	(S)-2-Amino-4-pentynoic acid|L-C-Propargylglycine|(S)-2-Amino-3-butynoic acid	-	DRUGBANK	DB04217	C4H5NO2	small molecule	-	73537-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSUAJFIEKRKPEE-VKHMYHEASA-N
22830	107873	1491	-	CTH	-	9606	Homo sapiens	unknown	target	Yu S (2000)	10954021	181760	4045	L-2-amino-3-butynoic acid	(S)-2-Amino-4-pentynoic acid|L-C-Propargylglycine|(S)-2-Amino-3-butynoic acid	-	DRUGBANK	DB04217	C4H5NO2	small molecule	-	73537-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DSUAJFIEKRKPEE-VKHMYHEASA-N
22831	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4046	1-Deaza-Adenosine	-	-	DRUGBANK	DB04218	C11H14N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVUDDRWKCUAERS-WGNDUZGJSA-N
22832	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4046	1-Deaza-Adenosine	-	-	DRUGBANK	DB04218	C11H14N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVUDDRWKCUAERS-WGNDUZGJSA-N
22833	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4046	1-Deaza-Adenosine	-	-	DRUGBANK	DB04218	C11H14N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVUDDRWKCUAERS-WGNDUZGJSA-N
22834	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4048	Rifamycin Cgp 4832	-	-	DRUGBANK	DB04220	C49H65N3O15	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHVBGOATCBIEAJ-UDTOXXEUSA-N
22835	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4048	Rifamycin Cgp 4832	-	-	DRUGBANK	DB04220	C49H65N3O15	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHVBGOATCBIEAJ-UDTOXXEUSA-N
22836	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22837	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Raman CS (2001)	11695891	181780	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22838	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22839	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4052	Oleic Acid	-	sha-lem	DRUGBANK	DB04224	C18H34O2	small molecule	-	112-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQPPMHVWECSIRJ-MDZDMXLPSA-N
22840	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4052	Oleic Acid	-	sha-lem	DRUGBANK	DB04224	C18H34O2	small molecule	-	112-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQPPMHVWECSIRJ-MDZDMXLPSA-N
22841	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4052	Oleic Acid	-	sha-lem	DRUGBANK	DB04224	C18H34O2	small molecule	-	112-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQPPMHVWECSIRJ-MDZDMXLPSA-N
22842	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4052	Oleic Acid	-	sha-lem	DRUGBANK	DB04224	C18H34O2	small molecule	-	112-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQPPMHVWECSIRJ-MDZDMXLPSA-N
22843	111388	5375	-	PMP2	FABP8|M-FABP|MP2|P2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4052	Oleic Acid	-	sha-lem	DRUGBANK	DB04224	C18H34O2	small molecule	-	112-80-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQPPMHVWECSIRJ-MDZDMXLPSA-N
22846	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4058	Nitromethyldethia Coenzyme A	-	-	DRUGBANK	DB04230	C22H37N8O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUGKTLRHGHIDCJ-MHLKFSCXSA-N
22847	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4058	Nitromethyldethia Coenzyme A	-	-	DRUGBANK	DB04230	C22H37N8O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUGKTLRHGHIDCJ-MHLKFSCXSA-N
22848	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4058	Nitromethyldethia Coenzyme A	-	-	DRUGBANK	DB04230	C22H37N8O18P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUGKTLRHGHIDCJ-MHLKFSCXSA-N
22849	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4060	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	-	-	DRUGBANK	DB04232	C20H23N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNGGPLKVDUPXFN-GOSISDBHSA-N
22850	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4060	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	-	-	DRUGBANK	DB04232	C20H23N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNGGPLKVDUPXFN-GOSISDBHSA-N
22851	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4060	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	-	-	DRUGBANK	DB04232	C20H23N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNGGPLKVDUPXFN-GOSISDBHSA-N
22852	850256	945889	b1319	ompG	ECK1315|JW1312	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22853	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22854	107618	1208	-	CLPS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22855	849928	945554	b0929	ompF	ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22856	849928	945554	b0929	ompF	ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22857	849928	945554	b0929	ompF	ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22858	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22862	849945	945571	b0957	ompA	ECK0948|JW0940|con|tolG|tut	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22863	849945	945571	b0957	ompA	ECK0948|JW0940|con|tolG|tut	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22864	849945	945571	b0957	ompA	ECK0948|JW0940|con|tolG|tut	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22865	851161	946820	b2344	fadL	ECK2338|JW2341|ttr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22866	851161	946820	b2344	fadL	ECK2338|JW2341|ttr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22867	851161	946820	b2344	fadL	ECK2338|JW2341|ttr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22868	849517	945128	b1256	ompW	ECK1250|JW1248|yciD	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22869	852764	948468	b3966	btuB	ECK3958|JW3938|bfe|cer|dcrC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22870	852764	948468	b3966	btuB	ECK3958|JW3938|bfe|cer|dcrC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22871	852764	948468	b3966	btuB	ECK3958|JW3938|bfe|cer|dcrC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
22872	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4062	N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide	-	-	DRUGBANK	DB04234	C20H29BrN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEDKSAKLZBMNMA-ROUUACIJSA-N
22873	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4063	4-Amino Hexanoic Acid	-	-	DRUGBANK	DB04235	C6H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROFNJLCLYMMXCT-YFKPBYRVSA-N
22874	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4063	4-Amino Hexanoic Acid	-	-	DRUGBANK	DB04235	C6H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROFNJLCLYMMXCT-YFKPBYRVSA-N
22875	106536	18	hCG_1984265	ABAT	GABA-AT|GABAT|NPD009	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4063	4-Amino Hexanoic Acid	-	-	DRUGBANK	DB04235	C6H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROFNJLCLYMMXCT-YFKPBYRVSA-N
22876	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4065	Tris(Hydroxyethyl)Aminomethane	-	-	DRUGBANK	DB04237	C7H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKODZWOPPOTFGA-UHFFFAOYSA-N
22877	106773	276	-	AMY1A	AMY1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4065	Tris(Hydroxyethyl)Aminomethane	-	-	DRUGBANK	DB04237	C7H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKODZWOPPOTFGA-UHFFFAOYSA-N
22878	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4066	N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid	-	-	DRUGBANK	DB04238	C26H28N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNANSBQAIRJZPA-DHIUTWEWSA-N
22879	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4066	N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid	-	-	DRUGBANK	DB04238	C26H28N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNANSBQAIRJZPA-DHIUTWEWSA-N
22880	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4066	N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid	-	-	DRUGBANK	DB04238	C26H28N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNANSBQAIRJZPA-DHIUTWEWSA-N
22881	852839	948545	b4039	ubiC	ECK4031|JW5713|sdgG?	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4070	P-Hydroxybenzoic Acid	-	-	DRUGBANK	DB04242	C7H6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJKROLUGYXJWQN-UHFFFAOYSA-N
22882	852839	948545	b4039	ubiC	ECK4031|JW5713|sdgG?	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4070	P-Hydroxybenzoic Acid	-	-	DRUGBANK	DB04242	C7H6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJKROLUGYXJWQN-UHFFFAOYSA-N
22885	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4072	1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone	-	-	DRUGBANK	DB04244	C26H31N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCDHZDINQZLSRR-BJKOFHAPSA-N
22886	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4072	1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone	-	-	DRUGBANK	DB04244	C26H31N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCDHZDINQZLSRR-BJKOFHAPSA-N
22887	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4072	1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone	-	-	DRUGBANK	DB04244	C26H31N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCDHZDINQZLSRR-BJKOFHAPSA-N
22888	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4074	CRA_23653	-	-	DRUGBANK	DB04246	C22H20N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22889	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4074	CRA_23653	-	-	DRUGBANK	DB04246	C22H20N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22890	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4074	CRA_23653	-	-	DRUGBANK	DB04246	C22H20N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
22891	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4076	Zinc Substituted Heme C	-	-	DRUGBANK	DB04249	C34H34N4O4Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSHBEULYPOLYCE-STIJKOADSA-N
22892	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4076	Zinc Substituted Heme C	-	-	DRUGBANK	DB04249	C34H34N4O4Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSHBEULYPOLYCE-STIJKOADSA-N
22893	119922	54205	-	CYCS	CYC|HCS|THC4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4076	Zinc Substituted Heme C	-	-	DRUGBANK	DB04249	C34H34N4O4Zn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSHBEULYPOLYCE-STIJKOADSA-N
22894	971775	3783733	-	BVRF2	-	10376	Human Herpesvirus 4	unknown	target	Imming P (2006)	17016423	171742	4078	Monoisopropyl Ester Phosphonic Acid Group	-	-	DRUGBANK	DB04251	C3H9O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGFMNFBZRAISGQ-UHFFFAOYSA-N
22895	971775	3783733	-	BVRF2	-	10376	Human Herpesvirus 4	unknown	target	Overington JP (2006)	17139284	171741	4078	Monoisopropyl Ester Phosphonic Acid Group	-	-	DRUGBANK	DB04251	C3H9O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGFMNFBZRAISGQ-UHFFFAOYSA-N
22896	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4079	N-Carbamoyl-L-Aspartate	-	-	DRUGBANK	DB04252	C5H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLKXYZVTANABHZ-REOHCLBHSA-N
22897	850154	945787	b1062	pyrC	ECK1047|JW1049	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4079	N-Carbamoyl-L-Aspartate	-	-	DRUGBANK	DB04252	C5H8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLKXYZVTANABHZ-REOHCLBHSA-N
22898	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4080	CB1954	-	-	DRUGBANK	DB04253	C9H8N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOCXQMCIOTUMJV-UHFFFAOYSA-N
22899	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4080	CB1954	-	-	DRUGBANK	DB04253	C9H8N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOCXQMCIOTUMJV-UHFFFAOYSA-N
22900	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4080	CB1954	-	-	DRUGBANK	DB04253	C9H8N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOCXQMCIOTUMJV-UHFFFAOYSA-N
22901	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4080	CB1954	-	-	DRUGBANK	DB04253	C9H8N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOCXQMCIOTUMJV-UHFFFAOYSA-N
22902	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4081	8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04254	C17H18FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARWHTQLGMWHTAZ-UHFFFAOYSA-N
22903	109168	2911	-	GRM1	GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4083	4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid	-	-	DRUGBANK	DB04256	C10H11NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNCAZYRLRMTVSF-SNVBAGLBSA-N
22904	109168	2911	-	GRM1	GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4083	4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid	-	-	DRUGBANK	DB04256	C10H11NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNCAZYRLRMTVSF-SNVBAGLBSA-N
22905	109168	2911	-	GRM1	GPRC1A|MGLU1|MGLUR1|PPP1R85|SCAR13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4083	4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid	-	-	DRUGBANK	DB04256	C10H11NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNCAZYRLRMTVSF-SNVBAGLBSA-N
22906	856067	938449	BSU02100	cypC	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4084	Palmitoleic Acid	-	-	DRUGBANK	DB04257	C16H30O2	small molecule	-	373-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECPZKHBENQXJG-BQYQJAHWSA-N
22907	856067	938449	BSU02100	cypC	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4084	Palmitoleic Acid	-	-	DRUGBANK	DB04257	C16H30O2	small molecule	-	373-49-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SECPZKHBENQXJG-BQYQJAHWSA-N
22908	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4085	Seocalcitol	(5Z,7E,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,25-triol|22-24-DIENE-24A,26A,27A,TRIHOMO-1ALPHA,25-DIHYDROXYVITAMIN D3	-	DRUGBANK	DB04258	C30H46O3	small molecule	-	134404-52-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVLLALCJVJNGQQ-SEODYNFXSA-N
22909	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4085	Seocalcitol	(5Z,7E,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,25-triol|22-24-DIENE-24A,26A,27A,TRIHOMO-1ALPHA,25-DIHYDROXYVITAMIN D3	-	DRUGBANK	DB04258	C30H46O3	small molecule	-	134404-52-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVLLALCJVJNGQQ-SEODYNFXSA-N
22910	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4087	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	-	-	DRUGBANK	DB04260	C10H14F2N5O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JANQQPWTLXUSCD-UHFFFAOYSA-N
22911	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4087	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	-	-	DRUGBANK	DB04260	C10H14F2N5O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JANQQPWTLXUSCD-UHFFFAOYSA-N
22912	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4087	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	-	-	DRUGBANK	DB04260	C10H14F2N5O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JANQQPWTLXUSCD-UHFFFAOYSA-N
22913	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4090	Geneticin	-	-	DRUGBANK	DB04263	C20H40N4O10	small molecule	-	49863-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRZYSWJRSDMWLG-DJWUNRQOSA-N
22914	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4090	Geneticin	-	-	DRUGBANK	DB04263	C20H40N4O10	small molecule	-	49863-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRZYSWJRSDMWLG-DJWUNRQOSA-N
22915	111007	4953	-	ODC1	ODC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4090	Geneticin	-	-	DRUGBANK	DB04263	C20H40N4O10	small molecule	-	49863-47-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BRZYSWJRSDMWLG-DJWUNRQOSA-N
22916	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4091	(10R)-10-Formyl-5,8,10-Trideazafolic Acid	-	-	DRUGBANK	DB04264	C23H22N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAOQLLQRJAXMGY-PBHICJAKSA-N
22917	851312	946973	b2500	purN	ECK2496|JW2485|ade	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4091	(10R)-10-Formyl-5,8,10-Trideazafolic Acid	-	-	DRUGBANK	DB04264	C23H22N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAOQLLQRJAXMGY-PBHICJAKSA-N
22918	849164	944762	b0031	dapB	ECK0032|JW0029	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4094	Dipicolinic Acid	-	-	DRUGBANK	DB04267	C7H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJJMNDUMQPNECX-UHFFFAOYSA-N
22919	849164	944762	b0031	dapB	ECK0032|JW0029	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4094	Dipicolinic Acid	-	-	DRUGBANK	DB04267	C7H5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJJMNDUMQPNECX-UHFFFAOYSA-N
22920	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4095	Methylumbelliferyl Chitotriose	-	-	DRUGBANK	DB04268	C34H47N3O18	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNYGKUQXGBVTRE-JWEWQUBASA-N
22921	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4095	Methylumbelliferyl Chitotriose	-	-	DRUGBANK	DB04268	C34H47N3O18	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNYGKUQXGBVTRE-JWEWQUBASA-N
22922	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4095	Methylumbelliferyl Chitotriose	-	-	DRUGBANK	DB04268	C34H47N3O18	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNYGKUQXGBVTRE-JWEWQUBASA-N
22923	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4096	Cyclotheonamide A	-	-	DRUGBANK	DB04269	C36H45N9O8	small molecule	-	129033-04-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDWXSPKJKIUEQF-BIXWYCRZSA-N
22924	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4096	Cyclotheonamide A	-	-	DRUGBANK	DB04269	C36H45N9O8	small molecule	-	129033-04-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDWXSPKJKIUEQF-BIXWYCRZSA-N
22925	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4096	Cyclotheonamide A	-	-	DRUGBANK	DB04269	C36H45N9O8	small molecule	-	129033-04-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDWXSPKJKIUEQF-BIXWYCRZSA-N
22926	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4097	(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid	-	-	DRUGBANK	DB04270	C25H25NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUZIMDSVRIBNNI-DEOSSOPVSA-N
22927	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4098	3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB04271	C8H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCKARVLFIJPHQU-UHFFFAOYSA-N
22928	850724	946367	b1850	eda	ECK1851|JW1839|hga|kdgA|kga	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22929	850724	946367	b1850	eda	ECK1851|JW1839|hga|kdgA|kga	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22930	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22931	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22932	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22933	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22934	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22935	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22936	107818	1431	-	CS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22937	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22938	115280	9955	UNQ2551/PRO6180	HS3ST3A1	30ST3A1|3OST3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22939	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22940	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22941	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22942	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22943	113217	7371	-	UCK2	TSA903|UK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22944	121804	58190	-	CTDSP1	NIF3|NLI-IF|NLIIF|SCP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22945	121804	58190	-	CTDSP1	NIF3|NLI-IF|NLIIF|SCP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22946	121804	58190	-	CTDSP1	NIF3|NLI-IF|NLIIF|SCP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22947	116328	11157	-	LSM6	YDR378C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22948	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22949	107104	635	-	BHMT	BHMT1|HEL-S-61p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22950	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22951	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22952	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22953	850507	946147	b1611	fumC	ECK1606|JW1603	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22954	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22955	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22956	114593	9146	-	HGS	HRS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22957	106780	283	-	ANG	ALS9|HEL168|RAA1|RNASE4|RNASE5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22958	106780	283	-	ANG	ALS9|HEL168|RAA1|RNASE4|RNASE5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22959	118081	27232	-	GNMT	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22960	118081	27232	-	GNMT	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22961	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22962	849411	945019	b0173	dxr	ECK0172|JW0168|ispC|yaeM	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22963	106849	353	-	APRT	AMP|APRTD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22964	115915	10673	RP11-153I24.1	TNFSF13B	BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22965	115915	10673	RP11-153I24.1	TNFSF13B	BAFF|BLYS|CD257|DTL|TALL-1|TALL1|THANK|TNFSF20|ZTNF4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22966	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22967	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22968	129252	259307	UNQ636/PRO1265	IL4I1	FIG1|LAAO|LAO	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22969	110356	4191	-	MDH2	M-MDH|MDH|MGC:3559|MOR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22970	852646	948349	b3857	mobA	ECK3849|JW3829|chlB|mob|narB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22971	852646	948349	b3857	mobA	ECK3849|JW3829|chlB|mob|narB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22972	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22973	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22974	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22975	109909	3704	My049	ITPA	C20orf37|HLC14-06-P|dJ794I6.3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22976	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22977	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22978	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22979	111966	6037	-	RNASE3	ECP|RNS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22980	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4100	8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine	-	-	DRUGBANK	DB04273	C10H11Cl2N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IADAQXMUWITWNG-UHFFFAOYSA-N
22981	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4100	8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine	-	-	DRUGBANK	DB04273	C10H11Cl2N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IADAQXMUWITWNG-UHFFFAOYSA-N
22982	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4100	8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine	-	-	DRUGBANK	DB04273	C10H11Cl2N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IADAQXMUWITWNG-UHFFFAOYSA-N
22983	112575	6697	-	SPR	SDR38C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4102	N-Acetyl Serotonin	-	-	DRUGBANK	DB04275	C12H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVAWJSIDNICKHF-UHFFFAOYSA-N
22984	107273	823	PIG30	CAPN1	CANP|CANP1|CANPL1|muCANP|muCL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4103	N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine	-	-	DRUGBANK	DB04276	C15H30N5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPQNJAXBPHVASB-QWRGUYRKSA-O
22985	854299	936619	BSU35020	nagBA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4104	Fructose -6-Phosphate	-	-	DRUGBANK	DB04277	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSXOAOHZAIYLCY-PBXRRBTRSA-N
22986	854299	936619	BSU35020	nagBA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4104	Fructose -6-Phosphate	-	-	DRUGBANK	DB04277	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSXOAOHZAIYLCY-PBXRRBTRSA-N
22987	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4105	2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide	-	-	DRUGBANK	DB04278	C17H32N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLLNYDDZOMCFDE-FZMZJTMJSA-N
22988	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4105	2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide	-	-	DRUGBANK	DB04278	C17H32N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLLNYDDZOMCFDE-FZMZJTMJSA-N
22989	109773	3558	-	IL2	IL-2|TCGF|lymphokine	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4105	2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide	-	-	DRUGBANK	DB04278	C17H32N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLLNYDDZOMCFDE-FZMZJTMJSA-N
22990	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4106	3-Isopropylmalic Acid	-	-	DRUGBANK	DB04279	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNQHMTFBUSSBJQ-WHFBIAKZSA-N
22991	850074	945702	b1136	icd	ECK1122|JW1122|icdA|icdE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4106	3-Isopropylmalic Acid	-	-	DRUGBANK	DB04279	C7H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNQHMTFBUSSBJQ-WHFBIAKZSA-N
22992	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4108	2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone	-	-	DRUGBANK	DB04281	C22H19ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKIDMHSZRQSXJE-CYVLTUHYSA-N
22994	851497	947165	b2679	proX	ECK2673|JW2654|osrA|proU	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4111	Proline Betaine	-	-	DRUGBANK	DB04284	C7H14NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMUNUTVVOOHQPW-ZCFIWIBFSA-O
22995	851497	947165	b2679	proX	ECK2673|JW2654|osrA|proU	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4111	Proline Betaine	-	-	DRUGBANK	DB04284	C7H14NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMUNUTVVOOHQPW-ZCFIWIBFSA-O
22996	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4112	{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid	-	-	DRUGBANK	DB04285	C31H25F2N4O3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBLDYRVJENYQNH-GHGCAVAYSA-N
22997	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4112	{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid	-	-	DRUGBANK	DB04285	C31H25F2N4O3PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBLDYRVJENYQNH-GHGCAVAYSA-N
22998	854525	936846	BSU35930	rbsD	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4113	beta-D-Ribopyranose	-	-	DRUGBANK	DB04286	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRBFZHDQGSBBOR-TXICZTDVSA-N
22999	854525	936846	BSU35930	rbsD	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4113	beta-D-Ribopyranose	-	-	DRUGBANK	DB04286	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRBFZHDQGSBBOR-TXICZTDVSA-N
23000	852563	948261	b3751	rbsB	ECK3745|JW3730|prlB|rbsP	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4113	beta-D-Ribopyranose	-	-	DRUGBANK	DB04286	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRBFZHDQGSBBOR-TXICZTDVSA-N
23001	852563	948261	b3751	rbsB	ECK3745|JW3730|prlB|rbsP	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4113	beta-D-Ribopyranose	-	-	DRUGBANK	DB04286	C5H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRBFZHDQGSBBOR-TXICZTDVSA-N
23002	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4114	(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid	-	-	DRUGBANK	DB04287	C31H37NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWLUIYFCMHKLKY-MUUNZHRXSA-N
23003	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4114	(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid	-	-	DRUGBANK	DB04287	C31H37NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWLUIYFCMHKLKY-MUUNZHRXSA-N
23004	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4115	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	-	-	DRUGBANK	DB04288	C23H31N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTVILUUAQWQWBK-IYARVYRRSA-N
23005	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4115	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	-	-	DRUGBANK	DB04288	C23H31N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTVILUUAQWQWBK-IYARVYRRSA-N
23006	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4115	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	-	-	DRUGBANK	DB04288	C23H31N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTVILUUAQWQWBK-IYARVYRRSA-N
23007	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4120	7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	-	-	DRUGBANK	DB04293	C16H16ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAPHQRWPEGVNBT-IJLUTSLNSA-N
23008	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4120	7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	-	-	DRUGBANK	DB04293	C16H16ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAPHQRWPEGVNBT-IJLUTSLNSA-N
23009	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4122	N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea	-	-	DRUGBANK	DB04295	C14H18N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSBCZGSPFATCOV-JPYZYGQNSA-N
23010	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4122	N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea	-	-	DRUGBANK	DB04295	C14H18N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSBCZGSPFATCOV-JPYZYGQNSA-N
23011	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4122	N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea	-	-	DRUGBANK	DB04295	C14H18N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSBCZGSPFATCOV-JPYZYGQNSA-N
23012	851135	946794	b2312	purF	ECK2306|JW2309|ade|purC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4123	5-Oxo-L-Norleucine	-	-	DRUGBANK	DB04296	C6H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSIJECNNZVKMJG-RXMQYKEDSA-N
23013	851135	946794	b2312	purF	ECK2306|JW2309|ade|purC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4123	5-Oxo-L-Norleucine	-	-	DRUGBANK	DB04296	C6H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSIJECNNZVKMJG-RXMQYKEDSA-N
23014	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
23015	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
23016	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
23017	119613	51564	-	HDAC7	HD7A|HDAC7A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
23018	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4126	Maleic Acid	-	-	DRUGBANK	DB04299	C4H4O4	small molecule	-	110-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-UPHRSURJSA-N
23019	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4126	Maleic Acid	-	-	DRUGBANK	DB04299	C4H4O4	small molecule	-	110-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-UPHRSURJSA-N
23020	109067	2805	-	GOT1	ASTQTL1|GIG18|cAspAT|cCAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4126	Maleic Acid	-	-	DRUGBANK	DB04299	C4H4O4	small molecule	-	110-16-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZCYOOQTPOCHFL-UPHRSURJSA-N
23021	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4128	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate	-	-	DRUGBANK	DB04301	C17H16N8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23022	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4128	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate	-	-	DRUGBANK	DB04301	C17H16N8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23023	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4128	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate	-	-	DRUGBANK	DB04301	C17H16N8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23024	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4129	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	-	-	DRUGBANK	DB04302	C11H14O2S	small molecule	-	82079-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYQNUQSGEWNWKV-XUIVZRPNSA-N
23025	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4129	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	-	-	DRUGBANK	DB04302	C11H14O2S	small molecule	-	82079-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYQNUQSGEWNWKV-XUIVZRPNSA-N
23026	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4129	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	-	-	DRUGBANK	DB04302	C11H14O2S	small molecule	-	82079-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYQNUQSGEWNWKV-XUIVZRPNSA-N
23027	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4132	5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine	-	-	DRUGBANK	DB04306	C15H14N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOJFGEAPSYQDIP-UHFFFAOYSA-N
23028	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4133	5-Hydroxy-N-Propargyl-1(R)-Aminoindan	-	-	DRUGBANK	DB04307	C12H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRSDGDXUWMMUEV-GFCCVEGCSA-N
23029	122085	64146	-	PDF	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4135	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	-	-	DRUGBANK	DB04310	C19H35N3O5	small molecule	-	13434-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLATMLVMSFZBN-VYDXJSESSA-N
23030	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4135	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	-	-	DRUGBANK	DB04310	C19H35N3O5	small molecule	-	13434-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLATMLVMSFZBN-VYDXJSESSA-N
23031	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4135	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	-	-	DRUGBANK	DB04310	C19H35N3O5	small molecule	-	13434-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLATMLVMSFZBN-VYDXJSESSA-N
23032	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4135	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	-	-	DRUGBANK	DB04310	C19H35N3O5	small molecule	-	13434-13-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLATMLVMSFZBN-VYDXJSESSA-N
23033	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4136	4-Phenylbutylamine	-	-	DRUGBANK	DB04311	C10H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGNFWIZBEATIAK-UHFFFAOYSA-N
23034	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4136	4-Phenylbutylamine	-	-	DRUGBANK	DB04311	C10H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGNFWIZBEATIAK-UHFFFAOYSA-N
23035	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4136	4-Phenylbutylamine	-	-	DRUGBANK	DB04311	C10H15N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGNFWIZBEATIAK-UHFFFAOYSA-N
23036	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4137	2,3-Difluorobenzyl Alcohol	-	-	DRUGBANK	DB04312	C7H6F2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSFGDUIJQWWBGY-UHFFFAOYSA-N
23037	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4137	2,3-Difluorobenzyl Alcohol	-	-	DRUGBANK	DB04312	C7H6F2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSFGDUIJQWWBGY-UHFFFAOYSA-N
23038	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4137	2,3-Difluorobenzyl Alcohol	-	-	DRUGBANK	DB04312	C7H6F2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSFGDUIJQWWBGY-UHFFFAOYSA-N
23039	108287	1968	-	EIF2S3	EIF2|EIF2G|EIF2gamma|eIF-2gA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23040	108287	1968	-	EIF2S3	EIF2|EIF2G|EIF2gamma|eIF-2gA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23041	108287	1968	-	EIF2S3	EIF2|EIF2G|EIF2gamma|eIF-2gA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23042	121129	56269	-	IRGC	CINEMA|IFGGE|IRGC1|Iigp5|R30953_1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23043	122761	79631	-	EFTUD1	FAM42A|HsT19294|RIA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23044	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23045	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23046	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23047	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23048	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23049	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23050	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23051	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23052	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23053	108237	1915	RP11-505P4.2	EEF1A1	CCS-3|CCS3|EE1A1|EEF-1|EEF1A|EF-Tu|EF1A|GRAF-1EF|HNGC:16303|LENG7|PTI1|eEF1A-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23054	106896	403	RP11-47A8.3	ARL3	ARFL3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23055	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23056	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23057	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23058	111806	5868	-	RAB5A	RAB5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23059	106893	400	-	ARL1	ARFL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23060	119315	51128	-	SAR1B	ANDD|CMRD|GTBPB|SARA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23061	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23062	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23063	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23064	119719	51762	-	RAB8B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23065	119719	51762	-	RAB8B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23066	119719	51762	-	RAB8B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23067	114299	8766	-	RAB11A	YL8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23068	114299	8766	-	RAB11A	YL8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23069	114299	8766	-	RAB11A	YL8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23070	111837	5901	OK/SW-cl.81	RAN	ARA24|Gsp1|TC4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23071	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23072	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23073	111941	6009	-	RHEB	RHEB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23074	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23075	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23076	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23077	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23078	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23079	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23080	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23081	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23082	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23083	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23084	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23085	855637	938009	BSU28190	engB	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23086	855637	938009	BSU28190	engB	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23087	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23088	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23089	113624	7879	-	RAB7A	PRO2706|RAB7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23090	128683	221079	-	ARL5B	ARL8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23091	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23092	111834	5898	-	RALA	RAL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23093	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23094	112911	7053	-	TGM3	TGE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23095	113135	7284	-	TUFM	COXPD4|EF-TuMT|EFTU|P43	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23096	113135	7284	-	TUFM	COXPD4|EF-TuMT|EFTU|P43	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23097	113135	7284	-	TUFM	COXPD4|EF-TuMT|EFTU|P43	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23098	850906	946559	b2051	wcaH	ECK2045|JW5335|gmm|nudD|yefC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23099	850906	946559	b2051	wcaH	ECK2045|JW5335|gmm|nudD|yefC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23100	111846	5911	RP11-128N14.2	RAP2A	K-REV|KREV|RAP2|RbBP-30	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23101	111846	5911	RP11-128N14.2	RAP2A	K-REV|KREV|RAP2|RbBP-30	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23102	109024	2762	RP1-118B18.1	GMDS	GMD|SDR3E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23103	114768	9367	-	RAB9A	RAB9	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23104	114768	9367	-	RAB9A	RAB9	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23105	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23106	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23107	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23108	106880	387	-	RHOA	ARH12|ARHA|RHO12|RHOH12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23109	106880	387	-	RHOA	ARH12|ARHA|RHO12|RHOH12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23110	106880	387	-	RHOA	ARH12|ARHA|RHO12|RHOH12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23111	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4141	D-[(N-Hydroxyamino)Carbonyl]Phenylalanine	-	-	DRUGBANK	DB04316	C10H12N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOFPEOPOAMOMBE-MRVPVSSYSA-N
23112	852753	948457	b3956	ppc	ECK3947|JW3928|asp|glu	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4142	3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid	-	-	DRUGBANK	DB04317	C4H5Cl2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBGSKYLUHGAGLB-UHFFFAOYSA-N
23113	852753	948457	b3956	ppc	ECK3947|JW3928|asp|glu	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4142	3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid	-	-	DRUGBANK	DB04317	C4H5Cl2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBGSKYLUHGAGLB-UHFFFAOYSA-N
23114	110463	4320	-	MMP11	SL-3|ST3|STMY3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4143	1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid	-	-	DRUGBANK	DB04318	C39H42N4O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPWFARUIZQCYBJ-NUHNATIRSA-N
23115	110463	4320	-	MMP11	SL-3|ST3|STMY3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4143	1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid	-	-	DRUGBANK	DB04318	C39H42N4O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPWFARUIZQCYBJ-NUHNATIRSA-N
23116	110463	4320	-	MMP11	SL-3|ST3|STMY3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4143	1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid	-	-	DRUGBANK	DB04318	C39H42N4O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPWFARUIZQCYBJ-NUHNATIRSA-N
23117	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4147	LY249543	-	-	DRUGBANK	DB04322	C21H25N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUQBAQVRAURMCL-IUODEOHRSA-N
23118	110622	4522	-	MTHFD1	MTHFC|MTHFD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4147	LY249543	-	-	DRUGBANK	DB04322	C21H25N5O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUQBAQVRAURMCL-IUODEOHRSA-N
23119	116785	23173	-	METAP1	MAP1A|MetAP1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4149	Ovalicin	-	-	DRUGBANK	DB04324	C16H26O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOXVFQCRPDLSFN-DGXTUMSLSA-N
23120	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4149	Ovalicin	-	-	DRUGBANK	DB04324	C16H26O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOXVFQCRPDLSFN-DGXTUMSLSA-N
23121	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4149	Ovalicin	-	-	DRUGBANK	DB04324	C16H26O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOXVFQCRPDLSFN-DGXTUMSLSA-N
23122	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4149	Ovalicin	-	-	DRUGBANK	DB04324	C16H26O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOXVFQCRPDLSFN-DGXTUMSLSA-N
23123	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23124	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23125	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23126	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23127	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23128	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23129	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23130	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4150	2-Phenylethylamine	-	-	DRUGBANK	DB04325	C8H12N	small molecule	-	64-04-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHHGXPLMPWCGHP-UHFFFAOYSA-O
23131	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23132	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23133	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23134	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23135	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23136	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23137	851610	947282	b2800	fucA	ECK2795|JW2771|fucC|prd	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23138	851610	947282	b2800	fucA	ECK2795|JW2771|fucC|prd	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23139	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23140	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23141	106730	229	RP11-490D19.1	ALDOB	ALDB|ALDO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4151	1,3-Dihydroxyacetonephosphate	-	-	DRUGBANK	DB04326	C3H7O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNGACRATGGDKBX-UHFFFAOYSA-N
23142	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4152	Phosphatidylethanolamine	-	-	DRUGBANK	DB04327	C41H83NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNGJLRDBYCPGB-KDXMTYKHSA-O
23143	115797	10544	-	PROCR	CCCA|CCD41|EPCR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4152	Phosphatidylethanolamine	-	-	DRUGBANK	DB04327	C41H83NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVNGJLRDBYCPGB-KDXMTYKHSA-O
23144	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4153	Shikimate-3-Phosphate	-	-	DRUGBANK	DB04328	C7H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYOJSKGCWNAKGW-HCWXCVPCSA-N
23145	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4153	Shikimate-3-Phosphate	-	-	DRUGBANK	DB04328	C7H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYOJSKGCWNAKGW-HCWXCVPCSA-N
23146	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4156	Monastrol	-	-	DRUGBANK	DB04331	C14H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOBCDGHHHHGHFA-LBPRGKRZSA-N
23147	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4156	Monastrol	-	-	DRUGBANK	DB04331	C14H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOBCDGHHHHGHFA-LBPRGKRZSA-N
23148	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4156	Monastrol	-	-	DRUGBANK	DB04331	C14H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOBCDGHHHHGHFA-LBPRGKRZSA-N
23149	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4159	6-hydroxydopa quinone	2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone	-	DRUGBANK	DB04334	C9H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMJSPIGDFKRRO-YFKPBYRVSA-N
23150	850303	945939	b1386	tynA	ECK1383|JW1381|maoA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4159	6-hydroxydopa quinone	2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone	-	DRUGBANK	DB04334	C9H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMJSPIGDFKRRO-YFKPBYRVSA-N
23151	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4159	6-hydroxydopa quinone	2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone	-	DRUGBANK	DB04334	C9H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMJSPIGDFKRRO-YFKPBYRVSA-N
23152	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4159	6-hydroxydopa quinone	2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone	-	DRUGBANK	DB04334	C9H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMJSPIGDFKRRO-YFKPBYRVSA-N
23153	114192	8639	-	AOC3	HPAO|SSAO|VAP-1|VAP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4159	6-hydroxydopa quinone	2,4,5-trihydroxyphenylalanine quinone|5-(2-carboxy-2-aminoethyl)-4-hydroxy-1,2-benzoquinone|5-(2-carboxy-2-aminoethyl)-2-hydroxy-1,4-benzoquinone|Topa quinone	-	DRUGBANK	DB04334	C9H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGMJSPIGDFKRRO-YFKPBYRVSA-N
23154	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4160	Inosine	Oxiamin|Inosina|Ribonosine|INO|Inosinum|beta-Inosine|Hypoxanthosine	rejuvesol	DRUGBANK	DB04335	C10H12N4O5	small molecule	D06BB05|G01AX02|S01XA10	58-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGQMRVRMYYASKQ-KQYNXXCUSA-N
23155	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4160	Inosine	Oxiamin|Inosina|Ribonosine|INO|Inosinum|beta-Inosine|Hypoxanthosine	rejuvesol	DRUGBANK	DB04335	C10H12N4O5	small molecule	D06BB05|G01AX02|S01XA10	58-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGQMRVRMYYASKQ-KQYNXXCUSA-N
23156	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4160	Inosine	Oxiamin|Inosina|Ribonosine|INO|Inosinum|beta-Inosine|Hypoxanthosine	rejuvesol	DRUGBANK	DB04335	C10H12N4O5	small molecule	D06BB05|G01AX02|S01XA10	58-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGQMRVRMYYASKQ-KQYNXXCUSA-N
23157	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4161	1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea	-	-	DRUGBANK	DB04336	C14H13ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQWKMDKTTCPCMQ-UHFFFAOYSA-N
23158	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4162	Methyl Isocyanide	-	-	DRUGBANK	DB04337	C2H3N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKSVHFXTRFQFL-UHFFFAOYSA-N
23159	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4162	Methyl Isocyanide	-	-	DRUGBANK	DB04337	C2H3N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKSVHFXTRFQFL-UHFFFAOYSA-N
23160	110321	4151	RP4-569D19.7	MB	PVALB|myoglobgin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4162	Methyl Isocyanide	-	-	DRUGBANK	DB04337	C2H3N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKSVHFXTRFQFL-UHFFFAOYSA-N
23161	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23162	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23163	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23164	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4163	SB220025	-	-	DRUGBANK	DB04338	C18H19FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSPFURGQAYMVAN-UHFFFAOYSA-N
23165	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4164	Carbocisteine	S-carboxymethylcysteine	-	DRUGBANK	DB04339	C5H9NO4S	small molecule	R05CB03	638-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBFLZEXEOZUWRN-VKHMYHEASA-N
23166	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4164	Carbocisteine	S-carboxymethylcysteine	-	DRUGBANK	DB04339	C5H9NO4S	small molecule	R05CB03	638-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBFLZEXEOZUWRN-VKHMYHEASA-N
23167	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4164	Carbocisteine	S-carboxymethylcysteine	-	DRUGBANK	DB04339	C5H9NO4S	small molecule	R05CB03	638-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBFLZEXEOZUWRN-VKHMYHEASA-N
23168	853137	948857	b2976	glcB	ECK2970|JW2943|glc	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4168	Glyoxalate, Glyoxylate	-	-	DRUGBANK	DB04343	C2H2O3	small molecule	-	298-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHLFWLYXYJOTON-UHFFFAOYSA-N
23169	853137	948857	b2976	glcB	ECK2970|JW2943|glc	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4168	Glyoxalate, Glyoxylate	-	-	DRUGBANK	DB04343	C2H2O3	small molecule	-	298-12-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHLFWLYXYJOTON-UHFFFAOYSA-N
23170	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4169	7,8-dimethylalloxazine	Riboflavin lumichrome|6,7-Dimethylalloxazine|7,8-dimethylisoalloxazine|lumichrome|7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione	-	DRUGBANK	DB04345	C12H10N4O2	small molecule	-	1086-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJTJUVIJVLLGSP-UHFFFAOYSA-N
23171	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4169	7,8-dimethylalloxazine	Riboflavin lumichrome|6,7-Dimethylalloxazine|7,8-dimethylisoalloxazine|lumichrome|7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione	-	DRUGBANK	DB04345	C12H10N4O2	small molecule	-	1086-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJTJUVIJVLLGSP-UHFFFAOYSA-N
23172	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4169	7,8-dimethylalloxazine	Riboflavin lumichrome|6,7-Dimethylalloxazine|7,8-dimethylisoalloxazine|lumichrome|7,8-dimethylbenzo[g]pteridine-2,4(1H,3H)-dione	-	DRUGBANK	DB04345	C12H10N4O2	small molecule	-	1086-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJTJUVIJVLLGSP-UHFFFAOYSA-N
23173	107485	1056	-	CEL	BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4172	Taurocholic Acid	-	-	DRUGBANK	DB04348	C26H45NO7S	small molecule	-	81-24-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBWWGRHZICKQGZ-GIHLXUJPSA-N
23174	107485	1056	-	CEL	BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4172	Taurocholic Acid	-	-	DRUGBANK	DB04348	C26H45NO7S	small molecule	-	81-24-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBWWGRHZICKQGZ-GIHLXUJPSA-N
23175	107485	1056	-	CEL	BAL|BSDL|BSSL|CELL|CEase|FAP|FAPP|LIPA|MODY8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4172	Taurocholic Acid	-	-	DRUGBANK	DB04348	C26H45NO7S	small molecule	-	81-24-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBWWGRHZICKQGZ-GIHLXUJPSA-N
23176	108470	2172	-	FABP6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4172	Taurocholic Acid	-	-	DRUGBANK	DB04348	C26H45NO7S	small molecule	-	81-24-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBWWGRHZICKQGZ-GIHLXUJPSA-N
23177	108470	2172	-	FABP6	I-15P|I-BABP|I-BALB|I-BAP|ILBP|ILBP3|ILLBP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4172	Taurocholic Acid	-	-	DRUGBANK	DB04348	C26H45NO7S	small molecule	-	81-24-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBWWGRHZICKQGZ-GIHLXUJPSA-N
23178	853625	935930	BSU34100	rsbQ	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4173	S-1,2-Propanediol	-	-	DRUGBANK	DB04349	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-VKHMYHEASA-N
23179	853625	935930	BSU34100	rsbQ	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4173	S-1,2-Propanediol	-	-	DRUGBANK	DB04349	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-VKHMYHEASA-N
23180	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4173	S-1,2-Propanediol	-	-	DRUGBANK	DB04349	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-VKHMYHEASA-N
23181	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4173	S-1,2-Propanediol	-	-	DRUGBANK	DB04349	C3H8O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-VKHMYHEASA-N
23182	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4174	Argadin	FO 7314	-	DRUGBANK	DB04350	C29H42N10O9	small molecule	-	289665-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOZYKTUSOWWQGR-KNPYFFGGSA-N
23183	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4174	Argadin	FO 7314	-	DRUGBANK	DB04350	C29H42N10O9	small molecule	-	289665-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOZYKTUSOWWQGR-KNPYFFGGSA-N
23184	849264	944864	b0118	acnB	ECK0117|JW0114|yacI|yacJ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4175	Aconitate Ion	-	-	DRUGBANK	DB04351	C6H3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTZCVFVGUGFEME-IWQZZHSRSA-K
23185	849264	944864	b0118	acnB	ECK0117|JW0114|yacI|yacJ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4175	Aconitate Ion	-	-	DRUGBANK	DB04351	C6H3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTZCVFVGUGFEME-IWQZZHSRSA-K
23186	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4175	Aconitate Ion	-	-	DRUGBANK	DB04351	C6H3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTZCVFVGUGFEME-IWQZZHSRSA-K
23187	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4175	Aconitate Ion	-	-	DRUGBANK	DB04351	C6H3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTZCVFVGUGFEME-IWQZZHSRSA-K
23188	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4175	Aconitate Ion	-	-	DRUGBANK	DB04351	C6H3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTZCVFVGUGFEME-IWQZZHSRSA-K
23189	854525	936846	BSU35930	rbsD	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4176	[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate	-	-	DRUGBANK	DB04352	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTVPXOYAKDPRHY-MBMOQRBOSA-N
23190	854525	936846	BSU35930	rbsD	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4176	[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate	-	-	DRUGBANK	DB04352	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTVPXOYAKDPRHY-MBMOQRBOSA-N
23191	119744	53343	PSEC0099	NUDT9	NUDT10	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4176	[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate	-	-	DRUGBANK	DB04352	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTVPXOYAKDPRHY-MBMOQRBOSA-N
23192	119744	53343	PSEC0099	NUDT9	NUDT10	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4176	[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate	-	-	DRUGBANK	DB04352	C5H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTVPXOYAKDPRHY-MBMOQRBOSA-N
23193	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23194	108855	2582	RP5-886K2.6	GALE	SDR1E1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23195	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23196	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23197	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23198	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23199	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23200	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23201	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23202	109247	2992	-	GYG1	GSD15|GYG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4178	Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester	-	-	DRUGBANK	DB04355	C15H24N2O17P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=HSCJRCZFDFQWRP-LJMZODOWSA-N
23203	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4179	9-Deazaguanine	-	-	DRUGBANK	DB04356	C6H5N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23204	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4179	9-Deazaguanine	-	-	DRUGBANK	DB04356	C6H5N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23205	109488	3251	-	HPRT1	HGPRT|HPRT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4179	9-Deazaguanine	-	-	DRUGBANK	DB04356	C6H5N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23206	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4182	Benzo[B]Thiophene-2-Boronic Acid	-	-	DRUGBANK	DB04360	C8H7BO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNCYPMUJDDXIRH-UHFFFAOYSA-N
23207	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4182	Benzo[B]Thiophene-2-Boronic Acid	-	-	DRUGBANK	DB04360	C8H7BO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNCYPMUJDDXIRH-UHFFFAOYSA-N
23208	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4185	Mesobiliverdin Iv Alpha	-	-	DRUGBANK	DB04363	C33H37N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23209	107114	645	-	BLVRB	BVRB|FLR|HEL-S-10|SDR43U1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4185	Mesobiliverdin Iv Alpha	-	-	DRUGBANK	DB04363	C33H37N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23210	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4187	Arecoline	-	-	DRUGBANK	DB04365	C8H13NO2	small molecule	-	63-75-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJJPJSXJAXAIPN-UHFFFAOYSA-N
23211	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4187	Arecoline	-	-	DRUGBANK	DB04365	C8H13NO2	small molecule	-	63-75-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJJPJSXJAXAIPN-UHFFFAOYSA-N
23212	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4188	3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB04366	C10H16N6O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKODIDNZKBYXJO-NVDYINRQSA-N
23213	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4188	3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB04366	C10H16N6O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKODIDNZKBYXJO-NVDYINRQSA-N
23214	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4188	3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate	-	-	DRUGBANK	DB04366	C10H16N6O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKODIDNZKBYXJO-NVDYINRQSA-N
23215	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4189	Debromohymenialdisine	-	-	DRUGBANK	DB04367	C11H10N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23216	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4189	Debromohymenialdisine	-	-	DRUGBANK	DB04367	C11H10N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23217	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4189	Debromohymenialdisine	-	-	DRUGBANK	DB04367	C11H10N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23218	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4189	Debromohymenialdisine	-	-	DRUGBANK	DB04367	C11H10N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23219	122085	64146	-	PDF	-	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4190	Bb-3497	-	-	DRUGBANK	DB04368	C16H31N3O4	small molecule	-	235784-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVDLWYHBABSSHC-CHWSQXEVSA-N
23220	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4190	Bb-3497	-	-	DRUGBANK	DB04368	C16H31N3O4	small molecule	-	235784-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVDLWYHBABSSHC-CHWSQXEVSA-N
23221	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4190	Bb-3497	-	-	DRUGBANK	DB04368	C16H31N3O4	small molecule	-	235784-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVDLWYHBABSSHC-CHWSQXEVSA-N
23222	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4190	Bb-3497	-	-	DRUGBANK	DB04368	C16H31N3O4	small molecule	-	235784-88-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVDLWYHBABSSHC-CHWSQXEVSA-N
23223	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4191	1,3,2-Dioxaborolan-2-Ol	-	-	DRUGBANK	DB04369	C2H5BO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBEDLGKSWBORBS-UHFFFAOYSA-N
23224	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4191	1,3,2-Dioxaborolan-2-Ol	-	-	DRUGBANK	DB04369	C2H5BO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBEDLGKSWBORBS-UHFFFAOYSA-N
23225	111628	5646	RP11-176F3.3	PRSS3	MTG|PRSS4|T9|TRY3|TRY4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4191	1,3,2-Dioxaborolan-2-Ol	-	-	DRUGBANK	DB04369	C2H5BO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBEDLGKSWBORBS-UHFFFAOYSA-N
23226	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4193	AL6528	-	-	DRUGBANK	DB04371	C13H12N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBBLOSCXOZYUSS-UHFFFAOYSA-N
23227	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4193	AL6528	-	-	DRUGBANK	DB04371	C13H12N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBBLOSCXOZYUSS-UHFFFAOYSA-N
23228	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4193	AL6528	-	-	DRUGBANK	DB04371	C13H12N2O5S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBBLOSCXOZYUSS-UHFFFAOYSA-N
23229	121818	58488	-	PCTP	PC-TP|STARD2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4194	Di-Linoleoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04372	C44H80NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVXDQWZBHIXIEJ-QLMRABNMSA-N
23230	121818	58488	-	PCTP	PC-TP|STARD2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4194	Di-Linoleoyl-3-Sn-Phosphatidylcholine	-	-	DRUGBANK	DB04372	C44H80NO8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVXDQWZBHIXIEJ-QLMRABNMSA-N
23231	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4196	4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole	-	-	DRUGBANK	DB04374	C14H25N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GROSWUGUHPUYIU-UHFFFAOYSA-N
23232	111566	5580	-	PRKCD	ALPS3|CVID9|MAY1|PKCD|nPKC-delta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4198	13-Acetylphorbol	-	-	DRUGBANK	DB04376	C22H30O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDSVJYOOAPRSDA-RPCQODIISA-N
23233	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4199	3-Hydroxy-3-Methyl-Glutaric Acid	-	-	DRUGBANK	DB04377	C6H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPOAOTPXWNWTSH-UHFFFAOYSA-N
23234	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4199	3-Hydroxy-3-Methyl-Glutaric Acid	-	-	DRUGBANK	DB04377	C6H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPOAOTPXWNWTSH-UHFFFAOYSA-N
23235	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4201	N-Methyl-N-(Methylbenzyl)Formamide	-	-	DRUGBANK	DB04379	C10H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYPINKULTUCCJA-VIFPVBQESA-N
23236	849538	945150	b0516	allC	ECK0509|JW0504|glxB7|ylbB	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4202	Diureido-Acetate	-	-	DRUGBANK	DB04380	C4H7N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUCLJNSWZCHRKL-UHFFFAOYSA-M
23237	849538	945150	b0516	allC	ECK0509|JW0504|glxB7|ylbB	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4202	Diureido-Acetate	-	-	DRUGBANK	DB04380	C4H7N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUCLJNSWZCHRKL-UHFFFAOYSA-M
23238	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4203	Crotonaldehyde	-	-	DRUGBANK	DB04381	C4H6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLUCVPSAIODCQM-NSCUHMNNSA-N
23239	106719	217	-	ALDH2	ALDH-E2|ALDHI|ALDM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4203	Crotonaldehyde	-	-	DRUGBANK	DB04381	C4H6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLUCVPSAIODCQM-NSCUHMNNSA-N
23240	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4204	2-Deoxy-Beta-D-Galactose	-	-	DRUGBANK	DB04382	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMMURAAUARKVCB-OMMKOOBNSA-N
23241	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4204	2-Deoxy-Beta-D-Galactose	-	-	DRUGBANK	DB04382	C6H12O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMMURAAUARKVCB-OMMKOOBNSA-N
23242	851005	946663	b2143	cdd	ECK2136|JW2131	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4207	3-Deazacytidine	-	-	DRUGBANK	DB04385	C10H14N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGADSZTVCUXSOK-BEYHFKMWSA-N
23243	851005	946663	b2143	cdd	ECK2136|JW2131	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4207	3-Deazacytidine	-	-	DRUGBANK	DB04385	C10H14N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGADSZTVCUXSOK-BEYHFKMWSA-N
23244	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23245	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23246	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23247	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23248	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23249	108563	2272	-	FHIT	AP3Aase|FRA3B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4211	Ado-P-Ch2-P-Ps-Ado	-	-	DRUGBANK	DB04389	C21H29N10O14P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJCWOSLCGXVJOD-LCFGXLPTSA-N
23250	108563	2272	-	FHIT	AP3Aase|FRA3B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4211	Ado-P-Ch2-P-Ps-Ado	-	-	DRUGBANK	DB04389	C21H29N10O14P3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJCWOSLCGXVJOD-LCFGXLPTSA-N
23251	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4212	Aeruginosin 98-B	-	-	DRUGBANK	DB04391	C29H46N6O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZVRXEOKWMIDDV-FEUXNLHUSA-N
23252	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4212	Aeruginosin 98-B	-	-	DRUGBANK	DB04391	C29H46N6O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZVRXEOKWMIDDV-FEUXNLHUSA-N
23253	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4212	Aeruginosin 98-B	-	-	DRUGBANK	DB04391	C29H46N6O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZVRXEOKWMIDDV-FEUXNLHUSA-N
23254	851885	947569	b1412	azoR	ECK1405|JW1409|acpD	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4213	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	-	-	DRUGBANK	DB04392	C19H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIZKPJUTKKJDGA-BETUJISGSA-N
23255	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4213	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	-	-	DRUGBANK	DB04392	C19H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIZKPJUTKKJDGA-BETUJISGSA-N
23256	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4213	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	-	-	DRUGBANK	DB04392	C19H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIZKPJUTKKJDGA-BETUJISGSA-N
23257	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4213	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	-	-	DRUGBANK	DB04392	C19H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIZKPJUTKKJDGA-BETUJISGSA-N
23258	850145	945778	b0578	nfsB	ECK0570|JW0567|dprA|nfnB|nfsI|ntr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4213	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	-	-	DRUGBANK	DB04392	C19H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIZKPJUTKKJDGA-BETUJISGSA-N
23259	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4215	3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide	-	-	DRUGBANK	DB04394	C10H11N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPCPYSKJIRSWIG-UHFFFAOYSA-N
23260	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4215	3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide	-	-	DRUGBANK	DB04394	C10H11N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPCPYSKJIRSWIG-UHFFFAOYSA-N
23261	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4215	3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide	-	-	DRUGBANK	DB04394	C10H11N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPCPYSKJIRSWIG-UHFFFAOYSA-N
23262	111231	5210	-	PFKFB4	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23263	111231	5210	-	PFKFB4	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23264	111231	5210	-	PFKFB4	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23265	852983	948691	b4170	mutL	ECK4166|JW4128	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23266	852983	948691	b4170	mutL	ECK4166|JW4128	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23267	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23268	108174	1841	-	DTYMK	CDC8|PP3731|TMPK|TYMK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23269	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23270	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23271	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23272	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23273	850725	946368	b1849	purT	ECK1850|JW1838	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23274	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23275	113054	7203	RP11-443G18.6	CCT3	CCT-gamma|CCTG|PIG48|TCP-1-gamma|TRIC5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23276	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23277	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23278	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23279	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23280	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23281	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23282	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23283	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23284	852760	948464	b3959	argB	ECK3950|JW5553	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23285	852760	948464	b3959	argB	ECK3950|JW5553	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23286	109911	3706	-	ITPKA	IP3-3KA|IP3KA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23287	109911	3706	-	ITPKA	IP3-3KA|IP3KA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23288	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23289	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23290	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23291	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23292	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23293	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23294	852513	948211	b3699	gyrB	Cou|ECK3691|JW5625|acrB|himB|hisU|hopA|nalC|parA|pcbA|pcpA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23295	116195	11004	RP11-269F19.1	KIF2C	CT139|KNSL6|MCAK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23296	116195	11004	RP11-269F19.1	KIF2C	CT139|KNSL6|MCAK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23297	116195	11004	RP11-269F19.1	KIF2C	CT139|KNSL6|MCAK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23298	120177	54822	-	TRPM7	ALSPDC|CHAK|CHAK1|LTRPC7|LTrpC-7|TRP-PLIK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23299	112611	6733	-	SRPK2	SFRSK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23300	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23301	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23302	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23303	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23304	111825	5888	-	RAD51	BRCC5|HRAD51|HsRad51|HsT16930|MRMV2|RAD51A|RECA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23305	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23306	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23307	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23308	109345	3098	-	HK1	HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23309	109345	3098	-	HK1	HK1-ta|HK1-tb|HK1-tc|HKD|HKI|HMSNR|HXK1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23310	852773	948479	b3974	coaA	ECK3966|JW3942|panK|rts|ts-9	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23311	852773	948479	b3974	coaA	ECK3966|JW3942|panK|rts|ts-9	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23312	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23313	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23314	851602	947272	b3404	envZ	ECK3391|JW3367|cpr|ompB|perA|tpo	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23315	851602	947272	b3404	envZ	ECK3391|JW3367|cpr|ompB|perA|tpo	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23316	107029	547	-	KIF1A	ATSV|C2orf20|HSN2C|MRD9|SPG30|UNC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23317	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23318	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23319	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23320	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23321	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23322	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23323	853324	949083	b0343	lacY	ECK0340|JW0334	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23324	853324	949083	b0343	lacY	ECK0340|JW0334	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23325	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23326	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23327	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4217	Thiodigalactoside	-	-	DRUGBANK	DB04396	C12H22O10S	small molecule	-	51555-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYKYBMOFPMXDRQ-SOIZYFOBSA-N
23328	111256	5236	-	PGM1	CDG1T|GSD14	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4218	Alpha-D-Glucose-1-Phosphate-6-Vanadate	-	-	DRUGBANK	DB04397	C6H13O12PV	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYRDAPWACIANBN-DPXSRCRQSA-M
23329	111256	5236	-	PGM1	CDG1T|GSD14	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4218	Alpha-D-Glucose-1-Phosphate-6-Vanadate	-	-	DRUGBANK	DB04397	C6H13O12PV	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYRDAPWACIANBN-DPXSRCRQSA-M
23330	111256	5236	-	PGM1	CDG1T|GSD14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4218	Alpha-D-Glucose-1-Phosphate-6-Vanadate	-	-	DRUGBANK	DB04397	C6H13O12PV	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYRDAPWACIANBN-DPXSRCRQSA-M
23331	849974	945600	b1014	putA	ECK1005|JW0999|poaA|putC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4219	Lactic Acid	-	dianeal pd 102 capd solution w	DRUGBANK	DB04398	C3H6O3	small molecule	G01AD01	50-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVTAAEKCZFNVCJ-UHFFFAOYSA-N
23332	849974	945600	b1014	putA	ECK1005|JW0999|poaA|putC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4219	Lactic Acid	-	dianeal pd 102 capd solution w	DRUGBANK	DB04398	C3H6O3	small molecule	G01AD01	50-21-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVTAAEKCZFNVCJ-UHFFFAOYSA-N
23333	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23334	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23335	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23336	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23337	112912	7054	-	TH	DYT14|DYT5b|TYH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23338	111125	5092	-	PCBD1	DCOH|PCBD|PCD|PHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23339	111125	5092	-	PCBD1	DCOH|PCBD|PCD|PHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23340	111125	5092	-	PCBD1	DCOH|PCBD|PCD|PHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23341	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23342	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23343	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
23344	850243	945876	b1444	patD	ECK1438|JW1439|prr|ydcW	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4221	[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde	-	-	DRUGBANK	DB04401	C5H12NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXKNCCSPZDCRFD-UHFFFAOYSA-N
23345	850243	945876	b1444	patD	ECK1438|JW1439|prr|ydcW	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4221	[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde	-	-	DRUGBANK	DB04401	C5H12NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXKNCCSPZDCRFD-UHFFFAOYSA-N
23346	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4222	Allosamizoline	-	-	DRUGBANK	DB04404	C9H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJAYSJDHSEFRI-YMVPXFTJSA-N
23347	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4222	Allosamizoline	-	-	DRUGBANK	DB04404	C9H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJAYSJDHSEFRI-YMVPXFTJSA-N
23348	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4223	2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid	-	-	DRUGBANK	DB04405	C28H25NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQYSXARQCHHHLK-OAQYLSRUSA-N
23349	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4223	2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid	-	-	DRUGBANK	DB04405	C28H25NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQYSXARQCHHHLK-OAQYLSRUSA-N
23350	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4225	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04407	C15H15N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTMLAWRVLMYMDF-UHFFFAOYSA-N
23351	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4225	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04407	C15H15N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTMLAWRVLMYMDF-UHFFFAOYSA-N
23352	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4225	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04407	C15H15N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTMLAWRVLMYMDF-UHFFFAOYSA-N
23353	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4227	Naphthalene Trisulfonate	-	-	DRUGBANK	DB04409	C10H5O9S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPBSAMLXSQCSOX-UHFFFAOYSA-K
23354	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4227	Naphthalene Trisulfonate	-	-	DRUGBANK	DB04409	C10H5O9S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPBSAMLXSQCSOX-UHFFFAOYSA-K
23355	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4227	Naphthalene Trisulfonate	-	-	DRUGBANK	DB04409	C10H5O9S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPBSAMLXSQCSOX-UHFFFAOYSA-K
23356	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4228	3-Phenylpropylamine	3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane	-	DRUGBANK	DB04410	C9H13N	small molecule	-	2038-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYUQWQRTDLVQGA-UHFFFAOYSA-N
23357	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4228	3-Phenylpropylamine	3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane	-	DRUGBANK	DB04410	C9H13N	small molecule	-	2038-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYUQWQRTDLVQGA-UHFFFAOYSA-N
23358	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4228	3-Phenylpropylamine	3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane	-	DRUGBANK	DB04410	C9H13N	small molecule	-	2038-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYUQWQRTDLVQGA-UHFFFAOYSA-N
23359	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4228	3-Phenylpropylamine	3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane	-	DRUGBANK	DB04410	C9H13N	small molecule	-	2038-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYUQWQRTDLVQGA-UHFFFAOYSA-N
23360	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4228	3-Phenylpropylamine	3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane	-	DRUGBANK	DB04410	C9H13N	small molecule	-	2038-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYUQWQRTDLVQGA-UHFFFAOYSA-N
23361	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4228	3-Phenylpropylamine	3-phenyl-1-propylamine|gamma-phenylpropylamine|benzenepropanamine|gamma-phenyl-n-propylamine|3-phenyl-N-propylamine|hydrocinnamylamine|3-phenylpropanamine|3-phenyl-1-aminopropane	-	DRUGBANK	DB04410	C9H13N	small molecule	-	2038-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LYUQWQRTDLVQGA-UHFFFAOYSA-N
23362	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4232	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	-	-	DRUGBANK	DB04416	C20H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJKGJGURDPRKGW-LJQANCHMSA-N
23363	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4232	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	-	-	DRUGBANK	DB04416	C20H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJKGJGURDPRKGW-LJQANCHMSA-N
23364	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4232	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	-	-	DRUGBANK	DB04416	C20H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJKGJGURDPRKGW-LJQANCHMSA-N
23365	112686	6817	OK/SW-cl.88	SULT1A1	HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4233	P-Nitrophenol	-	-	DRUGBANK	DB04417	C6H5NO3	small molecule	-	100-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTJIUGUIPKRLHP-UHFFFAOYSA-N
23366	112686	6817	OK/SW-cl.88	SULT1A1	HAST1/HAST2|P-PST|PST|ST1A1|ST1A3|STP|STP1|TSPST1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4233	P-Nitrophenol	-	-	DRUGBANK	DB04417	C6H5NO3	small molecule	-	100-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTJIUGUIPKRLHP-UHFFFAOYSA-N
23367	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4233	P-Nitrophenol	-	-	DRUGBANK	DB04417	C6H5NO3	small molecule	-	100-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTJIUGUIPKRLHP-UHFFFAOYSA-N
23368	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4233	P-Nitrophenol	-	-	DRUGBANK	DB04417	C6H5NO3	small molecule	-	100-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTJIUGUIPKRLHP-UHFFFAOYSA-N
23369	106777	280	-	AMY2B	AMY2|AMY3|HXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4233	P-Nitrophenol	-	-	DRUGBANK	DB04417	C6H5NO3	small molecule	-	100-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTJIUGUIPKRLHP-UHFFFAOYSA-N
23370	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4234	Adenylosuccinic Acid	N(6)-(1,2-dicarboxyethyl)AMP|N-[9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purin-6-yl]aspartic acid|N(6)-(1,2-dicarboxyethyl)-AMP|Aspartyl adenylate	-	DRUGBANK	DB04418	C14H18N5O11P	small molecule	-	19046-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBHPPMPBOJXRT-VWJPMABRSA-N
23371	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4234	Adenylosuccinic Acid	N(6)-(1,2-dicarboxyethyl)AMP|N-[9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purin-6-yl]aspartic acid|N(6)-(1,2-dicarboxyethyl)-AMP|Aspartyl adenylate	-	DRUGBANK	DB04418	C14H18N5O11P	small molecule	-	19046-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBHPPMPBOJXRT-VWJPMABRSA-N
23372	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4234	Adenylosuccinic Acid	N(6)-(1,2-dicarboxyethyl)AMP|N-[9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purin-6-yl]aspartic acid|N(6)-(1,2-dicarboxyethyl)-AMP|Aspartyl adenylate	-	DRUGBANK	DB04418	C14H18N5O11P	small molecule	-	19046-78-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBHPPMPBOJXRT-VWJPMABRSA-N
23373	112789	6927	-	HNF1A	HNF-1A|HNF1|IDDM20|LFB1|MODY3|TCF-1|TCF1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4235	Norleucine	-	-	DRUGBANK	DB04419	C6H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRQKBLKVPFOOQJ-RXMQYKEDSA-N
23374	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4235	Norleucine	-	-	DRUGBANK	DB04419	C6H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRQKBLKVPFOOQJ-RXMQYKEDSA-N
23375	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4235	Norleucine	-	-	DRUGBANK	DB04419	C6H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRQKBLKVPFOOQJ-RXMQYKEDSA-N
23376	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4237	2-Amino-4-Mercapto-Butyric Acid	-	-	DRUGBANK	DB04422	C4H9NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFFHZYDWPBMWHY-VKHMYHEASA-N
23377	854778	937106	BSU30670	luxS	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4237	2-Amino-4-Mercapto-Butyric Acid	-	-	DRUGBANK	DB04422	C4H9NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FFFHZYDWPBMWHY-VKHMYHEASA-N
23378	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4239	RPR128515	-	-	DRUGBANK	DB04424	C27H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFKVLKLCLYJKNF-MZNJEOGPSA-N
23379	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4239	RPR128515	-	-	DRUGBANK	DB04424	C27H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFKVLKLCLYJKNF-MZNJEOGPSA-N
23380	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4239	RPR128515	-	-	DRUGBANK	DB04424	C27H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFKVLKLCLYJKNF-MZNJEOGPSA-N
23381	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4241	Alpha-Methyl-N-Acetyl-D-Glucosamine	-	-	DRUGBANK	DB04426	C9H17NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEVOCXOZYFLVKN-LJASKYJCSA-N
23382	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4241	Alpha-Methyl-N-Acetyl-D-Glucosamine	-	-	DRUGBANK	DB04426	C9H17NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEVOCXOZYFLVKN-LJASKYJCSA-N
23383	110323	4153	RP11-94H3.1	MBL2	COLEC1|HSMBPC|MBL|MBL2D|MBP|MBP-C|MBP1|MBPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4241	Alpha-Methyl-N-Acetyl-D-Glucosamine	-	-	DRUGBANK	DB04426	C9H17NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEVOCXOZYFLVKN-LJASKYJCSA-N
23384	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4247	ZK-805623	-	-	DRUGBANK	DB04432	C20H18F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIHYCYAQUQHSG-UHFFFAOYSA-O
23385	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4249	Naphthyridine Inhibitor	-	-	DRUGBANK	DB04434	C17H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRBHUKMLAGQYHS-UHFFFAOYSA-N
23386	112531	6648	RP1-56L9.2	SOD2	IPOB|MNSOD|MVCD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4251	3-Fluorotyrosine	3-fluoro-L-tyrosine	-	DRUGBANK	DB04436	C9H10FNO3	small molecule	-	403-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIIAUOZUUGXERI-ZETCQYMHSA-N
23387	112531	6648	RP1-56L9.2	SOD2	IPOB|MNSOD|MVCD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4251	3-Fluorotyrosine	3-fluoro-L-tyrosine	-	DRUGBANK	DB04436	C9H10FNO3	small molecule	-	403-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIIAUOZUUGXERI-ZETCQYMHSA-N
23388	112531	6648	RP1-56L9.2	SOD2	IPOB|MNSOD|MVCD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4251	3-Fluorotyrosine	3-fluoro-L-tyrosine	-	DRUGBANK	DB04436	C9H10FNO3	small molecule	-	403-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIIAUOZUUGXERI-ZETCQYMHSA-N
23389	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4255	Purine Riboside	-	-	DRUGBANK	DB04440	C10H13N4O4	small molecule	-	550-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRWXACSTFXYYMV-QHOPCYEYSA-O
23390	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4255	Purine Riboside	-	-	DRUGBANK	DB04440	C10H13N4O4	small molecule	-	550-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRWXACSTFXYYMV-QHOPCYEYSA-O
23391	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4255	Purine Riboside	-	-	DRUGBANK	DB04440	C10H13N4O4	small molecule	-	550-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRWXACSTFXYYMV-QHOPCYEYSA-O
23392	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4256	2-Fluoroadenosine	6-amino-2-fluoro-9--D-ribofuranosylpurine|2-(6-amino-2-fluoro-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol	-	DRUGBANK	DB04441	C10H12FN5O4	small molecule	-	146-78-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-UUOKFMHZSA-N
23393	850026	945654	b4384	deoD	ECK4376|JW4347|pup	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4256	2-Fluoroadenosine	6-amino-2-fluoro-9--D-ribofuranosylpurine|2-(6-amino-2-fluoro-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol	-	DRUGBANK	DB04441	C10H12FN5O4	small molecule	-	146-78-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBUBKKRHXORPQB-UUOKFMHZSA-N
23394	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4257	2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB04442	C13H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23395	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4257	2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB04442	C13H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23396	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4257	2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine	-	-	DRUGBANK	DB04442	C13H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23397	852562	948260	b3752	rbsK	ECK3746|JW3731	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23398	852562	948260	b3752	rbsK	ECK3746|JW3731	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23399	852760	948464	b3959	argB	ECK3950|JW5553	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23400	852760	948464	b3959	argB	ECK3950|JW5553	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23401	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23402	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23403	119700	51727	RP11-511I2.1	CMPK1	CK|CMK|CMPK|UMK|UMP-CMPK|UMPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23404	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23405	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23406	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23407	110714	4629	-	MYH11	AAT4|FAA4|SMHC|SMMHC	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23408	110714	4629	-	MYH11	AAT4|FAA4|SMHC|SMMHC	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23409	110714	4629	-	MYH11	AAT4|FAA4|SMHC|SMMHC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23410	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23411	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23412	109041	2779	-	GNAT1	CSNBAD3|GBT1|GNATR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23413	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23414	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23415	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23416	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23417	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23418	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23419	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4259	Mercury Diiodide	-	-	DRUGBANK	DB04445	HgI2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFDLHELOZYVNJE-UHFFFAOYSA-L
23420	112691	6822	-	SULT2A1	DHEA-ST|DHEAS|HST|ST2|ST2A1|ST2A3|STD|hSTa	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4259	Mercury Diiodide	-	-	DRUGBANK	DB04445	HgI2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFDLHELOZYVNJE-UHFFFAOYSA-L
23421	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4260	Benzo[B]Thiophene-2-Carboxamidine	-	-	DRUGBANK	DB04446	C9H9N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZWDLUGQTRKBNA-UHFFFAOYSA-O
23422	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23423	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23424	110147	3956	-	LGALS1	GAL1|GBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23425	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23426	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23427	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23428	106718	216	RP11-151D14.2	ALDH1A1	ALDC|ALDH-E1|ALDH1|ALDH11|HEL-9|HEL-S-53e|HEL12|PUMB1|RALDH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23429	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23430	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23431	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23432	109209	2954	-	GSTZ1	GSTZ1-1|MAAI|MAI	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23433	110588	4482	-	MSRA	PMSR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23434	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23435	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23436	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23437	120177	54822	-	TRPM7	ALSPDC|CHAK|CHAK1|LTRPC7|LTrpC-7|TRP-PLIK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23438	111475	5479	-	PPIB	CYP-S1|CYPB|HEL-S-39|OI9|SCYLP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23439	850878	946531	b2020	hisD	ECK2015|JW2002	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23440	850878	946531	b2020	hisD	ECK2015|JW2002	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23441	852088	947776	b3281	aroE	ECK3268|JW3242	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23442	852088	947776	b3281	aroE	ECK3268|JW3242	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23443	854858	937204	BSU32150	paiA	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23444	854858	937204	BSU32150	paiA	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23445	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23446	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23447	855814	938194	BSU04620	acpS	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23448	855814	938194	BSU04620	acpS	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4261	1,4-Dithiothreitol	2,3-dihydroxy-1,4-dithiobutane	-	DRUGBANK	DB04447	C4H10O2S2	small molecule	-	3483-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHJLVAABSRFDPM-IMJSIDKUSA-N
23449	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4262	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	-	-	DRUGBANK	DB04448	C7H6F2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJZBWHOHNWJBX-UHFFFAOYSA-N
23450	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4262	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	-	-	DRUGBANK	DB04448	C7H6F2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJZBWHOHNWJBX-UHFFFAOYSA-N
23451	106638	126	-	ADH1C	ADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4262	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	-	-	DRUGBANK	DB04448	C7H6F2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJZBWHOHNWJBX-UHFFFAOYSA-N
23452	853623	935928	BSU30190	bioI	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	4264	Heptyl 1-Thiohexopyranoside	-	-	DRUGBANK	DB04450	C13H26O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPEGNLMTTNTJSP-LBELIVKGSA-N
23453	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4264	Heptyl 1-Thiohexopyranoside	-	-	DRUGBANK	DB04450	C13H26O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPEGNLMTTNTJSP-LBELIVKGSA-N
23454	849206	944805	b1094	acpP	ECK1080|JW1080	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4264	Heptyl 1-Thiohexopyranoside	-	-	DRUGBANK	DB04450	C13H26O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPEGNLMTTNTJSP-LBELIVKGSA-N
23455	107895	1515	UNQ268/PRO305	CTSV	CATL2|CTSL2|CTSU	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4265	4-Methylpiperazin-1-Yl Carbonyl Group	-	-	DRUGBANK	DB04451	C6H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTMGOLZSBTZMS-UHFFFAOYSA-N
23456	107895	1515	UNQ268/PRO305	CTSV	CATL2|CTSL2|CTSU	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4265	4-Methylpiperazin-1-Yl Carbonyl Group	-	-	DRUGBANK	DB04451	C6H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTMGOLZSBTZMS-UHFFFAOYSA-N
23457	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Imming P (2006)	17016423	171742	4265	4-Methylpiperazin-1-Yl Carbonyl Group	-	-	DRUGBANK	DB04451	C6H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTMGOLZSBTZMS-UHFFFAOYSA-N
23458	1230426	3647333	CR_07800W_A	SAP2	PEP11|orf19.11193|PRA|orf6.5306|CaO19.11193|IPF23558.1|CAP|PEP|CAWG_02075|IPF9220.2|Contig4-2800_0001|SAP2x|CaO6.5306|CA3138|PRA11|orf19.3708|CaO19.3708|CR_07800W_B|CR_07800W	237561	Candida albicans	unknown	target	Overington JP (2006)	17139284	171741	4265	4-Methylpiperazin-1-Yl Carbonyl Group	-	-	DRUGBANK	DB04451	C6H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQTMGOLZSBTZMS-UHFFFAOYSA-N
23459	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4268	Alpha-Aminobutyric Acid	-	-	DRUGBANK	DB04454	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCKQJZIFLGMSD-GSVOUGTGSA-N
23460	108898	2628	-	GATM	AGAT|AT|CCDS3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4268	Alpha-Aminobutyric Acid	-	-	DRUGBANK	DB04454	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCKQJZIFLGMSD-GSVOUGTGSA-N
23461	108270	1950	-	EGF	HOMG4|URG	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4268	Alpha-Aminobutyric Acid	-	-	DRUGBANK	DB04454	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCKQJZIFLGMSD-GSVOUGTGSA-N
23462	108270	1950	-	EGF	HOMG4|URG	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4268	Alpha-Aminobutyric Acid	-	-	DRUGBANK	DB04454	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCKQJZIFLGMSD-GSVOUGTGSA-N
23463	108270	1950	-	EGF	HOMG4|URG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4268	Alpha-Aminobutyric Acid	-	-	DRUGBANK	DB04454	C4H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCKQJZIFLGMSD-GSVOUGTGSA-N
23464	851497	947165	b2679	proX	ECK2673|JW2654|osrA|proU	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4269	Trimethyl Glycine	-	-	DRUGBANK	DB04455	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWIUHFFTVRNATP-UHFFFAOYSA-O
23465	851497	947165	b2679	proX	ECK2673|JW2654|osrA|proU	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4269	Trimethyl Glycine	-	-	DRUGBANK	DB04455	C5H12NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWIUHFFTVRNATP-UHFFFAOYSA-O
23466	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4271	2'-Deoxyguanosine-5'-Monophosphate	-	-	DRUGBANK	DB04457	C10H14N5O7P	small molecule	-	902-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTFMZDNNPPEQNG-KVQBGUIXSA-N
23467	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4271	2'-Deoxyguanosine-5'-Monophosphate	-	-	DRUGBANK	DB04457	C10H14N5O7P	small molecule	-	902-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTFMZDNNPPEQNG-KVQBGUIXSA-N
23468	108039	1675	-	CFD	ADIPSIN|ADN|DF|PFD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4273	3,4-Dichloroisocoumarin	-	-	DRUGBANK	DB04459	C9H4Cl2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUGXUUGGLDCZKB-UHFFFAOYSA-N
23469	108039	1675	-	CFD	ADIPSIN|ADN|DF|PFD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4273	3,4-Dichloroisocoumarin	-	-	DRUGBANK	DB04459	C9H4Cl2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUGXUUGGLDCZKB-UHFFFAOYSA-N
23470	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4274	(C8-S)-Hydantocidin 5'-Phosphate	[8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE	-	DRUGBANK	DB04460	C13H22N3O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAXSFYCTFIBEAR-MHHWUYOGSA-N
23471	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4274	(C8-S)-Hydantocidin 5'-Phosphate	[8,9-DIHYDROXY-3-(4-CARBOXY-HYDROXY-HYDROXYMETHYL-AMINO-BUTYL)-2,4-DIOXO-6-OXA-1,3-DIAZA-SPIRO[4.4]NON-7-YLMETHYL] PHOSPHATE	-	DRUGBANK	DB04460	C13H22N3O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAXSFYCTFIBEAR-MHHWUYOGSA-N
23472	113235	7389	RP11-69J16.2	UROD	PCT|UPD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4275	Coproporphyrin Iii	-	-	DRUGBANK	DB04461	C36H40N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23473	113235	7389	RP11-69J16.2	UROD	PCT|UPD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4275	Coproporphyrin Iii	-	-	DRUGBANK	DB04461	C36H40N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23474	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23475	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23476	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23477	107319	873	-	CBR1	CBR|SDR21C1|hCBR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4277	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	-	-	DRUGBANK	DB04463	C15H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPLGZXQPPYRNRC-UHFFFAOYSA-N
23478	111814	5876	RP4-682C21.3	RABGGTB	GGTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23479	111813	5875	-	RABGGTA	PTAR3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23480	850147	945780	b1225	narH	ECK1219|JW1216|chlC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23481	850175	945808	b1227	narI	ECK1221|JW1218|chlI	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23482	850149	945782	b1224	narG	ECK1218|JW1215|chlC|narC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23483	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23484	107044	567	CDABP0092	B2M	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23485	107739	1346	-	COX7A1	COX7A|COX7AH|COX7AM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23486	107733	1340	-	COX6B1	COX6B|COXG|COXVIb1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23487	107732	1339	-	COX6A2	COX6AH|COXVIAH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23488	107744	1351	-	COX8A	COX|COX8|COX8-2|COX8L|VIII|VIII-L	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23489	107743	1350	-	COX7C	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23490	107742	1349	-	COX7B	APLCC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23491	107738	1345	-	COX6C	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23492	107720	1327	-	COX4I1	COX4|COX4-1|COXIV	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23493	110616	4513	-	COX2	COII|MTCO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23494	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23495	110615	4512	-	COX1	COI|MTCO1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23496	852997	948705	b4192	ulaG	ECK4188|JW5868|yjfR	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23497	110631	4535	-	ND1	MTND1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23498	852091	947779	b3288	fmt	ECK3274|JW3249|yhdD	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23499	113164	7316	-	UBC	HMG20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23500	109351	3106	CDABP0067	HLA-B	AS|HLAB|SPDA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23501	107246	795	-	S100G	CABP|CABP1|CABP9K|CALB3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23502	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23503	110617	4514	-	COX3	COIII|MTCO3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23504	114778	9377	-	COX5A	COX|COX-VA|VA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23505	107722	1329	-	COX5B	COXVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23506	113835	8192	-	CLPP	DFNB81|PRLTS3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23507	849281	944881	b2688	gshA	ECK2683|JW2663|gshI	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23508	849281	944881	b2688	gshA	ECK2683|JW2663|gshI	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23509	849281	944881	b2688	gshA	ECK2683|JW2663|gshI	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4278	N-Formylmethionine	-	-	DRUGBANK	DB04464	C6H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYUSHNKNPOHWEZ-YFKPBYRVSA-N
23510	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23511	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23512	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23513	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23514	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23515	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23516	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4279	Lactose	-	lactol|lac-tol pwr 50gm/pck	DRUGBANK	DB04465	C12H22O11	small molecule	-	63-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUBGYTABKSRVRQ-QKKXKWKRSA-N
23517	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4280	SR12813	-	-	DRUGBANK	DB04466	C24H42O7P2	small molecule	-	126411-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQLJDECYQDRSBI-UHFFFAOYSA-N
23518	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4280	SR12813	-	-	DRUGBANK	DB04466	C24H42O7P2	small molecule	-	126411-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQLJDECYQDRSBI-UHFFFAOYSA-N
23519	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4281	Pyridoxyl-Alanine-5-Phosphate	PP3|LPG-PLP|n-(5'-phosphopyridoxyl)-l-alanine|Vitamin B6 complexed with alanine|alanyl-pyridoxal-5'-phosphate	-	DRUGBANK	DB04467	C11H17N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WACJCHFWJNNBPR-SSDOTTSWSA-N
23520	849927	945553	b0928	aspC	ECK0919|JW0911	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4281	Pyridoxyl-Alanine-5-Phosphate	PP3|LPG-PLP|n-(5'-phosphopyridoxyl)-l-alanine|Vitamin B6 complexed with alanine|alanyl-pyridoxal-5'-phosphate	-	DRUGBANK	DB04467	C11H17N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WACJCHFWJNNBPR-SSDOTTSWSA-N
23521	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Reed CA (2005)	15846122	181889	4282	Afimoxifene	4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT	-	DRUGBANK	DB04468	C26H29NO2	small molecule	-	68392-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXUZVZSFRXZGTL-QPLCGJKRSA-N
23522	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Reed CA (2005)	15846122	181889	4282	Afimoxifene	4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT	-	DRUGBANK	DB04468	C26H29NO2	small molecule	-	68392-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXUZVZSFRXZGTL-QPLCGJKRSA-N
23523	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4282	Afimoxifene	4-monohydroxytamoxifen|4-Hydroxytamoxifen|4-OHT	-	DRUGBANK	DB04468	C26H29NO2	small molecule	-	68392-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXUZVZSFRXZGTL-QPLCGJKRSA-N
23524	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4283	1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB04469	C15H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDSXCFSUGVAQSB-UHFFFAOYSA-N
23525	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4284	CRA_10656	-	-	DRUGBANK	DB04470	C18H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSHVHNIOQTZSOQ-UHFFFAOYSA-N
23526	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4285	2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB04471	C28H32N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMWVCTJKLAVRPB-MUUNZHRXSA-N
23527	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4285	2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	-	-	DRUGBANK	DB04471	C28H32N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMWVCTJKLAVRPB-MUUNZHRXSA-N
23528	110156	3965	-	LGALS9	HUAT|LGALS9A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4286	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	-	-	DRUGBANK	DB04472	C8H8N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHEGJYKMZJGYGW-QMMMGPOBSA-N
23529	112186	6278	-	S100A7	PSOR1|S100A7c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4288	1-Anilino-8-Naphthalene Sulfonate	-	-	DRUGBANK	DB04474	C16H13NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWEOQOXTVHGIFQ-UHFFFAOYSA-N
23530	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4289	Trencam-3,2-Hopo	-	-	DRUGBANK	DB04476	C7H7NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCIDBNKTKNBPKM-UHFFFAOYSA-N
23531	110126	3934	RP11-395P17.6	LCN2	24p3|MSFI|NGAL	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4289	Trencam-3,2-Hopo	-	-	DRUGBANK	DB04476	C7H7NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCIDBNKTKNBPKM-UHFFFAOYSA-N
23532	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4290	N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	-	-	DRUGBANK	DB04477	C29H32N6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDZQGEIYGFPMOB-USBJVFBQSA-N
23533	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4290	N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	-	-	DRUGBANK	DB04477	C29H32N6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDZQGEIYGFPMOB-USBJVFBQSA-N
23534	117681	26330	HSD35	GAPDHS	GAPD2|GAPDH-2|GAPDS|HSD-35	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4290	N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	-	-	DRUGBANK	DB04477	C29H32N6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDZQGEIYGFPMOB-USBJVFBQSA-N
23535	112535	6652	-	SORD	HEL-S-95n|SORD1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4291	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	-	-	DRUGBANK	DB04478	C11H19N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDTHNROWHAAVPJ-UHFFFAOYSA-N
23536	112535	6652	-	SORD	HEL-S-95n|SORD1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4291	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	-	-	DRUGBANK	DB04478	C11H19N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDTHNROWHAAVPJ-UHFFFAOYSA-N
23537	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4293	3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole	-	-	DRUGBANK	DB04480	C18H16FN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBDZLUOYAAVYHF-UHFFFAOYSA-N
23538	850602	946242	b0411	tsx	ECK0405|JW0401|T6rec|nupA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23539	850602	946242	b0411	tsx	ECK0405|JW0401|T6rec|nupA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23540	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23541	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23542	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23543	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23544	112939	7084	-	TK2	MTDPS2|MTTK|SCA31	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
23545	109839	3627	-	CXCL10	C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4300	N-Methylleucine	-	-	DRUGBANK	DB04487	C7H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJODGRWDFZVTKW-ZCFIWIBFSA-N
23546	109839	3627	-	CXCL10	C7|IFI10|INP10|IP-10|SCYB10|crg-2|gIP-10|mob-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4300	N-Methylleucine	-	-	DRUGBANK	DB04487	C7H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJODGRWDFZVTKW-ZCFIWIBFSA-N
23547	107754	1362	-	CPD	GP180	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4302	Guanidinoethylmercaptosuccinic acid	gemsa|Guanidinoethyl-Mercaptosuccinic Acid	-	DRUGBANK	DB04489	C7H13N3O4S	small molecule	-	77482-44-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKVCLXDFOQQABP-BYPYZUCNSA-N
23548	107754	1362	-	CPD	GP180	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4302	Guanidinoethylmercaptosuccinic acid	gemsa|Guanidinoethyl-Mercaptosuccinic Acid	-	DRUGBANK	DB04489	C7H13N3O4S	small molecule	-	77482-44-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKVCLXDFOQQABP-BYPYZUCNSA-N
23549	107754	1362	-	CPD	GP180	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4302	Guanidinoethylmercaptosuccinic acid	gemsa|Guanidinoethyl-Mercaptosuccinic Acid	-	DRUGBANK	DB04489	C7H13N3O4S	small molecule	-	77482-44-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKVCLXDFOQQABP-BYPYZUCNSA-N
23550	107098	629	DADB-122G4.5	CFB	AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4304	Diisopropylphosphono Group	-	-	DRUGBANK	DB04491	C6H15O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLKXLEPPVDUHBY-UHFFFAOYSA-N
23551	107098	629	DADB-122G4.5	CFB	AHUS4|ARMD14|BF|BFD|CFAB|CFBD|FB|FBI12|GBG|H2-Bf|PBF2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4304	Diisopropylphosphono Group	-	-	DRUGBANK	DB04491	C6H15O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLKXLEPPVDUHBY-UHFFFAOYSA-N
23552	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4304	Diisopropylphosphono Group	-	-	DRUGBANK	DB04491	C6H15O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLKXLEPPVDUHBY-UHFFFAOYSA-N
23553	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4304	Diisopropylphosphono Group	-	-	DRUGBANK	DB04491	C6H15O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLKXLEPPVDUHBY-UHFFFAOYSA-N
23554	111231	5210	-	PFKFB4	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23555	111231	5210	-	PFKFB4	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23556	111231	5210	-	PFKFB4	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23557	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23558	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23559	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23560	109082	2821	-	GPI	AMF|GNPI|NLK|PGI|PHI|SA-36|SA36	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23561	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23562	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23563	111228	5207	-	PFKFB1	F6PK|HL2K|PFRX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4306	Fructose-6-Phosphate	-	-	DRUGBANK	DB04493	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWGXPAPYGQALX-KAZBKCHUSA-N
23564	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4308	RU81843	-	-	DRUGBANK	DB04495	C30H34N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPXNASQNUOIPB-IZLXSDGUSA-N
23565	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4308	RU81843	-	-	DRUGBANK	DB04495	C30H34N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPXNASQNUOIPB-IZLXSDGUSA-N
23566	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4308	RU81843	-	-	DRUGBANK	DB04495	C30H34N3O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPXNASQNUOIPB-IZLXSDGUSA-N
23567	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4316	Sp-722	-	-	DRUGBANK	DB04503	C17H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDOUBGQRWFVQM-QWHCGFSZSA-N
23568	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4316	Sp-722	-	-	DRUGBANK	DB04503	C17H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDOUBGQRWFVQM-QWHCGFSZSA-N
23569	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4316	Sp-722	-	-	DRUGBANK	DB04503	C17H20N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDOUBGQRWFVQM-QWHCGFSZSA-N
23570	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4318	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04505	C20H22ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUJFGZAAFADPSF-UHFFFAOYSA-N
23571	111251	5230	RP4-570L12.1	PGK1	HEL-S-68p|MIG10|PGKA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23572	111251	5230	RP4-570L12.1	PGK1	HEL-S-68p|MIG10|PGKA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23573	111251	5230	RP4-570L12.1	PGK1	HEL-S-68p|MIG10|PGKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23574	111245	5224	-	PGAM2	GSD10|PGAM-M|PGAMM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23575	111245	5224	-	PGAM2	GSD10|PGAM-M|PGAMM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23576	111245	5224	-	PGAM2	GSD10|PGAM-M|PGAMM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23577	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23578	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23579	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4322	3-Phosphoglyceric Acid	-	-	DRUGBANK	DB04510	C3H7O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSJPPGNTCRNQQC-REOHCLBHSA-N
23580	134206	392399	-	LCN9	9230102I19Rik|HEL129	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4324	2-Isobutyl-3-Methoxypyrazine	-	-	DRUGBANK	DB04512	C9H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXFSPRAGHGMRSQ-UHFFFAOYSA-N
23581	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4325	N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide	-	-	DRUGBANK	DB04513	C16H21ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDEHCMNLNCJQST-UHFFFAOYSA-N
23582	112988	7134	-	TNNC1	CMD1Z|CMH13|TN-C|TNC|TNNC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4325	N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide	-	-	DRUGBANK	DB04513	C16H21ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDEHCMNLNCJQST-UHFFFAOYSA-N
23583	112991	7137	-	TNNI3	CMD1FF|CMD2A|CMH7|RCM1|TNNC1|cTnI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4325	N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide	-	-	DRUGBANK	DB04513	C16H21ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDEHCMNLNCJQST-UHFFFAOYSA-N
23584	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4326	Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester	-	-	DRUGBANK	DB04514	C19H24N7O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFYLLEBFVZTKHD-BWDUBGIRSA-N
23585	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4326	Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester	-	-	DRUGBANK	DB04514	C19H24N7O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFYLLEBFVZTKHD-BWDUBGIRSA-N
23586	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4326	Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester	-	-	DRUGBANK	DB04514	C19H24N7O13P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFYLLEBFVZTKHD-BWDUBGIRSA-N
23587	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4328	2-Deoxy-Glucitol-6-Phosphate	-	-	DRUGBANK	DB04516	C6H15O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPBNGZTTQNYHR-KVQBGUIXSA-N
23588	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4328	2-Deoxy-Glucitol-6-Phosphate	-	-	DRUGBANK	DB04516	C6H15O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPBNGZTTQNYHR-KVQBGUIXSA-N
23589	119562	51477	-	ISYNA1	INO1|INOS|IPS|IPS 1|IPS-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4328	2-Deoxy-Glucitol-6-Phosphate	-	-	DRUGBANK	DB04516	C6H15O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPBNGZTTQNYHR-KVQBGUIXSA-N
23590	852071	947759	b3805	hemC	ECK3799|JW5932|popE	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4329	Dipyrromethane Cofactor	-	-	DRUGBANK	DB04517	C20H24N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIVMSLFNTMAVDI-MRXNPFEDSA-N
23591	852071	947759	b3805	hemC	ECK3799|JW5932|popE	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4329	Dipyrromethane Cofactor	-	-	DRUGBANK	DB04517	C20H24N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIVMSLFNTMAVDI-MRXNPFEDSA-N
23592	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4330	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04518	C15H14N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJDRRZFRTKZLFT-UHFFFAOYSA-N
23593	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4330	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04518	C15H14N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJDRRZFRTKZLFT-UHFFFAOYSA-N
23594	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4330	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	-	-	DRUGBANK	DB04518	C15H14N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJDRRZFRTKZLFT-UHFFFAOYSA-N
23595	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4333	GSHNA	-	-	DRUGBANK	DB04521	C19H33N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICRIFHIWWXQBPY-GMIGGYDBSA-N
23596	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4333	GSHNA	-	-	DRUGBANK	DB04521	C19H33N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICRIFHIWWXQBPY-GMIGGYDBSA-N
23597	109195	2940	RP1-214M20.2	GSTA3	GSTA3-3|GTA3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4333	GSHNA	-	-	DRUGBANK	DB04521	C19H33N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICRIFHIWWXQBPY-GMIGGYDBSA-N
23598	114750	9344	UNQ2971/PRO7431	TAOK2	MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23599	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23600	849430	945041	b0383	phoA	ECK0378|JW0374|psiA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23601	111899	5967	-	REG1A	ICRF|P19|PSP|PSPS|PSPS1|PTP|REG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23602	110262	4087	-	SMAD2	JV18|JV18-1|MADH2|MADR2|hMAD-2|hSMAD2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23603	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23604	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23605	111942	6010	-	RHO	CSNBAD1|OPN2|RP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23606	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23607	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23608	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23609	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23610	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23611	112223	6317	-	SERPINB3	HsT1196|SCC|SCCA-1|SCCA-PD|SCCA1|T4-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23612	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23613	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23614	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23615	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23616	111574	5588	RP11-563J2.1	PRKCQ	PRKCT|nPKC-theta	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23617	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23618	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23619	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23620	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23621	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4334	Phosphonoserine	-	-	DRUGBANK	DB04522	C3H8NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZQFBWGGLXLEPQ-REOHCLBHSA-N
23622	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4335	Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate	-	-	DRUGBANK	DB04523	C13H23NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDSGOSWEKUGHOV-LLVKDONJSA-N
23623	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4336	Malonyl-Coenzyme A	-	-	DRUGBANK	DB04524	C24H38N7O19P3S	small molecule	-	524-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTYOQGRJFJAKNA-IJCONWDESA-N
23624	850364	946003	b1091	fabH	ECK1077|JW1077	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4336	Malonyl-Coenzyme A	-	-	DRUGBANK	DB04524	C24H38N7O19P3S	small molecule	-	524-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTYOQGRJFJAKNA-IJCONWDESA-N
23625	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4337	2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid	-	-	DRUGBANK	DB04525	C30H37N3O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUAJYWYRZTYQKS-DHIUTWEWSA-N
23626	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4337	2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid	-	-	DRUGBANK	DB04525	C30H37N3O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUAJYWYRZTYQKS-DHIUTWEWSA-N
23627	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4338	L-Glycero-D-Manno-Heptopyranose	-	-	DRUGBANK	DB04526	C7H14O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWQRWREUZVRGI-MAFUWASYSA-N
23628	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4338	L-Glycero-D-Manno-Heptopyranose	-	-	DRUGBANK	DB04526	C7H14O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGWQRWREUZVRGI-MAFUWASYSA-N
23629	115970	10747	-	MASP2	MAP19|MASP-2|MASP1P1|sMAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4339	Beta-Hydroxyasparagine	3-Hydroxyasparagine	-	DRUGBANK	DB04527	C4H8N2O4	small molecule	-	16712-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQTLPSCRBFYDNX-LWMBPPNESA-N
23630	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23631	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23632	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23633	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23634	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23635	849400	945006	b0344	lacZ	ECK0341|JW0335	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23636	114263	8724	RP3-429G5.4	SNX3	Grd19|MCOPS8|SDP3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23637	111286	5268	-	SERPINB5	PI5|maspin	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23638	111286	5268	-	SERPINB5	PI5|maspin	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23639	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23640	855803	938183	BSU29130	icd	-	224308	Bacillus subtilis	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23641	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23642	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23643	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23644	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23645	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23646	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23647	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23648	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23649	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23650	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23651	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23652	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23653	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23654	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4342	S,S-(2-Hydroxyethyl)Thiocysteine	-	-	DRUGBANK	DB04530	C5H11NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPUBRSXDQSFQBA-BYPYZUCNSA-N
23655	110411	4255	RP11-109A6.1	MGMT	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4343	Benzylcysteine	-	-	DRUGBANK	DB04531	C10H13NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHBAYRBVXCRIHT-VIFPVBQESA-N
23656	110411	4255	RP11-109A6.1	MGMT	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4343	Benzylcysteine	-	-	DRUGBANK	DB04531	C10H13NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHBAYRBVXCRIHT-VIFPVBQESA-N
23657	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23658	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23659	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23660	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23661	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4346	5-Nitroindazole	-	-	DRUGBANK	DB04534	C7H4N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23662	113292	7453	-	WARS	GAMMA-2|IFI53|IFP53	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4347	L-Tryptophanamide	-	-	DRUGBANK	DB04537	C11H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLSKPBDKNIXMBS-VIFPVBQESA-N
23663	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4349	Glyphosate	-	-	DRUGBANK	DB04539	C3H9NO5P	small molecule	-	1071-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDAORKBJWWYJS-UHFFFAOYSA-O
23664	849902	945528	b0908	aroA	ECK0899|JW0891	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4349	Glyphosate	-	-	DRUGBANK	DB04539	C3H9NO5P	small molecule	-	1071-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDAORKBJWWYJS-UHFFFAOYSA-O
23665	112022	6095	-	RORA	NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4350	Cholesterol	-	-	DRUGBANK	DB04540	C27H46O	small molecule	-	57-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVYWMOMLDIMFJA-MFYRMPRMSA-N
23666	112022	6095	-	RORA	NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4350	Cholesterol	-	-	DRUGBANK	DB04540	C27H46O	small molecule	-	57-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVYWMOMLDIMFJA-MFYRMPRMSA-N
23667	112022	6095	-	RORA	NR1F1|ROR1|ROR2|ROR3|RZR-ALPHA|RZRA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4350	Cholesterol	-	-	DRUGBANK	DB04540	C27H46O	small molecule	-	57-88-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVYWMOMLDIMFJA-MFYRMPRMSA-N
23668	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4352	3'-Azido-3'-Deoxythymidine-5'-Diphosphate	-	-	DRUGBANK	DB04542	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYVAFWJURKBJG-GJMOJQLCSA-N
23669	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4352	3'-Azido-3'-Deoxythymidine-5'-Diphosphate	-	-	DRUGBANK	DB04542	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYVAFWJURKBJG-GJMOJQLCSA-N
23670	110894	4830	-	NME1	AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4352	3'-Azido-3'-Deoxythymidine-5'-Diphosphate	-	-	DRUGBANK	DB04542	C10H15N5O10P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYVAFWJURKBJG-GJMOJQLCSA-N
23671	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4354	1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide	-	-	DRUGBANK	DB04544	C9H16N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUPVODXECQDZQR-MNDKRXPHSA-N
23672	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4354	1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide	-	-	DRUGBANK	DB04544	C9H16N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUPVODXECQDZQR-MNDKRXPHSA-N
23673	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4354	1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide	-	-	DRUGBANK	DB04544	C9H16N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUPVODXECQDZQR-MNDKRXPHSA-N
23674	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4359	4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB04549	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANTYZRUJFNZFI-UHFFFAOYSA-N
23675	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4359	4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB04549	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANTYZRUJFNZFI-UHFFFAOYSA-N
23676	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4359	4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide	-	-	DRUGBANK	DB04549	C14H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANTYZRUJFNZFI-UHFFFAOYSA-N
23677	852720	948423	b3926	glpK	ECK3918|JW3897	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4361	beta-D-fructofuranose 1,6-bisphosphate	1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate	-	DRUGBANK	DB04551	C6H14O12P2	small molecule	-	488-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNBGYGVWRKECFJ-JGWLITMVSA-N
23678	852720	948423	b3926	glpK	ECK3918|JW3897	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4361	beta-D-fructofuranose 1,6-bisphosphate	1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate	-	DRUGBANK	DB04551	C6H14O12P2	small molecule	-	488-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNBGYGVWRKECFJ-JGWLITMVSA-N
23679	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4361	beta-D-fructofuranose 1,6-bisphosphate	1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate	-	DRUGBANK	DB04551	C6H14O12P2	small molecule	-	488-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNBGYGVWRKECFJ-JGWLITMVSA-N
23680	111330	5313	-	PKLR	PK1|PKL|PKR|PKRL|RPK	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4361	beta-D-fructofuranose 1,6-bisphosphate	1,6-di-O-phosphono--D-fructofuranose|beta-D-Fructose 1,6-bisphosphate	-	DRUGBANK	DB04551	C6H14O12P2	small molecule	-	488-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNBGYGVWRKECFJ-JGWLITMVSA-N
23681	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Talbot S (2011)	21600945	182187	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23682	120073	54600	-	UGT1A9	HLUGP4|LUGP4|UDPGT|UDPGT 1-9|UGT-1I|UGT1-09|UGT1-9|UGT1.9|UGT1AI|UGT1I	9606	Homo sapiens	unknown	target	Mano Y (2006)	16278927	181918	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23683	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	unknown	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23684	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	inhibitor	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23685	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23686	107601	1187	RP11-5P18.7	CLCNKA	CLCK1|ClC-K1|hClC-Ka	9606	Homo sapiens	inducer	target	Picollo A (2007)	17659402	182031	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23687	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Alpert E (2007)	17098211	138173	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23688	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23689	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Diao HL (2007)	17485303	182008	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23690	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4365	Cytidine-5'-Diphosphate	-	-	DRUGBANK	DB04555	C9H15N3O11P2	small molecule	-	63-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWIADYZPOWUWEW-ZAKLUEHWSA-N
23691	849909	945535	b0910	cmk	ECK0901|JW0893|mssA|ycaF|ycaG	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4365	Cytidine-5'-Diphosphate	-	-	DRUGBANK	DB04555	C9H15N3O11P2	small molecule	-	63-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWIADYZPOWUWEW-ZAKLUEHWSA-N
23692	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4366	3-[(1s)-1-(Dimethylamino)Ethyl]Phenol	-	-	DRUGBANK	DB04556	C10H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GQZXRLWUYONVCP-QMMMGPOBSA-N
23693	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4367	Arachidonic Acid	-	-	DRUGBANK	DB04557	C20H32O2	small molecule	-	506-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZXBAPSDXZZRGB-CGRWFSSPSA-N
23694	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4367	Arachidonic Acid	-	-	DRUGBANK	DB04557	C20H32O2	small molecule	-	506-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZXBAPSDXZZRGB-CGRWFSSPSA-N
23695	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4367	Arachidonic Acid	-	-	DRUGBANK	DB04557	C20H32O2	small molecule	-	506-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZXBAPSDXZZRGB-CGRWFSSPSA-N
23700	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4369	N-(Chlorophenyl)-N'-Hydroxyguanidine	-	-	DRUGBANK	DB04559	C7H8ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYBXKTLYOMPMQY-UHFFFAOYSA-N
23701	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4370	4,7-Dioxosebacic Acid	-	-	DRUGBANK	DB04560	C10H14O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAWJQCMZICMIK-UHFFFAOYSA-N
23702	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4370	4,7-Dioxosebacic Acid	-	-	DRUGBANK	DB04560	C10H14O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAWJQCMZICMIK-UHFFFAOYSA-N
23703	849410	945017	b0369	hemB	ECK0366|JW0361|ncf	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4370	4,7-Dioxosebacic Acid	-	-	DRUGBANK	DB04560	C10H14O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAWJQCMZICMIK-UHFFFAOYSA-N
23704	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4370	4,7-Dioxosebacic Acid	-	-	DRUGBANK	DB04560	C10H14O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUAWJQCMZICMIK-UHFFFAOYSA-N
23705	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4372	Tricarballylic Acid	-	-	DRUGBANK	DB04562	C6H8O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQTIIICEAUMSDG-UHFFFAOYSA-N
23706	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4372	Tricarballylic Acid	-	-	DRUGBANK	DB04562	C6H8O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQTIIICEAUMSDG-UHFFFAOYSA-N
23707	106566	50	RP3-347H13.8	ACO2	ACONM|ICRD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4372	Tricarballylic Acid	-	-	DRUGBANK	DB04562	C6H8O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQTIIICEAUMSDG-UHFFFAOYSA-N
23708	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4373	CRA_9678	-	-	DRUGBANK	DB04563	C17H12BrN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23709	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4373	CRA_9678	-	-	DRUGBANK	DB04563	C17H12BrN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23710	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4373	CRA_9678	-	-	DRUGBANK	DB04563	C17H12BrN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23711	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4374	Gluconolactone	-	renacidin	DRUGBANK	DB04564	C6H10O6	small molecule	-	90-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHOQVHQSTUBQQK-SQOUGZDYSA-N
23712	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23713	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23714	125783	122622	-	ADSSL1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23715	850970	946624	b0125	hpt	ECK0124|JW5009	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23716	850970	946624	b0125	hpt	ECK0124|JW5009	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23717	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23718	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23719	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23720	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23721	852987	948695	b4177	purA	ECK4173|JW4135	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23722	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23723	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23724	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4376	Inosinic Acid	-	-	DRUGBANK	DB04566	C10H13N4O8P	small molecule	-	131-99-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GRSZFWQUAKGDAV-FCIPNVEPSA-N
23725	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Ishikawa M (1999)	9841767	181734	4380	Latamoxef	LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum	-	DRUGBANK	DB04570	C20H20N6O9S	small molecule	J01DD06	64952-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWCSIUVGFCSJCK-CAVRMKNVSA-N
23726	857707	940139	BSU04140	pbpC	-	224308	Bacillus subtilis	inhibitor	target	Labia R (1985)	3918982	181671	4380	Latamoxef	LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum	-	DRUGBANK	DB04570	C20H20N6O9S	small molecule	J01DD06	64952-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWCSIUVGFCSJCK-CAVRMKNVSA-N
23727	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Labia R (1985)	3918982	181671	4380	Latamoxef	LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum	-	DRUGBANK	DB04570	C20H20N6O9S	small molecule	J01DD06	64952-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWCSIUVGFCSJCK-CAVRMKNVSA-N
23728	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Labia R (1985)	3918982	181671	4380	Latamoxef	LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum	-	DRUGBANK	DB04570	C20H20N6O9S	small molecule	J01DD06	64952-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWCSIUVGFCSJCK-CAVRMKNVSA-N
23729	852006	947693	b3182	dacB	ECK3171|JW3149	511145	Escherichia coli	inhibitor	target	Labia R (1985)	3918982	181671	4380	Latamoxef	LMOX|moxalactam|Oxa-cephem|Lamoxactam|Latamoxef|Latamoxefum	-	DRUGBANK	DB04570	C20H20N6O9S	small molecule	J01DD06	64952-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWCSIUVGFCSJCK-CAVRMKNVSA-N
23730	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Mishra RG (2006)	16199482	181911	4383	Estriol	16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol	-	DRUGBANK	DB04573	C18H24O3	small molecule	G03CA04|G03CC06	50-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-ZXXIGWHRSA-N
23731	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	4383	Estriol	16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol	-	DRUGBANK	DB04573	C18H24O3	small molecule	G03CA04|G03CC06	50-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-ZXXIGWHRSA-N
23732	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4383	Estriol	16-alpha-Hydroxyestradiol|(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol|Estriel|16-hydroxyestradiol|(16,17)-estra-1,3,5(10)-triene-3,16,17-triol|Oestriol|3,16alpha,17beta-Trihydroxy-delta(1,3,5)-estratriene|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol|Trihydroxyestrin|Deuslon-a|Estriol|16alpha-hydroxyestradiol	-	DRUGBANK	DB04573	C18H24O3	small molecule	G03CA04|G03CC06	50-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-ZXXIGWHRSA-N
23733	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23734	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	agonist	target	Vijayanathan V (2007)	17464340	178364	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23735	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Sasson S (1991)	2011412	177583	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23736	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Lehnes K (2007)	17138652	178365	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23737	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23738	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Brama M (2007)	17125913	178366	4384	Estrone sulfate	Estrone bisulfate|Estrone-3-sulphate|estrone sulphate|Estra-1,3,5 (10)-triene-17-one-3-yl-sulfate|Estrone 3-sulfate|Estrone hemisulfate|Estrone hydrogen sulfate|Estrone, hydrogen sulfate	ogen .625|estropipate|ogen 2.5	DRUGBANK	DB04574	C18H22O5S	small molecule	-	481-97-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKKFKPJIXZFSSB-CBZIJGRNSA-N
23739	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Imming P (2006)	17016423	171742	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23740	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Chen X (2002)	11752352	171740	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23741	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Overington JP (2006)	17139284	171741	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23742	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	modulator	target	Shyu C (2011)	21075131	182176	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23743	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23744	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23745	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23746	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Shyu C (2011)	21075131	182176	4385	Quinestrol	Estrovis|Eston|Estrovister|Quinestrolo|Quinestrolum|17alpha-Ethynylestradiol 3-cyclopentyl ether|Quinestrol|Quilea|Estradiol-17-beta 3-cyclopentyl ether|17-alpha-Ethinylestradiol 3-cyclopentyl ether|Estrovis 4000|ethinyl estradiol 3-cyclopentyl ether|Plestrovis	-	DRUGBANK	DB04575	C25H32O2	small molecule	-	152-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWZUUYSISTUNDW-VAFBSOEGSA-N
23747	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Robinson MJ (1992)	1323952	176727	4386	Fleroxacin	FLRX|Fleroxacinum|Quinodis|Megalocin|Megalone|Fleroxicin|Megalone (TN)|Fleroxacine|Fleroxacin|Megalocin (TN)|Megalosin|Fleroxacino	-	DRUGBANK	DB04576	-	small molecule	J01MA08	79660-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23748	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4386	Fleroxacin	FLRX|Fleroxacinum|Quinodis|Megalocin|Megalone|Fleroxicin|Megalone (TN)|Fleroxacine|Fleroxacin|Megalocin (TN)|Megalosin|Fleroxacino	-	DRUGBANK	DB04576	-	small molecule	J01MA08	79660-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23749	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Hussy P (1986)	3015015	176728	4386	Fleroxacin	FLRX|Fleroxacinum|Quinodis|Megalocin|Megalone|Fleroxicin|Megalone (TN)|Fleroxacine|Fleroxacin|Megalocin (TN)|Megalosin|Fleroxacino	-	DRUGBANK	DB04576	-	small molecule	J01MA08	79660-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23750	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4387	1-(1-phenylcyclopentyl)methylamine	C-(1-Phenyl-cyclopentyl)-methylamine|1-Phenylcyclopentanemethylamine|1-(1-PHENYLCYCLOPENTYL)METHANAMINE	-	DRUGBANK	DB04577	C12H17N	small molecule	-	17511-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJWOFBVBNFLWLP-UHFFFAOYSA-N
23751	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4388	(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide	-	-	DRUGBANK	DB04578	C20H22FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEVYDSSAPNIURZ-AEFFLSMTSA-N
23752	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4389	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-	-	-	DRUGBANK	DB04579	C16H28N2O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUAMLRIDHTYTCM-WKLONVCASA-N
23753	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4393	5-(AMINOCARBONYL)-1,1':4',1''-TERPHENYL-3-CARBOXYLICACID	-	-	DRUGBANK	DB04583	C20H15NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAZPCGBRHLARSI-UHFFFAOYSA-N
23754	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4395	DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID	-	-	DRUGBANK	DB04585	C6H13BNO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCCYGXMAMSUXAV-FYTLMZHYSA-N
23755	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4398	N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB04588	C17H15ClN4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOHYJGNSESWEFT-UHFFFAOYSA-N
23756	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4400	N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE	-	-	DRUGBANK	DB04591	C22H23F2N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYJOAYZRCNHDNG-GOSISDBHSA-N
23757	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4408	Aniracetam	1-P-ANISOYL-2-PYRROLIDINONE	-	DRUGBANK	DB04599	C12H13NO3	small molecule	N06BX11	72432-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXNRTKGTQJPIJK-UHFFFAOYSA-N
23758	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Nakamura K (2001)	11412837	181773	4408	Aniracetam	1-P-ANISOYL-2-PYRROLIDINONE	-	DRUGBANK	DB04599	C12H13NO3	small molecule	N06BX11	72432-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXNRTKGTQJPIJK-UHFFFAOYSA-N
23759	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4408	Aniracetam	1-P-ANISOYL-2-PYRROLIDINONE	-	DRUGBANK	DB04599	C12H13NO3	small molecule	N06BX11	72432-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXNRTKGTQJPIJK-UHFFFAOYSA-N
23760	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	unknown	target	Nakamura K (2001)	11412837	181773	4408	Aniracetam	1-P-ANISOYL-2-PYRROLIDINONE	-	DRUGBANK	DB04599	C12H13NO3	small molecule	N06BX11	72432-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXNRTKGTQJPIJK-UHFFFAOYSA-N
23761	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4409	4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE	-	-	DRUGBANK	DB04600	C16H13BrN6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHDKYBCUDPSXGJ-UHFFFAOYSA-N
23762	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4410	4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE	-	-	DRUGBANK	DB04601	C16H14N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXGHQDVDVWOIU-UHFFFAOYSA-N
23763	112086	6167	-	RPL37	L37	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4411	PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE	-	-	DRUGBANK	DB04602	C12H19N6O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFPIKGKMRKBBBF-GRIPGOBMSA-N
23764	123814	83903	-	GSG2	HASPIN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4413	5-iodotubercidin	-	-	DRUGBANK	DB04604	C11H13IN4O4	small molecule	-	24386-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHSIXKUPQCKWBY-IOSLPCCCSA-N
23765	107839	1455	-	CSNK1G2	CK1g2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4413	5-iodotubercidin	-	-	DRUGBANK	DB04604	C11H13IN4O4	small molecule	-	24386-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHSIXKUPQCKWBY-IOSLPCCCSA-N
23766	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4413	5-iodotubercidin	-	-	DRUGBANK	DB04604	C11H13IN4O4	small molecule	-	24386-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHSIXKUPQCKWBY-IOSLPCCCSA-N
23767	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4416	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	-	-	DRUGBANK	DB04607	C20H14Cl2N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQAWGIKJINAKIZ-UHFFFAOYSA-N
23768	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4417	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	-	-	DRUGBANK	DB04608	C20H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAUZTOZLTFSMIE-UHFFFAOYSA-N
23769	853075	948792	b0142	folK	ECK0141|JW0138	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4419	7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin	Analogue of Pterin Substrate|2-amino-6-hydroxymethyl-7-methyl-7-phenethyl-7,8-dihydro-3h-pteridin-4-one	-	DRUGBANK	DB04610	C16H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMFJTCGUDFSWSW-INIZCTEOSA-N
23770	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4422	(R)-tacrine(10)-hupyridone	-	-	DRUGBANK	DB04614	C32H44N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROTFGKJJMRTWBD-HHHXNRCGSA-N
23771	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4423	(S)-tacrine(10)-hupyridone	-	-	DRUGBANK	DB04615	C32H44N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROTFGKJJMRTWBD-MHZLTWQESA-N
23772	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4424	TACRINE(8)-4-AMINOQUINOLINE	-	-	DRUGBANK	DB04616	C30H36N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNVOAAWEEGAXTN-UHFFFAOYSA-N
23773	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4425	(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM	-	-	DRUGBANK	DB04617	C21H33N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFBAUYQQFKFFCF-UHFFFAOYSA-P
23774	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Snell LD (1988)	2843389	181662	4428	Cycloleucine	1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate	-	DRUGBANK	DB04620	C6H11NO2	small molecule	-	52-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NILQLFBWTXNUOE-UHFFFAOYSA-N
23775	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Hershkowitz N (1989)	2556198	181657	4428	Cycloleucine	1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate	-	DRUGBANK	DB04620	C6H11NO2	small molecule	-	52-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NILQLFBWTXNUOE-UHFFFAOYSA-N
23776	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Herberg LJ (1990)	2170997	181648	4428	Cycloleucine	1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate	-	DRUGBANK	DB04620	C6H11NO2	small molecule	-	52-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NILQLFBWTXNUOE-UHFFFAOYSA-N
23777	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4428	Cycloleucine	1-Amino-cyclopentanecarboxylic acid|1-Aminocyclopentane-1-carboxylic acid|1-Amino-1-cyclopentanecarboxylic acid|Cycloleucin|Cyclo-leucine|1-Aminocyclopentanecarboxylic acid|Amino-1-cyclopentanecarboxylic acid|1-Aminocyclopentanecarboxylate	-	DRUGBANK	DB04620	C6H11NO2	small molecule	-	52-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NILQLFBWTXNUOE-UHFFFAOYSA-N
23778	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4435	Aplyronine A	-	-	DRUGBANK	DB04629	C59H101N3O14	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMXMEKJLQWJRHY-GDEZZODWSA-N
23779	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	unknown	target	Bunda S (2007)	17724138	182043	4436	Aldosterone	11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|Aldocorten|Aldocortin|Electrocortin|18-Oxocorticosterone|Aldosteronum|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|Elektrocortin|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|18-Aldocorticosterone|Aldocortene|(+)-aldosterone|11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al|Aldosterona|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|D-aldosterone	-	DRUGBANK	DB04630	C21H28O5	small molecule	H02AA01	52-39-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQSUYGKTWSAVDQ-ZVIOFETBSA-N
23780	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	unknown	target	Bruner KL (1997)	9392437	3987	4436	Aldosterone	11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|Aldocorten|Aldocortin|Electrocortin|18-Oxocorticosterone|Aldosteronum|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|Elektrocortin|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|18-Aldocorticosterone|Aldocortene|(+)-aldosterone|11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al|Aldosterona|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|D-aldosterone	-	DRUGBANK	DB04630	C21H28O5	small molecule	H02AA01	52-39-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQSUYGKTWSAVDQ-ZVIOFETBSA-N
23781	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4436	Aldosterone	11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|Aldocorten|Aldocortin|Electrocortin|18-Oxocorticosterone|Aldosteronum|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|Elektrocortin|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|18-Aldocorticosterone|Aldocortene|(+)-aldosterone|11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al|Aldosterona|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|D-aldosterone	-	DRUGBANK	DB04630	C21H28O5	small molecule	H02AA01	52-39-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQSUYGKTWSAVDQ-ZVIOFETBSA-N
23782	849677	945300	b0724	sdhB	ECK0713|JW0714	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4437	Atpenin A5	AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE	-	DRUGBANK	DB04631	C15H21Cl2NO5	small molecule	-	119509-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVULNOOPECCZRG-CIUDSAMLSA-N
23783	849698	945322	b0722	sdhD	ECK0711|JW0712	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4437	Atpenin A5	AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE	-	DRUGBANK	DB04631	C15H21Cl2NO5	small molecule	-	119509-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVULNOOPECCZRG-CIUDSAMLSA-N
23784	849692	945316	b0721	sdhC	ECK0710|JW0711|cybA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4437	Atpenin A5	AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE	-	DRUGBANK	DB04631	C15H21Cl2NO5	small molecule	-	119509-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVULNOOPECCZRG-CIUDSAMLSA-N
23785	849776	945402	b0723	sdhA	ECK0712|JW0713	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4437	Atpenin A5	AA5|AT5|3-[(2S,4S,5R)-5,6-DICHLORO-2,4-DIMETHYL-1-OXOHEXYL]-4-HYDROXY-5,6-DIMETHOXY-2(1H)-PYRIDINONE	-	DRUGBANK	DB04631	C15H21Cl2NO5	small molecule	-	119509-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVULNOOPECCZRG-CIUDSAMLSA-N
23786	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4438	4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE	-	-	DRUGBANK	DB04632	C24H26FN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHHBGNIRSUTQAS-UHFFFAOYSA-N
23787	112210	6303	-	SAT1	DC21|KFSD|KFSDX|SAT|SSAT|SSAT-1	9606	Homo sapiens	unknown	target	Bewley MC (2006)	16455797	181928	4439	N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine	BE3	-	DRUGBANK	DB04633	C11H27N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFYULDAPZWEGGQ-UHFFFAOYSA-N
23788	112210	6303	-	SAT1	DC21|KFSD|KFSDX|SAT|SSAT|SSAT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4439	N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine	BE3	-	DRUGBANK	DB04633	C11H27N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFYULDAPZWEGGQ-UHFFFAOYSA-N
23789	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4443	2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE	-	-	DRUGBANK	DB04638	C14H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZODKRWQWUWGCD-UHFFFAOYSA-N
23790	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4444	Biphenylalanine	-	-	DRUGBANK	DB04639	C15H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCZLABDVDPYLRZ-AWEZNQCLSA-N
23791	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4447	7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID	-	-	DRUGBANK	DB04642	C21H21Cl3N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQTOWNDCHQJXOQ-UHFFFAOYSA-N
23792	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4448	4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID	-	-	DRUGBANK	DB04643	C18H15Cl3N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYQVFMLCZJZZEM-UHFFFAOYSA-N
23793	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4449	4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID	-	-	DRUGBANK	DB04644	C20H20Cl2N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCEMCUPAYRPTLS-UHFFFAOYSA-N
23794	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4450	5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID	-	-	DRUGBANK	DB04645	C20H20Cl2N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NJJIFGCFUDDBSP-UHFFFAOYSA-N
23795	106878	383	-	ARG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4453	S-propylamine-L-cysteine	BPE	-	DRUGBANK	DB04648	C6H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYOVYWMBACBGOD-ZCFIWIBFSA-N
23796	110451	4306	-	NR3C2	MCR|MLR|MR|NR3C2VIT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4457	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE	-	-	DRUGBANK	DB04652	C21H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFXVFTZEKFJBZ-HJTSIMOOSA-N
23797	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4457	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE	-	-	DRUGBANK	DB04652	C21H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFXVFTZEKFJBZ-HJTSIMOOSA-N
23798	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4457	(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE	-	-	DRUGBANK	DB04652	C21H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFXVFTZEKFJBZ-HJTSIMOOSA-N
23799	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4459	4-PIPERIDIN-4-YLBUTANAL	-	-	DRUGBANK	DB04654	C9H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HADYAKDSDIXWOF-UHFFFAOYSA-N
23800	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4460	METOPRINE, METHODICHLOROPHEN	-	-	DRUGBANK	DB04655	C11H10Cl2N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQJHOPSWBGJHQS-UHFFFAOYSA-N
23801	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4462	Carboxin	Carboxine|Carbathiine|2,3-Dihydro-5-carboxanilido-6-methyl-1,4-oxathiin|Carbathiin|CBX|2,3-Dihydro-6-methyl-5-phenylcarbamoyl-1,4-oxathiin	-	DRUGBANK	DB04657	C12H13NO2S	small molecule	-	5234-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYSSRZJIHXQEHQ-UHFFFAOYSA-N
23802	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4464	(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	-	-	DRUGBANK	DB04659	C15H21NO8S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZDZCEOFJWRJIA-GGASBGQWSA-N
23803	107350	912	-	CD1D	CD1A|R3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4466	Cis-tetracosenoyl sulfatide	(2S,3R,4E)-n-nervonic-1-[beta-d-(3-sulfate)-galactopyranosyl]-2-amino-octadecene-3-ol	-	DRUGBANK	DB04661	C48H91NO11S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZQWQNAZXFNSEP-JCOQVFCVSA-N
23804	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4467	OLOMOUCINE II	-	-	DRUGBANK	DB04662	C19H26N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDUVSANREQEDRE-CQSZACIVSA-N
23805	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4469	Cyclohexyl-pentyl-maltoside	5-CYCLOHEXYLPENTYL 4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE|5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE|CYMAL-5	-	DRUGBANK	DB04664	C23H42O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVTGFZGNOSKUDA-ZNGNCRBCSA-N
23806	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4474	TRIAZOLOPYRIMIDINE	-	-	DRUGBANK	DB04669	C17H14BrN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWBFPKPWMSWWEA-UHFFFAOYSA-O
23807	121277	56953	-	NT5M	dNT-2|dNT2|mdN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4476	cyclic 3',5'-thymidine monophosphate	D4T-MP|2',3'-dideoxy-2',3-didehydrothymidine 5'-monophosphate|3',5'-Cyclic dtmp|Cyclic tmp|2',3'-dehydro-2',3'-deoxy-thymidine 5'-monophosphate|cTMP|d4TMP	-	DRUGBANK	DB04672	C10H13N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLPGURCDSRIXFL-JGVFFNPUSA-N
23808	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Dhagat U (2007)	18045204	179205	4478	2-HYDROXY-3,5-DIIODOBENZOIC ACID	-	-	DRUGBANK	DB04674	C7H4I2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHZVWQPHNWDCFS-UHFFFAOYSA-N
23809	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Blandin V (2000)	11093786	181765	4478	2-HYDROXY-3,5-DIIODOBENZOIC ACID	-	-	DRUGBANK	DB04674	C7H4I2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHZVWQPHNWDCFS-UHFFFAOYSA-N
23810	109715	3494	-	IGHA2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4480	Dansyllysine	DNS-lysine|Nepsilon-Dansyl-L-lysine|DNS|N(epsilon)-Dansyl-L-lysine	-	DRUGBANK	DB04676	C18H25N3O4S	small molecule	-	1101-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQPRNSWQIAHPMS-HNNXBMFYSA-N
23811	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4481	N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE	-	-	DRUGBANK	DB04677	C13H19N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVYBGDRWIWQPOV-GFCCVEGCSA-N
23812	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4484	GALACTOSE GREASE	-	-	DRUGBANK	DB04680	C16H30O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJZBQHWSENWEMY-DZQJYWQESA-N
23813	112980	7125	-	TNNC2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4486	Octylphenoxy polyethoxyethanol	Anapoe-305|alkylphenol-hydroxypolyoxyetheylene	-	DRUGBANK	DB04682	C22H38O5	small molecule	-	9036-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYDLBVPAAFVANX-UHFFFAOYSA-N
23814	108792	2516	RP11-101K10.1	NR5A1	AD4BP|ELP|FTZ1|FTZF1|POF7|SF-1|SF1|SPGF8|SRXY3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4487	(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE	-	-	DRUGBANK	DB04683	C40H75O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGIXWNRQEFVVRM-CTDKCSBDSA-N
23815	108187	1854	-	DUT	dUTPase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4489	1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB04685	C28H25FN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJNIPWYJQUGERM-BFLUCZKCSA-N
23816	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4492	ECGONINE METHYL ESTER	-	-	DRUGBANK	DB04688	C10H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQNNBXHAYSQRY-UYXSQOIJSA-N
23817	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4492	ECGONINE METHYL ESTER	-	-	DRUGBANK	DB04688	C10H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQNNBXHAYSQRY-UYXSQOIJSA-N
23818	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	4494	Camptothecin	(+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone	-	DRUGBANK	DB04690	C20H16N2O4	small molecule	-	7689-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSJKWCGYPAHWDS-FQEVSTJZSA-N
23819	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Teicher BA (2008)	18061144	182062	4494	Camptothecin	(+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone	-	DRUGBANK	DB04690	C20H16N2O4	small molecule	-	7689-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSJKWCGYPAHWDS-FQEVSTJZSA-N
23820	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	van der Merwe M (2008)	18056711	96060	4494	Camptothecin	(+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone	-	DRUGBANK	DB04690	C20H16N2O4	small molecule	-	7689-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSJKWCGYPAHWDS-FQEVSTJZSA-N
23821	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4494	Camptothecin	(+)-camptothecin|(s)-camptothecin|D-camptothecin|Camptothecine|20(S)-Camptothecin|(s)-(+)-camptothecin|(+)-camptothecine|21,22-Secocamptothecin-21-oic acid lactone	-	DRUGBANK	DB04690	C20H16N2O4	small molecule	-	7689-03-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSJKWCGYPAHWDS-FQEVSTJZSA-N
23822	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4499	FARNESYL THIOPYROPHOSPHATE	-	-	DRUGBANK	DB04695	C15H28O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYMLCRQRXFRQGP-PVMFERMNSA-N
23823	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4499	FARNESYL THIOPYROPHOSPHATE	-	-	DRUGBANK	DB04695	C15H28O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYMLCRQRXFRQGP-PVMFERMNSA-N
23824	110683	4598	-	MVK	LRBP|MK|MVLK|POROK3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4499	FARNESYL THIOPYROPHOSPHATE	-	-	DRUGBANK	DB04695	C15H28O6P2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYMLCRQRXFRQGP-PVMFERMNSA-N
23825	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4507	HESPERIDIN	-	-	DRUGBANK	DB04703	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
23826	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23827	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23828	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23829	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	4511	HYDROXYFASUDIL	-	-	DRUGBANK	DB04707	C14H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAVGJDAFCZAWSZ-UHFFFAOYSA-N
23830	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4513	(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE	-	-	DRUGBANK	DB04709	C20H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DEJXHCDDTLTVNB-FRVJLOGJSA-N
23831	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4518	ISOPENTENYL PYROPHOSPHATE	-	-	DRUGBANK	DB04714	C5H12O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUHSROFQTUXZQQ-UHFFFAOYSA-N
23832	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4518	ISOPENTENYL PYROPHOSPHATE	-	-	DRUGBANK	DB04714	C5H12O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUHSROFQTUXZQQ-UHFFFAOYSA-N
23833	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4518	ISOPENTENYL PYROPHOSPHATE	-	-	DRUGBANK	DB04714	C5H12O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUHSROFQTUXZQQ-UHFFFAOYSA-N
23834	849179	944777	b0029	ispH	ECK0030|JW0027|lytB|yaaE	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4518	ISOPENTENYL PYROPHOSPHATE	-	-	DRUGBANK	DB04714	C5H12O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUHSROFQTUXZQQ-UHFFFAOYSA-N
23835	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4519	IMIDAZOPYRIDAZIN 1	-	-	DRUGBANK	DB04715	C18H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVUBNTNWKIPCPS-UHFFFAOYSA-N
23836	113148	7297	-	TYK2	IMD35|JTK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4520	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	-	-	DRUGBANK	DB04716	C18H16FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDWQCSOSCCWIP-UHFFFAOYSA-N
23837	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4520	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	-	-	DRUGBANK	DB04716	C18H16FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDWQCSOSCCWIP-UHFFFAOYSA-N
23838	107983	1613	-	DAPK3	DLK|ZIP|ZIPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4520	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	-	-	DRUGBANK	DB04716	C18H16FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDWQCSOSCCWIP-UHFFFAOYSA-N
23839	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4520	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	-	-	DRUGBANK	DB04716	C18H16FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDWQCSOSCCWIP-UHFFFAOYSA-N
23840	109921	3718	-	JAK3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4520	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	-	-	DRUGBANK	DB04716	C18H16FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDWQCSOSCCWIP-UHFFFAOYSA-N
23841	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4523	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	-	-	DRUGBANK	DB04719	C9H7Br4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLPJGDQJLTYWCI-UHFFFAOYSA-N
23842	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4524	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	-	-	DRUGBANK	DB04720	C8H4Br4N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIGJZZDDPXRGTL-UHFFFAOYSA-N
23843	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4525	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	-	-	DRUGBANK	DB04721	C10H7Br4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHCZROILDUNGRT-UHFFFAOYSA-N
23844	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4526	2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE	-	-	DRUGBANK	DB04722	C22H20Cl2F2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISTCYDGUBPNUDF-CQSZACIVSA-N
23845	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4527	2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID	-	-	DRUGBANK	DB04723	C10H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHBCRXAIIVZWEW-MRVPVSSYSA-N
23846	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23847	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23848	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23849	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23850	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Imming P (2006)	17016423	171742	4533	GENTAMICIN C1A	-	-	DRUGBANK	DB04729	C19H39N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGXETMJINRLTH-BOZYPMBZSA-N
23851	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Overington JP (2006)	17139284	171741	4533	GENTAMICIN C1A	-	-	DRUGBANK	DB04729	C19H39N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGXETMJINRLTH-BOZYPMBZSA-N
23852	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Tamehiro N (2003)	14602594	178433	4533	GENTAMICIN C1A	-	-	DRUGBANK	DB04729	C19H39N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGXETMJINRLTH-BOZYPMBZSA-N
23853	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Hu H (2001)	11282646	178432	4533	GENTAMICIN C1A	-	-	DRUGBANK	DB04729	C19H39N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGXETMJINRLTH-BOZYPMBZSA-N
23854	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Schroeder R (2000)	10619838	178431	4533	GENTAMICIN C1A	-	-	DRUGBANK	DB04729	C19H39N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGXETMJINRLTH-BOZYPMBZSA-N
23855	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	adduct	target	Gill AE (2004)	15332709	177802	4533	GENTAMICIN C1A	-	-	DRUGBANK	DB04729	C19H39N5O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGXETMJINRLTH-BOZYPMBZSA-N
23856	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4536	1,6-DI-O-PHOSPHONO-D-MANNITOL	-	-	DRUGBANK	DB04733	C6H16O12P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOYYTQHMNDWRCW-KVTDHHQDSA-N
23857	125341	114771	-	PGLYRP3	PGRP-Ialpha|PGRPIA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4539	2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE	-	-	DRUGBANK	DB04736	C37H59N7O20	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPFMKPIBAIPLHT-RSJSDIDPSA-N
23858	111495	5501	-	PPP1CC	PP-1G|PP1C|PPP1G	9606	Homo sapiens	unknown	target	Maynes JT (2006)	16343532	181923	4541	Motuporin	nodularin-V	-	DRUGBANK	DB04738	C40H63N5O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MESJISIEDVKBAM-NSKZDGTMSA-N
23859	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4544	Myxothiazol	(2Z,6E)-7-{2'-[(2E,4E)-1,6-DIMETHYLHEPTA-2,4-DIENYL]-2,4'-BI-1,3-THIAZOL-4-YL}-3,5-DIMETHOXY-4-METHYLHEPTA-2,6-DIENAMIDE	-	DRUGBANK	DB04741	C25H33N3O3S2	small molecule	-	76706-55-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKTFQMCPGMTBMD-FYHMSGCOSA-N
23860	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23861	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23862	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rainsford KD (2006)	16846549	181954	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23863	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23864	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4554	Purvalanol A	6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv	-	DRUGBANK	DB04751	C19H25ClN6O	small molecule	-	212844-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXCMJLOPOFPBT-HNNXBMFYSA-N
23865	107840	1456	-	CSNK1G3	CKI-gamma 3|CSNK1G3L	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4554	Purvalanol A	6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv	-	DRUGBANK	DB04751	C19H25ClN6O	small molecule	-	212844-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXCMJLOPOFPBT-HNNXBMFYSA-N
23866	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4554	Purvalanol A	6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine|Purv	-	DRUGBANK	DB04751	C19H25ClN6O	small molecule	-	212844-53-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXCMJLOPOFPBT-HNNXBMFYSA-N
23867	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4556	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	-	-	DRUGBANK	DB04753	C13H16N3O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOEDLCUBOBTIHG-USQSKNHBSA-N
23868	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4557	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	-	-	DRUGBANK	DB04754	C12H16N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAPEMYRVFIHDJ-QWEIRQIHSA-N
23869	110921	4860	-	PNP	NP|PRO1837|PUNP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4560	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	-	-	DRUGBANK	DB04757	C11H14N5O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKAPYWCOOQBBHV-KXSYMAMXSA-N
23870	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4562	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)	-	-	DRUGBANK	DB04759	C22H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTBUZLPQANSGGE-UHFFFAOYSA-N
23871	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4563	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)	-	-	DRUGBANK	DB04760	C22H20F2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYFRREJCFXFNRR-UHFFFAOYSA-N
23872	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4564	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]	-	-	DRUGBANK	DB04761	C18H16N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHPBWKYFMTXWAA-UHFFFAOYSA-N
23873	122201	64499	-	TPSB2	TPS2|tryptaseB|tryptaseC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4567	[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE	-	-	DRUGBANK	DB04764	C26H29N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCLHROFBSWWOQO-UHFFFAOYSA-N
23874	117952	27010	-	TPK1	HTPK1|PP20|THMD5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4570	Pyrithiamine Pyrophosphate	-	-	DRUGBANK	DB04768	C14H21N4O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHKSTKOYQKNDSJ-UHFFFAOYSA-O
23875	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4571	5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione	5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINEDIONE|ZINC12504504|S1410|2A5U|SR-02000000919|GTPL6023|(5Z)-5-(QUINOXALIN-6-YLMETHYLIDENE)-1,3-THIAZOLIDINE-2,4-DIONE|ABP000101|AOB3848|AS605240|NCGC00261632-01|BCP9000323|5-QUINOXALIN-6-YLMETHYLENETHIAZOLIDINE-2,4-DIONE|BCP02097|CCG-101300|1287651-14-2|J-516278|HMS3650I15|AS 605240,5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINE-2,4-DIONE|(Z)-5-(QUINOXALIN-6-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE|AS 605240|HMS3262N16|SDCCGSBI-0086699.P002|TOX21_500947|AS-605240/AS605240|CC-118|LP00947|5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE|Q27088381|PI 3-KGAMMA INHIBITOR|QYT|648450-29-7|DB04769|SR-02000000919-2|HY-10109|5-[(QUINOXALIN-6-YL)METHYLIDENE]-1,3-THIAZOLIDINE-2,4-DIONE|BRD-K76773351-001-01-9|(5E)-5-(QUINOXALIN-6-YLMETHYLENE)-1,3-THIAZOLIDINE-2,4-DIONE|CS-0084|AS605240, >=98% (HPLC)|5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINE-2,4-DIONE|5-(QUINOXALIN-6-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE|SB19245|AKOS024457698|AS-16768|W-5475|NCGC00186030-01|AS-605240|PI 3-KG INHIBITOR|HMS3229I19|BDBM50324735	-	DRUGBANK	DB04769	C12H7N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQWZFLMPDUSYGV-POHAHGRESA-N
23876	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4572	O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL	-	-	DRUGBANK	DB04770	C19H25N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGADNQLEUZSUEJ-OAHLLOKOSA-N
23877	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4576	Reidispongiolide A	-	-	DRUGBANK	DB04774	C54H87NO13	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOYDTENNTZZQJM-DIUYYEMASA-N
23878	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4577	Reidispongiolide C	-	-	DRUGBANK	DB04775	C51H84O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GATPHXXEPJBDKA-DCQWOVGRSA-N
23879	114135	8566	PRED79	PDXK	C21orf124|C21orf97|HEL-S-1a|PKH|PNK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4578	(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol	Aftin-4|(2R)-2-({6-[Benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-1-butanol	-	DRUGBANK	DB04776	C20H28N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPYWONAECUVKHY-MRXNPFEDSA-N
23880	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4581	ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	-	-	DRUGBANK	DB04779	C10H13NO4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZFUNHITNWTQFU-KHPPLWFESA-N
23881	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4583	5-hydroxyvaleric acid	5-hydroxy-pentanoic acid|delta-hydroxyvaleric acid|5-Hydroxyvalerate|5-Hydroxypentanoate|5-hydroxypentanoic acid|5-hydroxy valeric acid|delta-Hydroxypentanoic acid	-	DRUGBANK	DB04781	C5H10O3	small molecule	-	13392-69-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHOJOSOUIAQEDH-UHFFFAOYSA-N
23882	106712	210	RP11-10I9.1	ALAD	ALADH|PBGS	9606	Homo sapiens	unknown	target	Erskine PT (2005)	16131755	181908	4583	5-hydroxyvaleric acid	5-hydroxy-pentanoic acid|delta-hydroxyvaleric acid|5-Hydroxyvalerate|5-Hydroxypentanoate|5-hydroxypentanoic acid|5-hydroxy valeric acid|delta-Hydroxypentanoic acid	-	DRUGBANK	DB04781	C5H10O3	small molecule	-	13392-69-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHOJOSOUIAQEDH-UHFFFAOYSA-N
23883	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4585	Sphinxolide B	-	-	DRUGBANK	DB04783	C53H85NO14	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MINVLQAHLUCDIO-GLLDUQGXSA-N
23884	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Murakami MT (2005)	15961104	181896	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23885	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23886	116980	23408	-	SIRT5	SIR2L5	9606	Homo sapiens	inhibitor	target	Schuetz A (2007)	17355872	181995	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23887	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	antagonist	target	Bose CK (2007)	17552360	182019	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23888	108770	2492	-	FSHR	FSHRO|LGR1|ODG1	9606	Homo sapiens	antagonist	target	McGeary RP (2008)	18991754	182088	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23889	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	antagonist	target	Homma R (2000)	11132624	181767	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23890	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	antagonist	target	Trujillo CA (2006)	16388598	181924	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23891	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	antagonist	target	Bogdanov YD (1998)	9647463	181729	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23892	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	antagonist	target	Churchill GC (1997)	9112981	181716	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23893	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	antagonist	target	Charlton SJ (1996)	8762097	181707	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23894	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	agonist	target	Wolner I (2005)	16056233	181902	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23895	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Monteiro RQ (2004)	15203120	181850	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23897	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4592	2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol	2,5-O,O-BIS-(3',3"-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL	-	DRUGBANK	DB04790	C20H22N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBIUTOFGXGGVKQ-XMTFNYHQSA-N
23898	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4593	2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL	-	-	DRUGBANK	DB04791	C20H22N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKBAWRNTUZFJKV-BSDSXHPESA-N
23899	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4594	2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL	-	-	DRUGBANK	DB04792	C20H22N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDEVHSIVANGYRI-XMTFNYHQSA-N
23900	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4595	2-O-(3'-AMIDINOPHENYL)-5-O-(4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL	-	-	DRUGBANK	DB04793	C20H22N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKBAWRNTUZFJKV-XMTFNYHQSA-N
23901	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4596	Bifonazole	Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole	-	DRUGBANK	DB04794	C22H18N2	small molecule	D01AC60|D01AC10	60628-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
23902	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Berg D (1984)	6372801	181679	4596	Bifonazole	Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole	-	DRUGBANK	DB04794	C22H18N2	small molecule	D01AC60|D01AC10	60628-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
23903	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Carrillo-Munoz AJ (2006)	16964330	174576	4596	Bifonazole	Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole	-	DRUGBANK	DB04794	C22H18N2	small molecule	D01AC60|D01AC10	60628-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
23904	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Rossello A (2002)	12383016	174575	4596	Bifonazole	Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole	-	DRUGBANK	DB04794	C22H18N2	small molecule	D01AC60|D01AC10	60628-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
23905	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Berg D (1984)	6396116	181680	4596	Bifonazole	Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole	-	DRUGBANK	DB04794	C22H18N2	small molecule	D01AC60|D01AC10	60628-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
23906	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Zhang JG (2002)	11992644	181793	4597	Thenoyltrifluoroacetone	alpha-Thenoyltrifluoroacetone|.alpha.-Thenoyltrifluoroacetone|2-Thenoyltrifluoroacetone|Perfluoroacetyl(2-thenoyl)methane|1-Thenoyl-3,3,3-trifluoroacetone|1,1,1-Trifluoro-3-(2-thenoyl)acetone|TTFA	-	DRUGBANK	DB04795	C8H5F3O2S	small molecule	-	326-91-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXBBUSUXYMIVOS-UHFFFAOYSA-N
23907	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4597	Thenoyltrifluoroacetone	alpha-Thenoyltrifluoroacetone|.alpha.-Thenoyltrifluoroacetone|2-Thenoyltrifluoroacetone|Perfluoroacetyl(2-thenoyl)methane|1-Thenoyl-3,3,3-trifluoroacetone|1,1,1-Trifluoro-3-(2-thenoyl)acetone|TTFA	-	DRUGBANK	DB04795	C8H5F3O2S	small molecule	-	326-91-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXBBUSUXYMIVOS-UHFFFAOYSA-N
23908	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4597	Thenoyltrifluoroacetone	alpha-Thenoyltrifluoroacetone|.alpha.-Thenoyltrifluoroacetone|2-Thenoyltrifluoroacetone|Perfluoroacetyl(2-thenoyl)methane|1-Thenoyl-3,3,3-trifluoroacetone|1,1,1-Trifluoro-3-(2-thenoyl)acetone|TTFA	-	DRUGBANK	DB04795	C8H5F3O2S	small molecule	-	326-91-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXBBUSUXYMIVOS-UHFFFAOYSA-N
23909	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4598	Inecalcitol	9,10-seco-14bh-19-norcholesta-5(z),7(e)-dien-1(r),3(r),25-triol-23-yne|19-nor-14-epi-23-yne-1,25 dihydroxyvitamin D3	-	DRUGBANK	DB04796	C26H40O3	small molecule	-	163217-09-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHGRMHMXKPQNGF-WNSNRMDMSA-N
23910	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4599	Triazolopyridine	-	-	DRUGBANK	DB04797	C18H15FN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVCXRBARSPBVMC-UHFFFAOYSA-N
23911	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4600	THIO-ATPA	-	-	DRUGBANK	DB04798	C10H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHWOAQCPEFTDOQ-LURJTMIESA-N
23912	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23913	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23914	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23915	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23916	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23917	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23918	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23919	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23920	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23921	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4601	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	UHDBT|6-Hydroxy-5-undecyl-4,7-benzothiazoledione|6-hydroxy-5-undecyl-1,3-benzothiazole-4,7-dione|3-undecyl-2-hydroxydioxobenzothiazol	-	DRUGBANK	DB04799	C18H25NO3S	small molecule	-	43152-58-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCWGBMWYLYKEIU-UHFFFAOYSA-N
23922	112086	6167	-	RPL37	L37	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4607	Virginiamycin S1	Staphylomycin S1|Staphylomycin S|Virginiamycin factor S|Virginiamycin factor S1	-	DRUGBANK	DB04805	C43H49N7O10	small molecule	-	23152-29-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEPMHVLSLDOMQC-IYPFLVAKSA-N
23923	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	4619	Metamizole	Dipyrone	-	DRUGBANK	DB04817	C13H16N3NaO4S	small molecule	N02BB72|N02BB52|N02BB02	50567-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJGAAPFSPWAYTJ-UHFFFAOYSA-M
23924	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Hovevey-Sion D (1989)	2506486	181654	4622	Nialamide	2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum	-	DRUGBANK	DB04820	C16H18N4O2	small molecule	N06AF02	51-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOIIUHRQUVNIDD-UHFFFAOYSA-N
23925	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Parvez S (1975)	1170911	181630	4622	Nialamide	2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum	-	DRUGBANK	DB04820	C16H18N4O2	small molecule	N06AF02	51-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOIIUHRQUVNIDD-UHFFFAOYSA-N
23926	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Hovevey-Sion D (1989)	2506486	181654	4622	Nialamide	2-(2-(Benzylcarbamyl)ethyl)hydrazide isonicotinic acid|Isonicitinic acid 2-[(2-benzylcarbamoyl)ethyl]hydrazide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide isonicotinic acid|N-Benzyl-3-(2-isonicotinoylhydrazino)propanamide|2-(2-(Benzylcarbamoyl)ethyl)hydrazide, isonicotinic acid|Isonicotinic acid, 2-[2-(benzylcarbamoylethyl]hydrazide|Pyridine-4-carboxylic 2-[2-(benzylcarbamoyl)ethyl]hydrazide|1-(2-(Benzylcarbamoyl)ethyl)-2-isonicotinoylhydrazine|N-benzyl-beta-(isonicotinoylhydrazine)propionamide|N-benzyl-beta-(isonicotinylhydrazino)propionamide|Isonicotinic acid, 2-[2-(benzylcarbamoyl)ethyl]hydrazide|Isonicotinic acid, 2-[2- (benzylcarbamoyl)ethyl]hydrazide|BEIH|Isonicotinic acid 2-((2-benzylcarbamoyl)ethyl)hydrazide|N-isonicotinyl hydrazide|N-isonicotinoyl-n'(beta-n-benzylcarboxamidoethyl)hydrazine|Isonicotinic acid, {2-[2-(benzylcarbamoyl)ethyl]hydrazide}|Isonicotinic acid, 2-(2-(benzylcarbamoyl)ethyl)hydrazide|2-[2-(Benzylcarbamoyl)ethyl]hydrazide isonicotinic acid|N-(2-(Benzylcarbamyl)ethylamino)isonicotinamide|Isonicotinic acid, {2-[2-(benzylcarbamoylethyl]hydrazide}|1-[2-(Benzylcarbamoyl)ethyl]-2-isonicotinoylhydrazine|Nialamida|Nialamidum	-	DRUGBANK	DB04820	C16H18N4O2	small molecule	N06AF02	51-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOIIUHRQUVNIDD-UHFFFAOYSA-N
23927	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Tatsumi M (1997)	9537821	174430	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23928	110493	4353	-	MPO	-	9606	Homo sapiens	unknown	target	Obach RS (2006)	16679384	181940	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23929	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Egashira T (1999)	10580379	181743	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23930	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	unknown	target	Tatsumi M (1997)	9537821	174430	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23931	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Egashira T (1999)	10580379	181743	4623	Nomifensine	(+-)-nomifensin|Nomifensin|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|(+)-nomiphensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|Nomifensina|Nomifensinum|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|(+-)-nomifensine|(+)-nomifensine|(R)-1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine	-	DRUGBANK	DB04821	C16H18N2	small molecule	N06AX04	24526-64-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXPANQJNYNUNES-UHFFFAOYSA-N
23932	120073	54600	-	UGT1A9	HLUGP4|LUGP4|UDPGT|UDPGT 1-9|UGT-1I|UGT1-09|UGT1-9|UGT1.9|UGT1AI|UGT1I	9606	Homo sapiens	unknown	target	Uesawa Y (2007)	16897040	181957	4626	Phenolphthalein	3,3-Bis(p-hydroxyphenyl)phthalide|Alpha-di(p-hydroxyphenyl)phthalide|Fenolftaleina|Phenolphthaleinum|Fenolftalein|3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1(3H)-one|3,3-Bis(4-hydroxyphenyl)phthalide|Phenolphtaleine|Dihydroxyphthalophenone|3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone|Phenophthalein	agarol eml strawberry|pilules 	DRUGBANK	DB04824	C20H14O4	small molecule	A06AB04	77-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJFMBFZCATUALV-UHFFFAOYSA-N
23933	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Lamers JM (1985)	2933041	179746	4627	Prenylamine	N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-1-propanamine|Prenilamina|N-(3'-Phenyl-2-propyl)-1,1-diphenyl-3-propyloamine|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin|N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine|DL-prenylamine|1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane|Prenylaminum|N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine	-	DRUGBANK	DB04825	C24H27N	small molecule	C01DX52|C01DX02	390-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFFPICMESYHZPQ-UHFFFAOYSA-N
23934	124494	85366	-	MYLK2	KMLC|MLCK|MLCK2|skMLCK	9606	Homo sapiens	unknown	target	Lamers JM (1985)	2933041	179746	4627	Prenylamine	N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-1-propanamine|Prenilamina|N-(3'-Phenyl-2-propyl)-1,1-diphenyl-3-propyloamine|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin|N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine|DL-prenylamine|1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane|Prenylaminum|N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine	-	DRUGBANK	DB04825	C24H27N	small molecule	C01DX52|C01DX02	390-64-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFFPICMESYHZPQ-UHFFFAOYSA-N
23935	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Hata AN (2005)	15563582	161179	4630	Zomepirac	Zomepiracum|5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid	-	DRUGBANK	DB04828	C15H14ClNO3	small molecule	M01AB04	33369-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXVNMYWKKDOREA-UHFFFAOYSA-N
23936	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	AGHAJANIAN GK (1964)	14209776	181833	4631	Lysergic Acid Diethylamide	N,n-diethyllysergamide|Dextrolysergic acid diethylamide|Lysergaure diethylamid|Lysergidum|Lysergide|D-LSD|LSD|Lysergamide|Lysergic acid amide|D-LSD-25|(+)-lysergic acid diethylamide|N,N-Diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide|n,n-diethyl-(+)-lysergamide|(+)-LSD|D-lysergic acid dethylamide|Lysergamid|Diethylamid kyseliny lysergove|N,n-diethyl-d-lysergamide|9,10-Didehydro-N,N-diethyl-6-methylergoline-8b-carboxamide|D-lysergic acid diethylamide|Lysergic acid diethylamide-25|LSD-25|D-lysergic acid n,n-diethylamide	-	DRUGBANK	DB04829	C20H25N3O	small molecule	-	50-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAYOSLLFUXYJDT-RDTXWAMCSA-N
23937	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
23938	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
23939	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Tatsumi M (1997)	9537821	174430	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
23940	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Egashira T (1996)	8842678	181710	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
23941	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Egashira T (1999)	10580379	181743	4634	Zimelidine	(z)-zimelidine|Zimeldine|(Z)-3-(4'-Bromophenyl)-3-(3''-pyridyl)dimethylallylamine|Cis-zimelidine|(Z)-3-[1-(p-Bromophenyl)-3-(dimethylamino)propenyl]pyridine	-	DRUGBANK	DB04832	C16H17BrN2	small molecule	N06AB02	56775-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYPPVKRFBIWMSX-SXGWCWSVSA-N
23942	107639	1234	-	CCR5	CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	4637	Maraviroc	-	selzentry|celsentri	DRUGBANK	DB04835	C29H41F2N5O	small molecule	J05AX09	376348-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSNHKUDZZFZSJB-QYOOZWMWSA-N
23943	107639	1234	-	CCR5	CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	4637	Maraviroc	-	selzentry|celsentri	DRUGBANK	DB04835	C29H41F2N5O	small molecule	J05AX09	376348-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSNHKUDZZFZSJB-QYOOZWMWSA-N
23944	107639	1234	-	CCR5	CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4637	Maraviroc	-	selzentry|celsentri	DRUGBANK	DB04835	C29H41F2N5O	small molecule	J05AX09	376348-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSNHKUDZZFZSJB-QYOOZWMWSA-N
23945	107639	1234	-	CCR5	CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	9606	Homo sapiens	antagonist	target	Agrawal-Gamse C (2009)	19692476	182123	4637	Maraviroc	-	selzentry|celsentri	DRUGBANK	DB04835	C29H41F2N5O	small molecule	J05AX09	376348-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSNHKUDZZFZSJB-QYOOZWMWSA-N
23946	107639	1234	-	CCR5	CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	9606	Homo sapiens	antagonist	target	Napier C (2005)	16298345	181920	4637	Maraviroc	-	selzentry|celsentri	DRUGBANK	DB04835	C29H41F2N5O	small molecule	J05AX09	376348-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSNHKUDZZFZSJB-QYOOZWMWSA-N
23947	107639	1234	-	CCR5	CC-CKR-5|CCCKR5|CCR-5|CD195|CKR-5|CKR5|CMKBR5|IDDM22	9606	Homo sapiens	antagonist	target	Levy JA (2009)	19098484	182094	4637	Maraviroc	-	selzentry|celsentri	DRUGBANK	DB04835	C29H41F2N5O	small molecule	J05AX09	376348-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSNHKUDZZFZSJB-QYOOZWMWSA-N
23948	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4638	Amineptine	-	-	DRUGBANK	DB04836	C22H28ClNO2	small molecule	N06AA19	57574-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDPUXONTAVMIKZ-UHFFFAOYSA-N
23949	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4638	Amineptine	-	-	DRUGBANK	DB04836	C22H28ClNO2	small molecule	N06AA19	57574-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDPUXONTAVMIKZ-UHFFFAOYSA-N
23950	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4638	Amineptine	-	-	DRUGBANK	DB04836	C22H28ClNO2	small molecule	N06AA19	57574-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDPUXONTAVMIKZ-UHFFFAOYSA-N
23951	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4638	Amineptine	-	-	DRUGBANK	DB04836	C22H28ClNO2	small molecule	N06AA19	57574-09-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDPUXONTAVMIKZ-UHFFFAOYSA-N
23952	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	4639	Clofedanol	Clofedianolo|Clofedanolum|Antitussin|Chlophedianol	chlo tuss|abanatuss ped drops|	DRUGBANK	DB04837	C17H20ClNO	small molecule	R05DB10	791-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRCHFMBCVFFYEQ-UHFFFAOYSA-N
23953	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4639	Clofedanol	Clofedianolo|Clofedanolum|Antitussin|Chlophedianol	chlo tuss|abanatuss ped drops|	DRUGBANK	DB04837	C17H20ClNO	small molecule	R05DB10	791-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRCHFMBCVFFYEQ-UHFFFAOYSA-N
23954	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	4639	Clofedanol	Clofedianolo|Clofedanolum|Antitussin|Chlophedianol	chlo tuss|abanatuss ped drops|	DRUGBANK	DB04837	C17H20ClNO	small molecule	R05DB10	791-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRCHFMBCVFFYEQ-UHFFFAOYSA-N
23955	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Maurer H (1988)	2905706	178298	4639	Clofedanol	Clofedianolo|Clofedanolum|Antitussin|Chlophedianol	chlo tuss|abanatuss ped drops|	DRUGBANK	DB04837	C17H20ClNO	small molecule	R05DB10	791-35-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRCHFMBCVFFYEQ-UHFFFAOYSA-N
23956	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Heffron F (1990)	2306268	181649	4640	Cyclandelate	3,5,5-Trimethylcyclohexyl amygdalate|3,3,5-Trimethylcyclohexyl mandelate|Cyclandelatum|Ciclandelato	cyclospasmol tablets 200mg	DRUGBANK	DB04838	C17H24O3	small molecule	C04AX01	456-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZHCOOQXZCIUNC-UHFFFAOYSA-N
23957	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Pascual J (1999)	10659603	181745	4640	Cyclandelate	3,5,5-Trimethylcyclohexyl amygdalate|3,3,5-Trimethylcyclohexyl mandelate|Cyclandelatum|Ciclandelato	cyclospasmol tablets 200mg	DRUGBANK	DB04838	C17H24O3	small molecule	C04AX01	456-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZHCOOQXZCIUNC-UHFFFAOYSA-N
23958	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	4641	Cyproterone acetate	Cyproterone 17-O-acetate	androcur|novo-cyproterone|novo	DRUGBANK	DB04839	C24H29ClO4	small molecule	G03HB01|G03HA01	427-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWFYSQMTEOIJJG-HEULQOMWNA-N
23959	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Cabeza M (2004)	15579329	181875	4641	Cyproterone acetate	Cyproterone 17-O-acetate	androcur|novo-cyproterone|novo	DRUGBANK	DB04839	C24H29ClO4	small molecule	G03HB01|G03HA01	427-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWFYSQMTEOIJJG-HEULQOMWNA-N
23960	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	4641	Cyproterone acetate	Cyproterone 17-O-acetate	androcur|novo-cyproterone|novo	DRUGBANK	DB04839	C24H29ClO4	small molecule	G03HB01|G03HA01	427-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWFYSQMTEOIJJG-HEULQOMWNA-N
23961	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Agoulnik IU (2009)	19463689	182108	4641	Cyproterone acetate	Cyproterone 17-O-acetate	androcur|novo-cyproterone|novo	DRUGBANK	DB04839	C24H29ClO4	small molecule	G03HB01|G03HA01	427-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWFYSQMTEOIJJG-HEULQOMWNA-N
23962	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	antagonist	target	Sonneveld E (2005)	15483189	181867	4641	Cyproterone acetate	Cyproterone 17-O-acetate	androcur|novo-cyproterone|novo	DRUGBANK	DB04839	C24H29ClO4	small molecule	G03HB01|G03HA01	427-51-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWFYSQMTEOIJJG-HEULQOMWNA-N
23963	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Galli A (1996)	8710929	180457	4642	Debrisoquin	Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum	-	DRUGBANK	DB04840	C10H13N3	small molecule	C02CC04	1131-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWPGJSVJDAJRLW-UHFFFAOYSA-N
23964	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Mitchell JR (1970)	5431666	181673	4642	Debrisoquin	Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum	-	DRUGBANK	DB04840	C10H13N3	small molecule	C02CC04	1131-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWPGJSVJDAJRLW-UHFFFAOYSA-N
23965	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Joyce PI (2002)	12401623	181803	4642	Debrisoquin	Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum	-	DRUGBANK	DB04840	C10H13N3	small molecule	C02CC04	1131-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWPGJSVJDAJRLW-UHFFFAOYSA-N
23966	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Yi E (2005)	16126010	180458	4642	Debrisoquin	Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum	-	DRUGBANK	DB04840	C10H13N3	small molecule	C02CC04	1131-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWPGJSVJDAJRLW-UHFFFAOYSA-N
23967	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inducer	target	Bryan-Lluka LJ (1996)	8740147	181706	4642	Debrisoquin	Debrisoquina|Debrisoquine|Debrisoquinum|Debrisoquin|Isocaramidine|Debrisochinum	-	DRUGBANK	DB04840	C10H13N3	small molecule	C02CC04	1131-64-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWPGJSVJDAJRLW-UHFFFAOYSA-N
23968	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23969	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23970	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Taylor JE (1986)	20493137	182154	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23971	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23972	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23973	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23974	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Uebele VN (2009)	19582593	182118	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23975	114426	8912	-	CACNA1H	CACNA1HB|Cav3.2|ECA6|EIG6	9606	Homo sapiens	inhibitor	target	Santi CM (2002)	11784784	181784	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23976	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23977	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23978	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23979	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23980	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Uebele VN (2009)	19582593	182118	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23981	114425	8911	RP1-172B20.4	CACNA1I	Cav3.3|ca(v)3.3	9606	Homo sapiens	inhibitor	target	Santi CM (2002)	11784784	181784	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23982	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23983	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23984	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Uebele VN (2009)	19582593	182118	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23985	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Santi CM (2002)	11784784	181784	4643	Flunarizine	Flunarizinum|1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine|Flunarizina	flunarizine|sibelium cap 5mg|n	DRUGBANK	DB04841	C26H26F2N2	small molecule	N07CA03	52468-60-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMANXXCATUTDDT-QPJJXVBHSA-N
23986	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23987	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Schotte A (1996)	8935801	181713	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23988	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23989	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23990	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wang SJ (2002)	11842444	181787	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23991	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Kenny BA (1990)	1696149	181641	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23992	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	inhibitor	target	Wang SJ (2002)	11842444	181787	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23993	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Schotte A (1996)	8935801	181713	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23994	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Ochillo RF (1982)	7122991	181681	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23995	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Tsai CS (1989)	2791613	181660	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23996	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Tsai CS (1995)	7623487	181685	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23997	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Ochillo RF (1982)	7122991	181681	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23998	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tsai CS (1989)	2791613	181660	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
23999	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Tsai CS (1995)	7623487	181685	4645	Mepenzolate	Mepenzolate|Mepenzolic acid	cantil	DRUGBANK	DB04843	C21H26NO3	small molecule	A03AB12	25990-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKNPSSNBBWDAGH-UHFFFAOYSA-N
24000	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4646	Tetrabenazine	1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina	tetrabenazine tablets|nitoman|	DRUGBANK	DB04844	C19H27NO3	small molecule	N07XX06	58-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJIEFSOBYUXJB-UHFFFAOYSA-N
24001	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Kim YS (2009)	19571144	182117	4646	Tetrabenazine	1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina	tetrabenazine tablets|nitoman|	DRUGBANK	DB04844	C19H27NO3	small molecule	N07XX06	58-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJIEFSOBYUXJB-UHFFFAOYSA-N
24002	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Gros Y (2010)	20007701	182140	4646	Tetrabenazine	1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina	tetrabenazine tablets|nitoman|	DRUGBANK	DB04844	C19H27NO3	small molecule	N07XX06	58-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJIEFSOBYUXJB-UHFFFAOYSA-N
24003	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Wimalasena K (2011)	20135628	182146	4646	Tetrabenazine	1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina	tetrabenazine tablets|nitoman|	DRUGBANK	DB04844	C19H27NO3	small molecule	N07XX06	58-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJIEFSOBYUXJB-UHFFFAOYSA-N
24004	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Goland R (2009)	19223416	182098	4646	Tetrabenazine	1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina	tetrabenazine tablets|nitoman|	DRUGBANK	DB04844	C19H27NO3	small molecule	N07XX06	58-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJIEFSOBYUXJB-UHFFFAOYSA-N
24005	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Zheng G (2007)	17233532	181982	4646	Tetrabenazine	1,2,4,6,7,11b-hexahydro-3-Isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|TBZ|Tetrabenzaine|2-oxo-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|Tetra benazin|Tetrabenazinum|2-oxo-3-Isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bh-benzo[a]quinolizine|Tetrabenzine|Tetrabenazina	tetrabenazine tablets|nitoman|	DRUGBANK	DB04844	C19H27NO3	small molecule	N07XX06	58-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKJIEFSOBYUXJB-UHFFFAOYSA-N
24006	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	inhibitor	target	Goodin S (2008)	18945860	182087	4647	Ixabepilone	Azaepothilone B|Aza-epothilone B	ixempra	DRUGBANK	DB04845	C27H42N2O5S	small molecule	L01DC04	219989-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FABUFPQFXZVHFB-PVYNADRNSA-N
24007	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	inhibitor	target	Denduluri N (2008)	18321240	182068	4647	Ixabepilone	Azaepothilone B|Aza-epothilone B	ixempra	DRUGBANK	DB04845	C27H42N2O5S	small molecule	L01DC04	219989-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FABUFPQFXZVHFB-PVYNADRNSA-N
24008	115654	10381	-	TUBB3	CDCBM|CDCBM1|CFEOM3|CFEOM3A|FEOM3|TUBB4|beta-4	9606	Homo sapiens	inhibitor	target	Vahdat L (2008)	18378531	182071	4647	Ixabepilone	Azaepothilone B|Aza-epothilone B	ixempra	DRUGBANK	DB04845	C27H42N2O5S	small molecule	L01DC04	219989-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FABUFPQFXZVHFB-PVYNADRNSA-N
24009	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Wedge SR (2005)	15899831	181891	4650	AZD2171	-	-	DRUGBANK	DB04849	C25H27FN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXJWYDDUDKYVKI-UHFFFAOYSA-N
24010	114821	9429	-	ABCG2	ABC15|ABCP|BCRP|BCRP1|BMDP|CD338|CDw338|EST157481|GOUT1|MRX|MXR|MXR1|UAQTL1	9606	Homo sapiens	unknown	target	Minderman H (2004)	15014037	181844	4652	Biricodar dicitrate	biricodar	-	DRUGBANK	DB04851	C46H57N3O21	small molecule	-	174254-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDMKJSJJXQDICL-ZXVJYWQYSA-N
24011	131028	340273	tcag7.1091	ABCB5	ABCB5alpha|ABCB5beta|EST422562	9606	Homo sapiens	unknown	target	Minderman H (2004)	15014037	181844	4652	Biricodar dicitrate	biricodar	-	DRUGBANK	DB04851	C46H57N3O21	small molecule	-	174254-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDMKJSJJXQDICL-ZXVJYWQYSA-N
24012	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	unknown	target	Minderman H (2004)	15014037	181844	4652	Biricodar dicitrate	biricodar	-	DRUGBANK	DB04851	C46H57N3O21	small molecule	-	174254-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDMKJSJJXQDICL-ZXVJYWQYSA-N
24013	110641	4547	-	MTTP	ABL|MTP	9606	Homo sapiens	unknown	target	Ueshima K (2005)	15684478	181881	4653	Implitapide	AEGR427	-	DRUGBANK	DB04852	C35H37N3O2	small molecule	-	177469-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMNXBQPRODZJQR-DITALETJSA-N
24014	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Cerqueira MD (2006)	16524538	181933	4654	Binodenoson	2-((Cyclohexylmethylene)hydrazino)adenosine|MRE 0470	-	DRUGBANK	DB04853	C17H25N7O4	small molecule	-	144348-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJFMHMFFBSOEPR-DNZQAUTHSA-N
24015	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Hodgson JM (2007)	17531571	182017	4654	Binodenoson	2-((Cyclohexylmethylene)hydrazino)adenosine|MRE 0470	-	DRUGBANK	DB04853	C17H25N7O4	small molecule	-	144348-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJFMHMFFBSOEPR-DNZQAUTHSA-N
24016	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	unknown	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24017	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24018	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	unknown	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24019	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Iwamoto T (2007)	17896959	182051	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24020	109977	3776	-	KCNK2	K2p2.1|TPKC1|TREK|TREK-1|TREK1|hTREK-1c|hTREK-1e	9606	Homo sapiens	inhibitor	target	Schmidt C (2012)	22790794	182206	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24021	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	unknown	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24022	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24023	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24024	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Lalevee N (2003)	12890054	181825	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24025	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Dale KM (2007)	17389667	181997	4655	Dronedarone	N-(2-Butyl-3-(P-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide|Multaq|SR 33589b|N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide|SR 33589	multaq	DRUGBANK	DB04855	C31H44N2O5S	small molecule	C01BD07	141626-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
24026	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	unknown	target	Persiani S (2006)	17112294	181975	4656	Dexloxiglumide	CR 2017|CR-2017	-	DRUGBANK	DB04856	C21H30Cl2N2O5	small molecule	-	119817-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNQZBKQEIFTHFZ-GOSISDBHSA-N
24027	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Zhu M (2008)	17908924	182052	4657	Brasofensine	-	-	DRUGBANK	DB04857	C16H20Cl2N2O	small molecule	-	171655-91-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRLIFEGHTNUYFL-QJDHNRDASA-N
24028	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Hatip-Al-Khatib I (2005)	15951830	181894	4659	Zanapezil	Zanepezil	-	DRUGBANK	DB04859	C25H32N2O	small molecule	-	142852-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMBLXLOXUGVTGB-UHFFFAOYSA-N
24029	119436	51284	UNQ248/PRO285	TLR7	TLR7-like	9606	Homo sapiens	unknown	target	Horsmans Y (2005)	16116638	181905	4660	Isatoribine	7-Thia-8-oxoguanosine|7-TOG|7-Deaza-7-thia-8-oxoguanosine	-	DRUGBANK	DB04860	C10H12N4O6S	small molecule	-	122970-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZYVRXZQAWPIAB-FCLHUMLKSA-N
24030	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Nuttall SL (2003)	12795776	175328	4661	Nebivolol	alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol	byvalson|nebivolol|bystolic	DRUGBANK	DB04861	C22H25F2NO4	small molecule	C07FB12|C07BB12|C07AB12	118457-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOHIRBRYDXPAMZ-UHFFFAOYSA-N
24031	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4661	Nebivolol	alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol	byvalson|nebivolol|bystolic	DRUGBANK	DB04861	C22H25F2NO4	small molecule	C07FB12|C07BB12|C07AB12	118457-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOHIRBRYDXPAMZ-UHFFFAOYSA-N
24032	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Gielen W (2006)	16961165	181965	4661	Nebivolol	alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol	byvalson|nebivolol|bystolic	DRUGBANK	DB04861	C22H25F2NO4	small molecule	C07FB12|C07BB12|C07AB12	118457-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOHIRBRYDXPAMZ-UHFFFAOYSA-N
24033	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	de Boer RA (2007)	17661735	182033	4661	Nebivolol	alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol	byvalson|nebivolol|bystolic	DRUGBANK	DB04861	C22H25F2NO4	small molecule	C07FB12|C07BB12|C07AB12	118457-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOHIRBRYDXPAMZ-UHFFFAOYSA-N
24034	109896	3690	-	ITGB3	BDPLT16|BDPLT2|CD61|GP3A|GPIIIa|GT	9606	Homo sapiens	unknown	target	Akkerhuis KM (2001)	11250974	181770	4663	Lefradafiban	-	-	DRUGBANK	DB04863	C23H25N3O6	small molecule	-	149503-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGCFXITVMNNKON-ROUUACIJSA-N
24035	109881	3674	-	ITGA2B	BDPLT16|BDPLT2|CD41|CD41B|GP2B|GPIIb|GT|GTA|HPA3|PPP1R93	9606	Homo sapiens	unknown	target	Akkerhuis KM (2001)	11250974	181770	4663	Lefradafiban	-	-	DRUGBANK	DB04863	C23H25N3O6	small molecule	-	149503-79-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGCFXITVMNNKON-ROUUACIJSA-N
24037	112042	6122	OK/SW-cl.32	RPL3	ASC-1|L3|TARBP-B	9606	Homo sapiens	antagonist	target	Tujebajeva RM (1992)	1730056	181644	4665	Omacetaxine mepesuccinate	()-homoharringtonine|Homoharringtonin|(2'R,3S,4S,5R)-()-homoharringtonine|Homoharringtonine|HHT	synribo	DRUGBANK	DB04865	C29H39NO9	small molecule	L01XX40	26833-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYFHYPWGAURHIV-JFIAXGOJSA-N
24038	112042	6122	OK/SW-cl.32	RPL3	ASC-1|L3|TARBP-B	9606	Homo sapiens	antagonist	target	Tujebajeva RM (1989)	2583270	181659	4665	Omacetaxine mepesuccinate	()-homoharringtonine|Homoharringtonin|(2'R,3S,4S,5R)-()-homoharringtonine|Homoharringtonine|HHT	synribo	DRUGBANK	DB04865	C29H39NO9	small molecule	L01XX40	26833-87-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYFHYPWGAURHIV-JFIAXGOJSA-N
24039	110457	4313	-	MMP2	CLG4|CLG4A|MMP-2|MMP-II|MONA|TBE-1	9606	Homo sapiens	unknown	target	Elkin M (2000)	11099465	181766	4666	Halofuginone	Tempostatin (Collgard Biopharmaceuticals)	-	DRUGBANK	DB04866	C16H17BrClN3O3	small molecule	-	55837-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVASCWIMLIKXLA-YSSOQSIOSA-N
24040	107674	1277	-	COL1A1	OI4	9606	Homo sapiens	unknown	target	Elkin M (2000)	11099465	181766	4666	Halofuginone	Tempostatin (Collgard Biopharmaceuticals)	-	DRUGBANK	DB04866	C16H17BrClN3O3	small molecule	-	55837-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVASCWIMLIKXLA-YSSOQSIOSA-N
24041	107328	886	-	CCKAR	CCK-A|CCK1-R|CCK1R|CCKRA	9606	Homo sapiens	unknown	target	Kreiss C (1998)	9712175	181732	4667	Lintitript	-	-	DRUGBANK	DB04867	C20H14ClN3O3S	small molecule	-	136381-85-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILNRQFBVVQUOLP-UHFFFAOYSA-N
24042	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Maekawa T (2007)	17929114	182055	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24043	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Kantarjian HM (2007)	17715389	182041	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24044	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Weisberg E (2006)	16721371	181947	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24045	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Swords R (2009)	19920925	182135	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24046	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Rosti G (2009)	19822896	182130	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24047	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	antagonist	target	Guo T (2007)	17699867	182039	4668	Nilotinib	Nilotinibum	tasigna	DRUGBANK	DB04868	C28H22F3N7O	small molecule	L01XE08	641571-10-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHZIURLSWUIHRB-UHFFFAOYSA-N
24048	107247	796	-	CALCA	CALC1|CGRP|CGRP-I|CGRP1|CT|KC	9606	Homo sapiens	unknown	target	Recober A (2007)	17665333	182035	4669	Olcegepant	-	-	DRUGBANK	DB04869	C38H47Br2N9O5	small molecule	-	204697-65-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITIXDWVDFFXNEG-JHOUSYSJSA-N
24049	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	unknown	target	Halford JC (2006)	16625817	181937	4671	Lorcaserin	Lorqess	belviq xr extended release ext	DRUGBANK	DB04871	C11H14ClN	small molecule	A08AA11	616202-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTTZERNUQAFMOF-QMMMGPOBSA-N
24050	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	unknown	target	Jandacek RJ (2005)	16259227	181916	4671	Lorcaserin	Lorqess	belviq xr extended release ext	DRUGBANK	DB04871	C11H14ClN	small molecule	A08AA11	616202-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTTZERNUQAFMOF-QMMMGPOBSA-N
24051	112733	6870	-	TACR3	HH11|NK-3R|NK3R|NKR|TAC3RL	9606	Homo sapiens	unknown	target	Tian G (2007)	17172464	181978	4672	Osanetant	-	-	DRUGBANK	DB04872	C35H41Cl2N3O2	small molecule	-	160492-56-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZOJBGLFWINFBF-UMSFTDKQSA-N
24052	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	unknown	target	McCullough JL (2006)	16495076	180022	4673	Piboserod	-	-	DRUGBANK	DB04873	C22H31N3O2	small molecule	-	152811-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVCSJPATKXABRQ-UHFFFAOYSA-N
24053	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	unknown	target	Darblade B (2005)	15902472	181892	4673	Piboserod	-	-	DRUGBANK	DB04873	C22H31N3O2	small molecule	-	152811-62-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVCSJPATKXABRQ-UHFFFAOYSA-N
24054	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Ross J (2007)	17845807	182047	4675	Pralnacasan	HMR 3480	-	DRUGBANK	DB04875	C26H29N5O7	small molecule	-	192755-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXAGHAZMQSCAKJ-WAHHBDPQSA-N
24055	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Ahren B (2004)	15562200	181871	4676	Vildagliptin	Galvus|Xiliarx|NVP-LAF-237|Jalra|EQUA|LAF237|Vildagliptin|NVP-LAF237|LAF-237|LAF 237	-	DRUGBANK	DB04876	C17H25N3O2	small molecule	A10BD08|A10BH02	274901-16-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYOKIDBDQMKNDQ-XWTIBIIYSA-N
24056	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Mentlein R (1993)	8100523	181692	4676	Vildagliptin	Galvus|Xiliarx|NVP-LAF-237|Jalra|EQUA|LAF237|Vildagliptin|NVP-LAF237|LAF-237|LAF 237	-	DRUGBANK	DB04876	C17H25N3O2	small molecule	A10BD08|A10BH02	274901-16-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYOKIDBDQMKNDQ-XWTIBIIYSA-N
24057	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Gupta R (2009)	19149538	182095	4676	Vildagliptin	Galvus|Xiliarx|NVP-LAF-237|Jalra|EQUA|LAF237|Vildagliptin|NVP-LAF237|LAF-237|LAF 237	-	DRUGBANK	DB04876	C17H25N3O2	small molecule	A10BD08|A10BH02	274901-16-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYOKIDBDQMKNDQ-XWTIBIIYSA-N
24058	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	inhibitor, competitive	target	Meschini S (2003)	14612920	181837	4677	Voacamine	Voacanginine|Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate|Vocamine	-	DRUGBANK	DB04877	C43H52N4O5	small molecule	-	3371-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCMIRXRRQJNZJT-XRMSBCOFSA-N
24059	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	inhibitor, competitive	target	Meschini S (2005)	16273216	181917	4677	Voacamine	Voacanginine|Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate|Vocamine	-	DRUGBANK	DB04877	C43H52N4O5	small molecule	-	3371-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCMIRXRRQJNZJT-XRMSBCOFSA-N
24060	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4678	Voglibose	Basen	-	DRUGBANK	DB04878	C10H21NO7	small molecule	A10BF03	83480-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZNCGRZWXLXZSZ-CIQUZCHMSA-N
24061	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Matsumura M (2009)	19568704	182116	4678	Voglibose	Basen	-	DRUGBANK	DB04878	C10H21NO7	small molecule	A10BF03	83480-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZNCGRZWXLXZSZ-CIQUZCHMSA-N
24062	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Fujimori Y (2009)	19281809	182100	4678	Voglibose	Basen	-	DRUGBANK	DB04878	C10H21NO7	small molecule	A10BF03	83480-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZNCGRZWXLXZSZ-CIQUZCHMSA-N
24063	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Iwasa M (2010)	20351564	182150	4678	Voglibose	Basen	-	DRUGBANK	DB04878	C10H21NO7	small molecule	A10BF03	83480-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZNCGRZWXLXZSZ-CIQUZCHMSA-N
24064	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Abe M (2010)	20025554	182141	4678	Voglibose	Basen	-	DRUGBANK	DB04878	C10H21NO7	small molecule	A10BF03	83480-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZNCGRZWXLXZSZ-CIQUZCHMSA-N
24065	114462	8972	-	MGAM	MG|MGA	9606	Homo sapiens	inhibitor	target	Satoh N (2006)	16713439	181945	4678	Voglibose	Basen	-	DRUGBANK	DB04878	C10H21NO7	small molecule	A10BF03	83480-29-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FZNCGRZWXLXZSZ-CIQUZCHMSA-N
24066	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Yamamoto A (2007)	17584317	182020	4679	Vatalanib	PTK 787|PTK/ZK|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate	-	DRUGBANK	DB04879	C20H15ClN4	small molecule	-	212141-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCOYDOIWSSHVCK-UHFFFAOYSA-N
24067	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	unknown	target	Yamamoto A (2007)	17584317	182020	4679	Vatalanib	PTK 787|PTK/ZK|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate	-	DRUGBANK	DB04879	C20H15ClN4	small molecule	-	212141-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCOYDOIWSSHVCK-UHFFFAOYSA-N
24068	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	unknown	target	Yamamoto A (2007)	17584317	182020	4679	Vatalanib	PTK 787|PTK/ZK|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine succinate	-	DRUGBANK	DB04879	C20H15ClN4	small molecule	-	212141-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCOYDOIWSSHVCK-UHFFFAOYSA-N
24069	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Sandroni C (2006)	16987374	181968	4680	Enoximone	Perfan	-	DRUGBANK	DB04880	C12H12N2O2S	small molecule	C01CE03	77671-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJKNESGOIKRXQY-UHFFFAOYSA-N
24070	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Boldt J (2007)	17714066	182040	4680	Enoximone	Perfan	-	DRUGBANK	DB04880	C12H12N2O2S	small molecule	C01CE03	77671-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJKNESGOIKRXQY-UHFFFAOYSA-N
24071	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Hubensack M (2008)	17932689	182056	4681	Elacridar	-	-	DRUGBANK	DB04881	C34H33N3O5	small molecule	-	143664-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSFCMRGOZNQUSW-UHFFFAOYSA-N
24072	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Carvajal RD (2007)	17325867	181991	4682	Edotecarin	ED-749|Edotecarina|Edotecarinum	-	DRUGBANK	DB04882	C29H28N4O11	small molecule	-	174402-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMVPQBFHUJZJCS-NTKFZFFISA-N
24073	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Saif MW (2005)	15929804	181893	4682	Edotecarin	ED-749|Edotecarina|Edotecarinum	-	DRUGBANK	DB04882	C29H28N4O11	small molecule	-	174402-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMVPQBFHUJZJCS-NTKFZFFISA-N
24074	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Xia QG (2006)	17049116	181972	4683	Darusentan	-	-	DRUGBANK	DB04883	C22H22N2O6	small molecule	-	171714-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEJVSJIALLTFRP-LJQANCHMSA-N
24075	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Orth SR (2007)	17890870	182050	4683	Darusentan	-	-	DRUGBANK	DB04883	C22H22N2O6	small molecule	-	171714-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEJVSJIALLTFRP-LJQANCHMSA-N
24076	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	unknown	target	Wang WF (2007)	17624269	182029	4684	Dapoxetine	Dapoxetinum|Dapoxetina	-	DRUGBANK	DB04884	C21H23NO	small molecule	G04BX14	119356-77-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USRHYDPUVLEVMC-FQEVSTJZSA-N
24077	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	unknown	target	Chey WD (2005)	15757394	181885	4685	Cilansetron	-	-	DRUGBANK	DB04885	C20H21N3O	small molecule	A03AE03	120635-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCNFDKWULDWJDS-OAHLLOKOSA-N
24078	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	unknown	target	Komoto S (2006)	16898618	181958	4685	Cilansetron	-	-	DRUGBANK	DB04885	C20H21N3O	small molecule	A03AE03	120635-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCNFDKWULDWJDS-OAHLLOKOSA-N
24079	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Hazen R (2007)	17620375	182027	4687	Brecanavir	BCV	-	DRUGBANK	DB04887	C33H41N3O10S2	small molecule	-	313682-08-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JORVRJNILJXMMG-OLNQLETPSA-N
24080	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Ford SL (2006)	16723584	181948	4687	Brecanavir	BCV	-	DRUGBANK	DB04887	C33H41N3O10S2	small molecule	-	313682-08-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JORVRJNILJXMMG-OLNQLETPSA-N
24081	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Reddy YS (2007)	17261626	181985	4687	Brecanavir	BCV	-	DRUGBANK	DB04887	C33H41N3O10S2	small molecule	-	313682-08-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JORVRJNILJXMMG-OLNQLETPSA-N
24082	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Auclair AL (2007)	17393144	181998	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24083	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Newman-Tancredi A (2007)	17659474	182032	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24084	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Bardin L (2006)	16237379	181914	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24085	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Auclair AL (2007)	17393144	181998	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24086	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Newman-Tancredi A (2007)	17659474	182032	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24087	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Basile AS (2007)	17325229	181989	4689	Bicifadine	-	-	DRUGBANK	DB04889	C12H15N	small molecule	-	71195-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFYVIGTWSQPCLF-UHFFFAOYSA-N
24088	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	unknown	target	Basile AS (2007)	17325229	181989	4689	Bicifadine	-	-	DRUGBANK	DB04889	C12H15N	small molecule	-	71195-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFYVIGTWSQPCLF-UHFFFAOYSA-N
24089	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	unknown	target	Basile AS (2007)	17325229	181989	4689	Bicifadine	-	-	DRUGBANK	DB04889	C12H15N	small molecule	-	71195-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFYVIGTWSQPCLF-UHFFFAOYSA-N
24090	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Andoh T (2006)	16914135	181960	4690	Bepotastine	TAU-284DS	bepreve	DRUGBANK	DB04890	C21H25ClN2O3	small molecule	-	125602-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWGDOWXRIALTES-UHFFFAOYSA-N
24091	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4690	Bepotastine	TAU-284DS	bepreve	DRUGBANK	DB04890	C21H25ClN2O3	small molecule	-	125602-71-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWGDOWXRIALTES-UHFFFAOYSA-N
24092	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Klein J (2007)	17594192	182024	4692	Phenserine	(-)-eseroline phenylcarbamate|(-)-phenserine	-	DRUGBANK	DB04892	C20H23N3O2	small molecule	-	101246-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBHFNBQPZCRWQP-QUCCMNQESA-N
24093	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Greig NH (2005)	16248851	181915	4692	Phenserine	(-)-eseroline phenylcarbamate|(-)-phenserine	-	DRUGBANK	DB04892	C20H23N3O2	small molecule	-	101246-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBHFNBQPZCRWQP-QUCCMNQESA-N
24094	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Janas AM (2005)	15620572	181876	4692	Phenserine	(-)-eseroline phenylcarbamate|(-)-phenserine	-	DRUGBANK	DB04892	C20H23N3O2	small molecule	-	101246-66-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBHFNBQPZCRWQP-QUCCMNQESA-N
24095	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Wakeling AE (2005)	16113095	181904	4693	AZD3409	-	-	DRUGBANK	DB04893	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24096	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Wakeling AE (2005)	16113095	181904	4693	AZD3409	-	-	DRUGBANK	DB04893	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24097	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	agonist	target	Fortune BE (2009)	19708854	182125	4694	Vapreotide	Vapreotidum|Vapreotida	-	DRUGBANK	DB04894	C57H70N12O9S2	small molecule	H01CB04	103222-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWXOGPJRIDTIRL-DOUNNPEJSA-N
24098	112630	6752	-	SSTR2	-	9606	Homo sapiens	inducer	target	Fortune BE (2009)	19708854	182125	4694	Vapreotide	Vapreotidum|Vapreotida	-	DRUGBANK	DB04894	C57H70N12O9S2	small molecule	H01CB04	103222-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWXOGPJRIDTIRL-DOUNNPEJSA-N
24099	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4694	Vapreotide	Vapreotidum|Vapreotida	-	DRUGBANK	DB04894	C57H70N12O9S2	small molecule	H01CB04	103222-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWXOGPJRIDTIRL-DOUNNPEJSA-N
24100	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Betoin F (1995)	7556407	181684	4694	Vapreotide	Vapreotidum|Vapreotida	-	DRUGBANK	DB04894	C57H70N12O9S2	small molecule	H01CB04	103222-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWXOGPJRIDTIRL-DOUNNPEJSA-N
24101	114356	8829	RP11-342D11.1	NRP1	BDCA4|CD304|NP1|NRP|VEGF165R	9606	Homo sapiens	unknown	target	Vinores SA (2007)	17717967	182042	4695	Pegaptanib	EYE 001|NX1838|Pegaptanib sodium|Pegaptanib Octasodium|NX 1838	macugen	DRUGBANK	DB04895	C294H342F13N107Na28O188P28[C2H4O]2n	biologic	S01LA03	222716-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24102	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Leo RJ (2006)	16869117	181956	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24103	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Moret C (1985)	3005901	181666	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24104	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24105	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24106	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24107	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24108	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24109	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24110	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24111	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24112	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24113	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24114	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24115	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24116	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24117	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24118	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Leo RJ (2006)	16869117	181956	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24119	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Moret C (1985)	3005901	181666	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24120	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Ersdal E (2007)	17532684	182018	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24121	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Testa L (2007)	17688383	182037	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24122	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24123	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Bergqvist D (2007)	17516699	182013	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24124	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Ho SJ (2007)	17319469	181988	4698	Ximelagatran	H 376/95|Ethyl 2-[[(1R)-1-cyclohexyl-2- [(2S)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate|Ximelagatranum|H 37695|Exarta|Exanta|H 376-95	-	DRUGBANK	DB04898	C24H35N5O5	small molecule	B01AE05	192939-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXIBCJHYVWYIKI-PZJWPPBQSA-N
24125	110941	4881	RP11-354A16.3	NPR1	ANPRA|ANPa|GUC2A|GUCY2A|NPRA	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	4699	Nesiritide	Natriuretic peptides B|BNP|Nesiritide recombinant|Brain natriuretic peptide 32	natrecor	DRUGBANK	DB04899	-	biologic	C01DX19	124584-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24126	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	unknown	target	Czuczman MS (2005)	15994148	181897	4701	Galiximab	N/A|IDEC-114	-	DRUGBANK	DB04901	-	biologic	-	357613-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24127	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	unknown	target	Gottlieb AB (2004)	15093549	181846	4701	Galiximab	N/A|IDEC-114	-	DRUGBANK	DB04901	-	biologic	-	357613-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24128	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	unknown	target	Leonard JP (2007)	17470451	182005	4701	Galiximab	N/A|IDEC-114	-	DRUGBANK	DB04901	-	biologic	-	357613-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24129	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	unknown	target	Storey RF (2007)	17980251	182060	4702	AZD6140	-	-	DRUGBANK	DB04902	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24130	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	unknown	target	Springthorpe B (2007)	17827008	182046	4702	AZD6140	-	-	DRUGBANK	DB04902	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24131	108830	2556	-	GABRA3	-	9606	Homo sapiens	unknown	target	Atack JR (2006)	16430927	181927	4703	Pagoclone	-	-	DRUGBANK	DB04903	C23H22ClN3O2	small molecule	-	133737-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIUPRQPBWVEQJJ-UHFFFAOYSA-N
24132	108829	2555	-	GABRA2	-	9606	Homo sapiens	unknown	target	Atack JR (2006)	16430927	181927	4703	Pagoclone	-	-	DRUGBANK	DB04903	C23H22ClN3O2	small molecule	-	133737-32-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIUPRQPBWVEQJJ-UHFFFAOYSA-N
24133	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	inducer	target	Vincent M (2006)	16413681	181926	4705	Tesmilifene	N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|DPPE|Depmpe	-	DRUGBANK	DB04905	C19H25NO	small molecule	-	98774-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFIXBCVWIPOYCD-UHFFFAOYSA-N
24134	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	inducer	target	Brandes LJ (2001)	10755318	181748	4705	Tesmilifene	N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|DPPE|Depmpe	-	DRUGBANK	DB04905	C19H25NO	small molecule	-	98774-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFIXBCVWIPOYCD-UHFFFAOYSA-N
24135	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Brandes LJ (1987)	2886214	181664	4705	Tesmilifene	N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine|DPPE|Depmpe	-	DRUGBANK	DB04905	C19H25NO	small molecule	-	98774-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFIXBCVWIPOYCD-UHFFFAOYSA-N
24142	115656	10383	RP13-122B23.2	TUBB4B	Beta2|TUBB2|TUBB2C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4710	Oxibendazole	methyl 5-[n-propoxy]benzimidazole-2-carbamate|Methyl 5-propoxy-2-benzimidazolecarbamate|(5-Propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester|Oxibendazolum|5-Propoxy-2-benzimidazolecarbamic acid methyl ester|Oxybendazole|Oxibendazolo|OBZ|Methyl (5-propoxy-1H-benzimidazol-2-yl)carbamate|Methyl 5-n-propoxy-2-benzimidazole carbamate	-	DRUGBANK	DB04910	C12H15N3O3	small molecule	-	20559-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAOCRURYZCVHMG-UHFFFAOYSA-N
24143	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Drummond GS (2004)	15686268	181882	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24144	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Cannon JB (1993)	8321837	181696	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24145	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Boeni RE (1993)	8265722	181695	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24146	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Nalos M (2003)	12785007	181819	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24147	109406	3163	-	HMOX2	HO-2	9606	Homo sapiens	unknown	target	Wagner KR (2000)	10872746	181754	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24148	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Drummond GS (2004)	15686268	181882	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24149	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Cannon JB (1993)	8321837	181696	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24150	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Boeni RE (1993)	8265722	181695	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24151	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Nalos M (2003)	12785007	181819	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24152	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Wagner KR (2000)	10872746	181754	4712	Stannsoporfin	tin-mesoporphyrin|Tin (IV) mesoporphyrin IX dichloride|SnMP	-	DRUGBANK	DB04912	-	small molecule	-	106344-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24153	115758	10495	RP5-875H3.1	ENOX2	APK1|COVA1|tNOX	9606	Homo sapiens	unknown	target	Morre DJ (2007)	17518268	182015	4714	Phenoxodiol	NV-06|Dehydroequol|3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol|Haginin E|NV06|Idronoxil	-	DRUGBANK	DB04915	C15H12O3	small molecule	-	81267-65-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZUBHVMHNVYXRR-UHFFFAOYSA-N
24154	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	unknown	target	Craig DA (1991)	1364818	181639	4715	Renzapride	-	-	DRUGBANK	DB04917	C16H22ClN3O2	small molecule	-	112727-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFUAYKVMQVBSNG-UHFFFAOYSA-N
24155	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	unknown	target	Tack J (2006)	16696817	181942	4715	Renzapride	-	-	DRUGBANK	DB04917	C16H22ClN3O2	small molecule	-	112727-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFUAYKVMQVBSNG-UHFFFAOYSA-N
24156	849200	944799	b0084	ftsI	ECK0085|JW0082|pbpB|sep	511145	Escherichia coli	unknown	target	Davies TA (2007)	17470659	182006	4716	Ceftobiprole	Ceftobiprole Medocaril	zevtera|zeftera	DRUGBANK	DB04918	C20H22N8O6S2	small molecule	J01DI01	209467-52-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOAZJEPQLGBXGO-SDAWRPRTSA-N
24157	108535	2244	-	FGB	HEL-S-78p	9606	Homo sapiens	unknown	target	Ahmed NK (1990)	1696922	181642	4717	Alfimeprase	-	-	DRUGBANK	DB04919	-	biologic	-	259074-76-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24158	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Ahmed NK (1990)	1696922	181642	4717	Alfimeprase	-	-	DRUGBANK	DB04919	-	biologic	-	259074-76-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24159	107232	778	-	CACNA1F	AIED|COD3|COD4|CORDX|CORDX3|CSNB2|CSNB2A|CSNBX2|Cav1.4|Cav1.4alpha1|JM8|JMC8|OA2	9606	Homo sapiens	unknown	target	Nordlander M (2004)	15492770	181868	4718	Clevidipine	Clevidipine butyrate	cleviprex	DRUGBANK	DB04920	C21H23Cl2NO6	small molecule	C08CA16	167221-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPBZROQVTHLCDU-UHFFFAOYSA-N
24160	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	unknown	target	Nordlander M (2004)	15492770	181868	4718	Clevidipine	Clevidipine butyrate	cleviprex	DRUGBANK	DB04920	C21H23Cl2NO6	small molecule	C08CA16	167221-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPBZROQVTHLCDU-UHFFFAOYSA-N
24161	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	unknown	target	Nordlander M (2004)	15492770	181868	4718	Clevidipine	Clevidipine butyrate	cleviprex	DRUGBANK	DB04920	C21H23Cl2NO6	small molecule	C08CA16	167221-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPBZROQVTHLCDU-UHFFFAOYSA-N
24162	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	unknown	target	Nordlander M (2004)	15492770	181868	4718	Clevidipine	Clevidipine butyrate	cleviprex	DRUGBANK	DB04920	C21H23Cl2NO6	small molecule	C08CA16	167221-71-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPBZROQVTHLCDU-UHFFFAOYSA-N
24163	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	unknown	target	Choung RS (2007)	17300287	181987	4721	Itopride	N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide	-	DRUGBANK	DB04924	C20H26N2O4	small molecule	A03FA07	122898-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQQIECGTIMUVDS-UHFFFAOYSA-N
24164	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Choung RS (2007)	17300287	181987	4721	Itopride	N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide	-	DRUGBANK	DB04924	C20H26N2O4	small molecule	A03FA07	122898-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQQIECGTIMUVDS-UHFFFAOYSA-N
24165	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Holtmann G (2006)	16495395	181932	4721	Itopride	N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide	-	DRUGBANK	DB04924	C20H26N2O4	small molecule	A03FA07	122898-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQQIECGTIMUVDS-UHFFFAOYSA-N
24166	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	unknown	target	Dafer RM (2007)	17425487	182000	4722	Desmoteplase	DSPA|Desmodus rotundus salivary plasminogen activator	-	DRUGBANK	DB04925	-	biologic	-	145137-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24167	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Breckenridge CB (2009)	19766671	182128	4727	Permethrin	Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate	kwellada-p crme rinse|leader l	DRUGBANK	DB04930	C21H20Cl2O3	small molecule	P03AC04|P03AC54	52645-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLPVAHGXHCWKJ-UHFFFAOYSA-N
24168	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Liu N (2009)	19960691	182137	4727	Permethrin	Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate	kwellada-p crme rinse|leader l	DRUGBANK	DB04930	C21H20Cl2O3	small molecule	P03AC04|P03AC54	52645-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLPVAHGXHCWKJ-UHFFFAOYSA-N
24169	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Chang C (2009)	19171193	182097	4727	Permethrin	Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate	kwellada-p crme rinse|leader l	DRUGBANK	DB04930	C21H20Cl2O3	small molecule	P03AC04|P03AC54	52645-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLPVAHGXHCWKJ-UHFFFAOYSA-N
24170	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	Cao Z (2011)	20881019	182168	4727	Permethrin	Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate	kwellada-p crme rinse|leader l	DRUGBANK	DB04930	C21H20Cl2O3	small molecule	P03AC04|P03AC54	52645-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLPVAHGXHCWKJ-UHFFFAOYSA-N
24171	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	inhibitor	target	McMahon C (2003)	14651650	181838	4727	Permethrin	Permethrin|3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester|(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate	kwellada-p crme rinse|leader l	DRUGBANK	DB04930	C21H20Cl2O3	small molecule	P03AC04|P03AC54	52645-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLLPVAHGXHCWKJ-UHFFFAOYSA-N
24172	110327	4157	-	MC1R	CMM5|MSH-R|SHEP2	9606	Homo sapiens	unknown	target	Fitzgerald LM (2006)	16293341	181919	4728	Afamelanotide	MT-I|Melanotan 1|Melanotan I	-	DRUGBANK	DB04931	C78H111N21O19	small molecule	D02BB02	75921-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAHFGYDRQSXQEB-LEBBXHLNSA-N
24173	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Bianchi G (1993)	8405101	181699	4729	Defibrotide	-	defitelio	DRUGBANK	DB04932	-	biologic	B01AX01	83712-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24174	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	unknown	target	Bianchi G (1993)	8405101	181699	4729	Defibrotide	-	defitelio	DRUGBANK	DB04932	-	biologic	B01AX01	83712-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24175	106648	136	-	ADORA2B	ADORA2	9606	Homo sapiens	unknown	target	Bianchi G (1993)	8405101	181699	4729	Defibrotide	-	defitelio	DRUGBANK	DB04932	-	biologic	B01AX01	83712-60-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24176	112954	7099	-	TLR4	ARMD10|CD284|TLR-4|TOLL	9606	Homo sapiens	unknown	target	Shimamoto A (2006)	16820585	181952	4730	Eritoran	-	-	DRUGBANK	DB04933	C66H126N2O19P2	small molecule	-	185955-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPSMYQFMCXXNPC-MFCPCZTFSA-N
24177	112954	7099	-	TLR4	ARMD10|CD284|TLR-4|TOLL	9606	Homo sapiens	unknown	target	Kim HM (2007)	17803912	182045	4730	Eritoran	-	-	DRUGBANK	DB04933	C66H126N2O19P2	small molecule	-	185955-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPSMYQFMCXXNPC-MFCPCZTFSA-N
24178	852782	948488	b3987	rpoB	ECK3978|JW3950|ftsR|groN|mbrD?|nitB|rif|ron|sdgB|stl|stv|tabD|tabG	511145	Escherichia coli	unknown	target	Fujii K (1995)	7492091	181682	4731	Rifalazil	3'-hydroxy-5'-(4-isobutyl-1-piperazinyl)benzoxazinorifamycin	-	DRUGBANK	DB04934	C51H64N4O13	small molecule	-	129791-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEFHFKKWYKVLDC-HTQYORAHSA-N
24179	112874	7015	-	TERT	CMM9|DKCA2|DKCB4|EST2|PFBMFT1|TCS1|TP2|TRT|hEST2|hTRT	9606	Homo sapiens	unknown	target	Kokhaei P (2007)	17258078	181984	4733	GV1001	-	-	DRUGBANK	DB04937	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24180	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Wurz GT (2005)	16153821	181910	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24181	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Komi J (2004)	15255284	181854	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24182	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Wurz GT (2005)	16153821	181910	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24183	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Komi J (2004)	15255284	181854	4734	Ospemifene	2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol|Deamino-hydroxytoremifene|2-(4-(4-Chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol|Osphena|FC-1271a|FC-1271	osphena	DRUGBANK	DB04938	C24H23ClO2	small molecule	G03XC05	128607-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUMKNAVTFCDUIE-VHXPQNKSSA-N
24184	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	unknown	target	Kuznetsov G (2004)	15313917	181859	4735	E7389	-	-	DRUGBANK	DB04940	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24185	123347	81027	-	TUBB1	-	9606	Homo sapiens	unknown	target	Dabydeen DA (2006)	16940412	181964	4735	E7389	-	-	DRUGBANK	DB04940	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24186	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	antagonist	target	Tradtrantip L (2010)	19808995	182129	4736	Crofelemer	SP-303|Provir	fulyzaq|mytesi	DRUGBANK	DB04941	-	small molecule	-	148465-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24187	120417	55107	-	ANO1	DOG1|ORAOV2|TAOS2|TMEM16A	9606	Homo sapiens	antagonist	target	Tradtrantip L (2010)	19808995	182129	4736	Crofelemer	SP-303|Provir	fulyzaq|mytesi	DRUGBANK	DB04941	-	small molecule	-	148465-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24188	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Miwako I (2007)	17925887	182054	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24189	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Jimi S (2007)	17611697	182025	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24190	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24191	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Unknown Authors (2004)	15563242	181873	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24192	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	agonist	target	Sanda T (2005)	15843826	181888	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24193	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Miwako I (2007)	17925887	182054	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24194	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Jimi S (2007)	17611697	182025	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24195	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Unknown Authors (2004)	15563242	181873	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24196	111850	5915	-	RARB	HAP|MCOPS12|NR1B2|RRB2	9606	Homo sapiens	agonist	target	Sanda T (2005)	15843826	181888	4737	Tamibarotene	Amnoid|Tamibarotene|retinobenzoic acid|Tamibaro|Am 80	-	DRUGBANK	DB04942	C22H25NO3	small molecule	-	94497-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUTNCGKQJGXKEM-UHFFFAOYSA-N
24197	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24198	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24199	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24200	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24201	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24202	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hesselink JM (2002)	12861482	181824	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24203	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kongsamut S (1996)	8997630	181714	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24204	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Hesselink JM (2002)	12861482	181824	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24205	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Kongsamut S (1996)	8997630	181714	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24206	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24207	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24208	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24209	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	unknown	target	Spencer TJ (2007)	17511972	182012	4741	Altropane	-	-	DRUGBANK	DB04947	C18H21FINO2	small molecule	-	180468-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTQLIPQFXVKRKJ-UNSMHXHVSA-N
24210	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Strang J (1999)	10598217	181744	4742	Lofexidine	Lofexidinum|Lofexidina|2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline	-	DRUGBANK	DB04948	C11H12Cl2N2O	small molecule	N07BC04	31036-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSMAGQUYOIHWFS-UHFFFAOYSA-N
24211	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Erb S (2000)	10882840	181755	4742	Lofexidine	Lofexidinum|Lofexidina|2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline	-	DRUGBANK	DB04948	C11H12Cl2N2O	small molecule	N07BC04	31036-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSMAGQUYOIHWFS-UHFFFAOYSA-N
24212	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Jin Y (1992)	1357064	181638	4742	Lofexidine	Lofexidinum|Lofexidina|2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline	-	DRUGBANK	DB04948	C11H12Cl2N2O	small molecule	N07BC04	31036-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSMAGQUYOIHWFS-UHFFFAOYSA-N
24213	111082	5045	-	FURIN	FUR|PACE|PCSK3|SPC1	9606	Homo sapiens	unknown	target	Burghardt I (2007)	17234158	181983	4745	Pirfenidone	-	esbriet	DRUGBANK	DB04951	C12H11NO	small molecule	L04AX05	53179-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISWRGOKTTBVCFA-UHFFFAOYSA-N
24214	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Punke MA (2007)	17456683	175184	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24215	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Wuttke TV (2005)	15662042	181879	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24216	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Hirano K (2007)	17184917	181979	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24217	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Main MJ (2000)	10908292	181758	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24218	109986	3785	RP11-261N11.2	KCNQ2	BFNC|BFNS1|EBN|EBN1|EIEE7|ENB1|HNSPC|KCNA11|KV7.2|KVEBN1	9606	Homo sapiens	unknown	target	Wickenden AD (2000)	10953053	181759	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24219	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Punke MA (2007)	17456683	175184	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24220	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Hirano K (2007)	17184917	181979	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24221	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Main MJ (2000)	10908292	181758	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24222	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Wickenden AD (2000)	10953053	181759	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24223	114580	9132	-	KCNQ4	DFNA2|DFNA2A|KV7.4	9606	Homo sapiens	unknown	target	Schroder RL (2001)	11378159	181772	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24224	114580	9132	-	KCNQ4	DFNA2|DFNA2A|KV7.4	9606	Homo sapiens	unknown	target	Hirano K (2007)	17184917	181979	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24225	114580	9132	-	KCNQ4	DFNA2|DFNA2A|KV7.4	9606	Homo sapiens	unknown	target	Borlak J (2006)	16713428	181944	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24226	121149	56479	RP11-257K9.5	KCNQ5	Kv7.5	9606	Homo sapiens	unknown	target	Hirano K (2007)	17184917	181979	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24227	121149	56479	RP11-257K9.5	KCNQ5	Kv7.5	9606	Homo sapiens	unknown	target	Borlak J (2006)	16713428	181944	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24228	121149	56479	RP11-257K9.5	KCNQ5	Kv7.5	9606	Homo sapiens	unknown	target	Hermann R (2003)	12545144	181809	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24229	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	unknown	target	Ellenbogen KA (2005)	15956124	181895	4748	Tecadenoson	-	-	DRUGBANK	DB04954	C14H19N5O5	small molecule	-	204512-90-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OESBDSFYJMDRJY-BAYCTPFLSA-N
24230	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	unknown	target	Peterman C (2005)	16230891	181913	4748	Tecadenoson	-	-	DRUGBANK	DB04954	C14H19N5O5	small molecule	-	204512-90-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OESBDSFYJMDRJY-BAYCTPFLSA-N
24231	106646	134	-	ADORA1	RDC7	9606	Homo sapiens	unknown	target	Prystowsky EN (2003)	13678937	181832	4748	Tecadenoson	-	-	DRUGBANK	DB04954	C14H19N5O5	small molecule	-	204512-90-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OESBDSFYJMDRJY-BAYCTPFLSA-N
24232	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Vincent JL (2000)	10829362	181750	4750	Afelimomab	MAK 195F|Fab 2	-	DRUGBANK	DB04956	-	biologic	L04AB03	156227-98-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24233	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Abrol R (2000)	11060832	181764	4751	Azimilide	-	-	DRUGBANK	DB04957	C23H28ClN5O3	small molecule	-	149908-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MREBEPTUUMTTIA-UHFFFAOYSA-N
24234	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Schmitt H (2001)	11573692	181777	4751	Azimilide	-	-	DRUGBANK	DB04957	C23H28ClN5O3	small molecule	-	149908-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MREBEPTUUMTTIA-UHFFFAOYSA-N
24235	109955	3753	-	KCNE1	ISK|JLNS|JLNS2|LQT2/5|LQT5|MinK	9606	Homo sapiens	unknown	target	Abrol R (2000)	11060832	181764	4751	Azimilide	-	-	DRUGBANK	DB04957	C23H28ClN5O3	small molecule	-	149908-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MREBEPTUUMTTIA-UHFFFAOYSA-N
24236	109955	3753	-	KCNE1	ISK|JLNS|JLNS2|LQT2/5|LQT5|MinK	9606	Homo sapiens	unknown	target	Schmitt H (2001)	11573692	181777	4751	Azimilide	-	-	DRUGBANK	DB04957	C23H28ClN5O3	small molecule	-	149908-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MREBEPTUUMTTIA-UHFFFAOYSA-N
24237	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	unknown	target	Abrol R (2000)	11060832	181764	4751	Azimilide	-	-	DRUGBANK	DB04957	C23H28ClN5O3	small molecule	-	149908-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MREBEPTUUMTTIA-UHFFFAOYSA-N
24238	109985	3784	-	KCNQ1	ATFB1|ATFB3|JLNS1|KCNA8|KCNA9|KVLQT1|Kv1.9|Kv7.1|LQT|LQT1|RWS|SQT2|WRS	9606	Homo sapiens	unknown	target	Schmitt H (2001)	11573692	181777	4751	Azimilide	-	-	DRUGBANK	DB04957	C23H28ClN5O3	small molecule	-	149908-53-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MREBEPTUUMTTIA-UHFFFAOYSA-N
24239	107371	933	-	CD22	SIGLEC-2|SIGLEC2	9606	Homo sapiens	unknown	target	Steinfeld SD (2006)	16918261	181961	4752	Epratuzumab	anti-CD22 IgG|humanised anti-CD22 antibody	-	DRUGBANK	DB04958	-	biologic	-	205923-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24240	107371	933	-	CD22	SIGLEC-2|SIGLEC2	9606	Homo sapiens	unknown	target	Carnahan J (2007)	16814387	181950	4752	Epratuzumab	anti-CD22 IgG|humanised anti-CD22 antibody	-	DRUGBANK	DB04958	-	biologic	-	205923-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24241	107371	933	-	CD22	SIGLEC-2|SIGLEC2	9606	Homo sapiens	unknown	target	Leonard JP (2007)	17530024	182016	4752	Epratuzumab	anti-CD22 IgG|humanised anti-CD22 antibody	-	DRUGBANK	DB04958	-	biologic	-	205923-57-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24242	110053	3855	-	KRT7	CK7|K2C7|K7|SCL	9606	Homo sapiens	unknown	target	Kanduc D (2002)	12072504	181795	4753	HspE7	HPV E7 Peptide Epitope Vaccine|HPV 16 E7/HSP65 Vaccine	-	DRUGBANK	DB04959	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24243	116934	23352	RP5-1126H10.1	UBR4	RBAF600|ZUBR1|p600	9606	Homo sapiens	unknown	target	Huh KW (2005)	16061792	145574	4753	HspE7	HPV E7 Peptide Epitope Vaccine|HPV 16 E7/HSP65 Vaccine	-	DRUGBANK	DB04959	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24244	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Venkatasubbarao K (2005)	15805288	181887	4754	Tipifarnib	Zarnestra	-	DRUGBANK	DB04960	C27H22Cl2N4O	small molecule	-	192185-72-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLHJCIYEEKOWNM-HHHXNRCGSA-N
24245	125094	94025	-	MUC16	CA125	9606	Homo sapiens	unknown	target	Berek JS (2004)	15268682	181855	4758	Oregovomab	Oregovamab|B43.13|MOAB B43.13|Monoclonal antibody B43.13	-	DRUGBANK	DB04964	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24246	125094	94025	-	MUC16	CA125	9606	Homo sapiens	unknown	target	Unknown Authors (2006)	17073521	181974	4758	Oregovomab	Oregovamab|B43.13|MOAB B43.13|Monoclonal antibody B43.13	-	DRUGBANK	DB04964	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24247	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4759	Lucanthone	1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona	-	DRUGBANK	DB04967	C20H24N2OS	small molecule	-	479-50-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBQPGGIHOFZRGH-UHFFFAOYSA-N
24248	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Bases RE (1997)	9169823	181719	4759	Lucanthone	1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona	-	DRUGBANK	DB04967	C20H24N2OS	small molecule	-	479-50-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBQPGGIHOFZRGH-UHFFFAOYSA-N
24249	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	Dassonneville L (1999)	10487533	181741	4759	Lucanthone	1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona	-	DRUGBANK	DB04967	C20H24N2OS	small molecule	-	479-50-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBQPGGIHOFZRGH-UHFFFAOYSA-N
24250	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Bases RE (1997)	9169823	181719	4759	Lucanthone	1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona	-	DRUGBANK	DB04967	C20H24N2OS	small molecule	-	479-50-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBQPGGIHOFZRGH-UHFFFAOYSA-N
24251	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Dassonneville L (1999)	10487533	181741	4759	Lucanthone	1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona	-	DRUGBANK	DB04967	C20H24N2OS	small molecule	-	479-50-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBQPGGIHOFZRGH-UHFFFAOYSA-N
24252	106825	328	-	APEX1	APE|APE1|APEN|APEX|APX|HAP1|REF1	9606	Homo sapiens	inhibitor	target	Luo M (2004)	15330152	181860	4759	Lucanthone	1-diethylaminoethylethylamino-4-methyl-thioxanthenone|Lucanthonum|Lucanthone|1-{[2-(diethylamino)ethyl]amino}-4-methylthioxanthen-9-one|1-((2-(Diethylamino)ethyl)amino)-4-methylthioxanthen-9-one|Lucantona	-	DRUGBANK	DB04967	C20H24N2OS	small molecule	-	479-50-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBQPGGIHOFZRGH-UHFFFAOYSA-N
24253	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Micheli F (2001)	16032484	181899	4762	Lesopitron	Lesopitran	-	DRUGBANK	DB04970	C15H21ClN6	small molecule	-	132449-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCPKWJUALHOPH-UHFFFAOYSA-N
24254	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Fisas MA (2004)	15331910	181861	4762	Lesopitron	Lesopitran	-	DRUGBANK	DB04970	C15H21ClN6	small molecule	-	132449-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHCPKWJUALHOPH-UHFFFAOYSA-N
24255	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Rosen LS (2003)	12738715	181816	4764	Canfosfamide	-	-	DRUGBANK	DB04972	C26H40Cl4N5O10PS	small molecule	-	158382-37-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLHWPALWODJPQ-QNWVGRARSA-N
24256	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Kavanagh JJ (2005)	16014111	181898	4764	Canfosfamide	-	-	DRUGBANK	DB04972	C26H40Cl4N5O10PS	small molecule	-	158382-37-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLHWPALWODJPQ-QNWVGRARSA-N
24257	111831	5894	-	RAF1	CMD1NN|CRAF|NS5|Raf-1|c-Raf	9606	Homo sapiens	unknown	target	Gokhale PC (2002)	12429653	181807	4765	LErafAON	-	-	DRUGBANK	DB04973	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24258	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	unknown	target	Atkinson SJ (2007)	17340571	181994	4767	Banoxantrone	AQ4N	-	DRUGBANK	DB04975	-	small molecule	-	136470-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24259	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Denes L (2006)	16861112	181955	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24260	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Langan YM (2003)	12581229	181810	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24261	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Howes JF (2007)	17199027	181981	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24262	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Denes L (2006)	16861112	181955	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24263	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Langan YM (2003)	12581229	181810	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24264	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Howes JF (2007)	17199027	181981	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24265	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Denes L (2006)	16861112	181955	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24266	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Langan YM (2003)	12581229	181810	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24267	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Howes JF (2007)	17199027	181981	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24268	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Denes L (2006)	16861112	181955	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24269	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Langan YM (2003)	12581229	181810	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24270	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Howes JF (2007)	17199027	181981	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24271	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Kellerman D (2002)	12458155	181808	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24272	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Meyer CH (2002)	12407169	181806	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24273	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Maminishkis A (2002)	12407168	181805	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24274	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Brunschweiger A (2006)	16475938	181931	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24275	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Nour M (2003)	14507899	181834	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24276	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Deterding RR (2007)	17446337	182003	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24277	111068	5029	RP11-800A3.4	P2RY2	HP2U|P2RU1|P2U|P2U1|P2UR|P2Y2|P2Y2R	9606	Homo sapiens	unknown	target	Deterding R (2005)	15704203	181883	4775	Denufosol	-	-	DRUGBANK	DB04983	C18H27N5O21P4	small molecule	-	211448-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPNPSEMJLALQSA-MIYUEGBISA-N
24278	110115	3921	-	RPSA	37LRP|67LR|ICAS|LAMBR|LAMR1|LBP|LBP/p40|LRP|LRP/LR|NEM/1CHD4|SA|lamR|p40	9606	Homo sapiens	unknown	target	Annabi B (2006)	16759641	181949	4776	PCK3145	-	-	DRUGBANK	DB04985	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24279	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	unknown	target	Farhan H (2006)	16963623	181966	4779	IGN311	-	-	DRUGBANK	DB04988	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24280	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	unknown	target	Farhan H (2006)	16963623	181966	4779	IGN311	-	-	DRUGBANK	DB04988	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24281	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4789	PSN9301	-	-	DRUGBANK	DB05001	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24282	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	ligand	target	Kedei N (2004)	15126366	181848	4800	Ingenol Mebutate	3-Ingenyl Angelate|Picato|ingenol mebutate|PEP005|Ingenol 3-angelate	picato	DRUGBANK	DB05013	C25H34O6	small molecule	D06BX02	75567-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDJHFHXMUKFKET-WDUFCVPESA-N
24283	111566	5580	-	PRKCD	ALPS3|CVID9|MAY1|PKCD|nPKC-delta	9606	Homo sapiens	ligand	target	Kedei N (2004)	15126366	181848	4800	Ingenol Mebutate	3-Ingenyl Angelate|Picato|ingenol mebutate|PEP005|Ingenol 3-angelate	picato	DRUGBANK	DB05013	C25H34O6	small molecule	D06BX02	75567-37-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDJHFHXMUKFKET-WDUFCVPESA-N
24284	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4822	KB2115	Eprotirome	-	DRUGBANK	DB05035	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24285	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Cazzola M (2005)	16022567	180980	4826	Indacaterol	QAB-149|5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one|QAB149|QAB 149	arcapta neohaler|ultibro breez	DRUGBANK	DB05039	C24H28N2O3	small molecule	R03AL04|R03AC18	312753-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZZUEBNBZAPZLX-QFIPXVFZSA-N
24286	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Almansa C (2004)	15481993	181866	4878	Cimicoxib	-	-	DRUGBANK	DB05095	C16H13ClFN3O3S	small molecule	-	265114-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYXDNECMRLFQMZ-UHFFFAOYSA-N
24287	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4974	MB07811	-	-	DRUGBANK	DB05192	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24288	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	unknown	target	Mahadevan D (2007)	17325667	181990	4997	MP470	-	-	DRUGBANK	DB05216	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24289	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	unknown	target	Melian EB (2002)	11790158	181785	5009	Beraprost	-	-	DRUGBANK	DB05229	C24H29NaO5	small molecule	B01AC19	88430-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTCZZXIRLARSET-VJRSQJMHSA-M
24290	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	unknown	target	Sage D (2007)	17663442	182034	5011	Tetrodotoxin	-	-	DRUGBANK	DB05232	C11H17N3O8	small molecule	-	4368-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBCPBUVHCASIJ-UFHSVNPDSA-O
24291	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	unknown	target	Sage D (2007)	17663442	182034	5011	Tetrodotoxin	-	-	DRUGBANK	DB05232	C11H17N3O8	small molecule	-	4368-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBCPBUVHCASIJ-UFHSVNPDSA-O
24292	112228	6323	-	SCN1A	EIEE6|FEB3|FEB3A|FHM3|GEFSP2|HBSCI|NAC1|Nav1.1|SCN1|SMEI	9606	Homo sapiens	unknown	target	Sage D (2007)	17663442	182034	5011	Tetrodotoxin	-	-	DRUGBANK	DB05232	C11H17N3O8	small molecule	-	4368-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBCPBUVHCASIJ-UFHSVNPDSA-O
24293	112238	6334	-	SCN8A	CERIII|CIAT|EIEE13|MED|NaCh6|Nav1.6|PN4	9606	Homo sapiens	unknown	target	Sage D (2007)	17663442	182034	5011	Tetrodotoxin	-	-	DRUGBANK	DB05232	C11H17N3O8	small molecule	-	4368-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBCPBUVHCASIJ-UFHSVNPDSA-O
24294	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Gomora JC (2001)	11641441	177137	5025	Methsuximide	Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine	celontin|celontin cap 300mg	DRUGBANK	DB05246	C12H13NO2	small molecule	N03AD03	77-41-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJXPJJZHWIXJCJ-UHFFFAOYSA-N
24295	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Wang G (2008)	19005061	177136	5025	Methsuximide	Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine	celontin|celontin cap 300mg	DRUGBANK	DB05246	C12H13NO2	small molecule	N03AD03	77-41-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJXPJJZHWIXJCJ-UHFFFAOYSA-N
24296	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Coulter DA (1989)	2545161	181655	5025	Methsuximide	Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine	celontin|celontin cap 300mg	DRUGBANK	DB05246	C12H13NO2	small molecule	N03AD03	77-41-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJXPJJZHWIXJCJ-UHFFFAOYSA-N
24297	114427	8913	-	CACNA1G	Ca(V)T.1|Cav3.1|NBR13	9606	Homo sapiens	inhibitor	target	Matthews EA (2001)	11274992	177138	5025	Methsuximide	Mesuximidum|Celontin|1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione|Alpha-methyl-alpha-phenyl n-methyl succinimide|Methsuximid|Metsuccimide|N,2-Dimethyl-2-phenylsuccinimide|1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione|Mesuximida|Mesuximide|Alpha-methylphensuximide|(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion|N-methyl-alpha-methyl-alpha-phenylsuccinimide|Metosuccimmide|1,3-Dimethyl-3-phenylsuccinimide|1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine	celontin|celontin cap 300mg	DRUGBANK	DB05246	C12H13NO2	small molecule	N03AD03	77-41-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJXPJJZHWIXJCJ-UHFFFAOYSA-N
24298	109368	3123	XXbac-BPG161M6.1	HLA-DRB1	DRB1|DRw10|HLA-DR1B|HLA-DRB|SS1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	5037	Glatiramer Acetate	Copoylmer 1|COP-1|Copolymer-1	teva-glatiramer acetate|glatop	DRUGBANK	DB05259	C254H422N70O72	biologic	L03AX13	147245-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24299	109368	3123	XXbac-BPG161M6.1	HLA-DRB1	DRB1|DRw10|HLA-DR1B|HLA-DRB|SS1	9606	Homo sapiens	binder	target	Arnon R (2004)	15371592	181863	5037	Glatiramer Acetate	Copoylmer 1|COP-1|Copolymer-1	teva-glatiramer acetate|glatop	DRUGBANK	DB05259	C254H422N70O72	biologic	L03AX13	147245-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24300	107009	526	-	ATP6V1B2	ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2	9606	Homo sapiens	inhibitor	target	Bockman R (2003)	12776254	181817	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24301	107009	526	-	ATP6V1B2	ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2	9606	Homo sapiens	inhibitor	target	Jakupec MA (2004)	15206110	181852	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24302	107009	526	-	ATP6V1B2	ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2	9606	Homo sapiens	inhibitor	target	Mattsson JP (1997)	9144341	181717	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24303	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	antagonist	target	Eby G (2005)	16122880	181906	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24304	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	antagonist	target	Jenis LG (1993)	8366144	181697	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24305	107101	632	RP11-54H19.5	BGLAP	BGP|OC|OCN	9606	Homo sapiens	antagonist	target	Guidon PT (1993)	8381250	181698	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24306	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Narasimhan J (1992)	1335254	181637	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24307	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Chitambar CR (2004)	15651176	181878	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24308	112155	6241	-	RRM2	R2|RR2|RR2M	9606	Homo sapiens	inhibitor	target	Straus DJ (2003)	12776257	181818	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24309	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Baldus S (2005)	16214034	181912	5039	Oxypurinol	DHPP|6-hydroxy allopurinol|Oxoallopurinol|Oxipurinolum|1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol|Oxipurinol|1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione|Alloxanthine|Oxyprim|metabolite of allopurinol|Alloxanthin	-	DRUGBANK	DB05262	C5H4N4O2	small molecule	-	2465-59-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXNFUBHNUDHIGC-UHFFFAOYSA-N
24310	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	unknown	target	Iwanaga T (2005)	16135657	181909	5039	Oxypurinol	DHPP|6-hydroxy allopurinol|Oxoallopurinol|Oxipurinolum|1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol|Oxipurinol|1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione|Alloxanthine|Oxyprim|metabolite of allopurinol|Alloxanthin	-	DRUGBANK	DB05262	C5H4N4O2	small molecule	-	2465-59-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXNFUBHNUDHIGC-UHFFFAOYSA-N
24311	107826	1439	CITF22-45C1.4	CSF2RB	CD131|CDw131|IL3RB|IL5RB|SMDP5	9606	Homo sapiens	unknown	target	Bhol KC (2007)	17436088	182002	5041	NPI 32101	-	-	DRUGBANK	DB05264	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24312	125848	124056	-	NOXO1	P41NOX|P41NOXA|P41NOXB|P41NOXC|SH3PXD5|SNX28	9606	Homo sapiens	antagonist	target	Kusumoto K (2005)	15458921	181865	5042	Ecabet	Ecabet sodium|Ecabet	-	DRUGBANK	DB05265	C20H28O5S	small molecule	-	33159-27-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWCWQNVIUXZOMJ-MISYRCLQSA-N
24313	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Yamazaki T (2011)	21036126	182173	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24314	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24315	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Yagi K (2010)	20124930	182144	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24316	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24317	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24318	111169	5143	-	PDE4C	DPDE1	9606	Homo sapiens	inhibitor	target	Huang Z (2006)	16313925	179103	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24319	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Yamazaki T (2011)	21036126	182173	5043	Ibudilast	Ke tas|3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Ibudilast|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|Ketas|Ibudilastum|AV-411|Tocris-1694|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|MN-166|Eyevinal	-	DRUGBANK	DB05266	C14H18N2O	small molecule	R03DC04	50847-11-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJVFLBOZORBYFE-UHFFFAOYSA-N
24320	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24321	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24322	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24323	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24324	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Scheller D (2009)	18704368	182084	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24325	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Scheller D (2009)	18704368	182084	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24326	108150	1816	-	DRD5	DBDR|DRD1B|DRD1L2	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24327	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24328	110636	4540	-	ND5	MTND5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5147	molecular iodine	-	-	DRUGBANK	DB05382	I2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNDPGZBMCMUPRI-UHFFFAOYSA-N
24329	109414	3172	RP5-1013A22.1	HNF4A	FRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5210	AVI-4557	-	-	DRUGBANK	DB05447	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24330	113147	7296	-	TXNRD1	GRIM-12|TR|TR1|TRXR1|TXNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5211	PX-12	1-methylpropyl 2-imidazolyl disulfide	-	DRUGBANK	DB05448	C7H12N2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPBPYQWMFCTCNG-UHFFFAOYSA-N
24331	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5222	TLK-199	-	-	DRUGBANK	DB05460	C27H35N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GWEJFLVSOGNLSS-WPFOTENUSA-N
24332	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5229	R667	-	-	DRUGBANK	DB05467	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24333	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5250	99mTc-ciprofloxacin	-	-	DRUGBANK	DB05488	C17H18FN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
24334	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5264	NM-702	-	-	DRUGBANK	DB05505	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24335	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Walker J (2004)	15562618	181872	5274	Sodium stibogluconate	Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate|Antimony (v) derivative OF sodium gluconate|Sodium stibogluconate|Stibinol|Stibogluconate de sodium|Estibogluconato sodico|Myostibin|Natrii stibogluconas|Stibanose|Stibanate|Stibatin|Antimony sodium gluconate|Pentostam	-	DRUGBANK	DB05630	C12H35Na3O26Sb2	small molecule	P01CB02	16037-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQDGWZZYGYKDLR-UZVLBLASSA-K
24336	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Chakraborty AK (1988)	2835038	181661	5274	Sodium stibogluconate	Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate|Antimony (v) derivative OF sodium gluconate|Sodium stibogluconate|Stibinol|Stibogluconate de sodium|Estibogluconato sodico|Myostibin|Natrii stibogluconas|Stibanose|Stibanate|Stibatin|Antimony sodium gluconate|Pentostam	-	DRUGBANK	DB05630	C12H35Na3O26Sb2	small molecule	P01CB02	16037-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQDGWZZYGYKDLR-UZVLBLASSA-K
24337	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	5274	Sodium stibogluconate	Trisodium 1-{[3-carboxylato-5-(1,2-dihydroxyethyl)-1-hydroxy-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]hept-1-yl]oxy}-5-(1,2-dihydroxyethyl)-1-oxido-2,6,7-trioxa-1lambda(5)-stibabicyclo[2.2.1]heptane-3-carboxylate nonahydrate|Antimony (v) derivative OF sodium gluconate|Sodium stibogluconate|Stibinol|Stibogluconate de sodium|Estibogluconato sodico|Myostibin|Natrii stibogluconas|Stibanose|Stibanate|Stibatin|Antimony sodium gluconate|Pentostam	-	DRUGBANK	DB05630	C12H35Na3O26Sb2	small molecule	P01CB02	16037-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQDGWZZYGYKDLR-UZVLBLASSA-K
24338	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	unknown	target	Beckers T (2007)	17455259	182004	5277	MGCD-0103	MGCD0103	-	DRUGBANK	DB05651	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24339	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	unknown	target	Khan N (2008)	17868033	182049	5277	MGCD-0103	MGCD0103	-	DRUGBANK	DB05651	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24340	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	unknown	target	Khan N (2008)	17868033	182049	5277	MGCD-0103	MGCD0103	-	DRUGBANK	DB05651	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24341	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	unknown	target	Beckers T (2007)	17455259	182004	5277	MGCD-0103	MGCD0103	-	DRUGBANK	DB05651	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24342	108960	2693	-	GHSR	-	9606	Homo sapiens	unknown	target	Venkova K (2007)	17436082	182001	5281	TZP-101	-	-	DRUGBANK	DB05657	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24343	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Spuentrup E (2007)	17948194	182058	5287	EP-2104R	EP 2104R	-	DRUGBANK	DB05675	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24344	108534	2243	-	FGA	Fib2	9606	Homo sapiens	unknown	target	Spuentrup E (2007)	17620942	182028	5287	EP-2104R	EP 2104R	-	DRUGBANK	DB05675	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24345	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	unknown	target	Wittig BM (2007)	17979029	182059	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24346	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	unknown	target	Reddy M (2007)	17761156	182044	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24347	107438	1003	-	CDH5	7B4|CD144	9606	Homo sapiens	unknown	target	Atar D (2006)	17019083	181970	5289	FX06	-	-	DRUGBANK	DB05685	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24348	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Pavlov VA (2007)	17334244	181992	5295	GTS-21	Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine	-	DRUGBANK	DB05708	C19H20N2O2	small molecule	-	148372-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPYWXZCFYPVCNQ-RVDMUPIBSA-N
24349	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Kim SW (2007)	17591554	182021	5295	GTS-21	Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine	-	DRUGBANK	DB05708	C19H20N2O2	small molecule	-	148372-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPYWXZCFYPVCNQ-RVDMUPIBSA-N
24350	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Stokes C (2004)	15213292	181853	5295	GTS-21	Dimethoxybenzylidene anabaseine|DMXB-Anabaseine|DMXB-A|3-(2,4-dimethoxybenzylidene)anabaseine	-	DRUGBANK	DB05708	C19H20N2O2	small molecule	-	148372-04-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPYWXZCFYPVCNQ-RVDMUPIBSA-N
24351	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	unknown	target	McEachern KA (2007)	17509920	182011	5299	Genz-112638	-	-	DRUGBANK	DB05715	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24352	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Lewis Phillips GD (2008)	19010901	182091	5339	Trastuzumab emtansine	T-DM1|Ado-trastuzumab emtansine|Trastuzumab-DM1|Ado-trastuzumab|Trastuzumab emtansine|Trastuzumab-MCC-DM1	kadcyla	DRUGBANK	DB05773	-	biologic	L01XC14	1018448-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24353	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Chen X (2002)	11752352	171740	5339	Trastuzumab emtansine	T-DM1|Ado-trastuzumab emtansine|Trastuzumab-DM1|Ado-trastuzumab|Trastuzumab emtansine|Trastuzumab-MCC-DM1	kadcyla	DRUGBANK	DB05773	-	biologic	L01XC14	1018448-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24354	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Barginear MF (2012)	23196784	182221	5339	Trastuzumab emtansine	T-DM1|Ado-trastuzumab emtansine|Trastuzumab-DM1|Ado-trastuzumab|Trastuzumab emtansine|Trastuzumab-MCC-DM1	kadcyla	DRUGBANK	DB05773	-	biologic	L01XC14	1018448-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24355	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5348	LGD-1550	-	-	DRUGBANK	DB05785	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24356	107958	1586	RP11-753C18.1	CYP17A1	CPT7|CYP17|P450C17|S17AH	9606	Homo sapiens	inhibitor	target	Vogiatzi P (2010)	20645691	182160	5374	Abiraterone	17-(3-Pyridyl)androsta-5,16-dien-3beta-ol|(3)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol	zytiga	DRUGBANK	DB05812	C24H31NO	small molecule	L02BX03	154229-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZOSMCIZMLWJML-VJLLXTKPSA-N
24357	111718	5746	-	PTH2R	PTHR2	9606	Homo sapiens	activator	target	Jin L (2000)	10837469	181751	5390	Parathyroid hormone	PTH(1-84)|parathyroid hormone (1-84) human recombinant|PTH|hPTH|Parathyrin|Preotact|Parathormone (human recombinant)|rhPTH|Parathyroid hormone|parathyroid hormone (rDNA)|rPTH|rhPTH(1-84)|hPTH(1-84)|rPTH(1-84)|Parathormone	natpara (parathyroid hormone)	DRUGBANK	DB05829	C408H674N126O126S2	biologic	H05AA03	9002-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24358	111717	5745	-	PTH1R	PFE|PTHR|PTHR1	9606	Homo sapiens	activator	target	Jin L (2000)	10837469	181751	5390	Parathyroid hormone	PTH(1-84)|parathyroid hormone (1-84) human recombinant|PTH|hPTH|Parathyrin|Preotact|Parathormone (human recombinant)|rhPTH|Parathyroid hormone|parathyroid hormone (rDNA)|rPTH|rhPTH(1-84)|hPTH(1-84)|rPTH(1-84)|Parathormone	natpara (parathyroid hormone)	DRUGBANK	DB05829	C408H674N126O126S2	biologic	H05AA03	9002-64-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24359	109790	3576	-	CXCL8	GCP-1|GCP1|IL8|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1	9606	Homo sapiens	antagonist	target	Spoettl T (2007)	16715250	181946	5414	Rivanicline	(3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine|(E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine|(E)-metanicotine|N-methyl-4-(3-pyridinyl)-(3E)-3-buten-1-amine|trans-metanicotine	-	DRUGBANK	DB05855	C10H14N2	small molecule	-	15585-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUOSGGQXEBBCJB-GORDUTHDSA-N
24360	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	unknown	target	Li X (2002)	12170059	181799	5414	Rivanicline	(3E)-N-methyl-4-(pyridin-3-yl)but-3-en-1-amine|(E)-N-Methyl-4-(3-pyridinyl)-3-butene-1-amine|(E)-metanicotine|N-methyl-4-(3-pyridinyl)-(3E)-3-buten-1-amine|trans-metanicotine	-	DRUGBANK	DB05855	C10H14N2	small molecule	-	15585-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUOSGGQXEBBCJB-GORDUTHDSA-N
24361	114389	8869	UNQ2510/PRO5998	ST3GAL5	SATI|SIAT9|SIATGM3S|ST3GalV	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5426	99mTc-14 F7 Mab	-	-	DRUGBANK	DB05867	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24362	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	inhibitor	target	Albert JS (2009)	21544959	182186	5500	CTS-21166	-	-	DRUGBANK	DB06073	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24363	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	inhibitor	target	Panza F (2009)	19655822	182121	5500	CTS-21166	-	-	DRUGBANK	DB06073	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24364	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Pouzet B (2002)	11888555	181790	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24365	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Mork A (2009)	19506838	182111	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24366	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cincotta SL (2010)	20856607	182166	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24367	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24368	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Mork A (2009)	19506838	182111	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24369	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24370	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2008)	18293356	182066	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24371	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Hietala J (2001)	11594443	181778	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24372	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	unknown	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24373	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	unknown	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24374	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	unknown	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24375	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Hietala J (2001)	11594443	181778	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24376	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24377	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Schreiber R (1994)	7530204	181683	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24378	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Hietala J (2001)	11594443	181778	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24379	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24380	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Kang J (2001)	11511086	180131	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24381	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Tang W (2001)	11689132	181779	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24382	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Rampe D (1998)	9694935	181731	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24383	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Olianas MC (2012)	22708686	182204	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24384	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Grinshpoon A (2000)	11004734	181762	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24385	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Nowak JZ (1983)	6302549	181677	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24386	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Csaba G (2003)	12967590	181830	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24387	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24388	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24389	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Grinshpoon A (2000)	11004734	181762	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24390	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Lucchelli A (2000)	10997731	175186	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24391	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	binder	target	Tatsumi M (1997)	9537821	174430	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24392	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Terai M (1989)	2576228	181658	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24393	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Dekeyne A (2006)	16814817	181951	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24394	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Grinshpoon A (2000)	11004734	181762	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24395	117179	23657	-	SLC7A11	CCBR1|xCT	9606	Homo sapiens	activator	target	Dean O (2011)	21118657	182180	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24396	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24397	106610	95	-	ACY1	ACY-1|ACY1D|HEL-S-5	9606	Homo sapiens	ligand	target	Uttamsingh V (1998)	9671543	181730	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24398	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24399	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24400	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24401	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24402	107569	1147	-	CHUK	IKBKA|IKK-alpha|IKK1|IKKA|NFKBIKA|TCF16	9606	Homo sapiens	inhibitor	target	Oka S (2000)	10788610	181749	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24403	109192	2937	-	GSS	GSHS|HEL-S-64p|HEL-S-88n	9606	Homo sapiens	stimulator	target	Martensson J (1989)	2502672	181653	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24404	109767	3551	-	IKBKB	IKK-beta|IKK2|IKKB|IMD15|NFKBIKB	9606	Homo sapiens	inhibitor	target	Oka S (2000)	10788610	181749	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24405	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5520	Rimonabant	-	-	DRUGBANK	DB06155	C22H21Cl3N4O	small molecule	A08AX01	168273-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZCPYUJPEARBJL-UHFFFAOYSA-N
24406	107668	1268	RP1-23D17.1	CNR1	CANN6|CB-R|CB1|CB1A|CB1K5|CB1R|CNR	9606	Homo sapiens	antagonist	target	Shire D (1996)	8636122	181704	5520	Rimonabant	-	-	DRUGBANK	DB06155	C22H21Cl3N4O	small molecule	A08AX01	168273-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZCPYUJPEARBJL-UHFFFAOYSA-N
24407	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Church LD (2009)	19169963	182096	5521	Canakinumab	ACZ-885|ACZ885	ilaris	DRUGBANK	DB06168	C6452H9958N1722O2010S42	biologic	L04AC08	914613-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24408	107875	1493	-	CTLA4	ALPS5|CD|CD152|CELIAC3|CTLA-4|GRD4|GSE|IDDM12	9606	Homo sapiens	unknown	target	Yang JC (2007)	18049334	182061	5522	Ipilimumab	MDX-010|MDX-101|MOAB-CTLA-4|MDX-CTLA-4	yervoy	DRUGBANK	DB06186	C6572H10126N1734O2080S40	biologic	L01XC11	477202-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24409	107093	624	-	BDKRB2	B2R|BK-2|BK2|BKR2|BRB2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5524	Icatibant	HOE 140	firazyr	DRUGBANK	DB06196	C59H89N19O13S	small molecule	B06AC02	130308-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QURWXBZNHXJZBE-MCDGZUPGSA-N
24410	107093	624	-	BDKRB2	B2R|BK-2|BK2|BKR2|BRB2	9606	Homo sapiens	antagonist	target	Privitera PJ (2003)	14514033	181835	5524	Icatibant	HOE 140	firazyr	DRUGBANK	DB06196	C59H89N19O13S	small molecule	B06AC02	130308-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QURWXBZNHXJZBE-MCDGZUPGSA-N
24411	106787	290	-	ANPEP	APN|CD13|GP150|LAP1|P150|PEPN	9606	Homo sapiens	inhibitor	target	Bawolak MT (2006)	17026984	181971	5524	Icatibant	HOE 140	firazyr	DRUGBANK	DB06196	C59H89N19O13S	small molecule	B06AC02	130308-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QURWXBZNHXJZBE-MCDGZUPGSA-N
24412	112239	6335	-	SCN9A	ETHA|FEB3B|GEFSP7|HSAN2D|NE-NA|NENA|Nav1.7|PN1|SFNP	9606	Homo sapiens	modulator	target	Suter MR (2013)	23221868	182223	5525	Rufinamide	RUF 331|Xilep|Banzel	banzel	DRUGBANK	DB06201	C10H8F2N4O	small molecule	N03AF03	106308-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POGQSBRIGCQNEG-UHFFFAOYSA-N
24413	109172	2915	-	GRM5	GPRC1E|MGLUR5|PPP1R86|mGlu5	9606	Homo sapiens	inhibitor	target	Wier HA (2011)	21351809	182185	5525	Rufinamide	RUF 331|Xilep|Banzel	banzel	DRUGBANK	DB06201	C10H8F2N4O	small molecule	N03AF03	106308-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POGQSBRIGCQNEG-UHFFFAOYSA-N
24414	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5527	Tapentadol	CG-5503|BN-200|Nucynta|Tapentadol	nucynta ir|nucynta extended-re	DRUGBANK	DB06204	C14H23NO	small molecule	N02AX06	175591-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTWDQCKEHXFFR-SMDDNHRTSA-N
24415	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tzschentke TM (2007)	17656655	182030	5527	Tapentadol	CG-5503|BN-200|Nucynta|Tapentadol	nucynta ir|nucynta extended-re	DRUGBANK	DB06204	C14H23NO	small molecule	N02AX06	175591-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTWDQCKEHXFFR-SMDDNHRTSA-N
24416	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5527	Tapentadol	CG-5503|BN-200|Nucynta|Tapentadol	nucynta ir|nucynta extended-re	DRUGBANK	DB06204	C14H23NO	small molecule	N02AX06	175591-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTWDQCKEHXFFR-SMDDNHRTSA-N
24417	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Raffa RB (2012)	22698264	182203	5527	Tapentadol	CG-5503|BN-200|Nucynta|Tapentadol	nucynta ir|nucynta extended-re	DRUGBANK	DB06204	C14H23NO	small molecule	N02AX06	175591-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTWDQCKEHXFFR-SMDDNHRTSA-N
24418	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	5527	Tapentadol	CG-5503|BN-200|Nucynta|Tapentadol	nucynta ir|nucynta extended-re	DRUGBANK	DB06204	C14H23NO	small molecule	N02AX06	175591-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTWDQCKEHXFFR-SMDDNHRTSA-N
24419	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5527	Tapentadol	CG-5503|BN-200|Nucynta|Tapentadol	nucynta ir|nucynta extended-re	DRUGBANK	DB06204	C14H23NO	small molecule	N02AX06	175591-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTWDQCKEHXFFR-SMDDNHRTSA-N
24420	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Lepor H (2010)	21114397	182179	5528	Silodosin	Rapaflo|KMD 3213|Urief|KAD 3213	rapaflo	DRUGBANK	DB06207	C25H32F3N3O4	small molecule	G04CA04	160970-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNCPYILNMDWPEY-QGZVFWFLSA-N
24421	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Lepor H (2010)	21114397	182179	5528	Silodosin	Rapaflo|KMD 3213|Urief|KAD 3213	rapaflo	DRUGBANK	DB06207	C25H32F3N3O4	small molecule	G04CA04	160970-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNCPYILNMDWPEY-QGZVFWFLSA-N
24422	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5528	Silodosin	Rapaflo|KMD 3213|Urief|KAD 3213	rapaflo	DRUGBANK	DB06207	C25H32F3N3O4	small molecule	G04CA04	160970-54-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNCPYILNMDWPEY-QGZVFWFLSA-N
24423	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	antagonist	target	Dovlatova NL (2008)	18485086	182077	5529	Prasugrel	Effient|Prasugrel	effient	DRUGBANK	DB06209	C20H20FNO3S	small molecule	B01AC22	150322-43-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTGLZDAWLRGWQN-UHFFFAOYSA-N
24424	110492	4352	RP1-92O14.1	MPL	C-MPL|CD110|MPLV|THCYT2|TPOR	9606	Homo sapiens	agonist	target	Kuter DJ (2009)	19642221	182120	5530	Eltrombopag	Promacta|Eltrombopagum|Eltrombopag	revolade|promacta	DRUGBANK	DB06210	C25H22N4O4	small molecule	B02BX05	496775-61-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDXWLKQMMKQXPV-QYQHSDTDSA-N
24425	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Aperis G (2011)	20868352	182167	5531	Tolvaptan	Samsca	samsca|jinarc	DRUGBANK	DB06212	C26H25ClN2O3	small molecule	C03XA01	150683-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYHCTFXIZSNGJT-XMMPIXPASA-N
24426	107035	554	-	AVPR2	ADHR|DI1|DIR|DIR3|NDI|V2R	9606	Homo sapiens	antagonist	target	Dixon MB (2008)	19337422	182101	5531	Tolvaptan	Samsca	samsca|jinarc	DRUGBANK	DB06212	C26H25ClN2O3	small molecule	C03XA01	150683-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYHCTFXIZSNGJT-XMMPIXPASA-N
24427	107033	552	-	AVPR1A	AVPR V1a|AVPR1|V1aR	9606	Homo sapiens	antagonist	target	Nemerovski C (2010)	20637957	182159	5531	Tolvaptan	Samsca	samsca|jinarc	DRUGBANK	DB06212	C26H25ClN2O3	small molecule	C03XA01	150683-30-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYHCTFXIZSNGJT-XMMPIXPASA-N
24428	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	agonist	target	Zoghbi GJ (2012)	22130964	182196	5532	Regadenoson	Regadenoson anhydrous	lexiscan	DRUGBANK	DB06213	C15H18N8O5	small molecule	C01EB21	313348-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZPZPHGJDAGEJZ-AKAIJSEGSA-N
24429	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24430	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24431	109594	3362	-	HTR6	5-HT6|5-HT6R	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24432	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24433	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24434	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24435	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Tadori Y (2011)	21658377	182191	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24436	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24437	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24438	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24439	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24440	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24441	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24442	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24443	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24444	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Tadori Y (2011)	21658377	182191	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24445	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24446	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24447	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24448	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24449	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24450	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24451	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24452	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24453	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24454	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24455	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24456	109593	3361	-	HTR5A	5-HT5A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24457	109593	3361	-	HTR5A	5-HT5A	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24458	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Fagiolini A (2013)	23356509	182227	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24459	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24460	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Fagiolini A (2013)	23356509	182227	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24461	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24462	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24463	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24464	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24465	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24466	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24467	108146	1812	-	DRD1	DADR|DRD1A	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24468	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24469	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24470	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24471	112233	6328	-	SCN3A	NAC3|Nav1.3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5534	Lacosamide	Erlosamide|SPM 927|Harkoseride|Vimpat	lacosamide|vimpat	DRUGBANK	DB06218	C13H18N2O3	small molecule	N03AX18	175481-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPPJLAIAVCUEMN-GFCCVEGCSA-N
24472	112240	6336	-	SCN10A	FEPS2|Nav1.8|PN3|SNS|hPN3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5534	Lacosamide	Erlosamide|SPM 927|Harkoseride|Vimpat	lacosamide|vimpat	DRUGBANK	DB06218	C13H18N2O3	small molecule	N03AX18	175481-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPPJLAIAVCUEMN-GFCCVEGCSA-N
24473	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	antagonist	target	Melillo SN (2010)	20424181	182152	5535	Rivaroxaban	Xarelto|BAY 59-7939|BAY59-7939	xarelto	DRUGBANK	DB06228	C19H18ClN3O5S	small molecule	B01AF01	366789-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFYHTZWPPHNLQ-AWEZNQCLSA-N
24474	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	antagonist	target	Ufer M (2010)	20135071	182145	5535	Rivaroxaban	Xarelto|BAY 59-7939|BAY59-7939	xarelto	DRUGBANK	DB06228	C19H18ClN3O5S	small molecule	B01AF01	366789-02-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFYHTZWPPHNLQ-AWEZNQCLSA-N
24475	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Kedia GT (2013)	23372609	182228	5536	Avanafil	(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide|Stendra|TA-1790	stendra	DRUGBANK	DB06237	C23H26ClN7O3	small molecule	G04BE10	330784-47-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEAJZXNPAWBCOA-INIZCTEOSA-N
24476	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24477	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24478	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24479	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Tarizzo VI (1994)	7969507	175564	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24480	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Sanders VM (1998)	9666280	175565	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24481	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24482	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Davis MP (2010)	21173850	182183	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24483	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Giovannoni MP (2009)	18680204	175590	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24484	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Du L (2010)	20412040	177674	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24485	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Bishop MJ (2007)	17266602	175573	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24486	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Burt RP (1996)	8825367	175572	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24487	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Senard JM (2001)	11482743	181774	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24488	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Lachnit WG (1997)	9138687	175574	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24489	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Rump LC (1995)	8590979	175575	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24490	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Davis MP (2010)	21173850	182183	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24491	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Giovannoni MP (2009)	18680204	175590	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24492	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Martinez A (1991)	1646718	175579	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24493	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Molinoff PB (1974)	4156788	175578	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24494	111090	5053	-	PAH	PH|PKU|PKU1	9606	Homo sapiens	inhibitor	target	Martinez A (1990)	2226440	175580	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24495	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Testa R (1995)	7674815	175584	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24496	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Kenny BA (1995)	7582530	175582	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24497	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Du L (2010)	20412040	177674	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24498	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Bishop MJ (2007)	17266602	175573	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24499	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24500	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24501	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Coman OA (2009)	19434307	182104	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24502	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24503	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	El-Armouche A (2009)	19110970	175562	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24504	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Gilsbach R (2007)	18064417	175563	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24505	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	agonist	target	Mersmann HJ (1998)	9464897	175567	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24506	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Davis MP (2010)	21173850	182183	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24507	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Nyroenen T (2001)	11306720	175591	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24508	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Giovannoni MP (2009)	18680204	175590	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24509	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Izzo NJ (1994)	8166240	175593	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24510	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Bishop MJ (2007)	17266602	175573	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24511	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Du L (2010)	20412040	177674	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24512	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Testa R (1995)	7773533	175592	5538	Droxidopa	L-Dihydroxyphenylserine|DOPS|L-threo-dihydroxyphenylserine|L-DOPS	northera	DRUGBANK	DB06262	C9H11NO5	small molecule	C01CA27	23651-95-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWYKJLNLSIPIN-JGVFFNPUSA-N
24513	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Gur S (2008)	18491987	182078	5539	Udenafil	DA-8159|Udenafil	-	DRUGBANK	DB06267	C25H36N6O4S	small molecule	G04BE11	268203-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYFNEFQTYQPVOC-UHFFFAOYSA-N
24514	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	5539	Udenafil	DA-8159|Udenafil	-	DRUGBANK	DB06267	C25H36N6O4S	small molecule	G04BE11	268203-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYFNEFQTYQPVOC-UHFFFAOYSA-N
24515	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Ahn GJ (2009)	19465935	182110	5539	Udenafil	DA-8159|Udenafil	-	DRUGBANK	DB06267	C25H36N6O4S	small molecule	G04BE11	268203-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYFNEFQTYQPVOC-UHFFFAOYSA-N
24516	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Kouvelas D (2009)	19860692	182131	5539	Udenafil	DA-8159|Udenafil	-	DRUGBANK	DB06267	C25H36N6O4S	small molecule	G04BE11	268203-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYFNEFQTYQPVOC-UHFFFAOYSA-N
24517	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	inhibitor	target	Zhao C (2011)	21054754	182174	5539	Udenafil	DA-8159|Udenafil	-	DRUGBANK	DB06267	C25H36N6O4S	small molecule	G04BE11	268203-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYFNEFQTYQPVOC-UHFFFAOYSA-N
24518	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kramp R (2001)	11704565	176862	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24519	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kiowski W (2001)	11447307	176863	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24520	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24521	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Sihvola RK (2002)	11849873	176861	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24522	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Martin C (2000)	10961375	176864	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24523	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Albertini M (2001)	11728166	176865	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24524	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Girgis RE (2007)	17472992	182007	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24525	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Richard V (1994)	7858879	176868	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24526	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Marano G (1998)	9806221	176869	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24527	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gardiner SM (1994)	7921608	176870	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24528	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24529	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Said SA (2005)	15629255	176866	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24530	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gupta SK (2005)	16335785	176867	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24531	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Girgis RE (2007)	17472992	182007	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24532	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Cosmi B (2003)	12818259	181821	5541	Sulodexide	-	-	DRUGBANK	DB06271	-	biologic	B01AB11	57821-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24533	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	5541	Sulodexide	-	-	DRUGBANK	DB06271	-	biologic	B01AB11	57821-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24534	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Harenberg J (1998)	9436179	181724	5541	Sulodexide	-	-	DRUGBANK	DB06271	-	biologic	B01AB11	57821-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24535	109303	3053	-	SERPIND1	D22S673|HC2|HCF2|HCII|HLS2|LS2|THPH10	9606	Homo sapiens	agonist	target	Cosmi B (2003)	12818259	181821	5541	Sulodexide	-	-	DRUGBANK	DB06271	-	biologic	B01AB11	57821-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24536	109784	3570	-	IL6R	CD126|IL-6R-1|IL-6RA|IL6Q|IL6RA|IL6RQ|gp80	9606	Homo sapiens	antibody	target	Smolen JS (2006)	16899109	181959	5542	Tocilizumab	Atlizumab|MRA|RoActemra	actemra	DRUGBANK	DB06273	C6428H9976N1720O2018S42	biologic	L04AC07	375823-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24537	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Beattie DT (2007)	17340127	181993	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24538	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Neary P (2005)	15882122	181890	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24539	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Beattie DT (2007)	17340127	181993	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24540	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Neary P (2005)	15882122	181890	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24541	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24542	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Saufl NM (2006)	16597533	181935	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24543	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Schmidt WK (2001)	11755894	181783	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24545	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Neary P (2005)	15882122	181890	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24546	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Kraft MD (2007)	17909271	182053	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
24547	111717	5745	-	PTH1R	PFE|PTHR|PTHR1	9606	Homo sapiens	binder	target	Chen X (2002)	11752352	171740	5544	Teriparatide	Teriparatide recombinant human	forteo	DRUGBANK	DB06285	C181H291N55O51S2	biologic	H05AA02	52232-67-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24548	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	5545	Temsirolimus	42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel	gd-temsirolimus|torisel	DRUGBANK	DB06287	C56H87NO16	small molecule	L01XE09	162635-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBPNZQVSJQDFBE-FUXHJELOSA-N
24549	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Radulovic S (2007)	17935273	182057	5545	Temsirolimus	42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel	gd-temsirolimus|torisel	DRUGBANK	DB06287	C56H87NO16	small molecule	L01XE09	162635-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBPNZQVSJQDFBE-FUXHJELOSA-N
24550	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor	target	Patard JJ (2008)	18265991	182064	5545	Temsirolimus	42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin|Torisel	gd-temsirolimus|torisel	DRUGBANK	DB06287	C56H87NO16	small molecule	L01XE09	162635-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBPNZQVSJQDFBE-FUXHJELOSA-N
24551	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Abbas AI (2009)	19337725	182102	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24552	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24553	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Horacek J (2006)	16696579	181941	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24554	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Rosenzweig P (2002)	12404702	181804	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24555	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24556	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Horacek J (2006)	16696579	181941	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24557	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Rosenzweig P (2002)	12404702	181804	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24558	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Tyson PJ (2004)	15204055	181851	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24559	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	antagonist	target	Obermeier M (2010)	19996149	182139	5548	Dapagliflozin	(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol	qtern|xigduo xr|farxiga|xigduo	DRUGBANK	DB06292	C21H25ClO6	small molecule	A10BD21|A10BD15|A10BX09	461432-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVHXJTBJCFBINQ-ADAARDCZSA-N
24560	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	inhibitor, competitive	target	Obermeier M (2010)	19996149	182139	5548	Dapagliflozin	(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol	qtern|xigduo xr|farxiga|xigduo	DRUGBANK	DB06292	C21H25ClO6	small molecule	A10BD21|A10BD15|A10BX09	461432-26-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVHXJTBJCFBINQ-ADAARDCZSA-N
24561	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Augeri DJ (2005)	16033281	181900	5549	Saxagliptin	BMS 477118|BMS-477118|(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile|Onglyza	kombiglyze xr|qtern|komboglyze	DRUGBANK	DB06335	C18H25N3O2	small molecule	A10BD10|A10BD21|A10BH03	361442-04-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGJUIPDUBHWZPV-SGTAVMJGSA-N
24562	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	antibody	target	Franklin MC (2004)	15093539	181845	5550	Pertuzumab	2C4 Antibody|MOAB 2C4|rhuMAb-2C4|Monoclonal Antibody 2C4|Omnitarg	perjeta|perjeta-herceptin	DRUGBANK	DB06366	-	biologic	L01XC13	380610-27-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24563	109768	3552	-	IL1A	IL-1A|IL1|IL1-ALPHA|IL1F1	9606	Homo sapiens	binder	target	Tran TH (2013)	23553601	182241	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24564	109768	3552	-	IL1A	IL-1A|IL1|IL1-ALPHA|IL1F1	9606	Homo sapiens	binder	target	Cronstein BN (2013)	23319019	182226	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24565	109772	3557	-	IL1RN	DIRA|ICIL-1RA|IL-1RN|IL-1ra|IL-1ra3|IL1F3|IL1RA|IRAP|MVCD4	9606	Homo sapiens	binder	target	Hawkins PN (2003)	12815153	181820	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24566	109772	3557	-	IL1RN	DIRA|ICIL-1RA|IL-1RN|IL-1ra|IL-1ra3|IL1F3|IL1RA|IRAP|MVCD4	9606	Homo sapiens	binder	target	Cronstein BN (2013)	23319019	182226	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24567	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Tran TH (2013)	23553601	182241	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24568	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Cronstein BN (2013)	23319019	182226	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24569	110205	4023	-	LPL	HDLCQ11|LIPD	9606	Homo sapiens	inhibitor	target	Sato K (1997)	9406449	181723	5554	Tyloxapol	-	-	DRUGBANK	DB06439	-	small molecule	R05CA01	25301-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UTFVNNPSMPINLE-UHFFFAOYSA-N
24570	110205	4023	-	LPL	HDLCQ11|LIPD	9606	Homo sapiens	inhibitor	target	Rodrigues B (1992)	1493594	181640	5554	Tyloxapol	-	-	DRUGBANK	DB06439	-	small molecule	R05CA01	25301-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UTFVNNPSMPINLE-UHFFFAOYSA-N
24571	110205	4023	-	LPL	HDLCQ11|LIPD	9606	Homo sapiens	inhibitor	target	Levine S (2006)	16839786	181953	5554	Tyloxapol	-	-	DRUGBANK	DB06439	-	small molecule	R05CA01	25301-02-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UTFVNNPSMPINLE-UHFFFAOYSA-N
24572	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	unknown	target	Sonpavde G (2007)	17288876	181986	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24573	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	inhibitor	target	Deeks ED (2012)	23072642	182214	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24574	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Sonpavde G (2007)	17288876	181986	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24575	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	inhibitor	target	Deeks ED (2012)	23072642	182214	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24576	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Sonpavde G (2007)	17288876	181986	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24577	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Sonpavde G (2007)	17288876	181986	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24578	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	inhibitor	target	Sonpavde G (2007)	17288876	181986	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24579	115336	10019	-	SH2B3	IDDM20|LNK	9606	Homo sapiens	inhibitor	target	Deeks ED (2012)	23072642	182214	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24580	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	inhibitor	target	Sonpavde G (2007)	17288876	181986	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24581	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	inhibitor	target	Deeks ED (2012)	23072642	182214	5557	Pazopanib	GW 78603|GW786034|Pazopanibum	votrient	DRUGBANK	DB06589	C21H23N7O2S	small molecule	L01XE11	444731-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUIHSIWYWATEQL-UHFFFAOYSA-N
24582	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Millan MJ (2005)	15289999	181857	5559	Agomelatine	Valdoxan	-	DRUGBANK	DB06594	C15H17NO2	small molecule	N06AX22	138112-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJYPHIXNFHFHND-UHFFFAOYSA-N
24583	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Millan MJ (2005)	15289999	181857	5559	Agomelatine	Valdoxan	-	DRUGBANK	DB06594	C15H17NO2	small molecule	N06AX22	138112-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJYPHIXNFHFHND-UHFFFAOYSA-N
24584	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Millan MJ (2005)	15289999	181857	5559	Agomelatine	Valdoxan	-	DRUGBANK	DB06594	C15H17NO2	small molecule	N06AX22	138112-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJYPHIXNFHFHND-UHFFFAOYSA-N
24585	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Harenberg J (2008)	18393142	182072	5560	Apixaban	apixabn|apixabanum	eliquis	DRUGBANK	DB06605	C25H25N5O4	small molecule	B01AF02	503612-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNZCBYKSOIHPEH-UHFFFAOYSA-N
24586	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Spyropoulos AC (2007)	17371192	181996	5560	Apixaban	apixabn|apixabanum	eliquis	DRUGBANK	DB06605	C25H25N5O4	small molecule	B01AF02	503612-47-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNZCBYKSOIHPEH-UHFFFAOYSA-N
24587	107268	818	RP11-574K11.6	CAMK2G	CAMK|CAMK-II|CAMKG	9606	Homo sapiens	inhibitor	target	Amsberg GK (2013)	23493838	182235	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
24588	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor	target	Remsing Rix LL (2009)	19039322	182092	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
24589	115969	10746	-	MAP3K2	MEKK2|MEKK2B	9606	Homo sapiens	inhibitor	target	Ahmad S (2013)	23134735	182217	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
24590	111591	5605	-	MAP2K2	CFC4|MAPKK2|MEK2|MKK2|PRKMK2	9606	Homo sapiens	inhibitor	target	Remsing Rix LL (2009)	19039322	182092	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
24591	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	inhibitor	target	Remsing Rix LL (2009)	19039322	182092	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
24592	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Swedberg MD (1988)	2901483	181665	5563	Flupirtine	Flupirtine	-	DRUGBANK	DB06623	C15H17FN4O2	small molecule	N02BG07	56995-20-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUUFBMODXQKSTD-UHFFFAOYSA-N
24593	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Cohen EE (2008)	18541897	182081	5564	Axitinib	-	inlyta	DRUGBANK	DB06626	-	small molecule	L01XE17	319460-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24594	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Cohen EE (2008)	18541897	182081	5564	Axitinib	-	inlyta	DRUGBANK	DB06626	-	small molecule	L01XE17	319460-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24595	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Cohen EE (2008)	18541897	182081	5564	Axitinib	-	inlyta	DRUGBANK	DB06626	-	small molecule	L01XE17	319460-85-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24596	109954	3752	RP4-773A18.7	KCND3	KCND3L|KCND3S|KSHIVB|KV4.3|SCA19|SCA22	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24597	109944	3742	-	KCNA6	HBK2|KV1.6|PPP1R96	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24598	109945	3743	-	KCNA7	HAK6|KV1.7	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24599	109940	3737	RP11-284N8.1	KCNA2	HBK5|HK4|HUKIV|KV1.2|MK2|NGK1|RBK2	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24600	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24601	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24602	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24603	109950	3748	-	KCNC3	KSHIIID|KV3.3|SCA13	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24604	109949	3747	-	KCNC2	KV3.2	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24605	109952	3750	-	KCND1	KV4.1	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24606	109947	3745	-	KCNB1	DRK1|EIEE26|KV2.1|h-DRK1	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24607	109946	3744	-	KCNA10	Kcn1|Kv1.8	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24608	109948	3746	-	KCNC1	KV3.1|KV4|NGK2	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24609	114724	9312	-	KCNB2	KV2.2	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24610	109942	3739	-	KCNA4	HBK4|HK1|HPCN2|HUKII|KCNA4L|KCNA8|KV1.4|PCN2	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24611	109953	3751	-	KCND2	KV4.2|RK5	9606	Homo sapiens	antagonist	target	Goodman AD (2013)	23184313	182218	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24612	114160	8600	RP11-86N24.2	TNFSF11	CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf	9606	Homo sapiens	antibody	target	Westenfeld R (2006)	16702197	181943	5566	Denosumab	-	prolia|xgeva	DRUGBANK	DB06643	C6404H9912N1724O2004S50	biologic	M05BX04	615258-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24613	114160	8600	RP11-86N24.2	TNFSF11	CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf	9606	Homo sapiens	antibody	target	Lipton A (2008)	18685421	182083	5566	Denosumab	-	prolia|xgeva	DRUGBANK	DB06643	C6404H9912N1724O2004S50	biologic	M05BX04	615258-40-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24614	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Larsen PJ (2008)	18333889	182069	5567	Liraglutide	NN-2211|Liraglutidum|N-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide|Victoza|NN2211|N-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide|NN 2211|Liraglutide recombinant|Arg34Lys26-(N--(-Glu(N--hexadecanoyl)))-GLP-1[7-37]|NNC 90-1170|Liraglutida	xultophy 100/3.6|saxenda|victo	DRUGBANK	DB06655	C172H265N43O51	biologic	A10BX07|A10AE56	204656-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24615	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Bock T (2003)	14678021	181841	5567	Liraglutide	NN-2211|Liraglutidum|N-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide|Victoza|NN2211|N-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide|NN 2211|Liraglutide recombinant|Arg34Lys26-(N--(-Glu(N--hexadecanoyl)))-GLP-1[7-37]|NNC 90-1170|Liraglutida	xultophy 100/3.6|saxenda|victo	DRUGBANK	DB06655	C172H265N43O51	biologic	A10BX07|A10AE56	204656-20-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24616	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Zatelli MC (2007)	17395978	181999	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24617	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	unknown	target	Bruns C (2002)	11980628	181791	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24618	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Zatelli MC (2007)	17395978	181999	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24619	112629	6751	-	SSTR1	SRIF-2|SS-1-R|SS1-R|SS1R	9606	Homo sapiens	unknown	target	Bruns C (2002)	11980628	181791	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24620	112630	6752	-	SSTR2	-	9606	Homo sapiens	unknown	target	Zatelli MC (2007)	17395978	181999	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24621	112630	6752	-	SSTR2	-	9606	Homo sapiens	unknown	target	Bruns C (2002)	11980628	181791	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24622	112631	6753	-	SSTR3	SS-3-R|SS3-R|SS3R|SSR-28	9606	Homo sapiens	unknown	target	Zatelli MC (2007)	17395978	181999	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24623	112631	6753	-	SSTR3	SS-3-R|SS3-R|SS3R|SSR-28	9606	Homo sapiens	unknown	target	Bruns C (2002)	11980628	181791	5568	Pasireotide	Pasireotidum|cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)|SOM 230|SOM-230|SOM230|Pasireotida	signifor lar|signifor	DRUGBANK	DB06663	C58H66N10O9	small molecule	H01CB05	396091-73-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMZMNAABQBOLAK-DBILLSOUSA-N
24624	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	antibody	target	Mittal M (2010)	21079302	182177	5569	Golimumab	-	simponi aria|simponi i.v.|simp	DRUGBANK	DB06674	C6530H10068N1752O2026S44	biologic	L04AB06	476181-74-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24625	107380	942	-	CD86	B7-2|B7.2|B70|CD28LG2|LAB72	9606	Homo sapiens	unknown	target	Vincenti F (2008)	18269922	182065	5570	Belatacept	BMS224818|BMS-224818|LEA29Y|CTLA4-Ig|LEA 29Y|CD152 antigen	nulojix	DRUGBANK	DB06681	C3508H5440N922O1096S32	biologic	L04AA28	706808-37-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24626	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	unknown	target	Yabu JM (2007)	17616278	182026	5570	Belatacept	BMS224818|BMS-224818|LEA29Y|CTLA4-Ig|LEA 29Y|CD152 antigen	nulojix	DRUGBANK	DB06681	C3508H5440N922O1096S32	biologic	L04AA28	706808-37-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24627	107379	941	-	CD80	B7|B7-1|B7.1|BB1|CD28LG|CD28LG1|LAB7	9606	Homo sapiens	unknown	target	Tedesco Silva H (2006)	16978033	181967	5570	Belatacept	BMS224818|BMS-224818|LEA29Y|CTLA4-Ig|LEA 29Y|CD152 antigen	nulojix	DRUGBANK	DB06681	C3508H5440N922O1096S32	biologic	L04AA28	706808-37-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24628	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Page ME (2002)	12183683	181802	5571	Vilazodone	Vilazodona|Vilazodonum	viibryd	DRUGBANK	DB06684	C26H27N5O2	small molecule	N06AX24	163521-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGEGOXDYSFKCPT-UHFFFAOYSA-N
24629	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Adamec R (2004)	15507223	181869	5571	Vilazodone	Vilazodona|Vilazodonum	viibryd	DRUGBANK	DB06684	C26H27N5O2	small molecule	N06AX24	163521-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGEGOXDYSFKCPT-UHFFFAOYSA-N
24630	108459	2161	-	F12	HAE3|HAEX|HAF	9606	Homo sapiens	activator	target	Takada K (1991)	1986546	181646	5572	Ethanolamine Oleate	Ethanolamine oleate|Monoethanolamine oleate|Oldamin|Ethamolin|beta-Hydroxyethylammonium oleate	ethanolamine oleate inj 50mg/m	DRUGBANK	DB06689	C20H41NO3	small molecule	C05BB01	2272-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGWDUNBJIMUFAP-KVVVOXFISA-N
24631	108459	2161	-	F12	HAE3|HAEX|HAF	9606	Homo sapiens	activator	target	Kang JH (1987)	3828735	181669	5572	Ethanolamine Oleate	Ethanolamine oleate|Monoethanolamine oleate|Oldamin|Ethamolin|beta-Hydroxyethylammonium oleate	ethanolamine oleate inj 50mg/m	DRUGBANK	DB06689	C20H41NO3	small molecule	C05BB01	2272-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGWDUNBJIMUFAP-KVVVOXFISA-N
24632	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Mojtahedin A (2009)	19552055	182115	5573	Mepyramine	Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine	caldomine dh enfant|midol pms 	DRUGBANK	DB06691	C17H23N3O	small molecule	R06AC01|D04AA02	91-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YECBIJXISLIIDS-UHFFFAOYSA-N
24633	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Snowman AM (1990)	1979798	176852	5573	Mepyramine	Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine	caldomine dh enfant|midol pms 	DRUGBANK	DB06691	C17H23N3O	small molecule	R06AC01|D04AA02	91-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YECBIJXISLIIDS-UHFFFAOYSA-N
24634	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Parsons ME (2006)	16402096	181925	5573	Mepyramine	Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine	caldomine dh enfant|midol pms 	DRUGBANK	DB06691	C17H23N3O	small molecule	R06AC01|D04AA02	91-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YECBIJXISLIIDS-UHFFFAOYSA-N
24635	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Chhabria MT (2009)	19537525	182113	5573	Mepyramine	Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine	caldomine dh enfant|midol pms 	DRUGBANK	DB06691	C17H23N3O	small molecule	R06AC01|D04AA02	91-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YECBIJXISLIIDS-UHFFFAOYSA-N
24636	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Moriyama K (2009)	19544046	182114	5573	Mepyramine	Mepyramine|pyrilamine|Pyranisamine|N-[(4-Methoxyphenyl)methyl]-n',n'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(P-Methoxybenzyl)-n',n'-dimethyl-N-(alpha-pyridyl)ethylenediamine|N',n'-dimethyl-N-(P-methoxybenzyl)-N-(2-pyridyl)ethylenediamine	caldomine dh enfant|midol pms 	DRUGBANK	DB06691	C17H23N3O	small molecule	R06AC01|D04AA02	91-84-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YECBIJXISLIIDS-UHFFFAOYSA-N
24637	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Mahdy AM (2004)	15277296	181856	5574	Aprotinin	Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine	trasylol|trasylol inj 10000 ki	DRUGBANK	DB06692	C284H432N84O79S7	biologic	B02AB01	9087-70-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24638	111356	5340	RP1-81D8.1	PLG	-	9606	Homo sapiens	unknown	target	Mahdy AM (2004)	15277296	181856	5574	Aprotinin	Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine	trasylol|trasylol inj 10000 ki	DRUGBANK	DB06692	C284H432N84O79S7	biologic	B02AB01	9087-70-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24639	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Mahdy AM (2004)	15277296	181856	5574	Aprotinin	Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine	trasylol|trasylol inj 10000 ki	DRUGBANK	DB06692	C284H432N84O79S7	biologic	B02AB01	9087-70-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24640	110016	3816	-	KLK1	KLKR|Klk6|hK1	9606	Homo sapiens	unknown	target	Mahdy AM (2004)	15277296	181856	5574	Aprotinin	Bovine Aprotinin|Trypsin Inhibitor, Pancreatic Basic|Bovine Pancreatic Trypsin Inhibitor|Fibrinolysis Inhibitor|BPTI|Aprotinin (bovine)|Aprotinin Concentrated Solution|Aprotinin Biosynthetic|Aprotinin Bovine	trasylol|trasylol inj 10000 ki	DRUGBANK	DB06692	C284H432N84O79S7	biologic	B02AB01	9087-70-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24641	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Kocarek TA (2002)	12433810	177513	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24642	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Liu L (2003)	12852453	177512	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24643	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Pappu AS (2003)	12677170	177515	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24644	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Stoebner PE (2003)	12671581	177514	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24645	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Cenedella RJ (2003)	12518039	177516	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24646	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24647	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	5575	Mevastatin	Compactin	-	DRUGBANK	DB06693	C23H34O5	small molecule	-	73573-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLFOPYRIVGYMJ-INTXDZFKSA-N
24648	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24649	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24650	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Yang HT (1996)	8894610	179193	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24651	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24652	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24653	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Petrusewicz J (1985)	2868542	181663	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24654	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24655	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5576	Xylometazoline	Balminil|Xylomethazoline	decongest nasal|otrivin medica	DRUGBANK	DB06694	C16H24N2	small molecule	R01AA07|R01AB06|S01GA53|S01GA03	526-36-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCJFAOMUPXHDK-UHFFFAOYSA-N
24656	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Liesenfeld KH (2006)	17061960	181973	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSGXQBZTULBEEQ-UHFFFAOYSA-N
24657	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Karthikeyan G (2010)	20424539	182153	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSGXQBZTULBEEQ-UHFFFAOYSA-N
24658	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Squizzato A (2009)	19756950	182126	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSGXQBZTULBEEQ-UHFFFAOYSA-N
24659	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Imming P (2006)	17016423	171742	5578	Arbekacin	Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin	-	DRUGBANK	DB06696	C22H44N6O10	small molecule	J01GB12	51025-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKKYBZZTJQGVCD-XTCKQBCOSA-N
24660	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Funatsu G (1977)	320034	181634	5578	Arbekacin	Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin	-	DRUGBANK	DB06696	C22H44N6O10	small molecule	J01GB12	51025-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKKYBZZTJQGVCD-XTCKQBCOSA-N
24661	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Overington JP (2006)	17139284	171741	5578	Arbekacin	Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin	-	DRUGBANK	DB06696	C22H44N6O10	small molecule	J01GB12	51025-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKKYBZZTJQGVCD-XTCKQBCOSA-N
24662	852156	947845	b3342	rpsL	ECK3329|JW3304|asuB|strA	511145	Escherichia coli	inhibitor	target	Carter AP (2000)	11014183	179093	5578	Arbekacin	Arbekacine|Habekacin|Arbekacina|ABK|Arbekacinum|Haberacin	-	DRUGBANK	DB06696	C22H44N6O10	small molecule	J01GB12	51025-85-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKKYBZZTJQGVCD-XTCKQBCOSA-N
24663	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Lacour M (2001)	11700150	181781	5580	Betahistine	2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine	pms-betahistine|serc 8 mg|teva	DRUGBANK	DB06698	C8H12N2	small molecule	N07CA01	5638-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUQMNUMQCIQDMZ-UHFFFAOYSA-N
24664	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	agonist	target	Barak N (2008)	18447604	182074	5580	Betahistine	2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine	pms-betahistine|serc 8 mg|teva	DRUGBANK	DB06698	C8H12N2	small molecule	N07CA01	5638-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUQMNUMQCIQDMZ-UHFFFAOYSA-N
24665	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	Lacour M (2001)	11700150	181781	5580	Betahistine	2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine	pms-betahistine|serc 8 mg|teva	DRUGBANK	DB06698	C8H12N2	small molecule	N07CA01	5638-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUQMNUMQCIQDMZ-UHFFFAOYSA-N
24666	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	Barak N (2008)	18447604	182074	5580	Betahistine	2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine	pms-betahistine|serc 8 mg|teva	DRUGBANK	DB06698	C8H12N2	small molecule	N07CA01	5638-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUQMNUMQCIQDMZ-UHFFFAOYSA-N
24667	116416	11255	-	HRH3	GPCR97|HH3R	9606	Homo sapiens	antagonist	target	Gbahou F (2010)	20530654	182156	5580	Betahistine	2-(beta-Methylaminoethyl)pyridine|Betahistina|Betahistinum|2-[2-(Methylamino)ethyl]pyridine|N-Methyl-2-(2-pyridinyl)ethanamine|[2-(2-Pyridyl)ethyl]methylamine|N-Methyl-2-pyridineethanamine	pms-betahistine|serc 8 mg|teva	DRUGBANK	DB06698	C8H12N2	small molecule	N07CA01	5638-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUQMNUMQCIQDMZ-UHFFFAOYSA-N
24668	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Anderson J (2009)	19450172	182106	5581	Degarelix	-	firmagon	DRUGBANK	DB06699	C82H103ClN18O16	small molecule	L02BX02	214766-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEUCPCLKGZSHTA-XYAYPHGZSA-N
24669	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Steinberg M (2010)	20110043	182143	5581	Degarelix	-	firmagon	DRUGBANK	DB06699	C82H103ClN18O16	small molecule	L02BX02	214766-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEUCPCLKGZSHTA-XYAYPHGZSA-N
24670	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Samant MP (2005)	15705170	181884	5581	Degarelix	-	firmagon	DRUGBANK	DB06699	C82H103ClN18O16	small molecule	L02BX02	214766-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEUCPCLKGZSHTA-XYAYPHGZSA-N
24671	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Kirby RS (2009)	20053189	171829	5581	Degarelix	-	firmagon	DRUGBANK	DB06699	C82H103ClN18O16	small molecule	L02BX02	214766-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEUCPCLKGZSHTA-XYAYPHGZSA-N
24672	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Deecher DC (2006)	16675639	181939	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24673	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Mason JN (2007)	17673606	182036	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24674	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Perry R (2009)	19698900	182124	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24675	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Reddy S (2010)	19919295	182134	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24676	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Kamath J (2008)	19086875	182093	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24677	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Liebowitz MR (2010)	20944767	182171	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24678	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Deecher DC (2006)	16675639	181939	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24679	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mason JN (2007)	17673606	182036	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24680	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Perry R (2009)	19698900	182124	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24681	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Reddy S (2010)	19919295	182134	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24682	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Kamath J (2008)	19086875	182093	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24683	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Liebowitz MR (2010)	20944767	182171	5582	Desvenlafaxine	O-desmethylvenlafaxine|Desvenlafaxine|ODV|Pristiq	pristiq extended release|prist	DRUGBANK	DB06700	C16H25NO2	small molecule	N06AX23	93413-62-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYYIDSXMWOZKMP-UHFFFAOYSA-N
24684	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Ding YS (1997)	9181638	181720	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24685	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Yang L (2004)	15322419	175959	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24686	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Gray JD (2007)	17611273	175958	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24687	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24688	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Markowitz JS (2008)	18480678	182076	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24689	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Tilley MR (2008)	18698001	175963	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24690	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Sandoval V (2001)	11160413	175960	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24691	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Chuhan YS (2006)	16246598	175961	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24692	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Davids E (2002)	11862378	181789	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24693	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Williard RL (2007)	17218796	175962	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24694	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Ding YS (1997)	9181638	181720	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24695	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24696	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Volkow ND (1999)	10025684	175966	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24697	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Izenwasser S (1999)	10414438	175967	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24698	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Wayment HK (1999)	10037500	175964	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24699	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Dresel SH (1999)	10199939	175965	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24700	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Markowitz JS (2008)	18480678	182076	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24701	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tilley MR (2008)	18698001	175963	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24702	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Davids E (2002)	11862378	181789	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24703	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24704	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Viggiano D (2004)	15303308	175968	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24705	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Volkow ND (1999)	10403500	175969	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24706	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Izenwasser S (1999)	10414438	175967	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24707	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Dresel SH (1999)	10199939	175965	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24708	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Stehouwer JS (2006)	17154506	175970	5583	Dexmethylphenidate	d-threo-methylphenidate|D-TMP|Dexmethylphenidate	dexmethylphenidate hydrochlori	DRUGBANK	DB06701	C14H19NO2	small molecule	N06BA11	40431-64-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUGOZIWVEXMGBE-CHWSQXEVSA-N
24709	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24710	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Nilvebrant L (2002)	12076307	181796	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24711	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24712	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24713	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Nilvebrant L (2002)	12076307	181796	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24714	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Mansfield KJ (2009)	19029429	181560	5584	Fesoterodine	FESO|Fesoterodine	toviaz	DRUGBANK	DB06702	C26H37NO3	small molecule	G04BD11	286930-02-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCCSDBARQIPTGU-HSZRJFAPSA-N
24715	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Parker EM (1988)	3129549	147713	5588	Isometheptene	Isometheptene	nodolor|prodrin|isometheptene 	DRUGBANK	DB06706	C9H19N	small molecule	A03AX10	503-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQUOJBERHHONY-UHFFFAOYSA-N
24716	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (1995)	7751968	174151	5588	Isometheptene	Isometheptene	nodolor|prodrin|isometheptene 	DRUGBANK	DB06706	C9H19N	small molecule	A03AX10	503-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQUOJBERHHONY-UHFFFAOYSA-N
24717	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Sulzer D (2005)	15955613	174152	5588	Isometheptene	Isometheptene	nodolor|prodrin|isometheptene 	DRUGBANK	DB06706	C9H19N	small molecule	A03AX10	503-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQUOJBERHHONY-UHFFFAOYSA-N
24718	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Valdivia LF (2004)	15094323	181847	5588	Isometheptene	Isometheptene	nodolor|prodrin|isometheptene 	DRUGBANK	DB06706	C9H19N	small molecule	A03AX10	503-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQUOJBERHHONY-UHFFFAOYSA-N
24719	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Parker EM (1988)	3129549	147713	5588	Isometheptene	Isometheptene	nodolor|prodrin|isometheptene 	DRUGBANK	DB06706	C9H19N	small molecule	A03AX10	503-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQUOJBERHHONY-UHFFFAOYSA-N
24720	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Valdivia LF (2004)	15094323	181847	5588	Isometheptene	Isometheptene	nodolor|prodrin|isometheptene 	DRUGBANK	DB06706	C9H19N	small molecule	A03AX10	503-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQUOJBERHHONY-UHFFFAOYSA-N
24721	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Habecker BA (2006)	16573647	175597	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24722	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Gutman DA (2006)	16989291	175596	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24723	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Mandela P (2006)	16879714	175595	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24724	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Boenisch H (2006)	16722247	175599	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24725	112421	6530	-	SLC6A2	NAT1|NET|NET1|SLC6A5	9606	Homo sapiens	inhibitor	target	Ksiazek P (2006)	17124432	175598	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24726	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Jastak JT (1983)	6355236	181678	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24727	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Yang HT (1996)	8894610	179193	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24728	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Hersh EV (2010)	20831932	182165	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
24729	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Liu T (2010)	19951374	182136	5591	Methacholine	Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh	methacholine omega|sterile pro	DRUGBANK	DB06709	C8H18NO2	small molecule	-	55-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZWOPGCLSHLLPA-UHFFFAOYSA-N
24730	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Fernandez-Rodriguez S (2010)	20347047	182149	5591	Methacholine	Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh	methacholine omega|sterile pro	DRUGBANK	DB06709	C8H18NO2	small molecule	-	55-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZWOPGCLSHLLPA-UHFFFAOYSA-N
24731	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Liu PS (2011)	20888332	182169	5591	Methacholine	Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh	methacholine omega|sterile pro	DRUGBANK	DB06709	C8H18NO2	small molecule	-	55-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZWOPGCLSHLLPA-UHFFFAOYSA-N
24732	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	agonist	target	Gosens R (2009)	19460789	182107	5591	Methacholine	Methacholine|Acetyl-beta-methylcholine|Acetylmethylcholine|MCh	methacholine omega|sterile pro	DRUGBANK	DB06709	C8H18NO2	small molecule	-	55-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZWOPGCLSHLLPA-UHFFFAOYSA-N
24733	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Small EJ (2006)	17084172	177399	5592	Methyltestosterone	17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android	methitest|eemt hs|esterified e	DRUGBANK	DB06710	C20H30O2	small molecule	G03EA01|G03EK01|G03BA02	58-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKMFJBGXUYNAG-HLXURNFRSA-N
24734	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Omwancha J (2006)	17086931	177398	5592	Methyltestosterone	17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android	methitest|eemt hs|esterified e	DRUGBANK	DB06710	C20H30O2	small molecule	G03EA01|G03EK01|G03BA02	58-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKMFJBGXUYNAG-HLXURNFRSA-N
24735	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	5592	Methyltestosterone	17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android	methitest|eemt hs|esterified e	DRUGBANK	DB06710	C20H30O2	small molecule	G03EA01|G03EK01|G03BA02	58-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKMFJBGXUYNAG-HLXURNFRSA-N
24736	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Maudsley S (2007)	17202804	177400	5592	Methyltestosterone	17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android	methitest|eemt hs|esterified e	DRUGBANK	DB06710	C20H30O2	small molecule	G03EA01|G03EK01|G03BA02	58-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKMFJBGXUYNAG-HLXURNFRSA-N
24737	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Lapauw B (2007)	17322500	177397	5592	Methyltestosterone	17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android	methitest|eemt hs|esterified e	DRUGBANK	DB06710	C20H30O2	small molecule	G03EA01|G03EK01|G03BA02	58-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKMFJBGXUYNAG-HLXURNFRSA-N
24738	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Petraki CD (2007)	17128417	177401	5592	Methyltestosterone	17-methyltestosterone|Methyltestosteronum|NSC-9701|Testred|4-Androstene-17alpha-methyl-17beta-ol-3-one|17-beta-Hydroxy-17-methylandrost-4-en-3-one|17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one|17alpha-Methyltestosterone|Metiltestosterona|17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one|Virilon|17beta-Hydroxy-17-methylandrost-4-en-3-one|Methyltestosterone|17-methyl-4-androsten-17-ol-3-one|17-methyltestosterone|17alpha-Methyl-3-oxo-4-androsten-17beta-ol|Android	methitest|eemt hs|esterified e	DRUGBANK	DB06710	C20H30O2	small molecule	G03EA01|G03EK01|G03BA02	58-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCKMFJBGXUYNAG-HLXURNFRSA-N
24739	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Fukushima H (2008)	17852165	182048	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24740	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Piletz JE (1996)	8930173	177889	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24741	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	agonist	target	Ogidigben MJ (2001)	11180982	181768	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24742	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Hrometz SL (1999)	10381812	181737	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24743	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Kai T (1999)	10459292	181739	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24744	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Leonardi A (2005)	16083326	181903	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24745	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Bogacka E (1999)	10481510	181740	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24746	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Piletz JE (1996)	8930173	177889	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24747	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Ogidigben MJ (2001)	11180982	181768	5593	Naphazoline	Nafazolin	blue collyrium|odan-naphazolin	DRUGBANK	DB06711	C14H14N2	small molecule	S01GA51|S01GA01|R01AA08|R01AB02	835-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNIIGCLFLJGOGP-UHFFFAOYSA-N
24748	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Rosenthal J (1994)	7898101	181689	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24749	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Honerjaeger P (1992)	1283184	181636	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24750	107237	783	RP11-383B4.2	CACNB2	CACNLB2|CAVB2|MYSB	9606	Homo sapiens	inhibitor	target	Araie M (2011)	20933604	182170	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24751	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	inhibitor	target	Peterson BZ (2006)	16675661	174772	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24752	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24753	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Araie M (2011)	20933604	182170	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24754	107235	781	H_DJ0560O14.1	CACNA2D1	CACNA2|CACNL2A|CCHL2A|LINC01112|lncRNA-N3	9606	Homo sapiens	inhibitor	target	Li GR (2006)	16484345	180227	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24755	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Rosenthal J (1994)	7898101	181689	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24756	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Morel N (1998)	9846638	175854	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24757	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	inhibitor	target	Sinnegger-Brauns MJ (2009)	19029287	174777	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24758	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Miyashita Y (2010)	20097194	175689	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24759	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Ogihara T (2009)	19634509	175694	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24760	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Murakami M (2001)	11426839	175690	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24761	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Qu YL (1998)	10374627	175691	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24762	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Furukawa T (1999)	10525060	175692	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24763	120911	55799	-	CACNA2D3	HSA272268	9606	Homo sapiens	inhibitor	target	Furukawa T (1997)	9249249	175693	5594	Nilvadipine	Nivadil	-	DRUGBANK	DB06712	C19H19N3O6	small molecule	C08CA10	75530-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAIIFDPAEUKBEP-UHFFFAOYSA-N
24764	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Kuhnz W (1995)	7750291	179326	5595	Norelgestromin	17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime	evra   -(6/0.60)|evra -(6/0.75	DRUGBANK	DB06713	C21H29NO2	small molecule	G03AA13	53016-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISHXLNHNDMZNMC-XUDSTZEESA-N
24765	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Juchem M (1993)	8384965	179327	5595	Norelgestromin	17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime	evra   -(6/0.60)|evra -(6/0.75	DRUGBANK	DB06713	C21H29NO2	small molecule	G03AA13	53016-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISHXLNHNDMZNMC-XUDSTZEESA-N
24766	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Graziottin A (2006)	17107221	179328	5595	Norelgestromin	17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime	evra   -(6/0.60)|evra -(6/0.75	DRUGBANK	DB06713	C21H29NO2	small molecule	G03AA13	53016-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISHXLNHNDMZNMC-XUDSTZEESA-N
24767	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	London RS (1992)	1324557	179329	5595	Norelgestromin	17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime	evra   -(6/0.60)|evra -(6/0.75	DRUGBANK	DB06713	C21H29NO2	small molecule	G03AA13	53016-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISHXLNHNDMZNMC-XUDSTZEESA-N
24768	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Pasqualini JR (2009)	19962254	182138	5595	Norelgestromin	17-Deacylnorgestimate|17-Deacetylnorgestimate|D-Norgestrel 3-oxime|Deacetylnorgestimate|Norplant 3-oxime|Levonorgestrel 3-oxime|18-Methylnorethindrone oxime|Levonorgestrel oxime	evra   -(6/0.60)|evra -(6/0.75	DRUGBANK	DB06713	C21H29NO2	small molecule	G03AA13	53016-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ISHXLNHNDMZNMC-XUDSTZEESA-N
24769	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	unknown	target	Docherty JR (2008)	18500382	182079	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24770	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	unknown	target	Sulzer D (2005)	15955613	174152	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24771	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Miller GM (2005)	15764732	174161	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24772	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234900	174160	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24773	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Wolinsky TD (2007)	17212650	174157	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24774	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Reese EA (2007)	17218486	174158	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24775	126416	134864	RP11-295F4.9	TAAR1	TA1|TAR1|TRAR1	9606	Homo sapiens	agonist	target	Xie Z (2007)	17234899	174159	5596	Propylhexedrine	-	benzedrex 09-19-2014	DRUGBANK	DB06714	C10H21N	small molecule	-	101-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCRIVQIOJSSCQD-UHFFFAOYSA-N
24776	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	potentiator	target	Franks NP (2006)	16402123	174522	5598	Fospropofol	Fospropofol	lusedra	DRUGBANK	DB06716	C13H21O5P	small molecule	-	258516-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVNNONOFASOXQV-UHFFFAOYSA-N
24777	108835	2561	-	GABRB2	-	9606	Homo sapiens	potentiator	target	Franks NP (2006)	16402123	174522	5598	Fospropofol	Fospropofol	lusedra	DRUGBANK	DB06716	C13H21O5P	small molecule	-	258516-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVNNONOFASOXQV-UHFFFAOYSA-N
24778	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	unknown	target	Kirby RS (2009)	20053189	171829	5601	Buserelin	Tiloryth|D-Ser(Tbu)6EA10LHRH|Etilamide|(Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH	suprefact inj 1mg/ml|suprefact	DRUGBANK	DB06719	C62H90N16O15	biologic	L02AE01	57982-77-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24779	110161	3973	-	LHCGR	HHG|LCGR|LGR2|LH/CG-R|LH/CGR|LHR|LHRHR|LSH-R|ULG5	9606	Homo sapiens	unknown	target	Kirby RS (2009)	20053189	171829	5601	Buserelin	Tiloryth|D-Ser(Tbu)6EA10LHRH|Etilamide|(Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH	suprefact inj 1mg/ml|suprefact	DRUGBANK	DB06719	C62H90N16O15	biologic	L02AE01	57982-77-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24780	108899	2629	-	GBA	GBA1|GCB|GLUC	9606	Homo sapiens	unknown	target	Pastores GM (2010)	20336596	182148	5602	Velaglucerase alfa	VPRIV|Imiglucerase	vpriv	DRUGBANK	DB06720	C2532H3850N672O711S16	biologic	A16AB10	884604-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24781	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Renner RM (2010)	20399943	182151	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24782	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Rose P (2007)	17516707	182014	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24783	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Berg J (1999)	10450786	181738	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24784	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bianchi M (2002)	11846620	181788	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24785	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Renner RM (2010)	20399943	182151	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24786	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rose P (2007)	17516707	182014	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24787	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Berg J (1999)	10450786	181738	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24788	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bianchi M (2002)	11846620	181788	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24789	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Zimmerman TJ (1979)	37605	181633	5606	Bufuralol	Bufuralolum	-	DRUGBANK	DB06726	C16H23NO2	small molecule	-	54340-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSEBTPPFLLCUMN-UHFFFAOYSA-N
24790	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Zimmerman TJ (1979)	37605	181633	5606	Bufuralol	Bufuralolum	-	DRUGBANK	DB06726	C16H23NO2	small molecule	-	54340-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSEBTPPFLLCUMN-UHFFFAOYSA-N
24791	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Zimmerman TJ (1979)	37605	181633	5606	Bufuralol	Bufuralolum	-	DRUGBANK	DB06726	C16H23NO2	small molecule	-	54340-62-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSEBTPPFLLCUMN-UHFFFAOYSA-N
24792	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hong YL (1995)	7486915	174738	5609	Sulfaphenazole	Sulfafenazolo|Sulfaphenazolum|Sulfaphenazol|3-(P-Aminobenzenesulfonamido)-2-phenylpyrazole|N(1)-(1-Phenylpyrazol-5-yl)sulfanilamide|Sulphaphenazole|5-Sulfanilamido-1-phenylpyrazole|Sulfafenazol|Sulfabid|N'-(1-phenylpyrazol-5-yl)sulfanilamide|1-Phenyl-5-sulfanilamidopyrazole	-	DRUGBANK	DB06729	C15H14N4O2S	small molecule	S01AB05|J01ED08	526-08-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCJHSGMANYXCW-UHFFFAOYSA-N
24793	107007	523	-	ATP6V1A	ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1	9606	Homo sapiens	inhibitor	target	Takami M (2003)	12689676	181814	5613	Bafilomycin A1	-	-	DRUGBANK	DB06733	C35H58O9	small molecule	-	88899-55-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDHNQDDQEHDUTM-JQWOJBOSSA-N
24794	107007	523	-	ATP6V1A	ATP6A1|ATP6V1A1|HO68|VA68|VPP2|Vma1	9606	Homo sapiens	inhibitor	target	Schuhmann T (2004)	15638326	181877	5614	Bafilomycin B1	Setamycin	-	DRUGBANK	DB06734	-	small molecule	-	88899-56-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24795	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	agonist	target	Christensen CB (1993)	8153059	181693	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24796	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24797	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24798	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24799	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24800	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24801	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24802	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24803	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	agonist	target	Christensen CB (1993)	8153059	181693	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24804	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Kristensen K (1996)	8878254	181711	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24805	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Christensen CB (1993)	8153059	181693	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24806	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24807	109163	2906	-	GRIN2D	EB11|GluN2D|NMDAR2D|NR2D	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24808	125509	116444	-	GRIN3B	GluN3B|NR3B	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24809	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24810	109160	2903	RP11-297M9.2	GRIN2A	EPND|FESD|GluN2A|LKS|NMDAR2A|NR2A	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24811	125508	116443	-	GRIN3A	GluN3A|NMDAR-L|NR3A	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24812	109162	2905	-	GRIN2C	GluN2C|NMDAR2C|NR2C	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24813	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Romics I (2003)	12823389	181822	5626	Drotaverine	Drotaverin|Drotin	-	DRUGBANK	DB06751	C24H31NO4	small molecule	A03AD02	14009-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFNSKIUKYOYRG-MOSHPQCFSA-N
24814	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Pareek A (2010)	20554370	182157	5626	Drotaverine	Drotaverin|Drotin	-	DRUGBANK	DB06751	C24H31NO4	small molecule	A03AD02	14009-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFNSKIUKYOYRG-MOSHPQCFSA-N
24815	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Muravyov AV (2007)	17502703	182009	5626	Drotaverine	Drotaverin|Drotin	-	DRUGBANK	DB06751	C24H31NO4	small molecule	A03AD02	14009-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFNSKIUKYOYRG-MOSHPQCFSA-N
24816	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Romics I (2003)	12823389	181822	5626	Drotaverine	Drotaverin|Drotin	-	DRUGBANK	DB06751	C24H31NO4	small molecule	A03AD02	14009-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFNSKIUKYOYRG-MOSHPQCFSA-N
24817	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	inhibitor	target	Toemoeskoezi Z (2002)	12163106	181798	5626	Drotaverine	Drotaverin|Drotin	-	DRUGBANK	DB06751	C24H31NO4	small molecule	A03AD02	14009-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMFNSKIUKYOYRG-MOSHPQCFSA-N
24818	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Simons FE (2011)	22035879	182195	5627	Alcaftadine	6,11-Dihydro-11-(1-Methyl-4-piperidinylidene)-5H-iMidazo[2,1-b][3]benzazepine-3-carboxaldehyde|Lastacaft|Alcaftadina|Alcaftadinum|Vilasta	lastacaft	DRUGBANK	DB06766	C19H21N3O	small molecule	S01GX11	147084-10-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWTBKTRZPHJQLH-UHFFFAOYSA-N
24819	107764	1373	-	CPS1	CPSASE1|PHN	9606	Homo sapiens	allosteric modulator	target	Hart EJ (2009)	19106093	94369	5632	Carglumic Acid	Acide carglumique|Acidum carglumicum|Carbamylglutamic acid|L-N-Carbamoylglutamic acid|(2S)-2-(Carbamoylamino)pentanedioic acid|Acido carglumico|N-Carbamoyl-L-Glutamic Acid|Carbaglu|Ureidoglutaric acid|(S)-2-ureidopentanedioic acid|Carbamino-L-glutamic acid|N-Carbamyl-L-glutamate|N-Carbamylglutamate	carbaglu	DRUGBANK	DB06775	C6H10N2O5	small molecule	A16AA05	1188-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCQLHJZYVOQKHU-VKHMYHEASA-N
24820	107764	1373	-	CPS1	CPSASE1|PHN	9606	Homo sapiens	allosteric modulator	target	Kasapkara CS (2011)	21207059	182184	5632	Carglumic Acid	Acide carglumique|Acidum carglumicum|Carbamylglutamic acid|L-N-Carbamoylglutamic acid|(2S)-2-(Carbamoylamino)pentanedioic acid|Acido carglumico|N-Carbamoyl-L-Glutamic Acid|Carbaglu|Ureidoglutaric acid|(S)-2-ureidopentanedioic acid|Carbamino-L-glutamic acid|N-Carbamyl-L-glutamate|N-Carbamylglutamate	carbaglu	DRUGBANK	DB06775	C6H10N2O5	small molecule	A16AA05	1188-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCQLHJZYVOQKHU-VKHMYHEASA-N
24821	107764	1373	-	CPS1	CPSASE1|PHN	9606	Homo sapiens	allosteric modulator	target	Unknown Authors (2008)	18516804	182080	5632	Carglumic Acid	Acide carglumique|Acidum carglumicum|Carbamylglutamic acid|L-N-Carbamoylglutamic acid|(2S)-2-(Carbamoylamino)pentanedioic acid|Acido carglumico|N-Carbamoyl-L-Glutamic Acid|Carbaglu|Ureidoglutaric acid|(S)-2-ureidopentanedioic acid|Carbamino-L-glutamic acid|N-Carbamyl-L-glutamate|N-Carbamylglutamate	carbaglu	DRUGBANK	DB06775	C6H10N2O5	small molecule	A16AA05	1188-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCQLHJZYVOQKHU-VKHMYHEASA-N
24822	115296	9971	-	NR1H4	BAR|FXR|HRR-1|HRR1|RIP14	9606	Homo sapiens	unknown	target	Xu Y (2010)	20104269	182142	5633	Chenodeoxycholic acid	Chenodeoxycholic acid|Anthropodesoxycholic acid|Anthropodeoxycholic acid|Chenodiol|Chenocholic acid|7alpha-Hydroxylithocholic acid|Gallodesoxycholic acid|CDCA|Chenic acid|3alpha,7alpha-Dihydroxy-5beta-cholanic acid|Chenodesoxycholic acid|Chenix	chenodiol|chenodal	DRUGBANK	DB06777	C24H40O4	small molecule	A05AA01	474-25-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-BSWAIDMHSA-N
24823	115296	9971	-	NR1H4	BAR|FXR|HRR-1|HRR1|RIP14	9606	Homo sapiens	unknown	target	Makishima M (1999)	10334992	181736	5633	Chenodeoxycholic acid	Chenodeoxycholic acid|Anthropodesoxycholic acid|Anthropodeoxycholic acid|Chenodiol|Chenocholic acid|7alpha-Hydroxylithocholic acid|Gallodesoxycholic acid|CDCA|Chenic acid|3alpha,7alpha-Dihydroxy-5beta-cholanic acid|Chenodesoxycholic acid|Chenix	chenodiol|chenodal	DRUGBANK	DB06777	C24H40O4	small molecule	A05AA01	474-25-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-BSWAIDMHSA-N
24824	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	inhibitor	target	Norrby K (2010)	21091776	182178	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24825	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	inhibitor	target	Marchetti M (2007)	17692905	182038	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24826	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	inhibitor	target	Takahashi H (2005)	16041398	181901	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24827	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Rey E (2000)	11044537	181763	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24828	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Rey E (2000)	11044537	181763	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24829	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Frydman A (1996)	8707165	181705	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24830	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	inhibitor	target	Mousa SA (2004)	15179449	181849	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24831	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	inhibitor	target	Bendz B (2000)	10847421	181752	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24832	112893	7035	-	TFPI	EPI|LACI|TFI|TFPI1	9606	Homo sapiens	inhibitor	target	Naumnik B (2011)	20682597	182162	5634	Dalteparin	Daltepariininatrium|Dalteparinum Natricum|Dalteparinnatrium|Dalteparin sodn sl|Dalteparina sdica|Dalteparino natrio druska|Dalteparin Sodyum|Heparin Fragment KABI 2165|Dalteparyna sodowa|Daltparine sodique|Dalteparin sodium|Dalteparin-ntrium|Tedelparin	fragmin inj.-liq 2500 iu(anti-	DRUGBANK	DB06779	-	small molecule	B01AB04	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24833	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Jamal KN (2009)	19668594	182122	5635	Difluprednate	DFBA|Durezol|Difluoroprednisolone butyrate acetate	durezol	DRUGBANK	DB06781	C27H34F2O7	small molecule	D07AC19	23674-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYQPLTPSGFELIB-JTQPXKBDSA-N
24834	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	agonist	target	Tajika T (2010)	20509750	182155	5635	Difluprednate	DFBA|Durezol|Difluoroprednisolone butyrate acetate	durezol	DRUGBANK	DB06781	C27H34F2O7	small molecule	D07AC19	23674-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYQPLTPSGFELIB-JTQPXKBDSA-N
24835	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	antagonist	target	Demirdag R (2013)	22974493	182211	5637	Mafenide	Bensulfamide|Maphenidum|4-Homosufanilamide|4-(aminomethyl)benzenesulfonamide	mafenide acetate|sulfamylon cr	DRUGBANK	DB06795	C7H10N2O2S	small molecule	D06BA03	138-39-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYMRLRRVMHJFTF-UHFFFAOYSA-N
24836	111031	4986	-	OPRK1	K-OR-1|KOR|KOR-1|OPRK	9606	Homo sapiens	antagonist	target	Yuan CS (2007)	17504835	182010	5638	Methylnaltrexone	MNTX	relistor	DRUGBANK	DB06800	C21H26NO4	small molecule	A06AH01	916055-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVLBPIPGETUEET-WIXLDOGYSA-O
24837	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Yuan CS (2007)	17504835	182010	5638	Methylnaltrexone	MNTX	relistor	DRUGBANK	DB06800	C21H26NO4	small molecule	A06AH01	916055-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVLBPIPGETUEET-WIXLDOGYSA-O
24838	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Gamache DA (2000)	10850857	181753	5639	Nepafenac	AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac	ilevro|nevanac	DRUGBANK	DB06802	C15H14N2O2	small molecule	S01BC10	78281-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFAQIPZVLVERP-UHFFFAOYSA-N
24839	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gamache DA (2000)	10850857	181753	5639	Nepafenac	AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac	ilevro|nevanac	DRUGBANK	DB06802	C15H14N2O2	small molecule	S01BC10	78281-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFAQIPZVLVERP-UHFFFAOYSA-N
24840	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Uy GL (2008)	18847313	182086	5642	Plerixafor	Mozobil|AMD3100|LM3100	mozobil	DRUGBANK	DB06809	C28H54N8	small molecule	L03AX16	110078-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YIQPUIGJQJDJOS-UHFFFAOYSA-N
24841	113607	7852	-	CXCR4	CD184|D2S201E|FB22|HM89|HSY3RR|LAP-3|LAP3|LCR1|LESTR|NPY3R|NPYR|NPYRL|NPYY3R|WHIM	9606	Homo sapiens	antagonist	target	Jujo K (2013)	23204107	182222	5642	Plerixafor	Mozobil|AMD3100|LM3100	mozobil	DRUGBANK	DB06809	C28H54N8	small molecule	L03AX16	110078-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YIQPUIGJQJDJOS-UHFFFAOYSA-N
24842	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	inhibitor	target	Shimanovsky A (2013)	23409799	182231	5645	Pralatrexate	N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid|PDX|10-Propargyl-10-deazaaminopterin|Pralatrexatum|Pralatrexato|Folotyn|(2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid|(2S)-2-((4-((1RS)-1-((2,4-diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid|HSDB 7786	folotyn	DRUGBANK	DB06813	C23H23N7O5	small molecule	L01BA05	146464-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSBUKJUDHAQEA-WMCAAGNKSA-N
24843	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	inhibitor	target	Shimanovsky A (2013)	23409799	182231	5645	Pralatrexate	N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid|PDX|10-Propargyl-10-deazaaminopterin|Pralatrexatum|Pralatrexato|Folotyn|(2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid|(2S)-2-((4-((1RS)-1-((2,4-diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid|HSDB 7786	folotyn	DRUGBANK	DB06813	C23H23N7O5	small molecule	L01BA05	146464-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGSBUKJUDHAQEA-WMCAAGNKSA-N
24844	112288	6387	-	CXCL12	IRH|PBSF|SCYB12|SDF1|TLSF|TPAR1	9606	Homo sapiens	binder	target	Koo CY (2008)	18991783	182089	5647	Tinzaparin	Tinzaparin sodium	innohep multi-dose vial- 10000	DRUGBANK	DB06822	-	small molecule	B01AB10	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24845	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Florian-Kujawski M (2004)	15767980	181886	5647	Tinzaparin	Tinzaparin sodium	innohep multi-dose vial- 10000	DRUGBANK	DB06822	-	small molecule	B01AB10	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24846	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Morris TA (2004)	15567452	181874	5647	Tinzaparin	Tinzaparin sodium	innohep multi-dose vial- 10000	DRUGBANK	DB06822	-	small molecule	B01AB10	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24847	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Bisio A (2009)	19888521	180716	5647	Tinzaparin	Tinzaparin sodium	innohep multi-dose vial- 10000	DRUGBANK	DB06822	-	small molecule	B01AB10	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24848	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	inhibitor	target	Schlesinger M (2009)	19888514	182133	5647	Tinzaparin	Tinzaparin sodium	innohep multi-dose vial- 10000	DRUGBANK	DB06822	-	small molecule	B01AB10	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24849	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5649	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	-	-	DRUGBANK	DB06828	C14H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSZDJRLPCLOQAM-UHFFFAOYSA-N
24850	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5650	4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB06829	C19H20BrNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXDVFLTWXCTCEX-UHFFFAOYSA-N
24851	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5651	(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	-	-	DRUGBANK	DB06830	C7H18O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJEGNOYPWRBKAE-UHFFFAOYSA-N
24852	111311	5293	RP11-558F24.3	PIK3CD	APDS|IMD14|P110DELTA|PI3K|p110D	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5652	2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE	-	-	DRUGBANK	DB06831	C21H15ClN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMYTDJYDSTEMB-UHFFFAOYSA-N
24853	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5652	2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE	-	-	DRUGBANK	DB06831	C21H15ClN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMYTDJYDSTEMB-UHFFFAOYSA-N
24854	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5653	2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL	-	-	DRUGBANK	DB06832	C15H10FNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQIMZDXIAHJKQP-UHFFFAOYSA-N
24855	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5653	2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL	-	-	DRUGBANK	DB06832	C15H10FNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQIMZDXIAHJKQP-UHFFFAOYSA-N
24856	108405	2101	-	ESRRA	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5654	1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE	-	-	DRUGBANK	DB06833	C23H28N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMIJMYOYKAKQPN-UHFFFAOYSA-N
24857	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5655	N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide	-	-	DRUGBANK	DB06834	C21H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZRYCTLOGNCQDG-UHFFFAOYSA-N
24858	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5656	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	-	-	DRUGBANK	DB06835	C22H31N2O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTQDLSDUHUFBQW-LEWJYISDSA-N
24859	111307	5289	-	PIK3C3	VPS34|hVps34	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5657	N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE	-	-	DRUGBANK	DB06836	C14H16ClN3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFVNFXCESCXMBC-UHFFFAOYSA-N
24860	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5657	N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE	-	-	DRUGBANK	DB06836	C14H16ClN3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFVNFXCESCXMBC-UHFFFAOYSA-N
24861	116277	11096	-	ADAMTS5	ADAM-TS 11|ADAM-TS 5|ADAM-TS5|ADAMTS-11|ADAMTS-5|ADAMTS11|ADMP-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5658	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	-	-	DRUGBANK	DB06837	C20H22N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXDKQRWTOJFQKH-BJZITVGISA-N
24862	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5659	methyl L-phenylalaninate	-	-	DRUGBANK	DB06838	C10H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSDUZFOSJDMAFZ-VIFPVBQESA-N
24863	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5661	diethyl [(1R)-1,5-diaminopentyl]boronate	-	-	DRUGBANK	DB06840	C9H23BN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYUGRVWDCBMIQX-VIFPVBQESA-N
24864	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5662	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide	-	-	DRUGBANK	DB06841	C21H32ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWPACVJPAFGBEQ-IKGGRYGDSA-O
24865	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5663	(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one	-	-	DRUGBANK	DB06842	C15H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMUULPVBYQBBK-GFCCVEGCSA-N
24866	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5663	(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one	-	-	DRUGBANK	DB06842	C15H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDMUULPVBYQBBK-GFCCVEGCSA-N
24867	106624	111	-	ADCY5	AC5|FDFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5664	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	-	-	DRUGBANK	DB06843	C10H14N5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFGZMOICZSFFLB-DSYKOEDSSA-N
24868	106622	108	-	ADCY2	AC2|HBAC2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5664	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	-	-	DRUGBANK	DB06843	C10H14N5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFGZMOICZSFFLB-DSYKOEDSSA-N
24869	109040	2778	RP4-543J19.4	GNAS	AHO|C20orf45|GNAS1|GPSA|GSA|GSP|NESP|PHP1A|PHP1B|PHP1C|POH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5664	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	-	-	DRUGBANK	DB06843	C10H14N5O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFGZMOICZSFFLB-DSYKOEDSSA-N
24870	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5665	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	-	-	DRUGBANK	DB06844	C21H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBXKBJLIESPLIK-UHFFFAOYSA-N
24871	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5665	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	-	-	DRUGBANK	DB06844	C21H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBXKBJLIESPLIK-UHFFFAOYSA-N
24872	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5666	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB06845	C20H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXYKSWZWRHMJTE-KRWDZBQOSA-N
24873	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5666	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB06845	C20H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXYKSWZWRHMJTE-KRWDZBQOSA-N
24874	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5667	7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID	-	-	DRUGBANK	DB06846	C24H28FNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVPCJBDHTUCOBT-RTBURBONSA-N
24875	113029	7177	-	TPSAB1	TPS1|TPS2|TPSB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5669	1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine	-	-	DRUGBANK	DB06848	C23H24N2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCUDZTCDUDDJGG-UHFFFAOYSA-N
24876	113029	7177	-	TPSAB1	TPS1|TPS2|TPSB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5670	1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine	-	-	DRUGBANK	DB06849	C22H24N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQWYWHUKHYFIPB-VQHVLOKHSA-N
24877	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5671	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB06850	C21H31N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYKFVFFOIYLADT-SFHVURJKSA-N
24878	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5671	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB06850	C21H31N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYKFVFFOIYLADT-SFHVURJKSA-N
24879	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5672	N-(pyridin-3-ylmethyl)aniline	-	-	DRUGBANK	DB06851	C12H12N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJXLHKJBRORJJJ-UHFFFAOYSA-N
24880	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5673	4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB06852	C23H22ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOVBBVMDHIRCTG-LJQANCHMSA-N
24881	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5674	N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06853	C22H33N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYTJPDBCLWUEBU-IBGZPJMESA-N
24882	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5674	N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06853	C22H33N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYTJPDBCLWUEBU-IBGZPJMESA-N
24883	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5675	2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06854	C20H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMGQGPVCSYOMNS-UHFFFAOYSA-N
24884	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5675	2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06854	C20H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMGQGPVCSYOMNS-UHFFFAOYSA-N
24885	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5676	6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06855	C18H19FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSUDDASMRZSVON-UHFFFAOYSA-N
24886	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5677	6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB06856	C22H24FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUYQYLFFFNSAAX-BUXKBTBVSA-N
24887	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5678	N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE	-	-	DRUGBANK	DB06857	C15H13ClIN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKGFTDAISIBIBV-UHFFFAOYSA-N
24888	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5679	N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06858	C23H35N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMLOIDMSBRJZAE-FQEVSTJZSA-N
24889	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5679	N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06858	C23H35N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMLOIDMSBRJZAE-FQEVSTJZSA-N
24890	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5680	N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE	-	-	DRUGBANK	DB06859	C19H27ClN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWIUMAPBZWNFNV-UHFFFAOYSA-N
24891	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5682	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	-	-	DRUGBANK	DB06861	C12H22N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCDJKFJACUMSOZ-AXFHLTTASA-N
24892	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5683	2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID	-	-	DRUGBANK	DB06862	C9H11NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCQUNSCHVXCSCJ-UHFFFAOYSA-N
24893	851075	946734	b2261	menC	ECK2255|JW2256	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5684	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	-	-	DRUGBANK	DB06864	C11H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJYRAJSESKVEAE-PSASIEDQSA-N
24894	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5685	6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	-	-	DRUGBANK	DB06865	C22H26N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSRRBAKATXAISL-LMNJBCLMSA-N
24895	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5686	6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	-	-	DRUGBANK	DB06866	C23H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMOUMGFCBOWPAB-RZUBCFFCSA-N
24896	111317	5300	-	PIN1	DOD|UBL5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5687	3,6,9,12,15,18-HEXAOXAICOSANE	-	-	DRUGBANK	DB06867	C14H30O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXFAFGFZFQHRLB-UHFFFAOYSA-N
24897	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5688	N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide	-	-	DRUGBANK	DB06868	C18H25ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQUULPKGCNPPBX-INIZCTEOSA-N
24898	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5689	1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE	-	-	DRUGBANK	DB06869	C24H35ClN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMHVHOJXEQTIEA-SIKLNZKXSA-N
24899	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5690	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	-	-	DRUGBANK	DB06870	C21H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OXHNQTSIKGHVBH-ANULTFPQSA-N
24900	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5691	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	-	-	DRUGBANK	DB06871	C19H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQMQOMRDADWGJJ-GBESFXJTSA-N
24901	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5691	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	-	-	DRUGBANK	DB06871	C19H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQMQOMRDADWGJJ-GBESFXJTSA-N
24902	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5692	1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB06872	C13H14N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWJXYUXIPSIOGG-UHFFFAOYSA-N
24903	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5693	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB06873	C21H22N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSXNPJKDZKLDET-UHFFFAOYSA-N
24904	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5695	3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE	-	-	DRUGBANK	DB06875	C17H10FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSSOSHDCWCMNDM-UHFFFAOYSA-N
24905	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5695	3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE	-	-	DRUGBANK	DB06875	C17H10FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSSOSHDCWCMNDM-UHFFFAOYSA-N
24906	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5696	N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE	-	-	DRUGBANK	DB06876	C24H24N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJWJKKXGAPWLGT-UHFFFAOYSA-N
24907	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5697	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB06877	C16H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPBUUQBZKJSWTN-UHFFFAOYSA-N
24908	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5698	1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB06878	C16H22ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTYYXGRJXJFTCD-KGLIPLIRSA-N
24909	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5699	5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE	-	-	DRUGBANK	DB06879	C21H22F2N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCFIRACCCDFXIP-UHFFFAOYSA-N
24910	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5700	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	-	-	DRUGBANK	DB06880	C15H25N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIKCMKYTGBHVSX-IHRRRGAJSA-N
24911	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5702	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	-	-	DRUGBANK	DB06882	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJWMLCDGRWWLAQ-UHFFFAOYSA-N
24912	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5702	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	-	-	DRUGBANK	DB06882	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJWMLCDGRWWLAQ-UHFFFAOYSA-N
24913	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5703	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea	-	-	DRUGBANK	DB06883	C20H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHNYNLNKNQJSHF-UHFFFAOYSA-N
24914	113843	8204	-	NRIP1	RIP140	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5704	4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE	-	-	DRUGBANK	DB06884	C17H20N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDXHRPPSJRQFX-UHFFFAOYSA-N
24915	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5704	4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE	-	-	DRUGBANK	DB06884	C17H20N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDXHRPPSJRQFX-UHFFFAOYSA-N
24916	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5707	3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER	-	-	DRUGBANK	DB06887	C16H23N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPSSYXOFPICMQD-ZDUSSCGKSA-N
24917	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5708	(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE	-	-	DRUGBANK	DB06888	C22H21N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBLPHMRCKHFBJB-OLZOCXBDSA-N
24918	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5711	5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE	-	-	DRUGBANK	DB06891	C8H7ClFN5O4S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOLJYLOVIHBQHO-UHFFFAOYSA-N
24919	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5712	(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide	-	-	DRUGBANK	DB06892	C15H12F3IN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLJJGJCIWWATJ-OOHURIHSSA-N
24920	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5714	1-DODECANOL	-	-	DRUGBANK	DB06894	C12H26O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQZZUXJYWNFBMV-UHFFFAOYSA-N
24921	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5715	1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide	-	-	DRUGBANK	DB06896	C25H16F2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBSFXHDOLBYWRJ-UHFFFAOYSA-N
24922	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5716	3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol	-	-	DRUGBANK	DB06897	C23H22ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMGKIHLBFPJYJL-HNNXBMFYSA-N
24923	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5717	4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol	-	-	DRUGBANK	DB06898	C13H12N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJXOCBVCWTJFP-UHFFFAOYSA-N
24924	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5717	4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol	-	-	DRUGBANK	DB06898	C13H12N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJXOCBVCWTJFP-UHFFFAOYSA-N
24925	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5718	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE	-	-	DRUGBANK	DB06899	C20H26N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEVNJZCKDVVND-UHFFFAOYSA-N
24926	111633	5652	-	PRSS8	CAP1|PROSTASIN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5719	1-[4-(hydroxymethyl)phenyl]guanidine	-	-	DRUGBANK	DB06900	C8H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAFHTIHHRCEJDS-UHFFFAOYSA-N
24927	121962	63036	-	CELA2A	ELA2A|PE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5720	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	-	-	DRUGBANK	DB06901	C10H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEWBFDLFXDTFGD-AEJSXWLSSA-N
24928	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5721	4-(1-methyl-1-phenylethyl)phenol	-	-	DRUGBANK	DB06902	C15H16O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBDSZLJBMIMQRS-UHFFFAOYSA-N
24929	851379	947040	b2568	lepB	ECK2566|JW2552|lep	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5723	(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE	-	-	DRUGBANK	DB06904	C13H17NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEPDBQXSCUYOPA-VHRDEZTHSA-N
24930	111507	5515	-	PPP2CA	PP2Ac|PP2CA|PP2Calpha|RP-C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5724	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	-	-	DRUGBANK	DB06905	C20H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJVCHYDYCYBBQX-HLTLHRPFSA-N
24931	111519	5527	-	PPP2R5C	B56G|PR61G	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5724	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	-	-	DRUGBANK	DB06905	C20H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJVCHYDYCYBBQX-HLTLHRPFSA-N
24932	111510	5518	-	PPP2R1A	PP2A-Aalpha|PP2AAALPHA|PR65A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5724	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	-	-	DRUGBANK	DB06905	C20H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJVCHYDYCYBBQX-HLTLHRPFSA-N
24933	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5727	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	-	-	DRUGBANK	DB06908	C24H23ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAWOPJKHTZCKMT-QFIPXVFZSA-N
24934	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5727	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	-	-	DRUGBANK	DB06908	C24H23ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAWOPJKHTZCKMT-QFIPXVFZSA-N
24935	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5728	1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide	-	-	DRUGBANK	DB06909	C21H25N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZGJNFBMYYEFGM-UHFFFAOYSA-N
24936	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5730	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB06911	C18H26ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHVBVJXZKNCSLP-CVEARBPZSA-N
24937	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5731	UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE	-	-	DRUGBANK	DB06912	C15H20O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WRPMDTWVLJJHMV-KHOBFWCSSA-N
24938	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5733	1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE	-	-	DRUGBANK	DB06914	C15H17ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPIOYRIZNLPLDH-UHFFFAOYSA-N
24939	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5735	N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE	-	-	DRUGBANK	DB06916	C22H24N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBCGUKCXRVUULK-QGZVFWFLSA-N
24940	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5736	(4-fluorophenyl)(pyridin-4-yl)methanone	-	-	DRUGBANK	DB06917	C12H8FNO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTRWBYGUMQEFFI-UHFFFAOYSA-N
24941	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5737	2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE	-	-	DRUGBANK	DB06918	C16H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRYXDGAKQGRHFG-UHFFFAOYSA-N
24942	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5738	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB06919	C21H24ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJHLRGCXPGIPCB-MOPGFXCFSA-N
24943	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5739	(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE	-	-	DRUGBANK	DB06920	C24H22ClFN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBKAVAGLMGMHI-WIYYLYMNSA-N
24944	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5740	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID	-	-	DRUGBANK	DB06921	C20H27N2O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNZHLCNFXRRIIC-RBUKOAKNSA-N
24945	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5741	2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	-	-	DRUGBANK	DB06922	C22H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZNPWASYMRBJCX-GOSISDBHSA-N
24946	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5742	2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE	-	-	DRUGBANK	DB06923	C16H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJUSXMYSVXZFDJ-UHFFFAOYSA-N
24947	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5743	(2R)-2-benzyl-3-nitropropanoic acid	-	-	DRUGBANK	DB06924	C10H11NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCXOTBPCUQHSAO-SECBINFHSA-N
24948	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5744	3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB06925	C23H17F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEIASMOUYNOXGA-UHFFFAOYSA-N
24949	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5745	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	-	-	DRUGBANK	DB06926	C18H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNICUWMFWZBIFP-IRQZEAMPSA-N
24950	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5746	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	-	-	DRUGBANK	DB06927	C16H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKJVCUXZMYKTLT-UHFFFAOYSA-N
24951	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5746	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	-	-	DRUGBANK	DB06927	C16H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKJVCUXZMYKTLT-UHFFFAOYSA-N
24952	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5746	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	-	-	DRUGBANK	DB06927	C16H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKJVCUXZMYKTLT-UHFFFAOYSA-N
24953	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5747	(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID	-	-	DRUGBANK	DB06928	C13H16IO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPTCQJLGUKWAEP-SNVBAGLBSA-N
24954	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5748	1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06929	C17H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYAZZWWVNUWKNB-AWEZNQCLSA-N
24955	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5749	N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide	-	-	DRUGBANK	DB06930	C19H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVLDNAVUCUAGDP-UHFFFAOYSA-N
24956	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5750	(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	-	-	DRUGBANK	DB06931	C9H22O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COHUUYPEYRMWTH-UHFFFAOYSA-N
24957	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5751	10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine	-	-	DRUGBANK	DB06932	C19H18N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVINUNQBDNEMSY-UHFFFAOYSA-N
24958	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5752	N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide	-	-	DRUGBANK	DB06933	C24H24N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJTCKUKIFXWJKG-UHFFFAOYSA-N
24959	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5755	N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide	-	-	DRUGBANK	DB06936	C19H28N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKJCSNKYXWOAQ-INIZCTEOSA-N
24960	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5756	4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB06937	C13H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBTXJDAHLMMIGY-UHFFFAOYSA-N
24961	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5757	4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide	-	-	DRUGBANK	DB06938	C21H15ClF3N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJLSMLDOCGOURY-UHFFFAOYSA-N
24962	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5758	N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE	-	-	DRUGBANK	DB06939	C17H30FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZFQBRSDORUYAB-YDMUCJKGSA-N
24963	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5759	N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide	-	-	DRUGBANK	DB06940	C19H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZTMFGIGOADCFX-UHFFFAOYSA-N
24964	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5760	(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide	-	-	DRUGBANK	DB06941	C13H19N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAASZVAHBVMHCO-NXVVXOECSA-N
24965	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5761	N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide	-	-	DRUGBANK	DB06942	C22H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNZKCCPFUWHBFY-IBGZPJMESA-N
24966	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5762	(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol	-	-	DRUGBANK	DB06943	C14H17NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLIQFUCBRCDFAI-ZDUSSCGKSA-N
24967	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5763	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	-	-	DRUGBANK	DB06944	C18H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIGZCVNCFXYBEG-UHFFFAOYSA-N
24968	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5763	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	-	-	DRUGBANK	DB06944	C18H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIGZCVNCFXYBEG-UHFFFAOYSA-N
24969	116277	11096	-	ADAMTS5	ADAM-TS 11|ADAM-TS 5|ADAM-TS5|ADAMTS-11|ADAMTS-5|ADAMTS11|ADMP-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5764	N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide	-	-	DRUGBANK	DB06945	C19H18F3NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOSWRYKPHVPIDJ-UHFFFAOYSA-N
24970	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5766	1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06947	C17H25N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHAMQFKGUUSJMU-KGLIPLIRSA-N
24971	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5767	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	-	-	DRUGBANK	DB06948	C18H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWWRLKIBRPJQJX-UHFFFAOYSA-N
24972	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5767	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	-	-	DRUGBANK	DB06948	C18H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWWRLKIBRPJQJX-UHFFFAOYSA-N
24973	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5770	(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid	-	-	DRUGBANK	DB06951	C13H17NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPHLTCNXHCHMOW-MNOVXSKESA-N
24974	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5772	2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE	-	-	DRUGBANK	DB06953	C25H17Cl2N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVWHVGIRXILXMU-XMMPIXPASA-N
24975	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5772	2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE	-	-	DRUGBANK	DB06953	C25H17Cl2N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVWHVGIRXILXMU-XMMPIXPASA-N
24976	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5773	2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate	-	-	DRUGBANK	DB06954	C16H21NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIASYWBGUYOWJR-UHFFFAOYSA-N
24977	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5775	N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB06956	C18H14ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTTFXKUTBNGQTP-UHFFFAOYSA-N
24978	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5776	4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB06957	C21H23ClN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDFJIEMVNDLSTB-UHFFFAOYSA-N
24979	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5777	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB06958	C16H20ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SORAKBHHTGVZCS-UHFFFAOYSA-N
24980	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5778	(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE	-	-	DRUGBANK	DB06959	C25H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUCZDJYEOAQTHL-VXKWHMMOSA-N
24981	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5778	(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE	-	-	DRUGBANK	DB06959	C25H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUCZDJYEOAQTHL-VXKWHMMOSA-N
24982	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5780	5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide	-	-	DRUGBANK	DB06961	C23H24ClN3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APGOABVITLQCKW-UHFFFAOYSA-N
24983	122201	64499	-	TPSB2	TPS2|tryptaseB|tryptaseC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5781	(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone	-	-	DRUGBANK	DB06962	C26H24N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKTUSHSSKIWDRY-UHFFFAOYSA-N
24984	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5782	3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide	-	-	DRUGBANK	DB06963	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFGCLYUGFRNYFE-INIZCTEOSA-N
24985	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5783	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB06964	C19H17ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXPCDMPJCKNLBY-UHFFFAOYSA-N
24986	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5786	6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB06967	C22H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLSVRCGEBXIIQO-UHFFFAOYSA-N
24987	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5788	2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide	-	-	DRUGBANK	DB06969	C21H23Cl2N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJUNQSYQHHIVFX-UHFFFAOYSA-N
24988	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5790	N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA	-	-	DRUGBANK	DB06971	C17H17N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVMUNGGWXRKCEU-UHFFFAOYSA-N
24989	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5791	7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile	-	-	DRUGBANK	DB06972	C22H15Cl2N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZCXQSNBTXDAJG-QFIPXVFZSA-N
24990	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5792	4,4'-PROPANE-2,2-DIYLDIPHENOL	-	-	DRUGBANK	DB06973	C15H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IISBACLAFKSPIT-UHFFFAOYSA-N
24991	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5794	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA	-	-	DRUGBANK	DB06976	C19H22N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWOOJEZSDPRYAZ-WFASDCNBSA-N
24992	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5795	(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE	-	-	DRUGBANK	DB06977	C23H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAASENZOSQYNPX-WMZHIEFXSA-N
24993	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5797	5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid	-	-	DRUGBANK	DB06979	C15H27N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEZPFPQAXAREGM-UHFFFAOYSA-N
24994	112391	6500	-	SKP1	EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5798	(2S)-2-(1H-indol-3-yl)hexanoic acid	-	-	DRUGBANK	DB06980	C14H17NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCBHCHBXRBYJGU-NSHDSACASA-N
24995	112391	6500	-	SKP1	EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5799	(2S)-2-(1H-indol-3-yl)pentanoic acid	-	-	DRUGBANK	DB06981	C13H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRCBLBWFQJDFJQ-JTQLQIEISA-N
24996	112391	6500	-	SKP1	EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5800	(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid	-	-	DRUGBANK	DB06982	C21H30N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWVCKFLATUTBCX-INIZCTEOSA-N
24997	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5801	(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol	-	-	DRUGBANK	DB06983	C19H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RBLKWWBHDUBPFN-UHFFFAOYSA-N
24998	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5802	(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL	-	-	DRUGBANK	DB06984	C13H19NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHTYSDQNKZIWBZ-ZOLYEBIHSA-N
24999	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5804	2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	-	-	DRUGBANK	DB06986	C16H13ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRHOLHTVXXSIMG-BXUZGUMPSA-N
25000	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5805	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	-	-	DRUGBANK	DB06987	C14H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-GFCCVEGCSA-N
25001	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5805	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	-	-	DRUGBANK	DB06987	C14H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-GFCCVEGCSA-N
25002	111751	5787	-	PTPRB	HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5807	{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID	-	-	DRUGBANK	DB06989	C19H21NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUACYXRSGYYBGT-UHFFFAOYSA-N
25003	113220	7374	-	UNG	DGU|HIGM4|HIGM5|UDG|UNG1|UNG15|UNG2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5808	4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID	-	-	DRUGBANK	DB06990	C15H14N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHDKIDMFBWLHAX-GONBZBRSSA-N
25004	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5809	N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide	-	-	DRUGBANK	DB06991	C17H22N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYOUIHFZUAKCEF-LLVKDONJSA-N
25005	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5810	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	-	-	DRUGBANK	DB06992	C20H23FN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDDLTBLAQYZIZ-UHFFFAOYSA-N
25006	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5811	(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine	-	-	DRUGBANK	DB06993	C20H28F2N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTAHVQJZNFGPHN-MQPLHJKPSA-N
25007	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5812	(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine	-	-	DRUGBANK	DB06994	C21H25ClFN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCCSSVMRGIQMGF-LPHOPBHVSA-N
25008	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5813	N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide	-	-	DRUGBANK	DB06995	C20H16F2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USBSTVPJNQLYEM-UHFFFAOYSA-N
25009	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5814	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB06996	C19H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFNMDMGNNKIXBT-CVEARBPZSA-N
25010	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5815	2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide	-	-	DRUGBANK	DB06997	C22H16F2N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMPOCDJEXAXXEZ-UHFFFAOYSA-N
25011	852520	948218	b3701	dnaN	ECK3693|JW3678	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5816	[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid	-	-	DRUGBANK	DB06998	C14H13Br2NO5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ABQHPGHMYXJJIV-MRVPVSSYSA-N
25012	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5817	N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide	-	-	DRUGBANK	DB06999	C17H14ClF2N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZDJQTHVDDOVHR-UHFFFAOYSA-N
25013	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5818	N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide	-	-	DRUGBANK	DB07000	C21H16F2N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILXJWLWSYAWJKZ-UHFFFAOYSA-N
25014	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5819	(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine	-	-	DRUGBANK	DB07001	C10H14N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIIBOYBTIWHZFJ-ZETCQYMHSA-N
25015	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5820	4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile	-	-	DRUGBANK	DB07002	C19H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZUVGMCKKLJAFX-UHFFFAOYSA-N
25016	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5821	(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine	-	-	DRUGBANK	DB07003	C8H10N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOXPJFCQDMQOX-YFKPBYRVSA-N
25017	112193	6285	-	S100B	NEF|S100|S100-B|S100beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5822	2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide	-	-	DRUGBANK	DB07004	C13H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUKZXTKQBXLMDO-UHFFFAOYSA-N
25018	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5823	D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide	-	-	DRUGBANK	DB07005	C22H28N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZFTWWJAUZOJDH-MOPGFXCFSA-O
25019	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5824	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	-	-	DRUGBANK	DB07006	C24H20N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOGOZJCRIFBTTN-UHFFFAOYSA-N
25020	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5825	(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine	-	-	DRUGBANK	DB07007	C17H19N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UDFXWCLBONUMNA-CYBMUJFWSA-N
25021	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5826	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE	-	-	DRUGBANK	DB07008	C20H14N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPXGYINSBORUMM-UHFFFAOYSA-N
25022	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5827	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL	-	-	DRUGBANK	DB07009	C17H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHOZVRGNIYFYHE-UHFFFAOYSA-N
25023	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5827	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL	-	-	DRUGBANK	DB07009	C17H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHOZVRGNIYFYHE-UHFFFAOYSA-N
25024	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5828	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07010	C21H17ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDJZASCRQRBYQS-UHFFFAOYSA-N
25025	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5828	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07010	C21H17ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PDJZASCRQRBYQS-UHFFFAOYSA-N
25026	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5829	(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE	-	-	DRUGBANK	DB07011	C22H23N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHOPJGKEAIIIDF-FQEVSTJZSA-N
25027	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5831	TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE	-	-	DRUGBANK	DB07013	C22H31N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXFCFGLSOUOCEA-UHFFFAOYSA-N
25028	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5832	2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole	-	-	DRUGBANK	DB07014	C17H13FN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUTZKAQTSPMEBI-UHFFFAOYSA-N
25029	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5833	(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine	-	-	DRUGBANK	DB07015	C18H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDSKICAQKGYYJF-OLZOCXBDSA-N
25030	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5834	(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline	-	-	DRUGBANK	DB07016	C10H13NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVVJJANGXMGMGC-SSDOTTSWSA-N
25031	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5835	(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one	-	-	DRUGBANK	DB07017	C15H19FN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYVZYASDRIAOPU-BJOHPYRUSA-N
25032	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5837	N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE	-	-	DRUGBANK	DB07019	C24H33N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDOKZPZLWNULU-MZNJEOGPSA-N
25033	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5838	N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide	-	-	DRUGBANK	DB07020	C20H14N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMDMJDCLPIVGQD-UHFFFAOYSA-N
25034	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5839	(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine	-	-	DRUGBANK	DB07021	C16H13F3N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOSYXEPELJIJHZ-RNCFNFMXSA-N
25035	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5840	3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPHTHYL}AMINO)CARBONYL]BENZENESULFONATE	-	-	DRUGBANK	DB07022	C21H21N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXERBGNIBOFZOW-UHFFFAOYSA-N
25036	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5841	(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE	-	-	DRUGBANK	DB07023	C18H21BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGLWHYRZHMOCMC-CVEARBPZSA-N
25037	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5842	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	-	-	DRUGBANK	DB07024	C19H17NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEXBEGBNDJVZPK-UHFFFAOYSA-N
25038	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5843	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07025	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBIHHEGEALBUMT-UHFFFAOYSA-N
25039	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5844	(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE	-	-	DRUGBANK	DB07026	C20H21N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPLDARNGJSQINK-OKZBNKHCSA-N
25040	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5845	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB07027	C21H24FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGZSVYZIJHGHMA-MOPGFXCFSA-N
25041	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5846	(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID	-	-	DRUGBANK	DB07028	C16H12BrClFNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLIGBZRXAQNUFO-UHFFFAOYSA-N
25042	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5847	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE	-	-	DRUGBANK	DB07029	C21H16N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQBNDYARFVOEGW-UHFFFAOYSA-N
25043	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5848	(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID	-	-	DRUGBANK	DB07030	C16H13ClN2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABIMMIJVWNHFI-UHFFFAOYSA-N
25044	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5849	R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID	-	-	DRUGBANK	DB07031	C23H26FNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANFHDFOMFRLLR-LJQANCHMSA-N
25045	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5850	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	-	-	DRUGBANK	DB07032	C14H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNNNDCMXZYWCCI-UHFFFAOYSA-N
25046	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5851	5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE	-	-	DRUGBANK	DB07033	C14H12N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWQVBIPGKIAUGA-QMMMGPOBSA-N
25047	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5852	2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID	-	-	DRUGBANK	DB07034	C17H13NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOKATEXROYSXDW-UHFFFAOYSA-N
25048	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5854	(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	-	-	DRUGBANK	DB07036	C20H20F2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPFRMIHXGMVMGF-BZSNNMDCSA-N
25049	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5855	(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL	-	-	DRUGBANK	DB07037	C12H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBZPCTWLFNYBND-QMMMGPOBSA-N
25050	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5856	2-(cyclohexylamino)benzoic acid	-	-	DRUGBANK	DB07038	C13H17NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSXMFCCPQQJLCR-UHFFFAOYSA-N
25051	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5857	(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide	-	-	DRUGBANK	DB07039	C18H14IN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXSZCFAPSDTELY-SFHVURJKSA-N
25052	109544	3312	-	HSPA8	HEL-33|HEL-S-72p|HSC54|HSC70|HSC71|HSP71|HSP73|HSPA10|LAP-1|LAP1|NIP71	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5863	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	-	-	DRUGBANK	DB07045	C17H18Cl2N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBJKVZXRYLCYGQ-XNIJJKJLSA-N
25053	107049	573	RP11-326F20.2	BAG1	BAG-1|HAP|RAP46	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5863	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	-	-	DRUGBANK	DB07045	C17H18Cl2N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBJKVZXRYLCYGQ-XNIJJKJLSA-N
25054	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5864	2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide	-	-	DRUGBANK	DB07046	C16H14ClF2IN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCADPEDUULETPK-SECBINFHSA-N
25055	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5866	N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide	-	-	DRUGBANK	DB07048	C17H26N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBYJCVDSFWJBSM-OAHLLOKOSA-N
25056	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5867	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	-	-	DRUGBANK	DB07049	C21H27N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOFGQQQVQZQJFS-MRXNPFEDSA-N
25057	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5868	5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide	-	-	DRUGBANK	DB07050	C8H8N4O4S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWDGTQXZLNDOKS-UHFFFAOYSA-N
25058	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5869	3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER	-	-	DRUGBANK	DB07051	C14H17N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUIZDUYEIRRDAV-UHFFFAOYSA-O
25059	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5871	2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	-	-	DRUGBANK	DB07053	C24H23F3N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWVYNPULGKGJOS-UHFFFAOYSA-N
25060	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5872	(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL	-	-	DRUGBANK	DB07054	C22H23F4N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSCWQKTUILTARV-MRXNPFEDSA-N
25061	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5874	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	-	-	DRUGBANK	DB07056	C18H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNWQLOFSMUGRNY-UHFFFAOYSA-N
25062	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5875	(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid	-	-	DRUGBANK	DB07057	C11H11NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPQOSKXLHCTVED-ZETCQYMHSA-N
25063	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5876	5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione	-	-	DRUGBANK	DB07058	C16H12N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBVJMUOTMRYUKR-UHFFFAOYSA-N
25064	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5877	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE	-	-	DRUGBANK	DB07059	C20H26N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSOZDYCSBLQX-UHFFFAOYSA-N
25065	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5878	3-(INDOL-3-YL) LACTATE	-	-	DRUGBANK	DB07060	C11H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGILAAMKEQUXLS-JTQLQIEISA-N
25066	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5879	1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL	-	-	DRUGBANK	DB07061	C22H32N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXYFCRIRLKSCRR-SFHVURJKSA-N
25067	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5881	{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID	-	-	DRUGBANK	DB07063	C18H11F3N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYHVTMFADJNSGS-UHFFFAOYSA-N
25068	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5882	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	-	-	DRUGBANK	DB07064	C20H24N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPVCRUIDFODATB-LJQANCHMSA-N
25069	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5883	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB07065	C19H12Cl2N6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHPKUZJCNHGFQA-UHFFFAOYSA-N
25070	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5884	2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	-	-	DRUGBANK	DB07066	C16H12ClN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJAHIGGEXIWVJG-LLVKDONJSA-N
25071	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5885	(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE	-	-	DRUGBANK	DB07067	C17H22N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQCDMTZMCHZYGO-FZMZJTMJSA-N
25072	111751	5787	-	PTPRB	HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5886	(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID	-	-	DRUGBANK	DB07068	C21H32N2O9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHLMZWXTBDMYOE-UHFFFAOYSA-N
25073	114454	8942	-	KYNU	KYNUU	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5887	3-Hydroxyhippuric acid	-	-	DRUGBANK	DB07069	C9H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDOFWFNMYJRHEW-UHFFFAOYSA-N
25074	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5888	(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid	-	-	DRUGBANK	DB07070	C21H21F4NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLLIPYDNFENMY-ZDUSSCGKSA-N
25075	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5889	(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE	-	-	DRUGBANK	DB07071	C12H18BN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZYCNKSJMJFKCBX-LLVKDONJSA-N
25076	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5890	(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE	-	-	DRUGBANK	DB07072	C18H19F6N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNKRZILQBKJWDS-WMFXKJRFSA-N
25077	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5891	5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one	-	-	DRUGBANK	DB07073	C13H18N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZXMARZBAUMWLK-UHFFFAOYSA-N
25078	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5892	6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER	-	-	DRUGBANK	DB07074	C21H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBRALHIKGRAMA-UHFFFAOYSA-N
25079	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5893	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE	-	-	DRUGBANK	DB07075	C23H24N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBKUBPBCFYCSRT-UHFFFAOYSA-N
25080	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5894	6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE	-	-	DRUGBANK	DB07076	C23H23N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWTQOPWAMQXIMI-UHFFFAOYSA-N
25081	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5895	(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE	-	-	DRUGBANK	DB07077	C10H14BN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTRUIYBNRUNGLM-SECBINFHSA-N
25082	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5896	(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE	-	-	DRUGBANK	DB07078	C20H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYSXURJZVXBSRV-WJDWOHSUSA-N
25083	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5897	3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol	-	-	DRUGBANK	DB07079	C13H16O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CARKQNSZFCLNKM-UHFFFAOYSA-N
25084	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25085	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25086	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25087	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25088	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25089	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5898	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07080	C17H12F9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGIWFELWJPNFDH-UHFFFAOYSA-N
25090	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5899	(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE	-	-	DRUGBANK	DB07081	C17H17F6N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FDEXEPZGMKFCTG-PSASIEDQSA-N
25091	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5900	1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL	-	-	DRUGBANK	DB07082	C11H8F9NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHDRSZOHKKZOQF-UHFFFAOYSA-N
25092	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5901	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	-	-	DRUGBANK	DB07083	C23H29N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZKKJPDVZGOOPU-PZJWPPBQSA-N
25093	849928	945554	b0929	ompF	ECK0920|JW0912|cmlB|coa|cry|nfxB?|tolF	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5902	N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide	-	-	DRUGBANK	DB07084	C22H27NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHKGWOJTUMJPNW-UHFFFAOYSA-N
25094	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5904	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07086	C16H20O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXIFNRNIQJKFLP-XHSDSOJGSA-N
25095	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5904	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07086	C16H20O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXIFNRNIQJKFLP-XHSDSOJGSA-N
25096	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5905	4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07087	C17H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMSZEVAWRFDVQX-GHVWTTSJSA-N
25097	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5905	4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07087	C17H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMSZEVAWRFDVQX-GHVWTTSJSA-N
25098	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5906	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07088	C20H28N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWXWAYUCJVQHOR-KRWDZBQOSA-N
25099	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5906	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07088	C20H28N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWXWAYUCJVQHOR-KRWDZBQOSA-N
25100	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5907	N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide	-	-	DRUGBANK	DB07089	C22H22ClN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZSMTBLDWPKVRW-UHFFFAOYSA-N
25101	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5909	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07091	C21H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWPMQJKXKKKSEY-SFHVURJKSA-N
25102	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5909	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07091	C21H30N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWPMQJKXKKKSEY-SFHVURJKSA-N
25103	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5910	(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE	-	-	DRUGBANK	DB07092	C22H30F2N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNAZOMVWUGPITI-LNMJFAINSA-N
25104	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5911	{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID	-	-	DRUGBANK	DB07093	C14H10ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQWICELTTDJODO-UHFFFAOYSA-N
25105	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5912	1-(2,2'-bithiophen-5-yl)methanamine	-	-	DRUGBANK	DB07094	C9H9NS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHYTVXBZSXZMGD-UHFFFAOYSA-N
25106	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5913	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07095	C21H30N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNCHHUFGEOJCNH-SFHVURJKSA-N
25107	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5913	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07095	C21H30N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNCHHUFGEOJCNH-SFHVURJKSA-N
25108	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5914	6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE	-	-	DRUGBANK	DB07096	C12H8N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSMIFVHARFVINF-UHFFFAOYSA-N
25109	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5917	N-[4-(benzyloxy)phenyl]glycinamide	-	-	DRUGBANK	DB07099	C15H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJPUATSIKWOSST-UHFFFAOYSA-N
25110	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5918	4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB07100	C13H15ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFPHEBUOQYYPDO-UHFFFAOYSA-N
25111	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5919	N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide	-	-	DRUGBANK	DB07101	C16H14F3IN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUDAHWBOROXANE-SECBINFHSA-N
25112	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5920	(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid	-	-	DRUGBANK	DB07102	C18H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYSBXIPCDJNEBG-INIZCTEOSA-N
25113	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5922	4-amino-N-[4-(benzyloxy)phenyl]butanamide	-	-	DRUGBANK	DB07104	C17H20N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTWBKNVNGVYTNZ-UHFFFAOYSA-N
25114	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5923	2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE	-	-	DRUGBANK	DB07105	C18H20ClN5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEEYGOJDTRVYGR-HNNXBMFYSA-N
25115	109418	3176	-	HNMT	HMT|HNMT-S1|HNMT-S2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5924	4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE	-	-	DRUGBANK	DB07106	C7H17N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFYJLJINUGVUHO-UHFFFAOYSA-N
25116	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5925	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	-	-	DRUGBANK	DB07107	C23H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGHXFHRRWFLILP-XJDXJNMNSA-N
25117	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5925	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	-	-	DRUGBANK	DB07107	C23H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGHXFHRRWFLILP-XJDXJNMNSA-N
25118	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5926	4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID	-	-	DRUGBANK	DB07108	C13H9FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXWNTLBMNCXRQN-UHFFFAOYSA-N
25119	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5928	4-(4-FLUOROBENZYL)PIPERIDINE	-	-	DRUGBANK	DB07110	C12H16FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLAKCHGEEBPDQI-UHFFFAOYSA-N
25120	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5929	(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid	-	-	DRUGBANK	DB07111	C22H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFRKCNPQVIJFAQ-HBUOOPIGSA-N
25121	120060	54583	PNAS-118	EGLN1	C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5930	N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE	-	-	DRUGBANK	DB07112	C12H9IN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FUMNLXHPILGSLC-UHFFFAOYSA-N
25122	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5931	(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE	-	-	DRUGBANK	DB07113	C24H25F2N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHZQOXQOUCGGGA-NRFANRHFSA-N
25123	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	5932	4-[(METHYLSULFONYL)AMINO]BENZOIC ACID	-	-	DRUGBANK	DB07114	C8H9NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SROHFTOYGFCJAF-UHFFFAOYSA-N
25124	132020	377677	-	CA13	CAXIII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5933	N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide	-	-	DRUGBANK	DB07115	C14H15ClN2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPPUTOHDQOYDIL-UHFFFAOYSA-N
25125	113220	7374	-	UNG	DGU|HIGM4|HIGM5|UDG|UNG1|UNG15|UNG2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5934	1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE	-	-	DRUGBANK	DB07116	C14H18NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXXYPWCUINVUHL-BFHYXJOUSA-N
25126	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5935	5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE	-	-	DRUGBANK	DB07117	C24H22N6O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMKQJGOROFNCGM-UHFFFAOYSA-N
25127	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5937	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	-	-	DRUGBANK	DB07119	C16H11ClO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHEHVRSGKUYDON-UHFFFAOYSA-N
25128	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5937	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	-	-	DRUGBANK	DB07119	C16H11ClO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHEHVRSGKUYDON-UHFFFAOYSA-N
25129	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5938	N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE	-	-	DRUGBANK	DB07120	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLXOHIUDKNRVBZ-UHFFFAOYSA-N
25130	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5939	4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07121	C17H23N3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANXPIMDONQTQF-HNNXBMFYSA-N
25131	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5940	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	-	-	DRUGBANK	DB07122	C15H15N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MERNPSIIBFTCAI-UHFFFAOYSA-N
25132	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5942	(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB07124	C22H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCIACUJJBPSOHE-KRWDZBQOSA-N
25133	107983	1613	-	DAPK3	DLK|ZIP|ZIPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5943	4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid	-	-	DRUGBANK	DB07125	C17H18N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKZYGUVAFJCULH-CYBMUJFWSA-N
25134	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5944	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	-	-	DRUGBANK	DB07126	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWXORKPNCHJYOF-UHFFFAOYSA-N
25135	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5944	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	-	-	DRUGBANK	DB07126	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWXORKPNCHJYOF-UHFFFAOYSA-N
25136	111751	5787	-	PTPRB	HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5945	{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID	-	-	DRUGBANK	DB07127	C21H21N5O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXDBFKLPNPUPRI-UHFFFAOYSA-N
25137	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5946	N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE	-	-	DRUGBANK	DB07128	C17H21ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTYBIJUAAWLJNU-UHFFFAOYSA-N
25138	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5947	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	-	-	DRUGBANK	DB07129	C11H17NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPIATFUUWWMKC-SNVBAGLBSA-N
25139	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5948	4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07130	C13H9BrO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVDWLRCTJUXCCB-UHFFFAOYSA-N
25140	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5949	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07131	C22H32N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOTBZTLJSXFKCP-IBGZPJMESA-N
25141	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5949	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	-	-	DRUGBANK	DB07131	C22H32N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOTBZTLJSXFKCP-IBGZPJMESA-N
25142	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5950	1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA	-	-	DRUGBANK	DB07132	C15H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJDBLWKTHMHALD-QMMMGPOBSA-N
25143	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5951	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	-	-	DRUGBANK	DB07133	C22H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHKWABXWPATIIG-UXHICEINSA-N
25144	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5952	5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	-	-	DRUGBANK	DB07134	C12H9ClN2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCPRWBWCEGWNKF-UHFFFAOYSA-N
25145	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5953	(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE	-	-	DRUGBANK	DB07135	C22H31FN6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPWDKZWKUOYOHA-UKSSEWCLSA-N
25146	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5954	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	-	-	DRUGBANK	DB07136	C23H33N2O6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFFOOKSVFDUPDH-FCHUYYIVSA-N
25147	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5955	(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE	-	-	DRUGBANK	DB07137	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPAWNIKVRIVDBT-PORMKJMCSA-N
25148	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5955	(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE	-	-	DRUGBANK	DB07137	C18H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPAWNIKVRIVDBT-PORMKJMCSA-N
25149	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5956	5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one	-	-	DRUGBANK	DB07138	C19H9Cl2F2N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEPKQEUBKLEPRA-UHFFFAOYSA-N
25150	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5957	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	-	-	DRUGBANK	DB07139	C13H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHKCOKRMJRDWAL-UHFFFAOYSA-N
25151	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5958	5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	-	-	DRUGBANK	DB07140	C22H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPENSYBRTSIYGO-AWEZNQCLSA-N
25152	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5959	5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	-	-	DRUGBANK	DB07141	C23H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVXYJVHNRPNRJL-HNNXBMFYSA-N
25153	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5960	5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	-	-	DRUGBANK	DB07142	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATFDKOLABYIYCC-INIZCTEOSA-N
25154	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5961	D-phenylalanyl-N-benzyl-L-prolinamide	-	-	DRUGBANK	DB07143	C21H25N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEPJWLFTTFHOQO-MOPGFXCFSA-N
25155	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5962	5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	-	-	DRUGBANK	DB07144	C24H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXVRKHUCSXVBM-AWEZNQCLSA-N
25156	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5963	(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE	-	-	DRUGBANK	DB07145	C25H27N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDMIPBHQKFOFQW-NSYGIPOTSA-N
25157	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5964	2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE	-	-	DRUGBANK	DB07146	C25H26N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUIQCYFSBGOBKE-UHFFFAOYSA-N
25158	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5965	methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate	-	-	DRUGBANK	DB07147	C24H24N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJWMYFBKJRVWJY-YKSBVNFPSA-N
25159	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5966	(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one	-	-	DRUGBANK	DB07148	C19H17ClFN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPAFVLDARQIHPU-HNNXBMFYSA-N
25160	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5967	(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	-	-	DRUGBANK	DB07149	C13H14FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCBAQTCTQXHTJG-ZETCQYMHSA-N
25161	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5968	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	-	-	DRUGBANK	DB07150	C17H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYQQTWUZKPWPRL-WOJGMQOQSA-N
25162	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5968	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	-	-	DRUGBANK	DB07150	C17H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYQQTWUZKPWPRL-WOJGMQOQSA-N
25163	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5969	4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one	-	-	DRUGBANK	DB07151	C17H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZXKZZMGLACNIJ-UHFFFAOYSA-N
25164	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5970	N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide	-	-	DRUGBANK	DB07152	C19H15FN6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYPILNNEZPSNTI-UHFFFAOYSA-N
25165	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5972	(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE	-	-	DRUGBANK	DB07154	C16H20F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWKGZJAAGSVROJ-MWLCHTKSSA-N
25166	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5974	(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione	-	-	DRUGBANK	DB07156	C21H20BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JFEKAVPMVOLVTH-UNOMPAQXSA-N
25167	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5975	(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE	-	-	DRUGBANK	DB07157	C21H27N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTFGEFWZCFCODU-RBUKOAKNSA-N
25168	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5976	5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE	-	-	DRUGBANK	DB07158	C13H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASEHARDUZDZEKS-UHFFFAOYSA-N
25169	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5977	6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one	-	-	DRUGBANK	DB07159	C22H23FN6O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHHQJBCNYHBUSI-UHFFFAOYSA-N
25170	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5978	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE	-	-	DRUGBANK	DB07160	C12H19NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZJYLQZZISBOTF-JBDRJPRFSA-N
25171	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5979	5-phenyl-1H-indazol-3-amine	-	-	DRUGBANK	DB07161	C13H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCUSNQPYUNLATP-UHFFFAOYSA-N
25172	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5980	4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide	-	-	DRUGBANK	DB07162	C17H20N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFJCXIOVAGJCKB-UHFFFAOYSA-N
25173	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5981	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	-	-	DRUGBANK	DB07163	C17H15FN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQCXWWWNUFQYJS-UHFFFAOYSA-N
25174	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5982	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	-	-	DRUGBANK	DB07164	C13H12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAGHIASAHLPQMS-UHFFFAOYSA-N
25175	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5982	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	-	-	DRUGBANK	DB07164	C13H12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAGHIASAHLPQMS-UHFFFAOYSA-N
25176	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5983	N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE	-	-	DRUGBANK	DB07165	C22H23Cl2N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOBGXPPOYFFGTK-UGKGYDQZSA-N
25177	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5984	5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE	-	-	DRUGBANK	DB07167	C19H21N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNPCFFIJVKYGHR-UHFFFAOYSA-N
25178	107266	816	-	CAMK2B	CAM2|CAMK2|CAMKB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5985	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile	-	-	DRUGBANK	DB07168	C19H20N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFMSRHREFZCFSN-UHFFFAOYSA-N
25179	108218	1889	RP3-329E20.1	ECE1	ECE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5988	5-(2-hydroxyethyl)nonane-1,9-diol	-	-	DRUGBANK	DB07171	C11H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VICIXNZSEUYGFV-UHFFFAOYSA-N
25180	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5989	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	-	-	DRUGBANK	DB07172	C20H30O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTAGQROYQYQRHF-CBVHGRPESA-N
25181	106644	132	-	ADK	AK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5990	7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB07173	C11H13IN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTXUAWGNGBSCRS-TZQXKBMNSA-N
25182	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5991	6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE	-	-	DRUGBANK	DB07174	C20H27N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPAPODFGOZXFLG-UHFFFAOYSA-N
25183	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5992	N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide	-	-	DRUGBANK	DB07175	C18H18N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXQRKICWSCAUGW-UHFFFAOYSA-N
25184	116604	22949	RP11-16L21.1	PTGR1	LTB4DH|PGR1|ZADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5994	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	-	-	DRUGBANK	DB07177	C20H30O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRTJDWROBKPZNV-DYTRGIJQSA-N
25185	126915	145482	-	PTGR2	HEL-S-298|PGR2|ZADH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5994	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	-	-	DRUGBANK	DB07177	C20H30O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRTJDWROBKPZNV-DYTRGIJQSA-N
25186	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5996	3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide	-	-	DRUGBANK	DB07179	C19H16BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXUJQXZHHGJMFM-UHFFFAOYSA-N
25187	110826	4751	-	NEK2	HsPK21|NEK2A|NLK1|PPP1R111|RP67	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5997	5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07180	C17H16ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIRPCWHHIWFKCD-GHXNOFRVSA-N
25188	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5998	4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide	-	-	DRUGBANK	DB07181	C21H18F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYKFWUXBFJJDTP-HXUWFJFHSA-N
25189	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5999	(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID	-	-	DRUGBANK	DB07182	C19H24N3O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFRHWTYCVGKGIE-KRWDZBQOSA-N
25190	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6000	N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide	-	-	DRUGBANK	DB07183	C24H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPVRYQAOUPSUDO-UHFFFAOYSA-N
25191	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6003	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	-	-	DRUGBANK	DB07186	C23H24N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYYNSDQVFIOSFH-UHFFFAOYSA-N
25192	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6003	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	-	-	DRUGBANK	DB07186	C23H24N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYYNSDQVFIOSFH-UHFFFAOYSA-N
25193	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6004	6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE	-	-	DRUGBANK	DB07187	C13H9ClN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXFPQPNUMWQRAO-UHFFFAOYSA-N
25194	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6006	(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid	-	-	DRUGBANK	DB07189	C29H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFZXMIUWGSTUAL-ZSOKXDGFSA-N
25195	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6007	3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide	-	-	DRUGBANK	DB07190	C21H30ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGFCNVHEEMBVJG-MOPGFXCFSA-N
25196	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6010	(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine	-	-	DRUGBANK	DB07193	C18H16F3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJJAYSSCWGUPKO-ABAIWWIYSA-N
25197	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6011	2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide	-	-	DRUGBANK	DB07194	C20H23N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGXADGTBNRSGV-ZDUSSCGKSA-N
25198	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6012	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07195	C18H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTZWKYVREFMAJA-QXWBOSQLSA-N
25199	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6012	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB07195	C18H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTZWKYVREFMAJA-QXWBOSQLSA-N
25200	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6013	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	-	-	DRUGBANK	DB07196	C12H13NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRKJJEJYTBOUTH-UHFFFAOYSA-N
25201	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6014	4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07197	C13H9BrO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZWUMLLRAVGBHC-UHFFFAOYSA-N
25202	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6015	5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE	-	-	DRUGBANK	DB07198	C15H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEKOZPXKBYLNK-UHFFFAOYSA-N
25203	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6015	5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE	-	-	DRUGBANK	DB07198	C15H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEKOZPXKBYLNK-UHFFFAOYSA-N
25204	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6019	6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07202	C19H13ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QINNOQKHPLWGBK-UHFFFAOYSA-N
25205	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6020	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	-	-	DRUGBANK	DB07203	C18H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUEGMEMDEAOAEG-UHFFFAOYSA-N
25206	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6020	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	-	-	DRUGBANK	DB07203	C18H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUEGMEMDEAOAEG-UHFFFAOYSA-N
25207	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6021	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	-	-	DRUGBANK	DB07204	C24H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQIXTEDFNFZMCM-SFHVURJKSA-N
25208	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6021	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	-	-	DRUGBANK	DB07204	C24H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQIXTEDFNFZMCM-SFHVURJKSA-N
25209	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6022	N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	-	-	DRUGBANK	DB07205	C15H24N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZJXCRHEMLAMRA-SDBHATRESA-N
25210	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6023	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE	-	-	DRUGBANK	DB07206	C15H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OSHSZKRWKLQZBV-UHFFFAOYSA-N
25211	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6024	2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB07207	C17H14N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKSIVONWCYACAP-UHFFFAOYSA-N
25212	108451	2152	-	F3	CD142|TF|TFA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6024	2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	-	-	DRUGBANK	DB07207	C17H14N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKSIVONWCYACAP-UHFFFAOYSA-N
25213	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6025	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	-	-	DRUGBANK	DB07208	C18H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFOOCZBVPQYRS-PSDPTOBYSA-N
25214	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6026	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	-	-	DRUGBANK	DB07209	C18H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLHUENSFQCPBQH-ZBKJIUGYSA-N
25215	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6027	3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB07210	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JECHSYMSTXETFI-UHFFFAOYSA-N
25216	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6028	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE	-	-	DRUGBANK	DB07211	C18H24ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMJHMJLNQLVUAV-GHYUOPHCSA-N
25217	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6028	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE	-	-	DRUGBANK	DB07211	C18H24ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMJHMJLNQLVUAV-GHYUOPHCSA-N
25218	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6029	N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE	-	-	DRUGBANK	DB07212	C19H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNGZRCYXFBHMRM-UHFFFAOYSA-N
25219	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6030	(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL	-	-	DRUGBANK	DB07213	C24H25N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FNWHPLLNMLOZTL-UHFFFAOYSA-N
25220	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6031	2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID	-	-	DRUGBANK	DB07215	C23H21F3N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILUPZUOBHCUBKB-UHFFFAOYSA-N
25221	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6031	2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID	-	-	DRUGBANK	DB07215	C23H21F3N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILUPZUOBHCUBKB-UHFFFAOYSA-N
25222	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6032	(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE	-	-	DRUGBANK	DB07216	C24H29ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMGCFGGMTCMSDP-QHCPKHFHSA-N
25223	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6032	(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE	-	-	DRUGBANK	DB07216	C24H29ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMGCFGGMTCMSDP-QHCPKHFHSA-N
25224	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6033	N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide	-	-	DRUGBANK	DB07217	C16H13FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVYPYORTKAIUGJ-UHFFFAOYSA-N
25225	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6034	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	-	-	DRUGBANK	DB07218	C12H10ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYKGPCNWPACUQV-UHFFFAOYSA-N
25226	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6034	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	-	-	DRUGBANK	DB07218	C12H10ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYKGPCNWPACUQV-UHFFFAOYSA-N
25227	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6035	BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	-	-	DRUGBANK	DB07219	C25H35N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMQNYWZURFTFHE-MQBSTWLZSA-N
25228	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6036	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	-	-	DRUGBANK	DB07220	C23H27N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXYIRNXOAJYLCU-UHFFFAOYSA-N
25229	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6037	(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM	-	-	DRUGBANK	DB07221	C16H38O6P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCMHKGWUOSRYCF-UHFFFAOYSA-O
25230	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6039	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	-	-	DRUGBANK	DB07223	C19H31N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWSRLSPWIEMLQ-YTFOTSKYSA-N
25231	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6040	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE	-	-	DRUGBANK	DB07224	C15H24N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FCCIQOJEDMDETP-QHZLYTNSSA-N
25232	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6041	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE	-	-	DRUGBANK	DB07225	C18H30N2O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFABOFMUPCWOPC-LHEWDLALSA-N
25233	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6042	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	-	-	DRUGBANK	DB07226	C21H12ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWZVNUNTFNELHL-UHFFFAOYSA-N
25234	111250	5229	-	PGGT1B	BGGI|GGTI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6043	4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE	-	-	DRUGBANK	DB07227	C22H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNUGFGAVPBYSHF-UHFFFAOYSA-N
25235	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6043	4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE	-	-	DRUGBANK	DB07227	C22H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNUGFGAVPBYSHF-UHFFFAOYSA-N
25236	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6043	4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE	-	-	DRUGBANK	DB07227	C22H20ClN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNUGFGAVPBYSHF-UHFFFAOYSA-N
25237	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6044	1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA	-	-	DRUGBANK	DB07228	C17H22ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIAYFZLMPSVQDV-NSHDSACASA-N
25238	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6045	3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE	-	-	DRUGBANK	DB07229	C22H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MINVOLKUPZPDNX-UHFFFAOYSA-N
25239	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6046	3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE	-	-	DRUGBANK	DB07230	C15H9BrO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHPCBFMFERFZLR-UHFFFAOYSA-N
25240	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6046	3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE	-	-	DRUGBANK	DB07230	C15H9BrO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHPCBFMFERFZLR-UHFFFAOYSA-N
25241	107888	1508	-	CTSB	APPS|CPSB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6047	N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE	-	-	DRUGBANK	DB07231	C22H29N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MERYMLLGRCNRKE-HILJTLORSA-N
25242	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6048	Veliparib	2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide|(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium	-	DRUGBANK	DB07232	C13H16N4O	small molecule	-	912444-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNAHVYVRKWKWKQ-CYBMUJFWSA-N
25243	115350	10038	-	PARP2	ADPRT2|ADPRTL2|ADPRTL3|ARTD2|PARP-2|pADPRT-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6048	Veliparib	2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide|(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium	-	DRUGBANK	DB07232	C13H16N4O	small molecule	-	912444-00-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNAHVYVRKWKWKQ-CYBMUJFWSA-N
25244	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6049	N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan	-	-	DRUGBANK	DB07233	C22H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFVPXERGVLDWIS-OAQYLSRUSA-N
25245	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6050	3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	-	-	DRUGBANK	DB07234	C17H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCBPNFWHHNJTGN-LLVKDONJSA-N
25246	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6051	N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07235	C19H19Cl2N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHOVRZGUSBMKKU-ZDUSSCGKSA-N
25247	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6052	3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL	-	-	DRUGBANK	DB07236	C17H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCGSYJVWLGYWTD-UHFFFAOYSA-N
25248	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6052	3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL	-	-	DRUGBANK	DB07236	C17H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCGSYJVWLGYWTD-UHFFFAOYSA-N
25249	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6053	{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone	-	-	DRUGBANK	DB07237	C22H21NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUWFJUJWAWMRQN-HXUWFJFHSA-N
25250	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6055	7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile	-	-	DRUGBANK	DB07239	C16H13ClN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJLVMTVZVJSNHG-UHFFFAOYSA-N
25251	107983	1613	-	DAPK3	DLK|ZIP|ZIPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6058	(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	-	-	DRUGBANK	DB07242	C18H18Cl2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGUIMGJMQKZRGM-LLVKDONJSA-N
25252	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6058	(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	-	-	DRUGBANK	DB07242	C18H18Cl2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGUIMGJMQKZRGM-LLVKDONJSA-N
25253	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6059	(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE	-	-	DRUGBANK	DB07243	C16H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQGFCATXRXQKNB-GDNZZTSVSA-N
25254	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6060	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07244	C19H19F2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRRWXMSVQYQCRX-UHFFFAOYSA-N
25255	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6060	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07244	C19H19F2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRRWXMSVQYQCRX-UHFFFAOYSA-N
25256	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6061	6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE	-	-	DRUGBANK	DB07245	C20H20N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEVBKBAFFJKFJZ-UHFFFAOYSA-N
25257	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6062	(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE	-	-	DRUGBANK	DB07246	C16H15F3N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKRPIBSCGZAUCH-OAHLLOKOSA-N
25258	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6063	[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA	-	-	DRUGBANK	DB07247	C21H18N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRPOHNDQBDHONJ-UHFFFAOYSA-N
25259	108451	2152	-	F3	CD142|TF|TFA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6063	[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA	-	-	DRUGBANK	DB07247	C21H18N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRPOHNDQBDHONJ-UHFFFAOYSA-N
25260	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6064	7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE	-	-	DRUGBANK	DB07248	C20H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YENZSPIOXMNEFF-UHFFFAOYSA-N
25261	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6065	N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine	-	-	DRUGBANK	DB07249	C24H27ClN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHIMVPIOWKYPSO-UHFFFAOYSA-N
25262	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6066	N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07250	C20H19ClN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMKLUOPMOJOUDZ-UHFFFAOYSA-N
25263	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6067	N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB07251	C19H20ClN5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVWFECUPYCFYBL-UHFFFAOYSA-N
25264	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6068	3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide	-	-	DRUGBANK	DB07252	C17H14ClN5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZHCXOMEOHEZDX-UHFFFAOYSA-N
25265	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6069	N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine	-	-	DRUGBANK	DB07253	C18H15ClN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTFCKBFCXDAZIU-UHFFFAOYSA-N
25266	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6070	N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE	-	-	DRUGBANK	DB07254	C18H16ClN5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQGTYXRWSIBDOZ-UHFFFAOYSA-N
25267	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6071	N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07255	C21H20ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNEWIQAEGKQNCE-UHFFFAOYSA-N
25268	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6072	3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE	-	-	DRUGBANK	DB07256	C18H14ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVQZIVCQLFGXFZ-UHFFFAOYSA-N
25269	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6073	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	-	-	DRUGBANK	DB07257	C19H15ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHMQZCPGFZBLBG-UHFFFAOYSA-N
25270	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6074	(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol	-	-	DRUGBANK	DB07258	C18H22N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQRJWLDQBNAQCC-GOSISDBHSA-N
25271	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6075	1-(4-thiophen-2-ylphenyl)methanamine	-	-	DRUGBANK	DB07259	C11H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKNLMMDEWQZCLJ-UHFFFAOYSA-N
25272	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6076	N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline	-	-	DRUGBANK	DB07260	C18H22N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HITMFLNAOQIZSN-QGZVFWFLSA-N
25273	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6077	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE	-	-	DRUGBANK	DB07261	C21H19N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVKDOURNRJCKJE-INIZCTEOSA-N
25274	849191	944790	b0048	folA	ECK0049|JW0047|tmrA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6078	1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE	-	-	DRUGBANK	DB07262	C10H11F3N4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWJNPCRXBNWCJC-UHFFFAOYSA-N
25275	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6079	[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid	-	-	DRUGBANK	DB07263	C22H18BrF2O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDTMVBQZDFMOIK-GOSISDBHSA-N
25276	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6080	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07264	C22H17Cl2FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMUYGRBBEDYUOP-HXUWFJFHSA-N
25277	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6081	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	-	-	DRUGBANK	DB07265	C23H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDARUOOLJCFUOY-UHFFFAOYSA-N
25278	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6082	8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one	-	-	DRUGBANK	DB07266	C21H24N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMMPEGZDRAGRC-UHFFFAOYSA-N
25279	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6083	2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine	-	-	DRUGBANK	DB07267	C19H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JONFDFIXMPXTRH-UHFFFAOYSA-N
25280	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6084	2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE	-	-	DRUGBANK	DB07268	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHPKKGUGRGRSGA-UHFFFAOYSA-N
25281	107752	1360	-	CPB1	CPB|PASP|PCPB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6085	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID	-	-	DRUGBANK	DB07269	C22H29N2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFUOOKBZBVUDBC-VQTJNVASSA-N
25282	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6086	N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE	-	-	DRUGBANK	DB07270	C20H15Cl2N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAYYMURZGLJDCT-UHFFFAOYSA-N
25283	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6087	(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE	-	-	DRUGBANK	DB07271	C17H19F6N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMDAPSXWBVPVOG-QMTHXVAHSA-N
25284	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6088	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	-	-	DRUGBANK	DB07272	C18H19BrN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKODDLYLEKSDJL-UHFFFAOYSA-N
25285	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6088	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	-	-	DRUGBANK	DB07272	C18H19BrN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKODDLYLEKSDJL-UHFFFAOYSA-N
25286	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6090	N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide	-	-	DRUGBANK	DB07274	C25H22N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZATGFXTWDKIEKC-UHFFFAOYSA-N
25287	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6092	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07276	C18H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGKZYFYGCWXMN-UHFFFAOYSA-N
25288	114864	9479	-	MAPK8IP1	IB1|JIP-1|JIP1|PRKM8IP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6092	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07276	C18H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEGKZYFYGCWXMN-UHFFFAOYSA-N
25289	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6093	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE	-	-	DRUGBANK	DB07277	C17H24ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAUZEBLXCOCAFL-JSGCOSHPSA-N
25290	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6093	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE	-	-	DRUGBANK	DB07277	C17H24ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IAUZEBLXCOCAFL-JSGCOSHPSA-N
25291	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6094	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE	-	-	DRUGBANK	DB07278	C17H22ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACEFOQMQINFMRW-DYCFVMESSA-N
25292	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6094	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE	-	-	DRUGBANK	DB07278	C17H22ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACEFOQMQINFMRW-DYCFVMESSA-N
25293	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6095	N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE	-	-	DRUGBANK	DB07279	C21H29N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMPSZYHYDMQFEO-KRWDZBQOSA-N
25294	106644	132	-	ADK	AK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6096	5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB07280	C23H24N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AINVOEOJEKKMKB-UHFFFAOYSA-N
25295	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6097	N~3~-BENZYLPYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07281	C12H13N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUKAGFLFIMVSQN-UHFFFAOYSA-N
25296	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6100	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07284	C17H16N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NQSBHBFOOVYRNM-UHFFFAOYSA-N
25297	110461	4318	-	MMP9	CLG4B|GELB|MANDP2|MMP-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6101	(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID	-	-	DRUGBANK	DB07285	C11H12F2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBQLOVWIRUXBAW-SECBINFHSA-N
25298	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6102	2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE	-	-	DRUGBANK	DB07286	C14H12ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEJORAMIZFOODM-PWSUYJOCSA-N
25299	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6104	N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide	-	-	DRUGBANK	DB07288	C19H16ClN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGPZCOONYBPZEW-UHFFFAOYSA-N
25300	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6105	5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07289	C20H16BrNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEQPGVUGYAUMSA-UHFFFAOYSA-N
25301	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6108	4-(2-amino-1,3-thiazol-4-yl)phenol	-	-	DRUGBANK	DB07292	C9H8N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGSJYYIRAFRPIT-UHFFFAOYSA-N
25302	111851	5916	-	RARG	NR1B3|RARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6110	3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID	-	-	DRUGBANK	DB07294	C23H26FNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AANFHDFOMFRLLR-IBGZPJMESA-N
25303	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6111	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	-	-	DRUGBANK	DB07295	C19H13NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGOULVZYQKJJKC-UHFFFAOYSA-N
25304	852766	948470	b3972	murB	ECK3964|JW3940|yijB	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6112	(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE	-	-	DRUGBANK	DB07296	C21H13ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLGHLEBIWUQEPR-PDGQHHTCSA-N
25305	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6113	5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB07297	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTILEOLOGGMFCS-UHFFFAOYSA-N
25306	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6114	3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07298	C10H7NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGZSWLHKOMFYHS-UHFFFAOYSA-N
25307	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6115	4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE	-	-	DRUGBANK	DB07299	C20H36N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXELQWLUDMEUHS-HOCLYGCPSA-N
25308	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6116	2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine	-	-	DRUGBANK	DB07300	C19H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSSGYSRUMIOURP-UHFFFAOYSA-N
25309	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6118	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	-	-	DRUGBANK	DB07302	C18H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPDSHTNEKLQQIJ-UINYOVNOSA-N
25310	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6119	N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07303	C18H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PGAWZMRRCVSRIM-UHFFFAOYSA-N
25311	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6120	5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID	-	-	DRUGBANK	DB07304	C12H7F3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSLFQKRPFOCZHR-UHFFFAOYSA-N
25312	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6121	5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID	-	-	DRUGBANK	DB07305	C11H6ClNO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDIHNBCCQWMVBW-UHFFFAOYSA-N
25313	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6122	ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	-	-	DRUGBANK	DB07306	C13H18ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEYLCGMINXDBN-UHFFFAOYSA-N
25314	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6123	N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide	-	-	DRUGBANK	DB07307	C26H23N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GQXMJOSCBRZMKE-UHFFFAOYSA-N
25315	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6124	5-(2-CHLOROBENZYL)-2-FUROIC ACID	-	-	DRUGBANK	DB07308	C12H9ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRUPEIZURHOLHV-UHFFFAOYSA-N
25316	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6125	5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID	-	-	DRUGBANK	DB07309	C13H9BrClNO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDVLYAYDIMUAAC-UHFFFAOYSA-N
25317	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6126	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	-	-	DRUGBANK	DB07310	C13H12F4N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNHNFKZUNFPPQE-MADCSZMMSA-N
25318	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6127	18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE	-	-	DRUGBANK	DB07311	C16H17ClN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRSWWYITYIOHOP-UHFFFAOYSA-N
25319	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6128	2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07312	C13H7Cl3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCXZHFCBNFFHRC-UHFFFAOYSA-N
25320	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6129	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID	-	-	DRUGBANK	DB07313	C14H13NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXQLTRSIZRSFTR-UHFFFAOYSA-N
25321	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6130	1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA	-	-	DRUGBANK	DB07314	C14H12ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URQYPXQXSVUVRG-UHFFFAOYSA-N
25322	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6131	5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide	-	-	DRUGBANK	DB07315	C17H15ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHCHFGSUYJUEBR-INIZCTEOSA-N
25323	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6132	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	-	-	DRUGBANK	DB07316	C23H30F3N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAVXIEFZKPJZRT-NRFANRHFSA-N
25324	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6133	(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one	-	-	DRUGBANK	DB07317	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKXNPYSVWOVZGX-CMDGGOBGSA-N
25325	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6134	N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE	-	-	DRUGBANK	DB07318	C15H14F2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOAUWUUBSXECNL-LLVKDONJSA-N
25326	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6135	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB07319	C13H10BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXSSKAZHCZWJPP-UHFFFAOYSA-N
25327	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6136	4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID	-	-	DRUGBANK	DB07320	C25H27N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEDLHZCDTXWLOC-SGNKCFNYSA-N
25328	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6137	2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE	-	-	DRUGBANK	DB07321	C20H15Cl2N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOKQLKWXOFRTHE-UHFFFAOYSA-N
25329	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6138	2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	-	-	DRUGBANK	DB07322	C17H17NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRXVUYHFDBLTEL-UHFFFAOYSA-N
25330	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6139	2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	-	-	DRUGBANK	DB07323	C22H25FN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CTZLIARLNXSXGL-ALCCZGGFSA-N
25331	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6140	3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE	-	-	DRUGBANK	DB07324	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUJWSOPIDUWELP-UHFFFAOYSA-N
25332	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6141	N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07325	C17H19N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCOKUBHAJVTVNG-FMIVXFBMSA-N
25333	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6142	6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide	-	-	DRUGBANK	DB07326	C19H11ClF3N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEGRQUWSKADGSP-UHFFFAOYSA-N
25334	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6144	METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE	-	-	DRUGBANK	DB07328	C20H29N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USDCNOQKDUFKRD-IKGGRYGDSA-N
25335	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6145	1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID	-	-	DRUGBANK	DB07329	C13H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVBLRUMXIXUAR-UHFFFAOYSA-N
25336	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6146	trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium	-	-	DRUGBANK	DB07330	C16H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXSIHXHEHABEJX-UHFFFAOYSA-N
25337	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6149	N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07333	C25H24N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRGKAARWVPUWSY-UHFFFAOYSA-N
25338	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6150	N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE	-	-	DRUGBANK	DB07334	C23H21N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTIZPBXCJPQDEM-UHFFFAOYSA-N
25339	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6151	3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL	-	-	DRUGBANK	DB07335	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWYBBCLGEHZSCP-UHFFFAOYSA-N
25340	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6151	3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL	-	-	DRUGBANK	DB07335	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWYBBCLGEHZSCP-UHFFFAOYSA-N
25341	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6152	4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL	-	-	DRUGBANK	DB07336	C21H16N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYPHGCGOSZJXOT-UHFFFAOYSA-N
25342	853994	936311	BSU10140	hemY	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	6154	5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID	-	-	DRUGBANK	DB07338	C14H7ClF3NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUFNQYOELLVIPL-UHFFFAOYSA-N
25343	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6155	(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione	-	-	DRUGBANK	DB07339	C9H9NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPHLQSHHTJORHI-SECBINFHSA-N
25344	109831	3619	-	INCENP	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6156	N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine	-	-	DRUGBANK	DB07340	C21H27N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFLJHSQHILSNCM-UHFFFAOYSA-N
25345	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6156	N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine	-	-	DRUGBANK	DB07340	C21H27N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFLJHSQHILSNCM-UHFFFAOYSA-N
25346	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6157	octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside	-	-	DRUGBANK	DB07341	C20H39NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHTLMVRROQXELT-HTYYFBMYSA-N
25347	109405	3162	CTA-286B10.6	HMOX1	HMOX1D|HO-1|HSP32|bK286B10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6158	1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone	-	-	DRUGBANK	DB07342	C15H20N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBCQJSMDKDHVKG-BVMXXOESSA-N
25348	118161	27349	AL022237.1	MCAT	FASN2C|MCT|MT|NET62|fabD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6160	3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL	-	-	DRUGBANK	DB07344	C12H26O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NJRFAMBTWHGSDE-UHFFFAOYSA-N
25349	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6161	4-(2-aminoethyl)-2-cyclohexylphenol	-	-	DRUGBANK	DB07345	C14H21NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOCCSEDGBYCYLS-UHFFFAOYSA-N
25350	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6162	4-(2-aminoethyl)-2-ethylphenol	-	-	DRUGBANK	DB07346	C10H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDAFQVRTSOETPE-UHFFFAOYSA-N
25351	107009	526	-	ATP6V1B2	ATP6B1B2|ATP6B2|HO57|VATB|VPP3|Vma2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6163	4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE	-	-	DRUGBANK	DB07347	C8H10FNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGSKVZWGBWPBTF-UHFFFAOYSA-N
25352	108868	2597	CDABP0047	GAPDH	G3PD|GAPD|HEL-S-162eP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6163	4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE	-	-	DRUGBANK	DB07347	C8H10FNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGSKVZWGBWPBTF-UHFFFAOYSA-N
25353	114687	9266	-	CYTH2	ARNO|CTS18|CTS18.1|PSCD2|PSCD2L|SEC7L|Sec7p-L|Sec7p-like	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6164	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	-	-	DRUGBANK	DB07348	C16H24O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQNZDYYTLMIZCT-KQPMLPITSA-N
25354	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6164	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	-	-	DRUGBANK	DB07348	C16H24O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQNZDYYTLMIZCT-KQPMLPITSA-N
25355	849871	945497	b0875	aqpZ	ECK0866|JW0859|bniP	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6165	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	-	-	DRUGBANK	DB07349	C19H36O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQSXQYRZHMGKIE-DLBZAZTESA-M
25356	850147	945780	b1225	narH	ECK1219|JW1216|chlC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6165	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	-	-	DRUGBANK	DB07349	C19H36O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQSXQYRZHMGKIE-DLBZAZTESA-M
25357	850175	945808	b1227	narI	ECK1221|JW1218|chlI	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6165	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	-	-	DRUGBANK	DB07349	C19H36O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQSXQYRZHMGKIE-DLBZAZTESA-M
25358	850149	945782	b1224	narG	ECK1218|JW1215|chlC|narC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6165	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	-	-	DRUGBANK	DB07349	C19H36O10P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQSXQYRZHMGKIE-DLBZAZTESA-M
25359	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6166	(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide	-	-	DRUGBANK	DB07350	C16H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFQOXIMRSMFQRI-BQYQJAHWSA-N
25360	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6167	O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE	-	-	DRUGBANK	DB07351	C21H25N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICACWKLCNCPHAM-YJBOKZPZSA-N
25361	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6169	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	-	-	DRUGBANK	DB07353	C11H18N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTBBVHAOBBELOH-KOLCDFICSA-N
25362	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6170	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	-	-	DRUGBANK	DB07354	C19H16NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXDREMZQGAILJU-UHFFFAOYSA-O
25363	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6172	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	-	-	DRUGBANK	DB07356	C14H23N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYVMJMYCUZCIPB-AVGNSLFASA-N
25364	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6173	4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	-	-	DRUGBANK	DB07357	C12H25NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSXUDXAZMKOOST-YBXAARCKSA-N
25365	108915	2645	-	GCK	FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6174	2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide	-	-	DRUGBANK	DB07358	C14H14N6OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JEBOJMQHVUEKBE-UHFFFAOYSA-N
25366	108915	2645	-	GCK	FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6175	3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide	-	-	DRUGBANK	DB07359	C19H15FN6OS3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJTQKYKXCYVFHX-UHFFFAOYSA-N
25367	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6176	1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea	-	-	DRUGBANK	DB07360	C19H15F3N6OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJHXPDTVQKWKHA-UHFFFAOYSA-N
25368	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6177	1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea	-	-	DRUGBANK	DB07361	C18H15ClN6OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAYAUAZLLLJJGH-UHFFFAOYSA-N
25369	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6178	1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea	-	-	DRUGBANK	DB07362	C19H17F3N8OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOLCZAFAGDOUFX-UHFFFAOYSA-N
25370	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6179	THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)	-	-	DRUGBANK	DB07363	C12H14N2O4S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUNRMHMEAWSZQE-UHFFFAOYSA-N
25371	114376	8851	-	CDK5R1	CDK5P35|CDK5R|NCK5A|p23|p25|p35|p35nck5a	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6180	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	-	-	DRUGBANK	DB07364	C16H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRIGRJPRGZCFAS-UHFFFAOYSA-N
25372	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6180	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	-	-	DRUGBANK	DB07364	C16H17N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRIGRJPRGZCFAS-UHFFFAOYSA-N
25373	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6182	2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER	-	-	DRUGBANK	DB07366	C17H26N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOCIXHUQBOUBAK-HNNXBMFYSA-N
25374	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6184	4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB07368	C8H10N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANPBNAUKOUYEGJ-UHFFFAOYSA-N
25375	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6185	N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide	-	-	DRUGBANK	DB07369	C23H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMJLSOJLEXWATP-UHFFFAOYSA-N
25376	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6187	3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID	-	-	DRUGBANK	DB07371	C18H16O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKQINRXZVYBCSC-UHFFFAOYSA-N
25377	112063	6143	-	RPL19	L19	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25378	112058	6138	TCBAP0781	RPL15	DBA12|EC45|L15|RPL10|RPLY10|RPYL10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25379	114752	9349	-	RPL23	L23|rpL17	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25380	117068	23521	-	RPL13A	L13A|TSTA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25381	126711	140801	-	RPL10L	RPL10_5_1358	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25382	119362	51187	My024	RSL24D1	C15orf15|HRP-L30-iso|L30|RLP24|RPL24|RPL24L|TVAS3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25383	112067	6147	-	RPL23A	L23A|MDA20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25384	119308	51121	-	RPL26L1	RPL26P1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25385	112052	6132	-	RPL8	L8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25386	112086	6167	-	RPL37	L37	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25387	112042	6122	OK/SW-cl.32	RPL3	ASC-1|L3|TARBP-B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25388	112055	6135	RP11-223J15.3	RPL11	DBA7|GIG34|L11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25389	110874	4809	CTA-216E10.8	NHP2L1	15.5K|FA-1|FA1|NHPX|OTK27|SNRNP15-5|SNU13|SPAG12|SSFA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKJYKKNCCRKFSL-RDBSUJKOSA-N
25390	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6191	5-BETA-ANDROSTANE-3,17-DIONE	-	-	DRUGBANK	DB07375	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJWOBJTTGJROA-QJISAEMRSA-N
25391	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6191	5-BETA-ANDROSTANE-3,17-DIONE	-	-	DRUGBANK	DB07375	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJWOBJTTGJROA-QJISAEMRSA-N
25392	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6191	5-BETA-ANDROSTANE-3,17-DIONE	-	-	DRUGBANK	DB07375	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAJWOBJTTGJROA-QJISAEMRSA-N
25393	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6192	5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)	-	-	DRUGBANK	DB07376	C12H13NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBEQQKBWUHCIOU-UHFFFAOYSA-N
25394	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6192	5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)	-	-	DRUGBANK	DB07376	C12H13NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBEQQKBWUHCIOU-UHFFFAOYSA-N
25395	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6193	N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE	-	-	DRUGBANK	DB07377	C15H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYBVYIPUGPZRSX-OLZOCXBDSA-N
25396	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6194	4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	-	-	DRUGBANK	DB07378	C14H29NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HABUHWBZDNZBSI-MBJXGIAVSA-N
25397	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6195	(2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol	(2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol|Aminopurvalanol	-	DRUGBANK	DB07379	C19H26ClN7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAMROQQYRRQPDL-OAHLLOKOSA-N
25398	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6196	1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	-	-	DRUGBANK	DB07380	C12H12F3NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTIIYPHJIDENCW-JTQLQIEISA-N
25399	108391	2081	-	ERN1	IRE1|IRE1P|IRE1a|hIRE1p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6198	N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine	-	-	DRUGBANK	DB07382	C17H16N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJNBSTLIALIIEW-UHFFFAOYSA-N
25400	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6199	N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE	-	-	DRUGBANK	DB07383	C12H14F3NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NETPVFJEHOGNPJ-JTQLQIEISA-N
25401	106994	506	-	ATP5B	ATPMB|ATPSB|HEL-S-271	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6200	1-ACETYL-2-CARBOXYPIPERIDINE	-	-	DRUGBANK	DB07384	C8H13NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACZWLDAHFCGCC-ZETCQYMHSA-N
25402	106987	498	-	ATP5A1	ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6200	1-ACETYL-2-CARBOXYPIPERIDINE	-	-	DRUGBANK	DB07384	C8H13NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACZWLDAHFCGCC-ZETCQYMHSA-N
25403	106997	509	RP11-401E9.1	ATP5C1	ATP5C|ATP5CL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6200	1-ACETYL-2-CARBOXYPIPERIDINE	-	-	DRUGBANK	DB07384	C8H13NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACZWLDAHFCGCC-ZETCQYMHSA-N
25404	108072	1728	-	NQO1	DHQU|DIA4|DTD|NMOR1|NMORI|QR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6201	3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE	-	-	DRUGBANK	DB07385	C19H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCSAVLOHDQNB-ZIFPNCEFSA-N
25405	113020	7167	-	TPI1	HEL-S-49|TIM|TPI|TPID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6202	3-(BUTYLSULPHONYL)-PROPANOIC ACID	-	-	DRUGBANK	DB07387	C7H14O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSHVAQAKBLEIEY-UHFFFAOYSA-N
25406	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6203	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	-	-	DRUGBANK	DB07388	C14H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNRMJBWADUSJTA-UHFFFAOYSA-N
25407	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6203	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	-	-	DRUGBANK	DB07388	C14H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNRMJBWADUSJTA-UHFFFAOYSA-N
25408	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6204	N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE	-	-	DRUGBANK	DB07389	C16H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QINCZVSBLITNRD-UHFFFAOYSA-N
25409	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6205	2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE	-	-	DRUGBANK	DB07390	C13H15N5O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKWXKADYTDWZIJ-VIFPVBQESA-N
25410	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6208	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	-	-	DRUGBANK	DB07393	C24H21N2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSKNNHAAFLPYHG-UHFFFAOYSA-N
25411	106994	506	-	ATP5B	ATPMB|ATPSB|HEL-S-271	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6209	AUROVERTIN B	-	-	DRUGBANK	DB07394	C25H32O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXCOFYWOWZJFEA-YJMRODJJSA-N
25412	106987	498	-	ATP5A1	ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6209	AUROVERTIN B	-	-	DRUGBANK	DB07394	C25H32O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXCOFYWOWZJFEA-YJMRODJJSA-N
25413	106997	509	RP11-401E9.1	ATP5C1	ATP5C|ATP5CL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6209	AUROVERTIN B	-	-	DRUGBANK	DB07394	C25H32O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXCOFYWOWZJFEA-YJMRODJJSA-N
25414	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6210	4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid	-	-	DRUGBANK	DB07395	C16H8ClF5N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWQGDIBCFLDHDO-UHFFFAOYSA-N
25415	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6211	1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid	-	-	DRUGBANK	DB07396	C20H17ClF3N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAJJGOCSAXKXBD-UHFFFAOYSA-N
25416	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6212	(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide	-	-	DRUGBANK	DB07397	C22H21N5O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITADELAVAWJACR-NSHDSACASA-N
25417	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6214	1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE	-	-	DRUGBANK	DB07400	C21H33N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEHSFPPTWRQOFS-MSOLQXFVSA-N
25418	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25419	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25420	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25421	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25422	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25423	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25424	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25425	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25426	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25427	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6215	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	-	-	DRUGBANK	DB07401	C22H17N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFDXOXNFNRHQEC-GHRIWEEISA-N
25428	111189	5163	-	PDK1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6217	4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE	-	-	DRUGBANK	DB07403	C19H18ClF3N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTDZLJHKVNTQGZ-GOSISDBHSA-N
25429	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6218	(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID	-	-	DRUGBANK	DB07404	C20H20O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXQQNSYZOQHKHD-UHFFFAOYSA-N
25430	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6219	1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE	-	-	DRUGBANK	DB07405	C19H16F2N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIZYIOOBBUHOBS-UHFFFAOYSA-N
25431	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6220	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	-	-	DRUGBANK	DB07406	C21H24N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWFFPYQWUWLDBV-NSHDSACASA-N
25432	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6221	5-(2-METHOXYPHENYL)-2-FUROIC ACID	-	-	DRUGBANK	DB07407	C12H10O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHWVDGYLKPLBES-UHFFFAOYSA-N
25433	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6222	5-(2-NITROPHENYL)-2-FUROIC ACID	-	-	DRUGBANK	DB07408	C11H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUFDYUSOQQYQRL-UHFFFAOYSA-N
25434	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6223	(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID	-	-	DRUGBANK	DB07409	C20H20O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPBUFKZCEBTBSK-UHFFFAOYSA-N
25435	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6224	[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID	-	-	DRUGBANK	DB07410	C20H18O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYVXAUZOTGITQZ-UHFFFAOYSA-N
25436	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6224	[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID	-	-	DRUGBANK	DB07410	C20H18O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYVXAUZOTGITQZ-UHFFFAOYSA-N
25437	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6226	1-biphenyl-2-ylmethanamine	-	-	DRUGBANK	DB07412	C13H13N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHXKXVFQHWJYOD-UHFFFAOYSA-N
25438	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6229	4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine	-	-	DRUGBANK	DB07415	C19H19FN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFLOFHKRBGKCOB-AWEZNQCLSA-N
25439	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6230	(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE	-	-	DRUGBANK	DB07416	C16H30O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCEXPOMAGTUEEX-AWEZNQCLSA-N
25440	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6232	(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide	-	-	DRUGBANK	DB07419	C18H13ClF4N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSFVOEAXHZGTRJ-KRWDZBQOSA-N
25441	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6234	4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile	-	-	DRUGBANK	DB07421	C18H16F3N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INVUBEGZQHQAMY-SJORKVTESA-N
25442	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6235	(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide	-	-	DRUGBANK	DB07422	C17H10F8N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMNRWNREMUMYQG-INIZCTEOSA-N
25443	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6236	(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide	-	-	DRUGBANK	DB07423	C19H18F3N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVXVTLGIDOACBJ-SFHVURJKSA-N
25444	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6238	{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid	-	-	DRUGBANK	DB07425	C20H24O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAZTOHXCZPOSA-UHFFFAOYSA-N
25445	112923	7067	-	THRA	AR7|CHNG6|EAR7|ERB-T-1|ERBA|ERBA1|NR1A1|THRA1|THRA2|c-ERBA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6238	{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid	-	-	DRUGBANK	DB07425	C20H24O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNAZTOHXCZPOSA-UHFFFAOYSA-N
25446	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6239	[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)	-	-	DRUGBANK	DB07426	C20H20O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWIARQRYIRVYCM-UHFFFAOYSA-N
25447	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6240	2-[(2-methoxy-5-methylphenoxy)methyl]pyridine	-	-	DRUGBANK	DB07427	C14H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVXQTLSOXWQOHO-UHFFFAOYSA-N
25448	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6240	2-[(2-methoxy-5-methylphenoxy)methyl]pyridine	-	-	DRUGBANK	DB07427	C14H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVXQTLSOXWQOHO-UHFFFAOYSA-N
25449	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6241	4-[(5-methoxy-2-methylphenoxy)methyl]pyridine	-	-	DRUGBANK	DB07428	C14H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBHBRRBLXCXQKV-UHFFFAOYSA-N
25450	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6241	4-[(5-methoxy-2-methylphenoxy)methyl]pyridine	-	-	DRUGBANK	DB07428	C14H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBHBRRBLXCXQKV-UHFFFAOYSA-N
25451	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6243	(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	-	-	DRUGBANK	DB07430	C21H18N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWRPDHVGMHLSZ-GFCCVEGCSA-N
25452	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6244	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	-	-	DRUGBANK	DB07431	C13H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXYKBKYDFZQOCB-SSDOTTSWSA-N
25453	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6244	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	-	-	DRUGBANK	DB07431	C13H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXYKBKYDFZQOCB-SSDOTTSWSA-N
25454	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6246	(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE	-	-	DRUGBANK	DB07433	C11H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNUWNIQGBRBQRE-YUMQZZPRSA-N
25455	119532	51426	-	POLK	DINB1|DINP|POLQ	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6248	1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE	-	-	DRUGBANK	DB07435	C20H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFANZDFKCCJYRF-NSISKUIASA-N
25456	113224	7378	-	UPP1	UDRPASE|UP|UPASE|UPP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6250	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB07437	C14H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPJAGILXQBHHSZ-UHFFFAOYSA-N
25457	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6250	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB07437	C14H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SPJAGILXQBHHSZ-UHFFFAOYSA-N
25458	853235	948987	b3831	udp	ECK3825|JW3808	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6251	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB07439	C21H22N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAWXCABXSPTFRN-UHFFFAOYSA-N
25459	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6252	4-TERT-BUTYLBENZENESULFONIC ACID	-	-	DRUGBANK	DB07440	C10H14O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZQMCUIWYRQLOG-UHFFFAOYSA-N
25460	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6253	3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID	-	-	DRUGBANK	DB07441	C19H17N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRBAOMHMZCGBOJ-UHFFFAOYSA-N
25461	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6253	3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID	-	-	DRUGBANK	DB07441	C19H17N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRBAOMHMZCGBOJ-UHFFFAOYSA-N
25462	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6254	(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide	-	-	DRUGBANK	DB07443	C17H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUVPBAIVOHJDOC-VBKFSLOCSA-N
25463	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6255	6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	-	-	DRUGBANK	DB07444	C19H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PKPNSCZPIWCHMW-UHFFFAOYSA-N
25464	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6257	N-(biphenyl-4-ylsulfonyl)-D-leucine	-	-	DRUGBANK	DB07446	C18H21NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBSVJQQVDISETN-QGZVFWFLSA-N
25465	112596	6718	-	AKR1D1	3o5bred|CBAS2|SRD5B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6258	5-beta-DIHYDROTESTOSTERONE	-	-	DRUGBANK	DB07447	C19H30O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVKAWKQGWWIWPM-MISPCMORSA-N
25466	119248	51056	-	LAP3	HEL-S-106|LAP|LAPEP|PEPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6259	(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid	-	-	DRUGBANK	DB07448	C19H24NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QELOIXSGJMIHBZ-MSOLQXFVSA-N
25467	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6260	N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE	-	-	DRUGBANK	DB07449	C14H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LWFFSSMDFWZNNW-LBPRGKRZSA-N
25468	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6261	2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE	-	-	DRUGBANK	DB07450	C19H11BrF2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMHZAHGTGIZZCT-LJQANCHMSA-N
25469	107924	1544	-	CYP1A2	CP12|P3-450|P450(PA)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6264	2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE	-	-	DRUGBANK	DB07453	C19H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFMMPHCGEFXGIP-UHFFFAOYSA-N
25470	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6265	(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	-	-	DRUGBANK	DB07454	C11H10BrF3N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDSWNDMHSBZXKX-JTQLQIEISA-N
25471	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6266	N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide	-	-	DRUGBANK	DB07455	C20H28N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZESUARCHWPARIF-HOTGVXAUSA-N
25472	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6267	3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	-	-	DRUGBANK	DB07456	C27H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBFDERUQORUFIN-QGZVFWFLSA-N
25473	111196	5170	-	PDPK1	PDK1|PDPK2|PDPK2P|PRO0461	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6268	3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	-	-	DRUGBANK	DB07457	C23H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APYXQTXFRIDSGE-UHFFFAOYSA-N
25474	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6269	3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE	-	-	DRUGBANK	DB07458	C27H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBFDERUQORUFIN-KRWDZBQOSA-N
25475	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6270	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	-	-	DRUGBANK	DB07459	C19H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVLSCZSVTCNAQX-UHFFFAOYSA-N
25476	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6271	2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE	-	-	DRUGBANK	DB07460	C23H25ClN6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYJNQQDJUOUFQJ-UHFFFAOYSA-N
25477	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6272	3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	-	-	DRUGBANK	DB07461	C15H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JVDDTUQPPBUQDD-DZGCQCFKSA-N
25478	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6273	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	-	-	DRUGBANK	DB07462	C13H9NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICLKAUQIPVFHOI-UHFFFAOYSA-N
25479	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6276	(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile	-	-	DRUGBANK	DB07465	C18H25N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGJUIPDUBHWZPV-YQBUGCKMSA-N
25480	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6278	4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide	-	-	DRUGBANK	DB07467	C16H16ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NDDAHWYSQHTHNT-JTQLQIEISA-N
25481	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6279	(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	-	-	DRUGBANK	DB07468	C18H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NJBBBRZNBVLTRZ-GOSISDBHSA-N
25482	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6280	(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	-	-	DRUGBANK	DB07469	C18H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAJFGRLMKVNMLH-GOSISDBHSA-N
25483	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6281	(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	-	-	DRUGBANK	DB07470	C17H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMYOVZXZIZTRD-QGZVFWFLSA-N
25484	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6282	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	-	-	DRUGBANK	DB07471	C22H20ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHCHLTQBLNUYRT-GFCCVEGCSA-N
25485	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6282	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	-	-	DRUGBANK	DB07471	C22H20ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHCHLTQBLNUYRT-GFCCVEGCSA-N
25486	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6285	3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE	-	-	DRUGBANK	DB07474	C22H19N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLTRPHMPCVLOJS-UHFFFAOYSA-N
25501	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6287	N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE	-	-	DRUGBANK	DB07476	C13H12N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRLVIVXGUGNENL-UHFFFAOYSA-N
25502	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6288	BIPHENYL-4-YL-ACETALDEHYDE	-	-	DRUGBANK	DB07477	C14H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRZAKQDHEVVFRX-UHFFFAOYSA-N
25503	111419	5423	-	POLB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6290	(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL	-	-	DRUGBANK	DB07479	C18H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCUHTHVUZQCBTI-KBAYOESNSA-N
25504	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6291	4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN	-	-	DRUGBANK	DB07480	C13H14O8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LGSCVLKUKMBYNC-UHFFFAOYSA-N
25505	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6293	(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE	-	-	DRUGBANK	DB07482	C9H17BN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSBZZZGVAIXJLD-YUMQZZPRSA-N
25506	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6295	(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid	-	-	DRUGBANK	DB07484	C12H15NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGGNZMVODZPHHK-SNVBAGLBSA-N
25507	108407	2104	-	ESRRG	ERR3|ERRgamma|NR3B3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6296	4,4'-cyclohexane-1,1-diyldiphenol	-	-	DRUGBANK	DB07485	C18H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SDDLEVPIDBLVHC-UHFFFAOYSA-N
25508	109889	3683	-	ITGAL	CD11A|LFA-1|LFA1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6297	3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline	-	-	DRUGBANK	DB07486	C21H18F6N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLSZVPNVFKKIRD-FNORWQNLSA-N
25509	107840	1456	-	CSNK1G3	CKI-gamma 3|CSNK1G3L	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6299	{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE	-	-	DRUGBANK	DB07488	C18H17N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQKUGFIWKSKCDL-UHFFFAOYSA-N
25510	107840	1456	-	CSNK1G3	CKI-gamma 3|CSNK1G3L	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6300	{[4-AMINO-2-(3-CHLOROANILINO)-1,3-THIAZOL-5-YL](4-FLUOROPHENYL)METHANONE	-	-	DRUGBANK	DB07489	C16H12ClFN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWGPTHOMFHDEEC-UHFFFAOYSA-O
25511	852959	948667	b4154	frdA	ECK4150|JW4115	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6301	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	-	-	DRUGBANK	DB07490	C14H11ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOZUMFSUQQHSCO-MRVPVSSYSA-N
25512	852960	948668	b4151	frdD	ECK4147|JW4112	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6301	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	-	-	DRUGBANK	DB07490	C14H11ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOZUMFSUQQHSCO-MRVPVSSYSA-N
25513	852958	948666	b4153	frdB	ECK4149|JW4114	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6301	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	-	-	DRUGBANK	DB07490	C14H11ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOZUMFSUQQHSCO-MRVPVSSYSA-N
25514	852972	948680	b4152	frdC	ECK4148|JW4113	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6301	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	-	-	DRUGBANK	DB07490	C14H11ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOZUMFSUQQHSCO-MRVPVSSYSA-N
25515	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6302	5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid	-	-	DRUGBANK	DB07491	C8H4Br3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGKQFJKPOZCZLD-UHFFFAOYSA-N
25516	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6304	(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE	-	-	DRUGBANK	DB07493	C16H9BrN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEQQJQHHJMQETK-YPKPFQOOSA-N
25517	124609	89832	-	CHRFAM7A	CHRNA7|CHRNA7-DR1|D-10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6305	(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE	-	-	DRUGBANK	DB07494	C24H30NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BADPXOSJBUEVTR-WKCHPHFGSA-N
25518	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6306	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07495	C19H18ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNAOTXNHVALTN-UHFFFAOYSA-N
25519	950578	8303012	BSU18239	yngHB	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	6308	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	-	-	DRUGBANK	DB07497	C10H16N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARDNWGMSCXSPBF-CIUDSAMLSA-N
25520	111124	5091	-	PC	PCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6308	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	-	-	DRUGBANK	DB07497	C10H16N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARDNWGMSCXSPBF-CIUDSAMLSA-N
25521	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6309	4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID	-	-	DRUGBANK	DB07498	C12H11N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQQYZJRCWBRIMW-UHFFFAOYSA-N
25522	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6311	(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one	-	-	DRUGBANK	DB07500	C21H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUGCRBMNFSAUOC-YRNVUSSQSA-N
25523	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6312	(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07501	C21H24BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEIJADBULOETOV-KRWDZBQOSA-N
25524	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6313	4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol	-	-	DRUGBANK	DB07502	C13H8BrNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZACPHWPRDKUPK-UHFFFAOYSA-N
25525	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6314	(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07503	C11H5F2NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRLVNYDXMUGOFI-YWEYNIOJSA-N
25526	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6315	(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07504	C21H24BrN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEIJADBULOETOV-QGZVFWFLSA-N
25527	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6317	L-BENZYLSUCCINIC ACID	-	-	DRUGBANK	DB07506	C11H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTOFKXZQQDSVFH-SECBINFHSA-N
25528	121884	59342	MSTP034	SCPEP1	HSCP1|RISC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6317	L-BENZYLSUCCINIC ACID	-	-	DRUGBANK	DB07506	C11H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GTOFKXZQQDSVFH-SECBINFHSA-N
25529	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6319	4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE	-	-	DRUGBANK	DB07508	C22H21N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEUAVGJWGDPTLF-UHFFFAOYSA-N
25530	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6320	difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron	-	-	DRUGBANK	DB07509	C22H31BF2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKJCLYKBRBEKW-UHFFFAOYSA-N
25531	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6323	7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE	-	-	DRUGBANK	DB07512	C17H11ClO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOCADHRNWNJARU-UHFFFAOYSA-N
25532	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6324	7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE	-	-	DRUGBANK	DB07513	C18H16ClNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMGUSOLCNQVZCT-UHFFFAOYSA-N
25533	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6325	3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one	-	-	DRUGBANK	DB07514	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHLGUOHREUTYTO-UHFFFAOYSA-N
25534	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6326	1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL	-	-	DRUGBANK	DB07515	C20H30ClF2N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHPMJMCBRFLML-BCXHYRKLSA-N
25535	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6330	(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	-	-	DRUGBANK	DB07519	C21H25N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDFBMQAUECXNKR-OAQYLSRUSA-N
25536	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6331	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	-	-	DRUGBANK	DB07520	C19H26F4N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJIKKEHGGYGGIX-HOTGVXAUSA-N
25537	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6332	6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL	-	-	DRUGBANK	DB07521	C22H31Cl2N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHTGPUXGIBWHPN-WEYGHZABSA-N
25538	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6333	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE	-	-	DRUGBANK	DB07522	C20H22N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSSWSEQPKCCATQ-VQTJNVASSA-N
25539	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6334	N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine	-	-	DRUGBANK	DB07524	C13H11N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQFGXDQUQWRXLE-UHFFFAOYSA-N
25540	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6335	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	-	-	DRUGBANK	DB07525	C15H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHQCCHWTDLTMJT-UHFFFAOYSA-N
25541	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6337	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07527	C20H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HORGTFOBJRCVMO-ZWKOTPCHSA-N
25542	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6338	3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one	-	-	DRUGBANK	DB07528	C21H15F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXUZQEYFKAZBPX-UHFFFAOYSA-N
25543	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6339	2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE	-	-	DRUGBANK	DB07529	C9H7N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHGOQMPIWSCKBA-FNORWQNLSA-N
25544	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6340	(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol	-	-	DRUGBANK	DB07530	C24H32F6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCHUQQNKOFNVDU-OSXMSNBXSA-N
25545	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6340	(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol	-	-	DRUGBANK	DB07530	C24H32F6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCHUQQNKOFNVDU-OSXMSNBXSA-N
25546	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6341	4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07531	C14H10N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNPRTUHVCHGFHJ-GHXNOFRVSA-N
25547	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6343	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07533	C15H13N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJJJERLTHDXEPT-JYRVWZFOSA-N
25548	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6343	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07533	C15H13N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJJJERLTHDXEPT-JYRVWZFOSA-N
25549	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6344	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07534	C14H11N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKUMVXIXUVYKDQ-GHXNOFRVSA-N
25550	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6344	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07534	C14H11N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKUMVXIXUVYKDQ-GHXNOFRVSA-N
25551	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6345	2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one	-	-	DRUGBANK	DB07535	C14H14N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRAZIAJSKFRSIP-UHFFFAOYSA-N
25552	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6347	N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide	-	-	DRUGBANK	DB07537	C21H26N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLEGTVIMOPPIBR-UHFFFAOYSA-N
25553	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6348	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07538	C15H10F3N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGVVHQNJKUNSFQ-WDZFZDKYSA-N
25554	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6348	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07538	C15H10F3N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGVVHQNJKUNSFQ-WDZFZDKYSA-N
25555	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6349	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	-	-	DRUGBANK	DB07539	C15H10N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRKRQCTYQGDKJ-GHXNOFRVSA-N
25556	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6349	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	-	-	DRUGBANK	DB07539	C15H10N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLRKRQCTYQGDKJ-GHXNOFRVSA-N
25557	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6350	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07540	C15H13N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKFVRSQELXTCFW-JYRVWZFOSA-N
25558	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6351	4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid	-	-	DRUGBANK	DB07541	C17H14BNO8S3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJPKFZAOXOEFHQ-UHFFFAOYSA-N
25559	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6352	5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID	-	-	DRUGBANK	DB07542	C16H31NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INCRGCAIRMMQQJ-ILXRZTDVSA-N
25560	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6353	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	-	-	DRUGBANK	DB07543	C18H22N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQXQGZPYHWWCEB-ZDUSSCGKSA-N
25561	107061	586	RP11-625L16.4	BCAT1	BCATC|BCT1|ECA39|MECA39|PNAS121|PP18	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6354	N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE	-	-	DRUGBANK	DB07544	C16H10ClF3N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLQBZYKAQQWOTK-UHFFFAOYSA-N
25562	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6355	N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE	-	-	DRUGBANK	DB07545	C21H18F3N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDTDWGQDFJPTPD-UHFFFAOYSA-N
25563	107842	1459	-	CSNK2A2	CK2A2|CSNK2A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6356	[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid	-	-	DRUGBANK	DB07546	C20H20N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBYRUZKRFAIQSR-UHFFFAOYSA-N
25564	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6358	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE	-	-	DRUGBANK	DB07548	C20H19F3N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXHWVKOKYDAROD-UHFFFAOYSA-N
25565	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6359	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE	-	-	DRUGBANK	DB07549	C21H23F3N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOYBPRBUPLYTPY-UHFFFAOYSA-P
25566	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6360	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE	-	-	DRUGBANK	DB07550	C20H17ClF3N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIGSBBKEPNQXRG-UHFFFAOYSA-N
25567	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6364	1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine	-	-	DRUGBANK	DB07555	C13H19AsF3NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUSVMAVUPPIHKA-LBPRGKRZSA-N
25568	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6365	N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE	-	-	DRUGBANK	DB07556	C18H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSIZUMJRKYHEBR-QGZVFWFLSA-N
25569	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6365	N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE	-	-	DRUGBANK	DB07556	C18H23N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSIZUMJRKYHEBR-QGZVFWFLSA-N
25570	112596	6718	-	AKR1D1	3o5bred|CBAS2|SRD5B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6366	(5BETA)-PREGNANE-3,20-DIONE	-	-	DRUGBANK	DB07557	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMRPGKVKISIQBV-XWOJZHJZSA-N
25571	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6366	(5BETA)-PREGNANE-3,20-DIONE	-	-	DRUGBANK	DB07557	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMRPGKVKISIQBV-XWOJZHJZSA-N
25572	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6366	(5BETA)-PREGNANE-3,20-DIONE	-	-	DRUGBANK	DB07557	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMRPGKVKISIQBV-XWOJZHJZSA-N
25573	115295	9970	-	NR1I3	CAR|CAR1|MB67	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6366	(5BETA)-PREGNANE-3,20-DIONE	-	-	DRUGBANK	DB07557	C21H32O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMRPGKVKISIQBV-XWOJZHJZSA-N
25574	111661	5688	RP5-1005F21.4	PSMA7	C6|HSPC|RC6-1|XAPC7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6367	ALLN	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|Calpain Inhibitor I|110044-82-1|MG-101|Acetylleucyl-Leucyl-Norleucinal|Calpain Inhibitor I	-	DRUGBANK	DB07558	C20H37N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMYKJLXRRQTBOR-BZSNNMDCSA-N
25575	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6368	(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide	-	-	DRUGBANK	DB07559	C17H12Cl2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDSLONVJHZPSBB-UVTDQMKNSA-N
25576	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6370	(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide	-	-	DRUGBANK	DB07561	C19H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPILZQUCBKIPAZ-AQTBWJFISA-N
25577	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6371	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	-	-	DRUGBANK	DB07562	C17H19N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGGSNQOBRJVAKL-UHFFFAOYSA-N
25578	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6371	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	-	-	DRUGBANK	DB07562	C17H19N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGGSNQOBRJVAKL-UHFFFAOYSA-N
25579	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6372	1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine	-	-	DRUGBANK	DB07563	C25H34N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCJSOJRPNOWSEH-UHFFFAOYSA-N
25580	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6375	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	-	-	DRUGBANK	DB07567	C28H31NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPVKGTWRXBSJKO-LHXLBICKSA-N
25581	849471	945082	b0437	clpP	ECK0431|JW0427|lopP|wseA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6379	N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE	-	-	DRUGBANK	DB07571	C24H32N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUWYQZGBCBSHFK-HSQYWUDLSA-N
25582	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6381	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	-	-	DRUGBANK	DB07573	C15H23NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HVMGGHDPXHODHE-AWEZNQCLSA-N
25583	113603	7846	-	TUBA1A	B-ALPHA-1|LIS3|TUBA3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6382	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	-	-	DRUGBANK	DB07574	C22H25NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYDIWMTWTXFWSY-HNNXBMFYSA-N
25584	124259	84790	-	TUBA1C	TUBA6|bcm948	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6382	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	-	-	DRUGBANK	DB07574	C22H25NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYDIWMTWTXFWSY-HNNXBMFYSA-N
25585	131483	347733	RP11-506K6.1	TUBB2B	PMGYSA|bA506K6.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6382	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	-	-	DRUGBANK	DB07574	C22H25NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYDIWMTWTXFWSY-HNNXBMFYSA-N
25586	115651	10376	-	TUBA1B	K-ALPHA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6382	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	-	-	DRUGBANK	DB07574	C22H25NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYDIWMTWTXFWSY-HNNXBMFYSA-N
25587	123515	81551	-	STMN4	RB3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6382	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	-	-	DRUGBANK	DB07574	C22H25NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TYDIWMTWTXFWSY-HNNXBMFYSA-N
25588	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6384	6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07577	C12H14N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XREDUPOVEQDQQS-UHFFFAOYSA-N
25589	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6386	BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE	-	-	DRUGBANK	DB07579	C16H24N2O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HAVIIPIIAVTNFO-YBHVHWSKSA-N
25590	106822	325	-	APCS	HEL-S-92n|PTX2|SAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6387	BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE	-	-	DRUGBANK	DB07580	C18H26N2O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNQQJZKGGHOMBD-CCNNFCOFSA-N
25591	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6390	(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB07583	C21H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLNNFNGBXLTQOB-RBUKOAKNSA-N
25592	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6390	(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB07583	C21H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLNNFNGBXLTQOB-RBUKOAKNSA-N
25593	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6391	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	-	DRUGBANK	DB07584	C15H13N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKGCSZUKOGMZAL-UHFFFAOYSA-N
25594	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6391	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	-	DRUGBANK	DB07584	C15H13N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OKGCSZUKOGMZAL-UHFFFAOYSA-N
25595	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6392	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	-	-	DRUGBANK	DB07585	C12H11ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFFJXGRXFASBDL-UHFFFAOYSA-N
25596	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6392	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	-	-	DRUGBANK	DB07585	C12H11ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFFJXGRXFASBDL-UHFFFAOYSA-N
25597	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6393	5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE	-	-	DRUGBANK	DB07586	C24H23N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOPFUKKMSDUVTQ-UHFFFAOYSA-N
25598	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6394	N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	-	-	DRUGBANK	DB07587	C20H22F4N4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLPXDVXMMYRTKN-ZOBUZTSGSA-N
25599	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6396	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE	-	-	DRUGBANK	DB07589	C22H26F3N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWWVPKCSDHDILN-OALUTQOASA-N
25600	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6398	N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE	-	-	DRUGBANK	DB07591	C10H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJHPYHUDDCVBNG-UHFFFAOYSA-N
25601	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6399	(1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE	-	-	DRUGBANK	DB07592	C18H27NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLZXUNHJWVLGTE-DLBZAZTESA-N
25602	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6400	1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE	-	-	DRUGBANK	DB07593	C19H27NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONABDOMWRCXLPX-KRWDZBQOSA-N
25603	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6401	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	-	-	DRUGBANK	DB07594	C20H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWPMENVYXDJDOW-UHFFFAOYSA-N
25604	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6401	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	-	-	DRUGBANK	DB07594	C20H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWPMENVYXDJDOW-UHFFFAOYSA-N
25605	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6402	(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE	-	-	DRUGBANK	DB07595	C18H15BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSIQKQLAGWVKSL-UHFFFAOYSA-O
25606	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6403	(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate	-	-	DRUGBANK	DB07596	C21H28N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTSPHKOMJMBWOU-NNKXXINSSA-N
25607	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6404	CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	-	-	DRUGBANK	DB07597	C10H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIMSEFZOOYSTDO-VHSXEESVSA-N
25608	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6405	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	-	-	DRUGBANK	DB07598	C13H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQEPVMAYUINZRE-GFCCVEGCSA-N
25609	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6407	4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol	-	-	DRUGBANK	DB07601	C19H20ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLIRVZVVCCIAKG-UHFFFAOYSA-N
25610	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6408	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	-	-	DRUGBANK	DB07602	C20H21N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLVZTRZPMRTVRC-INIZCTEOSA-N
25611	106977	487	-	ATP2A1	ATP2A|SERCA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6410	(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE	-	-	DRUGBANK	DB07604	C20H20N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLOAZVAJNNPPDI-DQYPLSBCSA-N
25612	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6411	2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE	-	-	DRUGBANK	DB07605	C20H17ClN4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHDQMXPAANQKDC-UHFFFAOYSA-N
25613	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6412	6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE	-	-	DRUGBANK	DB07606	C20H15Cl3N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OPRAIFVPXXVXDL-UHFFFAOYSA-N
25614	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6413	4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE	-	-	DRUGBANK	DB07607	C21H16IN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXDZANYWRNIAOR-HHHXNRCGSA-N
25615	108192	1859	-	DYRK1A	DYRK|DYRK1|HP86|MNB|MNBH|MRD7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6414	N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide	-	-	DRUGBANK	DB07608	C24H22ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDGOPNUGILVNJZ-IBGZPJMESA-N
25616	107927	1548	-	CYP2A6	CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6415	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	-	-	DRUGBANK	DB07609	C12H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJHSLLRNPASXIS-UHFFFAOYSA-N
25617	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6418	6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE	-	-	DRUGBANK	DB07612	C19H19F3N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQKJVNGGVLHNLA-UHFFFAOYSA-N
25618	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6419	3-phenyl-5-(1H-pyrazol-3-yl)isoxazole	-	-	DRUGBANK	DB07613	C12H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRSSTOPJERVMRZ-UHFFFAOYSA-N
25619	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6420	PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE	-	-	DRUGBANK	DB07614	C12H9N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRAHRUHGPGBWSI-UHFFFAOYSA-N
25620	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6421	Tranilast	2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid	-	DRUGBANK	DB07615	C18H17NO5	small molecule	-	53902-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZHGWWWHIYHZNX-CSKARUKUSA-N
25621	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6422	4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid	-	-	DRUGBANK	DB07616	C17H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKZZDHKJFDTYCH-UHFFFAOYSA-N
25622	107927	1548	-	CYP2A6	CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6423	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	-	-	DRUGBANK	DB07617	C11H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDGMPFRIYUFRRX-UHFFFAOYSA-N
25623	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6424	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	-	-	DRUGBANK	DB07618	C24H31N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AITZHKQVQNLKHI-UHFFFAOYSA-N
25624	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6425	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	-	-	DRUGBANK	DB07619	C24H27F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLRYWTWLHWACRP-GRWTVWFQSA-N
25625	107927	1548	-	CYP2A6	CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6427	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	-	-	DRUGBANK	DB07621	C10H10N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENAVORGWBTPJR-UHFFFAOYSA-N
25626	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6428	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	-	-	DRUGBANK	DB07622	C21H23N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKQVGZXTNLQSV-UHFFFAOYSA-N
25627	107927	1548	-	CYP2A6	CPA6|CYP2A|CYP2A3|CYPIIA6|P450C2A|P450PB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6429	4,4'-DIPYRIDYL DISULFIDE	-	-	DRUGBANK	DB07623	C10H8N2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHBAPGWWRFVTFS-UHFFFAOYSA-N
25628	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6430	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	-	-	DRUGBANK	DB07624	C19H26F3N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJFULAYRAKPBCY-DYVFJYSZSA-N
25629	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6431	4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide	-	-	DRUGBANK	DB07625	C21H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTPPZCTHZHCQD-UHFFFAOYSA-N
25630	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6432	4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	-	-	DRUGBANK	DB07626	C24H32ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKBBGCJYKCLKHE-UHFFFAOYSA-N
25631	107273	823	PIG30	CAPN1	CANP|CANP1|CANPL1|muCANP|muCL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6433	(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE	-	-	DRUGBANK	DB07627	C17H25N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBPWWBMTZYJGGV-KKUMJFAQSA-N
25632	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6434	6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one	-	-	DRUGBANK	DB07628	C17H14FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEWYEWDDQWYJLU-UHFFFAOYSA-N
25633	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6435	N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07629	C23H26ClN5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARPFWVKYXJZULB-DLBZAZTESA-N
25634	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6436	N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07630	C23H26ClN5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARPFWVKYXJZULB-IAGOWNOFSA-N
25635	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6438	5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide	-	-	DRUGBANK	DB07632	C8H6ClN3O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PZVGOWIIHCUHAO-UHFFFAOYSA-N
25636	106546	28	-	ABO	A3GALNT|A3GALT1|GTB|NAGAT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6439	octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside	-	-	DRUGBANK	DB07633	C20H38O9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FBVFDKBCZLMLQT-PPCMOIRNSA-N
25637	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6442	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	-	-	DRUGBANK	DB07636	C14H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAPIRLKYURUNFL-UHFFFAOYSA-N
25638	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6442	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	-	-	DRUGBANK	DB07636	C14H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAPIRLKYURUNFL-UHFFFAOYSA-N
25639	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6442	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	-	-	DRUGBANK	DB07636	C14H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAPIRLKYURUNFL-UHFFFAOYSA-N
25640	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6442	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	-	-	DRUGBANK	DB07636	C14H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAPIRLKYURUNFL-UHFFFAOYSA-N
25641	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6442	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	-	-	DRUGBANK	DB07636	C14H17NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAPIRLKYURUNFL-UHFFFAOYSA-N
25642	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6443	3,5 DIBROMOTYROSINE	-	-	DRUGBANK	DB07637	C9H9Br2NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COESHZUDRKCEPA-ZETCQYMHSA-N
25643	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6444	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07638	C18H16F2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJSMFUTULGSHNQ-ZOBUZTSGSA-N
25644	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6444	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07638	C18H16F2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJSMFUTULGSHNQ-ZOBUZTSGSA-N
25645	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6445	3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER	-	-	DRUGBANK	DB07639	C26H31N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOYXUXZQQVEADT-ZEQRLZLVSA-N
25646	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6447	DECYL(DIMETHYL)PHOSPHINE OXIDE	-	-	DRUGBANK	DB07641	C12H27OP	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSVLCKASFMVUSW-UHFFFAOYSA-N
25647	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6448	5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine	-	-	DRUGBANK	DB07642	C21H24FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYKIQIOWVKCVBP-UHFFFAOYSA-N
25648	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6449	5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine	-	-	DRUGBANK	DB07643	C21H23Cl2N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVLUVRFYGVJKGJ-UHFFFAOYSA-N
25649	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6450	5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine	-	-	DRUGBANK	DB07644	C16H15ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDHINEMSCUFEIP-VIFPVBQESA-N
25650	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6451	SEBACIC ACID	-	-	DRUGBANK	DB07645	C10H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXMXRPHRNRROMY-UHFFFAOYSA-N
25651	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6451	SEBACIC ACID	-	-	DRUGBANK	DB07645	C10H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXMXRPHRNRROMY-UHFFFAOYSA-N
25652	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6452	UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE	-	-	DRUGBANK	DB07646	C13H29NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZHBUVQCJMARBN-UHFFFAOYSA-N
25653	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6453	(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL	-	-	DRUGBANK	DB07647	C21H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBASHTSSQNDDAS-CQSZACIVSA-N
25654	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6454	(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL	-	-	DRUGBANK	DB07648	C21H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWEONIHFGKSPLC-MRXNPFEDSA-N
25655	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6457	N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE	-	-	DRUGBANK	DB07651	C21H24F2N3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPMMESISHWWXNM-ROUUACIJSA-N
25656	119532	51426	-	POLK	DINB1|DINP|POLQ	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6458	1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE	-	-	DRUGBANK	DB07652	C12H15F2O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMMWBGNJJMNAIJ-QJPTWQEYSA-N
25657	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6459	N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE	-	-	DRUGBANK	DB07653	C20H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXTCEUDVOCLEJG-UHFFFAOYSA-N
25658	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6460	(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC	-	-	DRUGBANK	DB07654	C21H19N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDJWWYRYKMXMKA-UHFFFAOYSA-N
25659	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6461	3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	-	-	DRUGBANK	DB07655	C20H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPJYGQHMIFDQIN-UHFFFAOYSA-N
25660	115438	10135	-	NAMPT	1110035O14Rik|PBEF|PBEF1|VF|VISFATIN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6462	N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-PYRIDIN-3-YLPROPANAMIDE	-	-	DRUGBANK	DB07656	C24H31N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKQGSFUTDYQJST-UHFFFAOYSA-N
25661	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6463	PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER	-	-	DRUGBANK	DB07657	C20H42NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLLQAGCLXXPCKZ-LJQANCHMSA-N
25662	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6464	AC-(D)PHE-PRO-BOROLYS-OH	-	-	DRUGBANK	DB07658	C21H33BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCQIHCRMWNRFNP-QYZOEREBSA-N
25663	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6465	AC-(D)PHE-PRO-BOROHOMOLYS-OH	-	-	DRUGBANK	DB07659	C22H35BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AILSWIBFGYYZTK-AABGKKOBSA-N
25664	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6466	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	-	-	DRUGBANK	DB07660	C20H31BN4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKWKWNKWBGQECF-SQNIBIBYSA-N
25665	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6468	N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE	-	-	DRUGBANK	DB07662	C17H13BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTUBKQUPEREOGA-UHFFFAOYSA-N
25666	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6468	N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE	-	-	DRUGBANK	DB07662	C17H13BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTUBKQUPEREOGA-UHFFFAOYSA-N
25667	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6469	2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID	-	-	DRUGBANK	DB07663	C18H13NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QISJEFYTLZTWIQ-CQSZACIVSA-N
25668	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6470	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	-	-	DRUGBANK	DB07664	C15H13F2N7O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIOBGGRZJITQX-UHFFFAOYSA-N
25669	115096	9748	-	SLK	LOSK|STK2|bA16H23.1|se20-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6470	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	-	-	DRUGBANK	DB07664	C15H13F2N7O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIOBGGRZJITQX-UHFFFAOYSA-N
25670	107264	814	-	CAMK4	CaMK IV|CaMK-GR|IV|caMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6470	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	-	-	DRUGBANK	DB07664	C15H13F2N7O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIOBGGRZJITQX-UHFFFAOYSA-N
25671	107840	1456	-	CSNK1G3	CKI-gamma 3|CSNK1G3L	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6470	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	-	-	DRUGBANK	DB07664	C15H13F2N7O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIOBGGRZJITQX-UHFFFAOYSA-N
25672	107609	1198	-	CLK3	PHCLK3|PHCLK3/152	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6470	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	-	-	DRUGBANK	DB07664	C15H13F2N7O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIOBGGRZJITQX-UHFFFAOYSA-N
25673	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6471	N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide	-	-	DRUGBANK	DB07665	C19H20F3N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STHCHQXQLDMISY-UHFFFAOYSA-N
25674	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6472	(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE	-	-	DRUGBANK	DB07666	C21H19F3N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OAWGQHXWGXOUKV-BEFAXECRSA-N
25675	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6474	3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID	-	-	DRUGBANK	DB07668	C14H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAEWDFYDSACHDN-CSKARUKUSA-N
25676	107938	1562	RP11-466J14.4	CYP2C18	CPCI|CYP2C|CYP2C17|P450-6B/29C|P450IIC17	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6476	4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07670	C17H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRHPBWNETCEFGS-UHFFFAOYSA-N
25677	849677	945300	b0724	sdhB	ECK0713|JW0714	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6477	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	-	-	DRUGBANK	DB07671	C13H18N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RROCMCBQTUYDSD-VIFPVBQESA-N
25678	849698	945322	b0722	sdhD	ECK0711|JW0712	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6477	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	-	-	DRUGBANK	DB07671	C13H18N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RROCMCBQTUYDSD-VIFPVBQESA-N
25679	849692	945316	b0721	sdhC	ECK0710|JW0711|cybA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6477	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	-	-	DRUGBANK	DB07671	C13H18N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RROCMCBQTUYDSD-VIFPVBQESA-N
25680	849776	945402	b0723	sdhA	ECK0712|JW0713	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6477	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	-	-	DRUGBANK	DB07671	C13H18N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RROCMCBQTUYDSD-VIFPVBQESA-N
25681	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6478	TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE	-	-	DRUGBANK	DB07672	C14H23NOSi	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDJXTRKZEHHECC-GASCZTMLSA-N
25682	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6481	Ragaglitazar	NN-622|(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID(-) DRF 2725|Q27088511|DRF-2725|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|NNC-61-0029|(2S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YLETHOXY)PHENYL]PROPANOIC ACID|1NYX|DRF|(-)-DRF-2725|DRF2725|(S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|DB07675|RAGAGLITAZAR|GTPL2664|BDBM50109551	-	DRUGBANK	DB07675	C25H25NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMUIIGVAWPWQAW-DEOSSOPVSA-N
25683	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6482	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	-	-	DRUGBANK	DB07676	C20H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLAPOFDFZKCPB-LBPRGKRZSA-N
25684	107264	814	-	CAMK4	CaMK IV|CaMK-GR|IV|caMK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6482	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	-	-	DRUGBANK	DB07676	C20H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLAPOFDFZKCPB-LBPRGKRZSA-N
25685	115351	10039	-	PARP3	ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6483	2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one	-	-	DRUGBANK	DB07677	C8H10N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRYKZAKEAVZGJD-UHFFFAOYSA-N
25686	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6484	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	-	-	DRUGBANK	DB07678	C22H30O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANAMDWGJXBYJEB-SHKDNAECSA-N
25687	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6484	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	-	-	DRUGBANK	DB07678	C22H30O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANAMDWGJXBYJEB-SHKDNAECSA-N
25688	107624	1215	-	CMA1	CYH|MCT1|chymase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6486	[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID	-	-	DRUGBANK	DB07680	C20H15ClNO4PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUJXISJLAPAFBO-IBGZPJMESA-N
25689	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6487	DODECANESULFONATE ION	-	-	DRUGBANK	DB07681	C12H25O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMOEFOXLIZJOW-UHFFFAOYSA-M
25690	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6488	N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine	-	-	DRUGBANK	DB07683	C17H17NO4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZWYSEXQXOXWKA-INIZCTEOSA-N
25691	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6489	5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID	-	-	DRUGBANK	DB07684	C12H13NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VENHBDIMAAXWKI-UHFFFAOYSA-N
25692	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6490	4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07685	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMAZGYDYIYLSLJ-UHFFFAOYSA-N
25693	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6491	4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07686	C17H21N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPOGRVWIIVMWRI-UHFFFAOYSA-N
25694	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6492	4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07687	C17H22N8O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRKQJAEQWVSCM-HAQNSBGRSA-N
25695	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6493	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07688	C17H20N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPJIMTALCNCQLV-UHFFFAOYSA-N
25696	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6493	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07688	C17H20N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPJIMTALCNCQLV-UHFFFAOYSA-N
25697	609057	728635	-	DHRS4L1	SDR25C4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6494	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	-	-	DRUGBANK	DB07689	C21H24N8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYNAFINLHQEHKU-UHFFFAOYSA-N
25701	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6496	2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid	-	-	DRUGBANK	DB07691	C23H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYILVHHTCYNIOS-UHFFFAOYSA-N
25702	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6497	1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	-	-	DRUGBANK	DB07692	C18H18F2N2O6S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHWNKRPMUBFWKE-UHFFFAOYSA-N
25703	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6501	methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate	-	-	DRUGBANK	DB07696	C11H19NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKEQESWFLCEUCV-QMMMGPOBSA-N
25704	111332	5315	-	PKM	CTHBP|HEL-S-30|OIP3|PK3|PKM2|TCB|THBP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6502	1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine	-	-	DRUGBANK	DB07697	C19H22N2O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMGDKYUJSFVHIY-UHFFFAOYSA-N
25705	123814	83903	-	GSG2	HASPIN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6503	3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine	-	-	DRUGBANK	DB07698	C18H14ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDNMRPIWJIDDAY-UHFFFAOYSA-N
25706	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6504	3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN	-	-	DRUGBANK	DB07700	C25H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVAJWBACBRSVPR-NDUHRLLKSA-N
25707	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6505	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	-	-	DRUGBANK	DB07701	C24H29NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADEBPBSSDYVVLD-HXUWFJFHSA-N
25708	121747	57727	RP11-465L10.6	NCOA5	CIA|bA465L10.6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6506	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	-	-	DRUGBANK	DB07702	C18H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-PNVOZDDCSA-N
25709	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6506	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	-	-	DRUGBANK	DB07702	C18H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PROQIPRRNZUXQM-PNVOZDDCSA-N
25710	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6509	1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE	-	-	DRUGBANK	DB07705	C18H15Cl3N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEZWWPYKPKIXLL-GOSISDBHSA-N
25711	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6511	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	-	-	DRUGBANK	DB07707	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEOPSILMAOYZBO-IUTAEKPZSA-N
25712	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6511	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	-	-	DRUGBANK	DB07707	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEOPSILMAOYZBO-IUTAEKPZSA-N
25713	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6512	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	-	-	DRUGBANK	DB07708	C13H9ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNHQDSBJVFFIAK-UHFFFAOYSA-N
25714	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6512	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	-	-	DRUGBANK	DB07708	C13H9ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNHQDSBJVFFIAK-UHFFFAOYSA-N
25715	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6513	PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07710	C22H30N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNZDHHNWUXIYOH-FQEVSTJZSA-N
25716	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6514	(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol	-	-	DRUGBANK	DB07711	C14H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOSAAWHGJUZBOG-WDEREUQCSA-N
25717	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6515	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	-	-	DRUGBANK	DB07712	C15H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMVVMYGKMGLJX-UHFFFAOYSA-N
25718	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6515	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	-	-	DRUGBANK	DB07712	C15H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMVVMYGKMGLJX-UHFFFAOYSA-N
25719	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6516	(1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID	-	-	DRUGBANK	DB07713	C17H22NO6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZVYQWLRCHLAGK-KRWDZBQOSA-N
25720	109191	2936	-	GSR	HEL-75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6517	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	-	-	DRUGBANK	DB07714	C17H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICGRXHWXPCXIKM-UHFFFAOYSA-N
25721	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6518	Emodin	3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE|Emodin|Emodol|Frangula Emodin|Schuttgelb|1,3,8-Trihydroxy-6-Methylanthracene-9,10-Dione|Rheum Emodin|Archin	-	DRUGBANK	DB07715	C15H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHMXXJGYXNZAPX-UHFFFAOYSA-N
25722	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6519	(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL	-	-	DRUGBANK	DB07716	C22H30O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDRIXSJOPKVWKM-HXGIDPQASA-N
25723	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6520	(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE	-	-	DRUGBANK	DB07717	C27H36F2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJODXHGZHBERGJ-JLYQOUBASA-N
25724	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6521	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	-	-	DRUGBANK	DB07718	C9H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKADPXVIOXHVKN-UHFFFAOYSA-N
25725	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6521	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	-	-	DRUGBANK	DB07718	C9H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKADPXVIOXHVKN-UHFFFAOYSA-N
25726	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6522	3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER	-	-	DRUGBANK	DB07719	C16H23N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPSSYXOFPICMQD-CYBMUJFWSA-N
25727	124609	89832	-	CHRFAM7A	CHRNA7|CHRNA7-DR1|D-10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6523	EPIBATIDINE	-	-	DRUGBANK	DB07720	C11H13ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NLPRAJRHRHZCQQ-IVZWLZJFSA-N
25728	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6526	3-(5-methoxy-1H-indol-3-yl)propanoic acid	-	-	DRUGBANK	DB07723	C12H13NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLSZCJIWILJKMR-UHFFFAOYSA-N
25729	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6527	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	-	-	DRUGBANK	DB07724	C19H19NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMPALHOKRBVHOJ-UHFFFAOYSA-N
25730	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6527	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	-	-	DRUGBANK	DB07724	C19H19NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMPALHOKRBVHOJ-UHFFFAOYSA-N
25731	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6527	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	-	-	DRUGBANK	DB07724	C19H19NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMPALHOKRBVHOJ-UHFFFAOYSA-N
25732	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6527	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	-	-	DRUGBANK	DB07724	C19H19NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMPALHOKRBVHOJ-UHFFFAOYSA-N
25733	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6529	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	-	-	DRUGBANK	DB07728	C18H14FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJJYJNMNYDNXNO-UHFFFAOYSA-N
25734	113617	7867	-	MAPKAPK3	3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6529	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	-	-	DRUGBANK	DB07728	C18H14FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJJYJNMNYDNXNO-UHFFFAOYSA-N
25735	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6531	5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE	-	-	DRUGBANK	DB07730	C9H7NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJABEDRGNJSWCC-UHFFFAOYSA-N
25736	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6532	4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL	-	-	DRUGBANK	DB07731	C9H10N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYZRKFOEZQBUEA-OUKQBFOZSA-N
25737	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6534	1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE	-	-	DRUGBANK	DB07733	C10H10F3N3OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDKGQVZBBSICLG-UHFFFAOYSA-N
25738	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6535	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	-	-	DRUGBANK	DB07734	C16H24N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNIXPLIQGKQSIE-UHFFFAOYSA-N
25739	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6536	N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	-	-	DRUGBANK	DB07735	C18H28N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUDVORCZGBAHNA-UHFFFAOYSA-N
25740	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6537	(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide	-	-	DRUGBANK	DB07736	C14H20FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEXXKSSFAKABEN-ZDUSSCGKSA-N
25741	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6538	(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide	-	-	DRUGBANK	DB07737	C15H22FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYTFYWWLBPDTNS-AWEZNQCLSA-N
25742	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6539	N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	-	-	DRUGBANK	DB07738	C18H27BrN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HESMISSJMKCCAV-UHFFFAOYSA-N
25743	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6540	(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE	-	-	DRUGBANK	DB07739	C14H19FN2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBUKSNPHYWXCDG-CYBMUJFWSA-N
25744	109400	3157	-	HMGCS1	HMGCS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6541	(3R,5S,7R,12S,13R)-13-FORMYL-12,14-DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID	-	-	DRUGBANK	DB07740	C18H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXYKBBOQNSGWJZ-JJTUDDRGSA-N
25745	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6542	4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE	-	-	DRUGBANK	DB07741	C24H27F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VPNYXOTTXAXSIH-SXYSDOLCSA-N
25746	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6543	N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE	-	-	DRUGBANK	DB07742	C14H12F2N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QASSMVGOSBNFQY-UHFFFAOYSA-N
25747	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6545	3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID	-	-	DRUGBANK	DB07744	C21H29N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYBAOBDVBPVSDJ-OWQGQXMQSA-N
25748	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6547	3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID	-	-	DRUGBANK	DB07746	C16H16FNO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MGUQWAOYPINSIT-UHFFFAOYSA-N
25749	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6548	(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	-	-	DRUGBANK	DB07747	C16H17ClN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTBGBMPLINFTBQ-OAHLLOKOSA-N
25750	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6550	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE	-	-	DRUGBANK	DB07749	C17H24N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRDDFQYJOFVDNR-HOTGVXAUSA-N
25751	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6551	(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07750	C21H23Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNLAGGCSJGJECE-MRXNPFEDSA-N
25752	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6552	(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07751	C21H23F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVSBKYYVBCKDBO-HNNXBMFYSA-N
25762	108630	2346	GIG27	FOLH1	FGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6555	N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid	-	-	DRUGBANK	DB07754	C16H19FN2O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDTMSHGCAZPVLC-RYUDHWBXSA-N
25763	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6556	(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07755	C21H23Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNLAGGCSJGJECE-INIZCTEOSA-N
25764	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6557	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	-	-	DRUGBANK	DB07756	C20H18F4N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPBGHVRNVGXPNM-UHFFFAOYSA-N
25765	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6558	(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one	-	-	DRUGBANK	DB07757	C17H19BrO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTEBGBCQCYMDPH-KRWDZBQOSA-N
25766	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6559	5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID	-	-	DRUGBANK	DB07758	C11H6Cl2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATAZLMGGQQLRBC-UHFFFAOYSA-N
25767	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6560	5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID	-	-	DRUGBANK	DB07759	C12H7F3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJPNRBZMRINMMR-UHFFFAOYSA-N
25768	113220	7374	-	UNG	DGU|HIGM4|HIGM5|UDG|UNG1|UNG15|UNG2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6561	3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid	-	-	DRUGBANK	DB07760	C15H14N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUYDQQMKXSQIQG-GONBZBRSSA-N
25769	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6562	(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL	-	-	DRUGBANK	DB07761	C21H23F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVSBKYYVBCKDBO-OAHLLOKOSA-N
25770	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25771	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25772	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25773	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25774	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25775	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25776	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25777	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25778	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25779	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6564	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB07763	C16H12F2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZZFJGCAYWBVBI-INIZCTEOSA-N
25780	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6565	FLUORESCIN	-	-	DRUGBANK	DB07764	C20H14O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MURGITYSBWUQTI-UHFFFAOYSA-N
25781	609057	728635	-	DHRS4L1	SDR25C4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6566	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	-	-	DRUGBANK	DB07765	C22H26N8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKCFUFHREWUXJJ-UHFFFAOYSA-N
25782	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6567	(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}	-	-	DRUGBANK	DB07766	C20H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUMZEVCWKZXFV-YOCZKUTFSA-N
25783	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6567	(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}	-	-	DRUGBANK	DB07766	C20H19N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKUMZEVCWKZXFV-YOCZKUTFSA-N
25784	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6569	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	-	-	DRUGBANK	DB07768	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-KZYORJDKSA-N
25785	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6569	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	-	-	DRUGBANK	DB07768	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-KZYORJDKSA-N
25786	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6570	S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	-	-	DRUGBANK	DB07769	C17H14F4N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJMFOTCDISOHDX-INIZCTEOSA-N
25787	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6572	[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID	-	-	DRUGBANK	DB07771	C17H30NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAOBYUCYSAOLHS-XGGJEREUSA-N
25788	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6572	[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID	-	-	DRUGBANK	DB07771	C17H30NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAOBYUCYSAOLHS-XGGJEREUSA-N
25789	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6572	[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID	-	-	DRUGBANK	DB07771	C17H30NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAOBYUCYSAOLHS-XGGJEREUSA-N
25790	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6573	(1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID	-	-	DRUGBANK	DB07772	C17H22NO6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZVYQWLRCHLAGK-QGZVFWFLSA-N
25791	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25792	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25793	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25794	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25795	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25796	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25797	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25798	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25799	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25800	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6577	FAMOXADONE	-	-	DRUGBANK	DB07778	C22H18N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCCSBWNGDMYFCW-QFIPXVFZSA-N
25801	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6578	N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE	-	-	DRUGBANK	DB07779	C22H26FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANQHSFFUNMTTRS-MOPGFXCFSA-N
25802	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25803	111814	5876	RP4-682C21.3	RABGGTB	GGTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25804	111813	5875	-	RABGGTA	PTAR3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25805	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25806	849274	944874	b0174	ispU	ECK0173|JW0169|rth|uppS|yaeS	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25807	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25808	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25809	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6579	FARNESYL DIPHOSPHATE	-	-	DRUGBANK	DB07780	C15H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWFJDQUYCIWHTN-YFVJMOTDSA-N
25810	854970	937316	BSU38290	thiE	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	6581	4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE	-	-	DRUGBANK	DB07782	C6H8F3N3O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKNJCTHTCAKKNG-UHFFFAOYSA-N
25811	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6582	1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB07783	C25H27N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUYYFMCFEPDDFL-OAQYLSRUSA-N
25812	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6583	[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID	-	-	DRUGBANK	DB07784	C21H23N3O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WBCOLMYVEBTZOA-OKRSVSQCSA-N
25813	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6584	1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE	-	-	DRUGBANK	DB07785	C19H21N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYAJDVNLQJVRHD-SCLBCKFNSA-N
25814	106614	100	-	ADA	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6585	1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB07786	C22H21ClN4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMFRBBHLVBWHGB-DJJJIMSYSA-N
25815	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6586	5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE	-	-	DRUGBANK	DB07787	C23H24FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNPFDRCIGCUCMN-UHFFFAOYSA-N
25816	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6587	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	-	-	DRUGBANK	DB07788	C19H22O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NEQZWEXWOFPKOT-RCPUWQGCSA-N
25817	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6588	1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea	-	-	DRUGBANK	DB07789	C18H17F3N10O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KNTGXMNWVXZIMW-UHFFFAOYSA-N
25818	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6589	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	-	-	DRUGBANK	DB07790	C20H26N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDXLQEXLXZCYSR-UHFFFAOYSA-N
25819	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6590	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB07791	C18H20N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZWCVBFANHIPTJ-UHFFFAOYSA-N
25820	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6591	(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	-	-	DRUGBANK	DB07792	C20H19ClN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUKPNWLGSLOHIF-AWEZNQCLSA-N
25821	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6592	(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	-	-	DRUGBANK	DB07793	C18H15ClN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACSGSLPOHKRZCY-GXTWGEPZSA-N
25822	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6593	5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE	-	-	DRUGBANK	DB07794	C18H13N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVECMUKVOMUNLE-UHFFFAOYSA-N
25823	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6594	3,7,3',4'-TETRAHYDROXYFLAVONE	-	-	DRUGBANK	DB07795	C15H10O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHEFDIBZLJXQHF-UHFFFAOYSA-N
25824	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6595	(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE	-	-	DRUGBANK	DB07796	C23H24FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJYCQHGTXMVIBG-MUGJNUQGSA-O
25825	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6597	(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	-	-	DRUGBANK	DB07798	C13H16F4N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBUDQLKRZPRPFD-LLVKDONJSA-N
25826	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6598	N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE	-	-	DRUGBANK	DB07800	C23H17ClN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIJGLXFQYBTIFY-UHFFFAOYSA-N
25827	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6599	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide	-	-	DRUGBANK	DB07801	C22H29N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOYITRCGMUXUDE-UHFFFAOYSA-N
25828	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6600	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	-	-	DRUGBANK	DB07802	C10H6Br2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSOLROYRAHCJNK-UHFFFAOYSA-N
25829	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6601	2-phenyl-1H-imidazole-4-carboxylic acid	-	-	DRUGBANK	DB07803	C10H8N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCAXKZJNJCKTQH-UHFFFAOYSA-N
25830	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6602	5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE	-	-	DRUGBANK	DB07804	C17H21ClN6O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FKCQUVAGEOSYRU-QWRGUYRKSA-N
25831	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6605	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	-	-	DRUGBANK	DB07807	C15H23NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKARZGURZMIRMA-RBSFLKMASA-N
25832	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6607	4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB07809	C21H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBJYEMUMDMGQQC-UHFFFAOYSA-N
25833	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6609	N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide	-	-	DRUGBANK	DB07811	C21H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBVTVSINEVHYSY-UHFFFAOYSA-N
25834	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6610	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	-	-	DRUGBANK	DB07812	C20H18N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWYNGDRSMHRPSY-MRXNPFEDSA-N
25835	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6610	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	-	-	DRUGBANK	DB07812	C20H18N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWYNGDRSMHRPSY-MRXNPFEDSA-N
25836	131319	344752	-	AADACL2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6612	GIBBERELLIN A3	-	-	DRUGBANK	DB07814	C19H22O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXORZMNAPKEEDV-OBDJNFEBSA-N
25837	131319	344752	-	AADACL2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6613	GIBBERELLIN A4	-	-	DRUGBANK	DB07815	C19H24O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSQSQJNRHICNNH-NFMPGMCNSA-N
25838	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6614	N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID	-	-	DRUGBANK	DB07816	C23H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGHMYJFHUHFOGL-UHFFFAOYSA-N
25839	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6619	(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE	-	-	DRUGBANK	DB07821	C7H17O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUGWOMGKDLYKO-ZCFIWIBFSA-N
25840	111087	5050	-	PAFAH1B3	PAFAHG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6619	(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE	-	-	DRUGBANK	DB07821	C7H17O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUGWOMGKDLYKO-ZCFIWIBFSA-N
25841	113667	7941	-	PLA2G7	LDL-PLA2|LP-PLA2|PAFAD|PAFAH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6619	(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE	-	-	DRUGBANK	DB07821	C7H17O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUGWOMGKDLYKO-ZCFIWIBFSA-N
25842	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6620	(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE	-	-	DRUGBANK	DB07822	C7H17O2P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUGWOMGKDLYKO-ZCFIWIBFSA-N
25843	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6621	(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid	-	-	DRUGBANK	DB07823	C12H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REFMTLIXGKZVDF-VRGHQRLXSA-N
25844	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6622	4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one	-	-	DRUGBANK	DB07824	C7H10N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAVWUEFMWJZZFB-UHFFFAOYSA-N
25845	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6623	(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid	-	-	DRUGBANK	DB07825	C13H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQGYWRZISBCKMW-JTQLQIEISA-N
25846	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6625	4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID	-	-	DRUGBANK	DB07827	C26H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLTYDFYSVZBKOB-UHFFFAOYSA-N
25847	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6626	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	-	-	DRUGBANK	DB07829	C14H10FN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BILJSHVAAVZERY-UHFFFAOYSA-N
25848	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6627	(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE	-	-	DRUGBANK	DB07830	C20H19F3N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIRIFWIKLRTNMB-DYVFJYSZSA-N
25849	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6628	2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB07831	C23H22F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHSORWZDEKFFLP-UHFFFAOYSA-N
25850	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6629	4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde	-	-	DRUGBANK	DB07832	C20H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VKQPTVJDZIILPG-UHFFFAOYSA-N
25851	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6630	N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide	-	-	DRUGBANK	DB07833	C24H18N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMMLSQFPBFKLHH-UHFFFAOYSA-N
25852	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6631	N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide	-	-	DRUGBANK	DB07834	C21H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOHZGCHKLPIBBX-UHFFFAOYSA-N
25853	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6632	N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide	-	-	DRUGBANK	DB07835	C22H24N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPSUAHGQHFKGG-UHFFFAOYSA-N
25854	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6633	1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL	-	-	DRUGBANK	DB07836	C16H32F3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBCDZAGHRGXDRX-HNNXBMFYSA-N
25855	112344	6446	RP1-188K17.1	SGK1	SGK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6634	[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid	-	-	DRUGBANK	DB07837	C25H18N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWXKLXXVFMYMDP-UHFFFAOYSA-N
25856	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6635	(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE	-	-	DRUGBANK	DB07838	C17H12N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWBCEZQPRYIGY-ZROIWOOFSA-N
25857	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6636	N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE	-	-	DRUGBANK	DB07839	C25H32N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFNWTXUFNNOQHD-QFIPXVFZSA-N
25858	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6637	(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol	-	-	DRUGBANK	DB07840	C21H14F2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQMUBYFTZASKLP-ZZEZOPTASA-N
25859	111814	5876	RP4-682C21.3	RABGGTB	GGTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25860	111813	5875	-	RABGGTA	PTAR3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25861	108517	2224	-	FDPS	FPPS|FPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25862	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25863	111250	5229	-	PGGT1B	BGGI|GGTI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25864	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25865	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6638	GERANYLGERANYL DIPHOSPHATE	-	-	DRUGBANK	DB07841	C20H36O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OINNEUNVOZHBOX-KGODAQDXSA-N
25866	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6639	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB07842	C17H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJMVTSLLWMPEKQ-INIZCTEOSA-N
25867	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6640	5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	-	-	DRUGBANK	DB07843	C19H22ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTJNKFUIOOJXNJ-WFASDCNBSA-N
25868	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6641	6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	-	-	DRUGBANK	DB07844	C19H22ClN3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHLKBODTBJLXRD-WFASDCNBSA-N
25869	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6642	2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide	-	-	DRUGBANK	DB07845	C22H21FN6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGYXXQRDIVRILX-UHFFFAOYSA-N
25870	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6643	1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE	-	-	DRUGBANK	DB07846	C22H27N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVHRCJQCKYPDRL-HOKHCIIBSA-N
25871	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6644	6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE	-	-	DRUGBANK	DB07847	C21H24ClN3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICLOZQFWTRAYPX-LIRRHRJNSA-N
25872	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6645	5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE	-	-	DRUGBANK	DB07848	C19H23ClN4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHNMMFGOJRIAEZ-LRDDRELGSA-N
25873	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6646	S-NONYL-CYSTEINE	-	-	DRUGBANK	DB07849	C12H25NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NYQGIUKEPYHDNY-NSHDSACASA-N
25874	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6647	(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid	-	-	DRUGBANK	DB07850	C9H13N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYLXWYPNDHPRPQ-NTSWFWBYSA-N
25875	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6648	(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE	-	-	DRUGBANK	DB07851	C20H26N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQJXBZGPJVSWFI-ROUUACIJSA-N
25876	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6649	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	-	-	DRUGBANK	DB07852	C10H7Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZTNDZALWLHXBA-UHFFFAOYSA-N
25877	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6649	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	-	-	DRUGBANK	DB07852	C10H7Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CZTNDZALWLHXBA-UHFFFAOYSA-N
25878	115096	9748	-	SLK	LOSK|STK2|bA16H23.1|se20-9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6650	[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE	-	-	DRUGBANK	DB07853	C22H19N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWMNWCNUTIFHRJ-JLPGSUDCSA-N
25879	119722	51765	RP6-213H19.1	STK26	MASK|MST4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6650	[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE	-	-	DRUGBANK	DB07853	C22H19N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWMNWCNUTIFHRJ-JLPGSUDCSA-N
25880	107267	817	-	CAMK2D	CAMKD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6650	[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE	-	-	DRUGBANK	DB07853	C22H19N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWMNWCNUTIFHRJ-JLPGSUDCSA-N
25881	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6651	N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	-	-	DRUGBANK	DB07854	C13H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRGSDHJXBVCQEL-UHFFFAOYSA-N
25882	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6651	N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	-	-	DRUGBANK	DB07854	C13H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRGSDHJXBVCQEL-UHFFFAOYSA-N
25883	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6652	(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	-	-	DRUGBANK	DB07855	C18H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWHMAWBXRCDOEB-HNNXBMFYSA-N
25884	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6652	(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	-	-	DRUGBANK	DB07855	C18H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWHMAWBXRCDOEB-HNNXBMFYSA-N
25885	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6653	6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE	-	-	DRUGBANK	DB07856	C22H20ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPWBHQIUIBFTQC-UHFFFAOYSA-N
25886	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6653	6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE	-	-	DRUGBANK	DB07856	C22H20ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HPWBHQIUIBFTQC-UHFFFAOYSA-N
25887	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6654	(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB07857	C17H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWVGILTYGZFGLR-QGZVFWFLSA-N
25888	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6654	(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB07857	C17H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWVGILTYGZFGLR-QGZVFWFLSA-N
25889	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6655	(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB07858	C17H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWVGILTYGZFGLR-KRWDZBQOSA-N
25890	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6655	(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB07858	C17H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWVGILTYGZFGLR-KRWDZBQOSA-N
25891	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6656	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	-	-	DRUGBANK	DB07859	C20H20ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZMOSYUFVYJEPY-UHFFFAOYSA-N
25892	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6656	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	-	-	DRUGBANK	DB07859	C20H20ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZMOSYUFVYJEPY-UHFFFAOYSA-N
25893	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6656	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	-	-	DRUGBANK	DB07859	C20H20ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZMOSYUFVYJEPY-UHFFFAOYSA-N
25894	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6656	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	-	-	DRUGBANK	DB07859	C20H20ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZMOSYUFVYJEPY-UHFFFAOYSA-N
25895	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6657	(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE	-	-	DRUGBANK	DB07860	C14H14ClN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNKKPFLBOWGVSF-CQSZACIVSA-N
25896	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6657	(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE	-	-	DRUGBANK	DB07860	C14H14ClN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PNKKPFLBOWGVSF-CQSZACIVSA-N
25897	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6659	7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE	-	-	DRUGBANK	DB07862	C15H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCPJCLJGTVTGRF-UHFFFAOYSA-N
25898	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6660	2-chloro-5-nitro-N-phenylbenzamide	-	-	DRUGBANK	DB07863	C13H9ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNTSIBUQMRRYIU-UHFFFAOYSA-N
25899	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6660	2-chloro-5-nitro-N-phenylbenzamide	-	-	DRUGBANK	DB07863	C13H9ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNTSIBUQMRRYIU-UHFFFAOYSA-N
25900	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6660	2-chloro-5-nitro-N-phenylbenzamide	-	-	DRUGBANK	DB07863	C13H9ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNTSIBUQMRRYIU-UHFFFAOYSA-N
25901	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6663	(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	-	-	DRUGBANK	DB07866	C15H26N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBTHYUAUBLEDJY-HNNXBMFYSA-N
25902	106550	32	-	ACACB	ACC2|ACCB|HACC275	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6667	(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID	-	-	DRUGBANK	DB07870	C15H11ClF3NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOCUAJYOYBLQRH-MRVPVSSYSA-N
25903	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6669	5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide	-	-	DRUGBANK	DB07872	C22H20ClFN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGIXVNAMZPBDK-CQSZACIVSA-N
25904	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6670	(1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	-	-	DRUGBANK	DB07873	C12H28O7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKVZONPEMODBBG-UHFFFAOYSA-N
25905	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6671	(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	-	-	DRUGBANK	DB07874	C19H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOCXPOKEPYGTJ-IBGZPJMESA-N
25906	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6672	5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide	-	-	DRUGBANK	DB07875	C22H20ClFN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARAVOODWJJJNBY-IRXDYDNUSA-N
25907	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6673	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	-	-	DRUGBANK	DB07876	C16H21N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWDORCFLUJZUQS-ZDUSSCGKSA-N
25908	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6673	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	-	-	DRUGBANK	DB07876	C16H21N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWDORCFLUJZUQS-ZDUSSCGKSA-N
25909	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6673	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	-	-	DRUGBANK	DB07876	C16H21N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWDORCFLUJZUQS-ZDUSSCGKSA-N
25910	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6674	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	-	-	DRUGBANK	DB07877	C18H21BrN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGWLDJLENCVRQ-UHFFFAOYSA-N
25911	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6674	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	-	-	DRUGBANK	DB07877	C18H21BrN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGWLDJLENCVRQ-UHFFFAOYSA-N
25912	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6675	N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE	-	-	DRUGBANK	DB07878	C21H28N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEHUTYXPQSSKAK-RVLLMHTFSA-N
25913	115106	9759	-	HDAC4	AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6676	N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB07879	C18H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMSIXMLQOONOQQ-UHFFFAOYSA-N
25914	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6678	N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE	-	-	DRUGBANK	DB07881	C23H29N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKQZZKSBRCTCQU-QFIPXVFZSA-N
25915	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6679	4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID	-	-	DRUGBANK	DB07882	C24H33N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFIZFTGABDUGCF-UPVHCHBVSA-N
25916	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6680	(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE	-	-	DRUGBANK	DB07883	C20H21NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJQDTOANLAPEIM-JRBPQWBISA-N
25917	108458	2160	-	F11	FXI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6684	(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE	-	-	DRUGBANK	DB07887	C11H16BN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIZOWFNBOXPJES-SNVBAGLBSA-N
25918	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6685	3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER	-	-	DRUGBANK	DB07888	C12H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXMJTYHQHQJLU-SNVBAGLBSA-N
25919	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6686	1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL	-	-	DRUGBANK	DB07889	C23H26N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCPXSBULBDYRLT-SFHVURJKSA-N
25920	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6690	PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE	-	-	DRUGBANK	DB07893	C15H22NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJQWWGCHPFSERW-CQSZACIVSA-N
25921	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6692	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID	-	-	DRUGBANK	DB07895	C15H33O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJNCEETVCWDDQB-KFWWJZLASA-N
25922	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6692	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID	-	-	DRUGBANK	DB07895	C15H33O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJNCEETVCWDDQB-KFWWJZLASA-N
25923	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6694	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	-	-	DRUGBANK	DB07897	C9H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SJEVZMRZAJQYFZ-UHFFFAOYSA-N
25924	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6696	(2S) N-ACETYL-L-ALANYL-ALPHAL-PHENYLALANYL-CHLOROETHYLKETONE	-	-	DRUGBANK	DB07899	C16H21ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WABWAIGLGFELMI-FZMZJTMJSA-N
25925	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6697	3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE	-	-	DRUGBANK	DB07900	C8H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVDHZNIQWHUORH-BQBZGAKWSA-N
25926	116785	23173	-	METAP1	MAP1A|MetAP1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6698	5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB07901	C18H17ClN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIUOABSWQSUEGK-UHFFFAOYSA-N
25927	116785	23173	-	METAP1	MAP1A|MetAP1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6699	TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE	-	-	DRUGBANK	DB07902	C14H16N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBMYJIFXSXKPFS-UHFFFAOYSA-N
25928	116785	23173	-	METAP1	MAP1A|MetAP1A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6700	3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07903	C14H16N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAVCWRXFMNCBCM-UHFFFAOYSA-N
25929	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6701	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	-	-	DRUGBANK	DB07905	C19H22O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SSNQAUBBJYCSMY-KNTMUCJRSA-N
25930	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6702	[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL	-	-	DRUGBANK	DB07906	C10H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RNUCRXHRBPLYTA-SECBINFHSA-N
25931	119941	54363	-	HAO1	GOX|GOX1|HAOX1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6703	(2S)-2-HYDROXYOCTANOIC ACID	-	-	DRUGBANK	DB07907	C8H16O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKRDADVRIYVCCY-ZETCQYMHSA-N
25932	111237	5216	-	PFN1	ALS18	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6704	7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN	-	-	DRUGBANK	DB07908	C12H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCGFYFKJZGIZMX-UHFFFAOYSA-N
25933	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6705	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	-	-	DRUGBANK	DB07909	C23H27NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBWILOKKNDYPLX-HBMCJLEFSA-N
25934	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6705	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	-	-	DRUGBANK	DB07909	C23H27NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBWILOKKNDYPLX-HBMCJLEFSA-N
25935	121811	58478	MSTP145	ENOPH1	E1|MASA|MST145|mtnC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6708	2-OXOHEPTYLPHOSPHONIC ACID	-	-	DRUGBANK	DB07912	C7H15O4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACMQFLCUSWMWKH-UHFFFAOYSA-N
25936	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6709	HOMOPHENYLALANINYLMETHANE	-	-	DRUGBANK	DB07913	C11H15NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDTWNRLBYDWRII-NSHDSACASA-N
25937	107284	834	-	CASP1	ICE|IL1BC|P45	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6712	3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID	-	-	DRUGBANK	DB07916	C24H25N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXMPYGCWDMKRMF-IRXDYDNUSA-N
25938	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6713	4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE	-	-	DRUGBANK	DB07917	C22H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZQGXAHOROZEKN-UHFFFAOYSA-N
25939	852959	948667	b4154	frdA	ECK4150|JW4115	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25940	853077	948794	b1475	fdnH	ECK1469|JW1471	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25941	850396	946035	b1474	fdnG	ECK1468|JW1470	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25942	850399	946038	b1476	fdnI	ECK1470|JW1472	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25943	852960	948668	b4151	frdD	ECK4147|JW4112	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25944	852958	948666	b4153	frdB	ECK4149|JW4114	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25945	852972	948680	b4152	frdC	ECK4148|JW4113	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6714	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	-	-	DRUGBANK	DB07918	C16H21NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZPACTGCRWDXCJ-UHFFFAOYSA-N
25946	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6715	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	-	-	DRUGBANK	DB07919	C13H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BXNJHAXVSOCGBA-UHFFFAOYSA-N
25947	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6716	N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide	-	-	DRUGBANK	DB07920	C14H12N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGRPZMQLAVBWPV-UHFFFAOYSA-N
25948	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6717	2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide	-	-	DRUGBANK	DB07921	C8H7FN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATANXIMWDMRRIO-UHFFFAOYSA-N
25949	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6718	N-oxo-2-(phenylsulfonylamino)ethanamide	-	-	DRUGBANK	DB07922	C8H8N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBEMJFIVKDOIBO-UHFFFAOYSA-N
25950	849871	945497	b0875	aqpZ	ECK0866|JW0859|bniP	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6719	octyl alpha-L-altropyranoside	-	-	DRUGBANK	DB07923	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEGSGKPQLMEBJL-QSLWVIQJSA-N
25951	849871	945497	b0875	aqpZ	ECK0866|JW0859|bniP	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6720	octyl beta-D-galactopyranoside	-	-	DRUGBANK	DB07924	C14H28O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEGSGKPQLMEBJL-MBJXGIAVSA-N
25952	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6722	N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE	-	-	DRUGBANK	DB07926	C19H29N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYZPDCGWIJYZMN-ZBFHGGJFSA-N
25953	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6723	3-{[(4-CARBOXY-2-HYDROXYANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07927	C12H9NO7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDPXXOOKKRIKFN-UHFFFAOYSA-N
25954	850778	946421	b1916	sdiA	ECK1915|JW1901|uvrX	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6724	N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE	-	-	DRUGBANK	DB07928	C12H21NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKEJEOJPJVRHMQ-JTQLQIEISA-N
25955	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6725	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	-	-	DRUGBANK	DB07929	C23H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGJACZABNQGPMT-UHFFFAOYSA-N
25956	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6725	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	-	-	DRUGBANK	DB07929	C23H28N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGJACZABNQGPMT-UHFFFAOYSA-N
25957	106567	51	-	ACOX1	ACOX|PALMCOX|SCOX	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6726	(3R)-3-HYDROXYDODECANOIC ACID	-	-	DRUGBANK	DB07930	C12H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUCMKTPAZLSKTL-LLVKDONJSA-N
25958	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6727	Hexestrol	Hexoestrolum|4,4'-(1,2-diethylethylene)diphenol|Mesohexestrol|Hexanoestrol|Synoestrolum|Erythrohexestrol|Meso-3,4-di(p-hydroxyphenyl)-n-hexane|Meso-hexestrol	-	DRUGBANK	DB07931	C18H22O2	small molecule	-	84-16-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBGSZCBWVPOOL-HDICACEKSA-N
25959	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6728	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate	-	-	DRUGBANK	DB07932	C22H18O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CRLQCBACIMUGDZ-BGYRXZFFSA-N
25960	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6728	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate	-	-	DRUGBANK	DB07932	C22H18O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CRLQCBACIMUGDZ-BGYRXZFFSA-N
25961	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6729	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07933	C18H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIESSJVMWNJCGZ-VKJFTORMSA-N
25962	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6729	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB07933	C18H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIESSJVMWNJCGZ-VKJFTORMSA-N
25963	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6730	[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE	-	-	DRUGBANK	DB07934	C22H36N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMUXFASJKPVMGU-HXUWFJFHSA-O
25964	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6732	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	-	-	DRUGBANK	DB07936	C24H30FN7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BACSZMCLZIDTIO-IBGZPJMESA-N
25965	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6736	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	-	-	DRUGBANK	DB07940	C20H19IN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUCWQTWGZGIYPV-UHFFFAOYSA-N
25966	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6737	3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide	-	-	DRUGBANK	DB07941	C22H19BrF2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCAJXIDMCNPGHZ-UHFFFAOYSA-N
25967	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6738	2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine	-	-	DRUGBANK	DB07942	C14H9F2N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJCHZVXSPFPKMX-UHFFFAOYSA-N
25968	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6739	2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol	-	-	DRUGBANK	DB07943	C20H20ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CATQHDWESBRRQA-UHFFFAOYSA-N
25969	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6740	N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE	-	-	DRUGBANK	DB07944	C20H22N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MPTWCWHNLVMCRW-UHFFFAOYSA-O
25970	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6742	N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide	-	-	DRUGBANK	DB07946	C19H21ClF3N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DZEJHPMTDNDECN-UHFFFAOYSA-N
25971	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6743	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	-	-	DRUGBANK	DB07947	C20H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUHWQSZMVMMRLM-UHFFFAOYSA-N
25972	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6743	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	-	-	DRUGBANK	DB07947	C20H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUHWQSZMVMMRLM-UHFFFAOYSA-N
25973	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6743	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	-	-	DRUGBANK	DB07947	C20H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUHWQSZMVMMRLM-UHFFFAOYSA-N
25974	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6743	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	-	-	DRUGBANK	DB07947	C20H22ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AUHWQSZMVMMRLM-UHFFFAOYSA-N
25975	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6744	({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID	-	-	DRUGBANK	DB07949	C18H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFQRPTKOSYMPOL-LALPNIDTSA-N
25976	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6745	1H-INDOL-3-YLACETIC ACID	-	-	DRUGBANK	DB07950	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEOVTRFCIGRIMH-UHFFFAOYSA-N
25977	107326	883	RP11-545E17.6	CCBL1	GTK|KAT1|KATI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6745	1H-INDOL-3-YLACETIC ACID	-	-	DRUGBANK	DB07950	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEOVTRFCIGRIMH-UHFFFAOYSA-N
25978	112391	6500	-	SKP1	EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6745	1H-INDOL-3-YLACETIC ACID	-	-	DRUGBANK	DB07950	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEOVTRFCIGRIMH-UHFFFAOYSA-N
25979	111166	5140	-	PDE3B	HcGIP1|cGIPDE1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25980	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25981	111174	5148	-	PDE6G	PDEG|RP57	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25982	111178	5152	-	PDE9A	HSPDE9A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25983	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25984	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25985	111177	5151	-	PDE8A	HsT19550	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25986	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6749	3-isobutyl-1-methyl-7H-xanthine	3-Isobutyl-1-methyxanthine|1-methyl-3-isobutylxanthine|1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione|IBMX|3-isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione|3-isobutyl-1-methylxanthine	-	DRUGBANK	DB07954	C10H14N4O2	small molecule	-	28822-58-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APIXJSLKIYYUKG-UHFFFAOYSA-N
25987	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6750	(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE	-	-	DRUGBANK	DB07955	C11H12BrNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMKXVWWBCFWRMP-UHFFFAOYSA-N
25988	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6751	[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER	-	-	DRUGBANK	DB07956	C17H23ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBHYPZDGTWSQFR-AWEZNQCLSA-N
25989	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6752	METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE	-	-	DRUGBANK	DB07957	C12H13NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DWYLZBJDRMVVPU-SNVBAGLBSA-N
25990	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6753	(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID	-	-	DRUGBANK	DB07958	C15H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMLOGGCSARAIGZ-UHFFFAOYSA-N
25991	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6754	3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE	-	-	DRUGBANK	DB07959	C14H10N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTKFRFMSUBOCIQ-UHFFFAOYSA-N
25992	110832	4759	-	NEU2	SIAL2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6755	5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07960	C12H19NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDVFOADQCFRSSP-MKPLZMMCSA-N
25993	112731	6868	-	ADAM17	ADAM18|CD156B|CSVP|NISBD|NISBD1|TACE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6759	(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07964	C17H22N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVZIHNYAZLXRRS-HNNXBMFYSA-N
25994	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6760	6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile	6-(Cyclohexylamino)-9-[2-(4-methyl-1-piperazinyl)ethyl]-9H-purine-2-carbonitrile	-	DRUGBANK	DB07965	C19H28N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGODDSLNRULSMM-UHFFFAOYSA-N
25995	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6761	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile	-	-	DRUGBANK	DB07966	C22H19N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVMCVWOODOWOLT-UHFFFAOYSA-N
25996	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6762	9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE	-	-	DRUGBANK	DB07967	C23H24N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJNKDTWKWYLERH-UHFFFAOYSA-N
25997	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6763	N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA	-	-	DRUGBANK	DB07968	C15H12ClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFOBTYLRURSVJE-UHFFFAOYSA-N
25998	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6764	3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol	-	-	DRUGBANK	DB07969	C20H19F3N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QNCYYRHIUFGGJX-UHFFFAOYSA-N
25999	108359	2045	-	EPHA7	EHK-3|EHK3|EK11|HEK11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6765	5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide	-	-	DRUGBANK	DB07970	C21H17F3N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAAYRHKJHDIDPH-UHFFFAOYSA-N
26000	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6768	N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07973	C25H31N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIPCBGDQVGKMPO-UHFFFAOYSA-N
26001	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6769	1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE	-	-	DRUGBANK	DB07974	C25H29ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDLMBQRBNPDCSS-UHFFFAOYSA-N
26002	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6770	2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID	-	-	DRUGBANK	DB07975	C20H14F5NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTGXLCZUWFYELR-UHFFFAOYSA-N
26003	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6771	3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07976	C19H14FNO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIUMGVUBDBDTDX-UHFFFAOYSA-N
26004	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6772	3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB07977	C19H10F5NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGNHUSCKOHDSMR-UHFFFAOYSA-N
26005	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6773	2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID	-	-	DRUGBANK	DB07978	C20H10F7NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULMUPVXFUDHRGH-UHFFFAOYSA-N
26006	107980	1610	-	DAO	DAAO|DAMOX|OXDA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6774	(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID	-	-	DRUGBANK	DB07979	C9H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFINRVRRNHRWEQ-UHFFFAOYSA-N
26007	124609	89832	-	CHRFAM7A	CHRNA7|CHRNA7-DR1|D-10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6775	(E)-imidacloprid	(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine	-	DRUGBANK	DB07980	C9H10ClN5O2	small molecule	-	138261-41-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTYJOPNNQFBPC-UHFFFAOYSA-N
26008	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6776	2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE	-	-	DRUGBANK	DB07981	C23H25ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKJWXEORYGBJFS-QGZVFWFLSA-N
26009	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6777	2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol	-	-	DRUGBANK	DB07982	C23H29N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVTKDXZNSUHUMO-UHFFFAOYSA-N
26010	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6778	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	-	-	DRUGBANK	DB07983	C19H16INO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXBFZYKAVCAPSV-UHFFFAOYSA-N
26011	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6779	2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE	-	-	DRUGBANK	DB07984	C23H25ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKJWXEORYGBJFS-KRWDZBQOSA-N
26012	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6780	+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE	-	-	DRUGBANK	DB07985	C20H24N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVALLOSAENRPQO-INIZCTEOSA-N
26013	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6781	[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID	-	-	DRUGBANK	DB07986	C19H22N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GNSLACGSDSJAIQ-UHFFFAOYSA-N
26014	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6782	[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER	-	-	DRUGBANK	DB07987	C19H18N4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWAKNMKLVLWIIQ-OAHLLOKOSA-N
26015	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6783	2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE	-	-	DRUGBANK	DB07988	C13H10F5N5O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HZAXNPDJVFUGDS-BYPYZUCNSA-N
26016	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6786	N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE	-	-	DRUGBANK	DB07991	C26H26N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APLJSSOXDWUNGV-GOSISDBHSA-N
26017	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6788	N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07993	C20H18N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPQUIIHPUGDHJK-UHFFFAOYSA-N
26018	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6789	N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE	-	-	DRUGBANK	DB07994	C26H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMBPJSHPAXOXBT-UHFFFAOYSA-N
26019	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6790	N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE	-	-	DRUGBANK	DB07995	C20H20BrN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZXNDJNWUTGDK-NSCUHMNNSA-N
26020	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6790	N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE	-	-	DRUGBANK	DB07995	C20H20BrN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZXNDJNWUTGDK-NSCUHMNNSA-N
26021	123814	83903	-	GSG2	HASPIN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6790	N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE	-	-	DRUGBANK	DB07995	C20H20BrN3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKZXNDJNWUTGDK-NSCUHMNNSA-N
26022	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6791	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine|1-(5-Isoquinolinesulfonyl)-2-methylpiperazine	-	DRUGBANK	DB07996	C14H17N3O2S	small molecule	-	84477-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDVFVCGFMNCYPV-UHFFFAOYSA-N
26023	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6791	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine|1-(5-Isoquinolinesulfonyl)-2-methylpiperazine	-	DRUGBANK	DB07996	C14H17N3O2S	small molecule	-	84477-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDVFVCGFMNCYPV-UHFFFAOYSA-N
26024	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6792	N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE	-	-	DRUGBANK	DB07997	C12H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWUXKNZVMEPPH-UHFFFAOYSA-N
26025	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6792	N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE	-	-	DRUGBANK	DB07997	C12H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJWUXKNZVMEPPH-UHFFFAOYSA-N
26026	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6793	{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID	-	-	DRUGBANK	DB07999	C16H11NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXLBOIRSEDMRPI-UHFFFAOYSA-N
26027	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6794	2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE	-	-	DRUGBANK	DB08000	C14H9NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTJGXDGAXGWOGR-UHFFFAOYSA-N
26028	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6795	5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID	-	-	DRUGBANK	DB08001	C22H19NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQSRCEFDWMQCCV-GQCTYLIASA-N
26029	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6796	ISOTHIAZOLIDINONE ANALOG	-	-	DRUGBANK	DB08003	C23H26N4O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UILYPHAKDBTKQV-UFYCRDLUSA-N
26030	123814	83903	-	GSG2	HASPIN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6797	(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol	-	-	DRUGBANK	DB08004	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUMVONFFLKPPIM-CQSZACIVSA-N
26031	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6798	4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide	-	-	DRUGBANK	DB08005	C20H23ClN6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARMFMDYRYOKSOW-UHFFFAOYSA-N
26032	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6799	N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08006	C20H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OXYDLVAOXASTMW-UHFFFAOYSA-N
26033	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6800	(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID	-	-	DRUGBANK	DB08007	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFDIRSBGRVEFZ-SECBINFHSA-N
26034	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6801	5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08008	C13H10F3N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRHHXKBKRNNFRV-UHFFFAOYSA-N
26035	121424	57172	RP1-272L16.2	CAMK1G	CLICK3|CLICKIII|VWS1|dJ272L16.1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6802	5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08009	C22H27ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPLJEFSRINKZLC-ATVHPVEESA-N
26036	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6803	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime	-	-	DRUGBANK	DB08010	C25H19FN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDHASJXGNUWZTM-ZLEWNXFRSA-N
26037	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6804	(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime	-	-	DRUGBANK	DB08011	C17H12F2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXIHOIDYHQSQKJ-HMMYKYKNSA-N
26038	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6808	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime	-	-	DRUGBANK	DB08015	C23H17FN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZYREAUDQRVVLV-DAFNUICNSA-N
26039	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6811	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	-	-	DRUGBANK	DB08018	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDRSQGJWTVRNGM-QFBILLFUSA-N
26040	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6811	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	-	-	DRUGBANK	DB08018	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDRSQGJWTVRNGM-QFBILLFUSA-N
26041	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6812	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	-	-	DRUGBANK	DB08019	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWCMAGONQJHIJZ-LPHOPBHVSA-N
26042	110909	4846	-	NOS3	ECNOS|eNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6812	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	-	-	DRUGBANK	DB08019	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWCMAGONQJHIJZ-LPHOPBHVSA-N
26043	108404	2100	-	ESR2	ER-BETA|ESR-BETA|ESRB|ESTRB|Erb|NR3A2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6813	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB08020	C20H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQLNMNKTIOREN-AOIWGVFYSA-N
26044	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6813	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	-	-	DRUGBANK	DB08020	C20H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHQLNMNKTIOREN-AOIWGVFYSA-N
26045	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6814	5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide	-	-	DRUGBANK	DB08021	C18H17BrClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEFJFXHHHNDHEN-UHFFFAOYSA-N
26046	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6815	(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile	-	-	DRUGBANK	DB08022	C20H16N6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCYPVQCPYKNSTG-OAHLLOKOSA-N
26047	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6816	N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine	-	-	DRUGBANK	DB08023	C18H21N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYNNWLVWJXWXFO-UHFFFAOYSA-N
26048	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6817	1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE	-	-	DRUGBANK	DB08024	C20H25N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUUVLSCVDXKQQV-OALUTQOASA-N
26049	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6818	N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08025	C24H25FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACGBFWCBVIXTPZ-OQIWPSSASA-N
26050	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6819	2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide	-	-	DRUGBANK	DB08026	C19H23N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AJLILYAPRHIFAS-UHFFFAOYSA-N
26051	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6821	BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE	-	-	DRUGBANK	DB08028	C13H14ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZVZPCRKQNRRBOQ-UHFFFAOYSA-N
26052	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6822	N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide	-	-	DRUGBANK	DB08029	C16H18N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQDWEVONJRXVDB-UHFFFAOYSA-N
26053	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6823	3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide	-	-	DRUGBANK	DB08030	C16H14N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZWFHJUEAVOHHG-UHFFFAOYSA-N
26054	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6825	N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08032	C18H22N2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZTHBWHANVWSRX-UHFFFAOYSA-N
26055	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6826	(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08033	C19H24N2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQKSYQYWUHUIEH-GFCCVEGCSA-N
26056	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6828	1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	-	-	DRUGBANK	DB08035	C18H23N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUPXEJURIFFVSX-UHFFFAOYSA-N
26057	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6830	(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide	-	-	DRUGBANK	DB08037	C25H28F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYBGWENAVMIGMM-GIFXNVAJSA-N
26058	111631	5650	-	KLK7	PRSS6|SCCE|hK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6831	L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide	-	-	DRUGBANK	DB08038	C16H25N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPAOOGAUUDSJCS-FMSGJZPZSA-N
26059	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6832	Su6656	330161-87-0|NCGC00094279-01|B5839|HMS3648O08|NCGC00015981-09|N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|2,3-DIHYDRO-N,N-DIMETHYL-2-OXO-3-[(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE]-1H-INDOLE-5-SULFONAMIDE|EX-A584|4071AH|AKOS015994571|MLS002153475|HMS2232C04|INSOLUTION&TRADE; SU6656|LOPAC0_000979|EU-0100979|NCGC00261664-01|S7774|Q7394936|NCGC00015981-03|1240328-42-0|SU 6656|SR-01000076237-6|HMS3263C19|(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE|CCG-205059|SU-6656|SU6656|ES-0024|SU 6656, >=98% (HPLC)|SDCCGSBI-0050952.P003|NCGC00015981-04|NCGC00094279-02|LOPAC-S-9692|NCGC00015981-02|HSCI1_000124|SR-01000076237-1|HMS3229I04|SR-01000076237|CS-3943|GTPL6044|TOX21_500979|DB08039|(Z)-N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|MFCD10565928|NCGC00015981-05|NCGC00015981-01|NCGC00015981-06|ZINC3875028|2-OXO-3-[1-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)-METH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOLE-5-SULFONIC ACID DIMETHYLAMIDE|SMR001230828|S 9692|LP00979|BRD-K97354755-001-01-5|HY-B0789|BDBM50307127	-	DRUGBANK	DB08039	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOGJQOUIVKBFGH-YBEGLDIGSA-N
26060	107267	817	-	CAMK2D	CAMKD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6832	Su6656	330161-87-0|NCGC00094279-01|B5839|HMS3648O08|NCGC00015981-09|N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|2,3-DIHYDRO-N,N-DIMETHYL-2-OXO-3-[(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE]-1H-INDOLE-5-SULFONAMIDE|EX-A584|4071AH|AKOS015994571|MLS002153475|HMS2232C04|INSOLUTION&TRADE; SU6656|LOPAC0_000979|EU-0100979|NCGC00261664-01|S7774|Q7394936|NCGC00015981-03|1240328-42-0|SU 6656|SR-01000076237-6|HMS3263C19|(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE|CCG-205059|SU-6656|SU6656|ES-0024|SU 6656, >=98% (HPLC)|SDCCGSBI-0050952.P003|NCGC00015981-04|NCGC00094279-02|LOPAC-S-9692|NCGC00015981-02|HSCI1_000124|SR-01000076237-1|HMS3229I04|SR-01000076237|CS-3943|GTPL6044|TOX21_500979|DB08039|(Z)-N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|MFCD10565928|NCGC00015981-05|NCGC00015981-01|NCGC00015981-06|ZINC3875028|2-OXO-3-[1-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)-METH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOLE-5-SULFONIC ACID DIMETHYLAMIDE|SMR001230828|S 9692|LP00979|BRD-K97354755-001-01-5|HY-B0789|BDBM50307127	-	DRUGBANK	DB08039	C19H21N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOGJQOUIVKBFGH-YBEGLDIGSA-N
26061	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6833	N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine	-	-	DRUGBANK	DB08040	C14H18N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJCFZTVYDSKXNM-GXSJLCMTSA-N
26062	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6835	N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine	-	-	DRUGBANK	DB08042	C22H24N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLXGQDHYCWXTAI-UHFFFAOYSA-N
26063	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6836	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	-	-	DRUGBANK	DB08043	C19H14F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDDLGNOZDKDSEG-UHFFFAOYSA-N
26064	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6837	(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE	-	-	DRUGBANK	DB08044	C19H17F6N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVVSPGQEXMJZIR-BMIGLBTASA-N
26065	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6838	4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL	-	-	DRUGBANK	DB08045	C18H18ClN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDGJOIYZAMLBW-UHFFFAOYSA-N
26066	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6839	2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide	-	-	DRUGBANK	DB08046	C14H11ClN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIVPVXMEBJLZRO-AWEZNQCLSA-N
26067	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6840	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol	-	-	DRUGBANK	DB08047	C17H13F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDUDMCQPFKPISO-UHFFFAOYSA-N
26068	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6840	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol	-	-	DRUGBANK	DB08047	C17H13F3N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDUDMCQPFKPISO-UHFFFAOYSA-N
26069	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6841	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB08048	C13H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLDZDEMGKFWJNR-UHFFFAOYSA-N
26070	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6841	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB08048	C13H10N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLDZDEMGKFWJNR-UHFFFAOYSA-N
26071	107707	1312	-	COMT	HEL-S-98n	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6842	7,8-dihydroxy-4-phenyl-2H-chromen-2-one	-	-	DRUGBANK	DB08049	C15H10O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRVIIPJSVKTPBK-UHFFFAOYSA-N
26072	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6844	(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE	-	-	DRUGBANK	DB08051	C22H24F3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXRHRPGYYNOBHO-QGZVFWFLSA-N
26073	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6845	1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08052	C17H17N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVRXTLZYXZNATH-UHFFFAOYSA-N
26074	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6846	1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08053	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITOYZJGFTNTKKR-UHFFFAOYSA-N
26075	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6847	1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08054	C17H16N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEZALMMCQYDFML-UHFFFAOYSA-N
26076	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6848	N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	-	-	DRUGBANK	DB08055	C18H13ClN4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNBICZMPIJMWGC-UHFFFAOYSA-N
26077	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6849	N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	-	-	DRUGBANK	DB08056	C20H18N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKYYLKPGILUPOA-UHFFFAOYSA-N
26078	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6850	N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine	-	-	DRUGBANK	DB08057	C22H23ClN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWJPPYCULHDHBB-HNNXBMFYSA-N
26079	115351	10039	-	PARP3	ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6851	4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one	-	-	DRUGBANK	DB08058	C21H21FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGEPGGJUGUMFHT-UHFFFAOYSA-N
26080	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6852	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	-	-	DRUGBANK	DB08059	C23H24O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDLHCMPXEPAAMD-QAIWCSMKSA-N
26081	111308	5290	-	PIK3CA	CLOVE|CWS5|MCAP|MCM|MCMTC|PI3K|p110-alpha	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6852	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	-	-	DRUGBANK	DB08059	C23H24O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDLHCMPXEPAAMD-QAIWCSMKSA-N
26082	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6852	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	-	-	DRUGBANK	DB08059	C23H24O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDLHCMPXEPAAMD-QAIWCSMKSA-N
26083	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6852	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE	-	-	DRUGBANK	DB08059	C23H24O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QDLHCMPXEPAAMD-QAIWCSMKSA-N
26084	106694	189	-	AGXT	AGT|AGT1|AGXT1|PH1|SPAT|SPT|TLH6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6853	4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID	-	-	DRUGBANK	DB08060	C10H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIASMBPERGWEBX-UHFFFAOYSA-N
26085	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6854	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	-	-	DRUGBANK	DB08061	C14H16ClN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GELALLNTKKLQLM-UHFFFAOYSA-N
26086	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6855	3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE	-	-	DRUGBANK	DB08062	C9H8ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YXVAYMRODBYXIQ-UHFFFAOYSA-N
26087	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6856	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE	-	-	DRUGBANK	DB08063	C24H20N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLZMYWLMBBLASX-UHFFFAOYSA-N
26088	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6856	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE	-	-	DRUGBANK	DB08063	C24H20N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HLZMYWLMBBLASX-UHFFFAOYSA-N
26089	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6857	N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA	-	-	DRUGBANK	DB08064	C20H22ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTMADESEDXKNFZ-UHFFFAOYSA-N
26090	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6858	2-(1H-pyrazol-3-yl)-1H-benzimidazole	-	-	DRUGBANK	DB08065	C10H8N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYTGPPNUOLLGBE-UHFFFAOYSA-N
26091	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6859	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	-	-	DRUGBANK	DB08066	C17H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPKSFXFWECAIBR-UHFFFAOYSA-N
26092	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6859	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	-	-	DRUGBANK	DB08066	C17H13N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPKSFXFWECAIBR-UHFFFAOYSA-N
26093	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6860	4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM	-	-	DRUGBANK	DB08067	C19H24N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LOLPPWBBNUVNQZ-UHFFFAOYSA-O
26094	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6861	N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-	-	-	DRUGBANK	DB08068	C23H25ClFN3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQJVDUKATDECHF-ICSRJNTNSA-N
26095	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6863	2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB08070	C12H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILTOXASLQDKYJW-UHFFFAOYSA-N
26096	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6863	2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	-	-	DRUGBANK	DB08070	C12H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILTOXASLQDKYJW-UHFFFAOYSA-N
26097	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6865	4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE	-	-	DRUGBANK	DB08072	C18H20Cl2N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYKUIRSGEMLIFT-UHFFFAOYSA-N
26098	109187	2932	-	GSK3B	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6866	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB08073	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTBGJGMTBHQTM-IBGZPJMESA-N
26099	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6866	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB08073	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTBGJGMTBHQTM-IBGZPJMESA-N
26100	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6866	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB08073	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTBGJGMTBHQTM-IBGZPJMESA-N
26101	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6866	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	-	-	DRUGBANK	DB08073	C24H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWTBGJGMTBHQTM-IBGZPJMESA-N
26102	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6867	3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine	-	-	DRUGBANK	DB08074	C10H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEPGTHDUUROBHM-UHFFFAOYSA-N
26103	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6868	4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08075	C7H7N5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHERIFNAOMUFRM-UHFFFAOYSA-N
26104	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6869	4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine	-	-	DRUGBANK	DB08076	C15H13Cl2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKSSZTMRRVJNNG-UHFFFAOYSA-N
26105	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6870	2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID	-	-	DRUGBANK	DB08077	C17H16Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYJPTSMWFKGZJM-UHFFFAOYSA-N
26106	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6870	2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID	-	-	DRUGBANK	DB08077	C17H16Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYJPTSMWFKGZJM-UHFFFAOYSA-N
26107	111463	5467	-	PPARD	FAAR|NR1C2|NUC1|NUCI|NUCII|PPARB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6871	{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid	-	-	DRUGBANK	DB08078	C22H26O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBBVCKCCQCQCTJ-UHFFFAOYSA-N
26108	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6872	7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline	-	-	DRUGBANK	DB08079	C22H17N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEAIZQNMNCHNFD-UHFFFAOYSA-N
26109	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6873	LATRUNCULIN B	-	-	DRUGBANK	DB08080	C20H29NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSHPHXHGRHSMIK-JRIKCGFMSA-N
26110	121642	57591	RP5-1042K10.11-009	MKL1	BSAC|MAL|MRTF-A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6873	LATRUNCULIN B	-	-	DRUGBANK	DB08080	C20H29NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSHPHXHGRHSMIK-JRIKCGFMSA-N
26111	124102	84501	-	SPIRE2	Spir-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6873	LATRUNCULIN B	-	-	DRUGBANK	DB08080	C20H29NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSHPHXHGRHSMIK-JRIKCGFMSA-N
26112	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6875	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	-	-	DRUGBANK	DB08082	C9H10ClNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBARCMIFTACERW-UHFFFAOYSA-N
26113	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6876	2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide	-	-	DRUGBANK	DB08083	C10H8N4O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGMVTZZDGKDTEU-UHFFFAOYSA-N
26114	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6877	IDD594	-	-	DRUGBANK	DB08084	C16H12BrF2NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCZUIWYXULSXSW-UHFFFAOYSA-N
26115	112924	7068	-	THRB	C-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6878	1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE	-	-	DRUGBANK	DB08085	C15H20O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IINHTEWASPUCMH-UHFFFAOYSA-N
26116	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6880	4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE	-	-	DRUGBANK	DB08087	C17H13N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHBIWLQQJPSMNP-CABCVRRESA-N
26117	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6881	2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile	-	-	DRUGBANK	DB08088	C15H13ClF3N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KALFKWQLCWAXJO-RNSKTZJQSA-N
26118	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6882	6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB08089	C14H9F9N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULBPQWIGZUGPHU-UHFFFAOYSA-N
26119	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6884	3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE	-	-	DRUGBANK	DB08091	C26H25FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIUFYIOMUILESI-UHFFFAOYSA-N
26120	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6885	3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide	-	-	DRUGBANK	DB08092	C19H18FN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMLSXFMXUNVCSK-UHFFFAOYSA-N
26121	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6886	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	-	-	DRUGBANK	DB08093	C16H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZANYTFSQVBOBA-UHFFFAOYSA-N
26122	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6887	(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE	-	-	DRUGBANK	DB08094	C18H21F2N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JRNJNYBQQYBCLE-UHFFFAOYSA-N
26123	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6888	3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA	-	-	DRUGBANK	DB08095	C23H26ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWYFTKPEHRQCCW-HNNXBMFYSA-N
26124	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6889	8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM	-	-	DRUGBANK	DB08096	C19H15ClF2N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZWKOUFZHPNIQSH-UHFFFAOYSA-N
26125	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6890	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	-	-	DRUGBANK	DB08097	C20H16F3N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGWSGDLIXOEZJG-UHFFFAOYSA-N
26126	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6891	[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid	-	-	DRUGBANK	DB08098	C8H5N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITBNJCVIFHSKRL-UHFFFAOYSA-N
26127	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6892	6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine	-	-	DRUGBANK	DB08099	C25H31N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOYVKYJWAXJTTE-NRFANRHFSA-N
26128	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6898	N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID	-	-	DRUGBANK	DB08105	C19H23NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAGYXJBYAFGRFR-KRWDZBQOSA-N
26129	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6899	N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID	-	-	DRUGBANK	DB08106	C19H23NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAGYXJBYAFGRFR-QGZVFWFLSA-N
26130	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6900	N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID	-	-	DRUGBANK	DB08107	C20H25NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIGACKDHLKEZFH-GOSISDBHSA-N
26131	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6901	N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	-	-	DRUGBANK	DB08108	C23H20N2O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUHRQSFXADUGJW-OAQYLSRUSA-N
26132	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6904	4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol	-	-	DRUGBANK	DB08111	C18H14N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGJYGQLGSXWEMY-UHFFFAOYSA-N
26133	849219	944818	b0088	murD	ECK0089|JW0086	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6905	N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	-	-	DRUGBANK	DB08112	C23H19FN2O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRJUSGUHNFMVCK-OAQYLSRUSA-N
26134	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6906	3-pyridin-4-yl-1H-indazole	-	-	DRUGBANK	DB08113	C12H9N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSRXUUDVRNWSTN-UHFFFAOYSA-N
26135	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6906	3-pyridin-4-yl-1H-indazole	-	-	DRUGBANK	DB08113	C12H9N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSRXUUDVRNWSTN-UHFFFAOYSA-N
26136	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6907	5-benzyl-1,3-thiazol-2-amine	-	-	DRUGBANK	DB08114	C10H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJIMLXBJUVLMMN-UHFFFAOYSA-N
26137	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6907	5-benzyl-1,3-thiazol-2-amine	-	-	DRUGBANK	DB08114	C10H10N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJIMLXBJUVLMMN-UHFFFAOYSA-N
26138	108915	2645	-	GCK	FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6910	2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide	-	-	DRUGBANK	DB08118	C15H16N6OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRJAKERBMMBUGR-UHFFFAOYSA-N
26139	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6911	1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	-	-	DRUGBANK	DB08119	C18H23F3N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZNXJCZDQRNGRC-GJZGRUSLSA-N
26140	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6913	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB08121	C21H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZTPJJNNACUQQR-FQEVSTJZSA-N
26141	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6914	N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB08122	C16H15N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKASAFLVQIJQOK-UVTDQMKNSA-N
26142	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6915	N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE	-	-	DRUGBANK	DB08123	C17H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEWPSTLKJDIUHW-UHFFFAOYSA-N
26143	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6916	3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE	-	-	DRUGBANK	DB08124	C20H15N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTQYGMLRLRXBPT-IDUWFGFVSA-N
26144	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6917	4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB08125	C18H14N4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOMPRXSVSIPRDT-PTNGSMBKSA-N
26145	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6918	3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	-	-	DRUGBANK	DB08126	C16H15N5O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DMCRNUMVSATRTP-LCYFTJDESA-N
26146	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6920	(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine	-	-	DRUGBANK	DB08128	C12H12F3N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHIJEPNAHYLKPE-RNSXUZJQSA-N
26147	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6921	(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol	-	-	DRUGBANK	DB08129	C9H10F3NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRBRWAPWPGAJMA-QMMMGPOBSA-N
26148	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6922	N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine	-	-	DRUGBANK	DB08130	C16H13F3IN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPDWDLAITHFTTP-UHFFFAOYSA-N
26149	853279	949035	b2827	thyA	ECK2823|JW2795	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6923	2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID	-	-	DRUGBANK	DB08131	C20H23N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYENGRJSPURSQB-HNNXBMFYSA-N
26150	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6924	5-hydroxynaphthalene-1-sulfonamide	-	-	DRUGBANK	DB08132	C10H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NFVBVKHGDDDCEA-UHFFFAOYSA-N
26151	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6925	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	-	-	DRUGBANK	DB08133	C14H12N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNHPHKFLWAPNOV-UHFFFAOYSA-N
26152	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6926	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	-	-	DRUGBANK	DB08134	C10H9ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RSNSGNZRUMHXAY-UHFFFAOYSA-N
26153	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6927	N-phenyl-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08135	C10H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMZYZYFPPQOFKY-UHFFFAOYSA-N
26154	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6928	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08136	C12H11FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWQKPKYIMQTGJK-UHFFFAOYSA-N
26155	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6929	(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08137	C17H13FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMWYSLJBNJUCRK-UHFFFAOYSA-N
26156	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6930	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08138	C17H11F3N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDRDBXXWQDFXEC-UHFFFAOYSA-N
26157	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6931	5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile	-	-	DRUGBANK	DB08139	C10H10ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFTLYNKTSANXFA-UHFFFAOYSA-N
26158	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6932	5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE	-	-	DRUGBANK	DB08140	C16H23N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FOESVLPZMGVWBM-JOCQHMNTSA-N
26159	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6933	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08141	C16H17F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KOMNQBZWMCFDTQ-VIFPVBQESA-N
26160	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6934	4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide	-	-	DRUGBANK	DB08142	C16H17Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVPNQJVDAFNBDN-UHFFFAOYSA-N
26161	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6935	5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE	-	-	DRUGBANK	DB08143	C22H19ClF2N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXIYSYYSKHUTQQ-RDJZCZTQSA-N
26162	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6936	6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	-	-	DRUGBANK	DB08144	C13H9Br2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGIPWJYTPOHUGK-UHFFFAOYSA-N
26163	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6937	6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE	-	-	DRUGBANK	DB08145	C15H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRPHIAJXODIASX-UHFFFAOYSA-N
26164	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6938	7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine	-	-	DRUGBANK	DB08146	C17H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFWNOFXQNCLFBC-UHFFFAOYSA-N
26165	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6939	4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid	-	-	DRUGBANK	DB08147	C24H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVENXKUQXLPW-UHFFFAOYSA-N
26166	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6940	1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	-	-	DRUGBANK	DB08148	C18H20ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOZMRRGNAZNWDN-UHFFFAOYSA-N
26167	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6940	1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	-	-	DRUGBANK	DB08148	C18H20ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOZMRRGNAZNWDN-UHFFFAOYSA-N
26168	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6941	1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	-	-	DRUGBANK	DB08149	C19H22ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCWPSUKJCKZEAO-UHFFFAOYSA-N
26169	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6941	1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	-	-	DRUGBANK	DB08149	C19H22ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCWPSUKJCKZEAO-UHFFFAOYSA-N
26170	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6942	4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium	-	-	DRUGBANK	DB08150	C18H21ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZIDZIGAXXNODG-UHFFFAOYSA-O
26171	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6942	4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium	-	-	DRUGBANK	DB08150	C18H21ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZIDZIGAXXNODG-UHFFFAOYSA-O
26172	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6943	(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol	-	-	DRUGBANK	DB08151	C14H17NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YLTDNVVQKRHCJP-RKQHYHRCSA-N
26173	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6944	{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate	-	-	DRUGBANK	DB08152	C20H27ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONXGIEJBNQLITK-INIZCTEOSA-N
26174	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6945	(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE	-	-	DRUGBANK	DB08153	C18H21ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZTAZMSAAIUZJV-HWKANZROSA-N
26175	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6947	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	-	-	DRUGBANK	DB08155	C10H14N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIMGUEXQORZTID-UHFFFAOYSA-N
26176	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6947	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	-	-	DRUGBANK	DB08155	C10H14N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIMGUEXQORZTID-UHFFFAOYSA-N
26177	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6948	3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID	-	-	DRUGBANK	DB08156	C9H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUEONDBIBADVGD-UHFFFAOYSA-N
26178	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6948	3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID	-	-	DRUGBANK	DB08156	C9H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUEONDBIBADVGD-UHFFFAOYSA-N
26179	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6949	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	-	-	DRUGBANK	DB08157	C11H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJBJALUJMRMNIR-UHFFFAOYSA-N
26180	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6949	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	-	-	DRUGBANK	DB08157	C11H15NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJBJALUJMRMNIR-UHFFFAOYSA-N
26181	113003	7150	RP3-511B24.1	TOP1	TOPI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6951	4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE	-	-	DRUGBANK	DB08159	C20H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHIJTWCJGCWHMT-UHFFFAOYSA-N
26182	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26183	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26184	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26185	114860	9475	-	ROCK2	ROCK-II	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6954	5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE	-	-	DRUGBANK	DB08162	C14H17N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGOGFTYYXHNFQH-UHFFFAOYSA-N
26186	106759	262	RP11-397G5.3	AMD1	ADOMETDC|AMD|SAMDC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6955	5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine	-	-	DRUGBANK	DB08163	C17H27N7O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUKYGMIDWKBMIW-IWCJZZDYSA-N
26187	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6956	(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE	-	-	DRUGBANK	DB08164	C22H21F3N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOBIXGZJSMAOFV-QRWLVFNGSA-N
26188	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6957	indane-5-sulfonamide	-	-	DRUGBANK	DB08165	C9H11NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVQJTFMKKZBBSX-UHFFFAOYSA-N
26189	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6958	(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	-	-	DRUGBANK	DB08166	C17H17ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPFQFJAOMCGYCP-GFCCVEGCSA-N
26190	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6959	3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM	-	-	DRUGBANK	DB08167	C16H18N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RBTBFTRPCNLSDE-UHFFFAOYSA-N
26191	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6960	7-AMINO-4-METHYL-CHROMEN-2-ONE	-	-	DRUGBANK	DB08168	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLNDAGDHSLMOKX-UHFFFAOYSA-N
26192	852181	947870	b3363	ppiA	ECK3351|JW3326|rot|rotA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	6960	7-AMINO-4-METHYL-CHROMEN-2-ONE	-	-	DRUGBANK	DB08168	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLNDAGDHSLMOKX-UHFFFAOYSA-N
26193	115411	10105	RP11-342M3.4	PPIF	CYP3|CyP-M|Cyp-D|CypD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6960	7-AMINO-4-METHYL-CHROMEN-2-ONE	-	-	DRUGBANK	DB08168	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLNDAGDHSLMOKX-UHFFFAOYSA-N
26194	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6961	(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide	-	-	DRUGBANK	DB08169	C19H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAGGGMPTWTUYHZ-ZCXUNETKSA-N
26195	110459	4316	-	MMP7	MMP-7|MPSL1|PUMP-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6962	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08170	C18H20N2O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AYFCYVLVRYQGME-QGZVFWFLSA-N
26196	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6964	(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide	-	-	DRUGBANK	DB08172	C18H15ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUDQXOMZBLEWBH-KAMYIIQDSA-N
26197	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6965	5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE	-	-	DRUGBANK	DB08173	C19H16ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCKHUNHXYMAFQM-UHFFFAOYSA-N
26198	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6966	5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE	-	-	DRUGBANK	DB08174	C22H20ClN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCPYHSAHOYXXQK-DLBZAZTESA-N
26199	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6967	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	-	-	DRUGBANK	DB08175	C16H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNYBEULOKRVZKY-ATCPXPEISA-N
26200	112169	6257	DADB-100D22.1	RXRB	DAUDI6|H-2RIIBP|NR2B2|RCoR-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6967	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	-	-	DRUGBANK	DB08175	C16H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNYBEULOKRVZKY-ATCPXPEISA-N
26201	115373	10062	-	NR1H3	LXR-a|LXRA|RLD-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6967	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	-	-	DRUGBANK	DB08175	C16H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNYBEULOKRVZKY-ATCPXPEISA-N
26202	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6968	(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE	-	-	DRUGBANK	DB08176	C11H12FN	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFVUPEQWSFCCFT-UHFFFAOYSA-N
26203	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6970	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08178	C12H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEWEQJWGGJUHO-UHFFFAOYSA-N
26204	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6970	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08178	C12H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGEWEQJWGGJUHO-UHFFFAOYSA-N
26205	109001	2739	-	GLO1	GLOD1|GLYI|HEL-S-74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6971	methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate	-	-	DRUGBANK	DB08179	C16H16O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXSEOJIXHWXQJ-UHFFFAOYSA-N
26206	111250	5229	-	PGGT1B	BGGI|GGTI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6972	2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE	-	-	DRUGBANK	DB08180	C19H37NO7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEMBPHBKZPOPBN-NWLVNBMCSA-N
26207	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6972	2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE	-	-	DRUGBANK	DB08180	C19H37NO7P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OEMBPHBKZPOPBN-NWLVNBMCSA-N
26208	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6974	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08182	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHMRPXZRUZLCNL-UHFFFAOYSA-N
26209	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6974	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	-	-	DRUGBANK	DB08182	C14H15N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHMRPXZRUZLCNL-UHFFFAOYSA-N
26210	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6975	3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile	-	-	DRUGBANK	DB08183	C16H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLAWZDWDVHWOW-YPMHNXCESA-N
26211	109921	3718	-	JAK3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6975	3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile	-	-	DRUGBANK	DB08183	C16H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLAWZDWDVHWOW-YPMHNXCESA-N
26212	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6975	3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile	-	-	DRUGBANK	DB08183	C16H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLAWZDWDVHWOW-YPMHNXCESA-N
26213	113148	7297	-	TYK2	IMD35|JTK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6975	3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile	-	-	DRUGBANK	DB08183	C16H20N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UJLAWZDWDVHWOW-YPMHNXCESA-N
26214	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6976	2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE	-	-	DRUGBANK	DB08184	C16H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOZKTHGEOJHIDP-UHFFFAOYSA-N
26215	114375	8850	-	KAT2B	CAF|P/CAF|PCAF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6978	(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE	-	-	DRUGBANK	DB08186	C13H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYQBFAGILCNRB-BQYQJAHWSA-N
26216	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6979	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	-	-	DRUGBANK	DB08187	C22H34N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDSVGJAUFNXYRR-WCIQWLHISA-N
26217	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6981	N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide	-	-	DRUGBANK	DB08190	C13H15IN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJDDSMSDZHURBJ-UHFFFAOYSA-N
26218	112344	6446	RP1-188K17.1	SGK1	SGK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6982	4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid	-	-	DRUGBANK	DB08191	C20H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSFDVNIKNYXUIP-UHFFFAOYSA-N
26219	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6983	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	-	-	DRUGBANK	DB08192	C16H18N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCUGCUQZFBURHR-LBPRGKRZSA-N
26220	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6985	4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine	-	-	DRUGBANK	DB08194	C8H11N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZWAEXRMZGFAN-UHFFFAOYSA-N
26221	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6986	(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE	-	-	DRUGBANK	DB08195	C18H21F2N3O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKWHKILAGONYKL-HNNXBMFYSA-N
26222	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6988	(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime	-	-	DRUGBANK	DB08197	C20H18FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYIXUSLGFINPTC-WVFAEZDRSA-N
26223	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6989	[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE	-	-	DRUGBANK	DB08198	C19H18N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGBBILLMZPWNFU-QGZVFWFLSA-N
26224	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6991	(1R)-MENTHYL HEXYL PHOSPHONATE GROUP	-	-	DRUGBANK	DB08200	C16H33O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAVIZOVSJOXCKT-OWCLPIDISA-N
26225	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6992	(1S)-MENTHYL HEXYL PHOSPHONATE GROUP	-	-	DRUGBANK	DB08201	C16H33O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAVIZOVSJOXCKT-XHSDSOJGSA-N
26226	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6993	4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE	-	-	DRUGBANK	DB08202	C12H19N5O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPPLIZHQOIGRPZ-UHFFFAOYSA-N
26227	128354	200895	-	DHFRL1	DHFRP4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6994	7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE	-	-	DRUGBANK	DB08203	C15H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQTGHZCEDQNMOZ-UHFFFAOYSA-N
26228	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6999	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	-	-	DRUGBANK	DB08208	C17H13F3N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMNKRBRQQAMACZ-UHFFFAOYSA-N
26229	108915	2645	-	GCK	FGQTL3|GK|GLK|HHF3|HK4|HKIV|HXKP|LGLK|MODY2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7001	2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE	-	-	DRUGBANK	DB08210	C14H12FN5OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUCYMQBDBXVNCE-UHFFFAOYSA-N
26230	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7004	1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE	-	-	DRUGBANK	DB08213	C20H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFAYCUAUBOGVDX-AWEZNQCLSA-N
26231	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7005	4-(1H-IMIDAZOL-1-YL)PHENOL	-	-	DRUGBANK	DB08214	C9H8N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYKCUAPYWQDIKR-UHFFFAOYSA-N
26232	107478	1048	-	CEACAM5	CD66e|CEA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7008	2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL	-	-	DRUGBANK	DB08217	C9H17NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRRNXPDUICGIEB-UHFFFAOYSA-N
26233	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7008	2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL	-	-	DRUGBANK	DB08217	C9H17NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRRNXPDUICGIEB-UHFFFAOYSA-N
26234	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7009	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	-	-	DRUGBANK	DB08218	C19H15N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLQVWKCQWFFUFJ-FCDQGJHFSA-N
26235	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7009	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	-	-	DRUGBANK	DB08218	C19H15N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLQVWKCQWFFUFJ-FCDQGJHFSA-N
26236	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7010	4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE	-	-	DRUGBANK	DB08219	C18H20N6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPSZSAKYXPWBRR-RELWKKBWSA-N
26237	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7010	4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE	-	-	DRUGBANK	DB08219	C18H20N6OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPSZSAKYXPWBRR-RELWKKBWSA-N
26238	115296	9971	-	NR1H4	BAR|FXR|HRR-1|HRR1|RIP14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7011	(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid	-	-	DRUGBANK	DB08220	C27H32O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPNNXCYIESWDSC-JRZBRKEGSA-N
26239	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7011	(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid	-	-	DRUGBANK	DB08220	C27H32O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RPNNXCYIESWDSC-JRZBRKEGSA-N
26240	112869	7010	-	TEK	CD202B|TIE-2|TIE2|VMCM|VMCM1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7012	N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE	-	-	DRUGBANK	DB08221	C24H18F3N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NESXBRNDMQUVNG-UHFFFAOYSA-N
26241	107618	1208	-	CLPS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7013	METHOXYUNDECYLPHOSPHINIC ACID	-	-	DRUGBANK	DB08222	C12H27O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBVUSHKPEBKWQP-UHFFFAOYSA-N
26242	111407	5406	RP11-33D13.1	PNLIP	PL|PNLIPD|PTL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7013	METHOXYUNDECYLPHOSPHINIC ACID	-	-	DRUGBANK	DB08222	C12H27O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBVUSHKPEBKWQP-UHFFFAOYSA-N
26243	107494	1066	-	CES1	ACAT|CE-1|CEH|CES2|HMSE|HMSE1|PCE-1|REH|SES1|TGH|hCE-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7015	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	-	-	DRUGBANK	DB08224	C18H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWSNTLOVYSRDEL-TVKPWXLESA-N
26244	852832	948538	b4034	malE	ECK4026|JW3994|malJ	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7017	1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE	-	-	DRUGBANK	DB08227	C13H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHMZILPINCAHPK-UHFFFAOYSA-N
26245	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7018	5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one	-	-	DRUGBANK	DB08228	C13H15NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTGZPMFPUDKJBX-UHFFFAOYSA-N
26246	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7019	[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID	-	-	DRUGBANK	DB08229	C20H23N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGMMFVVACJREFE-KRWDZBQOSA-N
26247	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7020	5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE	-	-	DRUGBANK	DB08230	C15H10O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARSRJFRKVXALTF-UHFFFAOYSA-N
26248	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26249	106870	375	-	ARF1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26250	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26251	117997	27095	CDABP0066	TRAPPC3	BET3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26252	111775	5817	-	PVR	CD155|HVED|NECL5|Necl-5|PVS|TAGE4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26253	109233	2978	RP1-139D8.2	GUCA1A	C6orf131|COD3|CORD14|GCAP|GCAP1|GUCA|GUCA1|dJ139D8.6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26254	112954	7099	-	TLR4	ARMD10|CD284|TLR-4|TOLL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26255	111526	5534	-	PPP3R1	CALNB1|CNB|CNB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26256	106877	382	-	ARF6	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26257	111522	5530	-	PPP3CA	CALN|CALNA|CALNA1|CCN1|CNA1|PPP2B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26258	117170	23643	-	LY96	ESOP-1|MD-2|MD2|ly-96	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26259	115718	10455	RP5-1013A10.1	ECI2	ACBD2|DRS-1|DRS1|HCA88|PECI|dJ1013A10.3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26260	852944	948652	b1187	fadR	ECK1175|JW1176|dec|ole|oleR|thdB	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26261	111890	5957	-	RCVRN	RCV1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26262	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26263	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26264	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26265	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26266	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26267	109842	3630	-	INS	IDDM|IDDM1|IDDM2|ILPR|IRDN|MODY10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26268	107252	801	-	CALM1	CALML2|CAMI|CPVT4|DD132|PHKD|caM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26269	109414	3172	RP5-1013A22.1	HNF4A	FRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26270	850210	945843	b1252	tonB	ECK1246|JW5195|T1rec|exbA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
26271	108453	2155	-	F7	SPCA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7022	{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID	-	-	DRUGBANK	DB08232	C21H16N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVBGZXXLVHYBKI-UHFFFAOYSA-N
26272	108451	2152	-	F3	CD142|TF|TFA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7022	{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID	-	-	DRUGBANK	DB08232	C21H16N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BVBGZXXLVHYBKI-UHFFFAOYSA-N
26273	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7023	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	-	-	DRUGBANK	DB08233	C18H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFSDQDHHBKYQOD-UHFFFAOYSA-N
26274	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7023	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	-	-	DRUGBANK	DB08233	C18H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFSDQDHHBKYQOD-UHFFFAOYSA-N
26275	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7024	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	-	-	DRUGBANK	DB08234	C17H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNFDQABYXZBKRK-UHFFFAOYSA-N
26276	115402	10095	-	ARPC1B	ARC41|p40-ARC|p41-ARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26277	115403	10096	-	ACTR3	ARP3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26278	115404	10097	-	ACTR2	ARP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26279	115401	10094	-	ARPC3	ARC21|p21-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26280	115415	10109	PRO2446	ARPC2	ARC34|PNAS-139|p34-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26281	115399	10092	RP1-127C7.3	ARPC5	ARC16|dJ127C7.3|p16-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26282	115400	10093	-	ARPC4	ARC20|P20-ARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7025	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	-	-	DRUGBANK	DB08235	C16H16N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACAKNPKRLPMONU-UHFFFAOYSA-N
26283	115402	10095	-	ARPC1B	ARC41|p40-ARC|p41-ARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26284	115403	10096	-	ACTR3	ARP3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26285	115404	10097	-	ACTR2	ARP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26286	115401	10094	-	ARPC3	ARC21|p21-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26287	115415	10109	PRO2446	ARPC2	ARC34|PNAS-139|p34-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26288	115399	10092	RP1-127C7.3	ARPC5	ARC16|dJ127C7.3|p16-Arc	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26289	115400	10093	-	ARPC4	ARC20|P20-ARC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7026	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	-	-	DRUGBANK	DB08236	C15H11BrClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEGQNJITMFBVAC-HNNXBMFYSA-N
26290	119532	51426	-	POLK	DINB1|DINP|POLQ	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7027	2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)	-	-	DRUGBANK	DB08237	C21H22N5O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COMPKRGNHXOXMN-GVDBMIGSSA-N
26291	108537	2246	-	FGF1	AFGF|ECGF|ECGF-beta|ECGFA|ECGFB|FGF-1|FGF-alpha|FGFA|GLIO703|HBGF-1|HBGF1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7028	5-AMINO-NAPHTALENE-2-MONOSULFONATE	-	-	DRUGBANK	DB08238	C10H9NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWPJYQYRSWYIGZ-UHFFFAOYSA-N
26292	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7029	(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08239	C23H25F2N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKLVBHMAIMEVEH-QFIPXVFZSA-N
26293	106728	226	-	ALDOA	ALDA|GSD12|HEL-S-87p	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7030	N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE	-	-	DRUGBANK	DB08240	C17H13ClNO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQAQWBFHPMSXKR-UHFFFAOYSA-N
26294	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7031	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	-	-	DRUGBANK	DB08241	C19H22N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUUOIINPNMNPIU-UHFFFAOYSA-N
26295	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7031	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	-	-	DRUGBANK	DB08241	C19H22N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUUOIINPNMNPIU-UHFFFAOYSA-N
26296	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7032	N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide	-	-	DRUGBANK	DB08242	C20H18N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYTBZXSFNNAVKU-UHFFFAOYSA-N
26297	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7033	(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE	-	-	DRUGBANK	DB08244	C21H20F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCOUEHUEFUDZIS-PMACEKPBSA-N
26298	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7035	(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08246	C19H18F2N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFFMEXQHWXEKBV-SFHVURJKSA-N
26299	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7036	6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE	-	-	DRUGBANK	DB08247	C15H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JABXNQUXGJTKRO-UHFFFAOYSA-N
26300	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7037	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	-	-	DRUGBANK	DB08248	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKDUVKJYBJDZQW-UHFFFAOYSA-N
26301	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7037	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	-	-	DRUGBANK	DB08248	C18H22N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKDUVKJYBJDZQW-UHFFFAOYSA-N
26302	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7038	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	-	-	DRUGBANK	DB08249	C18H38O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJELOWOAIAAUJT-UHFFFAOYSA-N
26303	110030	3832	-	KIF11	EG5|HKSP|KNSL1|MCLMR|TRIP5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7039	(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08250	C21H24F2N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQMVLDZJPRSNOG-NRFANRHFSA-N
26304	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7040	4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID	-	-	DRUGBANK	DB08251	C17H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNRAPROKLOUIRA-AWEZNQCLSA-N
26305	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7043	2-NAPHTHALENESULFONIC ACID	-	-	DRUGBANK	DB08254	C10H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVBGVZZKJNLNJU-UHFFFAOYSA-N
26306	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7043	2-NAPHTHALENESULFONIC ACID	-	-	DRUGBANK	DB08254	C10H8O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVBGVZZKJNLNJU-UHFFFAOYSA-N
26307	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7045	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	-	-	DRUGBANK	DB08256	C9H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVORCMBCUHQRDL-UHFFFAOYSA-N
26308	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7046	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	-	-	DRUGBANK	DB08257	C11H20N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSVFRGGLURJIMG-UHFFFAOYSA-N
26309	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7047	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	-	-	DRUGBANK	DB08258	C13H24N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFTVEPYSUSWBRD-UHFFFAOYSA-N
26310	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7048	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	-	-	DRUGBANK	DB08259	C14H26N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYTIWWDVOFXKPF-UHFFFAOYSA-N
26311	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7051	2,6-dicarboxynaphthalene	-	-	DRUGBANK	DB08262	C12H8O4	small molecule	-	1141-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXOHFPCZGPKIRD-UHFFFAOYSA-N
26312	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7051	2,6-dicarboxynaphthalene	-	-	DRUGBANK	DB08262	C12H8O4	small molecule	-	1141-38-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXOHFPCZGPKIRD-UHFFFAOYSA-N
26313	120794	55662	-	HIF1AN	FIH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7052	N-(carboxycarbonyl)-D-phenylalanine	-	-	DRUGBANK	DB08263	C11H11NO5	small molecule	-	856680-67-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULQWGBCNOHBNDB-MRVPVSSYSA-N
26314	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7054	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	-	-	DRUGBANK	DB08265	C14H13BN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQIDNSKBUXCODH-UHFFFAOYSA-N
26315	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7058	N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE	-	-	DRUGBANK	DB08270	C22H29F3N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QPXXBNKMAHUXBB-PMACEKPBSA-N
26316	114725	9313	-	MMP20	AI2A2|MMP-20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7059	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	-	-	DRUGBANK	DB08271	C13H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIRXORZYIXSWOB-UHFFFAOYSA-N
26317	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7059	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	-	-	DRUGBANK	DB08271	C13H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIRXORZYIXSWOB-UHFFFAOYSA-N
26318	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7059	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	-	-	DRUGBANK	DB08271	C13H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIRXORZYIXSWOB-UHFFFAOYSA-N
26319	110462	4319	-	MMP10	SL-2|STMY2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7059	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	-	-	DRUGBANK	DB08271	C13H20N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JIRXORZYIXSWOB-UHFFFAOYSA-N
26320	118625	28776	-	IGLV7-43	IGLV743|V3-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7061	4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION	-	-	DRUGBANK	DB08273	C14H16IN2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKGGMBQFWIIXJM-UHFFFAOYSA-M
26321	122884	79784	FP17425	MYH14	DFNA4|DFNA4A|MHC16|MYH17|NMHC II-C|NMHC-II-C|PNMHH|myosin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7064	N-METHYL O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE	-	-	DRUGBANK	DB08276	C9H13BeF3N2O9P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIFJVXDWLUOXQS-UHFFFAOYSA-J
26322	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7065	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	-	-	DRUGBANK	DB08277	C21H27ClFNO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULLPKOZNMAWTIP-JGSHYQHOSA-N
26323	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7068	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	-	-	DRUGBANK	DB08280	C22H30N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNVKIDPRYUGTTG-YINOZDTMSA-N
26324	108899	2629	-	GBA	GBA1|GCB|GLUC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7071	(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL	-	-	DRUGBANK	DB08283	C15H31NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTSCEGKYKXESFF-LXTVHRRPSA-N
26325	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7073	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	-	-	DRUGBANK	DB08285	C19H26N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQUNOCMDMIQIQK-OAHLLOKOSA-N
26326	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7073	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	-	-	DRUGBANK	DB08285	C19H26N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQUNOCMDMIQIQK-OAHLLOKOSA-N
26327	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7075	(1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08287	C17H26N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTGNVZPFJQOWFL-XJKSGUPXSA-N
26328	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7077	N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE	-	-	DRUGBANK	DB08289	C18H26N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKJXWOJUCCBWSC-UHFFFAOYSA-N
26329	114375	8850	-	KAT2B	CAF|P/CAF|PCAF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7078	N-(3-AMINOPROPYL)-2-NITROBENZENAMINE	-	-	DRUGBANK	DB08291	C9H13N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVGDDEYVTBKACE-UHFFFAOYSA-N
26330	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7079	(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	-	-	DRUGBANK	DB08292	C16H17ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQKZYZQONWDDLS-IWQZZHSRSA-N
26331	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7080	(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	-	-	DRUGBANK	DB08293	C16H17ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQKZYZQONWDDLS-HNQUOIGGSA-N
26332	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7081	2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID	-	-	DRUGBANK	DB08294	C8H7NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QBHBHOSRLDPIHG-UHFFFAOYSA-N
26333	118625	28776	-	IGLV7-43	IGLV743|V3-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7082	4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION	-	-	DRUGBANK	DB08295	C14H17N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAYGJFACOIKJCT-UHFFFAOYSA-M
26334	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7083	5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID	-	-	DRUGBANK	DB08296	C11H13NO7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XVVZSEXTAACTPS-UHFFFAOYSA-M
26335	849401	945007	b0345	lacI	ECK0342|JW0336	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7084	ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE	-	-	DRUGBANK	DB08297	C12H15NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWRPIVXPHLYETN-BVWHHUJWSA-N
26336	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7086	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	-	-	DRUGBANK	DB08299	C21H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTNUWEKKZHSUQO-UHFFFAOYSA-N
26337	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7086	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	-	-	DRUGBANK	DB08299	C21H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTNUWEKKZHSUQO-UHFFFAOYSA-N
26338	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7086	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	-	-	DRUGBANK	DB08299	C21H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTNUWEKKZHSUQO-UHFFFAOYSA-N
26339	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7087	1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08300	C16H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOKGZPYGRJDACN-UHFFFAOYSA-N
26340	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7088	N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE	-	-	DRUGBANK	DB08301	C14H15N3O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDCXQTPVTAIPNZ-UHFFFAOYSA-N
26341	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7089	3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid	-	-	DRUGBANK	DB08302	C16H15NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRHZCQDCMUWUKV-RAXLEYEMSA-N
26342	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7090	(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	-	DRUGBANK	DB08303	C18H28N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUMKMTBOHBENJI-SFHVURJKSA-N
26343	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7091	(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	-	-	DRUGBANK	DB08304	C18H27N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZBQVXXESPXFPZ-QGZVFWFLSA-N
26344	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7092	(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	-	-	DRUGBANK	DB08305	C19H29N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAGZLQCEURCKJ-QGZVFWFLSA-N
26345	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7093	3-{[(3-NITROANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB08306	C11H8N2O6S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CITCNTPVKZFUAJ-UHFFFAOYSA-N
26346	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7096	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	-	-	DRUGBANK	DB08309	C23H32N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMFGILNPFBVREA-UHFFFAOYSA-N
26347	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7096	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	-	-	DRUGBANK	DB08309	C23H32N6O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AMFGILNPFBVREA-UHFFFAOYSA-N
26348	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7098	6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB08312	C11H17N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGWXOLHKVGDQLN-UHFFFAOYSA-N
26349	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7099	nocodazole	-	-	DRUGBANK	DB08313	C14H11N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYRVNWMVYQXFEU-UHFFFAOYSA-N
26350	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7100	(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE	-	-	DRUGBANK	DB08314	C10H7BrN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YDCMMVTWXORJGO-UHFFFAOYSA-N
26351	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7101	2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE	-	-	DRUGBANK	DB08315	C18H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIJXWOGFYAWTNC-UHFFFAOYSA-N
26352	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7102	4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one	-	-	DRUGBANK	DB08316	C10H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYPFWRCGECJCBK-UHFFFAOYSA-N
26353	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7103	5-methyl-6-phenylquinazoline-2,4-diamine	-	-	DRUGBANK	DB08317	C15H14N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUCOXWPHDFINIW-UHFFFAOYSA-N
26354	852073	947761	b3256	accC	ECK3243|JW3224|fabG	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7104	6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine	-	-	DRUGBANK	DB08318	C11H13N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LRQXUZUFSOQMGU-UHFFFAOYSA-N
26355	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7106	DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE	-	-	DRUGBANK	DB08320	C24H24O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHKDFDHHMHBFLG-COPRSSIGSA-N
26356	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7106	DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE	-	-	DRUGBANK	DB08320	C24H24O7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHKDFDHHMHBFLG-COPRSSIGSA-N
26357	110297	4124	-	MAN2A1	AMan II|GOLIM7|MANA2|MANII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7107	(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol	-	-	DRUGBANK	DB08321	C15H29NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPZUHYMBTUUPML-KBXIAJHMSA-N
26358	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7108	2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID	-	-	DRUGBANK	DB08322	C23H20O10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJLMRHSHSNLOGC-NOPZTHQXSA-N
26359	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7109	3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE	-	-	DRUGBANK	DB08323	C16H28N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEYZCVBECUYIJZ-AWEZNQCLSA-N
26360	115724	10461	-	MERTK	MER|RP38|Tyro12|c-Eyk|c-mer	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7111	2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE	-	-	DRUGBANK	DB08325	C16H19ClN6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZEFMZCNXDQXOZ-UHFFFAOYSA-N
26361	119824	53944	-	CSNK1G1	CK1gamma1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7111	2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE	-	-	DRUGBANK	DB08325	C16H19ClN6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZEFMZCNXDQXOZ-UHFFFAOYSA-N
26362	116813	23205	-	ACSBG1	BG|BG1|BGM|GR-LACS|LPD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7112	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	-	-	DRUGBANK	DB08326	C10H6N2O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJVOROULKOMTKG-UHFFFAOYSA-N
26363	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7115	SULTHIAME	-	-	DRUGBANK	DB08329	C10H14N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HMHVCUVYZFYAJI-UHFFFAOYSA-N
26364	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26365	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26366	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26367	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26368	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26369	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26370	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26371	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26372	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26373	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7116	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	-	-	DRUGBANK	DB08330	C19H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEJCBCPEURAYAS-MEAXDALNSA-N
26374	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7118	[2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE	-	-	DRUGBANK	DB08332	C18H16O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IOWYALZFEJOVHO-HDICACEKSA-N
26375	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7119	4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	-	-	DRUGBANK	DB08333	C14H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWZBYSBZDQWXGQ-XNTDXEJSSA-N
26376	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7120	3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	-	-	DRUGBANK	DB08334	C14H16FNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPVNUGQNVVMJJP-CXUHLZMHSA-N
26377	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7121	4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME	-	-	DRUGBANK	DB08335	C13H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRHAIEVALGHVLW-NTEUORMPSA-N
26378	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7122	TERT-BUTYL [(1R)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE	-	-	DRUGBANK	DB08336	C11H19N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PARUDDGQWSBIIO-MRVPVSSYSA-N
26379	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7123	TERT-BUTYL [(1S)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE	-	-	DRUGBANK	DB08337	C11H19N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PARUDDGQWSBIIO-QMMMGPOBSA-N
26380	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7124	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	-	-	DRUGBANK	DB08338	C19H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIJNSOUPEZHEMC-UHFFFAOYSA-N
26381	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7125	6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE	-	-	DRUGBANK	DB08339	C21H16Cl2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIQFYVPVJZEOFS-UHFFFAOYSA-N
26382	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7126	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB08340	C17H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLYYAUZAGCZEKV-UHFFFAOYSA-N
26383	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7127	4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	-	-	DRUGBANK	DB08341	C19H25F3N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CAUFYHKGKDJMQG-HZPDHXFCSA-N
26384	121815	58485	-	TRAPPC1	BET5|MUM2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26385	119523	51399	CGI-104	TRAPPC4	HSPC172|PTD009|SBDN|SYNBINDIN|TRS23	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26386	125945	126003	-	TRAPPC5	TRS31	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26387	117997	27095	CDABP0066	TRAPPC3	BET3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26388	122538	79090	-	TRAPPC6A	TRS33	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26389	125777	122553	-	TRAPPC6B	TPC6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7128	S-PALMITOYL-L-CYSTEINE	-	-	DRUGBANK	DB08342	C19H37NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRAMWPHPFIXRCP-KRWDZBQOSA-N
26390	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7130	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08345	C17H15N9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUUKHQIKFHWIW-UHFFFAOYSA-N
26391	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7131	(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE	-	-	DRUGBANK	DB08346	C17H19ClO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUZYDHRGGDTZLG-DUXPYHPUSA-N
26392	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7132	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	-	-	DRUGBANK	DB08347	C16H21N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQEFAUFOQSCRMZ-LBPRGKRZSA-N
26393	127917	165631	-	PARP15	ARTD7|BAL3|pART7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7133	N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	-	-	DRUGBANK	DB08348	C17H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYJZZVDLGDDTCL-UHFFFAOYSA-N
26394	115351	10039	-	PARP3	ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7133	N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	-	-	DRUGBANK	DB08348	C17H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYJZZVDLGDDTCL-UHFFFAOYSA-N
26395	108258	1938	-	EEF2	EEF-2|EF-2|EF2|SCA26	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7133	N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	-	-	DRUGBANK	DB08348	C17H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYJZZVDLGDDTCL-UHFFFAOYSA-N
26396	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7134	N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide	-	-	DRUGBANK	DB08349	C24H21F2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMEYCLAVMZKZCS-UHFFFAOYSA-N
26397	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7135	5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08350	C22H20N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYQRHHQPEMOLKH-UHFFFAOYSA-N
26398	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7136	N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide	-	-	DRUGBANK	DB08351	C25H29N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNEXDVSJIUQQRH-UHFFFAOYSA-N
26399	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7137	6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine	-	-	DRUGBANK	DB08352	C19H16FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQYJTHIYAQQJAB-UHFFFAOYSA-N
26400	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7138	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08353	C19H21N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCVMTHVSAJMOPI-UHFFFAOYSA-N
26401	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7139	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08354	C19H14ClN7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCVULERVJOYHCP-UHFFFAOYSA-N
26402	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7140	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	-	-	DRUGBANK	DB08355	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOBRPBVIEUWYJR-UHFFFAOYSA-N
26403	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7140	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	-	-	DRUGBANK	DB08355	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOBRPBVIEUWYJR-UHFFFAOYSA-N
26404	111192	5166	-	PDK4	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7141	4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol	-	-	DRUGBANK	DB08356	C17H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSBFARPNIZUMHA-UHFFFAOYSA-N
26405	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7142	1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE	-	-	DRUGBANK	DB08357	C8H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRQYJINTUHWNHW-UHFFFAOYSA-N
26406	856485	938881	BSU01660	ybbD	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	7142	1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE	-	-	DRUGBANK	DB08357	C8H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RRQYJINTUHWNHW-UHFFFAOYSA-N
26407	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7143	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	-	-	DRUGBANK	DB08358	C21H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWFLADWRSCINST-UHFFFAOYSA-N
26408	113617	7867	-	MAPKAPK3	3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7143	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	-	-	DRUGBANK	DB08358	C21H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWFLADWRSCINST-UHFFFAOYSA-N
26409	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7144	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	-	-	DRUGBANK	DB08359	C12H12N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIIUOFPGDKBCEZ-UHFFFAOYSA-N
26410	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7145	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08360	C18H20N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIFHJPUTQBOBGJ-UHFFFAOYSA-N
26411	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7146	2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide	-	-	DRUGBANK	DB08361	C18H24N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZNTWOVDIXCHHS-LSDHHAIUSA-N
26412	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7147	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	-	-	DRUGBANK	DB08362	C20H16N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVKXQLGRDOMAGC-UHFFFAOYSA-N
26413	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7148	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	-	-	DRUGBANK	DB08363	C16H18N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LBPNOEAFWYTTEB-UHFFFAOYSA-N
26414	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7150	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	-	-	DRUGBANK	DB08365	C20H15BrClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUAHLMVOYLUYSB-UHFFFAOYSA-N
26415	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7151	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	-	-	DRUGBANK	DB08366	C24H29NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCWKSMHQPTGH-OFBLZTNGSA-N
26416	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7153	OCTANE-1,3,5,7-TETRACARBOXYLIC ACID	-	-	DRUGBANK	DB08368	C12H18O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEYGDIASMOPQFG-XLPZGREQSA-N
26417	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7154	1-(biphenyl-4-ylmethyl)-1H-imidazole	-	-	DRUGBANK	DB08369	C16H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLYMRVCQTVOYEW-UHFFFAOYSA-N
26418	109205	2950	-	GSTP1	DFN7|FAEES3|GST3|GSTP|HEL-S-22|PI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7155	S-(4-BROMOBENZYL)CYSTEINE	-	-	DRUGBANK	DB08370	C10H12BrNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZGWXEMBSFZEBK-VIFPVBQESA-N
26419	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7156	PARA-(BENZOYL)-PHENYLALANINE	-	-	DRUGBANK	DB08371	C16H15NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVIDEEHSOPHZBR-AWEZNQCLSA-N
26420	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7156	PARA-(BENZOYL)-PHENYLALANINE	-	-	DRUGBANK	DB08371	C16H15NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVIDEEHSOPHZBR-AWEZNQCLSA-N
26421	113203	7356	-	SCGB1A1	CC10|CC16|CCPBP|CCSP|UGB|UP-1|UP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7158	4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL	-	-	DRUGBANK	DB08373	C14H10Cl4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDBKPLOYRMCFIY-UHFFFAOYSA-N
26422	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7159	PHENYLALANYLMETHYLCHLORIDE	-	-	DRUGBANK	DB08374	C10H12ClNO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CNNSBPMDYXZFTQ-VIFPVBQESA-N
26423	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7160	PCNOTAXIME GROUP	-	-	DRUGBANK	DB08375	C14H15N5O6S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRDXEERHKBZJMY-KTFFUYHOSA-N
26424	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7162	PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE	-	-	DRUGBANK	DB08377	C13H17N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBXXIYHMPQZHCH-VIFPVBQESA-N
26425	110710	4625	-	MYH7	CMD1S|CMH1|MPD1|MYHCB|SPMD|SPMM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7163	4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID	-	-	DRUGBANK	DB08378	C14H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUETUOGYOWOLNJ-NSHDSACASA-N
26426	115871	10627	-	MYL12A	HEL-S-24|MLC-2B|MLCB|MRCL3|MRLC3|MYL2B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7163	4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID	-	-	DRUGBANK	DB08378	C14H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUETUOGYOWOLNJ-NSHDSACASA-N
26427	126617	140465	-	MYL6B	MLC1SA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7163	4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID	-	-	DRUGBANK	DB08378	C14H16N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SUETUOGYOWOLNJ-NSHDSACASA-N
26428	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7166	2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine	-	-	DRUGBANK	DB08382	C17H24F2N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWEWGXUTRTXFRF-KBPBESRZSA-N
26429	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7167	4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole	-	-	DRUGBANK	DB08383	C21H18N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XBMULXNXJLWLLD-UHFFFAOYSA-N
26430	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7168	2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline	-	-	DRUGBANK	DB08384	C25H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQDDHVVAAJVVKM-UHFFFAOYSA-N
26431	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7169	4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid	-	-	DRUGBANK	DB08385	C16H18N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QUAGUFNCKDDJFZ-UHFFFAOYSA-N
26432	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7170	2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline	-	-	DRUGBANK	DB08386	C24H18N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRWJZGHUCOFGPZ-UHFFFAOYSA-N
26433	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7171	2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline	-	-	DRUGBANK	DB08387	C25H20N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AZEXWHKOMMASPA-UHFFFAOYSA-N
26434	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7172	5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE	-	-	DRUGBANK	DB08388	C20H19FN2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRSYNYGEEYTXJV-UHFFFAOYSA-N
26435	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7173	6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	-	-	DRUGBANK	DB08389	C24H23N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPTQSRGSSJRBKJ-LJQANCHMSA-N
26436	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7175	6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	-	-	DRUGBANK	DB08391	C22H21N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBIIFKJMNRPNMT-CQSZACIVSA-N
26437	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7176	2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL	-	-	DRUGBANK	DB08392	C22H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARBUGBBNEFAECO-UHFFFAOYSA-N
26438	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7177	2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL	-	-	DRUGBANK	DB08393	C20H17N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHINZSKNAAVOZ-UHFFFAOYSA-N
26439	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7178	PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE	-	-	DRUGBANK	DB08394	C12H15N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLNKGRQBMNPVSJ-UHFFFAOYSA-N
26440	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7179	2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE	-	-	DRUGBANK	DB08395	C22H18FN3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSOXFJURLPCSOO-UHFFFAOYSA-N
26441	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7181	6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB08397	C12H9F2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKGNOWNPXBURRW-UHFFFAOYSA-N
26442	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7182	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE	-	-	DRUGBANK	DB08398	C13H12N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQVKZNNCIHJZLS-UHFFFAOYSA-N
26443	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7182	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE	-	-	DRUGBANK	DB08398	C13H12N4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQVKZNNCIHJZLS-UHFFFAOYSA-N
26444	106994	506	-	ATP5B	ATPMB|ATPSB|HEL-S-271	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7183	PICEATANNOL	-	-	DRUGBANK	DB08399	C14H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDRPUGZCRXZLFL-OWOJBTEDSA-N
26445	106987	498	-	ATP5A1	ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7183	PICEATANNOL	-	-	DRUGBANK	DB08399	C14H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDRPUGZCRXZLFL-OWOJBTEDSA-N
26446	106997	509	RP11-401E9.1	ATP5C1	ATP5C|ATP5CL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7183	PICEATANNOL	-	-	DRUGBANK	DB08399	C14H12O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDRPUGZCRXZLFL-OWOJBTEDSA-N
26447	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7184	4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid	-	-	DRUGBANK	DB08400	C19H19F3N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUEKMTNOUPAOBS-UHFFFAOYSA-N
26448	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7186	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	-	-	DRUGBANK	DB08402	C18H11Cl2N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDRRWBKNSHALL-UHFFFAOYSA-N
26449	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7186	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	-	-	DRUGBANK	DB08402	C18H11Cl2N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDRRWBKNSHALL-UHFFFAOYSA-N
26450	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7186	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	-	-	DRUGBANK	DB08402	C18H11Cl2N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDRRWBKNSHALL-UHFFFAOYSA-N
26451	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7187	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	-	-	DRUGBANK	DB08403	C18H27N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOPRTFSMCQNUCT-CABCVRRESA-N
26452	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7187	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	-	-	DRUGBANK	DB08403	C18H27N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MOPRTFSMCQNUCT-CABCVRRESA-N
26453	849206	944805	b1094	acpP	ECK1080|JW1080	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7188	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE	-	-	DRUGBANK	DB08404	C17H33N2O7PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXYQLYCKZTXHTF-HNNXBMFYSA-N
26454	849206	944805	b1094	acpP	ECK1080|JW1080	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7189	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE	-	-	DRUGBANK	DB08405	C18H35N2O7PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPSBILXXAVXCDA-INIZCTEOSA-N
26455	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7190	[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE	-	-	DRUGBANK	DB08406	C21H17N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NXCCIJQEAKMFGW-UHFFFAOYSA-N
26456	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7191	PLATENSIMYCIN	-	-	DRUGBANK	DB08407	C24H27NO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CSOMAHTTWTVBFL-OFBLZTNGSA-N
26457	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7193	4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE	-	-	DRUGBANK	DB08409	C13H17N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNMNPGKCSJFAGN-UHFFFAOYSA-N
26458	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7193	4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE	-	-	DRUGBANK	DB08409	C13H17N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNMNPGKCSJFAGN-UHFFFAOYSA-N
26459	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7194	PARA-NITROBENZYL GLUTARYL GLYCINIC ACID	-	-	DRUGBANK	DB08410	C14H17N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCFVFUIGNWHAJJ-UHFFFAOYSA-N
26460	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7195	PARA-NITROPHENYL PHOSPHONOBUTANOYL L-ALANINE	-	-	DRUGBANK	DB08411	C13H17N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBXXIYHMPQZHCH-VIFPVBQESA-N
26461	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7196	6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID	-	-	DRUGBANK	DB08412	C16H23N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYHHVZLGTMCKOR-UHFFFAOYSA-N
26462	106751	250	-	ALPP	ALP|PALP|PLAP|PLAP-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7197	METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER	-	-	DRUGBANK	DB08413	C7H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJPXTXIEAOSJBR-UHFFFAOYSA-N
26463	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7197	METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER	-	-	DRUGBANK	DB08413	C7H8NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJPXTXIEAOSJBR-UHFFFAOYSA-N
26464	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7199	(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE	-	-	DRUGBANK	DB08416	C19H28N2O7S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQSNIXKAKUZPSI-SSTWWWIQSA-N
26465	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7200	(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate	-	-	DRUGBANK	DB08418	C24H27N3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LSJKARAMQNGZDF-YOEKFXIASA-N
26466	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7202	1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID	-	-	DRUGBANK	DB08420	C23H27BN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFOIPTZMXQILSG-HKBOAZHASA-N
26467	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7204	[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE	-	-	DRUGBANK	DB08422	C21H27N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEIDRYBJURDUSW-MOPGFXCFSA-N
26468	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7205	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE	-	-	DRUGBANK	DB08423	C21H21FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QKZZJXRGCHXIAI-UHFFFAOYSA-N
26469	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7206	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE	-	-	DRUGBANK	DB08424	C19H18FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IJDQETGUEUJVTB-HNNXBMFYSA-N
26470	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7208	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE	-	-	DRUGBANK	DB08426	C19H17N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLXOQMHGHDZMSX-AWEZNQCLSA-N
26471	856605	939005	BSU22690	aroH	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	7209	PREPHENIC ACID	-	-	DRUGBANK	DB08427	C10H10O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPWMCUPFBRFMLH-HDKIZWTHSA-N
26472	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7211	N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide	-	-	DRUGBANK	DB08429	C23H28ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRGBOABBMKYMLG-UXHICEINSA-N
26473	128236	197021	UNQ3022/PRO9820	LCTL	KLG|KLPH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7212	PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE	-	-	DRUGBANK	DB08430	C12H15NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXFOBQXJWRLXMD-ZIQFBCGOSA-N
26474	852653	948356	b3863	polA	ECK3855|JW3835|resA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7214	THYMIDINE-5'-THIOPHOSPHATE	-	-	DRUGBANK	DB08432	C10H15N2O7PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJRKJKYGUAALCJ-XLPZGREQSA-N
26475	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7217	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	-	-	DRUGBANK	DB08435	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRUMKCAEVRUBK-XOVNXQNQSA-N
26476	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7218	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	-	-	DRUGBANK	DB08436	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCDXXNIRWRRGBX-UHFFFAOYSA-N
26477	112063	6143	-	RPL19	L19	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26478	112058	6138	TCBAP0781	RPL15	DBA12|EC45|L15|RPL10|RPLY10|RPYL10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26479	114752	9349	-	RPL23	L23|rpL17	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26480	117068	23521	-	RPL13A	L13A|TSTA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26481	126711	140801	-	RPL10L	RPL10_5_1358	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26482	849864	945490	b0885	aat	ECK0876|JW0868|ycaA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26483	119362	51187	My024	RSL24D1	C15orf15|HRP-L30-iso|L30|RLP24|RPL24|RPL24L|TVAS3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26484	112067	6147	-	RPL23A	L23A|MDA20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26485	119308	51121	-	RPL26L1	RPL26P1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26486	112052	6132	-	RPL8	L8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26487	112086	6167	-	RPL37	L37	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26488	112042	6122	OK/SW-cl.32	RPL3	ASC-1|L3|TARBP-B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26489	112055	6135	RP11-223J15.3	RPL11	DBA7|GIG34|L11	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7219	Puromycin	-	-	DRUGBANK	DB08437	C22H29N7O5	small molecule	-	53-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXWNCPJZOCPEPQ-NVWDDTSBSA-N
26491	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7221	Parecoxib	-	-	DRUGBANK	DB08439	C19H18N2O4S	small molecule	M01AH04	198470-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZRHLKRLEZJVIJ-UHFFFAOYSA-N
26492	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7223	6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE	-	-	DRUGBANK	DB08441	C13H14BrN5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWSQADBSXFTFKL-UHFFFAOYSA-N
26493	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7224	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	-	-	DRUGBANK	DB08442	C18H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWODFUZHWYZBHZ-MRXNPFEDSA-N
26494	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7225	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	-	-	DRUGBANK	DB08443	C11H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYGSNHBTZDYVSS-UHFFFAOYSA-N
26495	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7227	(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE	-	-	DRUGBANK	DB08445	C20H18F3N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFKWHPAWYJARQJ-DYVFJYSZSA-N
26496	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7229	3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL	-	-	DRUGBANK	DB08447	C14H20N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKQDXWHOFSMCSA-UHFFFAOYSA-N
26497	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7230	(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol	-	-	DRUGBANK	DB08448	C21H19N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCBWLKUEKANDCL-INIZCTEOSA-N
26498	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7231	2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid	-	-	DRUGBANK	DB08449	C17H10F3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEVFQDJUDLCOQY-UHFFFAOYSA-N
26499	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7232	N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine	-	-	DRUGBANK	DB08450	C21H16N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNHRWNUXTCATSG-UHFFFAOYSA-N
26500	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7233	N-(QUINOLIN-8-YL)METHANESULFONAMIDE	-	-	DRUGBANK	DB08451	C10H10N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYEPUTZVZYUENX-UHFFFAOYSA-N
26501	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26502	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26503	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26504	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26505	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26506	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26507	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26508	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26509	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26510	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7234	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	-	-	DRUGBANK	DB08453	C18H25NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMBFBUICIQJLPK-UHFFFAOYSA-N
26511	121382	57118	RP11-462F15.1	CAMK1D	CKLiK|CaM-K1|CaMKID	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7235	N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE	-	-	DRUGBANK	DB08454	C18H15N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYCUVOXSZBECAY-UHFFFAOYSA-N
26512	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7242	3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL	-	-	DRUGBANK	DB08461	C16H19N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMAIQPBRCNEJAT-UHFFFAOYSA-N
26513	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7243	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE	-	-	DRUGBANK	DB08462	C17H14N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGWHILNNHLDARR-UHFFFAOYSA-N
26514	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7244	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	-	-	DRUGBANK	DB08463	C24H29N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOCBJBNQIQQQGT-LJQANCHMSA-N
26515	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7244	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	-	-	DRUGBANK	DB08463	C24H29N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOCBJBNQIQQQGT-LJQANCHMSA-N
26516	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7245	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	-	-	DRUGBANK	DB08464	C18H18ClNO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUVWEHNRWHNDRF-UHFFFAOYSA-N
26517	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7245	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	-	-	DRUGBANK	DB08464	C18H18ClNO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUVWEHNRWHNDRF-UHFFFAOYSA-N
26518	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7246	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	-	-	DRUGBANK	DB08465	C18H20ClNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFYGLJKFZQGYPA-UHFFFAOYSA-N
26519	113036	7184	-	HSP90B1	ECGP|GP96|GRP94|HEL-S-125m|HEL35|TRA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7246	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	-	-	DRUGBANK	DB08465	C18H20ClNO7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFYGLJKFZQGYPA-UHFFFAOYSA-N
26520	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7247	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	-	-	DRUGBANK	DB08466	C14H14O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HITJFUSPLYBJPE-UHFFFAOYSA-N
26522	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7254	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	-	-	DRUGBANK	DB08473	C12H12Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHSQDZXAVJRBMX-DDHJBXDOSA-N
26523	856007	938389	BSU02700	estA	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	7256	[(4R)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE	-	-	DRUGBANK	DB08475	C12H23O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUTLRPVAJSANIT-NSHDSACASA-N
26524	110460	4317	-	MMP8	CLG1|HNC|MMP-8|PMNL-CL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7257	3-AMINO-AZACYCLOTRIDECAN-2-ONE	-	-	DRUGBANK	DB08476	C12H24N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQZLEYBEPASILI-NSHDSACASA-N
26525	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7258	5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide	-	-	DRUGBANK	DB08477	C19H18ClN3O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGFYHTZWPPHNLQ-AWEZNQCLSA-N
26526	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7259	N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide	-	-	DRUGBANK	DB08478	C9H9ClF3N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGFTZEOFHWPCDL-UHFFFAOYSA-N
26527	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7260	N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide	-	-	DRUGBANK	DB08479	C10H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VQKIGKHIRBCYNE-UHFFFAOYSA-N
26528	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7261	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	-	-	DRUGBANK	DB08480	C12H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFWOPQIDDNCCLL-KAQJVSAMSA-N
26529	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7263	[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER	-	-	DRUGBANK	DB08482	C19H35N3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKRONJXEXGFBRZ-ZNMIVQPWSA-N
26530	108497	2203	RP11-342C23.1	FBP1	FBP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7264	4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE	-	-	DRUGBANK	DB08484	C9H13N3O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHVDNDIAMJOEKH-UHFFFAOYSA-N
26531	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7266	2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID	-	-	DRUGBANK	DB08486	C20H23NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNFRJXLZYUTIII-UHFFFAOYSA-N
26532	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7266	2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID	-	-	DRUGBANK	DB08486	C20H23NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNFRJXLZYUTIII-UHFFFAOYSA-N
26533	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7267	3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB08487	C20H19ClN4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRMSFVUWLBPPLY-UHFFFAOYSA-N
26534	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7268	4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE	-	-	DRUGBANK	DB08488	C18H17ClN4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLWVUIRWJVKSSD-XBXARRHUSA-N
26535	110459	4316	-	MMP7	MMP-7|MPSL1|PUMP-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7269	N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE	-	-	DRUGBANK	DB08489	C25H36N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCBPAPVOMPJQHK-NQIIRXRSSA-N
26536	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7270	CTS-1027	4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE|193022-04-7|RS-130830|Ro-1130830	-	DRUGBANK	DB08490	C19H20ClNO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROSNVSQTEGHUKU-UHFFFAOYSA-N
26537	110456	4312	-	MMP1	CLG|CLGN	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7271	N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE	-	-	DRUGBANK	DB08491	C19H21NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARIRIZBKMKMEBD-UHFFFAOYSA-N
26538	106747	246	-	ALOX15	12-LOX|15-LOX-1|15LOX-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7272	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	-	-	DRUGBANK	DB08492	C17H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRDSGPLHVQJFLM-BUHFOSPRSA-N
26539	110459	4316	-	MMP7	MMP-7|MPSL1|PUMP-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7273	5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID	-	-	DRUGBANK	DB08493	C25H35N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AKWKBACKRMYPRV-NQIIRXRSSA-N
26540	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7275	4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB08495	C20H19ClN4O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXONTEUOQXFJJS-UHFFFAOYSA-N
26541	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7276	(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	-	-	DRUGBANK	DB08497	C19H14N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NKBDSMREMMRFSI-INIZCTEOSA-N
26542	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7277	(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	-	-	DRUGBANK	DB08498	C19H13ClN2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVSAMUIBGQSLDC-INIZCTEOSA-N
26543	107286	836	-	CASP3	CPP32|CPP32B|SCA-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7278	N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide	-	-	DRUGBANK	DB08499	C21H18FN3O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQXBKUVWJSZHSI-UHFFFAOYSA-N
26544	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7279	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	-	-	DRUGBANK	DB08500	C18H21NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCJBDRSKHARECB-PYTCMNEWSA-N
26545	111795	5837	-	PYGM	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7282	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	-	-	DRUGBANK	DB08503	C15H21NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRCKGDOSPBFICB-MZHQWRCYSA-N
26546	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7283	6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM	-	-	DRUGBANK	DB08504	C22H25FN6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZNHVIJAGMFQGMS-IHPCNDPISA-N
26547	851583	947253	b0932	pepN	ECK0923|JW0915	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7285	N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine	-	-	DRUGBANK	DB08506	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MMWNOZXGYRPSCJ-LZQZEXGQSA-N
26548	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7286	N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID	-	-	DRUGBANK	DB08507	C20H27N2O3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGUVBHLPMGERAT-NIYFSFCBSA-N
26549	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7289	5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE	-	-	DRUGBANK	DB08510	C25H38O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVTGFMKBPVLATL-DSOJQRAMSA-N
26550	109854	3643	-	INSR	CD220|HHF5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7292	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	-	-	DRUGBANK	DB08513	C20H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAIQRYUOBBCBSE-UHFFFAOYSA-N
26551	109874	3667	-	IRS1	HIRS-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7292	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	-	-	DRUGBANK	DB08513	C20H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAIQRYUOBBCBSE-UHFFFAOYSA-N
26552	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7292	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	-	-	DRUGBANK	DB08513	C20H19N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAIQRYUOBBCBSE-UHFFFAOYSA-N
26553	111664	5691	-	PSMB3	HC10-II	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26554	111661	5688	RP5-1005F21.4	PSMA7	C6|HSPC|RC6-1|XAPC7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26555	111660	5687	-	PSMA6	IOTA|PROS27|p27K	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26556	111659	5686	-	PSMA5	PSC5|ZETA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26557	111658	5685	-	PSMA4	HC9|HsT17706|PSC9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26558	111657	5684	-	PSMA3	HC8|PSC3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26559	111656	5683	-	PSMA2	HC3|MU|PMSA2|PSC2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26560	111655	5682	-	PSMA1	HC2|HEL-S-275|NU|PROS30	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26561	111663	5690	RP5-983H21.1	PSMB2	HC7-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26562	111662	5689	-	PSMB1	HC5|PMSB1|PSC5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26563	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26564	111665	5692	-	PSMB4	HN3|HsN3|PROS-26|PROS26	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26565	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26566	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7294	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	-	-	DRUGBANK	DB08515	C15H21NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVABESCRHMBHJD-FUQNVFFISA-N
26567	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7295	(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]	-	-	DRUGBANK	DB08516	C17H17FN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJJDIVMWGWHPFE-QDBSGRMGSA-N
26568	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7297	N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine	-	-	DRUGBANK	DB08519	C21H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQAPOSROFWHIB-UHFFFAOYSA-N
26569	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7298	(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE	-	-	DRUGBANK	DB08520	C24H39NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUCSBBBCFXBFFY-IBGZPJMESA-N
26570	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7299	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	-	-	DRUGBANK	DB08521	C21H16FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDMGBJANTYXAIV-HHHXNRCGSA-N
26571	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7299	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	-	-	DRUGBANK	DB08521	C21H16FN3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDMGBJANTYXAIV-HHHXNRCGSA-N
26572	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7300	4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE	-	-	DRUGBANK	DB08522	C18H16FN3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROKOFZNQCIIJMI-UHFFFAOYSA-N
26573	852092	947780	b3287	def	ECK3273|JW3248|fms	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7301	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	-	-	DRUGBANK	DB08523	C10H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GELOPWXSYZDPJT-UHFFFAOYSA-N
26574	107892	1512	-	CTSH	ACC-4|ACC-5|CPSB|minichain	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7304	CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE	-	-	DRUGBANK	DB08526	C22H36N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LHCNZPLAATYYPI-SLFFLAALSA-N
26575	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7305	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08527	C15H12N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGAKLLFPOGATII-UHFFFAOYSA-N
26576	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7305	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB08527	C15H12N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGAKLLFPOGATII-UHFFFAOYSA-N
26577	114842	9453	-	GGPS1	GGPPS|GGPPS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7307	(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)	-	-	DRUGBANK	DB08529	C17H34O6P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFKBXXKNHWTTCS-PHEQNACWSA-N
26578	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7308	7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE	-	-	DRUGBANK	DB08530	C18H23N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFSMMXJBEBXTJP-UHFFFAOYSA-O
26579	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7309	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08531	C18H13Cl2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CVYWYUAQFJMLEO-UHFFFAOYSA-N
26580	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7310	6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	-	-	DRUGBANK	DB08532	C18H14FN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WCNPGRRMPFCHEO-UHFFFAOYSA-N
26581	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7311	3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	-	-	DRUGBANK	DB08533	C13H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXRVAGIYXNQOKP-UHFFFAOYSA-N
26582	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7312	5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08534	C18H14FN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIYYXVHGBMLEC-UHFFFAOYSA-N
26583	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7313	3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08535	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMIZFGZXFDGISG-UHFFFAOYSA-N
26584	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7314	3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine	-	-	DRUGBANK	DB08536	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBUPHWYGVDAASU-UHFFFAOYSA-N
26585	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7315	3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine	-	-	DRUGBANK	DB08537	C18H14BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZLKFNBMXXLTLX-UHFFFAOYSA-N
26586	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7316	N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08538	C19H17F2N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQPVGVSQPQVZLD-UHFFFAOYSA-N
26587	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7317	3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	-	-	DRUGBANK	DB08539	C21H19N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCDIUVLNHCGSMH-UHFFFAOYSA-N
26588	109727	3507	-	IGHM	AGM1|MU|VH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7323	(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE	-	-	DRUGBANK	DB08545	C17H19NO4P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPTMOJMDCPUCJT-CYBMUJFWSA-M
26589	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7324	4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE	-	-	DRUGBANK	DB08546	C24H24N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CETLUACQMGBMFH-ZALSBGIRSA-N
26590	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7325	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	-	-	DRUGBANK	DB08547	C25H34O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBBNFGYRYNBDIH-DBGGZKJISA-N
26591	856007	938389	BSU02700	estA	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	7326	[(4S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE	-	-	DRUGBANK	DB08548	C12H23O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUTLRPVAJSANIT-LLVKDONJSA-N
26592	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7327	(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER	-	-	DRUGBANK	DB08549	C19H21N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MFDBNNQUDZFSES-KRWDZBQOSA-N
26593	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7328	7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE	-	-	DRUGBANK	DB08550	C9H9Cl2N	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPUBEDBBOGGIQ-UHFFFAOYSA-N
26594	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7329	(1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID	-	-	DRUGBANK	DB08551	C14H14BNO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQLQTGGLHBYZSA-ZDUSSCGKSA-N
26595	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7330	(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid	-	-	DRUGBANK	DB08552	C13H14BNO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LGJCDEZMANATFA-ZDUSSCGKSA-N
26596	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7331	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime	-	-	DRUGBANK	DB08553	C22H23N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWEFZSZCLBHIEQ-YYADALCUSA-N
26597	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7333	1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline	-	-	DRUGBANK	DB08555	C16H13BrClNO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKGXHBGCVQTQBH-UHFFFAOYSA-N
26598	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7335	2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide	-	-	DRUGBANK	DB08557	C22H23N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQKFKSJUBJPOLY-UHFFFAOYSA-N
26599	110130	3938	-	LCT	LAC|LPH|LPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7336	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	-	-	DRUGBANK	DB08558	C14H28O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGVLVOOFCGWBCS-RGDJUOJXSA-N
26600	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7336	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	-	-	DRUGBANK	DB08558	C14H28O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGVLVOOFCGWBCS-RGDJUOJXSA-N
26601	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7338	3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE	-	-	DRUGBANK	DB08560	C19H13F2N3O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GULUFDCOGAXLEP-UHFFFAOYSA-N
26602	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7339	BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE	-	-	DRUGBANK	DB08561	C21H16N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLBINCOCFGQAJM-UHFFFAOYSA-N
26603	136896	440786	-	LOC440786	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7340	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	-	-	DRUGBANK	DB08562	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTXJWRRYLLRFMG-MDZDMXLPSA-N
26604	109721	3500	-	IGHG1	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7340	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	-	-	DRUGBANK	DB08562	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTXJWRRYLLRFMG-MDZDMXLPSA-N
26605	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7340	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	-	-	DRUGBANK	DB08562	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTXJWRRYLLRFMG-MDZDMXLPSA-N
26606	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7341	(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide	-	-	DRUGBANK	DB08564	C20H20BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCIXBBSRVLSRJQ-QPJJXVBHSA-N
26607	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7342	L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID	-	-	DRUGBANK	DB08565	C14H17BNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDFLCBUAVBYWFW-AWEZNQCLSA-N
26608	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7343	D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID	-	-	DRUGBANK	DB08566	C14H17BNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDFLCBUAVBYWFW-CQSZACIVSA-N
26609	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7345	(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE	-	-	DRUGBANK	DB08568	C22H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPNUQXPIQBZCMR-IBGZPJMESA-N
26610	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7345	(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE	-	-	DRUGBANK	DB08568	C22H22N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPNUQXPIQBZCMR-IBGZPJMESA-N
26611	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7346	3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE	-	-	DRUGBANK	DB08569	C22H21BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPMRZSKJUTRBQ-IBGZPJMESA-N
26612	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7346	3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE	-	-	DRUGBANK	DB08569	C22H21BrN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLPMRZSKJUTRBQ-IBGZPJMESA-N
26613	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7349	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	-	-	DRUGBANK	DB08572	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBKLJTXDSBEVRV-UHFFFAOYSA-N
26614	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7349	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	-	-	DRUGBANK	DB08572	C18H22N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBKLJTXDSBEVRV-UHFFFAOYSA-N
26615	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7350	3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID	-	-	DRUGBANK	DB08573	C11H8ClNO4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRWKEEDITQJPCZ-UHFFFAOYSA-N
26616	110447	4301	-	MLLT4	AF6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7351	(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE	-	-	DRUGBANK	DB08574	C11H8F3NOS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBYVUUWMCCSRBI-MRVPVSSYSA-N
26617	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7352	2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM	-	-	DRUGBANK	DB08575	C15H16N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCUCDCAIOMIBEA-GFCCVEGCSA-O
26618	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7354	3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE	-	-	DRUGBANK	DB08577	C17H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNDVEAXZWJIOKB-JYRVWZFOSA-N
26619	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7360	2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide	-	-	DRUGBANK	DB08583	C21H22N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INAGORZAOFUKOZ-UHFFFAOYSA-N
26620	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7361	6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline	-	-	DRUGBANK	DB08584	C18H13N7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCZUAADEACICHN-UHFFFAOYSA-N
26621	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7365	2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE	-	-	DRUGBANK	DB08588	C21H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYNURZXTLNNKAP-QGZVFWFLSA-N
26622	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7367	1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE	-	-	DRUGBANK	DB08590	C22H24N4O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAYRKIZESVQSN-UHFFFAOYSA-N
26623	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7368	5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	-	-	DRUGBANK	DB08591	C15H14N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGXKSKWHHHYBFM-UHFFFAOYSA-N
26624	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7370	1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE	-	-	DRUGBANK	DB08593	C8H8N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDCZCUKQWRZSDT-UHFFFAOYSA-N
26625	107893	1513	RP11-363I22.4	CTSK	CTS02|CTSO|CTSO1|CTSO2|PKND|PYCD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7371	TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE	-	-	DRUGBANK	DB08594	C7H13N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWELYBAPJHIOQT-UHFFFAOYSA-N
26626	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7372	4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB08595	C17H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBZPJHFECDCNGT-BPUTZDHNSA-N
26627	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7372	4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	-	-	DRUGBANK	DB08595	C17H22O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BBZPJHFECDCNGT-BPUTZDHNSA-N
26628	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7373	5'-deoxy-5'-piperidin-1-ylthymidine	-	-	DRUGBANK	DB08596	C15H23N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMOUOGHZJCSNOZ-YNEHKIRRSA-N
26629	106605	90	-	ACVR1	ACTRI|ACVR1A|ACVRLK2|ALK2|FOP|SKR1|TSRI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7374	6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine	-	-	DRUGBANK	DB08597	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHBVYDAKJHETMP-UHFFFAOYSA-N
26630	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7374	6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine	-	-	DRUGBANK	DB08597	C24H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHBVYDAKJHETMP-UHFFFAOYSA-N
26631	110464	4321	-	MMP12	HME|ME|MME|MMP-12	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7376	N-[(4-methoxyphenyl)sulfonyl]-D-alanine	-	-	DRUGBANK	DB08599	C10H13NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTCIPBHRVYICGT-SSDOTTSWSA-N
26632	112168	6256	-	RXRA	NR2B1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7378	tributylstannanyl	-	-	DRUGBANK	DB08601	C12H27Sn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIILXFBHQILWPS-UHFFFAOYSA-N
26633	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7378	tributylstannanyl	-	-	DRUGBANK	DB08601	C12H27Sn	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIILXFBHQILWPS-UHFFFAOYSA-N
26634	111176	5150	RP11-707M3.3	PDE7A	HCP1|PDE7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7379	3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one	-	-	DRUGBANK	DB08602	C15H10F2N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFNBJSXMXXQLAW-UHFFFAOYSA-N
26635	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7381	Triclosan	2,4,4'-Trichloro-2'-hydroxydiphenyl ether|Triclosanum|5-Chloro-2-(2,4-dichloro-phenoxy)-phenol|Triclosan	astound antibacterial|lysol i.	DRUGBANK	DB08604	C12H7Cl3O2	small molecule	D08AE04|D09AA06	3380-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEFQLINVKFYRCS-UHFFFAOYSA-N
26636	850237	945870	b1288	fabI	ECK1283|JW1281|envM|gts|qmeA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7382	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	-	-	DRUGBANK	DB08605	C9H13BN2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVXLILKNSPCVRB-UHFFFAOYSA-N
26637	108030	1666	-	DECR1	DECR|NADPH|SDR18C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7382	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	-	-	DRUGBANK	DB08605	C9H13BN2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVXLILKNSPCVRB-UHFFFAOYSA-N
26638	852836	948542	b0159	mtn	ECK0158|JW0155|mtnN|pfs|yadA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7383	(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL	-	-	DRUGBANK	DB08606	C13H19N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTHMDFGHOCNNOE-ZJUUUORDSA-N
26639	107936	1558	-	CYP2C8	CPC8|CYPIIC8|MP-12/MP-20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7384	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB08607	C24H27NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-NTKDMRAZSA-N
26640	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7385	4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE	-	-	DRUGBANK	DB08608	C18H20F3N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWFSHKKFDSWNLZ-BWACUDIHSA-N
26641	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7386	(N-{4-[(ETHYLANILINO)SULFONYL]-2-METHYLPHENYL}-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANAMIDE	-	-	DRUGBANK	DB08609	C19H21F3N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHEIQJGQDUYUBE-GOSISDBHSA-N
26642	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7387	N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE	-	-	DRUGBANK	DB08610	C20H25ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFXJYVQAAFOZDP-UHFFFAOYSA-N
26643	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7388	2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL	-	-	DRUGBANK	DB08611	C14H11F3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGXPXFPIOHNDAN-UHFFFAOYSA-N
26644	115106	9759	-	HDAC4	AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7390	2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL	-	-	DRUGBANK	DB08613	C19H16F3N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBFUNBBOQCNFX-UHFFFAOYSA-N
26645	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7391	3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE	-	-	DRUGBANK	DB08614	C20H23F3N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYFMPKCOIMRDDD-KRWDZBQOSA-N
26646	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7392	2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM	-	-	DRUGBANK	DB08615	C16H17N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOVJJPLRUMZSDK-UHFFFAOYSA-O
26647	114134	8565	-	YARS	CMTDIC|TYRRS|YRS|YTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7393	4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE	-	-	DRUGBANK	DB08617	C11H12F3NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXIZYDKGLBPCAQ-VIFPVBQESA-N
26648	109722	3501	-	IGHG2	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7394	3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER	-	-	DRUGBANK	DB08618	C16H22NO5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJTKWTJTOSZMKO-PMOUVXMZSA-N
26649	124609	89832	-	CHRFAM7A	CHRNA7|CHRNA7-DR1|D-10	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7396	{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide	-	-	DRUGBANK	DB08620	C10H9ClN4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKKPVIRMVDYPB-UVTDQMKNSA-N
26650	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7399	2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID	-	-	DRUGBANK	DB08623	C14H14N2O5S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBBNCGUNWSPHOY-QWRGUYRKSA-N
26651	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7400	BENZOTHIAZOLE	-	-	DRUGBANK	DB08624	C13H17N5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MAJHCCQPIDXPAN-QMMMGPOBSA-N
26652	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	7401	Thiorphan	-	-	DRUGBANK	DB08626	C12H15NO3S	small molecule	-	76721-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJJKNPQAGWVLDQ-SNVBAGLBSA-N
26653	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7402	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	-	-	DRUGBANK	DB08627	C12H16O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTQYHVYLPKMOX-SJFBBLFCSA-N
26654	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7403	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	-	-	DRUGBANK	DB08628	C10H12O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXGVAQMIEXZDPM-BRAIEQGRSA-N
26655	106994	506	-	ATP5B	ATPMB|ATPSB|HEL-S-271	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7404	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	-	-	DRUGBANK	DB08629	C13H27N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOQLOPQBSFMPNJ-QWHCGFSZSA-N
26656	106987	498	-	ATP5A1	ATP5A|ATP5AL2|ATPM|COXPD22|HEL-S-123m|MC5DN4|MOM2|OMR|ORM|hATP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7404	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	-	-	DRUGBANK	DB08629	C13H27N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOQLOPQBSFMPNJ-QWHCGFSZSA-N
26657	106997	509	RP11-401E9.1	ATP5C1	ATP5C|ATP5CL1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7404	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	-	-	DRUGBANK	DB08629	C13H27N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOQLOPQBSFMPNJ-QWHCGFSZSA-N
26658	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7405	N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	-	-	DRUGBANK	DB08631	C15H15ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSIFVBCHJEYJP-UHFFFAOYSA-N
26659	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7406	1,3,5-BENZENETRICARBOXYLIC ACID	-	-	DRUGBANK	DB08632	C9H6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMKYBPDZANOJGF-UHFFFAOYSA-N
26660	109293	3043	-	HBB	CD113t-C|beta-globin	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7406	1,3,5-BENZENETRICARBOXYLIC ACID	-	-	DRUGBANK	DB08632	C9H6O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QMKYBPDZANOJGF-UHFFFAOYSA-N
26661	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7407	(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER	-	-	DRUGBANK	DB08633	C19H28ClNO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSHZHSPISPJWHW-PVDLLORBSA-N
26662	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7414	(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID	-	-	DRUGBANK	DB08640	C14H19NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IDDWUPNJUMHKFQ-DGCLKSJQSA-N
26663	108305	1990	-	CELA1	ELA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7415	(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID	-	-	DRUGBANK	DB08641	C13H16N2O7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPQYVEFTAZEPOD-BXKDBHETSA-N
26664	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7416	(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine	-	-	DRUGBANK	DB08642	C19H29N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JJWPLCQODKLEHY-JEOXALJRSA-N
26665	110458	4314	-	MMP3	CHDS6|MMP-3|SL-1|STMY|STMY1|STR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7417	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	-	-	DRUGBANK	DB08643	C24H31N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFAWBPLETHINFK-UNMCSNQZSA-N
26666	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7419	6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE	-	-	DRUGBANK	DB08645	C8H8Cl3N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMJSLTNSBFUCMU-MRVPVSSYSA-N
26667	109734	3514	-	IGKC	HCAK1|IGKCD|Km	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7421	TRAZEOLIDE	-	-	DRUGBANK	DB08647	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YUTXECPABXNXPU-DJJJIMSYSA-N
26668	851418	947081	b2599	pheA	ECK2596|JW2580	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7422	8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID	-	-	DRUGBANK	DB08648	C10H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRZHNRULRHECRF-JQCUSGDOSA-N
26669	856605	939005	BSU22690	aroH	-	224308	Bacillus subtilis	unknown	target	Berman HM (2000)	10592235	172122	7422	8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID	-	-	DRUGBANK	DB08648	C10H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRZHNRULRHECRF-JQCUSGDOSA-N
26670	113008	7155	-	TOP2B	TOPIIB|top2beta	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7425	3'-THIO-THYMIDINE-5'-PHOSPHATE	-	-	DRUGBANK	DB08651	C10H15N2O7PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BORVFKJZAOEGOO-GJMOJQLCSA-N
26671	111410	5409	-	PNMT	PENT|PNMTase	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7428	TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	-	-	DRUGBANK	DB08654	C10H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIMSEFZOOYSTDO-UWVGGRQHSA-N
26672	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7429	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	-	-	DRUGBANK	DB08655	C14H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MIGJEXKBUJPKJF-UHFFFAOYSA-N
26673	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7432	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	-	-	DRUGBANK	DB08658	C6H16NO3P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUNFIZRDIMDMIH-UHFFFAOYSA-N
26674	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7433	2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide	-	-	DRUGBANK	DB08659	C15H14N4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPDLAUCFAOODER-UHFFFAOYSA-N
26675	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7434	1,2,5,8-tetrahydroxyanthracene-9,10-dione	-	-	DRUGBANK	DB08660	C14H8O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBHKTXLEJZIDJF-UHFFFAOYSA-N
26676	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7435	1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione	-	-	DRUGBANK	DB08661	C14H21N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUSBTLVYPZUOAW-WOPDTQHZSA-N
26677	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7440	5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	-	-	DRUGBANK	DB08666	C10H7F3N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SNTJRGVKGCPNBK-KGQVPBNKSA-N
26678	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7441	4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine	-	-	DRUGBANK	DB08667	C9H7FN6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HALOLQDLOLYIOW-CNLUSAEGSA-N
26679	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7442	3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid	-	-	DRUGBANK	DB08668	C10H8N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIUSHRUXZPMNPD-CNLUSAEGSA-N
26680	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7443	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	-	-	DRUGBANK	DB08669	C20H31N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMHZOSJVDHAFEE-SVGFKBNWSA-N
26681	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7444	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	-	-	DRUGBANK	DB08670	C22H35N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIWZNHHLFMPGGO-PIKADFDJSA-N
26682	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7445	5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE	-	-	DRUGBANK	DB08671	C10H7F3N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJHMEAOMPGLBTJ-KGQVPBNKSA-N
26683	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7446	4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE	-	-	DRUGBANK	DB08672	C19H21FN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIWWNWQZJJKBTR-CYBMUJFWSA-N
26684	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7447	4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE	-	-	DRUGBANK	DB08673	C12H15N3O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPQUJAANWFHCJV-UHFFFAOYSA-N
26685	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7448	(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE	-	-	DRUGBANK	DB08674	C26H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USPFJPDEADLGIG-HSZRJFAPSA-N
26686	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7448	(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE	-	-	DRUGBANK	DB08674	C26H21N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USPFJPDEADLGIG-HSZRJFAPSA-N
26687	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7449	(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID	-	-	DRUGBANK	DB08675	C20H32N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRTCYJVIMJMLJO-ZPOCGUEASA-N
26688	108627	2342	-	FNTB	FPTB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7450	(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE	-	-	DRUGBANK	DB08676	C27H27N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBEQWWUQNVMGMR-PSUQPPDWSA-N
26689	108625	2339	-	FNTA	FPTA|PGGT1A|PTAR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7450	(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE	-	-	DRUGBANK	DB08676	C27H27N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBEQWWUQNVMGMR-PSUQPPDWSA-N
26690	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7451	N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE	-	-	DRUGBANK	DB08677	C13H15N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZOOPQQADNJEG-UHFFFAOYSA-N
26691	111751	5787	-	PTPRB	HPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7452	(4-ETHYLPHENYL)SULFAMIC ACID	-	-	DRUGBANK	DB08678	C8H11NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HXARYYGNSVTEFC-UHFFFAOYSA-N
26692	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7457	REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE	-	-	DRUGBANK	DB08683	C24H15N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OTPNDVKVEAIXTI-IYBDPMFKSA-N
26693	120060	54583	PNAS-118	EGLN1	C1orf12|ECYT3|HIF-PH2|HIFPH2|HPH-2|HPH2|PHD2|SM20|ZMYND6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7461	N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE	-	-	DRUGBANK	DB08687	C12H9ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUQVKRKGTAUJQA-UHFFFAOYSA-N
26694	109338	3091	-	HIF1A	HIF-1A|HIF-1alpha|HIF1|HIF1-ALPHA|MOP1|PASD8|bHLHe78	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7461	N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE	-	-	DRUGBANK	DB08687	C12H9ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUQVKRKGTAUJQA-UHFFFAOYSA-N
26695	120958	55856	HT012	ACOT13	PNAS-27|THEM2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7462	undecan-2-one	-	-	DRUGBANK	DB08688	C11H22O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYWIYKKSMDLRDC-UHFFFAOYSA-N
26696	852650	948353	b3860	dsbA	ECK3852|JW3832|dsf|iarA|ppfA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7463	UBIQUINONE-1	-	-	DRUGBANK	DB08689	C14H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOECUQMRSRVZQQ-UHFFFAOYSA-N
26697	112292	6391	-	SDHC	CYB560|CYBL|PGL3|QPS1|SDH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7463	UBIQUINONE-1	-	-	DRUGBANK	DB08689	C14H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOECUQMRSRVZQQ-UHFFFAOYSA-N
26698	850701	946344	b1185	dsbB	ECK1173|JW5182|dsbX|iarB|roxB|ycgA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7463	UBIQUINONE-1	-	-	DRUGBANK	DB08689	C14H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOECUQMRSRVZQQ-UHFFFAOYSA-N
26699	112290	6389	-	SDHA	CMD1GG|FP|PGL5|SDH1|SDH2|SDHF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7463	UBIQUINONE-1	-	-	DRUGBANK	DB08689	C14H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOECUQMRSRVZQQ-UHFFFAOYSA-N
26700	112293	6392	-	SDHD	CBT1|CII-4|CWS3|PGL|PGL1|QPs3|SDH4|cybS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7463	UBIQUINONE-1	-	-	DRUGBANK	DB08689	C14H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOECUQMRSRVZQQ-UHFFFAOYSA-N
26701	112291	6390	-	SDHB	CWS2|IP|PGL4|SDH|SDH1|SDH2|SDHIP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7463	UBIQUINONE-1	-	-	DRUGBANK	DB08689	C14H18O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SOECUQMRSRVZQQ-UHFFFAOYSA-N
26702	849776	945402	b0723	sdhA	ECK0712|JW0713	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26703	110619	4519	-	CYTB	MTCYB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26704	118920	29796	HSPC119	UQCR10	HSPC051|HSPC151|QCR9|UCCR7.2|UCRC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26705	113227	7381	-	UQCRB	MC3DN3|QCR7|QP-C|QPC|UQBC|UQBP|UQCR6|UQPC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26706	849677	945300	b0724	sdhB	ECK0713|JW0714	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26707	849698	945322	b0722	sdhD	ECK0711|JW0712	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26708	849692	945316	b0721	sdhC	ECK0710|JW0711|cybA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26709	850701	946344	b1185	dsbB	ECK1173|JW5182|dsbX|iarB|roxB|ycgA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26710	113230	7384	-	UQCRC1	D3S3191|QCR1|UQCR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26711	113232	7386	-	UQCRFS1	RIP1|RIS1|RISP|UQCR5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26712	116172	10975	-	UQCR11	0710008D09Rik|QCR10|UQCR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26713	113234	7388	-	UQCRH	QCR6|UQCR8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26714	117991	27089	-	UQCRQ	MC3DN4|QCR8|QP-C|QPC|UQCR7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26715	107917	1537	-	CYC1	MC3DN6|UQCR4	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26716	113231	7385	-	UQCRC2	MC3DN5|QCR2|UQCR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7464	UBIQUINONE-2	-	-	DRUGBANK	DB08690	C19H26O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SQQWBSBBCSFQGC-JLHYYAGUSA-N
26717	107609	1198	-	CLK3	PHCLK3|PHCLK3/152	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7465	ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate	-	-	DRUGBANK	DB08691	C15H13Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXJCGSPAPOTTSF-VURMDHGXSA-N
26718	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7465	ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate	-	-	DRUGBANK	DB08691	C15H13Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXJCGSPAPOTTSF-VURMDHGXSA-N
26719	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7466	D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID	-	-	DRUGBANK	DB08692	C10H14BClNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPCXTDQHLFRWCJ-SNVBAGLBSA-N
26720	107884	1504	-	CTRB1	CTRB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7467	L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID	-	-	DRUGBANK	DB08693	C10H14BClNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPCXTDQHLFRWCJ-JTQLQIEISA-N
26721	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7468	9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol	-	-	DRUGBANK	DB08694	C14H11N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHKPHCVZVYDFN-UHFFFAOYSA-N
26722	107331	890	-	CCNA2	CCN1|CCNA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7468	9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol	-	-	DRUGBANK	DB08694	C14H11N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RTHKPHCVZVYDFN-UHFFFAOYSA-N
26723	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7469	3-(4-nitrophenyl)-1H-pyrazole	-	-	DRUGBANK	DB08695	C9H7N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPIYADCDDIUVPS-UHFFFAOYSA-N
26724	111465	5469	-	MED1	CRSP1|CRSP200|DRIP205|DRIP230|PBP|PPARBP|PPARGBP|RB18A|TRAP220|TRIP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7470	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	-	-	DRUGBANK	DB08696	C23H36O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLUXQQUPXBIHH-KXNJMPKXSA-N
26725	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7470	5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	-	-	DRUGBANK	DB08696	C23H36O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLUXQQUPXBIHH-KXNJMPKXSA-N
26726	111344	5328	RP11-417O11.1	PLAU	ATF|BDPLT5|QPD|UPA|URK|u-PA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7471	4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	-	-	DRUGBANK	DB08697	C22H28ClN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDYIYIRPQKMWMM-UHFFFAOYSA-N
26727	107268	818	RP11-574K11.6	CAMK2G	CAMK|CAMK-II|CAMKG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7473	1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	-	-	DRUGBANK	DB08699	C17H21N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYCOTGCSHZKHPR-UHFFFAOYSA-N
26728	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7474	3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine	-	-	DRUGBANK	DB08700	C21H22Cl2FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTEIFNKAUNYNJU-GFCCVEGCSA-N
26729	110439	4293	-	MAP3K9	MEKK9|MLK1|PRKE1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7477	12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one	-	-	DRUGBANK	DB08703	C27H24N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGKKIHITEICGMN-UHFFFAOYSA-N
26730	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7479	6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE	-	-	DRUGBANK	DB08705	C18H11BrN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SVSYJTYGPLVUOZ-UHFFFAOYSA-N
26731	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7481	4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine	-	-	DRUGBANK	DB08707	C17H11ClN4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQVFETGXIRKVAQ-UHFFFAOYSA-N
26732	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7482	N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine	-	-	DRUGBANK	DB08708	C18H18F3N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYYDXQCAYXOGQT-UHFFFAOYSA-N
26733	111310	5292	-	PIM1	PIM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7483	2,3-diphenyl-1H-indole-7-carboxylic acid	-	-	DRUGBANK	DB08709	C21H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLUDUXWVPIEHDA-UHFFFAOYSA-N
26734	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7491	4-(3-ethylthiophen-2-yl)benzene-1,2-diol	-	-	DRUGBANK	DB08718	C12H12O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXLXQOMDQVQQLA-UHFFFAOYSA-N
26735	114205	8654	-	PDE5A	CGB-PDE|CN5A|PDE5	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7502	5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide	-	-	DRUGBANK	DB08729	C15H19N5O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FENWRHVHBZQJGW-UHFFFAOYSA-N
26736	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7503	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	-	-	DRUGBANK	DB08730	C26H25FN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPFBZMFUCGHBAP-UHFFFAOYSA-N
26737	852961	948669	b4150	ampC	ECK4146|JW4111|ampA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7504	2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	-	-	DRUGBANK	DB08731	C23H17NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPOKTQCDBPECSS-MRXNPFEDSA-N
26738	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7506	(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE	-	-	DRUGBANK	DB08733	C20H33N5O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GAHIXYNNFMCKFQ-HZSPNIEDSA-N
26739	113149	7298	OK/SW-cl.29	TYMS	HST422|TMS|TS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7507	6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB08734	C14H18Cl3N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZJYWCQPMNPRM-UHFFFAOYSA-N
26740	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7510	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL	-	-	DRUGBANK	DB08737	C18H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSYFYSFYUHBIHE-GLJUWKHASA-N
26741	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7511	1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one	-	-	DRUGBANK	DB08738	C26H28N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWCKZIJGKMCYCI-QFIPXVFZSA-N
26742	111541	5550	RP3-355L5.1	PREP	PE|PEP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7512	2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione	-	-	DRUGBANK	DB08739	C20H21F2N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSXNPAWXICXNGZ-HNNXBMFYSA-N
26743	107889	1509	-	CTSD	CLN10|CPSD|HEL-S-130P	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7513	CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE	-	-	DRUGBANK	DB08740	C14H29NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KGYZGGUJJIVOQX-MELADBBJSA-N
26744	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7515	1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)	-	-	DRUGBANK	DB08742	C26H34O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEEUUHVULXTFGS-BQXVGYHGSA-N
26745	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7515	1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)	-	-	DRUGBANK	DB08742	C26H34O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEEUUHVULXTFGS-BQXVGYHGSA-N
26746	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7516	2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE	-	-	DRUGBANK	DB08743	C20H23N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJNKUWDMCBZMTG-OAHLLOKOSA-N
26747	110898	4835	RP1-90J20.3	NQO2	DHQV|DIA6|NMOR2|QR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7517	6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one	-	-	DRUGBANK	DB08744	C12H11NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPXXJCMMMXZVSW-UHFFFAOYSA-N
26748	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7518	4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE	-	-	DRUGBANK	DB08745	C23H27ClN4O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QLHUDNKWOSQSMK-CXUHLZMHSA-N
26749	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7519	1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE	-	-	DRUGBANK	DB08746	C23H29ClN4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOSSOFIFNGGDKG-GIJQJNRQSA-N
26750	117154	23621	-	BACE1	ASP2|BACE|HSPC104	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7522	3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE	-	-	DRUGBANK	DB08749	C25H30N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTRFBFMYAJOXLG-UHFFFAOYSA-N
26751	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7523	1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE	-	-	DRUGBANK	DB08750	C20H22FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SFPCNWQWKOUNRT-UHFFFAOYSA-N
26752	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7524	N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	-	-	DRUGBANK	DB08751	C12H15N5O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSVJZZZGPPWEIC-UHFFFAOYSA-N
26753	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7525	N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	-	-	DRUGBANK	DB08752	C21H35N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSOCWQJNYLTDD-SFHVURJKSA-N
26754	107900	1520	-	CTSS	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7528	N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	-	-	DRUGBANK	DB08755	C25H36N4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQWUTQCRGGBPBT-WIOPSUGQSA-N
26755	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26756	111556	5569	-	PKIA	PRKACN1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26757	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26758	114860	9475	-	ROCK2	ROCK-II	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7529	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB08756	C14H21N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYOZTVGMEWJPKR-IJLUTSLNSA-N
26759	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7530	5-(2-chlorophenyl)furan-2-carbohydrazide	-	-	DRUGBANK	DB08757	C11H9ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQMRHWSGTVEDFG-UHFFFAOYSA-N
26760	852191	947882	b0168	map	ECK0166|JW0163|pepM	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	7531	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	-	-	DRUGBANK	DB08758	C12H10N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSNWYZBDIKCPIG-UHFFFAOYSA-N
26761	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7533	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB08760	C15H13ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPBLTMSKPQDJPW-AWEZNQCLSA-N
26762	107749	1357	-	CPA1	CPA	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7535	O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID	-	-	DRUGBANK	DB08762	C22H27N2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPJNMOBJDSFRTI-FCEWJHQRSA-N
26763	111626	5644	-	PRSS1	TRP1|TRY1|TRY4|TRYP1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7536	[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE	-	-	DRUGBANK	DB08763	C16H18N3O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FSNDLCSOLUMYRH-OAHLLOKOSA-N
26764	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7537	4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE	-	-	DRUGBANK	DB08764	C22H24BrFN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHTHHESEBZOYNR-UHFFFAOYSA-N
26765	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7538	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	-	-	DRUGBANK	DB08765	C7H6N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOBQTYVTDBXTL-UHFFFAOYSA-N
26766	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7538	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	-	-	DRUGBANK	DB08765	C7H6N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOBQTYVTDBXTL-UHFFFAOYSA-N
26767	119248	51056	-	LAP3	HEL-S-106|LAP|LAPEP|PEPS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7539	L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S	-	-	DRUGBANK	DB08766	C15H19NO3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQWLOWFDKAFKAP-WXHSDQCUSA-N
26768	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7541	N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE	-	-	DRUGBANK	DB08768	C10H13N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYVABZIGRDEKCD-UHFFFAOYSA-N
26769	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7542	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	-	-	DRUGBANK	DB08770	C16H15N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWTBZOIUWZOPFT-UHFFFAOYSA-N
26770	109523	3290	-	HSD11B1	11-DH|11-beta-HSD1|CORTRD2|HDL|HSD11|HSD11B|HSD11L|SDR26C1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7543	(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one	-	-	DRUGBANK	DB08771	C12H13FN2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJJBBNIYQKFZDK-SNVBAGLBSA-N
26771	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7544	3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID	-	-	DRUGBANK	DB08772	C19H12F3N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCSVCWVQNOXFGL-UHFFFAOYSA-N
26772	121325	57016	-	AKR1B10	AKR1B11|AKR1B12|ALDRLn|ARL-1|ARL1|HIS|HSI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7544	3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID	-	-	DRUGBANK	DB08772	C19H12F3N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCSVCWVQNOXFGL-UHFFFAOYSA-N
26773	115761	10499	-	NCOA2	GRIP1|KAT13C|NCoA-2|SRC2|TIF2|bHLHe75	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7545	RALOXIFENE CORE	-	-	DRUGBANK	DB08773	C14H10O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDGWZLQPNOETLH-UHFFFAOYSA-N
26774	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7545	RALOXIFENE CORE	-	-	DRUGBANK	DB08773	C14H10O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDGWZLQPNOETLH-UHFFFAOYSA-N
26775	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7546	1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine	-	-	DRUGBANK	DB08774	C17H19N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBRZCAKSBYWZTC-ZDUSSCGKSA-N
26776	114261	8722	-	CTSF	CATSF|CLN13	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7547	BENZOYL-TYROSINE-ALANINE-METHYL KETONE	-	-	DRUGBANK	DB08775	C21H24N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLDDOKCDXBMMKZ-LIRRHRJNSA-N
26777	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7548	N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE	-	-	DRUGBANK	DB08776	C9H11N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYHOEDBNAJPFKK-UHFFFAOYSA-N
26778	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7549	5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE	-	-	DRUGBANK	DB08777	C10H10N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMMOEJUJKIXUQZ-UHFFFAOYSA-N
26779	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7550	[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone	-	-	DRUGBANK	DB08778	C14H17N3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KEHNGAHNKVLUSC-UHFFFAOYSA-N
26780	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7551	2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol	-	-	DRUGBANK	DB08779	C9H10N2OS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWYGHJVEZLVLSU-UHFFFAOYSA-N
26781	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7552	6-MORPHOLIN-4-YL-9H-PURINE	-	-	DRUGBANK	DB08780	C9H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEOMXKNIFWDDGZ-UHFFFAOYSA-N
26782	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7553	1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE	-	-	DRUGBANK	DB08781	C11H14BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJUBFXSKTBULRW-ZETCQYMHSA-N
26783	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7554	4-(2-AMINOETHYL)BENZENESULFONAMIDE	-	-	DRUGBANK	DB08782	C8H12N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXNSVEQMUYPYJS-UHFFFAOYSA-N
26784	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7555	(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid	-	-	DRUGBANK	DB08783	C16H23NO6Se	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUSGDKNGCAEAX-ZDUSSCGKSA-N
26785	121509	57407	-	NMRAL1	HSCARG|SDR48A1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7556	2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID	-	-	DRUGBANK	DB08784	C12H9ClN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEXIXVLEDGNAKM-UHFFFAOYSA-N
26786	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7558	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	-	-	DRUGBANK	DB08786	C8H13N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCJHOFUOIQHNBC-UHFFFAOYSA-N
26787	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7559	4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine	-	-	DRUGBANK	DB08787	C16H11Cl2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJMNJFPEVJCQK-GHVJWSGMSA-N
26788	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7560	3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB08788	C17H15N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOPQHPBCVYHSFF-UHFFFAOYSA-N
26789	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7561	2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	-	-	DRUGBANK	DB08789	C15H12Cl2N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPEOXUOUTBMBCX-UHFFFAOYSA-N
26790	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7562	1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID	-	-	DRUGBANK	DB08790	C10H8N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZROILLPDIUNLSE-UHFFFAOYSA-N
26791	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7563	1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE	-	-	DRUGBANK	DB08791	C14H10N4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	USLOIFPDNUDIEG-UHFFFAOYSA-N
26792	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Swiader MJ (2005)	16129921	181907	7570	Antazoline	Antazoline|Vasocon-a	cooper a.r.|vasocon a eye drop	DRUGBANK	DB08799	C17H19N3	small molecule	R01AC04|R06AX05	91-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	REYFJDPCWQRWAA-UHFFFAOYSA-N
26793	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Kurenova EV (2009)	19610651	182119	7571	Chloropyramine	Chloropyramine|Halopyramine|Chlorpyramine	-	DRUGBANK	DB08800	C16H20ClN3	small molecule	R06AC03|D04AA09|R06AC53	59-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICKFFNBDFNZJSX-UHFFFAOYSA-N
26794	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Moree WJ (2010)	20800486	182164	7572	Dimetindene	Dimethindene	-	DRUGBANK	DB08801	C20H24N2	small molecule	D04AA13|R06AB03	5636-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVMQESMQSYOVGV-UHFFFAOYSA-N
26795	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Pfaff O (1995)	8608784	181703	7572	Dimetindene	Dimethindene	-	DRUGBANK	DB08801	C20H24N2	small molecule	D04AA13|R06AB03	5636-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVMQESMQSYOVGV-UHFFFAOYSA-N
26796	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Pfaff O (1995)	8608784	181703	7572	Dimetindene	Dimethindene	-	DRUGBANK	DB08801	C20H24N2	small molecule	D04AA13|R06AB03	5636-83-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVMQESMQSYOVGV-UHFFFAOYSA-N
26797	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Moreau A (1995)	8546983	181701	7573	Isothipendyl	Actapront	-	DRUGBANK	DB08802	C16H19N3S	small molecule	D04AA22|R06AD09	482-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQJBSDFFQWMKBQ-UHFFFAOYSA-N
26798	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Birgner C (2008)	18809391	182085	7575	Nandrolone decanoate	Deca-durabolin|19-nortestosterone decanoate|Nandrolone 17-decanoate	deca durabolin inj 100mg/ml|na	DRUGBANK	DB08804	C28H44O3	small molecule	-	360-70-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKWKMORAXJQQSR-MOPIKTETSA-N
26799	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Black JW (1994)	7725982	181688	7576	Metiamide	Metiamidum|Methiamide|Metiamida	-	DRUGBANK	DB08805	C9H16N4S2	small molecule	-	34839-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPBPLBWLMYGIQR-UHFFFAOYSA-N
26800	109510	3274	-	HRH2	H2R	9606	Homo sapiens	antagonist	target	Agrawal SS (2010)	20718616	182163	7577	Roxatidine acetate	Roxatidine acetate|Roxatidina|Roxatidine|Aceroxatidine	-	DRUGBANK	DB08806	C19H28N2O4	small molecule	A02BA06	78628-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMTZFNFIKUPEJC-UHFFFAOYSA-N
26801	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Haddjeri N (1999)	10331108	179344	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26802	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Andree B (1999)	10435400	179345	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26803	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Fornal CA (1999)	10490909	179342	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26804	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Smeraldi E (1999)	10088139	179343	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26805	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Gobert A (1999)	10432475	179341	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26806	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26807	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Wheeldon NM (1991)	1678274	179346	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26808	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1991)	1687398	179347	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26809	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Dejgaard A (1991)	1666931	179350	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26810	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26811	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Rubenstein LA (2006)	16574446	179348	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26812	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1990)	1979630	179349	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26813	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26814	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Watkins DJ (1996)	8884690	179354	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26815	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Joseph SS (2003)	14608456	179351	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26816	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Brodde OE (1988)	2907348	179353	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26817	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Doggrell SA (1991)	1687398	179347	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26818	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26819	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	partial agonist	target	Berendsen HH (1990)	2148726	179352	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26820	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Dawson LA (2000)	10727715	179355	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26821	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Herrick-Davis K (1988)	3141589	179357	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26822	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Leonhardt S (1989)	2664084	179356	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26823	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Ariani K (1989)	2512511	179359	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26824	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	unknown	target	Terron JA (1994)	7944828	179358	7578	Bopindolol	Sandonorm	-	DRUGBANK	DB08807	C23H28N2O3	small molecule	C07AA17|C07CA17	62658-63-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUOJIACWOAYWEZ-UHFFFAOYSA-N
26825	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	antagonist	target	Lenard NR (2003)	12606631	181811	7579	Bupranolol	Bupranol	-	DRUGBANK	DB08808	C14H22ClNO2	small molecule	C07AA19	14556-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQIRNZOQPUAHHV-UHFFFAOYSA-N
26826	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Lenard NR (2003)	12606631	181811	7579	Bupranolol	Bupranol	-	DRUGBANK	DB08808	C14H22ClNO2	small molecule	C07AA19	14556-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQIRNZOQPUAHHV-UHFFFAOYSA-N
26827	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	antagonist	target	Matsushita M (2003)	14660028	181839	7579	Bupranolol	Bupranol	-	DRUGBANK	DB08808	C14H22ClNO2	small molecule	C07AA19	14556-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQIRNZOQPUAHHV-UHFFFAOYSA-N
26828	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Zelaszczyk D (2009)	19439807	182105	7579	Bupranolol	Bupranol	-	DRUGBANK	DB08808	C14H22ClNO2	small molecule	C07AA19	14556-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HQIRNZOQPUAHHV-UHFFFAOYSA-N
26829	111189	5163	-	PDK1	-	9606	Homo sapiens	inhibitor	target	Stacpoole PW (1989)	2554095	181656	7580	Dichloroacetic Acid	dichloracetic acid|dichloroacetate|DCA	bichloracetic acid 100%	DRUGBANK	DB08809	C2H2Cl2O2	small molecule	-	79-43-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXTHNDFMNIQAHM-UHFFFAOYSA-N
26830	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Alarcon-de-la-Lastra Romero C (1997)	9211565	181721	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26831	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Alarcon de la Lastra C (1998)	9562338	181726	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26832	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Alarcon-de-la-Lastra Romero C (1997)	9211565	181721	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26833	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Alarcon de la Lastra C (1998)	9562338	181726	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26834	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Alarcon-de-la-Lastra Romero C (1997)	9211565	181721	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26835	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Alarcon de la Lastra C (1998)	9562338	181726	7581	Cinitapride	Paxapride	-	DRUGBANK	DB08810	C21H30N4O4	small molecule	-	66564-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDLBNXXKDMLZMF-UHFFFAOYSA-N
26836	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	inhibitor	target	Rundfeldt C (2010)	20967473	182172	7582	Tofisopam	Tofizopam|Emandaxin	-	DRUGBANK	DB08811	C22H26N2O4	small molecule	N05BA23	22345-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUJBDQSFYCKFAA-UHFFFAOYSA-N
26837	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	inhibitor	target	Rundfeldt C (2010)	20967473	182172	7582	Tofisopam	Tofizopam|Emandaxin	-	DRUGBANK	DB08811	C22H26N2O4	small molecule	N05BA23	22345-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUJBDQSFYCKFAA-UHFFFAOYSA-N
26838	111165	5139	-	PDE3A	CGI-PDE|CGI-PDE A|CGI-PDE-A	9606	Homo sapiens	inhibitor	target	Rundfeldt C (2010)	20967473	182172	7582	Tofisopam	Tofizopam|Emandaxin	-	DRUGBANK	DB08811	C22H26N2O4	small molecule	N05BA23	22345-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUJBDQSFYCKFAA-UHFFFAOYSA-N
26839	111164	5138	-	PDE2A	CGS-PDE|PDE2A1|PED2A4|cGSPDE	9606	Homo sapiens	inhibitor	target	Rundfeldt C (2010)	20967473	182172	7582	Tofisopam	Tofizopam|Emandaxin	-	DRUGBANK	DB08811	C22H26N2O4	small molecule	N05BA23	22345-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUJBDQSFYCKFAA-UHFFFAOYSA-N
26840	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Ludwig RJ (2006)	16525583	181934	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26841	112303	6403	RP1-86F14.2	SELP	CD62|CD62P|GMP140|GRMP|LECAM3|PADGEM|PSEL	9606	Homo sapiens	inhibitor	target	Simonis D (2007)	17629851	180194	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26842	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Frydman A (1996)	8707165	181705	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26843	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	potentiator	target	Davis R (1997)	9108990	181715	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26844	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	inhibitor	target	Sustar V (2009)	19261492	182099	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26845	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	inhibitor	target	Nagy Z (2009)	19757196	182127	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26846	108636	2353	-	FOS	AP-1|C-FOS|p55	9606	Homo sapiens	inhibitor	target	Sustar V (2009)	19261492	182099	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26847	108636	2353	-	FOS	AP-1|C-FOS|p55	9606	Homo sapiens	inhibitor	target	Nagy Z (2009)	19757196	182127	7583	Nadroparin	-	fraxiparine forte|fraxiparine	DRUGBANK	DB08813	-	small molecule	B01AB06	9041-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26848	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	antagonist	target	Dominguez MJ (1985)	3838919	181670	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26849	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	antagonist	target	Anninos H (2009)	19465361	182109	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26850	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Anninos H (2009)	19465361	182109	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26851	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Zhang W (2005)	15678110	181880	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26852	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Gomez-Isla T (2008)	18317243	182067	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26853	110857	4790	-	NFKB1	EBP-1|KBF1|NF-kB1|NF-kappa-B|NF-kappaB|NFKB-p105|NFKB-p50|NFkappaB|p105|p50	9606	Homo sapiens	antagonist	target	Whitehead SN (2007)	17194886	181980	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26854	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	antagonist	target	McNeely W (1998)	9617597	181728	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26855	116057	10846	-	PDE10A	HSPDE10A	9606	Homo sapiens	antagonist	target	De Miguel LS (2000)	10998082	181761	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26856	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	agonist	target	Gonzalez-Correa JA (2006)	16939630	181963	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26857	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	agonist	target	De Miguel LS (2000)	10998082	181761	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26858	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	agonist	target	Sanchez de Miguel L (1998)	9551715	181725	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26859	110906	4843	-	NOS2	HEP-NOS|INOS|NOS|NOS2A	9606	Homo sapiens	agonist	target	Anninos H (2009)	19465361	182109	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26860	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26861	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26862	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26863	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26864	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26865	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	unknown	target	Tarazi FI (2012)	22849428	182208	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26866	107844	1462	-	VCAN	CSPG2|ERVR|GHAP|PG-M|WGN|WGN1	9606	Homo sapiens	binder	target	Bignami A (1989)	2469524	181652	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26867	107844	1462	-	VCAN	CSPG2|ERVR|GHAP|PG-M|WGN|WGN1	9606	Homo sapiens	binder	target	Perides G (1989)	2466833	181651	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26868	109404	3161	-	HMMR	CD168|IHABP|RHAMM	9606	Homo sapiens	unknown	target	Turley EA (1982)	6185115	181674	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26869	135639	404037	-	HAPLN4	BRAL2	9606	Homo sapiens	binder	target	Spicer AP (2003)	12663660	181813	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26870	107169	708	-	C1QBP	GC1QBP|HABP1|SF2p32|gC1Q-R|gC1qR|p32	9606	Homo sapiens	binder	target	Yadav G (2009)	19004836	182090	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26871	112984	7130	-	TNFAIP6	TSG-6|TSG6	9606	Homo sapiens	binder	target	Lee TH (1992)	1730767	181645	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26872	112984	7130	-	TNFAIP6	TSG-6|TSG6	9606	Homo sapiens	binder	target	Kohda D (1996)	8797823	181708	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26873	112984	7130	-	TNFAIP6	TSG-6|TSG6	9606	Homo sapiens	binder	target	Wisniewski HG (1994)	7516184	9390	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26874	107794	1404	-	HAPLN1	CRTL1	9606	Homo sapiens	binder	target	Arming S (1997)	9288901	181722	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26875	107794	1404	-	HAPLN1	CRTL1	9606	Homo sapiens	binder	target	Spicer AP (2003)	12663660	181813	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26876	120727	55576	-	STAB2	FEEL2|FELE-2|FELL2|FEX2|HARE	9606	Homo sapiens	binder	target	Harris EN (2008)	18434317	182073	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26877	120727	55576	-	STAB2	FEEL2|FELE-2|FELL2|FEX2|HARE	9606	Homo sapiens	binder	target	Politz O (2002)	11829752	181786	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26878	120727	55576	-	STAB2	FEEL2|FELE-2|FELL2|FEX2|HARE	9606	Homo sapiens	binder	target	Harris EN (2007)	17145755	181977	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26879	120727	55576	-	STAB2	FEEL2|FELE-2|FELL2|FEX2|HARE	9606	Homo sapiens	binder	target	Zhou B (2003)	12626425	181812	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26880	126950	145864	UNQ238/PRO271	HAPLN3	EXLD1|HsT19883	9606	Homo sapiens	binder	target	Spicer AP (2003)	12663660	181813	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26881	107845	1463	-	NCAN	CSPG3	9606	Homo sapiens	binder	target	Prange CK (1998)	9795216	181733	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26882	109276	3026	-	HABP2	FSAP|HABP|HGFAL|PHBP	9606	Homo sapiens	binder	target	Choi-Miura NH (1996)	8827452	181709	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26883	109276	3026	-	HABP2	FSAP|HABP|HGFAL|PHBP	9606	Homo sapiens	binder	target	Choi-Miura NH (2001)	11217080	181769	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26884	116587	22927	RP11-172F4.4	HABP4	IHABP-4|IHABP4|Ki-1/57|SERBP1L	9606	Homo sapiens	binder	target	Huang L (2000)	10887182	181756	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26885	119166	50939	-	IMPG2	IPM200|RP56|SPACRCAN	9606	Homo sapiens	binder	target	Acharya S (2000)	10702256	181746	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26886	126823	143903	UNQ208/PRO234	LAYN	-	9606	Homo sapiens	binder	target	Bono P (2001)	11294894	181771	7587	Hyaluronic acid	Hyaluronan|Hyaluronate	wellage family mask small|deep	DRUGBANK	DB08818	C28H44N2O23	small molecule	S01KA01|M09AX01|S01KA51|D03AX05|R01AX09	9004-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KIUKXJAPPMFGSW-MNSSHETKSA-N
26887	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Pantcheva MB (2011)	21858491	182193	7588	Tafluprost	AFP-168|Zioptan	saflutan|zioptan	DRUGBANK	DB08819	C25H34F2O5	small molecule	S01EE05	209860-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSNODXPBBALQOF-VEJSHDCNSA-N
26888	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	potentiator	target	Yu H (2012)	22293084	182198	7589	Ivacaftor	Ivacaftorum|Kalydeco	kalydeco|orkambi	DRUGBANK	DB08820	C24H28N2O3	small molecule	R07AX30|R07AX02	873054-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PURKAOJPTOLRMP-UHFFFAOYSA-N
26889	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	7590	Azilsartan medoxomil	Azilsartan medoxomilo|Azilsartan|Azilsartan kamedoxomil|Edarbi|Azilsartanum medoxomilum	edarbi|edarbyclor	DRUGBANK	DB08822	C30H24N4O8	small molecule	C09CA09|C09DA09	863031-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJFSABGVXDWMIW-UHFFFAOYSA-N
26890	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Miura S (2014)	23563275	182242	7590	Azilsartan medoxomil	Azilsartan medoxomilo|Azilsartan|Azilsartan kamedoxomil|Edarbi|Azilsartanum medoxomilum	edarbi|edarbyclor	DRUGBANK	DB08822	C30H24N4O8	small molecule	C09CA09|C09DA09	863031-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJFSABGVXDWMIW-UHFFFAOYSA-N
26891	112492	6608	-	SMO	FZD11|Gx|SMOH	9606	Homo sapiens	antagonist	target	Sandhiya S (2013)	23662017	182250	7595	Vismodegib	Hedgehog Antagonist GDC-0449|Erivedge|GDC-0449|Vismodegibum	erivedge	DRUGBANK	DB08828	C19H14Cl2N2O3S	small molecule	L01XX43	879085-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPQMGSKTAYIVFO-UHFFFAOYSA-N
26892	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Furuta S (1993)	8513851	181700	7600	Temocapril	Temocaprilum	-	DRUGBANK	DB08836	C23H28N2O5S2	small molecule	C09AA14	111902-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIQOFIRCTOWDOW-BJLQDIEVSA-N
26893	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	inhibitor	target	Akk G (2003)	12824448	181823	7601	Tetraethylammonium	TEA	-	DRUGBANK	DB08837	C8H20N	small molecule	-	66-40-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBXCPBUEXACCNR-UHFFFAOYSA-N
26894	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	agonist	target	Akk G (2003)	12824448	181823	7601	Tetraethylammonium	TEA	-	DRUGBANK	DB08837	C8H20N	small molecule	-	66-40-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBXCPBUEXACCNR-UHFFFAOYSA-N
26895	200913	16531	RP24-486D21.1	Kcnma1	5730414M22Rik|BKCa|MaxiK|Slo|Slo1|mSlo|mSlo1	10090	Mus musculus	inhibitor	target	Latorre R (1982)	6278496	181675	7601	Tetraethylammonium	TEA	-	DRUGBANK	DB08837	C8H20N	small molecule	-	66-40-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBXCPBUEXACCNR-UHFFFAOYSA-N
26896	200913	16531	RP24-486D21.1	Kcnma1	5730414M22Rik|BKCa|MaxiK|Slo|Slo1|mSlo|mSlo1	10090	Mus musculus	inhibitor	target	Lang DG (1990)	1698974	181643	7601	Tetraethylammonium	TEA	-	DRUGBANK	DB08837	C8H20N	small molecule	-	66-40-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CBXCPBUEXACCNR-UHFFFAOYSA-N
26897	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Yang XC (1999)	9918557	181735	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
26898	107228	774	-	CACNA1B	BIII|CACNL1A5|CACNN|Cav2.2	9606	Homo sapiens	antagonist	target	Weng XC (2003)	12904272	181828	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
26899	114723	9311	-	ASIC3	ACCN3|DRASIC|SLNAC1|TNaC1	9606	Homo sapiens	agonist	target	Li WG (2010)	21143836	182181	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
26900	107556	1134	-	CHRNA1	ACHRA|ACHRD|CHRNA|CMS2A|FCCMS|SCCMS	9606	Homo sapiens	antagonist	target	Loring RH (1990)	2331571	181650	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
26901	109960	3758	-	KCNJ1	KIR1.1|ROMK|ROMK1	9606	Homo sapiens	antagonist	target	Shepherd RM (1996)	8922740	181712	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
26902	116358	11188	-	NISCH	I-1|IR1|IRAS|hIRAS	9606	Homo sapiens	agonist	target	Li G (1994)	7906055	181690	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
26903	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	7604	Uric Acid	2,6,8-Trihydroxypurine|Urate|7,9-dihydro-1H-purine-2,6,8(3H)-trione	-	DRUGBANK	DB08844	C5H4N4O3	small molecule	-	69-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEHOTFFKMJEONL-UHFFFAOYSA-N
26904	111794	5836	-	PYGL	GSD6	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	7604	Uric Acid	2,6,8-Trihydroxypurine|Urate|7,9-dihydro-1H-purine-2,6,8(3H)-trione	-	DRUGBANK	DB08844	C5H4N4O3	small molecule	-	69-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEHOTFFKMJEONL-UHFFFAOYSA-N
26905	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Cozza G (2006)	16610779	181936	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26906	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Sekiguchi Y (2009)	19414254	182103	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26907	107225	771	-	CA12	CAXII|HsT18816	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26908	111553	5566	-	PRKACA	PKACA	9606	Homo sapiens	inhibitor, competitive	target	Wang BH (1998)	9581512	181727	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26909	112591	6713	-	SQLE	-	9606	Homo sapiens	inhibitor	target	Abe I (2001)	11520216	181775	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26910	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	inhibitor, competitive	target	Wang BH (1998)	9581512	181727	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26911	111565	5579	-	PRKCB	PKC-beta|PKCB|PRKCB1|PRKCB2	9606	Homo sapiens	inhibitor, competitive	target	Wang BH (1998)	9581512	181727	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26912	107223	768	-	CA9	CAIX|MN	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26913	107221	766	-	CA7	CAVII	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26914	107220	765	RP3-477M7.7	CA6	CA-VI|GUSTIN	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26915	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26916	117162	23632	UNQ690/PRO1335	CA14	CAXiV	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26917	107217	762	-	CA4	CAIV|Car4|RP17	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26918	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	inhibitor	target	Cozza G (2006)	16610779	181936	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26919	107214	759	-	CA1	CA-I|CAB|Car1|HEL-S-11	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26920	107216	761	-	CA3	CAIII|Car3	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26921	116403	11238	-	CA5B	CA-VB	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26922	107218	763	-	CA5A	CA5|CA5AD|CAV|CAVA	9606	Homo sapiens	inhibitor	target	Innocenti A (2010)	20185318	182147	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26923	112430	6539	-	SLC6A12	BGT-1|BGT1|GAT2	9606	Homo sapiens	inhibitor	target	Ruiz-Tachiquin ME (2002)	12111824	181797	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26924	112431	6540	-	SLC6A13	GAT-2|GAT2|GAT3	9606	Homo sapiens	inhibitor	target	Sunol C (2010)	20512624	178994	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26925	112431	6540	-	SLC6A13	GAT-2|GAT2|GAT3	9606	Homo sapiens	inhibitor	target	Krogsgaard-Larsen P (2000)	10903390	181757	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26926	112431	6540	-	SLC6A13	GAT-2|GAT2|GAT3	9606	Homo sapiens	inhibitor	target	Schousboe A (1979)	458448	181635	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26927	112429	6538	-	SLC6A11	GAT-3|GAT3|GAT4	9606	Homo sapiens	inhibitor	target	Sunol C (2010)	20512624	178994	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26928	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Sunol C (2010)	20512624	178994	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26929	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	inhibitor	target	Morgan RE (2012)	22472908	182201	7608	Pitavastatin	Pitavastatinum|Pitavastatine|Pitavastatia	livalo	DRUGBANK	DB08860	C25H24FNO4	small molecule	C10AA08	147511-69-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGYFMXBACGZSIL-MCBHFWOFSA-N
26930	114380	8856	-	NR1I2	BXR|ONR1|PAR|PAR1|PAR2|PARq|PRR|PXR|SAR|SXR	9606	Homo sapiens	agonist	target	Sharma D (2013)	23583259	182246	7609	Rilpivirine	4-{[4-({4-[(E)-2-cyanovinyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile	complera|odefsey|edurant	DRUGBANK	DB08864	C22H18N6	small molecule	-	500287-72-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YIBOMRUWOWDFLG-ONEGZZNKSA-N
26931	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	inhibitor	target	Forde PM (2012)	22594847	182202	7610	Crizotinib	MET Tyrosine Kinase Inhibitor PF-02341066|(R)-Crizotinib|PF-2341066|C-Met/Hepatocyte Growth Factor Receptor Tyrosine Kinase Inhibitor PF-02341066|C-Met/HGFR Tyrosine Kinase Inhibitor PF-02341066|PF 2341066|Crizotinibum	xalkori	DRUGBANK	DB08865	C21H22Cl2FN5O	small molecule	L01XE16	877399-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTEIFNKAUNYNJU-GFCCVEGCSA-N
26932	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	inhibitor	target	Forde PM (2012)	22594847	182202	7610	Crizotinib	MET Tyrosine Kinase Inhibitor PF-02341066|(R)-Crizotinib|PF-2341066|C-Met/Hepatocyte Growth Factor Receptor Tyrosine Kinase Inhibitor PF-02341066|C-Met/HGFR Tyrosine Kinase Inhibitor PF-02341066|PF 2341066|Crizotinibum	xalkori	DRUGBANK	DB08865	C21H22Cl2FN5O	small molecule	L01XE16	877399-52-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTEIFNKAUNYNJU-GFCCVEGCSA-N
26933	119793	53637	-	S1PR5	EDG8|Edg-8|S1P5|SPPR-1|SPPR-2	9606	Homo sapiens	modulator	target	Zu Heringdorf DM (2013)	23579459	182245	7612	Fingolimod	Fingolimodum	gilenya	DRUGBANK	DB08868	C19H33NO2	small molecule	L04AA27	162359-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKGQTZUTZRNORY-UHFFFAOYSA-N
26934	119793	53637	-	S1PR5	EDG8|Edg-8|S1P5|SPPR-1|SPPR-2	9606	Homo sapiens	modulator	target	Bhabak KP (2013)	23579456	182244	7612	Fingolimod	Fingolimodum	gilenya	DRUGBANK	DB08868	C19H33NO2	small molecule	L04AA27	162359-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKGQTZUTZRNORY-UHFFFAOYSA-N
26935	108959	2692	-	GHRHR	GHRFR|GRFR|IGHD1B	9606	Homo sapiens	binder	target	Spooner LM (2012)	22298602	182199	7613	Tesamorelin	N-[(3E)-1-oxo-3-hexenyl]Somatoliberin (human pancreatic islet)|GHRH(1-44)	egrifta	DRUGBANK	DB08869	C216H360N72O63S	small molecule	H01AC06	218949-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAJJBLZKAIOLRM-YHAVXTEWSA-N
26936	107381	943	-	TNFRSF8	CD30|D1S166E|Ki-1	9606	Homo sapiens	binder	target	Francisco JA (2003)	12714494	181815	7614	Brentuximab vedotin	cAC10-vcMMAE	adcetris	DRUGBANK	DB08870	C6476H9930N1690O2030S40	biologic	L01XC12	914088-09-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26937	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Yakes FM (2011)	21926191	182194	7619	Cabozantinib	-	cometriq|cabometyx	DRUGBANK	DB08875	C28H24FN3O5	small molecule	L01XE26	849217-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIQOQHATWINJY-UHFFFAOYSA-N
26938	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Kurzrock R (2011)	21606412	182188	7619	Cabozantinib	-	cometriq|cabometyx	DRUGBANK	DB08875	C28H24FN3O5	small molecule	L01XE26	849217-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIQOQHATWINJY-UHFFFAOYSA-N
26939	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	antagonist	target	Kurzrock R (2011)	21606412	182188	7619	Cabozantinib	-	cometriq|cabometyx	DRUGBANK	DB08875	C28H24FN3O5	small molecule	L01XE26	849217-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIQOQHATWINJY-UHFFFAOYSA-N
26940	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	antagonist	target	Yakes FM (2011)	21926191	182194	7619	Cabozantinib	-	cometriq|cabometyx	DRUGBANK	DB08875	C28H24FN3O5	small molecule	L01XE26	849217-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIQOQHATWINJY-UHFFFAOYSA-N
26941	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	antagonist	target	Kurzrock R (2011)	21606412	182188	7619	Cabozantinib	-	cometriq|cabometyx	DRUGBANK	DB08875	C28H24FN3O5	small molecule	L01XE26	849217-68-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONIQOQHATWINJY-UHFFFAOYSA-N
26942	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	inhibitor	target	Yang LP (2012)	23061804	182213	7621	Ruxolitinib	INCB424|INCB018424	jakafi|jakavi	DRUGBANK	DB08877	C17H18N6	small molecule	L01XE18	941678-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFNKQEVNSGCOJV-OAHLLOKOSA-N
26943	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	inhibitor	target	Cervantes F (2013)	23514013	182236	7621	Ruxolitinib	INCB424|INCB018424	jakafi|jakavi	DRUGBANK	DB08877	C17H18N6	small molecule	L01XE18	941678-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFNKQEVNSGCOJV-OAHLLOKOSA-N
26944	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	inhibitor	target	Yang LP (2012)	23061804	182213	7621	Ruxolitinib	INCB424|INCB018424	jakafi|jakavi	DRUGBANK	DB08877	C17H18N6	small molecule	L01XE18	941678-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFNKQEVNSGCOJV-OAHLLOKOSA-N
26945	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	inhibitor	target	Cervantes F (2013)	23514013	182236	7621	Ruxolitinib	INCB424|INCB018424	jakafi|jakavi	DRUGBANK	DB08877	C17H18N6	small molecule	L01XE18	941678-49-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFNKQEVNSGCOJV-OAHLLOKOSA-N
26946	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Davis JP (1996)	8573583	181702	7624	Teriflunomide	(Z)-2-Cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-P-crotonotoluidide|Teriflunomidum|Aubagio|a 77-1726|Teriflunomida|HMR1726|HMR 1726|a 771726	aubagio	DRUGBANK	DB08880	-	small molecule	L04AA31	163451-81-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26947	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor	target	Palmer AM (2010)	21157651	182182	7624	Teriflunomide	(Z)-2-Cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-P-crotonotoluidide|Teriflunomidum|Aubagio|a 77-1726|Teriflunomida|HMR1726|HMR 1726|a 771726	aubagio	DRUGBANK	DB08880	-	small molecule	L04AA31	163451-81-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26948	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Jordan EJ (2012)	23094782	182216	7625	Vemurafenib	Zelboraf|PLX4032|BRAF(V600E) Kinase Inhibitor RO5185426	zelboraf	DRUGBANK	DB08881	C23H18ClF2N3O3S	small molecule	L01XE15	918504-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPXBXXGIAQBQNI-UHFFFAOYSA-N
26949	108137	1803	-	DPP4	ADABP|ADCP2|CD26|DPPIV|TP103	9606	Homo sapiens	inhibitor	target	Forst T (2012)	22149370	182197	7626	Linagliptin	(R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|BI 1356|Tradjenta|BI-1356|Trajenta	jentadueto xr|glyxambi|tradjen	DRUGBANK	DB08882	C25H28N8O2	small molecule	A10BD19|A10BH05|A10BD11	668270-12-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LTXREWYXXSTFRX-QGZVFWFLSA-N
26950	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	antagonist	target	Hanada T (2011)	21635236	182189	7627	Perampanel	prampanel|Perampanelum|3-(2-Cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one|perampanel	fycompa	DRUGBANK	DB08883	C23H15N3O	small molecule	N03AX22	380917-97-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PRMWGUBFXWROHD-UHFFFAOYSA-N
26951	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	binder	target	Browning DJ (2012)	22813448	182207	7629	Aflibercept	VEGF Trap|Ziv-Aflibercept|VEGF Trap-Eye	eylea|zaltrap	DRUGBANK	DB08885	C4318H6788N1164O1304S32	biologic	L01XX44|S01LA05	862111-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26952	113266	7423	-	VEGFB	VEGFL|VRF	9606	Homo sapiens	binder	target	Browning DJ (2012)	22813448	182207	7629	Aflibercept	VEGF Trap|Ziv-Aflibercept|VEGF Trap-Eye	eylea|zaltrap	DRUGBANK	DB08885	C4318H6788N1164O1304S32	biologic	L01XX44|S01LA05	862111-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26953	111249	5228	-	PGF	D12S1900|PGFL|PLGF|PlGF-2|SHGC-10760	9606	Homo sapiens	binder	target	Browning DJ (2012)	22813448	182207	7629	Aflibercept	VEGF Trap|Ziv-Aflibercept|VEGF Trap-Eye	eylea|zaltrap	DRUGBANK	DB08885	C4318H6788N1164O1304S32	biologic	L01XX44|S01LA05	862111-32-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26954	108621	2335	-	FN1	CIG|ED-B|FINC|FN|FNZ|GFND|GFND2|LETS|MSF	9606	Homo sapiens	cleavage	target	Tsui I (2012)	23193358	182220	7632	Ocriplasmin	-	jetrea	DRUGBANK	DB08888	C1214H1890N338O348S14	biologic	S01XA22	1048016-09-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26955	111662	5689	-	PSMB1	HC5|PMSB1|PSC5	9606	Homo sapiens	inhibitor	target	Kuhn DJ (2007)	17591945	182023	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
26956	111663	5690	RP5-983H21.1	PSMB2	HC7-I	9606	Homo sapiens	inhibitor	target	Kuhn DJ (2007)	17591945	182023	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
26957	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kortuem KM (2013)	23393020	182229	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
26958	111671	5698	DADB-223G19.3	PSMB9	LMP2|PSMB6i|RING12|beta1i	9606	Homo sapiens	inhibitor	target	Kuhn DJ (2007)	17591945	182023	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
26959	111672	5699	-	PSMB10	LMP10|MECL1|beta2i	9606	Homo sapiens	inhibitor	target	Kuhn DJ (2007)	17591945	182023	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
26960	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Kuhn DJ (2007)	17591945	182023	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
26961	109239	2984	-	GUCY2C	DIAR6|GUC2C|MECIL|MUCIL|STAR	9606	Homo sapiens	agonist	target	Busby RW (2013)	23090647	182215	7634	Linaclotide	L-Cysteinyl-L-cysteinyl-L-alpha-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-L-tyrosine cyclic (1->6),(2->10),(5->13)-tris(disulfide)|Linzess|Cys cys glu tyr cys cys asn pro ala cys thr gly cys tyr (disulfide bridge: 1-6; 2-10; 5-13)	constella|linzess	DRUGBANK	DB08890	C59H79N15O21S6	small molecule	A06AX04	851199-59-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXGCNMMJRFDFNR-WDRJZQOASA-N
26962	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Kashyap M (2013)	23550899	182240	7637	Mirabegron	Myrbetriq	myrbetriq	DRUGBANK	DB08893	C21H24N4O2S	small molecule	G04BD12	223673-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBAPPPCECJKMCM-IBGZPJMESA-N
26963	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	stimulator	target	Woodburn KW (2013)	23318685	182225	7638	Peginesatide	Erythropoiesis-Stimulating Agent (ESA)|Hematide	-	DRUGBANK	DB08894	(C2H4O)n(C2H4O)nC229H344N62O58S6	small molecule	B03XA04	913976-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26964	114746	9340	-	GLP2R	-	9606	Homo sapiens	agonist	target	Burness CB (2013)	23729002	182251	7644	Teduglutide	Teduglutide Recombinant|Glucagon-like peptide ii (2-glycine) (human)|(Gly2)glp-2|ALX-0600|HGDGSFSDEMNTILDNLAARDFINWLIQTKITD|ALX 0600|Gly(2)-glp-2|Teduglutide [rDNA origin]|His-gly-asp-gly-ser-phe-ser-asp-glu-met-asn-thr-ile-leu-asp-asn-leu-ala-ala-arg-asp-phe-ile-asn-trp-leu-ile-gln-thr-lys-ile-thr-asp|Gattex	revestive|gattex	DRUGBANK	DB08900	C164H252N44O55S	biologic	A16AX08	197922-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26965	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	inhibitor	target	O'Hare T (2009)	19878872	182132	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26966	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	inhibitor	target	Iqbal Z (2013)	23409026	182230	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26967	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	inhibitor	target	Gozgit JM (2013)	23468082	182234	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26968	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Ren M (2013)	23563700	182243	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26969	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Gozgit JM (2013)	23468082	182234	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26970	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	O'Hare T (2009)	19878872	182132	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26971	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	inhibitor	target	Gozgit JM (2013)	23468082	182234	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26972	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Gleixner KV (2013)	23539538	182238	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26973	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	inhibitor	target	Gozgit JM (2013)	23468082	182234	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26974	111911	5979	-	RET	CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1|RET51	9606	Homo sapiens	inhibitor	target	De Falco V (2013)	23526464	182237	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26975	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	inhibitor	target	O'Hare T (2009)	19878872	182132	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26976	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	Smith CC (2013)	23430109	182232	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26977	107083	613	-	BCR	ALL|BCR1|CML|D22S11|D22S662|PHL	9606	Homo sapiens	inhibitor	target	Iqbal Z (2013)	23409026	182230	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26978	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	inhibitor	target	Gushwa NN (2012)	23190395	182219	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26979	110245	4067	-	LYN	JTK8|p53Lyn|p56Lyn	9606	Homo sapiens	inhibitor	target	O'Hare T (2009)	19878872	182132	7645	Ponatinib	AP24534|AP 24534|Ponatinibum	iclusig	DRUGBANK	DB08901	C29H27F3N6O	small molecule	L01XE24	943319-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHXJVRSECIGDHY-UHFFFAOYSA-N
26980	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	neutralizer	target	Chimenti MS (2013)	23620660	182248	7648	Certolizumab pegol	CDP870	cimzia	DRUGBANK	DB08904	C2115H3252N556O673S16	biologic	L04AB05	428863-50-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26981	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	inhibitor	target	Lamos EM (2013)	23590413	182247	7651	Canagliflozin	Canagliflozin anhydrous	invokana|invokamet xr|invokame	DRUGBANK	DB08907	C24H25FO5S	small molecule	A10BX11|A10BD16	842133-18-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
26982	112414	6523	RP1-127L4.1	SLC5A1	D22S675|NAGT|SGLT1	9606	Homo sapiens	inhibitor	target	Lamos EM (2013)	23590413	182247	7651	Canagliflozin	Canagliflozin anhydrous	invokana|invokamet xr|invokame	DRUGBANK	DB08907	C24H25FO5S	small molecule	A10BX11|A10BD16	842133-18-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
26983	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	binder	target	Oh CJ (2012)	23056222	182212	7652	Dimethyl fumarate	trans-1,2-Ethylenedicarboxylic acid dimethyl ester|trans-Butenedioic acid dimethyl ester|Tecfidera|(e)-But-2-enedioic acid dimethyl ester|BG-12|1,2-Bis(methoxycarbonyl)-trans-ethylene|Fumaric acid, dimethyl ester|dimethyl (E) butenedioate|Dimethyl trans-ethylenedicarboxylate	tecfidera	DRUGBANK	DB08908	-	small molecule	N07XX09	624-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26984	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	inhibitor	target	Gertz MA (2013)	22917017	182210	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26985	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	McCurdy AR (2013)	23730498	182252	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26986	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Lopez-Girona A (2012)	22552008	150660	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26987	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Ito T (2010)	20223979	126437	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26988	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ferguson GD (2007)	17308870	159982	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26989	111591	5605	-	MAP2K2	CFC4|MAPKK2|MEK2|MKK2|PRKMK2	9606	Homo sapiens	inhibitor	target	Salama AK (2013)	23432625	182233	7655	Trametinib	JTP 74057|GSK 1120212|Trametinib Dimethyl Sulfoxide|Trametinibum	mekinist	DRUGBANK	DB08911	C26H23FIN5O4	small molecule	L01XE25	871700-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIRYPHYGHXZJBZ-UHFFFAOYSA-N
26990	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	inhibitor	target	Salama AK (2013)	23432625	182233	7655	Trametinib	JTP 74057|GSK 1120212|Trametinib Dimethyl Sulfoxide|Trametinibum	mekinist	DRUGBANK	DB08911	C26H23FIN5O4	small molecule	L01XE25	871700-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LIRYPHYGHXZJBZ-UHFFFAOYSA-N
26991	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	inhibitor	target	Gibney GT (2013)	23621583	182249	7656	Dabrafenib	Dabrafenib|GSK2118436a	tafinlar	DRUGBANK	DB08912	C23H20F3N5O2S2	small molecule	L01XE23	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BFSMGDJOXZAERB-UHFFFAOYSA-N
26994	114200	8648	-	NCOA1	F-SRC-1|KAT13A|RIP160|SRC1|bHLHe42|bHLHe74	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26995	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26996	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Cavender MA (2010)	20653327	182161	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26997	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26998	111461	5465	SC22CB-5E3.5	PPARA	NR1C1|PPAR|PPARalpha|hPPAR	9606	Homo sapiens	agonist	target	Cavender MA (2010)	20653327	182161	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26999	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Wizemann V (2008)	18208642	182063	7663	Epoetin Zeta	1-165-Erythropoietin (human clone B03XA01) glycoform zeta|Epoetinum zeta|Epoetina dseta|Epoetin zeta|Epotine zta	-	DRUGBANK	DB08923	C809H1301N229O240S5	biologic	-	604802-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27000	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Barosi G (2011)	21719882	182192	7663	Epoetin Zeta	1-165-Erythropoietin (human clone B03XA01) glycoform zeta|Epoetinum zeta|Epoetina dseta|Epoetin zeta|Epotine zta	-	DRUGBANK	DB08923	C809H1301N229O240S5	biologic	-	604802-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27001	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Svartengren J (1990)	2154737	181647	7667	Amperozide	-	-	DRUGBANK	DB08927	C23H29F2N3O	small molecule	-	75558-90-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNAIYOXJNVGUOM-UHFFFAOYSA-N
27002	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Bolli MH (2012)	22862294	182209	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27003	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Bruderer S (2012)	22458347	182200	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27004	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Dingemanse J (2014)	24261583	182254	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27005	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Bolli MH (2012)	22862294	182209	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27006	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Bruderer S (2012)	22458347	182200	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27007	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Dingemanse J (2014)	24261583	182254	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27008	1224602	3641571	C5_00660C_A	ERG11	orf6.2866|CYP51|C5_00660C_B|CaO19.8538|CaO6.1245|orf6.98|CaO19.922|orf19.922|P45014DM|L1A1|ERG16|CA1387|CaO6.98|Contig4-2692_0009|CAWG_04460|IPF19860.2|C5_00660C|orf6.1245|orf19.8538|CaO6.2866|IPF8427.2	237561	Candida albicans	inhibitor	target	Niwano Y (1999)	10520160	181742	7672	Luliconazole	-	luzu	DRUGBANK	DB08933	C14H9Cl2N3S2	small molecule	D01AC18	187164-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTAOBBFIOAEMLL-REQDGWNSSA-N
27009	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	antibody	target	Robak T (2009)	19513948	182112	7674	Obinutuzumab	Afutuzumab	gazyva	DRUGBANK	DB08935	C6512H10060N1712O2020S44	biologic	L01XC15	949142-50-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27010	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Enright BP (2010)	21058326	182175	7675	Chlorcyclizine	Chlorcyclizine|Chlorcyclizinum|Chlorcyclizin|Clorciclizina	dallergy|notuss-nx|bonine kids	DRUGBANK	DB08936	C18H21ClN2	small molecule	R06AE04	82-93-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFNAKBGANONZEQ-UHFFFAOYNA-N
27011	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Seppaelae T (1988)	3365283	181667	7690	Ifenprodil	-	-	DRUGBANK	DB08954	C21H27NO2	small molecule	C04AX28	23210-56-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYNVMODNBIQBMV-UHFFFAOYNA-N
27012	109159	2902	RP11-350O14.1	GRIN1	GluN1|MRD8|NMD-R1|NMDA1|NMDAR1|NR1	9606	Homo sapiens	antagonist	target	Seppaelae T (1988)	3365283	181667	7690	Ifenprodil	-	-	DRUGBANK	DB08954	C21H27NO2	small molecule	C04AX28	23210-56-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYNVMODNBIQBMV-UHFFFAOYNA-N
27013	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	antagonist	target	Ishitani R (1972)	4539395	181672	7731	Dimetacrine	Miroistonil|Istonil|3-(9,9-dimethylacridin-10-yl)-N,N-dimethyl-propan-1-amine|Linostil|Dimetacrine|Istonyl	-	DRUGBANK	DB08996	C20H26N2	small molecule	N06AA18	4757-55-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYQOGSFEJBUZBX-UHFFFAOYSA-N
27014	115569	10280	RP11-443P11.3	SIGMAR1	ALS16|OPRS1|SIG-1R|SR-BP|SR-BP1|SRBP|hSigmaR1|sigma1R	9606	Homo sapiens	agonist	target	Ring RM (2013)	23863923	182253	7747	Captodiame	Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine	-	DRUGBANK	DB09014	C21H29NS2	small molecule	N05BB02	486-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLPZXSZLLELBJ-UHFFFAOYNA-N
27015	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Ring RM (2013)	23863923	182253	7747	Captodiame	Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine	-	DRUGBANK	DB09014	C21H29NS2	small molecule	N05BB02	486-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLPZXSZLLELBJ-UHFFFAOYNA-N
27016	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Ring RM (2013)	23863923	182253	7747	Captodiame	Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine	-	DRUGBANK	DB09014	C21H29NS2	small molecule	N05BB02	486-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLPZXSZLLELBJ-UHFFFAOYNA-N
27017	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Wander TJ (1986)	3816971	181668	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27018	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Tatsumi M (1997)	9537821	174430	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27019	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Richelson E (1984)	6086881	176781	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27020	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	antagonist	target	Wander TJ (1986)	3816971	181668	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27021	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	antagonist	target	Tatsumi M (1997)	9537821	174430	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27022	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27023	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wander TJ (1986)	3816971	181668	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27024	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Tatsumi M (1997)	9537821	174430	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27025	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27026	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Wander TJ (1986)	3816971	181668	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27027	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Tatsumi M (1997)	9537821	174430	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27028	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	7749	Butriptyline	()-3-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-yl)-N,N,2-trimethylpropan-1-amine	-	DRUGBANK	DB09016	-	small molecule	N06AA15	35941-65-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27029	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Tonini M (2004)	14871277	181842	7751	Bromopride	Bromopridum|4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide|Bromoprid|Bromoprida|Bromopride	-	DRUGBANK	DB09018	C14H22BrN3O2	small molecule	A03FA04	4093-35-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIYAQDDTCWHPPL-UHFFFAOYSA-N
27030	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Walker N (2014)	25517706	182256	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27031	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	agonist	target	Houlihan LM (2001)	11553677	181776	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27032	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	agonist	target	Walker N (2014)	25517706	182256	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27033	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	agonist	target	Houlihan LM (2001)	11553677	181776	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27034	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Walker N (2014)	25517706	182256	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27035	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Houlihan LM (2001)	11553677	181776	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27036	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Walker N (2014)	25517706	182256	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27037	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	agonist	target	Houlihan LM (2001)	11553677	181776	7759	Cytisine	Sophorine|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|Baptitoxine|Ulexin	-	DRUGBANK	DB09028	C11H14N2O	small molecule	-	485-35-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANJTVLIZGCUXLD-DTWKUNHWSA-N
27038	109818	3605	-	IL17A	CTLA8|IL-17|IL-17A|IL17	9606	Homo sapiens	antagonist	target	Ohtsuki M (2014)	25354738	182255	7760	Secukinumab	-	cosentyx	DRUGBANK	DB09029	C6584H10134N1754O2042S44	biologic	L04AC10	1229022-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27039	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27040	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	61	Human Serum Albumin	Human albumin|Albumin human|Albumin microspheres, human|Albumin (human)|Albumin, human|Albumin, blood|Serum albumin	sterile diluent for allergenic	DRUGBANK	DB00062	C2936H4624N786O889S41	biologic	-	9048-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27041	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Danesh J (1999)	10361047	172127	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27042	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27043	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27044	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Grehan S (1997)	9200475	172129	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27045	112196	6288	-	SAA1	PIG4|SAA|SAA2|TP53I4	9606	Homo sapiens	unknown	target	Danesh J (2000)	10903648	172128	63	Serum albumin iodonated	Serum albumin precursor	-	DRUGBANK	DB00064	C2936H4624N786O889S41	biologic	-	9048-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27046	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
27047	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Botzki A (2004)	15322107	172874	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
27048	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
27049	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Li S (2001)	11278838	172873	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
27050	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Okorukwu ON (2003)	14567553	172872	120	Vitamin C	Ascorbic Acid|Ascorbinsure|acidum ascorbicum|L-Ascorbic Acid|L-Ascorbate|Ascorbicap|acide ascorbique|cido ascrbico|L-(+)-ascorbic acid|acidum ascorbinicum|Ascorbate	zinc plus lozenges|vitamin c 1	DRUGBANK	DB00126	C6H8O6	small molecule	-	50-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CIWBSHSKHKDKBQ-JLAZNSOCSA-N
27065	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	unknown	target	Ekins S (2007)	17194716	188471	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27066	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Schwab D (2003)	12699389	137014	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27067	120535	55244	-	SLC47A1	MATE1	9606	Homo sapiens	unknown	target	Wittwer MB (2013)	23241029	188472	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27068	109120	2862	-	MLNR	GPR38|MTLR1	9606	Homo sapiens	unknown	target	Li JJ (2004)	15027861	188473	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27069	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Ekins S (2002)	11961113	172332	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27070	106715	213	GIG20	ALB	ANALBA|FDAH|PRO0883|PRO0903|PRO1341	9606	Homo sapiens	unknown	target	Baneres-Roquet F (2009)	19164148	188474	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27071	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Du LP (2004)	15324906	188475	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27072	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Knuckley B (2008)	17964793	188476	200	Azithromycin	Azithromycinum|Azitromicina|Azithromycine	azithromycin for injection|riv	DRUGBANK	DB00207	C38H72N2O12	small molecule	J01FA10|J01RA07|S01AA26	83905-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQTOSJVFKKJCRP-BICOPXKESA-N
27073	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Bosnar M (2012)	22697905	188477	200	Azithromycin	Azithromycinum|Azitromicina|Azithromycine	azithromycin for injection|riv	DRUGBANK	DB00207	C38H72N2O12	small molecule	J01FA10|J01RA07|S01AA26	83905-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQTOSJVFKKJCRP-BICOPXKESA-N
27074	107044	567	CDABP0092	B2M	-	9606	Homo sapiens	unknown	target	Giorgetti S (2011)	21068391	188478	247	Doxycycline	Doxycyclin|6-deoxy-5-oxytetracycline|Doxycycline (anhydrous)|5-hydroxy--6-deoxytetracycline|Doxiciclina|Doxycyclinum|Anhydrous doxycycline|6alpha-deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline	acticlate|doxycycline tablets|	DRUGBANK	DB00254	C22H24N2O8	small molecule	J01AA02|A01AB22	564-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIWCJUYHHGXTC-AKNGSSGZSA-N
27075	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Knuckley B (2008)	17964793	188476	247	Doxycycline	Doxycyclin|6-deoxy-5-oxytetracycline|Doxycycline (anhydrous)|5-hydroxy--6-deoxytetracycline|Doxiciclina|Doxycyclinum|Anhydrous doxycycline|6alpha-deoxy-5-oxytetracycline|6-alpha-deoxy-5-oxytetracycline	acticlate|doxycycline tablets|	DRUGBANK	DB00254	C22H24N2O8	small molecule	J01AA02|A01AB22	564-25-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JBIWCJUYHHGXTC-AKNGSSGZSA-N
27076	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	312	Piperacillin	Pipracilline|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Piperacillina|Piperacillin|Piperacillin Anhydrous|Piperacillinum|Piperacilina	jamp-pip/taz|pipracil pharmacy	DRUGBANK	DB00319	C23H27N5O7S	small molecule	J01CA12|J01CR05	66258-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVBHGBMCVLDMKU-GXNBUGAJSA-N
27077	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	312	Piperacillin	Pipracilline|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Piperacillina|Piperacillin|Piperacillin Anhydrous|Piperacillinum|Piperacilina	jamp-pip/taz|pipracil pharmacy	DRUGBANK	DB00319	C23H27N5O7S	small molecule	J01CA12|J01CR05	66258-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVBHGBMCVLDMKU-GXNBUGAJSA-N
27078	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	312	Piperacillin	Pipracilline|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Piperacillina|Piperacillin|Piperacillin Anhydrous|Piperacillinum|Piperacilina	jamp-pip/taz|pipracil pharmacy	DRUGBANK	DB00319	C23H27N5O7S	small molecule	J01CA12|J01CR05	66258-76-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVBHGBMCVLDMKU-GXNBUGAJSA-N
27079	112453	6565	-	SLC15A2	PEPT2	9606	Homo sapiens	unknown	target	Pedretti A (2011)	21741846	188479	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27080	112869	7010	-	TEK	CD202B|TIE-2|TIE2|VMCM|VMCM1	9606	Homo sapiens	unknown	target	Gong XW (2012)	22406116	188480	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27081	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27082	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27083	112452	6564	RP11-130L10.1	SLC15A1	HPECT1|HPEPT1|PEPT1	9606	Homo sapiens	unknown	target	Luckner P (2005)	15567297	174805	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27084	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27085	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Sala-Rabanal M (2006)	16627568	175919	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27086	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	407	Ampicillin	D-(-)-Ampicillin|D-()-6-(-aminophenylacetamido)penicillanic acid|D-()-ampicillin|Aminobenzylpenicillin|Ampicilina|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Ampicillin Acid|D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid|Ampicilline|Ampicillinum|(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Anhydrous ampicillin|AP|Ampicillin Anhydrous|AMP|Ampicillin|6-(D-(2-amino-2-Phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|ABPC	penbritin pws 250mg/5ml|ampici	DRUGBANK	DB00415	C16H19N3O4S	small molecule	S01AA19|J01CR01|J01CA51|J01CA01	69-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVKUERGKIZMTKX-NJBDSQKTSA-N
27087	112452	6564	RP11-130L10.1	SLC15A1	HPECT1|HPEPT1|PEPT1	9606	Homo sapiens	unknown	target	Biegel A (2005)	15974593	188481	409	Phenoxymethylpenicillin	(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYACETAMIDO)-4-THIA-1- AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID|Phnoxymthylpnicilline|Fenoximetilpenicilina|Phenoxymethylenepenicillinic acid|(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|6-phenoxyacetamidopenicillanic acid|Penicillin Phenoxymethyl|Phenoxymethylpenicillinum|Penicillin V|Oracillin|PV|Phenoxomethylpenicillin|Phenoxymethyl Penicillin	nadopen v tab 500000iu|pen-vee	DRUGBANK	DB00417	C16H18N2O5S	small molecule	J01CE02|J01CE10	87-08-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BPLBGHOLXOTWMN-MBNYWOFBSA-N
27088	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Hayes MV (1983)	6413485	176060	430	Ceftazidime	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CAZ|Ceftazidim|Ceftazidima|Ceftazidime anhydrous|Ceftazidime|Ceftazidimum	ceptaz injection -  pws iv  2g	DRUGBANK	DB00438	C22H22N6O7S2	small molecule	J01DD52|J01DD02	78439-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ORFOPKXBNMVMKC-DWVKKRMSSA-N
27089	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
27090	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
27091	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
27092	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	448	Cefalotin	7-(2'-Thienylacetamido)cephalosporanic acid|Cefalotin|3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid|Cefalotine|Cefalotina|Cephalotin|Cefalotinum|7-(Thiophene-2-acetamido)cephalosporin|CET|7-(2-Thienylacetamido)cephalosporanic acid|Cephalothin|Cefalothin	keflin neutral inj 1gm|keflin 	DRUGBANK	DB00456	C16H16N2O6S2	small molecule	J01DB03	153-61-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XIURVHNZVLADCM-IUODEOHRSA-N
27093	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	477	Dicloxacillin	Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	dicloxacillin sodium	DRUGBANK	DB00485	C19H17Cl2N3O5S	small molecule	J01CF01	3116-76-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFAGHNZHGGCZAX-JKIFEVAISA-N
27094	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	477	Dicloxacillin	Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	dicloxacillin sodium	DRUGBANK	DB00485	C19H17Cl2N3O5S	small molecule	J01CF01	3116-76-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFAGHNZHGGCZAX-JKIFEVAISA-N
27095	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	477	Dicloxacillin	Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	dicloxacillin sodium	DRUGBANK	DB00485	C19H17Cl2N3O5S	small molecule	J01CF01	3116-76-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFAGHNZHGGCZAX-JKIFEVAISA-N
27096	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	477	Dicloxacillin	Dicloxacillinum|Dicloxacilina|Dicloxacillin|Dicloxacilline|Dicloxacillina|(2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	dicloxacillin sodium	DRUGBANK	DB00485	C19H17Cl2N3O5S	small molecule	J01CF01	3116-76-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFAGHNZHGGCZAX-JKIFEVAISA-N
27097	116073	10864	RP11-480N24.7	SLC22A7	NLT|OAT2	9606	Homo sapiens	unknown	target	Khamdang S (2003)	12650826	176188	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27098	120967	55867	-	SLC22A11	OAT4|hOAT4	9606	Homo sapiens	unknown	target	Takeda M (2002)	11909604	176187	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27099	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27100	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	unknown	target	Takeda M (2002)	11909604	176187	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27101	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27102	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	unknown	target	Takeda M (2002)	11909604	176187	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27103	112452	6564	RP11-130L10.1	SLC15A1	HPECT1|HPEPT1|PEPT1	9606	Homo sapiens	unknown	target	Luckner P (2005)	15567297	174805	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27104	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27105	112453	6565	-	SLC15A2	PEPT2	9606	Homo sapiens	unknown	target	Pedretti A (2011)	21741846	188479	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27106	106715	213	GIG20	ALB	ANALBA|FDAH|PRO0883|PRO0903|PRO1341	9606	Homo sapiens	unknown	target	Baneres-Roquet F (2009)	19164148	188474	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27107	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	485	Cefotaxime	(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxima|Cfotaxime|(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefotaxim|Cephotaxime|Cefotaximum|(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid	claforan add-vantage vials 1gm	DRUGBANK	DB00493	C16H17N5O7S2	small molecule	J01DD51|J01DD01	63527-52-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPRBEKHLDVQUJE-QSWIMTSFSA-N
27108	106715	213	GIG20	ALB	ANALBA|FDAH|PRO0883|PRO0903|PRO1341	9606	Homo sapiens	unknown	target	Baneres-Roquet F (2009)	19164148	188474	502	Vancomycin	Vancomycine|Vancomycinum|Vancomycin|Vancocin|Vancomicina|(2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]|(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid	vancomycin|sterile vancomycin 	DRUGBANK	DB00512	C66H75Cl2N9O24	small molecule	J01XA01|A07AA09	1404-90-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYPYJXKWCTUITO-LYRMYLQWSA-N
27109	857574	940002	BSU00070	gyrA	-	224308	Bacillus subtilis	unknown	target	Butler MM (2007)	17074800	188482	527	Ciprofloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum	riva-ciprofloxacin|cipro tab 2	DRUGBANK	DB00537	C17H18FN3O3	small molecule	S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03	85721-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
27110	853842	936151	BSU18090	parE	-	224308	Bacillus subtilis	unknown	target	Butler MM (2007)	17074800	188482	527	Ciprofloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum	riva-ciprofloxacin|cipro tab 2	DRUGBANK	DB00537	C17H18FN3O3	small molecule	S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03	85721-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
27111	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Keserue GM (2003)	12873512	188483	527	Ciprofloxacin	1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacine|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacino|1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid|Ciprofloxacin|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|Ciprofloxacinum	riva-ciprofloxacin|cipro tab 2	DRUGBANK	DB00537	C17H18FN3O3	small molecule	S02AA15|J01RA10|J01RA11|J01RA12|J01MA02|S03AA07|S01AE03	85721-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MYSWGUAQZAJSOK-UHFFFAOYSA-N
27112	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	557	Cephalexin	Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid	dom-cephalexin 250 - sus 250mg	DRUGBANK	DB00567	C16H17N3O4S	small molecule	J01DB01	15686-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
27113	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Mitsuoka K (2007)	17142565	176927	557	Cephalexin	Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid	dom-cephalexin 250 - sus 250mg	DRUGBANK	DB00567	C16H17N3O4S	small molecule	J01DB01	15686-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
27114	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	557	Cephalexin	Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid	dom-cephalexin 250 - sus 250mg	DRUGBANK	DB00567	C16H17N3O4S	small molecule	J01DB01	15686-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
27115	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	557	Cephalexin	Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid	dom-cephalexin 250 - sus 250mg	DRUGBANK	DB00567	C16H17N3O4S	small molecule	J01DB01	15686-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
27116	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	557	Cephalexin	Cefalexin anhydrous|Anhydrous cephalexin|Anhydrous cefalexin|Cfalexine|Cefalexina|Cefalexinum|Cephalexin anhydrous|7-beta-(D-alpha-Amino-alpha-phenylacetylamino)-3-methyl-3-cephem-4-carboxylic acid|(6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefalexin|7-(D-alpha-Aminophenylacetamido)desacetoxycephalosporanic acid	dom-cephalexin 250 - sus 250mg	DRUGBANK	DB00567	C16H17N3O4S	small molecule	J01DB01	15686-71-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAIPMKNFIOOWCQ-UEKVPHQBSA-N
27117	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	597	Nafcillin	(2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid	unipen injection pws 500mg/via	DRUGBANK	DB00607	C21H22N2O5S	small molecule	J01CF06	147-52-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPXLMGHLHQJAGZ-JTDSTZFVSA-N
27118	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	597	Nafcillin	(2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid	unipen injection pws 500mg/via	DRUGBANK	DB00607	C21H22N2O5S	small molecule	J01CF06	147-52-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPXLMGHLHQJAGZ-JTDSTZFVSA-N
27119	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	597	Nafcillin	(2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid	unipen injection pws 500mg/via	DRUGBANK	DB00607	C21H22N2O5S	small molecule	J01CF06	147-52-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPXLMGHLHQJAGZ-JTDSTZFVSA-N
27120	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	597	Nafcillin	(2-Ethoxy-1-naphthyl)penicillin|Nafcillinum|Nafcilina|(2S,5R,6R)-6-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Nafcilline|(2-Ethoxy-1-naphthalenyl)penicillin|Naphcillin|6-(2-Ethoxy-1-naphthamido)penicillanic acid	unipen injection pws 500mg/via	DRUGBANK	DB00607	C21H22N2O5S	small molecule	J01CF06	147-52-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPXLMGHLHQJAGZ-JTDSTZFVSA-N
27121	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	antagonist	target	Alvarez-Guerra M (1999)	10027088	177898	689	Nicergoline	Nicergolina|Nicergoline|Nicergolin|Sermion|Nicergolinum	-	DRUGBANK	DB00699	C24H26BrN3O3	small molecule	C04AE02	27848-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YSEXMKHXIOCEJA-FVFQAYNVSA-N
27122	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	703	Oxacillin	Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin	oxacillin	DRUGBANK	DB00713	C19H19N3O5S	small molecule	J01CF04	66-79-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWYHMGVUTGAWSP-JKIFEVAISA-N
27123	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	703	Oxacillin	Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin	oxacillin	DRUGBANK	DB00713	C19H19N3O5S	small molecule	J01CF04	66-79-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWYHMGVUTGAWSP-JKIFEVAISA-N
27124	112452	6564	RP11-130L10.1	SLC15A1	HPECT1|HPEPT1|PEPT1	9606	Homo sapiens	unknown	target	Luckner P (2005)	15567297	174805	703	Oxacillin	Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin	oxacillin	DRUGBANK	DB00713	C19H19N3O5S	small molecule	J01CF04	66-79-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWYHMGVUTGAWSP-JKIFEVAISA-N
27125	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	703	Oxacillin	Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin	oxacillin	DRUGBANK	DB00713	C19H19N3O5S	small molecule	J01CF04	66-79-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWYHMGVUTGAWSP-JKIFEVAISA-N
27126	112453	6565	-	SLC15A2	PEPT2	9606	Homo sapiens	unknown	target	Pedretti A (2011)	21741846	188479	703	Oxacillin	Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin	oxacillin	DRUGBANK	DB00713	C19H19N3O5S	small molecule	J01CF04	66-79-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWYHMGVUTGAWSP-JKIFEVAISA-N
27127	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	703	Oxacillin	Oxacillinum|5-Methyl-3-phenyl-4-isoxazolyl-penicillin|Oxazocillin|Oxazocilline|Oxacilina|6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid|Oxacilline|(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Oxacillin|(5-Methyl-3-phenyl-4-isoxazolyl)penicillin	oxacillin	DRUGBANK	DB00713	C19H19N3O5S	small molecule	J01CF04	66-79-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWYHMGVUTGAWSP-JKIFEVAISA-N
27128	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Neu HC (1975)	1095502	178113	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27129	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27130	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Neu HC (1975)	1095502	178113	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27131	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27132	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Neu HC (1975)	1095502	178113	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27133	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27134	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Neu HC (1975)	1095502	178113	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27135	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	729	Hetacillin	Phenazacillin|Htacilline|Hetacilina|6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid|Hetacillin|(2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Hetacillinum	-	DRUGBANK	DB00739	C19H23N3O4S	small molecule	J01CA18	3511-16-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DXVUYOAEDJXBPY-NFFDBFGFSA-N
27136	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Knuckley B (2008)	17964793	188476	749	Tetracycline	Tetrazyklin|Achromycin|Tetracyclin|Ttracycline|(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide|Tetracyclinum|Tsiklomitsin|Liquamycin|Abramycin|Anhydrotetracycline|Deschlorobiomycin	tetranext|acnecycline|medicycl	DRUGBANK	DB00759	C22H24N2O8	small molecule	J01RA08|S02AA08|A01AB13|A02BD02|S01AA09|D06AA04|J01AA07|A02BD08|S03AA02	60-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFVLGDICTFRJMM-WESIUVDSSA-N
27137	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	potentiator	target	Bennett MS (1999)	9989588	178394	777	Aciclovir	Aciclovirum|Acycloguanosine|Acyclovir	apo-acyclovir - tab 800mg|zovi	DRUGBANK	DB00787	C8H11N5O3	small molecule	J05AB01|D06BB53|D06BB03|S01AD03	59277-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKUXAQIIEYXACX-UHFFFAOYSA-N
27138	855957	938339	BSU03130	nadE	-	224308	Bacillus subtilis	unknown	target	Velu SE (2003)	12852767	188484	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
27139	108065	1719	-	DHFR	DHFRP1|DYR	9606	Homo sapiens	unknown	target	Al-Omary FA (2010)	20350811	188485	788	Gentamicin	-	sandoz pentasone|garasone opht	DRUGBANK	DB00798	C21H43N5O7	small molecule	S01AA11|S03AA06|J01GB03|D06AX07|S02AA14	1403-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEAZRRDELHUEMR-UHFFFAOYSA-N
27140	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Wang EJ (2001)	11716514	172321	835	Clofazimine	Clofazimine|Clofazimina|Clofaziminum|Clofazimin|Riminophenazine|Lamprene	-	DRUGBANK	DB00845	C27H22Cl2N4	small molecule	J04BA01	2030-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDQPAMHFFCXSNU-BGABXYSRSA-N
27141	114199	8647	-	ABCB11	ABC16|BRIC2|BSEP|PFIC-2|PFIC2|PGY4|SPGP	9606	Homo sapiens	unknown	target	Wang EJ (2003)	12739759	172309	835	Clofazimine	Clofazimine|Clofazimina|Clofaziminum|Clofazimin|Riminophenazine|Lamprene	-	DRUGBANK	DB00845	C27H22Cl2N4	small molecule	J04BA01	2030-63-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDQPAMHFFCXSNU-BGABXYSRSA-N
27142	108831	2557	-	GABRA4	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27143	108832	2558	-	GABRA5	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27144	108344	2030	-	SLC29A1	ENT1	9606	Homo sapiens	unknown	target	Allen-Gipson DS (2009)	19298329	188486	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27145	108829	2555	-	GABRA2	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27146	113255	7412	-	VCAM1	CD106|INCAM-100	9606	Homo sapiens	unknown	target	Arevalo E (2008)	18165316	188487	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27147	107564	1142	-	CHRNB3	-	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27148	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27149	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27150	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	unknown	target	Spanagel R (2009)	19342616	188489	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27151	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27152	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27153	107229	775	-	CACNA1C	CACH2|CACN2|CACNL1A1|CCHL1A1|CaV1.2|LQT8|TS	9606	Homo sapiens	unknown	target	Hendricson AW (2003)	12970385	188490	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27154	107233	779	-	CACNA1S	CACNL1A3|CCHL1A3|Cav1.1|HOKPP|HOKPP1|MHS5|TTPP1|hypoPP	9606	Homo sapiens	unknown	target	Hendricson AW (2003)	12970385	188490	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27155	109964	3762	-	KCNJ5	CIR|GIRK4|KATP1|KIR3.4|LQT13	9606	Homo sapiens	unknown	target	Spanagel R (2009)	19342616	188489	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27156	109149	2892	RP11-349N19.3	GRIA3	GLUR-C|GLUR-K3|GLUR3|GLURC|GluA3|MRX94	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27157	108833	2559	-	GABRA6	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27158	107230	776	-	CACNA1D	CACH3|CACN4|CACNL1A2|CCHL1A2|Cav1.3|PASNA|SANDD	9606	Homo sapiens	unknown	target	Hendricson AW (2003)	12970385	188490	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27159	109147	2890	-	GRIA1	GLUH1|GLUR1|GLURA|GluA1|HBGR1	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27160	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27161	128355	200909	-	HTR3D	5HT3D	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27162	128062	170572	-	HTR3C	-	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27163	108830	2556	-	GABRA3	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27164	115648	10369	RP5-1119A7.17	CACNG2	MRD10	9606	Homo sapiens	unknown	target	Hendricson AW (2003)	12970385	188490	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27165	130056	285242	-	HTR3E	5-HT3-E|5-HT3E|5-HT3c1	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27166	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27167	109419	3177	-	SLC29A2	DER12|ENT2|HNP36	9606	Homo sapiens	unknown	target	Allen-Gipson DS (2009)	19298329	188486	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27168	109962	3760	-	KCNJ3	GIRK1|KGA|KIR3.1	9606	Homo sapiens	unknown	target	Spanagel R (2009)	19342616	188489	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27169	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27170	108835	2561	-	GABRB2	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27171	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27172	108839	2565	-	GABRG1	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27173	109967	3765	RP11-536C5.1	KCNJ9	GIRK3|KIR3.3	9606	Homo sapiens	unknown	target	Spanagel R (2009)	19342616	188489	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27174	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27175	107557	1135	-	CHRNA2	-	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27176	108838	2564	-	GABRE	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27177	108841	2567	-	GABRG3	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27178	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27179	108834	2560	-	GABRB1	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27180	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27181	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27182	114615	9177	-	HTR3B	5-HT3B	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27183	107236	782	-	CACNB1	CAB1|CACNLB1|CCHLB1	9606	Homo sapiens	unknown	target	Hendricson AW (2003)	12970385	188490	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27184	108842	2568	-	GABRP	-	9606	Homo sapiens	unknown	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27185	109150	2893	-	GRIA4	GLUR4|GLUR4C|GLURD|GluA4	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27186	121345	57053	-	CHRNA10	-	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27187	107240	786	-	CACNG1	CACNLG	9606	Homo sapiens	unknown	target	Hendricson AW (2003)	12970385	188490	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27188	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	unknown	target	Ekins S (2007)	17194716	188471	906	Metronidazole	1-(-oxyethyl)-2-methyl-5-nitroimidazole|2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole|Metronidazolum|1-(-hydroxyethyl)-2-methyl-5-nitroimidazole|1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole|2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole|1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole|1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole|2-methyl-5-nitroimidazole-1-ethanol|1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole|Metronidazol|1-(-ethylol)-2-methyl-5-nitro-3-azapyrrole|1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole	flagyl 500 500mg|flagystatin c	DRUGBANK	DB00916	C6H9N3O3	small molecule	J01RA03|J01XD01|G01AF01|J01RA04|J01RA10|P01AB01|A01AB17|P01AB51|A02BD02|A02BD03|D06BX01|A02BD01|A02BD11|A02BD08	443-48-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAOCPAMSLUNLGC-UHFFFAOYSA-N
27189	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27190	107924	1544	-	CYP1A2	CP12|P3-450|P450(PA)	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27191	107935	1557	RP11-400G3.4	CYP2C19	CPCJ|CYP2C|CYPIIC17|CYPIIC19|P450C2C|P450IIC19	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27192	107936	1558	-	CYP2C8	CPC8|CYPIIC8|MP-12/MP-20	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27193	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	990	Cyclacillin	Ciclacilline|Bastcillin|Ultracillin|Citosarin|(1-Aminocyclohexyl)penicillin|Aminocyclohexylpenicillin|Ciclacillin|Cyclapen-W|Syngacillin|Vipicil|Calthor|6-(1-Aminocyclohexylcarboxamido)penicillanic acid|(2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Wyvital|Cyclapen|Cyclacillin|Ciclacillinum|Ciclacilina|Vastcillin|6-(1-Aminocyclohexanecarboxamido)penicillanic acid|Ciclacillum	-	DRUGBANK	DB01000	C15H23N3O4S	small molecule	-	3485-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGBLNBBNRORJKI-WCABBAIRSA-N
27194	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Champness JN (1998)	9715911	188493	994	Ganciclovir	2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol|Gancyclovir|9-[(1,3-dihydroxy-2-propoxy)methyl]guanine|2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one|GA2|2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone|Ganciclovir|9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine|Ganciclovirum|2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol|2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one	cytovene - pws 500mg/10m/-vial	DRUGBANK	DB01004	C9H13N5O4	small molecule	S01AD09|J05AB06	82410-32-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRSCQMHQWWYFCW-UHFFFAOYSA-N
27195	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	inhibitor	target	Kim OK (2001)	11178337	188497	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27196	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	inhibitor	target	Mdluli K (2007)	17970226	188498	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27197	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	inhibitor	target	Hosaka M (2003)	12835539	188496	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27198	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	inhibitor	target	Rafii F (2005)	15673722	176445	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27199	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	inhibitor	target	Harding I (2000)	11131958	188494	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27200	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	inhibitor	target	Kays MB (2007)	17253913	188495	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27201	4179035	930756	SP_0806	gyrB	-	170187	Streptococcus pneumoniae	inhibitor	target	Kim OK (2001)	11178337	188497	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27202	4179035	930756	SP_0806	gyrB	-	170187	Streptococcus pneumoniae	inhibitor	target	Mdluli K (2007)	17970226	188498	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27203	4179035	930756	SP_0806	gyrB	-	170187	Streptococcus pneumoniae	inhibitor	target	Hosaka M (2003)	12835539	188496	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27204	4179035	930756	SP_0806	gyrB	-	170187	Streptococcus pneumoniae	inhibitor	target	Rafii F (2005)	15673722	176445	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27205	4179035	930756	SP_0806	gyrB	-	170187	Streptococcus pneumoniae	inhibitor	target	Harding I (2000)	11131958	188494	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27206	4179035	930756	SP_0806	gyrB	-	170187	Streptococcus pneumoniae	inhibitor	target	Kays MB (2007)	17253913	188495	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27207	4179084	930805	SP_0855	SP_0855	-	170187	Streptococcus pneumoniae	inhibitor	target	Mdluli K (2007)	17970226	188498	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27208	4179084	930805	SP_0855	SP_0855	-	170187	Streptococcus pneumoniae	inhibitor	target	Hosaka M (2003)	12835539	188496	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27209	4179084	930805	SP_0855	SP_0855	-	170187	Streptococcus pneumoniae	inhibitor	target	Rafii F (2005)	15673722	176445	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27210	4179084	930805	SP_0855	SP_0855	-	170187	Streptococcus pneumoniae	inhibitor	target	Harding I (2000)	11131958	188494	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27211	4179084	930805	SP_0855	SP_0855	-	170187	Streptococcus pneumoniae	inhibitor	target	Kays MB (2007)	17253913	188495	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27212	4179081	930802	SP_0852	SP_0852	-	170187	Streptococcus pneumoniae	inhibitor	target	Mdluli K (2007)	17970226	188498	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27213	4179081	930802	SP_0852	SP_0852	-	170187	Streptococcus pneumoniae	inhibitor	target	Hosaka M (2003)	12835539	188496	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27214	4179081	930802	SP_0852	SP_0852	-	170187	Streptococcus pneumoniae	inhibitor	target	Rafii F (2005)	15673722	176445	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27215	4179081	930802	SP_0852	SP_0852	-	170187	Streptococcus pneumoniae	inhibitor	target	Harding I (2000)	11131958	188494	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27216	4179081	930802	SP_0852	SP_0852	-	170187	Streptococcus pneumoniae	inhibitor	target	Kays MB (2007)	17253913	188495	1033	Gatifloxacin	Gatifloxacin anhydrous|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|Gatifloxacinum|Gatifloxacino|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|Gatifloxacine	tequin|tequin iv|gatifloxacin|	DRUGBANK	DB01044	C19H22FN3O4	small molecule	S01AE06|J01MA16	112811-59-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUBOMFCQGDBHNK-UHFFFAOYSA-N
27217	107967	1595	-	CYP51A1	CP51|CYP51|CYPL1|LDM|P450-14DM|P450L1	9606	Homo sapiens	unknown	target	Ekins S (2007)	17194716	188471	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27218	118182	28234	-	SLCO1B3	HBLRR|LST-2|LST-3TM13|LST3|OATP-8|OATP1B3|OATP8|SLC21A8	9606	Homo sapiens	unknown	target	Vavricka SR (2002)	12085361	188499	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27219	112466	6579	-	SLCO1A2	OATP|OATP-A|OATP1A2|SLC21A3	9606	Homo sapiens	unknown	target	Vavricka SR (2002)	12085361	188499	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27220	116442	11309	-	SLCO2B1	OATP-B|OATP2B1|OATPB|SLC21A9	9606	Homo sapiens	unknown	target	Karlgren M (2012)	22541068	188500	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27221	115847	10599	-	SLCO1B1	HBLRR|LST-1|LST1|OATP-C|OATP1B1|OATP2|OATPC|SLC21A6	9606	Homo sapiens	unknown	target	Vavricka SR (2002)	12085361	188499	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27222	106715	213	GIG20	ALB	ANALBA|FDAH|PRO0883|PRO0903|PRO1341	9606	Homo sapiens	unknown	target	Baneres-Roquet F (2009)	19164148	188474	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27223	112452	6564	RP11-130L10.1	SLC15A1	HPECT1|HPEPT1|PEPT1	9606	Homo sapiens	unknown	target	Luckner P (2005)	15567297	174805	1041	Benzylpenicillin	Benzylpenicilline|Free penicillin II|Penicillin G|Benzylpenicillinic acid|6-(2-phenylacetamido)penicillanic acid|PG|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Benzylpenicillin|Bencilpenicilina|PCG|Benzylpenicillinum	penicillin g potassium inj 100	DRUGBANK	DB01053	C16H18N2O4S	small molecule	S01AA14|J01CE01	61-33-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGSARLDLIJGVTE-MBNYWOFBSA-N
27224	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	unknown	target	Takeda M (2002)	12130730	175259	1041	Benzylpenicillin	Benzylpenicilline|Free penicillin II|Penicillin G|Benzylpenicillinic acid|6-(2-phenylacetamido)penicillanic acid|PG|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Benzylpenicillin|Bencilpenicilina|PCG|Benzylpenicillinum	penicillin g potassium inj 100	DRUGBANK	DB01053	C16H18N2O4S	small molecule	S01AA14|J01CE01	61-33-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGSARLDLIJGVTE-MBNYWOFBSA-N
27225	112453	6565	-	SLC15A2	PEPT2	9606	Homo sapiens	unknown	target	Pedretti A (2011)	21741846	188479	1041	Benzylpenicillin	Benzylpenicilline|Free penicillin II|Penicillin G|Benzylpenicillinic acid|6-(2-phenylacetamido)penicillanic acid|PG|(2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Benzylpenicillin|Bencilpenicilina|PCG|Benzylpenicillinum	penicillin g potassium inj 100	DRUGBANK	DB01053	C16H18N2O4S	small molecule	S01AA14|J01CE01	61-33-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGSARLDLIJGVTE-MBNYWOFBSA-N
27226	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Yamada M (2007)	17724158	188501	1054	Cefditoren	-	cefditoren pivoxil|spectracef	DRUGBANK	DB01066	C19H18N6O5S3	small molecule	J01DD16	104145-95-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KMIPKYQIOVAHOP-YLGJWRNMSA-N
27227	117111	23569	-	PADI4	PAD|PAD4|PADI5|PDI4|PDI5	9606	Homo sapiens	unknown	target	Knuckley B (2008)	17964793	188476	1070	Streptomycin	Kantrex|STREPTOMYCIN|[2-Deoxy-2-(dimethylamino)-alpha-L-glucopyranosyl]-(1->2)-[5-deoxy-3-C-formyl-alpha-L-lyxofuranosyl]-(1->4)-{n',n'''-[(1,3,5/2,4,6)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl]diguanidine}|2,4-Diguanidino-3,5,6-trihydroxycyclohexyl 5-deoxy-2-O-(2-deoxy-2-methylamino-alpha-L-glucopyranosyl)-3-C-formyl-beta-L-lyxopentanofuranoside|SM	streptomycin sulfate injection	DRUGBANK	DB01082	C21H39N7O12	small molecule	J04AM01|A07AA04|A07AA54|J01GA01	57-92-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCSJYZPVAKXKNQ-HZYVHMACSA-N
27228	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1128	Cefadroxil	D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX	cefadroxil|nu-cefadroxil, 500 	DRUGBANK	DB01140	C16H17N3O5S	small molecule	J01DB05	66592-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOEGTKLJZSQCCD-UEKVPHQBSA-N
27229	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Ocheltree SM (2004)	14600253	188502	1128	Cefadroxil	D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX	cefadroxil|nu-cefadroxil, 500 	DRUGBANK	DB01140	C16H17N3O5S	small molecule	J01DB05	66592-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOEGTKLJZSQCCD-UEKVPHQBSA-N
27230	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1128	Cefadroxil	D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX	cefadroxil|nu-cefadroxil, 500 	DRUGBANK	DB01140	C16H17N3O5S	small molecule	J01DB05	66592-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOEGTKLJZSQCCD-UEKVPHQBSA-N
27231	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1128	Cefadroxil	D-Cefadroxil|Cefadroxilum|Cefadroxil anhydrous|Cefadroxilo|Cephadroxil|CDX	cefadroxil|nu-cefadroxil, 500 	DRUGBANK	DB01140	C16H17N3O5S	small molecule	J01DB05	66592-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOEGTKLJZSQCCD-UEKVPHQBSA-N
27232	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
27233	4179442	931164	SP_1673	SP_1673	-	170187	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1135	Cloxacillin	(2S,5R,6R)-6-({[3-(2-chlorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Cloxacilina|Cloxacillinum|(3-(O-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin|Cloxacilline|6-(3-(O-Chlorophenyl)-5-methyl-4-isoxazolecarboxamido)penicillanic acid|CLOXACILLIN	nu-cloxi capsules 500mg|nu-clo	DRUGBANK	DB01147	C19H18ClN3O5S	small molecule	J01CF02	61-72-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQOLIRLGBULYKD-JKIFEVAISA-N
27234	4178437	930153	SP_0336	SP_0336	-	170187	Streptococcus pneumoniae	inhibitor	target	Nagai K (2002)	11959556	188503	1138	Cefprozil	Cefprozilum|Cefprozil anhydrous|Cefprozilo|Cefzil	ava-cefprozil|cefzil powder fo	DRUGBANK	DB01150	C18H19N3O5S	small molecule	J01DC10	92665-29-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDLWHQDACQUCJR-ZAMMOSSLSA-N
27235	4178552	930269	SP_0369	SP_0369	-	170187	Streptococcus pneumoniae	inhibitor	target	Nagai K (2002)	11959556	188503	1138	Cefprozil	Cefprozilum|Cefprozil anhydrous|Cefprozilo|Cefzil	ava-cefprozil|cefzil powder fo	DRUGBANK	DB01150	C18H19N3O5S	small molecule	J01DC10	92665-29-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDLWHQDACQUCJR-ZAMMOSSLSA-N
27236	4179442	931164	SP_1673	SP_1673	-	170187	Streptococcus pneumoniae	inhibitor	target	Nagai K (2002)	11959556	188503	1138	Cefprozil	Cefprozilum|Cefprozil anhydrous|Cefprozilo|Cefzil	ava-cefprozil|cefzil powder fo	DRUGBANK	DB01150	C18H19N3O5S	small molecule	J01DC10	92665-29-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WDLWHQDACQUCJR-ZAMMOSSLSA-N
27237	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1151	Amdinocillin	Penicillin HX|Mecillinam	-	DRUGBANK	DB01163	C15H23N3O3S	small molecule	J01CA11	32887-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWWVAEOLVKTZFQ-ISVUSNJMSA-N
27238	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1151	Amdinocillin	Penicillin HX|Mecillinam	-	DRUGBANK	DB01163	C15H23N3O3S	small molecule	J01CA11	32887-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWWVAEOLVKTZFQ-ISVUSNJMSA-N
27239	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1151	Amdinocillin	Penicillin HX|Mecillinam	-	DRUGBANK	DB01163	C15H23N3O3S	small molecule	J01CA11	32887-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWWVAEOLVKTZFQ-ISVUSNJMSA-N
27240	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1151	Amdinocillin	Penicillin HX|Mecillinam	-	DRUGBANK	DB01163	C15H23N3O3S	small molecule	J01CA11	32887-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWWVAEOLVKTZFQ-ISVUSNJMSA-N
27241	118182	28234	-	SLCO1B3	HBLRR|LST-2|LST-3TM13|LST3|OATP-8|OATP1B3|OATP8|SLC21A8	9606	Homo sapiens	unknown	target	De Bruyn T (2013)	23571415	188504	1199	Clarithromycin	Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum	clarithromycin 500 mg|mylan-cl	DRUGBANK	DB01211	C38H69NO13	small molecule	J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09	81103-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGOYDEPGAOXOCK-KCBOHYOISA-N
27242	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	unknown	target	Keserue GM (2003)	12873512	188483	1199	Clarithromycin	Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum	clarithromycin 500 mg|mylan-cl	DRUGBANK	DB01211	C38H69NO13	small molecule	J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09	81103-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGOYDEPGAOXOCK-KCBOHYOISA-N
27243	111262	5243	-	ABCB1	ABC20|CD243|CLCS|GP170|MDR1|P-GP|PGY1	9606	Homo sapiens	unknown	target	Wang EJ (2001)	11716514	172321	1199	Clarithromycin	Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum	clarithromycin 500 mg|mylan-cl	DRUGBANK	DB01211	C38H69NO13	small molecule	J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09	81103-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGOYDEPGAOXOCK-KCBOHYOISA-N
27244	115847	10599	-	SLCO1B1	HBLRR|LST-1|LST1|OATP-C|OATP1B1|OATP2|OATPC|SLC21A6	9606	Homo sapiens	unknown	target	De Bruyn T (2013)	23571415	188504	1199	Clarithromycin	Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum	clarithromycin 500 mg|mylan-cl	DRUGBANK	DB01211	C38H69NO13	small molecule	J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09	81103-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGOYDEPGAOXOCK-KCBOHYOISA-N
27245	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	1199	Clarithromycin	Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum	clarithromycin 500 mg|mylan-cl	DRUGBANK	DB01211	C38H69NO13	small molecule	J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09	81103-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGOYDEPGAOXOCK-KCBOHYOISA-N
27246	112452	6564	RP11-130L10.1	SLC15A1	HPECT1|HPEPT1|PEPT1	9606	Homo sapiens	unknown	target	Luckner P (2005)	15567297	174805	1200	Ceftriaxone	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum	ceftriaxone|ceftriaxone sodium	DRUGBANK	DB01212	C18H18N8O7S3	small molecule	J01DD04|J01DD54	73384-59-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAAUVRVFOQPIGI-SPQHTLEESA-N
27247	114759	9356	-	SLC22A6	HOAT1|OAT1|PAHT|ROAT1	9606	Homo sapiens	unknown	target	Takeda M (2002)	11909604	176187	1200	Ceftriaxone	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum	ceftriaxone|ceftriaxone sodium	DRUGBANK	DB01212	C18H18N8O7S3	small molecule	J01DD04|J01DD54	73384-59-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAAUVRVFOQPIGI-SPQHTLEESA-N
27248	120967	55867	-	SLC22A11	OAT4|hOAT4	9606	Homo sapiens	unknown	target	Takeda M (2002)	11909604	176187	1200	Ceftriaxone	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum	ceftriaxone|ceftriaxone sodium	DRUGBANK	DB01212	C18H18N8O7S3	small molecule	J01DD04|J01DD54	73384-59-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAAUVRVFOQPIGI-SPQHTLEESA-N
27249	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Tomberg J (2010)	20704258	188505	1200	Ceftriaxone	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum	ceftriaxone|ceftriaxone sodium	DRUGBANK	DB01212	C18H18N8O7S3	small molecule	J01DD04|J01DD54	73384-59-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAAUVRVFOQPIGI-SPQHTLEESA-N
27250	114777	9376	-	SLC22A8	OAT3	9606	Homo sapiens	unknown	target	Takeda M (2002)	11909604	176187	1200	Ceftriaxone	(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cefatriaxone|Ceftriazone|Ceftriaxona|Ceftriaxonum	ceftriaxone|ceftriaxone sodium	DRUGBANK	DB01212	C18H18N8O7S3	small molecule	J01DD04|J01DD54	73384-59-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VAAUVRVFOQPIGI-SPQHTLEESA-N
27251	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
27252	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
27253	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
27254	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1299	Cefoxitin	Cephoxitin|Ceftoxitin|Cefoxitina|Cefoxitinum|CFX|Cefoxitin|Rephoxitin|Cefoxitine|(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	mefoxin pws inj 10gm/vial|mefo	DRUGBANK	DB01331	C16H17N3O7S2	small molecule	J01DC01	35607-66-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZOZEZRFJCJXNZ-ZBFHGGJFSA-N
27255	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1541	Meticillin	6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin	-	DRUGBANK	DB01603	C17H20N2O6S	small molecule	J01CF03	61-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJQXTJLFIWVMTO-TYNCELHUSA-N
27256	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1541	Meticillin	6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin	-	DRUGBANK	DB01603	C17H20N2O6S	small molecule	J01CF03	61-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJQXTJLFIWVMTO-TYNCELHUSA-N
27257	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1541	Meticillin	6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin	-	DRUGBANK	DB01603	C17H20N2O6S	small molecule	J01CF03	61-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJQXTJLFIWVMTO-TYNCELHUSA-N
27258	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	1541	Meticillin	6beta-(2,6-Dimethoxybenzamido)penicillanic acid|Methycillin|6-(2,6-Dimethoxybenzamido)penicillanic acid|Methicillin|(2S,5R,6R)-6-[(2,6-Dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|Meticillinum|Meticilina|Methicillinum|Meticillin|Meticilline|(2,6-Dimethoxyphenyl)penicillin	-	DRUGBANK	DB01603	C17H20N2O6S	small molecule	J01CF03	61-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RJQXTJLFIWVMTO-TYNCELHUSA-N
27259	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
27260	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	1580	Thymidine-5'-Phosphate	5'-dTMP|5'-TMP|Thymidine-5'-monophosphoric acid|Poly(t)|Polythymidylic acid|Polythymidine|Deoxyribosylthymine monophosphate|2'-Deoxythymidine 5'-monophosphate|Thymidine 5'MP|5-Methyl-dUMP|Polydeoxyribothymidylic acid|DTMP|Thymidylic acid|Thymidine 5'-(dihydrogen phosphate)|Thymidine monophosphate|5'-Thymidylic acid|Poly t|3'-Tmp|Thymidine 5'-phosphoric acid|Deoxythymydilic acid|Poly(DT)|Thymidine phosphate|Thymidylate|Thymidine-5'-Monophosphate|Deoxy TMP|Thymidine 5'-phosphate|3'-Thymidylic acid|Deoxythymidylic acid|Octothymidylate|Polydeoxythymidylic acid|Deoxythymidine 5'-phosphate|Deoxythymidine phosphate|Thymidylic acid polymer|Deoxythymidine 5'-monophosphate|Deoxythymidine monophosphate|Thymidine mononucleotide	-	DRUGBANK	DB01643	C10H15N2O8P	small molecule	-	365-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYOZYWVXFNDGLU-XLPZGREQSA-N
27261	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
27262	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	1686	S-Adenosyl-L-Homocysteine	-	-	DRUGBANK	DB01752	C14H20N6O5S	small molecule	-	979-92-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJUKTBDSGOFHSH-SRMDEQNCSA-N
27263	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	1800	Acetylgalactosamine-4-Sulfate	-	-	DRUGBANK	DB01872	C8H15NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHCJUIFHMJFEFZ-FMDGEEDCSA-N
27264	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	1800	Acetylgalactosamine-4-Sulfate	-	-	DRUGBANK	DB01872	C8H15NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHCJUIFHMJFEFZ-FMDGEEDCSA-N
27265	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	1831	D-Xylitol	-	-	DRUGBANK	DB01904	C5H12O5	small molecule	-	488-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEBKCHPVOIAQTA-SCDXWVJYSA-N
27266	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	1831	D-Xylitol	-	-	DRUGBANK	DB01904	C5H12O5	small molecule	-	488-81-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEBKCHPVOIAQTA-SCDXWVJYSA-N
27267	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	1838	2,2':6',2''-Terpyridine Platinum(Ii)	-	-	DRUGBANK	DB01912	C15H11N3Pt	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHCZSDBLJSVYIT-UNGNXWFZSA-N
27268	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	1838	2,2':6',2''-Terpyridine Platinum(Ii)	-	-	DRUGBANK	DB01912	C15H11N3Pt	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SHCZSDBLJSVYIT-UNGNXWFZSA-N
27269	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
27270	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
27271	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	1902	7,9-Dimethylguanine	-	-	DRUGBANK	DB01978	C7H10N5O	small molecule	-	55235-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAIGKGQHPIGYBB-UHFFFAOYSA-O
27272	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	1902	7,9-Dimethylguanine	-	-	DRUGBANK	DB01978	C7H10N5O	small molecule	-	55235-22-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NAIGKGQHPIGYBB-UHFFFAOYSA-O
27273	4252304	3199069	syc0881_c	hemL	-	269084	Synechococcus elongatus	unknown	target	Imming P (2006)	17016423	171742	1975	Gabaculine	-	-	DRUGBANK	DB02054	C7H7NO2	small molecule	-	87980-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDUHJPVQKIXHO-UHFFFAOYSA-N
27274	4252304	3199069	syc0881_c	hemL	-	269084	Synechococcus elongatus	unknown	target	Overington JP (2006)	17139284	171741	1975	Gabaculine	-	-	DRUGBANK	DB02054	C7H7NO2	small molecule	-	87980-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XFDUHJPVQKIXHO-UHFFFAOYSA-N
27275	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Imming P (2006)	17016423	171742	2022	DMP450	-	-	DRUGBANK	DB02102	C33H38N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWVVCFTECTRQS-YDPTYEFTSA-N
27276	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Overington JP (2006)	17139284	171741	2022	DMP450	-	-	DRUGBANK	DB02102	C33H38N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XGWVVCFTECTRQS-YDPTYEFTSA-N
27277	4252304	3199069	syc0881_c	hemL	-	269084	Synechococcus elongatus	unknown	target	Imming P (2006)	17016423	171742	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
27278	4252304	3199069	syc0881_c	hemL	-	269084	Synechococcus elongatus	unknown	target	Overington JP (2006)	17139284	171741	2061	Pyridoxamine-5'-Phosphate	-	-	DRUGBANK	DB02142	C8H13N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMJGSOSNSPKHNH-UHFFFAOYSA-N
27279	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	2102	N-Acetyl-D-Galactosamine 6-Sulfate	-	-	DRUGBANK	DB02186	C8H15NO9S	small molecule	-	157296-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJFVEEAIYIOATH-JAJWTYFOSA-N
27280	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	2102	N-Acetyl-D-Galactosamine 6-Sulfate	-	-	DRUGBANK	DB02186	C8H15NO9S	small molecule	-	157296-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJFVEEAIYIOATH-JAJWTYFOSA-N
27281	3508994	3707640	VACWR025	C3L	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
27282	3508994	3707640	VACWR025	C3L	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	2173	O2-Sulfo-Glucuronic Acid	-	-	DRUGBANK	DB02264	C6H10O10S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COJBCAMFZDFGFK-SZXBDDMQSA-N
27283	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	2231	5-Iodo-2'-Deoxyuridine-5'-Monophosphate	-	-	DRUGBANK	DB02324	C9H12IN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXFYBFRZROJDLL-DSYKOEDSSA-N
27284	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	2231	5-Iodo-2'-Deoxyuridine-5'-Monophosphate	-	-	DRUGBANK	DB02324	C9H12IN2O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXFYBFRZROJDLL-DSYKOEDSSA-N
27285	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Imming P (2006)	17016423	171742	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
27286	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Overington JP (2006)	17139284	171741	2243	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	-	-	DRUGBANK	DB02338	C21H30N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACFIXJIJDZMPPO-XCSFTKGKSA-N
27287	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	2392	9-(4-hydroxybutyl)-N2-phenylguanine	HBPG	-	DRUGBANK	DB02495	C15H17N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHBXNPBKSPYOFT-UHFFFAOYSA-N
27288	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	2392	9-(4-hydroxybutyl)-N2-phenylguanine	HBPG	-	DRUGBANK	DB02495	C15H17N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHBXNPBKSPYOFT-UHFFFAOYSA-N
27289	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Berman HM (2000)	10592235	172122	2392	9-(4-hydroxybutyl)-N2-phenylguanine	HBPG	-	DRUGBANK	DB02495	C15H17N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHBXNPBKSPYOFT-UHFFFAOYSA-N
27290	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	2397	6-(Dihydroxy-Isobutyl)-Thymine	-	-	DRUGBANK	DB02500	C9H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLCPDSJUXHDRGX-UHFFFAOYSA-N
27291	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	2397	6-(Dihydroxy-Isobutyl)-Thymine	-	-	DRUGBANK	DB02500	C9H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLCPDSJUXHDRGX-UHFFFAOYSA-N
27292	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Imming P (2006)	17016423	171742	2429	2,4,6-Triaminoquinazoline	-	-	DRUGBANK	DB02532	C8H9N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJBWEZVYRBKOCI-UHFFFAOYSA-N
27293	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Overington JP (2006)	17139284	171741	2429	2,4,6-Triaminoquinazoline	-	-	DRUGBANK	DB02532	C8H9N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LJBWEZVYRBKOCI-UHFFFAOYSA-N
27294	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
27295	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
27296	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	2505	Decylamine-N,N-Dimethyl-N-Oxide	-	-	DRUGBANK	DB02613	C12H27NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRKZFNZPJKEWPC-UHFFFAOYSA-N
27297	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Imming P (2006)	17016423	171742	2591	XV638	-	-	DRUGBANK	DB02702	C41H38N6O5S2	small molecule	-	183854-11-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDALSSGOBMTZEP-WLPVSNDTSA-N
27298	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Overington JP (2006)	17139284	171741	2591	XV638	-	-	DRUGBANK	DB02702	C41H38N6O5S2	small molecule	-	183854-11-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDALSSGOBMTZEP-WLPVSNDTSA-N
27299	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Imming P (2006)	17016423	171742	2617	SD146	-	-	DRUGBANK	DB02729	C49H42N8O5	small molecule	-	183854-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27300	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Overington JP (2006)	17139284	171741	2617	SD146	-	-	DRUGBANK	DB02729	C49H42N8O5	small molecule	-	183854-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27301	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	2650	9-Hydroxypropyladenine, R-Isomer	-	-	DRUGBANK	DB02765	C8H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZYTEBKXLVLMY-RXMQYKEDSA-N
27302	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	2650	9-Hydroxypropyladenine, R-Isomer	-	-	DRUGBANK	DB02765	C8H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZYTEBKXLVLMY-RXMQYKEDSA-N
27303	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	2800	(South)-Methanocarba-Thymidine	-	-	DRUGBANK	DB02921	C12H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRMLXZVSFIBRRJ-PEFMBERDSA-N
27304	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	2800	(South)-Methanocarba-Thymidine	-	-	DRUGBANK	DB02921	C12H16N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XRMLXZVSFIBRRJ-PEFMBERDSA-N
27305	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	2876	9-Hydroxypropyladenine, S-Isomer	-	-	DRUGBANK	DB03000	C8H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZYTEBKXLVLMY-RXMQYKEDSA-N
27306	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	2876	9-Hydroxypropyladenine, S-Isomer	-	-	DRUGBANK	DB03000	C8H11N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MJZYTEBKXLVLMY-RXMQYKEDSA-N
27307	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	2907	Dextrofloxacine	-	-	DRUGBANK	DB03034	C18H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSDSWSVVBLHKDQ-SNVBAGLBSA-N
27308	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	2907	Dextrofloxacine	-	-	DRUGBANK	DB03034	C18H20FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GSDSWSVVBLHKDQ-SNVBAGLBSA-N
27309	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	3024	D-Glucuronic Acid	D-(+)-glucuronate|D-glucuronate|alpha-delta-glucuronic acid|Glucuronic acid|Glucosiduronic acid|alpha-D-glucopyranuronic acid|alpha-D-glucuronic acid|Glucuronate|GCU|delta-(+)-glucuronic acid|delta-glucuronate|delta-(+)-glucuronate|D-(+)-glucuronic acid|alpha-delta-glucopyranuronic acid|Glucosiduronate	-	DRUGBANK	DB03156	C6H10O7	small molecule	-	6556-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMOLEFTQBMNLQ-QIUUJYRFSA-N
27310	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	3024	D-Glucuronic Acid	D-(+)-glucuronate|D-glucuronate|alpha-delta-glucuronic acid|Glucuronic acid|Glucosiduronic acid|alpha-D-glucopyranuronic acid|alpha-D-glucuronic acid|Glucuronate|GCU|delta-(+)-glucuronic acid|delta-glucuronate|delta-(+)-glucuronate|D-(+)-glucuronic acid|alpha-delta-glucopyranuronic acid|Glucosiduronate	-	DRUGBANK	DB03156	C6H10O7	small molecule	-	6556-12-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMOLEFTQBMNLQ-QIUUJYRFSA-N
27311	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	3032	6-Amino-1-Methylpurine	-	-	DRUGBANK	DB03164	C6H7N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27312	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	3032	6-Amino-1-Methylpurine	-	-	DRUGBANK	DB03164	C6H7N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27313	4182131	934744	spr0304	pbpX	-	171101	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	3058	N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate	-	-	DRUGBANK	DB03190	C20H36O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWSYOWHJNGZJGU-WPZSKCEQSA-N
27314	4182131	934744	spr0304	pbpX	-	171101	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	3058	N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate	-	-	DRUGBANK	DB03190	C20H36O12	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWSYOWHJNGZJGU-WPZSKCEQSA-N
27315	4181864	934448	spr1232	aroC	-	171101	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
27316	4181864	934448	spr1232	aroC	-	171101	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
27317	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	3146	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	-	-	DRUGBANK	DB03280	C20H30N7O23P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCFDSPQTEMXXLO-MZWJRZEOSA-N
27318	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	3146	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	-	-	DRUGBANK	DB03280	C20H30N7O23P5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCFDSPQTEMXXLO-MZWJRZEOSA-N
27319	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	3177	5-Bromovinyldeoxyuridine	-	-	DRUGBANK	DB03312	C11H13BrN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODZBBRURCPAEIQ-RNVICZODSA-N
27320	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	3177	5-Bromovinyldeoxyuridine	-	-	DRUGBANK	DB03312	C11H13BrN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODZBBRURCPAEIQ-RNVICZODSA-N
27321	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	3178	Cephalosporin C	-	-	DRUGBANK	DB03313	C16H22N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKIDJSKDBPKTQ-PXWWUCIGSA-O
27322	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	3178	Cephalosporin C	-	-	DRUGBANK	DB03313	C16H22N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKIDJSKDBPKTQ-PXWWUCIGSA-O
27323	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	3178	Cephalosporin C	-	-	DRUGBANK	DB03313	C16H22N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKIDJSKDBPKTQ-PXWWUCIGSA-O
27324	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	3178	Cephalosporin C	-	-	DRUGBANK	DB03313	C16H22N3O8S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOKIDJSKDBPKTQ-PXWWUCIGSA-O
27325	4181864	934448	spr1232	aroC	-	171101	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	3213	Cobalt Hexammine Ion	-	-	DRUGBANK	DB03350	CoH12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRZXATGLRMBRQI-UHFFFAOYSA-N
27326	4181864	934448	spr1232	aroC	-	171101	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	3213	Cobalt Hexammine Ion	-	-	DRUGBANK	DB03350	CoH12N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRZXATGLRMBRQI-UHFFFAOYSA-N
27327	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	3220	7n-Methyl-8-Hydroguanosine-5'-Triphosphate	-	-	DRUGBANK	DB03358	C11H20N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUJQMJUTTBGELS-FCIPNVEPSA-N
27328	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	3220	7n-Methyl-8-Hydroguanosine-5'-Triphosphate	-	-	DRUGBANK	DB03358	C11H20N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUJQMJUTTBGELS-FCIPNVEPSA-N
27329	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
27330	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
27331	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	3348	7-Methylguanosine	-	-	DRUGBANK	DB03493	C11H16N5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHAROSJZRTIOK-FCIPNVEPSA-O
27332	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	3348	7-Methylguanosine	-	-	DRUGBANK	DB03493	C11H16N5O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGHAROSJZRTIOK-FCIPNVEPSA-O
27333	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
27334	4180268	931994	SP_1937	SP_1937	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	3596	Tris	Tromethamine|Tris(hydroxymethyl)aminomethane|THAM	sooryehan hyo fermented sun bl	DRUGBANK	DB03754	C4H11NO3	small molecule	-	77-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LENZDBCJOHFCAS-UHFFFAOYSA-N
27335	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	3643	5-Bromothienyldeoxyuridine	-	-	DRUGBANK	DB03804	C13H13BrN2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGUZFFOBAZCVRK-VAOFZXAKSA-N
27336	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	3643	5-Bromothienyldeoxyuridine	-	-	DRUGBANK	DB03804	C13H13BrN2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGUZFFOBAZCVRK-VAOFZXAKSA-N
27337	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Berman HM (2000)	10592235	172122	3643	5-Bromothienyldeoxyuridine	-	-	DRUGBANK	DB03804	C13H13BrN2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGUZFFOBAZCVRK-VAOFZXAKSA-N
27338	3508994	3707640	VACWR025	C3L	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
27339	3508994	3707640	VACWR025	C3L	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	3794	N,O6-Disulfo-Glucosamine	-	-	DRUGBANK	DB03959	C6H13NO11S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQTRACMFIGDHSN-RUTHBDMASA-N
27340	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	3935	3-Methylcytosine	-	-	DRUGBANK	DB04103	C5H8N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPHQQDZIRIHPHU-UHFFFAOYSA-O
27341	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	3935	3-Methylcytosine	-	-	DRUGBANK	DB04103	C5H8N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPHQQDZIRIHPHU-UHFFFAOYSA-O
27342	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	3970	6-Hydroxypropylthymine	-	-	DRUGBANK	DB04139	C8H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIEJBPVNLZZLGQ-UHFFFAOYSA-N
27343	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	3970	6-Hydroxypropylthymine	-	-	DRUGBANK	DB04139	C8H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIEJBPVNLZZLGQ-UHFFFAOYSA-N
27344	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Imming P (2006)	17016423	171742	4139	1-Methylcytosine	-	-	DRUGBANK	DB04314	C5H7N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWPZZUQOWRWFDB-UHFFFAOYSA-N
27345	3508905	3707551	VACWR095	J3R	-	10245	Vaccinia Virus	unknown	target	Overington JP (2006)	17139284	171741	4139	1-Methylcytosine	-	-	DRUGBANK	DB04314	C5H7N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HWPZZUQOWRWFDB-UHFFFAOYSA-N
27346	4179734	931459	SP_1371	SP_1371	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	4153	Shikimate-3-Phosphate	-	-	DRUGBANK	DB04328	C7H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYOJSKGCWNAKGW-HCWXCVPCSA-N
27347	4179734	931459	SP_1371	SP_1371	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	4153	Shikimate-3-Phosphate	-	-	DRUGBANK	DB04328	C7H11O8P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYOJSKGCWNAKGW-HCWXCVPCSA-N
27348	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Imming P (2006)	17016423	171742	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
27349	1969430	5651987	LMJF_23_0270	PTR1	-	347515	Leishmania major	unknown	target	Overington JP (2006)	17139284	171741	4220	7,8-Dihydrobiopterin	D-erythro-7,8-dihydrobiopterin	-	DRUGBANK	DB04400	C9H13N5O3	small molecule	-	6779-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEMXZDUTFRTWPE-AWFVSMACSA-N
27350	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Imming P (2006)	17016423	171742	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
27351	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Overington JP (2006)	17139284	171741	4298	Deoxythymidine	Thymidine|thymine deoxyriboside|deoxyribosylthymine|2'-Deoxythymidine	-	DRUGBANK	DB04485	C10H14N2O5	small molecule	-	50-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IQFYYKKMVGJFEH-GJMOJQLCSA-N
27352	4179734	931459	SP_1371	SP_1371	-	170187	Streptococcus pneumoniae	inhibitor	target	Imming P (2006)	17016423	171742	4349	Glyphosate	-	-	DRUGBANK	DB04539	C3H9NO5P	small molecule	-	1071-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDAORKBJWWYJS-UHFFFAOYSA-O
27353	4179734	931459	SP_1371	SP_1371	-	170187	Streptococcus pneumoniae	inhibitor	target	Chen X (2002)	11752352	171740	4349	Glyphosate	-	-	DRUGBANK	DB04539	C3H9NO5P	small molecule	-	1071-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDAORKBJWWYJS-UHFFFAOYSA-O
27354	4179734	931459	SP_1371	SP_1371	-	170187	Streptococcus pneumoniae	inhibitor	target	Overington JP (2006)	17139284	171741	4349	Glyphosate	-	-	DRUGBANK	DB04539	C3H9NO5P	small molecule	-	1071-83-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDAORKBJWWYJS-UHFFFAOYSA-O
27355	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Imming P (2006)	17016423	171742	4358	4-Deoxy-D-Glucuronic Acid	-	-	DRUGBANK	DB04548	C6H10O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDYCNQXUUBOMI-RFPGKLGKSA-N
27356	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Overington JP (2006)	17139284	171741	4358	4-Deoxy-D-Glucuronic Acid	-	-	DRUGBANK	DB04548	C6H10O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGDYCNQXUUBOMI-RFPGKLGKSA-N
27357	3508994	3707640	VACWR025	C3L	-	10245	Vaccinia Virus	unknown	target	Ganesh VK (2005)	16086578	188506	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
27358	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Zhang Z (2005)	15937332	153560	4589	Tanaproget	-	-	DRUGBANK	DB04787	C16H15N3OS	small molecule	-	304853-42-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYVFWTPEBMRKSR-UHFFFAOYSA-N
27359	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	4589	Tanaproget	-	-	DRUGBANK	DB04787	C16H15N3OS	small molecule	-	304853-42-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYVFWTPEBMRKSR-UHFFFAOYSA-N
27360	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Hayashi T (2007)	17141277	188508	7761	Celiprolol	RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea	-	DRUGBANK	DB04846	C20H33N3O4	small molecule	C07AB08	56980-93-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOATXPAWOHTVSZ-UHFFFAOYSA-N
27361	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Yao EH (2008)	18636069	188509	7761	Celiprolol	RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea	-	DRUGBANK	DB04846	C20H33N3O4	small molecule	C07AB08	56980-93-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOATXPAWOHTVSZ-UHFFFAOYSA-N
27362	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	antagonist	target	Chen X (2007)	17384462	188507	7761	Celiprolol	RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea	-	DRUGBANK	DB04846	C20H33N3O4	small molecule	C07AB08	56980-93-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOATXPAWOHTVSZ-UHFFFAOYSA-N
27363	4178437	930153	SP_0336	SP_0336	-	170187	Streptococcus pneumoniae	unknown	target	Davies TA (2007)	17470659	182006	4716	Ceftobiprole	Ceftobiprole Medocaril	zevtera|zeftera	DRUGBANK	DB04918	C20H22N8O6S2	small molecule	J01DI01	209467-52-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VOAZJEPQLGBXGO-SDAWRPRTSA-N
27364	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	inhibitor	target	Singh A (2015)	26384788	188510	5018	Cobimetinib	-	cotellic	DRUGBANK	DB05239	C21H21F3IN3O2	small molecule	-	934660-93-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSMCAPRUBJMWDF-KRWDZBQOSA-N
27365	110018	3818	-	KLKB1	KLK3|PPK	9606	Homo sapiens	inhibitor	target	Lehmann A (2008)	18613770	188511	5081	Ecallantide	-	kalbitor	DRUGBANK	DB05311	-	small molecule	B06AC03	460738-38-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27366	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	inverse agonist	target	Friedman JH (2013)	24016069	188512	5086	Pimavanserin	-	nuplazid	DRUGBANK	DB05316	C25H34FN3O2	small molecule	-	706779-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RKEWSXXUOLRFBX-UHFFFAOYSA-N
27367	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	antagonist	target	Goodkin R (1990)	2182794	188513	7762	Ramucirumab	-	cyramza	DRUGBANK	DB05578	C6374H9864N1692O1996S46	biologic	L01XC21	947687-13-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27368	108631	2348	-	FOLR1	FBP|FOLR	9606	Homo sapiens	antibody	target	Kalli KR (2007)	18058577	188514	7763	Farletuzumab	Fareletuzumab	-	DRUGBANK	DB05595	-	biologic	-	896723-44-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27369	4178552	930269	SP_0369	SP_0369	-	170187	Streptococcus pneumoniae	unknown	target	Dalhoff A (2003)	12886052	188515	5283	faropenem medoxomil	SUN-A0026|Faropenem daloxate|SUN-208	-	DRUGBANK	DB05659	C17H19NO8S	small molecule	-	141702-36-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQBKWZPHJOEQAO-DVPVEWDBSA-N
27370	4179442	931164	SP_1673	SP_1673	-	170187	Streptococcus pneumoniae	unknown	target	Dalhoff A (2003)	12886052	188515	5283	faropenem medoxomil	SUN-A0026|Faropenem daloxate|SUN-208	-	DRUGBANK	DB05659	C17H19NO8S	small molecule	-	141702-36-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQBKWZPHJOEQAO-DVPVEWDBSA-N
27371	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27372	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27373	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	partial agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27374	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27375	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1998)	9850732	172163	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27376	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (2001)	11327694	172166	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27377	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Locci P (1995)	7648625	172165	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27378	112898	7040	-	TGFB1	CED|DPD1|LAP|TGFB|TGFbeta	9606	Homo sapiens	inhibitor	target	Chang NS (1997)	9435505	172164	7766	Hyaluronidase (Human Recombinant)	Hyaluronidase recombinant human|Recombinant human hyaluronidase	hylenex recombinant	DRUGBANK	DB06205	-	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27379	111007	4953	-	ODC1	ODC	9606	Homo sapiens	antagonist	target	Poulin R (1992)	1730582	188517	7768	Eflornithine	-difluoromethylornithine|DFMO|(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid	vaniqa	DRUGBANK	DB06243	C6H12F2N2O2	small molecule	P01CX03|D11AX16	70052-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLCYCQAOQCDTCN-UHFFFAOYSA-N
27380	111007	4953	-	ODC1	ODC	9606	Homo sapiens	blocker	target	Poulin R (1992)	1730582	188517	7768	Eflornithine	-difluoromethylornithine|DFMO|(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid	vaniqa	DRUGBANK	DB06243	C6H12F2N2O2	small molecule	P01CX03|D11AX16	70052-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VLCYCQAOQCDTCN-UHFFFAOYSA-N
27381	109592	3360	-	HTR4	5-HT4|5-HT4R	9606	Homo sapiens	agonist	target	Briejer MR (2001)	11438309	188518	7774	Prucalopride	-	resotran	DRUGBANK	DB06480	C18H26ClN3O3	small molecule	A06AX05	179474-81-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPMNHBXQOOVQJL-UHFFFAOYSA-N
27382	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Stoddart CA (2007)	18043758	188519	5556	Bevirimat	PA-457|YK-FH312	-	DRUGBANK	DB06581	C36H56O6	small molecule	-	174022-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJEJKUQEXFSVCJ-WRFMNRASSA-N
27383	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Basavaraju KP (2008)	18564273	188520	7775	Mepolizumab	-	nucala	DRUGBANK	DB06612	-	biologic	L04AC06	196078-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27384	109781	3567	-	IL5	EDF|IL-5|TRF	9606	Homo sapiens	antagonist	target	Garrett JK (2004)	14699394	188521	7775	Mepolizumab	-	nucala	DRUGBANK	DB06612	-	biologic	L04AC06	196078-29-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27385	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Spiller H (2008)	18259967	188522	7778	Tetryzoline	Tetrizolina|Tetryzolin|Ttryzoline|Tetryzolinum|(RS)-2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole|Tetrahydrozoline	visine multi-symptom|major red	DRUGBANK	DB06764	C13H16N2	small molecule	R01AA06|S01GA52|R01AB03|S01GA02	84-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYJAVTDNIXVSPW-UHFFFAOYSA-N
27386	4180008	931733	SP_1219	SP_1219	-	170187	Streptococcus pneumoniae	antagonist	target	Carter NJ (2009)	20030427	188523	5630	Besifloxacin	Besifloxacin|SS734	besivance	DRUGBANK	DB06771	C19H21ClFN3O3	small molecule	S01AE08	141388-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFFGVLORLPOAEC-SNVBAGLBSA-N
27387	4179084	930805	SP_0855	SP_0855	-	170187	Streptococcus pneumoniae	antagonist	target	Carter NJ (2009)	20030427	188523	5630	Besifloxacin	Besifloxacin|SS734	besivance	DRUGBANK	DB06771	C19H21ClFN3O3	small molecule	S01AE08	141388-76-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFFGVLORLPOAEC-SNVBAGLBSA-N
27388	36434	856398	YHR007C	ERG11	CYP51|sterol 14-demethylase|L000000577	559292	Saccharomyces cerevisiae	unknown	target	Berman HM (2000)	10592235	172122	5710	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	-	-	DRUGBANK	DB06890	C15H16N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MODBYAQUXXEFRM-CQSZACIVSA-N
27389	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	5729	[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE	-	-	DRUGBANK	DB06910	C25H30N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWJSQELMWLOYSO-LWSSLDFYSA-N
27390	4180562	933049	spr1514	murF	-	171101	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	5789	2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE	-	-	DRUGBANK	DB06970	C19H20ClN3O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MZCDQILVXXIMEV-UHFFFAOYSA-N
27391	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6001	6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione	-	-	DRUGBANK	DB07184	C16H26N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JKXLRLDPSLZEDD-UHFFFAOYSA-N
27392	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6008	4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE	-	-	DRUGBANK	DB07191	C20H15BrN6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYGWGZALEOIKDF-UHFFFAOYSA-N
27393	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6148	ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE	-	-	DRUGBANK	DB07332	C17H16Cl2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJPLEFFCVDQQFZ-INIZCTEOSA-N
27394	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6283	(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE	-	-	DRUGBANK	DB07472	C17H15NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQVDJZWFSZSGGA-QGZVFWFLSA-N
27395	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6284	(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER	-	-	DRUGBANK	DB07473	C18H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYIHODAXBBPFQF-MAUKXSAKSA-N
27396	4351372	923550	MT1988	MT1988	-	83331	Mycobacterium tuberculosis	unknown	target	Berman HM (2000)	10592235	172122	6307	1,3-DIPHENYLUREA	-	-	DRUGBANK	DB07496	C13H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GWEHVDNNLFDJLR-UHFFFAOYSA-N
27397	36434	856398	YHR007C	ERG11	CYP51|sterol 14-demethylase|L000000577	559292	Saccharomyces cerevisiae	unknown	target	Berman HM (2000)	10592235	172122	6369	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	-	-	DRUGBANK	DB07560	C17H25N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYLDPSVXLWTIAJ-HNNXBMFYSA-N
27398	36434	856398	YHR007C	ERG11	CYP51|sterol 14-demethylase|L000000577	559292	Saccharomyces cerevisiae	unknown	target	Berman HM (2000)	10592235	172122	6376	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	-	-	DRUGBANK	DB07568	C19H15N5O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADRNPUSZBRQDBG-KRWDZBQOSA-N
27399	36434	856398	YHR007C	ERG11	CYP51|sterol 14-demethylase|L000000577	559292	Saccharomyces cerevisiae	unknown	target	Berman HM (2000)	10592235	172122	6377	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	-	-	DRUGBANK	DB07569	C18H27N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCZKGSPGDOPDAI-LZWOXQAQSA-N
27400	36434	856398	YHR007C	ERG11	CYP51|sterol 14-demethylase|L000000577	559292	Saccharomyces cerevisiae	unknown	target	Berman HM (2000)	10592235	172122	6380	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	-	-	DRUGBANK	DB07572	C16H19N3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITYCDQJBLCTIID-UHFFFAOYSA-N
27401	36434	856398	YHR007C	ERG11	CYP51|sterol 14-demethylase|L000000577	559292	Saccharomyces cerevisiae	unknown	target	Berman HM (2000)	10592235	172122	6441	bis(4-hydroxyphenyl)methanone	-	-	DRUGBANK	DB07635	C13H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXNYJUSEXLAVNQ-UHFFFAOYSA-N
27402	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6580	N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA	-	-	DRUGBANK	DB07781	C16H16FN5OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQSCCWFMTRVFDA-UHFFFAOYSA-N
27403	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6596	N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA	-	-	DRUGBANK	DB07797	C15H16ClFN4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEBKSFPYWMOUBR-UHFFFAOYSA-N
27404	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6618	6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL	-	-	DRUGBANK	DB07820	C19H26N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVGVZWUORYLPAL-UHFFFAOYSA-N
27405	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6624	2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide	-	-	DRUGBANK	DB07826	C21H16ClNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTGVSZSMDOMAEB-UHFFFAOYSA-N
27406	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6661	4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07864	C17H16FNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVJFHKQYMKKIHK-UHFFFAOYSA-N
27407	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6664	6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07867	C18H22ClNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BNZHKKGOSYAQSW-UHFFFAOYSA-N
27408	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6665	6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07868	C18H22ClNOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CLKFNGKDJYMUPK-UHFFFAOYSA-N
27409	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6666	6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07869	C18H22ClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRBUGQMJMFAHKS-QHCPKHFHSA-N
27410	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6668	6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE	-	-	DRUGBANK	DB07871	C18H22ClNO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OQCFORGSZJSAEL-UHFFFAOYSA-N
27411	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6681	ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE	-	-	DRUGBANK	DB07884	C14H17FN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KELNNWMENBUHNS-NSHDSACASA-N
27412	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6689	1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE	-	-	DRUGBANK	DB07892	C14H16N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDMHBHNRWDNNCD-UHFFFAOYSA-N
27413	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6706	PHENYLALANINDIOL	-	-	DRUGBANK	DB07910	C9H13NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFTWVTAUEXLCHB-QMMMGPOBSA-N
27414	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6946	3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile	-	-	DRUGBANK	DB08154	C21H13Cl2N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHCLIFOVZDANCU-UHFFFAOYSA-N
27415	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	6980	6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL	-	-	DRUGBANK	DB08188	C17H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLILORUFDVLTSP-UHFFFAOYSA-N
27416	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7002	5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide	-	-	DRUGBANK	DB08211	C13H14BrN3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEPUPYVRZUWCQB-UHFFFAOYSA-N
27417	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7074	NAPHTHYLOXYACETIC ACID	-	-	DRUGBANK	DB08286	C12H10O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GHRYSOFWKRRLMI-UHFFFAOYSA-N
27418	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7157	1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA	-	-	DRUGBANK	DB08372	C16H19FN4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOVMZMFNTIUFLU-UHFFFAOYSA-N
27419	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	7160	PCNOTAXIME GROUP	-	-	DRUGBANK	DB08375	C14H15N5O6S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRDXEERHKBZJMY-KTFFUYHOSA-N
27420	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7164	6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one	-	-	DRUGBANK	DB08379	C17H12ClFN2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOVPOXGMADEKPP-UHFFFAOYSA-N
27421	4178412	930127	SP_0314	SP_0314	-	170187	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	7220	(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID	-	-	DRUGBANK	DB08438	C22H40O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XWTWKBKNEMLBKW-KCWNHAIFSA-N
27422	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10794682	188524	7221	Parecoxib	-	-	DRUGBANK	DB08439	C19H18N2O4S	small molecule	M01AH04	198470-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZRHLKRLEZJVIJ-UHFFFAOYSA-N
27423	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7226	3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile	-	-	DRUGBANK	DB08444	C20H14BrN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYGZQXRLQMFHDH-UHFFFAOYSA-N
27424	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7228	3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile	-	-	DRUGBANK	DB08446	C19H10BrClFN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHQMEDBYNUAVNE-UHFFFAOYSA-N
27425	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7240	3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile	-	-	DRUGBANK	DB08459	C20H12Cl2N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SVMHTBVIPYVDIL-UHFFFAOYSA-N
27426	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7241	3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile	-	-	DRUGBANK	DB08460	C20H13Cl2N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXDIHAQCVNNLIB-UHFFFAOYSA-N
27427	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7274	S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate	-	-	DRUGBANK	DB08494	C19H20ClN3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AWAKIULNKVOBKE-UHFFFAOYSA-N
27428	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7281	5-(3,5-DICHLOROPHENYL)THIO-4-ISOPROPYL-1-(PYRIDIN-4-YL-METHYL)-1H-IMIDAZOL-2-YL-METHYL CARBAMATE	-	-	DRUGBANK	DB08502	C20H20Cl2N4O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQXCVAGCMNFUMQ-UHFFFAOYSA-N
27429	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	7287	N-BENZOYL-D-ALANINE	-	-	DRUGBANK	DB08508	C10H11NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAQVHNZEONHPQG-SSDOTTSWSA-N
27430	4181932	934523	spr1310	def	-	171101	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	7301	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	-	-	DRUGBANK	DB08523	C10H15NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GELOPWXSYZDPJT-UHFFFAOYSA-N
27431	4181932	934523	spr1310	def	-	171101	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	7302	2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE	-	-	DRUGBANK	DB08524	C16H15NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZHFKBNAHHTUQBH-UHFFFAOYSA-N
27432	4181932	934523	spr1310	def	-	171101	Streptococcus pneumoniae	unknown	target	Berman HM (2000)	10592235	172122	7303	HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE	-	-	DRUGBANK	DB08525	C10H14N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJYUGRZKJXCRFF-UHFFFAOYSA-N
27433	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7306	2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE	-	-	DRUGBANK	DB08528	C15H14N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SWGDXLAZBZDUBR-UHFFFAOYSA-N
27434	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7375	4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE	-	-	DRUGBANK	DB08598	C16H20ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCSLUNOLLUVOOG-NSHDSACASA-N
27435	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7408	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	-	-	DRUGBANK	DB08634	C22H24N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSAAUHMSLCPIEX-UHFFFAOYSA-N
27436	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7439	6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE	-	-	DRUGBANK	DB08665	C15H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YCFJZPGDTZVVSM-UHFFFAOYSA-N
27437	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7453	2-METHYL-FURAN-3-CARBOTHIOIC ACID [4-CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)-PHENYL]-AMIDE	-	-	DRUGBANK	DB08679	C17H18ClNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZHIXLCGPOTQNB-UHFFFAOYSA-N
27438	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7454	N-[4-CLORO-3-(T-BUTYLOXOME)PHENYL-2-METHYL-3-FURAN-CARBOTHIAMIDE	-	-	DRUGBANK	DB08680	C17H19ClN2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLGIIOKXCKDKEU-VXLYETTFSA-N
27439	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7455	1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE	-	-	DRUGBANK	DB08681	C14H18ClNO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXTNFJKQZPETJA-UHFFFAOYSA-N
27440	1205538	155348	HIV1gp1	gag-pol	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7456	1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE	-	-	DRUGBANK	DB08682	C16H18ClNO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMQGUMRNTBJHEA-UHFFFAOYSA-N
27441	4182173	934791	spr0329	pbpA	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	7566	Azidocillin	Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	-	DRUGBANK	DB08795	C16H17N5O4S	small molecule	J01CE04	17243-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODFHGIPNGIAMDK-NJBDSQKTSA-N
27442	4181047	933569	spr1823	pbp2a	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	7566	Azidocillin	Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	-	DRUGBANK	DB08795	C16H17N5O4S	small molecule	J01CE04	17243-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODFHGIPNGIAMDK-NJBDSQKTSA-N
27443	4181402	933948	spr1517	pbp2b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	7566	Azidocillin	Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	-	DRUGBANK	DB08795	C16H17N5O4S	small molecule	J01CE04	17243-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODFHGIPNGIAMDK-NJBDSQKTSA-N
27444	4182263	934893	spr1909	pbp1b	-	171101	Streptococcus pneumoniae	inhibitor	target	Williamson R (1980)	7447421	175169	7566	Azidocillin	Azidocilline|Azidocillinum|Azidocilina|D-(-)-(alpha-Azidobenzyl)penicillin|(2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid	-	DRUGBANK	DB08795	C16H17N5O4S	small molecule	J01CE04	17243-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODFHGIPNGIAMDK-NJBDSQKTSA-N
27445	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Wood JM (2003)	12927775	188528	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27446	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Gradman AH (2006)	16965731	188529	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27447	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Nussberger J (2002)	11799102	188526	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27448	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Menard J (2006)	16467656	188527	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27449	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27450	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Azizi M (2006)	16508564	188525	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27451	108448	2149	-	F2R	CF2R|HTR|PAR-1|PAR1|TR	9606	Homo sapiens	antagonist	target	Bonaca MP (2009)	19715408	188530	7794	Vorapaxar	Ethyl N-[(3R,3aS,4S,4aR,7R,8aR,9aR)-4-[(E)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f]isobenzofuran-7-yl]carbamate|Carbamic acid, N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester|[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-Fluorophnyl)-2-pyridinyl]vinyl}-1-mthyl-3-oxododcahydronaphto[2,3-c]furan-6-yl]carbamate d'thyle|Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2- pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl ester	zontivity	DRUGBANK	DB09030	C29H33FN2O4	small molecule	B01AC26	618385-01-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBGXUVOIWDMMJE-QHNZEKIYSA-N
27452	109901	3695	-	ITGB7	-	9606	Homo sapiens	antibody	target	Soler D (2009)	19509315	188531	7796	Vedolizumab	Entyvio	entyvio	DRUGBANK	DB09033	C6528H10072N1732O2042S42	biologic	L04AA33	943609-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27453	109883	3676	-	ITGA4	CD49D|IA4	9606	Homo sapiens	antibody	target	Soler D (2009)	19509315	188531	7796	Vedolizumab	Entyvio	entyvio	DRUGBANK	DB09033	C6528H10072N1732O2042S42	biologic	L04AA33	943609-66-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27454	109312	3062	-	HCRTR2	OX2R	9606	Homo sapiens	antagonist	target	Palasz A (2014)	23702225	188532	7797	Suvorexant	[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone|[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-mthyl-1,4-diazpan-1-yl][5-mthyl-2-(2H-1,2,3-triazol-2-yl)phnyl]mthanone|[(7R)-4-(5-Chlor-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanon|[(7R)-4-(5-chlorobenzoxazol-2-yl)-7-methylhexahydro-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone	belsomra	DRUGBANK	DB09034	C23H23ClN6O2	small molecule	-	1030377-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYTNQNCOQXFQPK-MRXNPFEDSA-N
27455	109311	3061	-	HCRTR1	OX1R	9606	Homo sapiens	antagonist	target	Palasz A (2014)	23702225	188532	7797	Suvorexant	[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone|[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-mthyl-1,4-diazpan-1-yl][5-mthyl-2-(2H-1,2,3-triazol-2-yl)phnyl]mthanone|[(7R)-4-(5-Chlor-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanon|[(7R)-4-(5-chlorobenzoxazol-2-yl)-7-methylhexahydro-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone	belsomra	DRUGBANK	DB09034	C23H23ClN6O2	small molecule	-	1030377-33-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYTNQNCOQXFQPK-MRXNPFEDSA-N
27456	111160	5133	-	PDCD1	CD279|PD-1|PD1|SLEB2|hPD-1|hPD-l|hSLE1	9606	Homo sapiens	antibody	target	Taneja SS (2012)	23289116	188533	7798	Nivolumab	-	opdivo	DRUGBANK	DB09035	C6362H9862N1712O1995S42	biologic	L01XC17	946414-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27457	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antagonist	target	van Zaanen HC (1996)	8823310	188534	7799	Siltuximab	-	sylvant	DRUGBANK	DB09036	C6450H9932N1688O2016S50	biologic	L04AC11	541502-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27458	109783	3569	-	IL6	BSF2|HGF|HSF|IFNB2|IL-6	9606	Homo sapiens	antibody	target	van Zaanen HC (1996)	8823310	188534	7799	Siltuximab	-	sylvant	DRUGBANK	DB09036	C6450H9932N1688O2016S50	biologic	L04AC11	541502-14-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27459	111160	5133	-	PDCD1	CD279|PD-1|PD1|SLEB2|hPD-1|hPD-l|hSLE1	9606	Homo sapiens	antagonist	target	McDermott J (2015)	25685857	188535	7800	Pembrolizumab	-	keytruda	DRUGBANK	DB09037	C6504H10004N1716O2036S46	biologic	L01XC18	1374853-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27460	111160	5133	-	PDCD1	CD279|PD-1|PD1|SLEB2|hPD-1|hPD-l|hSLE1	9606	Homo sapiens	antibody	target	McDermott J (2015)	25685857	188535	7800	Pembrolizumab	-	keytruda	DRUGBANK	DB09037	C6504H10004N1716O2036S46	biologic	L01XC18	1374853-91-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27461	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	inhibitor	target	Vivian EM (2015)	25598831	188536	7801	Empagliflozin	(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene	jardiance|glyxambi|synjardy|sy	DRUGBANK	DB09038	C23H27ClO7	small molecule	A10BD19|A10BD20|A10BX12	864070-44-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBWASQILIWPZMG-QZMOQZSNSA-N
27462	112415	6524	-	SLC5A2	SGLT2	9606	Homo sapiens	antagonist	target	Vivian EM (2015)	25598831	188536	7801	Empagliflozin	(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene	jardiance|glyxambi|synjardy|sy	DRUGBANK	DB09038	C23H27ClO7	small molecule	A10BD19|A10BD20|A10BX12	864070-44-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OBWASQILIWPZMG-QZMOQZSNSA-N
27463	113204	7357	-	UGCG	GCS|GLCT1	9606	Homo sapiens	antagonist	target	Poole RM (2014)	25239269	188537	7802	Eliglustat	N-[(1R,2R)-1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(1-pyrrolidinyl)-2-propanyl]octanamide	cerdelga	DRUGBANK	DB09039	C23H36N2O4	small molecule	A16AX10	491833-29-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJZZPCZKBUKGGU-AUSIDOKSSA-N
27464	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Trujillo JM (2014)	25136065	188538	7806	Albiglutide	-	eperzan|tanzeum	DRUGBANK	DB09043	C3232H5032N864O979S41	biologic	A10BX13	782500-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27465	109002	2740	-	GLP1R	-	9606	Homo sapiens	agonist	target	Sanford M (2014)	25367716	188539	7807	Dulaglutide	-	trulicity	DRUGBANK	DB09045	C2646H4044N704O836S18	biologic	A10BX14	923950-08-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27466	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	inhibitor	target	McKeage K (2015)	25808831	188540	7808	Finafloxacin	gastrochinolon|gastroquinolone|8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid	xtoro	DRUGBANK	DB09047	C20H19FN4O4	small molecule	-	209342-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYMHQCNFKNMJAV-HOTGVXAUSA-N
27467	112732	6869	-	TACR1	NK1R|NKIR|SPR|TAC1R	9606	Homo sapiens	antagonist	target	Darmani NA (2015)	25687374	188541	7809	Netupitant	2-[3,5-Bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]propanamide	akynzeo	DRUGBANK	DB09048	C30H32F6N4O	small molecule	-	290297-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAXQNWCZJDTGBU-UHFFFAOYSA-N
27468	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Leonard J (2015)	25471070	188542	7810	Naloxegol	(5,6)-17-Allyl-6-[(20-hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl)oxy]-4,5-epoxymorphinan-3,14-diol	movantik	DRUGBANK	DB09049	C34H53NO11	small molecule	A06AH03	854601-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XNKCCCKFOQNXKV-ZRSCBOBOSA-N
27469	107368	930	-	CD19	B4|CVID3	9606	Homo sapiens	activator	target	Zugmaier G (2015)	25883042	188543	7813	Blinatumomab	-	blincyto	DRUGBANK	DB09052	C2367H3577N649O772S19	biologic	L01XC19	853426-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27470	107353	915	-	CD3D	CD3-DELTA|IMD19|T3D	9606	Homo sapiens	activator	target	Zugmaier G (2015)	25883042	188543	7813	Blinatumomab	-	blincyto	DRUGBANK	DB09052	C2367H3577N649O772S19	biologic	L01XC19	853426-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27471	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	inhibitor	target	Kim ES (2015)	25802231	188544	7814	Ibrutinib	1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one	imbruvica	DRUGBANK	DB09053	C25H24N6O2	small molecule	L01XE27	936563-96-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XYFPWWZEPKGCCK-GOSISDBHSA-N
27472	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	antagonist	target	Galkin AV (2007)	17185414	188545	7816	Ceritinib	critinib|N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide	zykadia	DRUGBANK	DB09063	C28H36ClN5O3S	small molecule	L01XE28	1032900-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VERWOWGGCGHDQE-UHFFFAOYSA-N
27473	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	antagonist	target	Marsilje TH (2013)	23742252	188546	7816	Ceritinib	critinib|N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide	zykadia	DRUGBANK	DB09063	C28H36ClN5O3S	small molecule	L01XE28	1032900-25-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VERWOWGGCGHDQE-UHFFFAOYSA-N
27474	106548	30	-	ACAA1	ACAA|PTHIO|THIO	9606	Homo sapiens	inhibitor	target	Kantor PF (2000)	10720420	188547	7818	Trimetazidine	1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride	-	DRUGBANK	DB09069	C14H22N2O3	small molecule	C01EB15	5011-34-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHWVSEOVJBQKBE-UHFFFAOYSA-N
27475	110640	4544	-	MTNR1B	FGQTL2|MEL-1B-R|MT2	9606	Homo sapiens	agonist	target	Lavedan C (2015)	25534555	188548	7819	Tasimelteon	tasimelton|N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide	hetlioz	DRUGBANK	DB09071	C15H19NO2	small molecule	N05CH03	609799-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOIAAWZLUQTIO-GXFFZTMASA-N
27476	110639	4543	-	MTNR1A	MEL-1A-R|MT1	9606	Homo sapiens	agonist	target	Lavedan C (2015)	25534555	188548	7819	Tasimelteon	tasimelton|N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide	hetlioz	DRUGBANK	DB09071	C15H19NO2	small molecule	N05CH03	609799-22-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PTOIAAWZLUQTIO-GXFFZTMASA-N
27477	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	inhibitor	target	Fry DW (2004)	15542782	188549	7820	Palbociclib	6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one	ibrance	DRUGBANK	DB09073	C24H29N7O2	small molecule	L01XE33	571190-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHJRHEGDXFFMBM-UHFFFAOYSA-N
27478	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	inhibitor	target	Fry DW (2004)	15542782	188549	7820	Palbociclib	6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one	ibrance	DRUGBANK	DB09073	C24H29N7O2	small molecule	L01XE33	571190-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AHJRHEGDXFFMBM-UHFFFAOYSA-N
27479	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	inhibitor	target	Verhagen CV (2015)	25981132	188550	7821	Olaparib	4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one	lynparza	DRUGBANK	DB09074	-	small molecule	L01XX46	763113-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27480	115351	10039	-	PARP3	ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3	9606	Homo sapiens	inhibitor	target	Verhagen CV (2015)	25981132	188550	7821	Olaparib	4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one	lynparza	DRUGBANK	DB09074	-	small molecule	L01XX46	763113-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27481	115350	10038	-	PARP2	ADPRT2|ADPRTL2|ADPRTL3|ARTD2|PARP-2|pADPRT-2	9606	Homo sapiens	inhibitor	target	Verhagen CV (2015)	25981132	188550	7821	Olaparib	4-(3-{[4-(cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorobenzyl)phthalazin-1(2H)-one	lynparza	DRUGBANK	DB09074	-	small molecule	L01XX46	763113-22-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27482	108457	2159	RP11-98F14.9	F10	FX|FXA	9606	Homo sapiens	inhibitor	target	Turpie AG (2008)	18096568	188551	7822	Edoxaban	-	lixiana|savaysa	DRUGBANK	DB09075	C24H30ClN7O4S	small molecule	-	480449-70-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HGVDHZBSSITLCT-JLJPHGGASA-N
27483	107553	1131	-	CHRM3	EGBRS|HM3	9606	Homo sapiens	antagonist	target	Salmon M (2013)	23435542	188552	7823	Umeclidinium	1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane	incruse ellipta|anoro ellipta	DRUGBANK	DB09076	C29H34NO2	small molecule	R03BB07|R03AL03	869185-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTWTVQXNAJTQP-UHFFFAOYSA-N
27484	107554	1132	-	CHRM4	HM4|M4R	9606	Homo sapiens	antagonist	target	Salmon M (2013)	23435542	188552	7823	Umeclidinium	1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane	incruse ellipta|anoro ellipta	DRUGBANK	DB09076	C29H34NO2	small molecule	R03BB07|R03AL03	869185-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTWTVQXNAJTQP-UHFFFAOYSA-N
27485	107550	1128	-	CHRM1	HM1|M1|M1R	9606	Homo sapiens	antagonist	target	Salmon M (2013)	23435542	188552	7823	Umeclidinium	1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane	incruse ellipta|anoro ellipta	DRUGBANK	DB09076	C29H34NO2	small molecule	R03BB07|R03AL03	869185-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTWTVQXNAJTQP-UHFFFAOYSA-N
27486	107555	1133	-	CHRM5	HM5	9606	Homo sapiens	antagonist	target	Salmon M (2013)	23435542	188552	7823	Umeclidinium	1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane	incruse ellipta|anoro ellipta	DRUGBANK	DB09076	C29H34NO2	small molecule	R03BB07|R03AL03	869185-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTWTVQXNAJTQP-UHFFFAOYSA-N
27487	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Salmon M (2013)	23435542	188552	7823	Umeclidinium	1-[2-(benzyloxy)ethyl]-4-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octane	incruse ellipta|anoro ellipta	DRUGBANK	DB09076	C29H34NO2	small molecule	R03BB07|R03AL03	869185-19-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTWTVQXNAJTQP-UHFFFAOYSA-N
27488	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27489	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27490	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27491	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27492	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27493	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27494	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27495	108555	2264	-	FGFR4	CD334|JTK2|TKF	9606	Homo sapiens	inhibitor	target	Matsui J (2008)	17943726	188553	7825	Lenvatinib	4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide|Lenvatinib Mesylate	lenvima	DRUGBANK	DB09078	C21H19ClN4O4	small molecule	L01XE29	417716-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WOSKHXYHFSIKNG-UHFFFAOYSA-N
27496	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27497	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27498	108552	2261	-	FGFR3	ACH|CD333|CEK2|HSFGFR3EX|JTK4	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27499	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27500	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27501	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27502	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27503	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27504	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27505	110245	4067	-	LYN	JTK8|p53Lyn|p56Lyn	9606	Homo sapiens	inhibitor	target	Hilberg F (2008)	18559524	188554	7826	Nintedanib	methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate	ofev	DRUGBANK	DB09079	C31H33N5O4	small molecule	L01XE31	656247-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZXHXSATPCNXJR-ZIADKAODSA-N
27506	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Bouyssou T (2010)	20371707	188555	7827	Olodaterol	-	inspiolto respimat|stiolto res	DRUGBANK	DB09080	C21H26N2O5	small molecule	R03AL06|R03AC19	868049-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COUYJEVMBVSIHV-SFHVURJKSA-N
27507	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Ruffolo RR (1982)	6123592	188557	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27508	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Horie K (1995)	8564227	188556	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27509	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	partial agonist	target	Ruffolo RR (1982)	6123592	188557	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27510	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	partial agonist	target	Horie K (1995)	8564227	188556	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27511	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Ruffolo RR (1982)	6123592	188557	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27512	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Horie K (1995)	8564227	188556	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27513	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Ruffolo RR (1982)	6123592	188557	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27514	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Horie K (1995)	8564227	188556	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27515	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Ruffolo RR (1982)	6123592	188557	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27516	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Horie K (1995)	8564227	188556	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27517	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	partial agonist	target	Ruffolo RR (1982)	6123592	188557	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27518	106656	146	-	ADRA1D	ADRA1|ADRA1A|ADRA1R|ALPHA1|DAR|dJ779E11.2	9606	Homo sapiens	partial agonist	target	Horie K (1995)	8564227	188556	7946	Cirazoline	-	-	DRUGBANK	DB09202	C13H16N2O	small molecule	-	59939-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YAORIDZYZDUZCM-UHFFFAOYSA-N
27519	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Yoshikawa T (2001)	11350861	188558	7951	AS-8112	-	-	DRUGBANK	DB09207	C17H27BrN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALSFUWTAOKVTF-GFCCVEGCSA-N
27520	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Yoshikawa T (2001)	11350861	188558	7951	AS-8112	-	-	DRUGBANK	DB09207	C17H27BrN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALSFUWTAOKVTF-GFCCVEGCSA-N
27521	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	McCann ME (2004)	15077695	188559	7961	Firocoxib	-	-	DRUGBANK	DB09217	C17H20O5S	small molecule	-	189954-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FULAPETWGIGNMT-UHFFFAOYSA-N
27522	116358	11188	-	NISCH	I-1|IR1|IRAS|hIRAS	9606	Homo sapiens	agonist	target	Ernsberger P (1993)	8380858	188560	7986	Moxonidine	-	-	DRUGBANK	DB09242	C9H12ClN5O	small molecule	C02LC05|C02AC05	75438-57-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPNJAUFVNXKLIM-UHFFFAOYSA-N
27523	111030	4985	-	OPRD1	OPRD	9606	Homo sapiens	antagonist	target	Fujita W (2014)	25261794	188561	8016	Eluxadoline	5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid	viberzi	DRUGBANK	DB09272	C32H35N5O5	small molecule	-	864821-90-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFNHIDANIVGXPE-FNZWTVRRSA-N
27524	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Dove LS (2013)	23583433	188562	8016	Eluxadoline	5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid	viberzi	DRUGBANK	DB09272	C32H35N5O5	small molecule	-	864821-90-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFNHIDANIVGXPE-FNZWTVRRSA-N
27525	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	agonist	target	Fujita W (2014)	25261794	188561	8016	Eluxadoline	5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid	viberzi	DRUGBANK	DB09272	C32H35N5O5	small molecule	-	864821-90-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QFNHIDANIVGXPE-FNZWTVRRSA-N
27526	129116	255738	PSEC0052	PCSK9	FH3|HCHOLA3|LDLCQ1|NARC-1|NARC1|PC9	9606	Homo sapiens	inhibitor	target	Devito F (2015)	26455563	188563	8046	Alirocumab	-	praluent	DRUGBANK	DB09302	C6472H9996N1736O2032S42	biologic	-	1245916-14-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27527	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Hendrickson LM (2013)	23641218	188488	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27528	4352387	924569	MT1417	MT1417	-	83331	Mycobacterium tuberculosis	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
27529	4351464	923642	MT1933	MT1933	-	83331	Mycobacterium tuberculosis	unknown	target	Berman HM (2000)	10592235	172122	7422	8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID	-	-	DRUGBANK	DB08648	C10H12O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRZHNRULRHECRF-JQCUSGDOSA-N
27530	4359045	13316550	RVBD_1761c	RVBD_1761c	-	83332	Mycobacterium tuberculosis	unknown	target	Berman HM (2000)	10592235	172122	7008	2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL	-	-	DRUGBANK	DB08217	C9H17NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRRNXPDUICGIEB-UHFFFAOYSA-N
27531	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Imming P (2006)	17016423	171742	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
27532	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Overington JP (2006)	17139284	171741	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
27533	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Suzuki M (2006)	16797734	174260	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
27534	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Henrot A (2002)	12122323	174259	187	Vidarabine	9--D-arabinofuranosyladenine|9-beta-D-arabinofuranosyl-adenine|Spongoadenosine|9--D-arabinofuranosyl-9H-purin-6-amine|2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol|Vidarabine|9-beta-D-Arabinofuranosyl-9H-purin-6-amine|9-beta-D-Arabinofuranosyladenine	-	DRUGBANK	DB00194	C10H13N5O4	small molecule	S01AD06|J05AB03	24356-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OIRDTQYFTABQOQ-UHTZMRCNSA-N
27535	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	unknown	target	Wild K (1997)	9336833	174669	242	Idoxuridine	5-Iododeoxyuridine|Joddeoxiuridin|IdU|1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil|5-iodo-2'-deoxyuridine|(+)-5-Iodo-2'-deoxyuridine|2'-Deoxy-5-iodouridine|Idoxuridinum|1beta-D-2'-Deoxyribofuranosyl-5-iodouracil|Iodoxuridine|1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil|Iododeoxyridine|Idoxuridin|Idoxuridine|5-Iodouracil deoxyriboside|Idoxuridina	sandoz idoxuridine|herplex|her	DRUGBANK	DB00249	C9H11IN2O5	small molecule	D06BB01|J05AB02|S01AD01	54-42-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQFRJNBWHJMXHO-RRKCRQDMSA-N
27536	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Imming P (2006)	17016423	171742	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
27537	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Hinata N (2006)	16834676	177004	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
27538	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Overington JP (2006)	17139284	171741	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
27539	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Teh BS (2004)	15050332	177003	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
27540	971415	2703374	HHV1gp034	UL23	-	10298	Human Herpesvirus 1	inducer	target	Satoh T (2004)	15145177	177005	567	Valaciclovir	Valacyclovir|L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester|Valaciclovirum|L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine	sandoz valacyclovir|pro-valacy	DRUGBANK	DB00577	C13H20N6O4	small molecule	J05AB11	124832-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDOVUKNUBWVHOX-QMMMGPOBSA-N
27541	114725	9313	-	MMP20	AI2A2|MMP-20	9606	Homo sapiens	inhibitor	target	Lebrasseur NK (2007)	17606858	179841	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
27542	114725	9313	-	MMP20	AI2A2|MMP-20	9606	Homo sapiens	inhibitor	target	Duhaney TA (2007)	17353509	179842	1028	Fenofibrate	Finofibrate|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester|Fenofibratum|Fenofibrato|Isopropyl (4'-(P-chlorobenzoyl)-2-phenoxy-2-methyl)propionate|Fenofibric acid|Fenofibrate|FNF|Isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate|Procetofen	fibricor|riva-fenofibrate micr	DRUGBANK	DB01039	C20H21ClO4	small molecule	C10AB11|C10AB05|C10BA03|C10BA04	49562-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMTINGFKWWXKFG-UHFFFAOYSA-N
27543	112815	6955	-	TRA	IMD7|TCRA|TCRD|TRA@|TRAC	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2626	3-Indolebutyric Acid	-	-	DRUGBANK	DB02740	C12H13NO2	small molecule	-	133-32-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JTEDVYBZBROSJT-UHFFFAOYSA-N
27544	4054743	1263511	D616_p97100	ompP	Fpla031	83333	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
27545	4054743	1263511	D616_p97100	ompP	Fpla031	83333	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
27546	4054743	1263511	D616_p97100	ompP	Fpla031	83333	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	4061	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	-	-	DRUGBANK	DB04233	C16H34O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEOZZFHAVXYAMB-UHFFFAOYSA-N
27547	4054815	1263584	D616_p97085	ssb	Fpla062	83333	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	4071	5-Methyluridine 5'-Monophosphate	-	-	DRUGBANK	DB04243	C10H15N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGWHDMPTQKSDTL-XZMZPDFPSA-N
27548	4054815	1263584	D616_p97085	ssb	Fpla062	83333	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	4071	5-Methyluridine 5'-Monophosphate	-	-	DRUGBANK	DB04243	C10H15N2O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IGWHDMPTQKSDTL-XZMZPDFPSA-N
27549	1205537	155030	HIV1gp2	gag	-	11676	Human Immunodeficiency Virus 1	unknown	target	Berman HM (2000)	10592235	172122	7021	MYRISTIC ACID	-	-	DRUGBANK	DB08231	C14H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUNFSRHWOTWDNC-UHFFFAOYSA-N
27550	119695	51716	-	CES1P1	CES1A2|CES1A3|CES4|CESR|PCE-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7389	1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE	-	-	DRUGBANK	DB08612	C11H19F3OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMQHRXUKAYSPPK-UHFFFAOYSA-N
27551	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	cofactor	target	Choi HP (2004)	15251194	172570	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27552	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	cofactor	target	Shoolingin-Jordan PM (2003)	12686158	172529	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27553	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Berman HM (2000)	10592235	172122	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27554	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Ravanel S (2001)	11752472	95631	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27555	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Berman HM (2000)	10592235	172122	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27556	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Heil SG (2001)	11386852	172643	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27557	115467	10165	-	SLC25A13	ARALAR2|CITRIN|CTLN2	9606	Homo sapiens	unknown	target	Satrustegui J (2007)	17237342	172923	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
27558	115467	10165	-	SLC25A13	ARALAR2|CITRIN|CTLN2	9606	Homo sapiens	unknown	target	Contreras L (2007)	17213189	172922	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
27559	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	unknown	target	Mukherjee M (2006)	16980404	172522	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
27560	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Shiraishi M (2002)	12010769	174247	186	Tramadol	(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|(+)-Tramadol	theratramadol-90|tramadol/acet	DRUGBANK	DB00193	C16H25NO2	small molecule	N02AX02|N02AX52	27203-92-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TVYLLZQTGLZFBW-ZBFHGGJFSA-N
27561	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Rogers KR (1992)	1621972	174356	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
27562	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Fiacchino F (1990)	2272786	174354	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
27563	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	agonist	target	Marshall CG (1990)	2133043	174355	195	Succinylcholine	Succinylcholine|Succinocholine|2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)|Succinylbischoline|Succinoylcholine|Succinic acid, diester with choline|Suxamethonium|Dicholine succinate|Succinyldicholine	succinylcholine chloride injec	DRUGBANK	DB00202	C14H30N2O4	small molecule	M03AB01	306-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXOIZCJOOAYSMI-UHFFFAOYSA-N
27564	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Richelson E (2000)	11132243	174623	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27565	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Wilner KD (2002)	11910268	174629	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27566	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Sprouse JS (1999)	10516958	174631	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27567	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Newman-Tancredi A (2003)	12923612	174630	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27568	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Stahl SM (2004)	14728084	174620	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27569	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Rollema H (2000)	10924666	174632	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27570	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Scott LJ (2000)	11129124	177725	664	Galantamine	Galanthamine|(-)-Galanthamine	reminyl   -(12mg)|pms-galantam	DRUGBANK	DB00674	C17H21NO3	small molecule	N06DA04	357-70-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASUTZQLVASHGKV-JDFRZJQESA-N
27571	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
27572	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
27573	109828	3615	hCG_2002013	IMPDH2	IMPD2|IMPDH-II	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	801	Ribavirin	1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|RBV|Ribavirinum|Tribavirin|Ribavirine|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|Ribavirin|Ribavirina	victrelis triple|ribasphere ri	DRUGBANK	DB00811	C8H12N4O5	small molecule	J05AB04	36791-04-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUCXVSUMQZMFG-AFCXAGJDSA-N
27574	107564	1142	-	CHRNB3	-	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27575	107565	1143	hCG_1731645	CHRNB4	-	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27576	107558	1136	-	CHRNA3	LNCR2|NACHRA3|PAOD2	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27577	107563	1141	RP11-61L14.4	CHRNB2	EFNL3|nAChRB2	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27578	107560	1138	-	CHRNA5	LNCR2	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27579	114463	8973	-	CHRNA6	CHNRA6	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27580	107559	1137	-	CHRNA4	BFNC|EBN|EBN1|NACHR|NACHRA4|NACRA4	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27581	107557	1135	-	CHRNA2	-	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27582	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27583	120731	55584	-	CHRNA9	HSA243342|NACHRA9	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27584	121345	57053	-	CHRNA10	-	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27585	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zheng L (2007)	17259377	181291	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
27586	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Tagami T (2009)	19147680	171006	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
27587	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Aracava Y (2005)	15522999	179864	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
27588	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Katoh Y (2006)	16685460	180931	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27589	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Roskoski R (2007)	17367763	180930	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27590	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Deprimo SE (2007)	17605814	180933	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27591	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Ahmed SI (2004)	15688612	180932	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27592	108612	2324	-	FLT4	FLT41|LMPH1A|PCL|VEGFR3	9606	Homo sapiens	inhibitor	target	Gridelli C (2007)	17296815	175811	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27593	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Schueneman AJ (2003)	12873999	180937	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27594	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27595	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Baratte S (2004)	14753710	180935	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27596	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Amino N (2006)	16533791	180934	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27597	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Schoeffski P (2006)	16418310	175821	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27598	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	inhibitor	target	Mendel DB (2003)	12538485	180936	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27599	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	Roskoski R (2007)	17367763	180930	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27600	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	inhibitor	target	O'Farrell AM (2003)	14654525	180938	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27601	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Joensuu H (2007)	17545799	180940	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27602	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27603	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Roskoski R (2007)	17367763	180930	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27604	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Baratte S (2004)	14753710	180935	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27605	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Schueneman AJ (2003)	12873999	180937	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27606	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor	target	Abrams TJ (2003)	12748309	180939	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27607	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	inhibitor	target	Abrams TJ (2003)	12748309	180939	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27608	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	inhibitor	target	Pietras K (2005)	15557593	180941	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27609	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	inhibitor	target	Gollob JA (2005)	16425993	175833	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27610	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	inhibitor	target	Baratte S (2004)	14753710	180935	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27611	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	inhibitor	target	Mendel DB (2003)	12538485	180936	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27612	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	inhibitor	target	Roskoski R (2007)	17367763	180930	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27613	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	inhibitor	target	Guo J (2006)	16648572	180942	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27614	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	inhibitor	target	Prenen H (2006)	16638875	180943	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27615	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27616	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	O'Farrell AM (2003)	12531805	180944	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27617	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	Schmidt-Arras D (2004)	15180525	180945	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27618	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	Yee KW (2004)	15304385	180946	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27619	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	Baratte S (2004)	14753710	180935	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27620	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	inhibitor	target	O'Farrell AM (2003)	14654525	180938	1255	Sunitinib	Sunitinibum	sutent	DRUGBANK	DB01268	C22H27FN4O2	small molecule	L01XE04	557795-19-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WINHZLLDWRZWRT-ATVHPVEESA-N
27621	107561	1139	-	CHRNA7	CHRNA7-2|NACHRA7	9606	Homo sapiens	antagonist	target	Pagan OR (2001)	11551210	181477	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
27622	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Zhanel GG (2007)	17488146	181573	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
27623	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Zhanel GG (2007)	17488146	181573	1536	Imipenem	(5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid|Imipenem|(5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid|Imipenem anhydrous|Imipenemum|IMP|N-Formimidoyl thienamycin|N-formimidoylthienamycin|Imipemide|Imipenem, n-formimidoyl thienamycin|(5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure	primaxin iv|imipenem and cilas	DRUGBANK	DB01598	C12H17N3O4S	small molecule	J01DH51	74431-23-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSKVGTPCRGIANV-ZXFLCMHBSA-N
27624	852983	948691	b4170	mutL	ECK4166|JW4128	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27625	852983	948691	b4170	mutL	ECK4166|JW4128	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27626	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27627	107542	1118	-	CHIT1	CHI3|CHIT|CHITD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27628	108913	2643	-	GCH1	DYT14|DYT5|DYT5a|GCH|GTP-CH-1|GTPCH1|HPABH4B	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27629	108913	2643	-	GCH1	DYT14|DYT5|DYT5a|GCH|GTP-CH-1|GTPCH1|HPABH4B	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27630	113649	7919	DAAP-97M17.4	DDX39B	BAT1|D6S81E|UAP56	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27631	113649	7919	DAAP-97M17.4	DDX39B	BAT1|D6S81E|UAP56	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27632	113649	7919	DAAP-97M17.4	DDX39B	BAT1|D6S81E|UAP56	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27633	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27634	851588	947258	b2787	gudD	ECK2781|JW2758|ygcX	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27635	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27636	106696	191	-	AHCY	SAHH|adoHcyase	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27637	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27638	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27639	120547	55256	HMFT1638	ADI1	APL1|ARD|Fe-ARD|MTCBP1|Ni-ARD|SIPL|mtnD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27640	114956	9588	-	PRDX6	1-Cys|AOP2|HEL-S-128m|NSGPx|PRX|aiPLA2|p29	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27641	114270	8732	RP3-488C13.1	RNGTT	CAP1A|HCE|HCE1|hCAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27642	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27643	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27644	111964	6035	-	RNASE1	RAC1|RIB1|RNS1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27645	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27646	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27647	111627	5645	-	PRSS2	TRY2|TRY8|TRYP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27648	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27649	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27650	119357	51181	-	DCXR	DCR|HCR2|HCRII|KIDCR|P34H|PNTSU|SDR20C1|XR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27651	106570	54	-	ACP5	SPENCDI|TRAP	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27652	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27653	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27654	851140	946799	b2323	fabB	ECK2317|JW2320|fabC	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27655	119392	51228	-	GLTP	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27656	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27657	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27658	109022	2760	-	GM2A	GM2-AP|SAP-3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27659	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27660	117170	23643	-	LY96	ESOP-1|MD-2|MD2|ly-96	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27661	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27662	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27663	849256	944856	b0150	fhuA	ECK0149|JW0146|T1|tonA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27664	851007	946665	b1095	fabF	ECK1081|JW1081|cvc|fabJ|vtr	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27665	107194	733	RP11-229P13.14-003	C8G	C8C	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27666	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27667	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27668	106640	128	-	ADH5	ADH-3|ADHX|FALDH|FDH|GSH-FDH|GSNOR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27669	110235	4057	-	LTF	GIG12|HEL110|HLF2|LF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27670	112954	7099	-	TLR4	ARMD10|CD284|TLR-4|TOLL	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27671	109414	3172	RP5-1013A22.1	HNF4A	FRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27672	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27673	113277	7436	RP11-320E16.1	VLDLR	CARMQ1|CHRMQ1|VLDLRCH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27674	850210	945843	b1252	tonB	ECK1246|JW5195|T1rec|exbA	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27675	850044	945672	b1415	aldA	ECK1408|JW1412|ald	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3467	Deoxycholic Acid	7-deoxycholic acid|Desoxycholsure|3alpha,12alpha-Dihydroxy-5beta-cholanic acid|desoxycholic acid|deoxycholate|(3,5,12)-3,12-dihydroxycholan-24-oic acid	belkyra|kybella	DRUGBANK	DB03619	C24H40O4	small molecule	-	83-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXGVEGMKQFWNSR-LLQZFEROSA-N
27676	122761	79631	-	EFTUD1	FAM42A|HsT19294|RIA1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3467	Deoxycholic Acid	7-deoxycholic acid|Desoxycholsure|3alpha,12alpha-Dihydroxy-5beta-cholanic acid|desoxycholic acid|deoxycholate|(3,5,12)-3,12-dihydroxycholan-24-oic acid	belkyra|kybella	DRUGBANK	DB03619	C24H40O4	small molecule	-	83-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXGVEGMKQFWNSR-LLQZFEROSA-N
27677	849497	945108	b0462	acrB	ECK0456|JW0451|acrE	511145	Escherichia coli	unknown	target	Berman HM (2000)	10592235	172122	3467	Deoxycholic Acid	7-deoxycholic acid|Desoxycholsure|3alpha,12alpha-Dihydroxy-5beta-cholanic acid|desoxycholic acid|deoxycholate|(3,5,12)-3,12-dihydroxycholan-24-oic acid	belkyra|kybella	DRUGBANK	DB03619	C24H40O4	small molecule	-	83-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KXGVEGMKQFWNSR-LLQZFEROSA-N
27678	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	3686	Cilomilast	Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid	-	DRUGBANK	DB03849	C20H25NO4	small molecule	-	153259-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFBUZOUXXHZCFB-OYOVHJISSA-N
27679	106663	154	-	ADRB2	ADRB2R|ADRBR|B2AR|BAR|BETA2AR	9606	Homo sapiens	agonist	target	Hayashi T (2007)	17141277	188508	7761	Celiprolol	RS)-N'-{3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N,N-diethylurea	-	DRUGBANK	DB04846	C20H33N3O4	small molecule	C07AB08	56980-93-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOATXPAWOHTVSZ-UHFFFAOYSA-N
27680	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	8063	Febuxostat	Febuxostatum|Fbuxostat|2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid|Febuxostat	uloric|febuxostat	DRUGBANK	DB04854	C16H16N2O3S	small molecule	M04AA03	144060-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQSJTQLCZDPROO-UHFFFAOYSA-N
27681	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4664	Huperzine A	L-huperzine A|()-huperazine A|()-selagine|selagine	-	DRUGBANK	DB04864	C15H18N2O	small molecule	-	102518-79-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRJBHWIHUMBLCN-YQEJDHNASA-N
27682	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Borsini F (2002)	12177684	181800	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27683	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Invernizzi RW (2003)	12890707	181826	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27684	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Borsini F (2002)	12177684	181800	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27685	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Invernizzi RW (2003)	12890707	181826	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27686	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Borsini F (2002)	12177684	181800	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27687	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Invernizzi RW (2003)	12890707	181826	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27688	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	unknown	target	Cerqueira MD (2006)	16524538	181933	4796	Apadenoson	-	-	DRUGBANK	DB05009	C23H30N6O6	small molecule	-	250386-15-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FLEVIENZILQUKB-XTWQNQIISA-N
27689	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	inhibitor	target	Devillier P (2008)	18336052	179288	8072	Levocetirizine	2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid	levocetirizine dihydrochloride	DRUGBANK	DB06282	C21H25ClN2O3	small molecule	R06AE09	130018-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-OAQYLSRUSA-N
27690	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Devillier P (2008)	18336052	179288	8072	Levocetirizine	2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid	levocetirizine dihydrochloride	DRUGBANK	DB06282	C21H25ClN2O3	small molecule	R06AE09	130018-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-OAQYLSRUSA-N
27691	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Cugno M (2001)	11460008	6756	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27692	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27693	123818	83933	RP3-402G11.7	HDAC10	HD10	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27694	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27695	115331	10014	-	HDAC5	HD5|NY-CO-9	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27696	119613	51564	-	HDAC7	HD7A|HDAC7A	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27697	115106	9759	-	HDAC4	AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27698	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27699	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27700	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27701	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27702	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	agonist	target	Haenisch B (2010)	20030735	179194	5589	Levonordefrin	alpha-Methylnoradrenaline|alpha-methylnorepinephrine|Neo-cobefrin|-methylnorepinephrine|Corbadrine	mepivacaine hydrochloride and 	DRUGBANK	DB06707	C9H13NO3	small molecule	-	829-74-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GEFQWZLICWMTKF-CDUCUWFYSA-N
27703	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	agonist	target	Li G (1994)	7906055	181690	7602	Agmatine	N-(4-aminobutyl)guanidine|1-amino-4-guanidobutane|(4-aminobutyl)guanidine|(4-aminobutyl) guanidine	-	DRUGBANK	DB08838	C5H14N4	small molecule	-	306-60-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYPPJABKJHAVHS-UHFFFAOYSA-N
27704	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
27705	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27706	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Belley M (1999)	10658574	174128	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27707	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27708	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Martin SC (1999)	10328880	174135	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27709	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Jones KA (2000)	11008066	174132	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27710	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27711	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Filippov AK (2000)	10751439	174130	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27712	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Braun M (2004)	15235087	174131	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27713	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27714	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Stringer JL (1999)	10094428	174140	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27715	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27716	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Motalli R (1999)	10444662	174138	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27717	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Ogasawara T (1999)	10494996	174139	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27718	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Mott DD (1999)	10482760	174136	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27719	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Garcia-Gil L (1999)	10386831	174137	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27720	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27721	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	7635	Arbaclofen	(R)-Baclofen|STX209|(R)-4-Amino-3-(4-chlorophenyl)butanoic acid|OS440	-	DRUGBANK	DB08891	-	small molecule	-	69308-37-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27722	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27723	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Belley M (1999)	10658574	174128	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27724	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27725	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Martin SC (1999)	10328880	174135	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27726	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Jones KA (2000)	11008066	174132	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27727	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27728	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Filippov AK (2000)	10751439	174130	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27729	114938	9568	-	GABBR2	GABABR2|GPR51|GPRC3B|HG20|HRIHFB2099	9606	Homo sapiens	agonist	target	Braun M (2004)	15235087	174131	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27730	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27731	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Stringer JL (1999)	10094428	174140	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27732	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Bowery NG (1993)	8388192	174129	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27733	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Motalli R (1999)	10444662	174138	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27734	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Ogasawara T (1999)	10494996	174139	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27735	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Mott DD (1999)	10482760	174136	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27736	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Garcia-Gil L (1999)	10386831	174137	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27737	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Lehmann A (2009)	19303900	174134	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27738	108825	2550	DAAP-188P13.3	GABBR1	GABABR1|GABBR1-3|GB1|GPRC3A|dJ271M21.1.1|dJ271M21.1.2	9606	Homo sapiens	agonist	target	Pittman QJ (1999)	10545129	174133	7636	Arbaclofen Placarbil	-	-	DRUGBANK	DB08892	-	small molecule	-	847353-30-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27739	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	inhibitor	target	Cugno M (2001)	11460008	6756	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27740	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Kloosterboer HJ (1988)	3139361	175069	8156	Norgestrel	LD norgestrel|17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one|Methylnorethindrone	low-ogestrel|ovrette tablets|e	DRUGBANK	DB09389	C21H28O2	small molecule	G03FB01|G03FA10|G03AA06	6533-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-UHFFFAOYSA-N
27741	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	binder	target	Hammond GL (2001)	11521119	175561	8156	Norgestrel	LD norgestrel|17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one|Methylnorethindrone	low-ogestrel|ovrette tablets|e	DRUGBANK	DB09389	C21H28O2	small molecule	G03FB01|G03FA10|G03AA06	6533-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-UHFFFAOYSA-N
27742	112593	6715	-	SRD5A1	S5AR 1	9606	Homo sapiens	inhibitor	target	Rabe T (2000)	11075290	175560	8156	Norgestrel	LD norgestrel|17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one|Methylnorethindrone	low-ogestrel|ovrette tablets|e	DRUGBANK	DB09389	C21H28O2	small molecule	G03FB01|G03FA10|G03AA06	6533-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WWYNJERNGUHSAO-UHFFFAOYSA-N
27743	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	cofactor	target	Heller T (2004)	14724775	195959	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27744	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	cofactor	target	Clayton PT (2006)	16763894	195969	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27745	106714	212	RP5-884M20.1	ALAS2	ALAS-E|ALASE|ANH1|ASB|XLDPP|XLEPP|XLSA	9606	Homo sapiens	cofactor	target	Astner I (2005)	16121195	195963	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27746	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Bourguignon J (1988)	3143355	196042	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27747	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Trakatellis A (1994)	7526359	196047	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27748	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Jagath JR (1997)	9305893	196048	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27749	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Bourguignon J (1988)	3143355	196042	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27750	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Trakatellis A (1994)	7526359	196047	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27751	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Jagath JR (1997)	9305893	196048	109	Pyridoxal Phosphate	Pyridoxal 5-monophosphoric acid ester|PLP|Pyridoxal phosphate anhydrous|3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinecarboxaldehyde|Pyridoxal 5-phosphate|Pyridoxal-P|Pyridoxal 5'-phosphate|Pyridoxal P|Codecarboxylase|Pyridoxal-5P|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate	-	DRUGBANK	DB00114	C8H10NO6P	small molecule	A11HA06	54-47-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGVDGCNFYWLIFO-UHFFFAOYSA-N
27752	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Larsson J (2000)	10893069	195951	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27753	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Ubbink JB (1999)	10024094	195943	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27754	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Holmes ZR (1999)	10233370	195946	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27755	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Heijmans BT (1999)	10196703	195944	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27756	110624	4524	RP11-56N19.4	MTHFR	-	9606	Homo sapiens	cofactor	target	Tsai MY (1999)	10208491	195945	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27757	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Li R (2003)	12668769	195955	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27758	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Angelaccio S (2003)	12902326	195957	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27759	112368	6472	-	SHMT2	GLYA|HEL-S-51e|SHMT	9606	Homo sapiens	cofactor	target	Appaji Rao N (2003)	12686103	195956	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27760	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Scarsdale JN (2000)	10656824	195950	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27761	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Rao JV (2000)	10998057	195952	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27762	112366	6470	-	SHMT1	CSHMT|SHMT	9606	Homo sapiens	cofactor	target	Li R (2003)	12668769	195955	111	Tetrahydrofolic acid	Tetrahydrofolic acid|(6S)-THFA|tetrahydrofolate|(6S)-Tetrahydrofolate|(6S)-Tetrahydrofolic acid|THF|5,6,7,8-tetrahydrofolate|5,6,7,8-tetrahydrofolic acid	-	DRUGBANK	DB00116	C19H23N7O6	small molecule	-	135-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSTNYGQPCMXVAQ-KIYNQFGBSA-N
27763	111007	4953	-	ODC1	ODC	9606	Homo sapiens	product of	target	Lee NK (2011)	21413019	196005	121	Spermine	N,N'-Bis(3-aminopropyl)-1,4-butanediamine|Spermine|4,9-Diazadodecane-1,12-diamine|4,9-Diaza-1,12-dodecanediamine	-	DRUGBANK	DB00127	C10H26N4	small molecule	-	71-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PFNFFQXMRSDOHW-UHFFFAOYSA-N
27764	115467	10165	-	SLC25A13	ARALAR2|CITRIN|CTLN2	9606	Homo sapiens	unknown	target	Saheki T (2007)	17591776	195979	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
27765	115467	10165	-	SLC25A13	ARALAR2|CITRIN|CTLN2	9606	Homo sapiens	unknown	target	Ikeda S (2007)	17354380	195978	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
27766	115467	10165	-	SLC25A13	ARALAR2|CITRIN|CTLN2	9606	Homo sapiens	unknown	target	Ikeda S (2007)	17228780	195975	122	L-Aspartic Acid	L-Aspartate|L-Asp|Asp|D|L-Aspartic acid|2-Aminosuccinic acid|(S)-2-aminosuccinic acid|L-Asparaginsure|L-Asparaginsaeure|(S)-2-aminobutanedioic acid|Aspartic acid	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00128	C4H7NO4	small molecule	-	56-84-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CKLJMWTZIZZHCS-REOHCLBHSA-N
27767	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Heal DJ (2013)	23539642	196018	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
27768	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Heal DJ (2013)	23539642	196018	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
27769	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Schmidt AW (2001)	11513838	195953	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
27770	109482	3242	-	HPD	4-HPPD|4HPPD|GLOD3|HPPDASE|PPD	9606	Homo sapiens	inhibitor	target	Santra S (2008)	18422479	195984	340	Nitisinone	Nitisinona|2-(alpha,alpha,alpha-Trifluoro-2-nitro-P-tuluoyl)-1,3-cyclohexanedione|Nitisinonum|Orfadin	mdk-nitisinone|nitisinone tabl	DRUGBANK	DB00348	C14H10F3NO5	small molecule	A16AX04	104206-65-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUBCNLGXQFSTLU-UHFFFAOYSA-N
27771	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Siddiqui MA (2004)	15139789	195960	369	Palonosetron	Palonosetronum|Palonosetron|Palonostron|Palonosetrn|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one|(3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one	aloxi|akynzeo	DRUGBANK	DB00377	C19H24N2O	small molecule	A04AA05|A04AA55	135729-56-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPZBLNMUGSZIPR-NVXWUHKLSA-N
27772	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Sadofsky LR (2008)	19085565	195985	397	Dexbrompheniramine	(+)-parabromdylamine|Dexbromfeniramina|(R)-3-(4-Bromophenyl)-3-(2-pyridyl)propyldimethylamine|Desbrofeniramina|Dexbrompheniraminum|Parabromodylamine|D-Brompheniramine|(S)-Brompheniramine|3-(4-bromophenyl)- N,N-dimethyl- 3-pyridin-2-yl-propan-1-amine|(+)-Brompheniraminum|(S)-(+)-Brompheniramine|Dexbrompheniramin|Dexbromphniramine	m-end max d|bionatuss dxp|pana	DRUGBANK	DB00405	C16H19BrN2	small molecule	R06AB06|R06AB56	132-21-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZDIGNSYAACHWNL-HNNXBMFYSA-N
27773	852004	947691	b3177	folP	ECK3166|JW3144|dhpS	511145	Escherichia coli	inhibitor	target	Hevener KE (2009)	19434845	195990	624	Sulfacetamide	N-[(P-Aminophenyl)sulfonyl]acetamide|N-Sulphanilylacetamide|Sulfacetamida|Sulphacetamide|P-Aminobenzenesulfonacetamide|N'-acetylsulfanilamide|Sulfacetamidum|N(1)-Acetylsulfanilamide|Sulfactamide|Sulfanilazetamid|Sulfacetamid|N-Sulfanilylacetamide|P-Aminobenzenesulfonoacetamide|N-((P-Aminophenyl)sulfonyl)acetamide|Acetosulfamine|Sulphacetamidum|N-(P-Aminobenzenesulfonyl)acetamide|N(1)-Acetyl-4-aminophenylsulfonamide|N-Acetylsulfanilamide|N-Acetyl-4-aminobenzenesulfonamide	sodium sulamyd 10%|balsulph op	DRUGBANK	DB00634	C8H10N2O3S	small molecule	D10AF06|S01AB04	144-80-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SKIVFJLNDNKQPD-UHFFFAOYSA-N
27774	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Sanner MA (1998)	9871530	196049	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
27775	108831	2557	-	GABRA4	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27776	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27777	108832	2558	-	GABRA5	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27778	108829	2555	-	GABRA2	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27779	109965	3763	-	KCNJ6	BIR1|GIRK-2|GIRK2|KATP-2|KATP2|KCNJ7|KIR3.2|hiGIRK2	9606	Homo sapiens	unknown	target	Bodhinathan K (2013)	24145411	196019	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27780	109964	3762	-	KCNJ5	CIR|GIRK4|KATP1|KIR3.4|LQT13	9606	Homo sapiens	unknown	target	Bodhinathan K (2013)	24145411	196019	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27781	108833	2559	-	GABRA6	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27782	108830	2556	-	GABRA3	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27783	109962	3760	-	KCNJ3	GIRK1|KGA|KIR3.1	9606	Homo sapiens	unknown	target	Bodhinathan K (2013)	24145411	196019	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27784	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27785	108835	2561	-	GABRB2	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27786	108839	2565	-	GABRG1	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27787	109967	3765	RP11-536C5.1	KCNJ9	GIRK3|KIR3.3	9606	Homo sapiens	unknown	target	Bodhinathan K (2013)	24145411	196019	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27788	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27789	108838	2564	-	GABRE	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27790	108841	2567	-	GABRG3	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27791	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27792	108834	2560	-	GABRB1	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27793	108842	2568	-	GABRP	-	9606	Homo sapiens	unknown	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27794	106561	43	-	ACHE	ACEE|ARACHE|N-ACHE|YT	9606	Homo sapiens	inhibitor	target	Naik RS (2009)	19470293	195992	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
27795	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Birks J (2006)	16437532	195965	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
27796	107064	590	-	BCHE	CHE1|CHE2|E1	9606	Homo sapiens	inhibitor	target	Naik RS (2009)	19470293	195992	979	Rivastigmine	(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Ena 713 Free Base	sandoz rivastigmine patch 5|my	DRUGBANK	DB00989	C14H22N2O2	small molecule	N06DA03	123441-03-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSVMFMHYUFZWBK-NSHDSACASA-N
27797	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Magyar K (1984)	6441926	196045	1026	Selegiline	L-Deprenalin|Selegilinum|()-selegiline|Selegilina	dom-selegiline|mylan-selegilin	DRUGBANK	DB01037	C13H17N	small molecule	N04BD01	14611-51-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MEZLKOACVSPNER-UHFFFAOYSA-N
27798	107551	1129	-	CHRM2	HM2	9606	Homo sapiens	antagonist	target	Liu H (2006)	16453179	195966	1063	Diphenhydramine	O-benzhydryldimethylaminoethanol|Diphenhydraminum|alpha-(2-Dimethylaminoethoxy)diphenylmethane|beta-Dimethylaminoethanol diphenylmethyl ether|2-(Benzhydryloxy)-N,N-dimethylethylamine|Difenhidramina|2-diphenylmethoxy-N,N-demthylethanamine|-dimethylaminoethyl benzhydryl ether|beta-Dimethylaminoethyl benzhydryl ether|N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine	cvs cough and severe cold nigh	DRUGBANK	DB01075	C17H21NO	small molecule	R06AA52|D04AA32|R06AA02	58-73-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVUWRFHKOJYTH-UHFFFAOYSA-N
27799	112459	6571	-	SLC18A2	SVAT|SVMT|VAT2|VMAT2	9606	Homo sapiens	inhibitor	target	Ellis JD (2011)	21370280	196004	1326	Ephedrine	(-)-Ephedrine|L(-)-Ephedrine|L-erythro-2-(Methylamino)-1-phenylpropan-1-ol|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane|Ephedrine|L-Ephedrine	nasal jelly thuna's|balminil n	DRUGBANK	DB01364	C10H15NO	small molecule	R01AA03|A08AA56|R01AB05|R03CA02|C01CA26|S01FB02	299-42-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWGRBVOPPLSCSI-WPRPVWTQSA-N
27800	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Magyar K (1984)	6441926	196045	1563	Pargyline	Eutonyl|Pargyline|Eutron	-	DRUGBANK	DB01626	C11H13N	small molecule	C02KC01|C02LL01	555-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPWPWRLQFGFJFI-UHFFFAOYSA-N
27801	106573	58	RP5-1068B5.2	ACTA1	ACTA|ASMA|CFTD|CFTD1|CFTDM|MPFD|NEM1|NEM2|NEM3	9606	Homo sapiens	inhibitor	target	Coue M (1987)	3556584	196043	2513	Latrunculin A	LAT-A|LatA|(+)-latrunculin A|(4R)-4-[(1R,4Z,8E,10Z,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one	-	DRUGBANK	DB02621	C22H31NO5S	small molecule	-	76343-93-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDVBPZROPPMBLW-IZGXTMSKSA-N
27802	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Glassman HN (1990)	1705633	195971	3253	Enalkiren	-	-	DRUGBANK	DB03395	C35H56N6O6	small molecule	-	113082-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXVERRYBYGQJZ-WRPDIKACSA-N
27803	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	inhibitor	target	Kroegel C (2007)	17155857	195974	3686	Cilomilast	Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid	-	DRUGBANK	DB03849	C20H25NO4	small molecule	-	153259-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFBUZOUXXHZCFB-OYOVHJISSA-N
27804	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	inhibitor	target	Kroegel C (2007)	17155857	195974	3686	Cilomilast	Ariflo|cis-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid	-	DRUGBANK	DB03849	C20H25NO4	small molecule	-	153259-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CFBUZOUXXHZCFB-OYOVHJISSA-N
27805	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	antagonist	target	Bruce SP (2006)	17132810	195972	8063	Febuxostat	Febuxostatum|Fbuxostat|2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid|Febuxostat	uloric|febuxostat	DRUGBANK	DB04854	C16H16N2O3S	small molecule	M04AA03	144060-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQSJTQLCZDPROO-UHFFFAOYSA-N
27806	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Deeks ED (2015)	26412054	196031	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27807	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Deeks ED (2015)	26412054	196031	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27808	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Deeks ED (2015)	26412054	196031	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27809	107093	624	-	BDKRB2	B2R|BK-2|BK2|BKR2|BRB2	9606	Homo sapiens	antagonist	target	Pruneau D (1999)	10596852	195948	4825	Anatibant	-	-	DRUGBANK	DB05038	C34H36Cl2N6O5S	small molecule	-	209733-45-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUHBBTKJWIBQMY-MHZLTWQESA-N
27810	110492	4352	RP1-92O14.1	MPL	C-MPL|CD110|MPLV|THCYT2|TPOR	9606	Homo sapiens	agonist	target	Krzyzanski W (2013)	23250851	196014	5101	Romiplostim	SU-5416|Semaxinib|Semaxanib	nplate	DRUGBANK	DB05332	C2634H4086N722O790S18	biologic	B02BX04	267639-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27811	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	antagonist	target	Baeumer W (2007)	17352685	195977	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27812	111170	5144	-	PDE4D	ACRDYS2|DPDE3|HSPDE4D|PDE43|PDE4DN2|STRK1	9606	Homo sapiens	antagonist	target	Abdulrahim H (2015)	25864487	196025	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27813	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	antagonist	target	Baeumer W (2007)	17352685	195977	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27814	111168	5142	RP5-876C12.1	PDE4B	DPDE4|PDEIVB	9606	Homo sapiens	antagonist	target	Abdulrahim H (2015)	25864487	196025	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27815	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	antagonist	target	Baeumer W (2007)	17352685	195977	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27816	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	antagonist	target	Abdulrahim H (2015)	25864487	196025	8064	Apremilast	Aprmilast|Apremilastum|N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast	otezla	DRUGBANK	DB05676	C22H24N2O7S	small molecule	L04AA32	608141-41-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMOZEMNVLZVGJZ-QGZVFWFLSA-N
27817	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	McCormack PL (2015)	26510944	196034	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27818	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	McCormack PL (2015)	26510944	196034	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27819	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	antagonist	target	McCormack PL (2015)	26510944	196034	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27820	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	McCormack PL (2015)	26510944	196034	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27821	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	McCormack PL (2015)	26510944	196034	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27822	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27823	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	inhibitor	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27824	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	antagonist	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27825	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	inhibitor	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27826	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	antagonist	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27827	115106	9759	-	HDAC4	AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA	9606	Homo sapiens	inhibitor	target	VanderMolen KM (2011)	21587264	196007	8066	Romidepsin	chromodax|istodax	istodax	DRUGBANK	DB06176	C24H36N4O6S2	small molecule	L01XX39	128517-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QDBHDZETSA-N
27828	106664	155	-	ADRB3	BETA3AR	9606	Homo sapiens	agonist	target	Grudell AB (2008)	18372395	195982	8067	Solabegron	-	-	DRUGBANK	DB06190	C23H23ClN2O3	small molecule	-	252920-94-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLDXOPKUNJTIRF-QFIPXVFZSA-N
27829	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	inhibitor	target	Matthews SJ (2009)	19243706	195987	8069	Doripenem	-	doribax|doripenem	DRUGBANK	DB06211	C15H24N4O6S2	small molecule	J01DH04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVAACINZEOAHHE-VFZPANTDSA-N
27830	849623	945240	b0635	mrdA	ECK0628|JW0630|pbpA	511145	Escherichia coli	antagonist	target	Matthews SJ (2009)	19243706	195987	8069	Doripenem	-	doribax|doripenem	DRUGBANK	DB06211	C15H24N4O6S2	small molecule	J01DH04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVAACINZEOAHHE-VFZPANTDSA-N
27831	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	inhibitor	target	Matthews SJ (2009)	19243706	195987	8069	Doripenem	-	doribax|doripenem	DRUGBANK	DB06211	C15H24N4O6S2	small molecule	J01DH04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVAACINZEOAHHE-VFZPANTDSA-N
27832	849243	944843	b0149	mrcB	ECK0148|JW0145|pbpF|ponB	511145	Escherichia coli	antagonist	target	Matthews SJ (2009)	19243706	195987	8069	Doripenem	-	doribax|doripenem	DRUGBANK	DB06211	C15H24N4O6S2	small molecule	J01DH04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVAACINZEOAHHE-VFZPANTDSA-N
27833	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	inhibitor	target	Matthews SJ (2009)	19243706	195987	8069	Doripenem	-	doribax|doripenem	DRUGBANK	DB06211	C15H24N4O6S2	small molecule	J01DH04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVAACINZEOAHHE-VFZPANTDSA-N
27834	852216	947907	b3396	mrcA	ECK3383|JW3359|ponA	511145	Escherichia coli	antagonist	target	Matthews SJ (2009)	19243706	195987	8069	Doripenem	-	doribax|doripenem	DRUGBANK	DB06211	C15H24N4O6S2	small molecule	J01DH04	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AVAACINZEOAHHE-VFZPANTDSA-N
27835	113006	7153	-	TOP2A	TOP2|TP2A	9606	Homo sapiens	unknown	target	Kurata T (2007)	17628745	195980	8071	Amrubicin	-	-	DRUGBANK	DB06263	C25H25NO9	small molecule	L01DB10	110267-81-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJZITPJGSQKZMX-XDPRQOKASA-N
27836	111033	4988	-	OPRM1	LMOR|M-OR-1|MOP|MOR|MOR1|OPRM	9606	Homo sapiens	antagonist	target	Buechler MW (2008)	19086236	195986	5543	Alvimopan	Anhydrous alvimopan|Alvimopan anhydrous	entereg	DRUGBANK	DB06274	C25H32N2O4	small molecule	A06AH02	156053-89-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPNUIXSCZBYVBB-JVFUWBCBSA-N
27837	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	inhibitor	target	Ferrer M (2011)	21639816	196009	8072	Levocetirizine	2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid	levocetirizine dihydrochloride	DRUGBANK	DB06282	C21H25ClN2O3	small molecule	R06AE09	130018-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-OAQYLSRUSA-N
27838	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Ferrer M (2011)	21639816	196009	8072	Levocetirizine	2-(2-{4-[(R)-(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid	levocetirizine dihydrochloride	DRUGBANK	DB06282	C21H25ClN2O3	small molecule	R06AE09	130018-77-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLPARSLTMPFCP-OAQYLSRUSA-N
27839	121782	57823	UNQ576/PRO1138	SLAMF7	19A|CD319|CRACC|CS1	9606	Homo sapiens	modulator	target	Markham A (2016)	26809244	196038	8073	Elotuzumab	Immunoglobulin G1, anti-(human protein CS1) (human-mouse HuLuc63 heavy chain), disulfide with human-mouse HuLuc63 kappa-chain, dimer|HuLuc63|Immunoglobulin G1, anti-(human SLAM family member 7 (CD2-like receptor activating cytotoxic cells, CD319 antigen)), humanized mouse monoclonal HuLuc63 gamma-1 heavy chain (222-214')-disulfide with humanized mouse monoclonal HuLuc63 kappa light chain (228-228'';231-231'')-bisdisulfide dimer	empliciti	DRUGBANK	DB06317	C6476H9982N1714O2016S42	biologic	-	915296-00-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27840	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Gruber C (2004)	15535430	195962	7770	Bazedoxifene	bazedoxifene/conjugated estrogens	duavee|duavive	DRUGBANK	DB06401	C30H34N2O3	small molecule	G03XC02|G03CC07	198481-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJGJABZCDBEDK-UHFFFAOYSA-N
27841	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	antagonist	target	Gruber C (2004)	15535430	195962	7770	Bazedoxifene	bazedoxifene/conjugated estrogens	duavee|duavive	DRUGBANK	DB06401	C30H34N2O3	small molecule	G03XC02|G03CC07	198481-32-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCJGJABZCDBEDK-UHFFFAOYSA-N
27842	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Casserly B (2009)	19920913	195995	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27843	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Spence R (2010)	20811346	195998	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27844	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kingman M (2009)	19601701	195993	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27845	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Richards DB (2009)	19389876	195988	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27846	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Casserly B (2009)	19920913	195995	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27847	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Kingman M (2009)	19601701	195993	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27848	107177	716	-	C1S	-	9606	Homo sapiens	inhibitor	target	Harpel PC (1975)	123251	195954	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27849	107176	715	-	C1R	-	9606	Homo sapiens	inhibitor	target	Harpel PC (1975)	123251	195954	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27850	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	inhibitor	target	Cicardi M (2005)	16267649	195964	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27851	108459	2161	-	F12	HAE3|HAEX|HAF	9606	Homo sapiens	inhibitor	target	de Agostini A (1984)	6725552	196046	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27852	108458	2160	-	F11	FXI	9606	Homo sapiens	inhibitor	target	Cicardi M (2005)	16267649	195964	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27853	110018	3818	-	KLKB1	KLK3|PPK	9606	Homo sapiens	inhibitor	target	van der Graaf F (1983)	6184384	196044	7771	C1 Esterase Inhibitor (Human)	C1 inhibitor|hC1INH|C1-esterase inhibitor, human|C1INH|C1-inhibiting factor|Human C1 inhibitor|Complement C1 esterase inhibitor|C1-inhibitor, plasma derived|Plasma protease C1 inhibitor|C1 inhibitor (human)|C1 inhibitor human|C1-INH|Human C1-esterase inhibitor	berinert 1500|berinert|beriner	DRUGBANK	DB06404	-	biologic	B06AC01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27854	113264	7421	-	VDR	NR1I1|PPP1R163	9606	Homo sapiens	suppressor	target	Ritter CS (2011)	21169421	196001	8075	Doxercalciferol	1-Hydroxyergocalciferol|Doxercalciferolum|(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol|Doxercalciferol|1-Hydroxyvitamin D2|1alpha-hydroxyvitamin D2|1-alpha-hydroxyergocalciferol|1-Hydroxyergocalciferol	doxercalciferol|hectorol	DRUGBANK	DB06410	C28H44O2	small molecule	H05BX03	54573-75-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKXBNHCUPKIYDM-CGMHZMFXSA-N
27855	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Davison SL (2006)	16633980	195967	8076	Oxymetholone	Oximetolona|17-Hydroxy-2-hydroxymethylidene-17-methyl-3-androstanone|Oxymetholon|Oxymetholonum|Oxymtholone	anapolon 50 tablets 50mg|anapo	DRUGBANK	DB06412	C21H32O3	small molecule	A14AA05	434-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICMWWNHDUZJFDW-DHODBPELSA-N
27856	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	activator	target	Davison SL (2006)	16633980	195967	8076	Oxymetholone	Oximetolona|17-Hydroxy-2-hydroxymethylidene-17-methyl-3-androstanone|Oxymetholon|Oxymetholonum|Oxymtholone	anapolon 50 tablets 50mg|anapo	DRUGBANK	DB06412	C21H32O3	small molecule	A14AA05	434-07-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ICMWWNHDUZJFDW-DHODBPELSA-N
27857	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	inhibitor	target	Loland CJ (2012)	22537794	196013	8077	Armodafinil	R-modafinil|()-2-[(R)-(diphenylmethyl)sulfinyl]acetamide	armodafinil|nuvigil	DRUGBANK	DB06413	C15H15NO2S	small molecule	N06BA13	112111-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-LJQANCHMSA-N
27858	112422	6531	-	SLC6A3	DAT|DAT1|PKDYS	9606	Homo sapiens	antagonist	target	Loland CJ (2012)	22537794	196013	8077	Armodafinil	R-modafinil|()-2-[(R)-(diphenylmethyl)sulfinyl]acetamide	armodafinil|nuvigil	DRUGBANK	DB06413	C15H15NO2S	small molecule	N06BA13	112111-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YFGHCGITMMYXAQ-LJQANCHMSA-N
27859	122309	64805	-	P2RY12	ADPG-R|BDPLT8|HORK3|P2T(AC)|P2Y(12)R|P2Y(AC)|P2Y(ADP)|P2Y(cyc)|P2Y12|SP1999	9606	Homo sapiens	inhibitor	target	Gan XD (2015)	26402735	196030	7773	Cangrelor	[dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid	kengreal	DRUGBANK	DB06441	C17H25Cl2F3N5O12P3S2	small molecule	B01AC25	163706-06-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAEBIVWUMLRPSK-IDTAVKCVSA-N
27860	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27861	123818	83933	RP3-402G11.7	HDAC10	HD10	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27862	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27863	115331	10014	-	HDAC5	HD5|NY-CO-9	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27864	119613	51564	-	HDAC7	HD7A|HDAC7A	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27865	115106	9759	-	HDAC4	AHO3|BDMR|HA6116|HD4|HDAC-4|HDAC-A|HDACA	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27866	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27867	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27868	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27869	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
27870	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	inhibitor	target	Du J (2009)	19427037	195989	8081	Ofatumumab	Ofatumumabum|HuMax-CD20|Ofatumumab	arzerra	DRUGBANK	DB06650	C6480H10022N1742O2020S44	biologic	L01XC10	679818-59-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27871	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	inhibitor	target	Doerner T (2008)	18388516	195983	8081	Ofatumumab	Ofatumumabum|HuMax-CD20|Ofatumumab	arzerra	DRUGBANK	DB06650	C6480H10022N1742O2020S44	biologic	L01XC10	679818-59-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27872	107369	931	-	MS4A1	B1|Bp35|CD20|CVID5|LEU-16|MS4A2|S7	9606	Homo sapiens	inhibitor	target	Glennie MJ (2007)	17768100	195981	8081	Ofatumumab	Ofatumumabum|HuMax-CD20|Ofatumumab	arzerra	DRUGBANK	DB06650	C6480H10022N1742O2020S44	biologic	L01XC10	679818-59-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27873	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	inverse agonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27874	109590	3358	RP11-810O3.1	HTR2C	5-HT2C|5-HTR2C|5HTR2C|HTR1C	9606	Homo sapiens	inverse agonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27875	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	inverse agonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27876	109589	3357	-	HTR2B	5-HT(2B)|5-HT2B	9606	Homo sapiens	inverse agonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27877	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27878	106659	150	-	ADRA2A	ADRA2|ADRA2R|ADRAR|ALPHA2AAR|ZNF32	9606	Homo sapiens	antagonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27879	106660	151	-	ADRA2B	ADRA2L1|ADRA2RL1|ADRARL1|ALPHA2BAR|alpha-2BAR	9606	Homo sapiens	antagonist	target	Ivgy-May N (2015)	26047892	196027	7776	Esmirtazapine	(S)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine	-	DRUGBANK	DB06678	C17H19N3	small molecule	-	61337-87-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-MRXNPFEDSA-N
27880	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	antagonist	target	Rini BI (2006)	16736512	195968	8083	Sipuleucel-T	Sipuleucel-T	provenge	DRUGBANK	DB06688	-	biologic	L03AX17	917381-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27881	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	antagonist	target	Burch PA (2004)	15176049	195961	8083	Sipuleucel-T	Sipuleucel-T	provenge	DRUGBANK	DB06688	-	biologic	L03AX17	917381-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27882	106571	55	-	ACPP	5-NT|ACP-3|ACP3	9606	Homo sapiens	antagonist	target	Mulders PF (2015)	26025563	196026	8083	Sipuleucel-T	Sipuleucel-T	provenge	DRUGBANK	DB06688	-	biologic	L03AX17	917381-47-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27883	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	agonist	target	Anand P (2011)	21852280	196010	8093	Capsaicin	-	coralite medicated heat|capzas	DRUGBANK	DB06774	C18H27NO3	small molecule	M02AB01|N01BX04	404-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKPUWZUDDOIDPM-SOFGYWHQSA-N
27884	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	agonist	target	Wallace M (2011)	21158551	196000	8093	Capsaicin	-	coralite medicated heat|capzas	DRUGBANK	DB06774	C18H27NO3	small molecule	M02AB01|N01BX04	404-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKPUWZUDDOIDPM-SOFGYWHQSA-N
27885	109060	2798	-	GNRHR	GNRHR1|GRHR|HH7|LHRHR|LRHR	9606	Homo sapiens	antagonist	target	Oberye J (2000)	10655292	195949	7780	Ganirelix	-	ganirelix acetate|orgalutran	DRUGBANK	DB06785	C80H113ClN18O13	small molecule	H01CC01	124904-93-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJNXBNATEDXMAK-PFLSVRRQSA-N
27886	112492	6608	-	SMO	FZD11|Gx|SMOH	9606	Homo sapiens	agonist	target	Porcu G (2015)	26658258	196037	8094	Halcinonide	(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one|Halcinonidum|Halcinonide|Halcinonid|Halcinonida	halog cream 0.1%|halog ont 0.1	DRUGBANK	DB06786	C24H32ClFO5	small molecule	D07AD02	3093-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUQNGPZZQDCDFT-JNQJZLCISA-N
27887	112492	6608	-	SMO	FZD11|Gx|SMOH	9606	Homo sapiens	activator	target	Porcu G (2015)	26658258	196037	8094	Halcinonide	(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS)-6b-(chloroacetyl)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one|Halcinonidum|Halcinonide|Halcinonid|Halcinonida	halog cream 0.1%|halog ont 0.1	DRUGBANK	DB06786	C24H32ClFO5	small molecule	D07AD02	3093-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUQNGPZZQDCDFT-JNQJZLCISA-N
27888	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	agonist	target	O'Brien JM (2016)	26558340	196036	7781	Hydroxyprogesterone caproate	Oxiprogesterone Caproate|Makena|Primolut depot|17alpha-Caproyloxypregn-4-ene-3,20-dione|Delalutin|Hydroxyprogesterone	hydroxyprogesterone caproate|m	DRUGBANK	DB06789	C27H40O4	small molecule	G03FA02|G03DA03	630-56-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DOMWKUIIPQCAJU-LJHIYBGHSA-N
27889	112633	6755	-	SSTR5	SS-5-R	9606	Homo sapiens	agonist	target	Buil-Bruna N (2016)	26416534	196032	7782	Lanreotide	Lanreotide acetate|Lanreotide|Somatuline Depot	somatuline autogel|somatuline 	DRUGBANK	DB06791	C54H69N11O10S2	small molecule	H01CB03	108736-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUDHBTGHUJUUFI-UHFFFAOYSA-N
27890	112630	6752	-	SSTR2	-	9606	Homo sapiens	agonist	target	Buil-Bruna N (2016)	26416534	196032	7782	Lanreotide	Lanreotide acetate|Lanreotide|Somatuline Depot	somatuline autogel|somatuline 	DRUGBANK	DB06791	C54H69N11O10S2	small molecule	H01CB03	108736-35-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUDHBTGHUJUUFI-UHFFFAOYSA-N
27891	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	unknown	target	Gemzell-Danielsson K (2013)	23437846	196017	8104	Ulipristal	-	ella|fibristal	DRUGBANK	DB08867	C28H35NO3	small molecule	G03XB02|G03AD02	159811-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKDLNTKNLJPAIY-WKWWZUSTSA-N
27892	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	antagonist	target	Gemzell-Danielsson K (2013)	23437846	196017	8104	Ulipristal	-	ella|fibristal	DRUGBANK	DB08867	C28H35NO3	small molecule	G03XB02|G03AD02	159811-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKDLNTKNLJPAIY-WKWWZUSTSA-N
27893	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	modulator	target	Gemzell-Danielsson K (2013)	23437846	196017	8104	Ulipristal	-	ella|fibristal	DRUGBANK	DB08867	C28H35NO3	small molecule	G03XB02|G03AD02	159811-51-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKDLNTKNLJPAIY-WKWWZUSTSA-N
27894	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	stimulator	target	Humbert M (2016)	26219978	196028	8105	Riociguat	Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate	adempas	DRUGBANK	DB08931	C20H19FN8O2	small molecule	C02KX05	625115-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXXSNCNJFUAIDG-UHFFFAOYSA-N
27895	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	stimulator	target	Soeiro-Pereira PV (2012)	22044316	196012	8105	Riociguat	Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate	adempas	DRUGBANK	DB08931	C20H19FN8O2	small molecule	C02KX05	625115-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXXSNCNJFUAIDG-UHFFFAOYSA-N
27896	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	agonist	target	Humbert M (2016)	26219978	196028	8105	Riociguat	Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate	adempas	DRUGBANK	DB08931	C20H19FN8O2	small molecule	C02KX05	625115-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXXSNCNJFUAIDG-UHFFFAOYSA-N
27897	109232	2977	-	GUCY1A2	GC-SA2|GUC1A2	9606	Homo sapiens	agonist	target	Soeiro-Pereira PV (2012)	22044316	196012	8105	Riociguat	Riociguat|BAY 63-2521|Riociguatum|Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate	adempas	DRUGBANK	DB08931	C20H19FN8O2	small molecule	C02KX05	625115-55-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WXXSNCNJFUAIDG-UHFFFAOYSA-N
27898	110144	3953	-	LEPR	CD295|LEP-R|LEPRD|OB-R|OBR	9606	Homo sapiens	agonist	target	Moon HS (2015)	25249580	196023	8107	Metreleptin	Metreleptinum|r-metHuLeptin|Metreleptin|Mtrleptine|Metreleptina|N-Methionylleptin	myalept	DRUGBANK	DB09046	C714H1167N191O221S6	biologic	-	186018-45-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27899	109583	3351	-	HTR1B	5-HT1B|5-HT1DB|HTR1D2|HTR1DB|S12	9606	Homo sapiens	partial agonist	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27900	112423	6532	-	SLC6A4	5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT	9606	Homo sapiens	inhibitor	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27901	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27902	109595	3363	RP11-103A2.1	HTR7	5-HT7	9606	Homo sapiens	antagonist	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27903	109591	3359	-	HTR3A	5-HT-3|5-HT3A|5-HT3R|5HT3R|HTR3	9606	Homo sapiens	antagonist	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27904	106662	153	-	ADRB1	ADRB1R|B1AR|BETA1AR|RHR	9606	Homo sapiens	ligand	target	Bang-Andersen B (2011)	21486038	196006	8112	Vortioxetine	4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium|vortioxetine cation	brintellix|trintellix	DRUGBANK	DB09068	C18H23N2S	small molecule	N06AX26	508233-74-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQNWZWMKLDQSAC-UHFFFAOYSA-O
27905	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	agonist	target	Escande A (2009)	19464167	195991	8113	Tibolone	17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one|tibolona|tibolonum	-	DRUGBANK	DB09070	C21H28O2	small molecule	G03CX01	5630-53-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WZDGZWOAQTVYBX-XOINTXKNSA-N
27906	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	modulator	target	Lanner JT (2010)	20961976	195999	7831	Tetracaine	Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate	denti-care denti-freeze topica	DRUGBANK	DB09085	C15H24N2O2	small molecule	D04AB06|N01BA03|C05AD02|S01HA03	94-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKCBAIGFKIBETG-UHFFFAOYSA-N
27907	112173	6261	-	RYR1	CCO|MHS|MHS1|PPP1R137|RYDR|RYR|RYR-1|SKRR	9606	Homo sapiens	modulator	target	Laver DR (2011)	21624373	196008	7831	Tetracaine	Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate	denti-care denti-freeze topica	DRUGBANK	DB09085	C15H24N2O2	small molecule	D04AB06|N01BA03|C05AD02|S01HA03	94-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKCBAIGFKIBETG-UHFFFAOYSA-N
27908	112174	6262	RP4-626J7.1	RYR2	ARVC2|ARVD2|RYR-2|RyR|VTSIP	9606	Homo sapiens	modulator	target	Lanner JT (2010)	20961976	195999	7831	Tetracaine	Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate	denti-care denti-freeze topica	DRUGBANK	DB09085	C15H24N2O2	small molecule	D04AB06|N01BA03|C05AD02|S01HA03	94-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKCBAIGFKIBETG-UHFFFAOYSA-N
27909	112174	6262	RP4-626J7.1	RYR2	ARVC2|ARVD2|RYR-2|RyR|VTSIP	9606	Homo sapiens	modulator	target	Laver DR (2011)	21624373	196008	7831	Tetracaine	Pontocaine|Ttracane|Medihaler-Tetracaine|2-(dimethylamino)ethyl 4-(butylamino)benzoate|p-(butylamino)benzoic acid -(dimethylamino)ethyl ester|p-Butylaminobenzoyl-2-dimethylaminoethanol|Dicaine|Amethocaine|Tetracaine HCl|Metraspray|Dithylaminothanol ester der p-butylaminobenzsure|Tetracana|Pontocaine HCl|Amethocaine HCl|2-(Dimethylamino)ethyl p-(butylamino)benzoate	denti-care denti-freeze topica	DRUGBANK	DB09085	C15H24N2O2	small molecule	D04AB06|N01BA03|C05AD02|S01HA03	94-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKCBAIGFKIBETG-UHFFFAOYSA-N
27910	108225	1901	-	S1PR1	CD363|CHEDG1|D1S3362|ECGF1|EDG-1|EDG1|S1P1	9606	Homo sapiens	agonist	target	Bolli MH (2010)	20446681	195997	7850	Asfotase Alfa	Asfotase alpha	strensiq	DRUGBANK	DB09105	C7108H11008N1968O2206S56	biologic	A16AB13	1174277-80-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27911	108225	1901	-	S1PR1	CD363|CHEDG1|D1S3362|ECGF1|EDG-1|EDG1|S1P1	9606	Homo sapiens	agonist	target	Piali L (2011)	21345969	196003	7850	Asfotase Alfa	Asfotase alpha	strensiq	DRUGBANK	DB09105	C7108H11008N1968O2206S56	biologic	A16AB13	1174277-80-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27912	111064	5025	-	P2RX4	P2X4|P2X4R	9606	Homo sapiens	antagonist	target	Tian M (2014)	24411477	196020	7864	Eslicarbazepine acetate	(10S)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide|(10S)-5-carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate|ESL|Stedesa	aptiom	DRUGBANK	DB09119	C17H16N2O3	small molecule	N03AF04	236395-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIALRBLEEWJACW-INIZCTEOSA-N
27913	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	partial agonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27914	109582	3350	-	HTR1A	5-HT-1A|5-HT1A|5HT1a|ADRB2RL1|ADRBRL1|G-21|PFMCD	9606	Homo sapiens	agonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27915	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27916	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27917	106661	152	-	ADRA2C	ADRA2L2|ADRA2RL2|ADRARL2|ALPHA2CAR	9606	Homo sapiens	antagonist	target	Oosterhof CA (2014)	25225185	196022	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27918	109588	3356	RP11-147L20.2	HTR2A	5-HT2A|HTR2	9606	Homo sapiens	antagonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27919	106657	147	-	ADRA1B	ADRA1|ALPHA1BAR	9606	Homo sapiens	antagonist	target	Oosterhof CA (2014)	25225185	196022	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27920	112492	6608	-	SMO	FZD11|Gx|SMOH	9606	Homo sapiens	antagonist	target	Burness CB (2015)	26323341	196029	7888	Sonidegib	Erismodegib|N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide	odomzo	DRUGBANK	DB09143	C26H26F3N3O3	small molecule	L01XX48	956697-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZZJRYRQSPEMTK-CALCHBBNSA-N
27921	106848	351	-	APP	AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2	9606	Homo sapiens	binder	target	Choi SR (2009)	19837759	195994	7894	Florbetapir (18F)	florbetapir-fluorine-18|18F-AV-45|4-{(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline|Florbetapir F-18|Florbetapir F18	amyvid	DRUGBANK	DB09149	C20H25FN2O3	small molecule	V09AX05	956103-76-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YNDIAUKFXKEXSV-CRYLGTRXSA-N
27922	106848	351	-	APP	AAA|ABETA|ABPP|AD1|APPI|CTFgamma|CVAP|PN-II|PN2	9606	Homo sapiens	binder	target	Beach TG (2016)	27031469	196039	7896	Flutemetamol (18F)	[18F]-Flutemetamol|2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|Flutemetamol F-18|flutemetamol (18F)|Flutemetamol F18|Flutemetamol F 18	vizamyl	DRUGBANK	DB09151	C14H11FN2OS	small molecule	V09AX04	765922-62-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VVECGOCJFKTUAX-HUYCHCPVSA-N
27923	107177	716	-	C1S	-	9606	Homo sapiens	inhibitor	target	Harpel PC (1975)	123251	195954	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27924	107176	715	-	C1R	-	9606	Homo sapiens	inhibitor	target	Harpel PC (1975)	123251	195954	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27925	111343	5327	-	PLAT	T-PA|TPA	9606	Homo sapiens	inhibitor	target	Cicardi M (2005)	16267649	195964	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27926	108459	2161	-	F12	HAE3|HAEX|HAF	9606	Homo sapiens	inhibitor	target	de Agostini A (1984)	6725552	196046	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27927	108458	2160	-	F11	FXI	9606	Homo sapiens	inhibitor	target	Cicardi M (2005)	16267649	195964	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27928	110018	3818	-	KLKB1	KLK3|PPK	9606	Homo sapiens	inhibitor	target	van der Graaf F (1983)	6184384	196044	7972	C1 Esterase Inhibitor (Recombinant)	C1 Inhibitor (Recombinant)|C1-INH|Conestat Alfa|C1INH	ruconest	DRUGBANK	DB09228	-	biologic	B06AC04	80295-38-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27929	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	modulator	target	Kuk K (2015)	26416827	196033	8024	Lumacaftor	lumacaftor|3-(6-{[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropane-1-carbonyl]amino}-3-methylpyridin-2-yl)benzoic acid|VRT 826809	orkambi	DRUGBANK	DB09280	C24H18F2N2O5	small molecule	R07AX30	936727-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UFSKUSARDNFIRC-UHFFFAOYSA-N
27930	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	inhibitor	target	Yosaatmadja Y (2015)	26522274	196035	8129	Osimertinib	N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide|Mereletinib	tagrisso	DRUGBANK	DB09330	C28H33N7O2	small molecule	-	1421373-65-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUYJMQONPNNFPI-UHFFFAOYSA-N
27931	107390	952	-	CD38	ADPRC 1|T10	9606	Homo sapiens	antibody	target	de Weers M (2011)	21187443	196002	8130	Daratumumab	HuMax-CD38	darzalex	DRUGBANK	DB09331	-	biologic	-	945721-28-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27932	113150	7299	-	TYR	ATN|CMM8|OCA1|OCA1A|OCAIA|SHEP3	9606	Homo sapiens	inhibitor	target	Patil S (2016)	27519292	196041	8199	Hydroquinone	p-hydroxyphenol|p-Benzenediol|benzene-1,4-diol|Eldoquin|1,4-dihydroxybenzene|p-Hydroquinone|1,4-benzenediol|4-Hydroxyphenol|quinol	elastiderm decolletage skin li	DRUGBANK	DB09526	C6H6O2	small molecule	D11AX11	123-31-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIGBRXMKCJKVMJ-UHFFFAOYSA-N
27933	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	antagonist	target	Kuenen B (2010)	20197484	195996	8209	Necitumumab	-	portrazza	DRUGBANK	DB09559	-	biologic	L01XC22	906805-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27934	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Kaufmann P (2015)	25850750	196024	8235	Selexipag	-	uptravi titration pack|uptravi	DRUGBANK	DB11362	C26H32N4O4S	small molecule	B01AC27	475086-01-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWZQTURMXZVHJ-UHFFFAOYSA-N
27935	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Souers AJ (2013)	23291630	196015	8250	Venetoclax	4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide	venclexta	DRUGBANK	DB11581	C45H50ClN7O7S	small molecule	-	1257044-40-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQBVNQSMGBZMKD-UHFFFAOYSA-N
27936	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor	target	Davids MS (2013)	23410971	196016	8250	Venetoclax	4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide	venclexta	DRUGBANK	DB11581	C45H50ClN7O7S	small molecule	-	1257044-40-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQBVNQSMGBZMKD-UHFFFAOYSA-N
27937	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27938	120973	55879	-	GABRQ	THETA	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27939	108833	2559	-	GABRA6	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27940	108833	2559	-	GABRA6	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27941	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27942	108840	2566	-	GABRG2	CAE2|ECA2|GEFSP3	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27943	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27944	108834	2560	-	GABRB1	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27945	108842	2568	-	GABRP	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27946	108842	2568	-	GABRP	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27947	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27948	108837	2563	-	GABRD	EIG10|EJM7|GEFSP5	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27949	108831	2557	-	GABRA4	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27950	108831	2557	-	GABRA4	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27951	108835	2561	-	GABRB2	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27952	108835	2561	-	GABRB2	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27953	108839	2565	-	GABRG1	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27954	108839	2565	-	GABRG1	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27955	108832	2558	-	GABRA5	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27956	108832	2558	-	GABRA5	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27957	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27958	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27959	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27960	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27961	108829	2555	-	GABRA2	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27962	108829	2555	-	GABRA2	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27963	108830	2556	-	GABRA3	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27964	108830	2556	-	GABRA3	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27965	108841	2567	-	GABRG3	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27966	108841	2567	-	GABRG3	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27967	108838	2564	-	GABRE	-	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27968	108838	2564	-	GABRE	-	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27969	114160	8600	RP11-86N24.2	TNFSF11	CD254|ODF|OPGL|OPTB2|RANKL|TRANCE|hRANKL2|sOdf	9606	Homo sapiens	antagonist	target	Reuter S (2012)	21955206	196011	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27970	109003	2741	-	GLRA1	HKPX1|STHE	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27971	109505	3269	-	HRH1	H1-R|hisH1	9606	Homo sapiens	antagonist	target	Wang XY (2016)	27110120	196040	8254	Bilastine	-	blexten	DRUGBANK	DB11591	C28H37N3O3	small molecule	R06AX29	202189-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACCMWZWAEFYUGZ-UHFFFAOYSA-N
27972	106715	213	GIG20	ALB	ANALBA|FDAH|PRO0883|PRO0903|PRO1341	9606	Homo sapiens	binder	target	Baneres-Roquet F (2009)	19164148	188474	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27973	106715	213	GIG20	ALB	ANALBA|FDAH|PRO0883|PRO0903|PRO1341	9606	Homo sapiens	binder	target	Naik KM (2016)	26239839	198165	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27974	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Stanat SJ (2003)	14674677	198167	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27975	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Volberg WA (2002)	12065733	198166	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27976	109959	3757	-	KCNH2	ERG-1|ERG1|H-ERG|HERG|HERG1|Kv11.1|LQT2|SQT1	9606	Homo sapiens	inhibitor	target	Du LP (2004)	15324906	188475	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27977	109120	2862	-	MLNR	GPR38|MTLR1	9606	Homo sapiens	unknown	target	Deloose E (2016)	26817505	198169	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27978	109120	2862	-	MLNR	GPR38|MTLR1	9606	Homo sapiens	unknown	target	Peeters T (1989)	2782416	198168	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27979	108464	2166	-	FAAH	FAAH-1|PSAB	9606	Homo sapiens	inhibitor	target	Hoegestaett ED (2005)	15987694	198170	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
27980	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Hoegestaett ED (2005)	15987694	198170	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
27981	113281	7442	-	TRPV1	VR1	9606	Homo sapiens	unknown	target	Mallet C (2010)	20862299	198171	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
27982	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Kraft SL (2014)	24038727	198172	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
27983	110301	4128	RP1-201D17__B.2	MAOA	MAO-A	9606	Homo sapiens	inhibitor	target	Holt A (1992)	1359073	198173	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
27984	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Kraft SL (2014)	24038727	198172	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
27985	110302	4129	RP1-201D17__B.1	MAOB	-	9606	Homo sapiens	inhibitor	target	Holt A (1992)	1359073	198173	1156	Procarbazine	Procarbazinum|p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide|N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide|N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine|1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine|Procarbazin|Procarbazina|N-Isopropyl--(2-methylhydrazino)-p-toluamide|2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine|N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide|4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide|N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide	matulane	DRUGBANK	DB01168	C12H19N3O	small molecule	L01XB01	671-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPTBDICYNRMXFX-UHFFFAOYSA-N
27986	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	agonist	target	Chen F (2005)	15994348	181621	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
27987	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27988	850762	946405	b1896	otsA	ECK1895|JW5312|pexA	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27989	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27990	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27991	131861	360203	RP11-98L5.1	GLT6D1	GLTDC1|GT6M7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27992	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Imming P (2006)	17016423	171742	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27993	849730	945354	b0759	galE	ECK0748|JW0742|galD	511145	Escherichia coli	unknown	target	Overington JP (2006)	17139284	171741	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27994	109247	2992	-	GYG1	GSD15|GYG	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1791	Uridine diphosphate glucose	UDPG|UDP-Glucose|Cogalactoisomerase|5'-Diphosphoglucose|Uridine 5'-pyrophosphate glucose ester|Uridine-5'-Diphosphoglucose|Co-galactoisomerase|Co-waldenase	-	DRUGBANK	DB01861	C15H24N2O17P2	small molecule	-	133-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HSCJRCZFDFQWRP-JZMIEXBBSA-N
27995	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2075	(R)-Propylene glycol	R-1,2-propanediol	-	DRUGBANK	DB02159	C3H8O2	small molecule	-	4254-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-GSVOUGTGSA-N
27996	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2075	(R)-Propylene glycol	R-1,2-propanediol	-	DRUGBANK	DB02159	C3H8O2	small molecule	-	4254-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-GSVOUGTGSA-N
27997	110247	4069	-	LYZ	LZM	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2075	(R)-Propylene glycol	R-1,2-propanediol	-	DRUGBANK	DB02159	C3H8O2	small molecule	-	4254-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNIAPMSPPWPWGF-GSVOUGTGSA-N
27998	113335	7498	-	XDH	XO|XOR	9606	Homo sapiens	inhibitor	target	Bruce SP (2006)	17132810	195972	8063	Febuxostat	Febuxostatum|Fbuxostat|2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid|Febuxostat	uloric|febuxostat	DRUGBANK	DB04854	C16H16N2O3S	small molecule	M04AA03	144060-53-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BQSJTQLCZDPROO-UHFFFAOYSA-N
27999	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	antibody	target	Wittig BM (2007)	17979029	182059	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28000	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	antibody	target	Reddy M (2007)	17761156	182044	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28001	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	unknown	target	Engel T (2016)	27433311	198174	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28002	109807	3593	-	IL12B	CLMF|CLMF2|IL-12B|IMD28|IMD29|NKSF|NKSF2	9606	Homo sapiens	unknown	target	Khanna R (2016)	27306074	198175	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28003	119611	51561	UNQ2498/PRO5798	IL23A	IL-23|IL-23A|IL23P19|P19|SGRF	9606	Homo sapiens	unknown	target	Engel T (2016)	27433311	198174	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28004	119611	51561	UNQ2498/PRO5798	IL23A	IL-23|IL-23A|IL23P19|P19|SGRF	9606	Homo sapiens	unknown	target	Khanna R (2016)	27306074	198175	5288	Ustekinumab	Stelera	stelara	DRUGBANK	DB05679	Anti-(human interleukin 12 p40 subunit) (human monoclonal CNTO 1275 1-chain)-immunoglobulin G1 disulfide with human monoclonal CNTO 1275 -chain dimer	biologic	L04AC05	815610-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28005	115296	9971	-	NR1H4	BAR|FXR|HRR-1|HRR1|RIP14	9606	Homo sapiens	agonist	target	Pellicciari R (2002)	12166927	198176	8284	Obeticholic acid	6alpha-Ethyl-chenodeoxycholic acid|6-ECDCA|6-ethylchenodeoxycholic acid|6-ethylchenodeoxycholic acid|6-Ethyl-CDCA	ocaliva	DRUGBANK	DB05990	C26H44O4	small molecule	A05AA04	459789-99-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXERDUOLZKYMJM-ZWECCWDJSA-N
28006	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	Doi T (2014)	24816152	198177	8285	Olaratumab	Lartruvo	lartruvo	DRUGBANK	DB06043	-	biologic	-	1024603-93-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28007	111182	5156	-	PDGFRA	CD140A|PDGFR-2|PDGFR2|RHEPDGFRA	9606	Homo sapiens	unknown	target	van der Graaf WT (2016)	27291995	198178	8285	Olaratumab	Lartruvo	lartruvo	DRUGBANK	DB06043	-	biologic	-	1024603-93-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
28008	122970	79885	-	HDAC11	HD11	9606	Homo sapiens	inhibitor	target	Geng L (2006)	17145876	195973	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
28009	122970	79885	-	HDAC11	HD11	9606	Homo sapiens	inhibitor	target	Beckers T (2007)	17455259	182004	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
28010	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Sansoe G (2005)	16085334	198179	8300	Candoxatrilat	Candoxatrilate	-	DRUGBANK	DB11623	C20H33NO7	small molecule	-	123122-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACZWIDANLCXHBM-HRCADAONSA-N
28011	110455	4311	-	MME	CALLA|CD10|NEP|SFE	9606	Homo sapiens	inhibitor	target	Alabaster CT (1989)	2611529	198180	8300	Candoxatrilat	Candoxatrilate	-	DRUGBANK	DB11623	C20H33NO7	small molecule	-	123122-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACZWIDANLCXHBM-HRCADAONSA-N
28012	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2011)	22014751	142167	8426	Bivalent ligand 1	Bivalent_ligand_1|SNIPER 11	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: SNIPER 11(cIAP1:BE04 --- AR:DHT)	-
28014	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2010)	20369832	125335	8428	Bivalent ligand 2	Bivalent_ligand_2|Compound 4b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	107772	1381	-	CRABP1	CRABP|CRABP-I|CRABPI|RBP5	9606	Homo sapiens	target	Standardized BVL Name: Compound 4b(cIAP1:methyl bestatin --- CRABPI/II:ATRA)	-
28016	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Zhang W (2017)	28542609	211389	8428	Bivalent ligand 2	Bivalent_ligand_2|Compound 4b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: Compound 4b(cIAP1:methyl bestatin --- CRABP-I/II:ATRA)	-
28018	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2011)	22014751	142167	8427	Bivalent ligand 3	Bivalent_ligand_3|SNIPER 13	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: SNIPER 13(cIAP1:BE04 --- ER:estrone)	-
28020	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2011)	22014751	142167	8423	Bivalent ligand 4	Bivalent_ligand_4|SNIPER 9	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	111849	5914	-	RARA	NR1B1|RAR	9606	Homo sapiens	target	Standardized BVL Name: SNIPER 9(cIAP1:BE04 --- RAR:Ch55)	-
28022	119489	51343	-	FZR1	CDC20C|CDH1|FZR|FZR2|HCDH|HCDH1	9606	Homo sapiens	degradation	recruited E3 ligase	Ohoka N (2014)	25375378	206180	8422	Bivalent ligand 5	Bivalent_ligand_5|SNIPER(TACC3)-1/SNIPER(TACC3)-2|SNIPER(TACC3)-1|SNIPER(TACC3)-2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	115723	10460	-	TACC3	ERIC-1|ERIC1	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(TACC3)-1(cIAP1:bestatin --- TACC3:KHS108)	-
28024	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Henning RK (2016)	26880702	211388	8425	Bivalent ligand 6	Bivalent_ligand_6|CPP-tri_a-PR	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: CPP-tri_a-PR(VHL:HIF1a peptide --- Akt:synthetic peptide)	-
28026	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	degradation	recruited E3 ligase	Sakamoto KM (2003)	14525958	111475	8424	Bivalent ligand 7	Bivalent_ligand_7|Protac-3|Protac 3	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: Protac-3(Beta-TrCP:IkBalpha phosphopeptide --- AR:DHT)	-
28028	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Schneekloth JS (2004)	15038727	211349	8421	Bivalent ligand 8	Bivalent_ligand_8|PROTAC 5|Protac-5	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-5 (VHL:HIF1a-polyarginine peptide sequence --- AR:DHT)	-
28030	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited E3 ligase	Schneekloth AR (2008)	18752944	85706	8420	Bivalent ligand 9	Bivalent_ligand_9|PROTAC 14|Protac-14	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 14(MDM2:nutlin-3 --- AR:SARM)	-
28032	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Lee H (2007)	17907127	211396	8450	Bivalent ligand 10	Bivalent_ligand_10|Api-Protac-II	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106699	196	-	AHR	bHLHe76	9606	Homo sapiens	target	Standardized BVL Name: ApiProtac-II(VHL:HIF1a pentapeptide --- AR:apigenin)	-
28034	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Lai AC (2016)	26593377	191787	8449	Bivalent ligand 11	Bivalent_ligand_11|DAS-VHL	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: DAS-VHL(VHL:HIF-1alpha hydroxyproline derived small molecule --- c-ABL:dasatinib)	-
28036	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Lai AC (2016)	26593377	191787	8452	Bivalent ligand 12	Bivalent_ligand_12|DAS-CRBN	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: DAS-CRBN(CRBN:pomalidomide --- BCR-ABL:dasatinib)	-
28038	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Lai AC (2016)	26593377	191787	8402	Bivalent ligand 43	Bivalent_ligand_43|BOS-CRBN	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: BOS-CRBN(CRBN:pomalidomide --- BCR-ABL:bosutinib)	-
28040	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Demizu Y (2016)	27666635	199362	8451	Bivalent ligand 13	Bivalent_ligand_13|SNIPER(ABL)2,3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(ABL)2,3(cIAP1:methyl bestatin --- BCR-ABL:imatinib derivative)	-
28042	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Raina K (2016)	27274052	211416	8446	Bivalent ligand 14	Bivalent_ligand_14|ARV-771	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: ARV-771(VHL:HIF-1alpha hydroxyproline derived small molecule --- BRD2:triazolo-diazepine acetamide BET-binding moiety)	-
28044	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Raina K (2016)	27274052	211416	8446	Bivalent ligand 14	Bivalent_ligand_14|ARV-771	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: ARV-771(VHL:HIF-1alpha hydroxyproline derived small molecule --- BRD3:triazolo-diazepine acetamide BET-binding moiety)	-
28046	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Raina K (2016)	27274052	211416	8446	Bivalent ligand 14	Bivalent_ligand_14|ARV-771	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: ARV-771(VHL:HIF-1alpha hydroxyproline derived small molecule --- BRD4:triazolo-diazepine acetamide BET-binding moiety)	-
28048	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Zengerle M (2015)	26035625	185990	8407	Bivalent ligand 44	Bivalent_ligand_44|compound MZ1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: compound MZ1(VHL:VHL-1 --- BRD2:JQ1)	-
28050	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Zengerle M (2015)	26035625	185990	8407	Bivalent ligand 44	Bivalent_ligand_44|compound MZ1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: compound MZ1(VHL:VHL-1 --- -BRD3:JQ1)	-
28052	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Zengerle M (2015)	26035625	185990	8407	Bivalent ligand 44	Bivalent_ligand_44|compound MZ1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound MZ1(VHL:VHL-1 --- BRD4:JQ1)	-
28054	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Winter GE (2015)	25999370	211411	8445	Bivalent ligand 15	Bivalent_ligand_15|dBET1|dBET6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: dBET1(CRBN:thalidomide --- BRD4:JQ1)	-
28056	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Lu J (2015)	26051217	211422	8408	Bivalent ligand 45	Bivalent_ligand_45|ARV-825	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: ARV-825(CRBN:pomalidomide --- BRD4:OTX015)	-
28058	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2015)	26075522	211358	8448	Bivalent ligand 16	Bivalent_ligand_16|PROTAC_ERRa	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108405	2101	-	ESRRA	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC_ERRalpha(VHL:HIF-1alpha hydroxyproline derived small molecule --- ERRa:thiazolidinedione-based compound 29)	-
28060	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	degradation	recruited E3 ligase	Sakamoto KM (2003)	14525958	111475	8447	Bivalent ligand 17	Bivalent_ligand_17|Protac-2|Protac 2	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: Protac-2(Beta-TrCP:IkBalpha phosphopeptide --- ER:estradiol)	-
28062	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Rodriguez-Gonzalez A (2008)	18794799	85962	8458	Bivalent ligand 18	Bivalent_ligand_18|Protac-B	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: Protac-B(VHL:HIF1a pentapeptide --- ER:estradiol)	-
28064	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Cyrus K (2010)	20572252	211420	8457	Bivalent ligand 19	Bivalent_ligand_19|PROTAC 5	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 5(VHL:HIF1a pentapeptide --- ER:estradiol (2 molecules))	-
28066	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Demizu Y (2012)	22277276	211397	8412	Bivalent ligand 20	Bivalent_ligand_20|SNIPER (ER) 5,6,7	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: SNIPER (ER) 5,6,7(cIAP1:bestatin --- ER:4-hydroxytamoxifen)	-
28068	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Okuhira K (2013)	23992566	211367	8413	Bivalent ligand 21	Bivalent_ligand_21|SNIPER(ER)-3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(ER)-3(cIAP1:methyl bestatin  --- ER:4-hydroxytamoxifen)	-
28070	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2012)	22658364	211406	8414	Bivalent ligand 22	Bivalent_ligand_22|Compound 6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: Compound 6(IAP pan-ligand:MV-1  --- CRABP-II:ATRA)	-
28072	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2012)	22658364	211406	8414	Bivalent ligand 22	Bivalent_ligand_22|Compound 6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: Compound 6(IAP pan-ligand:MV-1  --- CRABP-II: ATRA)	-
28074	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2012)	22658364	211406	8414	Bivalent ligand 22	Bivalent_ligand_22|Compound 6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: Compound 6(IAP pan-ligand:MV-1 --- CRABP-II: ATRA)	-
28076	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited E3 ligase	Ohoka N (2017)	28154167	211362	8415	Bivalent ligand 23	Bivalent_ligand_23|SNIPER(ER)-87	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(ER)-87(XIAP:LCL161 --- ER:4-hydroxytamoxifen)	-
28078	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited E3 ligase	Ohoka N (2017)	28154167	211362	8416	Bivalent ligand 24	Bivalent_ligand_24|SNIPER(BRD4)-1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(BRD4)-1(XIAP:LCL161 --- BRD4:JQ1)	-
28080	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited E3 ligase	Ohoka N (2017)	28154167	211362	8417	Bivalent ligand 25	Bivalent_ligand_25|SNIPER(ABL)-38	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(ABL)-38(XIAP:LCL161 --- BCR-ABL:dasatinib)	-
28082	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited E3 ligase	Ohoka N (2017)	28154167	211362	8418	Bivalent ligand 26	Bivalent_ligand_26|SNIPER(PDE4)-9	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111167	5141	-	PDE4A	DPDE2|PDE4|PDE46	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(PDE4)-9(XIAP:LCL161 --- PDE4:PDE4 inhibitor)	-
28084	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Rodriguez-Gonzalez A (2008)	18794799	85962	8419	Bivalent ligand 27	Bivalent_ligand_27|Protac-A	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: Protac-A(VHL:HIF1a pentapeptide --- AR:DHT)	-
28086	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Rodriguez-Gonzalez A (2008)	18794799	85962	8409	Bivalent ligand 28	Bivalent_ligand_28|Protac-AA	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: Protac-AA(VHL:HIF1a pentapeptide+a polyarginine tail and two glycine residues  --- AR:DHT)	-
28088	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Winter GE (2015)	25999370	211411	8410	Bivalent ligand 29	Bivalent_ligand_29|dFKBP-1|dFKBP-2|dFKBP-1/dFKBP-2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: dFKBP-1/dFKBP-2(CRBN:thalidomide --- FKBP12:SLF)	-
28090	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Hines J (2013)	23674677	194582	8460	Bivalent ligand 30	Bivalent_ligand_30|TrkAPPFRS2a|phosphoPROTAC	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116031	10818	-	FRS2	FRS2A|FRS2alpha|SNT|SNT-1|SNT1	9606	Homo sapiens	target	Standardized BVL Name: TrkAPPFRS2alpha(VHL:HIF1alpha septapeptide --- FRS2a:phosphorylated TrkA-derived decapeptide sequence)	-
28092	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	degradation	recruited E3 ligase	Sakamoto KM (2001)	11438690	115955	8459	Bivalent ligand 31	Bivalent_ligand_31|Protac-1	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	target	Standardized BVL Name: Protac-1(Beta-TrCP:IkBalpha phosphopeptide peptide --- MetAP-2:ovalicin)	-
28094	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Zhang D (2004)	14741260	211348	8432	Bivalent ligand 32	Bivalent_ligand_32|Fu-SMPI	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	target	Standardized BVL Name: Fu-SMPI(VHL:HIF-1alpha octapeptide --- MetAP-2:fumagillol)	-
28096	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Zhang D (2004)	14741260	211348	8411	Bivalent ligand 33	Bivalent_ligand_33|E2-SMPI/E2-octa|E2-SMPI|E2-octa	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: E2-SMPI/E2-octa(VHL:HIF-1alpha octapeptide --- ER:estradiol)	-
28098	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bargagna-Mohan P (2005)	15876533	211350	8456	Bivalent ligand 34	Bivalent_ligand_34|E2-penta	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: E2-penta(VHL:HIF-1alpha pentapeptide --- ER:estradiol)	-
28100	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Hines J (2013)	23674677	194582	8455	Bivalent ligand 35	Bivalent_ligand_35|ErbB2PPPI3K|phosphoPROTAC	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111313	5295	-	PIK3R1	AGM7|GRB1|IMD36|p85|p85-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: ErbB2PPPI3K(VHL:HIF1alpha septapeptide --- PI3K:ErbB3 peptide)	-
28102	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2015)	26075522	211358	8454	Bivalent ligand 36	Bivalent_ligand_36|PROTAC_RIPK2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114300	8767	WUGSC:H_RG437L15.1	RIPK2	CARD3|CARDIAK|CCK|GIG30|RICK|RIP2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC_RIPK2(VHL: HIF-1alpha hydroxyproline derived small molecule --- RIPK2:vandetanib)	-
28104	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Chu TT (2016)	27105281	211375	8453	Bivalent ligand 37	Bivalent_ligand_37|TH006	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: TH006(VHL:HIF1a peptide --- Tau:Beta-tubulin peptide)	-
28106	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Itoh Y (2011)	21515062	211395	8404	Bivalent ligand 38	Bivalent_ligand_38|SNIPER 6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107772	1381	-	CRABP1	CRABP|CRABP-I|CRABPI|RBP5	9606	Homo sapiens	target	Standardized BVL Name: SNIPER 6(cIAP-I:BE04- --- CRABP-I:ATRA)	-
28108	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Wang X (2016)	27473774	211351	8403	Bivalent ligand 40	Bivalent_ligand_40|PROTAC	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110263	4088	-	SMAD3	HSPC193|HsT17436|JV15-2|LDS1C|LDS3|MADH3	9606	Homo sapiens	target	Standardized BVL Name: (VHL:HIF1a peptide --- SMAD3:#8 SMC (EN300-72284))	-
28110	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Okuhira K (2017)	27965304	207511	8436	Bivalent ligand 41	Bivalent_ligand_41|SNIPER(CRABP)-4	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(CRABP)-4(cIAP1:methyl bestatin --- CRABP-II:ATRA)	-
28112	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Okuhira K (2017)	27965304	207511	8401	Bivalent ligand 42	Bivalent_ligand_42|SNIPER(CRABP)-11	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(CRABP)-11(IAP pan-ligand:MV1 --- CRABP-II:ATRA)	-
28114	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited E3 ligase	Okuhira K (2017)	27965304	207511	8401	Bivalent ligand 42	Bivalent_ligand_42|SNIPER(CRABP)-11	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(CRABP)-11(IAP pan-ligand:MV1 --- CRABP-II:ATRA)	-
28116	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited E3 ligase	Okuhira K (2017)	27965304	207511	8401	Bivalent ligand 42	Bivalent_ligand_42|SNIPER(CRABP)-11	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107773	1382	RP11-66D17.4	CRABP2	CRABP-II|RBP6	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(CRABP)-11(IAP pan-ligand:MV1 --- CRABP-II:ATRA)	-
28118	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Tomoshige S (2015)	26338696	191691	8399	Bivalent ligand 48	Bivalent_ligand_48|compound 1b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	107775	1385	-	CREB1	CREB	9606	Homo sapiens	target	Standardized BVL Name: compound 1b(cIAP1:BE04 --- HaloTag-CREB1)	-
28120	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Tomoshige S (2015)	26338696	191691	8399	Bivalent ligand 48	Bivalent_ligand_48|compound 1b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	109928	3725	-	JUN	AP-1|AP1|c-Jun	9606	Homo sapiens	target	Standardized BVL Name: compound 1b(cIAP1:BE04 --- HaloTag-c-jun)	-
28122	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Tomoshige S (2016)	27236416	205947	8400	Bivalent ligand 49	Bivalent_ligand_49|Compound 4a/4b|Compound 4a|Compound 4b|4a|4b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	112979	7124	DADB-70P7.1	TNF	DIF|TNF-alpha|TNFA|TNFSF2	9606	Homo sapiens	target	Standardized BVL Name: Compound 4a/4b(IAP pan-ligand:MV1 --- HaloTag-TNFalpha)	-
28124	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited E3 ligase	Tomoshige S (2016)	27236416	205947	8400	Bivalent ligand 49	Bivalent_ligand_49|Compound 4a/4b|Compound 4a|Compound 4b|4a|4b	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	107433	998	RP1-224A6.5	CDC42	CDC42Hs|G25K	9606	Homo sapiens	target	Standardized BVL Name: Compound 4a/4b(IAP pan-ligand:MV1 --- HaloTag-Cdc42)	-
28126	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Buckley DL (2015)	26070106	211383	8438	Bivalent ligand 50	Bivalent_ligand_50|HaloPROTAC3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC3(VHL:degradation moiety B --- HaloTag7-ERK1)	-
28128	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Buckley DL (2015)	26070106	211383	8438	Bivalent ligand 50	Bivalent_ligand_50|HaloPROTAC3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC3(VHL:degradation moiety B --- HaloTag7-MEK1)	-
28130	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Buhimschi AD (2018)	29851337	211398	8437	Bivalent ligand 51	Bivalent_ligand_51|MT-540|MT-541|MT-781|MT-802	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: MT-540/MT-541/MT-781/ MT-802 (CRBN:pomalidomide --- BTK:Ibrutinib)	-
28132	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Zhang C (2018)	29627725	211374	8440	Bivalent ligand 52	Bivalent_ligand_52|MS4077|MS4078|COMPOUND 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: MS4077/MS4078(CRBN:pomalidimide --- ALK:ceritinib)	-
28134	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Zhang X (2018)	29581547	211371	8443	Bivalent ligand 57	Bivalent_ligand_57|ARV-763	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: ARV-763 (VHL: :HIF-1alpha hydroxyproline derived small molecule --- BRD4:OTX015)	-
28136	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Robb CM (2017)	28636052	211400	8444	Bivalent ligand 56	Bivalent_ligand_56|PROTAC 3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 3(CRBN:thalidomide --- CDK9:aminopyrazole analog)	-
28138	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Burslem GM (2018)	29129716	211414	8440	Bivalent ligand 52	Bivalent_ligand_52|MS4077|MS4078|COMPOUND 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: compound 1(VHL:Ligand 9 --- EGFR:lapatinib)	-
28140	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Burslem GM (2018)	29129716	211414	8439	Bivalent ligand 53	Bivalent_ligand_53|COMPOUND 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: compound 3(VHL:Ligand 9 --- EGFR:gefitinib)	-
28142	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Burslem GM (2018)	29129716	211414	8442	Bivalent ligand 54	Bivalent_ligand_54|COMPOUND 3	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: compound 4(VHL:Ligand 9 --- EGFR:afatinib)	-
28144	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Burslem GM (2018)	29129716	211414	8440	Bivalent ligand 52	Bivalent_ligand_52|MS4077|MS4078|COMPOUND 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	target	Standardized BVL Name: compound 1(VHL:Ligand 9--- HER2:lapatinib)	-
28146	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Burslem GM (2018)	29129716	211414	8441	Bivalent ligand 55	Bivalent_ligand_55|Compound 7	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: compound 7(VHL:Ligand 9 --- c-Met:foretinib)	-
28148	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Jiang Y (2018)	29271628	211419	8405	Bivalent ligand 60	Bivalent_ligand_60|TD-PROTAC	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: TD-PROTAC(VHL:HIF1a pentapeptide --- ER: stabilized peptide TD-PERM)	-
28150	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited E3 ligase	Lu M (2018)	29407955	211357	8435	Bivalent ligand 58	Bivalent_ligand_58|Peptide 1	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: Peptide 1(Keap1:peptide Ac-LDPETGEYL-OH --- Tau:b-tubulin derived peptide)	-
28152	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Maniaci C (2017)	29018234	209238	8434	Bivalent ligand 59	Bivalent_ligand_59|CM9|CM10|CM11	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	target	Standardized BVL Name: CM9/CM10/CM11(VHL:Ligand 7 --- VHL:Ligand 7)	-
28154	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Winter GE (2017)	28673542	211369	8445	Bivalent ligand 15	Bivalent_ligand_15|dBET1|dBET6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: dBET6(CRBN:thalidomide --- BRD4:JQ1)	-
28156	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Schiedel M (2018)	28379698	211385	8406	Bivalent ligand 61	Bivalent_ligand_61|SirReal-based PROTAC (12)	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	target	Standardized BVL Name: SirReal-based PROTAC (12)(CRBN:thalidomide --- SIRT2:SirReal3b)	-
28158	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Gadd MS (2017)	28288108	210014	8430	Bivalent ligand 62	Bivalent_ligand_62|AT-1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: AT-1 (VHL:modified VH032 --- BRD4:JQ1)	-
28160	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114300	8767	WUGSC:H_RG437L15.1	RIPK2	CARD3|CARDIAK|CCK|GIG30|RICK|RIP2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1 (VHL: VHL ligand --- RIPK2: foretinib)	-
28162	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MAPK14:foretinib)	-
28164	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122928	79837	-	PIP4K2C	PIP5K2C	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- PIP4K2C:foretinib)	-
28166	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MET:foretinib)	-
28168	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- EPHB2:foretinib)	-
28170	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MARK4:foretinib)	-
28172	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- EPHB4:foretinib)	-
28174	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113617	7867	-	MAPKAPK3	3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MAPKAPK3:foretinib)	-
28176	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	570722	645745	-	MT1HL1	MT1P2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MT1HL1:foretinib)	-
28178	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110447	4301	-	MLLT4	AF6	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MLLT4:foretinib)	-
28180	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124910	92106	-	OXNAD1	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- OXNAD1:foretinib)	-
28182	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109905	3699	-	ITIH3	H3P	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ITIH3:foretinib)	-
28184	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108336	2021	-	ENDOG	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ENDOG:foretinib)	-
28186	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124429	85014	-	TMEM141	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- TMEM141:foretinib)	-
28188	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108176	1843	-	DUSP1	CL100|HVH1|MKP-1|MKP1|PTPN10	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- DUSP1:foretinib)	-
28190	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122671	79446	-	WDR25	C14orf67	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- WDR25:foretinib)	-
28192	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122312	64834	CGI-88	ELOVL1	Ssc1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ELOVL1:foretinib)	-
28194	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114837	9447	RP11-520H16.3	AIM2	PYHIN4	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- AIM2:foretinib)	-
28196	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MAPKAPK2:foretinib)	-
28198	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ABL2:foretinib)	-
28200	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116353	11183	-	MAP4K5	GCKR|KHS|KHS1|MAPKKKK5	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MAP4K5:foretinib)	-
28202	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113703	7994	-	KAT6A	MOZ|MYST3|RUNXBP2|ZC2HC6A|ZNF220	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- KAT6A:foretinib)	-
28204	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121967	63874	-	ABHD4	ABH4	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ABHD4:foretinib)	-
28206	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127816	162417	-	NAGS	AGAS|ARGA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- NAGS:foretinib)	-
28208	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121661	57614	-	KIAA1468	HsT3308|HsT885	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- KIAA1468:foretinib)	-
28210	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109833	3621	RP11-8D7.1	ING1	p24ING1c|p33|p33ING1|p33ING1b|p47|p47ING1a	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ING1:foretinib)	-
28212	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109212	2957	-	GTF2A1	TF2A1|TFIIA|TFIIA-42|TFIIAL	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- GTF2A1:foretinib)	-
28214	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- ABL1:foretinib)	-
28216	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124728	90522	hCG_1785221	YIF1B	FinGER8	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- YIF1B:foretinib)	-
28218	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120295	54957	-	TXNL4B	DLP|Dim2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- TXNL4B:foretinib)	-
28220	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122589	79172	-	CENPO	CENP-O|ICEN-36|MCM21R	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- CENPO:foretinib)	-
28222	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114300	8767	WUGSC:H_RG437L15.1	RIPK2	CARD3|CARDIAK|CCK|GIG30|RICK|RIP2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- RIPK2:foretinib)	-
28224	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- MET:foretinib)	-
28226	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- EPHB2:foretinib)	-
28228	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121262	56937	RP4-718J7.3	PMEPA1	STAG1|TMEPAI	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- PMEPA1:foretinib)	-
28230	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114138	8569	RP11-49P4.3	MKNK1	MNK1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- MKNK1:foretinib)	-
28232	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ABL2:foretinib)	-
28234	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	125430	115361	-	GBP4	Mpa2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- GBP4:foretinib)	-
28236	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106832	335	-	APOA1	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- APOA1:foretinib)	-
28238	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- EPHA2:foretinib)	-
28240	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108908	2638	-	GC	DBP|DBP/GC|GRD3|HEL-S-51|VDBG|VDBP	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- GC:foretinib)	-
28242	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- CSK:foretinib)	-
28244	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- FER:foretinib)	-
28246	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106682	174	-	AFP	AFPD|FETA|HPAFP	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- AFP:foretinib)	-
28248	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117221	23708	-	GSPT2	ERF3B|GST2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- GSPT2:foretinib)	-
28250	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- GSPT1:foretinib)	-
28252	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ZFP91:foretinib)	-
28254	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110607	4501	-	MT1X	MT-1l|MT1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- MT1X:foretinib)	-
28256	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106953	462	PRO0309	SERPINC1	AT3|AT3D|ATIII|THPH7	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- SERPINC1:foretinib)	-
28258	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ABL1:foretinib)	-
28260	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109905	3699	-	ITIH3	H3P	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ITIH3:foretinib)	-
28262	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122671	79446	-	WDR25	C14orf67	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- WDR25:foretinib)	-
28266	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116278	11097	-	NUPL2	CG1|NLP-1|NLP_1|hCG1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- NUPL2:foretinib)	-
28268	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110018	3818	-	KLKB1	KLK3|PPK	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- KLKB1:foretinib)	-
28270	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119555	51465	CGI-76	UBE2J1	HSPC153|HSPC205|HSU93243|NCUBE-1|NCUBE1|UBC6|Ubc6p	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- UBE2J1:foretinib)	-
28272	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115986	10767	RP11-349J5.1	HBS1L	EF-1a|ERFS|HBS1|HSPC276|eRF3c	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- HBS1L:foretinib)	-
28274	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107196	735	-	C9	ARMD15|C9D	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- C9:foretinib)	-
28276	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109289	3039	-	HBA1	HBA-T3|HBH	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- HBA1:foretinib)	-
28278	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109906	3700	PRO1851	ITIH4	GP120|H4P|IHRP|ITI-HC4|ITIHL1|PK-120|PK120	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ITIH4:foretinib)	-
28280	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108486	2192	CTA-941F9.7	FBLN1	FBLN|FIBL1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- FBLN1:foretinib)	-
28282	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109295	3045	-	HBD	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- HBD:foretinib)	-
28284	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112978	7123	-	CLEC3B	TN|TNA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- CLEC3B:foretinib)	-
28286	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110238	4060	-	LUM	LDC|SLRR2D	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- LUM:foretinib)	-
28288	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111202	5176	PIG35	SERPINF1	EPC-1|OI12|OI6|PEDF	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- SERPINF1:foretinib)	-
28290	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109459	3219	-	HOXB9	HOX-2.5|HOX2|HOX2E	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- HOXB9:foretinib)	-
28292	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107706	1311	-	COMP	EDM1|EPD1|MED|PSACH|THBS5	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- COMP:foretinib)	-
28294	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107171	710	-	SERPING1	C1IN|C1INH|C1NH|HAE1|HAE2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- SERPING1:foretinib)	-
28296	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107179	718	-	C3	AHUS5|ARMD9|ASP|C3a|C3b|CPAMD1|HEL-S-62p	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- C3:foretinib)	-
28298	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107181	720	DAMC-258G8.6	C4A	C4|C4A2|C4A3|C4A4|C4A6|C4AD|C4S|CO4|CPAMD2|RG	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- C4A:foretinib)	-
28300	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120295	54957	-	TXNL4B	DLP|Dim2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- TXNL4B:foretinib)	-
28302	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106524	2	-	A2M	A2MD|CPAMD5|FWP007|S863-7	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- A2M:foretinib)	-
28304	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111360	5345	-	SERPINF2	A2AP|AAP|ALPHA-2-PI|API|PLI	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- SERPINF2:foretinib)	-
28306	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109904	3698	RP11-264C14.2	ITIH2	H2P|SHAP	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ITIH2:foretinib)	-
28308	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108447	2147	-	F2	PT|RPRGL2|THPH1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- F2:foretinib)	-
28310	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118900	29767	-	TMOD2	N-TMOD|NTMOD	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- TMOD2:foretinib)	-
28312	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115875	10631	RP11-412K4.1	POSTN	OSF-2|OSF2|PDLPOSTN|PN|periostin	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- POSTN:foretinib)	-
28314	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	570722	645745	-	MT1HL1	MT1P2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- MT1HL1:foretinib)	-
28316	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110678	4591	-	TRIM37	MUL|POB1|TEF3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- TRIM37:foretinib)	-
28318	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- EPHB4:foretinib)	-
28320	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124429	85014	-	TMEM141	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- TMEM141:foretinib)	-
28324	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115331	10014	-	HDAC5	HD5|NY-CO-9	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- HDAC5:foretinib)	-
28326	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109676	3454	-	IFNAR1	AVP|IFN-alpha-REC|IFNAR|IFNBR|IFRC	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- IFNAR1:foretinib)	-
28328	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117585	26154	-	ABCA12	ARCI4A|ARCI4B|ICR2B|LI2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ABCA12:foretinib)	-
28330	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	937002	100188893	-	TOMM6	OBTP	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- TOMM6:foretinib)	-
28332	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114355	8828	-	NRP2	NP2|NPN2|PRO2714|VEGF165R2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- NRP2:foretinib)	-
28334	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- MLTK:foretinib)	-
28336	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119311	51124	HSPC039	IER3IP1	MEDS|PRO2309	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- IER3IP1:foretinib)	-
28338	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127816	162417	-	NAGS	AGAS|ARGA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- NAGS:foretinib)	-
28340	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited E3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126476	137392	-	FAM92A1	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- FAM92A1:foretinib)	-
28346	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Boselli M (2017)	28972160	211413	8325	IU1-47	Ethanone, 1-[1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-piperidinyl)-|1-[1-(4-Chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-piperidinyl)ethanone	-	CHEMSPIDER	588237	C19H23ClN2O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VXQIPRWKLACSKZ-UHFFFAOYSA-N
28347	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Zhao C (2017)	28086217	211382	8326	ZnPT, zinc pyrithione	Pyrithione zinc|Zinc bis(pyridine-2-thiolate 1-oxide)|2295|R953O2RHZ5|2-Pyridinethiol, 1-oxide, zinc salt (2:1)|Zinc bis(2-pyridinethiolate 1-oxide)	-	CHEMSPIDER	24255	C10H8N2O2S2Zn	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OTPSWLRZXRHDNX-UHFFFAOYSA-L
28348	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Zhao C (2017)	28086217	211382	8326	ZnPT, zinc pyrithione	Pyrithione zinc|Zinc bis(pyridine-2-thiolate 1-oxide)|2295|R953O2RHZ5|2-Pyridinethiol, 1-oxide, zinc salt (2:1)|Zinc bis(2-pyridinethiolate 1-oxide)	-	CHEMSPIDER	24255	C10H8N2O2S2Zn	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OTPSWLRZXRHDNX-UHFFFAOYSA-L
28349	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Wang X (2015)	25854145	187298	8327	VLX1570	4H-Azepin-4-one, 3,5-bis[(4-fluoro-3-nitrophenyl)methylene]hexahydro-1-(1-oxo-2-propen-1-yl)-, (3Z,5Z)-|(3Z,5Z)-1-Acryloyl-3,5-bis(4-fluoro-3-nitrobenzylidene)-4-azepanone	-	CHEMSPIDER	57373743	C23H17F2N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SCKXBVLYWLLALY-CQRYCMKKSA-N
28350	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Wang X (2015)	25854145	187298	8327	VLX1570	4H-Azepin-4-one, 3,5-bis[(4-fluoro-3-nitrophenyl)methylene]hexahydro-1-(1-oxo-2-propen-1-yl)-, (3Z,5Z)-|(3Z,5Z)-1-Acryloyl-3,5-bis(4-fluoro-3-nitrobenzylidene)-4-azepanone	-	CHEMSPIDER	57373743	C23H17F2N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SCKXBVLYWLLALY-CQRYCMKKSA-N
28351	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Wang X (2015)	25854145	187298	8328	b-AP15	(3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)-4-piperidinone|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-, (3E,5E)-|(3E,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one	-	CHEMSPIDER	4508454	C22H17N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GFARQYQBWJLZMW-JYFOCSDGSA-N
28352	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Wang X (2015)	25854145	187298	8328	b-AP15	(3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)-4-piperidinone|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-, (3E,5E)-|(3E,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one	-	CHEMSPIDER	4508454	C22H17N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GFARQYQBWJLZMW-JYFOCSDGSA-N
28353	113867	8239	RP5-1172N10.4	USP9X	DFFRX|FAF|FAM|MRX99	9606	Homo sapiens	inhibitor	target	Kapuria V (2010)	21045142	211373	8329	WP1130	2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-, (2E)-|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]acrylamide|MFCD18839228	-	CHEMSPIDER	9397884	C19H18BrN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LIDOPKHSVQTSJY-VMEIHUARSA-N
28354	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Kapuria V (2010)	21045142	211373	8329	WP1130	2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-, (2E)-|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]acrylamide|MFCD18839228	-	CHEMSPIDER	9397884	C19H18BrN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LIDOPKHSVQTSJY-VMEIHUARSA-N
28355	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Kapuria V (2010)	21045142	211373	8329	WP1130	2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-, (2E)-|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]acrylamide|MFCD18839228	-	CHEMSPIDER	9397884	C19H18BrN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LIDOPKHSVQTSJY-VMEIHUARSA-N
28356	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Kapuria V (2010)	21045142	211373	8329	WP1130	2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-, (2E)-|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]acrylamide|MFCD18839228	-	CHEMSPIDER	9397884	C19H18BrN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LIDOPKHSVQTSJY-VMEIHUARSA-N
28357	132019	377630	-	USP17L2	DUB-3|DUB3|USP17	9606	Homo sapiens	inhibitor	target	Wu Y (2017)	28198361	199410	8329	WP1130	2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-, (2E)-|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]acrylamide|MFCD18839228	-	CHEMSPIDER	9397884	C19H18BrN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LIDOPKHSVQTSJY-VMEIHUARSA-N
28358	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	8330	GW7647	GW7647|Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methyl-|2-[(4-{2-[(4-Cyclohexylbutyl)(cyclohexylcarbamoyl)amino]ethyl}phenyl)sulfanyl]-2-methylpropanoic acid	-	CHEMSPIDER	2637470	C29H46N2O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PKNYXWMTHFMHKD-UHFFFAOYSA-N
28359	121649	57599	-	WDR48	P80|SPG60|UAF1	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	8330	GW7647	GW7647|Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methyl-|2-[(4-{2-[(4-Cyclohexylbutyl)(cyclohexylcarbamoyl)amino]ethyl}phenyl)sulfanyl]-2-methylpropanoic acid	-	CHEMSPIDER	2637470	C29H46N2O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PKNYXWMTHFMHKD-UHFFFAOYSA-N
28360	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
28361	121649	57599	-	WDR48	P80|SPG60|UAF1	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
28362	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Dexheimer TS (2014)	25229643	211355	8331	ML323	ML323|N-(4-(1H-1,2,3-triazol-1-yl)benzyl)-2-(2-isopropylphenyl)-5-methylpyrimidin-4-amine|4-Pyrimidinamine, 5-methyl-2-[2-(1-methylethyl)phenyl]-N-[[4-(1H-1,2,3-triazol-1-yl)phenyl]methyl]-|2-(2-Isopropylphenyl)-5-methyl-N-[4-(1H-1,2,3-triazol-1-yl)benzyl]-4-pyrimidinamine	-	CHEMSPIDER	30646677	C23H24N6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VUIRVWPJNKZOSS-UHFFFAOYSA-N
28363	121649	57599	-	WDR48	P80|SPG60|UAF1	9606	Homo sapiens	inhibitor	target	Dexheimer TS (2014)	25229643	211355	8331	ML323	ML323|N-(4-(1H-1,2,3-triazol-1-yl)benzyl)-2-(2-isopropylphenyl)-5-methylpyrimidin-4-amine|4-Pyrimidinamine, 5-methyl-2-[2-(1-methylethyl)phenyl]-N-[[4-(1H-1,2,3-triazol-1-yl)phenyl]methyl]-|2-(2-Isopropylphenyl)-5-methyl-N-[4-(1H-1,2,3-triazol-1-yl)benzyl]-4-pyrimidinamine	-	CHEMSPIDER	30646677	C23H24N6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VUIRVWPJNKZOSS-UHFFFAOYSA-N
28364	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Pozhidaeva A (2017)	29056420	211409	8332	P50429	USP7/USP47 inhibitor|4-Cyano-5-[(3,5-dichloro-4-pyridinyl)sulfanyl]-N-[4-(methylsulfonyl)phenyl]-2-thiophenecarboxamide|2-Thiophenecarboxamide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]-	-	CHEMSPIDER	28668733	C18H11Cl2N3O3S3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GUDJFFQZIISQJB-UHFFFAOYSA-N
28365	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Pozhidaeva A (2017)	29056420	211409	8333	P22077	Ethanone, 1-[5-[(2,4-difluorophenyl)thio]-4-nitro-2-thienyl]-|1-{5-[(2,4-Difluorophenyl)sulfanyl]-4-nitro-2-thienyl}ethanone	-	CHEMSPIDER	28467528	C12H7F2NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RMAMGGNACJHXHO-UHFFFAOYSA-N
28366	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Tian Z (2014)	24319254	211391	8328	b-AP15	(3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)-4-piperidinone|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-, (3E,5E)-|(3E,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one	-	CHEMSPIDER	4508454	C22H17N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GFARQYQBWJLZMW-JYFOCSDGSA-N
28367	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Tian Z (2014)	24319254	211391	8328	b-AP15	(3E,5E)-1-Acryloyl-3,5-bis(4-nitrobenzylidene)-4-piperidinone|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-1-(1-oxo-2-propen-1-yl)-, (3E,5E)-|(3E,5E)-1-acryloyl-3,5-bis(4-nitrobenzylidene)piperidin-4-one	-	CHEMSPIDER	4508454	C22H17N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GFARQYQBWJLZMW-JYFOCSDGSA-N
28368	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	An T (2017)	28216017	211393	8334	P5091	Ethanone, 1-[5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl]-|1-{5-[(2,3-Dichlorophenyl)sulfanyl]-4-nitro-2-thienyl}ethanone|1-{5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl}ethan-1-one	-	CHEMSPIDER	2098223	C12H7Cl2NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LKZLGMAAKNEGCH-UHFFFAOYSA-N
28369	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Wang X (2016)	27264969	211363	8327	VLX1570	4H-Azepin-4-one, 3,5-bis[(4-fluoro-3-nitrophenyl)methylene]hexahydro-1-(1-oxo-2-propen-1-yl)-, (3Z,5Z)-|(3Z,5Z)-1-Acryloyl-3,5-bis(4-fluoro-3-nitrobenzylidene)-4-azepanone	-	CHEMSPIDER	57373743	C23H17F2N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SCKXBVLYWLLALY-CQRYCMKKSA-N
28370	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Wang X (2016)	27264969	211363	8327	VLX1570	4H-Azepin-4-one, 3,5-bis[(4-fluoro-3-nitrophenyl)methylene]hexahydro-1-(1-oxo-2-propen-1-yl)-, (3Z,5Z)-|(3Z,5Z)-1-Acryloyl-3,5-bis(4-fluoro-3-nitrobenzylidene)-4-azepanone	-	CHEMSPIDER	57373743	C23H17F2N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SCKXBVLYWLLALY-CQRYCMKKSA-N
28371	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Lee BH (2010)	20829789	211386	8335	IU1	1-[1-(4-Fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)ethanone|Ethanone, 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(1-pyrrolidinyl)-	-	CHEMSPIDER	588197	C18H21FN2O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JUWDSDKJBMFLHE-UHFFFAOYSA-N
28372	113194	7347	RP11-173B14.3	UCHL3	UCH-L3	9606	Homo sapiens	inhibitor	target	Liu Y (2003)	14522054	211347	8336	TCID	TCID|compound 6 [PMID: 17948018]|4,5,6,7-Tetrachloro-1H-indene-1,3(2H)-dione|1H-Indene-1,3(2H)-dione, 4,5,6,7-tetrachloro-	-	CHEMSPIDER	2011008	C9H2Cl4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IDLAOWFFKWRNHB-UHFFFAOYSA-N
28373	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Liu Y (2003)	14522054	211347	8337	C30	1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-, 3-(O-acetyloxime), (3Z)-|(3Z)-3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)-1,3-dihydro-2H-indol-2-one|LDN57444|LDN-57444|LDN 57444|	-	CHEMSPIDER	21395767	C17H11Cl3N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OPQRFPHLZZPCCH-PGMHBOJBSA-N
28374	113194	7347	RP11-173B14.3	UCHL3	UCH-L3	9606	Homo sapiens	inhibitor	target	Liu Y (2003)	14522054	211347	8337	C30	1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-, 3-(O-acetyloxime), (3Z)-|(3Z)-3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)-1,3-dihydro-2H-indol-2-one|LDN57444|LDN-57444|LDN 57444|	-	CHEMSPIDER	21395767	C17H11Cl3N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OPQRFPHLZZPCCH-PGMHBOJBSA-N
28375	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Reverdy C (2012)	22520753	131069	8338	HBX 19818	2-Acridinecarboxamide, 9-chloro-5,6,7,8-tetrahydro-N-[3-[methyl(phenylmethyl)amino]propyl]-|N-{3-[Benzyl(methyl)amino]propyl}-9-chloro-5,6,7,8-tetrahydro-2-acridinecarboxamide	-	CHEMSPIDER	30814431	C25H28ClN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZCALMLVWZSQGGR-UHFFFAOYSA-N
28376	115508	10213	-	PSMD14	PAD1|POH1|RPN11	9606	Homo sapiens	inhibitor	target	Li J (2017)	28244987	211399	8339	Capzimin	8-Sulfanyl-N-[2-(1,3-thiazol-2-yl)ethyl]-3-quinolinecarboxamide|3-Quinolinecarboxamide, 8-mercapto-N-[2-(2-thiazolyl)ethyl]-	-	CHEMSPIDER	61729338	C15H13N3OS2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MYNGHZGMRXNEEH-UHFFFAOYSA-N
28377	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Kapuria V (2010)	21045142	211373	8329	WP1130	2-Propenamide, 3-(6-bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]-, (2E)-|(2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylbutyl]acrylamide|MFCD18839228	-	CHEMSPIDER	9397884	C19H18BrN3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LIDOPKHSVQTSJY-VMEIHUARSA-N
28378	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	inhibitor	target	Yang Y (2007)	17909057	211378	8340	PYR-41	PYR-41|Ethyl 4-{(4Z)-4-[(5-nitro-2-furyl)methylene]-3,5-dioxo-1-pyrazolidinyl}benzoate|Benzoic acid, 4-[(4Z)-4-[(5-nitro-2-furanyl)methylene]-3,5-dioxo-1-pyrazolidinyl]-, ethyl ester	-	CHEMSPIDER	4492747	C17H13N3O7	small molecule	-	418805-02-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ARGIPZKQJGFSGQ-LCYFTJDESA-N
28379	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	inhibitor	target	An H (2015)	28717502	211368	8341	ABP-A3	N-(3-Ethynylphenyl)-5'-O-sulfamoyladenosine|Adenosine, 5'-O-(aminosulfonyl)-N-(3-ethynylphenyl)-	-	CHEMSPIDER	57643654	C18H18N6O6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LZNFQRSVDZCPTR-SCFUHWHPSA-N
28380	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	inhibitor	target	Xu GW (2010)	20075161	211377	8342	PYZD-4409	3,5-Pyrazolidinedione, 1-(3-chloro-4-fluorophenyl)-4-[(5-nitro-2-furanyl)methylene]-, (4E)-|(4E)-1-(3-Chloro-4-fluorophenyl)-4-[(5-nitro-2-furyl)methylene]-3,5-pyrazolidinedione	-	CHEMSPIDER	29394292	C14H7ClFN3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MSYMKEYWUWVZQY-RMKNXTFCSA-N
28381	113182	7334	-	UBE2N	HEL-S-71|UBC13|UBCHBEN; UBC13|UbcH-ben|UbcH13	9606	Homo sapiens	inhibitor	target	Hodge CD (2015)	25909880	186087	8343	NSC697923	2-[(4-Methylphenyl)sulfonyl]-5-nitrofuran|Furan, 2-[(4-methylphenyl)sulfonyl]-5-nitro-	-	CHEMSPIDER	349633	C11H9NO5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GAUHIPWCDXOLCZ-UHFFFAOYSA-N
28382	113182	7334	-	UBE2N	HEL-S-71|UBC13|UBCHBEN; UBC13|UbcH-ben|UbcH13	9606	Homo sapiens	inhibitor	target	Hodge CD (2015)	25909880	186087	8344	BAY 11-7082	3-(p-Tolylsulfonyl)acrylonitrile|3-(p-Toluenesulfonyl)acrylonitrile|3-((4-Methylphenyl)sulfonyl)-2-propenenitrile|2-Propenenitrile, 3-((4-methylphenyl)sulfonyl)-|(E)-3-(4-Methylphenylsulfonyl)-2-propenenitrile|BAY 11-7082|(2E)-3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile|2-Propenenitrile, 3-[(4-methylphenyl)sulfonyl]-, (2E)-|(2E)-3-[(4-Methylphenyl)sulfonyl]acrylonitrile|(E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE	-	CHEMSPIDER	4510086	C10H9NO2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOEWDSDBFRHVAP-KRXBUXKQSA-N
28383	107432	997	-	CDC34	E2-CDC34|UBC3|UBCH3|UBE2R1	9606	Homo sapiens	inhibitor	target	Ceccarelli DF (2011)	21683433	124394	8345	CC0651	L-Arabinonic acid, 4,5-dideoxy-5-(3',5'-dichloro[1,1'-biphenyl]-4-yl)-4-[(2-methoxyacetyl)amino]-|4,5-Dideoxy-5-(3',5'-Dichlorobiphenyl-4-Yl)-4-[(Methoxyacetyl)amino]-L-Arabinonic Acid|(2R,3S,4S)-5-(3',5'-Dichloro-[1,1'-biphenyl]-4-yl)-2,3-dihydroxy-4-(2-methoxyacetamido)pentanoic acid|4,5-Dideoxy-5-(3',5'-dichloro-4-biphenylyl)-4-[(methoxyacetyl)amino]-L-arabinonic acid	-	CHEMSPIDER	26329232	C20H21Cl2NO6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NTCBTNCWNRCBGX-YTQUADARSA-N
28384	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	modulator	target	Uehara T (2017)	28437394	211360	8346	E7820	3-Cyano-N-(3-cyano-4-methyl-1H-indole-7-yl)benzensulfonamide|Benzenesulfonamide, 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-|3-Cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide|E-7820	-	CHEMSPIDER	170592	C17H12N4O2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LWGUASZLXHYWIV-UHFFFAOYSA-N
28385	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	modulator	target	Uehara T (2017)	28437394	211360	8347	indisulam	indisulam|N-(3-Chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide|8199|WJ98J3NM90|1,4-Benzenedisulfonamide, N~1~-(3-chloro-1H-indol-7-yl)-|N-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide	-	CHEMSPIDER	187608	C14H12ClN3O4S2	small molecule	-	165668-41-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SETFNECMODOHTO-UHFFFAOYSA-N
28386	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	modulator	target	Uehara T (2017)	28437394	211360	8348	Chlorsulfaquinoxaline	O0408QB48D|Benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-|4-Amino-N-(5-chloro-2-quinoxalinyl)benzenesulfonamide|NSC-339004	-	CHEMSPIDER	65384	C14H11ClN4O2S	small molecule	-	97919-22-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CTSNHMQGVWXIEG-UHFFFAOYSA-N
28388	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	modulator	target	Han T (2017)	28302793	209322	8349	tasisulam	Tasisulam|1YC4W9MSLJ|9030|Benzamide, N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-|N-[(5-Bromo-2-thienyl)sulfonyl]-2,4-dichlorobenzamide|5-Bromo-N-(2,4-dichlorobenzoyl)-2-thiophenesulfonamide	-	CHEMSPIDER	8335746	C11H6BrCl2NO3S2	small molecule	-	519055-62-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WWONFUQGBVOKOF-UHFFFAOYSA-N
28389	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	modulator	target	Han T (2017)	28302793	209322	8348	Chlorsulfaquinoxaline	O0408QB48D|Benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-|4-Amino-N-(5-chloro-2-quinoxalinyl)benzenesulfonamide|NSC-339004	-	CHEMSPIDER	65384	C14H11ClN4O2S	small molecule	-	97919-22-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CTSNHMQGVWXIEG-UHFFFAOYSA-N
28390	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	inhibitor	target	Bennett J (2015)	25974391	190207	8350	compound 34	compound 34 [PMID: 25974391]|Benzenesulfonamide, N-[2,3-dihydro-6-(4-methoxyphenoxy)-1,3-dimethyl-2-oxo-1H-benzimidazol-5-yl]-3,4-dimethoxy-|3,4-Dimethoxy-N-[6-(4-methoxyphenoxy)-1,3-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl]benzenesulfonamide	-	CHEMSPIDER	29068819	C24H25N3O7S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KNVIUMWNYXDULF-UHFFFAOYSA-N
28391	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Yoshizaki Y (2017)	28638054	207216	8351	chlorophyllin sodium copper salt	Cuprate(3-), [18-carboxy-20-(carboxymethyl)-8-ethenyl-13-ethyl-3,7,12,17-tetramethyl-21H,23H-porphine-2-propanoato(5-)-kappaN~21~,kappaN~23~]-, sodium (1:3)|Trisodium [18-(2-carboxyethyl)-20-(carboxymethyl)-7-ethyl-3,8,13,17-tetramethyl-12-vinyl-2-porphyrincarboxylato(5-)-kappa~2~N,N']cuprate(3-)	-	CHEMSPIDER	32035047	C34H29CuN4Na3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QDAAKTODRKELHM-PJABRTMHSA-I
28392	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Yoshizaki Y (2017)	28638054	207216	8352	bonaphton	1,2-Naphthalenedione, 6-bromo-|6-Bromo-1,2-naphthalenedione	-	CHEMSPIDER	21868	C10H5BrO2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MXWZRRPNVLCHMY-UHFFFAOYSA-N
28393	114503	9039	-	UBA3	NAE2|UBE1C|hUBA3	9606	Homo sapiens	inhibitor	target	Soucy TA (2009)	19360080	209255	8353	Pevonedistat	MLN4924|MLN 4924|[(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl]methyl sulfamate|Pevonedistat|[(1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate|S3AZD8D215|9605|MLN4924	-	CHEMSPIDER	17625129	C21H25N5O4S	small molecule	-	905579-51-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MPUQHZXIXSTTDU-QXGSTGNESA-N
28394	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	Soucy TA (2009)	19360080	209255	8353	Pevonedistat	MLN4924|MLN 4924|[(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl]methyl sulfamate|Pevonedistat|[(1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate|S3AZD8D215|9605|MLN4924	-	CHEMSPIDER	17625129	C21H25N5O4S	small molecule	-	905579-51-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MPUQHZXIXSTTDU-QXGSTGNESA-N
28395	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	modulator	target	Matyskiela ME (2018)	28425720	207534	8354	Iberdomide, compound 6	Iberdomide|8V66F27X44|10632|UNII:8V66F27X44|CC-220|2,6-Piperidinedione, 3-[1,3-dihydro-4-[[4-(4-morpholinylmethyl)phenyl]methoxy]-1-oxo-2H-isoindol-2-yl]-, (3S)-|(3S)-3-(4-{[4-(4-Morpholinylmethyl)benzyl]oxy}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-piperidinedione	-	CHEMSPIDER	52085251	C25H27N3O5	small molecule	-	1323403-33-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IXZOHGPZAQLIBH-NRFANRHFSA-N
28398	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Zhang Z (2014)	24900784	211364	8355	RO5353	Spiro[pyrrolidine-3,6'-[6H]thieno[3,2-b]pyrrole]-5-carboxamide, N-[4-(aminocarbonyl)-2-methoxyphenyl]-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-4',5'-dihydro-5'-oxo-, (2S,3R,4R,5R)-|(2S,3R,4R,5R)-N-(4-Carbamoyl-2-methoxyphenyl)-2'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-5'-oxo-4',5'-dihydrospiro[pyrrolidine-3,6'-thieno[3,2-b]pyrrole]-5-carboxamide	-	CHEMSPIDER	31135029	C29H29Cl2FN4O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UOVSZRTTWLJPHE-HNXAPSNLSA-N
28399	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Zhang Z (2014)	24900784	211364	8356	RO2468	(2S,3R,4S,5R)-N-(4-Carbamoyl-2-methoxyphenyl)-6'-chloro-4-(3-chloro-2-fluorophenyl)-2-(2,2-dimethylpropyl)-2'-oxo-1',2'-dihydrospiro[pyrrolidine-3,3'-pyrrolo[3,2-c]pyridine]-5-carboxamide	-	CHEMSPIDER	31135031	C30H30Cl2FN5O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CGCOPBXAGSCZNX-FNQJWKMRSA-N
28400	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Tan G (2017)	28549433	207226	8357	JS-K	Ethyl 4-[(E)-(2,4-dinitrophenoxy)-NNO-azoxy]-1-piperazinecarboxylate|1-Piperazinecarboxylic acid, 4-[(E)-(2,4-dinitrophenoxy)-NNO-azoxy]-, ethyl ester	-	CHEMSPIDER	24684273	C13H16N6O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DNJRNBYZLPKSHV-XMHGGMMESA-N
28401	112373	6478	-	SIAH2	hSiah2	9606	Homo sapiens	inhibitor	target	Tan G (2017)	28549433	207226	8357	JS-K	Ethyl 4-[(E)-(2,4-dinitrophenoxy)-NNO-azoxy]-1-piperazinecarboxylate|1-Piperazinecarboxylic acid, 4-[(E)-(2,4-dinitrophenoxy)-NNO-azoxy]-, ethyl ester	-	CHEMSPIDER	24684273	C13H16N6O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DNJRNBYZLPKSHV-XMHGGMMESA-N
28402	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	modulator	target	Ramkumar KM (2013)	23826874	211390	8358	Pterostilbene	4-[(E)-2-(3,5-Dimethoxyphenyl)vinyl]phenol|Phenol, 4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]-|26R60S6A5I|3,5-dimethoxy-4'-hydroxystilbene|Phenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (E)-|4-(2-(3,5-Dimethoxyphenyl)ethenyl)phenol|4-Stilbenol, 3',5'-dimethoxy-, (E)-|3,5-Dimethoxy-4'-hydroxy-trans-stilbene|3',5'-Dimethoxy-4-stilbenol|Pterostilbene|4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenol|(E)-pterostilbene	-	CHEMSPIDER	4445042	C16H16O3	small molecule	-	537-42-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VLEUZFDZJKSGMX-ONEGZZNKSA-N
28403	120581	55294	-	FBXW7	AGO|CDC4|FBW6|FBW7|FBX30|FBXO30|FBXW6|SEL-10|SEL10|hAgo|hCdc4	9606	Homo sapiens	modulator	target	Huang HL (2012)	22389469	211417	8359	Oridonin	Oridonin|(1alpha,5beta,6beta,7alpha,8alpha,9beta,10alpha,13alpha,14R)-1,6,7,14-Tetrahydroxy-7,20-epoxykaur-16-en-15-one	-	CHEMSPIDER	23326877	C20H28O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SDHTXBWLVGWJFT-BAFGBBEMSA-N
28404	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	modulator	target	Matyskiela ME (2016)	27338790	199780	8360	CC-885	2,6-Piperidinedione, 3-[5-[[[(1Z)-[(3-chloro-4-methylphenyl)amino]hydroxymethylene]amino]methyl]-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-|N-(3-Chloro-4-methylphenyl)-N'-{[2-(2,6-dioxo-3-piperidinyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl]methyl}carbamimidic acid	-	CHEMSPIDER	59718492	C22H21ClN4O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOEVCIHTTTYVCC-UHFFFAOYSA-N
28405	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	modulator	target	Han T (2017)	28302793	209322	8347	indisulam	indisulam|N-(3-Chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide|8199|WJ98J3NM90|1,4-Benzenedisulfonamide, N~1~-(3-chloro-1H-indol-7-yl)-|N-(3-Chloro-1H-indol-7-yl)benzene-1,4-disulfonamide	-	CHEMSPIDER	187608	C14H12ClN3O4S2	small molecule	-	165668-41-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SETFNECMODOHTO-UHFFFAOYSA-N
28406	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Nepal M (2012)	22760073	211412	8361	Bavachinin	2-(4-Hydroxyphenyl)-7-methoxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one|4H-1-Benzopyran-4-one, 2,3-dihydro-2-(4-hydroxyphenyl)-7-methoxy-6-(3-methyl-2-buten-1-yl)-|2-(4-Hydroxyphenyl)-7-methoxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-on|2-(4-Hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-4H-chromen-4-one|2-(4-hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-enyl)-2,3-dihydro-4H-chromen-4-one|Bavachinin A	-	CHEMSPIDER	109499	C21H22O4	small molecule	-	19879-30-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VOCGSQHKPZSIKB-UHFFFAOYSA-N
28407	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Buckley DL (2012)	22369643	131566	8362	(4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL)BENZYL]-L-PROLINAMIDE	(4r)-4-Hydroxy-1-[(3-Methylisoxazol-5-Yl)acetyl]-N-[4-(1,3-Oxazol-5-Yl)benzyl]-L-Prolinamide|2-Pyrrolidinecarboxamide, 4-hydroxy-1-[2-(3-methyl-5-isoxazolyl)acetyl]-N-[[4-(5-oxazolyl)phenyl]methyl]-, (2S,4R)-|(4R)-4-Hydroxy-1-[(3-methyl-1,2-oxazol-5-yl)acetyl]-N-[4-(1,3-oxazol-5-yl)benzyl]-L-prolinamide	-	CHEMSPIDER	31133666	C21H22N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HFCLIEBJTGJKSV-AEFFLSMTSA-N
28408	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Galdeano C (2014)	25166285	167549	8363	(2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	L-Prolinamide, N-acetyl-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-|N-Acetyl-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide	-	CHEMSPIDER	35035176	C24H32N4O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GFVIEZBZIUKYOG-SVFBPWRDSA-N
28409	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Soares P (2018)	28853884	211366	8364	VH298	-	-	CHEMSPIDER	58804244	C54H66N10O8S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GYJMGEJLYDLYLJ-IUVJQGSXSA-N
28410	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Frost J (2016)	27811928	211370	8364	VH298	-	-	CHEMSPIDER	58804244	C54H66N10O8S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GYJMGEJLYDLYLJ-IUVJQGSXSA-N
28411	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Buckley DL (2012)	23065727	148591	8365	(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide	(2s,4r)-1-(2-Chlorophenyl)carbonyl-N-[(4-Chlorophenyl)methyl]-4-Oxidanyl-Pyrrolidine-2-Carboxamide|2-Pyrrolidinecarboxamide, 1-(2-chlorobenzoyl)-N-[(4-chlorophenyl)methyl]-4-hydroxy-, (2S,4R)-|(4R)-1-(2-Chlorobenzoyl)-N-(4-chlorobenzyl)-4-hydroxy-L-prolinamide	-	CHEMSPIDER	35034462	C19H18Cl2N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	POSPLUDREYFAQC-PBHICJAKSA-N
28412	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	inhibitor	target	Buckley DL (2012)	23065727	148591	8366	(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide	(2s,4r)-1-(3-Amino-2-Methylbenzoyl)-4-Hydroxy-N-(4-(4-Methylthiazol-5-Yl)benzyl)pyrrolidine-2-Carboxamide|2-Pyrrolidinecarboxamide, 1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (2S,4R)-|(4R)-1-(3-Amino-2-methylbenzoyl)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide	-	CHEMSPIDER	34258861	C24H26N4O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AFUSGLDYQSDIEU-NQIIRXRSSA-N
28413	122265	64750	-	SMURF2	-	9606	Homo sapiens	inhibitor	target	Mund T (2014)	25385595	170019	8367	heclin	2-Propenamide, N-(4-acetylphenyl)-3-(5-ethyl-2-furanyl)-, (2E)-|(2E)-N-(4-Acetylphenyl)-3-(5-ethyl-2-furyl)acrylamide	-	CHEMSPIDER	5783743	C17H17NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SPTWXRJNCFIDRQ-ZHACJKMWSA-N
28414	110811	4734	PIG53	NEDD4	NEDD4-1|RPF1	9606	Homo sapiens	inhibitor	target	Mund T (2014)	25385595	170019	8367	heclin	2-Propenamide, N-(4-acetylphenyl)-3-(5-ethyl-2-furanyl)-, (2E)-|(2E)-N-(4-Acetylphenyl)-3-(5-ethyl-2-furyl)acrylamide	-	CHEMSPIDER	5783743	C17H17NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SPTWXRJNCFIDRQ-ZHACJKMWSA-N
28415	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Mund T (2014)	25385595	170019	8367	heclin	2-Propenamide, N-(4-acetylphenyl)-3-(5-ethyl-2-furanyl)-, (2E)-|(2E)-N-(4-Acetylphenyl)-3-(5-ethyl-2-furyl)acrylamide	-	CHEMSPIDER	5783743	C17H17NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SPTWXRJNCFIDRQ-ZHACJKMWSA-N
28416	123747	83737	-	ITCH	ADMFD|AIF4|AIP4|NAPP1|dJ468O1.1	9606	Homo sapiens	inhibitor	target	Rossi M (2014)	24787015	211402	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
28417	113185	7337	-	UBE3A	ANCR|AS|E6-AP|EPVE6AP|HPVE6A	9606	Homo sapiens	inhibitor	target	Rossi M (2014)	24787015	211402	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GDLIGKIOYRNHDA-UHFFFAOYSA-N
28418	107427	991	-	CDC20	CDC20A|bA276H19.3|p55CDC	9606	Homo sapiens	inhibitor	target	Sackton KL (2014)	25156254	168402	8368	apcin	Carbamic acid, N-[2,2,2-trichloro-1-(2-pyrimidinylamino)ethyl]-, 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl ester|2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl [2,2,2-trichloro-1-(2-pyrimidinylamino)ethyl]carbamate	-	CHEMSPIDER	2108234	C13H14Cl3N7O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZEXHXVOGJFGTRX-UHFFFAOYSA-N
28419	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	inhibitor	target	Chan CH (2013)	23911321	209204	8369	SZL-P1-41	SZL-P1-41|4H-1-Benzopyran-4-one, 3-(2-benzothiazolyl)-6-ethyl-7-hydroxy-8-(1-piperidinylmethyl)-|3-(1,3-benzothiazol-2-yl)-6-ethyl-7-hydroxy-8-(piperidin-1-ylmethyl)-4H-chromen-4-one|3-(1,3-Benzothiazol-2-yl)-6-ethyl-7-hydroxy-8-(1-piperidinylmethyl)-4H-chromen-4-one	-	CHEMSPIDER	1079391	C24H24N2O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JKIXLEKBXHMXTN-UHFFFAOYSA-N
28420	112391	6500	-	SKP1	EMC19|OCP-II|OCP2|SKP1A|TCEB1L|p19A	9606	Homo sapiens	inhibitor	target	Liu YQ (2015)	26474281	191844	8370	6-OAP	(3S,3aR,4S,4aR,7aR,8R,9aR)-3,4a,8-Trimethyl-2,5-dioxo-2,3,3a,4,4a,5,7a,8,9,9a-decahydroazuleno[6,5-b]furan-4-yl (2Z)-2-methyl-2-butenoate|2-Butenoic acid, 2-methyl-, (3S,3aR,4S,4aR,7aR,8R,9aR)-2,3,3a,4,4a,5,7a,8,9,9a-decahydro-3,4a,8-trimethyl-2,5-dioxoazuleno[6,5-b]furan-4-yl ester, (2Z)-	-	CHEMSPIDER	21246838	C20H26O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KUPPZVXLWANEJJ-UXPPPGSFSA-N
28421	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	inhibitor	target	Chen Q (2008)	18305219	211404	8371	Compound A	4-({[3-(2,2-Dimethyltetrahydro-2H-pyran-4-yl)-4-phenylbutyl]amino}methyl)-N,N-dimethylaniline|2H-Pyran-4-propanamine, N-[[4-(dimethylamino)phenyl]methyl]tetrahydro-2,2-dimethyl-gamma-(phenylmethyl)-	-	CHEMSPIDER	2647927	C26H38N2O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BHBPSUYHNUDVJC-UHFFFAOYSA-N
28422	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	inhibitor	target	Wu L (2012)	23261596	150374	8372	SKP2E3LI-C5	(4-Bromo-2-{(Z)-[4-oxo-3-(3-pyridinylmethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}phenoxy)acetic acid|Acetic acid, 2-[4-bromo-2-[(Z)-[4-oxo-3-(3-pyridinylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]phenoxy]-	-	CHEMSPIDER	4666286	C18H13BrN2O4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IYCJJVVXEHZJHE-CHHVJCJISA-N
28423	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	inhibitor	target	Wu L (2012)	23261596	150374	8373	SKP2E3LI-C16	[4-({3-[2-(4-Chlorophenyl)-2-oxoethyl]-2,4-dioxo-1,3-thiazolidin-5-ylidene}methyl)phenoxy]acetic acid|Acetic acid, 2-[4-[[3-[2-(4-chlorophenyl)-2-oxoethyl]-2,4-dioxo-5-thiazolidinylidene]methyl]phenoxy]-	-	CHEMSPIDER	2186424	C20H14ClNO6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PROYNXVBTGKBIR-UHFFFAOYSA-N
28424	117657	26273	-	FBXO3	FBA|FBX3	9606	Homo sapiens	inhibitor	target	Chen BB (2013)	23542741	211387	8374	BC-1215	N,N'-Bis[4-(2-pyridinyl)benzyl]-1,2-ethanediamine|1,2-Ethanediamine, N~1~,N~2~-bis[[4-(2-pyridinyl)phenyl]methyl]-	-	CHEMSPIDER	35293716	C26H26N4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IXEPQJQQSLMESJ-UHFFFAOYSA-N
28425	117355	25827	-	FBXL2	FBL2|FBL3	9606	Homo sapiens	activator	target	Chen BB (2013)	23928698	194960	8375	BC-1258	1,2-Ethanediamine, N~1~,N~2~-bis[[4-(2-thiazolyl)phenyl]methyl]-|N,N'-Bis[4-(1,3-thiazol-2-yl)benzyl]-1,2-ethanediamine	-	CHEMSPIDER	35293709	C22H22N4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FRTSLZJCGAFSET-UHFFFAOYSA-N
28426	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	inhibitor	target	Nakajima H (2008)	18275844	211408	8376	GS143	Benzoic acid, 4-[(4E)-4-[[5-(2-fluorophenyl)-2-furanyl]methylene]-4,5-dihydro-5-oxo-3-(phenylmethyl)-1H-pyrazol-1-yl]-|4-[(4E)-3-Benzyl-4-{[5-(2-fluorophenyl)-2-furyl]methylene}-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]benzoic acid	-	CHEMSPIDER	35517727	C28H19FN2O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IZPMWFSVTDOCDI-HAVVHWLPSA-N
28427	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	inhibitor	target	Rico-Bautista E (2010)	21182779	211354	8377	SMIP004	N-(4-Butyl-2-methylphenyl)acetamide|Acetamide, N-(4-butyl-2-methylphenyl)-	-	CHEMSPIDER	2029029	C13H19NO	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZFVMECVBUGMWIX-UHFFFAOYSA-N
28429	107116	648	RP11-573G6.1	BMI1	FLVI2/BMI1|PCGF4|RNF51	9606	Homo sapiens	inhibitor	target	Alchanati I (2009)	19956605	124271	8378	PRT4165	2-Pyridin-3-ylmethylene-indan-1,3-dione|PRT-4165|J625FJL5DX|2-(Pyridin-3-ylmethylene)-1H-indene-1,3(2H)-dione|1H-Indene-1,3(2H)-dione, 2-(3-pyridinylmethylene)-|2-(3-Pyridinylmethylene)-1H-indene-1,3(2H)-dione	-	CHEMSPIDER	180156	C15H9NO2	small molecule	-	31083-55-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OMHZFEWYVFWVLI-UHFFFAOYSA-N
28430	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Tovar C (2013)	23400593	211352	8379	RG7112	RO-5045337|Q8MI0X869M|{(4S,5R)-4,5-Bis(4-chlorophenyl)-2-[2-ethoxy-4-(2-methyl-2-propanyl)phenyl]-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl}{4-[3-(methylsulfonyl)propyl]-1-piperazinyl}methanone|Methanone, [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]-	-	CHEMSPIDER	28189760	C38H48Cl2N4O4S	small molecule	-	939981-39-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QBGKPEROWUKSBK-QPPIDDCLSA-N
28431	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Ding Q (2013)	23808545	211356	8380	RG7388	idasanutlin|4-{[(3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-D-prolyl]amino}-3-methoxybenzoic acid|Benzoic acid, 4-[[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl]carbonyl]amino]-3-methoxy-	-	CHEMSPIDER	30831264	C31H29Cl2F2N3O4	small molecule	-	1229705-06-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TVTXCJFHQKSQQM-LJQIRTBHSA-N
28432	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Bill KL (2016)	26475335	211379	8381	SAR405838	8570LZ3RCA|SAR-405838|Spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, 6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxo-, (2'S,3R,4'S,5'R)-|(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide	-	CHEMSPIDER	30811498	C29H34Cl2FN3O3	small molecule	-	1303607-60-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IDKAKZRYYDCJDU-HBMMIIHUSA-N
28433	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Shangary S (2008)	18316739	208243	8382	MI-219	(2'R,3R,4'R,5'R)-6-Chloro-4'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5-fluoro-2'-(2-methyl-2-propanyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide|Spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, 6-chloro-4'-(3-chlorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-2'-(1,1-dimethylethyl)-5-fluoro-1,2-dihydro-2-oxo-, (2'R,3R,4'R,5'R)-	-	CHEMSPIDER	59695355	C26H30Cl2FN3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KUMSTKUNLHZBEQ-MWFJYFKBSA-N
28434	121411	57154	-	SMURF1	-	9606	Homo sapiens	inhibitor	target	Cao Y (2014)	24828823	164649	8383	A01	Methanone, [4-[[4-chloro-3-(trifluoromethyl)phenyl]sulfonyl]-1-piperazinyl][4-(5-methyl-1H-pyrazol-1-yl)phenyl]-|(4-{[4-Chloro-3-(trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)[4-(5-methyl-1H-pyrazol-1-yl)phenyl]methanone	-	CHEMSPIDER	11146868	C22H20ClF3N4O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QFYLTUDRXBNZFQ-UHFFFAOYSA-N
28435	121411	57154	-	SMURF1	-	9606	Homo sapiens	inhibitor	target	Cao Y (2014)	24828823	164649	8384	A17	1-Ethyl-6-fluoro-4-oxo-7-[4-(3-phenylpropanoyl)-1-piperazinyl]-1,4-dihydro-3-quinolinecarboxylic acid|3-Quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[4-(1-oxo-3-phenylpropyl)-1-piperazinyl]-	-	CHEMSPIDER	10931084	C25H26FN3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WSMQLUAQZNPXFD-UHFFFAOYSA-N
28437	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	An H (2015)	28717502	211368	8341	ABP-A3	N-(3-Ethynylphenyl)-5'-O-sulfamoyladenosine|Adenosine, 5'-O-(aminosulfonyl)-N-(3-ethynylphenyl)-	-	CHEMSPIDER	57643654	C18H18N6O6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LZNFQRSVDZCPTR-SCFUHWHPSA-N
28438	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Adams J (1999)	10363983	211346	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
28439	114214	8665	-	EIF3F	EIF3S5|eIF3-p47	9606	Homo sapiens	unknown	target	Wang RE (2011)	21798748	146659	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
28440	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Tang Y (2017)	28807012	211380	8385	HBX 41,108	7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile|9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 7-chloro-9-oxo-	-	CHEMSPIDER	17225370	C13H3ClN4O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BIGPXXAUSQLTQR-UHFFFAOYSA-N
28441	113221	7375	-	USP4	UNP|Unph	9606	Homo sapiens	inhibitor	target	Okada K (2013)	23791076	211401	8386	Vialinin A	Vialinin A|Benzeneacetic acid, 4,4'',5',6'-tetrahydroxy[1,1':4',1''-terphenyl]-2',3'-diyl ester|4,4'',5',6'-Tetrahydroxy-1,1':4',1''-terphenyl-2',3'-diyl bis(phenylacetate)	-	CHEMSPIDER	9737907	C34H26O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NOJUKCRPSUMHQQ-UHFFFAOYSA-N
28442	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Okada K (2013)	23791076	211401	8386	Vialinin A	Vialinin A|Benzeneacetic acid, 4,4'',5',6'-tetrahydroxy[1,1':4',1''-terphenyl]-2',3'-diyl ester|4,4'',5',6'-Tetrahydroxy-1,1':4',1''-terphenyl-2',3'-diyl bis(phenylacetate)	-	CHEMSPIDER	9737907	C34H26O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NOJUKCRPSUMHQQ-UHFFFAOYSA-N
28443	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Okada K (2013)	23791076	211401	8386	Vialinin A	Vialinin A|Benzeneacetic acid, 4,4'',5',6'-tetrahydroxy[1,1':4',1''-terphenyl]-2',3'-diyl ester|4,4'',5',6'-Tetrahydroxy-1,1':4',1''-terphenyl-2',3'-diyl bis(phenylacetate)	-	CHEMSPIDER	9737907	C34H26O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NOJUKCRPSUMHQQ-UHFFFAOYSA-N
28444	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Yan C (2018)	29462615	211405	8387	NSC 632839	4-Piperidinone, 3,5-bis[(4-methylphenyl)methylene]-, hydrochloride (1:1)|3,5-Bis(4-methylbenzylidene)piperidin-4-one hydrochloride (1:1)|3,5-Bis(4-methylbenzylidene)-4-piperidinone hydrochloride (1:1)	-	CHEMSPIDER	324262	C21H22ClNO	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZOKZLTXPTLIWOJ-UHFFFAOYSA-N
28445	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Chen X (2018)	29098502	211361	8388	Pyrithione cadmium	Cadmium bis(2-thioxo-1(2H)-pyridinolate)|2(1H)-Pyridinethione, 1-hydroxy-, cadmium salt (2:1)	-	CHEMSPIDER	178371	C10H8CdN2O2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YSWAWAYOPDDQJN-UHFFFAOYSA-N
28446	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Chen X (2018)	29098502	211361	8388	Pyrithione cadmium	Cadmium bis(2-thioxo-1(2H)-pyridinolate)|2(1H)-Pyridinethione, 1-hydroxy-, cadmium salt (2:1)	-	CHEMSPIDER	178371	C10H8CdN2O2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YSWAWAYOPDDQJN-UHFFFAOYSA-N
28447	115508	10213	-	PSMD14	PAD1|POH1|RPN11	9606	Homo sapiens	inhibitor	target	Song Y (2017)	28581522	211353	2270	1,10-Phenanthroline	-	-	DRUGBANK	DB02365	C12H8N2	small molecule	-	66-71-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DGEZNRSVGBDHLK-UHFFFAOYSA-N
28448	120360	55031	-	USP47	TRFP	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8333	P22077	Ethanone, 1-[5-[(2,4-difluorophenyl)thio]-4-nitro-2-thienyl]-|1-{5-[(2,4-Difluorophenyl)sulfanyl]-4-nitro-2-thienyl}ethanone	-	CHEMSPIDER	28467528	C12H7F2NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RMAMGGNACJHXHO-UHFFFAOYSA-N
28449	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28450	113221	7375	-	USP4	UNP|Unph	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28451	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28452	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28453	114555	9101	-	USP8	HumORF8|SPG59|UBPY	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28454	115283	9958	-	USP15	UNPH-2|UNPH4	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28455	116077	10868	-	USP20	LSFR3A|VDU2|hVDU2	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28456	121683	57646	-	USP28	-	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28457	120360	55031	-	USP47	TRFP	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28458	125956	126119	SBBI54	JOSD2	-	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28459	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28460	113194	7347	RP11-173B14.3	UCHL3	UCH-L3	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28461	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28462	125819	123228	FKSG8	SENP8	DEN1|NEDP1|PRSC2	9606	Homo sapiens	inhibitor	target	Altun M (2011)	22118674	126534	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZXOBLNBVNROVLC-UHFFFAOYSA-N
28463	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Liu N (2014)	24977961	211418	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
28464	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Liu N (2014)	24977961	211418	985	Auranofin	Auranofinum|Triethylphosphine gold|2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold|(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate|Auranofine|Ridaura|Auranofina|Auroafen	ridaura	DRUGBANK	DB00995	C20H34AuO9PS	small molecule	M01CB03	34031-32-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AUJRCFUBUPVWSZ-XTZHGVARSA-M
28465	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Coughlin K (2014)	24727327	211407	8390	RA-9	(3E,5E)-3,5-Bis(4-nitrobenzylidene)-4-piperidinone|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-, (3E,5E)-|(3E,5E)-3,5-bis(4-nitrobenzylidene)piperidin-4-one|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-, (E,E)-|NSC685125|(3E,5E)-3,5-Bis[(4-nitrophenyl)methylidene]piperidin-4-one	-	CHEMSPIDER	4579802	C19H15N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YUYPWAMLWZVHAE-KAVGSWPWSA-N
28466	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Coughlin K (2014)	24727327	211407	8390	RA-9	(3E,5E)-3,5-Bis(4-nitrobenzylidene)-4-piperidinone|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-, (3E,5E)-|(3E,5E)-3,5-bis(4-nitrobenzylidene)piperidin-4-one|4-Piperidinone, 3,5-bis[(4-nitrophenyl)methylene]-, (E,E)-|NSC685125|(3E,5E)-3,5-Bis[(4-nitrophenyl)methylidene]piperidin-4-one	-	CHEMSPIDER	4579802	C19H15N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YUYPWAMLWZVHAE-KAVGSWPWSA-N
28467	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Tian X (2011)	21133675	211365	8333	P22077	Ethanone, 1-[5-[(2,4-difluorophenyl)thio]-4-nitro-2-thienyl]-|1-{5-[(2,4-Difluorophenyl)sulfanyl]-4-nitro-2-thienyl}ethanone	-	CHEMSPIDER	28467528	C12H7F2NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RMAMGGNACJHXHO-UHFFFAOYSA-N
28468	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Zhou B (2013)	23696216	211384	8391	AC17	1H-Indole-2-sulfonic acid, 5-[2-(aminocarbonyl)hydrazinylidene]-2,3,5,6-tetrahydro-1-methyl-6-oxo-, sodium salt (1:1)|Sodium 5-(carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate	-	CHEMSPIDER	21161414	C10H11N4NaO5S	small molecule	-	51460-26-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HLFCZZKCHVSOAP-UHFFFAOYSA-M
28469	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Zhou B (2013)	23696216	211384	8391	AC17	1H-Indole-2-sulfonic acid, 5-[2-(aminocarbonyl)hydrazinylidene]-2,3,5,6-tetrahydro-1-methyl-6-oxo-, sodium salt (1:1)|Sodium 5-(carbamoylhydrazono)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate	-	CHEMSPIDER	21161414	C10H11N4NaO5S	small molecule	-	51460-26-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HLFCZZKCHVSOAP-UHFFFAOYSA-M
28470	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Cao MN (2014)	24534329	211376	8392	Curcusone D	Benz[e]azulene-1,4-dione, 2,3,6a,7,8,9,10,10a-octahydro-2-hydroxy-2,5-dimethyl-10-methylene-7-(1-methylethenyl)-, (2R,6aS)-|(2R,6aS)-2-Hydroxy-7-isopropenyl-2,5-dimethyl-10-methylene-2,3,6a,7,8,9,10,10a-octahydrobenzo[e]azulene-1,4-dione	-	CHEMSPIDER	153282	C20H24O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DBPPEQIYWCILTJ-QUWZQRFGSA-N
28471	116914	23326	-	USP22	USP3L	9606	Homo sapiens	inhibitor	target	Cao MN (2014)	24534329	211376	8392	Curcusone D	Benz[e]azulene-1,4-dione, 2,3,6a,7,8,9,10,10a-octahydro-2-hydroxy-2,5-dimethyl-10-methylene-7-(1-methylethenyl)-, (2R,6aS)-|(2R,6aS)-2-Hydroxy-7-isopropenyl-2,5-dimethyl-10-methylene-2,3,6a,7,8,9,10,10a-octahydrobenzo[e]azulene-1,4-dione	-	CHEMSPIDER	153282	C20H24O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DBPPEQIYWCILTJ-QUWZQRFGSA-N
28472	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Cao MN (2014)	24534329	211376	8392	Curcusone D	Benz[e]azulene-1,4-dione, 2,3,6a,7,8,9,10,10a-octahydro-2-hydroxy-2,5-dimethyl-10-methylene-7-(1-methylethenyl)-, (2R,6aS)-|(2R,6aS)-2-Hydroxy-7-isopropenyl-2,5-dimethyl-10-methylene-2,3,6a,7,8,9,10,10a-octahydrobenzo[e]azulene-1,4-dione	-	CHEMSPIDER	153282	C20H24O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DBPPEQIYWCILTJ-QUWZQRFGSA-N
28473	114555	9101	-	USP8	HumORF8|SPG59|UBPY	9606	Homo sapiens	inhibitor	target	Cao MN (2014)	24534329	211376	8392	Curcusone D	Benz[e]azulene-1,4-dione, 2,3,6a,7,8,9,10,10a-octahydro-2-hydroxy-2,5-dimethyl-10-methylene-7-(1-methylethenyl)-, (2R,6aS)-|(2R,6aS)-2-Hydroxy-7-isopropenyl-2,5-dimethyl-10-methylene-2,3,6a,7,8,9,10,10a-octahydrobenzo[e]azulene-1,4-dione	-	CHEMSPIDER	153282	C20H24O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DBPPEQIYWCILTJ-QUWZQRFGSA-N
28474	115283	9958	-	USP15	UNPH-2|UNPH4	9606	Homo sapiens	inhibitor	target	Cao MN (2014)	24534329	211376	8392	Curcusone D	Benz[e]azulene-1,4-dione, 2,3,6a,7,8,9,10,10a-octahydro-2-hydroxy-2,5-dimethyl-10-methylene-7-(1-methylethenyl)-, (2R,6aS)-|(2R,6aS)-2-Hydroxy-7-isopropenyl-2,5-dimethyl-10-methylene-2,3,6a,7,8,9,10,10a-octahydrobenzo[e]azulene-1,4-dione	-	CHEMSPIDER	153282	C20H24O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DBPPEQIYWCILTJ-QUWZQRFGSA-N
28475	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Cao MN (2014)	24534329	211376	8392	Curcusone D	Benz[e]azulene-1,4-dione, 2,3,6a,7,8,9,10,10a-octahydro-2-hydroxy-2,5-dimethyl-10-methylene-7-(1-methylethenyl)-, (2R,6aS)-|(2R,6aS)-2-Hydroxy-7-isopropenyl-2,5-dimethyl-10-methylene-2,3,6a,7,8,9,10,10a-octahydrobenzo[e]azulene-1,4-dione	-	CHEMSPIDER	153282	C20H24O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DBPPEQIYWCILTJ-QUWZQRFGSA-N
28476	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	Swords RT (2010)	20203261	211410	8353	Pevonedistat	MLN4924|MLN 4924|[(1S,2S,4R)-4-(4-{[(1S)-2,3-dihydro-1H-inden-1-yl]amino}-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl]methyl sulfamate|Pevonedistat|[(1S,2S,4R)-4-{4-[(1S)-2,3-Dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl]methyl sulfamate|S3AZD8D215|9605|MLN4924	-	CHEMSPIDER	17625129	C21H25N5O4S	small molecule	-	905579-51-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MPUQHZXIXSTTDU-QXGSTGNESA-N
28477	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Kawamura S (2014)	24524217	211421	8393	compund 4a	N~2~-Acetyl-N~4~-{4-(benzyloxy)-3-[(benzyloxy)methyl]butyl}-N~1~-{(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}-L-aspartamide|L-Aspartamide, N~2~-acetyl-N~1~-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-N~4~-[4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]butyl]-	-	CHEMSPIDER	34237644	C40H58BN3O7	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OGQMVFMKRZZEEH-JVCXTPEFSA-N
28478	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Kawamura S (2014)	24524217	211421	8394	compound 11a	L-Aspartamide, N~2~-acetyl-N~1~-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-N~4~-[4-(phenylmethoxy)butyl]-|N~2~-Acetyl-N~4~-[4-(benzyloxy)butyl]-N~1~-{(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}-L-aspartamide	-	CHEMSPIDER	34237654	C32H50BN3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ODIWGDQSSAWSIL-GKWCIWIWSA-N
28479	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Kawamura S (2014)	24524217	211421	8393	compund 4a	N~2~-Acetyl-N~4~-{4-(benzyloxy)-3-[(benzyloxy)methyl]butyl}-N~1~-{(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}-L-aspartamide|L-Aspartamide, N~2~-acetyl-N~1~-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-N~4~-[4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]butyl]-	-	CHEMSPIDER	34237644	C40H58BN3O7	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OGQMVFMKRZZEEH-JVCXTPEFSA-N
28480	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Kawamura S (2014)	24524217	211421	8394	compound 11a	L-Aspartamide, N~2~-acetyl-N~1~-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-N~4~-[4-(phenylmethoxy)butyl]-|N~2~-Acetyl-N~4~-[4-(benzyloxy)butyl]-N~1~-{(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}-L-aspartamide	-	CHEMSPIDER	34237654	C32H50BN3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ODIWGDQSSAWSIL-GKWCIWIWSA-N
28481	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Kawamura S (2014)	24524217	211421	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
28483	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	inhibitor	target	Sodji Q (2014)	25240614	211381	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
28487	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Roccaro AM (2010)	20110419	211392	8397	Oprozomib	ONX 0912|MZ37792Y8J|9597|Oprozomib|D-erythro-3-Pentulose, 4,5-anhydro-1,2-dideoxy-4-C-methyl-2-[[O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-L-seryl]amino]-1-phenyl-|4,5-Anhydro-1,2-dideoxy-4-methyl-2-({O-methyl-N-[(2-methyl-1,3-thiazol-5-yl)carbonyl]-L-seryl-O-methyl-L-seryl}amino)-1-phenyl-D-erythro-pent-3-ulose	-	CHEMSPIDER	28528375	C25H32N4O7S	small molecule	-	935888-69-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SWZXEVABPLUDIO-WSZYKNRRSA-N
28488	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Roccaro AM (2010)	20110419	211392	8397	Oprozomib	ONX 0912|MZ37792Y8J|9597|Oprozomib|D-erythro-3-Pentulose, 4,5-anhydro-1,2-dideoxy-4-C-methyl-2-[[O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-L-seryl]amino]-1-phenyl-|4,5-Anhydro-1,2-dideoxy-4-methyl-2-({O-methyl-N-[(2-methyl-1,3-thiazol-5-yl)carbonyl]-L-seryl-O-methyl-L-seryl}amino)-1-phenyl-D-erythro-pent-3-ulose	-	CHEMSPIDER	28528375	C25H32N4O7S	small molecule	-	935888-69-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SWZXEVABPLUDIO-WSZYKNRRSA-N
28490	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Liu N (2014)	24912524	211415	8578	CuPT	Copper(2+) bis(2-thioxo-1(2H)-pyridinolate)|2(1H)-Pyridinethione, 1-hydroxy-, copper(2+) salt (2:1)	-	CHEMSPIDER	76402	C10H8CuN2O2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	XDUPUJNNHFTMQS-UHFFFAOYSA-N
28491	119509	51377	RP11-101E13.2	UCHL5	CGI-70|INO80R|UCH-L5|UCH37	9606	Homo sapiens	inhibitor	target	Liu N (2014)	24912524	211415	8578	CuPT	Copper(2+) bis(2-thioxo-1(2H)-pyridinolate)|2(1H)-Pyridinethione, 1-hydroxy-, copper(2+) salt (2:1)	-	CHEMSPIDER	76402	C10H8CuN2O2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	XDUPUJNNHFTMQS-UHFFFAOYSA-N
28492	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Yan C (2018)	29462615	211405	8337	C30	1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-, 3-(O-acetyloxime), (3Z)-|(3Z)-3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)-1,3-dihydro-2H-indol-2-one|LDN57444|LDN-57444|LDN 57444|	-	CHEMSPIDER	21395767	C17H11Cl3N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OPQRFPHLZZPCCH-PGMHBOJBSA-N
28493	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Davis MI (2016)	27681596	198526	8596	ML364	Benzamide, 2-[[(4-methylphenyl)sulfonyl]amino]-N-(4-phenyl-2-thiazolyl)-4-(trifluoromethyl)-|2-{[(4-Methylphenyl)sulfonyl]amino}-N-(4-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide	-	CHEMSPIDER	30917317	C24H18F3N3O3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QZUGMNXETPARLI-UHFFFAOYSA-N
28494	107427	991	-	CDC20	CDC20A|bA276H19.3|p55CDC	9606	Homo sapiens	inhibitor	target	Zeng X (2010)	20951947	139860	8463	TAMe	TAME|tosyl-arginine methyl ester|tosyl-L-arginine methyl ester|Ts-Arg-OMe|p-toluensulfonyl-L-arginine methyl ester|Nalpha-p-tosyl-L-arginine methyl ester|methyl N2-(p-tosyl)-L-argininate|methyl N2-(p-toluenenesulfonyl)-L-argininate|methyl N2-[(p-tolyl)sulphonyl]-L-argininate|N2-(p-tolylsulfonyl)-L-arginine methyl ester|methyl N2-[(4-methylphenyl)sulfonyl]-L-argininate	-	CHEBI	62167	C14H22N4O4S	small molecule	-	1784-03-08	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FKMJXALNHKIDOD-LBPRGKRZSA-N
28495	119489	51343	-	FZR1	CDC20C|CDH1|FZR|FZR2|HCDH|HCDH1	9606	Homo sapiens	inhibitor	target	Zeng X (2010)	20951947	139860	8463	TAMe	TAME|tosyl-arginine methyl ester|tosyl-L-arginine methyl ester|Ts-Arg-OMe|p-toluensulfonyl-L-arginine methyl ester|Nalpha-p-tosyl-L-arginine methyl ester|methyl N2-(p-tosyl)-L-argininate|methyl N2-(p-toluenenesulfonyl)-L-argininate|methyl N2-[(p-tolyl)sulphonyl]-L-argininate|N2-(p-tolylsulfonyl)-L-arginine methyl ester|methyl N2-[(4-methylphenyl)sulfonyl]-L-argininate	-	CHEBI	62167	C14H22N4O4S	small molecule	-	1784-03-08	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FKMJXALNHKIDOD-LBPRGKRZSA-N
28496	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Lamberto I (2017)	29056421	211372	8464	9QD	XL188|N-[3-[[4-Hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl]methyl]-4-oxoquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide|N-[3-({4-hydroxy-1-[(3R)-3-phenylbutanoyl]piperidin-4-yl}methyl)-4-oxo-3,4-dihydroquinazolin-7-yl]-3-(4-methylpiperazin-1-yl)propanamide|SCHEMBL20856972|(R)-N-(3-((4-Hydroxy-1-(3-phenylbutanoyl)piperidin-4-yl)methyl)-4-oxo-3,4-dihydroquinazolin-7-yl)-3-(4-methylpiperazin-1-yl)propanamide|2305045-76-3	-	PDB	9QD	C32H42N6O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QLBYDWATOPNXBG-XMMPIXPASA-N
28498	107076	604	-	BCL6	BCL5|BCL6A|LAZ3|ZBTB27|ZNF51	9606	Homo sapiens	inhibitor	target	Cardenas MG (2016)	27482887	212314	8583	FX1	FX1|3-Thiazolidinepropanoic acid, 5-(5-chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-, (5Z)-|3-[(5Z)-5-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]propanoic acid	-	CHEMSPIDER	28612733	C14H9ClN2O4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VISHSGZPGQKEFX-KHPPLWFESA-N
28499	107076	604	-	BCL6	BCL5|BCL6A|LAZ3|ZBTB27|ZNF51	9606	Homo sapiens	inhibitor	target	Cerchietti LC (2010)	20385364	218656	8462	79-6	(2R)-2-[(5Z)-5-(5-bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanedioic acid|(2R)-2-[(5Z)-5-(5-Bromo-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]succinic acid|Butanedioic acid, 2-[(5Z)-5-(5-bromo-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinyl]-, (2R)-	-	CHEMSPIDER	25057870	C15H9BrN2O6S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QGNRETMYLHRUBB-OZEWEUHLSA-N
28500	116235	11047	-	ADRM1	ARM-1|ARM1|GP110	9606	Homo sapiens	inhibitor	target	Anchoori RK (2013)	24332045	163442	8573	RA190	(3Z,5Z)-1-[(2S)-2-Amino-3-phenylpropanoyl]-3,5-bis(3,4-dichlorobenzylidene)-4-piperidinone hydrochloride (1:1)|4-Piperidinone, 1-[(2S)-2-amino-1-oxo-3-phenylpropyl]-3,5-bis[(3,4-dichlorophenyl)methylene]-, (3Z,5Z)-, hydrochloride (1:1)	-	CHEMSPIDER	67896519	C28H23Cl5N2O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UMWXLEVUBFNYIK-VCCJZKHWSA-N
28501	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	activator	target	Sievers QL (2018)	30385546	212829	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
28502	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Zhou B (2018)	30473361	212965	6528	TBHQ	2-tert-butylbenzene-1,4-diol|tert-butylhydroquinone|MTBHQ|MX4375000|1-t-Butyl-1,4-dihydroxybenzene|1948-33-0|Hydroquinone, tert-butyl-|1,4-Benzenediol, 2-(1,1-dimethylethyl)-|2-(2-Methyl-2-propanyl)-1,4-benzenediol	-	DRUGBANK	DB07726	C10H14O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	tBHQ is shown to disrupt the interaction between KEAP1 and NFE2L2 preventing ubiquitination by KEAP1	BGNXCDMCOKJUMV-UHFFFAOYSA-N
28503	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Zhou B (2018)	30473361	212965	315	Floxuridine	beta-5-Fluoro-2'-deoxyuridine|Floxuridin|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Floxuridinum|5-Fluorouracil deoxyriboside|5-Fluorodeoxyuridine|Deoxyfluorouridine|5-Fluoro-2-desoxyuridine|Floxiridina|Fluoruridine Deoxyribose|2'-Deoxy-5-fluorouridine|FdU|Floxuridine|Fluorodeoxyuridine|5-Fluorouracil 2'-deoxyriboside|5FDU|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUDR	floxuridine	DRUGBANK	DB00322	C9H11FN2O5	small molecule	-	50-91-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	F-dUrd is shown to disrupt the interaction between KEAP1 and NFE2L2 preventing ubiquitination by KEAP1	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
28504	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Mills EL (2018)	29590092	212817	8585	4-octyl Itaconate	Butanedioic acid, 2-methylene-, 4-octyl ester|2-Methylene-4-(octyloxy)-4-oxobutanoic acid	-	CHEMSPIDER	68003917	C13H22O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KBASUIDPDITQHT-UHFFFAOYSA-N
28505	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Zhou Y (2018)	29670376	212575	8591	Butein	Butein|Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI)|2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-|(2E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one|(2E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one|(E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one|2056928|4WVS5M0LGF|(2E)-1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one[	-	CHEMSPIDER	4444634	C15H12O5	small molecule	-	487-52-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AYMYWHCQALZEGT-ORCRQEGFSA-N
28506	115283	9958	-	USP15	UNPH-2|UNPH4	9606	Homo sapiens	inhibitor	target	Ward SJ (2018)	30228188	213502	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
28507	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Mori T (2018)	29358579	213956	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
28508	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Ito T (2010)	20223979	126437	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
28509	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Chuang SJ (2018)	29449607	213957	344	Tioguanine	2-Amino-6-mercaptopurine|2-Amino-6-purinethiol|Tioguanin|2-aminopurine-6-thiol|6-TG|Tioguanine|2-amino-1,9-Dihydropurine-6-thione|2-Amino-1,7-dihydro-6H-purine-6-thione|6-Thioguanine|Thioguanine|2-Aminopurin-6-thiol|6-Mercaptoguanine|2-Amino 6mp|2-amino-1H-purine-6(7H)-thione|Tioguanina|ThG|TG|Tioguaninum|2-Amino-6-merkaptopurin|2-Aminopurine-6(1H)-thione|6-Mercapto-2-aminopurine|6-thioguanine	tabloid|lanvis	DRUGBANK	DB00352	C5H5N5S	small molecule	L01BB03	154-42-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WYWHKKSPHMUBEB-UHFFFAOYSA-N
28510	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	inhibitor	target	Wong DPW (2018)	30273379	213993	8600	andrographolide	[1R-[1a[E(S*)],4ab,5a,6a,8aa]]-3-[2-[Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-2(3H)-furanone|3a,14,15,18-Tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic Acid g-Lactone|Chuanxinlian|Kalmegh|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}dihydro-2(3H)-furanone|2(3H)-Furanone, 3-[2-[(1R,4aS,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-, (3E)-|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylendecahydro-1-naphthalenyl]ethyliden}dihydro-2(3H)-furanon|(3E)-4-hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one	-	CHEMSPIDER	16735664	C20H30O5	small molecule	-	5508-58-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BOJKULTULYSRAS-FNTFRYDESA-N
28511	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Gavory G (2018)	29200206	213952	8576	3-[4-(Aminomethyl)phenyl]-6-{[4-hydroxy-1-(4,4,4-trifluoro-3-phenylbutanoyl)-4-piperidinyl]methyl}-2-methyl-2,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one	7H-Pyrazolo[4,3-d]pyrimidin-7-one, 3-[4-(aminomethyl)phenyl]-2,6-dihydro-6-[[4-hydroxy-1-(4,4,4-trifluoro-1-oxo-3-phenylbutyl)-4-piperidinyl]methyl]-2-methyl-|3-[4-(Aminomethyl)phenyl]-6-{[4-hydroxy-1-(4,4,4-trifluoro-3-phenylbutanoyl)-4-piperidinyl]methyl}-2-methyl-2,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one	-	CHEMSPIDER	65324406	C29H31F3N6O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	PDB ID 5N9T	RLPQYKGBXQQARM-UHFFFAOYSA-N
28512	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Gavory G (2018)	29200206	213952	8575	7-bromanyl-3-[[4-oxidanyl-1-[(3~{R})-3-phenylbutanoyl]piperidin-4-yl]methyl]thieno[3,2-d]pyrimidin-4-one	7-Bromo-3-{[4-hydroxy-1-(3-phenylbutanoyl)-4-piperidinyl]methyl}thieno[3,2-d]pyrimidin-4(3H)-one|Thieno[3,2-d]pyrimidin-4(3H)-one, 7-bromo-3-[[4-hydroxy-1-(1-oxo-3-phenylbutyl)-4-piperidinyl]methyl]-	-	CHEMSPIDER	65324407	C22H24BrN3O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	PDB ID 5N9R	NRRXSEFLOFZNSO-UHFFFAOYSA-N
28513	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	inhibitor	target	Barghout SH (2019)	29884901	214627	8580	TAK-243	V9GGV0YCDI|TAK-243|Sulfamic acid, [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-[(trifluoromethyl)thio]phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl ester|{(1R,2R,3S,4R)-2,3-Dihydroxy-4-[(2-{3-[(trifluoromethyl)sulfanyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl}methyl sulfamate	-	CHEMSPIDER	58828173	C19H20F3N5O5S2	small molecule	-	1450833-55-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KJDAGXLMHXUAGV-DGWLBADLSA-N
28514	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8620	4,4'-Dimethyl-2,2',5,5'-biphenyltetrol	4,4'-dimethyl[1,1'-biphenyl]-2,2',5,5'-tetrol|4,4'-Dimethyl-2,2',5,5'-biphenyltetrol|[1,1'-Biphenyl]-2,2',5,5'-tetrol, 4,4'-dimethyl-	-	CHEMSPIDER	191018	C14H14O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 1 (NSC2805); Targets WWP2, WWP1 and Nedd4; Ligandbased NMR confirmed binding of compound to the WWP2 HECT catalytic domain.	DSVRCBOSZSZMRX-UHFFFAOYSA-N
28515	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8588	N-[(Z)-2-(2,5-Dihydroxyphenyl)vinyl]formamide	N-[(Z)-2-(2,5-Dihydroxyphenyl)vinyl]formamide|Formamide, N-[(Z)-2-(2,5-dihydroxyphenyl)ethenyl]-	-	CHEMSPIDER	4578295	C9H9NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 2 (NSC650438); Targets WWP2, WWP1 and Nedd4; Ligandbased NMR confirmed binding of compound to the WWP2 HECT catalytic domain.	SIHZWGODIRRSRA-ARJAWSKDSA-N
28516	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8595	4-Nitro-7-[(1-oxido-2-pyridinyl)sulfanyl]-2,1,3-benzoxadiazole	4-Nitro-7-[(1-oxido-2-pyridinyl)sulfanyl]-2,1,3-benzoxadiazole|2,1,3-Benzoxadiazole, 4-nitro-7-[(1-oxido-2-pyridinyl)thio]-	-	CHEMSPIDER	277406	C11H6N4O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 7 (NSC228155); Increased inhibition towards WWP2 and Nedd4 over WWP1; Showed no STD NMR experiment signal but could not be excluded as a binder to WWP2 HECT catalytic domain.	ICCFXXDUYSPKOL-UHFFFAOYSA-N
28517	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8605	3,5-Bis(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid	3,5-Bis(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid|Benzoic acid, 3,5-bis(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-	-	CHEMSPIDER	209302	C15H8N2O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 12 (NSC44750); Targets WWP2, WWP1 and Nedd4; No positive binding results in STD NMR experiment likley due to solubility issues.	RCBGGBMZYJSLJE-UHFFFAOYSA-N
28518	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8611	2-(3-Nitrophenyl)-3-nitrosoimidazo[1,2-a]pyrimidine	2-(3-Nitro-phenyl)-3-nitroso-imidazo[1,2-a]pyrimidine|2-(3-Nitrophenyl)-3-nitrosoimidazo[1,2-a]pyrimidine|Imidazo[1,2-a]pyrimidine, 2-(3-nitrophenyl)-3-nitroso-	-	CHEMSPIDER	301406	C12H7N5O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 16 (NSC369066); Increased inhibition towards WWP2 over WWP1 and Nedd4; Ligandbased NMR confirmed binding of compound to the WWP2 HECT catalytic domain.	QPWJAIUKYMKWGA-UHFFFAOYSA-N
28519	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8597	7,8-Dimethyl-10-(2-Acetoxyethyl)Isoalloxazine	7,8-Dimethyl-10-(2-Acetoxyethyl)Isoalloxazine|Benzo[g]pteridine-2,4(3H,10H)-dione, 10-[2-(acetyloxy)ethyl]-7,8-dimethyl-|2-(7,8-Dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl acetate	-	CHEMSPIDER	21222	C16H16N4O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 17 (NSC3064); Increased inhibition towards WWP2 over WWP1 and Nedd4; Ligandbased NMR confirmed binding of compound to the WWP2 HECT catalytic domain.	PVRDHKBVCDWVPD-UHFFFAOYSA-N
28520	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8610	S-[(2Z)-2-Amino-2-{[(6,6-dimethylbicyclo[3.1.1]hept-2-yl)methyl]imino}ethyl] hydrogen sulfurothioate	Thiosulfuric acid (H_2_S_2_O_3_), S-[(2Z)-2-amino-2-[[(6,6-dimethylbicyclo[3.1.1]hept-2-yl)methyl]imino]ethyl] ester|S-[(2Z)-2-Amino-2-{[(6,6-dimethylbicyclo[3.1.1]hept-2-yl)methyl]imino}ethyl] hydrogen sulfurothioate	-	CHEMSPIDER	268720	C12H22N2O3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 18 (NSC194308); Increased inhibition towards WWP2 over WWP1 and Nedd4; Ligandbased NMR confirmed binding of compound to the WWP2 HECT catalytic domain.	VOOABHIKMGRJFC-UHFFFAOYSA-N
28521	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8592	4-[(4-Methylphenyl)sulfinyl]-7-nitro-2,1,3-benzoxadiazole	4-[(4-Methylphenyl)sulfinyl]-7-nitro-2,1,3-benzoxadiazole|2,1,3-Benzoxadiazole, 4-[(4-methylphenyl)sulfinyl]-7-nitro-	-	CHEMSPIDER	277401	C13H9N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 19 (NSC228150); Increased inhibition towards WWP2 and Nedd4 over WWP1; No positive binding results in STD NMR experiment likley due to solubility issues.	FRBRHPUZSWIODD-UHFFFAOYSA-N
28522	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8604	10-(2-Methoxyethyl)-3-phenylbenzo[g]pteridine-2,4(3H,10H)-dione	10-(2-Methoxyethyl)-3-phenylbenzo[g]pteridine-2,4(3H,10H)-dione|Benzo[g]pteridine-2,4(3H,10H)-dione, 10-(2-methoxyethyl)-3-phenyl-	-	CHEMSPIDER	287083	C19H16N4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 20 (NSC288387); Increased inhibition towards WWP2 over WWP1 and Nedd4; Ligandbased NMR confirmed binding of compound to the WWP2 HECT catalytic domain.	VBIVGEJXWFOZBG-UHFFFAOYSA-N
28523	116244	11060	-	WWP2	AIP2|WWp2-like	9606	Homo sapiens	inhibitor	target	Watt JE (2018)	30207403	215624	8601	Methylium, tris(4-(diethylamino)phenyl)-	Methylium, tris(4-(diethylamino)phenyl)-|Methylium, tris(p-(diethylamino)phenyl)-|Ethanaminium, N-(4-(bis(4-(diethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-|Ethanaminium, N-[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-|4-{Bis[4-(diethylamino)phenyl]methylene}-N,N-diethyl-2,5-cyclohexadien-1-iminium	-	CHEMSPIDER	16065	C31H42N3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Compound 21 (NSC8675); Increased inhibition towards WWP2 over WWP1 and Nedd4; No positive binding results in STD NMR experiment likley due to solubility issues.	VYYRJGKHDDYUGK-UHFFFAOYSA-N
28524	124238	84749	-	USP30	-	9606	Homo sapiens	inhibitor	target	Kluge AF (2018)	29935771	216210	8598	Na-(Cyclohexylcarbonyl)-N-{5-[(2-methyl-2-propanyl)sulfamoyl]-1-naphthyl}-L-phenylalaninamide	Benzenepropanamide, alpha-[(cyclohexylcarbonyl)amino]-N-[5-[[(1,1-dimethylethyl)amino]sulfonyl]-1-naphthalenyl]-, (alphaS)-|Nalpha-(Cyclohexylcarbonyl)-N-{5-[(2-methyl-2-propanyl)sulfamoyl]-1-naphthyl}-L-phenylalaninamide	-	CHEMSPIDER	72380119	C30H37N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DQXORJHBZHLLTE-SANMLTNESA-N
28525	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Lu J (2016)	27764791	216708	8381	SAR405838	8570LZ3RCA|SAR-405838|Spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, 6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxo-, (2'S,3R,4'S,5'R)-|(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide	-	CHEMSPIDER	30811498	C29H34Cl2FN3O3	small molecule	-	1303607-60-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IDKAKZRYYDCJDU-HBMMIIHUSA-N
28526	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	inhibitor	target	Sun B (2018)	28663582	210027	8577	birabresib	OTX015|(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide|MFCD26960949|birabresib|MK-8628|X40LKS49S3|10407|2-[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-|OTX-015	-	CHEMSPIDER	8112374	C25H22ClN5O2S	small molecule	-	202590-98-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GNMUEVRJHCWKTO-FQEVSTJZSA-N
28527	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	inhibitor	target	Sun B (2018)	28663582	210027	8577	birabresib	OTX015|(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide|MFCD26960949|birabresib|MK-8628|X40LKS49S3|10407|2-[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-|OTX-015	-	CHEMSPIDER	8112374	C25H22ClN5O2S	small molecule	-	202590-98-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GNMUEVRJHCWKTO-FQEVSTJZSA-N
28528	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	inhibitor	target	Sun B (2018)	28663582	210027	8577	birabresib	OTX015|(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide|MFCD26960949|birabresib|MK-8628|X40LKS49S3|10407|2-[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-|OTX-015	-	CHEMSPIDER	8112374	C25H22ClN5O2S	small molecule	-	202590-98-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GNMUEVRJHCWKTO-FQEVSTJZSA-N
28529	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Sznarkowska A (2019)	30603043	218393	2193	Protoporphyrin Ix	protoporphyrin IX|protoporphyrin|553-12-8|Ooporphyrin|Protoporpyrin IX|ppIX|Porphyrinogen IX|Protoporphyrin IX disodium|Kammerers prophyrin	-	DRUGBANK	DB02285	C34H33N4O4	small molecule	-	553-12-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	PpIX ablates TAp73/MDM2, TAp73/MDMX and TAp73/Itch complexes	-
28530	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	inhibitor	target	Sznarkowska A (2019)	30603043	218393	2193	Protoporphyrin Ix	protoporphyrin IX|protoporphyrin|553-12-8|Ooporphyrin|Protoporpyrin IX|ppIX|Porphyrinogen IX|Protoporphyrin IX disodium|Kammerers prophyrin	-	DRUGBANK	DB02285	C34H33N4O4	small molecule	-	553-12-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	PpIX ablates TAp73/MDM2, TAp73/MDMX and TAp73/Itch complexes	-
28531	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Potts BC (2011)	21247382	218714	8396	Marizomib	(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one|(1R,4R,5S)-4-(2-Chloroethyl)-1-[(S)-(1S)-2-cyclohexen-1-yl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|(-)-salinosporamide A|marizomib|6-Oxa-2-azabicyclo[3.2.0]heptane-3,7-dione, 4-(2-chloroethyl)-1-[(S)-(1S)-2-cyclohexen-1-ylhydroxymethyl]-5-methyl-, (1R,4R,5S)-|Salinosporamide A|9205|703P9YDP7F|BDBM50398608	-	CHEMSPIDER	9522473	C15H20ClNO4	small molecule	-	437742-34-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NGWSFRIPKNWYAO-SHTIJGAHSA-N
28532	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Chou TF (2011)	21343295	220329	8618	MNS	MNS|3,4-Methylenedioxy-.beta.-nitrostyrene|3,4-Methylenedioxy-beta-nitrostyrene|1,3-Benzodioxole, 5- (2-nitroethenyl)-|5-[(E)-2-Nitrovinyl]-1,3-benzodioxole|1,3-Benzodioxole, 5-[(E)-2-nitroethenyl]-|Syk Inhibitor III|MFCD00014575|WL5270000|5-(2-NITRO-VINYL)-BENZO(1,3)DIOXOLE	-	CHEMSPIDER	585303	C9H7NO4	small molecule	-	1485-00-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KFLWBZPSJQPRDD-ONEGZZNKSA-N
28533	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Chou TF (2011)	21383145	220330	8574	DBeQ	2,4-dibenzylaminoquinazoline|2,4-Quinazolinediamine, N~2~,N~4~-bis(phenylmethyl)-|DBeQ|N2,N4-dibenzylquinazoline-2,4-diamine|N,N'-Dibenzyl-2,4-quinazolinediamine|MFCD03691820|JRF 12	-	CHEMSPIDER	589082	C22H20N4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QAIMUUJJAJBPCL-UHFFFAOYSA-N
28534	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Magnaghi P (2013)	23892893	220331	8581	NMS-873	Pyridine, 3-[3-(cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]-|NMS-873|MFCD28009371|3-[3-Cyclopentylsulfanyl-5-(4'-methanesulfonyl-2-methylbiphenyl-4-yloxymethyl)-[1,2,4]triazol-4-yl]-pyridine|3-[3-(Cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]-pyridine|3-[3-(Cyclopentylsulfanyl)-5-({[2-methyl-4'-(methylsulfonyl)-4-biphenylyl]oxy}methyl)-4H-1,2,4-triazol-4-yl]pyridine	-	CHEMSPIDER	29398603	C27H28N4O3S2	small molecule	-	1418013-75-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UJGTUKMAJVCBIS-UHFFFAOYSA-N
28535	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	modulator	target	Hagner PR (2015)	26002965	185946	8616	avadomide	2,6-Piperidinedione, 3-(5-amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-|3-(5-Amino-2-methyl-4-oxo-3(4H)-quinazolinyl)-2,6-piperidinedione|3-(5-Amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione|10599|28DZS29F59|UNII:28DZS29F59|avadomide	-	CHEMSPIDER	35521266	C14H14N4O3	small molecule	-	1015474-32-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	CC-122 recruits Aiolos and Ikaros and induces their ubiquitination by the CRL4CRBN E3 ubiquitin ligase complex	RSNPAKAFCAAMBH-UHFFFAOYSA-N
28536	118895	29761	-	USP25	USP21	9606	Homo sapiens	inhibitor	target	Wrigley JD (2017)	29131570	207318	8579	AZ1	Ethanol, 2-[[[5-bromo-2-[[4-fluoro-3-(trifluoromethyl)phenyl]methoxy]phenyl]methyl]amino]-|2-[(5-Bromo-2-{[4-fluoro-3-(trifluoromethyl)benzyl]oxy}benzyl)amino]ethanol	-	CHEMSPIDER	78316098	C17H16BrF4NO2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ITHSFXDGKQYOED-UHFFFAOYSA-N
28537	121683	57646	-	USP28	-	9606	Homo sapiens	inhibitor	target	Wrigley JD (2017)	29131570	207318	8579	AZ1	Ethanol, 2-[[[5-bromo-2-[[4-fluoro-3-(trifluoromethyl)phenyl]methoxy]phenyl]methyl]amino]-|2-[(5-Bromo-2-{[4-fluoro-3-(trifluoromethyl)benzyl]oxy}benzyl)amino]ethanol	-	CHEMSPIDER	78316098	C17H16BrF4NO2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ITHSFXDGKQYOED-UHFFFAOYSA-N
28539	122964	79876	-	UBA5	THIFP1|UBE1DC1	9606	Homo sapiens	inhibitor	target	Roberts AM (2017)	28186401	223662	8590	DKM 2-93	2-Chloro-N-(3,4-dimethoxybenzyl)acetamide|Acetamide, 2-chloro-N-[(3,4-dimethoxyphenyl)methyl]-|dkm 2-93|2-CHLORO-N-(3,4-DIMETHOXY-BENZYL)-ACETAMIDE	-	CHEMSPIDER	1786966	C11H14ClNO3	small molecule	-	65836-72-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	DKM-293 inhibits the ufmylation E1-like protein UBA5	CETPWRGZGWGPSV-UHFFFAOYSA-N
28540	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Lain S (2008)	18455128	78113	8621	Tenovin-1	N-[4-({[(4-tert-butylbenzoyl)amino]carbothioyl}amino)phenyl]acetamide|Tenovin-1|N-[(4-Acetamidophenyl)carbamothioyl]-4-tert-butylbenzamide|Benzamide, N-[[[4-(acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)-|N-[(4-Acetamidophenyl)carbamothioyl]-4-(2-methyl-2-propanyl)benzamide|N-[(4-acetamidoanilino)-sulfanylidenemethyl]-4-tert-butylbenzamide|BIQ6AID2B7	-	CHEMSPIDER	875023	C20H23N3O2S	small molecule	-	380315-80-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Tenovin-1 protects against MDM2-mediated p53 degradation and inhibits the protein deacetylating activities of SirT1 and SirT2.	WOWJIWFCOPZFGV-UHFFFAOYSA-N
28541	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Thompson T (2010)	20406950	223663	8606	Serdemetan	Serdemetan|1,4-Benzenediamine, N~1~-[2-(1H-indol-3-yl)ethyl]-N~4~-4-pyridinyl-|N-[2-(1H-Indol-3-yl)ethyl]-N'-(4-pyridinyl)-1,4-benzenediamine|9161|ID6YB4W3V8	-	CHEMSPIDER	9784341	C21H20N4	small molecule	-	881202-45-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CEGSUKYESLWKJP-UHFFFAOYSA-N
28542	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	inhibitor	target	Wang H (2011)	21075910	223664	8619	7-(4-Methyl-1-piperazinyl)-4-nitro-2,1,3-benzoxadiazole 1-oxide	7-(4-Methylpiperazin-1-yl)-4-nitro-2,1,3-benzoxadiazole 1-oxide|2,1,3-Benzoxadiazole, 7-(4-methyl-1-piperazinyl)-4-nitro-, 1-oxide|7-(4-Methyl-1-piperazinyl)-4-nitro-2,1,3-benzoxadiazole 1-oxide	-	CHEMSPIDER	38890	C11H13N5O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MWFZDJLPWDCQIL-UHFFFAOYSA-N
28543	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Issaeva N (2004)	15558054	144968	8582	RITA (NSC 652287)	(Furan-2,5-diyldithiene-5,2-diyl)dimethanol|2-Thiophenemethanol, 5,5'-(2,5-furandiyl)bis-|RITA (NSC 652287)|(2,5-Furandiyldi-5,2-thienediyl)dimethanol|[5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol	-	CHEMSPIDER	332269	C14H12O3S2	small molecule	-	213261-59-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	RITA binds to p53 and blocks the p53MDM2 interaction	KZENBFUSKMWCJF-UHFFFAOYSA-N
28544	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Ma T (2012)	22166212	220337	8613	Nutlin-3	NUTLIN-3, (-)-|NUTLIN 3|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-[4-METHOXY-2-(PROPAN-2-YLOXY)PHENYL]-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|EX-A1359|CC-452|(-)-NUTLIN-3|NUTLIN3A|Q27166862|SB19406|HMS3649P17|C30H30CL2N4O4|AS-75148|1960AH|RAC-4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NUTLIN (3A)|BCP9001003|(RAC)-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDROIMIDAZOL-1-YL)(PIPERAZIN-1-YL)METHANONE|S8059|ZINC16051336|4-((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|4-[(4S,5R)-4,5-BIS-(4-CHLORO-PHENYL)-2-(2-ISOPROPOXY-4-METHOXY-PHENYL)-4,5-DIHYDRO-IMIDAZOLE-1-CARBONYL]-PIPERAZIN-2-ONE|NUTLIN-3A CHIRAL|(4S,5R)-NUTLIN-3|2-PIPERAZINONE, 4-(((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-(4-METHOXY-2-(1-METHYLETHOXY)PHENYL)-1H-IMIDAZOL-1-YL)CARBONYL)-|4HG7|2603AH|A11501|4-[[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-[4-METHOXY-2-(1-METHYLETHOXY)PHENYL]-1H-IMIDAZOL-1-YL]CARBONYL]-2-PIPERAZINONE|SR-01000946691|W-5585|NUTLIN 3A|675576-98-4|UNII-53IA0V845C COMPONENT BDUHCSBCVGXTJM-WUFINQPMSA-N|NUTLIN-3A, >=98% (HPLC)|4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4, 5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NCGC00344347-05|NUTLIN-3A|SC-95163|UNII-L7C92IOE65|AKOS027422740|4J3E|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(4-METHOXY-2-PROPAN-2-YLOXYPHENYL)-4,5-DIHYDROIMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|HY-10029|CS-0296|SR-01000946691-1|NUTLIN-3A (CHIRAL)|L7C92IOE65|BDBM50229787	-	CHEMSPIDER	187530	C30H30Cl2N4O4	small molecule	-	548472-68-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BDUHCSBCVGXTJM-UHFFFAOYSA-N
28545	115385	10075	RP3-339A18.4	HUWE1	ARF-BP1|HECTH9|HSPC272|Ib772|LASU1|MULE|URE-B1|UREB1	9606	Homo sapiens	inhibitor	target	Peter S (2014)	25253726	223665	8594	BI8622	N-[4-(Aminomethyl)phenyl]-6-(4-cyano-4-phenyl-1-piperidinyl)-5-methyl-4-pyrimidinecarboxamide|4-Pyrimidinecarboxamide, N-[4-(aminomethyl)phenyl]-6-(4-cyano-4-phenyl-1-piperidinyl)-5-methyl-	-	CHEMSPIDER	75533993	C25H26N6O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IJHAXMJRQQTBPL-UHFFFAOYSA-N
28546	115385	10075	RP3-339A18.4	HUWE1	ARF-BP1|HECTH9|HSPC272|Ib772|LASU1|MULE|URE-B1|UREB1	9606	Homo sapiens	inhibitor	target	Peter S (2014)	25253726	223665	8617	BI8626	1,3-Benzenedimethanamine, N~1~-[8-[4-(phenylmethyl)-1-piperazinyl]pyrimido[5,4-d]pyrimidin-4-yl]-|N-[3-(Aminomethyl)benzyl]-8-(4-benzyl-1-piperazinyl)pyrimido[5,4-d]pyrimidin-4-amine	-	CHEMSPIDER	75533990	C25H28N8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DZDNGSNKWIORRZ-UHFFFAOYSA-N
28547	118893	29128	-	UHRF1	ICBP90|Np95|RNF106|hNP95|hUHRF1|huNp95	9606	Homo sapiens	inhibitor	target	Senisterra G (2018)	29562800	213633	8584	NV03	Thieno[2',3':4,5]pyrrolo[1,2-d][1,2,4]triazine-7(8H)-acetamide, N-[3-(diethylamino)propyl]-5,9-dimethyl-8-oxo-|N-[3-(Diethylamino)propyl]-2-(5,9-dimethyl-8-oxothieno[2',3':4,5]pyrrolo[1,2-d][1,2,4]triazin-7(8H)-yl)acetamide	-	CHEMSPIDER	78316460	C19H27N5O2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	NV03 is an antagonist of the UHRF1 - H3K9me3 interaction	KNZQAVKYBBYDKV-UHFFFAOYSA-N
28548	113168	7320	-	UBE2B	E2-17kDa|HHR6B|HR6B|RAD6B|UBC2	9606	Homo sapiens	inhibitor	target	Sanders MA (2013)	23339190	150227	8622	TZ9	1,3,5-Triazine-2-methanol, 4-amino-6-(phenylamino)-, 4-nitrobenzoate (ester)|(4-Amino-6-anilino-1,3,5-triazin-2-yl)methyl 4-nitrobenzoate	-	CHEMSPIDER	5909766	C17H14N6O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RRRDZFQRNJTKHL-UHFFFAOYSA-N
28549	110811	4734	PIG53	NEDD4	NEDD4-1|RPF1	9606	Homo sapiens	inhibitor	target	Aronchik I (2014)	25009292	166927	8623	Indole-3-carbidol	Indole-3-carbinol|indole-3-methanol|1H-Indol-3-ylmethanol|1H-Indole-3-methanol|3-Indolemethanol|Indole-3-carbidol	-	CHEMSPIDER	3581	C9H9NO	small molecule	-	700-06-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IVYPNXXAYMYVSP-UHFFFAOYSA-N
28550	116243	11059	-	WWP1	AIP5|Tiul1|hSDRP1	9606	Homo sapiens	inhibitor	target	Lee YR (2019)	31097636	223666	8623	Indole-3-carbidol	Indole-3-carbinol|indole-3-methanol|1H-Indol-3-ylmethanol|1H-Indole-3-methanol|3-Indolemethanol|Indole-3-carbidol	-	CHEMSPIDER	3581	C9H9NO	small molecule	-	700-06-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IVYPNXXAYMYVSP-UHFFFAOYSA-N
28551	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	inhibitor	target	Nooka AK (2019)	30694856	223667	8465	CC-92480	4-[4-[[4-[[2-[(3S)-2,6-Dioxopiperidin-3-yl]-1-oxo-3H-isoindol-4-yl]oxymethyl]phenyl]methyl]piperazin-1-yl]-3-fluorobenzonitrile|SCHEMBL20608563|BCP32805|HY-129395|CC92480|CC 92480|CS-0105182|2259648-80-9	-	PUBCHEM	137379043	C32H30FN5O4	small molecule	-	2259648-80-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YTINZZFBHWSAGL-NDEPHWFRSA-N
28552	113169	7321	-	UBE2D1	E2(17)KB1|SFT|UBC4/5|UBCH5|UBCH5A	9606	Homo sapiens	inhibitor	target	Chen H (2017)	28696694	208509	8572	UbcH5c-IN-1	(3aS,9bR)-8-[(2-Bromobenzyl)oxy]-6,9-dimethyl-3-methylene-3a,4,5,9b-tetrahydronaphtho[1,2-b]furan-2(3H)-one|Naphtho[1,2-b]furan-2(3H)-one, 8-[(2-bromophenyl)methoxy]-3a,4,5,9b-tetrahydro-6,9-dimethyl-3-methylene-, (3aS,9bR)-	-	CHEMSPIDER	71061570	C22H21BrO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IRBNWCSCHCJSLT-LAUBAEHRSA-N
28553	114554	9100	-	USP10	UBPO	9606	Homo sapiens	inhibitor	target	Shao S (2014)	24585095	223668	8614	Spautin-1	MFCD16962292|4-Quinazolinamine, 6-fluoro-N-[(4-fluorophenyl)methyl]-|6-Fluoro-N-(4-fluorobenzyl)-4-quinazolinamine|6-fluoro-N-[(4-fluorophenyl)methyl]-4-quinazolinamine|Spautin-1|C43	-	CHEMSPIDER	25199963	C15H11F2N3	small molecule	-	1262888-28-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AWIVHRPYFSSVOG-UHFFFAOYSA-N
28554	114465	8975	-	USP13	ISOT3|IsoT-3	9606	Homo sapiens	inhibitor	target	Shao S (2014)	24585095	223668	8614	Spautin-1	MFCD16962292|4-Quinazolinamine, 6-fluoro-N-[(4-fluorophenyl)methyl]-|6-Fluoro-N-(4-fluorobenzyl)-4-quinazolinamine|6-fluoro-N-[(4-fluorophenyl)methyl]-4-quinazolinamine|Spautin-1|C43	-	CHEMSPIDER	25199963	C15H11F2N3	small molecule	-	1262888-28-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AWIVHRPYFSSVOG-UHFFFAOYSA-N
28555	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Davies CW (2012)	22617491	132031	8615	Z-VAD(OMe)-FMK	Z-VAD-FMK|L-Alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-|N-[(Benzyloxy)carbonyl]-L-valyl-N-[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]-L-alaninamide|N-[(Benzyloxy)carbonyl]-L-valyl-N-[(3S)-5-fluoro-1-methoxy-1,4-dioxo-3-pentanyl]-L-alaninamide	-	CHEMSPIDER	4593742	C22H30FN3O7	small molecule	-	187389-52-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MIFGOLAMNLSLGH-QOKNQOGYSA-N
28556	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Mermerian AH (2007)	17449248	139107	8603	LDN-91946	3-Amino-2-benzoyl-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carboxylic acid|Thieno[2,3-b]pyridine-5-carboxylic acid, 3-amino-2-benzoyl-6,7-dihydro-6-oxo-|LDN-91946	-	CHEMSPIDER	826088	C15H10N2O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OJHMDRZMENMQFP-UHFFFAOYSA-N
28557	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Colombo M (2010)	20186914	223669	8593	DUBs-IN-1	DUBs-IN-1|(9E)-9-[(Benzyloxy)imino]-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile|9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-[(phenylmethoxy)imino]-, (9E)-	-	CHEMSPIDER	17225091	C20H11N5O	small molecule	-	924296-18-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GKOWDIBLCDZJHF-NCELDCMTSA-N
28558	114555	9101	-	USP8	HumORF8|SPG59|UBPY	9606	Homo sapiens	inhibitor	target	Colombo M (2010)	20186914	223669	8593	DUBs-IN-1	DUBs-IN-1|(9E)-9-[(Benzyloxy)imino]-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile|9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-[(phenylmethoxy)imino]-, (9E)-	-	CHEMSPIDER	17225091	C20H11N5O	small molecule	-	924296-18-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GKOWDIBLCDZJHF-NCELDCMTSA-N
28559	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Weinstock J (2012)	24900381	223670	8332	P50429	USP7/USP47 inhibitor|4-Cyano-5-[(3,5-dichloro-4-pyridinyl)sulfanyl]-N-[4-(methylsulfonyl)phenyl]-2-thiophenecarboxamide|2-Thiophenecarboxamide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]-	-	CHEMSPIDER	28668733	C18H11Cl2N3O3S3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GUDJFFQZIISQJB-UHFFFAOYSA-N
28560	120360	55031	-	USP47	TRFP	9606	Homo sapiens	inhibitor	target	Weinstock J (2012)	24900381	223670	8332	P50429	USP7/USP47 inhibitor|4-Cyano-5-[(3,5-dichloro-4-pyridinyl)sulfanyl]-N-[4-(methylsulfonyl)phenyl]-2-thiophenecarboxamide|2-Thiophenecarboxamide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(methylsulfonyl)phenyl]-	-	CHEMSPIDER	28668733	C18H11Cl2N3O3S3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GUDJFFQZIISQJB-UHFFFAOYSA-N
28561	120991	55905	-	RNF114	PSORS12|ZNF313	9606	Homo sapiens	inhibitor	target	Spradlin JN (2019)	31209351	220371	8586	Nimbolide	methyl [(2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cR)-8-(furan-3-yl)-2a,5a,6a,7-tetramethyl-2,5-dioxo-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-b'c']difuran-6-yl]acetate|2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-b'c']difuran-6-acetic acid, 8-(3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-2,5-dioxo-, methyl ester, (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cR)-|GY2370000|Methyl [(2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cR)-8-(3-furyl)-2a,5a,6a,7-tetramethyl-2,5-dioxo-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2H,5H-cyclopenta[b]furo[2',3',4':4,5]naphtho[2,3-d]furan-6-yl]acetate|nimbolide	-	CHEMSPIDER	10320669	C27H30O7	small molecule	-	25990-37-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JZIQWNPPBKFOPT-LSYMHUITSA-N
28562	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Kategaya L (2017)	29045385	208946	8608	GNE-6640	4-[2-Amino-4-ethyl-5-(1H-indazol-5-yl)-3-pyridinyl]phenol|Phenol, 4-[2-amino-4-ethyl-5-(1H-indazol-5-yl)-3-pyridinyl]-	-	CHEMSPIDER	61716303	C20H18N4O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZHYXJQQBKROZDX-UHFFFAOYSA-N
28563	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Kategaya L (2017)	29045385	208946	8609	GNE-6776	[3,3'-Bipyridine]-6-carboxamide, 6'-amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-|6'-Amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-3,3'-bipyridine-6-carboxamide	-	CHEMSPIDER	61716302	C20H20N4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UCYSSYGGXOFJKK-UHFFFAOYSA-N
28564	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Turnbull AP (2017)	29045389	220338	8607	FT671	4H-Pyrazolo[3,4-d]pyrimidin-4-one, 5-[[1-[(3S)-4,4-difluoro-3-(3-fluoro-1H-pyrazol-1-yl)-1-oxobutyl]-4-hydroxy-4-piperidinyl]methyl]-1-(4-fluorophenyl)-1,5-dihydro-|5-({1-[(3S)-4,4-Difluoro-3-(3-fluoro-1H-pyrazol-1-yl)butanoyl]-4-hydroxy-4-piperidinyl}methyl)-1-(4-fluorophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one	-	CHEMSPIDER	61709033	C24H23F4N7O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BLSNYSFLZAWBIV-SFHVURJKSA-N
28565	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Ritorto MS (2014)	25159004	223671	8344	BAY 11-7082	3-(p-Tolylsulfonyl)acrylonitrile|3-(p-Toluenesulfonyl)acrylonitrile|3-((4-Methylphenyl)sulfonyl)-2-propenenitrile|2-Propenenitrile, 3-((4-methylphenyl)sulfonyl)-|(E)-3-(4-Methylphenylsulfonyl)-2-propenenitrile|BAY 11-7082|(2E)-3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile|2-Propenenitrile, 3-[(4-methylphenyl)sulfonyl]-, (2E)-|(2E)-3-[(4-Methylphenyl)sulfonyl]acrylonitrile|(E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE	-	CHEMSPIDER	4510086	C10H9NO2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOEWDSDBFRHVAP-KRXBUXKQSA-N
28566	117950	27005	RP11-297K8.3	USP21	USP16|USP23	9606	Homo sapiens	inhibitor	target	Ritorto MS (2014)	25159004	223671	8344	BAY 11-7082	3-(p-Tolylsulfonyl)acrylonitrile|3-(p-Toluenesulfonyl)acrylonitrile|3-((4-Methylphenyl)sulfonyl)-2-propenenitrile|2-Propenenitrile, 3-((4-methylphenyl)sulfonyl)-|(E)-3-(4-Methylphenylsulfonyl)-2-propenenitrile|BAY 11-7082|(2E)-3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile|2-Propenenitrile, 3-[(4-methylphenyl)sulfonyl]-, (2E)-|(2E)-3-[(4-Methylphenyl)sulfonyl]acrylonitrile|(E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE	-	CHEMSPIDER	4510086	C10H9NO2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOEWDSDBFRHVAP-KRXBUXKQSA-N
28567	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	inhibitor	target	Koszela J (2018)	30097011	214402	8344	BAY 11-7082	3-(p-Tolylsulfonyl)acrylonitrile|3-(p-Toluenesulfonyl)acrylonitrile|3-((4-Methylphenyl)sulfonyl)-2-propenenitrile|2-Propenenitrile, 3-((4-methylphenyl)sulfonyl)-|(E)-3-(4-Methylphenylsulfonyl)-2-propenenitrile|BAY 11-7082|(2E)-3-[(4-methylphenyl)sulfonyl]prop-2-enenitrile|2-Propenenitrile, 3-[(4-methylphenyl)sulfonyl]-, (2E)-|(2E)-3-[(4-Methylphenyl)sulfonyl]acrylonitrile|(E)-3-(P-TOLUENESULFONYL)ACRYLONITRILE	-	CHEMSPIDER	4510086	C10H9NO2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOEWDSDBFRHVAP-KRXBUXKQSA-N
28568	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	De Cesare V (2018)	30017913	216529	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Positive hit in high screen assay validated by IC-50 determination.	HTQMVQVXFRQIKW-UHFFFAOYSA-N
28569	120389	55072	-	RNF31	HOIP|ZIBRA	9606	Homo sapiens	inhibitor	target	De Cesare V (2018)	30017913	216529	8091	Bendamustine	Ribomustine	treanda|bendeka	DRUGBANK	DB06769	C16H21Cl2N3O2	small molecule	L01AA09	16506-27-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Positive hit in high screen assay validated by IC-50 determination.	YTKUWDBFDASYHO-UHFFFAOYSA-N
28570	121411	57154	-	SMURF1	-	9606	Homo sapiens	inhibitor	target	Tian M (2019)	30587574	216560	8602	HS-152	4-Chloro-N-({3-[(4-methyl-1-piperazinyl)carbonyl]phenyl}carbamoyl)benzamide|Benzamide, 4-chloro-N-[[[3-[(4-methyl-1-piperazinyl)carbonyl]phenyl]amino]carbonyl]-	-	CHEMSPIDER	88296224	C20H21ClN4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OTPUQDJJEKBVQM-UHFFFAOYSA-N
28572	122265	64750	-	SMURF2	-	9606	Homo sapiens	inhibitor	target	Tian M (2019)	30587574	216560	8602	HS-152	4-Chloro-N-({3-[(4-methyl-1-piperazinyl)carbonyl]phenyl}carbamoyl)benzamide|Benzamide, 4-chloro-N-[[[3-[(4-methyl-1-piperazinyl)carbonyl]phenyl]amino]carbonyl]-	-	CHEMSPIDER	88296224	C20H21ClN4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Likely antagonist of the catalytic activity of the HECT domain in SMURF1/2.	OTPUQDJJEKBVQM-UHFFFAOYSA-N
28573	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Wang Y (2018)	30254335	212629	8589	IU1-248	Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]-|4-{3-[(4-Hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl}benzonitrile	-	CHEMSPIDER	88296270	C20H23N3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WFOUOZGIXDMUJU-UHFFFAOYSA-N
28574	114551	9097	-	USP14	TGT	9606	Homo sapiens	inhibitor	target	Wang Y (2018)	30254335	212629	8587	IU1-206	Ethanone, 1-[1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(4-hydroxy-1-piperidinyl)-|1-[1-(4-Chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(4-hydroxy-1-piperidinyl)ethanone	-	CHEMSPIDER	30575231	C19H23ClN2O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ORYIJHQLVLSPRM-UHFFFAOYSA-N
28575	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	inhibitor	target	Li H (2018)	30181285	215711	8612	D19	2-[(E)-(1,3-Benzothiazol-2-ylhydrazono)methyl]-1-benzothiophene-3-ol|Benzo[b]thiophene-2-carboxaldehyde, 3-hydroxy-, 2-(2-benzothiazolyl)hydrazone	-	CHEMSPIDER	88294931	C16H11N3OS2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NJUBGVFAHILBQL-RQZCQDPDSA-N
28576	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou B (2018)	28339196	211345	8466	Bivalent ligand 39	BETd-260|Bivalent_ligand_39	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: BETd-260(CRBN:thalidomide --- BDR4:HJB97 (compound 8))	-
28578	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou B (2018)	28339196	211345	8466	Bivalent ligand 39	BETd-260|Bivalent_ligand_39	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: BETd-260(CRBN:thalidomide --- BDR2:HJB97 (compound 8))	-
28580	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou B (2018)	28339196	211345	8466	Bivalent ligand 39	BETd-260|Bivalent_ligand_39	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: BETd-260(CRBN:thalidomide --- BDR3:HJB97 (compound 8))	-
28582	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yang K (2018)	29871848	223608	8529	Bivalent ligand 46	dHDAC6|Bivalent_ligand_46	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: dHDAC6(CRBN:pomalidomide --- HDAC6:pan-HDAC inhibitor AB3)	-
28584	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun Y (2018)	29875397	223609	8530	Bivalent ligand 47	P13|Bivalent_ligand_47	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: P13I(CRBN:pomalidomide --- BTK:Ibrutinib)	-
28586	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Testa A (2018)	29949369	213521	8431	Bivalent ligand 65	Bivalent_ligand_65|PROTAC 15a	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 15a (VHL: F-Hyp-containing HIF-1 epitope peptide --- BRD4:JQ1)	-
28588	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zorba A (2018)	30012605	215437	8496	Bivalent ligand 66	PROTAC9|PROTAC10|Bivalent_ligand_66	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 9/10 (CRBN:pomalidomide --- BTK:phenyl-pyrazole derivative analog)	-
28590	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qin C (2018)	30019901	215015	8497	Bivalent ligand 67	QCA570|Bivalent_ligand_67	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: QCA570 (CRBN:thalidomide --- BDR4: QCA276 (BET inhibitor 22))	-
28592	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qin C (2018)	30019901	215015	8497	Bivalent ligand 67	QCA570|Bivalent_ligand_67	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: QCA570 (CRBN:thalidomide --- BDR2: QCA276 (BET inhibitor 22))	-
28594	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qin C (2018)	30019901	215015	8497	Bivalent ligand 67	QCA570|Bivalent_ligand_67	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: QCA570 (CRBN:thalidomide --- BDR3: QCA276 (BET inhibitor 22))	-
28596	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Song Y (2019)	30962579	220135	8498	Bivalent ligand 68	WL40|Bivalent_ligand_68	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116235	11047	-	ADRM1	ARM-1|ARM1|GP110	9606	Homo sapiens	target	Standardized BVL Name: WL40 (CRBN:thalidomide --- RPN13:RA190)	-
28598	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2019)	30672516	223610	8510	Bivalent ligand 71	CRBN-6-5-5-VHL|Bivalent_ligand_71	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	target	Standardized BVL Name: (VHL:VH298 ---CRBN:pomalidomide)	-
28600	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smith BE (2019)	30631068	219514	8512	Bivalent ligand 72	SJFa PROTAC|Bivalent_ligand_72	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	target	SJFalpha PROTAC|Standardized BVL Name: (VHL:ligand 7 ---MAPK1:Foretinib)	-
28602	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smith BE (2019)	30631068	219514	8511	Bivalent ligand 73	SJFd PROTAC|Bivalent_ligand_73	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	target	SJFDelta PROTAC|Standardized BVL Name: (VHL:ligand 7 ---MAPK1:Foretinib)	-
28604	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Han X (2019)	30629437	223611	8514	Bivalent ligand 74	ARD-69|Bivalent_ligand_74	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	ARD-69|Standardized BVL Name: (VHL:VHL-e ---AR:enzalutamide)	-
28606	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Krajcovicova S (2019)	30601480	214852	8513	Bivalent ligand 75	8c|Bivalent_ligand_75	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	8c|Standardized BVL Name: (CRBN:thalidomide ---BTK:Despropenoylibrutinib)	-
28608	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Brand M (2019)	30595531	214853	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	BSJ-03-123|Standardized BVL Name: (CRBN:pomalidomide ---CDK6: palbociclib)	-
28610	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bian J (2018)	30196207	214922	8515	Bivalent ligand 77	compund 11c|Bivalent_ligand_77	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	11c|Standardized BVL Name: (CRBN:pomalidomide ---CDK9:wogonin)	-
28612	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Rana S (2019)	30935795	215476	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:pomalidomide ---CDK6: palbociclib)	-
28614	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	DeMars KM (2019)	30872008	215612	8445	Bivalent ligand 15	Bivalent_ligand_15|dBET1|dBET6	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: dBET1(CRBN:thalidomide --- BRD4:JQ1)	-
28616	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Hines J (2019)	30385614	215621	8518	Bivalent ligand 78	A1874|Bivalent_ligand_78	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: A1874(MDM2:idasanutlin --- BRD4:JQ1)	-
28618	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Tinworth CP (2019)	30807093	215660	8517	Bivalent ligand 79	Protac 3|Bivalent_ligand_79	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 3 ( CIAP1:piperazine --- BTK:ibrutinib)	-
28620	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li Y (2019)	30525597	223612	8490	Bivalent ligand 82	MD-224|Bivalent_ligand_82	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	target	Standardized BVL Name: MD-224 (CRBN:lenalidomide --- MDM2:MI-1061)	-
28622	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Olson CM (2018)	29251720	214651	8491	Bivalent ligand 83	THAL-SNS-032|Bivalent_ligand_83	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: THAL-SNS-032 (CRBN: thalidomide --- CDK9:SNS-032)	-
28624	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Burslem GM (2018)	29129716	211414	8492	Bivalent ligand 84	Compound 1|Bivalent_ligand_84	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 1 (VHL: compound 15 --- EGFR:lapatinib)	-
28626	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Burslem GM (2018)	29129716	211414	8492	Bivalent ligand 84	Compound 1|Bivalent_ligand_84	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108376	2064	-	ERBB2	CD340|HER-2|HER-2/neu|HER2|MLN 19|NEU|NGL|TKR1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 1(VHL: compound 15 --- ERBB2:lapitinib)	-
28628	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Burslem GM (2018)	29129716	211414	8468	Bivalent ligand 85	Compound 7|Bivalent_ligand_85	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 7 (VHL: compound 15 --- MET:foretinib)	-
28630	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Gechijian LN (2018)	29507391	223613	8494	Bivalent ligand 86	dTRIM24|Bivalent_ligand_86	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	target	Standardized BVL Name: dTRIM24 (VHL:VL-269 --- TRIM24:IACS-7e)	-
28632	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen H (2019)	30901674	215477	8495	Bivalent ligand 87	Compound 2|Bivalent_ligand_87	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: Compound 2 (CRBN:pomalidomide ---BRAF: BRAF ligand)	-
28634	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2018)	30118587	223614	8484	Bivalent ligand 88	Compound 15a|Bivalent_ligand_88	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	target	Standardized BVL Name: Compound 15a (CRBN:pomalidomide ---CRBN:pomalidomide)	-
28636	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Farnaby W (2019)	31178587	223615	8485	Bivalent ligand 89	ACBI1|Bivalent_ligand_89	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112479	6595	-	SMARCA2	BAF190|BRM|NCBRS|SNF2|SNF2L2|SNF2LA|SWI2|Sth1p|hBRM|hSNF2a	9606	Homo sapiens	target	Standardized BVL Name: ACBI1 (VHL:VH298 --- SMARCA2:SMARCABD ligand)	-
28638	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Farnaby W (2019)	31178587	223615	8485	Bivalent ligand 89	ACBI1|Bivalent_ligand_89	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112481	6597	-	SMARCA4	BAF190|BAF190A|BRG1|MRD16|RTPS2|SNF2|SNF2L4|SNF2LB|SWI2|hSNF2b	9606	Homo sapiens	target	Standardized BVL Name: ACBI1 (VHL:VH298 --- SMARCA4:SMARCABD ligand)	-
28640	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Farnaby W (2019)	31178587	223615	8485	Bivalent ligand 89	ACBI1|Bivalent_ligand_89	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120490	55193	-	PBRM1	BAF180|PB1	9606	Homo sapiens	target	Standardized BVL Name: ACBI1 (VHL:VH298 --- PBRM1:SMARCABD ligand)	-
28642	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Popow J (2019)	30739444	223616	8546	Bivalent ligand 90	BI-3663|Bivalent_ligand_90	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: BI-3663 (CRBN:pomalidomide --- PTK2:BI-4464)	-
28644	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang X (2019)	31209349	220534	8545	Bivalent ligand 91	KB02-SLF|Bivalent_ligand_91	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	small molecule|Standardized BVL Name: KB02-SLF (DCAF16:KB02 --- FKBP12:SLF)	-
28646	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang X (2019)	31209349	220534	8544	Bivalent ligand 92	KB02-JQ1|Bivalent_ligand_92	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	small molecule|Standardized BVL Name: KB02-JQ1 (DCAF16:KB02 --- BRD4:JQ1)	-
28648	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Tovell H (2019)	30978004	220718	8543	Bivalent ligand 93	HaloPROTAC-E|Bivalent_ligand_93	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	117195	23678	-	SGK3	CISK|SGK2|SGKL	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- HaloTag7-SGK3)	-
28650	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Tovell H (2019)	30978004	220718	8543	Bivalent ligand 93	HaloPROTAC-E|Bivalent_ligand_93	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	111307	5289	-	PIK3C3	VPS34|hVps34	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- HaloTag7-PIK3C3)	-
28652	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Z (2019)	31389699	220719	8542	Bivalent ligand 94	PROTAC C3|Bivalent_ligand_94	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110338	4170	-	MCL1	BCL2L3|EAT|MCL1-ES|MCL1L|MCL1S|Mcl-1|TM|bcl2-L-3|mcl1/EAT	9606	Homo sapiens	target	Standardized BVL Name: PROTAC C3 (CRBN:pomalidomide ---MCL1:Nap-1)	-
28654	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Z (2019)	31389699	220719	8504	Bivalent ligand 95	PROTAC C5|Bivalent_ligand_95	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	target	Standardized BVL Name: PROTAC C5 (CRBN:pomalidomide ---BCL2:S1-6)	-
28656	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Remillard D (2017)	28418626	207027	8503	Bivalent ligand 96	dBRD9|Bivalent_ligand_96	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122430	65980	UNQ3040/PRO9856	BRD9	LAVS3040|PRO9856	9606	Homo sapiens	target	Standardized BVL Name: Compound 6 (dBRD9) (CRBN:pomalidomide --- BRD9:GSK-3)	-
28658	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Q (2019)	31539241	220727	8502	Bivalent ligand 97	SIAIS178|Bivalent_ligand_97	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SIAIS178 (VHL:VHL1 --- BCR-ABL:dasatinib)	-
28660	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Posternak G (2020)	32778845	223178	8501	Bivalent ligand 98	P4B|Bivalent_ligand_98	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: P4B(CRBN:pomalidomide --- BRAF:BI 882370)	-
28662	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Burslem GM (2019)	31311809	223347	8506	Bivalent ligand 100	GMB-475|Bivalent_ligand_100	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: GMB-475(VHL:VHL1 --- BCR-ABL1:GNF-5)	-
28664	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Burslem GM (2018)	30427680	223617	8507	Bivalent ligand 101	FLT-3 PROTAC|Bivalent_ligand_101	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	target	Standardized BVL Name: FLT-3 PROTAC(VHL:VHL1 --- FLT3:quizartinib)	-
28666	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wei J (2019)	31730343	223618	8508	Bivalent ligand 102	MS432N|Bivalent_ligand_102	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	target	Standardized BVL Name: MS432N(VHL:VHL1 --- MAP2K1:PD0325901)	-
28668	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wei J (2019)	31730343	223618	8508	Bivalent ligand 102	MS432N|Bivalent_ligand_102	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111591	5605	-	MAP2K2	CFC4|MAPKK2|MEK2|MKK2|PRKMK2	9606	Homo sapiens	target	Standardized BVL Name: MS432N(VHL:VHL1 --- MAP2K2:PD0325901)	-
28670	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hatcher JM (2018)	29937979	223355	8509	Bivalent ligand 103	JH-XI-10-02|Bivalent_ligand_103	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107458	1024	-	CDK8	K35	9606	Homo sapiens	target	Standardized BVL Name: JH-XI-10-02 (CRBN:pomalidomide --- CDK8:JH-VIII-49)	-
28672	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Tovell H (2019)	31461270	222512	8483	Bivalent ligand 104	SGK3-PROTAC1|Bivalent_ligand_104	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117195	23678	-	SGK3	CISK|SGK2|SGKL	9606	Homo sapiens	target	Standardized BVL Name: SGK3-PROTAC1 (VHL:VH032 --- SGK3:308-R)	-
28674	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Cromm PM (2018)	30444612	223619	8557	Bivalent ligand 105	PROTAC-3|Bivalent_ligand_105	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-3 (VHL:SAR --- PTK2:defactinib)	-
28676	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Chan KH (2018)	28595007	223620	8539	Bivalent ligand 106	MZP-54|MZP-55|Bivalent_ligand_106	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: MZP-55 (VHL: --- BRD4:I-BET726)	-
28678	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chan KH (2018)	28595007	223620	8408	Bivalent ligand 45	Bivalent_ligand_45|ARV-825	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: ARV-825(CRBN:pomalidomide --- BRD4:OTX015)	-
28680	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Chan KH (2018)	28595007	223620	8407	Bivalent ligand 44	Bivalent_ligand_44|compound MZ1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound MZ1(VHL:VHL-1 --- BRD4:JQ1)	-
28682	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Q (2019)	30540295	223621	8505	Bivalent ligand 107	compound-3|Bivalent_ligand_107	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: compound-3 (MDM2:nutlin-3 --- PARP1:niraparib)	-
28684	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Khan S (2019)	31792461	223622	8499	Bivalent ligand 108	DT2216|Bivalent_ligand_108	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: DT2216 (VHL:VHL-L --- BCL2L1:ABT263)	-
28686	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang F (2020)	31813613	223623	8500	Bivalent ligand 109	compound 21|Bivalent_ligand_109	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound 21 (CRBN:pomalidomide --- BRD4:compound 5)	-
28688	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yang J (2019)	31560543	223624	8470	Bivalent ligand 110	MG-277|Bivalent_ligand_110	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: MG-277 (CRBN:lenalidomide --- GSPT1:MI-2103)	-
28690	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Chi JJ (2019)	31669221	222989	8469	Bivalent ligand 111	CP5V|Bivalent_ligand_111	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107427	991	-	CDC20	CDC20A|bA276H19.3|p55CDC	9606	Homo sapiens	target	Standardized BVL Name: CP5V (VHL:VHL1 --- CDC20:apcin-A)	-
28692	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zoppi V (2019)	30540463	223625	8493	Bivalent ligand 112	VZ185|Bivalent_ligand_112	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122430	65980	UNQ3040/PRO9856	BRD9	LAVS3040|PRO9856	9606	Homo sapiens	target	Standardized BVL Name: VZ185 (VHL:VHL4 --- BRD9: BRDL1)	-
28694	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zoppi V (2019)	30540463	223625	8493	Bivalent ligand 112	VZ185|Bivalent_ligand_112	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118883	29117	-	BRD7	BP75|CELTIX1|NAG4	9606	Homo sapiens	target	Standardized BVL Name: VZ185 (VHL:VHL4 --- BRD7: BRDL1)	-
28696	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bai L (2019)	31715132	223626	8467	Bivalent ligand 113	SD-36|Bivalent_ligand_113	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112651	6774	-	STAT3	ADMIO|APRF|HIES	9606	Homo sapiens	target	Standardized BVL Name: SD-36 (CRBN:lenalidomide --- STAT3:SI-109)	-
28698	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Papatzimas JW (2019)	31117518	220896	8571	Bivalent ligand 114	dMCL1-2|Bivalent_ligand_114	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110338	4170	-	MCL1	BCL2L3|EAT|MCL1-ES|MCL1L|MCL1S|Mcl-1|TM|bcl2-L-3|mcl1/EAT	9606	Homo sapiens	target	Standardized BVL Name: dMCL1-2 (CRBN:4-hydroxythalidomide --- MCL1:A-1210477)	-
28700	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kim K (2019)	31873151	223627	8570	Bivalent ligand 115	TD-165|Bivalent_ligand_115	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	target	Standardized BVL Name: TD-165 (VHL:VHL032 --- CRBN:pomalidomide)	-
28702	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen H (2019)	30901674	215477	8569	Bivalent ligand 116	compound 2|Bivalent_ligand_116	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: compound 2 (CRBN:pomalidomide --- B-RAF:B-RAF ligand)	-
28704	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	BasuRay S (2019)	31019090	223628	8568	Bivalent ligand 117	PROTAC3|Bivalent_ligand_117	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	228103	116939	-	Pnpla3	Adpn	10090	Mus musculus	target	Standardized BVL Name: PROTAC3 (VHL:hydroxyproline derivative  --- Pnpla3:HaloTag)	-
28706	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun Y (2019)	30858551	223629	8487	Bivalent ligand 118	L18I|Bivalent_ligand_118	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: L18I (CRBN:lenalidomide --- BTK:ibrutinib)	-
28708	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Nunes J (2019)	31312412	223630	8486	Bivalent ligand 119	compound 9|Bivalent_ligand_119	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (VHL:VHL ligand --- IRAK4: PF-06650833)	-
28710	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- PTK2B:TL13-87)	-
28712	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- AURKA:TL13-87)	-
28714	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- PTK2:TL13-87)	-
28716	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- BTK:TL13-87)	-
28718	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- TEC:TL13-87)	-
28720	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- FLT3:TL13-87)	-
28722	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108533	2242	-	FES	FPS	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- FES:TL13-87)	-
28724	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- AAK1:TL13-87)	-
28726	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- ULK1:TL13-87)	-
28728	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK12:TL13-87)	-
28730	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- FER:TL13-87)	-
28732	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- AURKB:TL13-87)	-
28734	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK13:TL13-87)	-
28736	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- MARK2:TL13-87)	-
28738	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- WEE1:TL13-87)	-
28740	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK7:TL13-87)	-
28742	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK17:TL13-87)	-
28744	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- GAK:TL13-87)	-
28746	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK5:TL13-87)	-
28748	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK6:TL13-87)	-
28750	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK2:TL13-87)	-
28752	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK9:TL13-87)	-
28754	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK4:TL13-87)	-
28756	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- PRKAA1:TL13-87)	-
28758	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- LIMK2:TL13-87)	-
28760	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- BLK:TL13-87)	-
28762	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- ITK:TL13-87)	-
28764	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- LCK:TL13-87)	-
28766	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8538	Bivalent ligand 121	TL13-117|Bivalent_ligand_121	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	target	Standardized BVL Name: TL13-117 (CRBN:pomalidomide --- FLT3:AC220)	-
28768	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8535	Bivalent ligand 122	CJH-005-067|Bivalent_ligand_122	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: CJH-005-067 (CRBN:pomalidomide --- BTK:bosutinib)	-
28770	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang HT (2018)	29129717	211728	8536	Bivalent ligand 123	DD-04-015|Bivalent_ligand_123	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DD-04-015 (CRBN:pomalidomide --- BTK:RN486)	-
28772	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qiu X (2019)	31066567	223631	8533	Bivalent ligand 124	SIAIS213110|Bivalent_ligand_124	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: SIAIS213110 (CRBN:lenalidomide --- BRD2:JQ1-acid)	-
28774	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qiu X (2019)	31066567	223631	8533	Bivalent ligand 124	SIAIS213110|Bivalent_ligand_124	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: SIAIS213110 (CRBN:lenalidomide --- BRD3:JQ1-acid)	-
28776	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qiu X (2019)	31066567	223631	8533	Bivalent ligand 124	SIAIS213110|Bivalent_ligand_124	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: SIAIS213110 (CRBN:lenalidomide --- BRD4:JQ1-acid)	-
28778	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lebraud H (2016)	28058282	223632	8534	Bivalent ligand 125	JQ1-CLIPTAC|Bivalent_ligand_125	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	CLIPTAC	PROTAC variant formed in cells by click chemistry; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: JQ1-CLIPTAC (CRBN:Tz-thalidomide --- BRD4:JQ1)	-
28780	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lebraud H (2016)	28058282	223632	8531	Bivalent ligand 126	ERK-CLIPTAC|Bivalent_ligand_126	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	CLIPTAC	PROTAC variant formed in cells by click chemistry; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111581	5595	-	MAPK3	ERK-1|ERK1|ERT2|HS44KDAP|HUMKER1A|P44ERK1|P44MAPK|PRKM3|p44-ERK1|p44-MAPK	9606	Homo sapiens	target	Standardized BVL Name: ERK-CLIPTAC (CRBN:Tz-thalidomide --- MAPK3:Probe 1)	-
28782	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lebraud H (2016)	28058282	223632	8531	Bivalent ligand 126	ERK-CLIPTAC|Bivalent_ligand_126	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	CLIPTAC	PROTAC variant formed in cells by click chemistry; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111580	5594	-	MAPK1	ERK|ERK-2|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk|p42-MAPK	9606	Homo sapiens	target	Standardized BVL Name: ERK-CLIPTAC (CRBN:Tz-thalidomide --- MAPK1:Probe 1)	-
28784	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao Y (2020)	32840532	223633	8532	Bivalent ligand 127	XZ9002|Bivalent_ligand_127	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: XZ9002 (VHL:VH032 --- HDAC3:SR-3558)	-
28786	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	de Wispelaere M (2019)	31371704	223634	8540	Bivalent ligand 128	DGY-08-097|Bivalent_ligand_128	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205534	951475	HCVgp1	HCVgp1	-	11103	Hepatitus C Virus	target	Standardized BVL Name: DGY-08-097(CRBN:tricyclic imide --- NS3/4A:telaprevir; Coronavirus Project; Target UniProt ID P0C045 (NS3/4A))	-
28788	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Degorce SL (2020)	32803978	223635	8541	Bivalent ligand 129	PROTAC 23|Bivalent_ligand_129	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116382	11213	-	IRAK3	ASRT5|IRAKM	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 23 (CRBN:W2 --- IRAK3:compound 5)	-
28790	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2020)	32201871	223636	8520	Bivalent ligand 130	compound 4|Bivalent_ligand_130	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: compound 4 (VHL:VHL ligand --- HDAC1:CI-994)	-
28792	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2020)	32201871	223636	8520	Bivalent ligand 130	compound 4|Bivalent_ligand_130	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	target	Standardized BVL Name: compound 4 (VHL:VHL ligand --- HDAC2:CI-994)	-
28794	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2020)	32201871	223636	8520	Bivalent ligand 130	compound 4|Bivalent_ligand_130	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: compound 4 (VHL:VHL ligand --- HDAC3:CI-994)	-
28836	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	degradation	lysosome-targeting protein	Banik SM (2020)	32728216	223640	8526	Bivalent ligand 136	Ab-2|Bivalent_ligand_136	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: Ab-2 (IGF2R:M6Pn glycopolypeptide ligand --- EGFR:cetuximab)	-
28838	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	degradation	lysosome-targeting protein	Banik SM (2020)	32728216	223640	8525	Bivalent ligand 137	Ab-3|Bivalent_ligand_137	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: Ab-3 (IGF2R:M6Pn glycopolypeptide ligand --- CD274:PD-L1 antibody)	-
28840	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wang M (2020)	32437146	223641	8528	Bivalent ligand 138	SHP2-D26|Bivalent_ligand_138	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	target	Standardized BVL Name: SHP2-D26 (VHL:VHL-1 ligand 6 --- PTPN11:compound 5)	-
28842	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Sun N (2020)	32179332	223642	8527	Bivalent ligand 139	SIAIS117|Bivalent_ligand_139	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: SIAIS117 (VHL:VHL-1 --- ALK:brigatinib)	-
28844	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	McCoull W (2018)	30335946	223643	8558	Bivalent ligand 140	PROTAC 15|Bivalent_ligand_140	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107076	604	-	BCL6	BCL5|BCL6A|LAZ3|ZBTB27|ZNF51	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 15 (CRBN:thalidomide --- BCL6:BCL6 ligand)	-
28846	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Mu X (2020)	31708096	223603	8559	Bivalent ligand 141	HBL-4|Bivalent_ligand_141	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: HBL-4  (CRBN:thalidomide --- BRD4:BI2536)	-
28848	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Mu X (2020)	31708096	223603	8559	Bivalent ligand 141	HBL-4|Bivalent_ligand_141	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: HBL-4  (CRBN:thalidomide --- PLK1:BI2536)	-
28850	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---ZFP91:pomalidomide)	-
28852	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---ZFP91:lenalidomide)	-
28854	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:thalidomide ---ZFP91:thalidomide)	-
28856	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	124982	92822	-	ZNF276	CENP-Z|CENPZ|ZADT|ZFP276|ZNF477	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---ZNF276:pomalidomide)	-
28858	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	125464	115950	-	ZNF653	E430039K05Rik|ZIP67	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---ZNF653:pomalidomide)	-
28860	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	125464	115950	-	ZNF653	E430039K05Rik|ZIP67	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---ZNF653:lenalidomide)	-
28862	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	120789	55657	-	ZNF692	AREBP|Zfp692	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---ZNF692:pomalidomide)	-
28864	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	120789	55657	-	ZNF692	AREBP|Zfp692	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---ZNF692:lenalidomide)	-
28866	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	120789	55657	-	ZNF692	AREBP|Zfp692	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:thalidomide ---ZNF692:thalidomide)	-
28868	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	127447	152485	-	ZNF827	-	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---ZNF827:pomalidomide)	-
28870	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	127447	152485	-	ZNF827	-	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---ZNF827:lenalidomide)	-
28872	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	127447	152485	-	ZNF827	-	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:thalidomide ---ZNF827:thalidomide)	-
28874	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---IKZF3:pomalidomide)	-
28876	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---IKZF3:lenalidomide)	-
28878	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:pomalidomide ---IKZF1:pomalidomide)	-
28880	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---IKZF1:lenalidomide)	-
28882	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121845	58525	-	WIZ	ZNF803	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:lenalidomide ---WIZ:lenalidomide)	-
28884	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sievers QL (2018)	30385546	212829	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121845	58525	-	WIZ	ZNF803	9606	Homo sapiens	target	Full length protein degraded in vivo|Standardized BVL Name: (CRBN:CC-122 ---WIZ:CC-122)	-
28886	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Crew AP (2018)	28692295	217494	8488	Bivalent ligand 80	PROTAC 3i|Bivalent_ligand_80	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118878	29110	-	TBK1	NAK|T2K	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 3i (VHL:VHL ligand 2 ---TBK1:ligand 1b)	-
28888	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li Z (2020)	31735695	223644	8489	Bivalent ligand 81	Bivalent_ligand_81	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:pomalidomide ---Wee1:ZNL-02-096)	-
28890	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Shan Y (2020)	32750566	223645	8563	Bivalent ligand 145	PROTAC 5|Bivalent_ligand_145	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 5(VHL:VH032 ---KDR:ABT-869)	-
28892	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	degradation	recruited e3 ligase	Li L (2020)	32713946	223646	8564	Bivalent ligand 146	DP1|Bivalent_ligand_146	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: DP1(DCAF15:E7820 --- BRD4:JQ1)	-
28894	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu Y (2020)	32717479	223647	8565	Bivalent ligand 147	Compound 11|Bivalent_ligand_147	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118953	29904	-	EEF2K	HSU93850|eEF-2K	9606	Homo sapiens	target	Standardized BVL Name: Compound 11l (CRBN:thalidomide --- EEF2K:A484954)	-
28896	111105	5071	KB-152G3.1	PARK2	AR-JP|LPRS2|PDJ|PRKN	9606	Homo sapiens	degradation	recruited e3 ligase	Schiedel M (2020)	32672888	223648	8566	Bivalent ligand 148	chloroalkylated SirReal 11|Bivalent_ligand_148	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	target	Standardized BVL Name: chloroalkylated SirReal 11 (HaloTag-PRKN--- SIRT2:SirReal3)	-
28898	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Simpson LM (2020)	32668203	223649	8567	Bivalent ligand 149	HaloPROTAC-E|Bivalent_ligand_149	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- ULK1-GFP:GFP-HaloTag)	-
28900	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Simpson LM (2020)	32668203	223649	8567	Bivalent ligand 149	HaloPROTAC-E|Bivalent_ligand_149	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	123547	81610	-	FAM83D	C20orf129|CHICA|dJ616B8.3	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- FAM83D-GFP:GFP-HaloTag)	-
28902	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Simpson LM (2020)	32668203	223649	8567	Bivalent ligand 149	HaloPROTAC-E|Bivalent_ligand_149	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	117195	23678	-	SGK3	CISK|SGK2|SGKL	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- SGK3-GFP:GFP-HaloTag)	-
28904	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Simpson LM (2020)	32668203	223649	8567	Bivalent ligand 149	HaloPROTAC-E|Bivalent_ligand_149	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- HRAS:RASabHaloTag)	-
28906	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Simpson LM (2020)	32668203	223649	8567	Bivalent ligand 149	HaloPROTAC-E|Bivalent_ligand_149	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-E (VHL:VH298 --- KRAS:RASabHaloTag)	-
28908	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Barrios AM (2020)	32615037	223650	8550	Bivalent ligand 150	compound 26|Bivalent_ligand_150	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	target	Standardized BVL Name: compound 26 (VHL:VHL ligand --- PTPN11:SHP099)	-
28910	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cheng J (2020)	32603594	223651	8549	Bivalent ligand 151	compound 17f|Bivalent_ligand_151	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111173	5147	-	PDE6D	JBTS22|PDED	9606	Homo sapiens	target	Standardized BVL Name: compound 17f (CRBN:pomalidomide --- PDE6D:deltazinone)	-
28912	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donoghue C (2020)	32634680	223652	8548	Bivalent ligand 152	NR-7h|Bivalent_ligand_152	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: NR-7h (CRBN:thalidomide --- MAPK14:PH-797804)	-
28914	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donoghue C (2020)	32634680	223652	8548	Bivalent ligand 152	NR-7h|Bivalent_ligand_152	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111586	5600	-	MAPK11	P38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta	9606	Homo sapiens	target	Standardized BVL Name: NR-7h (CRBN:thalidomide --- MAPK11:PH-797804)	-
28916	120991	55905	-	RNF114	PSORS12|ZNF313	9606	Homo sapiens	degradation	recruited e3 ligase	Tong B (2020)	32568522	223653	8547	Bivalent ligand 153	BT1|Bivalent_ligand_153	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: BT1 (RNF114:nimbolide --- BCR-ABL:dasatinib)	-
28918	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Liao H (2020)	32550000	223654	8554	Bivalent ligand 154	xStAx-VHLL|Bivalent_ligand_154	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	target	Standardized BVL Name: xStAx-VHLL (VHL:VHL ligand --- CTNNB1:xStAx)	-
28920	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Burslem GM (2020)	32519703	223655	8553	Bivalent ligand 155	GMB-805|Bivalent_ligand_155	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: GMB-805 (VHL:VHL1 --- BCR-ABL:ABL001)	-
28922	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Field SD (2020)	32501609	223656	8552	Bivalent ligand 156	Degrader 3|Bivalent_ligand_156	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116444	11313	RP5-886K2.5	LYPLA2	APT-2|DJ886K2.4	9606	Homo sapiens	target	Standardized BVL Name: Degrader 3 (CRBN:pomalidomide --- LYPLA2:fluorophosphonate reactive group)	-
28924	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gao H (2020)	32451721	223657	8551	Bivalent ligand 157	FAK-PROTAC|Bivalent_ligand_157	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	199587	14083	-	Ptk2	FAK|FRNK|Fadk|mKIAA4203|p125FAK	10090	Mus musculus	target	Standardized BVL Name: FC-11 (CRBN:pomalidomide --- Ptk2:PF562271)	-
28926	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	degradation	autophagy-targeting protein	Li Z (2020)	31690177	223658	8556	Bivalent ligand 158	ATTEC|Bivalent_ligand_158	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	109314	3064	-	HTT	HD|IT15	9606	Homo sapiens	target	Standardized BVL Name: ATTEC (MAP1LC3B --- mHTT)	-
28928	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jaime-Figueroa S (2020)	31879210	223659	8555	Bivalent ligand 159	SJF620|Bivalent_ligand_159	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: SJF620 (CRBN:lenalidomide --- BTK:Ibrutinib)	-
28930	111974	6047	RES4-26	RNF4	SLX5|SNURF	9606	Homo sapiens	degradation	recruited e3 ligase	Ward CC (2019)	31059647	220118	8477	Bivalent ligand 160	CCW 28-3|Bivalent_ligand_160	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: CCW 28-3 (RNF4:CCW 16 --- BRD4:JQ1)	-
28932	120991	55905	-	RNF114	PSORS12|ZNF313	9606	Homo sapiens	degradation	recruited e3 ligase	Spradlin JN (2019)	31209351	220371	8478	Bivalent ligand 161	XH2|Bivalent_ligand_161	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: XH2 (RNF114:nimbolide --- BRD4:JQ1)	-
28934	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Silva MC (2019)	30907729	219824	8475	Bivalent ligand 162	QC-01x96175|Bivalent_ligand_162	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: QC-01175 (CRBN:pomalidomide --- MAPT:T807)	-
28936	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8476	Bivalent ligand 163	BSJ-02-162|Bivalent_ligand_163	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ02162 (CRBN:thalidomide --- CDK4:palbociclib)	-
28938	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8476	Bivalent ligand 163	BSJ-02-162|Bivalent_ligand_163	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ02162 (CRBN:thalidomide --- CDK6:palbociclib)	-
28940	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8481	Bivalent ligand 164	BSJ-01-152|Bivalent_ligand_164	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ01152 (CRBN:thalidomide --- CDK4:ribociclib)	-
28942	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8481	Bivalent ligand 164	BSJ-01-152|Bivalent_ligand_164	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ01152 (CRBN:thalidomide --- CDK6:ribociclib)	-
28944	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8482	Bivalent ligand 165	BSJ-01-184|Bivalent_ligand_165	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ01184 (CRBN:thalidomide --- CDK4:abemaciclib)	-
28946	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8482	Bivalent ligand 165	BSJ-01-184|Bivalent_ligand_165	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ01184 (CRBN:thalidomide --- CDK6:abemaciclib)	-
28948	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8482	Bivalent ligand 165	BSJ-01-184|Bivalent_ligand_165	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: BSJ01184 (CRBN:thalidomide --- CDK9:abemaciclib)	-
28950	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8479	Bivalent ligand 166	BSJ-01-187|Bivalent_ligand_166	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ01187 (CRBN:thalidomide --- CDK4:ribociclib)	-
28952	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8480	Bivalent ligand 167	YKL-06-102|Bivalent_ligand_167	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: YKL06102 (CRBN:thalidomide --- CDK6:palbociclib)	-
28954	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8479	Bivalent ligand 166	BSJ-01-187|Bivalent_ligand_166	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: BSJ01187 (CRBN:thalidomide --- IKZF1:ribociclib)	-
28956	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8480	Bivalent ligand 167	YKL-06-102|Bivalent_ligand_167	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: YKL06102 (CRBN:thalidomide --- IZKF1:palbociclib)	-
28958	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8476	Bivalent ligand 163	BSJ-02-162|Bivalent_ligand_163	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: BSJ02162 (CRBN:thalidomide --- IZKF1:palbociclib)	-
28960	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8479	Bivalent ligand 166	BSJ-01-187|Bivalent_ligand_166	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: BSJ01187 (CRBN:thalidomide --- IKZF3:ribociclib)	-
28962	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8480	Bivalent ligand 167	YKL-06-102|Bivalent_ligand_167	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: YKL06102 (CRBN:thalidomide --- IZKF3:palbociclib)	-
28964	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8476	Bivalent ligand 163	BSJ-02-162|Bivalent_ligand_163	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: BSJ02162  (CRBN:thalidomide --- IZKF3:palbociclib)	-
28966	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8473	Bivalent ligand 168	BSJ-03-204|Bivalent_ligand_168	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ03204 (CRBN:thalidomide --- CDK4:palbociclib)	-
28968	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8473	Bivalent ligand 168	BSJ-03-204|Bivalent_ligand_168	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ03204 (CRBN:thalidomide --- CDK6:palbociclib)	-
28970	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8474	Bivalent ligand 169	BSJ-04-132|Bivalent_ligand_169	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ04132 (CRBN:thalidomide --- CDK4:ribociclib)	-
28972	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2019)	30802347	223660	8472	Bivalent ligand 170	BSJ-03-123|Bivalent_ligand_170	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ03123 (CRBN:thalidomide --- CDK6:palbociclib)	-
28974	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Ohoka N (2017)	29050782	208402	8471	Bivalent ligand 171	peptide 5|Bivalent_ligand_171	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	110913	4851	-	NOTCH1	AOS5|AOVD1|TAN1|hN1	9606	Homo sapiens	target	Standardized BVL Name: peptide 5 (BIRC2:MV1 --- NOTCH1:CSL)	-
28976	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited e3 ligase	Ohoka N (2017)	29050782	208402	8471	Bivalent ligand 171	peptide 5|Bivalent_ligand_171	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	110913	4851	-	NOTCH1	AOS5|AOVD1|TAN1|hN1	9606	Homo sapiens	target	Standardized BVL Name: peptide 5 (BIRC3:MV1 --- NOTCH1:CSL)	-
28978	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Ohoka N (2017)	29050782	208402	8471	Bivalent ligand 171	peptide 5|Bivalent_ligand_171	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	110913	4851	-	NOTCH1	AOS5|AOVD1|TAN1|hN1	9606	Homo sapiens	target	Standardized BVL Name: peptide 5 (XIAP1:MV1 --- NOTCH1:CSL)	-
29118	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	unknown	target	Murray JK (2015)	26288216	224769	9188	(1R,2As,4S,7S,10S,13S,19S,22S,25S,28S,31R,36R,39S,45R,48S,51S,54S,57R,60S,63S,66S,69S,72S,75S,78S,81S,84S,87S,90R,93S,96S,99S)-10,51,75,87-tetrakis(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-93-(3-amino-3-oxopropyl)-60,96-dibenzyl-19,28-bis[(2S)-butan-2-yl]-4,54,69-tris(3-carbamimidamidopropyl)-25-(carboxymethyl)-2a,22,39,48-tetrakis[(1R)-1-hydroxyethyl]-7,63,81-tris(hydroxymethyl)-72-[(4-hydroxyphenyl)methyl]-84-(1H-imidazol-5-ylmethyl)-99-methyl-66-(2-methylpropyl)-78-(2-methylsulfanylethyl)-1a,3,4a,6,9,12,18,21,24,27,30,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98-dotriacontaoxo-6a,7a,10a,11a,33,34-hexathia-a,2,3a,5,8,11,17,20,23,26,29,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88,91,94,97-dotriacontazatetracyclo[55.47.4.445,90.013,17]dodecahectane-36-carboxylic acid	BDBM50115771	-	PUBCHEM	122187344	C169H274N54O48S7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GVRGDWHECZKHIP-CINJXCJGSA-N
29119	109939	3736	-	KCNA1	AEMK|EA1|HBK1|HUK1|KV1.1|MBK1|MK1|RBK1	9606	Homo sapiens	unknown	target	Murray JK (2015)	26288216	224769	9189	(1R,2As,4S,7S,10S,13S,19S,22S,25S,28S,31R,36R,39S,45R,48S,51S,54S,57R,60S,63S,66S,69S,72S,75S,78S,81S,84S,87S,90R,93S,96S,99S)-10,51,75,87-tetrakis(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-93-(3-amino-3-oxopropyl)-60,96-dibenzyl-19,28-bis[(2S)-butan-2-yl]-78-butyl-4,54,69-tris(3-carbamimidamidopropyl)-25-(carboxymethyl)-2a,22,39,48-tetrakis[(1R)-1-hydroxyethyl]-7,63,81-tris(hydroxymethyl)-72-[(4-hydroxyphenyl)methyl]-84-(1H-imidazol-5-ylmethyl)-99-methyl-66-(2-methylpropyl)-1a,3,4a,6,9,12,18,21,24,27,30,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98-dotriacontaoxo-6a,7a,10a,11a,33,34-hexathia-a,2,3a,5,8,11,17,20,23,26,29,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88,91,94,97-dotriacontazatetracyclo[55.47.4.445,90.013,17]dodecahectane-36-carboxylic acid	BDBM50115767	-	PUBCHEM	122187340	C170H276N54O48S6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCAVQHJGLXITPN-HMILKZLESA-N
29120	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Murray JK (2015)	26288216	224769	9190	CID 122187346	BDBM50115773	-	PUBCHEM	122187346	C184H295N56O56PS7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IUXTUGDAYSHYDJ-UYSYBMGHSA-N
29121	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Murray JK (2015)	26288216	224769	9191	(1R,2As,4S,7S,10S,13S,19S,22S,25S,28S,31R,36R,39S,45R,48S,51S,54S,57R,60S,63S,66S,69S,72S,75S,78S,81S,84S,87S,90R,93S,96S,99S)-10,51,87-tris(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-75-(aminomethyl)-93-(3-amino-3-oxopropyl)-60,96-dibenzyl-19,28-bis[(2S)-butan-2-yl]-4,54,69-tris(3-carbamimidamidopropyl)-25-(carboxymethyl)-2a,22,39,48-tetrakis[(1R)-1-hydroxyethyl]-7,63,81-tris(hydroxymethyl)-72-[(4-hydroxyphenyl)methyl]-84-(1H-imidazol-5-ylmethyl)-99-methyl-66-(2-methylpropyl)-78-(2-methylsulfanylethyl)-1a,3,4a,6,9,12,18,21,24,27,30,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98-dotriacontaoxo-6a,7a,10a,11a,33,34-hexathia-a,2,3a,5,8,11,17,20,23,26,29,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88,91,94,97-dotriacontazatetracyclo[55.47.4.445,90.013,17]dodecahectane-36-carboxylic acid	BDBM50115772	-	PUBCHEM	122187345	C166H268N54O48S7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PFWOJTLVNOZSGQ-RIMJLNMDSA-N
29122	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Murray JK (2015)	26288216	224769	9188	(1R,2As,4S,7S,10S,13S,19S,22S,25S,28S,31R,36R,39S,45R,48S,51S,54S,57R,60S,63S,66S,69S,72S,75S,78S,81S,84S,87S,90R,93S,96S,99S)-10,51,75,87-tetrakis(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-93-(3-amino-3-oxopropyl)-60,96-dibenzyl-19,28-bis[(2S)-butan-2-yl]-4,54,69-tris(3-carbamimidamidopropyl)-25-(carboxymethyl)-2a,22,39,48-tetrakis[(1R)-1-hydroxyethyl]-7,63,81-tris(hydroxymethyl)-72-[(4-hydroxyphenyl)methyl]-84-(1H-imidazol-5-ylmethyl)-99-methyl-66-(2-methylpropyl)-78-(2-methylsulfanylethyl)-1a,3,4a,6,9,12,18,21,24,27,30,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98-dotriacontaoxo-6a,7a,10a,11a,33,34-hexathia-a,2,3a,5,8,11,17,20,23,26,29,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88,91,94,97-dotriacontazatetracyclo[55.47.4.445,90.013,17]dodecahectane-36-carboxylic acid	BDBM50115771	-	PUBCHEM	122187344	C169H274N54O48S7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GVRGDWHECZKHIP-CINJXCJGSA-N
29123	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Murray JK (2015)	26288216	224769	9189	(1R,2As,4S,7S,10S,13S,19S,22S,25S,28S,31R,36R,39S,45R,48S,51S,54S,57R,60S,63S,66S,69S,72S,75S,78S,81S,84S,87S,90R,93S,96S,99S)-10,51,75,87-tetrakis(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-93-(3-amino-3-oxopropyl)-60,96-dibenzyl-19,28-bis[(2S)-butan-2-yl]-78-butyl-4,54,69-tris(3-carbamimidamidopropyl)-25-(carboxymethyl)-2a,22,39,48-tetrakis[(1R)-1-hydroxyethyl]-7,63,81-tris(hydroxymethyl)-72-[(4-hydroxyphenyl)methyl]-84-(1H-imidazol-5-ylmethyl)-99-methyl-66-(2-methylpropyl)-1a,3,4a,6,9,12,18,21,24,27,30,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98-dotriacontaoxo-6a,7a,10a,11a,33,34-hexathia-a,2,3a,5,8,11,17,20,23,26,29,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85,88,91,94,97-dotriacontazatetracyclo[55.47.4.445,90.013,17]dodecahectane-36-carboxylic acid	BDBM50115767	-	PUBCHEM	122187340	C170H276N54O48S6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCAVQHJGLXITPN-HMILKZLESA-N
29124	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Zhang Y (2015)	26191364	212887	9192	(8S,11S,14S,17S,28S,31S,34S,37R)-37-(Cyclopropylsulfonylamino)-10,30-bis[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-14,34-bis(naphthalen-2-ylmethyl)-12,15,32,35-tetraoxo-2,23-dioxa-5,6,7,10,13,16,30,33,36-nonazahexacyclo[37.2.2.219,22.14,7.18,11.128,31]octatetraconta-1(42),4(48),5,19,21,39(43),40,45-octaene-17-carboxylic acid	BDBM50112346	-	PUBCHEM	122187534	C83H106N14O14S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MLQVQPMTZJBGEY-VGEDNRJQSA-N
29125	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Zhang Y (2015)	26191364	212887	9192	(8S,11S,14S,17S,28S,31S,34S,37R)-37-(Cyclopropylsulfonylamino)-10,30-bis[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-14,34-bis(naphthalen-2-ylmethyl)-12,15,32,35-tetraoxo-2,23-dioxa-5,6,7,10,13,16,30,33,36-nonazahexacyclo[37.2.2.219,22.14,7.18,11.128,31]octatetraconta-1(42),4(48),5,19,21,39(43),40,45-octaene-17-carboxylic acid	BDBM50112346	-	PUBCHEM	122187534	C83H106N14O14S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MLQVQPMTZJBGEY-VGEDNRJQSA-N
29126	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Holzer P (2015)	26181851	224770	9193	Nvp-cgm097	ZINC253387855|(1S)-1-(4-CHLOROPHENYL)-6-METHOXY-2-[4-[METHYL-[[4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL]METHYL]AMINO]PHENYL]-7-PROPAN-2-YLOXY-1,4-DIHYDROISOQUINOLIN-3-ONE|(S)-1-(4-CHLOROPHENYL)-7-ISOPROPOXY-6-METHOXY-2-(4-[METHYL[4-(4-METHYL-3-OXOPIPERAZIN-1-YL)-TRANS-CYCLOHEXYLMETHYL]AMINO]PHENYL)-1,4-DIHYDRO-2H-ISOQUINOLIN-3-ONE|4UF6MSL0ZH|NVP-CGM-097|KS-00000TSY|CCG-270337|US9051279, 106|(1S)-1-(4-CHLOROPHENYL)-6-METHOXY-2-[4-(METHYL{[TRANS-4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL]METHYL}AMINO)PHENYL]-7-(PROPAN-2-YLOXY)-1,4-DIHYDROISOQUINOLIN-3(2H)-ONE|EX-A1059|CS-3138|HY-15954|NVP-CGM097 (CGM-097)|NVP-CGM097|Q27454942|NCGC00390552-01|W5747|4T4|NVP CGM097|(1S)-1-(4-CHLOROPHENYL)-6-METHOXY-2-{4-[METHYL({[(1R,4R)-4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL]METHYL})AMINO]PHENYL}-7-(PROPAN-2-YLOXY)-1,2,3,4-TETRAHYDROISOQUINOLIN-3-ONE|C38H47CLN4O4|1313363-54-0|(1S)-1-(4-CHLOROPHENYL)-1,4-DIHYDRO-6-METHOXY-7-(1-METHYLETHOXY)-2-[4-[METHYL[[TRANS-4-(4-METHYL-3-OXO-1-PIPERAZINYL)CYCLOHEXYL]METHYL]AMINO]PHENYL]-3(2H)-ISOQUINOLINONE|CGM-097|(S)-1-(4-CHLOROPHENYL)-7-ISOPROPOXY-6-METHOXY-2-(4-(METHYL(((1R,4S)-4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL)METHYL)AMINO)PHENYL)-1,2-DIHYDROISOQUINOLIN-3(4H)-ONE|UNII-4UF6MSL0ZH|A16326|AS-75288|S7875|CGM097|J3.509.326E|CGM 097|BCP18308|AKOS030526402|BDBM162123	-	PUBCHEM	53240420	C38H47ClN4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CLRSLRWKONPSRQ-CPOWQTMSSA-N
29127	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9194	N-[6-[3-(5-Aminopentoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-1-methylimidazole-4-sulfonamide	NCCCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C=2N=CN(C=2)C)C=C(C=1)OCCC|BDBM50150822	-	PUBCHEM	118896579	C27H36N6O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KYGTZHDLDHFQHW-UHFFFAOYSA-N
29128	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9195	N-[6-[3-(4-Aminobutoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-1-methylimidazole-4-sulfonamide	NCCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C=2N=CN(C=2)C)C=C(C=1)OCCC|BDBM50150821	-	PUBCHEM	118896387	C26H34N6O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QVUCXHDGQWWKCE-UHFFFAOYSA-N
29129	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9196	N-[6-[3-(4-Aminobutoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-3,4-dimethoxybenzenesulfonamide	NCCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C2=CC(=C(C=C2)OC)OC)C=C(C=1)OCCC|BDBM50150820	-	PUBCHEM	118896486	C30H38N4O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QPZLILYRGDXDKP-UHFFFAOYSA-N
29130	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9197	N-[6-[3-(3-Aminopropoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-3,4-dimethoxybenzenesulfonamide	NCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C2=CC(=C(C=C2)OC)OC)C=C(C=1)OCCC|BDBM50150819	-	PUBCHEM	118896529	C29H36N4O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FUPXEMIBURHODB-UHFFFAOYSA-N
29131	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9198	N-[6-[3-[4-(Dimethylamino)butoxy]-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-3,4-dimethoxybenzenesulfonamide	1800477-30-8|Q27454585|N-[6-[3-[4-(DIMETHYLAMINO)BUTOXY]-5-PROPOXYPHENOXY]-1,3-DIMETHYL-2-OXOBENZIMIDAZOL-5-YL]-3,4-DIMETHOXYBENZENESULFONAMIDE|IACS-9571|4C1|CS-7640|HY-102000|J3.601.427J|N-(6-{3-[4-(DIMETHYLAMINO)BUTOXY]-5-PROPOXYPHENOXY}-1,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-5-YL)-3,4-DIMETHOXYBENZENESULFONAMIDE|BDBM50150818	-	PUBCHEM	91808039	C32H42N4O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HYQBRUSSCIAOOD-UHFFFAOYSA-N
29132	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9199	N-[1,3-Dimethyl-2-oxo-6-(3-propoxyphenoxy)benzimidazol-5-yl]-3,4-dimethoxybenzenesulfonamide	CN1C(N(C2=C1C=C(C(=C2)NS(=O)(=O)C1=CC(=C(C=C1)OC)OC)OC1=CC(=CC=C1)OCCC)C)=O|BDBM50150812	-	PUBCHEM	118896778	C26H29N3O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DYNNLYLIKZTWRT-UHFFFAOYSA-N
29133	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9200	N-[1,3-Dimethyl-2-oxo-6-(3-propoxyphenoxy)benzimidazol-5-yl]-1,2-dimethylimidazole-4-sulfonamide	CN1C(N(C2=C1C=C(C(=C2)NS(=O)(=O)C=1N=C(N(C=1)C)C)OC1=CC(=CC=C1)OCCC)C)=O|BDBM50150811	-	PUBCHEM	118896759	C23H27N5O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LSCCJMMALWILLE-UHFFFAOYSA-N
29134	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9201	N-[1,3-Dimethyl-6-[3-(2-methylpropoxy)phenoxy]-2-oxobenzimidazol-5-yl]-1,2-dimethylimidazole-4-sulfonamide	N-{1,3-DIMETHYL-6-[3-(2-METHYLPROPOXY)PHENOXY]-2-OXO-2,3-DIHYDRO-1H-1,3-BENZODIAZOL-5-YL}-1,2-DIMETHYL-1H-IMIDAZOLE-4-SULFONAMIDE|N-[1,3-DIMETHYL-6-[3-(2-METHYLPROPOXY)PHENOXY]-2-OXOBENZIMIDAZOL-5-YL]-1,2-DIMETHYLIMIDAZOLE-4-SULFONAMIDE|Q27454574|N-{1,3-DIMETHYL-6-[3-(2-METHYLPROPOXY)PHENOXY]-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-5-YL}-1,2-DIMETHYL-1H-IMIDAZOLE-4-SULFONAMIDE|4BK|BDBM50150808	-	PUBCHEM	91808037	C24H29N5O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QYVGOEVQCUQELI-UHFFFAOYSA-N
29135	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9202	N-[1,3-Dimethyl-2-oxo-6-[3-(oxolan-3-ylmethoxy)phenoxy]benzimidazol-5-yl]-1-methylimidazole-4-sulfonamide	CN1C(N(C2=C1C=C(C(=C2)NS(=O)(=O)C=1N=CN(C=1)C)OC1=CC(=CC=C1)OCC1COCC1)C)=O|BDBM50150761	-	PUBCHEM	118896487	C24H27N5O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XUYARXQUNNANMN-UHFFFAOYSA-N
29136	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9203	N-[6-[3-(6-Aminohexoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-1-methylimidazole-4-sulfonamide	N-(6-(3-((6-AMINOHEXYL)OXY)-5-PROPOXYPHENOXY)-1,3-DIMETHYL-2-OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOL-5-YL)-1-METHYL-1H-IMIDAZOLE-4-SULFONAMIDE|NCCCCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C=2N=CN(C=2)C)C=C(C=1)OCCC|BDBM50150758	-	PUBCHEM	118896376	C28H38N6O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZKGVLQRSNIMICL-UHFFFAOYSA-N
29137	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9204	N-[6-[3-(6-Hydroxyhexoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-1-methylimidazole-4-sulfonamide	OCCCCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C=2N=CN(C=2)C)C=C(C=1)OCCC|BDBM50150757	-	PUBCHEM	118896640	C28H37N5O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KVQHINMFWSWVOJ-UHFFFAOYSA-N
29138	114333	8805	-	TRIM24	PTC6|RNF82|TF1A|TIF1|TIF1A|TIF1ALPHA|hTIF1	9606	Homo sapiens	unknown	target	Palmer WS (2016)	26061247	224771	9205	N-[6-[3-(6-Aminohexoxy)-5-propoxyphenoxy]-1,3-dimethyl-2-oxobenzimidazol-5-yl]-3,4-dimethoxybenzenesulfonamide	NCCCCCCOC=1C=C(OC=2C(=CC3=C(N(C(N3C)=O)C)C=2)NS(=O)(=O)C2=CC(=C(C=C2)OC)OC)C=C(C=1)OCCC|BDBM50150756	-	PUBCHEM	118896472	C32H42N4O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CKWMQEHOKHQQEY-UHFFFAOYSA-N
29139	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9206	[(2S,4R)-1-[(5R,6S)-5-(4-Chloro-3-fluorophenyl)-6-(6-chloropyridin-3-yl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-4-fluoropyrrolidin-2-yl]-[(6R)-6-ethyl-4,7-diazaspiro[2.5]octan-7-yl]methanone	BDBM50069632	-	PUBCHEM	46840822	C34H38Cl2F2N6O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QUYOIFDRHGZSFZ-YABFKZQLSA-N
29140	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9207	[(2S,4R)-1-[(5R,6S)-5-(4-Chloro-3-fluorophenyl)-6-(6-chloropyridin-3-yl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-4-fluoropyrrolidin-2-yl]-[(6S)-6-methyl-4,7-diazaspiro[2.5]octan-7-yl]methanone	[(2S,4R)-1-[(5R,6S)-5-(4-CHLORO-3-FLUOROPHENYL)-6-(6-CHLOROPYRIDIN-3-YL)-6-METHYL-3-PROPAN-2-YL-5H-IMIDAZO[2,1-B][1,3]THIAZOLE-2-CARBONYL]-4-FLUOROPYRROLIDIN-2-YL]-[(6S)-6-METHYL-4,7-DIAZASPIRO[2.5]OCTAN-7-YL]METHANONE|(6S)-7-[(4R)-1-{[(5R,6S)-5-(4-CHLORO-3-FLUOROPHENYL)-6-(6-CHLOROPYRIDIN-3-YL)-3-ISOPROPYL-6-METHYL-5,6-DIHYDROIMIDAZO[2,1-B][1,3]THIAZOL-2-YL]CARBONYL}-4-FLUORO-L-PROLYL]-6-METHYL-4,7-DIAZASPIRO[2.5]OCTANE|BDBM50069631	-	PUBCHEM	46840819	C33H36Cl2F2N6O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OKIDBNYMCUVSLU-QSSUNTQZSA-N
29141	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9208	[(2S,5R)-1-[(5R,6S)-5-(4-Chloro-3-fluorophenyl)-6-(6-chloropyridin-3-yl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-[(6S)-6-methyl-4,7-diazaspiro[2.5]octan-7-yl]methanone	BDBM50069630	-	PUBCHEM	87252803	C34H39Cl2FN6O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KUZMUIBQNCSWPP-BYJYTBDMSA-N
29142	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9209	[(2S,5R)-1-[(5R,6S)-5-(4-Chloro-3-fluorophenyl)-6-(6-chloropyridin-3-yl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-(4,7-diazaspiro[2.5]octan-7-yl)methanone	BDBM50069629	-	PUBCHEM	87252745	C33H37Cl2FN6O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FZPRQVYQBJKIQG-KERGWKIMSA-N
29143	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9210	[(2S,5R)-1-[(5R,6S)-5-(4-Chloro-3-fluorophenyl)-6-(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-(4,7-diazaspiro[2.5]octan-7-yl)methanone	BDBM50069628	-	PUBCHEM	67058381	C34H38Cl2FN5O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LIFXVTDIRXSOPW-ZNGXGWPMSA-N
29144	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9211	[(2S,5R)-1-[(5R,6S)-5,6-Bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-(4,7-diazaspiro[2.5]octan-7-yl)methanone	BDBM50069627	-	PUBCHEM	44596000	C34H39Cl2N5O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XLBQSMBISPUIMT-MAMXRPNDSA-N
29145	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9212	[(2S,5R)-1-[(5R,6S)-5,6-Bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-(4-methyl-4,7-diazaspiro[2.5]octan-7-yl)methanone	BDBM50069626	-	PUBCHEM	67058380	C35H41Cl2N5O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZCAFJDRQRAWKAO-GRZVAKJNSA-N
29146	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Miyazaki M (2015)	25882531	224772	9213	[(2S,5R)-1-[(5R,6S)-5,6-Bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazole-2-carbonyl]-5-methylpyrrolidin-2-yl]-[(3R)-3,4-dimethylpiperazin-1-yl]methanone	(5R,6S)-5,6-BIS(4-CHLOROPHENYL)-2-[((2S,5R)-2-{[(3R)-3,4-DIMETHYLPIPERAZIN-1-YL]CARBONYL}-5-METHYLPYRROLIDIN-1-YL)CARBONYL]-3-ISOPROPYL-6-METHYL-5,6-DIHYDROIMIDAZO[2,1-B][1,3]THIAZOLE|[(2S,5R)-1-[(5R,6S)-5,6-BIS(4-CHLOROPHENYL)-6-METHYL-3-PROPAN-2-YL-5H-IMIDAZO[2,1-B][1,3]THIAZOLE-2-CARBONYL]-5-METHYLPYRROLIDIN-2-YL]-[(3R)-3,4-DIMETHYLPIPERAZIN-1-YL]METHANONE|BDBM50069625	-	PUBCHEM	58007373	C34H41Cl2N5O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZEYRMSIQYBSOGW-KBVCYFDGSA-N
29147	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Lawrence HR (2015)	25699576	224773	9214	BDBM98282	-	-	CHEMBL	CHEMBL2325940	C24H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PILAMBNAJPBLFA-RWXRFDSASA-N
29148	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Lawrence HR (2015)	25699576	224773	9215	5-Chloro-2-N-[4-(4-methylpiperazin-1-yl)phenyl]-4-N-[[(2S)-oxolan-2-yl]methyl]pyrimidine-2,4-diamine	BDBM50084465	-	PUBCHEM	117859438	C20H27ClN6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MMJSYUQCKWEFRW-KRWDZBQOSA-N
29149	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Lawrence HR (2015)	25699576	224773	9216	5-Chloro-2-N-[4-(4-methylpiperazin-1-yl)phenyl]-4-N-[[(2R)-oxolan-2-yl]methyl]pyrimidine-2,4-diamine	J3.522.184K|N-[[(R)-TETRAHYDROFURAN-2-YL]METHYL]-5-CHLORO-2-[[4-(4-METHYL-1-PIPERAZINYL)PHENYL]AMINO]PYRIMIDINE-4-AMINE|5-CHLORO-2-N-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-4-N-[[(2R)-OXOLAN-2-YL]METHYL]PYRIMIDINE-2,4-DIAMINE|BDBM50084464	-	PUBCHEM	90479825	C20H27ClN6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MMJSYUQCKWEFRW-QGZVFWFLSA-N
29150	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Lawrence HR (2015)	25699576	224773	5562	Bosutinib	SKI 606|Bosulif|4-((2,4-Dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|Bosutinib|SKI-606|Bosutinib Monohydrate|BDBM4552	bosulif	DRUGBANK	DB06616	C26H29Cl2N5O3	small molecule	L01XE14	380843-75-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UBPYILGKFZZVDX-UHFFFAOYSA-N
29151	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Lawrence HR (2015)	25699576	224773	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
29152	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9217	(8S,11S,14S,17S,29S,32S,35S,38S)-10,31-Bis[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-14,35-bis(naphthalen-2-ylmethyl)-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078360	-	PUBCHEM	71582189	C80H96N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RPYLESOPIPCLOC-IJLYYPGQSA-N
29153	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9218	(2S,5S,8S,11S,17S,20S,23S,26S)-4,19-Bis[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-8,23-bis(naphthalen-2-ylmethyl)-6,9,21,24-tetraoxo-1,4,7,10,14,15,16,19,22,25,29,30-dodecazapentacyclo[26.2.1.12,5.113,16.117,20]tetratriaconta-13(33),14,28(31),29-tetraene-11,26-dicarboxylic acid	BDBM50078359	-	PUBCHEM	71582339	C64H80N16O12	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCYVAJKIAWNFPS-WBVBMDTLSA-N
29154	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9219	(8S,11S,14S,17S,29S,32S,35S,38S)-10,31-Bis[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-14,35-bis(naphthalen-2-ylmethyl)-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078354	-	PUBCHEM	89569624	C84H100N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HZGOIKMHTUCXAI-KWEJKZBISA-N
29155	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9217	(8S,11S,14S,17S,29S,32S,35S,38S)-10,31-Bis[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-14,35-bis(naphthalen-2-ylmethyl)-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078360	-	PUBCHEM	71582189	C80H96N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RPYLESOPIPCLOC-IJLYYPGQSA-N
29156	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9218	(2S,5S,8S,11S,17S,20S,23S,26S)-4,19-Bis[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-8,23-bis(naphthalen-2-ylmethyl)-6,9,21,24-tetraoxo-1,4,7,10,14,15,16,19,22,25,29,30-dodecazapentacyclo[26.2.1.12,5.113,16.117,20]tetratriaconta-13(33),14,28(31),29-tetraene-11,26-dicarboxylic acid	BDBM50078359	-	PUBCHEM	71582339	C64H80N16O12	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCYVAJKIAWNFPS-WBVBMDTLSA-N
29157	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9220	(10S,13S,16S,19S,33S,36S,39S,42S)-16,39-Dibenzyl-12,35-bis[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3,14,17,26,37,40-hexaoxo-2,7,8,9,12,15,18,25,30,31,32,35,38,41-tetradecazaheptacyclo[42.2.2.221,24.16,9.110,13.129,32.133,36]tetrapentaconta-1(47),6(54),7,21,23,29(50),30,44(48),45,51-decaene-19,42-dicarboxylic acid	BDBM50078358	-	PUBCHEM	71581702	C74H94N18O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LKZUGDULMRPQJR-PZOHCTHGSA-N
29158	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9221	(8S,11S,14S,17S,29S,32S,35S,38S)-14,35-Dibenzyl-10,31-bis[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078357	-	PUBCHEM	71581703	C70H88N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VLPFNQKFYWKXGS-JCDMWVPISA-N
29159	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9222	(8S,11S,14S,17S,29S,32S,35S,38S)-10,31-Bis[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-14,35-bis(naphthalen-1-ylmethyl)-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078356	-	PUBCHEM	118732795	C78H92N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BUUIRUGUZNCDSQ-KCUAZDICSA-N
29160	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9223	(8S,11S,14S,17S,29S,32S,35S,38S)-10,31-Bis[(2S)-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-14,35-bis(naphthalen-2-ylmethyl)-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078355	-	PUBCHEM	71581838	C78H92N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSGZGDDJOKLCEY-PFFMIVSTSA-N
29161	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	unknown	target	Seigal BA (2015)	25695766	224774	9219	(8S,11S,14S,17S,29S,32S,35S,38S)-10,31-Bis[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-14,35-bis(naphthalen-2-ylmethyl)-12,15,33,36-tetraoxo-2,23-dioxa-5,6,7,10,13,16,26,27,28,31,34,37-dodecazaheptacyclo[38.2.2.219,22.14,7.18,11.125,28.129,32]pentaconta-1(43),4(50),5,19,21,25(46),26,40(44),41,47-decaene-17,38-dicarboxylic acid	BDBM50078354	-	PUBCHEM	89569624	C84H100N16O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HZGOIKMHTUCXAI-KWEJKZBISA-N
29163	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9224	CID 70677271	MI-1061|4-((3'R,4'S,5'R)-6''-CHLORO-4'-(3-CHLORO-2-FLUOROPHENYL)-2''-OXODISPIRO[CYCLOHEXANE-1,2'-PYRROLIDINE-3',3''-INDOLINE]-5'-CARBOXAMIDO)BENZOIC ACID|HY-125858|CS-0102051|1410737-34-6|BDBM50041086	-	PUBCHEM	70677271	C30H26Cl2FN3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BIDSEXPFIMKDMF-LOLKONATSA-N
29164	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9225	BDBM50041085	-	-	CHEMBL	CHEMBL3355429	C28H30Cl2FN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CQRICESTNDBKIY-KUGUZAOFSA-N
29165	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9226	CID 118720818	BDBM50041081	-	PUBCHEM	118720818	C27H30Cl2FN3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UKYBEEZQFSEMPW-LPJWUPNOSA-N
29166	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9227	BDBM50041075	-	-	CHEMBL	CHEMBL3355417	C30H34Cl2FN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UVWMOYGSAUBCGS-WPUIHRAISA-N
29167	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9228	BDBM50041074	-	-	CHEMBL	CHEMBL3355416	C29H32Cl2FN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QQOSBFYZJBKRMS-UAKSBLKBSA-N
29168	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9229	BDBM50041073	-	-	CHEMBL	CHEMBL3355415	C28H30Cl2FN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HQXQIUHXDOQUSV-XLKFOPSHSA-N
29169	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9230	BDBM50041031	-	-	CHEMBL	CHEMBL3355411	C28H32Cl2FN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IRTYMVBGDAJRNN-XLKFOPSHSA-N
29170	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Aguilar A (2014)	25496041	224775	9231	CID 71023165	US8629141, 15|BDBM112748	-	PUBCHEM	71023165	C29H33Cl2FN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZULOPCMLZWFEKU-ZLZBJJAKSA-N
29171	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Zhao Y (2015)	25396320	224776	8613	Nutlin-3	NUTLIN-3, (-)-|NUTLIN 3|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-[4-METHOXY-2-(PROPAN-2-YLOXY)PHENYL]-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|EX-A1359|CC-452|(-)-NUTLIN-3|NUTLIN3A|Q27166862|SB19406|HMS3649P17|C30H30CL2N4O4|AS-75148|1960AH|RAC-4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NUTLIN (3A)|BCP9001003|(RAC)-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDROIMIDAZOL-1-YL)(PIPERAZIN-1-YL)METHANONE|S8059|ZINC16051336|4-((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|4-[(4S,5R)-4,5-BIS-(4-CHLORO-PHENYL)-2-(2-ISOPROPOXY-4-METHOXY-PHENYL)-4,5-DIHYDRO-IMIDAZOLE-1-CARBONYL]-PIPERAZIN-2-ONE|NUTLIN-3A CHIRAL|(4S,5R)-NUTLIN-3|2-PIPERAZINONE, 4-(((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-(4-METHOXY-2-(1-METHYLETHOXY)PHENYL)-1H-IMIDAZOL-1-YL)CARBONYL)-|4HG7|2603AH|A11501|4-[[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-[4-METHOXY-2-(1-METHYLETHOXY)PHENYL]-1H-IMIDAZOL-1-YL]CARBONYL]-2-PIPERAZINONE|SR-01000946691|W-5585|NUTLIN 3A|675576-98-4|UNII-53IA0V845C COMPONENT BDUHCSBCVGXTJM-WUFINQPMSA-N|NUTLIN-3A, >=98% (HPLC)|4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4, 5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NCGC00344347-05|NUTLIN-3A|SC-95163|UNII-L7C92IOE65|AKOS027422740|4J3E|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(4-METHOXY-2-PROPAN-2-YLOXYPHENYL)-4,5-DIHYDROIMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|HY-10029|CS-0296|SR-01000946691-1|NUTLIN-3A (CHIRAL)|L7C92IOE65|BDBM50229787	-	CHEMSPIDER	187530	C30H30Cl2N4O4	small molecule	-	548472-68-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BDUHCSBCVGXTJM-UHFFFAOYSA-N
29172	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Rew Y (2014)	25384157	224777	9232	Mdm2 inhibitor amg-232	AC-29027|1352066-68-2|ZINC103248035|COMPOUND 2 [PMID: 24456472]|SB17210|AMG 232|GTPL11133|C28H35CL2NO5S|HY-12296|2-((3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-((S)-1-(ISOPROPYLSULFONYL)-3-METHYLBUTAN-2-YL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETIC ACID|KRT232|V2654|MDM2 INHIBITOR AMG-232|2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-3-METHYL-1-[(2S)-3-METHYL-1-PROPAN-2-YLSULFONYLBUTAN-2-YL]-2-OXOPIPERIDIN-3-YL]ACETIC ACID|AMG232|AOB87308|3-IPERIDINEACETIC ACID, 5-(3-HLOROPHENYL)-6-(4-HLOROPHENYL)-3-ETHYL-1-(1S)-2-ETHYL-1-[(1-ETHYLETHYL)ULFONYL]ETHYL]ROPYL]-2-XO-, (3R,5R,6S)-|AMG-232|UNII-7R7G6EH5UL|CS-3282|DB15299|(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-3-METHYL-1-((1S)-2-METHYL-1-(((1-METHYLETHYL)SULFONYL)METHYL)PROPYL)-2-OXO-3-PIPERIDINEACETIC ACID|NCGC00387801-04|AS-17007|NCGC00387801-05|KRT-232|1447813-21-9|7R7G6EH5UL|BDBM50448947	-	PUBCHEM	58573469	C28H35Cl2NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DRLCSJFKKILATL-YWCVFVGNSA-N
29173	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Rew Y (2014)	25384157	224777	9233	4-[[2-[(3R,5R,6S)-1-[(1S)-2-Tert-butylsulfonyl-1-cyclopropylethyl]-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]acetyl]amino]-2-methoxybenzoic acid	3UD|4WT2|US8952036, EX. 3|4-(2-((3R,5R,6S)-1-((S)-2-(TERT-BUTYLSULFONYL)-1-CYCLOPROPYLETHYL)-6-(4-CHLORO-3-FLUOROPHENYL)-5-(3-CHLOROPHENYL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETAMIDO)-2-METHOXYBENZOIC ACID|4-[[2-[(3R,5R,6S)-1-[(1S)-2-TERT-BUTYLSULFONYL-1-CYCLOPROPYLETHYL]-6-(4-CHLORO-3-FLUOROPHENYL)-5-(3-CHLOROPHENYL)-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETYL]AMINO]-2-METHOXYBENZOIC ACID|4-({[(3R,5R,6S)-1-[(1S)-2-(TERT-BUTYLSULFONYL)-1-CYCLOPROPYLETHYL]-6-(4-CHLORO-3-FLUOROPHENYL)-5-(3-CHLOROPHENYL)-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETYL}AMINO)-2-METHOXYBENZOIC ACID|Q27454148|BDBM144638	-	PUBCHEM	77108133	C37H41Cl2FN2O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QGOICCMBEDDFCI-NXQGQTBASA-N
29174	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9234	4-N-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030280	-	PUBCHEM	73506219	C63H82N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MAKVXIUNQHYAPX-UPKUDDMJSA-N
29175	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9235	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methoxy]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030278	-	PUBCHEM	90089727	C63H83N9O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PXWQVOUQYPMEME-NMZKVUILSA-N
29176	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9236	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[2-[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]ethynyl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030275	-	PUBCHEM	90089572	C64H81N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MZOKCLGAIIRHDG-KHFWCYFCSA-N
29177	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9237	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[2-[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]ethyl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030273	-	PUBCHEM	90089737	C64H85N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MRQUIOMXZIGPPW-KHFWCYFCSA-N
29178	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9238	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-N-[5-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]-1,3-benzothiazol-2-yl]-3-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3,7-dicarboxamide	BDBM50030272	-	PUBCHEM	118497975	C64H81N11O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SYZOGRWMVSXFBX-OVCCXHLHSA-N
29179	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9239	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-N-[5-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]-1,3-oxazol-2-yl]-3-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3,7-dicarboxamide	BDBM50030270	-	PUBCHEM	73507318	C60H79N11O9	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VYZMHQWZWYAOIA-QLYDQGARSA-N
29180	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9240	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030269	-	PUBCHEM	118323269	C63H83N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LDVMHSURAWAEBW-YUTDAYPPSA-N
29181	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9241	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1R)-1-(2-fluorophenyl)ethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030268	-	PUBCHEM	73603510	C61H80FN9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SUVGZSPIXFUCLS-NQFXVQPCSA-N
29182	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9242	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1R)-2-methoxy-1-phenylethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030266	-	PUBCHEM	73603641	C62H83N9O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZWQAFLMOTZHHO-DFNGJWONSA-N
29183	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9243	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1S)-2-methoxy-1-phenylethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030265	-	PUBCHEM	118715865	C62H83N9O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZWQAFLMOTZHHO-UICOXBBFSA-N
29184	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9234	4-N-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030280	-	PUBCHEM	73506219	C63H82N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MAKVXIUNQHYAPX-UPKUDDMJSA-N
29185	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9235	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methoxy]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030278	-	PUBCHEM	90089727	C63H83N9O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PXWQVOUQYPMEME-NMZKVUILSA-N
29186	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9236	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[2-[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]ethynyl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030275	-	PUBCHEM	90089572	C64H81N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MZOKCLGAIIRHDG-KHFWCYFCSA-N
29187	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9237	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[2-[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]ethyl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030273	-	PUBCHEM	90089737	C64H85N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MRQUIOMXZIGPPW-KHFWCYFCSA-N
29188	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9238	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-N-[5-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]-1,3-benzothiazol-2-yl]-3-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3,7-dicarboxamide	BDBM50030272	-	PUBCHEM	118497975	C64H81N11O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SYZOGRWMVSXFBX-OVCCXHLHSA-N
29189	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9239	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-N-[5-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]-1,3-oxazol-2-yl]-3-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3,7-dicarboxamide	BDBM50030270	-	PUBCHEM	73507318	C60H79N11O9	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VYZMHQWZWYAOIA-QLYDQGARSA-N
29190	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9240	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030269	-	PUBCHEM	118323269	C63H83N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LDVMHSURAWAEBW-YUTDAYPPSA-N
29191	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9241	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1R)-1-(2-fluorophenyl)ethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030268	-	PUBCHEM	73603510	C61H80FN9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SUVGZSPIXFUCLS-NQFXVQPCSA-N
29192	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9244	(3S)-N-[(1S)-1-(2,3-Difluorophenyl)ethyl]-2-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030267	-	PUBCHEM	118715864	C61H79F2N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XKVHXUXRQUCUTL-XNSIXTBXSA-N
29193	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9242	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1R)-2-methoxy-1-phenylethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030266	-	PUBCHEM	73603641	C62H83N9O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZWQAFLMOTZHHO-DFNGJWONSA-N
29194	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9243	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-N-[[4-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoyl]phenyl]methyl]-N-[(1S)-2-methoxy-1-phenylethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50030265	-	PUBCHEM	118715865	C62H83N9O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZWQAFLMOTZHHO-UICOXBBFSA-N
29195	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9245	4-N-[(3S)-2-[(2R)-3-[2-[3-[4-(3-Aminopropylamino)butylamino]propylamino]-2-oxoethyl]sulfanyl-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030264	-	PUBCHEM	118715866	C74H106N14O9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIWSKTYTWYRRIW-ONVBUOODSA-N
29196	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9246	4-N-[(3S)-2-[(2R)-3-[2-[3-[3-[4-(3-Aminopropylamino)butylamino]propylamino]propylamino]-2-oxoethyl]sulfanyl-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030263	-	PUBCHEM	118715867	C77H113N15O9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZMXKIYQYKSPEKG-ZLUZKAKLSA-N
29197	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9247	4-N-[(3S)-2-[(2R)-3-[2-[3-[3-[4-(3-Aminopropylamino)butylamino]propyl-carbamimidoylamino]propylamino]-2-oxoethyl]sulfanyl-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030262	-	PUBCHEM	118715868	C78H115N17O9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GDKDASNHAMUPQR-ZLUZKAKLSA-N
29198	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Kim KS (2014)	25278234	212888	9248	4-N-[(3S)-2-[(2R)-3-[2-[3-[Carbamimidoyl-[3-[carbamimidoyl-[4-[carbamimidoyl-[3-(diaminomethylideneamino)propyl]amino]butyl]amino]propyl]amino]propylamino]-2-oxoethyl]sulfanyl-3-methyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030261	-	PUBCHEM	118715869	C81H121N23O9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SLEYXAFJLKXZIB-ZLUZKAKLSA-N
29199	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2014)	25261927	224778	9249	N-[4-[3-Chloro-4-[(3S)-oxolan-3-yl]oxyanilino]thieno[2,3-d]pyrimidin-6-yl]-N'-hydroxyoctanediamide	BDBM50102566	-	PUBCHEM	118715746	C24H28ClN5O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DHVTZWIWZWPIFU-INIZCTEOSA-N
29200	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2014)	25261927	224778	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29201	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2014)	25233084	224779	9250	8-Mercapto-octanoic acid phenylamide	8-MERCAPTO-OCTANOIC ACID PHENYLAMIDE|ZINC13609343|N-PHENYL-8-SULFANYLOCTANAMIDE|8-MERCAPTO-N-PHENYLOCTANAMIDE|BDBM50027601	-	PUBCHEM	11149404	C14H21NOS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VTVJPXWTXILBGK-UHFFFAOYSA-N
29202	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2014)	25233084	224779	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29203	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Wang Y (2014)	25042256	224780	9251	2-[(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-morpholin-4-ylsulfonylethyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid	2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-MORPHOLIN-4-YLSULFONYLETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETIC ACID|BDBM50053052	-	PUBCHEM	67999720	C29H34Cl2N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSZIUWBZPLMUNE-GCMXZSHTSA-N
29204	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Wang Y (2014)	25042256	224780	9252	2-[(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-piperidin-1-ylsulfonylethyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid	2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-PIPERIDIN-1-YLSULFONYLETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETIC ACID|BDBM50053051	-	PUBCHEM	67998850	C30H36Cl2N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HLRWFQSMFDJFQQ-QXMDYEBFSA-N
29205	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Wang Y (2014)	25042256	224780	9253	2-[(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(methylsulfamoyl)ethyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid	2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-(METHYLSULFAMOYL)ETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETIC ACID|BDBM50053045	-	PUBCHEM	68000050	C26H30Cl2N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TUDCVMKUXPXOII-HLMLHLEXSA-N
29206	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Wang Y (2014)	25042256	224780	9254	2-[(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-cyclopropyl-2-(propan-2-ylsulfamoyl)ethyl]-3-methyl-2-oxopiperidin-3-yl]acetic acid	2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(1S)-1-CYCLOPROPYL-2-(PROPAN-2-YLSULFAMOYL)ETHYL]-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETIC ACID|BDBM50053040	-	PUBCHEM	68000097	C28H34Cl2N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OLQSAQIIKIWIRZ-YWCVFVGNSA-N
29207	111671	5698	DADB-223G19.3	PSMB9	LMP2|PSMB6i|RING12|beta1i	9606	Homo sapiens	unknown	target	de Bruin G (2014)	25006746	224781	9255	(2S)-1-[(2S)-2-[(2-Azidoacetyl)amino]propanoyl]-N-[(2S)-1-[[(2S)-3-cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-4,4-difluoropyrrolidine-2-carboxamide	BDBM50099953	-	PUBCHEM	118709680	C28H43F2N7O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BYGWQGGWZMNGGA-MDEFBCHOSA-N
29208	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	unknown	target	de Bruin G (2014)	25006746	224781	9256	N-[(2R)-1-[[(2S)-1-[[(2S)-3-Cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-3-(4-methoxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-3-methyl-1H-indene-2-carboxamide	LU-035I|BDBM50099686	-	PUBCHEM	101874279	C36H45N3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SIXKXOYWBKFIOX-CIEAOGCXSA-N
29209	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	unknown	target	de Bruin G (2014)	25006746	224781	9257	N-[(2R)-1-[[(2S)-1-[[(2S)-3-Cyclohexyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-3-methyl-1H-indene-2-carboxamide	LU-015I|BDBM50099664	-	PUBCHEM	101874275	C37H44N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HCSMZVMWZMSHSC-LZNHGOJSSA-N
29210	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	unknown	target	de Bruin G (2014)	25006746	224781	9258	N-[(2R)-1-[[(2S)-3-(1H-Indol-3-yl)-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-3-methyl-1H-indene-2-carboxamide	L-TRYPTOPHANAMIDE, N-((3-METHYL-1H-INDEN-2-YL)CARBONYL)-D-ALANYL-N-((1S)-2-((2R)-2-METHYL-2-OXIRANYL)-2-OXO-1-(PHENYLMETHYL)ETHYL)-|Q27295555|HY-123587|1416709-79-9|CS-0083586|UNII-ZI5ZER54A9|PR-924|ZI5ZER54A9|BDBM50099663	-	PUBCHEM	92135659	C37H38N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ADBUEVSHEJICCM-LZNHGOJSSA-N
29211	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	unknown	target	de Bruin G (2014)	25006746	224781	9259	Onx-0914 (PR-957)	C31H40N4O7|PR-957|Q27088204|SC-84030|HY-13207|(2S)-3-(4-METHOXYPHENYL)-N-[(2S)-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[(2S)-2-[2-(MORPHOLIN-4-YL)ACETAMIDO]PROPANAMIDO]PROPANAMIDE|(S)-3-(4-METHOXYPHENYL)-N-((S)-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)PROPANAMIDO)PROPANAMIDE|EX-A459|AS-35161|AKOS025404933|(2S)-N-[(1S)-1-BENZYL-2-[(2R)-2-METHYLOXIRAN-2-YL]-2-OXO-ETHYL]-3-(4-METHOXYPHENYL)-2-[[(2S)-2-[(2-MORPHOLINOACETYL)AMINO]PROPANOYL]AMINO]PROPANAMIDE|A12653|PR 957|ONX-0914 (PR-957)|960374-59-8|ONX 0914|ONX-0914|BCP07652|(2S)-3-(4-METHOXYPHENYL)-N-[(2S)-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]PROPANOYL]AMINO]PROPANAMIDE|CS-1625|GTPL9031|AOB87169|Y1243|S-7830|ZINC43207593|KS-00000XP8|BDBM50007203	-	PUBCHEM	23642227	C31H40N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WQAVPPWWLLVGFK-VTNASVEKSA-N
29212	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Ma Y (2014)	24900882	224782	9260	[(2R,3S)-2-(2-Hydroxyethyl)-3-[4-[2-(2-methoxyethoxy)phenyl]piperazine-1-carbonyl]-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone;hydrochloride	BDBM50020151	-	PUBCHEM	90644648	C35H39ClF6N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GAWXPLJRMGISPF-AAYBCKPTSA-N
29213	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Ma Y (2014)	24900882	224782	9261	[(2R,3S)-2-(2,3-Dihydroxypropyl)-3-[4-[2-(2-methoxyethoxy)phenyl]piperazine-1-carbonyl]-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone;hydrochloride	BDBM50020150	-	PUBCHEM	90644647	C36H41ClF6N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLKVYUYEIZLSOY-QAJMXTGNSA-N
29214	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Ma Y (2014)	24900882	224782	9262	[(2R,3S)-3-[4-[2-(2-Methoxyethoxy)phenyl]piperazine-1-carbonyl]-2-propyl-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone;hydrochloride	BDBM50020149	-	PUBCHEM	90644646	C36H41ClF6N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YOTYTBNHWCLYIW-BRMBYNPVSA-N
29215	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Ma Y (2014)	24900882	224782	9263	[(2R,3S)-3-[4-[2-(2-Methoxyethoxy)phenyl]piperazine-1-carbonyl]-2-prop-2-enyl-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone	BDBM50001929	-	PUBCHEM	23642310	C36H38F6N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QKOYVKQWXLFSPH-FJQKOURKSA-N
29216	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9264	2-[1-(3-Chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-4-yl]-5-methyl-1,3,4-oxadiazole	2-[1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-4-YL]-5-METHYL-1,3,4-OXADIAZOLE|BDBM50012598	-	PUBCHEM	67031670	C24H20Cl2F2N4O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WSYHJRPECYYALB-UHFFFAOYSA-N
29217	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9265	1-(3-Chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazole-4-carboxamide	1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOLE-4-CARBOXAMIDE|BDBM50012597	-	PUBCHEM	67032018	C22H19Cl2F2N3O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WCIBRTOQTDTZEH-UHFFFAOYSA-N
29218	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9266	1-(5-Chloro-2-methylphenyl)-5-(3-chlorophenyl)-2-phenylimidazole-4-carboxylic acid	1-(5-CHLORO-2-METHYLPHENYL)-5-(3-CHLOROPHENYL)-2-PHENYLIMIDAZOLE-4-CARBOXYLIC ACID|BDBM50012596	-	PUBCHEM	67035866	C23H16Cl2N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HGVSKSDYMUWDDZ-UHFFFAOYSA-N
29219	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9267	1-(5-Chloro-2-Methylphenyl)-5-(3-Chlorophenyl)-2-(3-Methylphenyl)-1h-Imidazole-4-Carboxylic Acid	1-(5-CHLORO-2-METHYLPHENYL)-5-(3-CHLOROPHENYL)-2-(3-METHYLPHENYL)IMIDAZOLE-4-CARBOXYLIC ACID|4OQ3|Q27453318|2V8|1-(5-CHLORO-2-METHYLPHENYL)-5-(3-CHLOROPHENYL)-2-(3-METHYLPHENYL)-1H-IMIDAZOLE-4-CARBOXYLIC ACID|BDBM50012595	-	PUBCHEM	50996417	C24H18Cl2N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UYJZPBBJELZWKZ-UHFFFAOYSA-N
29220	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9268	1-(3-Chloro-2-fluorophenyl)-5-(3-chlorophenyl)-2-phenylimidazole-4-carboxylic acid	1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLOROPHENYL)-2-PHENYLIMIDAZOLE-4-CARBOXYLIC ACID|BDBM50012594	-	PUBCHEM	67035746	C22H13Cl2FN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWKUHDIFHWGKSW-UHFFFAOYSA-N
29221	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9269	2-[2-[4-(5-Amino-1,3,4-oxadiazol-2-yl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-1-yl]-4-chloro-3-fluorophenyl]-N-phenylacetamide	2-[2-[4-(5-AMINO-1,3,4-OXADIAZOL-2-YL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-1-YL]-4-CHLORO-3-FLUOROPHENYL]-N-PHENYLACETAMIDE|BDBM50012593	-	PUBCHEM	67954180	C31H26Cl2F2N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LVTCZQLXJGEKOF-UHFFFAOYSA-N
29222	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9270	5-[1-(3-Chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-4-yl]-1,3,4-oxadiazol-2-amine	5-[1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-4-YL]-1,3,4-OXADIAZOL-2-AMINE|BDBM50012592	-	PUBCHEM	67954546	C23H19Cl2F2N5O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XPRXKGPGGKKGGT-UHFFFAOYSA-N
29223	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9271	2-[2-[4-(5-Amino-1,3,4-oxadiazol-2-yl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-1-yl]-4-chloro-3-fluorophenyl]-N-methylacetamide	2-[2-[4-(5-AMINO-1,3,4-OXADIAZOL-2-YL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-1-YL]-4-CHLORO-3-FLUOROPHENYL]-N-METHYLACETAMIDE|2-{2-[4-(5-AMINO-[1,3,4]OXADIAZOL-2-YL)-5-(3-CHLORO-4-FLUORO-PHENYL)-2-CYCLOHEXYL-IMIDAZOL-1-YL]-4-CHLORO-3-FLUORO-PHENYL}-N-METHYL-ACETAMIDE|BDBM50012591	-	PUBCHEM	67032045	C26H24Cl2F2N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FXKYGUQUTHFCIZ-UHFFFAOYSA-N
29224	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9272	1-(3-Chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazole-4-carboxylic acid	1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOLE-4-CARBOXYLIC ACID|BDBM50012590	-	PUBCHEM	67954173	C22H18Cl2F2N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OKZRWZNDCUYSPD-UHFFFAOYSA-N
29225	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9273	5-[1-(3-Chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-4-yl]-2H-tetrazole	5-[1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-4-YL]-2H-TETRAZOLE|BDBM50012589	-	PUBCHEM	67032499	C22H18Cl2F2N6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	APOKXFGOAIBPAE-UHFFFAOYSA-N
29226	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9274	1-(3-Chloro-2-fluorophenyl)-5-(3-chloro-4-fluorophenyl)-2-phenylimidazole-4-carboxylic acid	1-(3-CHLORO-2-FLUOROPHENYL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-PHENYLIMIDAZOLE-4-CARBOXYLIC ACID|BDBM50012588	-	PUBCHEM	67954174	C22H12Cl2F2N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FQIJHXGZFVSBLN-UHFFFAOYSA-N
29227	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9275	2-[2-[4-(5-Amino-1,3,4-oxadiazol-2-yl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-1-yl]-4-chloro-3-fluorophenyl]-N-tert-butylacetamide	2-[2-[4-(5-AMINO-1,3,4-OXADIAZOL-2-YL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-1-YL]-4-CHLORO-3-FLUOROPHENYL]-N-TERT-BUTYLACETAMIDE|BDBM50012587	-	PUBCHEM	60167943	C29H30Cl2F2N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SZZSUOGVLVLJPR-UHFFFAOYSA-N
29228	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Vaupel A (2014)	24704029	224783	9276	2-[2-[4-(5-Amino-1,3,4-oxadiazol-2-yl)-5-(3-chloro-4-fluorophenyl)-2-cyclohexylimidazol-1-yl]-4-chloro-3-fluorophenyl]-N-cyclohexylacetamide	2-[2-[4-(5-AMINO-1,3,4-OXADIAZOL-2-YL)-5-(3-CHLORO-4-FLUOROPHENYL)-2-CYCLOHEXYLIMIDAZOL-1-YL]-4-CHLORO-3-FLUOROPHENYL]-N-CYCLOHEXYLACETAMIDE|BDBM50012586	-	PUBCHEM	67034825	C31H32Cl2F2N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SMUUKZTVPGSBEE-UHFFFAOYSA-N
29229	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Pan W (2014)	24656661	224784	8613	Nutlin-3	NUTLIN-3, (-)-|NUTLIN 3|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-[4-METHOXY-2-(PROPAN-2-YLOXY)PHENYL]-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|EX-A1359|CC-452|(-)-NUTLIN-3|NUTLIN3A|Q27166862|SB19406|HMS3649P17|C30H30CL2N4O4|AS-75148|1960AH|RAC-4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NUTLIN (3A)|BCP9001003|(RAC)-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDROIMIDAZOL-1-YL)(PIPERAZIN-1-YL)METHANONE|S8059|ZINC16051336|4-((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|4-[(4S,5R)-4,5-BIS-(4-CHLORO-PHENYL)-2-(2-ISOPROPOXY-4-METHOXY-PHENYL)-4,5-DIHYDRO-IMIDAZOLE-1-CARBONYL]-PIPERAZIN-2-ONE|NUTLIN-3A CHIRAL|(4S,5R)-NUTLIN-3|2-PIPERAZINONE, 4-(((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-(4-METHOXY-2-(1-METHYLETHOXY)PHENYL)-1H-IMIDAZOL-1-YL)CARBONYL)-|4HG7|2603AH|A11501|4-[[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-[4-METHOXY-2-(1-METHYLETHOXY)PHENYL]-1H-IMIDAZOL-1-YL]CARBONYL]-2-PIPERAZINONE|SR-01000946691|W-5585|NUTLIN 3A|675576-98-4|UNII-53IA0V845C COMPONENT BDUHCSBCVGXTJM-WUFINQPMSA-N|NUTLIN-3A, >=98% (HPLC)|4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4, 5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NCGC00344347-05|NUTLIN-3A|SC-95163|UNII-L7C92IOE65|AKOS027422740|4J3E|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(4-METHOXY-2-PROPAN-2-YLOXYPHENYL)-4,5-DIHYDROIMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|HY-10029|CS-0296|SR-01000946691-1|NUTLIN-3A (CHIRAL)|L7C92IOE65|BDBM50229787	-	CHEMSPIDER	187530	C30H30Cl2N4O4	small molecule	-	548472-68-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BDUHCSBCVGXTJM-UHFFFAOYSA-N
29230	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Pan W (2014)	24656661	224784	9263	[(2R,3S)-3-[4-[2-(2-Methoxyethoxy)phenyl]piperazine-1-carbonyl]-2-prop-2-enyl-3-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-[4-(trifluoromethyl)pyridin-3-yl]methanone	BDBM50001929	-	PUBCHEM	23642310	C36H38F6N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QKOYVKQWXLFSPH-FJQKOURKSA-N
29231	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9277	(2S)-N-[(1S)-2-[(3Ar,7aS)-6-(2-phenylethyl)-3,3a,4,5,7,7a-hexahydro-2H-pyrrolo[2,3-c]pyridin-1-yl]-1-cyclohexyl-2-oxoethyl]-2-(methylamino)propanamide	CS-0006862|LBW242|867324-12-7|HY-15519|(2S)-N-[(1S)-2-[(3AR,7AS)-6-(2-PHENYLETHYL)-3,3A,4,5,7,7A-HEXAHYDRO-2H-PYRROLO[2,3-C]PYRIDIN-1-YL]-1-CYCLOHEXYL-2-OXOETHYL]-2-(METHYLAMINO)PROPANAMIDE|BDBM50364485	-	PUBCHEM	11503417	C27H42N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HCSMRSHIIKPNAK-LSAVBLLPSA-N
29232	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9278	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-4-[2-(2-methylphenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001139	-	PUBCHEM	90654412	C25H38N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VUHJRMSITOPODU-JELQSWKKSA-N
29233	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9279	(2S)-N-[(2S,7R,9S,13S)-4-[2-(4-Hydroxyphenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001138	-	PUBCHEM	90654411	C24H36N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HNEFKNCSOQRMCU-CRDRRFEFSA-N
29234	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9280	(2S)-N-[(2S,7R,9S,13S)-4-[2-(3-Methoxyphenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001136	-	PUBCHEM	90654409	C25H38N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PTCUWTLAVOGZOF-YFVPBJFGSA-N
29235	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9281	(2S)-N-[(2S,7R,9S,13S)-4-[2-(2-Methoxyphenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001135	-	PUBCHEM	90654408	C25H38N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NDQMUJBKPCHPFP-WFMNFSIZSA-N
29236	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9282	(2S)-N-[(2S,7R,9S,13S)-4-[2-(4-Fluorophenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001134	-	PUBCHEM	90654407	C24H35FN4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NPUNAPHKJPGXNY-ORDMVQLLSA-N
29237	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9283	(2S)-N-[(2S,7R,9S,13S)-4-[2-(2-Fluorophenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001133	-	PUBCHEM	90654406	C24H35FN4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HPONQTAHVJCUCR-CRDRRFEFSA-N
29238	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9284	(2S)-N-[(2S,7R,9S,13S)-4-[2-(4-Bromophenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001132	-	PUBCHEM	90654405	C24H35BrN4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCFKWSBDCRMWRK-ORDMVQLLSA-N
29239	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9285	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-14-oxo-4-(2-phenylethyl)-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001131	-	PUBCHEM	90654404	C24H36N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LTFVDAMNPLQBHE-WFMNFSIZSA-N
29240	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9286	(6S,9Ar)-2,2-dimethyl-6-[[(2S)-2-(methylamino)propanoyl]amino]-N-(5-methyl-2-phenylpyrazol-3-yl)-5-oxo-3,6,7,8,9,9a-hexahydro-[1,3]thiazolo[3,2-a]azepine-3-carboxamide	BDBM50001130	-	PUBCHEM	90654403	C25H34N6O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RBLGKKZTMVKMNE-CPCSJTIGSA-N
29241	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9287	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-4-[2-[6-[2-[(2S,7R,9S,13S)-13-[[(2S)-2-(methylamino)propanoyl]amino]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-4-yl]-2-oxo-1-phenylethoxy]hexa-2,4-diynoxy]-2-phenylacetyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001129	-	PUBCHEM	86276147	C54H70N8O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CNHIJRXXUZNFIO-TXLCXPLDSA-N
29242	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9288	Phenyl (2S,7R,9S,13S)-13-[[(2S)-2-(methylamino)propanoyl]amino]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecane-4-carboxylate	BDBM50001125	-	PUBCHEM	90654399	C23H32N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	COOWRGHTGIMRRI-SQIBXOBRSA-N
29243	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9289	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-14-oxo-4-(2-phenylacetyl)-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001101	-	PUBCHEM	90654394	C24H34N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RMWMSAOQRVQSSL-DARKYYSBSA-N
29244	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9290	(2S)-N-[(2S,7R,9S,13S)-4-[2-(1H-Indol-3-yl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001083	-	PUBCHEM	90654382	C26H37N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NXKKLSUXQLAFFE-SOFANIRLSA-N
29245	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9291	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-14-oxo-4-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001081	-	PUBCHEM	90654380	C25H35F3N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CBUKBSAVVSVBEX-ORDMVQLLSA-N
29246	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9292	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-4-[2-(4-nitrophenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001080	-	PUBCHEM	90654379	C24H35N5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AQTFKDCKLOSLNK-ORDMVQLLSA-N
29247	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9293	(2S)-N-[(2S,7R,9S,13S)-4-[2-(3,4-Dichlorophenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001079	-	PUBCHEM	90654378	C24H34Cl2N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FAPNSKGNSXRVLR-CBJPPDNLSA-N
29248	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9294	(2S)-N-[(2S,7R,9S,13S)-4-[2-(4-Chlorophenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]-2-(methylamino)propanamide	BDBM50001078	-	PUBCHEM	90654377	C24H35ClN4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DOFKWVQMIJUKCV-ORDMVQLLSA-N
29249	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9295	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-4-[2-(4-methylphenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001077	-	PUBCHEM	90654376	C25H38N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AQFHGNZPIGAZGV-JELQSWKKSA-N
29250	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9296	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-4-[2-(3-methylphenyl)ethyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001076	-	PUBCHEM	90654375	C25H38N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AVBZMSWFBFFJGJ-JELQSWKKSA-N
29251	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Hird AW (2014)	24631189	224785	9287	(2S)-2-(Methylamino)-N-[(2S,7R,9S,13S)-4-[2-[6-[2-[(2S,7R,9S,13S)-13-[[(2S)-2-(methylamino)propanoyl]amino]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-4-yl]-2-oxo-1-phenylethoxy]hexa-2,4-diynoxy]-2-phenylacetyl]-14-oxo-1,4-diazatricyclo[7.5.0.02,7]tetradecan-13-yl]propanamide	BDBM50001129	-	PUBCHEM	86276147	C54H70N8O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CNHIJRXXUZNFIO-TXLCXPLDSA-N
29252	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Gonzalez AZ (2014)	24601644	224786	9297	2-[2-[[(3R,5R,6S)-1-[(1S)-2-Tert-butylsulfonyl-1-cyclopropylethyl]-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]methyl]-1,3-thiazol-5-yl]acetic acid	(2-{[(3R,5R,6S)-1-[(1S)-2-(TERT-BUTYLSULFONYL)-1-CYCLOPROPYLETHYL]-6-(4-CHLORO-3-FLUOROPHENYL)-5-(3-CHLOROPHENYL)-3-METHYL-2-OXOPIPERIDIN-3-YL]METHYL}-1,3-THIAZOL-5-YL)ACETIC ACID|Q27453278|AM-6761|2U0|4ODE|BDBM50008748	-	PUBCHEM	73386675	C33H37Cl2FN2O5S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HNLHOKSDTBAERS-CWIPYCOQSA-N
29253	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Gonzalez AZ (2014)	24548297	224787	9298	2-[(2R,5R,6R)-4-[(1S)-2-Tert-butylsulfonyl-1-cyclopropylethyl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid	Q27453272|CS-0012311|AM-8735|[(2R,5R,6R)-4-[(1S)-2-(TERT-BUTYLSULFONYL)-1-CYCLOPROPYLETHYL]-6-(3-CHLOROPHENYL)-5-(4-CHLOROPHENYL)-3-OXOMORPHOLIN-2-YL]ACETIC ACID|4OBA|2TW|2-[(2R,5R,6R)-4-[(1S)-2-TERT-BUTYLSULFONYL-1-CYCLOPROPYLETHYL]-6-(3-CHLOROPHENYL)-5-(4-CHLOROPHENYL)-3-OXOMORPHOLIN-2-YL]ACETIC ACID|HY-12734|BDBM50007638	-	PUBCHEM	71544420	C27H31Cl2NO6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZTMSSDQFJNEUNG-WMMXXEOUSA-N
29254	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Sun D (2014)	24456472	224788	9232	Mdm2 inhibitor amg-232	AC-29027|1352066-68-2|ZINC103248035|COMPOUND 2 [PMID: 24456472]|SB17210|AMG 232|GTPL11133|C28H35CL2NO5S|HY-12296|2-((3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-((S)-1-(ISOPROPYLSULFONYL)-3-METHYLBUTAN-2-YL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETIC ACID|KRT232|V2654|MDM2 INHIBITOR AMG-232|2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-3-METHYL-1-[(2S)-3-METHYL-1-PROPAN-2-YLSULFONYLBUTAN-2-YL]-2-OXOPIPERIDIN-3-YL]ACETIC ACID|AMG232|AOB87308|3-IPERIDINEACETIC ACID, 5-(3-HLOROPHENYL)-6-(4-HLOROPHENYL)-3-ETHYL-1-(1S)-2-ETHYL-1-[(1-ETHYLETHYL)ULFONYL]ETHYL]ROPYL]-2-XO-, (3R,5R,6S)-|AMG-232|UNII-7R7G6EH5UL|CS-3282|DB15299|(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-3-METHYL-1-((1S)-2-METHYL-1-(((1-METHYLETHYL)SULFONYL)METHYL)PROPYL)-2-OXO-3-PIPERIDINEACETIC ACID|NCGC00387801-04|AS-17007|NCGC00387801-05|KRT-232|1447813-21-9|7R7G6EH5UL|BDBM50448947	-	PUBCHEM	58573469	C28H35Cl2NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DRLCSJFKKILATL-YWCVFVGNSA-N
29255	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Sun D (2014)	24456472	224788	9299	2-[(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-[(2S,3S)-2-hydroxypentan-3-yl]-3-methyl-2-oxopiperidin-3-yl]acetic acid	Q27451341|AM-8553|{(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(2S,3S)-2-HYDROXYPENTAN-3-YL]-3-METHYL-2-OXOPIPERIDIN-3-YL}ACETIC ACID|2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-[(2S,3S)-2-HYDROXYPENTAN-3-YL]-3-METHYL-2-OXOPIPERIDIN-3-YL]ACETIC ACID|2-((3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-((2S,3S)-2-HYDROXYPENTAN-3-YL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETIC ACID|0R3|BDBM50388626	-	PUBCHEM	56965957	C25H29Cl2NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YUALYRLIFVPOHL-VPLUBSIMSA-N
29256	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Huang Q (2014)	24432909	224789	9300	Unii-76pnd635L1	PF-06439015|(2R)-2-[5-[6-AMINO-5-[(1R)-1-[5-FLUORO-2-(TRIAZOL-2-YL)PHENYL]ETHOXY]PYRIDIN-3-YL]-4-METHYL-1,3-THIAZOL-2-YL]PROPANE-1,2-DIOL.|(2R)-2-[5-[6-AMINO-5-[(1R)-1-[5-FLUORO-2-(TRIAZOL-2-YL)PHENYL]ETHOXY]PYRIDIN-3-YL]-4-METHYL-1,3-THIAZOL-2-YL]PROPANE-1,2-DIOL|4CD0|(2R)-2-(5-(6-AMINO-5-((1R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)ETHOXY)-3-PYRIDINYL)-4-METHYL-2-THIAZOLYL)-1,2-PROPANEDIOL|1549629-82-4|AWJ|P-355|Q27076827|76PND635L1|ZINC98050687|1,2-PROPANEDIOL, 2-(5-(6-AMINO-5-((1R)-1-(5-FLUORO-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)ETHOXY)-3-PYRIDINYL)-4-METHYL-2-THIAZOLYL)-, (2R)-|PF 06439015|COMPOUND 8E [PMID: 24432909]|GTPL8137|NCGC00485046-01|UNII-76PND635L1|BDBM50448785	-	PUBCHEM	72710568	C22H23FN6O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DIXMBHMNEHPFCX-MCMMXHMISA-N
29257	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Blasdel LK (2013)	24269479	224790	9301	(1R,4R,5S)-4-(2-Chloroethyl)-1-[(S)-cyclohexyl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione	SALINOSPORAMIDE X1|BDBM50444464	-	PUBCHEM	11243977	C15H22ClNO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OJZFVOGTYOBPKD-GVARAGBVSA-N
29258	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Blasdel LK (2013)	24269479	224790	9302	(1R,4R,5S)-4-(3-Chloropropyl)-1-[(S)-cyclohexyl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione	BDBM50444463	-	PUBCHEM	72724741	C16H24ClNO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YQXBYNPDPJTCPP-APYUEPQZSA-N
29259	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Blasdel LK (2013)	24269479	224790	9303	(1R,4R,5S)-4-(2-Chloroethyl)-1-[(S)-cyclopropyl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione	BDBM50444462	-	PUBCHEM	72724804	C12H16ClNO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VKEICTONBXTKAQ-OSTYVCCYSA-N
29260	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Blasdel LK (2013)	24269479	224790	8396	Marizomib	(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one|(1R,4R,5S)-4-(2-Chloroethyl)-1-[(S)-(1S)-2-cyclohexen-1-yl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|(-)-salinosporamide A|marizomib|6-Oxa-2-azabicyclo[3.2.0]heptane-3,7-dione, 4-(2-chloroethyl)-1-[(S)-(1S)-2-cyclohexen-1-ylhydroxymethyl]-5-methyl-, (1R,4R,5S)-|Salinosporamide A|9205|703P9YDP7F|BDBM50398608	-	CHEMSPIDER	9522473	C15H20ClNO4	small molecule	-	437742-34-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NGWSFRIPKNWYAO-SHTIJGAHSA-N
29261	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Shiokawa Z (2013)	24169315	212886	9304	(3S,10As)-2-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)butanoyl]amino]acetyl]-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indole-3-carboxamide	Q27452924|(3S,10AS)-2-[(2S)-2-CYCLOHEXYL-2-[[(2S)-2-(METHYLAMINO)BUTANOYL]AMINO]ACETYL]-N-[(4R)-3,4-DIHYDRO-2H-CHROMEN-4-YL]-3,4,10,10A-TETRAHYDRO-1H-PYRAZINO[1,2-A]INDOLE-3-CARBOXAMIDE|(3S,10AS)-2-[(2S)-2-CYCLOHEXYL-2-{[(2S)-2-(METHYLAMINO)BUTANOYL]AMINO}ACETYL]-N-[(4R)-3,4-DIHYDRO-2H-CHROMEN-4-YL]-1,2,3,4,10,10A-HEXAHYDROPYRAZINO[1,2-A]INDOLE-3-CARBOXAMIDE|2DY|BDBM50443812	-	PUBCHEM	60198985	C34H45N5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TYXHMZBEDPKUQY-HDFVOGAFSA-N
29262	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Shiokawa Z (2013)	24169315	212886	9305	(3S,10As)-8-cyano-2-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)butanoyl]amino]acetyl]-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indole-3-carboxamide	(3S,10AS)-8-CYANO-2-[(2S)-2-CYCLOHEXYL-2-[[(2S)-2-(METHYLAMINO)BUTANOYL]AMINO]ACETYL]-N-[(4R)-3,4-DIHYDRO-2H-CHROMEN-4-YL]-3,4,10,10A-TETRAHYDRO-1H-PYRAZINO[1,2-A]INDOLE-3-CARBOXAMIDE|BDBM50443808	-	PUBCHEM	60198193	C35H44N6O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XIVQNOQUXQCLEI-NSKQSPGJSA-N
29263	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Shiokawa Z (2013)	24169315	212886	9306	(3S,10As)-8-chloro-2-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)butanoyl]amino]acetyl]-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indole-3-carboxamide	(3S,10AS)-8-CHLORO-2-[(2S)-2-CYCLOHEXYL-2-[[(2S)-2-(METHYLAMINO)BUTANOYL]AMINO]ACETYL]-N-[(4R)-3,4-DIHYDRO-2H-CHROMEN-4-YL]-3,4,10,10A-TETRAHYDRO-1H-PYRAZINO[1,2-A]INDOLE-3-CARBOXAMIDE|(3S)-N-[(4R)-3,4-DIHYDRO-2H-1-BENZOPYRAN-4BETA-YL]-2-[(S)-[(2S)-2-(METHYLAMINO)BUTANOYL]AMINOCYCLOHEXYLACETYL]-8-CHLORO-1,2,3,4,10,10AALPHA-HEXAHYDROPYRAZINO[1,2-A]INDOLE-3ALPHA-CARBOXAMIDE|BDBM50443807	-	PUBCHEM	60198300	C34H44ClN5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XDBOAVJEQWZFNY-HDFVOGAFSA-N
29264	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Shiokawa Z (2013)	24169315	212886	9307	(3S,10As)-6,8-dichloro-2-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)butanoyl]amino]acetyl]-N-[(4R)-3,4-dihydro-2H-chromen-4-yl]-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indole-3-carboxamide	(3S,10AS)-6,8-DICHLORO-2-[(2S)-2-CYCLOHEXYL-2-[[(2S)-2-(METHYLAMINO)BUTANOYL]AMINO]ACETYL]-N-[(4R)-3,4-DIHYDRO-2H-CHROMEN-4-YL]-3,4,10,10A-TETRAHYDRO-1H-PYRAZINO[1,2-A]INDOLE-3-CARBOXAMIDE|BDBM50443806	-	PUBCHEM	72736709	C34H43Cl2N5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KSALHYXGSMEPIV-MYEJIDBFSA-N
29265	110309	4139	-	MARK1	MARK|Par-1c|Par1c	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29266	110309	4139	-	MARK1	MARK|Par-1c|Par1c	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29267	117727	26524	-	LATS2	KPM	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29268	117727	26524	-	LATS2	KPM	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29269	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29270	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29271	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
29272	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29273	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29274	124084	84446	-	BRSK1	hSAD1	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29275	124084	84446	-	BRSK1	hSAD1	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29276	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29277	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29278	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29279	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29280	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29281	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29282	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
29283	127260	150094	-	SIK1	MSK|SIK|SNF1LK	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29284	127260	150094	-	SIK1	MSK|SIK|SNF1LK	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29285	127260	150094	-	SIK1	MSK|SIK|SNF1LK	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1242	Dasatinib	Dasatinib (anh.)|Dasatinib|N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide|BMS dasatinib|Anhydrous dasatinib|dasatinib (anhydrous)|anh. dasatinib|Dasatinibum|BDBM13216	sprycel	DRUGBANK	DB01254	C22H26ClN7O2S	small molecule	L01XE06	302962-49-8	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBNZXTGUTAYRHI-UHFFFAOYSA-N
29286	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29287	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29288	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29289	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29290	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Wells JA (2007)	18075579	224792	8613	Nutlin-3	NUTLIN-3, (-)-|NUTLIN 3|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-[4-METHOXY-2-(PROPAN-2-YLOXY)PHENYL]-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|EX-A1359|CC-452|(-)-NUTLIN-3|NUTLIN3A|Q27166862|SB19406|HMS3649P17|C30H30CL2N4O4|AS-75148|1960AH|RAC-4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NUTLIN (3A)|BCP9001003|(RAC)-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDROIMIDAZOL-1-YL)(PIPERAZIN-1-YL)METHANONE|S8059|ZINC16051336|4-((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|4-[(4S,5R)-4,5-BIS-(4-CHLORO-PHENYL)-2-(2-ISOPROPOXY-4-METHOXY-PHENYL)-4,5-DIHYDRO-IMIDAZOLE-1-CARBONYL]-PIPERAZIN-2-ONE|NUTLIN-3A CHIRAL|(4S,5R)-NUTLIN-3|2-PIPERAZINONE, 4-(((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-(4-METHOXY-2-(1-METHYLETHOXY)PHENYL)-1H-IMIDAZOL-1-YL)CARBONYL)-|4HG7|2603AH|A11501|4-[[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-4,5-DIHYDRO-2-[4-METHOXY-2-(1-METHYLETHOXY)PHENYL]-1H-IMIDAZOL-1-YL]CARBONYL]-2-PIPERAZINONE|SR-01000946691|W-5585|NUTLIN 3A|675576-98-4|UNII-53IA0V845C COMPONENT BDUHCSBCVGXTJM-WUFINQPMSA-N|NUTLIN-3A, >=98% (HPLC)|4-(4,5-BIS(4-CHLOROPHENYL)-2-(2-ISOPROPOXY-4-METHOXYPHENYL)-4, 5-DIHYDRO-1H-IMIDAZOLE-1-CARBONYL)PIPERAZIN-2-ONE|NCGC00344347-05|NUTLIN-3A|SC-95163|UNII-L7C92IOE65|AKOS027422740|4J3E|4-[(4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(4-METHOXY-2-PROPAN-2-YLOXYPHENYL)-4,5-DIHYDROIMIDAZOLE-1-CARBONYL]PIPERAZIN-2-ONE|HY-10029|CS-0296|SR-01000946691-1|NUTLIN-3A (CHIRAL)|L7C92IOE65|BDBM50229787	-	CHEMSPIDER	187530	C30H30Cl2N4O4	small molecule	-	548472-68-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BDUHCSBCVGXTJM-UHFFFAOYSA-N
29291	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Wells JA (2007)	18075579	224792	9309	DI-Chloro-benzo-diazepine	BENZODIAZEPINEDIONE, 1|(2S)-(4-CHLOROPHENYL)[(3S)-3-(4-CHLOROPHENYL)-7-IODO-2,5-DIOXO-1,2,3,5-TETRAHYDRO-4H-1,4-BENZODIAZEPIN-4-YL]ETHANOIC ACID|BMCL163310 COMPOUND 1|Q27459367|TDP-222669|(4-CHLOROPHENYL)[3-(4-CHLOROPHENYL)-7-IODO-2,5-DIOXO-1,2,3,5-TETRAHYDRO-4H-1,4-BENZODIAZEPIN-4-YL]ACETIC ACID|DIZ|(2S)-2-(4-CHLOROPHENYL)-2-[(3S)-3-(4-CHLOROPHENYL)-7-IODO-2,5-DIOXO-1,3-DIHYDRO-1,4-BENZODIAZEPIN-4-YL]ACETIC ACID|1T4E|JNJ-38732382|DI-CHLORO-BENZO-DIAZEPINE|BDBM31285	-	PUBCHEM	656933	C23H15Cl2IN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HQEQUYKKMMKSSX-PMACEKPBSA-N
29292	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi Q (2007)	18029178	224793	9310	3-[4-[3-[(1R)-1-[(5-Chloro-3-methyl-1-benzothiophene-2-carbonyl)amino]ethyl]-5-fluorophenoxy]-2-ethylphenyl]propanoic acid	(R)-3-(4-(3-(1-(5-CHLORO-3-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDO)ETHYL)-5-FLUOROPHENOXY)-2-ETHYLPHENYL)PROPANOIC ACID|BDBM50227754	-	PUBCHEM	44434362	C29H27ClFNO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WQCJKMGDGUHOFD-QGZVFWFLSA-N
29293	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi Q (2007)	18029178	224793	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29294	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Rydzewski RM (2006)	16686537	132619	9311	Benzyl N-[(2S,3S)-1-[[(2S)-4-(2,2-dimethylpropylamino)-1-[[(2S)-1-[[(E,3S)-5-methyl-1-methylsulfonylhex-1-en-3-yl]amino]-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamate	CBZ-ILE-NEOPENTYLASN-ALA-LEUVSME|BDBM50186721	-	PUBCHEM	11542118	C34H55N5O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LHKDGGRUJJWIPS-NBSSRRDYSA-N
29295	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Rydzewski RM (2006)	16686537	132619	9312	Tert-butyl (4S)-5-[[(2S)-1-[[(E,3S)-5-methyl-1-methylsulfonylhex-1-en-3-yl]amino]-1-oxopropan-2-yl]amino]-4-[[(2S,3S)-3-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-oxopentanoate	CBZ-ILE-GLU(OTBU)-ALA-LEUVSME|BDBM50186709	-	PUBCHEM	11556651	C34H54N4O9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZUSJEPYDXSSIAZ-NHVLHDLVSA-N
29296	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Rydzewski RM (2006)	16686537	132619	9313	(2S)-N'-(2,2-Dimethylpropyl)-N-[(2S)-1-[[(E,3S)-5-methyl-1-methylsulfonylhex-1-en-3-yl]amino]-1-oxopropan-2-yl]-2-[(4-methylphenyl)sulfonylamino]butanediamide	PTOSYL-NEOPENTYLASN-ALA-LEUVSME|BDBM50186696	-	PUBCHEM	11671614	C27H44N4O7S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SJRZTCJLZWVMBR-FGXWTBHQSA-N
29297	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Marastoni M (2006)	16603348	224794	9314	2-[[2-[Acetyl(methyl)amino]-3-methylpentanoyl]amino]-N-[3-hydroxy-1-[[4-methyl-1-(2-methyloxiran-2-yl)-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]-3-methylpentanamide	AKOS032947211|134381-21-8|BDBM50370717	-	PUBCHEM	9915668	C28H50N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DOGIDQKFVLKMLQ-UHFFFAOYSA-N
29298	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Marastoni M (2006)	16603348	224794	9315	Benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(E,3S)-5-methyl-1-methylsulfonylhex-1-en-3-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate	HMS1362N19|NCGC00163486-01|BENZYL (S)-4-METHYL-1-((S)-4-METHYL-1-((S,E)-5-METHYL-1-(METHYLSULFONYL)HEX-1-EN-3-YLAMINO)-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLCARBAMATE|CARBOBENZYLOXY-LEU-LEU-LEU-VINYL SULFONE|BRD-K15935639-001-02-0|HMS3403N19|BCBCMAP01_000228|193482-47-2|Z-LEU3-VS|L-LEUCINAMIDE, N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N-[(1S)-3-METHYL-1-[(E)-2-(METHYLSULFONYL)ETHENYL]BUTYL]-|HMS1990N19|IDI1_002214|BSPBIO_001238|NCGC00163486-02|L-LEUCINAMIDE, N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N-[(1S)-3-METHYL-1-[(1E)-2-(METHYLSULFONYL)ETHENYL]BUTYL]- (9CI)|HMS1792N19|BDBM50185157	-	PUBCHEM	5497183	C28H45N3O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DHLFJZAIZCMWEO-JDGFICQVSA-N
29299	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dropinski JF (2005)	16153845	224795	9316	1-(4-Tert-butylphenyl)-3-[3-(trifluoromethyl)phenoxy]indole-2-carboxylic acid	1-(4-TERT-BUTYL-PHENYL)-3-(3-TRIFLUOROMETHYL-PHENOXY)-1H-INDOLE-2-CARBOXYLIC ACID|BDBM50173359	-	PUBCHEM	11546956	C26H22F3NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QEDIKMQCSOVILD-UHFFFAOYSA-N
29300	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	unknown	target	Grasberger BL (2005)	15715460	224796	9309	DI-Chloro-benzo-diazepine	BENZODIAZEPINEDIONE, 1|(2S)-(4-CHLOROPHENYL)[(3S)-3-(4-CHLOROPHENYL)-7-IODO-2,5-DIOXO-1,2,3,5-TETRAHYDRO-4H-1,4-BENZODIAZEPIN-4-YL]ETHANOIC ACID|BMCL163310 COMPOUND 1|Q27459367|TDP-222669|(4-CHLOROPHENYL)[3-(4-CHLOROPHENYL)-7-IODO-2,5-DIOXO-1,2,3,5-TETRAHYDRO-4H-1,4-BENZODIAZEPIN-4-YL]ACETIC ACID|DIZ|(2S)-2-(4-CHLOROPHENYL)-2-[(3S)-3-(4-CHLOROPHENYL)-7-IODO-2,5-DIOXO-1,3-DIHYDRO-1,4-BENZODIAZEPIN-4-YL]ACETIC ACID|1T4E|JNJ-38732382|DI-CHLORO-BENZO-DIAZEPINE|BDBM31285	-	PUBCHEM	656933	C23H15Cl2IN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HQEQUYKKMMKSSX-PMACEKPBSA-N
29301	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Bao J (2005)	15603971	224797	9317	[(1S,8R,9R,10S,12R,13R)-9,10-Diacetyloxy-8-[(1R)-1-acetyloxyethyl]-16-[(2R)-2-(2-ethoxyphenyl)propyl]-16-hydroxy-1,12,15-trimethyl-6-oxatetracyclo[9.8.0.02,8.012,17]nonadeca-3,14-dien-13-yl] acetate	ACETICACID(R)-1-{(4R,4AR,5S,6R,6AR,11BS)-4,5,6-TRIACETOXY-1-[2-((R)-2-ETHOXY-PHENYL)-PROPYL]-1-HYDROXY-2,4A,11B-TRIMETHYL-1,2,3,4,4A,4B,5,6,9,11A,11B,12,13,13A-TETRADECAHYDRO-8-OXA-CYCLOHEPTA[A]PHENANTHREN-6A-YL}-ETHYL ESTER|BDBM50158218	-	PUBCHEM	44388853	C42H58O11	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UGQIUGDLIPCZDN-CHRSBYMISA-N
29302	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Bao J (2005)	15603971	224797	9318	Correloid	CORRELOID|BDBM50158201	-	PUBCHEM	44389018	C40H52O16	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VKDXHXWBOARFPD-MDAQDJAWSA-N
29303	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Nikolovska-Coleska Z (2004)	15115387	212873	9319	2-[[(2S)-5-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-6-[[2-(2,5-dioxopyrrolidin-1-yl)oxycarbonyl-6-(3-hydroxy-6-oxoxanthen-9-yl)benzoyl]amino]-3-methylhexanoic acid	BDBM50145772	-	PUBCHEM	44460525	C63H75N13O17	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PCMHILZLYCFWKH-LDZDWOFMSA-N
29304	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	unknown	target	Nikolovska-Coleska Z (2004)	15115387	212873	9320	(2S)-6-Amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2R)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid	6-AMINO-2-[(S)-2-((S)-2-{(S)-2-[((R)-{1-[(S)-2-((S)-2-AMINO-PROPIONYLAMINO)-5-GUANIDINO-1-OXO-PENTYL]-PYRROLIDIN-2-YL}-OXO-METHYL)-AMINO]-1-OXO-3-PHENYL-PROPYLAMINO}-1-OXO-PROPYLAMINO)-4-CARBAMOYL-1-OXO-BUTYLAMINO]-HEXANOIC ACID|BDBM50145770	-	PUBCHEM	44460459	C37H60N12O9	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CGCXTKPVWBLRRX-AGFHODQESA-N
29305	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Miao S (2003)	12643934	224798	9321	BDBM50125526	-	-	CHEMBL	CHEMBL16683	C25H31N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DWUAIAOAUXYSMK-WBANQOEISA-N
29306	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	unknown	target	He Y (2017)	28135237	224799	9322	A-395	(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(4-(4-(methylsulfonyl)piperazin-1-yl)phenyl)pyrrolidin-3-amine|2089148-72-9|GTPL9525|HY-101512|CS-0021615|J3.609.234C|(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-[4-(4-methylsulfonylpiperazin-1-yl)phenyl]pyrrolidin-3-amine|rel-(3R,4S)-1-(7-Fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(4-(4-(methylsulfonyl)piperazin-1-yl)phenyl)pyrrolidin-3-amine|rac-(3R,4S)-1-(7-fluoro-2,3-dihydro-1H-inden-1-yl)-N,N-dimethyl-4-(4-(4-(methylsulfonyl)piperazin-1-yl)phenyl)pyrrolidin-3-amine (4)|BDBM223987|BDBM50241662	-	PUBCHEM	123132213	C26H35FN4O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CMZCLMBPMLFJJU-YVEFUNNKSA-N
29307	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	unknown	target	Qi W (2017)	28135235	224800	9323	N-(Furan-2-Ylmethyl)-8-(4-Methylsulfonylphenyl)-[1,2,4]triazolo[4,3-C]pyrimidin-5-Amine	KS-00000U9I|N-(FURAN-2-YLMETHYL)-8-(4-(METHYLSULFONYL)PHENYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE|S8496|AK684382|CS-6391|N-[(FURAN-2-YL)METHYL]-8-(4-METHANESULFONYLPHENYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE|EX-A1724|AS-74203|N-(FURAN-2-YLMETHYL)-8-(4-METHYLSULFONYLPHENYL)-[1,2,4]TRIAZOLO[4,3-C]PYRIMIDIN-5-AMINE|EED-226|AKOS030632048|2083627-02-3|AC-29879|BCP19849|CCG-268284|MAK683(EED226/COMPOUND 43)|J3.609.221A|SB40406|ACN-051243|EED226|HY-101117|BDBM225230	-	PUBCHEM	123132228	C17H15N5O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DYIRSNMPIZZNBK-UHFFFAOYSA-N
29308	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Nalawansha DA (2017)	27977115	224801	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29309	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Nalawansha DA (2017)	27977115	224801	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29310	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Miyake Y (2016)	27454931	224802	9324	(2E,4S,5E)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,5-dienamide	S-TSA|BDBM197337	-	PUBCHEM	122198566	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ALCVRKZFLFWUAZ-CSFUQHBASA-N
29311	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Miyake Y (2016)	27454931	224802	9325	(2E,4R,5E)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,5-dienamide	R-TSA|BDBM197336	-	PUBCHEM	122198565	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ALCVRKZFLFWUAZ-LSSUCPAZSA-N
29312	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li J (2016)	27235003	224803	4802	Belinostat	UNII-F4H96P17NZ|NSC-726630|ZINC3818726|ABP000140|866323-14-0|SC-71101|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|SW219445-1|NSC726630|BELEODAQ|BCPP000351|EX-A180|PX 105684|QCR-181|BCP01741|BRD-K17743125-001-01-9|GTPL7496|(E)-N-HYDROXY-3-(3-(N-PHENYLSULFAMOYL)PHENYL)ACRYLAMIDE|BELINOSTAT - PXD101|SB16466|CC-489|AOB87787|BELINOSTAT|AX8144528|MLS006011091|AC-25046|AB0007889|BELINOSTAT (PXD101)|BELINOSTAT,PXD101, PX105684|W-5363|(E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|414864-00-9|D08870|(E)-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENEHYDROXAMIC ACID|BELINOSTAT [USAN:INN]|SMR004702879|Q4882925|E-BELINOSTAT|BELINOSTAT (PXD101)|PXD101|PXD 101|N-HYDROXY-3-(3-PHENYLSULPHAMOYLPHENYL)ACRYLAMIDE|API0003555|BELINOSTAT (USAN/INN)|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]ACRYLAMIDE|BELEODAQ (TN)|PUBCHEM22405|NCGC00263155-05|(E)-N-HYDROXY-3-(3-PHENYLSULFAMOYL-PHENYL)-ACRYLAMIDE|PXD-101|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PR|S1085|LS41098|PX-105684|BELINOSTAT PH3|N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE|EC-000.2286|BELINOSTAT/PXD101,PX105684/|5OG|DTXSID60194378|2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-, (2E)-|BCP9000386|PX105684|F4H96P17NZ|N-HYDROXY-3-[(PHENYLAMINO)SULFONYL]-TRANS-CINNAMAMIDE|AS-17068|BELINOSTAT(RANDOM CONFIGURATION)|A25012|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE|AKOS025401741|N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE|CCG-208758|2-PROPENAMIDE, N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-, (2E)-|DB05015|J-523584|BDBM25150	beleodaq	DRUGBANK	DB05015	C15H14N2O4S	small molecule	L01XX49	866323-14-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NCNRHFGMJRPRSK-MDZDMXLPSA-N
29313	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li J (2016)	27235003	224803	9326	(E)-N-Hydroxy-3-[3-[[(1S)-2-(naphthalen-1-ylamino)-2-oxo-1-phenylethyl]sulfamoyl]phenyl]prop-2-enamide	(S,E)-N-HYDROXY-3-(3-(N-(2-(NAPHTHALEN-1-YLAMINO)-2-OXO-1-PHENYLETHYL)SULFAMOYL)PHENYL)ACRYLAMIDE (10S)|BDBM198192	-	PUBCHEM	122198640	C27H23N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JCEFNCFZXQDHRY-ZOGILVBSSA-N
29314	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Sundberg TB (2016)	27224444	224804	9327	3-(2-Chloro-6-methylphenyl)-7-[2-methoxy-4-(1-methylpiperidin-4-yl)anilino]-1-(5-methoxypyridin-2-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one	BCP20631|YKL-05-099 (5)|CS-6458|SB18778|YKL-05-099|1936529-65-5|HY-101147|ZINC669678976|BDBM192716	-	PUBCHEM	121596782	C32H34ClN7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VQINULODWGEVBB-UHFFFAOYSA-N
29315	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Sundberg TB (2016)	27224444	224804	9328	3-(2-Chloro-6-methylphenyl)-7-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-1-(5-methoxypyridin-2-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one	YKL-05-096 (4)|BDBM192715	-	PUBCHEM	121596781	C31H33ClN8O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JPYJYNNIQRTRFF-UHFFFAOYSA-N
29316	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Sundberg TB (2016)	27224444	224804	9329	3-(2-Chloro-6-methylphenyl)-1-(5-methoxypyridin-2-yl)-7-[4-(4-methylpiperazin-1-yl)anilino]-4H-pyrimido[4,5-d]pyrimidin-2-one	YKL-05-095 (3)|BDBM192714	-	PUBCHEM	121596780	C30H31ClN8O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGLSPBMOSOBBBC-UHFFFAOYSA-N
29317	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Sundberg TB (2016)	27224444	224804	9330	3-(2-Chloro-6-methylphenyl)-1-(2,4-dimethoxyphenyl)-7-[4-(4-methylpiperazin-1-yl)anilino]-4H-pyrimido[4,5-d]pyrimidin-2-one	HG-9-91-01 DERIVATIVE, 2|BDBM192713	-	PUBCHEM	121596779	C32H34ClN7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WBAFRLZXKALIGS-UHFFFAOYSA-N
29318	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Sundberg TB (2016)	27224444	224804	9331	CID 78357808	HG-9-91-01 (1)|HG-9-91-01 (SIK INHIBITOR 1)|HY-15776|S8393|NCGC00378591-01|EX-A1279|N-(2,4-DIMETHOXYPHENYL)-N'-(2,6-DIMETHYLPHENYL)-N-{6-[4-(4-METHYLPIPERAZIN-1-YL)ANILINO]PYRIMIDIN-4-YL}UREA|1-(2,4-DIMETHOXYPHENYL)-3-(2,6-DIMETHYLPHENYL)-1-[6-[4-(4-METHYLPIPERAZIN-1-YL)ANILINO]PYRIMIDIN-4-YL]UREA|SIK INHIBITOR 1; HG 9-91-01; HG9-91-01; HG99101; HG-99101; HG 99101|ZINC147474927|CS-1749|SIK INHIBITOR 1|1456858-58-4|GTPL8049|HG-9-91-01|BCP25041|Q27077982|1-(2,4-DIMETHOXYPHENYL)-3-(2,6-DIMETHYLPHENYL)-1-(6-((4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4-YL)UREA|BDBM192712	-	PUBCHEM	78357808	C32H37N7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UYUHRKLITDJEHB-UHFFFAOYSA-N
29319	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yoo J (2016)	27060764	224805	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29320	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yoo J (2016)	27060764	224805	9332	N-Hydroxy-4-[2-[(E)-2-phenylethenyl]-1,3-thiazol-4-yl]butanamide	ONC(CCCC=1N=C(SC=1)\C=C\C1=CC=CC=C1)=O|BDBM50156678	-	PUBCHEM	102514716	C15H16N2O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HJPIJALRLZVGMS-MDZDMXLPSA-N
29321	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yoo J (2016)	27060764	224805	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29322	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Flick AC (2016)	27020685	224806	9333	Lobeglitazone sulfate	CKD 501|LOBEGLITAZONE SULFATE|CKD-501|2,4-THIAZOLIDINEDIONE, 5-((4-(2-((6-(4-METHOXYPHENOXY)-4- PYRIMIDINYL)METHYLAMINO)ETHOXY)PHENYL)METHYL)-, SULFATE (1:1)|SB16870|Q27271778|BDBM50152829	-	PUBCHEM	15951505	C24H26N4O9S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IFBYQAMJTBOBHB-UHFFFAOYSA-N
29323	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Waszkielewicz AM (2016)	26988801	224807	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29324	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9334	[(1S)-1-[[3-(3-Fluorophenyl)-3-[[(1S)-1,2,3,4-tetrahydronaphthalene-1-carbonyl]amino]propanoyl]amino]-3-methylbutyl]boronic acid	BDBM50160869	-	PUBCHEM	127032443	C25H32BFN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GVCLUQUSDQUHGE-OCESARCHSA-N
29325	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9335	[(1R)-3-Methyl-1-[[(2S)-3-phenyl-2-(5,6,7,8-tetrahydronaphthalene-1-carbonylamino)propanoyl]amino]butyl]boronic acid	BDBM50160868	-	PUBCHEM	44190247	C25H33BN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MZHTUAPXZCUHOQ-GOTSBHOMSA-N
29326	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9336	[(1R)-3-Methyl-1-[[(2S)-3-phenyl-2-[[(1S)-1,2,3,4-tetrahydronaphthalene-1-carbonyl]amino]propanoyl]amino]butyl]boronic acid	BDBM50160867	-	PUBCHEM	44191199	C25H33BN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HLDAUCRRBXUURL-VABKMULXSA-N
29327	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9337	[(1R)-1-[[(2S)-2-(Cyclopentanecarbonylamino)-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid	BDBM50160790	-	PUBCHEM	127032450	C20H31BN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HSLNJWMBARSHCF-ROUUACIJSA-N
29328	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9338	[(1R)-1-[[(2S)-2-(3,3-Dimethylbutanoylamino)-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid	BDBM50160783	-	PUBCHEM	127031260	C20H33BN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JHFWWIFBVREJLE-IRXDYDNUSA-N
29329	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9339	[(1R)-1-[[(2S)-2-(Butanoylamino)-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid	BDBM50160781	-	PUBCHEM	127032449	C18H29BN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HWPLIQKUQGRWFY-HOTGVXAUSA-N
29330	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9340	[(1R)-1-[[(2S)-2-(3-Methoxypropanoylamino)-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid	BDBM50160780	-	PUBCHEM	127032448	C18H29BN2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HZJJGJFERHRLCB-HOTGVXAUSA-N
29331	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	9341	[(1R)-1-[[(2S)-2-[(2-Methoxyacetyl)amino]-3-phenylpropanoyl]amino]-3-methylbutyl]boronic acid	BDBM50160778	-	PUBCHEM	127032447	C17H27BN2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FYRGCNALHUEGIG-GJZGRUSLSA-N
29332	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Shi J (2016)	26965867	224808	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
29334	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Simov V (2016)	26927423	224809	9342	BDBM50152595	-	-	CHEMBL	CHEMBL3780091	C18H21N5O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLWGOAGEDWMEBT-TXEJJXNPSA-N
29335	124084	84446	-	BRSK1	hSAD1	9606	Homo sapiens	unknown	target	Simov V (2016)	26927423	224809	9342	BDBM50152595	-	-	CHEMBL	CHEMBL3780091	C18H21N5O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLWGOAGEDWMEBT-TXEJJXNPSA-N
29336	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Mariano M (2016)	26896709	224810	4571	5-Quinoxalin-6-ylmethylene-thiazolidine-2,4-dione	5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINEDIONE|ZINC12504504|S1410|2A5U|SR-02000000919|GTPL6023|(5Z)-5-(QUINOXALIN-6-YLMETHYLIDENE)-1,3-THIAZOLIDINE-2,4-DIONE|ABP000101|AOB3848|AS605240|NCGC00261632-01|BCP9000323|5-QUINOXALIN-6-YLMETHYLENETHIAZOLIDINE-2,4-DIONE|BCP02097|CCG-101300|1287651-14-2|J-516278|HMS3650I15|AS 605240,5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINE-2,4-DIONE|(Z)-5-(QUINOXALIN-6-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE|AS 605240|HMS3262N16|SDCCGSBI-0086699.P002|TOX21_500947|AS-605240/AS605240|CC-118|LP00947|5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE|Q27088381|PI 3-KGAMMA INHIBITOR|QYT|648450-29-7|DB04769|SR-02000000919-2|HY-10109|5-[(QUINOXALIN-6-YL)METHYLIDENE]-1,3-THIAZOLIDINE-2,4-DIONE|BRD-K76773351-001-01-9|(5E)-5-(QUINOXALIN-6-YLMETHYLENE)-1,3-THIAZOLIDINE-2,4-DIONE|CS-0084|AS605240, >=98% (HPLC)|5-(6-QUINOXALINYLMETHYLENE)-2,4-THIAZOLIDINE-2,4-DIONE|5-(QUINOXALIN-6-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE|SB19245|AKOS024457698|AS-16768|W-5475|NCGC00186030-01|AS-605240|PI 3-KG INHIBITOR|HMS3229I19|BDBM50324735	-	DRUGBANK	DB04769	C12H7N3O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SQWZFLMPDUSYGV-POHAHGRESA-N
29337	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Mariano M (2016)	26896709	224810	9343	(3E)-3-(1,3-Benzothiazol-6-ylmethylidene)oxolan-2-one	BDBM50154348	-	PUBCHEM	127032014	C12H9NO2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FMOOGIYSVBVFIT-WEVVVXLNSA-N
29338	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Mariano M (2016)	26896709	224810	9344	(5Z)-5-(Quinolin-6-ylmethylidene)-2-sulfanylidene-1,3-thiazolidin-4-one	5-[1-QUINOLIN-6-YL-METH-(Z)-YLIDENE]-2-THIOXO-THIAZOLIDIN-4-ONE|(5Z)-5-(QUINOLIN-6-YLMETHYLIDENE)-2-SULFANYLIDENE-1,3-THIAZOLIDIN-4-ONE|ZINC9908493|BDBM50154342	-	PUBCHEM	11666231	C13H8N2OS2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZFGAUFCQRUSRCF-XFFZJAGNSA-N
29339	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9345	5-Benzyl-2-(1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151283	-	PUBCHEM	126582837	C20H18F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JJZFDILZILDRTQ-UHFFFAOYSA-N
29340	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9346	5-Cyclopropyl-2-(5-methyl-1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151282	-	PUBCHEM	126582839	C17H18F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GJSCCYDUKNGSLB-UHFFFAOYSA-N
29341	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9347	5-Cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151281	-	PUBCHEM	126582843	C20H22F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZUPRHDPCDWVJDA-UHFFFAOYSA-N
29342	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9348	5-(2-Methylpropyl)-2-(1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151280	-	PUBCHEM	126582841	C17H20F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AZLBBFOVLFWKTC-UHFFFAOYSA-N
29343	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9349	5-Cyclopropyl-2-(1,3-thiazol-2-yl)-N-(5,5,5-trifluoro-4-oxopentyl)-1,3-thiazole-4-carboxamide	BDBM50151278	-	PUBCHEM	126582908	C15H14F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UVCSQKKFUYQSGT-UHFFFAOYSA-N
29344	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9350	5-Cyclopropyl-2-(1,3-thiazol-2-yl)-N-(6,6,6-trifluoro-5-oxohexyl)-1,3-thiazole-4-carboxamide	BDBM50151277	-	PUBCHEM	91938063	C16H16F3N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OHRUWOKDVPCLPC-UHFFFAOYSA-N
29345	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Gong CJ (2016)	26890114	224811	9351	5-Cyclopropyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide	BDBM50020897	-	PUBCHEM	71468161	C15H18N4O3S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVJAEZIEZVJAFM-UHFFFAOYSA-N
29346	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9352	3-Pyrazin-2-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144216	-	PUBCHEM	127028943	C14H19N5OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYWQCXUVPDWXRB-UHFFFAOYSA-N
29347	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9353	3-(1H-Indol-3-yl)-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144214	-	PUBCHEM	137174935	C18H22N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QTJRTUWSBZMZMT-UHFFFAOYSA-N
29348	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9354	N-(6-Sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144212	-	PUBCHEM	127026695	C10H17N3OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OJQALHBLSWWPHJ-UHFFFAOYSA-N
29349	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9355	3-Phenyl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144210	-	PUBCHEM	127027677	C16H21N3OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SZTCVPCNBUBKBA-UHFFFAOYSA-N
29350	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9356	3-(3,4-Dimethoxyphenyl)-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50144209	-	PUBCHEM	127027679	C18H25N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KATIKUFCGSOWFA-UHFFFAOYSA-N
29351	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9357	N-(6-Sulfanylhexyl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazole-5-carboxamide	BDBM50144208	-	PUBCHEM	127027680	C19H27N3O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIUNIEQHYXYXSL-UHFFFAOYSA-N
29352	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9358	3-Pyridin-4-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50143997	-	PUBCHEM	127027995	C15H20N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KYZMEJZVXICXQX-UHFFFAOYSA-N
29353	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9359	3-Pyridin-3-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50143996	-	PUBCHEM	127025178	C15H20N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMHAIDYPJKYSES-UHFFFAOYSA-N
29354	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9360	3-Pyridin-2-yl-N-(6-sulfanylhexyl)-1H-pyrazole-5-carboxamide	BDBM50143995	-	PUBCHEM	127028973	C15H20N4OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VRGLHLDCWONREK-UHFFFAOYSA-N
29355	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29356	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26814680	224812	9361	7-Mercapto-heptanoic acid phenylamide	ZINC13609304|7-MERCAPTO-HEPTANOIC ACID PHENYLAMIDE|N-PHENYL-7-SULFANYLHEPTANAMIDE|THIOL-SAHA (T-SAHA)|BDBM152692	-	PUBCHEM	11379392	C13H19NOS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CFKBMXXDXYFDET-UHFFFAOYSA-N
29357	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Ghosh B (2016)	26804233	224813	9362	N'-Hydroxy-N-[(E)-(4-pyridin-3-ylphenyl)methylideneamino]heptanediamide	BRD-K51966546-001-02-2|BDBM50143887	-	PUBCHEM	73707550	C19H22N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SOSXJHXYTVYMTE-FYJGNVAPSA-N
29358	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Ghosh B (2016)	26804233	224813	9363	N'-Hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]heptanediamide	J3.581.861H|7-OXO-7-[2-[(Z)-(BIPHENYL-4-YL)METHYLENE]HYDRAZINO]HEPTANEHYDROXAMIC ACID|BRD-K35010406-001-01-1|BDBM50143884	-	PUBCHEM	25118059	C20H23N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AEIVDBATQVVQFS-RCCKNPSSSA-N
29359	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Peng FW (2016)	26741358	224814	9364	7-[4-(4-Bromoanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide	BDBM50142796	-	PUBCHEM	127028030	C22H25BrN4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BNWIAUUKBJSRSZ-UHFFFAOYSA-N
29360	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Ndubaku CO (2015)	26713112	224815	9365	BDBM50148921	-	-	CHEMBL	CHEMBL3770443	C25H25ClN6O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBCMHWUFWQFPLV-VVOJOOEHSA-N
29361	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Alverez C (2015)	26713109	224816	9366	1-[3-(5-Nitro-1H-indol-2-yl)phenyl]-N-[2-(4-propan-2-ylpiperazin-1-yl)ethyl]piperidin-4-amine	J3.640.579A|C(C)(C)N1CCN(CC1)CCNC1CCN(CC1)C1=CC(=CC=C1)C=1NC2=CC=C(C=C2C=1)[N+](=O)[O-]|N-[2-(4-ISOPROPYLPIPERAZINO)ETHYL]-1-[3-(5-NITRO-1H-INDOLE-2-YL)PHENYL]PIPERIDINE-4-AMINE|BDBM50158905	-	PUBCHEM	127031857	C28H38N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QOGCSASIXKSUDD-UHFFFAOYSA-N
29362	124197	84678	-	KDM2B	CXXC2|FBXL10|Fbl10|JHDM1B|PCCX2	9606	Homo sapiens	unknown	target	McAllister TE (2016)	26710088	224817	9367	2-(1-Methylimidazol-4-yl)-4-(2H-tetrazol-5-yl)pyridine	2-(1-METHYL-1H-IMIDAZOL-4-YL)-4- (2H-TETRAZOL-5-YL)PYRIDINE|2-(1-METHYL-1H-IMIDAZOL-4-YL)-4-(2H-TETRAZOL-5-YL)PYRIDINE|2-(1-METHYLIMIDAZOL-4-YL)-4-(2H-TETRAZOL-5-YL)PYRIDINE|US10273222, EXAMPLE 62|BDBM50158696	-	PUBCHEM	90407594	C10H9N7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JYEUQFOUZAUNTD-UHFFFAOYSA-N
29363	124197	84678	-	KDM2B	CXXC2|FBXL10|Fbl10|JHDM1B|PCCX2	9606	Homo sapiens	unknown	target	McAllister TE (2016)	26710088	224817	9368	2-[5-[4-(Cyclopropylmethoxy)phenyl]-1-methylimidazol-4-yl]pyridine-4-carboxylic acid	2-[5-[4-(CYCLOPROPYLMETHOXY)PHENYL]-1-METHYLIMIDAZOL-4-YL]PYRIDINE-4-CARBOXYLIC ACID|BDBM50158695	-	PUBCHEM	90407841	C20H19N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWJQMQXBUJYTHO-UHFFFAOYSA-N
29364	124197	84678	-	KDM2B	CXXC2|FBXL10|Fbl10|JHDM1B|PCCX2	9606	Homo sapiens	unknown	target	McAllister TE (2016)	26710088	224817	9369	2-[5-(4-Methoxyphenyl)-1-methylimidazol-4-yl]pyridine-4-carboxylic acid	2-[5-(4-METHOXYPHENYL)-1-METHYLIMIDAZOL-4-YL]PYRIDINE-4-CARBOXYLIC ACID|NCGC00390841-01|BDBM50158694	-	PUBCHEM	90407809	C17H15N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XGBOARWPNSLLHZ-UHFFFAOYSA-N
29365	124197	84678	-	KDM2B	CXXC2|FBXL10|Fbl10|JHDM1B|PCCX2	9606	Homo sapiens	unknown	target	McAllister TE (2016)	26710088	224817	9370	2-(1-Methylimidazol-4-yl)pyridine-4-carboxylic acid	2-(1-METHYLIMIDAZOL-4-YL)PYRIDINE-4-CARBOXYLIC ACID|2-(1-METHYL-1H-IMIDAZOL-4-YL)PYRIDINE-4-CARBOXYLIC ACID|BDBM50158693	-	PUBCHEM	86268882	C10H9N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CZNFQLDDPKKPMX-UHFFFAOYSA-N
29366	124197	84678	-	KDM2B	CXXC2|FBXL10|Fbl10|JHDM1B|PCCX2	9606	Homo sapiens	unknown	target	McAllister TE (2016)	26710088	224817	9371	2-{5-[(4-Chloro-2-Methylphenyl)methoxy]-1h-Pyrazol-1-Yl}pyridine-4-Carboxylic Acid	2-(5-((4-CHLORO-2-METHYLBENZYL)OXY)-1HPYRAZOL-1-YL)ISONICOTINIC ACID (N19)|2-[5-[(4-CHLORO-2-METHYLPHENYL)METHOXY]PYRAZOL-1-YL]PYRIDINE-4-CARBOXYLIC ACID|NCGC00390881-02|6EP|QC-3611|2-{5-[(4-CHLORO-2-METHYLPHENYL)METHOXY]-1H-PYRAZOL-1-YL}PYRIDINE-4-CARBOXYLIC ACID|Q27456366|1613410-75-5|BDBM191600	-	PUBCHEM	74766595	C17H14ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PSOBPHXKKHPWMU-UHFFFAOYSA-N
29367	124197	84678	-	KDM2B	CXXC2|FBXL10|Fbl10|JHDM1B|PCCX2	9606	Homo sapiens	unknown	target	McAllister TE (2016)	26710088	224817	9372	2-(((2-((2-(Dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinic acid	2-(((2-((2-(DIMETHYLAMINO)ETHYL)(ETHYL)AMINO)-2-OXOETHYL)AMINO)METHYL)ISONICOTINIC ACID (KDM5-C49)|2-[[[2-[2-(DIMETHYLAMINO)ETHYL-ETHYLAMINO]-2-OXOETHYL]AMINO]METHYL]PYRIDINE-4-CARBOXYLIC ACID|2-[({2-[(2-(DIMETHYLAMINO)-ETHYL)(ETHYL)AMINO]-2-OXOETHYL}AMINO)METHYL]ISONICOTINIC ACID|1596348-16-1|6OQJ5L847C|KDM5-C49|UNII-6OQJ5L847C|2-(((2-((2-(DIMETHYLAMINO)ETHYL)(ETHYL)AMINO)-2-OXOETHYL)AMINO)METHYL)ISONICOTINIC ACID|4-PYRIDINECARBOXYLIC ACID, 2-(((2-((2-(DIMETHYLAMINO)ETHYL)ETHYLAMINO)-2-OXOETHYL)AMINO)METHYL)BDBM191598	-	PUBCHEM	86346639	C15H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RGGMVQDDHDCRDM-UHFFFAOYSA-N
29368	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dixit VA (2016)	26708109	224818	9373	5-{[4-(Benzyloxy)phenyl]methylene}-2,4,6(1H,3H,5H)-pyrimidinetrione	5-{[4-(PHENYLMETHOXY)PHENYL]METHYLENE}-1,3-DIHYDROPYRIMIDINE-2,4,6-TRIONE|242473-63-8|5-[4-(BENZYLOXY)BENZYLIDENE]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE|AKOS000514744|5-{[4-(BENZYLOXY)PHENYL]METHYLENE}-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE|KS-00001T0W|ZINC3139774|5-[(4-PHENYLMETHOXYPHENYL)METHYLIDENE]-1,3-DIAZINANE-2,4,6-TRIONE|ST50170955|MCULE-1677643513|12P-135|STK804651|5-[4-(BENZYLOXY)BENZYLIDENE]BARBITURIC ACID|5-{[4-(BENZYLOXY)PHENYL]METHYLIDENE}-1,3-DIAZINANE-2,4,6-TRIONE|BDBM50137109	-	PUBCHEM	2851123	C18H14N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RPNLKHSBSLHOSQ-UHFFFAOYSA-N
29369	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dixit VA (2016)	26708109	224818	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29370	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	9374	4-[3-(4-Fluorophenyl)-5-(6-sulfanylhexylcarbamoyl)pyrazol-1-yl]butanoic acid	BDBM50143530	-	PUBCHEM	127026737	C20H26FN3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GUKWYUINVSHUKE-UHFFFAOYSA-N
29371	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	9375	2-[3-(4-Fluorophenyl)-5-(6-sulfanylhexylcarbamoyl)pyrazol-1-yl]acetic acid	BDBM50143508	-	PUBCHEM	127026735	C18H22FN3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KDSZJUGHUQDOGC-UHFFFAOYSA-N
29372	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	9376	(1R,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone	ROMIDEPSIN (FK228, DEPSIPEPTIDE)|ZINC136702520|128517-07-7|BDBM50048864	-	PUBCHEM	11947684	C24H36N4O6S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OHRURASPPZQGQM-QSVHVVLASA-N
29373	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wen J (2016)	26706171	224819	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29374	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9377	4-[(E)-N-[[4-(Dimethylamino)benzoyl]-methylamino]-C-methylcarbonimidoyl]-N-hydroxybenzamide	BDBM50146080	-	PUBCHEM	127025647	C19H22N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JCTMSWPCFNKFGT-DEDYPNTBSA-N
29375	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9378	4-[(E)-N-[[4-(Dimethylamino)benzoyl]amino]-C-methylcarbonimidoyl]-N-hydroxybenzamide	BDBM50146079	-	PUBCHEM	122601076	C18H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YBJMRJLHXVKOOB-XDHOZWIPSA-N
29376	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9379	4-[(E)-[[4-(Dimethylamino)benzoyl]-methylhydrazinylidene]methyl]-N-hydroxybenzamide	BDBM50146077	-	PUBCHEM	127025646	C18H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YOJNZHSNJLHVML-XDHOZWIPSA-N
29377	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	9380	4-[(E)-[[4-(Dimethylamino)benzoyl]hydrazinylidene]methyl]-N-hydroxybenzamide	BDBM50146076	-	PUBCHEM	122601008	C17H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HHDICTUTXIOTBC-WOJGMQOQSA-N
29378	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Rodrigues DA (2016)	26705137	224820	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29379	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9381	4-[(2S)-1-[5-(3,5-Dimethyl-1,2-oxazol-4-yl)-2-(2-phenylethyl)benzimidazol-1-yl]propan-2-yl]morpholine	BDBM50151662	-	PUBCHEM	127031779	C27H32N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SAMCWHOXZPKYQG-IBGZPJMESA-N
29380	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9382	[[(3R)-4-[[3-[2-[2-[[(5S)-5-Acetamido-6-amino-6-oxohexyl]amino]-2-oxoethyl]sulfanylethylamino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl hydrogen phosphate	AC-LYS(COA)-NH2|BDBM50255529	-	PUBCHEM	44571034	C31H53N10O19P3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YGZKIOPJGFQDSR-QGSWMBNESA-N
29381	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9383	(2S)-2-[2-[[(1S)-1-Carboxy-3-[5-[(Z)-[(5S)-5-[3-(diaminomethylideneamino)propyl]-3,6-dioxopiperazin-2-ylidene]methyl]-2-hydroxyphenoxy]propyl]amino]-2-oxoethyl]-2-hydroxybutanedioic acid	BDBM50151656	-	PUBCHEM	127033885	C25H32N6O12	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GRAFKVRBLJRCBH-NCBISDQCSA-N
29382	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9384	(2S)-2-[[(3S)-3-Carboxy-5-[[(1S)-1-carboxy-3-[5-[(Z)-[(5S)-5-[3-(diaminomethylideneamino)propyl]-3,6-dioxopiperazin-2-ylidene]methyl]-2-hydroxyphenoxy]propyl]amino]-3-hydroxy-5-oxopentanoyl]amino]butanedioic acid	NK-13650A|BDBM50151655	-	PUBCHEM	71481176	C29H37N7O15	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CVSHHZDMYAPZPV-DFYJTYCZSA-N
29383	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Simon RP (2016)	26701186	224821	9385	Tert-butyl N-[5-[[2-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]acetyl]amino]pentyl]carbamate	BDBM50151651	-	PUBCHEM	50899265	C33H58N9O19P3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XQXLJFXFNXYRML-HSJNEKGZSA-N
29384	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kachhadia V (2016)	26689485	224822	9386	(E)-3-[4-[(E)-3-(Cyclopropylamino)-2-(4-fluorophenyl)prop-1-enyl]phenyl]-N-hydroxyprop-2-enamide	BDBM50143215	-	PUBCHEM	25269097	C21H21FN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NODIYCZWVUUEMT-HTZRGULJSA-N
29385	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kachhadia V (2016)	26689485	224822	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29386	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Reddy DN (2016)	26681404	224823	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29387	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Reddy DN (2016)	26681404	224823	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29388	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Reddy DN (2016)	26681404	224823	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29389	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29390	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9387	N-Hydroxy-2-naphthalen-2-yl-1,3-oxazole-4-carboxamide	BDBM50148620	-	PUBCHEM	127027175	C14H10N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SAZKVZYUJRPYFI-UHFFFAOYSA-N
29391	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9388	2-(4-Chlorophenyl)-N-hydroxy-1,3-oxazole-4-carboxamide	BDBM50148617	-	PUBCHEM	127025656	C10H7ClN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KHHYTDYDQPEPGS-UHFFFAOYSA-N
29392	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9389	N-Hydroxy-2-(4-phenylphenyl)-1,3-oxazole-4-carboxamide	BDBM50148613	-	PUBCHEM	127028391	C16H12N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TXHNXBSXQZDEJE-UHFFFAOYSA-N
29393	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	9390	2-(4-Bromophenyl)-N-hydroxy-1,3-oxazole-4-carboxamide	N-HYDROXY-2-(4-BROMOPHENYL)OXAZOLE-4-CARBOXAMIDE|P7V|J3.601.433D|2-(4-BROMOPHENYL)-N-HYDROXY-1,3-OXAZOLE-4-CARBOXAMIDE|BDBM50148612	-	PUBCHEM	127027171	C10H7BrN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KHPRTOQUGAUDCM-UHFFFAOYSA-N
29394	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Senger J (2016)	26653328	224824	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29395	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Thaler F (2016)	26629860	224825	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29396	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Romero FA (2016)	26572217	224826	9391	Sgc-cbp30	Q27088793|GTPL7529|C28H33CLN4O3|4-[(2S)-1-[2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZIMIDAZOL-1-YL]PROPAN-2-YL]MORPHOLINE|HY-15826|(S)-4-(1-(2-(3-CHLORO-4-METHOXYPHENETHYL)-5-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-1-YL)PROPAN-2-YL)MORPHOLINE|S7256|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-1,3-BENZODIAZOLE|AOB4800|5-(3,5-DIMETHYLISOXAZOLE-4-YL)-2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-1-[(S)-2-MORPHOLINOPROPYL]-1H-BENZOIMIDAZOLE|EX-A2159|SGC-CBP30|CCG-269770|AKOS024458401|NCGC00351475-07|A13227|ZINC96170456|CS-2096|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-BENZIMIDAZOLE|SW219645-1|2LO|AS-56079|SGC-CBP30, >=98% (HPLC)|2715AH|1613695-14-9|BDBM188519	-	PUBCHEM	72201027	C28H33ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GEPYBHCJBORHCE-SFHVURJKSA-N
29397	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Ni M (2015)	26481659	224827	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29398	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Peng FW (2015)	26475519	224828	9392	6-[4-(2,4-Dichloroanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyhexanamide	BDBM50132484	-	PUBCHEM	122195536	C21H22Cl2N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HQVSMMXKDYANJJ-UHFFFAOYSA-N
29399	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9393	Ricolinostat	SW219836-1|ZINC89630354|W-5979|AS-73344|D10661|ROCILINOSTAT (ACY-1215)|GTPL7010|ROCILINOSTAT|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]PYRIMIDINE-5-CARBOXAMIDE|ACY-63|DTXSID40157148|RICOLINOSTAT (USAN/INN)|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)-|CCG-269054|AK151416|7-{[2-(DIPHENYLAMINO)PYRIMIDIN-5-YL]FORMAMIDO}-N-HYDROXYHEPTANAMIDE|SMR004702950|EX-A139|UNII-WKT909C62B|ACN-030031|S8001|AH4|CS-0965|DB12376|Q27088553|NS00073045|ACY-1215|1316214-52-4|SB17054|CC-661|HMS3426C09|US8609678, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE [26]|AB0032517|BCP06028|A11940|X5832|AC-30258|2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE|MLS006011181|N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-2-(N-PHENYLANILINO)PYRIMIDINE-5-CARBOXAMIDE|HY-16026|WKT909C62B|NCGC00345802-05|J-690127|ACY1215|AX8288032|AKOS024259260|RICOLINOSTAT (ACY-1215)|RICOLINOSTAT [USAN:INN]|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-5-PYRIMIDINECARBOXAMIDE|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-|NCGC00345802-01|RICOLINOSTAT|HMS3653F17|KS-00000SAV|BDBM50439674	-	PUBCHEM	53340666	C24H27N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QGZYDVAGYRLSKP-UHFFFAOYSA-N
29400	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9394	N-Hydroxy-6-[4-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]hexanamide	ONC(CCCCCOC1=CC=C(C=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)=O|BDBM50151381	-	PUBCHEM	122550126	C22H26N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YHQAMQHTTOJBPC-UHFFFAOYSA-N
29401	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9395	N-Hydroxy-5-[4-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]pentanamide	ONC(CCCCOC1=CC=C(C=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)=O|BDBM50151380	-	PUBCHEM	122550235	C21H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VINHTOOQEORVNT-UHFFFAOYSA-N
29402	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9396	N-Hydroxy-2-[4-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]acetamide	ONC(COC1=CC=C(C=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)=O|BDBM50151378	-	PUBCHEM	122550234	C18H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MPMPKDWQOVDGGV-UHFFFAOYSA-N
29403	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9397	N-Hydroxy-6-[2-methoxy-5-[methyl-(2-methylquinazolin-4-yl)amino]phenoxy]hexanamide	ONC(CCCCCOC1=C(C=CC(=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)OC)=O|BDBM50151377	-	PUBCHEM	122550213	C23H28N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOLDSRJBCFTJIA-UHFFFAOYSA-N
29404	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9398	Hdac6-IN-1	HY-18947|CS-0014660|SKLB-23BB|S8743|N-HYDROXY-4-[2-METHOXY-5-[METHYL(2-METHYLQUINAZOLINE-4-YL)AMINO]PHENOXY]BUTANAMIDE|ONC(CCCOC1=C(C=CC(=C1)N(C1=NC(=NC2=CC=CC=C12)C)C)OC)=O|J3.553.794E|1815580-06-3|HDAC6-IN-1|BDBM50151375	-	PUBCHEM	122550211	C21H24N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FWXZZFONXWYSEF-UHFFFAOYSA-N
29405	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9399	N-Hydroxy-6-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]hexanamide	BDBM50151325	-	PUBCHEM	127031757	C21H28N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YUAKVYNOFMVTES-UHFFFAOYSA-N
29406	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9400	N-Hydroxy-5-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]pentanamide	BDBM50151324	-	PUBCHEM	127030500	C20H26N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZRIVRHBHISBBGJ-UHFFFAOYSA-N
29407	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9401	N-Hydroxy-4-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]butanamide	BDBM50150960	-	PUBCHEM	127031734	C19H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMJDOVVCXHTCNO-UHFFFAOYSA-N
29408	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9402	N-Hydroxy-2-[4-[methyl-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)amino]phenoxy]acetamide	BDBM50150959	-	PUBCHEM	127031756	C17H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZDRSRLVZCRYVJO-UHFFFAOYSA-N
29409	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9403	N-Hydroxy-6-[4-[methyl(quinazolin-4-yl)amino]phenoxy]hexanamide	ONC(CCCCCOC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150955	-	PUBCHEM	122550135	C21H24N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NXBDQDGEFPQVSI-UHFFFAOYSA-N
29410	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9404	N-Hydroxy-5-[4-[methyl(quinazolin-4-yl)amino]phenoxy]pentanamide	ONC(CCCCOC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150954	-	PUBCHEM	122550134	C20H22N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TYGPIYZPTOOAMW-UHFFFAOYSA-N
29411	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9405	N-Hydroxy-4-[4-[methyl(quinazolin-4-yl)amino]phenoxy]butanamide	ONC(CCCOC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150953	-	PUBCHEM	122550129	C19H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MGPSFMYVFDFUJS-UHFFFAOYSA-N
29412	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	9406	N-Hydroxy-2-[4-[methyl(quinazolin-4-yl)amino]phenoxy]acetamide	ONC(COC1=CC=C(C=C1)N(C1=NC=NC2=CC=CC=C12)C)=O|BDBM50150951	-	PUBCHEM	122550132	C17H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WKPDRDKNRMYFAG-UHFFFAOYSA-N
29413	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	8079	Panobinostat	(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide|panobinostat|BDBM29589	farydak	DRUGBANK	DB06603	C21H23N3O2	small molecule	L01XX42	404950-80-7	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FPOHNWQLNRZRFC-ZHACJKMWSA-N
29414	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang Z (2016)	26443078	224829	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29415	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Musso L (2015)	26376355	224830	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29416	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jain AD (2015)	26363505	224831	9407	(4S)-5-[[(2S)-1-[[(2S)-1-Amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[2-[[(2S,3R)-2-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[2-(3-hydroxy-6-oxoxanthen-9-yl)-5-isothiocyanatobenzoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]butanoyl]amino]butanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-5-oxopentanoic acid	BDBM50130558	-	PUBCHEM	122194818	C67H79N11O22S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OQIWZBQSWOIZFA-IEZRXWCASA-N
29417	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jain AD (2015)	26363505	224831	9408	2,2'-(Naphthalene-1,4-Diylbis(((4-Methoxyphenyl)sulfonyl)azanediyl))diacetamide	2,2'-(NAPHTHALENE-1,4-DIYLBIS{[(4-METHOXYPHENYL)SULFONYL]IMINO})DIACETAMIDE (NON-PREFERRED NAME)|41P|2,2'-(NAPHTHALENE-1,4-DIYLBIS(((4-METHOXYPHENYL)SULFONYL)AZANEDIYL))DIACETAMIDE|Q27454330|BDBM50130549	-	PUBCHEM	91885637	C28H28N4O8S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZUIXHSIMKQZYPV-UHFFFAOYSA-N
29418	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jain AD (2015)	26363505	224831	9409	2,2'-(Naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetic acid	COMPOUND 2 [PMID: 24512214]|CPUY192018|2,2'-(NAPHTHALENE-1,4-DIYLBIS(((4-METHOXYPHENYL)SULFONYL)AZANEDIYL))DIACETIC ACID|2,2'-[1,4-NAPHTHALENEDIYLBIS[(4-METHOXYPHENYLSULFONYL)IMINO]]BISACETIC ACID|BRD-K55096910-001-01-4|COMPOUND 18E [PMID: 26258437]|GTPL9710|1567836-15-0|2-[[4-[CARBOXYMETHYL-(4-METHOXYPHENYL)SULFONYLAMINO]NAPHTHALEN-1-YL]-(4-METHOXYPHENYL)SULFONYLAMINO]ACETIC ACID|BDBM50006932	-	PUBCHEM	73330369	C28H26N2O10S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSIQJUNYMMCTB-UHFFFAOYSA-N
29419	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2015)	26331334	224832	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29420	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Muthyala R (2015)	26264503	224833	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29421	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Muthyala R (2015)	26264503	224833	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29422	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Chessari G (2015)	26218264	224834	9410	1-(6-Benzyl-3,3-dimethyl-2H-pyrrolo[3,2-c]pyridin-1-yl)-2-[(2R,5R)-2-(methoxymethyl)-5-methylpiperazin-1-yl]ethanone	1-(6-BENZYL-3,3-DIMETHYL-2H-PYRROLO[3,2-C]PYRIDIN-1-YL)-2-[(2R,5R)-2-(METHOXYMETHYL)-5-METHYLPIPERAZIN-1-YL]ETHANONE|US9018214, 63|1-(3,3-DIMETHYL-6-BENZYL-2,3-DIHYDRO-1H-PYRROLO[3,2-C]PYRIDINE-1-YL)-2-((3R,6R)-3-METHYL-6-METHOXYMETHYLPIPERAZINE-1-YL)ETHANONE|BDBM156012	-	PUBCHEM	70981017	C25H34N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XOZJVPQFZSCGTE-WIYYLYMNSA-N
29423	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9411	N-[1-(2-Chloro-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-CHLORO-4-METHYLPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109015	-	PUBCHEM	122184850	C24H27ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IJGUAWCQKOESOS-UHFFFAOYSA-N
29424	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9412	N-[1-(2-Bromo-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-BROMO-4-METHYLPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109014	-	PUBCHEM	122184851	C24H27BrN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QNXRAIMDOJFMKD-UHFFFAOYSA-N
29425	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9413	N'-Hydroxy-N-[1-(4-methylanilino)isoquinolin-7-yl]octanediamide	N-[1-[(4-METHYLPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109013	-	PUBCHEM	122184847	C24H28N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DHMRFGYKNXQOFG-UHFFFAOYSA-N
29426	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9414	N'-Hydroxy-N-[1-(naphthalen-2-ylamino)isoquinolin-7-yl]octanediamide	BDBM50109011	-	PUBCHEM	122184848	C27H28N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HUKJAHRJEYMMCE-UHFFFAOYSA-N
29427	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9415	N-[1-(4-Bromo-2-fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-FLUORO-4-BROMOPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109010	-	PUBCHEM	122184845	C23H24BrFN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DFKQAHYOXDWTAQ-UHFFFAOYSA-N
29428	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9416	(E)-N-Hydroxy-3-[4-[[[1-(4-methylanilino)isoquinolin-7-yl]amino]methyl]phenyl]prop-2-enamide	BDBM50109009	-	PUBCHEM	122185150	C26H24N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KPLJHTZFLSOICT-MDWZMJQESA-N
29429	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9417	N-[1-(3-Chloro-2-fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-FLUORO-3-CHLOROPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109008	-	PUBCHEM	122184846	C23H24ClFN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LYWPEQFLYUJPIU-UHFFFAOYSA-N
29430	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9418	N'-Hydroxy-N-(1-morpholin-4-ylisoquinolin-7-yl)octanediamide	BDBM50109006	-	PUBCHEM	122184854	C21H28N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DTLWMGPSWXSCIY-UHFFFAOYSA-N
29431	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9419	N'-Hydroxy-N-[1-(4-propan-2-ylpiperazin-1-yl)isoquinolin-7-yl]octanediamide	BDBM50109004	-	PUBCHEM	122184855	C24H35N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KUEFYQRLDVPNAG-UHFFFAOYSA-N
29432	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9420	N-[1-(2-Fluoroanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	N-[1-[(2-FLUOROPHENYL)AMINO]ISOQUINOLINE-7-YL]-N'-HYDROXYOCTANEDIAMIDE|BDBM50109002	-	PUBCHEM	122184852	C23H25FN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AGZGHJKLKCIIAU-UHFFFAOYSA-N
29433	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9421	N-[2-[(2,4-Dimethoxyphenyl)methyl]-1-oxoisoquinolin-7-yl]-N'-hydroxyoctanediamide	BDBM50109000	-	PUBCHEM	122185147	C26H31N3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIKBCAFOYUWQMO-UHFFFAOYSA-N
29434	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9422	N-[1-(2-Fluoro-4-methylanilino)isoquinolin-7-yl]-N'-hydroxyoctanediamide	BDBM50108999	-	PUBCHEM	122184849	C24H27FN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLJIGRZNVRDVNW-UHFFFAOYSA-N
29435	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9423	N'-Hydroxy-N-[2-(3-methylbutyl)-1-oxoisoquinolin-7-yl]octanediamide	BDBM50108184	-	PUBCHEM	122185146	C22H31N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FSIYMAGFRRSGGY-UHFFFAOYSA-N
29436	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9424	N-[2-[2-(Diethylamino)ethyl]-1-oxoisoquinolin-7-yl]-N'-hydroxyoctanediamide	BDBM50108162	-	PUBCHEM	122184858	C23H34N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZAKBEXUJXNNGOJ-UHFFFAOYSA-N
29437	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9425	N-(2-Butyl-1-oxoisoquinolin-7-yl)-N'-hydroxyoctanediamide	BDBM50108142	-	PUBCHEM	122184857	C21H29N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIMZZSMMMYOQJV-UHFFFAOYSA-N
29438	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	9426	N'-Hydroxy-N-[1-(3-methoxypropylamino)isoquinolin-7-yl]octanediamide	BDBM50108129	-	PUBCHEM	122184856	C21H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MGLLPZGTTQFMEG-UHFFFAOYSA-N
29439	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yang W (2015)	26211462	224835	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29440	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Smith CR (2015)	26087137	224836	9427	4-Amino-8-(5-Methyl-1h-Indazol-6-Yl)cinnoline-3-Carboxamide	4-AMINO-8-(5-METHYL-1H-INDAZOL-6-YL)CINNOLINE-3-CARBOXAMIDE|4-AMINO-8-(5-METHYL-1H-INDAZOLE-6-YL)CINNOLINE-3-CARBOXAMIDE|4L6|Q27454796|BDBM50097393	-	PUBCHEM	71765510	C17H14N6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PTHVKCSYXICMAR-UHFFFAOYSA-N
29441	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Zhan P (2015)	26086931	224837	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29442	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	unknown	target	Zhan P (2015)	26086931	224837	9391	Sgc-cbp30	Q27088793|GTPL7529|C28H33CLN4O3|4-[(2S)-1-[2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZIMIDAZOL-1-YL]PROPAN-2-YL]MORPHOLINE|HY-15826|(S)-4-(1-(2-(3-CHLORO-4-METHOXYPHENETHYL)-5-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-1-YL)PROPAN-2-YL)MORPHOLINE|S7256|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-1,3-BENZODIAZOLE|AOB4800|5-(3,5-DIMETHYLISOXAZOLE-4-YL)-2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-1-[(S)-2-MORPHOLINOPROPYL]-1H-BENZOIMIDAZOLE|EX-A2159|SGC-CBP30|CCG-269770|AKOS024458401|NCGC00351475-07|A13227|ZINC96170456|CS-2096|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-BENZIMIDAZOLE|SW219645-1|2LO|AS-56079|SGC-CBP30, >=98% (HPLC)|2715AH|1613695-14-9|BDBM188519	-	PUBCHEM	72201027	C28H33ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GEPYBHCJBORHCE-SFHVURJKSA-N
29443	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Zhan P (2015)	26086931	224837	9391	Sgc-cbp30	Q27088793|GTPL7529|C28H33CLN4O3|4-[(2S)-1-[2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)BENZIMIDAZOL-1-YL]PROPAN-2-YL]MORPHOLINE|HY-15826|(S)-4-(1-(2-(3-CHLORO-4-METHOXYPHENETHYL)-5-(3,5-DIMETHYLISOXAZOL-4-YL)-1H-BENZO[D]IMIDAZOL-1-YL)PROPAN-2-YL)MORPHOLINE|S7256|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-1,3-BENZODIAZOLE|AOB4800|5-(3,5-DIMETHYLISOXAZOLE-4-YL)-2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-1-[(S)-2-MORPHOLINOPROPYL]-1H-BENZOIMIDAZOLE|EX-A2159|SGC-CBP30|CCG-269770|AKOS024458401|NCGC00351475-07|A13227|ZINC96170456|CS-2096|2-[2-(3-CHLORO-4-METHOXYPHENYL)ETHYL]-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(2S)-2-(MORPHOLIN-4-YL)PROPYL]-1H-BENZIMIDAZOLE|SW219645-1|2LO|AS-56079|SGC-CBP30, >=98% (HPLC)|2715AH|1613695-14-9|BDBM188519	-	PUBCHEM	72201027	C28H33ClN4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GEPYBHCJBORHCE-SFHVURJKSA-N
29444	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Clausen DJ (2015)	26054247	224838	9428	(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3-thia-7,14,17,21-tetrazatricyclo[14.3.1.12,5]henicosa-1(20),2(21),16,18-tetraene-6,9,13-trione	BDBM50098420	-	PUBCHEM	122181882	C23H30N4O4S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YSQNJKVHVWRCPW-FXHDEUNJSA-N
29445	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Clausen DJ (2015)	26054247	224838	9429	(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3-thia-7,14,20,21-tetrazatricyclo[14.3.1.12,5]henicosa-1(19),2(21),16(20),17-tetraene-6,9,13-trione	(4R)-4,2-[CARBONYLIMINO[(S)-2-OXO-1-ISOPROPYLETHYLENE]OXY[(S)-1-OXO-7-MERCAPTO-4-HEPTENE-3,1-DIYL]IMINOMETHYLENE(PYRIDINE-2,6-DIYL)]-4BETA-METHYL-4,5-DIHYDROTHIAZOLE|BDBM50098418	-	PUBCHEM	25257993	C23H30N4O4S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	USYOVMNNRIHXJQ-BEIBECRVSA-N
29446	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Clausen DJ (2015)	26054247	224838	9430	(5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione	(4R)-4,2'-[CARBONYLIMINO[(S)-1-OXO-3-METHYLBUTANE-2,1-DIYL]OXY[(S)-1-OXO-7-MERCAPTO-4-HEPTENE-3,1-DIYL]IMINOMETHYLENE]-4BETA-METHYL-4,5-DIHYDRO-2,4'-BITHIAZOLE|(2S,5S,17R)-2-ISOPROPYL-5-[(E)-4-MERCAPTO-1-BUTENYL]-17-METHYL-13,10:17,14-DIEPINITRILO-4-OXA-11,15-DITHIA-1,8-DIAZACYCLOOCTADECA-12-ENE-3,7,18-TRIONE|BDBM50098414	-	PUBCHEM	24938735	C21H28N4O4S3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VEDPEVJAYWVUSJ-BNVDZZMOSA-N
29447	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Yadav RR (2015)	26048785	224839	9431	5-(4-Pyridin-3-ylthiophen-2-yl)-1,3-thiazole	BDBM50105913	-	PUBCHEM	122184057	C12H8N2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WNKQZLFWZLQFOH-UHFFFAOYSA-N
29448	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang C (2015)	25993269	224840	9432	Naphthalen-1-yl 6-[4-[[8-(hydroxyamino)-8-oxooctanoyl]amino]phenyl]-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	BDBM50094760	-	PUBCHEM	122181047	C36H36N2O8S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PQXAOJPTBDMVNK-UHFFFAOYSA-N
29449	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang C (2015)	25993269	224840	9433	8-[4-[6-(3-Hydroxyphenoxy)sulfonyl-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl]anilino]-8-oxooctanoic acid	BDBM50094750	-	PUBCHEM	122180823	C32H33NO9S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HNLHZLHXGMYVNW-UHFFFAOYSA-N
29450	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang C (2015)	25993269	224840	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29451	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Du G (2015)	25978962	224841	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29452	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Daniel KB (2015)	25974739	224842	9434	N-Phenyl-N'-[(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methoxy]octanediamide	BDBM50089657	-	PUBCHEM	122177622	C24H30N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HXFDEOSGMWWMSA-UHFFFAOYSA-N
29453	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Daniel KB (2015)	25974739	224842	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29454	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	unknown	target	Henry JR (2015)	25965804	224843	9435	LY-3009120	AS-74984|LY 3009120|GTPL8943|1GDT36RARO|UNII-1GDT36RARO|KS-00001CZH|3-(3,3-DIMETHYLBUTYL)-1-{2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL}UREA|J3.580.324F|AC-30240|LY-3009120|S7842|1454682-72-4|DP 4978|NCGC00481604-01|UREA, N-(3,3-DIMETHYLBUTYL)-N'-[2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL]-|UREA, N-(3,3-DIMETHYLBUTYL)-N'-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO(2,3-D)PYRIMIDIN-6-YL)PHENYL)-|1-(3,3-DIMETHYLBUTYL)-3-[2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL]UREA|SB16924|DP-4978|4Z5|1-(3,3-DIMETHYLBUTYL)-3-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO(2,3-D)PYRIMIDIN-6-YL)PHENYL)UREA|LY3009120|QC-11801|AK173776|BCP23869|1-(3,3-DIMETHYLBUTYL)-3-{2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL}UREA|N-(3,3-DIMETHYLBUTYL)-N'-[2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL]UREA|EX-A1638|ZINC205861291|1-(2-FLUORO-4-METHYL-5-(2-METHYLAMINO-7-METHYLPYRIDO[2,3-D]PYRIMIDINE-6-YL)PHENYL)-3-(3,3-DIMETHYLBUTYL)UREA|DP-4978;LY-3009120|Q27082823|HY-12558|CCG-268937|1-(3,3-DIMETHYLBUTYL)-3-(2-FLUORO-4-METHYL-5-(7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL)PHENYL)UREA|BDBM50096279	-	PUBCHEM	71721540	C23H29FN6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HHCBMISMPSAZBF-UHFFFAOYSA-N
29455	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Duan W (2015)	25906087	224844	9436	6-[[4-(Benzenesulfonyl)-5-oxido-1,2,5-oxadiazol-5-ium-3-yl]oxy]-N-hydroxyhexanamide	BDBM50087853	-	PUBCHEM	118737455	C14H17N3O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AGDGTFUFKSHWRN-UHFFFAOYSA-N
29456	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Duan W (2015)	25906087	224844	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29457	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Di Pompo G (2015)	25905694	224845	9437	N-Hydroxy-5-[[6-oxo-4-(4-phenylphenyl)-1H-pyrimidin-2-yl]sulfanyl]pentanamide	MC1742|MC 1742|5-{[4-(BIPHENYL-4-YL)-6-OXO-1,6-DIHYDROPYRIMIDIN-2-YL]SULFANYL}-N-HYDROXYPENTANAMIDE|ZINC140782936|5-[[6-OXO-4-(4-PHENYLPHENYL)-1H-PYRIMIDIN-2-YL]SULFANYL]PENTANEHYDROXAMIC ACID|AKOS027470271|1776116-74-5|BDBM50087845	-	PUBCHEM	136173089	C21H21N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AOFVDNFTELWRHV-UHFFFAOYSA-N
29458	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Di Pompo G (2015)	25905694	224845	9438	N-[6-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]pyridin-3-yl]-2,3-diphenylpropanamide	J3.561.771J|MC-2625|BDBM50087841	-	PUBCHEM	118737400	C23H21N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UQSIPNLHOWORHA-BUHFOSPRSA-N
29459	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9439	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[6-(hydroxyamino)-6-oxohexyl]benzamide	BDBM50080071	-	PUBCHEM	136961657	C20H24N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LAPSXONRKCNPMH-UHFFFAOYSA-N
29460	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9440	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-hydroxybenzamide	BDBM50080008	-	PUBCHEM	136961654	C14H13N7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DUXRBKWTYAMJCH-UHFFFAOYSA-N
29461	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9441	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide	BDBM50080007	-	PUBCHEM	136961658	C21H26N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FDKBZGYHEWRDAU-UHFFFAOYSA-N
29462	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9442	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[8-(hydroxyamino)-8-oxooctyl]benzamide	BDBM50080006	-	PUBCHEM	136961659	C22H28N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMZXWCBRVCVILS-UHFFFAOYSA-N
29463	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Sodji QH (2015)	25899338	224846	9443	4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-N-[9-(hydroxyamino)-9-oxononyl]benzamide	BDBM50080005	-	PUBCHEM	136961660	C23H30N8O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QJGGEUHIPSSJGP-UHFFFAOYSA-N
29464	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	He S (2015)	25815139	224847	9444	N-Hydroxy-7-[3-[4-[[(7-hydroxy-21-methyl-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7,15(20),16,18-heptaen-17-yl)amino]methyl]phenyl]-1,2,4-oxadiazol-5-yl]heptanamide	BDBM50089085	-	PUBCHEM	122177957	C35H37N7O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FTVNKVXRXIRGTC-UHFFFAOYSA-N
29465	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	He S (2015)	25815139	224847	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29466	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9445	4-Methoxy-N-(2-methyl-2-phenylpropyl)-1,2-benzothiazol-3-amine	4-METHOXY-N-(2-METHYL-2-PHENYLPROPYL)-1,2-BENZOTHIAZOL-3-AMINE|BDBM50120918	-	PUBCHEM	16050950	C18H20N2OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NKBXMDAHDCPWMN-UHFFFAOYSA-N
29467	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9446	4-Methoxy-3-[(2-methyl-2-phenylpropyl)amino]-1H-isoindol-1-one	CTK3F7042|929022-79-7|4-METHOXY-3-[(2-METHYL-2-PHENYLPROPYL)AMINO]-1H-ISOINDOL-1-ONE|DTXSID90581575|4-METHOXY-3-[(2-METHYL-2-PHENYLPROPYL)AMINO]ISOINDOL-1-ONE|1H-ISOINDOL-1-ONE, 4-METHOXY-3-[(2-METHYL-2-PHENYLPROPYL)AMINO]BDBM50120917	-	PUBCHEM	135402003	C19H20N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WVNWIKASGFTXTN-UHFFFAOYSA-N
29468	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9447	BDBM50120916	-	-	CHEMBL	CHEMBL3623052	C25H34N4O5S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LCBXDZXDQBCBKU-WBANQOEISA-N
29469	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9448	BDBM50120914	-	-	CHEMBL	CHEMBL3622362	C23H29N3O5S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CJQQFOJFFTZBPF-RXAXNXDRSA-N
29470	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9449	BDBM50120913	-	-	CHEMBL	CHEMBL3622361	C24H26F3N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWGJTTLXQUOTQV-QBNMFFNISA-N
29471	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9450	BDBM50120912	-	-	CHEMBL	CHEMBL3622351	C27H29N5O5S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SLEKHKOESUNGDP-GEQDBVPJSA-N
29472	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9451	BDBM50120911	-	-	CHEMBL	CHEMBL3622350	C25H28F3N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IIYZDGPAUKPRTM-XZMJRDFISA-N
29473	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9452	BDBM50120909	-	-	CHEMBL	CHEMBL3622348	C24H29N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FZCOOJYUTWQXHI-XZMJRDFISA-N
29474	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9453	BDBM50120908	-	-	CHEMBL	CHEMBL3623054	C22H24N6O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YRYVRDWTFZNPGZ-VVOJOOEHSA-N
29475	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9454	BDBM50120907	-	-	CHEMBL	CHEMBL3623053	C25H27N5O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HPNMBDREXVAELJ-FEHRVWHQSA-N
29476	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9455	BDBM50120904	-	-	CHEMBL	CHEMBL3622346	C21H24N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BIALXFMHWCNRAQ-OQIWPSSASA-N
29477	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9456	BDBM50120903	-	-	CHEMBL	CHEMBL3622360	C25H31N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QWHKGOUNYNQXJA-FEHRVWHQSA-N
29478	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9457	BDBM50120901	-	-	CHEMBL	CHEMBL3622358	C24H29N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WFCSBBBTESOXNH-XZMJRDFISA-N
29479	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9458	BDBM50120899	-	-	CHEMBL	CHEMBL3622355	C30H34N4O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KUEIYBKAAMYFKI-IQBDUEADSA-N
29480	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2015)	25801931	224848	9459	4-Methoxy-N-(2-methyl-2-phenylpropyl)-1,2-benzoxazol-3-amine	4-METHOXY-N-(2-METHYL-2-PHENYLPROPYL)-1,2-BENZOXAZOL-3-AMINE|BDBM50022110	-	PUBCHEM	16050462	C18H20N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FRLKYVJLDPLCNR-UHFFFAOYSA-N
29481	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9460	4-[[(3S)-1-(4-Chlorophenyl)-3-methyl-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	J3.522.188C|4-[[(3S)-1-(4-CHLOROPHENYL)-2-OXO-3-METHYLPYRROLIDINE-3-YL]AMINO]BENZHYDROXIMIC ACID|BDBM50078748	-	PUBCHEM	118733374	C18H18ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMBODOHYRWZQEW-SFHVURJKSA-N
29482	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9461	N-Hydroxy-4-[(3-methyl-2-oxo-1-quinolin-6-ylpyrrolidin-3-yl)amino]benzamide	N-HYDROXY-4-[(3-METHYL-2-OXO-1-QUINOLIN-6-YLPYRROLIDIN-3-YL)AMINO]BENZAMIDE|BDBM50078747	-	PUBCHEM	57524107	C21H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RSKIXUXUCRJFFV-UHFFFAOYSA-N
29483	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9462	4-[[1-(4-Chlorophenyl)-3-methyl-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(4-CHLOROPHENYL)-3-METHYL-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|1390618-15-1|BDBM50078695	-	PUBCHEM	57524021	C18H18ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMBODOHYRWZQEW-UHFFFAOYSA-N
29484	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9463	4-[[1-(4-Cyanophenyl)-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(4-CYANOPHENYL)-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|BDBM50078690	-	PUBCHEM	57524835	C18H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YOFSZHJBQOKORL-UHFFFAOYSA-N
29485	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9464	4-[[1-(3,4-Dichlorophenyl)-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(3,4-DICHLOROPHENYL)-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|BDBM50078687	-	PUBCHEM	57524908	C17H15Cl2N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BVYKJJVMJBRGCE-UHFFFAOYSA-N
29486	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9465	4-[[1-(3-Chlorophenyl)-2-oxopyrrolidin-3-yl]amino]-N-hydroxybenzamide	4-[[1-(3-CHLOROPHENYL)-2-OXOPYRROLIDIN-3-YL]AMINO]-N-HYDROXYBENZAMIDE|BDBM50078680	-	PUBCHEM	57524666	C17H16ClN3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TZTDSVDQFPJDKR-UHFFFAOYSA-N
29487	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9466	(7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide	(R)-7BETA-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOHYDROXIMIC ACID|BDBM50027662	-	PUBCHEM	92045024	C20H19N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWLFQRZKKHIDTM-QGZVFWFLSA-N
29488	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29489	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lin X (2015)	25734520	224849	9467	N-Hydroxy-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-1,2,3,4-tetrahydroquinoline-6-carboxamide	US8716285, 53|BDBM120996	-	PUBCHEM	56933019	C19H18N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YWYZSTJJOZEEKF-UHFFFAOYSA-N
29490	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9468	10-Bromo-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097868	-	PUBCHEM	122181014	C16H9BrN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PCUWPDUAQBAWHT-UHFFFAOYSA-N
29491	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9469	10-Chloro-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097867	-	PUBCHEM	122181013	C16H9ClN2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ABRIIMZXUFHPCH-UHFFFAOYSA-N
29492	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9470	10-Chloro-2-(3-methoxyphenyl)-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097863	-	PUBCHEM	122181024	C23H15ClN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VCFPJHJKTXRDGD-UHFFFAOYSA-N
29493	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9471	10-Bromo-3-methoxy-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097855	-	PUBCHEM	122181018	C17H11BrN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ARYGGCNDASPYNG-UHFFFAOYSA-N
29494	114023	8445	-	DYRK2	-	9606	Homo sapiens	unknown	target	Falke H (2015)	25730262	224850	9472	10-Chloro-3-methoxy-11H-indolo[3,2-c]quinoline-6-carboxylic acid	BDBM50097854	-	PUBCHEM	122181017	C17H11ClN2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WXMYTQDKBPDSSR-UHFFFAOYSA-N
29495	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Milite C (2015)	25730130	224851	9473	1,3,5-Tribenzylpyrimidine-2,4,6(1H,3H,5H)-trione	1,3,5-TRIBENZYLPYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE|ZINC1701219|CTK7H0853|NSC109117|NSC-109117|BDBM50081172	-	PUBCHEM	268735	C25H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SFFBIIMMBIRGKT-UHFFFAOYSA-N
29496	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	unknown	target	Milite C (2015)	25730130	224851	9474	5-Benzoyl-1,3-dibenzyl-1,3-diazinane-2,4,6-trione	BDBM50081171	-	PUBCHEM	118735269	C25H20N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ILBMLQVDTUJJKC-UHFFFAOYSA-N
29497	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9475	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)pyrimidin-2-yl]pyrrolidine-3-carboxylic acid	BDBM50377302	-	PUBCHEM	10347566	C29H27F3N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ABIFPJDABNXEMK-GGAORHGYSA-N
29498	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9476	(3R,4S)-4-[[3-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)pyrimidin-2-yl]pyrrolidine-3-carboxylic acid	BDBM50063315	-	PUBCHEM	58977541	C29H27F3N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIUUZBXRQNCUIL-GGAORHGYSA-N
29499	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9477	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)-1,3-oxazol-2-yl]pyrrolidine-3-carboxylic acid	BDBM50063313	-	PUBCHEM	58977463	C28H26F3N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMYUDUHXSWKCSZ-IRLDBZIGSA-N
29500	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9478	(3R,4S)-4-[[3-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-phenylpyrrolidine-3-carboxylic acid	BDBM50063311	-	PUBCHEM	58977846	C30H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WWXVNRULVDGHSD-SQHAQQRYSA-N
29501	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9479	(3R,4S)-4-[2-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]ethyl]-1-phenoxycarbonylpyrrolidine-3-carboxylic acid	BDBM50063099	-	PUBCHEM	10370056	C32H32N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JHPSLFHGWGTITM-NAKRPHOHSA-N
29502	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9480	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-phenoxycarbonylpyrrolidine-3-carboxylic acid	BDBM50063089	-	PUBCHEM	10346786	C31H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IAXWLNXPJOTFTP-SQHAQQRYSA-N
29503	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9481	Birinapant	AS-17035|DB11782|D10417|SMR004702997|AKOS030526366|ZINC96941868|BIRINAPANT [USAN:INN]|TL-32711|TL32711|UNII-6O4Z07B57R|Q27075298|Z-3165|TL 32711|A12738|BIRINAPANT (USAN/INN)|(2S,2'S)-N,N'-[(6,6'-DIFLUORO-1H,1'H-2,2'-BIINDOLE-3,3'-DIYL)BIS{METHANEDIYL[(2R,4S)-4-HYDROXYPYRROLIDINE-2,1-DIYL][(2S)-1-OXOBUTANE-1,2-DIYL]}]BIS[2-(METHYLAMINO)PROPANAMIDE] (NON-PREFERRED NAME)|S7015|C42H56F2N8O6|ABP001107|(2S,2'S)-N,N'-((2S,2'S)-((3S,3'S,5R,5'R)-5,5'-((6,6'-DIFLUORO-1H,1'H-[2,2'-BIINDOLE]-3,3'-DIYL)BIS(METHYLENE))BIS(3-HYDROXYPYRROLIDINE-5,1-DIYL))BIS(1-OXOBUTANE-2,1-DIYL))BIS(2-(METHYLAMINO)PROPANAMIDE)|(2S)-N-[(2S)-1-[(2R,4S)-2-[[6-FLUORO-2-[6-FLUORO-3-[[(2R,4S)-4-HYDROXY-1-[(2S)-2-[[(2S)-2-(METHYLAMINO)PROPANOYL]AMINO]BUTANOYL]PYRROLIDIN-2-YL]METHYL]-1H-INDOL-2-YL]-1H-INDOL-3-YL]METHYL]-4-HYDROXYPYRROLIDIN-1-YL]-1-OXOBUTAN-2-YL]-2-(METHYLAMINO)PROPANAM|HY-16591|CS-1719|2269AH|CCG-270498|(2S,2'S)-N,N'-[(6,6'-DIFLUORO-1H,1'H-2,2'-BIINDOLE-3,3'-DIYL)BIS{METHANEDIYL[(2R,4S)-4-HYDROXYPYRROLIDINE-2,1-DIYL][(2S)-1-OXOBUTANE-1,2-DIYL]}]BIS[2-(METHYLAMINO)PROPANAMIDE]|(2S,2'S)-N,N'-((2S,2'S)-1,1'-((3S,3'S,5R,5'R)-5,5'-(6,6'-DIFLUORO-1H,1'H-2,2'-BIINDOLE-3,3'-DIYL)BIS(METHYLENE)BIS(3-HYDROXYPYRROLIDINE-5,1-DIYL))BIS(1-OXOBUTANE-2,1-DIYL))BIS(2-(METHYLAMINO)PROPANAMIDE)|BIRINAPANT|EX-A258|SW220103-1|(2S)-N-[(2S)-1-[(2R,4S)-2-[[6-FLUORO-2-[6-FLUORO-3-[[(2R,4S)-4-HYDROXY-1-[(2S)-2-[[(2S)-2-(METHYLAMINO)PROPANOYL]AMINO]BUTANOYL]PYRROLIDIN-2-YL]METHYL]-1H-INDOL-2-YL]-1H-INDOL-3-YL]METHYL]-4-HYDROXYPYRROLIDIN-1-YL]-1-OXOBUTAN-2-YL]-2-(METHYLAMINO)PROPANAMIDE|GTPL7432|PROPANAMIDE, N,N'-[(6,6'-DIFLUORO[2,2'-BI-1H-INDOLE]-3,3'-DIYL)BIS[METHYLENE[(2R,4S)-4-HYDROXY-2,1-PYRROLIDINEDIYL][(1S)-1-ETHYL-2-OXO-2,1-ETHANEDIYL]]]BIS[2-(METHYLAMINO)-, (2S,2'S)-|6O4Z07B57R|BIRINAPANT (TL32711)|DTXSID30155057|GT6|AOB87396|SC-93462|MLS006011237|SB16522|1260251-31-7|BDBM50071920	-	PUBCHEM	49836020	C42H56F2N8O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PKWRMUKBEYJEIX-DXXQBUJASA-N
29504	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9482	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]carbamoylamino]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50071863	-	PUBCHEM	73506880	C56H78N10O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HEUQZEJFJZTMAR-JSNDJGPMSA-N
29505	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9483	N-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-N'-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]-2,2,3,3,4,4-hexafluoropentanediamide	BDBM50071851	-	PUBCHEM	90089551	C60H78F6N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QPEYDHPWFLBNLA-JSNDJGPMSA-N
29506	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9484	N'-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]pentanediamide	BDBM50071850	-	PUBCHEM	118497874	C60H84N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NQARVPNPYPHNOD-MLOMWMBNSA-N
29507	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9485	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[[4-[2-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]amino]ethyl]benzoyl]amino]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50071849	-	PUBCHEM	118732584	C64H86N10O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AWMDVTVHSSNVGB-KHFWCYFCSA-N
29508	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9486	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[(3R,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	(S)-2-((S)-3,3-DIMETHYL-2-((S)-2-(METHYLAMINO)PROPANAMIDO)BUTANOYL)-7-((3R,5S)-1-((S)-3,3-DIMETHYL-2-((S)-2-(METHYLAMINO)PROPANAMIDO)BUTANOYL)-5-(((R)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)CARBAMOYL)PYRROLIDIN-3-YL)-N-((R)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE|BDBM50071848	-	PUBCHEM	72704974	C55H76N8O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MCUCXLXZRLIPIS-JSNDJGPMSA-N
29509	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9487	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]oxy-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50071847	-	PUBCHEM	72704975	C55H76N8O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IBUAVNGTMFWXEN-JSNDJGPMSA-N
29510	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9488	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]amino]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	(S)-2-((S)-3,3-DIMETHYL-2-((S)-2-(METHYLAMINO)PROPANAMIDO)BUTANOYL)-7-(((3S,5S)-1-((S)-3,3-DIMETHYL-2-((S)-2-(METHYLAMINO)PROPANAMIDO)BUTANOYL)-5-(((R)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)CARBAMOYL)PYRROLIDIN-3-YL)AMINO)-N-((R)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE|J3.503.491I|(3S)-2-(N-METHYL-L-ALA-3-METHYL-L-VAL-)-7-[[(2S,4S)-1-(N-METHYL-L-ALA-3-METHYL-L-VAL-)-2-[[(R)-TETRALIN-1-YL]CARBAMOYL]-4-PYRROLIDINYL]AMINO]-N-[(R)-TETRALIN-1-YL]-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE|BDBM50071846	-	PUBCHEM	117710478	C55H77N9O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WBLPGUTUYUQRAH-JSNDJGPMSA-N
29511	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9489	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]-3-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3,7-dicarboxamide	(S)-2-((S)-3,3-DIMETHYL-2-((S)-2-(METHYLAMINO)PROPANAMIDO)BUTANOYL)-N7-((3S,5S)-1-((S)-3,3-DIMETHYL-2-((S)-2-(METHYLAMINO)PROPANAMIDO)BUTANOYL)-5-(((R)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)CARBAMOYL)PYRROLIDIN-3-YL)-N3-((R)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3,7-DICARBOXAMIDE|BDBM50071845	-	PUBCHEM	72705162	C56H77N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UROIIFBMEHPIGR-JSNDJGPMSA-N
29512	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9490	(2S,4S)-1-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-4-N-[(3S)-2-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-2-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]pyrrolidine-2,4-dicarboxamide	BDBM50071844	-	PUBCHEM	72705161	C56H77N9O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LVSCGNZQGKTFCG-NVLPYBLVSA-N
29513	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9491	(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-7-[[2-[[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]amino]-2-oxoethyl]amino]-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide	BDBM50071843	-	PUBCHEM	73507094	C57H80N10O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GPKBDHHTTCGIAO-QLYDQGARSA-N
29514	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9492	N'-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]oxamide	BDBM50071821	-	PUBCHEM	73505798	C57H78N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NZLKULFMTUXYTR-JSNDJGPMSA-N
29515	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9493	1-N'-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]cyclobutane-1,1-dicarboxamide	BDBM50071820	-	PUBCHEM	73505797	C61H84N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OMVBPXMCVLZSMI-PRXWBPHPSA-N
29516	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	unknown	target	Perez HL (2015)	25584393	224853	9234	4-N-[(3S)-2-[(2S)-3,3-Dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-3-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]-3,4-dihydro-1H-isoquinolin-7-yl]-1-N-[(3S,5S)-1-[(2S)-3,3-dimethyl-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]-5-[[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl]pyrrolidin-3-yl]benzene-1,4-dicarboxamide	BDBM50030280	-	PUBCHEM	73506219	C63H82N10O8	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MAKVXIUNQHYAPX-UPKUDDMJSA-N
29517	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9494	(2S)-N'-Hydroxy-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]-N-phenyloctanediamide	BDBM50042849	-	PUBCHEM	72947043	C18H24N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GHCWLYKERZOPPW-KBPBESRZSA-N
29518	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9495	(2S)-N'-Hydroxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyloctanediamide	ST8086AA1|(2S)-N-[(1S)-7-(HYDROXYAMINO)-7-OXO-1-(PHENYLCARBAMOYL)HEPTYL]-5-OXO-PYRROLIDINE-2-CARBOXAMIDE|BDBM50042848	-	PUBCHEM	72946833	C19H26N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QMGDCUHFYVMSBA-GJZGRUSLSA-N
29519	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9496	(2S)-N'-Hydroxy-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-N-[3-(trifluoromethyl)phenyl]octanediamide	ST-8078-AA1|(2R)-N-[(1S)-7-(HYDROXYAMINO)-7-OXO-1-[[3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL]HEPTYL]-5-OXO-PYRROLIDINE-2-CARBOXAMIDE|ST8078AA1|SB19290|1528755-83-0|BDBM50042847	-	PUBCHEM	72710871	C20H25F3N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XVGBJXUAVWXLJX-LSDHHAIUSA-N
29520	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9497	(2S)-N'-Hydroxy-N-(3-methylphenyl)-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]octanediamide	(2R)-N-[(1S)-7-(HYDROXYAMINO)-1-(M-TOLYLCARBAMOYL)-7-OXO-HEPTYL]-5-OXO-PYRROLIDINE-2-CARBOXAMIDE|ST8074AA1|BDBM50042846	-	PUBCHEM	72947044	C20H28N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DAGWCJGDWGPDPA-JKSUJKDBSA-N
29521	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9498	(2R)-N-[(2S)-1-Anilino-1-oxo-7-sulfanylheptan-2-yl]-5-oxopyrrolidine-2-carboxamide	BDBM50042845	-	PUBCHEM	91884636	C18H25N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YYSCXBPFYMVUDP-LSDHHAIUSA-N
29522	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	9499	(2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamide	BDBM50027520	-	PUBCHEM	118719817	C19H24F3N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CXRLQBYGPWEWJP-LSDHHAIUSA-N
29523	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Giannini G (2015)	25563890	224854	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29524	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9500	BDBM50040557	-	-	CHEMBL	CHEMBL3361178	C24H25N5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RFOKLKNGIPKNDF-JCNLHEQBSA-N
29525	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9501	BDBM50040551	-	-	CHEMBL	CHEMBL3361184	C25H28N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UVMHVBWGXWQOLU-XUTJKUGGSA-N
29526	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9502	BDBM50040550	-	-	CHEMBL	CHEMBL3361185	C24H26N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FPPFUGYLWPKNTA-UAPYVXQJSA-N
29527	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9503	BDBM50040513	-	-	CHEMBL	CHEMBL3361210	C25H28FN5O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VLNGECBZQIDCNU-WGSAOQKQSA-N
29528	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9504	BDBM50040512	-	-	CHEMBL	CHEMBL3361211	C27H31N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMCROPORCNMTHB-MEMLXQNLSA-N
29529	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9505	BDBM50040506	-	-	CHEMBL	CHEMBL3361216	C27H32N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QYDMQKBOHABCOZ-AQYVVDRMSA-N
29530	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9506	BDBM50040505	-	-	CHEMBL	CHEMBL3361217	C26H31N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IAHVLWVJZMFEPN-XYWHTSSQSA-N
29531	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9507	BDBM50040499	-	-	CHEMBL	CHEMBL3361223	C27H29N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMBRNCPCPMAUCV-MXVIHJGJSA-N
29532	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9508	BDBM50040498	-	-	CHEMBL	CHEMBL3361224	C26H29N7O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XBDONALUAKOWDJ-WGSAOQKQSA-N
29533	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9509	BDBM50040497	-	-	CHEMBL	CHEMBL3361225	C27H29N5OS	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PUERLUHEKCOMSQ-MXVIHJGJSA-N
29534	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	unknown	target	Cervi G (2014)	25474526	171150	9510	BDBM50040496	-	-	CHEMBL	CHEMBL3361226	C27H30N6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LJIJDHSXMUSZQW-MXVIHJGJSA-N
29535	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2015)	25462271	224855	9511	N-[(2S)-1-[3-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]phenoxy]-3-(1H-indol-3-yl)propan-2-yl]-4-methoxybenzamide	BDBM50038747	-	PUBCHEM	118720522	C28H27N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UXMMCAXDMKCFRK-UNJYKCMZSA-N
29536	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2015)	25462271	224855	9512	N-[(2S)-1-[3-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]phenoxy]-3-(1H-indol-3-yl)propan-2-yl]-2-methoxybenzamide	BDBM50038729	-	PUBCHEM	118720529	C28H27N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSRRZSNVPQPAFD-ARKBFRDHSA-N
29537	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2015)	25462271	224855	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29538	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Zwick V (2014)	25455492	224856	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29539	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9513	N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide	1454308-22-5|DB-096476|BDBM50440912	-	PUBCHEM	73333311	C14H15N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FOBBYTXDJVRRLB-UHFFFAOYSA-N
29540	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9514	N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide	ZINC68248700|N-HYDROXY-2-(1-METHYLPYRROLE-2-CARBONYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-6-CARBOXAMIDE|EX-A1852|BCP29593|SYN1218|CS-0064770|N-HYDROXY-2-(1-METHYL-1H-PYRROLE-2-CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBOXAMIDE|MPI 5A;MPI5A;HDAC6 INHIBITOR;HISTONE DEACETYLASE 6|1259296-46-2|MPI_5A|MPI-5A|DB-092801|HY-113957|1,2,3,4-TETRAHYDRO-N-HYDROXY-2-[(1-METHYL-1H-PYRROL-2-YL)CARBONYL]-6-ISOQUINOLINECARBOXAMIDE|BDBM50440907	-	PUBCHEM	49831258	C16H17N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NNQAQGDSGCGFER-UHFFFAOYSA-N
29541	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	8395	Tubastatin A	N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide|2XTSOX1NF8|Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-|Tubastatin A|N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide|BDBM50380399	-	CHEMSPIDER	28295021	C20H21N3O2	small molecule	-	1239262-52-2	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GOVYBPLHWIEHEJ-UHFFFAOYSA-N
29542	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9515	N-Hydroxy-7-(4-phenylbenzoyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide	N-HYDROXY-7-(4-PHENYLBENZOYL)-6,8-DIHYDRO-5H-IMIDAZO[1,2-A]PYRAZINE-2-CARBOXAMIDE|BDBM50036305	-	PUBCHEM	53390842	C20H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OGQGBQMGXFYPBR-UHFFFAOYSA-N
29543	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9516	7-(1-Benzothiophene-2-carbonyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide	7-(1-BENZOTHIOPHENE-2-CARBONYL)-N-HYDROXY-6,8-DIHYDRO-5H-IMIDAZO[1,2-A]PYRAZINE-2-CARBOXAMIDE|BDBM50036304	-	PUBCHEM	58465842	C16H14N4O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GBJSJGWUCWJYTR-UHFFFAOYSA-N
29544	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9517	2-(4,5-Dichloro-1-methylpyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	2-(4,5-DICHLORO-1-METHYLPYRROLE-2-CARBONYL)-N-HYDROXY-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036303	-	PUBCHEM	58465719	C14H14Cl2N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GPVDZHZKWSWTAW-UHFFFAOYSA-N
29545	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9518	2-(1-Benzothiophene-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	BDBM50036301	-	PUBCHEM	118719410	C17H15N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PKOFMNJPOQAOMK-UHFFFAOYSA-N
29546	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9519	N-Hydroxy-2-(4-methoxybenzoyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(4-METHOXYBENZOYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036300	-	PUBCHEM	87400677	C16H17N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZBYDKMSHGGWYID-UHFFFAOYSA-N
29547	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9520	2-(Cyclohexanecarbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	2-(CYCLOHEXANECARBONYL)-N-HYDROXY-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036299	-	PUBCHEM	58465664	C15H21N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IRYNPILZVVOIKV-UHFFFAOYSA-N
29548	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9521	N-Hydroxy-2-(1-methylindole-5-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(1-METHYLINDOLE-5-CARBONYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036296	-	PUBCHEM	58465755	C18H18N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZVYGMGIDIFWWGW-UHFFFAOYSA-N
29549	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9522	N-Hydroxy-2-(4-phenylbenzoyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(4-PHENYLBENZOYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036295	-	PUBCHEM	58465681	C21H19N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSAEIUYNAKOEW-UHFFFAOYSA-N
29550	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9523	N-Hydroxy-5-(1-methylindole-2-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide	N-HYDROXY-5-(1-METHYLINDOLE-2-CARBONYL)-6,7-DIHYDRO-4H-PYRAZOLO[1,5-A]PYRAZINE-2-CARBOXAMIDE|BDBM50036291	-	PUBCHEM	58465705	C17H17N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ODOAGJBJOFXVAD-UHFFFAOYSA-N
29551	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9524	N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide	N-HYDROXY-2-(1-METHYLPYRROLE-2-CARBONYL)-3,4-DIHYDRO-1H-PYRROLO[1,2-A]PYRAZINE-7-CARBOXAMIDE|BDBM50036285	-	PUBCHEM	58465708	C14H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HXYDFXUSMZJLIU-UHFFFAOYSA-N
29552	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	9525	Tubacin	AC-28328|DIOX-H_003551|Q27089032|AC1O7Y2P|TUBACIN (BML-GR362)|CTK8E6516|S2239|A10954|EX-A2172|1350555-93-9|HY-13428|CCG-270408|ZINC27551136|TUBACIN, >=98% (HPLC)|GTPL7374|537049-40-4|NCGC00346840-01|SW219084-1|BRD-K98426715-001-01-9|Y6280|N1-(4-((2R,4R,6S)-4-(((4,5-DIPHENYLOXAZOL-2-YL)THIO)METHYL)-6-(4-(HYDROXYMETHYL)PHENYL)-1,3-DIOXAN-2-YL)PHENYL)-N8-HYDROXYOCTANEDIAMIDE|N-[4-[(2R,4R,6S)-4-[[(4,5-DIPHENYL-2-OXAZOLYL)THIO]METHYL]-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL]PHENYL]-N'-HYDROXYOCTANEDIAMIDE|C41H43N3O7S|OCTANEDIAMIDE, N1-(4-((2R,4R,6S)-4-(((4,5-DIPHENYL-2-OXAZOLYL)THIO)METHYL)-6-(4-(HYDROXYMETHYL)PHENYL)-1,3-DIOXAN-2-YL)PHENYL)-N8-HYDROXY-, REL-|UNII-02C2G1D30D COMPONENT BHUZLJOUHMBZQY-YXQOSMAKSA-N|NCGC00346840-03|CS-5738|N-[4-[(2R,4R,6S)-4-[[4,5-DI(PHENYL)-1,3-OXAZOL-2-YL]SULFANYLMETHYL]-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL]PHENYL]-N'-HYDROXYOCTANEDIAMIDE|N-[4-[(2R,4R,6S)-4-[(4,5-DIPHENYL-1,3-OXAZOL-2-YL)SULFANYLMETHYL]-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL]PHENYL]-N'-HYDROXYOCTANEDIAMIDE|N-(4-{(2R,4R,6S)-4-{[(4,5-DIPHENYL-1,3-OXAZOL-2-YL)SULFANYL]METHYL}-6-[4-(HYDROXYMETHYL)PHENYL]-1,3-DIOXAN-2-YL}PHENYL)-N -HYDROXYOCTANEDIAMIDE|AKOS024457607|TUBACIN|KS-0000185J|BDBM22449	-	PUBCHEM	6675804	C41H43N3O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BHUZLJOUHMBZQY-YXQOSMAKSA-N
29553	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Blackburn C (2014)	25454270	224857	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29554	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang G (2014)	25238284	224858	9526	N-Hydroxy-2-[[5-(3-nitrophenyl)furan-2-yl]methyl]-3,4-dihydro-1H-isoquinoline-7-carboxamide	2-[5-(3-NITROPHENYL)FURFURYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-7-CARBOHYDROXIMIC ACID|BDBM50027664	-	PUBCHEM	101882265	C21H19N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PMFDRULHDRRWFP-UHFFFAOYSA-N
29555	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang G (2014)	25238284	224858	9466	(7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide	(R)-7BETA-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOHYDROXIMIC ACID|BDBM50027662	-	PUBCHEM	92045024	C20H19N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWLFQRZKKHIDTM-QGZVFWFLSA-N
29556	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tang G (2014)	25238284	224858	9527	(7S)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide	BDBM50027661	-	PUBCHEM	118715268	C20H19N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MWLFQRZKKHIDTM-KRWDZBQOSA-N
29557	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	9528	N-Hydroxy-5-[1-[(4-phenylphenyl)methyl]pyrazol-3-yl]pentanamide	BDBM50026431	-	PUBCHEM	118714377	C21H23N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIMAODGURWKHJY-UHFFFAOYSA-N
29558	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	9529	N-Hydroxy-5-(1-phenylpyrazol-3-yl)pentanamide	BDBM50026430	-	PUBCHEM	118714371	C14H17N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SRBLEOJYOQUWOH-UHFFFAOYSA-N
29559	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	9530	5-[1-[(4-Anilinophenyl)methyl]pyrazol-3-yl]-N-hydroxypentanamide	BDBM50026429	-	PUBCHEM	118714376	C21H24N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XXOUJCCBKBTDDB-UHFFFAOYSA-N
29560	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Yao Y (2014)	25218912	224859	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29561	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Salvador LA (2014)	25147612	224860	9531	(5R,8S,11S)-5-Methyl-11-[(E)-4-[[(E)-4-[(5R,8S,11S)-5-methyl-6,9,13-trioxo-8-propan-2-yl-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-trien-11-yl]but-3-enyl]disulfanyl]but-1-enyl]-8-propan-2-yl-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione	BDBM50101331	-	PUBCHEM	118712502	C42H54N8O8S6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VXQMEGLYMWVBHB-UOLLFOIHSA-N
29562	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Salvador LA (2014)	25147612	224860	9532	Largazole Thiol	LARGAZOLE THIOL|BDBM50020912	-	PUBCHEM	56663191	C21H28N4O4S3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VEDPEVJAYWVUSJ-FJNFOTEGSA-N
29563	124227	84727	-	SPSB2	GRCC9|SSB2	9606	Homo sapiens	unknown	target	Yap BK (2014)	25068993	224861	9533	2-[(4S,7S,10S,13S,16S,19S,22S,25R)-25-Acetamido-7,10,13-tris(2-amino-2-oxoethyl)-16-[(2S)-butan-2-yl]-4-carbamoyl-6,9,12,15,18,21,24-heptaoxo-22-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacos-19-yl]acetic acid	BDBM50055509	-	PUBCHEM	118711530	C35H56N12O14S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VXFIYXDXPBZJRN-VNDFSXJLSA-N
29564	124227	84727	-	SPSB2	GRCC9|SSB2	9606	Homo sapiens	unknown	target	Yap BK (2014)	25068993	224861	9534	(3S)-3-[[(2S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-4-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2R)-1-amino-1-oxo-3-sulfanylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid	BDBM50055507	-	PUBCHEM	102369413	C35H58N12O14S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CWCPBBZVUALKSD-HFOKRWRUSA-N
29565	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	unknown	target	Zhang W (2014)	25068800	224862	9535	BDBM50055496	-	-	CHEMBL	CHEMBL3326006	C28H40N6O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MJSHVHLADKXCML-RQNOJGIXSA-N
29566	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9536	(2r)-2-Benzyl-3-[3-({[4-(Piperidin-1-Yl)benzoyl]amino}methyl)-4-Propoxyphenyl]propanoic Acid	Q27459965|(2R)-2-BENZYL-3-[3-({[4-(PIPERIDIN-1-YL)BENZOYL]AMINO}METHYL)-4-PROPOXYPHENYL]PROPANOIC ACID|(2R)-2-BENZYL-3-[3-[[(4-PIPERIDIN-1-YLBENZOYL)AMINO]METHYL]-4-PROPOXYPHENYL]PROPANOIC ACID|MEKT-28|EK8|BDBM50050557	-	PUBCHEM	56929502	C32H38N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ISYAJDFASPMBOB-HHHXNRCGSA-N
29567	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9537	(2R)-2-[[3-[[[4-(Azocan-1-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	(R)-2-[3-[[[4-(OCTAHYDROAZOCINE-1-YL)BENZOYL]AMINO]METHYL]-4-(PROPYLOXY)BENZYL]-3-PHENYLPROPANOIC ACID|BDBM50050556	-	PUBCHEM	102313443	C34H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NLXAFEDDAOLUIF-GDLZYMKVSA-N
29568	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9538	(2R)-2-[[3-[[[4-(Azonan-1-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050555	-	PUBCHEM	118708437	C35H44N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LEXLSPDBTSINAM-SSEXGKCCSA-N
29569	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9539	(2R)-2-Benzyl-3-[4-propoxy-3-[[[4-(3,3,5,5-tetramethylpiperidin-1-yl)benzoyl]amino]methyl]phenyl]propanoic acid	BDBM50050554	-	PUBCHEM	118708440	C36H46N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CTTGJGHAKDHCCV-GDLZYMKVSA-N
29570	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9540	(2R)-2-[[3-[[[4-(8-Azabicyclo[3.2.1]octan-8-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	(R)-2-[3-[[[4-(8-AZABICYCLO[3.2.1]OCTANE-8-YL)BENZOYL]AMINO]METHYL]-4-(PROPYLOXY)BENZYL]-3-PHENYLPROPANOIC ACID|BDBM50050553	-	PUBCHEM	102313442	C34H40N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JRGNQRQWJGAPES-WWUHRCHBSA-N
29571	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9541	(2R)-2-[[3-[[[4-(9-Azabicyclo[3.3.1]nonan-9-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050552	-	PUBCHEM	118708441	C35H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HTWMBKHFCRGFJX-WHIWCKBPSA-N
29572	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9542	(2R)-2-[[3-[[[4-(3-Azabicyclo[3.2.1]octan-3-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050551	-	PUBCHEM	118708442	C34H40N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SOCVTCXYXPQYPF-VMJMFXBVSA-N
29573	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9543	(2R)-2-[[3-[[[4-(2-Azatricyclo[3.3.1.13,7]decan-2-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050550	-	PUBCHEM	118708443	C36H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GRIHSHBOOIEZBN-YQNGJPPUSA-N
29574	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	9544	(E)-N-Hydroxy-3-[4-[[5-(naphthalen-1-ylmethyl)-1,3,4-oxadiazol-2-yl]methyl]phenyl]prop-2-enamide	N-HYDROXY-3-[4-[5-(1-NAPHTHYLMETHYL)-1,3,4-OXADIAZOLE-2-YLMETHYL]PHENYL]PROPENEAMIDE|BDBM50047967	-	PUBCHEM	102366363	C23H19N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DQHBWINPWGGELF-OUKQBFOZSA-N
29575	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	9545	(E)-N-Hydroxy-3-[4-[5-(1H-indol-3-ylmethyl)-1,3,4-oxadiazol-2-yl]phenyl]prop-2-enamide	BDBM50047966	-	PUBCHEM	118707836	C20H16N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MTSNUBCDRYSBCQ-JXMROGBWSA-N
29576	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	9546	(E)-N-Hydroxy-3-[4-[5-(naphthalen-1-ylmethyl)-1,3,4-oxadiazol-2-yl]phenyl]prop-2-enamide	BDBM50047965	-	PUBCHEM	118707835	C22H17N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LBRVMWDZJHBLGD-JLHYYAGUSA-N
29577	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Valente S (2014)	24972008	224864	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29578	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Chen F (2014)	24944733	224865	9532	Largazole Thiol	LARGAZOLE THIOL|BDBM50020912	-	PUBCHEM	56663191	C21H28N4O4S3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VEDPEVJAYWVUSJ-FJNFOTEGSA-N
29579	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9547	BDBM50022113	-	-	CHEMBL	CHEMBL3298231	C25H32N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AYMVSAPTKYQTRO-FEHRVWHQSA-N
29580	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9548	CID 90645434	4-ethyl-3-[(2-methyl-2-phenylpropyl)amino]isoindol-1-one|BDBM50022112	-	PUBCHEM	90645434	C20H22N2O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HUHNFFKPYZJMIB-UHFFFAOYSA-N
29581	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9549	2-Chloro-5-methoxy-N-(2-methyl-2-phenylpropyl)quinazolin-4-amine	929022-63-9|2-CHLORO-5-METHOXY-N-(2-METHYL-2-PHENYLPROPYL)QUINAZOLIN-4-AMINE|4-QUINAZOLINAMINE,2-CHLORO-5-METHOXY-N-(2-METHYL-2-PHENYLPROPYL)-|ZINC34949037|BDBM50022111	-	PUBCHEM	16051050	C19H20ClN3O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLEQOKDDRKNDTM-UHFFFAOYSA-N
29582	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9459	4-Methoxy-N-(2-methyl-2-phenylpropyl)-1,2-benzoxazol-3-amine	4-METHOXY-N-(2-METHYL-2-PHENYLPROPYL)-1,2-BENZOXAZOL-3-AMINE|BDBM50022110	-	PUBCHEM	16050462	C18H20N2O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FRLKYVJLDPLCNR-UHFFFAOYSA-N
29583	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9550	4-Ethyl-N-(2-methyl-2-phenylpropyl)-1,2-benzothiazol-3-amine	BDBM50022109	-	PUBCHEM	90645433	C19H22N2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IKPLYVUNYODPGZ-UHFFFAOYSA-N
29584	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9551	5-Methoxy-4-[(2-methyl-2-phenylpropyl)amino]-1H-quinazolin-2-one	5-METHOXY-4-[(2-METHYL-2-PHENYLPROPYL)AMINO]-1H-QUINAZOLIN-2-ONE|BDBM50022108	-	PUBCHEM	16102139	C19H21N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAYXJKGOWYBZSE-UHFFFAOYSA-N
29585	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Johnson JA (2014)	24881565	224866	9552	8-Methoxy-N-(2-methyl-2-phenylpropyl)isoquinolin-1-amine	ZINC34948862|8-METHOXY-N-(2-METHYL-2-PHENYLPROPYL)ISOQUINOLIN-1-AMINE|BDBM50022107	-	PUBCHEM	16050952	C20H22N2O	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WZDLNTAETYKZDN-UHFFFAOYSA-N
29586	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9553	N-[7-(Hydroxyamino)-7-oxoheptyl]-2-methoxyquinoline-6-carboxamide	BDBM50044648	-	PUBCHEM	117829456	C18H23N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VVZXDYPDBYYVAY-UHFFFAOYSA-N
29587	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9554	N-[7-(Hydroxyamino)-7-oxoheptyl]-1-methyl-2-oxoquinoline-6-carboxamide	BDBM50044646	-	PUBCHEM	117829462	C18H23N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FVXNWIVUIWQBNB-UHFFFAOYSA-N
29588	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9555	N-[7-(Hydroxyamino)-7-oxoheptyl]-4,4-dimethyl-2-oxo-1,3-dihydroquinoline-6-carboxamide	BDBM50044645	-	PUBCHEM	86581005	C19H27N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OEQQELYWLWKXKU-UHFFFAOYSA-N
29589	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9556	N'-Hydroxy-N-(2-oxo-1H-quinolin-6-yl)octanediamide	BDBM50044640	-	PUBCHEM	117829479	C17H21N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMKXBBIZQUFLCC-UHFFFAOYSA-N
29590	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Tashima T (2014)	24864038	224867	9557	BDBM50033636	-	-	CHEMBL	CHEMBL3309297	C22H29N3O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RIHKXPFNMAZMOA-KTRQRASZSA-N
29591	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Johnson TW (2014)	24819116	224868	9558	Lorlatinib	PF06463922(LORLATINIB)|BCP10287|ZINC98208524|PFE-PKIS 10|D11012|(10R)-7-AMINO-12-FLUORO-10,15,16,17-TETRAHYDRO-2,10,16-TRIMETHYL-15-OXO-2H-4,8-METHENOPYRAZOLO[4,3-H][2,5,11]BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE|HY-12215|7-AMINO-12-FLUORO-2,10,16-TRIMETHYL-15-OXO-10,15,16,17-TETRAHYDRO-2H-8,4-(METHENO)PYRAZOLO(4,3-H)(2,5,11)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE|CS-3983|S7536|DB12130|AK175603|PF 06463922|GTPL7476|PF-06463922 LORLATINIB|LORLATINIB,PF-06463922|LORLATINIBUM|OSP71S83EU|LORATINIB|PF06463922|PF-06463922|EX-A828|UNII-OSP71S83EU|A14207|LORVIQUA|LORBRENA|(10R)-7-AMINO-12-FLUORO-2,10,16-TRIMETHYL-15-OXO-10,15,16,17-TETRAHYDRO-2H-8,4-(METHENO)PYRAZOLO[4,3-H][2,5,11]BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE|1454846-35-5|NCGC00386417-02|C21H19FN6O2|J-690185|(10R)-7-AMINO-12-FLUORO-2,10,16-TRIMETHYL-15-OXO-10,15,16,17-TETRAHYDRO-2H-8,4-(METHENO)PYRAZOLO[4,3-H][2,5,11]-BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE|4CLI|2H-4,8-METHENOPYRAZOLO(4,3-H)(2,5,11)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE, 7-AMINO-12-FLUORO-10,15,16,17-TETRAHYDRO-2,10,16-TRIMETHYL-15-OXO-, (10R)-|CCG-268718|LORLATINIB [USAN:INN]|AKOS027250753|LORBRENA (TN)|LORLATINIB (JAN/USAN/INN)|KS-00000T6C|2H-4,8-METHENOPYRAZOLO[4,3-H][2,5,11]BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE, 7-AMINO-12-FLUORO-10,15,16,17-TETRAHYDRO-2,10,16-TRIMETHYL-15-OXO-, (10R)-|Q27285820|(10R)-7-AMINO-12-FLUORO-2,10,16-TRIMETHYL-15-OXO-10,15,16,17-TETRAHYDRO-2H-4,8-METHENOPYRAZOLO[4,3-H][2,5,11]BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE|MFCD28144520|4CLJ|2641AH|NCGC00386417-13|LORLATINIB|BDBM50018830	-	PUBCHEM	71731823	C21H19FN6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IIXWYSCJSQVBQM-LLVKDONJSA-N
29592	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	unknown	target	Kawamura S (2014)	24814885	224869	9559	(2R,3S)-3-[(2S)-Butan-2-yl]-4-oxo-N-[4-phenylmethoxy-3-(phenylmethoxymethyl)butyl]oxetane-2-carboxamide	BDBM50007208	-	PUBCHEM	90655062	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SODXRIYSSYNQGD-KSNOWIBYSA-N
29593	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	unknown	target	Kawamura S (2014)	24814885	224869	9560	Benzyl N-[(2S)-1-[[(2R)-1-[(1R,2S)-2-[[(2R,3S)-3-[(2S)-butan-2-yl]-4-oxooxetane-2-carbonyl]amino]cyclopropyl]-4-phenylbutan-2-yl]amino]-1-oxopropan-2-yl]carbamate	BDBM50007207	-	PUBCHEM	90655061	C32H41N3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YUZQDEBWPUFQAF-RBFWQIJRSA-N
29594	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	unknown	target	Zhang J (2014)	24767818	224870	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
29595	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	unknown	target	Zhang J (2014)	24767818	224870	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
29596	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee HY (2014)	24766560	224871	9393	Ricolinostat	SW219836-1|ZINC89630354|W-5979|AS-73344|D10661|ROCILINOSTAT (ACY-1215)|GTPL7010|ROCILINOSTAT|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]PYRIMIDINE-5-CARBOXAMIDE|ACY-63|DTXSID40157148|RICOLINOSTAT (USAN/INN)|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)-|CCG-269054|AK151416|7-{[2-(DIPHENYLAMINO)PYRIMIDIN-5-YL]FORMAMIDO}-N-HYDROXYHEPTANAMIDE|SMR004702950|EX-A139|UNII-WKT909C62B|ACN-030031|S8001|AH4|CS-0965|DB12376|Q27088553|NS00073045|ACY-1215|1316214-52-4|SB17054|CC-661|HMS3426C09|US8609678, 2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE [26]|AB0032517|BCP06028|A11940|X5832|AC-30258|2-(DIPHENYLAMINO)-N-(7-(HYDROXYAMINO)-7-OXOHEPTYL)PYRIMIDINE-5-CARBOXAMIDE|MLS006011181|N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-2-(N-PHENYLANILINO)PYRIMIDINE-5-CARBOXAMIDE|HY-16026|WKT909C62B|NCGC00345802-05|J-690127|ACY1215|AX8288032|AKOS024259260|RICOLINOSTAT (ACY-1215)|RICOLINOSTAT [USAN:INN]|2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-5-PYRIMIDINECARBOXAMIDE|5-PYRIMIDINECARBOXAMIDE, 2-(DIPHENYLAMINO)-N-[7-(HYDROXYAMINO)-7-OXOHEPTYL]-|NCGC00345802-01|RICOLINOSTAT|HMS3653F17|KS-00000SAV|BDBM50439674	-	PUBCHEM	53340666	C24H27N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QGZYDVAGYRLSKP-UHFFFAOYSA-N
29597	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee HY (2014)	24766560	224871	9561	(E)-N-Hydroxy-3-(3-pyrrolo[2,3-b]pyridin-1-ylsulfonylphenyl)prop-2-enamide	N-HYDROXY-3-[3-(1H-PYRROLO[2,3-B]PYRIDINE-1-YLSULFONYL)PHENYL]PROPENEAMIDE|(E)-N-HYDROXY-3-(3-PYRROLO[2,3-B]PYRIDIN-1-YLSULFONYLPHENYL)PROP-2-ENAMIDE|BDBM50015233	-	PUBCHEM	86765212	C16H13N3O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OXPJGPURVBXIAP-VOTSOKGWSA-N
29598	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee HY (2014)	24766560	224871	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29599	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Zhang J (2014)	24751157	224872	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
29600	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Zhang J (2014)	24751157	224872	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
29601	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	9562	(E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide	(E)-N-HYDROXY-3-[4-(4-METHOXYPHENYL)PHENYL]PROP-2-ENAMIDE|N-HYDROXY-E-3-(4''-METHOXYBIPHENYL-4-YL)-ACRYLAMIDE|BDBM50293361	-	PUBCHEM	15986509	C16H15NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WKQPXLKFQLGQSM-NYYWCZLTSA-N
29602	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	9563	(E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide	N-HYDROXY-E-3-(4''-HYDROXYBIPHENYL-4-YL)-ACRYLAMIDE|(E)-N-HYDROXY-3-[4-(4-HYDROXYPHENYL)PHENYL]PROP-2-ENAMIDE|BDBM50293358	-	PUBCHEM	15986418	C15H13NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MGGQEULGVBEMAL-XCVCLJGOSA-N
29603	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29604	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Cincinelli R (2014)	24742384	224873	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29605	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Li X (2014)	24694055	224874	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29606	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Taddei M (2014)	24588105	224875	9564	1-(2,4-Dihydroxy-5-propan-2-ylphenyl)-N-[7-(hydroxyamino)-7-oxoheptyl]-5-[4-(morpholin-4-ylmethyl)phenyl]triazole-4-carboxamide	BDBM50008222	-	PUBCHEM	90655296	C30H40N6O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IBHAGSBJXPUIFA-UHFFFAOYSA-N
29607	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Taddei M (2014)	24588105	224875	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29608	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Baruchello R (2014)	24565573	224876	9565	5-(2,4-Dihydroxy-5-propan-2-ylbenzoyl)-N-[7-(hydroxyamino)-7-oxoheptyl]-6,7-dihydro-4H-[1,2]oxazolo[4,5-c]pyridine-3-carboxamide	BDBM50007730	-	PUBCHEM	86302594	C24H32N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MSHYQCFSRGHYAU-UHFFFAOYSA-N
29609	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Baruchello R (2014)	24565573	224876	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29610	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jiang ZY (2014)	24512214	163212	9409	2,2'-(Naphthalene-1,4-diylbis(((4-methoxyphenyl)sulfonyl)azanediyl))diacetic acid	COMPOUND 2 [PMID: 24512214]|CPUY192018|2,2'-(NAPHTHALENE-1,4-DIYLBIS(((4-METHOXYPHENYL)SULFONYL)AZANEDIYL))DIACETIC ACID|2,2'-[1,4-NAPHTHALENEDIYLBIS[(4-METHOXYPHENYLSULFONYL)IMINO]]BISACETIC ACID|BRD-K55096910-001-01-4|COMPOUND 18E [PMID: 26258437]|GTPL9710|1567836-15-0|2-[[4-[CARBOXYMETHYL-(4-METHOXYPHENYL)SULFONYLAMINO]NAPHTHALEN-1-YL]-(4-METHOXYPHENYL)SULFONYLAMINO]ACETIC ACID|BDBM50006932	-	PUBCHEM	73330369	C28H26N2O10S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSIQJUNYMMCTB-UHFFFAOYSA-N
29611	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	unknown	target	Jiang ZY (2014)	24512214	163212	9566	(4S)-5-[[(2S)-1-[[(2S)-1-Amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[2-[[(2S,3R)-2-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2-[(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)carbamothioylamino]-4-methylpentanoyl]amino]propanoyl]amino]butanoyl]amino]butanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-5-oxopentanoic acid	BDBM50006930	-	PUBCHEM	90655040	C67H81N11O23S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WHORBCNXCLZUFL-HDFZMCSMSA-N
29612	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	unknown	target	Hasegawa M (2014)	24321833	224877	9567	Z-Leu-leu-leu-al	CBZ-LEU-LEU-LEU-AL|Z-LLL|BRD-0970|BENZYLOXYCARBONYL-LEU-LEU-LEUCINAL|COMPOUND 5B [PMID: 16686537]|DTXSID3042639|KBIOSS_000030|EX-A1500|MFCD00674886|KBIO3_000059|CARBOBENZOXYL-LEUCINYL-LEUCINYL-LEUCINAL-H|NCGC00161679-02|X7579|MG-132 [Z-LEU-LEU-LEU-CHO]|CCG-207860|Z-LEU-LEU-LEUCINAL|Q3272916|BRD0970|MG-132-1|AOB4946|BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE|NCGC00161679-01|UNM000011053701|L-LEUCINAMIDE, N-((PHENYLMETHOXY)CARBONYL)-L-LEUCYL-N-(1-FORMYL-3-METHYLBUTYL)-, (S)-|SR-01000864598-1|CBZ-L-LEU-L-LEU-L-LEU-H|CCG-208036|N-BENZYLOXYCARBONYL-L-LEUCYL-L-LEUCYL-L-LEUCINAL|LLL CPD|Z-LEU-LEU-LEU-AL, >=90% (HPLC)|Z-LLLAL|BENZYLOXYCARBONYL-LEU-LEU-LEU-ALDEHYDE|MG 132|CS-0471|BENZYL N-[(1S)-3-METHYL-1-[[(1S)-3-METHYL-1-[[(2S)-4-METHYL-1-OXO-PENTAN-2-YL]CARBAMOYL]BUTYL]CARBAMOYL]BUTYL]CARBAMATE|SC-93546|133407-82-6|SW219780-1|KBIO3_000060|ZX-AFC000065|MG132/MG-132/|S2619|Z-LEU-LEU-LEU-AL|PHENYLMETHYL N-[(2S)-4-METHYL-1-[[(2S)-4-METHYL-1-[[(2S)-4-METHYL-1-OXOPENTAN-2-YL]AMINO]-1-OXOPENTAN-2-YL]AMINO]-1-OXOPENTAN-2-YL]CARBAMATE|CARBOBENZOXY-L-LEUCYL-L-LEUCYL-L-LEUCINAL|BIC3742|IDI1_033780|MG-132|BRD-K60230970-001-06-8|CARBOBENZOXY-LEUCYL-LEUCYL-LEUCINAL|Z-LEU-LEU-LEU-ALDEHYDE|HMS3402B12|CBZ-L-LEU-L-LEU-L-LEU-CHO|ABP000958|BRD-K60230970-001-08-4|(S)-N-((PHENYLMETHOXY)CARBONYL)-L-LEUCYL-N-(1-FORMYL-3-METHYLBUTYL)-L-LEUCINAMIDE|BIO2_000030|Z-L-LEU-L-LEU-L-LEU-H|(S)-4-METHYL-2-(3-PHENYL-PROPIONYLAMINO)-PENTANOIC ACID [(S)-1-((S)-1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|ACN-047884|Z-LLL-ALDEHYDE|CBZ-LEU-LEU-LEUCINAL|N-[(BENZYLOXY)CARBONYL]-L-LEUCYL-N-[(1S)-1-FORMYL-3-METHYLBUTYL]-L-LEUCINAMIDE|NCGC00161679-03|BENZYL(S)-4-METHYL-1-((S)-4-METHYL-1-((S)-4-METHYL-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLCARBAMATE|AS-55854|HY-13259|W-5117|L-LEUCINAMIDE, N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N1-[(1S)-1-FORMYL-3-METHYLBUTYL]-|BRD-K60230970-001-05-0|SB19111|MLS006011220|N-[(BENZYLOXY)CARBONYL]-L-LEUCYL-N-[(2S)-4-METHYL-1-OXOPENTAN-2-YL]-L-LEUCINAMIDE|CARBOBENZOXY-LEU-LEU-LEUCINAL|{1-[1-(1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL]-3-METHYL-BUTYL}-CARBAMIC ACID BENZYL ESTER|(R)-MG132|HMS1361B12|BSPBIO_001310|CC-245|HMS1989B12|C26H41N3O5|BIO2_000510|Z-LLL-H|MG132|PI-102|(S)-MG132|BENZYL N-[(1S)-1-[[(1S)-1-[[(1S)-1-FORMYL-3-METHYL-BUTYL]CARBAMOYL]-3-METHYL-BUTYL]CARBAMOYL]-3-METHYL-BUTYL]CARBAMATE|UNII-RF1P63GW3K|BENZYL ((S)-4-METHYL-1-(((S)-4-METHYL-1-(((S)-4-METHYL-1-OXOPENTAN-2-YL)AMINO)-1-OXOPENTAN-2-YL)AMINO)-1-OXOPENTAN-2-YL)CARBAMATE|SMR002530629|{(S)-1-[(S)-1-((S)-1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL]-3-METHYL-BUTYL}-CARBAMIC ACID BENZYL ESTER|KS-00000XP9|QCR-183|BRD-K60230970-001-04-3|1211877-36-9|NCGC00161679-04|BRD-K60230970-001-07-6|KBIO2_005166|ZINC13476439|GTPL8616|BCBCMAP01_000028|HMS1791B12|N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N-[(1S)-1-FORMYL-3-METHYLBUTYL]-L-LEUCINAMIDE|KBIO2_002598|L-LEUCINAMIDE, N-((PHENYLMETHOXY)CARBONYL)-L-LEUCYL-N-((1S)-1-FORMYL-3-METHYLBUTYL)-|Z-LLL-CHO|AKOS027420457|BENZYLOXYCARBONYL-LEUCYL-LEUCYL-LEUCINAL|ZLLL-CHO|Z-LEU-LEU-LEU-H|KBIO2_000030|N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N-(1-FORMYL-3-METHYLBUTYL)-(S)-L-LEUCINAMIDE|KBIOGR_000030|BENZYL (S)-4-METHYL-1-((S)-4-METHYL-1-((S)-4-METHYL-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLCARBAMATE|CTK8F0239|CBZ-LEU-LEU-LEU-H|AB0033810|{1-[(S)-(S)-1-((S)-1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL]-3-METHYL-BUTYL}-CARBAMIC ACID BENZYL ESTER|RF1P63GW3K|BRD-K60230970-001-10-0|ZLLLAL|BDBM50069985	-	PUBCHEM	462382	C26H41N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TZYWCYJVHRLUCT-VABKMULXSA-N
29613	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18440229	224878	9568	1-[5-(2,3-Dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2-difluoroethan-1-one	THIOPHENE DERIVATIVE, 15H|1-[5-(2,3-DIHYDRO-1H-INDOL-1-YLCARBONYL)THIOPHEN-2-YL]-2,2-DIFLUOROETHAN-1-ONE|BDBM25172	-	PUBCHEM	25023808	C15H11F2NO2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WZGNPOPOCGTSMZ-UHFFFAOYSA-N
29614	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18440229	224878	9569	CID 24857909	THIOPHENE DERIVATIVE, 3I|N-METHYL-N-(QUINOXALIN-6-YLMETHYL)-5-(2,2,2-TRIFLUOROACETYL)THIOPHENE-2-CARBOXAMIDE|BDBM25163	-	PUBCHEM	24857909	C17H12F3N3O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RLNCISDDCDFAHS-UHFFFAOYSA-N
29615	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	9570	4-[[1-(3-Aminopropyl)triazol-4-yl]methylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide	BDBM50377688	-	PUBCHEM	44449588	C20H31N7O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VYBKJKUFXIAVJM-UHFFFAOYSA-N
29616	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	9571	5-[3-[4-[[4-[[7-(Hydroxyamino)-7-oxoheptyl]carbamoyl]anilino]methyl]triazol-1-yl]propylcarbamothioylamino]-2-(3-oxoxanthen-9-yl)benzoic acid	BDBM50377687	-	PUBCHEM	44448637	C41H42N8O7S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SIKVCWVCYQGEQT-UHFFFAOYSA-N
29617	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29618	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Mazitschek R (2008)	18430569	224879	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29619	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Nakao Y (2008)	18397826	224880	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29620	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Casimiro-Garcia A (2008)	18394907	224881	9572	(S)-3-{4-[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-pyrrol-1-yl-propionic acid	(S)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PYRROL-1-YL-PROPIONIC ACID|(S)-3-[4-[2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY]PHENYL]-2-PYRROL-1-YL-PROPIONIC ACID|(2S)-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PYRROL-1-YLPROPANOIC ACID|(ALPHAS)-ALPHA-(1H-PYRROLE-1-YL)-4-[2-(2-PHENYL-5-METHYL-4-OXAZOLYL)ETHOXY]BENZENEPROPIONIC ACID|PHENYLPROPANOIC ACID DERIVATIVE, 7|BDBM34017	-	PUBCHEM	9866595	C25H24N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OCWDFPOKWYMLGH-QHCPKHFHSA-N
29621	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Finlay HJ (2008)	18374568	224882	9573	N-[(8S)-8-[(4-Ethylphenyl)sulfonylamino]-5,6,7,8-tetrahydronaphthalen-2-yl]-N-[(6-methylpyridin-2-yl)methyl]-3-phenylpropanamide	BDBM50376745	-	PUBCHEM	44450682	C34H37N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OZIVHWHJMJVZCH-XIFFEERXSA-N
29622	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Finlay HJ (2008)	18374568	224882	9574	N-[(3S,4R)-6-[(2S)-2-[(2,6-Dimethylanilino)methyl]pyrrolidine-1-carbonyl]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-4-ethylbenzenesulfonamide	RAC-TRANS-N-(6-((S)-2-((2,6-DIMETHYLPHENYLAMINO)METHYL)PYRROLIDINE-1-CARBONYL)-3-HYDROXY-2,2-DIMETHYL-3,4-DIHYDRO-2H-CHROMEN-4-YL)-4-ETHYLBENZENESULFONAMIDE|N-((3S,4R)-6-((S)-2-((2,6-DIMETHYLPHENYLAMINO)METHYL)PYRROLIDINE-1-CARBONYL)-3-HYDROXY-2,2-DIMETHYL-3,4-DIHYDRO-2H-CHROMEN-4-YL)-4-ETHYLBENZENESULFONAMIDE|BDBM50211535	-	PUBCHEM	17752926	C33H41N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZGNURVKJDROBKC-RVQNBHMFSA-N
29623	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Finlay HJ (2008)	18374568	224882	9575	N-[3-(4-Ethyl-benzenesulfonylamino)-2-hydroxy-indan-5-yl]-3-methoxy-benzamide	N-((2R,3R)-3-(4-ETHYLPHENYLSULFONAMIDO)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-5-YL)-3-METHOXYBENZAMIDE|N-[3-(4-ETHYL-BENZENESULFONYLAMINO)-2-HYDROXY-INDAN-5-YL]-3-METHOXY-BENZAMIDE|BDBM50099581	-	PUBCHEM	17748224	C25H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KCRNOVULDSNKBZ-DNQXCXABSA-N
29624	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18370373	224883	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29625	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18308563	224884	4802	Belinostat	UNII-F4H96P17NZ|NSC-726630|ZINC3818726|ABP000140|866323-14-0|SC-71101|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|SW219445-1|NSC726630|BELEODAQ|BCPP000351|EX-A180|PX 105684|QCR-181|BCP01741|BRD-K17743125-001-01-9|GTPL7496|(E)-N-HYDROXY-3-(3-(N-PHENYLSULFAMOYL)PHENYL)ACRYLAMIDE|BELINOSTAT - PXD101|SB16466|CC-489|AOB87787|BELINOSTAT|AX8144528|MLS006011091|AC-25046|AB0007889|BELINOSTAT (PXD101)|BELINOSTAT,PXD101, PX105684|W-5363|(E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENAMIDE|414864-00-9|D08870|(E)-3-[3-(PHENYLSULFAMOYL)PHENYL]PROP-2-ENEHYDROXAMIC ACID|BELINOSTAT [USAN:INN]|SMR004702879|Q4882925|E-BELINOSTAT|BELINOSTAT (PXD101)|PXD101|PXD 101|N-HYDROXY-3-(3-PHENYLSULPHAMOYLPHENYL)ACRYLAMIDE|API0003555|BELINOSTAT (USAN/INN)|(2E)-N-HYDROXY-3-[3-(PHENYLSULFAMOYL)PHENYL]ACRYLAMIDE|BELEODAQ (TN)|PUBCHEM22405|NCGC00263155-05|(E)-N-HYDROXY-3-(3-PHENYLSULFAMOYL-PHENYL)-ACRYLAMIDE|PXD-101|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PR|S1085|LS41098|PX-105684|BELINOSTAT PH3|N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE|EC-000.2286|BELINOSTAT/PXD101,PX105684/|5OG|DTXSID60194378|2-PROPENAMIDE, N-HYDROXY-3-(3-((PHENYLAMINO)SULFONYL)PHENYL)-, (2E)-|BCP9000386|PX105684|F4H96P17NZ|N-HYDROXY-3-[(PHENYLAMINO)SULFONYL]-TRANS-CINNAMAMIDE|AS-17068|BELINOSTAT(RANDOM CONFIGURATION)|A25012|N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE|AKOS025401741|N-HYDROXY-3-(3-(PHENYLSULFAMOYL)PHENYL)PROP-2-ENAMIDE|CCG-208758|2-PROPENAMIDE, N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-, (2E)-|DB05015|J-523584|BDBM25150	beleodaq	DRUGBANK	DB05015	C15H14N2O4S	small molecule	L01XX49	866323-14-0	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NCNRHFGMJRPRSK-MDZDMXLPSA-N
29626	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18308563	224884	9576	Dacinostat	AS-74728|(2E)-N-HYDROXY-3-(4-{[(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL}PHENYL)PROP-2-ENAMIDE|S1095|ABP000476|AOB87324|SB19288|404951-53-7|Z-3310|(2E)-N-HYDROXY-3-[4-({(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]AMINO}METHYL)PHENYL]PROP-2-ENAMIDE|MLS006011098|(E)-N-HYDROXY-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-2-PROPENAMIDE|LAQ824 (NVP-LAQ824,DACINOSTAT)|AK174336|139303-EP2292617A1|EX-A2226|LAQ824; DACINOSTAT; NVP-LAQ824|ZINC1494627|Q27076972|DACINOSTAT (NVP-LAQ824, LAQ824)|V10P524501|BCP9000839|UNII-V10P524501|2-PROPENAMIDE, N-HYDROXY-3-[4-[[(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-, (2E)-|A825135|LAQ824 (DACINOSTAT)|139303-EP2270008A1|X7607|BRD-K56957086-001-02-2|DACINOSTAT [INN]|LAQ824/|CS-1974|X7530|LS-192513|NVP-LAQ824|(2E)-N-HYDROXY-3-(4-({(2-HYDROXYETHYL)(2-(1H-INDOL-3-YL)ETHYL)AMINO}METHYL)PHENYL)PROPENAMIDE|HY-13606|DTXSID1041055|EC-000.2469|(E)-N-HYDROXY-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METH YL]PHENYL]PROP-2-ENAMIDE|NVP-LAQ 824|GTPL7497|2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-HYDROXYETHYL)(2-(1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)-, (2E)-|LAQ824,NVP-LAQ824|LAQ-824|CCG-208761|LAQ824|SMR004701446|N-HYDROXY-3-[4-[[(2-HYDROXYETHYL)[2-(1H-INDOL-3-YL)ETHYL]-AMINO]METHYL]PHENYL]-2E-2-PROPENAMIDE|SW219385-1|SMR004702886|BCP01747|(E)-N-HYDROXY-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]PROP-2-ENAMIDE|AKOS015899788|DACINOSTAT|MLS006010418|(E)-3-[4-[[2-HYDROXYETHYL-[2-(1H-INDOL-3-YL)ETHYL]AMINO]METHYL]PHENYL]-N-OXIDANYL-PROP-2-ENAMIDE|BDBM19428	-	PUBCHEM	6445533	C22H25N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWDQBBCUWLSASG-MDZDMXLPSA-N
29627	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2008)	18308563	224884	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29628	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9577	(2S,3S)-1-(4-Tert-butylphenyl)-3-[[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	BDBM50372118	-	PUBCHEM	10369999	C33H34N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XRVNSFDHOMAYDC-YTMVLYRLSA-N
29629	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9578	(2S,3S)-1-(4-Methoxyphenyl)-3-[[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	Q27465016|(2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2-CARBOXYLIC ACID|REW|(2S,3S)-1-(4-METHOXYPHENYL)-3-{3-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]BENZYL}-4-OXOAZETIDINE-2-CARBOXYLIC ACID|BDBM50372107	-	PUBCHEM	10391684	C30H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DKIUFVFEAUCDLY-BDYUSTAISA-N
29630	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9579	(2S,3S)-1-(4-Methoxyphenyl)-3-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	BDBM50372105	-	PUBCHEM	9983904	C30H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WTRWFOXPPRLKFP-BDYUSTAISA-N
29631	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29632	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Paris M (2008)	18247554	224886	9580	2-Propenamide, N-hydroxy-3-(4-(((2-hydroxyethyl)(2-(1H-indol-2-yl)ethyl)amino)methyl)phenyl)-	591207-53-3|LAQ 824|2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-HYDROXYETHYL)(2-(1H-INDOL-2-YL)ETHYL)AMINO)METHYL)PHENYL)BDBM50372470	-	PUBCHEM	44456564	C22H25N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FGJCGXHQLHHNFO-MDZDMXLPSA-N
29633	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Paris M (2008)	18247554	224886	9581	(2S)-2-[(1-Methylpiperidin-2-yl)amino]-8-oxo-N-(4-phenyl-1,3-thiazol-2-yl)nonanamide	BDBM50372446	-	PUBCHEM	44456965	C24H34N4O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KQYOQEZNUIXORM-AIBWNMTMSA-N
29634	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Paris M (2008)	18247554	224886	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29635	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Witter DJ (2008)	18060775	114009	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29636	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Schaefer S (2008)	18054239	123981	9582	6-[(3S,9S,12R)-3-Benzyl-6,6-dimethyl-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]-N-hydroxyhexanamide	6-((5S,11S,13AR)-5-BENZYL-8,8-DIMETHYL-4,7,10,13-TETRAOXO-TETRADECAHYDRO-3A,6,9,12-TETRAAZA-CYCLOPENTACYCLODODECEN-11-YL)-HEXANOIC ACID HYDROXYAMIDE|6-((9S,13AR)-5-(S)-1-BENZYL-8,8-DIMETHYL-4,7,10,13-TETRAOXO-TETRADECAHYDRO-3A,6,9,12-TETRAAZA-CYCLOPENTACYCLODODECEN-11-YL)-HEXANOIC ACID HYDROXYAMIDE|BDBM50154337	-	PUBCHEM	9806551	C26H37N5O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XWZYWFHHLWISBR-SLFFLAALSA-N
29637	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Potterat O (2007)	18044841	224887	9583	Chlorocyclinone B	METHYL 9-[1-(ACETYLOXYETHYL)]-2-CHLORO-6,8-DIHYDROXY-1-METHOXY-3-METHYL-7,12-DIOXO-7,12-DIHYDROTETRAPHENE-10-CARBOXYLATE|CHLOROCYCLINONE B|BDBM50228360	-	PUBCHEM	24762580	C26H21ClO9	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MFLXCCWOEBQIHW-UHFFFAOYSA-N
29638	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Potterat O (2007)	18044841	224887	9584	Chlorocyclinone C	METHYL 2-CHLORO-6,8-DIHYDROXY-9-{1-[(HYDROXYACETYL)OXY]ETHYL}-1-METHOXY-3-METHYL-7,12-DIOXO-7,12-DIHYDROTETRAPHENE-10-CARBOXYLATE|CHLOROCYCLINONE C|BDBM50228359	-	PUBCHEM	24180661	C26H21ClO10	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMNHPKWXMIGBEL-UHFFFAOYSA-N
29639	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Bain J (2007)	17850214	224888	6832	Su6656	330161-87-0|NCGC00094279-01|B5839|HMS3648O08|NCGC00015981-09|N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|2,3-DIHYDRO-N,N-DIMETHYL-2-OXO-3-[(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE]-1H-INDOLE-5-SULFONAMIDE|EX-A584|4071AH|AKOS015994571|MLS002153475|HMS2232C04|INSOLUTION&TRADE; SU6656|LOPAC0_000979|EU-0100979|NCGC00261664-01|S7774|Q7394936|NCGC00015981-03|1240328-42-0|SU 6656|SR-01000076237-6|HMS3263C19|(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE|CCG-205059|SU-6656|SU6656|ES-0024|SU 6656, >=98% (HPLC)|SDCCGSBI-0050952.P003|NCGC00015981-04|NCGC00094279-02|LOPAC-S-9692|NCGC00015981-02|HSCI1_000124|SR-01000076237-1|HMS3229I04|SR-01000076237|CS-3943|GTPL6044|TOX21_500979|DB08039|(Z)-N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|MFCD10565928|NCGC00015981-05|NCGC00015981-01|NCGC00015981-06|ZINC3875028|2-OXO-3-[1-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)-METH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOLE-5-SULFONIC ACID DIMETHYLAMIDE|SMR001230828|S 9692|LP00979|BRD-K97354755-001-01-5|HY-B0789|BDBM50307127	-	DRUGBANK	DB08039	C19H21N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LOGJQOUIVKBFGH-YBEGLDIGSA-N
29640	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Lee S (2007)	17588744	224889	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29641	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9585	N-[4-[2-[[(2S)-2-Amino-3-phenylpropanoyl]amino]phenyl]phenyl]-N'-hydroxyoctanediamide	OCTANEDIOIC ACID [2''-(2-AMINO-3-PHENYLPROPIONYLAMINO)-BIPHENYL-4-YL]AMIDE HYDROXYAMIDE|BDBM50214441	-	PUBCHEM	16733294	C29H34N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SZYFHRXJYNBDKS-VWLOTQADSA-N
29642	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9586	N-[4-[2-[[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]phenyl]phenyl]-N'-hydroxyoctanediamide	OCTANEDIOIC ACID {2''-[2-AMINO-3-(4-HYDROXY-PHENYL)PROPIONYLAMINO]BIPHENYL-4-YL}AMIDE HYDROXYAMIDE|BDBM50214439	-	PUBCHEM	16733417	C29H34N4O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BKQJCMOVBFAIQR-VWLOTQADSA-N
29643	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9587	N-[4-[2-[[(2S)-2-Amino-3-(1H-indol-3-yl)propanoyl]amino]phenyl]phenyl]-N'-hydroxyoctanediamide	OCTANEDIOIC ACID {2''-[2-AMINO-3-(1H-INDOL-3-YL)PROPIONYLAMINO]BIPHENYL-4-YL}AMIDE HYDROXYAMIDE|BDBM50214436	-	PUBCHEM	16733410	C31H35N5O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ACGVFMBQNSCSQI-SANMLTNESA-N
29644	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9588	1-(4-(Dimethylamino)phenyl)-3-(7-(hydroxyamino)-7-oxoheptyl)urea	7-[[4-(DIMETHYLAMINO)PHENYL]CARBAMOYLAMINO]-N-HYDROXYHEPTANAMIDE|1-(4-(DIMETHYLAMINO)PHENYL)-3-(7-(HYDROXYAMINO)-7-OXOHEPTYL)UREA|7-[3-(4-DIMETHYLAMINO-PHENYL)-UREIDO]-HEPTANOIC ACID HYDROXYAMIDE|7-[3-(4-DIMETHYLAMINOPHENYL)-UREIDO]HEPTANOIC ACID HYDROXYAMIDE|BDBM50214433	-	PUBCHEM	11558827	C16H26N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZYOHRYKXMFPCNU-UHFFFAOYSA-N
29645	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9589	N'-Hydroxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]octanediamide	OCTANEDIOIC ACID HYDROXYAMIDE [4-(3-NITRO-PHENYL)THIAZOL-2-YL]AMIDE|N'-HYDROXY-N-[4-(3-NITROPHENYL)-1,3-THIAZOL-2-YL]OCTANEDIAMIDE|BDBM50214432	-	PUBCHEM	16733411	C17H20N4O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LJFNWCGSOPRFNA-UHFFFAOYSA-N
29646	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9590	3-[[4-(Dimethylamino)phenyl]methylcarbamoylamino]-N-hydroxypropanamide	8-[3-(4-DIMETHYLAMINOBENZYL)UREIDO]OCTANOIC ACID HYDROXYAMIDE|BDBM50214431	-	PUBCHEM	16733415	C13H20N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FJIZCQBWUCHHAR-UHFFFAOYSA-N
29647	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Kozikowski AP (2007)	17539623	115857	9591	N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide	828920-13-4|6-(2-MERCAPTOACETYLAMINO)-HEXANOIC ACID QUINOLIN-8-YLAMIDE|N-(8-QUINOLYL)-6-[(MERCAPTOACETYL)AMINO]HEXANAMIDE|N-(QUINOLIN-8-YL)-6-(2-SULFANYLACETAMIDO)HEXANAMIDE|N-QUINOLIN-8-YL-6-[(2-SULFANYLACETYL)AMINO]HEXANAMIDE|HEXANAMIDE, 6-[(MERCAPTOACETYL)AMINO]-N-8-QUINOLINYL-|CTK3D5606|6-(2-MERCAPTO-ACETYLAMINO)-HEXANOIC ACID QUINOLIN-8-YLAMIDE|DTXSID10587453|6-(2-MERCAPTOACETAMIDO)-N-(QUINOLIN-8-YL)HEXANAMIDE|BDBM50161470	-	PUBCHEM	16733414	C17H21N3O2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KQBNGYXGCIUPHR-UHFFFAOYSA-N
29648	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2007)	17462888	224890	9592	(3S,4R)-4-[Butyl-(4-ethylphenyl)sulfonylamino]-3-hydroxy-2,2-dimethyl-N-(2-phenylethyl)-3,4-dihydrochromene-6-carboxamide	(3S,4R)-4-(N-BUTYL-4-ETHYLPHENYLSULFONAMIDO)-3-HYDROXY-2,2-DIMETHYL-N-PHENETHYLCHROMAN-6-CARBOXAMIDE|BDBM50211550	-	PUBCHEM	44426357	C32H40N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MJJYOGKDYSSXAT-IHLOFXLRSA-N
29649	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2007)	17462888	224890	9593	N-[(3R,4S)-6-[(2R)-2-[(2,6-Dimethylanilino)methyl]pyrrolidine-1-carbonyl]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-4-ethylbenzenesulfonamide	N-((3R,4S)-6-((R)-2-((2,6-DIMETHYLPHENYLAMINO)METHYL)PYRROLIDINE-1-CARBONYL)-3-HYDROXY-2,2-DIMETHYL-3,4-DIHYDRO-2H-CHROMEN-4-YL)-4-ETHYLBENZENESULFONAMIDE|BDBM50211547	-	PUBCHEM	44426394	C33H41N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZGNURVKJDROBKC-SDDUWZMOSA-N
29650	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2007)	17462888	224890	9594	N-[(3S,4R)-6-(5-Amino-3-phenylpyrazole-1-carbonyl)-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-4-ethylbenzenesulfonamide	N-((3S,4R)-6-(5-AMINO-3-PHENYL-1H-PYRAZOLE-1-CARBONYL)-3-HYDROXY-2,2-DIMETHYL-3,4-DIHYDRO-2H-CHROMEN-4-YL)-4-ETHYLBENZENESULFONAMIDE|BDBM50211521	-	PUBCHEM	44426329	C29H30N4O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TUAUXGUOYDDDKI-SXOMAYOGSA-N
29651	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2007)	17462888	224890	9595	(3S,4R)-N-(2-Anilinoethyl)-N-ethyl-4-[(4-ethylphenyl)sulfonylamino]-3-hydroxy-2,2-dimethyl-3,4-dihydrochromene-6-carboxamide	(3S,4R)-N-ETHYL-4-(4-ETHYLPHENYLSULFONAMIDO)-3-HYDROXY-2,2-DIMETHYL-N-(2-(PHENYLAMINO)ETHYL)-3,4-DIHYDRO-2H-CHROMENE-6-CARBOXAMIDE|BDBM50211518	-	PUBCHEM	44426325	C30H37N3O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QKIYRCPRFNAXAQ-IZLXSDGUSA-N
29652	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Lloyd J (2007)	17462888	224890	9575	N-[3-(4-Ethyl-benzenesulfonylamino)-2-hydroxy-indan-5-yl]-3-methoxy-benzamide	N-((2R,3R)-3-(4-ETHYLPHENYLSULFONAMIDO)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-5-YL)-3-METHOXYBENZAMIDE|N-[3-(4-ETHYL-BENZENESULFONYLAMINO)-2-HYDROXY-INDAN-5-YL]-3-METHOXY-BENZAMIDE|BDBM50099581	-	PUBCHEM	17748224	C25H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KCRNOVULDSNKBZ-DNQXCXABSA-N
29653	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Pochetti G (2007)	17403688	224891	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29654	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Gross MF (2007)	17350840	224892	9575	N-[3-(4-Ethyl-benzenesulfonylamino)-2-hydroxy-indan-5-yl]-3-methoxy-benzamide	N-((2R,3R)-3-(4-ETHYLPHENYLSULFONAMIDO)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-5-YL)-3-METHOXYBENZAMIDE|N-[3-(4-ETHYL-BENZENESULFONYLAMINO)-2-HYDROXY-INDAN-5-YL]-3-METHOXY-BENZAMIDE|BDBM50099581	-	PUBCHEM	17748224	C25H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KCRNOVULDSNKBZ-DNQXCXABSA-N
29655	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Devasthale PV (2007)	17292606	224893	9596	2-((3-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)(naphthalen-1-ylmethyl)amino)acetic acid	2-((3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)(NAPHTHALEN-1-YLMETHYL)AMINO)ACETIC ACID|BDBM50205086	-	PUBCHEM	22087541	C32H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NICLRQUMPVQLFM-UHFFFAOYSA-N
29656	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9597	6-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-N-[[(2S)-oxolan-2-yl]methyl]-5-phenylfuro[2,3-d]pyrimidin-4-amine	6-[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]PHENYL]-N-[[(2S)-OXOLAN-2-YL]METHYL]-5-PHENYLFURO[2,3-D]PYRIMIDIN-4-AMINE|(S)-6-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)PHENYL)-5-PHENYL-N-((TETRAHYDROFURAN-2-YL)METHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204590	-	PUBCHEM	44438320	C29H33N5O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IYUXAJHPXXWFQO-DEOSSOPVSA-N
29657	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9598	Aim-100	5,6-DIPHENYL-4-[(S)-(TETRAHYDROFURAN-2-YL)-METHYL]AMINO FURO[2,3-D]PYRIMIDINE|AIM-100|873305-35-2|EX-A3635|MLS006010340|(S)-5,6-DIPHENYL-N-((TETRAHYDROFURAN-2-YL)METHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|S2212|AIM 100|5,6-DIPHENYL-N-[[(2S)-TETRAHYDRO-2-FURANYL]METHYL]FURO[2,3-D]PYRIMIDIN-4-AMINE|ZINC28879084|N-[[(2S)-OXOLAN-2-YL]METHYL]-5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-AMINE|AKOS024458428|W-5920|NCGC00347279-01|HY-15290|NCGC00347279-04|DTXSID20467671|5,6-DIPHENYL-N-[[(2S)-TETRAHYDROFURAN-2-YL]METHYL]FURO[2,3-D]PYRIMIDIN-4-AMINE|SMR004701402|3426AH|AIM 100;AIM100|CS-0702|BDBM50204589	-	PUBCHEM	11501591	C23H21N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XNFHHOXCDUAYSR-SFHVURJKSA-N
29658	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9599	6-[4-[2-(Dimethylamino)ethoxy]phenyl]-N-[[(2S)-oxolan-2-yl]methyl]-5-phenylfuro[2,3-d]pyrimidin-4-amine	6-[4-[2-(DIMETHYLAMINO)ETHOXY]PHENYL]-N-[[(2S)-OXOLAN-2-YL]METHYL]-5-PHENYLFURO[2,3-D]PYRIMIDIN-4-AMINE|{6-[4-(2-DIMETHYLAMINO-ETHOXY)-PHENYL]-5-PHENYL-FURO[2,3-D]PYRIMIDIN-4-YL}-(TETRAHYDRO-FURAN-2-(S)-YL-METHYL)-AMINE|(S)-6-(4-(2-(DIMETHYLAMINO)ETHOXY)PHENYL)-5-PHENYL-N-((TETRAHYDROFURAN-2-YL)METHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204587	-	PUBCHEM	44438318	C27H30N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XNSZHQUDPHATEN-QFIPXVFZSA-N
29659	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9600	6-[3-Methoxy-4-(2-piperidin-1-ylethoxy)phenyl]-N-[[(2S)-oxolan-2-yl]methyl]-5-phenylfuro[2,3-d]pyrimidin-4-amine	6-(3-METHOXY-4-(2-(PIPERIDIN-1-YL)ETHOXY)PHENYL)-5-PHENYL-N-(((S)-TETRAHYDROFURAN-2-YL)METHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|6-[3-METHOXY-4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-N-[[(2S)-OXOLAN-2-YL]METHYL]-5-PHENYLFURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204586	-	PUBCHEM	11519350	C31H36N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IOSKHROQBBQEOB-DEOSSOPVSA-N
29660	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9601	N-[[(2S)-Oxolan-2-yl]methyl]-5-phenyl-6-[4-(2-pyrrolidin-1-ylethoxy)phenyl]furo[2,3-d]pyrimidin-4-amine	N-[[(2S)-OXOLAN-2-YL]METHYL]-5-PHENYL-6-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-4-AMINE|(S)-5-PHENYL-6-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)-N-((TETRAHYDROFURAN-2-YL)METHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204585	-	PUBCHEM	11677453	C29H32N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YSWLNXFQMMFDFG-DEOSSOPVSA-N
29661	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9602	[4-[5-Phenyl-4-(2-piperazin-1-ylethylamino)furo[2,3-d]pyrimidin-6-yl]phenyl]-piperidin-1-ylmethanone	(4-(5-PHENYL-4-(2-(PIPERAZIN-1-YL)ETHYLAMINO)FURO[2,3-D]PYRIMIDIN-6-YL)PHENYL)(PIPERIDIN-1-YL)METHANONE|[4-[5-PHENYL-4-(2-PIPERAZIN-1-YLETHYLAMINO)FURO[2,3-D]PYRIMIDIN-6-YL]PHENYL]-PIPERIDIN-1-YLMETHANONE|BDBM50204584	-	PUBCHEM	11634876	C30H34N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SXBGVYYYZFBEKG-UHFFFAOYSA-N
29662	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9603	(4-Ethylpiperazin-1-yl)-[4-[4-[[(2S)-oxolan-2-yl]methylamino]-5-phenylfuro[2,3-d]pyrimidin-6-yl]phenyl]methanone	(4-ETHYLPIPERAZIN-1-YL)-[4-[4-[[(2S)-OXOLAN-2-YL]METHYLAMINO]-5-PHENYLFURO[2,3-D]PYRIMIDIN-6-YL]PHENYL]METHANONE|(S)-(4-ETHYLPIPERAZIN-1-YL)(4-(5-PHENYL-4-((TETRAHYDROFURAN-2-YL)METHYLAMINO)FURO[2,3-D]PYRIMIDIN-6-YL)PHENYL)METHANONE|BDBM50204583	-	PUBCHEM	11656437	C30H33N5O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FACSDOITOHWERB-DEOSSOPVSA-N
29663	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9604	5-Phenyl-N-(2-piperazin-1-ylethyl)-6-[4-(2-pyrrolidin-1-ylethoxy)phenyl]furo[2,3-d]pyrimidin-4-amine	5-PHENYL-N-(2-(PIPERAZIN-1-YL)ETHYL)-6-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|5-PHENYL-N-(2-PIPERAZIN-1-YLETHYL)-6-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204582	-	PUBCHEM	11684933	C30H36N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DMZTWOCJNVKCBW-UHFFFAOYSA-N
29664	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9605	5-Phenyl-N-(2-phenylethyl)-6-[4-(2-pyrrolidin-1-ylethoxy)phenyl]furo[2,3-d]pyrimidin-4-amine	Q27076548|COMPOUND 30 [PMID: 17280833]|GTPL8193|5-PHENYL-N-(2-PHENYLETHYL)-6-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-4-AMINE|5-PHENYL-N-(2-PHENYLETHYL)-6-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]FURO[3,2-E]PYRIMIDIN-4-AMINE|N-PHENETHYL-5-PHENYL-6-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204580	-	PUBCHEM	11540659	C32H32N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CYXPHNZJEDAZDD-UHFFFAOYSA-N
29665	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9606	N-Isopropyl-5-phenyl-6-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)furo[2,3-d]pyrimidin-4-amine	N-ISOPROPYL-5-PHENYL-6-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|5-PHENYL-N-PROPAN-2-YL-6-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204579	-	PUBCHEM	11626406	C27H30N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SSVDSZIWJBBCNN-UHFFFAOYSA-N
29666	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9607	6-(4-(Morpholinomethyl)phenyl)-5-phenyl-N-(2-(piperazin-1-yl)ethyl)furo[2,3-d]pyrimidin-4-amine	6-(4-(MORPHOLINOMETHYL)PHENYL)-5-PHENYL-N-(2-(PIPERAZIN-1-YL)ETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|6-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]-5-PHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204577	-	PUBCHEM	11620266	C29H34N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YKMSWECJITXGJA-UHFFFAOYSA-N
29667	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9608	6-(4-Morpholinophenyl)-5-phenyl-N-(2-(piperazin-1-yl)ethyl)furo[2,3-d]pyrimidin-4-amine	6-(4-MORPHOLIN-4-YLPHENYL)-5-PHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|6-(4-MORPHOLINOPHENYL)-5-PHENYL-N-(2-(PIPERAZIN-1-YL)ETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204576	-	PUBCHEM	11648745	C28H32N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YHTSUIXFAAQWLU-UHFFFAOYSA-N
29668	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	DiMauro EF (2007)	17280833	224894	9609	6-(4-Methyl-2,3-dihydro-1,4-benzoxazin-7-yl)-5-phenyl-N-(2-piperazin-1-ylethyl)furo[2,3-d]pyrimidin-4-amine	6-(4-METHYL-2,3-DIHYDRO-1,4-BENZOXAZIN-7-YL)-5-PHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|6-(4-METHYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZIN-7-YL)-5-PHENYL-N-(2-(PIPERAZIN-1-YL)ETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE|BDBM50204575	-	PUBCHEM	11626947	C27H30N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SWTRMCZKDHCOOZ-UHFFFAOYSA-N
29669	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Martin MW (2007)	17276681	224895	9610	3-Phenyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-N-(2-pyridin-3-ylethyl)furo[2,3-b]pyridin-4-amine	3-PHENYL-2-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-N-(2-PYRIDIN-3-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE|3-PHENYL-2-{4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENYL}-N-[2-(PYRIDIN-3-YL)ETHYL]FURO[2,3-B]PYRIDIN-4-AMINE|2,3-DIARYLFURO[2,3-B]PYRIDINE-4-AMINE, 19|BDBM17723	-	PUBCHEM	11519208	C33H34N4O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QKKHXTGUTLRIAS-UHFFFAOYSA-N
29670	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Martin MW (2007)	17276681	224895	9611	2-[4-(2-Imidazol-1-ylethoxy)phenyl]-3-phenyl-N-(2-piperazin-1-ylethyl)furo[2,3-b]pyridin-4-amine	2-{4-[2-(1H-IMIDAZOL-1-YL)ETHOXY]PHENYL}-3-PHENYL-N-[2-(PIPERAZIN-1-YL)ETHYL]FURO[2,3-B]PYRIDIN-4-AMINE|2,3-DIARYLFURO[2,3-B]PYRIDINE-4-AMINE, 15|2-[4-(2-IMIDAZOL-1-YLETHOXY)PHENYL]-3-PHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE|BDBM17719	-	PUBCHEM	11613133	C30H32N6O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WYNDNQIGGGWABE-UHFFFAOYSA-N
29671	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9612	3-[4-[(3R)-3-(4-Ethyl-2-pyridin-3-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-ETHYL-2-(PYRIDIN-3-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199783	-	PUBCHEM	44439626	C27H31NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QNTSQSFJMIOVQR-HXUWFJFHSA-N
29672	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9613	3-[2-Ethyl-4-[(3R)-3-[2-pyridin-2-yl-4-(trifluoromethyl)phenoxy]butoxy]phenyl]propanoic acid	3-(2-ETHYL-4-((R)-3-(2-(PYRIDIN-2-YL)-4-(TRIFLUOROMETHYL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199781	-	PUBCHEM	11409173	C27H28F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JUWZDSPINIDMLW-GOSISDBHSA-N
29673	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9614	3-[4-[(3R)-3-(4-Ethyl-2-pyridin-2-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-ETHYL-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199779	-	PUBCHEM	11178006	C27H31NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KZAXXZUCCUNGNL-HXUWFJFHSA-N
29674	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9615	3-[2-Methyl-4-[(3R)-3-[2-pyridin-2-yl-4-(trifluoromethyl)phenoxy]butoxy]phenyl]propanoic acid	3-(2-METHYL-4-((R)-3-(2-(PYRIDIN-2-YL)-4-(TRIFLUOROMETHYL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199777	-	PUBCHEM	44439633	C26H26F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AIUXBXGPPYWHFP-GOSISDBHSA-N
29675	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9616	3-[2-Ethyl-4-[(3R)-3-(4-ethyl-2-pyridin-2-ylphenoxy)butoxy]phenyl]propanoic acid	3-(2-ETHYL-4-((R)-3-(4-ETHYL-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199776	-	PUBCHEM	11155087	C28H33NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYZNATQOXOBZSD-HXUWFJFHSA-N
29676	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9617	3-[4-[(3R)-3-(4-Chloro-2-pyridin-2-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-CHLORO-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199773	-	PUBCHEM	11247654	C25H26ClNO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PHVHNSMKCROBSA-GOSISDBHSA-N
29677	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9618	(R)-3-(4-(3-(2-Benzoyl-4-ethylphenoxy)butoxy)-2-methylphenyl)propanoic acid	(R)-3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|(R)-3-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50194627	-	PUBCHEM	11431103	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-OAQYLSRUSA-N
29678	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29679	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Trotter BW (2006)	17125248	224897	9619	3-Cyano-N-(2-hydroxyethyl)-6-methoxy-4-phenylisoquinoline-1-carboxamide	LS-193154|3-CYANO-N-(2-HYDROXYETHYL)-6-METHOXY-4-PHENYLISOQUINOLINE-1-CARBOXAMIDE|BDBM50199068	-	PUBCHEM	11995422	C20H17N3O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HFSNQOXBPWZLHD-UHFFFAOYSA-N
29680	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Jackson CM (2007)	17095219	224898	9620	2-(3,4-Dimethylphenyl)-3-[(4-methoxyphenyl)methoxy]-1,3-thiazolidin-4-one	DTXSID70658810|CTK3H0749|2-(3,4-DIMETHYLPHENYL)-3-(4-METHOXYBENZYLOXY)THIAZOLIDIN-4-ONE|4-THIAZOLIDINONE, 2-(3,4-DIMETHYLPHENYL)-3-[(4-METHOXYPHENYL)METHOXY]-|921611-08-7|2-(3,4-DIMETHYLPHENYL)-3-[(4-METHOXYPHENYL)METHOXY]-1,3-THIAZOLIDIN-4-ONE|BDBM50198249	-	PUBCHEM	44418119	C19H21NO3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NROGBECHHOOJMM-UHFFFAOYSA-N
29681	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Jackson CM (2007)	17095219	224898	9621	2-(3,4-Dimethylphenyl)-3-(4-methoxyphenethyl)-2-methylthiazolidin-4-one	2-(3,4-DIMETHYLPHENYL)-3-(4-METHOXYPHENETHYL)-2-METHYLTHIAZOLIDIN-4-ONE|BDBM50198247	-	PUBCHEM	44418146	C21H25NO2S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JZFNWTIJEGVREY-UHFFFAOYSA-N
29682	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9622	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(pyrazin-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-{4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-[(PYRAZIN-2-YLOXYCARBONYLAMINO)-METHYL]-PHENYL}-PROPIONIC ACID|BDBM50195716	-	PUBCHEM	44420485	C33H30N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VATCVNIKAWMLQK-UHFFFAOYSA-N
29683	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9623	3-[4-[2-[5-Methyl-2-(4-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENOXYPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-(4-PHENOXYPHENYL)OXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|BDBM50195715	-	PUBCHEM	10144243	C32H34N2O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MAINKGNWZLMMRF-UHFFFAOYSA-N
29684	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9624	3-(2-((Isopropoxycarbonyl)methyl)-4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|BDBM50195714	-	PUBCHEM	10205220	C26H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QDTHAXJGRDPCSZ-UHFFFAOYSA-N
29685	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9625	3-[4-[2-[5-Methyl-2-(4-pyrimidin-2-ylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-(4-(PYRIMIDIN-2-YL)PHENYL)OXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-[5-METHYL-2-(4-PYRIMIDIN-2-YLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|BDBM50195713	-	PUBCHEM	10119824	C30H32N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NTXHMSZOGJFPTJ-UHFFFAOYSA-N
29686	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9626	3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-[(pyrazin-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-(((PYRAZIN-2-YLOXY)CARBONYL)METHYL)PHENYL)PROPANOIC ACID|BDBM50195711	-	PUBCHEM	44420506	C27H26N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CASKZOPCCIBBBW-UHFFFAOYSA-N
29687	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9627	3-(2-((Benzyloxycarbonyl)methyl)-4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid	3-(2-((BENZYLOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-(PHENYLMETHOXYCARBONYLAMINOMETHYL)PHENYL]PROPANOIC ACID|BDBM50195710	-	PUBCHEM	17984540	C30H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FUTRFISBYXLQDO-UHFFFAOYSA-N
29688	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9628	3-[4-[2-(5-Methyl-2-morpholin-4-yl-1,3-thiazol-4-yl)ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-MORPHOLINOTHIAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-MORPHOLIN-4-YL-1,3-THIAZOL-4-YL)ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-{2-(ISOPROPOXYCARBONYLAMINOMETHYL)-4-[2-(5-METHYL-2-MORPHOLIN-4-YL-THIAZOL-4-YL)ETHOXY]-PHENYL}PROPIONIC ACID|BDBM50195708	-	PUBCHEM	9805639	C24H33N3O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IACIAFCVQNZHDL-UHFFFAOYSA-N
29689	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9629	3-[2-[(Benzylsulfonylamino)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid	3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-((PHENYLMETHYLSULFONAMIDO)METHYL)PHENYL)PROPANOIC ACID|BDBM50195707	-	PUBCHEM	44420484	C29H30N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AFMUUVLVLJLAEP-UHFFFAOYSA-N
29690	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9630	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-[4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-(ISOPROPOXYCARBONYLAMINO-METHYL)-PHENYL]-PROPIONIC ACID|BDBM50195702	-	PUBCHEM	10143678	C32H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLZAMMQCUXFOTM-UHFFFAOYSA-N
29691	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29692	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9631	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-PROPOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|3-(5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-(PROPOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|BDBM50195706	-	PUBCHEM	11317867	C28H32N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WVKGGZXCUUYLIT-UHFFFAOYSA-N
29693	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9632	3-[2-(2,2-Dimethylpropoxycarbonyl)-5-[2-[5-methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-[2-(2,2-DIMETHYLPROPOXYCARBONYL)-5-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|5-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-8-(2-CARBOXY-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID 2,2-DIMETHYL-PROPYL ESTER|BDBM50195705	-	PUBCHEM	44420402	C36H40N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JYMSZNJYYIGFPC-UHFFFAOYSA-N
29694	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9633	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-methylpropoxycarbonyl)-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-(2-(ISOBUTOXYCARBONYL)-5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-(2-METHYLPROPOXYCARBONYL)-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195704	-	PUBCHEM	44420566	C29H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZGYKSGFEFIEJCW-UHFFFAOYSA-N
29695	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9634	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-prop-2-ynoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-(5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-((PROP-2-YNYLOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-PROP-2-YNOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195703	-	PUBCHEM	44420565	C28H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KZTWWKBUXGHLOG-UHFFFAOYSA-N
29696	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9630	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-[4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-(ISOPROPOXYCARBONYLAMINO-METHYL)-PHENYL]-PROPIONIC ACID|BDBM50195702	-	PUBCHEM	10143678	C32H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLZAMMQCUXFOTM-UHFFFAOYSA-N
29697	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9635	3-[5-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-propoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	5-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-8-(2-CARBOXY-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID PROPYL ESTER|3-[5-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-PROPOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195699	-	PUBCHEM	11421714	C34H36N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LLUZQFNWHGWRKI-UHFFFAOYSA-N
29698	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9636	Farglitazar	GTPL2672|O-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHYL]-N-[2-(PHENYLCARBONYL)PHENYL]-L-TYROSINE|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID(GI 262570)|(S)-2-(2-BENZOYLPHENYLAMINO)-3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|GI262570; FARGLITAZAR|FARGLITAZAR (USAN/INN)|KBIOSS_002350|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)|KBIOGR_002347|3433GY7132|DSSTOX_CID_27310|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-|D04132|KBIO2_007483|1FM9|DTXSID1047310|UNII-3433GY7132|NCGC00254050-01|FARGLITAZAR [USAN]|DSSTOX_GSID_47310|TOX21_300218|NCGC00247940-01|(S)-2-((2-BENZOYLPHENYL)AMINO)-3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|LS-184758|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|GI262570X|GI-262570|FARGLITAZAR|GI-262570X|FARGLITAZAR [USAN:INN]|196808-45-4|DSSTOX_RID_82260|CMAP_000025|2(S)-(2-BENZOYLPHENYLAMINO)-3-[4-[2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY]PHENYL]PROPIONIC ACID|(2S)-2-[[2-(BENZOYL)PHENYL]AMINO]-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]PROPANOIC ACID|Q5435087|G1-262570|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL]- (9CI)|GI262570|GI 262570|KBIO2_002347|(S)-2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL]-|GI 262570X|ZINC49639808|N-(O-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-L-TYROSINE|KBIO2_004915|BDBM50085044	-	PUBCHEM	170364	C34H30N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZZCHHVUQYRMYLW-HKBQPEDESA-N
29699	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29700	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2006)	16987657	224901	9637	(2S)-N'-Hydroxy-2-[[2-(5-methoxy-2-methyl-1H-indol-3-yl)acetyl]amino]-N-[2-(2-phenyl-1H-indol-3-yl)ethyl]octanediamide	(S)-N8-HYDROXY-2-(2-(5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETAMIDO)-N1-(2-(2-PHENYL-1H-INDOL-3-YL)ETHYL)OCTANEDIAMIDE|(2S)-N'-HYDROXY-2-[[2-(5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETYL]AMINO]-N-[2-(2-PHENYL-1H-INDOL-3-YL)ETHYL]OCTANEDIAMIDE|BDBM50195108	-	PUBCHEM	11664499	C36H41N5O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VBWCMILVHANAGG-YTTGMZPUSA-N
29701	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jones P (2006)	16987657	224901	9638	N-[(2S)-1,8-Dioxo-1-[(4-phenyl-1,3-thiazol-2-yl)amino]nonan-2-yl]-1-methylpiperidine-2-carboxamide	(2S)-2-[(1-METHYLPIPERIDIN-2-YL)FORMAMIDO]-8-OXO-N-(4-PHENYL-1,3-THIAZOL-2-YL)NONANAMIDE|N-[(2S)-1,8-DIOXO-1-[(4-PHENYL-1,3-THIAZOL-2-YL)AMINO]NONAN-2-YL]-1-METHYLPIPERIDINE-2-CARBOXAMIDE|BIS-AMIDE INHIBITOR, 15|BDBM25144	-	PUBCHEM	16036765	C25H34N4O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVGAXXKEFDOLGL-AIBWNMTMSA-N
29702	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9639	3-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-pentyloxy]-2-methyl-phenyl}-propionic acid	3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-PENTYLOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)PENTOXY]-2-METHYLPHENYL]PROPANOIC ACID|BDBM50194638	-	PUBCHEM	16085984	C30H34O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KEUWMDZMXVQKJB-UHFFFAOYSA-N
29703	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9640	(r)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-fluoro-phenyl}-propionic acid	3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-FLUOROPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-FLUORO-PHENYL}-PROPIONIC ACID|BDBM50194637	-	PUBCHEM	16085987	C25H24ClFO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WXCQOBJBCVSXBR-QGZVFWFLSA-N
29704	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9641	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|BDBM50194635	-	PUBCHEM	16085985	C26H27ClO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZARBOTMPCCXOHE-LJQANCHMSA-N
29705	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9642	3-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	LS-193043|3-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|BDBM50194634	-	PUBCHEM	11305717	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-UHFFFAOYSA-N
29706	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9643	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-trifluoromethyl-phenyl}-propionic acid	3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-(TRIFLUOROMETHYL)PHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-TRIFLUOROMETHYL-PHENYL}-PROPIONIC ACID|BDBM50194633	-	PUBCHEM	16085982	C26H24ClF3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIOGFQCBUGMDNX-QGZVFWFLSA-N
29707	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9644	(R)-3-{4-[3-(4-Ethyl-2-phenoxy-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	3-[4-[(3R)-3-(4-ETHYL-2-PHENOXYPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-ETHYL-2-PHENOXY-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|BDBM50194631	-	PUBCHEM	16085980	C28H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VWGFBGMULZAECR-OAQYLSRUSA-N
29708	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9645	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-ethyl-phenyl}-propionic acid	LS-193041|3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-ETHYLPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-ETHYL-PHENYL}-PROPIONIC ACID|BDBM50194630	-	PUBCHEM	16085988	C27H29ClO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIPGEDLLCCHFDI-LJQANCHMSA-N
29709	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9646	2-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-butoxy]-phenoxy}-2-methyl-propionic acid	2-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY]PHENOXY]-2-METHYLPROPANOIC ACID|2-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50194629	-	PUBCHEM	11340513	C29H32O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ILHLGCBMPLPUEJ-UHFFFAOYSA-N
29710	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9647	(R)-3-{2-Methyl-4-[3-(2-phenoxy-4-trifluoromethyl-phenoxy)-butoxy]-phenyl}-propionic acid	3-[2-METHYL-4-[(3R)-3-[2-PHENOXY-4-(TRIFLUOROMETHYL)PHENOXY]BUTOXY]PHENYL]PROPANOIC ACID|(R)-3-{2-METHYL-4-[3-(2-PHENOXY-4-TRIFLUOROMETHYL-PHENOXY)-BUTOXY]-PHENYL}-PROPIONIC ACID|BDBM50194628	-	PUBCHEM	16085986	C27H27F3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CDXOSGNAXOTFBO-LJQANCHMSA-N
29711	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9618	(R)-3-(4-(3-(2-Benzoyl-4-ethylphenoxy)butoxy)-2-methylphenyl)propanoic acid	(R)-3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|(R)-3-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50194627	-	PUBCHEM	11431103	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-OAQYLSRUSA-N
29712	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9648	2-(4-(3-(2-Benzoyl-4-ethylphenoxy)propoxy)phenoxy)-2-methylpropanoic acid	2-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)PROPOXY)PHENOXY)-2-METHYLPROPANOIC ACID|BDBM50194626	-	PUBCHEM	16085983	C28H30O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AFQIAKAIRKBLKC-UHFFFAOYSA-N
29713	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9649	(R)-3-{2-Methyl-4-[3-(2-phenoxy-4-trifluoromethoxy-phenoxy)-butoxy]-phenyl}-propionic acid	(R)-3-{2-METHYL-4-[3-(2-PHENOXY-4-TRIFLUOROMETHOXY-PHENOXY)-BUTOXY]-PHENYL}-PROPIONIC ACID|3-[2-METHYL-4-[(3R)-3-[2-PHENOXY-4-(TRIFLUOROMETHOXY)PHENOXY]BUTOXY]PHENYL]PROPANOIC ACID|BDBM50194625	-	PUBCHEM	16085981	C27H27F3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CQHWVRVOKKOIJC-LJQANCHMSA-N
29714	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9650	3-{4-[3-(2-Benzyl-4-ethyl-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	3-[4-[3-(2-BENZYL-4-ETHYLPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|3-{4-[3-(2-BENZYL-4-ETHYL-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|BDBM50194624	-	PUBCHEM	11316788	C29H34O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QRUJOOQWHBDHME-UHFFFAOYSA-N
29715	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29716	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Nanda KK (2006)	16949818	224903	9651	N,N-Diisopropyl-3-phenyl-4-(3-phenylpropanamido)-2-(pyridin-3-yl)butanamide	N,N-DIISOPROPYL-3-PHENYL-4-(3-PHENYLPROPANAMIDO)-2-(PYRIDIN-3-YL)BUTANAMIDE|3-PHENYL-4-(3-PHENYLPROPANOYLAMINO)-N,N-DI(PROPAN-2-YL)-2-PYRIDIN-3-YLBUTANAMIDE|BDBM50194549	-	PUBCHEM	16067971	C30H37N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SBVQSSIMWONYEL-UHFFFAOYSA-N
29717	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Nanda KK (2006)	16949818	224903	9652	4-(3-(2-Fluorophenyl)propanamido)-N,N-diisopropyl-3-phenyl-2-(pyridin-3-yl)butanamide	4-(3-(2-FLUOROPHENYL)PROPANAMIDO)-N,N-DIISOPROPYL-3-PHENYL-2-(PYRIDIN-3-YL)BUTANAMIDE|4-[3-(2-FLUOROPHENYL)PROPANOYLAMINO]-3-PHENYL-N,N-DI(PROPAN-2-YL)-2-PYRIDIN-3-YLBUTANAMIDE|BDBM50194539	-	PUBCHEM	16067972	C30H36FN3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CFODJXSQXWCMFC-UHFFFAOYSA-N
29718	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Nanda KK (2006)	16949818	224903	9653	N,N-Diisopropyl-3-phenyl-4-(3-phenylbutanamido)-2-(pyridin-3-yl)butanamide	N,N-DIISOPROPYL-3-PHENYL-4-(3-PHENYLBUTANAMIDO)-2-(PYRIDIN-3-YL)BUTANAMIDE|3-PHENYL-4-(3-PHENYLBUTANOYLAMINO)-N,N-DI(PROPAN-2-YL)-2-PYRIDIN-3-YLBUTANAMIDE|BDBM50194512	-	PUBCHEM	16067973	C31H39N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MYRMFKGJHYHGEX-UHFFFAOYSA-N
29719	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Fluxe A (2006)	16942878	224904	9654	[(E)-(2,3-Diethyl-1-methyl-6,7-dihydro-5H-indol-4-ylidene)amino] N-phenylcarbamate	(E)-THYL-1-METHYL-6,7-DIHYDRO-1H-INDOL-4(5H)-ONE O-PHENYLCARBAMOYL OXIME|BDBM50194360	-	PUBCHEM	16049818	C20H25N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IPBYCCUTXNVVAE-CJLVFECKSA-N
29720	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Fluxe A (2006)	16942878	224904	9655	[(E)-(3-Ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-ylidene)amino] N-phenylcarbamate	(E)--2-METHYL-6,7-DIHYDRO-1H-INDOL-4(5H)-ONE O-PHENYLCARBAMOYL OXIME|BDBM50194358	-	PUBCHEM	135401985	C18H21N3O2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NATLTWZVCBHRJN-LTGZKZEYSA-N
29721	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9656	1-(3-(Trifluoromethyl)benzyl)-N-(naphthalen-2-ylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(NAPHTHALEN-2-YLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193752	-	PUBCHEM	44419355	C27H19F3N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RSDUQVSYQVYCFK-UHFFFAOYSA-N
29722	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9657	3-(4-Methoxyphenyl)-N-(2-methylphenyl)sulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(O-TOLYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193751	-	PUBCHEM	44419391	C31H25F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIJPWVGTDPKGSQ-UHFFFAOYSA-N
29723	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9658	1-(3-(Trifluoromethyl)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193750	-	PUBCHEM	44419352	C24H16F6N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BNRJBWWXERRJDS-UHFFFAOYSA-N
29724	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9659	3-(4-Methoxyphenyl)-N-(Phenylsulfonyl)-1-[3-(Trifluoromethyl)benzyl]-1h-Indole-2-Carboxamide	76023-EP2308860A1|3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)-1-[3-(TRIFLUOROMETHYL)BENZYL]-1H-INDOLE-2-CARBOXAMIDE|N-(BENZENESULFONYL)-3-(4-METHOXYPHENYL)-1-[[3-(TRIFLUOROMETHYL)PHENYL]METHYL]INDOLE-2-CARBOXAMIDE|2HFP|1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|Q27463924|(3-(4-METHOXYPHENYL)-1-{[3-(TRIFLUOROMETHYL)PHENYL]METHYL}INDOL-2-YL)-N-(PHENYLSULFONYL) CARBOXAMIDE|NSI|BDBM50193748	-	PUBCHEM	9549238	C30H23F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCPFCXDCWUXOGT-UHFFFAOYSA-N
29725	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9660	N-(4-Fluorophenyl)sulfonyl-3-(4-methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(4-FLUOROPHENYLSULFONYL)-3-(4-METHOXYPHENYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193744	-	PUBCHEM	44419390	C30H22F4N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AOVDRHLXGSLJQB-UHFFFAOYSA-N
29726	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9661	1-(3-(Trifluoromethyl)benzyl)-N-(2-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(2-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193742	-	PUBCHEM	44419356	C24H16F6N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RYZBTWSMNGDKFD-UHFFFAOYSA-N
29727	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9662	1-(3-(Trifluoromethoxy)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHOXY)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193741	-	PUBCHEM	44419366	C24H16F6N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVMATXNFISADDB-UHFFFAOYSA-N
29728	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9663	N-(5-Chlorothiophen-2-yl)sulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(5-CHLOROTHIOPHEN-2-YLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193739	-	PUBCHEM	44419357	C21H14ClF3N2O3S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZRPUUOXOGLOCQT-UHFFFAOYSA-N
29729	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9664	3-(4-Methoxyphenyl)-N-methylsulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(METHYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193736	-	PUBCHEM	44419392	C25H21F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RUSDVKUNFXBCHZ-UHFFFAOYSA-N
29730	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9665	Methyl 2-[[3-(4-methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carbonyl]sulfamoyl]benzoate	2-{[3-(4-METHOXY-PHENYL)-1-(3-TRIFLUOROMETHYL-BENZYL)-1H-INDOLE-2-CARBONYL]-SULFAMOYL}-BENZOIC ACID METHYL ESTER|BDBM50193734	-	PUBCHEM	44419255	C32H25F3N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RRLTYQDNNRNQPH-UHFFFAOYSA-N
29731	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9666	1-(3-(Benzyloxy)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(BENZYLOXY)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193733	-	PUBCHEM	44419381	C30H23F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NZNRDAXVBYSQEB-UHFFFAOYSA-N
29732	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9667	3-(4-Methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]-N-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193729	-	PUBCHEM	44419253	C31H22F6N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LINUGMFIDAUGBH-UHFFFAOYSA-N
29733	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29734	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	9668	Tert-butyl N-[(2S)-1-(cycloheptylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate	TERT-BUTYL N-[(1S)-1-(CYCLOHEPTYLCARBAMOYL)-6-SULFANYLHEXYL]CARBAMATE|TERT-BUTYL N-[(2S)-1-(CYCLOHEPTYLAMINO)-1-OXO-7-SULFANYLHEPTAN-2-YL]CARBAMATE|THIOLATE ANALOGUE, 18A|BDBM19136	-	PUBCHEM	11844893	C19H36N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTVMPAGMFUPGRI-INIZCTEOSA-N
29735	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	9669	Tert-butyl N-[(2S)-1-(cyclohexylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate	TERT-BUTYL N-[(1S)-1-(CYCLOHEXYLCARBAMOYL)-6-SULFANYLHEXYL]CARBAMATE|THIOLATE ANALOGUE, 17A|TERT-BUTYL N-[(2S)-1-(CYCLOHEXYLAMINO)-1-OXO-7-SULFANYLHEPTAN-2-YL]CARBAMATE|BDBM19135	-	PUBCHEM	11844892	C18H34N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NREURQUIJSGJMZ-HNNXBMFYSA-N
29736	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	9670	Tert-butyl N-[(2S)-1-(cyclopentylamino)-1-oxo-7-sulfanylheptan-2-yl]carbamate	TERT-BUTYL N-[(1S)-1-(CYCLOPENTYLCARBAMOYL)-6-SULFANYLHEXYL]CARBAMATE|TERT-BUTYL N-[(2S)-1-(CYCLOPENTYLAMINO)-1-OXO-7-SULFANYLHEPTAN-2-YL]CARBAMATE|THIOLATE ANALOGUE, 16A|BDBM19134	-	PUBCHEM	11844891	C17H32N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IKSFNOMXHPMYIQ-AWEZNQCLSA-N
29737	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Suzuki T (2006)	16884291	224905	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29738	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9671	3-(1-((2-(3,5-Dimethylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DIMETHYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DIMETHYL-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DIMETHYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188038	-	PUBCHEM	10455511	C26H28N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DSKLBNZCCNQVBC-UHFFFAOYSA-N
29739	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9672	3-(1-((2-(3,5-Dichlorophenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DICHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DICHLORO-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DICHLOROPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188037	-	PUBCHEM	10344769	C24H22Cl2N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RQMKNZHMAWCBJL-UHFFFAOYSA-N
29740	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9673	3-(1-((2-(3-Chlorophenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-(1-((2-(3-CHLOROPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|3-[1-[[2-(3-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3-CHLORO-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|BDBM50188035	-	PUBCHEM	9980586	C24H23ClN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HMMQETYZLNQVSF-UHFFFAOYSA-N
29741	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9674	3-(1-((2-(3,5-Dimethoxyphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DIMETHOXYPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DIMETHOXY-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DIMETHOXYPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188025	-	PUBCHEM	10412116	C26H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PMZZWDLQGMUYFU-UHFFFAOYSA-N
29742	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9675	3-(1-((2-(4-Tert-butylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-(1-((2-(4-TERT-BUTYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|3-[1-[[2-(4-TERT-BUTYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|BDBM50188024	-	PUBCHEM	10072967	C28H32N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FVPCEABQEUPZJE-UHFFFAOYSA-N
29743	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9676	2-Ethoxy-3-(1-((2-(4-isopropylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)propanoic acid	2-ETHOXY-3-[1-[[5-METHYL-2-(4-PROPAN-2-YLPHENYL)-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]PROPANOIC ACID|2-ETHOXY-3-(1-((2-(4-ISOPROPYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)PROPANOIC ACID|BDBM50188023	-	PUBCHEM	10343538	C27H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UDXHXODNGSKQKU-UHFFFAOYSA-N
29744	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9677	2-Ethoxy-3-(1-((2-(4-ethylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)propanoic acid	RAC-2-ETHOXY-3-{1-[2-(4-ETHYL-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-PROPIONIC ACID|2-ETHOXY-3-[1-[[2-(4-ETHYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]PROPANOIC ACID|2-ETHOXY-3-(1-((2-(4-ETHYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)PROPANOIC ACID|BDBM50188022	-	PUBCHEM	10342769	C26H28N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTXIDZKNOYTSIW-UHFFFAOYSA-N
29745	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Lu IL (2006)	16640330	171129	9678	N-[1-(4-Fluorophenyl)-3-(2-thienyl)-1H-pyrazol-5-YL]-3,5-bis(trifluoromethyl)benzenesulfonamide	N-(1-(4-FLUOROPHENYL)-3-(THIOPHEN-2-YL)-1H-PYRAZOL-5-YL)-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|MCULE-9080417768|Q27465446|N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|N-[1-(4-FLUOROPHENYL)-3-THIOPHEN-2-YL-1H-PYRAZOL-5-YL]-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|ZINC24800189|2G0H|BDBM50185944	-	PUBCHEM	2742759	C21H12F7N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BQSKQGGQDUBLNS-UHFFFAOYSA-N
29746	111663	5690	RP5-983H21.1	PSMB2	HC7-I	9606	Homo sapiens	unknown	target	Marastoni M (2006)	16603348	224794	9679	Ethyl (E,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[(3-hydroxy-2-methylbenzoyl)amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]amino]-6-methylhept-2-enoate	HMB-PHE-GLN-LEU-VE|BDBM50185159	-	PUBCHEM	44411546	C32H42N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VERCUUHDSDHZNE-HQSFGPFHSA-N
29747	111663	5690	RP5-983H21.1	PSMB2	HC7-I	9606	Homo sapiens	unknown	target	Marastoni M (2006)	16603348	224794	9680	Ethyl (E,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-6-methylhept-2-enoate	H-TYR-VAL-GLN-LEU-VE|BDBM50185158	-	PUBCHEM	44411707	C29H45N5O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSGMPWLDSQFOIU-YLKYAQCOSA-N
29748	111663	5690	RP5-983H21.1	PSMB2	HC7-I	9606	Homo sapiens	unknown	target	Marastoni M (2006)	16603348	224794	9681	Ethyl (E,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[(3-hydroxy-2-methylbenzoyl)amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-6-methylhept-2-enoate	HMB-VAL-GLN-LEU-VE|BDBM50185156	-	PUBCHEM	16084592	C28H42N4O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PWQJCQOSOVJZKC-KFMGUWMRSA-N
29749	111663	5690	RP5-983H21.1	PSMB2	HC7-I	9606	Homo sapiens	unknown	target	Marastoni M (2006)	16603348	224794	9682	Ethyl (E,4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-6-methylhept-2-enoate	H-PHE-VAL-GLN-LEU-VE|BDBM50185155	-	PUBCHEM	44411716	C29H45N5O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NTQHQJQYFBCDLD-BRYGMPRLSA-N
29750	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2006)	16451087	171122	4493	2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	CAY10573|(5-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID|5-[3-(6-BENZOYL-1-PROPYL-2-NAPHTHYLOXY)PROPOXY]-1H-INDOLE-1-ACETIC ACID|Q27095435|1444AH|853652-40-1|5-[3-[(6-BENZOYL-1-PROPYL-2-NAPHTHALENYL)OXY]PROPOXY]-1H-INDOLE-1-ACETIC ACID|2F4B|2-(5-{3-[(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID|ZINC12504466|2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID|DB04689|2-(5-(3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY)-1H-INDOL-1-YL)ACETIC ACID|[5-(3-{[6-(PHENYLCARBONYL)-1-PROPYLNAPHTHALEN-2-YL]OXY}PROPOXY)-1H-INDOL-1-YL]ACETIC ACID|NS00070789|BDBM50181911	-	DRUGBANK	DB04689	C33H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZXWVCCFKIRBLDP-UHFFFAOYSA-N
29751	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2006)	16451087	171122	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29752	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2005)	16366601	224907	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29753	110474	4331	-	MNAT1	CAP35|MAT1|RNF66|TFB3	9606	Homo sapiens	unknown	target	Caligiuri M (2005)	16242653	66939	9683	Cdk/Crk Inhibitor	PYRAZOLOPYRIMIDONE ANALOG, RGB-286147|NCGC00345809-02|K00600A|GTPL5943|784211-09-2|BCP29074|1-(2,6-DICHLOROPHENYL)-6-[[4-(2-HYDROXYETHOXY)PHENYL]METHYL]-3-PROPAN-2-YL-2H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE|ZINC29056064|Q27075833|1-(2,6-DICHLOROPHENYL)-1,5-DIHYDRO-6-((4-(2-HYDROXYETHOXY)PHENYL)METHYL)-3-(1-METHYLETHYL)-4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE|1-(2,6-DICHLOROPHENYL)-6-{[4-(2-HYDROXYETHOXY)PHENYL]METHYL}-3-(PROPAN-2-YL)-1H,2H,4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE|RGB-286147|A16795|HMS3229E20|CCG-206832|CTK8F1289|HMS3674M03|DTXSID60429556|CDK/CRK INHIBITOR|NCGC00345809-01|EX-229;EX 229;AMPK ACTIVATOR 991|BDBM59227	-	PUBCHEM	135473382	C23H22Cl2N4O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RSQPNXBTPUXMQN-UHFFFAOYSA-N
29754	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Morphy R (2005)	16220969	224908	9684	2-Methyl-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid	2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145712	-	PUBCHEM	10139247	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-UHFFFAOYSA-N
29755	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Shinji C (2005)	16137884	224909	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29756	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9685	(2S)-2-[(2-Oxo-3,5,7-tripropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	I(S)-(4-ISOPROPYL-PHENYL)-(2-OXO-3,5,7-TRIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-ACETIC ACID|BDBM50169254	-	PUBCHEM	11247998	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGNJRUSCVGOQDZ-DEOSSOPVSA-N
29757	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9686	(S)-(4-Isopropyl-phenyl)-(4-propionyl-2,6-dipropyl-phenoxy)-acetic acid	(S)-(4-ISOPROPYL-PHENYL)-(4-PROPIONYL-2,6-DIPROPYL-PHENOXY)-ACETIC ACID|BDBM50169253	-	PUBCHEM	11223613	C26H34O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BLBKQSCECDPYAW-VWLOTQADSA-N
29758	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9687	(2S)-2-[(2-Oxo-3-propan-2-yl-5,7-dipropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	(S)-(3-ISOPROPYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-(4-ISOPROPYL-PHENYL)-ACETIC ACID|BDBM50169245	-	PUBCHEM	11339979	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CMBADTBQKXKEOM-DEOSSOPVSA-N
29759	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9688	(2S)-2-[(3-Methyl-2-oxo-5,7-dipropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	(S)-(4-ISOPROPYL-PHENYL)-(3-METHYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-ACETIC ACID|BDBM50169233	-	PUBCHEM	11189474	C25H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSBAWOCZJWUIIT-QFIPXVFZSA-N
29760	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9689	(S)-(3-Ethyl-2-oxo-5,7-dipropyl-2,3-dihydro-benzooxazol-6-yloxy)-(4-isopropyl-phenyl)-acetic acid	(S)-(3-ETHYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-(4-ISOPROPYL-PHENYL)-ACETIC ACID|BDBM50169227	-	PUBCHEM	11178156	C26H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WEQANHSKIULRFP-QHCPKHFHSA-N
29761	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9690	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]acetonitrile	{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-ACETONITRILE|BDBM50166303	-	PUBCHEM	44400131	C27H21F3N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZAJIYHJMAFTGB-UHFFFAOYSA-N
29762	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9691	(2S)-2-[5-[1-(6-Chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxy-2-propylphenoxy]propanoic acid	(S)-2-{5-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-2-PROPYL-PHENOXY}-PROPIONIC ACID|BDBM50166302	-	PUBCHEM	44399972	C29H24ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NKVXQMXXQRJUBJ-INIZCTEOSA-N
29763	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9692	(4-Methoxyphenyl)-[2-methyl-3-[(3-prop-2-ynoxyphenyl)methyl]-5-(trifluoromethoxy)indol-1-yl]methanone	(4-METHOXY-PHENYL)-[2-METHYL-3-(3-PROP-2-YNYLOXY-BENZYL)-5-TRIFLUOROMETHOXY-INDOL-1-YL]-METHANONE|BDBM50166301	-	PUBCHEM	44399967	C28H22F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HEMWJRLDDQKGLA-UHFFFAOYSA-N
29764	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9693	(2S)-2-[2-Chloro-5-[1-(6-chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(2S)-2-[2-CHLORO-5-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|(S)-2-{2-CHLORO-5-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166300	-	PUBCHEM	10371027	C26H17Cl2F3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PESUMSRASMUYKX-ZDUSSCGKSA-N
29765	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9694	(2S)-2-[4-Chloro-3-[1-(6-chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(S)-2-{4-CHLORO-3-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-(4-CHLORO-3-(1-(6-CHLOROBENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YLOXY)PHENOXY)PROPANOIC ACID|(2S)-2-[4-CHLORO-3-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|BDBM50166298	-	PUBCHEM	10438226	C26H17Cl2F3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NOWYXMPKECMLMR-ZDUSSCGKSA-N
29766	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9695	(2S)-2-[3-[[1-(6-Methoxyquinolin-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(S)-2-{3-[1-(6-METHOXY-QUINOLIN-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166296	-	PUBCHEM	44399773	C30H25F3N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VBLJJBHFZCXXCW-SFHVURJKSA-N
29767	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9696	(2R)-2-[4-Chloro-3-[[1-(6-methoxy-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(R)-2-{4-CHLORO-3-[1-(6-METHOXY-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166295	-	PUBCHEM	44399983	C28H22ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QRGIUBNDZNAVAU-OAHLLOKOSA-N
29768	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9697	(2S)-2-[3-[1-(6-Chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(2S)-2-[3-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|(S)-2-{3-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166293	-	PUBCHEM	10437965	C26H18ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGORCQXXKHIAFG-AWEZNQCLSA-N
29769	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9698	(2S)-2-[3-[[1-(4-Methoxyphenyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(S)-2-{3-[1-(4-METHOXY-PHENYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166292	-	PUBCHEM	44399778	C27H24F3NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WASROFIOUZGJFW-KRWDZBQOSA-N
29770	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9699	(2S)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3- YL]METHYL]PHENOXY]PROPANOIC ACID|Q27087738|(S)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|MRL24|(2S)-2-[3-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|GTPL6743|(S)-2-(3-((1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL)METHYL)PHENOXY)PROPANOIC ACID|NCGC00390369-01|(2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL 24|BDBM50157917	-	PUBCHEM	9958543	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-KRWDZBQOSA-N
29771	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Fabian MA (2005)	15711537	224911	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29772	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	unknown	target	Fabian MA (2005)	15711537	224911	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29773	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9700	{4-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-acetic acid	2-[4-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]ACETIC ACID|{4-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-ACETIC ACID|BDBM50157938	-	PUBCHEM	10226701	C26H22ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YAGQPGVXBAGTLQ-UHFFFAOYSA-N
29774	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9701	CID 10143056	Q27087737|(2S)-2-(2-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL20|(2S)-2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|GTPL6742|(2S)-2-[2-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|(S)-2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157936	-	PUBCHEM	10143056	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-KRWDZBQOSA-N
29775	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9702	2-{3-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{3-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[3-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157934	-	PUBCHEM	10184159	C27H24ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UZJIHIMYKLEBBQ-UHFFFAOYSA-N
29776	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9703	2-{2-[1-(4-Methoxy-benzoyl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157933	-	PUBCHEM	10208548	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-UHFFFAOYSA-N
29777	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9704	(2R)-2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2R)-2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|(R)-2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157932	-	PUBCHEM	10119125	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-QGZVFWFLSA-N
29778	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9705	2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50157931	-	PUBCHEM	10230642	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SGUDWIZALUVLKT-UHFFFAOYSA-N
29779	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9706	2-{2-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-[2-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|2-{2-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157930	-	PUBCHEM	10277333	C27H24ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XICCHOADKSBRIM-UHFFFAOYSA-N
29780	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9707	(2R)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2R)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|(R)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157927	-	PUBCHEM	44388966	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-QGZVFWFLSA-N
29781	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9708	2-{3-[1-(4-Methoxy-benzoyl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157926	-	PUBCHEM	10279905	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-UHFFFAOYSA-N
29782	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9709	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]butanoic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-BUTYRIC ACID|BDBM50157925	-	PUBCHEM	44389085	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XTHHGKZVXMNJNA-UHFFFAOYSA-N
29783	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9710	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]pentanoic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PENTANOIC ACID|BDBM50157921	-	PUBCHEM	44389098	C30H28F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UNNWWBCMUJHNAH-UHFFFAOYSA-N
29784	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9711	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50157920	-	PUBCHEM	10280496	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WTIUDROYDYCRCV-UHFFFAOYSA-N
29785	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9712	2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]butanoic acid	2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-BUTYRIC ACID|BDBM50157919	-	PUBCHEM	44388998	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CHGUIFODGMMMKV-UHFFFAOYSA-N
29786	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9713	2-[2-[[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-{2-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|2-[2-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|BDBM50157918	-	PUBCHEM	10184971	C28H26ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIPJZUFYVANNKA-UHFFFAOYSA-N
29787	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9699	(2S)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3- YL]METHYL]PHENOXY]PROPANOIC ACID|Q27087738|(S)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|MRL24|(2S)-2-[3-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|GTPL6743|(S)-2-(3-((1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL)METHYL)PHENOXY)PROPANOIC ACID|NCGC00390369-01|(2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL 24|BDBM50157917	-	PUBCHEM	9958543	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-KRWDZBQOSA-N
29788	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9714	2-[3-[[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-{3-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|2-[3-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|BDBM50157916	-	PUBCHEM	10228304	C28H26ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NJQKVYQTUIWJEQ-UHFFFAOYSA-N
29789	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9715	(S)-3-{4-[3-(Biphenyl-4-yloxy)-propoxy]-phenyl}-2-methoxy-propionic acid	(2S)-2-METHOXY-3-[4-[3-(4-PHENYLPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|(S)-3-{4-[3-(BIPHENYL-4-YLOXY)-PROPOXY]-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157061	-	PUBCHEM	10223023	C25H26O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CFJFKSKRLAYDHM-DEOSSOPVSA-N
29790	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9716	(S)-2-Methoxy-3-{4-[4-(4-phenoxy-phenoxy)-but-1-ynyl]-phenyl}-propionic acid	(S)-2-METHOXY-3-{4-[4-(4-PHENOXY-PHENOXY)-BUT-1-YNYL]-PHENYL}-PROPIONIC ACID|(2S)-2-METHOXY-3-[4-[4-(4-PHENOXYPHENOXY)BUT-1-YNYL]PHENYL]PROPANOIC ACID|(2S)-2-METHOXY-3-{4-[4-(4-PHENOXY-PHENOXY)-BUT-1-YNYL]-PHENYL}-PROPIONIC ACID|BDBM50157060	-	PUBCHEM	10136660	C26H24O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PXPYSVWYMMGIEN-VWLOTQADSA-N
29791	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9717	(S)-3-{4-[3-(4-Benzoyl-phenoxy)-propoxy]-phenyl}-2-methoxy-propionic acid	(2S)-3-[4-[3-(4-BENZOYLPHENOXY)PROPOXY]PHENYL]-2-METHOXYPROPANOIC ACID|(S)-3-{4-[3-(4-BENZOYL-PHENOXY)-PROPOXY]-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157059	-	PUBCHEM	10226233	C26H26O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONPSUOOPYWPISK-DEOSSOPVSA-N
29792	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9718	(S)-2-Methoxy-3-{3-methoxy-4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid	(2S)-2-METHOXY-3-[3-METHOXY-4-[3-(4-PHENOXYPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|(S)-2-METHOXY-3-{3-METHOXY-4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|BDBM50157058	-	PUBCHEM	10297760	C26H28O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IUORCUOWVWRBDQ-VWLOTQADSA-N
29793	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9719	(S)-2-Methoxy-3-{4-[5-(4-phenoxy-phenoxy)-pent-1-ynyl]-phenyl}-propionic acid	(2S)-2-METHOXY-3-[4-[5-(4-PHENOXYPHENOXY)PENT-1-YNYL]PHENYL]PROPANOIC ACID|(S)-2-METHOXY-3-{4-[5-(4-PHENOXY-PHENOXY)-PENT-1-YNYL]-PHENYL}-PROPIONIC ACID|(2S)-2-METHOXY-3-{4-[5-(4-PHENOXY-PHENOXY)-PENT-1-YNYL]-PHENYL}-PROPIONIC ACID|BDBM50157057	-	PUBCHEM	10113515	C27H26O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KNNHPJKYTMZLEP-SANMLTNESA-N
29794	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9720	Naveglitazar	UNII-Y995M7GM0G|LY 519818|476436-68-7|LY-519818|HY-U00036A|(2S)-2-METHOXY-3-(4-(3-(4-PHENOXYPHENOXY)PROPOXY)PHENYL)PROPANOIC ACID|D08949|BENZENEPROPANOIC ACID, ALPHA-METHOXY-4-(3-(4-PHENOXYPHENOXY)PROPOXY)-, (ALPHAS)-|LY-818|ZINC3950327|CCRIS 9448|LY519818|(S)-2-METHOXY-3-{4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|Q27294403|NAVEGLITAZAR (USAN/INN)|(2S)-2-METHOXY-3-[4-[3-(4-PHENOXYPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|NAVEGLITAZAR [USAN:INN]|LY-9818|LY9818|LY 9818|CS-0021934|DB12662|NAVEGLITAZAR|Y995M7GM0G|BDBM50157056	-	PUBCHEM	9888484	C25H26O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OKJHGOPITGTTIM-DEOSSOPVSA-N
29795	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9721	(S)-3-{4-[3-(4-Benzoyl-phenoxy)-propoxy]-3-chloro-phenyl}-2-methoxy-propionic acid	(2S)-3-[4-[3-(4-BENZOYLPHENOXY)PROPOXY]-3-CHLOROPHENYL]-2-METHOXYPROPANOIC ACID|(S)-3-{4-[3-(4-BENZOYL-PHENOXY)-PROPOXY]-3-CHLORO-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157055	-	PUBCHEM	44392315	C26H25ClO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XCVUGMYZFJHTQE-DEOSSOPVSA-N
29796	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9722	(S)-2-Ethoxy-3-{4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid	NAVAGLITAZAR|(S)-2-ETHOXY-3-{4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|BDBM50157054	-	PUBCHEM	10115344	C26H28O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QTVFGQWILVTOFS-VWLOTQADSA-N
29797	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29798	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Jose B (2004)	15454224	224914	4124	Trichostatin A	LS-74195|ANTIBIOTIC A-300|CCG-208142|NCGC00162453-05|TRICHOSTATIN A, >=98% (HPLC), FROM STREPTOMYCES SP.|A 300|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6R-DIMETHYL-7-OXO-2E,4E-HEPTADIENAMIDE|MFCD03848392|SW219664-1|[R-(E,E)]-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|HMS3649O20|3X2S926L3Z|HMS1792L09|ABP000141|HMS1362L09|HY-15144|Q-201864|TRICHLOSTATIN A|3C10|NCGC_TSA|AS-74315|HMS1990L09|AKOS015899840|SC-73346|SR-05000013796-3|ZINC100014731|BRD-K68202742-001-05-8|TRICHOSTATIN A??, VETEC(TM) REAGENT GRADE, FROM STREPTOMYCES SP., >=98%|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENEHYDROXAMIC ACID|7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|(2E,4E,6R)-7-(4-DIMETHYLAMINOPHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-HEPTA-2,4-DIENAMIDE|TRICHOSTATIN A FROM STREPTOMYCES SP.|Q425894|GTPL7005|C17H22N2O3|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHEN YL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMID E|S1045|DB04297|7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TRICHOSTATIN A/TSA|NCGC00162453-15|(2E,4E,6R)-7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXOHEPTA-2,4-DIENAMIDE|ZX-AFC000233|(2E,4E,6R)-7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-2,4-HEPTADIENAMIDE|TSN|SGCTO-002|NCGC00162453-03|NCGC00162453-01|TRICOSTATIN A|M984|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|BRD-K68202742-001-04-1|TRICHOSTATINE A|880T196|1C3R|TRICHOSTATIN|TRICHOSTATIN-A - TSA|TRICHOSTATIN A,TSA|W-5309|(R)-TRICHOSTATIN A|HMS3403L09|UNII-30RHG284Z4 COMPONENT RTKIYFITIVXBLE-QEQCGCAPSA-N|CCG-208681|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)- (9CI)|58880-19-6|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, [R-(E,E)]-|SR-05000013796|NCGC00162453-04|GNF-PF-1011|BCP01776|M02571|TRICHOSTATIN(S)|SMR004702883|MLS006011095|EX-A1665|DTXSID6037063|NCGC00162453-02|A-300-I|UNII-3X2S926L3Z|3F0R|CS-0499|A8183|BCPP000035|SB17023|2,4-HEPTADIENAMIDE, 7-(4-(DIMETHYLAMINO)PHENYL)-N-HYDROXY-4,6-DIMETHYL-7-OXO-|(6R)-N-HYDROXY-4,6-DIMETHYL-7-OXO-7-[4-(DIMETHYLAMINO)PHENYL]-2,4-HEPTADIENAMIDE|2,4-HEPTADIENAMIDE, 7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|2,4-HEPTADIENAMIDE,7-[4-(DIMETHYLAMINO)PHENYL]-N-HYDROXY-4,6-DIMETHYL-7-OXO-, (2E,4E,6R)-|TRICHOSTATIN A (TSA)|LMPK01000055|CC-238|TRICHOSTATIN A|TSA|BDBM19130	-	DRUGBANK	DB04297	C17H22N2O3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTKIYFITIVXBLE-QEQCGCAPSA-N
29799	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9723	3-{4-[2-(2-Biphenyl-3-yl-5-methyl-oxazol-4-yl)ethoxy]-phenyl}-2-methyl-2-phenoxypropionic acid	3-{4-[2-(2-BIPHENYL-3-YL-5-METHYL-OXAZOL-4-YL)ETHOXY]-PHENYL}-2-METHYL-2-PHENOXYPROPIONIC ACID|3-{4-[2-(2-BIPHENYL-3-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-[5-METHYL-2-(3-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145723	-	PUBCHEM	10119393	C34H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QUFDAJDYOPXGGD-UHFFFAOYSA-N
29800	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9724	(2S)-2-Methyl-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|(S)-2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|BDBM50145722	-	PUBCHEM	10004270	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-NDEPHWFRSA-N
29801	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9725	(2S)-2-Methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	Q27083197|(S)-2-METHYL-3-{4-[2-(5-METHYL-2-THIOPHEN-2-YL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|LY-510929|(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|LY-929|(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-(PHENOXY)PROPANOIC ACID|LY 510929|GTPL2657|BDBM50145721	-	PUBCHEM	9890585	C26H25NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSPYUOBNIMILB-SANMLTNESA-N
29802	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9726	(2S)-3-[4-[2-(2-Cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-methyl-2-phenoxypropanoic acid	(S)-3-{4-[2-(2-CYCLOHEXYL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|BDBM50145719	-	PUBCHEM	11178750	C28H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OYRNUVYEOVJEPD-NDEPHWFRSA-N
29803	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9727	3-{4-[2-(2-Cyclohexyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid	3-{4-[2-(2-CYCLOHEXYL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|3-[4-[2-(2-CYCLOHEXYL-5-METHYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-METHYL-2-PHENOXYPROPANOIC ACID|BDBM50145718	-	PUBCHEM	11374677	C28H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OYRNUVYEOVJEPD-UHFFFAOYSA-N
29804	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9684	2-Methyl-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid	2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145712	-	PUBCHEM	10139247	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-UHFFFAOYSA-N
29805	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9728	2-Methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|2-METHYL-3-{4-[2-(5-METHYL-2-THIOPHEN-2-YL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|BDBM50145710	-	PUBCHEM	10276539	C26H25NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSPYUOBNIMILB-UHFFFAOYSA-N
29806	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Baell JB (2004)	15084131	224916	9729	Methyl (1S,2R,3S,4R,5R,8R,11R,12R,15S,16S,22R,23R,24S)-3,4,23,24-tetraacetyloxy-22-(1-acetyloxyethyl)-11-hydroxy-2,5,15-trimethyl-9-methylidene-19-oxo-7,20-dioxahexacyclo[13.9.0.02,12.05,11.06,8.016,22]tetracos-17-ene-6-carboxylate	1-[12B-HYDROXY-1B,3A,10B-TRIMETHYL-2,3,4,5-TETRA(METHYLCARBONYLOXY)-14-METHYLENE-1A-METHYLOXYCARBONYL-8-OXO-1A,1B,2,3,3A,3B,4,5,5A,6,8,10A,10B,11,12,12A,12B,13,14,14A-ICOSAHYDROOXIRENO[2'',3'':7,8]CHRYSENO[2,1-C]OXEPIN-5-YL]ETHYL ACETATE|BDBM50145062	-	PUBCHEM	44315262	C40H52O16	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VKDXHXWBOARFPD-GMNMBZFNSA-N
29807	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	unknown	target	Wu TY (2004)	14698179	224917	2443	Vorinostat	Vorinostatum|SAHA|Suberoylanilide hydroxamic acid|Octanedioic acid hydroxyamide phenylamide|Zolinza|Suberanilohydroxamic acid|SHH|BDBM19149	zolinza	DRUGBANK	DB02546	C14H20N2O3	small molecule	L01XX38	149647-78-9	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WAEXFXRVDQXREF-UHFFFAOYSA-N
29808	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9730	5-[3-[3-(4-Cycloheptyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133669	-	PUBCHEM	44345278	C28H35NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSCDIBRPSQPEET-UHFFFAOYSA-N
29809	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9731	5-[3-[3-(4-Cyclopentyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133667	-	PUBCHEM	44345252	C26H31NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BZLTUCWBZRKZHF-UHFFFAOYSA-N
29810	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9732	5-[3-[3-[2-Propyl-4-(cyclohexylmethyl)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(CYCLOHEXYLMETHYL)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50133666	-	PUBCHEM	44345031	C28H35NO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UJHOOSFHNXHHKX-UHFFFAOYSA-N
29811	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9733	(5S)-5-[3-[3-(4-Benzoyl-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133663	-	PUBCHEM	70694429	C28H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OZZBRLWUSGYQBE-SANMLTNESA-N
29812	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9734	(5R)-5-[3-[3-[4-(1,2-Benzoxazol-3-yl)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133661	-	PUBCHEM	54583265	C28H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLAXJZRUAXLLMT-AREMUKBSSA-N
29813	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9735	5-[3-[3-(4-Cyclohexyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133658	-	PUBCHEM	44345458	C27H33NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYMUSJRQCDBZCQ-UHFFFAOYSA-N
29814	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9736	5-[3-[3-[2-Propyl-4-(cyclohexylcarbonyl)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(CYCLOHEXYLCARBONYL)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50133654	-	PUBCHEM	44344982	C28H33NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DSILKMLNLQMKEG-UHFFFAOYSA-N
29815	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9737	(5S)-5-[3-[3-(4-Phenoxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131503	-	PUBCHEM	54583268	C27H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZNLPWBJCSSSCCR-VWLOTQADSA-N
29816	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	unknown	target	Berger D (2003)	12941327	224919	9738	4-[3-Chloro-4-(1-methylimidazol-2-yl)sulfanylanilino]-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile	3-CYANOQUINOLINE, 8|4-[3-CHLORO-4-(1-METHYL-1H-IMIDAZOLE-2-YLTHIO)PHENYLAMINO]-6-METHOXY-7-(3-MORPHOLINOPROPOXY)QUINOLINE-3-CARBONITRILE|4-[3-CHLORO-4-(1-METHYLIMIDAZOL-2-YL)SULFANYLANILINO]-6-METHOXY-7-(3-MORPHOLIN-4-YLPROPOXY)QUINOLINE-3-CARBONITRILE|4-({3-CHLORO-4-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]PHENYL}AMINO)-6-METHOXY-7-[3-(MORPHOLIN-4-YL)PROPOXY]QUINOLINE-3-CARBONITRILE|BDBM28123	-	PUBCHEM	10303277	C28H29ClN6O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QSENMPAGYMUVDE-UHFFFAOYSA-N
29817	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9739	(5R)-5-[3-[3-[4-(4-Hydroxyphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131514	-	PUBCHEM	54587161	C27H27NO6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMCOHKMLPVPQBF-RUZDIDTESA-N
29818	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9740	(5S)-5-[3-[3-[4-(4-Chloro-3-methylphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131512	-	PUBCHEM	54580272	C28H28ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RHXBMPROSWDTQC-SANMLTNESA-N
29819	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9741	5-[3-[3-[2-Propyl-4-(3,4-dichlorophenoxy)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(3,4-DICHLOROPHENOXY)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50131511	-	PUBCHEM	44327417	C27H25Cl2NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SXOUCNMFIUAZNE-UHFFFAOYSA-N
29820	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9742	(5S)-5-[3-[3-[4-(4-Fluorophenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131506	-	PUBCHEM	54584231	C27H26FNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BEESZPXMMFEPAP-VWLOTQADSA-N
29821	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9743	(5R)-5-[3-[3-[4-(4-Fluoro-3-methylphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131505	-	PUBCHEM	54585196	C28H28FNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TVEAXARFLUXLEB-AREMUKBSSA-N
29822	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9744	(5R)-5-[3-[3-[4-(4-Chlorophenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131504	-	PUBCHEM	54585195	C27H26ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BSYLKYWBLKSLBJ-RUZDIDTESA-N
29823	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9737	(5S)-5-[3-[3-(4-Phenoxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131503	-	PUBCHEM	54583268	C27H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZNLPWBJCSSSCCR-VWLOTQADSA-N
29824	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9745	(5S)-5-[3-[3-(4-Phenoxyphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131502	-	PUBCHEM	54581270	C24H21NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BTMVNTBNPIYHBM-QFIPXVFZSA-N
29825	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Ebdrup S (2003)	12672231	170525	6481	Ragaglitazar	NN-622|(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID(-) DRF 2725|Q27088511|DRF-2725|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|NNC-61-0029|(2S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YLETHOXY)PHENYL]PROPANOIC ACID|1NYX|DRF|(-)-DRF-2725|DRF2725|(S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|DB07675|RAGAGLITAZAR|GTPL2664|BDBM50109551	-	DRUGBANK	DB07675	C25H25NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WMUIIGVAWPWQAW-DEOSSOPVSA-N
29826	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Santini C (2003)	12657263	224921	9746	2-[3-Chloro-4-[3-[4-[(Z)-C-ethyl-N-hydroxycarbonimidoyl]-3-hydroxy-2-propylphenoxy]propylsulfanyl]phenyl]acetic acid	3-CHLORO-4-[3-[2-PROPYL-3-HYDROXY-4-[1-(HYDROXYIMINO)PROPYL]PHENOXY]PROPYLTHIO]BENZENEACETIC ACID|BDBM50126019	-	PUBCHEM	136088972	C23H28ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLVVAYSKHQLKES-PLRJNAJWSA-N
29827	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Santini C (2003)	12657263	224921	9747	Benzeneacetic acid, 3-chloro-4-((3-((3-phenyl-7-propyl-6-benzofuranyl)oxy)propyl)thio)-	UNII-O937X0Z5EM|{3-CHLORO-4-[3-(3-PHENYL-7-PROPYL-BENZOFURAN-6-YLOXY)-PROPYLSULFANYL]-PHENYL}-ACETIC ACID|BENZENEACETIC ACID, 3-CHLORO-4-((3-((3-PHENYL-7-PROPYL-6-BENZOFURANYL)OXY)PROPYL)THIO)-|3-CHLORO-4-(3-(3-PHENYL-7-PROPYLBENZOFURAN-6-YLOXY)PROPYLTHIO)-PHENYLACETIC ACID|L-796,449|L796449|O937X0Z5EM|2-[3-CHLORO-4-[3-[(3-PHENYL-7-PROPYL-1-BENZOFURAN-6-YL)OXY]PROPYLSULFANYL]PHENYL]ACETIC ACID|L-796449|L 796449|Q27078434|{3-CHLORO-4-[3-(3-PHENYL-7-PROPYL-BENZOFURAN-6-YLOXY)-PROPYLSULFANYL]-PHENYL}-ACETIC ACID(L-796449)|GTPL2689|194608-80-5|BDBM50085040	-	PUBCHEM	9891946	C28H27ClO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KAPDPGZDHUCILF-UHFFFAOYSA-N
29828	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Brooks DA (2001)	11405642	224922	9748	5-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	AD 5061|AD-5061|BM-131246|AD 7057|AD5061|5-{4-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHOXY]BENZYL}-2,4-THIAZOLIDINEDIONE|GTPL2663|5-({4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}METHYL)-1,3-THIAZOLIDINE-2,4-DIONE|Q27074311|HY-101758|AD-7057|CS-6704|5-[[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]METHYL]-1,3-THIAZOLIDINE-2,4-DIONE|AD7057|BDBM50064451	-	PUBCHEM	9953271	C22H20N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GUTCYOKMCPFRGH-UHFFFAOYSA-N
29829	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Brooks DA (2001)	11405642	224922	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29830	109943	3741	-	KCNA5	ATFB7|HCK1|HK2|HPCN1|KV1.5|PCN1	9606	Homo sapiens	unknown	target	Coghlan MJ (2001)	11356099	224923	9575	N-[3-(4-Ethyl-benzenesulfonylamino)-2-hydroxy-indan-5-yl]-3-methoxy-benzamide	N-((2R,3R)-3-(4-ETHYLPHENYLSULFONAMIDO)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-5-YL)-3-METHOXYBENZAMIDE|N-[3-(4-ETHYL-BENZENESULFONYLAMINO)-2-HYDROXY-INDAN-5-YL]-3-METHOXY-BENZAMIDE|BDBM50099581	-	PUBCHEM	17748224	C25H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KCRNOVULDSNKBZ-DNQXCXABSA-N
29831	109941	3738	RP11-284N8.3	KCNA3	HGK5|HLK3|HPCN3|HUKIII|KV1.3|MK3|PCN3	9606	Homo sapiens	unknown	target	Coghlan MJ (2001)	11356099	224923	9749	Methyl (1S,2S,3S,4R,5S,6S,8R,12S,15S,16S,22R,23R,24S)-3,4,24-triacetyloxy-22-[(1R)-1-acetyloxyethyl]-2,5,15-trimethyl-9-methylidene-19-oxo-23-prop-1-en-2-yloxy-7,20-dioxahexacyclo[13.9.0.02,12.05,11.06,8.016,22]tetracos-17-ene-6-carboxylate	5-ISOPROPENYLOXY-1B,3A,10B-TRIMETHYL-2,3-DI(METHYLCARBONYLOXY)-5A-(1-METHYLCARBONYLOXYETHYL)-14-METHYLENE-1A-METHYLOXYCARBONYL-8-OXO-1A,1B,2,3,3A,3B,4,5,5A,6,8,10A,10B,11,12,12A,12B,13,14,14A-ICOSAHYDROOXIRENO[3'',2'':7,8]CHRYSENO[2,1-C]OXEPIN-4-YLACETA|BDBM50099583	-	PUBCHEM	44290049	C41H54O14	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VBCYJMDXVYKTHI-SMYFPHPLSA-N
29832	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henke BR (1999)	10612594	224924	9750	2-Phenyl-3-(4-methoxyphenethyl)-1H-indole-5-acetic acid	{3-[2-(4-METHOXY-PHENYL)-ETHYL]-2-PHENYL-1H-INDOL-5-YL}-ACETIC ACID(GW 0207)|2-PHENYL-3-(4-METHOXYPHENETHYL)-1H-INDOLE-5-ACETIC ACID|258345-12-9|2-(3-(4-METHOXYPHENETHYL)-2-PHENYL-1H-INDOL-5-YL)ACETIC ACID|2-[3-[2-(4-METHOXYPHENYL)ETHYL]-2-PHENYL-1H-INDOL-5-YL]ACETIC ACID|{3-[2-(4-METHOXY-PHENYL)-ETHYL]-2-PHENYL-1H-INDOL-5-YL}-ACETIC ACID|GW0207|BDBM50083625	-	PUBCHEM	10068664	C25H23NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YZLHLVJLTOPOHC-UHFFFAOYSA-N
29833	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Parks DJ (1998)	9934490	224925	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29834	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Cao K (2020)	32211658	226774	9929	Cisplatin	transplatin|cis-platin|cis-Diamminedichlorplatine|Dichloroplatinum diammoniate|cis-Diamineplatinum(II) dichloride|MFCD00011623|TP2450000|UNII:Q20Q21Q62J|TP2455000|Cisplatin impurity A	-	CHEMSPIDER	76401	H6Cl2N2Pt	small molecule	-	14913-33-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LXZZYRPGZAFOLE-UHFFFAOYSA-L
29835	107920	1540	HSPC057	CYLD	BRSS|CDMT|CYLD1|CYLDI|EAC|MFT|MFT1|SBS|TEM|USPL2	9606	Homo sapiens	inhibitor	target	Yamanaka S (2021)	33390248	226776	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MZBFFXLYQTWKNV-INIZCTEOSA-N
29836	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Ishizawa J (2018)	29490944	228642	9913	DS-3032B	-	-	CHEMSPIDER	71060369	C37H44Cl2FN5O8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WPJOGWGXMTUHPW-CIPNXXNHSA-N
29837	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Holzer P (2015)	26181851	224770	9193	Nvp-cgm097	ZINC253387855|(1S)-1-(4-CHLOROPHENYL)-6-METHOXY-2-[4-[METHYL-[[4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL]METHYL]AMINO]PHENYL]-7-PROPAN-2-YLOXY-1,4-DIHYDROISOQUINOLIN-3-ONE|(S)-1-(4-CHLOROPHENYL)-7-ISOPROPOXY-6-METHOXY-2-(4-[METHYL[4-(4-METHYL-3-OXOPIPERAZIN-1-YL)-TRANS-CYCLOHEXYLMETHYL]AMINO]PHENYL)-1,4-DIHYDRO-2H-ISOQUINOLIN-3-ONE|4UF6MSL0ZH|NVP-CGM-097|KS-00000TSY|CCG-270337|US9051279, 106|(1S)-1-(4-CHLOROPHENYL)-6-METHOXY-2-[4-(METHYL{[TRANS-4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL]METHYL}AMINO)PHENYL]-7-(PROPAN-2-YLOXY)-1,4-DIHYDROISOQUINOLIN-3(2H)-ONE|EX-A1059|CS-3138|HY-15954|NVP-CGM097 (CGM-097)|NVP-CGM097|Q27454942|NCGC00390552-01|W5747|4T4|NVP CGM097|(1S)-1-(4-CHLOROPHENYL)-6-METHOXY-2-{4-[METHYL({[(1R,4R)-4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL]METHYL})AMINO]PHENYL}-7-(PROPAN-2-YLOXY)-1,2,3,4-TETRAHYDROISOQUINOLIN-3-ONE|C38H47CLN4O4|1313363-54-0|(1S)-1-(4-CHLOROPHENYL)-1,4-DIHYDRO-6-METHOXY-7-(1-METHYLETHOXY)-2-[4-[METHYL[[TRANS-4-(4-METHYL-3-OXO-1-PIPERAZINYL)CYCLOHEXYL]METHYL]AMINO]PHENYL]-3(2H)-ISOQUINOLINONE|CGM-097|(S)-1-(4-CHLOROPHENYL)-7-ISOPROPOXY-6-METHOXY-2-(4-(METHYL(((1R,4S)-4-(4-METHYL-3-OXOPIPERAZIN-1-YL)CYCLOHEXYL)METHYL)AMINO)PHENYL)-1,2-DIHYDROISOQUINOLIN-3(4H)-ONE|UNII-4UF6MSL0ZH|A16326|AS-75288|S7875|CGM097|J3.509.326E|CGM 097|BCP18308|AKOS030526402|BDBM162123	-	PUBCHEM	53240420	C38H47ClN4O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CLRSLRWKONPSRQ-CPOWQTMSSA-N
29838	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Furet P (2016)	27542305	228643	9857	Siremadlin	-	-	CHEMSPIDER	27542305	C11H6F3N3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NJLJARSIRPKVMU-UHFFFAOYSA-N
29839	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Sun D (2014)	24456472	224788	9232	Mdm2 inhibitor amg-232	AC-29027|1352066-68-2|ZINC103248035|COMPOUND 2 [PMID: 24456472]|SB17210|AMG 232|GTPL11133|C28H35CL2NO5S|HY-12296|2-((3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-((S)-1-(ISOPROPYLSULFONYL)-3-METHYLBUTAN-2-YL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETIC ACID|KRT232|V2654|MDM2 INHIBITOR AMG-232|2-[(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-3-METHYL-1-[(2S)-3-METHYL-1-PROPAN-2-YLSULFONYLBUTAN-2-YL]-2-OXOPIPERIDIN-3-YL]ACETIC ACID|AMG232|AOB87308|3-IPERIDINEACETIC ACID, 5-(3-HLOROPHENYL)-6-(4-HLOROPHENYL)-3-ETHYL-1-(1S)-2-ETHYL-1-[(1-ETHYLETHYL)ULFONYL]ETHYL]ROPYL]-2-XO-, (3R,5R,6S)-|AMG-232|UNII-7R7G6EH5UL|CS-3282|DB15299|(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-3-METHYL-1-((1S)-2-METHYL-1-(((1-METHYLETHYL)SULFONYL)METHYL)PROPYL)-2-OXO-3-PIPERIDINEACETIC ACID|NCGC00387801-04|AS-17007|NCGC00387801-05|KRT-232|1447813-21-9|7R7G6EH5UL|BDBM50448947	-	PUBCHEM	58573469	C28H35Cl2NO5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DRLCSJFKKILATL-YWCVFVGNSA-N
29840	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Yi H (2018)	29716622	228645	9893	APG-115	-	-	CHEMSPIDER	64853887	C34H38Cl2FN3O4	small molecule	-	1818393-16-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YJCZPJQGFSSFOL-MNZPCBJKSA-N
29841	113866	8237	RP4-659F15.2	USP11	UHX1	9606	Homo sapiens	inhibitor	target	Burkhart RA (2013)	23696131	156300	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KKZJGLLVHKMTCM-UHFFFAOYSA-N
29842	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Tang WK (2019)	30591537	219833	9881	CB-5083	1-[4-(Benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide|1H-Indole-4-carboxamide, 1-[7,8-dihydro-4-[(phenylmethyl)amino]-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-|CB-5083|591IV6UL6J	-	CHEMSPIDER	35519806	C24H23N5O2	small molecule	-	1542705-92-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RDALZZCKQFLGJP-UHFFFAOYSA-N
29843	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Chou TF (2013)	23316025	228646	9895	ML240	2-(2-Amino-1H-benzimidazol-1-yl)-N-benzyl-8-methoxy-4-quinazolinamine|ML240|CID-49830258|MFCD28137687|ML-240|2-(2-amino-1H-benzimidazol-1-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine|4-Quinazolinamine, 2-(2-amino-1H-benzimidazol-1-yl)-8-methoxy-N-(phenylmethyl)-	-	CHEMSPIDER	34500429	C23H20N6O	small molecule	-	1346527-98-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NHAMBLRUUJAFOY-UHFFFAOYSA-N
29844	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Chou TF (2013)	23316025	228646	9927	ML241	N-Benzyl-2-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-5,6,7,8-tetrahydro-4-quinazolinamine hydrochloride (1:1)|4-Quinazolinamine, 2-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-5,6,7,8-tetrahydro-N-(phenylmethyl)-, hydrochloride (1:1)	-	CHEMSPIDER	57251285	C23H25ClN4O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DYHMHNNBOLCULH-UHFFFAOYSA-N
29845	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Poehler R (2018)	29271116	216019	9861	MSC1094308	4,4-Bis(4-fluorophenyl)-N-[(6-fluoro-2,3,4,9-tetrahydro-1H-carbazol-3-yl)methyl]-1-butanamine|1H-Carbazole-3-methanamine, N-[4,4-bis(4-fluorophenyl)butyl]-6-fluoro-2,3,4,9-tetrahydro-	-	CHEMSPIDER	78316408	C29H29F3N2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OCZIMUMAPGQEBH-UHFFFAOYSA-N
29846	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Magnaghi P (2013)	23892893	220331	9840	NMS-859	Acetamide, 2-chloro-N-[3-[(1,1-dioxido-1,2-benzisothiazol-3-yl)amino]phenyl]-|2-Chloro-N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)amino]phenyl}acetamide	-	CHEMSPIDER	34224308	C15H12ClN3O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JWMFLBAPPIWNGG-UHFFFAOYSA-N
29847	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Sasazawa Y (2012)	22360440	228647	9900	Xanthohumol	2-propen-1-one, 1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxyphenyl)-, (2E)-|Xanthohumol|(2E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one|MFCD00210576|2',4,4'-trihydroxy-6'-methoxy-3'-prenylchalcone|1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one|T4467YT1NT|(E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-butenyl)phenyl]-3-(4-hydroxyphenyl)propenone|(2E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one|XANTHOHUMOL FROM HOP (HUMULUS LUPULUS)|2-Propen-1-one, 1-[2,4-dihydroxy-6-methoxy-3-(3-methyl-2-buten-1-yl)phenyl]-3-(4-hydroxyphenyl)-, (2E)-	-	CHEMSPIDER	555077	C21H22O5	small molecule	-	569-83-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ORXQGKIUCDPEAJ-YRNVUSSQSA-N
29848	114402	8883	HPP1	NAE1	A-116A10.1|APPBP1|ula-1	9606	Homo sapiens	inhibitor	target	Yoshimura C (2019)	31092565	228648	9877	TAS4464	7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-[5-[(aminosulfonyl)amino]-5-deoxy-beta-D-ribofuranosyl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]-|7-[5-Deoxy-5-(sulfamoylamino)-beta-D-ribofuranosyl]-5-[(2-ethoxy-6-fluorophenyl)ethynyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	CHEMSPIDER	75533883	C21H23FN6O6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TZTRUHFXPVXWRD-QTQZEZTPSA-N
29849	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kuhn DJ (2007)	17591945	182023	7633	Carfilzomib	GTPL7420|SMR004660024|QCR-96|(2S)-4-METHYL-N-[(2S)-1-[[(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL]AMINO]-1-OXO-3-PHENYLPROPAN-2-YL]-2-[[(2S)-2-[(2-MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL]AMINO]PENTANAMIDE|DSSTOX_RID_82886|CARFILZOMIB (JAN/USAN/INN)|(2S)-N-((1S)-1-BENZYL-2-(((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRAN-2-YL)CARBONYL)BUTYL)AMINO)-2-OXOETHYL)-4-METHYL-2-(((2S)-2-((MORPHOLIN-4-YLACETYL)AMINO)-4-PHENYLBUTANOYL)AMINO)PENTANAMIDE|CS-0984|72X6E3J5AR|HY-10455|UNII-72X6E3J5AR|CC-684|EX-A2037|ZINC49841054|CARFILZOMIB; PR171|N-{(2S)-2-[(MORPHOLIN-4-YLACETYL)AMINO]-4-PHENYLBUTANOYL}-L-LEUCYL-N-{(2S)-4-METHYL-1-[(2R)-2-METHYLOXIRAN-2-YL]-1-OXOPENTAN-2-YL}-L-PHENYLALANINAMIDE|KYPROLIS|NCGC00249613-02|AKOS025401910|SC-91032|D08880|AOB87759|Y0441|AB01565867_02|(ALPHAS)-ALPHA-[[2-(4-MORPHOLINYL)ACETYL]AMINO]BENZENEBUTANOYL-L-LEUCYL-N-[(1S)-3-METHYL-1-[[(2R)-2-METHYL-2-OXIRANYL]CARBONYL]BUTYL]-L-PHENYLALANINAMIDE|SR-01000941582|CARFILZOMIB [USAN:INN]|ONO-7057|L-PHENYLALANINAMIDE, (ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-|CARFILZOMIB|CARFILZOMIB?PR-171?/KYPROLIS|AS-17059|PR-171|C40H57N5O7|SR-01000941582-1|Q15366934|(S)-4-METHYL-N-((S)-1-(((S)-4-METHYL-1-((R)-2-METHYLOXIRAN-2-YL)-1-OXOPENTAN-2-YL)AMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|(S)-4-METHYL-N-((S)-1-((S)-4-METHYL-1-((R)-2- METHYLOXIRAN-2-YL)-1 -OXOPENTAN-2-YLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL)-2-((S)-2-(2-MORPHOLINOACETAMIDO)-4-PHENYLBUTANAMIDO)PENTANAMIDE|CARFILZOMIB (PR-171)|TOX21_113079_1|AB0008111|DSSTOX_CID_28616|KS-00000SR1|MLS006011102|NCGC00249613-03|AK546882|CCG-270405|TOX21_113079|NCGC00249613-11|S2853|868540-17-4|AC-27051|NCGC00249613-01|(ALPHAS)-ALPHA-((4-MORPHOLINYLACETYL)AMINO)BENZENEBUTANOYL-L-LEUCYL-N-((1S)-3-METHYL-1-(((2R)-2-METHYLOXIRANYL)CARBONYL)BUTYL)-L-PHE NYLALANINAMIDE|J-501773|SW218090-2|SB16813|KYPROLIS (TN)|CARFILZOMIB(PR171)|CS-W004540|DB08889|DSSTOX_GSID_48690|S-7798|DTXSID4048690|BDBM50277889	kyprolis	DRUGBANK	DB08889	C40H57N5O7	small molecule	L01XX45	868540-17-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BLMPQMFVWMYDKT-NZTKNTHTSA-N
29850	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	inhibitor	target	Kraus M (2015)	26069288	228649	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
29851	111671	5698	DADB-223G19.3	PSMB9	LMP2|PSMB6i|RING12|beta1i	9606	Homo sapiens	inhibitor	target	Kraus M (2015)	26069288	228649	181	Bortezomib	N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|BDBM50069989	act bortezomib|velcade|bortezo	DRUGBANK	DB00188	C19H25BN4O4	small molecule	L01XX32	179324-69-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GXJABQQUPOEUTA-RDJZCZTQSA-N
29852	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Kraus M (2015)	26069288	228649	9934	LU-102	N-[1-[4-(Aminomethyl)-3-methylsulfonylphenyl]but-3-en-2-yl]-5-[[(2S)-2-azido-3-phenylpropanoyl]amino]-2-(2-methylpropyl)-4-oxooctanamide|N3Phe-Leu-Leu-Phe(4-CH2NH2)VS|azido-phenylalanyl-leucyl-leucyl-4-aminomethylphenylalanyl methyl vinyl sulfone|azido-Phe-Leu-Leu-4-aminomethyl-Phe-methyl vinyl sulfone	-	PUBCHEM	122381404	C33H46N6O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KSYVIWDORIKTLM-VMYWCARFSA-N
29853	111672	5699	-	PSMB10	LMP10|MECL1|beta2i	9606	Homo sapiens	inhibitor	target	Kraus M (2015)	26069288	228649	9934	LU-102	N-[1-[4-(Aminomethyl)-3-methylsulfonylphenyl]but-3-en-2-yl]-5-[[(2S)-2-azido-3-phenylpropanoyl]amino]-2-(2-methylpropyl)-4-oxooctanamide|N3Phe-Leu-Leu-Phe(4-CH2NH2)VS|azido-phenylalanyl-leucyl-leucyl-4-aminomethylphenylalanyl methyl vinyl sulfone|azido-Phe-Leu-Leu-4-aminomethyl-Phe-methyl vinyl sulfone	-	PUBCHEM	122381404	C33H46N6O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KSYVIWDORIKTLM-VMYWCARFSA-N
29854	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	List A (2014)	24285701	228650	9842	Omuralide	6-Oxa-2-azabicyclo[3.2.0]heptane-3,7-dione, 1-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-, (1S,4R,5S)-|(1S,4R,5S)-1-[(1S)-1-Hydroxy-2-methylpropyl]-4-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione	-	CHEMSPIDER	24704745	C10H15NO4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FWPWHHUJACGNMZ-NUMRIWBASA-N
29855	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Yang H (2008)	18537678	228651	9908	Lactacystin	Lactacystin|N-Acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-2-pyrrolidinyl}carbonyl)-L-cysteine|L-cysteine, S-[[(2R,3S,4R)-3,4-dihydro-3,5-dihydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-2H-pyrrol-2-yl]carbonyl]-N-(1-hydroxyethylidene)-, (E)-|N-Acetyl-S-({(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidin-2-yl}carbonyl)-L-cysteine|L-Cysteine, N-acetyl-S-[[(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-2-pyrrolidinyl]carbonyl]-|MFCD01076525	-	CHEMSPIDER	5042546	C15H24N2O7S	small molecule	-	133343-34-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DAQAKHDKYAWHCG-RWTHQLGUSA-N
29856	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Yang H (2008)	18537678	228651	9892	Epigallocatechin gallate	EGCG|Epigallocatechin 3-gallate|Epigallocatechin gallate|(-)-Epigallocatechin gallate|(-)-EGCG|(-)-Epigallocatechin-3-o-gallate|(-)-epigallocatechin 3-gallate|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate|Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|(-)-Epigallocatechin 3-O-gallate|3,4,5-Trihydroxybenzoic acid (2R-cis)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|(-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate|KB5200000|MFCD00075940|(-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate	-	CHEMSPIDER	58575	C22H18O11	small molecule	-	989-51-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WMBWREPUVVBILR-WIYYLYMNSA-N
29857	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Chen D (2005)	15857606	228652	6168	apigenin	-	-	DRUGBANK	DB07352	C15H10O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KZNIFHPLKGYRTM-UHFFFAOYSA-N
29858	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Chen D (2005)	15857606	228652	4044	Quercetin	3,5,7,3',4'-Pentahydroxyflavone	-	DRUGBANK	DB04216	C15H10O7	small molecule	-	117-39-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	REFJWTPEDVJJIY-UHFFFAOYSA-N
29859	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kazi A (2003)	12963483	142316	1582	Genistein	Genisterin|5,7,4'-Trihydroxyisoflavone|4',5, 7-Trihydroxyisoflavone|Genisteol	-	DRUGBANK	DB01645	C15H10O5	small molecule	-	446-72-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TZBJGXHYKVUXJN-UHFFFAOYSA-N
29860	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Yang H (2006)	16651429	228653	9878	Celastrol	Celastrol|Tripterine|(2R,4aS,6aS,12bR,14aS,14bR)-10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid|2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, (2R,4aS,6aS,12bR,14aS,14bR)-|(2R,4aS,6aS,12bR,14aS,14bR)-10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-2-picenecarboxylic acid|Tripterin|MFCD03424073|10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-picene-2-carboxylic acid|L8GG98663L	-	CHEMSPIDER	109405	C29H38O4	small molecule	-	34157-83-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KQJSQWZMSAGSHN-JJWQIEBTSA-N
29861	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Yang H (2008)	17541980	228654	9851	Pristimerin	Pristimerin|Celastrol-methylether|Methyl (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylate|2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-, methyl ester, (2R,4aS,6aS,12bR,14aS,14bR)-|Methyl (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-2-picenecarboxylate|MFCD01711331|CELASTROL METHYL ESTER|(9b,13a,14b,20a)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26 -trinoroleana-1(10),3,5,7-tertraen-29-oic acid methyl ester|28ZK7PR57S	-	CHEMSPIDER	140269	C30H40O4	small molecule	-	1258-84-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JFACETXYABVHFD-WXPPGMDDSA-N
29862	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kisselev AF (2012)	22284358	228655	9836	MLN9708	MLN9708|IXAZOMIB CITRATE 1,3,2-DIOXABORINANE|4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid|1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-|Ninlaro|ixazomib|MLN-9708	-	CHEMSPIDER	25027413	C20H23BCl2N2O9	small molecule	-	1201902-80-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YTXSYWAKVMZICI-PVCZSOGJSA-N
29863	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hines J (2008)	18482702	228656	9837	Fellutamide B	N~2~-[(3R)-3-Hydroxydodecanoyl]-L-asparaginyl-N~1~-(4-methyl-1-oxo-2-pentanyl)-L-glutamamide|L-Glutamamide, N~2~-[(3R)-3-hydroxy-1-oxododecyl]-L-asparaginyl-N~1~-(1-formyl-3-methylbutyl)-	-	CHEMSPIDER	17209898	C27H49N5O7	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MFXAGCQVWGPEJH-FTMYTLCRSA-N
29864	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Rydzewski RM (2006)	16686537	132619	9917	PSI	PSI|tert-Butyl (4S)-4-{[(2S,3S)-2-{[(benzyloxy)carbonyl]amino}-3-methylpentanoyl]amino}-5-{[(2S)-1-{[(2S)-4-methyl-1-oxopentan-2-yl]amino}-1-oxopropan-2-yl]amino}-5-oxopentanoate (non-preferred name)|MFCD00671409|Z-Ile-Glu(O-t-butyl)-Ala-Leucinal	-	CHEMSPIDER	8136267	C32H50N4O8	small molecule	-	158442-41-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TYFTWYMXUWCOOB-YICLCXKGSA-N
29865	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Meng L (1999)	10468620	133715	9924	Epoxomicin	Epoxomicin|L-Threoninamide, N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-|N-acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-threoninamide|MFCD03791061|Y0900I3U8U|N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-threoninamide	-	CHEMSPIDER	9401737	C28H50N4O7	small molecule	-	134381-21-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOGIDQKFVLKMLQ-JTHVHQAWSA-N
29866	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Meng L (1999)	10383134	228657	9845	Eponemycin	N-[(2S)-3-Hydroxy-1-({(2S)-1-[(2R)-2-(hydroxymethyl)-2-oxiranyl]-4-methyl-1-oxo-4-penten-2-yl}amino)-1-oxo-2-propanyl]-6-methylheptanamide|Heptanamide, N-[(1S)-1-(hydroxymethyl)-2-[[(1S)-1-[[(2R)-2-(hydroxymethyl)oxiranyl]carbonyl]-3-methyl-3-buten-1-yl]amino]-2-oxoethyl]-6-methyl-	-	CHEMSPIDER	8267816	C20H34N2O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZPLVYYNMRMBNGE-TWOQFEAHSA-N
29867	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	inhibitor	target	Meng L (1999)	10383134	228657	9845	Eponemycin	N-[(2S)-3-Hydroxy-1-({(2S)-1-[(2R)-2-(hydroxymethyl)-2-oxiranyl]-4-methyl-1-oxo-4-penten-2-yl}amino)-1-oxo-2-propanyl]-6-methylheptanamide|Heptanamide, N-[(1S)-1-(hydroxymethyl)-2-[[(1S)-1-[[(2R)-2-(hydroxymethyl)oxiranyl]carbonyl]-3-methyl-3-buten-1-yl]amino]-2-oxoethyl]-6-methyl-	-	CHEMSPIDER	8267816	C20H34N2O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZPLVYYNMRMBNGE-TWOQFEAHSA-N
29868	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kisselev AF (2012)	22284358	228655	9911	PS-519	PS-519	-	CHEMSPIDER	8052873	C12H19NO4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KMXHEXRPYSXLRN-JDVQERKKSA-N
29869	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kawamura S (2013)	23547757	228658	9889	Belactosin A	L-Alanyl-3-{(1S,2S)-2-[({(2R,3S)-3-[(2S)-2-butanyl]-4-oxo-2-oxetanyl}carbonyl)amino]cyclopropyl}-L-alanine|L-Alanine, L-alanyl-3-[(1S,2S)-2-[[[(2R,3S)-3-[(1S)-1-methylpropyl]-4-oxo-2-oxetanyl]carbonyl]amino]cyclopropyl]-	-	CHEMSPIDER	24704887	C17H27N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZSYIAUXMQLVKIL-BLTCOFLISA-N
29870	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Kawamura S (2013)	23547757	228658	9889	Belactosin A	L-Alanyl-3-{(1S,2S)-2-[({(2R,3S)-3-[(2S)-2-butanyl]-4-oxo-2-oxetanyl}carbonyl)amino]cyclopropyl}-L-alanine|L-Alanine, L-alanyl-3-[(1S,2S)-2-[[[(2R,3S)-3-[(1S)-1-methylpropyl]-4-oxo-2-oxetanyl]carbonyl]amino]cyclopropyl]-	-	CHEMSPIDER	24704887	C17H27N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZSYIAUXMQLVKIL-BLTCOFLISA-N
29871	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9931	Tyropeptin A	N-(3-methylbutanoyl)-L-tyrosyl-N-[1-(4-hydroxyphenyl)-3-oxopropan-2-yl]-L-valinamide|L-Valinamide, N-(3-methyl-1-oxobutyl)-L-tyrosyl-N-[1-formyl-2-(4-hydroxyphenyl)ethyl]-|Tyropeptin A|N-(3-Methylbutanoyl)-L-tyrosyl-N-[1-(4-hydroxyphenyl)-3-oxo-2-propanyl]-L-valinamide	-	CHEMSPIDER	9908676	C28H37N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OSMJFYFZOAVCNP-KLZDYHPHSA-N
29872	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9931	Tyropeptin A	N-(3-methylbutanoyl)-L-tyrosyl-N-[1-(4-hydroxyphenyl)-3-oxopropan-2-yl]-L-valinamide|L-Valinamide, N-(3-methyl-1-oxobutyl)-L-tyrosyl-N-[1-formyl-2-(4-hydroxyphenyl)ethyl]-|Tyropeptin A|N-(3-Methylbutanoyl)-L-tyrosyl-N-[1-(4-hydroxyphenyl)-3-oxo-2-propanyl]-L-valinamide	-	CHEMSPIDER	9908676	C28H37N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OSMJFYFZOAVCNP-KLZDYHPHSA-N
29873	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9925	Tyropeptin B	N-Butyryl-L-tyrosyl-N-[1-(4-hydroxyphenyl)-3-oxo-2-propanyl]-L-leucinamide|L-Leucinamide, N-(1-oxobutyl)-L-tyrosyl-N-[1-formyl-2-(4-hydroxyphenyl)ethyl]-	-	CHEMSPIDER	9202817	C28H37N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SYAOZPXWOOYNES-MHKYCTGGSA-N
29874	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9925	Tyropeptin B	N-Butyryl-L-tyrosyl-N-[1-(4-hydroxyphenyl)-3-oxo-2-propanyl]-L-leucinamide|L-Leucinamide, N-(1-oxobutyl)-L-tyrosyl-N-[1-formyl-2-(4-hydroxyphenyl)ethyl]-	-	CHEMSPIDER	9202817	C28H37N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SYAOZPXWOOYNES-MHKYCTGGSA-N
29875	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Momose I (2007)	17420589	228660	9896	TP-110	O-methyl-N-(naphthalen-1-ylacetyl)-L-tyrosyl-N-[1-(4-methoxyphenyl)-3-oxopropan-2-yl]-L-valinamide|L-Valinamide, O-methyl-N-[2-(1-naphthalenyl)acetyl]-L-tyrosyl-N-[1-formyl-2-(4-methoxyphenyl)ethyl]-|O-Methyl-N-(1-naphthylacetyl)-L-tyrosyl-N-[1-(4-methoxyphenyl)-3-oxo-2-propanyl]-L-valinamide	-	CHEMSPIDER	9767341	C37H41N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IJDYUMDIJFFMQQ-ROSKKCPQSA-N
29876	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kroll M (1999)	10508680	228661	9843	Gliotoxin	Gliotoxin|[3R-(3a,5ab,6b,10aa)]-2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione|(1R,7S,8S,11R)-7-Hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0~1,9~.0~3,8~]pentadeca-3,5-diene-10,14-dione|10H-3,10a-(Iminomethano)[1,2,4]dithiazino[4,3-a]indole-4,11(3H)-dione, 5a,6-dihydro-6-hydroxy-3-(hydroxymethyl)-12-methyl-, (3R,5aS,6S,10aR)-|(3R,5aS,6S,10aR)-6-hydroxy-3-(hydroxymethyl)-2-methyl-2,3,6,10-tetrahydro-5aH-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione|(3R,5aS,6S,10aR)-2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione|epithiodiketopiperazine|KB4725000|MFCD00058534|50675|5L648PH06K|Aspergillin solution|Gliotoxin solution	-	CHEMSPIDER	5988	C13H14N2O4S2	small molecule	-	67-99-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FIVPIPIDMRVLAY-RBJBARPLSA-N
29877	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Ozcan S (2013)	23547706	228662	9914	PI-1840	N-Isopropyl-2-(4-propylphenoxy)-N-{[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl}acetamide|Acetamide, N-(1-methylethyl)-2-(4-propylphenoxy)-N-[[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl]-	-	CHEMSPIDER	29403217	C22H26N4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZVVXAODXPVWGMF-UHFFFAOYSA-N
29878	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Groll M (2001)	11493007	55322	9909	TMC-95A	TMC-95A	-	CHEMSPIDER	8050373	C33H38N6O10	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZIAXNZCTODBCKW-BOYGTWLISA-N
29879	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	inhibitor	target	Groll M (2001)	11493007	55322	9909	TMC-95A	TMC-95A	-	CHEMSPIDER	8050373	C33H38N6O10	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZIAXNZCTODBCKW-BOYGTWLISA-N
29880	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Groll M (2001)	11493007	55322	9909	TMC-95A	TMC-95A	-	CHEMSPIDER	8050373	C33H38N6O10	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZIAXNZCTODBCKW-BOYGTWLISA-N
29881	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	inhibitor	target	Yang Y (2019)	31038581	219731	9863	SKPin C1	SKPin C1|Acetic acid, 2-[4-bromo-2-[(E)-[4-oxo-3-(3-pyridinylmethyl)-2-thioxo-5-thiazolidinylidene]methyl]phenoxy]-|(4-Bromo-2-{(E)-[4-oxo-3-(3-pyridinylmethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}phenoxy)acetic acid	-	CHEMSPIDER	35308320	C18H13BrN2O4S2	small molecule	-	432001-69-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IYCJJVVXEHZJHE-VIZOYTHASA-N
29882	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Cai Q (2011)	21443232	228663	9886	AT-406	Pyrrolo[1,2-a][1,5]diazocine-8-carboxamide, N-(diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxo-, (5S,8S,10aR)-|AT-406|N65WC8PXDD|(5S,8S,10aR)-N-(Diphenylmethyl)-5-[(N-methyl-L-alanyl)amino]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide	-	CHEMSPIDER	28424114	C32H43N5O4	small molecule	-	1071992-81-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LSXUTRRVVSPWDZ-MKKUMYSQSA-N
29883	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	inhibitor	target	Cai Q (2011)	21443232	228663	9886	AT-406	Pyrrolo[1,2-a][1,5]diazocine-8-carboxamide, N-(diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxo-, (5S,8S,10aR)-|AT-406|N65WC8PXDD|(5S,8S,10aR)-N-(Diphenylmethyl)-5-[(N-methyl-L-alanyl)amino]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide	-	CHEMSPIDER	28424114	C32H43N5O4	small molecule	-	1071992-81-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LSXUTRRVVSPWDZ-MKKUMYSQSA-N
29884	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	inhibitor	target	Cai Q (2011)	21443232	228663	9886	AT-406	Pyrrolo[1,2-a][1,5]diazocine-8-carboxamide, N-(diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxo-, (5S,8S,10aR)-|AT-406|N65WC8PXDD|(5S,8S,10aR)-N-(Diphenylmethyl)-5-[(N-methyl-L-alanyl)amino]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide	-	CHEMSPIDER	28424114	C32H43N5O4	small molecule	-	1071992-81-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LSXUTRRVVSPWDZ-MKKUMYSQSA-N
29885	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Ardecky RJ (2013)	23743278	228664	9868	GDC-0152	2-Pyrrolidinecarboxamide, 1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)-1-oxopropyl]amino]acetyl]-N-(4-phenyl-1,2,3-thiadiazol-5-yl)-, (2S)-|GDC-0152|L-alpha-Glutamyl-L-tryptophyl-L-glutamic acid|4KW1M48SHS|1-{(2S)-2-Cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-(4-phenyl-1,2,3-thiadiazol-5-yl)-L-prolinamide	-	CHEMSPIDER	28521870	C25H34N6O3S	small molecule	-	873652-48-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WZRFLSDVFPIXOV-LRQRDZAKSA-N
29886	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Archer CR (2012)	22870914	228665	9855	Syringolin A	L-Valine, N-[[[(1S)-2-methyl-1-[[[(3E,5S,8S,9E)-5-(1-methylethyl)-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]amino]carbonyl]propyl]amino]carbonyl]-|N-{[(2S)-1-{[(3E,5S,8S,9E)-5-Isopropyl-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]amino}-3-methyl-1-oxo-2-butanyl]carbamoyl}-L-valine|syringolin A	-	CHEMSPIDER	25058932	C24H39N5O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RUWSLQOIGKYPEZ-YPXRAQKDSA-N
29887	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	inhibitor	target	Archer CR (2012)	22870914	228665	9855	Syringolin A	L-Valine, N-[[[(1S)-2-methyl-1-[[[(3E,5S,8S,9E)-5-(1-methylethyl)-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]amino]carbonyl]propyl]amino]carbonyl]-|N-{[(2S)-1-{[(3E,5S,8S,9E)-5-Isopropyl-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]amino}-3-methyl-1-oxo-2-butanyl]carbamoyl}-L-valine|syringolin A	-	CHEMSPIDER	25058932	C24H39N5O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RUWSLQOIGKYPEZ-YPXRAQKDSA-N
29888	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Archer CR (2012)	22870914	228665	9855	Syringolin A	L-Valine, N-[[[(1S)-2-methyl-1-[[[(3E,5S,8S,9E)-5-(1-methylethyl)-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]amino]carbonyl]propyl]amino]carbonyl]-|N-{[(2S)-1-{[(3E,5S,8S,9E)-5-Isopropyl-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]amino}-3-methyl-1-oxo-2-butanyl]carbamoyl}-L-valine|syringolin A	-	CHEMSPIDER	25058932	C24H39N5O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RUWSLQOIGKYPEZ-YPXRAQKDSA-N
29889	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9899	Glidobactin A	2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-|(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide	-	CHEMSPIDER	4943654	C27H44N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TYGJUQYJMIOZLZ-QQXADAIISA-N
29890	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9899	Glidobactin A	2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-|(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide	-	CHEMSPIDER	4943654	C27H44N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TYGJUQYJMIOZLZ-QQXADAIISA-N
29891	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9899	Glidobactin A	2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-|(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide	-	CHEMSPIDER	4943654	C27H44N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TYGJUQYJMIOZLZ-QQXADAIISA-N
29892	111672	5699	-	PSMB10	LMP10|MECL1|beta2i	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9899	Glidobactin A	2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-|(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide	-	CHEMSPIDER	4943654	C27H44N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	TYGJUQYJMIOZLZ-QQXADAIISA-N
29893	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9847	Glidobactin C	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-tetradecadienamide|2,4-Tetradecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	4943596	C29H48N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UHXDSKADPILIPT-OHIHYABUSA-N
29894	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9847	Glidobactin C	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-tetradecadienamide|2,4-Tetradecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	4943596	C29H48N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UHXDSKADPILIPT-OHIHYABUSA-N
29895	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9847	Glidobactin C	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-tetradecadienamide|2,4-Tetradecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	4943596	C29H48N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UHXDSKADPILIPT-OHIHYABUSA-N
29896	111672	5699	-	PSMB10	LMP10|MECL1|beta2i	9606	Homo sapiens	inhibitor	target	Pawar A (2020)	32123742	228666	9847	Glidobactin C	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-tetradecadienamide|2,4-Tetradecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	4943596	C29H48N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UHXDSKADPILIPT-OHIHYABUSA-N
29897	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Clerc J (2009)	19359491	228667	9871	Syringolin B	L-Valine, N-[[[(1S)-2-methyl-1-[[[(3E,5S,8S)-5-(1-methylethyl)-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]amino]carbonyl]-|N-{[(2S)-1-{[(3E,5S,8S)-5-Isopropyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-3-methyl-1-oxo-2-butanyl]carbamoyl}-L-valine|syringolin B	-	CHEMSPIDER	26329033	C24H41N5O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AIMDTYKFJMYVNG-NGGLIGEOSA-N
29898	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9885	Cepafungin I	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-11-methyl-2,4-dodecadienamide|2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-11-methyl-, (2E,4E)-	-	CHEMSPIDER	4943721	C28H46N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SVHNVAFCZJDSIW-VBFMYEFXSA-N
29899	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9885	Cepafungin I	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-11-methyl-2,4-dodecadienamide|2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3Z,5S,8S,10S)-10-hydroxy-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-11-methyl-, (2E,4E)-	-	CHEMSPIDER	4943721	C28H46N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	SVHNVAFCZJDSIW-VBFMYEFXSA-N
29900	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9894	Luminmycin A	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide|2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	28646456	C27H44N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CXVPCSSIDACGGV-SBSLBVBZSA-N
29901	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9894	Luminmycin A	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide|2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	28646456	C27H44N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CXVPCSSIDACGGV-SBSLBVBZSA-N
29902	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9894	Luminmycin A	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide|2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	28646456	C27H44N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CXVPCSSIDACGGV-SBSLBVBZSA-N
29903	111672	5699	-	PSMB10	LMP10|MECL1|beta2i	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9894	Luminmycin A	(2E,4E)-N-[(2S,3R)-3-Hydroxy-1-{[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino}-1-oxo-2-butanyl]-2,4-dodecadienamide|2,4-Dodecadienamide, N-[(1S,2R)-2-hydroxy-1-[[[(3E,5S,8S)-5-methyl-2,7-dioxo-1,6-diazacyclododec-3-en-8-yl]amino]carbonyl]propyl]-, (2E,4E)-	-	CHEMSPIDER	28646456	C27H44N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CXVPCSSIDACGGV-SBSLBVBZSA-N
29904	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9912	TMC-95B	TMC-95B	-	CHEMSPIDER	8253792	C33H38N6O10	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZIAXNZCTODBCKW-NKGUOCGVSA-N
29905	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9912	TMC-95B	TMC-95B	-	CHEMSPIDER	8253792	C33H38N6O10	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZIAXNZCTODBCKW-NKGUOCGVSA-N
29906	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Nickeleit I (2008)	18598941	228668	9884	Argyrin A	Argyrin	-	CHEMSPIDER	9279960	C40H44N10O8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MXGWDBFUMHUPTG-SKZNYKRCSA-N
29907	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	inhibitor	target	Nickeleit I (2008)	18598941	228668	9884	Argyrin A	Argyrin	-	CHEMSPIDER	9279960	C40H44N10O8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MXGWDBFUMHUPTG-SKZNYKRCSA-N
29908	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Nickeleit I (2008)	18598941	228668	9884	Argyrin A	Argyrin	-	CHEMSPIDER	9279960	C40H44N10O8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MXGWDBFUMHUPTG-SKZNYKRCSA-N
29909	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Allardyce DJ (2019)	31074944	228669	9928	Argyrin B	argyrin B	-	CHEMSPIDER	8116406	C41H46N10O8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OVJDNZFLEREPKG-VPMCBBNJSA-N
29910	111671	5698	DADB-223G19.3	PSMB9	LMP2|PSMB6i|RING12|beta1i	9606	Homo sapiens	inhibitor	target	Allardyce DJ (2019)	31074944	228669	9928	Argyrin B	argyrin B	-	CHEMSPIDER	8116406	C41H46N10O8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OVJDNZFLEREPKG-VPMCBBNJSA-N
29911	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Buelow L (2010)	20358576	228670	9848	Argyrin F	-	-	CHEMSPIDER	9258555	C40H44N10O9S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FJSMXOTZGJRIEU-GZAHMLPMSA-N
29912	111667	5694	-	PSMB6	DELTA|LMPY|Y	9606	Homo sapiens	inhibitor	target	Buelow L (2010)	20358576	228670	9848	Argyrin F	-	-	CHEMSPIDER	9258555	C40H44N10O9S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FJSMXOTZGJRIEU-GZAHMLPMSA-N
29913	111668	5695	RP11-101K10.7	PSMB7	Z	9606	Homo sapiens	inhibitor	target	Buelow L (2010)	20358576	228670	9848	Argyrin F	-	-	CHEMSPIDER	9258555	C40H44N10O9S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	FJSMXOTZGJRIEU-GZAHMLPMSA-N
29914	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9888	Phepropeptin A	Cyclo(D-leucyl-L-valyl-L-leucyl-D-phenylalanyl-L-prolyl-L-leucyl)	-	CHEMSPIDER	9214884	C37H58N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QVOWLQGIVUTHGK-ZAFXZDQFSA-N
29915	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9867	Phepropeptin B	Cyclo(D-leucyl-L-valyl-L-leucyl-D-phenylalanyl-L-prolyl-L-phenylalanyl)	-	CHEMSPIDER	9040729	C40H56N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WPYOCTODIOSRQG-WOXDTIJASA-N
29916	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9875	Phepropeptin C	Cyclo(L-alloisoleucyl-L-leucyl-D-phenylalanyl-D-prolyl-L-leucyl-D-leucyl)	-	CHEMSPIDER	78437893	C38H60N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AKQUYKYHJPCGHJ-OMPYVEQSSA-N
29917	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9915	Phepropeptin D	Cyclo(L-alloisoleucyl-L-leucyl-D-phenylalanyl-D-prolyl-L-phenylalanyl-D-leucyl)	-	CHEMSPIDER	78438532	C41H58N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RDFYNJULNCUNKD-SJZSTPBESA-N
29918	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Hubbell GE (2020)	33791679	228659	9852	Scytonemide A	3-[(2R,5S,8S,11S,14S,15Z,17S)-5-[(2S)-2-Butanyl]-17-(4-hydroxybenzyl)-8-(hydroxymethyl)-14-isobutyl-11-isopropyl-3,6,9,12,18,21-hexaoxo-1,4,7,10,13,16,19-heptaazacyclohenicos-15-en-2-yl]propanamide|Scytonemide A	-	CHEMSPIDER	35518448	C36H56N8O9	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HJKXQQVDTIEFDD-FAVUQDIBSA-N
29919	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	inhibitor	target	Ward GA (2018)	29695633	228671	9891	ASTX660	1-[6-(4-Fluorobenzyl)-5-(hydroxymethyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-{[(3R)-3-methyl-4-morpholinyl]methyl}-1-piperazinyl]ethanone|Ethanone, 1-[6-[(4-fluorophenyl)methyl]-2,3-dihydro-5-(hydroxymethyl)-3,3-dimethyl-1H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-[[(3R)-3-methyl-4-morpholinyl]methyl]-1-piperazinyl]-	-	CHEMSPIDER	71061559	C30H42FN5O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YCXOHEXZVKOGEV-DNRQZRRGSA-N
29920	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Ward GA (2018)	29695633	228671	9891	ASTX660	1-[6-(4-Fluorobenzyl)-5-(hydroxymethyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-{[(3R)-3-methyl-4-morpholinyl]methyl}-1-piperazinyl]ethanone|Ethanone, 1-[6-[(4-fluorophenyl)methyl]-2,3-dihydro-5-(hydroxymethyl)-3,3-dimethyl-1H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-[[(3R)-3-methyl-4-morpholinyl]methyl]-1-piperazinyl]-	-	CHEMSPIDER	71061559	C30H42FN5O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YCXOHEXZVKOGEV-DNRQZRRGSA-N
29921	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Hennessy EJ (2013)	24320998	228672	9883	AZD5582	AZD5582|AZD 5582|2-Pyrrolidinecarboxamide, N,N'-[2,4-hexadiyne-1,6-diylbis[oxy[(1S,2R)-2,3-dihydro-1H-indene-2,1-diyl]]]bis[1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)-1-oxopropyl]amino]acetyl]-, (2S,2'S)-	-	CHEMSPIDER	31133160	C58H78N8O8	small molecule	-	1258392-53-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WLMCRYCCYXHPQF-ZVMUOSSASA-N
29922	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	inhibitor	target	Hennessy EJ (2013)	24320998	228672	9883	AZD5582	AZD5582|AZD 5582|2-Pyrrolidinecarboxamide, N,N'-[2,4-hexadiyne-1,6-diylbis[oxy[(1S,2R)-2,3-dihydro-1H-indene-2,1-diyl]]]bis[1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)-1-oxopropyl]amino]acetyl]-, (2S,2'S)-	-	CHEMSPIDER	31133160	C58H78N8O8	small molecule	-	1258392-53-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WLMCRYCCYXHPQF-ZVMUOSSASA-N
29923	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	inhibitor	target	Hennessy EJ (2013)	24320998	228672	9883	AZD5582	AZD5582|AZD 5582|2-Pyrrolidinecarboxamide, N,N'-[2,4-hexadiyne-1,6-diylbis[oxy[(1S,2R)-2,3-dihydro-1H-indene-2,1-diyl]]]bis[1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)-1-oxopropyl]amino]acetyl]-, (2S,2'S)-	-	CHEMSPIDER	31133160	C58H78N8O8	small molecule	-	1258392-53-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WLMCRYCCYXHPQF-ZVMUOSSASA-N
29924	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Sun H (2007)	17999504	228673	9923	SM-164	SM-164	-	CHEMSPIDER	26335076	C62H84N14O6	small molecule	-	957135-43-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LGYDZXNSSLRFJS-IOQQVAQYSA-N
29925	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Nikolovska-Coleska Z (2004)	15115387	212873	9930	Embelin	Embelin|2,5-Dihydroxy-3-undecyl-2,5-cyclohexadiene-1,4-dione|2,5-Cyclohexadiene-1,4-dione, 2,5-dihydroxy-3-undecyl-|2,5-Dihydroxy-3-undecyl-1,4-benzoquinone|Embelic acid|Emberine|MFCD00016369	-	CHEMSPIDER	3105	C17H26O4	small molecule	-	550-24-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IRSFLDGTOHBADP-UHFFFAOYSA-N
29926	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	inhibitor	target	Kester RF (2013)	24093940	165954	9862	LCL-161	N-[(1S)-1-Cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]-1-pyrrolidinyl}-2-oxoethyl]-N~2~-methylalaninamide|Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-|LCL-161|6TNS415Y3P	-	CHEMSPIDER	30687709	C26H33FN4O3S	small molecule	-	1005342-46-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UFPFGVNKHCLJJO-SSKFGXFMSA-N
29927	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Kester RF (2013)	24093940	165954	9862	LCL-161	N-[(1S)-1-Cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]-1-pyrrolidinyl}-2-oxoethyl]-N~2~-methylalaninamide|Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-|LCL-161|6TNS415Y3P	-	CHEMSPIDER	30687709	C26H33FN4O3S	small molecule	-	1005342-46-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	UFPFGVNKHCLJJO-SSKFGXFMSA-N
29928	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Yang H (2009)	19165859	138350	9866	Shikonin	Shikonin|1,4-Naphthalenedione, 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-pentenyl]-|1,4-Naphthalenedione, 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-penten-1-yl]-|5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-en-1-yl]-1,4-naphthoquinone|5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-penten-1-yl]-1,4-naphthoquinone|3IK6592UBW|(+)-Alkannin	-	CHEMSPIDER	420739	C16H16O5	small molecule	-	517-89-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NEZONWMXZKDMKF-SNVBAGLBSA-N
29929	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kazi A (2014)	24570003	220336	9914	PI-1840	N-Isopropyl-2-(4-propylphenoxy)-N-{[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl}acetamide|Acetamide, N-(1-methylethyl)-2-(4-propylphenoxy)-N-[[3-(3-pyridinyl)-1,2,4-oxadiazol-5-yl]methyl]-	-	CHEMSPIDER	29403217	C22H26N4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZVVXAODXPVWGMF-UHFFFAOYSA-N
29930	115863	10617	-	STAMBP	AMSH|MICCAP	9606	Homo sapiens	inhibitor	target	Bednash JS (2017)	28492230	211768	9876	BC-1471	N-(2-Furylmethyl)-2-{[6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-3,4-dihydro-2-quinazolinyl]sulfanyl}acetamide|Acetamide, 2-[[3,4-dihydro-6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-2-quinazolinyl]thio]-N-(2-furanylmethyl)-	-	CHEMSPIDER	2541949	C27H28N4O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HBAWGWWMULJGHR-UHFFFAOYSA-N
29931	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Ndubaku C (2015)	25364867	228674	9922	2-phenylbenzo[f][1,3]benzoxazole-4,9-dione	-	-	CHEMSPIDER	444479	C17H9NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CMYQQADDUUDCCA-UHFFFAOYSA-N
29932	116077	10868	-	USP20	LSFR3A|VDU2|hVDU2	9606	Homo sapiens	inhibitor	target	Harrigan JA (2018)	28959952	228675	9864	2-Amino-6-[(E)-2-(3-fluorophenyl)vinyl]-1H-indole-3-carbonitrile	1H-Indole-3-carbonitrile, 2-amino-6-[(E)-2-(3-fluorophenyl)ethenyl]-|2-Amino-6-[(E)-2-(3-fluorophenyl)vinyl]-1H-indole-3-carbonitrile	-	CHEMSPIDER	71117287	C17H12FN3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CGXBPMZRTMXEIA-SNAWJCMRSA-N
29933	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Potu H (2014)	24980819	228676	9910	(2E)-2-Cyano-3-(3,6-dichloro-2-pyridinyl)-N-(1-{4-[2-(4-morpholinyl)ethoxy]phenyl}butyl)acrylamide	(2E)-2-Cyano-3-(3,6-dichloro-2-pyridinyl)-N-(1-{4-[2-(4-morpholinyl)ethoxy]phenyl}butyl)acrylamide|2-Propenamide, 2-cyano-3-(3,6-dichloro-2-pyridinyl)-N-[1-[4-[2-(4-morpholinyl)ethoxy]phenyl]butyl]-, (2E)-	-	CHEMSPIDER	86595640	C25H28Cl2N4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IIKVQQNZHGBYGQ-KNTRCKAVSA-N
29934	113867	8239	RP5-1172N10.4	USP9X	DFFRX|FAF|FAM|MRX99	9606	Homo sapiens	inhibitor	target	Potu H (2014)	24980819	228676	9910	(2E)-2-Cyano-3-(3,6-dichloro-2-pyridinyl)-N-(1-{4-[2-(4-morpholinyl)ethoxy]phenyl}butyl)acrylamide	(2E)-2-Cyano-3-(3,6-dichloro-2-pyridinyl)-N-(1-{4-[2-(4-morpholinyl)ethoxy]phenyl}butyl)acrylamide|2-Propenamide, 2-cyano-3-(3,6-dichloro-2-pyridinyl)-N-[1-[4-[2-(4-morpholinyl)ethoxy]phenyl]butyl]-, (2E)-	-	CHEMSPIDER	86595640	C25H28Cl2N4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IIKVQQNZHGBYGQ-KNTRCKAVSA-N
29935	116939	23358	hCG_33036	USP24	-	9606	Homo sapiens	inhibitor	target	Peterson LF (2015)	25814533	228677	9910	(2E)-2-Cyano-3-(3,6-dichloro-2-pyridinyl)-N-(1-{4-[2-(4-morpholinyl)ethoxy]phenyl}butyl)acrylamide	(2E)-2-Cyano-3-(3,6-dichloro-2-pyridinyl)-N-(1-{4-[2-(4-morpholinyl)ethoxy]phenyl}butyl)acrylamide|2-Propenamide, 2-cyano-3-(3,6-dichloro-2-pyridinyl)-N-[1-[4-[2-(4-morpholinyl)ethoxy]phenyl]butyl]-, (2E)-	-	CHEMSPIDER	86595640	C25H28Cl2N4O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IIKVQQNZHGBYGQ-KNTRCKAVSA-N
29936	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Vu B (2013)	24900694	228678	8379	RG7112	RO-5045337|Q8MI0X869M|{(4S,5R)-4,5-Bis(4-chlorophenyl)-2-[2-ethoxy-4-(2-methyl-2-propanyl)phenyl]-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl}{4-[3-(methylsulfonyl)propyl]-1-piperazinyl}methanone|Methanone, [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]-	-	CHEMSPIDER	28189760	C38H48Cl2N4O4S	small molecule	-	939981-39-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QBGKPEROWUKSBK-QPPIDDCLSA-N
29937	113041	7189	-	TRAF6	MGC:3310|RNF85	9606	Homo sapiens	inhibitor	target	Brenke JK (2018)	29950522	216477	9880	C25-140	1-Propanone, 3-[3,5-dimethyl-1-(3-methyl-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-1H-pyrazol-4-yl]-1-[4-(phenylmethyl)-1-piperidinyl]-|1-(4-Benzyl-1-piperidinyl)-3-[3,5-dimethyl-1-(3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-1H-pyrazol-4-yl]-1-propanone	-	CHEMSPIDER	29053655	C26H31N7O	small molecule	-	1358099-18-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	HFKVRXVHZGBRKF-UHFFFAOYSA-N
29938	118893	29128	-	UHRF1	ICBP90|Np95|RNF106|hNP95|hUHRF1|huNp95	9606	Homo sapiens	inhibitor	target	Myrianthopoulos V (2016)	27049577	195311	9904	NSC232003	(5Z)-5-[1-(Hydroxyamino)ethylidene]-2,4(3H,5H)-pyrimidinedione|2,4(3H,5H)-Pyrimidinedione, 5-[1-(hydroxyamino)ethylidene]-, (5Z)-	-	CHEMSPIDER	4513358	C6H7N3O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IXSSYZRLNVZFMP-ARJAWSKDSA-N
29939	124085	84447	-	SYVN1	DER3|HRD1	9606	Homo sapiens	inhibitor	target	Fujita H (2018)	30365055	218199	9844	LS-102	1,3,5-Triazine-2,4,6-triamine, N~4~-6-benzoxazolyl-N~6~-[(1S)-1-cyclohexylethyl]-N~2~-ethyl-N~2~-[2-(ethylamino)ethyl]-|N~4~-(1,3-Benzoxazol-6-yl)-N~6~-[(1S)-1-cyclohexylethyl]-N~2~-ethyl-N~2~-[2-(ethylamino)ethyl]-1,3,5-triazine-2,4,6-triamine	-	CHEMSPIDER	92169543	C24H36N8O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DEDHMXBDEJSZFE-KRWDZBQOSA-N
29940	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	inhibitor	target	Reed D (2010)	20080970	228679	9926	SJ 172550	SJ 172550|MFCD03142926|SJ-172550|2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]-acetic acid methyl ester|Methyl {2-chloro-6-ethoxy-4-[(Z)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-4H-pyrazol-4-ylidene)methyl]phenoxy}acetate|Acetic acid, 2-[2-chloro-4-[(Z)-(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]-, methyl ester	-	CHEMSPIDER	1104430	C22H21ClN2O5	small molecule	-	431979-47-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RKKFQJXGAQWHBZ-YVLHZVERSA-N
29941	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Gu L (2016)	27666947	228680	9898	MX69	Benzoic acid, 4-[8-[[(3,4-dimethylphenyl)amino]sulfonyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]-|4-{8-[(3,4-Dimethylphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl}benzoic acid	-	CHEMSPIDER	3290554	C27H26N2O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	XCBONKHCCRJMNW-UHFFFAOYSA-N
29942	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	inhibitor	target	Gu L (2016)	27666947	228680	9898	MX69	Benzoic acid, 4-[8-[[(3,4-dimethylphenyl)amino]sulfonyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl]-|4-{8-[(3,4-Dimethylphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl}benzoic acid	-	CHEMSPIDER	3290554	C27H26N2O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	XCBONKHCCRJMNW-UHFFFAOYSA-N
29943	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Wang S (2019)	30803229	219782	9901	WS-383	1H-Tetrazole-1-ethanamine, 5-[[2-[[(4-chlorophenyl)methyl]thio]-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]thio]-N,N-dimethyl-, hydrochloride (1:1)|2-[5-({2-[(4-Chlorobenzyl)sulfanyl]-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)-1H-tetrazol-1-yl]-N,N-dimethylethanamine hydrochloride (1:1)	-	CHEMSPIDER	72380023	C18H21Cl2N9S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LJZUAAKUJAXXHQ-UHFFFAOYSA-N
29944	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Zhang Z (2014)	24997575	228681	9839	RO8994	RO8994|Spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, N-[4-(aminocarbonyl)-2-methoxyphenyl]-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-2-oxo-, (2'S,3R,4'S,5'R)-|(2'S,3R,4'S,5'R)-N-(4-Carbamoyl-2-methoxyphenyl)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide	-	CHEMSPIDER	31135025	C31H31Cl2FN4O4	small molecule	-	1309684-94-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MURAVORBGFDSMA-ISKXDESKSA-N
29945	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	inhibitor	target	Karan G (2016)	26883273	228682	9865	Ctx1	9-Acridinecarbonitrile, 3,6-diamino-|3,6-Diamino-9-acridinecarbonitrile	-	CHEMSPIDER	384728	C14H10N4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PUMGFEMNXBLDKD-UHFFFAOYSA-N
29946	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Huang Y (2014)	24405416	228683	9841	YH239-EE	1H-Indole-2-carboxylic acid, 6-chloro-3-[1-[[(4-chlorophenyl)methyl]formylamino]-2-[(1,1-dimethylethyl)amino]-2-oxoethyl]-, ethyl ester|Ethyl 6-chloro-3-{1-[(4-chlorobenzyl)(formyl)amino]-2-[(2-methyl-2-propanyl)amino]-2-oxoethyl}-1H-indole-2-carboxylate|YH239-EE|YH 239-EE	-	CHEMSPIDER	31042602	C25H27Cl2N3O4	small molecule	-	1364488-67-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OTUBDDRFPQLPKD-UHFFFAOYSA-N
29947	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Porter JR (2010)	20856941	228684	9838	BH3I-1	BH3I-1|MFCD03453544|5-(p-Bromobenzylidine)-alpha-isopropyl-4-oxo-2-thioxo-3-thiozolidineacetic acid|3-Thiazolidineacetic acid, 5-[(4-bromophenyl)methylene]-alpha-(1-methylethyl)-4-oxo-2-thioxo-, (5E)-|2-[(5E)-5-(4-Bromobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-3-methylbutanoic acid	-	CHEMSPIDER	23291035	C15H14BrNO3S2	small molecule	-	300817-68-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	COHIEJLWRGREHV-YRNVUSSQSA-N
29948	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Chen R (2017)	28581721	228685	9751	Bivalent ligand 197	CG428|Bivalent_ligand_197	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	-	-	-	-	-	-	-	-	-	-
29949	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Gollner A (2016)	27775892	228686	9872	BI-0252	Benzoic acid, 4-[(3S,3'S,3a'S,5'R,6a'S)-6-chloro-3'-(3-chloro-2-fluorophenyl)-1'-(cyclopropylmethyl)-1,2,3',3'a,4',5',6',6'a-octahydro-2-oxospiro[3H-indole-3,2'(1'H)-pyrrolo[3,2-b]pyrrol]-5'-yl]-|4-[(3S,3'S,3a'S,5'R,6a'S)-6-Chloro-3'-(3-chloro-2-fluorophenyl)-1'-(cyclopropylmethyl)-2-oxo-1,2,3',3a',4',5',6',6a'-octahydro-1'H-spiro[indole-3,2'-pyrrolo[3,2-b]pyrrol]-5'-yl]benzoic acid	-	CHEMSPIDER	59053072	C30H26Cl2FN3O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CCPUFNJKOGKOOG-AFKAWQRRSA-N
29950	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Wang S (2019)	30803229	219782	9869	2-[5-({2-[(4-Chlorobenzyl)sulfanyl]-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)-1H-tetrazol-1-yl]-N,N-dimethylethanamine	2-[5-({2-[(4-Chlorobenzyl)sulfanyl]-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)-1H-tetrazol-1-yl]-N,N-dimethylethanamine|1H-Tetrazole-1-ethanamine, 5-[[2-[[(4-chlorophenyl)methyl]thio]-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]thio]-N,N-dimethyl-	-	CHEMSPIDER	84398507	C18H20ClN9S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MGESDQAAIJOGJA-UHFFFAOYSA-N
29951	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Zhou H (2017)	29074978	206893	9870	DI-591	N-[(1S)-1-Cyclohexyl-2-{[3-(4-morpholinyl)propanoyl]amino}ethyl]-3-(6-isopropyl-1,3-benzothiazol-2-yl)-N~2~-propionyl-L-alaninamide|2-Benzothiazolepropanamide, N-[(1S)-1-cyclohexyl-2-[[3-(4-morpholinyl)-1-oxopropyl]amino]ethyl]-6-(1-methylethyl)-alpha-[(1-oxopropyl)amino]-, (alphaS)-	-	CHEMSPIDER	88297468	C31H47N5O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CNJKDQGPBAWNRY-IZZNHLLZSA-N
29952	120504	55208	RP11-102K13.4	DCUN1D2	C13orf17	9606	Homo sapiens	inhibitor	target	Zhou H (2017)	29074978	206893	9870	DI-591	N-[(1S)-1-Cyclohexyl-2-{[3-(4-morpholinyl)propanoyl]amino}ethyl]-3-(6-isopropyl-1,3-benzothiazol-2-yl)-N~2~-propionyl-L-alaninamide|2-Benzothiazolepropanamide, N-[(1S)-1-cyclohexyl-2-[[3-(4-morpholinyl)-1-oxopropyl]amino]ethyl]-6-(1-methylethyl)-alpha-[(1-oxopropyl)amino]-, (alphaS)-	-	CHEMSPIDER	88297468	C31H47N5O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CNJKDQGPBAWNRY-IZZNHLLZSA-N
29953	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Wang W (2018)	30217928	228687	9860	MA242	Acetic acid, 2,2,2-trifluoro-, compd. with 7-[[(4-chlorophenyl)methyl]amino]-3,4-dihydro-1-[(4-methylphenyl)sulfonyl]pyrrolo[4,3,2-de]quinolin-8(1H)-one (1:1)|7-[(4-Chlorobenzyl)amino]-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrrolo[4,3,2-de]quinolin-8(1H)-one trifluoroacetate (1:1)	-	CHEMSPIDER	75533946	C26H21ClF3N3O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YTSFRIUMZUCDMV-UHFFFAOYSA-N
29954	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Graves B (2012)	22745160	216713	9905	RO-5963	2-{(4E)-4-[(6-Chloro-7-methyl-1H-indol-3-yl)methylene]-2,5-dioxo-1-imidazolidinyl}-2-(3,4-difluorophenyl)-N-(1,3-dihydroxy-2-propanyl)acetamide|1-Imidazolidineacetamide, 4-[(6-chloro-7-methyl-1H-indol-3-yl)methylene]-alpha-(3,4-difluorophenyl)-N-[2-hydroxy-1-(hydroxymethyl)ethyl]-2,5-dioxo-, (4E)-	-	CHEMSPIDER	75533987	C24H21ClF2N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZFYQBPVMECJUBO-FBCYGCLPSA-N
29955	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	inhibitor	target	Graves B (2012)	22745160	216713	9905	RO-5963	2-{(4E)-4-[(6-Chloro-7-methyl-1H-indol-3-yl)methylene]-2,5-dioxo-1-imidazolidinyl}-2-(3,4-difluorophenyl)-N-(1,3-dihydroxy-2-propanyl)acetamide|1-Imidazolidineacetamide, 4-[(6-chloro-7-methyl-1H-indol-3-yl)methylene]-alpha-(3,4-difluorophenyl)-N-[2-hydroxy-1-(hydroxymethyl)ethyl]-2,5-dioxo-, (4E)-	-	CHEMSPIDER	75533987	C24H21ClF2N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZFYQBPVMECJUBO-FBCYGCLPSA-N
29956	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Chen R (2017)	28581721	228685	9921	2-[4-({(4S,5R)-4,5-Bis(4-chlorophenyl)-2-[2-ethoxy-4-(2-methyl-2-propanyl)phenyl]-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl}carbonyl)-1-piperazinyl]-1-(4-morpholinyl)ethanone dihydrochloride	2-[4-({(4S,5R)-4,5-Bis(4-chlorophenyl)-2-[2-ethoxy-4-(2-methyl-2-propanyl)phenyl]-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl}carbonyl)-1-piperazinyl]-1-(4-morpholinyl)ethanone dihydrochloride|Ethanone, 2-[4-[[(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl]carbonyl]-1-piperazinyl]-1-(4-morpholinyl)-, hydrochloride (1:2)	-	CHEMSPIDER	35308372	C40H51Cl4N5O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LSDSITOZGWIHGA-IBBBAUQKSA-N
29957	113165	7317	CTD-2522E6.1	UBA1	A1S9|A1S9T|A1ST|AMCX1|CFAP124|GXP1|POC20|SMAX2|UBA1A|UBE1|UBE1X	9606	Homo sapiens	inhibitor	target	Ungermannova D (2012)	22274912	228688	9920	NSC 624206	N-(2-((p-Chlorobenzyl)dithio)ethyl)decylamine hydrochloride|Decylamine, N-(2-((p-chlorobenzyl)dithio)ethyl)-, hydrochloride|N-{2-[(4-Chlorobenzyl)disulfanyl]ethyl}-1-decanamine hydrochloride (1:1)|NSC 624206|1-Decanamine, N-[2-[[(4-chlorophenyl)methyl]dithio]ethyl]-, hydrochloride (1:1)|N-(2-((4-Chlorobenzyl)dithio)ethyl)-1-decanamine hydrochloride	-	CHEMSPIDER	320695	C19H33Cl2NS2	small molecule	-	13116-77-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JQHUAYXPNPTQRO-UHFFFAOYSA-N
29958	111666	5693	-	PSMB5	LMPX|MB1|X	9606	Homo sapiens	inhibitor	target	Kazi A (2009)	19471122	228689	9918	PI-083	Benzenesulfonamide, 4-[(3-chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)amino]-N-2-pyridinyl-|4-[(3-Chloro-1,4-dioxo-1,4-dihydro-2-naphthalenyl)amino]-N-(2-pyridinyl)benzenesulfonamide	-	CHEMSPIDER	209482	C21H14ClN3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QRPKNPKHGNUFGK-UHFFFAOYSA-N
29959	111669	5696	DAAP-57C1.3	PSMB8	ALDD|D6S216|D6S216E|JMP|LMP7|NKJO|PSMB5i|RING10	9606	Homo sapiens	inhibitor	target	Ho YK (2007)	17462577	228690	9919	MFCD17215971	DIHYDROEPONEMYCIN|MFCD17215971|N-[(2S)-3-Hydroxy-1-({(2S)-1-[(2R)-2-(hydroxymethyl)-2-oxiranyl]-4-methyl-1-oxo-2-pentanyl}amino)-1-oxo-2-propanyl]-6-methylheptanamide|Heptanamide, N-[(1S)-1-(hydroxymethyl)-2-[[(1S)-1-[[(2R)-2-(hydroxymethyl)oxiranyl]carbonyl]-3-methylbutyl]amino]-2-oxoethyl]-6-methyl-	-	CHEMSPIDER	8267936	C20H36N2O6	small molecule	-	126463-64-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IUDBVFIQSSOIDB-TWOQFEAHSA-N
29960	111671	5698	DADB-223G19.3	PSMB9	LMP2|PSMB6i|RING12|beta1i	9606	Homo sapiens	inhibitor	target	Ho YK (2007)	17462577	228690	9919	MFCD17215971	DIHYDROEPONEMYCIN|MFCD17215971|N-[(2S)-3-Hydroxy-1-({(2S)-1-[(2R)-2-(hydroxymethyl)-2-oxiranyl]-4-methyl-1-oxo-2-pentanyl}amino)-1-oxo-2-propanyl]-6-methylheptanamide|Heptanamide, N-[(1S)-1-(hydroxymethyl)-2-[[(1S)-1-[[(2R)-2-(hydroxymethyl)oxiranyl]carbonyl]-3-methylbutyl]amino]-2-oxoethyl]-6-methyl-	-	CHEMSPIDER	8267936	C20H36N2O6	small molecule	-	126463-64-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	IUDBVFIQSSOIDB-TWOQFEAHSA-N
29961	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Huryn DM (2020)	31550150	228641	9895	ML240	2-(2-Amino-1H-benzimidazol-1-yl)-N-benzyl-8-methoxy-4-quinazolinamine|ML240|CID-49830258|MFCD28137687|ML-240|2-(2-amino-1H-benzimidazol-1-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine|4-Quinazolinamine, 2-(2-amino-1H-benzimidazol-1-yl)-8-methoxy-N-(phenylmethyl)-	-	CHEMSPIDER	34500429	C23H20N6O	small molecule	-	1346527-98-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NHAMBLRUUJAFOY-UHFFFAOYSA-N
29962	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Huryn DM (2020)	31550150	228641	9887	LC-1028	N-{1-[(4Z)-4-(Benzylimino)-3,4,5,6,7,8-hexahydro-2-quinazolinyl]-2-methyl-1H-indol-4-yl}-2-butynamide|2-Butynamide, N-[1-[(4Z)-3,4,5,6,7,8-hexahydro-4-[(phenylmethyl)imino]-2-quinazolinyl]-2-methyl-1H-indol-4-yl]-	-	CHEMSPIDER	88296358	C28H27N5O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YOUVOKAIDVNCJA-UHFFFAOYSA-N
29963	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Huryn DM (2020)	31550150	228641	9854	UPCDC30245	1-[3-(5-Fluoro-1H-indol-2-yl)phenyl]-N-[2-(4-isopropyl-1-piperazinyl)ethyl]-4-piperidinamine|1-Piperazineethanamine, N-[1-[3-(5-fluoro-1H-indol-2-yl)phenyl]-4-piperidinyl]-4-(1-methylethyl)-|1-(3-(5-Fluoro-1h-Indol-2-Yl)phenyl)piperidin-4-Yl)(2-(4-Isopropyl-Piperazin1-Yl)ethyl)-Carbamate|1-(3-(5-Fluoro-1H-indol-2-yl)phenyl)-N-(2-(4-isopropylpiperazin-1-yl)ethyl)piperidin-4-amine|UPCDC30245	-	CHEMSPIDER	58825106	C28H38FN5	small molecule	-	1883351-01-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LZHXZCVDLATFAR-UHFFFAOYSA-N
29964	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Alverez C (2016)	26985295	195724	9879	SMDC818909	3-Amino-N-(2-methyl-1H-indol-5-yl)-2-pyrazinecarboxamide|2-Pyrazinecarboxamide, 3-amino-N-(2-methyl-1H-indol-5-yl)-	-	CHEMSPIDER	30141951	C14H13N5O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PJTNJJWGQNSQDQ-UHFFFAOYSA-N
29965	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Alverez C (2016)	26985295	195724	9849	2-Amino-N-(2-methyl-1H-indol-5-yl)nicotinamide	3-Pyridinecarboxamide, 2-amino-N-(2-methyl-1H-indol-5-yl)-|2-Amino-N-(2-methyl-1H-indol-5-yl)nicotinamide	-	CHEMSPIDER	75831997	C15H14N4O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GWHPATATCVJNBI-UHFFFAOYSA-N
29966	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Huryn DM (2020)	31550150	228641	9932	Eeyarestatin 1	Eeyarestatin I|3-(4-Chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-1-(2-{(2E)-2-[(2E)-3-(5-nitro-2-furyl)prop-2-en-1-ylidene]hydrazino}-2-oxoethyl)-2-oxoimidazolidin-4-yl]-1-hydroxyurea|1-Imidazolidineacetic acid, 3-(4-chlorophenyl)-4-[[[(4-chlorophenyl)amino]carbonyl]hydroxyamino]-5,5-dimethyl-2-oxo-, 2-[(1E,2E)-3-(5-nitro-2-furanyl)-2-propen-1-ylidene]hydrazide|3-(4-Chlorophenyl)-1-[3-(4-chlorophenyl)-5,5-dimethyl-1-(2-{(2E)-2-[(2E)-3-(5-nitro-2-furyl)-2-propen-1-ylidene]hydrazino}-2-oxoethyl)-2-oxo-4-imidazolidinyl]-1-hydroxyurea|Eeyarestatin 1	-	CHEMSPIDER	24606066	C27H25Cl2N7O7	small molecule	-	412960-54-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	JTUXTPWYZXWOIB-LWWHHIEBSA-N
29967	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Segura-Cabrera A (2017)	28322292	228692	250	Clotrimazole	Mycelex (tn)|1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole|1-(o-Chlorotrityl)imidazole|Lotrimin (tn)|1-(-(2-Chlorophenyl)benzhydryl)imidazole|1-(o-Chloro-,-diphenylbenzyl)imidazole|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole	myclo solution|clotrimazole ex	DRUGBANK	DB00257	C22H17ClN2	small molecule	A01AB18|G01AF02|D01AC01	23593-75-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VNFPBHJOKIVQEB-UHFFFAOYSA-N
29968	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Segura-Cabrera A (2017)	28322292	228692	627	Astemizole	Astemizolum|1-(P-Fluorobenzyl)-2-((1-(P-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|1-(P-Fluorobenzyl)-2-((1-(2-(P-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|Astemison|Astmizole|Astemizol	hismanal tab 10mg|hismanal sus	DRUGBANK	DB00637	C28H31FN4O	small molecule	R06AX11	68844-77-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GXDALQBWZGODGZ-UHFFFAOYSA-N
29969	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Segura-Cabrera A (2017)	28322292	228692	9907	Ebastine	Ebastine|1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone|4'-tert-Butyl-4-[4-(diphenylmethoxy)piperidino]butyrophenone|4-Diphenylmethoxy-1-[3-(4-tert-butylbenzoyl)propyl]piperidine|4-[4-(Diphenylmethoxy)-1-piperidinyl]-1-[4-(2-methyl-2-propanyl)phenyl]-1-butanone|1-Butanone, 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-|1-(4-tert-butylphenyl)-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one|Ebastin|MFCD00865661	-	CHEMSPIDER	3079	C32H39NO2	small molecule	-	90729-43-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MJJALKDDGIKVBE-UHFFFAOYSA-N
29970	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Wijeratne EM (2016)	26812276	228693	9897	Oxaspirol B	2-Oxaspiro[4.5]dec-7-ene-1,4-dione, 6-[(1E,3E)-1,3-heptadien-1-yl]-9,10-dihydroxy-3-methylene-, (6R,9R,10R)-|(6R,9R,10R)-6-[(1E,3E)-1,3-Heptadien-1-yl]-9,10-dihydroxy-3-methylene-2-oxaspiro[4.5]dec-7-ene-1,4-dione	-	CHEMSPIDER	58927941	C17H20O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GIXMLHVPEUCNBI-VRRHEOGASA-N
29971	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor	target	Suvarna K (2019)	30610116	228694	9856	NPD8733	N-[2-(4-Methoxybenzoyl)-1-benzofuran-3-yl]acetamide|Acetamide, N-[2-(4-methoxybenzoyl)-3-benzofuranyl]-	-	CHEMSPIDER	792712	C18H15NO4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	NQZBUYPGHZTWIR-UHFFFAOYSA-N
29972	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	inhibitor	target	Blees JS (2012)	23056346	146614	9874	Erioflorin	2-Propenoic acid, 2-methyl-, (1aR,3S,4E,5aR,8aR,9R,10aR)-1a,2,3,5a,7,8,8a,9,10,10a-decahydro-3-hydroxy-4,10a-dimethyl-8-methylene-7-oxooxireno[5,6]cyclodeca[1,2-b]furan-9-yl ester|(1aR,3S,4E,5aR,8aR,9R,10aR)-3-Hydroxy-4,10a-dimethyl-8-methylene-7-oxo-1a,2,3,5a,7,8,8a,9,10,10a-decahydrooxireno[5,6]cyclodeca[1,2-b]furan-9-yl methacrylate	-	CHEMSPIDER	4530237	C19H24O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	BUIOBTSUIYLOKG-VKGAXADOSA-N
29973	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Weinstock J (2012)	24900381	223670	8334	P5091	Ethanone, 1-[5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl]-|1-{5-[(2,3-Dichlorophenyl)sulfanyl]-4-nitro-2-thienyl}ethanone|1-{5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl}ethan-1-one	-	CHEMSPIDER	2098223	C12H7Cl2NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LKZLGMAAKNEGCH-UHFFFAOYSA-N
29974	120360	55031	-	USP47	TRFP	9606	Homo sapiens	inhibitor	target	Weinstock J (2012)	24900381	223670	8334	P5091	Ethanone, 1-[5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl]-|1-{5-[(2,3-Dichlorophenyl)sulfanyl]-4-nitro-2-thienyl}ethanone|1-{5-[(2,3-dichlorophenyl)thio]-4-nitro-2-thienyl}ethan-1-one	-	CHEMSPIDER	2098223	C12H7Cl2NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	LKZLGMAAKNEGCH-UHFFFAOYSA-N
29975	124238	84749	-	USP30	-	9606	Homo sapiens	inhibitor	target	Yue W (2014)	24513856	228695	9846	15-Oxospiramilactone	8a,11-Ethano-6,12b-propano-9H-naphth[1,2-d]oxocin-1,9(2H)-dione, decahydro-8-hydroxy-6-methyl-10-methylene-, (6S,6aR,8R,8aR,11S,12aS,12bS)-|15-oxospiramilactone|(1S,2S,4S,7R,8R,10R,11S)-8-Hydroxy-11-methyl-5-methylene-14-oxapentacyclo[9.5.3.2~4,7~.0~1,10~.0~2,7~]henicosane-6,16-dione	-	CHEMSPIDER	65321854	C22H30O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	RCPPZYXWUAJXMA-KGYWYPJXSA-N
29976	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
29977	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Chen J (2011)	22118673	211359	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
29978	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9850	C527	c527|2-(4-Fluorophenyl)naphtho[2,3-d][1,3]oxazole-4,9-dione|Naphth[2,3-d]oxazole-4,9-dione, 2-(4-fluorophenyl)-	-	CHEMSPIDER	1725101	C17H8FNO3	small molecule	-	192718-06-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ULJDFEYQOPCCPM-UHFFFAOYSA-N
29979	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9850	C527	c527|2-(4-Fluorophenyl)naphtho[2,3-d][1,3]oxazole-4,9-dione|Naphth[2,3-d]oxazole-4,9-dione, 2-(4-fluorophenyl)-	-	CHEMSPIDER	1725101	C17H8FNO3	small molecule	-	192718-06-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ULJDFEYQOPCCPM-UHFFFAOYSA-N
29980	113194	7347	RP11-173B14.3	UCHL3	UCH-L3	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9850	C527	c527|2-(4-Fluorophenyl)naphtho[2,3-d][1,3]oxazole-4,9-dione|Naphth[2,3-d]oxazole-4,9-dione, 2-(4-fluorophenyl)-	-	CHEMSPIDER	1725101	C17H8FNO3	small molecule	-	192718-06-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ULJDFEYQOPCCPM-UHFFFAOYSA-N
29981	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9850	C527	c527|2-(4-Fluorophenyl)naphtho[2,3-d][1,3]oxazole-4,9-dione|Naphth[2,3-d]oxazole-4,9-dione, 2-(4-fluorophenyl)-	-	CHEMSPIDER	1725101	C17H8FNO3	small molecule	-	192718-06-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ULJDFEYQOPCCPM-UHFFFAOYSA-N
29982	128522	219333	-	USP12	UBH1|USP12L1	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9850	C527	c527|2-(4-Fluorophenyl)naphtho[2,3-d][1,3]oxazole-4,9-dione|Naphth[2,3-d]oxazole-4,9-dione, 2-(4-fluorophenyl)-	-	CHEMSPIDER	1725101	C17H8FNO3	small molecule	-	192718-06-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ULJDFEYQOPCCPM-UHFFFAOYSA-N
29983	113241	7398	-	USP1	UBP	9606	Homo sapiens	inhibitor	target	Mistry H (2013)	24130053	161617	9916	SJB3-019A	Naphth[2,3-d]oxazole-4,9-dione, 2-(3-pyridinyl)-|2-(3-Pyridinyl)naphtho[2,3-d][1,3]oxazole-4,9-dione	-	CHEMSPIDER	44208868	C16H8N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	DOYPPVCQHGJUBC-UHFFFAOYSA-N
29984	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Magiera K (2017)	28343940	228696	9859	LCAHA	Cholan-24-amide, N,3-dihydroxy-, (3alpha)-|(3alpha)-N,3-Dihydroxycholan-24-amide	-	CHEMSPIDER	88297896	C24H41NO3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WZXAGWREMCSWMF-YPLGJCPNSA-N
29985	112373	6478	-	SIAH2	hSiah2	9606	Homo sapiens	inhibitor	target	Shah M (2009)	19712206	228697	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
29986	112372	6477	-	SIAH1	SIAH1A	9606	Homo sapiens	inhibitor	target	Zhang Q (2017)	27776223	199360	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
29987	112373	6478	-	SIAH2	hSiah2	9606	Homo sapiens	inhibitor	target	Zhang Q (2017)	27776223	199360	163	Menadione	Menadione|Vitamin K3|2-Methyl-1,4-naphthochinon|2-Methyl-1,4-Naphthalenedione|2-Methyl-1,4-naphthoquinone	-	DRUGBANK	DB00170	C11H8O2	small molecule	B02BA02	58-27-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MJVAVZPDRWSRRC-UHFFFAOYSA-N
29988	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Schauer NJ (2020)	31682427	228698	9906	NSC632839	4-Piperidinone, 3,5-bis[(4-methylphenyl)methylene]-, (3E)-, hydrochloride (1:1)|(3E)-3,5-Bis(4-methylbenzylidene)-4-piperidinone hydrochloride (1:1)	-	CHEMSPIDER	57427760	C21H22ClNO	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZOKZLTXPTLIWOJ-OJWWICQKSA-N
29989	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Schauer NJ (2020)	31682427	228698	9906	NSC632839	4-Piperidinone, 3,5-bis[(4-methylphenyl)methylene]-, (3E)-, hydrochloride (1:1)|(3E)-3,5-Bis(4-methylbenzylidene)-4-piperidinone hydrochloride (1:1)	-	CHEMSPIDER	57427760	C21H22ClNO	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ZOKZLTXPTLIWOJ-OJWWICQKSA-N
29990	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Schauer NJ (2020)	31682427	228698	9902	Spongiacidin A	Pyrrolo[2,3-c]azepin-8(1H)-one, 4-(2-amino-5-oxo-4-imidazolidinylidene)-2,3-dibromo-4,5,6,7-tetrahydro-, (4E)-|(4E)-4-(2-Amino-5-oxo-4-imidazolidinylidene)-2,3-dibromo-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8(1H)-one	-	CHEMSPIDER	24699820	C11H11Br2N5O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	CTHGIINQRBTFRV-ZZXKWVIFSA-N
29991	113867	8239	RP5-1172N10.4	USP9X	DFFRX|FAF|FAM|MRX99	9606	Homo sapiens	inhibitor	target	Peng Z (2014)	24457091	228699	9903	CP2005	2-Propenamide, N,N'-[1,3-phenylenebis(methylene)]bis[3-(6-bromo-2-pyridinyl)-2-cyano-, (2Z,2'Z)-|(2Z,2'Z)-N,N'-[1,3-Phenylenebis(methylene)]bis[3-(6-bromo-2-pyridinyl)-2-cyanoacrylamide]	-	CHEMSPIDER	31138442	C26H18Br2N6O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	OTSJSSHNIUCAGH-YZLQMOBTSA-N
29992	114977	9616	-	RNF7	CKBBP1|ROC2|SAG	9606	Homo sapiens	inhibitor	target	Yu Q (2020)	32145688	226735	9858	Gossypol	N,N,1,3-Tetramethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine|1H-Pyrazolo[3,4-d]pyrimidin-4-amine, N,N,1,3-tetramethyl-|Dipotassium Salt|Sodium Salt|BL193|ssypol|AT101|TASH1|POGOSIN	-	CHEMSPIDER	32145688	C30H30O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QBKSWRVVCFFDOT-UHFFFAOYSA-N
29993	115301	9978	RP11-554C12.1	RBX1	BA554C12.1|RNF75|ROC1	9606	Homo sapiens	inhibitor	target	Yu Q (2020)	32145688	226735	9858	Gossypol	N,N,1,3-Tetramethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine|1H-Pyrazolo[3,4-d]pyrimidin-4-amine, N,N,1,3-tetramethyl-|Dipotassium Salt|Sodium Salt|BL193|ssypol|AT101|TASH1|POGOSIN	-	CHEMSPIDER	32145688	C30H30O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	QBKSWRVVCFFDOT-UHFFFAOYSA-N
29994	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Scott DC (2017)	28581483	211304	9853	NAcM-HIT	Urea, N-[1-(phenylmethyl)-4-piperidinyl]-N'-[3-(trifluoromethyl)phenyl]-|1-(1-Benzyl-4-piperidinyl)-3-[3-(trifluoromethyl)phenyl]urea	-	CHEMSPIDER	3073302	C20H22F3N3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	MXZRHPHRSQJCML-UHFFFAOYSA-N
29995	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Scott DC (2017)	28581483	211304	9933	NAcM-OPT	Urea, N-(1-butyl-4-piperidinyl)-N'-(3,4-dichlorophenyl)-N-(phenylmethyl)-|1-Benzyl-1-(1-butyl-4-piperidinyl)-3-(3,4-dichlorophenyl)urea	-	CHEMSPIDER	59052433	C23H29Cl2N3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	VPHJABWIKCBGMC-UHFFFAOYSA-N
29996	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Kim HS (2019)	31465221	228079	9890	3-Methyl-N-[(4S,5R)-3-methyl-4-(4-methylphenyl)-6-oxo-1-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-b]pyridin-5-yl]benzamide	Benzamide, 3-methyl-N-[(4S,5R)-4,5,6,7-tetrahydro-3-methyl-4-(4-methylphenyl)-6-oxo-1-phenyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-|3-Methyl-N-[(4S,5R)-3-methyl-4-(4-methylphenyl)-6-oxo-1-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-b]pyridin-5-yl]benzamide	-	CHEMSPIDER	78310128	C28H26N4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	This small molecule corresponds to Compound 1 in this paper.	WMAFBTHYXHDENE-LOSJGSFVSA-N
29997	119920	54165	-	DCUN1D1	DCNL1|DCUN1L1|RP42|SCCRO|SCRO|Tes3	9606	Homo sapiens	inhibitor	target	Kim HS (2019)	31465221	228079	9935	N-[1-[4-(Aminomethyl)-3-methylsulfonylphenyl]but-3-en-2-yl]-5-[[(2S)-2-azido-3-phenylpropanoyl]amino]-2-(2-methylpropyl)-4-oxooctanamide	N-[1-[4-(Aminomethyl)-3-methylsulfonylphenyl]but-3-en-2-yl]-5-[[(2S)-2-azido-3-phenylpropanoyl]amino]-2-(2-methylpropyl)-4-oxooctanamide|N3Phe-Leu-Leu-Phe(4-CH2NH2)VS|azido-phenylalanyl-leucyl-leucyl-4-aminomethylphenylalanyl methyl vinyl sulfone|azido-Phe-Leu-Leu-4-aminomethyl-Phe-methyl vinyl sulfone|N-[(4S,5S)-1-[(1S)-Cyclohex-3-en-1-yl]-7-ethyl-4-(4-fluorophenyl)-3-methyl-6-oxo-4,5-dihydropyrazolo[3,4-b]pyridin-5-yl]-3-methylbenzamide	-	PUBCHEM	145946100	C29H31FN4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	This small molecule corresponds to Compound 27 in this paper.	DRGYLPYZJGVISN-AFESJLNVSA-N
30005	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Turnbull AP (2017)	29045389	220338	9882	FT827	Ethenesulfonamide, N-[4'-[[4-[(1,4-dihydro-1-methyl-4-oxo-5H-pyrazolo[3,4-d]pyrimidin-5-yl)methyl]-4-hydroxy-1-piperidinyl]carbonyl][1,1'-biphenyl]-2-yl]-|N-[4'-({4-Hydroxy-4-[(1-methyl-4-oxo-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)methyl]-1-piperidinyl}carbonyl)-2-biphenylyl]ethenesulfonamide	-	CHEMSPIDER	71117270	C27H28N6O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	GFNJQQBUZURQMA-UHFFFAOYSA-N
30006	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu M (2020)	33163345	228700	9771	Bivalent ligand 172	compound 2c|Bivalent_ligand_172	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109832	3620	-	IDO1	IDO|IDO-1|INDO	9606	Homo sapiens	target	Standardized BVL Name: compuound 2c (CRBN:lenalidomide --- IDO1:Epa)	-
30008	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Z (2020)	32779949	228701	9770	Bivalent ligand 173	compound 2|Bivalent_ligand_173	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: compound 2 (CRBN:lenalidomide --- PARP1: Olaparib)	-
30010	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu J (2020)	32128407	228702	9767	Bivalent ligand 174	opto-dBET1|Bivalent_ligand_174	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: opto-dBET1 (CRBN:opto-pomalidomide --- BRD2:JQ1)	-
30012	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu J (2020)	32128407	228702	9767	Bivalent ligand 174	opto-dBET1|Bivalent_ligand_174	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: opto-dBET1 (CRBN:opto-pomalidomide --- BRD3:JQ1)	-
30014	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu J (2020)	32128407	228702	9767	Bivalent ligand 174	opto-dBET1|Bivalent_ligand_174	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: opto-dBET1 (CRBN:opto-pomalidomide --- BRD4:JQ1)	-
30016	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu J (2020)	32128407	228702	9766	Bivalent ligand 175	opto-dALK|Bivalent_ligand_175	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: opto-dALK(CRBN:opto-pomalidomide --- ALK:ceritinib)	-
30018	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2020)	32128406	228703	9769	Bivalent ligand 176	PHOTAC-I-3|Bivalent_ligand_176	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-3 (CRBN:lenalidomide --- BRD2:JQ1)	-
30020	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2020)	32128406	228703	9769	Bivalent ligand 176	PHOTAC-I-3|Bivalent_ligand_176	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-3 (CRBN:lenalidomide --- BRD3:JQ1)	-
30022	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2020)	32128406	228703	9769	Bivalent ligand 176	PHOTAC-I-3|Bivalent_ligand_176	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-3 (CRBN:lenalidomide --- BRD4:JQ1)	-
30024	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2020)	32128406	228703	9768	Bivalent ligand 177	PHOTAC-II-6|Bivalent_ligand_177	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-II-6 (CRBN:thalidomide --- FKBP12:SLF)	-
30026	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Si J (2020)	32860752	228704	9777	Bivalent ligand 178	SS44|Bivalent_ligand_178	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: SS44 (CRBN:thalidomide --- MAPK41: ZYF0033)	-
30028	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang J (2020)	32888499	228705	9776	Bivalent ligand 179	Degrader-5|Bivalent_ligand_179	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: Degrader-5 (CRBN:thalidomide --- IRAK4: compound 1)	-
30030	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cao C (2020)	32924477	228706	9800	Bivalent ligand 180	SK-575|Bivalent_ligand_180	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: SK-575 (CRBN:thalidomide --- PARP1: Olaparib)	-
30032	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Takahashi D (2020)	31958028	228707	9801	Bivalent ligand 181	ARD-61|Bivalent_ligand_181	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARD-61 (VHL:HXD079 --- AR:ARi-16)	-
30034	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Takahashi D (2020)	31958028	228707	9801	Bivalent ligand 181	ARD-61|Bivalent_ligand_181	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111260	5241	-	PGR	NR3C3|PR	9606	Homo sapiens	target	Standardized BVL Name: ARD-61 (VHL:HXD079 --- PR:ARi-16)	-
30036	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Takwale AD (2020)	32961381	228708	9802	Bivalent ligand 182	TD-802|Bivalent_ligand_182	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: TD-802 (CRBN:TD-106 --- AR:compound 3)	-
30038	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smith BE (2019)	30631068	219514	9803	Bivalent ligand 183	SJFDelta|Bivalent_ligand_183	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111589	5603	RP1-179N16.4	MAPK13	MAPK 13|MAPK-13|PRKM13|SAPK4|p38delta	9606	Homo sapiens	target	Standardized BVL Name: SJF (VHL:ligand 7 ---MAPK13:Foretinib)	-
30040	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111589	5603	RP1-179N16.4	MAPK13	MAPK 13|MAPK-13|PRKM13|SAPK4|p38delta	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2 (CRBN:CRBN ligand --- MAPK13:foretinib)|Standardized BVL Name: PROTAC2 (CRBN:CRBN ligand --- MERTK:foretinib)	-
30042	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen H (2019)	30901674	215477	9796	Bivalent ligand 184	Compound 2|Bivalent_ligand_184	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: Compound 2 (CRBN:pomalidomide --- BRAF: rigosertib)	-
30044	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	An Z (2019)	30603959	228709	9798	Bivalent ligand 186	PROTAC NP8|Bivalent_ligand_186	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: PROTAC NP8 (CRBN:pomalidomide --- HDAC6:Nexturastat A (Nex A))	-
30046	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu H (2019)	31271281	228479	9797	Bivalent ligand 185	PROTAC 12d|Bivalent_ligand_185	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 12d (CRBN:pomalidomide --- HDAC6:Nexturastat A (Nex A))	-
30048	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu H (2019)	31271281	228479	9797	Bivalent ligand 185	PROTAC 12d|Bivalent_ligand_185	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 12d (CRBN:pomalidomide --- IKZF1:Nexturastat A (Nex A))	-
30050	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu H (2019)	31271281	228479	9797	Bivalent ligand 185	PROTAC 12d|Bivalent_ligand_185	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 12d (CRBN:pomalidomide --- IKZF3:Nexturastat A (Nex A))	-
30052	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	degradation	recruited e3 ligase	Du X (2019)	31693911	222755	9805	Bivalent ligand 188	Bivalent_ligand_188	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114952	9584	RP11-353C18.2	RBM39	CAPER|CAPERalpha|FSAP59|HCC1|RNPC2	9606	Homo sapiens	target	Standardized BVL Name: (DCAF15:E7820 ---RBM39:E7820)	-
30054	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	degradation	recruited e3 ligase	Han T (2017)	28302793	209322	9806	Bivalent ligand 189	Bivalent_ligand_189	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114952	9584	RP11-353C18.2	RBM39	CAPER|CAPERalpha|FSAP59|HCC1|RNPC2	9606	Homo sapiens	target	Standardized BVL Name: (DCAF15:indisulam ---RBM39:indisulam)	-
30056	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	degradation	recruited e3 ligase	Han T (2017)	28302793	209322	9758	Bivalent ligand 190	Bivalent_ligand_190	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114952	9584	RP11-353C18.2	RBM39	CAPER|CAPERalpha|FSAP59|HCC1|RNPC2	9606	Homo sapiens	target	Standardized BVL Name: (DCAF15:tasisulam ---RBM39:tasisulam)	-
30058	124705	90379	-	DCAF15	C19orf72	9606	Homo sapiens	degradation	recruited e3 ligase	Han T (2017)	28302793	209322	9757	Bivalent ligand 191	Bivalent_ligand_191	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114952	9584	RP11-353C18.2	RBM39	CAPER|CAPERalpha|FSAP59|HCC1|RNPC2	9606	Homo sapiens	target	Standardized BVL Name: (DCAF15:chloroquinoxaline sulfonamide ---RBM39:chloroquinoxaline sulfonamide)	-
30060	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bassi ZI (2018)	30200762	228710	9799	Bivalent ligand 187	GSK699|Bivalent_ligand_187	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108918	2648	-	KAT2A	GCN5|GCN5L2|PCAF-b|hGCN5	9606	Homo sapiens	target	Standardized BVL Name: GSK699 (CRBN:thalidomide --- KAT2A:GSK4027)	-
30062	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bassi ZI (2018)	30200762	228710	9799	Bivalent ligand 187	GSK699|Bivalent_ligand_187	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114375	8850	-	KAT2B	CAF|P/CAF|PCAF	9606	Homo sapiens	target	Standardized BVL Name: GSK699 (CRBN:thalidomide --- KAT2B:GSK4027)	-
30064	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- ALK:TAE684)	-
30066	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- AURKA:TAE684)	-
30068	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- RPS6KA1:TAE684)	-
30070	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- PTK2:TAE684)	-
30072	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9756	Bivalent ligand 192	compound 9|Bivalent_ligand_192	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- FER:TAE684)	-
30074	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- ALK:ceritinib)	-
30076	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- AURKA:ceritinib)	-
30078	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- RPS6KA1:ceritinib)	-
30080	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- PTK2:ceritinib)	-
30082	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2018)	29660984	228711	9755	Bivalent ligand 193	compound 11|Bivalent_ligand_193	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: compound 11 (CRBN:pomalidomide --- FER:ceritinib)	-
30084	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121316	57001	DC11	ACN9	SDHAF3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- SDHAF3:foretinib)	-
30086	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121596	57537	-	SORCS2	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- SORCS2:foretinib)	-
30088	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108474	2177	-	FANCD2	FA-D2|FA4|FACD|FAD|FAD2|FANCD	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- FANCD2:foretinib)	-
30090	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116553	22887	-	FOXJ3	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- FOXJ3:foretinib)	-
30092	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107851	1469	-	CST1	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2 (CRBN:CRBN ligand --- CST1:foretinib)	-
30094	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Girardini M (2019)	30826187	220662	9754	Bivalent ligand 194	PROTAC 14a|Bivalent_ligand_194	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 14a (VHL:VH032 ---CRBN:pomalidomide	-
30096	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Girardini M (2019)	30826187	220662	9753	Bivalent ligand 195	PROTAC 18b|Bivalent_ligand_195	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 18b (VHL:VH101 ---CRBN:pomalidomide)	-
30098	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen L (2020)	33058680	228712	9752	Bivalent ligand 196	CG416|Bivalent_ligand_196	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	target	Standardized BVL Name: CG416 (CRBN:pomalidomide --- NTRK1:GNF-8625)	-
30100	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen L (2020)	33058680	228712	9752	Bivalent ligand 196	CG416|Bivalent_ligand_196	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110970	4915	RP11-263K15.1	NTRK2	GP145-TrkB|TRKB|trk-B	9606	Homo sapiens	target	Standardized BVL Name: CG416 (CRBN:pomalidomide --- NTRK2:GNF-8625)	-
30102	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen L (2020)	33058680	228712	9752	Bivalent ligand 196	CG416|Bivalent_ligand_196	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110971	4916	-	NTRK3	TRKC|gp145(trkC)	9606	Homo sapiens	target	Standardized BVL Name: CG416 (CRBN:pomalidomide --- NTRK3:GNF-8625)	-
30104	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen L (2020)	33058680	228712	9751	Bivalent ligand 197	CG428|Bivalent_ligand_197	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110969	4914	-	NTRK1	MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA	9606	Homo sapiens	target	Standardized BVL Name: CG428 (CRBN:pomalidomide --- NTRK1:GNF-8625)	-
30106	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen L (2020)	33058680	228712	9751	Bivalent ligand 197	CG428|Bivalent_ligand_197	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110970	4915	RP11-263K15.1	NTRK2	GP145-TrkB|TRKB|trk-B	9606	Homo sapiens	target	Standardized BVL Name: CG428 (CRBN:pomalidomide --- NTRK2:GNF-8625)	-
30108	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen L (2020)	33058680	228712	9751	Bivalent ligand 197	CG428|Bivalent_ligand_197	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110971	4916	-	NTRK3	TRKC|gp145(trkC)	9606	Homo sapiens	target	Standardized BVL Name: CG428 (CRBN:pomalidomide --- NTRK3:GNF-8625)	-
30110	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2020)	32550983	228713	9762	Bivalent ligand 198	compound 1|Bivalent_ligand_198	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: compound 1 (VHL:VHL-1 --- SNCA:BTA-1)	-
30112	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2020)	32550983	228713	9761	Bivalent ligand 199	compound 4|Bivalent_ligand_199	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: compound 4 (VHL:VHL-1 --- SNCA:BTA-1)	-
30114	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2020)	32550983	228713	9787	Bivalent ligand 200	compound 5|Bivalent_ligand_200	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (VHL:VHL-1 --- SNCA:BTA-1)	-
30116	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2020)	32550983	228713	9786	Bivalent ligand 201	compound 7|Bivalent_ligand_201	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (VHL:VHL-1 --- SNCA:SNCA ligand)	-
30118	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2020)	32550983	228713	9785	Bivalent ligand 202	compound 34|Bivalent_ligand_202	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: compound 34 (VHL:VHL-1 --- SNCA:SNCA ligand)	-
30120	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2020)	32550983	228713	9784	Bivalent ligand 203	compound 30|Bivalent_ligand_203	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: compound 30 (CRBN:thalidomide --- SNCA:SNCA ligand)	-
30122	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou L (2020)	31945665	228714	9783	Bivalent ligand 204	6C|Bivalent_ligand_204	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107925	1545	-	CYP1B1	CP1B|CYPIB1|GLC3A|P4501B1	9606	Homo sapiens	target	Standardized BVL Name: 6C (CRBN:thalidomide --- CYP1B1:-naphthoflavone derivative 5)	-
30124	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9782	Bivalent ligand 205	JP1|Bivalent_ligand_205	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: JP1 (XIAP:Boc-IAP --- JAK1:pyrimidine)	-
30126	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9781	Bivalent ligand 206	JP2|Bivalent_ligand_206	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: JP2 (XIAP:Boc-IAP --- JAK1:pyrimidine)	-
30128	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9780	Bivalent ligand 207	JP3|Bivalent_ligand_207	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: JP3 (XIAP:Boc-IAP --- JAK1:pyrimidine)	-
30130	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9795	Bivalent ligand 208	JP4|Bivalent_ligand_208	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: JP4 (XIAP:Boc-IAP --- JAK1:pyrimidine)	-
30132	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9794	Bivalent ligand 209	JP5|Bivalent_ligand_209	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: JP5 (XIAP:Boc-IAP --- JAK1:quinoxaline)	-
30134	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9824	Bivalent ligand 210	JP6|Bivalent_ligand_210	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: JP6 (XIAP:Boc-IAP --- JAK1:quinoxaline)	-
30136	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9782	Bivalent ligand 205	JP1|Bivalent_ligand_205	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: JP1 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30138	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9781	Bivalent ligand 206	JP2|Bivalent_ligand_206	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: JP2 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30140	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9780	Bivalent ligand 207	JP3|Bivalent_ligand_207	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: JP3 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30142	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9795	Bivalent ligand 208	JP4|Bivalent_ligand_208	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: JP4 (XIAP:Boc-IAP --- JAK2:pyrimidine)	-
30144	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9794	Bivalent ligand 209	JP5|Bivalent_ligand_209	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: JP5 (XIAP:Boc-IAP --- JAK2:quinoxaline)	-
30146	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Shah RR (2020)	32001089	227145	9824	Bivalent ligand 210	JP6|Bivalent_ligand_210	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: JP6 (XIAP:Boc-IAP --- JAK2:quinoxaline)	-
30148	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hsu JH (2020)	31786184	226149	9825	Bivalent ligand 211	PROTAC 1|Bivalent_ligand_211	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 1 (VHL:VH032 --- EED: EED ligand)	-
30150	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hsu JH (2020)	31786184	226149	9826	Bivalent ligand 212	PROTAC 2|Bivalent_ligand_212	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 2 (VHL:VH032 --- EED: EED ligand)	-
30152	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hsu JH (2020)	31786184	226149	9825	Bivalent ligand 211	PROTAC 1|Bivalent_ligand_211	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 1 (VHL:VH032 --- EZH2: EED ligand)	-
30154	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hsu JH (2020)	31786184	226149	9826	Bivalent ligand 212	PROTAC 2|Bivalent_ligand_212	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 2 (VHL:VH032 --- EZH2: EED ligand)	-
30156	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hsu JH (2020)	31786184	226149	9825	Bivalent ligand 211	PROTAC 1|Bivalent_ligand_211	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117059	23512	-	SUZ12	CHET9|JJAZ1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 1 (VHL:VH032 --- SUZ12: EED ligand)	-
30158	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hsu JH (2020)	31786184	226149	9826	Bivalent ligand 212	PROTAC 2|Bivalent_ligand_212	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117059	23512	-	SUZ12	CHET9|JJAZ1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 2 (VHL:VH032 --- SUZ12: EED ligand)	-
30160	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	You I (2020)	31859249	224930	9827	Bivalent ligand 213	INY-03-041|Bivalent_ligand_213	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041 (CRBN:lenalidomide --- AKT1:GDC-0068)	-
30162	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	You I (2020)	31859249	224930	9827	Bivalent ligand 213	INY-03-041|Bivalent_ligand_213	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041 (CRBN:lenalidomide --- AKT2:GDC-0068)	-
30164	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	You I (2020)	31859249	224930	9827	Bivalent ligand 213	INY-03-041|Bivalent_ligand_213	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041 (CRBN:lenalidomide --- AKT3:GDC-0068)	-
30166	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao B (2019)	31512882	228715	9820	Bivalent ligand 214	IYx96IY-pom (4)|Bivalent_ligand_214	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110971	4916	-	NTRK3	TRKC|gp145(trkC)	9606	Homo sapiens	target	Standardized BVL Name: IYIY-pom (4) (CRBN:pomalidomide --- NTRK3: IY-IY-TEG)	-
30168	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li MX (2020)	32321253	228716	9821	Bivalent ligand 215	P22A|Bivalent_ligand_215	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	target	Standardized BVL Name: P22A (CRBN:pomalidomide --- HMGCR:Atorvastatin)	-
30170	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- BRD4-FKBP12F36V:AP1867)	-
30172	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- BRD4-FKBP12F36V:AP1867)	-
30174	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- HDAC1-FKBP12F36V:AP1867)	-
30176	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- HDAC1-FKBP12F36V:AP1867)	-
30178	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	target	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- MYC-FKBP12F36V:AP1867)	-
30180	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	target	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- MYC-FKBP12F36V:AP1867)	-
30182	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- PLK1-FKBP12F36V:AP1867)	-
30184	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- PLK1-FKBP12F36V:AP1867)	-
30186	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9822	Bivalent ligand 216	dTAG-7|Bivalent_ligand_216	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: dTAG-7 (CRBN:phthalimide --- EZH2-FKBP12F36V:AP1867)	-
30188	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nabet B (2018)	29581585	228717	9823	Bivalent ligand 217	dTAG-13|Bivalent_ligand_217	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: dTAG-13 (CRBN:phthalimide --- EZH2-FKBP12F36V:AP1867)	-
30190	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112401	6510	-	SLC1A5	AAAT|ASCT2|ATBO|M7V1|M7VS1|R16|RDRC	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC1A5-FKBP12F36V:AP1867)	-
30192	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112406	6515	-	SLC2A3	GLUT3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC2A3-FKBP12F36V:AP1867)	-
30194	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123509	81539	-	SLC38A1	ATA1|NAT2|SAT1|SNAT1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC38A1-FKBP12F36V:AP1867)	-
30196	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112404	6513	-	SLC2A1	DYT17|DYT18|DYT9|EIG12|GLUT|GLUT-1|GLUT1|GLUT1DS|HTLVR|PED	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC2A1-FKBP12F36V:AP1867)	-
30198	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC9A15-FKBP12F36V:AP1867)	-
30200	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC16A1-FKBP12F36V:AP1867)	-
30202	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113652	7922	DADB-100D22.3	SLC39A7	D6S115E|D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC39A7-FKBP12F36V:AP1867)	-
30204	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115726	10463	-	SLC30A9	C4orf1|GAC63|HUEL|ZNT9	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC30A9-FKBP12F36V:AP1867)	-
30206	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	131484	347734	RP1-302G2.3	SLC35B2	PAPST1|SLL|UGTrel4	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC35B2-FKBP12F36V:AP1867)	-
30208	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114632	9197	-	SLC33A1	ACATN|AT-1|AT1|CCHLND|SPG42	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC33A1-FKBP12F36V:AP1867)	-
30210	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127480	153129	-	SLC38A9	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC38A9-FKBP12F36V:AP1867)	-
30212	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	9832	Bivalent ligand 218	PROTAC dTAG13|Bivalent_ligand_218	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119943	54407	-	SLC38A2	ATA2|PRO1068|SAT2|SNAT2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG13 (CRBN:phthalimide --- SLC38A2-FKBP12F36V:AP1867)	-
30214	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9833	Bivalent ligand 219	iRucaparib-TP3|Bivalent_ligand_219	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: iRucaparib-TP3 (CRBN:pomalidomide --- PARP1:Rucaparib)	-
30216	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9789	Bivalent ligand 220	iRucaparib-TP4|Bivalent_ligand_220	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: iRucaparib-TP4 (CRBN:pomalidomide --- PARP1:Rucaparib)	-
30218	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9788	Bivalent ligand 221	vRucaparib-TP3|Bivalent_ligand_221	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: vRucaparib-TP3 (VHL:HIF-1 peptide --- PARP1:Rucaparib)	-
30220	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9791	Bivalent ligand 222	vRucaparib-TP4|Bivalent_ligand_222	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: vRucaparib-TP4 (VHL:HIF-1 peptide --- PARP1:Rucaparib)	-
30222	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9790	Bivalent ligand 223	iRucaparib-AP5|Bivalent_ligand_223	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: iRucaparib-AP5 (CRBN:pomalidomide --- PARP1:Rucaparib)	-
30224	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9793	Bivalent ligand 224	iRucaparib-AP6|Bivalent_ligand_224	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106652	142	RP11-125A15.2	PARP1	ADPRT|ADPRT 1|ADPRT1|ARTD1|PARP|PARP-1|PPOL|pADPRT-1	9606	Homo sapiens	target	Standardized BVL Name: iRucaparib-AP6 (CRBN:pomalidomide --- PARP1:Rucaparib)	-
30226	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9792	Bivalent ligand 225	iVeliparib-AP6|Bivalent_ligand_225	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115350	10038	-	PARP2	ADPRT2|ADPRTL2|ADPRTL3|ARTD2|PARP-2|pADPRT-2	9606	Homo sapiens	target	Standardized BVL Name: iVeliparib-AP6 (CRBN:pomalidomide --- PARP1:Veliparib)	-
30228	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9790	Bivalent ligand 223	iRucaparib-AP5|Bivalent_ligand_223	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115351	10039	-	PARP3	ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3	9606	Homo sapiens	target	Standardized BVL Name: iRucaparib-AP5 (CRBN:pomalidomide --- PARP3:Rucaparib)	-
30230	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang S (2019)	31659317	228718	9793	Bivalent ligand 224	iRucaparib-AP6|Bivalent_ligand_224	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115351	10039	-	PARP3	ADPRT3|ADPRTL2|ADPRTL3|ARTD3|IRT1|PADPRT-3	9606	Homo sapiens	target	Standardized BVL Name: iRucaparib-AP6 (CRBN:pomalidomide --- PARP3:Rucaparib)	-
30232	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Manda S (2020)	32340152	228719	9818	Bivalent ligand 256	CPR3|Bivalent_ligand_256	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	target	Standardized BVL Name: CPR3 (CRBN:pomalidomide --- IGF1R:RBx10080307)	-
30234	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Manda S (2020)	32340152	228719	9831	Bivalent ligand 226	CPR4|Bivalent_ligand_226	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109701	3480	-	IGF1R	CD221|IGFIR|IGFR|JTK13	9606	Homo sapiens	target	Standardized BVL Name: CPR4 (CRBN:pomalidomide --- IGF1R:RBx10080307)	-
30236	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Manda S (2020)	32340152	228719	9818	Bivalent ligand 256	CPR3|Bivalent_ligand_256	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: CPR3 (CRBN:pomalidomide --- Src:RBx10080307)	-
30238	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Manda S (2020)	32340152	228719	9831	Bivalent ligand 226	CPR4|Bivalent_ligand_226	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: CPR4 (CRBN:pomalidomide --- Src:RBx10080307)	-
30240	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ishoey M (2018)	29356495	228720	9808	Bivalent ligand 227	MI-389|Bivalent_ligand_227	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: MI-389 (CRBN:phthalimide --- GSPT1:sunitinib)	-
30242	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ishoey M (2018)	29356495	228720	9765	Bivalent ligand 228	compound 8|Bivalent_ligand_228	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 8 (CRBN:phthalimide --- GSPT1:PHA665752)	-
30244	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ishoey M (2018)	29356495	228720	9829	Bivalent ligand 229	compound 27|Bivalent_ligand_229	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 27 (CRBN:phthalimide --- GSPT1:ponatinib)	-
30246	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Testa A (2020)	31746102	228721	9834	Bivalent ligand 230	macroPROTAC-1|Bivalent_ligand_230	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: macroPROTAC1 (VHL:VH032 ---BRD4:JQ1)	-
30248	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Shibata N (2018)	28594553	228722	9835	Bivalent ligand 231	SNIPER(AR)-51/compound 42a|Bivalent_ligand_231	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: SNIPER(AR)-51/compound 42a (BIRC2:bestatin --- AR:AR antagonist-1)	-
30250	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9813	Bivalent ligand 232	vhhGFP4-SPOP|Bivalent_ligand_232	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-SPOP (SPOP:vhhGFP4 --- H2B:GFP)	-
30252	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9819	Bivalent ligand 233	3G86.32|Bivalent_ligand_233	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: 3G86.32 (SPOP:3G86.32 --- H2B:GFP)	-
30254	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9830	Bivalent ligand 234	bGFP-A|Bivalent_ligand_234	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: bGFP-A (SPOP:bGFP-A --- H2B:GFP)	-
30256	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9810	Bivalent ligand 235	bGFP-C|Bivalent_ligand_235	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: bGFP-C (SPOP:bGFP-C --- H2B:GFP)	-
30258	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9828	Bivalent ligand 236	GS2|Bivalent_ligand_236	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: GS2 (SPOP:GS2 --- H2B:GFP)	-
30260	116887	23291	-	FBXW11	BTRC2|BTRCP2|FBW1B|FBXW1B|Fbw11|Hos	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9763	Bivalent ligand 237	vhhGFP4-BetaTrCP|Bivalent_ligand_237	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-TrCP (TrCP:vhhGFP4 --- H2B:GFP)	-
30262	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9811	Bivalent ligand 238	vhhGFP4-SKP2|Bivalent_ligand_238	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-SKP2 (SKP2:vhhGFP4 --- H2B:GFP)	-
30264	120581	55294	-	FBXW7	AGO|CDC4|FBW6|FBW7|FBX30|FBXO30|FBXW6|SEL-10|SEL10|hAgo|hCdc4	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9804	Bivalent ligand 239	vhhGFP4-FBW7|Bivalent_ligand_239	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-FBW7 (FBW7:vhhGFP4 --- H2B:GFP)	-
30266	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9775	Bivalent ligand 240	vhhGFP4-VHL|Bivalent_ligand_240	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-VHL (VHL:vhhGFP4 --- H2B:GFP)	-
30268	114362	8835	-	SOCS2	CIS2|Cish2|SOCS-2|SSI-2|SSI2|STATI2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9774	Bivalent ligand 241	vhhGFP4-SOCS2|Bivalent_ligand_241	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-SOCS2 (SOCS2:vhhGFP4 --- H2B:GFP)	-
30270	126610	140456	-	ASB11	-	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9773	Bivalent ligand 242	vhhGFP4-ASB1|Bivalent_ligand_242	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-ASB1 (ASB1:vhhGFP4 --- H2B:GFP)	-
30272	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9772	Bivalent ligand 243	vhhGFP4-CHIP|Bivalent_ligand_243	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	113945	8349	-	HIST2H2BE	GL105|H2B|H2B.1|H2BFQ|H2BGL105|H2BQ	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-CHIP (CHIP:vhhGFP4 --- H2B:GFP)	-
30274	120581	55294	-	FBXW7	AGO|CDC4|FBW6|FBW7|FBX30|FBXO30|FBXW6|SEL-10|SEL10|hAgo|hCdc4	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9804	Bivalent ligand 239	vhhGFP4-FBW7|Bivalent_ligand_239	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-FBW7 (FBW7:vhhGFP4 --- PCNA:GFP)	-
30276	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9775	Bivalent ligand 240	vhhGFP4-VHL|Bivalent_ligand_240	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-VHL (VHL:vhhGFP4 --- PCNA:GFP)	-
30278	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9772	Bivalent ligand 243	vhhGFP4-CHIP|Bivalent_ligand_243	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-CHIP (CHIP:vhhGFP4 --- PCNA:GFP)	-
30280	114362	8835	-	SOCS2	CIS2|Cish2|SOCS-2|SSI-2|SSI2|STATI2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9774	Bivalent ligand 241	vhhGFP4-SOCS2|Bivalent_ligand_241	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-SOCS2 (SOCS2:vhhGFP4 --- PCNA:GFP)	-
30282	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9813	Bivalent ligand 232	vhhGFP4-SPOP|Bivalent_ligand_232	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: vhhGFP4-SPOP (SPOP:vhhGFP4 --- PCNA-GFP)	-
30284	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9819	Bivalent ligand 233	3G86.32|Bivalent_ligand_233	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: 3G86.32 (SPOP:3G86.32 --- PCNA:GFP)	-
30286	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9830	Bivalent ligand 234	bGFP-A|Bivalent_ligand_234	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: bGFP-A (SPOP:bGFP-A  --- PCNA:GFP)	-
30288	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9810	Bivalent ligand 235	bGFP-C|Bivalent_ligand_235	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: bGFP-C (SPOP:bGFP-C  --- PCNA:GFP)	-
30290	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2020)	32123106	226780	9828	Bivalent ligand 236	GS2|Bivalent_ligand_236	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	111142	5111	-	PCNA	ATLD2	9606	Homo sapiens	target	Standardized BVL Name: GS2 (SPOP:GS2 --- PCNA:GFP)	-
30292	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Han X (2019)	31804827	227993	9779	Bivalent ligand 244	ARD-266|Bivalent_ligand_244	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARD-266 (VHL:VHL-g --- AR:ARi-16)	-
30294	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Vannam R (2021)	33400925	228723	9778	Bivalent ligand 245	dCBP-1|Bivalent_ligand_245	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	target	Standardized BVL Name: dCBP-1 (CRBN:lenalidomide --- EP300:GNE-781)	-
30296	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Vannam R (2021)	33400925	228723	9778	Bivalent ligand 245	dCBP-1|Bivalent_ligand_245	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	target	Standardized BVL Name: dCBP-1 (CRBN:lenalidomide --- CREBBP:GNE-781)	-
30298	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li Y (2019)	30525597	223612	9809	Bivalent ligand 246	MD-222|Bivalent_ligand_246	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	target	Standardized BVL Name: MD-222 (CRBN:lenalidomide --- MDM2:MI-1061)	-
30300	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2018)	30067223	228458	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121420	57167	-	SALL4	DRRS|HSAL4|ZNF797|dJ1112F19.1	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:thalidomide --- SALL4:thalidomide)	-
30302	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2018)	30067223	228458	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121420	57167	-	SALL4	DRRS|HSAL4|ZNF797|dJ1112F19.1	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:pomalidomide --- SALL4:pomalidomide)	-
30304	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2018)	30067223	228458	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121420	57167	-	SALL4	DRRS|HSAL4|ZNF797|dJ1112F19.1	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:lenalidomide --- SALL4:lenalidomide)	-
30306	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Petzold G (2016)	26909574	193065	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:lenalidomide --- CSNK1A1:lenalidomide)	-
30308	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Lv L (2020)	32804079	223704	9760	Bivalent ligand 247	HQ461|Bivalent_ligand_247	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: HQ461 (DDB1:HQ461 --- CDK12 + CCNK:HQ461)	-
30310	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Slabicki M (2020)	32494016	228456	9807	Bivalent ligand 248	R-CR8|Bivalent_ligand_248	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: R-CR8 (DDB1:CR8 --- CDK12 + CCNK:CR8)	-
30312	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Mayor-Ruiz C (2020)	32747809	228457	9764	Bivalent ligand 249	dCeMM1|Bivalent_ligand_249	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: dCeMM1 (DDB1:dCeMM1 --- CDK12 + CCNK:dCeMM1)	-
30314	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Mayor-Ruiz C (2020)	32747809	228457	9812	Bivalent ligand 250	dCeMM2|Bivalent_ligand_250	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: dCeMM2 (DDB1:dCeMM2 --- CDK12 + CCNK:dCeMM2)	-
30316	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Mayor-Ruiz C (2020)	32747809	228457	9759	Bivalent ligand 251	dCeMM3|Bivalent_ligand_251	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: dCeMM3 (DDB1:dCeMM3 --- CDK12 + CCNK:dCeMM3)	-
30318	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Mayor-Ruiz C (2020)	32747809	228457	9814	Bivalent ligand 252	dCeMM4|Bivalent_ligand_252	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: dCeMM4 (DDB1:dCeMM4 --- CDK12 + CCNK:dCeMM4)	-
30320	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Alabi S (2021)	33568647	228724	9815	Bivalent ligand 253	SJF-0628|Bivalent_ligand_253	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: SJF-0628 (VHL:HIF-1alpha hydroxyproline derived small molecule --- BRAF V600E mutant:vemurafenib)	-
30322	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Tochigi T (2020)	32219443	226662	9816	Bivalent ligand 254	Bivalent_ligand_254	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107960	1588	-	CYP19A1	ARO|ARO1|CPV1|CYAR|CYP19|CYPXIX|P-450AROM	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:lenalidomide --- CYP19A1:lenalidomide)	-
30324	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu H (2019)	31271281	228479	9817	Bivalent ligand 255	Bivalent_ligand_255	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: (CRBN:pomalidomide  ---HDAC6:Nexturastat A)	-
30326	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- YES1:foretinib)	-
30328	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108379	2067	-	ERCC1	COFS4|RAD10|UV20	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand --- ERCC1:foretinib)	-
30330	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bondeson DP (2018)	29129718	208144	8429	Bivalent ligand 64	Bivalent_ligand_64|PROTAC 2	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122928	79837	-	PIP4K2C	PIP5K2C	9606	Homo sapiens	target	Standardized BVL Name: PROTAC2(CRBN:CRBN ligand ---PIP4K2C:foretinib)	-
30332	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112401	6510	-	SLC1A5	AAAT|ASCT2|ATBO|M7V1|M7VS1|R16|RDRC	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC1A5-FKBP12F36V:AP1867)	-
30334	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112406	6515	-	SLC2A3	GLUT3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC2A3-FKBP12F36V:AP1867)	-
30336	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123509	81539	-	SLC38A1	ATA1|NAT2|SAT1|SNAT1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC38A1-FKBP12F36V:AP1867)	-
30338	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112404	6513	-	SLC2A1	DYT17|DYT18|DYT9|EIG12|GLUT|GLUT-1|GLUT1|GLUT1DS|HTLVR|PED	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC2A1-FKBP12F36V:AP1867)	-
30340	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC9A15-FKBP12F36V:AP1867)	-
30342	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112454	6566	RP4-580L15.1	SLC16A1	HHF7|MCT|MCT1|MCT1D	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC16A1-FKBP12F36V:AP1867)	-
30344	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113652	7922	DADB-100D22.3	SLC39A7	D6S115E|D6S2244E|H2-KE4|HKE4|KE4|RING5|ZIP7	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC39A7-FKBP12F36V:AP1867)	-
30346	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115726	10463	-	SLC30A9	C4orf1|GAC63|HUEL|ZNT9	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC30A9-FKBP12F36V:AP1867)	-
30348	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	131484	347734	RP1-302G2.3	SLC35B2	PAPST1|SLL|UGTrel4	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC35B2-FKBP12F36V:AP1867)	-
30350	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114632	9197	-	SLC33A1	ACATN|AT-1|AT1|CCHLND|SPG42	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC33A1-FKBP12F36V:AP1867)	-
30352	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127480	153129	-	SLC38A9	-	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC38A9-FKBP12F36V:AP1867)	-
30354	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8519	Bivalent ligand 131	PROTAC dTAG7|Bivalent_ligand_131	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119943	54407	-	SLC38A2	ATA2|PRO1068|SAT2|SNAT2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC dTAG7 (CRBN:phthalimide --- SLC38A2-FKBP12F36V:AP1867)	-
30356	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8522	Bivalent ligand 132	d9A-2|Bivalent_ligand_132	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112438	6548	RP4-633N17.1	SLC9A1	APNH|NHE-1|NHE1|PPP1R143	9606	Homo sapiens	target	Standardized BVL Name: d9A2 (CRBN:phthalimide --- SLC9A1:W9A)	-
30358	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8522	Bivalent ligand 132	d9A-2|Bivalent_ligand_132	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112439	6549	-	SLC9A2	NHE2	9606	Homo sapiens	target	Standardized BVL Name: d9A2 (CRBN:phthalimide --- SLC9A2:W9A)	-
30360	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8522	Bivalent ligand 132	d9A-2|Bivalent_ligand_132	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	132934	389015	-	SLC9A4	NHE4	9606	Homo sapiens	target	Standardized BVL Name: d9A2 (CRBN:phthalimide --- SLC9A4:W9A)	-
30362	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8522	Bivalent ligand 132	d9A-2|Bivalent_ligand_132	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124198	84679	-	SLC9A7	NHE-7|NHE7|SLC9A6	9606	Homo sapiens	target	Standardized BVL Name: d9A2 (CRBN:phthalimide --- SLC9A7:W9A)	-
30364	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bensimon A (2020)	32386596	223637	8522	Bivalent ligand 132	d9A-2|Bivalent_ligand_132	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127264	150159	-	SLC9B1	NHA1|NHEDC1	9606	Homo sapiens	target	Standardized BVL Name: d9A2 (CRBN:phthalimide --- SLC9B1:W9A)	-
30366	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jin YH (2020)	32153174	223638	8521	Bivalent ligand 133	Azo-PROTAC-4C|Bivalent_ligand_133	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: Azo-PROTAC-4C (CRBN:lenalidomide --- BCR-ABL:dasatinib)	-
30368	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xue G (2019)	31566962	223639	8524	Bivalent ligand 134	pc-PROTAC1|Bivalent_ligand_134	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: pc-PROTAC1 (CRBN:thalidomide --- BCR4:JQ1)	-
30370	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xue G (2019)	31566962	223639	8523	Bivalent ligand 135	pc-PROTAC3|Bivalent_ligand_135	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: pc-PROTAC3 (CRBN:thalidomide --- BTK:MT-802)	-
30372	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	inhibitor	target	Pairawan S (2021)	33663585	228644	9937	ALRN-6924	CS-0044703	-	PUBCHEM	381833444	-	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	-
30373	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	inhibitor	target	Pairawan S (2021)	33663585	228644	9937	ALRN-6924	CS-0044703	-	PUBCHEM	381833444	-	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	-
30374	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Lin HC (2021)	33582217	231961	812	Disulfiram	Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide	antabuse tab 0.25gm|antabuse t	DRUGBANK	DB00822	C10H20N2S4	small molecule	P03AA54|P03AA04|N07BB01	97-77-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AUZONCFQVSMFAP-UHFFFAOYSA-N
30375	117950	27005	RP11-297K8.3	USP21	USP16|USP23	9606	Homo sapiens	inhibitor	target	Lin HC (2021)	33582217	231961	812	Disulfiram	Tetraethylthiuram Disulfide|Tetraethylthioperoxydicarbonic Diamide|Tetraethylthiuram Disulphide|1,1'-dithiobis(N,N-diethylthioformamide)|N,N,N',N'-tetraethylthiuram disulfide|Antabuse (tn)|Disulfiram|Bis(diethylthiocarbamoyl) disulfide	antabuse tab 0.25gm|antabuse t	DRUGBANK	DB00822	C10H20N2S4	small molecule	P03AA54|P03AA04|N07BB01	97-77-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	AUZONCFQVSMFAP-UHFFFAOYSA-N
30376	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Lin HC (2021)	33582217	231961	344	Tioguanine	2-Amino-6-mercaptopurine|2-Amino-6-purinethiol|Tioguanin|2-aminopurine-6-thiol|6-TG|Tioguanine|2-amino-1,9-Dihydropurine-6-thione|2-Amino-1,7-dihydro-6H-purine-6-thione|6-Thioguanine|Thioguanine|2-Aminopurin-6-thiol|6-Mercaptoguanine|2-Amino 6mp|2-amino-1H-purine-6(7H)-thione|Tioguanina|ThG|TG|Tioguaninum|2-Amino-6-merkaptopurin|2-Aminopurine-6(1H)-thione|6-Mercapto-2-aminopurine|6-thioguanine	tabloid|lanvis	DRUGBANK	DB00352	C5H5N5S	small molecule	L01BB03	154-42-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WYWHKKSPHMUBEB-UHFFFAOYSA-N
30377	117950	27005	RP11-297K8.3	USP21	USP16|USP23	9606	Homo sapiens	inhibitor	target	Lin HC (2021)	33582217	231961	344	Tioguanine	2-Amino-6-mercaptopurine|2-Amino-6-purinethiol|Tioguanin|2-aminopurine-6-thiol|6-TG|Tioguanine|2-amino-1,9-Dihydropurine-6-thione|2-Amino-1,7-dihydro-6H-purine-6-thione|6-Thioguanine|Thioguanine|2-Aminopurin-6-thiol|6-Mercaptoguanine|2-Amino 6mp|2-amino-1H-purine-6(7H)-thione|Tioguanina|ThG|TG|Tioguaninum|2-Amino-6-merkaptopurin|2-Aminopurine-6(1H)-thione|6-Mercapto-2-aminopurine|6-thioguanine	tabloid|lanvis	DRUGBANK	DB00352	C5H5N5S	small molecule	L01BB03	154-42-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	WYWHKKSPHMUBEB-UHFFFAOYSA-N
30378	116183	10987	-	COPS5	CSN5|JAB1|MOV-34|SGN5	9606	Homo sapiens	inhibitor	target	Liu Y (2020)	33354502	229845	3947	Berberine	-	-	DRUGBANK	DB04115	C20H18NO4	small molecule	-	2086-83-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	YBHILYKTIRIUTE-UHFFFAOYSA-N
30379	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Li X (2020)	32029476	227136	9970	Parthenolide	Parthenolide|(1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one|Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-|(-)-Parthenolide|(1aR,4E,7aS,10aS,10bR)-1a,5-Dimethyl-8-methylene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one	-	CHEMSPIDER	4976071	C15H20O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	KTEXNACQROZXEV-PVLRGYAZSA-N
30380	114553	9099	-	USP2	UBP41|USP9	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 70	MZBFFXLYQTWKNV-INIZCTEOSA-N
30381	113221	7375	-	USP4	UNP|Unph	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 34	MZBFFXLYQTWKNV-INIZCTEOSA-N
30382	113751	8078	-	USP5	ISOT	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 72	MZBFFXLYQTWKNV-INIZCTEOSA-N
30383	114552	9098	-	USP6	HRP1|TRE17|TRE2|TRESMCR|Tre-2|USP6-short	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 22	MZBFFXLYQTWKNV-INIZCTEOSA-N
30384	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 28	MZBFFXLYQTWKNV-INIZCTEOSA-N
30385	114555	9101	-	USP8	HumORF8|SPG59|UBPY	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 74	MZBFFXLYQTWKNV-INIZCTEOSA-N
30386	114554	9100	-	USP10	UBPO	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 74	MZBFFXLYQTWKNV-INIZCTEOSA-N
30387	113866	8237	RP4-659F15.2	USP11	UHX1	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 73	MZBFFXLYQTWKNV-INIZCTEOSA-N
30388	115283	9958	-	USP15	UNPH-2|UNPH4	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 30	MZBFFXLYQTWKNV-INIZCTEOSA-N
30389	115848	10600	MSTP039	USP16	UBP-M|UBPM	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 32	MZBFFXLYQTWKNV-INIZCTEOSA-N
30390	132019	377630	-	USP17L2	DUB-3|DUB3|USP17	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 26	MZBFFXLYQTWKNV-INIZCTEOSA-N
30391	116077	10868	-	USP20	LSFR3A|VDU2|hVDU2	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 39	MZBFFXLYQTWKNV-INIZCTEOSA-N
30392	116939	23358	hCG_33036	USP24	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 100	MZBFFXLYQTWKNV-INIZCTEOSA-N
30393	123764	83844	RP1-97K10.1	USP26	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 26	MZBFFXLYQTWKNV-INIZCTEOSA-N
30394	133302	389856	-	USP27X	USP22L|USP27	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 60	MZBFFXLYQTWKNV-INIZCTEOSA-N
30395	121683	57646	-	USP28	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 41	MZBFFXLYQTWKNV-INIZCTEOSA-N
30396	121696	57663	-	USP29	HOM-TES-84/86	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 37	MZBFFXLYQTWKNV-INIZCTEOSA-N
30397	121548	57478	RP11-20G6.3	USP31	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 16	MZBFFXLYQTWKNV-INIZCTEOSA-N
30398	124189	84669	-	USP32	NY-REN-60|USP10	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 45	MZBFFXLYQTWKNV-INIZCTEOSA-N
30399	116671	23032	-	USP33	VDU1	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 95	MZBFFXLYQTWKNV-INIZCTEOSA-N
30400	121613	57558	-	USP35	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 86	MZBFFXLYQTWKNV-INIZCTEOSA-N
30401	121651	57602	-	USP36	DUB1	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 71	MZBFFXLYQTWKNV-INIZCTEOSA-N
30402	121720	57695	-	USP37	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 31	MZBFFXLYQTWKNV-INIZCTEOSA-N
30403	124165	84640	-	USP38	HP43.8KD	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 40	MZBFFXLYQTWKNV-INIZCTEOSA-N
30404	123904	84132	tcag7.880	USP42	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 47	MZBFFXLYQTWKNV-INIZCTEOSA-N
30405	124430	85015	RP11-98I9.5	USP45	-	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 31	MZBFFXLYQTWKNV-INIZCTEOSA-N
30406	120360	55031	-	USP47	TRFP	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 33	MZBFFXLYQTWKNV-INIZCTEOSA-N
30407	107920	1540	HSPC057	CYLD	BRSS|CDMT|CYLD1|CYLDI|EAC|MFT|MFT1|SBS|TEM|USPL2	9606	Homo sapiens	inhibitor	target	Yamanaka S (2020)	31898971	227000	9873	Subquinocin	L-Methionine, N-[[[1,2-dihydro-2-(2-methylpropyl)-1-oxo-4-isoquinolinyl]amino]carbonyl]-, methyl ester|Methyl N-[(2-isobutyl-1-oxo-1,2-dihydro-4-isoquinolinyl)carbamoyl]-L-methioninate	-	CHEMSPIDER	88297784	C20H27N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Inhibition (%) 61	MZBFFXLYQTWKNV-INIZCTEOSA-N
30436	128336	200576	-	PIKFYVE	CFD|FAB1|HEL37|PIP5K|PIP5K3|ZFYVE29	9606	Homo sapiens	inhibitor	target	Kettunen PP (2022)	888800000867	239399	9969	Apilimod	Benzaldehyde, 3-methyl-, 2-[6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone|apilimod|4-{6-[2-(3-Methylbenzylidene)hydrazino]-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl}morpholine	-	CHEMSPIDER	21234847	C23H26N6O2	small molecule	-	541550-19-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Indirect: PIK5K inhibitor	HSKAZIJJKRAJAV-UHFFFAOYSA-N
30501	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10155	Bivalent ligand 257	POM-PERM3-R7|Bivalent_ligand_257	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: POM-PERM3-R7 (CRBN:pomalidomide ---AR:PERM3-R7)	-
30503	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10155	Bivalent ligand 257	POM-PERM3-R7|Bivalent_ligand_257	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: POM-PERM3-R7 (CRBN:pomalidomide ---ESR1:PERM3-R7)	-
30505	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10144	Bivalent ligand 258	VH032-PERM3-R7|Bivalent_ligand_258	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: VH032-PERM3-R7 (VHL:VH032 ---AR:PERM3-R7)	-
30507	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10144	Bivalent ligand 258	VH032-PERM3-R7|Bivalent_ligand_258	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: VH032-PERM3-R7 (VHL:VH032 ---ESR1:PERM3-R7)	-
30509	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10145	Bivalent ligand 259	MV1-PERM3-R7|Bivalent_ligand_259	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: MV1-PERM3-R7 (XIAP:MV1 ---AR:PERM3-R7)	-
30511	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10145	Bivalent ligand 259	MV1-PERM3-R7|Bivalent_ligand_259	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: MV1-PERM3-R7 (XIAP:MV1 ---ESR1:PERM3-R7)	-
30513	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10145	Bivalent ligand 259	MV1-PERM3-R7|Bivalent_ligand_259	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: MV1-PERM3-R7 (BIRC2:MV1 ---AR:PERM3-R7)	-
30515	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10145	Bivalent ligand 259	MV1-PERM3-R7|Bivalent_ligand_259	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: MV1-PERM3-R7 (BIRC2:MV1 ---ESR1:PERM3-R7)	-
30517	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10002	Bivalent ligand 260	LCL-PERM3-R7|Bivalent_ligand_260	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: LCL-PERM3-R7 (XIAP:LCL161 ---AR:PERM3-R7)	-
30519	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10002	Bivalent ligand 260	LCL-PERM3-R7|Bivalent_ligand_260	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: LCL-PERM3-R7 (XIAP:LCL161 ---AR:PERM3-R7)	-
30521	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10002	Bivalent ligand 260	LCL-PERM3-R7|Bivalent_ligand_260	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: LCL-PERM3-R7 (BIRC2:LCL161 ---ESR1:PERM3-R7)	-
30523	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2020)	32631565	229142	10002	Bivalent ligand 260	LCL-PERM3-R7|Bivalent_ligand_260	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: LCL-PERM3-R7 (BIRC2:LCL161 ---ESR1:PERM3-R7)	-
30525	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	degradation	autophagy-targeting protein	Takahashi D (2019)	31606272	239579	10001	Bivalent ligand 261	AUTAC1|Bivalent_ligand_261	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 autophagosome recruiting moiety--linker--target binding moiety; target degraded via autophagic degradation	116184	10988	-	METAP2	MAP2|MNPEP|p67|p67eIF2	9606	Homo sapiens	target	Standardized BVL Name: AUTAC1 (S-guanylation ---MetAP2:fumagillol)	-
30527	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	degradation	autophagy-targeting protein	Takahashi D (2019)	31606272	239579	10004	Bivalent ligand 262	AUTAC2|Bivalent_ligand_262	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 autophagosome recruiting moiety--linker--target binding moiety; target degraded via autophagic degradation	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: AUTAC2 (S-guanylation --- FKBP12:SLF)	-
30529	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	degradation	autophagy-targeting protein	Takahashi D (2019)	31606272	239579	10003	Bivalent ligand 263	AUTAC3|Bivalent_ligand_263	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 autophagosome recruiting moiety--linker--target binding moiety; target degraded via autophagic degradation	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: AUTAC3  (S-guanylation --- BRD4:JQ1)	-
30531	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide---AAK1:TAE684)	-
30533	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ABL1:TAE684)	-
30535	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ABL2:TAE684)	-
30537	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- AKT2:TAE684)	-
30539	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- AKT3:TAE684)	-
30541	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- AURKA:TAE684)	-
30543	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- AURKB:TAE684)	-
30545	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BCKDK:TAE684)	-
30547	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BLK:TAE684)	-
30549	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BMP2K:TAE684)	-
30551	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107125	657	-	BMPR1A	10q23del|ACVRLK3|ALK3|CD292|SKR5	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BMPR1A:TAE684)	-
30553	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BUB1:TAE684)	-
30555	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- BUB1B:TAE684)	-
30557	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113914	8317	-	CDC7	CDC7L1|HsCDC7|Hsk1|huCDC7	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDC7:TAE684)	-
30559	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK10:TAE684)	-
30561	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK12:TAE684)	-
30563	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK13:TAE684)	-
30565	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111239	5218	-	CDK14	PFTAIRE1|PFTK1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK14:TAE684)	-
30567	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK16:TAE684)	-
30569	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK17:TAE684)	-
30571	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111156	5129	RP11-288G13.1	CDK18	PCTAIRE|PCTAIRE3|PCTK3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK18:TAE684)	-
30573	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK2:TAE684)	-
30575	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK4:TAE684)	-
30577	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK5:TAE684)	-
30579	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK6:TAE684)	-
30581	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK7:TAE684)	-
30583	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CDK9:TAE684)	-
30585	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CSK:TAE684)	-
30587	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- CSNK1D:TAE684)	-
30589	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- EPHB2:TAE684)	-
30591	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108364	2050	-	EPHB4	HTK|MYK1|TYRO11	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- EPHB4:TAE684)	-
30593	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- FER:TAE684)	-
30595	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- FYN:TAE684)	-
30597	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- GAK:TAE684)	-
30599	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	128490	204851	RP4-786G8.2	HIPK1	Myak|Nbak2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- HIPK1:TAE684)	-
30601	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ITK:TAE684)	-
30603	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LATS1:TAE684)	-
30605	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LCK:TAE684)	-
30607	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LIMK1:TAE684)	-
30609	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LIMK2:TAE684)	-
30611	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	125700	120892	-	LRRK2	AURA17|DARDARIN|PARK8|RIPK7|ROCO2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- LRRK2:TAE684)	-
30613	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP3K1:TAE684)	-
30615	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP3K11:TAE684)	-
30617	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113566	7786	-	MAP3K12	DLK|MEKK12|MUK|ZPK|ZPKP1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP3K12:TAE684)	-
30619	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124089	84451	RP5-862P8.2	KIAA1804	MLK4|dJ862P8.3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP3K21:TAE684)	-
30621	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP4K1:TAE684)	-
30623	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114063	8491	-	MAP4K3	GLK|MAPKKKK3|MEKKK 3|MEKKK3|RAB8IPL1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAP4K3:TAE684)	-
30625	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111583	5597	-	MAPK6	ERK3|HsT17250|PRKM6|p97MAPK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAPK6:TAE684)	-
30627	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAPK7:TAE684)	-
30629	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MARK2:TAE684)	-
30631	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MARK4:TAE684)	-
30633	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116670	23031	-	MAST3	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MAST3:TAE684)	-
30635	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MKNK2:TAE684)	-
30637	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110826	4751	-	NEK2	HsPK21|NEK2A|NLK1|PPP1R111|RP67	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- NEK2:TAE684)	-
30639	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PDK3:TAE684)	-
30641	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PLK1:TAE684)	-
30643	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PLK4:TAE684)	-
30645	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127591	157285	-	SGK223	PRAGMIN	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PRAG1:TAE684)	-
30647	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PRKAA1:TAE684)	-
30649	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PRKAA2:TAE684)	-
30651	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PTK2:TAE684)	-
30653	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PTK2B:TAE684)	-
30655	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111720	5753	-	PTK6	BRK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- PTK6:TAE684)	-
30657	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120896	55781	-	RIOK2	RIO2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RIOK2:TAE684)	-
30659	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RPS6KA1:TAE684)	-
30661	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118144	27330	-	RPS6KA6	PP90RSK4|RSK4	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RPS6KA6:TAE684)	-
30663	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RPS6KB1:TAE684)	-
30665	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117810	26750	-	RPS6KC1	RPK118|RSKL1|S6K-delta-1|S6PKh1|humS6PKh1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- RPS6KC1:TAE684)	-
30667	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	132609	388228	-	SBK1	SBK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- SBK1:TAE684)	-
30669	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- SIK2:TAE684)	-
30671	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- SRC:TAE684)	-
30673	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- STK17A:TAE684)	-
30675	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- STK17B:TAE684)	-
30677	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	129429	282974	RP11-140A10.1	STK32C	PKE|YANK3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- STK32C:TAE684)	-
30679	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122426	65975	-	STK33	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- STK33:TAE684)	-
30681	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123816	83931	-	STK40	SHIK|SgK495	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- STK40:TAE684)	-
30683	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TEC:TAE684)	-
30685	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112904	7046	RP11-96L7.1	TGFBR1	AAT5|ACVRLK4|ALK-5|ALK5|ESS1|LDS1|LDS1A|LDS2A|MSSE|SKR4|TGFR-1|tbetaR-I	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TGFBR1:TAE684)	-
30687	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114253	8711	-	TNK1	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TNK1:TAE684)	-
30689	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TNK2:TAE684)	-
30691	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121756	57761	RP5-1103G7.7	TRIB3	C20orf97|NIPK|SINK|SKIP3|TRB3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TRIB3:TAE684)	-
30693	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120177	54822	-	TRPM7	ALSPDC|CHAK|CHAK1|LTRPC7|LTrpC-7|TRP-PLIK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TRPM7:TAE684)	-
30695	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- TTK:TAE684)	-
30697	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- UHMK1:TAE684)	-
30699	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ULK1:TAE684)	-
30701	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117470	25989	-	ULK3	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- ULK3:TAE684)	-
30703	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- WEE1:TAE684)	-
30705	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- YES1:TAE684)	-
30707	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10009	Bivalent Ligand 265	dAURK-4|Bivalent_Ligand_265	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: dAURK-4 (CRBN:thalidomide---AURKA:Alisertib)	-
30709	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10009	Bivalent Ligand 265	dAURK-4|Bivalent_Ligand_265	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: dAURK-4 (CRBN:thalidomide--- AURKB:Alisertib)	-
30711	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10012	Bivalent Ligand 266	FMF-05-178-1|Bivalent_Ligand_266	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: FMF-05-178-1 (VHL:VHL-1---BLK:XMD)	-
30713	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10012	Bivalent Ligand 266	FMF-05-178-1|Bivalent_Ligand_266	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: FMF-05-178-1 (VHL:VHL-1--- CSK:XMD)	-
30715	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide---AAK1:TAE684)	-
30717	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- ABL1:TAE684)	-
30719	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- AURKA:TAE684)	-
30721	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- AURKB:TAE684)	-
30723	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BLK:TAE684)	-
30725	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107125	657	-	BMPR1A	10q23del|ACVRLK3|ALK3|CD292|SKR5	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BMPR1A:TAE684)	-
30727	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BUB1:TAE684)	-
30729	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- BUB1B:TAE684)	-
30731	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK10:TAE684)	-
30733	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK12:TAE684)	-
30735	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK13:TAE684)	-
30737	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK17:TAE684)	-
30739	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK2:TAE684)	-
30741	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK4:TAE684)	-
30743	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK5:TAE684)	-
30745	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK6:TAE684)	-
30747	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK7:TAE684)	-
30749	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CDK9:TAE684)	-
30751	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- COQ8A:TAE684)	-
30753	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123009	79934	-	ADCK4	NPHS9	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- COQ8B:TAE684)	-
30755	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CSNK1D:TAE684)	-
30757	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- CSNK1E:TAE684)	-
30759	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118953	29904	-	EEF2K	HSU93850|eEF-2K	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- EEF2K:TAE684)	-
30761	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- FER:TAE684)	-
30763	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108609	2321	-	FLT1	FLT|FLT-1|VEGFR-1|VEGFR1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- FLT1:TAE684)	-
30765	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- GAK:TAE684)	-
30767	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123814	83903	-	GSG2	HASPIN	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- HASPIN:TAE684)	-
30769	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- IRAK4:TAE684)	-
30771	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- ITK:TAE684)	-
30773	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- LCK:TAE684)	-
30775	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- LIMK1:TAE684)	-
30777	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- LIMK2:TAE684)	-
30779	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MAP3K11:TAE684)	-
30781	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124089	84451	RP5-862P8.2	KIAA1804	MLK4|dJ862P8.3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MAP3K21:TAE684)	-
30783	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MAP4K1:TAE684)	-
30785	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114063	8491	-	MAP4K3	GLK|MAPKKKK3|MEKKK 3|MEKKK3|RAB8IPL1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MAP4K3:TAE684)	-
30787	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111583	5597	-	MAPK6	ERK3|HsT17250|PRKM6|p97MAPK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MAPK6:TAE684)	-
30789	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MAPK7:TAE684)	-
30791	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MARK2:TAE684)	-
30793	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MARK4:TAE684)	-
30795	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110826	4751	-	NEK2	HsPK21|NEK2A|NLK1|PPP1R111|RP67	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- NEK2:TAE684)	-
30797	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119685	51701	-	NLK	-	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- NLK:TAE684)	-
30799	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PDK2:TAE684)	-
30801	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PLK4:TAE684)	-
30803	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127591	157285	-	SGK223	PRAGMIN	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PRAG1:TAE684)	-
30805	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PRKAA1:TAE684)	-
30807	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- PTK2B:TAE684)	-
30809	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120896	55781	-	RIOK2	RIO2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- RIOK2:TAE684)	-
30811	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- RPS6KA1:TAE684)	-
30813	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- SIK2:TAE684)	-
30815	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- SRC:TAE684)	-
30817	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112669	6793	-	STK10	LOK|PRO2729	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- STK10:TAE684)	-
30819	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- STK17A:TAE684)	-
30821	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- STK35:TAE684)	-
30823	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- TEC:TAE684)	-
30825	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- TNK2:TAE684)	-
30827	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- ULK1:TAE684)	-
30829	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117470	25989	-	ULK3	-	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- ULK3:TAE684)	-
30831	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- WEE1:TAE684)	-
30833	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- YES1:TAE684)	-
30835	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide---ABL2:GNF-7)	-
30837	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- AURKA:GNF-7)	-
30839	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- BLK:GNF-7)	-
30841	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- BUB1:GNF-7)	-
30843	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	609064	728642	RP1-283E3.2	CDK11A	CDC2L2|CDC2L3|CDK11-p110|CDK11-p46|CDK11-p58|PITSLRE|p58GTA	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- CDK11A:GNF-7)	-
30845	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- CDK11B:GNF-7)	-
30847	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- CDK4:GNF-7)	-
30849	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- CSK:GNF-7)	-
30851	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110975	4921	RP11-572K18.1	DDR2	MIG20a|NTRKR3|TKT|TYRO10	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- DDR2:GNF-7)	-
30853	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108356	2042	-	EPHA3	EK4|ETK|ETK1|HEK|HEK4|TYRO4	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- EPHA3:GNF-7)	-
30855	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108363	2049	-	EPHB3	ETK2|HEK2|TYRO6	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- EPHB3:GNF-7)	-
30857	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108365	2051	-	EPHB6	HEP	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- EPHB6:GNF-7)	-
30859	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- FER:GNF-7)	-
30861	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- FYN:GNF-7)	-
30863	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- GAK:GNF-7)	-
30865	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LATS1:GNF-7)	-
30867	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LCK:GNF-7)	-
30869	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LIMK1:GNF-7)	-
30871	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LIMK2:GNF-7)	-
30873	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	125700	120892	-	LRRK2	AURA17|DARDARIN|PARK8|RIPK7|ROCO2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LRRK2:GNF-7)	-
30875	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110245	4067	-	LYN	JTK8|p53Lyn|p56Lyn	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- LYN:GNF-7)	-
30877	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP3K1:GNF-7)	-
30879	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP3K11:GNF-7)	-
30881	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP3K20:GNF-7)	-
30883	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP4K1:GNF-7)	-
30885	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP4K2:GNF-7)	-
30887	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116353	11183	-	MAP4K5	GCKR|KHS|KHS1|MAPKKKK5	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAP4K5:GNF-7)	-
30889	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111586	5600	-	MAPK11	P38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK11:GNF-7)	-
30891	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112207	6300	-	MAPK12	ERK-6|ERK3|ERK6|MAPK 12|P38GAMMA|PRKM12|SAPK-3|SAPK3	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK12:GNF-7)	-
30893	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK14:GNF-7)	-
30895	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK8:GNF-7)	-
30897	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK9:GNF-7)	-
30899	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPKAPK2:GNF-7)	-
30901	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MKNK2:GNF-7)	-
30903	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119685	51701	-	NLK	-	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- NLK:GNF-7)	-
30905	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- PLK1:GNF-7)	-
30907	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- PTK2:GNF-7)	-
30909	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- PTK2B:GNF-7)	-
30911	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114274	8737	-	RIPK1	RIP|RIP1	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- RIPK1:GNF-7)	-
30913	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114300	8767	WUGSC:H_RG437L15.1	RIPK2	CARD3|CARDIAK|CCK|GIG30|RICK|RIP2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- RIPK2:GNF-7)	-
30915	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- RPS6KA3:GNF-7)	-
30917	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- SIK2:GNF-7)	-
30919	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- SRC:GNF-7)	-
30921	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114750	9344	UNQ2971/PRO7431	TAOK2	MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide---TAOK2:GNF-7)	-
30923	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- TEC:GNF-7)	-
30925	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- TNK2:GNF-7)	-
30927	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- TTK:GNF-7)	-
30929	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- UHMK1:GNF-7)	-
30931	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- ULK1:GNF-7)	-
30933	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- WEE1:GNF-7)	-
30935	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- YES1:GNF-7)	-
30937	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1---AAK1:TAE)	-
30939	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- ABL2:TAE)	-
30941	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- AURKA:TAE)	-
30943	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- AURKB:TAE)	-
30945	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- BUB1B:TAE)	-
30947	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113914	8317	-	CDC7	CDC7L1|HsCDC7|Hsk1|huCDC7	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDC7:TAE)	-
30949	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK1:TAE)	-
30951	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK12:TAE)	-
30953	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK13:TAE)	-
30955	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK2:TAE)	-
30957	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK4:TAE)	-
30959	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDk6:TAE)	-
30961	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK7:TAE)	-
30963	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CDK9:TAE)	-
30965	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CHEK1:TAE)	-
30967	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- CSNK1D:TAE)	-
30969	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108355	2041	-	EPHA1	EPH|EPHT|EPHT1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- EPHA1:TAE)	-
30971	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- FER:TAE)	-
30973	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- FGFR1:TAE)	-
30975	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- GAK:TAE)	-
30977	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- IRAK4:TAE)	-
30979	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- ITK:TAE)	-
30981	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- LIMK2:TAE)	-
30983	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MAP4K2:TAE)	-
30985	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114063	8491	-	MAP4K3	GLK|MAPKKKK3|MEKKK 3|MEKKK3|RAB8IPL1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MAP4K3:TAE)	-
30987	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111583	5597	-	MAPK6	ERK3|HsT17250|PRKM6|p97MAPK	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MAPK6:TAE)	-
30989	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MAPK7:TAE)	-
30991	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MARK4:TAE)	-
30993	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115171	9833	RP11-8N6.1	MELK	HPK38	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- MELK:TAE)	-
30995	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118978	29941	RP11-545E17.1	PKN3	-	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PKN3:TAE)	-
30997	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PLK4:TAE)	-
30999	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PRKAA1:TAE)	-
31001	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PTK2:TAE)	-
31003	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111720	5753	-	PTK6	BRK	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- PTK6:TAE)	-
31005	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114468	8986	-	RPS6KA4	MSK2|RSK-B	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- RPS6KA4:TAE)	-
31007	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- SIK2:TAE)	-
31009	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- STK35:TAE)	-
31011	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- TNK2:TAE)	-
31013	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- UHMK1:TAE)	-
31015	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- ULK1:TAE)	-
31017	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10006	Bivalent Ligand 268	FMF-06-098-1|Bivalent_Ligand_268	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-098-1 (VHL:VHL-1--- WEE1:TAE)	-
31019	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide---AAK1:Ceritinib)	-
31021	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- AURKA:Ceritinib)	-
31023	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- AURKB:Ceritinib)	-
31025	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
31027	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK12:Ceritinib)	-
31029	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK16:Ceritinib)	-
31031	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK17:Ceritinib)	-
31033	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK2:Ceritinib)	-
31035	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK5:Ceritinib)	-
31037	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK7:Ceritinib)	-
31039	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CDK9:Ceritinib)	-
31041	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- CLK1:Ceritinib)	-
31043	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- FER:Ceritinib)	-
31045	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- GSK3A:Ceritinib)	-
31047	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- GSK3B:Ceritinib)	-
31049	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116382	11213	-	IRAK3	ASRT5|IRAKM	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- IRAK3:Ceritinib)	-
31051	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- MAP3K11:Ceritinib)	-
31053	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- MAPK8:Ceritinib)	-
31055	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
31057	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110825	4750	-	NEK1	NY-REN-55|SRPS2|SRPS2A|SRTD6	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- NEK1:Ceritinib)	-
31059	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110827	4752	RP11-248G5.5	NEK3	HSPK36	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- NEK3:Ceritinib)	-
31061	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112663	6787	-	NEK4	NRK2|STK2|pp12301	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- NEK4:Ceritinib)	-
31063	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- NEK9:Ceritinib)	-
31065	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- NUAK1:Ceritinib)	-
31067	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PRKAA1:Ceritinib)	-
31069	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PRKAA2:Ceritinib)	-
31071	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PTK2:Ceritinib)	-
31073	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- PTK2B:Ceritinib)	-
31075	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- RPS6KA1:Ceritinib)	-
31077	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- RPS6KA3:Ceritinib)	-
31079	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114468	8986	-	RPS6KA4	MSK2|RSK-B	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- RPS6KA4:Ceritinib)	-
31081	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122426	65975	-	STK33	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- STK33:Ceritinib)	-
31083	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- STK35:Ceritinib)	-
31085	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116457	11329	-	STK38	NDR|NDR1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- STK38:Ceritinib)	-
31087	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118878	29110	-	TBK1	NAK|T2K	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- TBK1:Ceritinib)	-
31089	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- TEC:Ceritinib)	-
31091	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- TTK:Ceritinib)	-
31093	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- WEE1:Ceritinib)	-
31095	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide---ABL1:GNF-7)	-
31097	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- ABL2:GNF-7)	-
31099	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- BLK:GNF-7)	-
31101	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- BUB1:GNF-7)	-
31103	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- CDK11B:GNF-7)	-
31105	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- CDK4:GNF-7)	-
31107	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- CSK:GNF-7)	-
31109	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108365	2051	-	EPHB6	HEP	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- EPHB6:GNF-7)	-
31111	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- FER:GNF-7)	-
31113	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- FYN:GNF-7)	-
31115	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- GAK:GNF-7)	-
31117	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- LCK:GNF-7)	-
31119	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- LIMK1:GNF-7)	-
31121	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAP3K1:GNF-7)	-
31123	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAP3K11:GNF-7)	-
31125	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAP3K20:GNF-7)	-
31127	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAP4K1:GNF-7)	-
31129	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK14:GNF-7)	-
31131	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK8:GNF-7)	-
31133	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK9:GNF-7)	-
31135	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPKAPK2:GNF-7)	-
31137	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MKNK2:GNF-7)	-
31139	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115586	10298	-	PAK4	-	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- PAK4:GNF-7)	-
31141	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127209	149420	RP11-96L14.4	PDIK1L	CLIK1L|STK35L2	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- PDIK1L:GNF-7)	-
31143	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- PTK2B:GNF-7)	-
31145	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- RPS6KA1:GNF-7)	-
31147	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- RPS6KA3:GNF-7)	-
31149	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- SIK2:GNF-7)	-
31151	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- SRC:GNF-7)	-
31153	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- TNK2:GNF-7)	-
31155	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- UHMK1:GNF-7)	-
31157	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide--- ULK1:GNF-7)	-
31159	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: DB0662 (CRBN:thalidomide---YES1:GNF-7)	-
31161	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide---AAK1:Rebastinib)	-
31163	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- ABL2:Rebastinib)	-
31165	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- AURKA:Rebastinib)	-
31167	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- AURKB:Rebastinib)	-
31169	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- BLK:Rebastinib)	-
31171	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- BUB1B:Rebastinib)	-
31173	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK13:Rebastinib)	-
31175	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK17:Rebastinib)	-
31177	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK2:Rebastinib)	-
31179	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK4:Rebastinib)	-
31181	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK5:Rebastinib)	-
31183	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK6:Rebastinib)	-
31185	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK7:Rebastinib)	-
31187	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- CDK9:Rebastinib)	-
31189	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- FER:Rebastinib)	-
31191	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- ITK:Rebastinib)	-
31193	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- LCK:Rebastinib)	-
31195	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- LIMK1:Rebastinib)	-
31197	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- LIMK2:Rebastinib)	-
31199	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- MAP3K11:Rebastinib)	-
31201	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- MARK4:Rebastinib)	-
31203	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- PLK4:Rebastinib)	-
31205	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- PRKAA1:Rebastinib)	-
31207	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- RPS6KA1:Rebastinib)	-
31209	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- SRC:Rebastinib)	-
31211	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112669	6793	-	STK10	LOK|PRO2729	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- STK10:Rebastinib)	-
31213	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116457	11329	-	STK38	NDR|NDR1	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- STK38:Rebastinib)	-
31215	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- TEC:Rebastinib)	-
31217	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- TNK2:Rebastinib)	-
31219	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- ULK1:Rebastinib)	-
31221	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117470	25989	-	ULK3	-	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- ULK3:Rebastinib)	-
31223	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10036	Bivalent Ligand 271	TL13-97|Bivalent_Ligand_271	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: TL13-97 (CRBN:pomalidomide--- WEE1:Rebastinib)	-
31225	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide---ABL1:Ponatinib)	-
31227	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- ABL2:Ponatinib)	-
31229	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- BLK:Ponatinib)	-
31231	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111239	5218	-	CDK14	PFTAIRE1|PFTK1	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- CDK14:Ponatinib)	-
31233	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- CDK17:Ponatinib)	-
31235	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- CDK5:Ponatinib)	-
31237	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- CDK6:Ponatinib)	-
31239	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- COQ8A:Ponatinib)	-
31241	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108355	2041	-	EPHA1	EPH|EPHT|EPHT1	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- EPHA1:Ponatinib)	-
31243	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108288	1969	-	EPHA2	ARCC2|CTPA|CTPP1|CTRCT6|ECK	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- EPHA2:Ponatinib)	-
31245	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- FER:Ponatinib)	-
31247	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- FYN:Ponatinib)	-
31249	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- GAK:Ponatinib)	-
31251	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109863	3654	-	IRAK1	IRAK|pelle	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- IRAK1:Ponatinib)	-
31253	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- LCK:Ponatinib)	-
31255	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110245	4067	-	LYN	JTK8|p53Lyn|p56Lyn	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- LYN:Ponatinib)	-
31257	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAP3K1:Ponatinib)	-
31259	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAP3K20:Ponatinib)	-
31261	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112748	6885	RP1-154G14.1	MAP3K7	MEKK7|TAK1|TGF1a	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAP3K7:Ponatinib)	-
31263	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAP4K2:Ponatinib)	-
31265	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116353	11183	-	MAP4K5	GCKR|KHS|KHS1|MAPKKKK5	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAP4K5:Ponatinib)	-
31267	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- MAPK14:Ponatinib)	-
31269	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- PDK1:Ponatinib)	-
31271	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- PDK2:Ponatinib)	-
31273	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- PDK3:Ponatinib)	-
31275	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114274	8737	-	RIPK1	RIP|RIP1	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- RIPK1:Ponatinib)	-
31277	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114300	8767	WUGSC:H_RG437L15.1	RIPK2	CARD3|CARDIAK|CCK|GIG30|RICK|RIP2	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- RIPK2:Ponatinib)	-
31279	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- SRC:Ponatinib)	-
31281	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112669	6793	-	STK10	LOK|PRO2729	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- STK10:Ponatinib)	-
31283	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119490	51347	-	TAOK3	DPK|JIK|MAP3K18	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- TAOK3:Ponatinib)	-
31285	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10033	Bivalent Ligand 272	SB1-G-187|Bivalent_Ligand_272	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-187 (CRBN:Thalidomide--- YES1:Ponatinib)	-
31287	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1---ABL1:GNF-7)	-
31289	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- ABL2:GNF-7)	-
31291	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- BLK:GNF-7)	-
31293	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- CDK11B:GNF-7)	-
31295	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- CDK4:GNF-7)	-
31297	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116290	11113	-	CIT	CRIK|STK21	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- CIT:GNF-7)	-
31299	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- CSK:GNF-7)	-
31301	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108356	2042	-	EPHA3	EK4|ETK|ETK1|HEK|HEK4|TYRO4	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- EPHA3:GNF-7)	-
31303	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- FER:GNF-7)	-
31305	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- GAK:GNF-7)	-
31307	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1---a LCK:GNF-7)	-
31309	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- LIMK2:GNF-7)	-
31311	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAP3K20:GNF-7)	-
31313	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112748	6885	RP1-154G14.1	MAP3K7	MEKK7|TAK1|TGF1a	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAP3K7:GNF-7)	-
31315	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAP4K1:GNF-7)	-
31317	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAP4K2:GNF-7)	-
31319	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116353	11183	-	MAP4K5	GCKR|KHS|KHS1|MAPKKKK5	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAP4K5:GNF-7)	-
31321	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPK14:GNF-7)	-
31323	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPK7:GNF-7)	-
31325	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPK9:GNF-7)	-
31327	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPKAPK2:GNF-7)	-
31329	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113617	7867	-	MAPKAPK3	3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPKAPK3:GNF-7)	-
31331	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127209	149420	RP11-96L14.4	PDIK1L	CLIK1L|STK35L2	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- PDIK1L:GNF-7)	-
31333	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- PTK2B:GNF-7)	-
31335	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114274	8737	-	RIPK1	RIP|RIP1	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- RIPK1:GNF-7)	-
31337	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- RPS6KA1:GNF-7)	-
31339	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- SIK2:GNF-7)	-
31341	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- STK35:GNF-7)	-
31343	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114750	9344	UNQ2971/PRO7431	TAOK2	MAP3K17|PSK|PSK1|PSK1-BETA|TAO1|TAO2	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- TAOK2:GNF-7)	-
31345	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- TNK2:GNF-7)	-
31347	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: DB1114 (VHL:VHL-1--- ULK1:GNF-7)	-
31349	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1---ABL1:GNF-7)	-
31351	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- ABL2:GNF-7)	-
31353	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- BLK:GNF-7)	-
31355	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107421	984	-	CDK11B	CDC2L1|CDK11|CDK11-p110|CDK11-p46|CDK11-p58|CLK-1|PITSLREA|PK58|p58|p58CDC2L1|p58CLK-1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- CDK11B:GNF-7)	-
31357	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- CDK4:GNF-7)	-
31359	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- CSK:GNF-7)	-
31361	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108356	2042	-	EPHA3	EK4|ETK|ETK1|HEK|HEK4|TYRO4	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- EPHA3:GNF-7)	-
31363	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- FER:GNF-7)	-
31365	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- GAK:GNF-7)	-
31367	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- LIMK1:GNF-7)	-
31369	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAP3K20:GNF-7)	-
31371	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAP4K1:GNF-7)	-
31373	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAP4K2:GNF-7)	-
31375	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114063	8491	-	MAP4K3	GLK|MAPKKKK3|MEKKK 3|MEKKK3|RAB8IPL1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAP4K3:GNF-7)	-
31377	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116353	11183	-	MAP4K5	GCKR|KHS|KHS1|MAPKKKK5	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAP4K5:GNF-7)	-
31379	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK14:GNF-7)	-
31381	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK7:GNF-7)	-
31383	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK8:GNF-7)	-
31385	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK9:GNF-7)	-
31387	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPKAPK2:GNF-7)	-
31389	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113617	7867	-	MAPKAPK3	3PK|MAPKAP-K3|MAPKAP3|MAPKAPK-3|MK-3	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPKAPK3:GNF-7)	-
31391	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119685	51701	-	NLK	-	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- NLK:GNF-7)	-
31393	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	127209	149420	RP11-96L14.4	PDIK1L	CLIK1L|STK35L2	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- PDIK1L:GNF-7)	-
31395	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- PTK2B:GNF-7)	-
31397	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114274	8737	-	RIPK1	RIP|RIP1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- RIPK1:GNF-7)	-
31399	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- RPS6KA1:GNF-7)	-
31401	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- RPS6KA3:GNF-7)	-
31403	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- SIK2:GNF-7)	-
31405	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116963	23387	L19	SIK3	QSK|SIK-3	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- SIK3:GNF-7)	-
31407	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- STK35:GNF-7)	-
31409	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- TNK2:GNF-7)	-
31411	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: DB1113 (VHL:VHL-1--- ULK1:GNF-7)	-
31413	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide---AAK1:Ceritinib)	-
31415	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- AURKA:Ceritinib)	-
31417	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- AURKB:Ceritinib)	-
31419	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
31421	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK12:Ceritinib)	-
31423	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK16:Ceritinib)	-
31425	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK17:Ceritinib)	-
31427	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK2:Ceritinib)	-
31429	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK5:Ceritinib)	-
31431	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK7:Ceritinib)	-
31433	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CDK9:Ceritinib)	-
31435	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- CLK1:Ceritinib)	-
31437	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- FER:Ceritinib)	-
31439	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- GSK3A:Ceritinib)	-
31441	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- GSK3B:Ceritinib)	-
31443	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116382	11213	-	IRAK3	ASRT5|IRAKM	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- IRAK3:Ceritinib)	-
31445	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- MAP3K11:Ceritinib)	-
31447	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- MAPK8:Ceritinib)	-
31449	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
31451	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- NUAK1:Ceritinib)	-
31453	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- PRKAA1:Ceritinib)	-
31455	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111550	5563	-	PRKAA2	AMPK|AMPK2|AMPKa2|PRKAA	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- PRKAA2:Ceritinib)	-
31457	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- PTK2B:Ceritinib)	-
31459	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- RPS6KA1:Ceritinib)	-
31461	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- RPS6KA3:Ceritinib)	-
31463	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122426	65975	-	STK33	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- STK33:Ceritinib)	-
31465	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116457	11329	-	STK38	NDR|NDR1	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- STK38:Ceritinib)	-
31467	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- TTK:Ceritinib)	-
31469	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide---AURKA:AT7519)	-
31471	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- BUB1:AT7519)	-
31473	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- BUB1B:AT7519)	-
31475	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK13:AT7519)	-
31477	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111239	5218	-	CDK14	PFTAIRE1|PFTK1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK14:AT7519)	-
31479	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK17:AT7519)	-
31481	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK4:AT7519)	-
31483	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CDK9:AT7519)	-
31485	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107536	1111	-	CHEK1	CHK1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CHEK1:AT7519)	-
31487	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CLK1:AT7519)	-
31489	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CSNK1A1:AT7519)	-
31491	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- CSNK1D:AT7519)	-
31493	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107982	1612	-	DAPK1	DAPK	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- DAPK1:AT7519)	-
31495	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108391	2081	-	ERN1	IRE1|IRE1P|IRE1a|hIRE1p	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- ERN1:AT7519)	-
31497	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- GSK3A:AT7519)	-
31499	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- GSK3B:AT7519)	-
31501	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- MAP3K1:AT7519)	-
31503	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- NUAK1:AT7519)	-
31505	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- PIK3CG:AT7519)	-
31507	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116228	11040	-	PIM2	-	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- PIM2:AT7519)	-
31509	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- PLK1:AT7519)	-
31511	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120896	55781	-	RIOK2	RIO2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- RIOK2:AT7519)	-
31513	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- STK17A:AT7519)	-
31515	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- STK17B:AT7519)	-
31517	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- TTK:AT7519)	-
31519	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- UHMK1:AT7519)	-
31521	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10037	Bivalent Ligand 276	MFH-5-126-1|Bivalent_Ligand_276	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-126-1 (CRBN:pomalidomide--- WEE1:AT7519)	-
31523	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1---AAK1:Thienopyrimidines)	-
31525	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK1:Thienopyrimidines)	-
31527	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK16:Thienopyrimidines)	-
31529	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK2:Thienopyrimidines)	-
31531	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK4:Thienopyrimidines)	-
31533	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- CDK6:Thienopyrimidines)	-
31535	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	136426	440275	-	EIF2AK4	GCN2|PVOD2	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- EIF2AK4:Thienopyrimidines)	-
31537	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- GAK:Thienopyrimidines)	-
31539	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- LATS1:Thienopyrimidines)	-
31541	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- LIMK2:Thienopyrimidines)	-
31543	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111583	5597	-	MAPK6	ERK3|HsT17250|PRKM6|p97MAPK	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MAPK6:Thienopyrimidines)	-
31545	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114120	8550	-	MAPKAPK5	MAPKAP-K5|MK-5|MK5|PRAK	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MAPKAPK5:Thienopyrimidines)	-
31547	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MARK2:Thienopyrimidines)	-
31549	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MARK4:Thienopyrimidines)	-
31551	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MKNK2:Thienopyrimidines)	-
31553	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- NEK9:Thienopyrimidines)	-
31555	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- RPS6KB1:Thienopyrimidines)	-
31557	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- SIK2:Thienopyrimidines)	-
31559	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120211	54861	-	SNRK	HSNFRK	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- SNRK:Thienopyrimidines)	-
31561	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- STK17A:Thienopyrimidines)	-
31563	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- STK17B:Thienopyrimidines)	-
31565	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- STK35:Thienopyrimidines)	-
31567	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: RSS0680 (VHL:VHL-1--- WEE1:Thienopyrimidines)	-
31569	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide---AAK1:TAE684)	-
31571	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- ABL2:TAE684)	-
31573	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- AURKA:TAE684)	-
31575	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- BLK:TAE684)	-
31577	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- BMP2K:TAE684)	-
31579	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK12:TAE684)	-
31581	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK13:TAE684)	-
31583	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK17:TAE684)	-
31585	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK2:TAE684)	-
31587	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK4:TAE684)	-
31589	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK5:TAE684)	-
31591	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK6:TAE684)	-
31593	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK7:TAE684)	-
31595	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- CDK9:TAE684)	-
31597	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- FER:TAE684)	-
31599	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- GAK:TAE684)	-
31601	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- ITK:TAE684)	-
31603	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- LCK:TAE684)	-
31605	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- LIMK2:TAE684)	-
31607	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- PRKAA1:TAE684)	-
31609	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- PTK2B:TAE684)	-
31611	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- RPS6KA1:TAE684)	-
31613	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- SRC:TAE684)	-
31615	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10041	Bivalent Ligand 278	SK-3-93|Bivalent_Ligand_278	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: SK-3-93 (CRBN:Thalidomide--- WEE1:TAE684)	-
31617	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide---AAK1:Thienopyrimidines)	-
31619	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- AURKA:Thienopyrimidines)	-
31621	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- BMP2K:Thienopyrimidines)	-
31623	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123981	84254	-	CAMKK1	CAMKKA	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- CAMKK1:Thienopyrimidines)	-
31625	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- CDK16:Thienopyrimidines)	-
31627	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- CDK4:Thienopyrimidines)	-
31629	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- CDK6:Thienopyrimidines)	-
31631	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111596	5610	-	EIF2AK2	EIF2AK1|PKR|PPP1R83|PRKR	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- EIF2AK2:Thienopyrimidines)	-
31633	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- FER:Thienopyrimidines)	-
31635	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- GAK:Thienopyrimidines)	-
31637	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- LCK:Thienopyrimidines)	-
31639	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- LIMK2:Thienopyrimidines)	-
31641	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110442	4296	-	MAP3K11	MEKK11|MLK-3|MLK3|PTK1|SPRK	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- MAP3K11:Thienopyrimidines)	-
31643	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- MAPK8:Thienopyrimidines)	-
31645	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- MAPK9:Thienopyrimidines)	-
31647	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- NEK9:Thienopyrimidines)	-
31649	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- PLK4:Thienopyrimidines)	-
31651	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- PTK2B:Thienopyrimidines)	-
31653	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- SIK2:Thienopyrimidines)	-
31655	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- STK17A:Thienopyrimidines)	-
31657	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- STK17B:Thienopyrimidines)	-
31659	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- ULK1:Thienopyrimidines)	-
31661	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117470	25989	-	ULK3	-	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- ULK3:Thienopyrimidines)	-
31663	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- WEE1:Thienopyrimidines)	-
31665	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10070	Bivalent Ligand 280	DD-02-198|Bivalent_Ligand_280	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: DD-02-198 (VHL:VH032---MAPK14:AZ628)	-
31667	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10069	Bivalent Ligand 281	DD-03-171|Bivalent_Ligand_281	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DD-03-171 (CRBN:pomalidomide---BTK:CGI-1746)	-
31669	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10068	Bivalent Ligand 282	DD-04-118|Bivalent_Ligand_282	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DD-04-118 (CRBN:Thalidomide---BTK:CGI-1746)	-
31671	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide---CDK4:TAE684)	-
31673	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- AURKA:TAE684)	-
31675	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- WEE1:TAE684)	-
31677	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- BLK:TAE684)	-
31679	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- FER:TAE684)	-
31681	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK6:TAE684)	-
31683	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- LIMK2:TAE684)	-
31685	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- AAK1:TAE684)	-
31687	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK5:TAE684)	-
31689	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK2:TAE684)	-
31691	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- ITK:TAE684)	-
31693	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK17:TAE684)	-
31695	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- LCK:TAE684)	-
31697	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- PTK2B:TAE684)	-
31699	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK9:TAE684)	-
31701	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK7:TAE684)	-
31703	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK13:TAE684)	-
31705	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- PRKAA1:TAE684)	-
31707	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- CDK12:TAE684)	-
31709	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- BMP2K:TAE684)	-
31711	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10067	Bivalent Ligand 283	LT2-49|Bivalent_Ligand_283	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112669	6793	-	STK10	LOK|PRO2729	9606	Homo sapiens	target	Standardized BVL Name: LT2-49 (CRBN:Thalidomide--- STK10:TAE684)	-
31713	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide---AURKA:Dabrafenib)	-
31715	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- BCKDK:Dabrafenib)	-
31717	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK1:Dabrafenib)	-
31719	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK16:Dabrafenib)	-
31721	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK17:Dabrafenib)	-
31723	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK2:Dabrafenib)	-
31725	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107453	1018	-	CDK3	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK3:Dabrafenib)	-
31727	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK4:Dabrafenib)	-
31729	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CDK6:Dabrafenib)	-
31731	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- COQ8A:Dabrafenib)	-
31733	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123009	79934	-	ADCK4	NPHS9	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- COQ8B:Dabrafenib)	-
31735	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- CSK:Dabrafenib)	-
31737	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111596	5610	-	EIF2AK2	EIF2AK1|PKR|PPP1R83|PRKR	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- EIF2AK2:Dabrafenib)	-
31739	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- LIMK1:Dabrafenib)	-
31741	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- LIMK2:Dabrafenib)	-
31743	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- MAP3K20:Dabrafenib)	-
31745	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119685	51701	-	NLK	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- NLK:Dabrafenib)	-
31747	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- PLK1:Dabrafenib)	-
31749	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- PDK1:Dabrafenib)	-
31751	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- PDK2:Dabrafenib)	-
31753	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10066	Bivalent Ligand 284	DD-03-106|Bivalent_Ligand_284	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115689	10420	-	TESK2	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-106 (CRBN:pomalidomide--- TESK2:Dabrafenib)	-
31755	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide---ABL1:PP58 (kinobeads) 212391-57-6)	-
31757	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- ABL2:PP58 (kinobeads) 212391-57-6)	-
31759	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- AURKA:PP58 (kinobeads) 212391-57-6)	-
31761	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- BLK:PP58 (kinobeads) 212391-57-6)	-
31763	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- CSK:PP58 (kinobeads) 212391-57-6)	-
31765	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108356	2042	-	EPHA3	EK4|ETK|ETK1|HEK|HEK4|TYRO4	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- EPHA3:PP58 (kinobeads) 212391-57-6)	-
31767	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108365	2051	-	EPHB6	HEP	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- EPHB6:PP58 (kinobeads) 212391-57-6)	-
31769	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- FYN:PP58 (kinobeads) 212391-57-6)	-
31771	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- GAK:PP58 (kinobeads) 212391-57-6)	-
31773	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- LCK:PP58 (kinobeads) 212391-57-6)	-
31775	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- LIMK2:PP58 (kinobeads) 212391-57-6)	-
31777	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- MAPK14:PP58 (kinobeads) 212391-57-6)	-
31779	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119685	51701	-	NLK	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- NLK:PP58 (kinobeads) 212391-57-6)	-
31781	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- PDK1:PP58 (kinobeads) 212391-57-6)	-
31783	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114544	9088	-	PKMYT1	MYT1|PPP1R126	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- PKMYT1:PP58 (kinobeads) 212391-57-6)	-
31785	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- SIK2:PP58 (kinobeads) 212391-57-6)	-
31787	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- SRC:PP58 (kinobeads) 212391-57-6)	-
31789	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- TNK2:PP58 (kinobeads) 212391-57-6)	-
31791	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- WEE1:PP58 (kinobeads) 212391-57-6)	-
31793	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10065	Bivalent Ligand 285	SB1-G-192-1|Bivalent_Ligand_285	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-192-1 (CRBN:Thalidomide--- YES1:PP58 (kinobeads) 212391-57-6)	-
31795	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide---AAK1:TAE684)	-
31797	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- AURKA:TAE684)	-
31799	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- BLK:TAE684)	-
31801	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK12:TAE684)	-
31803	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK17:TAE684)	-
31805	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK2:TAE684)	-
31807	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK4:TAE684)	-
31809	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK5:TAE684)	-
31811	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK6:TAE684)	-
31813	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK7:TAE684)	-
31815	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- CDK9:TAE684)	-
31817	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- FER:TAE684)	-
31819	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- ITK:TAE684)	-
31821	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- LCK:TAE684)	-
31823	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- LIMK2:TAE684)	-
31825	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- PTK2B:TAE684)	-
31827	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112669	6793	-	STK10	LOK|PRO2729	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- STK10:TAE684)	-
31829	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10064	Bivalent Ligand 286	SK-3-89|Bivalent_Ligand_286	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: SK-3-89 (CRBN:Thalidomide--- WEE1:TAE684)	-
31831	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide---CDK4:GNF-7)	-
31833	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- BLK:GNF-7)	-
31835	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- FER:GNF-7)	-
31837	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- LIMK2:GNF-7)	-
31839	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- GAK:GNF-7)	-
31841	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- CSK:GNF-7)	-
31843	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- SIK2:GNF-7)	-
31845	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- LCK:GNF-7)	-
31847	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- PTK2B:GNF-7)	-
31849	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- SRC:GNF-7)	-
31851	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- ABL2:GNF-7)	-
31853	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- MAPK14:GNF-7)	-
31855	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide---a MAPK9:GNF-7)	-
31857	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- MAP4K2:GNF-7)	-
31859	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- MKNK2:GNF-7)	-
31861	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- MAP3K20:GNF-7)	-
31863	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB0663 (CRBN:Thalidomide--- TNK2:GNF-7)	-
31865	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide---BLK:GNF-7)	-
31867	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- CDK4:GNF-7)	-
31869	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- CLK1:GNF-7)	-
31871	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- CSK:GNF-7)	-
31873	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- FER:GNF-7)	-
31875	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- LCK:GNF-7)	-
31877	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- LIMK1:GNF-7)	-
31879	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- MAPK8:GNF-7)	-
31881	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- MAPK9:GNF-7)	-
31883	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- MKNK2:GNF-7)	-
31885	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- PLK1:GNF-7)	-
31887	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- PTK2B:GNF-7)	-
31889	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- SIKa2:GNF-7)	-
31891	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- SRC:GNF-7)	-
31893	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- TNK2:GNF-7)	-
31895	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- UHMK1:GNF-7)	-
31897	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113357	7525	-	YES1	HsT441|P61-YES|Yes|c-yes	9606	Homo sapiens	target	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- YES1:GNF-7)	-
31899	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide---AAK1:MRT68921)	-
31901	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- AURKA:MRT68921)	-
31903	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- AURKB:MRT68921)	-
31905	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- BMP2K:MRT68921)	-
31907	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- CDK10:MRT68921)	-
31909	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- CDK9:MRT68921)	-
31911	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- GAK:MRT68921)	-
31913	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK2:MRT68921)	-
31915	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK3:MRT68921)	-
31917	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK4:MRT68921)	-
31919	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- SIK2:MRT68921)	-
31921	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- STK17A:MRT68921)	-
31923	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- STK17B:MRT68921)	-
31925	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120211	54861	-	SNRK	HSNFRK	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- SNRK:MRT68921)	-
31927	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- ULK1:MRT68921)	-
31929	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- WEE1:MRT68921)	-
31931	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide---AURKA:Ceritinib)	-
31933	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK1:Ceritinib)	-
31935	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK12:Ceritinib)	-
31937	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK16:Ceritinib)	-
31939	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK17:Ceritinib)	-
31941	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK2:Ceritinib)	-
31943	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK4:Ceritinib)	-
31945	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK5:Ceritinib)	-
31947	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK6:Ceritinib)	-
31949	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK7:Ceritinib)	-
31951	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- CDK9:Ceritinib)	-
31953	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111588	5602	RP13-514E23.1	MAPK10	JNK3|JNK3A|PRKM10|SAPK1b|p493F12|p54bSAPK	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK10:Ceritinib)	-
31955	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK8:Ceritinib)	-
31957	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK9:Ceritinib)	-
31959	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- RPS6KA1:Ceritinib)	-
31961	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide---AAK1:TAE684)	-
31963	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- AURKA:TAE684)	-
31965	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- BLK:TAE684)	-
31967	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK12:TAE684)	-
31969	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK17:TAE684)	-
31971	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK2:TAE684)	-
31973	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK5:TAE684)	-
31975	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK7:TAE684)	-
31977	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- CDK9:TAE684)	-
31979	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- FER:TAE684)	-
31981	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- ITK:TAE684)	-
31983	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- LCK:TAE684)	-
31985	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- LIMK2:TAE684)	-
31987	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- PTK2B:TAE684)	-
31989	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10090	Bivalent Ligand 291	SK-3-87|Bivalent_Ligand_291	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: SK-3-87 (CRBN:pomalidomide--- WEE1:TAE684)	-
31991	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide---CDK4:Dinaciclib)	-
31993	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- WEE1:Dinaciclib)	-
31995	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- STK17A:Dinaciclib)	-
31997	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111362	5347	-	PLK1	PLK|STPK13	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- PLK1:Dinaciclib)	-
31999	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- BUB1:Dinaciclib)	-
32001	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- TTK:Dinaciclib)	-
32003	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- UHMK1:Dinaciclib)	-
32005	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- MAP3K1:Dinaciclib)	-
32007	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107166	701	-	BUB1B	BUB1beta|BUBR1|Bub1A|MAD3L|MVA1|SSK1|hBUBR1	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- BUB1B:Dinaciclib)	-
32009	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120896	55781	-	RIOK2	RIO2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- RIOK2:Dinaciclib)	-
32011	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- NUAK1:Dinaciclib)	-
32013	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116228	11040	-	PIM2	-	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- PIM2:Dinaciclib)	-
32015	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10091	Bivalent Ligand 292	MFH-5-115-2|Bivalent_Ligand_292	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-115-2 (CRBN:pomalidomide--- CSNK1A1:Dinaciclib)	-
32017	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide---AAK1:APY-24)	-
32019	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- AURKA:APY-24)	-
32021	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- AURKB:APY-24)	-
32023	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- BMP2K:APY-24)	-
32025	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- CDK9:APY-24)	-
32027	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- EPHB2:APY-24)	-
32029	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- GSK3B:APY-24)	-
32031	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- ITK:APY-24)	-
32033	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- LATS1:APY-24)	-
32035	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- MAP4K2:APY-24)	-
32037	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- NEK9:APY-24)	-
32039	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115586	10298	-	PAK4	-	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- PAK4:APY-24)	-
32041	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- PLK4:APY-24)	-
32043	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10092	Bivalent Ligand 293	BJG-04-203|Bivalent_Ligand_293	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: BJG-04-203 (VHL:pomalidomide--- STK17B:APY-24)	-
32045	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111239	5218	-	CDK14	PFTAIRE1|PFTK1	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide---CDK14:not specified)	-
32047	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- CSNK1A1:not specified)	-
32049	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- CSNK1D:not specified)	-
32051	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- CSNK1E:not specified)	-
32053	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- GSK3A:not specified)	-
32055	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- GSK3B:not specified)	-
32057	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- LIMK2:not specified)	-
32059	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110378	4214	-	MAP3K1	MAPKKK1|MEKK|MEKK 1|MEKK1|SRXY6	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- MAP3K1:not specified)	-
32061	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119075	50488	-	MINK1	B55|MAP4K6|MINK|YSK2|ZC3|hMINK|hMINKbeta	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- MINK1:not specified)	-
32063	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- NUAK1:not specified)	-
32065	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115586	10298	-	PAK4	-	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- PAK4:not specified)	-
32067	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116228	11040	-	PIM2	-	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- PIM2:not specified)	-
32069	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112669	6793	-	STK10	LOK|PRO2729	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- STK10:not specified)	-
32071	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- STK17B:not specified)	-
32073	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- STK35:not specified)	-
32075	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10085	Bivalent Ligand 294	WH-10417-099|Bivalent_Ligand_294	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112665	6789	-	STK4	KRS2|MST1|TIIAC|YSK3	9606	Homo sapiens	target	Standardized BVL Name: WH-10417-099 (CRBN:pomalidomide--- STK4:not specified)	-
32077	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide---AAK1:Thienopyrimidines)	-
32079	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- AURKA:Thienopyrimidines)	-
32081	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123981	84254	-	CAMKK1	CAMKKA	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- CAMKK1:Thienopyrimidines)	-
32083	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- CDK4:Thienopyrimidines)	-
32085	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- CDK6:Thienopyrimidines)	-
32087	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- LIMK2:Thienopyrimidines)	-
32089	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- NEK9:Thienopyrimidines)	-
32091	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- PTK2B:Thienopyrimidines)	-
32093	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- STK17A:Thienopyrimidines)	-
32095	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- STK17B:Thienopyrimidines)	-
32097	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- ULK1:Thienopyrimidines)	-
32099	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117470	25989	-	ULK3	-	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- ULK3:Thienopyrimidines)	-
32101	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10086	Bivalent Ligand 295	RSS0628|Bivalent_Ligand_295	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: RSS0628 (CRBN:Thalidomide--- WEE1:Thienopyrimidines)	-
32103	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1---AAK1:MRT68921)	-
32105	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- GAK:MRT68921)	-
32107	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK2:MRT68921)	-
32109	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110310	4140	-	MARK3	CTAK1|KP78|PAR1A|Par-1a	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK3:MRT68921)	-
32111	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK4:MRT68921)	-
32113	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- RPS6KB1:MRT68921)	-
32115	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- SIK2:MRT68921)	-
32117	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116963	23387	L19	SIK3	QSK|SIK-3	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- SIK3:MRT68921)	-
32119	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120211	54861	-	SNRK	HSNFRK	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- SNRK:MRT68921)	-
32121	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- STK17A:MRT68921)	-
32123	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- STK17B:MRT68921)	-
32125	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- ULK1:MRT68921)	-
32127	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- WEE1:MRT68921)	-
32129	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide---AURKA:Ceritinib)	-
32131	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- AURKB:Ceritinib)	-
32133	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK1:Ceritinib)	-
32135	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK2:Ceritinib)	-
32137	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- CDK5:Ceritinib)	-
32139	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111585	5599	-	MAPK8	JNK|JNK-46|JNK1|JNK1A2|JNK21B1/2|PRKM8|SAPK1|SAPK1c	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- MAPK8:Ceritinib)	-
32141	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
32143	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- PTK2:Ceritinib)	-
32145	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- RPS6KA1:Ceritinib)	-
32147	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- RPS6KA3:Ceritinib)	-
32149	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122426	65975	-	STK33	-	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- STK33:Ceritinib)	-
32151	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- TTK:Ceritinib)	-
32153	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide---ABL1:TX1-85-1)	-
32155	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- ABL2:TX1-85-1)	-
32157	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- AURKA:TX1-85-1)	-
32159	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- BLK:TX1-85-1)	-
32161	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- CSK:TX1-85-1)	-
32163	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- CSNK1E:TX1-85-1)	-
32165	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- FYN:TX1-85-1)	-
32167	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- LATS1:TX1-85-1)	-
32169	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- LCK:TX1-85-1)	-
32171	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- LIMK1:TX1-85-1)	-
32173	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111593	5607	-	MAP2K5	HsT17454|MAPKK5|MEK5|PRKMK5	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- MAP2K5:TX1-85-1)	-
32175	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10083	Bivalent Ligand 298	SB1-G-181|Bivalent_Ligand_298	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-181 (CRBN:pomalidomide--- SRC:TX1-85-1)	-
32177	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1---AAK1:TG101209)	-
32179	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- CDK16:TG101209)	-
32181	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- WEE1:TG101209)	-
32183	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- GAK:TG101209)	-
32185	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121760	57787	-	MARK4	MARK4L|MARK4S|MARKL1|MARKL1L|PAR-1D	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- MARK4:TG101209)	-
32187	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- NEK9:TG101209)	-
32189	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112112	6198	-	RPS6KB1	PS6K|S6K|S6K-beta-1|S6K1|STK14A|p70 S6KA|p70(S6K)-alpha|p70-S6K|p70-alpha	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- RPS6KB1:TG101209)	-
32191	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- SIK2:TG101209)	-
32193	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116963	23387	L19	SIK3	QSK|SIK-3	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- SIK3:TG101209)	-
32195	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120211	54861	-	SNRK	HSNFRK	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- SNRK:TG101209)	-
32197	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- STK17A:TG101209)	-
32199	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10084	Bivalent Ligand 299	JWG-123|Bivalent_Ligand_299	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: JWG-123 (VHL:VHL-1--- STK17B:TG101209)	-
32201	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide---ABL1:TX1-85-1)	-
32203	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- ABL2:TX1-85-1)	-
32205	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- BLK:TX1-85-1)	-
32207	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107838	1454	RP1-5O6.1	CSNK1E	CKIepsilon|HCKIE	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- CSNK1E:TX1-85-1)	-
32209	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- CSK:TX1-85-1)	-
32211	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- FYN:TX1-85-1)	-
32213	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- LATS1:TX1-85-1)	-
32215	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- LCK:TX1-85-1)	-
32217	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- LIMK1:TX1-85-1)	-
32219	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111593	5607	-	MAP2K5	HsT17454|MAPKK5|MEK5|PRKMK5	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- MAP2K5:TX1-85-1)	-
32221	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10021	Bivalent Ligand 300	SB1-G-200|Bivalent_Ligand_300	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-200 (CRBN:Thalidomide--- SRC:TX1-85-1)	-
32223	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide---BLK:Quizartinib)	-
32225	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- CDK5:Quizartinib)	-
32227	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- FER:Quizartinib)	-
32229	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- GAK:Quizartinib)	-
32231	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109863	3654	-	IRAK1	IRAK|pelle	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- IRAK1:Quizartinib)	-
32233	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- LCK:Quizartinib)	-
32235	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111809	5871	-	MAP4K2	BL44|GCK|RAB8IP	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- MAP4K2:Quizartinib)	-
32237	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- MAPK14:Quizartinib)	-
32239	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114274	8737	-	RIPK1	RIP|RIP1	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- RIPK1:Quizartinib)	-
32241	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10022	Bivalent Ligand 301	TL13-150|Bivalent_Ligand_301	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: TL13-150 (CRBN:pomalidomide--- SRC :Quizartinib)	-
32243	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111239	5218	-	CDK14	PFTAIRE1|PFTK1	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide---CDK14:not specified)	-
32245	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107837	1453	-	CSNK1D	ASPS|CKIdelta|FASPS2|HCKID	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- CSNK1D:not specified)	-
32247	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- GSK3A:not specified)	-
32249	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- GSK3B:not specified)	-
32251	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- NUAK1:not specified)	-
32253	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116228	11040	-	PIM2	-	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- PIM2:not specified)	-
32255	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114684	9262	-	STK17B	DRAK2	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- STK17B:not specified)	-
32257	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126760	140901	-	STK35	CLIK1|STK35L1	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- STK35:not specified)	-
32259	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10019	Bivalent Ligand 302	WH-9533-153|Bivalent_Ligand_302	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112665	6789	-	STK4	KRS2|MST1|TIIAC|YSK3	9606	Homo sapiens	target	Standardized BVL Name: WH-9533-153 (CRBN:pomalidomide--- STK4:not specified)	-
32261	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide---COQ8A:Adavosertib)	-
32263	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109130	2872	-	MKNK2	GPRK7|MNK2	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- MKNK2:Adavosertib)	-
32265	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115586	10298	-	PAK4	-	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PAK4:Adavosertib)	-
32267	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PDK1:Adavosertib)	-
32269	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PDK2:Adavosertib)	-
32271	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PDK3:Adavosertib)	-
32273	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111570	5584	-	PRKCI	DXS1179E|PKCI|nPKC-iota	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- PRKCI:Adavosertib)	-
32275	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	125042	93627	HSPC302	TBCK	TBCKL	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- TBCK:Adavosertib)	-
32277	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10020	Bivalent Ligand 303	ZNL-02-096|Bivalent_Ligand_303	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: ZNL-02-096 (CRBN:pomalidomide--- WEE1:Adavosertib)	-
32279	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative---BLK:GNF-7)	-
32281	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107164	699	-	BUB1	BUB1A|BUB1L|hBUB1	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- BUB1:GNF-7)	-
32283	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- CDK4:GNF-7)	-
32285	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- LIMK2:GNF-7)	-
32287	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- SIK2:GNF-7)	-
32289	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- STK17A:GNF-7)	-
32291	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- TEC:GNF-7)	-
32293	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115485	10188	-	TNK2	ACK|ACK-1|ACK1|p21cdc42Hs	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- TNK2:GNF-7)	-
32295	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10017	Bivalent Ligand 304	DB118430|Bivalent_Ligand_304	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	126088	127933	-	UHMK1	KIS|KIST|P-CIP2	9606	Homo sapiens	target	Standardized BVL Name: DB118430 (IAP:LCL161 derivative--- UHMK1:GNF-7)	-
32297	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide---AURKA:PND-1186)	-
32299	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- CDK10:PND-1186)	-
32301	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- CDK7:PND-1186)	-
32303	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- MAPK7:PND-1186)	-
32305	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- PTK2B:PND-1186)	-
32307	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- RPS6KA1:PND-1186)	-
32309	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- RPS6KA3:PND-1186)	-
32311	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122426	65975	-	STK33	-	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- STK33:PND-1186)	-
32313	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10018	Bivalent Ligand 305	MFH-5-103-1|Bivalent_Ligand_305	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-103-1 (CRBN:pomalidomide--- WEE1:PND-1186)	-
32315	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide---BCKDK:Palbociclib)	-
32317	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- CDK4:Palbociclib)	-
32319	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- CDK6:Palbociclib)	-
32321	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- COQ8A:Palbociclib)	-
32323	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- PDK1:Palbociclib)	-
32325	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- PDK2:Palbociclib)	-
32327	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- PDK3:Palbociclib)	-
32329	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	8516	Bivalent ligand 76	protac 6|BSJ-03-123|Bivalent_ligand_76	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-123 (CRBN:pomalidomide--- WEE1:Palbociclib)	-
32331	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide---AAK1:kinobeads)	-
32333	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- AURKA:kinobeads)	-
32335	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114646	9212	-	AURKB	AIK2|AIM-1|AIM1|ARK2|AurB|IPL1|PPP1R48|STK12|STK5|aurkb-sv1|aurkb-sv2	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- AURKB:kinobeads)	-
32337	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- CDK6:kinobeads)	-
32339	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- CDK9:kinobeads)	-
32341	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- FGR2:kinobeads)	-
32343	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- STK17A:kinobeads)	-
32345	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10015	Bivalent Ligand 306	SB1-G-194|Bivalent_Ligand_306	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-194 (CRBN:Thalidomide--- TTK:kinobeads)	-
32347	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	609064	728642	RP1-283E3.2	CDK11A	CDC2L2|CDC2L3|CDK11-p110|CDK11-p46|CDK11-p58|PITSLRE|p58GTA	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide---CDK11A:AT7519)	-
32349	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- CDK9:AT7519)	-
32351	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- CLK1:AT7519)	-
32353	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- GSK3A:AT7519)	-
32355	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- GSK3B:AT7519)	-
32357	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111312	5294	-	PIK3CG	PI3CG|PI3K|PI3Kgamma|PIK3|p110gamma|p120-PI3K	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- PIK3CG:AT7519)	-
32359	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10016	Bivalent Ligand 307	FMF-04-147-1|Bivalent_Ligand_307	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117195	23678	-	SGK3	CISK|SGK2|SGKL	9606	Homo sapiens	target	Standardized BVL Name: FMF-04-147-1 (CRBN:pomalidomide--- SGK3:AT7519)	-
32361	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide---AURKA:PND-1186)	-
32363	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115221	9891	-	NUAK1	ARK5	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- NUAK1:PND-1186)	-
32365	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108480	2185	-	PTK2B	CADTK|CAKB|FADK2|FAK2|PKB|PTK|PYK2|RAFTK	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- PTK2B:PND-1186)	-
32367	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- RPS6KA1:PND-1186)	-
32369	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112111	6197	RP11-393H10.3	RPS6KA3	CLS|HU-3|ISPK-1|MAPKAPK1B|MRX19|RSK|RSK2|S6K-alpha3|p90-RSK2|pp90RSK2	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- RPS6KA3:PND-1186)	-
32371	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122426	65975	-	STK33	-	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- STK33:PND-1186)	-
32373	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10013	Bivalent Ligand 308	MFH-5-116-1|Bivalent_Ligand_308	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: MFH-5-116-1 (CRBN:pomalidomide--- WEE1:PND-1186)	-
32375	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide---BCKDK:Ribociclib)	-
32377	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- CDK4:Ribociclib)	-
32379	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- CDK6:Ribociclib)	-
32381	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- COQ8A:Ribociclib)	-
32383	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- PDK1:Ribociclib)	-
32385	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- PDK2:Ribociclib)	-
32387	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10014	Bivalent Ligand 309	BSJ-04-132|Bivalent_Ligand_309	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: BSJ-04-132 (CRBN:Thalidomide--- PDK3:Ribociclib)	-
32389	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide---ABL2:Ibrutinib)	-
32391	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- BLK:Ibrutinib)	-
32393	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- CSK:Ibrutinib)	-
32395	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108810	2534	RP1-66H14.1	FYN	SLK|SYN|p59-FYN	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- FYN:Ibrutinib)	-
32397	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- LCK:Ibrutinib)	-
32399	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- SRC:Ibrutinib)	-
32401	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9990	Bivalent Ligand 310	DD-03-119|Bivalent_Ligand_310	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112865	7006	-	TEC	PSCTK4	9606	Homo sapiens	target	Standardized BVL Name: DD-03-119 (CRBN:pomalidomide--- TEC:Ibrutinib)	-
32403	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide---BLK:Vemurafenib)	-
32405	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- CSK:Vemurafenib)	-
32407	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- LCK:Vemurafenib)	-
32409	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- LIMK2:Vemurafenib)	-
32411	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111593	5607	-	MAP2K5	HsT17454|MAPKK5|MEK5|PRKMK5	9606	Homo sapiens	target	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- MAP2K5:Vemurafenib)	-
32413	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9989	Bivalent Ligand 311	dRAF-3|Bivalent_Ligand_311	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: dRAF-3 (CRBN:Thalidomide--- MAP3K20 :Vemurafenib)	-
32415	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide---AKT1:Ipatasertib)	-
32417	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide--- AKT2:Ipatasertib)	-
32419	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide--- AKT3:Ipatasertib)	-
32421	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide--- CDK4:Ipatasertib)	-
32423	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111583	5597	-	MAPK6	ERK3|HsT17250|PRKM6|p97MAPK	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide--- MAPK6:Ipatasertib)	-
32425	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9992	Bivalent Ligand 312	INY-03-041-01|Bivalent_Ligand_312	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: INY-03-041-01 (CRBN:lenalidomide--- STK17A :Ipatasertib)	-
32427	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9991	Bivalent Ligand 313	TL13-178|Bivalent_Ligand_313	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: TL13-178 (CRBN:pomalidomide---CDK4:Ponatininb)	-
32429	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9991	Bivalent Ligand 313	TL13-178|Bivalent_Ligand_313	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: TL13-178 (CRBN:pomalidomide--- LIMK1:Ponatininb)	-
32431	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9991	Bivalent Ligand 313	TL13-178|Bivalent_Ligand_313	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119725	51776	HCCS4	ZAK	AZK|MLK7|MLT|MLTK|MRK|mlklak|pk	9606	Homo sapiens	target	Standardized BVL Name: TL13-178 (CRBN:pomalidomide--- MAP3K20:Ponatininb)	-
32433	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9991	Bivalent Ligand 313	TL13-178|Bivalent_Ligand_313	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: TL13-178 (CRBN:pomalidomide--- MAPK14:Ponatininb)	-
32435	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9994	Bivalent Ligand 314	ZNL-03-127|Bivalent_Ligand_314	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: ZNL-03-127 (CRBN:pomalidomide---BLK:XMD8-87)	-
32437	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9994	Bivalent Ligand 314	ZNL-03-127|Bivalent_Ligand_314	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: ZNL-03-127 (CRBN:pomalidomide--- LIMK1:XMD8-87)	-
32439	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9994	Bivalent Ligand 314	ZNL-03-127|Bivalent_Ligand_314	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: ZNL-03-127 (CRBN:pomalidomide--- LIMK2:XMD8-87)	-
32441	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9994	Bivalent Ligand 314	ZNL-03-127|Bivalent_Ligand_314	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: ZNL-03-127 (CRBN:pomalidomide--- STK17A:XMD8-87)	-
32443	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	target	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide---BCKDK:Dabrafenib)	-
32445	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	121312	56997	PP265	ADCK3	ARCA2|CABC1|COQ10D4|COQ8|SCAR9	9606	Homo sapiens	target	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide--- COQ8A:Dabrafenib)	-
32447	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide--- LIMK1:Dabrafenib)	-
32449	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide--- PDK1:Dabrafenib)	-
32451	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide--- PDK2:Dabrafenib)	-
32453	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9993	Bivalent Ligand 315	DD-03-107|Bivalent_Ligand_315	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: DD-03-107 (CRBN:lenalidomide--- PDK3:Dabrafenib)	-
32455	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9996	Bivalent Ligand 316	INY-02-164|Bivalent_Ligand_316	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: INY-02-164 (CRBN:Thalidomide---AKT1:Ipatasertib)	-
32457	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9996	Bivalent Ligand 316	INY-02-164|Bivalent_Ligand_316	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: INY-02-164 (CRBN:Thalidomide--- AKT2:Ipatasertib)	-
32459	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9996	Bivalent Ligand 316	INY-02-164|Bivalent_Ligand_316	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: INY-02-164 (CRBN:Thalidomide--- AKT3:Ipatasertib)	-
32461	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9996	Bivalent Ligand 316	INY-02-164|Bivalent_Ligand_316	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115583	10295	-	BCKDK	BCKDKD|BDK	9606	Homo sapiens	target	Standardized BVL Name: INY-02-164 (CRBN:Thalidomide--- BCKDK:Ipatasertib)	-
32463	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: JWG-118 (CRBN:Thalidomide---AAK1:TG101209)	-
32465	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: JWG-118 (CRBN:Thalidomide--- AURKA:TG101209)	-
32467	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: JWG-118 (CRBN:Thalidomide--- BMP2K:TG101209)	-
32469	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9995	Bivalent Ligand 317	JWG-118|Bivalent_Ligand_317	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: JWG-118 (CRBN:Thalidomide--- GAK:TG101209)	-
32471	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide---AAK1:APY-24)	-
32473	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide--- AURKA:APY-24)	-
32475	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120735	55589	HRIHFB2017	BMP2K	BIKE	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide--- BMP2K:APY-24)	-
32477	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9987	Bivalent Ligand 318	SB1-G-190|Bivalent_Ligand_318	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: SB1-G-190 (CRBN:Thalidomide--- GSK3A:APY-24)	-
32479	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9986	Bivalent Ligand 319	BSJ-03-204|Bivalent_Ligand_319	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-204 (CRBN:thalidomide---CDK4:Palbociclib)	-
32481	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9986	Bivalent Ligand 319	BSJ-03-204|Bivalent_Ligand_319	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-204 (CRBN:Thalidomide--- CDK6:Palbociclib)	-
32483	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9986	Bivalent Ligand 319	BSJ-03-204|Bivalent_Ligand_319	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-204 (CRBN:Thalidomide--- PDK1:Palbociclib)	-
32485	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	9986	Bivalent Ligand 319	BSJ-03-204|Bivalent_Ligand_319	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: BSJ-03-204 (CRBN:Thalidomide--- WEE1:Palbociclib)	-
32487	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10138	Bivalent Ligand 320	DB-3-291|Bivalent_Ligand_320	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: DB-3-291 (CRBN:thalidomide---ABL2:dasatinib)	-
32489	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10138	Bivalent Ligand 320	DB-3-291|Bivalent_Ligand_320	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107109	640	-	BLK	MODY11	9606	Homo sapiens	target	Standardized BVL Name: DB-3-291 (CRBN:thalidomide--- BLK:dasatinib)	-
32491	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10138	Bivalent Ligand 320	DB-3-291|Bivalent_Ligand_320	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DB-3-291 (CRBN:thalidomide--- CSK:dasatinib)	-
32493	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10138	Bivalent Ligand 320	DB-3-291|Bivalent_Ligand_320	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: DB-3-291 (CRBN:thalidomide--- WEE1:dasatinib)	-
32495	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10139	Bivalent Ligand 321	JWG-148|Bivalent_Ligand_321	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106545	27	RP11-177A2.3	ABL2	ABLL|ARG	9606	Homo sapiens	target	Standardized BVL Name: JWG-148 (VHL:VHL-1---ABL2:not specified)	-
32497	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10139	Bivalent Ligand 321	JWG-148|Bivalent_Ligand_321	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108362	2048	-	EPHB2	CAPB|DRT|EK5|EPHT3|ERK|Hek5|PCBC|Tyro5	9606	Homo sapiens	target	Standardized BVL Name: JWG-148 (VHL:VHL-1--- EPHB2:not specified)	-
32499	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10139	Bivalent Ligand 321	JWG-148|Bivalent_Ligand_321	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116840	23235	-	SIK2	LOH11CR1I|QIK|SNF1LK2	9606	Homo sapiens	target	Standardized BVL Name: JWG-148 (VHL:VHL-1--- SIK2:not specified)	-
32501	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10139	Bivalent Ligand 321	JWG-148|Bivalent_Ligand_321	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113148	7297	-	TYK2	IMD35|JTK1	9606	Homo sapiens	target	Standardized BVL Name: JWG-148 (VHL:VHL-1--- TYK2:not specified)	-
32503	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10140	Bivalent Ligand 322	DD-03-156|Bivalent_Ligand_322	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: DD-03-156 (VHL:VHL-1--- CDK17:Dabrafenib)	-
32505	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10140	Bivalent Ligand 322	DD-03-156|Bivalent_Ligand_322	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DD-03-156 (VHL:VHL-1--- LIMK1:Dabrafenib)	-
32507	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10140	Bivalent Ligand 322	DD-03-156|Bivalent_Ligand_322	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DD-03-156 (VHL:VHL-1--- LIMK2:Dabrafenib)	-
32509	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10141	Bivalent Ligand 323	BSJ-01-147|Bivalent_Ligand_323	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ-01-147 (CRBN:pomalidomide---CDK4:Palbociclib)	-
32511	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10141	Bivalent Ligand 323	BSJ-01-147|Bivalent_Ligand_323	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-01-147 (CRBN:pomalidomide--- CDK6:Palbociclib)	-
32513	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10141	Bivalent Ligand 323	BSJ-01-147|Bivalent_Ligand_323	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: BSJ-01-147 (CRBN:pomalidomide--- WEE1:Palbociclib)	-
32515	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10134	Bivalent Ligand 324	INY-01-140-1|Bivalent_Ligand_324	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111189	5163	-	PDK1	-	9606	Homo sapiens	target	Standardized BVL Name: INY-01-140-1 (CRBN:Thalidomide---PDK1:MK-2206)	-
32517	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10134	Bivalent Ligand 324	INY-01-140-1|Bivalent_Ligand_324	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111190	5164	-	PDK2	PDHK2|PDKII	9606	Homo sapiens	target	Standardized BVL Name: INY-01-140-1 (CRBN:Thalidomide--- PDK2:MK-2206)	-
32519	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10134	Bivalent Ligand 324	INY-01-140-1|Bivalent_Ligand_324	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111191	5165	-	PDK3	CMTX6|GS1-358P8.4	9606	Homo sapiens	target	Standardized BVL Name: INY-01-140-1 (CRBN:Thalidomide--- PDK3:MK-2206)	-
32521	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10135	Bivalent Ligand 325	TL13-12|Bivalent_Ligand_325	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: TL13-12 (CRBN:pomalidomide---AURKA:TAE684)	-
32523	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10135	Bivalent Ligand 325	TL13-12|Bivalent_Ligand_325	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TL13-12 (CRBN:pomalidomide--- FER:TAE684)	-
32525	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10135	Bivalent Ligand 325	TL13-12|Bivalent_Ligand_325	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111572	5586	RP5-905H16.1	PKN2	PAK2|PRK2|PRKCL2|PRO2042|Pak-2|STK7	9606	Homo sapiens	target	Standardized BVL Name: TL13-12 (CRBN:pomalidomide--- PRK2:TAE684)	-
32527	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10136	Bivalent Ligand 326	JWG-120|Bivalent_Ligand_326	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: JWG-120 (CRBN:Thalidomide---AAK1:not specified)	-
32529	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10136	Bivalent Ligand 326	JWG-120|Bivalent_Ligand_326	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: JWG-120 (CRBN:Thalidomide--- AURKA:not specified)	-
32531	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10137	Bivalent Ligand 327	INY-04-125-01|Bivalent_Ligand_327	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114563	9113	-	LATS1	WARTS|wts	9606	Homo sapiens	target	Standardized BVL Name: INY-04-125-01 (VHL:VHL-1--- LATS1:MK-2206)	-
32533	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10137	Bivalent Ligand 327	INY-04-125-01|Bivalent_Ligand_327	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114685	9263	-	STK17A	DRAK1	9606	Homo sapiens	target	Standardized BVL Name: INY-04-125-01 (VHL:VHL-1--- STK17A:MK-2206)	-
32535	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10142	Bivalent Ligand 328	JWG-122|Bivalent_Ligand_328	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: JWG-122 (VHL:VHL-1---AAK1:TG101209)	-
32537	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10142	Bivalent Ligand 328	JWG-122|Bivalent_Ligand_328	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: JWG-122 (VHL:VHL-1--- GAK:TG101209)	-
32539	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10143	Bivalent Ligand 329	ZZ-1-31B|Bivalent_Ligand_329	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: ZZ-1-31B (VHL:VH032---CDK9:SNS032)	-
32541	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10143	Bivalent Ligand 329	ZZ-1-31B|Bivalent_Ligand_329	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	target	Standardized BVL Name: ZZ-1-31B (VHL:VH032---CLK1:SNS032)	-
32543	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10117	Bivalent Ligand 330	TL13-112|Bivalent_Ligand_330	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: TL13-112 (CRBN:pomalidomide---FER:TAE684)	-
32545	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10117	Bivalent Ligand 330	TL13-112|Bivalent_Ligand_330	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: TL13-112 (CRBN:pomalidomide--- PTK2:TAE684)	-
32547	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10117	Bivalent Ligand 330	TL13-112|Bivalent_Ligand_330	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112109	6195	RP11-492M19.2	RPS6KA1	HU-1|MAPKAPK1A|RSK|RSK1|p90Rsk	9606	Homo sapiens	target	Standardized BVL Name: TL13-112 (CRBN:pomalidomide---RPS6KA1:TAE684)	-
32549	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10116	Bivalent Ligand 331	YKL-06-102|Bivalent_Ligand_331	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: YKL-06-102 (CRBN:pomalidomide---CDK4:Palbociclib)	-
32551	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10116	Bivalent Ligand 331	YKL-06-102|Bivalent_Ligand_331	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: YKL-06-102 (CRBN:pomalidomide---CDK6:Palbociclib)	-
32553	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Donovan KA (2020)	33275901	231643	10116	Bivalent Ligand 331	YKL-06-102|Bivalent_Ligand_331	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: YKL-06-102 (CRBN:pomalidomide---WEE1:Palbociclib)	-
32555	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xu C (2021)	34469831	232212	10115	Bivalent Ligand 332	Bivalent_Ligand_332	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120250	54904	DC28	WHSC1L1	NSD3|pp14328	9606	Homo sapiens	target	Standardized BVL Name: MS9715 (VHL:VHL1-Me---NSD3:BI-9321)	-
32557	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gama-Brambila RA (2021)	34048672	232264	10114	Bivalent Ligand 333	Bivalent_Ligand_333	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117017	23451	-	SF3B1	Hsh155|MDS|PRP10|PRPF10|SAP155|SF3b155	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-O4I2 (CRBN:Thalidomide---SF3B1:O4I2)	-
32559	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yan S (2021)	34093856	232273	10110	Bivalent ligand 334	dCeMM4|Bivalent_ligand_334	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	110359	4194	RP11-430C7.1	MDM4	HDMX|MDMX|MRP1	9606	Homo sapiens	target	Standardized BVL Name: Nano-MP@PSI (VHL:Nano-MP@PSI---MDMX:Nano-MP@PSI)	-
32561	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qu X (2021)	33773286	232265	10113	Bivalent Ligand 335	Bivalent_Ligand_335	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: SIAIS125 (CRBN:pomalidomide---EGFR(L858R+T790M mutant):SIAIS092)	-
32563	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qu X (2021)	33773286	232265	10112	Bivalent Ligand 336	Bivalent_Ligand_336	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: SIAIS126 (CRBN:pomalidomide---EGFR(L858R+T790M mutant):SIAIS092)	-
32565	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu R (2021)	34700270	232271	10111	Bivalent Ligand 337	Bivalent_Ligand_337	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: WWL0245 (CRBN:thalidomide---BRD4:WNY0824)	-
32567	123251	80344	GL014	DCAF11	PRO2389|WDR23	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang X (2021)	33783207	232094	10121	Bivalent Ligand 338	21-SLF|Bivalent_Ligand_338	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: 21-SLF (DCAF11:not specified---FKBP12:SLF)	-
32569	123251	80344	GL014	DCAF11	PRO2389|WDR23	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang X (2021)	33783207	232094	10120	Bivalent Ligand 339	21-ARL|Bivalent_Ligand_339	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: 21-ARL (DCAF11:not specified---AR:AR ligand)	-
32571	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao L (2021)	34937944	232716	10098	Bivalent Ligand 340	AU-15330|Bivalent_Ligand_340	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112479	6595	-	SMARCA2	BAF190|BRM|NCBRS|SNF2|SNF2L2|SNF2LA|SWI2|Sth1p|hBRM|hSNF2a	9606	Homo sapiens	target	Standardized BVL Name: AU-15330 (VHL:VL285---SMARCA2:AU-15139)	-
32573	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao L (2021)	34937944	232716	10098	Bivalent Ligand 340	AU-15330|Bivalent_Ligand_340	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112481	6597	-	SMARCA4	BAF190|BAF190A|BRG1|MRD16|RTPS2|SNF2|SNF2L4|SNF2LB|SWI2|hSNF2b	9606	Homo sapiens	target	Standardized BVL Name: AU-15330 (VHL:VL285---SMARCA4:AU-15139)	-
32575	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao L (2021)	34937944	232716	10098	Bivalent Ligand 340	AU-15330|Bivalent_Ligand_340	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120490	55193	-	PBRM1	BAF180|PB1	9606	Homo sapiens	target	Standardized BVL Name: AU-15330 (VHL:VL285---PBRM1:AU-15139)	-
32577	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Huber ME (2021)	34936714	232717	10099	Bivalent Ligand 341	13|Bivalent_Ligand_341	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116017	10803	-	CCR9	CC-CKR-9|CDw199|GPR-9-6|GPR28	9606	Homo sapiens	target	Standardized BVL Name: 13 (VHL:(S,R,S)-AHPC---CCR9:vercirnon)	-
32579	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang C (2021)	34927316	232727	10096	Bivalent Ligand 342	SPNCOX|Bivalent_Ligand_342	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	target	Standardized BVL Name: SPNCOX (VHL:GSGSALAPYIP---PTGS1:indomethacin)	-
32581	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang C (2021)	34927316	232727	10096	Bivalent Ligand 342	SPNCOX|Bivalent_Ligand_342	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	target	Standardized BVL Name: SPNCOX (VHL:GSGSALAPYIP---PTGS2:indomethacin)	-
32583	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lu X (2021)	34916494	232728	10097	Bivalent Ligand 343	XL5-VHL-2|Bivalent_Ligand_343	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116235	11047	-	ADRM1	ARM-1|ARM1|GP110	9606	Homo sapiens	target	Standardized BVL Name: XL5-VHL-2 (VHL:VHL ligand---ADRM1:XL5)	-
32585	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lu Y (2021)	34885822	232750	10102	Bivalent Ligand 344	21a|Bivalent_Ligand_344	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: 21a(CRBN:lenalidomide---HDAC6:benzamide)	-
32587	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hahn F (2021)	34884662	232751	10103	Bivalent Ligand 345	THAL-SNS032|Bivalent_Ligand_345	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: THAL-SNS032(CRBN:thalidomide---CDK2:SNS032; Coronavirus Project)	-
32589	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hahn F (2021)	34884662	232751	10103	Bivalent Ligand 345	THAL-SNS032|Bivalent_Ligand_345	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: THAL-SNS032(CRBN:thalidomide---CDK2:SNS032; Coronavirus Project)	-
32591	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hahn F (2021)	34884662	232751	10103	Bivalent Ligand 345	THAL-SNS032|Bivalent_Ligand_345	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: THAL-SNS032(CRBN:thalidomide---CDK2:SNS032; Coronavirus Project)	-
32593	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Liu J (2021)	34100597	232747	10100	Bivalent Ligand 346	Bivalent_Ligand_346	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111902	5970	-	RELA	NFKB3|p65	9606	Homo sapiens	target	Standardized BVL Name: NF-kB-PROTAC (dNF-kB)(VHL:VHLL-X-BCN---RELA:N3-ODN)	-
32595	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Liu J (2021)	34100597	232747	10101	Bivalent Ligand 347	Bivalent_Ligand_347	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108201	1869	-	E2F1	E2F-1|RBAP1|RBBP3|RBP3	9606	Homo sapiens	target	Standardized BVL Name: E2F-PROTAC (dE2F) (VHL:VHLL-X-BCN---E2F1:N3-ODN)	-
32597	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cao Z (2021)	34860497	239580	10105	Bivalent Ligand 348	14a|Bivalent_Ligand_348	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: 14a (CRBN:pomalidomide---HDAC6:indirubin)	-
32599	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34855399	232882	10106	Bivalent Ligand 349	MS98|Bivalent_Ligand_349	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: MS98 (VHL:VHL-2---AKT1:GDC-0068)	-
32601	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34855399	232882	10106	Bivalent Ligand 349	MS98|Bivalent_Ligand_349	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: MS98 (VHL:VHL-2---AKT2:GDC-0068)	-
32603	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34855399	232882	10106	Bivalent Ligand 349	MS98|Bivalent_Ligand_349	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: MS98 (VHL:VHL-2---AKT3:GDC-0068)	-
32605	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34855399	232882	10078	Bivalent Ligand 350	MS170|Bivalent_Ligand_350	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: MS170 (CRBN:pomalidomide---AKT1:GDC-0068)	-
32607	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34855399	232882	10078	Bivalent Ligand 350	MS170|Bivalent_Ligand_350	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: MS170 (CRBN:pomalidomide---AKT2:GDC-0068)	-
32609	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34855399	232882	10078	Bivalent Ligand 350	MS170|Bivalent_Ligand_350	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: MS170 (CRBN:pomalidomide---AKT3:GDC-0068)	-
32611	114397	8878	-	SQSTM1	A170|OSIL|PDB3|ZIP3|p60|p62|p62B	9606	Homo sapiens	degradation	lysosome-targeting protein	Zheng ZG (2021)	32432943	233272	10077	Bivalent Ligand 351	lycorine|Bivalent_Ligand_351	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	116596	22937	PSEC0227	SCAP	-	9606	Homo sapiens	target	Standardized BVL Name: lycorine (SQSTM1:lycorine---SCAP:lycorine)	-
32613	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ghidini A (2021)	33108679	233302	10080	Bivalent Ligand 352	ORN3P1|Bivalent_Ligand_352	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122842	79727	-	LIN28A	CSDD1|LIN-28|LIN28|ZCCHC1|lin-28A	9606	Homo sapiens	target	Standardized BVL Name: ORN3P1 (VHL:HIF1a peptide---LIN28A:AGGAGAU)	-
32615	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ghidini A (2021)	33108679	233302	10079	Bivalent Ligand 353	ORN7P1|Bivalent_Ligand_353	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122842	79727	-	LIN28A	CSDD1|LIN-28|LIN28|ZCCHC1|lin-28A	9606	Homo sapiens	target	Standardized BVL Name: ORN7P1 (VHL:HIF1a peptide---LIN28A:AGGAGAUAACU)	-
32617	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ghidini A (2021)	33108679	233302	10074	Bivalent Ligand 354	ORN9P1|Bivalent_Ligand_354	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120107	54715	-	RBFOX1	2BP1|A2BP1|FOX-1|FOX1|HRNBP1	9606	Homo sapiens	target	Standardized BVL Name: ORN9P1 (VHL:HIF1a peptide---RBFOX1:UGCAUGU)	-
32619	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ghidini A (2021)	33108679	233302	10073	Bivalent Ligand 355	ORN3VH032|Bivalent_Ligand_355	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122842	79727	-	LIN28A	CSDD1|LIN-28|LIN28|ZCCHC1|lin-28A	9606	Homo sapiens	target	Standardized BVL Name: ORN3VH032 (VHL:VH032---LIN28A:AGGAGAU)	-
32621	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu H (2021)	34217059	233625	10076	Bivalent Ligand 356	SIAIS056|Bivalent_Ligand_356	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: SIAIS056 (CRBN:pomalidomide---BCR-ABL:dasatinib)	-
32623	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nguyen TT (2022)	35335338	234961	10075	Bivalent Ligand 357	ARV-110|Bivalent_Ligand_357	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARV-110/bavdegalutamide (CRBN:Thalidomide 5-fluoride---AR:enzalutamide ligand)	-
32625	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lv D (2021)	34824248	234973	10072	Bivalent Ligand 358	753b|Bivalent_Ligand_358	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: 753b (VHL:VHL ligand---BCL2L1:ABT263)	-
32627	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lv D (2021)	34824248	234973	10072	Bivalent Ligand 358	753b|Bivalent_Ligand_358	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	target	Standardized BVL Name: 753b (VHL:VHL ligand---BCL2:ABT263)	-
32629	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cao S (2021)	34694800	235015	10071	Bivalent Ligand 359	PROTAC 1|Bivalent_Ligand_359	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	target	Standardized BVL Name: PROATC 1 (CRBN:pomalidomide---FLT3:dovitinib)	-
32631	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cao S (2021)	34694800	235015	10046	Bivalent Ligand 360	PROTAC 2|Bivalent_Ligand_360	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	target	Standardized BVL Name: PROATC 2 (CRBN:pomalidomide---FLT3:dovitinib)	-
32633	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Eron SJ (2021)	34582690	235023	10047	Bivalent Ligand 361	CFT-1297|Bivalent_Ligand_361	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: CFT-1297 (CRBN:thalidomide---BRD4:triazoloazepine ligand)	-
32635	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Roberts BL (2020)	32255606	235043	10048	Bivalent Ligand 362	AM-A3|Bivalent_Ligand_362	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: AM-A3 (VHL:VHL ligand---ER:raloxifene)	-
32637	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	He K (2020)	32317208	235047	10049	Bivalent Ligand 363	PROTAC 16c|Bivalent_Ligand_363	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 16c (CRBN:lenalidomide---EGFR:osimertinib)	-
32639	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Law RP (2021)	34416073	239581	10050	Bivalent Ligand 364	GSK215|Bivalent_Ligand_364	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: GSK215 (VHL:VHL-021 ---PTK2:VS-4718)	-
32641	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lin X (2020)	32829249	223472	10051	Bivalent Ligand 365	ARV-471|Bivalent_Ligand_365	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ARV-471(CRBN:lenalidomide---ESR1:Lasofoxifene)	-
32643	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bond AG (2021)	34652918	235084	10052	Bivalent Ligand 367	AGB1|Bivalent_Ligand_367	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: AGB1 (VHL:VH032---BromoTag-BRD2:ET-JQ1-OH)	-
32645	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bond AG (2021)	34652918	235084	10044	Bivalent Ligand 368	AGB2|Bivalent_Ligand_368	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: AGB2 (VHL:VH032---BromoTag-BRD2:ET-JQ1-OH)	-
32647	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bond AG (2021)	34652918	235084	10045	Bivalent Ligand 369	AGB3|Bivalent_Ligand_369	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: AGB3 (VHL:VH032---BromoTag-BRD2:ET-JQ1-OH)	-
32649	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Silva MC (2022)	35317195	235160	10028	Bivalent Ligand 370	QC-01-175|Bivalent_Ligand_370	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: QC-01-175 (CRBN:pomalidomide---MAPT:T807)	-
32651	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Silva MC (2022)	35317195	235160	10027	Bivalent Ligand 371	FMF-06-049|Bivalent_Ligand_371	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-049 (CRBN:pomalidomide---MAPT:T807)	-
32653	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Silva MC (2022)	35317195	235160	10026	Bivalent Ligand 372	FMF-06-038|Bivalent_Ligand_372	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: FMF-06-038 (CRBN:pomalidomide---MAPT:T807)	-
32655	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10025	Bivalent Ligand 373	JPS014|Bivalent_Ligand_373	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: JPS014 (VHL:VHL ligand---HDAC1:CI-994)	-
32657	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10025	Bivalent Ligand 373	JPS014|Bivalent_Ligand_373	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	target	Standardized BVL Name: JPS014 (VHL:VHL ligand---HDAC2:CI-994)	-
32659	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10025	Bivalent Ligand 373	JPS014|Bivalent_Ligand_373	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: JPS014 (VHL:VHL ligand---HDAC3:CI-994)	-
32661	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10032	Bivalent Ligand 374	JPS016|Bivalent_Ligand_374	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: JPS016 (VHL:VHL ligand---HDAC1:CI-994)	-
32663	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10032	Bivalent Ligand 374	JPS016|Bivalent_Ligand_374	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	target	Standardized BVL Name: JPS016 (VHL:VHL ligand---HDAC2:CI-994)	-
32665	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10032	Bivalent Ligand 374	JPS016|Bivalent_Ligand_374	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: JPS016 (VHL:VHL ligand---HDAC3:CI-994)	-
32667	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Smalley JP (2022)	35293758	235205	10031	Bivalent Ligand 375	JPS036|Bivalent_Ligand_375	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: JPS036 (VHL:fluorinated cyclopropane VHL analogue---HDAC3:CI-994)	-
32669	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu Q (2022)	34864330	235159	10030	Bivalent Ligand 376	BP3|Bivalent_Ligand_376	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	target	Standardized BVL Name: BP3 (CRBN:pomalidomide---HSP90AA1:BIIB021)	-
32671	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (CRBN:pomalidomide---JAK2:ruxolitinib)	-
32673	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: compound 6 (CRBN:pomalidomide---JAK2:baricitinib)	-
32675	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (CRBN:pomalidomide---JAK2:ruxolitinib N-propyl analog)	-
32677	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10007	Bivalent Ligand 380	compound 8|Bivalent_Ligand_380	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: compound 8 (CRBN:thalidomide---JAK2:baricitinib)	-
32679	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (CRBN:pomalidomide---JAK1:ruxolitinib)	-
32681	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109921	3718	-	JAK3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (CRBN:pomalidomide---JAK3:ruxolitinib)	-
32683	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (CRBN:pomalidomide---GSPT1:ruxolitinib)	-
32685	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (CRBN:pomalidomide---IKZF1:ruxolitinib)	-
32687	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10029	Bivalent Ligand 377	compound 5|Bivalent_Ligand_377	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113148	7297	-	TYK2	IMD35|JTK1	9606	Homo sapiens	target	Standardized BVL Name: compound 5 (CRBN:pomalidomide---TYK2:ruxolitinib)	-
32689	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: compound 6 (CRBN:pomalidomide---JAK1:baricitinib)	-
32691	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109921	3718	-	JAK3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	9606	Homo sapiens	target	Standardized BVL Name: compound 6 (CRBN:pomalidomide---JAK3:baricitinib)	-
32693	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 6 (CRBN:pomalidomide---GSPT1:baricitinib)	-
32695	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: compound 6 (CRBN:pomalidomide---IKZF1:baricitinib)	-
32697	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10024	Bivalent Ligand 378	compound 6|Bivalent_Ligand_378	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113148	7297	-	TYK2	IMD35|JTK1	9606	Homo sapiens	target	Standardized BVL Name: compound 6 (CRBN:pomalidomide---TYK2:baricitinib)	-
32699	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109919	3716	-	JAK1	JAK1A|JAK1B|JTK3	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (CRBN:pomalidomide---JAK1:ruxolitinib N-propyl analog)	-
32701	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109921	3718	-	JAK3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (CRBN:pomalidomide---JAK3:ruxolitinib N-propyl analog)	-
32703	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (CRBN:pomalidomide---GSPT1:ruxolitinib N-propyl analog)	-
32705	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (CRBN:pomalidomide---IKZF1:ruxolitinib N-propyl analog)	-
32707	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chang Y (2021)	34110416	235255	10023	Bivalent Ligand 379	compound 7|Bivalent_Ligand_379	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113148	7297	-	TYK2	IMD35|JTK1	9606	Homo sapiens	target	Standardized BVL Name: compound 7 (CRBN:pomalidomide---TYK2:ruxolitinib N-propyl analog)	-
32709	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Adhikari B (2020)	32989298	235317	10007	Bivalent Ligand 380	compound 8|Bivalent_Ligand_380	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: JB158 (CRBN:thalidomide---AURKA:alisertib)	-
32711	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Adhikari B (2020)	32989298	235317	10008	Bivalent Ligand 381	JB170|Bivalent_Ligand_381	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: JB170 (CRBN:thalidomide---AURKA:alisertib)	-
32713	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Shen Y (2020)	32787082	235326	10118	Bivalent Ligand 382	compound 15|Bivalent_Ligand_382	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115688	10419	-	PRMT5	HRMT1L5|IBP72|JBP1|SKB1|SKB1Hs	9606	Homo sapiens	target	Standardized BVL Name: compound 15 (VHL:VHL-2---PRMT5:EPZ015666)	-
32715	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2019)	30990042	235710	10133	Bivalent Ligand 383	ERD-308|Bivalent_Ligand_383	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ERD-308 (VHL:compound 11---ESR1:raloxifene)	-
32717	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107420	983	-	CDK1	CDC2|CDC28A|P34CDC2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK1:TL13-87)	-
32719	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK2:TL13-87)	-
32721	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK4:TL13-87)	-
32723	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK5:TL13-87)	-
32725	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK6:TL13-87)	-
32727	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK7:TL13-87)	-
32729	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107458	1024	-	CDK8	K35	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK8:TL13-87)	-
32731	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK9:TL13-87)	-
32733	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK10:TL13-87)	-
32735	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116725	23097	RP11-346C16.5	CDK19	CDC2L6|CDK11|bA346C16.3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK11:TL13-87)	-
32737	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK12:TL13-87)	-
32739	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114176	8621	-	CDK13	CDC2L|CDC2L5|CHED|hCDK13	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK13:TL13-87)	-
32741	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111239	5218	-	CDK14	PFTAIRE1|PFTK1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK14:TL13-87)	-
32743	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111154	5127	-	CDK16	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK16:TL13-87)	-
32745	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111155	5128	-	CDK17	PCTAIRE2|PCTK2	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK17:TL13-87)	-
32747	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Riching KM (2021)	33190579	235709	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111156	5129	RP11-288G13.1	CDK18	PCTAIRE|PCTAIRE3|PCTK3	9606	Homo sapiens	target	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- CDK18:TL13-87)	-
32749	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang J (2022)	35210568	236436	9999	Bivalent ligand 384	MS177|Bivalent_ligand_384	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: MS177 (CRBN:pomalidomide --- EZH2:C24)	-
32751	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Potjewyd F (2020)	31831267	236457	10000	Bivalent ligand 385	UNC6852|Bivalent_ligand_385	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: UNC6852 (VHL:VH032-amine --- EZH2:EED226)	-
32753	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Potjewyd F (2020)	31831267	236457	10000	Bivalent ligand 385	UNC6852|Bivalent_ligand_385	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: UNC6852 (VHL:VH032-amine --- EED:EED226)	-
32755	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Potjewyd F (2020)	31831267	236457	10000	Bivalent ligand 385	UNC6852|Bivalent_ligand_385	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117059	23512	-	SUZ12	CHET9|JJAZ1	9606	Homo sapiens	target	Standardized BVL Name: UNC6852 (VHL:VH032-amine --- SUZ12:EED226)	-
32757	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Durbin AD (2022)	34772733	236045	9997	Bivalent ligand 386	JQAD1|Bivalent_ligand_386	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108347	2033	RP1-85F18.1	EP300	KAT3B|RSTS2|p300	9606	Homo sapiens	target	Standardized BVL Name: JQAD1 (CRBN:pomalidomide --- EP300:A485)	-
32759	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yamanaka S (2022)	35013300	235958	9998	Bivalent ligand 387	5-hydroxythalidomide|Bivalent_ligand_387	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: 5-hydroxythalidomide (CRBN:5-hydroxythalidomide --- GSPT1:5-hydroxythalidomide)	-
32761	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yamanaka S (2022)	35013300	235958	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: CC-885 (CRBN:CC-885 --- GSPT1:CC-885)	-
32763	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yamanaka S (2022)	35013300	235958	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	113534	7750	RP11-264J4.7	ZMYM2	FIM|MYM|RAMP|SCLL|ZNF198	9606	Homo sapiens	target	Standardized BVL Name: pomalidomide (CRBN:pomalidomide --- ZMYM2:pomalidomide)	-
32765	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yamanaka S (2022)	35013300	235958	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121643	57592	RP11-126K1.3	ZNF687	-	9606	Homo sapiens	target	Standardized BVL Name: CC-885 (CRBN:CC-885 --- ZNF687:CC-885)	-
32767	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yamanaka S (2022)	35013300	235958	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	target	Standardized BVL Name: CC-885 (CRBN:CC-885 --- CSNK1A1:CC-885)	-
32769	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Shimizu N (2021)	34764413	235318	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	113498	7704	-	ZBTB16	PLZF|ZNF145	9606	Homo sapiens	target	Standardized BVL Name: pomalidomide (CRBN:pomalidomide --- ZBTB16:pomalidomide)	-
32771	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Wei J (2021)	34520194	236464	10082	Bivalent ligand 389	MS83|Bivalent_ligand_389	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: MS83 (KEAP1:KEAP1-L --- BRD4:unspecified)	-
32773	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Wei J (2021)	34520194	236464	10082	Bivalent ligand 389	MS83|Bivalent_ligand_389	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: MS83 (KEAP1:KEAP1-L --- BRD3:unspecified)	-
32775	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Y (2020)	31991291	227147	10094	Bivalent ligand 390	Cer/Pom-PEG@GNPs|Bivalent_ligand_390	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: Cer/Pom-PEG@GNPs (CRBN:pomalidomide --- ALK:ceritinib)	-
32777	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gockel LM (2022)	35128717	236481	10093	Bivalent ligand 391	PROTAC35|Bivalent_ligand_391	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: PROTAC35 (CRBN:pomalidomide --- AR:enzalutamide)	-
32779	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Salami J (2018)	30271980	239582	10147	Bivalent ligand 392	ARCC-4|Bivalent_ligand_392	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARCC-4 (VHL:HIF-1alpha hydroxyproline derived small molecule --- AR:enzalutamide)	-
32781	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	He S (2021)	34221872	233411	10146	Bivalent ligand 393	PROTAC 11a-1|Bivalent_ligand_393	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 11a-1 (MDM2:Nutlin-3 derivative compound 2 --- MDM2:Nutlin-3 derivative compound 2)	-
32783	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2020)	32865967	229378	10149	Bivalent ligand 394	ZXH-1-161|Bivalent_ligand_394	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: ZXH-1-161 (CRBN:lenalidomide --- GSPT1:lenalidomide)	-
32785	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2020)	32865967	229378	10148	Bivalent ligand 395	ZXH-1-084|Bivalent_ligand_395	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: ZXH-1-084 (CRBN:lenalidomide --- GSPT1:lenalidomide)	-
32787	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2020)	32865967	229378	10151	Bivalent ligand 396	ZXH-1-167|Bivalent_ligand_396	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: ZXH-1-167 (CRBN:lenalidomide --- GSPT1:lenalidomide)	-
32789	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2020)	32865967	229378	10150	Bivalent ligand 397	ZXH-2-160|Bivalent_ligand_397	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: ZXH-2-160 (CRBN:lenalidomide --- GSPT1:lenalidomide)	-
32791	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Powell CE (2020)	32865967	229378	10153	Bivalent ligand 398	ZXH-2-164|Bivalent_ligand_398	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: ZXH-2-164 (CRBN:lenalidomide --- GSPT1:lenalidomide)	-
32793	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Cotton AD (2021)	33395526	231300	10152	Bivalent ligand 399	AC-1|Bivalent_ligand_399	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: AC-1 (RNF43:RNF43 ab, R0 clone --- CD274:atezolizumab)	-
32795	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10123	Bivalent ligand 400	R3/atz|Bivalent_ligand_400	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: R3/atz (RNF43:RNF43 ab, R3 clone --- CD274:atezolizumab)	-
32797	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10122	Bivalent ligand 401	R6/atz|Bivalent_ligand_401	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: R6/atz (RNF43:RNF43 ab, R6 clone --- CD274:atezolizumab)	-
32799	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10125	Bivalent ligand 402	R0/ctx|Bivalent_ligand_402	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: R0/ctx (RNF43:RNF43 ab, R0 clone --- EGFR:cetuximab)	-
32801	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10124	Bivalent ligand 403	R0/matu|Bivalent_ligand_403	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: R0/matu (RNF43:RNF43 ab, R0 clone --- EGFR:matuzumab)	-
32803	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10127	Bivalent ligand 404	R0/neci|Bivalent_ligand_404	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: R0/neci (RNF43:RNF43 ab, R0 clone --- EGFR:necitumumab)	-
32805	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10126	Bivalent ligand 405	R0/pani|Bivalent_ligand_405	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: R0/pani (RNF43:RNF43 ab, R0 clone --- EGFR:panitumumab)	-
32807	120241	54894	-	RNF43	RNF124|URCC	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10129	Bivalent ligand 406	R3/ctx|Bivalent_ligand_406	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: R3/ctx  (RNF43:RNF43 ab, R3 clone --- EGFR:cetuximab)	-
32809	123905	84133	hCG_40978	ZNRF3	BK747E2.3|RNF203	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10128	Bivalent ligand 407	Z18/atz|Bivalent_ligand_407	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: Z18/atz (ZNRF3:Z18 --- CD274:atezolizumab)	-
32811	123905	84133	hCG_40978	ZNRF3	BK747E2.3|RNF203	9606	Homo sapiens	degradation	recruited e3 ligase	Gosavi PM (2022)	35505873	237057	10131	Bivalent ligand 408	Z18/ctx|Bivalent_ligand_408	-	BIOGRID	-	-	antibody	-	-	BIOGRID	AbTAC	Antibody-based PROTACs, in which bispecific IgGs bind to two proteins simultaneously, an E3 and POI; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: Z18/ctx (ZNRF3:Z18 --- EGFR:cetuximab)	-
32813	114343	8816	-	DCAF5	BCRG2|BCRP2|D14S1461E|WDR22	9606	Homo sapiens	degradation	recruited e3 ligase	Nalawansha DA (2022)	35311258	239583	10130	Bivalent ligand 409	KL-4|Bivalent_ligand_409	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: KL-4 (DCAF5:L3MBTL3-UNC1215 --- FKBP1A:SLF)	-
32815	114343	8816	-	DCAF5	BCRG2|BCRP2|D14S1461E|WDR22	9606	Homo sapiens	degradation	recruited e3 ligase	Nalawansha DA (2022)	35311258	239583	10108	Bivalent ligand 410	KL-7|Bivalent_ligand_410	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: KL-7  (DCAF5:L3MBTL3-UNC1215 --- BRD2:JQ1)	-
32817	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lu J (2022)	35084180	239584	10109	Bivalent ligand 411	8e|Bivalent_ligand_411	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: 8e (CRBN:lenalidomide ---TTK:TTK inhibitor 6)	-
32819	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lu J (2022)	35084180	239584	10104	Bivalent ligand 412	8j|Bivalent_ligand_412	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113123	7272	RP3-357D13.2	TTK	CT96|ESK|MPH1|MPS1|MPS1L1|PYT	9606	Homo sapiens	target	Standardized BVL Name: 8j (CRBN:lenalidomide ---TTK:TTK inhibitor 6)	-
32821	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Alcock LJ (2022)	35300081	239585	10107	Bivalent ligand 413	PROTAC11/SJ10542|Bivalent_ligand_413	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109920	3717	-	JAK2	JTK10|THCYT3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC11/SJ10542 (CRBN:phenyl glutarimide --- JAK2:baricitinib)	-
32823	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Alcock LJ (2022)	35300081	239585	10107	Bivalent ligand 413	PROTAC11/SJ10542|Bivalent_ligand_413	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109921	3718	-	JAK3	JAK-3|JAK3_HUMAN|JAKL|L-JAK|LJAK	9606	Homo sapiens	target	Standardized BVL Name: PROTAC11/SJ10542 (CRBN:phenyl glutarimide --- JAK3:baricitinib)	-
32825	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bond MJ (2020)	32875077	239586	10095	Bivalent ligand 414	LC-2|Bivalent_ligand_414	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: LC-2 (VHL:HIF-1alpha hydroxyproline derived small molecule --- KRAS-G12c:MRTX849)	-
32827	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Guo L (2022)	35397401	239587	10132	Bivalent ligand 415	LG-AR-14|Bivalent_ligand_415	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: LG-AR-14 (VHL:VHL ligand --- AR:AR ligand 3)	-
32829	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Guo L (2022)	35397401	239587	9988	Bivalent ligand 416	LG-BRD-12|Bivalent_ligand_416	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: LG-BRD-12 (VHL:VHL ligand --- BRD4:JQ1)	-
32831	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2022)	35119851	239588	10043	Bivalent ligand 417	compound 20|Bivalent_ligand_417	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: compound 20 (VHL:VHL-1 --- AKT:AZD5363)	-
32833	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2022)	35119851	239588	10154	Bivalent ligand 418	compound 35|Bivalent_ligand_418	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	target	Standardized BVL Name: compound 35 (CRBN:pomalidomide --- AKT:AZD5363)	-
32835	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2022)	35119851	239588	10043	Bivalent ligand 417	compound 20|Bivalent_ligand_417	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: compound 20 (VHL:VHL-1 --- AKT:AZD5363)	-
32837	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2022)	35119851	239588	10154	Bivalent ligand 418	compound 35|Bivalent_ligand_418	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	target	Standardized BVL Name: compound 35 (CRBN:pomalidomide --- AKT:AZD5363)	-
32839	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2022)	35119851	239588	10043	Bivalent ligand 417	compound 20|Bivalent_ligand_417	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: compound 20 (VHL:VHL-1 --- AKT:AZD5363)	-
32841	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2022)	35119851	239588	10154	Bivalent ligand 418	compound 35|Bivalent_ligand_418	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	target	Standardized BVL Name: compound 35 (CRBN:pomalidomide --- AKT:AZD5363)	-
32843	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li X (2022)	35395864	239589	10119	Bivalent ligand 419	compound 1|Bivalent_ligand_419	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110444	4298	-	MLLT1	ENL|LTG19|YEATS1	9606	Homo sapiens	target	Standardized BVL Name: compound 1 (CRBN:thalidomide --- MLLT1:SGC-iMLLT)	-
32845	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Pillow TH (2020)	31674143	239590	10060	Bivalent ligand 420	GNE-987|Bivalent_ligand_420	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: GNE-987 ( VHL:VHL-1 --- BRD4:BET inhibitor)	-
32847	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wang H (2022)	35344835	239591	10059	Bivalent ligand 421	HL-8|Bivalent_ligand_421	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111308	5290	-	PIK3CA	CLOVE|CWS5|MCAP|MCM|MCMTC|PI3K|p110-alpha	9606	Homo sapiens	target	Standardized BVL Name: HL-8(VHL:VHL ligand --- PIK3CA:compound 15a)	-
32849	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Gui W (2022)	35802347	238278	10058	Bivalent ligand 422	WJ638|Bivalent_ligand_422	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	target	Standardized BVL Name: WJ638 (VHL: VH032 --- VHL: VH032)	-
32851	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Gui W (2022)	35802347	238278	10057	Bivalent ligand 423	WJ051|Bivalent_ligand_423	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: WJ051  (VHL: VH032 --- BRD4:JQ1)	-
32853	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Gui W (2022)	35802347	238278	10056	Bivalent ligand 424	WJ281|Bivalent_ligand_424	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: WJ281  (VHL: VH032 --- BRD4:JQ1)	-
32855	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Gui W (2022)	35802347	238278	10055	Bivalent ligand 425	WJ287|Bivalent_ligand_425	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: WJ287  (VHL: VH032 --- BRD4:JQ1)	-
32857	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reddi RN (2021)	34817989	239592	10054	Bivalent ligand 426	CoLDR PROTAC 1n|Bivalent_ligand_426	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: CoLDR PROTAC 1n (CRBN:thalidomide --- BTK)	-
32859	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huber AD (2022)	35978691	238928	10053	Bivalent ligand 427	SJPYT-195|Bivalent_ligand_427	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: SJPYT-195 (CRBN:SJPYT-195 --- GSPT1:SJPYT-195)	-
32861	115365	10054	HRIHFB2115	UBA2	ARX|SAE2	9606	Homo sapiens	inhibitor	target	He X (2017)	28892090	242731	10200	ML-792	Sulfamic acid, [(1R,2S,4R)-4-[[5-[[1-[(3-bromophenyl)methyl]-1H-pyrazol-3-yl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester|{(1R,2S,4R)-4-[(5-{[1-(3-Bromobenzyl)-1H-pyrazol-3-yl]carbonyl}-4-pyrimidinyl)amino]-2-hydroxycyclopentyl}methyl sulfamate	-	CHEMSPIDER	71061543	C21H23BrN6O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	PZCKLTWSXFDLLP-OGWOLHLISA-N
32862	116235	11047	-	ADRM1	ARM-1|ARM1|GP110	9606	Homo sapiens	inhibitor	target	Rao G (2018)	30280096	242985	10178	CLEFMA	CLEFMA|4-[3,5-Bis[(2-chlorophenyl)methylene]-4-oxo-1-piperidinyl]-4-oxo-2-butenoic acid|(2Z)-4-[(3E,5E)-3,5-Bis(2-chlorobenzylidene)-4-oxo-1-piperidinyl]-4-oxo-2-butenoic acid|2-Butenoic acid, 4-[(3E,5E)-3,5-bis[(2-chlorophenyl)methylene]-4-oxo-1-piperidinyl]-4-oxo-, (2Z)-	-	CHEMSPIDER	26351206	C23H17Cl2NO4	small molecule	-	1246964-32-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ABOUDPJRQGWQNW-GGDLZHBGSA-N
32863	116235	11047	-	ADRM1	ARM-1|ARM1|GP110	9606	Homo sapiens	inhibitor	target	Rao G (2018)	30280096	242985	10244	EF24	4-Piperidinone, 3,5-bis[(2-fluorophenyl)methylene]-, (3E,5E)-, hydrochloride (1:1)|(3E,5E)-3,5-Bis(2-fluorobenzylidene)-4-piperidinone hydrochloride (1:1)	-	CHEMSPIDER	88296132	C19H16ClF2NO	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	-	ILMJCEBAMHGBAA-XETSTSIRSA-N
32864	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	inhibitor	target	Keating D (2018)	30334692	246257	10254	Elexacaftor	Elexacaftor|N-[(1,3-Dimethyl-1H-pyrazol-4-yl)sulfonyl]-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]nicotinamide|3-Pyridinecarboxamide, N-[(1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl]-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]-	-	CHEMSPIDER	75531299	C26H34F3N7O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Targets Phe508del CFTR protein; Trikafta (comprising elexacaftor, tezacaftor and ivacaftor) drug combination therapy for Cystic Fibrosis	MVRHVFSOIWFBTE-INIZCTEOSA-N
32865	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	inhibitor	target	Keating D (2018)	30334692	246257	10260	Tezacaftor	8RW88Y506K|1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]cyclopropanecarboxamide|tezacaftorum|Tezacaftor|Cyclopropanecarboxamide, 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-|1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methyl-2-propanyl)-1H-indol-5-yl}cyclopropanecarboxamide	-	CHEMSPIDER	28637762	C26H27F3N2O6	small molecule	-	1152311-62-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Targets Phe508del CFTR protein; Trikafta (comprising elexacaftor, tezacaftor and ivacaftor) drug combination therapy for Cystic Fibrosis	MJUVRTYWUMPBTR-MRXNPFEDSA-N
32866	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	inhibitor	target	Keating D (2018)	30334692	246257	7589	Ivacaftor	Ivacaftorum|Kalydeco	kalydeco|orkambi	DRUGBANK	DB08820	C24H28N2O3	small molecule	R07AX30|R07AX02	873054-44-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Targets Phe508del CFTR protein; Trikafta (comprising elexacaftor, tezacaftor and ivacaftor) drug combination therapy for Cystic Fibrosis	PURKAOJPTOLRMP-UHFFFAOYSA-N
32867	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	inhibitor	target	Middleton PG (2019)	31697873	246258	10343	Trikafta	TRIKAFTA|2398469-65-1|DTXSID601027908	-	PUBCHEM	165363555	C76H82F6N6O15	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Targets Phe508del CFTR protein; Trikafta (comprising elexacaftor, tezacaftor and ivacaftor) drug combination therapy for Cystic Fibrosis	RYTZFBLERBKCRL-XQAUMGQKSA-N
32868	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Tao Y (2022)	36170674	241674	10355	Bivalent ligand 428	YT41R|Bivalent_ligand_428	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: YT41R (DCAF1:MY-1B --- FKBP12:SLF)	-
32870	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Tao Y (2022)	36170674	241674	10353	Bivalent ligand 429	YT47R|Bivalent_ligand_429	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: YT47R (DCAF1:MY-1B --- FKBP12:SLF)	-
32872	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Tao Y (2022)	36170674	241674	10370	Bivalent ligand 430	YT117R|Bivalent_ligand_430	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: YT117R (DCAF1:MY-1B ---BRD4:JQ1)	-
32874	115421	10116	-	FEM1B	F1A-ALPHA|F1AA|FEM1-beta	9606	Homo sapiens	degradation	recruited e3 ligase	Henning NJ (2022)	34994556	235307	10371	Bivalent ligand 431	NJH-1-106|Bivalent_ligand_431	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: NJH-1-106 (FEM1B:EN106 ---BRD4:JQ1)	-
32876	115421	10116	-	FEM1B	F1A-ALPHA|F1AA|FEM1-beta	9606	Homo sapiens	degradation	recruited e3 ligase	Henning NJ (2022)	34994556	235307	10372	Bivalent ligand 432	NJH-2-142|Bivalent_ligand_432	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: NJH-2-142 (FEM1B:EN106 ---ABL1:dasatinib)	-
32878	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lier S (2022)	34838332	242581	10373	Bivalent ligand 433	MDEG-541|Bivalent_ligand_433	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110694	4609	-	MYC	MRTL|MYCC|bHLHe39|c-Myc	9606	Homo sapiens	target	Standardized BVL Name: MDEG-541  (CRBN:thalidomide --- MYC:10058-F4)	-
32880	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Teng KW (2021)	33976200	242625	10366	Bivalent ligand 434	VHL-12VC1.2 fusion|Bivalent_ligand_434	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: VHL12VC1.2 fusion (VHL --- KRAS(G12C):12VC1.2)	-
32882	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Teng KW (2021)	33976200	242625	10367	Bivalent ligand 435	VHL-12VC1.1 fusion|Bivalent_ligand_435	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: VHL12VC1.1 fusion (VHL --- KRAS(G12C):12VC1.1)	-
32884	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Roeth S (2020)	32668202	242881	10368	Bivalent ligand 436	VHL-aGFP16 AdPROM|Bivalent_ligand_436	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: VHL-aGFP16 AdPROM (VHL:aGFP16 --- KRAS:GFP)	-
32886	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Roeth S (2020)	32668202	242881	10369	Bivalent ligand 437	VHL-aHRAS AdPROM|Bivalent_ligand_437	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: VHL-aHRAS AdPROM (VHL --- KRAS:aHRAS)	-
32888	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Roeth S (2020)	32668202	242881	10369	Bivalent ligand 437	VHL-aHRAS AdPROM|Bivalent_ligand_437	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: VHL-aHRAS AdPROM (VHL --- HRAS:aHRAS)	-
32890	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10362	Bivalent ligand 438	iDAb RAS-UBOX|Bivalent_ligand_438	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: iDAb RAS-UBOX (CHIP --- KRAS:iDAB RAS)	-
32892	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10362	Bivalent ligand 438	iDAb RAS-UBOX|Bivalent_ligand_438	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: iDAb RAS-UBOX (CHIP --- HRAS:iDAB RAS)	-
32894	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10362	Bivalent ligand 438	iDAb RAS-UBOX|Bivalent_ligand_438	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110952	4893	RP5-1000E10.2	NRAS	ALPS4|CMNS|N-ras|NCMS|NRAS1|NS6	9606	Homo sapiens	target	Standardized BVL Name: iDAb RAS-UBOX (CHIP --- NRAS:iDAB RAS)	-
32896	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10363	Bivalent ligand 439	UBOX-iDAb RAS|Bivalent_ligand_439	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: UBOX-iDAb RAS (CHIP --- KRAS:iDAB RAS)	-
32898	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10363	Bivalent ligand 439	UBOX-iDAb RAS|Bivalent_ligand_439	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: UBOX-iDAb RAS (CHIP --- HRAS:iDAB RAS)	-
32900	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10363	Bivalent ligand 439	UBOX-iDAb RAS|Bivalent_ligand_439	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110952	4893	RP5-1000E10.2	NRAS	ALPS4|CMNS|N-ras|NCMS|NRAS1|NS6	9606	Homo sapiens	target	Standardized BVL Name: UBOX-iDAb RAS (CHIP --- NRAS:iDAB RAS)	-
32902	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10402	Bivalent ligand 440	VHL-iDAb RAS|Bivalent_ligand_440	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: VHL-iDAb RAS (VHL --- KRAS:iDAB RAS)	-
32904	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10402	Bivalent ligand 440	VHL-iDAb RAS|Bivalent_ligand_440	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110952	4893	RP5-1000E10.2	NRAS	ALPS4|CMNS|N-ras|NCMS|NRAS1|NS6	9606	Homo sapiens	target	Standardized BVL Name: VHL-iDAb RAS (VHL --- NRAS:iDAB RAS)	-
32906	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bery N (2020)	32591521	242882	10401	Bivalent ligand 441	VHL-DP KRAS|Bivalent_ligand_441	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: VHL-DP KRAS (VHL --- KRAS:DARPin K19)	-
32908	114457	8945	RP11-529I10.2	BTRC	BETA-TRCP|FBW1A|FBXW1|FBXW1A|FWD1|bTrCP|bTrCP1|betaTrCP	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10404	Bivalent ligand 442	xcexb2TrCP-vhhGFP4|Bivalent_ligand_442	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: TrCP-vhhGFP4 (BTRC:vhhGFP4 --- KRAS:GFP)	-
32910	120581	55294	-	FBXW7	AGO|CDC4|FBW6|FBW7|FBX30|FBXO30|FBXW6|SEL-10|SEL10|hAgo|hCdc4	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10403	Bivalent ligand 443	FBW7-vhhGFP4|Bivalent_ligand_443	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: FBW7-vhhGFP4 (FBW7:vhhGFP4 --- KRAS:GFP)	-
32912	112393	6502	-	SKP2	FBL1|FBXL1|FLB1|p45	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10398	Bivalent ligand 444	SKP2-vhhGFP4|Bivalent_ligand_444	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: SKP2-vhhGFP4 (SKP2:vhhGFP4 --- KRAS:GFP4)	-
32914	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10397	Bivalent ligand 445	SPOP-vhhGFP4|Bivalent_ligand_445	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: SPOP-vhhGFP4 (SPOP:vhhGFP4 --- KRAS:GFP)	-
32916	114362	8835	-	SOCS2	CIS2|Cish2|SOCS-2|SSI-2|SSI2|STATI2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10400	Bivalent ligand 446	SOCS2-vhhGFP4|Bivalent_ligand_446	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: SOCS2-vhhGFP4 (SOCS2:vhhGFP4 --- KRAS:GFP)	-
32918	115563	10273	LA16c-313D11.6	STUB1	CHIP|HSPABP2|NY-CO-7|SCAR16|SDCCAG7|UBOX1	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10399	Bivalent ligand 447	CHIP-vhhGFP4|Bivalent_ligand_447	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: CHIP-vhhGFP4 (STUB1:vhhGFP4 --- KRAS:GFP)	-
32920	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10409	Bivalent ligand 448	NS1-SPOP|Bivalent_ligand_448	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: NS1-SPOP (SPOP --- KRAS:NS1)	-
32922	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10408	Bivalent ligand 449	K27-SPOP|Bivalent_ligand_449	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: K27-SPOP (SPOP --- KRAS:DARPin K27)	-
32924	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10408	Bivalent ligand 449	K27-SPOP|Bivalent_ligand_449	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	109501	3265	-	HRAS	C-BAS/HAS|C-H-RAS|C-HA-RAS1|CTLO|H-RASIDX|HAMSV|HRAS1|RASH1|p21ras	9606	Homo sapiens	target	Standardized BVL Name: K27-SPOP (SPOP --- HRAS:DARPin K27)	-
32926	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10408	Bivalent ligand 449	K27-SPOP|Bivalent_ligand_449	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110952	4893	RP5-1000E10.2	NRAS	ALPS4|CMNS|N-ras|NCMS|NRAS1|NS6	9606	Homo sapiens	target	Standardized BVL Name: K27-SPOP (SPOP --- NRAS:DARPin K27)	-
32928	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10379	Bivalent ligand 450	R11.1.6-SPOP|Bivalent_ligand_450	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: R11.1.6-SPOP (SPOP --- KRAS:R11.1.1)	-
32930	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10374	Bivalent ligand 451	K27-VHL|Bivalent_ligand_451	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: K27-VHL (VHL --- KRAS:DARPin K27)	-
32932	113993	8405	-	SPOP	BTBD32|TEF2	9606	Homo sapiens	degradation	recruited e3 ligase	Lim S (2021)	33655066	242886	10359	Bivalent ligand 452	K19-SPOP|Bivalent_ligand_452	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: K19-SPOP (SPOP --- KRAS:DARPin K19 )	-
32934	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen P (2021)	34455300	243005	10365	Bivalent ligand 453	4f|Bivalent_ligand_453	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107925	1545	-	CYP1B1	CP1B|CYPIB1|GLC3A|P4501B1	9606	Homo sapiens	target	Standardized BVL Name: 4f (CRBN:thalidomide --- CYP1B1:-naphthoflavone)	-
32936	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen Y (2022)	34959180	243006	10385	Bivalent ligand 454	PF15|Bivalent_ligand_454	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108610	2322	RP11-153M24.3	FLT3	CD135|FLK-2|FLK2|STK1	9606	Homo sapiens	target	Standardized BVL Name: PF15 (CRBN:lenalidomide --- FLT3:compound 9b)	-
32938	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bricelj A (2021)	34795861	243021	10389	Bivalent ligand 455	SAB401|Bivalent_ligand_455	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SAB401 (CRBN:thalidomide --- CDK6:palbociclib)	-
32940	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bricelj A (2021)	34795861	243021	10377	Bivalent ligand 456	SAB355|Bivalent_ligand_456	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: SAB355 (CRBN:pomalidomide --- CDK6:palbociclib)	-
32942	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bricelj A (2021)	34795861	243021	10382	Bivalent ligand 457	CST837|Bivalent_ligand_457	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: CST837 (CRBN:thalidomide --- CDK6:palbociclib)	-
32944	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bricelj A (2021)	34795861	243021	10360	Bivalent ligand 458	CST651/PROTAC 27|Bivalent_ligand_458	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: CST651/PROTAC 27 (VHL:modified VH298 --- CDK6:palbociclib)	-
32946	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bricelj A (2021)	34795861	243021	10389	Bivalent ligand 455	SAB401|Bivalent_ligand_455	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: SAB401 (CRBN:thalidomide --- CDK4:palbociclib)	-
32948	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bricelj A (2021)	34795861	243021	10389	Bivalent ligand 455	SAB401|Bivalent_ligand_455	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: SAB401 (CRBN:thalidomide --- IZKF3:palbociclib)	-
32950	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang L (2023)	35015337	246241	10380	Bivalent ligand 504	PZ15227|Bivalent_ligand_504	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: PZ15227 (CRBN:pomalidomide --- BCL2L1:ABT263)	-
32952	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qu L (2021)	34649182	243029	10381	Bivalent ligand 505	PT-65|Bivalent_ligand_505	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109186	2931	-	GSK3A	-	9606	Homo sapiens	target	Standardized BVL Name: PT-65 (CRBN:pomalidomide --- GSK3A:AZD2858)	-
32954	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qu L (2021)	34649182	243029	10381	Bivalent ligand 505	PT-65|Bivalent_ligand_505	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: PT-65 (CRBN:pomalidomide --- GSK3B:AZD2858)	-
32956	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10361	Bivalent ligand 459	PROTAC 34|Bivalent_ligand_459	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 34 (VHL:modified VH298 --- CDK6:palbociclib)	-
32958	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10360	Bivalent ligand 458	CST651/PROTAC 27|Bivalent_ligand_458	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: CST651/PROTAC 27 (VHL:modified VH298 --- CDK6:palbociclib)	-
32960	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10418	Bivalent ligand 460	PROTAC 11|Bivalent_ligand_460	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 11 (CRBN:pomalidomide --- CDK6:palbociclib)	-
32962	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10415	Bivalent ligand 461	PROTAC 35|Bivalent_ligand_461	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 35 (cIAP1:IAP ligand --- CDK6:palbociclib)	-
32964	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10415	Bivalent ligand 461	PROTAC 35|Bivalent_ligand_461	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 35 (cIAP1:IAP ligand --- CDK4:palbociclib)	-
32966	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10415	Bivalent ligand 461	PROTAC 35|Bivalent_ligand_461	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 35 (cIAP2:IAP ligand --- CDK4:palbociclib)|Standardized BVL Name: PROTAC 35 (XIAP:IAP ligand --- CDK4:palbociclib)	-
32968	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Steinebach C (2020)	33133483	244369	10415	Bivalent ligand 461	PROTAC 35|Bivalent_ligand_461	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 35 (cIAP2:IAP ligand --- CDK6:palbociclib)|Standardized BVL Name: PROTAC 35 (XIAP:IAP ligand --- CDK6:palbociclib)	-
32970	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hansen JD (2020)	32130004	246242	10413	Bivalent ligand 462	CC-92480|Bivalent_ligand_462	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: CC-92480 (mezigdomide) (CRBN: CC-92480 (mezigdomide) --- IKZF3: CC-92480 (mezigdomide))	-
32972	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hansen JD (2020)	32130004	246242	10413	Bivalent ligand 462	CC-92480|Bivalent_ligand_462	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: CC-92480 (mezigdomide) (CRBN: CC-92480 (mezigdomide) --- IKZF1: CC-92480 (mezigdomide))	-
32974	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Matyskiela ME (2018)	28425720	207534	10411	Bivalent ligand 463	CC-220|Bivalent_ligand_463	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: CC-220 (iberdomide) (CRBN:CC-220 (iberdomide) --- IKZF3: CC-220 (iberdomide))	-
32976	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Matyskiela ME (2018)	28425720	207534	10411	Bivalent ligand 463	CC-220|Bivalent_ligand_463	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: CC-220 (iberdomide) (CRBN:CC-220 (iberdomide) --- IKZF1: CC-220 (iberdomide))	-
32978	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hagner PR (2015)	26002965	185946	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: CC-122 (Avadomide) (CRBN:CC-122 (Avadomide) --- IKZF3: CC-122 (Avadomide))	-
32980	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hagner PR (2015)	26002965	185946	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: CC-122 (Avadomide) (CRBN:CC-122 (Avadomide) --- IKZF1: CC-122 (Avadomide))	-
32982	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Mo Z (2021)	33847741	232060	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	target	Standardized BVL Name: CC-122 (Avadomide) (CRBN:CC-122 (Avadomide) --- ZFP91: CC-122 (Avadomide))	-
32984	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase		34027417	232355	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	113534	7750	RP11-264J4.7	ZMYM2	FIM|MYM|RAMP|SCLL|ZNF198	9606	Homo sapiens	target	Standardized BVL Name: CC-122 (Avadomide) (CRBN:CC-122 (Avadomide) --- ZMYM2: CC-122 (Avadomide))	-
32986	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu W (2022)	34936696	246243	10413	Bivalent ligand 462	CC-92480|Bivalent_ligand_462	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	target	Standardized BVL Name: CC-92480 (mezigdomide) (CRBN: CC-92480 (mezigdomide) --- ZFP91: CC-92480 (mezigdomide))	-
32988	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hansen JD (2018)	28358507	246244	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: CC-885 (CRBN:CC-885 --- IKZF3:CC-885)	-
32990	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao M (2021)	33676183	232098	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: CC-885 (CRBN:CC-885 --- CDK4:CC-885)	-
32992	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hao BB (2020)	32210356	246245	10081	Bivalent ligand 388	CC-885|Bivalent_ligand_388	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107133	665	-	BNIP3L	BNIP3a|NIX	9606	Homo sapiens	target	Standardized BVL Name: CC-885 (CRBN:CC-885 --- BNIP3L:CC-885)	-
32994	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Surka C (2021)	33197925	229264	10396	Bivalent ligand 464	CC-90009|Bivalent_ligand_464	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: CC-90009 (eragidomide) (CRBN:CC-90009 (eragidomide) --- GSPT1: CC-90009 (eragidomide)	-
32996	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10376	Bivalent ligand 465	BTX-1188|Bivalent_ligand_465	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: BTX-1188 (CRBN:BTX-1188 --- GSPT1:BTX-1188)	-
32998	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10376	Bivalent ligand 465	BTX-1188|Bivalent_ligand_465	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: BTX-1188 (CRBN:BTX-1188 --- IKZF3:BTX-1188)	-
33000	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10376	Bivalent ligand 465	BTX-1188|Bivalent_ligand_465	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: BTX-1188 (CRBN:BTX-1188 --- IKZF1:BTX-1188)	-
33002	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10429	Bivalent ligand 466	CC-91633|Bivalent_ligand_466	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107836	1452	-	CSNK1A1	CK1|CK1a|CKIa|HEL-S-77p|HLCDGP1|PRO2975	9606	Homo sapiens	target	Standardized BVL Name: CC-91633 (BMS-986397) (CRBN:CC-91633 (BMS-986397) --- CSNK1A1:CC-91633 (BMS-986397))	-
33004	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10423	Bivalent ligand 467	CFT7455|Bivalent_ligand_467	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: CFT7455 (CRBN:CFT7455 --- IKZF3:CFT7455)	-
33006	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10423	Bivalent ligand 467	CFT7455|Bivalent_ligand_467	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: CFT7455 (CRBN:CFT7455 --- IKZF1:CFT7455)	-
33008	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10407	Bivalent ligand 468	CC-99282|Bivalent_ligand_468	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: CC-99282 (CRBN:CC-99282 --- IKZF3:CC-99282)	-
33010	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Fuchs O (2023)	35933246	246246	10407	Bivalent ligand 468	CC-99282|Bivalent_ligand_468	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: CC-99282 (CRBN:CC-99282 --- IKZF1:CC-99282)	-
33012	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Henning NJ (2022)	35210618	236326	10406	Bivalent ligand 469	NJH-2-057|Bivalent_ligand_469	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	107506	1080	tcag7.78	CFTR	ABC35|ABCC7|CF|CFTR/MRP|MRP7|TNR-CFTR|dJ760C5.1	9606	Homo sapiens	target	Standardized BVL Name: NJH-2-057 (OTUB1:EN523 --- deltaF508-CFTR:lumacaftor)	-
33014	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Henning NJ (2022)	35210618	236326	10358	Bivalent ligand 470	LEB-03-144|Bivalent_ligand_470	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: LEB-03-144 (OTUB1:EN523 --- WEE1:AZD1775)	-
33016	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Henning NJ (2022)	35210618	236326	10375	Bivalent ligand 471	LEB-03-146|Bivalent_ligand_471	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: LEB-03-146 (OTUB1:EN523 --- WEE1:AZD1775)	-
33018	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10394	Bivalent ligand 472	FOXO-DUBTAC #6|Bivalent_ligand_472	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	108598	2309	-	FOXO3	AF6q21|FKHRL1|FKHRL1P2|FOXO2|FOXO3A	9606	Homo sapiens	target	Standardized BVL Name: FOXO-DUBTAC #6 (OTUB1:DUBL-X-BCN --- FOXO3A:N3-ODN)	-
33020	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10410	Bivalent ligand 473	p53-DUBTACs #6|Bivalent_ligand_473	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	target	Standardized BVL Name: p53-DUBTACs #6 (OTUB1:DUBL-X-BCN --- TP53:p53-ODN)	-
33022	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10428	Bivalent ligand 474	p53-DUBTACs #7|Bivalent_ligand_474	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	113010	7157	-	TP53	BCC7|LFS1|P53|TRP53	9606	Homo sapiens	target	Standardized BVL Name: p53-DUBTACs #7 (OTUB1:DUBL-X-BCN --- TP53:p53-ODN)	-
33024	120751	55611	HSPC263	OTUB1	OTB1|OTU1	9606	Homo sapiens	deubiquitination	recruited deubiquitinase	Liu J (2022)	35786952	245265	10417	Bivalent ligand 475	IRF-DUBTAC #7|Bivalent_ligand_475	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	DUBTAC	Deubiquitinase-targeting chimera; structured as DUB binding moiety--linker--target binding moiety; target deubiquitinated via recruited deubiquitinase (DUB)	109869	3661	-	IRF3	-	9606	Homo sapiens	target	Standardized BVL Name: IRF-DUBTAC #7 (OTUB1:DUBL-X-BCN --- IRF3:N3-IRF3-ODN)	-
33026	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	degradation	recruited e3 ligase	Shergalis AG (2023)	36656921	245121	10364	Bivalent ligand 476	1a|Bivalent_ligand_476	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: 1a (DCAF16:1a---BRD2:1a)	-
33028	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	degradation	recruited e3 ligase	Shergalis AG (2023)	36656921	245121	10364	Bivalent ligand 476	1a|Bivalent_ligand_476	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 1a (DCAF16:1a---BRD4:1a)	-
33030	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	 (2022)	35491637	246247	10405	Bivalent ligand 477	ARV-766|Bivalent_ligand_477	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARV-766 (CRBN:glutarimide---AR:aryloxy tetramethylcyclobutane)	-
33032	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xiang W (2021)	34473519	246248	10420	Bivalent ligand 478	ARD-2585|Bivalent_ligand_478	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARD-2585 (CRBN:thalidomide---AR:modified compound 9)	-
33034	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xie H (2021)	36046114	246249	10414	Bivalent ligand 479	CC-94676/AR-LDD|Bivalent_ligand_479	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: CC-94676/AR-LDD (CRBN:unspecified---AR:unspecified)	-
33036	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Dobrovolsky D (2019)	30545835	246250	10387	Bivalent ligand 480	DD-03-007|Bivalent_ligand_480	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DD-03-007 (CRBN:thalidomide---BTK:CGI1746)	-
33038	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Dobrovolsky D (2019)	30545835	246250	10386	Bivalent ligand 481	DD-03-171|Bivalent_ligand_481	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DD-03-171 (CRBN:thalidomide---BTK:CGI1746)	-
33040	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Dobrovolsky D (2019)	30545835	246250	10386	Bivalent ligand 481	DD-03-171|Bivalent_ligand_481	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: DD-03-171 (CRBN:thalidomide---IKZF1:CGI1746)	-
33042	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Dobrovolsky D (2019)	30545835	246250	10386	Bivalent ligand 481	DD-03-171|Bivalent_ligand_481	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: DD-03-171 (CRBN:thalidomide---IKZF3:CGI1746)	-
33044	123322	80829	FKSG11	ZFP91	DMS-8|DSM-8|PZF|ZFP-91|ZNF757	9606	Homo sapiens	degradation	recruited e3 ligase	Liu TT (2022)	36375317	244515	10412	Bivalent ligand 482	bufalin|Bivalent_ligand_482	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	108202	1870	-	E2F2	E2F-2	9606	Homo sapiens	target	Standardized BVL Name: bufalin (ZFP91:bufalin---E2F2:bufalin)	-
33046	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Su W (2023)	36647763	245466	10388	Bivalent ligand 483	CDTAC CDTAC PD-L1:CRBN|Bivalent_ligand_483	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: CDTAC CDTAC PD-L1:CRBN (CRBN:thalidomide---CD274:BMS-1166)	-
33048	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang L (2022)	36250201	241369	10391	Bivalent ligand 484	ZL216|Bivalent_ligand_484	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110771	4691	-	NCL	C23	9606	Homo sapiens	target	Standardized BVL Name: ZL216 (VHL:AHPC ---NCL:AS1411)	-
33050	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Miao J (2023)	37836790	246251	10390	Bivalent ligand 485	P9|Bivalent_ligand_485	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	target	Standardized BVL Name: P9 (VHL:VHL-2 --- PTPN11:compound 4)	-
33052	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	antiviral	recruited e3 ligase	Desantis J (2021)	34534839	232373	10393	Bivalent ligand 486	PROTAC 3 anti-viral|Bivalent_ligand_486	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123135	80142	RP11-395P17.2	PTGES2	C9orf15|GBF-1|GBF1|PGES2|mPGES-2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 3 anti-viral (VHL: HIF-1alpha hydroxyproline derived small molecule---PTGES2:indomethacin; Coronavirus Project)	-
33054	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	antiviral	recruited e3 ligase	Desantis J (2021)	34534839	232373	10392	Bivalent ligand 487	PROTAC 5 anti-viral|Bivalent_ligand_487	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	123135	80142	RP11-395P17.2	PTGES2	C9orf15|GBF-1|GBF1|PGES2|mPGES-2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 5 anti-viral (VHL: HIF-1alpha hydroxyproline derived small molecule---PTGES2:indomethacin; Coronavirus Project)	-
33056	111969	6041	RP11-20H6.1	RNASEL	PRCA1|RNS4	9606	Homo sapiens	antiviral	recruited ribonuclease	Haniff HS (2020)	33140033	246252	10384	Bivalent ligand 488	C5-RIBOTAC|Bivalent_ligand_488	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	RIBOTAC	Ribonuclease Targeting Chimera; structured as a ribonuclease recruiting moiety-linker-RNA binding moiety	4383849	43740578	GU280_gp01	ORF1ab	ORF1ab polyprotein|1ab|SARS-CoV2 ORF1ab|SARS-CoV-2 ORF1ab|Replicase|R1AB_SARS2|PRO_0000449618	2697049	Severe acute respiratory syndrome coronavirus 2	target	Standardized BVL Name: C5-RIBOTAC (RNASEL:heterocyclic RNase L-recruiting molecule --- Orf1ab:C5; Coronavirus Project; Target UniProt ID PRO_0000449618 (ORF1ab))	-
33058	111969	6041	RP11-20H6.1	RNASEL	PRCA1|RNS4	9606	Homo sapiens	degradation 	recruited ribonuclease	Su X (2021)	34278671	246253	10383	Bivalent ligand 489	Chimera-E|Bivalent_ligand_489	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	RIBOTAC	Ribonuclease Targeting Chimera; structured as a ribonuclease recruiting moiety-linker-RNA binding moiety	4383845	43740570	GU280_gp04	E	env|envelope|SARS-CoV2 E|E protein|emp|SARS-CoV-2 E|VEMP_SARS2|PRO_0000449651	2697049	Severe acute respiratory syndrome coronavirus 2	target	Standardized BVL Name: ChimeraE (RNASEL:4A25 --- E: complementary oligonucleotide sequence; Coronavirus Project; Target UniProt ID PRO_0000449651 (E))	-
33060	111969	6041	RP11-20H6.1	RNASEL	PRCA1|RNS4	9606	Homo sapiens	antiviral	recruited ribonuclease	Su X (2021)	34278671	246253	10419	Bivalent ligand 490	Chimera-S4|Bivalent_ligand_490	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	RIBOTAC	Ribonuclease Targeting Chimera; structured as a ribonuclease recruiting moiety-linker-RNA binding moiety	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	target	Standardized BVL Name: ChimeraS4 (RNASEL:4A25 --- S:complementary oligonucleotide sequence; Coronavirus Project; Target UniProt ID PRO_0000449646 (S))	-
33062	112615	6737	-	TRIM21	RNF81|RO52|Ro/SSA|SSA|SSA1	9606	Homo sapiens	antiviral	recruited e3 ligase	Chatterjee P (2020)	33230174	239810	10425	Bivalent ligand 491	23-mer|Bivalent_ligand_491	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	target	The authors fused the RBD-binding proteins to the CHIPTPR modified E3 ubiquitin ligase domain to prevent circumvent the need to express Trim21 in trans|Standardized BVL Name: 23-mer (A2N)-CHIPTPR (TRIM21:NA --- S RBD domain: sACE2 derived 23-mer (A2N) peptide; Coronavirus Project; Target UniProt ID PRO_0000449646 (S))	-
33064	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation/antiviral	recruited e3 ligase	Alugubelli YR (2023)	888800001046	245523	10426	Bivalent ligand 492	antiviral MDP2|Bivalent_ligand_492	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	4383849	43740578	GU280_gp01	ORF1ab	ORF1ab polyprotein|1ab|SARS-CoV2 ORF1ab|SARS-CoV-2 ORF1ab|Replicase|R1AB_SARS2|PRO_0000449618	2697049	Severe acute respiratory syndrome coronavirus 2	target	Standardized BVL Name: antiviral MDP2 (CRBN:thalidomide---Nsp5/MPro:MPI8; Coronavirus Project; Target UniProt ID PRO_0000449623 (nsp5))	-
33066	112615	6737	-	TRIM21	RNF81|RO52|Ro/SSA|SSA|SSA1	9606	Homo sapiens	degradation 	recruited e3 ligase	Fletcher A (2023)	37925433	246254	10427	Bivalent ligand 493	T21RBCC-VHHHuR|Bivalent_ligand_493	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	bioPROTAC	Engineered intracellular proteins consisting of a target-binding domain directly fused to an E3 ubiquitin ligase; NOTE: the format for this BVL name is (E3:GFP binding scaffold fusion --- Target:GFP fusion)	108309	1994	-	ELAVL1	ELAV1|HUR|Hua|MelG	9606	Homo sapiens	target	Standardized BVL Name: T21RBCC-VHHHuR (TRIM21:NA--- ELAVL1:VHH ab)	-
33068	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation 	recruited e3 ligase	Mason JW (2023)	37919549	245925	10424	Bivalent ligand 494	CIP-1|Bivalent_ligand_494	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: CIP-1 (VHL:MZ1---BRD4:BB3-114)	-
33070	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation 	recruited e3 ligase	Mason JW (2023)	37919549	245925	10357	Bivalent ligand 495	CIP-3|Bivalent_ligand_495	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: CIP-3 (VHL:MZ1---BRD4:BB2-109)	-
33072	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation 	recruited e3 ligase	Mason JW (2023)	37919549	245925	10422	Bivalent ligand 496	CIP-4|Bivalent_ligand_496	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: CIP-4 (VHL:MZ1---BRD4:BB2-109)	-
33074	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation 	recruited e3 ligase	Mason JW (2023)	37919549	245925	10356	Bivalent ligand 497	CIP-22|Bivalent_ligand_497	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: CIP-22 (VHL:MZ1---BRD2:BB2-109)	-
33076	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation 	recruited e3 ligase	Zhang X (2020)	32145645	246255	10395	Bivalent ligand 498	XZ739|Bivalent_ligand_498	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: XZ739 (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33078	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation 	recruited e3 ligase	Zhang X (2020)	32145645	246255	10421	Bivalent ligand 499	12c|Bivalent_ligand_499	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: 12c (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33080	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation 	recruited e3 ligase	Zhang X (2020)	32145645	246255	10416	Bivalent ligand 500	15a|Bivalent_ligand_500	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: 15a (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33082	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation 	recruited e3 ligase	Zhang X (2020)	32145645	246255	10354	Bivalent ligand 501	16a|Bivalent_ligand_501	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: 16a (CRBN: pomalidomide ---BCL-XL:ABT-263)	-
33084	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation 	recruited e3 ligase	Zhang X (2020)	32145645	246255	10378	Bivalent ligand 502	6c|Bivalent_ligand_502	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: 6c (VHL:VHL ligand ---BCL-XL:ABT-263)	-
33086	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation 	recruited e3 ligase	Zhang X (2020)	32171162	246256	10352	Bivalent ligand 503	14o|Bivalent_ligand_503	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: 14o (VHL:VHL ligand --- EGFRL858R/T790M:XTF-262)	-
33088	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Gordon CJ (2020)	32284326	239594	9968	Remdesivir	L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile|Veklury|remdesivir|UNII:3QKI37EEHE|GS-5734|2-Ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name)	-	CHEMSPIDER	58827832	C27H35N6O8P	small molecule	-	1809249-37-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor	RWWYLEGWBNMMLJ-YSOARWBDSA-N
33089	4383949	1489680	SARS-CoV-1ab-nsp12ab	nsp12ab	nsp12|sars1ab|orf1ab|SARS-CoV nsp12ab|SARS-CoV nsp12|SARS-CoV sars1ab|orf1ab-nsp12|orf1ab-nsp12ab|pp1ab|RNA-directed RNA polymerase|Pol|RdRp|R1AB_CVHSA|PRO_0000037318	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Agostini ML (2018)	29511076	222024	9968	Remdesivir	L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile|Veklury|remdesivir|UNII:3QKI37EEHE|GS-5734|2-Ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name)	-	CHEMSPIDER	58827832	C27H35N6O8P	small molecule	-	1809249-37-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor; antiviral activity against SARS-CoV-2 in HAE cultures	RWWYLEGWBNMMLJ-YSOARWBDSA-N
33090	4383896	14254602	G128_gp01ab_nsp12	nsp12ab	ORF1ab|nsp12|rep|1AB|MERS-CoV nsp12|orf1ab-nsp12|orf1ab-nsp12ab|nsp12ab|RNA polymerase|R1AB_CVEMC|PRO_0000422449	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Agostini ML (2018)	29511076	222024	9968	Remdesivir	L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile|Veklury|remdesivir|UNII:3QKI37EEHE|GS-5734|2-Ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name)	-	CHEMSPIDER	58827832	C27H35N6O8P	small molecule	-	1809249-37-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor; antiviral activity against SARS-CoV-2 in HAE cultures	RWWYLEGWBNMMLJ-YSOARWBDSA-N
33091	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Kabinger F (2021)	34381216	239595	9952	Molnupiravir	3,4-Dihydrocytidine, N-hydroxy-, 5'-(2-methylpropanoate)|N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine|EIDD-2801|Molnupiravir	-	CHEMSPIDER	84400552	C13H19N3O7	small molecule	-	2349386-89-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor	HTNPEHXGEKVIHG-QCNRFFRDSA-N
33092	4383949	1489680	SARS-CoV-1ab-nsp12ab	nsp12ab	nsp12|sars1ab|orf1ab|SARS-CoV nsp12ab|SARS-CoV nsp12|SARS-CoV sars1ab|orf1ab-nsp12|orf1ab-nsp12ab|pp1ab|RNA-directed RNA polymerase|Pol|RdRp|R1AB_CVHSA|PRO_0000037318	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Barnard DL (2004)	15074711	239596	9952	Molnupiravir	3,4-Dihydrocytidine, N-hydroxy-, 5'-(2-methylpropanoate)|N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine|EIDD-2801|Molnupiravir	-	CHEMSPIDER	84400552	C13H19N3O7	small molecule	-	2349386-89-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor	HTNPEHXGEKVIHG-QCNRFFRDSA-N
33093	4383896	14254602	G128_gp01ab_nsp12	nsp12ab	ORF1ab|nsp12|rep|1AB|MERS-CoV nsp12|orf1ab-nsp12|orf1ab-nsp12ab|nsp12ab|RNA polymerase|R1AB_CVEMC|PRO_0000422449	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Agostini ML (2019)	31578288	239597	9952	Molnupiravir	3,4-Dihydrocytidine, N-hydroxy-, 5'-(2-methylpropanoate)|N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine|EIDD-2801|Molnupiravir	-	CHEMSPIDER	84400552	C13H19N3O7	small molecule	-	2349386-89-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor	HTNPEHXGEKVIHG-QCNRFFRDSA-N
33094	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Fu Z (2021)	33473130	230134	7430	GRL0617	5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide	-	DRUGBANK	DB08656	C20H20N2O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral PLpro papain-like protease; antiviral activity against SARS-CoV-2 in Vero E6 cells	UVERBUNNCOKGNZ-CQSZACIVSA-N
33095	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Unoh Y (2022)	35352927	239599	9978	Ensitrelvir	1,3,5-Triazine-2,4(1H,3H)-dione, 6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]dihydro-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-, (6E)-|(6E)-6-[(6-Chloro-2-methyl-2H-indazol-5-yl)imino]-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione	-	CHEMSPIDER	115007411	C22H17ClF3N9O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in VeroE6/TMPRSS2 cells	QMPBBNUOBOFBFS-UHFFFAOYSA-N
33096	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Swaim CD (2021)	34632326	234511	344	Tioguanine	2-Amino-6-mercaptopurine|2-Amino-6-purinethiol|Tioguanin|2-aminopurine-6-thiol|6-TG|Tioguanine|2-amino-1,9-Dihydropurine-6-thione|2-Amino-1,7-dihydro-6H-purine-6-thione|6-Thioguanine|Thioguanine|2-Aminopurin-6-thiol|6-Mercaptoguanine|2-Amino 6mp|2-amino-1H-purine-6(7H)-thione|Tioguanina|ThG|TG|Tioguaninum|2-Amino-6-merkaptopurin|2-Aminopurine-6(1H)-thione|6-Mercapto-2-aminopurine|6-thioguanine	tabloid|lanvis	DRUGBANK	DB00352	C5H5N5S	small molecule	L01BB03	154-42-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	WYWHKKSPHMUBEB-UHFFFAOYSA-N
33097	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	sars-cov-2 inhibitor	target	Zhou Y (2022)	36217030	238593	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: Alpha-1A adrenergic receptor inhibitor	OGHNVEJMJSYVRP-UHFFFAOYSA-N
33098	4383864	43740578	GU280_gp01_nsp16	nsp16	ORF1ab|ORF1ab-nsp16|SARS-CoV2 nsp16|SARS-CoV-2 nsp16|2-O-methyltransferase|R1AB_SARS2|PRO_0000449633	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Krafcikova P (2020)	32709887	238333	1836	Sinefungin	Adenosyl-ornithine|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxydecofuranuronic acid|(2S,5S)-2,5-diamino-6-[(2R,3S,R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]hexanoic acid|sinefunginum|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-beta-D-ribo-decofuranuronic acid|sinefungina|sinefungine	-	DRUGBANK	DB01910	C15H23N7O5	small molecule	-	58944-73-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: pan-MTase inhibitor	LMXOHSDXUQEUSF-YECHIGJVSA-N
33099	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Hoffman RL (2020)	33054210	239600	9959	PF-00835231	1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-|N-[(2S)-1-({(2S)-4-Hydroxy-3-oxo-1-[(3S)-2-oxo-3-pyrrolidinyl]-2-butanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide	-	CHEMSPIDER	9736673	C24H32N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	QDIMHKWNHMVDJB-WBAXXEDZSA-N
33100	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Hoffman RL (2020)	33054210	239600	9959	PF-00835231	1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-|N-[(2S)-1-({(2S)-4-Hydroxy-3-oxo-1-[(3S)-2-oxo-3-pyrrolidinyl]-2-butanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide	-	CHEMSPIDER	9736673	C24H32N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	QDIMHKWNHMVDJB-WBAXXEDZSA-N
33101	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Dai W (2020)	32321856	239601	9982	MPro Inhibitor 11a	1H-Indole-2-carboxamide, N-[(1S)-1-(cyclohexylmethyl)-2-[[(1S)-1-formyl-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]amino]-2-oxoethyl]-|MPro Inhibitor 11a|N-[(2S)-3-Cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxo-3-pyrrolidinyl]-2-propanyl}amino)-2-propanyl]-1H-indole-2-carboxamide|Bofutrelvir	-	CHEMSPIDER	88294718	C25H32N4O4	small molecule	-	2103278-86-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	HPKJGHVHQWJOOT-ZJOUEHCJSA-N
33102	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Dai W (2020)	32321856	239601	9981	MPro Inhibitor 11b	MPro Inhibitor 11b|3-Fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxo-3-pyrrolidinyl]-2-propanyl}-L-phenylalaninamide|1H-Indole-2-carboxamide, N-[(1S)-1-[(3-fluorophenyl)methyl]-2-[[(1S)-1-formyl-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]amino]-2-oxoethyl]-	-	CHEMSPIDER	88294719	C25H25FN4O4	small molecule	-	2413716-71-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	HCRBVFBQANEDDM-CUWPLCDZSA-N
33103	4383950	1489680	SARS-CoV-1ab-nsp13ab	nsp13ab	nsp13|sars1ab|orf1ab|SARS-CoV nsp13ab|SARS-CoV nsp13|SARS-CoV sars1ab|orf1ab-nsp13|orf1ab-nsp13ab|pp1ab|Helicase|Hel|R1AB_CVHSA|PRO_0000037319	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Adedeji AO (2012)	22733076	239602	9957	SSYA10-001	4-allyl-5-{[(2-nitrophenyl)thio]methyl}-4H-1,2,4-triazole-3-thiol|3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-[[(2-nitrophenyl)thio]methyl]-4-(2-propen-1-yl)-|4-Allyl-5-{[(2-nitrophenyl)sulfanyl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione	-	CHEMSPIDER	2085693	C12H12N4O2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral helicase inhibitor	VWFIHGWHMXSTAO-UHFFFAOYSA-N
33104	4383897	14254602	G128_gp01ab_nsp13	nsp13ab	ORF1ab|nsp13|rep|1AB|MERS-CoV nsp13|orf1ab-nsp13|orf1ab-nsp13ab|nsp13ab|Helicase|R1AB_CVEMC|PRO_0000422450	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Adedeji AO (2014)	24841268	239603	9957	SSYA10-001	4-allyl-5-{[(2-nitrophenyl)thio]methyl}-4H-1,2,4-triazole-3-thiol|3H-1,2,4-Triazole-3-thione, 2,4-dihydro-5-[[(2-nitrophenyl)thio]methyl]-4-(2-propen-1-yl)-|4-Allyl-5-{[(2-nitrophenyl)sulfanyl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione	-	CHEMSPIDER	2085693	C12H12N4O2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral helicase inhibitor	VWFIHGWHMXSTAO-UHFFFAOYSA-N
33105	4383950	1489680	SARS-CoV-1ab-nsp13ab	nsp13ab	nsp13|sars1ab|orf1ab|SARS-CoV nsp13ab|SARS-CoV nsp13|SARS-CoV sars1ab|orf1ab-nsp13|orf1ab-nsp13ab|pp1ab|Helicase|Hel|R1AB_CVHSA|PRO_0000037319	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Tanner JA (2005)	15797214	239604	9938	Bananin	AKOS016036756|BANANIN|HY-145113|CS-0356439	-	PUBCHEM	59053860	C14H17NO8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral helicase inhibitor	-
33106	4383951	1489680	SARS-CoV-1ab-nsp14ab	nsp14ab	nsp14|sars1ab|orf1ab|SARS-CoV nsp14ab|SARS-CoV nsp14|SARS-CoV sars1ab|orf1ab-nsp14|orf1ab-nsp14ab|pp1ab|Guanine-N7 methyltransferase|ExoN|R1AB_CVHSA|PRO_0000037320	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov-2 inhibitor	target	Bouvet M (2010)	20421945	238722	9963	Aurintricarboxylic acid	ATA|Aurintricarboxylic acid|Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-|3,3'-[(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methanediyl]bis(6-hydroxybenzoic acid)|3,3'-[(3-Carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylene]bis(6-hydroxybenzoic acid)|3,3'-[(3-Carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis(6-hydroxybenzoic acid)|MFCD00011663	-	CHEMSPIDER	2172	C22H14O9	small molecule	-	4431-00-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: pan-MTase inhibitor	GIXWDMTZECRIJT-UHFFFAOYSA-N
33107	4383953	1489680	SARS-CoV-1ab-nsp16ab	nsp16ab	nsp16|sars1ab|orf1ab|SARS-CoV nsp16ab|SARS-CoV nsp16|SARS-CoV sars1ab|orf1ab-nsp16|orf1ab-nsp16ab|pp1ab|2-O-methyltransferase|R1AB_CVHSA|PRO_0000037322	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov-2 inhibitor	target	Bouvet M (2010)	20421945	238722	9963	Aurintricarboxylic acid	ATA|Aurintricarboxylic acid|Benzoic acid, 5-((3-carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxy-|3,3'-[(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methanediyl]bis(6-hydroxybenzoic acid)|3,3'-[(3-Carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylene]bis(6-hydroxybenzoic acid)|3,3'-[(3-Carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methylene]bis(6-hydroxybenzoic acid)|MFCD00011663	-	CHEMSPIDER	2172	C22H14O9	small molecule	-	4431-00-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: pan-MTase inhibitor	GIXWDMTZECRIJT-UHFFFAOYSA-N
33108	108020	1654	-	DDX3X	CAP-Rf|DBX|DDX14|DDX3|HLP2	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ciccosanti F (2021)	33781803	238050	9985	RK-33	3,7-Bis(4-methoxybenzyl)-3,7-dihydro-2H-diimidazo[4,5-d:4',5'-f][1,3]diazepin-2-one|2H-Diimidazo[4,5-d:4',5'-f][1,3]diazepin-2-one, 3,7-dihydro-3,7-bis[(4-methoxyphenyl)methyl]-	-	CHEMSPIDER	26383637	C23H20N6O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: DD3X3 inhibitor	COUMZXFUZDBRCZ-UHFFFAOYSA-N
33109	107068	596	-	BCL2	Bcl-2|PPP1R50	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Patten JJ (2022)	35992305	239003	9955	obatoclax	2-{(2Z)-2-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-3-methoxy-2H-pyrrol-5-yl}-1H-indole|2-{(2Z)-2-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-3-methoxy-2H-pyrrol-5-yl}-1H-indole|1H-Indole, 2-[(2Z)-2-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-3-methoxy-2H-pyrrol-5-yl]-|Obatoclax|QN4128B52A	-	CHEMSPIDER	21430401	C20H19N3O	small molecule	-	803712-67-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: BCL2 inhibitor; Prevented ]80% SARS-CoV-2 infection in primary intestinal epithelial cell cultures.	RFTSSZJZXOSICM-GRSHGNNSSA-N
33110	114840	9451	-	EIF2AK3	PEK|PERK|WRS	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Patten JJ (2022)	35992305	239003	9956	GSK2606414	1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]ethanone|Ethanone, 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]-|GSK2606414|GSK 2606414|7-Methyl-5-[1-[[3-(trifluoromethyl)phenyl]acetyl]-2,3-dihydro-1H-indol-5-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	-	CHEMSPIDER	28643060	C24H20F3N5O	small molecule	-	1337531-36-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: EIF2AK3 inhibitor; Prevented ]80% SARS-CoV-2 infection in primary intestinal epithelial cell cultures.	SIXVRXARNAVBTC-UHFFFAOYSA-N
33111	111307	5289	-	PIK3C3	VPS34|hVps34	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Patten JJ (2022)	35992305	239003	9972	omipalisib	GSK2126458|GSK 2126458|Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-|2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide|2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide|Omipalisib|2,4-Difluoro-N-{2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide|2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide	-	CHEMSPIDER	25027388	C25H17F2N5O3S	small molecule	-	1086062-66-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PI3K and mTOR inhibitor; Inhibited SARS-CoV-2 S pseudotyped LV entry by ]95% in A549 cells expressing recombinant ACE2.	CGBJSGAELGCMKE-UHFFFAOYSA-N
33112	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Patten JJ (2022)	35992305	239003	9960	BAY-2402234	Benzamide, N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-4,5-dihydro-3-(hydroxymethyl)-5-oxo-1H-1,2,4-triazol-1-yl]-5-fluoro-2-[(1S)-2,2,2-trifluoro-1-methylethoxy]-|N-(2-Chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoro-2-propanyl]oxy}benzamide|N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-5-fluoro-2-{[(2S)-1,1,1-trifluoropropan-2-yl]oxy}benzamide	-	CHEMSPIDER	71117591	C21H18ClF5N4O4	small molecule	-	2225819-06-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: DHODH inhibitor; Inhibited SARS-CoV-2 S pseudotyped LV entry by ]95% in A549 cells expressing recombinant ACE2.	KNVJMHHAXCPZHF-JTQLQIEISA-N
33113	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zhang L (2020)	32198291	221191	9984	2-Methyl-2-propanyl {1-[(2S)-1-({(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxo-3-pyrrolidinyl]-2-butanyl}amino)-3-cyclopropyl-1-oxo-2-propanyl]-2-oxo-1,2-dihydro-3-pyridinyl}carbamate	2-Methyl-2-propanyl {1-[(2S)-1-({(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxo-3-pyrrolidinyl]-2-butanyl}amino)-3-cyclopropyl-1-oxo-2-propanyl]-2-oxo-1,2-dihydro-3-pyridinyl}carbamate	-	CHEMSPIDER	88294383	C31H41N5O7	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	FRACPXUHUTXLCX-BELIEFIBSA-N
33114	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Peng Q (2021)	33521757	227499	10347	Favipiravir	AM20080851|EX-A2285|Z1255381648|FAVIPIRAVIR|BCPP000056|T 705,CAS;259793-96-9|FAVIPIRAVIR [USAN:INN:JAN]|6-FLUORO-3,4-DIHYDRO-3-OXO-2-PYRAZINECARBOXAMIDE; 6-FLUORO-3,4-DIHYDRO-3-OXO-PYRAZINECARBOXAMIDE; 6-FLUORO-3-HYDROXY-2-PYRAZINECARBOXAMIDE; FAVIPIRAVIR; T 705; T 705 (PHARMACEUTICAL)|SY110833|AVIPIRAVIR|AKOS005166863|FAVIPIRA|FT-0701282|6-FLUORO-3,4-DIHYDRO-3-OXO-2-PYRAZINECARBOXAMIDE|A25520|6-FLUORO-3-HYDROXY-PYRAZINE-2-CARBOXAMIDE|ZCGNOVWYSGBHAU-UHFFFAOYSA-N|AVIGAN (TN)|J-518718|EN300-1601539|6-FLUORO-3-OXO-3,4-DIHYDROPYRAZINE-2-CARBOXAMIDE|FT-0686297|FAVIPIRAVIR [WHO-DD]|T-705|FAVIPIRAVIRUM|5-FLUORO-2-OXO-1H-PYRAZINE-3-CARBOXAMIDE|FAVIPIRAVIR [MI]|259793-96-9|EW5GL2X7E0|DTXSID60948878|FAVIPIRAVIR [INN]|D09537|6-FLUORO-3-HYDROXYPYRAZINE-2-CARBO XAMIDE|CS-0612|PB42412|6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE|FAPILAVIR|HY-14768|AVIGAN|PYRAZINECARBOXAMIDE, 6-FLUORO-3,4-DIHYDRO-3-OXO-|DB12466|FAVILAVIR|Q16934561|6-FLUORO-3-HYDROXY-2-PYRAZINECARBOXAMIDE|A902150|T 705|AREPLIVIR|FAVIPIRAVIR [JAN]|NCGC00373041-03|T-705 CPD|AC-28900|T705|BCP02422|6-FLUORO-3,4-DIHYDRO-3-OXO-PYRAZINECARBOXAMIDE|GTPL11139|UNII-EW5GL2X7E0|CCG-266269|S7975|FAVIPIRAVIR (T-705)|AKOS015995178|PB25591|NCGC00373041-06|FAVIPIRAVIR; T-705|2-PYRAZINECARBOXAMIDE, 6-FLUORO-3-HYDROXY-|J05AX27|MFCD12032148|MS-20791|AVIFAVIR|FAVIPIRAVIR [USAN]|FAVIPIRAVIR (JAN/USAN/INN)	-	PUBCHEM	492405	C5H4FN3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor	ZCGNOVWYSGBHAU-UHFFFAOYSA-N
33115	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Hattori SI (2021)	33510133	239605	9939	GRL-1720	GRL-1720|INDOLE CHLOROPYRIDINYL-ESTER DERIVED, 2|Indole chloropyridinyl-ester derived, 2	-	PUBCHEM	156600307	C14H11ClN2O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33116	128336	200576	-	PIKFYVE	CFD|FAB1|HEL37|PIP5K|PIP5K3|ZFYVE29	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Kettunen P (2023)	37039676	246118	9969	Apilimod	Benzaldehyde, 3-methyl-, 2-[6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl]hydrazone|apilimod|4-{6-[2-(3-Methylbenzylidene)hydrazino]-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl}morpholine	-	CHEMSPIDER	21234847	C23H26N6O2	small molecule	-	541550-19-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PIK5K inhibitor; viral inhibition mechanism undetermined	HSKAZIJJKRAJAV-UHFFFAOYSA-N
33117	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Iqbal S (2023)	37627846	238898	9940	F1877-0839	F1877-0839|AKOS024616227|872595-28-3|1-(3-METHOXYPHENYL)-5-OXO-N-[5-[2-OXO-2-(1,3-THIAZOL-2-YLAMINO)ETHYL]SULFANYL-1,3,4-THIADIAZOL-2-YL]PYRROLIDINE-3-CARBOXAMIDE|1-(3-METHOXYPHENYL)-5-OXO-N-(5-((2-OXO-2-(THIAZOL-2-YLAMINO)ETHYL)THIO)-1,3,4-THIADIAZOL-2-YL)PYRROLIDINE-3-CARBOXAMIDE|1-(3-METHOXYPHENYL)-5-OXO-N-[5-({[(1,3-THIAZOL-2-YL)CARBAMOYL]METHYL}SULFANYL)-1,3,4-THIADIAZOL-2-YL]PYRROLIDINE-3-CARBOXAMIDE|1-(3-methoxyphenyl)-5-oxo-N-(5-((2-oxo-2-(thiazol-2-ylamino)ethyl)thio)-1,3,4-thiadiazol-2-yl)pyrrolidine-3-carboxamide	-	PUBCHEM	16832490	C19H18N6O4S3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined. Authors identified SARS-CoV-2 (WT) Spike inhibitors using experimental ACE2 Inhibition TR-FRET Assay, high throughput Screening and Molecular Dynamic Simulation (MDS).	-
33118	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Iqbal S (2023)	37627846	238898	9941	F0470-0003	3-(2-CHLOROPHENYL)-5-METHYL-N-(5-((2-OXO-2-(THIAZOL-2-YLAMINO)ETHYL)THIO)-1,3,4-THIADIAZOL-2-YL)ISOXAZOLE-4-CARBOXAMIDE|AKOS002046982|391868-57-8|ZINC16977044|3-(2-CHLOROPHENYL)-5-METHYL-N-(5-{[2-OXO-2-(1,3-THIAZOL-2-YLAMINO)ETHYL]THIO}-1,3,4-THIADIAZOL-2-YL)ISOXAZOLE-4-CARBOXAMIDE|3-(2-CHLOROPHENYL)-5-METHYL-N-[5-({[(1,3-THIAZOL-2-YL)CARBAMOYL]METHYL}SULFANYL)-1,3,4-THIADIAZOL-2-YL]-1,2-OXAZOLE-4-CARBOXAMIDE|F0470-0003|OPREA1_347251|3-(2-CHLOROPHENYL)-5-METHYL-N-[5-[2-OXO-2-(1,3-THIAZOL-2-YLAMINO)ETHYL]SULFANYL-1,3,4-THIADIAZOL-2-YL]-1,2-OXAZOLE-4-CARBOXAMIDE|3-(2-chlorophenyl)-5-methyl-N-(5-((2-oxo-2-(thiazol-2-ylamino)ethyl)thio)-1,3,4-thiadiazol-2-yl)isoxazole-4-carboxamide	-	PUBCHEM	4564796	C18H13ClN6O3S3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined. Authors identified SARS-CoV-2 (WT) Spike inhibitors using experimental ACE2 Inhibition TR-FRET Assay, high throughput Screening and Molecular Dynamic Simulation (MDS).	-
33119	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kato Y (2021)	888800000233	227570	1230	Clomipramine	Clomipraminum|3-Chloroimipramine|Monochlorimipramine|3-(3-chloro-10,11-dihydro-5H-Dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine|Clomipramine|Clomipramina|g 34586|Chlorimipramine|3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine	gen-clomipramine - tab 50mg|pm	DRUGBANK	DB01242	C19H23ClN2	small molecule	N06AA04	303-49-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational)	GDLIGKIOYRNHDA-UHFFFAOYSA-N
33120	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Srinivasan V (2022)	35953531	238809	9983	4-(2-hydroxyethyl)phenol	Tyrosol|Benzeneethanol, 4-hydroxy-|4-Hydroxyphenylethanol|4-(2-Hydroxyethyl)phenol|p-Hydroxyphenethyl alcohol|2-(4-Hydroxyphenyl)ethanol|4-Hydroxyphenethyl alcohol|4-Hydroxyphenylethyl alcohol|b-(4-Hydroxyphenyl)ethanol|b-(p-Hydroxyphenyl)ethanol|beta-(4-Hydroxyphenyl)ethanol|beta-(p-Hydroxyphenyl)ethanol|4-(2-Hydroxyethyl)benzolol|2-(4-Hydroxyphenyl)ethan-1-ol|phenethyl alcohol, 4-hydroxy-|p-Hydroxyphenylethanol|Ethanol, 2-(4-hydroxyphenyl)-|4-hydroxy-Benzeneethanol|UNII-1AK4MU3SNX|p-HPEA|1AK4MU3SNX	-	CHEMSPIDER	9964	C8H10O2	small molecule	-	501-94-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	YCCILVSKPBXVIP-UHFFFAOYSA-N
33121	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Srinivasan V (2022)	35953531	238809	9953	Methyl 3,4-dihydroxybenzoate	Methyl 3,4-dihydroxybenzoate|Protocatechuic acid, methyl ester|Benzoic acid, 3,4-dihydroxy-, methyl ester|methyl esterprotocatechuic acid	-	CHEMSPIDER	253113	C8H8O4	small molecule	-	2150-43-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	CUFLZUDASVUNOE-UHFFFAOYSA-N
33122	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Grosse M (2022)	35891385	238812	8389	PR-619	2,6-diamino-5-(cyanothio)pyridin-3-yl thiocyanate|2,6-Diamino-3,5-pyridinediyl bis(thiocyanate)|Thiocyanic acid, 2,6-diamino-3,5-pyridinediyl ester	-	CHEMSPIDER	2096054	C7H5N5S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	ZXOBLNBVNROVLC-UHFFFAOYSA-N
33123	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Grosse M (2022)	35891385	238812	8385	HBX 41,108	7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile|9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 7-chloro-9-oxo-	-	CHEMSPIDER	17225370	C13H3ClN4O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	BIGPXXAUSQLTQR-UHFFFAOYSA-N
33124	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Zou Z (2022)	35866602	238813	9970	Parthenolide	Parthenolide|(1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one|Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)-|(-)-Parthenolide|(1aR,4E,7aS,10aS,10bR)-1a,5-Dimethyl-8-methylene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one	-	CHEMSPIDER	4976071	C15H20O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	KTEXNACQROZXEV-PVLRGYAZSA-N
33125	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2021)	34341772	227572	10346	Jun9-72-2	Phenol, 4-[[methyl[(1R)-1-(1-naphthalenyl)ethyl]amino]methyl]-|4-({Methyl[(1R)-1-(1-naphthyl)ethyl]amino}methyl)phenol	-	CHEMSPIDER	115285268	C20H21NO	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	QFTKMDZKABQMHI-OAHLLOKOSA-N
33126	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Shan H (2021)	33979649	239606	9942	GTPL11543	N-{3-FLUORO-5-[({1-[(1R)-1-(NAPHTHALEN-1-YL)ETHYL]PIPERIDIN-4-YL}FORMAMIDO)METHYL]PHENYL}-4-METHYLPIPERAZINE-1-CARBOXAMIDE|GTPL11543|COMPOUND 19 [PMID: 33979649]|N-{3-fluoro-5-[({1-[(1R)-1-(naphthalen-1-yl)ethyl]piperidin-4-yl}formamido)methyl]phenyl}-4-methylpiperazine-1-carboxamide	-	PUBCHEM	155925847	C31H38FN5O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	-
33127	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	9975	Asunaprevir	1,1-dimethylethyl [(1S)-1-{[(2S,4R)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate|Asunaprevir|Cyclopropanecarboxamide, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, (1R,2S)-|3-Methyl-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-L-prolinamide|L-Prolinamide, N-[(1,1-dimethylethoxy)carbonyl]-3-methyl-L-valyl-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-, (4R)-|UNII-S9X0KRJ00S|S9X0KRJ00S	-	CHEMSPIDER	17235944	C35H46ClN5O9S	small molecule	-	630420-16-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	XRWSZZJLZRKHHD-WVWIJVSJSA-N
33128	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	5547	Simeprevir	-	galexos|olysio	DRUGBANK	DB06290	C38H47N5O7S2	small molecule	J05AE14	923604-59-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	JTZZSQYMACOLNN-VDWJNHBNSA-N
33129	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	9976	Vaniprevir	Vaniprevir|Vaniprevirum|CV3X74AO1H	-	CHEMSPIDER	28475381	C38H55N5O9S	small molecule	-	923590-37-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KUQWGLQLLVFLSM-ONAXAZCASA-N
33130	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	9965	Narlaprevir	Narlaprevir|2857LA2O07	-	CHEMSPIDER	10031710	C36H61N5O7S	small molecule	-	865466-24-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	RICZEKWVNZFTNZ-LFGITCQGSA-N
33131	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	8249	Grazoprevir	(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide|Grazoprevir|Grazoprevir anhydrous	zepatier	DRUGBANK	DB11575	C38H50N6O9S	small molecule	-	1350514-68-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	OBMNJSNZOWALQB-NCQNOWPTSA-N
33132	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	7617	Boceprevir	Victrelis|SCH 503034	victrelis triple|victrelis	DRUGBANK	DB08873	C27H45N5O5	small molecule	J05AE12	394730-60-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	LHHCSNFAOIFYRV-DOVBMPENSA-N
33133	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	5272	Telaprevir	(1S,3AR,6as)-(2S)-2-cyclohexyl-N-(pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-((1S)-1-((cyclopropylamino)oxoacetyl)butyl)octahydrocyclopenta(c)pyrrole-1-carboxamide|MP-424|VX 950|Incivek|VX-950	incivek	DRUGBANK	DB05521	C36H53N7O6	small molecule	J05AE11	402957-28-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	BBAWEDCPNXPBQM-GDEBMMAJSA-N
33134	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	8041	Paritaprevir	(2R,6S,12Z,13aR,14aR,16aS)-N-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide|Veruprevir	technivie|viekira pak|holkira 	DRUGBANK	DB09297	C40H43N7O7S	small molecule	J05AX67|J05AX66	1216941-48-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	UAUIUKWPKRJZJV-MDJGTQRPSA-N
33135	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	8249	Grazoprevir	(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide|Grazoprevir|Grazoprevir anhydrous	zepatier	DRUGBANK	DB11575	C38H50N6O9S	small molecule	-	1350514-68-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	OBMNJSNZOWALQB-NCQNOWPTSA-N
33136	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	5547	Simeprevir	-	galexos|olysio	DRUGBANK	DB06290	C38H47N5O7S2	small molecule	J05AE14	923604-59-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	JTZZSQYMACOLNN-VDWJNHBNSA-N
33137	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bafna K (2021)	33984267	239607	9976	Vaniprevir	Vaniprevir|Vaniprevirum|CV3X74AO1H	-	CHEMSPIDER	28475381	C38H55N5O9S	small molecule	-	923590-37-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	KUQWGLQLLVFLSM-ONAXAZCASA-N
33138	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Drayman N (2021)	34285133	239608	9977	Masitinib	Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-|4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide|Masitinib|N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide|4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-1,3-thiazol-2-yl]amino}phenyl)benzamide	-	CHEMSPIDER	8250179	C28H30N6OS	small molecule	-	790299-79-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	WJEOLQLKVOPQFV-UHFFFAOYSA-N
33139	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Logan A (2022)	888800000762	238022	9936	LMW-DS	Ibsolvmir|Dextran sulfate sodium	-	PUBCHEM	440234653	-	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined; Delta, omicron and wuhan variant tested	-
33140	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2020)	32541865	239609	7617	Boceprevir	Victrelis|SCH 503034	victrelis triple|victrelis	DRUGBANK	DB08873	C27H45N5O5	small molecule	J05AE12	394730-60-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	LHHCSNFAOIFYRV-DOVBMPENSA-N
33141	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2020)	32541865	239609	9944	GC-376	BCP32603|GC-376; GC 376|GC376|(2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate	-	PUBCHEM	146681255	C21H30N3O8S-	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33142	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2020)	32541865	239609	9967	Calpain Inhibitor II	Calpain inhibitor II|N-Acetyl-L-leucyl-N-[(2S)-4-(methylsulfanyl)-1-oxo-2-butanyl]-L-leucinamide|N-acetyl-L-leucyl-N-[(1S)-1-formyl-3-(methylthio)propyl]-L-leucinamide|SUAM-312|MFCD00065506|1D8SBU367Z|N-Acetyl-L-leucyl-N-[(2S)-4-(methylsulfanyl)-1-oxobutan-2-yl]-L-leucinamide|L-Leucinamide, N-acetyl-L-leucyl-N-[(1S)-1-formyl-3-(methylthio)propyl]-|N-Acetyl-L-leucyl-L-leucyl-L-methioninal	-	CHEMSPIDER	108711	C19H35N3O4S	small molecule	-	136632-32-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	RJWLAIMXRBDUMH-ULQDDVLXSA-N
33143	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2020)	32541865	239609	9979	Calpain Inhibitor XII	Calpain Inhibitor XII|Carbamic acid, N-[1-[[[1-[1,2-dioxo-2-[(2-pyridinylmethyl)amino]ethyl]butyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester|N~2~-[(benzyloxy)carbonyl]-N-{1,2-dioxo-1-[(pyridin-2-ylmethyl)amino]hexan-3-yl}leucinamide|N~2~-[(Benzyloxy)carbonyl]-N-{1,2-dioxo-1-[(2-pyridinylmethyl)amino]-3-hexanyl}leucinamide	-	CHEMSPIDER	21396054	C26H34N4O5	small molecule	-	181769-57-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	PLVWMBFPIAQRHK-UHFFFAOYSA-N
33144	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Kitamura N (2022)	33891389	239610	9945	JUN8763A	N-([1,1'-BIPHENYL]-4-YL)-N-((R)-2-OXO-2-(((S)-1-PHENYLETHYL)AMINO)-1-(PYRIDIN-3-YL)ETHYL)FURAN-2-CARBOXAMIDE|GLXC-25592|X7V|JUN8-76-3A|N-([1,1'-BIPHENYL]-4-YL)-N-[(1R)-2-OXO-2-{[(1S)-1-PHENYLETHYL]AMINO}-1-(PYRIDIN-3-YL)ETHYL]FURAN-2-CARBOXAMIDE|JUN8763A|N-([1,1'-biphenyl]-4-yl)-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]furan-2-carboxamide|JUN8-76-3A	-	PUBCHEM	155289416	C32H27N3O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33145	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Campagna J (2022)	888800000722	237482	5530	Eltrombopag	Promacta|Eltrombopagum|Eltrombopag	revolade|promacta	DRUGBANK	DB06210	C25H22N4O4	small molecule	B02BX05	496775-61-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	XDXWLKQMMKQXPV-QYQHSDTDSA-N
33146	112968	7113	-	TMPRSS2	PP9284|PRSS10	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2020)	33143316	239611	9973	Aprotinin	Cinchonan-9-ol, 10,11-dihydro-6'-methoxy-, (8alpha,9R)-, hydrobromide (1:1)|(8alpha,9R)-6'-Methoxy-10,11-dihydrocinchonan-9-ol hydrobromide (1:1)	-	CHEMSPIDER	2016499	C20H27BrN2O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: TMPRSS2 inhibitor	BKKQYYLUFOIOJF-YYQSSQEESA-N
33147	117618	26227	RP4-683H9.1	PHGDH	3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	9954	NCT-503	1-Piperazinecarbothioamide, N-(4,6-dimethyl-2-pyridinyl)-4-[[4-(trifluoromethyl)phenyl]methyl]-|N-(4,6-Dimethyl-2-pyridinyl)-4-[4-(trifluoromethyl)benzyl]-1-piperazinecarbothioamide|NCT-503|N-(4,6-Dimethylpyridin-2-yl)-4-(4-(trifluoromethyl)benzyl)piperazine-1-carbothioamide	-	CHEMSPIDER	57621588	C20H23F3N4S	small molecule	-	1916571-90-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PHGDH inhibitor; viral inhibition mechanism undetermined; Delta and Omicron variant tested	PJNSZIQUFLWRLH-UHFFFAOYSA-N
33148	109346	3099	-	HK2	HKII|HXK2	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2020)	32408336	223364	9980	2-Deoxy-D-glucose	2-Deoxy-D-glucose|2-DG|2-deoxyglucose|2-Deoxy-D-arabino-hexopyranose|D-arabino-Hexopyranose, 2-deoxy-|D-arabino-2-Desoxyhexose|(4R,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol|2-deoxy-D-glucopyranose	-	CHEMSPIDER	388402	C6H12O5	small molecule	-	154-17-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: HK2 inhibitor; viral inhibition mechanism undetermined	PMMURAAUARKVCB-CERMHHMHSA-N
33149	112968	7113	-	TMPRSS2	PP9284|PRSS10	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Li K (2021)	34340553	239612	9950	nafamostat	Nafamostat|Nafamstat|Futhan|6-Amidino-2-naphthyl-4-guanidinobenzoate|4-[(Aminoiminomethyl)amino]benzoic Acid 6-(Aminoiminomethyl)-2-naphthalenyl Ester|6-carbamimidoylnaphthalen-2-yl 4-carbamimidamidobenzoate|Benzoic acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester|6-Carbamimidoyl-2-naphthyl 4-carbamimidamidobenzoate|6-Carbamimidoyl-2-naphthyl 4-[(diaminomethylene)amino]benzoate|Y25LQ0H97D|Benzoic acid, 4-[(diaminomethylene)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester|6-carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate	-	CHEMSPIDER	4260	C19H17N5O2	small molecule	-	81525-10-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: TMPRSS2 inhibitor	MQQNFDZXWVTQEH-UHFFFAOYSA-N
33150	113258	7415	-	VCP	ALS14|HEL-220|HEL-S-70|IBMPFD|IBMPFD1|TERA|p97	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2020)	32408336	223364	8581	NMS-873	Pyridine, 3-[3-(cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]-|NMS-873|MFCD28009371|3-[3-Cyclopentylsulfanyl-5-(4'-methanesulfonyl-2-methylbiphenyl-4-yloxymethyl)-[1,2,4]triazol-4-yl]-pyridine|3-[3-(Cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]-pyridine|3-[3-(Cyclopentylsulfanyl)-5-({[2-methyl-4'-(methylsulfonyl)-4-biphenylyl]oxy}methyl)-4H-1,2,4-triazol-4-yl]pyridine	-	CHEMSPIDER	29398603	C27H28N4O3S2	small molecule	-	1418013-75-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: p97 inhibitor; viral inhibition mechanism undetermined	UJGTUKMAJVCBIS-UHFFFAOYSA-N
33151	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Papp H (2022)	888800000685	237180	8302	Rucaparib	-	rubraca	DRUGBANK	DB12332	C19H18FN3O	small molecule	-	283173-50-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (experimental);	HMABYWSNWIZPAG-UHFFFAOYSA-N
33152	106877	382	-	ARF6	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Mirabelli C (2023)	37342971	236292	9974	NAV-2729	NAV2729|Grassofermata|Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(4-chlorophenyl)-5-(4-nitrophenyl)-2-(phenylmethyl)-|2-Benzyl-3-(4-chlorophenyl)-5-(4-nitrophenyl)pyrazolo[1,5-a]pyrimidin-7(4H)-one	-	CHEMSPIDER	21510462	C25H17ClN4O3	small molecule	-	419547-11-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ARF6 inhibitor; viral inhibition mechanism undetermined	GUUWHOSUKOCRHG-UHFFFAOYSA-N
33153	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Jochmans D (2023)	36625640	236293	9959	PF-00835231	1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-|N-[(2S)-1-({(2S)-4-Hydroxy-3-oxo-1-[(3S)-2-oxo-3-pyrrolidinyl]-2-butanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide	-	CHEMSPIDER	9736673	C24H32N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	QDIMHKWNHMVDJB-WBAXXEDZSA-N
33154	4383849	43740578	GU280_gp01	ORF1ab	ORF1ab polyprotein|1ab|SARS-CoV2 ORF1ab|SARS-CoV-2 ORF1ab|Replicase|R1AB_SARS2|PRO_0000449618	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Roy SS (2022)	888800000660	236299	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: ORF1 G4 binding	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
33155	4383849	43740578	GU280_gp01	ORF1ab	ORF1ab polyprotein|1ab|SARS-CoV2 ORF1ab|SARS-CoV-2 ORF1ab|Replicase|R1AB_SARS2|PRO_0000449618	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Roy SS (2022)	888800000660	236299	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: ORF1 G4 binding	WIKYUJGCLQQFNW-UHFFFAOYSA-N
33156	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Hirose Y (2022)	36229406	236284	9946	8a (YH-6)	8a (YH-6)|4-fluoro-N-[(2S)-1-[2-(2-fluoroacetyl)-2-[[(3S)-2-oxopyrrolidin-3-yl]methyl]hydrazinyl]-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide	-	PUBCHEM	165416578	C22H27F2N5O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33157	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Hirose Y (2022)	36229406	236284	9946	8a (YH-6)	8a (YH-6)|4-fluoro-N-[(2S)-1-[2-(2-fluoroacetyl)-2-[[(3S)-2-oxopyrrolidin-3-yl]methyl]hydrazinyl]-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide	-	PUBCHEM	165416578	C22H27F2N5O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33158	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Hirose Y (2022)	36229406	236284	9946	8a (YH-6)	8a (YH-6)|4-fluoro-N-[(2S)-1-[2-(2-fluoroacetyl)-2-[[(3S)-2-oxopyrrolidin-3-yl]methyl]hydrazinyl]-4-methyl-1-oxopentan-2-yl]-1H-indole-2-carboxamide	-	PUBCHEM	165416578	C22H27F2N5O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33159	108836	2562	-	GABRB3	ECA5	9606	Homo sapiens	activator/sars-cov-2 inhibitor	target	Tian J (2022)	36389819	239613	2427	Gamma(Amino)-Butyric Acid	-	-	DRUGBANK	DB02530	C4H9NO2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: GABA-receptor agonist; viral inhibition mechanism undetermined	BTCSSZJGUNDROE-UHFFFAOYSA-N
33160	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Raymonda MH (2022)	34871905	239614	1246	Lapatinib	GW 572016|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib tosilate hydrate|N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|FMM|Tykerb	tykerb	DRUGBANK	DB01259	C29H26ClFN4O4S	small molecule	L01XE07	231277-92-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	BCFGMOOMADDAQU-UHFFFAOYSA-N
33161	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Raymonda MH (2022)	34871905	239614	2916	Doramapimod	DSSTOX_RID_83151|KINOME_2137|CCG-264915|1-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|ZINC24044436|DORAMAPIMOD1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|NSC785337|AKOS005256489|S1574|ALBB-035131|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|MLS006010153|NCGC00241104-07|BIRB 0796|NSC-785337|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|1-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-3-(4-(2-(MORPHOLIN-4-YL)ETHOXY)NAPHTHALEN-1-YL)UREA|1-(3-(TERT-BUTYL)-1-(P-TOLYL)-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA.|CS-0219|BIRB796|1-(3-TERT-BUTYL-1-P-TOLYL-1H-PYRAZOL-5-YL)-3-(4-(2-MORPHOLINOETHOXY)NAPHTHALEN-1-YL)UREA|BIRB 796BS|MFCD09752957|BIRB 796 (DORAMAPIMOD)|UNII-HO1A8B3YVV|SR-00000002531|Q-101419|B96|EX-A4530|DB03044|D03736|TOX21_113386_1|AS-19375|BIRB 796 BS|SW219700-1|1-[5-TERT-BUTYL-2-(4-METHYLPHENYL)-3-PYRAZOLYL]-3-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|285983-48-4|UREA, N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-(2-(4-MORPHOLINYL)ETHOXY)-1-NAPHTHALENYL)-|UREA, N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-|BIRB-796 BS|DORAMAPIMOD (BIRB-796)|BIRB-796, 3|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3(4-(2-MORPHOLIN-4-YL-ETHOXY)NAPHTHALEN-1-YL)UREA|BIRB-796|FT-0667779|DSSTOX_GSID_48957|NCGC00241104-01|BIRB 796|BCPP000333|DORAMAPIMOD|BCP01896|1-[5-TERT-BUTYL-2-(P-TOLYL)PYRAZOL-3-YL]-3-[4-(2-MORPHOLINOETHOXY)-1-NAPHTHYL]UREA|CID_156422|BRD-K74065929-001-01-5|N-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-N'-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA|TOX21_113386|GTPL5668|SMR004458704|1KV2|P38 MAP KINASE INHIBITOR X, BIRB 796 - CAS 285983-48-4|1-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-3-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|N-[3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]- N'-[4-[2-(4-MORPHOLINYL)ETHOXY]-1-NAPHTHALENYL]-UREA|NCGC00241104-02|DSSTOX_CID_28883|DORAMAPIMOD [INN]|BIRB 796,DORAMAPIMOD|DORAMAPIMOD [USAN]|HMS3295M15|DORAMAPIMOD (USAN/INN)|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|DTXSID2048957|DIARYL UREA COMPOUND 10|HMS3747G11|HO1A8B3YVV|DORAMAPIMOD (BIRB 796)|SR-00000002531-1|DORAMAPIMOD [WHO-DD]|BCP9000416|US8933228, BIRB 796|HY-10320|BIBR-796|AC-24379|HMS3655C07|DORAMAPIMOD [USAN:INN]|A819503|SB16634|Q27077098|BIRB-0796|3-[2-(4-METHYLPHENYL)-5-TERT-BUTYL-PYRAZOL-3-YL]-1-[4-(2-MORPHOLIN-4-YLETHOXY)NAPHTHALEN-1-YL]UREA|3-[3-TERT-BUTYL-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL]-1-{4-[2-(MORPHOLIN-4-YL)ETHOXY]NAPHTHALEN-1-YL}UREA	-	DRUGBANK	DB03044	C31H37N5O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: p38 MAPK inhibitor; viral inhibition mechanism undetermined	MVCOAUNKQVWQHZ-UHFFFAOYSA-N
33162	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Raymonda MH (2022)	34871905	239614	9964	17-AAG	Tanespimycin|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|2-azabicyclo[16.3.1]docosa-2,4,6,10,18,21-hexaene-20,22-dione, 3,13-dihydroxy-9-(hydroxyiminomethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (2E,4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|17-demethoxygeldanamycin|MFCD04973892|Geldanamycin,17-demethoxy-17-(2-propenylamino)-|4GY0AVT3L4	-	CHEMSPIDER	21106220	C31H43N3O8	small molecule	-	75747-14-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: HSP90 inhibitor; viral inhibition mechanism undetermined	AYUNIORJHRXIBJ-TXHRRWQRSA-N
33163	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	inhibitor/sars-cov inhibitor	target	Li C (2020)	33179566	239615	9964	17-AAG	Tanespimycin|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|2-azabicyclo[16.3.1]docosa-2,4,6,10,18,21-hexaene-20,22-dione, 3,13-dihydroxy-9-(hydroxyiminomethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (2E,4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|17-demethoxygeldanamycin|MFCD04973892|Geldanamycin,17-demethoxy-17-(2-propenylamino)-|4GY0AVT3L4	-	CHEMSPIDER	21106220	C31H43N3O8	small molecule	-	75747-14-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV indirect chemical interaction: HSP90 inhibitor; viral inhibition mechanism undetermined	AYUNIORJHRXIBJ-TXHRRWQRSA-N
33164	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	inhibitor/mers-cov inhibitor	target	Li C (2020)	33179566	239615	9964	17-AAG	Tanespimycin|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-(Allylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate|2-azabicyclo[16.3.1]docosa-2,4,6,10,18,21-hexaene-20,22-dione, 3,13-dihydroxy-9-(hydroxyiminomethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (2E,4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|2-Azabicyclo[16.3.1]docosa-4,6,10,18,21-pentaene-3,20,22-trione, 9-[(aminocarbonyl)oxy]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19-(2-propen-1-ylamino)-, (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-|17-demethoxygeldanamycin|MFCD04973892|Geldanamycin,17-demethoxy-17-(2-propenylamino)-|4GY0AVT3L4	-	CHEMSPIDER	21106220	C31H43N3O8	small molecule	-	75747-14-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV indirect chemical interaction: HSP90 inhibitor; viral inhibition mechanism undetermined	AYUNIORJHRXIBJ-TXHRRWQRSA-N
33165	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Oh CK (2023)	36175661	234735	9947	NMT5	NMT5|[3-(AMINOMETHYL)-5,7-DIMETHYL-1-ADAMANTYL]METHYL NITRATE|GTPL12201|[3-(Aminomethyl)-5,7-dimethyl-1-adamantyl]methyl nitrate	-	PUBCHEM	155354575	C14H24N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 modifying (experimental)	-
33166	108068	1723	-	DHODH	DHOdehase|POADS|URA1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Demarest JF (2022)	36041646	239616	3377	Brequinar	6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid	-	DRUGBANK	DB03523	C23H15F2NO2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: DHODH inhibitor; viral inhibition is potentiated in the presence of dipyridamole	PHEZJEYUWHETKO-UHFFFAOYSA-N
33167	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Hu H (2022)	36308706	239366	10348	Tetramethylcystamine	Ethanamine, 2,2'-dithiobis[N,N-dimethyl-|2,2'-DITHIOBIS(N,N-DIMETHYLETHANAMINE)|ETHANAMINE, 2,2'-DITHIOBIS(N,N-DIMETHYL-|DTXSID30147932|TMTS|BIS[2-(N,N-DIMETHYLAMINO)ETHYL]DISULFIDE|N-(2-([2-(DIMETHYLAMINO)ETHYL]DISULFANYL)ETHYL)-N,N-DIMETHYLAMINE #|N,N'-TETRAMETHYLCYSTAMINE|ETHANAMINE, 2,2'-DITHIOBIS[N,N-DIMETHYL-|2-[2-(DIMETHYLAMINO)ETHYLDISULFANYL]-N,N-DIMETHYLETHANAMINE|ETHYLAMINE, 2,2'-DITHIOBIS(N,N-DIMETHYL-|BIS(2-DIMETHYLAMINOETHYL)DISULFIDE|NSC101840|UNII-VHF51F4YIW|VHF51F4YIW|BIS[2-(DIMETHYLAMINO)ETHYL] PERSULFIDE|BIS(2-DIMETHYLAMINOETHANE) DISULFIDE|BIS(.BETA.-DIMETHYLAMINOETHYL) DISULFIDE|N,N-TETRAMETHYLCYSTAMINE|(2-{[2-(DIMETHYLAMINO)ETHYL]DISULFANYL}ETHYL)DIMETHYLAMINE|N,N,N',N'-TETRAMETHYLCYSTAMINE|2,2'-DISULFANEDIYLBIS(N,N-DIMETHYLETHANAMINE)|EN300-1723123|BIS(N,N-DIMETHYL-2-AMINOETHYL)DISULFIDE|AKOS028108413|BIS-(2-(N,N-DIMETHYLAMINO)ETHYL)DISULFIDE|BIS(2-DIMETHYLAMINOETHYL) DISULFIDE|ETHANAMINE,2'-DITHIOBIS[N,N-DIMETHYL-|NSC-101840|TETRAMETHYLCYSTAMINE|BIS(2-DIMETHYLAMINOETHYL)DISULPHIDE|BIS(DIMETHYLAMINOETHYL)DISULFIDE|NSC 101840|1072-11-3|NCIOPEN2_004842	-	PUBCHEM	28485	C8H20N2S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	BAEWLQWSDPXZDM-UHFFFAOYSA-N
33168	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	activator	target	Hu H (2022)	36308706	239366	9948	Dimesna	CID 26501|Tavocept|disodium;2-(2-sulfonatoethyldisulfanyl)ethanesulfonate	-	PUBCHEM	26501	C7H20N4O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro activator	-
33169	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	activator	target	Hu H (2022)	36308706	239366	9962	pyritinol	Pyrithioxin|Pyrithioxine|Encephabol|Dinerfene|Enerbol|pyritinol|Pyrithioxine (JAN)|Bis(4-hydroxymethyl-5-hydroxy-6-methyl-3-pyridylmethyl)disulfide|4-Pyridinemethanol, 3,3'-[dithiobis(methylene)]bis[5-hydroxy-6-methyl-|Bis[(3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl)methyl] Disulfide|Bis(4-hydroxymethyl-5-hydroxy-6-methyl-3-pyridylmethyl) Disulfide|3,3'-[Dithiobis(methylene)]bis[5-hydroxy-6-methyl-4-pyridinemethanol]|5,5'-[Disulfanediylbis(methylene)]bis[4-(hydroxymethyl)-2-methylpyridin-3-ol]|5,5'-[Disulfanediylbis(methylene)]bis[4-(hydroxymethyl)-2-methyl-3-pyridinol]|MFCD00151477|AK5Q5FZH2R	-	CHEMSPIDER	13561	C16H20N2O4S2	small molecule	-	1098-97-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro activator	SIXLXDIJGIWWFU-UHFFFAOYSA-N
33170	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	activator	target	Hu H (2022)	36308706	239366	3175	Oxidized Glutathione Disulfide	-	-	DRUGBANK	DB03310	C20H32N6O12S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro activator	YPZRWBKMTBYPTK-DDHJBXDOSA-N
33171	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Hou X (2022)	888800000836	239368	9971	GT-0918	4-[4,4-Dimethyl-3-[6-[3-(2-oxazolyl)propyl]-3-pyridinyl]-5-oxo-2-thioxo-1-imidazolidinyl]-3-fluoro-2-(trifluoromethyl)benzonitrile|GT-0918|Benzonitrile, 4-[4,4-dimethyl-3-[6-[3-(2-oxazolyl)propyl]-3-pyridinyl]-5-oxo-2-thioxo-1-imidazolidinyl]-3-fluoro-2-(trifluoromethyl)-|4-(4,4-Dimethyl-3-{6-[3-(1,3-oxazol-2-yl)propyl]-3-pyridinyl}-5-oxo-2-thioxo-1-imidazolidinyl)-3-fluoro-2-(trifluoromethyl)benzonitrile	-	CHEMSPIDER	52084193	C24H19F4N5O2S	small molecule	-	1398046-21-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AR inhibitor	KCBJGVDOSBKVKP-UHFFFAOYSA-N
33172	108123	1786	-	DNMT1	ADCADN|AIM|CXXC9|DNMT|HSN1E|MCMT	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zhang Y (2022)	34672954	237984	918	Azacitidine	Azacitidine|Azacitidina|4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one|Azacitidinum|5 AZC|Azacytidine|5-Azacytidine	azacitidine|vidaza	DRUGBANK	DB00928	C8H12N4O5	small molecule	L01BC07	320-67-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: DNMT1 inhibitor; Viral inhibition in anti- SARS-CoV-2 infection assays in Vero E6 cells.	NMUSYJAQQFHJEW-KVTDHHQDSA-N
33173	106976	486	-	FXYD2	ATP1G1|HOMG2	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zhang Y (2022)	34672954	237984	8253	Thimerosal	ethylmercurithiosalicylate sodium|thiomersalate|sodium ethylmercurithiosalicylate|o-(ethylmercurithio)benzoic acid sodium salt|ethylmercurithiosalicylic acid sodium salt|ethyl(2-mercaptobenzoato-S)mercury sodium salt|Tiomersal|Thiomersal|Thiomersalum|sodium merthiolate|[(o-carboxyphenyl)thio]ethylmercury sodium salt|mercurothiolate	-	DRUGBANK	DB11590	C9H9HgNaO2S	small molecule	D08AK06	54-64-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: FXYD2 antagonist; Viral inhibition in anti- SARS-CoV-2 infection assays in Vero E6 cells.	RTKIYNMVFMVABJ-UHFFFAOYSA-L
33174	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Cantini F (2020)	32333918	239617	9958	Baricitinib	3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-|Baricitinib|INCB028050|LY3009104|{1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}ethanenitrile|{1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidinyl}acetonitrile|Olumiant	-	CHEMSPIDER	26373084	C16H17N7O2S	small molecule	-	1187594-09-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AP2 Associated kinase inhibitor	XUZMWHLSFXCVMG-UHFFFAOYSA-N
33175	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Morin-Dewaele M (2022)	36473907	239618	957	Desloratadine	Descarboethoxyloratadine|DESLORATADINE|8-chloro-6,11-dihydro-11-(4-Piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine	allergy control desloratadine|	DRUGBANK	DB00967	C19H19ClN2	small molecule	R06AX27	100643-71-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	JAUOIFJMECXRGI-UHFFFAOYSA-N
33176	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Vatansever EC (2021)	33597253	239619	1232	Bepridil	Bepridil|Bepadin	-	DRUGBANK	DB01244	C24H34N2O	small molecule	C08EA02	64706-54-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	UIEATEWHFDRYRU-UHFFFAOYSA-N
33177	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Vatansever EC (2021)	33597253	239619	9907	Ebastine	Ebastine|1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone|4'-tert-Butyl-4-[4-(diphenylmethoxy)piperidino]butyrophenone|4-Diphenylmethoxy-1-[3-(4-tert-butylbenzoyl)propyl]piperidine|4-[4-(Diphenylmethoxy)-1-piperidinyl]-1-[4-(2-methyl-2-propanyl)phenyl]-1-butanone|1-Butanone, 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-|1-(4-tert-butylphenyl)-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one|Ebastin|MFCD00865661	-	CHEMSPIDER	3079	C32H39NO2	small molecule	-	90729-43-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	MJJALKDDGIKVBE-UHFFFAOYSA-N
33178	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Vatansever EC (2021)	33597253	239619	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	YVUQSNJEYSNKRX-UHFFFAOYSA-N
33179	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Hou Y (2021)	33609497	239620	447	Loratadine	Loratadina|Claritin|Loratadinum	family dollar allergy relief|l	DRUGBANK	DB00455	C22H23ClN2O2	small molecule	R06AX13	79794-75-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	JCCNYMKQOSZNPW-UHFFFAOYSA-N
33180	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Ge S (2021)	34052578	239621	962	Azelastine	Azelastina|Azelastinum|4-(P-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone	azelastine hydrochloride|dymis	DRUGBANK	DB00972	C22H24ClN3O	small molecule	R06AX19|S01GX07|R01AC03	58581-89-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	MBUVEWMHONZEQD-UHFFFAOYSA-N
33181	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Nejat R (2021)	34319871	239529	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
33182	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Li Y (2022)	36411632	239760	10169	oroxylin A	Oroxylin|oroxylin A|4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-methoxy-2-phenyl-|5,7-Dihydroxy-6-methoxyflavone|5,7-Dihydroxy-6-methoxy-2-phenyl-4H-1-benzopyran-4-one|baicalein 6-methyl ether|MFCD02259441|6-Methoxybaicalein|53K24Z586G|5,7-Dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one	-	CHEMSPIDER	4478428	C16H12O5	small molecule	-	480-11-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (computational)	LKOJGSWUMISDOF-UHFFFAOYSA-N
33183	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Pitsillou E (2020)	33364229	239789	10247	hypericin	Hypericin|hypericum red|VIMRxyn|1,3,4,6,8,13-Hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione|Phenanthro[1,10,9,8-opqra]perylene-7,14-dione, 1,3,4,6,8,13-hexahydroxy-10,11-dimethyl-|Cyclo werrol|1917913|MFCD00016683|7V2F1075HD|4,5,7,4',5',7'-Hexahydroxy-2,2'-dimethylnaphthodianthrone|CYCLOSAN	-	CHEMSPIDER	4444511	C30H16O8	small molecule	-	548-04-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	BTXNYTINYBABQR-UHFFFAOYSA-N
33184	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Pitsillou E (2020)	33364229	239789	1633	Rutin	rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside	-	DRUGBANK	DB01698	C27H30O16	small molecule	C05CA01|C05CA51	153-18-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	IKGXIBQEEMLURG-BKUODXTLSA-N
33185	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Pitsillou E (2020)	33364229	239789	10183	cyanidin-3-O-glucoside	Chrysanthemin|asterin|Cyanidin 3-glucoside|Kuromanin|Cyanidin Chloride 3-Glucoside|KUROMANIN CHLORIDE|Cyanidin 3-O-glucoside chloride|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-chromeniumyl beta-D-glucopyranoside chloride|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-chromeniumyl-beta-D-glucopyranosidechlorid|beta-D-Glucopyranoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1-benzopyrylium-3-yl, chloride (1:1)|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}chromenium chloride|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}chromeniumchlorid|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl beta-D-glucopyranoside chloride|MFCD27665410|CYANIDIN 3-GLUCOSIDE CHLORIDE|8X15R84UEM|Glucocyanidin chloride|Cyanidin 3-O-glucoside (chloride)|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1??-chromen-1-ylium chloride	-	CHEMSPIDER	170681	C21H21ClO11	small molecule	-	47705-70-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	YTMNONATNXDQJF-UBNZBFALSA-N
33186	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Hamed MIA (2021)	35493159	240073	602	Bisoprolol	(+-)-1-((alpha-(2-Isopropoxyethoxy)-P-tolyl)oxy)-3-(isopropylamino)-2-propanol|Bisoprololum|(RS)-1-(4-(2-isopropoxyethoxymethyl)phenoxy)-3-(isopropylamino)-2-propanol|Bisoprolol	monocor   -(5mg)|bisoprolol fu	DRUGBANK	DB00612	C18H31NO4	small molecule	C07BB07|C09BX02|C07FB07|C07AB07|C07AB57	66722-44-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	VHYCDWMUTMEGQY-UHFFFAOYSA-N
33187	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Hamed MIA (2021)	35493159	240073	4661	Nebivolol	alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)|Nebivololum|Narbivolol|1,1'-[Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)]-2,2'-iminodiethanol|alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol)|1,1'-Bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol	byvalson|nebivolol|bystolic	DRUGBANK	DB04861	C22H25F2NO4	small molecule	C07FB12|C07BB12|C07AB12	118457-14-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KOHIRBRYDXPAMZ-UHFFFAOYSA-N
33188	107027	545	-	ATR	FCTCS|FRP1|MEC1|SCKL|SCKL1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10213	berzosertib	VE-822|UNII:L423PRV3V3|VX-970|Berzosertib|L423PRV3V3|5-[4-(Isopropylsulfonyl)phenyl]-3-(3-{4-[(methylamino)methyl]phenyl}-1,2-oxazol-5-yl)-2-pyrazinamine|2-Pyrazinamine, 3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-	-	CHEMSPIDER	30773968	C24H25N5O3S	small molecule	-	1232416-25-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ATR inhibitor (PMID: 31018854); viral inhibition mechanism undetermined	JZCWLJDSIRUGIN-UHFFFAOYSA-N
33191	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Costanzi E (2021)	34769210	240265	9567	Z-Leu-leu-leu-al	CBZ-LEU-LEU-LEU-AL|Z-LLL|BRD-0970|BENZYLOXYCARBONYL-LEU-LEU-LEUCINAL|COMPOUND 5B [PMID: 16686537]|DTXSID3042639|KBIOSS_000030|EX-A1500|MFCD00674886|KBIO3_000059|CARBOBENZOXYL-LEUCINYL-LEUCINYL-LEUCINAL-H|NCGC00161679-02|X7579|MG-132 [Z-LEU-LEU-LEU-CHO]|CCG-207860|Z-LEU-LEU-LEUCINAL|Q3272916|BRD0970|MG-132-1|AOB4946|BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE|NCGC00161679-01|UNM000011053701|L-LEUCINAMIDE, N-((PHENYLMETHOXY)CARBONYL)-L-LEUCYL-N-(1-FORMYL-3-METHYLBUTYL)-, (S)-|SR-01000864598-1|CBZ-L-LEU-L-LEU-L-LEU-H|CCG-208036|N-BENZYLOXYCARBONYL-L-LEUCYL-L-LEUCYL-L-LEUCINAL|LLL CPD|Z-LEU-LEU-LEU-AL, >=90% (HPLC)|Z-LLLAL|BENZYLOXYCARBONYL-LEU-LEU-LEU-ALDEHYDE|MG 132|CS-0471|BENZYL N-[(1S)-3-METHYL-1-[[(1S)-3-METHYL-1-[[(2S)-4-METHYL-1-OXO-PENTAN-2-YL]CARBAMOYL]BUTYL]CARBAMOYL]BUTYL]CARBAMATE|SC-93546|133407-82-6|SW219780-1|KBIO3_000060|ZX-AFC000065|MG132/MG-132/|S2619|Z-LEU-LEU-LEU-AL|PHENYLMETHYL N-[(2S)-4-METHYL-1-[[(2S)-4-METHYL-1-[[(2S)-4-METHYL-1-OXOPENTAN-2-YL]AMINO]-1-OXOPENTAN-2-YL]AMINO]-1-OXOPENTAN-2-YL]CARBAMATE|CARBOBENZOXY-L-LEUCYL-L-LEUCYL-L-LEUCINAL|BIC3742|IDI1_033780|MG-132|BRD-K60230970-001-06-8|CARBOBENZOXY-LEUCYL-LEUCYL-LEUCINAL|Z-LEU-LEU-LEU-ALDEHYDE|HMS3402B12|CBZ-L-LEU-L-LEU-L-LEU-CHO|ABP000958|BRD-K60230970-001-08-4|(S)-N-((PHENYLMETHOXY)CARBONYL)-L-LEUCYL-N-(1-FORMYL-3-METHYLBUTYL)-L-LEUCINAMIDE|BIO2_000030|Z-L-LEU-L-LEU-L-LEU-H|(S)-4-METHYL-2-(3-PHENYL-PROPIONYLAMINO)-PENTANOIC ACID [(S)-1-((S)-1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|ACN-047884|Z-LLL-ALDEHYDE|CBZ-LEU-LEU-LEUCINAL|N-[(BENZYLOXY)CARBONYL]-L-LEUCYL-N-[(1S)-1-FORMYL-3-METHYLBUTYL]-L-LEUCINAMIDE|NCGC00161679-03|BENZYL(S)-4-METHYL-1-((S)-4-METHYL-1-((S)-4-METHYL-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLCARBAMATE|AS-55854|HY-13259|W-5117|L-LEUCINAMIDE, N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N1-[(1S)-1-FORMYL-3-METHYLBUTYL]-|BRD-K60230970-001-05-0|SB19111|MLS006011220|N-[(BENZYLOXY)CARBONYL]-L-LEUCYL-N-[(2S)-4-METHYL-1-OXOPENTAN-2-YL]-L-LEUCINAMIDE|CARBOBENZOXY-LEU-LEU-LEUCINAL|{1-[1-(1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL]-3-METHYL-BUTYL}-CARBAMIC ACID BENZYL ESTER|(R)-MG132|HMS1361B12|BSPBIO_001310|CC-245|HMS1989B12|C26H41N3O5|BIO2_000510|Z-LLL-H|MG132|PI-102|(S)-MG132|BENZYL N-[(1S)-1-[[(1S)-1-[[(1S)-1-FORMYL-3-METHYL-BUTYL]CARBAMOYL]-3-METHYL-BUTYL]CARBAMOYL]-3-METHYL-BUTYL]CARBAMATE|UNII-RF1P63GW3K|BENZYL ((S)-4-METHYL-1-(((S)-4-METHYL-1-(((S)-4-METHYL-1-OXOPENTAN-2-YL)AMINO)-1-OXOPENTAN-2-YL)AMINO)-1-OXOPENTAN-2-YL)CARBAMATE|SMR002530629|{(S)-1-[(S)-1-((S)-1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL]-3-METHYL-BUTYL}-CARBAMIC ACID BENZYL ESTER|KS-00000XP9|QCR-183|BRD-K60230970-001-04-3|1211877-36-9|NCGC00161679-04|BRD-K60230970-001-07-6|KBIO2_005166|ZINC13476439|GTPL8616|BCBCMAP01_000028|HMS1791B12|N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N-[(1S)-1-FORMYL-3-METHYLBUTYL]-L-LEUCINAMIDE|KBIO2_002598|L-LEUCINAMIDE, N-((PHENYLMETHOXY)CARBONYL)-L-LEUCYL-N-((1S)-1-FORMYL-3-METHYLBUTYL)-|Z-LLL-CHO|AKOS027420457|BENZYLOXYCARBONYL-LEUCYL-LEUCYL-LEUCINAL|ZLLL-CHO|Z-LEU-LEU-LEU-H|KBIO2_000030|N-[(PHENYLMETHOXY)CARBONYL]-L-LEUCYL-N-(1-FORMYL-3-METHYLBUTYL)-(S)-L-LEUCINAMIDE|KBIOGR_000030|BENZYL (S)-4-METHYL-1-((S)-4-METHYL-1-((S)-4-METHYL-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLAMINO)-1-OXOPENTAN-2-YLCARBAMATE|CTK8F0239|CBZ-LEU-LEU-LEU-H|AB0033810|{1-[(S)-(S)-1-((S)-1-FORMYL-3-METHYL-BUTYLCARBAMOYL)-3-METHYL-BUTYLCARBAMOYL]-3-METHYL-BUTYL}-CARBAMIC ACID BENZYL ESTER|RF1P63GW3K|BRD-K60230970-001-10-0|ZLLLAL|BDBM50069985	-	PUBCHEM	462382	C26H41N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	TZYWCYJVHRLUCT-VABKMULXSA-N
33192	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Lee S (2021)	34868052	240341	10285	Casirivimab	-	-	PUBCHEM	442064779	-	monoclonal antibody	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike binding (experimental), antiviral activity against SARS-CoV-2 WT, Alpha, Beta and Gamma variants	-
33193	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Lee S (2021)	34868052	240341	10286	Imdevimab	-	-	PUBCHEM	442064836	-	monoclonal antibody	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike binding (experimental), antiviral activity against SARS-CoV-2 WT, Alpha, Beta and Gamma variants	-
33194	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kiyan Y (2022)	36207386	240352	10173	CaD/Calcium dobesilate	Calcium Doxybensylate|Calcium bis(2,5-dihydroxybenzenesulfonate)|MFCD00867249|5921X1560Q|205E|Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)|2,5-Dihydroxybenzenesulfonic acid calcium salt|calcium 2,5-dihydroxybenzenesulfonate|Calcium dobesilate|Dobesilate calcium	-	CHEMSPIDER	27837	C12H10CaO10S2	small molecule	-	20123-80-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-heparan sulfate interaction inhibitor, Spike binding undetermined	QGNBTYAQAPLTMX-UHFFFAOYSA-L
33195	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Zhou L (2022)	36053674	240134	10287	HLX70	-	-	PUBCHEM	468403880	-	monoclonal antibody	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : WT, Delta, and Omicron variant Spike binding (experimental) (PMID 33264452 and 36053674), antiviral activity against SARS-CoV-2 WT, Alpha (B.1.1.7) and Epsilon (B.1.429) variants (PMID 34285198 and 33262452)	-
33196	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Wnorowska S (2022)	35846513	240057	10269	carlina oxide	Carlina oxide|furan, 2-(3-phenyl-1-propynyl)-|2-(3-Phenyl-1-propyn-1-yl)furan|Furan, 2-(3-phenyl-1-propyn-1-yl)-	-	CHEMSPIDER	144325	C13H10O	small molecule	-	502-22-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational)	ICRHFCVRNWSKQH-UHFFFAOYSA-N
33197	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10202	Torin 2	Torin 2|9-(6-AMINOPYRIDIN-3-YL)-1-[3-(TRIFLUOROMETHYL)PHENYL]-1H,2H-BENZO[H]1,6-NAPHTHYRIDIN-2-ONE|Benzo[h][1,6]naphthyridin-2(1H)-one, 9-(6-amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]-|9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h][1,6]naphthyridin-2(1H)-one	-	CHEMSPIDER	26232176	C24H15F3N4O	small molecule	-	1223001-51-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: mTOR inhibitor (PMID: 26239364); viral inhibition mechanism undetermined	GUXXEUUYCAYESJ-UHFFFAOYSA-N
33198	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10207	vistusertib	AZD-2014|AZD 2014|vistusertib	-	CHEMSPIDER	28294977	C25H30N6O3	small molecule	-	1009298-59-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: mTOR inhibitor (PMID: 27031247); viral inhibition mechanism undetermined	JUSFANSTBFGBAF-IRXDYDNUSA-N
33199	108757	2475	-	MTOR	FRAP|FRAP1|FRAP2|RAFT1|RAPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Garcia G (2021)	33784499	240019	10258	dactolisib	BEZ-235|2-Methyl-2-{4-[3-methyl-2-oxo-8-(3-quinolinyl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile|Benzeneacetonitrile, 4-[2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-alpha,alpha-dimethyl-|NVP-BEZ 235|NVP-BEZ235|BEZ 235|NVP-BEZ235-NX|BEZ235|Dactolisib|NVPBEZ235|NVP BEZ235	-	CHEMSPIDER	10151099	C30H23N5O	small molecule	-	915019-65-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: mTOR inhibitor; viral inhibition mechanism undetermined	JOGKUKXHTYWRGZ-UHFFFAOYSA-N
33200	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kiew LV (2021)	33857754	240463	10270	Ramiprilat	Ramiprilat|6N5U4QFC3G|(2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-Carboxy-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid	-	CHEMSPIDER	4576531	C21H28N2O5	small molecule	-	87269-97-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	KEDYTOTWMPBSLG-HILJTLORSA-N
33201	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kiew LV (2021)	33857754	240463	10184	Perindoprilat	2UV6ZNQ92K|(2S-(1(R*(R*)),2a,3ab,7ab))-Octahydro-1-(2-((1-carboxybutyl)amino)-1-oxopropyl)-1H-indole-2-carboxylic Acid|Perindoprilat|S-9780|(2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-Carboxybutyl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid	-	CHEMSPIDER	65017	C17H28N2O5	small molecule	-	95153-31-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	ODAIHABQVKJNIY-PEDHHIEDSA-N
33202	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kiew LV (2021)	33857754	240463	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	HDACQVRGBOVJII-JBDAPHQKSA-N
33203	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ni X (2021)	33850605	240527	10228	GS-441524	GS-441524|(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile|(2R,3R,4S,5R)-2-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile	-	CHEMSPIDER	28499294	C12H13N5O4	small molecule	-	1191237-69-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Nsp3 binding (experimental) (PMID 33850605), antiviral activity (PMID 33523654)	BRDWIEOJOWJCLU-LTGWCKQJSA-N
33204	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kim YS (2021)	34445310	240533	10188	geraniin	Geraniin|benzoic acid, 3,4,5-trihydroxy-, (3R,4aR,11R,11aS,25R,25aR,29S)-2,3,4,4a,9,11a,13,22,24,25,25a,27-dodecahydro-3,4,4,6,7,15,16,17,18,19,20-undecahydroxy-2,9,13,22,27-pentaoxo-3,5-epoxy-25,11-(epoxymethano)-11H-dibenzo[h,j]dibenzo[7,8:9,10][1,5]dioxacycloundecino[3,2-b][1,6]dioxacyclododecin-29-yl ester|(1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-Undecahydroxy-2,5,10,23,31-pentaoxo-6,9,24,27,30,40-hexaoxaoctacyclo[34.3.1.0~4,38~.0~7,26~.0~8,29~.0~11,16~.0~17,22~.0~32,37~]tetraconta-3,11,13,15,17,19,21,32,34,36-decaen-28-yl 3,4,5-trihydroxybenzoate	-	CHEMSPIDER	10270376	C41H28O27	small molecule	-	60976-49-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding and ACE2 binding (experimental)	JQQBXPCJFAKSPG-SVYIMCMUSA-N
33205	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Balkrishna A (2021)	33737804	240540	10261	withanone	withanone|WITHANONE(SH)|GY036XA633|(22R)-6alpha,7alpha-Epoxy-5,17,22-trihydroxy-1-oxo-5alpha-ergosta-2,24-dien-26-oic acid delta-lactone|MFCD09264639|Ergosta-2,24-diene-1,26-dione, 6,7:22,26-diepoxy-5,17-dihydroxy-, (5alpha,6alpha,7alpha,22R)-|(5alpha,6alpha,7alpha,22R)-5,17-Dihydroxy-6,7:22,26-diepoxyergosta-2,24-diene-1,26-dione	-	CHEMSPIDER	10294995	C28H38O6	small molecule	-	27570-38-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike and ACE2 binding (computational)	FAZIYUIDUNHZRG-PCTWTJKKSA-N
33206	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Chakraborty S (2022)	36098617	246221	10261	withanone	withanone|WITHANONE(SH)|GY036XA633|(22R)-6alpha,7alpha-Epoxy-5,17,22-trihydroxy-1-oxo-5alpha-ergosta-2,24-dien-26-oic acid delta-lactone|MFCD09264639|Ergosta-2,24-diene-1,26-dione, 6,7:22,26-diepoxy-5,17-dihydroxy-, (5alpha,6alpha,7alpha,22R)-|(5alpha,6alpha,7alpha,22R)-5,17-Dihydroxy-6,7:22,26-diepoxyergosta-2,24-diene-1,26-dione	-	CHEMSPIDER	10294995	C28H38O6	small molecule	-	27570-38-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	FAZIYUIDUNHZRG-PCTWTJKKSA-N
33207	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Chakraborty S (2022)	36098617	246221	10186	withaferin A	4b,27-Dihydroxy-1-oxo-5b,6b-epoxywitha-2,24-dienolide|5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic Acid d-Lactone|(4b,5b,6b,22R)-5,6-Epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dien-26-oic acid d-lactone|(4beta,5beta,6beta,22R)-4,27-Dihydroxy-5,6:22,26-diepoxyergosta-2,24-diene-1,26-dione|Ergosta-2,24-diene-1,26-dione, 5,6:22,26-diepoxy-4,27-dihydroxy-, (4beta,5beta,6beta,22R)-|MFCD10687098|Withaferine|5,6-Epoxy-4,27-dihydroxy-1-oxowitha-2,24-dienolide|Withaferin A|Withaferine A	-	CHEMSPIDER	233064	C28H38O6	small molecule	-	5119-48-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	DBRXOUCRJQVYJQ-CKNDUULBSA-N
33208	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Shi TH (2020)	32977949	246222	8600	andrographolide	[1R-[1a[E(S*)],4ab,5a,6a,8aa]]-3-[2-[Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-2(3H)-furanone|3a,14,15,18-Tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic Acid g-Lactone|Chuanxinlian|Kalmegh|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}dihydro-2(3H)-furanone|2(3H)-Furanone, 3-[2-[(1R,4aS,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-, (3E)-|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylendecahydro-1-naphthalenyl]ethyliden}dihydro-2(3H)-furanon|(3E)-4-hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one	-	CHEMSPIDER	16735664	C20H30O5	small molecule	-	5508-58-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor (Antiviral activity, PMID: 33844528)	BOJKULTULYSRAS-FNTFRYDESA-N
33209	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Shi TH (2020)	32977949	246222	8600	andrographolide	[1R-[1a[E(S*)],4ab,5a,6a,8aa]]-3-[2-[Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-2(3H)-furanone|3a,14,15,18-Tetrahydroxy-5b,9bH,10a-labda-8(20),12-dien-16-oic Acid g-Lactone|Chuanxinlian|Kalmegh|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}dihydro-2(3H)-furanone|2(3H)-Furanone, 3-[2-[(1R,4aS,6R,8aS)-decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]dihydro-4-hydroxy-, (3E)-|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylendecahydro-1-naphthalenyl]ethyliden}dihydro-2(3H)-furanon|(3E)-4-hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one|(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl]ethylidene}dihydrofuran-2(3H)-one	-	CHEMSPIDER	16735664	C20H30O5	small molecule	-	5508-58-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	BOJKULTULYSRAS-FNTFRYDESA-N
33210	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Binette V (2021)	34223589	240577	10181	corilagin	corilagin|Benzoic acid, 3,4,5-trihydroxy-, (8R,10S,11R,12S,19R)-5,7,8,11,12,14-hexahydro-1,2,3,11,16,17,18,19-octahydroxy-5,14-dioxo-8,12-methano-10H-dibenzo[j,l][1,4,8]trioxacyclotetradecin-10-yl ester|(1S,19R,21S,22R,23R)-6,7,8,11,12,13,22,23-Octahydroxy-3,16-dioxo-2,17,20-trioxatetracyclo[17.3.1.0~4,9~.0~10,15~]tricosa-4,6,8,10,12,14-hexaen-21-yl 3,4,5-trihydroxybenzoate|MFCD00238565	-	CHEMSPIDER	66248	C27H22O18	small molecule	-	2088321-44-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (experimental)	TUSDEZXZIZRFGC-XIGLUPEJSA-N
33211	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Binette V (2021)	34223589	240577	10288	1,3,6-tri-O-galloyl-beta-D-glucose	BETA-D-GLUCOPYRANOSE 1,3,6-TRIGALLATE|NSC 69861|(2S,3R,4S,5R,6R)-3,5-DIHYDROXY-6-(((3,4,5-TRIHYDROXYBENZOYL)OXY)METHYL)TETRAHYDRO-2H-PYRAN-2,4-DIYL BIS(3,4,5-TRIHYDROXYBENZOATE)|1,3,6-TRI-O-GALLOYLGLUCOSE|1,3,6-TRI-O-GALLOYL--D-GLUCOSE|ACON1_002062|1,3,6-TRI-O-GALLOYL-B-D-GLUCOSE|1,3,6-TRI-O-GALLOYL-.BETA.-D-GLUCOPYRANOSE|BETA-D-GLUCOPYRANOSE-1,3,6-TRIS(3,4,5-TRIHYDROXYBENZOATE|E87143|1,3,6-TRI-O-GALLOYL-BETA-D-GLUCOSE|[(2R,3R,4S,5R,6S)-3,5-DIHYDROXY-4,6-BIS[(3,4,5-TRIHYDROXYBENZOYL)OXY]TETRAHYDROPYRAN-2-YL]METHYL 3,4,5-TRIHYDROXYBENZOATE|1,3,6-TRIGALLOYL GLUCOSE|MS-30889|1,3,6-TRI-O-GALLOYL-B-D-GLUCOPYRANOSE|NCGC00179867-01|1,3,6-TRI-O-GALLOYL- BETA -D-GLUCOSE|BETA-D-GLUCOPYRANOSE, 1,3,6-TRIS(3,4,5-TRIHYDROXYBENZOATE)|CS-0032136|DTXSID3041667|NSC-69861|GLUCOPYRANOSE, 1,3,6-TRIGALLATE, .BETA.-D-|1,3,6-TRI-O-GALLOYL GLUCOSE|GALLOTANNINS|.BETA.-D-GLUCOPYRANOSE 1,3,6-TRIGALLATE|O8718334XJ|W-201661|AKOS015965331|.TANNIN|NCGC00179867-02|GLUCOPYRANOSE, 1,3,6-TRIGALLATE, BETA-D-|18483-17-5|HY-N6006|1,3,6-TRIS(3,4,5-TRIHYDROXYBENZOATE)BETA-D-GLUCOPYRANOSE|C17458|.BETA.-D-GLUCOPYRANOSE, 1,3,6-TRIS(3,4,5-TRIHYDROXYBENZOATE)|Q13423012|1,3,6-TRI-O-GALLOYL-BETA-D-GLUCOPYRANOSE|TANNIC ACID (CORILAGIN)|AC-20241|MEGXP0_001387|1,3,6-TRIGALLOYLGLUCOSE, >=95% (LC/MS-ELSD)|1,3,6-TRI-O-GALLOYL-BETA-D-GLUCOSE, ANALYTICAL STANDARD|J303.464J|UNII-O8718334XJ	-	PUBCHEM	452707	C27H24O18	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (experimental)	RNKMOGIPOMVCHO-SJMVAQJGSA-N
33212	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Olaleye OA (2021)	33732940	240625	4617	Clioquinol	7-Iodo-5-chloro-8-hydroxyquinoline|5-Chlor-7-jod-8-hydroxy-chinolin|5-chloro-7-iodoquinolin-8-ol|Clioquinolum|Chloroiodoquin|Iodochloroxyquinoline|Iodochlorhydroxyquin|7-Iodo-5-chloroxine|Iodochlorhydroxyquinoline|5-Chloro-7-iodo-8-hydroxyquinoline|Iodochlorohydroxyquin|5-Chloro-8-hydroxy-7-iodoquinoline|5-Chloro-7-iodo-8-quinolinol	phen-oris - ont top|dermoscrib	DRUGBANK	DB04815	C9H5ClINO	small molecule	S02AA05|G01AC02|P01AA02|P01AA52|D09AA10|D08AH30	130-26-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human ACE2 inhibitor	QCDFBFJGMNKBDO-UHFFFAOYSA-N
33213	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Olaleye OA (2021)	33732940	240625	10229	CLBQ14	7-Bromo-5-chloro-8-quinolinol|7-bromo-5-chloroquinolin-8-ol|5-Chloro-7-bromo-8-hydroxyquinoline|7-Bromo-5-chloro-8-hydroxyquinoline|8-Quinolinol, 7-bromo-5-chloro-	-	CHEMSPIDER	74091	C9H5BrClNO	small molecule	-	7640-33-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human ACE2 inhibitor	ADJQQSUBKRASQN-UHFFFAOYSA-N
33214	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Olaleye OA (2021)	33732940	240625	1231	Chloroxine	5,7-Dichloroxine|Chlorquinol|5,7-Dichloro-8-quinolinol|5,7-Dichloro-8-oxyquinoline|5,7-Dichlorooxine|CHQ|5,7-Dichloro-8-hydroxyquinoline|5,7-Dichlor-8-hydroxychinolin	-	DRUGBANK	DB01243	C9H5Cl2NO	small molecule	-	773-76-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human ACE2 inhibitor	WDFKMLRRRCGAKS-UHFFFAOYSA-N
33215	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Henss L (2021)	33830908	241214	9892	Epigallocatechin gallate	EGCG|Epigallocatechin 3-gallate|Epigallocatechin gallate|(-)-Epigallocatechin gallate|(-)-EGCG|(-)-Epigallocatechin-3-o-gallate|(-)-epigallocatechin 3-gallate|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate|Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|(-)-Epigallocatechin 3-O-gallate|3,4,5-Trihydroxybenzoic acid (2R-cis)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|(-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate|KB5200000|MFCD00075940|(-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate	-	CHEMSPIDER	58575	C22H18O11	small molecule	-	989-51-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor; antiviral activity against SARS-CoV-2 WT, MUC-IMB-1, and Delta variants	WMBWREPUVVBILR-WIYYLYMNSA-N
33216	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ohgitani E (2021)	34208050	240738	10166	TSA/Theasinensin A	Benzoic acid, 3,4,5-trihydroxy-, (4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-diyl)bis[(2R,3R)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-2,3-diyl] ester|Theasinensin D|theasinensin A|(4,4',5,5',6,6'-Hexahydroxy-2,2'-biphenyldiyl)bis[(2R,3R)-5,7-dihydroxy-3,4-dihydro-2H-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)|(4,4',5,5',6,6'-hexahydroxybiphenyl-2,2'-diyl)bis[(2R,3R)-5,7-dihydroxy-3,4-dihydro-2H-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)	-	CHEMSPIDER	390965	C44H34O22	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, antiviral activity against SARS-CoV-2 JPN/TY/WK-521	YUULFXAQUWEYNP-GXAWFILRSA-N
33217	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ohgitani E (2021)	34208050	240738	10221	"TFDG/theaflavin 3,3'-di-O-gallate"	(3,4,5-Trihydroxy-6-oxo-6H-benzo[7]annulene-1,8-diyl)bis(5,7-dihydroxy-3,4-dihydro-2H-chromene-2,3-diyl) bis(3,4,5-trihydroxybenzoate)|Benzoic acid, 3,4,5-trihydroxy-, (3,4,5-trihydroxy-6-oxo-6H-benzocycloheptene-1,8-diyl)bis(3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-2,3-diyl) ester	-	CHEMSPIDER	2825757	C43H32O20	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, antiviral activity against SARS-CoV-2 JPN/TY/WK-521	ZEASWHWETFMWCV-UHFFFAOYSA-N
33218	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Burkard C (2015)	25653449	246223	10273	bufalin	3beta,14beta-dihydroxy-5beta-bufa-20,22-dienolide|(3b,5b)-3,14-Dihydroxybufa-20,22-dienolide|(3beta,5beta)-3,14-Dihydroxybufa-20,22-dienolide|Bufalin: Bufa-20,22-dienolide, 3,14-dihydroxy-, (3b,5b)-,|EI2962500|U549S98QLW|Bufa-20,22-dienolide, 3,14-dihydroxy-, (3.beta.,5.beta.)-|5.beta.-Bufa-20,22-dienolide, 3.beta.,14-dihydroxy-|Bufalin|5beta,20(22)-Bufadienolide-3beta,14-diol|3beta,14-Dihydroxy-5beta,20(22)-bufadienolide|Bufa-20,22-dienolide, 3,14-dihydroxy-, (3beta,5beta)-	-	CHEMSPIDER	7826155	C24H34O4	small molecule	-	465-21-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV indirect chemical interaction: ATP1A1 inhibitor	QEEBRPGZBVVINN-BMPKRDENSA-N
33219	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Burkard C (2015)	25653449	246223	1080	Ouabain	Ouabagenin-L-rhamnosid|Ouabagenin L-Rhamnoside|Ouabaine|Strodival|Ouabain|G-Strophanthin|Oubain|3-(alpha-L-Rhamnopyranosyloxy)-1beta,5beta,11alpha,14,19-pentahydroxy-5beta-card-20(22)-enolide|Ouabain anhydrous	-	DRUGBANK	DB01092	C29H44O12	small molecule	C01AC01	630-60-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV indirect chemical interaction: ATP1A1 inhibitor	LPMXVESGRSUGHW-HBYQJFLCSA-N
33220	106966	476	RP4-655J12.1	ATP1A1	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zhang ZR (2020)	33011739	246224	10273	bufalin	3beta,14beta-dihydroxy-5beta-bufa-20,22-dienolide|(3b,5b)-3,14-Dihydroxybufa-20,22-dienolide|(3beta,5beta)-3,14-Dihydroxybufa-20,22-dienolide|Bufalin: Bufa-20,22-dienolide, 3,14-dihydroxy-, (3b,5b)-,|EI2962500|U549S98QLW|Bufa-20,22-dienolide, 3,14-dihydroxy-, (3.beta.,5.beta.)-|5.beta.-Bufa-20,22-dienolide, 3.beta.,14-dihydroxy-|Bufalin|5beta,20(22)-Bufadienolide-3beta,14-diol|3beta,14-Dihydroxy-5beta,20(22)-bufadienolide|Bufa-20,22-dienolide, 3,14-dihydroxy-, (3beta,5beta)-	-	CHEMSPIDER	7826155	C24H34O4	small molecule	-	465-21-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ATP1A1 inhibitor	QEEBRPGZBVVINN-BMPKRDENSA-N
33221	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	7943	Netoglitazone	MCC 555|PGX-510|RWJ-241947	-	DRUGBANK	DB09199	C21H16FNO3S	small molecule	-	161600-01-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	PKWDZWYVIHVNKS-UHFFFAOYSA-N
33222	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10289	Bictegravir	BICTEGRAVIR [USAN:INN]|A902376|GTPL11575|CS-0014685|BICTEGRAVIR (USAN/INN)|BICTEGRAVIR [USAN]|AKOS032954062|S5911|1611493-60-7|BICTEGRAVIR [WHO-DD]|UNII-8GB79LOJ07|BCP25703|BICTEGRAVIR [MI]|BICTEGRAVIR [INN]|EX-A3161|(2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2, 1-B][1,3]OXAZEPINE-10-CARBOXAMIDE|DTXSID701027937|GS-9883|SOLUWJRYJLAZCX-LYOVBCGYSA-N|BICTEGRAVIRUM|US9663528, 42|(1S,11R,13R)-5-HYDROXY-3,6-DIOXO-N-[(2,4,6-TRIFLUOROPHENYL)METHYL]-12-OXA-2,9-DIAZATETRACYCLO[11.2.1.0(2),(1)(1).0?,?]HEXADECA-4,7-DIENE-7-CARBOXAMIDE|DB11799|D10909|DT-0020|2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE, 2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-, (2R,5S,13AR)-|8GB79LOJ07|BICTEGRAVIR|(1S,11R,13R)-5-HYDROXY-3,6-DIOXO-N-[(2,4,6-TRIFLUOROPHENYL)METHYL]-12-OXA-2,9-DIAZATETRACYCLO[11.2.1.0^{2,11}.0^{4,9}]HEXADECA-4,7-DIENE-7-CARBOXAMIDE|GS 9883|HY-17605|EN300-22793610|(1S,11R,13R)-5-HYDROXY-3,6-DIOXO-N-[(2,4,6-TRIFLUOROPHENYL)METHYL]-12-OXA-2,9-DIAZATETRACYCLO[11.2.1.02,11.04,9]HEXADECA-4,7-DIENE-7-CARBOXAMIDE|AC-30658|GS-9883-01|AMY12383|GS9883|GS-9883; GS 9883; GS9883; GS-9883-01|(2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE|N16998|Q27270406	-	PUBCHEM	90311989	C21H18F3N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	SOLUWJRYJLAZCX-LYOVBCGYSA-N
33223	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10167	ANA-12	N2-(2-{[(2-oxoazepan-3-yl)amino]carbonyl}phenyl)benzo[b]thiophene-2-carboxamide|Benzo[b]thiophene-2-carboxamide, N-[2-[[(hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]-|N-{2-[(2-Oxo-3-azepanyl)carbamoyl]phenyl}-1-benzothiophene-2-carboxamide|ANA-12|N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide|N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]-benzo[b]thiophene-2-carboxamide|MFCD00117444|ANA 12|N-{2-[(2-OXO-3-AZEPANYL)CARBAMOYL]PHENYL}-1-BENZOTHIOPHENE-2-CARB OXAMIDE|BCP16021|N-[2-[[(HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO]CARBONYL]PHENYL]BENZO[B]THIOPHENE-2-CARBOXAMIDE|HY-12497|N-[2-[[(HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO]CARBONYL]PHENYL]-BENZO[B]THIOPHENE-2-CARBOXAMIDE|BENZO(B)THIOPHENE-2-CARBOXAMIDE, N-(2-(((HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO)CARBONYL)PHENYL)-|S7745|CCG-222404|UNII-54S4JPT8JX|NCGC00379202-06|MAYBRIDGE1_001394|HMS3886N17|N-(2-((2-OXOAZEPAN-3-YL)CARBAMOYL)PHENYL)BENZO[B]THIOPHENE-2-CARBOXAMIDE|219766-25-3|A878840|OPREA1_341312|EX-A815|HMS545H08|54S4JPT8JX|FT-0700267|CS-3616|J-690263|N-{2-[(2-OXOAZEPAN-3-YL)CARBAMOYL]PHENYL}-1-BENZOTHIOPHENE-2-CARBOXAMIDE|DTXSID501045818|ANA-12, >=98% (HPLC)|N-(2-(2-OXOAZEPAN-3-YLCARBAMOYL)PHENYL)BENZO[B]THIOPHENE-2-CARBOXAMIDE|N-[2-[(2-OXOAZEPAN-3-YL)CARBAMOYL]PHENYL]-1-BENZOTHIOPHENE-2-CARBOXAMIDE|AS-16798|ANA-12|AC-32995|N-(2-(((HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO)CARBONYL)PHENYL)BENZO(B)THIOPHENE-2-CARBOXAMIDE|MFCD00117444|AKOS024458344|ANA12|NCGC00379202-10	-	CHEMSPIDER	2078460	C22H21N3O3S	small molecule	-	219766-25-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	TUSCYCAIGRVBMD-UHFFFAOYSA-N
33224	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10291	Bisdemethoxycurcumin	BISDEMETHOXYCUCURMIN|1,7-BIS(4-HYDROXYPHENYL)HEPTA-1,6-DIENE-3,5-DIONE|1,7-BIS(4-HYDROXYPHENYL)-1,6-HEPTADIENE-3,5-DIONE|(E,E)-BISDEMETHOXYCURCUMIN|(1E,6E)-1,7-BIS(4-HYDROXYPHENYL)HEPTA-1,6-DIENE-3,5-DIONE|BISDESMETHOXYCURCUMIN|Q-100322|AC-34720|1,6-HEPTADIENE-3,5-DIONE, 1,7-BIS(4-HYDROXYPHENYL)-, (E,E)-|E-100(III)|DIDEMETHOXYCURCUMIN|(1E,4Z,6E)-5-HYDROXY-1,7-BIS-(4-HYDROXY-PHENYL)-HEPTA-1,4,6-TRIEN-3-ONE|A875406|BHCMT|DIDE METHOXYCURCU MIN|DI-P-COUMAROYLMETHANE|S3938|INS-100(III)|BIS(P-HYDROXYCINNAMOYL)METHANE|24939-16-0|NSC687839|22608-12-4|AKOS015902102|CURCUMIN LLL|(1E,6E)-1,7-BIS(4-HYDROXYPHENYL)-HEPTA-1,6-DIENE-3,5-DIONE|AC-24239|UNII-2EFO1BP34R|INS NO.100(III)|P,P'-DIHYDROXYDICINNAMOYLMETHANE|BIS(4-HYDROXYCINNAMOYL)METHANE|HY-N0007A|CCG-208635|1,7-BIS(4-HYDROXYPHENYL)-1,6-HEPTADIENE-3,5-DIONE(E,E)|CURCUMIN III|DTXSID00872663|BISDEMETHOXY CURCUMIN|B3347|CCG-207959|BISDEMETHOXYCURCUMIN|CURCUMIN III;DIDEMETHOXYCURCUMIN|1,7-BIS(4-HYDROXYPHENYL)-3-HYDROXY-1,3,6-HEPTATRIEN-5-ONE|ZAA93916|1,7-BIS-(4-HYDROXYPHENYL)-HEPTA-1,6-DIENE-3,5-DIONE|BISDESMETHOXYCURCUMIN [USP-RS]|CS-0018287|BIS-DEMETHOXYCURCUMIN|(1E,6E)-1,7-BIS-(4-HYDROXY-PHENYL)-HEPTA-1,6-DIENE-3,5-DIONE|Q4917168|BISDEMETHOXYCURCUMIN, ANALYTICAL STANDARD|33171-05-0|5-HYDROXY-1,7-BIS-(4-HYDROXY-PHENYL)-HEPTA-1,4,6-TRIEN-3-ONE|BDMC;(E,E)-CURCUMIN III|CURCUMINOID A|AS-68737|MFCD03419284|2EFO1BP34R|1,6-HEPTADIENE-3,5-DIONE, 1,7-BIS(4-HYDROXYPHENYL)-|ADAMANTAN-1-YL-ACETICACIDHYDRAZIDE|BRD-K37445107-001-01-9|NSC-687839|BISDEMETHOXYCURCUMIN, >=98% (HPLC), SOLID|CID_5324473|C19H16O4|AS-57295|1,6-HEPTADIENE-3,5-DIONE, 1,7-BIS(4-HYDROXYPHENYL)-, (1E,6E)-|(1E,6E)-1,7-BIS(4-HYDROXYPHENYL)-1,6-HEPTADIENE-3,5-DIONE|BIS-DEMETHOXYCURCUMIN [INCI]	-	PUBCHEM	5315472	C19H16O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	PREBVFJICNPEKM-YDWXAUTNSA-N
33225	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10292	Galloflavin Potassium	POTASSIUM;2,9,10-TRIHYDROXY-6,8-DIOXOPYRANO[3,2-C]ISOCHROMEN-3-OLATE|GALLOFLAVINPOTASSIUMSALT|POTASSIUM 8,9,10-TRIHYDROXY-2,6-DIOXO-2,6-DIHYDROPYRANO[3,2-C]ISOCHROMEN-3-OLATE|AKOS024458351|3,8,9,10-TETRAHYDROXY-PYRANO[3,2-C][2]BENZOPYRAN-2,6-DIONE POTASSIUM SALT|1780260-20-9|GALLOFLAVIN POTASSIUM|3,8,9,10-TETRAHYDROXYPYRANO[3,2-C][2]BENZOPYRAN-2,6-DIONE POTASSIUM SALT	-	PUBCHEM	136645905	C12H5KO8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	ZXTYKQDMPYEPEX-UHFFFAOYSA-M
33226	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10293	Icilin	HY-11062|ICILIN(AG 3-5)|'3-(2-HYDROXYPHENYL)-6-(3-NITROPHENYL)-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE'|NCGC00015571-07|ICILLIN|ICILIN|AG 3-5 CPD|BRN 0700310|MFCD01689072|AS-35111|TOX21_500426|CS70PZQ4QJ|HMS2769B07|AG 3-5|SDCCGSBI-0050411.P002|BI164563|1-(2-HYDROXYPHENYL)-4-(3-NITROPHENYL)-1,2,3,6-TETRAHYDROPYRIMIDIN-2-ONE|NCGC00025205-02|GTPL2429|AG-3-5|C20171|HMS3412H21|NCGC00025205-01|BRD-K48869804-001-04-7|AC-35209|ICILIN- BIO-X|SR-01000075377-1|3,4-DIHYDRO-3-(2-HYDROXYPHENYL)-6-(3-NITROPHENYL)-(1H)-PYRIMIDIN-2-ONE|HMS3676H21|SR-01000075377-4|5-24-03-00255 (BEILSTEIN HANDBOOK REFERENCE)|Q5986473|NCGC00015571-01|LOPAC-I-9532|LP00426|1-(2-HYDROXYPHENYL)-4-(3-NITROPHENYL)-3,6-DIHYDROPYRIMIDIN-2-ONE|CCG-221730|NCGC00015571-05|3-(2-HYDROXYPHENYL)-6-(3-NITROPHENYL)-1,2,3,4-TETRAHYDROPYRIMIDIN-2-ONE|AG 3-5; AG3-5; AG-3-5|NCGC00015571-02|NCGC00025205-03|3-(2-HYDROXYPHENYL)-6-(3-NITROPHENYL)-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE|C16H13N3O4|UNII-CS70PZQ4QJ|NCGC00015571-15|NCGC00015571-03|I 9532|DTXSID70190442|HMS3261E14|CCG-204518|SMR000299977|SR-01000075377-2|ICILIN, >=97% (HPLC), SOLID|2(1H)-PYRIMIDINONE, 3,6-DIHYDRO-1-(2-HYDROXYPHENYL)-4-(3-NITROPHENYL)-|A903163|MLS000693445|CS-1922|EU-0100426|MLS002153471|36945-98-9|ICILIN [MI]|AKOS000370368|BCP27818|TOCRIS-1531|SR-01000075377|NCGC00261111-01|1-(2-HYDROXYPHENYL)-4-(3-NITROPHENYL)-1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE|LOPAC0_000426|EX-A279|1-(2'-HYDROXYPHENYL)-4-(3''-NITROPHENYL)-1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE|SMP2_000128|3-(2-HYDROXYPHENYL)-6-(3-NITROPHENYL)-3,4-DIHYDRO-2(1H)-PYRIMIDINONE|AG-3-5; 1-(2-HYDROXYPHENYL)-4-(3-NITROPHENYL)-1,2,3,6-TETRAHYDROPYRIMIDIN-2-ONE|SR-01000075377-9|HB1153|3,6-DIHYDRO-1-(2-HYDROXYPHENYL)-4-(3-NITROPHENYL)-2(1H)-PYRIMIDINONE|HMS3648E15|HMS3268C05|FT-0700300|3-(2-HYDROXYPHENYL)-6-(3-NITROPHENYL)-1,4-DIHYDROPYRIMIDIN-2-ONE|NCGC00015571-04|RCEFMOGVOYEGJN-UHFFFAOYSA-N	-	PUBCHEM	161930	C16H13N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	RCEFMOGVOYEGJN-UHFFFAOYSA-N
33227	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	RMMXLENWKUUMAY-UHFFFAOYSA-N
33228	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10294	Benzoic acid, 4-(2-(5,6-dihydro-5,5-dimethyl-8-phenyl-2-naphthalenyl)ethenyl)-, (E)-	Q27283498|M531IV9E0V|NCGC00370835-06|(E)-4-(2-(5,5-DIMETHYL-8-PHENYL-5,6-DIHYDRONAPHTHALEN-2-YL)VINYL)BENZOICACID|BMS453|BENZOIC ACID, 4-(2-(5,6-DIHYDRO-5,5-DIMETHYL-8-PHENYL-2-NAPHTHALENYL)ETHENYL)-, (E)-|BMS 453|BENZOIC ACID, 4-((1E)-2-(5,6-DIHYDRO-5,5-DIMETHYL-8-PHENYL-2-NAPHTHALENYL)ETHENYL)-|4-[(E)-2-(5,5-DIMETHYL-8-PHENYL-5,6-DIHYDRONAPHTHALEN-2-YL)VINYL]BENZOIC ACID|4-[(1E)-2-(5,6-DIHYDRO-5,5-DIMETHYL -8-PHENYL-2-NAPHTHALENYL)ETHENYL]-BENZOIC ACID|164108-16-1|BMS-189453|BMS189453|4-[(1E)-2-(5,6-DIHYDRO-5,5-DIMETHYL-8-PHENYL-2-NAPHTHALENYL)ETHENYL]-BENZOIC ACID|166977-43-1|BMS-189453, >=98% (HPLC)|4-[(E)-2-(5,5-DIMETHYL-8-PHENYL-6H-NAPHTHALEN-2-YL)ETHENYL]BENZOIC ACID|UNII-M531IV9E0V|J-010327|BMS 189453|A899389|BMS 453;BMS453;BMS 189453;BMS-189453;BMS189453|AC-36599|EX-A4818|(E)-4-[2-(5,5-DIMETHYL-8-PHENYL-5,6-DIHYDRONAPHTHALEN-2-YL)VINYL]BENZOIC ACID|BMS-453|(E)-4-(2-(5,5-DIMETHYL-8-PHENYL-5,6-DIHYDRONAPHTHALEN-2-YL)VINYL)BENZOIC ACID|AKOS024457612|CS-0019762|BENZOIC ACID, 4-[(1E)-2-(5,6-DIHYDRO-5,5-DIMETHYL-8-PHENYL-2-NAPHTHALENYL)ETHENYL]-|HY-100608|E)-4-[2-(5,6-DIHYDRO-5,5-DIMETHYL-8-PHENYL-2-NAPHTHALENYL)ETHENYL]-BENZOIC ACID|AS-16498	-	PUBCHEM	9875424	C27H24O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	VUODRPPTYLBGFM-CMDGGOBGSA-N
33229	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2023)	37112982	246119	10295	Nomilin	NSC 297134|NOMILIN|1-(ACETYLOXY)-1,2-DIHYDROOBACUNOIC ACID ETA-LACTONE|DRM0753K4T|AC1L2HUM|AC-34406|AI3-37935|1-(ACETYLOXY)-1,2-DIHYDROOBACUNOIC ACID .EPISLON.-LACTONE|NSC-297134|(1S,3AS,4AR,4BR,6AR,11S,11AR,11BR,13AS)-1-(FURAN-3-YL)-4B,7,7,11A,13A-PENTAMETHYL-3,5,9-TRIOXOHEXADECAHYDROOXEPINO[4',3':3,4]BENZO[1,2-F]OXIRENO[2,3-D]ISOCHROMEN-11-YL ACETATE|C08773|1-(ACETYLOXY)-1,2-DIHYDROOBACUNOIC ACID .EPSILON.-LACTONE|KST-1A9791|AKOS037514753|G3L|OBACUNOIC ACID, 1-(ACETYLOXY)-1,2-DIHYDRO-, ETA-LACTONE|1-(ACETYLOXY)-1,2-DIHYDROOBACUNOIC ACID E-LACTONE|AC1Q6OA3|1063-77-0|UNII-DRM0753K4T|(3-FURYL-PENTAMETHYL-TRIOXO-[?]YL) ACETATE|(1S,3AS,4AR,4BR,6AR,11S,11AR,11BR,13AS)-11-(ACETYLOXY)-1-(3-FURANYL)DECAHYDRO-4B,7,7,11A,13A-PENTAMETHYLOXIRENO(4,4A)-2-BENZOPYRAN(6,5-G)(2)BENZOXEPIN-3,5,9(3AH,4BH,6H)-TRIONE|CS-0009075|NOMILIN [MI]|HY-N0547|FT-0603541|Q1191572|SR-05000002184|(1R,2R,4S,7R,8S,11R,12R,13S,18R)-7-(FURAN-3-YL)-1,8,12,17,17-PENTAMETHYL-5,15,20-TRIOXO-3,6,16-TRIOXAPENTACYCLO[9.9.0.0?,?.0?,?.0??,??]ICOSAN-13-YL ACETATE|SR-05000002184-2	-	PUBCHEM	72320	C28H34O9	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding	KPDOJFFZKAUIOE-WNGDLQANSA-N
33230	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Uppal T (2022)	37192863	246225	7927	Dasabuvir	N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamide|Sodium 3-(3-tert-butyl-4-methoxy-5-{6 [(methylsulfonyl)amino]naphthalene-2-yl}phenyl)-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ide hydrate (1:1:1)	viekira pak|viekira xr|holkira	DRUGBANK	DB09183	C26H27N3O5S	small molecule	J05AX16|J05AX66	1132935-63-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor	NBRBXGKOEOGLOI-UHFFFAOYSA-N
33231	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Jana ID (2022)	36712339	246226	1250	Posaconazole	-	posanol|noxafil	DRUGBANK	DB01263	C37H42F2N8O4	small molecule	J02AC04	171228-49-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Spike-Ace Interaction Inhibitor	RAGOYPUPXAKGKH-XAKZXMRKSA-N
33232	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Roy A (2022)	35598780	234382	10296	N-[4-[(thieno[2,3-d]pyrimidin-4-ylamino)sulfamoyl]phenyl]acetamide	HMS1662H21|CCG-242450	-	PUBCHEM	2808616	C14H13N5O3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: nsp3 MAC1 inhibitor	HPLMIOJDTKVKPA-UHFFFAOYSA-N
33233	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Roy A (2022)	35598780	234382	10297	N-[(3-chlorophenyl)methyl]-3,5-dimethoxy-N-[3-oxo-3-(piperazin-1-yl)propyl]benzamide	N-[(3-CHLOROPHENYL)METHYL]-3,5-DIMETHOXY-N-[3-OXO-3-(PIPERAZIN-1-YL)PROPYL]BENZAMIDE|AKOS004971231	-	PUBCHEM	50779772	C23H28ClN3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: nsp3 MAC1 inhibitor	YGTGHRPCPIFMSM-UHFFFAOYSA-N
33234	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Roy A (2022)	35598780	234382	10298	{5-[1-(3-Bromobenzoyl)-4-piperidyl]pyrazolo[1,5-a]pyridin-3-yl}(piperidino)methanone	{5-[1-(3-BROMOBENZOYL)-4-PIPERIDYL]PYRAZOLO[1,5-A]PYRIDIN-3-YL}(PIPERIDINO)METHANONE|AKOS005060713	-	PUBCHEM	50849069	C25H27BrN4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: nsp3 MAC1 inhibitor	FZEFXPYPDXOKEG-UHFFFAOYSA-N
33235	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Roy A (2022)	35598780	234382	10299	{5-[1-(4-Bromobenzoyl)-4-piperidyl]pyrazolo[1,5-a]pyridin-3-yl}(piperidino)methanone	{5-[1-(4-BROMOBENZOYL)-4-PIPERIDYL]PYRAZOLO[1,5-A]PYRIDIN-3-YL}(PIPERIDINO)METHANONE|AKOS005060452	-	PUBCHEM	50848809	C25H27BrN4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: nsp3 MAC1 inhibitor	FORPAFQIIOPZTB-UHFFFAOYSA-N
33236	4383888	14254602	G128_gp01ab_nsp3	nsp3ab	ORF1ab|nsp3|rep|1AB|MERS-CoV nsp3|orf1ab-nsp3|orf1ab-nsp3ab|nsp3ab|Papain-like proteinase|R1AB_CVEMC|PRO_0000422441	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Roy A (2022)	35598780	234382	10296	N-[4-[(thieno[2,3-d]pyrimidin-4-ylamino)sulfamoyl]phenyl]acetamide	HMS1662H21|CCG-242450	-	PUBCHEM	2808616	C14H13N5O3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: nsp3 MAC1 inhibitor	HPLMIOJDTKVKPA-UHFFFAOYSA-N
33237	4383888	14254602	G128_gp01ab_nsp3	nsp3ab	ORF1ab|nsp3|rep|1AB|MERS-CoV nsp3|orf1ab-nsp3|orf1ab-nsp3ab|nsp3ab|Papain-like proteinase|R1AB_CVEMC|PRO_0000422441	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Roy A (2022)	35598780	234382	10298	{5-[1-(3-Bromobenzoyl)-4-piperidyl]pyrazolo[1,5-a]pyridin-3-yl}(piperidino)methanone	{5-[1-(3-BROMOBENZOYL)-4-PIPERIDYL]PYRAZOLO[1,5-A]PYRIDIN-3-YL}(PIPERIDINO)METHANONE|AKOS005060713	-	PUBCHEM	50849069	C25H27BrN4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: nsp3 MAC1 inhibitor	FZEFXPYPDXOKEG-UHFFFAOYSA-N
33238	4383888	14254602	G128_gp01ab_nsp3	nsp3ab	ORF1ab|nsp3|rep|1AB|MERS-CoV nsp3|orf1ab-nsp3|orf1ab-nsp3ab|nsp3ab|Papain-like proteinase|R1AB_CVEMC|PRO_0000422441	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Roy A (2022)	35598780	234382	10299	{5-[1-(4-Bromobenzoyl)-4-piperidyl]pyrazolo[1,5-a]pyridin-3-yl}(piperidino)methanone	{5-[1-(4-BROMOBENZOYL)-4-PIPERIDYL]PYRAZOLO[1,5-A]PYRIDIN-3-YL}(PIPERIDINO)METHANONE|AKOS005060452	-	PUBCHEM	50848809	C25H27BrN4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: nsp3 MAC1 inhibitor	FORPAFQIIOPZTB-UHFFFAOYSA-N
33239	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Kladnik J (2022)	35943189	234390	8326	ZnPT, zinc pyrithione	Pyrithione zinc|Zinc bis(pyridine-2-thiolate 1-oxide)|2295|R953O2RHZ5|2-Pyridinethiol, 1-oxide, zinc salt (2:1)|Zinc bis(2-pyridinethiolate 1-oxide)	-	CHEMSPIDER	24255	C10H8N2O2S2Zn	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	OTPSWLRZXRHDNX-UHFFFAOYSA-L
33240	106647	135	-	ADORA2A	A2aR|ADORA2|RDC8	9606	Homo sapiens	activator/sars-cov-2 inhibitor	target	Mann BJ (2022)	888800000889	240918	4796	Apadenoson	-	-	DRUGBANK	DB05009	C23H30N6O6	small molecule	-	250386-15-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: A2A receptor (A2AR) agonist; viral inhibition mechanism undetermined	FLEVIENZILQUKB-XTWQNQIISA-N
33241	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov-2 inhibitor	target	Ding S (2022)	35677392	233874	10190	VE607	1-[3-(2-Hydroxy-3-piperidin-1-yl-propoxy)-phenoxy]-3-piperidin-1-yl-propan-2-ol|3,3'-[1,3-Phenylenebis(oxy)]bis[1-(1-piperidinyl)-2-propanol]|1-Piperidineethanol, alpha,alpha'-[1,3-phenylenebis(oxymethylene)]bis-	-	CHEMSPIDER	2386276	C22H36N2O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (experimental)	FHFSLXLDKXBOQN-UHFFFAOYSA-N
33242	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ding S (2022)	35677392	233874	10190	VE607	1-[3-(2-Hydroxy-3-piperidin-1-yl-propoxy)-phenoxy]-3-piperidin-1-yl-propan-2-ol|3,3'-[1,3-Phenylenebis(oxy)]bis[1-(1-piperidinyl)-2-propanol]|1-Piperidineethanol, alpha,alpha'-[1,3-phenylenebis(oxymethylene)]bis-	-	CHEMSPIDER	2386276	C22H36N2O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (experimental)	FHFSLXLDKXBOQN-UHFFFAOYSA-N
33243	107540	1116	-	CHI3L1	ASRT7|CGP-39|GP-39|GP39|HC-gp39|HCGP-3P|YKL-40|YKL40|YYL-40|hCGP-39	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Kamle S (2022)	35735790	246227	10170	Kasugamycin	Kasugamycin|Kasumin|3-O-(2-Amino-4-((carboxyiminomethyl)amino)-2,3,4,6-tetradeoxy-a-D-arabino-hexopyranosyl)-D-chiro-inositol|(1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside|(1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl-2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside|alpha-D-arabino-Hexopyranoside, (1alpha,2beta,3alpha,4alpha,5beta,6beta)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-|{[(2R,3S,5S,6R)-5-Amino-2-methyl-6-{[(1S,2R,3S,4R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}tetrahydro-2H-pyran-3-yl]amino}(imino)acetic acid|O957UYB9DY	-	CHEMSPIDER	16736502	C14H25N3O9	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CHI3L1 inhibitor	PVTHJAPFENJVNC-MHRBZPPQSA-N
33244	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Li C (2022)	35836239	232861	10281	ANTHRAQUINONE	Anthraquinone|9,10-Anthracenedione|9,10-Anthraquinone|390030|MFCD00001188|CB4725000	-	CHEMSPIDER	13835294	C14H8O2	small molecule	-	84-65-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	RZVHIXYEVGDQDX-UHFFFAOYSA-N
33245	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Li C (2022)	35836239	232861	10252	TANNIC ACID	Gallotannin|Glycerite|MFCD00066397|Tannic acid, beta|tannic acid|Tanninum|beta-D-Glucopyranose, pentakis[3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoate]|1,2,3,4,6-Pentakis-O-{3,4-dihydroxy-5-[(3,4,5-trihydroxybenzoyl)oxy]benzoyl}-beta-D-glucopyranose	-	CHEMSPIDER	17286569	C76H52O46	small molecule	-	5424-20-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	LRBQNJMCXXYXIU-PPKXGCFTSA-N
33246	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Li C (2022)	35836239	232861	10217	9-Methoxycanthin-6-one	8-Methoxycanthin-6-one|6H-Indolo[3,2,1-de][1,5]naphthyridin-6-one, 9-methoxy-|9-methoxycanthin-6-one|9-Methoxy-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one	-	CHEMSPIDER	8057099	C15H10N2O2	small molecule	-	74991-91-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike and ACE2 binding (computational)	OWCRARVHWCCRAG-UHFFFAOYSA-N
33247	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Li C (2022)	35836239	232861	10177	Nafamostat mesylate	Benzoic acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester, methanesulfonate (1:2)|6-carbamimidoylnaphthalen-2-yl 4-carbamimidamidobenzoate methanesulfonate (1:2)|6-Carbamimidoyl-2-naphthyl 4-carbamimidamidobenzoate methanesulfonate (1:2)|Nafamostat (mesylate)|MFCD00941430|DG2736000|1D2T74921W|4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate|Nafamostat mesylate|Nafamostat Mesilate	-	CHEMSPIDER	49623	C21H25N5O8S2	small molecule	-	82956-11-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	SRXKIZXIRHMPFW-UHFFFAOYSA-N
33248	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov-2 inhibitor	target	Ho TY (2007)	16730806	242471	6518	Emodin	3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE|Emodin|Emodol|Frangula Emodin|Schuttgelb|1,3,8-Trihydroxy-6-Methylanthracene-9,10-Dione|Rheum Emodin|Archin	-	DRUGBANK	DB07715	C15H10O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	RHMXXJGYXNZAPX-UHFFFAOYSA-N
33249	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yang J (2023)	36604514	240888	10265	gamabufotalin	Gamabufogenin|Gamabufotalin|Gamabufagin|Bufa-20,22-dienolide, 3,11,14-trihydroxy-, (3.beta.,5.beta.,11.alpha.)-|3b,11a,14-Trihydroxy-5b-bufa-20,22-dienolide|(3b,5b,11a)-3,11,14-Trihydroxybufa-20,22-dienolide|(3beta,5beta,11alpha)-3,11,14-Trihydroxybufa-20,22-dienolide|Bufa-20,22-dienolide, 3,11,14-trihydroxy-, (3beta,5beta,11alpha)-	-	CHEMSPIDER	228041	C24H34O5	small molecule	-	465-11-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined; Delta and omicron variants tested	FMTLOAVOGWSPEF-KJRPADTMSA-N
33250	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yang J (2023)	36604514	240888	10179	bruceine A	bruceine A|BRUCEIN A|Methyl (11beta,12alpha,13beta,15beta)-3,11,12-trihydroxy-15-[(3-methylbutanoyl)oxy]-2,16-dioxo-13,20-epoxypicras-3-en-21-oate|Picras-3-en-21-oic acid, 13,20-epoxy-3,11,12-trihydroxy-15-(3-methyl-1-oxobutoxy)-2,16-dioxo-, methyl ester, (11beta,12alpha,13beta,15beta)-	-	CHEMSPIDER	140665	C26H34O11	small molecule	-	25514-31-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined; Delta and omicron variants tested	LPZSTPCYWWRQFU-VILODJCFSA-N
33251	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yang J (2023)	36604514	240888	6190	Anisomycin	-	-	DRUGBANK	DB07374	C14H19NO4	small molecule	-	22862-76-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined; Delta and omicron variants tested	YKJYKKNCCRKFSL-RDBSUJKOSA-N
33252	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Han Y (2021)	33116299	240889	10164	quinacrine dihydrochloride	Mepacrine dihydrochloride|QUINACRINE DIHYDROCHLORIDE|1,4-Pentanediamine, N4- (6-chloro-2-methoxy-9-acridinyl)-N1,N1-diethyl-, dihydrochloride|3-chloro-7-methoxy-9-[1-methyl-4-(diethylamino)butylamino]acridine dihydrochloride|Acridine, 6-chloro-9-[[4- (diethylamino)-1-methylbutyl]amino]-2-methoxy-, dihydrochloride|N'-(6-Chloro-2-methoxy-acridin-9-yl)-N,N-diethyl-pentane-1,4-diamine dihydrochloride|Atebrin dihydrochloride|Quinacrine hydrochloride anhydrous|6-Chloro-9-(4-diethylamino-1-methylbutylamino)-2-methoxyacridine dihydrochloride|N~4~-(6-Chloro-2-methoxyacridin-9-yl)-N~1~,N~1~-diethylpentane-1,4-diamine dihydrochloride|1,4-pentanediamine, N~4~-(6-chloro-2-methoxy-9-acridinyl)-N~1~,N~1~-diethyl-, dihydrochloride|N~4~-(6-Chloro-2-methoxy-9-acridinyl)-N~1~,N~1~-diethyl-1,4-pentanediamine dihydrochloride|1,4-Pentanediamine, N~4~-(6-chloro-2-methoxy-9-acridinyl)-N~1~,N~1~-diethyl-, hydrochloride (1:2)|MFCD00012659|AR7875000	-	CHEMSPIDER	6003	C23H32Cl3N3O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	UDKVBVICMUEIKS-UHFFFAOYSA-N
33253	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Han Y (2021)	33116299	240889	609	Imatinib	Imatinibum|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-P-toluidide|4-(4-METHYL-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|Imatinib Methansulfonate|STI 571|Imatinib	imatinib mesylate|pms-imatinib	DRUGBANK	DB00619	C29H31N7O	small molecule	L01XE01	152459-95-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, ACE2 binding (experimental)	KTUFNOKKBVMGRW-UHFFFAOYSA-N
33254	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov-2 inhibitor	target	Jansen-Olliges L (2022)	36611877	240222	1014	Mycophenolic acid	Acide mycophenolique|Micofenolico acido|Acido micofenolico|Mycophenolate|Mycophenolsure|(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acidum mycophenolicum	myfortic|mycophenolic acid|apo	DRUGBANK	DB01024	C17H20O6	small molecule	L04AA06	24280-93-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	HPNSFSBZBAHARI-RUDMXATFSA-N
33255	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov-2 inhibitor	target	Jansen-Olliges L (2022)	36611877	240222	10282	cohaerin F	(7R,8R)-7-Hydroxy-3-(4-hydroxy-2-methyl-6-oxo-1-cyclohexen-1-yl)-7-methyl-8-(3-methyl-2-oxononyl)-7,8-dihydro-6H-isochromen-6-one|6H-2-Benzopyran-6-one, 7,8-dihydro-7-hydroxy-3-(4-hydroxy-2-methyl-6-oxo-1-cyclohexen-1-yl)-7-methyl-8-(3-methyl-2-oxononyl)-, (7R,8R)-	-	CHEMSPIDER	9865793	C27H36O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	MDZAMUBMPBLGAO-MMMYSLHOSA-N
33256	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov-2 inhibitor	target	Jansen-Olliges L (2022)	36611877	240222	10236	cohaerin C	(6aR,9S,9aR)-3-(4-Hydroxy-2-methyl-6-oxo-1-cyclohexen-1-yl)-6a-methyl-9-(2-methyloctanoyl)-9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione|6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione, 9,9a-dihydro-3-(4-hydroxy-2-methyl-6-oxo-1-cyclohexen-1-yl)-6a-methyl-9-(2-methyl-1-oxooctyl)-, (6aR,9S,9aR)-	-	CHEMSPIDER	78437274	C28H34O7	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	GKKNMNFXYPXAOJ-GNEHSSTKSA-N
33257	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov-2 inhibitor	target	Jansen-Olliges L (2022)	36611877	240222	10219	multiformin C	(6aS)-3-(2-Hydroxy-6-methylphenyl)-6a-methyl-9-(2-methylbutanoyl)-6H-furo[2,3-h]isochromene-6,8(6aH)-dione|6H-Furo[2,3-h]-2-benzopyran-6,8(6aH)-dione, 3-(2-hydroxy-6-methylphenyl)-6a-methyl-9-(2-methyl-1-oxobutyl)-, (6aS)-	-	CHEMSPIDER	9756982	C24H22O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	PDIQMKRQFHBXJF-JGRONMTFSA-N
33258	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Puhl AC (2022)	35983371	240395	1124	Carvedilol	(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol|Carvedilolum|SKF 105517|Carvedilol	novo-carvedilol tablets|mylan-	DRUGBANK	DB01136	C24H26N2O4	small molecule	C07AG02	72956-09-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Spike binding (experimental)	OGHNVEJMJSYVRP-UHFFFAOYSA-N
33259	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Invernizzi L (2022)	35419694	241007	10214	punicalagin	MFCD09838017|Punicalagin	-	CHEMSPIDER	29272136	C48H28O30	small molecule	-	65995-63-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike or ACE2 binding undetermined	ZJVUMAFASBFUBG-UYMKNUMKSA-N
33260	4383861	43740578	GU280_gp01_nsp13	nsp13	ORF1ab|ORF1ab-nsp13|Hel|SARS-CoV2 nsp13|SARS-CoV-2 nsp13|Helicase|R1AB_SARS2|PRO_0000449630	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Lu L (2022)	35985407	241008	10214	punicalagin	MFCD09838017|Punicalagin	-	CHEMSPIDER	29272136	C48H28O30	small molecule	-	65995-63-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral nsp13 inhibitor, antiviral activity against SARS-CoV-2 BetaCoV/Shenzhen/SZTH-003/2020	ZJVUMAFASBFUBG-UYMKNUMKSA-N
33261	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Du R (2021)	33872675	241010	10214	punicalagin	MFCD09838017|Punicalagin	-	CHEMSPIDER	29272136	C48H28O30	small molecule	-	65995-63-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral nsp5 inhibitor	ZJVUMAFASBFUBG-UYMKNUMKSA-N
33262	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Du R (2021)	33872675	241010	10226	chebulagic acid	chebulagic acid	-	CHEMSPIDER	391031	C41H30O27	small molecule	-	23094-71-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral nsp5 inhibitor	HGJXAVROWQLCTP-YABCKIEDSA-N
33263	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Li H (2021)	34586788	241011	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral nsp5 inhibitor	AFSDNFLWKVMVRB-UHFFFAOYSA-N
33264	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Xiang Y (2023)	36521705	241019	10156	Ginkgolic acid C17:1 (GA171)	Ginkgolic Acid C17:1|2-[(10Z)-Heptadec-10-en-1-yl]-6-hydroxybenzoic acid|Benzoic acid, 2-[(10Z)-10-heptadecen-1-yl]-6-hydroxy-|6-[(10Z)-Heptadecenyl]salicylic acid|Ginkgolic acid II|2-[(10Z)-10-Heptadecen-1-yl]-6-hydroxybenzoic acid|MFCD09752804	-	CHEMSPIDER	4580130	C24H38O3	small molecule	-	111047-30-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike and ACE2 binding (experimental), antiviral activity against SARS-CoV-2 Delta, Gamma, and Omicron variants	MBYNDKVOZOAOIS-FPLPWBNLSA-N
33265	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Bertini S (2022)	35322395	232831	676	Pentosan Polysulfate	Pentosane polysulfate|Pentosanpolysulfat|Pentosan sulfuric polyester|Pentosano polisulfato|Pentosani polysulfas	elmiron	DRUGBANK	DB00686	C10H18O21S4	small molecule	C05BA04|G04BX15	37300-21-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike binding (experimental)	FCCNSUIJIOOXEZ-SJYYZXOBSA-N
33266	128218	196527	-	ANO6	BDPLT7|SCTS|TMEM16F	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Cappelletto A (2023)	36684586	232840	5640	Niclosamide	Niclocide	-	DRUGBANK	DB06803	C13H8Cl2N2O4	small molecule	P02DA01	50-65-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ANO6 inhibitor; viral inhibition mechanism undetermined	RJMUSRYZPJIFPJ-UHFFFAOYSA-N
33267	128218	196527	-	ANO6	BDPLT7|SCTS|TMEM16F	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Cappelletto A (2023)	36684586	232840	835	Clofazimine	Clofazimine|Clofazimina|Clofaziminum|Clofazimin|Riminophenazine|Lamprene	-	DRUGBANK	DB00845	C27H22Cl2N4	small molecule	J04BA01	2030-63-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ANO6 inhibitor; viral inhibition mechanism undetermined	WDQPAMHFFCXSNU-BGABXYSRSA-N
33268	109894	3688	RP11-479G22.2	ITGB1	CD29|FNRB|GPIIA|MDF2|MSK12|VLA-BETA|VLAB	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Huntington KE (2022)	35631444	232850	10274	GLPG-0187	GLPG0187|GLPG-0187|L-Alanine, 3-[[2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(4-methoxyphenyl)sulfonyl]-|3-({2,5-Dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl]-4-pyrimidinyl}amino)-N-[(4-methoxyphenyl)sulfonyl]-L-alanine	-	CHEMSPIDER	52085532	C29H37N7O5S	small molecule	-	1320346-97-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: Integrin inhibitor; viral inhibition mechanism undetermined; omicron and delta variants especially inhibited	CXHCNOMGODVIKB-VWLOTQADSA-N
33269	111595	5609	-	MAP2K7	JNKK2|MAPKK7|MEK|MEK 7|MKK7|PRKMK7|SAPKK-4|SAPKK4	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Huntington KE (2022)	35631444	232850	10165	VS-6766	CH5126766|D0D4252V97|Ro-5126766 Free Base|Ro 5126766|N-(3-Fluoro-4-{[4-methyl-2-oxo-7-(2-pyrimidinyloxy)-2H-chromen-3-yl]methyl}-2-pyridinyl)-N'-methylsulfuric diamide|Sulfamide, N-[3-fluoro-4-[[4-methyl-2-oxo-7-(2-pyrimidinyloxy)-2H-1-benzopyran-3-yl]methyl]-2-pyridinyl]-N'-methyl-	-	CHEMSPIDER	17623621	C21H18FN5O5S	small molecule	-	946128-88-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: Integrin inhibitor; viral inhibition mechanism undetermined	LMMJFBMMJUMSJS-UHFFFAOYSA-N
33270	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10300	(1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-N-[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	162685261	C26H45N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	BKEPDWNBCUBDEN-KOUJMVCDSA-N
33271	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10301	(1R,2S,5S)-N-[(2S,3S)-4-amino-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]-3-sulfanylbutan-2-yl]-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	I70	-	PUBCHEM	162640229	C27H46N6O6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	IWWUKKKRPZXUGC-LJRYSRKVSA-N
33272	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10302	(1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-N-[(2S,3R)-4-(cyclopropylmethylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	164575876	C31H52N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	RTEPKJZIQYUGOI-BLTUZGSGSA-N
33273	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10303	(1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-N-[(2S,3R)-4-(ethylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	164575892	C29H50N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	GKUBEDOOUKCUOW-YTNBPZCUSA-N
33274	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10304	(1R,2S,5S)-N-[(2S,3R)-4-(butylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	164575877	C31H54N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	CYAFTCDKLGXDCI-BLTUZGSGSA-N
33275	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10305	(1R,2S,5S)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-N-[(2S,3R)-4-(hexylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	164575878	C33H58N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	NSGOBCXXBBPKSX-FQCPSNFCSA-N
33276	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10306	(1R,2S,5S)-N-[(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	164575879	C34H52N6O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	WFDSDFTYLISRSE-ADSPCUKESA-N
33277	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10307	(6S)-5-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-N-[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]-5-azaspiro[2.4]heptane-6-carboxamide	-	-	PUBCHEM	164575891	C25H43N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	QPINBLRCPHAOCS-XLAORIBOSA-N
33278	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10308	Unk-Gly(tBu)-Ala(tBu)-Ala((S)-2-oxopyrrolidin-3-yl)-ol	-	-	PUBCHEM	164575890	C25H47N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	AXOUOMLRYWWRDK-XLAORIBOSA-N
33279	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Alugubelli YR (2021)	888800000489	232837	10309	(1R,2S,5S)-3-[(2S)-3,3-dimethyl-2-(3-methylbutanoylamino)butanoyl]-N-[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	-	PUBCHEM	164575880	C26H44N4O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	YJDABKUOTKRKDF-RZCQQDKOSA-N
33280	116072	10863	-	ADAM28	ADAM 28|ADAM23|MDC-L|MDC-Lm|MDC-Ls|MDCL|eMDC II|eMDCII	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yamamoto M (2021)	888800000485	232833	2164	Ilomastat	GM6001|Galardin	-	DRUGBANK	DB02255	C20H28N4O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:ADAM28 inhibitor; exact viral inhibition mechanism undetermined but authors show disruption of the metalloproteinase pathway is involved	NITYDPDXAAFEIT-DYVFJYSZSA-N
33281	110465	4322	-	MMP13	CLG3|MANDP1|MMP-13	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yamamoto M (2021)	888800000485	232833	7270	CTS-1027	4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE|193022-04-7|RS-130830|Ro-1130830	-	DRUGBANK	DB08490	C19H20ClNO6S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:MMP13 inhibitor; exact viral inhibition mechanism undetermined but authors show disruption of the metalloproteinase pathway is involved	ROSNVSQTEGHUKU-UHFFFAOYSA-N
33282	106616	102	-	ADAM10	AD10|AD18|CD156c|HsT18717|MADM|RAK|kuz	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yamamoto M (2021)	888800000485	232833	10255	GW280264X	N~6~-[(Benzyloxy)carbonyl]-N~2~-{(2R,3S)-3-[formyl(hydroxy)amino]-2-isobutylhexanoyl}-N-1,3-thiazol-2-yl-L-lysinamide|benzyl N-[(5S)-5-[(2R,3S)-3-(N-hydroxyformamido)-2-(2-methylpropyl)hexanamido]-5-[(1,3-thiazol-2-yl)carbamoyl]pentyl]carbamate|Carbamic acid, N-[(5S)-5-[[(2R,3S)-3-(formylhydroxyamino)-2-(2-methylpropyl)-1-oxohexyl]amino]-6-oxo-6-(2-thiazolylamino)hexyl]-, phenylmethyl ester	-	CHEMSPIDER	43055104	C28H41N5O6S	small molecule	-	866924-39-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:ADAM10 inhibitor; exact viral inhibition mechanism undetermined but authors show disruption of the metalloproteinase pathway ans specifically ADAM10 is involved	SKJLITFHSZNZMQ-SGNDLWITSA-N
33283	106616	102	-	ADAM10	AD10|AD18|CD156c|HsT18717|MADM|RAK|kuz	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yamamoto M (2021)	888800000485	232833	10349	GI254023X	N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide|N(2)-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE|GHVMTHKJUAOZJP-CGTJXYLNSA-N|(2R,3S)-3-(FORMYL-HYDROXYAMINO)-2-(3-PHENYL-1-PROPYL)BUTANOIC ACID [(1S)-2,2-DIMETHYL-1-METHYLCARBAMOYL-1-PROPYL]AMIDE|N^2^-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE|AC-27562|S8660|(R)-N-((S)-3,3-DIMETHYL-1-(METHYLAMINO)-1-OXOBUTAN-2-YL)-2-((S)-1-(NHYDROXYFORMAMIDO)|GI254023X|EX-A4990|A818145|Q27449782|GI254023X, >=98% (HPLC)|DTXSID20433275|(2R,3S)-3-(FORMYLHYDROXYAMINO)-2-(3-PHENYL-1-PROPYL)BUTANOIC ACID [(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)-1-PROPYL]AMIDE|N~2~-[(2R)-2-{(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL}-5-PHENYLPENTANOYL]-N,3-DIMETHYL-L-VALINAMIDE|CCG-268545|GI4023;SRI028594|(2R)-N-[(1S)-2,2-DIMETHYL-1-[(METHYLAMINO)CARBONYL]-PROPYL]-2-[(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL]-5-PHENYLPENTANAMIDE|GI 254023X|GI4023|GI-254023X|(2R)-N-[(1S)-2,2-DIMETHYL-1-[(METHYLAMINO)CARBONYL]PROPYL]-2-[(1S)-1-(N-HYDROXYFORMAMIDO)ETHYL]-5-PHENYLPENTANAMIDE|GTPL9687|(R)-N-((S)-3,3-DIMETHYL-1-(METHYLAMINO)-1-OXOBUTAN-2-YL)-2-((S)-1-(N-HYDROXYFORMAMIDO)ETHYL)-5-PHENYLPENTANAMIDE|CS-7675|BIDD:PXR0042|260264-93-5|NCGC00370683-05|AS-16438|HY-19956|AKOS024457920|(2R)-N-[(2S)-3,3-DIMETHYL-1-(METHYLAMINO)-1-OXOBUTAN-2-YL]-2-[(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL]-5-PHENYLPENTANAMIDE|BENZENEPENTANAMIDE, N-[(1S)-2,2-DIMETHYL-1-[(METHYLAMINO)CARBONYL]PROPYL]-ALPHA-[(1S)-1-(FORMYLHYDROXYAMINO)ETHYL]-, (ALPHAR)-|MFCD19381832|(2R)-N-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-2-[(1S)-1-[FORMYL(HYDROXY)AMINO]ETHYL]-5-PHENYL-PENTANAMIDE|GI-4023|J-016226	-	PUBCHEM	9952396	C21H33N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:ADAM10 inhibitor; exact viral inhibition mechanism undetermined but authors show disruption of the metalloproteinase pathway ans specifically ADAM10 is involved	GHVMTHKJUAOZJP-CGTJXYLNSA-N
33284	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yang X (2022)	35723434	232852	10245	SGC-CK2-1	Propanamide, N-[5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-methylphenyl]-|N-(5-{[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}-2-methylphenyl)propanamide	-	CHEMSPIDER	98644473	C20H21N7O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:CSNK2A inhibitor; exact viral inhibition mechanism undetermined	YKDZIFFKQUNVHH-UHFFFAOYSA-N
33285	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Chen KY (2022)	35278581	246228	4662	Merimepodib	MMPD	-	DRUGBANK	DB04862	C23H24N4O6	small molecule	-	198821-22-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	JBPUGFODGPKTDW-SFHVURJKSA-N
33286	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2022)	35404564	232480	10196	KY-226	Benzamide, 4-[[([1,1'-biphenyl]-4-ylmethyl)thio]methyl]-N-(hexylsulfonyl)-|4-{[(4-Biphenylylmethyl)sulfanyl]methyl}-N-(hexylsulfonyl)benzamide	-	CHEMSPIDER	84393651	C27H31NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	MKXMABKUVSOEJF-UHFFFAOYSA-N
33287	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Ma C (2022)	35404564	232480	10174	tropifexor	2-[(3-endo)-3-({5-Cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid|6-Benzothiazolecarboxylic acid, 2-[(3-endo)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-4-isoxazolyl]methoxy]-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-|tropifexor|NMZ08KM76Z	-	CHEMSPIDER	59718652	C29H25F4N3O5S	small molecule	-	1383816-29-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	VYLOOGHLKSNNEK-PIIMJCKOSA-N
33288	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Ma C (2022)	35404564	232480	10189	EACC	Ethyl [(2-{[(5-nitro-2-thienyl)carbonyl]amino}-3-thienyl)carbonyl]carbamate|Carbamic acid, N-[[2-[[(5-nitro-2-thienyl)carbonyl]amino]-3-thienyl]carbonyl]-, ethyl ester	-	CHEMSPIDER	2936247	C13H11N3O6S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	ISLJZDYAPAUORR-UHFFFAOYSA-N
33289	4383941	1489680	SARS-CoV-1ab-nsp3ab	nsp3ab	nsp3|sars1ab|orf1ab|SARS-CoV nsp3ab|SARS-CoV nsp3|SARS-CoV sars1ab|orf1ab-nsp3|orf1ab-nsp3ab|pp1ab|Papain-like proteinase|PL-PRO|PL2-PRO|R1AB_CVHSA|PRO_0000037311	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Ma C (2022)	35404564	232480	10196	KY-226	Benzamide, 4-[[([1,1'-biphenyl]-4-ylmethyl)thio]methyl]-N-(hexylsulfonyl)-|4-{[(4-Biphenylylmethyl)sulfanyl]methyl}-N-(hexylsulfonyl)benzamide	-	CHEMSPIDER	84393651	C27H31NO3S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: PLPro inhibitor	MKXMABKUVSOEJF-UHFFFAOYSA-N
33290	4383941	1489680	SARS-CoV-1ab-nsp3ab	nsp3ab	nsp3|sars1ab|orf1ab|SARS-CoV nsp3ab|SARS-CoV nsp3|SARS-CoV sars1ab|orf1ab-nsp3|orf1ab-nsp3ab|pp1ab|Papain-like proteinase|PL-PRO|PL2-PRO|R1AB_CVHSA|PRO_0000037311	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Ma C (2022)	35404564	232480	10174	tropifexor	2-[(3-endo)-3-({5-Cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid|6-Benzothiazolecarboxylic acid, 2-[(3-endo)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-4-isoxazolyl]methoxy]-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-|tropifexor|NMZ08KM76Z	-	CHEMSPIDER	59718652	C29H25F4N3O5S	small molecule	-	1383816-29-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: PLPro inhibitor	VYLOOGHLKSNNEK-PIIMJCKOSA-N
33291	4383941	1489680	SARS-CoV-1ab-nsp3ab	nsp3ab	nsp3|sars1ab|orf1ab|SARS-CoV nsp3ab|SARS-CoV nsp3|SARS-CoV sars1ab|orf1ab-nsp3|orf1ab-nsp3ab|pp1ab|Papain-like proteinase|PL-PRO|PL2-PRO|R1AB_CVHSA|PRO_0000037311	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Ma C (2022)	35404564	232480	10189	EACC	Ethyl [(2-{[(5-nitro-2-thienyl)carbonyl]amino}-3-thienyl)carbonyl]carbamate|Carbamic acid, N-[[2-[[(5-nitro-2-thienyl)carbonyl]amino]-3-thienyl]carbonyl]-, ethyl ester	-	CHEMSPIDER	2936247	C13H11N3O6S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: PLPro inhibitor	ISLJZDYAPAUORR-UHFFFAOYSA-N
33292	4383888	14254602	G128_gp01ab_nsp3	nsp3ab	ORF1ab|nsp3|rep|1AB|MERS-CoV nsp3|orf1ab-nsp3|orf1ab-nsp3ab|nsp3ab|Papain-like proteinase|R1AB_CVEMC|PRO_0000422441	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Ma C (2022)	35404564	232480	10174	tropifexor	2-[(3-endo)-3-({5-Cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid|6-Benzothiazolecarboxylic acid, 2-[(3-endo)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-4-isoxazolyl]methoxy]-8-azabicyclo[3.2.1]oct-8-yl]-4-fluoro-|tropifexor|NMZ08KM76Z	-	CHEMSPIDER	59718652	C29H25F4N3O5S	small molecule	-	1383816-29-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS direct chemical interaction: PLPro inhibitor	VYLOOGHLKSNNEK-PIIMJCKOSA-N
33293	125319	114548	-	NLRP3	AGTAVPRL|AII|AVP|C1orf7|CIAS1|CLR1.1|FCAS|FCAS1|FCU|MWS|NALP3|PYPAF1	9606	Homo sapiens	inhibitor	target	Wu X (2023)	37260746	246229	10256	MCC950	MCC950|N-(1,2,3,5,6,7-Hexahydro-s-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide|2-Furansulfonamide, N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-	-	CHEMSPIDER	8086044	C20H24N2O5S	small molecule	-	210826-40-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:NLRP3 inhibitor; viral inhibition undetermined	HUUSXLKCTQDPGL-UHFFFAOYSA-N
33294	111549	5562	-	PRKAA1	AMPK|AMPKa1	9606	Homo sapiens	activator/sars-cov-2 inhibitor	target	Parthasarathy H (2023)	36417940	246230	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:AMPK activator; viral inhibition mechanism undetermined	XZWYZXLIPXDOLR-UHFFFAOYSA-N
33295	108897	2627	-	GATA6	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Israeli M (2022)	35469023	237746	10310	3-(2,5-dimethyl-1H-pyrrol-1-yl)thiophene-2-carboxylic acid	PYRROTHIOGATAIN|3-(2,5-DIMETHYL-1H-PYRROL-1-YL)THIOPHENE-2-CARBOXYLIC ACID|MFCD00100444|HMS1662N17|OPREA1_183759|477888-48-5|CS-0145035|EN300-51104|3-(2,5-DIMETHYL-1H-PYRROL-1-YL)THIOPHENE-2-CARBOXYLICACID|AKOS000138297|2R-0045|Z245326682|3-(2,5-DIMETHYLPYRROL-1-YL)THIOPHENE-2-CARBOXYLIC ACID|3-(2,5-DIMETHYL-1H-PYRROL-1-YL)-2-THIOPHENECARBOXYLIC ACID	-	PUBCHEM	2808418	C11H11NO2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:GATA6 inhibitor; exact viral inhibition mechanism undetermined	ISEFROSMDUZELK-UHFFFAOYSA-N
33296	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Li J (2022)	35389231	232203	9961	Paxlovid	(1R,2S,5S)-N-{(1S)-1-Cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide|3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-|(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	CHEMSPIDER	114826566	C23H32F3N5O4	small molecule	-	2628280-40-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	LIENCHBZNNMNKG-OJFNHCPVSA-N
33297	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Li J (2022)	35389231	232203	9961	Paxlovid	(1R,2S,5S)-N-{(1S)-1-Cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide|3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-|(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	CHEMSPIDER	114826566	C23H32F3N5O4	small molecule	-	2628280-40-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	LIENCHBZNNMNKG-OJFNHCPVSA-N
33298	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Li J (2022)	35389231	232203	9961	Paxlovid	(1R,2S,5S)-N-{(1S)-1-Cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide|3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-|(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide	-	CHEMSPIDER	114826566	C23H32F3N5O4	small molecule	-	2628280-40-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor, and MERS activity in PMID: 34726479	LIENCHBZNNMNKG-OJFNHCPVSA-N
33299	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Zhang Q (2022)	35440680	232187	1192	Mitoxantrone	Mitoxantrona|Mitoxantronum|Mitoxantrone|1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione	mitoxantrone injection|mitoxan	DRUGBANK	DB01204	C22H28N4O6	small molecule	L01DB07	65271-80-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-heparin interaction inhibitor	KKZJGLLVHKMTCM-UHFFFAOYSA-N
33300	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Meewan I (2022)	35745663	232197	10259	Dimorpholinethiuram disulfide	Dimorpholinethiuram disulfide|Bis(morpholinothiocarbonyl) disulfide|Dimorpholin-4-yldithioperoxyanhydride|MFCD00072237|di(4-morpholinyl)dithioperoxyanhydride|Di-4-morpholinyldithioperoxyanhydride	-	CHEMSPIDER	12359	C10H16N2O2S4	small molecule	-	729-46-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KKVYOWPPMNSLCP-UHFFFAOYSA-N
33301	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Meewan I (2022)	35745663	232197	10259	Dimorpholinethiuram disulfide	Dimorpholinethiuram disulfide|Bis(morpholinothiocarbonyl) disulfide|Dimorpholin-4-yldithioperoxyanhydride|MFCD00072237|di(4-morpholinyl)dithioperoxyanhydride|Di-4-morpholinyldithioperoxyanhydride	-	CHEMSPIDER	12359	C10H16N2O2S4	small molecule	-	729-46-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	KKVYOWPPMNSLCP-UHFFFAOYSA-N
33302	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Meewan I (2022)	35745663	232197	10193	Thiram	Thiram|Nomersan|Thiuramyl|Tiuramyl|Thiurad|Thylate|Tulisan|Tyradin|Tuads|Vanguard GF|Tetramethylthiuram disulfide|Bis(dimethylthiocarbamoyl) disulfide|Bis(dimethylthiocarbamyl) disulfide|Bis[(dimethylamino)carbonothioyl] disulfide|Basultra|Betoxin|[Dithiobis(carbonothioylnitrilo)]tetramethane|[Disulfanediylbis(carbonothioylnitrilo)]tetramethane|Methane, [dithiobis(carbonothioylnitrilo)]tetrakis-|[Disulfanediylbis(carbonothioylnitrilo)]tetramethan|Methane, 1,1',1'',1'''-[dithiobis(carbonothioylnitrilo)]tetrakis-|MFCD00008325|JO1400000	-	CHEMSPIDER	5256	C6H12N2S4	small molecule	-	137-26-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KUAZQDVKQLNFPE-UHFFFAOYSA-N
33303	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Meewan I (2022)	35745663	232197	10193	Thiram	Thiram|Nomersan|Thiuramyl|Tiuramyl|Thiurad|Thylate|Tulisan|Tyradin|Tuads|Vanguard GF|Tetramethylthiuram disulfide|Bis(dimethylthiocarbamoyl) disulfide|Bis(dimethylthiocarbamyl) disulfide|Bis[(dimethylamino)carbonothioyl] disulfide|Basultra|Betoxin|[Dithiobis(carbonothioylnitrilo)]tetramethane|[Disulfanediylbis(carbonothioylnitrilo)]tetramethane|Methane, [dithiobis(carbonothioylnitrilo)]tetrakis-|[Disulfanediylbis(carbonothioylnitrilo)]tetramethan|Methane, 1,1',1'',1'''-[dithiobis(carbonothioylnitrilo)]tetrakis-|MFCD00008325|JO1400000	-	CHEMSPIDER	5256	C6H12N2S4	small molecule	-	137-26-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	KUAZQDVKQLNFPE-UHFFFAOYSA-N
33304	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	inhibitor/sars-cov-2 activator	target	Chen IP (2022)	35839775	232204	10195	dBET6	-	-	CHEMSPIDER	71046111	C42H45ClN8O7S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:BRD3 inhibitor; BRD3 inhibition results in enhanced viral replication in cultured cells and in mice	JGQPZPLJOBHHBK-UFXYQILXSA-N
33305	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	inhibitor/sars-cov-2 activator	target	Chen IP (2022)	35839775	232204	10195	dBET6	-	-	CHEMSPIDER	71046111	C42H45ClN8O7S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:BRD4 inhibitor; BRD3 inhibition results in enhanced viral replication in cultured cells and in mice	JGQPZPLJOBHHBK-UFXYQILXSA-N
33306	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	inhibitor/sars-cov-2 activator	target	Chen IP (2022)	35839775	232204	10243	JQ1	JQ1|(6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium|(+)-JQ1|(S)-(+)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl ester, (6S)-|JQ-1|2-Methyl-2-propanyl [(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate|MFCD22683748|1MRH0IMX0W|JQ 1(+)	-	CHEMSPIDER	26323622	C23H25ClN4O2S	small molecule	-	1268524-70-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:BRD3 inhibitor; BRD3 inhibition results in enhanced viral replication in cultured cells and in mice	DNVXATUJJDPFDM-KRWDZBQOSA-N
33307	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	inhibitor/sars-cov-2 activator	target	Chen IP (2022)	35839775	232204	10243	JQ1	JQ1|(6s)-6-(2-Tert-butoxy-2-oxoethyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6,7-dihydrothieno[3,2-F][1,2,4]triazolo[4,3-A][1,4]diazepin-10-ium|(+)-JQ1|(S)-(+)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl ester, (6S)-|JQ-1|2-Methyl-2-propanyl [(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate|MFCD22683748|1MRH0IMX0W|JQ 1(+)	-	CHEMSPIDER	26323622	C23H25ClN4O2S	small molecule	-	1268524-70-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:BRD4 inhibitor; BRD3 inhibition results in enhanced viral replication in cultured cells and in mice	DNVXATUJJDPFDM-KRWDZBQOSA-N
33308	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Puhl AC (2022)	35609344	231752	10161	Pyronaridine	Pyronaridine|4-[(7-Chloro-2-methoxybenzo[b]-1,5-naphthyridin-10-yl)amino]-2,6-bis(1-pyrrolidinylmethyl)phenol|4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol|Phenol, 4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(1-pyrrolidinylmethyl)-|4-({7-chloro-2-methoxybenzo[b]1,5-naphthyridin-10-yl}amino)-2,6-bis[(pyrrolidin-1-yl)methyl]phenol|4-[(7-Chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(1-pyrrolidinylmethyl)phenol	-	CHEMSPIDER	10647812	C29H32ClN5O2	small molecule	-	74847-35-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	DJUFPMUQJKWIJB-UHFFFAOYSA-N
33309	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Chaves OA (2022)	35759391	231762	5560	Apixaban	apixabn|apixabanum	eliquis	DRUGBANK	DB06605	C25H25N5O4	small molecule	B01AF02	503612-47-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	QNZCBYKSOIHPEH-UHFFFAOYSA-N
33310	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Chaves OA (2022)	35759391	231762	5535	Rivaroxaban	Xarelto|BAY 59-7939|BAY59-7939	xarelto	DRUGBANK	DB06228	C19H18ClN3O5S	small molecule	B01AF01	366789-02-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KGFYHTZWPPHNLQ-AWEZNQCLSA-N
33311	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Chaves OA (2022)	35759391	231762	10206	GC376	Sodium (2S)-2-({N-[(benzyloxy)carbonyl]-L-leucyl}amino)-1-hydroxy-3-(2-oxo-3-pyrrolidinyl)-1-propanesulfonate|3-Pyrrolidinepropanesulfonic acid, alpha-hydroxy-beta-[[(2S)-4-methyl-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]pentyl]amino]-2-oxo-, sodium salt, (betaS)- (1:1)	-	CHEMSPIDER	29396096	C21H30N3NaO8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	BSPJDKCMFIPBAW-JPBGFCRCSA-M
33312	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Chaves OA (2022)	35759391	231762	5577	Dabigatran etexilate	Ethyl 3-[[[4-[[[(hexyloxyl)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino] propanoate|Dabigatran	pradaxa	DRUGBANK	DB06695	C34H41N7O5	small molecule	B01AE07	211915-06-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KSGXQBZTULBEEQ-UHFFFAOYSA-N
33313	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Thoene J (2022)	36115282	231753	10210	Cysteamine HCl	mea hydrochloride|Cysteamine Hydrochloride|2-Aminoethanethiol Hydrochloride|2-Mercaptoethylammonium chloride|2-Mercaptoethylamine hydrochloride|1-Aminoethane-2-thiol hydrochloride|.beta.-Mercaptoethylamine hydrochloride|1-Amino-2-mercaptoethane hydrochloride|2-Mercapto  ethyl  amine hydrochloride|beta-Mercapto  ethylamine hydrochloride|Cysteinamine Hydrochloride|b-Mercaptoethylamine Hydrochloride|2-Mercaptoethanamine Hydrochloride|Aminoethanethiol hydrochloride|Ethanethiol, 2-amino-, hydrochloride (1:1)|2-Aminoethanethiol hydrochloride (1:1)|IF1B771SVB|2-amino-ethanethiol, monohydrochloride|KJ0200000	-	CHEMSPIDER	8729	C2H8ClNS	small molecule	-	16904-32-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, effective against alpha, beta, lambda, gamma, delta and omicron variants	OGMADIBCHLQMIP-UHFFFAOYSA-N
33314	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Cao L (2022)	35579533	231759	10205	ATV006	[(2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methyl 2-methylpropanoate (non-preferred name)	-	CHEMSPIDER	115037299	C16H19N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; effective against early strain B.1, and two prevalent SARS-CoV variants of concern (VOC), the Beta (B.1.351) and Delta (B.1.671.2) variants	YIHPGVCWGSURHO-VSBTWAGUSA-N
33315	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Vandyck K (2021)	34029993	243376	10231	PF-07304814	1H-Indole-2-carboxamide, 4-methoxy-N-[(1S)-3-methyl-1-[[[(1S)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]-3-(phosphonooxy)propyl]amino]carbonyl]butyl]-|(3S)-3-({N-[(4-Methoxy-1H-indol-2-yl)carbonyl]-L-leucyl}amino)-2-oxo-4-[(3S)-2-oxo-3-pyrrolidinyl]butyl dihydrogen phosphate	-	CHEMSPIDER	114935506	C24H33N4O9P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	FQKALOFOWPDTED-WBAXXEDZSA-N
33316	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2021)	35062273	231003	10194	NBCoV1	(Z)-2-Chloro-5-(5-((4-oxo-3-phenethyl-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid|MFCD03103051|Benzoic acid, 2-chloro-5-[5-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-|2-Chloro-5-(5-{(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-2-furyl)benzoic acid	-	CHEMSPIDER	1701907	C23H16ClNO4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, NBCoV Small Molecules Neutralize the SARS-CoV-2 Variants B.1.1.7 UK (Alpha), B.1.351 RSA (Beta), and B.1.617.2 India (Delta)	NWSIRTZGRAGTPQ-MOSHPQCFSA-N
33317	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov inhibitor	target	Curreli F (2021)	35062273	231003	10194	NBCoV1	(Z)-2-Chloro-5-(5-((4-oxo-3-phenethyl-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid|MFCD03103051|Benzoic acid, 2-chloro-5-[5-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-|2-Chloro-5-(5-{(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-2-furyl)benzoic acid	-	CHEMSPIDER	1701907	C23H16ClNO4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction : Spike-ACE2 interaction inhibitor	NWSIRTZGRAGTPQ-MOSHPQCFSA-N
33318	4383879	14254594	G128_gp02	S	spike|MERS-CoV S|MERS-CoV spike|S protein|surface|SPIKE_CVEMC|PRO_0000422465	1335626	Middle-East Respiratory Syndrome-related Coronavirus	mers-cov inhibitor	target	Curreli F (2021)	35062273	231003	10194	NBCoV1	(Z)-2-Chloro-5-(5-((4-oxo-3-phenethyl-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid|MFCD03103051|Benzoic acid, 2-chloro-5-[5-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-|2-Chloro-5-(5-{(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-2-furyl)benzoic acid	-	CHEMSPIDER	1701907	C23H16ClNO4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction : Spike-ACE2 interaction inhibitor	NWSIRTZGRAGTPQ-MOSHPQCFSA-N
33319	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Curreli F (2021)	35062273	231003	10241	NBCoV2	Benzoic acid, 3-[5-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-|3-(5-{(Z)-[4-Oxo-3-(2-phenylethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-2-furyl)benzoic acid	-	CHEMSPIDER	24635738	C23H17NO4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, NBCoV Small Molecules Neutralize the SARS-CoV-2 Variants B.1.1.7 UK (Alpha), B.1.351 RSA (Beta), and B.1.617.2 India (Delta)	WAJXCRXCBWHFKY-ZHZULCJRSA-N
33320	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov inhibitor	target	Curreli F (2021)	35062273	231003	10241	NBCoV2	Benzoic acid, 3-[5-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-|3-(5-{(Z)-[4-Oxo-3-(2-phenylethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-2-furyl)benzoic acid	-	CHEMSPIDER	24635738	C23H17NO4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction : Spike-ACE2 interaction inhibitor	WAJXCRXCBWHFKY-ZHZULCJRSA-N
33321	4383879	14254594	G128_gp02	S	spike|MERS-CoV S|MERS-CoV spike|S protein|surface|SPIKE_CVEMC|PRO_0000422465	1335626	Middle-East Respiratory Syndrome-related Coronavirus	mers-cov inhibitor	target	Curreli F (2021)	35062273	231003	10241	NBCoV2	Benzoic acid, 3-[5-[(Z)-[4-oxo-3-(2-phenylethyl)-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-|3-(5-{(Z)-[4-Oxo-3-(2-phenylethyl)-2-thioxo-1,3-thiazolidin-5-ylidene]methyl}-2-furyl)benzoic acid	-	CHEMSPIDER	24635738	C23H17NO4S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction : Spike-ACE2 interaction inhibitor	WAJXCRXCBWHFKY-ZHZULCJRSA-N
33322	113272	7431	RP11-124N14.1	VIM	CTRCT30|HEL113	9606	Homo sapiens	sars-cov-2 inhibitor	target	Li Z (2021)	34634931	231011	10311	1-(4-fluorophenyl)-3-[4-[[4-morpholin-4-yl-6-[(E)-2-phenylethenyl]-1,3,5-triazin-2-yl]amino]phenyl]urea	-	-	PUBCHEM	162658628	C28H26FN7O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ALD-R491 binds to vimentin and alters its organization with downstream effects on endocytosis, endosomal trafficking, and exosomal release and ultimately viral infection by SARS-CoV-2	VCCVHWUDWBSEKU-GIDUJCDVSA-N
33323	111564	5578	-	PRKCA	AAG6|PKC-alpha|PKCA|PRKACA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Dowey R (2022)	35382002	246231	10159	Ruboxistaurin	Ruboxistaurin|Arxxant|(18S)-18-[(Dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1~7,14~.0~2,6~.0~8,13~.0~22,27~]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione|9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, 9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-, (9S)-|721809WQCP	-	CHEMSPIDER	135727	C28H28N4O3	small molecule	-	169939-94-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PKC inhibitor, reduces neutrophil extracellular trap (NET) formation in patients with COVID-19, possibly reducing proinflammatory and tissue-damaging consequences of neutrophils during diseas	ZCBUQCWBWNUWSU-SFHVURJKSA-N
33324	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Latha D (2022)	35403091	246232	10249	Andrographidine C	Andrographidine C|7,8-Dimethoxy-4-oxo-2-phenyl-4H-chromen-5-yl beta-D-glucopyranoside|4H-1-Benzopyran-4-one, 5-(beta-D-glucopyranosyloxy)-7,8-dimethoxy-2-phenyl-	-	CHEMSPIDER	10306100	C23H24O10	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; target determined by molecular docking	WGCQDTNINMCFAY-PUIBNRJISA-N
33325	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Latha D (2022)	35403091	246232	1782	Kaempherol	-	-	DRUGBANK	DB01852	C15H10O6	small molecule	-	520-18-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, target determined by molecular docking	IYRMWMYZSQPJKC-UHFFFAOYSA-N
33326	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Latha D (2022)	35403091	246232	7740	Clinofibrate	-	-	DRUGBANK	DB09006	C28H36O6	small molecule	-	30299-08-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor, target determined by molecular docking	OGGAHXJZRRGBTK-UHFFFAOYNA-N
33327	4383850	43740578	GU280_gp01_nsp1	nsp1	ORF1ab|ORF1ab-nsp1|SARS-CoV2 nsp1|SARS-CoV-2 nsp1|leader protein|R1AB_SARS2|PRO_0000449619	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Kumar P (2022)	35425590	246233	10272	Mitoxantrone dihydrochloride	MITOZANTRONE|Novantron|Onkotrone|Mitoxantrone hydrochloride|Mitoxantrone dihydrochloride|MITOXANTHRONE HYDROCHLORIDE|1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride|1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthraquinone Dihydrochloride|novatrone|Mitoxantrone 2HCl|MITOXANTRONE HCl|9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, hydrochloride (1:2)|1,4-Dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracen-9,10-diondihydrochlorid|1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione dihydrochloride|9,10-anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, dihydrochloride|1,4-Dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthraquinone dihydrochloride|NSC-310739|MFCD00242943|UNII-U6USW86RD0|U6USW86RD0|CB5748500	-	CHEMSPIDER	46292	C22H30Cl2N4O6	small molecule	-	70476-82-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: NSP1 binder	ZAHQPTJLOCWVPG-UHFFFAOYSA-N
33328	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Schaefer A (2022)	35315683	246120	10182	GS-621763	(2R,3R,4R,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-cyano-5-[(isobutyryloxy)methyl]tetrahydrofuran-3,4-diyl bis(2-methylpropanoate) (non-preferred name)	-	CHEMSPIDER	115010292	C24H31N5O7	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor	RVSSLHFYCSUAHY-JQGROFRJSA-N
33329	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	6367	ALLN	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|Calpain Inhibitor I|110044-82-1|MG-101|Acetylleucyl-Leucyl-Norleucinal|Calpain Inhibitor I	-	DRUGBANK	DB07558	C20H37N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	FMYKJLXRRQTBOR-BZSNNMDCSA-N
33330	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	10232	Calpain Inhibitor III	Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenylpropan-2-yl]amino}butan-2-yl]carbamate|Carbamic acid, N-[(1S)-1-[[[(1S)-1-formyl-2-phenylethyl]amino]carbonyl]-2-methylpropyl]-, phenylmethyl ester|Benzyl [(2S)-3-methyl-1-oxo-1-{[(2S)-1-oxo-3-phenyl-2-propanyl]amino}-2-butanyl]carbamate|Z-Val-Phe-H	-	CHEMSPIDER	65358	C22H26N2O4	small molecule	-	88191-84-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	NGBKFLTYGSREKK-PMACEKPBSA-N
33331	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	10192	Calpeptin	MFCD00155623|N-Benzyloxycarbonyl-L-leucylnorieucinal|Z-Leu-Nle-CHO|Carbamic acid, N-[(1S)-1-[[[(1S)-1-formylpentyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester|N~2~-[(benzyloxy)carbonyl]-N-[(2S)-1-oxohexan-2-yl]-L-leucinamide|Calpeptin|N~2~-[(Benzyloxy)carbonyl]-N-[(2S)-1-oxo-2-hexanyl]-L-leucinamide	-	CHEMSPIDER	66091	C20H30N2O4	small molecule	-	117591-20-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	PGGUOGKHUUUWAF-ROUUACIJSA-N
33332	107274	824	-	CAPN2	CANP2|CANPL2|CANPml|mCANP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Zeng Q (2022)	888800000850	239382	10246	E-64d	Loxistatin|EST|(2S-(2a,3b(R*)))-3-(((3-Methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)oxiranecarboxylic Acid Ethyl Ester|(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester|E-64d|Ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxo-2-pentanyl}carbamoyl)-2-oxiranecarboxylate|RR0404300|MFCD00132883|L5W337AOUR|2-Oxiranecarboxylic acid, 3-[(Z)-hydroxy[[(1S)-1-[(Z)-hydroxy[(3-methylbutyl)imino]methyl]-3-methylbutyl]imino]methyl]-, ethyl ester, (2S,3S)-|(2S,3S)-3-(Ethoxycarbonyl)-N-{(1Z,2S)-1-hydroxy-4-methyl-1-[(3-methylbutyl)imino]-2-pentanyl}-2-oxiranecarboximidic acid|2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)-|Ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate|aloxistatin	-	CHEMSPIDER	59098	C17H30N2O5	small molecule	-	88321-09-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CAPN2 inhibitor; Calpain inhibitors strongly inhibit VSV-SARS-CoV-2 infection and KO of CAPN2 inhibits infection and viral replication suggesting this target it important for viral progression	SRVFFFJZQVENJC-IHRRRGAJSA-N
33333	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Choudhary S (2022)	888800000862	239394	10284	Lithocholic acid	Lithocholic acid|3alpha-hydroxy-5beta-cholanic acid|3alpha-hydroxy-5beta-cholan-24-oic acid|3-alpha-Hydroxy-5-beta-cholanic acid|5beta-Cholan-24-oic acid, 3alpha-hydroxy-|(3alpha,5beta)-3-Hydroxycholan-24-oic acid|5-beta-Cholan-24-oic acid, 3-alpha-hydroxy-|4-10-00-00785 (Beilstein Handbook Reference)|Cholan-24-oic acid, 3-hydroxy-, (3alpha,5beta)-|Cholan-24-oic acid, 3-hydroxy-, (3-alpha,5-beta)- (9CI)|Cholan-24-oic acid, 3-hydroxy-, (3.alpha.,5.beta.)-|3a-Hydroxycholanic Acid|3a-Hydroxy-5b-cholan-24-oic Acid|17b-(1-Methyl-3-carboxypropyl)etiocholan-3a-ol|(3a,5b)-3-hydroxycholan-24-oic acid|(3a,5b)-3-hydroxy-cholan-24-oic acid|5beta-Cholan-24-oic acid-3alpha-ol|4-10-00-00785|(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-Hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid|3217757|cholan-24-oic acid, 3-hydroxy-, (3a,5b)-|MFCD00003682|5QU0I8393U|FZ2275000	-	CHEMSPIDER	9519	C24H40O3	small molecule	-	434-13-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	SMEROWZSTRWXGI-HVATVPOCSA-N
33334	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Thijssen V (2023)	37339194	246123	7626	Linagliptin	(R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|BI 1356|Tradjenta|BI-1356|Trajenta	jentadueto xr|glyxambi|tradjen	DRUGBANK	DB08882	C25H28N8O2	small molecule	A10BD19|A10BH05|A10BD11	668270-12-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	LTXREWYXXSTFRX-QGZVFWFLSA-N
33335	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Thijssen V (2023)	37339194	246123	10180	flupenthixol	2-Trifluoromethyl-9-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propylidene)thioxanthene|2-Trifluoromethyl-9-(3-(4-(beta-hydroxyethyl)-1-piperazinyl)propylidene)thioxanthene|2-Trifluoromethyl-9-[3-[4-(b-hydroxyethyl)-1-piperazinyl]propylidene]thioxanthene|trans-Flupenthixol|<i>trans</i>-flupenthixol|(E)-Flupentixol|FLUPENTIXOL, (E)-|1-Piperazineethanol, 4-[(3E)-3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]-|trans-(E)-Flupentixol|trans-Flupentixol|2-(4-{(3E)-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}-1-piperazinyl)ethanol|2-(4-{(3E)-3-[2-(Trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethanol|Flupentiol	-	CHEMSPIDER	4445171	C23H25F3N2OS	small molecule	-	53772-85-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	NJMYODHXAKYRHW-BLLMUTORSA-N
33336	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Thijssen V (2023)	37339194	246123	10312	Teneligliptin	Q15269678|((2S,4S)-4-(4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL)PYRROLIDIN-2-YL)(1,3-THIAZOLIDIN-3-YL)METHANONE|NCGC00378896-03|3-{(2S,4S)-4-[4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL]PYRROLIDIN-2-YLCARBONYL}THIAZOLIDINE|((2S,4S)-4-(4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL)PYRROLIDIN-2-YL)(THIAZOLIDIN-3-YL)METHANONE|AS-83281|CS-0882|TENELIGLIPTIN [WHO-DD]|AC-27649|TENELIGLIPTIN (INN)|760937-92-6|TENELI|TENELIGLIPTIN [MI]|[(2S,4S)-4-[4-(5-METHYL-2-PHENYLPYRAZOL-3-YL)PIPERAZIN-1-YL]PYRROLIDIN-2-YL]-(1,3-THIAZOLIDIN-3-YL)METHANONE|AKOS025401965|D08616|AMY40806|MFCD13195565|WGRQANOPCQRCME-PMACEKPBSA-N|HY-14806|M51|NCGC00378896-04|28ZHI4CF9C|906093-29-6|TELIGLIETIN|DB11950|TENELIGLIPTIN|MP-513|((2S,4S)-4-(4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL)PYRROLIDIN-2-YL)(THIAZOLIDIN-3-YL)METHANONE HYDROBROMIDE|NCGC00378896-02|GTPL9906|TENELIGLIPTIN  (CONTAIN AROUND 5% HEXANES)|DTXSID30997419|{(2S,4S)-4-[4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL]PYRROLIDIN-2-YL}(1,3-THIAZOLIDIN-3-YL)METHANONE|MP513|UNII-28ZHI4CF9C|COMPOUND 8G [PMID: 22959556]|TENELIGLIPTIN [INN]|{4-[4-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)PIPERAZIN-1-YL]PYRROLIDIN-2-YL}(1,3-THIAZOLIDIN-3-YL)METHANONE	-	PUBCHEM	11949652	C22H30N6OS	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	WGRQANOPCQRCME-PMACEKPBSA-N
33337	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10266	EIDD-1931	EIDD-1931|N-Hydroxycytidine|Cytidine, N-hydroxy-|Uridine, 4-oxime|N4-Hydroxycytidine	-	CHEMSPIDER	170635	C9H13N3O6	small molecule	-	3258-02-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor	XCUAIINAJCDIPM-XVFCMESISA-N
33338	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10271	BLZ945	7W3V82OQ0P|4-[(2-{[(1R,2R)-2-hydroxycyclohexyl]amino}-1,3-benzothiazol-6-yl)oxy]-N-methylpyridine-2-carboxamide|BLZ-945|4-[(2-{[(1R,2R)-2-Hydroxycyclohexyl]amino}-1,3-benzothiazol-6-yl)oxy]-N-methyl-2-pyridinecarboxamide|2-Pyridinecarboxamide, 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-	-	CHEMSPIDER	29362221	C20H22N4O3S	small molecule	-	953769-46-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CSF-1R inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	ADZBMFGQQWPHMJ-RHSMWYFYSA-N
33339	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10157	PLX5622	PLX5622|3-Pyridinemethanamine, 5-fluoro-N-[6-fluoro-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-2-methoxy-|6-Fluoro-N-[(5-fluoro-2-methoxy-3-pyridinyl)methyl]-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinamine	-	CHEMSPIDER	58933701	C21H19F2N5O	small molecule	-	1303420-67-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CSF-1R inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	NSMOZFXKTHCPTQ-UHFFFAOYSA-N
33340	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10185	Pexidartinib	pexidartinib|5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)-3-pyridinyl]methyl}-2-pyridinamine|3-Pyridinemethanamine, N-[5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-	-	CHEMSPIDER	35308322	C20H15ClF3N5	small molecule	-	1029044-16-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CSF-1R inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	JGWRKYUXBBNENE-UHFFFAOYSA-N
33341	107823	1436	-	CSF1R	C-FMS|CD115|CSF-1R|CSFR|FIM2|FMS|HDLS|M-CSF-R	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10224	CEP-32496	CEP-32496|AGERAFENIB|78I4VEX88N|Urea, N-[3-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N'-[5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl]-|1-{3-[(6,7-Dimethoxy-4-quinazolinyl)oxy]phenyl}-3-[5-(1,1,1-trifluoro-2-methyl-2-propanyl)-1,2-oxazol-3-yl]urea	-	CHEMSPIDER	28506650	C24H22F3N5O5	small molecule	-	1188910-76-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CSF-1R inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	DKNUPRMJNUQNHR-UHFFFAOYSA-N
33342	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10175	NH125	3-Benzyl-1-hexadecyl-2-methyl-1H-imidazol-3-ium|1H-Imidazolium, 1-hexadecyl-2-methyl-3-(phenylmethyl)-	-	CHEMSPIDER	8612264	C27H45N2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CaMK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	ZZXUNAFAKNKXFW-UHFFFAOYSA-N
33343	113996	8408	-	ULK1	ATG1|ATG1A|UNC51|Unc51.1|hATG1	9606	Homo sapiens	activator/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10239	BL-918	Benzeneacetamide, alpha-[[[[3,5-bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N-(2,4-difluorophenyl)-, (alphaR)-|(2R)-2-({[3,5-Bis(trifluoromethyl)phenyl]carbamothioyl}amino)-N-(2,4-difluorophenyl)-2-phenylacetamide	-	CHEMSPIDER	71116224	C23H15F8N3OS	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ULK1 activator; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	BDBWQANRZRCMMD-LJQANCHMSA-N
33344	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10280	WAY-337530	Acetamide, N-[(8-hydroxy-7-quinolinyl)[4-(1-methylethyl)phenyl]methyl]-|N-[(8-Hydroxy-7-quinolinyl)(4-isopropylphenyl)methyl]acetamide	-	CHEMSPIDER	2194959	C21H22N2O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CLK1 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	MWQWZIWMSWUMLW-UHFFFAOYSA-N
33345	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10227	WAY-322243	Butanamide, N-[(8-hydroxy-7-quinolinyl)-2-thienylmethyl]-|N-[(8-Hydroxy-7-quinolinyl)(2-thienyl)methyl]butanamide	-	CHEMSPIDER	2388694	C18H18N2O2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CLK1 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	HQMZBXRQASJEMD-UHFFFAOYSA-N
33346	107606	1195	-	CLK1	CLK|CLK/STY|STY	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10204	WAY-337532	N-[(5-Chloro-8-hydroxy-7-quinolinyl)(2-methoxyphenyl)methyl]acetamide|Acetamide, N-[(5-chloro-8-hydroxy-7-quinolinyl)(2-methoxyphenyl)methyl]-	-	CHEMSPIDER	2194596	C19H17ClN2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CLK1 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	VBZSJOLGJVSKSW-UHFFFAOYSA-N
33347	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10209	Azaindole 1	TC-S 7001|6-Chloro-N~4~-{3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl}-2,4-pyrimidinediamine|2,4-Pyrimidinediamine, 6-chloro-N~4~-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-|(6-chloro-N4-(3,5-difluoro-4-((3-methyl-1H-pyrrolo(2,3-b)pyridin-4-yl)oxy)-phenyl)pyrimidine-2,4-diamine)	-	CHEMSPIDER	9698986	C18H13ClF2N6O	small molecule	-	867017-68-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	NRSGWEVTVGZDFC-UHFFFAOYSA-N
33348	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10197	GSK269962A	GSK269962A|GSK269962|GSK 269962	-	CHEMSPIDER	17253632	C29H30N8O5	small molecule	-	850664-21-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	YOVNFNXUCOWYSG-UHFFFAOYSA-N
33349	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10212	ZINC00881524	N-(4,5-Dihydronaphtho[1,2-d][1,3]thiazol-2-yl)-2-(3,4-dimethoxyphenyl)acetamide|Benzeneacetamide, N-(4,5-dihydronaphtho[1,2-d]thiazol-2-yl)-3,4-dimethoxy-	-	CHEMSPIDER	968152	C21H20N2O3S	small molecule	-	557782-81-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	DQNMDJGZWFZNHS-UHFFFAOYSA-N
33350	112020	6093	-	ROCK1	P160ROCK|ROCK-I	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10158	WAY-658513	2-(2-Chloro-6-fluorophenyl)-N-[4-(4-pyridinyl)-1,3-thiazol-2-yl]acetamide|Benzeneacetamide, 2-chloro-6-fluoro-N-[4-(4-pyridinyl)-2-thiazolyl]-	-	CHEMSPIDER	4012517	C16H11ClFN3OS	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: ROCK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	BPGUVXHQHDKSTA-UHFFFAOYSA-N
33351	111095	5058	-	PAK1	PAKalpha	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10203	LCH-7749944	2,4-Quinazolinediamine, N~2~-(3-methoxyphenyl)-N~4~-[(tetrahydro-2-furanyl)methyl]-|N~2~-(3-Methoxyphenyl)-N~4~-(tetrahydro-2-furanylmethyl)-2,4-quinazolinediamine|N-[2-(3-methoxyanilino)-4-quinazolinyl]-N-(tetrahydro-2-furanylmethyl)amine	-	CHEMSPIDER	2224829	C20H22N4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: PAK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	FBWZAFQEOKNGQL-UHFFFAOYSA-N
33352	120971	55872	-	PBK	CT84|HEL164|Nori-3|SPK|TOPK	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10234	OTS964	OTS964 (hydrochloride)|Thieno[2,3-c]quinolin-4(5H)-one, 9-[4-[(1R)-2-(dimethylamino)-1-methylethyl]phenyl]-8-hydroxy-6-methyl-, hydrochloride (1:1)|9-{4-[(2R)-1-(Dimethylamino)-2-propanyl]phenyl}-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one hydrochloride (1:1)	-	CHEMSPIDER	38772354	C23H25ClN2O2S	small molecule	-	1338545-07-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: TOPK inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	YHPWOYBWUWSJDW-UQKRIMTDSA-N
33353	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	5470	OSI-930	-	-	DRUGBANK	DB05913	-	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: c-KIT inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	-
33354	110015	3815	-	KIT	C-Kit|CD117|PBT|SCFR	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10223	Amuvatinib	N-(1,3-Benzodioxol-5-ylmethyl)-4-([1]benzofuro[3,2-d]pyrimidin-4-yl)-1-piperazinecarbothioamide|1-Piperazinecarbothioamide, N-(1,3-benzodioxol-5-ylmethyl)-4-(benzofuro[3,2-d]pyrimidin-4-yl)-|Amuvatinib|SO9S6QZB4R	-	CHEMSPIDER	9457280	C23H21N5O3S	small molecule	-	850879-09-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: c-KIT inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	FOFDIMHVKGYHRU-UHFFFAOYSA-N
33355	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10278	THAL-SNS-032	N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)-1-{[(2-{2-[2-(2-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}ethoxy)ethoxy]ethoxy}ethyl)carbamoyl]methyl}piperidine-4-carboxamide	-	CHEMSPIDER	65324400	C40H52N8O10S2	small molecule	-	2139287-33-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CDK9 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	BXDZOYLPNAIDOC-UHFFFAOYSA-N
33356	107457	1022	-	CDK7	CAK1|CDKN7|HCAK|MO15|STK1|p39MO15	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10225	LDC4297	LDC-4297|Pyrazolo[1,5-a]-1,3,5-triazin-4-amine, 8-(1-methylethyl)-2-(3-piperidinyloxy)-N-[[2-(1H-pyrazol-1-yl)phenyl]methyl]-|8-Isopropyl-2-(3-piperidinyloxy)-N-[2-(1H-pyrazol-1-yl)benzyl]pyrazolo[1,5-a][1,3,5]triazin-4-amine	-	CHEMSPIDER	58790025	C23H28N8O	small molecule	-	1453834-21-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CDK7 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	LSGRZENCFIIHNV-UHFFFAOYSA-N
33357	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bojkova D (2023)	36644320	239397	10267	Indirubin-3'-Oxime	[2,3'-Bi-1H-indol]-2'-ol, 3-nitroso-|3-Nitroso-1H,1'H-2,3'-biindol-2'-ol	-	CHEMSPIDER	23207173	C16H11N3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CDK5 inhibitor; viral inhibition mechanism undetermined; anti-delta and omicron activity determined by a Caco-2-F03 cell line platform and caspase 3/7 activity as readout method	FQCPPVRJPILDIK-UHFFFAOYSA-N
33358	107587	1173	-	AP2M1	AP50|CLAPM1|mu2	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yuan S (2020)	32923629	241564	10268	ACA	ACA|N-(p-Amylcinnamoyl)anthranilic acid|N-(p-amylcinnamoyl) Anthranilic Acid|2-[[1-oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]-benzoic acid|2-[[1-oxo-3-(4-pentylphenyl)prop-2-enyl]amino]benzoic acid|MFCD00211365|N-(4-Pentylcinnamoyl)anthranilic acid|2-[[(2E)-1-Oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]benzoic acid|2-{[(2E)-3-(4-Pentylphenyl)-2-propenoyl]amino}benzoic acid|Benzoic acid, 2-[[(2E)-1-oxo-3-(4-pentylphenyl)-2-propen-1-yl]amino]-|2-{[(2E)-3-(4-pentylphenyl)prop-2-enoyl]amino}benzoic acid|ACAA	-	CHEMSPIDER	4510067	C21H23NO3	small molecule	-	99196-74-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AP2M1 inhibitor (disrupts interaction with proteins of other viral families); AP2M1 binding; antiviral activity against SARS-CoV-2, SARS-CoV and MERS	GAMRBCZMOOMBSQ-CCEZHUSRSA-N
33359	4383845	43740570	GU280_gp04	E	env|envelope|SARS-CoV2 E|E protein|emp|SARS-CoV-2 E|VEMP_SARS2|PRO_0000449651	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ewart G (2023)	37549173	241436	10240	BIT225	BIT-225|N-(Aminoiminomethyl)-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthalenecarboxamide|N-(Diaminomethylene)-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide|2-Naphthalenecarboxamide, N-(diaminomethylene)-5-(1-methyl-1H-pyrazol-4-yl)-	-	CHEMSPIDER	10176885	C16H15N5O	small molecule	-	917909-71-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: E inhibitor, mechanism undetermined; in vivo inhibition of E-protein ion channels in Xenopus oocytes; antiviral activity against SARS-CoV-2 Wuhan-Hu-1, Delta, Omicron, BR, SA, and UK strains in cells; antiviral activity in mouse models	WVROWPPEIMRGAB-UHFFFAOYSA-N
33360	112550	6667	-	SP1	-	9606	Homo sapiens	sars-cov-2 inhibitor	target	Han H (2024)	38375778	241442	5643	Plicamycin	Mithramycine|Mithracin|Mithramycinum|Plicamycine|Plicamycin|Plicamycinum|Mithramycin|Aureolic acid	-	DRUGBANK	DB06810	C52H76O24	small molecule	L01DC02	18378-89-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: SP1 inhibitor, mechanism undetermined; antiviral activity in cells and hamsters	CFCUWKMKBJTWLW-BKHRDMLASA-N
33361	113348	7514	-	XPO1	CRM1|emb|exp1	9606	Homo sapiens	sars-cov-2 activator	target	Rahman MM (2023)	888800000921	241443	10263	Selinexor	2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2Z)-|(2Z)-3-{3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-N'-(2-pyrazinyl)acrylohydrazide|selinexor	-	CHEMSPIDER	32701989	C17H11F6N7O	small molecule	-	1393477-72-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: XPO1 inhibitor, mechanism undetermined; enhances SARS-CoV-2 infection and replication	DEVSOMFAQLZNKR-RJRFIUFISA-N
33362	107777	1387	-	CREBBP	CBP|KAT3A|RSTS	9606	Homo sapiens	sars-cov-2 inhibitor	target	Kelch MA (2023)	37342561	241452	10275	PRI-724	PRI-724|N-Benzyl-6-(4-hydroxybenzyl)-8-(1-naphthylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide|2H-Pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide, hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-	-	CHEMSPIDER	19546236	C33H32N4O4	small molecule	-	847591-62-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CBP-CTNNB1 interaction inhibitor; CBP interactor; antiviral activity against SARS-CoV-2 Wuhan-Hu-1, Zeta, Epsilon, Kappa, Alpha, Beta, Delta, and Omicron variants, SARS-CoV and MERS	HQWTUOLCGKIECB-UHFFFAOYSA-N
33363	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Yang C (2020)	33024075	241855	10215	Salvianolic acid C	Salvianolic Acid C|(2R)-3-(3,4-Dihydroxyphenyl)-2-({(2E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-1-benzofuran-4-yl]prop-2-enoyl}oxy)propanoic acid|Benzenepropanoic acid, alpha-[[(2E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-4-benzofuranyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxy-, (alphaR)-|(2R)-3-(3,4-Dihydroxyphenyl)-2-({(2E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-1-benzofuran-4-yl]-2-propenoyl}oxy)propanoic acid|(R,E)-3-(3,4-dihydroxyphenyl)-2-((3-(2-(3,4-dihydroxyphenyl)-7-hydroxybenzofuran-4-yl)acryloyl)oxy)propanoic acid	-	CHEMSPIDER	24534179	C26H20O10	small molecule	-	115841-09-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike inhibitor; S binding (experimental) and disruption of S protein core 6-HB formation; antiviral activity against SARS-CoV-2 Wuhan-Hu-1	GCJWPRRNLSHTRY-VURDRKPISA-N
33364	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Guo C (2023)	36985506	242021	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N protein-RNA interaction inhibitor; N binding (experimental)	FIAFUQMPZJWCLV-UHFFFAOYSA-N
33365	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Liu H (2020)	33242394	242032	10313	COVA1-16	-	-	PUBCHEM	440964525	-	antibody	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: S protein inhibitor; S binding (experimental); antiviral activity against SARS-CoV-2 (Frankfurt 1 and USA/CA-CZB-1072/2020) (see also PMID 32540902)	-
33366	4383915	1489668	SARS-CoV-2	S	ORF2|2|spike glycoprotein|E2|surface|S protein|SARS-CoV S|SARS-CoV Spike|peplomer|SPIKE_CVHSA|PRO_0000037208	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov inhibitor	target	Liu H (2020)	33242394	242032	10313	COVA1-16	-	-	PUBCHEM	440964525	-	antibody	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: S protein inhibitor;  S binding (experimental)	-
33367	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Cicka D (2023)	36921991	242054	10216	gossypol acetate	Gossypol Acetic Acid|GOSSYPOL ACETIC ACID, (R)-|MFCD00058385|(+/-)-Gossypol-acetic acid|MD7360000|[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, compd. with acetic acid (1:1)|1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-2,2'-binaphthalene-8,8'-dicarbaldehyde - acetic acid (1:1)	-	CHEMSPIDER	197885	C32H34O10	small molecule	-	866541-93-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: S-TMPRSS2 interaction inhibitor, S binding (experimental)	NIOHNDKHQHVLKA-UHFFFAOYSA-N
33368	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Cicka D (2023)	36921991	242054	452	Verteporfin	Verteporfina|Verteporfinum|Vertporfine|Verteporfin	visudyne	DRUGBANK	DB00460	C41H42N4O8	small molecule	S01LA01	129497-78-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: S-TMPRSS2 interaction inhibitor, S binding (experimental)	YTZALCGQUPRCGW-MXVXOLGGSA-N
33369	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Cicka D (2023)	36921991	242054	10222	Eltrombopag Olamine	Eltrombopag olamine|UNII-4U07F515LG|4U07F515LG|3'-{(2Z)-2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-3-biphenylcarboxylic acid - 2-aminoethanol (1:2)|[1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)|Revolade|Promacta	-	CHEMSPIDER	28475107	C29H36N6O6	small molecule	-	496775-62-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: S-TMPRSS2 interaction inhibitor, S binding (experimental)	PLILLUUXAVKBPY-SBIAVEDLSA-N
33370	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Ahamad S (2022)	35401674	242119	354	Anidulafungin	Eraxis|Anidulafunginum|Anidulafungine|Anidulafungin|Anidulafungina|N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.09,13]heptacosan-18-yl]- 4-{4-[4-(pentyloxy)phenyl]phenyl}benzamide|(4R,5R)-4,5-Dihydroxy-N-[[4''-(pentyloxy)-p-terphenyl-4-yl]carbonyl]-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6->1)-peptide|V-Echinocandin	eraxis|gd-anidulafungin	DRUGBANK	DB00362	C58H73N7O17	small molecule	J02AX06	166663-25-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human ACE2 inhibitor; ACE2 binding (computational)	JHVAMHSQVVQIOT-MFAJLEFUSA-N
33371	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Lockbaum GJ (2021)	33503819	242922	10250	ML188	N-{2-[(2-Methyl-2-propanyl)amino]-2-oxo-1-(3-pyridinyl)ethyl}-N-[4-(2-methyl-2-propanyl)phenyl]-2-furamide|3-Pyridineacetamide, N-(1,1-dimethylethyl)-alpha-[[4-(1,1-dimethylethyl)phenyl](2-furanylcarbonyl)amino]-	-	CHEMSPIDER	29394795	C26H31N3O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Mpro/nsp5 inhibitor; nsp5 binding (experimental); in vitro inhibition	JXGIYKRRPGCLFV-UHFFFAOYSA-N
33372	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Jacobs J (2013)	23231439	242927	10250	ML188	N-{2-[(2-Methyl-2-propanyl)amino]-2-oxo-1-(3-pyridinyl)ethyl}-N-[4-(2-methyl-2-propanyl)phenyl]-2-furamide|3-Pyridineacetamide, N-(1,1-dimethylethyl)-alpha-[[4-(1,1-dimethylethyl)phenyl](2-furanylcarbonyl)amino]-	-	CHEMSPIDER	29394795	C26H31N3O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: 3CLpro/nsp5 inhibitor; nsp5 binding (experimental); in vitro inhibition; antiviral activity against SARS-CoV Urbani isolate	JXGIYKRRPGCLFV-UHFFFAOYSA-N
33373	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Shannon A (2022)	35110538	243303	10314	AT-9010 (tetrasodium)	CS-0181237|PD164890|HY-139165A|AT-9010 TETRASODIUM|AT-9010 (TETRASODIUM)	-	PUBCHEM	162642756	C11H13FN5Na4O13P3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: nsp12 inhibitor; nsp12 binding (experimental); in vitro inhibition	YSFIWHKJCYGPPP-ZJECJYFYSA-J
33374	4383949	1489680	SARS-CoV-1ab-nsp12ab	nsp12ab	nsp12|sars1ab|orf1ab|SARS-CoV nsp12ab|SARS-CoV nsp12|SARS-CoV sars1ab|orf1ab-nsp12|orf1ab-nsp12ab|pp1ab|RNA-directed RNA polymerase|Pol|RdRp|R1AB_CVHSA|PRO_0000037318	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Shannon A (2022)	35110538	243303	10314	AT-9010 (tetrasodium)	CS-0181237|PD164890|HY-139165A|AT-9010 TETRASODIUM|AT-9010 (TETRASODIUM)	-	PUBCHEM	162642756	C11H13FN5Na4O13P3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: nsp12 inhibitor; in vitro inhibition	YSFIWHKJCYGPPP-ZJECJYFYSA-J
33375	4383864	43740578	GU280_gp01_nsp16	nsp16	ORF1ab|ORF1ab-nsp16|SARS-CoV2 nsp16|SARS-CoV-2 nsp16|2-O-methyltransferase|R1AB_SARS2|PRO_0000449633	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Klima M (2022)	36040262	243275	10315	(2~{s})-2-Azanyl-4-[[(2~{s},3~{s},4~{r},5~{r})-5-(4-Azanyl-5-Cyano-Pyrrolo[2,3-D]pyrimidin-7-Yl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]methylsulfanyl]butanoic Acid	S-(((2S,3S,4R,5R)-5-(4-AMINO-5-CYANO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL)-L-HOMOCYSTEINE|(2~{S})-2-AZANYL-4-[[(2~{S},3~{S},4~{R},5~{R})-5-(4-AZANYL-5-CYANO-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-3,4-BIS(OXIDANYL)OXOLAN-2-YL]METHYLSULFANYL]BUTANOIC ACID|6NR|GLXC-26167|SS148|1985669-27-9|Q27456478	-	PUBCHEM	121225442	C16H20N6O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: nsp16 inhibitor; nsp16 binding (experimental); in vitro inhibition	XLTWYAYAFLGUEQ-OPYVMVOTSA-N
33377	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Noske GD (2023)	36941262	243590	10316	MAT-POS-e194df51-1	KG9|MAT-POS-E194DF51-1|(4S)-6-CHLORO-2-[(1-CYANOCYCLOPROPYL)METHANESULFONYL]-N-(ISOQUINOLIN-4-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-4-CARBOXAMIDE	-	PUBCHEM	156906151	C24H21ClN4O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	YAYDSAMHSQCKIM-OAQYLSRUSA-N
33378	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Dai W (2022)	33872498	243632	9982	MPro Inhibitor 11a	1H-Indole-2-carboxamide, N-[(1S)-1-(cyclohexylmethyl)-2-[[(1S)-1-formyl-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]amino]-2-oxoethyl]-|MPro Inhibitor 11a|N-[(2S)-3-Cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxo-3-pyrrolidinyl]-2-propanyl}amino)-2-propanyl]-1H-indole-2-carboxamide|Bofutrelvir	-	CHEMSPIDER	88294718	C25H32N4O4	small molecule	-	2103278-86-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	HPKJGHVHQWJOOT-ZJOUEHCJSA-N
33379	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Wang Q (2023)	36844485	243597	10317	7-(6-Nitro-2,3-dihydroindol-1-yl)-7-oxidanylidene-heptanoic acid	Q83|7-(6-NITRO-2,3-DIHYDROINDOL-1-YL)-7-OXIDANYLIDENE-HEPTANOIC ACID	-	PUBCHEM	167311807	C15H18N2O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor; Omicron BA.4	YZWRRAZXWGNXFP-UHFFFAOYSA-N
33380	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Toelzer C (2020)	32958580	239998	10318	Linoleic Acid	CIS,CIS,9,12-OCTADECADIENOIC ACID|HSDB 5200|LINOLEIC ACID, PURE|CIS-D9,12-OCTADECADIENOIC ACID|LINOLEIC ACID, LIQUID, BIOREAGENT, SUITABLE FOR CELL CULTURE|LINOLEIC ACID, TECHNICAL, 60-74% (GC)|9KJL21T0QJ|HMS3886F05|EN300-383983|UNIFAC 6550|9-(Z), 12-(Z)-OCTADECADIENOIC ACID|9-CIS,12-CIS-OCTADECADIENOATE|(9Z,12Z)-OCTADECA-9,12-DIENOIC ACID|C18:2, N-6,9 ALL-CIS|ALL-CIS-9,12-OCTADECADIENOIC ACID|EINECS 200-470-9|60-33-3|LINOLEIC ACID [HSDB]|C18:2|9,12-LINOLEIC ACID|LINOLEIC ACID (MART.)|DTXCID505505|9,12-OCTADECADIENOIC ACID (9Z,12Z)-|9,12-OCTADECADIENOIC ACID, (E,E)-|LINOLEIC ACID (CONSTITUENT OF BORAGE SEED OIL)|NSC281243|UNII-9KJL21T0QJ|TELFAIRIC ACID|CIS-.DELTA.9,12-OCTADECADIENOIC ACID|LINOLEIC ACID, >=93% (GC)|ACON1_000270|DELTA9,12-OCTADECADIENOIC ACID|SR-01000944790-1|A832696|EXTRA LINOLEIC 90|CIS,12-OCTADECADIENOIC ACID|POLYLIN NO 515|BML3-C03|HMS1791E16|FATTY ACID 18:2 N-6|9-CIS,12-CIS-OCTADECADIENOIC ACID|LIN|(9Z,12Z)-9,12-OCTADECADIENOIC ACID|CCRIS 652|LINOLEIC ACID (CONSTITUENT OF SAW PALMETTO)|CIS-DELTA9,12-OCTADECADIENOIC ACID|30175-49-6|14C-LINOLEIC ACID|LINOLEIC ACID (CONSTITUENT OF SPIRULINA)|NCGC00091049-03|CIS,CIS-OCTADECA-9,12-DIENOIC ACID|NCGC00259720-01|BMSE000497|AKOS015951293|LEINOLEIC ACID|CIS,CIS-9,12-OCTADECADIENOIC ACID|ALL-CIS-9,12-OCTADECADIENOATE|ALPHA-LINOLEIC ACID|LINOLEIC ACID (CONSTITUENT OF FLAX SEED OIL)|BP-31121|CS-0009742|LINOLEIC ACID, >=95%, FG|C18:2 9C, 12C OMEGA6 TODOS CIS-9,12-OCTADIENOICO|LINOLEIC ACID [MI]|C18:2 9C|LINOLEIC ACID, 95%|12C OMEGA6 TODOS CIS-9,12-OCTADIENOICO|LINOLEIC ACID [VANDF]|NSC 281243|CIS-D9,12-OCTADECADIENOATE|OCTADECA-9,12-DIENOIC ACID, (CIS,CIS)-|LINOLEIC ACID (C18:2) (CONSTITUENT OF KRILL OIL)|9-CIS,12-CIS-LINOLEIC ACID|(Z,Z)-OCTADECA-9, 12-DIENOIC ACID|NCGC00091049-05|9,12-OCTADECADIENOIC ACID, (Z,Z)-, LABELED WITH CARBON-14|(14C)ALPHA-LINOLENIC ACID|AC-33770|HMS3649F07|LINOLEIC ACID (CONSTITUENT OF SPIRULINA) [DSC]|EMERSOL 310|C18:2 (N-6)|(9Z,12Z)-9,12-OCTADECADIENOATE|9,12-OCTADECADIENOIC ACID, (Z)-|HMS1361E16|IDI1_033844|RONACARE ASC 3|(9Z,12Z)-OCTADECADIENOIC ACID|9,12-OCTADECADIENOIC ACID|CIS,CIS-LINOLEATE|NCGC00091049-06|L0124|OCTADECA-9,12-DIENOIC ACID|9,12-OCTADECADIENOIC ACID (Z,Z)-|80969-37-5|(Z)-9,12-OCTADECADIENOIC ACID|9Z,12Z-OCTADECADIENOIC ACID|LINOLEIC ACID|NSC-281243|FEMA NO. 3380, LINOLEIC ACID-|HMS1989E16|CIS-DELTA(9,12)-OCTADECADIENOIC ACID|(14C)-LINOLEIC ACID|LINOLEIC ACID [WHO-DD]|NCGC00091049-01|LINOLEIC ACID [MART.]|LINOLIC ACID|(Z,Z)-9,12-OCTADECADIENOIC ACID|LMFA01030120|ACID, 9,12-OCTADECADIENOIC|LINOLEIC ACID, ANALYTICAL STANDARD|CIS-9,CIS-12-OCTADECADIENOATE|C01595|SR-01000944790-3|CIS, CIS-OCTADECA-9,12-DIENOIC ACID|BMSE000604|9,12-OCTADECADIENOIC ACID, (Z,Z)-|NCGC00091049-02|LINOLEIC-ACID|Q407426|BRD-K08973992-001-03-9|TOX21_111067|N-6,9 ALL-CIS|8016-21-5|CIS-9,CIS-12-OCTADECADIENOIC ACID,|9,12 OCTADECADIENOIC ACID|8024-22-4|CIS-9, CIS-12-OCTADECADIENOIC ACID|LEINOLIC ACID|ACIDO LINOLEICO|9,12-OCTADECADIENOIC ACID (VAN)|VESPULA PENSYLVANICA B708568K063|AI3-11132|CIS-9,CIS-12-OCTADECADIENOIC ACID|LINOLEIC ACID, >=99%|(9Z,12Z)-9,12-OCTADECADIENOIC-1-13C ACID|AS-12672|DB14104|LINOLEIC ACID, PURISS., 90%|5CE5E1F3-8859-4C5B-9AFE-E44A7076DF6E|SR-01000944790|DTXSID2025505|ACIDELINOLEIQUE|9Z,12Z-LINOLEIC ACID|L0053|9Z,12Z-OCTADECADIENOATE|POLYIN NO.515|UNII-7552P0K6PN|HMS3402E16|NCGC00257024-01|TRANS-9,TRANS-12-OCTADECADIENOIC ACID|LINOLEIC ACID, 2.0 MG/ML IN ETHANOL, CERTIFIED REFERENCE MATERIAL|7552P0K6PN|HY-N0729|9Z,12Z-LINOLEATE|CIS,CIS-9,12-OCTADECADIENOIC ACID; LINOLEATE; EMERSOL315; LINOLEIC; UNIFAC6550;|CCRIS 650|EMERSOL 315|LINOLEIC|NCGC00091049-04|AI3-36448|9,12-OCTADECADIENOIC ACID, CIS,CIS-|PAMOLYN 125 (SALT/MIX)|TOX21_202171|LINOLEIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC]|LINOLEATE|MFCD00064241|NCGC00091049-07|(Z,Z)-9,12-OCTADECADIENOATE|9, (Z)-|LINOLEIC ACID [INCI]|S5821|FA(18:2(9Z,12Z))|LINOLEIC ACID, >=95%|EPITOPE ID:117705|LINOLATE|9-CIS,12-CIS-LINOLEATE|VITAMIN F COMPONENT LINOLEIC ACID|ACIDE LINOLEIQUE|CIS,CIS-LINOLEIC ACID|BSPBIO_001374|85594-37-2|9,Z)-|TOX21_303080|GTPL1052|ACIDE CIS-LINOLEIQUE|LINOLEIC ACID [FCC]	-	PUBCHEM	5280450	C18H32O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Binds Spike protein, possible modification of Spike-Ace2 interaction, synergizes with remdesivir	OYHQOLUKZRVURQ-HZJYTTRNSA-N
33381	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Staufer O (2022)	35165285	246072	4052	Oleic Acid	-	sha-lem	DRUGBANK	DB04224	C18H34O2	small molecule	-	112-80-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, additional ref: 33692215	ZQPPMHVWECSIRJ-MDZDMXLPSA-N
33382	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Tong L (2022)	35862773	246234	745	Tretinoin	ATRA|Tretinoin|Tretinoine (french) (einecs)|Retin-a|all-trans-beta-Retinoic acid|All Trans-Retinoic Acid|Trtinone|All Trans Retinoic Acid|Solage|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)|Retionic Acid|trans-Retinoic acid|all-trans-Retinoic acid|RETINOIC acid|Retisol-a|Vesanoid|Ro 1-5488|Vitinoin|Renova|AGN 100335|Vitamin A acid|(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid|all-trans-Tretinoin|Tretin m|beta-Retinoic acid|all-(e)-Retinoic acid|Stieva-a|Tretinoina|Tretinoinum|all-trans-Vitamin a1 acid|Eudyna|all-trans-Vitamin a acid|Acide retinoique (french) (dsl)	tretinoin gel microsphere|viti	DRUGBANK	DB00755	C20H28O2	small molecule	L01XX14|D10AD01|D10AD51	302-79-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor	SHGAZHPCJJPHSC-YCNIQYBTSA-N
33383	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Tan B (2023)	36580641	243374	10319	benzyl (3S,3aS,6aR)-3-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxylate	UAWJ9-36-1|PD195025	-	PUBCHEM	156596252	C23H29N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	XXWDDQJFYNJUCB-HVTWWXFQSA-N
33384	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Tan B (2023)	36580641	243374	10320	CID 155818902	UAWJ9-36-3|BENZYL (1R,2S,5S)-2-[[(2S)-1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL]CARBAMOYL]-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLATE|BENZYL (1R,2S,5S)-2-({(2S)-1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL}CARBAMOYL)-6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLATE|GTPL11701	-	PUBCHEM	155818902	C23H31N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	KXNVRILCTPCDNL-VMXHOPILSA-N
33385	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Tan B (2023)	36580641	243374	10321	Sodium (2S)-2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonate	UAWJ247|1802664-84-1|GLXC-26538|SODIUM (2S)-2-((S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-PHENYLPROPANAMIDO)-1-HYDROXY-3-((S)-2-OXOPYRROLIDIN-3-YL)PROPANE-1-SULFONATE	-	PUBCHEM	167312260	C24H28N3NaO8S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	VFYODHDNARQKEF-SJZJPLIYSA-M
33386	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Tan B (2023)	36580641	243374	10322	2-(N-(2-chloroacetyl)-4-phenylanilino)-N-[(1S)-1-phenylethyl]-2-pyridin-3-ylacetamide	JUN9-54-1	-	PUBCHEM	162396332	C29H26ClN3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	XQECDPKLDAEYEC-QDLLFRBVSA-N
33387	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Tan B (2023)	36580641	243374	10323	(2R)-2-(N-(2,2-dichloroacetyl)-4-phenylanilino)-N-[(1S)-1-phenylethyl]-2-pyridin-3-ylacetamide	JUN9-62-2R|PD193964	-	PUBCHEM	162396343	C29H25Cl2N3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	LEOCNIZCHQOMFL-RXFWQSSRSA-N
33388	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Qiao J (2021)	33602867	246235	10324	CID 155803069	(1R,2R,5S)-6,6-DIMETHYL-N-[(2S)-1-OXO-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL]-3-[2-[4-(TRIFLUOROMETHOXY)PHENOXY]ACETYL]-3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXAMIDE|MI-09|GLXC-25594|MI09	-	PUBCHEM	155803069	C24H28F3N3O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	RBWMYPKAPIYTJQ-DEGWKOFMSA-N
33389	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Qiao J (2021)	33602867	246235	10325	(3S,3aS,6aR)-2-[3-(3,5-difluorophenyl)propanoyl]-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide	GLXC-26317|COMPOUND 18I [PMID: 33602867]|MI23|(1S,3AR,6AS)-2-(3-(3,5-DIFLUOROPHENYL)PROPANOYL)-N-((S)-1-OXO-3-((S)-2-OXOPYRROLIDIN-3-YL)PROPAN-2-YL)OCTAHYDROCYCLOPENTA[C]PYRROLE-1-CARBOXAMIDE|GTPL11432|MI-23	-	PUBCHEM	155804440	C24H29F2N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	ZUAZJPLYYVHKFN-NAFADOBPSA-N
33390	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Qiao J (2021)	33602867	246235	10326	CID 155803090	GLXC-25593|MI-30|MI30|(3R,3AR,6AR)-2-[2-(2,4-DICHLOROPHENOXY)ACETYL]-N-[(2S)-1-OXO-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL]-3,3A,4,5,6,6A-HEXAHYDRO-1H-CYCLOPENTA[C]PYRROLE-3-CARBOXAMIDE	-	PUBCHEM	155803090	C23H27Cl2N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	HKJKOHDJUKCNRG-IEBLYUSBSA-N
33391	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Li J (2022)	35809383	243373	10231	PF-07304814	1H-Indole-2-carboxamide, 4-methoxy-N-[(1S)-3-methyl-1-[[[(1S)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]-3-(phosphonooxy)propyl]amino]carbonyl]butyl]-|(3S)-3-({N-[(4-Methoxy-1H-indol-2-yl)carbonyl]-L-leucyl}amino)-2-oxo-4-[(3S)-2-oxo-3-pyrrolidinyl]butyl dihydrogen phosphate	-	CHEMSPIDER	114935506	C24H33N4O9P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	FQKALOFOWPDTED-WBAXXEDZSA-N
33392	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Li J (2022)	35809383	243373	10231	PF-07304814	1H-Indole-2-carboxamide, 4-methoxy-N-[(1S)-3-methyl-1-[[[(1S)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]-3-(phosphonooxy)propyl]amino]carbonyl]butyl]-|(3S)-3-({N-[(4-Methoxy-1H-indol-2-yl)carbonyl]-L-leucyl}amino)-2-oxo-4-[(3S)-2-oxo-3-pyrrolidinyl]butyl dihydrogen phosphate	-	CHEMSPIDER	114935506	C24H33N4O9P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	FQKALOFOWPDTED-WBAXXEDZSA-N
33393	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Li J (2022)	35809383	243373	10231	PF-07304814	1H-Indole-2-carboxamide, 4-methoxy-N-[(1S)-3-methyl-1-[[[(1S)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]-3-(phosphonooxy)propyl]amino]carbonyl]butyl]-|(3S)-3-({N-[(4-Methoxy-1H-indol-2-yl)carbonyl]-L-leucyl}amino)-2-oxo-4-[(3S)-2-oxo-3-pyrrolidinyl]butyl dihydrogen phosphate	-	CHEMSPIDER	114935506	C24H33N4O9P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	FQKALOFOWPDTED-WBAXXEDZSA-N
33394	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yao Y (2023)	37467664	243884	10248	Fostamatinib	2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-|Fostamatinib|SQ8A3S5101|TAVALISSE|[6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl}amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate	-	CHEMSPIDER	9846198	C23H26FN6O9P	small molecule	-	901119-35-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human ACE2 binding (computational); antiviral activity against SARS-CoV-2 in A549 cells	GKDRMWXFWHEQQT-UHFFFAOYSA-N
33395	121864	59272	UNQ868/PRO1885	ACE2	ACEH	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yao Y (2023)	37467664	243884	7626	Linagliptin	(R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|BI 1356|Tradjenta|BI-1356|Trajenta	jentadueto xr|glyxambi|tradjen	DRUGBANK	DB08882	C25H28N8O2	small molecule	A10BD19|A10BH05|A10BD11	668270-12-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human ACE2 binding (computational); antiviral activity against SARS-CoV-2 in A549 cells	LTXREWYXXSTFRX-QGZVFWFLSA-N
33396	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yao Y (2023)	37467664	243884	10162	Lysergol	Lysergol|Ergoline-8-methanol, 9,10-didehydro-6-methyl-, (8.beta.)-|9,10-Didehydro-6-methylergoline-8beta-methanol|9,10-Didehydro-6-methylergoline-8b-methanol|Methanol, 1-[(8beta)-9,10-didehydro-6-methylergolin-8-yl]-|[(8beta)-6-Methyl-9,10-didehydroergolin-8-yl]methanol|(+)-lysergol	-	CHEMSPIDER	14267	C16H18N2O	small molecule	-	602-85-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human GRP78 binding (computational); antiviral activity against SARS-CoV-2 in A549 cells	BIXJFIJYBLJTMK-MEBBXXQBSA-N
33397	109541	3309	-	HSPA5	BIP|GRP78|HEL-S-89n|MIF2	9606	Homo sapiens	sars-cov-2 inhibitor	target	Yao Y (2023)	37467664	243884	10218	Sophoridine	sophoridine|1H,5H,10H-Dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one, dodecahydro-, (7aR,13aR,13bR,13cS)-|(5beta)-Matridin-15-one|(7aR,13aR,13bR,13cS)-Dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one|Allomatrine|W5S1M800J7|(+)-Allomatrine|(-)-Sophoridine	-	CHEMSPIDER	145087	C15H24N2O	small molecule	-	6882-68-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human GRP78 binding (computational); antiviral activity against SARS-CoV-2 in A549 cells	ZSBXGIUJOOQZMP-BHPKHCPMSA-N
33398	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Mercaldi GF (2022)	36323732	244096	10168	CA/chicoric acid	(2R,3R)-2,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}succinic acid|(2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid|L-Cichoric acid|2,3-Dicaffeoyl-L-tartaric acid|(2R,3R)-2,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy}butanedioic acid|2,3-Di-trans-caffeoyltartaric acid|MFCD22683653|S4YY3V8YHD|( -)-Chicoric acid|2R,3R-O-dicaffeoyltartaric acid|Butanedioic acid, 2,3-bis[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-, (2R,3R)-|Dicaffeoyl-L-tartaric acid|Chicoric acid, (-)-|(-)-L-Chicoric acid|(-)-Chicoric acid|Cichoric acid|Chicoric acid|(2R,3R)-2,3-Bis{[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]oxy}succinic acid	-	CHEMSPIDER	4445078	C22H18O12	small molecule	-	6537-80-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral N-RNA interaction inhibitor; N binding (experimental); antiviral activity against SARS-CoV-2/SP02/human/2020/BRA	YDDGKXBLOXEEMN-IABMMNSOSA-N
33399	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Saxena U (2023)	888800000968	243898	323	Metformin	Metformine|Metformine pamoate|Haurymellin|1,1-Dimethylbiguanide|Metformina|N,N-Dimethylimidodicarbonimidic diamide|Metforminum|Metformin|Dimethylbiguanid	apo-metformin 850 mg tablets|g	DRUGBANK	DB00331	C4H11N5	small molecule	A10BD03|A10BD05|A10BD11|A10BD10|A10BD02|A10BD13|A10BD14|A10BD15|A10BD16|A10BD17|A10BD18|A10BD07|A10BD08|A10BA02|A10BD20	657-24-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor	XZWYZXLIPXDOLR-UHFFFAOYSA-N
33400	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Saxena S (2021)	888800000281	228565	4665	Omacetaxine mepesuccinate	()-homoharringtonine|Homoharringtonin|(2'R,3S,4S,5R)-()-homoharringtonine|Homoharringtonine|HHT	synribo	DRUGBANK	DB04865	C29H39NO9	small molecule	L01XX40	26833-87-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor; S binding (computational); antiviral activity against SARS-CoV-2 in Vero E6 cells (cites PMID: 32251767 )	HYFHYPWGAURHIV-JFIAXGOJSA-N
33401	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Yamaoka Y (2022)	35891441	244390	10230	Soyasaponin I	(3beta,22beta)-22,24-Dihydroxyolean-12-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid|beta-D-Glucopyranosiduronic acid, (3beta,22beta)-22,24-dihydroxyolean-12-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->2)-|soyasaponin 1|Soyasaponin-Bb|Soyasaponin Bb|Soyasaponin I	-	CHEMSPIDER	108898	C48H78O18	small molecule	-	51330-27-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor; S binding (experimental); antiviral activity against SARS-CoV-2 Wuhan, Delta, Omicron BA.1 and Omicron BA.2	PTDAHAWQAGSZDD-IOVCITQVSA-N
33402	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Chen Y (2022)	36468859	246236	1092	Sertraline	cis-(+)-Sertraline|Sertraline|(+)-Sertraline|Sertralina|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|(1S,4S)-Sertraline|CP 51974|Sertralinum	ipg-sertraline|sertraline|nu-s	DRUGBANK	DB01104	C17H17Cl2N	small molecule	N06AB06	79617-96-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor; S binding; antiviral activity against SARS-CoV-2 in Vero E6 cells	VGKDLMBJGBXTGI-SJCJKPOMSA-N
33403	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zhao Y (2021)	33864621	246237	10208	Sepantronium Bromide	Sepantronium bromide|1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide|4,9-dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(2-pyrazinylmethyl)-1H-naphth[2,3-d]imidazolium, bromide (1:1)|YM-155|7H5Q4J1CM5|1H-Naphth[2,3-d]imidazolium, 4,9-dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(2-pyrazinylmethyl)-, bromide (1:1)|1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(2-pyrazinylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide	-	CHEMSPIDER	9353328	C20H19BrN4O3	small molecule	-	781661-94-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	QBIYUDDJPRGKNJ-UHFFFAOYSA-M
33404	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zhao Y (2021)	33864621	246237	10235	cryptotanshinone	(1R)-1,6,6-Trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione|Tanshinone C|SF8282645|MFCD07636810|1,2,6,7,8,9-hexahydro-1,6,6-trimethyl- (R)-phenanthro(1,2-b)furan-10,11-dione|(R)-(-)-1,6,6-Trimethyl-1,2,6,7,8,9-hexahydrophenanthro[1,2-b]furan-10,11-dione|Cryptotanshinon|Phenanthro[1,2-b]furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (1R)-|Phenanthro(1,2-b)furan-10,11-dione, 1,2,6,7,8,9-hexahydro-1,6,6-trimethyl-, (R)-|Cryptotanshinone	-	CHEMSPIDER	140851	C19H20O3	small molecule	-	35825-57-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	GVKKJJOMQCNPGB-JTQLQIEISA-N
33405	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zhao Y (2021)	33864621	246237	10327	Tanshinone I	MLS006011773|1,6-DIMETHYL-10H,11H-PHENANTHRO[1,2-B]FURAN-10,11-DIONE|1,6-DIMETHYLPHENANTHRO[1,2-B]FURAN-10,11-DIONE|NCGC00247624-01|568-73-0|AIGAZQPHXLWMOJ-UHFFFAOYSA-|SMR000445578|AC-7999|FT-0632407|Q27247588|03UUH3J385|NCGC00247624-02|TANSHINONE I, >=98% (HPLC)|NCGC00247624-03|1,6-DIMETHYL-PHENANTHRO(1,2-B)FURAN-10,11-DIONE|1,6-DIMETHYLNAPHTHO[1,2-G][1]BENZOFURAN-10,11-DIONE|Q-100655|C18H12O3|TANSHINONE I, ANALYTICAL STANDARD|S2364|CID_114917|TANSHINONE A|A831218|PHENANTHRO[1,2-B]FURAN-10,11-DIONE, 1,6-DIMETHYL-|AKOS005613012|1,6-DIMETHYLPHENANTHRO(1,2-B)FURAN-10,11-DIONE|TANSHINONE I (CONSTITUENT OF CHINESE SALVIA) [DSC]|HMS2222J14|UNII-03UUH3J385|1,6-DIMETHYL-PHENANTHRO[1,2-B]FURAN-10,11-DIONE|CCG-267206|SW219821-1|TANSHINONEI|TANSHINONE-I|MLS000697676|TANSHINON I, TANSHINONE A, TANSHINQUINONE I|1,6-DIMETHYLPHENANTHRO[1,2-B]FURAN-10,11-DIONE #|INCHI=1/C18H12O3/C1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/H3-8H,1-2H3|1,6-DIMETHYLNAPHTHO[1,2-G]BENZOFURAN-10,11-DIONE|TANSHINONE|DTXSID90972247|1,6-DIMETHYLNAPHTHO[1,2-G]BENZOFURAN-10,11-QUINONE|HMS3656A11|54693-68-4|TANSHINON I|PHENANTHRO(1,2-B)FURAN-10,11-DIONE, 1,6-DIMETHYL-|TANSHINONE I,(S)|TANSHINONE I (CONSTITUENT OF CHINESE SALVIA)|TANSHINONE I|HY-N0134|MFCD00210563|AS-68049|NCGC00247624-05|TRISTEARYLORTHOFORMATE|BCP28292	-	PUBCHEM	114917	C18H12O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	AIGAZQPHXLWMOJ-UHFFFAOYSA-N
33406	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zhao Y (2021)	33864621	246237	7430	GRL0617	5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide	-	DRUGBANK	DB08656	C20H20N2O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: PLPro inhibitor	UVERBUNNCOKGNZ-CQSZACIVSA-N
33407	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Panagiotopoulos A (2021)	34128351	245325	10283	P-CYMENE	p-isopropyltoluene|p-cymene|p-methylcumene|p-methyl cumene|para-cymene|4-Isopropyltoluene|4-cymene|Cumene, p-methyl-|Cymene|Cymene, p-|1-Isopropyl-4-methylbenzene|4-methyl isopropylbenzene|Benzene, 1-methyl-4-(1-methylethyl)-|4-methyl-1-(propan-2-yl)benzene|Benzene, 1-methyl-4- (1-methylethyl)-|p-methyl-Cumene|1-isopropyl-4-methyl-Benzene|1-Methyl-4-(1-methylethyl)-benzene|p-Mentha-1,3,5-triene|1903377|1-methyl-4-(propan-2-yl)benzene|MFCD00008893|1G1C8T1N7Q|4V31KQF934	-	CHEMSPIDER	7183	C10H14	small molecule	-	13816-33-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: predicted nucleocapsid (N) protein interactor with demonstrated anti-SARS-CoV-2 plaque formation and titer properties	HFPZCAJZSCWRBC-UHFFFAOYSA-N
33408	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Martinez DR (2023)	888800000993	244293	10205	ATV006	[(2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methyl 2-methylpropanoate (non-preferred name)	-	CHEMSPIDER	115037299	C16H19N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; antiviral activity against SARS-CoV-2 WA/1 and SARS-CoV-2 BA.1 Omicron variant in A549-hACE2 cells and mice	YIHPGVCWGSURHO-VSBTWAGUSA-N
33409	4383949	1489680	SARS-CoV-1ab-nsp12ab	nsp12ab	nsp12|sars1ab|orf1ab|SARS-CoV nsp12ab|SARS-CoV nsp12|SARS-CoV sars1ab|orf1ab-nsp12|orf1ab-nsp12ab|pp1ab|RNA-directed RNA polymerase|Pol|RdRp|R1AB_CVHSA|PRO_0000037318	694009	Severe acute respiratory syndrome-related coronavirus	sars-cov inhibitor	target	Martinez DR (2023)	888800000993	244293	10205	ATV006	[(2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methyl 2-methylpropanoate (non-preferred name)	-	CHEMSPIDER	115037299	C16H19N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: RdRp inhibitor; antiviral activity against SARS-CoV in A549-hACE2 cells and mice	YIHPGVCWGSURHO-VSBTWAGUSA-N
33410	4383896	14254602	G128_gp01ab_nsp12	nsp12ab	ORF1ab|nsp12|rep|1AB|MERS-CoV nsp12|orf1ab-nsp12|orf1ab-nsp12ab|nsp12ab|RNA polymerase|R1AB_CVEMC|PRO_0000422449	1335626	Middle-East Respiratory Syndrome-related Coronavirus	mers-cov inhibitor	target	Martinez DR (2023)	888800000993	244293	10205	ATV006	[(2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methyl 2-methylpropanoate (non-preferred name)	-	CHEMSPIDER	115037299	C16H19N5O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: RdRp inhibitor; antiviral activity against MERS-CoV in A549-hACE2 cells and mice	YIHPGVCWGSURHO-VSBTWAGUSA-N
33411	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Yotsuyanagi H (2024)	38335000	244291	9978	Ensitrelvir	1,3,5-Triazine-2,4(1H,3H)-dione, 6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]dihydro-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-, (6E)-|(6E)-6-[(6-Chloro-2-methyl-2H-indazol-5-yl)imino]-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione	-	CHEMSPIDER	115007411	C22H17ClF3N9O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor; effective in clincial trial against SARS-CoV-2	QMPBBNUOBOFBFS-UHFFFAOYSA-N
33412	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zapata-Cardona MI (2023)	36891537	246238	5646	Raltegravir	MK-0518|RAL	isentress	DRUGBANK	DB06817	C20H21FN6O5	small molecule	J05AR16|J05AX08	518048-05-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; D614G strain, additional evidence in PMID: 34311539	CZFFBEXEKNGXKS-UHFFFAOYSA-N
33413	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zapata-Cardona MI (2023)	36891537	246238	699	Lamivudine	Lamivudinum|beta-L-3'-Thia-2',3'-dideoxycytidine|beta-L-2',3'-Dideoxy-3'-thiacytidine|2',3'-Dideoxy-3'-thiacytidine|3TC|(-)-2'-Deoxy-3'-thiacytidine|Epivir|3'-Thia-2',3'-dideoxycytidine|Lamivudine|Lamivudin|(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine|Lamivudina	apo-zidovudine-lamivudine-nevi	DRUGBANK	DB00709	C8H11N3O3S	small molecule	J05AF05|J05AR01|J05AR02|J05AR05|J05AR04|J05AR07|J05AR16|J05AR12|J05AR13|J05AR11	134678-17-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; D614G strain, additional evidence in PMID: 34367956	JTEGQNOMFQHVDC-NKWVEPMBSA-N
33414	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zapata-Cardona MI (2023)	36891537	246238	869	Emtricitabine	(-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one|(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine|Emtricitabin|4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one|(-)-2'-Deoxy-5-fluoro-3'-thiacytidine|(2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone|Emtricitabina|4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one|Emtricitabine|(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine|(-)-FTC|5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine|Emtricitabinum	stribild|truvada|emtriva|odefs	DRUGBANK	DB00879	C8H10FN3O3S	small molecule	J05AR19|J05AF09|J05AR08|J05AR03|J05AR18|J05AR06|J05AR09|J05AR17	143491-57-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; D614G strain	XQSPYNMVSIKCOC-NTSWFWBYSA-N
33415	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Li J (2022)	35809383	243373	9959	PF-00835231	1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-3-hydroxy-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]propyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-|N-[(2S)-1-({(2S)-4-Hydroxy-3-oxo-1-[(3S)-2-oxo-3-pyrrolidinyl]-2-butanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide	-	CHEMSPIDER	9736673	C24H32N4O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	QDIMHKWNHMVDJB-WBAXXEDZSA-N
33416	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Li J (2022)	35809383	243373	9944	GC-376	BCP32603|GC-376; GC 376|GC376|(2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate	-	PUBCHEM	146681255	C21H30N3O8S-	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor	-
33417	111317	5300	-	PIN1	DOD|UBL5	9606	Homo sapiens	sars-cov-2 inhibitor	target	Aviner R (2023)	888800000985	244285	10191	Juglone	Juglone|Regianin|Nucin|5-Hydroxy-1,4-naphthoquinone|5-HNQ|5-Hydroxy-1,4-naphthalenedione|5-hydroxynaphthalene-1,4-dione|1,4-Naphthalenedione, 5-hydroxy-|5-Hydroxy-1,4-naphthochinone|1909764|5-hydroxy-1,4-dihydronaphthalene-1,4-dione	-	CHEMSPIDER	3674	C10H6O3	small molecule	-	481-13-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human PIN1 inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	KQPYUDDGWXQXHS-UHFFFAOYSA-N
33418	109180	2923	-	PDIA3	ER60|ERp57|ERp60|ERp61|GRP57|GRP58|HEL-S-269|HEL-S-93n|HsT17083|P58|PI-PLC	9606	Homo sapiens	sars-cov-2 inhibitor	target	Aviner R (2023)	888800000985	244285	10201	16F16	2-(2-Chloroacetyl)-2,3,4,9-tetrahydro-1-methyl-1H-pyrido[3,4-b]indole-1-carboxylic acid methyl ester|MFCD20134198|PDI INHIBITOR 16F16|16F16|Methyl 2-(chloroacetyl)-1-methyl-2,3,4,9-tetrahydro-1H-beta-carboline-1-carboxylate|1H-Pyrido[3,4-b]indole-1-carboxylic acid, 2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1-methyl-, methyl ester|Methyl 2-(2-chloroacetyl)-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylate	-	CHEMSPIDER	3749199	C16H17ClN2O3	small molecule	-	922507-80-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human PDIA3 inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	BCSIRYFYAKLJDK-UHFFFAOYSA-N
33419	120991	55905	-	RNF114	PSORS12|ZNF313	9606	Homo sapiens	sars-cov-2 inhibitor	target	Aviner R (2023)	888800000985	244285	8586	Nimbolide	methyl [(2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cR)-8-(furan-3-yl)-2a,5a,6a,7-tetramethyl-2,5-dioxo-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-b'c']difuran-6-yl]acetate|2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-b'c']difuran-6-acetic acid, 8-(3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-2,5-dioxo-, methyl ester, (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cR)-|GY2370000|Methyl [(2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cR)-8-(3-furyl)-2a,5a,6a,7-tetramethyl-2,5-dioxo-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2H,5H-cyclopenta[b]furo[2',3',4':4,5]naphtho[2,3-d]furan-6-yl]acetate|nimbolide	-	CHEMSPIDER	10320669	C27H30O7	small molecule	-	25990-37-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human RNF114 inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	JZIQWNPPBKFOPT-LSYMHUITSA-N
33420	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Zhong B (2022)	35600064	244624	8359	Oridonin	Oridonin|(1alpha,5beta,6beta,7alpha,8alpha,9beta,10alpha,13alpha,14R)-1,6,7,14-Tetrahydroxy-7,20-epoxykaur-16-en-15-one	-	CHEMSPIDER	23326877	C20H28O6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vro e6cells	SDHTXBWLVGWJFT-BAFGBBEMSA-N
33421	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Wang Z (2023)	37379907	240920	10242	Aclarubicin	1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranosyl]oxy]-, methyl ester	-	CHEMSPIDER	1931	C42H53NO15	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: RdRp inhibitor; antiviral activity against SARS-CoV-2 in Calu-3 cells	USZYSDMBJDPRIF-UHFFFAOYSA-N
33422	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Dhaka P (2023)	37956938	240924	7943	Netoglitazone	MCC 555|PGX-510|RWJ-241947	-	DRUGBANK	DB09199	C21H16FNO3S	small molecule	-	161600-01-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding; antiviral activity against SARS-CoV-2 in Vero E6 cells	PKWDZWYVIHVNKS-UHFFFAOYSA-N
33423	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Dhaka P (2023)	37956938	240924	10277	Bictegravir	(1S,11R,13R)-5-Hydroxy-3,6-dioxo-N-(2,4,6-trifluorobenzyl)-12-oxa-2,9-diazatetracyclo[11.2.1.0~2,11~.0~4,9~]hexadeca-4,7-diene-7-carboxamide|2,5-Methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-, (2R,5S,13aR)-|bictegravir|8GB79LOJ07|UNII:8GB79LOJ07|GS-9883-01|GS-9883|(2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide	-	CHEMSPIDER	44208822	C21H18F3N3O5	small molecule	-	1611493-60-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding; antiviral activity against SARS-CoV-2 in Vero E6 cells	SOLUWJRYJLAZCX-LYOVBCGYSA-N
33424	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Dhaka P (2023)	37956938	240924	10167	ANA-12	N2-(2-{[(2-oxoazepan-3-yl)amino]carbonyl}phenyl)benzo[b]thiophene-2-carboxamide|Benzo[b]thiophene-2-carboxamide, N-[2-[[(hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]-|N-{2-[(2-Oxo-3-azepanyl)carbamoyl]phenyl}-1-benzothiophene-2-carboxamide|ANA-12|N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide|N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]-benzo[b]thiophene-2-carboxamide|MFCD00117444|ANA 12|N-{2-[(2-OXO-3-AZEPANYL)CARBAMOYL]PHENYL}-1-BENZOTHIOPHENE-2-CARB OXAMIDE|BCP16021|N-[2-[[(HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO]CARBONYL]PHENYL]BENZO[B]THIOPHENE-2-CARBOXAMIDE|HY-12497|N-[2-[[(HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO]CARBONYL]PHENYL]-BENZO[B]THIOPHENE-2-CARBOXAMIDE|BENZO(B)THIOPHENE-2-CARBOXAMIDE, N-(2-(((HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO)CARBONYL)PHENYL)-|S7745|CCG-222404|UNII-54S4JPT8JX|NCGC00379202-06|MAYBRIDGE1_001394|HMS3886N17|N-(2-((2-OXOAZEPAN-3-YL)CARBAMOYL)PHENYL)BENZO[B]THIOPHENE-2-CARBOXAMIDE|219766-25-3|A878840|OPREA1_341312|EX-A815|HMS545H08|54S4JPT8JX|FT-0700267|CS-3616|J-690263|N-{2-[(2-OXOAZEPAN-3-YL)CARBAMOYL]PHENYL}-1-BENZOTHIOPHENE-2-CARBOXAMIDE|DTXSID501045818|ANA-12, >=98% (HPLC)|N-(2-(2-OXOAZEPAN-3-YLCARBAMOYL)PHENYL)BENZO[B]THIOPHENE-2-CARBOXAMIDE|N-[2-[(2-OXOAZEPAN-3-YL)CARBAMOYL]PHENYL]-1-BENZOTHIOPHENE-2-CARBOXAMIDE|AS-16798|ANA-12|AC-32995|N-(2-(((HEXAHYDRO-2-OXO-1H-AZEPIN-3-YL)AMINO)CARBONYL)PHENYL)BENZO(B)THIOPHENE-2-CARBOXAMIDE|MFCD00117444|AKOS024458344|ANA12|NCGC00379202-10	-	CHEMSPIDER	2078460	C22H21N3O3S	small molecule	-	219766-25-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding; antiviral activity against SARS-CoV-2 in Vero E6 cells	TUSCYCAIGRVBMD-UHFFFAOYSA-N
33425	4383847	43740575	GU280_gp10	N	nuc|nucleocapsid|SARS-CoV2 N|N protein|ncap|SARS-CoV-2 N|Nucleoprotein|NCAP_SARS2|PRO_0000449656	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Dhaka P (2023)	37956938	240924	10233	Bisdemethoxycurcumin	Bisdemethoxycurcumin|curcumin III|Bis(p-hydroxycinnamoyl)methane|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (1E,6E)-|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (E,E)-|(1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione|Didemethoxycurcumin|(1E,6E)-1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione|Bisdesmethoxycurcumin|MFCD03419284|2EFO1BP34R|(E,E)-1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione	-	CHEMSPIDER	4474770	C19H16O4	small molecule	-	33171-05-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: N binding; antiviral activity against SARS-CoV-2 in Vero E6 cells	PREBVFJICNPEKM-YDWXAUTNSA-N
33426	106710	207	-	AKT1	AKT|CWS6|PKB|PKB-ALPHA|PRKBA|RAC|RAC-ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10172	GSK-690693	GSK-690693|4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methyl-3-butyn-2-ol|3-Butyn-2-ol, 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-|MFCD14105605|4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol	-	CHEMSPIDER	20557532	C21H27N7O3	small molecule	-	937174-76-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AKT inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	KGPGFQWBCSZGEL-ZDUSSCGKSA-N
33427	106711	208	-	AKT2	HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10172	GSK-690693	GSK-690693|4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methyl-3-butyn-2-ol|3-Butyn-2-ol, 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-|MFCD14105605|4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol	-	CHEMSPIDER	20557532	C21H27N7O3	small molecule	-	937174-76-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AKT inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	KGPGFQWBCSZGEL-ZDUSSCGKSA-N
33428	115318	10000	-	AKT3	MPPH|MPPH2|PKB-GAMMA|PKBG|PRKBG|RAC-PK-gamma|RAC-gamma|STK-2	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10172	GSK-690693	GSK-690693|4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methyl-3-butyn-2-ol|3-Butyn-2-ol, 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-|MFCD14105605|4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol	-	CHEMSPIDER	20557532	C21H27N7O3	small molecule	-	937174-76-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: AKT inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	KGPGFQWBCSZGEL-ZDUSSCGKSA-N
33429	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10248	Fostamatinib	2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-|Fostamatinib|SQ8A3S5101|TAVALISSE|[6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl}amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate	-	CHEMSPIDER	9846198	C23H26FN6O9P	small molecule	-	901119-35-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: SYK inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	GKDRMWXFWHEQQT-UHFFFAOYSA-N
33430	115083	9734	-	HDAC9	HD7|HD7b|HD9|HDAC|HDAC7|HDAC7B|HDAC9B|HDAC9FL|HDRP|MITR	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: histone deacetylase (HDAC) inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	NIJJYAXOARWZEE-UHFFFAOYSA-N
33431	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: histone deacetylase (HDAC) inhibitor; SIRT5 activator	NIJJYAXOARWZEE-UHFFFAOYSA-N
33432	107765	1374	-	CPT1A	CPT1|CPT1-L|L-CPT1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	1006	Glyburide	1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide|Glibenclamidum|Micronase|Diabeta|1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|Glibenclamida|Glyburide|5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|Glynase	diabeta 5mg|euglucon|ntp-glybu	DRUGBANK	DB01016	C23H28ClN3O5S	small molecule	A10BB01	10238-21-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: CPT1A inhibitor; antiviral activity against SARS-CoV-2 in Caco-2 cells	ZNNLBTZKUZBEKO-UHFFFAOYSA-N
33433	111017	4967	-	OGDH	AKGDH|E1k|OGDC	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10257	CPI-613	6,8-Bis(benzylsulfanyl)octanoic acid|Octanoic acid, 6,8-bis[(phenylmethyl)thio]-|CPI-613|MFCD22420826|UNII:E76113IR49|E76113IR49|6,8-Bis(benzylthio)-octanoic acid|6,8-Bis[(phenylmethyl)thio-octanoic acid|6,8-Bis[(phenylmethyl)thio]octanoic acid	-	CHEMSPIDER	28189062	C22H28O2S2	small molecule	-	95809-78-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: KGDHC inhibitor; antiviral activity against SARS-CoV-2 in Caco-2 cells	ZYRLHJIMTROTBO-UHFFFAOYSA-N
33434	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Teshima K (2023)	36987590	244749	10262	curcumin	diferuloylmethane|(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)-|(E,E)-1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione|(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione|C Yellow 15|trans,trans-Curcumin|Diferulylmethane|Curcumin|CURCUMINE	-	CHEMSPIDER	839564	C21H20O6	small molecule	-	8024-37-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational); antiviral activity against SARS-CoV-2 in Vero E6 cells	VFLDPWHFBUODDF-FCXRPNKRSA-N
33435	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Teshima K (2023)	36987590	244749	10237	demethoxycurcumin	demethoxycurcumin|curcumin II|monodemethoxycurcumin|(1E,6E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione|Desmethoxycurcumin|(E,E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione|(1E,6E)-Demethoxycurcumin|MFCD03427310|(1E,6E)-1-(4-Hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione|1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-, (1E,6E)-|1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)-	-	CHEMSPIDER	4579941	C20H18O5	small molecule	-	22608-11-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational); antiviral activity against SARS-CoV-2 in Vero E6 cells	HJTVQHVGMGKONQ-LUZURFALSA-N
33436	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Teshima K (2023)	36987590	244749	10233	Bisdemethoxycurcumin	Bisdemethoxycurcumin|curcumin III|Bis(p-hydroxycinnamoyl)methane|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (1E,6E)-|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxyphenyl)-, (E,E)-|(1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione|Didemethoxycurcumin|(1E,6E)-1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione|Bisdesmethoxycurcumin|MFCD03419284|2EFO1BP34R|(E,E)-1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione	-	CHEMSPIDER	4474770	C19H16O4	small molecule	-	33171-05-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational); antiviral activity against SARS-CoV-2 in Vero E6 cells	PREBVFJICNPEKM-YDWXAUTNSA-N
33437	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Teshima K (2023)	36987590	244749	10238	curcumin sulfate	1,6-Heptadiene-3,5-dione, 1-(4-hydroxy-3-methoxyphenyl)-7-[3-methoxy-4-(sulfooxy)phenyl]-, (1E,6E)-|4-[(1E,6E)-7-(4-Hydroxy-3-methoxyphenyl)-3,5-dioxo-1,6-heptadien-1-yl]-2-methoxyphenyl hydrogen sulfate|CURCUMIN SULFATE	-	CHEMSPIDER	34988878	C21H20O9S	small molecule	-	339286-19-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational); antiviral activity against SARS-CoV-2 in Vero E6 cells	NEJVQQBBTRFOHB-FCXRPNKRSA-N
33438	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Passariello M (2022)	35628365	244860	10328	SOTROVIMAB	-	-	PUBCHEM	472422617	-	monoclonal antibody	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (experimental)	-
33439	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Passariello M (2022)	35628365	244860	10171	mulberrofuran G	albanol A|Mulberrofuran G|3aH-Benzo[c][1]benzopyrano[4,3,2-ij][2]benzopyran-4,11-diol, 8a-(2,4-dihydroxyphenyl)-1,8a,13b,13c-tetrahydro-6-(6-hydroxy-2-benzofuranyl)-2-methyl-, (3aR,8aS,13bR,13cS)-|(3aR,8aS,13bR,13cS)-8a-(2,4-Dihydroxyphenyl)-6-(6-hydroxy-1-benzofuran-2-yl)-2-methyl-1,8a,13b,13c-tetrahydro-3aH-benzo[3,4]isochromeno[1,8-bc]chromene-4,11-diol	-	CHEMSPIDER	8135141	C34H26O8	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, S and ACE2 binding (experimental); antiviral activity against SARS-CoV-2 betaCoV/Korea/KCDC03/2020	MJJWBJFYYRAYKU-OPKNDJPNSA-N
33440	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Turlington M (2013)	24080461	243989	10251	ML300	N-{4-[(1H-Benzotriazol-1-ylacetyl)(3-thienylmethyl)amino]phenyl}cyclopropanecarboxamide|1H-1,2,3-Benzotriazole-1-acetamide, N-[4-[(cyclopropylcarbonyl)amino]phenyl]-N-(3-thienylmethyl)-	-	CHEMSPIDER	30840805	C23H21N5O2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	OCKMJWOFMCSMEX-UHFFFAOYSA-N
33441	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Han SH (2022)	34347470	246239	10251	ML300	N-{4-[(1H-Benzotriazol-1-ylacetyl)(3-thienylmethyl)amino]phenyl}cyclopropanecarboxamide|1H-1,2,3-Benzotriazole-1-acetamide, N-[4-[(cyclopropylcarbonyl)amino]phenyl]-N-(3-thienylmethyl)-	-	CHEMSPIDER	30840805	C23H21N5O2S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	OCKMJWOFMCSMEX-UHFFFAOYSA-N
33442	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Han SH (2022)	34347470	246239	10350	CCF0058981	2-(benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-[4-(1H-imidazol-5-yl)phenyl]acetamide|2708934-53-4|CS-0200377|N-[4-(1H-IMIDAZOL-4-YL)PHENYL]-2-(1H-BENZO[D][1,2,3]TRIAZOL-1-YL)-N-(3-CHLOROBENZYL)ACETAMIDE|AKOS040758899|CCF0058981|N-(4-(1H-IMIDAZOL-5-YL)PHENYL)-2-(1H-BENZO[D][1,2,3]TRIAZOL-1-YL)-N-(3-CHLOROBENZYL)ACETAMIDE|HY-132306|GTPL11658|CCF981|MS-27971|ML300-BASED SC INHIBITOR 41|COMPOUND 41 [PMID: 34347470]|EX-A5913	-	PUBCHEM	156027237	C24H19ClN6O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells	NQTRFDLUODRJKC-UHFFFAOYSA-N
33444	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Boby ML (2023)	37943932	245995	10316	MAT-POS-e194df51-1	KG9|MAT-POS-E194DF51-1|(4S)-6-CHLORO-2-[(1-CYANOCYCLOPROPYL)METHANESULFONYL]-N-(ISOQUINOLIN-4-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE-4-CARBOXAMIDE	-	PUBCHEM	156906151	C24H21ClN4O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in A549-ACE2-TMPRSS2 cells and HeLa-ACE2 cells; COVID Moonshot	YAYDSAMHSQCKIM-OAQYLSRUSA-N
33445	113192	7345	-	UCHL1	HEL-117|NDGOA|PARK5|PGP 9.5|PGP9.5|PGP95|Uch-L1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bednash JS (2023)	36730646	245710	8337	C30	1H-Indole-2,3-dione, 5-chloro-1-[(2,5-dichlorophenyl)methyl]-, 3-(O-acetyloxime), (3Z)-|(3Z)-3-(Acetoxyimino)-5-chloro-1-(2,5-dichlorobenzyl)-1,3-dihydro-2H-indol-2-one|LDN57444|LDN-57444|LDN 57444|	-	CHEMSPIDER	21395767	C17H11Cl3N2O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human UCHL1 deubiquitinase (DUB) inhibitor; ACE2 protein is stabilized by UCHL1 DUB activity that is antagonized by LDN-57444; antiviral activity against SARS-CoV-2 in Calu-3 cells	OPQRFPHLZZPCCH-PGMHBOJBSA-N
33446	4383848	43740568	GU280_gp02	S	spike|SARS-CoV2 S|SARS-CoV2 spike|S protein|surface|SARS-CoV-2 spike|SARS-CoV-2 S|SPIKE_SARS2|PRO_0000449646	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ohashi H (2021)	33817567	245721	10211	Cepharanthine	Cepharanthine|Cepharanthin|Cepharantin|(+)-cepharanthine|O-Methylcepharanoline|6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan|6',12'-Dimethoxy-2,2'-dimethyl-6,7-[methylenebis(oxy)]oxyacanthan|CEP|(14S,27R)-22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene|MFCD00210482|7592YJ0J6T|[14aS-(14aR*,26aS*)]-2,3,13,14,14a,15,26,26a-octahydro-22,30-dimethoxy-1,14-dimethyl- H-4,6:16,19-Dietheno-21,25-metheno-12H-[1,3]dioxolo[4,5-g]pyrido[2',3':17,18][1,10]dioxacycloeicosino[2,3,4-ij]isoquinoline|FK0527000	-	CHEMSPIDER	9791	C37H38N2O6	small molecule	-	481-49-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Spike-ACE2 interaction inhibitor, Spike binding (computational); antiviral activity against SARS-CoV-2 in VeroE6/TMPRSS2 cells and Calu-3 cells	YVPXVXANRNDGTA-WDYNHAJCSA-N
33447	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Ohashi H (2021)	33817567	245721	213	Nelfinavir	Viracept	viracept|viracept -50mg|virace	DRUGBANK	DB00220	C32H45N3O4S	small molecule	J05AE04	159989-64-7	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor, Viral Mpro/3CLpro binding (computational); antiviral activity against SARS-CoV-2 in VeroE6/TMPRSS2 cells and Calu-3 cells	QAGYKUNXZHXKMR-HKWSIXNMSA-N
33448	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Geng ZZ (2023)	37561993	246240	10329	benzyl 3-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]carbamoyl]-2-azaspiro[4.4]nonane-2-carboxylate	MPI60|HY-155813|CS-0887714	-	PUBCHEM	168510422	C24H31N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	OYFTZDRWXGWCFB-NFBCFJMWSA-N
33449	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10330	4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole	SW218141-2|4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-5-(4-PYRIDYL)-1H-IMIDAZOLE;SB-203580|SR-01000597367|J-008891|HMS3267B07|BCP01763|CDMGBJANTYXAIV-UHFFFAOYSA-N|RWJ-64809|US9187470, 104 (SB203580)|4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-5-(4-PYRIDYL)-1H-IMIDAZOLE|PYRIDINE, 4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-YL]- & Z-100|4-[5-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-3H-IMIDAZOL-4-YL]PYRIDINE|OU13V1EYWQ|SB 203580|AKOS015994568|HMS1792H05|AM81234|4-{4-(4-FLUOROPHENYL)-2-[4-(METHANESULFINYL)PHENYL]-1H-IMIDAZOL-5-YL}PYRIDINE|PB-203580|UNII-OU13V1EYWQ|HMS3403H05|RAC-4-(5-(4-FLUOROPHENYL)-2-(4-((R)- METHANESULFINYL)PHENYL)-1H-IMIDAZOL-4-YL)PYRIDINE|NCGC00025035-04|PB203580|HMS3676M17|CCG-206878|BIO1_000745|4-{4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-5-YL}PYRIDINE|HB1302|NCGC00025035-05|4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFONYL)PHENYL]-1H-IMIDAZOL-4-YL]PYRIDINE|4-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-5-(4-PYRIDYL)-1H-IMIDAZOLE|S1076|F0864|HMS3244I16|BIO1_000256|NCGC00025035-02|A15256|NCGC00025035-01|J-513573|RWJ 64809|K00038|PYRIDINE, 4-(4-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-5-YL)-|ES-0013|NSC-755772|PYRIDINE, 4-[4-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-5-YL]-|TOCRIS-1402|4-(5-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-4-YL)PYRIDINE|4-[4-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-1H-IMIDAZOL-5-YL]PYRIDINE|PYRIDINE, 4-(5-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-4-YL)-|SB203580|4-[4-(4-FLUOROPHENYL)-2-(4-METHANESULFINYLPHENYL)-1H-IMIDAZOL-5-YL]PYRIDINE|BIRB-203580|4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-4-YL]PYRIDINE|HMS3295M11|NSC755772|BRD-A37704979-003-01-2|SB 203580, SOLID, >=98% (HPLC)|SB 203580 & Z-100|SR-01000597367-1|CBIOL_001970|ADEZMAPIMOD|NCGC00381704-12|PYRIDINE, 4-[5-(4-FLUOROPHENYL)-2-[4-(METHYLSULFINYL)PHENYL]-1H-IMIDAZOL-YL]-|KINOME_2521|4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE|ADEZMAPIMOD [INN]|SMR004701767|1PME|TOCRIS-1202|SB16633|MLS006010840|HMS3244I15|4-(4-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)-PHENYL)-1H-IMIDAZOL-5-YL)PYRIDINE|AC-32046|BIO1_001234|4-(4-FLUOROPHENYL)-2-(4-METHYLSULFINYLPHENYL)-5-(4-PYRIDYL)1H-IMIDAZOLE|EX-A134|GTPL5269|NCGC00025035-03|SB-203580|DTXSID2040577|CS-0140|152121-47-6|PB 203580|FT-0674525|BIRB203580|4-(4-(4-FLUOROPHENYL)-2-(4-(METHYLSULFINYL)PHENYL)-1H-IMIDAZOL-5-YL)PYRIDINE|HMS3412M17|CID_176155|F17411|HMS3654M15|SB 203580 - CAS 152121-47-6|SB203580,RWJ 64809,PB 203580|BRD-A37704979-001-02-4|Q7389023|C21H16FN3OS|BCPP000074|RWJ64809|HMS3244J15|MFCD00922198|HMS1990H05|HY-10256|AKOS005145971|HMS3229O04|BSPBIO_001104	-	PUBCHEM	176155	C21H16FN3OS	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human p38 inhibitor;  antiviral activity against SARS-CoV-2 in ACE2-A549 cells	CDMGBJANTYXAIV-UHFFFAOYSA-N
33450	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10331	Silmitasertib	GTPL8126|J-516169|EX-8673|HMS3244N13|NSC-761193|AS-16253|EN300-6482034|5-[(3-CHLOROPHENYL)AMINO]PYRIDO[4,3-C]QUINOLINE-8-CARBOXYLIC ACID|SB17201|Q27076934|5-((3-CHLOROPHENYL)AMINO)BENZO-[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945|HMS3746E13|CX-4945 (SILMITASERTIB)|CCG-264955|BCP02399|HMS3244M14|SILMITASERTIB [INN]|HMS3244M13|1009820-21-6|CX-4945,CAS:1009820-21-6|5-(3-CHLOROPHENYLAMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)-BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|C19H12CLN3O2|5-[(3-CHLOROPHENYL)AMINO]-BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945 FREE ACID|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|DB15408|SILMITASERTIBUM|5-[(3-CHLOROPHENYL)AMINO]BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|FT-0723994|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CS-0563|NCGC00263192-02|NCGC00263192-09|AC-28426|W-204393|HY-50855|SILMITASERTIB|J-000296|5-((3-CHLOROPHENYL)AMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|BCP9000560|SILMITASERTIB; CX 4945|NSC-800885|CX-4945 (SILMITASERIB)|A25034|MFCD13184796|CX 4945 (SILMITASERTIB)|BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)-|SY069677|DTXCID9066093|AKOS005266722|CX4945 (SILMITASERTIB)|C6RWP0N0L2|SW218157-2|SILMITASERTIB (CX-4945)|HMS3655F16|BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-[(3-CHLOROPHENYL)AMINO]-|EX-A070|S2248|5-(3-CHLOROANILINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX4945|CX 4945|UNII-C6RWP0N0L2|DTXSID40143602|SILMITASERTIB [WHO-DD]|5-(3-CHLOROPHENYLAMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|NSC761193|3NG|NSC800885|NCGC00263192-01	-	PUBCHEM	24748573	C19H12ClN3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CSNK2A1 and CSNK2A2 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	MUOKSQABCJCOPU-UHFFFAOYSA-N
33451	107842	1459	-	CSNK2A2	CK2A2|CSNK2A1	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10331	Silmitasertib	GTPL8126|J-516169|EX-8673|HMS3244N13|NSC-761193|AS-16253|EN300-6482034|5-[(3-CHLOROPHENYL)AMINO]PYRIDO[4,3-C]QUINOLINE-8-CARBOXYLIC ACID|SB17201|Q27076934|5-((3-CHLOROPHENYL)AMINO)BENZO-[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945|HMS3746E13|CX-4945 (SILMITASERTIB)|CCG-264955|BCP02399|HMS3244M14|SILMITASERTIB [INN]|HMS3244M13|1009820-21-6|CX-4945,CAS:1009820-21-6|5-(3-CHLOROPHENYLAMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)-BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|C19H12CLN3O2|5-[(3-CHLOROPHENYL)AMINO]-BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945 FREE ACID|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|DB15408|SILMITASERTIBUM|5-[(3-CHLOROPHENYL)AMINO]BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|FT-0723994|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CS-0563|NCGC00263192-02|NCGC00263192-09|AC-28426|W-204393|HY-50855|SILMITASERTIB|J-000296|5-((3-CHLOROPHENYL)AMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|BCP9000560|SILMITASERTIB; CX 4945|NSC-800885|CX-4945 (SILMITASERIB)|A25034|MFCD13184796|CX 4945 (SILMITASERTIB)|BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)-|SY069677|DTXCID9066093|AKOS005266722|CX4945 (SILMITASERTIB)|C6RWP0N0L2|SW218157-2|SILMITASERTIB (CX-4945)|HMS3655F16|BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-[(3-CHLOROPHENYL)AMINO]-|EX-A070|S2248|5-(3-CHLOROANILINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX4945|CX 4945|UNII-C6RWP0N0L2|DTXSID40143602|SILMITASERTIB [WHO-DD]|5-(3-CHLOROPHENYLAMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|NSC761193|3NG|NSC800885|NCGC00263192-01	-	PUBCHEM	24748573	C19H12ClN3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CSNK2A1 and CSNK2A2 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	MUOKSQABCJCOPU-UHFFFAOYSA-N
33452	107036	558	-	AXL	ARK|JTK11|Tyro7|UFO	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10332	Gilteritinib	6-ETHYL-3-(3-METHOXY-4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)ANILINO)-5-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PYRAZINE-2-CARBOXAMIDE|MFCD28144685|NSC-787854|AKOS030234455|2-PYRAZINECARBOXAMIDE, 6-ETHYL-3-((3-METHOXY-4-(4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)PHENYL)AMINO)-5-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-|NSC787854|6-ETHYL-3-((3-METHOXY-4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)PHENYL)AMINO)-5-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)PYRAZINE-2-CARBOXAMIDE|EX-A2775|GILTERITINIB HCL|CS-3885|GILTERITINIB [USAN]|2-PYRAZINECARBOXAMIDE, 6-ETHYL-3-[[3-METHOXY-4-[4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL]PHENYL]AMINO]-5-[(TETRAHYDRO-2H-PYRAN-4-YL)AMINO]-|6-ETHYL-3-{3-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]ANILINO}-5-[(OXAN-4-YL)AMINO]PYRAZINE-2-CARBOXAMIDE|DB12141|US8969336, 577|GILTERITINIB (ASP-2215)|GILTERITINIB [WHO-DD]|6-ETHYL-3-((3-METHOXY-4-(4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)PHENYL)AMINO)-5-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-2-PYRAZINECARBOXAMIDE|GILTERITINIB (USAN/INN)|DTXSID701027949|66D92MGC8M|GILTERITINIB [USAN:INN]|ASP-2215|NSC-788454|C6F|NCGC00481652-02|L01XE54|D10709|NSC800106|6-ETHYL-3-({3-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]PHENYL}AMINO)-5-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PYRAZINE-2-CARBOXAMIDE|GTPL8708|CCG-270016|AS-35199|NSC788454|1254053-43-4|A901674|Q27077802|XOSPATA|ASP2215|GILTERITINIBUM|6-ETHYL-3-((3-METHOXY-4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)PHENYL)-AMINO)-5-((TETRAHYDRO-2H-PYRAN-4-YL)AMINO)PYRAZINE-2-CARBOXAMIDE|GILTERITINIB (ASP2215)|GILTERITINIB(ASP2215)|NSC-800106|GILTERITINIB [INN]|6-ETHYL-3-{3-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]ANILINO}-5-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PYRAZINE-2-CARBOXAMIDE|BCP28756|UNII-66D92MGC8M|NCGC00481652-01|AC-29030|SB16988|NSC-787846|SY099594|NSC787846|HY-12432|US8969336, 547|6-ETHYL-3-(3-METHOXY-4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)ANILINO)-5-((OXAN-4-YL)AMINO)PYRAZINE-2-CARBOXAMIDE|BG166434|ASP 2215|6-ETHYL-3-[[3-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]PHENYL]AMINO]-5-(OXAN-4-YLAMINO)PYRAZINE-2-CARBOXAMIDE|S7754|GILTERITINIB [MI]|6-ETHYL-3-[[3-METHOXY-4-[4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDYL]PHENYL]AMINO]-5-[(TETRAHYDROPYRAN-4-YL)AMINO]PYRAZINE-2-CARBOXAMIDE|GILTERITINIB|6-ETHYL-3-[3-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]ANILINO]-5-(OXAN-4-YLAMINO)PYRAZINE-2-CARBOXAMIDE	-	PUBCHEM	49803313	C29H44N8O3	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human AXL inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	GYQYAJJFPNQOOW-UHFFFAOYSA-N
33453	111586	5600	-	MAPK11	P38B|P38BETA2|PRKM11|SAPK2|SAPK2B|p38-2|p38Beta	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10333	Ralimetinib	5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL)-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO(4,5-B)PYRIDIN-2-YLAMINE|UNII-73I34XW4HD|SB16635|NCGC00346537-01|XPPBBJCBDOEXDN-UHFFFAOYSA-N|NSC-766820|LSN-2322600 FREE BASE|BCPP000180|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|RALIMETINIB [USAN]|Q27088512|862505-00-8|RALIMETINIB [INN]|LY 2228820|RALIMETINIB [USAN:INN]|LY2228820 FREE BASE|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|862505-00-8 (FREE BASE)|RALIMETINIB [WHO-DD]|NCGC00346537-05|LY22288220|DB11787|AKOS027282678|HMS3674E21|3H-IMIDAZO(4,5-B)PYRIDIN-2-AMINE, 5-(2-(1,1-DIMETHYLETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-|GTPL7959|3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE,5-[2-(1,1-DIMETHYLETHYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)-|CS-0008496|D10658|RALIMETINIB (USAN/INN)|(5P)-5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|DTXSID00235456|HY-13241A|BCP02033|LY-2228820|73I34XW4HD|RALIMETINIB ( LY2228820)|NSC766820|NCGC00346537-03|E98891|RALIMETINIB|YXT|5-(2-(TERT-BUTYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|LSN2322600 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-YLAMINE|LY-2228820 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUOROPHENYL)-3H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[5,4-B]PYRIDIN-2-AMINE|NSC785335|NSC-785335|BCP9000871|FT-0727743	-	PUBCHEM	11539025	C24H29FN6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK11/MAPK14 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	XPPBBJCBDOEXDN-UHFFFAOYSA-N
33454	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10333	Ralimetinib	5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL)-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO(4,5-B)PYRIDIN-2-YLAMINE|UNII-73I34XW4HD|SB16635|NCGC00346537-01|XPPBBJCBDOEXDN-UHFFFAOYSA-N|NSC-766820|LSN-2322600 FREE BASE|BCPP000180|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|RALIMETINIB [USAN]|Q27088512|862505-00-8|RALIMETINIB [INN]|LY 2228820|RALIMETINIB [USAN:INN]|LY2228820 FREE BASE|5-(2-(TERT-BUTYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|862505-00-8 (FREE BASE)|RALIMETINIB [WHO-DD]|NCGC00346537-05|LY22288220|DB11787|AKOS027282678|HMS3674E21|3H-IMIDAZO(4,5-B)PYRIDIN-2-AMINE, 5-(2-(1,1-DIMETHYLETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-(2,2-DIMETHYLPROPYL)-|GTPL7959|3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE,5-[2-(1,1-DIMETHYLETHYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)-|CS-0008496|D10658|RALIMETINIB (USAN/INN)|(5P)-5-[2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL]-3-(2,2-DIMETHYLPROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|5-(2-TERT-BUTYL-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|DTXSID00235456|HY-13241A|BCP02033|LY-2228820|73I34XW4HD|RALIMETINIB ( LY2228820)|NSC766820|NCGC00346537-03|E98891|RALIMETINIB|YXT|5-(2-(TERT-BUTYL)-5-(4-FLUOROPHENYL)-1H-IMIDAZOL-4-YL)-3-NEOPENTYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-AMINE|LSN2322600 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUORO-PHENYL)-1H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYL-PROPYL)-3H-IMIDAZO[4,5-B]PYRIDIN-2-YLAMINE|LY-2228820 FREE BASE|5-[2-TERT-BUTYL-5-(4-FLUOROPHENYL)-3H-IMIDAZOL-4-YL]-3-(2,2-DIMETHYLPROPYL)IMIDAZO[5,4-B]PYRIDIN-2-AMINE|NSC785335|NSC-785335|BCP9000871|FT-0727743	-	PUBCHEM	11539025	C24H29FN6	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK11/MAPK14 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	XPPBBJCBDOEXDN-UHFFFAOYSA-N
33455	111589	5603	RP1-179N16.4	MAPK13	MAPK 13|MAPK-13|PRKM13|SAPK4|p38delta	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10334	1-(3-Tert-Butyl-1-Methyl-1h-Pyrazol-5-Yl)-3-[4-(Pyridin-4-Yloxy)phenyl]urea	229002-10-2|Z1084765976|AKOS040733667|COMPOUND 61 [WO2014015056A2]|MAPK13 INHIBITOR COMPOUND 61|N-(3-TERT-BUTYL-1-METHYL-5-PYRAZOLYL)-N'-(4-(4-PYRIDINYLOXY)PHENYL)UREA|4EYJ|GTPL11096|MS-25838|1-(5-TERT-BUTYL-2-METHYLPYRAZOL-3-YL)-3-(4-PYRIDIN-4-YLOXYPHENYL)UREA|MHSLDASSAFCCDO-UHFFFAOYSA-N|1-(3-TERT-BUTYL-1-METHYL-1H-PYRAZOL-5-YL)-3-(4-(PYRIDIN-4-YLOXY)PHENYL)UREA|Q27463685|CS-0014526|N61|1-(3-TERT-BUTYL-1-METHYL-1H-PYRAZOL-5-YL)-3-[4-(PYRIDIN-4-YLOXY)PHENYL]UREA|HY-18850|MAPK13-IN-1	-	PUBCHEM	17941505	C20H23N5O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK13 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	MHSLDASSAFCCDO-UHFFFAOYSA-N
33456	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10335	p38alpha Inhibitor 1	5-(2,4-DIFLUOROPHENOXY)-N-(2-(DIMETHYLAMINO)ETHYL)-1-ISOBUTYL-1H-INDAZOLE-6-CARBOXAMIDE|ARRY-797|1034189-82-6|CS-0085271|P38?? INHIBITOR 1|EX-A3148|ARRY-371797|ARRY371797|1036404-17-7|COMPOUND 7 [PMID: 19950901]|ARRY797|P38A INHIBITOR 1|P38 ALPHA INHIBITOR 1|P38-ALPHA- INHIBITOR 1|-(2,4-DIFLUOROPHENOXY)-N-[2-(DIMETHYLAMINO)ETHYL]-1-(2-METHYLPROPYL)INDAZOLE-6-CARBOXAMIDE|P38ALPHA INHIBITOR 1|HY-114423|AKOS040733949|ARRY-797; ARRY-371797|P38|A INHIBITOR 1|MS-27245|5-(2,4-DIFLUOROPHENOXY)-N-[2-(DIMETHYLAMINO)ETHYL]-1-(2-METHYLPROPYL)INDAZOLE-6-CARBOXAMIDE|GTPL11095	-	PUBCHEM	46883775	C22H26F2N4O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human MAPK14 inhibitor;  antiviral activity against SARS-CoV-2 in ACE2-A549 cells	IFGWYHGYNVGVRB-UHFFFAOYSA-N
33457	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10176	dinaciclib	Dinaciclib|SCH 727965|SCH727965|2-[(2S)-1-(3-Ethyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol|4V8ECV0NBQ|2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-, (2S)-	-	CHEMSPIDER	25027387	C21H28N6O2	small molecule	-	779353-01-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CDK2/5/9 inhibitor;  antiviral activity against SARS-CoV-2 in VERO-E6 and ACE2-A549 cells	PIMQWRZWLQKKBJ-SFHVURJKSA-N
33458	107455	1020	-	CDK5	PSSALRE	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10176	dinaciclib	Dinaciclib|SCH 727965|SCH727965|2-[(2S)-1-(3-Ethyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol|4V8ECV0NBQ|2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-, (2S)-	-	CHEMSPIDER	25027387	C21H28N6O2	small molecule	-	779353-01-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CDK2/5/9 inhibitor;  antiviral activity against SARS-CoV-2 in VERO-E6 and ACE2-A549 cells	PIMQWRZWLQKKBJ-SFHVURJKSA-N
33459	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10176	dinaciclib	Dinaciclib|SCH 727965|SCH727965|2-[(2S)-1-(3-Ethyl-7-{[(1-oxido-3-pyridinyl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)-2-piperidinyl]ethanol|4V8ECV0NBQ|2-Piperidineethanol, 1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-, (2S)-	-	CHEMSPIDER	25027387	C21H28N6O2	small molecule	-	779353-01-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CDK2/5/9 inhibitor;  antiviral activity against SARS-CoV-2 in VERO-E6 and ACE2-A549 cells	PIMQWRZWLQKKBJ-SFHVURJKSA-N
33460	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Sanders BC (2023)	36977673	241489	10336	PLpro inhibitor 7	METHYL (R,E)-4-(2-(3-(2-((1-(NAPHTHALEN-1-YL)ETHYL)CARBAMOYL)PHENYL)PROPANOYL)HYDRAZINEYL)-4-OXOBUT-2-ENOATE|METHYL (E)-4-[2-[3-[2-[[(1R)-1-NAPHTHALEN-1-YLETHYL]CARBAMOYL]PHENYL]PROPANOYL]HYDRAZINYL]-4-OXOBUT-2-ENOATE|PLPRO INHIBITOR 7|PLPRO-IN-7|GTPL12596|PLPRO INHIBITOR 7 [PMID: 36977673]|GLXC-25760	-	PUBCHEM	164946795	C27H27N3O5	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral PLpro papain-like protease	QEHLIVYTSIQCOG-IECKCJDVSA-N
33461	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Otava T (2021)	34152728	246035	10279	TO507	(2S)-2-Amino-4-[({(2S,3S,4R,5R)-5-[4-amino-5-(3-quinolinylethynyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-dihydroxytetrahydro-2-furanyl}methyl)sulfanyl]butanoic acid (non-preferred name)	-	CHEMSPIDER	123962500	C26H26N6O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral nsp14 methyltransferase Inhibitor	SPMFBZXXQBXKFX-LUOSIZPJSA-N
33462	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Nigam A (2023)	888800001013	245490	10198	NSC620333	9H-Purin-6-amine, 9-[5-S-[(4-chlorophenyl)methyl]-5-thiopentofuranosyl]-|9-[5-S-(4-Chlorobenzyl)-5-thiopentofuranosyl]-9H-purin-6-amine	-	CHEMSPIDER	319110	C17H18ClN5O3S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral nsp14 methyltransferase Inhibitor	IJLUIMSYWGUZCP-UHFFFAOYSA-N
33463	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Grabinski W (2023)	888800001014	245491	10187	Meisoindigo	(3E)-1-Methyl-3-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)-1,3-dihydro-2H-indol-2-one|2H-Indol-2-one, 3-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-1,3-dihydro-1-methyl-, (3E)-|(E)-1-methyl-1H,1'H,2H,2'H-[3,3'-biindolylidene]-2,2'-dione|Methylisoindigotin|Meisoindigo	-	CHEMSPIDER	4586320	C17H12N2O2	small molecule	-	97207-47-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	QNOCRUSVMMAKSC-CCEZHUSRSA-N
33464	113348	7514	-	XPO1	CRM1|emb|exp1	9606	Homo sapiens	inhibitor/sars-cov-2 activator	target	Rahman MM (2023)	888800000921	241443	10337	Selinexor	MFCD27987944|SELINEXOR [USAN]|SELINEXOR [MI]|D11222|KPT-330|1393477-72-9|A857179|N-HYDROXY-N'-(2-PHENYLETHYL)ISOPHTHALAMIDE|SELINEXOR [INN]|J-690156|SELINEXOR FREE BASE|(2Z)-3-{3-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-1H-1,2,4-TRIAZOL-1-YL}-N'-(PYRAZIN-2-YL)PROP-2-ENEHYDRAZIDE|SELINEXORUM|CRM1 NUCLEAR EXPORT INHIBITOR KPT-330|COMPOUND 70 (WO2013019561A1)|L01XX66|GTPL10036|EX-A870|NCGC00386310-01|(Z)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE|SELINEXOR [WHO-DD]|2-PROPENOIC ACID, 3-[3-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-1H-1,2,4-TRIAZOL-1-YL]-, 2-(2-PYRAZINYL)HYDRAZIDE, (2Z)-|CCG-269161|XPOVIO|NSC-780203|(Z)-3-[3-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-1,2,4-TRIAZOL-1-YL]-N'-PYRAZIN-2-YLPROP-2-ENEHYDRAZIDE|NCGC00386310-03|COMPOUND 70 [WO2013019561A1]|31TZ62FO8F|NSC780203|NSC-781780|SELINEXOR [USAN:INN]|SELINEXOR;(Z)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE|KPT330;SELINEXOR|SELINEXOR (USAN/INN)|1621865-82-4|KPT-330(SELINEXOR)|HY-17536|SELECTIVE INHIBITOR OF NUCLEAR EXPORT KPT-330|AC-33645|XPOVIO (TN)|ATG-010|SELINEXOR (KPT-330)|DTXSID801026013|EN300-7360494|S7252|Q27256082|DB11942|UNII-31TZ62FO8F|KPT330|KPT 330|SINE KPT-330|2-PROPENOIC ACID, 3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-, 2-(2-PYRAZINYL)HYDRAZIDE, (2Z)-|SELINEXOR [ORANGE BOOK]|NSC781780|NEXPOVIO|AKOS027325566|(2Z)-2-(2-PYRAZINYL)HYDRAZIDE-3-[3-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-1H-1,2,4-TRIAZOL-1-YL]-2-PROPENOIC ACID|SELINEXOR|SW219336-1|BS-15022	-	PUBCHEM	71481097	C17H11F6N7O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human XPO1 inhibitor;  the authors show that Selinexor treatment unexpectedly enhances the in vitro replication of coronaviruses, including SARS-CoV-2 A549ACE2 cells	DEVSOMFAQLZNKR-RJRFIUFISA-N
33465	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	sars-cov-2 inhibitor	target	Kelch MA (2023)	37342561	241452	10338	Foscenvivint	2H-PYRAZINO(2,1-C)(1,2,4)TRIAZINE-1(6H)-CARBOXAMIDE, HEXAHYDRO-2,9-DIMETHYL-4,7-DIOXO-N-(PHENYLMETHYL)-6-((4-(PHOSPHONOOXY)PHENYL)METHYL)-8-(8-QUINOLINYLMETHYL)-, (6S,9S,9AS)-|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7- DIOXO-8-((QUINOLIN-8-YL)METHYL)OCTAHYDRO-2HPYRAZINO(2,1-C)(1,2,4)TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|1198780-38-9|43Y934BBZ6|UNII-43Y934BBZ6|PRI724|(S,S)-ICG-001|1422253-38-0 (PRI-724)|HY-112045|FOSCENVIVINT|EX-A3641|[4-[[(6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)-3,6,9,9A-TETRAHYDROPYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL]METHYL]PHENYL] DIHYDROGEN PHOSPHATE|DB15034|1422253-38-0|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)OCTAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|AC-31548||A-CATENIN/CBP-IN-1|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)OCTAHYDRO-1H-PYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|PRI-724|FOSCENVIVINT [INN]|CS-0042484|(6S,9S,9AS)-HEXAHYDRO-2,9-DIMETHYL-4,7-DIOXO-N-(PHENYLMETHYL)-6-[[4-(PHOSPHONOOXY)PHENYL]METHYL]-8-(8-QUINOLINYLMETHYL)-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE	-	PUBCHEM	71509318	C33H35N6O7P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: small-molecule inhibitor of the Beta-catenin/CBP interaction; shows anti-viral acitivity against multiple coronaviruses including SARS-CoV-2 variants (Ancestral variants: B (FFM5), B.1 (FFM7, D614G); variants of interest (VOI): P.2 (Zeta), B.1.429 (Epsilon), B.1.617.1 (Kappa); deescalated variants of concern (VOC): B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta); VOC: B.1.1.529 BA.1, BA.2, and BA.5 (Omicron), SARS-CoV-1, and Influenza A virus in A549-AT cells	VHOZWHQPEJGPCC-AZXNYEMZSA-N
33466	110899	4836	-	NMT1	NMT	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Saber SH (2023)	888800000916	241438	10339	1-[5-[3,4-Difluoro-2-[2-(1,3,5-trimethylpyrazol-4-yl)ethoxy]phenyl]-1-methylindazol-3-yl]-N,N-dimethylmethanamine	1-[5-[3,4-BIS(FLUORANYL)-2-[2-(1,3,5-TRIMETHYLPYRAZOL-4-YL)ETHOXY]PHENYL]-1-METHYL-INDAZOL-3-YL]-~{N},~{N}-DIMETHYL-METHANAMINE|5-[3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY]PHENYL]-N,N,1-TRIMETHYL-1H-INDAZOLE-3-METHANAMINE|1-[5-[3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYLPYRAZOL-4-YL)ETHOXY]PHENYL]-1-METHYLINDAZOL-3-YL]-N,N-DIMETHYLMETHANAMINE|IMP-1088|HY-112258|AKOS040759783|2059148-82-0|1-(5-(3,4-DIFLUORO-2-(2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY)PHENYL)-1-METHYL-1H-INDAZOL-3-YL)-N,N-DIMETHYLMETHANAMINE|CS-0044399|ZT62NQ6YEV|AC-36920|1H-INDAZOLE-3-METHANAMINE, 5-[3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY]PHENYL]-N,N,1-TRIMETHYL-|EX-A2075|Q53818335|MS-28249|IMP-1008|IMP1088|5-(3,4-DIFLUORO-2-(2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY)PHENYL)-N,N,1-TRIMETHYL-1H-INDAZOLE-3-METHANAMINE|1-(5-{3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY]PHENYL}-1-METHYL-1H-INDAZOL-3-YL)-N,N-DIMETHYLMETHANAMINE|DTXSID301336328	-	PUBCHEM	132274735	C25H29F2N5O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human NMT1/NMT2 inhibitor; shows antiviral acitivity against SARS-COV-2 Omicron and Delta variants	SOXNKJCQBRQUMS-UHFFFAOYSA-N
33467	114794	9397	RP11-455B2.2	NMT2	-	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Saber SH (2023)	888800000916	241438	10339	1-[5-[3,4-Difluoro-2-[2-(1,3,5-trimethylpyrazol-4-yl)ethoxy]phenyl]-1-methylindazol-3-yl]-N,N-dimethylmethanamine	1-[5-[3,4-BIS(FLUORANYL)-2-[2-(1,3,5-TRIMETHYLPYRAZOL-4-YL)ETHOXY]PHENYL]-1-METHYL-INDAZOL-3-YL]-~{N},~{N}-DIMETHYL-METHANAMINE|5-[3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY]PHENYL]-N,N,1-TRIMETHYL-1H-INDAZOLE-3-METHANAMINE|1-[5-[3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYLPYRAZOL-4-YL)ETHOXY]PHENYL]-1-METHYLINDAZOL-3-YL]-N,N-DIMETHYLMETHANAMINE|IMP-1088|HY-112258|AKOS040759783|2059148-82-0|1-(5-(3,4-DIFLUORO-2-(2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY)PHENYL)-1-METHYL-1H-INDAZOL-3-YL)-N,N-DIMETHYLMETHANAMINE|CS-0044399|ZT62NQ6YEV|AC-36920|1H-INDAZOLE-3-METHANAMINE, 5-[3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY]PHENYL]-N,N,1-TRIMETHYL-|EX-A2075|Q53818335|MS-28249|IMP-1008|IMP1088|5-(3,4-DIFLUORO-2-(2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY)PHENYL)-N,N,1-TRIMETHYL-1H-INDAZOLE-3-METHANAMINE|1-(5-{3,4-DIFLUORO-2-[2-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ETHOXY]PHENYL}-1-METHYL-1H-INDAZOL-3-YL)-N,N-DIMETHYLMETHANAMINE|DTXSID301336328	-	PUBCHEM	132274735	C25H29F2N5O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human NMT1/NMT2 inhibitor; shows antiviral acitivity against SARS-COV-2 Omicron and Delta variants	SOXNKJCQBRQUMS-UHFFFAOYSA-N
33468	4383856	43740578	GU280_gp01_nsp7	nsp7	ORF1ab|ORF1ab-nsp7|SARS-CoV2 nsp7|SARS-CoV-2 nsp7|R1AB_SARS2|PRO_0000449625	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Rani R (2023)	888800000987	244287	10211	Cepharanthine	Cepharanthine|Cepharanthin|Cepharantin|(+)-cepharanthine|O-Methylcepharanoline|6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan|6',12'-Dimethoxy-2,2'-dimethyl-6,7-[methylenebis(oxy)]oxyacanthan|CEP|(14S,27R)-22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene|MFCD00210482|7592YJ0J6T|[14aS-(14aR*,26aS*)]-2,3,13,14,14a,15,26,26a-octahydro-22,30-dimethoxy-1,14-dimethyl- H-4,6:16,19-Dietheno-21,25-metheno-12H-[1,3]dioxolo[4,5-g]pyrido[2',3':17,18][1,10]dioxacycloeicosino[2,3,4-ij]isoquinoline|FK0527000	-	CHEMSPIDER	9791	C37H38N2O6	small molecule	-	481-49-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral RNA-dependent RNA polymerase (RdRp) nsp12-nsp7-nsp8 complex inhibitor, nsp7-nsp8 binding; antiviral activity against SARS-CoV-2 in VeroE6 cells	YVPXVXANRNDGTA-WDYNHAJCSA-N
33469	4383856	43740578	GU280_gp01_nsp7	nsp7	ORF1ab|ORF1ab-nsp7|SARS-CoV2 nsp7|SARS-CoV-2 nsp7|R1AB_SARS2|PRO_0000449625	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Rani R (2023)	888800000987	244287	10264	Fangchinoline	Limacine|(1beta)-6,6',12-Trimethoxy-2,2'-dimethylberbaman-7-ol|7-O-Demethyltetrandine|DR9280000|Frangchinoline|MFCD03427706|(+)-Limacine|Fangchinoline	-	CHEMSPIDER	66173	C37H40N2O6	small molecule	-	436-77-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral RNA-dependent RNA polymerase (RdRp) nsp12-nsp7-nsp8 complex inhibitor, nsp7-nsp8 binding; antiviral activity against SARS-CoV-2 in VeroE6 cells	IIQSJHUEZBTSAT-VMPREFPWSA-N
33470	4383856	43740578	GU280_gp01_nsp7	nsp7	ORF1ab|ORF1ab-nsp7|SARS-CoV2 nsp7|SARS-CoV-2 nsp7|R1AB_SARS2|PRO_0000449625	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Rani R (2023)	888800000987	244287	10276	Sennoside B	Sennoside B|(9R,9'S)-5,5'-Bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid|[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-|(9R,9'S)-4,4'-Dihydroxy-10,10'-dioxo-5,5'-bis{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid|[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(?-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-	-	CHEMSPIDER	82569	C42H38O20	small molecule	-	128-57-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral RNA-dependent RNA polymerase (RdRp) nsp12-nsp7-nsp8 complex inhibitor, nsp7-nsp8 binding; antiviral activity against SARS-CoV-2 in VeroE6 cells	IPQVTOJGNYVQEO-AIFLABODSA-N
33471	4383857	43740578	GU280_gp01_nsp8	nsp8	ORF1ab|ORF1ab-nsp8|SARS-CoV2 nsp8|SARS-CoV-2 nsp8|R1AB_SARS2|PRO_0000449626	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Rani R (2023)	888800000987	244287	10211	Cepharanthine	Cepharanthine|Cepharanthin|Cepharantin|(+)-cepharanthine|O-Methylcepharanoline|6',12'-Dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan|6',12'-Dimethoxy-2,2'-dimethyl-6,7-[methylenebis(oxy)]oxyacanthan|CEP|(14S,27R)-22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene|MFCD00210482|7592YJ0J6T|[14aS-(14aR*,26aS*)]-2,3,13,14,14a,15,26,26a-octahydro-22,30-dimethoxy-1,14-dimethyl- H-4,6:16,19-Dietheno-21,25-metheno-12H-[1,3]dioxolo[4,5-g]pyrido[2',3':17,18][1,10]dioxacycloeicosino[2,3,4-ij]isoquinoline|FK0527000	-	CHEMSPIDER	9791	C37H38N2O6	small molecule	-	481-49-2	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral RNA-dependent RNA polymerase (RdRp) nsp12-nsp7-nsp8 complex inhibitor, nsp7-nsp8 binding; antiviral activity against SARS-CoV-2 in VeroE6 cells	YVPXVXANRNDGTA-WDYNHAJCSA-N
33472	4383857	43740578	GU280_gp01_nsp8	nsp8	ORF1ab|ORF1ab-nsp8|SARS-CoV2 nsp8|SARS-CoV-2 nsp8|R1AB_SARS2|PRO_0000449626	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Rani R (2023)	888800000987	244287	10264	Fangchinoline	Limacine|(1beta)-6,6',12-Trimethoxy-2,2'-dimethylberbaman-7-ol|7-O-Demethyltetrandine|DR9280000|Frangchinoline|MFCD03427706|(+)-Limacine|Fangchinoline	-	CHEMSPIDER	66173	C37H40N2O6	small molecule	-	436-77-1	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral RNA-dependent RNA polymerase (RdRp) nsp12-nsp7-nsp8 complex inhibitor, nsp7-nsp8 binding; antiviral activity against SARS-CoV-2 in VeroE6 cells	IIQSJHUEZBTSAT-VMPREFPWSA-N
33473	4383857	43740578	GU280_gp01_nsp8	nsp8	ORF1ab|ORF1ab-nsp8|SARS-CoV2 nsp8|SARS-CoV-2 nsp8|R1AB_SARS2|PRO_0000449626	2697049	Severe acute respiratory syndrome coronavirus 2	sars-cov-2 inhibitor	target	Rani R (2023)	888800000987	244287	10276	Sennoside B	Sennoside B|(9R,9'S)-5,5'-Bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid|[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-|(9R,9'S)-4,4'-Dihydroxy-10,10'-dioxo-5,5'-bis{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylic acid|[9,9'-Bianthracene]-2,2'-dicarboxylic acid, 5,5'-bis(?-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo-, (9R,9'S)-	-	CHEMSPIDER	82569	C42H38O20	small molecule	-	128-57-4	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral RNA-dependent RNA polymerase (RdRp) nsp12-nsp7-nsp8 complex inhibitor, nsp7-nsp8 binding; antiviral activity against SARS-CoV-2 in VeroE6 cells	IPQVTOJGNYVQEO-AIFLABODSA-N
33474	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ramsey JR (2024)	38134034	245509	9979	Calpain Inhibitor XII	Calpain Inhibitor XII|Carbamic acid, N-[1-[[[1-[1,2-dioxo-2-[(2-pyridinylmethyl)amino]ethyl]butyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester|N~2~-[(benzyloxy)carbonyl]-N-{1,2-dioxo-1-[(pyridin-2-ylmethyl)amino]hexan-3-yl}leucinamide|N~2~-[(Benzyloxy)carbonyl]-N-{1,2-dioxo-1-[(2-pyridinylmethyl)amino]-3-hexanyl}leucinamide	-	CHEMSPIDER	21396054	C26H34N4O5	small molecule	-	181769-57-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CTSL inhibitor; Calpain inhibitor XII (CI-XII), MG-101 and CatL inhibitor IV (CLI-IV) possess antiviral activity in the very low nanomolar IC50 range in Vero E6 cells	PLVWMBFPIAQRHK-UHFFFAOYSA-N
33475	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ramsey JR (2024)	38134034	245509	6367	ALLN	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE|Calpain Inhibitor I|110044-82-1|MG-101|Acetylleucyl-Leucyl-Norleucinal|Calpain Inhibitor I	-	DRUGBANK	DB07558	C20H37N3O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CTSL inhibitor; Calpain inhibitor XII (CI-XII), MG-101 and CatL inhibitor IV (CLI-IV) possess antiviral activity in the very low nanomolar IC50 range in Vero E6 cells	FMYKJLXRRQTBOR-BZSNNMDCSA-N
33476	107894	1514	RP11-65B23.1	CTSL	CATL|CTSL1|MEP	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Ramsey JR (2024)	38134034	245509	10340	1-Naphthalenylsulfonyl-Ile-Trp-aldehyde	J-009852|N-(1NAPHTHALENYLSULFONYL)- IW-CHO|(2S,3S)-N-[(2S)-1-(1H-INDOL-3-YL)-3-OXOPROPAN-2-YL]-3-METHYL-2-(NAPHTHALEN-1-YLSULFONYLAMINO)PENTANAMIDE|(3S)-N-((S)-1-(1H-INDOL-3-YL)-3-OXOPROPAN-2-YL)-3-METHYL-2-(NAPHTHALENE-1-SULFONAMIDO)PENTANAMIDE|161709-56-4|1-NAPHTHALENYLSULFONYL-ILE-TRP-ALDEHYDE|CATHEPSIN L INHIBITOR IV|MFCD00932733|N-(1-NAPHTHALENYLSULFONYL)-ILE-TRP-ALDEHYDE	-	PUBCHEM	9957276	C27H29N3O4S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CTSL inhibitor; Calpain inhibitor XII (CI-XII), MG-101 and CatL inhibitor IV (CLI-IV) possess antiviral activity in the very low nanomolar IC50 range in Vero E6 cells	FFPHAWVFZQFOJA-JCWFFFCVSA-N
33477	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Elshaier YAMM (2023)	888800001037	245514	10341	Chlorpheniramine Maleate	UNII-V1Q0O9OJ9Z|RU-TUSS CAPSULES|HY-B0286A|CHLORPHENIRAMINE MALEATE COMPONENT OF ISOCLOR|CHLORPROPHENPYRIDAMINE MALEATE|ZODRYL AC 40|HMS501N18|SINE OFF|CHLORPHENIRAMINE MALEATE 4 MG|CHLOROPROPHENPYRIDAMINE MALEATE|2-(P-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)BENZYL)PYRIDINE MALEATE (1:1)|2-PYRIDINEPROPANAMINE, GAMMA-(4-CHLOROPHENYL)-N,N-DIMETHYL-, (Z)-2-BUTENEDIOATE (1:1)|CHLORPHENIRAMINE MALEATE COMPONENT OF DRIZE|CHLORPHENIRAMINE MALEATE COMPONENT OF ADVIL ALLERGY SINUS|2-PYRIDINEPROPANAMINE, .GAMMA.-(4-CHLOROPHENYL)-N,N-DIMETHYL-, (Z)-2-BUTENEDIOATE (1:1)|113-92-8|CHLORPHENAMINE MALEATE [EP MONOGRAPH]|CHLORPHENIRAMINE MALEATE COMPONENT OF CODIMAL-L.A. 12|ALUNEX|AKOS015951220|SPRINSOL|DTXCID00321|CLORRELIEF KIDS|CLEAR CHOICE ALLERGY RELIEF|ALLERGY RELIEF4 HOUR|SMR000653461|(+/-)-CHLORPHENIRAMINE.MALEATE, 1MG/ML IN METHANOL|CHLOR-TRIMETON 12 HOUR|AS-13167|MEDIQUE CHLORPHEN|PHARMAKON1600-01505530|(A+/-)-CHLORPHENIRAMINE MALEATE|HMS2232B23|ZODRYL AC 25|2-(P-CHLORO-ALPHA-(2-(DIMETHYLAMINO)ETHYL)BENZYL)PYRIDINE MALEATE (1:1)|(Z)-BUT-2-ENEDIOIC ACID;3-(4-CHLOROPHENYL)-N,N-DIMETHYL-3-PYRIDIN-2-YLPROPAN-1-AMINE|CHLORPHENAMINE MALEATES|MALEATE, CHLORPHENIRAMINE|PUERMIN|ANTI ALLERGY|CCRIS 1418|CHLORPHENIRAMINE (MALEATE)|(+/-)-CHLORPHENIRAMINE MALEATE|(Y)-CHLORPHENIRAMINE MALEATE|NC00286|NCGC00260946-01|PHARBECHLOR|TOX21_500261|CHLORPHENIRAMINE MALEATE [VANDF]|W-108612|MFCD00069225|ALLERCLOR|CHLORPHENIRAMINE MALEATE [ORANGE BOOK]|CHLORPHENAMINE MALEATE, EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD|HISTASPAN|NSC 756684|CHLORPHENAMINE MALEATE [WHO-DD]|CVSHEALTH CHILDRENS ALLERGY RELIEF POPS|( INVERTED QUESTION MARK)-CHLORPHENIRAMINE MALEATE|C 3025|EFIDAC 24 CHLORPHENIRAMINE MALEATE|(?)-CHLORPHENIRAMINE MALEATE|LOHIST|CCG-101036|AC-267|HMS1568G16|CHLORTRIMETON|CHLORPHENIRAMINE MALEATE (USP-RS)|PHENALIN|CHLOR-TRIMETON (TN)|CHLORPHENIRAMINE MALEATE, UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD|DL-2(-P-CHLORO-ALPHA-2-(DIMETHYLAMINO)ETHYLBENZYL)PYRIDINE BIMALEATE|CCG-221565|CONTAC COMPONENT CHLORPHENIRAMINE MALEATE|WAL-FINATE|SR-01000075261|CHLORPHENIRAMINE MALEATE COMPONENT OF TRIAMINIC|(+/-)-CHLORPHENIRAMINE MALEATE SALT, >=99% (PERCHLORIC ACID TITRATION)|CHLORPHENIRAMINE MALEATE (USP:JAN)|EU-0100261|CHLOR-TRIPOLON|CHLORPHENAMINE HYDROGEN MALEATE|DBAKFASWICGISY-BTJKTKAUSA-N|HMS3712G16|SR-01000075261-9|1-(P-CHLORPHENYL)-1-(2-PYRIDYL)-3-DIMETHYLAMINOPROPAN MALEAT [GERMAN]|TELDRIN (TN)|SMR000466271|KLOROMIN|C07780|CHLOR-TRIMETON MALEATE|CHLOROPHENIRAMINE MALEATE|POLARONIL [GERMAN]|AMF0009|[3-(4-CHLORO-PHENYL)-3-PYRIDIN-2-YL-PROPYL]-DIMETHYL-AMINE MALEATE|LP00261|SW196372-4|PYRIDAMAL 100|GAMMA-(4-CHLOROPHENYL)-N,N-DIMETHYL-2-PYRIDINEPROPANAMINE(Z)-2-BUTENEDIOATE (1:1)|SILDEC PE|PYRIDAMAL-100|CHLOR-TRIMETON ALLERGY|CHLORPHEN-12|ZODRYL AC 50|CHLORPHENIRAMINE MALEATE SALT|CHLORPHENAMINE MALEATE (EP MONOGRAPH)|PRESTWICK_57|NASOHIST|CHLORPHENAMINE HYDROGEN MALEATE [WHO-IP]|HMS2095G16|CHLORPHENIRAMINE MALEATE COMPONENT OF CONTAC|DL-2-(P-CHLORO-ALPHA-2-(DIMETHYLAMINO)ETHYLBENZYL)PYRIDINE MALEATE|ALLERGY TIME|HMS3260F04|TRIAMINIC COMPONENT CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE (USP MONOGRAPH)|DL-CHLORPHENIRAMINE MALEATE|HISTASPAN-PLUS|ED CHLORPED JR|EFIDAC|LORPHEN|MLS001424173|CHLORPHENAMINI HYDROGENOMALEAS [WHO-IP LATIN]|CHLORMENE|CHLORPHENAMINI HYDROGENOMALEAS|SR-01000075261-1|CLORRELIEF|HISTAPAN|HMS2093N19|CHLOR-TRIMETON|C-METON|CHLORPHENIRAMINE MALEATE [USP-RS]|IBIOTON|CHLOROPHENAMINEMALEATE|HISTALEN|CHLORPHENIRAMINE MALEATE 4MG|GAMMA-(4-CHLOROPHENYL)-N,N-DIMETHYL-2-PYRIDINEPROPANAMINE (Z)-2-BUTENEDIOATE|1-P-CHLOROPHENYL-1-(2-PYRIDYL)-3-DIMETHYLAMINOPROPANE MALEATE|NCGC00093720-01|ANTAGONATE|CHLORPHENIRAMINE MALEATE, PHARMACEUTICAL SECONDARY STANDARD; CERTIFIED REFERENCE MATERIAL|CODIMAL-L.A. 12 COMPONENT CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE OROS TABLETS|HMS2230F21|CHLORPHENIRAMINE MALEATE [MI]|Q27106157|ALLERGIN|ALKA-SELTZER PLUS|F2173-0923|D70131|V1Q0O9OJ9Z|2-PYRIDINEPROPANAMINE, GAMMA-(4-CHLOROPHENYL)-N,N-DIMETHYL-, (2Z)-2-BUTENEDIOATE (1:1)|CHLORPHENIRAMINE MALEATE (JP17/USP)|HISTADUR DURA-TABS|CHLORPHENAMINE MALEATE [MART.]|HMS2051L14|HISTASPAN-D|NCI-C55265|ISOCLOR COMPONENT CHLORPHENIRAMINE MALEATE|CHLOR-TRIMETON INJECTION|NSC-756684|PHENETRON|D00665|3-(4-CHLOROPHENYL)-N,N-DIMETHYL-3-PYRIDIN-2-YLPROPAN-1-AMINIUM (2Z)-3-CARBOXYPROP-2-ENOATE|NEORESTAMIN|CARBINOXAMIDE MALEATE|1-(N,N-DIMETHYLAMINO)-3-(P-CHLOROPHENYL-3-ALPHA-PYRIDYL)PROPANE MALEATE|PIRITON|CHLORPHENIRAMINE MALEATE COMPONENT OF DEMAZIN|CHLORPHENAMINE MALEATE (MART.)|DEMAZIN COMPONENT CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE COMPONENT OF ORNADE|ZODRYL AC 80|(+/-)-CHLORPHENIRAMINE.MALEATE|ZODRYL AC 30|3-(4-CHLOROPHENYL)-N,N-DIMETHYL-3-(PYRIDIN-2-YL)PROPAN-1-AMINE MALEATE|ORNADE COMPONENT CHLORPHENIRAMINE MALEATE|PYRIDINE, 2-(P-CHLORO-ALPHA-(2-(DIMETHYLAMINO)ETHYL)BENZYL)-, MALEATE (1:1)|SYNISTAMIN|MLS001148230|NSC759156|HABEN HERB|CHLORPHENIRAMINE MALEATE [USP:JAN]|MLS000758311|CHLORPHENAMINE MALEATE|CCG-220117|ZODRYL AC 60|S1816|ADVIL ALLERGY SINUS COMPONENT CHLORPHENIRAMINE MALEATE|PYRIDAMAL|CHLORPHENIRAMINE MALEATE [JAN]|CORFEN|HMS3884O10|ONLY FORALLERGY|CHLORPHENAMINEMALEATE|DEHIST|PIRIEX|(+/-)-CHLORPHENIRAMINE MALEATE SALT|CHLORTABS|NCGC00093720-02|CHLOR-TRIMETON OD|DRIZE COMPONENT CHLORPHENIRAMINE MALEATE|CHLOR-ALLERGY 4-HOUR|M.P. CHLORCAPS T.D.|1-(P-CHLORPHENYL)-1-(2-PYRIDYL)-3-DIMETHYLAMINOPROPAN MALEAT|EINECS 204-037-5|CHLORPHENIRAMINE MALEATE [USP MONOGRAPH]|CHLORPHENIRAMINE MALEATE	-	PUBCHEM	5281068	C20H23ClN2O4	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro protease inhibitor; authors found that CPM displayed dose-dependent antiviral effects against SARS-CoV-2 in Vero E6 cells, the action is thought to occur through multiple targets including Mpro and Spike	DBAKFASWICGISY-BTJKTKAUSA-N
33478	128336	200576	-	PIKFYVE	CFD|FAB1|HEL37|PIP5K|PIP5K3|ZFYVE29	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Kant R (2023)	888800000997	244297	10253	apilimod dimesylate	APILIMOD MESYLATE|4-{6-[(1E,2E)-2-(3-Methylbenzylidene)hydrazino]-2-[2-(2-pyridinyl)ethoxy]-4-pyrimidinyl}morpholine methanesulfonate (1:2)|Benzaldehyde, 3-methyl-, 2-[(4E)-6-(4-morpholinyl)-2-[2-(2-pyridinyl)ethoxy]-4(1H)-pyrimidinylidene]hydrazone, methanesulfonate (1:2)	-	CHEMSPIDER	9702116	C25H34N6O8S2	small molecule	-	870087-36-8	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human PIKFYVE inhibitor; Combined treatment with apilimod dimesylate and nafamostat mesylate prevents SARS-COV-2 Wuhan, Alpha, Beta, Delta, or Omicron infections in cell culture	GAJWNIKZLYZYSY-OKUPSQOASA-N
33479	112968	7113	-	TMPRSS2	PP9284|PRSS10	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Kant R (2023)	888800000997	244297	10342	Nafamostat mesylate	SW219392-1|BENZOIC ACID, 4-((AMINOIMINOMETHYL)AMINO)-, 6-(AMINOIMINOMETHYL)-2-NAPHTHALENYL ESTER, DIMETHANESULPHONATE|NAFAMSTAT|AC-984|N0959|FT-0601583|NAFAMOSTAT DIMETHANESULFONATE [MI]|NAFAMOSTAT MESILATE (JP17)|DTXSID7046128|6-AMIDINO-2-NAPHTHYL 4-GUANIDINO-BENZOATE DIMETHANESULPHONATE|BENZOIC ACID, 4-((AMINOIMINOMETHYL)AMINO)-, 6-(AMINOIMINOMETHYL)-2-NAPHTHALENYL ESTER, DIMETHANESULFONATE|CCG-207877|6-AMIDINO-2-NAPHTHYL P-GUANIDINOBENZOATE, DIMETHANESULPHONATE|NAFAMOSTAT MESYLATE, >=98% (HPLC)|D01670|BCP04841|AKOS015852498|6-[AMINO(IMINO)METHYL]-2-NAPHTHYL 4-{[AMINO(IMINO)METHYL]AMINO}BENZOATE DIMETHANESULFONATE|S1386|NAFAMOSTAT (MESYLATE)|FUTHAN|NAFAMOSTAT MESYLATE|RONASTAT|HS-0059|NAFAMOSTAT MESYLATE (USAN)|NAFAMOSTAT MESILATE [JAN]|F52835|NAFAMOSTAT MESILATE [MART.]|6-CARBAMIMIDOYLNAPHTHALEN-2-YL 4-GUANIDINOBENZOATE DIMETHANESULFONATE|AMY8859|HY-B0190A|HMS3654J21|BA164628|NAFAMSTAT MESILATE|Q27252259|NAFAMOSTAT MESYLATE [USAN]|RONASTAT (TN)|NAFAMOSTAT MESYLATE- BIO-X|J-518196|NAFAMOSTAT MESILATE|4-[(AMINOIMINOMETHYL)AMINO]BENZOIC ACID 6-(AMINOIMINOMETHYL)-2-NAPHTHALENYL ESTER DIMETHANESULFONATE|NAFAMOSTAT MESILATE [WHO-DD]|82956-11-4|MFCD00941430|FUT-175|(6-CARBAMIMIDOYLNAPHTHALEN-2-YL) 4-(DIAMINOMETHYLIDENEAMINO)BENZOATE;METHANESULFONIC ACID|6-AMIDINO-2-NAPHTHYL P-GUANIDINOBENZOATE, DIMETHANESULFONATE|6-AMIDINO-2-NAPHTHYL 4-GUANIDINOBENZOATE BIS(METHANESULFONATE)|4-GUANIDINOBENZOIC ACID 6-AMIDINO-2-NAPHTHYL ESTER BIS(METHANESULFONATE)|1D2T74921W|NAFAMOSTAT MESYLATE; FUTHAN; NAFAMOSTAT MESILATE; FUT-175	-	PUBCHEM	5311180	C21H25N5O8S2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human TMPRSS2 inhibitor; Combined treatment with apilimod dimesylate and nafamostat mesylate prevents SARS-COV-2 Wuhan, Alpha, Beta, Delta, or Omicron infections in cell culture	SRXKIZXIRHMPFW-UHFFFAOYSA-N
33480	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Choudhary S (2024)	38059400	244298	10220	azadirachtin	Azadirachtin|dimethyl (2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-10-(acetyloxy)-3,5-dihydroxy-4-[(1aR,2S,3aS,6aS,7S,7aS)-6a-hydroxy-7a-methyl-3a,6a,7,7a-tetrahydro-2,7-methanofuro[2,3-b]oxireno[e]oxepin-1a(2H)-yl]-4-methyl-8-{[(2E)-2-methylbut-2-enoyl]oxy}octahydro-1H-naphtho[1,8a-c:4,5-b'c']difuran-5,10a(8H)-dicarboxylate|O4U1SAF85H|Dimethyl-(2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-10-acetoxy-3,5-dihydroxy-4-[(1S,2S,6S,8S,9R,11S)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.0~2,6~.0~9,11~]dodec-3-en-9-yl]-4-methyl-8-{[(2E)-2-methylbut-2-enoyl]oxy}octahydro-1H-furo[3',4':4,4a]naphtho[1,8-bc]furan-5,10a(8H)-dicarboxylat|Dimethyl (2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-10-acetoxy-3,5-dihydroxy-4-[(1S,2S,6S,8S,9R,11S)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.0~2,6~.0~9,11~]dodec-3-en-9-yl]-4-methyl-8-{[(2E)-2-methylbut-2-enoyl]oxy}octahydro-1H-furo[3',4':4,4a]naphtho[1,8-bc]furan-5,10a(8H)-dicarboxylate|1H,7H-naphtho[1,8a-c:4,5-b'c']difuran-5,10a(8H)-dicarboxylic acid, 10-(acetyloxy)octahydro-3,5-dihydroxy-4-methyl-8-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-[(1aR,2S,3aS,6aS,7S,7aS)-3a,6a,7,7a-tetrahydro-6a-hydroxy-7a-methyl-2,7-methanofuro[2,3-b]oxireno[e]oxepin-1a(2H)-yl]-, dimethyl ester, (2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-	-	CHEMSPIDER	4444685	C35H44O16	small molecule	-	11141-17-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero cells	FTNJWQUOZFUQQJ-NDAWSKJSSA-N
33481	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Choudhary S (2024)	38059400	244298	10160	withanolide A	(5alpha,6alpha,7alpha,22R)-6,7-Epoxy-5,20,22-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid delta-lactone|MFCD07779143|Withaniol|(5alpha,6alpha,7alpha,8xi,22R)-5,20-Dihydroxy-6,7:22,26-diepoxyergosta-2,24-diene-1,26-dione|Ergosta-2,24-diene-1,26-dione, 6,7:22,26-diepoxy-5,20-dihydroxy-, (5alpha,6alpha,7alpha,8xi,22R)-|withanolide A	-	CHEMSPIDER	9469353	C28H38O6	small molecule	-	32911-62-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero cells	DXWHOKCXBGLTMQ-SFQAJKIESA-N
33482	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Choudhary S (2024)	38059400	244298	10220	azadirachtin	Azadirachtin|dimethyl (2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-10-(acetyloxy)-3,5-dihydroxy-4-[(1aR,2S,3aS,6aS,7S,7aS)-6a-hydroxy-7a-methyl-3a,6a,7,7a-tetrahydro-2,7-methanofuro[2,3-b]oxireno[e]oxepin-1a(2H)-yl]-4-methyl-8-{[(2E)-2-methylbut-2-enoyl]oxy}octahydro-1H-naphtho[1,8a-c:4,5-b'c']difuran-5,10a(8H)-dicarboxylate|O4U1SAF85H|Dimethyl-(2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-10-acetoxy-3,5-dihydroxy-4-[(1S,2S,6S,8S,9R,11S)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.0~2,6~.0~9,11~]dodec-3-en-9-yl]-4-methyl-8-{[(2E)-2-methylbut-2-enoyl]oxy}octahydro-1H-furo[3',4':4,4a]naphtho[1,8-bc]furan-5,10a(8H)-dicarboxylat|Dimethyl (2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-10-acetoxy-3,5-dihydroxy-4-[(1S,2S,6S,8S,9R,11S)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.0~2,6~.0~9,11~]dodec-3-en-9-yl]-4-methyl-8-{[(2E)-2-methylbut-2-enoyl]oxy}octahydro-1H-furo[3',4':4,4a]naphtho[1,8-bc]furan-5,10a(8H)-dicarboxylate|1H,7H-naphtho[1,8a-c:4,5-b'c']difuran-5,10a(8H)-dicarboxylic acid, 10-(acetyloxy)octahydro-3,5-dihydroxy-4-methyl-8-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-[(1aR,2S,3aS,6aS,7S,7aS)-3a,6a,7,7a-tetrahydro-6a-hydroxy-7a-methyl-2,7-methanofuro[2,3-b]oxireno[e]oxepin-1a(2H)-yl]-, dimethyl ester, (2aR,3S,4S,4aR,5S,7aS,8S,10R,10aS,10bR)-	-	CHEMSPIDER	4444685	C35H44O16	small molecule	-	11141-17-6	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral PLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero cells	FTNJWQUOZFUQQJ-NDAWSKJSSA-N
33483	4383852	43740578	GU280_gp01_nsp3	nsp3	ORF1ab|ORF1ab-nsp3|SARS-CoV2 nsp3|SARS-CoV-2 nsp3|R1AB_SARS2|PRO_0000449621	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Choudhary S (2024)	38059400	244298	10160	withanolide A	(5alpha,6alpha,7alpha,22R)-6,7-Epoxy-5,20,22-trihydroxy-1-oxo-ergosta-2,24-dien-26-oic acid delta-lactone|MFCD07779143|Withaniol|(5alpha,6alpha,7alpha,8xi,22R)-5,20-Dihydroxy-6,7:22,26-diepoxyergosta-2,24-diene-1,26-dione|Ergosta-2,24-diene-1,26-dione, 6,7:22,26-diepoxy-5,20-dihydroxy-, (5alpha,6alpha,7alpha,8xi,22R)-|withanolide A	-	CHEMSPIDER	9469353	C28H38O6	small molecule	-	32911-62-9	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral PLpro protease inhibitor; antiviral activity against SARS-CoV-2 in Vero cells	DXWHOKCXBGLTMQ-SFQAJKIESA-N
33484	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Unoh Y (2022)	35352927	239599	9978	Ensitrelvir	1,3,5-Triazine-2,4(1H,3H)-dione, 6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]dihydro-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-, (6E)-|(6E)-6-[(6-Chloro-2-methyl-2H-indazol-5-yl)imino]-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione	-	CHEMSPIDER	115007411	C22H17ClF3N9O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor; antiviral activity against SARS-CoV in VeroE6/TMPRSS2 cells	QMPBBNUOBOFBFS-UHFFFAOYSA-N
33485	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Unoh Y (2022)	35352927	239599	9978	Ensitrelvir	1,3,5-Triazine-2,4(1H,3H)-dione, 6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]dihydro-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-, (6E)-|(6E)-6-[(6-Chloro-2-methyl-2H-indazol-5-yl)imino]-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4-dione	-	CHEMSPIDER	115007411	C22H17ClF3N9O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral Mpro/3CLpro protease inhibitor; antiviral activity against MERS-CoV in VeroE6/TMPRSS2 cells	QMPBBNUOBOFBFS-UHFFFAOYSA-N
33486	4383854	43740578	GU280_gp01_nsp5	nsp5	ORF1ab|ORF1ab-nsp5|SARS-CoV2 nsp5|SARS-CoV-2 nsp5|Mpro|3CLpro|3C-like proteinase|R1AB_SARS2|PRO_0000449623	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor	target	Hu X (2022)	36146880	246025	10199	YH-53	N-[(2S)-1-({(2S)-1-(1,3-Benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxo-3-pyrrolidinyl]-2-propanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide|1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-2-(2-benzothiazolyl)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]ethyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-	-	CHEMSPIDER	30837128	C30H33N5O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	JBLLRCOZJMVOAE-HSQYWUDLSA-N
33487	4383943	1489680	SARS-CoV-1ab-nsp5ab	nsp5ab	nsp5|sars1ab|orf1ab|SARS-CoV nsp5ab|SARS-CoV nsp5|SARS-CoV sars1ab|orf1ab-nsp5|orf1ab-nsp5ab|pp1ab|3C-like proteinase|3CL-PRO|3CLp|R1AB_CVHSA|PRO_0000037312	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor	target	Hu X (2022)	36146880	246025	10199	YH-53	N-[(2S)-1-({(2S)-1-(1,3-Benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxo-3-pyrrolidinyl]-2-propanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide|1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-2-(2-benzothiazolyl)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]ethyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-	-	CHEMSPIDER	30837128	C30H33N5O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	JBLLRCOZJMVOAE-HSQYWUDLSA-N
33488	4383890	14254602	G128_gp01ab_nsp5	nsp5ab	ORF1ab|nsp5|rep|1AB|MERS-CoV nsp5|orf1ab-nsp5|orf1ab-nsp5ab|nsp5ab|3C-like proteinase|R1AB_CVEMC|PRO_0000422443	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor	target	Hu X (2022)	36146880	246025	10199	YH-53	N-[(2S)-1-({(2S)-1-(1,3-Benzothiazol-2-yl)-1-oxo-3-[(3S)-2-oxo-3-pyrrolidinyl]-2-propanyl}amino)-4-methyl-1-oxo-2-pentanyl]-4-methoxy-1H-indole-2-carboxamide|1H-Indole-2-carboxamide, N-[(1S)-1-[[[(1S)-2-(2-benzothiazolyl)-2-oxo-1-[[(3S)-2-oxo-3-pyrrolidinyl]methyl]ethyl]amino]carbonyl]-3-methylbutyl]-4-methoxy-	-	CHEMSPIDER	30837128	C30H33N5O5S	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction : Viral Mpro/3CLpro protease inhibitor	JBLLRCOZJMVOAE-HSQYWUDLSA-N
33489	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Pruijssers AJ (2020)	32668216	246028	9968	Remdesivir	L-Alanine, N-[(S)-hydroxyphenoxyphosphinyl]-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-D-altrononitrile|Veklury|remdesivir|UNII:3QKI37EEHE|GS-5734|2-Ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate (non-preferred name)	-	CHEMSPIDER	58827832	C27H35N6O8P	small molecule	-	1809249-37-3	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells and Calu3 2B4 cells	RWWYLEGWBNMMLJ-YSOARWBDSA-N
33490	4383860	43740578	GU280_gp01_nsp12	nsp12	ORF1ab|ORF1ab-nsp12|SARS-CoV2 nsp12|SARS-CoV-2 nsp12|RNA-directed RNA polymerase|R1AB_SARS2|PRO_0000449629	2697049	Severe acute respiratory syndrome coronavirus 2	inhibitor/sars-cov-2 inhibitor	target	Pruijssers AJ (2020)	32668216	246028	10228	GS-441524	GS-441524|(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile|(2R,3R,4S,5R)-2-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile	-	CHEMSPIDER	28499294	C12H13N5O4	small molecule	-	1191237-69-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor; antiviral activity against SARS-CoV-2 in Vero E6 cells and Calu3 2B4 cells	BRDWIEOJOWJCLU-LTGWCKQJSA-N
33493	4383949	1489680	SARS-CoV-1ab-nsp12ab	nsp12ab	nsp12|sars1ab|orf1ab|SARS-CoV nsp12ab|SARS-CoV nsp12|SARS-CoV sars1ab|orf1ab-nsp12|orf1ab-nsp12ab|pp1ab|RNA-directed RNA polymerase|Pol|RdRp|R1AB_CVHSA|PRO_0000037318	694009	Severe acute respiratory syndrome-related coronavirus	inhibitor/sars-cov inhibitor	target	Agostini ML (2018)	29511076	222024	10228	GS-441524	GS-441524|(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile|(2R,3R,4S,5R)-2-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile	-	CHEMSPIDER	28499294	C12H13N5O4	small molecule	-	1191237-69-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor; antiviral activity against SARS-CoV in primary human airway epithelial cell (HAE) cultures	BRDWIEOJOWJCLU-LTGWCKQJSA-N
33494	4383896	14254602	G128_gp01ab_nsp12	nsp12ab	ORF1ab|nsp12|rep|1AB|MERS-CoV nsp12|orf1ab-nsp12|orf1ab-nsp12ab|nsp12ab|RNA polymerase|R1AB_CVEMC|PRO_0000422449	1335626	Middle-East Respiratory Syndrome-related Coronavirus	inhibitor/mers-cov inhibitor	target	Agostini ML (2018)	29511076	222024	10228	GS-441524	GS-441524|(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furancarbonitrile|(2R,3R,4S,5R)-2-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile	-	CHEMSPIDER	28499294	C12H13N5O4	small molecule	-	1191237-69-0	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project MERS-CoV direct chemical interaction: Viral RNA-directed RNA polymerase inhibitor; antiviral activity against MERS-CoV in primary human airway epithelial cell (HAE) cultures	BRDWIEOJOWJCLU-LTGWCKQJSA-N
33495	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ji J (2023)	36892138	247218	10736	Bivalent ligand 506	ARE-PROTAC C2|bivalent_ligand_506	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110852	4780	-	NFE2L2	NRF2	9606	Homo sapiens	target	Standardized BVL Name: ARE-PROTAC C2 (CRBN:lenalidomide --- NFE2L2:5-TGAG/CNNNGC-3)	-
33497	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Rosenberg SC (2023)	36773603	247269	10737	Bivalent ligand 507	GNE-579|bivalent_ligand_507	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110852	4780	-	NFE2L2	NRF2	9606	Homo sapiens	target	Standardized BVL Name: GNE-579 (VHL:VH032 --- EGFRExon19/L858R:Compound A)	-
33499	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hung CL (2023)	36893587	247251	10738	Bivalent ligand 508	ITRI-90|bivalent_ligand_508	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ITRI-90 (VHL:VHL HCl salt --- AR/AR-V(LBD):AZD3514 )	-
33501	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hung CL (2023)	36893587	247251	10739	Bivalent ligand 509	ITRI-125|bivalent_ligand_509	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ITRI-125 (VHL:VHL HCl salt --- AR/AR-V(LBD):AZD3514 )	-
33503	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hung CL (2023)	36893587	247251	10740	Bivalent ligand 510	ITRI-126|bivalent_ligand_510	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ITRI-126 (CRBN:lenalidomide --- AR/AR-V(LBD):AZD3514 )	-
33505	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Lee GT (2021)	33277442	229865	10741	Bivalent ligand 511	MTX-23|bivalent_ligand_511	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: MTX-23 (VHL:CRL2VHL compound --- AR/AR-V7:AR DBD binding molecule)	-
33507	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Han X (2021)	34431670	256613	10742	Bivalent ligand 512	ARD-2128|bivalent_ligand_512	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARD-2128 (CRBN:thalidomide --- AR:ARi-184)	-
33509	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xie H (2023)	36749666	248602	10743	Bivalent ligand 513	Degrader 13|bivalent_ligand_513	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: Degrader 13 (CRBN: 1,2,3-trisubstituted PDHU --- BRD4:JQ1)	-
33511	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Thomas E (2023)	36831540	248703	10744	Bivalent ligand 514	VNPP433-3b|bivalent_ligand_514	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: VNPP433-3 (MDM2:VNPP433-3 --- AR/AR-V7: VNPP433-3)	-
33513	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	10745	Bivalent ligand 515	isoindolinone (EM12)|bivalent_ligand_515	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: isoindolinone (EM12) (CRBN: isoindolinone (EM12) --- IKZF1:isoindolinone (EM12))	-
33515	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	10746	Bivalent ligand 516	4-OH-EM12|bivalent_ligand_516	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: 4-OH-EM12 (CRBN:4-OH-EM12 --- IKZF1:4-OH-EM12)	-
33517	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	10747	Bivalent ligand 517	5-OH-EM12|bivalent_ligand_517	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: 5-OH-EM12 (CRBN:5-OH-EM12 --- GSPT1:5-OH-EM12)	-
33519	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: lenalidomide (CRBN:lenalidomide --- GSPT1:lenalidomide)	-
33521	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	8561	Bivalent ligand 143	lenalidomide|Bivalent_ligand_143	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: lenalidomide (CRBN:lenalidomide --- IKZF1:lenalidomide)	-
33523	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	10748	Bivalent ligand 518	5-NH2-EM12|bivalent_ligand_518	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: 5-NH2-EM12 (CRBN:5-NH2-EM12 --- IKZF1:5-NH2-EM12)	-
33525	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	10749	Bivalent ligand 519	6-NH2-EM12|bivalent_ligand_519	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: 6-NH2-EM12 (CRBN: 6-NH2-EM12 --- IKZF1: 6-NH2-EM12)	-
33527	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: thalidomide (CRBN:thalidomide --- GSPT1:thalidomide)	-
33529	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	8562	Bivalent ligand 144	thalidomide|Bivalent_ligand_144	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: thalidomide (CRBN:thalidomide --- IKZF1:thalidomide)	-
33531	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	9998	Bivalent ligand 387	5-hydroxythalidomide|Bivalent_ligand_387	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: 5-hydroxythalidomide (CRBN:5-OH-Thal --- GSPT1:5-OH-Thal)	-
33533	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	8560	Bivalent ligand 142	pomalidomide|Bivalent_ligand_142	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: pomalidomide (CRBN:pomalidomide --- IKZF1:pomalidomide)	-
33535	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Nowak RP (2023)	36970148	250541	10750	Bivalent ligand 521	5-NH2-Thal|bivalent_ligand_521	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: 5-NH2-Thal (CRBN:5-NH2-Thal --- IKZF1:5-NH2-Thal)	-
33537	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Furihata H (2020)	32929090	228972	9998	Bivalent ligand 387	5-hydroxythalidomide|Bivalent_ligand_387	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	121420	57167	-	SALL4	DRRS|HSAL4|ZNF797|dJ1112F19.1	9606	Homo sapiens	target	Standardized BVL Name: 5-hydroxythalidomide (CRBN: 5-hydroxythalidomide --- SALL4:5-hydroxythalidomide)	-
33539	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	37030566	250553	10751	Bivalent ligand 522	PROTAC-1|bivalent_ligand_522	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-1 (VHL:VH032 --- BRAF:S5)	-
33541	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	37030566	250553	10752	Bivalent ligand 523	PROTAC-2|bivalent_ligand_523	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-2 (VHL:VH032 --- BRAF:S5)	-
33543	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	37030566	250553	10753	Bivalent ligand 524	PROTAC-3|bivalent_ligand_524	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-3 (VHL:VH032 --- BRAF:S5)	-
33545	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	37030566	250553	10751	Bivalent ligand 522	PROTAC-1|bivalent_ligand_522	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-1 (VHL:VH032 --- KDR:S5)	-
33547	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	37030566	250553	10752	Bivalent ligand 523	PROTAC-2|bivalent_ligand_523	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109992	3791	-	KDR	CD309|FLK1|VEGFR|VEGFR2	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-2 (VHL:VH032 --- KDR:S5)	-
33549	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bouguenina H (2023)	37418539	256614	10754	Bivalent ligand 525	16|bivalent_ligand_525	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122430	65980	UNQ3040/PRO9856	BRD9	LAVS3040|PRO9856	9606	Homo sapiens	target	Standardized BVL Name: 16 (CRBN:pomalidomide --- BRD9:GSK-3)	-
33551	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bouguenina H (2023)	37418539	256614	8493	Bivalent ligand 112	VZ185|Bivalent_ligand_112	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122430	65980	UNQ3040/PRO9856	BRD9	LAVS3040|PRO9856	9606	Homo sapiens	target	Standardized BVL Name: VZ185 (VHL:VHL4 --- BRD9: BRDL1)	-
33553	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bouguenina H (2023)	37418539	256614	8503	Bivalent ligand 96	dBRD9|Bivalent_ligand_96	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122430	65980	UNQ3040/PRO9856	BRD9	LAVS3040|PRO9856	9606	Homo sapiens	target	Standardized BVL Name: Compound 6 (dBRD9) (CRBN:pomalidomide --- BRD9:GSK-3)	-
33555	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bai L (2017)	28209615	256615	10755	Bivalent ligand 526	BETd-246|bivalent_ligand_526	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: BETd-246 (CRBN:thalidomide --- BRD2:BETi-211)	-
33557	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bai L (2017)	28209615	256615	10755	Bivalent ligand 526	BETd-246|bivalent_ligand_526	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: BETd-246 (CRBN:thalidomide --- BRD3:BETi-211)	-
33559	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bai L (2017)	28209615	256615	10755	Bivalent ligand 526	BETd-246|bivalent_ligand_526	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: BETd-246 (CRBN:thalidomide --- BRD4:BETi-211)	-
33561	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Carvalho LAR (2024)	38195841	256612	10756	Bivalent ligand 527	C8|bivalent_ligand_527	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115701	10434	-	LYPLA1	APT-1|APT1|LPL-I|LPL1|hAPT1	9606	Homo sapiens	target	Standardized BVL Name: C8 (CRBN:pomalidomide --- LYPLA1:aryl sulfonyl fluoride reactive group)	-
33563	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Song H (2024)	38194774	256616	10757	Bivalent ligand 528	18a|bivalent_ligand_528	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: 18a (BIRC2:bestatin --- GPX4:RSL3)	-
33565	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2023)	37289649	256617	10758	Bivalent ligand 529	BD-7148|bivalent_ligand_529	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: BD-7148 (CRBN:pomalidomide --- BRD4:QCA276)	-
33567	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2023)	37289649	256617	10759	Bivalent ligand 530	BD-9136|bivalent_ligand_530	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: BD-9136 (CRBN:pomalidomide --- BRD4:QCA276)	-
33569	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen Y (2021)	33488968	256618	10760	Bivalent ligand 531	compound 9|bivalent_ligand_531	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (CRBN:pomalidomide --- IRAK4:compound 1)	-
33571	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10761	Bivalent ligand 532	DBr-1|bivalent_ligand_532	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122430	65980	UNQ3040/PRO9856	BRD9	LAVS3040|PRO9856	9606	Homo sapiens	target	Standardized BVL Name: DBr-1 (DCAF1: DCAF1 Binder 13 --- BRD9:BI-9564)	-
33573	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10762	Bivalent ligand 533	DDa-1|bivalent_ligand_533	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: DDa-1 (DCAF1: DCAF1 Binder 13 --- CSK:dasatinib)	-
33575	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10762	Bivalent ligand 533	DDa-1|bivalent_ligand_533	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110173	3985	-	LIMK2	-	9606	Homo sapiens	target	Standardized BVL Name: DDa-1 (DCAF1: DCAF1 Binder 13 --- LIMK2:dasatinib)	-
33577	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10762	Bivalent ligand 533	DDa-1|bivalent_ligand_533	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DDa-1 (DCAF1: DCAF1 Binder 13 --- BTK:dasatinib)	-
33579	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10763	Bivalent ligand 534	DBt-5|bivalent_ligand_534	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DBt-5 (DCAF1: DCAF1 Binder 13 --- BTK:BTKi)	-
33581	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10764	Bivalent ligand 535	DBt-10|bivalent_ligand_535	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: DBt-10 (DCAF1: DCAF1 Binder 13 --- BTK:BTKi)	-
33583	115079	9730	-	VPRBP	DCAF1	9606	Homo sapiens	degradation	recruited e3 ligase	Schroeder M (2024)	38177131	256619	10764	Bivalent ligand 535	DBt-10|bivalent_ligand_535	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110172	3984	-	LIMK1	LIMK|LIMK-1	9606	Homo sapiens	target	Standardized BVL Name: DBt-10 (DCAF1: DCAF1 Binder 13 --- LIMK1:BTKi)	-
33585	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	De Dominici M (2020)	32040545	256620	10765	Bivalent ligand 536	YX-2-107|bivalent_ligand_536	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: YX-2-107 (CRBN:thalidomide --- CDK6:palbociclib)	-
33587	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	De Dominici M (2020)	32040545	256620	10766	Bivalent ligand 537	YX-2-233|bivalent_ligand_537	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: YX-2-233 (MDM2:RG7112 --- CDK6:palbociclib)	-
33589	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	De Dominici M (2020)	32040545	256620	10766	Bivalent ligand 537	YX-2-233|bivalent_ligand_537	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: YX-2-233 (MDM2:RG7112 --- CDK4:palbociclib)	-
33591	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Winzker M (2020)	31829492	256621	10767	Bivalent ligand 538	PROTAC 3|bivalent_ligand_538	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111173	5147	-	PDE6D	JBTS22|PDED	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 3 (CRBN:pomalidomide --- PDE6D:deltasonamide1)	-
33593	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Winzker M (2020)	31829492	256621	10768	Bivalent ligand 539	PROTAC 5|bivalent_ligand_539	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111173	5147	-	PDE6D	JBTS22|PDED	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 5 (VHL:VHL ligand --- PDE6D:deltasonamide1)	-
33595	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang X (2019)	31754664	256622	10769	Bivalent ligand 540	XZ424|bivalent_ligand_540	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: XZ424 (CRBN:pomalidomide --- BCL2L1:compound 3 (A-1155463 derivative))	-
33597	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao B (2019)	30758029	256623	10770	Bivalent ligand 541	pal-pom|bivalent_ligand_541	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: pal-pom (CRBN:pomalidomide --- CDK6:palbociclib)	-
33599	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao B (2019)	30758029	256623	10770	Bivalent ligand 541	pal-pom|bivalent_ligand_541	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: pal-pom (CRBN:pomalidomide --- CDK4:palbociclib)	-
33601	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao B (2019)	30758029	256623	10771	Bivalent ligand 542	rib-pom|bivalent_ligand_542	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: rib-pom (CRBN:pomalidomide --- CDK6:ribociclib)	-
33603	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao B (2019)	30758029	256623	10771	Bivalent ligand 542	rib-pom|bivalent_ligand_542	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: rib-pom (CRBN:pomalidomide --- CDK4:ribociclib)	-
33605	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ding M (2023)	36563515	256624	10772	Bivalent ligand 543	degrader 8b|bivalent_ligand_543	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: degrader 8b (CRBN:lenalidomide --- BRD4:JQ1)	-
33607	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Y (2021)	33839580	254238	10773	Bivalent ligand 544	Compound 21a|bivalent_ligand_544	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: Compound 21a (CRBN:thalidomide --- PD-L1 :BMS-37 diaryl ether analogue)	-
33609	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li L (2021)	34715575	254240	10774	Bivalent ligand 545	KP-14|bivalent_ligand_545	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110043	3845	-	KRAS	C-K-RAS|CFC2|K-RAS2A|K-RAS2B|K-RAS4A|K-RAS4B|KI-RAS|KRAS1|KRAS2|NS|NS3|RASK2	9606	Homo sapiens	target	Standardized BVL Name: KP-14 (CRBN:pomalidomide --- KRas G12C:KRas G12C-IN-3)	-
33611	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Vemulapalli V (2021)	34411482	254241	10775	Bivalent ligand 546	R1-5C|bivalent_ligand_546	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	target	Standardized BVL Name: R15C (CRBN:pomalidomide --- SHP2:RMC-45503)	-
33613	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Aublette MC (2022)	35231578	254243	10776	Bivalent ligand 547	MA055|bivalent_ligand_547	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: MA055 (VHL:VH032 --- Wee1:AZD1775)	-
33615	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Aublette MC (2022)	35231578	254243	10777	Bivalent ligand 548	MA071|bivalent_ligand_548	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: MA071 (CRBN:pomalidomide --- Wee1:AZD1775)	-
33617	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie H (2023)	37703322	254337	10779	Bivalent ligand 550	compound 3b|bivalent_ligand_550	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115760	10498	-	CARM1	PRMT4	9606	Homo sapiens	target	Standardized BVL Name: compound 3b (VHL:VHL-1 --- CARM1:TP-064)	-
33619	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie H (2023)	37703322	254337	10780	Bivalent ligand 551	compound 3e|bivalent_ligand_551	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115760	10498	-	CARM1	PRMT4	9606	Homo sapiens	target	Standardized BVL Name: compound 3e (VHL:VHL-1 --- CARM1:TP-064)	-
33621	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Verano AL (2022)	36007246	256625	10781	Bivalent ligand 552	ALV-07-082-03|bivalent_ligand_552	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: ALV-07-082-03 (CRBN: DKY709 --- CDK4:palbociclib)	-
33623	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Verano AL (2022)	36007246	256625	10781	Bivalent ligand 552	ALV-07-082-03|bivalent_ligand_552	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: ALV-07-082-03 (CRBN: DKY709 --- CDK6:palbociclib)	-
33625	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Verano AL (2022)	36007246	256625	10781	Bivalent ligand 552	ALV-07-082-03|bivalent_ligand_552	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116485	22807	-	IKZF2	ANF1A2|HELIOS|ZNF1A2|ZNFN1A2	9606	Homo sapiens	target	Standardized BVL Name: ALV-07-082-03 (CRBN: DKY709 --- IKZF2:DKY709)	-
33627	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bonazzi S (2023)	36863346	256626	10782	Bivalent ligand 553	NVP-DKY709|bivalent_ligand_553	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116485	22807	-	IKZF2	ANF1A2|HELIOS|ZNF1A2|ZNFN1A2	9606	Homo sapiens	target	Standardized BVL Name: NVP-DKY709 (CRBN: DKY709 --- IKZF2:DKY709)	-
33629	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Liu X (2022)	36007011	256627	10783	Bivalent ligand 554	XL01126|bivalent_ligand_554	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	125700	120892	-	LRRK2	AURA17|DARDARIN|PARK8|RIPK7|ROCO2	9606	Homo sapiens	target	Standardized BVL Name: XL01126 (VHL:VH101 --- LRRK2:HG-10-102-01)	-
33631	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qin Q (2022)	35978496	256628	10784	Bivalent ligand 555	PROTAC A13|bivalent_ligand_555	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: PROTAC A13 (CRBN:pomalidomide --- PTK2:PF-562271 derivative 1)	-
33633	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	degradation	autophagy-targeting protein	Mei L (2023)	37424101	254385	10785	Bivalent ligand 556	QBP-LIR|bivalent_ligand_556	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	109314	3064	-	HTT	HD|IT15	9606	Homo sapiens	target	Standardized BVL Name: QBP-LIR (MAP1LC3B:LIR --- HTT65Q:QBP)	-
33635	120375	55054	hCG_1817841	ATG16L1	APG16L|ATG16A|ATG16L|IBD10|WDR30	9606	Homo sapiens	degradation	autophagy-targeting protein	Mei L (2023)	37424101	254385	10786	Bivalent ligand 557	QBP-ABP|bivalent_ligand_557	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	109314	3064	-	HTT	HD|IT15	9606	Homo sapiens	target	Standardized BVL Name: QBP-ABP (ATG16L1:ABP --- HTT65Q:QBP)	-
33637	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bhumireddy A (2022)	34767914	254422	10787	Bivalent ligand 558	Compound 6|bivalent_ligand_558	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: Compound 6 (VHL:VHL ligand Compound 11 --- AR-V7:VPC-14228)	-
33639	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Shibata N (2022)	35085722	254450	10788	Bivalent ligand 559	Compound 5a/SNIPER(TACC3)-11|bivalent_ligand_559	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	115723	10460	-	TACC3	ERIC-1|ERIC1	9606	Homo sapiens	target	Standardized BVL Name: Compound 5a/SNIPER(TACC3)-11 (cIAP1:LCL161 derivative Compound 11 --- FGFR3-TACC3:KHS108)	-
33641	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xiang W (2023)	37683104	254465	10789	Bivalent ligand 560	ARD-1676|bivalent_ligand_560	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARD-1676 (CRBN:CRBN Ligand 27 --- AR:AR4034)	-
33643	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang L (2021)	34094836	254471	10790	Bivalent ligand 561	Compound 7o|bivalent_ligand_561	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106543	25	RP11-83J21.1	ABL1	ABL|JTK7|bcr/abl|c-ABL|c-ABL1|p150|v-abl	9606	Homo sapiens	target	Standardized BVL Name: Compound 7o (CRBN:pomalidomide --- Bcr-Abl:GZD824)	-
33645	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Luo G (2021)	34094835	254500	10791	Bivalent ligand 562	21c|bivalent_ligand_562	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	target	Standardized BVL Name: 21c (VHL:VHL231 --- HMGCR:lactone opened lovastatin acid)	-
33647	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Luo G (2021)	34094835	254500	10792	Bivalent ligand 563	21b|bivalent_ligand_563	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109399	3156	-	HMGCR	LDLCQ3	9606	Homo sapiens	target	Standardized BVL Name: 21b (VHL:VHL231 --- HMGCR:lactone lovastatin acid)	-
33649	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun Y (2023)	37593574	254507	10793	Bivalent ligand 564	15-271|bivalent_ligand_564	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: 15-271 (CRBN:pomalidomide --- BTK:Ibrutinib)	-
33651	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cheng W (2021)	34788776	254514	10794	Bivalent ligand 565	ha-PROTAC 13|bivalent_ligand_565	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: ha-PROTAC 13 (CRBN:lenalidomide --- EGFRDel19:HALG-gefitinib 4-anilinoquinazoline core)	-
33653	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cheng W (2021)	34788776	254514	10795	Bivalent ligand 566	PROTAC 11|bivalent_ligand_566	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 11 (CRBN:lenalidomide --- EGFRDel19:gefitinib 4-anilinoquinazoline core)	-
33655	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chotitumnavee J (2022)	35311871	254516	10796	Bivalent ligand 567	compound 4c|bivalent_ligand_567	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	target	Standardized BVL Name: compound 4c (CRBN:pomalidomide --- HDAC8:Compound 2 (NCC-149 analogue))	-
33657	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao C (2023)	37098288	254517	10797	Bivalent ligand 568	CT-4|bivalent_ligand_568	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	target	Standardized BVL Name: CT-4 (CRBN:pomalidomide --- HDAC8:Compound 4)	-
33659	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xu H (2021)	34124002	254519	10798	Bivalent ligand 569	Compound 3|bivalent_ligand_569	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113222	7376	-	NR1H2	LXR-b|LXRB|NER|NER-I|RIP15|UNR	9606	Homo sapiens	target	Standardized BVL Name: Compound 3 (VHL:VH032 --- LXRB:GW3965)	-
33661	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Lim YS (2023)	36269842	256629	10799	Bivalent ligand 570	UBX-382|bivalent_ligand_570	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: UBX-382 (CRBN:thalidomide --- BTK:novel BTK ligand)	-
33663	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Miao J (2023)	38020389	256630	10800	Bivalent ligand 571	TP1L|bivalent_ligand_571	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111737	5771	-	PTPN2	PTN2|PTPT|TC-PTP|TCELLPTP|TCPTP	9606	Homo sapiens	target	Standardized BVL Name: TP1L (CRBN:lenalidomide --- PTPN2:inhibitor 3)	-
33665	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gazorpak M (2023)	38071198	256631	10801	Bivalent ligand 572	KH-102|bivalent_ligand_572	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	target	Standardized BVL Name: KH-102 (CRBN:lenalidomide --- NR3C1:dexamethasone)	-
33667	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gazorpak M (2023)	38071198	256631	10802	Bivalent ligand 573	KH-103|bivalent_ligand_573	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109165	2908	-	NR3C1	GCCR|GCR|GCRST|GR|GRL	9606	Homo sapiens	target	Standardized BVL Name: KH-103 (CRBN:lenalidomide --- NR3C1:dexamethasone)	-
33669	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Murgai A (2022)	35852517	256632	10803	Bivalent ligand 574	PROTAC 17|bivalent_ligand_574	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 17 (CRBN:thalidomide --- USP7:XL188)	-
33671	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Miller DSJ (2022)	35814929	256633	10804	Bivalent ligand 575	CST905|bivalent_ligand_575	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107141	673	-	BRAF	B-RAF1|BRAF1|NS7|RAFB1	9606	Homo sapiens	target	Standardized BVL Name: CST905 (VHL:VH032 --- BRAF:PLX7683)	-
33673	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wu Y (2022)	35755293	256634	10805	Bivalent ligand 576	PROTAC A7|bivalent_ligand_576	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115438	10135	-	NAMPT	1110035O14Rik|PBEF|PBEF1|VF|VISFATIN	9606	Homo sapiens	target	Standardized BVL Name: PROTAC A7 (VHL:VHL-1 --- NAMPT:MS7)	-
33675	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Swartzel JC (2022)	35749470	256635	10806	Bivalent ligand 577	JCS-1|bivalent_ligand_577	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118787	28960	HSPC015	DCPS	DCS1|HINT-5|HINT5|HSL1	9606	Homo sapiens	target	Standardized BVL Name: JCS-1 (VHL:VL285 --- DCPS:RG3039)	-
33677	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Sun Y (2022)	35717870	256636	10807	Bivalent ligand 578	SYL2158|bivalent_ligand_578	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120250	54904	DC28	WHSC1L1	NSD3|pp14328	9606	Homo sapiens	target	Standardized BVL Name: SYL2158 (VHL:VHL-1 --- NSD3:BI-9321)	-
33679	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Pei Y (2022)	35691827	256637	10808	Bivalent ligand 579	U7D-1|bivalent_ligand_579	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	target	Standardized BVL Name: U7D-1 (CRBN:pomalidomide --- USP7: compound 4)	-
33681	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zeng S (2024)	38086239	256638	10809	Bivalent ligand 580	compound B1|bivalent_ligand_580	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116354	11184	-	MAP4K1	HPK1	9606	Homo sapiens	target	Standardized BVL Name: compound B1 (CRBN:thalidomide --- MAP4K1:compound 1)	-
33683	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yang H (2019)	31769449	256639	10810	Bivalent ligand 581	NH2|bivalent_ligand_581	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: NH2 (CRBN:pomalidomide --- HDAC6:Nexturastat A (Nex A))	-
33685	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC1:CI-994)	-
33687	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC2:CI-994)	-
33689	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC3:CI-994)	-
33691	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC1:CI-994)	-
33693	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC2:CI-994)	-
33695	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC3:CI-994)	-
33697	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC1:CI-994)	-
33699	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109316	3066	-	HDAC2	HD2|RPD3|YAF1	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC2:CI-994)	-
33701	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	degradation	recruited e3 ligase	Baker IM (2023)	35948047	256640	10811	Bivalent ligand 582	JPS026|bivalent_ligand_582	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: JPS026 (IAP:IAP ligand ---HDAC3:CI-994)	-
33703	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yang Z (2021)	34417569	254508	10812	Bivalent ligand 583	GBD-9|bivalent_ligand_583	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: GBD-9 (CRBN:pomalidomide --- BTK:ibrutinib derivative)	-
33705	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yang Z (2021)	34417569	254508	10812	Bivalent ligand 583	GBD-9|bivalent_ligand_583	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: GBD-9 (CRBN:pomalidomide --- GSPT1:ibrutinib derivative)	-
33707	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2021)	34586829	254522	10813	Bivalent ligand 584	MS67|bivalent_ligand_584	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116272	11091	-	WDR5	BIG-3|CFAP89|SWD3	9606	Homo sapiens	target	Standardized BVL Name: MS67 (VHL:VHL-1-Me --- WDR5:OICR-9429)	-
33709	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	38019706	254524	10814	Bivalent ligand 585	MS132/Compound 11|bivalent_ligand_585	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116272	11091	-	WDR5	BIG-3|CFAP89|SWD3	9606	Homo sapiens	target	Standardized BVL Name: MS132 (VHL:VHL-1 --- WDR5:precursor 2 (OICR-9429 derivative))	-
33711	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	38019706	254524	10815	Bivalent ligand 586	Compound 25|bivalent_ligand_586	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116272	11091	-	WDR5	BIG-3|CFAP89|SWD3	9606	Homo sapiens	target	Standardized BVL Name: Compound 25 (CRBN:-oxyacetamide bridged pomalidomide --- WDR5:OICR-9429)	-
33713	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wang W (2021)	33859747	254525	10816	Bivalent ligand 587	C004019|bivalent_ligand_587	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110308	4137	-	MAPT	DDPAC|FTDP-17|MAPTL|MSTD|MTBT1|MTBT2|PPND|PPP1R103|TAU	9606	Homo sapiens	target	Standardized BVL Name: C004019 (VHL:VH032 --- tau:triazole-based tau binder moiety)	-
33715	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu X (2021)	34568836	254526	10817	Bivalent ligand 588	MS140|bivalent_ligand_588	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: MS140 (CRBN:pomalidomide --- CDK4:Palbociclib)	-
33717	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu X (2021)	34568836	254526	10817	Bivalent ligand 588	MS140|bivalent_ligand_588	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: MS140 (CRBN:pomalidomide --- CDK6:Palbociclib)	-
33719	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sang R (2023)	37376788	254527	10818	Bivalent ligand 589	C-02|bivalent_ligand_589	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109346	3099	-	HK2	HKII|HXK2	9606	Homo sapiens	target	Standardized BVL Name: C-02 (CRBN:Thalidomide --- HK2:lonidamine)	-
33721	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Peyman M (2023)	37826940	254528	10819	Bivalent ligand 590	ALT-PG2|bivalent_ligand_590	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	target	Standardized BVL Name: ALT-PG2 (CRBN:Thalidomide --- sEH:t-TUCB)	-
33723	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Y (2023)	36947831	254529	10820	Bivalent ligand 591	compound 1a|bivalent_ligand_591	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	target	Standardized BVL Name: compound 1a (CRBN:Thalidomide --- sEH:t-TUCB)	-
33725	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	LegaardAndersson J (2023)	37807669	254535	10821	Bivalent ligand 600	Compound 3|bivalent_ligand_600	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113306	7468	RP11-262P20.3	WHSC1	MMSET|NSD2|REIIBP|TRX5|WHS	9606	Homo sapiens	target	Standardized BVL Name: compound 3 (VHL:VHL4 --- NSD2:DEL140 compound 1)	-
33727	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Pan P (2023)	37751283	254536	10822	Bivalent ligand 601	PPM-3|bivalent_ligand_601	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111584	5598	-	MAPK7	BMK1|ERK4|ERK5|PRKM7	9606	Homo sapiens	target	Standardized BVL Name: PPM-3 (VHL:VH032 --- ERK5:XMD8-92)	-
33729	117649	26263	-	FBXO22	FBX22|FISTC1	9606	Homo sapiens	degradation	recruited e3 ligase	Basu AA (2024)	38965383	254538	10823	Bivalent ligand 602	22-SLF|bivalent_ligand_602	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: 22-SLF (FBXO22:22 --- FKBP12:SLF)	-
33731	117649	26263	-	FBXO22	FBX22|FISTC1	9606	Homo sapiens	degradation	recruited e3 ligase	Basu AA (2024)	38965383	254538	10824	Bivalent ligand 603	22a-SLF|bivalent_ligand_603	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: 22-SLF (FBXO22:22a --- FKBP12:SLF)	-
33733	117649	26263	-	FBXO22	FBX22|FISTC1	9606	Homo sapiens	degradation	recruited e3 ligase	Basu AA (2024)	38965383	254538	10825	Bivalent ligand 604	22-JQ1|bivalent_ligand_604	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 22-JQ1 (FBXO22:22 --- BRD4:JQ1)	-
33735	117649	26263	-	FBXO22	FBX22|FISTC1	9606	Homo sapiens	degradation	recruited e3 ligase	Basu AA (2024)	38965383	254538	10826	Bivalent ligand 605	22-TAE|bivalent_ligand_605	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: 22-TAE (FBXO22:22 --- ALK:TAE)	-
33737	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ko T (2023)	37712589	254591	10827	Bivalent ligand 606	CaMKIIa-PHOTAC|bivalent_ligand_606	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which degradation activity can be regulated by exposure to light; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107265	815	-	CAMK2A	CAMKA	9606	Homo sapiens	target	Standardized BVL Name: CaMKII-PHOTAC (CRBN:lenalidomide --- CAMK2A:bosutinib)	-
33739	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Castellani B (2023)	37699425	254593	10828	Bivalent ligand 607	Compound 9|bivalent_ligand_607	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: Compound 9 (VHL:MTX-23 CRL2VHL ligand derivative --- AR:AR DBD binding molecule)	-
33741	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Fan H (2023)	37683536	254595	10829	Bivalent ligand 608	precursor 1a|bivalent_ligand_608	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: precursor 1a (VHL:VHL Ligand with GSH-responsive capping group --- BRD4:JQ1)	-
33743	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu T (2023)	37672930	254597	10830	Bivalent ligand 609	CP-07|bivalent_ligand_609	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: CP-07 (CRBN:thalidomide --- CDK9:LWT-111)	-
33745	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ji W (2023)	37658265	254598	10831	Bivalent ligand 610	degrader 10e|bivalent_ligand_610	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111161	5134	RP1-191N21.2	PDCD2	RP8|ZMYND7	9606	Homo sapiens	target	Standardized BVL Name: degrader 10e (CRBN:thalidomide --- PDCD2:TEAD palmitoylation inhibitor)	-
33747	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen Z (2023)	37647546	254601	10832	Bivalent ligand 611	ERD-3111|bivalent_ligand_611	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ERD-3111 (CRBN:TX-16 --- ESRA:lasofoxifene)	-
33749	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10833	Bivalent ligand 612	FC-14369|bivalent_ligand_612	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-14369 (CRBN:thalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33751	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10834	Bivalent ligand 613	FC-13182|bivalent_ligand_613	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-13182 (CRBN:thalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33753	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10835	Bivalent ligand 614	FC-13887|bivalent_ligand_614	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-13887 (CRBN:thalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33755	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10836	Bivalent ligand 615	FC-12988|bivalent_ligand_615	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-12988 (CRBN:lenalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33757	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10837	Bivalent ligand 616	FC-13818|bivalent_ligand_616	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-13818 (CRBN:thalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33759	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10838	Bivalent ligand 617	FC-13935|bivalent_ligand_617	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-13935 (CRBN:thalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33761	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10839	Bivalent ligand 618	FC-14228|bivalent_ligand_618	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-14228 (CRBN:thalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33763	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Emert-Sedlak LA (2024)	38508197	254603	10840	Bivalent ligand 619	FC-14367|bivalent_ligand_619	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	1205545	156110	HIV1gp9	nef	-	11676	Human Immunodeficiency Virus 1	target	Standardized BVL Name: FC-14367 (CRBN:lenalidomide --- Nef:hydroxypyrazole Nef-targeting moiety)	-
33765	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao C (2023)	37638390	254605	10841	Bivalent ligand 620	P7|bivalent_ligand_620	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: P7 (VHL:VHL-021 --- HDAC3:16 (BRD3308 derivative))	-
33767	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Li H (2023)	37636080	254606	10842	Bivalent ligand 621	Comp-K|bivalent_ligand_621	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	target	Standardized BVL Name: Comp-K (VHL:VH032 --- CypA:2d (CypA-L1))	-
33769	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Li H (2023)	37636080	254606	10843	Bivalent ligand 622	Comp-L|bivalent_ligand_622	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	target	Standardized BVL Name: Comp-L (VHL:VH032 --- CypA:2d (CypA-L1))	-
33771	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Li H (2023)	37636080	254606	10844	Bivalent ligand 623	Comp-M|bivalent_ligand_623	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111474	5478	-	PPIA	CYPA|CYPH|HEL-S-69p	9606	Homo sapiens	target	Standardized BVL Name: Comp-M (VHL:VH032 --- CypA:3c (CypA-L2))	-
33773	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kumarasamy V (2023)	37626264	254608	10845	Bivalent ligand 624	BSJ-02-162|bivalent_ligand_624	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: BSJ-02-162 (CRBN:pomalidomide --- CDK4:palbociclib)	-
33775	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kumarasamy V (2023)	37626264	254608	10845	Bivalent ligand 624	BSJ-02-162|bivalent_ligand_624	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: BSJ-02-162 (CRBN:pomalidomide --- CDK6:palbociclib)	-
33777	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kumarasamy V (2023)	37626264	254608	10846	Bivalent ligand 625	FN-POM|bivalent_ligand_625	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: FN-POM (CRBN:pomalidomide --- CDK2:N-1501)	-
33779	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang Q (2023)	37619298	254609	10847	Bivalent ligand 626	X10g|bivalent_ligand_626	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	target	Standardized BVL Name: X10g (CRBN:pomalidomide --- HSP90AA1:AT13387 analogue X1)	-
33781	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Wang L (2024)	38334978	254612	10848	Bivalent ligand 627	NR-V04|bivalent_ligand_627	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109407	3164	-	NR4A1	GFRP1|HMR|N10|NAK-1|NGFIB|NP10|NUR77|TR3	9606	Homo sapiens	target	Standardized BVL Name: NR-V04 (VHL:VHL-032 --- NR4A1:celastrol)	-
33783	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Li C (2023)	37605297	254613	10849	Bivalent ligand 628	PIK5-12d|bivalent_ligand_628	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	128336	200576	-	PIKFYVE	CFD|FAB1|HEL37|PIP5K|PIP5K3|ZFYVE29	9606	Homo sapiens	target	Standardized BVL Name: PIK5-12d (VHL:VHL Ligand --- PIKfyve:apilimod)	-
33785	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hatcher JM (2023)	37591317	254614	10850	Bivalent ligand 629	JH-XII-03-02 (6)|bivalent_ligand_629	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	211674	66725	-	Lrrk2	4921513O20Rik|9330188B09Rik|AW561911|D630001M17Rik|Gm927|cI-46	10090	Mus musculus	target	Standardized BVL Name: JH-XII-03-02(6) (CRBN:pomalidomide --- LRRK2:MLi-2)	-
33787	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao Y (2023)	37572669	254616	10851	Bivalent ligand 630	YX968 (25)|bivalent_ligand_630	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114368	8841	-	HDAC3	HD3|RPD3|RPD3-2	9606	Homo sapiens	target	Standardized BVL Name: YX968 (25) (VHL:VHL-021 --- HDAC3:Compound 15)	-
33789	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao Y (2023)	37572669	254616	10851	Bivalent ligand 630	YX968 (25)|bivalent_ligand_630	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	120968	55869	CDA07	HDAC8	CDLS5|HD8|HDACL1|MRXS6|RPD3|WTS	9606	Homo sapiens	target	Standardized BVL Name: YX968 (25) (VHL:VHL-021 --- HDAC8:Compound 15)	-
33791	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Xie H (2023)	37572533	254628	10852	Bivalent ligand 631	E-3P-MDM2|bivalent_ligand_631	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: E-3P-MDM2 (MDM2:Nutlin-3 --- EZH2:Tazemetostat (EPZ6438))	-
33793	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Xie H (2023)	37572533	254628	10853	Bivalent ligand 632	E-4P-MDM2|bivalent_ligand_632	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: E-4P-MDM2 (MDM2:Nutlin-3 --- EZH2:Tazemetostat (EPZ6438))	-
33795	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang B (2023)	37556600	254637	10854	Bivalent ligand 633	BWA-522 (28)|bivalent_ligand_633	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: BWA-522 (28) (CRBN:thalidomide --- AR:EPI-002)	-
33797	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li Y (2023)	37552639	254640	10855	Bivalent ligand 634	AD4|bivalent_ligand_634	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115114	9768	L5	KIAA0101	NS5ATP9|OEATC|OEATC-1|OEATC1|PAF|PAF15|p15(PAF)|p15/PAF|p15PAF	9606	Homo sapiens	target	Standardized BVL Name: AD4 (CRBN:pomalidomide --- PCLAF:SM1044)	-
33799	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gadiyar V (2023)	37545504	254641	10856	Bivalent ligand 635	KTX-335|bivalent_ligand_635	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	201398	17289	RP23-30M20.1	Mertk	Eyk|Mer|Nyk|nmf12	10090	Mus musculus	target	Standardized BVL Name: KTX-335 (CRBN:CRBN ligand (non IMiD) --- MERTK:MERTK ligand)	-
33801	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gadiyar V (2023)	37545504	254641	10857	Bivalent ligand 636	KTX-652|bivalent_ligand_636	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	201398	17289	RP23-30M20.1	Mertk	Eyk|Mer|Nyk|nmf12	10090	Mus musculus	target	Standardized BVL Name: KTX-652 (CRBN:CRBN ligand (non IMiD) --- MERTK:MERTK ligand)	-
33803	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gadiyar V (2023)	37545504	254641	10857	Bivalent ligand 636	KTX-652|bivalent_ligand_636	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	204922	26362	-	Axl	AI323647|Ark|Tyro7|Ufo	10090	Mus musculus	target	Standardized BVL Name: KTX-652 (CRBN:CRBN ligand (non IMiD) --- AXL:MERTK ligand)	-
33805	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gadiyar V (2023)	37545504	254641	10858	Bivalent ligand 637	KTX-978|bivalent_ligand_637	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	201398	17289	RP23-30M20.1	Mertk	Eyk|Mer|Nyk|nmf12	10090	Mus musculus	target	Standardized BVL Name: KTX-978 (CRBN:CRBN ligand (non IMiD) --- MERTK:MERTK ligand)	-
33807	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gadiyar V (2023)	37545504	254641	10858	Bivalent ligand 637	KTX-978|bivalent_ligand_637	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	204922	26362	-	Axl	AI323647|Ark|Tyro7|Ufo	10090	Mus musculus	target	Standardized BVL Name: KTX-978 (CRBN:CRBN ligand (non IMiD) --- AXL:MERTK ligand)	-
33809	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gadiyar V (2023)	37545504	254641	10858	Bivalent ligand 637	KTX-978|bivalent_ligand_637	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	204395	22174	RP23-356L21.1	Tyro3	AI323366|Brt|Dtk|Etk-2|Rse|Sky|TK19-2|Tif|etk2/tyro3	10090	Mus musculus	target	Standardized BVL Name: KTX-978 (CRBN:CRBN ligand (non IMiD) --- TYRO3:MERTK ligand)	-
33811	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Rathje OH (2023)	37535857	254770	10859	Bivalent ligand 638	Compound 36|bivalent_ligand_638	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	128244	197259	-	MLKL	hMLKL	9606	Homo sapiens	target	Standardized BVL Name: Compound 36 (CRBN:Lenalidomide --- MLKL:Ligand 1)	-
33813	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yang L (2023)	37523716	254780	10860	Bivalent ligand 639	SMD-3040 (29)|bivalent_ligand_639	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112479	6595	-	SMARCA2	BAF190|BRM|NCBRS|SNF2|SNF2L2|SNF2LA|SWI2|Sth1p|hBRM|hSNF2a	9606	Homo sapiens	target	Standardized BVL Name: SMD-3040 (29) (VHL:VHL Ligand --- SMARCA2:compound 3)	-
33815	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yang L (2023)	37523716	254780	10861	Bivalent ligand 640	Compound 15|bivalent_ligand_640	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112479	6595	-	SMARCA2	BAF190|BRM|NCBRS|SNF2|SNF2L2|SNF2LA|SWI2|Sth1p|hBRM|hSNF2a	9606	Homo sapiens	target	Standardized BVL Name: Compound 15 (VHL:VHL Ligand --- SMARCA2:compound 3)	-
33817	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Yang L (2023)	37523716	254780	10861	Bivalent ligand 640	Compound 15|bivalent_ligand_640	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112481	6597	-	SMARCA4	BAF190|BAF190A|BRG1|MRD16|RTPS2|SNF2|SNF2L4|SNF2LB|SWI2|hSNF2b	9606	Homo sapiens	target	Standardized BVL Name: Compound 15 (VHL:VHL Ligand --- SMARCA4:compound 3)	-
33819	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Cantley J (2022)	36357397	254785	10862	Bivalent ligand 641	A947|bivalent_ligand_641	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112479	6595	-	SMARCA2	BAF190|BRM|NCBRS|SNF2|SNF2L2|SNF2LA|SWI2|Sth1p|hBRM|hSNF2a	9606	Homo sapiens	target	Standardized BVL Name: A947 (VHL:VHL Ligand --- SMARCA2:SMARCA2/4/PBRM1 Ligand)	-
33821	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Cantley J (2022)	36357397	254785	10862	Bivalent ligand 641	A947|bivalent_ligand_641	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112481	6597	-	SMARCA4	BAF190|BAF190A|BRG1|MRD16|RTPS2|SNF2|SNF2L4|SNF2LB|SWI2|hSNF2b	9606	Homo sapiens	target	Standardized BVL Name: A947 (VHL:VHL Ligand --- SMARCA4:SMARCA2/4/PBRM1 Ligand)	-
33823	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Kofink C (2022)	36216795	254788	10863	Bivalent ligand 642	ACBI2|bivalent_ligand_642	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112479	6595	-	SMARCA2	BAF190|BRM|NCBRS|SNF2|SNF2L2|SNF2LA|SWI2|Sth1p|hBRM|hSNF2a	9606	Homo sapiens	target	Standardized BVL Name: ACBI2 (VHL:VHL ligand VH101 --- SMARCA2:SMARCA2/4/PBRM1 binder compound 3)	-
33825	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ismail TM (2023)	37509135	254795	10864	Bivalent ligand 643	RGC-01-05-18|bivalent_ligand_643	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112183	6275	-	S100A4	18A2|42A|CAPL|FSP1|MTS1|P9KA|PEL98	9606	Homo sapiens	target	Standardized BVL Name: RGC-01-05-18 (CRBN:thalidomide --- S100A4:US-10113)	-
33827	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Huang J (2023)	37487306	254800	10865	Bivalent ligand 644	compound 15|bivalent_ligand_644	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 15 (CRBN:pomalidomide --- BTK:ibrutinib)	-
33829	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bockstiegel J (2023)	37481141	254804	10866	Bivalent ligand 645	A6|bivalent_ligand_645	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: A6 (CRBN:thalidomide --- HDAC6:pan-HDAC inhibitor SAHA)	-
33831	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ayinde OR (2023)	37465296	254805	10867	Bivalent ligand 646	Compound 14|bivalent_ligand_646	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: Compound 14 (CRBN:thalidomide --- CDK9:AT7519)	-
33833	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Gui W (2023)	37449865	254807	10868	Bivalent ligand 647	WJ662|bivalent_ligand_647	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	target	Standardized BVL Name: WJ662 (VHL:VH 032 --- VHL:VH 032)	-
33835	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Valdivia A (2023)	37449845	254808	10869	Bivalent ligand 648	Compound 11|bivalent_ligand_648	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	target	Standardized BVL Name: Compound 11 (VHL:VH032 --- TG2:MT4)	-
33837	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Valdivia A (2023)	37449845	254808	10870	Bivalent ligand 649	Compound 7|bivalent_ligand_649	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	target	Standardized BVL Name: Compound 7 (VHL:VH032 --- TG2:MT4)	-
33839	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wurnig S (2023)	37448856	254811	10871	Bivalent ligand 650	3a|bivalent_ligand_650	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	target	Standardized BVL Name: 3a (CRBN:pomalidomide --- HSP90AA1:geldanamycin)	-
33841	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wurnig S (2023)	37448856	254811	10871	Bivalent ligand 650	3a|bivalent_ligand_650	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109558	3326	RP1-302G2.1	HSP90AB1	D6S182|HSP84|HSP90B|HSPC2|HSPCB	9606	Homo sapiens	target	Standardized BVL Name: 3a (CRBN:pomalidomide --- HSP90AB1:geldanamycin)	-
33843	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li P (2023)	37425039	254812	10872	Bivalent ligand 651	D10|bivalent_ligand_651	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: D10 (CRBN:thalidomide --- c-MET:tepotinib)	-
33845	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li P (2023)	37425039	254812	10873	Bivalent ligand 652	D15|bivalent_ligand_652	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: D15 (CRBN:thalidomide --- c-MET:tepotinib)	-
33847	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wei Y (2023)	37418973	254814	10874	Bivalent ligand 653	compound 9q|bivalent_ligand_653	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 9q (CRBN:Lenalidomide --- GSPT1:CC-885 target ligand derivative)	-
33849	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bagka M (2023)	37393376	254824	10875	Bivalent ligand 654	HPP-9|bivalent_ligand_654	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: HPP-9 (CRBN:Hydroxythalidomide --- BRD2:HPI-1)	-
33851	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bagka M (2023)	37393376	254824	10875	Bivalent ligand 654	HPP-9|bivalent_ligand_654	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: HPP-9 (CRBN:Hydroxythalidomide --- BRD3:HPI-1)	-
33853	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bagka M (2023)	37393376	254824	10875	Bivalent ligand 654	HPP-9|bivalent_ligand_654	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: HPP-9 (CRBN:Hydroxythalidomide --- BRD4:HPI-1)	-
33855	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Qi M (2023)	37386884	254833	10876	Bivalent ligand 655	PROTAC I-d|bivalent_ligand_655	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	206135	50868	-	Keap1	INRF2|mKIAA0132	10090	Mus musculus	target	Standardized BVL Name: PROTAC I-d (CRBN:pomalidomide --- Keap1:CDDO)	-
33857	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Han X (2023)	37382562	254846	10877	Bivalent ligand 656	ARD-2051|bivalent_ligand_656	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: ARD-2051 (CRBN:thalidomide --- AR:AR ligand 15a methyl derivative)	-
33859	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang P (2023)	37369332	254853	10878	Bivalent ligand 657	compound C5|bivalent_ligand_657	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115438	10135	-	NAMPT	1110035O14Rik|PBEF|PBEF1|VF|VISFATIN	9606	Homo sapiens	target	Standardized BVL Name: compound C5 (VHL:VHL ligand 2 --- NAMPT:FK866)	-
33861	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Park SY (2023)	37348157	254854	10879	Bivalent ligand 658	SD2267|bivalent_ligand_658	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	target	Standardized BVL Name: SD2267 (CRBN:pomalidomide --- KEAP1:Compound 8)	-
33863	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ody BK (2023)	37625128	254777	10880	Bivalent ligand 659	HaloPROTAC-4b|bivalent_ligand_659	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-4b (CRBN:pomalidomide --- EGFR:EGFP-HaloTag2)	-
33865	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ody BK (2023)	37625128	254777	10881	Bivalent ligand 660	HaloPROTAC-5c|bivalent_ligand_660	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-5c (CRBN:pomalidomide --- EGFR:EGFP-HaloTag2)	-
33867	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ody BK (2023)	37625128	254777	10882	Bivalent ligand 661	HaloPROTAC-3|bivalent_ligand_661	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: HaloPROTAC-3 (VHL:degradation moiety B --- EGFR:EGFP-HaloTag2)	-
33869	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10883	Bivalent ligand 662	11|bivalent_ligand_662	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: 11 (CRBN:pomalidomide --- AR:Enzalutamide)	-
33871	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10884	Bivalent ligand 663	13|bivalent_ligand_663	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106862	367	RP11-383C12.1	AR	AIS|DHTR|HUMARA|HYSP1|KD|NR3C4|SBMA|SMAX1|TFM	9606	Homo sapiens	target	Standardized BVL Name: 13 (CRBN:pomalidomide --- AR:Androgen receptor antagonist 1)	-
33873	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10885	Bivalent ligand 664	14|bivalent_ligand_664	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 14 (CRBN:pomalidomide --- BRD4:JQ1)	-
33875	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10886	Bivalent ligand 665	15|bivalent_ligand_665	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 15 (CRBN:pomalidomide --- BRD4:JQ1)	-
33877	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10887	Bivalent ligand 666	16|bivalent_ligand_666	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 16 (CRBN:pomalidomide --- BRD4:JQ1)	-
33879	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10888	Bivalent ligand 667	18|bivalent_ligand_667	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118878	29110	-	TBK1	NAK|T2K	9606	Homo sapiens	target	Standardized BVL Name: 18 (CRBN:pomalidomide --- TBK1:N-[3-[(2-anilino-5-bromopyrimidin-4-yl)amino]propyl]-N-methylcyclobutanecarboxamide)	-
33881	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10889	Bivalent ligand 668	19|bivalent_ligand_668	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118878	29110	-	TBK1	NAK|T2K	9606	Homo sapiens	target	Standardized BVL Name: 19 (CRBN:pomalidomide --- TBK1:N-[3-[(2-anilino-5-bromopyrimidin-4-yl)amino]propyl]-N-methylcyclobutanecarboxamide)	-
33883	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620218	256641	10890	Bivalent ligand 669	21|bivalent_ligand_669	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108405	2101	-	ESRRA	ERR1|ERRa|ERRalpha|ESRL1|NR3B1	9606	Homo sapiens	target	Standardized BVL Name: 21 (CRBN:pomalidomide --- ERRalpha:E3 ligase Ligand 5)	-
33885	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10891	Bivalent ligand 670	I-215|bivalent_ligand_670	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-215 (CRBN:pomalidomide--- IRAK4:IRAK4 binding moiety 1)	-
33887	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10892	Bivalent ligand 671	I-219|bivalent_ligand_671	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-219 (CRBN:pomalidomide--- IRAK4:IRAK4 binding moiety 1)	-
33889	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10893	Bivalent ligand 672	I-222|bivalent_ligand_672	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-222 (CRBN:pomalidomide--- IRAK4:IRAK4 binding moiety 2)	-
33891	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10894	Bivalent ligand 673	I-228|bivalent_ligand_673	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-228 (CRBN:thalidomide--- IRAK4:IRAK4 binding moiety 3)	-
33893	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10895	Bivalent ligand 674	I-265|bivalent_ligand_674	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-265 (CRBN:Compound I-1--- IRAK4:IRAK4 binding moiety 4)	-
33895	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10896	Bivalent ligand 675	I-283|bivalent_ligand_675	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-283 (CRBN:pomalidomide--- IRAK4:IRAK4 binding moiety 5)	-
33897	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10897	Bivalent ligand 676	I-305|bivalent_ligand_676	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-305 (CRBN:pomalidomide--- IRAK4:IRAK4 binding moiety 1)	-
33899	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10898	Bivalent ligand 677	I-308|bivalent_ligand_677	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-308 (CRBN:thalidomide--- IRAK4:IRAK4 binding moiety 3)	-
33901	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10899	Bivalent ligand 678	I-309|bivalent_ligand_678	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-309 (CRBN:thalidomide--- IRAK4:IRAK4 binding moiety 6)	-
33903	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kargbo RB (2019)	31620217	256642	10900	Bivalent ligand 679	I-313|bivalent_ligand_679	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: I-313 (CRBN:thalidomide--- IRAK4:IRAK4 binding moiety 3)	-
33905	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zheng M (2021)	33706076	256643	10901	Bivalent ligand 680	SP4|bivalent_ligand_680	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111745	5781	-	PTPN11	BPTP3|CFC|NS1|PTP-1D|PTP2C|SH-PTP2|SH-PTP3|SHP2	9606	Homo sapiens	target	Standardized BVL Name: SP4 (CRBN:pomalidomide --- PTPN11:SHP099)	-
33907	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li Z (2020)	33088687	256644	10902	Bivalent ligand 681	9c|bivalent_ligand_681	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106658	148	-	ADRA1A	ADRA1C|ADRA1L1|ALPHA1AAR	9606	Homo sapiens	target	Standardized BVL Name: 9c (CRBN:pomalidomide --- ADRA1A:prazosin)	-
33909	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sinatra L (2020)	32780485	256645	10903	Bivalent ligand 682	HDAC PROTAC 4|bivalent_ligand_682	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: HDAC PROTAC 4 (CRBN:thalidomide-based ligand ---HDAC1:HAIR D)	-
33911	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sinatra L (2020)	32780485	256645	10903	Bivalent ligand 682	HDAC PROTAC 4|bivalent_ligand_682	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: HDAC PROTAC 4 (CRBN:thalidomide-based ligand ---HDAC1:HAIR D)	-
33913	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sinatra L (2022)	36473103	256646	10904	Bivalent ligand 683	A6|bivalent_ligand_683	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: A6 (CRBN:thalidomide --- HDAC6:vorinostat-like HDAC ligand)	-
33915	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sinatra L (2022)	36473103	256646	10904	Bivalent ligand 683	A6|bivalent_ligand_683	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109315	3065	RP4-811H24.2	HDAC1	GON-10|HD1|RPD3|RPD3L1	9606	Homo sapiens	target	Standardized BVL Name: A6 (CRBN:thalidomide --- HDAC1:vorinostat-like HDAC ligand)	-
33917	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sinatra L (2022)	36473103	256646	10905	Bivalent ligand 684	B4|bivalent_ligand_684	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115330	10013	JM21	HDAC6	CPBHM|HD6|PPP1R90	9606	Homo sapiens	target	Standardized BVL Name: B4 (CRBN:thalidomide --- HDAC6:benzimidazole-based HDAC6 ligand)	-
33919	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu F (2022)	35652200	256647	10906	Bivalent ligand 685	dAurA383|bivalent_ligand_685	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: dAurA383 (CRBN:thalidomide --- AURKA:MLN8237)	-
33921	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Liu F (2022)	35652200	256647	10907	Bivalent ligand 686	dAurA425|bivalent_ligand_686	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: dAurA425 (VHL:VH032 --- AURKA:MLN8237)	-
33923	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Liu F (2022)	35652200	256647	10908	Bivalent ligand 687	dAurA450|bivalent_ligand_687	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112666	6790	RP5-1167H4.6	AURKA	AIK|ARK1|AURA|AURORA2|BTAK|PPP1R47|STK15|STK6|STK7	9606	Homo sapiens	target	Standardized BVL Name: dAurA450 (cIAP1:cIAP1 ligand --- AURKA:MLN8237)	-
33925	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang L (2021)	33664520	256648	10909	Bivalent ligand 688	CPS2|bivalent_ligand_688	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: CPS2 (CRBN:pomalidomide --- CDK2:J2)	-
33927	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jin J (2022)	36509291	256649	10910	Bivalent ligand 689	TSM-1|bivalent_ligand_689	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112651	6774	-	STAT3	ADMIO|APRF|HIES	9606	Homo sapiens	target	Standardized BVL Name: TSM-1 (CRBN:lenalidomide --- STAT3:Toosendanin)	-
33929	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	36508995	256650	10911	Bivalent ligand 690	SV|bivalent_ligand_690	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	target	Standardized BVL Name: SV (VHL:VH032 --- PDGFRB:sorafenib)	-
33931	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	36508995	256650	10912	Bivalent ligand 691	SL|bivalent_ligand_691	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	target	Standardized BVL Name: SL (CRBN:lenalidomide --- PDGFRB:sorafenib)	-
33933	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Si R (2023)	36508995	256650	10913	Bivalent ligand 692	SF|bivalent_ligand_692	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111185	5159	-	PDGFRB	CD140B|IBGC4|IMF1|JTK12|PDGFR|PDGFR-1|PDGFR1	9606	Homo sapiens	target	Standardized BVL Name: SF (CRBN:4-fluoro-thalidomide --- PDGFRB:sorafenib)	-
33935	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen H (2023)	36473314	256651	10914	Bivalent ligand 693	PROTAC 14|bivalent_ligand_693	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 14 (CRBN:thalidomide --- KEAP1:inhibitor 2)	-
33937	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen J (2022)	35395439	256652	10915	Bivalent ligand 694	7f|bivalent_ligand_694	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 7f (CRBN:pomalidomide --- BRD4:ABBV-744)	-
33939	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen J (2022)	35395439	256652	10916	Bivalent ligand 695	13d|bivalent_ligand_695	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 13d (CRBN:pomalidomide ---BRD4:ABBV-744)	-
33941	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Xiao Z (2021)	34018657	255460	10917	Bivalent ligand 696	MD13|bivalent_ligand_696	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	target	Standardized BVL Name: MD13 (CRBN:pomalidomide --- MIF:Compound 3 (MIF tautomerase inhibitor))	-
33943	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Du G (2021)	33915015	255461	10918	Bivalent ligand 697	DGY-09-192|bivalent_ligand_697	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108551	2260	-	FGFR1	BFGFR|CD331|CEK|FGFBR|FGFR-1|FLG|FLT-2|FLT2|HBGFR|HH2|HRTFDS|KAL2|N-SAM|OGD|bFGF-R-1	9606	Homo sapiens	target	Standardized BVL Name: DGY-09-192 (VHL:VHL ligand --- FGFR1:BGJ398)	-
33945	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Du G (2021)	33915015	255461	10918	Bivalent ligand 697	DGY-09-192|bivalent_ligand_697	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	target	Standardized BVL Name: DGY-09-192 (VHL:VHL ligand --- FGFR2:BGJ398)	-
33947	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou H (2021)	34141084	255462	10919	Bivalent ligand 698	SD-91|bivalent_ligand_698	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112651	6774	-	STAT3	ADMIO|APRF|HIES	9606	Homo sapiens	target	Standardized BVL Name: SD-91 (CRBN:lenalidomide --- STAT3:SI-191)	-
33949	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang H (2022)	35178183	255463	10920	Bivalent ligand 699	Compound 6h|bivalent_ligand_699	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: Compound 6h (VHL:VHL ligand --- EGFR Del19/T790M/C797S:brigatinib analog 3)	-
33951	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen S (2023)	37119666	255464	10921	Bivalent ligand 700	compound 3e|bivalent_ligand_700	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 3e (CRBN:Lenalidomide-6-F --- BTK:ARQ-531 derivative)	-
33953	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Y (2021)	34509879	255466	10922	Bivalent ligand 701	compound 4f|bivalent_ligand_701	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 4f (CRBN:pomalidomide --- BTK:warhead A (ARQ531 derivative Compound 4))	-
33955	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Y (2021)	34509879	255466	10923	Bivalent ligand 702	compound 4g|bivalent_ligand_702	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 4g (CRBN:pomalidomide --- BTK:warhead A (ARQ531 derivative Compound 4))	-
33957	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Y (2021)	34509879	255466	10924	Bivalent ligand 703	compound 6c|bivalent_ligand_703	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 6c (CRBN:pomalidomide --- BTK:warhead B (ARQ531 derivative Compound 6))	-
33959	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Y (2021)	34509879	255466	10925	Bivalent ligand 704	compound 6d|bivalent_ligand_704	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 6d (CRBN:pomalidomide --- BTK:warhead B (ARQ531 derivative Compound 6))	-
33961	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhao Y (2021)	34509879	255466	10926	Bivalent ligand 705	compound 6e|bivalent_ligand_705	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: compound 6e (CRBN:pomalidomide --- BTK:warhead B (ARQ531 derivative Compound 6))	-
33963	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang B (2021)	33862513	232662	10928	Bivalent ligand 707	WB214|bivalent_ligand_707	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	target	Standardized BVL Name: WB214 (CRBN:lenalidomide --- MDM2:MDM2 Ugi ligand 1)	-
33965	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang B (2021)	33862513	232662	10928	Bivalent ligand 707	WB214|bivalent_ligand_707	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: WB214 (CRBN:lenalidomide --- GSPT1:MDM2 Ugi ligand 1)	-
33967	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang B (2021)	33862513	232662	10929	Bivalent ligand 708	compound 36|bivalent_ligand_708	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109190	2935	-	GSPT1	551G9.2|ETF3A|GST1|eRF3a	9606	Homo sapiens	target	Standardized BVL Name: compound 36 (CRBN:lenalidomide --- GSPT1:MDM2 Ugi ligand 1 derivative)	-
33969	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Shi W (2022)	35279611	255470	10930	Bivalent ligand 709	compound 20|bivalent_ligand_709	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107036	558	-	AXL	ARK|JTK11|Tyro7|UFO	9606	Homo sapiens	target	Standardized BVL Name: compound 20 (CRBN:lenalidomide --- AXL:R428 derivative)	-
33971	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Shi W (2022)	35279611	255470	10931	Bivalent ligand 710	compound 22|bivalent_ligand_710	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107036	558	-	AXL	ARK|JTK11|Tyro7|UFO	9606	Homo sapiens	target	Standardized BVL Name: compound 22 (CRBN:lenalidomide --- AXL:R428 derivative)	-
33973	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Niu T (2022)	34864331	255472	10932	Bivalent ligand 711	PP-C8|bivalent_ligand_711	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: PP-C8 (CRBN:pomalidomide --- CDK12:compound 3 (CDK12 inhibitor 1 derivative))	-
33975	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2021)	33753926	255473	10933	Bivalent ligand 712	BSJ-4-116|bivalent_ligand_712	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: BSJ-4-116 (CRBN:thalidomide --- CDK12:TL13-87 derivative)	-
33977	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jiang B (2021)	33753926	255473	10934	Bivalent ligand 713	BSJ-4-23|bivalent_ligand_713	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119715	51755	RP11-390P24.1	CDK12	CRK7|CRKR|CRKRS	9606	Homo sapiens	target	Standardized BVL Name: BSJ-4-23 (CRBN:thalidomide --- CDK12:THZ531 fragment 5)	-
33979	108009	1642	-	DDB1	DDBA|UV-DDB1|XAP1|XPCE|XPE|XPE-BF	9606	Homo sapiens	degradation	recruited e3 ligase	Dieter SM (2021)	34289372	255474	10935	Bivalent ligand 714	NCT02|bivalent_ligand_714	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	114339	8812	-	CCNK	CPR4	9606	Homo sapiens	target	Standardized BVL Name: NCT02 (DDB1:NCT02 --- CCNK:NCT02)	-
33981	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hati S (2021)	34560429	255476	10936	Bivalent ligand 715	PROTAC-8|bivalent_ligand_715	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107452	1017	-	CDK2	CDKN2|p33(CDK2)	9606	Homo sapiens	target	Standardized BVL Name: PROTAC-8 (VHL:VH032 --- CDK2:AZD5438)	-
33983	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bai M (2024)	38512906	255477	10937	Bivalent ligand 716	Halo-PROTAC 3|bivalent_ligand_716	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	117422	25921	-	ZDHHC5	DHHC5|ZNF375	9606	Homo sapiens	target	Standardized BVL Name: Halo-PROTAC 3 (VHL:VH032 --- zDHHC5:Halo-zDHHC5)	-
33985	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bai M (2024)	38512906	255477	10938	Bivalent ligand 717	Halo-PROTAC 1|bivalent_ligand_717	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	117422	25921	-	ZDHHC5	DHHC5|ZNF375	9606	Homo sapiens	target	Standardized BVL Name: Halo-PROTAC 1 (VHL:fluorocyclopropane-containing VHL-targeting ligand --- zDHHC5:Halo-zDHHC5)	-
33987	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Bai M (2024)	38512906	255477	10939	Bivalent ligand 718	Halo-PROTAC 2|bivalent_ligand_718	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	128991	253832	-	ZDHHC20	4933421L13Rik|DHHC-20	9606	Homo sapiens	target	Standardized BVL Name: Halo-PROTAC 2 (CRBN:pomalidomide --- zDHHC20:Halo-zDHHC20)	-
33989	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bai M (2024)	38512906	255477	10937	Bivalent ligand 716	Halo-PROTAC 3|bivalent_ligand_716	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	128991	253832	-	ZDHHC20	4933421L13Rik|DHHC-20	9606	Homo sapiens	target	Standardized BVL Name: Halo-PROTAC 3 (VHL:VH032 --- zDHHC20:Halo-zDHHC20)	-
33991	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bai M (2024)	38512906	255477	10938	Bivalent ligand 717	Halo-PROTAC 1|bivalent_ligand_717	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	HaloPROTAC	PROTAC variant that induces degradation of HaloTag fusion proteins; structured as E3 binding moiety--linker--HaloTag binding moiety; target degraded via UPS	128991	253832	-	ZDHHC20	4933421L13Rik|DHHC-20	9606	Homo sapiens	target	Standardized BVL Name: Halo-PROTAC 1 (VHL:fluorocyclopropane-containing VHL-targeting ligand --- zDHHC20:Halo-zDHHC20)	-
33993	204518	22346	-	Vhl	Vhlh	10090	Mus musculus	degradation	recruited e3 ligase	Zhang C (2021)	34006860	256653	10940	Bivalent ligand 719	SPNpro|bivalent_ligand_719	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	200512	15930	-	Ido1	Ido|Indo	10090	Mus musculus	target	Standardized BVL Name: SPNpro (VHL:HIF1a peptide --- Ido:NLG919)	-
33995	204518	22346	-	Vhl	Vhlh	10090	Mus musculus	degradation	recruited e3 ligase	Zhang C (2021)	34006860	256653	10940	Bivalent ligand 719	SPNpro|bivalent_ligand_719	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	229050	209176	C230043N17	Ido2	AI265623|C230043N17Rik|Ido-2|Indol1	10090	Mus musculus	target	Standardized BVL Name: SPNpro (VHL:HIF1a peptide --- Ido:NLG919)	-
33997	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zheng X (2024)	39151120	256654	10941	Bivalent ligand 720	KT-474|bivalent_ligand_720	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119322	51135	RP11-210N13.4	IRAK4	IPD1|IRAK-4|NY-REN-64|REN64	9606	Homo sapiens	target	Standardized BVL Name: KT-474 (CRBN: (3S)-3-(3-methyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-1-yl)piperidine-2,6-dione --- IRAK4:compound 4)	-
33999	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Li N (2025)	40045307	256655	10942	Bivalent ligand 721	KT-333|bivalent_ligand_721	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112651	6774	-	STAT3	ADMIO|APRF|HIES	9606	Homo sapiens	target	Standardized BVL Name: KT-333 (VHL:VHL ligand --- STAT3:undisclosed)	-
34001	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Salvaris RT (2025)	39941922	256656	10943	Bivalent ligand 722	NX-5948 (BTK-IN-24)|bivalent_ligand_722	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: NX-5948 (CRBN:undisclosed --- BTK:undisclosed)	-
34003	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Salvaris RT (2025)	39941922	256656	10944	Bivalent ligand 723	NX-2127|bivalent_ligand_723	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: NX-2127 (CRBN:Thalidomide 5-fluoride --- BTK:BTK ligand 10)	-
34005	123565	81631	-	MAP1LC3B	ATG8F|LC3B|MAP1A/1BLC3|MAP1LC3B-a	9606	Homo sapiens	degradation	autophagy-targeting protein	Pei J (2021)	34816823	256657	10945	Bivalent ligand 724	10f|bivalent_ligand_724	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	AUTAC/ATTEC	Autophagosome Tethering Compound; structured as a LC3 binding moiety--linker--target binding moiety; target degraded via autophagic degradation	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: 10f (MAP1LC3B:GW5074 --- BRD4:JQ1)	-
34007	109703	3482	-	IGF2R	CD222|CIMPR|M6P-R|MPR1|MPRI	9606	Homo sapiens	degradation	lysosome-targeting protein	Zhou P (2024)	39267779	256658	10946	Bivalent ligand 725	V5|bivalent_ligand_725	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	113265	7422	RP1-261G23.1	VEGFA	MVCD1|VEGF|VPF	9606	Homo sapiens	target	Standardized BVL Name: V5 (IGF2R:M6PR-A --- VEGF:VEGF-A2)	-
34009	106924	432	-	ASGR1	ASGPR|ASGPR1|CLEC4H1|HL-1	9606	Homo sapiens	degradation	lysosome-targeting protein	Du J (2024)	38910165	256659	10947	Bivalent ligand 726	OEGMA10-BMS-110-GalMA10|bivalent_ligand_726	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: OEGMA10-BMS-110-GalMA10 (ASGR1:GalMA --- CD274:BMS-1)	-
34011	106924	432	-	ASGR1	ASGPR|ASGPR1|CLEC4H1|HL-1	9606	Homo sapiens	degradation	lysosome-targeting protein	Du J (2024)	38910165	256659	10948	Bivalent ligand 727	OEGMA10-CP10-GalMA10|bivalent_ligand_727	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	118891	29126	-	CD274	B7-H|B7H1|PD-L1|PDCD1L1|PDCD1LG1|PDL1	9606	Homo sapiens	target	Standardized BVL Name: OEGMA10-CP10-GalMA10 (ASGR1:GalMA --- CD274:cycloPep)	-
34013	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	degradation	lysosome-targeting protein	Loppinet E (2023)	37590164	256660	10949	Bivalent ligand 728	HB-3-2|bivalent_ligand_728	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	113724	8029	RP11-416D8.1	CUBN	IFCR|MGA1|gp280	9606	Homo sapiens	target	Standardized BVL Name: HB-3-2 (TGM2:Ac-PQLPF-NH2 --- CUBN:vitamin B12)	-
34015	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	degradation	lysosome-targeting protein	Loppinet E (2023)	37590164	256660	10950	Bivalent ligand 729	HB-3-20|bivalent_ligand_729	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	109891	3685	-	ITGAV	CD51|MSK8|VNRA|VTNR	9606	Homo sapiens	target	Standardized BVL Name: HB-3-20 (TGM2:Ac-PQLPF-NH2 --- ITGAV:RGDVF)	-
34017	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	degradation	lysosome-targeting protein	Loppinet E (2023)	37590164	256660	10950	Bivalent ligand 729	HB-3-20|bivalent_ligand_729	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	109899	3693	-	ITGB5	-	9606	Homo sapiens	target	Standardized BVL Name: HB-3-20 (TGM2:Ac-PQLPF-NH2 --- ITGB5:RGDVF)	-
34019	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	degradation	lysosome-targeting protein	Loppinet E (2023)	37590164	256660	10951	Bivalent ligand 730	HB-3-23|bivalent_ligand_730	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	109891	3685	-	ITGAV	CD51|MSK8|VNRA|VTNR	9606	Homo sapiens	target	Standardized BVL Name: HB-3-23 (TGM2:Ac-PQLPF-NH2 --- ITGAV:RGDVF)	-
34021	112910	7052	RP5-1054A22.2	TGM2	G-ALPHA-h|GNAH|HEL-S-45|TG2|TGC	9606	Homo sapiens	degradation	lysosome-targeting protein	Loppinet E (2023)	37590164	256660	10951	Bivalent ligand 730	HB-3-23|bivalent_ligand_730	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	109899	3693	-	ITGB5	-	9606	Homo sapiens	target	Standardized BVL Name: HB-3-23 (TGM2:Ac-PQLPF-NH2 --- ITGB5:RGDVF)	-
34023	106924	432	-	ASGR1	ASGPR|ASGPR1|CLEC4H1|HL-1	9606	Homo sapiens	degradation	lysosome-targeting protein	Wu Y (2023)	36722696	256661	10952	Bivalent ligand 731	GalNAc-AptPDGF|bivalent_ligand_731	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	111181	5155	LL22NC03-10C3.2	PDGFB	IBGC5|PDGF-2|PDGF2|SIS|SSV|c-sis	9606	Homo sapiens	target	Standardized BVL Name: GalNAc-AptPDGF (ASGR1:tri-GalNAc --- PDGFB:AptPDGF)	-
34025	106924	432	-	ASGR1	ASGPR|ASGPR1|CLEC4H1|HL-1	9606	Homo sapiens	degradation	lysosome-targeting protein	Wu Y (2023)	36722696	256661	10953	Bivalent ligand 732	GalNAc-AptPTK7|bivalent_ligand_732	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	LYTAC	Lysosome Targeting Chimera; structured as glycopeptide ligand--linker--target binding moiety; target degraded via endosome-lysosome system	111721	5754	-	PTK7	CCK-4|CCK4	9606	Homo sapiens	target	Standardized BVL Name: GalNAc-AptPTK7 (ASGR1:tri-GalNAc --- PTK7:AptPTK7)	-
34027	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10954	Bivalent ligand 733	PS-RC-1|bivalent_ligand_733	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: PS-RC-1 (CRBN:pomalidomide ---IKZF1:pomalidomide)	-
34029	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10954	Bivalent ligand 733	PS-RC-1|bivalent_ligand_733	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: PS-RC-1 (CRBN:pomalidomide ---IKZF3:pomalidomide)	-
34031	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10955	Bivalent ligand 734	PS-1|bivalent_ligand_734	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: PS-1 (CRBN:pomalidomide ---IKZF1:pomalidomide)	-
34033	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10955	Bivalent ligand 734	PS-1|bivalent_ligand_734	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: PS-1 (CRBN:pomalidomide ---IKZF3:pomalidomide)	-
34035	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10956	Bivalent ligand 735	PS-2|bivalent_ligand_735	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: PS-2 (CRBN:pomalidomide ---IKZF1:pomalidomide)	-
34037	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10956	Bivalent ligand 735	PS-2|bivalent_ligand_735	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: PS-2 (CRBN:pomalidomide ---IKZF3:pomalidomide)	-
34039	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yu X (2023)	36712232	256662	10956	Bivalent ligand 735	PS-2|bivalent_ligand_735	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: PS-2 (CRBN:pomalidomide ---BTK:poseltinib)	-
34041	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2021)	34432252	256663	10957	Bivalent ligand 736	PHOTAC-I-3|bivalent_ligand_736	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	113715	8019	RP11-374P20.3	BRD3	ORFX|RING3L	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-3 (CRBN:lenalidomide ---BRD3:JQ1)	-
34043	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2021)	34432252	256663	10957	Bivalent ligand 736	PHOTAC-I-3|bivalent_ligand_736	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-3 (CRBN:lenalidomide --- BRD4:JQ1)	-
34045	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2021)	34432252	256663	10957	Bivalent ligand 736	PHOTAC-I-3|bivalent_ligand_736	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	111973	6046	DADB-17J1.3	BRD2	D6S113E|FSH|FSRG1|NAT|RING3|RNF3	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-3 (CRBN:lenalidomide --- BRD2:JQ1)	-
34047	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2021)	34432252	256663	10958	Bivalent ligand 737	PHOTAC-I-10|bivalent_ligand_737	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-I-10 (CRBN:thalidomide --- BRD4:JQ1)	-
34049	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2021)	34432252	256663	10959	Bivalent ligand 738	PHOTAC-II-5|bivalent_ligand_738	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-II-5 (CRBN:glutarimide --- FKBP12:SLF)	-
34051	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Reynders M (2021)	34432252	256663	10960	Bivalent ligand 739	PHOTAC-II-6|bivalent_ligand_739	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Opto-PROTAC	PROTAC variant in which a light-inducible degradation tag can be used to regulate target degradation activity; structured as E3 binding moiety with a photolabile caging group--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: PHOTAC-II-6 (CRBN:glutarimide --- FKBP12:SLF)	-
34053	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2020)	33284613	256664	10961	Bivalent ligand 740	MS928|bivalent_ligand_740	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	target	Standardized BVL Name: MS928 (VHL:VHL-1 --- MAP2K1:PD0325901)	-
34055	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2020)	33284613	256664	10961	Bivalent ligand 740	MS928|bivalent_ligand_740	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111591	5605	-	MAP2K2	CFC4|MAPKK2|MEK2|MKK2|PRKMK2	9606	Homo sapiens	target	Standardized BVL Name: MS928 (VHL:VHL-1 --- MAP2K2:PD0325901)	-
34057	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2020)	33284613	256664	10962	Bivalent ligand 741	MS934|bivalent_ligand_741	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	target	Standardized BVL Name: MS934 (VHL:VHL-1 --- MAP2K1:PD0325901)	-
34059	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2020)	33284613	256664	10962	Bivalent ligand 741	MS934|bivalent_ligand_741	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111591	5605	-	MAP2K2	CFC4|MAPKK2|MEK2|MKK2|PRKMK2	9606	Homo sapiens	target	Standardized BVL Name: MS934 (VHL:VHL-1 --- MAP2K2:PD0325901)	-
34061	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2020)	33284613	256664	10963	Bivalent ligand 742	MS910|bivalent_ligand_742	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111590	5604	-	MAP2K1	CFC3|MAPKK1|MEK1|MKK1|PRKMK1	9606	Homo sapiens	target	Standardized BVL Name: MS910 (CRBN:pomalidomide --- MAP2K1:PD0325901)	-
34063	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2020)	33284613	256664	10963	Bivalent ligand 742	MS910|bivalent_ligand_742	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111591	5605	-	MAP2K2	CFC4|MAPKK2|MEK2|MKK2|PRKMK2	9606	Homo sapiens	target	Standardized BVL Name: MS910 (CRBN:pomalidomide --- MAP2K2:PD0325901)	-
34065	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu Z (2021)	33606537	256665	10964	Bivalent ligand 743	E7|bivalent_ligand_743	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: E7 (CRBN:4-hydroxythalidomide --- EZH2:EPZ6438)	-
34067	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu Z (2021)	33606537	256665	10964	Bivalent ligand 743	E7|bivalent_ligand_743	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: E7 (CRBN:4-hydroxythalidomide --- EED:EPZ6438)	-
34069	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu Z (2021)	33606537	256665	10964	Bivalent ligand 743	E7|bivalent_ligand_743	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117059	23512	-	SUZ12	CHET9|JJAZ1	9606	Homo sapiens	target	Standardized BVL Name: E7 (CRBN:4-hydroxythalidomide --- SUZ12:EPZ6438)	-
34071	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Liu Z (2021)	33606537	256665	10964	Bivalent ligand 743	E7|bivalent_ligand_743	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111863	5928	-	RBBP4	NURF55|RBAP48|lin-53	9606	Homo sapiens	target	Standardized BVL Name: E7 (CRBN:4-hydroxythalidomide --- RBBP4:EPZ6438)	-
34073	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Dragovich PS (2021)	33596073	256666	10965	Bivalent ligand 744	compound 8|bivalent_ligand_744	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound 8 (VHL:VH032 --- BRD4:compound 4-fragment 5)	-
34075	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Dragovich PS (2021)	33596073	256666	10966	Bivalent ligand 745	compound 9|bivalent_ligand_745	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound 9 (VHL:VH032 --- BRD4:compound 4-fragment 5)	-
34077	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Dragovich PS (2021)	33596073	256666	10967	Bivalent ligand 746	compound 12|bivalent_ligand_746	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound 12 (VHL:VH032 --- BRD4:compound 4-fragment 5)	-
34079	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Dragovich PS (2021)	33596073	256666	10968	Bivalent ligand 747	compound 13|bivalent_ligand_747	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: compound 13 (VHL:VH032 --- BRD4:compound 4-fragment 5)	-
34081	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hong JY (2020)	33214845	256667	10969	Bivalent ligand 748	TM-P2-Thal|bivalent_ligand_748	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	target	Standardized BVL Name: TM-P2-Thal (CRBN:thalidomide --- SIRT2: TM)	-
34083	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hong JY (2020)	33214845	256667	10970	Bivalent ligand 749	TM-P4-Thal|bivalent_ligand_749	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	target	Standardized BVL Name: TM-P4-Thal (CRBN:thalidomide --- SIRT2: TM)	-
34085	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yokoo H (2021)	33603969	256668	10971	Bivalent ligand 750	PROTAC(H-PGDS)-1|bivalent_ligand_750	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	target	Standardized BVL Name: PROTAC(H-PGDS)-1 (CRBN:pomalidomide --- HPGDS:TFC-007)	-
34087	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10972	Bivalent ligand 751	UNC7700|bivalent_ligand_751	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: UNC7700 (VHL:VH032-amine ---EED:EED226)	-
34089	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10972	Bivalent ligand 751	UNC7700|bivalent_ligand_751	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: UNC7700 (VHL:VH032-amine ---EZH2:EED226)	-
34091	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10972	Bivalent ligand 751	UNC7700|bivalent_ligand_751	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117059	23512	-	SUZ12	CHET9|JJAZ1	9606	Homo sapiens	target	Standardized BVL Name: UNC7700 (VHL:VH032-amine ---SUZ12:EED226)	-
34093	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10973	Bivalent ligand 752	UNC7327|bivalent_ligand_752	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: UNC7327 (VHL:VH032-amine ---EED:EED226)	-
34095	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10973	Bivalent ligand 752	UNC7327|bivalent_ligand_752	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108446	2146	-	EZH2	ENX-1|ENX1|EZH1|EZH2b|KMT6|KMT6A|WVS|WVS2	9606	Homo sapiens	target	Standardized BVL Name: UNC7327 (VHL:VH032-amine ---EZH2:EED226)	-
34097	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10973	Bivalent ligand 752	UNC7327|bivalent_ligand_752	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117059	23512	-	SUZ12	CHET9|JJAZ1	9606	Homo sapiens	target	Standardized BVL Name: UNC7327 (VHL:VH032-amine ---SUZ12:EED226)	-
34099	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Bashore FM (2023)	36877831	256669	10974	Bivalent ligand 753	UNC7698|bivalent_ligand_753	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: UNC7698 (VHL:VH032-amine ---EED:EED226)	-
34101	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun X (2019)	30729032	256670	10975	Bivalent ligand 754	RC32|bivalent_ligand_754	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108570	2280	RP11-314N13.2	FKBP1A	FKBP-12|FKBP-1A|FKBP1|FKBP12|PKC12|PKCI2|PPIASE	9606	Homo sapiens	target	Standardized BVL Name: RC32 (CRBN:pomalidomide --- FKBP1A:rapamycin)	-
34103	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun X (2019)	30729032	256670	10975	Bivalent ligand 754	RC32|bivalent_ligand_754	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108571	2281	-	FKBP1B	FKBP12.6|FKBP1L|OTK4|PKBP1L|PPIase	9606	Homo sapiens	target	Standardized BVL Name: RC32 (CRBN:pomalidomide --- FKBP1B:rapamycin)	-
34105	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun X (2019)	30729032	256670	10975	Bivalent ligand 754	RC32|bivalent_ligand_754	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	199682	14225	RP23-419G21.5	Fkbp1a	FKBP12|Fkbp|Fkbp1	10090	Mus musculus	target	Standardized BVL Name: RC32 (CRBN:pomalidomide --- Fkbp1a:rapamycin)	-
34107	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun X (2019)	30729032	256670	10975	Bivalent ligand 754	RC32|bivalent_ligand_754	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	247668	25639	-	Fkbp1a	FKBP12|Fkbp2	10116	Rattus norvegicus	target	Standardized BVL Name: RC32 (CRBN:pomalidomide --- Fkbp1a:rapamycin)	-
34109	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kim SA (2019)	30684871	220042	10976	Bivalent ligand 755	TD-106|bivalent_ligand_755	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	115604	10320	tcag7.1178	IKZF1	Hs.54452|IK1|IKAROS|LYF1|LyF-1|PPP1R92|PRO0758|ZNFN1A1	9606	Homo sapiens	target	Standardized BVL Name: TD-106 (CRBN:TD-106 --- IKZF1:TD-106)	-
34111	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kim SA (2019)	30684871	220042	10976	Bivalent ligand 755	TD-106|bivalent_ligand_755	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	116484	22806	RP11-94L15.2	IKZF3	AIO|AIOLOS|ZNFN1A3	9606	Homo sapiens	target	Standardized BVL Name: TD-106 (CRBN:TD-106 --- IKZF3:TD-106)	-
34113	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kim SA (2019)	30684871	220042	10977	Bivalent ligand 756	TD-428|bivalent_ligand_756	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117036	23476	-	BRD4	CAP|HUNK1|HUNKI|MCAP	9606	Homo sapiens	target	Standardized BVL Name: TD-428 (CRBN:TD-106 --- BRD4:JQ1)	-
34115	117123	23588	-	KLHDC2	HCLP-1|HCLP1|LCP	9606	Homo sapiens	degradation	recruited e3 ligase	Kim Y (2023)	37567174	256416	10978	Bivalent ligand 757	KYH1872/Compound 26|bivalent_ligand_757	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	124876	91754	-	NEK9	NERCC|NERCC1|Nek8	9606	Homo sapiens	target	Standardized BVL Name: KYH1872 (KLHDC2:SelK peptide --- NEK9:YHJ1039)	-
34117	117123	23588	-	KLHDC2	HCLP-1|HCLP1|LCP	9606	Homo sapiens	degradation	recruited e3 ligase	Kim Y (2023)	37567174	256416	10978	Bivalent ligand 757	KYH1872/Compound 26|bivalent_ligand_757	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111719	5747	-	PTK2	FADK|FAK|FAK1|FRNK|PPP1R71|p125FAK|pp125FAK	9606	Homo sapiens	target	Standardized BVL Name: KYH1872 (KLHDC2:SelK peptide --- FAK:YHJ1039)	-
34119	117123	23588	-	KLHDC2	HCLP-1|HCLP1|LCP	9606	Homo sapiens	degradation	recruited e3 ligase	Kim Y (2023)	37567174	256416	10978	Bivalent ligand 757	KYH1872/Compound 26|bivalent_ligand_757	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: KYH1872 (KLHDC2:SelK peptide --- CDK4:YHJ1039)	-
34121	117123	23588	-	KLHDC2	HCLP-1|HCLP1|LCP	9606	Homo sapiens	degradation	recruited e3 ligase	Kim Y (2023)	37567174	256416	10978	Bivalent ligand 757	KYH1872/Compound 26|bivalent_ligand_757	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: KYH1872 (KLHDC2:SelK peptide --- CDK6:YHJ1039)	-
34123	117123	23588	-	KLHDC2	HCLP-1|HCLP1|LCP	9606	Homo sapiens	degradation	recruited e3 ligase	Kim Y (2023)	37567174	256416	10978	Bivalent ligand 757	KYH1872/Compound 26|bivalent_ligand_757	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113303	7465	-	WEE1	WEE1A|WEE1hu	9606	Homo sapiens	target	Standardized BVL Name: KYH1872 (KLHDC2:SelK peptide --- WEE1:YHJ1039)	-
34125	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Wen T (2023)	37298935	256429	10979	Bivalent ligand 758	Compound 5|bivalent_ligand_758	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: Compound 5 (cIAP1 :bestatin --- SNCA:sery384)	-
34127	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Yi J (2023)	37291217	253028	10980	Bivalent ligand 759	PU7-1|bivalent_ligand_759	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113622	7874	-	USP7	HAUSP|TEF1	9606	Homo sapiens	target	Standardized BVL Name: PU7-1 (CRBN:lenalidomaide --- USP7:XL-177A)	-
34129	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sun Y (2023)	37279162	256430	10981	Bivalent ligand 760	SP27|bivalent_ligand_760	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	115956	10733	-	PLK4	SAK|STK18	9606	Homo sapiens	target	Standardized BVL Name: SP27 (CRBN:thalidomide --- PLK4:CZS-035)	-
34131	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	degradation	recruited e3 ligase	Pu C (2023)	37276679	256431	10982	Bivalent ligand 761	compound A4|bivalent_ligand_761	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107454	1019	-	CDK4	CMM3|PSK-J3	9606	Homo sapiens	target	Standardized BVL Name: compound A4 (DCAF16:KB02 --- CDK4:Palbociclib)	-
34133	120224	54876	-	DCAF16	C4orf30	9606	Homo sapiens	degradation	recruited e3 ligase	Pu C (2023)	37276679	256431	10982	Bivalent ligand 761	compound A4|bivalent_ligand_761	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107456	1021	-	CDK6	MCPH12|PLSTIRE	9606	Homo sapiens	target	Standardized BVL Name: compound A4 (DCAF16:KB02 --- CDK6:Palbociclib)	-
34135	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Tong Y (2023)	37267712	256432	10983	Bivalent ligand 762	Compound 2b|bivalent_ligand_762	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112506	6622	-	SNCA	NACP|PARK1|PARK4|PD1	9606	Homo sapiens	target	Standardized BVL Name: Compound 2b (CRBN:pomalidomide --- SNCA:sery308)	-
34137	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zahid H (2023)	37260298	256433	10984	Bivalent ligand 763	Compound 8|bivalent_ligand_763	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108481	2186	-	BPTF	FAC1|FALZ|NURF301	9606	Homo sapiens	target	Standardized BVL Name: Compound 8 (CRBN:pomalidomide --- BPTF:TP-238)	-
34139	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zahid H (2023)	37260298	256433	10984	Bivalent ligand 763	Compound 8|bivalent_ligand_763	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	118176	27443	-	CECR2	-	9606	Homo sapiens	target	Standardized BVL Name: Compound 8 (CRBN:pomalidomide --- CECR2:TP-238)	-
34141	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zahid H (2023)	37260298	256433	10985	Bivalent ligand 764	Compound 9|bivalent_ligand_764	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108481	2186	-	BPTF	FAC1|FALZ|NURF301	9606	Homo sapiens	target	Standardized BVL Name: Compound 9 (CRBN:pomalidomide --- BPTF:TP-238)	-
34143	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Cai M (2023)	37257255	256438	10986	Bivalent ligand 765	GDC-22|bivalent_ligand_765	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: GDC-22 (VHL:VHL Ligand --- GPX4:ML162-1)	-
34145	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ma L (2023)	37220310	256439	10987	Bivalent ligand 766	LC-MB12|bivalent_ligand_766	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108554	2263	-	FGFR2	BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25	9606	Homo sapiens	target	Standardized BVL Name: LC-MB12 (CRBN:thalidomide --- FGFR2 :infigratinib)	-
34147	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Guardigni M (2023)	37218653	256440	10988	Bivalent ligand 767	Compound 1|bivalent_ligand_767	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109187	2932	-	GSK3B	-	9606	Homo sapiens	target	Standardized BVL Name: Compound 1 (CRBN:pomalidomide --- GSK3B:SB-216763)	-
34149	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Y (2023)	37196766	256442	10989	Bivalent ligand 768	SIAIS352008|bivalent_ligand_768	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SIAIS352008 (CRBN:lenalidomide --- AAK1:brigatinib)	-
34151	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Y (2023)	37196766	256442	10989	Bivalent ligand 768	SIAIS352008|bivalent_ligand_768	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: SIAIS352008 (CRBN:lenalidomide --- GAK:brigatinib)	-
34153	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Y (2023)	37196766	256442	10989	Bivalent ligand 768	SIAIS352008|bivalent_ligand_768	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SIAIS352008 (CRBN:lenalidomide --- FER:brigatinib)	-
34155	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Y (2023)	37196766	256442	10990	Bivalent ligand 769	SIAIS262039|bivalent_ligand_769	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116520	22848	RP11-427H3.3	AAK1	-	9606	Homo sapiens	target	Standardized BVL Name: SIAIS262039 (CRBN:lenalidomide --- AAK1:brigatinib)	-
34157	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Y (2023)	37196766	256442	10990	Bivalent ligand 769	SIAIS262039|bivalent_ligand_769	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108853	2580	-	GAK	DNAJ26|DNAJC26	9606	Homo sapiens	target	Standardized BVL Name: SIAIS262039 (CRBN:lenalidomide --- GAK:brigatinib)	-
34159	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhang Y (2023)	37196766	256442	10990	Bivalent ligand 769	SIAIS262039|bivalent_ligand_769	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108532	2241	-	FER	FerT|PPP1R74|Pe1Fe10|Pe1Fe13|Pe1Fe3|Pe1Fe6|TYK3	9606	Homo sapiens	target	Standardized BVL Name: SIAIS262039 (CRBN:lenalidomide --- FER:brigatinib)	-
34161	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Li YQ (2023)	37195170	256443	10991	Bivalent ligand 770	PTD10|bivalent_ligand_770	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107160	695	RP1-164F3.2	BTK	AGMX1|AT|ATK|BPK|IMD1|PSCTK1|XLA	9606	Homo sapiens	target	Standardized BVL Name: PTD10 (CRBN:pomalidomide --- BTK:GDC-0853)	-
34163	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhu Z (2023)	37183204	256444	10992	Bivalent ligand 771	UNC9036|bivalent_ligand_771	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	130988	340061	-	TMEM173	ERIS|MITA|MPYS|NET23|SAVI|STING|hMITA|hSTING	9606	Homo sapiens	target	Standardized BVL Name: UNC9036 (VHL:VH032 --- STING:diABZI compound 3)	-
34165	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhu Z (2023)	37183204	256444	10993	Bivalent ligand 772	UNC8899|bivalent_ligand_772	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	130988	340061	-	TMEM173	ERIS|MITA|MPYS|NET23|SAVI|STING|hMITA|hSTING	9606	Homo sapiens	target	Standardized BVL Name: UNC8899 (VHL:VH032 --- STING:diABZI compound 3)	-
34167	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhu Z (2023)	37183204	256444	10994	Bivalent ligand 773	UNC8900|bivalent_ligand_773	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	130988	340061	-	TMEM173	ERIS|MITA|MPYS|NET23|SAVI|STING|hMITA|hSTING	9606	Homo sapiens	target	Standardized BVL Name: UNC8900 (VHL:VH032 --- STING:diABZI compound 3)	-
34169	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Y (2023)	37182514	256445	10995	Bivalent ligand 774	PF|bivalent_ligand_774	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	203183	20371	RP23-54C14.1	Foxp3	JM2|scurfin|sf	10090	Mus musculus	target	Standardized BVL Name: PF (CRBN:pomalidomide --- FoxP3:P60 (FoxP3 binding peptide))	-
34171	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang Y (2023)	37182514	256445	10995	Bivalent ligand 774	PF|bivalent_ligand_774	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119170	50943	JM2	FOXP3	AIID|DIETER|IPEX|PIDX|XPID	9606	Homo sapiens	target	Standardized BVL Name: PF (CRBN:pomalidomide --- FoxP3:P60 (FoxP3 binding peptide))	-
34173	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Cui J (2023)	37175323	256446	10996	Bivalent ligand 775	XR-4|bivalent_ligand_775	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	target	Standardized BVL Name: XR-4 (MDM2:Compound 2 (spiroindolinone pyrrolidinecarboxamide Nutlin-3 derivative) --- MDM2:Compound 2 (spiroindolinone pyrrolidinecarboxamide Nutlin-3 derivative))	-
34175	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie B (2023)	37163809	256447	10997	Bivalent ligand 776	PROTAC 8a|bivalent_ligand_776	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 8a (VHL:VHL ligand --- ESR1:OBHSA)	-
34177	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie B (2023)	37161783	256448	10998	Bivalent ligand 777	ZD12|bivalent_ligand_777	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ZD12 (VHL:VHL ligand --- ESR1:OBHSA)	-
34179	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie B (2023)	37161783	256448	10999	Bivalent ligand 778	ZD11|bivalent_ligand_778	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ZD11 (VHL:VHL ligand --- ESR1:OBHSA)	-
34181	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie B (2023)	37161783	256448	11000	Bivalent ligand 779	ZD8|bivalent_ligand_779	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ZD8 (VHL:VHL ligand --- ESR1:OBHSA)	-
34183	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Xie B (2023)	37161783	256448	11001	Bivalent ligand 780	ZD2|bivalent_ligand_780	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108403	2099	RP1-130E4.1	ESR1	ER|ESR|ESRA|ESTRR|Era|NR3A1	9606	Homo sapiens	target	Standardized BVL Name: ZD2 (VHL:VHL ligand --- ESR1:OBHSA)	-
34185	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Gong L (2023)	37105002	256450	11002	Bivalent ligand 781	AP-1|bivalent_ligand_781	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: AP-1 (CRBN:thalidomide --- ALK:A1)	-
34187	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Tseng YL (2023)	37101169	256451	11003	Bivalent ligand 782	PROTAC 2/JMF4560|bivalent_ligand_782	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117003	23435	RP4-635E18.2	TARDBP	ALS10|TDP-43	9606	Homo sapiens	target	Standardized BVL Name: PROTAC 2/JMF4560 (CRBN:pomalidomide --- TDP43:BTA)	-
34189	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zheng C (2023)	37098297	256452	11004	Bivalent ligand 783	R17|bivalent_ligand_783	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: R17 (CRBN:lenalidomide --- GPX4:RSL3 analogue)	-
34191	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zheng C (2023)	37098297	256452	11005	Bivalent ligand 784	NC-R17|bivalent_ligand_784	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: NC-R17 (CRBN:lenalidomide --- GPX4:RSL3 analogue)	-
34193	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Chen Y (2023)	37094179	256453	11006	Bivalent ligand 785	DeFer-2|bivalent_ligand_785	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	199759	14325	-	Ftl1	Ftl|Ftl-1|L-ferritin	10090	Mus musculus	target	Standardized BVL Name: DeFer-2 (VHL:VH032 --- FTL:oleic acid)	-
34195	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Chen Y (2023)	37094179	256453	11006	Bivalent ligand 785	DeFer-2|bivalent_ligand_785	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	199755	14319	-	Fth1	FHC|Fth|HFt|MFH	10090	Mus musculus	target	Standardized BVL Name: DeFer-2 (VHL:VH032 --- FTH1:oleic acid)	-
34197	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wang H (2023)	37087895	256454	11007	Bivalent ligand 786	DC-2|bivalent_ligand_786	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: DC-2 (CRBN:pomalidomide --- GPX4:ML210)	-
34199	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Tokarski RJ (2023)	37071962	256455	11008	Bivalent ligand 787	Compound 15e|bivalent_ligand_787	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: Compound 15e (CRBN:thalidomide --- CDK9:AT7519)	-
34201	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Tokarski RJ (2023)	37071962	256455	11009	Bivalent ligand 788	Compound 16|bivalent_ligand_788	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: Compound 16 (CRBN:thalidomide --- CDK9:AT7519)	-
34203	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sharma C (2023)	37063743	256456	11010	Bivalent ligand 789	PRO-SIRT2|bivalent_ligand_789	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	116593	22933	-	SIRT2	SIR2|SIR2L|SIR2L2	9606	Homo sapiens	target	Standardized BVL Name: PRO-SIRT2 (CRBN:thalidomide --- SIRT2:Probe 3A)	-
34205	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	degradation	recruited e3 ligase	Wang W (2023)	37002536	256462	11011	Bivalent ligand 790	Compound 13|bivalent_ligand_790	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	SNIPER	Specific and Non-genetic Inhibitor-of-apoptosis proteins (IAPs)-dependent Protein Eraser; structured as IAP ligand--linker--target binding moiety; target degraded via UPS	201282	17133	-	Maff	-	10090	Mus musculus	target	Standardized BVL Name: Compound 13 (cIAP1:bestatin --- MAFF:lathyrol)	-
34207	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Wu Y (2022)	36386476	256471	11012	Bivalent ligand 791	ZCY-PROTAC|bivalent_ligand_791	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	117264	23764	CTA-447C4.1	MAFF	U-MAF|hMafF	9606	Homo sapiens	target	Standardized BVL Name: ZCY-PROTAC (CRBN:thalidomide --- MAFF:lathyrol)	-
34209	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11013	Bivalent ligand 792	hetero-PROTAC 9|bivalent_ligand_792	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 9 (VHL:Me-VHL1 --- cIAP1:CST530)	-
34211	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11013	Bivalent ligand 792	hetero-PROTAC 9|bivalent_ligand_792	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 9 (VHL:Me-VHL1 --- cIAP2:CST530)	-
34213	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11013	Bivalent ligand 792	hetero-PROTAC 9|bivalent_ligand_792	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 9 (VHL:Me-VHL1 --- XIAP:CST530)	-
34215	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11014	Bivalent ligand 793	hetero-PROTAC 25|bivalent_ligand_793	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 25 (CRBN:thalidomide --- cIAP1:CST530)	-
34217	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11014	Bivalent ligand 793	hetero-PROTAC 25|bivalent_ligand_793	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106827	330	-	BIRC3	AIP1|API2|CIAP2|HAIP1|HIAP1|MALT2|MIHC|RNF49|c-IAP2	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 25 (CRBN:thalidomide --- cIAP2:CST530)	-
34219	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11014	Bivalent ligand 793	hetero-PROTAC 25|bivalent_ligand_793	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 25 (CRBN:thalidomide --- XIAP:CST530)	-
34221	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Ng YLD (2023)	36996313	256472	11015	Bivalent ligand 794	hetero-PROTAC 27|bivalent_ligand_794	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106828	331	RP1-315G1.5	XIAP	API3|BIRC4|IAP-3|ILP1|MIHA|XLP2|hIAP-3|hIAP3	9606	Homo sapiens	target	Standardized BVL Name: hetero-PROTAC 27 (CRBN:thalidomide --- XIAP:CST530)	-
34223	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Dong J (2023)	36973833	256473	11016	Bivalent ligand 795	DU-14|bivalent_ligand_795	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111736	5770	-	PTPN1	PTP1B	9606	Homo sapiens	target	Standardized BVL Name: DU-14 (VHL:(S,R,S)-AHPC-Me --- PTP1B:DI-03)	-
34225	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Dong J (2023)	36973833	256473	11016	Bivalent ligand 795	DU-14|bivalent_ligand_795	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111737	5771	-	PTPN2	PTN2|PTPT|TC-PTP|TCELLPTP|TCPTP	9606	Homo sapiens	target	Standardized BVL Name: DU-14 (VHL:(S,R,S)-AHPC-Me --- TC-PTP:DI-03)	-
34227	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Son SH (2023)	36968534	256474	11017	Bivalent ligand 796	PRZ-18002|bivalent_ligand_796	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: PRZ-18002 (CRBN:pomalidomide --- MAPK14:p-p38 ligand)	-
34229	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou D (2023)	36959108	256475	11018	Bivalent ligand 797	Compound 28|bivalent_ligand_797	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109907	3702	-	ITK	EMT|LPFS1|LYK|PSCTK2	9606	Homo sapiens	target	Standardized BVL Name: Compound 28 (CRBN:pomalidomide --- ITK:GNE-9822)	-
34231	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Sohbati H (2022)	36942064	256498	11019	Bivalent ligand 798	compound 2|bivalent_ligand_798	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109827	3614	-	IMPDH1	IMPD|IMPD1|LCA11|RP10|sWSS2608	9606	Homo sapiens	target	Standardized BVL Name: compound 2 (CRBN:pomalidomide --- IMPDH:mycophenolic acid)	-
34233	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhu L (2023)	36924654	256499	11020	Bivalent ligand 799	PD-4|bivalent_ligand_799	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: PD-4 (CRBN:pomalidomide --- GPX4:ML-162)	-
34235	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Zhu L (2023)	36924654	256499	11021	Bivalent ligand 819	PD-P2|bivalent_ligand_819	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	target	Standardized BVL Name: PD-P2 (CRBN:pomalidomide --- GPX4:ML-162)	-
34237	110358	4193	-	MDM2	ACTFS|HDMX|hdm2	9606	Homo sapiens	degradation	recruited e3 ligase	Chang M (2022)	36910255	256500	11022	Bivalent ligand 800	BMM4|bivalent_ligand_800	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107070	598	RP5-857M17.3	BCL2L1	BCL-XL/S|BCL2L|BCLX|BCLXL|BCLXS|Bcl-X|PPP1R52|bcl-xL|bcl-xS	9606	Homo sapiens	target	Standardized BVL Name: BMM4 (MDM2:Nutlin-3 --- BCL-XL:ABT-263)	-
34239	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cheng W (2023)	36906965	256503	11023	Bivalent ligand 801	ha-PROTAC 9|bivalent_ligand_801	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: ha-PROTAC 9 (CRBN:HALG-lenalidomide --- EGFRDel19:target ligand)	-
34241	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cheng W (2023)	36906965	256503	11024	Bivalent ligand 802	ha-PROTAC 10|bivalent_ligand_802	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	108276	1956	-	EGFR	ERBB|ERBB1|HER1|NISBD2|PIG61|mENA	9606	Homo sapiens	target	Standardized BVL Name: ha-PROTAC 10 (CRBN:HALG-lenalidomide --- EGFRDel19:target ligand)	-
34243	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Teng M (2023)	36898968	256504	11025	Bivalent ligand 803	TMX-4153|bivalent_ligand_803	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	122928	79837	-	PIP4K2C	PIP5K2C	9606	Homo sapiens	target	Standardized BVL Name: TMX-4153 (VHL:VHL ligand --- PIP4K2C:TMX-4140 )	-
34245	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Zhou Z (2023)	36897932	256505	11026	Bivalent ligand 804	ZZ151|bivalent_ligand_804	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112537	6654	-	SOS1	GF1|GGF1|GINGF|HGF|NS4	9606	Homo sapiens	target	Standardized BVL Name: ZZ151 (VHL:VHL ligand --- SOS1:BI-3406)	-
34247	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jarusiewicz JA (2023)	36793425	256510	11027	Bivalent ligand 805	SJ34739/PD-PROTAC 2|bivalent_ligand_805	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SJ34739/PD-PROTAC 2 (CRBN:phenyl dihydrouracil (PD) --- LCK:dasatinib)	-
34249	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jarusiewicz JA (2023)	36793425	256510	11028	Bivalent ligand 806	SJ42176/thal-PROTAC 3|bivalent_ligand_806	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SJ42176/thal-PROTAC 3 (CRBN:thalidamide) --- LCK:dasatinib)	-
34251	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jarusiewicz JA (2023)	36793425	256510	11029	Bivalent ligand 807	SJ34769/PG-PROTAC 4|bivalent_ligand_807	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SJ34769/PG-PROTAC 4 (CRBN:phenyl glutarimide (PG) --- LCK:dasatinib)	-
34253	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Jarusiewicz JA (2023)	36793425	256510	11030	Bivalent ligand 808	SJ43489/PD-PROTAC 5|bivalent_ligand_808	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SJ43489/PD-PROTAC 5 (CRBN:phenyl dihydrouracil (PD) --- LCK:dasatinib)	-
34255	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2022)	36001679	256518	11031	Bivalent ligand 809	SJ11646|bivalent_ligand_809	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110124	3932	RP4-675E8.4	LCK	IMD22|LSK|YT16|p56lck|pp58lck	9606	Homo sapiens	target	Standardized BVL Name: SJ11646 (CRBN:phenyl glutarimide (PG) --- LCK:dasatinib)	-
34257	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2022)	36001679	256518	11031	Bivalent ligand 809	SJ11646|bivalent_ligand_809	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107832	1445	-	CSK	-	9606	Homo sapiens	target	Standardized BVL Name: SJ11646 (CRBN:phenyl glutarimide (PG) --- CSK:dasatinib)	-
34259	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Hu J (2022)	36001679	256518	11031	Bivalent ligand 809	SJ11646|bivalent_ligand_809	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112592	6714	RP5-823N20.1	SRC	ASV|SRC1|c-SRC|p60-Src	9606	Homo sapiens	target	Standardized BVL Name: SJ11646 (CRBN:phenyl glutarimide (PG) --- SRC:dasatinib)	-
34261	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Cubillos-Rojas M (2023)	36765568	256520	11032	Bivalent ligand 810	NR-11c|bivalent_ligand_810	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107819	1432	RP1-179N16.5	MAPK14	CSBP|CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA	9606	Homo sapiens	target	Standardized BVL Name: NR-11c (VHL:VHL ligand --- MAPK14:PH-797804)	-
34263	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Pei J (2023)	36750097	256521	11033	Bivalent ligand 811	Conjugate 955|bivalent_ligand_811	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107459	1025	RP11-228B15.5	CDK9	C-2k|CDC2L4|CTK1|PITALRE|TAK	9606	Homo sapiens	target	Standardized BVL Name: Conjugate 955 (KEAP1:piperlongumine (PL) --- CDK9:SNS-032)	-
34265	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Pei J (2023)	36750097	256521	11033	Bivalent ligand 811	Conjugate 955|bivalent_ligand_811	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114128	8558	-	CDK10	PISSLRE	9606	Homo sapiens	target	Standardized BVL Name: Conjugate 955 (KEAP1:piperlongumine (PL) --- CDK10:SNS-032)	-
34267	115156	9817	-	KEAP1	INrf2|KLHL19	9606	Homo sapiens	degradation	recruited e3 ligase	Pei J (2023)	36750097	256521	11034	Bivalent ligand 812	Conjugate 819|bivalent_ligand_812	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106739	238	-	ALK	CD246|NBLST3	9606	Homo sapiens	target	Standardized BVL Name: Conjugate 819 (KEAP1:piperlongumine (PL) --- EML4-ALK:ceritinib)	-
34269	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Park KS (2023)	36737841	256522	11035	Bivalent ligand 813	MS147|bivalent_ligand_813	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107116	648	RP11-573G6.1	BMI1	FLVI2/BMI1|PCGF4|RNF51	9606	Homo sapiens	target	Standardized BVL Name: MS147 (VHL:VHL1 --- BMI1:EED226)	-
34271	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Park KS (2023)	36737841	256522	11035	Bivalent ligand 813	MS147|bivalent_ligand_813	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	111972	6045	GS1-120K12.1	RNF2	BAP-1|BAP1|DING|HIPI3|RING1B|RING2	9606	Homo sapiens	target	Standardized BVL Name: MS147 (VHL:VHL1 --- RING1B:EED226)	-
34273	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	degradation	recruited e3 ligase	Park KS (2023)	36737841	256522	11035	Bivalent ligand 813	MS147|bivalent_ligand_813	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	114265	8726	-	EED	HEED|WAIT1	9606	Homo sapiens	target	Standardized BVL Name: MS147 (VHL:VHL1 --- EED:EED226)	-
34275	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kaneshige A (2023)	36735833	256523	11036	Bivalent ligand 814	AK-2292|bivalent_ligand_814	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112653	6776	-	STAT5A	MGF|STAT5	9606	Homo sapiens	target	Standardized BVL Name: AK-2292 (CRBN:lenalidomide analogue --- STAT5A:phosphotyrosine mimetic STAT5/6 inhibitor 12)	-
34277	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Kaneshige A (2023)	36735833	256523	11036	Bivalent ligand 814	AK-2292|bivalent_ligand_814	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	112654	6777	-	STAT5B	STAT5	9606	Homo sapiens	target	Standardized BVL Name: AK-2292 (CRBN:lenalidomide analogue --- STAT5B:phosphotyrosine mimetic STAT5/6 inhibitor 12)	-
34279	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	O'Herin CB (2023)	36735827	256525	11037	Bivalent ligand 815	Degrader 11|bivalent_ligand_815	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107215	760	-	CA2	CA-II|CAC|CAII|Car2|HEL-76	9606	Homo sapiens	target	Standardized BVL Name: Degrader 11 (CRBN:pomalidomide --- CA2:p-sulfamoyl benzamide metal binding pharmacophore (MBP) moiety)	-
34281	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	He R (2023)	36695404	256526	11038	Bivalent ligand 816	compound 6n|bivalent_ligand_816	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	107036	558	-	AXL	ARK|JTK11|Tyro7|UFO	9606	Homo sapiens	target	Standardized BVL Name: compound 6n (CRBN:lenalidomide --- AXL:HH30134 analogue 9im)	-
34283	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Chen JJ (2023)	36692137	256527	11039	Bivalent ligand 817	PRO-6 E|bivalent_ligand_817	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	110391	4233	-	MET	AUTS9|HGFR|RCCP2|c-Met	9606	Homo sapiens	target	Standardized BVL Name: PRO-6 E (CRBN:pomalidomide --- MET:Crizotinib)	-
34285	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	degradation	recruited e3 ligase	Cruite JT (2022)	36128501	256671	11040	Bivalent ligand 818	EM12-FS|bivalent_ligand_818	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	Molecular Glue	Single chemical moiety that contacts both the E3 and the target in a ternary complex; structured as a single chemical entity without linkers; target degraded via UPS or otherwise inactivated in the ternary complex	120405	55093	-	WDYHV1	C8orf32	9606	Homo sapiens	target	Standardized BVL Name: EM12-FS (CRBN:EM12-FS --- NTAQ1:EM12-FS)	-
